FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Greaves, LC
   Elson, JL
   Nooteboom, M
   Grady, JP
   Taylor, GA
   Taylor, RW
   Mathers, JC
   Kirkwood, TBL
   Turnbull, DM
AF Greaves, Laura C.
   Elson, Joanna L.
   Nooteboom, Marco
   Grady, John P.
   Taylor, Geoffrey A.
   Taylor, Robert W.
   Mathers, John C.
   Kirkwood, Thomas B. L.
   Turnbull, Doug M.
TI Comparison of Mitochondrial Mutation Spectra in Ageing Human Colonic
   Epithelium and Disease: Absence of Evidence for Purifying Selection in
   Somatic Mitochondrial DNA Point Mutations
SO PLOS GENETICS
LA English
DT Article
ID SUBSTANTIA-NIGRA NEURONS; AMINO-ACID SUBSTITUTIONS; CYTOCHROME-B GENE;
   STEM-CELLS; EXERCISE INTOLERANCE; RESPIRATORY-CHAIN; HUMAN LIVER;
   DELETIONS; MICE; AGE
AB Human ageing has been predicted to be caused by the accumulation of molecular damage in cells and tissues. Somatic mitochondrial DNA (mtDNA) mutations have been documented in a number of ageing tissues and have been shown to be associated with cellular mitochondrial dysfunction. It is unknown whether there are selective constraints, which have been shown to occur in the germline, on the occurrence and expansion of these mtDNA mutations within individual somatic cells. Here we compared the pattern and spectrum of mutations observed in ageing human colon to those observed in the general population (germline variants) and those associated with primary mtDNA disease. The pathogenicity of the protein encoding mutations was predicted using a computational programme, MutPred, and the scores obtained for the three groups compared. We show that the mutations associated with ageing are randomly distributed throughout the genome, are more frequently non-synonymous or frameshift mutations than the general population, and are significantly more pathogenic than population variants. Mutations associated with primary mtDNA disease were significantly more pathogenic than ageing or population mutations. These data provide little evidence for any selective constraints on the occurrence and expansion of mtDNA mutations in somatic cells of the human colon during human ageing in contrast to germline mutations seen in the general population.
C1 [Greaves, Laura C.; Mathers, John C.; Kirkwood, Thomas B. L.; Turnbull, Doug M.] Newcastle Univ, Inst Ageing & Hlth, Ctr Brain Ageing & Vital, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Greaves, Laura C.; Nooteboom, Marco; Grady, John P.; Taylor, Geoffrey A.; Taylor, Robert W.; Turnbull, Doug M.] Newcastle Univ, Inst Ageing & Hlth, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Elson, Joanna L.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Mathers, John C.] Inst Ageing & Hlth, Human Nutr Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle
   University - UK; Newcastle University - UK
RP Greaves, LC (corresponding author), Newcastle Univ, Inst Ageing & Hlth, Ctr Brain Ageing & Vital, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
EM laura.greaves@ncl.ac.uk
OI Mathers, John/0000-0003-3406-3002; Greaves, Laura/0000-0002-8071-5916;
   /0000-0002-3551-5624; Grady, John/0000-0001-9667-3872; Turnbull,
   Doug/0000-0002-8878-9901
FU Newcastle University Centre for Brain Ageing and Vitality; BBSRC; EPSRC;
   ESRC; MRC as part of the cross-Council Lifelong Health and Wellbeing
   Initiative [G0700718]; Food Standards Agency [N12015]; Wellcome Trust
   Centre for Mitochondrial Research [906919]; MRC [MC_G0802536, G0700718,
   G0800674] Funding Source: UKRI; Medical Research Council [G0700718B,
   G0700718, G0800674, MC_G0802536] Funding Source: researchfish; National
   Institute for Health Research [NF-SI-0508-10260] Funding Source:
   researchfish
FX This work was supported by the Newcastle University Centre for Brain
   Ageing and Vitality supported by BBSRC, EPSRC, ESRC, and MRC as part of
   the cross-Council Lifelong Health and Wellbeing Initiative (G0700718),
   the Food Standards Agency [N12015], and the Wellcome Trust Centre for
   Mitochondrial Research (906919). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Acin-Pérez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021
   Alston CL, 2010, NEUROMUSCULAR DISORD, V20, P131, DOI 10.1016/j.nmd.2009.10.010
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Blackwood JK, 2011, J PATHOL, V225, P181, DOI 10.1002/path.2965
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   Brierley EJ, 1997, REV CLIN GERONTOL, V7, P95
   Bruno C, 2003, MUSCLE NERVE, V28, P508, DOI 10.1002/mus.10429
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Cottrell DA, 2001, NEUROBIOL AGING, V22, P265, DOI 10.1016/S0197-4580(00)00234-7
   Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63
   De Alwis N, 2009, HEPATOLOGY, V50, P992, DOI 10.1002/hep.23160
   Downham E, 2008, NEUROMUSCULAR DISORD, V18, P310, DOI 10.1016/j.nmd.2008.01.003
   Elson JL, 2004, AM J HUM GENET, V74, P229, DOI 10.1086/381505
   Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801
   Elson JL, 2001, AM J HUM GENET, V68, P145, DOI 10.1086/316938
   Elson JL, 2009, HUM MUTAT, V30, pE984, DOI 10.1002/humu.21113
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Fellous TG, 2009, STEM CELLS, V27, P1410, DOI 10.1002/stem.67
   Fellous TG, 2009, HEPATOLOGY, V49, P1655, DOI 10.1002/hep.22791
   Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017
   Fragaki K, 2009, MITOCHONDRION, V9, P346, DOI 10.1016/j.mito.2009.06.002
   Gaisa NT, 2011, J PATHOL, V225, P163, DOI 10.1002/path.2945
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Greaves LC, 2010, EXP GERONTOL, V45, P573, DOI 10.1016/j.exger.2010.01.013
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   Gutierrez-Gonzalez L, 2009, J PATHOL, V217, P489, DOI 10.1002/path.2502
   HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686
   Hinttala R, 2006, J MED GENET, V43, P881, DOI 10.1136/jmg.2006.042168
   Hornig-Do HT, 2012, EMBO J, V31, P1293, DOI 10.1038/emboj.2011.477
   Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93
   Khrapko K, 2011, NAT GENET, V43, P726, DOI 10.1038/ng.895
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0
   Kirkwood TBL, 2011, CURR BIOL, V21, pR701, DOI 10.1016/j.cub.2011.07.020
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   Lee HC, 2010, AGEING RES REV, V9, pS47, DOI 10.1016/j.arr.2010.08.009
   Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Marotta R, 2011, J CLIN NEUROSCI, V18, P290, DOI 10.1016/j.jocn.2010.06.001
   Mcdonald SAC, 2008, GASTROENTEROLOGY, V134, P500, DOI 10.1053/j.gastro.2007.11.035
   McFarland R, 2007, CURR TOP DEV BIOL, V77, P113, DOI 10.1016/S0070-2153(06)77005-3
   Mitchell AL, 2006, J MED GENET, V43, P175, DOI 10.1136/jmg.2005.032474
   MITOMAP, 2011, MITOMAP HUMAN MITOCH
   MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510X(90)90006-9
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   NASS MMK, 1966, P NATL ACAD SCI USA, V56, P1215, DOI 10.1073/pnas.56.4.1215
   Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509
   Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Pereira L, 2011, AM J HUM GENET, V88, P433, DOI 10.1016/j.ajhg.2011.03.006
   Rana M, 2000, ANN NEUROL, V48, P774, DOI 10.1002/1531-8249(200011)48:5<774::AID-ANA11>3.0.CO;2-I
   Rand DM, 2008, PLOS BIOL, V6, P229, DOI 10.1371/journal.pbio.0060035
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Schägger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777
   Shin MG, 2004, BLOOD, V103, P553, DOI 10.1182/blood-2003-05-1724
   Shoubridge EA, 2008, SCIENCE, V319, P914, DOI 10.1126/science.1154515
   Shoubridge EA, 2007, CURR TOP DEV BIOL, V77, P87, DOI 10.1016/S0070-2153(06)77004-1
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Sun C, 2007, GENOMICS, V89, P338, DOI 10.1016/j.ygeno.2006.11.005
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Troen BR, 2003, MT SINAI J MED, V70, P3
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258
   Wong LJC, 2007, MUSCLE NERVE, V36, P279, DOI 10.1002/mus.20807
   Yao YG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000681
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
NR 75
TC 55
Z9 61
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7404
J9 PLOS GENET
JI PLoS Genet.
PD NOV
PY 2012
VL 8
IS 11
AR e1003082
DI 10.1371/journal.pgen.1003082
PG 10
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 048DY
UT WOS:000311891600062
PM 23166522
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Bonelli, MA
   Desenzani, S
   Cavallini, G
   Donati, A
   Romani, AA
   Bergamini, E
   Borghetti, AF
AF Bonelli, Mara A.
   Desenzani, Silvia
   Cavallini, Gabriella
   Donati, Alessio
   Romani, Antonello A.
   Bergamini, Ettore
   Borghetti, Angelo F.
TI Low-level caloric restriction rescues proteasome activity and Hsc70
   level in liver of aged rats
SO BIOGERONTOLOGY
LA English
DT Article
DE aging; caloric restriction; Hsc70; liver; proteasome
ID ONSET DIETARY RESTRICTION; HEAT-SHOCK PROTEINS; MOLECULAR CHAPERONES;
   LIFE-SPAN; HUMAN FIBROBLASTS; OXIDATIVE STRESS; AGING PROCESS;
   DEGRADATION; ACCUMULATION; PROTEOLYSIS
AB Proteasome activity is known to decrease with aging in ad libitum (AL) fed rats. Severe caloric restriction (CR) significantly extends the maximum life-span of rats, and counteracts the age-associated decrease in liver proteasome activities. Since few investigations have explored whether lower CR diets might positively counteract the age associated decrease in proteasome activity, we then investigated the effects of a mild CR regimen on animal life-span, proteasome content and function. In addition, we addressed the question whether both CR regimens might also affect the expression of Hsc70 protein, a constitutive chaperone reported to share a role in the function of proteasome complex and in the repair of proteotoxic damage, and whose level decreased during aging. In contrast to severe CR, mild CR had a poor effect on life-span; however, it better counteracted the decrease of proteasome activities. Both regimens, however, maintain Hsc70 in liver of old rats at level comparable to that of young rats. Interestingly, the effects of aging and CRs on liver proteasome enzyme activities did not appear to be associated with parallel changes in the amount of proteasome proteins suggesting that the quality (molecular activity of the enzymes) rather than the quantity are likely to be modified with age. In conclusion, the results presented in this work show that a mild CR can have beneficial effects on liver function of aging rats because is adequate to counteract the decrease of proteasome function and Hsc70 chaperone level.
C1 [Bonelli, Mara A.; Desenzani, Silvia; Romani, Antonello A.; Borghetti, Angelo F.] Univ Parma, Sez Patol Mol & Immunol, Dipartimento Med Sperimentale, I-43100 Parma, Italy.
   [Cavallini, Gabriella; Donati, Alessio; Bergamini, Ettore] Univ Pisa, Dipartimento Patol Sperimentale, I-56126 Pisa, Italy.
C3 University of Parma; University of Pisa
RP Borghetti, AF (corresponding author), Univ Parma, Sez Patol Mol & Immunol, Dipartimento Med Sperimentale, Via Volturno 39, I-43100 Parma, Italy.
EM angelo.borghetti@unipr.it
CR Arslan MA, 2006, BIOGERONTOLOGY, V7, P383, DOI 10.1007/s10522-006-9053-7
   Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010
   Bergamini E, 2004, INT J BIOCHEM CELL B, V36, P2392, DOI 10.1016/j.biocel.2004.05.007
   Berrigan D, 2002, CARCINOGENESIS, V23, P817, DOI 10.1093/carcin/23.5.817
   Bokov A, 2004, MECH AGEING DEV, V125, P811, DOI 10.1016/j.mad.2004.07.009
   Bonelli MA, 2004, EXP GERONTOL, V39, P423, DOI 10.1016/j.exger.2003.12.004
   Bonelli MA, 2001, EXP CELL RES, V267, P165, DOI 10.1006/excr.2001.5237
   Bulteau AL, 2000, EXP GERONTOL, V35, P767, DOI 10.1016/S0531-5565(00)00136-4
   Carrard G, 2002, INT J BIOCHEM CELL B, V34, P1461, DOI 10.1016/S1357-2725(02)00085-7
   Cavallini G, 2002, AGING CLIN EXP RES, V14, P152
   Chen QH, 2006, FREE RADICAL BIO MED, V40, P120, DOI 10.1016/j.freeradbiomed.2005.08.048
   Chondrogianni N, 2005, EXP GERONTOL, V40, P931, DOI 10.1016/j.exger.2005.09.004
   Chondrogianni N, 2003, J BIOL CHEM, V278, P28026, DOI 10.1074/jbc.M301048200
   Chondrogianni N, 2002, BIOGERONTOLOGY, V3, P121, DOI 10.1023/A:1015236203379
   Chondrogianni N, 2007, EXP GERONTOL, V42, P899, DOI 10.1016/j.exger.2007.01.012
   Conconi M, 1997, MOL BIOL REP, V24, P45, DOI 10.1023/A:1006852506884
   Conconi M, 1996, ARCH BIOCHEM BIOPHYS, V331, P232, DOI 10.1006/abbi.1996.0303
   Cuervo AM, 2000, EXP GERONTOL, V35, P119, DOI 10.1016/S0531-5565(00)00075-9
   Duffy PH, 2001, AGING-CLIN EXP RES, V13, P263
   Esser C, 2004, BBA-MOL CELL RES, V1695, P171, DOI 10.1016/j.bbamcr.2004.09.020
   Fernandes G, 1997, J CLIN IMMUNOL, V17, P85, DOI 10.1023/A:1027344730553
   Gaczynska M, 2001, MECH AGEING DEV, V122, P235, DOI 10.1016/S0047-6374(00)00246-3
   Garrido C, 2003, CELL DEATH DIFFER, V10, P619, DOI 10.1038/sj.cdd.4401229
   Gonzalez-Dosal R, 2006, ANN NY ACAD SCI, V1067, P474, DOI 10.1196/annals.1354.068
   GOODRICK CL, 1983, J GERONTOL, V38, P36, DOI 10.1093/geronj/38.1.36
   Goto S, 2002, ANN NY ACAD SCI, V959, P50, DOI 10.1111/j.1749-6632.2002.tb02082.x
   Goto S, 2001, ANN NY ACAD SCI, V928, P54
   Goto S, 2007, ANN NY ACAD SCI, V1100, P431, DOI 10.1196/annals.1395.048
   Greenwald P, 2001, EUR J CANCER, V37, P948, DOI 10.1016/S0959-8049(01)00070-3
   Grune T, 2001, J GERONTOL A-BIOL, V56, pB459, DOI 10.1093/gerona/56.11.B459
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0
   Hayashi T, 1998, MECH AGEING DEV, V102, P55, DOI 10.1016/S0047-6374(98)00011-6
   Hipkiss AR, 2007, MECH AGEING DEV, V128, P412, DOI 10.1016/j.mad.2007.03.002
   Hipkiss AR, 2006, EXP GERONTOL, V41, P464, DOI 10.1016/j.exger.2006.03.004
   HOLLIDAY R, 1996, UNDERSTANDING AGEING
   Kavazis AN, 2007, EXP PHYSIOL, V92, P895, DOI 10.1113/expphysiol.2007.038307
   Keller JN, 2000, MECH AGEING DEV, V113, P61, DOI 10.1016/S0047-6374(99)00101-3
   Lee DH, 1998, MOL CELL BIOL, V18, P30, DOI 10.1128/MCB.18.1.30
   Lüders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613
   Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X
   McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2
   Merker K, 2001, MECH AGEING DEV, V122, P595, DOI 10.1016/S0047-6374(01)00219-6
   Nardai G, 2002, EXP GERONTOL, V37, P1257, DOI 10.1016/S0531-5565(02)00134-1
   PETRONINI PG, 1993, BRIT J CANCER, V67, P493, DOI 10.1038/bjc.1993.92
   PETRONINI PG, 1989, J CELL PHYSIOL, V140, P202, DOI 10.1002/jcp.1041400203
   Radák Z, 2002, EXP GERONTOL, V37, P1423, DOI 10.1016/S0531-5565(02)00116-X
   Rattan SIS, 2004, MECH AGEING DEV, V125, P285, DOI 10.1016/j.mad.2004.01.006
   Roth GS, 2002, SCIENCE, V297, P811, DOI 10.1126/science.1071851
   Schmidtke G, 1997, J MOL BIOL, V268, P95, DOI 10.1006/jmbi.1997.0947
   Selsby JT, 2005, EXP GERONTOL, V40, P37, DOI 10.1016/j.exger.2004.08.012
   SHIBATANI T, 1996, J GERONTOL BIOL SCI, V51, P316
   Sitte N, 2000, FREE RADICAL BIO MED, V28, P701, DOI 10.1016/S0891-5849(99)00279-8
   Soti C, 2003, EXP GERONTOL, V38, P1037, DOI 10.1016/S0531-5565(03)00185-2
   Soti C, 2002, CELL STRESS CHAPERON, V7, P186, DOI 10.1379/1466-1268(2002)007<0186:CCOA>2.0.CO;2
   STARKEREED PE, 1989, ARCH BIOCHEM BIOPHYS, V275, P559, DOI 10.1016/0003-9861(89)90402-5
   Syntichaki P, 2007, NATURE, V445, P922, DOI 10.1038/nature05603
   Tavernarakis N, 2002, MECH AGEING DEV, V123, P215, DOI 10.1016/S0047-6374(01)00341-4
   Tavernarakis N, 2007, CELL CYCLE, V6, P1168, DOI 10.4161/cc.6.10.4230
   Vittorini S, 1999, J GERONTOL A-BIOL, V54, pB318, DOI 10.1093/gerona/54.8.B318
   Ward WF, 2000, BIOGERONTOLOGY, V1, P195, DOI 10.1023/A:1010076818119
NR 61
TC 29
Z9 30
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 1389-5729
J9 BIOGERONTOLOGY
JI Biogerontology
PD FEB
PY 2008
VL 9
IS 1
BP 1
EP 10
DI 10.1007/s10522-007-9111-9
PG 10
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 248MD
UT WOS:000252156500001
PM 17902036
DA 2024-02-19
ER

PT J
AU Imre, S
   Firbas, JH
   Noble, RC
AF Imre, S
   Firbas, JH
   Noble, RC
TI Reduced lipid peroxidation capacity and desaturation as biochemical
   markers of aging
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
DE lipid peroxidation; liver; mouse; polyunsaturated fatty acids
ID FATTY-ACID COMPOSITION; RAT-LIVER MICROSOMES; AGE-RELATED-CHANGES;
   SUPEROXIDE-DISMUTASE; MICE
AB The lipid peroxidation capacity, the lipid composition and the fatty acid composition of the major lipid fractions have been compared in the liver tissue of mice at different ages. Compared with mice at 2 months of age, there was a notable reduction in peroxidation capacity in the livers of mice at 12 and 26 months of age. These observations were associated with changes in the proportions of the major C18, C20 and C22 polyunsaturated fatty acids expressed in all the major lipid fractions and were accompanied by alterations in lipid composition. From the relationship between these features it is suggested that, under in vivo conditions, regulation of the aging processes may be intimately related to the metabolism of the polyunsaturated fatty acids and associated aspects of lipid metabolism. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
C1 Univ Debrecen, Sch Med, Inst Pathophysiol, H-4012 Debrecen, Hungary.
   Scottish Agr Coll, Dept Biochem Sci, Auchincruive KA6 5HW, Ayr, Scotland.
C3 University of Debrecen; Scottish Agricultural College
RP Imre, S (corresponding author), Univ Debrecen, Sch Med, Inst Pathophysiol, POB 23, H-4012 Debrecen, Hungary.
EM simre@jaguar.dote.hu
CR BARRETT MC, 1975, BIOCHEM SOC T, V3, P124, DOI 10.1042/bst0030124
   BORDONI A, 1988, BIOCHEM INT, V17, P1001
   CHRISTIE WW, 1970, ANALYST, V95, P940, DOI 10.1039/an9709500940
   CHRISTIE WW, 1984, FOOD CONSTITUENTS FO, P1
   CUTLER RG, 1985, P NATL ACAD SCI USA, V82, P4798, DOI 10.1073/pnas.82.14.4798
   GRINNA LS, 1977, MECH AGEING DEV, V6, P197, DOI 10.1016/0047-6374(77)90021-5
   GURR MI, 1969, EUR J BIOCHEM, V9, P70, DOI 10.1111/j.1432-1033.1969.tb00577.x
   HALL DA, 1975, BIOCHEM SOC T, V3, P42
   Harman D., 1986, FREE RADICALS AGING, P3
   HAWCROFT DM, 1974, MECH AGEING DEV, V3, P121, DOI 10.1016/0047-6374(74)90010-4
   HRELIA S, 1989, BIOCHEM BIOPH RES CO, V163, P348, DOI 10.1016/0006-291X(89)92142-6
   HUNTER FE, 1963, J BIOL CHEM, V238, P828
   IMRE S, 1987, MECH AGEING DEV, V38, P259, DOI 10.1016/0047-6374(87)90094-7
   IMRE S, 1990, RADICALS, IONS AND TISSUE DAMAGE, P101
   IMRE S, 1984, MECH AGEING DEV, V28, P297, DOI 10.1016/0047-6374(84)90030-7
   MEAD JF, 1986, LIPIDS CHEM BIOCH NU, P133
   PELUFFO RO, 1974, J NUTR, V104, P894, DOI 10.1093/jn/104.7.894
   SHAND JH, 1980, ANAL BIOCHEM, V101, P894
   STOCKS J, 1974, CLIN SCI MOL MED, V47, P215, DOI 10.1042/cs0470215
   TOLMASOFF JM, 1980, P NATL ACAD SCI-BIOL, V77, P2777, DOI 10.1073/pnas.77.5.2777
   ULMANN L, 1991, LIPIDS, V26, P127, DOI 10.1007/BF02544006
NR 21
TC 13
Z9 14
U1 0
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-4943
EI 1872-6976
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PD JUL-AUG
PY 2000
VL 31
IS 1
BP 5
EP 12
DI 10.1016/S0167-4943(00)00058-3
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 357PM
UT WOS:000089510100002
PM 10989158
DA 2024-02-19
ER

PT J
AU Vidal, K
   Breuillé, D
   Serrant, P
   Denis, P
   Glomot, F
   Béchereau, F
   Papet, I
AF Vidal, Karine
   Breuille, Denis
   Serrant, Patrick
   Denis, Philippe
   Glomot, Francoise
   Bechereau, Fabienne
   Papet, Isabelle
TI Long-term cysteine fortification impacts cysteine/glutathione
   homeostasis and food intake in ageing rats
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Ageing rats; Dietary cysteine; Frailty; Low-grade inflammation
ID OXIDATIVE STRESS; N-ACETYLCYSTEINE; GLUTATHIONE; SUPPLEMENTATION;
   MORTALITY; BRAIN; AGE; INTERLEUKIN-6; DEFICIENCY; METABOLISM
AB Healthy ageing is associated with higher levels of glutathione. The study aimed to determine whether long-term dietary fortification with cysteine increases cysteine and glutathione pools, thus alleviating age-associated low-grade inflammation and resulting in global physiological benefits.
   The effect of a 14-week dietary fortification with cysteine was studied in non-inflamed (NI, healthy at baseline) and in spontaneously age-related low-grade inflamed (LGI, prefrail at baseline) 21-month-old rats. Fifty-seven NI rats and 14 LGI rats received cysteine-supplemented diet (4.0 g/kg of free cysteine added to the standard diet containing 2.8 g/kg cysteine). Fifty-six NI rats and 16 LGI rats received a control alanine-supplemented diet.
   Cysteine fortification in NI rats increased free cysteine (P < 0.0001) and glutathione (P < 0.03) in the liver and the small intestine. In LGI rats, cysteine fortification increased total non-protein cysteine (P < 0.0007) and free cysteine (P < 0.03) in plasma, and free cysteine (P < 0.02) and glutathione (P < 0.01) in liver. Food intake decreased over time in alanine-fed rats (r (2) = 0.73, P = 0.0002), whereas it was constant in cysteine-fed rats (r (2) = 0.02, P = 0.68). Cysteine fortification did not affect inflammatory markers, mortality, body weight loss, or tissue masses.
   Doubling the dietary intake of cysteine in old rats increased cysteine and glutathione pools in selected tissues. Additionally, it alleviated the age-related decline in food intake. Further validation of these effects in the elderly population suffering from age-related anorexia would suggest a useful therapeutic approach to the problem.
C1 [Vidal, Karine; Breuille, Denis; Serrant, Patrick] Nestle Res Ctr, Dept Nutr & Hlth, CH-10000 Lausanne 26, Switzerland.
   [Denis, Philippe; Glomot, Francoise; Bechereau, Fabienne; Papet, Isabelle] INRA, UNH, UMR 1019, CRNH Auvergne, F-63000 Clermont Ferrand, France.
   [Denis, Philippe; Glomot, Francoise; Bechereau, Fabienne; Papet, Isabelle] Univ Auvergne, Clermont Univ, Unite Nutr Humaine, F-63000 Clermont Ferrand, France.
C3 Nestle SA; INRAE; Universite Clermont Auvergne (UCA)
RP Papet, I (corresponding author), INRA, UNH, UMR 1019, CRNH Auvergne, BP 10448, F-63000 Clermont Ferrand, France.
EM Isabelle.Papet@clermont.inra.fr
FU Institut National de la Recherche Agronomique (INRA), France; Nestle,
   Switzerland
FX The authors would like to acknowledge Marie Perrot for help in the
   statistical analysis, Jacques Vuichoud for the determination of amino
   acids in the standard diet, the Staff of the Unite Experimentale de
   Nutrition Comparee for animal care, and Viral Vishnuprasad Brahmbhatt
   (Nestle Research Center) for improving the manuscript. This work was
   supported by Institut National de la Recherche Agronomique (INRA),
   France, and Nestle, Switzerland.
CR Aoyama K, 2006, NAT NEUROSCI, V9, P119, DOI 10.1038/nn1609
   Arranz L, 2008, FREE RADICAL BIO MED, V45, P1252, DOI 10.1016/j.freeradbiomed.2008.07.014
   Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Breuillé D, 2006, CLIN NUTR, V25, P634, DOI 10.1016/j.clnu.2005.11.009
   CHEN TS, 1989, P SOC EXP BIOL MED, V190, P399
   Cohen HJ, 2003, AM J MED, V114, P180, DOI 10.1016/S0002-9343(02)01484-5
   Dröge W, 2005, PHILOS T R SOC B, V360, P2355, DOI 10.1098/rstb.2005.1770
   Elshorbagy AK, 2012, OBESITY, V20, P473, DOI 10.1038/oby.2011.93
   Ferrucci L, 2002, J AM GERIATR SOC, V50, P1947, DOI 10.1046/j.1532-5415.2002.50605.x
   Ferrucci L, 2008, J GERONTOL A-BIOL, V63, P1416, DOI 10.1093/gerona/63.12.1416
   FRIES JF, 1983, MILBANK FUND Q, V61, P397, DOI 10.2307/3349864
   GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627
   Gautron L, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.23.003.2009
   Grattagliano I, 2004, EXP GERONTOL, V39, P1323, DOI 10.1016/j.exger.2004.06.001
   Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8
   Hack V, 1998, BLOOD, V92, P59, DOI 10.1182/blood.V92.1.59.413a05_59_67
   Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2
   Hauer K, 2003, J MOL MED, V81, P118, DOI 10.1007/s00109-002-0406-7
   Hernadfalvi N, 2007, EUR CYTOKINE NETW, V18, P86, DOI 10.1684/ecn.2007.0090
   JULIUS M, 1994, J CLIN EPIDEMIOL, V47, P1021, DOI 10.1016/0895-4356(94)90117-1
   Kanwar SS, 2007, NUTR HOSP, V22, P95
   Kim CJ, 2009, BBA-GEN SUBJECTS, V1790, P1161, DOI 10.1016/j.bbagen.2009.05.018
   Landi F, 2010, J AM MED DIR ASSOC, V11, P153, DOI 10.1016/j.jamda.2009.09.003
   LANG CA, 1992, J LAB CLIN MED, V120, P720
   Maher P, 2005, AGEING RES REV, V4, P288, DOI 10.1016/j.arr.2005.02.005
   MALLOY MH, 1981, ANAL BIOCHEM, V113, P407, DOI 10.1016/0003-2697(81)90095-6
   Malmezat T, 1998, J NUTR, V128, P97, DOI 10.1093/jn/128.1.97
   Mayot G, 2007, EXP GERONTOL, V42, P498, DOI 10.1016/j.exger.2007.01.003
   Meng SJ, 2010, INT J MOL SCI, V11, P1509, DOI 10.3390/ijms11041509
   Morrison JP, 2005, J APPL PHYSIOL, V99, P2271, DOI 10.1152/japplphysiol.00412.2005
   Mosoni L, 2004, EXP GERONTOL, V39, P203, DOI 10.1016/j.exger.2003.10.014
   Obled C, 2002, CURR OPIN CLIN NUTR, V5, P189, DOI 10.1097/00075197-200203000-00012
   Obled C, 2004, METABOLIC THERAPEUTI, P667
   Sekhar RV, 2011, AM J CLIN NUTR, V94, P847, DOI 10.3945/ajcn.110.003483
   Stipanuk MH, 2009, AMINO ACIDS, V37, P55, DOI 10.1007/s00726-008-0202-y
   Thakurta IG, 2012, BIOGERONTOLOGY, V13, P479, DOI 10.1007/s10522-012-9392-5
NR 37
TC 9
Z9 13
U1 1
U2 9
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD APR
PY 2014
VL 53
IS 3
BP 963
EP 971
DI 10.1007/s00394-013-0600-0
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA AE5UI
UT WOS:000334054400026
PM 24136353
OA Green Submitted
DA 2024-02-19
ER

PT J
AU Lu, J
   Zhang, C
   Wang, WG
   Xu, WP
   Chen, WD
   Tao, LM
   Li, Z
   Zhang, Y
   Cheng, JG
AF Lu, Jian
   Zhang, Cheng
   Wang, Weiguo
   Xu, Wenping
   Chen, Weidong
   Tao, Liming
   Li, Zhong
   Zhang, Yang
   Cheng, Jiagao
TI Exposure to environmental concentrations of glyphosate induces
   cardiotoxicity through cellular senescence and reduced cell
   proliferation capacity
SO ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY
LA English
DT Article; Early Access
DE Glyphosate; AC16; Senescence; Cardiomyocyte proliferation; Endoplasmic
   reticulum
ID CARDIOMYOCYTE PROLIFERATION; HERBICIDE GLYPHOSATE; HEART-FAILURE;
   ZEBRAFISH; TOXICITY; STRESS; BLOOD; LIVER; RATS
AB Glyphosate (GLY), the preeminent herbicide utilized globally, is known to be exposed to the environment and population on a chronic basis. Exposure to GLY and the consequent health risks are alarming public health problems that are attracting international attention. However, the cardiotoxicity of GLY has been a matter of dispute and uncertainty. Here, AC16 cardiomyocytes and zebrafish were exposed to GLY. This study found that low concentrations of GLY lead to morphological enlargement of AC16 human cardiomyocytes, indicating a senescent state. The increased expression of P16, P21, and P53 following exposure to GLY demonstrated that GLY causes senescence in AC16. Moreover, it was mechanistically confirmed that GLY-induced senescence in AC16 cardiomyocytes was produced by ROS-mediated DNA damage. In terms of in vivo cardiotoxicity, GLY decreased the proliferative capacity of cardiomyocytes in zebrafish through the notch signaling pathway, resulting in a reduction of cardiomyocytes. It was also found that GLY caused zebrafish cardiotoxicity associated with DNA damage and mitochondrial damage. KEGG analysis after RNA-seq shows a significant enrichment of protein processing pathways in the endoplasmic reticulum (ER) after GLY exposure. Importantly, GLY induced ER stress in AC16 cells and zebrafish by activating PERK-eIF2 & alpha;-ATF4 pathway. Our study has thus provided the first novel insights into the mechanism underlying GLY-induced cardiotoxicity. Furthermore, our findings emphasize the need for increased attention to the potential cardiotoxic effects of GLY.
C1 [Lu, Jian; Wang, Weiguo; Xu, Wenping; Chen, Weidong; Tao, Liming; Li, Zhong; Zhang, Yang; Cheng, Jiagao] East China Univ Sci & Technol, Sch Pharm, Shanghai Key Lab Chem Biol, Shanghai 200237, Peoples R China.
   [Zhang, Cheng] UT southwestern Med Ctr, Dept Pathol, Dallas, TX 75390 USA.
C3 East China University of Science & Technology; University of Texas
   System; University of Texas Southwestern Medical Center Dallas
RP Zhang, Y; Cheng, JG (corresponding author), East China Univ Sci & Technol, Sch Pharm, Shanghai Key Lab Chem Biol, Shanghai 200237, Peoples R China.
EM zhangyang@ecust.edu.cn; jgcheng@ecust.edu.cn
OI lu, jian/0000-0002-0834-4292; Zhang, Yang/0000-0002-6804-1840
FU Shanghai Sailing Program [19YF1411100]; Fundamental Research Funds for
   the Cen- tral Universities
FX This work was financial Sponsored by Shanghai Sailing Program
   (NO.19YF1411100) and the Fundamental Research Funds for the Cen- tral
   Universities.
CR Acquavella JF, 2004, ENVIRON HEALTH PERSP, V112, P321, DOI 10.1289/ehp.6667
   Andreotti G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133382
   Arrigo E, 2020, VASC PHARMACOL, V132, DOI 10.1016/j.vph.2020.106701
   Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s
   Berni I, 2023, ENVIRON RES, V217, DOI 10.1016/j.envres.2022.114868
   Borlaug BA, 2011, EUR HEART J, V32, P670, DOI 10.1093/eurheartj/ehq426
   Chan YC, 2007, TOXICOL IN VITRO, V21, P595, DOI 10.1016/j.tiv.2006.12.007
   Chong WC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040771
   Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044
   Davalli P, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3565127
   Dickhout JG, 2011, CIRC RES, V108, P629, DOI 10.1161/CIRCRESAHA.110.226803
   Dolan T, 2013, ENVIRON SCI TECHNOL, V47, P4999, DOI 10.1021/es304955g
   Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904
   European Commission H. Commission C.P.D.-G. o t E., 2002, REV REP ACT SUBST GL
   Ferramosca A, 2021, REPROD TOXICOL, V99, P48, DOI 10.1016/j.reprotox.2020.11.011
   Gu JL, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0093-5
   Gude NA, 2018, NAT REV CARDIOL, V15, P523, DOI 10.1038/s41569-018-0061-5
   Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708
   Horth H., 2009, WRC report UC8073, 2
   Hoshino A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3308
   Hou LF, 2013, ENVIRON HEALTH PERSP, V121, P919, DOI 10.1289/ehp.1206432
   Hu B, 2022, NAT GENET, V54, P1227, DOI 10.1038/s41588-022-01129-5
   Katsuumi G, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00018
   Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147
   Larsen K, 2012, ENVIRON TOXICOL PHAR, V34, P811, DOI 10.1016/j.etap.2012.09.005
   Lee J, 2019, NATURE, V572, P335, DOI 10.1038/s41586-019-1406-x
   Lesnefsky EJ, 2016, CIRC RES, V118, P1593, DOI 10.1161/CIRCRESAHA.116.307505
   Liu XN, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22131-1
   Liu Y., ENVIRON TOXICOL PHAR, V83
   Lu J, 2022, SCI TOTAL ENVIRON, V851, DOI 10.1016/j.scitotenv.2022.158308
   Lu L, 2022, ENVIRON POLLUT, V314, DOI 10.1016/j.envpol.2022.120314
   MacGrogan D, 2010, CURR TOP DEV BIOL, V92, P333, DOI 10.1016/S0070-2153(10)92011-5
   Matrone G, 2017, CELL MOL LIFE SCI, V74, P1367, DOI 10.1007/s00018-016-2404-x
   Mesnage R, 2015, FOOD CHEM TOXICOL, V84, P133, DOI 10.1016/j.fct.2015.08.012
   Milic M, 2018, ARH HIG RADA TOKSIKO, V69, P154, DOI 10.2478/aiht-2018-69-3114
   Oie E, 2010, SCAND CARDIOVASC J, V44, P359, DOI 10.3109/14017431.2010.511256
   Owens WA, 2021, MECH AGEING DEV, V198, DOI 10.1016/j.mad.2021.111540
   Peillex C, 2020, J IMMUNOTOXICOL, V17, P163, DOI 10.1080/1547691X.2020.1804492
   Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857
   Roy NM, 2016, ENVIRON TOXICOL PHAR, V46, P292, DOI 10.1016/j.etap.2016.08.010
   Rozpedek W, 2016, CURR MOL MED, V16, P533, DOI 10.2174/1566524016666160523143937
   Salama A., 2021, Int. J. Mol. Sci., V22
   Scribner E.A., 2007, Concentrations of glyphosate, its degradation product, aminomethylphosphonic acid, and glufosinate in groundand surface-water, rainfall, and soil samples collected in the United States, 2001-06
   Sun MJ, 2019, WATER RES, V163, DOI 10.1016/j.watres.2019.07.007
   Tekeli I, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170116
   van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001
   Van Stempvoort DR, 2014, CHEMOSPHERE, V95, P455, DOI 10.1016/j.chemosphere.2013.09.095
   Verfaillie T, 2012, CELL DEATH DIFFER, V19, P1880, DOI 10.1038/cdd.2012.74
   Wang JC, 2012, CIRC RES, V111, P245, DOI 10.1161/CIRCRESAHA.111.261388
   Wang L, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0767-9
   Wang SY, 2018, BRIT J PHARMACOL, V175, P1293, DOI 10.1111/bph.13888
   Wang WW, 2022, J HAZARD MATER, V426, DOI 10.1016/j.jhazmat.2021.128042
   Wozniak E, 2018, FOOD CHEM TOXICOL, V120, P510, DOI 10.1016/j.fct.2018.07.035
   Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569
   Yuan JH, 2018, J GERONTOL A-BIOL, V73, P1027, DOI 10.1093/gerona/gly002
   Zhang C., 2017, AUTOPHAGY INFLAMM CA, V4
   Zhang F, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082943
   Zhang JW, 2019, CHEMOSPHERE, V237, DOI 10.1016/j.chemosphere.2019.124435
   Zhao L, 2014, P NATL ACAD SCI USA, V111, P1403, DOI 10.1073/pnas.1311705111
   Zong ZH, 2012, BBA-MOL CELL RES, V1823, P1395, DOI 10.1016/j.bbamcr.2012.06.001
   Zouaoui K, 2013, FORENSIC SCI INT, V226, pE20, DOI 10.1016/j.forsciint.2012.12.010
NR 61
TC 1
Z9 1
U1 4
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0147-6513
EI 1090-2414
J9 ECOTOX ENVIRON SAFE
JI Ecotox. Environ. Safe.
PD 2023 AUG
PY 2023
VL 261
AR 115112
DI 10.1016/j.ecoenv.2023.115112
EA JUN 2023
PG 11
WC Environmental Sciences; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology; Toxicology
GA K0YX1
UT WOS:001013799300001
PM 37290295
OA gold
DA 2024-02-19
ER

PT J
AU Li, Q
   Zhu, ZZ
   Wang, CD
   Cai, L
   Lu, JL
   Wang, YC
   Xu, JD
   Su, ZP
   Zheng, WM
   Chen, XB
AF Li, Qun
   Zhu, Zhangzhang
   Wang, Chengde
   Cai, Lin
   Lu, Jianglong
   Wang, Yongchun
   Xu, Jiadong
   Su, Zhipeng
   Zheng, Weiming
   Chen, Xianbin
TI CTRP9 ameliorates cellular senescence via PGC-1α/AMPK signaling in
   mesenchymal stem cells
SO INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
LA English
DT Article
DE mesenchymal stem cells; senescence; C1q and tumor necrosis
   factor-related protein 9; peroxisome proliferator-activated receptor
   gamma coactivator-1 alpha; AMP-activated protein kinase
ID MIGRATION INHIBITORY FACTOR; ACTIVATED PROTEIN-KINASE; ADIPONECTIN;
   ISCHEMIA; PATHWAY; STROKE; INJURY; FATE; AGE
AB Stroke is the second most common cause of death worldwide, and thus, it imposes great financial burdens on both individuals and society. Mesenchymal stem cell (MSC) therapy is a promising approach for ischemic brain injury. However, MSC treatment potential is progressively reduced with age, limiting their therapeutic efficacy for brain repair post-stroke. C1q and tumor necrosis factor-related protein 9 (CTRP9) is a novel cytoprotective cytokine with antioxidant effects, which is highly expressed in brain tissue. The present study tested the hypothesis that CTRP9 might act as an antisenescence factor to promote the rejuvenation of aged MSCs. MSCs were isolated from the bone marrow of young (8-weeks-old) and aged (18-months-old) male C57BL/6 mice. Cell proliferation was measured by Cell Counting Kit-8 assay and cell viability was determined by MTT assay. Gene expression levels of interleukin (IL)-6 and IL-10 were evaluated with reverse transcription-quantitative polymerase chain reaction, and secretion of vascular endothelial growth factor, basic fibroblast growth factor, hepatocyte growth factor, and insulin-like growth factor were measured by ELISA. The expression levels of proteins in the peroxisome proliferator-activated receptor gamma coactivator (PGC)-1 alpha/AMP-activated protein kinase (AMPK) signaling pathway were investigated with western blotting. Oxidative stress was evaluated by detecting mitochondrial membrane potential, reactive oxygen species, superoxide dismutase activity and malondialdehyde. MSCs isolated from aged mice exhibited reduced proliferation and viability, and impaired immunoregulatory and paracrine abilities, compared with MSCs from younger mice. CTRP9 had a significant antisenescence effect in aged MSCs by activating PGC-1 alpha/AMPK signaling and decreasing the oxidative response. Silencing either PGC-1 alpha or AMPK abolished the above effects of CTRP9. These results suggest that CTRP9 may have a critical role in cellular senescence by facilitating stem cell rejuvenation, and may therefore have the potential to enhance the efficacy of stem cell therapy.
C1 [Li, Qun; Zhu, Zhangzhang; Wang, Chengde; Cai, Lin; Lu, Jianglong; Wang, Yongchun; Xu, Jiadong; Su, Zhipeng; Zheng, Weiming; Chen, Xianbin] Wenzhou Med Univ, Affiliated Hosp 1, Dept Neurosurg, 2 Fuxue Lane, Wenzhou 325000, Zhejiang, Peoples R China.
C3 Wenzhou Medical University
RP Zheng, WM; Chen, XB (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Neurosurg, 2 Fuxue Lane, Wenzhou 325000, Zhejiang, Peoples R China.
EM zhwm61@126.com; chenxianbin777@126.com
RI zheng, weiming/B-1911-2012; Cai, Lin/AAD-3411-2022
OI Cai, Lin/0000-0002-7087-4948
FU Zhejiang Provincial Natural Science Foundation of China [LQ17C060002,
   LY16H160053, LY17H160052]; Medical Scientific Research foundation of
   Zhejiang Province of China [WKJ-ZJ-1525]; Wenzhou Science and Technology
   Plan Project [Y20170088]
FX This study was supported by the Zhejiang Provincial Natural Science
   Foundation of China (grant nos. LQ17C060002, LY16H160053 and
   LY17H160052), the Medical Scientific Research foundation of Zhejiang
   Province of China (grant no. WKJ-ZJ-1525) and the Wenzhou Science and
   Technology Plan Project (grant no. Y20170088).
CR Akunuru S, 2016, TRENDS MOL MED, V22, P701, DOI 10.1016/j.molmed.2016.06.003
   Badan I, 2003, J CEREBR BLOOD F MET, V23, P845, DOI 10.1097/01.WCB.0000071883.63724.A7
   Bai SX, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1902025
   Chandel NS, 2014, NEW ENGL J MED, V371, P177, DOI 10.1056/NEJMcibr1405701
   Crepin T, 2015, AM J TRANSPLANT, V15, P1028, DOI 10.1111/ajt.13092
   Gervois P, 2016, MED RES REV, V36, P1080, DOI 10.1002/med.21400
   Gharibi B, 2014, STEM CELLS, V32, P2256, DOI 10.1002/stem.1709
   Goldberg J, 2018, AGING CELL, V17, DOI 10.1111/acel.12715
   Goldstein BJ, 2009, NAT CLIN PRACT CARD, V6, P27, DOI 10.1038/ncpcardio1398
   Gonon AT, 2008, CARDIOVASC RES, V78, P116, DOI 10.1093/cvr/cvn017
   Iadecola C, 2017, NEURON, V96, P17, DOI 10.1016/j.neuron.2017.07.030
   Jung CH, 2016, MOL CELL ENDOCRINOL, V419, P235, DOI 10.1016/j.mce.2015.10.023
   Li HJ, 2017, J CLIN INVEST, V127, P1241, DOI 10.1172/JCI89511
   Liu MC, 2017, CELL TRANSPLANT, V26, P1505, DOI 10.1177/0963689717721221
   Liu Q, 2017, J CELL MOL MED, V21, P2823, DOI 10.1111/jcmm.13196
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Loisel S, 2017, STEM CELLS, V35, P1431, DOI 10.1002/stem.2580
   Oakhill JS, 2012, TRENDS ENDOCRIN MET, V23, P125, DOI 10.1016/j.tem.2011.12.006
   Otsu K, 2009, BLOOD, V113, P4197, DOI 10.1182/blood-2008-09-176198
   Patten IS, 2012, TRENDS ENDOCRIN MET, V23, P90, DOI 10.1016/j.tem.2011.09.007
   Rabinovitch RC, 2017, CELL REP, V21, P1, DOI 10.1016/j.celrep.2017.09.026
   Riera CE, 2016, ANNU REV BIOCHEM, V85, P35, DOI 10.1146/annurev-biochem-060815-014451
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Smith BD, 2009, J CLIN ONCOL, V27, P2758, DOI 10.1200/JCO.2008.20.8983
   Solis MA, 2016, STEM CELLS, V34, P2512, DOI 10.1002/stem.2404
   Sun HJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061097
   Townsley DM, 2014, BLOOD, V124, P2775, DOI 10.1182/blood-2014-05-526285
   van Velthoven CTJ, 2012, ANN NEUROL, V71, P785, DOI 10.1002/ana.23543
   van Velthoven CTJ, 2012, PEDIATR RES, V71, P474, DOI 10.1038/pr.2011.64
   Xia WZ, 2017, MOL MED REP, V16, P7039, DOI 10.3892/mmr.2017.7430
   Xia WZ, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0076-3
   Xia WZ, 2015, MOL CELL BIOCHEM, V404, P11, DOI 10.1007/s11010-015-2361-y
   Xie ZD, 2018, MOL MED REP, V17, P2695, DOI 10.3892/mmr.2017.8169
   Yan WJ, 2017, CIRCULATION, V136, P2162, DOI 10.1161/CIRCULATIONAHA.117.029557
   Yang GK, 2017, J MOL ENDOCRINOL, V58, P179, DOI 10.1530/JME-16-0171
   Ye XC, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/7682960
   Zhao DJ, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/6437467
NR 37
TC 13
Z9 16
U1 0
U2 16
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1107-3756
EI 1791-244X
J9 INT J MOL MED
JI Int. J. Mol. Med.
PD AUG
PY 2018
VL 42
IS 2
BP 1054
EP 1063
DI 10.3892/ijmm.2018.3666
PG 10
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA GP1MX
UT WOS:000440581300036
PM 29749459
OA Bronze
DA 2024-02-19
ER

PT J
AU Sleiman, MB
   Jha, P
   Houtkooper, R
   Williams, RW
   Wang, X
   Auwerx, J
AF Sleiman, Maroun Bou
   Jha, Pooja
   Houtkooper, Riekelt
   Williams, Robert W.
   Wang, Xu
   Auwerx, Johan
TI The Gene-Regulatory Footprint of Aging Highlights Conserved Central
   Regulators
SO CELL REPORTS
LA English
DT Article
ID DNA METHYLATION; LIFE-SPAN; EXPRESSION; PROTEIN; AGE; MITOCHONDRIAL;
   TRANSCRIPTOME; ACCUMULATION; LONGEVITY; ALIGNER
AB Many genes and pathways have been linked to aging, yet our understanding of underlying molecular mechanisms is still lacking. Here, we measure changes in the transcriptome, histone modifications, and DNA methylome in three metabolic tissues of adult and aged mice. Transcriptome and methylome changes dominate the liver aging footprint, whereas heart and muscle globally increase chromatin accessibility, especially in aging pathways. In mouse and human data from multiple tissues and regulatory layers, age-related transcription factor expression changes and binding site enrichment converge on putative aging modulators, including ZIC1, CXXC1, HMGA1, MECP2, SREBF1, SREBF2, ETS2, ZBTB7A, and ZNF518B. Using Mendelian randomization, we establish possible epidemiological links between expression of some of these transcription factors or their targets, including CXXC1, ZNF518B, and BBC3, and longevity. We conclude that conserved modulators are at the core of the molecular footprint of aging, and variation in tissue-specific expression of some may affect human longevity.
C1 [Sleiman, Maroun Bou; Jha, Pooja; Houtkooper, Riekelt; Wang, Xu; Auwerx, Johan] Ecole Polytech Fed Lausanne, Inst Bioengn, Lab Integrat Syst Physiol, CH-1015 Lausanne, Switzerland.
   [Williams, Robert W.] Univ Tennessee, Dept Genet Genom & Informat, Memphis, TN 38163 USA.
   [Houtkooper, Riekelt] Univ Amsterdam, Amsterdam UMC, Lab Genet Metab Dis, Amsterdam Gastroenterol & Metab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.
   [Wang, Xu] Shanghai Jiao Tong Univ, Joint Ctr Single Cell Biol, Sch Agr & Biol, Shanghai 200240, Peoples R China.
C3 Swiss Federal Institutes of Technology Domain; Ecole Polytechnique
   Federale de Lausanne; University of Tennessee System; University of
   Tennessee Health Science Center; University of Amsterdam; Shanghai Jiao
   Tong University
RP Wang, X; Auwerx, J (corresponding author), Ecole Polytech Fed Lausanne, Inst Bioengn, Lab Integrat Syst Physiol, CH-1015 Lausanne, Switzerland.; Wang, X (corresponding author), Shanghai Jiao Tong Univ, Joint Ctr Single Cell Biol, Sch Agr & Biol, Shanghai 200240, Peoples R China.
EM xu.wang@sjtu.edu.cn; admin.auwerx@epfl.ch
RI Houtkooper, Riekelt/P-5001-2019; Auwerx, Johan/ABE-9307-2021; Wang,
   Xu/T-8608-2017
OI Jha, Pooja/0000-0002-0293-9287; Wang, Xu/0000-0002-9267-8278;
   Houtkooper, Riekelt/0000-0001-9961-0842; Bou Sleiman,
   Maroun/0000-0002-1375-7577; Auwerx, Johan/0000-0002-5065-5393
FU Ecole Polytechnique Federale de Lausanne; European Research Council
   [ERCAdG-787702]; Swiss National Science Foundation [SNSF 310030B160318];
   AgingX program of the Swiss Initiative in Systems Biology [RTD
   2013/153]; GRL grant of the National Research Foundation of Korea [NRF
   2017K1A1A2013124]; National Institutes of Health (NIH) [R01AG043930]
FX We are grateful to the members of the Auwerx lab and the mouse
   phenotyping unit at EPFL (Ecole Polytechnique Federale de Lausanne;
   Center of Phenogenomics) for support and helpful discussions. We thank
   Arwen Gao, Terytty Yang Li, and Evan G. Williams for their input. We
   thank the EPFL school of life science information technology (IT) group
   for help in maintaining the IT infrastructure necessary to perform the
   work. We equally thank the Brunet and Benayoun labs, the GTEx
   Consortium, and the UK Biobank for making their data available. We thank
   the anonymous reviewers and the editors for their constructive remarks.
   This work was supported by grants from Ecole Polytechnique Federale de
   Lausanne, the European Research Council (ERCAdG-787702), the Swiss
   National Science Foundation (SNSF 310030B160318), the AgingX program of
   the Swiss Initiative in Systems Biology (RTD 2013/153), the GRL grant of
   the National Research Foundation of Korea (NRF 2017K1A1A2013124), and
   the National Institutes of Health (NIH) (R01AG043930).
CR Akalin A, 2015, BIOINFORMATICS, V31, P1127, DOI 10.1093/bioinformatics/btu775
   Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R87, 10.1186/gb-2012-13-10-r87]
   Benayoun BA, 2019, GENOME RES, V29, P697, DOI 10.1101/gr.240093.118
   Benayoun BA, 2015, NAT REV MOL CELL BIO, V16, P593, DOI 10.1038/nrm4048
   Bien-Ly N, 2012, J NEUROSCI, V32, P4803, DOI 10.1523/JNEUROSCI.0033-12.2012
   Booth LN, 2016, MOL CELL, V62, P728, DOI 10.1016/j.molcel.2016.05.013
   Carroll TS, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00075
   Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431
   Chondrogianni N, 2015, FASEB J, V29, P611, DOI 10.1096/fj.14-252189
   CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443
   Dement GA, 2007, EXP CELL RES, V313, P77, DOI 10.1016/j.yexcr.2006.09.014
   Dutta S, 2016, LIFE SCI, V152, P244, DOI 10.1016/j.lfs.2015.10.025
   Gottschalk William K, 2016, J Alzheimers Dis Parkinsonism, V6
   Han JW, 2001, P NATL ACAD SCI USA, V98, P11318, DOI 10.1073/pnas.201208798
   Hemani G, 2018, ELIFE, V7, DOI 10.7554/eLife.34408
   Horvath S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1030-0
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188
   Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134
   Huang SS, 2015, CELL REP, V13, P196, DOI 10.1016/j.celrep.2015.08.060
   Johnson AA, 2012, REJUV RES, V15, P483, DOI 10.1089/rej.2012.1324
   Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230
   Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980
   Kim J, 2019, CANCER CELL, V35, P191, DOI 10.1016/j.ccell.2018.12.012
   Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167
   Kulakovskiy IV, 2013, NUCLEIC ACIDS RES, V41, pD195, DOI 10.1093/nar/gks1089
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]
   Li LL, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.168609
   Li MD, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0093-y
   Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214
   Liu XS, 2014, GENE DEV, V28, P1917, DOI 10.1101/gad.245910.114
   Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653
   Lun ATL, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1191
   Mao L, 2009, MOL CELL BIOL, V29, P5426, DOI 10.1128/MCB.00105-09
   McDaid AF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15842
   McKittrick E, 2004, P NATL ACAD SCI USA, V101, P1525, DOI 10.1073/pnas.0308092100
   Morris B.J., 2018, BIOCH BIOPHYS ACTA M, V1865, P1718
   Nacarelli T, 2019, NAT CELL BIOL, V21, P397, DOI 10.1038/s41556-019-0287-4
   Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052
   Nascimento EBM, 2018, OBESITY, V26, P135, DOI 10.1002/oby.22062
   Ori A, 2015, CELL SYST, V1, P224, DOI 10.1016/j.cels.2015.08.012
   Pal S, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600584
   Pilling LC, 2017, AGING-US, V9, P2504, DOI 10.18632/aging.101334
   Pilling LC, 2016, AGING-US, V8, P547, DOI 10.18632/aging.100930
   Reid SJ, 2004, MOL BRAIN RES, V125, P120, DOI 10.1016/j.molbrainres.2004.03.018
   Riera CE, 2016, ANNU REV BIOCHEM, V85, P35, DOI 10.1146/annurev-biochem-060815-014451
   Salero E, 2001, J BIOL CHEM, V276, P1881, DOI 10.1074/jbc.M007008200
   Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107
   Schumacher B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000161
   Shao W, 2012, CELL METAB, V16, P414, DOI 10.1016/j.cmet.2012.09.002
   Sheydina A, 2012, AGING CELL, V11, P350, DOI 10.1111/j.1474-9726.2012.00794.x
   Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23
   Sorrentino V, 2017, NATURE, V552, P187, DOI 10.1038/nature25143
   Stegle O, 2012, NAT PROTOC, V7, P500, DOI 10.1038/nprot.2011.457
   Stovner EB, 2019, BIOINFORMATICS, V35, P4392, DOI 10.1093/bioinformatics/btz232
   Stubbs TM, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1203-5
   Su J, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0059-1
   Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779
   Tvardovskiy A, 2017, NUCLEIC ACIDS RES, V45, P9272, DOI 10.1093/nar/gkx696
   van Deursen JM, 2019, SCIENCE, V364, P636, DOI 10.1126/science.aaw1299
   Wang MH, 2015, SCI REP-UK, V5, DOI 10.1038/srep16923
   Wang TN, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1186-2
   Wu YR, 2005, J NEURAL TRANSM, V112, P539, DOI 10.1007/s00702-004-0197-9
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1
   Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693
   Zhu Y, 2016, AGING CELL, V15, P428, DOI 10.1111/acel.12445
NR 67
TC 15
Z9 16
U1 2
U2 13
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD SEP 29
PY 2020
VL 32
IS 13
AR 108203
DI 10.1016/j.celrep.2020.108203
PG 16
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA NU6AB
UT WOS:000573722100013
PM 32997995
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Lee, MJ
   Kim, EH
   Bae, SJ
   Kim, GA
   Park, SW
   Choe, J
   Jung, CH
   Lee, WJ
   Kim, HK
AF Lee, Min Jung
   Kim, Eun-Hee
   Bae, Sung-Jin
   Kim, Gi-Ae
   Park, Sung Won
   Choe, Jaewon
   Jung, Chang Hee
   Lee, Woo Je
   Kim, Hong-Kyu
TI Age-Related Decrease in Skeletal Muscle Mass Is an Independent Risk
   Factor for Incident Nonalcoholic Fatty Liver Disease: A 10-Year
   Retrospective Cohort Study
SO GUT AND LIVER
LA English
DT Article
DE Aging Body composition; Sarcopenia; Non-alcoholic fatty liver disease
ID INSULIN-RESISTANCE; HEPATIC STEATOSIS; VITAMIN-D; SARCOPENIA;
   ASSOCIATION; NAFLD; BODY; POPULATION; ULTRASOUND; DIAGNOSIS
AB Background/Aims: Sarcopenia has emerged as an important risk factor for nonalcoholic fatty liver disease (NAFLD). Although aging is the main cause of sarcopenia, the longitudinal association between age-related body composition changes and NAFLD development has not been fully investigated. Thus, we evaluated whether age-related increased fat mass or decreased muscle mass is an independent risk factor for incident NAFLD. Methods: We conducted a retrospective cohort study involving 4,398 initially NAFLD-free subjects who underwent routine health examinations during 2004 to 2005 and returned for a follow-up during 2014 to 2015. Their body composition was measured by bioelectrical impedance analysis, and fatty liver was diagnosed by abdominal ultrasonography. Results: At the 10-year follow-up, 591 out of 4,398 participants (13.4%) had developed NAFLD. In men and women, both increased fat mass and decreased appendicular skeletal muscle mass (ASM) with aging were significantly associated with incident NAFLD after adjustment. A subgroup analysis according to the baseline obesity status showed that increased fat mass was significantly associated with incident NAFLD in obese and nonobese subjects. However, decreased ASM was significantly associated with incident NAFLD in nonobese but not in obese subjects. According to AASM tertiles (decrease of ASM), the odds ratios for incident NAFLD in nonobese subjects were 1.38 (95% confidence interval [CI], 1.04 to 1.84) for the second tertile and 1.81 (95% CI, 1.34 to 2.45) for the third tertile after adjustment (p=0.001). Conclusions: A progressive increase in fat mass and a loss of ASM with aging were significantly associated with incident NAFLD. This association was more prominent in nonobese subjects.
C1 [Lee, Min Jung; Kim, Eun-Hee; Bae, Sung-Jin; Kim, Gi-Ae; Park, Sung Won; Choe, Jaewon; Kim, Hong-Kyu] Univ Ulsan, Coll Med, Hlth Screening & Promot Ctr, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
   [Jung, Chang Hee; Lee, Woo Je] Univ Ulsan, Asan Med Ctr, Dept Internal Med, Coll Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
C3 University of Ulsan; University of Ulsan
RP Kim, HK (corresponding author), Univ Ulsan, Coll Med, Hlth Screening & Promot Ctr, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.; Lee, WJ (corresponding author), Univ Ulsan, Asan Med Ctr, Dept Internal Med, Coll Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea.
EM lwjatlas@amc.seoul.kr; hkkim0801@amc.seoul.kr
RI Kim, Gi-Ae/AAZ-2547-2021; Jung, Chang Hee/AAU-7897-2020
CR Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014
   [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005
   Bano A, 2016, J CLIN ENDOCR METAB, V101, P3204, DOI 10.1210/jc.2016-1300
   Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012
   Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762
   Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034
   Dasarathy S, 2009, J HEPATOL, V51, P1061, DOI 10.1016/j.jhep.2009.09.001
   Eliades M, 2013, ALIMENT PHARM THER, V38, P246, DOI 10.1111/apt.12377
   Flannery C, 2012, DIABETES, V61, P2711, DOI 10.2337/db12-0206
   Hong HC, 2014, HEPATOLOGY, V59, P1772, DOI 10.1002/hep.26716
   Kaido T, 2013, AM J TRANSPLANT, V13, P2506, DOI 10.1111/ajt.12373
   Kim D, 2018, DIGEST LIVER DIS, V50, P389, DOI 10.1016/j.dld.2017.12.014
   Kim HK, 2009, AM J MED SCI, V337, P98, DOI 10.1097/MAJ.0b013e3181812879
   Kim M, 2015, GERIATR GERONTOL INT, V15, P1013, DOI 10.1111/ggi.12384
   Koo BK, 2018, LIVER INT, V38, P695, DOI 10.1111/liv.13587
   Koo BK, 2017, J HEPATOL, V66, P123, DOI 10.1016/j.jhep.2016.08.019
   Larsen BA, 2016, J CLIN ENDOCR METAB, V101, P1847, DOI 10.1210/jc.2015-3643
   Lee YH, 2015, J HEPATOL, V63, P486, DOI 10.1016/j.jhep.2015.02.051
   Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002
   Lim S, 2010, DIABETES CARE, V33, P1652, DOI 10.2337/dc10-0107
   Ling CHY, 2011, CLIN NUTR, V30, P610, DOI 10.1016/j.clnu.2011.04.001
   Meng G, 2016, SCI REP-UK, V6, DOI 10.1038/srep33255
   Miller AM, 2011, HEPATOLOGY, V54, P846, DOI 10.1002/hep.24517
   Moon SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130740
   Phillips T, 2005, FASEB J, V19, P668, DOI 10.1096/fj.04-2870fje
   Ruhl Constance E, 2004, Clin Liver Dis, V8, P501, DOI 10.1016/j.cld.2004.04.008
   SAVERYMUTTU SH, 1986, BRIT MED J, V292, P13, DOI 10.1136/bmj.292.6512.13
   Tanaka K, 2014, BIOCHEM BIOPH RES CO, V450, P482, DOI 10.1016/j.bbrc.2014.05.145
   Targher G, 2014, AM J KIDNEY DIS, V64, P638, DOI 10.1053/j.ajkd.2014.05.019
   Utzschneider KM, 2006, J CLIN ENDOCR METAB, V91, P4753, DOI 10.1210/jc.2006-0587
   World Health Organization Western Pacific Region; International Association for the Study of Obesity; International Obesity Task Force, 2000, AS PAC PERSP RED OB
   Zelber-Sagi S, 2012, J HEPATOL, V56, P1145, DOI 10.1016/j.jhep.2011.12.011
   Zhang HJ, 2013, J HEPATOL, V59, P557, DOI 10.1016/j.jhep.2013.04.030
   Zhao L, 2015, SCI REP-UK, V5, DOI 10.1038/srep10222
NR 34
TC 54
Z9 55
U1 0
U2 7
PU EDITORIAL OFFICE GUT & LIVER
PI SEOUL
PA 305 LOTTE GOLD ROSE II, 890-59, DAECHI 4-DONG, GANGNAM-GU, SEOUL,
   135-839, SOUTH KOREA
SN 1976-2283
EI 2005-1212
J9 GUT LIVER
JI Gut Liver
PD JAN
PY 2019
VL 13
IS 1
BP 67
EP +
DI 10.5009/gnl18070
PG 17
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA HH5KK
UT WOS:000455765000013
PM 30037166
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Jin, JL
   Wang, GL
   Iakova, P
   Shi, XR
   Haefliger, S
   Finegold, M
   Timchenko, NA
AF Jin, Jingling
   Wang, Guo-Li
   Iakova, Polina
   Shi, Xiurong
   Haefliger, Simon
   Finegold, Milton
   Timchenko, Nikolai A.
TI Epigenetic changes play critical role in age-associated dysfunctions of
   the liver
SO AGING CELL
LA English
DT Article
DE aging; body homeostasis; C; EBP alpha; epigenetic control; liver;
   proliferation
ID CCAAT/ENHANCER-BINDING-PROTEIN; C/EBP-ALPHA; CELLULAR SENESCENCE;
   REGENERATING LIVER; PROLIFERATION; DNA; INHIBITION; ARREST; MICE
AB P>CCAAT/Enhancer Binding Proteins family proteins are important regulators of liver functions. Here, we show the critical role of C/EBP alpha-mediated chromatin remodeling in the age-associated dysfunctions of the liver and in the maintenance of physiological homeostasis. Because ph-S193 isoform of C/EBP alpha is increased in livers of old mice, we have generated C/EBP alpha-S193D knockin mice, which mimic the ph-S193 isoform of C/EBP alpha. Analyses of these mice showed that the S193D mutation causes chromatin remodeling leading to histological appearance of 'foci-like' nodules, which are also observed in livers of old mice. These 'foci-like' structures contain K9 trimethylated histone H3, a marker of heterochromatin. The increase of heterochromatin regions in S193D mice correlates with the elevation of S193D-C/EBP alpha-HDAC1 complexes and with dys-regulation of gene expression including epigenetic silencing of cyclin D1 and D2 promoters and the inhibition of liver proliferation. The elimination of C/EBP alpha-HDAC1 complexes in S193D mice by inhibition of HDAC1 corrects chromatin structure and normalizes expression of cyclin D1 and D2. We found that epigenetic dys-regulation is also associated with the elevation of C/EBP beta and with the increase of C/EBP alpha/beta heterodimers in S193D mice. The C/EBP alpha/beta heterodimers activate transcription of Glut4 and increase the levels of Glut4. As the result, S193D livers have accelerated uptake of glucose and accumulation of glycogen in the liver. Thus, this study demonstrates that the phosphorylation of C/EBP alpha at S193 leads to the appearance of heterochromatin regions, which correlates with the development of age-related dysfunctions of the liver.
C1 [Jin, Jingling; Wang, Guo-Li; Iakova, Polina; Shi, Xiurong; Haefliger, Simon; Finegold, Milton; Timchenko, Nikolai A.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.
C3 Baylor College of Medicine
RP Timchenko, NA (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, 1 Baylor Plaza, Houston, TX 77030 USA.
EM nikolait@bcm.tmc.edu
RI Haefliger, Simon/A-7420-2015
OI Haefliger, Simon/0000-0002-9721-3314; Jin, Jingling/0000-0002-4365-1837
FU NIH [GM55188, CA100070, AG20752]
FX We thank Estela Medrano and Gretchen Darlington for the discussion of
   this work and for useful suggestions. This work is supported by NIH
   grants GM55188, CA100070 and AG20752 (NAT).
CR Bandyopadhyay D, 2007, AGING CELL, V6, P577, DOI 10.1111/j.1474-9726.2007.00308.x
   Benko T, 2010, J INVEST SURG, V23, P12, DOI 10.3109/08941930903469466
   BUCHER NLR, 1964, CANCER RES, V24, P509
   Chipchase MD, 2003, HEPATOLOGY, V38, P958, DOI 10.1053/jhep.2003.50421
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Corbin IR, 2002, HEPATOLOGY, V36, P345, DOI 10.1053/jhep.2002.34742
   Demarco IA, 2006, NAT METHODS, V3, P519, DOI 10.1038/NMETH889
   Eipel C, 2010, TRANSPL INT, V23, P998, DOI 10.1111/j.1432-2277.2010.01079.x
   Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969
   FRY M, 1984, J CELL PHYSIOL, V118, P225, DOI 10.1002/jcp.1041180302
   Gielchinsky Y, 2010, GENE DEV, V24, P543, DOI 10.1101/gad.563110
   Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0
   Jin JL, 2009, AGING-US, V1, P582, DOI 10.18632/aging.100060
   Jin JL, 2009, CELL CYCLE, V8, P2356, DOI 10.4161/cc.8.15.9248
   Jin JL, 2009, MOL CELL BIOL, V29, P3867, DOI 10.1128/MCB.00456-09
   Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459
   Krupczak-Hollis K, 2003, HEPATOLOGY, V38, P1552, DOI 10.1016/j.hep.2003.08.052
   Kuk JL, 2009, AGEING RES REV, V8, P339, DOI 10.1016/j.arr.2009.06.001
   Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172
   Miller M, 2003, J BIOL CHEM, V278, P15178, DOI 10.1074/jbc.M300417200
   Moser MJ, 2001, DIGEST DIS SCI, V46, P907, DOI 10.1023/A:1010791915733
   Müller C, 2004, J BIOL CHEM, V279, P7353, DOI 10.1074/jbc.M312709200
   Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X
   Pedersen TÅ, 2001, GENE DEV, V15, P3208, DOI 10.1101/gad.209901
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Sedivy JM, 2008, EXP CELL RES, V314, P1909, DOI 10.1016/j.yexcr.2008.02.023
   Seo YH, 2008, AGING CELL, V7, P894, DOI 10.1111/j.1474-9726.2008.00436.x
   Tan EH, 2005, CANCER RES, V65, P10330, DOI 10.1158/0008-5472.CAN-04-4486
   Timchenko NA, 1997, MOL CELL BIOL, V17, P7353, DOI 10.1128/MCB.17.12.7353
   Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005
   Wang GL, 2006, MOL CELL BIOL, V26, P2570, DOI 10.1128/MCB.26.7.2570-2582.2006
   Wang GL, 2004, GENE DEV, V18, P912, DOI 10.1101/gad.1183304
   Wang GL, 2008, J BIOL CHEM, V283, P26169, DOI 10.1074/jbc.M803544200
   Wang GL, 2008, J BIOL CHEM, V283, P26179, DOI 10.1074/jbc.M803545200
   Wang GL, 2008, EXP CELL RES, V314, P1626, DOI 10.1016/j.yexcr.2008.01.028
   Wang GL, 2007, J BIOL CHEM, V282, P1468, DOI 10.1074/jbc.M608226200
   Wang GL, 2010, J CLIN INVEST, V120, P2549, DOI 10.1172/JCI41933
   Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5
   WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557
NR 39
TC 27
Z9 30
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD OCT
PY 2010
VL 9
IS 5
BP 895
EP 910
DI 10.1111/j.1474-9726.2010.00617.x
PG 16
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 651AQ
UT WOS:000281897400019
PM 20698834
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Qian, Y
   Zhang, J
   Zhou, XR
   Yi, RK
   Mu, JF
   Long, XY
   Pan, YN
   Zhao, X
   Liu, WW
AF Qian, Yu
   Zhang, Jing
   Zhou, Xianrong
   Yi, Ruokun
   Mu, Jianfei
   Long, Xingyao
   Pan, Yanni
   Zhao, Xin
   Liu, Weiwei
TI <i>Lactobacillus plantarum</i> CQPC11 Isolated from Sichuan Pickled
   Cabbages Antagonizes d-galactose-Induced Oxidation and Aging in Mice
SO MOLECULES
LA English
DT Article
DE Lactobacillus plantarum CQPC11; pickled cabbage; oxidation; aging; mice
ID NITRIC-OXIDE; SUPEROXIDE-DISMUTASE; DAMAGE; FERMENTATION; INVOLVEMENT;
   STRESS; INJURY; PAOCAI; FOOD
AB Chinese pickled cabbage is a traditional fermented food that contains abundant microbes produced during the process of fermentation. In this work, an in vivo animal study was conducted to investigate the effects of a newly isolated lactic acid bacterium (Lactobacillus plantarum CQPC11, LP-CQPC11) on d-galactose-induced oxidation and aging in mice. Analysis of the serum and tissue samples of these mice using molecular biology approaches showed that LP-CQPC11 suppressed the decrease in thymus, brain, heart, liver, spleen, and kidney indices caused by oxidation and aging. Furthermore, LP-CQPC11 increased the levels of SOD (superoxide dismutase), GSH-Px (glutathione peroxidase), and GSH (glutathione), whereas it reduced the levels of NO (nitric oxide) and MDA (malondialdehyde) in the serum, liver, and spleen of oxidation and aging mouse models. Pathological observation indicated that LP-CQPC11 alleviated the damage caused by oxidation and aging on the liver and spleen of mice. qPCR analysis indicated that LP-CQPC11 effectively upregulated the expression of nNOS (neuronal nitric oxide synthase), eNOS (endothelial nitric oxide synthase), Cu/Zn-SOD (cuprozinc-superoxide dismutase), Mn-SOD (manganese superoxide dismutase), CAT (catalase), HO-1 (heme oxygenase-1), Nrf2 (nuclear factor-erythroid 2 related factor 2), -GCS (-glutamylcysteine synthetase), and NQO1 (NAD(P)H dehydrogenase [quinone] 1), but downregulated the expression of iNOS (inducible nitric oxide synthase) in the mouse liver and spleen. Western blot analysis showed that LP-CQPC11 effectively upregulated SOD1 (Cu/Zn-SOD), SOD2 (Mn-SOD), CAT, GSH1 (c-glutamylcysteine synthetase), and GSH2 (glutathione synthetase) protein expression in mouse liver and spleen tissues. These findings suggest that LP-CQPC11 can effectively prevent d-galactose-induced oxidation and aging in mice, and the effect is even better than that of the commonly used Lactobacillus delbruechii subsp. bulgaricus (LDSB) and vitamin C in the industry. Thus, LP-CQPC11 may be potentially employed as a probiotic strain.
C1 [Qian, Yu; Zhou, Xianrong; Yi, Ruokun; Mu, Jianfei; Long, Xingyao; Pan, Yanni; Zhao, Xin] Chongqing Univ Educ, Chongqing Collaborat Innovat Ctr Funct Food, Chongqing 400067, Peoples R China.
   [Qian, Yu; Yi, Ruokun; Zhao, Xin] Chongqing Univ Educ, Chongqing Engn Res Ctr Funct Food, Chongqing 400067, Peoples R China.
   [Qian, Yu; Yi, Ruokun; Zhao, Xin] Chongqing Univ Educ, Chongqing Engn Lab Res & Dev Funct Food, Chongqing 400067, Peoples R China.
   [Qian, Yu] Chongqing Univ Educ, Coll Biol & Chem Engn, Chongqing 400067, Peoples R China.
   [Zhang, Jing] Chongqing Chem Ind Vocat Coll, Environm & Qual Inspect Coll, Chongqing 401228, Peoples R China.
   [Zhou, Xianrong; Mu, Jianfei] Southwest Univ, Coll Food Sci, Chongqing 400715, Peoples R China.
   [Long, Xingyao; Pan, Yanni] Cha Univ, Dept Food Sci & Biotechnol, Seongnam 13488, Gyeongghi Do, South Korea.
   [Liu, Weiwei] Chongqing Med Univ, Sch Publ Hlth & Management, Chongqing 400016, Peoples R China.
C3 Chongqing University of Education; Chongqing University of Education;
   Chongqing University of Education; Chongqing University of Education;
   Southwest University - China; Pochon Cha University; Chongqing Medical
   University
RP Zhao, X (corresponding author), Chongqing Univ Educ, Chongqing Collaborat Innovat Ctr Funct Food, Chongqing 400067, Peoples R China.; Zhao, X (corresponding author), Chongqing Univ Educ, Chongqing Engn Res Ctr Funct Food, Chongqing 400067, Peoples R China.; Zhao, X (corresponding author), Chongqing Univ Educ, Chongqing Engn Lab Res & Dev Funct Food, Chongqing 400067, Peoples R China.; Liu, WW (corresponding author), Chongqing Med Univ, Sch Publ Hlth & Management, Chongqing 400016, Peoples R China.
EM qianyubaby@126.com; zjinger0810@126.com; zhouxr@foods.ac.cn;
   yirk@cque.edu.cn; mujianfei@foods.ac.cn; longyaoyao@foods.ac.cn;
   panyanni@foods.ac.cn; zhaoxin@cque.edu.cn; weiweiliu521@gmail.com
FU Program for Innovation Team Building at Institutions of Higher Education
   in Chongqing [CXTDX201601040]; Research Project of Chongqing University
   of Education, China [KY2015TBZC]
FX The present research was supported by the Program for Innovation Team
   Building at Institutions of Higher Education in Chongqing
   [CXTDX201601040] and the Research Project of Chongqing University of
   Education [KY2015TBZC], China.
CR Bakir M, 2016, CYTOTECHNOLOGY, V68, P1131, DOI 10.1007/s10616-015-9871-z
   Berndt C, 2017, ANTIOXID REDOX SIGN, V27, P1235, DOI 10.1089/ars.2017.7132
   Bonthius DJ, 2015, NEUROTOXICOLOGY, V46, P60, DOI 10.1016/j.neuro.2014.11.009
   Buford TW, 2016, AGEING RES REV, V26, P96, DOI 10.1016/j.arr.2016.01.007
   Chard S, 2017, J GERONTOL B-PSYCHOL, V72, P319, DOI 10.1093/geronb/gbw119
   Chen G., 2014, J FOOD SCI TECHNOLOG, V6, P1, DOI DOI 10.19026/ajfst.6.3021
   Chen XY, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8081249
   Chen XY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082212
   Chen XY, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060545
   Dai CS, 2017, TOXICOL MECH METHOD, V27, P165, DOI 10.1080/15376516.2016.1273424
   Eroglu E, 2017, NITRIC OXIDE-BIOL CH, V70, P59, DOI 10.1016/j.niox.2017.09.001
   Fang WT, 2010, ACTA PHARMACOL SIN, V31, P485, DOI 10.1038/aps.2010.23
   Folbergrová J, 2013, INT J DEV NEUROSCI, V31, P123, DOI 10.1016/j.ijdevneu.2012.11.011
   Fukai T, 2000, J CLIN INVEST, V105, P1631, DOI 10.1172/JCI9551
   Hong C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10443-6
   Hosen MB, 2015, INT J REPROD BIOMED, V13, P525
   Huang Y, 2009, FOOD CONTROL, V20, P1030, DOI 10.1016/j.foodcont.2008.12.008
   Iwayama K, 2017, BMC PHARMACOL TOXICO, V18, DOI 10.1186/s40360-017-0119-8
   Jiang XP, 2017, ENVIRON TOXICOL, V32, P1908, DOI 10.1002/tox.22413
   Khan SS, 2017, AGING CELL, V16, P624, DOI 10.1111/acel.12601
   Kitada M, 2016, AGING-US, V8, P2290, DOI 10.18632/aging.101068
   Kosenko EA, 2017, FREE RADICAL BIO MED, V113, P109, DOI 10.1016/j.freeradbiomed.2017.09.023
   Lee MH, 2001, J NEUROCHEM, V78, P32, DOI 10.1046/j.1471-4159.2001.00416.x
   Lei LH, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1975-x
   Li GJ, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8050752
   Li L, 2016, NEURAL REGEN RES, V11, P807, DOI 10.4103/1673-5374.182709
   Liang HP, 2018, ANN MICROBIOL, V68, P111, DOI 10.1007/s13213-017-1321-z
   Liu AP, 2017, J AGR FOOD CHEM, V65, P2580, DOI 10.1021/acs.jafc.7b00050
   [刘思雨 Liu Siyu], 2017, [食品与机械, Food and Machinery], V33, P26
   Liu WL, 2014, ADV MATER RES-SWITZ, V884-885, P429, DOI 10.4028/www.scientific.net/AMR.884-885.429
   Manini TM, 2010, AGEING RES REV, V9, P1, DOI 10.1016/j.arr.2009.08.002
   Qian Y, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8030363
   Selvaratnam JS, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.141671
   Sue YM, 2009, NEPHROL DIAL TRANSPL, V24, P769, DOI 10.1093/ndt/gfn545
   Tang T, 2013, AFR J TRADIT COMPLEM, V10, P12, DOI 10.4314/ajtcam.v10i4.3
   Tessari P, 2015, J NEPHROL, V28, P257, DOI 10.1007/s40620-014-0136-2
   Vinusha KS, 2018, BIOCHEM BIOPHYS REP, V14, P140, DOI 10.1016/j.bbrep.2018.04.009
   Wang FB, 2016, PLANT PHYSIOL BIOCH, V109, P248, DOI 10.1016/j.plaphy.2016.10.005
   Wang JJ, 2008, DEVELOPMENT, V29, P163
   Wang YL, 2016, TOXICOL APPL PHARM, V308, P91, DOI 10.1016/j.taap.2016.07.006
   WARNER HR, 1994, FREE RADICAL BIO MED, V17, P249, DOI 10.1016/0891-5849(94)90080-9
   Wells SM, 2007, AM J RESP CELL MOL, V36, P520, DOI 10.1165/rcmb.2006-0302SM
   [杨吉霞 Yang Jixia], 2015, [食品科学, Food Science], V36, P158
   Zhang J, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8091498
   Zhao X, 2018, MOLECULES, V23, DOI 10.3390/molecules23010204
NR 45
TC 43
Z9 47
U1 2
U2 39
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD NOV
PY 2018
VL 23
IS 11
AR 3026
DI 10.3390/molecules23113026
PG 17
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA HC2OO
UT WOS:000451641900298
PM 30463304
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Xiong, D
   Gao, F
   Shao, JB
   Pan, YY
   Wang, S
   Wei, D
   Ye, SG
   Chen, Y
   Chen, R
   Yue, BQ
   Li, J
   Chen, JY
AF Xiong, Dian
   Gao, Fei
   Shao, Jingbo
   Pan, Yueyun
   Wang, Song
   Wei, Dong
   Ye, Shugao
   Chen, Yuan
   Chen, Rui
   Yue, Bingqing
   Li, Juan
   Chen, Jingyu
TI Arctiin-encapsulated DSPE-PEG bubble-like nanoparticles inhibit alveolar
   epithelial type 2 cell senescence to alleviate pulmonary fibrosis via
   the p38/p53/p21 pathway
SO FRONTIERS IN PHARMACOLOGY
LA English
DT Article
DE idiopathic pulmonary fibrosis; alveolar epithelial type 2 cells;
   cellular senescence; arctiin; nanoparticle; DSPE-PEG; p38/p53/p21
   signaling axis; traditional Chinese medicine
ID P38 MAPK INHIBITOR; DELIVERY; PHARMACOLOGY; ACTIVATION
AB Background: Idiopathic pulmonary fibrosis is a severe and deadly form of diffuse parenchymal lung disease and treatment options are few. Alveolar epithelial type 2 (AEC2) cell senescence is implicated in the pathogenies of IPF. A major bioactive compound from the traditional Chinese medicine Fructus arctii, arctiin (ARC) has robust anti-inflammatory, anti-senescence, and anti-fibrosis functions. However, the potential therapeutic effects of ARC on IPF and the underlying mechanisms involved are still unknown.Methods: First of all, ARC was identified as an active ingredient by network pharmacology analysis and enrichment analysis of F. arctii in treating IPF. We developed ARC-encapsulated DSPE-PEG bubble-like nanoparticles (ARC@DPBNPs) to increase ARC hydrophilicity and achieve high pulmonary delivery efficiency. C57BL/6 mice were used to establish a bleomycin (BLM)-induced pulmonary fibrosis model for assessing the treatment effect of ARC@DPBNPs on lung fibrosis and the anti-senescence properties of AEC2. Meanwhile, p38/p53 signaling in AEC2 was detected in IPF lungs, BLM-induced mice, and an A549 senescence model. The effects of ARC@DPBNPs on p38/p53/p21 were assessed in vivo and in vitro.Results: Pulmonary route of administration of ARC@DPBNPs protected mice against BLM-induced pulmonary fibrosis without causing significant damage to the heart, liver, spleen, or kidney. ARC@DPBNPs blocked BLM-induced AEC2 senescence in vivo and in vitro. The p38/p53/p21 signaling axis was significantly activated in the lung tissues of patients with IPF, senescent AEC2, and BLM-induced lung fibrosis. ARC@DPBNPs attenuated AEC2 senescence and pulmonary fibrosis by inhibiting the p38/p53/p21 pathway.Conclusion: Our data suggest that the p38/p53/p21 signaling axis plays a pivotal role in AEC2 senescence in pulmonary fibrosis. The p38/p53/p21 signaling axis inhibition by ARC@DPBNPs provides an innovative approach to treating pulmonary fibrosis in clinical settings.
C1 [Xiong, Dian; Shao, Jingbo; Pan, Yueyun; Wei, Dong; Ye, Shugao; Chen, Yuan; Chen, Jingyu] Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Lung Transplantat Ctr, Dept Thorac Surg, Wuxi, Peoples R China.
   [Gao, Fei] Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Dept Emergency, Wuxi, Peoples R China.
   [Gao, Fei] Nanjing Gen Hosp Nanjing Mil Reg, Dept Emergency, Nanjing, Peoples R China.
   [Wang, Song] Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Dept Intens Care Med, Wuxi, Peoples R China.
   [Chen, Rui; Chen, Jingyu] Chongqing Med Univ, Coll Lab Med, Key Lab Clin Lab Diagnost, Minist Educ, Chongqing, Peoples R China.
   [Yue, Bingqing] Zhejiang Univ, Affiliated Hosp 2, Dept Lung Transplantat, Sch Med, Hangzhou, Peoples R China.
   [Li, Juan] Fudan Univ, Dept Chem, Shanghai, Peoples R China.
C3 Nanjing Medical University; Nanjing Medical University; Nanjing Medical
   University; Chongqing Medical University; Zhejiang University; Fudan
   University
RP Chen, JY (corresponding author), Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Lung Transplantat Ctr, Dept Thorac Surg, Wuxi, Peoples R China.; Chen, JY (corresponding author), Chongqing Med Univ, Coll Lab Med, Key Lab Clin Lab Diagnost, Minist Educ, Chongqing, Peoples R China.; Li, J (corresponding author), Fudan Univ, Dept Chem, Shanghai, Peoples R China.
EM chenjy@wuxiph.com; juanli0905@163.com
RI chen, jingyu/AAY-2275-2021
FU National Natural Science Foundation of China [82070059]; Natural Science
   Foundation Youth Project of China of Jiangsu Province [BK20220224];
   Youth Project of Wuxi Health and Family Planning Commission [Q202127]
FX Funding This study was supported by the National Natural Science
   Foundation of China (No. 82070059, China), Natural Science Foundation
   Youth Project of China of Jiangsu Province (No. BK20220224, China), and
   Youth Project of Wuxi Health and Family Planning Commission (No.
   Q202127, China).
CR Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205
   Bae S, 2014, BIOL RES, V47, DOI 10.1186/0717-6287-47-50
   Chen H, 2020, EUR J PHARMACOL, V875, DOI 10.1016/j.ejphar.2020.173053
   D'souza AA, 2016, EXPERT OPIN DRUG DEL, V13, P1257, DOI 10.1080/17425247.2016.1182485
   da Silva Adriana Lopes, 2017, Biophys Rev, V9, P793, DOI 10.1007/s12551-017-0319-x
   Dandekar P, 2010, J AEROSOL MED PULM D, V23, P343, DOI 10.1089/jamp.2009.0784
   Gaulton A, 2017, NUCLEIC ACIDS RES, V45, pD945, DOI 10.1093/nar/gkw1074
   Gfeller D, 2013, BIOINFORMATICS, V29, P3073, DOI 10.1093/bioinformatics/btt540
   Ghumman M, 2021, EUR J PHARM BIOPHARM, V164, P1, DOI 10.1016/j.ejpb.2021.03.017
   Goda C, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008692
   Han MS, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.882678
   Hayashi K, 2010, BIOL PHARM BULL, V33, P1199, DOI 10.1248/bpb.33.1199
   Hirose M, 2000, CANCER LETT, V155, P79, DOI 10.1016/S0304-3835(00)00411-0
   Kellogg D L, 2021, Curr Mol Biol Rep, V7, P31, DOI 10.1007/s40610-021-00145-4
   Kim KY, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051088
   King CS, 2015, CURR OPIN PULM MED, V21, P479, DOI 10.1097/MCP.0000000000000190
   Kropski JA, 2019, ANNU REV MED, V70, P211, DOI 10.1146/annurev-med-041317-102715
   Lee S, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-16
   Li J, 2017, J PHARMACOL SCI, V135, P97, DOI 10.1016/j.jphs.2017.05.012
   Li Y, 2022, J PHARM PHARMACOL, V74, P321, DOI 10.1093/jpp/rgab140
   Liu JQ, 2021, DRUG DES DEV THER, V15, P3255, DOI 10.2147/DDDT.S319786
   Liu XY, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/5598980
   Matsuda S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21186746
   Matsuoka H, 2002, AM J PHYSIOL-LUNG C, V283, pL103, DOI 10.1152/ajplung.00187.2001
   Matsuzaki Y, 2008, ONCOL REP, V19, P721
   Mora AL, 2017, NAT REV DRUG DISCOV, V16, DOI [10.1038/nrd.2017.225, 10.1038/nrd.2017.170]
   Oh KK, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23042055
   Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6
   Parimon T, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22126214
   Porsio B, 2018, ACS APPL MATER INTER, V10, P165, DOI 10.1021/acsami.7b14992
   Qiu T, 2019, AGING-US, V11, P7492, DOI 10.18632/aging.102262
   Rommasi F, 2021, NANOSCALE RES LETT, V16, DOI 10.1186/s11671-021-03553-8
   Ru JL, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-13
   Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020
   Sanchez-Prieto R, 2000, CANCER RES, V60, P2464
   Szklarczyk D, 2021, NUCLEIC ACIDS RES, V49, pD605, DOI 10.1093/nar/gkaa1074
   Tian YQ, 2019, AGING CELL, V18, DOI 10.1111/acel.12858
   Underwood DC, 2000, AM J PHYSIOL-LUNG C, V279, pL895, DOI 10.1152/ajplung.2000.279.5.L895
   Wang X, 2021, ACS APPL MATER INTER, V13, P39112, DOI 10.1021/acsami.1c11583
   Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD1074, DOI 10.1093/nar/gkx1037
   Wolters PJ, 2018, LANCET RESP MED, V6, P154, DOI 10.1016/S2213-2600(18)30007-9
   Xu Y, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.90558
   Yao CF, 2021, AM J RESP CRIT CARE, V203, P707, DOI 10.1164/rccm.202004-1274OC
   Zariwala MG, 2014, COLLOID SURFACE B, V115, P86, DOI 10.1016/j.colsurfb.2013.11.028
   Zeng N, 2012, INT J PHARMACEUT, V424, P58, DOI 10.1016/j.ijpharm.2011.12.058
   Zhang YK, 2021, BIOMED PHARMACOTHER, V133, DOI 10.1016/j.biopha.2020.111072
   Zhou Y, 2022, NUCLEIC ACIDS RES, V50, pD1398, DOI 10.1093/nar/gkab953
NR 47
TC 2
Z9 2
U1 7
U2 15
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1663-9812
J9 FRONT PHARMACOL
JI Front. Pharmacol.
PD MAR 14
PY 2023
VL 14
AR 1141800
DI 10.3389/fphar.2023.1141800
PG 19
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA A7QR4
UT WOS:000957033100001
PM 36998607
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Arora, AS
   Zafar, S
   Kollmar, O
   Llorens, F
   Tahir, W
   Vanselow, S
   Kumar, P
   Schmerr, MJ
   Schmitz, M
   Zerr, I
AF Arora, Amandeep Singh
   Zafar, Saima
   Kollmar, Otto
   Llorens, Franc
   Tahir, Waqas
   Vanselow, Sven
   Kumar, Prateek
   Schmerr, Mary Jo
   Schmitz, Matthias
   Zerr, Inga
TI Application of capillary immunoelectrophoresis revealed an age- and
   gender-dependent regulated expression of PrPC in liver
SO ELECTROPHORESIS
LA English
DT Article
DE Age; Capillary immunoelectrophoresis; Gender; Liver; PrPC
ID CELLULAR PRION PROTEIN; LASER-INDUCED FLUORESCENCE;
   ZONE-ELECTROPHORESIS; MOUSE; ADSORPTION; TISSUES; EMBRYOS; CELLS; SHEEP;
   VARY
AB The cellular prion protein (PrPC) is a glycoprotein, anchored to the plasma membrane and abundantly expressed in the central nervous system. The expression of PrPC in the peripheral tissues is low and only little information is available on its functions in the nonneuronal tissues. The antioxidant function of PrPC during the activation of hepatic stellate cells has already been reported. Therefore, the aim of the study was to expand our knowledge on the functions of PrPC by detailed characterization of its expressional profile in the liver. In a combined strategy by using capillary immunoelectrophoresis and standard techniques, we have shown a sexually dimorphic expression of PrPC in mice and human liver tissues. Further, we showed a significant age-dependent upregulation of PrPC expression in the liver of 14-and 9-month-old mice as compared to 3 months of age. Therefore, this study may provide new insights into the gender-specific role of PrPC in the liver, which may further be linked to its protective role against oxidative stress during aging. In addition, the current study also shows an application of immunoelectrophoresis with a low coefficient of variation to analyze the miniscule amount of PrPC in the mouse liver tissue.
C1 [Arora, Amandeep Singh; Zafar, Saima; Llorens, Franc; Tahir, Waqas; Vanselow, Sven; Kumar, Prateek; Schmitz, Matthias; Zerr, Inga] Univ Med Ctr Gottingen, Clin Dementia Ctr, Dept Neurol, D-37075 Gottingen, Germany.
   [Arora, Amandeep Singh; Zafar, Saima; Llorens, Franc; Tahir, Waqas; Vanselow, Sven; Kumar, Prateek; Schmitz, Matthias; Zerr, Inga] German Ctr Neurodegenerat Dis DZNE, Gottingen, Germany.
   [Kollmar, Otto] Univ Med Ctr Gottingen, Dept Gen Visceral & Pediat Surg, D-37075 Gottingen, Germany.
   [Schmerr, Mary Jo] Iowa State Univ, US DOE, Ames Lab, Ames, IA USA.
C3 University of Gottingen; Helmholtz Association; German Center for
   Neurodegenerative Diseases (DZNE); University of Gottingen; Iowa State
   University; United States Department of Energy (DOE); Ames National
   Laboratory
RP Zerr, I (corresponding author), Univ Med Ctr Gottingen, Clin Dementia Ctr, Dept Neurol, Robert Koch Str 40, D-37075 Gottingen, Germany.
EM ingazerr@med.uni-goettingen.de
RI kumar, prateek/AHA-0283-2022; Zafar, Saima/AAE-2799-2019; Zafar,
   Saima/GWZ-7001-2022
OI kumar, prateek/0000-0001-5875-4065; Zafar, Saima/0000-0002-4261-0339;
   Arora, Amandeep Singh/0000-0003-1045-1967; , Franc/0000-0002-9756-7497
FU EU Joint Program - Neurodegenerative Disease Research (JPND - DEMTEST)
   [01ED1201A]; Robert Koch Institute through Federal Ministry of Health
   [1369-341]; European Commission [222887, FP7-KBBE-2007-2A]
FX The authors acknowledge the financial support provided by grants from
   the EU Joint Program - Neurodegenerative Disease Research (JPND -
   DEMTEST (Biomarker based diagnosis of rapid progressive
   dementias-optimization of diagnostic protocols, 01ED1201A), also partly
   supported by the Robert Koch Institute through funds from the Federal
   Ministry of Health (grant no. 1369-341), and by a grant from the
   European Commission (Protecting the food chain from prions: shaping
   European priorities through basic and applied research (PRIORITY, No.
   222887) project number: FP7-KBBE-2007-2A), technical support by Katrin
   Thune, Mohsin Rosemol George, Simranjit Singh Rehal, and Nadine
   Gotzmann.
CR Appleby BS, 2007, J NEUROPSYCH CLIN N, V19, P428, DOI 10.1176/appi.neuropsych.19.4.428
   Bergendahl V, 2003, J IMMUNOL METHODS, V277, P117, DOI 10.1016/S0022-1759(03)00183-2
   de Jong S, 2012, ANAL CHEM, V84, P453, DOI 10.1021/ac2030333
   DEHAAN JB, 1994, PEDIATR RES, V35, P188, DOI 10.1203/00006450-199402000-00013
   Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101
   Ford MJ, 2002, NEUROSCIENCE, V113, P177, DOI 10.1016/S0306-4522(02)00155-0
   Gas B, 1997, ELECTROPHORESIS, V18, P2123, DOI 10.1002/elps.1150181203
   Gasperini L, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00044
   HORIUCHI M, 1995, J GEN VIROL, V76, P2583, DOI 10.1099/0022-1317-76-10-2583
   Ikeda K, 1998, AM J PATHOL, V153, P1695, DOI 10.1016/S0002-9440(10)65683-0
   Jackman R, 2003, ELECTROPHORESIS, V24, P892, DOI 10.1002/elps.200390112
   Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007
   Loeuillet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013166
   Mar C.-T., 2011, NEUROSCI MED, V2, P384
   Meyne F, 2009, J ALZHEIMERS DIS, V17, P863, DOI 10.3233/JAD-2009-1110
   Mode A, 2006, DRUG METAB REV, V38, P197, DOI 10.1080/03602530600570057
   Moudjou M, 2001, J GEN VIROL, V82, P2017, DOI 10.1099/0022-1317-82-8-2017
   Mouillet-Richard S, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00007
   Peralta OA, 2012, MOL REPROD DEV, V79, P488, DOI 10.1002/mrd.22057
   Politopoulou G, 2000, HAEMATOLOGICA, V85, P580
   SCHURE MR, 1993, ANAL CHEM, V65, P3024, DOI 10.1021/ac00069a015
   Towns J. K., 1992, ANAL CHEM, V63, P1132
   Waggoner DJ, 2000, J BIOL CHEM, V275, P7455, DOI 10.1074/jbc.275.11.7455
   Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705
   Williams WM, 2004, NEUROPATH APPL NEURO, V30, P161, DOI 10.1111/j.1365-2990.2003.00523.x
   Yang WC, 2005, ELECTROPHORESIS, V26, P1751, DOI 10.1002/elps.200410202
NR 26
TC 3
Z9 3
U1 2
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0173-0835
EI 1522-2683
J9 ELECTROPHORESIS
JI Electrophoresis
PD DEC
PY 2015
VL 36
IS 24
BP 3026
EP 3033
DI 10.1002/elps.201500244
PG 8
WC Biochemical Research Methods; Chemistry, Analytical
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA DA8BB
UT WOS:000368028200007
PM 26377521
DA 2024-02-19
ER

PT J
AU Sánchez-Hidalgo, M
   Guerrero Montávez, JM
   Carrascosa-Salmoral, MD
   Naranjo Gutierrez, MD
   Lardone, PJ
   Romero, CAD
AF Sanchez-Hidalgo, Marina
   Guerrero Montavez, Juan Miguel
   Carrascosa-Salmoral, Maria del Pilar
   Naranjo Gutierrez, Maria del Carmen
   Lardone, Patricia Judith
   de la Lastra Romero, Catalina Alarcon
TI Decreased MT1 and MT2 melatonin receptor expression in extrapineal
   tissues of the rat during physiological aging
SO JOURNAL OF PINEAL RESEARCH
LA English
DT Article
DE aging; extrapineal melatonin; melatonin receptors; neuroimmunomodulation
ID AGE-RELATED-CHANGES; MESSENGER-RNA; PINEAL MELATONIN; BINDING-SITES;
   ALZHEIMERS-DISEASE; SUPRACHIASMATIC NUCLEUS; DIETARY MELATONIN;
   MEMBRANE-RECEPTOR; OXIDATIVE DAMAGE; HARDERIAN-GLAND
AB Aging is a complex process associated with a diminished ability to respond to stress, a progressive increase in free radical generation and a decline in immune function. Melatonin, a molecule with a great functional versatility exerts anti-oxidant, oncostatic, immunomodulatory, and anti-aging properties. Melatonin levels drop during aging and it has been speculated that the loss of melatonin may accelerate aging. This study was designed to elucidate whether aging involves responsiveness to reduced melatonin. Melatonin membrane receptor (MT1 and MT2) expression and MT1 protein expression were analyzed in extrapineal tissues (thymus, spleen, liver, kidney, and heart) of 3- and 12-month-old rats using real time polymerase chain reaction and western blotting analysis. Moreover, melatonin in tissues was measured by high performance liquid chromatography. We report for the first time, an age-related reduction in mRNA MT1 and MT2 expression levels as well as MT1 protein expression in all tissues tested except the thymus, where surprisingly, both melatonin receptor levels were significantly higher in 12-month-old rats and MT1 protein expression maintained unchanged with age. Diminished melatonin concentrations were measured in spleen, liver, and heart during aging. As a conclusion, physiological aging seems to exert responsiveness to melatonin and consequently, the loss of this potent anti-oxidant may contribute to onset of aging.
C1 [Sanchez-Hidalgo, Marina; de la Lastra Romero, Catalina Alarcon] Univ Seville, Fac Pharm, Dept Pharmacol, E-41012 Seville, Spain.
   [Sanchez-Hidalgo, Marina; Guerrero Montavez, Juan Miguel; Carrascosa-Salmoral, Maria del Pilar; Naranjo Gutierrez, Maria del Carmen; Lardone, Patricia Judith] Virgen del Rocio Univ Hosp, Seville, Spain.
   [Sanchez-Hidalgo, Marina; Guerrero Montavez, Juan Miguel; Carrascosa-Salmoral, Maria del Pilar; Naranjo Gutierrez, Maria del Carmen; Lardone, Patricia Judith] Univ Seville, Sch Med, Dept Med Biochem & Mol Biol, E-41012 Seville, Spain.
C3 University of Sevilla; Virgen del Rocio University Hospital; University
   of Sevilla
RP Romero, CAD (corresponding author), Univ Seville, Fac Pharm, Dept Pharmacol, Profesor Garcia Gonzalez 2, E-41012 Seville, Spain.
EM hidalgosanz@us.es; calarcon@us.es
RI Lardone, Patricia J/H-1959-2015; Guerrero, Juan Manuel/AFS-1946-2022;
   Alarcon-de-la-Lastra, Catalina C/F-6282-2013; Sanchez-Hidalgo,
   Marina/E-9231-2010; IBIS, NEUROINMUNO/O-9306-2015; NARANJO GUTIÉRREZ,
   MARÍA DEL CARMEN/G-2105-2016
OI Lardone, Patricia J/0000-0003-1793-3985; Guerrero, Juan
   Manuel/0000-0001-5529-9837; Alarcon-de-la-Lastra, Catalina
   C/0000-0001-6625-3818; Sanchez-Hidalgo, Marina/0000-0002-9210-2404;
   Guerrero, Juan Miguel/0000-0001-7553-0119
FU Postgraduate National Program of FPU [P06CTS-0160, PI 060091,
   RD06/00130001]; Spanish MEC
FX This work was supported by grants of the Andalucian (P06CTS-0160) and
   Spanish (PI 060091; RD06/00130001) governments. MSH gratefully
   acknowledges support from a Postgraduate National Program of FPU
   fellowship and financial sponsorship from the Spanish MEC.
CR Arlt W, 2004, AGING CELL, V3, P209, DOI 10.1111/j.1474-9728.2004.00109.x
   Benloucif S, 1997, AM J PHYSIOL-REG I, V273, pR1855, DOI 10.1152/ajpregu.1997.273.6.R1855
   Blask DE, 2004, CARCINOGENESIS, V25, P951, DOI 10.1093/carcin/bgh090
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CARDINALI DP, 1972, ENDOCRINOLOGY, V91, P247, DOI 10.1210/endo-91-1-247
   Carrillo-Vico A, 2003, CELL MOL LIFE SCI, V60, P2272, DOI 10.1007/s00018-003-3207-4
   Carrillo-Vico A, 2006, CURR OPIN INVEST DR, V7, P423
   Carrillo-Vico A, 2005, ENDOCRINE, V27, P189, DOI 10.1385/ENDO:27:2:189
   Carrillo-Vico A, 2003, FASEB J, V17, P755, DOI 10.1096/fj.02-0501fje
   Dubocovich ML, 2005, ENDOCRINE, V27, P101, DOI 10.1385/ENDO:27:2:101
   Ekmekcioglu C, 2003, J PINEAL RES, V35, P40, DOI 10.1034/j.1600-079X.2003.00051.x
   Fernandes PACM, 2006, J PINEAL RES, V41, P344, DOI 10.1111/j.1600-079X.2006.00373.x
   Fujieda H, 2003, NEUROSCIENCE, V120, P301, DOI 10.1016/S0306-4522(03)00298-7
   Gruver AL, 2007, J PATHOL, V211, P144, DOI 10.1002/path.2104
   Guerrero Juan M., 2002, Current Topics in Medicinal Chemistry, V2, P167, DOI 10.2174/1568026023394335
   Lahiri DK, 2004, J PINEAL RES, V36, P217, DOI 10.1111/j.1600-079X.2004.00120.x
   Lardone PJ, 2006, J CELL PHYSIOL, V206, P273, DOI 10.1002/jcp.20461
   LAUDON M, 1988, NEUROENDOCRINOLOGY, V48, P577, DOI 10.1159/000125066
   LIU ZM, 1993, J ENDOCRINOL, V138, P51, DOI 10.1677/joe.0.1380051
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   LOPEZGONZALEZ MA, 1993, J NEUROIMMUNOL, V45, P121, DOI 10.1016/0165-5728(93)90171-T
   Matsubara E, 2003, J NEUROCHEM, V85, P1101, DOI 10.1046/j.1471-4159.2003.01654.x
   MENENDEZPELAEZ A, 1993, J PINEAL RES, V14, P34, DOI 10.1111/j.1600-079X.1993.tb00482.x
   Naranjo MC, 2007, CELL MOL LIFE SCI, V64, P781, DOI 10.1007/s00018-007-6435-1
   Okatani Y, 2002, NEUROBIOL AGING, V23, P639, DOI 10.1016/S0197-4580(02)00005-2
   Pang C. S., 1993, Biological Signals, V2, P228
   Pang CS, 2002, J PINEAL RES, V32, P243, DOI 10.1034/j.1600-079X.2002.01860.x
   PANG SF, 1990, J PINEAL RES, V8, P179, DOI 10.1111/j.1600-079X.1990.tb00678.x
   Paul P, 1999, J PHARMACOL EXP THER, V290, P334
   Poirel VJ, 2003, NEUROENDOCRINOL LETT, V24, P33
   Pontes GN, 2006, J PINEAL RES, V41, P136, DOI 10.1111/j.1600-079X.2006.00345.x
   Poon AMS, 2001, BIOL SIGNAL RECEPT, V10, P367
   Pozo D, 1997, FASEB J, V11, P466, DOI 10.1096/fasebj.11.6.9194527
   Rafii-El-Idrissi M, 1998, J NEUROIMMUNOL, V86, P190, DOI 10.1016/S0165-5728(98)00048-4
   Reiter RJ, 1998, P W PHARMACOL SOC, V41, P229
   REITER RJ, 1991, ENDOCR REV, V12, P151, DOI 10.1210/edrv-12-2-151
   Reiter RJ, 2002, ANN NY ACAD SCI, V959, P238, DOI 10.1111/j.1749-6632.2002.tb02096.x
   REITER RJ, 1981, ENDOCRINOLOGY, V109, P1295, DOI 10.1210/endo-109-4-1295
   REITER RJ, 1980, SCIENCE, V210, P1372, DOI 10.1126/science.7434032
   Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x
   Rodríguez MI, 2007, J PINEAL RES, V42, P272, DOI 10.1111/j.1600-079X.2006.00416.x
   Sallinen P, 2005, LIFE SCI, V76, P1123, DOI 10.1016/j.lfs.2004.08.016
   Sanchez-Hidalgo M, 2007, AM J PHYSIOL-REG I, V292, pR2208, DOI 10.1152/ajpregu.00013.2007
   Savaskan E, 2005, J PINEAL RES, V38, P10, DOI 10.1111/j.1600-079X.2004.00169.x
   Sharman KG, 2002, NEUROBIOL AGING, V23, P633, DOI 10.1016/S0197-4580(01)00329-3
   Tan DX, 2007, J PINEAL RES, V42, P28, DOI 10.1111/j.1600-079X.2006.00407.x
   Tan DX, 2007, J PINEAL RES, V43, P317, DOI 10.1111/j.1600-079X.2007.00513.x
   Tan DX, 2000, FREE RADICAL BIO MED, V29, P1177, DOI 10.1016/S0891-5849(00)00435-4
   Tijmes M, 1996, STEROIDS, V61, P65, DOI 10.1016/0039-128X(95)00197-X
   Turjanski AG, 2004, PROTEIN SCI, V13, P2925, DOI 10.1110/ps.04611404
   VISWANATHAN M, 1992, NEUROENDOCRINOLOGY, V56, P864, DOI 10.1159/000126318
   WHEALIN JM, 1993, NEUROSCI LETT, V154, P149, DOI 10.1016/0304-3940(93)90193-O
   Winczyk K, 2002, TUMOR BIOL, V23, P298, DOI 10.1159/000068569
   Wolkove N, 2007, CAN MED ASSOC J, V176, P1299, DOI 10.1503/cmaj.060792
   Wu YH, 2007, NEUROBIOL AGING, V28, P1239, DOI 10.1016/j.neurobiolaging.2006.06.002
   YU HS, 1981, J ENDOCRINOL, V91, P477, DOI 10.1677/joe.0.0910477
NR 56
TC 81
Z9 87
U1 0
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3098
EI 1600-079X
J9 J PINEAL RES
JI J. Pineal Res.
PD JAN
PY 2009
VL 46
IS 1
BP 29
EP 35
DI 10.1111/j.1600-079X.2008.00604.x
PG 7
WC Endocrinology & Metabolism; Neurosciences; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Neurosciences & Neurology; Physiology
GA 377AC
UT WOS:000261223100005
PM 18513209
DA 2024-02-19
ER

PT J
AU LIU, XT
   STEWART, CA
   KING, RL
   DANNER, DA
   DELLORCO, RT
   MCCLUNG, JK
AF LIU, XT
   STEWART, CA
   KING, RL
   DANNER, DA
   DELLORCO, RT
   MCCLUNG, JK
TI PROHIBITIN EXPRESSION DURING CELLULAR SENESCENCE OF HUMAN-DIPLOID
   FIBROBLASTS
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
ID RETINOBLASTOMA GENE-PRODUCT; DNA-SYNTHESIS; MICROINJECTION SYSTEM;
   MESSENGER-RNA; RAT-LIVER; PROTEIN; PHOSPHORYLATION; INHIBITORS; ASSAY;
   P53
AB Prohibitin is an evolutionarily conserved gene postulated to possess tumor suppressor activity and to contribute to the limited lifespan of human diploid fibroblast-like cells. Prohibitin mRNA and protein expression and its ability to become post-translationally modified were determined in human diploid fibroblast-like cells of different in vitro ages. The expression of prohibitin mRNA and protein changes little with increasing in vitro age; however, its protein product is post-synthetically modified in younger but not older cells. These results suggest that prohibitin is similar to the retinoblastoma gene product whose anti-proliferative activity remains active in older cells because it is not post-synthetically modified. (C) 1994 Academic Press, Inc.
C1 NIA,GENET MOLEC LAB,BALTIMORE,MD 21224.
C3 National Institutes of Health (NIH) - USA; NIH National Institute on
   Aging (NIA)
RP LIU, XT (corresponding author), OKLAHOMA MED RES FDN,NOBLE CTR BIOMED RES,OKLAHOMA CITY,OK 73104, USA.
CR Barile MF., 1973, TISSUE CULTURE METHO, P729, DOI 10.1016/B978-0-12-427150-0.50160-1
   BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4
   CAMPISI J, 1992, EXP GERONTOL, V27, P397, DOI 10.1016/0531-5565(92)90071-7
   COBRINIK D, 1992, TRENDS BIOCHEM SCI, V17, P312, DOI 10.1016/0968-0004(92)90443-D
   DELLORCO RT, IN PRESS EXP GERONTO
   EVELETH DD, 1986, NUCLEIC ACIDS RES, V14, P6169, DOI 10.1093/nar/14.15.6169
   FERLUGA J, 1990, MECH AGEING DEV, V53, P267, DOI 10.1016/0047-6374(90)90044-G
   FISCELLA M, 1993, ONCOGENE, V8, P1519
   Franklin D.S., 1993, J CELL BIOCHEM, V17D, P159
   GOLDSTEIN S, 1990, SCIENCE, V249, P1129, DOI 10.1126/science.2204114
   HARA E, 1991, BIOCHEM BIOPH RES CO, V179, P528, DOI 10.1016/0006-291X(91)91403-Y
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   KINGSTON RE, 1987, CURRENT PROTOCOLS MO
   LUMPKIN CK, 1986, SCIENCE, V232, P393, DOI 10.1126/science.2421407
   LUMPKIN CK, 1985, EXP CELL RES, V160, P544, DOI 10.1016/0014-4827(85)90201-0
   MCCLUNG JK, 1992, EXP GERONTOL, V27, P413, DOI 10.1016/0531-5565(92)90074-A
   MCCLUNG JK, 1989, BIOCHEM BIOPH RES CO, V164, P1316, DOI 10.1016/0006-291X(89)91813-5
   MIHARA K, 1989, SCIENCE, V246, P1300, DOI 10.1126/science.2588006
   MILNE DM, 1992, NUCLEIC ACIDS RES, V20, P1627
   NUELL MJ, 1991, MOL CELL BIOL, V11, P1372, DOI 10.1128/MCB.11.3.1372
   NUELL MJ, 1989, EXP GERONTOL, V24, P469, DOI 10.1016/0531-5565(89)90053-3
   OFARRELL PH, 1975, J BIOL CHEM, V250, P4007
   PEACOCKE M, 1991, J CELL BIOCHEM, V45, P147, DOI 10.1002/jcb.240450205
   PEPPERKOK R, 1988, P NATL ACAD SCI USA, V85, P6748, DOI 10.1073/pnas.85.18.6748
   PEPPERKOK R, 1988, EXP CELL RES, V178, P369, DOI 10.1016/0014-4827(88)90406-5
   PEREIRASMITH OM, 1983, SCIENCE, V221, P964, DOI 10.1126/science.6879195
   SATO T, 1992, CANCER RES, V52, P1643
   SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2
   SHEGEOKA H, 1991, MECH AGEING DEV, V57, P63
   SMITH JR, 1990, J GERONTOL, V45, pB32, DOI 10.1093/geronj/45.2.B32
   SMITH JR, 1992, EXP GERONTOL, V27, P409, DOI 10.1016/0531-5565(92)90073-9
   STEIN GH, 1990, SCIENCE, V249, P666, DOI 10.1126/science.2166342
   STEWART CA, 1992, IN VITRO CELL DEV-AN, V28A, P211, DOI 10.1007/BF02631094
   TOBEY RA, 1988, EXP CELL RES, V172, P400
   WRIGHT WE, 1989, MOL CELL BIOL, V9, P3088, DOI 10.1128/MCB.9.7.3088
   ZAMBETTI G, 1987, EXP CELL RES, V172, P397, DOI 10.1016/0014-4827(87)90397-1
NR 36
TC 45
Z9 51
U1 0
U2 0
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD MAY 30
PY 1994
VL 201
IS 1
BP 409
EP 414
DI 10.1006/bbrc.1994.1716
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA NN877
UT WOS:A1994NN87700056
PM 8198603
DA 2024-02-19
ER

PT J
AU POMMIER, SA
AF POMMIER, SA
TI VITAMIN-A, ELECTRICAL-STIMULATION, AND CHILLING RATE EFFECTS ON
   LYSOSOMAL-ENZYME ACTIVITY IN AGING BOVINE MUSCLE
SO JOURNAL OF FOOD SCIENCE
LA English
DT Article
DE MEAT AGING; BOVINE; CATHEPSIN; CHILLING RATE; ELECTRICAL STIMULATION
ID POLYACRYLAMIDE GEL-ELECTROPHORESIS; INTRAMUSCULAR COLLAGEN;
   LONGISSIMUS-DORSI; FRAGMENTATION INDEX; POSTMORTEM STORAGE;
   IONIC-STRENGTH; TENDERNESS; CARCASSES; BEEF; PALATABILITY
AB Means of enhancing the rate of aging of bovine meat were investigated to provide some understanding of the tenderization process. Vitamin A was administered to finishing steers, carcasses were electrically stimulated, and longissimus doris muscle samples chilled at 2 different rates. Liver cathepsin D, beta-glucuronidase and hexosaminidase were increased (P < 0.05) with vitamin A supplementation but muscle enzymes were not affected. Chilling rate, electrical stimulation and time significantly (P < 0.05) affected cathepsin D distribution patterns, meat color, Warner-Bratzler, myofibrillar fragmentation index and collagen data. Troponin-T degradation was enhanced by aging. Thus, vitamin A can modify liver catheptic enzyme activity but does not affect muscle enzymes at these levels.
RP POMMIER, SA (corresponding author), LENNOXVILLE RES STN AGR CANADA, POB 90, 2000 RD 108 E, LENNOXVILLE J1M 1Z3, QUEBEC, CANADA.
CR [Anonymous], 1987, VITAMIN TOLERANCE AN
   BARRETT AJ, 1977, LYSOSOMES LABORATORY, P124
   Bendall J. R., 1973, STRUCTURE FUNCTION M, P243
   BERGMAN I, 1963, ANAL CHEM, V35, P1961, DOI 10.1021/ac60205a053
   CALKINS CR, 1980, J FOOD SCI, V45, P111, DOI 10.1111/j.1365-2621.1980.tb03882.x
   CASSENS RG, 1967, J FOOD SCI, V32, P13, DOI 10.1111/j.1365-2621.1967.tb01947.x
   CHRYSTALL BB, 1976, NEW ZEAL J AGR RES, V19, P7, DOI 10.1080/00288233.1976.10421039
   Czarnecki M, 1969, Pol Med J, V8, P1143
   DUTSON TR, 1983, J FOOD BIOCHEM, V7, P223, DOI 10.1111/j.1745-4514.1983.tb00800.x
   DUTSON TR, 1980, J FOOD SCI, V45, P1097, DOI 10.1111/j.1365-2621.1980.tb07533.x
   GOLL DE, 1983, J FOOD BIOCHEM, V7, P137, DOI 10.1111/j.1745-4514.1983.tb00795.x
   GOLL DE, 1974, P RECIP MEAT C, V27, P250
   GOODMAN DS, 1980, FED PROC, V39, P2716
   HAWKINS RR, 1987, J ANIM SCI, V64, P171, DOI 10.2527/jas1987.641171x
   HILL F, 1966, J FOOD SCI, V31, P161, DOI 10.1111/j.1365-2621.1966.tb00472.x
   HIRSCH JG, 1964, FED PROC, V23, P1023
   JEREMIAH LE, 1984, CAN J ANIM SCI, V64, P1045, DOI 10.4141/cjas84-118
   JEREMIAH LE, 1981, CAN J ANIM SCI, V61, P53, DOI 10.4141/cjas81-008
   JEREMIAH LE, 1985, MEAT SCI, V12, P155, DOI 10.1016/0309-1740(85)90015-4
   KOOHMARAIE M, 1984, J FOOD SCI, V49, P290, DOI 10.1111/j.1365-2621.1984.tb13731.x
   KOOHMARAIE M, 1988, J FOOD SCI, V53, P407, DOI 10.1111/j.1365-2621.1988.tb07717.x
   KOOHMARAIE M, 1989, J ANIM SCI, V67, P934, DOI 10.2527/jas1989.674934x
   KOOHMARAIE M, 1984, J FOOD SCI, V49, P292, DOI 10.1111/j.1365-2621.1984.tb13732.x
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Locker R H, 1975, Adv Food Res, V21, P157
   LOFFLER BM, 1984, ANAL BIOCHEM, V142, P312, DOI 10.1016/0003-2697(84)90470-6
   MARSH BB, 1968, J FOOD SCI, V33, P12, DOI 10.1111/j.1365-2621.1968.tb00875.x
   MARTIN AH, 1970, CAN J ANIM SCI, V50, P235, DOI 10.4141/cjas70-036
   MCKEITH FK, 1981, J FOOD SCI, V46, P13, DOI 10.1111/j.1365-2621.1981.tb14519.x
   MCKEITH FK, 1980, J FOOD PROTECT, V43, P795, DOI 10.4315/0362-028X-43.10.795
   MILLS EW, 1989, MEAT SCI, V26, P115, DOI 10.1016/0309-1740(89)90034-X
   MOELLER PW, 1976, J FOOD SCI, V41, P216, DOI 10.1111/j.1365-2621.1976.tb01143.x
   OLSON DG, 1976, J FOOD SCI, V41, P1036, DOI 10.1111/j.1365-2621.1976.tb14384.x
   PATERSON BC, 1986, J FOOD SCI, V51, P876, DOI 10.1111/j.1365-2621.1986.tb11189.x
   Penny I F, 1979, Meat Sci, V3, P135, DOI 10.1016/0309-1740(79)90015-9
   POMMIER SA, 1987, MEAT SCI, V21, P203, DOI 10.1016/0309-1740(87)90090-8
   ROGERSON KM, 1975, BIOCHEM PHARMACOL, V24, P2293, DOI 10.1016/0006-2952(75)90269-5
   SAVELL JW, 1978, J ANIM SCI, V46, P1221, DOI 10.2527/jas1978.4651221x
   SAVELL JW, 1979, P RECIP MEAT C, V32, P113
   SCOPES RK, 1964, BIOCHEM J, V91, P201, DOI 10.1042/bj0910201
   SMITH GC, 1977, P MEAT IND RES CONF, V29, P147
   SONAIYA EB, 1982, J FOOD SCI, V47, P889, DOI 10.1111/j.1365-2621.1982.tb12738.x
   SUDHAKARAN PR, 1974, J NUTR, V104, P1466, DOI 10.1093/jn/104.11.1466
   SUDHAKARAN PR, 1976, ATHEROSCLEROSIS, V24, P281, DOI 10.1016/0021-9150(76)90083-6
   WEISSMANN G, 1964, FED PROC, V23, P1038
   WU FY, 1987, J ANIM SCI, V65, P597, DOI 10.2527/jas1987.652597x
   WU JJ, 1981, J FOOD SCI, V46, P1132, DOI 10.1111/j.1365-2621.1981.tb03008.x
   YATES LD, 1983, J MOL BIOL, V168, P123, DOI 10.1016/S0022-2836(83)80326-X
   1985, SAS K USERS GUIDE ST
   1984, NUTRIENT REQUIREMENT
   [No title captured]
NR 51
TC 14
Z9 17
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-1147
EI 1750-3841
J9 J FOOD SCI
JI J. Food Sci.
PD JAN-FEB
PY 1992
VL 57
IS 1
BP 30
EP 35
DI 10.1111/j.1365-2621.1992.tb05417.x
PG 6
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA HD555
UT WOS:A1992HD55500008
DA 2024-02-19
ER

PT J
AU ISHIGAMI, A
   REED, TD
   ROTH, GS
AF ISHIGAMI, A
   REED, TD
   ROTH, GS
TI EFFECT OF AGING ON EGF STIMULATED DNA-SYNTHESIS AND EGF RECEPTOR LEVELS
   IN PRIMARY CULTURED RAT HEPATOCYTES
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
ID GROWTH-FACTOR; AGE; GLYCOGENOLYSIS; BINDING; LIVER; CELLS
C1 NIA,FRANCIS SCOTT KEY MED CTR,GERONTOL RES CTR,BALTIMORE,MD 21224.
C3 National Institutes of Health (NIH) - USA; NIH National Institute on
   Aging (NIA)
CR Adelman RC, 1972, MECH AGEING DEV, V1, P49, DOI 10.1016/0047-6374(72)90052-8
   BENDECK JL, 1985, PEDIATR RES, V19, P862, DOI 10.1203/00006450-198508000-00018
   BUCHER NLR, 1964, CANCER RES, V24, P509
   CRISTOFALO VJ, 1985, CRC HDB CELL BIOL AG
   CRUISE JL, 1986, J CELL PHYSIOL, V127, P39, DOI 10.1002/jcp.1041270106
   DUTARTRE P, 1991, MECH AGEING DEV, V59, P275, DOI 10.1016/0047-6374(91)90138-P
   GRAHAM SM, 1987, AM J PHYSIOL, V253, pE277, DOI 10.1152/ajpendo.1987.253.3.E277
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   ISHIGAMI A, 1993, IN PRESS J CELL PHYS
   Jackson TR, 1990, CURR OPIN CELL BIOL, V2, P167, DOI 10.1016/0955-0674(90)90002-V
   KATZ MS, 1987, BIOCHEM BIOPH RES CO, V147, P724, DOI 10.1016/0006-291X(87)90990-9
   KOLLER MM, 1992, ARCH ORAL BIOL, V37, P219, DOI 10.1016/0003-9969(92)90092-M
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MORIARITY DM, 1980, ARCH BIOCHEM BIOPHYS, V203, P506, DOI 10.1016/0003-9861(80)90208-8
   Ohashi M, 1980, EXP GERONTOL, V15, P539
   PHILLIPS PD, 1983, J CELL PHYSIOL, V114, P311, DOI 10.1002/jcp.1041140309
   RUBIN RA, 1983, J BIOL CHEM, V258, P5177
   STARRATT AN, 1974, CAN J MICROBIOL, V20, P416, DOI 10.1139/m74-063
   YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303
NR 19
TC 40
Z9 41
U1 0
U2 0
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD OCT 15
PY 1993
VL 196
IS 1
BP 181
EP 186
DI 10.1006/bbrc.1993.2232
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA MC105
UT WOS:A1993MC10500026
PM 8216291
OA hybrid
DA 2024-02-19
ER

PT J
AU Morales-Prieto, N
   de Lerma, NL
   Pacheco, IL
   Huertas-Abril, PV
   Pérez, J
   Peinado, R
   Abril, N
AF Morales-Prieto, Noelia
   Lopez de Lerma, Nieves
   Pacheco, Isabel L.
   Huertas-Abril, Paula V.
   Perez, Jose
   Peinado, Rafael
   Abril, Nieves
TI Protective effect of Pedro-Ximenez must against
   <i>p</i>,<i>p</i>′-DDE-induced liver damages in aged <i>Mus spretus</i>
   mice
SO FOOD AND CHEMICAL TOXICOLOGY
LA English
DT Article
DE Transcriptional analysis; Aging; Mus spretus; Hepatoprotection;
   Pedro-ximenez grape must; p,p '-DDE; Organochlorine; Oxidative damage
ID P,P'-DICHLORODIPHENYLDICHLOROETHYLENE DDE EXPOSURE; REDOX PROTEOMICS
   REVEALS; ANTIOXIDANT ACTIVITY; PHENOLIC CONTENT; RETINOIC ACID; GRAPE
   POMACE; CANCER DRUG; IN-VITRO; P'-DDE; METABOLISM
AB Aging is characterized by deterioration of biomolecules and impaired stress responses that make the elderly especially vulnerable to environmental pollutants. The pesticide p,p'-DDE is a DDT derivative that generates great concern because of its wide distribution and its harmful effects on both human health and the environment. We analyzed here the biological responses elicited by p,p'-DDE exposure in the liver of aged Mus spretus mice. Data demonstrate that the elderly constitute a population especially sensitive to this noxious environmental pollutant. We also demonstrated here that the daily consumption of sun-dried Pedro Ximenez (PX) white-grape must (PXM) protects the liver of aged mice from both the age and the damages caused by p,p'-DDE exposure. The PXM activity was exerted through the restoration of the hepatic metabolisms of lipids and carbohydrates and, probably, is a consequence of the ability of this polyphenol-rich mixture to avoid oxidative stress. Nutritional interventions including PXM, which ameliorates the effects of unavoidable exposure to pesticides in our food, are helpful tools that can help elderly populations to enjoy a healthy and expanded lifetime.
C1 [Morales-Prieto, Noelia; Huertas-Abril, Paula V.; Abril, Nieves] Univ Cordoba, Dept Bioquim & Biol Mol, Campus Extelencia Int Agr CeiA3, Campus Rabanales,Edificio Severn Ochoa, E-14071 Cordoba, Spain.
   [Lopez de Lerma, Nieves; Peinado, Rafael] Univ Cordoba, Dept Quim Agr, Campus Rabanales,Edificio Marie Curie, E-14071 Cordoba, Spain.
   [Pacheco, Isabel L.; Perez, Jose] Univ Cordoba, Dept Anat & Anat Patol Comparadas, Fac Vet, Campus Rabanales,Edificio Sanidad Anim, E-14071 Cordoba, Spain.
C3 Universidad de Cordoba; Universidad de Cordoba; Universidad de Cordoba
RP Abril, N (corresponding author), Univ Cordoba, Dept Biochem & Mol Biol, Bldg Severo Ochoa,2nd Floor,Campus Rabanales, Cordoba 14014, Spain.
EM bb1abdim@uco.es
RI Abril, Nieves/G-2764-2010; Pérez-Naranjo, José/JFT-1427-2023; Prieto,
   Noelia Morales/R-9973-2018; Pérez, José/K-1353-2014; Peinado,
   Rafael/L-2298-2014; Lopez de Lerma, Nieves/M-2682-2015
OI Abril, Nieves/0000-0001-8248-8561; Prieto, Noelia
   Morales/0000-0002-0123-2773; Pérez, José/0000-0002-8311-522X; Peinado,
   Rafael/0000-0002-0136-8793; Huertas-Abril, Paula V./0000-0003-4600-9521;
   Lopez de Lerma, Nieves/0000-0001-8961-0216; Pacheco Luque, Isabel
   Lourdes/0009-0009-9066-3898
FU European Regional Development Fund; Spanish Ministry of Economy and
   Competitiveness [CTM2012-38720-C03-02, CTM2015-67902-C2-1-P]; Agency of
   Economy, Competitiveness, Science and Employment from the Andalusian
   Government [BIO-1657]; Andalusian Plan of Research, Development and
   Innovation [BIO-187]
FX This work was co-financed by the European Regional Development Fund, the
   Spanish Ministry of Economy and Competitiveness (CTM2012-38720-C03-02
   and CTM2015-67902-C2-1-P), the Agency of Economy, Competitiveness,
   Science and Employment from the Andalusian Government (BIO-1657) and by
   the Andalusian Plan of Research, Development and Innovation to group
   BIO-187. The authors would like to thank Mrs. Esther Donoso her
   technical assistance, the staff of the Experimental Animals Service
   (SAEX) from the University of Cordoba for its help with mouse care and
   experimentation and the staff of the Genomics and Translational Genetic
   Service from the Principe Felipe Research Centre (Valencia) for their
   technical support with the microarray analyses. The authors also
   thankfully acknowledge the computer resources and assistance provided by
   the PAB (Andalusian Bioinformatics Platform) centre located at the
   University of Malaga (www.scbi.uma.es).
CR Abril N, 2015, SCI TOTAL ENVIRON, V523, P16, DOI [10.1016/j.scitotenv.2015.03.116, 10.1016/j.scitotenv.201]
   Abril N, 2014, ENVIRON SCI TECHNOL, V48, P2183, DOI 10.1021/es4053973
   Amador-Noguez D, 2007, AGING CELL, V6, P453, DOI 10.1111/j.1474-9726.2007.00300.x
   Andreola F, 2004, J BIOL CHEM, V279, P3434, DOI 10.1074/jbc.M305832200
   Beard J, 2006, SCI TOTAL ENVIRON, V355, P78, DOI 10.1016/j.scitotenv.2005.02.022
   Ben Rhouma K, 2001, HUM EXP TOXICOL, V20, P393, DOI 10.1191/096032701682692946
   Bettermann K, 2016, ONCOTARGET, V7, P73309, DOI 10.18632/oncotarget.12325
   Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185
   Boumahrou N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-80
   Brazma A, 2009, THESCIENTIFICWORLDJO, V9, P420, DOI 10.1100/tsw.2009.57
   Brubaker AL, 2011, AGING DIS, V2, P346
   Brunetti L, 2004, EUR J PHARMACOL, V493, P41, DOI 10.1016/j.ejphar.2004.04.020
   Carter KH, 2015, AM J TROP MED HYG, V92, P302, DOI 10.4269/ajtmh.14-0368
   Cetkovic-Cvrlje M, 2016, J IMMUNOTOXICOL, V13, P108, DOI 10.3109/1547691X.2015.1017060
   Chao C, 2002, MECH AGEING DEV, V123, P1469, DOI 10.1016/S0047-6374(02)00086-6
   Dejager L, 2009, TRENDS GENET, V25, P234, DOI 10.1016/j.tig.2009.03.007
   Dowling V, 2006, AQUAT TOXICOL, V77, P11, DOI 10.1016/j.aquatox.2005.10.011
   Dumitriu D, 2015, J FUNCT FOODS, V17, P380, DOI 10.1016/j.jff.2015.06.003
   Feart C, 2005, EUR J ENDOCRINOL, V152, P449, DOI 10.1530/eje.1.01858
   Fernandes E., 2016, GRAPE POLYPHENOL RIC, P389
   Fleming JL, 2013, PEERJ, V1, DOI 10.7717/peerj.68
   Fuellen G, 2019, AGING DIS, V10, P883, DOI 10.14336/AD.2018.1030
   Fuhrman B, 2001, J AGR FOOD CHEM, V49, P3164, DOI 10.1021/jf001378j
   Gessner D.K., 2016, J ANIM PHYSL ANIM NU
   Giovinazzo G, 2015, PLANT FOOD HUM NUTR, V70, P454, DOI 10.1007/s11130-015-0518-1
   Go YM, 2017, CLIN SCI, V131, P1669, DOI 10.1042/CS20160897
   Goulois J, 2017, PEST MANAG SCI, V73, P325, DOI 10.1002/ps.4319
   Howell GE, 2015, TOXICOLOGY, V328, P112, DOI 10.1016/j.tox.2014.12.017
   Hrycay E, 2014, MOL CELL BIOCHEM, V389, P119, DOI 10.1007/s11010-013-1933-y
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249
   Jiang P, 2013, TOXICOL MECH METHOD, V23, P396, DOI 10.3109/15376516.2013.769655
   Jurado J, 2003, J BIOL CHEM, V278, P45546, DOI 10.1074/jbc.M307866200
   Kaliora AC, 2017, J MED FOOD, V20, P301, DOI 10.1089/jmf.2016.0123
   Kay AR, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00041
   Kim HG, 2003, MOL CELLS, V16, P278
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kim YB, 2016, PROCEEDINGS OF THE 54TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2016), VOL 2, P8
   Koga T, 2016, J BIOL CHEM, V291, P25255, DOI 10.1074/jbc.M116.755447
   Koyanagi T, 2015, XENOBIOTICA, V45, P312, DOI 10.3109/00498254.2014.979271
   Krikorian R, 2012, J AGR FOOD CHEM, V60, P5736, DOI 10.1021/jf300277g
   Kvetnansky R, 2009, PHYSIOL REV, V89, P535, DOI 10.1152/physrev.00042.2006
   Lanzi CR, 2016, FOOD FUNCT, V7, P1544, DOI [10.1039/c5fo01065a, 10.1039/C5FO01065A]
   Li Q, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/504953
   Li TG, 2014, PHARMACOL REV, V66, P948, DOI 10.1124/pr.113.008201
   Lind PM, 2014, ENVIRON RES, V129, P27, DOI 10.1016/j.envres.2013.12.003
   Liu HW, 2015, J AGR FOOD CHEM, V63, P8407, DOI 10.1021/acs.jafc.5b02501
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Mahler KL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-626
   Malikova J, 2017, J STEROID BIOCHEM, V174, P192, DOI 10.1016/j.jsbmb.2017.09.007
   Marinho HS, 2014, REDOX BIOL, V2, P535, DOI 10.1016/j.redox.2014.02.006
   Marouani N, 2017, REPROD BIOL ENDOCRIN, V15, DOI 10.1186/s12958-017-0259-0
   Monteiro MS, 2015, J APPL TOXICOL, V35, P253, DOI 10.1002/jat.3014
   Morales-Prieto N, 2018, ENVIRON POLLUT, V238, P150, DOI 10.1016/j.envpol.2018.03.005
   Morales-Prieto N, 2018, FOOD CHEM TOXICOL, V114, P292, DOI 10.1016/j.fct.2018.02.047
   Morales-Prieto N, 2017, CHEMOSPHERE, V186, P848, DOI 10.1016/j.chemosphere.2017.08.057
   Morales-Prieto N, 2017, ENVIRON POLLUT, V230, P178, DOI 10.1016/j.envpol.2017.06.031
   Morales-Prieto N, 2017, J FUNCT FOODS, V34, P89, DOI 10.1016/j.jff.2017.04.025
   Moreno J, 2007, FOOD CHEM, V104, P224, DOI 10.1016/j.foodchem.2006.11.028
   Muñoz-Arnanz J, 2011, ENVIRON POLLUT, V159, P3640, DOI 10.1016/j.envpol.2011.07.027
   Murayama H, 2008, CLIN CHIM ACTA, V391, P31, DOI 10.1016/j.cca.2008.01.023
   Nicolopoulou-Stamati P, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00148
   Nishida Takuto, 2017, Advances in Biological Regulation, V66, P2, DOI 10.1016/j.jbior.2017.05.004
   Olson ST, 2011, PROG MOL BIOL TRANSL, V99, P185, DOI 10.1016/S1877-1173(11)99005-X
   Peinado J, 2010, EUR FOOD RES TECHNOL, V231, P363, DOI 10.1007/s00217-010-1279-6
   Peinado J, 2009, FOOD CHEM, V114, P1050, DOI 10.1016/j.foodchem.2008.10.068
   Peinado J, 2013, J FUNCT FOODS, V5, P1566, DOI 10.1016/j.jff.2013.06.007
   Peixoto H, 2016, J AGR FOOD CHEM, V64, P1283, DOI 10.1021/acs.jafc.5b05812
   del Villar LP, 2013, PARASITE, V20, DOI 10.1051/parasite/2013027
   Quan C, 2016, ENVIRON TOXICOL, V31, P593, DOI 10.1002/tox.22072
   Rak A, 2017, REPRODUCTION, V153, pR215, DOI 10.1530/REP-17-0002
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Rodríguez-Alcalá LM, 2015, J AGR FOOD CHEM, V63, P9341, DOI 10.1021/acs.jafc.5b03274
   Ruiz-Laguna J, 2016, ENVIRON SCI POLLUT R, V23, P5853, DOI 10.1007/s11356-015-5824-5
   Salihovic S, 2016, ENVIRON INT, V88, P60, DOI 10.1016/j.envint.2015.12.015
   Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3
   Sierra-Santoyo A, 2005, ARCH TOXICOL, V79, P7, DOI 10.1007/s00204-004-0603-y
   Stevanato R, 2004, J AGR FOOD CHEM, V52, P6287, DOI 10.1021/jf049898s
   Stoyanova II, 2014, NEUROBIOL DIS, V72, P72, DOI [10.1016/j.nbd2014.08.026, 10.1016/j.nbd.2014.08.026]
   Syal G, 2012, AM J PHYSIOL-GASTR L, V303, pG1077, DOI 10.1152/ajpgi.00227.2012
   Tajiri K, 2013, WORLD J GASTROENTERO, V19, P8459, DOI 10.3748/wjg.v19.i46.8459
   Taverna M, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-4
   Thompson LA, 2017, J VET MED SCI, V79, P751, DOI 10.1292/jvms.16-0214
   Vandooren J, 2016, ADV DRUG DELIVER REV, V97, P144, DOI 10.1016/j.addr.2015.12.020
   Vissavajjhala P., 2017, NUTR FUNCTIONAL FOOD, P3
   Vyskocilová E, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/408573
   Wang J, 2016, INT J FOOD SCI TECH, V51, P2360, DOI 10.1111/ijfs.13215
   WHO, 2011, GLOBAL HLTH AGING
   Wnuk A, 2016, NEUROTOX RES, V29, P155, DOI 10.1007/s12640-015-9572-6
   Wong S, 2010, ENDOCRINOLOGY, V151, P185, DOI 10.1210/en.2009-0590
   Wyde ME, 2003, MOL PHARMACOL, V64, P474, DOI 10.1124/mol.64.2.474
   Ruiz FX, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00058
   Yamazaki H, 2017, CHEM RES TOXICOL, V30, P53, DOI 10.1021/acs.chemrestox.6b00286
   Yang Wei, 2015, EXCLI J, V14, P1273, DOI 10.17179/excli2015-734
   Yoo KS, 2016, GUT LIVER, V10, P687, DOI 10.5009/gnl16033
   Zhang HQ, 2015, FREE RADICAL BIO MED, V88, P314, DOI 10.1016/j.freeradbiomed.2015.05.036
NR 96
TC 2
Z9 2
U1 1
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0278-6915
EI 1873-6351
J9 FOOD CHEM TOXICOL
JI Food Chem. Toxicol.
PD FEB
PY 2020
VL 136
AR 110984
DI 10.1016/j.fct.2019.110984
PG 13
WC Food Science & Technology; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Toxicology
GA KM3IS
UT WOS:000514015300029
PM 31765701
DA 2024-02-19
ER

PT J
AU Dorling, JL
   Ravussin, E
   Redman, LM
   Bhapkar, M
   Huffman, KM
   Racette, SB
   Das, SK
   Apolzan, JW
   Kraus, WE
   Höchsmann, C
   Martin, CK
AF Dorling, James L.
   Ravussin, Eric
   Redman, Leanne M.
   Bhapkar, Manju
   Huffman, Kim M.
   Racette, Susan B.
   Das, Sai K.
   Apolzan, John W.
   Kraus, William E.
   Hochsmann, Christoph
   Martin, Corby K.
CA CALERIE Phase 2 Study Grp
TI Effect of 2 years of calorie restriction on liver biomarkers: results
   from the CALERIE phase 2 randomized controlled trial
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article; Early Access
DE Energy restriction; Liver enzymes; Bilirubin; Cardiometabolic health;
   Aging
ID NONALCOHOLIC FATTY LIVER; HEPATIC INSULIN-RESISTANCE; INDUCED
   WEIGHT-LOSS; SERUM BILIRUBIN; COMPREHENSIVE ASSESSMENT; METABOLIC
   SYNDROME; REDUCING INTAKE; DISEASE; ENZYMES; RISK
AB Purpose Calorie restriction (CR) is an effective treatment for obesity-related liver and metabolic disease. However, CR studies in individuals without obesity are needed to see if CR could delay disease onset. Liver biomarkers indicate hepatic health and are linked to cardiometabolic disease. Our aim was to examine the effects of a 2-year CR intervention on liver biomarkers in healthy individuals without obesity. Methods The Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy (CALERIE) study was a 2-year randomized controlled trial. Overall, 218 participants (body mass index: 25.1 +/- 1.7 kg/m(2)) were enrolled into a control group (n = 75) that ate ad libitum (AL), or a CR group (n = 143) that aimed to decrease energy intake by 25%. Alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT), and bilirubin were measured during the trial. Results At month 24, relative to the AL group, ALP (- 7 +/- 1 IU/L;P < 0.01) and GGT (- 0.11 +/- 0.04 log IU/L;P = 0.02) decreased and bilirubin increased (0.21 +/- 0.06 log mg/dL;P < 0.01) in the CR group; no between-group differences in ALT (- 1 +/- 1 IU/L;P > 0.99) or AST (2 +/- 2 IU/L;P = 0.68) were revealed. However, sex-by-treatment-by-time interactions (P < 0.01) were observed, with CR (vs. control) inducing reduced ALT and GGT and increased AST in men only (P <= 0.02). Conclusions In metabolically healthy individuals without obesity, 2 years of CR improves several liver biomarkers, with potentially greater improvements in men. These data suggest that sustained CR may improve long-term liver and metabolic disease risk in healthy adults.
C1 [Dorling, James L.; Ravussin, Eric; Redman, Leanne M.; Apolzan, John W.; Hochsmann, Christoph; Martin, Corby K.] Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.
   [Bhapkar, Manju; Huffman, Kim M.; Kraus, William E.] Duke Univ, Sch Med, Durham, NC USA.
   [Racette, Susan B.] Washington Univ, St Louis, MO 63110 USA.
   [Das, Sai K.] Tufts Univ, USDA, Human Nutr Res Ctr Aging, JM, Boston, MA 02111 USA.
C3 Louisiana State University System; Louisiana State University;
   Pennington Biomedical Research Center; Duke University; Washington
   University (WUSTL); Tufts University; United States Department of
   Agriculture (USDA)
RP Dorling, JL (corresponding author), Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.
EM jdorling326@gmail.com
RI Höchsmann, Christoph/IWM-5488-2023; Racette, Susan/GXV-8800-2022;
   Racette, Susan B/GLS-6669-2022; Apolzan, John William/N-1949-2017;
   Ravussin, Eric/N-1985-2017; Redman, Leanne M/N-1986-2017
OI Racette, Susan B/0000-0002-6932-1887; Apolzan, John
   William/0000-0001-8492-7820; Ravussin, Eric/0000-0003-2129-547X;
   Hochsmann, Christoph/0000-0003-2007-3007; Dorling,
   James/0000-0002-1917-2828
FU National Institute on Aging, National Institutes of Health [U01AG022132,
   U01AG020478, U01AG020487, U01AG020480]; National Institute of Diabetes
   and Digestive and Kidney Diseases, National Institutes of Health
   [U01AG022132, U01AG020478, U01AG020487, U01AG020480]; National Obesity
   Research Center - National Institute of Diabetes and Digestive and
   Kidney Diseases [P30 DK072476]; National Institute of General Medical
   Sciences of the National Institutes of Health - Louisiana Clinical and
   Translational Science Center [1 U54 GM104940]; American Heart
   Association [20POST35210907]; National Institutes of Health National
   Research Service Award [T32 DK064584]
FX The research was supported by the National Institute on Aging and the
   National Institute of Diabetes and Digestive and Kidney Diseases,
   National Institutes of Health (Grants U01AG022132, U01AG020478,
   U01AG020487, and U01AG020480); National Obesity Research Center (Grant
   P30 DK072476), sponsored by the National Institute of Diabetes and
   Digestive and Kidney Diseases; and the National Institute of General
   Medical Sciences of the National Institutes of Health, which funds the
   Louisiana Clinical and Translational Science Center (Grant 1 U54
   GM104940). The work was also supported by the American Heart Association
   (Grant #20POST35210907) (J.L.D). C. H is supported by a National
   Institutes of Health National Research Service Award (T32 DK064584). The
   funder for this exploratory analysis had a role in study design and data
   collection, but no role in data analysis, data interpretation, or
   writing of the manuscript. The corresponding author had access to all
   the data and had final responsibility for the decision to submit for
   publication.
CR ANDERSEN T, 1991, J HEPATOL, V12, P224, DOI 10.1016/0168-8278(91)90942-5
   Bonnet F, 2011, DIABETES, V60, P1660, DOI 10.2337/db10-1806
   Bugianesi E, 2005, J CLIN ENDOCR METAB, V90, P3498, DOI 10.1210/jc.2004-2240
   Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012
   Chang Y, 2007, CLIN CHEM, V53, P686, DOI 10.1373/clinchem.2006.081257
   Choi SH, 2013, NUTR METAB CARDIOVAS, V23, P31, DOI 10.1016/j.numecd.2011.03.001
   Christensen P, 2011, CLIN OBES, V1, P31, DOI 10.1111/j.1758-8111.2011.00006.x
   Chung GE, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000573
   Cohen J., 1977, Statistical Power Analysis for the Behavioral Sciences, V1st
   Cohen J., 1992, Curr Dir Psychol Sci, V1, P98, DOI DOI 10.1111/1467-8721.EP10768783
   Dandona P, 2005, CIRCULATION, V111, P1448, DOI 10.1161/01.CIR.0000158483.13093.9D
   Day CP, 2002, BEST PRACT RES CL GA, V16, P663, DOI 10.1053/bega.2002.0333
   de Luis DA, 2008, DIABETES RES CLIN PR, V79, P74, DOI 10.1016/j.diabres.2007.07.015
   Dhurandhar NV, 2015, INT J OBESITY, V39, P1109, DOI 10.1038/ijo.2014.199
   Drummen M, 2018, AM J PHYSIOL-ENDOC M, V315, pE885, DOI 10.1152/ajpendo.00162.2018
   Elffers TW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185403
   Eslamparast T, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080800
   Gasteyger C, 2008, AM J CLIN NUTR, V87, P1141, DOI 10.1093/ajcn/87.5.1141
   Horsfall LJ, 2011, JAMA-J AM MED ASSOC, V305, P691, DOI 10.1001/jama.2011.124
   Kane AE, 2018, CURR OPIN PHYSIOL, V6, P28, DOI 10.1016/j.cophys.2018.03.008
   Kraus WE, 2019, LANCET DIABETES ENDO, V7, P673, DOI 10.1016/S2213-8587(19)30151-2
   Kumashiro N, 2011, P NATL ACAD SCI USA, V108, P16381, DOI 10.1073/pnas.1113359108
   Kunutsor SK, 2014, ATHEROSCLEROSIS, V236, P7, DOI 10.1016/j.atherosclerosis.2014.06.006
   Kunutsor SK, 2014, INT J EPIDEMIOL, V43, P187, DOI 10.1093/ije/dyt192
   Kwak MS, 2012, CLIN MOL HEPATOL, V18, P383, DOI 10.3350/cmh.2012.18.4.383
   Kwon H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09723-y
   Larson-Meyer DE, 2008, OBESITY, V16, P1355, DOI 10.1038/oby.2008.201
   Lonardo A, 2019, HEPATOLOGY, V70, P1457, DOI 10.1002/hep.30626
   Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462
   Meydani SN, 2016, AGING-US, V8, P1416, DOI 10.18632/aging.100994
   Morsiani C, 2019, AGEING RES REV, V51, P24, DOI 10.1016/j.arr.2019.02.002
   Most J, 2018, AM J PHYSIOL-ENDOC M, V314, pE396, DOI 10.1152/ajpendo.00261.2017
   Newsome PN, 2018, GUT, V67, P6, DOI 10.1136/gutjnl-2017-314924
   Novotny L, 2003, EXP BIOL MED, V228, P568, DOI 10.1177/15353702-0322805-29
   Pang Q, 2015, WORLD J GASTROENTERO, V21, P1650, DOI 10.3748/wjg.v21.i5.1650
   Pieper C, 2011, CLIN TRIALS, V8, P155, DOI 10.1177/1740774511398369
   Racette SB, 2012, AM J PHYSIOL-ENDOC M, V302, pE441, DOI 10.1152/ajpendo.00290.2011
   Ravussin E, 2015, J GERONTOL A-BIOL, V70, P1097, DOI 10.1093/gerona/glv057
   Rickman AD, 2011, CONTEMP CLIN TRIALS, V32, P874, DOI 10.1016/j.cct.2011.07.002
   Rochon J, 2011, J GERONTOL A-BIOL, V66, P97, DOI 10.1093/gerona/glq168
   Romashkan SV, 2016, ONCOTARGET, V7, P19124, DOI 10.18632/oncotarget.8093
   SALVAGGIO A, 1991, CLIN CHEM, V37, P720
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Stewart TM, 2013, CONTEMP CLIN TRIALS, V34, P10, DOI 10.1016/j.cct.2012.08.011
   Stranges S, 2004, HEPATOLOGY, V39, P754, DOI 10.1002/hep.20149
   Taylor R, 2008, DIABETOLOGIA, V51, P1781, DOI 10.1007/s00125-008-1116-7
   ter Horst KW, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00182
   Wallace TM, 2007, DIABETES CARE, V30, P2673, DOI 10.2337/dc06-1758
   Wang JN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172631
   Whitehead JP, 2006, DIABETES OBES METAB, V8, P264, DOI 10.1111/j.1463-1326.2005.00510.x
   Yamamoto M, 2007, J GASTROEN HEPATOL, V22, P498, DOI 10.1111/j.1440-1746.2006.04548.x
   Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788
   Yoon HJ, 2014, WORLD J HEPATOL, V6, P800, DOI 10.4254/wjh.v6.i11.800
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
NR 54
TC 10
Z9 11
U1 2
U2 4
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD 2021 APR
PY 2021
VL 60
IS 3
BP 1633
EP 1643
DI 10.1007/s00394-020-02361-7
EA AUG 2020
PG 11
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA RB4OG
UT WOS:000559685700001
PM 32803412
OA Green Accepted
DA 2024-02-19
ER

PT J
AU SINGH, S
   KANUNGO, MS
AF SINGH, S
   KANUNGO, MS
TI CHANGES IN EXPRESSION AND CRE BINDING-PROTEINS OF THE FIBRONECTIN GENE
   DURING AGING OF THE RAT
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
ID MESSENGER-RNAS; TRANSCRIPTION; LIVER; CAMP; DEXAMETHASONE; SEQUENCE;
   ELEMENT; REGION; BRAIN
C1 BANARAS HINDU UNIV,DEPT ZOOL,MOLEC BIOL LAB,VARANASI 221005,UTTAR PRADESH,INDIA.
C3 Banaras Hindu University (BHU)
CR AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303
   BRUKE EM, 1991, BIOCHEM BIOPH RES CO, V178, P620
   CHANDRASEKHAR S, 1983, P NATL ACAD SCI-BIOL, V80, P4747, DOI 10.1073/pnas.80.15.4747
   CHATURVEDI MM, 1985, BIOCHEM BIOPH RES CO, V127, P604, DOI 10.1016/S0006-291X(85)80203-5
   DEAN DC, 1988, J CELL BIOL, V106, P2159, DOI 10.1083/jcb.106.6.2159
   GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2
   GUERTIN M, 1983, BIOCHEMISTRY-US, V22, P4296, DOI 10.1021/bi00287a021
   HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179
   HORIKOSHI M, 1988, CELL, V54, P1033, DOI 10.1016/0092-8674(88)90118-3
   Hynes R.O., 1990, FIBRONECTINS
   IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8
   KORNBLIHTT AR, 1985, EMBO J, V4, P1755, DOI 10.1002/j.1460-2075.1985.tb03847.x
   MAEKAWA T, 1989, EMBO J, V8, P2023, DOI 10.1002/j.1460-2075.1989.tb03610.x
   MURO AF, 1992, J BIOL CHEM, V267, P12767
   MURTY CVR, 1988, BIOCHIM BIOPHYS ACTA, V949, P27, DOI 10.1016/0167-4781(88)90050-4
   PATEL RS, 1987, EMBO J, V6, P2565, DOI 10.1002/j.1460-2075.1987.tb02545.x
   RAMSAY N, 1984, EMBO J, V3, P2605, DOI 10.1002/j.1460-2075.1984.tb02181.x
   ROY AK, 1985, MOL ASPECTS MED, V8, P1, DOI 10.1016/0098-2997(85)90004-4
   RUOSLAHTI E, 1989, CANCER CELL-MON REV, V1, P119
   SCHWARZBAUER JE, 1991, BIOESSAYS, V13, P527, DOI 10.1002/bies.950131006
   SCHWARZBAUER JE, 1985, P NATL ACAD SCI USA, V82, P1424, DOI 10.1073/pnas.82.5.1424
   SCHWARZBAUER JE, 1983, CELL, V35, P421, DOI 10.1016/0092-8674(83)90175-7
   SINGH S, 1991, BIOCHEM BIOPH RES CO, V181, P131, DOI 10.1016/S0006-291X(05)81391-9
   TAMKUN JW, 1983, J BIOL CHEM, V258, P4641
   VERRI A, 1990, NUCLEIC ACIDS RES, V18, P5775, DOI 10.1093/nar/18.19.5775
NR 25
TC 15
Z9 15
U1 0
U2 2
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD MAY 28
PY 1993
VL 193
IS 1
BP 440
EP 445
DI 10.1006/bbrc.1993.1643
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA LE381
UT WOS:A1993LE38100063
PM 8503932
DA 2024-02-19
ER

PT J
AU Yang, H
   Wu, JW
   Wang, SP
   Severi, I
   Sartini, L
   Frizzell, N
   Cinti, S
   Yang, GS
   Mitchell, GA
AF Yang, Hao
   Wu, Jiang W.
   Wang, Shu P.
   Severi, Ilenia
   Sartini, Loris
   Frizzell, Norma
   Cinti, Saverio
   Yang, Gongshe
   Mitchell, Grant A.
TI Adipose-Specific Deficiency of Fumarate Hydratase in Mice Protects
   Against Obesity, Hepatic Steatosis, and Insulin Resistance
SO DIABETES
LA English
DT Article
ID DIET-INDUCED THERMOGENESIS; MITOCHONDRIAL DYSFUNCTION; HEREDITARY
   LEIOMYOMATOSIS; ADIPONECTIN SECRETION; ACQUIRED OBESITY; MESSENGER-RNA;
   TISSUE; FAT; ADIPOCYTES; MODELS
AB Obesity and type 2 diabetes are associated with impaired mitochondria! function in adipose tissue. To study the effects of primary deficiency of mitochondrial energy metabolism in fat, we generated mice with adipose-specific deficiency of fumarate hydratase (FH), an integral Krebs cycle enzyme (AFHKO mice). AFHKO mice have severe ultrastructural abnormalities of mitochondria, ATP depletion in white adipose tissue (WAT) and brown adipose tissue, low WAT mass with small adipocytes, and impaired thermogenesis with large unilocular brown adipocytes. AFHKO mice are strongly protected against obesity, insulin resistance, and fatty liver despite aging and high-fat feeding. AFHKO white adipocytes showed normal lipolysis but low triglyceride synthesis. ATP depletion in normal white adipocytes by mitochondria! toxins also decreased triglyceride synthesis, proportionally to ATP depletion, suggesting that reduced triglyceride synthesis may result nonspecifically from adipocyte energy deficiency. At thermoneutrality, protection from insulin resistance and hepatic steatosis was diminished. Taken together, the results show that under the cold stress of regular animal room conditions, adipocyte-specific FH deficiency in mice causes mitochondria! energy depletion in adipose tissues and protects from obesity, hepatic steatosis, and insulin resistance, suggesting that in cold-stressed animals, mitochondria! function in adipose tissue is a determinant of fat mass and insulin sensitivity.
C1 [Yang, Hao; Yang, Gongshe] Northwest A&F Univ, Coll Sci & Technol, Lab Anim Fat Deposit & Muscle Dev, Yangling, Shaanxi, Peoples R China.
   [Yang, Hao; Wu, Jiang W.; Wang, Shu P.; Mitchell, Grant A.] Univ Montreal, Dept Pediat, Div Med Genet, Montreal, PQ, Canada.
   [Yang, Hao; Wu, Jiang W.; Wang, Shu P.; Mitchell, Grant A.] CHU St Justine, Montreal, PQ, Canada.
   [Severi, Ilenia; Sartini, Loris; Cinti, Saverio] Univ Politecn Marche, Univ Ancona, United Hosp, Dept Expt & Clin Med,Ctr Obes, Ancona, Italy.
   [Frizzell, Norma] Univ South Carolina, Sch Med, Dept Pharmacol Physiol & Neurosci, Columbia, SC USA.
C3 Northwest A&F University - China; Universite de Montreal; Universite de
   Montreal; Centre Hospitalier Universitaire Sainte-Justine; Marche
   Polytechnic University; University of South Carolina System; University
   of South Carolina Columbia
RP Yang, GS (corresponding author), Northwest A&F Univ, Coll Sci & Technol, Lab Anim Fat Deposit & Muscle Dev, Yangling, Shaanxi, Peoples R China.; Mitchell, GA (corresponding author), Univ Montreal, Dept Pediat, Div Med Genet, Montreal, PQ, Canada.
EM gsyang999@hotmail.com; grant.mitchell@recherche-ste-justine.qc.ca
OI Yang, Gongshe/0000-0003-2003-979X; CINTI, Saverio/0000-0003-0362-5017;
   Severi, Ilenia/0000-0002-3985-1131
FU Canadian Institutes for Health research [221920]
FX This work was supported in part by Canadian Institutes for Health
   research grant 221920 to G.A.M.
CR Allegri G, 2010, J INHERIT METAB DIS, V33, P411, DOI 10.1007/s10545-010-9134-2
   [Anonymous], 1993, GENEREVIEWS
   Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255
   Bardella C, 2012, MOL CELL BIOL, V32, P3081, DOI 10.1128/MCB.06160-11
   Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09
   Butler AA, 2010, DIABETES, V59, P323, DOI 10.2337/db09-1471
   Cannon Barbara, 2008, V456, P109, DOI 10.1007/978-1-59745-245-8_8
   Chen M, 2010, CELL METAB, V11, P320, DOI 10.1016/j.cmet.2010.02.013
   Choo HJ, 2006, DIABETOLOGIA, V49, P784, DOI 10.1007/s00125-006-0170-2
   Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200
   COHEN PP, 1946, J BIOL CHEM, V166, P239
   Dahlman I, 2006, DIABETES, V55, P1792, DOI 10.2337/db05-1421
   Danson MJ, 2001, METHOD ENZYMOL, V331, P3
   den Boer M, 2004, ARTERIOSCL THROM VAS, V24, P644, DOI 10.1161/01.ATV.0000116217.57583.6e
   DIMAURO S, 2006, MITOCHONDRIAL MED
   Elmasri H, 2009, FASEB J, V23, P3865, DOI 10.1096/fj.09-134882
   Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0
   Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010
   Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014
   Fortier M, 2004, AM J PHYSIOL-ENDOC M, V287, pE282, DOI 10.1152/ajpendo.00203.2003
   Frizzell N, 2009, J BIOL CHEM, V284, P25772, DOI 10.1074/jbc.M109.019257
   Fu YC, 2000, J LIPID RES, V41, P2017
   Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361
   Heinonen S, 2015, DIABETES, V64, P3135, DOI 10.2337/db14-1937
   Karp CL, 2012, J EXP MED, V209, P1069, DOI 10.1084/jem.20120988
   Koh EH, 2007, DIABETES, V56, P2973, DOI 10.2337/db07-0510
   Kraus D, 2015, BIO PROTOC, V5, P5
   Kusminski CM, 2012, TRENDS ENDOCRIN MET, V23, P435, DOI 10.1016/j.tem.2012.06.004
   Lee KY, 2013, DIABETES, V62, P864, DOI 10.2337/db12-1089
   Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027
   Pietiläinen KH, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050051
   Pollard PJ, 2007, CANCER CELL, V11, P311, DOI 10.1016/j.ccr.2007.02.005
   RATNER S, 1953, J BIOL CHEM, V204, P115
   Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135
   Rustin P, 1997, BBA-MOL BASIS DIS, V1361, P185, DOI 10.1016/S0925-4439(97)00035-5
   Ryu MJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003356
   SILLERUD LO, 1986, J BIOL CHEM, V261, P4380
   Sirois J, 2006, MECH DEVELOP, V123, P869, DOI 10.1016/j.mod.2006.08.011
   Stewart L, 2008, ARCH DERMATOL, V144, P1584, DOI 10.1001/archdermatol.2008.517
   SUZUKI T, 1992, EUR J BIOCHEM, V207, P767, DOI 10.1111/j.1432-1033.1992.tb17107.x
   Szkudelski T, 2011, PHYSIOL RES, V60, P521, DOI 10.33549/physiolres.931971
   Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138
   Vernochet C, 2014, FASEB J, V28, P4408, DOI 10.1096/fj.14-253971
   Vernochet C, 2012, CELL METAB, V16, P765, DOI 10.1016/j.cmet.2012.10.016
   Wang CH, 2013, FEBS J, V280, P1039, DOI 10.1111/febs.12096
   Wortham NC, 2006, FERTIL STERIL, V86, P961, DOI 10.1016/j.fertnstert.2006.02.106
   Wu JW, 2012, ENDOCRINOLOGY, V153, P2198, DOI 10.1210/en.2011-1518
   Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984
   Yin X, 2014, J CLIN ENDOCR METAB, V99, pE209, DOI 10.1210/jc.2013-3042
NR 49
TC 19
Z9 19
U1 0
U2 11
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0012-1797
EI 1939-327X
J9 DIABETES
JI Diabetes
PD NOV
PY 2016
VL 65
IS 11
BP 3396
EP 3409
DI 10.2337/db16-0136
PG 14
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA EA3VX
UT WOS:000386538500018
PM 27554470
OA Bronze, Green Published
DA 2024-02-19
ER

PT J
AU Luo, ZG
   Yu, GY
   Lee, HW
   Li, LH
   Wang, LY
   Yang, DQ
   Pan, YF
   Ding, C
   Qian, J
   Wu, LJ
   Chu, YW
   Yi, J
   Wang, XD
   Sun, Y
   Jeong, LS
   Liu, J
   Jia, LJ
AF Luo, Zhongguang
   Yu, Guangyang
   Lee, Hyuk Woo
   Li, Lihui
   Wang, Lingyan
   Yang, Dongqin
   Pan, Yongfu
   Ding, Chan
   Qian, Jing
   Wu, Lijun
   Chu, Yiwei
   Yi, Jing
   Wang, Xiangdong
   Sun, Yi
   Jeong, Lak Shin
   Liu, Jie
   Jia, Lijun
TI The Nedd8-Activating Enzyme Inhibitor MLN4924 Induces Autophagy and
   Apoptosis to Suppress Liver Cancer Cell Growth
SO CANCER RESEARCH
LA English
DT Article
ID E3 UBIQUITIN LIGASE; BETA-TRCP; CHECKPOINT ACTIVATION; MTOR INHIBITOR;
   DRUG DISCOVERY; MECHANISM; SKP2; REREPLICATION; DEGRADATION; SENESCENCE
AB Posttranslational neddylation of cullins in the Cullin-Ring E3 ligase (CRL) complexes is needed for proteolytic degradation of CRL substrates, whose accumulation induces cell-cycle arrest, apoptosis, and senescence. The Nedd8-activating enzyme (NAE) is critical for neddylation of CRL complexes and their growth-promoting function. Recently, the anticancer small molecule MLN4924 currently in phase I trials was determined to be an inhibitor of NAE that blocks cullin neddylation and inactivates CRL, triggering an accumulation of CRL substrates that trigger cell-cycle arrest, apoptosis, and senescence in cancer cells. Here, we report that MLN4924 also triggers autophagy in response to CRL inactivation and that this effect is important for the ability of MLN4924 to suppress the outgrowth of liver cancer cells in vitro and in vivo. MLN4924-induced autophagy was attributed partially to inhibition of mTOR activity, due to accumulation of the mTOR inhibitory protein Deptor, as well as to induction of reactive oxygen species stress. Inhibiting autophagy enhanced MLN4924-induced apoptosis, suggesting that autophagy is a survival signal triggered in response to CRL inactivation. In a xenograft model of human liver cancer, MLN4924 was well-tolerated and displayed a significant antitumor effect characterized by CRL inactivation and induction of autophagy and apoptosis in liver cancer cells. Together, our findings support the clinical investigation of MLN4924 for liver cancer treatment and provide a preclinical proof-of-concept for combination therapy with an autophagy inhibitor to enhance therapeutic efficacy. Cancer Res; 72(13); 3360-71. (C) 2012 AACR.
C1 [Luo, Zhongguang; Yu, Guangyang; Li, Lihui; Yang, Dongqin; Pan, Yongfu; Qian, Jing; Chu, Yiwei; Liu, Jie; Jia, Lijun] Fudan Univ, Shanghai Med Coll, Dept Immunol, Shanghai 200032, Peoples R China.
   [Chu, Yiwei; Jia, Lijun] Fudan Univ, Biotherapy Res Ctr, Shanghai 200032, Peoples R China.
   [Luo, Zhongguang; Yang, Dongqin; Wu, Lijun; Liu, Jie] Fudan Univ, Huashan Hosp, Dept Digest Dis, Shanghai 200032, Peoples R China.
   [Wang, Lingyan; Wang, Xiangdong; Jia, Lijun] Fudan Univ, Zhongshan Hosp, Biomed Res Ctr, Shanghai 200032, Peoples R China.
   [Ding, Chan] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai, Peoples R China.
   [Yi, Jing] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Biochem & Cell Biol, Shanghai 200030, Peoples R China.
   [Lee, Hyuk Woo; Jeong, Lak Shin] Ewha Womans Univ, Dept Bioinspired Sci, Seoul, South Korea.
   [Lee, Hyuk Woo; Jeong, Lak Shin] Ewha Womans Univ, Coll Pharm, Seoul, South Korea.
   [Sun, Yi] Univ Michigan, Dept Radiat Oncol, Div Radiat & Canc Biol, Ann Arbor, MI 48109 USA.
C3 Fudan University; Fudan University; Fudan University; Fudan University;
   Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research
   Institute, CAAS; Shanghai Jiao Tong University; Ewha Womans University;
   Ewha Womans University; University of Michigan System; University of
   Michigan
RP Jia, LJ (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Immunol, 130 Dong An Rd, Shanghai 200032, Peoples R China.
EM lakjeong@ewha.ac.kr; jieliu28@hotmail.com; jialijun2002@yahoo.com.cn
RI Sun, Yi/K-1025-2014; Wang, Xiangdong/F-2913-2014; Luo,
   Zhongguang/HKM-5966-2023; chen, gang/JRX-1197-2023; SUN,
   YI/JBS-2950-2023
OI Sun, Yi/0000-0002-5841-4287; Luo, Zhongguang/0000-0002-7620-307X; 
FU National Natural Science Foundation Grant of China [81172092, 31071204,
   91129702, 81125001]; National Basic Research Program of China (973
   program) [2012CB910302]
FX This work is supported by National Natural Science Foundation Grant of
   China (81172092), National Basic Research Program of China (973 program,
   2012CB910302) and National Natural Science Foundation Grant of China
   (31071204 to L. Jia), and National Natural Science Foundation Grant of
   China (91129702, 81125001) to J. Liu.
CR Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017
   Böck BC, 2010, J BIOL CHEM, V285, P21644, DOI 10.1074/jbc.M109.096628
   Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024
   Chan CH, 2010, THESCIENTIFICWORLDJO, V10, P1001, DOI 10.1100/tsw.2010.89
   Duan SS, 2011, MOL CELL, V44, P317, DOI 10.1016/j.molcel.2011.09.005
   Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019
   Ferenci P, 2010, J CLIN GASTROENTEROL, V44, P239, DOI 10.1097/MCG.0b013e3181d46ef2
   Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219
   Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396
   Gao DM, 2011, MOL CELL, V44, P290, DOI 10.1016/j.molcel.2011.08.030
   Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858
   Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717
   Hoffman RM, 2006, NAT PROTOC, V1, P1429, DOI 10.1038/nprot.2006.223
   Jia L, 2011, CURR CANCER DRUG TAR, V11, P347, DOI 10.2174/156800911794519734
   Jia LJ, 2011, NEOPLASIA, V13, P561, DOI 10.1593/neo.11420
   Jia LJ, 2011, J BIOL CHEM, V286, P3379, DOI 10.1074/jbc.M110.188425
   Jia LJ, 2009, CANCER RES, V69, P4974, DOI 10.1158/0008-5472.CAN-08-4671
   Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025
   Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678
   Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529
   Larance M, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014407
   Lee HW, 2011, J ORG CHEM, V76, P3557, DOI 10.1021/jo2001897
   Liao H, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009183
   Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815
   Lin JJ, 2010, CANCER RES, V70, P10310, DOI 10.1158/0008-5472.CAN-10-2062
   Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239
   Milhollen MA, 2011, CANCER RES, V71, P3042, DOI 10.1158/0008-5472.CAN-10-2122
   Milhollen MA, 2010, BLOOD, V116, P1515, DOI 10.1182/blood-2010-03-272567
   Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026
   Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028
   Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056
   Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218
   Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046
   Petroski MD, 2010, CHEM BIOL, V17, P6, DOI 10.1016/j.chembiol.2010.01.002
   Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547
   Sarcar B, 2011, MOL CANCER THER, V10, P2405, DOI 10.1158/1535-7163.MCT-11-0469
   Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007
   Separovic D, 2011, BIOCHEM BIOPH RES CO, V409, P372, DOI 10.1016/j.bbrc.2011.04.091
   Soucy Teresa A, 2010, Genes Cancer, V1, P708, DOI 10.1177/1947601910382898
   Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884
   Swords RT, 2010, BLOOD, V115, P3796, DOI 10.1182/blood-2009-11-254862
   Thomas MB, 2005, J CLIN ONCOL, V23, P8093, DOI 10.1200/JCO.2004.00.1537
   Ullén A, 2010, INT J ONCOL, V37, P15, DOI 10.3892/ijo_00000648
   Wang SH, 2009, TOXICOL SCI, V108, P124, DOI 10.1093/toxsci/kfn266
   Wei DP, 2012, CANCER RES, V72, P282, DOI 10.1158/0008-5472.CAN-11-2866
   Xirodimas DP, 2008, BIOCHEM SOC T, V36, P802, DOI 10.1042/BST0360802
   Yee KS, 2009, CELL DEATH DIFFER, V16, P1135, DOI 10.1038/cdd.2009.28
   Zhang Y, 2012, J CELL PHYSIOL, V227, P35, DOI 10.1002/jcp.22722
   Zhao YC, 2011, MOL CELL, V44, P304, DOI 10.1016/j.molcel.2011.08.029
   Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a
NR 50
TC 189
Z9 214
U1 3
U2 50
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 0008-5472
EI 1538-7445
J9 CANCER RES
JI Cancer Res.
PD JUL 1
PY 2012
VL 72
IS 13
BP 3360
EP 3371
DI 10.1158/0008-5472.CAN-12-0388
PG 12
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA 986OB
UT WOS:000307350700025
PM 22562464
OA Bronze, Green Submitted
DA 2024-02-19
ER

PT J
AU SRIVASTAVA, VK
   TILLEY, RD
   HART, RW
   BUSBEE, DL
AF SRIVASTAVA, VK
   TILLEY, RD
   HART, RW
   BUSBEE, DL
TI EFFECT OF DIETARY RESTRICTION ON THE FIDELITY OF DNA-POLYMERASES IN
   AGING MICE
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE DIETARY RESTRICTION; DNA POLYMERASES; MICE; AGING; HEPATIC TISSUE
ID PROTEIN KINASE-C; HUMAN-FIBROBLASTS; DECREASED FIDELITY;
   MOLECULAR-BIOLOGY; SYNTHESIS INVITRO; ACTIVITY FORM; LIFE-SPAN; ALPHA;
   REPLICATION; INFIDELITY
AB DNA polymerases purified from hepatic tissues of C57BL/6 mice showed an age-related decrease in both specific activity and fidelity of the various enzyme forms. Polymerases from dietary restricted mice exhibited less of a decline in specific activity and copied synthetic DNA templates with relatively higher fidelity than did enzymes from animals fed ad libitum. Polymerases treated with inositol-1,4-bisphosphate [I(1,4)P2] showed varying levels of increased activity, with fidelity increases up to 3-fold. These data indicate that aging is associated with decreases in both specific activity and fidelity of DNA polymerases isolated from a nondividing tissue, and that dietary restriction impedes the age-related decline in both specific activity and fidelity of these polymerases. The data further indicate that DNA polymerases may interact with phosphoinositide hydrolysis products resulting in increased specific activity and fidelity of the enzymes. Phosphoinositide interactions with polymerases could constitute an important mechanism moderating the age-related decrease in function and accuracy of DNA polymerases.
C1 TEXAS A&M UNIV SYST,COLL VET MED,DEPT ANAT,DIV CELL BIOL,COLLEGE STN,TX 77843.
   NATL CTR TOXICOL RES,JEFFERSON,AR 72079.
C3 Texas A&M University System; Texas A&M University College Station; US
   Food & Drug Administration (FDA)
FU NIA NIH HHS [AG06347, AG07739] Funding Source: Medline
CR ABBOTTS J, 1984, J BIOL CHEM, V259, P6712
   AGARWAL SS, 1978, J CELL PHYSL, V106, P235
   BARTON RW, 1974, FED PROC, V33, P1419
   BATTULA N, 1974, J BIOL CHEM, V249, P4086
   BERG P, 1962, INFORMATIONAL MACROM, P1467
   BERRIDGE MJ, 1985, SCI AM, V253, P142, DOI 10.1038/scientificamerican1085-142
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Burnet M., 1974, INTRINSIC MUTAGENESI
   BUSBEE D, 1987, J NATL CANCER I, V79, P1231
   BYRNES JJ, 1977, BIOCHEMISTRY-US, V16, P3740, DOI 10.1021/bi00636a002
   CAMPBELL JL, 1986, ANNU REV BIOCHEM, V55, P733, DOI 10.1146/annurev.biochem.55.1.733
   CHAN JYH, 1979, P NATL ACAD SCI USA, V76, P814, DOI 10.1073/pnas.76.2.814
   DANSE JM, 1981, FEBS LETT, V124, P84, DOI 10.1016/0014-5793(81)80059-2
   DELFINI C, 1985, P NATL ACAD SCI USA, V82, P2220, DOI 10.1073/pnas.82.8.2220
   DOWNEY KM, 1990, BIOESSAYS, V12, P231, DOI 10.1002/bies.950120507
   DUBE DK, 1975, BIOCHEM BIOPH RES CO, V67, P1041, DOI 10.1016/0006-291X(75)90779-2
   FERSHT AR, 1983, J MOL BIOL, V165, P633, DOI 10.1016/S0022-2836(83)80271-X
   FERSHT AR, 1979, P NATL ACAD SCI USA, V76, P4996
   FRY M, 1981, J CELL PHYSIOL, V106, P435, DOI 10.1002/jcp.1041060313
   FRY M, 1976, BIOCHEMISTRY-US, V15, P4319, DOI 10.1021/bi00664a028
   FRY M, 1986, ANIMAL CELL DNA POLY
   FULDER SJ, 1975, CELL, V6, P67, DOI 10.1016/0092-8674(75)90075-6
   GILLIN FD, 1976, J BIOL CHEM, V251, P5225
   HALL ZW, 1968, J MOL BIOL, V36, P321, DOI 10.1016/0022-2836(68)90158-7
   HARLEY CB, 1980, P NATL ACAD SCI-BIOL, V77, P1885, DOI 10.1073/pnas.77.4.1885
   HIBNER U, 1980, NATURE, V285, P300, DOI 10.1038/285300a0
   HOLLIDAY R, 1981, J THEOR BIOL, V93, P627, DOI 10.1016/0022-5193(81)90225-3
   HOPEFIELD JJ, 1980, P NATL ACAD SCI USA, V77, P5248
   KIRKWOOD TBL, 1980, J THEOR BIOL, V82, P363, DOI 10.1016/0022-5193(80)90243-X
   KORNBERG A, 1982, DNA REPLICATION
   KRAUSS SW, 1987, J BIOL CHEM, V262, P3432
   KRAUSS SW, 1986, J CELL PHYSIOL, V126, P99, DOI 10.1002/jcp.1041260114
   KRAUSS SW, 1980, BIOCHEMISTRY-US, V19, P220, DOI 10.1021/bi00542a033
   KUNKEL TA, 1979, P NATL ACAD SCI USA, V76, P6331, DOI 10.1073/pnas.76.12.6331
   KUNKEL TA, 1981, SCIENCE, V213, P765, DOI 10.1126/science.6454965
   LAKS MS, 1980, BIOCHEM BIOPH RES CO, V96, P697, DOI 10.1016/0006-291X(80)91411-4
   LICASTRO F, 1988, AGE, V11, P48, DOI 10.1007/BF02431772
   LINDELL TJ, 1982, LIFE SCI, V31, P625, DOI 10.1016/0024-3205(82)90763-9
   LINN S, 1976, P NATL ACAD SCI USA, V73, P2818, DOI 10.1073/pnas.73.8.2818
   LOEB LA, 1986, PROG NUCLEIC ACID RE, V33, P57, DOI 10.1016/S0079-6603(08)60020-3
   LOEB LA, 1982, ANNU REV BIOCHEM, V52, P429
   MAEDA H, 1985, J GERONTOL, V40, P671, DOI 10.1093/geronj/40.6.671
   MAJERUS PW, 1986, SCIENCE, V234, P1519, DOI 10.1126/science.3024320
   MERRY BJ, 1987, MECH AGEING DEV, V39, P189, DOI 10.1016/0047-6374(87)90008-X
   MURRAY V, 1981, J MOL BIOL, V146, P55, DOI 10.1016/0022-2836(81)90366-1
   NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651
   ORGEL LE, 1970, P NATL ACAD SCI USA, V67, P1476, DOI 10.1073/pnas.67.3.1476
   ORGEL LE, 1963, P NATL ACAD SCI USA, V49, P517, DOI 10.1073/pnas.49.4.517
   PENG S, 1990, MECH AGEING DEV, V52, P71, DOI 10.1016/0047-6374(90)90145-6
   RICHARDSON A, 1982, LIFE SCI, V31, P605, DOI 10.1016/0024-3205(82)90761-5
   SHELDRAKE AR, 1974, NATURE, V250, P381, DOI 10.1038/250381a0
   SILBER JR, 1985, J BIOL CHEM, V260, P1304
   SIROVER MA, 1976, SCIENCE, V194, P1434, DOI 10.1126/science.1006310
   SLOAN DL, 1975, J BIOL CHEM, V250, P8913
   SO AG, 1988, BIOCHEMISTRY-US, V27, P4591, DOI 10.1021/bi00413a001
   SRIVASTAVA VK, 1991, EXP GERONTOL, V26, P97, DOI 10.1016/0531-5565(91)90066-U
   SYLVIA V, 1988, CELL, V54, P651, DOI 10.1016/S0092-8674(88)80009-6
   SYLVIA VL, 1989, INT J BIOCHEM, V21, P347, DOI 10.1016/0020-711X(89)90357-1
   SZILARD L, 1959, P NATL ACAD SCI USA, V45, P30, DOI 10.1073/pnas.45.1.30
   WEINDRUCH R, 1982, SCIENCE, V215, P1415, DOI 10.1126/science.7063854
   WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641
   WEINDRUCH R, 1988, RETARDATION AGING DI
   WERAARCHAKUL N, 1989, EXP CELL RES, V181, P197, DOI 10.1016/0014-4827(89)90193-6
   YU BP, 1982, J GERONTOL, V37, P130, DOI 10.1093/geronj/37.2.130
NR 64
TC 18
Z9 19
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0531-5565
J9 EXP GERONTOL
JI Exp. Gerontol.
PY 1991
VL 26
IS 5
BP 453
EP 466
DI 10.1016/0531-5565(91)90034-J
PG 14
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA GL102
UT WOS:A1991GL10200008
PM 1756777
DA 2024-02-19
ER

PT J
AU Okada, H
   Senmaru, T
   Fukui, M
   Kondo, Y
   Ishigami, A
   Maruyama, N
   Obayashi, H
   Yamazaki, M
   Nakamura, N
   Hasegawa, G
AF Okada, Hiroshi
   Senmaru, Takafumi
   Fukui, Michiaki
   Kondo, Yoshitaka
   Ishigami, Akihito
   Maruyama, Naoki
   Obayashi, Hiroshi
   Yamazaki, Masahiro
   Nakamura, Naoto
   Hasegawa, Goji
TI Senescence marker protein-30/gluconolactonase deficiency exacerbates
   diabetic nephropathy through tubular injury in a mouse model of type 1
   diabetes
SO JOURNAL OF DIABETES INVESTIGATION
LA English
DT Article
DE Diabetic nephropathy; Senescence marker protein-30; Tubular injury
ID PERMEABILITY TRANSITION PORE; PROTEIN-30 SMP30; OXIDATIVE STRESS;
   CELL-DEATH; HYPOXIA; MICE; PROGRESSION; HIF-1; LIVER
AB Aims/IntroductionSenescence marker protein-30 (SMP30) is abundantly expressed in renal proximal tubule cells, but its expression decreases with age. Previous studies have shown that reduced SMP30 expression could contribute to aging-associated deterioration of cellular function and tissue injury. In the present study, we investigated the effects of SMP30 deficiency on the pathogenesis of diabetic nephropathy.
   Materials and MethodsDiabetes was induced using streptozotocin in male SMP30 knockout mice (KO) and wild-type mice at 7weeks-of-age. VitaminC was added to the drinking water to prevent vitaminC deficiency in KO mice. The mice were killed 12weeks after the induction of diabetes.
   ResultsUrinary biomarkers for proximal tubule damage were significantly increased in non-diabetic KO mice compared with wild-type mice. Furthermore, diabetes-induced tubular damage was significantly exacerbated by SMP30 deletion. Morphological analysis showed a link between cortical tubulointerstitial fibrosis area and the degree of tubular damage. However, SMP30 deletion did not affect mesangial expansion. Tubular injury was associated with accumulation of hypoxia-inducible factor-1 and increased hypoxia-inducible factor-1 targeted gene expression. SMP30 deletion initiated oxidative stress; however, it did not exacerbate the oxidative stress seen in diabetic mice. In contrast, tubular inflammation was associated with SMP30 deletion only in diabetic mice.
   ConclusionsBased on this evidence, we concluded that SMP30 deficiency exacerbates proximal tubule injury in diabetic mice. Decreased SMP30 could contribute to the increased incidence of various chronic kidney diseases, including diabetic nephropathy, with age.
C1 [Okada, Hiroshi; Senmaru, Takafumi; Fukui, Michiaki; Yamazaki, Masahiro; Nakamura, Naoto; Hasegawa, Goji] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Endocrinol & Metab, Kyoto, Japan.
   [Obayashi, Hiroshi] Inst Bioresponse Informat, Kyoto, Japan.
   [Kondo, Yoshitaka; Ishigami, Akihito; Maruyama, Naoki] Tokyo Metropolitan Inst Gerontol, Tokyo, Japan.
C3 Kyoto Prefectural University of Medicine; Tokyo Metropolitan Institute
   of Gerontology
RP Hasegawa, G (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Endocrinol & Metab, Kyoto, Japan.
EM goji@koto.kpu-m.ac.jp
RI Okada, Hiroshi/AAG-1588-2020; Yoshitaka, Kondo/AFK-7721-2022
OI Okada, Hiroshi/0000-0002-1707-970X; Yoshitaka,
   Kondo/0000-0002-0046-9429; Ishigami, Akihito/0000-0001-7875-7482; Fukui,
   Michiaki/0000-0003-0903-1797
FU Japan Society for the Promotion of Science [23591317]; Grants-in-Aid for
   Scientific Research [15H04505, 23591317] Funding Source: KAKEN
FX The present study was supported by a Grant-in-Aid for Scientific
   Research (23591317 to GH) from the Japan Society for the Promotion of
   Science. We gratefully acknowledge Muneo Tsujikawa for his experimental
   assistance. VC powder was kindly provided by DSM Nutrition Japan (Tokyo,
   Japan). The authors declare no conflict of interest.
CR Anders HJ, 2011, KIDNEY INT, V80, P915, DOI 10.1038/ki.2011.217
   Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007
   Dalla Vestra M, 2000, DIABETES METAB, V26, P8
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327
   Halestrap AP, 2003, CURR MED CHEM, V10, P1507, DOI 10.2174/0929867033457278
   Hasegawa G, 2010, ENDOCRINOLOGY, V151, P529, DOI 10.1210/en.2009-1163
   Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487
   Higgins DF, 2004, AM J PHYSIOL-RENAL, V287, pF1223, DOI 10.1152/ajprenal.00245.2004
   Huang XX, 2001, MOL CELL BIOCHEM, V224, P1, DOI 10.1023/A:1011990300114
   Ichas F, 1998, BBA-BIOENERGETICS, V1366, P33, DOI 10.1016/S0005-2728(98)00119-4
   Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   Ishigarni A, 2007, GERIATR GERONTOL INT, V7, P316, DOI 10.1111/j.1447-0594.2007.00420.x
   Ishii K, 2005, HISTOL HISTOPATHOL, V20, P761, DOI 10.14670/HH-20.761
   Kaissling B, 2013, BBA-MOL BASIS DIS, V1832, P931, DOI 10.1016/j.bbadis.2013.02.010
   Kimura K, 2008, AM J PHYSIOL-RENAL, V295, pF1023, DOI 10.1152/ajprenal.90209.2008
   Kiss E, 2003, TRANSPLANTATION, V76, P480, DOI 10.1097/01.TP.0000066354.31050.5A
   Kiss E, 2010, AM J PATHOL, V176, P2150, DOI 10.2353/ajpath.2010.090370
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Lin Y, 2013, ENDOCRINOLOGY, V154, P3855, DOI 10.1210/en.2013-1053
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Maruyama N, 2010, GERIATR GERONTOL INT, V10, pS88, DOI 10.1111/j.1447-0594.2010.00586.x
   Najafian B, 2009, DIABETES RES CLIN PR, V83, P1, DOI 10.1016/j.diabres.2008.08.024
   Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757
   Park H, 2010, J GASTROENTEROL, V45, P426, DOI 10.1007/s00535-009-0154-3
   Sato T, 2006, AM J RESP CRIT CARE, V174, P530, DOI 10.1164/rccm.200511-1816OC
   Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366
   Shoag J, 2010, ARTERIOSCL THROM VAS, V30, P662, DOI 10.1161/ATVBAHA.108.181636
   Son TG, 2006, MECH AGEING DEV, V127, P451, DOI 10.1016/j.mad.2006.01.005
   Stroka DM, 2001, FASEB J, V15, P2445, DOI 10.1096/fj.01-0125com
   Vallon V, 2011, AM J PHYSIOL-REG I, V300, pR1009, DOI 10.1152/ajpregu.00809.2010
   Wada T, 2000, KIDNEY INT, V58, P1492, DOI 10.1046/j.1523-1755.2000.00311.x
   Wenz Tina, 2011, J Aging Res, V2011, P810619, DOI 10.4061/2011/810619
   Yumura W, 2006, HISTOL HISTOPATHOL, V21, P1151, DOI 10.14670/HH-21.1151
NR 35
TC 16
Z9 18
U1 0
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2040-1116
EI 2040-1124
J9 J DIABETES INVEST
JI J. Diabetes Investig.
PD JAN
PY 2015
VL 6
IS 1
BP 35
EP 43
DI 10.1111/jdi.12252
PG 9
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA AX9PR
UT WOS:000347234800007
PM 25621131
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Li, R
   Dong, J
   Bu, XQ
   Huang, Y
   Yang, JY
   Dong, X
   Liu, J
AF Li, Ran
   Dong, Juan
   Bu, Xiu-Qin
   Huang, Yong
   Yang, Jing-Yu
   Dong, Xuan
   Liu, Jie
TI RETRACTED: Interleukin-6 promotes the migration and cellular senescence
   and inhibits apoptosis of human intrahepatic biliary epithelial cells
   (Retracted Article)
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Article; Retracted Publication
DE apoptosis; cellular senescence; epithelial-mesenchymal transition; human
   intrahepatic biliary epithelial cells; interleukin-6; migration
ID MESENCHYMAL TRANSITION; BREAST-CANCER; EXPRESSION; LIVER; PROLIFERATION;
   METASTASIS; DISEASE
AB Biliary epithelial cells (BEC) are closely related to some immune regulatory bile duct diseases. However, the complexity and polymorphism of the morphology and function of bile duct cells have hindered further investigation. Therefore, the aim of this study is to investigate how interleukin-6 (IL-6) affects the migration, cellular senescence, and apoptosis of human intrahepatic biliary epithelial cells (HIBECs). The HIBECs were stimulated by different concentrations of IL-6 (0, 5, 10, 15, and 20ng/mL, respectively). Transwell assay was performed in order to measure the migration abilities, positive -Galactosidase staining for the cellular senescence of HIBECs, MTT assay for changes of proliferation after IL-6 treatment and flow cytometry for cell cycle and apoptosis. The reverse transcription quantitative polymerase chain reaction (RT-qPCR) and Western blotting were conducted in order to detect the mRNA and protein expressions of epithelial-mesenchymal transition (EMT) markers in HIBECs. In comparison to the 0ng/mL group, in the 5, 10, 15, and 20ng/mL groups, a significant increase in the number of migratory HIBECs, proliferation, along with mRNA and protein expressions of EMT markers was observed. While the mRNA and protein expressions of epithelial markers, the number of -galactosidase positive staining cells, as well as apoptosis rate of HIBECs dramatic decreased. Further, the aforementioned changes were significantly more evident in the 15 and 20ng/mL groups in comparison to the 5 and 10ng/mL groups. IL-6 may stimulate EMT, enhance the migration and proliferation, and inhibit apoptosis of HIBECs, thus delaying cellular senescence.
C1 [Li, Ran] Shandong Acad Med Sci, Dept Gastroenterol, Affiliated Hosp 3, Jining, Peoples R China.
   [Li, Ran; Bu, Xiu-Qin; Huang, Yong; Yang, Jing-Yu; Dong, Xuan] Shandong Inst Parasit Dis, Dept Gastroenterol, Jining, Peoples R China.
   [Dong, Juan] Jining Rencheng Dist Peoples Hosp, Dept Gastroenterol, Jining, Peoples R China.
   [Liu, Jie] Jining 1 Peoples Hosp, Dept Gastroenterol, 6 Jiankang Rd, Jining 272011, Shandong, Peoples R China.
C3 University of Jinan; Shandong First Medical University & Shandong
   Academy of Medical Sciences
RP Liu, J (corresponding author), Jining 1 Peoples Hosp, Dept Gastroenterol, 6 Jiankang Rd, Jining 272011, Shandong, Peoples R China.
EM liujie6j@163.com
RI Yang, Jing/HZJ-2451-2023; jing, yang/JDV-8487-2023
CR Bieghs V, 2013, TRENDS IMMUNOL, V34, P446, DOI 10.1016/j.it.2013.04.005
   Causier B, 2002, PLANT MOL BIOL, V50, P855, DOI 10.1023/A:1021214007897
   Chen HF, 2011, STEM CELL REV REP, V7, P722, DOI 10.1007/s12015-011-9233-y
   Deng YH, 2011, DIGEST DIS SCI, V56, P731, DOI 10.1007/s10620-010-1347-6
   Ding XM, 2014, CHIN J CANCER, V33, P140, DOI 10.5732/cjc.013.10094
   Ezure T, 2000, AM J PATHOL, V156, P1627, DOI 10.1016/S0002-9440(10)65034-1
   Glaser S, 2010, AM J PHYSIOL-GASTR L, V299, pG769, DOI 10.1152/ajpgi.00237.2010
   Huang Shan, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P173
   Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001
   Jiang GX, 2010, MOL BIOL REP, V37, P3813, DOI 10.1007/s11033-010-0036-z
   Kokkinos MI, 2007, CELLS TISSUES ORGANS, V185, P191, DOI 10.1159/000101320
   Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018
   Lehle K, 2005, TRANSPL P, V37, P159, DOI 10.1016/j.transproceed.2004.12.140
   Li TY, 2010, ANN SURG ONCOL, V17, P1937, DOI 10.1245/s10434-010-0925-3
   Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639
   Nakanuma Yasuni, 2013, Methods Mol Biol, V945, P303, DOI 10.1007/978-1-62703-125-7_18
   Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620
   Rygiel KA, 2010, LIVER TRANSPLANT, V16, P567, DOI 10.1002/lt.22029
   Sasaki Motoko, 2010, Hepat Res Treat, V2010, P205128, DOI 10.1155/2010/205128
   Sasaki M, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/452143
   Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034
   Siljamäki E, 2014, ARCH DERMATOL RES, V306, P131, DOI 10.1007/s00403-013-1391-0
   Xiao YT, 2015, J HEPATOL, V62, P889, DOI 10.1016/j.jhep.2014.10.033
   Xie GZ, 2012, INT J ONCOL, V40, P1171, DOI 10.3892/ijo.2011.1275
   Yadav A, 2011, MOL CANCER RES, V9, P1658, DOI 10.1158/1541-7786.MCR-11-0271
   Yao X, 2012, ONCOTARGETS THER, V5, P255, DOI 10.2147/OTT.S36213
   Zhao LJ, 2011, J SURG RES, V171, P819, DOI 10.1016/j.jss.2010.04.059
NR 27
TC 8
Z9 9
U1 0
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-2312
EI 1097-4644
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PD FEB
PY 2018
VL 119
IS 2
BP 2135
EP 2143
DI 10.1002/jcb.26375
PG 9
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA FQ9UX
UT WOS:000418708300080
PM 28857276
OA Bronze
DA 2024-02-19
ER

PT J
AU Sone, K
   Mori, M
   Mori, N
AF Sone, Kiyoaki
   Mori, Mari
   Mori, Nozomu
TI Selective upregulation of p66-Shc gene expression in the liver and brain
   of aged rats
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
DE Adapter; Anti-aging; Longevity; Phosphotyrosine; Signal transduction
ID OXIDATIVE STRESS-RESPONSE; REDUCED ASSOCIATION; SIGNALING PATHWAY;
   ADAPTER PROTEINS; EGF RECEPTOR; N-SHC; P66(SHC); CENTENARIANS;
   ACTIVATION; MEDICINE
AB The phosphotyrosine signaling followed by various receptor activations conforms a unique signaling platform during metazoan evolution, and is crucial for animal development, maturation, and aging. Shc is the most versatile bipartite phosphotyrosine signal adaptor harboring phosphotrosine-biding (PTB) and Src-homology2 (SH2) domains. Among the Shc adaptor family members, p66-Shc is of potential interest in aging studies, since its deletion in mice resulted in a longer lifespan and/or higher quality of life in later stages of life. However, a few studies have examined the gene expression profiles of p66-Shc in aging tissues. Here, we quantified the expression levels of transcripts of Shc-related isoforms in the liver and brain of young adult, middle-aged, and aged rats, and found that p66-Shc gene expression is specifically up-regulated in the aged liver and brain. In the aged liver tissue, p66-Shc expression was also evident at the protein level, and accumulated in the soluble fraction of the aged tissue. These results indicate that p66-Shc is not only related to animal longevity but also affected during aging, and thus the repression of p66-Shc could become a potential target for an anti-aging strategy. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
C1 [Mori, Mari; Mori, Nozomu] Nagasaki Univ, Sch Med, Dept Anat & Neurobiol, Nagasaki 8528523, Japan.
   [Sone, Kiyoaki; Mori, Nozomu] NILS, Dept Mol Genet, Oobu, Aichi 4748522, Japan.
   [Mori, Mari] Johns Hopkins Univ, Ctr Biotechnol Educ, Dept Bioinformat, Baltimore, MD 21218 USA.
C3 Nagasaki University; Johns Hopkins University
RP Mori, N (corresponding author), Nagasaki Univ, Sch Med, Dept Anat & Neurobiol, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.
EM morinosm@nagasaki-u.ac.jp
RI Mori, Mari/V-5601-2019
OI Mori, Mari/0000-0001-6425-7137
FU MEXT, Japan; Asian CORE Program from JSPS; Smoking Research Foundation;
   Grants-in-Aid for Scientific Research [24650200] Funding Source: KAKEN
FX We thank Ms. Y. Kadokawa and K. Onga for technical assistance. This
   research was supported by a Grant-in-Aid for Scientific Research
   (Kiban-B) from MEXT, Japan, and also in part by the Asian CORE Program
   from JSPS and Smoking Research Foundation (to NM).
CR Bonfini L, 1996, TRENDS BIOCHEM SCI, V21, P257, DOI 10.1016/S0968-0004(96)10033-5
   Camici GG, 2011, GERONTOLOGY, V57, P101, DOI 10.1159/000314227
   Cosentino F, 2008, ARTERIOSCL THROM VAS, V28, P622, DOI 10.1161/ATVBAHA.107.156059
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Francia P, 2009, J MOL MED, V87, P885, DOI 10.1007/s00109-009-0499-3
   Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011
   Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700
   Haga S, 2010, LAB INVEST, V90, P1718, DOI 10.1038/labinvest.2010.119
   Hutter D, 2000, J GERONTOL A-BIOL, V55, pB125, DOI 10.1093/gerona/55.3.B125
   Jiang XG, 2003, AGING CELL, V2, P47, DOI 10.1046/j.1474-9728.2003.00030.x
   Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002
   Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980
   Kojima T, 2001, BIOCHEM BIOPH RES CO, V284, P1039, DOI 10.1006/bbrc.2001.5080
   Kontani Y, 2005, AGING CELL, V4, P147, DOI 10.1111/j.1474-9726.2005.00157.x
   Lai KMV, 2000, GENE DEV, V14, P1132
   Liu HY, 2002, J BIOL CHEM, V277, P26046, DOI 10.1074/jbc.M111659200
   Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991
   Luzi L, 2000, CURR OPIN GENET DEV, V10, P668, DOI 10.1016/S0959-437X(00)00146-5
   Migliaccio E, 1997, EMBO J, V16, P706, DOI 10.1093/emboj/16.4.706
   Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311
   Mori N, 2003, J CLIN BIOCHEM NUTR, V34, P69
   Mori N, 2002, NEUROBIOL AGING, V23, P255, DOI 10.1016/S0197-4580(01)00286-X
   Mori N, 2011, MED HYPOTHESES, V77, P996, DOI 10.1016/j.mehy.2011.08.030
   Nakamura T, 1996, ONCOGENE, V13, P1111
   Nakamura T, 1998, J BIOL CHEM, V273, P6960, DOI 10.1074/jbc.273.12.6960
   Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004
   OBryan JP, 1996, P NATL ACAD SCI USA, V93, P2729, DOI 10.1073/pnas.93.7.2729
   Orsini F, 2006, BIOL CHEM, V387, P1405, DOI 10.1515/BC.2006.176
   Palmer HJ, 1999, J BIOL CHEM, V274, P11424, DOI 10.1074/jbc.274.16.11424
   Pandolfi S, 2005, MECH AGEING DEV, V126, P839, DOI 10.1016/j.mad.2005.03.004
   Purdom S, 2003, TRENDS MOL MED, V9, P206, DOI 10.1016/S1471-4914(03)00048-0
   Ravichandran KS, 2001, ONCOGENE, V20, P6322, DOI 10.1038/sj.onc.1204776
   Tomilov AA, 2011, AGING CELL, V10, P55, DOI 10.1111/j.1474-9726.2010.00641.x
   Trinei M, 2009, AGING-US, V1, P503, DOI 10.18632/aging.100057
NR 34
TC 7
Z9 9
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-4943
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PD NOV-DEC
PY 2012
VL 55
IS 3
BP 744
EP 748
DI 10.1016/j.archger.2011.11.001
PG 5
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 004GC
UT WOS:000308667900038
PM 22130185
OA Green Submitted
DA 2024-02-19
ER

PT J
AU Yang, XN
   Jiang, J
   Wang, Q
   Duan, JW
   Chen, N
   Wu, D
   Xia, YK
AF Yang, Xiaona
   Jiang, Jin
   Wang, Qing
   Duan, Jiawei
   Chen, Na
   Wu, Di
   Xia, Yankai
TI Gender difference in hepatic AMPK pathway activated lipid metabolism
   induced by aged polystyrene microplastics exposure
SO ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY
LA English
DT Article; Early Access
DE Polystyrene microplastics; Estradiol; AMPK; Lipid metabolism; Liver;
   Ovary
ID GUT MICROBIOTA; ACCUMULATION; SYSTEM; INGESTION; CELLS
AB Microplastics (MPs) pollution becomes an increasing concern and researchers keep exploring the health effects caused by MPs exposure. The ageing process in the environment significantly alters the physicochemical characteristics of MPs and subsequently affects their toxicities. The health effects of aged MPs exposure and the mechanism underlying are worthy of exploration. Polystyrene microplastics (PS-MPs) (with size less than 50 mu m) were obtained by grinding and screening polystyrene materials. PS-MPs continued to be aged by ozone treatment (0.4 mg/min, 9 h). Both male and female C57BL/6 mice were orally exposed to 0 or 2 mg/kg/d aged PS-MPs for 28 days. Results showed that PS-MPs were found in liver, ovary and spleen of females and liver, testis and spleen of males in the aged PS-MPs group. Exposure to aged PS-MPs significantly decreased abdominal fat/body coefficient, the adipocyte size and the serum LDL-C level in females. Compared to the control, serum estradiol (E2) level, the mRNA expression levels of genes regulating E2 production (17 beta-hsd, 3 beta-hsd and Star) in ovary and the protein expression levels of E2 receptors (ERa, ER beta), AMPKa and p-AMPKa1 in liver increased significantly, and the mRNA expression levels of AMP-activated protein kinase (AMPK) downstream genes (Srebp-1c, Fas and Scd1) in liver decreased significantly in the female aged PS-MPs group. Liver metabolomic profiling showed that differential metabolites between female aged PS-MPs group and female control group were enriched in biotin metabolism and the level of biotin increased significantly in the female aged PS-MPs group. However, no significant changes were detected in males. These results indicated that aged PS-MPs exposure increased ovarian E2 production and activated the AMPK pathway in the liver which might inhibit liver lipid synthesis only in females. Our findings provide new insights into the potential sex-specific health effects of environmental MPs pollution.
C1 [Yang, Xiaona; Jiang, Jin; Wang, Qing; Duan, Jiawei; Chen, Na; Wu, Di; Xia, Yankai] Nanjing Med Univ, Ctr Global Hlth, Sch Publ Hlth, State Key Lab Reprod Med, Nanjing 211166, Peoples R China.
   [Yang, Xiaona; Jiang, Jin; Wang, Qing; Duan, Jiawei; Chen, Na; Wu, Di; Xia, Yankai] Nanjing Med Univ, Sch Publ Hlth, Key Lab Modern Toxicol, Minist Educ, Nanjing 211166, Peoples R China.
C3 Nanjing Medical University; Nanjing Medical University
RP Wu, D (corresponding author), Nanjing Med Univ, Sch Publ Hlth, State Key Lab Reprod Med, Nanjing 211166, Peoples R China.
EM diwu@njmu.edu.cn
OI JIANG, JIN/0000-0002-0999-2961
FU Nanjing Medical University Public Health Pilot Project [JX1033180417]
FX This study was supported by the Nanjing Medical University Public Health
   Pilot Project (JX1033180417).
CR Aguilera-Méndez A, 2012, BIOFACTORS, V38, P387, DOI 10.1002/biof.1034
   Barnes DKA, 2009, PHILOS T R SOC B, V364, P1985, DOI 10.1098/rstb.2008.0205
   Botterell ZLR, 2019, ENVIRON POLLUT, V245, P98, DOI 10.1016/j.envpol.2018.10.065
   Cappello S, 2021, J HAZARD MATER, V414, DOI 10.1016/j.jhazmat.2021.125586
   Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005
   Chen HB, 2022, SCI TOTAL ENVIRON, V811, DOI 10.1016/j.scitotenv.2021.152350
   Chen HB, 2021, J HAZARD MATER, V419, DOI 10.1016/j.jhazmat.2021.126482
   Chen T, 2021, BMC MED, V19, DOI 10.1186/s12916-021-01991-w
   Compa M, 2018, MAR POLLUT BULL, V128, P89, DOI 10.1016/j.marpolbul.2018.01.009
   Deng YF, 2017, SCI REP-UK, V7, DOI 10.1038/srep46687
   Fan XX, 2018, ANTIOXID REDOX SIGN, V28, P339, DOI 10.1089/ars.2017.7090
   Fernandez-Mejia C, 2005, J NUTR BIOCHEM, V16, P424, DOI 10.1016/j.jnutbio.2005.03.018
   Gaston E, 2020, APPL SPECTROSC, V74, P1079, DOI 10.1177/0003702820920652
   Guimaraes ATB, 2021, J HAZARD MATER, V407, DOI 10.1016/j.jhazmat.2020.124833
   Guo L, 2020, FOOD FUNCT, V11, P5664, DOI [10.1039/d0fo00594k, 10.1039/D0FO00594K]
   Han Y, 2021, TOXICOL RES-GER, V37, P443, DOI 10.1007/s43188-020-00086-7
   Hou BL, 2021, J HAZARD MATER, V405, DOI 10.1016/j.jhazmat.2020.124028
   Im C., 2021, J NUCL MED, V120
   Jeon SM, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.81
   Jeyasanta KI, 2020, MAR POLLUT BULL, V154, DOI 10.1016/j.marpolbul.2020.111055
   Jin HB, 2021, J HAZARD MATER, V401, DOI 10.1016/j.jhazmat.2020.123430
   Ke R, 2018, CELL BIOL INT, V42, P384, DOI 10.1002/cbin.10915
   Lai WC, 2021, J HAZARD MATER, V419, DOI 10.1016/j.jhazmat.2021.126454
   Landrigan PJ, 2020, ANN GLOB HEALTH, V86, DOI 10.5334/aogh.2831
   Lee J, 2017, CELL REP, V20, P655, DOI 10.1016/j.celrep.2017.06.080
   Li BQ, 2020, CHEMOSPHERE, V244, DOI 10.1016/j.chemosphere.2019.125492
   Li JY, 2018, WATER RES, V137, P362, DOI 10.1016/j.watres.2017.12.056
   Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009
   Liu GZ, 2019, ENVIRON POLLUT, V246, P26, DOI 10.1016/j.envpol.2018.11.100
   Liu J, 2019, ENVIRON SCI TECHNOL, V53, P5805, DOI 10.1021/acs.est.9b00787
   Liu P, 2020, CHEMOSPHERE, V242, DOI 10.1016/j.chemosphere.2019.125193
   Liu XM, 2021, J HAZARD MATER, V407, DOI 10.1016/j.jhazmat.2020.124836
   Liu ZQ, 2022, J HAZARD MATER, V424, DOI 10.1016/j.jhazmat.2021.127629
   Lu L, 2018, SCI TOTAL ENVIRON, V631-632, P449, DOI 10.1016/j.scitotenv.2018.03.051
   Lv WQ, 2019, SCI TOTAL ENVIRON, V652, P1209, DOI 10.1016/j.scitotenv.2018.10.321
   Miranda DD, 2016, MAR POLLUT BULL, V103, P109, DOI 10.1016/j.marpolbul.2015.12.035
   Miranda MN, 2021, SCI TOTAL ENVIRON, V796, DOI 10.1016/j.scitotenv.2021.148914
   Moreno-Méndez E, 2019, BIOFACTORS, V45, P259, DOI 10.1002/biof.1480
   Mu YW, 2022, CHEMOSPHERE, V291, DOI 10.1016/j.chemosphere.2021.132944
   Pedram A, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004013
   Qi YL, 2018, SCI TOTAL ENVIRON, V645, P1048, DOI 10.1016/j.scitotenv.2018.07.229
   Ragusa A, 2021, ENVIRON INT, V146, DOI 10.1016/j.envint.2020.106274
   Salehi M, 2018, J HAZARD MATER, V347, P242, DOI 10.1016/j.jhazmat.2017.12.066
   Schwabl P, 2019, ANN INTERN MED, V171, P453, DOI 10.7326/M19-0618
   Sghaier R, 2019, FREE RADICAL RES, V53, P535, DOI 10.1080/10715762.2019.1612891
   Singh P, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-26
   Smith BK, 2016, AM J PHYSIOL-ENDOC M, V311, pE730, DOI 10.1152/ajpendo.00225.2016
   Steer M, 2017, ENVIRON POLLUT, V226, P250, DOI 10.1016/j.envpol.2017.03.062
   Sun HQ, 2021, ECOTOX ENVIRON SAFE, V220, DOI 10.1016/j.ecoenv.2021.112340
   Tang YQ, 2021, SCI TOTAL ENVIRON, V766, DOI 10.1016/j.scitotenv.2020.142572
   Thompson RC, 2004, SCIENCE, V304, P838, DOI 10.1126/science.1094559
   Tian LL, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000444
   Wang M, 2019, CRIT REV FOOD SCI, V59, pS116, DOI 10.1080/10408398.2018.1544542
   Wang X, 2020, ENVIRON SCI TECHNOL, V54, P6202, DOI 10.1021/acs.est.9b07016
   Wang Y, 2020, J AGR FOOD CHEM, V68, P15154, DOI 10.1021/acs.jafc.0c05060
   Xie XM, 2020, ECOTOX ENVIRON SAFE, V190, DOI 10.1016/j.ecoenv.2019.110133
   Xiong X, 2018, ENVIRON POLLUT, V235, P899, DOI 10.1016/j.envpol.2017.12.081
   Xu S, 2020, SCI TOTAL ENVIRON, V703, DOI 10.1016/j.scitotenv.2019.134699
   Yang YF, 2019, J HAZARD MATER, V366, P703, DOI 10.1016/j.jhazmat.2018.12.048
   Yao XL, 2020, THERIOGENOLOGY, V157, P303, DOI 10.1016/j.theriogenology.2020.08.011
   Zheng HB, 2021, SCI TOTAL ENVIRON, V750, DOI 10.1016/j.scitotenv.2020.143085
   Zvekic M, 2022, ENVIRON SCI-PROC IMP, V24, P52, DOI 10.1039/d1em00392e
NR 62
TC 11
Z9 11
U1 11
U2 47
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0147-6513
EI 1090-2414
J9 ECOTOX ENVIRON SAFE
JI Ecotox. Environ. Safe.
PD 2022 OCT 15
PY 2022
VL 245
AR 114105
DI 10.1016/j.ecoenv.2022.114105
EA SEP 2022
PG 10
WC Environmental Sciences; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology; Toxicology
GA 5V3AW
UT WOS:000877106700001
PM 36155338
OA gold
DA 2024-02-19
ER

PT J
AU Barakat, DJ
   Zhang, J
   Barberi, T
   Denmeade, SR
   Friedman, AD
   Paz-Priel, I
AF Barakat, D. J.
   Zhang, J.
   Barberi, T.
   Denmeade, S. R.
   Friedman, A. D.
   Paz-Priel, I.
TI CCAAT/Enhancer binding protein β controls androgen-deprivation-induced
   senescence in prostate cancer cells
SO ONCOGENE
LA English
DT Article
ID TRANSCRIPTION FACTOR SP1; C/EBP-BETA; GENE-EXPRESSION; SECRETORY
   PHENOTYPE; RECEPTOR; PROLIFERATION; DIFFERENTIATION; THERAPY; ALPHA;
   OVEREXPRESSION
AB The processes associated with transition to castration-resistant prostate cancer (PC) growth are not well understood. Cellular senescence is a stable cell cycle arrest that occurs in response to sublethal stress. It is often overcome in malignant transformation to confer a survival advantage. CCAAT/Enhancer Binding Protein (C/EBP) beta function is frequently deregulated in human malignancies and interestingly, androgen-sensitive PC cells express primarily the liver-enriched inhibitory protein isoform. We found that C/EBP beta expression is negatively regulated by androgen receptor (AR) activity and that treatment of androgen-sensitive cell lines with anti-androgens increases C/EBP beta mRNA and protein levels. Accordingly, we also find that C/EBP beta levels are significantly elevated in primary PC samples from castration-resistant compared with therapy-naive patients. Chromatin immunoprecipitation demonstrated enhanced binding of the AR to the proximal promoter of the CEBPB gene in the presence of dihydroxytestosterone. Upon androgen deprivation, induction of C/EBP beta is facilitated by active transcription as evident by increased histone 3 acetylation at the C/EBP beta promoter. Also, the androgen agonist R1881 suppresses the activity of a CEBPB promoter reporter. Loss of C/EBP beta expression prevents growth arrest following androgen deprivation or anti-androgen challenge. Accordingly, suppression of C/EBP beta under low androgen conditions results in reduced expression of senescence-associated secretory genes, significantly decreased number of cells displaying heterochromatin foci and increased numbers of Ki67-positive cells. Ectopic expression of C/EBP beta caused pronounced morphological changes, reduced PC cell growth and increased the number of senescent LNCaP cells. Lastly, we found that senescence contributes to PC cell survival under androgen deprivation, and C/EBP beta-deficient cells were significantly more susceptible to killing by cytotoxic chemotherapy following androgen deprivation. Our data demonstrate that upregulation of C/EBP beta is critical for complete maintenance of androgen deprivation-induced senescence and that targeting C/EBP beta expression may synergize with anti-androgen or chemotherapy in eradicating PC.
C1 [Barakat, D. J.; Zhang, J.; Barberi, T.; Friedman, A. D.; Paz-Priel, I.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Div Pediat Oncol, Baltimore, MD 21231 USA.
   [Denmeade, S. R.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Div Med Oncol, Baltimore, MD 21231 USA.
C3 Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins
   University; Johns Hopkins Medicine
RP Paz-Priel, I (corresponding author), Johns Hopkins Univ, Bunting Blaustein Canc Res Bldg 1,Room 208,1650 O, Baltimore, MD 21231 USA.
EM ipazpri1@jhmi.edu
OI Barakat, David/0000-0001-7057-178X
FU St Baldrick's Foundation; Mitchell Foundation; Walsh Prostate Cancer
   Research Fund; Samuel Waxman Cancer Research Foundation; Department of
   Defense [PC131609]; National Institutes of Health [T32 CA60441]; Giant
   Food Children's Cancer Research Fund;  [P30 CA006973]
FX This research was supported by grants from the St Baldrick's Foundation
   (to IP-P), the Mitchell Foundation (to IP-P), the Walsh Prostate Cancer
   Research Fund (to IP-P and ADF), the Samuel Waxman Cancer Research
   Foundation (to ADF), Department of Defense grant PC131609 (to DJB),
   National Institutes of Health T32 CA60441 (to TB), the Giant Food
   Children's Cancer Research Fund and P30 CA006973.
CR Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   American Cancer Society, 2013, CANC FACTS FIG 2013
   Bagchi MK, 2006, CELL CYCLE, V5, P922, DOI 10.4161/cc.5.9.2712
   Baretton GB, 1999, BRIT J CANCER, V80, P546, DOI 10.1038/sj.bjc.6690390
   Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716
   Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537
   Boruk M, 1998, MOL ENDOCRINOL, V12, P1749, DOI 10.1210/me.12.11.1749
   Burton DGA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068003
   Cahu J, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.183
   Cai CM, 2011, CANCER CELL, V20, P457, DOI 10.1016/j.ccr.2011.09.001
   Calkhoven CF, 2000, GENE DEV, V14, P1920
   Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218
   Christenson LK, 1999, J BIOL CHEM, V274, P26591, DOI 10.1074/jbc.274.37.26591
   Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Dean JP, 2008, BRIT J CANCER, V98, P245, DOI 10.1038/sj.bjc.6604087
   Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191
   Denmeade S R, 1996, Adv Pharmacol, V35, P281, DOI 10.1016/S1054-3589(08)60278-1
   Denmeade SR, 1996, PROSTATE, V28, P251
   Ewald JA, 2013, PROSTATE, V73, P337, DOI 10.1002/pros.22571
   Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125
   Henshall SM, 2001, CLIN CANCER RES, V7, P544
   Jia L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003645
   Kawabata R, 2011, INT J ONCOL, V38, P1489, DOI 10.3892/ijo.2011.991
   Kim MH, 2008, PROSTATE, V68, P1362, DOI 10.1002/pros.20801
   Kim MH, 2009, PROSTATE, V69, P1435, DOI 10.1002/pros.20993
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Kurz DJ, 2000, J CELL SCI, V113, P3613
   Lee CT, 1999, CLIN CANCER RES, V5, P977
   Lehmann BD, 2008, CANCER RES, V68, P7864, DOI 10.1158/0008-5472.CAN-07-6538
   Lu S, 2000, MOL ENDOCRINOL, V14, P753, DOI 10.1210/me.14.5.753
   MacManus CF, 2007, MOL CANCER RES, V5, P737, DOI 10.1158/1541-7786.MCR-07-0032
   Manna S, 2013, J IMMUNOL, V191, P2837, DOI 10.4049/jimmunol.1300895
   Mantena SR, 2006, P NATL ACAD SCI USA, V103, P1870, DOI 10.1073/pnas.0507261103
   Martinez LA, 2002, CARCINOGENESIS, V23, P1289, DOI 10.1093/carcin/23.8.1289
   Mehta HH, 2011, CANCER RES, V71, P5154, DOI 10.1158/0008-5472.CAN-10-4513
   Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X
   Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562
   Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106
   Paz-Priel I, 2011, BLOOD, V117, P4085, DOI 10.1182/blood-2010-07-294470
   Pernicová Z, 2011, NEOPLASIA, V13, P526, DOI 10.1593/neo.11182
   Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112
   Seaton A, 2008, CARCINOGENESIS, V29, P1148, DOI 10.1093/carcin/bgn109
   Sebastian T, 2005, EMBO J, V24, P3301, DOI 10.1038/sj.emboj.7600789
   Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9
   Sharma NL, 2013, CANCER CELL, V23, P35, DOI 10.1016/j.ccr.2012.11.010
   STEIN B, 1995, MOL CELL BIOL, V15, P4971
   Steinman RA, 2000, MOL MED, V6, P736, DOI 10.1007/BF03402190
   Svensson C, 2014, NUCLEIC ACIDS RES, V42, P999, DOI 10.1093/nar/gkt921
   Tanabe A, 2000, BIOL PHARM BULL, V23, P1424, DOI 10.1248/bpb.23.1424
   Timchenko NA, 1999, NUCLEIC ACIDS RES, V27, P4517, DOI 10.1093/nar/27.22.4517
   Wang WZ, 2007, PROSTATE, V67, P1238, DOI 10.1002/pros.20595
   Wang XP, 1999, BLOOD, V94, P560, DOI 10.1182/blood.V94.2.560.414k41_560_571
   Yuan HQ, 2005, CARCINOGENESIS, V26, P793, DOI 10.1093/carcin/bgi021
   Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108
   Zhang ZH, 2006, MODERN PATHOL, V19, P1339, DOI 10.1038/modpathol.3800655
   Zhou JF, 2001, CANCER RES, V61, P2328
NR 57
TC 30
Z9 34
U1 0
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0950-9232
EI 1476-5594
J9 ONCOGENE
JI Oncogene
PD NOV
PY 2015
VL 34
IS 48
BP 5912
EP 5922
DI 10.1038/onc.2015.41
PG 11
WC Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics &
   Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics &
   Heredity
GA CX1CO
UT WOS:000365434000006
PM 25772238
OA Bronze, Green Accepted
DA 2024-02-19
ER

PT J
AU RUIZ, P
   PULIDO, JA
   MARTINEZ, C
   CARRASCOSA, JM
   SATRUSTEGUI, J
   ANDRES, A
AF RUIZ, P
   PULIDO, JA
   MARTINEZ, C
   CARRASCOSA, JM
   SATRUSTEGUI, J
   ANDRES, A
TI EFFECT OF AGING ON THE KINETIC CHARACTERISTICS OF THE INSULIN-RECEPTOR
   AUTOPHOSPHORYLATION IN RAT ADIPOCYTES
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
ID TYROSINE KINASE-ACTIVITY; INTRINSIC PHOSPHATASE-ACTIVITY;
   PHOSPHORYLATION; PROTEIN; RESISTANCE; BINDING; LIVER; TISSUE;
   DEPHOSPHORYLATION; MEMBRANE
C1 UNIV AUTONOMA MADRID,FAC CIENCIAS,CSIC,CTR BIOL MOLEC,DEPT BIOL MOLEC,E-28049 MADRID,SPAIN.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous
   University of Madrid
RI Martinez, Carmen/P-6661-2017; Carrascosa, Jose Manuel/J-4946-2013;
   ANDRES, ANTONIO/G-8794-2015; Satrustegui, Jorgina/R-6732-2019
OI Martinez, Carmen/0000-0001-7226-9154; Carrascosa, Jose
   Manuel/0000-0003-4266-0771; ANDRES, ANTONIO/0000-0002-9892-8338;
   Satrustegui Gil Delgado, Jorgina/0000-0003-3377-2667
CR ANDERSON CM, 1991, J BIOL CHEM, V266, P21760
   BOLINDER J, 1983, DIABETES, V32, P959, DOI 10.2337/diabetes.32.10.959
   BRYERASH M, 1987, DIABETES S1, V36, pA56
   BURANT CF, 1988, ENDOCRINOLOGY, V122, P427, DOI 10.1210/endo-122-2-427
   CARRASCOSA JM, 1989, BIOCHEM BIOPH RES CO, V160, P303, DOI 10.1016/0006-291X(89)91656-2
   DAVIDSON MB, 1979, METABOLISM, V28, P688, DOI 10.1016/0026-0495(79)90024-6
   DEBANT A, 1987, AM J PHYSIOL, V252, pE273, DOI 10.1152/ajpendo.1987.252.2.E273
   DEFRONZO RA, 1979, DIABETES, V28, P1095, DOI 10.2337/diab.28.12.1095
   DUHAULT J, 1987, DIABETOLOGIA, V30, pA515
   FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908
   FINK RI, 1986, J CLIN INVEST, V77, P2034, DOI 10.1172/JCI112533
   FREIDENBERG GR, 1985, J BIOL CHEM, V260, P2444
   FREIDENBERG GR, 1987, J CLIN INVEST, V79, P240, DOI 10.1172/JCI112789
   GOREN HJ, 1987, BIOCHEMISTRY-US, V26, P2374, DOI 10.1021/bi00382a044
   HARING H, 1986, J BIOL CHEM, V261, P3869
   HARING H, 1986, BIOCHEM J, V234, P9
   HARING HU, 1984, BIOCHEMISTRY-US, V23, P3298, DOI 10.1021/bi00309a028
   HARING HU, 1990, DIABETES ANN, V5, P537
   HARLOW E, 1988, NATIBODIES LABORATOR, P72
   HERRERA R, 1986, J BIOL CHEM, V261, P1980
   KARASIK A, 1990, J BIOL CHEM, V265, P10226
   KASUGA M, 1982, SCIENCE, V215, P185, DOI 10.1126/science.7031900
   KONO S, 1990, AM J PHYSIOL, V259, pE27, DOI 10.1152/ajpendo.1990.259.1.E27
   KOWALSKI A, 1983, BIOCHEM BIOPH RES CO, V117, P885, DOI 10.1016/0006-291X(83)91679-0
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LAU KHW, 1989, BIOCHEM J, V257, P23, DOI 10.1042/bj2570023
   LEWIS RE, 1990, BIOCHEMISTRY-US, V29, P1807, DOI 10.1021/bi00459a020
   LONNROTH P, 1986, J CLIN ENDOCR METAB, V62, P433
   MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9
   MARTINEZ C, 1989, BIOCHEM J, V263, P267, DOI 10.1042/bj2630267
   MASSAGUE J, 1982, J BIOL CHEM, V257, P6729
   MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1
   NADIV O, 1990, 4 INT S INS R EC INS, P146
   OLEFSKY JM, 1975, ENDOCRINOLOGY, V96, P1486, DOI 10.1210/endo-96-6-1486
   PAGANO G, 1981, METABOLISM, V30, P46, DOI 10.1016/0026-0495(81)90217-1
   PERLMAN R, 1989, J BIOL CHEM, V264, P8946
   PILCH PF, 1979, J BIOL CHEM, V254, P3375
   PILLAY TS, 1991, BIOCHEM BIOPH RES CO, V179, P962, DOI 10.1016/0006-291X(91)91912-V
   RODBELL M, 1964, J BIOL CHEM, V239, P375
   ROSEN OM, 1987, SCIENCE, V237, P1452, DOI 10.1126/science.2442814
   ROWE JW, 1983, J CLIN INVEST, V71, P1581, DOI 10.1172/JCI110914
   TAKAYAMA S, 1988, J BIOL CHEM, V263, P3440
   ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0
NR 43
TC 22
Z9 22
U1 0
U2 6
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0003-9861
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUL
PY 1992
VL 296
IS 1
BP 231
EP 238
DI 10.1016/0003-9861(92)90567-G
PG 8
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA HY138
UT WOS:A1992HY13800030
PM 1318691
DA 2024-02-19
ER

PT J
AU Bresilla, D
   Habisch, H
   Pritisanac, I
   Zarse, K
   Parichatikanond, W
   Ristow, M
   Madl, T
   Madreiter-Sokolowski, CT
AF Bresilla, Doruntina
   Habisch, Hansjoerg
   Pritisanac, Iva
   Zarse, Kim
   Parichatikanond, Warisara
   Ristow, Michael
   Madl, Tobias
   Madreiter-Sokolowski, Corina T.
TI The sex-specific metabolic signature of C57BL/6NRj mice during aging
SO SCIENTIFIC REPORTS
LA English
DT Article
ID AGE; GLUCOSE; EXPRESSION; ESTROGEN; CHOLINE; GENDER; WOMEN; MEN
AB Due to intact reactive oxygen species homeostasis and glucose metabolism, C57BL/6NRj mice are especially suitable to study cellular alterations in metabolism. We applied Nuclear Magnetic resonance spectroscopy to analyze five different tissues of this mouse strain during aging and included female and male mice aged 3, 6, 12, and 24 months. Metabolite signatures allowed separation between the age groups in all tissues, and we identified the most prominently changing metabolites in female and male tissues. A refined analysis of individual metabolite levels during aging revealed an early onset of age-related changes at 6 months, sex-specific differences in the liver, and a biphasic pattern for various metabolites in the brain, heart, liver, and lung. In contrast, a linear decrease of amino acids was apparent in muscle tissues. Based on these results, we assume that age-related metabolic alterations happen at a comparably early aging state and are potentially associated with a metabolic switch. Moreover, identified differences between female and male tissues stress the importance of distinguishing between sexes when studying age-related changes and developing new treatment approaches. Besides, metabolomic features seem to be highly dependent on the genetic background of mouse strains.
C1 [Bresilla, Doruntina; Habisch, Hansjoerg; Pritisanac, Iva; Madl, Tobias; Madreiter-Sokolowski, Corina T.] Med Univ Graz, Gottfried Schatz Res Ctr, Mol Biol & Biochem, Neue Stiftingtalstr 6-4, A-8010 Graz, Austria.
   [Zarse, Kim; Ristow, Michael] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Lab Energy Metab, Inst Translat Med, Schorenstr 16, CH-8603 Schwerzenbach, Switzerland.
   [Parichatikanond, Warisara] Mahidol Univ, Fac Pharm, Dept Pharmacol, Bangkok 10400, Thailand.
   [Parichatikanond, Warisara] Mahidol Univ, Fac Pharm, Ctr Biopharmaceut Sci Hlth Ageing BSHA, Bangkok 10400, Thailand.
   [Madl, Tobias; Madreiter-Sokolowski, Corina T.] BioTechMed Graz, Graz, Austria.
C3 Medical University of Graz; Swiss Federal Institutes of Technology
   Domain; ETH Zurich; Mahidol University; Mahidol University
RP Madl, T; Madreiter-Sokolowski, CT (corresponding author), Med Univ Graz, Gottfried Schatz Res Ctr, Mol Biol & Biochem, Neue Stiftingtalstr 6-4, A-8010 Graz, Austria.; Madl, T; Madreiter-Sokolowski, CT (corresponding author), BioTechMed Graz, Graz, Austria.
EM tobias.madl@medunigraz.at; corina.madreiter@medunigraz.at
RI Madreiter-Sokolowski, Corina/AAK-4722-2020; Ristow, Michael/O-9858-2014;
   Zarse, Kim/D-2133-2016; Madl, Tobias/B-1682-2012
OI Madreiter-Sokolowski, Corina/0000-0002-8631-9949; Ristow,
   Michael/0000-0003-2109-2453; Zarse, Kim/0000-0003-2542-6123; Madl,
   Tobias/0000-0002-9725-5231; Habisch, Hansjorg/0000-0001-5537-506X
FU Austrian Science Fund FWF [J4205, P28854, I3792, DK-MCD W1226, DOC-130];
   Swiss National Science Foundation [31003A_176127]; Horizon 2020 program
   of the European Union [633589]; Austrian Research Promotion Agency FFG
   [864690, 870454]; Integrative Metabolism Research Center Graz; Styrian
   Government (Zukunftsfonds, doc.funds program); City of Graz; Austrian
   Exchange Service OEAD; BioTechMed-Graz (Flagship project DYNIMO);
   Austrian Infrastructure Program 2016/2017; Austrian Science Fund (FWF)
   [I3792, J4205] Funding Source: Austrian Science Fund (FWF); Swiss
   National Science Foundation (SNF) [31003A_176127] Funding Source: Swiss
   National Science Foundation (SNF)
FX This study was funded by the Austrian Science Fund FWF (J4205 to C.M.S.;
   P28854, I3792, DK-MCD W1226, DOC-130 to T.M.), the Swiss National
   Science Foundation (31003A_176127 to M.R.), the Horizon 2020 program of
   the European Union (633589 to M.R.), the Austrian Research Promotion
   Agency FFG (864690 and 870454 to T.M.), the Integrative Metabolism
   Research Center Graz, the Austrian Infrastructure Program 2016/2017, the
   Styrian Government (Zukunftsfonds, doc.funds program), the City of Graz
   and BioTechMed-Graz (Flagship project DYNIMO), and the Austrian Exchange
   Service OEAD (Ernst Mach Follow-Up Grant to W.P.).
CR Adav SS, 2021, AGING DIS, V12, P646, DOI 10.14336/AD.2020.0909
   Baker DJ, 2017, TRENDS BIOCHEM SCI, V42, P702, DOI 10.1016/j.tibs.2017.06.005
   Berezhnoy DS, 2019, AMINO ACIDS, V51, P139, DOI 10.1007/s00726-018-2667-7
   Berger C, 2005, STROKE, V36, pE4, DOI 10.1161/01.STR.0000151328.70519.e9
   Brewer Rachel A, 2016, Nutr Healthy Aging, V4, P31, DOI 10.3233/NHA-160007
   Brinton RD, 2012, ENDOCRINOLOGY, V153, P3571, DOI 10.1210/en.2012-1340
   Casquero AC, 2006, J LIPID RES, V47, P1526, DOI 10.1194/jlr.M600135-JLR200
   Chandler JD, 2016, AM J PHYSIOL-REG I, V311, pR906, DOI 10.1152/ajpregu.00298.2016
   Chee C, 2016, DIABETES, V65, P840, DOI 10.2337/db15-1383
   Chen P, 2002, P NATL ACAD SCI USA, V99, P9031, DOI 10.1073/pnas.132076299
   Chia CW, 2018, CIRC RES, V123, P886, DOI 10.1161/CIRCRESAHA.118.312806
   Cho SJ, 2017, AM J RESP CELL MOL, V56, P521, DOI 10.1165/rcmb.2016-0225OC
   Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310
   Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862
   Eisenberg T, 2014, CELL METAB, V19, P431, DOI 10.1016/j.cmet.2014.02.010
   Fergusson G, 2014, MOL METAB, V3, P848, DOI 10.1016/j.molmet.2014.09.006
   Finkel T, 2015, NAT MED, V21, P1416, DOI 10.1038/nm.3998
   Flurkey K. C., 2007, AM COLL LAB ANIMAL M, V3, P637, DOI [10.1016/B978-012369454-6/50074-1, DOI 10.1016/B978-012369454-6/50074-1]
   Fujita S, 2006, J NUTR, V136, p277S, DOI 10.1093/jn/136.1.277S
   Gent DN, 2013, J SPORT SCI, V31, P97, DOI 10.1080/02640414.2012.721561
   GREENBLATT RB, 1976, J AM GERIATR SOC, V24, P173, DOI 10.1111/j.1532-5415.1976.tb04294.x
   Guo SZ, 2019, ARCH PHYSIOL BIOCHEM, V125, P470, DOI 10.1080/13813455.2019.1638414
   Hägg S, 2021, ELIFE, V10, DOI 10.7554/eLife.63425
   Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134
   Kaczor JJ, 2006, J GERONTOL A-BIOL, V61, P339, DOI 10.1093/gerona/61.4.339
   Karakelides H, 2010, DIABETES, V59, P89, DOI 10.2337/db09-0591
   Khan M, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-177
   Kirchengast S, 2009, ANTHROPOL ANZ, V67, P139, DOI 10.1127/0003-5548/2009/0018
   Kirov II, 2021, NEUROBIOL AGING, V98, P42, DOI 10.1016/j.neurobiolaging.2020.10.024
   Klinge CM, 2020, REDOX BIOL, V31, DOI 10.1016/j.redox.2020.101435
   Knopp RH, 1997, J CLIN ENDOCR METAB, V82, P3952, DOI 10.1210/jc.82.12.3952
   Koopman M, 2016, NAT PROTOC, V11, P1798, DOI 10.1038/nprot.2016.106
   Lamberts SWJ, 1997, SCIENCE, V278, P419, DOI 10.1126/science.278.5337.419
   Lee D, 2015, AGING CELL, V14, P8, DOI 10.1111/acel.12277
   Liang YR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24146-z
   Lindle RS, 1997, J APPL PHYSIOL, V83, P1581, DOI 10.1152/jappl.1997.83.5.1581
   Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a
   Lynch S, 2021, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.610516
   Madreiter-Sokolowski CT, 2020, REDOX BIOL, V36, DOI 10.1016/j.redox.2020.101678
   Masuda S, 2009, EXP GERONTOL, V44, P280, DOI 10.1016/j.exger.2008.12.003
   Mekada K, 2009, EXP ANIM TOKYO, V58, P141, DOI 10.1538/expanim.58.141
   Peleg S, 2016, EMBO REP, V17, P455, DOI 10.15252/embr.201541132
   Petr MA, 2021, ELIFE, V10, DOI 10.7554/eLife.62952
   Pifferi F, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0024-8
   Pontzer H, 2021, SCIENCE, V373, P808, DOI 10.1126/science.abe5017
   Rao KNS, 2020, REDOX BIOL, V36, DOI 10.1016/j.redox.2020.101650
   Reynolds TH, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.13995
   Ristow M, 2014, NAT MED, V20, P709, DOI 10.1038/nm.3624
   Rivera Jose de Jesus, 2016, Gerontol Geriatr Med, V2, p2333721416667879, DOI 10.1177/2333721416667879
   Sithara T, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.669497
   Smith CD, 2020, J BIOL CHEM, V295, P16207, DOI 10.1074/jbc.RA120.013899
   Spinelli R, 2020, J ENDOCRINOL INVEST, V43, P1373, DOI 10.1007/s40618-020-01255-z
   Teixeira FC, 2020, PSYCHOPHARMACOLOGY, V237, P811, DOI 10.1007/s00213-019-05419-5
   Tomás-Loba A, 2013, AGING CELL, V12, P93, DOI 10.1111/acel.12025
   Traini E, 2013, CURR ALZHEIMER RES, V10, P1070, DOI 10.2174/15672050113106660173
   Varlamov Oleg, 2014, Front Endocrinol (Lausanne), V5, P241, DOI 10.3389/fendo.2014.00241
   Varshavi D, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00028
   Vermeulen A, 2002, Aging Male, V5, P98, DOI 10.1080/713604678
   Vignoli A, 2019, ANGEW CHEM INT EDIT, V58, P968, DOI 10.1002/anie.201804736
   Vozenilek AE, 2018, J VASC RES, V55, P98, DOI 10.1159/000486337
   Yan H, 2019, DIABETES, V68, P291, DOI 10.2337/db18-0638
   Yanai S, 2021, FRONT AGING NEUROSCI, V13, DOI 10.3389/fnagi.2021.697621
   YAO ZM, 1988, J BIOL CHEM, V263, P2998
   Yin C, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.647743
   ZEISEL SH, 1989, J NUTR, V119, P800, DOI 10.1093/jn/119.5.800
   Zhang FR, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11020235
   Zhang NF, 2018, ANIM NUTR, V4, P11, DOI 10.1016/j.aninu.2017.08.009
   Zhou QS, 2022, METABOLITES, V12, DOI 10.3390/metabo12010017
   Zhuang HH, 2021, GEROSCIENCE, V43, P2679, DOI 10.1007/s11357-021-00387-1
   Zhuang JJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42485-3
   Zuo L, 2021, ADV EXP MED BIOL, V1304, P187, DOI 10.1007/978-3-030-68748-9_11
NR 71
TC 1
Z9 1
U1 0
U2 1
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD DEC 6
PY 2022
VL 12
IS 1
AR 21050
DI 10.1038/s41598-022-25396-8
PG 14
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 9B1IK
UT WOS:000934498000009
PM 36473898
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Bendikov-Bar, I
   Malitsky, S
   Itkin, M
   Rusal, M
   Sagi, D
AF Bendikov-Bar, Inna
   Malitsky, Sergey
   Itkin, Maxim
   Rusal, Mark
   Sagi, Dror
TI Metabolomic Changes Are Predictive of Aging in Laying Hens
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article; Early Access
DE Biomarkers; Computational biology; Laying hens; System biology;
   Time-restricted feeding
ID EGG QUALITY; AGE; VARIABILITY; EXPRESSION; GENETICS; PROTEIN; MODELS;
   LIVER; DIET
AB Aging in vertebrates is an extremely complex process that is still poorly understood. One confining factor to studying vertebrate aging is the lack of appropriate models. The laying hen is a good model to study vertebrate aging, as it can be maintained under standard housing conditions, its breeds are genetically well defined and it exhibits significant aging phenotypes at around 18 months of age. Furthermore, laying hens are maintained in a challenging realistic environment and possess a fully functional immune system. Here we used, for the first time, metabolomic profiling of laying hens' blood for identifying biomarkers of aging. Random forest classifier was used to quantify the quality of the markers and found that the markers can predict the correct age group of individuals with 90% accuracy. Animals under time-restricted feeding, a condition known to increase health span, appeared younger under the markers, indicating that the aging biomarkers can also predict the effectiveness of environmental treatments. Additionally, we found that noise, defined as the ratio between the standard deviation and the mean, is an exceptionally robust and universal biomarker of aging, as metabolomic noise increases significantly with age in laying hens, humans, and mice. Our study suggests the laying hen as a useful model to study aging in vertebrates and establishes metabolomic noise as a novel, universal biomarker of aging.
C1 [Bendikov-Bar, Inna; Rusal, Mark; Sagi, Dror] Agr Res Org, Inst Anim Sci, Volcani Ctr, POB 15159, IL-7528809 Rishon Leziyyon, Israel.
   [Malitsky, Sergey; Itkin, Maxim] Weizmann Inst Sci, Life Sci Core Facil, Rehovot, Israel.
C3 VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Weizmann Institute of
   Science
RP Sagi, D (corresponding author), Agr Res Org, Inst Anim Sci, Volcani Ctr, POB 15159, IL-7528809 Rishon Leziyyon, Israel.
EM dror.sagi@mail.huji.ac.il
RI Itkin, Maxim/AFU-5181-2022
OI Itkin, Maxim/0000-0003-1348-2814
CR Abolins S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14811
   Alves-Bezerra M, 2018, COMPR PHYSIOL, V8, P1, DOI 10.1002/cphy.c170012
   [Anonymous], Relationships between feather score and egg production and feed consumption of different layer hybrids kept in conventional cages
   Antar RS, 2004, POULTRY SCI, V83, P447, DOI 10.1093/ps/83.3.447
   Austad SN, 2005, MECH AGEING DEV, V126, P43, DOI 10.1016/j.mad.2004.09.022
   Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844
   Bain MM, 2016, BRIT POULTRY SCI, V57, P330, DOI 10.1080/00071668.2016.1161727
   Balasubramanian P, 2020, AGEING RES REV, V64, DOI 10.1016/j.arr.2020.101189
   Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807
   Beck MM, 2004, POULTRY SCI, V83, P200, DOI 10.1093/ps/83.2.200
   Benjamini Y., 1995, J R STAT SOC, V57, P289, DOI [10.1111/j.2517-6161.1995.tb02031.x, DOI 10.2307/2346101]
   Berry WD, 2003, POULTRY SCI, V82, P971, DOI 10.1093/ps/82.6.971
   Chaleckis R, 2016, P NATL ACAD SCI USA, V113, P4252, DOI 10.1073/pnas.1603023113
   Cheung P, 2018, CELL, V173, P1385, DOI 10.1016/j.cell.2018.03.079
   Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014
   Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010
   Finch CE, 2011, BIOESSAYS, V33, P27, DOI 10.1002/bies.201000111
   Froy O, 2010, AGING-US, V2, P7, DOI 10.18632/aging.100116
   Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134
   Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002
   Jang C, 2018, CELL, V173, P822, DOI 10.1016/j.cell.2018.03.055
   Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815
   Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980
   Kim SK, 2007, J EXP BIOL, V210, P1607, DOI 10.1242/jeb.004887
   Levy O, 2020, NAT METAB, V2, DOI 10.1038/s42255-020-00304-4
   Liang L, 2020, CELL, V181, P1680, DOI 10.1016/j.cell.2020.05.002
   Liu XT, 2018, J ZHEJIANG UNIV-SC B, V19, P390, DOI [10.1631/jzus.B1700054, 10.1631/jzus.b1700054]
   Lohr KE, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42434-0
   Malitsky S, 2016, NEW PHYTOL, V210, P88, DOI 10.1111/nph.13852
   MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491
   Manoogian ENC, 2017, AGEING RES REV, V39, P59, DOI 10.1016/j.arr.2016.12.006
   Martinez-Jimenez CP, 2017, SCIENCE, V355, P1433, DOI 10.1126/science.aah4115
   Mignon-Grasteau S, 2015, POULTRY SCI, V94, P586, DOI 10.3382/ps/pev028
   Mitchell SJ, 2015, ANNU REV ANIM BIOSCI, V3, P283, DOI 10.1146/annurev-animal-022114-110829
   Newgard CB, 2017, CELL METAB, V25, P43, DOI 10.1016/j.cmet.2016.09.018
   Raymond B, 2018, J ANIM SCI, V96, P2525, DOI 10.1093/jas/sky157
   Robinson O, 2020, AGING CELL, V19, DOI 10.1111/acel.13149
   Rodwell GEJ, 2004, PLOS BIOL, V2, P2191, DOI 10.1371/journal.pbio.0020427
   Rozenboim I, 2016, POULTRY SCI, V95, P612, DOI 10.3382/ps/pev367
   Ruby JG, 2018, ELIFE, V7, DOI 10.7554/eLife.31157
   Sánchez-Blanco A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002047
   Singh PP, 2019, CELL, V177, P200, DOI 10.1016/j.cell.2019.02.038
   Southworth LK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000776
   Stehman SV, 1997, REMOTE SENS ENVIRON, V62, P77, DOI 10.1016/S0034-4257(97)00083-7
   Su G, 2006, POULTRY SCI, V85, P191, DOI 10.1093/ps/85.2.191
   Tin Kam Ho, 1995, Proceedings of the Third International Conference on Document Analysis and Recognition, P278, DOI 10.1109/ICDAR.1995.598994
   Tokarz J, 2017, TRENDS ENDOCRIN MET, V28, P705, DOI 10.1016/j.tem.2017.07.001
   Urfer SR, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9121086
   Valenzano DR, 2015, CELL, V163, P1539, DOI 10.1016/j.cell.2015.11.008
   Whitehead CC, 2000, POULTRY SCI, V79, P1033, DOI 10.1093/ps/79.7.1033
   Zheng L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7001
NR 51
TC 4
Z9 4
U1 1
U2 4
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD 2021 OCT
PY 2021
VL 76
IS 10
BP 1757
EP 1768
DI 10.1093/gerona/glab135
EA MAY 2021
PG 12
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA YL1QF
UT WOS:000745673000020
PM 33978733
DA 2024-02-19
ER

PT J
AU Voelkl, J
   Pakladok, T
   Lin, Y
   Viereck, R
   Lebedeva, A
   Kukuk, D
   Pichler, BJ
   Alesutan, I
   Lang, F
AF Voelkl, Jakob
   Pakladok, Tatsiana
   Lin, Yun
   Viereck, Robert
   Lebedeva, Aleksandra
   Kukuk, Damaris
   Pichler, Bernd J.
   Alesutan, Ioana
   Lang, Florian
TI Up-Regulation of Hepatic Alpha-2-HS-Glycoprotein Transcription by
   Testosterone <i>via</i> Androgen Receptor Activation
SO CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
LA English
DT Article
DE Fetuin-A; Alpha-2-HS-glycoprotein; Testosterone; Androgen receptor; ADT;
   AREs
ID LOW SERUM TESTOSTERONE; FETUIN-A LEVELS; VASCULAR CALCIFICATION;
   INSULIN-RESISTANCE; GENE; SENSITIVITY; MORTALITY; STIFFNESS; PROTEIN;
   MEN
AB Background/Aims: Fetuin-A (alpha-2-HS-glycoprotein, AHSG), a liver borne plasma protein, contributes to the prevention of soft tissue calcification, modulates inflammation, reduces insulin sensitivity and fosters weight gain following high fat diet or ageing. In polycystic ovary syndrome, fetuin-A levels correlate with free androgen levels, an observation pointing to androgen sensitivity of fetuin-A expression. The present study thus explored whether the expression of hepatic fetuin-A is modified by testosterone. Methods: HepG2 cells were treated with testosterone and androgen receptor antagonist flutamide, and were silenced with androgen receptor siRNA. To test the in vivo relevance, male mice were subjected to androgen deprivation therapy (ADT) for 7 weeks. ARSG m RNA levels were determined by quantitative RT-PCR and fetuin-A protein abundance by Western blotting. Results: In HepG2 cells, AHSG mRNA expression and fetuin-A protein abundance were both up regulated following testosterone treatment. The human alpha-2-HS-glycoprotein gene harbors putative androgen receptor response elements in the proximal 5 kb promoter sequence relative to TSS. The effect of testosterone on AHSG mRNA levels was abrogated by silencing of the androgen receptor in HepG2 cells. Moreover, treatment of HepG2 cells with the androgen receptor antagonist flutamide in presence of endogenous ligands in the medium significantly down regulated AHSG mRNA expression and fetuin-A protein abundance. In addition, ADT of male mice was followed by a significant decrease of hepatic Ahsg mRNA expression and fetuin-A protein levels. Conclusions: Testosterone participates in the regulation of hepatic fetuin-A expression, an effect mediated, at least partially, by androgen receptor activation. Copyright (C) 2014 S. Karger AG, Basel
C1 [Voelkl, Jakob; Pakladok, Tatsiana; Viereck, Robert; Lebedeva, Aleksandra; Alesutan, Ioana; Lang, Florian] Univ Tubingen, Dept Physiol, D-72076 Tubingen, Germany.
   [Lin, Yun; Kukuk, Damaris; Pichler, Bernd J.] Univ Tubingen, Dept Preclin Imaging & Radiopharm, Werner Siemens Imaging Ctr, D-72076 Tubingen, Germany.
   [Lebedeva, Aleksandra] Russian Acad Med Sci, Inst Expt Med, Dept Immunol, St Petersburg, Russia.
C3 Eberhard Karls University of Tubingen; Siemens AG; Eberhard Karls
   University of Tubingen; Russian Academy of Medical Sciences; Institute
   of Experimental Medicine
RP Lang, F (corresponding author), Univ Tubingen, Inst Physiol, Gmelinstr 5, D-72076 Tubingen, Germany.
EM florian.lang@uni-tuebingen.de
RI Voelkl, Jakob/T-4298-2019; Lebedeva, Aleksandra/ABI-2117-2020; Pichler,
   Bernd J/B-4483-2012
OI Voelkl, Jakob/0000-0002-6318-5087
FU Deutsche Forschungsgemeinschaft [KFO 274]; Open Access Publishing Fund
   of Tuebingen University; Swiss Werner Siemens Foundation
FX The authors acknowledge the meticulous preparation of the manuscript by
   Lejla Subasic and Tanja Loch. This study was supported by the Deutsche
   Forschungsgemeinschaft (KFO 274), Open Access Publishing Fund of
   Tuebingen University and the Swiss Werner Siemens Foundation.
CR Alesutan I, 2013, KIDNEY BLOOD PRESS R, V37, P475, DOI 10.1159/000355728
   Alesutan I, 2013, CELL PHYSIOL BIOCHEM, V32, P728, DOI 10.1159/000354475
   BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7
   Dousdampanis P, 2013, THER APHER DIAL, DOI 10.1111/1744-9987.12101
   Enli Y, 2013, GYNECOL ENDOCRINOL, V29, P1036, DOI 10.3109/09513590.2013.829442
   Guillory B, 2010, AM J PATHOL, V177, P2635, DOI 10.2353/ajpath.2010.100177
   Haring R, 2011, AM J NEPHROL, V33, P209, DOI 10.1159/000324562
   Hermans MMH, 2007, KIDNEY INT, V72, P202, DOI 10.1038/sj.ki.5002178
   Horie-Inoue K, 2004, BIOCHEM BIOPH RES CO, V325, P1312, DOI 10.1016/j.bbrc.2004.10.174
   Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311
   Ikeda H, 2002, BIOCHEM J, V364, P563, DOI 10.1042/BJ20011756
   JahnenDechent W, 1997, J BIOL CHEM, V272, P31496, DOI 10.1074/jbc.272.50.31496
   Jones TH, 2009, ATHEROSCLEROSIS, V207, P318, DOI 10.1016/j.atherosclerosis.2009.04.016
   Ketteler M, 2002, BLOOD PURIFICAT, V20, P473, DOI 10.1159/000063554
   Kuro-o M, 2013, NAT REV NEPHROL, V9, P650, DOI 10.1038/nrneph.2013.111
   Kyriazis J, 2011, NEPHROL DIAL TRANSPL, V26, P2971, DOI 10.1093/ndt/gfq847
   Lee CM, 2013, BIOSCI REP, V33
   Li W, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016945, 10.1371/journal.pone.0021082]
   Mathews ST, 2002, DIABETES, V51, P2450, DOI 10.2337/diabetes.51.8.2450
   Mathews ST, 2006, BIOCHEM BIOPH RES CO, V350, P437, DOI 10.1016/j.bbrc.2006.09.071
   McGill JI, 2012, CLEV CLIN J MED, V79, P797, DOI 10.3949/ccjm.79a.12010
   Moe SM, 2004, CIRC RES, V95, P560, DOI 10.1161/01.RES.0000141775.67189.98
   Mori K, 2012, ADV CLIN CHEM, V56, P175, DOI 10.1016/B978-0-12-394317-0.00010-8
   Pakladok T, 2013, CELL PHYSIOL BIOCHEM, V31, P785, DOI 10.1159/000350096
   Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851
   Papadopoulou N, 2009, IUBMB LIFE, V61, P56, DOI 10.1002/iub.150
   Rasul S, 2012, ENDOCRINE, V42, P496, DOI 10.1007/s12020-012-9754-4
   Read JT, 2007, J BIOL CHEM, V282, P31954, DOI 10.1074/jbc.M702099200
   Ruige JB, 2013, J CLIN ENDOCR METAB, V98, P4300, DOI 10.1210/jc.2013-1970
   Sakwe AM, 2010, J BIOL CHEM, V285, P41827, DOI 10.1074/jbc.M110.128926
   Schäfer C, 2003, J CLIN INVEST, V112, P357, DOI [10.1172/JCI200317202, 10.1172/JCI17202]
   Shroff R, 2013, J AM SOC NEPHROL, V24, P179, DOI 10.1681/ASN.2011121191
   Shroff RC, 2008, CIRCULATION, V118, P1748, DOI 10.1161/CIRCULATIONAHA.108.783738
   Siegel-Axel DI, 2014, DIABETOLOGIA, V57, P1057, DOI 10.1007/s00125-014-3177-0
   Singh M, 2012, J PHARM PHARMACOL, V64, P1703, DOI 10.1111/j.2042-7158.2012.01561.x
   Spitzer M, 2013, NAT REV ENDOCRINOL, V9, P414, DOI 10.1038/nrendo.2013.73
   Staude H, 2013, KIDNEY BLOOD PRESS R, V37, P68, DOI 10.1159/000343402
   Tirabassi G, 2013, INTERN EMERG MED, V8, pS65, DOI 10.1007/s11739-013-0914-1
   Verrijdt G, 2003, MOL GENET METAB, V78, P175, DOI 10.1016/S1096-7192(03)00003-9
   Vlachopoulos C, 2014, ATHEROSCLEROSIS, V233, P278, DOI 10.1016/j.atherosclerosis.2013.12.010
   Voelkl J, 2013, CELL PHYSIOL BIOCHEM, V32, P25, DOI 10.1159/000350120
   Wang HC, 2010, J CEREBR BLOOD F MET, V30, P493, DOI 10.1038/jcbfm.2009.247
   Westenfeld R, 2009, J AM SOC NEPHROL, V20, P1264, DOI 10.1681/ASN.2008060572
   Wolff M, 2013, CELL PHYSIOL BIOCHEM, V32, P849, DOI 10.1159/000354487
   Xu Y, 2011, ATHEROSCLEROSIS, V216, P180, DOI 10.1016/j.atherosclerosis.2011.01.020
   Yeap BB, 2012, CRIT REV CL LAB SCI, V49, P168, DOI 10.3109/10408363.2012.725461
   Yilmaz MI, 2011, CLIN J AM SOC NEPHRO, V6, P1617, DOI 10.2215/CJN.10681210
   Zirkin BR, 2012, J ANDROL, V33, P1111, DOI 10.2164/jandrol.112.017160
NR 48
TC 12
Z9 14
U1 0
U2 8
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1015-8987
EI 1421-9778
J9 CELL PHYSIOL BIOCHEM
JI Cell. Physiol. Biochem.
PY 2014
VL 33
IS 6
BP 1911
EP 1920
DI 10.1159/000362968
PG 10
WC Cell Biology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Physiology
GA AL8WD
UT WOS:000339419500025
PM 25011927
OA gold
DA 2024-02-19
ER

PT J
AU Karimi, M
   Castagné, R
   Delpierre, C
   Albertus, G
   Berger, E
   Vineis, P
   Kumari, M
   Kelly-Irving, M
   Chadeau-Hyam, M
AF Karimi, Maryam
   Castagne, Raphaele
   Delpierre, Cyrille
   Albertus, Gaelle
   Berger, Eloise
   Vineis, Paolo
   Kumari, Meena
   Kelly-Irving, Michelle
   Chadeau-Hyam, Marc
TI Early-life inequalities and biological ageing: a multisystem Biological
   Health Score approach in UnderstandingSociety
SO JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH
LA English
DT Article
DE biomarkers; biological ageing; social epidemiology
ID ALLOSTATIC LOAD; NETWORK MEDICINE; MACARTHUR; MORTALITY
AB Social position is known to play a role in the quality of ageing, notably through the stimulation/dysregulation of key physiological systems in response to external stresses. Using data from one wave of Understanding Society including 9088 participants, we defined, as an extension of the allostatic load, a synthetic Biological Health Score (BHS) capturing the wear-and-tear of four physiological systems (endocrine, inflammatory, cardiovascular and metabolic systems) and two organs (liver and kidney). We used 16 established blood-derived biomarkers of these systems to calculate the BHS and explored the relative contribution of socioeconomic position to the BHS and its main components across age groups. We identified a systematic decreasing education-related gradient of the BHS (p<0.001) leading to lower biological risk in participants with longer education. Education-related differences in the BHS were detected early in life, and were not attributable to lifestyle and behavioural factors. We found a consistent contribution of the inflammatory and metabolic systems to the overall score throughout from early adulthood onwards, while the contribution of the other four systems seems to vary across age groups and gender. Our findings highlight the social-to-biological processes ultimately leading to health inequalities, and suggest that such disparities can already be detected in the 20-40 years old age group and cannot be fully explained by lifestyle and behavioural factors. This may define early adulthood social condition as a precursor to accelerated biological ageing and as an important target for public health policies.
C1 [Karimi, Maryam; Vineis, Paolo; Chadeau-Hyam, Marc] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England.
   [Karimi, Maryam; Vineis, Paolo; Chadeau-Hyam, Marc] Imperial Coll London, MRC, PHE Ctr Environm & Hlth, London, England.
   [Castagne, Raphaele; Delpierre, Cyrille; Albertus, Gaelle; Berger, Eloise; Kelly-Irving, Michelle] Univ Toulouse, UMR1027, UPS, INSERM, Toulouse, France.
   [Vineis, Paolo] IIGM, Turin, Italy.
   [Kumari, Meena] Univ Essex, Inst Social & Econ Res, Colchester, Essex, England.
C3 Imperial College London; Imperial College London; Universite de
   Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de
   la Sante et de la Recherche Medicale (Inserm); Italian Institute for
   Genomic Medicine (IIGM); University of Essex
RP Chadeau-Hyam, M (corresponding author), Imperial Coll, Sch Publ Hlth, London W2 1PG, England.
EM m.chadeau@imperial.ac.uk
RI Kelly-Irving, Michelle/G-3151-2010; Karimi, Maryam/U-3279-2019; Chadeau,
   Marc/AAN-7586-2021; Kelly Irving, Michelle/AAA-5052-2022
OI Kelly-Irving, Michelle/0000-0001-5749-4791; Karimi,
   Maryam/0000-0003-3301-8795; Chadeau, Marc/0000-0001-8341-5436; Kelly
   Irving, Michelle/0000-0001-5749-4791; Kumari, Meena/0000-0001-9716-1035;
   delpierre, cyrille/0000-0002-0831-080X
FU European Commission [633666]; Public Health England [MR/L01341X/1];
   Economic and Social Research Council (ESRC) [ES/N00812X/1]; University
   of Essex; ESRC [RES-596-28-0001, ES/M008592/1]; Medical Research Council
   [MR/R024227/1]; National Institute on Aging (NIA) [R01AG056477]; Medical
   Research Council; ESRC [ES/M008592/1, ES/N00812X/1] Funding Source:
   UKRI; MRC [MR/R024227/1, MR/N01104X/1, MR/L01341X/1, MR/N01104X/2]
   Funding Source: UKRI
FX This study was supported by the European Commission (Horizon 2020 grant
   no 633666 to PV). The Centre for Environment and Health is supported by
   the Medical Research Council and Public Health England (MR/L01341X/1).
   Biological measures in Understanding Society were funded through an
   enhancement to Economic and Social Research Council (ESRC) grant
   ES/N00812X/1. MKu is supported by the University of Essex and ESRC
   (grants RES-596-28-0001 and ES/M008592/1). MK-I is supported by the
   Medical Research Council (MR/R024227/1) and the National Institute on
   Aging (NIA), US (R01AG056477). The funders had no role in the design and
   conduct of the study; collection, management, analysis and
   interpretation of the data; and preparation, review or approval of this
   manuscript.
CR [Anonymous], 2004, IMP OV HLTH ED REV E
   [Anonymous], UND SOC WAV 2 3 NURS
   Barabási AL, 2007, NEW ENGL J MED, V357, P404, DOI 10.1056/NEJMe078114
   Barabási AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918
   Belsky DW, 2015, P NATL ACAD SCI USA, V112, pE4104, DOI 10.1073/pnas.1506264112
   Castagne R, 2016, SCI REP, P6
   Castagne R, 2016, SCI REP, P6, DOI [10.1371/journal.pone.0047246, DOI 10.1371/JOURNAL.PONE.0047246]
   Castagné R, 2016, SCI REP-UK, V6, DOI 10.1038/srep25170
   Crimmins E, 2008, ADV CLIN CHEM, V46, P161, DOI 10.1016/S0065-2423(08)00405-8
   Fiorito G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16391-5
   Gruenewald TL, 2012, SOC SCI MED, V74, P75, DOI 10.1016/j.socscimed.2011.09.037
   Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016
   Hendi AJ, 2018, BMJ-BRIT MED J, P362
   Horvath S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1030-0
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Karlamangla AS, 2006, PSYCHOSOM MED, V68, P500, DOI 10.1097/01.psy.0000221270.93985.82
   Karlamangla AS, 2002, J CLIN EPIDEMIOL, V55, P696, DOI 10.1016/S0895-4356(02)00399-2
   Kelly-Irving M, 2015, INT J PUBLIC HEALTH, V60, P629, DOI 10.1007/s00038-015-0688-5
   Levine ME, 2013, J GERONTOL A-BIOL, V68, P667, DOI 10.1093/gerona/gls233
   McEwen BS, 2015, METABOLISM, V64, pS2, DOI 10.1016/j.metabol.2014.10.029
   MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093
   McFall S.L., 2014, Understanding Society -UK Household Longitudinal Study: Waves 2 and 3 Nurse Health Assessment, 2010-2012, Guide to Nurse Health Assessment
   Robertson T, 2014, BMC PUBLIC HEALTH, P14
   Seeman TE, 1997, ARCH INTERN MED, V157, P2259
   Seeman T, 2010, ANN NY ACAD SCI, V1186, P223, DOI 10.1111/j.1749-6632.2009.05341.x
   Shiels PG, 2017, PRACT LAB MED, V7, P49, DOI 10.1016/j.plabm.2016.04.002
   Solís CB, 2016, PSYCHONEUROENDOCRINO, V74, P24, DOI 10.1016/j.psyneuen.2016.08.018
   Sood S, 2015, GENOME BIOL, P16
   Sturmberg JP, 2017, J EVAL CLIN PRACT, V23, P199, DOI 10.1111/jep.12587
NR 29
TC 19
Z9 19
U1 0
U2 7
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0143-005X
EI 1470-2738
J9 J EPIDEMIOL COMMUN H
JI J. Epidemiol. Community Health
PD AUG
PY 2019
VL 73
IS 8
BP 693
EP 702
DI 10.1136/jech-2018-212010
PG 10
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA IN8HJ
UT WOS:000478920900003
PM 30944170
OA Green Published, Green Accepted, hybrid
DA 2024-02-19
ER

PT J
AU Lo Re, V
   Kallan, MJ
   Tate, JP
   Localio, AR
   Lim, JK
   Goetz, MB
   Klein, MB
   Rimland, D
   Rodriguez-Barradas, MC
   Butt, AA
   Gibert, CL
   Brown, ST
   Park, L
   Dubrow, R
   Reddy, KR
   Kostman, JR
   Strom, BL
   Justice, AC
AF Lo Re, Vincent, III
   Kallan, Michael J.
   Tate, Janet P.
   Localio, A. Russell
   Lim, Joseph K.
   Goetz, Matthew Bidwell
   Klein, Marina B.
   Rimland, David
   Rodriguez-Barradas, Maria C.
   Butt, Adeel A.
   Gibert, Cynthia L.
   Brown, Sheldon T.
   Park, Lesley
   Dubrow, Robert
   Reddy, K. Rajender
   Kostman, Jay R.
   Strom, Brian L.
   Justice, Amy C.
TI Hepatic Decompensation in Antiretroviral-Treated Patients Co-Infected
   With HIV and Hepatitis C Virus Compared With Hepatitis C
   Virus-Monoinfected Patients A Cohort Study
SO ANNALS OF INTERNAL MEDICINE
LA English
DT Article
ID HUMAN-IMMUNODEFICIENCY-VIRUS; CHRONIC LIVER-DISEASE; POLYMERASE
   CHAIN-REACTION; SIMPLE NONINVASIVE INDEX; VETERANS AGING COHORT;
   PROTEIN-S DEFICIENCY; SOCIETY-USA PANEL; FIBROSIS PROGRESSION;
   HEPATOCELLULAR-CARCINOMA; HIV/HCV COINFECTION
AB Background: The incidence and determinants of hepatic decompensation have been incompletely examined among patients co-infected with HIV and hepatitis C virus (HCV) in the antiretroviral therapy (ART) era, and few studies have compared outcome rates with those of patients with chronic HCV alone.
   Objective: To compare the incidence of hepatic decompensation between antiretroviral-treated patients co-infected with HIV and HCV and HCV-monoinfected patients and to evaluate factors associated with decompensation among co-infected patients receiving ART.
   Design: Retrospective cohort study.
   Setting: Veterans Health Administration.
   Patients: 4280 co-infected patients who initiated ART and 6079 HCV-monoinfected patients receiving care between 1997 and 2010. All patients had detectable HCV RNA and were HCV treatment-naive.
   Measurements: Incident hepatic decompensation, determined by diagnoses of ascites, spontaneous bacterial peritonitis, or esophageal variceal hemorrhage.
   Results: The incidence of hepatic decompensation was greater among co-infected than monoinfected patients (7.4% vs. 4.8% at 10 years; P < 0.001). Compared with HCV-monoinfected patients, co-infected patients had a higher rate of hepatic decompensation (hazard ratio [HR] accounting for competing risks, 1.56 [95% CI, 1.31 to 1.86]). Co-infected patients who maintained HIV RNA levels less than 1000 copies/mL still had higher rates of decompensation than HCV-monoinfected patients (HR, 1.44 [CI, 1.05 to 1.99]). Baseline advanced hepatic fibrosis (FIB-4 score >3.25) (HR, 5.45 [CI, 3.79 to 7.84]), baseline hemoglobin level less than 100 g/L (HR, 2.24 [CI, 1.20 to 4.20]), diabetes mellitus (HR, 1.88 [CI, 1.38 to 2.56]), and nonblack race (HR, 2.12 [CI, 1.65 to 2.72]) were each associated with higher rates of decompensation among co-infected patients.
   Limitation: Observational study of predominantly male patients.
   Conclusion: Despite receiving ART, patients co-infected with HIV and HCV had higher rates of hepatic decompensation than HCV-monoinfected patients. Rates of decompensation were higher for co-infected patients with advanced liver fibrosis, severe anemia, diabetes, and nonblack race.
C1 Univ Penn, Philadelphia, PA 19104 USA.
   Philadelphia VA Med Ctr, Philadelphia, PA USA.
   VA Connecticut Healthcare Syst, West Haven, CT 06516 USA.
   Yale Univ, Sch Med, West Haven, CT 06516 USA.
   Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA.
   VA Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA.
   Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.
   McGill Univ, Ctr Hlth, Montreal, PQ, Canada.
   Atlanta VA Med Ctr, Atlanta, GA 30033 USA.
   Emory Univ, Sch Med, Atlanta, GA USA.
   Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA.
   Baylor Coll Med, Houston, TX 77030 USA.
   Univ Pittsburgh, Sch Med, Pittsburgh, PA 15213 USA.
   Sheikh Khalifa Med City, Abu Dhabi, U Arab Emirates.
   Washington DC VA Med Ctr, Washington, DC 20422 USA.
   George Washington Univ, Med Ctr, Washington, DC 20037 USA.
   James J Peters VA Med Ctr, New York, NY USA.
   Mt Sinai Sch Med, New York, NY USA.
   Rutgers State Univ, Newark, NJ 07103 USA.
C3 University of Pennsylvania; University of Pennsylvania; Pennsylvania
   Medicine; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); Philadelphia Veterans Affairs Medical Center; US
   Department of Veterans Affairs; Veterans Health Administration (VHA); VA
   Connecticut Healthcare System; Yale University; Yale University; US
   Department of Veterans Affairs; Veterans Health Administration (VHA); VA
   Greater Los Angeles Healthcare System; University of California System;
   University of California Los Angeles; University of California Los
   Angeles Medical Center; David Geffen School of Medicine at UCLA; McGill
   University; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical
   Center; Emory University; Baylor College of Medicine; Baylor College of
   Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE);
   University of Pittsburgh; George Washington University; US Department of
   Veterans Affairs; Veterans Health Administration (VHA); James J. Peters
   VA Medical Center; Icahn School of Medicine at Mount Sinai; Rutgers
   University System; Rutgers University New Brunswick; Rutgers University
   Newark
RP Lo Re, V (corresponding author), Univ Penn, Penn Ctr AIDS Res, Ctr Clin Epidemiol & Biostat, Div Infect Dis,Dept Med,Perelman Sch Med, 836 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.
EM vincentl@mail.med.upenn.edu
RI Re, Vincent Lo/N-7817-2015; Goetz, Matthew Bidwell/GPX-4090-2022; Park,
   Lesley S./AFV-4294-2022; Brown, Stephen/A-2513-2016
OI Park, Lesley S./0000-0002-3848-7753; Brown, Stephen/0000-0002-0210-4562;
   Butt, Adeel/0000-0002-1118-1826; Goetz, Matthew/0000-0003-4542-992X;
   Klein, Marina/0000-0002-3063-8430
FU National Institute of Allergy and Infectious Diseases [K01 AI070001];
   National Institute on Alcohol Abuse and Alcoholism [U01 AA13566];
   National Institute of Mental Health [T32 MH020031]; National Institutes
   of Health
FX National Institutes of Health.
CR [Anonymous], GUID IND REPR DEV TO
   Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409
   Berenguer J, 2009, HEPATOLOGY, V50, P407, DOI 10.1002/hep.23020
   Bissell DM, 1999, HEPATOLOGY, V29, P988, DOI 10.1002/hep.510290351
   BISSUEL F, 1992, J ACQ IMMUN DEF SYND, V5, P484
   Blanco F, 2011, J VIRAL HEPATITIS, V18, P11, DOI 10.1111/j.1365-2893.2009.01261.x
   Bräu N, 2006, J HEPATOL, V44, P47, DOI 10.1016/j.jhep.2005.07.006
   Butt AA, 2004, HEPATOLOGY, V40, P115, DOI 10.1002/hep.20289
   Butt AA, 2009, AIDS, V23, P1227, DOI 10.1097/QAD.0b013e32832bd7af
   Cain LE, 2009, STAT MED, V28, P1725, DOI 10.1002/sim.3585
   Chu C, 2011, J URBAN HEALTH, V88, P507, DOI 10.1007/s11524-010-9540-7
   Cole SR, 2010, AM J EPIDEMIOL, V171, P198, DOI 10.1093/aje/kwp347
   El-Serag HB, 2004, GASTROENTEROLOGY, V126, P460, DOI 10.1053/j.gastro.2003.10.065
   Fanning L, 1999, HEPATOLOGY, V29, P904, DOI 10.1002/hep.510290310
   FEFFER SE, 1995, SOUTHERN MED J, V88, P1126, DOI 10.1097/00007611-199511000-00008
   Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170
   Frederick T, 2009, AIDS PATIENT CARE ST, V23, P915, DOI 10.1089/apc.2009.0111
   FREEDMAN VA, 1995, DEMOGRAPHY, V32, P459, DOI 10.2307/2061691
   Freiberg MS, 2011, CIRC-CARDIOVASC QUAL, V4, P425, DOI 10.1161/CIRCOUTCOMES.110.957415
   Fultz SL, 2006, MED CARE, V44, pS25, DOI 10.1097/01.mlr.0000223670.00890.74
   Gandhi NR, 2013, PHARMACOEPIDEM DR S, V22, P1019, DOI 10.1002/pds.3476
   Garcia-Tsao G, 2010, HEPATOLOGY, V51, P1445, DOI 10.1002/hep.23478
   Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909
   GRETCH D, 1994, J INFECT DIS, V169, P1219, DOI 10.1093/infdis/169.6.1219
   Hisada M, 2005, HEPATOLOGY, V42, P1446, DOI 10.1002/hep.20938
   Hosmer W, 1999, APPL SURVIVAL ANAL R
   Hui JM, 2003, GASTROENTEROLOGY, V125, P1695, DOI 10.1053/j.gastro.2003.08.032
   Justice AC, 2004, AIDS, V18, pS49, DOI 10.1097/00002030-200401001-00008
   Justice AC, 2012, CLIN INFECT DIS, V54, P984, DOI 10.1093/cid/cir989
   KATO N, 1993, HEPATOLOGY, V18, P16, DOI 10.1002/hep.1840180104
   Kazis LE, 1998, ARCH INTERN MED, V158, P626, DOI 10.1001/archinte.158.6.626
   Kenny-Walsh E, 1999, NEW ENGL J MED, V340, P1228, DOI 10.1056/NEJM199904223401602
   Kramer JR, 2005, AM J GASTROENTEROL, V100, P56, DOI 10.1111/j.1572-0241.2005.40670.x
   LAU JYN, 1993, LANCET, V341, P1501, DOI 10.1016/0140-6736(93)90635-T
   Limketkai BN, 2012, JAMA-J AM MED ASSOC, V308, P370, DOI 10.1001/jama.2012.7844
   Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848
   Lin WY, 2013, J INFECT DIS, V207, pS13, DOI 10.1093/infdis/jis926
   LITTLE RJA, 1982, AM STAT, V36, P38, DOI 10.2307/2684091
   Lo Re V, 2011, PHARMACOEPIDEM DR S, V20, P689, DOI 10.1002/pds.2148
   Lo Re V, 2009, AIDS, V23, P2191, DOI 10.1097/QAD.0b013e32832ec258
   MITA E, 1994, J HEPATOL, V21, P468, DOI 10.1016/S0168-8278(05)80330-7
   Paradis V, 2001, HEPATOLOGY, V34, P738, DOI 10.1053/jhep.2001.28055
   Pineda JA, 2005, HEPATOLOGY, V41, P779, DOI 10.1002/hep.20626
   Pineda JA, 2007, HEPATOLOGY, V46, P622, DOI 10.1002/hep.21757
   Poynard T, 2001, J HEPATOL, V34, P730, DOI 10.1016/S0168-8278(00)00097-0
   Qurishi N, 2003, LANCET, V362, P1708, DOI 10.1016/S0140-6736(03)14844-1
   Raymond HF, 2011, SEX TRANSM DIS, V38, P219, DOI 10.1097/OLQ.0b013e3181f68ed4
   Royston P, 2005, STATA J, V5, P188, DOI 10.1177/1536867X0500500204
   Sathiakumar N, 1998, J OCCUP ENVIRON MED, V40, P808, DOI 10.1097/00043764-199809000-00010
   Sherman KE, 2002, CLIN INFECT DIS, V34, P831, DOI 10.1086/339042
   SORICE M, 1994, THROMB RES, V73, P165, DOI 10.1016/0049-3848(94)90095-7
   Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178
   Sugerman RW, 1996, PEDIATR INFECT DIS J, V15, P106, DOI 10.1097/00006454-199602000-00003
   Sulkowski M, 2013, LANCET INFECT DIS, V13, P597, DOI 10.1016/S1473-3099(13)70149-X
   Sulkowski MS, 2007, AIDS, V21, P2209, DOI 10.1097/QAD.0b013e3282f10de9
   Sulkowski MS, 2013, ANN INTERN MED, V159, P86, DOI 10.7326/0003-4819-159-2-201307160-00654
   Sulkowski MS, 2004, AIDS, V18, P2277, DOI 10.1097/00002030-200411190-00008
   Sulkowski MS, 2000, JAMA-J AM MED ASSOC, V283, P74, DOI 10.1001/jama.283.1.74
   Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450
   Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961
   van Sighem A, 2008, JAIDS-J ACQ IMM DEF, V48, P104, DOI 10.1097/QAI.0b013e31816a1d4f
   Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346
   Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632
   Yeni PG, 2002, JAMA-J AM MED ASSOC, V288, P222, DOI 10.1001/jama.288.2.222
   Youssef Wael, 2002, Semin Gastrointest Dis, V13, P17
   Zarski JP, 2003, J HEPATOL, V38, P307, DOI 10.1016/S0168-8278(02)00387-2
   Zeuzem S, 1996, HEPATOLOGY, V24, P1003
NR 67
TC 204
Z9 214
U1 2
U2 15
PU AMER COLL PHYSICIANS
PI PHILADELPHIA
PA INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA
SN 0003-4819
EI 1539-3704
J9 ANN INTERN MED
JI Ann. Intern. Med.
PD MAR 18
PY 2014
VL 160
IS 6
BP 369
EP +
DI 10.7326/M13-1829
PG 14
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA AD8MW
UT WOS:000333521300013
PM 24723077
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Yang, CB
   Xia, SY
   Zhang, W
   Shen, HM
   Wang, JG
AF Yang, Chuanbin
   Xia, Siyu
   Zhang, Wei
   Shen, Han-Ming
   Wang, Jigang
TI Modulation of <i>Atg</i> genes expression in aged rat liver, brain, and
   kidney by caloric restriction analyzed via single-nucleus/cell RNA
   sequencing
SO AUTOPHAGY
LA English
DT Article; Early Access
DE Aging; ATGs; autophagy; brain; caloric restriction (CR); kidney; liver;
   longevity; single-cell RNA sequencing
ID LYSOSOMAL CATHEPSINS; AUTOPHAGY; DISEASE; HEALTH; HOMEOSTASIS
AB Dysregulation of macroautophagy/autophagy has been closely implicated in aging. Caloric restriction (CR) is an effective intervention of aging partially via activation of autophagy. Recently, a high-throughput single-cell RNA-seq technique has been employed to detect the comprehensive transcriptomes of individual cells. However, the transcriptional networks of ATG (autophagy related) genes in the aging process and the modulation of ATG genes expression by CR at the single-cell level have not been elucidated. Here, by performing data analysis of single nucleus/cells RNA sequencing in rats undergoing aging and the modulation by CR, we demonstrate that the transcription patterns of Atg genes in different cell types of rat liver, brain, and kidney are highly heterogeneous. Importantly, CR reversed aging-induced changes of multiple Atg genes across different cell types in the brain, liver, and kidney. In summary, our results, for the first time, provide comprehensive information on Atg gene expression in specific cell types of different organs in a mammal during aging and give novel insight into the protective role of autophagy and CR in aging at the single-cell resolution.
C1 [Yang, Chuanbin; Xia, Siyu; Zhang, Wei; Wang, Jigang] Jinan Univ, Clin Med Coll 2, Shenzhen Peoples Hosp, Dept Geriatr, Shenzhen, Guangdong, Peoples R China.
   [Yang, Chuanbin; Xia, Siyu; Zhang, Wei; Wang, Jigang] Southern Univ Sci & Technol, Affiliated Hosp 1, Shenzhen, Guangdong, Peoples R China.
   [Xia, Siyu; Zhang, Wei] Jinan Univ, Integrated Chinese & Western Med Postdoctoral Res, Guangzhou, Guangdong, Peoples R China.
   [Shen, Han-Ming] Univ Macau, Fac Hlth Sci, Taipa, Macao, Peoples R China.
   [Wang, Jigang] China Acad Chinese Med Sci, Artemisinin Res Ctr, Inst Chinese Mat Med, Beijing, Peoples R China.
C3 Jinan University; Southern University of Science & Technology; Jinan
   University; University of Macau; Institute of Chinese Materia Medica,
   CACMS; China Academy of Chinese Medical Sciences
RP Yang, CB (corresponding author), Jinan Univ, Clin Med Coll 2, Shenzhen Peoples Hosp, Dept Geriatr, Shenzhen, Guangdong, Peoples R China.; Yang, CB (corresponding author), Southern Univ Sci & Technol, Affiliated Hosp 1, Shenzhen, Guangdong, Peoples R China.; Shen, HM (corresponding author), Univ Macau, Fac Hlth Sci, Taipa, Macao, Peoples R China.; Wang, JG (corresponding author), China Acad Chinese Med Sci, Artemisinin Res Ctr, Inst Chinese Mat Med, Beijing, Peoples R China.
EM h1094103@connect.hku.hk; hmshen@um.edu.mo; jgwang@icmm.ac.cn
RI Yang, Chuanbin/AAS-7324-2020; SHEN, HAN-MING/HSF-3303-2023; Yanagi,
   Yasuo/AFN-0692-2022; Wang, Jigang/HJB-2711-2022
OI Yang, Chuanbin/0000-0001-8288-4038; SHEN, HAN-MING/0000-0001-7369-5227;
   Yanagi, Yasuo/0000-0002-0362-7285; Wang, Jigang/0000-0002-0575-0105;
   Xia, Siyu/0000-0002-4241-4944
FU Major Nature Science and Technology Program of China for Innovative Drug
   [2017ZX09101002-001-001-05]
FX This work was supported by the Major Nature Science and Technology
   Program of China for Innovative Drug [2017ZX09101002-001-001-05].
CR Allaire M, 2019, J HEPATOL, V70, P985, DOI 10.1016/j.jhep.2019.01.026
   Audesse AJ, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008097
   B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563
   Bagherniya M, 2018, AGEING RES REV, V47, P183, DOI 10.1016/j.arr.2018.08.004
   Belibi F, 2011, AM J PHYSIOL-RENAL, V300, pF1235, DOI 10.1152/ajprenal.00348.2010
   Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096
   Cai CZ, 2021, AUTOPHAGY, V17, P1112, DOI 10.1080/15548627.2020.1760623
   Carmona-Gutierrez D, 2016, AGEING RES REV, V32, P2, DOI 10.1016/j.arr.2016.04.009
   Cui J, 2012, AGE, V34, P329, DOI 10.1007/s11357-011-9237-1
   Drobny A, 2022, BBA-MOL CELL RES, V1869, DOI 10.1016/j.bbamcr.2022.119243
   Escobar KA, 2019, AGING CELL, V18, DOI 10.1111/acel.12876
   Fontana L, 2021, J EXP MED, V218, DOI 10.1084/jem.20190086
   Fukuo Y, 2014, HEPATOL RES, V44, P1026, DOI 10.1111/hepr.12282
   Glassock RJ, 2016, NEPHRON, V134, P25, DOI 10.1159/000445450
   Horrillo D, 2013, J BIOL REG HOMEOS AG, V27, P377
   Hou YJ, 2019, NAT REV NEUROL, V15, P565, DOI 10.1038/s41582-019-0244-7
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Leidal AM, 2018, NAT CELL BIOL, V20, P1338, DOI 10.1038/s41556-018-0235-8
   Lenoir O, 2016, KIDNEY INT, V90, P950, DOI 10.1016/j.kint.2016.04.014
   Levine B, 2019, CELL, V176, P11, DOI 10.1016/j.cell.2018.09.048
   Li WQ, 2015, J GERONTOL A-BIOL, V70, P263, DOI 10.1093/gerona/glu040
   Liu GH, 2021, NUCLEIC ACIDS RES, V49, pD825, DOI 10.1093/nar/gkaa894
   Liu WJ, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2002-6
   Ma S, 2020, CELL, V180, P984, DOI 10.1016/j.cell.2020.02.008
   Madeo F, 2019, CELL METAB, V29, P592, DOI 10.1016/j.cmet.2019.01.018
   Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704
   Pareja-Cajiao M, 2021, EXP GERONTOL, V144, DOI 10.1016/j.exger.2020.111193
   Peeters JGC, 2019, AUTOPHAGY, V15, P98, DOI 10.1080/15548627.2018.1509608
   Ploeger JM, 2017, CANCER PREV RES, V10, P660, DOI 10.1158/1940-6207.CAPR-17-0174
   Rajawat YS, 2009, AGEING RES REV, V8, P199, DOI 10.1016/j.arr.2009.05.001
   Rudnicka E, 2020, MATURITAS, V139, P6, DOI 10.1016/j.maturitas.2020.05.018
   Saad R, 2020, NEW ENGL J MED, V382, P1773, DOI 10.1056/NEJMc2001176
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Shimokawa I, 2015, AGING CELL, V14, P707, DOI 10.1111/acel.12340
   Stoka V, 2016, AGEING RES REV, V32, P22, DOI 10.1016/j.arr.2016.04.010
   Takabatake Y, 2014, NEPHROL DIAL TRANSPL, V29, P1639, DOI 10.1093/ndt/gft535
   Tan PW, 2019, AUTOPHAGY, V15, P2019, DOI 10.1080/15548627.2019.1656956
   Tang CY, 2020, NAT REV NEPHROL, V16, P489, DOI 10.1038/s41581-020-0309-2
   Ueno T, 2017, NAT REV GASTRO HEPAT, V14, P170, DOI 10.1038/nrgastro.2016.185
   Wang M, 2021, THERANOSTICS, V11, P5010, DOI 10.7150/thno.55645
   Wong SQ, 2020, HUM GENET, V139, P277, DOI 10.1007/s00439-019-02031-7
   Ximerakis M, 2019, NAT NEUROSCI, V22, P1696, DOI 10.1038/s41593-019-0491-3
   Xu XM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144442
   Yamamoto T, 2016, AUTOPHAGY, V12, P801, DOI 10.1080/15548627.2016.1159376
   Yang Chuanbin, 2022, Acta Pharm Sin B, V12, P1707, DOI 10.1016/j.apsb.2022.01.017
   Yang CB, 2020, PHARMACOL THERAPEUT, V216, DOI 10.1016/j.pharmthera.2020.107673
   Yang CB, 2017, AUTOPHAGY, V13, P2028, DOI 10.1080/15548627.2017.1379633
   Yla-Anttila Paivi, 2018, Small GTPases, V9, P57, DOI 10.1080/21541248.2017.1317699
   Zhang H, 2021, PROTEIN CELL, V12, P695, DOI 10.1007/s13238-021-00852-9
   Zhang MJ, 2021, ELIFE, V10, DOI 10.7554/eLife.62293
   Zhang W, 2022, ACTA PHARM SIN B, V12, P1019, DOI 10.1016/j.apsb.2022.01.008
NR 51
TC 3
Z9 3
U1 3
U2 21
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1554-8627
EI 1554-8635
J9 AUTOPHAGY
JI Autophagy
PD 2023 FEB 1
PY 2023
VL 19
IS 2
BP 706
EP 715
DI 10.1080/15548627.2022.2091903
EA JUN 2022
PG 10
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA A5RB8
UT WOS:000815368500001
PM 35737739
OA Green Published
DA 2024-02-19
ER

PT J
AU Ramesh, G
   Das, S
   Sadashiva, SRB
AF Ramesh, Gautham
   Das, Shubhankar
   Sadashiva, Satish Rao Bola
TI Berberine, a natural alkaloid sensitizes human hepatocarcinoma to
   ionizing radiation by blocking autophagy and cell cycle arrest resulting
   in senescence
SO JOURNAL OF PHARMACY AND PHARMACOLOGY
LA English
DT Article; Early Access
DE G2; M arrest; ionizing radiation; mitotic catastrophe; polyphenols;
   radioresistance
ID G2 ARREST; CANCER; MECHANISMS; APOPTOSIS; HELA; RADIORESISTANCE;
   MITOCHONDRIA; CHEMOTHERAPY; RADIOTHERAPY; INHIBITION
AB Objective To study the radiosensitizing potential of Berberine and the underlying mechanism in human hepatocarcinoma (HepG2) cells. Methods HepG2 cells were challenged with X-rays in combination with Berberine treatment and severalin vitroassays were performed. Alteration in cell viability was determined by MTT assay. Changes in intracellular ROS levels, mitochondrial membrane potential/mass, intracellular acidic vesicular organelles as well as cell cycle arrest and apoptotic cell death were analysed by flow cytometry. Induction of autophagy was assessed by staining the cells with Monodansylcadaverine/Lysotracker red dyes and immunoblotting for LC3I/II and p62 proteins. Phase-contrast/fluorescence microscopy was employed to study mitotic catastrophe and senescence. Cellular senescence was confirmed by immunoblotting for p21 levels and ELISA for Interleukin-6. Key findings X-rays + Berberine had a synergistic effect in reducing cell proliferation accompanied by a robust G2/M arrest. Berberine-mediated radiosensitization was associated with elevated levels of LC3II and p62 suggesting blocked autophagy that was followed by mitotic catastrophe and senescence. Treatment of cells with X-rays + Berberine resulted in increased oxidative stress, hyperpolarized mitochondria with increased mitochondrial mass and reduced ATP levels. Conclusions The study expands the understanding of the pharmacological properties of Berberine and its applicability as a radiosensitizer towards treating liver cancer.
C1 [Ramesh, Gautham] Manipal Acad Higher Educ, Manipal Sch Life Sci, Dept Biotechnol, Manipal, Karnataka, India.
   [Das, Shubhankar; Sadashiva, Satish Rao Bola] Manipal Acad Higher Educ, Manipal Sch Life Sci, Dept Radiat Biol & Toxicol, Manipal 576104, Karnataka, India.
C3 Manipal Academy of Higher Education (MAHE); Manipal Academy of Higher
   Education (MAHE)
RP Sadashiva, SRB (corresponding author), Manipal Acad Higher Educ, Manipal Sch Life Sci, Dept Radiat Biol & Toxicol, Manipal 576104, Karnataka, India.
EM rao.satish@manipal.edu
OI DAS, SHUBHANKAR/0000-0002-8044-532X
CR Agnarelli A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28952-3
   Aithal BK, 2009, CELL BIOL INT, V33, P1039, DOI 10.1016/j.cellbi.2009.06.018
   Al-Dimassi S, 2014, CLIN TRANSL ONCOL, V16, P511, DOI 10.1007/s12094-014-1162-1
   Azzam EI, 2012, CANCER LETT, V327, P48, DOI 10.1016/j.canlet.2011.12.012
   Carocho M, 2013, ANTI-CANCER AGENT ME, V13, P1236, DOI 10.2174/18715206113139990301
   Chen S, 2013, TOXICOL LETT, V221, P64, DOI 10.1016/j.toxlet.2013.05.641
   Colagrande S, 2016, WORLD J GASTROENTERO, V22, P7645, DOI 10.3748/wjg.v22.i34.7645
   Cui Hang, 2012, J Signal Transduct, V2012, P646354, DOI 10.1155/2012/646354
   Das S, 2020, FREE RADICAL BIO MED, V152, P715, DOI 10.1016/j.freeradbiomed.2020.01.015
   de Jesus KA, 2017, ONCOLOGY, V3, P165, DOI [10.1007/s10330-017-0223-3, DOI 10.1007/S10330-017-0223-3]
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Diogo CV, 2011, CURR DRUG TARGETS, V12, P850
   Farooqi AA, 2019, CANCERS, V11, DOI 10.3390/cancers11040478
   Forkink M, 2014, BBA-BIOENERGETICS, V1837, P1247, DOI 10.1016/j.bbabio.2014.04.008
   Gewirtz DA, 2014, CANCER RES, V74, P647, DOI 10.1158/0008-5472.CAN-13-2966
   Ghisolfi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043628
   Gire V, 2015, CELL CYCLE, V14, P297, DOI 10.1080/15384101.2014.1000134
   Gonçalves AP, 2011, BBA-MOL CELL RES, V1813, P492, DOI 10.1016/j.bbamcr.2011.01.006
   Gonzalez RE, 2011, CELL CYCLE, V10, P3505, DOI 10.4161/cc.10.20.17778
   Guo JP, 2018, TRANSL CANCER RES, V7, P765, DOI 10.21037/tcr.2018.05.20
   Habtemariam S, 2020, MOLECULES, V25, DOI 10.3390/molecules25061426
   Hasima N, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.467
   Hazra B, 2012, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00094
   HERRMANN M, 1994, NUCLEIC ACIDS RES, V22, P5506, DOI 10.1093/nar/22.24.5506
   Hou Q, 2011, CANCER SCI, V102, P1287, DOI 10.1111/j.1349-7006.2011.01933.x
   Hwang SY, 2015, ONCOL REP, V33, P1691, DOI 10.3892/or.2015.3744
   Imenshahidi M, 2016, PHYTOTHER RES, V30, P1745, DOI 10.1002/ptr.5693
   Indo HP, 2007, MITOCHONDRION, V7, P106, DOI 10.1016/j.mito.2006.11.026
   Jantová S, 2003, J PHARM PHARMACOL, V55, P1143, DOI 10.1211/002235703322277186
   Jin YL, 2017, EUR J PHARMACOL, V794, P106, DOI 10.1016/j.ejphar.2016.11.037
   KAUFMANN SH, 1993, CANCER RES, V53, P3976
   Kitazumi I, 2011, FEBS J, V278, P427, DOI 10.1111/j.1742-4658.2010.07975.x
   Korolchuk VI, 2017, EBIOMEDICINE, V21, P7, DOI 10.1016/j.ebiom.2017.03.020
   Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150
   Lee IJ, 2011, SEMIN RADIAT ONCOL, V21, P303, DOI 10.1016/j.semradonc.2011.05.008
   Liu B, 2010, ACTA PHARMACOL SIN, V31, P1154, DOI 10.1038/aps.2010.118
   Liu D, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00009
   Liu YX, 2020, BIOCHEM PHARMACOL, V174, DOI 10.1016/j.bcp.2019.113776
   Mackeh R, 2013, J CELL SCI, V126, P1071, DOI 10.1242/jcs.115626
   Malik A, 2016, ANAL CELL PATHOL, V2016, DOI 10.1155/2016/6146595
   Martinez-Castillo M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165971
   Mathiassen SG, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00051
   Mc Gee MM, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/146282
   Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207
   Moulder JE, 2019, INT J RADIAT BIOL, V95, P940, DOI 10.1080/09553002.2019.1569779
   Munafó DB, 2001, J CELL SCI, V114, P3619
   Noren Hooten N, 2017, JOVE-J VIS EXP, DOI 10.3791/55533
   Ortiz LMG, 2014, MOLECULES, V19, P12349, DOI 10.3390/molecules190812349
   Park W, 2005, INT J RADIAT ONCOL, V61, P1143, DOI 10.1016/j.ijrobp.2004.08.028
   Peng PL, 2008, INT J RADIAT ONCOL, V70, P529, DOI 10.1016/j.ijrobp.2007.08.034
   Peng WX, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2016.91
   Raghav D, 2017, BIOCHEMISTRY-US, V56, P2594, DOI 10.1021/acs.biochem.7b00101
   Rawat DS, 2013, ANTI-CANCER AGENT ME, V13, P1551, DOI 10.2174/187152061310131206154445
   Reed JC, 1998, BBA-BIOENERGETICS, V1366, P127, DOI 10.1016/S0005-2728(98)00108-X
   Serafim TL, 2008, CANCER CHEMOTH PHARM, V61, P1007, DOI 10.1007/s00280-007-0558-9
   Tabrizian P, 2015, ANN SURG, V261, P947, DOI 10.1097/SLA.0000000000000710
   Tait SWG, 2014, J CELL SCI, V127, P2135, DOI 10.1242/jcs.093575
   Tan S, 2015, TOXICOL IN VITRO, V30, P506, DOI 10.1016/j.tiv.2015.09.011
   Tang L, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0758-7
   Thomé MP, 2016, J CELL SCI, V129, P4622, DOI 10.1242/jcs.195057
   VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I
   Wang H, 2018, TRENDS PHARMACOL SCI, V39, P24, DOI 10.1016/j.tips.2017.11.003
   Wang JY, 2019, BIOMED PHARMACOTHER, V110, P646, DOI 10.1016/j.biopha.2018.11.080
   Wang Y, 2012, MUTAT RES-FUND MOL M, V734, P20, DOI 10.1016/j.mrfmmm.2012.04.005
   Widlak P, 2000, ACTA BIOCHIM POL, V47, P1037
   Wu J, 2015, MOL CANCER THER, V14, P553, DOI 10.1158/1535-7163.MCT-14-0618
   Yan XJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep41712
   Yu R, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-49
   Zeng XZ, 2020, INT J RADIAT BIOL, V96, P1060, DOI 10.1080/09553002.2020.1770358
   Zhang L, 2016, SCI REP-UK, V6, DOI 10.1038/srep28116
NR 70
TC 11
Z9 11
U1 2
U2 14
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0022-3573
EI 2042-7158
J9 J PHARM PHARMACOL
JI J. Pharm. Pharmacol.
PD 2020 DEC
PY 2020
VL 72
IS 12
BP 1893
EP 1908
DI 10.1111/jphp.13354
EA AUG 2020
PG 16
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA OJ6TL
UT WOS:000560823000001
PM 32815562
OA Bronze
DA 2024-02-19
ER

PT S
AU Lenaz, G
   Bovina, C
   D'aurelio, M
   Fato, R
   Formiggini, G
   Genova, ML
   Giuliano, G
   Pich, MM
   Paolucci, U
   Castelli, GP
   Ventura, B
AF Lenaz, G
   Bovina, C
   D'aurelio, M
   Fato, R
   Formiggini, G
   Genova, ML
   Giuliano, G
   Pich, MM
   Paolucci, U
   Castelli, GP
   Ventura, B
BE Harman, D
TI Role of mitochondria in oxidative stress and aging
SO INCREASING HEALTHY LIFE SPAN: CONVENTIONAL MEASURES AND SLOWING THE
   INNATE AGING PROCESS
SE Annals of the New York Academy of Sciences
LA English
DT Article; Proceedings Paper
CT 9th Congress of the International-Association-of-Biomedical-Gerontology
CY JUN 27-30, 2001
CL VANCOUVER, CANADA
SP Int Assoc Biomed Gerontol, Now Foods, Glenn Fdn Med Res, Wild Blueberry Assoc N Amer
DE oxidative stress; bioenergetic defects; coenzyme Q; rotenone
ID OXYGEN RADICAL GENERATION; COENZYME-Q REDUCTASE; PERFUSED-RAT-LIVER;
   COMPLEX-I DEFECTS; HEART-MITOCHONDRIA; NEURODEGENERATIVE DISEASES;
   LIPID-PEROXIDATION; HYDROGEN-PEROXIDE; RESPIRATORY-CHAIN;
   SUBMITOCHONDRIAL PARTICLES
AB The mitochondrial respiratory chain is a powerful source of reactive oxygen species (ROS), considered as the pathogenic agent of many diseases and of aging. We have investigated the role of Complex I in superoxide radical production and found by combined use of specific inhibitors of Complex I that the one-electron donor in the Complex to oxygen is a redox center located prior to the sites where three different types of coenzyme Q (CoQ) competitors bind, to be identified with an Fe-S cluster, most probably N2, or possibly an ubisemiquinone intermediate insensitive to all the above inhibitors. Short-chain coenzyme Q analogues enhance superoxide formation, presumably by mediating electron transfer from N2 to oxygen. The clinically used CoQ analogue idebenone is particularly effective, raising doubts about its safety as a drug. The mitochondrial theory of aging considers somatic mutations of mitochondrial DNA induced by ROS as the primary cause of energy decline; in rat liver mitochondria, Complex I appears to be most affected by aging and to become strongly rate limiting for electron transfer. Mitochondrial energetics is also deranged in human platelets upon aging, as demonstrated by the decreased Pasteur effect (enhancement of lactate production by respiratory inhibitors). Cells counteract oxidative stress by antioxidants: CoQ is the only lipophilic antioxidant to be biosynthesized. Exogenous CoQ, however, protects cells from oxidative stress by conversion into its reduced antioxidant form by cellular reductases. The plasma membrane oxidoreductase and DT-diaphorase are two such systems: likewise, they are overexpressed under oxidative stress conditions.
C1 Univ Bologna, Dipartimento Biochim G Moruzzi, I-40126 Bologna, Italy.
C3 University of Bologna
RP Lenaz, G (corresponding author), Univ Bologna, Dipartimento Biochim G Moruzzi, Via Irnerio 48, I-40126 Bologna, Italy.
EM lenaz@biocfarm.unibo.it
RI Ventura, Barbara/B-8819-2009
OI Ventura, Barbara/0000-0002-8207-1659
CR Andersson M, 1995, MECH AGEING DEV, V85, P1, DOI 10.1016/0047-6374(95)01642-2
   ANDERSSON M, 1994, BBA-LIPID LIPID MET, V1214, P79, DOI 10.1016/0005-2760(94)90012-4
   APPELKVIST EL, 1994, MOL ASPECTS MED, V15, P37, DOI 10.1016/0098-2997(94)90011-6
   Barja G, 1999, J BIOENERG BIOMEMBR, V31, P347, DOI 10.1023/A:1005427919188
   Barrientos A, 1999, J BIOL CHEM, V274, P16188, DOI 10.1074/jbc.274.23.16188
   BATTINO M, 1995, MECH AGEING DEV, V78, P173, DOI 10.1016/0047-6374(94)01535-T
   Beal MF, 1999, BIOFACTORS, V9, P261, DOI 10.1002/biof.5520090222
   Beal MF, 1998, BBA-BIOENERGETICS, V1366, P211, DOI 10.1124/jpet.112.192138
   BEYER RE, 1985, MECH AGEING DEV, V32, P267, DOI 10.1016/0047-6374(85)90085-5
   Beyer RE, 1996, P NATL ACAD SCI USA, V93, P2528, DOI 10.1073/pnas.93.6.2528
   BEYER RE, 1990, HIGHLIGHTS IN UBIQUINONE RESEARCH, P191
   Blasi MA, 2001, OPHTHALMOLOGICA, V215, P51, DOI 10.1159/000050826
   BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707
   BOVERIS A, 1984, METHOD ENZYMOL, V105, P429
   Brandt U, 1997, BBA-BIOENERGETICS, V1318, P79, DOI 10.1016/S0005-2728(96)00141-7
   CADENAS E, 1977, ARCH BIOCHEM BIOPHYS, V180, P248, DOI 10.1016/0003-9861(77)90035-2
   CADENAS E, 1992, ADV ENZYMOL RAMB, V65, P97
   CAPALDI RA, 1982, BIOCHIM BIOPHYS ACTA, V694, P291, DOI 10.1016/0304-4157(82)90009-0
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   Crane FL, 1997, MOL ASPECTS MED, V18, pS1
   CROFT S, 1992, FREE RADICAL RES COM, V17, P21, DOI 10.3109/10715769209061086
   D'Aurelio M, 2001, MECH AGEING DEV, V122, P823, DOI 10.1016/S0047-6374(01)00239-1
   DAPRADA M, 1988, EXPERIENTIA, V44, P115
   Davey GP, 1996, J NEUROCHEM, V66, P1617
   DAVIES KJA, 1986, J BIOL CHEM, V261, P3060
   DEGAETANO G, 1981, CLIN HAEMATOL, V10, P297
   DEGLIESPOSTI M, 1990, ARCH BIOCHEM BIOPHYS, V283, P258, DOI 10.1016/0003-9861(90)90640-K
   DIPLOCK AT, 1994, MOL ASPECTS MED, V15, P293, DOI 10.1016/0098-2997(94)90005-1
   ERNSTER L, 1995, BBA-MOL BASIS DIS, V1271, P195, DOI 10.1016/0925-4439(95)00028-3
   ERNSTER L, 1992, BIOFACTORS, V3, P241
   ERNSTER L, 1993, ACTIVE OXYGENS, LIPID PEROXIDES, AND ANTIOXIDANTS, P1
   Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2
   Esposti MD, 1996, ARCH BIOCHEM BIOPHYS, V330, P395, DOI 10.1006/abbi.1996.0267
   Esposti MD, 1996, BIOCHEM J, V313, P327, DOI 10.1042/bj3130327
   ESPOSTI MD, 1994, FEBS LETT, V352, P375, DOI 10.1016/0014-5793(94)00971-6
   ESPOSTI MD, 1993, BIOCHEM BIOPH RES CO, V190, P1090, DOI 10.1006/bbrc.1993.1161
   Fato R, 1996, BIOCHEMISTRY-US, V35, P2705, DOI 10.1021/bi9516034
   Formiggini G, 1996, BIOCHEM MOL BIOL INT, V39, P1135
   FRIDOVICH I, 1986, ADV ENZYMOL RAMB, V58, P61
   GENOVA ML, 1995, BIOCHEM J, V311, P105, DOI 10.1042/bj3110105
   Genova ML, 1997, FEBS LETT, V410, P467
   GILLIS JC, 1994, DRUG AGING, V5, P133, DOI 10.2165/00002512-199405020-00007
   Glinn MA, 1997, BBA-BIOENERGETICS, V1318, P246, DOI 10.1016/S0005-2728(96)00142-9
   GOTZ ME, 1994, PHARMACOL THERAPEUT, V63, P37, DOI 10.1016/0163-7258(94)90055-8
   HARMAN D, 1988, MOL CELL BIOCHEM, V84, P155, DOI 10.1007/BF00421050
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   Herrero A, 2000, J BIOENERG BIOMEMBR, V32, P609, DOI 10.1023/A:1005626712319
   HOLMSEN H, 1980, THROMB HAEMOSTASIS, V42, P1460
   HOLMSEN H, 1987, HEMOSTASIS THROMBOSI, P631
   Howell N, 1997, J BIOENERG BIOMEMBR, V29, P165, DOI 10.1023/A:1022690030664
   Huertas JR, 1999, BIOFACTORS, V9, P337, DOI 10.1002/biof.5520090233
   Kacser H, 1979, BIOCHEM SOC T, V7, P1149, DOI 10.1042/bst0071149
   KAGAN V, 1990, BIOCHEM BIOPH RES CO, V169, P851, DOI 10.1016/0006-291X(90)91971-T
   KALEN A, 1990, LIPIDS, V25, P93, DOI 10.1007/BF02562211
   KARLSSON J, 1993, CLIN INVESTIGATOR, V71, pS84
   KROGER A, 1973, EUR J BIOCHEM, V34, P358, DOI 10.1111/j.1432-1033.1973.tb02767.x
   Kuznetsov AV, 1997, BBA-MOL BASIS DIS, V1360, P142, DOI 10.1016/S0925-4439(96)00072-5
   LARM JA, 1994, J BIOL CHEM, V269, P30097
   LAWEN A, 1994, MOL ASPECTS MED, V15, P13
   Lenaz G, 1997, MOL CELL BIOCHEM, V174, P329, DOI 10.1023/A:1006854619336
   Lenaz G, 1998, BBA-BIOENERGETICS, V1366, P53, DOI 10.1016/S0005-2728(98)00120-0
   Lenaz G, 2000, BBA-BIOENERGETICS, V1459, P397, DOI 10.1016/S0005-2728(00)00177-8
   Lenaz G, 1998, BBA-BIOENERGETICS, V1364, P207, DOI 10.1016/S0005-2728(98)00028-0
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Low PA, 1997, DIABETES, V46, pS38, DOI 10.2337/diab.46.2.S38
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   MORENOSANCHEZ R, 1991, BIOCHIM BIOPHYS ACTA, V1060, P284, DOI 10.1016/S0005-2728(05)80318-4
   Morré DM, 2000, J EXP BIOL, V203, P1513
   NOHL H, 1986, BIOCHEM BIOPH RES CO, V138, P533, DOI 10.1016/S0006-291X(86)80529-0
   Nohl H, 1996, FREE RADICAL BIO MED, V20, P207, DOI 10.1016/0891-5849(95)02038-1
   Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9
   Ozawa T, 1997, PHYSIOL REV, V77, P425, DOI 10.1152/physrev.1997.77.2.425
   Pich MM, 1996, FEBS LETT, V380, P176, DOI 10.1016/0014-5793(96)00037-3
   Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1
   RICHTER C, 1988, FEBS LETT, V241, P1, DOI 10.1016/0014-5793(88)81018-4
   Robinson BH, 1998, BBA-BIOENERGETICS, V1364, P271, DOI 10.1016/S0005-2728(98)00033-4
   Schapira AHV, 1998, BBA-BIOENERGETICS, V1364, P261, DOI 10.1016/S0005-2728(98)00032-2
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Skulachev VP, 1996, Q REV BIOPHYS, V29, P169, DOI 10.1017/S0033583500005795
   SODERBERG M, 1990, J NEUROCHEM, V54, P415, DOI 10.1111/j.1471-4159.1990.tb01889.x
   TAKAHASHI T, 1995, BIOCHEM J, V309, P883, DOI 10.1042/bj3090883
   TAKESHIGE K, 1980, BIOMEDICAL CLIN ASPE, V2, P15
   TRUMPOWER BL, 1981, J BIOENERG BIOMEMBR, V13, P1, DOI 10.1007/BF00744743
   TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0
   VALLS V, 1994, BIOCHEM MOL BIOL INT, V33, P633
   VILLALBA JM, 1995, P NATL ACAD SCI USA, V92, P4887, DOI 10.1073/pnas.92.11.4887
   Wong A, 1997, BIOCHEM BIOPH RES CO, V239, P139, DOI 10.1006/bbrc.1997.7443
   Yagi T, 1998, BBA-BIOENERGETICS, V1364, P125, DOI 10.1016/S0005-2728(98)00023-1
   Zarbin MA, 1998, EUR J OPHTHALMOL, V8, P199, DOI 10.1177/112067219800800401
   Zhang YY, 1996, J NUTR, V126, P2089, DOI 10.1093/jn/126.9.2089
NR 91
TC 316
Z9 348
U1 1
U2 27
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
BN 1-57331-360-2
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2002
VL 959
BP 199
EP 213
DI 10.1111/j.1749-6632.2002.tb02094.x
PG 15
WC Geriatrics & Gerontology; Multidisciplinary Sciences
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Science & Technology - Other Topics
GA BU36U
UT WOS:000175782200018
PM 11976197
DA 2024-02-19
ER

PT J
AU Malousi, A
   Andreou, AZ
   Kouidou, S
AF Malousi, Andigoni
   Andreou, Alexandra-Zoi
   Kouidou, Sofia
TI In silico structural analysis of sequences containing
   5-hydroxymethylcytosine reveals its potential as binding regulator for
   development, ageing and cancer-related transcription factors
SO EPIGENETICS
LA English
DT Article; Early Access
DE 5-hydroxymethylcytosine; methyl-cytosine; G-quadruplex; palindromes;
   nucleosome; transcription factors; ageing; in silicons analysis; liver
ID G-QUADRUPLEX STRUCTURES; DNA METHYLATION; GENE; EXPRESSION; REPEATS;
   TET1; DETERMINANTS; METHYLOME; CHROMATIN; CYTOSINE
AB The presence of 5-hydroxymethyl cytosine in DNA has been previously associated with ageing. Using in silico analysis of normal liver samples we presently observed that in 5-hydroxymethyl cytosine sequences, DNA methylation is dependent on the co-presence of G-quadruplexes and palindromes. This association exhibits discrete patterns depending on G-quadruplex and palindrome densities. DNase-Seq data show that 5-hydroxymethyl cytosine sequences are common among liver nucleosomes (p< 2.2x10(-16)) and threefold more frequent than nucleosome sequences. Nucleosomes lacking palindromes and potential G-quadruplexes are rare in vivo (1%) and nucleosome occupancy potential decreases with increasing G-quadruplexes. Palindrome distribution is similar to that previously reported in nucleosomes. In low and mixed complexity sequences 5-hydroxymethyl cytosine is frequently located next to three elements: G-quadruplexes or imperfect G-quadruplexes with CpGs, or unstable hairpin loops (TCCCAY(6)TGGGA) mostly located in antisense strands or finally A-/T-rich segments near these motifs. The high frequencies and selective distribution of pentamer sequences (including TCCCA, TGGGA) probably indicate the positive contribution of 5-hydroxymethyl cytosine to stabilize the formation of structures unstable in the absence of this cytosine modification. Common motifs identified in all total 5-hydroxymethyl cytosine-containing sequences exhibit high homology to recognition sites of several transcription factor families: homeobox, factors involved in growth, mortality/ageing, cancer, neuronal function, vision, and reproduction. We conclude that cytosine hydroxymethylation could play a role in the recognition of sequences with G-quadruplexes/palindromes by forming epigenetically regulated DNA 'springs' and governing expansions or compressions recognized by different transcription factors or stabilizing nucleosomes. The balance of these epigenetic elements is lost in hepatocellular carcinoma.
C1 [Malousi, Andigoni; Kouidou, Sofia] Aristotle Univ Thessaloniki, Lab Biol Chem, Sch Med, Thessaloniki, Greece.
   [Andreou, Alexandra-Zoi] Univ Munster, Inst Phys Chem, Munster, Germany.
C3 Aristotle University of Thessaloniki; University of Munster
RP Kouidou, S (corresponding author), Aristotle Univ Thessaloniki, Biol Chem Lab, Sch Med, Thessaloniki 54124, Greece.
EM kouidou@auth.gr
RI Malousi, Andigoni/A-9460-2012
OI Malousi, Andigoni/0000-0002-1968-7020; Kouidou,
   Sofia/0000-0002-1934-3260
CR Anastasiadou C, 2011, DNA CELL BIOL, V30, P267, DOI 10.1089/dna.2010.1094
   Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335
   Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573
   Brown ML, 1996, J MOL BIOL, V262, P600, DOI 10.1006/jmbi.1996.0539
   BRUKNER I, 1994, J MOL BIOL, V236, P26, DOI 10.1006/jmbi.1994.1115
   C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012
   Campilongo R, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006839
   Chang XJ, 2016, ACM T KNOWL DISCOV D, V11, DOI 10.1145/2910585
   Cheng MP, 2018, NUCLEIC ACIDS RES, V46, P9264, DOI 10.1093/nar/gky757
   Chiu T-P, 2019, TFBSSHAPE EXPANDED M
   Collings CK, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0125-5
   Czech A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39213-2
   Della Ragione Floriana, 2012, Frontiers in Genetics, V3, P181, DOI 10.3389/fgene.2012.00181
   DeNizio JE, 2019, BIOCHEMISTRY-US, V58, P411, DOI 10.1021/acs.biochem.8b00912
   Eddy J, 2011, NUCLEIC ACIDS RES, V39, P4975, DOI 10.1093/nar/gkr079
   Falabella M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41464-y
   Farnung L, 2017, NATURE, V550, P539, DOI 10.1038/nature24046
   Gackowski D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144859
   Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064
   GUO S, 2017, SCI REP UK, V7
   Halder K, 2009, MOL BIOSYST, V5, P1703, DOI 10.1039/b905132e
   Hänsel-Hertsch R, 2016, NAT GENET, V48, P1267, DOI 10.1038/ng.3662
   Hegyi H, 2015, SCI REP-UK, V5, DOI 10.1038/srep09165
   Hon J, 2017, BIOINFORMATICS, V33, P3373, DOI 10.1093/bioinformatics/btx413
   Ji DB, 2014, CHEM RES TOXICOL, V27, P1304, DOI 10.1021/tx500169u
   Joseph SR, 2017, ELIFE, V6, DOI 10.7554/eLife.23326
   Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667
   Khoueiry R, 2017, NAT GENET, V49, P1061, DOI 10.1038/ng.3868
   Khrapunov S, 2016, BIOCHEMISTRY-US, V55, P4275, DOI 10.1021/acs.biochem.6b00451
   Kizaki S, 2016, CHEM-EUR J, V22, P16598, DOI 10.1002/chem.201602435
   Klug A, 2010, Q REV BIOPHYS, V43, P1, DOI 10.1017/S0033583510000089
   Klungland A, 2017, FREE RADICAL BIO MED, V107, P62, DOI 10.1016/j.freeradbiomed.2016.11.038
   Kouidou S, 2006, MUTAT RES-FUND MOL M, V599, P167, DOI 10.1016/j.mrfmmm.2006.03.002
   Kwok CK, 2017, TRENDS BIOTECHNOL, V35, P997, DOI 10.1016/j.tibtech.2017.06.012
   Lei M, 2019, BBA-GENE REGUL MECH, V1862, DOI 10.1016/j.bbagrm.2019.194409
   Li WS, 2017, CELL RES, V27, P1243, DOI 10.1038/cr.2017.121
   Li X, 2016, GENOME RES, V26, P1730, DOI 10.1101/gr.211854.116
   Lin IH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170779
   Liu MJ, 2015, GENOME RES, V25, P1182, DOI 10.1101/gr.188680.114
   Ludwig AK, 2017, NUCLEIC ACIDS RES, V45, P2438, DOI 10.1093/nar/gkw1197
   Luo CY, 2018, SCIENCE, V361, P1336, DOI 10.1126/science.aat6806
   Ma Q, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0248-3
   Malousi A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55453-8
   Malygin EG, 2012, CRIT REV BIOCHEM MOL, V47, P97, DOI 10.3109/10409238.2011.620942
   Mao SQ, 2018, NAT STRUCT MOL BIOL, V25, P951, DOI 10.1038/s41594-018-0131-8
   Maor GL, 2015, TRENDS GENET, V31, P274, DOI 10.1016/j.tig.2015.03.002
   MARTINEZBALBAS MA, 1995, NUCLEIC ACIDS RES, V23, P2464, DOI 10.1093/nar/23.13.2464
   Masoud SS, 2018, CHEM PHARM BULL, V66, P1091, DOI 10.1248/cpb.c18-00720
   McGinty RK, 2015, CHEM REV, V115, P2255, DOI 10.1021/cr500373h
   Melamed P, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00022
   Mellén M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022
   Morgan RK, 2018, J NUCLEIC ACIDS, V2018, DOI 10.1155/2018/9281286
   Mukherjee AK, 2019, TRENDS GENET, V35, P129, DOI 10.1016/j.tig.2018.11.001
   Ngo TTM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10813
   Öberg C, 2012, J MOL BIOL, V419, P183, DOI 10.1016/j.jmb.2012.03.007
   Owen-Hughes T, 2012, CURR OPIN CELL BIOL, V24, P296, DOI 10.1016/j.ceb.2012.02.003
   Pages H., 2019, Biostrings: Efficient Manipulation of Biological Strings. R package version 2.62.0
   Parry Lee, 2011, Genes Cancer, V2, P618, DOI 10.1177/1947601911418499
   Perriaud L, 2014, CARCINOGENESIS, V35, P2706, DOI 10.1093/carcin/bgu206
   Ponnaluri VKC, 2017, EPIGENETICS-US, V12, P123, DOI 10.1080/15592294.2016.1265713
   Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47
   Riedmann C, 2016, SCI REP-UK, V6, DOI 10.1038/srep33186
   Roque A, 2004, NUCLEIC ACIDS RES, V32, P6111, DOI 10.1093/nar/gkh945
   Salami F, 2015, GENE, V568, P19, DOI 10.1016/j.gene.2015.05.012
   SCHMIDT A, 2020, CELLS BASEL, V9
   Shukla A, 2015, GENE, V564, P109, DOI 10.1016/j.gene.2015.03.075
   Smit AFA., 2008, RepeatModeler Open-1.0
   Stroud H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r54
   Struhl K, 2013, NAT STRUCT MOL BIOL, V20, P267, DOI 10.1038/nsmb.2506
   Tammen Stephanie A, 2014, J Cancer Prev, V19, P301, DOI [10.15430/JCP.2014.19.4.301, 10.15430/JCP.2014.19.2.301]
   Team RC, 2020, R: A Language and Environment for Statistical
   Tippana R, 2014, NUCLEIC ACIDS RES, V42, P8106, DOI 10.1093/nar/gku464
   Varizhuk A, 2019, BIOESSAYS, V41, DOI 10.1002/bies.201900091
   Wang XY, 2017, MOL CELL, V65, P1056, DOI 10.1016/j.molcel.2017.02.003
   Watanabe R, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0473
   Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066
   Yu B, 2015, ONCOTARGET, V6, P3627, DOI 10.18632/oncotarget.2875
   Yu DG, 2003, P NATL ACAD SCI USA, V100, P7207, DOI 10.1073/pnas.1232375100
   Zheng ZQ, 2017, ELIFE, V6, DOI 10.7554/eLife.25384
NR 79
TC 1
Z9 1
U1 0
U2 6
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1559-2294
EI 1559-2308
J9 EPIGENETICS-US
JI Epigenetics
PD 2021 MAY 4
PY 2021
VL 16
IS 5
BP 503
EP 518
DI 10.1080/15592294.2020.1805693
EA SEP 2020
PG 16
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA RS5MH
UT WOS:000566644500001
PM 32752914
OA Bronze, Green Published
DA 2024-02-19
ER

PT J
AU Eyol, E
   Boleij, A
   Taylor, RR
   Lewis, AL
   Berger, MR
AF Eyol, Erguel
   Boleij, Annemarie
   Taylor, Rachel R.
   Lewis, Andrew L.
   Berger, Martin R.
TI Chemoembolisation of rat colorectal liver metastases with drug eluting
   beads loaded with irinotecan or doxorubicin
SO CLINICAL & EXPERIMENTAL METASTASIS
LA English
DT Article
DE colorectal liver metastases; chemoembolisation; drug eluting beads;
   irinotecan; doxorubicin
ID PROSPECTIVE RANDOMIZED TRIAL; COLON-CARCINOMA CELLS; IN-VITRO; MODEL;
   CANCER; RESISTANCE; GROWTH; VIVO; GEMCITABINE; FLOXURIDINE
AB Systemic chemotherapy has limited success in treating liver metastasis of colorectal cancer. Alternative approaches such as hepatic arterial infusion or trans arterial chemoembolisation aim to deliver the chemotherapy locally to address the predominant liver disease. Chemoembolisation with drug eluting beads (DEB) designed to deliver drug at the target over a protracted period of time is a new strategy to reduce the tumor burden of liver metastases. To test this hypothesis, DEB possessing anionic groups capable of ionically complexing with cationic drugs were synthesised by a suspension polymerisation method and were fractionated to produce an average size of 75 mu m. The DEB were loaded with the desired concentration of either doxorubicin hydrochloride or irinotecan hydrochloride prior to administration by immersion in the drug solution, yielding essentially 100% loading efficiency. To determine their effect in vivo, a transplantable orthotopic and isogenic rat liver metastasis model was used which is based on intraportal injection of 4 x 10(6) beta-galactosidase transfected CC531 rat colorectal cancer cells into male WAG/Rij rats. By MTT assay, the cells were shown to be sensitive to both drugs in vitro with the IC50 being by two orders of magnitude lower for doxorubicin (110 nM after 72 h) compared to irinotecan (25 mu M after 72 h). For the in vivo phase, a differential expression of the ERK MAP kinase between tumor cells cultured in vitro and those inoculated in vivo was noted using Western blotting techniques. This was considered to be indicative of passage-induced cell senescence that reduced the sensitivity of the tumor cells to DEB chemoembolisation. This notwithstanding, administration of DEB loaded with irinotecan or doxorubicin by single injection into the hepatic artery showed significant anticancer activity, as measured by a reduction in the tumor burden of the liver and a corresponding reduction in liver weight. Comparing the two agents, irinotecan appears more advantageous because of its significant activity and excellent tolerability following administration at two dosages of either 20 or 30 mg/kg. Doxorubicin showed a narrower window of activity, being effective at 4 mg/kg but ineffective at the lower dose of 2 mg/kg. We conclude that chemoembolisation with DEB with either agent may have potential for treating patients with colorectal liver metastasis, although irinotecan DEB appeared to have a more favourable safety profile.
C1 [Eyol, Erguel; Boleij, Annemarie; Berger, Martin R.] German Canc Res Ctr, Toxicol & Chemotherapy Unit, D-69120 Heidelberg, Germany.
   [Taylor, Rachel R.; Lewis, Andrew L.] Biocompatibles UK Ltd, Surrey GU9 8QL, England.
C3 Helmholtz Association; German Cancer Research Center (DKFZ);
   Biocompatibles International PLC
RP Berger, MR (corresponding author), German Canc Res Ctr, Toxicol & Chemotherapy Unit, Im Neuenheimer Feld 120, D-69120 Heidelberg, Germany.
EM m.berger@dkfz.de
RI Taylor, Rachel/JPL-7282-2023; Boleij, Annemarie/L-3975-2013
OI Boleij, Annemarie/0000-0003-4495-5880; Lewis, Andrew/0000-0001-5779-5631
CR Adam R, 2004, SURG CLIN N AM, V84, P659, DOI 10.1016/j.suc.2003.12.005
   Aguirre-Ghiso JA, 2004, CANCER RES, V64, P7336, DOI 10.1158/0008-5472.CAN-04-0113
   Aguirre-Ghiso JA, 2001, MOL BIOL CELL, V12, P863, DOI 10.1091/mbc.12.4.863
   Aguirre-Ghiso JA, 2003, CANCER RES, V63, P1684
   BAST EC, 2000, CANC MED, P1436
   Bulavin DV, 2004, ADV CANCER RES, V92, P95, DOI 10.1016/S0065-230X(04)92005-2
   CHANG AE, 1987, ANN SURG, V206, P685, DOI 10.1097/00000658-198712000-00001
   De Vita V.T., 2004, CANC PRINCIPLES PRAC, V7th
   Fusai G, 2003, Colorectal Dis, V5, P2, DOI 10.1046/j.1463-1318.2003.00410.x
   GONZALEZ MV, 2007, IN PRESS J MAT SCI M
   GOUPIL DW, 2001, Patent No. 2001068721
   Katakura Y, 2006, BIOSCI BIOTECH BIOCH, V70, P1076, DOI 10.1271/bbb.70.1076
   KEMENY N, 1993, J CLIN ONCOL, V11, P330, DOI 10.1200/JCO.1993.11.2.330
   KEMENY N, 1987, ANN INTERN MED, V107, P459, DOI 10.7326/0003-4819-107-4-459
   LANG EK, 1993, RADIOLOGY, V189, P417, DOI 10.1148/radiology.189.2.8210369
   Lewis AL, 2006, J VASC INTERV RADIOL, V17, P335, DOI 10.1097/01.RVI.0000195323.46152.B3
   Lewis AL, 2007, J MATER SCI-MATER M, V18, P1691, DOI 10.1007/s10856-007-3068-8
   Lewis AL, 2006, J VASC INTERV RADIOL, V17, P1335, DOI 10.1097/01.RVI.0000228416.21560.7F
   Li XT, 2004, CLIN EXP METASTAS, V21, P331, DOI 10.1023/B:CLIN.0000046134.80393.34
   Nestler G, 2005, SURG ENDOSC, V19, P280, DOI 10.1007/s00464-003-9301-8
   Oosterling SJ, 2005, J PATHOL, V207, P147, DOI 10.1002/path.1830
   Ranganathan AC, 2006, CANCER RES, V66, P1702, DOI 10.1158/0008-5472.CAN-05-3092
   Rodenbach M, 2005, J CANCER RES CLIN, V131, P289, DOI 10.1007/s00432-004-0643-y
   ROUGIER P, 1992, J CLIN ONCOL, V10, P1112, DOI 10.1200/JCO.1992.10.7.1112
   Saenger J, 2004, J CANCER RES CLIN, V130, P203, DOI 10.1007/s00432-003-0523-x
   Seelig MH, 2004, ONCOL REP, V11, P1107
   Taylor RR, 2007, EUR J PHARM SCI, V30, P7, DOI 10.1016/j.ejps.2006.09.002
   van Duijnhoven FH, 2005, CLIN EXP METASTAS, V22, P247, DOI 10.1007/s10585-005-8479-7
   van Duijnhoven FH, 2003, PHOTOCHEM PHOTOBIOL, V78, P235, DOI 10.1562/0031-8655(2003)078<0235:IAOPTO>2.0.CO;2
   Varela M, 2007, J HEPATOL, V46, P474, DOI 10.1016/j.jhep.2006.10.020
   WAGMAN LD, 1990, J CLIN ONCOL, V8, P1885, DOI 10.1200/JCO.1990.8.11.1885
   Wittmer A, 1999, CLIN EXP METASTAS, V17, P369, DOI 10.1023/A:1006643831825
NR 32
TC 37
Z9 42
U1 0
U2 11
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0262-0898
J9 CLIN EXP METASTAS
JI Clin. Exp. Metastasis
PD MAY
PY 2008
VL 25
IS 3
BP 273
EP 282
DI 10.1007/s10585-008-9142-x
PG 10
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA 290HB
UT WOS:000255112800009
PM 18259882
DA 2024-02-19
ER

PT J
AU Oliviero, G
   Kovalchuk, S
   Rogowska-Wrzesinska, A
   Schwämmle, V
   Jensen, ON
AF Oliviero, Giorgio
   Kovalchuk, Sergey
   Rogowska-Wrzesinska, Adelina
   Schwammle, Veit
   Jensen, Ole N.
TI Distinct and diverse chromatin proteomes of ageing mouse organs reveal
   protein signatures that correlate with physiological functions
SO ELIFE
LA English
DT Article
DE proteomics; ageing; organ proteomes; epigenetics; chromatin; mass
   spectrometry; Mouse
ID PROTEASOME ACTIVITY; STEM-CELLS; HISTONE VARIANTS; TARGET GENES; AGE;
   COMPLEX; HEALTH; DIFFERENTIATION; INSTABILITY; RECRUITMENT
AB Temporal molecular changes in ageing mammalian organs are of relevance to disease aetiology because many age-related diseases are linked to changes in the transcriptional and epigenetic machinery that regulate gene expression. We performed quantitative proteome analysis of chromatin-enriched protein extracts to investigate the dynamics of the chromatin proteomes of the mouse brain, heart, lung, kidney, liver, and spleen at 3, 5, 10, and 15 months of age. Each organ exhibited a distinct chromatin proteome and sets of unique proteins. The brain and spleen chromatin proteomes were the most extensive, diverse, and heterogenous among the six organs. The spleen chromatin proteome appeared static during the lifespan, presenting a young phenotype that reflects the permanent alertness state and important role of this organ in physiological defence and immunity. We identified a total of 5928 proteins, including 2472 nuclear or chromatin-associated proteins across the six mouse organs. Up to 3125 proteins were quantified in each organ, demonstrating distinct and organ-specific temporal protein expression timelines and regulation at the post-translational level. Bioinformatics meta-analysis of these chromatin proteomes revealed distinct physiological and ageing-related features for each organ. Our results demonstrate the efficiency of organelle-specific proteomics for in vivo studies of a model organism and consolidate the hypothesis that chromatin-associated proteins are involved in distinct and specific physiological functions in ageing organs.
C1 [Oliviero, Giorgio; Kovalchuk, Sergey; Rogowska-Wrzesinska, Adelina; Schwammle, Veit; Jensen, Ole N.] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark.
   [Oliviero, Giorgio; Kovalchuk, Sergey; Rogowska-Wrzesinska, Adelina; Schwammle, Veit; Jensen, Ole N.] Univ Southern Denmark, VILLUM Ctr Bioanalyt Sci, Odense, Denmark.
   [Oliviero, Giorgio] Univ Coll Dublin, Syst Biol Ireland, Dublin, Ireland.
C3 University of Southern Denmark; University of Southern Denmark;
   University College Dublin
RP Jensen, ON (corresponding author), Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark.; Jensen, ON (corresponding author), Univ Southern Denmark, VILLUM Ctr Bioanalyt Sci, Odense, Denmark.
EM jenseno@bmb.sdu.dk
RI Rogowska-Wrzesinska, Adelina/F-2888-2013; Kovalchuk, Sergey
   I/J-3247-2014; Jensen, Ole N./J-1763-2012
OI Rogowska-Wrzesinska, Adelina/0000-0002-9876-0061; Kovalchuk, Sergey
   I/0000-0001-5273-3431; Jensen, Ole N./0000-0003-1862-8528; Schwammle,
   Veit/0000-0002-9708-6722
FU Villum Fonden [7292]; Danmarks Grundforskningsfond DNRF [82]; Danish
   Agency for Science and Higher Education [5072-00007B]
FX Villum Fonden 7292 Ole N Jensen; Danmarks Grundforskningsfond DNRF #82
   Ole N Jensen; Danish Agency for Science and Higher Education 5072-00007B
   Giorgio Oliviero
CR Adams J, 2003, CANCER TREAT REV, V29, P3, DOI 10.1016/S0305-7372(03)00081-1
   Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105
   Arancio W, 2014, GERONTOLOGY, V60, P197, DOI 10.1159/000357206
   Bardag-Gorce F, 1999, MOL BIOL REP, V26, P89, DOI 10.1023/A:1006968208077
   Barrero MJ, 2013, J BIOL CHEM, V288, P16110, DOI 10.1074/jbc.M113.466144
   Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055
   Bulteau AL, 2000, EXP GERONTOL, V35, P767, DOI 10.1016/S0531-5565(00)00136-4
   Burtner CR, 2010, NAT REV MOL CELL BIO, V11, P567, DOI 10.1038/nrm2944
   Busuttil R, 2007, NEUROSCIENCE, V145, P1341, DOI 10.1016/j.neuroscience.2006.09.060
   Carrard G, 2003, INT J BIOCHEM CELL B, V35, P728, DOI 10.1016/S1357-2725(02)00356-4
   Chandler H, 2013, CURR OPIN CELL BIOL, V25, P765, DOI 10.1016/j.ceb.2013.07.005
   Chondrogianni N, 2010, ADV EXP MED BIOL, V694, P38
   Christoforou A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms9992
   Conway JR, 2017, BIOINFORMATICS, V33, P2938, DOI 10.1093/bioinformatics/btx364
   Delgado-Morales R., 2017, NEUROEPIGENOMICS AGI, DOI [10.1007/978-3-319-53889-1, DOI 10.1007/978-3-319-53889-1]
   Douet J, 2017, J CELL SCI, V130, P1570, DOI 10.1242/jcs.199216
   Drazic A, 2016, BBA-PROTEINS PROTEOM, V1864, P1372, DOI 10.1016/j.bbapap.2016.06.007
   Dutta S, 2016, LIFE SCI, V152, P244, DOI 10.1016/j.lfs.2015.10.025
   Edifizi D, 2015, BIOMOLECULES, V5, P1855, DOI 10.3390/biom5031855
   Epel ES, 2014, J GERONTOL A-BIOL, V69, pS10, DOI 10.1093/gerona/glu055
   Farrants AKÖ, 2008, FEBS LETT, V582, P2041, DOI 10.1016/j.febslet.2008.04.032
   Ferguson RE, 2005, PROTEOMICS, V5, P566, DOI 10.1002/pmic.200400941
   Feser J, 2011, FEBS LETT, V585, P2041, DOI 10.1016/j.febslet.2010.11.016
   Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607
   Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020
   Gamper AM, 2009, MOL CELL BIOL, V29, P266, DOI 10.1128/MCB.00315-08
   Garfinkel BP, 2016, GENES BRAIN BEHAV, V15, P678, DOI 10.1111/gbb.12312
   Garfinkel BP, 2015, NUCLEIC ACIDS RES, V43, P2074, DOI 10.1093/nar/gkv089
   Gillette TG, 2015, CIRC RES, V116, P1245, DOI 10.1161/CIRCRESAHA.116.303630
   Go YM, 2017, CLIN SCI, V131, P1669, DOI 10.1042/CS20160897
   Grozinger CM, 2002, CHEM BIOL, V9, P3, DOI 10.1016/S1074-5521(02)00092-3
   Haigis MC, 2010, MOL CELL, V40, P333, DOI 10.1016/j.molcel.2010.10.002
   Herrmann C, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2175
   HOLDSWORTH RJ, 1991, BRIT J SURG, V78, P270, DOI 10.1002/bjs.1800780305
   Hu DX, 2016, J ZHEJIANG UNIV-SC B, V17, P821, DOI 10.1631/jzus.B1600253
   Hyun K, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.11
   Kerepesi C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22240-w
   Kim J, 2005, MOL CELL, V20, P759, DOI 10.1016/j.molcel.2005.11.012
   Korthauer K, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1716-1
   Koziol JA, 2010, FEBS LETT, V584, P941, DOI 10.1016/j.febslet.2010.01.031
   Kupis W, 2016, J PHYSIOL BIOCHEM, V72, P371, DOI 10.1007/s13105-016-0492-6
   Lang F, 2018, J PROTEOME RES, V17, P3333, DOI 10.1021/acs.jproteome.8b00093
   Laugesen A, 2014, CELL STEM CELL, V14, P735, DOI 10.1016/j.stem.2014.05.006
   Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083
   Li MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r48
   Lin W, 2007, DEV DYNAM, V236, P1547, DOI 10.1002/dvdy.21160
   MASSE S, 1991, PACE, V14, P538, DOI 10.1111/j.1540-8159.1991.tb02826.x
   McCann TS, 2014, BIOMOLECULES, V4, P1026, DOI 10.3390/biom4041026
   Medvedeva YA, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav067
   Mei Z, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0461-5
   Murabito JM, 2012, J GERONTOL A-BIOL, V67, P470, DOI 10.1093/gerona/gls089
   Murgia M, 2017, CELL REP, V19, P2396, DOI 10.1016/j.celrep.2017.05.054
   Oberdoerffer P, 2007, NAT REV MOL CELL BIO, V8, P692, DOI 10.1038/nrm2238
   Oliviero G, 2016, MOL CELL PROTEOMICS, V15, P3450, DOI 10.1074/mcp.M116.062240
   Petropoulos I, 2000, J GERONTOL A-BIOL, V55, pB220, DOI 10.1093/gerona/55.5.B220
   Phifer-Rixey M, 2015, ELIFE, V4, DOI 10.7554/eLife.05959
   Postnikoff SDL, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00183
   Rajendran R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/368276
   Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i
   Saez I, 2014, CURR GENOMICS, V15, P38, DOI 10.2174/138920291501140306113344
   Saksouk N, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/1756-8935-8-3
   Santos AL, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5716409
   Schmidt M, 2014, BBA-MOL CELL RES, V1843, P13, DOI 10.1016/j.bbamcr.2013.08.012
   Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624
   Shavlakadze T, 2019, CELL REP, V28, P3263, DOI 10.1016/j.celrep.2019.08.043
   Shoji Hirotaka, 2019, Neuropsychopharmacology Reports, V39, P100, DOI 10.1002/npr2.12052
   Shoji H, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0191-9
   Signolet J, 2015, FEBS J, V282, P1692, DOI 10.1111/febs.13132
   Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200
   Spruijt CG, 2016, CELL REP, V17, P783, DOI 10.1016/j.celrep.2016.09.037
   Streubel G, 2017, EMBO J, V36, P2216, DOI 10.15252/embj.201696307
   Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937
   Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003
   Tacutu R, 2013, NUCLEIC ACIDS RES, V41, pD1027, DOI 10.1093/nar/gks1155
   Takahashi S, 2018, CELL MOL LIFE SCI, V75, P1191, DOI 10.1007/s00018-017-2703-x
   Tan JKH, 2018, NPJ REGEN MED, V3, DOI 10.1038/s41536-018-0039-2
   Tanaka K, 2009, P JPN ACAD B-PHYS, V85, P12, DOI [10.2183/pjab.85.12, 10.2183/pjab/85.12]
   Tobin SC, 2012, FEBS LETT, V586, P2874, DOI 10.1016/j.febslet.2012.07.024
   Turner VM, 2017, BIOGERONTOLOGY, V18, P723, DOI 10.1007/s10522-017-9707-7
   Tvardovskiy A, 2017, NUCLEIC ACIDS RES, V45, P9272, DOI 10.1093/nar/gkx696
   Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/NMETH.3901, 10.1038/nmeth.3901]
   van Mierlo G, 2019, PROTEOMICS, V19, DOI 10.1002/pmic.201900047
   Vaquero A, 2009, INT J DEV BIOL, V53, P303, DOI 10.1387/ijdb.082675av
   Varier RA, 2016, J BIOL CHEM, V291, P7313, DOI 10.1074/jbc.M115.701227
   Walther DM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004523
   Xu WT, 2000, NAT GENET, V26, P229, DOI 10.1038/79973
   Xu Y, 2017, NUCLEIC ACIDS RES, V45, pD264, DOI 10.1093/nar/gkw1011
NR 87
TC 5
Z9 5
U1 1
U2 7
PU eLIFE SCIENCES PUBL LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD MAR 8
PY 2022
VL 11
AR e73524
DI 10.7554/eLife.73524
PG 27
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA 0H9QV
UT WOS:000779063900001
PM 35259090
OA Green Submitted, gold, Green Published
DA 2024-02-19
ER

PT J
AU Ohtake, Y
   Maruko, A
   Ohishi, N
   Fukumoto, M
   Ohkubo, Y
AF Ohtake, Yosuke
   Maruko, Akiko
   Ohishi, Nao
   Fukumoto, Manabu
   Ohkubo, Yasuhito
TI Effect of aging on EGF-induced proliferative response in primary
   cultured periportal and perivenous hepatocytes
SO JOURNAL OF HEPATOLOGY
LA English
DT Article
DE aging; DNA synthesis; EGF; EGFR; periportal hepatocytes; perivenous
   hepatocytes
ID EPIDERMAL-GROWTH-FACTOR; AGE-RELATED DECLINE; DNA-SYNTHESIS; FACTOR
   RECEPTOR; REDUCED ASSOCIATION; ZONAL DIFFERENCES; RAT HEPATOCYTES;
   ACTIVATION; SHC; TRANSGLUTAMINASE
AB Background/Aims: Aging relates to declined proliferative capacity of the liver, but the molecular mechanism is not well understood. We examined whether functional changes of epidermal growth factor (EGF) receptor (EGFR) are involved in age-related decline in EGF-induced DNA synthesis using hepatocytes isolated in periportal and perivenous regions of the liver, which differ in the proliferative capacity.
   Methods: Periportal hepatocytes (PPH) and perivenous hepatocytes (PVH) in 7-, 30-, and 90-week-old rats were isolated using the digitonin/collagenase perfusion technique. DNA synthesis was assessed by [methyl-H-3]thymidine incorporation. EGFR binding affinity to EGF was analyzed by Scatchard analysis using [(125)]EGF. EGFR dimerization and phosphorylation were determined by Western blot analysis.
   Results: EGF-induced DNA synthesis was greater in PPH than in PVH from rats of 7 weeks, but the zonal difference disappeared with aging. [I-125]EGF binding studies indicated that high-affinity EGFR in both subpopulations also disappeared with aging. Furthermore, EGF-induced dimerization in both subpopulations was down-regulated with aging, and the pattern of EGFR phosphorylation was parallel to that of dimerization.
   Conclusions: These data suggest that age-related decline in EGF-induced DNA synthesis of PPH and PVH is caused by down-regulation of EGFR dimerization through the decrease of high-affinity EGFR. (c) 2007 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
C1 [Ohtake, Yosuke; Maruko, Akiko; Ohishi, Nao; Ohkubo, Yasuhito] Tohoku Pharmaceut Univ, Dept Radiopharm, Aoba Ku, Sendai, Miyagi 9818558, Japan.
   [Fukumoto, Manabu] Tohoku Univ, Inst Dev Aging & Canc, Dept Pathol, Aoba Ku, Sendai, Miyagi 9808575, Japan.
C3 Tohoku Medical & Pharmaceutical University; Tohoku University
RP Ohtake, Y (corresponding author), Tohoku Pharmaceut Univ, Dept Radiopharm, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.
EM y-ohtake@tohoku-pharm.ac.jp
RI Fukumoto, Manabu/L-1444-2019
CR BELLOT F, 1990, J CELL BIOL, V110, P491, DOI 10.1083/jcb.110.2.491
   Castillo C, 2004, ENDOCRINE, V25, P33, DOI 10.1385/ENDO:25:1:33
   Dawson JP, 2005, MOL CELL BIOL, V25, P7734, DOI 10.1128/MCB.25.17.7734-7742.2005
   DEFIZE LHK, 1989, J CELL BIOL, V109, P2495, DOI 10.1083/jcb.109.5.2495
   ENAT R, 1984, P NATL ACAD SCI-BIOL, V81, P1411, DOI 10.1073/pnas.81.5.1411
   Ferguson KM, 2004, BIOCHEM SOC T, V32, P742, DOI 10.1042/BST0320742
   Fukujin H, 2000, BIOCHEM BIOPH RES CO, V278, P698, DOI 10.1006/bbrc.2000.3863
   GEBHARDT R, 1992, PROG HISTOCHEM CYTOC, V26, P164, DOI 10.1016/S0079-6336(11)80092-6
   GEBHARDT R, 1988, SCAND J GASTROENTERO, V23, P8, DOI 10.3109/00365528809095909
   GEBHARDT R, 1992, PHARMACOL THERAPEUT, V53, P275, DOI 10.1016/0163-7258(92)90055-5
   GEBHARDT R, 1990, CANCER RES, V50, P4407
   Hashimoto A, 1999, J BIOL CHEM, V274, P20139, DOI 10.1074/jbc.274.29.20139
   HENSLER PJ, 1995, AM J PATHOL, V147, P1
   Herbst RS, 2004, INT J RADIAT ONCOL, V59, P21, DOI 10.1016/j.ijrobp.2003.11.041
   Hutter D, 2000, J GERONTOL A-BIOL, V55, pB125, DOI 10.1093/gerona/55.3.B125
   Imai K, 1998, AM J PHYSIOL-GASTR L, V275, pG1394, DOI 10.1152/ajpgi.1998.275.6.G1394
   ISHIGAMI A, 1993, BIOCHEM BIOPH RES CO, V196, P181, DOI 10.1006/bbrc.1993.2232
   JUNGERMANN K, 1986, ENZYME, V35, P161, DOI 10.1159/000469338
   Lemmon MA, 1997, EMBO J, V16, P281, DOI 10.1093/emboj/16.2.281
   Leserer M, 2000, IUBMB LIFE, V49, P405
   LINDROS KO, 1985, BIOCHEM J, V228, P757, DOI 10.1042/bj2280757
   Liu YS, 1996, J BIOL CHEM, V271, P3604
   MARTI U, 1993, HEPATOLOGY, V18, P1432, DOI 10.1002/hep.1840180623
   Maruko A, 2006, CELL PROLIFERAT, V39, P183, DOI 10.1111/j.1365-2184.2006.00379.x
   NAKAMURA T, 1983, J BIOCHEM-TOKYO, V94, P1029, DOI 10.1093/oxfordjournals.jbchem.a134444
   NAKAMURA T, 1983, P NATL ACAD SCI-BIOL, V80, P7229, DOI 10.1073/pnas.80.23.7229
   Ohtake Y, 2005, BIOL PHARM BULL, V28, P349, DOI 10.1248/bpb.28.349
   Ohtake Y, 2004, BIOL PHARM BULL, V27, P1758, DOI 10.1248/bpb.27.1758
   Palmer HJ, 1999, J BIOL CHEM, V274, P11424, DOI 10.1074/jbc.274.16.11424
   PEACOCKE M, 1991, J CELL BIOCHEM, V45, P147, DOI 10.1002/jcb.240450205
   REITMAN S, 1957, AM J CLIN PATHOL, V28, P56, DOI 10.1093/ajcp/28.1.56
   Sakaguchi K, 1998, MOL ENDOCRINOL, V12, P536, DOI 10.1210/me.12.4.536
   SAWADA N, 1988, CANCER RES, V48, P1618
   TAKEHARA T, 1992, J BIOCHEM-TOKYO, V112, P330, DOI 10.1093/oxfordjournals.jbchem.a123900
   TSUKAMOTO I, 1993, BIOCHEM MOL BIOL INT, V30, P773
   Wang XH, 2001, P NATL ACAD SCI USA, V98, P11468, DOI 10.1073/pnas.201360898
   WELLNER VP, 1966, BIOCHEMISTRY-US, V5, P872, DOI 10.1021/bi00867a010
NR 37
TC 11
Z9 11
U1 0
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0168-8278
EI 1600-0641
J9 J HEPATOL
JI J. Hepatol.
PD FEB
PY 2008
VL 48
IS 2
BP 246
EP 254
DI 10.1016/j.jhep.2007.08.009
PG 9
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 264XS
UT WOS:000253324300010
PM 18006107
DA 2024-02-19
ER

PT J
AU Lo Re, V
   Kallan, MJ
   Tate, JP
   Lim, JK
   Goetz, MB
   Klein, MB
   Rimland, D
   Rodriguez-Barradas, MC
   Butt, AA
   Gibert, CL
   Brown, ST
   Park, LS
   Dubrow, R
   Reddy, KR
   Kostman, JR
   Justice, AC
   Localio, AR
AF Lo Re, Vincent, III
   Kallan, Michael J.
   Tate, Janet P.
   Lim, Joseph K.
   Goetz, Matthew Bidwell
   Klein, Marina B.
   Rimland, David
   Rodriguez-Barradas, Maria C.
   Butt, Adeel A.
   Gibert, Cynthia L.
   Brown, Sheldon T.
   Park, Lesley S.
   Dubrow, Robert
   Reddy, K. Rajender
   Kostman, Jay R.
   Justice, Amy C.
   Localio, A. Russell
TI Predicting Risk of End-Stage Liver Disease in Antiretroviral-Treated
   Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients
SO OPEN FORUM INFECTIOUS DISEASES
LA English
DT Article
DE end-stage liver disease; hepatic decompensation; HIV; hepatitis C;
   HIV/HCV coinfection
ID SIMPLE NONINVASIVE INDEX; VETERANS AGING COHORT; NATIONAL DEATH INDEX;
   HEPATITIS-C; INFECTED VETERANS; HEPATOCELLULAR-CARCINOMA; SIGNIFICANT
   FIBROSIS; ANTIVIRAL THERAPY; PHARMACY RECORDS; HIV
AB Background. End-stage liver disease (ESLD) is an important cause of morbidity among human immunodeficiency virus (HIV)/hepatitis C virus (HCV)-coinfected patients. Quantifying the risk of this outcome over time could help determine which coinfected patients should be targeted for risk factor modification and HCV treatment. We evaluated demographic, clinical, and laboratory variables to predict risk of ESLD in HIV/HCV-coinfected patients receiving antiretroviral therapy (ART).
   Methods. We conducted a retrospective cohort study among 6016 HIV/HCV-coinfected patients who received ART within the Veterans Health Administration between 1997 and 2010. The main outcome was incident ESLD, defined by hepatic decompensation, hepatocellular carcinoma, or liver-related death. Cox regression was used to develop prognostic models based on baseline demographic, clinical, and laboratory variables, including FIB-4 and aspartate aminotransferase-to-platelet ratio index, previously validated markers of hepatic fibrosis. Model performance was assessed by discrimination and decision curve analysis.
   Results. Among 6016 HIV/HCV patients, 532 (8.8%) developed ESLD over a median of 6.6 years. A model comprising FIB-4 and race had modest discrimination for ESLD (c-statistic, 0.73) and higher net benefit than alternative strategies of treating no or all coinfected patients at relevant risk thresholds. For FIB-4 > 3.25, ESLD risk ranged from 7.9% at 1 year to 26.0% at 5 years among non-blacks and from 2.4% at 1 year to 14.0% at 5 years among blacks.
   Conclusions. Race and FIB-4 provided important predictive information on ESLD risk among HIV/HCV patients. Estimating risk of ESLD using these variables could help direct HCV treatment decisions among HIV/HCV-coinfected patients.
C1 [Lo Re, Vincent, III; Reddy, K. Rajender; Kostman, Jay R.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA.
   [Lo Re, Vincent, III; Kallan, Michael J.; Localio, A. Russell] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA.
   [Lo Re, Vincent, III; Kallan, Michael J.; Localio, A. Russell] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA.
   [Lo Re, Vincent, III] Philadelphia VA Med Ctr, Med Serv, Philadelphia, PA USA.
   [Tate, Janet P.; Lim, Joseph K.; Justice, Amy C.] VA Connecticut Healthcare Syst, West Haven, CT USA.
   [Tate, Janet P.; Lim, Joseph K.; Park, Lesley S.; Dubrow, Robert; Justice, Amy C.] Yale Univ, Sch Med, New Haven, CT USA.
   [Goetz, Matthew Bidwell] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA.
   [Goetz, Matthew Bidwell] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90024 USA.
   [Klein, Marina B.] McGill Univ, Ctr Hlth, Chron Viral Illness Serv, Montreal, PQ, Canada.
   [Rimland, David] Atlanta VA Med Ctr, Atlanta, GA USA.
   [Rimland, David] Emory Univ, Sch Med, Atlanta, GA 30322 USA.
   [Rodriguez-Barradas, Maria C.] Baylor Coll Med, Infect Dis Sect, Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA.
   [Rodriguez-Barradas, Maria C.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA.
   [Butt, Adeel A.] VA Pittsburgh Healthcare Syst, Pittsburgh, PA 15240 USA.
   [Butt, Adeel A.] Hamad Healthcare Qual Inst, Doha, Qatar.
   [Butt, Adeel A.] Hamad Med Corp, Doha, Qatar.
   [Gibert, Cynthia L.] George Washington Univ, Med Ctr, Washington DC VA Med Ctr, Washington, DC 20037 USA.
   [Brown, Sheldon T.] James J Peters VA Med Ctr, New York, NY USA.
   [Brown, Sheldon T.] Mt Sinai Sch Med, New York, NY USA.
   [Park, Lesley S.; Dubrow, Robert] Yale Univ, Sch Publ Hlth, New Haven, CT USA.
C3 University of Pennsylvania; University of Pennsylvania; University of
   Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US
   Department of Veterans Affairs; Veterans Health Administration (VHA);
   Philadelphia Veterans Affairs Medical Center; US Department of Veterans
   Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare
   System; Yale University; US Department of Veterans Affairs; Veterans
   Health Administration (VHA); VA Greater Los Angeles Healthcare System;
   University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA; McGill University; US Department of Veterans
   Affairs; Veterans Health Administration (VHA); Atlanta VA Medical
   Center; Atlanta VA Health Care System; Emory University; Baylor College
   of Medicine; Baylor College of Medicine; US Department of Veterans
   Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare
   System; Hamad Medical Corporation; Hamad General Hospital; Hamad Medical
   Corporation; George Washington University; US Department of Veterans
   Affairs; Veterans Health Administration (VHA); James J. Peters VA
   Medical Center; Icahn School of Medicine at Mount Sinai; Yale University
RP Lo Re, V (corresponding author), Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, 836 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.
EM vincentl@mail.med.upenn.edu
RI Park, Lesley S./AFV-4294-2022; Re, Vincent Lo/N-7817-2015; Goetz,
   Matthew Bidwell/GPX-4090-2022
OI Park, Lesley S./0000-0002-3848-7753; Butt, Adeel/0000-0002-1118-1826;
   Justice, Amy/0000-0003-0139-5502
FU National Institute of Allergy and Infectious Diseases [K01 AI070001];
   National Institute on Alcohol Abuse and Alcoholism [U01 AA13566];
   National Cancer Institute [F31 CA180775]
FX This study was supported by research grant funding from the National
   Institute of Allergy and Infectious Diseases (K01 AI070001; to V. L.
   R.), National Institute on Alcohol Abuse and Alcoholism (U01 AA13566; to
   A. C. J.), and National Cancer Institute (F31 CA180775; to L. S. P.).
CR Bambha K, 2012, AIDS, V26, P599, DOI 10.1097/QAD.0b013e32834fa121
   Barreiro P, 2011, J INFECT DIS, V203, P1629, DOI 10.1093/infdis/jir113
   Braithwaite RS, 2007, AIDS, V21, P1579, DOI 10.1097/QAD.0b013e3281532b31
   Butt AA, 2004, HEPATOLOGY, V40, P115, DOI 10.1002/hep.20289
   Collett D., 2003, MODELING SURVIVAL DA
   Dieterich D, 2014, CLIN INFECT DIS, V59, P1579, DOI 10.1093/cid/ciu675
   El-Serag HB, 2014, AM J GASTROENTEROL, V109, P1427, DOI 10.1038/ajg.2014.214
   ELIXHAUSER A, 1990, MED CARE, V28, P882, DOI 10.1097/00005650-199010000-00003
   FISHER SG, 1995, AM J EPIDEMIOL, V141, P242, DOI 10.1093/oxfordjournals.aje.a117426
   Fultz SL, 2006, MED CARE, V44, pS25, DOI 10.1097/01.mlr.0000223670.00890.74
   Grossberg R, 2004, J CLIN EPIDEMIOL, V57, P1107, DOI 10.1016/j.jclinepi.2004.04.002
   Günthard HF, 2014, JAMA-J AM MED ASSOC, V312, P410, DOI 10.1001/jama.2014.8722
   Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4
   Heisler M, 2008, CIRCULATION, V117, P2884, DOI 10.1161/CIRCULATIONAHA.107.724104
   Justice AC, 2004, AIDS, V18, pS49, DOI 10.1097/00002030-200401001-00008
   Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5
   Kirk GD, 2013, ANN INTERN MED, V158, P658, DOI 10.7326/0003-4819-158-9-201305070-00604
   Limketkai BN, 2012, JAMA-J AM MED ASSOC, V308, P370, DOI 10.1001/jama.2012.7844
   Lo Re V, 2014, ANN INTERN MED, V160, P369, DOI 10.7326/M13-1829
   Lo Re V, 2011, PHARMACOEPIDEM DR S, V20, P689, DOI 10.1002/pds.2148
   Macías J, 2009, HEPATOLOGY, V50, P1056, DOI 10.1002/hep.23136
   Meissner EG, 2014, J INFECT DIS, V209, P1700, DOI 10.1093/infdis/jit827
   Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698
   Noureddin M, 2013, HEPATOLOGY, V58, P1548, DOI 10.1002/hep.26506
   Park LS, 2011, CANCER EPIDEM BIOMAR, V20, P2512, DOI 10.1158/1055-9965.EPI-11-0582
   Pineda JA, 2007, HEPATOLOGY, V46, P622, DOI 10.1002/hep.21757
   Rosen HR, 2007, HEPATOLOGY, V46, P350, DOI 10.1002/hep.21714
   Royston P, 2005, STATA J, V5, P188, DOI 10.1177/1536867X0500500204
   Sarkar M, 2012, HEPATOLOGY, V56, P1699, DOI 10.1002/hep.25859
   Sathiakumar N, 1998, J OCCUP ENVIRON MED, V40, P808, DOI 10.1097/00043764-199809000-00010
   Sherman KE, 2002, CLIN INFECT DIS, V34, P831, DOI 10.1086/339042
   Shiffman ML, 2013, LIVER INT, V33, P105, DOI 10.1111/liv.12066
   Steinbrook R, 2014, JAMA INTERN MED, V174, P1172, DOI 10.1001/jamainternmed.2014.2135
   STEINER JF, 1988, MED CARE, V26, P814, DOI 10.1097/00005650-198808000-00007
   Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5
   Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178
   Sulkowski MS, 2014, JAMA-J AM MED ASSOC, V312, P353, DOI 10.1001/jama.2014.7734
   Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361
   Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346
   Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632
   Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837
NR 41
TC 9
Z9 11
U1 0
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 2328-8957
J9 OPEN FORUM INFECT DI
JI Open Forum Infect. Dis.
PD SUM
PY 2015
VL 2
IS 3
DI 10.1093/ofid/ofv109
PG 9
WC Immunology; Infectious Diseases; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Infectious Diseases; Microbiology
GA CX6BP
UT WOS:000365786500024
PM 26284259
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Ferri, E
   Rossi, PD
   Scichilone, M
   Lucchi, TA
   Arosio, B
AF Ferri, Evelyn
   Rossi, Paolo D.
   Scichilone, Martina
   Lucchi, Tiziano A.
   Arosio, Beatrice
TI Liver Enzymes in a Cohort of Community-Dwelling Older Persons: Focus on
   Sex Contribution
SO NUTRIENTS
LA English
DT Article
DE liver; sex; aging; dementia; alanine aminotransferase; aspartate
   aminotransferase
ID ALANINE AMINOTRANSFERASE ACTIVITY; ALL-CAUSE MORTALITY;
   HEPATIC-ENCEPHALOPATHY; ALZHEIMERS-DISEASE; INSULIN-RESISTANCE;
   DEMENTIA; FRAILTY; TRANSAMINASE; PATHOGENESIS; ASSOCIATION
AB Dysfunctions in liver metabolic activities may increase the risk of cognitive impairment and dementia. In a cohort of community-dwelling older persons investigated for a suspected cognitive decline, we studied the association between liver status and dementia, considering sex and frailty contribution. Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) concentrations, and the AST/ALT ratio were used to assess liver function in 419 older adults (248 persons with dementia and 171 age- and sex-matched subjects without cognitive decline). Although the serum concentrations of the liver enzymes were in the physiologic range, patients with dementia showed lower ALT concentrations (p = 0.005) and higher AST/ALT ratios (p = 0.003) compared to controls. The same differences were found when comparing men with and without dementia (ALT, p = 0.009; AST/ALT ratio, p = 0.003) but disappeared in women. Curiously, comparing women and men with the same diagnosis, the ALT concentrations were lower (p = 0.008), and the AST/ALT ratio was higher (p = 0.001) in control women than men, whereas no significant difference was found between persons with dementia. In conclusion, in our cohort of older people living in the community, the association between serum aminotransferases and dementia was remarked. Moreover, our results support attention to sex difference in liver function, suggesting a role in the pathogenesis of dementia.
C1 [Ferri, Evelyn; Rossi, Paolo D.; Scichilone, Martina; Lucchi, Tiziano A.] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Via Pace 9, I-20122 Milan, Italy.
   [Arosio, Beatrice] Univ Milan, Dept Clin Sci & Community Hlth, Via Pace 9, I-20122 Milan, Italy.
C3 IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan
RP Ferri, E (corresponding author), Fdn IRCCS Ca Granda Osped Maggiore Policlin, Via Pace 9, I-20122 Milan, Italy.
EM evelyn.ferri@policlinico.mi.it
OI Ferri, Evelyn/0000-0002-7423-3793; Scichilone,
   Martina/0000-0001-8917-3925; Arosio, Beatrice/0000-0002-0615-3580
FU Italian Ministry of Health; Fondazione IRCCS Ca' Granda Ospedale
   Maggiore Policlinico of Milan;  [R.C. 2022 200-01]
FX This research was funded by Italian Ministry of Health, Ricerca Corrente
   2022 (R.C. 2022 200-01). The APC was funded by Fondazione IRCCS Ca'
   Granda Ospedale Maggiore Policlinico of Milan.
CR American Psychiatric Association, 2013, Diagnostic and statistical manual of mental disorders, P50
   [Anonymous], GLOBAL DATABASE BODY
   Arosio B, 2022, NUTRIENTS, V14, DOI 10.3390/nu14061142
   Bai G, 2021, BMC MED, V19, DOI 10.1186/s12916-021-02104-3
   Beraza Naiara, 2008, Hepatology, V48, P1011, DOI 10.1002/hep.22478
   Bosoi CR, 2009, METAB BRAIN DIS, V24, P95, DOI 10.1007/s11011-008-9112-7
   Buday B, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0222-3
   Butterworth RF, 2013, NAT REV GASTRO HEPAT, V10, P522, DOI 10.1038/nrgastro.2013.99
   Chen PH, 2009, WORLD J GASTROENTERO, V15, P5598, DOI 10.3748/wjg.15.5598
   Clarke JR, 2018, J ALZHEIMERS DIS, V64, pS405, DOI 10.3233/JAD-179911
   de Bruijn RFAG, 2013, EUR J EPIDEMIOL, V28, P277, DOI 10.1007/s10654-013-9773-3
   De Reuck J, 2018, FOLIA NEUROPATHOL, V56, P81, DOI 10.5114/fn.2018.76610
   Della Torre S, 2018, CELL METAB, V28, P256, DOI 10.1016/j.cmet.2018.05.021
   Demographia, About us
   Dubois B, 2014, LANCET NEUROL, V13, P614, DOI 10.1016/S1474-4422(14)70090-0
   Elinav E, 2005, AM J GASTROENTEROL, V100, P2201, DOI 10.1111/j.1572-0241.2005.41822.x
   Elinav E, 2006, J AM GERIATR SOC, V54, P1719, DOI 10.1111/j.1532-5415.2006.00921.x
   Ellinger JJ, 2011, J BIOMOL NMR, V49, P221, DOI 10.1007/s10858-011-9481-9
   Estrada LD, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00174
   Fierini F, 2020, J NEUROL SCI, V410, DOI 10.1016/j.jns.2019.116662
   Giambattistelli F, 2012, NEUROBIOL AGING, V33, P1633, DOI 10.1016/j.neurobiolaging.2011.03.005
   Giannini E, 1999, DIGEST DIS SCI, V44, P1249, DOI 10.1023/A:1026609231094
   James BD, 2012, JAMA-J AM MED ASSOC, V307, P1798, DOI 10.1001/jama.2012.3556
   Kamada Y, 2016, BBA CLIN, V5, P101, DOI 10.1016/j.bbacli.2016.02.004
   Kapogiannis D, 2011, LANCET NEUROL, V10, P187, DOI 10.1016/S1474-4422(10)70277-5
   King JA, 2020, ALCOHOL, V83, P75, DOI 10.1016/j.alcohol.2019.07.005
   Koehler EM, 2014, LIVER INT, V34, P296, DOI 10.1111/liv.12311
   Le Couteur DG, 2010, J GERONTOL A-BIOL, V65, P712, DOI 10.1093/gerona/glq082
   Li W, 2022, FRONT MED-LAUSANNE, V9, DOI 10.3389/fmed.2022.780174
   Liu YM, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0920-4
   Lu YF, 2021, J ALZHEIMERS DIS, V79, P1775, DOI 10.3233/JAD-201241
   Maggi A, 2018, MOL METAB, V15, P3, DOI 10.1016/j.molmet.2018.02.012
   Magni E, 1996, EUR J NEUROL, V3, P198, DOI 10.1111/j.1468-1331.1996.tb00423.x
   Mauvais-Jarvis F, 2013, ENDOCR REV, V34, P309, DOI 10.1210/er.2012-1055
   Mitnitski A B, 2001, ScientificWorldJournal, V1, P323
   Nho K, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.7978
   Nichols E, 2022, LANCET PUBLIC HEALTH, V7, pE105, DOI 10.1016/S2468-2667(21)00249-8
   Ochoa-Sanchez R, 2018, J CLIN EXP HEPATOL, V8, P262, DOI 10.1016/j.jceh.2018.08.001
   Ogino E, 2019, ALZHEIMERS DEMENT, V15, P1603, DOI 10.1016/j.jalz.2019.07.013
   Pacifico L, 2013, CLIN CHIM ACTA, V422, P29, DOI 10.1016/j.cca.2013.03.030
   Petroff D, 2022, CLIN GASTROENTEROL H, V20, P641, DOI 10.1016/j.cgh.2021.01.039
   Popa-Wagner A, 2020, NEURAL REGEN RES, V15, P394, DOI 10.4103/1673-5374.266045
   Poulose SM, 2017, ADV NUTR, V8, P804, DOI 10.3945/an.117.016261
   Qian K, 2015, DIABETES-METAB RES, V31, P562, DOI 10.1002/dmrr.2655
   Ramaty E, 2014, EUR J INTERN MED, V25, P919, DOI 10.1016/j.ejim.2014.10.019
   Reis HJ, 2009, CURR MED CHEM, V16, P796, DOI 10.2174/092986709787549271
   Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051
   Rockwood K, 2011, CAN MED ASSOC J, V183, pE487, DOI 10.1503/cmaj.101271
   Romero-Gómez M, 2015, J HEPATOL, V62, P437, DOI 10.1016/j.jhep.2014.09.005
   Rose CF, 2020, J HEPATOL, V73, P1526, DOI 10.1016/j.jhep.2020.07.013
   Sookoian S, 2016, AM J CLIN NUTR, V103, P422, DOI 10.3945/ajcn.115.118695
   Sookoian S, 2012, WORLD J GASTROENTERO, V18, P3775, DOI 10.3748/wjg.v18.i29.3775
   Toledo JB, 2017, ALZHEIMERS DEMENT, V13, P965, DOI 10.1016/j.jalz.2017.01.020
   Tramunt B, 2020, DIABETOLOGIA, V63, P453, DOI 10.1007/s00125-019-05040-3
   Vespasiani-Gentilucci U, 2018, J GERONTOL A-BIOL, V73, P925, DOI 10.1093/gerona/glx126
   Vozarova B, 2002, DIABETES, V51, P1889, DOI 10.2337/diabetes.51.6.1889
   Wahl D, 2019, NEUROBIOL DIS, V130, DOI 10.1016/j.nbd.2019.104481
   Williams KH, 2016, METABOLISM, V65, P783, DOI 10.1016/j.metabol.2015.12.008
   Yamazaki H, 2019, J GASTROEN HEPATOL, V34, P1793, DOI 10.1111/jgh.14631
   Zhang YF, 2010, ENDOCRINE, V38, P181, DOI 10.1007/s12020-010-9369-6
NR 60
TC 3
Z9 3
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD DEC
PY 2022
VL 14
IS 23
AR 4973
DI 10.3390/nu14234973
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 6Y7OY
UT WOS:000897281300001
PM 36501002
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Luo, CT
   Ding, WX
   Zhu, SB
   Chen, YL
   Liu, XH
   Deng, HT
AF Luo, Chengting
   Ding, Wenxi
   Zhu, Songbiao
   Chen, Yuling
   Liu, Xiaohui
   Deng, Haiteng
TI Nicotinamide Mononucleotide Administration Amends Protein Acetylome of
   Aged Mouse Liver
SO CELLS
LA English
DT Article
DE acetylome; aging; nicotinamide mononucleotide; NAD (P) transhydrogenase;
   fatty acid beta oxidation; TCA cycle
ID FATTY-ACID OXIDATION; NAD(+); SIRT3; ACETYLATION; METABOLISM;
   DEACETYLATION; MITOCHONDRIA; HOMEOSTASIS; ACTIVATION; EXPRESSION
AB It is known that the activities of nicotine adenine dinucleotide (NAD(+))-dependent deacetylase decline in the aging mouse liver, and nicotinamide mononucleotide (NMN)-mediated activation of deacetylase has been shown to increase healthspans. However, age-induced changes of the acetylomic landscape and effects of NMN treatment on protein acetylation have not been reported. Here, we performed immunoprecipitation coupled with label-free quantitative LC-MS/MS (IPMS) to identify the acetylome and investigate the effects of aging and NMN on liver protein acetylation. In total, 7773 acetylated peptides assigned to 1997 proteins were commonly identified from young and aged livers treated with vehicle or NMN. The major biological processes associated with proteins exhibiting increased acetylation from aged livers were oxidation-reduction and metabolic processes. Proteins with decreased acetylation from aged livers mostly participated in transport and translation processes. Furthermore, NMN treatment inhibited the aging-related increase of acetylation on proteins regulating fatty acid beta oxidation, the tricarboxylic acid (TCA) cycle and valine degradation. In particular, NAD (P) transhydrogenase (NNT) was markedly hyperacetylated at K70 in aged livers, and NMN treatment decreased acetylation intensity without altering protein levels. Acetylation at cytochrome 3a25 (Cyp3a25) at K141 was also greatly increased in aged livers, and NMN treatment totally arrested this increase. Our extensive identification and analysis provide novel insight and potential targets to combat aging and aging-related functional decline.
C1 [Luo, Chengting; Ding, Wenxi; Zhu, Songbiao] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China.
   [Luo, Chengting; Ding, Wenxi; Zhu, Songbiao; Chen, Yuling; Liu, Xiaohui; Deng, Haiteng] Tsinghua Univ, Ctr Synthet & Systemat Biol, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China.
C3 Tsinghua University; Tsinghua University
RP Deng, HT (corresponding author), Tsinghua Univ, Ctr Synthet & Systemat Biol, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China.
EM luoct@mail.tsinghua.edu.cn; dwx18@mails.tsinghua.edu.cn;
   zhusongbiao@mail.tsinghua.edu.cn; chenyuling2016@mail.tsinghua.edu.cn;
   xiaohui2013@mail.tsinghua.edu.cn; dht@mail.tsinghua.edu.cn
RI chen, yuling/JMQ-4121-2023
OI Deng, Haiteng/0000-0001-9496-1280; Luo, Chengting/0000-0003-1738-4031
FU National Natural Science Foundation of China [82172556]; Beijing
   Municipal Science and Technology Commission [5214025]
FX This study was supported by National Natural Science Foundation of China
   (grant NO. 82172556) and Beijing Municipal Science and Technology
   Commission (NO. 5214025).
CR Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105
   ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786
   Benigni A, 2019, ANTIOXID REDOX SIGN, V31, P1255, DOI 10.1089/ars.2018.7703
   Bertoldo MJ, 2020, CELL REP, V30, P1670, DOI 10.1016/j.celrep.2020.01.058
   Camacho-Pereira J, 2016, CELL METAB, V23, P1127, DOI 10.1016/j.cmet.2016.05.006
   Cantó C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022
   Cantó C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023
   Caton PW, 2011, DIABETOLOGIA, V54, P3083, DOI 10.1007/s00125-011-2288-0
   Chen D, 2021, MOL CELL, V81, P3833, DOI 10.1016/j.molcel.2021.06.027
   Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371
   Covarrubias AJ, 2021, NAT REV MOL CELL BIO, V22, P119, DOI 10.1038/s41580-020-00313-x
   Elhassan YS, 2019, CELL REP, V28, P1717, DOI 10.1016/j.celrep.2019.07.043
   Forero-Baena Nicolas, 2015, Biochim Open, V1, P61, DOI 10.1016/j.biopen.2015.11.001
   Frederick DW, 2016, CELL METAB, V24, P269, DOI 10.1016/j.cmet.2016.07.005
   Gameiro PA, 2013, J BIOL CHEM, V288, P12967, DOI 10.1074/jbc.M112.396796
   Gerhart-Hines Z, 2011, MOL CELL, V44, P851, DOI 10.1016/j.molcel.2011.12.005
   Ghosh AK, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10112839
   Gong B, 2013, NEUROBIOL AGING, V34, P1581, DOI 10.1016/j.neurobiolaging.2012.12.005
   Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103
   Hershberger KA, 2017, NAT REV NEPHROL, V13, P213, DOI 10.1038/nrneph.2017.5
   Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778
   Ho HY, 2017, REDOX BIOL, V12, P916, DOI 10.1016/j.redox.2017.04.035
   Hong GL, 2018, FREE RADICAL BIO MED, V123, P125, DOI 10.1016/j.freeradbiomed.2018.05.073
   Huang P, 2022, J NUTR BIOCHEM, V101, DOI 10.1016/j.jnutbio.2021.108911
   Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622
   Kaludercic N, 2020, J BIOL CHEM, V295, P16217, DOI 10.1074/jbc.H120.016368
   Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026
   Klimova N, 2019, J NEUROSCI RES, V97, P975, DOI 10.1002/jnr.24397
   Kwon S, 2017, J BIOL CHEM, V292, P17312, DOI 10.1074/jbc.M117.778720
   Magni G, 1999, ADV ENZYMOL RAMB, V73, P135, DOI 10.1002/9780470123195.ch5
   Martin AS, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93885
   MCCAY CM, 1975, NUTR REV, V33, P241
   Mills KF, 2016, CELL METAB, V24, P795, DOI 10.1016/j.cmet.2016.09.013
   Oldford C, 2019, FREE RADICAL BIO MED, V135, P15, DOI 10.1016/j.freeradbiomed.2019.02.012
   Park J, 2013, MOL CELL, V50, P919, DOI 10.1016/j.molcel.2013.06.001
   PHILLIPS DM, 1963, BIOCHEM J, V87, P258, DOI 10.1042/bj0870258
   Rao KNS, 2020, REDOX BIOL, V36, DOI 10.1016/j.redox.2020.101650
   RIGGS MG, 1977, NATURE, V268, P462, DOI 10.1038/268462a0
   RINE J, 1987, GENETICS, V116, P9
   Ronchi JA, 2013, FREE RADICAL BIO MED, V63, P446, DOI 10.1016/j.freeradbiomed.2013.05.049
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Smith CD, 2020, J BIOL CHEM, V295, P16207, DOI 10.1074/jbc.RA120.013899
   Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013
   Waddell J, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10113031
   Wang Q, 2015, NEUROSCIENCE, V286, P109, DOI 10.1016/j.neuroscience.2014.11.045
   Wang SF, 2018, REDOX BIOL, V17, P89, DOI 10.1016/j.redox.2018.04.006
   Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014
   Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206
   Zong ZY, 2021, FREE RADICAL BIO MED, V162, P571, DOI 10.1016/j.freeradbiomed.2020.11.014
   Zou XH, 2017, CANCER RES, V77, P3990, DOI 10.1158/0008-5472.CAN-16-2393
NR 50
TC 7
Z9 7
U1 3
U2 20
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD MAY
PY 2022
VL 11
IS 10
AR 1654
DI 10.3390/cells11101654
PG 17
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 1P2BC
UT WOS:000801819800001
PM 35626691
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Kakarla, P
   Kesireddy, S
   Christiaan, L
AF Kakarla, Pushpalatha
   Kesireddy, Sathyavelureddy
   Christiaan, Leeuwenburgh
TI Exercise training with ageing protects against ethanol induced
   myocardial glutathione homeostasis
SO FREE RADICAL RESEARCH
LA English
DT Article
DE exercise training; ethanol; ageing; glutathione system; myocardium; male
   rat
ID OXIDATIVE STRESS; LIPID-PEROXIDATION; ANTIOXIDANT DEFENSES;
   SKELETAL-MUSCLE; S-TRANSFERASES; RAT-LIVER; AGE; GENERATION; DEPLETION;
   MICE
AB Glutathione plays a central role in the maintenance of cellular antioxidant defense. The alterations in the glutathione and associated recyclic enzymes caused by both exercise training and ethanol are well documented; however, their interactive effects with age are not well understood. Therefore, the influence of ageing and the interactive effects of exercise training and ethanol on the myocardial glutathione system in 3 months and 18 months old rats were examined. The results showed a significant (p < 0.01) reduction in GSH content, Se and non-Se GSH-Px, GR and GST activities in the myocardium of rat with age. A significant increase (p < 0.05) in the activities of these enzymes was observed in both age groups of rats in response to exercise training. This exercise-induced elevation of Se and non-Se GSH-Px and GR activities was more pronounced in the 18 months old rats when compared to 3 months old rats. Ethanol consumption significantly (p < 0.05) reduced the GSH content, Se and non-Se GSH-Px and GR activities in both age groups of rats. In contrast, ethanol consumption significantly (p < 0.05) increased the activity of GST. The combined action of exercise plus ethanol significantly (p < 0.05) elevated the GSH content, Se and non-Se GSH-Px, GR and GST activities when compared to the ethanol treated rats in both age groups, indicating the suppression of ethanol-induced oxidative stress by exercise training. In conclusion, there was a compensatory myocardial response lessening ethanol-induced oxidative stress by exercise training, which seemed to result from the higher activity of glutathione recycling and utilizing enzymes, which may be critical for preventing chronic oxidative damage to the myocardium during ageing and even due to ethanol consumption.
C1 [Kakarla, Pushpalatha; Kesireddy, Sathyavelureddy] Sri Venkateswara Univ, Dept Zool, Div Exercise Physiol, Tirupati 517502, Andhra Pradesh, India.
   [Christiaan, Leeuwenburgh] Univ Florida, Dept Aging & Geriatr, Coll Med,Inst Aging, Div Biol Aging,Biochem Aging Lab, Gainesville, FL 32611 USA.
C3 Sri Venkateswara University; State University System of Florida;
   University of Florida
RP Kakarla, P (corresponding author), 25-753 Naidu Bldg,Rangapuram Rd, Chittoor 517408, Andhra Pradesh, India.
EM pushpa6k@yahoo.com
OI Leeuwenburgh, Christiaan/0000-0003-0826-4257
CR BRAY TM, 1993, CAN J PHYSIOL PHARM, V71, P746, DOI 10.1139/y93-111
   CAO GH, 1995, ARCH BIOCHEM BIOPHYS, V320, P195, DOI 10.1006/abbi.1995.1359
   CARLBERG I, 1985, METHOD ENZYMOL, V113, P484
   CHEN LH, 1995, ALCOHOL, V12, P453, DOI 10.1016/0741-8329(95)00030-U
   EKSTROM G, 1989, BIOCHEM PHARMACOL, V38, P1313, DOI 10.1016/0006-2952(89)90338-9
   FLOHE L, 1984, METHOD ENZYMOL, V105, P114
   FRIEDBERG T, 1979, J BIOL CHEM, V254, P2028
   GUERRI C, 1994, ADV EXP MED BIOL, V366, P291
   Gul Mustafa, 2000, Indian Journal of Experimental Biology, V38, P625
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   HARMAN D, 1986, BIOL AGING, P255
   HAZELTON GA, 1980, BIOCHEM J, V88, pF2
   Heaton MB, 2002, NEUROSCI LETT, V334, P83, DOI 10.1016/S0304-3940(02)01123-0
   HIRANO T, 1992, HEPATOLOGY, V16, P1423
   HUSSAIN K, 2003, PATHOPHYSIOLOGY, V10, P47
   Jang IS, 2001, MECH AGEING DEV, V122, P561, DOI 10.1016/S0047-6374(01)00236-6
   Ji L L, 1995, Exerc Sport Sci Rev, V23, P135
   Ji L.L., 2000, HDB OXIDANTS ANTIOXI, P689
   JI LL, 1995, FREE RADICAL BIO MED, V18, P1079, DOI 10.1016/0891-5849(94)00212-3
   JI LL, 1993, MED SCI SPORT EXER, V25, P225
   Kakarla P, 2005, FEBS J, V272, P72
   Kakarla P, 2005, FREE RADICAL RES, V39, P1211, DOI 10.1080/10715760500315118
   KAKARLA P, 2005, THESIS S V U TIRUPAT
   KAPLOWITZ N, 1985, ANNU REV PHARMACOL, V25, P715, DOI 10.1146/annurev.pharmtox.25.1.715
   LEEUWENBURGH C, 1995, ARCH BIOCHEM BIOPHYS, V316, P941, DOI 10.1006/abbi.1995.1125
   LEEUWENBURGH C, 1994, AM J PHYSIOL, V267, pR439, DOI 10.1152/ajpregu.1994.267.2.R439
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MATSUO M, 1993, AGE RELATED ALTERATI, P143
   MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431
   Miquel J., 1986, FREE RADICALS AGING, P51
   MORTON S, 1985, BIOCHEM PHARMACOL, V34, P1559, DOI 10.1016/0006-2952(85)90699-9
   NICHOLAS ASH, 2003, ALCOHOLISM CLIN EXPT, V27, P577
   NORDMANN R, 1992, FREE RADICAL BIO MED, V12, P219, DOI 10.1016/0891-5849(92)90030-K
   Oh SI, 1998, J NUTR, V128, P758, DOI 10.1093/jn/128.4.758
   Paradis V, 1997, HEPATOLOGY, V26, P135
   POWERS SK, 1994, AM J PHYSIOL, V266, pR375, DOI 10.1152/ajpregu.1994.266.2.R375
   Pushpalatha K, 2007, ACTA BIOL HUNG, V58, P173, DOI 10.1556/ABiol.58.2007.2.4
   REED D J, 1984, Pharmacological Reviews, V36, p25S
   Rouach H, 1997, HEPATOLOGY, V25, P351
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   THEODORUS P, 1981, METHOD ENZYMOL, V77, P373
   Vina J, 1996, J APPL PHYSIOL, V81, P2199, DOI 10.1152/jappl.1996.81.5.2199
   YANG CM, 1991, PHARMACOLOGY, V42, P28
NR 43
TC 3
Z9 3
U1 0
U2 4
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1071-5762
EI 1029-2470
J9 FREE RADICAL RES
JI Free Radic. Res.
PD MAY
PY 2008
VL 42
IS 5
BP 428
EP 434
DI 10.1080/10715760802069462
PG 7
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 311EI
UT WOS:000256583100003
PM 18551810
DA 2024-02-19
ER

PT J
AU Léonard, JF
   Courcol, M
   Mariet, C
   Charbonnier, A
   Boitier, E
   Duchesne, M
   Parker, F
   Genet, B
   Supatto, F
   Roberts, R
   Gautier, JC
AF Léonard, JF
   Courcol, M
   Mariet, C
   Charbonnier, A
   Boitier, E
   Duchesne, M
   Parker, F
   Genet, B
   Supatto, F
   Roberts, R
   Gautier, JC
TI Proteomic characterization of the effects of clofibrate on protein
   expression in rat liver
SO PROTEOMICS
LA English
DT Article
DE clofibrate; liver proteome; nongenotoxic carcinogenesis
ID ACTIVATED RECEPTOR-ALPHA; SENESCENCE MARKER PROTEIN-30;
   NECROSIS-FACTOR-ALPHA; DIFFERENCE GEL-ELECTROPHORESIS; MESSENGER-RNA
   EXPRESSION; ACYL-COA OXIDASE; PEROXISOME-PROLIFERATOR; MOUSE-LIVER;
   HEPATOCELLULAR CARCINOMAS; MASS-SPECTROMETRY
AB Clofibrate is a peroxisome proliferator known to induce liver tumours in rats. A proteomics study was conducted to provide new insights into the molecular mechanisms of clofibrate-induced non-genotoxic hepatocarcinogenesis. Rats were treated with 250 mg/kg day clofibrate orally and sacrificed after 7 days. Proteins extracted from the liver were analysed by 2-DE using DIGE technology. The protein identification performed by MS showed that clofibrate induced up-regulation of 77 proteins and down-regulation of 27 proteins. The highest expression ratios corresponded to proteins involved in a series of biochemical pathways such as lipid metabolism, fatty acid metabolism, amino acid metabolism, protein metabolism, citric acid cycle, xenobiotic detoxification and oxidative stress. Proteins implicated in cell proliferation and apoptosis, such as prohibitin, 10-formyl tetrahydrofolate dehydrogenase, senescence marker protein-30, pyridoxine 5'-phosphate oxidase and vimentin, were also identified as being regulated. These results provide leads for further investigations into the molecular mechanisms of liver tumours induced by clofibrate. In addition, MS results showed that a series of regulated proteins were detected as several spots corresponding to different pI and/or M-r. Differential effects on those variants could result from specific PTM and could be a specific molecular signature of the clofibrate-induced protein expression modulation in rat liver.
C1 Sanofi Aventis, Drug Safety Evaluat, F-94403 Vitry Sur Seine, France.
   Sanofi Aventis, Genom Sci, F-94403 Vitry Sur Seine, France.
C3 Sanofi-Aventis; Sanofi France; Sanofi-Aventis; Sanofi France
RP Léonard, JF (corresponding author), Sanofi Aventis, Drug Safety Evaluat, 13 Quai Jules Guesde, F-94403 Vitry Sur Seine, France.
EM jean-francois.leonard@sanofi-aventis.com
CR Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006
   Anderson NL, 1996, TOXICOL APPL PHARM, V137, P75, DOI 10.1006/taap.1996.0059
   Argiriadi MA, 1999, P NATL ACAD SCI USA, V96, P10637, DOI 10.1073/pnas.96.19.10637
   ASAMOTO M, 1994, CANCER LETT, V83, P201, DOI 10.1016/0304-3835(94)90320-4
   ASHBY J, 1994, HUM EXP TOXICOL, V13, pS1, DOI 10.1177/096032719401300201
   Baker VA, 2004, ENVIRON HEALTH PERSP, V112, P428, DOI 10.1289/ehp.6677
   Byun Y, 2001, CELL DEATH DIFFER, V8, P443, DOI 10.1038/sj.cdd.4400840
   Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200
   Chen GA, 2002, CLIN CANCER RES, V8, P2298
   Chevalier S, 2000, EUR J BIOCHEM, V267, P4624, DOI 10.1046/j.1432-1327.2000.01487.x
   Chevalier S, 1999, J CELL SCI, V112, P4785
   Chevalier S, 2000, CURR PROTEIN PEPT SC, V1, P325, DOI 10.2174/1389203003381298
   Chu RY, 2004, MOL CELL BIOL, V24, P6288, DOI 10.1128/MCB.24.14.6288-6297.2004
   Cosulich S, 2000, CARCINOGENESIS, V21, P579, DOI 10.1093/carcin/21.4.579
   David RM, 1999, TOXICOL SCI, V50, P195, DOI 10.1093/toxsci/50.2.195
   Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649
   Edvardsson U, 1999, ELECTROPHORESIS, V20, P935, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<935::AID-ELPS935>3.0.CO;2-6
   Fruchart JC, 1998, AM J CARDIOL, V81, P912
   Fujita T, 1996, MECH AGEING DEV, V87, P219, DOI 10.1016/0047-6374(96)01711-3
   Gonzalez FJ, 1998, J NATL CANCER I, V90, P1702, DOI 10.1093/jnci/90.22.1702
   Görg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031
   Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117
   Hashimoto T, 1999, J BIOL CHEM, V274, P19228, DOI 10.1074/jbc.274.27.19228
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   Ishigami T, 2001, PATHOL INT, V51, P491, DOI 10.1046/j.1440-1827.2001.01238.x
   Karp NA, 2004, PROTEOMICS, V4, P1421, DOI 10.1002/pmic.200300681
   Kennedy S, 2002, BIOMARKERS, V7, P269, DOI 10.1080/13547500210127318
   Kersten S, 2001, FASEB J, V15, P1971, DOI 10.1096/fj.01-0147com
   Kim J, 2002, ELECTROPHORESIS, V23, P4142, DOI 10.1002/elps.200290032
   Krupenko SA, 2002, CELL GROWTH DIFFER, V13, P227
   KUTZBACH C, 1971, METHODS ENZYMOL B, V18, P793
   Latruffe N, 2001, BIOCHEM SOC T, V29, P305
   LEE SST, 1995, MOL CELL BIOL, V15, P3012
   LIDA M, 2003, CARCINOGENESIS, V24, P757
   Macdonald N, 2001, ARCH TOXICOL, V75, P415, DOI 10.1007/s002040100259
   Mateos-Cáceres PJ, 2004, J AM COLL CARDIOL, V44, P1578, DOI 10.1016/j.jacc.2004.06.073
   Meyer K, 2003, CARCINOGENESIS, V24, P975, DOI 10.1093/carcin/bgg040
   Michel C, 2003, AM J PATHOL, V163, P2191, DOI 10.1016/S0002-9440(10)63577-8
   Misawa H, 2002, J CELL BIOCHEM, V84, P143, DOI 10.1002/jcb.1274
   MOODY DE, 1992, DRUG METAB DISPOS, V20, P779
   Ngo EO, 1998, BIOCHEMISTRY-US, V37, P7741, DOI 10.1021/bi972983r
   NUELL MJ, 1991, MOL CELL BIOL, V11, P1372, DOI 10.1128/MCB.11.3.1372
   Peters JM, 1997, CARCINOGENESIS, V18, P2029, DOI 10.1093/carcin/18.11.2029
   Praml C, 1998, CANCER RES, V58, P5014
   Reddy JK, 2004, AM J PATHOL, V164, P2305, DOI 10.1016/S0002-9440(10)63787-X
   REDDY JK, 1980, NATURE, V283, P397, DOI 10.1038/283397a0
   SchulteHermann R, 1995, MUTAT RES-FUND MOL M, V333, P81, DOI 10.1016/0027-5107(95)00134-4
   Seow TK, 2000, ELECTROPHORESIS, V21, P1787, DOI 10.1002/(SICI)1522-2683(20000501)21:9<1787::AID-ELPS1787>3.0.CO;2-A
   Takahashi H, 1999, J CELL BIOCHEM, V74, P663, DOI 10.1002/(SICI)1097-4644(19990915)74:4<663::AID-JCB15>3.0.CO;2-2
   Tonge R, 2001, PROTEOMICS, V1, P377
   TOPPING DC, 1987, TOXICOL IND HEALTH, V3, P63, DOI 10.1177/074823378700300206
   Wang KJ, 2004, WORLD J GASTROENTERO, V10, P2179
   WEBER G, 1983, CANCER RES, V43, P3466
   Wetmore BA, 2004, TOXICOL PATHOL, V32, P619, DOI 10.1080/01926230490518244
   White IR, 2003, PROTEOMICS, V3, P505, DOI 10.1002/pmic.200390064
   Yeldandi AV, 2000, MUTAT RES-FUND MOL M, V448, P159, DOI 10.1016/S0027-5107(99)00234-1
   Zeindl-Eberhart E, 2004, HEPATOLOGY, V39, P540, DOI 10.1002/hep.20060
   Zeindl-Eberhart E, 2001, ELECTROPHORESIS, V22, P3009, DOI 10.1002/1522-2683(200108)22:14<3009::AID-ELPS3009>3.0.CO;2-V
NR 58
TC 24
Z9 28
U1 0
U2 3
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1615-9853
J9 PROTEOMICS
JI Proteomics
PD MAR
PY 2006
VL 6
IS 6
BP 1915
EP 1933
DI 10.1002/pmic.200500251
PG 19
WC Biochemical Research Methods; Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 027MV
UT WOS:000236420600024
PM 16470657
DA 2024-02-19
ER

PT J
AU Ferreira, M
   Francisco, S
   Soares, AR
   Nobre, A
   Pinheiro, M
   Reis, A
   Neto, S
   Rodrigues, AJ
   Sousa, N
   Moura, G
   Santos, MAS
AF Ferreira, Margarida
   Francisco, Stephany
   Soares, Ana R.
   Nobre, Ana
   Pinheiro, Miguel
   Reis, Andreia
   Neto, Sonya
   Rodrigues, Ana Joao
   Sousa, Nuno
   Moura, Gabriela
   Santos, Manuel A. S.
TI Integration of segmented regression analysis with weighted gene
   correlation network analysis identifies genes whose expression is
   remodeled throughout physiological aging in mouse tissues
SO AGING-US
LA English
DT Article
DE aging; transcriptome; mus musculus; trendy; WGCNA
ID PYRUVATE-DEHYDROGENASE COMPLEX; SKELETAL-MUSCLE; PREFRONTAL CORTEX;
   PROTEIN-SYNTHESIS; R PACKAGE; AGE; LIVER; TRANSCRIPTOME; BRAIN;
   METAANALYSIS
AB Gene expression alterations occurring with aging have been described for a multitude of species, organs, and cell types. However, most of the underlying studies rely on static comparisons of mean gene expression levels between age groups and do not account for the dynamics of gene expression throughout the lifespan. These studies also tend to disregard the pairwise relationships between gene expression profiles, which may underlie commonly altered pathways and regulatory mechanisms with age. To overcome these limitations, we have combined segmented regression analysis with weighted gene correlation network analysis (WGCNA) to identify high-confidence signatures of aging in the brain, heart, liver, skeletal muscle, and pancreas of C57BL/6 mice in a publicly available RNA-Seq dataset (GSE132040). Functional enrichment analysis of the overlap of genes identified in both approaches showed that immune-and inflammation-related responses are prominently altered in the brain and the liver, while in the heart and the muscle, aging affects amino and fatty acid metabolism, and tissue regeneration, respectively, which reflects an age-related global loss of tissue function. We also explored sexual dimorphism in the aging mouse transcriptome and found the liver and the muscle to have the most pronounced gender differences in gene expression throughout the lifespan, particularly in proteostasis-related pathways. While the data showed little overlap among the age-dysregulated genes between tissues, aging triggered common biological processes in distinct tissues, which we highlight as important features of murine tissue physiological aging.
C1 [Ferreira, Margarida; Francisco, Stephany; Soares, Ana R.; Nobre, Ana; Pinheiro, Miguel; Reis, Andreia; Neto, Sonya; Moura, Gabriela; Santos, Manuel A. S.] Univ Aveiro, Inst Biomed iBiMED, Dept Med Sci, P-3810193 Aveiro, Portugal.
   [Rodrigues, Ana Joao; Sousa, Nuno] Univ Minho, Sch Med, Life & Hlth Sci Res Inst ICVS, P-4710057 Braga, Portugal.
   [Rodrigues, Ana Joao; Sousa, Nuno] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal.
C3 Universidade de Aveiro; Universidade do Minho
RP Santos, MAS (corresponding author), Univ Aveiro, Inst Biomed iBiMED, Dept Med Sci, P-3810193 Aveiro, Portugal.
EM msantos@ua.pt
RI Soares, Ana Raquel/G-7331-2014; Rodrigues, Ana João/D-3782-2012; Sousa,
   Nuno/C-2782-2009; Francisco, Stephany/GQA-4722-2022; Moura,
   Gabriela/E-6717-2010; Pinheiro, Miguel/K-4467-2017
OI Soares, Ana Raquel/0000-0003-4000-7461; Rodrigues, Ana
   João/0000-0003-1968-7968; Francisco, Stephany/0000-0003-0022-3872;
   Moura, Gabriela/0000-0003-2243-6123; Pinheiro,
   Miguel/0000-0002-6601-7513; Reis, Andreia/0000-0001-6238-3017; Neto,
   Sonya/0000-0002-4675-2940
FU Portuguese Foundation for Science and Technology (FCT); FEDER (Fundo
   Europeu de Desenvolvimento Regional) funds through the COMPETE 2020;
   Operational Programme for Competitiveness and Internationalization
   (POCI) [POCI-01-0145-FEDER-022184, POCI-01-0145-FEDER-016428-PAC,
   POCI-01-0145-FEDER-029843]; European Regional Development Fund
   [Centro-01-0145-FEDER-000003, CENTRO-01-0246-FEDER-000018,
   POCI-01-0145-FEDER-016385]; FCT [SFRH/BD/131736/2017,
   SFRH/BD/148323/2019, UID/BIM/04501/2020]; Fundação para a Ciência e a
   Tecnologia [SFRH/BD/131736/2017, SFRH/BD/148323/2019] Funding Source:
   FCT
FX This work was supported by the Portuguese Foundation for Science and
   Technology (FCT) and FEDER (Fundo Europeu de Desenvolvimento Regional)
   funds through the COMPETE 2020, Operational Programme for
   Competitiveness and Internationalization (POCI) (GenomePT:
   POCI010145FEDER022184; MEDPERSYST: POCI010145FEDER016428PAC; WISDOM:
   POCI-01-0145-FEDER-029843) and by Centro 2020 program, Portugal 2020 and
   European Regional Development Fund (pAGE Integrated project:
   Centro010145FEDER000003; MEDISIS: CENTRO010246FEDER000018; NETDIAMOND:
   POCI010145FEDER016385) . The iBiMED research unit is supported by FCT
   (UID/BIM/04501/2020) . MF and SF are directly supported by FCT grants
   (SFRH/BD/131736/2017 and SFRH/BD/148323/2019) .
CR Almanzar N, NAT, V2020
   Almanzar N, 2020, NATURE, V583, P590, DOI 10.1038/s41586-020-2496-1
   Amatu A, 2019, ANN ONCOL, V30, pVIII5, DOI 10.1093/annonc/mdz383
   Anders S., 2010, GENOME BIOL, V11, pR106, DOI DOI 10.1186/gb-2010-11-10-r106
   Anisimova AS, 2020, P NATL ACAD SCI USA, V117, P15581, DOI 10.1073/pnas.2001788117
   [Anonymous], 2020, TUTORIALS WGCNA R PA
   [Anonymous], 2020, WGCNA PACKAGE FREQUE
   [Anonymous], 2020, GEO ACCESSION VIEWER
   [Anonymous], 2021, GENE ONTOLOGY ANNOTA
   Askanas V, 2015, BBA-MOL BASIS DIS, V1852, P633, DOI [10.1016/j.bbadis.201409.005, 10.1016/j.bbadis.2014.09.005]
   Aslam MS, 2020, J DRUG TARGET, V28, P368, DOI 10.1080/1061186X.2019.1693576
   Augereau C, 2016, ANAL BIOCHEM, V500, P60, DOI 10.1016/j.ab.2016.02.008
   Azevedo-Pouly ACP, 2014, JOVE-J VIS EXP, DOI 10.3791/51779
   Babagana M, 2020, HEDGEHOG DYSTREGULAT, DOI [10.1101/2020.08.16.253237, DOI 10.1101/2020.08.16.253237]
   Bacher R, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2405-x
   Bakken TE, 2016, NATURE, V535, P367, DOI 10.1038/nature18637
   Barry C, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007543
   Barthelemy Florian, 2018, J Neuromuscul Dis, V5, P21, DOI 10.3233/JND-170251
   Bartlett K, 2004, EUR J BIOCHEM, V271, P462, DOI 10.1046/j.1432-1033.2003.03947.x
   Benayoun BA, 2019, GENOME RES, V29, P697, DOI 10.1101/gr.240093.118
   Beveridge NJ, 2014, SCHIZOPHRENIA BULL, V40, P399, DOI 10.1093/schbul/sbs198
   Boisvert MM, 2018, CELL REP, V22, P269, DOI 10.1016/j.celrep.2017.12.039
   Byron O, 2017, SUBCELL BIOCHEM, V83, P523, DOI 10.1007/978-3-319-46503-6_19
   Cabello-Verrugio C, 2007, J BIOL CHEM, V282, P18842, DOI 10.1074/jbc.M700243200
   Cabello-Verrugio C, 2012, J BIOL CHEM, V287, P6773, DOI 10.1074/jbc.M111.312488
   Cao KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074578
   Carlson M, 2019, org.Mm.eg.db: Genome wide annotation for Mouse. R package version 3.8.2
   Cellerino A, 2017, SEMIN CELL DEV BIOL, V70, P177, DOI 10.1016/j.semcdb.2017.06.012
   Chen AN, 2020, AGING-US, V12, P23187, DOI 10.18632/aging.104089
   Chen L, 2020, Liver Research, V4, P28, DOI [DOI 10.1016/J.LIVRES.2020.01.002, 10.1016/j.livres.2020.01.002]
   Chen WJ, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22042123
   Chen X, 2019, J Parkinsons Dis Alzheimers Dis, V6, DOI 10.13188/2376-922x.1000028
   Chu PG, 2001, APPL IMMUNOHISTO M M, V9, P97, DOI 10.1097/00022744-200106000-00001
   Clark D, 2020, AGING CELL, V19, DOI 10.1111/acel.13112
   Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524
   Conway JR, 2017, BIOINFORMATICS, V33, P2938, DOI 10.1093/bioinformatics/btx364
   Cruz-Topete D, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00347
   David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450
   de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073
   Defour A, 2017, HUM MOL GENET, V26, P1979, DOI 10.1093/hmg/ddx065
   Dixon-Salazar TJ, 2014, J NEUROSCI, V34, P11844, DOI 10.1523/JNEUROSCI.4642-12.2014
   Drosatos K, 2016, PATHOBIOL AGING AGE, V6, DOI 10.3402/pba.v6.32221
   Du M, 2017, MOL VIS, V23, P707
   Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525
   Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97
   Ellis JM, 2011, MOL CELL BIOL, V31, P1252, DOI 10.1128/MCB.01085-10
   Erraji-Benchekroun L, 2005, BIOL PSYCHIAT, V57, P549, DOI 10.1016/j.biopsych.2004.10.034
   Fanò G, 2001, J MUSCLE RES CELL M, V22, P345, DOI 10.1023/A:1013122805060
   Fissolo N, 2021, NEUROL-NEUROIMMUNOL, V8, DOI 10.1212/NXI.0000000000000941
   Francisco S, 2020, AGEING RES REV, V62, DOI 10.1016/j.arr.2020.101119
   Frenk S, 2018, BIOGERONTOLOGY, V19, P547, DOI 10.1007/s10522-018-9750-z
   Fu CX, 2006, MECH AGEING DEV, V127, P905, DOI 10.1016/j.mad.2006.09.006
   Gao K, 2020, CHIN MED-UK, V15, DOI 10.1186/s13020-020-0299-9
   García-Suárez  O, 2006, ANAT EMBRYOL, V211, P465, DOI 10.1007/s00429-006-0098-9
   Gheller BJF, 2016, ANNU REV NUTR, V36, P129, DOI 10.1146/annurev-nutr-071715-050901
   Glass D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r75
   Gomez-Verjan JC, 2018, HUM GENET, V137, P865, DOI 10.1007/s00439-018-1955-3
   Groh N, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00138
   Hamer G, 2010, NAT METHODS, V7, P473, DOI [10.1038/NMETH.1460, 10.1038/nmeth.1460]
   Handzlik MK, 2018, J PHYSIOL-LONDON, V596, P3357, DOI 10.1113/JP275357
   Harries LW, 2011, AGING CELL, V10, P868, DOI 10.1111/j.1474-9726.2011.00726.x
   Ho TC, 2015, AM J PHYSIOL-CELL PH, V309, pC159, DOI 10.1152/ajpcell.00344.2014
   Hord JM, 2016, EXP GERONTOL, V83, P148, DOI 10.1016/j.exger.2016.08.006
   Horvath S., 2020, CORRECTED R CODE
   Hosseinzadeh S, 2019, SMARTSEQ2 HTP GENERA, DOI [10.17504/protocols.io.2uvgew6, DOI 10.17504/PROTOCOLS.IO.2UVGEW6]
   Hu Y, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00259
   Hughes CE, 2018, FEBS J, V285, P2944, DOI 10.1111/febs.14466
   Hyyti OM, 2010, AM J PHYSIOL-HEART C, V299, pH868, DOI 10.1152/ajpheart.00931.2009
   InanlooRahatloo K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183874
   Irizar H, 2015, EXP GERONTOL, V72, P50, DOI 10.1016/j.exger.2015.09.003
   Irizar PA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02395-2
   Jenkins EC, 2020, EMBO REP, V21, DOI 10.15252/embr.201948978
   Jonker MJ, 2013, AGING CELL, V12, P901, DOI 10.1111/acel.12118
   Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200
   Kucera Mike, 2016, F1000Res, V5, P1717
   Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559
   Lazarczyk MJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26199
   Lee JS, 2012, MECH AGEING DEV, V133, P467, DOI 10.1016/j.mad.2012.05.006
   Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200
   Lesnefsky EJ, 2016, CIRC RES, V118, P1593, DOI 10.1161/CIRCRESAHA.116.307505
   Li BH, 2017, TRANSL RES, V180, P103, DOI 10.1016/j.trsl.2016.08.006
   Li CH, 2018, GENES GENET SYST, V93, P221, DOI 10.1266/ggs.17-00052
   Li ML, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-01962-z
   Liu Y, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01081
   Lonardo A, 2019, HEPATOLOGY, V70, P1457, DOI 10.1002/hep.30626
   Lopes-Ramos CM, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107795
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Lucas A, 2018, METHODS MOL BIOL, V1826, P1, DOI 10.1007/978-1-4939-8645-3_1
   Lukjanenko L, 2016, NAT MED, V22, P897, DOI 10.1038/nm.4126
   Mangold CA, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0920-8
   Mangold CA, 2017, J GERONTOL A-BIOL, V72, P16, DOI 10.1093/gerona/glv232
   Martín-Fernández B, 2016, AGE, V38, P225, DOI 10.1007/s11357-016-9933-y
   McKeever PM, 2017, NEUROBIOL AGING, V57, P104, DOI 10.1016/j.neurobiolaging.2017.05.014
   Melis JPM, 2013, AGING-US, V5, P782, DOI 10.18632/aging.100606
   Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984
   Merienne N, 2019, CELL REP, V26, P2477, DOI 10.1016/j.celrep.2019.02.003
   Moreau R, 2004, BIOCHEM BIOPH RES CO, V325, P48, DOI 10.1016/j.bbrc.2004.10.011
   Morris JH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-436
   Naqvi S, 2019, SCIENCE, V365, P249, DOI 10.1126/science.aaw7317
   Oesper L, 2011, SOURCE CODE BIOL MED, V6, DOI 10.1186/1751-0473-6-7
   Oh VKS, 2021, GENES-BASEL, V12, DOI 10.3390/genes12030352
   Okada K, 2015, CIRC-HEART FAIL, V8, P799, DOI 10.1161/CIRCHEARTFAILURE.114.001958
   Oldham MC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-63
   Ori A, 2015, CELL SYST, V1, P224, DOI 10.1016/j.cels.2015.08.012
   Palmer D, 2021, AGING-US, V13, P3313, DOI 10.18632/aging.202648
   Patel MS, 2014, J BIOL CHEM, V289, P16615, DOI 10.1074/jbc.R114.563148
   Pickering AM, 2015, J CLIN INVEST, V125, P2059, DOI 10.1172/JCI80514
   Potikha T, 2019, FASEB J, V33, P7995, DOI 10.1096/fj.201900017R
   Robinson MW, 2016, CELL MOL IMMUNOL, V13, P267, DOI 10.1038/cmi.2016.3
   Roostalu U, 2012, DEV CELL, V22, P515, DOI 10.1016/j.devcel.2011.12.008
   Rosa-Caldwell ME, 2019, BIOL SEX DIFFER, V10, DOI 10.1186/s13293-019-0257-3
   Rossetti CL, 2019, EXP PHYSIOL, V104, P677, DOI 10.1113/EP087518
   Sampathkumar NK, 2020, HUM GENET, V139, P333, DOI 10.1007/s00439-019-02082-w
   Sanchez D, 2000, PANCREAS, V21, P407, DOI 10.1097/00006676-200011000-00012
   SAYEGH JF, 1989, NEUROCHEM RES, V14, P1165, DOI 10.1007/BF00965625
   Schaum N, 2020, NATURE, V583, P596, DOI 10.1038/s41586-020-2499-y
   Schaum N, 2018, NATURE, V562, P367, DOI 10.1038/s41586-018-0590-4
   SHAHBAZIAN FM, 1987, INT J DEV NEUROSCI, V5, P39, DOI 10.1016/0736-5748(87)90046-3
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Sheeran FL, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/4532592
   Singh P, 2008, HEPATOLOGY, V47, P1680, DOI 10.1002/hep.22224
   Smith LK, 2015, NAT MED, V21, P932, DOI 10.1038/nm.3898
   Srivastava A, 2020, GENOM PROTEOM BIOINF, V18, P430, DOI 10.1016/j.gpb.2020.12.001
   Stacpoole PW, 2012, AGING CELL, V11, P371, DOI 10.1111/j.1474-9726.2012.00805.x
   Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004
   Stegeman R, 2017, J MOL BIOL, V429, P2427, DOI 10.1016/j.jmb.2017.06.019
   Tetruashvily MM, 2016, BRAIN BEHAV IMMUN, V56, P197, DOI 10.1016/j.bbi.2016.01.008
   Timmons JA, 2019, AGING CELL, V18, DOI 10.1111/acel.12970
   Tocchi A, 2015, BBA-BIOENERGETICS, V1847, P1424, DOI 10.1016/j.bbabio.2015.07.009
   Ubaida-Mohien C, 2019, ELIFE, V8, DOI 10.7554/eLife.49874
   Vanni S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15778-8
   Vi L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07666-0
   Voutetakis K, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/732914
   Walther DM, 2015, CELL, V161, P919, DOI 10.1016/j.cell.2015.03.032
   Wang WJ, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4257-6
   Wang YH, 2019, BBA-MOL BASIS DIS, V1865, P1853, DOI 10.1016/j.bbadis.2018.12.008
   Wang YL, 2018, AGING-US, V10, P606, DOI 10.18632/aging.101416
   Welle S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001385
   Xiang L, 2021, GENES DIS, DOI 10.1016/j.gendis.2021.02.008
   Ximerakis M, 2019, NAT NEUROSCI, V22, P1696, DOI 10.1038/s41593-019-0491-3
   Xiong J, 2020, HEPATOLOGY, V71, P1228, DOI 10.1002/hep.30921
   Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506
   Yates AD, 2020, NUCLEIC ACIDS RES, V48, pD682, DOI 10.1093/nar/gkz966
   Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Yu Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4230
   Yuan LS, 2017, GENOM DATA, V14, P132, DOI 10.1016/j.gdata.2017.10.006
   Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201
   Zhang MJ, 2021, ELIFE, V10, DOI 10.7554/eLife.62293
   Zhou QZ, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107694
   Zhou XC, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/6140728
NR 153
TC 6
Z9 7
U1 2
U2 9
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD JUL 31
PY 2021
VL 13
IS 14
BP 18150
EP 18190
PG 41
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA TT7NB
UT WOS:000680530300013
PM 34330884
OA gold, Green Submitted, Green Published
DA 2024-02-19
ER

PT J
AU Fielden, J
   Ruggiano, A
   Popovic, M
   Ramadan, K
AF Fielden, John
   Ruggiano, Annamaria
   Popovic, Marta
   Ramadan, Kristijan
TI DNA protein crosslink proteolysis repair: From yeast to premature ageing
   and cancer in humans
SO DNA REPAIR
LA English
DT Article
DE DNA-protein crosslinks; SPRTN protease; Post-translational modification;
   Genome stability; Ageing; Cancer
ID TOPOISOMERASE-I; PROTEASOMAL DEGRADATION; GENOMIC INSTABILITY; CLEAVAGE
   COMPLEXES; SUMO-1 CONJUGATION; DVC1 C1ORF124; REPLICATION; UBIQUITIN;
   SPARTAN/C1ORF124; TRANSCRIPTION
AB DNA-protein crosslinks (DPCs) are a specific type of DNA lesion consisting of a protein covalently and irreversibly bound to DNA, which arise after exposure to physical and chemical crosslinking agents. DPCs can be bulky and thereby pose a barrier to DNA replication and transcription. The persistence of DPCs during S phase causes DNA replication stress and genome instability. The toxicity of DPCs is exploited in cancer therapy: many common chemotherapeutics kill cancer cells by inducing DPC formation.
   Recent work from several laboratories discovered a specialized repair pathway for DPCs, namely DPC proteolysis (DPCP) repair. DPCP repair is carried out by replication-coupled DNA-dependent metalloproteases: Wss1 in yeast and SPRTN in metazoans. Mutations in SPRTN cause premature ageing and liver cancer in humans and mice; thus, defective DPC repair has great clinical ramifications. In the present review, we will revise the current knowledge on the mechanisms of DPCP repair and on the regulation of DPC protease activity, while highlighting the most significant unresolved questions in the field. Finally, we will discuss the impact of faulty DPC repair on disease and cancer therapy.
C1 [Fielden, John; Ruggiano, Annamaria; Ramadan, Kristijan] Univ Oxford, Canc Res UK, Roosevelt Dr, Oxford OX3 7DQ, England.
   [Fielden, John; Ruggiano, Annamaria; Ramadan, Kristijan] Univ Oxford, Med Res Council, Oxford Inst Radiat Oncol, Dept Oncol, Roosevelt Dr, Oxford OX3 7DQ, England.
   [Popovic, Marta] Rudjer Boskovic Inst, Bijenicka Cesta 54, Zagreb 10000, Croatia.
C3 Cancer Research UK; University of Oxford; University of Oxford; UK
   Research & Innovation (UKRI); Medical Research Council UK (MRC); Rudjer
   Boskovic Institute
RP Ramadan, K (corresponding author), Univ Oxford, Canc Res UK, Roosevelt Dr, Oxford OX3 7DQ, England.; Ramadan, K (corresponding author), Univ Oxford, Med Res Council, Oxford Inst Radiat Oncol, Dept Oncol, Roosevelt Dr, Oxford OX3 7DQ, England.
EM kristijan.ramadan@oncology.ox.ac.uk
RI Ruggiano, Annamaria/ABF-4337-2021
OI Ruggiano, Annamaria/0000-0003-4514-7922; Popovic,
   Marta/0000-0002-9464-5824; Fielden, John/0000-0002-9068-1844
FU Medical Council Research Programme [MC_EX_MR/K022830/1]; Cancer Research
   UK; EMBO LTF [ALTF 1109-2017]; Croatian Science Foundation installation
   grant [UIP-2017-05-5258]; MRC [MC_UU_00001/1, MC_EX_MR/K022830/1]
   Funding Source: UKRI
FX We thank a Medical Council Research Programme grant to K.R
   (MC_EX_MR/K022830/1) and a Cancer Research UK studentship to J.F. A.R.
   is supported by an EMBO LTF (ALTF 1109-2017). M.P is in part supported
   by the Croatian Science Foundation installation grant
   (UIP-2017-05-5258).
CR Alagoz M., 2013, PLOS ONE, V8, DOI DOI 10.1371/JOURNAL.PONE.0058239
   Aparicio T, 2016, J CELL BIOL, V212, P399, DOI 10.1083/jcb.201504005
   Arnold D, 2012, ONKOLOGIE, V35, P42, DOI 10.1159/000334821
   Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438
   Balakirev M. Y., 2015, ELIFE, P4
   Barker S, 2005, MUTAT RES-REV MUTAT, V589, P111, DOI 10.1016/j.mrrev.2004.11.003
   Canela A, 2017, CELL, V170, P507, DOI 10.1016/j.cell.2017.06.034
   Carmen M. A., 2016, ELIFE, P5
   Centore RC, 2012, MOL CELL, V46, P625, DOI 10.1016/j.molcel.2012.05.020
   Chaudhuri AR, 2012, NAT STRUCT MOL BIOL, V19, P417, DOI 10.1038/nsmb.2258
   Chválová K, 2007, NUCLEIC ACIDS RES, V35, P1812, DOI 10.1093/nar/gkm032
   Davis EJ, 2012, NAT STRUCT MOL BIOL, V19, P1093, DOI 10.1038/nsmb.2394
   Delabaere L, 2014, CURR BIOL, V24, P2281, DOI 10.1016/j.cub.2014.08.010
   Desai SD, 2003, MOL CELL BIOL, V23, P2341, DOI 10.1128/MCB.23.7.2341-2350.2003
   Deshpande RA, 2016, MOL CELL, V64, P593, DOI 10.1016/j.molcel.2016.10.010
   Duxin JP, 2014, CELL, V159, P346, DOI 10.1016/j.cell.2014.09.024
   El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314
   Gao R, 2014, J BIOL CHEM, V289, P17960, DOI 10.1074/jbc.M114.565374
   Ghosal G, 2012, J BIOL CHEM, V287, P34225, DOI 10.1074/jbc.M112.400135
   Gomez-Herreros F, 2014, NAT GENET, V46, P516, DOI 10.1038/ng.2929
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Heideker J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001320
   Hendriks IA, 2015, CELL REP
   Hendriks IA, 2017, NAT STRUCT MOL BIOL, V24, P325, DOI 10.1038/nsmb.3366
   Hendriks IA, 2014, NAT STRUCT MOL BIOL, V21, P927, DOI 10.1038/nsmb.2890
   Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991
   Huang SYN, 2011, EXPERT OPIN THER PAT, V21, P1285, DOI 10.1517/13543776.2011.604314
   Ide H., 2015, FORMATION REPAIR BIO
   Ide H, 2011, MUTAT RES-FUND MOL M, V711, P113, DOI 10.1016/j.mrfmmm.2010.12.007
   Interthal H, 2011, BIOCHEM J, V436, P559, DOI 10.1042/BJ20101841
   Juhasz S, 2012, NUCLEIC ACIDS RES, V40, P10795, DOI 10.1093/nar/gks850
   Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436
   Katyal S, 2014, NAT NEUROSCI, V17, P813, DOI 10.1038/nn.3715
   Lessel D, 2014, NAT GENET, V46, P1239, DOI 10.1038/ng.3103
   Lin CP, 2008, J BIOL CHEM, V283, P21074, DOI 10.1074/jbc.M803493200
   Liu CY, 2007, LUNG CANCER, V55, P303, DOI 10.1016/j.lungcan.2006.10.019
   Lopez-Mosqueda J, 2016, ELIFE, V5, DOI 10.7554/eLife.21491
   Machida Y, 2012, CELL CYCLE, V11, P3395, DOI 10.4161/cc.21694
   Mao Y, 2000, J BIOL CHEM, V275, P26066, DOI 10.1074/jbc.M001831200
   Mao Y, 2001, J BIOL CHEM, V276, P40652, DOI 10.1074/jbc.M104009200
   Mao Y, 2000, P NATL ACAD SCI USA, V97, P4046, DOI 10.1073/pnas.080536597
   Marchand C, 2016, ACS CHEM BIOL, V11, P1925, DOI 10.1021/acschembio.5b01047
   Maskey RS, 2017, NUCLEIC ACIDS RES, V45, P4564, DOI 10.1093/nar/gkx107
   Maskey RS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6744
   Ming X, 2017, CHEM RES TOXICOL, V30, P980, DOI 10.1021/acs.chemrestox.6b00389
   Mórocz M, 2017, NUCLEIC ACIDS RES, V45, P3172, DOI 10.1093/nar/gkw1315
   Mosbech A, 2012, NAT STRUCT MOL BIOL, V19, P1084, DOI 10.1038/nsmb.2395
   Munk S, 2017, CELL REP, V21, P546, DOI 10.1016/j.celrep.2017.09.059
   Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753
   Hoa NN, 2016, MOL CELL, V64, P580, DOI 10.1016/j.molcel.2016.10.011
   Nie MH, 2012, J BIOL CHEM, V287, P29610, DOI 10.1074/jbc.M112.379768
   Niimi A, 2008, P NATL ACAD SCI USA, V105, P16125, DOI 10.1073/pnas.0802727105
   Nitiss John L, 2002, Curr Opin Investig Drugs, V3, P1512
   OLEINICK N L, 1987, British Journal of Cancer, V55, P135
   Patel K, 2010, NUCLEIC ACIDS RES, V38, P4313, DOI 10.1093/nar/gkq187
   Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977
   Pommier Y, 2014, DNA REPAIR, V19, P114, DOI 10.1016/j.dnarep.2014.03.020
   Pommier Y, 2012, NAT REV DRUG DISCOV, V11, P25, DOI 10.1038/nrd3404
   Ramadan K, 2017, CHROMOSOMA, V126, P17, DOI 10.1007/s00412-016-0587-4
   Reardon JT, 2006, CELL CYCLE, V5, P1366, DOI 10.4161/cc.5.13.2892
   Schellenberg MJ, 2017, SCIENCE, V357, P1412, DOI 10.1126/science.aam6468
   Schmelz K, 2005, LEUKEMIA, V19, P103, DOI 10.1038/sj.leu.2403552
   Sczepanski JT, 2010, P NATL ACAD SCI USA, V107, P22475, DOI 10.1073/pnas.1012860108
   Sordet O, 2008, J MOL BIOL, V381, P540, DOI 10.1016/j.jmb.2008.06.028
   Stingele J, 2016, MOL CELL, V64, P688, DOI 10.1016/j.molcel.2016.09.031
   Stingele J, 2015, NAT REV MOL CELL BIO, V16, P455, DOI 10.1038/nrm4015
   Stingele J, 2015, TRENDS BIOCHEM SCI, V40, P67, DOI 10.1016/j.tibs.2014.10.012
   Stingele J, 2014, CELL, V158, P327, DOI 10.1016/j.cell.2014.04.053
   Szende B, 2010, CELL BIOL INT, V34, P1273, DOI 10.1042/CBI20100532
   Toth A, 2017, DNA REPAIR, V49, P33, DOI 10.1016/j.dnarep.2016.10.007
   Vaz B, 2017, TRENDS BIOCHEM SCI, V42, P483, DOI 10.1016/j.tibs.2017.03.005
   Vaz B, 2016, MOL CELL, V64, P704, DOI 10.1016/j.molcel.2016.09.032
   Wei Y, 2017, MOL CELL, V66, P581, DOI 10.1016/j.molcel.2017.04.017
   Yang XY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08834-w
   Zhang HF, 2004, CANCER RES, V64, P1114, DOI 10.1158/0008-5472.CAN-03-2858
NR 75
TC 39
Z9 45
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1568-7864
EI 1568-7856
J9 DNA REPAIR
JI DNA Repair
PD NOV
PY 2018
VL 71
SI SI
BP 198
EP 204
DI 10.1016/j.dnarep.2018.08.025
PG 7
WC Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Toxicology
GA HA0KH
UT WOS:000449896400024
PM 30170832
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU Thompson, RF
   Atzmon, G
   Gheorghe, C
   Liang, HQ
   Lowes, C
   Greally, JM
   Barzilai, N
AF Thompson, Reid F.
   Atzmon, Gil
   Gheorghe, Ciprian
   Liang, Hong Qian
   Lowes, Christina
   Greally, John M.
   Barzilai, Nir
TI Tissue-specific dysregulation of DNA methylation in aging
SO AGING CELL
LA English
DT Article
DE aging; DNA methylation; epigenetics; liver; tissue-specific; visceral
   adiposity
ID STEM-CELLS; INSULIN-RESISTANCE; GENE-EXPRESSION; CYTOSINE METHYLATION;
   INTRAABDOMINAL FAT; METABOLIC SYNDROME; MAJOR DETERMINANT;
   MASS-SPECTROMETRY; LIFE-SPAN; IN-VIVO
AB P>The normal aging process is a complex phenomenon associated with physiological alterations in the function of cells and organs over time. Although an attractive candidate for mediating transcriptional dysregulation, the contribution of epigenetic dysregulation to these progressive changes in cellular physiology remains unclear. In this study, we employed the genome-wide HpaII tiny fragment enrichment by ligation-mediated PCR assay to define patterns of cytosine methylation throughout the rat genome and the luminometric methylation analysis assay to measure global levels of DNA methylation in the same samples. We studied both liver and visceral adipose tissues and demonstrated significant differences in DNA methylation with age at > 5% of sites analyzed. Furthermore, we showed that epigenetic dysregulation with age is a highly tissue-dependent phenomenon. The most distinctive loci were located at intergenic sequences and conserved noncoding elements, and not at promoters nor at CG-dinucleotide-dense loci. Despite this, we found that there was a subset of genes at which cytosine methylation and gene expression changes were concordant. Finally, we demonstrated that changes in methylation occur consistently near genes that are involved in metabolism and metabolic regulation, implicating their potential role in the pathogenesis of age-related diseases. We conclude that different patterns of epigenetic dysregulation occur in each tissue over time and may cause some of the physiological changes associated with normal aging.
C1 [Thompson, Reid F.; Lowes, Christina; Greally, John M.; Barzilai, Nir] Albert Einstein Coll Med, Dept Genet Computat Genet, Bronx, NY 10461 USA.
   [Thompson, Reid F.; Greally, John M.] Albert Einstein Coll Med, Dept Med Hematol, Bronx, NY 10461 USA.
   [Atzmon, Gil; Liang, Hong Qian; Barzilai, Nir] Albert Einstein Coll Med, Dept Med Endocrinol, Bronx, NY 10461 USA.
   [Atzmon, Gil; Liang, Hong Qian; Barzilai, Nir] Albert Einstein Coll Med, Inst Aging Res, Bronx, NY 10461 USA.
   [Greally, John M.] Albert Einstein Coll Med, Ctr Epigenom, Bronx, NY 10461 USA.
   [Gheorghe, Ciprian] Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10461 USA.
C3 Yeshiva University; Albert Einstein College of Medicine; Yeshiva
   University; Albert Einstein College of Medicine; Yeshiva University;
   Albert Einstein College of Medicine; Yeshiva University; Albert Einstein
   College of Medicine; Yeshiva University; Albert Einstein College of
   Medicine; Yeshiva University; Albert Einstein College of Medicine
RP Greally, JM (corresponding author), Albert Einstein Coll Med, Dept Genet Computat Genet, 1301 Morris Pk Ave,Price 322, Bronx, NY 10461 USA.
EM john.greally@einstein.yu.eduNir; nir.barzilai@einstein.yu.edu
RI atzmon, gil/N-3967-2017; Greally, John/AAF-9540-2019
OI atzmon, gil/0000-0001-6895-3607; Greally, John/0000-0001-6069-7960;
   Thompson, Reid/0000-0003-3661-5296; Gheorghe,
   Ciprian/0000-0002-1918-3260
FU National Institutes of Health [AG21654, AG18381, HG004401, HD044078];
   Core laboratories of the Albert Einstein Diabetes Research and Training
   Center [DK 20541]; Einstein's Center for Epigenomics; NIA [T32]
FX This work was supported by grants from the National Institutes of Health
   (AG21654 and AG18381 to N.B., HG004401 and HD044078 to J.M.G.) and by
   the Core laboratories of the Albert Einstein Diabetes Research and
   Training Center (DK 20541) and by Einstein's Center for Epigenomics. The
   contributions of Dr. Shahina Maqbool and Gael Westby of the Einstein
   Epigenomics Shared Facility are gratefully acknowledged. R.F.T was
   supported by a NIA T32 training grant.
CR Ahuja N, 1998, CANCER RES, V58, P5489
   Akintola AD, 2008, AM J PHYSIOL-RENAL, V294, pF170, DOI 10.1152/ajprenal.00285.2007
   Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533
   Barbot W, 2002, NUCLEIC ACIDS RES, V30, P2365, DOI 10.1093/nar/30.11.2365
   Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515
   Barzilai N, 1998, J CLIN INVEST, V101, P1353, DOI 10.1172/JCI485
   BIRD A, 1985, CELL, V40, P91, DOI 10.1016/0092-8674(85)90312-5
   Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877
   Bollati V, 2009, MECH AGEING DEV, V130, P234, DOI 10.1016/j.mad.2008.12.003
   Busuttil RA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000876
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   Carr DB, 2004, DIABETES, V53, P2087, DOI 10.2337/diabetes.53.8.2087
   Chen JC, 2004, EXP HEMATOL, V32, P1025, DOI 10.1016/j.exphem.2004.08.001
   Chu MW, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-50
   de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174
   Duncan AW, 2009, GASTROENTEROLOGY, V137, P466, DOI 10.1053/j.gastro.2009.05.044
   DUNCAN SA, 1994, P NATL ACAD SCI USA, V91, P7598, DOI 10.1073/pnas.91.16.7598
   Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909
   Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102
   Einstein FH, 2008, FASEB J, V22, P3450, DOI 10.1096/fj.08-109041
   Fishman S, 2007, FASEB J, V21, P53, DOI 10.1096/fj.06-6557com
   Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102
   GARTNER K, 1990, LAB ANIM, V24, P71, DOI 10.1258/002367790780890347
   Glass JL, 2007, NUCLEIC ACIDS RES, V35, P6798, DOI 10.1093/nar/gkm489
   GOLBUS J, 1990, EUR J IMMUNOL, V20, P1869, DOI 10.1002/eji.1830200836
   Goyal R, 2006, NUCLEIC ACIDS RES, V34, P1182, DOI 10.1093/nar/gkl002
   Gurland BJ, 2004, J GERONTOL A-BIOL, V59, P859
   Hayashi T, 2003, DIABETES CARE, V26, P650, DOI 10.2337/diacare.26.3.650
   Hjelmborg JV, 2006, HUM GENET, V119, P312, DOI 10.1007/s00439-006-0144-y
   Huffman DM, 2009, BBA-GEN SUBJECTS, V1790, P1117, DOI 10.1016/j.bbagen.2009.01.008
   Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249
   JACKSON RA, 1988, DIABETES, V37, P119, DOI 10.2337/diabetes.37.1.119
   Jiang MH, 2008, DIABETOLOGIA, V51, P1525, DOI 10.1007/s00125-008-1034-8
   Johnson N.L., 1992, UNIVARIATE DISCRETE
   Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286
   Karasik D, 2004, J GERONTOL A-BIOL, V59, P218
   Karimi M, 2006, EXP CELL RES, V312, P1989, DOI 10.1016/j.yexcr.2006.03.006
   Kennedy ET, 2006, AM J CLIN NUTR, V83, p410S
   Khulan B, 2006, GENOME RES, V16, P1046, DOI 10.1101/gr.5273806
   Kwabi-Addo B, 2007, CLIN CANCER RES, V13, P3796, DOI 10.1158/1078-0432.CCR-07-0085
   Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029
   Maslov AY, 2009, BBA-GEN SUBJECTS, V1790, P963, DOI 10.1016/j.bbagen.2009.03.020
   Meulle A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003345
   Muzumdar R, 2008, AGING CELL, V7, P438, DOI 10.1111/j.1474-9726.2008.00391.x
   Neese RA, 2002, P NATL ACAD SCI USA, V99, P15345, DOI 10.1073/pnas.232551499
   Nieves DJ, 2003, DIABETES, V52, P172, DOI 10.2337/diabetes.52.1.172
   Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769
   Ordovas JM, 2008, J PERIODONTOL, V79, P1508, DOI 10.1902/jop.2008.080232
   Pelicci PG, 2004, J CLIN INVEST, V113, P4, DOI 10.1172/JCI200420750
   Peng H, 2001, BRIT J CANCER, V85, P930, DOI 10.1054/bjoc.2001.2000
   Rhee J, 2006, J BIOL CHEM, V281, P14683, DOI 10.1074/jbc.M512636200
   ROSSETTI L, 1990, J CLIN INVEST, V85, P1785, DOI 10.1172/JCI114636
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Sharpless NE, 2004, J CLIN INVEST, V113, P160, DOI 10.1172/JCI200420761
   Song F, 2005, P NATL ACAD SCI USA, V102, P3336, DOI 10.1073/pnas.0408436102
   Song F, 2009, GENOMICS, V93, P130, DOI 10.1016/j.ygeno.2008.09.003
   Szanto I, 2000, P NATL ACAD SCI USA, V97, P2355, DOI 10.1073/pnas.050580497
   Thompson RF, 2008, BIOINFORMATICS, V24, P1161, DOI 10.1093/bioinformatics/btn096
   Thompson RF, 2009, BIOINFORMATICS, V25, P2164, DOI 10.1093/bioinformatics/btp382
   Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498
   Van Zant G, 2003, EXP HEMATOL, V31, P659, DOI 10.1016/S0301-472X(03)00088-2
   Vilkaitis G, 2005, J BIOL CHEM, V280, P64, DOI 10.1074/jbc.M411126200
   Vogt G, 2008, J EXP BIOL, V211, P510, DOI 10.1242/jeb.008755
   Whitelaw NC, 2006, HUM MOL GENET, V15, pR131, DOI 10.1093/hmg/ddl200
   Yagi S, 2008, GENOME RES, V18, P1969, DOI 10.1101/gr.074070.107
   Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929
NR 66
TC 153
Z9 173
U1 0
U2 10
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1474-9718
J9 AGING CELL
JI Aging Cell
PD AUG
PY 2010
VL 9
IS 4
BP 506
EP 518
DI 10.1111/j.1474-9726.2010.00577.x
PG 13
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 629JZ
UT WOS:000280195100006
PM 20497131
OA Green Accepted, hybrid
DA 2024-02-19
ER

PT J
AU Kawahori, K
   Kondo, Y
   Yuan, XM
   Kawasaki, Y
   Hanzawa, N
   Tsujimoto, K
   Wada, F
   Kohda, T
   Ishigami, A
   Yamada, T
   Ogawa, Y
   Hashimoto, K
AF Kawahori, Kenichi
   Kondo, Yoshitaka
   Yuan, Xunmei
   Kawasaki, Yuki
   Hanzawa, Nozomi
   Tsujimoto, Kazutaka
   Wada, Fumiko
   Kohda, Takashi
   Ishigami, Akihito
   Yamada, Tetsuya
   Ogawa, Yoshihiro
   Hashimoto, Koshi
TI Ascorbic acid during the suckling period is required for proper DNA
   demethylation in the liver
SO SCIENTIFIC REPORTS
LA English
DT Article
ID VITAMIN-C-DEFICIENCY; MOUSE-LIVER; MICE; CARCINOMA; OXIDATION; PLASMA;
   SMP30; FETAL; CELL
AB Ascorbic acid (AA, vitamin C) serves as a cofactor for ten-eleven translocation (TET) enzymes and induces DNA demethylation in vitro. However, its role in DNA demethylation in vivo remains unclear. We previously reported that DNA demethylation in the mouse liver was enhanced during the suckling period. Therefore, we hypothesized that DNA demethylation is enhanced in an AA-dependent manner during the suckling period. To examine our hypothesis, we employed wild-type (WT) mice, which synthesize AA, and senescence marker protein-30/gluconolactonase (SMP30/GNL) knockout (KO) mice, which cannot synthesize AA, and analyzed the DNA methylation status in the livers of offspring in both the suckling period and adulthood. SMP30/GNL KO offspring showed DNA hypermethylation in the liver possibly due to low plasma and hepatic AA levels during the suckling period despite the administration of rescue-dose AA to dams. Furthermore, DNA hypermethylation of the fibroblast growth factor 21 gene (Fgf21), a PPAR alpha target gene, persisted into adulthood. In contrast, a high-dose AA administration to SMP30/GNL KO dams during the lactation period restored DNA demethylation in the livers of offspring. Even though a slight increase was observed in plasma AA levels with the administration of rescue-dose AA to WT dams during the gestation and lactation periods, DNA demethylation in the livers of offspring was minimally enhanced. The present results demonstrate that AA intake during the suckling period is required for proper DNA demethylation in the liver.
C1 [Kawahori, Kenichi; Yuan, Xunmei; Hanzawa, Nozomi; Tsujimoto, Kazutaka; Wada, Fumiko; Yamada, Tetsuya] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Endocrinol & Metab, Tokyo 1138510, Japan.
   [Kondo, Yoshitaka; Ishigami, Akihito] Tokyo Metropolitan Inst Gerontol, Mol Regulat Aging, Tokyo 1730015, Japan.
   [Kondo, Yoshitaka] Waseda Univ, Fac Human Sci, Biomed Gerontol Lab, Tokorozawa, Saitama 3591192, Japan.
   [Yuan, Xunmei; Ogawa, Yoshihiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol & Cellular Metab, Tokyo 1138510, Japan.
   [Kawasaki, Yuki; Kohda, Takashi] Tokyo Med & Dent Univ, Med Res Inst, Dept Epigenet, Bunkyo Ku, Tokyo 1138510, Japan.
   [Kohda, Takashi] Univ OfYamanashi, Fac Life & Environm Sci, Dept Biotechnol, Lab Embryol & Genom, Kofu, Yamanashi 4008510, Japan.
   [Ogawa, Yoshihiro] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.
   [Hashimoto, Koshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Preempt Med & Metab, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.
   [Hashimoto, Koshi] Dokkyo Med Univ, Saitama Med Ctr, Dept Diabet Endocrinol & Hematol, 2-1-50 Minami Koshigaya, Koshigaya, Saitama 3438555, Japan.
C3 Tokyo Medical & Dental University (TMDU); Tokyo Metropolitan Institute
   of Gerontology; Waseda University; Tokyo Medical & Dental University
   (TMDU); Tokyo Medical & Dental University (TMDU); Kyushu University;
   Tokyo Medical & Dental University (TMDU); Dokkyo Medical University
RP Ogawa, Y (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol & Cellular Metab, Tokyo 1138510, Japan.; Ogawa, Y (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.; Hashimoto, K (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Preempt Med & Metab, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.; Hashimoto, K (corresponding author), Dokkyo Med Univ, Saitama Med Ctr, Dept Diabet Endocrinol & Hematol, 2-1-50 Minami Koshigaya, Koshigaya, Saitama 3438555, Japan.
EM yogawa@med.kyushu-u.ac.jp; k-hashi@dokkyomed.ac.jp
RI Yoshitaka, Kondo/AFK-7721-2022; Kohda, Takashi/C-2879-2014
OI Yoshitaka, Kondo/0000-0002-0046-9429; Kohda,
   Takashi/0000-0002-6856-5601; Ogawa, Yoshihiro/0000-0002-0834-2836
FU Japan Society for the Promotion of Science (JSPS) [19K09018, 16H05331];
   Secom Science and Technology Foundation; Takeda Science Foundation;
   Mishima Kaiun Memorial Foundation; Grants-in-Aid for Scientific Research
   [16H05331, 19K09018] Funding Source: KAKEN
FX This work was supported in part by Grants-in-Aid for Scientific Research
   (KAKENHI) from the Japan Society for the Promotion of Science (JSPS)
   [grant Numbers 19K09018 (K.H.), 16H05331 (Y.O.)]; Secom Science and
   Technology Foundation (Y.O.); Takeda Science Foundation (K.H.); and
   Mishima Kaiun Memorial Foundation (K.H.).
CR Amano A, 2010, ARCH BIOCHEM BIOPHYS, V496, P38, DOI 10.1016/j.abb.2010.01.012
   Amenya HZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34989
   Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362
   Chen JK, 2013, NAT GENET, V45, P1504, DOI 10.1038/ng.2807
   Chung TL, 2010, STEM CELLS, V28, P1848, DOI 10.1002/stem.493
   DiTroia SP, 2019, NATURE, V573, P271, DOI 10.1038/s41586-019-1536-1
   Ehara T, 2015, DIABETES, V64, P775, DOI 10.2337/db14-0158
   Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001
   Gillberg L, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0739-5
   HA TY, 1990, J NUTR SCI VITAMINOL, V36, P227, DOI 10.3177/jnsv.36.227
   Hackett JA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0328
   Hansen SN, 2014, NUTRIENTS, V6, P3818, DOI 10.3390/nu6093818
   Hatada I, 2008, J HUM GENET, V53, P185, DOI 10.1007/s10038-007-0228-0
   Hill PWS, 2018, NATURE, V555, P392, DOI 10.1038/nature25964
   Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003
   Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   Ishigarni A, 2007, GERIATR GERONTOL INT, V7, P316, DOI 10.1111/j.1447-0594.2007.00420.x
   Iwama M, 2011, NUTRITION, V27, P471, DOI 10.1016/j.nut.2010.04.010
   Kishimoto Y, 2013, PEDIATR RES, V73, P578, DOI 10.1038/pr.2013.22
   Kobayashi Y, 2012, PEDIATR NEPHROL, V27, P2233, DOI 10.1007/s00467-012-2248-z
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294
   Maeda N, 2000, P NATL ACAD SCI USA, V97, P841, DOI 10.1073/pnas.97.2.841
   Maruyama N, 2010, GERIATR GERONTOL INT, V10, pS88, DOI 10.1111/j.1447-0594.2010.00586.x
   NISHIKIMI M, 1988, ARCH BIOCHEM BIOPHYS, V267, P842, DOI 10.1016/0003-9861(88)90093-8
   Pan X, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/861302
   Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589
   Sato Y, 2010, BIOL PHARM BULL, V33, P364, DOI 10.1248/bpb.33.364
   Schjoldager JG, 2015, EUR J NUTR, V54, P667, DOI 10.1007/s00394-014-0809-6
   Seisenberger S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0330
   Shorey-Kendrick LE, 2017, AM J RESP CRIT CARE, V196, P745, DOI 10.1164/rccm.201610-2141OC
   Starczak M, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1581-9
   Thomassin H, 2001, EMBO J, V20, P1974, DOI 10.1093/emboj/20.8.1974
   Yin RC, 2013, J AM CHEM SOC, V135, P10396, DOI 10.1021/ja4028346
   Yuan XM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03038-w
NR 36
TC 12
Z9 13
U1 0
U2 5
PU NATURE RESEARCH
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD DEC 4
PY 2020
VL 10
IS 1
AR 21228
DI 10.1038/s41598-020-77962-7
PG 13
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA PT8IA
UT WOS:000608853300014
PM 33277554
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Zhou, J
   Li, X
   Wang, YP
   Zhang, Y
   Jia, XS
   Fan, JM
   Zhang, QNA
   Hu, FD
   Li, W
AF Zhou, Jing
   Li, Xue
   Wang, Yanping
   Zhang, Yan
   Jia, Xusen
   Fan, Jingmin
   Zhang, Qiannian
   Hu, Fangdi
   Li, Wen
TI Interventional effect of <i>Codonopsis pilosula</i> oligosaccharides
   against D-galactose-induced aging in SD rats via suppression of
   oxidative stress, inflammation, and apoptosis
SO JOURNAL OF CARBOHYDRATE CHEMISTRY
LA English
DT Article; Early Access
DE C. pilosula oligosaccharide; aging; anti-oxidation; anti-inflammatory;
   anti-apoptosis
ID BRAIN; PREBIOTICS; PROTEIN; LIVER; CELL
AB Oligosaccharides are one of the major bioactive components in Codonopsis pilosula. The present study was to investigate the protective effect of C. pilosula oligosaccharides (CPO) on d-galactose (D-Gal)-induced aging and to illuminate the underlying mechanisms. The results indicated that CPO effectively increased the growth rate as indicated by body weight, attenuated the decline of thymus and liver indexes, and mitigated the pathological liver injury compared with model group rats. CPO could elevate the activities of anti-oxidative enzymes, including CAT, GSH-Px, and SOD, and reduce MDA level in serum, improve SOD and GSH-Px activities in liver, down-regulate the phosphorylation of MAPK cascade signal transduction components - ERK, JNK, and p38, and inhibit the activation of downstream NF-kappa B signaling. In addition, CPO treatment noticeably prevented the overexpression of inflammatory factors such as TNF-alpha, IL-6, and IL-1 beta in serum, inhibited the expression of apoptosis-related proteins caspase-3, caspase-9, and the ratio of Bax/Bcl-2 in liver caused by the inflammatory cascade, reduced cell apoptosis, and improved liver damage. The above studies suggested that CPO could effectively mitigate the D-Gal-induced aging, and the underlying mechanism might be closely related to ROS-induced oxidative stress, inflammation, and apoptosis.
C1 [Zhou, Jing; Li, Xue; Wang, Yanping; Jia, Xusen; Fan, Jingmin; Zhang, Qiannian; Hu, Fangdi; Li, Wen] Lanzhou Univ, Sch Pharm, 199 Dong Gang Rd West, Lanzhou 730000, Peoples R China.
   [Zhang, Yan] Dong EE Jiao Co Ltd, Natl Engn Res Ctr Gelatin Based Tradit Chinese Me, Liaocheng, Shandong, Peoples R China.
C3 Lanzhou University
RP Hu, FD; Li, W (corresponding author), Lanzhou Univ, Sch Pharm, 199 Dong Gang Rd West, Lanzhou 730000, Peoples R China.
EM hufd@lzu.edu.cn; lwen@lzu.edu.cn
RI Li, yu/HHZ-5236-2022
FU National Key Research and Development Program of China [2018YFC1706300,
   2018YFC1706306]; National Natural Science Foundation of China
   [81972018]; Key Research and Development Project of GanSu Province
   [20YF2FA019]; People's Livelihood Special Project from Technical
   Innovation Guide Plan of Gansu Province [20CX4FK014]; Talent Innovation
   and Entrepreneurship Project of Lanzhou [2017-RC115, 2020-RC41]; Key
   Project of the Fundamental Research Funds for the Central Universities
   [lzujbky-2020-sp13]
FX The authors acknowledge [the National Key Research and Development
   Program of China #1] under Grant [number 2018YFC1706300,
   2018YFC1706306]; [the National Natural Science Foundation of China #2]
   under Grant [number 81972018]; [the Key Research and Development Project
   of GanSu Province #3] under Grant [number 20YF2FA019]; [the People's
   Livelihood Special Project from Technical Innovation Guide Plan of Gansu
   Province #4] under Grant [number 20CX4FK014]; [the Talent Innovation and
   Entrepreneurship Project of Lanzhou #5] under Grant [number
   2017-RC115,2020-RC41]; and [the Key Project of the Fundamental Research
   Funds for the Central Universities #6] under Grant [number
   lzujbky-2020-sp13].
CR Aunan JR, 2016, BRIT J SURG, V103, pE29, DOI 10.1002/bjs.10053
   Azman KF, 2019, BIOGERONTOLOGY, V20, P763, DOI 10.1007/s10522-019-09837-y
   Bai RB, 2020, FOOD FUNCT, V11, P3306, DOI [10.1039/c9fo02969a, 10.1039/C9FO02969A]
   Bai RB, 2020, J FUNCT FOODS, V72, DOI 10.1016/j.jff.2020.104070
   Baynes JW, 2001, EXP GERONTOL, V36, P1527, DOI 10.1016/S0531-5565(01)00138-3
   Cai JG, 2017, PAK J PHARM SCI, V30, P1179
   Cebe T, 2014, EXP GERONTOL, V57, P132, DOI 10.1016/j.exger.2014.05.017
   Chen P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19732-0
   Chen WX, 2015, J CARBOHYD CHEM, V34, P475, DOI 10.1080/07328303.2015.1095924
   Çoban J, 2014, GERIATR GERONTOL INT, V14, P490, DOI 10.1111/ggi.12096
   Gambino V, 2013, AGING CELL, V12, P435, DOI 10.1111/acel.12060
   Gao JQ, 2018, CLIN INTERV AGING, V13, P1859, DOI 10.2147/CIA.S173838
   GARCIA I, 1992, SCIENCE, V258, P302, DOI 10.1126/science.1411528
   Haider S, 2015, LIFE SCI, V124, P110, DOI 10.1016/j.lfs.2015.01.016
   Hsia CH, 2012, BRIT J NUTR, V107, P1787, DOI 10.1017/S0007114511005150
   Hu F.D, 2020, CHIN TRAD PATENT MED, V42, P1001, DOI [10.3969/j.issn.1001-1528.2020.09.050, DOI 10.3969/J.ISSN.1001-1528.2020.09.050]
   Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682
   Kelly G, 2008, ALTERN MED REV, V13, P315
   Kim HI, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020620
   Kong SZ, 2018, MAR DRUGS, V16, DOI 10.3390/md16060181
   Liu C, 2015, INT IMMUNOPHARMACOL, V24, P299, DOI 10.1016/j.intimp.2014.12.023
   Meng Y, 2020, INT J BIOL MACROMOL, V163, P1677, DOI 10.1016/j.ijbiomac.2020.09.117
   Park MJ, 2016, J MICROBIOL BIOTECHN, V26, P1224, DOI 10.4014/jmb.1602.02049
   Parnell JA, 2009, AM J CLIN NUTR, V89, P1751, DOI 10.3945/ajcn.2009.27465
   Peng XY, 2014, INT DAIRY J, V34, P80, DOI 10.1016/j.idairyj.2013.08.004
   Ranaivo HR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-68
   Roberfroid M, 2007, J NUTR, V137, p830S, DOI 10.1093/jn/137.3.830S
   Roberfroid MB, 2007, J NUTR, V137, p2493S, DOI 10.1093/jn/137.11.2493S
   Sarikhani M, 2018, CELL DEATH DIFFER, V25, P1638, DOI 10.1038/s41418-018-0069-8
   Srikanth V, 2011, NEUROBIOL AGING, V32, P763, DOI 10.1016/j.neurobiolaging.2009.04.016
   Uddin MN, 2010, J IMMUNOTOXICOL, V7, P165, DOI 10.3109/15476910903510806
   Ullah F, 2015, NEUROCHEM INT, V90, P114, DOI 10.1016/j.neuint.2015.07.001
   Xu LQ, 2016, FOOD FUNCT, V7, P4545, DOI 10.1039/c6fo01057a
   Yanar K, 2011, BASIC CLIN PHARMACOL, V109, P423, DOI 10.1111/j.1742-7843.2011.00756.x
   Yen CH, 2017, NUTR NEUROSCI, V20, P228, DOI [10.1080/1028415x.2015.1110952, 10.1080/1028415X.2015.1110952]
   Yu T, 2017, AM J MED SCI, V353, P282, DOI 10.1016/j.amjms.2016.09.014
   Yu YH, 2015, PHARMACOL BIOCHEM BE, V133, P122, DOI 10.1016/j.pbb.2015.03.020
   Yu YH, 2015, MOL CELL BIOCHEM, V403, P287, DOI 10.1007/s11010-015-2358-6
   Zhang X, 2019, J ETHNOPHARMACOL, V234, P44, DOI 10.1016/j.jep.2018.12.050
   Zhu JH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0097616, 10.1371/journal.pone.0115507]
NR 40
TC 2
Z9 2
U1 2
U2 46
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0732-8303
EI 1532-2327
J9 J CARBOHYD CHEM
JI J. Carbohydr. Chem.
PD 2021 MAR 31
PY 2021
VL 40
IS 1-3
BP 115
EP 134
DI 10.1080/07328303.2021.1921786
EA JUN 2021
PG 20
WC Biochemistry & Molecular Biology; Chemistry, Organic
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA UD2LR
UT WOS:000662799200001
DA 2024-02-19
ER

PT J
AU Um, JH
   Kim, SJ
   Kim, DW
   Ha, MY
   Jang, JH
   Kim, DW
   Chung, BS
   Kang, CD
   Kim, SH
AF Um, JH
   Kim, SJ
   Kim, DW
   Ha, MY
   Jang, JH
   Kim, DW
   Chung, BS
   Kang, CD
   Kim, SH
TI Tissue-specific changes of DNA repair protein Ku and mtHSP70 in aging
   rats and their retardation by caloric restriction
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE aging; Ku70; tissue-specific expression; caloric restriction; mtHSP70
ID HEAT-SHOCK PROTEINS; GENE-EXPRESSION; OXIDATIVE STRESS; DOWN-REGULATION;
   AGE; LONGEVITY; APOPTOSIS; KINASE; CELLS; LOCALIZATION
AB To provide an improved understanding of the molecular basis of the aging process, it is necessary to measure biological age on a tissue-specific basis. The role of DNA damage has emerged as a significant mechanism for determination of life span, and DNA repair genes and stress-response genes are also implicated in the aging process. In the present study, we investigated the changes of DNA-PK activity, especially Ku activity, in the various tissues including kidney, lung, testis and liver during aging and its correlation with mtHSP70 expression. We showed that the modulation of Ku activity during the aging process was highly tissue-specific as shown with highly impaired Ku activity in testis and unaffected Ku activity in liver with age, and the level of Ku70 or Ku80 was differentially expressed in each aging tissue. We found also that age-associated alteration of Ku70/80 was prevented or not prevented by caloric restriction (CR) in a tissue-specific manner. Age-related decline in Ku70 during the aging process was associated with the increase of mtHSP70, which could play a role as a predictive marker for aging related to Ku regulation, and CR retarded aging-induced mtHSP70. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
C1 Pusan Natl Univ, Dept Biochem, Coll Med, Pusan 602739, South Korea.
   Chang Won Natl Univ, Dept Microbiol, Coll Nat Sci, Chang Won 641773, South Korea.
C3 Pusan National University; Changwon National University
RP Kim, SH (corresponding author), Pusan Natl Univ, Dept Biochem, Coll Med, Pusan 602739, South Korea.
EM ksh7738@pusan.ac.kr
CR Barja G, 2002, AGEING RES REV, V1, P397, DOI 10.1016/S1568-1637(02)00008-9
   BHATTACHARYYA T, 1995, J BIOL CHEM, V270, P1705, DOI 10.1074/jbc.270.4.1705
   Bree RT, 2002, BIOGERONTOLOGY, V3, P195, DOI 10.1023/A:1016299812327
   Chai WH, 2002, J BIOL CHEM, V277, P47242, DOI 10.1074/jbc.M208542200
   Concannon CG, 2003, APOPTOSIS, V8, P61, DOI 10.1023/A:1021601103096
   Fenech M, 1998, ANN NY ACAD SCI, V854, P23, DOI 10.1111/j.1749-6632.1998.tb09889.x
   Frasca D, 1999, EXP GERONTOL, V34, P645, DOI 10.1016/S0531-5565(99)00026-1
   Frasca D, 1998, MECH AGEING DEV, V100, P197, DOI 10.1016/S0047-6374(97)00137-1
   Gabai VL, 1998, FEBS LETT, V438, P1, DOI 10.1016/S0014-5793(98)01242-3
   Goldbaum O, 2001, J NEUROCHEM, V78, P1233, DOI 10.1046/j.1471-4159.2001.00507.x
   Gu YS, 1997, IMMUNITY, V7, P653, DOI 10.1016/S1074-7613(00)80386-6
   Han ES, 2000, MECH AGEING DEV, V115, P157, DOI 10.1016/S0047-6374(00)00119-6
   HATTORI M, 1990, DNA CELL BIOL, V9, P777, DOI 10.1089/dna.1990.9.777
   Heal RD, 1997, BBA-MOL CELL RES, V1357, P31, DOI 10.1016/S0167-4889(97)00009-8
   Heydari AR, 1996, DEV GENET, V18, P114, DOI 10.1002/(SICI)1520-6408(1996)18:2&lt;114::AID-DVG4&gt;3.0.CO;2-C
   IWASAKI K, 1988, J GERONTOL, V43, pB5, DOI 10.1093/geronj/43.1.B5
   Jeggo PA, 1997, MUTAT RES-DNA REPAIR, V384, P1, DOI 10.1016/S0921-8777(97)00009-8
   Kang HK, 1999, MOL CELLS, V9, P286
   Kaul SC, 2000, FEBS LETT, V474, P159, DOI 10.1016/S0014-5793(00)01594-5
   Kaul SC, 2002, EXP GERONTOL, V37, P1157, DOI 10.1016/S0531-5565(02)00135-3
   Kim SH, 1999, BIOCHEM BIOPH RES CO, V262, P516, DOI 10.1006/bbrc.1999.1229
   Kim SH, 1999, CANCER RES, V59, P4012
   Kirkwood TBL, 2002, J INHERIT METAB DIS, V25, P189, DOI 10.1023/A:1015625811569
   Knight JA, 2001, ADV CLIN CHEM, V35, P1, DOI 10.1016/S0065-2423(01)35014-X
   Knowlton AA, 1998, J MOL CELL CARDIOL, V30, P811, DOI 10.1006/jmcc.1998.0646
   Kritchevsky D, 2002, HYBRIDOMA HYBRIDOM, V21, P147, DOI 10.1089/153685902317401753
   Lansdorp PM, 2000, MECH AGEING DEV, V118, P23, DOI 10.1016/S0047-6374(00)00151-2
   Lee SH, 2002, MOL CELLS, V13, P159
   Lieber MR, 1999, GENES CELLS, V4, P77, DOI 10.1046/j.1365-2443.1999.00245.x
   MASSA SM, 1995, J NEUROSCI RES, V40, P807, DOI 10.1002/jnr.490400612
   MAYER PJ, 1991, ANN HUM BIOL, V18, P405, DOI 10.1080/03014469100001702
   Merry BJ, 2002, INT J BIOCHEM CELL B, V34, P1340, DOI 10.1016/S1357-2725(02)00038-9
   Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0
   Ouyang H, 1997, J EXP MED, V186, P921, DOI 10.1084/jem.186.6.921
   Pollack M, 2001, J GERONTOL A-BIOL, V56, pB475, DOI 10.1093/gerona/56.11.B475
   Raffoul J J, 1999, J Nutr Health Aging, V3, P102
   Ran QT, 2000, BIOCHEM BIOPH RES CO, V275, P174, DOI 10.1006/bbrc.2000.3237
   Salminen A, 1997, BIOCHEM BIOPH RES CO, V238, P712, DOI 10.1006/bbrc.1997.7371
   Shimada A, 2002, J GERONTOL A-BIOL, V57, pB415, DOI 10.1093/gerona/57.12.B415
   Söti C, 2002, NEUROCHEM INT, V41, P383, DOI 10.1016/S0197-0186(02)00043-8
   Syntin P, 2001, ENDOCRINOLOGY, V142, P5277, DOI 10.1210/en.142.12.5277
   UN JH, 2003, LEUKEMIA RES, V27, P509
   van den Bosch M, 2002, BIOL CHEM, V383, P873
   Vogel H, 1999, P NATL ACAD SCI USA, V96, P10770, DOI 10.1073/pnas.96.19.10770
   Volloch V, 1999, EXP CELL RES, V253, P483, DOI 10.1006/excr.1999.4682
   Wadhwa R, 2002, EXP CELL RES, V274, P246, DOI 10.1006/excr.2002.5468
   Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901
   Weindruch R, 2001, J NUTR, V131, p918S, DOI 10.1093/jn/131.3.918S
   Yokoyama K, 2002, FEBS LETT, V516, P53, DOI 10.1016/S0014-5793(02)02470-5
   YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657
   Zhang YP, 2002, EXP GERONTOL, V37, P777, DOI 10.1016/S0531-5565(02)00013-X
NR 51
TC 49
Z9 53
U1 0
U2 6
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD AUG-SEP
PY 2003
VL 124
IS 8-9
BP 967
EP 975
DI 10.1016/S0047-6374(03)00169-6
PG 9
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 728QF
UT WOS:000185727300015
PM 14499502
DA 2024-02-19
ER

PT J
AU Andert, A
   Alizai, HP
   Ulmer, TF
   Heidenhain, C
   Ziegler, P
   Brümmendorf, TH
   Neumann, UP
   Beier, F
   Klink, CD
AF Andert, Anne
   Alizai, Hamid P.
   Ulmer, Tom Florian
   Heidenhain, Christoph
   Ziegler, Patrick
   Bruemmendorf, Tim H.
   Neumann, Ulf Peter
   Beier, Fabian
   Klink, Christian D.
TI Influence of Telomere Length in Hepatocytes on Liver Regeneration after
   Partial Hepatectomy in Rats
SO EUROPEAN SURGICAL RESEARCH
LA English
DT Article
DE Liver surgery; Liver regeneration; Telomere length
ID CELLULAR SENESCENCE; OXIDATIVE STRESS; REDUCTION; DYNAMICS; DISEASE; AGE
AB Background: The aim of this study was to investigate telomere length in hepatocytes as a biomarker for liver regeneration after partial hepatectomy (PH) in rats. Materials and Methods: Sixty male Wistar rats underwent a 70% PH. One-month-old rats were assigned to group Y (n = 30) and 4-month-old rats were assigned to group O (n = 30). The rats were euthanized, and their livers were then harvested at postoperative day (POD) 1, 2, 3, 4, or 7. Telomere lengths and established parameters for liver regeneration (residual liver weight and levels of proliferating cell nuclear antigen [PCNA], Ki67, and interleukin [IL]-6) were measured. Results: We observed a significant increase in residual liver weight in group Y compared to that in group O (p = 0.001). The levels of Ki67 (p = 0.016), PCNA (p < 0.0001), and IL-6 (p < 0.001) were significantly higher in group Y. Furthermore, the rats in group Y had significantly earlier peak values of Ki67 and PCNA. Telomeres were significantly longer at the time of PH in group Y (p = 0.001). We showed a correlation between telomere length at the day of PH and liver regeneration. Animals with longer telomeres at the time of PH had better liver regeneration (p = 0.015). In group Y, animals with increased liver regeneration (median cut-off: >122%) did not show any significant difference in telomere length (p = 0.587) compared to rats with regular regeneration (< 122%). However, in the older animals, rats with increased regeneration had significantly longer telomeres (p = 0.019) than rats with regular regeneration. Conclusion: Telomere length in rat hepatocytes depends on age, and animals with long telomeres had earlier and better regeneration of healthy liver tissue than rats with short telomeres. Our data confirms that telomere length in rat hepatocytes could be used as a possible predictive marker for liver regeneration, and could help to identify older individuals with a high capacity for hepatic regeneration. (C) 2018 S. Karger AG, Basel
C1 [Andert, Anne; Alizai, Hamid P.; Ulmer, Tom Florian; Neumann, Ulf Peter; Klink, Christian D.] Uniklin RWTH Aachen, Dept Gen Visceral & Transplant Surg, Pauwelsstr 30, DE-52074 Aachen, Germany.
   [Ziegler, Patrick; Bruemmendorf, Tim H.; Beier, Fabian] Uniklin RWTH Aachen, Dept Hematol Oncol Hemostaseol & Stem Cell Transp, Aachen, Germany.
   [Ziegler, Patrick] Uniklin RWTH Aachen, Inst Occupat & Social Med, Aachen, Germany.
   [Heidenhain, Christoph] Sana Hosp Dusseldorf Gerresheim, Dept Gen & Visceral Surg, Dusseldorf, Germany.
C3 RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen
   University; RWTH Aachen University Hospital; RWTH Aachen University;
   RWTH Aachen University Hospital
RP Andert, A (corresponding author), Uniklin RWTH Aachen, Dept Gen Visceral & Transplant Surg, Pauwelsstr 30, DE-52074 Aachen, Germany.
EM aandert@ukaachen.de
FU START-Program of the Faculty of Medicine, RWTH Aachen
FX This research project was supported by the START-Program of the Faculty
   of Medicine, RWTH Aachen.
CR Aikata H, 2000, EXP CELL RES, V256, P578, DOI 10.1006/excr.2000.4862
   Baerlocher GM, 2006, NAT PROTOC, V1, P2365, DOI 10.1038/nprot.2006.263
   Bartsch F, 2015, VISZERALMEDIZIN, V31, P189, DOI 10.1159/000433482
   Beier F, 2015, LEUKEMIA RES, V39, P1292, DOI 10.1016/j.leukres.2015.09.003
   Beier F, 2015, J HEPATOL, V63, P446, DOI 10.1016/j.jhep.2015.03.022
   Belghiti J, 2000, J AM COLL SURGEONS, V191, P38, DOI 10.1016/S1072-7515(00)00261-1
   de Jesus BB, 2012, CIRC RES, V111, P97, DOI 10.1161/CIRCRESAHA.111.247866
   BEYER HS, 1991, J LAB CLIN MED, V117, P101
   Biondo-Simões Maria de Lourdes Pessole, 2006, Acta Cir. Bras., V21, P197, DOI 10.1590/S0102-86502006000400002
   Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656
   Brümmendorf TH, 2006, LEUKEMIA, V20, P1706, DOI 10.1038/sj.leu.2404339
   Cherif H, 2003, NUCLEIC ACIDS RES, V31, P1576, DOI 10.1093/nar/gkg208
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Drummond MW, 2007, STEM CELLS, V25, P1853, DOI 10.1634/stemcells.2007-0057
   Fukuda T, 2016, EXP ANIM TOKYO, V65, P135, DOI 10.1538/expanim.15-0082
   Gagliano N, 2007, DIGEST DIS, V25, P118, DOI 10.1159/000099475
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0
   Jara M, 2015, J SURG RES, V193, P184, DOI 10.1016/j.jss.2014.07.041
   KITADA T, 1995, BIOCHEM BIOPH RES CO, V211, P33, DOI 10.1006/bbrc.1995.1774
   Lang H, 2006, CHIRURG, V77, P325, DOI 10.1007/s00104-006-1177-4
   LINDSEY J, 1991, MUTAT RES, V256, P45, DOI 10.1016/0921-8734(91)90032-7
   Markus P, 2000, ONKOLOGE, V6, P348
   Martins PNA, 2008, MICROSURG, V28, P187, DOI 10.1002/micr.20478
   Sekoguchi S, 2007, J GASTROEN HEPATOL, V22, P182, DOI 10.1111/j.1440-1746.2006.04454.x
   Takubo K, 2000, J GERONTOL A-BIOL, V55, pB533, DOI 10.1093/gerona/55.11.B533
   TSUKAMOTO I, 1993, BIOCHEM MOL BIOL INT, V30, P773
   Urabe Y, 1996, LIVER, V16, P293
   von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2
   Weidner CI, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r24
   Werner B, 2015, ELIFE, V4, DOI 10.7554/eLife.08687
NR 31
TC 3
Z9 3
U1 1
U2 13
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0014-312X
EI 1421-9921
J9 EUR SURG RES
JI Eur. Surg. Res.
PY 2018
VL 59
IS 1-2
BP 83
EP 90
DI 10.1159/000489090
PG 8
WC Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery
GA GQ0WC
UT WOS:000441339600001
PM 29886505
DA 2024-02-19
ER

PT J
AU Derous, D
   Mitchell, SE
   Wang, L
   Green, CL
   Wang, YC
   Chen, LN
   Han, JDJ
   Promislow, DEL
   Lusseau, D
   Douglas, A
   Speakman, JR
AF Derous, Davina
   Mitchell, Sharon E.
   Wang, Lu
   Green, Cara L.
   Wang, Yingchun
   Chen, Luonan
   Han, Jing-Dong J.
   Promislow, Daniel E. L.
   Lusseau, David
   Douglas, Alex
   Speakman, John R.
TI The effects of graded levels of calorie restriction: XI. Evaluation of
   the main hypotheses underpinning the life extension effects of CR using
   the hepatic transcriptome
SO AGING-US
LA English
DT Article
DE aging; calorie restriction; gene expression; liver; transcriptomics
ID NF-KAPPA-B; SHORT-TERM CALORIE; OXIDATIVE DNA-DAMAGE;
   AGE-RELATED-CHANGES; CANCER STEM-CELLS; DIETARY RESTRICTION;
   GENE-EXPRESSION; PROTEIN RESTRICTION; HYDROGEN-SULFIDE; XENOBIOTIC
   METABOLISM
AB Calorie restriction (CR) may extend longevity by modulating the mechanisms involved in aging. Different hypotheses have been proposed for its main mode of action. We quantified hepatic transcripts of male C57BL/6 mice exposed to graded levels of CR (0% to 40% CR) for three months, and evaluated the responses relative to these various hypotheses. Of the four main signaling pathways implied to be linked to the impact of CR on lifespan (insulin/insulin like growth factor 1 (IGF-1), nuclear factor-kappa beta (NF-kappa B), mechanistic target of rapamycin (mTOR) and sirtuins (SIRTs)), all the pathways except SIRT were altered in a manner consistent with increased lifespan. However, the expression levels of SIRT4 and SIRT7 were decreased with increasing levels of CR. Changes consistent with altered fuel utilization under CR may reduce reactive oxygen species production, which was paralleled by reduced protection. Downregulated major urinary protein (MUP) transcription suggested reduced reproductive investment. Graded CR had a positive effect on autophagy and xenobiotic metabolism, and was protective with respect to cancer signaling. CR had no significant effect on fibroblast growth factor-21 (FGF21) transcription but affected transcription in the hydrogen sulfide production pathway. Responses to CR were consistent with several different hypotheses, and the benefits of CR on lifespan likely reflect the combined impact on multiple aging related processes.
C1 [Derous, Davina; Mitchell, Sharon E.; Green, Cara L.; Lusseau, David; Douglas, Alex; Speakman, John R.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland.
   [Derous, Davina; Douglas, Alex] Univ Aberdeen, Ctr Genome Enabled Biol & Med, Aberdeen, Scotland.
   [Wang, Lu; Wang, Yingchun; Speakman, John R.] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing, Peoples R China.
   [Chen, Luonan] Chinese Acad Sci, Shanghai Inst Biol Sci, Max Planck Partner Inst Computat Biol, Key Lab Computat Biol, Shanghai, Peoples R China.
   [Han, Jing-Dong J.] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Key Lab Syst Biol,Innovat Ctr Cell Signaling Netw, Shanghai, Peoples R China.
   [Promislow, Daniel E. L.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA.
   [Promislow, Daniel E. L.] Univ Washington, Dept Biol, Seattle, WA 98195 USA.
C3 University of Aberdeen; University of Aberdeen; Chinese Academy of
   Sciences; Institute of Genetics & Developmental Biology, CAS; Max Planck
   Society; Chinese Academy of Sciences; Chinese Academy of Sciences;
   Center for Excellence in Molecular Cell Science, CAS; University of
   Washington; University of Washington Seattle; University of Washington;
   University of Washington Seattle
RP Douglas, A; Speakman, JR (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland.; Douglas, A (corresponding author), Univ Aberdeen, Ctr Genome Enabled Biol & Med, Aberdeen, Scotland.; Speakman, JR (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing, Peoples R China.
EM a.douglas@abdn.ac.uk; j.speakman@abdn.ac.uk
RI Derous, Davina/AAH-4740-2020; Promislow, Daniel/AAF-3332-2019; Mitchell,
   Sharon/GYD-4854-2022; Lusseau, David/AAV-9295-2021; John, Speakman
   R/A-9494-2008
OI Derous, Davina/0000-0002-9041-4607; Lusseau, David/0000-0003-1245-3747;
   Douglas, Alex/0000-0001-6606-1058; Wang, Lu/0000-0002-1654-3259;
   Promislow, Daniel/0000-0001-7088-4495
FU UK Biotechnology and Biological Sciences Research Council BBSRC
   [BB/G009953/1, BB/J020028/1]; Centre for Genome Enabled Biology and
   Medicine, Aberdeen, UK; Office of Naval Research (ONR) [N000141512377];
   U.S. Department of Defense (DOD) [N000141512377] Funding Source: U.S.
   Department of Defense (DOD); BBSRC [BB/J020028/1, BB/G009953/1] Funding
   Source: UKRI; Biotechnology and Biological Sciences Research Council
   [BB/J020028/1] Funding Source: researchfish
FX The work was supported by the UK Biotechnology and Biological Sciences
   Research Council BBSRC (grants BB/G009953/1 and BB/J020028/1 to JRS and
   SEM) and a studentship of DD supported by the Centre for Genome Enabled
   Biology and Medicine, Aberdeen, UK. DL was supported by Office of Naval
   Research (ONR) grant N000141512377.
CR Adler AS, 2007, GENE DEV, V21, P3244, DOI 10.1101/gad.1588507
   Allen RG, 1997, J BIOL CHEM, V272, P24805, DOI 10.1074/jbc.272.40.24805
   Amador-Noguez D, 2004, AGING CELL, V3, P423, DOI 10.1111/j.1474-9728.2004.00125.x
   Amador-Noguez D, 2007, AGING CELL, V6, P453, DOI 10.1111/j.1474-9726.2007.00300.x
   AMES BN, 1995, BBA-MOL BASIS DIS, V1271, P165, DOI 10.1016/0925-4439(95)00024-X
   Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Argentino DP, 2005, J GERONTOL A-BIOL, V60, P28, DOI 10.1093/gerona/60.1.28
   Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002
   BERGER FG, 1981, BIOCHEM GENET, V19, P1261, DOI 10.1007/BF00484578
   Beynon RJ, 2004, PEPTIDES, V25, P1553, DOI 10.1016/j.peptides.2003.12.025
   Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010
   Blüher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   BREESE CR, 1991, J GERONTOL, V46, pB180, DOI 10.1093/geronj/46.5.B180
   Bross TG, 2005, AGING CELL, V4, P309, DOI 10.1111/j.1474-9726.2005.00181.x
   Burger JMS, 2010, AGING CELL, V9, P327, DOI 10.1111/j.1474-9726.2010.00560.x
   Burks DJ, 2000, NATURE, V407, P377, DOI 10.1038/35030105
   Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598
   Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200
   Choi SS, 2010, J BIOL CHEM, V285, P36551, DOI 10.1074/jbc.M110.168542
   Colman RJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4557
   Derous D, 2017, J GERONTOL A
   Derous D, 2016, AGING-US, V8, P917, DOI 10.18632/aging.100944
   Derous D, 2016, AGING-US, V8, P642, DOI 10.18632/aging.100895
   Duffy PH, 2004, AGING CLIN EXP RES, V16, P448, DOI 10.1007/BF03327400
   Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683
   Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x
   Fontana L, 2004, P NATL ACAD SCI USA, V101, P6659, DOI 10.1073/pnas.0308291101
   Fontana L, 2010, AGE, V32, P97, DOI 10.1007/s11357-009-9118-z
   Ford E, 2006, GENE DEV, V20, P1075, DOI 10.1101/gad.1399706
   Fromenty B, 2004, DIABETES METAB, V30, P121, DOI 10.1016/S1262-3636(07)70098-8
   Froy O, 2008, REJUV RES, V11, P467, DOI 10.1089/rej.2008.0669
   Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000
   Gems D, 2007, AGING CELL, V6, P421, DOI 10.1111/j.1474-9726.2007.00309.x
   Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633
   Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225
   Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219
   Giannakou ME, 2004, TRENDS CELL BIOL, V14, P408, DOI 10.1016/j.tcb.2004.07.006
   Gietzen DW, 2004, J NUTR, V134, P717, DOI 10.1093/jn/134.4.717
   Gredilla R, 2001, J BIOENERG BIOMEMBR, V33, P279, DOI 10.1023/A:1010603206190
   Green CL, 2017, AGING CELL, V16, P529, DOI 10.1111/acel.12570
   Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486
   Hagopian K, 2003, EXP GERONTOL, V38, P267, DOI 10.1016/S0531-5565(02)00202-4
   Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057
   Hara R, 2001, GENES CELLS, V6, P269, DOI 10.1046/j.1365-2443.2001.00419.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Hine C, 2015, CELL, V160, P132, DOI 10.1016/j.cell.2014.11.048
   Hirst J, 2008, BIOCHEM SOC T, V36, P976, DOI 10.1042/BST0360976
   HOLLAND R, 1985, FEBS LETT, V181, P308, DOI 10.1016/0014-5793(85)80282-9
   Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293
   Hu WW, 2007, NATURE, V450, P721, DOI 10.1038/nature05993
   Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255
   Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003
   Johnson RF, 2011, CANCER RES, V71, P5588, DOI 10.1158/0008-5472.CAN-10-4252
   Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861
   Kaaks R, 2001, P NUTR SOC, V60, P91, DOI 10.1079/PNS200070
   Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570
   Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815
   Katewa SD, 2011, EXP GERONTOL, V46, P382, DOI 10.1016/j.exger.2010.11.036
   Kawauchi K, 2008, NAT CELL BIOL, V10, P611, DOI 10.1038/ncb1724
   KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0
   Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980
   Kevork HA, 2004, EXP GERONTOL, V39, P1145, DOI 10.1016/j.exger.2004.04.009
   Kim HJ, 2002, MECH AGEING DEV, V123, P1589, DOI 10.1016/S0047-6374(02)00094-5
   Kim SS, 2016, MOL GENET GENOMICS, V291, P831, DOI 10.1007/s00438-015-1150-3
   Kimura H, 2011, AMINO ACIDS, V41, P113, DOI 10.1007/s00726-010-0510-x
   Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942
   Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282
   King PJ, 2008, J ENDOCRINOL, V198, P439, DOI 10.1677/JOE-08-0161
   KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0
   Koopman JJE, 2016, AGING-US, V8, P539, DOI 10.18632/aging.100919
   Kowald A, 2015, EXP GERONTOL, V71, P89, DOI 10.1016/j.exger.2015.08.006
   Kuhla A, 2014, J GERONTOL A-BIOL, V69, P915, DOI 10.1093/gerona/glt160
   Kuhla A, 2011, J GERONTOL A-BIOL, V66, P1192, DOI 10.1093/gerona/glr124
   Laeger T, 2014, J CLIN INVEST, V124, P3913, DOI 10.1172/JCI74915
   Lambert AJ, 2004, MECH AGEING DEV, V125, P529, DOI 10.1016/j.mad.2004.06.002
   Lambert AJ, 2004, EXP GERONTOL, V39, P289, DOI 10.1016/j.exger.2003.12.009
   Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Laurent G, 2013, MOL CELL, V50, P686, DOI 10.1016/j.molcel.2013.05.012
   Lee CC, 2006, CANCER CAUSE CONTROL, V17, P525, DOI 10.1007/s10552-005-9003-8
   Lee CH, 2010, CANCER RES, V70, P1564, DOI 10.1158/0008-5472.CAN-09-3228
   Lees EK, 2014, AGING CELL, V13, P817, DOI 10.1111/acel.12238
   Levine AJ, 2011, NAT REV MOL CELL BIO, V12, P259, DOI 10.1038/nrm3086
   Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]
   Longo VD, 2010, TRENDS PHARMACOL SCI, V31, P89, DOI 10.1016/j.tips.2009.11.004
   López-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6
   Lusseau D, 2015, SCI REP-UK, V5, DOI 10.1038/srep13198
   Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320
   Mattison JA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14063
   Mauro C, 2011, NAT CELL BIOL, V13, P1272, DOI 10.1038/ncb2324
   McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63
   McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200
   MEDVEDEV ZA, 1990, BIOL REV, V65, P375, DOI 10.1111/j.1469-185X.1990.tb01428.x
   Mercken EM, 2013, AGING CELL, V12, P645, DOI 10.1111/acel.12088
   Merry BJ, 2002, INT J BIOCHEM CELL B, V34, P1340, DOI 10.1016/S1357-2725(02)00038-9
   Meyer UA, 2007, DRUG METAB REV, V39, P639, DOI 10.1080/03602530701498737
   Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178
   Mitchell SJ, 2016, CELL METAB, V23, P1093, DOI 10.1016/j.cmet.2016.05.027
   Mitchell SE, 2017, ONCOTARGET, V8, P17453, DOI 10.18632/oncotarget.15294
   Mitchell SE, 2016, ONCOTARGET, V7, P19147, DOI 10.18632/oncotarget.8158
   Mitchell SE, 2015, ONCOTARGET, V6, P23213, DOI 10.18632/oncotarget.4003
   Mitchell SE, 2015, ONCOTARGET, V6, P18314, DOI 10.18632/oncotarget.4506
   Mitchell SE, 2015, ONCOTARGET, V6, P15902, DOI 10.18632/oncotarget.4142
   Moreau K, 2010, CURR OPIN CELL BIOL, V22, P206, DOI 10.1016/j.ceb.2009.12.002
   Mori K, 2007, TOXICOL PATHOL, V35, P242, DOI 10.1080/01926230601156286
   Morselli E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.8
   Mostoslavsky R, 2006, CELL, V124, P315, DOI [10.1016/j.cell.2005.11.044, 10.1016/J.CEL.2005.11.044]
   Musi N, 2014, CELLULAR ENDOCRINOLOGY IN HEALTH AND DISEASE, P229, DOI 10.1016/B978-0-12-408134-5.00014-7
   Nakagawa T, 2011, J CELL SCI, V124, P833, DOI 10.1242/jcs.081067
   Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200
   Nogueira LM, 2012, CANCER MED-US, V1, P275, DOI 10.1002/cam4.23
   Olgun A, 2002, EXP GERONTOL, V37, P639, DOI 10.1016/S0531-5565(02)00009-8
   Omiecinski CJ, 2011, TOXICOL SCI, V120, pS49, DOI 10.1093/toxsci/kfq338
   Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239
   Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488
   Park J, 2011, ENDOCR-RELAT CANCER, V18, pC25, DOI 10.1530/ERC-11-0163
   Patel P, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-10
   Pesta DH, 2015, AGING-US, V7, P1086, DOI 10.18632/aging.100854
   Robertson LT, 2015, J NUTR, V145, P1717, DOI 10.3945/jn.114.199380
   Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086
   Samad F, 1997, MOL MED, V3, P37, DOI 10.1007/BF03401666
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   Selman C, 2005, MECH AGEING DEV, V126, P783, DOI 10.1016/j.mad.2005.02.004
   Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com
   Selman C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016144
   Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221
   Shang ZX, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-23
   Sharp ZD, 2010, J GERONTOL A-BIOL, V65, P580, DOI 10.1093/gerona/glp212
   Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868
   Sliwowska JH, 2014, PHYSIOL BEHAV, V133, P197, DOI 10.1016/j.physbeh.2014.05.021
   Sohal RS, 2014, FREE RADICAL BIO MED, V73, P366, DOI 10.1016/j.freeradbiomed.2014.05.015
   Speakman JR, 2016, EXP GERONTOL, V86, P28, DOI 10.1016/j.exger.2016.03.011
   Speakman JR, 2007, J NUTR, V137, P1078, DOI 10.1093/jn/137.4.1078
   Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001
   Speakman JR, 2002, J NUTR, V132, p1583S, DOI 10.1093/jn/132.6.1583S
   Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007
   Steinbaugh MJ, 2012, AM J PHYSIOL-ENDOC M, V303, pE488, DOI 10.1152/ajpendo.00110.2012
   Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490
   Stone KP, 2014, DIABETES, V63, P3721, DOI 10.2337/db14-0464
   Takemori K, 2011, LIFE SCI, V88, P1088, DOI 10.1016/j.lfs.2011.04.002
   Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730
   Taylor P, 2010, BIOL RHYTHM RES, V33, P37
   Team RC, 2020, R: A Language and Environment for Statistical
   Tereshina E V, 2009, Adv Gerontol, V22, P129
   Tilstra JS, 2011, AGING DIS, V2, P449
   Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638
   Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120
   Tsai SY, 2016, CELL REP, V16, P1903, DOI 10.1016/j.celrep.2016.07.029
   Tsuchiya T, 2004, PHYSIOL GENOMICS, V17, P307, DOI 10.1152/physiolgenomics.00039.2004
   Tucci P, 2012, AGING-US, V4, P525, DOI 10.18632/aging.100481
   Turturro A, 2002, J GERONTOL A-BIOL, V57, pB379, DOI 10.1093/gerona/57.11.B379
   van Heemst D, 2010, AGING DIS, V1, P147
   Vazquez BN, 2017, NUCLEUS-PHILA, V8, P107, DOI 10.1080/19491034.2016.1264552
   Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a
   Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106
   Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007
   Whiteman M, 2006, BIOCHEM BIOPH RES CO, V343, P303, DOI 10.1016/j.bbrc.2006.02.154
   Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x
   Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147
   WOODHOUSE K, 1992, DRUG AGING, V2, P243, DOI 10.2165/00002512-199202030-00007
   Wronska A, 2016, GERONTOLOGY, V62, P304, DOI 10.1159/000441603
   Wyse CA, 2010, BIOL LETTERS, V6, P696, DOI 10.1098/rsbl.2010.0152
   Yang L, 2015, CELL REPORTS
   Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005
   Zhang Y, 2013, MOL CELL BIOL, V33, P1104, DOI 10.1128/MCB.01215-12
   Zhang Y, 2012, ELIFE, V1, DOI 10.7554/eLife.00065
   Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737
NR 171
TC 28
Z9 29
U1 0
U2 17
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD JUL
PY 2017
VL 9
IS 7
BP 1770
EP 1824
PG 55
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA FC7VI
UT WOS:000407050000011
PM 28768896
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Wang, X
   Chang, QY
   Wang, Y
   Su, F
   Zhang, SC
AF Wang, Xia
   Chang, Qingyun
   Wang, Yu
   Su, Feng
   Zhang, Shicui
TI Late-Onset Temperature Reduction Can Retard the Aging Process in Aged
   Fish Via a Combined Action of an Anti-Oxidant System and the
   Insulin/Insulin-Like Growth Factor 1 Signaling Pathway
SO REJUVENATION RESEARCH
LA English
DT Article
ID LIFE-SPAN; CAENORHABDITIS-ELEGANS; CALORIC RESTRICTION;
   AMBIENT-TEMPERATURE; LIPOFUSCIN PIGMENT; OXIDATIVE STRESS; MODEL SYSTEM;
   NOTHOBRANCHIUS; LONGEVITY; ACCUMULATION
AB Two different mechanisms are considered to be related to aging. Cumulative molecular damage caused by reactive oxygen species (ROS), the by-products of oxidative phosphorylation, is one of these mechanisms (ROS concept). Deregulated nutrient sensing by the insulin/insulin-like growth factor 1 (IGF-1) signaling (IIS) pathway is the second mechanism (IIS concept). Temperature reduction (TR) is known to modulate aging and prolong life span in a variety of organisms, but the mechanisms remain poorly defined. Here we first demonstrate that late-onset TR from 26 degrees C to 22 degrees C extends mean life span and maximum life span by approximately 5.2 and 3 weeks, respectively, in the annual fish Nothobranchius guentheri. We then show that TR is able to decrease the accumulation of the histological aging markers senescence-associated beta-galactosidase (SA-beta-Gal) in the epithelium and lipofuscin (LF) in the liver and to reduce protein oxidation and lipid peroxidation levels in the muscle. We also show that TR can enhance the activities of catalase, glutathione peroxidase, and superoxide dismutase, and stimulate the synthesis of SirT1 and FOXO3A/FOXO1A, both of which are the downstream regulators of the IIS pathway. Taken together, our findings suggest that late-onset TR, a simple non-intrusion intervention, can retard the aging process in aged fish, resulting in their life span extension, via a synergistic action of an anti-oxidant system and the IIS pathway. This also suggests that combined assessment of the ROS and IIS concepts will contribute to providing a more comprehensive view of the anti-aging process.
C1 [Wang, Xia; Chang, Qingyun; Wang, Yu; Zhang, Shicui] Ocean Univ China, Inst Evolut & Marine Biodivers, Lab Evolut & Dev, Qingdao 266003, Peoples R China.
   [Wang, Xia; Chang, Qingyun; Wang, Yu; Zhang, Shicui] Ocean Univ China, Dept Marine Biol, Qingdao 266003, Peoples R China.
   [Su, Feng] Qingdao Univ Sci & Technol, Inst Chem Engn, Qingdao, Peoples R China.
C3 Ocean University of China; Ocean University of China; Qingdao University
   of Science & Technology
RP Zhang, SC (corresponding author), Ocean Univ China, Inst Evolut & Marine Biodivers, Lab Evolut & Dev, Qingdao 266003, Peoples R China.
EM sczhang@ouc.edu.cn
FU Natural Science Foundation of China [31372505]; Ministry of Science and
   Technology of China [2012CB114404]
FX This work was in part supported by the grants of Natural Science
   Foundation of China (31372505) and Ministry of Science and Technology of
   China (2012CB114404).
CR Barzilai N, 2012, RAMBAM MAIMONIDES ME, V3, DOI 10.5041/RMMJ.10087
   Brunk UT, 2002, FREE RADICAL BIO MED, V33, P611, DOI 10.1016/S0891-5849(02)00959-0
   Collins JJ, 2006, EXP GERONTOL, V41, P1032, DOI 10.1016/j.exger.2006.06.038
   Cruzen C, 2009, CLIN GERIATR MED, V25, P733, DOI 10.1016/j.cger.2009.07.001
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539
   Garinis GA, 2008, NAT CELL BIOL, V10, P1241, DOI 10.1038/ncb1108-1241
   Genade T, 2005, AGING CELL, V4, P223, DOI 10.1111/j.1474-9726.2005.00165.x
   Gonsalves SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015934
   Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701
   Hsu CY, 2009, AGING CELL, V8, P726, DOI 10.1111/j.1474-9726.2009.00525.x
   Hsu CY, 2008, J GERONTOL A-BIOL, V63, P1267, DOI 10.1093/gerona/63.12.1267
   Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980
   Kim DH, 2006, MECH AGEING DEV, V127, P719, DOI 10.1016/j.mad.2006.05.002
   Kishi S, 2004, ANN NY ACAD SCI, V1019, P521, DOI 10.1196/annals.1297.097
   Kishi S, 2003, EXP GERONTOL, V38, P777, DOI 10.1016/S0531-5565(03)00108-6
   LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215
   Liu CS, 2012, BIOGERONTOLOGY, V13, P501, DOI 10.1007/s10522-012-9395-2
   LIU RK, 1975, J GERONTOL, V30, P129, DOI 10.1093/geronj/30.2.129
   LIU RK, 1966, NATURE, V212, P1277, DOI 10.1038/2121277a0
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   MANN DMA, 1978, J NEUROL SCI, V37, P83, DOI 10.1016/0022-510X(78)90229-0
   Mariño G, 2010, P NATL ACAD SCI USA, V107, P16268, DOI 10.1073/pnas.1002696107
   MARKOFSKY J, 1972, EXP GERONTOL, V7, P131, DOI 10.1016/0531-5565(72)90007-1
   Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432
   Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532
   Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016
   Okutan H, 2005, CLIN BIOCHEM, V38, P191, DOI 10.1016/j.clinbiochem.2004.10.003
   Olsen A, 2006, BIOGERONTOLOGY, V7, P221, DOI 10.1007/s10522-006-9018-x
   REICHEL W, 1968, J GERONTOL, V23, P71, DOI 10.1093/geronj/23.1.71
   Renner O, 2009, CURR MOL MED, V9, P612, DOI 10.2174/156652409788488766
   Sarup P, 2014, EXP GERONTOL, V50, P34, DOI 10.1016/j.exger.2013.11.017
   Schumacher B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000161
   Seo K, 2013, AGING CELL, V12, P1073, DOI 10.1111/acel.12140
   SOHAL RS, 1993, P NATL ACAD SCI USA, V90, P7255, DOI 10.1073/pnas.90.15.7255
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   SPITZ DR, 1989, ANAL BIOCHEM, V179, P8, DOI 10.1016/0003-2697(89)90192-9
   Strauss RE, 1999, GROWTH DEVELOP AGING, V63, P151
   Terzibasi E, 2007, EXP GERONTOL, V42, P81, DOI 10.1016/j.exger.2006.06.039
   URSINI F, 1985, BIOCHIM BIOPHYS ACTA, V839, P62, DOI 10.1016/0304-4165(85)90182-5
   Valenzano DR, 2006, AGING CELL, V5, P275, DOI 10.1111/j.1474-9726.2006.00212.x
   Walford RL, 1965, EXP GERONTOL, V1, P161, DOI 10.1016/0531-5565(65)90019-7
   WEST CD, 1979, J COMP NEUROL, V186, P109, DOI 10.1002/cne.901860108
   Zheng JY, 2005, AGING CELL, V4, P209, DOI 10.1111/j.1474-9726.2005.00159.x
NR 45
TC 15
Z9 16
U1 0
U2 20
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1549-1684
EI 1557-8577
J9 REJUV RES
JI Rejuv. Res.
PD DEC 1
PY 2014
VL 17
IS 6
BP 507
EP 517
DI 10.1089/rej.2014.1581
PG 11
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA AW6XF
UT WOS:000346408200006
PM 25298234
OA Green Published
DA 2024-02-19
ER

PT J
AU Benzi, A
   Spinelli, S
   Sturla, L
   Heine, M
   Fischer, AW
   Koch-Nolte, F
   Mittrücker, HW
   Guse, AH
   De Flora, A
   Heeren, J
   Bruzzone, S
AF Benzi, Andrea
   Spinelli, Sonia
   Sturla, Laura
   Heine, Markus
   Fischer, Alexander W.
   Koch-Nolte, Friedrich
   Mittruecker, Hans-Willi
   Guse, Andreas H.
   De Flora, Antonio
   Heeren, Joerg
   Bruzzone, Santina
TI Role of Liver CD38 in the Regulation of Metabolic Pathways during
   Cold-Induced Thermogenesis in Mice
SO CELLS
LA English
DT Article
DE CD38; NAD(P)(H); hepatic metabolism; thermogenesis; browning
ID ENZYME CD38; PROTEIN; GLUCONEOGENESIS; DYSFUNCTION; CONVERSION;
   INHIBITOR; COUPLES; SIRT3; ACID
AB Boosting NAD(+) levels are considered a promising means to promote healthy aging and ameliorate dysfunctional metabolism. The expression of CD38, the major NAD(+)-consuming enzyme, is downregulated during thermogenesis in both brown and white adipose tissues (BAT and WAT). Moreover, BAT activation and WAT "browning" were enhanced in Cd38(-/-) mice. In this study, the role of CD38 in the liver during thermogenesis was investigated, with the liver being the central organ controlling systemic energy metabolism. Wild-type mice and Cd38(-/-) mice were exposed to cold temperatures, and levels of metabolites and enzymes were measured in the livers and plasma. During cold exposure, CD38 expression was downregulated in the liver, as in BAT and WAT, with a concomitant increase in NAD(H) and a marked decrease in NADPH levels. Glucose-6-phosphate dehydrogenase and the malic enzyme, along with enzymes in the glycolytic pathway, were downregulated, which is in line with glucose-6-P being re-directed towards glucose release. In Cd38(-/-) mice, the cross-regulation between glycolysis and glucose release was lost, although this did not impair the glucose release from glycogen. Glycerol levels were decreased in the liver from Cd38(-/-) animals upon cold exposure, suggesting that glyceroneogenesis, as gluconeogenesis, was not properly activated in the absence of CD38. SIRT3 activity, regulating mitochondrial metabolism, was enhanced by cold exposure, whereas its activity was already high at a warm temperature in Cd38(-/-) mice and was not further increased by the cold. Notably, FGF21 and bile acid release was enhanced in the liver of Cd38(-/-) mice, which might contribute to enhanced BAT activation in Cd38(-/-) mice. These results demonstrate that CD38 inhibition can be suggested as a strategy to boost NAD(+) and would not negatively affect hepatic functions during thermogenesis.
C1 [Benzi, Andrea; Spinelli, Sonia; Sturla, Laura; De Flora, Antonio; Bruzzone, Santina] Univ Genoa, Sect Biochem, DIMES, I-16132 Genoa, Italy.
   [Heine, Markus; Fischer, Alexander W.; Guse, Andreas H.; Heeren, Joerg] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Cell Biol, D-20246 Hamburg, Germany.
   [Koch-Nolte, Friedrich; Mittruecker, Hans-Willi] Univ Med Ctr Hamburg Eppendorf, Inst Immunol, D-20246 Hamburg, Germany.
C3 University of Genoa; University of Hamburg; University Medical Center
   Hamburg-Eppendorf; University of Hamburg; University Medical Center
   Hamburg-Eppendorf
RP Bruzzone, S (corresponding author), Univ Genoa, Sect Biochem, DIMES, I-16132 Genoa, Italy.; Heeren, J (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Cell Biol, D-20246 Hamburg, Germany.
EM heeren@uke.de; santina.bruzzone@unige.it
RI ; Bruzzone, Santina/A-4264-2015
OI Koch-Nolte, Friedrich/0000-0003-1730-6674; Heeren,
   Joerg/0000-0002-5647-1034; Fischer, Alexander/0000-0001-6717-9090;
   Spinelli, Sonia/0000-0001-9847-4308; Bruzzone,
   Santina/0000-0003-2034-3716
FU DFG; Faculty Research Visit Grant from the DAAD (German Academic
   Exchange Service) for this project [335447727 - SFB 1328]; University of
   Genova; Italian Ministry of Education, University and Research;
   Compagnia di San Paolo [PRIN2017Z5LR5Z_003]
FX F.K.-N., H.-W.M., A.H.G., and J.H. were supported by DFG grants
   (project-ID: 335447727 - SFB 1328). S.B. was granted by a Faculty
   Research Visit Grant from the DAAD (German Academic Exchange Service)
   for this project. S.B. was also supported by the University of Genova,
   by the Italian Ministry of Education, University and Research
   (PRIN2017Z5LR5Z_003), and by Compagnia di San Paolo.
CR Abumrad NA, 2017, CELL METAB, V26, P454, DOI 10.1016/j.cmet.2017.08.018
   Ameka M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37198-y
   Barbosa MTP, 2007, FASEB J, V21, P3629, DOI 10.1096/fj.07-8290com
   Benzi A, 2021, NUTRIENTS, V13, DOI 10.3390/nu13113734
   Benzi A, 2021, BBA-MOL CELL BIOL L, V1866, DOI 10.1016/j.bbalip.2020.158819
   Braidy N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019194
   Camacho-Pereira J, 2016, CELL METAB, V23, P1127, DOI 10.1016/j.cmet.2016.05.006
   Chang SH, 2019, OBES REV, V20, P241, DOI 10.1111/obr.12796
   Chini CCS, 2020, NAT METAB, V2, DOI 10.1038/s42255-020-00298-z
   Chini EN, 2018, TRENDS PHARMACOL SCI, V39, P424, DOI 10.1016/j.tips.2018.02.001
   Cosker F, 2010, J BIOL CHEM, V285, P38251, DOI 10.1074/jbc.M110.125864
   Deaglio S, 2011, ADV PHARMACOL, V61, P301, DOI 10.1016/B978-0-12-385526-8.00010-2
   Deshpande DA, 2017, PHARMACOL THERAPEUT, V172, P116, DOI 10.1016/j.pharmthera.2016.12.002
   Escande C, 2013, DIABETES, V62, P1084, DOI 10.2337/db12-1139
   Fliegert R, 2017, NAT CHEM BIOL, V13, P1036, DOI [10.1038/NCHEMBIO.2415, 10.1038/nchembio.2415]
   Grefhorst A, 2018, J ENDOCRINOL, V238, P91, DOI 10.1530/JOE-18-0076
   Grozio A, 2013, J BIOL CHEM, V288, P25938, DOI 10.1074/jbc.M113.470435
   Heine M, 2018, CELL METAB, V28, P644, DOI 10.1016/j.cmet.2018.06.020
   Higgins CB, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28717-7
   Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791
   Kim SY, 2010, J BIOL CHEM, V285, P576, DOI 10.1074/jbc.M109.076216
   Lan T, 2017, CELL METAB, V26, P709, DOI 10.1016/j.cmet.2017.09.005
   Lee HC, 1997, ADV EXP MED BIOL, V419, P411
   Li Y, 2022, AGING DIS, V13, P1239, DOI 10.14336/AD.2022.0318
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Morandi F, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121527
   Navas LE, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-020-00354-w
   Pham TX, 2019, BBA-MOL BASIS DIS, V1865, P2451, DOI 10.1016/j.bbadis.2019.06.009
   Radenkovic D, 2020, PHARMACEUTICALS-BASE, V13, DOI 10.3390/ph13090247
   Rah SY, 2017, FASEB J, V31, P3126, DOI 10.1096/fj.201601290R
   Rah SY, 2015, SCI REP-UK, V5, DOI 10.1038/srep10741
   Rajman L, 2018, CELL METAB, V27, P529, DOI 10.1016/j.cmet.2018.02.011
   Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024
   Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200
   Simcox J, 2017, CELL METAB, V26, P509, DOI 10.1016/j.cmet.2017.08.006
   SISTARE FD, 1985, J BIOL CHEM, V260, P2748
   Sociali G, 2019, FASEB J, V33, P3704, DOI 10.1096/fj.201800321R
   Stromland O, 2021, MECH AGEING DEV, V199, DOI 10.1016/j.mad.2021.111569
   Sturla L, 2009, J BIOL CHEM, V284, P28045, DOI 10.1074/jbc.M109.035329
   Tarrago MG, 2018, CELL METAB, V27, P1081, DOI 10.1016/j.cmet.2018.03.016
   TOEWS CJ, 1970, J BIOL CHEM, V245, P818
   van de Donk NWCJ, 2018, BLOOD, V131, P13, DOI 10.1182/blood-2017-06-740944
   Wei XJ, 2020, FEBS LETT, V594, P1711, DOI 10.1002/1873-3468.13779
   Worthmann A, 2017, NAT MED, V23, P839, DOI 10.1038/nm.4357
   Xiao WS, 2018, ANTIOXID REDOX SIGN, V28, P251, DOI 10.1089/ars.2017.7216
   Xie L, 2021, INT J BIOL SCI, V17, P4305, DOI 10.7150/ijbs.65588
   Yang Y, 2020, NAT METAB, V2, P364, DOI 10.1038/s42255-020-0194-9
   Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014
   Yoshino M, 2021, SCIENCE, V372, P1224, DOI 10.1126/science.abe9985
   Zapata-Pérez R, 2021, FASEB J, V35, DOI 10.1096/fj.202001826R
   Zélicourt A, 2022, EMBO MOL MED, V14, DOI 10.15252/emmm.202012860
   Zuo WY, 2021, CARDIOVASC DRUG THER, V35, P815, DOI 10.1007/s10557-020-07007-8
NR 52
TC 0
Z9 0
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD DEC
PY 2022
VL 11
IS 23
AR 3812
DI 10.3390/cells11233812
PG 19
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 6Y8SG
UT WOS:000897357500001
PM 36497069
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU SAITO, K
   KANEKO, H
   SATO, K
   YOSHITAKE, A
   YAMADA, H
AF SAITO, K
   KANEKO, H
   SATO, K
   YOSHITAKE, A
   YAMADA, H
TI AGE-RELATED-CHANGES IN METABOLISM OF DIETHOFENCARB - RELATIONSHIP
   BETWEEN METABOLISM IN RAT AND HEPATIC DRUG-METABOLIZING
   ENZYME-ACTIVITIES
SO XENOBIOTICA
LA English
DT Article
ID MODEL-COMPOUND; CONJUGATION; DISPOSITION
AB 1.  Age-related changes in metabolism of diethofencarb (DFC) (isopropyl-1,4-diethoxycarbanilate) and hepatic drug-metabolizing enzyme activities were studied in male Sprague-Dawley rats aged 2, 8, 16 and 21 months.
   2.  Following a single oral dose of C-14-DFC (500 mg/kg), the major route of elimination of the C-14 for 7 days was urine (85.6-97.8%) at all ages.
   3.  Analysis of urinary metabolites showed that deethylation of C-14-DFC was constant for all age groups; however, sulphation and acetylation significantly decreased, and glucuronidation increased, with age.
   4.  Hepatic PAPS-sulphotransferase  and acetyl-CoA:N-acetyltransferase in DFC metabolism significantly decreased with age, whereas no significant effects of ageing on O-deethylase and UDP-glucuronyltransferase were observed.
   5.  Results show that age-related differences in the ratios of urinary metabolites of DFC resulted to some extent from changes in the hepatic drug-metabolizing enzyme activities.
RP SAITO, K (corresponding author), SUMITOMO CHEM CO LTD,ENVIRONM HLTH SCI LAB,1-98,3-CHOME KASUGADE NAKA,KONOHANA KU,OSAKA 544,JAPAN.
OI Saito, Koichi/0000-0001-6497-5286
CR ANDRES HH, 1985, ANAL BIOCHEM, V145, P367, DOI 10.1016/0003-2697(85)90376-8
   [Anonymous], ENZYMATIC BASIS DETO
   BORGHOFF SJ, 1988, TOXICOL APPL PHARM, V92, P453, DOI 10.1016/0041-008X(88)90185-8
   BORGHOFF SJ, 1986, DRUG METAB DISPOS, V14, P417
   BORGHOFF SJ, 1984, DRUG METAB DISPOS, V13, P62
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CHENGELIS CP, 1988, XENOBIOTICA, V18, P1225, DOI 10.3109/00498258809042246
   CHENGELIS CP, 1988, XENOBIOTICA, V18, P1211, DOI 10.3109/00498258809042245
   GALINSKI RE, 1986, J PHARM EXPT THERAPE, V237, P2107
   HODGSON E, 1987, TXB MODERN TOXICOLOG, P51
   IWASAKI K, 1986, XENOBIOTICA, V16, P651, DOI 10.3109/00498258609043555
   JACKSON MR, 1988, MOL PHARMACOL, V34, P638
   JAKOBY WB, 1980, ENZYMATIC BASIS DETO, V2, P199
   KANEKO H, 1987, J PESTIC SCI, V12, P385
   KATO R, 1964, BIOCHEM PHARMACOL, V13, P1037, DOI 10.1016/0006-2952(64)90100-5
   Lake B. G., 1987, BIOCH TOXICOLOGY PRA, P183
   MCMAHON TF, 1989, DRUG METAB DISPOS, V17, P506
   RIKANS LE, 1989, DRUG METAB REV, V20, P87, DOI 10.3109/03602538908994145
   RIKANS LE, 1984, TOXICOL APPL PHARM, V73, P243, DOI 10.1016/0041-008X(84)90329-6
   RIKANS LE, 1982, BIOCHEM PHARMACOL, V31, P2339, DOI 10.1016/0006-2952(82)90527-5
   Schmucker D. L., 1979, PHARMACOL REV, V30, P445
   SCHMUCKER DL, 1985, PHARMACOL REV, V37, P133
   SEKURA RD, 1979, J BIOL CHEM, V254, P5658
   SHIBA K, 1990, J PESTIC SCI, V15, P395
   SPEARMAN ME, 1984, BIOCHEM PHARMACOL, V33, P1309, DOI 10.1016/0006-2952(84)90185-0
   SWEENY DJ, 1985, DRUG METAB DISPOS, V13, P377
   TIMBRELL JA, 1982, PRINCIPLES BIOCH TOX, P48
   WEBER WW, 1980, ENZYMATIC BASIS DETO, V2, P169
NR 28
TC 20
Z9 20
U1 0
U2 1
PU TAYLOR & FRANCIS LTD
PI LONDON
PA ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE
SN 0049-8254
J9 XENOBIOTICA
JI Xenobiotica
PD MAY
PY 1991
VL 21
IS 5
BP 575
EP 582
DI 10.3109/00498259109039497
PG 8
WC Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Toxicology
GA FQ382
UT WOS:A1991FQ38200003
PM 1949890
DA 2024-02-19
ER

PT J
AU Schifano, E
   Conta, G
   Preziosi, A
   Ferrante, C
   Batignani, G
   Mancini, P
   Tomassini, A
   Sciubba, F
   Scopigno, T
   Uccelletti, D
   Miccheli, A
AF Schifano, Emily
   Conta, Giorgia
   Preziosi, Adele
   Ferrante, Carino
   Batignani, Giovanni
   Mancini, Patrizia
   Tomassini, Alberta
   Sciubba, Fabio
   Scopigno, Tullio
   Uccelletti, Daniela
   Miccheli, Alfredo
TI 2-hydroxyisobutyric acid (2-HIBA) modulates ageing and fat deposition
   in<i> Caenorhabditis</i> elegans
SO FRONTIERS IN MOLECULAR BIOSCIENCES
LA English
DT Article
DE 2-hydroxyisobutyric acid; Caenorhabditis elegans; ageing; lipid
   metabolism; oxidative stress; high-glucose diet; metabolomics; CARS
ID LIPID DROPLETS; LIFE-SPAN; URINE; MODEL; METABOLOMICS; METABOLISM; BLOOD
AB High levels of 2-hydroxyisobutyric acid (2-HIBA) were found in urines of patients with obesity and hepatic steatosis, suggesting a potential involvement of this metabolite in clinical conditions. The gut microbial origin of 2-HIBA was hypothesized, however its actual origin and role in biological processes are still not clear. We investigated how treatment with 2-HIBA affected the physiology of the model organism Caenorhabditis elegans, in both standard and high-glucose diet (HGD) growth conditions, by targeted transcriptomic and metabolomic analyses, Coherent Anti-Stokes Raman Scattering (CARS) and two-photon fluorescence microscopy. In standard conditions, 2-HIBA resulted particularly effective to extend the lifespan, delay ageing processes and stimulate the oxidative stress resistance in wild type nematodes through the activation of insulin/IGF-1 signaling (IIS) and p38 MAPK pathways and, consequently, through a reduction of ROS levels. Moreover, variations of lipid accumulation observed in treated worms correlated with transcriptional levels of fatty acid synthesis genes and with the involvement of peptide transporter PEP-2. In HGD conditions, the effect of 2-HIBA on C. elegans resulted in a reduction of the lipid droplets deposition, accordingly with an increase of acs-2 gene transcription, involved in beta-oxidation processes. In addition, the pro-longevity effect appeared to be correlated to higher levels of tryptophan, which may play a role in restoring the decreased viability observed in the HGD untreated nematodes.
C1 [Schifano, Emily; Preziosi, Adele; Uccelletti, Daniela] Sapienza Univ Rome, Dept Biol & Biotechnol C Darwin, Rome, Italy.
   [Conta, Giorgia; Tomassini, Alberta; Sciubba, Fabio; Miccheli, Alfredo] Sapienza Univ Rome, Dept Environm Biol, Rome, Italy.
   [Conta, Giorgia; Tomassini, Alberta; Sciubba, Fabio; Miccheli, Alfredo] Sapienza Univ Rome, NMR based Metabol Lab Sapienza NMLab, Rome, Italy.
   [Ferrante, Carino; Batignani, Giovanni; Scopigno, Tullio] Sapienza Univ Rome, Dept Phys, Rome, Italy.
   [Ferrante, Carino; Batignani, Giovanni; Scopigno, Tullio] Ist Italiano Tecnol, Ctr Life Nano & Neurosci, Rome, Italy.
   [Mancini, Patrizia] Sapienza Univ Rome, Dept Expt Med, Rome, Italy.
C3 Sapienza University Rome; Sapienza University Rome; Sapienza University
   Rome; Sapienza University Rome; Istituto Italiano di Tecnologia - IIT;
   Sapienza University Rome
RP Uccelletti, D (corresponding author), Sapienza Univ Rome, Dept Biol & Biotechnol C Darwin, Rome, Italy.
EM daniela.uccelletti@uniroma1.it
RI Batignani, Giovanni/AES-4394-2022; Schifano, Emily/IUM-4443-2023
OI FERRANTE, CARINO/0000-0002-6391-0672
FU European Union's Horizon 2020 research and innovation programme Graphene
   Flagship; Regione Lazio (SIMBA);  [881603];  [36389]
FX TS acknowledges the support from the European Union's Horizon 2020
   research and innovation programme Graphene Flagship under grant
   agreement No 881603 and from Regione Lazio (SIMBA, No 36389).
CR Alcántar-Fernández J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226652
   Alcántar-Fernández J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199888
   Amin AM, 2021, ADV CLIN CHEM, V102, P233, DOI 10.1016/bs.acc.2020.08.003
   Arneth B, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102467
   Baumeister R, 2006, J ENDOCRINOL, V190, P191, DOI 10.1677/joe.1.06856
   Bianchi L, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10010157
   Calvani R, 2010, INT J OBESITY, V34, P1095, DOI 10.1038/ijo.2010.44
   Coleman RA, 2002, J NUTR, V132, P2123, DOI 10.1093/jn/132.8.2123
   Conta G, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.688440
   Diaz SO, 2011, J PROTEOME RES, V10, P3732, DOI 10.1021/pr200352m
   Edwards C, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0167-2
   Elliott P, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5680
   Geier FM, 2011, ANAL CHEM, V83, P3730, DOI 10.1021/ac2001109
   Gil AM, 2018, J PROTEOME RES, V17, P1278, DOI 10.1021/acs.jproteome.7b00878
   Guantario B, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00595
   Guerra JVS, 2021, NUTRIENTS, V13, DOI 10.3390/nu13082830
   Hofer P, 2020, METABOLITES, V10, DOI 10.3390/metabo10040147
   Irwin C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24128-1
   Lee GD, 2006, AGING CELL, V5, P515, DOI 10.1111/j.1474-9726.2006.00241.x
   Lee J, 2015, SCI REP-UK, V5, DOI 10.1038/srep17128
   Li SW, 2016, G3-GENES GENOM GENET, V6, P2407, DOI 10.1534/g3.116.030866
   Li YY, 2017, FRONT CHEM, V5, DOI 10.3389/fchem.2017.00054
   Markaki M, 2020, CURR OPIN BIOTECH, V63, P118, DOI 10.1016/j.copbio.2019.12.011
   Marrocco F, 2022, COMMUN BIOL, V5, DOI 10.1038/s42003-022-03468-9
   Meissner B, 2004, J BIOL CHEM, V279, P36739, DOI 10.1074/jbc.M403415200
   Mi K, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00398
   Miquel S, 2014, GUT MICROBES, V5, P146, DOI 10.4161/gmic.27651
   Miranda-Vizuete A, 2017, REDOX BIOL, V11, P708, DOI 10.1016/j.redox.2016.12.020
   Mullaney BC, 2010, CELL METAB, V12, P398, DOI 10.1016/j.cmet.2010.08.013
   Nomura T, 2010, GENES NUTR, V5, P17, DOI 10.1007/s12263-009-0157-y
   Papaevgeniou N, 2017, FREE RADICAL BIO MED, V108, pS48, DOI 10.1016/j.freeradbiomed.2017.04.175
   Ponziani FR, 2021, LIVER INT, V41, P1320, DOI 10.1111/liv.14876
   Preidis GA, 2014, J NUTR, V144, P273, DOI 10.3945/jn.113.183731
   Schifano E, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9112290
   Schifano E, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7020045
   Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011
   Shen PY, 2018, ANNU REV FOOD SCI T, V9, P1, DOI 10.1146/annurev-food-030117-012709
   Shen PY, 2018, CRIT REV FOOD SCI, V58, P741, DOI 10.1080/10408398.2016.1220914
   Spanier B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006279
   van der Goot AT, 2013, TRENDS MOL MED, V19, P336, DOI 10.1016/j.molmed.2013.02.007
   van der Goot AT, 2012, P NATL ACAD SCI USA, V109, P14912, DOI 10.1073/pnas.1203083109
   Vernocchi P, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21228730
   Vrablik TL, 2015, BBA-MOL CELL BIOL L, V1851, P1337, DOI 10.1016/j.bbalip.2015.06.004
   Wishart DS, 2019, PHYSIOL REV, V99, P1819, DOI 10.1152/physrev.00035.2018
   Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065
   Yoon DS, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.2774
   Yousri NA, 2015, DIABETOLOGIA, V58, P1855, DOI 10.1007/s00125-015-3636-2
   Zanni E, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01206
   Zecic A, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010109
   Zhou JJ, 2019, CURR MED SCI, V39, P679, DOI 10.1007/s11596-019-2091-6
NR 50
TC 3
Z9 3
U1 4
U2 16
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-889X
J9 FRONT MOL BIOSCI
JI Front. Mol. Biosci.
PD NOV 23
PY 2022
VL 9
AR 986022
DI 10.3389/fmolb.2022.986022
PG 18
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 6Z6PO
UT WOS:000897896300001
PM 36533081
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Malatesta, M
   Baldelli, B
   Battistelli, S
   Fattoretti, P
   Bertoni-Freddari, C
AF Malatesta, M
   Baldelli, B
   Battistelli, S
   Fattoretti, P
   Bertoni-Freddari, C
TI Aging affects the distribution of the circadian CLOCK protein in rat
   hepatocytes
SO MICROSCOPY RESEARCH AND TECHNIQUE
LA English
DT Article
DE aging; cell nucleus; cireadian rhythm; electron microscopy; liver;
   transcription factor
ID DROSOPHILA PERIOD GENE; SUPRACHIASMATIC NUCLEUS; PERICHROMATIN FIBRILS;
   EXPRESSION; TRANSCRIPTION; RHYTHMS; MOUSE; LOCALIZATION; NUCLEOLAR; MICE
AB Several biochemical, physiological, and behavioral processes exhibit cyclic oscillations of about 24 h, which have been defined as circadian rhythms. In mammals, the primary circathan-pacemaker resides in the suprachiasmatic nuclei; however, cell-autonomous circadian oscillators occur also in extraneural tissues, including the liver. CLOCK protein is a transcription factor essential for normal circadian rhythms and recent studies have demonstrated that it undergoes intranuclear redistribution in hepatocytes, along the daily cycle. It is known that aging leads to a progressive deterioration of the circadian rhythm at the behavioral, physiological, and cellular levels; in addition, aging affects the organization of nuclear structural components involved in transcription and splicing. In this view, we carried out ultrastructural immunocytochemical analyses on hepatocytes of adult and old rats, so as to investigate possible qualitative and quantitative modifications of CLOCK protein, in relation to the aging process. Our observations demonstrated that most CLOCK protein was always located in the cell nucleus, where it accumulated on perichromatin fibrils (the sites of premRNA transcription and early splicing); in addition, CLOCK showed daily oscillations in the different nuclear compartments, but these oscillations differed significantly between adult and old animals. This unusual distribution of CLOCK protein during aging could be related to the prolonged diurnal activity of old animals and/or to altered nuclear pathways.
C1 Univ Urbino, Ist Istol & Anal Lab, I-61029 Urbino, Italy.
   INRCA, Ancona, Italy.
C3 University of Urbino; IRCCS INRCA
RP Malatesta, M (corresponding author), Univ Urbino, Ist Istol & Anal Lab, I-61029 Urbino, Italy.
EM malatesta@uniurb.it
RI Fattoretti, Patrizia/A-8152-2011
OI Fattoretti, Patrizia/0000-0003-1998-0080; MALATESTA,
   Manuela/0000-0001-8196-9232
CR Asai M, 2001, J NEUROSCI RES, V66, P1133, DOI 10.1002/jnr.10010
   Aujard F, 2001, NEUROSCIENCE, V106, P255, DOI 10.1016/S0306-4522(01)00285-8
   BAUREN G, 1994, CELL, V76, P183, DOI 10.1016/0092-8674(94)90182-1
   BERNHARD W, 1969, J ULTRA MOL STRUCT R, V27, P250, DOI 10.1016/S0022-5320(69)80016-X
   Biggiogera M, 2001, J CELL SCI, V114, P3199
   Bjarnason GA, 2001, AM J PATHOL, V158, P1793, DOI 10.1016/S0002-9440(10)64135-1
   Cmarko D, 2000, HISTOCHEM CELL BIOL, V113, P181, DOI 10.1007/s004180050437
   Davidson AJ, 2004, LIVER INT, V24, P179, DOI 10.1111/j.1478-3231.2004.00917.x
   Dawson K A, 1987, Prog Clin Biol Res, V227B, P107
   Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8
   Fakan S, 1980, Int Rev Cytol, V65, P255
   FAKAN S, 1984, J CELL BIOL, V98, P358, DOI 10.1083/jcb.98.1.358
   Fakan Stanislav, 1994, Trends in Cell Biology, V4, P86, DOI 10.1016/0962-8924(94)90180-5
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   Harms E, 2004, J BIOL RHYTHM, V19, P361, DOI 10.1177/0748730404268111
   Imai S, 1998, EXP GERONTOL, V33, P555
   Ishida N, 2001, BIOCHEM BIOPH RES CO, V286, P1, DOI 10.1006/bbrc.2001.5207
   JIMENEZGARCIA LF, 1993, EXP CELL RES, V207, P220, DOI 10.1006/excr.1993.1186
   Kim EY, 2002, NEURON, V34, P69, DOI 10.1016/S0896-6273(02)00639-6
   King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7
   KLEIN DC, 1991, SUPRACHIASMATIC NUCL, P488
   Kolker DE, 2004, NEUROBIOL AGING, V25, P517, DOI 10.1016/j.neurobiolaging.2003.06.007
   Kolker DE, 2003, J BIOL RHYTHM, V18, P159, DOI 10.1177/0748730403251802
   Kornmann B, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.11.e51
   Malatesta M, 2003, EUR J HISTOCHEM, V47, P233
   Malatesta M, 2003, MICROSC RES TECHNIQ, V61, P414, DOI 10.1002/jemt.10310
   Malatesta M, 2003, MECH AGEING DEV, V124, P175, DOI 10.1016/S0047-6374(02)00117-3
   MALATESTA M, 2004, ANN NY ACAD SCI, V1019, P1
   Morse D, 2002, TRENDS NEUROSCI, V25, P632, DOI 10.1016/S0166-2236(02)02274-9
   Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5
   Puvion E, 1996, EXP CELL RES, V229, P217, DOI 10.1006/excr.1996.0363
   Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647
   Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857
   Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698
   Spector DL, 1996, EXP CELL RES, V229, P189, DOI 10.1006/excr.1996.0358
   Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9
   Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086
   VAZQUEZNIN GH, 1990, CHROMOSOMA, V99, P44, DOI 10.1007/BF01737288
   Villeponteau B, 1997, EXP GERONTOL, V32, P383, DOI 10.1016/S0531-5565(96)00155-6
   VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Weinert H, 2001, CHRONOBIOL INT, V18, P559, DOI 10.1081/CBI-100103976
NR 42
TC 14
Z9 14
U1 0
U2 1
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1059-910X
J9 MICROSC RES TECHNIQ
JI Microsc. Res. Tech.
PD SEP
PY 2005
VL 68
IS 1
BP 45
EP 50
DI 10.1002/jemt.20221
PG 6
WC Anatomy & Morphology; Biology; Microscopy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Anatomy & Morphology; Life Sciences & Biomedicine - Other Topics;
   Microscopy
GA 974AG
UT WOS:000232563100005
PM 16208722
DA 2024-02-19
ER

PT J
AU Le, F
   Lou, HY
   Wang, QJ
   Wang, N
   Wang, LY
   Li, LJ
   Yang, XY
   Zhan, QT
   Lou, YY
   Jin, F
AF Le, Fang
   Lou, Hang-ying
   Wang, Qi-jing
   Wang, Ning
   Wang, Li-ya
   Li, Le-jun
   Yang, Xin-yun
   Zhan, Qi-tao
   Lou, Yi-yun
   Jin, Fan
TI Increased hepatic INSIG-SCAP-SREBP expression is associated with
   cholesterol metabolism disorder in assisted reproductive
   technology-conceived aged mice
SO REPRODUCTIVE TOXICOLOGY
LA English
DT Article
DE Assisted reproductive technologies; Cardiometabolism; INSIG-SCAP-SREBP;
   Mice; Aging
ID IN-VITRO FERTILIZATION; DNA METHYLATION; CHILDREN; OUTCOMES; INSULIN;
   EMBRYOS; HEALTH; DYSFUNCTION; INFERTILITY; MATURATION
AB Although most children conceived by assisted reproductive technology (ART) are healthy, there are concerns regarding the potential long-term health implications of ART. It has been reported that alterations in insulin-induced gene (INSIG), sterol regulatory element binding protein (SREBP), and SREBP cleavage-activating protein (SCAP) are involved in cardiometabolic changes. Thus, ART mouse models were established via in vitro fertilization (IVF), intracytoplasmic injection (ICSI), and in vitro oocyte maturation (IVM). A significantly higher systolic blood pressure was identified in the IVM aged female mice. In addition, abnormalities in the blood lipids and liver function were identified in the IVM- or ICSI-conceived elderly mice. Furthermore, ICSI or IVM significantly affected the hepatic expression and methylation of INSIG-SCAP-SREBP from a young to old age. Our animal data indicated that ICSI or IVM result in a higher risk of cholesterol metabolism dysfunction in older mice, which may be associated with long-term alterations of INSIG-SCAP-SREBP.
C1 [Le, Fang; Lou, Hang-ying; Wang, Qi-jing; Wang, Ning; Wang, Li-ya; Li, Le-jun; Yang, Xin-yun; Zhan, Qi-tao; Jin, Fan] Zhejiang Univ, Womens Hosp, Ctr Reprod Med, Sch Med, Hangzhou 310006, Zhejiang, Peoples R China.
   [Jin, Fan] Minist Educ, Key Lab Reprod Genet, Hangzhou 310006, Zhejiang, Peoples R China.
   [Lou, Yi-yun] Hangzhou Hosp Tradit Chinese Med, Dept Gynecol, Hangzhou 310006, Zhejiang, Peoples R China.
C3 Zhejiang University
RP Jin, F (corresponding author), Zhejiang Univ, Womens Hosp, Dept Reprod Endocrinol, Sch Med, 1 Xueshi Rd, Hangzhou 310006, Zhejiang, Peoples R China.
EM jinfan@zju.edu.cn
RI Lou, Yiyun/IRY-9237-2023; Wang, Tao/AAT-3028-2020; ZHOU,
   YUE/IZE-6277-2023; wang, xueting/JPY-2782-2023; liu,
   xinyu/IWD-6630-2023; li, yansong/JXL-5023-2024
OI Lou, Yiyun/0000-0002-9154-5422; Wang, Tao/0000-0003-1225-0173; Wang,
   Qijing/0000-0003-4186-4617
FU National Basic Research Programs of China [2012CB944901]; National
   Natural Science Foundation of China [81501321, 81571500, 81370760,
   81801475]; Zhejiang Provincial Natural Science Foundation of China
   [LZ13H040001, Z13H040002, LY15H040008]
FX This work was supported by the National Basic Research Programs of China
   [2012CB944901]; National Natural Science Foundation of China [81501321,
   81571500, 81370760, 81801475]; and Zhejiang Provincial Natural Science
   Foundation of China [LZ13H040001, Z13H040002, and LY15H040008].
CR Belbasis L, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0692-5
   Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009
   Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5
   CEDERHOLM J, 1985, SCAND J CLIN LAB INV, V45, P741, DOI 10.3109/00365518509155289
   Ceelen M, 2008, J CLIN ENDOCR METAB, V93, P1682, DOI 10.1210/jc.2007-2432
   Cervino AC, 2005, GENOMICS, V86, P505, DOI 10.1016/j.ygeno.2005.07.010
   Charles MA, 2016, M S-MED SCI, V32, P15, DOI 10.1051/medsci/20163201004
   Chason RJ, 2011, TRENDS ENDOCRIN MET, V22, P412, DOI 10.1016/j.tem.2011.05.005
   Chen ZJ, 2016, NEW ENGL J MED, V375, P523, DOI 10.1056/NEJMoa1513873
   del Collado M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02467-9
   Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005
   Dunning KR, 2014, REPRODUCTION, V148, pR15, DOI 10.1530/REP-13-0251
   Dunning KR, 2010, BIOL REPROD, V83, P909, DOI 10.1095/biolreprod.110.084145
   Ecker DJ, 2004, P NATL ACAD SCI USA, V101, P1595, DOI 10.1073/pnas.0306846101
   El Hajj N, 2017, HUM REPROD, V32, P1761, DOI 10.1093/humrep/dex209
   Engelking LJ, 2004, J CLIN INVEST, V113, P1168, DOI 10.1172/JCI200420978
   Eppig JJ, 2009, HUM REPROD, V24, P922, DOI 10.1093/humrep/den466
   Espenshade PJ, 2006, J CELL SCI, V119, P973, DOI 10.1242/jcs02866
   Fernández-Gonzalez R, 2004, P NATL ACAD SCI USA, V101, P5880, DOI 10.1073/pnas.0308560101
   Feuer S, 2016, HEALTHCARE-BASEL, V4, DOI 10.3390/healthcare4030051
   Fleming TP, 2015, J DEV ORIG HLTH DIS, V6, P377, DOI 10.1017/S2040174415001105
   Halliday J, 2014, FERTIL STERIL, V101, P1055, DOI 10.1016/j.fertnstert.2014.01.006
   Hatirnaz S, 2018, TURK J OBSTET GYNECO, V15, P112, DOI 10.4274/tjod.23911
   Heidemann LA, 2019, J PEDIAT-BRAZIL, V95, P291, DOI 10.1016/j.jped.2018.02.009
   Helmerhorst FM, 2004, BRIT MED J, V328, P261, DOI 10.1136/bmj.37957.560278.EE
   Katari S, 2009, HUM MOL GENET, V18, P3769, DOI 10.1093/hmg/ddp319
   Kuo AH, 2018, J PHYSIOL-LONDON, V596, P5777, DOI 10.1113/JP275139
   Le F, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.106070
   Lewis S, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0377-3
   Luke B, 2017, AM J OBSTET GYNECOL, V217, P270, DOI 10.1016/j.ajog.2017.03.012
   Margolis CF, 1996, INT J OBESITY, V20, P784
   Marquart TJ, 2010, P NATL ACAD SCI USA, V107, P12228, DOI 10.1073/pnas.1005191107
   Miles HL, 2007, J CLIN ENDOCR METAB, V92, P3441, DOI 10.1210/jc.2006-2465
   Moini A, 2012, EUR J OBSTET GYN R B, V165, P29, DOI 10.1016/j.ejogrb.2012.07.008
   Polotsky VY, 2001, AM J RESP CRIT CARE, V164, P1470, DOI 10.1164/ajrccm.164.8.2101100
   Rimoldi SF, 2015, EUR J PREV CARDIOL, V22, P1399, DOI 10.1177/2047487314535117
   Sakka SD, 2010, FERTIL STERIL, V94, P1693, DOI 10.1016/j.fertnstert.2009.09.049
   Savage T, 2011, HUM REPROD, V26, P2392, DOI 10.1093/humrep/der212
   Scherrer U, 2012, CIRCULATION, V125, P1890, DOI 10.1161/CIRCULATIONAHA.111.071183
   Seggers J, 2016, FERTIL STERIL, V105, P590, DOI 10.1016/j.fertnstert.2015.11.015
   Sieber MH, 2015, CURR BIOL, V25, P993, DOI 10.1016/j.cub.2015.02.019
   Suvorov A, 2016, ENDOCRINOLOGY, V157, P2586, DOI 10.1210/en.2016-1145
   Turkgeldi E, 2016, EUR J OBSTET GYN R B, V207, P129, DOI 10.1016/j.ejogrb.2016.10.010
   Valenzuela-Alcaraz B, 2013, CIRCULATION, V128, P1442, DOI 10.1161/CIRCULATIONAHA.113.002428
   Vincent RN, 2016, FERTIL STERIL, V106, P739, DOI 10.1016/j.fertnstert.2016.04.036
   von Arx R, 2015, J APPL PHYSIOL, V118, P1200, DOI 10.1152/japplphysiol.00533.2014
   Vrooman LA, 2017, REPROD TOXICOL, V68, P72, DOI 10.1016/j.reprotox.2016.07.015
   Walker AK, 2011, CELL, V147, P840, DOI 10.1016/j.cell.2011.09.045
   Wang N, 2012, REPROD TOXICOL, V34, P420, DOI 10.1016/j.reprotox.2012.04.012
   Watkins AJ, 2007, P NATL ACAD SCI USA, V104, P5449, DOI 10.1073/pnas.0610317104
   Whitelaw N, 2014, HUM REPROD, V29, P1452, DOI 10.1093/humrep/deu094
   Wilde E, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005204
   Yabe D, 2003, P NATL ACAD SCI USA, V100, P3155, DOI 10.1073/pnas.0130116100
   Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3
NR 54
TC 9
Z9 9
U1 1
U2 19
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0890-6238
J9 REPROD TOXICOL
JI Reprod. Toxicol.
PD MAR
PY 2019
VL 84
BP 9
EP 17
DI 10.1016/j.reprotox.2018.12.003
PG 9
WC Reproductive Biology; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Reproductive Biology; Toxicology
GA HQ4YR
UT WOS:000462417700002
PM 30562550
DA 2024-02-19
ER

PT J
AU Ma, BY
   Ju, AJ
   Zhang, SS
   An, Q
   Xu, SR
   Liu, J
   Yu, L
   Fu, Y
   Luo, YZ
AF Ma, Boyuan
   Ju, Anji
   Zhang, Shaosen
   An, Qi
   Xu, Siran
   Liu, Jie
   Yu, Li
   Fu, Yan
   Luo, Yongzhang
TI Albumosomes formed by cytoplasmic pre-folding albumin maintain
   mitochondrial homeostasis and inhibit nonalcoholic fatty liver disease
SO SIGNAL TRANSDUCTION AND TARGETED THERAPY
LA English
DT Article
ID PHASE-SEPARATION; AGGRESOME FORMATION; MISFOLDED PROTEIN; OXIDATIVE
   STRESS; CHAPERONE; CONSEQUENCES; DEGRADATION; DYSFUNCTION; BIOGENESIS;
   METABOLISM
AB Hepatic mitochondrial dysfunction contributes to the progression of nonalcoholic fatty liver disease (NAFLD). However, the factors that maintain mitochondrial homeostasis, especially in hepatocytes, are largely unknown. Hepatocytes synthesize various high-level plasma proteins, among which albumin is most abundant. In this study, we found that pre-folding albumin in the cytoplasm is completely different from folded albumin in the serum. Mechanistically, endogenous pre-folding albumin undergoes phase transition in the cytoplasm to form a shell-like spherical structure, which we call the "albumosome". Albumosomes interact with and trap pre-folding carnitine palmitoyltransferase 2 (CPT2) in the cytoplasm. Albumosomes control the excessive sorting of CPT2 to the mitochondria under high-fat-diet-induced stress conditions; in this way, albumosomes maintain mitochondrial homeostasis from exhaustion. Physiologically, albumosomes accumulate in hepatocytes during murine aging and protect the livers of aged mice from mitochondrial damage and fat deposition. Morphologically, mature albumosomes have a mean diameter of 4 mu m and are surrounded by heat shock protein Hsp90 and Hsp70 family proteins, forming a larger shell. The Hsp90 inhibitor 17-AAG promotes hepatic albumosomal accumulation in vitro and in vivo, through which suppressing the progression of NAFLD in mice.
C1 [Ma, Boyuan; Ju, Anji; Zhang, Shaosen; An, Qi; Xu, Siran; Liu, Jie; Fu, Yan; Luo, Yongzhang] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.
   [Ma, Boyuan; Ju, Anji; Zhang, Shaosen; An, Qi; Xu, Siran; Liu, Jie; Fu, Yan; Luo, Yongzhang] Tsinghua Univ, Natl Engn Res Ctr Prot Technol, Beijing 100084, Peoples R China.
   [Ma, Boyuan; Ju, Anji; Zhang, Shaosen; An, Qi; Xu, Siran; Liu, Jie; Fu, Yan; Luo, Yongzhang] Tsinghua Univ, Beijing Key Lab Prot Therapeut, Beijing 100084, Peoples R China.
   [Yu, Li] Tsinghua Univ, Tsinghua Univ Peking Univ Joint Ctr Life Sci, Sch Life Sci, Beijing Frontier Res Ctr Biol Struct, Beijing 100084, Peoples R China.
   [Zhang, Shaosen] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Dept Etiol & Carcinogenesis, Beijing 100021, Peoples R China.
   [Liu, Jie] Shenzhen Blood Ctr, Immunogenet Lab, Shenzhen 518025, Guangdong, Peoples R China.
C3 Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua
   University; Chinese Academy of Medical Sciences - Peking Union Medical
   College; Cancer Institute & Hospital - CAMS; Peking Union Medical
   College
RP Fu, Y; Luo, YZ (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.; Fu, Y; Luo, YZ (corresponding author), Tsinghua Univ, Natl Engn Res Ctr Prot Technol, Beijing 100084, Peoples R China.; Fu, Y; Luo, YZ (corresponding author), Tsinghua Univ, Beijing Key Lab Prot Therapeut, Beijing 100084, Peoples R China.
EM fuyan@mail.tsinghua.edu.cn; yluo@mail.tsinghua.edu.cn
RI Wang, Rong/JQI-7854-2023; lu, yuan/JZD-0832-2024; Ma,
   Boyuan/IYT-3973-2023; zhang, yan/JGL-8022-2023; Yu, Yue/JWP-9103-2024;
   LI, Xiang/JBJ-8387-2023; Zhang, Yusi/JNS-2335-2023; Liu,
   Shaobo/JUU-5767-2023; WANG, YUHAO/KBB-0213-2024; Wang,
   Yue/JRY-8962-2023; zheng, liang/JVO-2610-2024; Li, Shuyao/JRY-8603-2023;
   li, jiaxin/JNT-5073-2023; Li, Xinyue/JVN-4601-2024; liu,
   xingyu/JXW-9444-2024; chen, xu/JNT-3068-2023; li, tao/JVO-9006-2024;
   wang, yu/IUQ-6654-2023
OI Wang, Rong/0009-0009-5350-5743; Ma, Boyuan/0000-0002-6220-3386; Wang,
   Yue/0000-0001-8673-6358; Zhang, Shaosen/0000-0003-0010-1445
FU Science and Technology Major Project of Ministry of Science and
   Technology of the PRC [20181821569]; Feasibility Study of Application
   Scheme of Recombinant Serum Albumin of Protgen (Shenzhen) Ltd.
   [20182000354]
FX We thank Dr. Pilong Li, Dr. Liang Ge, Dr. Peng Li, and Dr. Ligong Chen
   at Tsinghua University for helpful suggestions on the manuscript; the
   Metabolomics Facility Center of Metabolomics and lipidomics and the
   Proteomics Facility Center in National Protein Science Technology Center
   of Tsinghua University for LC-MS/MS; the Cell Biology Facility of the
   Center of Biomedical Analysis of Tsinghua University for TEM; the State
   Key Laboratory of Membrane Biology for confocal microscopy; and the
   Center of Biomedical Analysis of Tsinghua University for mitochondria
   respiration test and flow cytometry. This study is supported by the
   Science and Technology Major Project of Ministry of Science and
   Technology of the PRC (No. 20181821569) and Feasibility Study of
   Application Scheme of Recombinant Serum Albumin of Protgen (Shenzhen)
   Ltd. (No. 20182000354).
CR ACHARYA U, 1995, CELL, V82, P895, DOI 10.1016/0092-8674(95)90269-4
   Aleixo MAA, 2019, FEBS J, V286, P1925, DOI 10.1111/febs.14782
   Ambade A, 2014, J HEPATOL, V61, P903, DOI 10.1016/j.jhep.2014.05.024
   Anastasia I, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108873
   Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7
   Begriche K, 2006, MITOCHONDRION, V6, P1, DOI 10.1016/j.mito.2005.10.004
   Bennett CF, 2022, NAT REV MOL CELL BIO, V23, P817, DOI 10.1038/s41580-022-00506-6
   BLOUIN A, 1977, J CELL BIOL, V72, P441, DOI 10.1083/jcb.72.2.441
   Bose M, 2022, CELL, V185, P1308, DOI 10.1016/j.cell.2022.02.022
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Brown ZJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0687-6
   Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012
   Chen Z, 2020, FREE RADICAL BIO MED, V152, P116, DOI 10.1016/j.freeradbiomed.2020.02.025
   Cui LJ, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.618322
   Das R, 2020, BIOCHEM SOC T, V48, P631, DOI 10.1042/BST20190987
   Di Ciaula A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22105375
   Feige MJ, 2011, CURR OPIN CELL BIOL, V23, P167, DOI 10.1016/j.ceb.2010.10.012
   Feng M., 2021, J VIS EXP, V176, pe61812
   Foerster F, 2022, J HEPATOL, V76, P446, DOI 10.1016/j.jhep.2021.09.007
   Galves M, 2019, TRENDS BIOCHEM SCI, V44, P872, DOI 10.1016/j.tibs.2019.04.007
   García-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239
   Gosis BS, 2022, SCIENCE, V376, P264, DOI 10.1126/science.abf8271
   Gu JE, 2021, CELL RES, V31, P1024, DOI 10.1038/s41422-021-00526-5
   Gu JG, 2020, P NATL ACAD SCI USA, V117, P31123, DOI 10.1073/pnas.2002437117
   HACKENBROCK CR, 1966, J CELL BIOL, V30, P269, DOI 10.1083/jcb.30.2.269
   Huang DIQ, 2021, NAT REV GASTRO HEPAT, V18, P223, DOI 10.1038/s41575-020-00381-6
   Huang D, 2021, CELL METAB, V33, P1655, DOI 10.1016/j.cmet.2021.05.006
   Huh JY, 2020, CELL METAB, V32, DOI 10.1016/j.cmet.2020.10.010
   Jain S, 2016, CELL, V164, P487, DOI 10.1016/j.cell.2015.12.038
   Jiang D, 2019, NAT CELL BIOL, V21, P966, DOI 10.1038/s41556-019-0358-6
   Jiao HF, 2021, CELL, V184, P2896, DOI 10.1016/j.cell.2021.04.027
   Johnston JA, 2002, CELL MOTIL CYTOSKEL, V53, P26, DOI 10.1002/cm.10057
   Kaushik S, 2018, NAT REV MOL CELL BIO, V19, P365, DOI 10.1038/s41580-018-0001-6
   Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5
   Koliaki C, 2015, CELL METAB, V21, P739, DOI 10.1016/j.cmet.2015.04.004
   Koritzinsky M, 2013, J CELL BIOL, V203, P615, DOI 10.1083/jcb.201307185
   Kroschwald S, 2017, CELL, V168, P947, DOI 10.1016/j.cell.2017.02.029
   Kuan YC, 2017, J BIOL CHEM, V292, P3016, DOI 10.1074/jbc.M116.767277
   Lebeau J, 2018, CELL REP, V22, P2827, DOI 10.1016/j.celrep.2018.02.055
   Lee CA, 2018, PROTEIN CELL, V9, P693, DOI 10.1007/s13238-017-0469-4
   Lee J, 2015, CELL REP, V10, P266, DOI 10.1016/j.celrep.2014.12.023
   Lee J, 2019, ARCH PHARM RES, V42, P935, DOI 10.1007/s12272-019-01178-1
   Li D, 2022, TRENDS CELL BIOL, V32, P1, DOI 10.1016/j.tcb.2021.08.004
   Li LO, 2009, J BIOL CHEM, V284, P27816, DOI 10.1074/jbc.M109.022467
   Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879
   Liu HY, 2023, J TRANSL MED, V21, DOI 10.1186/s12967-023-03957-3
   Liu L, 2020, DEV CELL, V52, P196, DOI 10.1016/j.devcel.2019.11.012
   Liu QX, 2021, CELL, V184, P5559, DOI 10.1016/j.cell.2021.10.001
   Liu ZY, 2020, NAT STRUCT MOL BIOL, V27, P363, DOI 10.1038/s41594-020-0399-3
   Loomba R, 2021, CELL, V184, P2537, DOI 10.1016/j.cell.2021.04.015
   Luengo TM, 2019, TRENDS CELL BIOL, V29, P164, DOI 10.1016/j.tcb.2018.10.004
   Ly LD, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2016.157
   Lyu XC, 2021, DEV CELL, V56, P2592, DOI 10.1016/j.devcel.2021.08.015
   Ma XY, 2022, CELL, V185, P1325, DOI 10.1016/j.cell.2022.03.005
   Mansouri A, 2018, GASTROENTEROLOGY, V155, P629, DOI 10.1053/j.gastro.2018.06.083
   Masarone M, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/9547613
   Mateju D, 2017, EMBO J, V36, P1669, DOI 10.15252/embj.201695957
   Merlot AM, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00299
   Middleton P, 2021, THER ADV GASTROENTER, V14, DOI 10.1177/17562848211031394
   MOLDEUS PW, 1973, J BIOL CHEM, V248, P8574
   Nong JX, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202012112
   Oka OBV, 2013, BBA-MOL CELL RES, V1833, P2425, DOI 10.1016/j.bbamcr.2013.02.007
   Palmer KJ, 2004, TRENDS CELL BIOL, V14, P57, DOI 10.1016/j.tcb.2003.12.001
   Pérez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398
   Petitpas I, 2001, J MOL BIOL, V314, P955, DOI 10.1006/jmbi.2000.5208
   Prasun P, 2021, TRANSL GASTROENT HEP, V6, DOI 10.21037/tgh-20-125
   Prosser SL, 2022, NAT CELL BIOL, V24, P483, DOI 10.1038/s41556-022-00869-0
   Quinlan GJ, 2005, HEPATOLOGY, V41, P1211, DOI 10.1002/hep.20720
   Riback JA, 2017, CELL, V168, P1028, DOI 10.1016/j.cell.2017.02.027
   Roche M, 2008, FEBS LETT, V582, P1783, DOI 10.1016/j.febslet.2008.04.057
   Roopenian DC, 2015, MABS-AUSTIN, V7, P344, DOI 10.1080/19420862.2015.1008345
   Rosenzweig R, 2019, NAT REV MOL CELL BIO, V20, P665, DOI 10.1038/s41580-019-0133-3
   Schopf FH, 2017, NAT REV MOL CELL BIO, V18, P345, DOI 10.1038/nrm.2017.20
   Schulze RJ, 2019, J CELL BIOL, V218, P2096, DOI 10.1083/jcb.201903090
   Shum M, 2020, MOL METAB, V50, DOI 10.1016/j.molmet.2020.101134
   Stojanovski D, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011320
   Sun DX, 2018, CELL RES, V28, P405, DOI 10.1038/s41422-018-0017-7
   Sunny NE, 2011, CELL METAB, V14, P804, DOI 10.1016/j.cmet.2011.11.004
   Tang JZ, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11081191
   Tao YQ, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-31790-7
   Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89
   Tong XH, 2022, SIGNAL TRANSDUCT TAR, V7, DOI 10.1038/s41392-022-01076-x
   Trefts E, 2017, CURR BIOL, V27, pR1147, DOI 10.1016/j.cub.2017.09.019
   Van Treeck B, 2018, P NATL ACAD SCI USA, V115, P2734, DOI 10.1073/pnas.1800038115
   WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x
   Wang B, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00678-1
   Wang LM, 2023, NAT REV MOL CELL BIO, V24, P186, DOI 10.1038/s41580-022-00529-z
   Wang SS, 2020, NUCLEIC ACIDS RES, V48, DOI 10.1093/nar/gkaa498
   Wiedemann N, 2017, ANNU REV BIOCHEM, V86, P685, DOI 10.1146/annurev-biochem-060815-014352
   Wu YX, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00575-7
   Yang Y, 2022, SCIENCE, V375, P167, DOI 10.1126/science.abm7285
   Yin Q, 2022, CELL REP, V40, DOI 10.1016/j.celrep.2022.111071
   Yu HY, 2021, SCIENCE, V371, P585, DOI 10.1126/science.abb4309
   Yu XY, 2021, NAT CELL BIOL, V23, P330, DOI 10.1038/s41556-021-00659-0
   Zhang GM, 2018, CELL, V174, P1492, DOI 10.1016/j.cell.2018.08.006
   Zhang HC, 2022, NAT CELL BIOL, V24, P340, DOI 10.1038/s41556-022-00846-7
   Zheng ZG, 2019, THERANOSTICS, V9, P5769, DOI 10.7150/thno.36505
   Zhou W, 2021, MOL CELL, V81, P739, DOI 10.1016/j.molcel.2021.01.024
   Zhu GY, 2020, CELL, V183, P490, DOI 10.1016/j.cell.2020.09.002
NR 99
TC 1
Z9 1
U1 4
U2 8
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 2095-9907
EI 2059-3635
J9 SIGNAL TRANSDUCT TAR
JI Signal Transduct. Target. Ther.
PD JUN 16
PY 2023
VL 8
IS 1
AR 229
DI 10.1038/s41392-023-01437-0
PG 20
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA J7PG6
UT WOS:001011498900002
PM 37321990
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Adejumo, A
   Noll, A
   Rogal, SS
   Yakovchenko, V
   Chia, LD
   Spoutz, P
   Morgan, TR
   Bajaj, JS
AF Adejumo, Adeyinka
   Noll, Alan
   Rogal, Shari S.
   Yakovchenko, Vera
   Chia, Linda
   Spoutz, Patrick
   Morgan, Timothy R.
   Bajaj, Jasmohan S.
TI Dementia Frequently Coexists With Hepatic Encephalopathy but Not Other
   Cirrhosis Complications in US Veterans
SO AMERICAN JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
DE geriatrics; Alzheimer's dementia; PTSD; head trauma; lactulose;
   rifaximin
ID HEPATOCELLULAR-CARCINOMA; LIVER-DISEASE; HEAD-INJURY; RISK; PREVALENCE;
   BURDEN
AB INTRODUCTION:Hepatic encephalopathy (HE) is a common decompensating event in patients with cirrhosis. Because of the aging population of patients with cirrhosis, differentiating HE from nonhepatic etiologies of cognitive impairment, such as dementia, is increasingly important.METHODS:Veterans with cirrhosis were identified via International Classification of Diseases-10 codes between October 1, 2019, and September 30, 2021, using the VA Corporate Data Warehouse. Baseline characteristics were compared between cohorts based on the presence vs absence of dementia. Factors associated with having a diagnosis of dementia were evaluated using multivariate logistic regression models, adjusting for demographics, comorbid illnesses, cirrhosis etiology, and cirrhosis complications.RESULTS:A total of 71,552 veterans with cirrhosis were identified, of which, 5,647 (7.89%) veterans had a diagnosis of dementia. Veterans with dementia were older, more frequently White, urban located, and diagnosed with alcohol-related cirrhosis, metabolic syndrome, brain trauma, and cerebrovascular disease more frequently. On multivariable analysis, the presence of any decompensating event was associated with dementia. Multivariable analysis of individual decompensating events revealed HE to be associated with a dementia diagnosis, but not ascites, independent of other risk factors analyzed.DISCUSSION:Dementia is commonly diagnosed in patients with cirrhosis and correlates with a diagnosis of HE, independent of alcohol use, brain injury, age, and other metabolic risk factors. Dementia did not correlate with other decompensating events. Increased awareness of the overlap between dementia and HE, as well as reliable diagnostic and treatment strategies, is needed for the aging population of veterans with cirrhosis.
C1 [Adejumo, Adeyinka; Noll, Alan; Rogal, Shari S.] Univ Pittsburgh, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA USA.
   [Rogal, Shari S.; Yakovchenko, Vera] VA Vet Affairs Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, Pittsburgh, PA USA.
   [Chia, Linda] Vet Integrated Serv Network 8, Pharm Benefits Management, Bay Pines, FL USA.
   [Spoutz, Patrick] Vet Integrated Serv Network 20, Pharm Benefits Management, Vancouver, WA USA.
   [Morgan, Timothy R.] VA Long Beach Healthcare Syst, Gastroenterol Sect, Long Beach, CA USA.
   [Bajaj, Jasmohan S.] Virginia Commonwealth Univ, Med Ctr, Div Gastroenterol Hepatol & Nutr, Richmond, VA 23219 USA.
   [Bajaj, Jasmohan S.] Cent Virginia Vet Healthcare Syst, GI Sect, Richmond, VA 23249 USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); University
   of Pittsburgh; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); VA Long Beach Healthcare System; Virginia
   Commonwealth University
RP Bajaj, JS (corresponding author), Virginia Commonwealth Univ, Med Ctr, Div Gastroenterol Hepatol & Nutr, Richmond, VA 23219 USA.; Bajaj, JS (corresponding author), Cent Virginia Vet Healthcare Syst, GI Sect, Richmond, VA 23249 USA.
EM adejumoac@upmc.edu; nollag@upmc.edu; rogalss@upmc.edu;
   Vera.Yakovchenko@va.gov; linda.chia@va.gov; Patrick.Spoutz@va.gov;
   timothy.morgan@va.gov; jasmohan.bajaj@vcuhealth.org
RI Rogal, Shari/AGN-8326-2022
OI Rogal, Shari/0000-0001-8184-1546
CR Bajaj JS, 2012, ALIMENT PHARM THER, V36, P866, DOI 10.1111/apt.12045
   Bajaj JS, 2022, CLIN GASTROENTEROL H, V20, pS20, DOI 10.1016/j.cgh.2022.04.035
   Bajaj JS, 2020, CLIN GASTROENTEROL H, V18, P3008, DOI 10.1016/j.cgh.2020.03.033
   Bajaj JS, 2016, SCI REP-UK, V6, DOI 10.1038/srep38481
   Bajaj JS, 2011, AM J GASTROENTEROL, V106, P1646, DOI 10.1038/ajg.2011.157
   Bajaj JS, 2010, GASTROENTEROLOGY, V138, P2332, DOI 10.1053/j.gastro.2010.02.015
   Beste LA, 2015, GASTROENTEROLOGY, V149, P1471, DOI 10.1053/j.gastro.2015.07.056
   Davis BC, 2018, ALCOHOL CLIN EXP RES, V42, P660, DOI 10.1111/acer.13605
   Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857
   Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316
   Hirode G, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.1997
   Ibáñez-Samaniego L, 2022, EUR J NEUROL, V29, P400, DOI 10.1111/ene.15138
   Kaplan DE, 2018, CLIN GASTROENTEROL H, V16, P106, DOI 10.1016/j.cgh.2017.07.024
   Kodishala C, 2023, J RHEUMATOL, V50, P48, DOI 10.3899/jrheum.220200
   Krishnan LL, 2005, DEMENT GERIATR COGN, V20, P245, DOI 10.1159/000087345
   Maclagan Laura C, 2022, CMAJ Open, V10, pE610, DOI 10.9778/cmajo.20210301
   Nichols E., 2022, LANCET PUBLIC HEALTH, V7, pe105, DOI [10.1016/S2468-2667(21)00249-8, DOI 10.1016/S2468-2667(21)00249-8]
   Orman ES, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.6412
   Parikh NS, 2022, EUR J NEUROL, V29, P2622, DOI 10.1111/ene.15437
   Peters Ruth, 2008, BMC Geriatr, V8, P36, DOI [10.1186/1471-2318-8-18, 10.1186/1471-2318-8-36]
   Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998
   Rehm J, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-018-0453-0
   Richard-Eaglin A, 2020, GERIATR NURS, V41, P505, DOI 10.1016/j.gerinurse.2020.06.006
   Roderburg Christoph, 2021, Eur Heart J Open, V1, poeab003, DOI 10.1093/ehjopen/oeab003
   Rogal S, 2020, HEPATOLOGY, V71, P2080, DOI 10.1002/hep.31042
   Tinetti M, 2017, J AM GERIATR SOC, V65, P2115, DOI 10.1111/jgs.14979
   van der Flier WM, 2005, J NEUROL NEUROSUR PS, V76, pV2, DOI 10.1136/jnnp.2005.082867
   Vilstrup H, 2014, HEPATOLOGY, V60, P715, DOI 10.1002/hep.27210
   Xiao T, 2022, NEUROLOGY, V99, pE565, DOI 10.1212/WNL.0000000000200770
   Zhu CW, 2021, FRONT PSYCHIATRY, V12, DOI 10.3389/fpsyt.2021.610334
NR 30
TC 3
Z9 3
U1 1
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0002-9270
EI 1572-0241
J9 AM J GASTROENTEROL
JI Am. J. Gastroenterol.
PD MAR
PY 2023
VL 118
IS 3
BP 475
EP 480
DI 10.14309/ajg.0000000000002189
PG 6
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA I4IS3
UT WOS:001002439300025
PM 36649134
DA 2024-02-19
ER

PT J
AU Longbotham, D
   Young, A
   Nana, G
   Feltbower, R
   Hidalgo, E
   Toogood, G
   Lodge, PA
   Attia, M
   Prasad, KR
AF Longbotham, David
   Young, Alastair
   Nana, Gael
   Feltbower, Richard
   Hidalgo, Ernest
   Toogood, Giles
   Lodge, Peter A.
   Attia, Magdy
   Prasad, K. Rajendra
TI The impact of age on post-operative liver function following right
   hepatectomy: a retrospective, single centre experience
SO HPB
LA English
DT Article
ID PORTAL-VEIN EMBOLIZATION; ELDERLY-PATIENTS; COLORECTAL METASTASES;
   HEPATIC-DYSFUNCTION; MAJOR HEPATECTOMY; RESECTION; MORTALITY; DISEASE;
   OUTCOMES; OLDER
AB Background: An increasing number of patients undergoing liver resection are of advancing age. The impact of ageing on liver regeneration and post-operative outcomes following a major resection are uncertain. We aimed to investigate risk factors for patients who developed Post Hepatectomy Liver Failure (PHLF) following right hepatectomy with age as the primary risk-factor.
   Method: Patients undergoing right hepatectomy between July 2004-July 2018 were included. ROC analysis was performed to identify at which age PHLF development-risk increased. Secondary endpoints were length of stay (LOS), complications, and cost.
   Results: 332-patients were included. ROC demonstrated a cut-off age of 75-years in which PHLF risk increased. >75 there was an increased risk of PHLF (35% >75yrs vs. 7% <75yrs (p = <0.001), OR = 8.8 (95% CI = 3.6- 21)) There was no difference between the age groups for any other PHLF risk factor. Patients >75yrs had longer LOS (11-days vs. 7-days (p = 0.04). Patients who developed PHLF had increased hospital costs: 10,987.50 pound (6175- pound 46,050) pound vs. 2575 pound (900- pound 46,050 pound p = 0.01).
   Conclusions: Patients >75yrs have increased risk of developing PHLF after right hepatectomy, contributing to increased mortality and economic burden. Pre-operatively identifying patients at-risk of PHLF is important to consider liver volume optimization strategies and improve outcomes.
C1 [Longbotham, David; Young, Alastair; Nana, Gael; Hidalgo, Ernest; Toogood, Giles; Lodge, Peter A.; Attia, Magdy; Prasad, K. Rajendra] St James Univ Hosp, Dept Hepatobiliary & Transplantat Surg, Div Surg, Beckett St, Leeds LS9 7TF, W Yorkshire, England.
   [Feltbower, Richard] Univ Leeds, Div Epidemiol & Biostat, Leeds LS2 9JT, W Yorkshire, England.
C3 Saint James's University Hospital; University of Leeds
RP Attia, M (corresponding author), St James Univ Hosp, Dept HPB & Transplantat, Div Surg, Beckett St, Leeds LS9 7TF, W Yorkshire, England.
EM magdy.attia@nhs.net
OI Toogood, Giles/0000-0003-4535-6249; Hidalgo Llompart,
   Ernest/0000-0002-4680-9580
CR Allard MA, 2013, ANN SURG, V258, P822, DOI 10.1097/SLA.0b013e3182a64b38
   [Anonymous], 2014, REFERENCE COSTS GROU
   Bockhorn M, 2009, INT J COLORECTAL DIS, V24, P83, DOI 10.1007/s00384-008-0571-4
   Boland BS, 2014, J CLIN EXP HEPATOL, V4, P1, DOI 10.1016/j.jceh.2014.01.003
   Caratozzolo E, 2007, G CHIR, V28, P419
   Carino ND, 2008, CRIT REV ONCOL HEMAT, V67, P273, DOI 10.1016/j.critrevonc.2008.05.003
   CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8
   Clavien PA, 2010, HEPATOLOGY, V52, P715, DOI 10.1002/hep.23713
   Eguchi H, 2000, DIGEST DIS SCI, V45, P1383, DOI 10.1023/A:1005564205755
   Farges O, 2003, ANN SURG, V237, P208, DOI 10.1097/00000658-200302000-00010
   Fernandez FG, 2005, J AM COLL SURGEONS, V200, P845, DOI 10.1016/j.jamcollsurg.2005.01.024
   FONG Y, 1995, ANN SURG, V222, P426
   Fong YM, 2006, ANN SURG, V243, P8, DOI 10.1097/01.sla.0000193599.57858.9b
   Fox M, 2011, REV CLIN GERONTOL, V21, P1, DOI 10.1017/S0959259810000365
   Gedaly R, 2009, ANN SURG, V249, P414, DOI 10.1097/SLA.0b013e31819a032d
   Halazun KJ, 2007, ANN SURG, V246, P1065, DOI 10.1097/SLA.0b013e3181492795
   Jamagin WR, 2002, ANN SURG, V236, P397, DOI 10.1097/01.SLA.0000029003.66466.B3
   Kaibori M, 2009, J SURG ONCOL, V99, P154, DOI 10.1002/jso.21221
   Kanas Gena P, 2012, Clin Epidemiol, V4, P283, DOI 10.2147/CLEP.S34285
   Karoui M, 2006, ANN SURG, V243, P1, DOI 10.1097/01.sla.0000193603.26265.c3
   Kauffmann Rondi, 2014, Hepatobiliary Surg Nutr, V3, P238, DOI 10.3978/j.issn.2304-3881.2014.09.01
   Khatri VP, 2005, J CLIN ONCOL, V23, P8490, DOI 10.1200/JCO.2004.00.6155
   Mann CD, 2008, EJSO-EUR J SURG ONC, V34, P428, DOI 10.1016/j.ejso.2007.03.013
   Menon KV, 2006, J AM COLL SURGEONS, V203, P677, DOI 10.1016/j.jamcollsurg.2006.07.025
   Motoyama H, 2015, AM J SURG, V209, P733, DOI 10.1016/j.amjsurg.2014.05.026
   Orcutt ST, 2012, HPB, V14, P863, DOI 10.1111/j.1477-2574.2012.00577.x
   Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433
   Rahbari NN, 2011, SURGERY, V149, P713, DOI 10.1016/j.surg.2010.10.001
   Schindl MJ, 2005, GUT, V54, P289, DOI 10.1136/gut.2004.046524
   SHIMADA M, 1994, SURG TODAY, V24, P44, DOI 10.1007/BF01676884
   Shindoh J, 2013, BRIT J SURG, V100, P1777, DOI 10.1002/bjs.9317
   Simoneau E, 2012, HPB, V14, P461, DOI 10.1111/j.1477-2574.2012.00476.x
   Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007
   Strasberg SM, 2013, ANN SURG, V257, P377, DOI 10.1097/SLA.0b013e31825a01f6
   Tanaka K, 2009, WORLD J HEPATOL, V1, P79, DOI 10.4254/wjh.v1.i1.79
   Tzeng CWD, 2014, HPB, V16, P459, DOI 10.1111/hpb.12155
   Vallance AE, 2018, HPB
   van Lienden KP, 2013, CARDIOVASC INTER RAD, V36, P25, DOI 10.1007/s00270-012-0440-y
   Wang H, 2014, PLOS ONE, V9, P6620
   Wang ZL, 2013, EXP GERONTOL, V48, P705, DOI 10.1016/j.exger.2013.05.059
   Wiggans MG, 2013, HPB SURG
   Young AL, 2012, HPB, V14, P194, DOI 10.1111/j.1477-2574.2011.00426.x
NR 42
TC 7
Z9 7
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1365-182X
EI 1477-2574
J9 HPB
JI HPB
PD JAN
PY 2020
VL 22
IS 1
BP 151
EP 160
DI 10.1016/j.hpb.2019.06.014
PG 10
WC Gastroenterology & Hepatology; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Surgery
GA KQ1XC
UT WOS:000516722700020
PM 31337601
OA hybrid
DA 2024-02-19
ER

PT J
AU Lin, BB
   Xu, DQ
   Wu, SQ
   Qi, SS
   Xu, YM
   Liu, X
   Zhang, XY
   Chen, C
AF Lin, Beibei
   Xu, Dingqiao
   Wu, Sanqiao
   Qi, Shanshan
   Xu, Youmei
   Liu, Xiang
   Zhang, Xiaoying
   Chen, Chen
TI Antioxidant Effects of <i>Sophora davidi</i> (Franch.) Skeels on
   d-Galactose-Induced Aging Model in Mice <i>via</i> Activating the
   SIRT1/p53 Pathway
SO FRONTIERS IN PHARMACOLOGY
LA English
DT Article
DE SIRT1; p53; D-galactose; anti-aging; Sophora davidi (franch; ) skeels
   fruits extract
ID COGNITIVE IMPAIRMENT
AB This study investigated the protective effect of Sophora davidi (Franch.) Skeels fruits extract (SDE) on d-galactose-induced acute aging in mice. Ultra performance liquid chromatography coupled with tine-of-flight mass spectrometry (UPLC-Q-TOF/MS) was performed to identify the composition of compounds in SDE. KM mice were divided stochastically into the normal control group (NC, saline), d-galactose (D-gal) model group, vitamin C (Vc) group (positive control), low-, medium-and high-dose SDE treat groups. After 28 days administration and fasting overnight, the serum, liver, and brain samples of mice were collected. The levels of inducible nitric oxide synthase (iNOS), acetylcholinesterase (AChE) activity in the brain, malondialdehyde (MDA) and reduced glutathione (GSH) content, superoxide dismutase (SOD) and total antioxidant capacity (T-AOC) activity in the liver and brain were measured. Immunohistochemistry was applied to detect silent information regulator 1 (SIRT1) and p53 protein expression in the liver and brain, and quantitative real-time polymerase chain reaction (qRT-PCR) was used to detect the expression of nuclear factor kappa B (NF-kappa B), tumor necrosis factor (TNF-alpha), interleukin-6 (IL-6), interleukin-1 beta (IL-1 beta), and anti-aging factor Klotho in the liver and brain. The results showed that UPLC-Q-TOF/MS identified 78 compounds in SDE. SDE could reduce the iNOS activity in serum and AChE activity in the brain, upregulate the levels of SOD, T-AOC and GSH in liver and brain, and debase the MDA content in liver and brain. SDE could downregulate the mRNA expressions of TNF-alpha, NF-kB, IL-1 beta, and IL-6 in the liver and brain, and elevate the mRNA expression of Klotho. SDE improved the pathological changes of the liver and brain induced by D-gal, increased the expression of SIRT1 protein in the liver and brain, and inhibited the expression of p53 protein induced by D-gal. To summarize, SDE demonstrated clear anti-aging effect, and its mechanism may be relevant to the activation of the SIRT1/p53 signal pathway.
C1 [Lin, Beibei; Wu, Sanqiao; Qi, Shanshan; Xu, Youmei; Liu, Xiang; Zhang, Xiaoying; Chen, Chen] Shaanxi Univ Technol, Coll Biol Sci & Engn, Chinese German Joint Lab Nat Prod Res, Hanzhong, Peoples R China.
   [Xu, Dingqiao] Shaanxi Univ Chinese Med, Key Lab Shaanxi Adm Tradit Chinese Med TCM Compat, Xian, Peoples R China.
   [Zhang, Xiaoying] Univ Minho, Dept Biol, Ctr Mol & Environm Biol, Campus Gualtar, Braga, Portugal.
C3 Shaanxi University of Technology; Shaanxi University of Chinese
   Medicine; Universidade do Minho
RP Zhang, XY; Chen, C (corresponding author), Shaanxi Univ Technol, Coll Biol Sci & Engn, Chinese German Joint Lab Nat Prod Res, Hanzhong, Peoples R China.; Zhang, XY (corresponding author), Univ Minho, Dept Biol, Ctr Mol & Environm Biol, Campus Gualtar, Braga, Portugal.
EM zhang@bio.uminho.pt; cchen@snut.edu.cn
RI Qi, Shanshan/IVU-8388-2023; Yan, Jing/JFA-6705-2023
FU Shaanxi Province Key Research and Development Plan, China [2016NY-161];
   Innovation Capability Support Program of Shaanxi, China [2019XY-04];
   Shaanxi Provincial Education Department, China [19JC012]
FX This study was funded by the Shaanxi Province Key Research and
   Development Plan (grant number 2016NY-161), Innovation Capability
   Support Program of Shaanxi (grant number 2019XY-04) and Scientific
   Research Program Funded by Shaanxi Provincial Education Department
   (grant number 19JC012), China.
CR Rahim RA, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18073532
   Anavi S, 2020, FREE RADICAL BIO MED, V146, P16, DOI 10.1016/j.freeradbiomed.2019.10.411
   Bektas A, 2018, EXP GERONTOL, V105, P10, DOI 10.1016/j.exger.2017.12.015
   Boozari M, 2019, PHYTOTHER RES, V33, P546, DOI 10.1002/ptr.6265
   Hano Christophe, 2020, Medicines (Basel), V7, DOI 10.3390/medicines7050026
   Huang Y, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00760
   Kim Y, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03261-8
   Kong SZ, 2018, MAR DRUGS, V16, DOI 10.3390/md16060181
   Li JJ, 2015, BRAIN RES, V1595, P19, DOI 10.1016/j.brainres.2014.10.012
   Li QS, 2018, BRAIN RES BULL, V137, P311, DOI 10.1016/j.brainresbull.2018.01.007
   Li XX, 2019, J PHYSIOL BIOCHEM, V75, P29, DOI 10.1007/s13105-018-0647-8
   Lin BB, 2019, CHEM BIODIVERS, V16, DOI 10.1002/cbdv.201900080
   Ma YJ, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/8938207
   Mijit M, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10030420
   Mu JF, 2021, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.600219
   Nagy G, 2015, J AM SOC MASS SPECTR, V26, P677, DOI 10.1007/s13361-014-1072-z
   Nicole E., 2008, INT J MOL MED, V21, P223, DOI [10.3892/ijmm.21.2.223, DOI 10.3892/IJMM.21.2.223]
   Qing WX, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00234
   Ruan QW, 2013, MECH AGEING DEV, V134, P89, DOI 10.1016/j.mad.2012.12.005
   Tai ZG, 2011, FOOD CHEM, V126, P1648, DOI 10.1016/j.foodchem.2010.12.048
   Tian Y., 2019, FOOD SCI, V40, P300, DOI [10.15255/KUI.2013.027, DOI 10.15255/KUI.2013.027]
   Tundis R, 2009, J ENZYM INHIB MED CH, V24, P818, DOI 10.1080/14756360802399662
   Wang YH, 2009, AGEING RES REV, V8, P43, DOI 10.1016/j.arr.2008.10.002
   Wang ZQ, 2016, INT J ONCOL, V49, P2331, DOI 10.3892/ijo.2016.3734
   Xiao P, 1999, PHYTOCHEMISTRY, V50, P189, DOI 10.1016/S0031-9422(98)00486-5
   Xie YX, 2017, MOLECULES, V22, DOI 10.3390/molecules22111913
   [曾露露 Zeng Lulu], 2018, [中国药学杂志, Chinese Pharmaceutical Journal], V53, P1470
   Zhao HD, 2018, FOOD NUTR RES, V62, DOI 10.29219/fnr.v62.1371
   Zhao MH, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00071
   Zhou XX, 2013, PHYTOCHEM LETT, V6, P372, DOI 10.1016/j.phytol.2013.05.002
   Zhu SY, 2017, BIOMED ENVIRON SCI, V30, P623, DOI 10.3967/bes2017.083
NR 31
TC 3
Z9 3
U1 3
U2 30
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1663-9812
J9 FRONT PHARMACOL
JI Front. Pharmacol.
PD DEC 6
PY 2021
VL 12
AR 754554
DI 10.3389/fphar.2021.754554
PG 15
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA XR5FY
UT WOS:000732255900001
PM 34938181
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Hakeem, A
   Reza, S
   Moinuddin, S
   Bhatti, S
   Khalid, I
   Noor, R
   Mahmood, K
AF Hakeem, Abdul
   Reza, Shahzad
   Moinuddin, Salman
   Bhatti, Sabha
   Khalid, Imran
   Noor, Rahat
   Mahmood, Khaild
TI Cirrhosis in Werner's syndrome: An unusual presentation of premature
   aging
SO MEDICAL SCIENCE MONITOR
LA English
DT Article
DE Werner's syndrome; premature ageing; cirrhosis
ID SYNDROME ADULT PROGERIA; SYNDROME PROTEIN; NATURAL-HISTORY; RESISTANT;
   GENETICS
AB Background: Werner's syndrome (WS) is an rare autosomal recessive, hereditary systemic disease with progeroid features, usually presenting in adolescence. It is associated with increased genetic instability and I elevated risk of neoplasia. Clinical manifestations include small stature, scleroderma-like changes in the skin, juvenile cataracts, and premature aging. It. has been reported mostly in ophthalmoles in dic skin, logical, dermatological, and orthopedics literature. It. is now being correctly acknowledged as a I condition where a lack of Werner's protein (WRN protein) results in an overall decline of normal physiological functions of various organ systems. Cirrhosis is an extremely rare manifestation of Werner's syndrome and has been reported in <4% of patients.
   Case Report: A case of cirrhosis in a patient with Werner's syndrome is described. A 25-year-old male presented with features of premature senility and progressive abdominal distension with black tarry stools of over six moths duration. His clinical presentation and work-up including a biopsy were consistent with cirrhosis. The work-Up for Other causes of chronic liver disease was negative. He was medically managed for portal hypertension. Despite maximal medical therapy, lie (lied due to recurrent episodes of hematemesis.
   Conclusions: This case is not only die first documented case of Werner's front Pakistan, but describes an unusual presentation: cirrhosis, a very rare complication of WS. Overproduction of types I and III collagen and nonalcoholic steatohepatitis secondary to insulin resistance and dyslipidemia possibly contribute to cirrhosis in WS.
C1 Univ Wisconsin Hosp & Clin, Madison, WI 53705 USA.
   Civil Hosp, Karachi, Pakistan.
   Aga Khan Univ Hosp, Karachi, Pakistan.
C3 University of Wisconsin System; University of Wisconsin Madison; Dow
   University of Health Sciences; Aga Khan University
RP Hakeem, A (corresponding author), Univ Wisconsin Hosp & Clin, 2705 Univ Ave 11, Madison, WI 53705 USA.
EM a.hakeem@hosp.wisc.edu
RI Hakeem, Abdul/HLQ-7358-2023
CR ARAKAWA M, 1990, J INVEST DERMATOL, V94, P187, DOI 10.1111/1523-1747.ep12874489
   Barak Y, 2001, COMPR PSYCHIAT, V42, P508, DOI 10.1053/comp.2001.27895
   BYUNGCHEN A, 2004, J BIOL CHEM, V279, P53465
   Chen Lishan, 2002, Journal of Biomedicine & Biotechnology, V2, P46, DOI 10.1155/S1110724302201011
   EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001
   Fossel M, 2000, J PEDIATR ENDOCR MET, V13, P1477
   GOTO M, 1979, J CLIN INVEST, V64, P695, DOI 10.1172/JCI109511
   Goto M, 2000, CLIN EXP RHEUMATOL, V18, P760
   Goto M, 1997, MECH AGEING DEV, V98, P239, DOI 10.1016/S0047-6374(97)00111-5
   GOTO M, 1996, BIOMARKERS PREV, V5, P239
   Gray MD, 1997, NAT GENET, V17, P100, DOI 10.1038/ng0997-100
   Hatamochi Atsushi, 1994, Journal of Dermatological Science, V7, P210, DOI 10.1016/0923-1811(94)90097-3
   HRABKO RP, 1982, ARCH DERMATOL, V118, P106, DOI 10.1001/archderm.118.2.106
   IRWIN GW, 1953, AM J MED, V15, P266, DOI 10.1016/0002-9343(53)90079-5
   Ishikawa Y, 2000, JPN J CANCER RES, V91, P1345, DOI 10.1111/j.1349-7006.2000.tb00924.x
   Liou I, 2006, J CLIN GASTROENTEROL, V40, pS11
   Mori S, 1988, Nihon Ronen Igakkai Zasshi, V25, P626
   MURATA K, 1985, ADV EXP MED BIOL, V190, P285
   Nehlin JO, 2000, ANN NY ACAD SCI, V908, P167
   Oshima J, 2000, BIOESSAYS, V22, P894, DOI 10.1002/1521-1878(200010)22:10<894::AID-BIES4>3.3.CO;2-2
   Sogawa M, 2001, Ann Thorac Cardiovasc Surg, V7, P378
   TOLLEFSBOL TO, 1984, AGE, V7, P75, DOI 10.1007/BF02432205
   WERNER O, 2004, THESIS KIEL U
   YAMADA H, 1979, TAISYA, V16, P1215
   Yamada K, 1999, DIABETES CARE, V22, P2094, DOI 10.2337/diacare.22.12.2094
   Yamamoto K, 2003, J Orthop Surg (Hong Kong), V11, P224
NR 26
TC 4
Z9 5
U1 0
U2 1
PU INT SCIENTIFIC LITERATURE, INC
PI ALBERTSON
PA 1125 WILLIS AVE, ALBERTSON, NY 11507 USA
SN 1234-1010
J9 MED SCI MONITOR
JI Med. Sci. Monitor
PD MAY
PY 2007
VL 13
IS 5
BP CS61
EP CS66
PG 6
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 173EK
UT WOS:000246856100012
PM 17476199
DA 2024-02-19
ER

PT J
AU Shabalina, IG
   Landreh, L
   Edgar, D
   Hou, M
   Gibanova, N
   Atanassova, N
   Petrovic, N
   Hultenby, K
   Söder, O
   Nedergaard, J
   Svechnikov, K
AF Shabalina, Irina G.
   Landreh, Luise
   Edgar, Daniel
   Hou, Mi
   Gibanova, Natalia
   Atanassova, Nina
   Petrovic, Natasa
   Hultenby, Kjell
   Soder, Olle
   Nedergaard, Jan
   Svechnikov, Konstantin
TI Leydig cell steroidogenesis unexpectedly escapes mitochondrial
   dysfunction in prematurely aging mice
SO FASEB JOURNAL
LA English
DT Article
DE cytochrome b5; reactive oxygen species; respiratory chain deficiency;
   testosterone synthesis
ID MTDNA MUTATOR MICE; TESTOSTERONE SYNTHESIS; LIVER-MITOCHONDRIA;
   ADIPOSE-TISSUE; DNA POLYMERASE; PROTEIN; MEMBRANE; OUTER; RAT; MUTATIONS
AB Point mutations and deletions of mitochondrial DNA (mtDNA) accumulate in tissues during aging in animals and humans and are the basis for mitochondrial diseases. Testosterone synthesis occurs in the mitochondria of Leydig cells. Mitochondrial dysfunction (as induced here experimentally in mtDNA mutator mice that carry a proofreading-deficient form of mtDNA polymerase gamma, leading to mitochondrial dysfunction in all cells types so far studied) would therefore be expected to lead to low testosterone levels. Although mtDNA mutator mice showed a dramatic reduction in testicle weight (only 15% remaining) and similar decreases in number of spermatozoa, testosterone levels in mt DNA mutator mice were unexpectedly fully unchanged. Leydig cell did not escape mitochondrial damage (only 20% of complex I and complex IV remaining) and did show high levels of reactive oxygen species (ROS) production (>5-fold increased), and permeabilized cells demonstrated absence of normal mitochondrial function. Nevertheless, within intact cells, mitochondrial membrane potential remained high, and testosterone production was maintained. This implies development of a compensatory mechanism. A rescuing mechanism involving electronsfrom the pentose phosphate pathway transferred via a 3-fold up-regulated cytochrome b5 to cytochrome c, allowing for mitochondrial energization, is suggested. Thus, the Leydig cells escape mitochondrial dysfunction via a unique rescue pathway. Such a pathway, bypassing respiratory chain dysfunction, may be of relevance with regard to mitochondrial disease therapy and to managing ageing in general.
C1 [Shabalina, Irina G.; Edgar, Daniel; Gibanova, Natalia; Petrovic, Natasa; Nedergaard, Jan] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, SE-10691 Stockholm, Sweden.
   [Landreh, Luise; Hou, Mi; Soder, Olle; Svechnikov, Konstantin] Astrid Lindgrens Children Hosp, Pediat Endocrinol Unit, Dept Womens & Childrens Hlth, Stockholm, Sweden.
   [Edgar, Daniel; Hultenby, Kjell] Karolinska Inst, Dept Lab Med, Huddinge, Sweden.
   [Atanassova, Nina] Pathol & Anthropol Museum, Inst Expt Morphol, Sofia, Bulgaria.
C3 Stockholm University; Karolinska Institutet; Bulgarian Academy of
   Sciences
RP Nedergaard, J (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Arrhenius Labs F3, SE-10691 Stockholm, Sweden.
EM jan.nedergaard@su.se
RI Nedergaard, Jan/A-1706-2010; Atanassova, Nina/AAH-2722-2021; Shabalina,
   Irina/AAC-3720-2019; Nedergaard, Jan/Q-8286-2019; Shabalina, Irina
   G/A-4225-2011
OI Atanassova, Nina/0000-0002-9032-3588; Shabalina,
   Irina/0000-0002-2915-6450; Shabalina, Irina G/0000-0002-2915-6450;
   Nedergaard, Jan/0000-0003-2070-1587
FU Swedish Research Council; Children's Cancer Fund; European Union;
   Karolinska Institutet Research Fund; Frimurare Barnhuset Foundation;
   Olle Engkvist Byggmastare Foundation; Gunvor och Josef Aners Foundation;
   EU-FP7 collaborative project DIABAT [HEALTH-F2-2011-278373]; Knut and
   Alice Wallenberg's Foundation; Mitoengineering Research Institute
FX The authors thank Aleksandra Trifunovic for providing the initial
   breeding pair of mtDNA mutator mice, and Barbara Cannon for stimulating
   discussions. Financial support was received from the Swedish Research
   Council, Children's Cancer Fund, the European Union, Karolinska
   Institutet Research Fund and Frimurare Barnhuset Foundation (to O.S.),
   Olle Engkvist Byggmastare and Gunvor och Josef Aners Foundations (to
   K.S.), the Swedish Research Council, the EU-FP7 collaborative project
   DIABAT (HEALTH-F2-2011-278373), the Knut and Alice Wallenberg's
   Foundation (to J.N.) and the Mitoengineering Research Institute (to
   I.G.S. and N.G.).
CR Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Allen JA, 2006, ENDOCRINOLOGY, V147, P3924, DOI 10.1210/en.2005-1204
   ARCHAKOV AI, 1974, FEBS LETT, V39, P239, DOI 10.1016/0014-5793(74)80059-1
   BARNARD T, 1969, J ULTRA MOL STRUCT R, V29, P311, DOI 10.1016/S0022-5320(69)90109-9
   BERNARDI P, 1981, J BIOL CHEM, V256, P7187
   Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7
   Bodrova ME, 1998, FEBS LETT, V435, P269, DOI 10.1016/S0014-5793(98)01072-2
   Chen HL, 2001, EXP GERONTOL, V36, P1361, DOI 10.1016/S0531-5565(01)00118-8
   Dai Dao-Fu, 2014, Longev Healthspan, V3, P6, DOI 10.1186/2046-2395-3-6
   Dai Y, 2013, MITOCHONDRION, V13, P282, DOI 10.1016/j.mito.2013.03.006
   Dillon LM, 2012, HUM MOL GENET, V21, P2288, DOI 10.1093/hmg/dds049
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   ERNSTER L, 1981, FEBS LETT, V132, P6, DOI 10.1016/0014-5793(81)80415-2
   Fox R, 2011, P NATL ACAD SCI USA, V108, P8779, DOI 10.1073/pnas.1106344108
   Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kukat A, 2011, BIOCHEM BIOPH RES CO, V409, P394, DOI 10.1016/j.bbrc.2011.04.145
   Logan A, 2014, AGING CELL, V13, P765, DOI 10.1111/acel.12212
   Midzak A, 2011, MOL CELL ENDOCRINOL, V336, P70, DOI 10.1016/j.mce.2010.12.007
   Midzak AS, 2007, ENDOCRINOLOGY, V148, P2583, DOI 10.1210/en.2006-1488
   Mito T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055789
   Nieschlag E, 1999, CLIN ENDOCRINOL, V51, P139, DOI 10.1046/j.1365-2265.1999.00846.x
   Ogishima T, 2003, J BIOL CHEM, V278, P21204, DOI 10.1074/jbc.M301698200
   PAYNE AH, 1980, ENDOCRINOLOGY, V106, P1424, DOI 10.1210/endo-106-5-1424
   Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030
   Rone MB, 2009, BBA-MOL CELL BIOL L, V1791, P646, DOI 10.1016/j.bbalip.2009.03.001
   Ross JM, 2010, P NATL ACAD SCI USA, V107, P20087, DOI 10.1073/pnas.1008189107
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044
   Sharpe RM, 2000, BIOL REPROD, V62, P1685, DOI 10.1095/biolreprod62.6.1685
   SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415
   Stocco DM, 2001, ANNU REV PHYSIOL, V63, P193, DOI 10.1146/annurev.physiol.63.1.193
   Svechnikov K, 2003, J MOL ENDOCRINOL, V30, P59, DOI 10.1677/jme.0.0300059
   Svechnikov KV, 2001, MOL CELL ENDOCRINOL, V182, P193, DOI 10.1016/S0303-7207(01)00554-8
   Tan AS, 2000, J IMMUNOL METHODS, V238, P59, DOI 10.1016/S0022-1759(00)00156-3
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   WEIBEL ER, 1978, J CELL BIOL, V77, P584, DOI 10.1083/jcb.77.2.584
   Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104
   WREFORD NG, 1995, MICROSC RES TECHNIQ, V32, P423, DOI 10.1002/jemt.1070320505
NR 39
TC 14
Z9 19
U1 0
U2 7
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD AUG
PY 2015
VL 29
IS 8
BP 3274
EP 3286
DI 10.1096/fj.15-271825
PG 13
WC Biochemistry & Molecular Biology; Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA CN9VA
UT WOS:000358796900016
PM 25900807
DA 2024-02-19
ER

PT J
AU Okatani, Y
   Wakatsuki, A
   Reiter, RJ
   Enzan, H
   Miyahara, Y
AF Okatani, Y
   Wakatsuki, A
   Reiter, RJ
   Enzan, H
   Miyahara, Y
TI Protective effect of melatonin against mitochondrial injury induced by
   ischemia and reperfusion of rat liver
SO EUROPEAN JOURNAL OF PHARMACOLOGY
LA English
DT Article
DE melatonin; antioxidant; free radical; mitochondria; ischemia/reperfusion
ID SENESCENCE-ACCELERATED MICE; PERMEABILITY TRANSITION PORE; OXIDATIVE
   DAMAGE; RESPIRATORY-CHAIN; GLUTATHIONE-PEROXIDASE; SUPEROXIDE-DISMUTASE;
   REACTIVE OXYGEN; DNA-DAMAGE; COMPLEX-I; BRAIN
AB Melatonin, a pineal secretory product, is a potent scavenger of a variety of free radicals. The aim of this study was to investigate the effect of melatonin on the prevention of mitochondrial injury induced by hepatic ischemia and reperfusion. Rats were subjected to 70 min of hepatic ischemia and 2 h of reperfusion. Fifteen minutes prior to ischemia and at reperfusion, animals received vehicle or melatonin (10 mg/kg body weight) intraperitoneally. In the vehicle-treated animals, the respiratory control index, ADP/O, State 3 respiration and dinitrophenol-induced uncoupled respiration decreased markedly after ischemia/reperfusion and were restored by melatonin administration. Similarly, pH change coupled with mitochondrial energy transfer was suppressed by ischemia/reperfusion with the effects being reduced by melatonin treatment. Mitochondrial lipid peroxidation was elevated in the ischemic/reperfused vehicle-treated livers, but this elevation was attenuated by melatonin. Mitochondrial glutathione peroxidase activity decreased in the vehicle-treated group with this decrease being reduced by melatonin treatment. Electron microscopic studies demonstrated that treatment with melatonin restored to near normal the ischemia/reperfusion-induced disorganization of mitochondrial structure. Melatonin protects against mitochondrial injury which reduces mitochondrial oxidative stress and improves ischemia/reperfusion-induced hepatic energy metabolism. (C) 2003 Elsevier Science B.V. All rights reserved.
C1 Kochi Med Sch, Dept Clin Nursing Sci, Nanko Ku, Kochi 7838505, Japan.
   Kochi Med Sch, Dept Obstet & Gynecol, Nanko Ku, Kochi 7838505, Japan.
   Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78284 USA.
   Kochi Med Sch, Dept Pathol 1, Nanko Ku, Kochi 7838505, Japan.
C3 Kochi University; Kochi University; University of Texas System;
   University of Texas Health Science Center at San Antonio; Kochi
   University
RP Okatani, Y (corresponding author), Kochi Med Sch, Dept Clin Nursing Sci, Nanko Ku, Kochi 7838505, Japan.
EM okataniy@med.kochi-ms.ac.jp
CR Absi E, 2000, J PINEAL RES, V29, P40, DOI 10.1034/j.1600-079X.2000.290106.x
   Acuna Castroviejo Dario, 2002, Curr Top Med Chem, V2, P133
   Acuña-Castroviejo D, 2001, J PINEAL RES, V30, P65, DOI 10.1034/j.1600-079X.2001.300201.x
   Allegra M, 2003, J PINEAL RES, V34, P1, DOI 10.1034/j.1600-079X.2003.02112.x
   Antolin I, 1996, FASEB J, V10, P882, DOI 10.1096/fasebj.10.8.8666165
   BARLOWWALDEN LR, 1995, NEUROCHEM INT, V26, P497, DOI 10.1016/0197-0186(94)00154-M
   BERNARDI P, 1994, J BIOENERG BIOMEMBR, V26, P509, DOI 10.1007/BF00762735
   CHANCE B, 1956, ADV ENZYMOL REL S BI, V17, P65
   Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233
   Cuzzocrea S, 2001, J PINEAL RES, V30, P1, DOI 10.1034/j.1600-079X.2001.300101.x
   DEGROOT H, 1994, HEPATO-GASTROENTEROL, V41, P328
   Fiskum G, 1999, J CEREBR BLOOD F MET, V19, P351, DOI 10.1097/00004647-199904000-00001
   Garcia JJ, 1997, FEBS LETT, V408, P297, DOI 10.1016/S0014-5793(97)00447-X
   Hirata Y, 1996, J PEDIATR SURG, V31, P1199, DOI 10.1016/S0022-3468(96)90231-6
   HOGEBOOM GH, 1985, METHOD ENZYMOL, V181, P16
   JAESCHKE H, 1991, CHEM-BIOL INTERACT, V79, P115, DOI 10.1016/0009-2797(91)90077-K
   Jeon BR, 2001, SHOCK, V15, P112, DOI 10.1097/00024382-200115020-00006
   KOBAYASHI H, 1991, J SURG RES, V51, P240, DOI 10.1016/0022-4804(91)90101-Q
   Livrea MA, 1997, FREE RADICAL BIO MED, V23, P706, DOI 10.1016/S0891-5849(97)00018-X
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Martín M, 2002, INT J BIOCHEM CELL B, V34, P348, DOI 10.1016/S1357-2725(01)00138-8
   Martín M, 2000, J PINEAL RES, V28, P242, DOI 10.1034/j.1600-079X.2000.280407.x
   MARUBAYASHI S, 1986, SURGERY, V99, P184
   MCCORD JM, 1985, NEW ENGL J MED, V312, P159
   MITTNACHT S, 1981, J BIOL CHEM, V256, P3199
   Morioka N, 1999, J PINEAL RES, V27, P202, DOI 10.1111/j.1600-079X.1999.tb00616.x
   NISHIMURA M, 1962, BIOCHIM BIOPHYS ACTA, V59, P177
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Okatani Y, 2000, J PINEAL RES, V28, P89, DOI 10.1034/j.1600-079X.2001.280204.x
   Okatani Y, 2002, J PINEAL RES, V32, P143, DOI 10.1034/j.1600-079x.2002.1o106.x
   Okatani Y, 2002, NEUROBIOL AGING, V23, P639, DOI 10.1016/S0197-4580(02)00005-2
   Okatani Y, 2002, J PINEAL RES, V33, P127, DOI 10.1034/j.1600-079X.2002.02109.x
   Pablos M.I., 1997, NEUROENDOCRINOL LETT, V18, P49
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   Pappolla MA, 1999, J PINEAL RES, V27, P226, DOI 10.1111/j.1600-079X.1999.tb00619.x
   Poeggeler B, 2002, J PINEAL RES, V33, P20, DOI 10.1034/j.1600-079X.2002.01873.x
   Reiter RJ, 2001, ANN NY ACAD SCI, V939, P200
   Reiter RJ, 2001, CELL BIOCHEM BIOPHYS, V34, P237, DOI 10.1385/CBB:34:2:237
   Reiter RJ., 2000, CURR TOP BIOPHYS, V24, P171
   Rodríguez-Reynoso S, 2001, J SURG RES, V100, P141, DOI 10.1006/jsre.2001.6185
   ROMANI F, 1988, EUR SURG RES, V20, P335, DOI 10.1159/000128783
   Sahna E, 2002, J PINEAL RES, V32, P194, DOI 10.1034/j.1600-079x.2002.1o853.x
   Sener G, 2002, J PINEAL RES, V32, P120, DOI 10.1034/j.1600-079x.2002.1848.x
   Sewerynek E, 1996, HEPATO-GASTROENTEROL, V43, P898
   Sun FY, 2002, J PINEAL RES, V33, P48, DOI 10.1034/j.1600-079X.2002.01891.x
   SUZUKI S, 1994, CIRC SHOCK, V42, P204
   TAKAHASHI T, 1955, SEIKAGAKU, V26, P690
   Tan DX, 2001, FASEB J, V15, P2294, DOI 10.1096/fj.01-0309fje
   Tan DX, 1998, BIOCHEM BIOPH RES CO, V253, P614, DOI 10.1006/bbrc.1998.9826
   Tan DX, 2000, FREE RADICAL BIO MED, V29, P1177, DOI 10.1016/S0891-5849(00)00435-4
   Tesoriere L, 2001, J PINEAL RES, V31, P114, DOI 10.1034/j.1600-079x.2001.310204.x
   Wakatsuki A, 2001, J PINEAL RES, V31, P167, DOI 10.1034/j.1600-079x.2001.310211.x
   WU TW, 1991, HEPATOLOGY, V13, P575, DOI 10.1002/hep.1840130328
   ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A
NR 54
TC 96
Z9 106
U1 1
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0014-2999
EI 1879-0712
J9 EUR J PHARMACOL
JI Eur. J. Pharmacol.
PD MAY 23
PY 2003
VL 469
IS 1-3
BP 145
EP 152
DI 10.1016/S0014-2999(03)01643-1
PG 8
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 688HD
UT WOS:000183427400018
PM 12782196
DA 2024-02-19
ER

PT J
AU Wang, HB
   Lu, J
   Stevens, T
   Roberts, A
   Mandel, J
   Avula, R
   Ma, BW
   Wu, YJ
   Wang, JL
   Van't Land, C
   Finkel, T
   Vockley, JE
   Airik, M
   Airik, R
   Muzumdar, R
   Gong, ZW
   Torbenson, MS
   Prochownik, EV
AF Wang, Huabo
   Lu, Jie
   Stevens, Taylor
   Roberts, Alexander
   Mandel, Jordan
   Avula, Raghunandan
   Ma, Bingwei
   Wu, Yijen
   Wang, Jinglin
   Van't Land, Clinton
   Finkel, Toren
   Vockley, Jerry E.
   Airik, Merlin
   Airik, Rannar
   Muzumdar, Radhika
   Gong, Zhenwei
   Torbenson, Michel S.
   Prochownik, Edward V.
TI Premature aging and reduced cancer incidence associated with
   near-complete body-wide<i> Myc</i> inactivation
SO CELL REPORTS
LA English
DT Article; Early Access
ID C-MYC; INTESTINAL CRYPTS; HUMAN-FIBROBLASTS; GENE-EXPRESSION; MOUSE
   MODELS; P53 FUNCTION; DNA-DAMAGE; MITOCHONDRIA; ONCOGENE; DEFECTS
AB MYC proto-oncogene dysregulation alters metabolism, translation, and other functions in ways that support tumor induction and maintenance. Although Myc+/- mice are healthier and longer-lived than control mice, the long-term ramifications of more complete Myc loss remain unknown. We now describe the chronic consequences of body-wide Myc inactivation initiated postnatally. "MycKO"mice acquire numerous features of premature aging, including altered body composition and habitus, metabolic dysfunction, hepatic steatosis, and dysregulation of gene sets involved in functions that normally deteriorate with aging. Yet, MycKO mice have extended lifespans that correlate with a 3-to 4-fold lower lifetime cancer incidence. Aging tissues from normal mice and humans also downregulate Myc and gradually alter many of the same Myc target gene sets seen in MycKO mice. Normal aging and its associated cancer predisposition are thus highly linked via Myc.
C1 [Wang, Huabo; Lu, Jie; Stevens, Taylor; Roberts, Alexander; Mandel, Jordan; Avula, Raghunandan; Wang, Jinglin; Prochownik, Edward V.] UPMC Childrens Hosp Pittsburgh, Div Hematol Oncol, Pittsburgh, PA 15224 USA.
   [Avula, Raghunandan] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15224 USA.
   [Ma, Bingwei] Tongji Univ, Sch Med, Shanghai, Peoples R China.
   [Wu, Yijen] Univ Pittsburgh, Dept Dev Biol, Pittsburgh, PA USA.
   [Wang, Jinglin] Cent South Univ, Xiangya Sch Med, Changsha 410013, Hunan, Peoples R China.
   [Van't Land, Clinton; Vockley, Jerry E.] UPMC Childrens Hosp Pittsburgh, Div Med Genet, Pittsburgh, PA 15224 USA.
   [Finkel, Toren] Dept Internal Med, Div Cardiol, Pittsburgh, PA 15224 USA.
   [Finkel, Toren] UPMC Aging Inst, Pittsburgh, PA 15224 USA.
   [Airik, Merlin; Airik, Rannar] Childrens Hosp Pittsburgh, Div Nephrol, Pittsburgh, PA 15224 USA.
   [Muzumdar, Radhika; Gong, Zhenwei] UPMC Childrens Hosp Pittsburgh, Div Endocrinol, Pittsburgh, PA 15224 USA.
   [Torbenson, Michel S.] Mayo Clin, Div Lab Med & Pathol, Rochester, MN 55905 USA.
   [Prochownik, Edward V.] UPMC, Dept Microbiol & Mol Genet, Pittsburgh, PA 15261 USA.
   [Prochownik, Edward V.] Hillman Canc Ctr UPMC, Pittsburgh, PA 15232 USA.
   [Prochownik, Edward V.] UPMC, Pittsburgh Liver Res Ctr, Pittsburgh, PA 15261 USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); University
   of Pittsburgh; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); University of Pittsburgh; Tongji University; Pennsylvania
   Commonwealth System of Higher Education (PCSHE); University of
   Pittsburgh; Central South University; Pennsylvania Commonwealth System
   of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania
   Commonwealth System of Higher Education (PCSHE); University of
   Pittsburgh; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); University of Pittsburgh; Mayo Clinic; Pennsylvania
   Commonwealth System of Higher Education (PCSHE); University of
   Pittsburgh; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); University of Pittsburgh
RP Prochownik, EV (corresponding author), UPMC Childrens Hosp Pittsburgh, Div Hematol Oncol, Pittsburgh, PA 15224 USA.; Prochownik, EV (corresponding author), UPMC, Dept Microbiol & Mol Genet, Pittsburgh, PA 15261 USA.; Prochownik, EV (corresponding author), Hillman Canc Ctr UPMC, Pittsburgh, PA 15232 USA.; Prochownik, EV (corresponding author), UPMC, Pittsburgh Liver Res Ctr, Pittsburgh, PA 15261 USA.
EM procev@chp.edu
OI WANG, HUABO/0000-0003-2551-3243
FU NIH [RO1 CA174713, P50 CA 210964, 22IN42]; Hyundai Hope on Wheels
   Scholar grant; Rally Foundation Independent Investigator grant [DK RO1
   109907]; UPMC Children's Hospital of Pittsburgh Foundation
FX This work was supported by NIH grant RO1 CA174713, a Hyundai Hope on
   Wheels Scholar grant, Rally Foundation Independent Investigator grant
   22IN42, and The UPMC Children's Hospital of Pittsburgh Foundation (all
   to E.V.P) . J.E.V. was supported by NIH grant DK RO1 109907. M.S.T. was
   sup-ported by NIH grant P50 CA 210964. Analysis of RNA-seq data was
   partly supported by The University of Pittsburgh Center for Research
   Computing. Acylcarnitine profiling was performed in collaboration with
   the Rangos Research Center Metabolic Core LC/MS/MS services at the
   Department of Pediatrics, University of Pittsburgh Medical Center.
CR Almanzar N, 2020, NATURE, V583, P590, DOI 10.1038/s41586-020-2496-1
   Anisimova AS, 2018, AGING-US, V10, P4269, DOI 10.18632/aging.101721
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152
   Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602
   Beaulieu ME, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aar5012
   Benanti JA, 2007, MOL CANCER RES, V5, P1181, DOI 10.1158/1541-7786.MCR-06-0372
   Bertolotti M, 2014, WORLD J GASTROENTERO, V20, P14185, DOI 10.3748/wjg.v20.i39.14185
   Bettess MD, 2005, MOL CELL BIOL, V25, P7868, DOI 10.1128/MCB.25.17.7868-7878.2005
   Bhadra M, 2020, HUM GENET, V139, P357, DOI 10.1007/s00439-019-02094-6
   Billin AN, 2006, CURR TOP MICROBIOL, V302, P255
   Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Bruss MD, 2010, AM J PHYSIOL-ENDOC M, V298, pE108, DOI 10.1152/ajpendo.00524.2009
   Camarda R, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00035
   Castro B, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2237
   Chadt A, 2020, PFLUG ARCH EUR J PHY, V472, P1273, DOI 10.1007/s00424-020-02417-x
   Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128
   Cronin-Fenton DP, 2014, FUTURE ONCOL, V10, P107, DOI [10.2217/fon.13.168, 10.2217/FON.13.168]
   CUTHBERT AW, 1995, J PHYSIOL-LONDON, V482, P449, DOI 10.1113/jphysiol.1995.sp020531
   Dall'Ara E, 2016, MECH AGEING DEV, V160, P93, DOI 10.1016/j.mad.2016.08.001
   Dang CV, 2011, COLD SH Q B, V76, P369, DOI 10.1101/sqb.2011.76.011296
   Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014
   Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003
   Dang CV, 2010, CANCER RES, V70, P859, DOI 10.1158/0008-5472.CAN-09-3556
   DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671
   DEAN R, 1986, BIOCHEM BIOPH RES CO, V135, P105, DOI 10.1016/0006-291X(86)90948-4
   Deschênes M, 2017, AGING CELL, V16, P918, DOI 10.1111/acel.12646
   Destro-Bisol G, 1999, AM J PHYS ANTHROPOL, V109, P269, DOI 10.1002/(SICI)1096-8644(199906)109:2&lt;269::AID-AJPA11&gt;3.0.CO;2-#
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Dolezal JM, 2017, J BIOL CHEM, V292, P10068, DOI 10.1074/jbc.M117.782052
   Donate LE, 2011, PHILOS T R SOC B, V366, P76, DOI 10.1098/rstb.2010.0291
   Dubois NC, 2008, DEVELOPMENT, V135, P2455, DOI 10.1242/dev.022707
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207
   Edmunds LR, 2016, ONCOTARGET, V7, P30379, DOI 10.18632/oncotarget.8856
   Edmunds LR, 2015, J BIOL CHEM, V290, P20100, DOI 10.1074/jbc.A114.580662
   Edmunds LR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134049
   EI-Gharbawy A, 2018, PEDIATR CLIN N AM, V65, P317, DOI 10.1016/j.pcl.2017.11.006
   Ewels PA, 2020, NAT BIOTECHNOL, V38, P276, DOI 10.1038/s41587-020-0439-x
   Fazzini F, 2021, J INTERN MED, V290, P190, DOI 10.1111/joim.13242
   Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136
   Fernandez-Flores A, 2019, J CUTAN PATHOL, V46, P508, DOI 10.1111/cup.13467
   Folgueras AR, 2018, CIRC RES, V123, P905, DOI 10.1161/CIRCRESAHA.118.312204
   Gabay M, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014241
   Gartel AL, 2003, EXP CELL RES, V283, P17, DOI 10.1016/S0014-4827(02)00020-4
   Ge ZQ, 2018, CELL REP, V23, P213, DOI 10.1016/j.celrep.2018.03.047
   Germano G, 2017, NATURE, V552, P116, DOI 10.1038/nature24673
   Ghosh A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082661
   GIBSON KM, 1994, EUR J PEDIATR, V153, pS62, DOI 10.1007/BF02138780
   Goetzman ES, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00129
   Goh Jorming, 2015, Curr Protoc Mouse Biol, V5, P283, DOI 10.1002/9780470942390.mo140295
   Gomez-Roman N, 2006, BIOCHEM SOC SYMP, V73, P141, DOI 10.1042/bss0730141
   Gonskikh Y, 2017, MECH AGEING DEV, V168, P30, DOI 10.1016/j.mad.2017.04.003
   Graves JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037699
   Grisanzio Chiara, 2010, Genes Cancer, V1, P555, DOI 10.1177/1947601910381380
   Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313
   Han HY, 2019, CANCER CELL, V36, P483, DOI 10.1016/j.ccell.2019.10.001
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Hedrick PW, 2012, TRENDS ECOL EVOL, V27, P698, DOI 10.1016/j.tree.2012.08.012
   Herkert Barbara, 2010, Genes Cancer, V1, P580, DOI 10.1177/1947601910379012
   Hofmann JW, 2015, CELL, V160, P477, DOI 10.1016/j.cell.2014.12.016
   Honma T, 2011, J NUTR SCI VITAMINOL, V57, P123, DOI 10.3177/jnsv.57.123
   Houten SM, 2016, ANNU REV PHYSIOL, V78, P23, DOI 10.1146/annurev-physiol-021115-105045
   Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134
   Howlett SE, 2015, INTERD T GERONT GERI, V41, P15, DOI 10.1159/000381131
   Iwase T, 2021, BREAST CANCER RES TR, V186, P273, DOI 10.1007/s10549-020-06092-5
   Jackson LE, 2017, CANCER RES, V77, P5795, DOI 10.1158/0008-5472.CAN-17-1325
   Jang JY, 2018, J CLIN INVEST, V128, P3662, DOI 10.1172/JCI120842
   Jiang T, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0787-5
   Jones TR, 1997, PARASITOL TODAY, V13, P107, DOI 10.1016/S0169-4758(96)10083-1
   Kalb R, 2006, GENOME DYN, V1, P218, DOI 10.1159/000092510
   Kalkat M, 2018, MOL CELL, V72, P836, DOI 10.1016/j.molcel.2018.09.031
   Kalkat M, 2017, GENES-BASEL, V8, DOI 10.3390/genes8060151
   Kang CF, 2018, ENDOCRINOLOGY, V159, P3801, DOI 10.1210/en.2018-00574
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Keenan AB, 2019, NUCLEIC ACIDS RES, V47, pW212, DOI 10.1093/nar/gkz446
   Kirkinezos IG, 2001, SEMIN CELL DEV BIOL, V12, P449, DOI 10.1006/scdb.2001.0282
   Knoch J, 2012, EUR J DERMATOL, V22, P443, DOI 10.1684/ejd.2012.1654
   Koks S, 2016, MECH AGEING DEV, V160, P41, DOI 10.1016/j.mad.2016.10.001
   Kress TR, 2016, CANCER RES, V76, P3463, DOI 10.1158/0008-5472.CAN-16-0316
   Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377
   Lenaz G, 1997, MOL CELL BIOCHEM, V174, P329, DOI 10.1023/A:1006854619336
   Lesnefsky EJ, 2016, CIRC RES, V118, P1593, DOI 10.1161/CIRCRESAHA.116.307505
   Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005
   Ling SP, 2020, DIABETES CARE, V43, P2313, DOI 10.2337/dc20-0204
   Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039
   Matthews SM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212850
   Meshorer E, 2002, AGING CELL, V1, P10, DOI 10.1046/j.1474-9728.2002.00005.x
   Mihalik SJ, 2010, OBESITY, V18, P1695, DOI 10.1038/oby.2009.510
   Mina AI, 2018, CELL METAB, V28, P656, DOI 10.1016/j.cmet.2018.06.019
   Molenaars M, 2020, CELL METAB, V31, P549, DOI 10.1016/j.cmet.2020.01.011
   Müller I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097285
   Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06
   Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746
   Ness KK, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2017.76.7467
   O'Donnell T, 2018, BMC CANCER, V18, DOI 10.1186/s12885-017-3825-0
   O'Driscoll M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012773
   Opresko PL, 2017, AGEING RES REV, V33, P52, DOI 10.1016/j.arr.2016.05.009
   Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200
   Pappas LE, 2019, EUR J CLIN NUTR, V73, P172, DOI 10.1038/s41430-018-0324-6
   Park Y, 2005, ANNU REV MED, V56, P495, DOI 10.1146/annurev.med.56.082103.104546
   Pessayre D, 2001, SEMIN LIVER DIS, V21, P57, DOI 10.1055/s-2001-12929
   Pettan-Brewer C, 2011, PATHOBIOL AGING AGE, V1, DOI 10.3402/pba.v1i0.7202
   Ponti F, 2020, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00861
   Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184
   Prochownik EV, 2007, CELL CYCLE, V6, P1024, DOI 10.4161/cc.6.9.4161
   Prochownik EV, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11243974
   Prochownik EV, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11040747
   Prochownik EV, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10040762
   Prochownik Edward V, 2010, Genes Cancer, V1, P650
   Pshenichnaya I, 2012, PIGM CELL MELANOMA R, V25, P312, DOI 10.1111/j.1755-148X.2012.00998.x
   Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030
   Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X
   Roake CM, 2020, NAT REV MOL CELL BIO, V21, P384, DOI 10.1038/s41580-020-0234-z
   Rosca MG, 2012, DIABETES, V61, P2074, DOI 10.2337/db11-1437
   Rosselot C, 2019, DIABETES, V68, P1934, DOI 10.2337/db18-1368
   Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Schumacher B, 2021, NATURE, V592, P695, DOI 10.1038/s41586-021-03307-7
   Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Smith JR, 2002, J GERONTOL A-BIOL, V57, pB239, DOI 10.1093/gerona/57.6.B239
   Snyder JM, 2016, VET PATHOL, V53, P233, DOI 10.1177/0300985815610391
   Solvie D, 2022, NATURE, V612, P148, DOI 10.1038/s41586-022-05469-4
   Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260
   Soucek L, 2010, CURR OPIN GENET DEV, V20, P91, DOI 10.1016/j.gde.2009.11.001
   Srivastava S, 2017, GENES-BASEL, V8, DOI 10.3390/genes8120398
   Stefanatos R, 2011, CELL CYCLE, V10, P1528, DOI 10.4161/cc.10.10.15496
   Swaminathan S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16447-7
   Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x
   Team RC, 2020, R: A Language and Environment for Statistical
   Toth MJ, 2000, EUR J CLIN NUTR, V54, pS121, DOI 10.1038/sj.ejcn.1601033
   Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x
   Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a
   Turi Z, 2019, AGING-US, V11, P2512, DOI 10.18632/aging.101922
   Uchitomi R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46929-8
   Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8
   Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541
   Wang H, 2008, ONCOGENE, V27, P1905, DOI 10.1038/sj.onc.1210823
   Wang H., 2022, CELLS-BASEL, V11, DOI [10.3390/cells11244087, DOI 10.3390/CELLS11244087]
   Wang HB, 2022, CELL MOL GASTROENTER, V13, P1785, DOI 10.1016/j.jcmgh.2022.02.018
   Wang HB, 2021, CELL MOL GASTROENTER, V12, P199, DOI 10.1016/j.jcmgh.2021.02.004
   Wang HB, 2018, J BIOL CHEM, V293, P14740, DOI 10.1074/jbc.RA118.004099
   Wang HB, 2016, J BIOL CHEM, V291, P26241, DOI 10.1074/jbc.M116.754218
   Wang HB, 2015, ONCOTARGET, V6, P32380, DOI 10.18632/oncotarget.6116
   Wang HB, 2015, ONCOTARGET, V6, P15857, DOI 10.18632/oncotarget.4327
   Wang HB, 2013, ONCOTARGET, V4, P936, DOI 10.18632/oncotarget.1108
   Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021
   Ward JM, 2006, EXP TOXICOL PATHOL, V57, P377, DOI 10.1016/j.etp.2006.01.007
   White MC, 2014, AM J PREV MED, V46, pS7, DOI 10.1016/j.amepre.2013.10.029
   Whitehead JC, 2014, J GERONTOL A-BIOL, V69, P621, DOI 10.1093/gerona/glt136
   Wu TZ, 2021, INNOVATION-AMSTERDAM, V2, DOI 10.1016/j.xinn.2021.100141
   Xie Zhuorui, 2021, Curr Protoc, V1, pe90, DOI 10.1002/cpz1.90
   Xu J., 2005, CURR PROTOC MOL BIOL, pmb2801, DOI [10.1002/0471142727, DOI 10.1002/0471142727.MB2801-70]
   Yan CY, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a032409
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Zhang MJ, 2021, ELIFE, V10, DOI 10.7554/eLife.62293
   Zhang WQ, 2019, J BIOL CHEM, V294, P17524, DOI 10.1074/jbc.RA119.009979
   Zhuang D, 2008, ONCOGENE, V27, P6623, DOI 10.1038/onc.2008.258
   Zirath H, 2013, P NATL ACAD SCI USA, V110, P10258, DOI 10.1073/pnas.1222404110
NR 164
TC 4
Z9 4
U1 4
U2 4
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD 2023 AUG 29
PY 2023
VL 42
IS 8
AR 112830
DI 10.1016/j.celrep.2023.112830
EA JUL 2023
PG 27
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA P9GV1
UT WOS:001053696000001
PM 37481724
OA gold, Green Accepted
DA 2024-02-19
ER

PT J
AU Anisimov, VN
AF Anisimov, VN
TI Ageing and the mechanisms of carcinogenesis: Some practical implications
SO JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
LA English
DT Article
DE non-genotoxic carcinogens; tumor promoters; testing methodology; ageing
ID LIFE-SPAN; INCREASED SUSCEPTIBILITY; RODENT CARCINOGENICITY; GENOMIC
   INSTABILITY; ENDOMETRIAL CANCER; NEONATAL EXPOSURE; OXIDATIVE DAMAGE;
   RAT-LIVER; DNA; MUTATIONS
AB Two-year protocols are commonly used for long-term assay of chemicals for carcinogenicity. However, in some cases, if animals have been exposed to tested agent from the young age and sacrificed at the age of 2, an underestimation of the carcinogenic potential of non-genotoxic agents and tumor promoters is possible. Data available show that exposure to non-genotoxic agents or tumor promoters result in tumor development in older than in young animals. Age-related accumulation of "premalignant" cells in several tissues is here discussed. Accumulation with age of spontaneous mutations or mutations evoked by endogenous mutagens can induce genome instability and, hence, increase the sensitivity to carcinogens and/or tumor promoters. It seems reasonable to recommed the use of old animals for long-term assay of compounds with suspected non-genotoxic and tumor-promoting activity. It may be important to reevaluate standard two-year protocols for long-term assay for car cinogenicity and it is recommended to keep animals for at least 30 months, better until natural death, despite non profitable from an economical point of view it is more reliable.
C1 NN Petrov Oncol Res Inst, Expt Oncol Lab, St Petersburg 189646, Russia.
C3 N.N. Petrov Research Institute of Oncology
RP Anisimov, VN (corresponding author), NN Petrov Oncol Res Inst, Expt Oncol Lab, Pesochny 2, St Petersburg 189646, Russia.
CR AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   AMES BN, 1991, MUTAT RES, V50, P3
   Anisimov V.N., 1987, CARCINOGENESIS AGING, V2
   ANISIMOV VN, 1995, MUTAT RES-DNAGING G, V316, P173, DOI 10.1016/0921-8734(95)90003-9
   ANISIMOV VN, 1992, MUTAT RES, V275, P97, DOI 10.1016/0921-8734(92)90013-F
   ANISIMOV VN, 1989, SEMIN ONCOL, V16, P10
   ANISIMOV VN, 1995, MUTAT RES-DNAGING G, V316, P139, DOI 10.1016/0921-8734(95)90007-1
   ANISIMOV VN, 1994, J EXP CLIN CANC RES, V13, P31
   ANISIMOV VN, 1993, ENV HLTH CRITERIA, V144
   ANISIMOV VN, 1992, J CANC RES CLIN ONCO, P111
   Anisimov VN, 1992, GERIATRIC ONCOLOGY, P53
   Anisimov VN, 1987, CARCINOGENESIS AGING, V1
   BISHOP JM, 1991, CELL, V64, P235, DOI 10.1016/0092-8674(91)90636-D
   Bohr VA, 1995, CARCINOGENESIS, V16, P2885, DOI 10.1093/carcin/16.12.2885
   BOORMAN GA, 1994, TOXICOL PATHOL, V22, P105, DOI 10.1177/019262339402200204
   CATANIA J, 1991, MUTAT RES, V256, P283, DOI 10.1016/0921-8734(91)90019-8
   CATTLEY RC, 1991, CARCINOGENESIS, V12, P469, DOI 10.1093/carcin/12.3.469
   CHENG KC, 1993, ADV CANCER RES, V60, P121
   COUNTS JL, 1994, MOL CARCINOGEN, V11, P185, DOI 10.1002/mc.2940110402
   DIPPLE D, 1995, CARCINOGENESIS, P437
   DU MQ, 1994, MOL CARCINOGEN, V11, P170, DOI 10.1002/mc.2940110308
   DUBINA TL, 1975, INTRO EXPT GERONTOLO
   EBBESEN P, 1971, J NATL CANCER I, V47, P241
   EBBESEN P, 1985, IARC SCI PUBL, V58, P167
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   Geschickter CF, 1939, SCIENCE, V89, P35, DOI 10.1126/science.89.2298.35-a
   HARLEY CB, 1992, EXP GERONTOL, V27, P375, DOI 10.1016/0531-5565(92)90068-B
   Harris C C, 1992, IARC Sci Publ, P67
   HEMMINKI K, 1994, IARC SCI PUBL, V125
   HIGGINS PJ, 1986, AGE, V9, P71, DOI 10.1007/BF02432271
   HURSTING SD, 1995, CANCER RES, V55, P3949
   Jones P A, 1990, Adv Cancer Res, V54, P1, DOI 10.1016/S0065-230X(08)60806-4
   KINSELLA K, 1996, EPIDEMIOLOGY OLD AGE, P32
   KIRKWOOD TBL, 1989, MUTAT RES, V219, P1, DOI 10.1016/0921-8734(89)90035-0
   KNUD AGQ, 1993, P NATL ACAD SCI USA, P10914
   KRAUPPGRASL B, 1991, CANCER RES, V51, P666
   Lehman T A, 1994, IARC Sci Publ, P399
   LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0
   LUTZ WK, 1990, MUTAT RES, V238, P287, DOI 10.1016/0165-1110(90)90020-C
   Martin GM, 1996, NAT GENET, V13, P25, DOI 10.1038/ng0596-25
   MATOCHA MF, 1987, BIOCHEM BIOPH RES CO, V147, P1, DOI 10.1016/S0006-291X(87)80078-5
   McMichael AJ, 1992, IARC SCI PUBL, V116
   Monro A, 1996, EXP TOXICOL PATHOL, V48, P155, DOI 10.1016/S0940-2993(96)80036-4
   Montesano R., 1986, IARC SCI PUBLICATION, V83
   MULKSINOVA KN, 1983, I BIOPHYSICS USSR MI, V7074
   NAIR J, 1995, CARCINOGENESIS, V16, P613, DOI 10.1093/carcin/16.3.613
   Olovnikov AM, 1996, EXP GERONTOL, V31, P443, DOI 10.1016/0531-5565(96)00005-8
   ONO T, 1993, AGE AGEING, V22, P534
   PAGANINIHILL A, 1989, BRIT J CANCER, V59, P445, DOI 10.1038/bjc.1989.91
   PARK JW, 1988, P NATL ACAD SCI USA, V85, P7467, DOI 10.1073/pnas.85.20.7467
   PITOT HC, 1993, CANCER-AM CANCER SOC, V72, P962, DOI 10.1002/1097-0142(19930801)72:3+<962::AID-CNCR2820721303>3.0.CO;2-H
   RANDERATH K, 1993, IARC SCI PUBL, V124, P157
   REDDY JK, 1995, 24 IARC, P41
   REITER RJ, 1995, J PINEAL RES, V18, P1, DOI 10.1111/j.1600-079X.1995.tb00133.x
   REUBER MD, 1967, J NATL CANCER I, V38, P891
   SCHETTLER G, 1991, RISK ASSESSMENT CHEM
   SCHROEDE.HA, 1971, J NUTR, V101, P1531, DOI 10.1093/jn/101.11.1531
   SCHULTEHERMANN R, 1983, CANCER RES, V43, P839
   SEMSEI I, 1989, ONCOGENE, V4, P465
   SHAPIRO S, 1985, NEW ENGL J MED, V313, P969, DOI 10.1056/NEJM198510173131601
   SHAY JW, 1993, INT J ONCOL, V3, P559
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   SMITH KC, 1992, MUTAT RES, V277, P139, DOI 10.1016/0165-1110(92)90002-Q
   STREHLER BL, 1986, EXP GERONTOL, V21, P283, DOI 10.1016/0531-5565(86)90038-0
   SUMMERHAYES IC, 1979, J NATL CANCER I, V62, P1017
   TENNANT RW, 1995, ENVIRON HEALTH PERSP, V103, P942, DOI 10.2307/3432740
   TURK PW, 1995, CARCINOGENESIS, V16, P1253, DOI 10.1093/carcin/16.5.1253
   Vaziri H, 1996, EXP GERONTOL, V31, P295, DOI 10.1016/0531-5565(95)02025-X
   VIJG J, 1993, COMP BIOCHEM PHYS B, V104, P429, DOI 10.1016/0305-0491(93)90264-6
   WALLACE SS, 1994, ANN NY ACAD SCI, P726
   WARD JM, 1988, CANCER LETT, V39, P9, DOI 10.1016/0304-3835(88)90035-3
   WARD JM, 1983, J NATL CANCER I, V71, P815
   Ward JM, 1996, TOXICOL PATHOL, V24, P129, DOI 10.1177/019262339602400117
   Williams GM, 1996, EXP TOXICOL PATHOL, V48, P101, DOI 10.1016/S0940-2993(96)80030-3
   World Health Organization, 1990, GLOB EST HLTH SIT AS
   WYNFORDTHOMAS D, 1995, MOL CARCINOGEN, V12, P119
NR 76
TC 15
Z9 15
U1 0
U2 0
PU APSIT ASSOC PROM STUD IMMUNOL TUMOR
PI ROME
PA VIALE REGINA ELENA 291, 00161 ROME, ITALY
SN 0392-9078
J9 J EXP CLIN CANC RES
JI J. Exp. Clin. Cancer Res.
PD SEP
PY 1998
VL 17
IS 3
BP 263
EP 268
PG 6
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA 132KP
UT WOS:000076629200003
PM 9894760
DA 2024-02-19
ER

PT J
AU Wang, DQH
AF Wang, DQH
TI Aging per se is an independent risk factor for cholesterol gallstone
   formation in gallstone susceptible mice
SO JOURNAL OF LIPID RESEARCH
LA English
DT Article
DE bile salt; bile flow; phospholipid; gallbladder size; mucin gel; HMG-CoA
   reduclase; cholesterol 7 alpha-hydroxylase
ID BILE-ACID METABOLISM; AGE-RELATED-CHANGES; PHENOTYPIC CHARACTERIZATION;
   GALLBLADDER CONTRACTILITY; NATURAL-HISTORY; INBRED STRAINS; LITH GENES;
   GUINEA-PIG; ABSORPTION; DISEASE
AB Cholesterol gallstones occur rarely in childhood and adolescence and increase linearly with age in both genders. To explore whether aging per se increases cholesterol saturation of bile and gallstone prevalence, and to investigate age-related changes in hepatic and biliary lipid metabolism, we studied gallstone-susceptible C57L mice and resistant AKR mice of both genders fed 8 weeks with a lithogenic diet containing 1% cholesterol, 0.5% cholic acid, and 15% butter fat starting at (young adult) 8, (older adult) 36, and (aged) 50-weeks-of-age. After the 8-week feeding, gallstone prevalence, gallbladder size, biliary lipid secretion rate, and HMG-CoA reductase activity were significantly greater but cholesterol 7alpha-hydroxylase activity was lower in C57L mice of both genders compared with AKR mice. Increasing age augmented biliary secretion and intestinal absorption of cholesterol, reduced hepatic synthesis and biliary secretion of bile salts, and decreased gallbladder contractility, all of which increased susceptibility to cholesterol cholelithiasis in C57L mice. We conclude that aging per se is an independent risk factor for cholesterol gallstone formation. Because aging increases significantly biliary cholesterol hypersecretion and gallstone prevalence in C57L mice carrying Lith genes, it is highly like that Longevity (aging) genes can enhance lithogenesis of Lith (gallstone) genes.
C1 Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Gastroenterol Div, Boston, MA 02115 USA.
   Harvard Digest Dis Ctr, Boston, MA USA.
C3 Harvard University; Beth Israel Deaconess Medical Center; Harvard
   Medical School; Harvard University; Harvard Medical School
RP Wang, DQH (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Gastroenterol Div, Boston, MA 02115 USA.
EM dqwang@caregroup.harvard.edu
CR BARTLETT GR, 1959, J BIOL CHEM, V234, P466
   BERTOLOTTI M, 1993, J LIPID RES, V34, P1001
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Carey M C, 1992, Prog Liver Dis, V10, P139
   CAREY MC, 1978, J LIPID RES, V19, P945
   Chen Q, 1999, GASTROENTEROLOGY, V116, P678, DOI 10.1016/S0016-5085(99)70190-3
   CHOI YS, 1987, EXP GERONTOL, V22, P339, DOI 10.1016/0531-5565(87)90032-5
   Corradini SG, 2000, GASTROENTEROLOGY, V118, P912, DOI 10.1016/S0016-5085(00)70177-6
   DIEHL AK, 1991, GASTROENTEROL CLIN N, V20, P1
   DOERNER KC, 1995, J LIPID RES, V36, P1168
   EINARSSON K, 1985, NEW ENGL J MED, V313, P277, DOI 10.1056/NEJM198508013130501
   Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898
   FOX RR, 1997, HDB GENETICALLY STAN, P9
   FRIEDMAN GD, 1966, J CHRON DIS, V19, P273, DOI 10.1016/0021-9681(66)90132-9
   FUJIYAMA M, 1979, HIROSHIMA J MED SCI, V28, P23
   HEUMAN DM, 1989, J LIPID RES, V30, P719
   HOLLANDER D, 1979, EXP GERONTOL, V14, P201, DOI 10.1016/0531-5565(79)90020-2
   HYLEMON PB, 1989, ANAL BIOCHEM, V182, P212, DOI 10.1016/0003-2697(89)90581-2
   IDO K, 1995, J GASTROEN HEPATOL, V10, P517, DOI 10.1111/j.1440-1746.1995.tb01340.x
   KAHNG KU, 1994, SURG CLIN N AM, V74, P345, DOI 10.1016/S0039-6109(16)46286-9
   KEANE P, 1986, SURG GYNECOL OBSTET, V163, P555
   KHALIL T, 1985, SURGERY, V98, P423
   KHANUJA B, 1995, P NATL ACAD SCI USA, V92, P7729, DOI 10.1073/pnas.92.17.7729
   Lammert F, 1999, J LIPID RES, V40, P2080
   LIEBER MM, 1952, ANN SURG, V135, P394, DOI 10.1097/00000658-195203000-00011
   NEIDERHISER DH, 1976, J LIPID RES, V17, P117
   Paigen B., 2002, GENETIC BASIS COMMON, P298
   PALASCIANO G, 1992, AM J GASTROENTEROL, V87, P493
   Perls T, 2000, J AM GERIATR SOC, V48, P1483, DOI 10.1111/jgs.2000.48.11.1483
   PILOTTO A, 1995, AGING-CLIN EXP RES, V7, P234, DOI 10.1007/BF03324341
   POSTON GJ, 1990, GASTROENTEROLOGY, V98, P993, DOI 10.1016/0016-5085(90)90024-U
   POSTON GJ, 1988, MECH AGEING DEV, V46, P225, DOI 10.1016/0047-6374(88)90127-3
   Puca AA, 2001, P NATL ACAD SCI USA, V98, P10505, DOI 10.1073/pnas.181337598
   ROSENTHAL RA, 1993, EXP GERONTOL, V28, P459, DOI 10.1016/0531-5565(93)90071-K
   ROSSI SS, 1987, J LIPID RES, V28, P589
   SAMA C, 1990, SEMIN LIVER DIS, V10, P149, DOI 10.1055/s-2008-1040469
   SCOBEY MW, 1992, J NUTR, V122, P917, DOI 10.1093/jn/122.4.917
   SPADY DK, 1983, BIOCHIM BIOPHYS ACTA, V753, P381, DOI 10.1016/0005-2760(83)90062-0
   STAHLBERG D, 1991, LIPIDS, V26, P349, DOI 10.1007/BF02537197
   TORVIK A, 1950, ACTA CHIR SCAND, V120, P168
   TRABER MG, 1978, J LIPID RES, V19, P448
   Uchida K, 1996, JPN J PHARMACOL, V71, P113, DOI 10.1254/jjp.71.113
   UCHIDA K, 1978, J LIPID RES, V19, P544
   UPP JR, 1987, ANN SURG, V205, P641, DOI 10.1097/00000658-198706000-00005
   VALDIVIESO V, 1978, GASTROENTEROLOGY, V74, P871
   VANDERWERF SDJ, 1981, EUR J CLIN INVEST, V11, P425, DOI 10.1111/j.1365-2362.1981.tb02009.x
   Vijg J, 2002, MECH AGEING DEV, V123, P195, DOI 10.1016/S0047-6374(01)00346-3
   Wang DQ, 2000, GASTROENTEROLOGY, V118, pA715, DOI 10.1016/S0016-5085(00)84989-6
   Wang DQH, 1999, J LIPID RES, V40, P2066
   Wang DQH, 2001, J LIPID RES, V42, P1820
   Wang DQH, 1999, AM J PHYSIOL-GASTR L, V276, pG751, DOI 10.1152/ajpgi.1999.276.3.G751
   Wang DWH, 1998, HEPATOLOGY, V28, p163A
   Wang XD, 1997, J BIOMED MATER RES, V38, P1
   WANK SA, 1995, AM J PHYSIOL-GASTR L, V269, pG628, DOI 10.1152/ajpgi.1995.269.5.G628
   Xiao ZL, 1999, AM J PHYSIOL-GASTR L, V276, pG1401, DOI 10.1152/ajpgi.1999.276.6.G1401
   YAMAMOTO M, 1971, ATHEROSCLEROSIS, V13, P365, DOI 10.1016/0021-9150(71)90079-7
   YU PR, 1995, AM J PHYSIOL-GASTR L, V269, pG659, DOI 10.1152/ajpgi.1995.269.5.G659
   Yu PR, 1996, AM J PHYSIOL-GASTR L, V271, pG56, DOI 10.1152/ajpgi.1996.271.1.G56
   Zurcher C, 1982, MOUSE BIOMEDICAL RES, P11
NR 59
TC 41
Z9 45
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0022-2275
EI 1539-7262
J9 J LIPID RES
JI J. Lipid Res.
PD NOV
PY 2002
VL 43
IS 11
BP 1950
EP 1959
DI 10.1194/jlr.M200078-JLR200
PG 10
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 616FY
UT WOS:000179294500019
PM 12401894
OA hybrid
DA 2024-02-19
ER

PT J
AU Waki, K
   Anno, K
   Ono, T
   Ide, T
   Chayama, K
   Tahara, H
AF Waki, Koji
   Anno, Kumiko
   Ono, Taeko
   Ide, Toshinori
   Chayama, Kazuaki
   Tahara, Hidetoshi
TI Establishment of functional telomerase immortalized human hepatocytes
   and a hepatic stellate cell line for telomere-targeting anticancer drug
   development
SO CANCER SCIENCE
LA English
DT Article
ID HUMAN FETAL HEPATOCYTES; HEPATOCELLULAR CARCINOMAS; ENDOTHELIAL-CELLS;
   OVERHANG; TELOMESTATIN; FIBROSIS; ACTIVATION; SENESCENCE; PROTECTION;
   INHIBITOR
AB We previously reported that the telomere-targeting drug telomestatin induces apoptosis accompanied by G-tail reduction and dissociation of binding protein TRF2 from telomeres in cancer cell lines but not normal or human telomerase reverse transcriptase (hTERT)-immortalized cells. Because telomere-targeting drugs induce growth arrest in normal cells at higher doses, their development is dependent on the ability to predict toxicity before in vivo use, but no models for this are available. Here, we established two new cell lines, telomerase immortalized human fetal hepatocytes, Hc3716-hTERT, and telomerase immortalized hepatic stellate cells, NPC-hTERT. Examinations showed that Hc3716-hTERT maintained normal mammalian cell morphology, cell growth, albumin expression, and wild-type p53 responsiveness, whereas NPC-hTERT maintained hepatic stellate-like morphology, expression of hepatic stellate markers, alpha-smooth muscle actin, and secretion of type I collagen, an extracellular matrix protein. Given our finding that telomere G-tail length in Hc3716 cells was decreased in senescence and increased by hTERT infection, we next examined the effect of high-dose telomestatin-induced telomere dysfunction and G-tail shortening on cellular functions in Hc3716-hTERT cells. Interestingly, telomestatin decreased expression of cytochrome P450 (CYP) family members CYP3A3/4, CYP3A5, and CYP3A7, mRNA and induced albumin expression at both mRNA and protein levels. These gene expression responses to telomestatin were similar to those of the normal parental cell Hc3716. These established cell lines thus represent the first model for predicting the side-effects of telomere-targeting drugs in normal cells, and should be powerful tools in the development of these drugs. (Cancer Sci 2010).
C1 [Anno, Kumiko; Ono, Taeko; Ide, Toshinori; Tahara, Hidetoshi] Hiroshima Univ, Grad Sch Biomed Sci, Dept Cellular & Mol Biol, Hiroshima, Japan.
   [Waki, Koji; Chayama, Kazuaki] Hiroshima Univ, Dept Med & Mol Sci, Div Frontier Med Sci Programs Biomed Res, Hiroshima, Japan.
C3 Hiroshima University; Hiroshima University
RP Tahara, H (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Cellular & Mol Biol, Hiroshima, Japan.
EM toshi@hiroshima-u.ac.jp
RI Chayama, Kazuaki/B-2493-2016; Anno, Kumiko/A-9118-2014
OI Chayama, Kazuaki/0000-0002-5530-5341
FU Ministry of Education, Culture, Sports, Science and Technology, Japan;
   Takeda Science Foundation;  [20014015]
FX This work was partially supported by the Ministry of Education, Culture,
   Sports, Science and Technology, Japan, with a Grant-in-Aid for
   Scientific Research on Priority Areas (Grant No. 20014015), and the
   Takeda Science Foundation.
CR Anno K, 2007, BIOCHEM BIOPH RES CO, V353, P926, DOI 10.1016/j.bbrc.2006.12.112
   Bhatia SN, 1999, FASEB J, V13, P1883, DOI 10.1096/fasebj.13.14.1883
   Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349
   Carney SA, 2002, LAB INVEST, V82, P719, DOI 10.1097/01.LAB.0000017499.51216.3E
   Chai WH, 2005, MOL CELL BIOL, V25, P2158, DOI 10.1128/MCB.25.6.2158-2168.2005
   de Lange T, 2004, NAT REV MOL CELL BIO, V5, P323, DOI 10.1038/nrm1359
   de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080
   Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247
   Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005
   Hino H, 1999, BIOCHEM BIOPH RES CO, V256, P184, DOI 10.1006/bbrc.1999.0288
   KITADA M, 1985, ARCH BIOCHEM BIOPHYS, V241, P275, DOI 10.1016/0003-9861(85)90383-2
   Lázaro CA, 2003, HEPATOLOGY, V38, P1095, DOI 10.1053/jhep.2003.50448
   MAHER JJ, 1990, J CLIN INVEST, V86, P1641, DOI 10.1172/JCI114886
   Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X
   MURAKAMI K, 1995, LAB INVEST, V72, P731
   Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955
   Nakamura Y, 1999, CLIN CHEM, V45, P1718
   Nakayama JI, 1998, NAT GENET, V18, P65, DOI 10.1038/ng0198-65
   Rockey DC, 2001, SEMIN LIVER DIS, V21, P337, DOI 10.1055/s-2001-17551
   Schuppan D, 2001, SEMIN LIVER DIS, V21, P351, DOI 10.1055/s-2001-17556
   Shin-ya K, 2001, J AM CHEM SOC, V123, P1262, DOI 10.1021/ja005780q
   Stewart SA, 2003, NAT GENET, V33, P492, DOI 10.1038/ng1127
   SZOSTAK JW, 1982, CELL, V29, P245, DOI 10.1016/0092-8674(82)90109-X
   TAHARA H, 1995, CANCER RES, V55, P2734
   Tahara H, 2006, ONCOGENE, V25, P1955, DOI 10.1038/sj.onc.1209217
   Tahara H, 2005, NAT METHODS, V2, P829, DOI 10.1038/NMETH797
   Tauchi T, 2003, ONCOGENE, V22, P5338, DOI 10.1038/sj.onc.1206833
   Tsuruga Y, 2008, CELL TRANSPLANT, V17, P1083, DOI 10.3727/096368908786991542
   Wege H, 2003, GASTROENTEROLOGY, V124, P432, DOI 10.1053/gast.2003.50064
   WRIGHTON SA, 1989, ARCH BIOCHEM BIOPHYS, V268, P144, DOI 10.1016/0003-9861(89)90575-4
   Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127
NR 31
TC 23
Z9 27
U1 1
U2 4
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1347-9032
J9 CANCER SCI
JI Cancer Sci.
PD JUL
PY 2010
VL 101
IS 7
BP 1678
EP 1685
DI 10.1111/j.1349-7006.2010.01576.x
PG 8
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA 611FB
UT WOS:000278795800016
PM 20456367
DA 2024-02-19
ER

PT J
AU Bojanic, DD
   Tarr, PT
   Gale, GD
   Smith, DJ
   Bok, D
   Chen, B
   Nusinowitz, S
   Lövgren-Sandblom, A
   Björkhem, I
   Edwards, PA
AF Bojanic, Dragana D.
   Tarr, Paul T.
   Gale, Greg D.
   Smith, Desmond J.
   Bok, Dean
   Chen, Bryan
   Nusinowitz, Steven
   Loevgren-Sandblom, Anita
   Bjoerkhem, Ingemar
   Edwards, Peter A.
TI Differential expression and function of ABCG1 and ABCG4 during
   development and aging
SO JOURNAL OF LIPID RESEARCH
LA English
DT Article
DE oxysterols; liver X receptor; sterol regulatory element binding
   protein-2; central nervous system
ID CELLULAR CHOLESTEROL EFFLUX; DILUTION MASS-SPECTROMETRY; CASSETTE
   TRANSPORTERS G1; HIGH-DENSITY-LIPOPROTEIN; MEDIATE CHOLESTEROL;
   SIGNALING PATHWAYS; MICE; BRAIN; ACCUMULATION; MOUSE
AB ABCG1 and ABCG4 are highly homologous members of the ATP binding cassette (ABC) transporter family that regulate cellular cholesterol homeostasis. In adult mice, ABCG1 is known to be expressed in numerous cell types and tissues, whereas ABCG4 expression is limited to the central nervous system (CNS). Here, we show significant differences in expression of these two transporters during development. Examination of beta-galactosidase-stained tissue sections from Abcg1(-/-) LacZ and Abcg4(-/-) LacZ knockin mice shows that ABCG4 is highly but transiently expressed both in hematopoietic cells and in enterocytes during development. In contrast, ABCG1 is expressed in macrophages and in endothelial cells of both embryonic and adult liver. We also show that ABCG1 and ABCG4 are both expressed as early as E12.5 in the embryonic eye and developing CNS. Loss of both ABCG1 and ABCG4 results in accumulation in the retina and/or brain of oxysterols, in altered expression of liver X receptor and sterol-regulatory element binding protein-2 target genes, and in a stress response gene. Finally, behavioral tests show that Abcg4(-/-) mice have a general deficit in associative fear memory. Together, these data indicate that loss of ABCG1 and/or ABCG4 from the CNS results in changes in metabolic pathways and in behavior. Bojanic, D. D., P. T. Tarr, G. D. Gale, D. J. Smith, D. Bok, B. Chen, S. Nusinowitz, A. Lovgren-Sandblom, I. Bjorkhem, and P. A. Edwards. Differential expression and function of ABCG1 and ABCG4 during development and ageing. J. Lipid Res. 2010. 51: 169-181.
C1 [Bojanic, Dragana D.; Edwards, Peter A.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA.
   [Edwards, Peter A.] Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Los Angeles, CA 90095 USA.
   [Edwards, Peter A.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA.
   [Gale, Greg D.; Smith, Desmond J.] Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.
   [Bok, Dean; Chen, Bryan; Nusinowitz, Steven] Jules Stein Eye Inst, Los Angeles, CA 90095 USA.
   [Bok, Dean] Dept Neurobiol, Los Angeles, CA 90095 USA.
   [Bok, Dean] Brain Res Inst, Los Angeles, CA 90095 USA.
   [Loevgren-Sandblom, Anita; Bjoerkhem, Ingemar] Karolinska Inst, S-10401 Stockholm, Sweden.
   [Tarr, Paul T.] CALTECH, Div Biol, Pasadena, CA 91125 USA.
C3 University of California System; University of California Los Angeles;
   University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA; University of California System; University of
   California Los Angeles; Karolinska Institutet; California Institute of
   Technology
RP Edwards, PA (corresponding author), Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA.
EM pedwards@mednet.ucla.edu
OI Bjorkhem, Ingemar/0000-0002-0575-9425
FU National Institutes of Health [NIH-30568, NIH-68445, RO1MH71779];
   Laubisch Fund; HDL Pfizer Award
FX This work was supported by grants from the National Institutes of Health
   (NIH-30568 and NIH-68445 to P.A.E.), Grant RO1MH71779 (to D.J.S.) from
   the Laubisch Fund, an HDL Pfizer Award (to P. A. E.), and the Swedish
   Science Council and Brain Power (to I.B.). Its contents are solely the
   responsibility of the authors and do not necessarily represent the
   official views of the National Institutes of Health.
CR Albert AD, 2005, PROG LIPID RES, V44, P99, DOI 10.1016/j.plipres.2005.02.001
   Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8
   Anagnostaras SG, 2000, LEARN MEMORY, V7, P58, DOI 10.1101/lm.7.1.58
   Annicotte JS, 2004, ANAT REC PART A, V277A, P312, DOI 10.1002/ar.a.20015
   Annilo T, 2001, CYTOGENET CELL GENET, V94, P196, DOI 10.1159/000048816
   Baldán A, 2006, J BIOL CHEM, V281, P29401, DOI 10.1074/jbc.M606597200
   Baldán A, 2009, J LIPID RES, V50, pS80, DOI 10.1194/jlr.R800044-JLR200
   Basso F, 2006, BIOCHEM BIOPH RES CO, V351, P398, DOI 10.1016/j.bbrc.2006.10.044
   Björkhem I, 2000, TRENDS ENDOCRIN MET, V11, P180, DOI 10.1016/S1043-2760(00)00255-1
   Burgess B, 2008, ARTERIOSCL THROM VAS, V28, P1731, DOI 10.1161/ATVBAHA.108.168542
   Choi SH, 2006, J NEUROSCI METH, V156, P182, DOI 10.1016/j.jneumeth.2006.03.002
   Cserepes J, 2004, BIOCHEM BIOPH RES CO, V320, P860, DOI 10.1016/j.bbrc.2004.06.037
   Dean M, 2001, J BIOENERG BIOMEMBR, V33, P475, DOI 10.1023/A:1012823120935
   Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003
   DZELETOVIC S, 1995, ANAL BIOCHEM, V225, P73, DOI 10.1006/abio.1995.1110
   Engel T, 2007, FEBS LETT, V581, P1673, DOI 10.1016/j.febslet.2007.03.038
   Ewart GD, 1998, METHOD ENZYMOL, V292, P213
   Fliesler SJ, 1997, INT J BIOCHEM CELL B, V29, P877, DOI 10.1016/S1357-2725(97)00018-6
   Gelissen IC, 2006, ARTERIOSCL THROM VAS, V26, P534, DOI 10.1161/01.ATV.0000200082.58536.e1
   Giusto NM, 2000, PROG LIPID RES, V39, P315, DOI 10.1016/S0163-7827(00)00009-6
   Heverin M, 2007, ARTERIOSCL THROM VAS, V27, P2191, DOI 10.1161/ATVBAHA.107.149823
   Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593
   Kedzierski W, 1997, INVEST OPHTH VIS SCI, V38, P498
   Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002
   Kotti TJ, 2006, P NATL ACAD SCI USA, V103, P3869, DOI 10.1073/pnas.0600316103
   Krakowiak PA, 2003, HUM MOL GENET, V12, P1631, DOI 10.1093/hmg/ddg172
   LANGE Y, 1995, J LIPID RES, V36, P1092
   LUND E, 1989, SCAND J CLIN LAB INV, V49, P165, DOI 10.3109/00365518909105417
   Lund EG, 2003, J BIOL CHEM, V278, P22980, DOI 10.1074/jbc.M303415200
   Marschner A, 2008, J NEUROSCI, V28, P9030, DOI 10.1523/JNEUROSCI.1651-08.2008
   Meaney S, 2002, J LIPID RES, V43, P2130, DOI 10.1194/jlr.M200293-JLR200
   Nakamura K, 2004, J BIOL CHEM, V279, P45980, DOI 10.1074/jbc.M408652200
   Nie T, 2001, BEHAV NEUROSCI, V115, P951, DOI 10.1037//0735-7044.115.4.951
   Nusinowitz S, 2007, EXP EYE RES, V84, P1104, DOI 10.1016/j.exer.2007.02.009
   O'Reilly RC, 2001, PSYCHOL REV, V108, P311, DOI 10.1037//0033-295X.108.2.311
   Oldfield S, 2002, BBA-MOL CELL RES, V1591, P175, DOI 10.1016/S0167-4889(02)00269-0
   Out R, 2007, ARTERIOSCL THROM VAS, V27, P594, DOI 10.1161/01.ATV.0000257136.24308.0c
   Pfrieger FW, 2003, BBA-BIOMEMBRANES, V1610, P271, DOI 10.1016/S0005-2736(03)00024-5
   Porter FD, 2003, CURR OPIN PEDIATR, V15, P607, DOI 10.1097/00008480-200312000-00011
   Radu RA, 2008, INVEST OPHTH VIS SCI, V49, P3821, DOI 10.1167/iovs.07-1470
   SCHAFFER R, 1982, CLIN CHEM, V28, P5
   Tarr PT, 2008, J LIPID RES, V49, P169, DOI 10.1194/jlr.M700364-JLR200
   Tarr PT, 2009, BBA-MOL CELL BIOL L, V1791, P584, DOI 10.1016/j.bbalip.2009.01.007
   Tontonoz P, 2003, MOL ENDOCRINOL, V17, P985, DOI 10.1210/me.2003-0061
   Uehara Y, 2008, BRAIN RES, V1217, P239, DOI 10.1016/j.brainres.2008.04.048
   Vaughan AM, 2005, J BIOL CHEM, V280, P30150, DOI 10.1074/jbc.M505368200
   Vaughan AM, 2006, J LIPID RES, V47, P2433, DOI 10.1194/jlr.M600218-JLR200
   Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101
   Wang N, 2008, FASEB J, V22, P1073, DOI 10.1096/fj.07-9944com
   Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9
   Westerfeld Corey, 2008, Semin Ophthalmol, V23, P59, DOI 10.1080/08820530701745249
   Wojcik AJ, 2008, J IMMUNOL, V180, P4273, DOI 10.4049/jimmunol.180.6.4273
   Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372
NR 53
TC 66
Z9 74
U1 0
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0022-2275
EI 1539-7262
J9 J LIPID RES
JI J. Lipid Res.
PD JAN
PY 2010
VL 51
IS 1
BP 169
EP 181
DI 10.1194/jlr.M900250-JLR200
PG 13
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 531HF
UT WOS:000272654600017
PM 19633360
OA Green Published, hybrid, Green Accepted
DA 2024-02-19
ER

PT J
AU Zhao, XX
   Zhao, Y
   Jiang, YP
   Zhang, Q
AF Zhao, Xiaoxuan
   Zhao, Yang
   Jiang, Yuepeng
   Zhang, Qin
TI Deciphering the endometrial immune landscape of RIF during the window of
   implantation from cellular senescence by integrated bioinformatics
   analysis and machine learning
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE recurrent implantation failure; immune landscape; cellular senescence;
   bioinformatics; machine learning
ID EXPRESSION; CELLS; DECIDUALIZATION; RESTORATION; APOPTOSIS; PATHWAY;
   DISEASE; WOMEN; LIVER
AB Recurrent implantation failure (RIF) is an extremely thorny issue in in-vitro fertilization (IVF)-embryo transfer (ET). However, its intricate etiology and pathological mechanisms are still unclear. Nowadays, there has been extensive interest in cellular senescence in RIF, and its involvement in endometrial immune characteristics during the window of implantation (WOI) has captured scholars' growing concerns. Therefore, this study aims to probe into the pathological mechanism of RIF from cellular senescence and investigate the correlation between cellular senescence and endometrial immune characteristics during WOI based on bioinformatics combined with machine learning strategy, so as to elucidate the underlying pathological mechanisms of RIF and to explore novel treatment strategies for RIF. Firstly, the gene sets of GSE26787 and GSE111974 from the Gene Expression Omnibus (GEO) database were included for the weighted gene correlation network analysis (WGCNA), from which we concluded that the genes of the core module were closely related to cell fate decision and immune regulation. Subsequently, we identified 25 cellular senescence-associated differentially expressed genes (DEGs) in RIF by intersecting DEGs with cellular senescence-associated genes from the Cell Senescence (CellAge) database. Moreover, functional enrichment analysis was conducted to further reveal the specific molecular mechanisms by which these molecules regulate cellular senescence and immune pathways. Then, eight signature genes were determined by the machine learning method of support vector machine-recursive feature elimination (SVM-RFE), random forest (RF), and artificial neural network (ANN), comprising LATS1, EHF, DUSP16, ADCK5, PATZ1, DEK, MAP2K1, and ETS2, which were also validated in the testing gene set (GSE106602). Furthermore, distinct immune microenvironment abnormalities in the RIF endometrium during WOI were comprehensively explored and validated in GSE106602, including infiltrating immunocytes, immune function, and the expression profiling of human leukocyte antigen (HLA) genes and immune checkpoint genes. Moreover, the correlation between the eight signature genes with the endometrial immune landscape of RIF was also evaluated. After that, two distinct subtypes with significantly distinct immune infiltration characteristics were identified by consensus clustering analysis based on the eight signature genes. Finally, a "KEGG pathway-RIF signature genes-immune landscape" association network was constructed to intuitively uncover their connection. In conclusion, this study demonstrated that cellular senescence might play a pushing role in the pathological mechanism of RIF, which might be closely related to its impact on the immune microenvironment during the WOI phase. The exploration of the molecular mechanism of cellular senescence in RIF is expected to bring new breakthroughs for disease diagnosis and treatment strategies.
C1 [Zhao, Xiaoxuan; Zhang, Qin] Zhejiang Chinese Med Univ, Dept Tradit Chinese Med TCM Gynecol, Hangzhou Hosp Tradit Chinese Med, Hangzhou, Peoples R China.
   [Zhao, Yang] Hebei Coll Tradit Chinese Med, Coll Basic Med, Shijiazhuang, Hebei, Peoples R China.
   [Jiang, Yuepeng] Zhejiang Chinese Med Univ, Coll Pharm, Hangzhou, Peoples R China.
C3 Zhejiang Chinese Medical University; Zhejiang Chinese Medical University
RP Zhang, Q (corresponding author), Zhejiang Chinese Med Univ, Dept Tradit Chinese Med TCM Gynecol, Hangzhou Hosp Tradit Chinese Med, Hangzhou, Peoples R China.
EM Zhaqin01@163.com
FU Research on the Secondary Development of Jianpi Antai Mixture
   [2021C03080]
FX This study was supported by the Research on the Secondary Development of
   Jianpi Antai Mixture (2021C03080).
CR Abbott TR, 2020, CELL, V181, P865, DOI 10.1016/j.cell.2020.04.020
   Al-Lamee H, 2022, REPROD FERTIL, V3, P30, DOI 10.1530/RAF-21-0093
   Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068
   Avelar RA, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-01990-9
   Avruch J, 2012, SEMIN CELL DEV BIOL, V23, P770, DOI 10.1016/j.semcdb.2012.07.002
   Bateman A, 2021, NUCLEIC ACIDS RES, V49, pD480, DOI 10.1093/nar/gkaa1100
   Behmoaras J, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202010162
   Bert S, 2021, IMMUNOLOGY, V164, P665, DOI 10.1111/imm.13392
   Biau G, 2016, TEST-SPAIN, V25, P197, DOI 10.1007/s11749-016-0481-7
   Birch J, 2020, GENE DEV, V34, P1565, DOI 10.1101/gad.343129.120
   Bora G, 2021, J OBSTET GYNAECOL RE, V47, P1610, DOI 10.1111/jog.14710
   Brighton PJ, 2017, ELIFE, V6, DOI 10.7554/eLife.31274
   Cheloufi M, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.656701
   Chen PG, 2022, J ASSIST REPROD GEN, V39, P2143, DOI 10.1007/s10815-022-02578-x
   Childs BG, 2016, SCIENCE, V354, P472, DOI 10.1126/science.aaf6659
   Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245
   Cimadomo D, 2021, HUM REPROD, V36, P929, DOI 10.1093/humrep/deab014
   Coughlan C, 2014, REPROD BIOMED ONLINE, V28, P14, DOI 10.1016/j.rbmo.2013.08.011
   Deryabin PI, 2022, HUM REPROD, V37, P1505, DOI 10.1093/humrep/deac112
   Deryabin P, 2020, CELL MOL LIFE SCI, V77, P1357, DOI 10.1007/s00018-019-03374-0
   Durairaj RRP, 2017, MOL HUM REPROD, V23, P478, DOI 10.1093/molehr/gax023
   Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207
   Fan L, 2021, J REPROD DEVELOP, V67, P359, DOI 10.1262/jrd.2021-006
   Fernandes SE, 2021, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.744013
   Flavin P, 2011, FEBS LETT, V585, P2537, DOI 10.1016/j.febslet.2011.07.005
   Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69
   Gellersen B, 2014, ENDOCR REV, V35, P851, DOI 10.1210/er.2014-1045
   González-Osuna L, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23052543
   Hapangama DK, 2008, REPROD BIOMED ONLINE, V17, P416, DOI 10.1016/S1472-6483(10)60227-1
   Huang ML, 2014, SCI WORLD J, DOI 10.1155/2014/795624
   Ito K, 2013, CPT-PHARMACOMET SYST, V2, DOI 10.1038/psp.2013.56
   Jia Y, 2022, AM J REPROD IMMUNOL, V87, DOI 10.1111/aji.13513
   Jin HH, 2017, EUR J PHARM SCI, V96, P323, DOI 10.1016/j.ejps.2016.10.002
   Köstlin-Gille N, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00161
   Kong CS, 2021, FASEB J, V35, DOI 10.1096/fj.202002217R
   Krop J, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01182
   Kuroda K, 2021, AM J REPROD IMMUNOL, V85, DOI 10.1111/aji.13376
   Kusama K, 2021, BIOCHEM BIOPH RES CO, V571, P174, DOI 10.1016/j.bbrc.2021.07.075
   Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559
   Le T, 2021, BRIEF BIOINFORM, V22, DOI 10.1093/bib/bbaa219
   Lee KS, 2022, FRONT BIOSCI-LANDMRK, V27, DOI 10.31083/j.fbl2703101
   Li GQ, 2022, FRONT ENDOCRINOL, V13, DOI 10.3389/fendo.2022.839865
   Li XL, 2017, J LEUKOCYTE BIOL, V102, P915, DOI 10.1189/jlb.3A1216-527R
   Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401
   Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004
   Liu JF, 2022, PROTEOME SCI, V20, DOI 10.1186/s12953-022-00194-2
   Liu ZT, 2022, FRONT PHYSIOL, V13, DOI 10.3389/fphys.2022.841437
   Lunin SM, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23084109
   Manakanatas C, 2022, AGING-US, V14, P195, DOI 10.18632/aging.203820
   Marquez-Exposito L, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.662020
   Menon R, 2016, AGING-US, V8, P216, DOI 10.18632/aging.100891
   Mikawa R, 2018, AGING CELL, V17, DOI 10.1111/acel.12827
   Mundra PA, 2010, IEEE T NANOBIOSCI, V9, P31, DOI 10.1109/TNB.2009.2035284
   Ohara Y, 2022, REPROD MED BIOL, V21, DOI 10.1002/rmb2.12444
   Ovadya Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07825-3
   Pantos K, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23042198
   Parvanov D, 2021, J ASSIST REPROD GEN, V38, P2087, DOI 10.1007/s10815-021-02182-5
   Peng JJ, 2021, BMC BIOINFORMATICS, V22, DOI 10.1186/s12859-021-04187-4
   Pourmoghadam Z, 2020, J REPROD IMMUNOL, V142, DOI 10.1016/j.jri.2020.103182
   Rawlings TM, 2021, ELIFE, V10, DOI [10.7554/eLife.69603, 10.7554/eLife.69603.sa1, 10.7554/eLife.69603.sa2]
   Recalcati S, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9111585
   Rosado-Olivieri EA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09404-6
   Roy AL, 2020, CELL, V183, P1143, DOI 10.1016/j.cell.2020.10.032
   Sadeghpour S, 2020, IMMUNOPHARM IMMUNOT, V42, P632, DOI 10.1080/08923973.2020.1835951
   Safran M., 2021, Practical guide to life science databases, P27, DOI DOI 10.1007/978-981-16-5812-9_2
   Salminen A, 2021, J MOL MED, V99, P1553, DOI 10.1007/s00109-021-02123-w
   Sanz H, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2451-4
   Sauerbrun-Cutler MT, 2021, AM J REPROD IMMUNOL, V85, DOI 10.1111/aji.13393
   Shi YJ, 2022, SENSORS-BASEL, V22, DOI 10.3390/s22155507
   Shive C, 2022, FRONT AGING-LAUSANNE, V3, DOI 10.3389/fragi.2022.840827
   Sín P, 2022, DIAGNOSTICS, V12, DOI 10.3390/diagnostics12040850
   Sjöstedt E, 2020, SCIENCE, V367, P1090, DOI 10.1126/science.aay5947
   Sternberg PW, 2022, GENETICS, V220, DOI 10.1093/genetics/iyac022
   Sun PS, 2022, FRONT GENET, V13, DOI 10.3389/fgene.2022.866005
   Sun Y, 2015, J RECEPT SIG TRANSD, V35, P600, DOI 10.3109/10799893.2015.1030412
   Tang JY, 2021, ANALYST, V146, P5880, DOI 10.1039/d0an02155e
   Tegge AN, 2016, BIOINFORMATICS, V32, P242, DOI 10.1093/bioinformatics/btv549
   Teh WT, 2016, J ASSIST REPROD GEN, V33, P1419, DOI 10.1007/s10815-016-0773-6
   Tsuda S, 2021, HUM IMMUNOL, V82, P346, DOI 10.1016/j.humimm.2021.01.019
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   Wang HF, 2022, ONCOIMMUNOLOGY, V11, DOI 10.1080/2162402X.2021.2011673
   Wang Y, 2017, NEOPLASMA, V64, P543, DOI 10.4149/neo_2017_408
   Wang ZX, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10123327
   Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170
   Woon EV, 2022, HUM REPROD UPDATE, V28, P548, DOI 10.1093/humupd/dmac006
   Wu CL, 2016, NUCLEIC ACIDS RES, V44, pD313, DOI 10.1093/nar/gkv1104
   Xu XX, 2021, AGING CELL, V20, DOI 10.1111/acel.13465
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Yamaguchi K, 2019, AM J REPROD IMMUNOL, V81, DOI 10.1111/aji.13097
   Zhai J, 2022, REPROD BIOL ENDOCRIN, V20, DOI 10.1186/s12958-022-00947-w
   Zhang J, 2021, EBIOMEDICINE, V68, DOI 10.1016/j.ebiom.2021.103409
NR 91
TC 5
Z9 6
U1 3
U2 13
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD SEP 5
PY 2022
VL 13
AR 952708
DI 10.3389/fimmu.2022.952708
PG 18
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA 5P1GZ
UT WOS:000872909200001
PM 36131919
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Huard, CA
   Gao, XQ
   Hazra, MED
   Hazra, ROD
   Lebsock, K
   Easley, JT
   Millett, PJ
   Huard, J
AF Huard, Charles A.
   Gao, Xueqin
   Hazra, Maria E. Dey
   Hazra, Rony-Orijit Dey
   Lebsock, Kimberly
   Easley, Jeremiah T.
   Millett, Peter J.
   Huard, Johnny
TI Effects of Fisetin Treatment on Cellular Senescence of Various Tissues
   and Organs of Old Sheep
SO ANTIOXIDANTS
LA English
DT Article
DE fisetin; cellular senescence; sheep; beta-galactosidase; cerebral brain
   cortex; cerebellum; hippocampus; neurons; astrocytes; microglia; lung;
   liver; spleen
ID FLAVONOID FISETIN; OXIDATIVE STRESS; PROTECTS; ENHANCEMENT; MUSCLE;
   CELLS
AB Fisetin has been shown to be beneficial for brain injury and age-related brain disease via different mechanisms. The purpose of this study was to determine the presence of senescent cells and the effects of fisetin on cellular senescence in the brain and other vital organs in old sheep, a more translational model. Female sheep 6-7 years old (N = 6) were treated with 100 mg/kg fisetin or vehicle alone on two consecutive days a week for 8 weeks. All vital organs were harvested at the time of sacrifice. Histology, immunofluorescence staining, and RT-Q-PCR were performed on different regions of brain tissues and other organs. Our results indicated that fisetin treatment at the current regimen did not affect the general morphology of the brain. The presence of senescent cells in both the cerebral brain cortex and cerebellum and non-Cornu Ammonis (CA) area of the hippocampus was detected by senescent-associated beta-galactosidase (SA- beta-Gal) staining and GL13 (lipofuscin) staining. The senescent cells detected were mainly neurons in both gray and white matter of either the cerebral brain cortex, cerebellum, or non-CA area of the hippocampus. Very few senescent cells were detected in the neurons of the CA1-4 area of the hippocampus, as revealed by GL13 staining and GLB1 colocalization with NEUN. Fisetin treatment significantly decreased the number of SA- beta-Gal(+) cells in brain cortex white matter and GL13(+) cells in the non-CA area of the hippocampus, and showed a decreasing trend of SA- beta-Gal(+) cells in the gray matter of both the cerebral brain cortex and cerebellum. Furthermore, fisetin treatment significantly decreased P16(+) and GLB1(+) cells in neuronal nuclear protein (NEUN)(+) neurons, glial fibrillary acidic protein (GFAP)(+) astrocytes, and ionized calcium binding adaptor molecule 1 (IBA1)(+) microglia cells in both gray and white matter of cerebral brain cortex. Fisetin treatment significantly decreased GLB1(+) cells in microglia cells, astrocytes, and NEUN+ neurons in the non-CA area of the hippocampus. Fisetin treatment significantly decreased plasma S100B. At the mRNA level, fisetin significantly downregulated GLB1 in the liver, showed a decreasing trend in GLB1 in the lung, heart, and spleen tissues, and significantly decreased P21 expression in the liver and lung. Fisetin treatment significantly decreased TREM2 in the lung tissues and showed a trend of downregulation in the liver, spleen, and heart. A significant decrease in NRLP3 in the liver was observed after fisetin treatment. Finally, fisetin treatment significantly downregulated SOD1 in the liver and spleen while upregulating CAT in the spleen. In conclusion, we found that senescent cells were widely present in the cerebral brain cortex and cerebellum and non-CA area of the hippocampus of old sheep. Fisetin treatment significantly decreased senescent neurons, astrocytes, and microglia in both gray and white matter of the cerebral brain cortex and non-CA area of the hippocampus. In addition, fisetin treatment decreased senescent gene expressions and inflammasomes in other organs, such as the lung and the liver. Fisetin treatment represents a promising therapeutic strategy for age-related diseases.
C1 [Huard, Charles A.; Gao, Xueqin; Hazra, Maria E. Dey; Hazra, Rony-Orijit Dey; Millett, Peter J.; Huard, Johnny] Steadman Philippon Res Inst, Linda & Mitch Hart Ctr Regenerat & Personalized Me, Vail, CO 81657 USA.
   [Hazra, Maria E. Dey; Hazra, Rony-Orijit Dey; Millett, Peter J.] Steadman Clin, Vail, CO 81657 USA.
   [Hazra, Rony-Orijit Dey] Charite Univ Med Berlin, Freie Univ Berlin, Humboldt Univ Berlin, Berlin Inst Hlth,Ctr Musculoskeletal Surg,Dept Sho, D-14195 Berlin, Germany.
   [Lebsock, Kimberly; Easley, Jeremiah T.] Colorado State Univ, Dept Clin Sci, Preclin Surg Res Lab, Ft Collins, CO 80523 USA.
C3 Steadman Philippon Research Institute; Berlin Institute of Health; Free
   University of Berlin; Humboldt University of Berlin; Charite
   Universitatsmedizin Berlin; Colorado State University
RP Gao, XQ; Huard, J (corresponding author), Steadman Philippon Res Inst, Linda & Mitch Hart Ctr Regenerat & Personalized Me, Vail, CO 81657 USA.
EM chuard@sprivail.org; xgao@sprivail.org; rony@deyhazra.de;
   kimberly.menges@colostate.edu; eremiah.easley@colostate.edu;
   drmillett@thesteadmanclinic.com; jhuard@sprivail.org
OI Gao, Xueqin/0000-0001-5833-1548; Dey Hazra,
   Rony-Orijit/0000-0002-3530-6726; Millett, Peter/0000-0002-8298-3746
FU This project was funded by a Philanthropic gift from the Borgen Family
   and from the Linda and Mitch Hart Family foundation. We appreciate
   Anna-Laura Nelson, Sudheer Ravuri, and Jacob Singer for proofreading our
   revised manuscript.
FX This project was funded by a Philanthropic gift from the Borgen Family
   and from the Linda and Mitch Hart Family foundation. We appreciate
   Anna-Laura Nelson, Sudheer Ravuri, and Jacob Singer for proofreading our
   revised manuscript.
CR Ahmad S, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.612078
   Antignano I, 2023, CELL MOL LIFE SCI, V80, DOI 10.1007/s00018-023-04775-y
   Beauséjour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417
   Chen C, 2018, CEREBROVASC DIS, V45, P154, DOI 10.1159/000488117
   Chen YP, 2019, PHYTOMEDICINE, V57, P1, DOI 10.1016/j.phymed.2018.09.179
   Cho I, 2020, FOOD SCI NUTR, V8, P6633, DOI 10.1002/fsn3.1956
   Chuang JY, 2014, MOLECULES, V19, P8820, DOI 10.3390/molecules19078820
   Cordaro M, 2022, BIOMEDICINES, V10, DOI 10.3390/biomedicines10061448
   Currais A, 2018, J GERONTOL A-BIOL, V73, P299, DOI 10.1093/gerona/glx104
   Currais A, 2014, AGING CELL, V13, P379, DOI 10.1111/acel.12185
   Das J, 2020, EXP GERONTOL, V138, DOI 10.1016/j.exger.2020.111006
   Dong B, 2018, J NUTR BIOCHEM, V62, P221, DOI 10.1016/j.jnutbio.2018.08.010
   Ehren JL, 2013, BIOCHEM PHARMACOL, V85, P1816, DOI 10.1016/j.bcp.2013.04.010
   Elsallabi O, 2022, MOLECULES, V27, DOI 10.3390/molecules27030738
   Evangelou K, 2017, AGING CELL, V16, P192, DOI 10.1111/acel.12545
   Farr JN, 2017, NAT MED, V23, P1072, DOI 10.1038/nm.4385
   Gao XQ, 2014, FASEB J, V28, P3792, DOI 10.1096/fj.13-247965
   Gerdes EOW, 2020, INT REV NEUROBIOL, V155, P203, DOI 10.1016/bs.irn.2020.03.019
   Gonzales Mitzi M, 2023, Res Sq, DOI 10.21203/rs.3.rs-2809973/v1
   Gruendler R, 2020, MOLECULES, V25, DOI 10.3390/molecules25246018
   Hickson LJ, 2019, EBIOMEDICINE, V47, P446, DOI 10.1016/j.ebiom.2019.08.069
   Huang WJ, 2022, NAT REV NEPHROL, V18, P611, DOI 10.1038/s41581-022-00601-z
   Ju HY, 2023, KIDNEY RES CLIN PRAC, V42, P325, DOI 10.23876/j.krcp.22.034
   Khosla S, 2020, NAT REV ENDOCRINOL, V16, P263, DOI 10.1038/s41574-020-0335-y
   Kim SG, 2023, ARCH GERONTOL GERIAT, V108, DOI 10.1016/j.archger.2023.104927
   Kirkland JL, 2020, J INTERN MED, V288, P518, DOI 10.1111/joim.13141
   Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091
   Li SY, 2023, JCI INSIGHT, V8, DOI 10.1172/jci.insight.166643
   Liu L, 2022, AGING-US, V14, P7650, DOI 10.18632/aging.204275
   Liu L, 2022, J CACHEXIA SARCOPENI, V13, P3137, DOI 10.1002/jcsm.13101
   Maher P, 2008, ARCH BIOCHEM BIOPHYS, V476, P139, DOI 10.1016/j.abb.2008.03.023
   Maher P, 2006, P NATL ACAD SCI USA, V103, P16568, DOI 10.1073/pnas.0607822103
   Maher P, 2006, FREE RADICAL RES, V40, P1105, DOI 10.1080/10715760600672509
   Maher Pamela, 2021, Brain Plast, V6, P155, DOI 10.3233/BPL-200104
   Maher P, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9111113
   Maher P, 2009, GENES NUTR, V4, P297, DOI 10.1007/s12263-009-0142-5
   Maher PA, 2020, YALE J BIOL MED, V93, P365
   Michetti F, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms24119605
   Michetti F, 2019, J NEUROCHEM, V148, P168, DOI 10.1111/jnc.14574
   Molagoda IMN, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10081215
   Mullen M, 2023, STEM CELLS, V41, P698, DOI 10.1093/stmcls/sxad036
   Ng PY, 2023, FEBS J, V290, P1326, DOI 10.1111/febs.16315
   Park C, 2023, J MICROBIOL BIOTECHN, V33, P591, DOI 10.4014/jmb.2212.12042
   Park C, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.927898
   Park S, 2022, PHARMACEUTICALS-BASE, V15, DOI 10.3390/ph15121528
   Piechota M, 2016, ONCOTARGET, V7, P81099, DOI 10.18632/oncotarget.12752
   Ravula AR, 2021, EUR J PHARMACOL, V910, DOI 10.1016/j.ejphar.2021.174492
   Singh S, 2019, BIOCHEM CELL BIOL, V97, P480, DOI 10.1139/bcb-2018-0159
   Singh S, 2018, LIFE SCI, V193, P171, DOI 10.1016/j.lfs.2017.11.004
   Song SL, 2020, ADV SCI, V7, DOI 10.1002/advs.202002611
   Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596
   Xiao SF, 2021, INT J BIOL MACROMOL, V178, P381, DOI 10.1016/j.ijbiomac.2021.02.210
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Xu M, 2015, ELIFE, V4, DOI 10.7554/eLife.12997
   Xu M, 2015, P NATL ACAD SCI USA, V112, pE6301, DOI 10.1073/pnas.1515386112
   Yan L, 2021, EXP THER MED, V21, DOI 10.3892/etm.2020.9457
   Yousefzadeh MJ, 2018, EBIOMEDICINE, V36, P18, DOI 10.1016/j.ebiom.2018.09.015
NR 57
TC 2
Z9 2
U1 2
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3921
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD AUG
PY 2023
VL 12
IS 8
AR 1646
DI 10.3390/antiox12081646
PG 27
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science
   & Technology
GA Q3ST4
UT WOS:001056756700001
PM 37627641
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU James, A
   Hunter, M
   Straker, LM
   Beilby, J
   Bucks, R
   Davis, T
   Eikelboom, RH
   Hillman, D
   Hui, JN
   Hung, J
   Knuiman, M
   Mackey, DA
   Newton, RU
   Palmer, LJ
   Musk, AWB
AF James, Alan
   Hunter, Michael
   Straker, Leon M.
   Beilby, John
   Bucks, Romola
   Davis, Tim
   Eikelboom, Robert H.
   Hillman, David
   Hui, Jennie
   Hung, Joe
   Knuiman, Matthew
   Mackey, David A.
   Newton, Robert U.
   Palmer, Lyle J.
   Musk, A. W. Bill
CA Busselton Hlth Ageing Study BHAS I
TI Rationale, design and methods for a community-based study of clustering
   and cumulative effects of chronic disease processes and their effects on
   ageing: the Busselton healthy ageing study
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Busselton; Healthy ageing; Clusters of illness; Cross-sectional;
   Prevalence; Multi-morbidity
ID CARDIOVASCULAR-DISEASE; COHORT PROFILE; BACK-PAIN; QUESTIONNAIRE;
   VALIDITY; MORTALITY; RISK; HEMOCHROMATOSIS; RELIABILITY; POPULATION
AB Background: The global trend of increased life expectancy and increased prevalence of chronic and degenerative diseases will impact on health systems. To identify effective intervention and prevention strategies, greater understanding of the risk factors for and cumulative effects of chronic disease processes and their effects on function and quality of life is needed.
   The Busselton Healthy Ageing Study aims to enhance understanding of ageing by relating the clustering and interactions of common chronic conditions in adults to function. Longitudinal (3-5 yearly) follow-up is planned.
   Methods/design: Phase I (recruitment) is a cross-sectional community-based prospective cohort study involving up to 4,000 'Baby Boomers' (born from 1946 to 1964) living in the Busselton Shire, Western Australia. The study protocol involves a detailed, self-administered health and risk factor questionnaire and a range of physical assessments including body composition and bone density measurements, cardiovascular profiling (blood pressure, ECG and brachial pulse wave velocity), retinal photography, tonometry, auto-refraction, spirometry and bronchodilator responsiveness, skin allergy prick tests, sleep apnoea screening, tympanometry and audiometry, grip strength, mobility, balance and leg extensor strength. Cognitive function and reserve, semantic memory, and pre-morbid intelligence are assessed. Participants provide a fasting blood sample for assessment of lipids, blood glucose, C-reactive protein and renal and liver function, and RNA, DNA and serum are stored. Clinically relevant results are provided to all participants. The prevalence of risk factors, symptoms and diagnosed illness will be calculated and the burden of illness will be estimated based on the observed relationships and clustering of symptoms and illness within individuals. Risk factors for combinations of illness will be compared with those for single illnesses and the relation of combinations of illness and symptoms to cognitive and physical function will be estimated.
   Discussion: This study will enable a thorough characterization of multiple disease processes and their risk factors within a community-based sample of individuals to determine their singular, interactive and cumulative effects on ageing. The project will provide novel cross-sectional data and establish a cohort that will be used for longitudinal analyses of the genetic, lifestyle and environmental factors that determine whether an individual ages well or with impairment.
C1 [James, Alan; Hillman, David] Sir Charles Gairdner Hosp, West Australian Sleep Disorders Inst, Dept Pulm Physiol & Sleep Med, Perth, WA, Australia.
   [Straker, Leon M.] Curtin Univ, Sch Physiotherapy, Perth, WA 6845, Australia.
   [Straker, Leon M.] Curtin Univ, Curtin Hlth Innovat Res Inst, Perth, WA 6845, Australia.
   [Beilby, John; Hui, Jennie] Univ Western Australia, Pathwest, Perth, WA 6009, Australia.
   [Bucks, Romola] Univ Western Australia, Sch Psychol, Perth, WA 6009, Australia.
   [Davis, Tim] Fremantle Hosp, Perth, WA, Australia.
   [Davis, Tim] Univ Western Australia, Sch Med & Hlth, Perth, WA 6009, Australia.
   [Eikelboom, Robert H.] Univ Western Australia, Ear Sci Inst Australia, Ear Sci Ctr, Perth, WA, Australia.
   [Eikelboom, Robert H.] Univ Western Australia, Sch Surg, Perth, WA, Australia.
   [Hillman, David] Univ Western Australia, Sch Anat & Surg, Perth, WA 6009, Australia.
   [Hunter, Michael; Hui, Jennie; Knuiman, Matthew; Musk, A. W. Bill] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia.
   [Mackey, David A.] Univ Western Australia, Lions Eye Inst, Ctr Ophthalmol & Visual Sci, Perth, WA 6009, Australia.
   [Newton, Robert U.] Edith Cowan Univ, Hlth & Wellness Inst, Perth, WA, Australia.
   [Palmer, Lyle J.] Univ Toronto, Ontario Inst Canc Res, Toronto, ON, Canada.
   [Palmer, Lyle J.] Univ Toronto, Samuel Lunenfeld Res Inst, Toronto, ON, Canada.
   [Hunter, Michael; Musk, A. W. Bill] Sir Charles Gairdner Hosp, Dept Resp Med, Perth, WA, Australia.
   [James, Alan; Hung, Joe; Musk, A. W. Bill] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia.
   [Beilby, John; Hui, Jennie] Univ Western Australia, Sch Pathol & Lab, Perth, WA 6009, Australia.
C3 Curtin University; Curtin University; University of Western Australia;
   University of Western Australia; University of Western Australia; Ear
   Science Institute Australia; University of Western Australia; University
   of Western Australia; University of Western Australia; University of
   Western Australia; University of Western Australia; Lions Eye Institute;
   Edith Cowan University; University of Toronto; Ontario Institute for
   Cancer Research; University of Toronto; Sinai Health System Toronto;
   Lunenfeld Tanenbaum Research Institute; University of Western Australia;
   University of Western Australia; University of Western Australia
RP James, A (corresponding author), Sir Charles Gairdner Hosp, West Australian Sleep Disorders Inst, Dept Pulm Physiol & Sleep Med, Perth, WA, Australia.
EM Alan.James.SCGH@health.wa.gov.au
RI Straker, Leon M/B-2407-2013; Mackey, David/AGK-9226-2022; Hunter,
   Michael/IAN-2950-2023; Palmer, Lyle John/N-1948-2019; Davis, Timothy
   ME/M-5144-2014; Bucks, Romola Starr/B-9164-2011; Palmer, Lyle
   John/K-3196-2014; Newton, Robert Usher/A-3466-2009; Knuiman, Matthew
   W/I-5549-2013; Eikelboom, Robert/B-2820-2013; Hunter, Michael
   L/B-3213-2013; Hui, Jennie/A-9543-2013; Mackey, David A/H-5340-2014
OI Straker, Leon M/0000-0002-7786-4128; Hunter,
   Michael/0000-0001-6704-4815; Palmer, Lyle John/0000-0002-1628-3055;
   Bucks, Romola Starr/0000-0002-4207-4724; Palmer, Lyle
   John/0000-0002-1628-3055; Newton, Robert Usher/0000-0003-0302-6129;
   Eikelboom, Robert/0000-0003-2911-5381; Hunter, Michael
   L/0000-0001-6704-4815; Hui, Jennie/0000-0002-1653-2496; Mackey, David
   A/0000-0001-7914-4709; Knuiman, Matthew/0000-0001-8874-2305; Hillman,
   David/0000-0001-9987-539X; Davis, Timothy/0000-0003-0749-7411; Beilby,
   John/0000-0002-4915-2254
FU Office of Science and Department of Health of the Government of Western
   Australia; City of Busselton; School of Physiotherapy, Curtin
   University; Ear Science Institute Australia Inc.; Lions Hearing
   Foundation of Western Australia Inc.
FX The BHAS Investigators wish to acknowledge the National Health and
   Medical Research Council (NHMRC) Equipment Grant scheme for purchase of
   essential equipment. The Busselton Population Medical Research Institute
   receives funding from the Office of Science and Department of Health of
   the Government of Western Australia, the City of Busselton, a bequest of
   the late Dr Janet Elder and private donors. We thank the Western
   Australian Country Health Service - South West for core infrastructure
   support. In-kind equipment and consumable support for the BHAS is
   gratefully received from ResMed Science Centre, Stallergens and BD
   Biosciences. Financial support has also been provided by School of
   Physiotherapy, Curtin University; Ear Science Institute Australia Inc.;
   and Lions Hearing Foundation of Western Australia Inc. The BHAS
   Investigators thank Prue Cormie, Mark Divitini, Chris Ellis, Natalia
   Lizama, Marion Macnish, Kashif Mukhtar, Barbara Rabey and Paul White for
   technical support and assistance in the operation of the study. We thank
   the operational team in Busselton of Elspeth Inglis, Aida Embling, Darcy
   Bennett, Shelley Cheetham, Jessica Storey, Debra Burwood, Dianne Toovey,
   Stephanie Murphy and Jenifer George for participant recruitment and data
   collection, and the community of Busselton for their ongoing support and
   participation.
CR Adams C, 2005, ACTA PAEDIATR, V94, P275, DOI 10.1080/08035250410024303
   Australian Bureau of Statistics, 2006, NAT HLTH SURV 2004 2
   Australian Bureau of Statistics, 2006, AUSTR SOC TRENDS 200
   Australian Institute of Health and Welfare, 2008, Projection of Australian health care expenditure by disease, 2003 to 2033
   BANDALOS D, 1990, EDUC PSYCHOL MEAS, V50, P49, DOI 10.1177/0013164490501005
   Banks E, 2008, INT J EPIDEMIOL, V37, P941, DOI 10.1093/ije/dym184
   Barondess JA, 2008, J AM GERIATR SOC, V56, P145, DOI 10.1111/j.1532-5415.2007.01513.x
   Björkstén MG, 1999, APPL ERGON, V30, P325, DOI 10.1016/S0003-6870(98)00033-7
   Bremner AP, 2012, J CLIN ENDOCR METAB, V97, P1554, DOI 10.1210/jc.2011-3020
   Buatois S, 2008, J AM GERIATR SOC, V56, P1575, DOI 10.1111/j.1532-5415.2008.01777.x
   Chin MW, 2009, MED J AUSTRALIA, V190, P429, DOI 10.5694/j.1326-5377.2009.tb02491.x
   Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB
   CULLEN K, 1983, J CHRON DIS, V36, P371, DOI 10.1016/0021-9681(83)90169-8
   Cumming RG, 2009, INT J EPIDEMIOL, V38, P374, DOI 10.1093/ije/dyn071
   Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0
   Davis TME, 2006, MED J AUSTRALIA, V184, P325, DOI 10.5694/j.1326-5377.2006.tb00264.x
   Desai A, 2010, PHYS THER, V90, P748, DOI 10.2522/ptj.20090100
   Dionne CE, 2008, SPINE, V33, P95, DOI 10.1097/BRS.0b013e31815e7f94
   Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   Franco OH, 2009, MATURITAS, V63, P13, DOI 10.1016/j.maturitas.2009.02.006
   Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108
   Harland NJ, 2003, REHABIL PSYCHOL, V48, P296, DOI 10.1037/0090-5550.48.4.296
   Harris C, 2000, INT J IND ERGONOM, V26, P337, DOI 10.1016/S0169-8141(00)00009-3
   Hennessy M., 1995, The 18th Annual Brain Impairment Conference, P183
   Holden L, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-417
   Hung J, 2008, HEART LUNG CIRC, V17, P90, DOI 10.1016/j.hlc.2007.07.002
   James AL, 2005, AM J RESP CRIT CARE, V171, P109, DOI 10.1164/rccm.200402-230OC
   JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540
   Keith MS, 1998, BRAIN INJURY, V12, P1037, DOI 10.1080/026990598121945
   Kivimäki M, 2011, INT J EPIDEMIOL, V40, P845, DOI 10.1093/ije/dyr114
   Knuiman MW, 2004, AUST NZ J PUBL HEAL, V28, P267, DOI 10.1111/j.1467-842X.2004.tb00706.x
   Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x
   KUORINKA I, 1987, APPL ERGON, V18, P233, DOI 10.1016/0003-6870(87)90010-X
   Lezak MD, 1995, NEUROPSYCHOLOGICAL A
   Linton SJ, 1998, CLIN J PAIN, V14, P209, DOI 10.1097/00002508-199809000-00007
   Linton SJ, 2003, CLIN J PAIN, V19, P80, DOI 10.1097/00002508-200303000-00002
   Lovibond S.H., 1995, Manual for the Depression Anxiety Stress Scales, V2
   LOYD BH, 1984, EDUC PSYCHOL MEAS, V44, P501, DOI 10.1177/0013164484442033
   MALLAMPATI SR, 1985, CAN ANAESTH SOC J, V32, P429, DOI 10.1007/BF03011357
   Margolis RH, 2010, INT J AUDIOL, V49, P185, DOI 10.3109/14992020903092608
   McEvoy M, 2010, INT J EPIDEMIOL, V39, P1452, DOI 10.1093/ije/dyp343
   Milward EA, 2010, J ALZHEIMERS DIS, V20, P617, DOI 10.3233/JAD-2010-1402
   Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312
   Musk AW, 2011, EUR RESPIR J, V38, P1053, DOI 10.1183/09031936.00102110
   Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002
   Newton RU, 2010, PRINCIPLES ATHLETE T
   O'Leary CM, 2004, EUR J CARDIOV PREV R, V11, P350, DOI 10.1097/01.hjr.0000136457.36990.1a
   Olynyk JK, 1999, NEW ENGL J MED, V341, P718, DOI 10.1056/NEJM199909023411002
   Olynyk JK, 2004, MAYO CLIN PROC, V79, P309, DOI 10.4065/79.3.309
   Olynyk JK, 2009, AM J GASTROENTEROL, V104, P1715, DOI 10.1038/ajg.2009.229
   Onyx J., 2000, J APPL BEHAV SCI, V36, P23, DOI [DOI 10.1177/0021886300361002, 10.1177/0021886300361002]
   PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x
   Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501
   SAMET JM, 1978, AM J EPIDEMIOL, V108, P435, DOI 10.1093/oxfordjournals.aje.a112642
   Siahpush M, 2006, J EPIDEMIOL COMMUN H, V60, P1077, DOI 10.1136/jech.2005.042572
   Smith W, 2004, HYPERTENSION, V44, P442, DOI 10.1161/01.HYP.0000140772.40322.ec
   Symonds TL, 1996, OCCUP MED-OXFORD, V46, P25, DOI 10.1093/occmed/46.1.25
   Treasury Australia, 2010, INT REP 2010 AUSTR 2
   WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B
   Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003
   Wedderkopp N, 2008, SPINE, V26, P1879
   Welborn T., 1998, BUSSELTON STUDY MAPP
NR 63
TC 42
Z9 42
U1 1
U2 20
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD OCT 8
PY 2013
VL 13
AR 936
DI 10.1186/1471-2458-13-936
PG 12
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA 283ZI
UT WOS:000329285100003
PM 24099269
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Cho, MJ
   Kim, DH
   Ha, S
   Bang, E
   Jung, HJ
   Moon, HR
   Chung, HY
AF Cho, Mun Joo
   Kim, Dae Hyun
   Ha, Sugyeong
   Bang, EunJin
   Jung, Hee Jin
   Moon, Hyung Ryong
   Chung, Hae Young
TI MHY2013 Modulates Age-related Inflammation and Insulin Resistance by
   Suppressing the Akt/FOXO1/IL-1β Axis and MAPK-mediated NF-κB Signaling
   in Aged Rat Liver
SO APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
LA English
DT Article
DE MHY2013; FOXO1; NF-kappa B; insulin resistance; inflammation
ID ACTIVATED PROTEIN-KINASES; PPAR PAN AGONIST; TRANSCRIPTION FACTORS;
   METHYL METHANESULFONATE; CALORIE RESTRICTION; FATTY-ACID; P38 MAPK;
   PATHWAY; EXPRESSION; FOXO1
AB Chronic inflammation is a major risk factor underlying aging and age-associated diseases. It impairs normal lipid accumulation, adipose tissue function, and mitochondrial function, which eventually lead to insulin resistance. Peroxisome proliferator-activated receptors (PPARs) critically regulate gluconeogenesis, lipid metabolism, and the lipid absorption and breakdown process, and PPAR activity decreases in the liver during aging. In the present study, we investigated the ability of 2-(4-(5,6-methylenedioxybenzo[d]thiazol-2-yl)-2-methylphenoxy)-2-methylpropanoic acid (MHY2013), synthesized PPAR alpha/PPAR beta/PPAR gamma pan agonist, to suppress the inflammatory response and attenuate insulin resistance in aged rat liver. Six- and 20-month-old rats were divided into 4 groups: young and old rats fed ad libitum; and old rats fed ad libitum supplemented with MHY2013 (1 mg and 5 mg/kg/d for 4 wk). We found that MHY2013 supplementation efficiently downregulated the activity of nuclear factor-kappa B through JNK/ERK/p38 mitogen-activated protein kinase signaling in the liver of aged rats. In addition, MHY2013 treatment increased hepatic insulin signaling, and the downstream signaling activity of FOXO1, which is negatively regulated by Akt. Downregulation of Akt increases expression of FOXO1, which acts as a transcription factor and increases transcription of interleukin-1 beta, leading to hepatic inflammation. The major finding of this study is that MHY2013 acts as a therapeutic agent against age-related inflammation associated with insulin resistance by activating PPAR alpha, PPAR beta, and PPAR gamma. Thus, the study provides evidence for the anti-inflammatory properties of MHY2013, and the role it plays in the regulation of age-related alterations in signal transduction pathways.
C1 [Cho, Mun Joo; Kim, Dae Hyun; Ha, Sugyeong; Bang, EunJin; Jung, Hee Jin; Moon, Hyung Ryong; Chung, Hae Young] Pusan Natl Univ, Coll Pharm, Dept Pharm, 2 Busandaehak Ro 63beon Gil, Busan 46241, South Korea.
C3 Pusan National University
RP Chung, HY (corresponding author), Pusan Natl Univ, Coll Pharm, Dept Pharm, 2 Busandaehak Ro 63beon Gil, Busan 46241, South Korea.
EM hyjung@pusan.ac.kr
FU National Research Foundation of Korea (NRF) - Korean government
   [MSIT-2018R1A2A3075425, MSIP-2009-0083538]; Cooperative Research Program
   for Agriculture Science & Technology Development Rural Development
   Administration, Republic of Korea [PJ006522132013]
FX Supported by the National Research Foundation of Korea (NRF) grant
   funded by the Korean government (MSIT-2018R1A2A3075425;
   MSIP-2009-0083538) and Cooperative Research Program for Agriculture
   Science & Technology Development (Project No. PJ006522132013) Rural
   Development Administration, Republic of Korea.
CR Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0
   An HJ, 2018, BIOL PHARM BULL, V41, P29, DOI 10.1248/bpb.b17-00371
   An HJ, 2017, ONCOTARGET, V8, P16912, DOI 10.18632/oncotarget.14818
   Aneta D, 2012, J BIOL CHEM, V287, P44749
   Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891
   Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010
   Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421
   Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976
   Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4
   Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336
   Chio CC, 2004, CELL SIGNAL, V16, P565, DOI 10.1016/j.cellsig.2003.10.003
   Cho SY, 2003, MOL CELL BIOCHEM, V243, P153, DOI 10.1023/A:1021624520740
   Chung HY, 2006, ANTIOXID REDOX SIGN, V8, P572, DOI 10.1089/ars.2006.8.572
   Chung HY, 2002, MICROSC RES TECHNIQ, V59, P264, DOI 10.1002/jemt.10203
   Chung HY, 2001, ANN NY ACAD SCI, V928, P327
   Chung HY, 2000, REV CLIN GERONTOL, V10, P207, DOI DOI 10.1017/S0959259800010327
   Debril MB, 2001, J MOL MED, V79, P30, DOI 10.1007/s001090000145
   Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048
   Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649
   Fagerberg B, 2005, DIABETOLOGIA, V48, P1716, DOI 10.1007/s00125-005-1846-8
   FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908
   Furuyama T, 2002, MICROSC RES TECHNIQ, V59, P331, DOI 10.1002/jemt.10213
   Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629
   Gennaro G, 2003, ARTERIOSCL THROM VAS, V23, P204, DOI 10.1161/01.ATV.0000053182.58636.BE
   Ghadir MR, 2010, HEPAT MON, V10, P285
   Go EK, 2005, J GERONTOL A-BIOL, V60, P1252, DOI 10.1093/gerona/60.10.1252
   Gutiérrez María Lucía, 2012, Univ. Sci., V17, P167
   Helenius M, 1996, BIOCHEM J, V318, P603, DOI 10.1042/bj3180603
   Hoekman MFM, 2006, GENE EXPR PATTERNS, V6, P134, DOI 10.1016/j.modgep.2005.07.003
   Hsieh CC, 2003, MECH AGEING DEV, V124, P733, DOI 10.1016/S0047-6374(03)00083-6
   ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0
   Jay MA, 2007, CURR DIABETES REV, V3, P33, DOI 10.2174/157339907779802067
   Kawamori D, 2006, J BIOL CHEM, V281, P1091, DOI 10.1074/jbc.M508510200
   Kim DH, 2008, BIOGERONTOLOGY, V9, P33, DOI 10.1007/s10522-007-9114-6
   Kim HJ, 2002, MECH AGEING DEV, V123, P1589, DOI 10.1016/S0047-6374(02)00094-5
   Kim HJ, 2002, FREE RADICAL BIO MED, V32, P991, DOI 10.1016/S0891-5849(02)00798-0
   Kim JY, 2006, AGING CELL, V5, P401, DOI 10.1111/j.1474-9726.2006.00233.x
   Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319
   Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991
   Manabe I, 2011, CIRC J, V75, P2739, DOI 10.1253/circj.CJ-11-1184
   Martinez SC, 2008, DIABETES, V57, P846, DOI 10.2337/db07-0595
   Moschen AR, 2011, MOL MED, V17, P840, DOI 10.2119/molmed.2010.00108
   Nagy L, 2012, PHYSIOL REV, V92, P739, DOI 10.1152/physrev.00004.2011
   Park MH, 2014, ARCH PHARM RES, V37, P1507, DOI 10.1007/s12272-014-0474-6
   Petersen KF, 2000, DIABETES, V49, P827, DOI 10.2337/diabetes.49.5.827
   Pourcet Benoit, 2006, Expert Opin Emerg Drugs, V11, P379, DOI 10.1517/14728214.11.3.379
   Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353
   Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812
   Suh Y, 2001, MUTAT RES-GEN TOX EN, V497, P11, DOI 10.1016/S1383-5718(01)00207-8
   Suh YS, 2001, MECH AGEING DEV, V122, P1797, DOI 10.1016/S0047-6374(01)00301-3
   Sung B, 2004, J GERONTOL A-BIOL, V59, P997
   Tissenbaum HA, 1998, GENETICS, V148, P703
   Umezawa K, 2002, ANTI-CANCER DRUG DES, V5, P239
   Wahli W, 2012, TRENDS ENDOCRIN MET, V23, P351, DOI 10.1016/j.tem.2012.05.001
   Wang HQ, 2003, J BIOL CHEM, V278, P45737, DOI 10.1074/jbc.M300574200
   Yoon SW, 2003, J BIOL CHEM, V278, P32914, DOI 10.1074/jbc.M302444200
   Yu BP, 1996, FREE RADICAL BIO MED, V21, P651, DOI 10.1016/0891-5849(96)00162-1
   Zhang J, 2001, ANTIOXID REDOX SIGN, V3, P493, DOI 10.1089/15230860152409121
NR 58
TC 4
Z9 4
U1 2
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1541-2016
EI 1533-4058
J9 APPL IMMUNOHISTO M M
JI Appl. Immunohistochem.
PD SEP
PY 2020
VL 28
IS 8
BP 579
EP 592
DI 10.1097/PAI.0000000000000782
PG 14
WC Anatomy & Morphology; Medical Laboratory Technology; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Anatomy & Morphology; Medical Laboratory Technology; Pathology
GA NY6QB
UT WOS:000576510300005
PM 32902936
DA 2024-02-19
ER

PT J
AU Li, DD
   Li, WJ
   Kong, SZ
   Li, SD
   Guo, JQ
   Guo, MH
   Cai, TT
   Li, N
   Chen, RZ
   Luo, RQ
   Tan, WX
AF Li, Dong-Dong
   Li, Wen-Jie
   Kong, Song-Zhi
   Li, Si-Dong
   Guo, Jia-Qi
   Guo, Min-Hui
   Cai, Ting-Ting
   Li, Ning
   Chen, Ri-Zhi
   Luo, Rong-Qiong
   Tan, Wei-Xiang
TI Protective effects of collagen polypeptide from tilapia skin against
   injuries to the liver and kidneys of mice induced by D-galactose
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Article
DE Tilapia skin collagen polypeptide (TSCP); D-galactose; Oxidative stress;
   Hepatic damages; Nephritic injuries; Amino acid sequence
ID OXIDATIVE STRESS; ANTIOXIDANT PEPTIDES; PROTEIN HYDROLYSATE; TROXERUTIN
   PROTECTS; AST/ALT RATIO; AGING MODEL; MOUSE-LIVER; IN-VITRO;
   PURIFICATION; DAMAGE
AB We wished to investigate the role of a tilapia skin collagen polypeptide (TSCP; molecular weight < 3 kDa) in alleviating liver and kidney injuries in aging mice induced by D-galactose (D-gal) and its underlying mechanism of action. First, we characterized TSCP. TSCP was passed through a 3-kDa ultrafiltration membrane, desalted in water by a solid-phase extraction column, purified further by reverse phase-high performance liquid chromatography, and analyzed by electrospray ionization mass spectrometry and tandem mass spectrometry. TSCP contained 17 types of amino acids (AAs) and 41 peptide chains of length 7 AAs to 22 AAs. The content of free AAs and total AAs of TSCP was 13.5% and 93.79%, respectively. Next, we undertook animal experiments. Mice were injected once-daily with D-gal (300 mg/kg body weight, s.c.) for 8 weeks, and TSCP was administered simultaneously once-daily by intragastric gavage. TSCP could visibly improve the decreased body weight, depressed appetite, and mental deterioration of mice triggered by D-gal. TSCP could also alleviate D-gal-induced damage to the liver and kidneys according to histopathology (especially high-dose TSCP). Consistent with these macroscopic and pathologic changes, TSCP could also prevent D-gal-induced increases in serum levels of alanine aminotransferase, aspartate transaminase, alkaline phosphatase, lipid peroxidation, creatinine and uric acid, as well as decreases in serum levels of immunoglobulin (Ig)G and IgM. Moreover, TSCP improved the activities of superoxide dismutase, catalase, and glutathione peroxidase, but also inhibited the increases in the levels of malondialdehyde and inducible nitric oxide synthase expression in the liver and kidneys of D-gal-treated mice. These results suggest that TSCP can alleviate the injuries to the liver and kidneys in aging mice induced by D-gal, and that its mechanism of action might be, at least partially, associated with attenuation of oxidative stress and enhancement of immune function.
C1 [Li, Dong-Dong; Kong, Song-Zhi; Li, Si-Dong; Guo, Jia-Qi; Guo, Min-Hui; Cai, Ting-Ting; Tan, Wei-Xiang] Guangdong Ocean Univ, Fac Chem & Environm Sci, Zhanjiang, Guangdong, Peoples R China.
   [Li, Wen-Jie; Li, Ning] Guangdong Ocean Univ, Affiliated Hosp, Dept Hematol, Zhanjiang, Guangdong, Peoples R China.
   [Chen, Ri-Zhi; Luo, Rong-Qiong] Zhanjiang Jianliyuan Med Articles Co Ltd, Zhanjiang, Guangdong, Peoples R China.
C3 Guangdong Ocean University; Guangdong Ocean University
RP Kong, SZ (corresponding author), Guangdong Ocean Univ, Fac Chem & Environm Sci, Zhanjiang, Guangdong, Peoples R China.; Li, WJ (corresponding author), Guangdong Ocean Univ, Affiliated Hosp, Dept Hematol, Zhanjiang, Guangdong, Peoples R China.
EM dglwj.135@163.com; kongsongzhi@126.com
RI Guo, Jiaqi/GSO-0702-2022; Li, Sidong/AAH-6955-2019
FU National Natural Science Foundation of China [81803684]; Natural Science
   Foundation of Guangdong Province [2015A030310121, 2018A030313416]; Team
   Project of Innovation and Entrepreneurship for Undergraduates of
   Guangdong Ocean University [CCTD201828]; Innovation and Entrepreneurship
   Training Program for Guangdong College Students [CXXL2018114]; special
   funds for the cultivation of Guangdong college students' scientific and
   technological innovation ("climbing program" special funds) [pdjhb0240,
   pdjhb0242]
FX This work was supported by the National Natural Science Foundation of
   China (No. 81803684), the Natural Science Foundation of Guangdong
   Province (No. 2015A030310121, and No. 2018A030313416), the Team Project
   of Innovation and Entrepreneurship for Undergraduates of Guangdong Ocean
   University (No. CCTD201828), the Innovation and Entrepreneurship
   Training Program for Guangdong College Students (No. CXXL2018114), and
   the special funds for the cultivation of Guangdong college students'
   scientific and technological innovation ("climbing program" special
   funds) (No. pdjhb0240, and No. pdjhb0242).
CR Agrawal S, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0412-9
   Ahn MY, 2015, TOXICOL RES-GER, V31, P173, DOI 10.5487/TR.2015.31.2.173
   Ai X. F., 2010, CHINESE J COMP MED, V20, P41
   Asanuma Katsuhiko, 2003, Clin Exp Nephrol, V7, P255, DOI 10.1007/s10157-003-0259-6
   Avramovic N, 2012, HIPPOKRATIA, V16, P241
   Baar MP, 2017, CELL, V169, P132, DOI 10.1016/j.cell.2017.02.031
   Behrman HR, 2001, J SOC GYNECOL INVEST, V8, pS40, DOI 10.1016/S1071-5576(00)00106-4
   Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907
   Bougatef A, 2009, FOOD CHEM, V114, P1198, DOI 10.1016/j.foodchem.2008.10.075
   Camargo CA, 1997, HEPATOLOGY, V26, P1513, DOI 10.1002/hep.510260619
   CHAN KM, 1993, J FOOD SCI, V58, P1, DOI 10.1111/j.1365-2621.1993.tb03199.x
   Chen GJ, 2018, INT J BIOL MACROMOL, V107, P166, DOI 10.1016/j.ijbiomac.2017.08.160
   Chen H., 2016, BOUND VALUE PROBL, V2016, P1, DOI DOI 10.1214/15-STS531
   Chen SL, 2015, FOOD CHEM, V188, P350, DOI 10.1016/j.foodchem.2015.04.084
   Choonpicharn S, 2015, J FOOD SCI TECH MYS, V52, P3134, DOI 10.1007/s13197-014-1581-6
   Çoban J, 2014, GERIATR GERONTOL INT, V14, P490, DOI 10.1111/ggi.12096
   Dekkers E, 2011, FOOD CHEM, V124, P640, DOI 10.1016/j.foodchem.2010.06.088
   DJABOUROV M, 1993, BIORHEOLOGY, V30, P191
   Du Z, 2015, NEUROSCIENCE, V286, P281, DOI 10.1016/j.neuroscience.2014.11.061
   Fan J, 2012, MOLECULES, V17, P12836, DOI 10.3390/molecules171112836
   Feng Y., 2016, 2016 12th IEEE/ASME International Conference on Mechatronic and Embedded Systems and Applications (MESA), P1, DOI 10.1109/MESA.2016.7587102
   Galkin F, 2019, AGEING RES REV, V49, P104, DOI 10.1016/j.arr.2018.11.008
   Hadzi-Petrushev N, 2015, PHYSIOL RES, V64, P61, DOI 10.33549/physiolres.932786
   He QM, 2013, J IMMUNOL, V191, P5858, DOI 10.4049/jimmunol.1302273
   Hu WX, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0642-3
   Indo HP, 2015, J CLIN BIOCHEM NUTR, V56, P1, DOI 10.3164/jcbn.14-42
   Jamilah B, 2002, FOOD CHEM, V77, P81, DOI 10.1016/S0308-8146(01)00328-4
   Jan H., 2013, PLOS ONE, V8, P1
   Jin WG, 2012, EUR FOOD RES TECHNOL, V234, P863, DOI 10.1007/s00217-012-1700-4
   Jing HJ, 2018, INT J BIOL MACROMOL, V106, P1270, DOI 10.1016/j.ijbiomac.2017.08.138
   Kim J, 2016, MED DOSIM, V41, P113, DOI 10.1016/j.meddos.2015.10.004
   Kumar NSS, 2012, AMINO ACIDS, V42, P1641, DOI 10.1007/s00726-011-0858-6
   Kuo PC, 1997, BIOCHEM BIOPH RES CO, V234, P289, DOI 10.1006/bbrc.1997.6562
   Ladomenou F, 2016, ARCH DIS CHILDHOOD-E, V101, P129, DOI 10.1136/archdischild-2015-309060
   Lei LH, 2016, J CHIN MED ASSOC, V79, P205, DOI 10.1016/j.jcma.2015.06.023
   Li C, 2016, ADV METEOROL, V2016, DOI 10.1155/2016/6583906
   Li Meng-Yun, 2014, Shengli Xuebao, V66, P605
   Li MY, 2016, PAK VET J, V36, P356
   Li SS, 2018, INT J BIOL MACROMOL, V106, P1297, DOI 10.1016/j.ijbiomac.2017.08.135
   Liu AJ, 2009, BIOSCI BIOTECH BIOCH, V73, P1461, DOI 10.1271/bbb.80558
   Liu CM, 2010, FOOD CHEM TOXICOL, V48, P2809, DOI 10.1016/j.fct.2010.07.011
   Lv HM, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1543-z
   Mardinoglu A, 2018, CELL METAB, V27, P559, DOI 10.1016/j.cmet.2018.01.005
   Mo ZZ, 2017, REJUV RES, V20, P231, DOI 10.1089/rej.2016.1870
   Ngo DH, 2010, J FUNCT FOODS, V2, P107, DOI 10.1016/j.jff.2010.02.001
   Nyblom H, 2004, ALCOHOL ALCOHOLISM, V39, P336, DOI 10.1093/alcalc/agh074
   Papaioannou A, 2009, CENT EUR J MED, V4, P37, DOI 10.2478/s11536-008-0085-z
   Piovezan R. D., 2002, AGEING RES REV
   Rehman SU, 2017, MOL NEUROBIOL, V54, P255, DOI 10.1007/s12035-015-9604-5
   Ren ZZ, 2018, INT J BIOL MACROMOL, V120, P811, DOI 10.1016/j.ijbiomac.2018.08.114
   Salmon AB, 2010, FREE RADICAL BIO MED, V48, P642, DOI 10.1016/j.freeradbiomed.2009.12.015
   Samarghandian S, 2016, BIOCHEM RES INT, V2016, DOI 10.1155/2016/2645237
   Sathivel A, 2014, PHARM BIOL, V52, P498, DOI 10.3109/13880209.2013.846915
   Sheth SG, 1998, AM J GASTROENTEROL, V93, P44, DOI 10.1111/j.1572-0241.1998.044_c.x
   Sinturel F, 2017, CELL, V169, P651, DOI 10.1016/j.cell.2017.04.015
   Sun LP, 2013, J FUNCT FOODS, V5, P154, DOI 10.1016/j.jff.2012.09.006
   Sun QA, 2011, J FOOD SCI TECH MYS, V48, P53, DOI 10.1007/s13197-010-0115-0
   Wang QK, 2014, FOOD CHEM, V145, P991, DOI 10.1016/j.foodchem.2013.08.099
   Wei HF, 2005, BEHAV BRAIN RES, V157, P245, DOI 10.1016/j.bbr.2004.07.003
   Wimmer RA, 2019, NATURE, V565, P505, DOI 10.1038/s41586-018-0858-8
   Xie ZJ, 2008, FOOD CHEM, V111, P370, DOI 10.1016/j.foodchem.2008.03.078
   Xu LQ, 2016, FOOD FUNCT, V7, P4545, DOI 10.1039/c6fo01057a
   Yu YH, 2015, PHARMACOL BIOCHEM BE, V133, P122, DOI 10.1016/j.pbb.2015.03.020
   Zhang L, 2017, FOOD FUNCT, V8, P1698, DOI [10.1039/c6fo01499b, 10.1039/C6FO01499B]
   Zhang X, 2019, J ETHNOPHARMACOL, V234, P44, DOI 10.1016/j.jep.2018.12.050
   Zhang ZF, 2009, J AGR FOOD CHEM, V57, P7731, DOI 10.1021/jf9012357
   Zhang ZF, 2009, FOOD CHEM TOXICOL, V47, P496, DOI 10.1016/j.fct.2008.12.005
   Zhao HD, 2018, FOOD NUTR RES, V62, DOI 10.29219/fnr.v62.1371
   Zhao L, 2019, J FUNCT FOODS, V52, P587, DOI 10.1016/j.jff.2018.11.044
   Zhen YZ, 2016, EXP THER MED, V11, P303, DOI 10.3892/etm.2015.2858
   Zhuang YL, 2011, J FOOD SCI, V76, pC483, DOI 10.1111/j.1750-3841.2011.02108.x
NR 71
TC 23
Z9 26
U1 2
U2 39
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD SEP
PY 2019
VL 117
AR 109204
DI 10.1016/j.biopha.2019.109204
PG 11
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA IM2EA
UT WOS:000477804500094
PM 31387177
OA gold
DA 2024-02-19
ER

PT J
AU McMurphy, T
   Huang, W
   Liu, XL
   Siu, JJ
   Queen, NJ
   Xiao, R
   Cao, L
AF McMurphy, Travis
   Huang, Wei
   Liu, Xianglan
   Siu, Jason J.
   Queen, Nicholas J.
   Xiao, Run
   Cao, Lei
TI Hypothalamic gene transfer of BDNF promotes healthy aging in mice
SO AGING CELL
LA English
DT Article
DE adipose tissue; aging; BDNF; gene transfer; hypothalamus; steatosis
ID NEUROTROPHIC FACTOR BDNF; DORSOMEDIAL HYPOTHALAMUS; DIETARY RESTRICTION;
   DEPRESSED-PATIENTS; MOLECULAR THERAPY; IKK-BETA; KAPPA-B; OBESITY;
   ACTIVATION; RECEPTORS
AB The aging process and age-related diseases all involve perturbed energy adaption and impaired ability to cope with adversity. Brain-derived neurotrophic factor (BDNF) in the hypothalamus plays important role in regulation of energy balance. Our previous studies show that recombinant adeno-associated virus (AAV)-mediated hypothalamic BDNF gene transfer alleviates obesity, diabetes, and metabolic syndromes in both diet-induced and genetic models. Here we examined the efficacy and safety of a built-in autoregulatory system to control transgene BDNF expression mimicking the body's natural feedback systems in middle-aged mice. Twelve-month-old mice were treated with either autoregulatory BDNF vector or yellow fluorescence protein (YFP) control, maintained on normal diet, and monitored for 28 weeks. BDNF gene transfer prevented the development of aging-associated metabolic declines characterized by: preventing aging-associated weight gain, reducing adiposity, reversing the decline of brown fat activity, increasing adiponectin while reducing leptin and insulin in circulation, improving glucose tolerance, increasing energy expenditure, alleviating hepatic steatosis, and suppressing inflammatory genes in the hypothalamus and adipose tissues. Moreover, BDNF treatment reduced anxiety-like and depression-like behaviors. These safety and efficacy data provide evidence that hypothalamic BDNF is a target for promoting healthy aging.
C1 [McMurphy, Travis; Huang, Wei; Liu, Xianglan; Siu, Jason J.; Queen, Nicholas J.; Xiao, Run; Cao, Lei] Ohio State Univ, Coll Med, Dept Canc Biol & Genet, Columbus, OH 43210 USA.
   [McMurphy, Travis; Huang, Wei; Liu, Xianglan; Siu, Jason J.; Queen, Nicholas J.; Xiao, Run; Cao, Lei] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA.
C3 University System of Ohio; Ohio State University; University System of
   Ohio; Ohio State University; James Cancer Hospital & Solove Research
   Institute
RP Cao, L (corresponding author), Ohio State Univ, Coll Med, Dept Canc Biol & Genet, Columbus, OH 43210 USA.
EM lei.cao@osumc.edu
RI Cao, Lei/H-3185-2019; li, Li/JPA-0218-2023
OI Queen, Nicholas/0000-0003-1864-5790; Cao, Lei/0000-0003-0322-4985
FU National Institute on Aging [AG041250]; National Cancer Institute
   [CA163640, CA166590, CA178227]
FX National Institute on Aging, Grant/Award Number: AG041250; National
   Cancer Institute, Grant/Award Number: CA163640, CA166590, CA178227
CR Barone FC, 2008, PHARMACOLOGY, V81, P11, DOI 10.1159/000107662
   Cao L, 2012, ANNU REV NEUROSCI, V35, P331, DOI 10.1146/annurev-neuro-062111-150546
   Cao L, 2011, CELL METAB, V14, P324, DOI 10.1016/j.cmet.2011.06.020
   Cao L, 2010, CELL, V142, P52, DOI 10.1016/j.cell.2010.05.029
   Cao L, 2009, NAT MED, V15, P447, DOI 10.1038/nm.1933
   Cryan JF, 2004, MOL PSYCHIATR, V9, P326, DOI 10.1038/sj.mp.4001457
   de Noronha SR, 2017, BEHAV BRAIN RES, V316, P38, DOI 10.1016/j.bbr.2016.08.042
   Duan WZ, 2003, P NATL ACAD SCI USA, V100, P2911, DOI 10.1073/pnas.0536856100
   Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0
   Enerbäck S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Gorski JA, 2003, NEUROSCIENCE, V121, P341, DOI 10.1016/S0306-4522(03)00426-3
   Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2
   Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593
   Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101
   Karege F, 2005, BIOL PSYCHIAT, V57, P1068, DOI 10.1016/j.biopsych.2005.01.008
   Khabour OF, 2010, INT J IMMUNOGENET, V37, P293, DOI 10.1111/j.1744-313X.2010.00925.x
   Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013
   Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x
   LINDSAY RM, 1994, NEUROBIOL AGING, V15, P249, DOI 10.1016/0197-4580(94)90124-4
   Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726
   Mattson MP, 2004, AGEING RES REV, V3, P445, DOI 10.1016/j.arr.2004.08.001
   Meek TH, 2013, DIABETES, V62, P1512, DOI 10.2337/db12-0837
   Mitchell SJ, 2016, CELL METAB, V23, P1093, DOI 10.1016/j.cmet.2016.05.027
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Purkayastha S, 2011, NAT MED, V17, P883, DOI 10.1038/nm.2372
   Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748
   Robins C, 2014, HUM GENET, V133, P1451, DOI 10.1007/s00439-014-1492-7
   Russo SJ, 2012, NAT NEUROSCI, V15, P1475, DOI 10.1038/nn.3234
   Sackmann-Sala L, 2012, OBESITY, V20, P101, DOI 10.1038/oby.2011.235
   Samuels BA, 2011, EUR J NEUROSCI, V33, P1152, DOI 10.1111/j.1460-9568.2011.07614.x
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   SHEKHAR A, 1993, BRAIN RES, V627, P17, DOI 10.1016/0006-8993(93)90743-7
   Shimizu E, 2003, BIOL PSYCHIAT, V54, P70, DOI 10.1016/S0006-3223(03)00181-1
   Silva MSCF, 2014, BEHAV BRAIN RES, V271, P249, DOI 10.1016/j.bbr.2014.06.018
   Siu JSJ, 2017, MOL THER-METH CLIN D, V7, P83, DOI 10.1016/j.omtm.2017.09.005
   Tang YZ, 2015, TRENDS NEUROSCI, V38, P36, DOI 10.1016/j.tins.2014.10.002
   Tang YZ, 2013, CELL CYCLE, V12, P2711, DOI 10.4161/cc.26054
   Tapia-Arancibia L, 2008, BRAIN RES REV, V59, P201, DOI 10.1016/j.brainresrev.2008.07.007
   Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660
   Wang C, 2003, GENE THER, V10, P1528, DOI 10.1038/sj.gt.3302011
   Xiao R, 2016, CANCER IMMUNOL RES, V4, P488, DOI 10.1158/2326-6066.CIR-15-0297
   Xu BJ, 2016, NAT REV NEUROSCI, V17, P282, DOI 10.1038/nrn.2016.24
   Zhang G, 2013, NATURE, V497, P211, DOI 10.1038/nature12143
   Zhang R, 2017, MOL PSYCHIATR, V22, P733, DOI 10.1038/mp.2016.136
   Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043
NR 46
TC 29
Z9 32
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD APR
PY 2019
VL 18
IS 2
AR e12846
DI 10.1111/acel.12846
PG 14
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA HO5JY
UT WOS:000460963500008
PM 30585393
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Nakashima, M
   Kinoshita, M
   Nakashima, H
   Kotani, A
   Ishikiriyama, T
   Kato, S
   Hiroi, S
   Seki, S
AF Nakashima, Masahiro
   Kinoshita, Manabu
   Nakashima, Hiroyuki
   Kotani, Aya
   Ishikiriyama, Takuya
   Kato, Shoichiro
   Hiroi, Sadayuki
   Seki, Shuhji
TI Pioglitazone improves phagocytic activity of liver recruited macrophages
   in elderly mice possibly by promoting glucose catabolism
SO INNATE IMMUNITY
LA English
DT Article
DE Aging; glycolysis; liver; phagocytosis; recruited macrophage
ID ESCHERICHIA-COLI; KUPFFER CELLS; T-CELLS; BACTERICIDAL ACTIVITY;
   HIGH-FAT; SEPSIS; GAMMA; ENHANCEMENT; GLYCOLYSIS; RESPONSES
AB Recent studies have revealed that the immunological function of leukocytes is dependent on their cellular metabolism, and some researchers have advocated the beneficial effects of pioglitazone against sepsis in young mice, although bacterial infections are more prevalent in elderly hosts. Here, we investigated pioglitazone's preventative effect against sepsis induced by intravenous injection of a lethal dose of Escherichia coli in elderly mice (50-60 wk old) and examined its immunological and metabolic effects on liver leukocytes. Pioglitazone improved bacterial elimination in the peripheral blood, lowered serum pro-inflammatory cytokines (TNF-alpha, IL-12, IFN-gamma), and prevented septic death. It also enhanced bacterial elimination in the liver, by increasing the phagocytic and bactericidal activities of liver F4/80(+)CD11b(+) recruited macrophages (M phi), their CD206 expression and reactive oxygen species production. Quantitative PCR revealed that pioglitazone treatment enhanced gene expression of rate-limiting enzymes for glycolysis in hepatic CD11b(+) cells (including neutrophils and recruited M phi), and their improved phagocytic and bactericidal activities were abolished by glycolysis inhibiting reagents. These findings present the possibility that pioglitazone strengthens the phagocytic and bactericidal activities of liver recruited M phi and that these immunological activities are closely associated with their glucose catabolism.
C1 [Nakashima, Masahiro; Kinoshita, Manabu; Nakashima, Hiroyuki; Kotani, Aya; Ishikiriyama, Takuya; Seki, Shuhji] Natl Def Med Coll, Dept Immunol & Microbiol, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.
   [Kato, Shoichiro] Natl Def Med Coll, Dept Internal Med, Tokorozawa, Saitama, Japan.
   [Hiroi, Sadayuki] Nitobebunka Coll, Dept Pathol, Nakano Ku, Tokyo, Japan.
C3 National Defense Medical College - Japan; National Defense Medical
   College - Japan
RP Nakashima, M (corresponding author), Natl Def Med Coll, Dept Immunol & Microbiol, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.
EM masahiro@ndmc.ac.jp
OI Nakashima, Masahiro/0000-0003-4385-5802; Nakashima,
   Hiroyuki/0000-0001-6066-3031
FU JSPS KAKENHI Grant [17K08611]; National Defense Medical College;
   Grants-in-Aid for Scientific Research [17K08611] Funding Source: KAKEN
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: Masahiro
   Nakashima has received a JSPS KAKENHI Grant (Grant Number 17K08611).
   Manabu Kinoshita (advanced research program entitled "CBRN Defense") and
   Hiroyuki Nakashima (special program entitled "Host defense by liver
   lymphocytes and myeloid cells") have received Grants from the National
   Defense Medical College. The other authors have no funding to declare.
CR A-Gonzalez N, 2017, J EXP MED, V214, P1281, DOI 10.1084/jem.20161375
   Adams MD, 1998, BIOCHEM PHARMACOL, V55, P1915, DOI 10.1016/S0006-2952(98)00052-5
   Ashare A, 2006, AM J RESP CRIT CARE, V173, P644, DOI 10.1164/rccm.200509-1470OC
   BEATTY CH, 1976, PEDIATR RES, V10, P149, DOI 10.1203/00006450-197603000-00001
   BENACERRAF B, 1959, J EXP MED, V110, P27, DOI 10.1084/jem.110.1.27
   Carpéné C, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8030074
   da Silva FP, 2007, NAT MED, V13, P1368, DOI 10.1038/nm1665
   Emara M, 2011, J BIOL CHEM, V286, P13033, DOI 10.1074/jbc.M111.220657
   Fernandez-Boyanapalli RF, 2015, J ALLERGY CLIN IMMUN, V135, P517, DOI 10.1016/j.jaci.2014.10.034
   Ferreira AE, 2014, J IMMUNOL, V192, P2357, DOI 10.4049/jimmunol.1302375
   Gao B, 2008, HEPATOLOGY, V47, P729, DOI 10.1002/hep.22034
   Habu Y, 2004, IMMUNOLOGY, V113, P35, DOI 10.1111/j.1365-2567.2004.01932.x
   Ikarashi M, 2013, J LEUKOCYTE BIOL, V94, P1325, DOI 10.1189/jlb.0313144
   Inatsu A, 2009, HEPATOLOGY, V49, P2044, DOI 10.1002/hep.22888
   Kaplan J, 2014, INNATE IMMUN-LONDON, V20, P519, DOI 10.1177/1753425913501565
   Kaplan Jennifer M, 2011, Open Inflamm J, V4, P120
   Kinoshita M, 2006, CLIN EXP IMMUNOL, V143, P41, DOI 10.1111/j.1365-2249.2005.02973.x
   Kinoshita M, 2017, J INNATE IMMUN, V9, P493, DOI 10.1159/000475931
   Kinoshita M, 2011, INFECT IMMUN, V79, P2670, DOI 10.1128/IAI.01298-10
   Kinoshita M, 2010, J HEPATOL, V53, P903, DOI 10.1016/j.jhep.2010.04.037
   Malech HL, 2007, CURR OPIN HEMATOL, V14, P29, DOI 10.1097/00062752-200701000-00007
   Nakashima H, 2016, SCI REP-UK, V6, DOI 10.1038/srep34466
   Nishikawa K, 2015, MOL NUTR FOOD RES, V59, P1155, DOI 10.1002/mnfr.201400564
   Obara N, 2010, J HEPATOL, V53, P326, DOI 10.1016/j.jhep.2010.02.029
   Okaya T, 2005, SHOCK, V24, P421, DOI 10.1097/01.shk.0000181282.14050.11
   Pappas G, 2009, DRUG AGING, V26, P363, DOI 10.2165/00002512-200926050-00001
   Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989
   Picard F, 2002, ANNU REV NUTR, V22, P167, DOI 10.1146/annurev.nutr.22.010402.102808
   Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024
   Sato K, 2005, EUR J IMMUNOL, V35, P593, DOI 10.1002/eji.200425520
   Seki S, 2000, IMMUNOL REV, V174, P35, DOI 10.1034/j.1600-0528.2002.017404.x
   Shono S, 2011, SHOCK, V36, P484, DOI 10.1097/SHK.0b013e31822dc6e4
   Tsujimura Y, 2011, J SURG RES, V171, pE215, DOI 10.1016/j.jss.2011.08.012
   van den Berg JM, 2011, EUR J PEDIATR, V170, P1369, DOI 10.1007/s00431-011-1584-5
   Venter G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096786
   Yano H, 2012, INFECT IMMUN, V80, P4409, DOI 10.1128/IAI.00787-12
   Zingarelli B, 2005, SHOCK, V23, P393, DOI 10.1097/01.shk.0000160521.91363.88
NR 37
TC 4
Z9 4
U1 1
U2 1
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1753-4259
EI 1753-4267
J9 INNATE IMMUN-LONDON
JI Innate Immun.
PD AUG
PY 2019
VL 25
IS 6
BP 356
EP 368
DI 10.1177/1753425919849620
PG 13
WC Biochemistry & Molecular Biology; Immunology; Medicine, Research &
   Experimental; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Immunology; Research & Experimental
   Medicine; Microbiology
GA II7BE
UT WOS:000475346500005
PM 31096821
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Lin, EY
   Chagnaadorj, A
   Huang, SJ
   Wang, CC
   Chiang, YH
   Cheng, CW
AF Lin, En-Yuan
   Chagnaadorj, Amarzaya
   Huang, Shyh-Jer
   Wang, Ching-Chiung
   Chiang, Yung-Hsiao
   Cheng, Chao-Wen
TI Hepatoprotective Activity of the Ethanolic Extract of <i>Polygonum
   multiflorum</i> Thunb. against Oxidative Stress-Induced Liver Injury
SO EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE
LA English
DT Article
ID PROTECTS; NRF2; MICE; ACETAMINOPHEN; CHOLESTASIS; ACTIVATION;
   RESISTANCE; TOXICITY
AB Oxidative stress is an important pathological mechanism in various liver diseases. Polygonum multiflorum Thunb. (PM) can be used for the treatment of diseases associated with aging, hyperlipidemia, and oxidative stress in traditional Chinese medicine. In this study, we examined the hepatoprotective effects of the ethanolic extract of PM (PME) in in vitro and in vivo models. The PME induced expression of antioxidant-response-element- (ARE-) related genes in HepG2 cells showed a dose-dependent manner. Pretreatment of HepG2 cell with PME suppressed H2O2 - and acetaminophen- (APAP-) induced cellular reactive oxygen species (ROS) generation and cytotoxicity. In APAP-induced mouse liver injury, pretreatment with PME also showed ability to increase the survival rate and reduce the severity of liver injury. Treatment with PME attenuated bile duct ligation-induced extrahepatic cholestatic liver injury and further increased multidrug resistance protein 4 (MRP4) and reduced organic anion-transporting polypeptide (OATP) expression. Furthermore, increased nuclear translocation of the nuclear factor erythroid 2-related factor 2 (Nrf2) was observed after treatment with PME in both in vivo models. In conclusion, the current study showed the hepatoprotective activity of PME by regulating the redox state in liver injury through Nrf2 activation and controlling hepatic bile acid homeostasis in obstructive cholestasis, through bile acid transporter expression modulation.
C1 [Lin, En-Yuan; Chagnaadorj, Amarzaya; Chiang, Yung-Hsiao; Cheng, Chao-Wen] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan.
   [Lin, En-Yuan] Taiwan Adventist Hosp, Dept Surg, Div Neurosurg, Taipei, Taiwan.
   [Chagnaadorj, Amarzaya] Mongolian Natl Univ Med Sci, Dept Internal Med, Ulaanbaatar, Mongolia.
   [Huang, Shyh-Jer] Hualien Tzu Chi Hosp, Skin Inst, Hualien, Taiwan.
   [Wang, Ching-Chiung] Taipei Med Univ, Coll Pharm, Grad Inst Pharmacognosy, Taipei, Taiwan.
   [Wang, Ching-Chiung] Taipei Med Univ, Sch Pharm, Coll Pharm, Taipei, Taiwan.
   [Wang, Ching-Chiung; Cheng, Chao-Wen] Taipei Med Univ, Taipei Med Univ Hosp, Tradit Herbal Med Res Ctr, Taipei, Taiwan.
   [Chiang, Yung-Hsiao] Taipei Med Univ, Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan.
C3 Taipei Medical University; Mongolian National University of Medical
   Sciences; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital;
   Taipei Medical University; Taipei Medical University; Taipei Medical
   University; Taipei Medical University Hospital; Taipei Medical
   University Hospital; Taipei Medical University
RP Cheng, CW (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan.; Cheng, CW (corresponding author), Taipei Med Univ, Taipei Med Univ Hosp, Tradit Herbal Med Res Ctr, Taipei, Taiwan.
EM ccheng@tmu.edu.tw
OI Cheng, Chao-Wen/0000-0002-0466-6630; Huang, Shyh-Jer/0000-0002-6457-2003
FU Taipei Medical University; Ministry of Science and Technology of Taiwan
   [105-2320-B-038-050, 106-2320-B-038-036-MY2]
FX his study was funded by the Taipei Medical University. Chao-Wen Cheng is
   supported by Ministry of Science and Technology of Taiwan under grants
   105-2320-B-038-050 and 106-2320-B-038-036-MY2. The authors thank Ms.
   Chiao-Ni Chen for technical support. This manuscript was edited by
   Wallace Academic Editing.
CR Abmayr Susan M, 2006, Curr Protoc Mol Biol, VChapter 12, DOI [10.1002/0471141755.ph1203s35, 10.1002/0471142727.mb1201s75]
   Ahn SM, 2016, J ETHNOPHARMACOL, V188, P13, DOI 10.1016/j.jep.2016.04.058
   Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098
   Chen P, 2015, EUR J PHARMACOL, V765, P131, DOI 10.1016/j.ejphar.2015.08.029
   Chen P, 2014, DRUG METAB DISPOS, V42, P844, DOI 10.1124/dmd.113.056549
   Cheng CW, 2011, J HEPATOL, V54, P746, DOI 10.1016/j.jhep.2010.07.018
   Cichoz-Lach H, 2014, WORLD J GASTROENTERO, V20, P8082, DOI 10.3748/wjg.v20.i25.8082
   Gomes A, 2005, J BIOCHEM BIOPH METH, V65, P45, DOI 10.1016/j.jbbm.2005.10.003
   Halilbasic E, 2013, J HEPATOL, V58, P155, DOI 10.1016/j.jhep.2012.08.002
   Ibrahim SRM, 2018, FOOD FUNCT, V9, P3291, DOI [10.1039/c8fo00378e, 10.1039/C8FO00378E]
   Ip SP, 1997, PHYTOTHER RES, V11, P42, DOI 10.1002/(SICI)1099-1573(199702)11:1<42::AID-PTR940>3.3.CO;2-X
   Jaeschke H, 2002, TOXICOL SCI, V65, P166, DOI 10.1093/toxsci/65.2.166
   Jung KA, 2011, GUT LIVER, V5, P493, DOI 10.5009/gnl.2011.5.4.493
   Lei X, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/459749
   Li DK, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/9456785
   Li LM, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7580707
   Li S, 2015, INT J MOL SCI, V16, P26087, DOI 10.3390/ijms161125942
   Lin EY, 2018, ENVIRON TOXICOL, V33, P72, DOI 10.1002/tox.22496
   Lv LS, 2014, CARBOHYD POLYM, V99, P765, DOI 10.1016/j.carbpol.2013.09.007
   Ma KF, 2014, GENET MOL RES, V13, P5637, DOI 10.4238/2014.July.25.19
   Mennone A, 2006, HEPATOLOGY, V43, P1013, DOI 10.1002/hep.21158
   Ni HM, 2012, TOXICOL SCI, V127, P438, DOI 10.1093/toxsci/kfs133
   Okada K, 2009, BIOCHEM BIOPH RES CO, V389, P431, DOI 10.1016/j.bbrc.2009.08.156
   Okawa H, 2006, BIOCHEM BIOPH RES CO, V339, P79, DOI 10.1016/j.bbrc.2005.10.185
   Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002
   PRESCOTT LF, 1983, DRUGS, V25, P290, DOI 10.2165/00003495-198325030-00002
   Reisman SA, 2009, TOXICOL SCI, V109, P31, DOI 10.1093/toxsci/kfp047
   Weerachayaphorn J, 2012, AM J PHYSIOL-GASTR L, V302, pG925, DOI 10.1152/ajpgi.00263.2011
   Xie YC, 2015, TOXICOL APPL PHARM, V289, P213, DOI 10.1016/j.taap.2015.09.022
   Xu S., 2017, SCI REPORTS, V7
   Yan HY, 2018, TOXICOLOGY, V396, P1, DOI 10.1016/j.tox.2018.01.007
   Yan MZ, 2018, REDOX BIOL, V17, P274, DOI 10.1016/j.redox.2018.04.019
   Yang JB, 2018, BIOMED PHARMACOTHER, V99, P205, DOI 10.1016/j.biopha.2018.01.033
NR 33
TC 15
Z9 18
U1 1
U2 11
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1741-427X
EI 1741-4288
J9 EVID-BASED COMPL ALT
JI Evid.-based Complement Altern. Med.
PY 2018
VL 2018
AR 4130307
DI 10.1155/2018/4130307
PG 9
WC Integrative & Complementary Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Integrative & Complementary Medicine
GA GY4GX
UT WOS:000448520800001
PM 30416531
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Zhao, X
   Yi, RK
   Zhou, XR
   Mu, JF
   Long, XY
   Pan, YN
   Song, JL
   Park, KY
AF Zhao, Xin
   Yi, Ruokun
   Zhou, Xianrou
   Mu, Jianfei
   Long, Xingyao
   Pan, Yanni
   Song, Jia-Le
   Park, Kun-Young
TI Preventive effect of <i>Lactobacillus plantarum</i> KSFY02 isolated from
   naturally fermented yogurt from Xinjiang, China, on D-galactose-induced
   oxidative aging in mice
SO JOURNAL OF DAIRY SCIENCE
LA English
DT Article
DE Lactobacillus plantarum; superoxide dismutase; D-galactose; mRNA
   expression; protein expression
ID NITRIC-OXIDE; SUPEROXIDE-DISMUTASE; DAMAGE; INVOLVEMENT; STRESS; INJURY
AB Yogurt from Xinjiang, China, is a traditional and naturally fermented food, and abundant microorganisms are produced during its fermentation process. In this study, we carried out in vivo animal experiments to explore the effect of a newly isolated lactic acid bacterial strain, Lactobacillus plantarum KSFY02 (LPKSFY02), on oxidative aging. We used D-galactose to induce oxidative aging in mice and analyzed the serum and tissues of those mice using molecular biology detection methods. The results showed that LP-KSFY02 could inhibit the decreases in the thymic, cerebral, cardiac, liver, spleen, and kidney indices of mice caused by oxidative aging. The LP-KSFY02 strain increased activity of superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), and glutathione (GSH) and reduced levels of nitric oxide (NO) and malondialdehyde in the serum, liver, and spleen of the oxidative aging mice. Pathological observation demonstrated that LP-KSFY02 alleviated damage to the liver and spleen of oxidative aging mice. Quantitative PCR showed that LP-KSFY02 effectively upregulated mRNA expression of neuronal nitric oxide synthase (Nos1), endothelial nitric oxide synthase (Nose), copper/zinc superoxide dismutase (Sod1), manganese superoxide dismutase (Sod2), catalase (Cat), heme oxygenase-1 (Hmox1), nuclear factor erythroid 2 related factor 2 (Nfe2l2), gamma-glutamylcysteine synthetase (Gclm), and quinone oxidoreductase 1 (Nqo1) in mouse liver and spleen and downregulated expression of inducible nitric oxide synthase (Nos2). Western blot analysis revealed that LP-KSFY02 effectively upregulated protein expression of SOD1, SOD2, CAT, GSH1, and GSH2 in mouse liver and spleen tissues. Therefore, LP-KSFY02 can effectively prevent D-galactose-induced oxidative aging in mice. Its efficacy was superior to that of Lactobacillus delbrueckii asp. bulgaricus (LDSB) and vitamin C, which are commonly used in the medical field as antioxidants. Thus, LP-KSFY02 is a high-quality strain with probiotic potential.
C1 [Zhao, Xin; Yi, Ruokun; Zhou, Xianrou; Mu, Jianfei; Long, Xingyao; Pan, Yanni; Park, Kun-Young] Chongqing Univ Educ, Chongqing Collaborat Innovat Ctr Funct Food, Chongqing 400067, Peoples R China.
   [Zhou, Xianrou; Mu, Jianfei] Southwest Univ, Coll Food Sci, Chongqing 400715, Peoples R China.
   [Long, Xingyao; Pan, Yanni; Park, Kun-Young] Cha Univ, Dept Food Sci & Biotechnol, Seongnam 13488, Gyeonggi, South Korea.
   [Song, Jia-Le] Guilin Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Guilin 541004, Guangxi, Peoples R China.
C3 Chongqing University of Education; Southwest University - China; Pochon
   Cha University; Guilin Medical University
RP Park, KY (corresponding author), Chongqing Univ Educ, Chongqing Collaborat Innovat Ctr Funct Food, Chongqing 400067, Peoples R China.; Park, KY (corresponding author), Cha Univ, Dept Food Sci & Biotechnol, Seongnam 13488, Gyeonggi, South Korea.; Song, JL (corresponding author), Guilin Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Guilin 541004, Guangxi, Peoples R China.
EM songjiale@glmc.edu.cn; kunypark@cha.ac.kr
FU Program for Innovation Team Building at Institutions of Higher Education
   in Chongqing [CXTDX201601040]; Research Project of Chongqing University
   of Education [KY2015TBZC]
FX This research was supported by the Program for Innovation Team Building
   at Institutions of Higher Education in Chongqing (CXTDX201601040) and
   the Research Project of Chongqing University of Education (KY2015TBZC),
   China.
CR Bakir M, 2016, CYTOTECHNOLOGY, V68, P1131, DOI 10.1007/s10616-015-9871-z
   Berndt C, 2017, ANTIOXID REDOX SIGN, V27, P1235, DOI 10.1089/ars.2017.7132
   Bonthius DJ, 2015, NEUROTOXICOLOGY, V46, P60, DOI 10.1016/j.neuro.2014.11.009
   Buford TW, 2016, AGEING RES REV, V26, P96, DOI 10.1016/j.arr.2016.01.007
   Chard S, 2017, J GERONTOL B-PSYCHOL, V72, P319, DOI 10.1093/geronb/gbw119
   Chen XY, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8081249
   Chen XY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082212
   Chen XY, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060545
   Dai CS, 2017, TOXICOL MECH METHOD, V27, P165, DOI 10.1080/15376516.2016.1273424
   Di Meo S, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1245049
   Eroglu E, 2017, NITRIC OXIDE-BIOL CH, V70, P59, DOI 10.1016/j.niox.2017.09.001
   Fang WT, 2010, ACTA PHARMACOL SIN, V31, P485, DOI 10.1038/aps.2010.23
   Folbergrová J, 2013, INT J DEV NEUROSCI, V31, P123, DOI 10.1016/j.ijdevneu.2012.11.011
   Fukai T, 2000, J CLIN INVEST, V105, P1631, DOI 10.1172/JCI9551
   [何捷 He Jie], 2015, [食品科学, Food Science], V36, P130
   Hong C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10443-6
   Hosen MB, 2015, INT J REPROD BIOMED, V13, P525
   Iwayama K, 2017, BMC PHARMACOL TOXICO, V18, DOI 10.1186/s40360-017-0119-8
   Jiang XP, 2017, ENVIRON TOXICOL, V32, P1908, DOI 10.1002/tox.22413
   Khan SS, 2017, AGING CELL, V16, P624, DOI 10.1111/acel.12601
   Kitada M, 2016, AGING-US, V8, P2290, DOI 10.18632/aging.101068
   Kosenko EA, 2017, FREE RADICAL BIO MED, V113, P109, DOI 10.1016/j.freeradbiomed.2017.09.023
   Lee MH, 2001, J NEUROCHEM, V78, P32, DOI 10.1046/j.1471-4159.2001.00416.x
   Lei LH, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1975-x
   Li GJ, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8050752
   Li L, 2016, NEURAL REGEN RES, V11, P807, DOI 10.4103/1673-5374.182709
   [刘思雨 Liu Siyu], 2017, [食品与机械, Food and Machinery], V33, P26
   Manini TM, 2010, AGEING RES REV, V9, P1, DOI 10.1016/j.arr.2009.08.002
   Ohshima T, 1999, P NATL ACAD SCI USA, V96, P6423, DOI 10.1073/pnas.96.11.6423
   Selvaratnam JS, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.141671
   Sue YM, 2009, NEPHROL DIAL TRANSPL, V24, P769, DOI 10.1093/ndt/gfn545
   Sun TianSong, 2006, China Dairy Industry, V34, P4
   Tang T, 2013, AFR J TRADIT COMPLEM, V10, P12, DOI 10.4314/ajtcam.v10i4.3
   Tessari P, 2015, J NEPHROL, V28, P257, DOI 10.1007/s40620-014-0136-2
   Tuo N., 2012, J CHIN I FOOD SCI TE, V12, P161
   Vinusha KS, 2018, BIOCHEM BIOPHYS REP, V14, P140, DOI 10.1016/j.bbrep.2018.04.009
   Wang FB, 2016, PLANT PHYSIOL BIOCH, V109, P248, DOI 10.1016/j.plaphy.2016.10.005
   Wang YL, 2016, TOXICOL APPL PHARM, V308, P91, DOI 10.1016/j.taap.2016.07.006
   WARNER HR, 1994, FREE RADICAL BIO MED, V17, P249, DOI 10.1016/0891-5849(94)90080-9
   Wei H, 2018, MINERALS-BASEL, V8, DOI 10.3390/min8090363
   Wells SM, 2007, AM J RESP CELL MOL, V36, P520, DOI 10.1165/rcmb.2006-0302SM
   Xing ZN, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13101037
   [杨洁 Yang Jie], 2015, [食品工业科技, Science & Technology of Food Industry], V36, P324
   Zhang J, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8091498
   Zhao Chunfeng, 2012, Journal of Chinese Institute of Food Science and Technology, V12, P53
   Zhao X, 2018, MOLECULES, V23, DOI 10.3390/molecules23010204
NR 46
TC 29
Z9 33
U1 2
U2 47
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0022-0302
EI 1525-3198
J9 J DAIRY SCI
JI J. Dairy Sci.
PD JUL
PY 2019
VL 102
IS 7
BP 5899
EP 5912
DI 10.3168/jds.2018-16033
PG 14
WC Agriculture, Dairy & Animal Science; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Food Science & Technology
GA ID5ZK
UT WOS:000471756100007
PM 31103296
OA hybrid
DA 2024-02-19
ER

PT J
AU Yigitbilek, F
   Conley, SM
   Tang, H
   Saadiq, IM
   Jordan, KL
   Lerman, LO
   Taner, T
AF Yigitbilek, Furkan
   Conley, Sabena M.
   Tang, Hui
   Saadiq, Ishran M.
   Jordan, Kyra L.
   Lerman, Lilach O.
   Taner, Timucin
TI Comparable <i>in vitro</i> Function of Human Liver-Derived and Adipose
   Tissue-Derived Mesenchymal Stromal Cells: Implications for Cell-Based
   Therapy
SO FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
LA English
DT Article
DE Mesenchymal stroma; stem cells; liver; adipose tissue; cellular
   senescence; angiogenesis
ID STEM-CELLS; IMMUNOMODULATION
AB Mesenchymal stem/stromal cells (MSCs) have been investigated extensively for their immunotherapeutic and regenerative properties, which may differ by cell source. In MSCs harvested from donors matched for sex, age, and body mass index, we compared the proliferative and migration functions of liver-derived MSCs (L-MSCs) and adipose tissue-derived MSCs (A-MSCs) (n = 6 donors each). Cellular senescence was evaluated by senescence-associated beta-galactosidase enzyme activity and expression of senescence-associated secretory phenotype (SASP) factors using real-time quantitative polymerase chain and by western blot assay. The pro-angiogenic and reparative potency of MSCs was compared by co-culturing MSCs with injured human umbilical vein endothelial cells (HUVEC). The proliferation and migration properties were similar in L-MSCs and A-MSCs. Although cell cycle arrest and SASP genes were similarly expressed in both MSCs, tumor necrosis factor alpha gene and protein expression were significantly downregulated in L-MSCs. In co-cultured injured HUVEC, A-MSCs restored significantly more tubes and tube connections than L-MSCs. Therefore, despite many functional similarities between L-MSCs and A-MSCs, L-MSCs have enhanced immunomodulatory properties, while A-MSCs appear to have better pro-angiogenic and vascular reparative potency. Availability of a broad range of cellular options might enable selecting cell-based therapy appropriate for the specific underlying disease.
C1 [Yigitbilek, Furkan; Taner, Timucin] Mayo Clin, William J von Liebig Ctr Transplantat & Clin Rege, Rochester, MN 55905 USA.
   [Conley, Sabena M.; Tang, Hui; Saadiq, Ishran M.; Jordan, Kyra L.; Lerman, Lilach O.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA.
   [Taner, Timucin] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA.
C3 Mayo Clinic; Mayo Clinic; Mayo Clinic
RP Taner, T (corresponding author), Mayo Clin, William J von Liebig Ctr Transplantat & Clin Rege, Rochester, MN 55905 USA.; Taner, T (corresponding author), Mayo Clin, Dept Immunol, Rochester, MN 55905 USA.
EM taner.timucin@mayo.edu
RI Taner, Timucin/J-8588-2019
OI Taner, Timucin/0000-0003-0641-2930
FU American Association for the Study of Liver Diseases Foundation 2017
   Career Development Award in Liver Transplantation; Burroughs Wellcome
   Foundation; NIH [DK120292]; Mayo Clinic E. Rolland Dickson Research
   Scholarship in Transplantation
FX This study was supported by the American Association for the Study of
   Liver Diseases Foundation 2017 Career Development Award in Liver
   Transplantation, the Mayo Clinic E. Rolland Dickson Research Scholarship
   in Transplantation, The Burroughs Wellcome Foundation, and NIH grant
   number DK120292.
CR Abrol N, 2019, WORLD J GASTROENTERO, V25, P3123, DOI 10.3748/wjg.v25.i25.3123
   Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A
   Baxter MA, 2004, STEM CELLS, V22, P675, DOI 10.1634/stemcells.22-5-675
   Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469
   Chapel A, 2003, J GENE MED, V5, P1028, DOI 10.1002/jgm.452
   Conley SM, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00197
   Davignon JL, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1725-6
   DeCicco-Skinner KL, 2014, JOVE-J VIS EXP, DOI 10.3791/51312
   Devine SM, 2003, BLOOD, V101, P2999, DOI 10.1182/blood-2002-06-1830
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Dou L, 2018, SEMIN LIVER DIS, V38, P170, DOI 10.1055/s-0038-1646949
   Fan XL, 2020, CELL MOL LIFE SCI, V77, P2771, DOI 10.1007/s00018-020-03454-6
   Gnani D, 2019, AGING CELL, V18, DOI 10.1111/acel.12933
   Han Y, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080886
   Khan SY, 2017, SCI REP-UK, V7, DOI 10.1038/srep39501
   Kozlowska U, 2019, WORLD J STEM CELLS, V11, P347, DOI 10.4252/wjsc.v11.i6.347
   Krtolica A, 2002, INT J BIOCHEM CELL B, V34, P1401, DOI 10.1016/S1357-2725(02)00053-5
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   Lunyak VV, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00220
   Mattar P, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00560
   Najar M, 2016, CYTOTHERAPY, V18, P160, DOI 10.1016/j.jcyt.2015.10.011
   Scarfe L, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1076-x
   Strioga M, 2012, STEM CELLS DEV, V21, P2724, DOI 10.1089/scd.2011.0722
   Suvakov S, 2019, BIOL SEX DIFFER, V10, DOI 10.1186/s13293-019-0263-5
   Taner T, 2020, LIVER TRANSPLANT, V26, P549, DOI 10.1002/lt.25718
   Taner T, 2018, KIDNEY INT, V93, P1465, DOI 10.1016/j.kint.2018.01.022
   Taner T, 2017, KIDNEY INT, V91, P1193, DOI 10.1016/j.kint.2016.12.016
   Taner T, 2016, KIDNEY INT, V89, P909, DOI 10.1016/j.kint.2015.10.016
   Thomson AW, 2010, NAT REV IMMUNOL, V10, P753, DOI 10.1038/nri2858
   Turinetto V, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071164
   Ullah M, 2019, ISCIENCE, V15, P421, DOI 10.1016/j.isci.2019.05.004
   Waldner M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01642
   Wang Y, 2014, NAT IMMUNOL, V15, P1009, DOI 10.1038/ni.3002
   Yoo KH, 2009, CELL IMMUNOL, V259, P150, DOI 10.1016/j.cellimm.2009.06.010
   Zheng MJ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02525
   Zhou YY, 2019, J CLIN MED, V8, DOI 10.3390/jcm8071025
NR 37
TC 5
Z9 9
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-634X
J9 FRONT CELL DEV BIOL
JI Front. Cell. Dev. Biol.
PD MAR 26
PY 2021
VL 9
AR 641792
DI 10.3389/fcell.2021.641792
PG 11
WC Cell Biology; Developmental Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Developmental Biology
GA RK3GL
UT WOS:000638187700001
PM 33842466
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU BRAVO, E
   PIGNATELLI, E
   MASELLA, R
   VERNA, R
   CANTAFORA, A
AF BRAVO, E
   PIGNATELLI, E
   MASELLA, R
   VERNA, R
   CANTAFORA, A
TI INFLUENCE OF AGE ON HEPATIC-UPTAKE OF HDL1-CHOLESTEROL IN MALE WISTAR
   RATS WITH BILE-DUCT CANNULATION
SO JOURNAL OF BIOCHEMISTRY
LA English
DT Article
DE AGING; BILE; LIPOPROTEIN; LIVER; METABOLISM
ID LIPOPROTEIN CLASSES; CHOLESTERYL ESTER; INVIVO; CHYLOMICRON; METABOLISM
AB We have shown previously that the age-dependent increase in plasma cholesterol levels observed in male Wistar rats is associated with relevant changes in the lipoprotein pattern (in particular, with a much higher proportion of the HDL1 class) that are evident in animals from the age of 9 months. In this study, the possibility that a decreased catabolism of HDL1 cholesterol may cause this is evaluated by infusing this lipoprotein fraction labeled with [C-14]cholesterol into both young (3.5+/-0.5 months) and adult (13.0+/-1.0 months) male Wistar rats with a permanent biliary drainage. The clearance of radioactivity from the blood compartment was slower in the older animals than in the younger ones. Conversely, the incorporation of radioactivity into plasma cholesteryl esters and the secretion of radioactivity into bile was higher in the younger animals. These results support the hypothesis that the age-related increase in HDL1 proportion is due, at least in part, to a slower liver catabolism of HDL1-cholesterol.
C1 IST SUPER SANITA,METAB & PATHOL BIOCHEM LAB,I-00161 ROME,ITALY.
   UNIV LAQUILA,CATTEDRA CLIN PATHOL,I-67100 LAQUILA,ITALY.
C3 Istituto Superiore di Sanita (ISS); University of L'Aquila
RI Masella, Roberta/B-4109-2015; Bravo, Elena/K-2170-2012; Bravo,
   Elena/AAH-7512-2021
OI Masella, Roberta/0000-0002-3173-1573; Bravo, Elena/0000-0002-3473-6767;
   Bravo, Elena/0000-0002-3473-6767; VERNA, Roberto/0000-0002-1869-3912
CR BARTLETT GR, 1959, J BIOL CHEM, V234, P466
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BRAVO E, 1989, BIOCHIM BIOPHYS ACTA, V1003, P315, DOI 10.1016/0005-2760(89)90238-5
   BRAVO E, 1992, COMP BIOCHEM PHYS B, V101, P637, DOI 10.1016/0305-0491(92)90352-R
   BRAVO E, 1992, BIOCHIM BIOPHYS ACTA, V1123, P85, DOI 10.1016/0005-2760(92)90174-T
   BRAVO E, 1990, BIOCHIM BIOPHYS ACTA, V1045, P74, DOI 10.1016/0005-2760(90)90205-C
   CANTAFORA A, 1992, ARCH GERONTOL GERI S, V3, P93
   CHAPMAN MJ, 1981, J LIPID RES, V22, P339
   DIBIASE A, 1989, ITAL J GASTROENTEROL, V21, P204
   LANDIN B, 1984, J LIPID RES, V25, P559
   LEE SM, 1991, MECH AGEING DEV, V61, P85, DOI 10.1016/0047-6374(91)90008-N
   LEE SM, 1992, MECH AGEING DEV, V64, P123, DOI 10.1016/0047-6374(92)90101-I
   MAHLEY R W, 1978, P181
   MAHLEY RW, 1982, MED CLIN N AM, V66, P375, DOI 10.1016/S0025-7125(16)31426-2
   RIGLER MW, 1983, J CHROMATOGR, V277, P321, DOI 10.1016/S0378-4347(00)84852-5
   SHERRILL BC, 1980, J BIOL CHEM, V255, P1804
   YAMASHITA S, 1990, J CLIN INVEST, V86, P688, DOI 10.1172/JCI114764
NR 17
TC 9
Z9 9
U1 0
U2 0
PU JAPANESE BIOCHEMICAL SOC
PI TOKYO
PA ISHIKAWA BLDG-3F 25-16 HONGO-5-CHOME, TOKYO TOKYO 113, JAPAN
SN 0021-924X
J9 J BIOCHEM-TOKYO
JI J. Biochem. (Tokyo)
PD MAY
PY 1994
VL 115
IS 5
BP 833
EP 836
DI 10.1093/oxfordjournals.jbchem.a124425
PG 4
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA NL051
UT WOS:A1994NL05100007
PM 7961593
DA 2024-02-19
ER

PT J
AU Panici, JA
   Wang, FY
   Bonkowski, MS
   Spong, A
   Bartke, A
   Pawlikowska, L
   Kwok, PY
   Masternak, MM
AF Panici, Jacob A.
   Wang, Feiya
   Bonkowski, Michael S.
   Spong, Adam
   Bartke, Andrzej
   Pawlikowska, Ludmila
   Kwok, Pui-Yan
   Masternak, Michal M.
TI Is Altered Expression of Hepatic Insulin-Related Genes in Growth Hormone
   Receptor Knockout Mice Due to GH Resistance or a Difference in
   Biological Life Spans?
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE Aging; GHRKO; Insulin
ID CALORIC RESTRICTION; TARGETED DISRUPTION; SIGNALING SYSTEM; MOUSE;
   SUPERFAMILY; GLUCOSE; MUSCLE; LIVER; MODEL; IRS-1
AB Growth hormone receptor knockout (GHRKO) mice live about 40%-55% longer than their normal (N) littermates. Previous studies of 21-month-old GHRKO and N mice showed major alterations of the hepatic expression of genes involved in insulin signaling. Differences detected at this age may have been caused by the knockout of the growth hormone receptor (GHR) or by differences in biological age between GHRKO and N mice. To address this question, we compared GHRKO and N mice at ages corresponding to the same percentage of median life span to see if the differences of gene expression persisted. Comparison of GHRKO and N mice at similar to 50% of biological life span showed significant differences in hepatic expression of all 14 analyzed genes. We conclude that these changes are due to disruption of GHR gene and the consequent Suppression of growth hormone signaling rather than to differences in "biological age" between mutant and normal animals sampled at the same chronological age.
C1 [Panici, Jacob A.; Wang, Feiya; Spong, Adam; Bartke, Andrzej; Masternak, Michal M.] So Illinois Univ, Sch Med, Dept Internal Med, Springfield, IL 62794 USA.
   [Bonkowski, Michael S.] MIT, Dept Biol, Cambridge, MA 02139 USA.
   [Bartke, Andrzej] So Illinois Univ, Sch Med, Dept Physiol, Springfield, IL 62794 USA.
   [Pawlikowska, Ludmila; Kwok, Pui-Yan] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA.
   [Pawlikowska, Ludmila] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA.
C3 Southern Illinois University System; Southern Illinois University;
   Massachusetts Institute of Technology (MIT); Southern Illinois
   University System; Southern Illinois University; University of
   California System; University of California San Francisco; University of
   California System; University of California San Francisco
RP Masternak, MM (corresponding author), So Illinois Univ, Sch Med, Dept Internal Med, 801 N Rutledge, Springfield, IL 62794 USA.
EM mmasternak@siumed.edu
RI Kwok, Pui-Yan/F-7725-2014; Bartke, Andzej/D-6640-2017
OI Kwok, Pui-Yan/0000-0002-5087-3059; Bartke, Andzej/0000-0002-2569-557X;
   Bonkowski, Michael/0000-0003-3416-4612
FU National Institute on Aging [AG 19899, U 19 AG023122]; Ellison Medical
   Foundation; Southern Illinois University Geriatrics Medicine and
   Research Initiative; Southern Illinois University School of Medicine;
   Glenn Foundation for Medical Research
FX National Institute on Aging (AG 19899 and U 19 AG023122), Ellison
   Medical Foundation, Southern Illinois University Geriatrics Medicine and
   Research Initiative, Central Research Committee of Southern Illinois
   University School of Medicine, and Glenn Foundation for Medical
   Research.
CR BACKER JM, 1993, J BIOL CHEM, V268, P8204
   Berryman DE, 2004, GROWTH HORM IGF RES, V14, P309, DOI 10.1016/j.ghir.2004.02.005
   Bonkowski MS, 2006, P NATL ACAD SCI USA, V103, P7901, DOI 10.1073/pnas.0600161103
   CHORNCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156
   Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608
   Coschigano KT, 2003, ENDOCRINOLOGY, V144, P3799, DOI 10.1210/en.2003-0374
   de Magalhaes JP, 2005, GENETICS, V169, P265, DOI 10.1534/genetics.104.032292
   DEFRONZO RA, 1981, DIABETES CARE, V4, P493, DOI 10.2337/diacare.4.4.493
   Liu JL, 2004, AM J PHYSIOL-ENDOC M, V287, pE405, DOI 10.1152/ajpendo.00423.2003
   Masternak MM, 2007, PPAR RES, V2007, DOI 10.1155/2007/28436
   Masternak MM, 2006, EXP GERONTOL, V41, P417, DOI 10.1016/j.exger.2006.01.009
   Masternak Michal M., 2002, Journal of Applied Genetics, V43, P235
   Masternak MM, 2005, J GERONTOL A-BIOL, V60, P1394, DOI 10.1093/gerona/60.11.1394
   Masternak MM, 2005, J GERONTOL A-BIOL, V60, P1238, DOI 10.1093/gerona/60.10.1238
   Masternak MM, 2005, EXP GERONTOL, V40, P679, DOI 10.1016/j.exger.2005.06.003
   Masternak MM, 2005, EXP GERONTOL, V40, P491, DOI 10.1016/j.exger.2005.04.002
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Petkov PM, 2004, GENOMICS, V83, P902, DOI 10.1016/j.ygeno.2003.11.007
   SPENCE JC, 1920, Q J MED, V14, P314
   Weindruch R., 1988, RETARDATION AGING DI
   WHITE MF, 1994, CURR OPIN GENET DEV, V4, P47, DOI 10.1016/0959-437X(94)90090-6
   WHITE MF, 1994, J BIOL CHEM, V269, P1
   Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215
NR 23
TC 38
Z9 42
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD NOV
PY 2009
VL 64
IS 11
BP 1126
EP 1133
DI 10.1093/gerona/glp111
PG 8
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 509UU
UT WOS:000271044900004
PM 19706698
OA Green Published
DA 2024-02-19
ER

PT J
AU Haider, A
   Gooren, LJG
   Padungtod, P
   Saad, F
AF Haider, A.
   Gooren, L. J. G.
   Padungtod, P.
   Saad, F.
TI Improvement of the Metabolic Syndrome and of Non-alcoholic Liver
   Steatosis upon Treatment of Hypogonadal Elderly Men with Parenteral
   Testosterone Undecanoate
SO EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
LA English
DT Article
DE testosterone; metabolic syndrome; liver steatosis; aging
ID HORMONE-BINDING GLOBULIN; LOW SERUM TESTOSTERONE; ADIPOSE-TISSUE; OLDER
   MEN; ERECTILE DYSFUNCTION; ANDROGEN DEFICIENCY; SEXUAL DYSFUNCTION;
   INSULIN-RESISTANCE; BODY-COMPOSITION; MORTALITY
AB This is a study of a cohort of 117 men aged between 34-69 years, with plasma testosterone levels between 5.9-12.1 nmol/L (N > 14.0 nmol/L) who were treated with administration of testosterone undecanoate for 1 year as the sole intervention. There was a remarkable improvement of body weight, BMI and waist size along with an improvement of lipid profiles. Liver fat is highly significantly and linearly correlated with all components of the metabolic syndrome. Hepatic inflammation secondary to liver steatosis is a potential contributor to the low-grade inflammation associated with the metabolic syndrome. Elevations of liver enzymes are associated with higher CRP concentrations. Levels of ALT (GPT) AST (GOT) and CRP had decreased significantly after one year of testosterone treatment. At baseline 74/117 met the criteria of the metabolic syndrome as defined by the NCEP and after one year of testosterone treatment this number had declined to 42/117.
C1 [Saad, F.] Bayer Schering Pharma, Sci Affairs Mens Healthcare, Berlin, Germany.
   [Gooren, L. J. G.] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands.
   [Padungtod, P.] Chiang Mai Univ, Fac Vet Med, Chiang Mai, Thailand.
   [Saad, F.] Gulf Med Univ, Sch Med, Ajman, U Arab Emirates.
C3 Bayer AG; Bayer Healthcare Pharmaceuticals; Vrije Universiteit
   Amsterdam; VU UNIVERSITY MEDICAL CENTER; Chiang Mai University
RP Saad, F (corresponding author), Bayer Schering Pharma AG, Sci Affairs, BU Primary Care Mens Healthcare, D-13342 Berlin, Germany.
EM Farid.Saad@bayerhealthcare.com
CR Allan CA, 2008, J CLIN ENDOCR METAB, V93, P139, DOI 10.1210/jc.2007-1291
   Allan CA, 2007, INT J IMPOT RES, V19, P448, DOI 10.1038/sj.ijir.3901552
   ALLAN CA, 2007, J CLIN ENDOCRINOL ME
   Allan CA, 2006, MED J AUSTRALIA, V185, P424, DOI 10.5694/j.1326-5377.2006.tb00639.x
   Araujo AB, 2004, J CLIN ENDOCR METAB, V89, P5920, DOI 10.1210/jc.2003-031719
   Araujo AB, 2007, ARCH INTERN MED, V167, P1252, DOI 10.1001/archinte.167.12.1252
   Basaria S, 2006, CANCER-AM CANCER SOC, V106, P581, DOI 10.1002/cncr.21642
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Esmaillzadeh A, 2006, AM J CLIN NUTR, V83, P173, DOI 10.1093/ajcn/83.1.173
   Kalyani Rita R, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P226, DOI 10.1097/MED.0b013e32814db856
   Kaplan SA, 2006, J UROLOGY, V176, P1524, DOI 10.1016/j.juro.2006.06.003
   Kaufman JM, 2005, ENDOCR REV, V26, P833, DOI 10.1210/er.2004-0013
   Kerner A, 2005, ARTERIOSCL THROM VAS, V25, P193, DOI 10.1161/01.ATV.0000148324.63685.6a
   Khaw KT, 2007, CIRCULATION, V116, P2694, DOI 10.1161/CIRCULATIONAHA.107.719005
   Kotronen A, 2007, J CLIN ENDOCR METAB, V92, P3490, DOI 10.1210/jc.2007-0482
   Laaksonen DE, 2004, DIABETES CARE, V27, P1036, DOI 10.2337/diacare.27.5.1036
   Laughlin GA, 2008, J CLIN ENDOCR METAB, V93, P68, DOI 10.1210/jc.2007-1792
   Liu PY, 2007, J CLIN ENDOCR METAB, V92, P3599, DOI 10.1210/jc.2007-0862
   MARIN P, 1995, J CLIN ENDOCR METAB, V80, P239, DOI 10.1210/jc.80.1.239
   Mohr BA, 2006, EUR J ENDOCRINOL, V155, P443, DOI 10.1530/eje.1.02241
   Münzer T, 2001, J CLIN ENDOCR METAB, V86, P3604, DOI 10.1210/jc.86.8.3604
   Musso G, 2008, DIABETES CARE, V31, P562, DOI 10.2337/dc07-1526
   Page ST, 2005, J CLIN ENDOCR METAB, V90, P1502, DOI 10.1210/jc.2004-1933
   Pitteloud N, 2005, J CLIN ENDOCR METAB, V90, P2636, DOI 10.1210/jc.2004-2190
   Rector RS, 2008, WORLD J GASTROENTERO, V14, P185, DOI 10.3748/wjg.14.185
   Rodriguez A, 2007, J CLIN ENDOCR METAB, V92, P3568, DOI 10.1210/jc.2006-2764
   Saad F, 2008, ANDROLOGIA, V40, P44, DOI 10.1111/j.1439-0272.2008.00807.x
   Saad F, 2008, J ANDROL, V29, P102, DOI 10.2164/jandrol.107.002774
   Saad F, 2007, ARCH ANDROLOGY, V53, P353, DOI 10.1080/01485010701730880
   Schroeder ET, 2004, J CLIN ENDOCR METAB, V89, P4863, DOI 10.1210/jc.2004-0784
   Shores MM, 2004, J AM GERIATR SOC, V52, P2077, DOI 10.1111/j.1532-5415.2004.52562.x
   Shores MM, 2006, ARCH INTERN MED, V166, P1660, DOI 10.1001/archinte.166.15.1660
   Smith MR, 2006, J CLIN ENDOCR METAB, V91, P1305, DOI 10.1210/jc.2005-2507
   Stellato RK, 2000, DIABETES CARE, V23, P490, DOI 10.2337/diacare.23.4.490
   Svartberg J, 2008, INT J IMPOT RES, V20, P378, DOI 10.1038/ijir.2008.19
   Yassin AA, 2007, J UROLOGY, V177, P288, DOI 10.1016/S0022-5347(18)31103-0
   Yialamas MA, 2007, J CLIN ENDOCR METAB, V92, P4254, DOI 10.1210/jc.2007-0454
NR 37
TC 65
Z9 75
U1 0
U2 2
PU JOHANN AMBROSIUS BARTH VERLAG MEDIZINVERLAGE HEIDELBERG GMBH
PI STUTTGART
PA RUEDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0947-7349
EI 1439-3646
J9 EXP CLIN ENDOCR DIAB
JI Exp. Clin. Endocrinol. Diabet.
PD MAR
PY 2010
VL 118
IS 3
BP 167
EP 171
DI 10.1055/s-0029-1202774
PG 5
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 579JP
UT WOS:000276366300005
PM 19472103
DA 2024-02-19
ER

PT J
AU Piao, LM
   Huang, Z
   Inoue, A
   Kuzuya, M
   Cheng, XW
AF Piao, Limei
   Huang, Zhe
   Inoue, Aiko
   Kuzuya, Masafumi
   Cheng, Xian Wu
TI Human umbilical cord-derived mesenchymal stromal cells ameliorate
   aging-associated skeletal muscle atrophy and dysfunction by modulating
   apoptosis and mitochondrial damage in SAMP10 mice
SO STEM CELL RESEARCH & THERAPY
LA English
DT Article
DE Umbilical cord-derived mesenchymal stromal cell; Sarcopenia; Apoptosis;
   Inflammation; Mitochondria; SAMP10
ID STEM-CELLS; REGENERATIVE CAPACITY; BONE-MARROW; SARCOPENIA
AB Background Skeletal muscle mass and function losses in aging individuals are associated with quality of life deterioration and disability. Mesenchymal stromal cells exert immunomodulatory and anti-inflammatory effects and could yield beneficial effects in aging-related degenerative disease. Methods and results We investigated the efficacy of umbilical cord-derived mesenchymal stromal cells (UC-MSCs) on sarcopenia-related skeletal muscle atrophy and dysfunction in senescence-accelerated mouse prone 10 (SAMP10) mice. We randomly assigned 24-week-old male SAMP10 mice to a UC-MSC treatment group and control group. At 12 weeks post-injection, the UC-MSC treatment had ameliorated sarcopenia-related muscle changes in performance, morphological structures, and mitochondria biogenesis, and it enhanced the amounts of proteins or mRNAs for myosin heavy chain, phospho-AMP-activated protein kinase, phospho-mammalian target of rapamycin, phospho-extracellular signal-regulated kinase1/2, peroxisome proliferator-activated receptor-gamma coactivator, GLUT-4, COX-IV, and hepatocyte growth factor in both gastrocnemius and soleus muscles, and it reduced the levels of proteins or mRNAs for cathepsin K, cleaved caspase-3/-8, tumor necrosis factor-alpha, monocyte chemoattractant protein-1, and gp91(phox) mRNAs. The UC-MSC treatment retarded mitochondria damage, cell apoptosis, and macrophage infiltrations, and it enhanced desmin/laminin expression and proliferating and CD34(+)/Integrin alpha(+)(7) cells in both types of skeletal muscle of the SAMP10 mice. In vitro, we observed increased levels of HGF, PAX-7, and MoyD mRNAs at the 4th passage of UC-MSCs. Conclusions Our results suggest that UC-MSCs can improve sarcopenia-related skeletal muscle atrophy and dysfunction via anti-apoptosis, anti-inflammatory, and mitochondrial biogenesis mechanisms that might be mediated by an AMPK-PGC1-alpha axis, indicating that UC-MSCs may provide a promising treatment for sarcopenia/muscle diseases.
C1 [Piao, Limei; Huang, Zhe; Cheng, Xian Wu] Nagoya Univ, Grad Sch Med, Dept Human Life Cord Appl Cell Therapy, Nagoya, Aichi 4668550, Japan.
   [Piao, Limei; Cheng, Xian Wu] Yanbian Univ Hosp, Dept Cardiol & Hypertens, Yanji 133000, Jilin, Peoples R China.
   [Inoue, Aiko; Kuzuya, Masafumi] Nagoya Univ, Dept Community Healthcare & Geriatr, Grad Sch Med, Nagoya, Aichi 4668550, Japan.
   [Kuzuya, Masafumi] Nagoya Univ, Inst Innovat Future Soc, Grad Sch Med, Nagoya, Aichi 4668550, Japan.
C3 Nagoya University; Yanbian University; Nagoya University; Nagoya
   University
RP Huang, Z; Cheng, XW (corresponding author), Nagoya Univ, Grad Sch Med, Dept Human Life Cord Appl Cell Therapy, Nagoya, Aichi 4668550, Japan.; Cheng, XW (corresponding author), Yanbian Univ Hosp, Dept Cardiol & Hypertens, Yanji 133000, Jilin, Peoples R China.
EM huangtetsu@163.com; chengxw0908@163.com
RI Masafumi, Kuzuya/IXW-9378-2023; Piao, Limei/JVO-8202-2024
OI PIAO, LIMEI/0000-0001-5808-9990; Cheng, Xian Wu/0000-0002-9758-0632
FU National Natural Science Foundation of China [81770485]; Ministry of
   Education, Culture, Sports, Science, and Technology of Japan [20H03574];
   Grants-in-Aid for Scientific Research [20H03574] Funding Source: KAKEN
FX This work was supported in part by a grant from the National Natural
   Science Foundation of China (no. 81770485) and a grant from the Ministry
   of Education, Culture, Sports, Science, and Technology of Japan (no.
   20H03574).
CR Anderson R, 2009, BBA-GEN SUBJECTS, V1790, P1059, DOI 10.1016/j.bbagen.2009.04.005
   Arthur ST, 2012, INT J BIOL SCI, V8, P731, DOI 10.7150/ijbs.4262
   Arutyunyan I, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/6901286
   Balnis J, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21030955
   Brass EP, 2011, J AM GERIATR SOC, V59, P530, DOI 10.1111/j.1532-5415.2010.03285.x
   Brotto M, 2012, J PHARMACOL EXP THER, V343, P540, DOI 10.1124/jpet.112.191759
   Chen QZ, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2678-7
   Cheng XW, 2010, CIRCULATION, V122, P707, DOI 10.1161/CIRCULATIONAHA.109.909218
   Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464
   DEFRONZO RA, 1985, J CLIN INVEST, V76, P149, DOI 10.1172/JCI111938
   Dibble CC, 2015, TRENDS CELL BIOL, V25, P545, DOI 10.1016/j.tcb.2015.06.002
   Flack Kyle D, 2010, J Aging Res, V2011, P127315, DOI 10.4061/2011/127315
   Fry CS, 2015, NAT MED, V21, P76, DOI 10.1038/nm.3710
   Gauthaman K, 2010, STEM CELL REV REP, V6, P86, DOI [10.1007/s12015-009-9107-8, 10.1007/s12015-010-9166-x]
   Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633
   Giannoulis MG, 2012, ENDOCR REV, V33, P314, DOI 10.1210/er.2012-1002
   Golpanian S, 2017, J GERONTOL A-BIOL, V72, P1505, DOI 10.1093/gerona/glx056
   Goto H, 2021, STEM CELLS INT, V2021, DOI 10.1155/2021/9202990
   Harkin A, 2014, NEW ENGL J MED, V371, P2333, DOI 10.1056/NEJMcibr1411568
   Hsieh JY, 2010, STEM CELLS DEV, V19, P1895, DOI 10.1089/scd.2009.0485
   Inoue A, 2017, J CACHEXIA SARCOPENI, V8, P370, DOI 10.1002/jcsm.12166
   Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991
   Klimczak A, 2018, ARCH IMMUNOL THER EX, V66, P341, DOI 10.1007/s00005-018-0509-7
   Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200
   Li N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093645
   Linard C, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1051-6
   Loprinzi PD, 2016, CHRONIC ILLN, V12, P157, DOI 10.1177/1742395316641998
   Martinez BP, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0570-x
   Mukai T, 2018, REGEN THER, V9, P32, DOI 10.1016/j.reth.2018.08.001
   Nagamura-Inoue Tokiko, 2014, World J Stem Cells, V6, P195, DOI 10.4252/wjsc.v6.i2.195
   Ogasawara S, 2018, J CACHEXIA SARCOPENI, V9, P160, DOI 10.1002/jcsm.12248
   Park BW, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay6994
   Pasco JA, 2015, CURR OSTEOPOROS REP, V13, P351, DOI 10.1007/s11914-015-0279-7
   Peake J, 2010, AM J PHYSIOL-REG I, V298, pR1485, DOI 10.1152/ajpregu.00467.2009
   Rea IM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00586
   Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3
   Song Ya-Nan, 2017, Zhongguo Zhong Yao Za Zhi, V42, P4656, DOI 10.19540/j.cnki.cjcmm.20170928.022
   Tanaka E, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00133
   Tarnawski AS, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10081964
   Troyer DL, 2008, STEM CELLS, V26, P591, DOI 10.1634/stemcells.2007-0439
   Tsiftsoglou AS, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10082140
   Wang YQ, 2008, CHINESE MED J-PEKING, V121, P2290, DOI 10.1097/00029330-200811020-00015
   Wang YH, 2020, REGEN THER, V15, P285, DOI 10.1016/j.reth.2020.11.002
   Yu Y, 2018, J NUTR HEALTH AGING, V22, P710, DOI 10.1007/s12603-018-1015-7
   Zhang L, 2015, CHINESE J PHYSIOL, V58, P343, DOI 10.4077/CJP.2015.BAE369
   Zhu H, 2017, SCI REP-UK, V7, DOI 10.1038/srep39889
NR 46
TC 9
Z9 10
U1 3
U2 13
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1757-6512
J9 STEM CELL RES THER
JI Stem Cell Res. Ther.
PD JUN 3
PY 2022
VL 13
IS 1
AR 226
DI 10.1186/s13287-022-02895-z
PG 17
WC Cell & Tissue Engineering; Cell Biology; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Research & Experimental Medicine
GA 1V1BV
UT WOS:000805834900005
PM 35659361
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Liu, CL
   Zhu, SJ
   Zhang, J
   Wu, PP
   Wang, X
   Du, S
   Wang, EZ
   Kang, YK
   Song, K
   Yu, JT
AF Liu, Chunlong
   Zhu, Shijie
   Zhang, Jian
   Wu, Panpan
   Wang, Xuan
   Du, Sen
   Wang, Enzhao
   Kang, Yunkang
   Song, Kun
   Yu, Jiangtao
TI Global, regional, and national burden of liver cancer due to
   non-alcoholic steatohepatitis, 1990-2019: a decomposition and
   age-period-cohort analysis
SO JOURNAL OF GASTROENTEROLOGY
LA English
DT Article; Early Access
DE Liver cancer due to NASH; Decomposition analysis; Age-period-cohort
   analysis; Global burden of disease; Joinpoint analysis
ID CELLULAR SENESCENCE; OBESITY; DISEASE; SEX; PATHOPHYSIOLOGY; RISK
AB BackgroundIdentifying past temporal trends in non-alcoholic steatohepatitis (NASH)-associated liver cancer (NALC) can increase public awareness of the disease and facilitate future policy development.MethodsAnnual deaths and age-standardized death rates (ASDR) for NALC from 1990 to 2019 were collected from the Global Burden of Disease (GBD) 2019 study. The long-term trend and the critical inflection of mortality of NALC were detected by Joinpoint analysis. Age-period-cohort analysis was employed to evaluate the effects of age, period, and cohort. Last, decomposition analysis was used to reveal the aging and population growth effects for NALC burden.ResultsBetween 1990 and 2019, the ASDR of NALC witnessed an overall declining trend on a global scale, with a decrease in females and a stable trend in males. However, the global ASDR demonstrated a significant upward trend from 2010 to 2019. Southern sub-Saharan Africa and Southeast Asia have the highest NALC burdens, while high socio-demographic index (SDI) region experienced the fastest escalation of NALC burdens over 30 years. The decomposition analysis revealed that population growth and aging were the primary catalysts behind the increase in global NALC deaths. Age-period-cohort analyses showed that NALC mortality declined the fastest among females aged 40-45 years in high SDI region, accompanied by a deteriorating period effect trend during the period of 2010-2019.ConclusionThe global absolute deaths and ASDR of NALC have witnessed a rise in the past decade, with populations exhibiting considerable disparities based on sex, age, and region. Population growth, aging, and metabolism-related factors were the main factors behind the increase in global NALC deaths.
C1 [Liu, Chunlong; Wu, Panpan; Wang, Xuan; Song, Kun; Yu, Jiangtao] Anhui Med Univ, Fuyang Peoples Hosp, Dept Hepatobiliary & Pancreat Surg, Fuyang 236000, Peoples R China.
   [Zhu, Shijie] Wuhan Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Wuhan 430071, Peoples R China.
   [Zhang, Jian] China Med Univ, Dept Neurosurg, Clin Coll 7, Fushun 113001, Peoples R China.
   [Du, Sen; Yu, Jiangtao] Bengbu Med Coll, Fuyang Peoples Hosp, Dept Hepatobiliary & Pancreat Surg, Fuyang 236000, Peoples R China.
   [Wang, Enzhao; Song, Kun] Wannan Med Coll, Grad Sch, Wuhu 241000, Anhui, Peoples R China.
   [Kang, Yunkang] Anhui Med Univ, Fuyang Peoples Hosp, Dept Orthoped, Fuyang 236000, Peoples R China.
C3 Anhui Medical University; Wuhan University; Bengbu Medical College;
   Wannan Medical College; Anhui Medical University
RP Song, K; Yu, JT (corresponding author), Anhui Med Univ, Fuyang Peoples Hosp, Dept Hepatobiliary & Pancreat Surg, Fuyang 236000, Peoples R China.; Yu, JT (corresponding author), Bengbu Med Coll, Fuyang Peoples Hosp, Dept Hepatobiliary & Pancreat Surg, Fuyang 236000, Peoples R China.; Song, K (corresponding author), Wannan Med Coll, Grad Sch, Wuhu 241000, Anhui, Peoples R China.
EM 2021203050015@whu.edu.cn; 1215904195@qq.com; yhzy502@163.com
RI Wang, Siyi/JNT-2690-2023; Zhu, Shijie/IWV-0196-2023
OI Zhu, Shijie/0000-0003-1931-7430; Yu, Jiangtao/0000-0002-8362-8092
FU We acknowledge GBD2019 collaborators whose outstanding contributions
   have enabled us to complete this study.
FX We acknowledge GBD2019 collaborators whose outstanding contributions
   have enabled us to complete this study.
CR Aunan JR, 2016, BRIT J SURG, V103, pE29, DOI 10.1002/bjs.10053
   Aunan JR, 2017, AGING DIS, V8, P628, DOI 10.14336/AD.2017.0103
   Boutari Chrysoula, 2022, Metabolism, V133, P155217, DOI 10.1016/j.metabol.2022.155217
   Calcinotto A, 2019, PHYSIOL REV, V99, P1047, DOI 10.1152/physrev.00020.2018
   Camhi SM, 2011, OBESITY, V19, P402, DOI 10.1038/oby.2010.248
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Cheng XJ, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003138
   Choi S, 2023, CLIN MOL HEPATOL, V29, P433, DOI 10.3350/cmh.2022.0316
   Das Gupta P, 1994, Genus, V50, P171
   Di Mauro S, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222111905
   DiStefano JK, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqaa134
   Engin A, 2017, ADV EXP MED BIOL, V960, P1, DOI 10.1007/978-3-319-48382-5_1
   Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9
   Frohme J, 2020, HEPATOBIL SURG NUTR, V9, P543, DOI 10.21037/hbsn.2020.03.03
   Gupta PD, 1993, STANDARDIZATION DECO
   Gutiérrez-Cuevas J, 2023, CANCERS, V15, DOI 10.3390/cancers15010023
   Gutiérrez-Cuevas J, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222111629
   Han AX, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155294
   Ioannou GN, 2021, J HEPATOL, V75, P1476, DOI 10.1016/j.jhep.2021.08.012
   Kautzky-Willer A, 2016, ENDOCR REV, V37, P278, DOI 10.1210/er.2015-1137
   Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.3.CO;2-Q
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Lazarus JV, 2022, J HEPATOL, V76, P771, DOI 10.1016/j.jhep.2021.10.025
   Lazarus JV, 2022, NAT REV GASTRO HEPAT, V19, P60, DOI 10.1038/s41575-021-00523-4
   Li ZY, 2023, DIABETOL METAB SYNDR, V15, DOI 10.1186/s13098-022-00976-w
   Liu Y, 2022, CANCER MED-US, V11, P1310, DOI 10.1002/cam4.4551
   Maric C, 2005, HYPERTENSION, V46, P475, DOI 10.1161/01.HYP.0000178600.88820.b2
   Mason WM., 1985, COHORT ANAL SOCIAL R, P1, DOI DOI 10.1007/978-1-4613-8536-3
   Mubarik S, 2022, J ADV RES, V37, P185, DOI 10.1016/j.jare.2021.07.012
   Murray CJL, 2020, LANCET, V396, P1223, DOI [10.1016/S0140-6736(20)30752-2, 10.1016/S0140-6736(20)30925-9]
   Arab JP, 2020, ANN HEPATOL, V19, P674, DOI 10.1016/j.aohep.2020.09.006
   Pang J, 2022, DIABETOL METAB SYNDR, V14, DOI 10.1186/s13098-022-00885-y
   Pirillo A, 2021, NAT REV CARDIOL, V18, P689, DOI 10.1038/s41569-021-00541-4
   Powell EE, 2021, LANCET, V397, P2212, DOI 10.1016/S0140-6736(20)32511-3
   Rosenberg PS, 2014, CANCER EPIDEM BIOMAR, V23, P2296, DOI 10.1158/1055-9965.EPI-14-0300
   Seidell JC, 2015, ANN NUTR METAB, V66, P7, DOI 10.1159/000375143
   Shi ZM, 2020, J DIABETES, V12, P134, DOI 10.1111/1753-0407.12975
   Song C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103649
   Taddei S, 2006, CURR HYPERTENS REP, V8, P84, DOI 10.1007/s11906-006-0045-4
   Tan DJH, 2022, LANCET ONCOL, V23, P521, DOI 10.1016/S1470-2045(22)00078-X
   Tapper EB, 2018, NAT REV GASTRO HEPAT, V15, P274, DOI 10.1038/nrgastro.2018.10
   Targher G, 2021, NAT REV GASTRO HEPAT, V18, P599, DOI 10.1038/s41575-021-00448-y
   Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011
   United Nations, 2019, World population prospects
   Wang D, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.1047129
   Wang WT, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-14701-0
   Wang YF, 2021, LANCET DIABETES ENDO, V9, P446, DOI 10.1016/S2213-8587(21)00118-2
   Wong VWS, 2018, NAT REV GASTRO HEPAT, V15, P461, DOI 10.1038/s41575-018-0014-9
   Wu WT, 2022, FRONT CARDIOVASC MED, V9, DOI 10.3389/fcvm.2022.891963
   Yang Y, 2016, NUTRIENTS, V8, DOI 10.3390/nu8090537
   Younes R, 2021, J HEPATOL, V75, P786, DOI 10.1016/j.jhep.2021.05.008
   Younossi ZM, 2023, HEPATOLOGY, V77, P1335, DOI 10.1097/HEP.0000000000000004
   Younossi ZM, 2018, HEPATOLOGY, V68, P349, DOI 10.1002/hep.29721
   Younossi ZM, 2015, HEPATOLOGY, V62, p739A
   Zhou JH, 2020, HEPATOLOGY, V71, P1851, DOI 10.1002/hep.31150
   Zhu SJ, 2022, ORAL ONCOL, V134, DOI 10.1016/j.oraloncology.2022.106189
NR 56
TC 1
Z9 1
U1 9
U2 9
PU SPRINGER JAPAN KK
PI TOKYO
PA SHIROYAMA TRUST TOWER 5F, 4-3-1 TORANOMON, MINATO-KU, TOKYO, 105-6005,
   JAPAN
SN 0944-1174
EI 1435-5922
J9 J GASTROENTEROL
JI J. Gastroenterol.
PD 2023 DEC
PY 2023
VL 58
IS 12
BP 1222
EP 1236
DI 10.1007/s00535-023-02040-4
EA SEP 2023
PG 15
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA Y7AW2
UT WOS:001058249900001
PM 37665532
DA 2024-02-19
ER

PT J
AU Liu, B
   Anno, K
   Kobayashi, T
   Piao, J
   Tahara, H
   Ohdan, H
AF Liu, Biou
   Anno, Kumiko
   Kobayashi, Tsuyoshi
   Piao, Jinlian
   Tahara, Hidetoshi
   Ohdan, Hideki
TI Influence of donor liver telomere and G-tail on clinical outcome after
   living donor liver transplantation
SO PLOS ONE
LA English
DT Article
ID CELLULAR SENESCENCE; RIGHT HEPATECTOMY; REGENERATION; LENGTH; AGE;
   HEPATOCYTES; SURVIVAL; FAILURE; TISSUES; SAFETY
AB It has been reported that donor age affects patient outcomes after liver transplantation, and that telomere length is associated with age. However, to our knowledge, the impact of donor age and donor liver telomere length in liver transplantation has not been well investigated. This study aimed to clarify the influence of the length of telomere and G-tail from donor livers on the outcomes of living donors and recipients after living donor liver transplantation. The length of telomere and G-tail derived from blood samples and liver tissues of 55 living donors, measured using the hybridization protection assay. The length of telomeres from blood samples was inversely correlated with ages, whereas G-tail length from blood samples and telomere and G-tail lengths from liver tissues were not correlated with ages. Age, telomere, and G-tail length from blood did not affect postoperative liver failure and early liver regeneration of donors. On the other hand, the longer the liver telomere, the poorer the liver regeneration tended to be, especially with significant difference in donor who underwent right hemihepatectomy. We found that the survival rate of recipients who received liver graft with longer telomeres was inferior to that of those who received liver graft with shorter ones. An elderly donor, longer liver telomere, and higher Model for End-Stage Liver Disease score were identified as independent risk factors for recipient survival after transplantation. In conclusion, telomere shortening in healthy liver does not correlate with age, whereas longer liver telomeres negatively influence donor liver regeneration and recipient survival after living donor liver transplantation. These results can direct future studies and investigations on telomere shortening in the clinical and experimental transplant setting.
C1 [Liu, Biou; Kobayashi, Tsuyoshi; Piao, Jinlian; Ohdan, Hideki] Hiroshima Univ, Dept Gastroenterol & Transplant Surg, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan.
   [Anno, Kumiko; Tahara, Hidetoshi] Hiroshima Univ, Dept Cellular & Mol Biol, Grad Sch Pharmaceut Sci, Hiroshima, Japan.
C3 Hiroshima University; Hiroshima University
RP Kobayashi, T (corresponding author), Hiroshima Univ, Dept Gastroenterol & Transplant Surg, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan.
EM tsukoba@hiroshima-u.ac.jp
RI Kobayashi, Tsuyoshi/Z-6029-2019; Ohdan, Hideki/G-4719-2019; Anno,
   Kumiko/A-9118-2014; Kobayashi, Tsuyoshi/G-9017-2019; Kobayashi,
   Tsuyoshi/Q-8364-2019; Tahara, Hidetoshi/G-7697-2019
OI Kobayashi, Tsuyoshi/0000-0001-7364-1798; Ohdan,
   Hideki/0000-0002-9066-1288; Kobayashi, Tsuyoshi/0000-0001-7364-1798;
   Tahara, Hidetoshi/0000-0003-3054-4175
FU  [26310106]
FX This study was supportd by grant number Grant-in-Aid for Scientific
   Research (B) 26310106,
   https://kaken.nii.ac.jp/report/KAKENHI-PROJECT-26310106/26310106seika/.T
   he funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Adam R, 2012, J HEPATOL, V57, P675, DOI 10.1016/j.jhep.2012.04.015
   Aikata H, 2000, EXP CELL RES, V256, P578, DOI 10.1006/excr.2000.4862
   Andert A, 2018, EUR SURG RES, V59, P83, DOI 10.1159/000489090
   Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656
   Calado RT, 2013, SEMIN HEMATOL, V50, P165, DOI 10.1053/j.seminhematol.2013.03.030
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Courtwright AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162409
   Denchi EL, 2006, GENE DEV, V20, P2648, DOI 10.1101/gad.1453606
   Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0
   Djojosubroto MW, 2003, MOL CELLS, V15, P164
   Español-Suñer R, 2012, GASTROENTEROLOGY, V143, P1564, DOI 10.1053/j.gastro.2012.08.024
   Feng S, 2006, AM J TRANSPLANT, V6, P783, DOI 10.1111/j.1600-6143.2006.01242.x
   Fernandes AI, 2015, LIVER INT, V35, P1116, DOI 10.1111/liv.12433
   Gadalla SM, 2015, JAMA-J AM MED ASSOC, V313, P594, DOI 10.1001/jama.2015.7
   Han JH, 2014, ANN SURG TREAT RES, V86, P184, DOI 10.4174/astr.2014.86.4.184
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   Hartmann D, 2011, HEPATOLOGY, V53, P1608, DOI 10.1002/hep.24217
   Hirashima K, 2013, MOL CELL BIOL, V33, P2988, DOI 10.1128/MCB.00136-13
   Hirashio S, 2014, CLIN J AM SOC NEPHRO, V9, P2117, DOI 10.2215/CJN.10010913
   Hoare M, 2010, J HEPATOL, V53, P950, DOI 10.1016/j.jhep.2010.06.009
   Ikegami T, 2008, TRANSPL P, V40, P1471, DOI 10.1016/j.transproceed.2008.02.084
   Itamoto T, 2006, TRANSPLANT INT, V19, P177, DOI 10.1111/j.1432-2277.2006.00269.x
   Iwamoto T, 2008, TRANSPLANTATION, V85, P1240, DOI 10.1097/TP.0b013e31816c7e90
   Keswani RN, 2004, LIVER TRANSPLANT, V10, P957, DOI 10.1002/lt.20155
   Kuramitsu K, 2016, J GASTROINTEST SURG, V20, P757, DOI 10.1007/s11605-016-3080-8
   LINDSEY J, 1991, MUTAT RES, V256, P45, DOI 10.1016/0921-8734(91)90032-7
   Lué A, 2016, WORLD J GASTROENTERO, V22, P4966, DOI 10.3748/wjg.v22.i21.4966
   Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X
   Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261
   McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331
   Miyaoka Y, 2012, CURR BIOL, V22, P1166, DOI 10.1016/j.cub.2012.05.016
   Nezu T, 2015, EBIOMEDICINE, V2, P960, DOI 10.1016/j.ebiom.2015.05.025
   Oshita A, 2012, TRANSPLANTATION, V93, P1024, DOI 10.1097/TP.0b013e31824c9e25
   Parfrey LW, 2008, MOL BIOL EVOL, V25, P787, DOI 10.1093/molbev/msn032
   Rahbari NN, 2011, SURGERY, V149, P713, DOI 10.1016/j.surg.2010.10.001
   Rana A, 2008, AM J TRANSPLANT, V8, P2537, DOI 10.1111/j.1600-6143.2008.02400.x
   Reese PP, 2008, TRANSPLANTATION, V85, P1737, DOI 10.1097/TP.0b013e3181722f75
   Russolillo N, 2015, ANN SURG ONCOL, V22, P4046, DOI 10.1245/s10434-015-4478-3
   SHAMPAY J, 1988, P NATL ACAD SCI USA, V85, P534, DOI 10.1073/pnas.85.2.534
   Shirabe K, 2013, SCAND J SURG, V102, P101, DOI 10.1177/1457496913482250
   Tachtatzis PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127511
   Tahara H, 2005, NAT METHODS, V2, P829, DOI 10.1038/NMETH797
   Tahara H, 2017, METHODS MOL BIOL, V1587, P63, DOI 10.1007/978-1-4939-6892-3_6
   Takubo K, 2000, J GERONTOL A-BIOL, V55, pB533, DOI 10.1093/gerona/55.11.B533
   Tanemura A, 2012, WORLD J SURG, V36, P1102, DOI 10.1007/s00268-012-1496-1
   Tashiro H, 2007, WORLD J SURG, V31, P2222, DOI 10.1007/s00268-007-9217-x
   Theise ND, 1999, HEPATOLOGY, V30, P1425, DOI 10.1002/hep.510300614
   TSUKAMOTO I, 1993, BIOCHEM MOL BIOL INT, V30, P773
   Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Yang BY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166828
   Yokoi H, 2005, TRANSPL INT, V18, P915, DOI 10.1111/j.1432-2277.2005.00158.x
   ZAJICEK G, 1985, LIVER, V5, P293
   Zappa M, 2009, RADIOLOGY, V252, P426, DOI [10.1148/radiol.2523080922, 10.1148/radiol.2522080922]
NR 54
TC 1
Z9 1
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 7
PY 2019
VL 14
IS 3
AR e0213462
DI 10.1371/journal.pone.0213462
PG 19
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA HO1AY
UT WOS:000460638800090
PM 30845248
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Lee, JW
   Huang, JD
   Rodriguez, IR
AF Lee, Jung Wha
   Huang, Jiahn-Dar
   Rodriguez, Ignacio R.
TI Extra-hepatic metabolism of 7-ketocholesterol occurs by esterification
   to fatty acids via cPLA2α and SOAT1 followed by selective efflux to HDL
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
LA English
DT Article
DE 7-Ketocholesterol; 7-Ketocholesterol fatty acid ester; SOAT1; cPLA2
   alpha; HDL; Cultured RPE cell
ID CHOLESTEROL 7-ALPHA-HYDROXYLASE; HEPATIC-METABOLISM; OXYSTEROL; MICE;
   SULFOTRANSFERASE; EXPRESSION; CELLS; LIVER; ACYLTRANSFERASE;
   LOCALIZATION
AB Accumulation of 7-ketocholesterol (7KCh) in tissues has been previously associated with various chronic aging diseases. Orally ingested 7KCh is readily metabolized by the liver and does not pose a toxicity threat. However, 7KCh formed in situ, usually associated with lipoprotein deposits, can adversely affect surrounding tissues by causing inflammation and cytotoxicity. In this study we have investigated various mechanisms for extrahepatic metabolism of 7KCh (e.g. hydroxylation, sulfation) and found only esterification to fatty acids. The esterification of 7KCh to fatty acids involves the combined action of cytosolic phospholipase A2 alpha (cPLA2 alpha) and sterol O-acyltransferase (SOAT1). Inhibition of either one of these enzymes ablates 7KCh-fatty acid ester (7KFAE) formation. The 7KFAEs are not toxic and do not induce inflammatory responses. However, they can be unstable and re-release 7KCh. The higher the degree of unsaturation, the more unstable the 7KFAE (e.g. 18:0 > 18:1 > 18:2 >> 18:3 20:4). Biochemical inhibition and siRNA knockdown of SOAT1 and cPLA2a ablated the 7KFAE synthesis in cultured ARPE19 cells, but had little effect on the 7KCh-induced inflammatory response. Overexpression of SOAT1 reduced the 7KCh-induced inflammatory response and provided some protection from cell death. This effect is likely due to the increased conversion of 7KCh to 7KFAEs, which reduced the intracellular 7KCh levels. Addition of HDL selectively increased the efflux of 7KFAEs and enhanced the effect of SOAT1 overexpression. Our data suggests an additional function for HDL in aiding extra-hepatic tissues to eliminate 7KCh by returning 7KFAEs to the liver for bile acid formation. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Lee, Jung Wha; Huang, Jiahn-Dar; Rodriguez, Ignacio R.] NEI, NIH, LRCMB, Mech Retinal Dis Sect, Bethesda, MD 20892 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Eye Institute
   (NEI)
RP Lee, JW (corresponding author), NEI, NIH, LRCMB, Mech Retinal Dis Sect, 6 Ctr Dr,MSC0608,Bldg 6 Rm 131, Bethesda, MD 20892 USA.
EM leej@nei.nih.gov
FU National Eye Institute Intramural Research Program
FX This work was supported by the National Eye Institute Intramural
   Research Program.
CR Brown AJ, 1996, J LIPID RES, V37, P320
   Cases S, 1998, J BIOL CHEM, V273, P26755, DOI 10.1074/jbc.273.41.26755
   Chang CCY, 2000, J BIOL CHEM, V275, P28083
   Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200
   ERICKSON SK, 1977, J BIOL CHEM, V252, P5186
   Eveland SS, 2007, ANAL BIOCHEM, V368, P239, DOI 10.1016/j.ab.2007.06.003
   Falany CN, 2006, J STEROID BIOCHEM, V102, P214, DOI 10.1016/j.jsbmb.2006.09.011
   Falany CN, 2013, DRUG METAB REV, V45, P388, DOI 10.3109/03602532.2013.835609
   Freeman NE, 2005, J LIPID RES, V46, P1933, DOI 10.1194/jlr.M500101-JLR200
   Fuda H, 2007, J LIPID RES, V48, P1343, DOI 10.1194/jlr.M700018-JLR200
   Huang JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100985
   Kontush A, 2014, CARDIOVASC RES, V103, P341, DOI 10.1093/cvr/cvu147
   Larrayoz IM, 2010, INVEST OPHTH VIS SCI, V51, P4942, DOI 10.1167/iovs.09-4854
   Lee RG, 2000, J LIPID RES, V41, P1991
   Li-Hawkins J, 2000, J BIOL CHEM, V275, P16536, DOI 10.1074/jbc.M001811200
   Linkous A, 2010, CELL MICROBIOL, V12, P1369, DOI 10.1111/j.1462-5822.2010.01505.x
   Lyons MA, 2002, BBA-MOL CELL BIOL L, V1581, P119, DOI 10.1016/S1388-1981(02)00156-7
   Lyons MA, 2001, LIPIDS, V36, P701, DOI 10.1007/s11745-001-0775-8
   Lyons MA, 2001, BBA-MOL CELL BIOL L, V1530, P209, DOI 10.1016/S1388-1981(01)00083-X
   Lyons MA, 1999, J LIPID RES, V40, P1846
   Miyazaki Akira, 2003, Curr Opin Investig Drugs, V4, P1095
   Moreira EF, 2009, INVEST OPHTH VIS SCI, V50, P523, DOI 10.1167/iovs.08-2373
   Omoto Y, 2005, P NATL ACAD SCI USA, V102, P2814, DOI 10.1073/pnas.0500198102
   Pettersson H, 2009, BBA-MOL CELL BIOL L, V1791, P1206, DOI 10.1016/j.bbalip.2009.08.010
   Pikuleva IA, 2014, PROG RETIN EYE RES, V41, P64, DOI 10.1016/j.preteyeres.2014.03.002
   Poli G, 2013, REDOX BIOL, V1, P125, DOI 10.1016/j.redox.2012.12.001
   Pullingr CR, 2002, J CLIN INVEST, V110, P109, DOI 10.1172/JCI200215387
   Rodriguez IR, 2014, EXP EYE RES, V128, P151, DOI 10.1016/j.exer.2014.09.009
   Rodríguez IR, 2010, J LIPID RES, V51, P2847, DOI 10.1194/jlr.R004820
   TAMASAWA N, 1994, BBA-LIPID LIPID MET, V1214, P20, DOI 10.1016/0005-2760(94)90004-3
   WAXMAN DJ, 1992, J STEROID BIOCHEM, V43, P1055, DOI 10.1016/0960-0760(92)90333-E
   Wu ZL, 1999, J LIPID RES, V40, P2195
   Yu CJ, 1999, J BIOL CHEM, V274, P36139, DOI 10.1074/jbc.274.51.36139
NR 33
TC 15
Z9 17
U1 0
U2 32
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1388-1981
EI 0006-3002
J9 BBA-MOL CELL BIOL L
JI Biochim. Biophys. Acta Mol. Cell Biol. Lipids
PD MAY
PY 2015
VL 1851
IS 5
BP 605
EP 619
DI 10.1016/j.bbalip.2015.01.007
PG 15
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA CE4LF
UT WOS:000351801400009
PM 25617738
OA Green Accepted, hybrid
DA 2024-02-19
ER

PT J
AU Cao, K
   Lv, WQ
   Wang, XQ
   Dong, SS
   Liu, XY
   Yang, TL
   Xu, J
   Zeng, MQ
   Zou, X
   Zhao, DN
   Ma, QQ
   Lin, M
   Long, JG
   Zang, WJ
   Gao, F
   Feng, ZH
   Liu, JK
AF Cao, Ke
   Lv, Weiqiang
   Wang, Xueqiang
   Dong, Shanshan
   Liu, Xuyun
   Yang, Tielin
   Xu, Jie
   Zeng, Mengqi
   Zou, Xuan
   Zhao, Daina
   Ma, Qingqing
   Lin, Mu
   Long, Jiangang
   Zang, Weijin
   Gao, Feng
   Feng, Zhihui
   Liu, Jiankang
TI Hypermethylation of Hepatic Mitochondrial <i>ND6</i> Provokes Systemic
   Insulin Resistance
SO ADVANCED SCIENCE
LA English
DT Article; Early Access
DE DNA methyltransferase 1 (DNMT1); insulin resistance; mitochondrial
   dysfunction; mitochondrial NADH&#8208; dehydrogenase 6 (ND6); obesity
   and type 2 diabetes mellitus (T2DM)
AB Mitochondrial epigenetics is rising as intriguing notion for its potential involvement in aging and diseases, while the details remain largely unexplored. Here it is shown that among the 13 mitochondrial DNA (mtDNA) encoded genes, NADH-dehydrogenase 6 (ND6) transcript is primarily decreased in obese and type 2 diabetes populations, which negatively correlates with its distinctive hypermethylation. Hepatic mtDNA sequencing in mice unveils that ND6 presents the highest methylation level, which dramatically increases under diabetic condition due to enhanced mitochondrial translocation of DNA methyltransferase 1 (DNMT1) promoted by free fatty acid through adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) activation. Hepatic knockdown of ND6 or overexpression of Dnmt1 similarly impairs mitochondrial function and induces systemic insulin resistance both in vivo and in vitro. Genetic or chemical targeting hepatic DNMT1 shows significant benefits against insulin resistance associated metabolic disorders. These findings highlight the pivotal role of ND6 epigenetic network in regulating mitochondrial function and onset of insulin resistance, shedding light on potential preventive and therapeutic strategies of insulin resistance and related metabolic disorders from a perspective of mitochondrial epigenetics.
C1 [Cao, Ke; Lv, Weiqiang; Wang, Xueqiang; Liu, Xuyun; Xu, Jie; Zeng, Mengqi; Zhao, Daina; Long, Jiangang; Feng, Zhihui; Liu, Jiankang] Xi An Jiao Tong Univ, Ctr Mitochondrial Biol & Med, Sch Life Sci & Technol, Key Lab Biomed Informat Engn,Minist Educ, Xian 710049, Shaanxi, Peoples R China.
   [Feng, Zhihui; Liu, Jiankang] Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, Xian 710049, Shaanxi, Peoples R China.
   [Zou, Xuan; Liu, Jiankang] Xi An Jiao Tong Univ, Affiliated Hosp 2, Natl & Local Joint Engn Res Ctr Biodiag & Biother, Xian 710004, Shaanxi, Peoples R China.
   [Dong, Shanshan; Yang, Tielin] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Minist Educ, Biomed Informat & Genom Ctr,Key Lab Biomed Inform, Xian 710049, Shaanxi, Peoples R China.
   [Ma, Qingqing; Lin, Mu] Guizhou Aerosp Hosp, Zunyi 563099, Guizhou, Peoples R China.
   [Zang, Weijin] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Pharmacol, Xian 710061, Shaanxi, Peoples R China.
   [Gao, Feng] Fourth Mil Med Univ, Sch Aerosp Med, Xian 710032, Peoples R China.
C3 Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong
   University; Xi'an Jiaotong University; Xi'an Jiaotong University; Air
   Force Military Medical University
RP Feng, ZH; Liu, JK (corresponding author), Xi An Jiao Tong Univ, Ctr Mitochondrial Biol & Med, Sch Life Sci & Technol, Key Lab Biomed Informat Engn,Minist Educ, Xian 710049, Shaanxi, Peoples R China.; Feng, ZH; Liu, JK (corresponding author), Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, Xian 710049, Shaanxi, Peoples R China.; Liu, JK (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Natl & Local Joint Engn Res Ctr Biodiag & Biother, Xian 710004, Shaanxi, Peoples R China.
EM zhfeng@mail.xjtu.edu.cn; j.liu@mail.xjtu.edu.cn
RI Zou, Xuan/A-6452-2015; Feng, Zhihui/E-7408-2011; Wang,
   Xueqiang/JNE-3515-2023
OI Feng, Zhihui/0000-0002-2448-6565; Wang, Xueqiang/0000-0001-7476-401X
FU National Natural Science Foundation of China [31701025, 81571050,
   31770917, 31570777, 91649106]; Natural Science Foundation of Shaanxi
   [2018JZ3005]; China Postdoctoral Science Foundation [2017M613108];
   Fundamental Research Funds for the Central Universities [Z201806073,
   xjj2018081]; National Basic Research Program [2015CB553602]
FX The authors thank the technical assistance from Dr. Lei Chen, Dr. Shujun
   Han, Hua Li, Qiong Sun, Yan Wang, and Zhen Wang at the Center for
   Mitochondrial Biology and Medicine, Xi'an Jiaotong University. This work
   was supported by the National Natural Science Foundation of China
   (31701025 to K.C.; 81571050 to Z.F.; 31770917, 31570777, 91649106 to
   J.L.), The Natural Science Foundation of Shaanxi (2018JZ3005 to J.L.),
   the General Financial Grant from the China Postdoctoral Science
   Foundation (2017M613108 to K.C.), the Fundamental Research Funds for the
   Central Universities (Z201806073, xjj2018081 to K.C.), and the National
   Basic Research Program (2015CB553602).
CR Arena G, 2018, MOL CELL, V69, P594, DOI 10.1016/j.molcel.2018.01.023
   Bangen JM, 2017, HEPATOLOGY, V66, P1242, DOI 10.1002/hep.29275
   Bellizzi D, 2013, DNA RES, V20, P537, DOI 10.1093/dnares/dst029
   Bordoni L, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-02150-9
   Byun HM, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003218
   Cao K, 2014, FREE RADICAL BIO MED, V67, P396, DOI 10.1016/j.freeradbiomed.2013.11.029
   Chatterjee A, 2016, CELL, V167, P722, DOI 10.1016/j.cell.2016.09.052
   Chestnut BA, 2011, J NEUROSCI, V31, P16619, DOI 10.1523/JNEUROSCI.1639-11.2011
   Choi MS, 2015, BRIT J NUTR, V113, P867, DOI 10.1017/S0007114515000100
   Corsi S, 2020, CLIN EPIGENETICS, V12, DOI 10.1186/s13148-020-00825-5
   DAWID IB, 1974, SCIENCE, V184, P80, DOI 10.1126/science.184.4132.80
   Dou XY, 2019, GENOME RES, V29, P1622, DOI 10.1101/gr.234021.117
   Dzitoyeva S, 2012, NEUROBIOL AGING, V33, P2881, DOI 10.1016/j.neurobiolaging.2012.02.006
   Fiedler EC, 2018, CELL METAB, V28, P534, DOI 10.1016/j.cmet.2018.09.015
   Gao D, 2010, J BIOL CHEM, V285, P29965, DOI 10.1074/jbc.M110.128694
   Gao KX, 2021, CELL RES, V31, P219, DOI 10.1038/s41422-020-00394-5
   Garcia D, 2017, MOL CELL, V66, P789, DOI 10.1016/j.molcel.2017.05.032
   Ghoshal K, 2005, MOL CELL BIOL, V25, P4727, DOI 10.1128/MCB.25.11.4727-4741.2005
   Hao JJ, 2010, J NUTR BIOCHEM, V21, P634, DOI 10.1016/j.jnutbio.2009.03.012
   Hong EE, 2013, MOL CELL BIOL, V33, P2683, DOI 10.1128/MCB.00220-13
   Inyard AC, 2009, DIABETES, V58, P2457, DOI 10.2337/db08-1077
   Jayaprakash AD, 2015, NUCLEIC ACIDS RES, V43, P2177, DOI 10.1093/nar/gkv052
   Pirola CJ, 2013, GUT, V62, P1356, DOI 10.1136/gutjnl-2012-302962
   Jung SB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03998-z
   Kinde B, 2015, P NATL ACAD SCI USA, V112, P6800, DOI 10.1073/pnas.1411269112
   Kraja AT, 2019, AM J HUM GENET, V104, P112, DOI 10.1016/j.ajhg.2018.12.001
   Lee MS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05721-4
   Liu BJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23421
   Liu JK, 2009, ADV DRUG DELIVER REV, V61, P1343, DOI 10.1016/j.addr.2009.06.007
   Marin TL, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aaf7478
   McManus MJ, 2019, CELL METAB, V29, P78, DOI 10.1016/j.cmet.2018.08.002
   Mechta M., 2018, JOVE-J VIS EXP, V135, P57772
   Mechta M, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00166
   Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001
   Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056
   NASS MMK, 1973, J MOL BIOL, V80, P155, DOI 10.1016/0022-2836(73)90239-8
   Owa C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192722
   Patil V, 2019, NUCLEIC ACIDS RES, V47, P10072, DOI 10.1093/nar/gkz762
   Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478
   POLLACK Y, 1984, NUCLEIC ACIDS RES, V12, P4811, DOI 10.1093/nar/12.12.4811
   Porcelli AM, 2009, J BIOL CHEM, V284, P2045, DOI 10.1074/jbc.M807321200
   Saini SK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01743-y
   Schmid AI, 2011, DIABETES CARE, V34, P448, DOI 10.2337/dc10-1076
   Shock LS, 2011, P NATL ACAD SCI USA, V108, P3630, DOI 10.1073/pnas.1012311108
   Stroud DA, 2016, NATURE, V538, P123, DOI 10.1038/nature19754
   Sun LJ, 2010, LIFE SCI, V86, P39, DOI 10.1016/j.lfs.2009.11.003
   van der Wijst MGP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00263-z
   van der Wijst MGP, 2015, TRENDS GENET, V31, P353, DOI 10.1016/j.tig.2015.03.009
   Volkov P, 2017, DIABETES, V66, P1074, DOI 10.2337/db16-0996
   Wallace DC, 2018, NAT GENET, V50, P1642, DOI 10.1038/s41588-018-0264-z
   Wang YZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142034
   Wong M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00279
   Xu J, 2014, J NUTR, V144, P475, DOI 10.3945/jn.113.187450
   Zhang XR, 2014, CELL, V158, P607, DOI 10.1016/j.cell.2014.05.047
NR 54
TC 18
Z9 19
U1 5
U2 43
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
EI 2198-3844
J9 ADV SCI
JI Adv. Sci.
PD 2021 JUN
PY 2021
VL 8
IS 11
AR 2004507
DI 10.1002/advs.202004507
EA MAY 2021
PG 16
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA SO7AC
UT WOS:000645975200001
PM 34141522
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Tung, BT
   Rodríguez-Bies, E
   Ballesteros-Simarro, M
   Motilva, V
   Navas, P
   López-Lluch, G
AF Bui Thanh Tung
   Rodriguez-Bies, Elisabet
   Ballesteros-Simarro, Manuel
   Motilva, Virginia
   Navas, Placido
   Lopez-Lluch, Guillermo
TI Modulation of Endogenous Antioxidant Activity by Resveratrol and
   Exercise in Mouse Liver is Age Dependent
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE Resveratrol; Aging; Exercise; Endogenous antioxidant system; Glutathione
ID GLUTATHIONE S-TRANSFERASES; FREE-RADICAL THEORY; OXIDATIVE STRESS;
   PLASMA-MEMBRANE; GENE-EXPRESSION; CALORIC RESTRICTION; LIFE-SPAN;
   THIOREDOXIN; PROTECTION; REDUCTASE
AB Aging is a multifactorial process in which oxidative damage plays an important role. Resveratrol (RSV) and exercise delay some of the damages occurring during aging and increase life span and health span. We treated mice at different ages with RSV during 6 months and trained them during the last 6 weeks to determine if RSV and exercise induce changes in endogenous antioxidant activities in liver and if their effects depend on the age of the animal at the beginning of the intervention. Aging was accompanied by the increase in oxidative damage in liver especially affecting the glutathione-dependent system. Both RSV and exercise reversed the effect of aging and maintained high activities of glutathione, glutathione peroxidase, and glutathione transferase activities in old animals. NAD(P)H: quinone acceptor oxidoreductase activity was also increased. Modulation of antioxidant activities was not completely accompanied by changes at the protein level. Whereas glutathione peroxidase 1 protein increased in parallel to the higher activity in old animals, NAD(P)H: quinone acceptor oxidoreductase protein decreased by RSV although the activity was enhanced. Our results indicate that RSV and exercise revert the effect of aging in liver of old animals maintaining higher antioxidant activities and decreasing oxidative damage. Short-term interventions are enough to produce beneficial effects of RSV or exercise at later ages.
C1 [Bui Thanh Tung; Rodriguez-Bies, Elisabet; Ballesteros-Simarro, Manuel; Navas, Placido; Lopez-Lluch, Guillermo] Univ Pablo de Olavide, Ctr Andaluz Biol Desarrollo, Inst Salud Carlos III, CIBERER,CSIC, Seville 41013, Spain.
   [Bui Thanh Tung; Motilva, Virginia] Univ Seville, Fac Farm, Dept Farmacol, Seville, Spain.
C3 Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica
   en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC);
   Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental
   Biology (CABD); University of Sevilla
RP López-Lluch, G (corresponding author), Univ Pablo de Olavide, Ctr Andaluz Biol Desarrollo, Carretera Utrera Km 1, Seville 41013, Spain.
EM glopllu@upo.es
RI NAVAS, PLACIDO/R-5943-2019; Rodríguez-Bies, Elisabet/A-4459-2016;
   Lopez-Lluch, Guillermo/N-4742-2014
OI NAVAS, PLACIDO/0000-0002-4115-7966; Rodríguez-Bies,
   Elisabet/0000-0002-5910-2920; Lopez-Lluch,
   Guillermo/0000-0001-9830-8502; Motilva Sanchez,
   Virginia/0000-0001-5674-6969
FU Andalusian Government as the BIO177 group through Fondo Europeo de
   Desarrollo Regional (FEDER) funds (European Commission); Spanish
   Government (Spanish Ministry of Science and Innovation) [DEP2009-12019,
   DEP2012-39985]; Agencia Espanola de Cooperacion Internacional para el
   Desarrollo (AECID) program (Spanish Ministry of Foreign Affair)
FX The research group is financed by the Andalusian Government as the
   BIO177 group through Fondo Europeo de Desarrollo Regional (FEDER) funds
   (European Commission). Research has been financed by the Spanish
   Government grants DEP2009-12019 and DEP2012-39985 (Spanish Ministry of
   Science and Innovation). B.T.T. received a fellowship from the Agencia
   Espanola de Cooperacion Internacional para el Desarrollo (AECID) program
   (Spanish Ministry of Foreign Affair). E.R.B., M.B.S., P.N., and G.L.L.
   are also members of the Centro de Investigacion Biomedica en Red de
   Enfermedades Raras, Instituto Carlos III.
CR Aebi H, 1984, Methods Enzymol, V105, P121
   Agarwal B, 2013, INT J CARDIOL, V166, P246, DOI 10.1016/j.ijcard.2012.09.027
   ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548
   [Anonymous], 2009, Handbook of theories of aging
   Arner ESJ, 1996, BIOCHEM BIOPH RES CO, V225, P268, DOI 10.1006/bbrc.1996.1165
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Bello RI, 2005, EXP GERONTOL, V40, P694, DOI 10.1016/j.exger.2005.07.003
   BENSON AM, 1980, P NATL ACAD SCI-BIOL, V77, P5216, DOI 10.1073/pnas.77.9.5216
   BJORNSTEDT M, 1995, J BIOL CHEM, V270, P11761, DOI 10.1074/jbc.270.20.11761
   Bradamante S, 2004, CARDIOVASC DRUG REV, V22, P169
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Bronikowski AM, 2002, GENETICS, V161, P1763
   CARLBERG I, 1985, METHOD ENZYMOL, V113, P484
   Crane FL, 2013, J GERONTOL A-BIOL, V68, P368, DOI 10.1093/gerona/gls184
   Csiszar A, 2012, J GERONTOL A-BIOL, V67, P811, DOI 10.1093/gerona/glr228
   Datta K, 2000, NATL MED J INDIA, V13, P304
   De Cabo R, 2004, EXP GERONTOL, V39, P297, DOI 10.1016/j.exger.2003.12.003
   de Haan LHJ, 2006, TOXICOL IN VITRO, V20, P594, DOI 10.1016/j.tiv.2005.10.005
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   FLOHE L, 1984, METHOD ENZYMOL, V105, P114
   FOURNIER D, 1992, J BIOL CHEM, V267, P1840
   Gérard-Monnier D, 1998, CHEM RES TOXICOL, V11, P1176, DOI 10.1021/tx9701790
   Gündüz F, 2004, PHYSIOL RES, V53, P171, DOI 10.33549/physiolres.930384
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   Harman D, 2006, ANN NY ACAD SCI, V1067, P10, DOI 10.1196/annals.1354.003
   Hill KE, 1997, ANAL BIOCHEM, V253, P123, DOI 10.1006/abio.1997.2373
   HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199
   Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960
   Hyun DH, 2010, EXP NEUROL, V225, P423, DOI 10.1016/j.expneurol.2010.07.020
   Jackson JR, 2011, J GERONTOL A-BIOL, V66, P751, DOI 10.1093/gerona/glr047
   Ji LL, 1998, ANN NY ACAD SCI, V854, P102, DOI 10.1111/j.1749-6632.1998.tb09896.x
   JI LL, 1991, GERONTOLOGY, V37, P317
   Junqueira Virginia B. C., 2004, Molecular Aspects of Medicine, V25, P5, DOI 10.1016/j.mam.2004.02.003
   Kaczor JJ, 2007, FREE RADICAL BIO MED, V43, P145, DOI 10.1016/j.freeradbiomed.2007.04.003
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   López-Lluch G, 2005, AGE, V27, P153, DOI 10.1007/s11357-005-2726-3
   López-Lluch G, 2008, EXP GERONTOL, V43, P813, DOI 10.1016/j.exger.2008.06.014
   López-Lluch G, 2010, MECH AGEING DEV, V131, P225, DOI 10.1016/j.mad.2010.02.003
   Lu T, 2008, EXP CELL RES, V314, P1918, DOI 10.1016/j.yexcr.2008.01.011
   Mallikarjuna K, 2010, ALCOHOL, V44, P523, DOI 10.1016/j.alcohol.2010.07.004
   MARKLUND S, 1974, EUR J BIOCHEM, V47, P469
   May JM, 1997, J BIOL CHEM, V272, P22607, DOI 10.1074/jbc.272.36.22607
   Mercken EM, 2012, AGEING RES REV, V11, P390, DOI 10.1016/j.arr.2011.11.005
   Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178
   Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034
   Navarro A, 2004, AM J PHYSIOL-REG I, V286, pR505, DOI 10.1152/ajpregu.00208.2003
   Navarro F, 1998, FASEB J, V12, P1665, DOI 10.1096/fasebj.12.15.1665
   Valcarcel-Ares MN, 2012, J GERONTOL A-BIOL, V67, P821, DOI 10.1093/gerona/glr229
   Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011
   Plewka A, 1998, MECH AGEING DEV, V105, P197, DOI 10.1016/S0047-6374(98)00086-4
   Polidori MC, 2000, INT J SPORTS MED, V21, P154, DOI 10.1055/s-2000-8881
   Rikans LE, 1997, BBA-MOL BASIS DIS, V1362, P116, DOI 10.1016/S0925-4439(97)00067-7
   Robinson CE, 1999, ANAL BIOCHEM, V266, P48, DOI 10.1006/abio.1998.2932
   Rodríguez-Bies E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013900
   Ross D, 2004, DRUG METAB REV, V36, P639, DOI 10.1081/DMR-200033465
   Ryan MJ, 2010, J GERONTOL A-BIOL, V65, P815, DOI 10.1093/gerona/glq080
   Shih PH, 2007, BIOGERONTOLOGY, V8, P71, DOI 10.1007/s10522-006-9033-y
   SIES H, 1993, EUR J BIOCHEM, V215, P213, DOI 10.1111/j.1432-1033.1993.tb18025.x
   Spanier G, 2009, J PHYSIOL PHARMACOL, V60, P111
   Strong R, 2013, J GERONTOL A-BIOL, V68, P6, DOI 10.1093/gerona/gls070
   Talalay P, 1995, TOXICOL LETT, V82-3, P173, DOI 10.1016/0378-4274(95)03553-2
   Thirunavukkarasu V, 2003, COMP BIOCHEM PHYS C, V135, P31, DOI 10.1016/S1532-0456(03)00045-0
   Ungvari Z, 2011, AM J PHYSIOL-HEART C, V301, pH363, DOI 10.1152/ajpheart.01134.2010
   Ungvari Z, 2011, J GERONTOL A-BIOL, V66, P741, DOI 10.1093/gerona/glr044
   Ungvari Z, 2011, EXERC SPORT SCI REV, V39, P128, DOI 10.1097/JES.0b013e3182141f80
   Ungvari Z, 2009, AM J PHYSIOL-HEART C, V297, pH1876, DOI 10.1152/ajpheart.00375.2009
   Wallerath T, 2002, CIRCULATION, V106, P1652, DOI 10.1161/01.CIR.0000029925.18593.5C
   Wong YT, 2009, FREE RADICAL BIO MED, V46, P799, DOI 10.1016/j.freeradbiomed.2008.12.016
   Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789
   Xia L, 2003, J BIOL CHEM, V278, P2141, DOI 10.1074/jbc.M210456200
   YILDIRIM O, 1994, BIOMATERIALS, V15, P587, DOI 10.1016/0142-9612(94)90208-9
   YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139
NR 74
TC 39
Z9 41
U1 0
U2 17
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD APR
PY 2014
VL 69
IS 4
BP 398
EP 409
DI 10.1093/gerona/glt102
PG 12
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA AD6QI
UT WOS:000333385500004
PM 23861386
OA Bronze
DA 2024-02-19
ER

PT J
AU Cipriano, C
   Giacconi, R
   Muzzioli, M
   Gasparini, N
   Orlando, F
   Corradi, A
   Cabassi, E
   Mocchegiani, E
AF Cipriano, C
   Giacconi, R
   Muzzioli, M
   Gasparini, N
   Orlando, F
   Corradi, A
   Cabassi, E
   Mocchegiani, E
TI Metallothionein (I+II) confers, via <i>c-myc</i>, immune plasticity in
   oldest mice:: model of partial hepatectomy/liver regeneration
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE IL-6; sIL-6R; NK cell activity; IL-2; cancer; successful ageing
ID LIVER-REGENERATION; ZINC-DEFICIENCY; GENE-EXPRESSION; IL-6; RAT;
   OVEREXPRESSION; SUSCEPTIBILITY; AMPLIFICATION; CENTENARIANS; APOPTOSIS
AB Because of its similarity to ageing in impaired immune efficiency 48 h after surgical procedures on young partially hepatectomised mice, partial hepatectomy/liver regeneration (pHx) provides a good model for the study of inflammation in ageing. In old age, high metallothionein (I + II) (MT) sequesters a substantial number of intracellular zinc ions consequently leading to low zinc ion bioavailability for an adequate immune response. Corticosterone and IL-6 affect MTmRNA induction in inflammation and after pHx against oxidative damage. The aim of this study was to investigate the role played by MT in conferring immune plasticity in ageing and in very old age using the pHx model. 48 h after their partial hepatectomy, the crude zinc balance was negative in young, old and very old mice coupled with increased MT, corticosterone, sIL-6R and IL-6. Concomitantly, Natural Killer (NK) cell activity and IL-2 production decreased. Complete restoration of the nutritional-endocrine-immune parameters occurred 15 days from the surgical procedures in young and very old mice, but not in old or transgenic mice overexpressing MT. A significant positive or inverse correlation among nutritional-endocrine-immune parameters exists in young and very old mice, but not in old mice during liver regeneration. Since MT also affects c-myc, the gene expression of c-myc declines from 48 h to days 7 and 15 after pHx in young and very old mice, but remains constantly high in old pHx mice for the same days. This circumstance leads to the appearance of tumours in the long run in old pHx mice and survival times that are shorter than old sham controls. Because complete remodelling also occurs in IL-6 and in sIL-6R in very old mice during liver regeneration, the pre-existing inflammation is not detrimental in very old age. As such, very old mice are still responsive to large inflammation, such as pHx, thanks to correct MT homeostasis. Correct MT homeostasis, via c-myc, is therefore pivotal in both suitable liver regeneration and in conferring immune plasticity with subsequent successful ageing. High MT plays an extremely harmful role in ageing: on one hand it lowers zinc ion bioavailability levels required for immune efficiency and on the other hand it increases c-myc expression. The combination of immune depression and enhanced c-myc, via high MT, may trigger the appearance of age-related degenerative diseases. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
C1 Italian Natl Ctr Ageing, Dept Res, Sect Nutr Immun & Ageing, Ctr Immunol, I-60121 Ancona, Italy.
   INRCA, Vet Serv, Ancona, Italy.
   Univ Parma, Fac Med Vet, Dept Anim Hlth Pathol Unit, I-43100 Parma, Italy.
C3 IRCCS INRCA; University of Parma
RP Mocchegiani, E (corresponding author), Italian Natl Ctr Ageing, Dept Res, Sect Nutr Immun & Ageing, Ctr Immunol, Via Birarelli 8, I-60121 Ancona, Italy.
RI Orlando, Fiorenza/AAB-3441-2021; CORRADI, ATTILIO/GZB-1783-2022;
   CORRADI, ATTILIO/ITT-3032-2023; Giacconi, Robertina/J-5349-2018
OI Orlando, Fiorenza/0000-0001-7351-4430; CORRADI,
   ATTILIO/0000-0002-4511-9748; CORRADI, ATTILIO/0000-0002-4511-9748;
   Giacconi, Robertina/0000-0002-1468-2140
CR Andrews GK, 2000, BIOCHEM PHARMACOL, V59, P95, DOI 10.1016/S0006-2952(99)00301-9
   Bonafè M, 2001, EUR J IMMUNOL, V31, P2357, DOI 10.1002/1521-4141(200108)31:8<2357::AID-IMMU2357>3.0.CO;2-X
   BUUNSGAARD H, 2001, CURR OPIN HEMATOL, V8, P131
   De Miglio MR, 1999, MOL CARCINOGEN, V25, P21, DOI 10.1002/(SICI)1098-2744(199905)25:1<21::AID-MC3>3.3.CO;2-J
   EBADI E, 1988, NUTR GROWTH CANC, P161
   Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2
   *FELASA WORK GROUP, 1994, LAB ANIM, V28, P1
   FRANCESCHI C, 1995, IMMUNOL TODAY, V16, P12, DOI 10.1016/0167-5699(95)80064-6
   Giuliani N, 2001, EXP GERONTOL, V36, P547, DOI 10.1016/S0531-5565(00)00220-5
   Gordon GJ, 2000, AM J PATHOL, V157, P771, DOI 10.1016/S0002-9440(10)64591-9
   HARRINGTON EA, 1994, EMBO J, V13, P3286, DOI 10.1002/j.1460-2075.1994.tb06630.x
   HOFFMAN AL, 1994, SEMIN LIVER DIS, V14, P190, DOI 10.1055/s-2007-1007311
   Houlston RS, 1998, EUR J HUM GENET, V6, P80, DOI 10.1038/sj.ejhg.5200156
   KAGI JHR, 1988, BIOCHEMISTRY-US, V27, P8509, DOI 10.1021/bi00423a001
   Kawate S, 1999, ONCOLOGY-BASEL, V57, P157, DOI 10.1159/000012024
   Kelley-Loughnane N, 2002, HEPATOLOGY, V35, P525, DOI 10.1053/jhep.2002.31351
   Kelly EJ, 1996, J NUTR, V126, P1782
   Maione D, 1998, EMBO J, V17, P5588, DOI 10.1093/emboj/17.19.5588
   Mecocci P, 2000, FREE RADICAL BIO MED, V28, P1243, DOI 10.1016/S0891-5849(00)00246-X
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   Mocchegiani E, 1997, LIFE SCI, V61, P1125, DOI 10.1016/S0024-3205(97)00646-2
   Mocchegiani E, 1998, MECH AGEING DEV, V106, P183, DOI 10.1016/S0047-6374(98)00115-8
   Mocchegiani E, 2000, TRENDS PHARMACOL SCI, V21, P205, DOI 10.1016/S0165-6147(00)01476-0
   Mocchegiani E, 2002, EXP GERONTOL, V37, P349, DOI 10.1016/S0531-5565(01)00202-9
   Mocchegiani E, 2002, MECH AGEING DEV, V123, P675, DOI 10.1016/S0047-6374(01)00414-6
   Moser MJ, 2001, DIGEST DIS SCI, V46, P907, DOI 10.1023/A:1010791915733
   OKUDA Y, 1995, J NEUROIMMUNOL, V62, P103, DOI 10.1016/0165-5728(95)00114-H
   Quaife CJ, 1998, TOXICOL APPL PHARM, V148, P148, DOI 10.1006/taap.1997.8321
   Sharma R, 2002, INT J CARDIOL, V85, P161, DOI 10.1016/S0167-5273(02)00244-9
   Shih CM, 2002, LUNG CANCER, V36, P125, DOI 10.1016/S0169-5002(01)00467-6
   Shimada M, 1996, INT SURG, V81, P49
   Temple NJ, 2002, NUTRITION, V18, P343, DOI 10.1016/S0899-9007(01)00759-6
   TOHYAMA C, 1993, HEPATOLOGY, V18, P1193
   TURNLUND JR, 1986, J NUTR, V116, P1239, DOI 10.1093/jn/116.7.1239
   Waelput W, 2001, J EXP MED, V194, P1617, DOI 10.1084/jem.194.11.1617
   Wapnir RA, 2000, J NUTR, V130, p1388S, DOI 10.1093/jn/130.5.1388S
   Wesselkamper SC, 2000, AM J PHYSIOL-LUNG C, V279, pL575, DOI 10.1152/ajplung.2000.279.3.L575
   Wikby A, 1998, MECH AGEING DEV, V102, P187, DOI 10.1016/S0047-6374(97)00151-6
NR 38
TC 20
Z9 23
U1 0
U2 2
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD AUG-SEP
PY 2003
VL 124
IS 8-9
BP 877
EP 886
DI 10.1016/S0047-6374(03)00146-5
PG 10
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 728QF
UT WOS:000185727300005
PM 14499492
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Mocchegiani, E
   Verbanac, D
   Santarelli, L
   Tibaldi, A
   Muzzioli, M
   RadosevicStasic, B
   Milin, C
AF Mocchegiani, E
   Verbanac, D
   Santarelli, L
   Tibaldi, A
   Muzzioli, M
   RadosevicStasic, B
   Milin, C
TI Zinc and metallothioneins on cellular immune effectiveness during liver
   regeneration in young and old mice
SO LIFE SCIENCES
LA English
DT Article
DE zinc; metallothioneins; thymulin; immune system; partial hepatectomy;
   liver growth
ID EXTRATHYMIC T-CELLS; PARTIAL-HEPATECTOMY; BIOLOGICAL-ACTIVITY; NEGATIVE
   SELECTION; TRANSGENIC MICE; THYMIC HORMONE; MOUSE-LIVER; ACTIVATION;
   DIFFERENTIATION; RECEPTOR
AB Partial hepatectomy in young mice (pHx) induces thymic atrophy, disregulation of thymocytes subsets and a strong accumulation of zinc in thymic tissue after 1-2 days of liver regeneration. Zinc is relevant for good immune functioning. Restoration of zinc into both the thymus and thymocytes subsets in the late period of liver regeneration is observed in young pHx mice. These findings have suggested a link between the thymus and the liver influencing T-cell functions and involving zinc. This kind of link could be relevant in aging because thymic involution, negative crude zinc balance and crippled immune functions are constant events. The preminence of a liver extrathymic T-cell pathway after pHx or during aging has been suggested. Thus the study of pHx in young and old mice may offer a good model to better understand the role played both by thymic involution and by liver extrathymic T-cell pathway and the role of zinc in these physiological processes during aging. Young pHx mice after 1-2 days of liver regeneration show: reduced thymic endocrine activity, increment of double negative (DN) thymocytes subsets, impairment of peripheral immune efficiency (PHA, NK activity and IL-2) and negative crude zinc balance, which are all restored in the late period of liver regeneration. By contrast the thymic and peripheral immune defects and the negative crude zinc balance, already present in old sham mice, are not modified during liver regeneration in old pHx mice. Circulating leukocytes and lymphocytes are not significantly modified both in young and old pHx mice as compared to respective sham controls. Zinc may also be crucial for extrathymic T-cells pathway, being preminent in aging, rather than in young age, due to its metallothioneins (MT) binding capacity. MT are significantly increased in young pHx and in aging inducing a low zinc-free quota for thymic and peripheral immune efficiency in young pHx mice, and for extrathymic T-cell pathway, in old age. Thus low zinc bioavailability, due to MT, may play a pivotal role, not only for thymocytes but also for liver extrathymic T-cell pathway.
C1 UNIV RIJEKA, FAC MED, DPT PHYSIOL & IMMUNOL, RIJEKA, CROATIA.
   UNIV RIJEKA, FAC MED, DPT CHEM & BIOCHEM, RIJEKA, CROATIA.
C3 University of Rijeka; University of Rijeka
RP Mocchegiani, E (corresponding author), INRCA ANCONA, RES DEPT, CTR IMMUNOL, VIA G BIRARELLI 8, I-60121 ANCONA, ITALY.
RI santarelli, lory/I-7429-2012; Radošević-Stašić, Biserka/Q-7051-2018;
   Verbanac, Donatella/AAN-1947-2021; Santarelli, Lory/AAU-4494-2020
OI Radošević-Stašić, Biserka/0000-0002-3331-9320; Verbanac,
   Donatella/0000-0002-9106-1604; santarelli, lory/0000-0003-1015-7098
CR ABO T, 1991, J EXP MED, V174, P417, DOI 10.1084/jem.174.2.417
   ABO T, 1992, BIOMED RES-TOKYO, V13, P1
   ALLEN JI, 1983, J LAB CLIN MED, V102, P577
   ARONSON M, 1993, MECH AGEING DEV, V72, P49, DOI 10.1016/0047-6374(93)90130-J
   BACH JF, 1975, ANN NY ACAD SCI, V249, P186, DOI 10.1111/j.1749-6632.1975.tb29068.x
   Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782
   BREMNER I, 1987, J NUTR, V117, P1595, DOI 10.1093/jn/117.9.1595
   CHANDRA RK, 1983, IMMUNOL TODAY, V4, P322, DOI 10.1016/0167-5699(83)90196-2
   COUSINS RJ, 1988, FASEB J, V2, P2884, DOI 10.1096/fasebj.2.13.2458983
   Crispe IN, 1996, IMMUNOL TODAY, V17, P522, DOI 10.1016/S0167-5699(96)80906-6
   DARDENNE M, 1982, P NATL ACAD SCI-BIOL, V79, P5370, DOI 10.1073/pnas.79.17.5370
   DINARELLO CA, 1986, ANNU REV MED, V37, P173
   EBADI M, 1988, NUTRITION GROWTH CAN, P161
   FABRIS N, 1995, AGING-CLIN EXP RES, V7, P77, DOI 10.1007/BF03324297
   FABRIS N, 1994, ANN NY ACAD SCI, V719, P353, DOI 10.1111/j.1749-6632.1994.tb56842.x
   Fausto Nelson, 1994, P1059
   Fernandez FJ, 1971, CLIN CHEM NEWSL, V3, P24, DOI DOI 10.1021/AC60164A712
   FISHMAN MJ, 1966, GEOLOGICAL SURVEY WA, P1540
   FRANCAVILLA A, 1993, J SURG ONCOL, P1
   FRY AM, 1989, SCIENCE, V246, P1044, DOI 10.1126/science.2511630
   GAMMON G, 1991, IMMUNOL TODAY, V12, P193, DOI 10.1016/0167-5699(91)90052-U
   Goldstein A.L., 1984, THYMIC HORMONES LYMP
   GRIDER A, 1989, J LAB CLIN MED, V113, P221
   HERBERMAN RB, 1981, SCIENCE, V214, P24, DOI 10.1126/science.7025208
   HOFFMAN AL, 1994, SEMIN LIVER DIS, V14, P190, DOI 10.1055/s-2007-1007311
   IIAI T, 1992, IMMUNOLOGY, V77, P556
   IIAI T, 1994, CELL IMMUNOL, V153, P412, DOI 10.1006/cimm.1994.1039
   LADEFOGED K, 1980, CLIN CHIM ACTA, V100, P149, DOI 10.1016/0009-8981(80)90076-5
   MASUDA T, 1991, J IMMUNOL, V147, P2907
   MICHALOPOULOS GK, 1990, FASEB J, V4, P176, DOI 10.1096/fasebj.4.2.2404819
   MILIN C, 1995, CROAT CHEM ACTA, V68, P559
   MILLER GG, 1992, SCAND J IMMUNOL, V36, P269, DOI 10.1111/j.1365-3083.1992.tb03099.x
   MISHELL BB, 1980, SELECTED METHODS CEL, P3
   MOAKE JL, 1977, ANN INTERN MED, V86, P576, DOI 10.7326/0003-4819-86-5-576
   MOCCHEGIANI E, 1994, BLOOD, V83, P749
   MOCCHEGIANI E, 1995, INT J IMMUNOPHARMACO, V17, P703, DOI 10.1016/0192-0561(95)00059-B
   Mocchegiani E, 1996, J PHARMACOL EXP THER, V277, P1200
   MOCCHEGIANI E, 1994, J NEUROIMMUNOL, V53, P189, DOI 10.1016/0165-5728(94)90029-9
   MULLERHERMELINK HK, 1984, ADV EXP MED BIOL, V17, P142
   NADAL C, 1995, LIVER, V15, P63
   OHTEKI T, 1990, J EXP MED, V172, P7, DOI 10.1084/jem.172.1.7
   OHTEKI T, 1991, EUR J IMMUNOL, V21, P1733, DOI 10.1002/eji.1830210722
   OHTEKI T, 1992, J IMMUNOL, V149, P1562
   ONU M, 1989, JAP J SURG, V19, P726
   PRASAD AS, 1985, CLIN ENDOCRINOL META, V14, P567, DOI 10.1016/S0300-595X(85)80007-4
   ROCHA B, 1990, EUR J IMMUNOL, V20, P919, DOI 10.1002/eji.1830200430
   ROCHA B, 1991, J EXP MED, V173, P483, DOI 10.1084/jem.173.2.483
   SAKAI A, 1976, SURG GYNECOL OBSTET, V143, P914
   SATO Y, 1993, IMMUNOLOGY, V78, P86
   SCHEUHAMMER AM, 1991, METHOD ENZYMOL, V205, P78
   SEKI S, 1991, CELL IMMUNOL, V137, P46, DOI 10.1016/0008-8749(91)90055-G
   SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0
   SHERMAN B, 1985, J CLIN ENDOCR METAB, V61, P439, DOI 10.1210/jcem-61-3-439
   Shimada M, 1996, INT SURG, V81, P49
   STEER CJ, 1995, FASEB J, V9, P1396, DOI 10.1096/fasebj.9.14.7589980
   TAKAHAMA Y, 1992, SCIENCE, V258, P653, DOI 10.1126/science.1357752
   TANAKA Y, 1990, SCAND J IMMUNOL, V31, P547, DOI 10.1111/j.1365-3083.1990.tb02805.x
   Taub R, 1996, FASEB J, V10, P413, DOI 10.1096/fasebj.10.4.8647340
   THOMAS DJ, 1989, MECH AGEING DEV, V47, P241, DOI 10.1016/0047-6374(89)90036-5
   TOHYAMA C, 1993, HEPATOLOGY, V18, P1193
   VINEY J, 1990, GUT, V31, P841, DOI 10.1136/gut.31.8.841
   WILTROUT RH, 1989, J IMMUNOL, V143, P372
   ZIMMERMAN GA, 1992, IMMUNOL TODAY, V13, P93, DOI 10.1016/0167-5699(92)90149-2
NR 63
TC 33
Z9 37
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
EI 1879-0631
J9 LIFE SCI
JI Life Sci.
PD AUG 15
PY 1997
VL 61
IS 12
BP 1125
EP 1145
DI 10.1016/S0024-3205(97)00646-2
PG 21
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA XT140
UT WOS:A1997XT14000003
PM 9315504
DA 2024-02-19
ER

PT J
AU Chan, YC
   Wang, MF
   Chang, HC
AF Chan, YC
   Wang, MF
   Chang, HC
TI <i>Polygonum multiflorum</i> extracts improve cognitive performance in
   senescence accelerated mice
SO AMERICAN JOURNAL OF CHINESE MEDICINE
LA English
DT Article
DE Polygonum multiflorum Thunb.; learning and memory; malondialdehyde;
   lipofuscin; antioxidants
ID RAT-HEART MITOCHONDRIA; SUPEROXIDE-DISMUTASE; LIPID-PEROXIDATION; MOUSE
   SAM; STRESS; STRAIN; BRAIN; LIVER; VIVO
AB The objective of this study was to investigate the effects of Polygonum multiflorum (PM) Thunb. on the learning and memory ability in one- and seven-month-old male senescence accelerated mice (SAMP8). The mice were fed with two different diets for 18 weeks; they were casein dietary group (control group) and casein diet supplemented with PM extracts. Active shuttle avoidance test was performed to determine the learning and memory ability of the mice while the spongy degeneration and the lipofuscin, malondialdehyde, and total thiol levels of the brain were measured to evaluate the extent of the brain degeneration and oxidative status. Results of active shuttle avoidance test showed the mice fed with the PM extracts had significantly better learning and memory ability than the control group. The spongy degeneration and the lipofuscin and malondialdehyde concentrations of the mice in the PM groups were significantly lower than the control in both age groups, whereas the total thiol levels were higher but not significantly different. It was concluded that the supplement of the PM extracts could improve the learning and memory ability and reduce the brain pathological changes in mice. This might be due to the antioxidant phytochemicals of the PM extracts.
C1 Providence Univ, Dept Food & Nutr, Taichung 43301, Taiwan.
C3 Providence University - Taiwan
RP Chan, YC (corresponding author), Providence Univ, Dept Food & Nutr, 200 Chung Chi Rd, Taichung 43301, Taiwan.
EM ycchan@pu.edu.tw
OI Chan, Yin Ching/0000-0001-9602-0775
CR [Anonymous], ACTA PHARM SIN
   Bickford PC, 2000, BRAIN RES, V866, P211, DOI 10.1016/S0006-8993(00)02280-0
   Borek C, 2001, J NUTR, V131, p1010S, DOI 10.1093/jn/131.3.1010S
   CAND F, 1989, FREE RADICAL BIO MED, V7, P59, DOI 10.1016/0891-5849(89)90101-9
   Chaudhary A, 1995, GERONTOLOGY, V41, P229
   Diamond BJ, 2000, ARCH PHYS MED REHAB, V81, P668, DOI 10.1053/mr.2000.3840
   ELLMAN GL, 1978, ANAL BIOCHEM, V93, P98
   FLOOD JF, 1993, NEUROBIOL AGING, V14, P153, DOI 10.1016/0197-4580(93)90091-O
   HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1
   HONG CY, 1994, AM J CHINESE MED, V22, P63, DOI 10.1142/S0192415X94000085
   HOSOKAWA M, 1984, MECH AGEING DEV, V26, P91, DOI 10.1016/0047-6374(84)90168-4
   HUANG HC, 1991, EUR J PHARMACOL, V198, P211
   Ip SP, 1997, PHYTOTHER RES, V11, P42, DOI 10.1002/(SICI)1099-1573(199702)11:1<42::AID-PTR940>3.3.CO;2-X
   KADAR T, 1990, BRAIN RES, V512, P113, DOI 10.1016/0006-8993(90)91178-J
   Kim JS, 2000, AM J CHINESE MED, V28, P343, DOI 10.1142/S0192415X00000404
   LIN TJ, 1991, BIOCHEM PHARMACOL, V42, P1805
   LIU JK, 1993, MECH AGEING DEV, V71, P23, DOI 10.1016/0047-6374(93)90032-M
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   OHTA A, 1989, BRAIN RES, V498, P195, DOI 10.1016/0006-8993(89)90421-6
   PARK JW, 1996, J GERONTOL, V51, P337
   SOHAL RS, 1989, ADV EXP MED BIOL, V266, P17
   TAKEDA T, 1994, INT CONGR SER, V1062, P15
   XIAO PG, 1993, J ETHNOPHARMACOL, V38, P167, DOI 10.1016/0378-8741(93)90012-T
   YAGI H, 1989, J NEUROPATH EXP NEUR, V48, P577, DOI 10.1097/00005072-198909000-00008
   Yim TK, 1998, PLANTA MED, V64, P607, DOI 10.1055/s-2006-957531
   Zhang Hongen, 1999, Journal of Environmental Pathology Toxicology and Oncology, V18, P127
NR 26
TC 36
Z9 43
U1 1
U2 6
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0192-415X
J9 AM J CHINESE MED
JI Am. J. Chin. Med.
PY 2003
VL 31
IS 2
BP 171
EP 179
DI 10.1142/S0192415X03000862
PG 9
WC Integrative & Complementary Medicine; Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Integrative & Complementary Medicine; General & Internal Medicine
GA 694QA
UT WOS:000183784300002
PM 12856856
DA 2024-02-19
ER

PT J
AU Mak, KM
   Chu, E
   Lau, KHV
   Kwong, AJ
AF Mak, Ki M.
   Chu, Edward
   Lau, K. H. Vincent
   Kwong, Allison J.
TI Liver Fibrosis in Elderly Cadavers: Localization of Collagen Types I,
   III, and IV, α-Smooth Muscle Actin, and Elastic Fibers
SO ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY
   BIOLOGY
LA English
DT Article
DE elderly cadaveric liver; collagens; a-smooth muscle actin; hepatic
   stellate cells; myofibroblasts; elastic fibers
ID FIBROTIC HUMAN; PERIVENULAR FIBROSIS; HEPATITIS-C; DISEASE; CELLS;
   ULTRASTRUCTURE; EXPRESSION
AB We have shown a high prevalence of liver fibrosis in elderly cadavers with diverse causes of death by Sirius red stain; however, the various collagen types in these samples have yet to be evaluated. To further characterize the histopathology of the fibrotic lesions in the livers of these elderly cadavers, this study used immunohistochemistry and histochemistry to identify the principal collagens produced in liver fibrosis, fibrogenic cells and elastic fibers. Collagen I and III immunoreactions were found to colocalize in collagen fibers of fibrotic central veins, perisinusoidal fibrotic foci, portal tract stroma, and fibrous septa. a-Smooth muscle actin-expressing perisinusoidal hepatic stellate cells (HSCs), as well as perivenular, portal, and septal myofibroblasts, were closely associated with collagen fibers, reflecting their fibrogenic functions. HSCs and myofibroblasts were also noted to express collagen IV, which may contribute to production of basal lamina-like structures. In fibrotic livers, the sinusoidal lining showed variable immunostaining for collagen IV. Collagen IV immunostaining revealed vascular proliferation and atypical ductular reaction at the portalseptal parenchymal borders, as well as capillary-like vessels in the lobular parenchyma. While elastic fibers were absent in the space of Disse, they were found to codistribute with collagens in portal tracts, fibrous septa and central veins. Our combined assessment of collagen types, HSCs, myofibroblasts, and elastic fibers is significant in understanding the histopathology of fibrosis in the aging liver. Anat Rec, 2012. (C) 2012 Wiley Periodicals, Inc.
C1 [Mak, Ki M.] Mt Sinai Sch Med, Ctr Anat & Funct Morphol, Dept Med Educ, New York, NY 10029 USA.
   [Mak, Ki M.; Chu, Edward; Lau, K. H. Vincent; Kwong, Allison J.] Mt Sinai Sch Med, Dept Medcial Educ, New York, NY 10029 USA.
C3 Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at
   Mount Sinai
RP Mak, KM (corresponding author), Mt Sinai Sch Med, Ctr Anat & Funct Morphol, Dept Med Educ, Box 1007,1 Gustave L Levy Pl, New York, NY 10029 USA.
EM ki.mak@mssm.edu
OI Lau, K. H. Vincent/0000-0003-1416-5589; Kwong,
   Allison/0000-0002-3874-6612
CR Cassiman D, 2002, J HEPATOL, V36, P200, DOI 10.1016/S0168-8278(01)00260-4
   CLEMENT B, 1986, HEPATOLOGY, V6, P225, DOI 10.1002/hep.1840060212
   Davis GL, 2010, GASTROENTEROLOGY, V138, P513, DOI 10.1053/j.gastro.2009.09.067
   DESMET V, 1995, PATHOL RES PRACT, V191, P513, DOI 10.1016/S0344-0338(11)80870-8
   Fox M, 2011, REV CLIN GERONTOL, V21, P1, DOI 10.1017/S0959259810000365
   Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007
   Friedman SL, 2003, J HEPATOL, V38, pS38, DOI 10.1016/S0168-8278(02)00429-4
   Frith J, 2010, MATURITAS, V65, P210, DOI 10.1016/j.maturitas.2009.11.010
   Gan L, 2011, CURR GERONTOL GERIAT, V2011
   GEERTS A, 1990, HEPATOLOGY, V12, P233, DOI 10.1002/hep.1840120209
   GRIMAUD JA, 1980, J HISTOCHEM CYTOCHEM, V28, P1145, DOI 10.1177/28.11.7000887
   Gulubova MV, 2000, HISTOCHEM J, V32, P151, DOI 10.1023/A:1004043206422
   HAHN E, 1980, GUT, V21, P63, DOI 10.1136/gut.21.1.63
   JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772
   LOPEZDELEON A, 1985, J HISTOCHEM CYTOCHEM, V33, P737, DOI 10.1177/33.8.2410480
   Lorena D, 2004, LAB INVEST, V84, P203, DOI 10.1038/labinvest.3700023
   Mak K.M., 1993, INT FALK S, V71, P167
   Mak KM, 2012, ANAT REC, V295, P40, DOI 10.1002/ar.21525
   MAK KM, 1986, ARCH PATHOL LAB MED, V110, P513
   Martín-Carbonero L, 2004, CLIN INFECT DIS, V38, P128, DOI 10.1086/380130
   McLean AJ, 2003, J PATHOL, V200, P112, DOI 10.1002/path.1328
   NAKANO M, 1982, GASTROENTEROLOGY, V83, P777
   NAKANO M, 1982, AM J PATHOL, V106, P145
   Nakayama H, 2008, HISTOL HISTOPATHOL, V23, P407, DOI 10.14670/HH-23.407
   PORTO LC, 1990, ANAT RECORD, V228, P392, DOI 10.1002/ar.1092280405
   PORTO LC, 1990, PATHOL RES PRACT, V186, P668, DOI 10.1016/S0344-0338(11)80232-3
   Ramadori G, 2004, LAB INVEST, V84, P153, DOI 10.1038/labinvest.3700030
   Ren CL, 2003, J HEPATOL, V38, P770, DOI 10.1016/S0168-8278(03)00144-2
   ROJKIND M, 1976, P NATL ACAD SCI USA, V73, P539, DOI 10.1073/pnas.73.2.539
   Rudolph R, 1979, GASTROENTEROLOGY, V44, P239
   SCHAFFNER F, 1963, GASTROENTEROLOGY, V44, P239
   Seitz HK, 2007, CLIN GERIATR MED, V23, P905, DOI 10.1016/j.cger.2007.06.010
   Sell S, 1998, HEPATOLOGY, V27, P317, DOI 10.1002/hep.510270202
   Wells RG., 2007, TXB HEPATOLOGY, P264
NR 34
TC 23
Z9 28
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-8486
EI 1932-8494
J9 ANAT REC
JI Anat. Rec.
PD JUL
PY 2012
VL 295
IS 7
BP 1159
EP 1167
DI 10.1002/ar.22504
PG 9
WC Anatomy & Morphology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Anatomy & Morphology
GA 958LI
UT WOS:000305238200010
PM 22644959
DA 2024-02-19
ER

PT J
AU Zhang, Y
   Shi, CC
   Zhang, HP
   Li, GQ
   Li, SS
AF Zhang, Yi
   Shi, Cheng-Cheng
   Zhang, Hua-Peng
   Li, Gong-Quan
   Li, Shan-Shan
TI MLN4924 suppresses neddylation and induces cell cycle arrest,
   senescence, and apoptosis in human osteosarcoma
SO ONCOTARGET
LA English
DT Article
DE osteosarcoma; neddylation; MLN4924
ID NEDD8-ACTIVATING ENZYME-INHIBITOR; CULLIN-RING LIGASES; PROTEIN
   NEDDYLATION; LIVER-CANCER; HEPATOCELLULAR-CARCINOMA; BCL-2 INHIBITORS;
   UBIQUITIN LIGASE; NEDD8; THERAPY; PATHWAY
AB Neddylation is a post-translational protein modification process associated with carcinogenesis and cancer development. MLN4924, a pharmaceutical neddylation inhibitor, induces potent anti-cancer effects in multiple types of cancers. In this study, we investigated the effects of MLN4924 on human osteosarcoma (OS). Levels of both NEDD8 activating enzyme E1 (NAE1) and ubiquitin-conjugating enzyme E2M (Ube2M), two critical components of the neddylation pathway, were much higher in OS tissues and cells than in normal osseous tissues and cells. MLN4924 treatment led to DNA damage, reduced cell viability, senescence and apoptosis in OS cells. Moreover, MLN4924 inhibited OS xenograft tumor growth in mice. Mechanistically, MLN4924 blocked the neddylation of cullins and induced accumulation of several tumor-suppressive substrates of Cullin-RING E3 ubiquitin ligases (CRLs), including CDT1, Wee1, p21, p27, Noxa, and p16. These results suggest clinical studies investigating the utility of MLN4924 for the treatment of OS are warranted.
C1 [Zhang, Yi] Zhengzhou Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Zhengzhou, Henan, Peoples R China.
   [Zhang, Yi; Shi, Cheng-Cheng] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.
   [Shi, Cheng-Cheng] Zhengzhou Univ, Affiliated Hosp 1, Dept Pharm, Zhengzhou, Henan, Peoples R China.
   [Zhang, Hua-Peng; Li, Gong-Quan] Zhengzhou Univ, Affiliated Hosp 1, Dept Hepatobiliary & Pancreat Surg, Zhengzhou, Henan, Peoples R China.
   [Zhang, Hua-Peng; Li, Gong-Quan] Zhengzhou Univ, Affiliated Hosp 1, Open & Key Lab Hepatobiliary & Pancreat Surg, Zhengzhou, Henan, Peoples R China.
   [Zhang, Hua-Peng; Li, Gong-Quan] Zhengzhou Univ, Affiliated Hosp 1, Digest Organ Transplantat Henan Univ, Zhengzhou, Henan, Peoples R China.
   [Li, Shan-Shan] Zhengzhou Univ, Affiliated Hosp 1, Dept Pathol, Zhengzhou, Henan, Peoples R China.
C3 Zhengzhou University; University of Minnesota System; Zhengzhou
   University; Zhengzhou University; Zhengzhou University; Zhengzhou
   University; Zhengzhou University
RP Zhang, Y (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Zhengzhou, Henan, Peoples R China.; Zhang, Y (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.
EM zhangyimed@163.com
RI Zhang, Yi/GZG-4051-2022; Li, Shanshan/HLH-7747-2023
CR Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220
   Barbier-Torres L, 2015, ONCOTARGET, V6, P2509, DOI 10.18632/oncotarget.3191
   Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024
   Chen P, 2015, ONCOTARGET, V6, P9002, DOI 10.18632/oncotarget.3282
   Dengler MA, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.552
   Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022
   Gao Q, 2014, ONCOTARGET, V5, P7820, DOI 10.18632/oncotarget.2309
   Godbersen JC, 2014, CLIN CANCER RES, V20, P1576, DOI 10.1158/1078-0432.CCR-13-0987
   Hua W, 2015, NEURO-ONCOLOGY, V17, P1333, DOI 10.1093/neuonc/nov066
   Knorr KLB, 2015, CELL DEATH DIFFER, V22, P2133, DOI 10.1038/cdd.2015.74
   Lauricella M, 2003, CELL DEATH DIFFER, V10, P930, DOI 10.1038/sj.cdd.4401251
   Li GQ, 2016, ONCOTARGET, V7, P2462, DOI 10.18632/oncotarget.6275
   Li LH, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju083
   Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208
   Luo ZG, 2012, CANCER RES, V72, P3360, DOI 10.1158/0008-5472.CAN-12-0388
   Mackintosh C, 2013, ONCOGENE, V32, P1441, DOI 10.1038/onc.2012.153
   Merlet J, 2009, CELL MOL LIFE SCI, V66, P1924, DOI 10.1007/s00018-009-8712-7
   Milhollen MA, 2012, CANCER CELL, V21, P388, DOI 10.1016/j.ccr.2012.02.009
   Milhollen MA, 2011, CANCER RES, V71, P3042, DOI 10.1158/0008-5472.CAN-10-2122
   Milhollen MA, 2010, BLOOD, V116, P1515, DOI 10.1182/blood-2010-03-272567
   Nawrocki ST, 2013, CLIN CANCER RES, V19, P3577, DOI 10.1158/1078-0432.CCR-12-3212
   Nawrocki ST, 2012, EXPERT OPIN INV DRUG, V21, P1563, DOI 10.1517/13543784.2012.707192
   Ohh M, 2002, EMBO REP, V3, P177, DOI 10.1093/embo-reports/kvf028
   Olivero M, 2014, ONCOTARGET, V5, P5992, DOI 10.18632/oncotarget.2042
   Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414
   Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547
   Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183
   Soucy Teresa A, 2010, Genes Cancer, V1, P708, DOI 10.1177/1947601910382898
   Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884
   Swords RT, 2015, BRIT J HAEMATOL, V169, P534, DOI 10.1111/bjh.13323
   Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137
   Wang YC, 2015, CANCER BIOL THER, V16, P420, DOI 10.1080/15384047.2014.1003003
   Wittenburg LA, 2012, J CELL BIOCHEM, V113, P773, DOI 10.1002/jcb.23403
   Xie P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4733
   Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129
   Zhang SJ, 2012, CELL SIGNAL, V24, P1803, DOI 10.1016/j.cellsig.2012.05.009
   Zhang Y, 2015, ONCOTARGET, V6, P44274, DOI 10.18632/oncotarget.6236
   Zhao YC, 2014, ANTIOXID REDOX SIGN, V21, P2383, DOI 10.1089/ars.2013.5795
NR 38
TC 36
Z9 38
U1 0
U2 7
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
EI 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD JUL 19
PY 2016
VL 7
IS 29
BP 45263
EP 45274
DI 10.18632/oncotarget.9481
PG 12
WC Oncology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Cell Biology
GA DY8SX
UT WOS:000385402300034
PM 27223074
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Vijg, J
   Dolle, MET
   Martus, HJ
   Boerrigter, METI
AF Vijg, J
   Dolle, MET
   Martus, HJ
   Boerrigter, METI
TI Transgenic mouse models for studying mutations in vivo: applications in
   aging research
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article; Proceedings Paper
CT 1st International NILS Workshop on Longevity Sciences - The Role of
   Molecular Genetics in Longevity Sciences
CY NOV   29, 1996
CL OBU, JAPAN
SP Natl Inst Longev Sci
DE aging; mutation; transgenic mice
ID SOMATIC MUTATION; MICE; AGE; INVIVO; GENE; FREQUENCY; RESTRICTION;
   CHROMOSOME; DELETIONS; DAMAGE
AB To study mutation accumulation in the DNA of somatic cells and tissues during aging in vivo, a transgenic mouse model has been constructed. The model harbors plasmid vectors, containing the lacZ reporter gene, integrated head to tail at various chromosomal locations. Procedures have been worked out to efficiently recover the plasmids into E. coli host cells. A positive selection system, permitting only E. coli cells with a lacZ mutated plasmid to grow, allows for the accurate determination of mutation frequencies as the ratio of mutant colonies versus the total number of transformants, i.e., the total number of plasmid copies recovered. Results obtained from a life span study of plasmid mice with vector clusters on chromosome 3 and 4 indicated age-related mutation accumulation in the liver, but not in the brain. Comparison of the mutational spectra revealed a significantly larger proportion of large size-change mutations in liver than in brain.
C1 HARVARD UNIV,INST MED,BETH ISRAEL DEACONESS MED CTR,BOSTON,MA 02115.
C3 Harvard University; Beth Israel Deaconess Medical Center
RP Vijg, J (corresponding author), HARVARD UNIV,SCH MED,DIV AGING,SUITE 921,AVE LOUIS PASTEUR,BOSTON,MA 02115, USA.
FU NIA NIH HHS [1 P30 AG13314-01, P01 1801 AG10829-01] Funding Source:
   Medline; NIEHS NIH HHS [1 R01 ES/CA 08797-01] Funding Source: Medline
CR ALBERTINI RJ, 1990, ANNU REV GENET, V24, P305
   BOERRIGTER MET, IN PRESS MUTATION RE
   BOERRIGTER MET, IN PRESS ENV MOL MUT
   Bronson R.T., 1990, GENETICS AGING, P280
   BRONSON RT, 1991, GROWTH DEVELOP AGING, V55, P169
   CURTIS H, 1963, RADIAT RES, V19, P337, DOI 10.2307/3571455
   DACRUZ AD, 1997, ENVIRON MOL MUTAGEN, V29, P221
   DEBOER JG, TECHNOLOGIES DETEC 2, P411
   DEMPSEY JL, 1993, MUTAT RES, V291, P141, DOI 10.1016/0165-1161(93)90153-Q
   Dolle MET, 1996, MUTAGENESIS, V11, P111, DOI 10.1093/mutage/11.1.111
   FAILLA G, 1958, ANN NY ACAD SCI, V71, P1124, DOI 10.1111/j.1749-6632.1958.tb46828.x
   Franceschi C, 1989, Aging (Milano), V1, P3
   FUKUCHI K, 1989, P NATL ACAD SCI USA, V86, P5893, DOI 10.1073/pnas.86.15.5893
   GILLE JJP, 1994, CARCINOGENESIS, V15, P2695, DOI 10.1093/carcin/15.12.2695
   GORELICK NJ, 1995, ENVIRON MOL MUTAGEN, V25, P218, DOI 10.1002/em.2850250309
   GOSSEN J, 1993, TRENDS GENET, V9, P27, DOI 10.1016/0168-9525(93)90069-T
   GOSSEN JA, 1991, MUTAT RES, V250, P423, DOI 10.1016/0027-5107(91)90198-W
   GOSSEN JA, 1995, MUTAT RES-FUND MOL M, V331, P89, DOI 10.1016/0027-5107(95)00055-N
   GOSSEN JA, 1992, NUCLEIC ACIDS RES, V20, P3254, DOI 10.1093/nar/20.12.3254
   GOSSEN JA, 1988, NUCLEIC ACIDS RES, V16, P9343, DOI 10.1093/nar/16.19.9343
   GOSSEN JA, 1989, P NATL ACAD SCI USA, V86, P7971, DOI 10.1073/pnas.86.20.7971
   GOSSEN JA, 1993, BIOTECHNIQUES, V14, P326
   GRIST SA, 1992, MUTAT RES, V266, P189, DOI 10.1016/0027-5107(92)90186-6
   JONES IM, 1995, MUTAT RES-DNAGING G, V338, P129, DOI 10.1016/0921-8734(95)00018-2
   Kipling D, 1996, NAT GENET, V13, P78, DOI 10.1038/ng0596-78
   KITAGAWA K, 1990, J MATER SCI LETT, V9, P603, DOI 10.1007/BF00725891
   KOHLER SW, 1991, P NATL ACAD SCI USA, V88, P7958, DOI 10.1073/pnas.88.18.7958
   Leach EG, 1996, MUTAGENESIS, V11, P49, DOI 10.1093/mutage/11.1.49
   LEE AT, 1994, FASEB J, V8, P545, DOI 10.1096/fasebj.8.8.8181674
   LIU YF, 1994, P NATL ACAD SCI USA, V91, P8910, DOI 10.1073/pnas.91.19.8910
   MACPHEE DG, 1995, CANCER RES, V55, P5489
   MALAMY MH, 1966, COLD SPRING HARB SYM, V31, P189, DOI 10.1101/SQB.1966.031.01.027
   Martin GM, 1996, NAT GENET, V13, P25, DOI 10.1038/ng0596-25
   Martin GM, 1996, HUM MOL GENET, V5, P215, DOI 10.1093/hmg/5.2.215
   ONO T, 1995, MUTAT RES-DNAGING G, V338, P183, DOI 10.1016/0921-8734(95)00023-Y
   RAMSEY MJ, 1995, MUTAT RES-DNAGING G, V338, P95, DOI 10.1016/0921-8734(95)00015-X
   STREHLER BL, 1995, MUTAT RES-DNAGING G, V338, P3, DOI 10.1016/0921-8734(95)00006-R
   STUART GR, IN PRESS ENV MOL MUT
   SZILARD L, 1959, P NATL ACAD SCI USA, V45, P35
   TAO KS, 1993, P NATL ACAD SCI USA, V90, P10681, DOI 10.1073/pnas.90.22.10681
   TAYLOR R, 1994, J NIH RES, V6, P58
   VIJG J, 1993, COMP BIOCHEM PHYS B, V104, P429, DOI 10.1016/0305-0491(93)90264-6
   Weindruch R, 1996, SCI AM, V274, P46, DOI 10.1038/scientificamerican0196-46
   Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258
NR 44
TC 11
Z9 13
U1 1
U2 1
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD DEC
PY 1997
VL 98
IS 3
BP 189
EP 202
DI 10.1016/S0047-6374(97)00107-3
PG 14
WC Cell Biology; Geriatrics & Gerontology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA YB781
UT WOS:A1997YB78100002
PM 9352489
DA 2024-02-19
ER

PT J
AU Fang, WW
   Guo, J
   Cao, Y
   Wang, SY
   Pang, C
   Li, M
   Dou, L
   Man, Y
   Huang, XQ
   Shen, T
   Li, J
AF Fang, Weiwei
   Guo, Jun
   Cao, Yuan
   Wang, Shuyue
   Pang, Cheng
   Li, Meng
   Dou, Lin
   Man, Yong
   Huang, Xiuqing
   Shen, Tao
   Li, Jian
TI MicroRNA-20a-5p contributes to hepatic glycogen synthesis through
   targeting p63 to regulate p53 and PTEN expression
SO JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
LA English
DT Article
DE miR-20a-5p; glycogen synthesis; p63; p53; PTEN
ID CELLULAR SENESCENCE; INSULIN-RESISTANCE; TUMOR PROGRESSION; CANCER;
   PROLIFERATION; CELLS; LEADS; TRANSCRIPTION; MIR-20A-5P; DEFICIENCY
AB Recently, it is implicated that aberrant expression of microRNAs (miRs) is associated with insulin resistance. However, the role of miR-17 family in hepatic insulin resistance and its underlying mechanisms remain unknown. In this study, we provided mechanistic insight into the effects of miR-20a-5p, a member of miR-17 family, on the regulation of AKT/GSK pathway and glycogenesis in hepatocytes. MiR-20a-5p was down-regulated in the liver of db/db mice, and NCTC1469 cells and Hep1-6 cells treated with high glucose, accompanied by reduced glycogen content and impaired insulin signalling. Notably, inhibition of miR-20a-5p significantly reduced glycogen synthesis and AKT/GSK activation, whereas overexpression of miR-20a-5p led to elevated glycogenesis and activated AKT/GSK signalling pathway. In addition, miR-20a-5p mimic could reverse high glucose-induced impaired glycogenesis and AKT/GSK activation in NCTC1469 and Hep1-6 cells. P63 was identified as a target of miR-20a-5p by bioinformatics analysis and luciferase reporter assay. Knockdown of p63 in the NCTC1469 cells and the Hep1-6 cells by transfecting with siRNA targeting p63 could increase glycogen content and reverse miR-20a-5p inhibition-induced reduced glycogenesis and activation of AKT and GSK, suggesting that p63 participated in miR-20a-5p-mediated glycogenesis in hepatocytes. Moreover, our results indicate that p63 might directly bind to p53, thereby regulating PTEN expression and in turn participating in glycogenesis. In conclusion, we found novel evidence suggesting that as a member of miR-17 family, miR-20a-5p contributes to hepatic glycogen synthesis through targeting p63 to regulate p53 and PTEN expression.
C1 [Fang, Weiwei; Li, Jian] Chinese Acad Med Sci, Peking Union Med Coll, Grad Sch, Beijing, Peoples R China.
   [Fang, Weiwei; Guo, Jun; Cao, Yuan; Wang, Shuyue; Pang, Cheng; Li, Meng; Dou, Lin; Man, Yong; Huang, Xiuqing; Shen, Tao; Li, Jian] Beijing Inst Geriatr, Key Lab Geriatr, Beijing, Peoples R China.
   [Fang, Weiwei; Guo, Jun; Cao, Yuan; Wang, Shuyue; Pang, Cheng; Li, Meng; Dou, Lin; Man, Yong; Huang, Xiuqing; Shen, Tao; Li, Jian] Minist Hlth, Beijing Hosp, Beijing, Peoples R China.
C3 Chinese Academy of Medical Sciences - Peking Union Medical College;
   Peking Union Medical College; Beijing Hospital
RP Li, J (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Grad Sch, Beijing, Peoples R China.; Li, J (corresponding author), Beijing Inst Geriatr, Key Lab Geriatr, Beijing, Peoples R China.
EM lijian@bjhmoh.cn
RI Shen, Tao/AGP-6511-2022
OI Shen, Tao/0000-0001-5856-0818
FU National Basic Research Program of China [2012CB517502, 2014CB910503];
   National Natural Science Foundation of China [81070634, 81270887]
FX This work was supported by grants from National Basic Research Program
   of China (2012CB517502, 2014CB910503) and National Natural Science
   Foundation of China (81070634, 81270887).
CR Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039
   Angerstein C, 2012, MOL NEUROBIOL, V45, P520, DOI 10.1007/s12035-012-8270-0
   Arcolino FO, 2010, INT J EXP PATHOL, V91, P144, DOI 10.1111/j.1365-2613.2009.00696.x
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Bir F, 2014, MED SCI MONITOR, V20, P219, DOI 10.12659/MSM.890394
   Calvano CMC, 2014, TUMOR BIOL, V35, P7733, DOI 10.1007/s13277-014-2025-7
   Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918
   Dou L, 2015, SCI REP-UK, V5, DOI 10.1038/srep11602
   Dou L, 2015, CELL PHYSIOL BIOCHEM, V35, P1413, DOI 10.1159/000373962
   Dou L, 2013, J BIOL CHEM, V288, P22596, DOI 10.1074/jbc.M112.423145
   Fatt MP, 2014, CELL DEATH DIFFER, V21, P1546, DOI 10.1038/cdd.2014.61
   Freeman DJ, 2003, CANCER CELL, V3, P117, DOI 10.1016/S1535-6108(03)00021-7
   Guibinga GH, 2013, HUM MOL GENET, V22, P4502, DOI 10.1093/hmg/ddt298
   Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993
   He AB, 2007, MOL ENDOCRINOL, V21, P2785, DOI 10.1210/me.2007-0167
   Hossain A, 2006, MOL CELL BIOL, V26, P8191, DOI 10.1128/MCB.00242-06
   Jiang ZY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094639
   Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305
   Koga F, 2003, CLIN CANCER RES, V9, P5501
   Leao M, 2015, EXP CELL RES, V330, P164, DOI 10.1016/j.yexcr.2014.09.028
   Li AG, 2006, MOL CELL, V23, P575, DOI 10.1016/j.molcel.2006.06.028
   Li Y, 2007, ONCOGENE, V26, P2220, DOI 10.1038/sj.onc.1210311
   Ling HY, 2009, CLIN EXP PHARMACOL P, V36, pe32, DOI 10.1111/j.1440-1681.2009.05207.x
   Masse I, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.62
   Meira M, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/897249
   Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026
   Nakanishi A, 2014, INT J ONCOL, V44, P1813, DOI 10.3892/ijo.2014.2377
   Ng WL, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.563
   Puszynski K, 2008, J THEOR BIOL, V254, P452, DOI 10.1016/j.jtbi.2008.05.039
   Rezaei M, 2014, HYPERTENSION, V64, P860, DOI 10.1161/HYPERTENSIONAHA.114.00002
   Ryu HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017343
   Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9
   Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459
   Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112
   Urist MJ, 2002, AM J PATHOL, V161, P1199, DOI 10.1016/S0002-9440(10)64396-9
   Vandormael-Pournin S, 2015, CELL DEATH DIFFER, V22, P108, DOI 10.1038/cdd.2014.122
   Vasilatou D, 2013, LEUKEMIA RES, V37, P251, DOI 10.1016/j.leukres.2012.11.011
   Wang IK, 2015, LIFE SCI, V136, P133, DOI 10.1016/j.lfs.2015.07.002
   Wen Y, 2015, INT J CANCER, V137, P1679, DOI 10.1002/ijc.29544
   Xu Q, 2013, BMC CLIN PATHOL, V13, DOI 10.1186/1472-6890-13-11
   Yang WM, 2015, MOL NUTR FOOD RES, V59, P2303, DOI 10.1002/mnfr.201500107
   Yao Jeng-Yuan, 2012, Biomed J, V35, P457, DOI 10.4103/2319-4170.104410
   Ye SB, 2014, ONCOTARGET, V5, P5439, DOI 10.18632/oncotarget.2118
   Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079
   Yu ZR, 2014, ONCOTARGET, V5, P1083, DOI 10.18632/oncotarget.1804
   Zhang JX, 2013, LANCET ONCOL, V14, P1295, DOI 10.1016/S1470-2045(13)70491-1
   Zhao K, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0137-1
   Zhi F, 2015, NEURO-ONCOLOGY, V17, P383, DOI 10.1093/neuonc/nou169
   Zhong L, 2014, BIOMED RES INT-UK, V2014, DOI 10.1155/2014/291280
   Zhou MX, 2003, CANCER RES, V63, P6357
   Zhu YN, 2015, INT J GYNECOL OBSTET, V130, P49, DOI 10.1016/j.ijgo.2015.01.010
NR 51
TC 37
Z9 38
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
EI 1582-4934
J9 J CELL MOL MED
JI J. Cell. Mol. Med.
PD AUG
PY 2016
VL 20
IS 8
BP 1467
EP 1480
DI 10.1111/jcmm.12835
PG 14
WC Cell Biology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Research & Experimental Medicine
GA DW4CE
UT WOS:000383588900006
PM 27019188
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Ejaz, A
   Epperly, MW
   Hou, W
   Greenberger, JS
   Rubin, JP
AF Ejaz, Asim
   Epperly, Michael W.
   Hou, Wen
   Greenberger, Joel S.
   Rubin, J. Peter
TI Adipose-Derived Stem Cell Therapy Ameliorates Ionizing Irradiation
   Fibrosis via Hepatocyte Growth Factor-Mediated Transforming Growth
   Factor-β Downregulation and Recruitment of Bone Marrow Cells
SO STEM CELLS
LA English
DT Article
DE Adipose-derived stem cells; Radiation; Fibrosis; Skin; Transforming
   growth factor; Hepatocyte growth factor
ID SMALL GTPASE DIRAS3; PULMONARY-FIBROSIS; IN-VITRO; TISSUE; SKIN;
   MIGRATION; GROWTH-FACTOR-BETA-1; FIBROGENESIS; FIBROBLASTS; SENESCENCE
AB Radiation therapy to anatomic regions, including the head and neck, chest wall, and extremities, can produce radiation-induced fibrosis (RIF). To elucidate the cellular and molecular mechanism(s) involved in RIF, female C57BL/6J mice were irradiated to the right flank to 35 Gy in single fraction using 6 Mv electrons. Radiation fibrosis was detected by day 14, was increased by day 28, and confirmed by Masson's trichrome histological staining for collagen. Biopsied tissue at day 14 showed an increase in expression of fibrosis-related genes including transforming growth factor-beta (TGF-beta) and collagens 1-6. A single adipose-derived stem cell (ASC) injection on day 28 at the irradiated site decreased by day 40: epithelial thickness, collagen deposition, and significantly improved limb excursion compared with irradiated controls. Noncontact transwell coculture of ASCs above a monolayer of irradiated human foreskin fibroblasts downregulated fibrosis-related genes TGF-beta, connective tissue growth factor, interleukin-1, NF-kB, tumor necrosis factor, and collagens 1-6. Hepatocyte growth factor (HGF) secreted by ASCs was identified as a novel mechanism by which ASCs exert antifibrotic effects by downregulating fibrotic gene expression in irradiated cells and recruiting bone marrow cells to the irradiated site. In conclusion, these data indicate a mechanistic role of HGF secreted by ASCs in reducing RIF. Stem Cells 2019;37:791-802
C1 [Ejaz, Asim; Rubin, J. Peter] Univ Pittsburgh, Med Ctr, Dept Plast Surg, 3550 Terrace St,6B Scaife Hall, Pittsburgh, PA 15261 USA.
   [Epperly, Michael W.; Hou, Wen; Greenberger, Joel S.] Univ Pittsburgh, Inst Canc, Dept Radiat Oncol, Pittsburgh, PA USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); University
   of Pittsburgh; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); University of Pittsburgh
RP Rubin, JP (corresponding author), Univ Pittsburgh, Med Ctr, Dept Plast Surg, 3550 Terrace St,6B Scaife Hall, Pittsburgh, PA 15261 USA.
EM rubinjp@upmc.edu
RI Rubin, J Peter/IUN-2187-2023; Ejaz, Asim/J-9236-2019
OI Greenberger, Joel/0000-0003-2271-7566
FU CMCR NIAID/NIH [U19A168021]; NCI/NIH [R01-CA114246-08A1]
FX This study was supported by CMCR NIAID/NIH Grant U19A168021 and NCI/NIH
   Grant R01-CA114246-08A1.
CR Akita S, 2012, RADIAT PROT DOSIM, V151, P656, DOI 10.1093/rpd/ncs176
   Akita S, 2014, ADV WOUND CARE, V3, P1, DOI 10.1089/wound.2012.0403
   ARCANGEL.G, 1974, BRIT J RADIOL, V47, P44, DOI 10.1259/0007-1285-47-553-44
   BARCELLOSHOFF MH, 1993, CANCER RES, V53, P3880
   Bentzen SM, 2006, NAT REV CANCER, V6, P702, DOI 10.1038/nrc1950
   Berhane H, 2013, IN VIVO, V27, P571
   Bessout R, 2015, J PATHOL, V237, P435, DOI 10.1002/path.4590
   Borovikova AA, 2018, ANN PLAS SURG, V80, P297, DOI 10.1097/SAP.0000000000001278
   Brand RM, 2017, J INVEST DERMATOL, V137, P576, DOI 10.1016/j.jid.2016.09.033
   Cavinato M, 2017, J GERONTOL A-BIOL, V72, P632, DOI 10.1093/gerona/glw150
   Citrin DE, 2017, RADIAT RES, V188, P1, DOI 10.1667/RR14784.1
   Collino M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/569623
   Dörr W, 2001, RADIOTHER ONCOL, V61, P223, DOI 10.1016/S0167-8140(01)00429-7
   Ejaz A, 2017, AGING-US, V9, P860, DOI 10.18632/aging.101197
   Ejaz A, 2016, EBIOMEDICINE, V6, P149, DOI 10.1016/j.ebiom.2016.03.030
   Epperly MW, 2006, IN VIVO, V20, P573
   Faghahati S, 2010, ANN CHIR PLAST ESTH, V55, P169, DOI 10.1016/j.anplas.2009.05.004
   Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018
   Flanders KC, 2002, AM J PATHOL, V160, P1057, DOI 10.1016/S0002-9440(10)64926-7
   Gallet P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029399
   Giannopoulou M, 2008, AM J PATHOL, V173, P30, DOI 10.2353/ajpath.2008.070583
   GREENBERGER JS, 1983, P NATL ACAD SCI-BIOL, V80, P2931, DOI 10.1073/pnas.80.10.2931
   Gronhoj C, 2017, TRIALS, V18, DOI 10.1186/s13063-017-1856-0
   Haubner F, 2015, INT J MOL SCI, V16, P25947, DOI 10.3390/ijms161125935
   Haubner F, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-66
   Hoerl S, 2017, STEM CELL RES, V22, P1, DOI 10.1016/j.scr.2017.05.004
   Hsiao STF, 2012, STEM CELLS DEV, V21, P2189, DOI 10.1089/scd.2011.0674
   Huang SP, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-51
   Inoue T, 2002, FASEB J, V16, P268, DOI 10.1096/fj.02-0442fje
   Jensen DH, 2014, OR SURG OR MED OR PA, V117, P335, DOI 10.1016/j.oooo.2013.11.496
   Kalash R, 2013, RADIAT RES, V180, P474, DOI 10.1667/RR3233.1
   Khonji N, 2010, BRIT J SURG, V97, P795, DOI 10.1002/bjs.7101
   Kolle SFT, 2013, LANCET, V382, P1113, DOI 10.1016/S0140-6736(13)61410-5
   Kolle SFT, 2012, J PLAST SURG HAND SU, V46, P59, DOI 10.3109/2000656X.2012.668326
   Kucia M, 2006, ARCH IMMUNOL THER EX, V54, P121, DOI 10.1007/s00005-006-0015-1
   Liu YH, 2004, AM J PHYSIOL-RENAL, V287, pF7, DOI 10.1152/ajprenal.00451.2003
   Marcelin G, 2017, CELL METAB, V25, P673, DOI 10.1016/j.cmet.2017.01.010
   Minteer D, 2013, ADV BIOCHEM ENG BIOT, V129, P59, DOI 10.1007/10_2012_146
   Minteer DM, 2015, CLIN PLAST SURG, V42, P169, DOI 10.1016/j.cps.2014.12.007
   Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076
   Mizuno H, 2010, AESTHET SURG J, V30, P381, DOI 10.1177/1090820X10373063
   Mou S, 2009, KAOHSIUNG J MED SCI, V25, P577, DOI 10.1016/S1607-551X(09)70560-1
   Nakamura T, 2011, J GASTROEN HEPATOL, V26, P188, DOI 10.1111/j.1440-1746.2010.06549.x
   Ohnishi S, 2007, FEBS LETT, V581, P3961, DOI 10.1016/j.febslet.2007.07.028
   RANDALL K, 1995, INT J RADIAT BIOL, V68, P301, DOI 10.1080/09553009514551231
   Riccobono D, 2016, HEALTH PHYS, V111, P117, DOI 10.1097/HP.0000000000000515
   Riccobono D, 2012, HEALTH PHYS, V103, P120, DOI 10.1097/HP.0b013e318240595b
   Rigotti G, 2007, PLAST RECONSTR SURG, V119, P1409, DOI 10.1097/01.prs.0000256047.47909.71
   Rosu-Myles M, 2005, J CELL SCI, V118, P4343, DOI 10.1242/jcs.02555
   Shukla L, 2015, FRONT SURG, V2, DOI 10.3389/fsurg.2015.00001
   Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271
   Suga H, 2010, PLAST RECONSTR SURG, V126, P1911, DOI 10.1097/PRS.0b013e3181f4468b
   Suga H, 2009, STEM CELLS, V27, P238, DOI 10.1634/stemcells.2008-0261
   Sultan SM, 2011, PLAST RECONSTR SURG, V128, P363, DOI 10.1097/PRS.0b013e31821e6e90
   Thanik VD, 2011, PLAST RECONSTR SURG, V127, P560, DOI 10.1097/PRS.0b013e3181fed4f7
   Xin XH, 2001, AM J PATHOL, V158, P1111, DOI 10.1016/S0002-9440(10)64058-8
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Zhu YX, 2008, CELL BIOCHEM FUNCT, V26, P664, DOI 10.1002/cbf.1488
NR 58
TC 24
Z9 27
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1066-5099
EI 1549-4918
J9 STEM CELLS
JI Stem Cells
PD JUN
PY 2019
VL 37
IS 6
BP 791
EP 802
DI 10.1002/stem.3000
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology;
   Oncology; Cell Biology; Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology
GA IG8IB
UT WOS:000474038500010
PM 30861238
OA Bronze, Green Accepted
DA 2024-02-19
ER

PT J
AU Makwana, K
   Patel, SA
   Velingkaar, N
   Ebron, JS
   Shukla, GC
   Kondratov, RV
AF Makwana, Kuldeep
   Patel, Sonal Arvind
   Velingkaar, Nikkhil
   Ebron, Jey Sabith
   Shukla, Girish C.
   Kondratov, Roman V.
TI Aging and calorie restriction regulate the expression of miR-125a-5p and
   its target genes <i>Stat3</i>, <i>Casp2</i> and <i>Stard13</i>
SO AGING-US
LA English
DT Article
DE MicroRNA; transcription; calorie restriction; aging; longevity
ID AGE-ASSOCIATED CHANGES; INSULIN-RESISTANCE; OXIDATIVE STRESS;
   SKELETAL-MUSCLE; APOPTOSIS; MICRORNA; MIRNAS; RECEPTOR; LIVER;
   DEGRADATION
AB Calorie restriction (CR) is a dietary intervention known to delay aging. In order, to understand molecular mechanisms of CR, we analyzed the expression of 983 MicroRNAs (miRNAs) in the liver of female mice after 2 years of 30% CR using micro-array. 16 miRNAs demonstrated significant changes in their expression upon CR in comparison with age-matched control. mmu-miR-125a-5p (miR-125a-5p) was significantly upregulated upon CR, and in agreement with this, the expression of mRNAs for its three predicted target genes: Stat3, Casp2, and Stard13 was significantly downregulated in the liver of CR animals. The expression of precursor miRNA for miR-125a-5p was also upregulated upon CR, which suggests its regulation at the level of transcription. Upon aging miR-125a-5p expression was downregulated while the expression of its target genes was upregulated. Thus, CR prevented age-associated changes in the expression of miR-125a-5p and its targets. We propose that miR-125a-5p dependent downregulation of Stat3, Casp2, and Stard13 contributes to the calorie restriction-mediated delay of aging.
C1 [Makwana, Kuldeep; Patel, Sonal Arvind; Velingkaar, Nikkhil; Ebron, Jey Sabith; Shukla, Girish C.; Kondratov, Roman V.] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA.
   [Makwana, Kuldeep; Patel, Sonal Arvind; Velingkaar, Nikkhil; Ebron, Jey Sabith; Shukla, Girish C.; Kondratov, Roman V.] Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA.
C3 University System of Ohio; Cleveland State University; University System
   of Ohio; Cleveland State University
RP Kondratov, RV (corresponding author), Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA.; Kondratov, RV (corresponding author), Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA.
EM r.kondratov@csuohio.edu
RI Patel, Sonal/ABI-8347-2020; Makwana, Kuldeep/AAD-9386-2022; Velingkaar,
   Nikkhil/ABC-8132-2020
OI Patel, Sonal/0000-0003-2268-6114; Makwana, Kuldeep/0000-0003-0890-8120;
   Velingkaar, Nikkhil/0000-0003-1571-0833; Shukla,
   Girish/0000-0003-1982-2218; Kondratov, Roman/0000-0003-3449-745X; Ebron,
   Jey Sabith/0000-0002-5820-4175
FU NIH [2R01AG039547]; GRHD center at Cleveland State University;
   department of defense prostate cancer research program
   [W81XWH-14-1-0508, W81XWH-14-1-0509]
FX This work is funded by NIH grant 2R01AG039547 and GRHD center at
   Cleveland State University to RVK. Research in GCS lab is supported by
   the grants W81XWH-14-1-0508 and W81XWH-14-1-0509 from the department of
   defense prostate cancer research program.
CR Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031
   Barneda-Zahonero B, 2012, MOL ONCOL, V6, P579, DOI 10.1016/j.molonc.2012.07.003
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Bhattacharjya S, 2013, CELL DEATH DIFFER, V20, P430, DOI 10.1038/cdd.2012.135
   Bonomini F, 2015, AGING DIS, V6, P109, DOI 10.14336/AD.2014.0305
   Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9
   Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035
   Chen T, 2009, CARDIOVASC RES, V83, P131, DOI 10.1093/cvr/cvp121
   Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060
   Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102
   Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635
   Dhahbi JM, 2013, AGING-US, V5, P130, DOI 10.18632/aging.100540
   Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203
   Figueredo DD, 2015, BLOOD CELL MOL DIS, V54, P364, DOI 10.1016/j.bcmd.2015.01.004
   FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908
   Guarente L, 2013, GENE DEV, V27, P2072, DOI 10.1101/gad.227439.113
   Heilbronn LK, 2003, AM J CLIN NUTR, V78, P361, DOI 10.1093/ajcn/78.3.361
   Hsieh TH, 2015, ONCOTARGET, V6, P494, DOI 10.18632/oncotarget.2674
   Jiang LL, 2011, EXP LUNG RES, V37, P387, DOI 10.3109/01902148.2010.492068
   Kato M, 2013, AGEING RES REV, V12, P429, DOI 10.1016/j.arr.2012.03.012
   Kim JH, 2008, J BIOL CHEM, V283, P708, DOI 10.1074/jbc.M708568200
   Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098
   Larson-Meyer DE, 2006, DIABETES CARE, V29, P1337, DOI 10.2337/dc05-2565
   Lee Changhan., 2016, F1000Research, V5, DOI [10.12688/f1000research.7136.1, DOI 10.12688/F1000RESEARCH.7136.1]
   Lee JH, 2004, EXP GERONTOL, V39, P1361, DOI 10.1016/j.exger.2004.06.015
   LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y
   Lee S, 2015, J GERIATR CARDIOL, V12, P569, DOI 10.11909/j.issn.1671-5411.2015.05.011
   Li D., 2015, SCI REP, V5, P6, DOI DOI 10.1007/S12598-015-0553-Y
   Li N, 2011, MECH AGEING DEV, V132, P75, DOI 10.1016/j.mad.2010.12.004
   Lopez-Cruzan M, 2013, BIOGERONTOLOGY, V14, P121, DOI 10.1007/s10522-013-9415-x
   López-Lluch G, 2016, J PHYSIOL-LONDON, V594, P2043, DOI 10.1113/JP270543
   Maes OC, 2008, MECH AGEING DEV, V129, P534, DOI 10.1016/j.mad.2008.05.004
   Mercken EM, 2013, AGING-US, V5, P692, DOI 10.18632/aging.100598
   Mori MA, 2012, CELL METAB, V16, P336, DOI 10.1016/j.cmet.2012.07.017
   Omodei D, 2011, FEBS LETT, V585, P1537, DOI 10.1016/j.febslet.2011.03.015
   Ortman BJM, 2014, EC STAT ADM US DEP C, V1964, P1
   Patel SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep25970
   Phelouzat MA, 1995, APOPTOSIS AGING M S
   Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076
   Prasannarong M, 2012, BBA-MOL BASIS DIS, V1822, P1051, DOI 10.1016/j.bbadis.2012.02.018
   Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015
   Riehl A, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-12
   Rodríguez-Rodero S, 2011, AGING DIS, V2, P186
   Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200
   Seals D.R., 2015, J. Physiol, DOI DOI 10.1113/JPHYSIOL.2014.282665
   Shende VR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022586
   Smith-Vikos T, 2012, J CELL SCI, V125, P7, DOI 10.1242/jcs.099200
   Tang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035435
   Tang L, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.41
   Thomas RP, 2002, J GASTROINTEST SURG, V6, P445, DOI 10.1016/S1091-255X(01)00010-5
   Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806
   Van Remmen H, 2011, COMP PHYSL S, P171
   Vickers Kasey C, 2010, Curr Opin Endocrinol Diabetes Obes, V17, P150, DOI 10.1097/MED.0b013e32833727a1
   Wang GF, 2009, FEBS J, V276, P5571, DOI 10.1111/j.1742-4658.2009.07238.x
   Weatherall D, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P119
   Weindruch R, 1996, TOXICOL PATHOL, V24, P742, DOI 10.1177/019262339602400618
   Weindruch R, 2001, J NUTR, V131, p918S, DOI 10.1093/jn/131.3.918S
   Wilsey J, 2004, J ENDOCRINOL, V181, P297, DOI 10.1677/joe.0.1810297
   Wunderlich Claudia M, 2013, JAKSTAT, V2, pe23878, DOI 10.4161/jkst.23878
   Xu MW, 2017, AGING DIS, V8, P277, DOI 10.14336/AD.2016.1109
   Xu X, 1996, AM J PHYSIOL, V271, P34
   Yamagishi S, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-015-0090-z
   Yau TO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006566
   Zhang JH, 2003, AGEING RES REV, V2, P357, DOI 10.1016/S1568-1637(03)00026-6
   Zhang YP, 2002, EXP GERONTOL, V37, P777, DOI 10.1016/S0531-5565(02)00013-X
NR 65
TC 23
Z9 24
U1 0
U2 12
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD JUL
PY 2017
VL 9
IS 7
BP 1825
EP 1843
DI 10.18632/aging.101270
PG 19
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA FC7VI
UT WOS:000407050000012
PM 28783714
OA gold, Green Submitted, Green Published
DA 2024-02-19
ER

PT J
AU Shimokawa, I
   Higami, Y
AF Shimokawa, I
   Higami, Y
TI Leptin signaling and aging: insight from caloric restriction
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE caloric restriction; aging; leptin; neuroendocrine; metabolic adaptation
ID NEUROPEPTIDE-Y; FOOD RESTRICTION; GENE-EXPRESSION; DIETARY RESTRICTION;
   GLUCOSE-TRANSPORT; MESSENGER-RNA; BODY-WEIGHT; SECRETION; GALANIN; RAT
AB Organisms have evolved neuroendocrine and metabolic response systems to enhance survival during periods of food shortage, which occur frequently in nature. The anti-aging effect of caloric restriction (CR) might derive from these adaptive responses to maximize organism survival. The present article discusses the potential role for leptin. a hormone secreted from adipocytes. as a key signal that induces the adaptive responses relevant to CR. Evidence indicates that a CR-induced reduction of the plasma leptin concentration suppresses the gonadal., somatotropic, and thyroidal axes, and activates the adrenal axis. Metabolic adaptation, a shift in fuel utilization mainly conducted in the liver, seems to require leptin signaling. Although alternative signaling pathways might also mediate the anti-aging effects of CR. leptin signaling could be a substantial pathway involved in these effects. Molecular dissection of the mechanisms underlying the effects of CR will contribute to a better understanding of the aging process, leading to the extension of a healthy lifespan in humans. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
C1 Nagasaki Univ, Sch Med, Dept Pathol, Nagasaki 8528523, Japan.
C3 Nagasaki University
RP Shimokawa, I (corresponding author), Nagasaki Univ, Sch Med, Dept Pathol, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.
OI Shimokawa, Isao/0000-0001-8901-1029; Higami,
   Yoshikazu/0000-0003-1381-0777
CR Adam CL, 1997, J ENDOCRINOL, V152, P329, DOI 10.1677/joe.0.1520329
   Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0
   BarkerGibb ML, 1996, NEUROENDOCRINOLOGY, V64, P194, DOI 10.1159/000127118
   Barzilai N, 1999, J GERONTOL A-BIOL, V54, pB89, DOI 10.1093/gerona/54.3.B89
   Bornstein SR, 1997, NAT MED, V3, P937, DOI 10.1038/nm0997-937
   BRADY LS, 1990, NEUROENDOCRINOLOGY, V52, P441, DOI 10.1159/000125626
   DUFFY PH, 1989, MECH AGEING DEV, V48, P117, DOI 10.1016/0047-6374(89)90044-4
   Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376
   HARRISON DE, 1984, P NATL ACAD SCI-BIOL, V81, P1835, DOI 10.1073/pnas.81.6.1835
   HOLLIDAY R, 1989, BIOESSAYS, V10, P125, DOI 10.1002/bies.950100408
   Hwang BH, 1997, BRAIN RES BULL, V43, P509, DOI 10.1016/S0361-9230(97)80004-4
   Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223
   Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411
   Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X
   MASORO EJ, 1992, J GERONTOL, V47, pB202, DOI 10.1093/geronj/47.6.B202
   Masoro EJ, 1999, J GERONTOL A-BIOL, V54, pB97, DOI 10.1093/gerona/54.3.B97
   MASORO EJ, 1996, J GERONTOL B-PSYCHOL, V51, P387
   MCCARTER RJ, 1992, AM J PHYSIOL, V263, pE448, DOI 10.1152/ajpendo.1992.263.3.E448
   McShane TM, 1999, J GERONTOL A-BIOL, V54, pB14, DOI 10.1093/gerona/54.1.B14
   NELSON JF, 1994, MODULATION AGING PRO, P37
   Phillips MS, 1996, NAT GENET, V13, P18, DOI 10.1038/ng0596-18
   Pralong FP, 1998, ENDOCRINOLOGY, V139, P4264, DOI 10.1210/en.139.10.4264
   Ranganathan S, 1998, ENDOCRINOLOGY, V139, P2509, DOI 10.1210/en.139.5.2509
   Roth GS, 1999, J AM GERIATR SOC, V47, P896, DOI 10.1111/j.1532-5415.1999.tb03851.x
   Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534
   Shimokawa I, 1999, AGING-CLIN EXP RES, V11, P380, DOI 10.1007/BF03339816
   Shimokawa I, 2001, J Nutr Health Aging, V5, P43
   SMITH SA, 1986, DIABETES RES CLIN EX, V3, P83
   Unger RH, 1999, P NATL ACAD SCI USA, V96, P2327, DOI 10.1073/pnas.96.5.2327
   Wanagat J, 1999, TOXICOL SCI, V52, P35
   Wetter TJ, 1999, AM J PHYSIOL-ENDOC M, V276, pE728
   Xu B, 1999, ENDOCRINOLOGY, V140, P2868, DOI 10.1210/en.140.6.2868
   ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0
   Zierath JR, 1998, DIABETES, V47, P1, DOI 10.2337/diabetes.47.1.1
NR 34
TC 39
Z9 44
U1 0
U2 2
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD SEP 30
PY 2001
VL 122
IS 14
BP 1511
EP 1519
DI 10.1016/S0047-6374(01)00284-6
PG 9
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 468ZT
UT WOS:000170788600002
PM 11511393
DA 2024-02-19
ER

PT J
AU LEMAY, J
   AUDET, M
   YOUSEF, IM
   TUCHWEBER, B
AF LEMAY, J
   AUDET, M
   YOUSEF, IM
   TUCHWEBER, B
TI HEPATIC DRUG-METABOLISM DURING DEVELOPMENT IN FOOD-RESTRICTED FEMALE
   SPRAGUE-DAWLEY RATS
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE DRUG METABOLISM; DIETARY RESTRICTION; DEVELOPMENT; LIVER
ID S-TRANSFERASE ACTIVITIES; FUNCTION OXIDASE SYSTEM; DIETARY RESTRICTION;
   CALORIC RESTRICTION; FISCHER-344 RAT; AGING RATS; GLUCOSE-6-PHOSPHATASE
   ACTIVITY; LIVER MICROSOMES; AGE; ENZYMES
AB Hepatic drug metabolism was investigated in female Sprague-Dawley rats fed ad libitum (A) or a restricted diet (R) (implemented from age 1 month), at 1.5, 4.5 and 12 months to determine the short- and long-term effects of caloric restriction.
   Microsomal cytochrome P-450 content and NADPH cytochrome c reductase activity were not modified by age.  While dietary restriction did not affect cytochrome P-450, it significantly increased NADPH cytochrome c reductase activity at all time periods when compared to corresponding A-fed groups.  Aniline hydroxylase and aminopyrine N-dimethylase activity tended to decrease with age in the A-fed groups but the differences did not prove to be statistically significant.  A significant decrease of aminopyrine N-demethylase was observed with age in R rats.  A significant reduction of aniline hydroxylase activity was noted in the R groups compared to age-matched A-fed controls.  In contrast, aminopyrine N-demethylase activity increased significantly, but only at 1.5 months of age.
   Glutathione S-transferase activity was augmented between 1.5 and 4.5 months of age, and this was followed by a significant decrease at age 12 months in both A and R groups.  Dietary restriction had no effect on this enzymatic activity.
   The microsomal cholesterol and phospholipid content as well as the cholesterol/phospholipid molar ratio changed significantly between 1.5 and 4.5 months of age but not between 4.5 and 12 months of age.  These parameters were unaltered by dietary restriction.
   In conclusion, in the female Sprague-Dawley rat there are no statistically significant changes in hepatic microsomal components and drug metabolizing capacity between 1.5 and 12 months of age.  Dietary restriction resulted in significant changes in enzymes related to drug metabolism which varied with the enzyme examined.  In general, these changes were similar after short- or long-term dietary intervention.
C1 UNIV MONTREAL,DEPT NUTR,CP 6128,SUCCURSALE A,MONTREAL H3C 3J7,QUEBEC,CANADA.
   UNIV MONTREAL,DEPT PHARMACOL,MONTREAL H3C 3J7,QUEBEC,CANADA.
C3 Universite de Montreal; Universite de Montreal
CR BARTLETT GR, 1959, J BIOL CHEM, V234, P466
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   CHENGELIS CP, 1988, XENOBIOTICA, V18, P1211, DOI 10.3109/00498258809042245
   CHHABRA RS, 1974, DRUG METAB DISPOS, V2, P443
   FERLAND G, 1989, LIPIDS, V24, P842, DOI 10.1007/BF02535757
   FERNANDES G, 1984, Pharmacological Reviews, V36, p123S
   FEUERS RJ, 1989, MECH AGEING DEV, V48, P179, DOI 10.1016/0047-6374(89)90049-3
   FUJITA S, 1985, BIOCHEM PHARMACOL, V34, P3891, DOI 10.1016/0006-2952(85)90440-X
   GRINNA LS, 1977, GERONTOLOGY, V23, P342, DOI 10.1159/000212206
   GRINNA LS, 1975, EXP GERONTOL, V10, P319, DOI 10.1016/0531-5565(75)90021-2
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   HASHMI RS, 1986, J NUTR, V116, P682, DOI 10.1093/jn/116.4.682
   KATO R, 1989, J BIOCH, V17, P114
   KITANI K, 1988, LIFE CHEM REPORTS, V6, P143
   KOIZUMI A, 1987, J NUTR, V117, P361, DOI 10.1093/jn/117.2.361
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P221, DOI 10.1016/0047-6374(89)90084-5
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P207, DOI 10.1016/0047-6374(89)90083-3
   LEAKEY JEA, 1989, MECH AGEING DEV, V48, P157, DOI 10.1016/0047-6374(89)90047-X
   LEAKEY JEA, 1989, MECH AGEING DEV, V48, P145, DOI 10.1016/0047-6374(89)90046-8
   MAEDA H, 1985, J GERONTOL, V40, P671, DOI 10.1093/geronj/40.6.671
   MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9
   MASORO EJ, 1985, J NUTR, V115, P842, DOI 10.1093/jn/115.7.842
   MASORO EJ, 1988, J GERONTOL, V43, pB59, DOI 10.1093/geronj/43.3.B59
   MATAKI T, 1985, J PHARMACOL EXP THER, V223, P222
   MAZEL P, 1971, FUNDAMENTALS DRUG ME, P546
   MCDONELL RE, 1985, NUTRITIONAL PATHOLOG, V10, P321
   OMURA T, 1964, J BIOL CHEM, V239, P2370
   RIKANS LE, 1989, DRUG METAB DISPOS, V17, P114
   ROTH GS, 1984, BRAIN RES, V300, P27, DOI 10.1016/0006-8993(84)91337-4
   RUTTEN AAJJL, 1987, ARCH TOXICOL, V61, P27, DOI 10.1007/BF00324544
   SACHAN DS, 1982, J NUTR, V112, P2301, DOI 10.1093/jn/112.12.2301
   SACHAN DS, 1982, BIOCHEM BIOPH RES CO, V104, P984, DOI 10.1016/0006-291X(82)91346-8
   SCHMUCKER DL, 1980, EXP GERONTOL, V15, P7, DOI 10.1016/0531-5565(80)90018-2
   SCHMUCKER DL, 1984, MECH AGEING DEV, V27, P207, DOI 10.1016/0047-6374(84)90046-0
   SCHWARTZ MORTON K., 1961, METHODS MED RES, V9, P5
   SPEARMAN ME, 1984, BIOCHEM PHARMACOL, V33, P1309, DOI 10.1016/0006-2952(84)90185-0
   TUCHWEBER B, 1987, LIFE SCI, V41, P2091, DOI 10.1016/0024-3205(87)90526-1
   VANBEZOOIJEN CFA, 1984, MECH AGEING DEV, V25, P1, DOI 10.1016/0047-6374(84)90126-X
   YANG CS, 1988, PHARMACOL THERAPEUT, V38, P53, DOI 10.1016/0163-7258(88)90102-7
NR 39
TC 1
Z9 1
U1 0
U2 2
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD SEP
PY 1991
VL 60
IS 1
BP 75
EP 87
DI 10.1016/0047-6374(91)90111-C
PG 13
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA GH764
UT WOS:A1991GH76400008
PM 1745066
DA 2024-02-19
ER

PT J
AU Tillman, JB
   Mote, PL
   Dhahbi, JM
   Walford, RL
   Spindler, SR
AF Tillman, JB
   Mote, PL
   Dhahbi, JM
   Walford, RL
   Spindler, SR
TI Dietary energy restriction in mice negatively regulates hepatic
   glucose-regulated protein 78 (GRP78) expression at the
   posttranscriptional level
SO JOURNAL OF NUTRITION
LA English
DT Article
DE energy restriction; glucose regulated protein 78; aging; mice;
   posttranscriptional regulation; mRNA stability
ID MESSENGER-RNA DEGRADATION; TRANSMEMBRANE PROTEIN; GENE-EXPRESSION;
   CELLS; INDUCTION; TRANSCRIPTION; HYBRIDIZATION; SECRETION; OXIDATION;
   CALORIES
AB Dietary energy restriction delays age-related physiologic changes, increases maximum life span, and reduces cancer incidence. We showed previously that 50% energy restriction in mice reduces hepatic expression of glucose-regulated protein mRNA by 50 to 80%. Changes in glucose-regulated protein 78 (GRP78) levels can either decrease or increase the rate of secretion of specific proteins. Therefore, energy restriction probably produces a global change in the spectrum of proteins secreted by the liver. These studies were initiated to investigate the molecular basis for the negative regulation of the gene. By use of transfection and nuclear run-on techniques, the strong induction of GRP78 gene transcription in cultured cells subjected to acute, extreme glucose deprivation has been well characterized. However, negative regulation of GRP78 gene expression in vivo by energy restriction is not as well understood. In our studies, a reduction in GRP78 protein levels determined using Western blotting closely paralleled a reduction in hepatic GRP78 mRNA measured by Northern and dot blotting. In each case the changes were statistically significant. This close correspondence indicates that energy restriction does not influence the translation rate or the stability of GRP78 protein. No statistically significant difference in the rate of transcription of the gene was detected in energy-restricted mice by use of transcription run-on assays. These results strongly suggest that energy restriction results in destabilization of GRP78 mRNA, thereby repressing hepatic expression of the gene.
C1 UNIV CALIF RIVERSIDE,DEPT BIOCHEM,RIVERSIDE,CA 92521.
   UNIV CALIF LOS ANGELES,DEPT PATHOL,SCH MED,LOS ANGELES,CA 90024.
C3 University of California System; University of California Riverside;
   University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA
OI Tillman, John/0000-0003-2912-2370
FU NIA NIH HHS [AG00424] Funding Source: Medline
CR ALY R, 1994, NUCLEIC ACIDS RES, V22, P2922, DOI 10.1093/nar/22.15.2922
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   BILIR BM, 1993, J BIOL CHEM, V268, P19776
   BRASIER AR, 1989, BIOTECHNIQUES, V7, P1116
   BRAWERMAN G, 1989, CELL, V57, P9, DOI 10.1016/0092-8674(89)90166-9
   CAO XJ, 1995, J BIOL CHEM, V270, P494, DOI 10.1074/jbc.270.1.494
   CARLSON SG, 1993, MOL CELL BIOL, V13, P4736, DOI 10.1128/MCB.13.8.4736
   CASEY JL, 1988, SCIENCE, V240, P924, DOI 10.1126/science.2452485
   COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A
   DORNER AJ, 1988, MOL CELL BIOL, V8, P4063, DOI 10.1128/MCB.8.10.4063
   DORNER AJ, 1992, EMBO J, V11, P1563, DOI 10.1002/j.1460-2075.1992.tb05201.x
   HEYDARI AR, 1995, J NUTR, V125, P410
   KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0
   LIN AY, 1984, P NATL ACAD SCI-BIOL, V81, P988, DOI 10.1073/pnas.81.4.988
   Little Edward, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P1
   LIU ES, 1992, J BIOL CHEM, V267, P7128
   MASORO EJ, 1989, J GERONTOL, V44, pB20, DOI 10.1093/geronj/44.1.B20
   MASORO EJ, 1993, J AM GERIATR SOC, V41, P994, DOI 10.1111/j.1532-5415.1993.tb06767.x
   MASORO EJ, 1983, J NUTR, V113, P880, DOI 10.1093/jn/113.4.880
   MEYER S, 1991, EUR J BIOCHEM, V202, P985, DOI 10.1111/j.1432-1033.1991.tb16460.x
   MORI K, 1993, CELL, V74, P743
   MOTE PL, 1991, J GERONTOL, V46, pB95, DOI 10.1093/geronj/46.3.B95
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   PARFETT CLJ, 1989, GENE, V82, P291, DOI 10.1016/0378-1119(89)90054-1
   PETERSEN RB, 1989, CELL REGUL, V1, P135, DOI 10.1091/mbc.1.1.135
   PROSTKO CR, 1989, BIOCHEM J, V258, P295, DOI 10.1042/bj2580295
   SACHS AB, 1993, CELL, V74, P413, DOI 10.1016/0092-8674(93)80043-E
   SEMENKOVICH CF, 1993, J BIOL CHEM, V268, P6961
   SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7
   SPINDLER SR, 1990, J NUTR, V120, P1412, DOI 10.1093/jn/120.11.1412
   SPINDLER SR, 1982, J BIOL CHEM, V257, P1627
   SPINDLER SR, 1991, J GERONTOL, V46, pB233, DOI 10.1093/geronj/46.6.B233
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201
   TILLMAN JB, 1995, GENE, V158, P225, DOI 10.1016/0378-1119(95)00083-I
   TILLMAN JB, 1996, IN PRESS J BIOL CHEM
   ULATOWSKI LM, 1993, J BIOL CHEM, V268, P7482
   WALFORD RL, 1992, P NATL ACAD SCI USA, V89, P11533, DOI 10.1073/pnas.89.23.11533
   WEINDRUCH R, 1988, RETARDATION AGING DI
   WHITE BA, 1982, J BIOL CHEM, V257, P8569
   YOUNGMAN LD, 1992, P NATL ACAD SCI USA, V89, P9112, DOI 10.1073/pnas.89.19.9112
NR 41
TC 21
Z9 22
U1 0
U2 0
PU AMER INST NUTRITION
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0022-3166
J9 J NUTR
JI J. Nutr.
PD FEB
PY 1996
VL 126
IS 2
BP 416
EP 423
DI 10.1093/jn/126.2.416
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nutrition & Dietetics
GA TU525
UT WOS:A1996TU52500007
PM 8632214
OA hybrid
DA 2024-02-19
ER

PT J
AU Zheng, J
   Wu, HZ
   Zhang, ZY
   Yao, SQ
AF Zheng, Jing
   Wu, Huizhong
   Zhang, Zhiying
   Yao, Songqiang
TI Dynamic co-expression modular network analysis in nonalcoholic fatty
   liver disease
SO HEREDITAS
LA English
DT Article
DE Fatty liver; Obesity; Gene regulatory network
ID HEPATIC INSULIN-RESISTANCE; R PACKAGE; PROGRESSION; SENSITIVITY;
   SIGNATURES; NAFLD
AB Background Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease affecting people's health worldwide. Exploring the potential biomarkers and dynamic networks during NAFLD progression is urgently important. Material and methods Differentially expressed genes (DEGs) in obesity, NAFL and NASH were screened from GSE126848 and GSE130970, respectively. Gene set enrichment analysis of DEGs was conducted to reveal the Gene Ontology (GO) biological process in each period. Dynamic molecular networks were constructed by DyNet to illustrate the common and distinct progression of health- or obesity-derived NAFLD. The dynamic co-expression modular analysis was carried out by CEMiTool to elucidate the key modulators, networks, and enriched pathways during NAFLD. Results A total of 453 DEGs were filtered from obesity, NAFL and NASH periods. Function annotation showed that health-NAFLD sequence was mainly associated with dysfunction of metabolic syndrome pathways, while obesity-NAFLD sequence exhibited dysregulation of Cell cycle and Cellular senescence pathways. Nine nodes including COL3A1, CXCL9, CYCS, CXCL10, THY1, COL1A2, SAA1, CDKN1A, and JUN in the dynamic networks were commonly identified in health- and obesity-derived NAFLD. Moreover, CYCS, whose role is unknown in NAFLD, possessed the highest correlation with NAFLD activity score, lobular inflammation grade, and the cytological ballooning grade. Dynamic co-expression modular analysis showed that module 4 was activated in NAFL and NASH, while module 3 was inhibited at NAFLD stages. Module 3 was negatively correlated with CXCL10, and module 4 was positively correlated with COL1A2 and THY1. Conclusion Dynamic network analysis and dynamic gene co-expression modular analysis identified a nine-gene signature as the potential key regulator in NAFLD progression, which provided comprehensive regulatory mechanisms underlying NAFLD progression.
C1 [Zheng, Jing; Yao, Songqiang] Hangzhou Hosp, Zhejiang Med & Hlth Grp, Dept Pharm, 1 Banshan Rd, Hangzhou 310022, Peoples R China.
   [Wu, Huizhong] Zhejiang Quhua Hosp, Dept Pharm, Quzhou 324002, Peoples R China.
   [Zhang, Zhiying] Hangzhou Jianggan Dist Peoples Hosp, Dept Pharm, Hangzhou 310016, Peoples R China.
RP Yao, SQ (corresponding author), Hangzhou Hosp, Zhejiang Med & Hlth Grp, Dept Pharm, 1 Banshan Rd, Hangzhou 310022, Peoples R China.
EM songqiangyao888@163.com
RI LIU, YU/HTR-1607-2023
CR Ahrens M, 2013, CELL METAB, V18, P296, DOI 10.1016/j.cmet.2013.07.004
   Alvarez CS, 2020, HEPATOLOGY, V72, P430, DOI 10.1002/hep.31040
   Antonucci L, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101137
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Chen F, 2021, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.611213
   Chen Y, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180719
   Chen Y, 2015, BIOCHEM BIOPH RES CO, V459, P529, DOI 10.1016/j.bbrc.2015.02.143
   Dorn C, 2010, INT J CLIN EXP PATHO, V3, P505
   Drescher HK, 2017, J HEPATOL, V66, P1251, DOI 10.1016/j.jhep.2017.02.001
   Eslam M, 2020, LANCET GASTROENTEROL, V5, P713, DOI 10.1016/S2468-1253(20)30090-X
   Goenawan IH, 2016, BIOINFORMATICS, V32, P2713, DOI 10.1093/bioinformatics/btw187
   González-Rodríguez A, 2018, MOL METAB, V7, P132, DOI 10.1016/j.molmet.2017.10.008
   Heffern MC, 2016, P NATL ACAD SCI USA, V113, P14219, DOI 10.1073/pnas.1613628113
   Hoang SA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48746-5
   Huang SZ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25658-4
   Jojima T, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205237
   Kaminsky-Kolesnikov Y, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/5393761
   Kawaguchi T, 2020, J GASTROENTEROL, V55, P363, DOI 10.1007/s00535-019-01650-1
   Lawrence M, 2009, BIOINFORMATICS, V25, P1841, DOI 10.1093/bioinformatics/btp328
   Leclerc D, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201801001
   Li DY, 2021, BIOCHEM BIOPH RES CO, V555, P54, DOI 10.1016/j.bbrc.2021.02.124
   Li L, 2019, DIABETES METAB SYNDR, V12, P969, DOI 10.2147/DMSO.S207021
   Li M, 2015, DIABETES, V64, P4023, DOI 10.2337/db14-1891
   Lou Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05044-2
   Lytle KA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173376
   Pais R, 2016, J HEPATOL, V65, P1245, DOI 10.1016/j.jhep.2016.07.033
   Pan X., 1802, FRONT IMMUNOL, V2020, P11
   Petersen MC, 2016, J CLIN INVEST, V126, P4361, DOI 10.1172/JCI86013
   Romero-Gómez M, 2017, J HEPATOL, V67, P829, DOI 10.1016/j.jhep.2017.05.016
   Russo PST, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2053-1
   Samuel VT, 2018, CELL METAB, V27, P22, DOI 10.1016/j.cmet.2017.08.002
   Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200
   Schuppan D, 2018, J HEPATOL, V68, P238, DOI 10.1016/j.jhep.2017.11.012
   Seidman JS, 2020, IMMUNITY, V52, P1057, DOI 10.1016/j.immuni.2020.04.001
   Suppli MP, 2019, AM J PHYSIOL-GASTR L, V316, pG462, DOI 10.1152/ajpgi.00358.2018
   ter Horst KW, 2017, CELL REP, V19, P1997, DOI 10.1016/j.celrep.2017.05.035
   Tomita K, 2016, SCI REP-UK, V6, DOI 10.1038/srep28786
   Valensin D, 2016, J INORG BIOCHEM, V163, P292, DOI 10.1016/j.jinorgbio.2016.04.012
   Wei LP, 2020, FOOD FUNCT, V11, P3952, DOI [10.1039/d0fo00124d, 10.1039/D0FO00124D]
   Wree A, 2014, J MOL MED, V92, P1069, DOI 10.1007/s00109-014-1170-1
   Wruck W, 2017, STEM CELLS, V35, P89, DOI 10.1002/stem.2454
   Wruck W, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.68
   Ying L, 2017, CLIN EXP PHARMACOL P, V44, P1180, DOI 10.1111/1440-1681.12844
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Zhang X, 2017, THERANOSTICS, V7, P2822, DOI 10.7150/thno.19068
   Zhang X, 2014, J HEPATOL, V61, P1365, DOI 10.1016/j.jhep.2014.07.006
NR 46
TC 4
Z9 4
U1 2
U2 10
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1601-5223
J9 HEREDITAS
JI Hereditas
PD AUG 21
PY 2021
VL 158
IS 1
AR 31
DI 10.1186/s41065-021-00196-8
PG 14
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA UD4BP
UT WOS:000687153700001
PM 34419146
OA gold, Green Published
DA 2024-02-19
ER

PT S
AU Yu, BP
   Yang, R
AF Yu, BP
   Yang, R
BE Kitani, K
   Aoba, A
   Goto, S
TI Critical evaluation of the free radical theory of aging - A proposal for
   the oxidative stress hypothesis
SO PHARMACOLOGICAL INTERVENTION IN AGING AND AGE-ASSOCIATED DISORDERS:
   PROCEEDINGS OF THE SIXTH CONGRESS OF THE INTERNATIONAL ASSOCIATION OF
   BIOMEDICAL GERONTOLOGY
SE Annals of the New York Academy of Sciences
LA English
DT Article; Proceedings Paper
CT 6th Congress for the International-Association-of-Biomedical-Gerontology
CY AUG 20-23, 1995
CL TOKYO, JAPAN
SP Int Assoc Biomed Gerontol
ID LIPID-PEROXIDATION; FOOD RESTRICTION; METABOLIC-RATE; NITRIC-OXIDE;
   MEMBRANE FLUIDITY; AGE; BRAIN; LIVER; ANTIOXIDANT; MODULATION
C1 YONSEI UNIV, BIOPROD RES CTR, DEPT FOOD & BIOTECHNOL, SEOUL 120749, SOUTH KOREA.
C3 Yonsei University
RP Yu, BP (corresponding author), UNIV TEXAS, HLTH SCI CTR, DEPT PHYSIOL, SAN ANTONIO, TX 78284 USA.
FU NIA NIH HHS [AG01188] Funding Source: Medline
CR BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   BARJA G, 1994, FREE RADICAL RES, V21, P317, DOI 10.3109/10715769409056584
   BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074
   CHEN JJ, 1994, FREE RADICAL BIO MED, V17, P411, DOI 10.1016/0891-5849(94)90167-8
   CHOE M, 1995, FREE RADICAL BIO MED, V18, P977, DOI 10.1016/0891-5849(94)00217-8
   CHOI JH, 1994, AGE, V17, P93, DOI 10.1007/BF02435012
   CHOI JH, 1995, FREE RADICAL BIO MED, V18, P133, DOI 10.1016/0891-5849(94)00106-T
   CHOUDHARY AK, 1994, SCIENCE, V265, P1580
   DICE JF, 1993, PHYSIOL REV, V73, P149, DOI 10.1152/physrev.1993.73.1.149
   ENESCO HE, 1990, GERONTOLOGY, V3, P256
   ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HEGNER D, 1980, MECH AGEING DEV, V14, P101, DOI 10.1016/0047-6374(80)90109-8
   HOLMES DJ, 1995, J GERONTOL A-BIOL, V50, pB59, DOI 10.1093/gerona/50A.2.B59
   JACOB RA, 1995, NUTR RES, V15, P755, DOI 10.1016/0271-5317(95)00041-G
   KIM JD, IN PRESS FREE RADICA
   KOIZUMI A, 1987, J NUTR, V117, P361, DOI 10.1093/jn/117.2.361
   KRISTAL BS, 1992, J GERONTOL, V47, pB107, DOI 10.1093/geronj/47.4.B107
   LAGANIERE S, 1993, GERONTOLOGY, V39, P7, DOI 10.1159/000213509
   LAHERA V, 1994, NEWS PHYSIOL SCI, V9, P268
   LAI CC, 1994, NEUROSCI LETT, V179, P37, DOI 10.1016/0304-3940(94)90929-6
   LANE MA, IN PRESS J GERONTOL
   Lee D W, 1990, Aging (Milano), V2, P357
   LOPEZTORRES M, 1993, FREE RADICAL BIO MED, V15, P133, DOI 10.1016/0891-5849(93)90052-V
   LUHTALA TA, 1994, J GERONTOL, V49, P13231
   Masoro Edward J., 1995, P3
   MASORO EJ, 1982, P NATL ACAD SCI-BIOL, V79, P4239, DOI 10.1073/pnas.79.13.4239
   MATSUO M, 1993, J GERONTOL, V48, P133
   MCCARTER R, 1985, AM J PHYSIOL, V248, pE488
   MIGUEL J, 1992, MUTAT RES, V275, P209
   REITER RJ, 1995, J PINEAL RES, V18, P1, DOI 10.1111/j.1600-079X.1995.tb00133.x
   SAWADA M, 1992, J CELL BIOCHEM, V48, P296, DOI 10.1002/jcb.240480310
   SCHMIDT HHHW, 1994, CELL, V78, P919, DOI 10.1016/0092-8674(94)90267-4
   SNYDER SH, 1992, SCIENCE, V257, P494, DOI 10.1126/science.1353273
   SOHAL RS, 1993, AGING-CLIN EXP RES, V5, P3, DOI 10.1007/BF03324120
   TAPPEL AL, 1977, PHARM INTERVENTION A, P111
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   WOLFF SP, 1987, BIOCHEM J, V245, P243, DOI 10.1042/bj2450243
   YAMAZAKI I, 1987, FREE RADICAL BIO MED, V3, P397, DOI 10.1016/0891-5849(87)90018-9
   YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139
   YU BP, 1995, MCBU, P331
   YU BP, 1993, AGING-CLIN EXP RES, V5, P243, DOI 10.1007/BF03324162
   ZAHN H, 1992, MECH AGEING DEV, V62, P111
NR 44
TC 132
Z9 143
U1 0
U2 4
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
BN 1-57331-031-X
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 1996
VL 786
BP 1
EP 11
DI 10.1111/j.1749-6632.1996.tb39047.x
PG 11
WC Geriatrics & Gerontology; Multidisciplinary Sciences; Pharmacology &
   Pharmacy
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Science & Technology - Other Topics;
   Pharmacology & Pharmacy
GA BF92J
UT WOS:A1996BF92J00001
PM 8687010
DA 2024-02-19
ER

PT J
AU Mi, J
   Garcia-Arcos, I
   Alvarez, R
   Cristobal, S
AF Mi, Jia
   Garcia-Arcos, Itsaso
   Alvarez, Ruben
   Cristobal, Susana
TI Age-related subproteomic analysis of mouse liver and kidney peroxisomes
SO PROTEOME SCIENCE
LA English
DT Article
ID MUSSELS MYTILUS-EDULIS; AGING-RELATED PROTEINS;
   3-HYDROXY-3-METHYLGLUTARYL-COA LYASE; SUPEROXIDE-DISMUTASE; PROTEOMIC
   ANALYSIS; RAT-LIVER; IDENTIFICATION; EXPRESSION; CATALASE; ENZYME
AB Background: Despite major recent advances in the understanding of peroxisomal functions and how peroxisomes arise, only scant information is available regarding this organelle in cellular aging. The aim of this study was to characterize the changes in the protein expression profile of aged versus young liver and kidney peroxisome-enriched fractions from mouse and to suggest possible mechanisms underlying peroxisomal aging. Peroxisome-enriched fractions from 10 weeks, 18 months and 24 months C57bl/6J mice were analyzed by quantitative proteomics.
   Results: Peroxisomal proteins were enriched by differential and density gradient centrifugation and proteins were separated by two-dimensional electrophoresis (2-DE), quantified and identified by mass spectrometry (MS). In total, sixty-five proteins were identified in both tissues. Among them, 14 proteins were differentially expressed in liver and 21 proteins in kidney. The eight proteins differentially expressed in both tissues were involved in beta-oxidation, alpha-oxidation, isoprenoid biosynthesis, amino acid metabolism, and stress response. Quantitative proteomics, clustering methods, and prediction of transcription factors, all indicated that there is a decline in protein expression at 18 months and a recovery at 24 months.
   Conclusion: These results indicate that some peroxisomal proteins show a tissue-specific functional response to aging. This response is probably dependent on their differential regeneration capacity. The differentially expressed proteins could lead several cellular effects: such as alteration of fatty acid metabolism that could alert membrane protein functions, increase of the oxidative stress and contribute to decline in bile salt synthesis. The ability to detect age-related variations in the peroxisomal proteome can help in the search for reliable and valid aging biomarkers.
C1 [Mi, Jia; Garcia-Arcos, Itsaso; Cristobal, Susana] Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, SE-75124 Uppsala, Sweden.
   [Alvarez, Ruben; Cristobal, Susana] Stockholm Univ, Arrhenius Labs Nat Sci, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.
C3 Uppsala University; Stockholm University
RP Cristobal, S (corresponding author), Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, Box 596, SE-75124 Uppsala, Sweden.
EM Jia.Mi@dbb.su.se; ofbgaari@ehu.es; rubenalva@andaluciajunta.es;
   Susana.Cristobal@dbb.su.se
RI Álvarez-Asencio, Rubén/I-3583-2015
OI Álvarez-Asencio, Rubén/0000-0002-0790-194X; Cristobal,
   Susana/0000-0002-3894-2218; Garcia-Arcos, Itsaso/0000-0002-4190-3252
CR Amelina H, 2007, J PROTEOME RES, V6, P2094, DOI 10.1021/pr060689s
   Apraiz I, 2006, MOL CELL PROTEOMICS, V5, P1274, DOI 10.1074/mcp.M500333-MCP200
   ASHMARINA LI, 1994, J BIOL CHEM, V269, P31929
   Ashmarina LI, 1999, J LIPID RES, V40, P70
   BEIER K, 1993, VIRCHOWS ARCH B, V63, P139, DOI 10.1007/BF02899254
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Breitling R, 2002, J LIPID RES, V43, P2031, DOI 10.1194/jlr.R200010-JLR200
   Butterfield D Allan, 2006, NeuroRx, V3, P344, DOI 10.1016/j.nurx.2006.05.003
   Cancio I, 2000, HISTOCHEM CELL BIOL, V113, P51, DOI 10.1007/s004180050007
   Chang JS, 2003, MECH AGEING DEV, V124, P33, DOI 10.1016/S0047-6374(02)00167-7
   Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516
   Clizbe DB, 2007, J BIOL CHEM, V282, P6668, DOI 10.1074/jbc.M610922200
   De Broe ME, 2005, NEPHROL DIAL TRANSPL, V20, P2318, DOI 10.1093/ndt/gfi164
   Drahos Kate L, 2005, J Biomol Tech, V16, P347
   Duffield JS, 2005, J CLIN INVEST, V115, P1743, DOI 10.1172/JCI22593
   Emanuelsson O, 2003, J MOL BIOL, V330, P443, DOI 10.1016/S0022-2836(03)00553-9
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Foulon V, 1999, P NATL ACAD SCI USA, V96, P10039, DOI 10.1073/pnas.96.18.10039
   GERSCHMAN R, 1954, SCIENCE, V119, P623, DOI 10.1126/science.119.3097.623
   GHOSH MK, 1986, ANAL BIOCHEM, V159, P169, DOI 10.1016/0003-2697(86)90323-4
   GRAHAM JM, 1993, BIOMEMBRANE PROTOCOL, V19, P1
   Hamacher M, 2006, PROTEOMICS, V6, P4890, DOI 10.1002/pmic.200600295
   Hogenboom S, 2004, J LIPID RES, V45, P697, DOI 10.1194/jlr.M300373-JLR200
   Hogenboom S, 2004, MOL GENET METAB, V81, P216, DOI 10.1016/j.ymgme.2003.12.001
   Hogenboom S, 2004, J CELL SCI, V117, P631, DOI 10.1242/jcs.00910
   Kim CH, 2004, EXP GERONTOL, V39, P1155, DOI 10.1016/j.exger.2004.04.003
   Kiri Ajay N, 2005, J Biomol Tech, V16, P371
   Konova E, 2004, EXP GERONTOL, V39, P249, DOI 10.1016/j.exger.2003.10.003
   Kovacs WJ, 2007, HISTOCHEM CELL BIOL, V127, P273, DOI 10.1007/s00418-006-0254-6
   Kovacs WJ, 2002, PROG LIPID RES, V41, P369, DOI 10.1016/S0163-7827(02)00002-4
   Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046
   Lee JH, 2006, PROTEOMICS, V6, P1351, DOI 10.1002/pmic.200500287
   Legakis JE, 2002, MOL BIOL CELL, V13, P4243, DOI 10.1091/mbc.E02-06-0322
   Li M, 2007, J BIOCHEM MOL BIOL, V40, P72
   Marinescu VD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-79
   MDE LBS, 2006, ACTA CIR BRAS, V21, P197
   Mi J, 2007, BIOMARKERS, V12, P47, DOI 10.1080/13547500600943528
   Mi J, 2005, PROTEOMICS, V5, P3954, DOI 10.1002/pmic.200401243
   Mi J, 2007, PROTEOMICS, V7, P1916, DOI 10.1002/pmic.200600638
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   Migliaccio E, 2006, ANTIOXID REDOX SIGN, V8, P600, DOI 10.1089/ars.2006.8.600
   Moldovan L, 2004, HISTOCHEM CELL BIOL, V122, P395, DOI 10.1007/s00418-004-0676-y
   Moser HW, 1996, ANN NY ACAD SCI, V804, P427, DOI 10.1111/j.1749-6632.1996.tb18634.x
   NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9
   Neuberger G, 2003, J MOL BIOL, V328, P581, DOI 10.1016/S0022-2836(03)00319-X
   NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603
   Oppermann UCT, 1999, FEBS LETT, V451, P238, DOI 10.1016/S0014-5793(99)00586-4
   Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803
   PERICHON R, 1995, BIOCHIMIE, V77, P288, DOI 10.1016/0300-9084(96)88138-7
   Perichon R, 1995, BIOCHEM MOL BIOL INT, V37, P475
   Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2
   Petriv OI, 2004, J BIOL CHEM, V279, P19996, DOI 10.1074/jbc.M400207200
   Piec I, 2005, FASEB J, V19, P1143, DOI 10.1096/fj.04-3084fje
   POON HF, 2005, NEUROBIOL AGING
   Robinson LJ, 2003, J PROTEOME RES, V2, P556, DOI 10.1021/pr034035k
   SEMSEI I, 1989, BIOCHEM BIOPH RES CO, V164, P620, DOI 10.1016/0006-291X(89)91505-2
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320
   Tsay HJ, 2000, J BIOMED SCI, V7, P466
   VOLKL A, 1985, EUR J BIOCHEM, V149, P257, DOI 10.1111/j.1432-1033.1985.tb08920.x
   Wang SP, 1998, HUM MOL GENET, V7, P2057, DOI 10.1093/hmg/7.13.2057
   Wilkinson TJ, 2000, AGE AGEING, V29, P111, DOI 10.1093/ageing/29.2.111
   Yamaguchi Y, 1998, EXP CELL RES, V242, P120, DOI 10.1006/excr.1998.4102
   Yang SY, 2005, FEBS J, V272, P4874, DOI 10.1111/j.1742-4658.2005.04911.x
   Youssef JA, 2005, AGEING RES REV, V4, P103, DOI 10.1016/j.arr.2004.10.002
NR 65
TC 13
Z9 13
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1477-5956
J9 PROTEOME SCI
JI Proteome Sci.
PD NOV 27
PY 2007
VL 5
AR 19
DI 10.1186/1477-5956-5-19
PG 15
WC Biochemical Research Methods
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 261CC
UT WOS:000253055700001
PM 18042274
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Petr, MA
   Alfaras, I
   Krawcyzk, M
   Bair, WN
   Mitchell, SJ
   Morrell, CH
   Studenski, SA
   Price, NL
   Fishbein, KW
   Spencer, RG
   Scheibye-Knudsen, M
   Lakatta, EG
   Ferrucci, L
   Aon, MA
   Bernier, M
   de Cabo, R
AF Petr, Michael A.
   Alfaras, Irene
   Krawcyzk, Melissa
   Bair, Woei-Nan
   Mitchell, Sarah J.
   Morrell, Christopher H.
   Studenski, Stephanie A.
   Price, Nathan L.
   Fishbein, Kenneth W.
   Spencer, Richard G.
   Scheibye-Knudsen, Morten
   Lakatta, Edward G.
   Ferrucci, Luigi
   Aon, Miguel A.
   Bernier, Michel
   de Cabo, Rafael
TI A cross-sectional study of functional and metabolic changes during aging
   through the lifespan in male mice
SO ELIFE
LA English
DT Article
ID INSULIN-RESISTANCE; GAIT SPEED; ENERGETIC COST; FRAILTY INDEX; HEALTH;
   HALLMARKS; SURVIVAL; GLUCOSE; MUSCLE; TIME
AB Aging is associated with distinct phenotypical, physiological, and functional changes, leading to disease and death. The progression of aging-related traits varies widely among individuals, influenced by their environment, lifestyle, and genetics. In this study, we conducted physiologic and functional tests cross-sectionally throughout the entire lifespan of male C57BL/6N mice. In parallel, metabolomics analyses in serum, brain, liver, heart, and skeletal muscle were also performed to identify signatures associated with frailty and age-dependent functional decline. Our findings indicate that declines in gait speed as a function of age and frailty are associated with a dramatic increase in the energetic cost of physical activity and decreases in working capacity. Aging and functional decline prompt organs to rewire their metabolism and substrate selection and toward redox-related pathways, mainly in liver and heart. Collectively, the data provide a framework to further understand and characterize processes of aging at the individual organism and organ levels.
C1 [Petr, Michael A.; Scheibye-Knudsen, Morten] Univ Copenhagen, Ctr Hlth Aging, ICMM, Copenhagen, Denmark.
   [Petr, Michael A.; Alfaras, Irene; Bair, Woei-Nan; Mitchell, Sarah J.; Studenski, Stephanie A.; Price, Nathan L.; Ferrucci, Luigi; Aon, Miguel A.; Bernier, Michel; de Cabo, Rafael] NIA, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA.
   [Krawcyzk, Melissa; Morrell, Christopher H.; Lakatta, Edward G.; Aon, Miguel A.] NIA, Lab Cardiovasc Sci, NIH, Baltimore, MD 21224 USA.
   [Bair, Woei-Nan] Univ Sci, Dept Phys Therapy, Philadelphia, PA USA.
   [Studenski, Stephanie A.] Univ Pittsburgh, Dept Med, Div Geriatr Med, Pittsburgh, PA USA.
   [Price, Nathan L.] Yale Univ, Integrat Cell Signaling & Neurobiol Metab Program, Sch Med, New Haven, CT USA.
   [Price, Nathan L.] Yale Univ, Vasc Biol & Therapeut Program, Sch Med, New Haven, CT USA.
   [Price, Nathan L.] Yale Univ, Dept Comparat Med, Sch Med, New Haven, CT USA.
   [Price, Nathan L.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA.
   [Fishbein, Kenneth W.; Spencer, Richard G.] NIA, Lab Clin Invest, NIH, Baltimore, MD 21224 USA.
   [Alfaras, Irene] Univ Pittsburgh, Inst Aging, Sch Med, Pittsburgh, PA USA.
   [Mitchell, Sarah J.] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland.
C3 University of Copenhagen; National Institutes of Health (NIH) - USA; NIH
   National Institute on Aging (NIA); National Institutes of Health (NIH) -
   USA; NIH National Institute on Aging (NIA); Pennsylvania Commonwealth
   System of Higher Education (PCSHE); University of Pittsburgh; Yale
   University; Yale University; Yale University; Yale University; National
   Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA);
   Pennsylvania Commonwealth System of Higher Education (PCSHE); University
   of Pittsburgh; Swiss Federal Institutes of Technology Domain; ETH Zurich
RP de Cabo, R (corresponding author), NIA, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA.
EM decabora@grc.nia.nih.gov
RI de Cabo, Rafael Carlos/E-7996-2010; Aon, Miguel Antonio/A-6564-2008
OI de Cabo, Rafael Carlos/0000-0003-2830-5693; Aon, Miguel
   Antonio/0000-0002-4355-5431; Bernier, Michel/0000-0002-5948-368X;
   Fishbein, Kenneth/0000-0002-6353-4603; Alfaras Cardenal,
   Irene/0000-0002-2073-9641; Scheibye-Knudsen, Morten/0000-0002-6637-1280
FU National Institute on Aging [AG000335-04]
FX National Institute on Aging AG000335-04 Rafael de Cabo; The funders had
   no role in study design, data collection and interpretation, or the
   decision to submit the work for publication.
CR Adelnia F, 2020, AGING CELL, V19, DOI 10.1111/acel.13124
   Aon MA, 2020, CELL METAB, V32, P100, DOI 10.1016/j.cmet.2020.04.018
   Bair WN, 2019, J GERONTOL A-BIOL, V74, P1413, DOI 10.1093/gerona/glz015
   Barzilai N, 2012, J GERONTOL A-BIOL, V67, P1329, DOI 10.1093/gerona/gls145
   Bellantuono I, 2020, NAT PROTOC, V15, P540, DOI 10.1038/s41596-019-0256-1
   Chong Jasmine, 2019, Curr Protoc Bioinformatics, V68, pe86, DOI 10.1002/cpbi.86
   Dall'Ara E, 2016, MECH AGEING DEV, V160, P93, DOI 10.1016/j.mad.2016.08.001
   de Cabo R, 2019, NEW ENGL J MED, V381, P2541, DOI 10.1056/NEJMra1905136
   Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805
   Di Francesco A, 2018, SCIENCE, V362, P770, DOI 10.1126/science.aau2095
   European Environmental Agency, 2020, R LANG ENV STAT COMP, P24275, DOI DOI 11/44679/INDEX.HTM
   Feridooni HA, 2015, J GERONTOL A-BIOL, V70, P686, DOI 10.1093/gerona/glu161
   Ferrucci L, 2020, AGING CELL, V19, DOI 10.1111/acel.13080
   Fiehn O, 2008, TRAC-TREND ANAL CHEM, V27, P261, DOI 10.1016/j.trac.2008.01.007
   Fischer KE, 2016, AGING-US, V8, P2370, DOI 10.18632/aging.101059
   Girard J, 2008, DIABETES METAB, V34, P439, DOI 10.1016/j.diabet.2008.04.002
   Hardy OT, 2012, CURR OPIN ENDOCRINOL, V19, P81, DOI 10.1097/MED.0b013e3283514e13
   Higham TE, 2011, PHILOS T R SOC B, V366, P1463, DOI 10.1098/rstb.2010.0354
   Justice JN, 2014, AGE, V36, P583, DOI 10.1007/s11357-013-9589-9
   Kalyani RR, 2012, J GERONTOL A-BIOL, V67, P1300, DOI 10.1093/gerona/glr141
   Kane AE, 2016, J GERONTOL A-BIOL, V71, P333, DOI 10.1093/gerona/glu315
   Longo VD, 2016, CELL METAB, V23, P1048, DOI 10.1016/j.cmet.2016.06.001
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Mercken EM, 2014, AGING CELL, V13, P787, DOI 10.1111/acel.12220
   Miller RA, 2002, AGING CELL, V1, P22, DOI 10.1046/j.1474-9728.2002.00006.x
   Mina AI, 2018, CELL METAB, V28, P656, DOI 10.1016/j.cmet.2018.06.019
   Mitchell SJ, 2019, CELL METAB, V29, P221, DOI 10.1016/j.cmet.2018.08.011
   Mitchell SJ, 2018, CELL METAB, V27, P667, DOI 10.1016/j.cmet.2018.02.001
   Mitchell SJ, 2016, CELL METAB, V23, P1093, DOI 10.1016/j.cmet.2016.05.027
   Palliyaguru DL, 2019, MECH AGEING DEV, V180, P42, DOI 10.1016/j.mad.2019.03.005
   Peng PS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40902-1
   Rosario BL, 2016, J GERONTOL A-BIOL, V71, P968, DOI 10.1093/gerona/glv224
   Rosso AL, 2017, NEUROLOGY, V89, P336, DOI 10.1212/WNL.0000000000004153
   Scheen AJ, 2017, DIABETES RES CLIN PR, V127, P290, DOI 10.1016/j.diabres.2016.12.008
   Schmidt Nielsen K., 1984, SCALING WHY IS ANIMA, DOI [10.1017/CBO9781139167826, DOI 10.1017/CBO9781139167826]
   Schrack JA, 2016, J GERONTOL A-BIOL, V71, P947, DOI 10.1093/gerona/glw002
   Shavlakadze T, 2019, CELL REP, V28, P3263, DOI 10.1016/j.celrep.2019.08.043
   Shuster A, 2012, BRIT J RADIOL, V85, P1, DOI 10.1259/bjr/38447238
   Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923
   TAYLOR CR, 1970, AM J PHYSIOL, V219, P1104, DOI 10.1152/ajplegacy.1970.219.4.1104
   Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004
   White DK, 2013, J GERONTOL A-BIOL, V68, P456, DOI 10.1093/gerona/gls197
   Whitehead JC, 2014, J GERONTOL A-BIOL, V69, P621, DOI 10.1093/gerona/glt136
   Wilson A, 2011, PHILOS T R SOC B, V366, P1540, DOI 10.1098/rstb.2010.0361
   Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11
NR 46
TC 34
Z9 37
U1 2
U2 7
PU ELIFE SCIENCES PUBLICATIONS LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD APR 20
PY 2021
VL 10
AR e62952
DI 10.7554/eLife.62952
PG 25
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA RZ3QU
UT WOS:000648512600001
PM 33876723
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Hou, MJ
   Li, XX
   Li, XP
   Zhang, JJ
   Jia, L
AF Hou, Minjie
   Li, Xiaoxu
   Li, Xueping
   Zhang, Jianjun
   Jia, Le
TI Structure Analysis, Antioxidant Activity, Anti-Aging, and Organ
   Protective Effects of <i>Pholiota adiposa</i> Residue Polysaccharides
SO STARCH-STARKE
LA English
DT Article; Early Access
DE anti-aging; d-galactose; Pholiota adiposa residue; polysaccharides
ID IN-VITRO ANTIOXIDANT; INDUCED LIVER; INJURY; PURIFICATION; HEALTHY;
   LONGAN; MICE
AB The structure analysis, antioxidant activity in vitro, and organ repair evaluation of Pholiota adiposa residue polysaccharides (PRP) on d-galactose-induced aging mice in this work are carried out. The structural results show that PRP contains beta glycoside bonded pyranose and is mainly composed of mannose glucose and galactose. The in vitro antioxidant assay demonstrates that PRP has superior reducing power and scavenging activities on hydroxyl, superoxide anion and DPPH radicals. The in vivo animal experiments confirmed that PRP can effectively increase organ index, reduce the levels of IL-6 and TNF-alpha and the contents of ALT, AST, ALP, CREA, and UA in serum induced by d-galactose. It can significantly increase the content of HYP in skin. Meanwhile, the activities of SOD, GSH-PX, and CAT are improved and the accumulation of MDA is reduced by repairing the structure and function of the damaged liver, kidney, and brain. These results demonstrate that PRP have certain organ protection effects on d-galactose-induced aging mice, indicating that it has potential application values in functional anti-aging food and natural medicine.
C1 [Hou, Minjie; Li, Xiaoxu; Li, Xueping; Zhang, Jianjun; Jia, Le] Shandong Agr Univ, Coll Life Sci, Tai An 271018, Peoples R China.
C3 Shandong Agricultural University
RP Zhang, JJ; Jia, L (corresponding author), Shandong Agr Univ, Coll Life Sci, Tai An 271018, Peoples R China.
EM zhangjj@sdau.edu.cn; jiale0525@163.com
FU Focus on research and development plan in Shandong province
   [2019GSF107028]
FX Acknowledgements This work was supported by grants from Focus on
   research and development plan in Shandong province (2019GSF107028).
CR Adamo A, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.584232
   Bai XW, 2021, J INDIAN CHEM SOC, V98, DOI 10.1016/j.jics.2021.100146
   Cao B, 2022, BMC COMPLEMENT MED, V22, DOI 10.1186/s12906-022-03535-y
   Claudio P., 2019, CANCER RES, V40, P225
   Denic A, 2022, CURR OPIN NEPHROL HY, V31, P228, DOI 10.1097/MNH.0000000000000780
   Ding QY, 2016, INT J BIOL MACROMOL, V85, P133, DOI 10.1016/j.ijbiomac.2015.12.058
   Duan Z, 2020, INT J BIOL MACROMOL, V162, P533, DOI 10.1016/j.ijbiomac.2020.06.107
   El-Ramady H, 2022, SUSTAINABILITY-BASEL, V14, DOI 10.3390/su14094941
   Feng Y, 2016, PHARM BIOL, V54, P1027, DOI 10.3109/13880209.2015.1093510
   Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057
   Gambino V, 2013, AGING CELL, V12, P435, DOI 10.1111/acel.12060
   Govindan S, 2016, EXP TOXICOL PATHOL, V68, P329, DOI 10.1016/j.etp.2016.04.001
   Han B, 2016, INT J BIOL MACROMOL, V87, P85, DOI 10.1016/j.ijbiomac.2016.01.086
   Hu WL, 2013, BIOTECHNOL LETT, V35, P1309, DOI 10.1007/s10529-013-1206-6
   Huo JY, 2016, BANGL J PHARMACOL, V11, pS168, DOI 10.3329/bjp.v11iS1.27010
   Li HP, 2019, MOLECULES, V24, DOI 10.3390/molecules24152698
   Li SS, 2018, INT J BIOL MACROMOL, V109, P457, DOI 10.1016/j.ijbiomac.2017.12.108
   Li SS, 2018, INT J BIOL MACROMOL, V106, P1297, DOI 10.1016/j.ijbiomac.2017.08.135
   Liu Y, 2014, INT J BIOL MACROMOL, V64, P63, DOI 10.1016/j.ijbiomac.2013.11.029
   Ma Z, 2015, INT J BIOL MACROMOL, V73, P236, DOI 10.1016/j.ijbiomac.2014.11.028
   Pan Y, 2013, MOLECULES, V18, P1693, DOI 10.3390/molecules18021693
   Potok OA, 2022, KIDNEY MED, V4, DOI [10.1016/j.xkme.2022.100416, 10.1016/ j.xkme.2022.100416]
   Pourmemar E, 2017, EXP GERONTOL, V87, P16, DOI 10.1016/j.exger.2016.11.011
   Rong Y, 2019, CARBOHYD POLYM, V213, P247, DOI 10.1016/j.carbpol.2019.03.007
   Sadiqi S, 2022, MOLECULES, V27, DOI 10.3390/molecules27196281
   Song XL, 2022, FOOD FUNCT, V13, P2441, DOI [10.1039/d1fo03486c, 10.1039/D1FO03486C]
   Sun WH, 2021, PHYSIOL RES, V70, P425, DOI 10.33549/physiolres.934640
   Sun WX, 2022, FOOD BIOSCI, V47, DOI 10.1016/j.fbio.2022.101690
   Sun WX, 2021, FOOD FUNCT, V12, P6389, DOI [10.1039/d1fo00399b, 10.1039/D1FO00399B]
   Tu JQ, 2021, J FOOD BIOCHEM, V45, DOI 10.1111/jfbc.13871
   Wang X, 2020, J MOL STRUCT, V1208, DOI 10.1016/j.molstruc.2020.127895
   Xu DF, 2019, FOOD FUNCT, V10, P6792, DOI 10.1039/c8fo01833b
   Yang H., 2018, INT J BIOL MACROMOL, V121, P1203
   Yang ZW, 2022, FOOD FUNCT, V13, P5153, DOI [10.1039/d1fo03628a, 10.1039/D1FO03628A]
   Yi Y, 2012, CARBOHYD POLYM, V87, P636, DOI 10.1016/j.carbpol.2011.08.034
   YUAN FF, 2019, ASTROPHYS J SUPPL S, V24, P3517
   Zhang C, 2017, INT J BIOL MACROMOL, V95, P778, DOI 10.1016/j.ijbiomac.2016.12.003
   Zhao HJ, 2017, INT J BIOL MACROMOL, V102, P351, DOI 10.1016/j.ijbiomac.2017.04.039
   Zheng L, 2015, J SCI FOOD AGR, V95, P3117, DOI 10.1002/jsfa.7048
   Zhu MS, 2020, THER ADV CHRONIC DIS, V11, DOI 10.1177/2040622320964125
NR 40
TC 1
Z9 1
U1 14
U2 16
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 0038-9056
EI 1521-379X
J9 STARCH-STARKE
JI Starch-Starke
PD 2023 JUL
PY 2023
VL 75
IS 7-8
DI 10.1002/star.202200237
EA APR 2023
PG 10
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA K8OG7
UT WOS:000975338800001
DA 2024-02-19
ER

PT J
AU Sanz, N
   Diez-Fernández, C
   Andrés, D
   Cascales, M
AF Sanz, N
   Diez-Fernández, C
   Andrés, D
   Cascales, M
TI Hepatotoxicity and aging:: endogenous antioxidant systems in hepatocytes
   from 2-, 6-, 12-, 18- and 30-month-old rats following a necrogenic dose
   of thioacetamide
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE aging and thioacetamide hepatotoxicity antioxidant defense; catalase;
   superoxide dismutase; glutathione peroxidase
ID REACTIVE OXYGEN; GLUTATHIONE; DAMAGE; NECROSIS; REGENERATION;
   METABOLISM; PARAMETERS; MECHANISM; ENZYMES; INJURY
AB The influence of aging on the mechanisms of liver injury and regeneration A as Studied in a model of hepatotoxicity induced 2-, 6-, 12-, 18- and 30-month-old rats by a sublethal dose of thioacetamide (500 mg/kg body weight). a soft nucleophilic and hepatoloxic compound metabolized by the hepatic microsomal FAD monooxygenase system. Samples- blood and hepatocytes were obtained at 0, 12, 24, 48, 72 and 96 h following thioacetamide intoxication. Parameters of liver injury in serum (NADPH-isocitrate dehydrogenase (ICDH) activity) indicate that the severity of injury was significantly higher in the adult groups (6 and 12 months old) when compared either with the youngest (2 months old) or oldest ( 18 and 30 months old) groups. Parameters related to biotransformation. such as microsonial FAD monooxygenase, followed mainly the same pattern of age-dependent changes as those observed for injury. The profile of glutathione-S-transferase activity showed an initial induction parallel to liver injury and opposite to the levels of reduced glutathione and protein -SH groups. Enzyme activities and gene expression of the systems involved in the cell endogenous antioxidant defense. such as Mn- and Cu,Zn-superoxide dismutases (SOD), catalase and glutathione peroxidase (GPX) showed significant age-dependent changes that can he summarized as follows: an increase in all enzyme activities and gene expression and a decreased ability to restore the initial activities following, 96 h of thioacetamide. We conclude. first, that the gene expression and activity of the enzymes involved in the intracellular antioxidant defense system increased with aging. which can be considered a consequence of the enhanced oxidative state of the cell decreased in GSH and second, that the lower and delayed response in the aged groups significantly influenced the restoration towards normal of GSH and the antioxidant enzyme activities. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Complutense, Fac Farm, CSIC, Inst Bioquim, E-28040 Madrid, Spain.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); Complutense
   University of Madrid
RP Cascales, M (corresponding author), Univ Complutense, Fac Farm, CSIC, Inst Bioquim, Plaza Ramon & Cajal SN, E-28040 Madrid, Spain.
EM cascales@farm.ucm.es
CR Aebi H.E., 1987, Methods Enzym. Anal., V3, P273
   AMASINO RM, 1986, ANAL BIOCHEM, V152, P304, DOI 10.1016/0003-2697(86)90413-6
   [Anonymous], METHODS ENZYMATIC AN
   BELLOMO G, 1992, P NATL ACAD SCI USA, V89, P4412, DOI 10.1073/pnas.89.10.4412
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CASCALES M, 1992, HEPATOLOGY, V16, P232, DOI 10.1002/hep.1840160134
   CHIELI E, 1984, TOXICOLOGY, V31, P41, DOI 10.1016/0300-483X(84)90154-9
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Chung YH, 2001, J GASTROEN HEPATOL, V16, P328, DOI 10.1046/j.1440-1746.2001.02447.x
   Del Maestro R.F., 1983, OXYGEN RADICALS THEI, V2, P28
   DiezFernandez C, 1996, BIOCHEM PHARMACOL, V51, P1159, DOI 10.1016/0006-2952(96)00030-5
   DiezFernandez C, 1996, J HEPATOL, V24, P460, DOI 10.1016/S0168-8278(96)80167-X
   DIEZFERNANDEZ C, 1993, HEPATOLOGY, V18, P912, DOI 10.1002/hep.1840180424
   DIMONTE D, 1984, ARCH BIOCHEM BIOPHYS, V235, P334, DOI 10.1016/0003-9861(84)90206-6
   FRIDOVICH I, 1999, ANN NY ACAD SCI, V839, P13
   GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6
   GUNZLER WA, 1974, Z KLIN CHEM KLIN BIO, V12, P444
   GUTTERIDGE JMC, 1990, TRENDS BIOCHEM SCI, V15, P129, DOI 10.1016/0968-0004(90)90206-Q
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HASSAN HM, 1988, FREE RADICAL BIO MED, V5, P377, DOI 10.1016/0891-5849(88)90111-6
   ISHIKAWA T, 1992, TRENDS BIOCHEM SCI, V17, P463, DOI 10.1016/0968-0004(92)90489-V
   KAPLOWITZ N, 1985, ANNU REV PHARMACOL, V25, P715, DOI 10.1146/annurev.pharmtox.25.1.715
   Katz Norbert, 1993, P55
   NADAL C, 1992, TR ADV LIV, P123
   Norwood TH, 1996, EXP GERONTOL, V31, P61, DOI 10.1016/0531-5565(95)02020-9
   PLEWKA A, 1994, MECH AGEING DEV, V74, P79, DOI 10.1016/0047-6374(94)90100-7
   PRINCIPE P, 1989, CYTOMETRY, V10, P750, DOI 10.1002/cyto.990100613
   Rattan SIS, 1996, EXP GERONTOL, V31, P33, DOI 10.1016/0531-5565(95)02022-5
   REED DJ, 1990, ANNU REV PHARMACOL, V30, P603, DOI 10.1146/annurev.pa.30.040190.003131
   Sanz N, 1999, TOXICOL APPL PHARM, V154, P40, DOI 10.1006/taap.1998.8541
   Sanz N, 1997, J HEPATOL, V27, P525, DOI 10.1016/S0168-8278(97)80358-3
   Sanz N, 1998, BIOFACTORS, V8, P103, DOI 10.1002/biof.5520080118
   Seglen PO, 1993, METHODS TOXICOL, P231
   SHIMIZU N, 1984, J BIOL CHEM, V259, P4414
   SUM CY, 1982, BIOCHEM PHARMACOL, V31, P69, DOI 10.1016/0006-2952(82)90238-6
   SUTHANTHIRAN M, 1990, P NATL ACAD SCI USA, V87, P3343, DOI 10.1073/pnas.87.9.3343
   Tian LQ, 1998, FREE RADICAL BIO MED, V24, P1477, DOI 10.1016/S0891-5849(98)00025-2
   TILLY JL, 1995, ENDOCRINOLOGY, V136, P242, DOI 10.1210/en.136.1.242
   YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139
NR 40
TC 49
Z9 50
U1 0
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 1879-260X
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD MAY 21
PY 2002
VL 1587
IS 1
BP 12
EP 20
AR PII S0925-4439(02)00048-0
DI 10.1016/S0925-4439(02)00048-0
PG 9
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 559NM
UT WOS:000176032300003
PM 12009419
OA hybrid
DA 2024-02-19
ER

PT J
AU Chaudhuri, AR
   de Waal, EM
   Pierce, A
   Van Remmen, H
   Ward, WE
   Richardson, A
AF Chaudhuri, Asish R.
   de Waal, Eric M.
   Pierce, Anson
   Van Remmen, Holly
   Ward, Walter E.
   Richardson, Arlan
TI Detection of protein carbonyls in aging liver tissue: A
   fluorescence-based proteornic approach
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE protein oxidation; protein carbonyls; fluorescence; proteomics; aging
ID METAL-CATALYZED OXIDATION; AMINO-ACID-RESIDUES; GEL-ELECTROPHORESIS;
   IMMUNOCHEMICAL DETECTION; SUPEROXIDE-DISMUTASE; PROTEOMIC ANALYSIS;
   OXIDIZED PROTEINS; PLASMA-PROTEINS; DAMAGE; IDENTIFICATION
AB Protein carbonyls are commonly used as a marker of protein oxidation in cells and tissues. Currently, 2,4-dinitrophenyl hydrazine (DNPH) is widely used (spectrophotometrically or immunologically) to quantify the global carbonyl levels in proteins and identify the specific proteins that are carbonylated. We have adapted a fluorescence-based approach using fluorescein-5-thiosemicarbazide (FTC), to quantify the global protein carbonyls as well as the carbonyl levels on individual proteins in the proteome. Protein carbonyls generated in vitro were quantified by labeling the oxidized proteins with FTC followed by separating the FTC-labeled protein from free probe by gel electrophoresis. The reaction of FTC with protein carbonyls was found to be specific for carbonyl groups. We measured protein carbonyl levels in the livers of young and old mice, and found a significant increase (two-fold) in the global protein carbonyl levels with age. Using 2-D gel electrophoresis, we used this assay to directly measure the chances in protein carbonyl levels in specific proteins. We identified 12 proteins showing a greater than two-fold increase in carbonyl content (pmoles of carbonyls/mu g of protein) with age. Most of the 12 proteins contained transition metal binding sites, with Cu/Zn superoxide dismutase containing the highest molar ratio of carbonyls in old mice. Thus, the fluorescence-based assay gives investigators the ability to identify potential target proteins that become oxidized under different pathological and physiological conditions. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
C1 Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.
   Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX 78229 USA.
   Univ Texas, Hlth Sci Ctr, Dept Physiol, San Antonio, TX 78229 USA.
   Univ Texas, Hlth Sci Ctr, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA.
   S Texas Vet Hlth Care Syst, Ctr Geriatr Res Educ & Clin, San Antonio, TX 78284 USA.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio; University of Texas System; University of Texas Health
   Science Center at San Antonio; University of Texas System; University of
   Texas Health Science Center at San Antonio; University of Texas System;
   University of Texas Health Science Center at San Antonio; Geriatric
   Research Education & Clinical Center; US Department of Veterans Affairs;
   Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans
   Hospital
RP Richardson, A (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.
EM richardsona@uthscsa.edu
RI Pierce, Anson/D-1079-2012
OI Pierce, Anson/0000-0002-1383-0180
FU NIA NIH HHS [R01 AG025362, P01 AG19316, P01 AG020591] Funding Source:
   Medline
CR AGARWAL S, 1993, BIOCHEM BIOPH RES CO, V194, P1203, DOI 10.1006/bbrc.1993.1950
   AGARWAL S, 1994, ARCH BIOCHEM BIOPHYS, V309, P24, DOI 10.1006/abbi.1994.1078
   AHN B, 1987, ANAL BIOCHEM, V161, P245, DOI 10.1016/0003-2697(87)90448-9
   Alam ZI, 1997, J NEUROCHEM, V69, P1326
   AMICI A, 1989, J BIOL CHEM, V264, P3341
   Andrus PK, 1998, J NEUROCHEM, V71, P2041
   Bal W, 1998, J INORG BIOCHEM, V70, P33, DOI 10.1016/S0162-0134(98)00010-5
   Bautista J, 1998, BIOSCI BIOTECH BIOCH, V62, P419, DOI 10.1271/bbb.62.419
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Butterfield DA, 2001, MECH AGEING DEV, V122, P945, DOI 10.1016/S0047-6374(01)00249-4
   CABISCOL E, 1995, J BIOL CHEM, V270, P14742, DOI 10.1074/jbc.270.24.14742
   CAO GH, 1995, ARCH BIOCHEM BIOPHYS, V320, P106, DOI 10.1006/abbi.1995.1347
   Chang JS, 2003, MECH AGEING DEV, V124, P33, DOI 10.1016/S0047-6374(02)00167-7
   Chao CC, 1997, P NATL ACAD SCI USA, V94, P2969, DOI 10.1073/pnas.94.7.2969
   CHIEN CI, 1994, BBA-PROTEIN STRUCT M, V1204, P175, DOI 10.1016/0167-4838(94)90006-X
   Choi J, 2005, J BIOL CHEM, V280, P11648, DOI 10.1074/jbc.M414327200
   Choi JG, 2002, BIOCHEM BIOPH RES CO, V293, P1566, DOI 10.1016/S0006-291X(02)00420-5
   Conrad CC, 2001, PROTEOMICS, V1, P829, DOI 10.1002/1615-9861(200107)1:7<829::AID-PROT829>3.0.CO;2-R
   Dominguez C, 1998, DIABETES CARE, V21, P1736, DOI 10.2337/diacare.21.10.1736
   Doorn JA, 2002, CHEM RES TOXICOL, V15, P1445, DOI 10.1021/tx025590o
   Evans P, 1999, METHOD ENZYMOL, V300, P145
   Friguet B, 2006, FEBS LETT, V580, P2910, DOI 10.1016/j.febslet.2006.03.028
   FUJITA S, 1985, BIOCHEM PHARMACOL, V34, P3891, DOI 10.1016/0006-2952(85)90440-X
   Goto S, 1999, MECH AGEING DEV, V107, P245, DOI 10.1016/S0047-6374(98)00133-X
   Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064
   Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341
   Jana CK, 2002, ARCH BIOCHEM BIOPHYS, V397, P433, DOI 10.1006/abbi.2001.2690
   Jung YD, 1997, ARCH BIOCHEM BIOPHYS, V345, P311, DOI 10.1006/abbi.1997.0268
   KELLER RJ, 1993, CHEM RES TOXICOL, V6, P430, DOI 10.1021/tx00034a007
   Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477
   Korolainen MA, 2002, ELECTROPHORESIS, V23, P3428, DOI 10.1002/1522-2683(200210)23:19<3428::AID-ELPS3428>3.0.CO;2-5
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LEVINE RL, 1990, METHOD ENZYMOL, V186, P464
   LEVINE RL, 1994, METHOD ENZYMOL, V233, P346
   Levine RL, 2000, IUBMB LIFE, V50, P301, DOI 10.1080/15216540051081056
   MacGillivray RTA, 1998, BIOCHEMISTRY-US, V37, P7919, DOI 10.1021/bi980355j
   MARIA CS, 1995, FEBS LETT, V374, P85
   Marini I, 1997, ARCH BIOCHEM BIOPHYS, V340, P383, DOI 10.1006/abbi.1997.9882
   MASKOS Z, 1992, ARCH BIOCHEM BIOPHYS, V296, P521, DOI 10.1016/0003-9861(92)90606-W
   NADKARNI DV, 1995, CHEM RES TOXICOL, V8, P284, DOI 10.1021/tx00044a014
   Nakamura A, 1996, J BIOCHEM, V119, P768
   Nakamura M, 2002, ANAL BIOCHEM, V304, P231, DOI 10.1006/abio.2002.5595
   Olivares-Corichi IM, 2005, FRONT BIOSCI-LANDMRK, V10, P838, DOI 10.2741/1577
   OLIVER CN, 1987, J BIOL CHEM, V262, P5488
   OLIVER CN, 1990, P NATL ACAD SCI USA, V87, P5144, DOI 10.1073/pnas.87.13.5144
   Parrado J, 1999, FREE RADICAL BIO MED, V26, P362, DOI 10.1016/S0891-5849(98)00202-0
   Pleshakova OV, 1998, MECH AGEING DEV, V103, P45, DOI 10.1016/S0047-6374(98)00012-8
   PRUTZ WA, 1985, ARCH BIOCHEM BIOPHYS, V243, P125, DOI 10.1016/0003-9861(85)90780-5
   Reinheckel T, 2000, ARCH BIOCHEM BIOPHYS, V376, P59, DOI 10.1006/abbi.1999.1680
   Reverter-Branchat G, 2004, J BIOL CHEM, V279, P31983, DOI 10.1074/jbc.M404849200
   REYERO C, 1975, EUR J BIOCHEM, V56, P137, DOI 10.1111/j.1432-1033.1975.tb02216.x
   REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357
   RIGO A, 1977, BIOCHEM J, V161, P31, DOI 10.1042/bj1610031
   Robinson CE, 1999, ANAL BIOCHEM, V266, P48, DOI 10.1006/abio.1998.2932
   RUZICKA FJ, 1977, J BIOL CHEM, V252, P8440
   Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536
   Schöneich C, 2000, J PHARMACEUT BIOMED, V21, P1093, DOI 10.1016/S0731-7085(99)00182-X
   SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540
   SOHAL RS, 1993, P NATL ACAD SCI USA, V90, P7255, DOI 10.1073/pnas.90.15.7255
   STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053
   STADTMAN ER, 1990, FREE RADICAL BIO MED, V9, P315, DOI 10.1016/0891-5849(90)90006-5
   Telci A, 2000, HORM METAB RES, V32, P40, DOI 10.1055/s-2007-978584
   Tezel G, 2005, INVEST OPHTH VIS SCI, V46, P3177, DOI 10.1167/iovs.05-0208
   Thomas JA, 2001, EXP GERONTOL, V36, P1519, DOI 10.1016/S0531-5565(01)00137-1
   Tian LQ, 1998, FREE RADICAL BIO MED, V24, P1477, DOI 10.1016/S0891-5849(98)00025-2
   Touyz RM, 2004, BRAZ J MED BIOL RES, V37, P1263, DOI 10.1590/S0100-879X2004000800018
   Uchida K, 2003, AMINO ACIDS, V25, P249, DOI 10.1007/s00726-003-0015-y
   Vittorini S, 1999, J GERONTOL A-BIOL, V54, pB318, DOI 10.1093/gerona/54.8.B318
   Ward Walter F, 2002, Prog Mol Subcell Biol, V29, P35
   Yan LJ, 1998, ANAL BIOCHEM, V263, P67, DOI 10.1006/abio.1998.2799
   Yoo YS, 2004, ELECTROPHORESIS, V25, P1334, DOI 10.1002/elps.200405890
NR 71
TC 126
Z9 141
U1 2
U2 47
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD NOV
PY 2006
VL 127
IS 11
BP 849
EP 861
DI 10.1016/j.mad.2006.08.006
PG 13
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 105RF
UT WOS:000242049300005
PM 17002888
DA 2024-02-19
ER

PT J
AU Guo, DH
   Cheng, LZ
   Shen, Y
   Li, W
   Li, QJ
   Zhong, Y
   Miao, Y
AF Guo, Donghao
   Cheng, Lizhen
   Shen, Yun
   Li, Wei
   Li, Qinjie
   Zhong, Yuan
   Miao, Ya
TI 6-Bromoindirubin-3′-oxime (6BIO) prevents myocardium from aging by
   inducing autophagy
SO AGING-US
LA English
DT Article
DE 6-Bromoindirubin-3 '-oxime; aging; oxidative stress; autophagy;
   rapamycin
ID RAPAMYCIN EXTENDS LIFE; CARDIOVASCULAR-DISEASES; SMALL-MOLECULE; AGE;
   INHIBITION; HEALTH; TARGET; CELLS; LIVER
AB 6-Bromoindirubin-3'-oxime (6BIO) is a novel small molecule that exerts positive effects on several age-related alterations. However, the anti-aging effects of 6BIO on the aging heart remain unknown. Here in, we aim to investigate the effects of 6BIO on the myocardium and its underlying mechanism in vivo and vitro. Following 6BIO treatment, an increased p53 contents, a reduced p16 and beta-gal levels, and attenuation of cardiac fibrosis were observed, suggesting 6BIO retarded aging of cardiomyocytes. As observed, 6BIO reduced p62 contents, elevated the levels of Beclin-1 and the ratio of LC3II/I, indicating the induction of autophagy, while the reduction of the accumulation of ROS indicated 6BIO alleviated oxidative stress. In addition, 6BIO treatment inhibited both GSK3 signaling and mTOR signaling. 6BIO might be a promising agent for preventing myocardium from aging.
C1 [Guo, Donghao; Cheng, Lizhen; Shen, Yun; Li, Wei; Li, Qinjie; Zhong, Yuan; Miao, Ya] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Geriatr, Shanghai, Peoples R China.
   [Guo, Donghao] Chinese Univ Hong Kong, Fac Med, Dept Med & Therapeut, Div Cardiol, Hong Kong, Peoples R China.
C3 Shanghai Jiao Tong University; Chinese University of Hong Kong
RP Zhong, Y; Miao, Y (corresponding author), Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Geriatr, Shanghai, Peoples R China.
EM zhongyuan_zhy@163.com; nning-my@163.com
RI Guo, Donghao/AAB-5671-2020
OI Guo, Donghao/0000-0002-8300-8176
FU Shanghai Natural Science Foundation [19ZR1438800]; National Natural
   Science Foundation of China [81300933]
FX This study was funded by grants from Shanghai Natural Science Foundation
   (No. 19ZR1438800) and the National Natural Science Foundation of China
   (No. 81300933).
CR Abdellatif M, 2020, PROG MOL BIOL TRANSL, V172, P87, DOI 10.1016/bs.pmbts.2020.04.022
   Aguilar-Alonso P, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/1390483
   Avrahami L, 2013, J BIOL CHEM, V288, P1295, DOI 10.1074/jbc.M112.409250
   Baar EL, 2016, AGING CELL, V15, P155, DOI 10.1111/acel.12425
   Bakeeva L, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030566
   Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI [10.1161/CIR.0000000000000659, 10.1161/CIR.0000000000000746]
   Chang JC, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8060564
   Chen Jian-Hua, 2007, Methods Mol Biol, V371, P179
   Chiao YA, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a025148
   Fang R, 2015, INT J NANOMED, V10, P4691, DOI 10.2147/IJN.S81451
   Flynn JM, 2013, AGING CELL, V12, P851, DOI 10.1111/acel.12109
   Gao GY, 2020, INT J MOL MED, V45, P195, DOI 10.3892/ijmm.2019.4407
   Guo DH, 2020, AGING-US, V12, P931, DOI 10.18632/aging.102666
   Guo DH, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00320
   Hara H, 2018, JACC-BASIC TRANSL SC, V3, P639, DOI 10.1016/j.jacbts.2018.07.005
   He H, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.533
   Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5
   Jiang JF, 2010, BIOMED PHARMACOTHER, V64, P482, DOI 10.1016/j.biopha.2010.01.005
   Kaplán P, 2019, PHYSIOL RES, V68, P883, DOI 10.33549/physiolres.934170
   Kennedy BK, 2014, TRANSL RES, V163, P456, DOI 10.1016/j.trsl.2013.11.007
   Kim YS, 2016, SCI REP-UK, V6, DOI 10.1038/srep30726
   Le Dour C, 2017, HUM MOL GENET, V26, P333, DOI 10.1093/hmg/ddw389
   Li J, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00772
   Liu J, 2018, STEM CELL RES, V31, P5, DOI 10.1016/j.scr.2018.06.001
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Marín-Aguilar F, 2020, AGING CELL, V19, DOI 10.1111/acel.13050
   Martínez-Cisuelo V, 2016, EXP GERONTOL, V83, P130, DOI 10.1016/j.exger.2016.08.002
   Miyamoto S, 2019, CELL DEATH DIFFER, V26, P653, DOI 10.1038/s41418-019-0286-9
   Miyazawa T, 2019, IUBMB LIFE, V71, P430, DOI 10.1002/iub.2008
   Nicolaou KA, 2012, BIOCHEM BIOPH RES CO, V425, P76, DOI 10.1016/j.bbrc.2012.07.053
   Olivieri F, 2013, CURR PHARM DESIGN, V19, P1710
   Pulakat L, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00774
   Shen S, 2015, STEM CELLS DEV, V24, P724, DOI 10.1089/scd.2014.0230
   Siegmund SE, 2017, HUM MOL GENET, V26, P4588, DOI 10.1093/hmg/ddx341
   Sklirou AD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11662-7
   Suresh SN, 2017, AUTOPHAGY, V13, P1221, DOI 10.1080/15548627.2017.1302045
   Tian JF, 2019, AGING DIS, V10, P1302, DOI 10.14336/AD.2018.1020
   Tsakiri EN, 2017, ANTIOXID REDOX SIGN, V27, P1027, DOI 10.1089/ars.2016.6910
   Zhang XW, 2017, MOL THER, V25, P79, DOI 10.1016/j.ymthe.2016.10.017
   Zhang YQ, 2014, J GERONTOL A-BIOL, V69, P119, DOI 10.1093/gerona/glt056
NR 40
TC 10
Z9 10
U1 0
U2 12
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD DEC 31
PY 2020
VL 12
IS 24
BP 26047
EP 26062
DI 10.18632/aging.202253
PG 16
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA PP1AO
UT WOS:000605601500018
PM 33401248
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Swisshelm, K
   Machl, A
   Planitzer, S
   Robertson, R
   Kubbies, M
   Hosier, S
AF Swisshelm, K
   Machl, A
   Planitzer, S
   Robertson, R
   Kubbies, M
   Hosier, S
TI <i>SEMP1</i>, a senescence-associated cDNA isolated from human mammary
   epithelial cells, is a member of an epithelial membrane protein
   superfamily
SO GENE
LA English
DT Article
DE differential display; epithelial membrane protein; HMECs; senescence
ID CLOSTRIDIUM-PERFRINGENS ENTEROTOXIN; PERIPHERAL MYELIN PROTEIN-22;
   MESSENGER-RNA; IN-VIVO; DIFFERENTIAL DISPLAY; TUMOR SUPPRESSION;
   RETINOIC ACID; GENE FAMILY; EXPRESSION; IDENTIFICATION
AB We have cloned a human cDNA, SEMP1 (senescence-associated epithelial membrane protein 1), using differential display (DD) of mRNA. We compared mRNA expression profiles between cultured normal senescent human mammary epithelial cells (HMECs) and proliferating, early passage HMECs. From the amino acid sequence of the open reading frame (ORF) of the cDNA, we infer that the protein belongs to a family of membrane-associated, epithelial cell-specific proteins. The translation product has 91% identity to a mouse protein, claudin-1, a tight junction (TJ)-associated protein. SEMP1 mRNA is expressed in human tissues, including adult and fetal liver, pancreas, placenta, adrenals, prostate and ovary but at low or undetectable levels in a number of human breast cancer cell lines. SEMP1 is a member of a superfamily of epithelial membrane proteins (EMPs), which may have multiple potential functions, including maintenance and regulation of cell polarity and permeability, perhaps through mechanisms involving tight junctions. (C) 1999 Elsevier Science B.V. All rights reserved.
C1 Univ Washington, Dept Pathol, Seattle, WA 98195 USA.
   Roche Pharmaceut Res, Dept Cell Analyt, Penzberg, Germany.
C3 University of Washington; University of Washington Seattle; Roche
   Holding
RP Swisshelm, K (corresponding author), Univ Washington, Dept Pathol, Box 357470, Seattle, WA 98195 USA.
EM kswiss@u.washington.edu
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   BRIEHL MM, 1991, MOL ENDOCRINOL, V5, P1381, DOI 10.1210/mend-5-10-1381
   Bronstein JM, 1996, NEUROLOGY, V47, P772, DOI 10.1212/WNL.47.3.772
   Capel B, 1998, ANNU REV PHYSIOL, V60, P497, DOI 10.1146/annurev.physiol.60.1.497
   Cereijido M, 1998, ANNU REV PHYSIOL, V60, P161, DOI 10.1146/annurev.physiol.60.1.161
   Chen Z, 1998, LAB INVEST, V78, P353
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   ENGLEMAN DM, 1986, ANN REV BIOPHYS CHEM, V15, P321
   Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362
   HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V347, P166
   Jiang WG, 1998, BIOCHEM BIOPH RES CO, V244, P414, DOI 10.1006/bbrc.1998.8288
   Katahira J, 1997, J BIOL CHEM, V272, P26652, DOI 10.1074/jbc.272.42.26652
   Katahira J, 1997, J CELL BIOL, V136, P1239, DOI 10.1083/jcb.136.6.1239
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   LABORDA J, 1991, NUCLEIC ACIDS RES, V19, P3998, DOI 10.1093/nar/19.14.3998
   LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393
   LIANG P, 1995, METHOD ENZYMOL, V254, P304
   Madara JL, 1998, ANNU REV PHYSIOL, V60, P143, DOI 10.1146/annurev.physiol.60.1.143
   MANFIOLETTI G, 1990, MOL CELL BIOL, V10, P2924, DOI 10.1128/MCB.10.6.2924
   Mullin JM, 1997, J EXP ZOOL, V279, P484, DOI 10.1002/(SICI)1097-010X(19971201)279:5<484::AID-JEZ11>3.0.CO;2-8
   Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1
   Peacock RE, 1997, GENOMICS, V46, P443, DOI 10.1006/geno.1997.5033
   RIO MC, 1987, P NATL ACAD SCI USA, V84, P9243, DOI 10.1073/pnas.84.24.9243
   SAGER R, 1991, ENVIRON HEALTH PERSP, V93, P59, DOI 10.2307/3431170
   SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7
   Sirotkin H, 1997, GENOMICS, V42, P245, DOI 10.1006/geno.1997.4734
   Smith JR, 1996, SCIENCE, V273, P63, DOI 10.1126/science.273.5271.63
   SOMMERS CL, 1994, BREAST CANCER RES TR, V31, P325, DOI 10.1007/BF00666165
   SPREYER P, 1991, EMBO J, V10, P3661, DOI 10.1002/j.1460-2075.1991.tb04933.x
   Stampfer M., 1985, Journal of Tissue Culture Methods, V9, P107
   SWISSHELM K, 1994, CELL GROWTH DIFFER, V5, P133
   SWISSHELM K, 1995, P NATL ACAD SCI USA, V92, P4472, DOI 10.1073/pnas.92.10.4472
   TAYLOR V, 1995, J BIOL CHEM, V270, P28824, DOI 10.1074/jbc.270.48.28824
   Taylor V, 1996, GENE, V175, P115, DOI 10.1016/0378-1119(96)00134-5
NR 38
TC 74
Z9 87
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-1119
EI 1879-0038
J9 GENE
JI Gene
PD JAN 21
PY 1999
VL 226
IS 2
BP 285
EP 295
DI 10.1016/S0378-1119(98)00553-8
PG 11
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 164WW
UT WOS:000078487400016
PM 9931503
DA 2024-02-19
ER

PT J
AU Myasoedova, KN
   Silachev, DN
AF Myasoedova, K. N.
   Silachev, D. N.
TI Effect of long-term treatment with antioxidant SkQ1 Added to drinking
   water on cytochromes P450 level in rat liver
SO BIOCHEMISTRY-MOSCOW
LA English
DT Article
DE cytochrome P450; SkQ1; mitochondria-targeted antioxidant
ID TARGETED PLASTOQUINONE DERIVATIVES; INTERRUPT EXECUTION; METABOLISM;
   SENESCENCE; TOOLS
AB Mitochondria-targeted cationic antioxidant plastoquinonyl decyltriphenylphosphonium (SkQ1) added to drinking water in therapeutic doses (250 nmol/kg per day) for a long time (up to 24 months) does not induce cytochromes P450 in rat liver.
C1 [Myasoedova, K. N.] Moscow MV Lomonosov State Univ, Fac Fundamental Med, Moscow 119991, Russia.
   [Myasoedova, K. N.; Silachev, D. N.] Moscow MV Lomonosov State Univ, Inst Mitoengn, Moscow 119991, Russia.
   [Silachev, D. N.] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow 119991, Russia.
C3 Lomonosov Moscow State University; Lomonosov Moscow State University;
   Lomonosov Moscow State University
RP Myasoedova, KN (corresponding author), Moscow MV Lomonosov State Univ, Fac Fundamental Med, Moscow 119991, Russia.
EM skulach@genebee.msu.ru
RI Silachev, Denis/ABE-8515-2020; Silachev, Denis N/C-9464-2012
OI Silachev, Denis/0000-0003-0581-9755
FU Russian Science Foundation [14-50-00029]
FX This study was supported by the Russian Science Foundation (project No.
   14-50-00029).
CR Antonenko YN, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1273, DOI 10.1134/S0006297908120018
   Coon MJ, 2002, J BIOL CHEM, V277, P28351, DOI 10.1074/jbc.R200015200
   Dawson R., 1991, DIRECTORY BIOCH
   Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103
   Furge LL, 2006, BIOCHEM MOL BIOL EDU, V34, P66, DOI 10.1002/bmb.2006.49403402066
   Guengerich FP, 2006, P NATL ACAD SCI USA, V103, P13565, DOI 10.1073/pnas.0606333103
   Lyakhovich V. V, 1981, INDUCTION ENZYMES XE
   Myasoedova KN, 2008, BIOCHEMISTRY-MOSCOW+, V73, P965, DOI 10.1134/S0006297908090022
   Myasoedova KN, 2014, BIOCHEMISTRY-MOSCOW+, V79, P1130, DOI 10.1134/S0006297914100149
   Neroev VV, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1317, DOI 10.1134/S0006297908120043
   OMURA T, 1964, J BIOL CHEM, V239, P2370
   Severin FF, 2010, P NATL ACAD SCI USA, V107, P663, DOI 10.1073/pnas.0910216107
   Skulachev MV, 2011, CURR DRUG TARGETS, V12, P800
   Skulachev VP, 2009, BBA-BIOENERGETICS, V1787, P437, DOI 10.1016/j.bbabio.2008.12.008
   Yani Ye. V., 2012, PRAKT MED, V1, P134
NR 15
TC 1
Z9 2
U1 0
U2 2
PU MAIK NAUKA/INTERPERIODICA/SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013-1578 USA
SN 0006-2979
EI 0320-9725
J9 BIOCHEMISTRY-MOSCOW+
JI Biochem.-Moscow
PD DEC
PY 2015
VL 80
IS 12
BP 1626
EP 1628
DI 10.1134/S0006297915120123
PG 3
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA CY6BB
UT WOS:000366491000012
PM 26638689
DA 2024-02-19
ER

PT J
AU Bonomini, F
   Filippini, F
   Hayek, T
   Aviram, M
   Keidar, S
   Rodella, LF
   Coleman, R
   Rezzani, R
AF Bonomini, Francesca
   Filippini, Francesca
   Hayek, Tony
   Aviram, Michael
   Keidar, Shlomo
   Rodella, Luigi F.
   Coleman, Raymond
   Rezzani, Rita
TI Apolipoprotein E and its role in aging and survival
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Apolipoprotein E; Aging; Liver; Kidney; Heart
ID OXIDATIVE STRESS; ATHEROSCLEROSIS; AGE; MICE; LIPOFUSCIN; MECHANISMS;
   EXPRESSION; PROTEINS; KIDNEY; MOUSE
AB The study of biological aging has seen spectacular progress in the last decade and markers are increasingly employed for understanding physiological processes that change with age. Recently, it has been demonstrated that apolipoprotein E (apoE) has a major impact on longevity, but its mechanisms are still not fully understood. ApoE-deficient (E-0) mice have proved to be a very popular model for studying spontaneous hypercholesterolemia and the subsequent development of atherosclerotic lesions, but only limited data are available with regard to aging and aging changes. We used this murine model to better characterize the involvement of apoE in aging and to evaluate its role in the maintenance of normal organ morphology. Our results show that E-0 mice at different ages (6, 12, 20 weeks old) developed age-dependent morphological and biochemical alterations, including fibrosis (newly formed collagen), pro-inflammatory cytokine (IL-6 and iNOS), lipofuscin accumulation, and decrease of antioxidant enzymes (superoxide dismutase and catalase) in several organs (kidney, liver and heart). It is significant that the observed degenerative findings in E-0 mice at different ages (6, 12, 20 weeks old) were not identified in control mice (C57BL), at 6, 12 and 20 weeks of age. Consequently, since these mice showed enzymatic and structural alterations, normally linked to the age, such as increase of lipofuscin, pro-inflammatory cytokines and decrease of antioxidant enzymes, we can conclude that apoE is a useful player in studies of longevity and age-related diseases, such as inflammatory status and atherosclerosis that are known risk factors for functional decline and early mortality. Moreover, it is possible that apoE may also play a role in other pathological conditions including, for example, cancer, rheumatoid arthritis and macular degeneration. (C) 2009 Elsevier Inc. All rights reserved.
C1 [Rezzani, Rita] Univ Brescia, Sch Med, Anat Sect, Dept Biomed Sci & Biotechnol,Div Human Anat, I-25123 Brescia, Italy.
   [Hayek, Tony; Aviram, Michael; Keidar, Shlomo] Technion Israel Inst Technol, Lipid Res Lab, Haifa, Israel.
   [Coleman, Raymond] Technion Israel Inst Technol, Rappaport Fac Med, Dept Anat & Cell Biol, Haifa, Israel.
C3 University of Brescia; Technion Israel Institute of Technology; Technion
   Israel Institute of Technology; Rappaport Faculty of Medicine
RP Rezzani, R (corresponding author), Univ Brescia, Sch Med, Anat Sect, Dept Biomed Sci & Biotechnol,Div Human Anat, Viale Europa 11, I-25123 Brescia, Italy.
EM rezzani@med.unibs.it
RI Francesca, Bonomini/E-9931-2010; Rodella, Luigi Fabrizio/F-1079-2010;
   Rezzani, Rita/E-9528-2010
OI Filippini, Francesca/0000-0001-5884-8635; Bonomini,
   Francesca/0000-0001-7210-0308; Rodella, Luigi
   Fabrizio/0000-0002-9497-4708
FU University of Brescia
FX We thank Dr R. Coates for the English revision of the paper. This study
   was supported by the grant (ex-60%) of the University of Brescia.
CR Adelman R C, 1978, Birth Defects Orig Artic Ser, V14, P355
   Ang LS, 2008, EXP GERONTOL, V43, P615, DOI 10.1016/j.exger.2008.03.010
   Aviram M, 2008, J AGR FOOD CHEM, V56, P1148, DOI 10.1021/jf071811q
   BJORKSTEN J, 1974, THEORETICAL ASPECTS, P43
   Brinkley TE, 2009, J GERONTOL A-BIOL, V64, P455, DOI 10.1093/gerona/gln038
   Brunk UT, 2002, FREE RADICAL BIO MED, V33, P611, DOI 10.1016/S0891-5849(02)00959-0
   Chung HY, 2009, AGEING RES REV, V8, P18, DOI 10.1016/j.arr.2008.07.002
   COBAN S, 2008, J SURG RES
   Coleman R, 2006, ACTA HISTOCHEM, V108, P415, DOI 10.1016/j.acthis.2006.07.002
   Crimmins E, 2008, ADV CLIN CHEM, V46, P161, DOI 10.1016/S0065-2423(08)00405-8
   Csiszar A, 2007, ACTA PHYSIOL HUNG, V94, P107, DOI 10.1556/APhysiol.94.2007.1-2.10
   DICE JF, 1993, PHYSIOL REV, V73, P149, DOI 10.1152/physrev.1993.73.1.149
   DURSUN E, 2009, ACTA HISTOCHEM
   Finch CE, 1997, SCIENCE, V278, P407, DOI 10.1126/science.278.5337.407
   FLORINI JR, 1981, MECH AGEING DEV, V15, P165, DOI 10.1016/0047-6374(81)90072-5
   Gupta S, 2000, SEMIN CANCER BIOL, V10, P161
   Jung T, 2007, ANN NY ACAD SCI, V1119, P97, DOI 10.1196/annals.1404.008
   JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   Kurdi M, 2009, AM J PHYSIOL-HEART C, V297, pH1545, DOI 10.1152/ajpheart.00032.2009
   Martin JE, 2007, J PATHOL, V211, P198, DOI 10.1002/path.2111
   Massey AC, 2006, CURR TOP DEV BIOL, V73, P205, DOI 10.1016/S0070-2153(05)73007-6
   Meir KS, 2004, ARTERIOSCL THROM VAS, V24, P1006, DOI 10.1161/01.ATV.0000128849.12617.f4
   Melov S, 2002, ANN NY ACAD SCI, V959, P330, DOI 10.1111/j.1749-6632.2002.tb02104.x
   Moghadasian MH, 2001, FASEB J, V15, P2623, DOI 10.1096/fj.01-0463com
   PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G
   Rajawat YS, 2009, AGEING RES REV, V8, P199, DOI 10.1016/j.arr.2009.05.001
   Rattan SIS, 2008, HUM EXP TOXICOL, V27, P151, DOI 10.1177/0960327107083409
   Rizzoni D, 2006, J CLIN ENDOCR METAB, V91, P2638, DOI 10.1210/jc.2006-0101
   Roberts CK, 2009, LIFE SCI, V84, P705, DOI 10.1016/j.lfs.2009.02.026
   Rodella LF, 2007, ACTA HISTOCHEM, V109, P45, DOI 10.1016/j.acthis.2006.08.002
   Rodwell GEJ, 2004, PLOS BIOL, V2, P2191, DOI 10.1371/journal.pbio.0020427
   Rosenblat M, 2006, J AGR FOOD CHEM, V54, P1928, DOI 10.1021/jf0528207
   Schmucker DL, 2001, DRUG AGING, V18, P837, DOI 10.2165/00002512-200118110-00005
   Schneider E. L., 1996, HDB BIOL AGING
   Smith JD, 2002, AGEING RES REV, V1, P345, DOI 10.1016/S1568-1637(02)00005-3
   Stacchiotti A, 2006, HISTOL HISTOPATHOL, V21, P131, DOI 10.14670/HH-21.131
   Szweda PA, 2003, AGEING RES REV, V2, P383, DOI 10.1016/S1568-1637(03)00028-X
   Terman Alexei, 2005, Heart Lung Circ, V14, P107, DOI 10.1016/j.hlc.2004.12.023
   Troen BR, 2003, MT SINAI J MED, V70, P3
   Weinert BT, 2003, J APPL PHYSIOL, V95, P1706, DOI 10.1152/japplphysiol.00288.2003
   Zhang HY, 2009, NEPHROLOGY, V14, P302, DOI 10.1111/j.1440-1797.2008.01072.x
   Zhou Q, 2007, OPHTHAL EPIDEMIOL, V14, P399, DOI 10.1080/09286580701331974
   Zhou XJ, 2008, KIDNEY INT, V74, P710, DOI 10.1038/ki.2008.319
NR 44
TC 48
Z9 51
U1 0
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD FEB
PY 2010
VL 45
IS 2
BP 149
EP 157
DI 10.1016/j.exger.2009.11.006
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 561TW
UT WOS:000275003100009
PM 19941948
DA 2024-02-19
ER

PT J
AU Iizuka, Y
   Kim, H
   Nakasatomi, M
   Matsumoto, A
   Shimizu, J
AF Iizuka, Yuzuru
   Kim, Hyounju
   Nakasatomi, Maki
   Matsumoto, Akiyo
   Shimizu, Jun
TI Phenotypic and genotypic changes in obesity and type 2 diabetes of male
   KK mice with aging
SO EXPERIMENTAL ANIMALS
LA English
DT Article
DE age-related changes; glucose metabolism; KK strain; lipid metabolism;
   model mouse
ID ADIPOSE-TISSUE; FATTY LIVER; INSULIN-RESISTANCE; ADIPONECTIN;
   METABOLISM; PROTEIN; AGE
AB Research into the prevention and treatment of age-related metabolic diseases are important in the present-day situation of the aging population. We propose that an elderly diabetic mouse model may be useful to such research as it exhibits deterioration of glucose and lipid metabolism. Although the KK mouse strain is commonly used as a model of moderate obesity and type 2 diabetes, the utility of this strain as an elderly obese and diabetic model mouse for research into aging remains unclear. The present study aimed to investigate age-related changes of glucose and lipid metabolism in male KK mice fed a standard chow diet. We demonstrate that 40 weeks KK mice exhibit age-related dysfunctions, such as development of insulin resistance associated with pancreatic islet hypertrophy and decreased lipolysis in white adipose tissue (WAT) compared with 15 weeks KK mice. However, aging does not appear to cause mitochondrial dysfunction of brown adipose tissue. Unexpectedly, hyperglycemia, potential glucose uptake in insulin-sensitive organs, hepatic lipid accumulation, hypertrophy of adipocytes, and inflammation in epididymal WAT did not worsen but rather compensated in 40 weeks KK mice. Our data indicate that the use of male KK mice as an elderly obese and diabetic mouse model has some limitations and in order to represent a useful elderly obese and diabetic animal model, it may be necessary to induce deterioration of glucose and lipid metabolism in KK mice through breeding with high-sucrose or high-fat diets.
C1 [Iizuka, Yuzuru] Tokyo Womens Med Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.
   [Kim, Hyounju] Teikyo Heisei Univ, Fac Hlth & Med Sci, Dept Hlth & Dietet, Toshima Ku, 2-51-4 Higashi Ikebukuro, Tokyo 1708445, Japan.
   [Nakasatomi, Maki; Matsumoto, Akiyo; Shimizu, Jun] Josai Univ, Fac Pharmaceut Sci, Dept Clin Dietet & Human Nutr, 1-1 Keyakidai, Sakado, Saitama 3500295, Japan.
C3 Tokyo Women's Medical University; Josai University
RP Kim, H (corresponding author), Teikyo Heisei Univ, Fac Hlth & Med Sci, Dept Hlth & Dietet, Toshima Ku, 2-51-4 Higashi Ikebukuro, Tokyo 1708445, Japan.
EM hyounju.kim@thu.ac.jp
CR Akagiri S, 2008, J CLIN BIOCHEM NUTR, V42, P150, DOI 10.3164/jcbn.2008022
   Aoi W, 2011, BIOCHEM BIOPH RES CO, V413, P330, DOI 10.1016/j.bbrc.2011.08.097
   Berndt A, 2014, VET PATHOL, V51, P846, DOI 10.1177/0300985813501335
   Bunprajun T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066628
   Cinti S, 2017, BIOCHIMIE, V134, P71, DOI 10.1016/j.biochi.2016.09.008
   dos Santos JM, 2012, CELL BIOCHEM FUNCT, V30, P191, DOI 10.1002/cbf.1834
   Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Gong ZW, 2017, MOL CELL ENDOCRINOL, V455, P115, DOI 10.1016/j.mce.2016.12.022
   Honma T, 2011, J NUTR SCI VITAMINOL, V57, P123, DOI 10.3177/jnsv.57.123
   HOUMARD JA, 1995, DIABETES, V44, P555, DOI 10.2337/diabetes.44.5.555
   Iizuka Y, 2016, PROSTAG LEUKOTR ESS, V115, P53, DOI 10.1016/j.plefa.2016.10.007
   IKEDA H, 1994, DIABETES RES CLIN PR, V24, pS313, DOI 10.1016/0168-8227(94)90268-2
   Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005
   Katsuta Wakana, 2018, J Phys Ther Sci, V30, P42, DOI 10.1589/jpts.30.42
   Kondo K., 1957, B EXP ANIMAL, V6, P107, DOI 10.1538/expanim1957.6.4_107
   Kuhla A, 2011, J GERONTOL A-BIOL, V66, P1192, DOI 10.1093/gerona/glr124
   Liu HH, 2015, AGEING RES REV, V19, P43, DOI 10.1016/j.arr.2014.12.001
   Ma JH, 2014, J BIOL CHEM, V289, P133, DOI 10.1074/jbc.M113.533240
   Meier JJ, 2013, DIABETES CARE, V36, pS113, DOI 10.2337/dcS13-2008
   Mendoza-Nunez Victor Manuel, 2009, BMC Geriatr, V9, P40, DOI 10.1186/1471-2318-9-40
   Mennes E, 2014, J GERONTOL A-BIOL, V69, P1060, DOI 10.1093/gerona/glt156
   Nakamura M, 1967, Diabetologia, V3, P212, DOI 10.1007/BF01222198
   Narita T, 2018, EXP GERONTOL, V104, P127, DOI 10.1016/j.exger.2018.01.016
   Nishimura M., 1969, EXP ANIMALS, V18, P147, DOI [DOI 10.1538/EXPANIM1957.18.4_147, 10.1538/expanim1957.18.4_147]
   Okosun IS, 2001, OBES RES, V9, P1, DOI 10.1038/oby.2001.1
   Petersen MC, 2018, PHYSIOL REV, V98, P2133, DOI 10.1152/physrev.00063.2017
   Reddi A S, 1988, Adv Exp Med Biol, V246, P7
   Sellayah D, 2014, ENDOCRINOLOGY, V155, P485, DOI 10.1210/en.2013-1629
   Serrano R, 2009, MECH AGEING DEV, V130, P189, DOI 10.1016/j.mad.2008.11.005
   Tanimura Y, 2019, EXP PHYSIOL, V104, P1051, DOI 10.1113/EP087449
   TOMITA T, 1992, PANCREAS, V7, P367, DOI 10.1097/00006676-199205000-00015
   Ueno N, 1998, MECH AGEING DEV, V100, P67, DOI 10.1016/S0047-6374(97)00123-1
   VELASQUEZ MT, 1990, FASEB J, V4, P2850, DOI 10.1096/fasebj.4.11.2199283
   Weir GC, 2001, DIABETES, V50, pS154, DOI 10.2337/diabetes.50.2007.S154
   Yadav A, 2013, CLIN CHIM ACTA, V417, P80, DOI 10.1016/j.cca.2012.12.007
   Yamashita M, 2016, J NUTR SCI VITAMINOL, V62, P249, DOI 10.3177/jnsv.62.249
   Zoico E, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00368
NR 38
TC 1
Z9 2
U1 3
U2 5
PU INT PRESS EDITING CENTRE INC
PI TOKYO
PA 1-2-3 SUGAMO, TOSHIMA-KU, TOKYO, 170 0002, JAPAN
SN 1341-1357
EI 1881-7122
J9 EXP ANIM TOKYO
JI Exp. Anim.
PY 2022
VL 71
IS 1
BP 71
EP 81
DI 10.1538/expanim.21-0109
PG 11
WC Veterinary Sciences; Zoology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Veterinary Sciences; Zoology
GA ZQ6PX
UT WOS:000767225800003
PM 34588391
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Barzilai, N
   Rossetti, L
AF Barzilai, N
   Rossetti, L
TI Age-related changes in body composition are associated with hepatic
   insulin resistance in conscious rats
SO AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
LA English
DT Article
DE fat mass; glucose-6-phosphate; glucose-6-phosphatase
ID GLUCOSE-PRODUCTION; FAT DISTRIBUTION; METABOLISM; OBESITY;
   RESPONSIVENESS; DISEASE; TISSUE; DIET
AB Age-dependent changes in body composition and hepatic ([H-3]glucose) glucose metabolism were examined in 2-, 4-, and 14-mo-old (n = 26) conscious Sprague-Dawley rats. Hepatic glucose production (HGP) and hepatic glucose-6-phosphatase maximum velocity were decreased land 30%, respectively, between 2 and 4 mo but were unchanged with further aging. However, between 4 and 14 mo, twofold higher plasma insulin levels were required to maintain similar HGP,suggesting that hepatic insulin resistance develops sr with age. Utilizing hepatic-pancreatic clamp technique, we showed that a much higher rate of insulin infusion(1.6 +/- 0.1 vs. 0.8 +/- 0.1 mU . kg-1 . min-1) was needed to achieve similar plasma glucose levels and HGP. Furthermore, when 4-mo-old rats were infused with insulin at similar rates as the 14-mo-old rats, HGP was decreased by similar to 30%. Because hepatic insulin sensitivity was inversely related to the increase in body weight (r(2) = 0.876) and free fatty acid levels (r(2) = 0.843), we suggest that age-related changes in body composition may lead to the impairment of hepatic glucose metabolism.
C1 YESHIVA UNIV ALBERT EINSTEIN COLL MED, CTR DIABET RES & TRAINING, BRONX, NY 10461 USA.
C3 Yeshiva University; Albert Einstein College of Medicine
RP Barzilai, N (corresponding author), YESHIVA UNIV ALBERT EINSTEIN COLL MED, DEPT MED, DIV ENDOCRINOL, 1300 MORRIS PK AVE, BRONX, NY 10461 USA.
FU NIA NIH HHS [K08-AG00639] Funding Source: Medline; NIDDK NIH HHS
   [R29-DK-45024, R01-DK-48321] Funding Source: Medline
CR BALDINI P, 1988, MECH AGEING DEV, V42, P17, DOI 10.1016/0047-6374(88)90059-0
   BARZILAI N, 1995, BIOCHEM J, V310, P819, DOI 10.1042/bj3100819
   BARZILAI N, 1995, AM J PHYSIOL-ENDOC M, V269, pE591, DOI 10.1152/ajpendo.1995.269.3.E591
   BARZILAI N, 1989, AGE, V12, P13, DOI 10.1007/BF02432513
   BARZILAI N, 1993, J BIOL CHEM, V268, P25019
   BERTRAND HA, 1980, J GERONTOL, V35, P827, DOI 10.1093/geronj/35.6.827
   BJORNTORP P, 1990, ARTERIOSCLEROSIS, V10, P493, DOI 10.1161/01.ATV.10.4.493
   BODEN G, 1994, J CLIN INVEST, V93, P2438, DOI 10.1172/JCI117252
   BODEN G, 1993, DIABETES CARE, V16, P728, DOI 10.2337/diacare.16.5.728
   BOGARDUS C, 1985, AM J PHYSIOL, V248, pE286, DOI 10.1152/ajpendo.1985.248.3.E286
   BORKAN GA, 1983, J GERONTOL, V38, P673, DOI 10.1093/geronj/38.6.673
   BRANCHOROMERO E, 1977, J AM GERIATR SOC, V25, P299
   COON PJ, 1992, J CLIN ENDOCR METAB, V75, P1125, DOI 10.1210/jc.75.4.1125
   DEFRONZO RA, 1979, DIABETES, V28, P1095, DOI 10.2337/diab.28.12.1095
   FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908
   FRAZE E, 1987, J AM GERIATR SOC, V35, P224, DOI 10.1111/j.1532-5415.1987.tb02313.x
   FULCHER GR, 1992, DIABETES, V41, P1400, DOI 10.2337/diabetes.41.11.1400
   HAZZARD DG, 1992, J GERONTOL, V47, pB63, DOI 10.1093/geronj/47.3.B63
   JACKSON RA, 1988, DIABETES, V37, P119, DOI 10.2337/diabetes.37.1.119
   JENSEN MD, 1989, J CLIN INVEST, V83, P1168, DOI 10.1172/JCI113997
   KALANT N, 1988, MECH AGEING DEV, V46, P89, DOI 10.1016/0047-6374(88)90117-0
   KONO S, 1990, AM J PHYSIOL, V259, pE27, DOI 10.1152/ajpendo.1990.259.1.E27
   NISHIMURA H, 1988, AM J PHYSIOL, V254, pE92, DOI 10.1152/ajpendo.1988.254.1.E92
   NOLEN GA, 1972, J NUTR, V102, P1477
   OSHAUGHNESSY IM, 1992, J CLIN ENDOCR METAB, V74, P1075, DOI 10.1210/jc.74.5.1075
   PRAGER R, 1986, J CLIN INVEST, V78, P472, DOI 10.1172/JCI112599
   REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595
   ROBERT JJ, 1982, DIABETES, V31, P203, DOI 10.2337/diabetes.31.3.203
   ROSSETTI L, 1993, J CLIN INVEST, V92, P1126, DOI 10.1172/JCI116681
   VRANIC M, 1992, DIABETES, V41, P1188, DOI 10.2337/diabetes.41.9.1188
   WILLIAMSON JR, 1966, P NATL ACAD SCI USA, V56, P247, DOI 10.1073/pnas.56.1.247
   WOLFE RR, 1984, TRACERS METABOLIC RE, V9, P17
NR 32
TC 43
Z9 43
U1 0
U2 0
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1849
EI 1522-1555
J9 AM J PHYSIOL-ENDOC M
JI Am. J. Physiol.-Endocrinol. Metab.
PD JUN
PY 1996
VL 270
IS 6
BP E930
EP E936
DI 10.1152/ajpendo.1996.270.6.E930
PG 7
WC Endocrinology & Metabolism; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Endocrinology & Metabolism; Physiology
GA UT489
UT WOS:A1996UT48900002
PM 8764175
DA 2024-02-19
ER

PT J
AU JIMENEZ, JAL
   BORDONI, A
   HRELIA, S
   ROSSI, CA
   TURCHETTO, E
   NAVARRO, SZ
   BIAGI, PL
AF JIMENEZ, JAL
   BORDONI, A
   HRELIA, S
   ROSSI, CA
   TURCHETTO, E
   NAVARRO, SZ
   BIAGI, PL
TI EVIDENCE FOR A DETECTABLE DELTA-6-DESATURASE ACTIVITY IN RAT-HEART
   MICROSOMES - AGING INFLUENCE ON ENZYME-ACTIVITY
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
ID FATTY-ACID COMPOSITION; AGE-RELATED-CHANGES; LIVER MICROSOMES;
   DESATURATION; BIOSYNTHESIS; DEFICIENCY; REVERSE
C1 UNIV BOLOGNA, DIPARTIMENTO BIOCHIM G MORUZZI, I-40126 BOLOGNA, ITALY.
C3 University of Bologna
RI Jimenez, Jose Angel Lopez/AAA-2321-2019; Hrelia, Silvana/P-2864-2015;
   Bordoni, Alessandra/J-3047-2012
OI Hrelia, Silvana/0000-0001-7857-4512; Bordoni,
   Alessandra/0000-0003-4579-1662
CR BIAGI PL, 1991, BIOCHIM BIOPHYS ACTA, V1083, P187, DOI 10.1016/0005-2760(91)90041-F
   BORDONI A, 1991, BIOCHEM BIOPH RES CO, V174, P869, DOI 10.1016/0006-291X(91)91498-2
   BORDONI A, 1988, BIOCHEM INT, V17, P1001
   BRENNER RR, 1971, LIPIDS, V6, P567, DOI 10.1007/BF02531137
   CLARK DL, 1985, BIOCHEM PHARMACOL, V34, P4305, DOI 10.1016/0006-2952(85)90289-8
   DESCRIJVER R, 1980, LIPIDS, V15, P512
   DUMM INTD, 1984, LIPIDS, V19, P91, DOI 10.1007/BF02534497
   GRINNA LS, 1972, BIOCHIM BIOPHYS ACTA, V288, P347, DOI 10.1016/0005-2736(72)90255-6
   HRELIA S, 1989, BIOCHEM BIOPH RES CO, V163, P348, DOI 10.1016/0006-291X(89)92142-6
   LEFKOWITH JB, 1985, J BIOL CHEM, V260, P5736
   MARCEL YL, 1972, J BIOL CHEM, V247, P4433
   NEEDLEMAN P, 1985, BIOCHIM BIOPHYS ACTA, V836, P267, DOI 10.1016/0005-2760(85)90075-X
   TAHIN QS, 1981, EUR J BIOCHEM, V121, P5, DOI 10.1111/j.1432-1033.1981.tb06421.x
   ZEVENBERGEN JL, 1986, ENZYMES LIPID METABO, V2, P647
NR 14
TC 32
Z9 32
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD MAY 14
PY 1993
VL 192
IS 3
BP 1037
EP 1041
DI 10.1006/bbrc.1993.1521
PG 5
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA LC531
UT WOS:A1993LC53100009
PM 8507178
DA 2024-02-19
ER

PT J
AU BRAVO, E
   BOTHAM, KM
   MINDHAM, MA
   MAYES, PA
   MARINELLI, T
   CANTAFORA, A
AF BRAVO, E
   BOTHAM, KM
   MINDHAM, MA
   MAYES, PA
   MARINELLI, T
   CANTAFORA, A
TI DECREASED HEPATIC-UPTAKE AND PROCESSING OF HIGH-DENSITY-LIPOPROTEIN
   UNESTERIFIED CHOLESTEROL AND CHOLESTERYL ESTER WITH AGE IN THE RAT
SO JOURNAL OF BIOCHEMISTRY
LA English
DT Article
DE AGING; BILIARY STEROIDS; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; RAT
AB As part of a study of the effects of aging on lipoprotein metabolism, the uptake and processing in vivo of cholesterol from high density lipoprotein (HDL) was compared in young (3 months of age) and mature (10-12 months of age) rats by studying the fate of HDL [H-3] unesterified cholesterol or [H-3]cholesteryl ester after intravenous administration. Radioactivity from [H-3] unesterified cholesterol was cleared from the blood more slowly in older rats, and this difference was accounted for by decreased uptake by the liver. Uptake by other tissues was unaffected. In addition, a shift in the distribution of radioactivity across the plasma lipoprotein density range from the d = 1.125-1.250 g/ml (HDL(3)) to the d= 1.050-1.085 g/ml (HDL(1)) fraction was observed in the mature as compared to the young rat group. The secretion of radioactivity from [H-3] unesterified cholesterol into bile was also decreased in the older animals, particularly in the first hour after injection of the label. In the case of HDL labeled with [H-3] cholesteryl ester, clearance from the blood was similar in both age groups in the first 30 min after injection, but was significantly lower in older rats at later time points. After 180 min, less radioactivity was found in the VLDL density fraction in mature as compared to young rats, suggesting that hepatic secretion of VLDL cholesterol originating from HDL cholesteryl ester is less efficient in the older animals. The amount of radioactivity from HDL [H-3]cholesteryl ester secreted in bile was less in the mature rat group at all time points measured. In addition, labeled bile acid from both HDL unesterified and esterified cholesterol accumulated in the liver to a greater extent in older as compared to younger animals. These results demonstrate that the efficiency of reverse cholesterol transport associated with HDL decreases with age in the rat, and that both slower biliary excretion and slower hepatic metabolism of HDL unesterified cholesterol and cholesteryl ester contribute to this process. It is likely that this effect is associated with the increase in plasma cholesterol levels which occurs with age. Caution is necessary when applying these results to species having the cholesteryl ester transfer protein.
C1 UNIV LONDON ROYAL COLL VET SURG, DEPT VET BASIC SCI, LONDON NW1 0TU, ENGLAND.
C3 University of London; University of London Royal Veterinary College
RP BRAVO, E (corresponding author), IST SUPER SANITA, METAB & PATHOL BIOCHEM LAB, VIALE REGINA ELENA, I-00161 ROME, ITALY.
RI Bravo, Elena/K-2170-2012; Bravo, Elena/AAH-7512-2021
OI Bravo, Elena/0000-0002-3473-6767; Bravo, Elena/0000-0002-3473-6767;
   Botham, Kathleen/0000-0002-0221-979X
CR BARTER PJ, 1978, BIOCHIM BIOPHYS ACTA, V531, P233, DOI 10.1016/0005-2760(78)90147-9
   BECKETT GJ, 1979, CLIN CHIM ACTA, V93, P145, DOI 10.1016/0009-8981(79)90255-9
   BOTHAM KM, 1983, FEBS LETT, V151, P19, DOI 10.1016/0014-5793(83)80333-0
   BRAVO E, 1989, BIOCHIM BIOPHYS ACTA, V1003, P315, DOI 10.1016/0005-2760(89)90238-5
   BRAVO E, 1990, BIOCHIM BIOPHYS ACTA, V1045, P74, DOI 10.1016/0005-2760(90)90205-C
   BRAVO E, 1994, J BIOCHEM-TOKYO, V115, P833, DOI 10.1093/oxfordjournals.jbchem.a124425
   CANTAFORA A, 1993, ARCH GERONTOL GERIAT, V16, P249, DOI 10.1016/0167-4943(93)90036-H
   CANTAFORA A, 1992, ARCH GERONTOL GERI S, V3, P93
   DUPONT J, 1985, LIPIDS, V20, P825, DOI 10.1007/BF02534408
   ERICKSSON S, 1957, P SOC EXP BIOL MED, V94, P578
   ESNAULTDUPUY C, 1987, BIOCHIMIE, V69, P45, DOI 10.1016/0300-9084(87)90270-7
   FERLAND G, 1989, LIPIDS, V24, P842, DOI 10.1007/BF02535757
   GAVISH D, 1987, J LIPID RES, V28, P257
   GLOMSET JA, 1968, J LIPID RES, V9, P155
   KITANI K, 1981, MECH AGEING DEV, V7, P381
   KREISBERG RA, 1987, AM J MED, V82, P54, DOI 10.1016/0002-9343(87)90272-5
   KRITCHEVSKY D, 1979, FED PROC, V38, P2001
   KROKER R, 1980, MECH AGEING DEV, V12, P367, DOI 10.1016/0047-6374(80)90069-X
   KRUZA Z, 1973, EXP GERONTOL, V8, P29
   MALHOTRA S, 1978, MECH AGEING DEV, V8, P445, DOI 10.1016/0047-6374(78)90044-1
   MILLER NE, 1985, NATURE, V314, P109, DOI 10.1038/314109a0
   MINDHAM MA, 1991, BIOCHEM J, V279, P503, DOI 10.1042/bj2790503
   MINDHAM MA, 1990, BIOCHEM J, V268, P499, DOI 10.1042/bj2680499
   MINDHAM MA, 1994, BIOCHEM SOC T, V22, pS107, DOI 10.1042/bst022107s
   MINDHAM MA, 1993, BIOCHEM J, V302, P207
   ORAM JF, 1989, INT CONGR SER, V826, P225
   PORTMAN OW, 1980, BIOCHIM BIOPHYS ACTA, V619, P545, DOI 10.1016/0005-2760(80)90106-X
   REICHL D, 1986, CLIN SCI, V70, P221, DOI 10.1042/cs0700221
   REICHL D, 1982, ATHEROSCLEROSIS, V44, P73, DOI 10.1016/0021-9150(82)90054-5
   RIFKIND BM, 1990, AM J CARDIOL, V66, pA3, DOI 10.1016/0002-9149(90)90561-E
   ROSENMAN RH, 1952, P SOC EXP BIOL MED, V81, P296, DOI 10.3181/00379727-81-19855
   SCHWARTZ CC, 1981, BIOCHIM BIOPHYS ACTA, V663, P143, DOI 10.1016/0005-2760(81)90201-0
   SCHWARTZ CC, 1978, SCIENCE, V200, P62, DOI 10.1126/science.204996
   SCOBEY MW, 1989, AM J PHYSIOL, V257, pG644, DOI 10.1152/ajpgi.1989.257.4.G644
   SHEFER S, 1972, J LIPID RES, V13, P402
   SIEDEL J, 1983, CLIN CHEM, V29, P1075
   STAHLBERG D, 1991, LIPIDS, V26, P349, DOI 10.1007/BF02537197
   STONE BG, 1992, J LIPID RES, V33, P1665
   STONE BG, 1985, J CLIN INVEST, V76, P1773, DOI 10.1172/JCI112168
   UCHIDA K, 1978, J LIPID RES, V19, P544
NR 40
TC 0
Z9 0
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0021-924X
J9 J BIOCHEM
JI J. Biochem.
PD NOV
PY 1994
VL 116
IS 5
BP 1088
EP 1095
DI 10.1093/oxfordjournals.jbchem.a124632
PG 8
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA PQ969
UT WOS:A1994PQ96900025
PM 7896736
DA 2024-02-19
ER

PT J
AU Wagner, V
   Kern, F
   Hahn, O
   Schaum, N
   Ludwig, N
   Fehlmann, T
   Engel, A
   Henn, D
   Rishik, S
   Isakova, A
   Tan, MCL
   Sit, R
   Neff, N
   Hart, M
   Meese, E
   Quake, S
   Wyss-Coray, T
   Keller, A
AF Wagner, Viktoria
   Kern, Fabian
   Hahn, Oliver
   Schaum, Nicholas
   Ludwig, Nicole
   Fehlmann, Tobias
   Engel, Annika
   Henn, Dominic
   Rishik, Shusruto
   Isakova, Alina
   Tan, Michelle
   Sit, Rene
   Neff, Norma
   Hart, Martin
   Meese, Eckart
   Quake, Steve
   Wyss-Coray, Tony
   Keller, Andreas
TI Characterizing expression changes in noncoding RNAs during aging and
   heterochronic parabiosis across mouse tissues
SO NATURE BIOTECHNOLOGY
LA English
DT Article; Early Access
ID LIFE-SPAN; MICRORNAS; BIOMARKER
AB Molecular mechanisms of organismal and cell aging remain incompletely understood. We, therefore, generated a body-wide map of noncoding RNA (ncRNA) expression in aging (16 organs at ten timepoints from 1 to 27 months) and rejuvenated mice. We found molecular aging trajectories are largely tissue-specific except for eight broadly deregulated microRNAs (miRNAs). Their individual abundance mirrors their presence in circulating plasma and extracellular vesicles (EVs) whereas tissue-specific ncRNAs were less present. For miR-29c-3p, we observe the largest correlation with aging in solid organs, plasma and EVs. In mice rejuvenated by heterochronic parabiosis, miR-29c-3p was the most prominent miRNA restored to similar levels found in young liver. miR-29c-3p targets the extracellular matrix and secretion pathways, known to be implicated in aging. We provide a map of organism-wide expression of ncRNAs with aging and rejuvenation and identify a set of broadly deregulated miRNAs, which may function as systemic regulators of aging via plasma and EVs.
   An atlas of noncoding RNA in aging and rejuvenated mice identifies a set of deregulated miRNAs.
C1 [Wagner, Viktoria; Kern, Fabian; Fehlmann, Tobias; Engel, Annika; Rishik, Shusruto; Keller, Andreas] Saarland Univ, Clin Bioinformat, Saarbrucken, Germany.
   [Kern, Fabian; Hahn, Oliver; Schaum, Nicholas; Wyss-Coray, Tony; Keller, Andreas] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.
   [Kern, Fabian; Keller, Andreas] Saarland Univ Campus, Helmholtz Inst Pharmaceut Res Saarland HIPS, Helmholtz Ctr Infect Res HZI, Saarbrucken, Germany.
   [Ludwig, Nicole; Hart, Martin; Meese, Eckart] Saarland Univ, Dept Human Genet, Saarbrucken, Saarland, Germany.
   [Henn, Dominic] Univ Texas Southwestern Med Ctr, Dept Plast Surg, Dallas, TX USA.
   [Isakova, Alina; Tan, Michelle; Sit, Rene; Neff, Norma; Quake, Steve] Stanford Univ, Dept Bioengn, Stanford, CA USA.
   [Wyss-Coray, Tony] Stanford Univ, Phil & Penny Knight Initiat Brain Resilience, Stanford, CA 94305 USA.
C3 Saarland University; Stanford University; Helmholtz Association;
   Helmholtz-Center for Infection Research; Saarland University; Saarland
   University; University of Texas System; University of Texas Southwestern
   Medical Center Dallas; Stanford University; Stanford University
RP Keller, A (corresponding author), Saarland Univ, Clin Bioinformat, Saarbrucken, Germany.; Wyss-Coray, T; Keller, A (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.; Keller, A (corresponding author), Saarland Univ Campus, Helmholtz Inst Pharmaceut Res Saarland HIPS, Helmholtz Ctr Infect Res HZI, Saarbrucken, Germany.; Wyss-Coray, T (corresponding author), Stanford Univ, Phil & Penny Knight Initiat Brain Resilience, Stanford, CA 94305 USA.
EM twc@stanford.edu; andreas.keller@ccb.uni-saarland.de
RI Engel, Annika/JNR-0469-2023; Meese, Eckart Ulrich/ABD-1983-2021
OI Ludwig, Nicole/0000-0003-4703-7567; Engel, Annika/0000-0001-5570-3115;
   Isakova, Alina/0000-0003-1113-6889; Wagner, Viktoria
   Philine/0000-0002-1957-0658; Kern, Fabian Michael/0000-0002-8223-3750;
   Fehlmann, Tobias/0000-0003-1967-2918; Wyss-Coray,
   Tony/0000-0001-5893-0831
FU M.J. Fox Foundation [MJFF-021418]; Schaller-Nikolich Foundation;
   Saarland University; DFG [466168626]
FX We thank all members of the Wyss-Coray and Meese lab, as well as all
   members of the Keller lab for feedback and support. We would like to
   thank the C. Zuckerberg Biohub. This study is funded by the M.J. Fox
   Foundation (MJFF-021418; A. K. and T.W-C.), the Schaller-Nikolich
   Foundation (A.K.) and Saarland University. Computational resources used
   within this study were financed through the DFG project 466168626
   (A.K.).
CR Bartel DP, 2018, CELL, V173, P20, DOI 10.1016/j.cell.2018.03.006
   Buschmann D, 2016, NUCLEIC ACIDS RES, V44, P5995, DOI 10.1093/nar/gkw545
   Castellano JM, 2015, JAMA NEUROL, V72, P1191, DOI 10.1001/jamaneurol.2015.1616
   Clark PM, 2014, SCI REP-UK, V4, DOI 10.1038/srep05947
   Ding DQ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02622-w
   Fehlmann T, 2021, NUCLEIC ACIDS RES, V49, pW397, DOI 10.1093/nar/gkab268
   Fehlmann T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19665-1
   Fehlmann T, 2018, BIOINFORMATICS, V34, P1621, DOI 10.1093/bioinformatics/btx814
   Garcia-Martin R, 2022, NATURE, V601, P446, DOI 10.1038/s41586-021-04234-3
   Gerstner N, 2020, NUCLEIC ACIDS RES, V48, pW515, DOI 10.1093/nar/gkaa306
   Horvath S, 2018, NAT REV GENET, V19, P371, DOI 10.1038/s41576-018-0004-3
   Hücker SM, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24611-w
   Kern F, 2021, bioRxiv, DOI [10.1101/2021.05.07.443093, 10.1101/2021.05.07.443093, DOI 10.1101/2021.05.07.443093]
   Kern F, 2021, NUCLEIC ACIDS RES, V49, P127, DOI 10.1093/nar/gkaa1161
   Kumari R, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109390
   Levine ME, 2018, AGING-US, V10, P573, DOI 10.18632/aging.101414
   Li XZG, 2013, MOL CELL, V50, P67, DOI 10.1016/j.molcel.2013.02.016
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Ludwig N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05070-0
   Lyu GL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06710-3
   Mavrogonatou E, 2019, MATRIX BIOL, V75-76, P27, DOI 10.1016/j.matbio.2017.10.004
   O'Brien J, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00402
   Pálovics R, 2022, NATURE, V603, P309, DOI 10.1038/s41586-022-04461-2
   Pan HY, 2021, CANCER CELL INT, V21, DOI 10.1186/s12935-020-01644-7
   Patil AH, 2022, GIGASCIENCE, V11, DOI 10.1093/gigascience/giac083
   Raabe CA, 2014, NUCLEIC ACIDS RES, V42, P1414, DOI 10.1093/nar/gkt1021
   Schaum N, 2020, NATURE, V583, P596, DOI 10.1038/s41586-020-2499-y
   Schaum N, 2018, NATURE, V562, P367, DOI 10.1038/s41586-018-0590-4
   Singh J, 2016, AM J PHYSIOL-GASTR L, V311, pG964, DOI 10.1152/ajpgi.00290.2016
   Szczyrba J, 2017, PROSTATE CANCER, V2017, DOI 10.1155/2017/4893921
   Szklarczyk D, 2021, NUCLEIC ACIDS RES, V49, pD605, DOI 10.1093/nar/gkaa1074
   Takeda T, 2016, BIOCHEM BIOPH RES CO, V471, P454, DOI 10.1016/j.bbrc.2016.02.055
   Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043
   Tosar JP, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-017-0001-7
   Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112
   Valdes AM, 2013, NAT REV GENET, V14, P601, DOI 10.1038/nrg3553
   van der Maaten L, 2008, J MACH LEARN RES, V9, P2579
   van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105
   Wu H, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1281-7
   Ximerakis M, 2019, NAT NEUROSCI, V22, P1696, DOI 10.1038/s41593-019-0491-3
   Yan Z, 2011, NUCLEIC ACIDS RES, V39, P6596, DOI 10.1093/nar/gkr298
   Yuan Y, 2021, AGING DIS, V12, P1304, DOI 10.14336/AD.2021.0115
   Zhang YL, 2017, NATURE, V548, P52, DOI 10.1038/nature23282
   Zhou Z, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03838-x
NR 44
TC 4
Z9 4
U1 3
U2 14
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 1087-0156
EI 1546-1696
J9 NAT BIOTECHNOL
JI Nat. Biotechnol.
PD 2023 APR 27
PY 2023
DI 10.1038/s41587-023-01751-6
EA APR 2023
PG 28
WC Biotechnology & Applied Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology
GA E7ND2
UT WOS:000977358900002
PM 37106037
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU Zambonin, L
   Prata, C
   Cabrini, L
   Maraldi, T
   Florentini, D
   Sega, FVD
   Hakim, G
   Landi, L
AF Zambonin, Laura
   Prata, Cecilia
   Cabrini, Luciana
   Maraldi, Tullia
   Florentini, Diana
   Sega, Francesco Vieceli Dalla
   Hakim, Gabriele
   Landi, Laura
TI Effect of radical stress and ageing on the occurrence of <i>trans</i>
   fatty acids in rats fed a <i>trans</i>-free diet
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE trans fatty acids; cis/trans isomerization; radical stress; membrane
   phospholipids; ageing; vitamin A; vitamin E
ID THIYL RADICALS; ARACHIDONIC ACIDS; OXIDATIVE STRESS; SYSTEMIC
   INFLAMMATION; LIPID-COMPOSITION; ISOMERIZATION; PHOSPHOLIPIDS; RESIDUES;
   BIOMARKERS; ANTIOXIDANTS
AB In a previous paper, we demonstrated that tissue trans fatty acids can not only derive from the diet but also be endogenously formed. The central focus of this study was to prove that the in vivo isomerization occurs via a radical process. Two different models of radical insult were used: CCl4 and AAPH injection to rats fed a diet completely free of trans isomers. Following this acute radical stress, a significant increase in unnatural trans fatty acid content of erythrocyte, kidney, and heart, but not liver, was observed. These results can be mainly explained by the high content, particularly in the liver, of antioxidant vitamins A and E that exhibit also an "anti-isomerizing" effect. Since during ageing cellular components are exposed to increasing radical insults, the observation of a significant trans fatty acid accumulation in 30-month-old rats could confirm that the in vivo formation of unnatural isomers is due to a radical process. Trans fatty acids can influence the physical characteristics of bilayer microdomains, affecting membrane properties and functions; thus, knowledge of biological radical species responsible for cis/trans isomerization and their possible sources can provide protective systems for preserving lipid geometry. (c) 2007 Elsevier Inc. All rights reserved.
C1 [Zambonin, Laura; Prata, Cecilia; Cabrini, Luciana; Maraldi, Tullia; Florentini, Diana; Sega, Francesco Vieceli Dalla; Hakim, Gabriele; Landi, Laura] Univ Bologna, Dipartimento Biochim, Alma Mater Studiorum, I-40126 Bologna, Italy.
C3 University of Bologna
RP Landi, L (corresponding author), Univ Bologna, Dipartimento Biochim, Alma Mater Studiorum, Via Irnerio 48, I-40126 Bologna, Italy.
EM laura.landi@unibo.it
RI Maraldi, Tullia/J-5264-2016; Vieceli Dalla Sega,
   Francesco/GQZ-1869-2022; Zambonin, Laura/J-4883-2012
OI Maraldi, Tullia/0000-0003-3331-2513; Vieceli Dalla Sega,
   Francesco/0000-0003-3445-3983; Prata, Cecilia/0000-0003-2766-9006;
   ZAMBONIN, LAURA/0000-0001-7050-7825
CR Balazy M, 2000, J PHYSIOL PHARMACOL, V51, P597
   BALDWIN SA, 1989, METHOD ENZYMOL, V174, P39
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Caboni MF, 1996, J AM OIL CHEM SOC, V73, P1561, DOI 10.1007/BF02523525
   Casal S, 2001, J CHROMATOGR B, V763, P1, DOI 10.1016/S0378-4347(01)00349-8
   Chatgilialoglu C, 2002, FREE RADICAL BIO MED, V33, P1681, DOI 10.1016/S0891-5849(02)01143-7
   Chatgilialoglu C, 2000, J AM CHEM SOC, V122, P4593, DOI 10.1021/ja994169s
   Dawson HD, 2000, J NUTR, V130, P1280, DOI 10.1093/jn/130.5.1280
   DOOLEY MM, 1990, FREE RADICAL BIO MED, V9, P199, DOI 10.1016/0891-5849(90)90028-H
   Ferreri C, 2005, CELL MOL LIFE SCI, V62, P834, DOI 10.1007/s00018-005-4475-y
   Ferreri C, 2005, FREE RADICAL BIO MED, V38, P1180, DOI 10.1016/j.freeradbiomed.2004.12.026
   Ferreri C, 2002, FREE RADICAL BIO MED, V33, P1516, DOI 10.1016/S0891-5849(02)01083-3
   Ferreri C, 2001, J AM CHEM SOC, V123, P4459, DOI 10.1021/ja0040969
   Ferreri C, 1999, CHEM COMMUN, P407, DOI 10.1039/a809674k
   Fiorentini D, 1999, FREE RADICAL BIO MED, V26, P661, DOI 10.1016/S0891-5849(98)00255-X
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014
   Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492
   Ibrahim SA, 2001, J NUTR BIOCHEM, V12, P116, DOI 10.1016/S0955-2863(00)00150-9
   Jiang HL, 1999, J BIOL CHEM, V274, P16235, DOI 10.1074/jbc.274.23.16235
   Kadiiska MB, 2005, FREE RADICAL BIO MED, V38, P698, DOI 10.1016/j.freeradbiomed.2004.09.017
   Kadiiska MB, 2005, FREE RADICAL BIO MED, V38, P711, DOI 10.1016/j.freeradbiomed.2004.10.024
   Kadiiska MB, 2000, FREE RADICAL BIO MED, V28, P838, DOI 10.1016/S0891-5849(00)00198-2
   Kermorvant-Duchemin E, 2005, NAT MED, V11, P1339, DOI 10.1038/nm1336
   KINSELLA JE, 1981, AM J CLIN NUTR, V34, P2307, DOI 10.1093/ajcn/34.10.2307
   Lopez-Garcia E, 2005, J NUTR, V135, P562, DOI 10.1093/jn/135.3.562
   Mozaffarian D, 2004, AM J CLIN NUTR, V80, P1521, DOI 10.1093/ajcn/80.6.1521
   Mozaffarian D, 2004, AM J CLIN NUTR, V79, P606, DOI 10.1093/ajcn/79.4.606
   NIKI E, 1988, CHEM-BIOL INTERACT, V67, P81, DOI 10.1016/0009-2797(88)90088-9
   Rauch J, 2003, J BIOL CHEM, V278, P47508, DOI 10.1074/jbc.M308089200
   RECKNAGEL RO, 1989, PHARMACOL THERAPEUT, V43, P139, DOI 10.1016/0163-7258(89)90050-8
   SGOUTAS DS, 1969, LIPIDS, V4, P283, DOI 10.1007/BF02533187
   Sprinz H, 2000, BBA-MOL CELL BIOL L, V1483, P91, DOI 10.1016/S1388-1981(99)00175-4
   Sprinz H, 2001, ADV COLLOID INTERFAC, V89, P313, DOI 10.1016/S0001-8686(00)00063-4
   Sundram K, 1997, J NUTR, V127, pS514, DOI 10.1093/jn/127.3.514S
   TERAO K, 1986, Journal of Free Radicals in Biology and Medicine, V2, P193
   WALLING C, 1959, J AM CHEM SOC, V81, P1144, DOI 10.1021/ja01514a032
   Willett WC, 2006, ATHEROSCLEROSIS SUPP, V7, P5, DOI 10.1016/j.atherosclerosissup.2006.04.002
   Wu DY, 2004, CURR OPIN LIPIDOL, V15, P43, DOI 10.1097/00041433-200402000-00009
   Zaloga Gary P, 2006, Nutr Clin Pract, V21, P505, DOI 10.1177/0115426506021005505
   Zambonin L, 2006, FREE RADICAL BIO MED, V40, P1549, DOI 10.1016/j.freeradbiomed.2005.12.021
   2006, FREE RADIC RES, V40, P1229
NR 43
TC 21
Z9 22
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD FEB 15
PY 2008
VL 44
IS 4
BP 594
EP 601
DI 10.1016/j.freeradbiomed.2007.10.034
PG 8
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 261OS
UT WOS:000253090200011
PM 18021747
DA 2024-02-19
ER

PT J
AU Schröder, K
   Schütz, S
   Schlöffel, I
   Bätz, S
   Takac, I
   Weissmann, N
   Michaelis, UR
   Koyanagi, M
   Brandes, RP
AF Schroeder, Katrin
   Schuetz, Susanne
   Schloeffel, Isabella
   Baetz, Sina
   Takac, Ina
   Weissmann, Norbert
   Michaelis, U. Ruth
   Koyanagi, Masamichi
   Brandes, Ralf P.
TI Hepatocyte Growth Factor Induces a Proangiogenic Phenotype and Mobilizes
   Endothelial Progenitor Cells by Activating Nox2
SO ANTIOXIDANTS & REDOX SIGNALING
LA English
DT Article
ID PROTEIN-TYROSINE-PHOSPHATASE; FACTOR-INDUCED MIGRATION; FACTOR RECEPTOR;
   NAD(P)H OXIDASE; SIGNAL-TRANSDUCTION; NADPH OXIDASES; UP-REGULATION;
   EXPRESSION; PATHWAY; MET
AB Hepatocyte growth factor (HGF) by stimulating the receptor tyrosine kinase c-Met induces angiogenesis and tissue regeneration. HGF has been shown to antagonize the angiotensin II-induced senescence of endothelial progenitor cells (EPCs), which is mediated by NADPH oxidase-dependent reactive oxygen species (ROS) formation. As growth factors, however, usually require ROS for their signaling, we hypothesized that the proangiogenic effects of HGF require NADPH oxidases and focused on the homolog Nox2, which is most abundantly expressed in EPCs and endothelial cells. Indeed, HGF increased the H2O2 formation in EPCs and human umbilical vein endothelial cells (HUVECs), and this effect was not observed in Nox2-deficient cells. HGF induced the mobilization of EPCs and vascular outgrowth from aortic explants in wild-type (WT) but not Nox2(y/-) mice. HGF also stimulated migration and tube formation in HUVECs, and antisense oligonucleotides against Nox2 prevented this effect. To identify the signal transduction underlying these effects, we focused on the kinases Jak2 and Jnk. In HUVECs, HGF increased the phosphorylation of these in a Nox2-dependent manner as demonstrated by antisense oligonucleotides. Also, the HGF-induced Jak2-dependent activation of a STAT3 reporter construct was attenuated after downregulation of Nox2. Accordingly, the HGF-stimulated tube formation of HUVEC was blocked by inhibitors of Jak2 and Jnk. In vivo treatment with the Jnk inhibitor SP600125 blocked the HGF-induced mobilization of EPCs. Ex vivo, SP600125 blocked HGF-induced migration and tube formation. We conclude that HGF-induced mobilization of EPCs and the proangiogenic effects of the growth factor require a Nox2-dependent ROS-mediated activation of Jak2 and Jnk. Antioxid. Redox Signal. 15, 915-923.
C1 [Schroeder, Katrin; Schuetz, Susanne; Schloeffel, Isabella; Baetz, Sina; Takac, Ina; Michaelis, U. Ruth; Brandes, Ralf P.] Goethe Univ Frankfurt, Inst Kardiovaskulare Physiol, D-60590 Frankfurt, Germany.
   [Weissmann, Norbert] Univ Giessen, Lung Ctr, ECCPS, Giessen, Germany.
   [Koyanagi, Masamichi] Goethe Univ Frankfurt, Inst Cardiovasc Regenerat, D-60590 Frankfurt, Germany.
C3 Goethe University Frankfurt; Justus Liebig University Giessen; Goethe
   University Frankfurt
RP Schröder, K (corresponding author), Goethe Univ Frankfurt, Inst Kardiovaskulare Physiol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.
EM schroeder@zphys1.uni-frankfurt.de
RI Brandes, Ralf P/L-3058-2017; Schröder, Katrin/E-6874-2013
OI Brandes, Ralf P/0000-0002-8035-0048; Schröder,
   Katrin/0000-0002-3099-526X; Weissmann, Norbert/0000-0003-2675-3871
FU Deutsche Forschungsgemeinschaft [SFB815/TP1, SFB834/TPA2]; excellence
   cluster cardio-pulmonary system (ECCPS); Hugelschaffner-Stiftung;
   Goethe-University; Grants-in-Aid for Scientific Research [23591083]
   Funding Source: KAKEN
FX This study was supported by grants from the Deutsche
   Forschungsgemeinschaft (SFB815/TP1 [K. S.], SFB834/TPA2 [R. P. B.]), the
   excellence cluster cardio-pulmonary system (ECCPS) (R. P. B.), the
   Hugelschaffner-Stiftung (K. S.), and the Goethe-University.
CR Brandes RP, 2010, FREE RADICAL BIO MED, V49, P687, DOI 10.1016/j.freeradbiomed.2010.04.030
   Brandes RP, 2005, CARDIOVASC RES, V65, P16, DOI 10.1016/j.cardiores.2004.08.007
   Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023
   CANTLEY LG, 1995, J AM SOC NEPHROL, V5, P1872
   Chan PC, 2010, ONCOGENE, V29, P698, DOI 10.1038/onc.2009.363
   Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049
   Comoglio P M, 1993, EXS, V65, P131
   Datla SR, 2007, HYPERTENSION, V50, P636, DOI 10.1161/HYPERTENSIONAHA.107.092296
   Ding SL, 2003, BLOOD, V101, P4816, DOI 10.1182/blood-2002-06-1731
   GRANT DS, 1993, P NATL ACAD SCI USA, V90, P1937, DOI 10.1073/pnas.90.5.1937
   Hong HY, 2008, FEBS LETT, V582, P861, DOI 10.1016/j.febslet.2008.02.012
   Jaster R, 1997, MOL CELL BIOL, V17, P3364, DOI 10.1128/MCB.17.6.3364
   Kamimoto M, 2009, BIOCHEM BIOPH RES CO, V380, P333, DOI 10.1016/j.bbrc.2009.01.080
   Kitta K, 2001, FREE RADICAL BIO MED, V31, P902, DOI 10.1016/S0891-5849(01)00663-3
   KMIECIK TE, 1992, BLOOD, V80, P2454
   Kodama A, 2000, MOL BIOL CELL, V11, P2565, DOI 10.1091/mbc.11.8.2565
   Kohlstedt K, 2004, CIRC RES, V94, P60, DOI 10.1161/01.RES.0000107195.13573.E4
   Krötz F, 2005, J AM COLL CARDIOL, V45, P1700, DOI 10.1016/j.jacc.2005.02.039
   Lee IT, 2008, J IMMUNOL, V181, P5098, DOI 10.4049/jimmunol.181.7.5098
   Li JX, 2008, J BIOL CHEM, V283, P34260, DOI 10.1074/jbc.M806087200
   Lin HH, 2009, J THROMB HAEMOST, V7, P1401, DOI 10.1111/j.1538-7836.2009.03478.x
   Machide M, 2006, J BIOL CHEM, V281, P8765, DOI 10.1074/jbc.M512298200
   Mahadev K, 2004, MOL CELL BIOL, V24, P1844, DOI 10.1128/MCB.24.5.1844-1854.2004
   Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8
   Nakamura T, 2000, J CLIN INVEST, V106, P1511, DOI 10.1172/JCI10226
   Nakamura Y, 2008, CIRC RES, V102, P1182, DOI 10.1161/CIRCRESAHA.107.167080
   Ponce ML, 2001, METH MOLEC MED, V46, P205, DOI 10.1385/1-59259-143-4:205
   Radhakrishnan Neetu, 2005, Nephron Physiology, V101, P92
   Rush S, 2007, EXP CELL RES, V313, P121, DOI 10.1016/j.yexcr.2006.09.018
   Sanada F, 2009, HYPERTENSION, V53, P77, DOI 10.1161/HYPERTENSIONAHA.108.120725
   Sangwan V, 2008, J BIOL CHEM, V283, P34374, DOI 10.1074/jbc.M805916200
   Schieffer B, 2000, CIRC RES, V87, P1195, DOI 10.1161/01.RES.87.12.1195
   Schröder K, 2007, ARTERIOSCL THROM VAS, V27, P1736, DOI 10.1161/ATVBAHA.107.142117
   Schröder K, 2009, CIRC RES, V105, P537, DOI 10.1161/CIRCRESAHA.109.205138
   Sharma P, 2008, IMMUNITY, V29, P551, DOI 10.1016/j.immuni.2008.07.019
   Stuart KA, 2000, INT J EXP PATHOL, V81, P17, DOI 10.1046/j.1365-2613.2000.00138.x
   Sugano M, 2009, MOL CELL BIOCHEM, V322, P113, DOI 10.1007/s11010-008-9946-7
   Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016
   Ushio-Fukai M, 2002, CIRC RES, V91, P1160, DOI 10.1161/01.RES.0000046227.65158.F8
   van der Wijk T, 2004, J BIOL CHEM, V279, P44355, DOI 10.1074/jbc.M407483200
   Wagner AH, 2001, FASEB J, V15, P2121, DOI 10.1096/fj.01-0123com
   You WK, 2008, BMB REP, V41, P833, DOI 10.5483/BMBRep.2008.41.12.833
   Zhang YW, 2003, P NATL ACAD SCI USA, V100, P12718, DOI 10.1073/pnas.2135113100
   Zheng H, 2008, ATHEROSCLEROSIS, V201, P36, DOI 10.1016/j.atherosclerosis.2008.02.011
NR 44
TC 37
Z9 39
U1 1
U2 8
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1523-0864
EI 1557-7716
J9 ANTIOXID REDOX SIGN
JI Antioxid. Redox Signal.
PD AUG
PY 2011
VL 15
IS 4
BP 915
EP 923
DI 10.1089/ars.2010.3533
PG 9
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 792TX
UT WOS:000292774400006
PM 21050133
DA 2024-02-19
ER

PT J
AU McCarty, MF
AF McCarty, MF
TI Chronic activation of AMP-activated kinase as a strategy for slowing
   aging
SO MEDICAL HYPOTHESES
LA English
DT Article
ID ACETYL-COA CARBOXYLASE; PROTEIN-KINASE; MAMMALIAN TARGET; IGF-I;
   5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBONUCLEOSIDE; SKELETAL-MUSCLE;
   ADIPOSE-TISSUE; TERM TREATMENT; CELL-SURVIVAL; METFORMIN
AB Caloric restriction down-regulates insulin secretion and systemic IGF-I activity, and there is reason to suspect that these effects are key mediators of caloric restriction's favorable impact on longevity. Alternative strategies for down-regulating these hormones are thus of great interest; chronic activation of AMP-activated kinase (AMPK) - clinically achievable with the drug metformin - may have utility in this regard. In the liver, AMPK slows hepatic glucose output by down-regulating expression of glucose-6-phosphatase and phosphoenolpyruvate carboxykinase; in skeletal muscle, it boosts the efficiency of insulin-stimulated glucose uptake by increasing expression of GLUT-4. These effects evidently mandate a down-regulation of insulin secretion. The resulting reduction of hepatic insulin activity can be expected to suppress hepatic production of IGF-I while boosting that of IGFBP-1, thereby decreasing plasma free IGF-I. AMPK can also directly stimulate IGFBP-1 synthesis in hepatocytes, and interfere with the ras/raf/erk pathway of IGF-I signaling. In non-diabetics, metformin therapy is indeed reported to reduce plasma levels of insulin and of free IGF-I; indeed, this is thought to be the mechanism whereby metformin suppresses excess androgen production in PCOS. A pro-Longevity effect of the related biguanide phenformin has already been reported in tumor-prone mice, and mouse longevity studies with metformin are currently in progress. The development of AMPK activators which do not share metformin's modest risk of inducing lactic acidosis - apparently reflecting an inhibition of mitochondrial complex 1 that is not intrinsic to AMPK activity - might aid the practical applicability of this pro-longevity strategy. (C) 2004 Elsevier Ltd. All rights reserved.
C1 NutriGuard Res, Encinitas, CA 92024 USA.
RP McCarty, MF (corresponding author), NutriGuard Res, 1051 Hermes Ave, Encinitas, CA 92024 USA.
EM mccarty@pantox.com
CR Abbasi F, 1998, DIABETES CARE, V21, P1301, DOI 10.2337/diacare.21.8.1301
   Bartke A, 2003, BIOGERONTOLOGY, V4, P1, DOI 10.1023/A:1022448532248
   BAXTER RC, 1994, HORM RES, V42, P140, DOI 10.1159/000184186
   Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200
   Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358
   Brown-Borg HM, 2003, TRENDS ENDOCRIN MET, V14, P151, DOI 10.1016/S1043-2760(03)00051-1
   Chen S., 2004, J BIOL CHEM
   CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.tb20498.x
   DA SX, 2003, BIOCHEM J, V371, P761
   DE L, 2000, J CLIN ENDOCR METAB, V85, P1598
   DEAN W, 2003, METFORMIN EFFECTIVE
   DILMAN VM, 1978, ARCH GESCHWULSTFORSC, V48, P1
   DILMAN VM, 1980, GERONTOLOGY, V26, P241, DOI 10.1159/000212423
   El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223
   EVANS GW, 1994, ADV SCI RES, V1, P19
   Flechtner-Mors M, 1999, DIABETIC MED, V16, P1000, DOI 10.1046/j.1464-5491.1999.00189.x
   Fontbonne A, 1996, DIABETES CARE, V19, P920, DOI 10.2337/diacare.19.9.920
   Frayn KN, 1998, ATHEROSCLEROSIS, V141, pS41, DOI 10.1016/S0021-9150(98)00216-0
   Fruehwald-Schultes B, 2002, METABOLISM, V51, P531, DOI 10.1053/meta.2002.31332
   Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200
   Fürstenberger G, 2002, LANCET ONCOL, V3, P298, DOI 10.1016/S1470-2045(02)00731-3
   Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998
   Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x
   Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420
   Jessen N, 2003, J APPL PHYSIOL, V94, P1373, DOI 10.1152/japplphysiol.00250.2002
   Kay JP, 2001, METABOLISM, V50, P1457, DOI 10.1053/meta.2001.28078
   KENT S, 2003, BIOMARKET PHARM DEV
   Kim J, 2001, J BIOL CHEM, V276, P19102, DOI 10.1074/jbc.M011579200
   Kimura N, 2003, GENES CELLS, V8, P65, DOI 10.1046/j.1365-2443.2003.00615.x
   Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512
   Kolodziejczyk B, 2000, FERTIL STERIL, V73, P1149, DOI 10.1016/S0015-0282(00)00501-X
   KRENTZ AJ, 1994, DRUG SAFETY, V11, P223, DOI 10.2165/00002018-199411040-00002
   Lee A, 1998, OBES RES, V6, P47, DOI 10.1002/j.1550-8528.1998.tb00314.x
   Lewitt MS, 2001, BIOCHEM BIOPH RES CO, V282, P1126, DOI 10.1006/bbrc.2001.4702
   Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991
   McCarty MF, 2003, MED HYPOTHESES, V60, P784, DOI 10.1016/S0306-9877(02)00235-9
   MCCARTY MF, 1993, MED HYPOTHESES, V41, P316, DOI 10.1016/0306-9877(93)90073-Y
   Mogul H R, 2001, Heart Dis, V3, P285
   MORROW VA, 2003, J BIOL CHEM
   Musi N, 2002, DIABETES, V51, P2074, DOI 10.2337/diabetes.51.7.2074
   Ngo TH, 2002, CANCER CAUSE CONTROL, V13, P929, DOI 10.1023/A:1021911517010
   Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607
   Panwalkar A, 2004, CANCER-AM CANCER SOC, V100, P657, DOI 10.1002/cncr.20026
   Parr T, 1997, GERONTOLOGY, V43, P182
   Pasquali R, 2000, J CLIN ENDOCR METAB, V85, P2767, DOI 10.1210/jc.85.8.2767
   PHILLIPS LS, 1991, DIABETES, V40, P1525, DOI 10.2337/diabetes.40.11.1525
   ROURU J, 1995, EUR J PHARMACOL, V273, P99, DOI 10.1016/0014-2999(94)00669-X
   Ruderman NB, 2003, BIOCHEM SOC T, V31, P202, DOI 10.1042/bst0310202
   Salt IP, 2000, DIABETES, V49, P1649, DOI 10.2337/diabetes.49.10.1649
   SATO R, 1993, P NATL ACAD SCI USA, V90, P9261, DOI 10.1073/pnas.90.20.9261
   SIM ATR, 1988, FEBS LETT, V233, P294, DOI 10.1016/0014-5793(88)80445-9
   STUMVOLL M, 1995, NEW ENGL J MED, V333, P550, DOI 10.1056/NEJM199508313330903
   VASILEVA IA, 1980, VOP ONKOL+, V26, P34
   Winder WW, 1997, J APPL PHYSIOL, V82, P219, DOI 10.1152/jappl.1997.82.1.219
   Zheng DH, 2001, J APPL PHYSIOL, V91, P1073, DOI 10.1152/jappl.2001.91.3.1073
   Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505
NR 56
TC 74
Z9 83
U1 0
U2 7
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0306-9877
EI 1532-2777
J9 MED HYPOTHESES
JI Med. Hypotheses
PY 2004
VL 63
IS 2
BP 334
EP 339
DI 10.1016/j.mehy.2004.01.043
PG 6
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 841DM
UT WOS:000222909500028
PM 15236799
DA 2024-02-19
ER

PT J
AU Rakic, A
   Milovanovich, ID
   Trbovich, AM
   Stefanovic, S
   Nikolic, D
   Jankovic, S
   Soldatovic, I
   De Luka, SR
AF Rakic, Aleksandar
   Milovanovich, Ivan D.
   Trbovich, Alexander M.
   Stefanovic, Srdan
   Nikolic, Dragica
   Jankovic, Sasa
   Soldatovic, Ivan
   De Luka, Silvio R.
TI Trace elements in different tissues in aging rats
SO JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
LA English
DT Article
DE Aging; Trace elements; Animal model; Healthy tissue
ID REPRODUCTIVE FUNCTIONS; AUTOPSY TISSUES; IRON STATUS; CADMIUM; COPPER;
   MECHANISMS; APOPTOSIS; EXPOSURE; HEALTH; KIDNEY
AB Background: Trace elements (TE) in the human body provide a connecting link between the environment, lifestyle and biochemical modulation of homeodynamics. On the other hand, many non-essential (toxic) elements are linked to numerous diseases. Our study tried to identify differences in TE levels between healthy old and young Wistar rats in blood and the tissues of kidney, liver, heart, and testicles. Furthermore, we wanted to see if there were age-related differences in correlations between essential and/or non-essential (toxic) TE within and between mentioned tissues.
   Methods: We used 28 healthy male Wistar rats which were divided into two age groups: young, aged 10 weeks (n = 15) and old, aged 36 months (n = 13). The animals were sacrificed under general anesthesia and the blood samples, and samples from the tissues of the heart, kidneys, testicles, and liver were used for the determination of TE content in them. Analysis of the 16 elements was performed by inductively coupled plasma mass spectrometry (ICP-MS).
   Results: Toxic elements in old rats (As, Hg, and Cd) were significantly higher in all of the tissues where the difference in levels of these elements was found. Tissues of the kidney and liver had the most correlations between TE in old and young rats, respectively. In both old and young rats, arsenic was the toxic element that had most of the correlations with other essential or non-essential elements. In old rats, most of the TE correlations were detected between the tissues of the kidney and heart (11 correlations), while in young rats most of the correlations were observed between the tissues of kidney and liver, and kidney and testicles (with 9 correlations both).
   Conclusions: Our study has found significant changes in levels of trace elements in all of the mentioned tissues, with kidney and testicles being the tissues with the most TE differences between the two aged groups. This and other similar studies should encourage other investigators to evaluate the mutual connections between TE and physiological, or the "unhealthy" aging. More studies with more tissues included, more biomarkers of the systemic function, and even molecular methods are needed to provide the answers to numerous questions relating to TE and aging.
C1 [Rakic, Aleksandar; Trbovich, Alexander M.; De Luka, Silvio R.] Univ Belgrade, Fac Med, Dept Pathol Physiol, Dr Subotica 1, Belgrade 11000, Serbia.
   [Milovanovich, Ivan D.] Univ Childrens Hosp, Tirsova 10, Belgrade 11000, Serbia.
   [Stefanovic, Srdan; Nikolic, Dragica; Jankovic, Sasa] Inst Meat Hyg & Technol, Kacanskog 13, Belgrade 11000, Serbia.
   [Soldatovic, Ivan] Univ Belgrade, Fac Med, Dept Med Stat & Informat, Dr Subotica 15, Belgrade 11000, Serbia.
C3 University of Belgrade; University of Belgrade; University of Belgrade
RP De Luka, SR (corresponding author), Univ Belgrade, Fac Med, Dept Pathol Physiol, Dr Subotica 1, Belgrade 11000, Serbia.
EM aleksandar.rakic@med.bg.ac.rs; milovani@yahoo.com;
   alexander.m.trbovich@gmail.com; srdjan.stefanovic@inmes.rs;
   dragica.nikolic@inmes.rs; sasa.jankovic@inmes.rs;
   ivan.soldatovic@med.bg.ac.rs; silvio.de-luka@med.bg.ac.rs
RI De Luka, Silvio R./E-4079-2019; Rakic, Aleksandar/HSE-6872-2023;
   Milovanović, Ivan/JWP-2566-2024
OI De Luka, Silvio R./0000-0002-0859-9252; Rakic,
   Aleksandar/0000-0003-1443-0311; Stefanovic, Srdjan/0000-0002-8011-5654;
   jankovic, sasa/0000-0002-5223-6993; Milovanovic,
   Ivan/0000-0001-5262-0891
FU Ministry of Education, Science and Technological Development, Republic
   of Serbia [III-41013]
FX This study was supported by the grant No III-41013 from the Ministry of
   Education, Science and Technological Development, Republic of Serbia.
CR Al-Azemi M, 2010, J ASSIST REPROD GEN, V27, P469, DOI 10.1007/s10815-010-9426-3
   ALEXANDE.CS, 1972, AM J MED, V53, P395, DOI 10.1016/0002-9343(72)90136-2
   Ambeskovic M, 2013, BIOGERONTOLOGY, V14, P557, DOI 10.1007/s10522-013-9464-1
   Aunan JR, 2017, AGING DIS, V8, P628, DOI 10.14336/AD.2017.0103
   Babaknejad N, 2018, BIOL TRACE ELEM RES, V185, P106, DOI 10.1007/s12011-017-1218-5
   Brewer GJ, 2010, CHEM RES TOXICOL, V23, P319, DOI 10.1021/tx900338d
   Cabello-Verrugio C, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/4310469
   da Costa JP, 2016, AGEING RES REV, V29, P90, DOI 10.1016/j.arr.2016.06.005
   DOMINGO JL, 1989, REV ENVIRON CONTAM T, V108, P105
   Ekmekcioglu C, 2001, NAHRUNG, V45, P309, DOI 10.1002/1521-3803(20011001)45:5&lt;309::AID-FOOD309&gt;3.0.CO;2-0
   Fairweather-Tait Susan J, 2014, Mech Ageing Dev, V136-137, P22, DOI 10.1016/j.mad.2013.11.005
   Souza ACF, 2016, J TOXICOL ENV HEAL A, V79, P274, DOI 10.1080/15287394.2016.1150926
   Flatt T, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0562-z
   Silva APG, 2018, TOXICOLOGY, V409, P1, DOI 10.1016/j.tox.2018.07.005
   IARC working group on the evaluation of carcinogenic risks to humans, 1993, WORK GROUP EV CARC R
   Jana K, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-9
   Juloski JT, 2020, J TRACE ELEM MED BIO, V59, DOI 10.1016/j.jtemb.2020.126451
   KOIZUMI N, 1989, ENVIRON RES, V49, P104, DOI 10.1016/S0013-9351(89)80025-8
   LASKEY JW, 1984, TOXICOL APPL PHARM, V73, P250, DOI 10.1016/0041-008X(84)90330-2
   Lee M.-R., BLOOD MERCURY CONCEN, DOI [10.1186/s12940-017-0228-2., DOI 10.1186/S12940-017-0228-2]
   Lind PM, 2012, SCI TOTAL ENVIRON, V416, P80, DOI 10.1016/j.scitotenv.2011.11.064
   Linna A, 2004, OCCUP ENVIRON MED, V61, P877, DOI 10.1136/oem.2003.009605
   Liu F, 2016, J INORG BIOCHEM, V164, P99, DOI 10.1016/j.jinorgbio.2016.09.005
   Liu W, 2017, HUM EXP TOXICOL, V36, P949, DOI 10.1177/0960327116677355
   Malavolta M, 2015, MECH AGEING DEV, V151, P93, DOI 10.1016/j.mad.2015.01.004
   Mikulewicz M, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8297814
   MORIN Y, 1967, CAN MED ASSOC J, V97, P926
   Nawrot TS, 2010, BIOMETALS, V23, P769, DOI 10.1007/s10534-010-9343-z
   Niccoli T, 2012, CURR BIOL, V22, pR741, DOI 10.1016/j.cub.2012.07.024
   Ninomiya R, 1997, Environ Health Prev Med, V1, P178, DOI 10.1007/BF02931213
   Nordberg M, 2016, J TRACE ELEM MED BIO, V38, P46, DOI 10.1016/j.jtemb.2016.04.006
   Ogórek M, 2017, POSTEP HIG MED DOSW, V71, P662
   Packer M, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.116.003604
   Pedigo N G, 1988, Reprod Toxicol, V2, P45
   Prasad AS, 2014, J TRACE ELEM MED BIO, V28, P364, DOI 10.1016/j.jtemb.2014.07.019
   Rahil-Khazen R, 2002, J TRACE ELEM MED BIO, V16, P15, DOI 10.1016/S0946-672X(02)80004-9
   Rahil-Khazen R, 2002, BIOMETALS, V15, P87, DOI 10.1023/A:1013197120350
   Rani A, 2014, INT J ENVIRON HEAL R, V24, P378, DOI 10.1080/09603123.2013.835032
   Ratnaike RN, 2003, POSTGRAD MED J, V79, P391, DOI 10.1136/pmj.79.933.391
   Rehman K, 2018, J CELL BIOCHEM, V119, P157, DOI 10.1002/jcb.26234
   RIORDAN JF, 1976, MED CLIN N AM, V60, P661, DOI 10.1016/S0025-7125(16)31851-X
   Rocha JBT, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/831890
   Roychoudhury S, 2016, PHYSIOL RES, V65, P11, DOI 10.33549/physiolres.933063
   Sakhaee E, 2012, ANDROLOGIA, V44, P110, DOI 10.1111/j.1439-0272.2010.01147.x
   Say AE, 2002, AM HEART J, V143, P257, DOI 10.1067/mhj.2002.120306
   SCHROEDER HA, 1967, CIRCULATION, V35, P570, DOI 10.1161/01.CIR.35.3.570
   Sfar S, 2009, EXP GERONTOL, V44, P812, DOI 10.1016/j.exger.2009.10.008
   Shih H, 2011, J AM COLL CARDIOL, V57, P9, DOI 10.1016/j.jacc.2010.08.623
   Shimamura T, 2013, J TRACE ELEM MED BIO, V27, P286, DOI 10.1016/j.jtemb.2013.04.006
   Shimamura T, 2013, J TRACE ELEM MED BIO, V27, P12, DOI 10.1016/j.jtemb.2012.05.005
   Stefanidou M, 2006, ARCH TOXICOL, V80, P1, DOI 10.1007/s00204-005-0009-5
   Sullivan JL, 2004, J LAB CLIN MED, V144, P280, DOI 10.1016/j.lab.2004.10.006
   Thévenod F, 2013, ARCH TOXICOL, V87, P1743, DOI 10.1007/s00204-013-1110-9
   TIRAN B, 1995, ARCH ENVIRON HEALTH, V50, P242, DOI 10.1080/00039896.1995.9940394
   Titorenko VI, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072049
   Valenzuela R, 2018, NUTRITION, V45, P49, DOI 10.1016/j.nut.2017.07.007
   Wang L, 2009, BIOL TRACE ELEM RES, V127, P53, DOI 10.1007/s12011-008-8223-7
   Wang SH, 2008, CELL MOL LIFE SCI, V65, P3640, DOI 10.1007/s00018-008-8383-9
   Wyles CC, 2017, J BONE JOINT SURG AM, V99, DOI 10.2106/JBJS.17.00159
   Yang H, 2015, INT J MOL SCI, V16, P1484, DOI 10.3390/ijms16011484
   Yang JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057186
   Yin DZ, 2016, CURR TOP MED CHEM, V16, P503, DOI 10.2174/1568026615666150813142854
   Zubair M, 2017, ANDROLOGIA, V49, DOI 10.1111/and.12791
NR 63
TC 1
Z9 2
U1 0
U2 7
PU ELSEVIER GMBH
PI MUNICH
PA HACKERBRUCKE 6, 80335 MUNICH, GERMANY
SN 0946-672X
EI 1878-3252
J9 J TRACE ELEM MED BIO
JI J. Trace Elem. Med. Biol.
PD DEC
PY 2020
VL 62
AR 126604
DI 10.1016/j.jtemb.2020.126604
PG 9
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA OM4WV
UT WOS:000586028000035
PM 32634768
DA 2024-02-19
ER

PT J
AU Sogawa, N
   Sogawa, CA
   Oda, N
   Fujioka, T
   Onodera, K
   Furuta, H
AF Sogawa, N
   Sogawa, CA
   Oda, N
   Fujioka, T
   Onodera, K
   Furuta, H
TI The effects of ovariectomy and female sex hormones on hepatic
   metallothionein-I gene expression after injection of cadmium chloride in
   mice
SO PHARMACOLOGICAL RESEARCH
LA English
DT Article
DE metallothionein; cadmium; female sex hormones; ovariectomy
ID HEPATOTOXICITY; INDUCTION; BRAIN; ZINC
AB Metallothioneins (MTs) have a low molecular weight and have been considered to be important metal-binding proteins in defense from cadmium (Cd) toxicity in animals. These proteins are known to be induced by the injection of heavy metals such as Cd. Previously, we developed the measurement of the MT mRNA expression by the RT-PCR method. In this study, to clarify the relation between Cd-induced MT-I mRNA expression and female sex hormones in liver, we investigated the influences of the ovariectomy and female sex hormones on hepatic MT-I mRNA expression after Cd injection, and also investigated the effects of aging on hepatic MT-I mRNA expression in mice after Cd injection. We analysed the MT-I mRNA expression by the KT-PCR method. Cd-induced MT-I mRNA expression in ovariectomized mice was more than that in sham-operated mice (9 weeks old). Both 17 beta -estradiol and progesterone reduced the Cd-induced MT-I mRNA expression in ovariectomized mice (9 weeks old). Moreover, the MT-I mRNA expression in male mice was more than that of females (9 weeks old). However, the sex difference in the gene expression was not found in younger (4 weeks old) or older (46 weeks old) mice. These results suggest that the expression of hepatic MT-I mRNA after Cd injection is influenced by female sex hormones. (C) 2001 Academic Press.
C1 Okayama Univ, Grad Sch Med & Dent, Dept Dent Pharmacol, Okayama 7008525, Japan.
C3 Okayama University
RP Sogawa, N (corresponding author), Okayama Univ, Grad Sch Med & Dent, Dept Dent Pharmacol, 2-5-1 Shikata Cho, Okayama 7008525, Japan.
RI SOGAWA, Chiharu/B-1994-2011
CR ANDERSEN RD, 1983, EUR J BIOCHEM, V131, P497, DOI 10.1111/j.1432-1033.1983.tb07289.x
   CHISOLM JC, 1985, MED HYPOTHESES, V17, P231, DOI 10.1016/0306-9877(85)90128-8
   CHOUDHURI S, 1995, TOXICOL APPL PHARM, V131, P144, DOI 10.1006/taap.1995.1056
   FUJIOKA T, 2001, JPN J ORAL BIOL, V43, P83
   HAMER DH, 1986, ANNU REV BIOCHEM, V55, P913, DOI 10.1146/annurev.biochem.55.1.913
   ISHIZAKI A, 1968, Japanese Journal of Hygiene, V23, P271
   Kagi J H, 1987, Experientia Suppl, V52, P25
   KAGI JHR, 1960, J BIOL CHEM, V235, P3460
   KERSHAW WC, 1990, TOXICOL APPL PHARM, V106, P448, DOI 10.1016/0041-008X(90)90339-V
   KINOSHITA T, 1992, ANAL BIOCHEM, V206, P231, DOI 10.1016/0003-2697(92)90358-E
   LEBER AP, 1976, TOXICOL APPL PHARM, V37, P403, DOI 10.1016/0041-008X(76)90202-7
   Liu YP, 1995, TOXICOL APPL PHARM, V135, P222, DOI 10.1006/taap.1995.1227
   MASTERS BA, 1994, P NATL ACAD SCI USA, V91, P584, DOI 10.1073/pnas.91.2.584
   Mehra R K, 1987, Experientia Suppl, V52, P565
   Palmiter R D, 1987, Experientia Suppl, V52, P63
   PALMITER RD, 1992, P NATL ACAD SCI USA, V89, P6333, DOI 10.1073/pnas.89.14.6333
   QUAIFE CJ, 1994, BIOCHEMISTRY-US, V33, P7250, DOI 10.1021/bi00189a029
   Sogawa N, 2000, METHOD FIND EXP CLIN, V22, P663, DOI 10.1358/mf.2000.22.9.802280
NR 18
TC 21
Z9 21
U1 0
U2 0
PU ACADEMIC PRESS LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-6618
J9 PHARMACOL RES
JI Pharmacol. Res.
PD JUL
PY 2001
VL 44
IS 1
BP 53
EP 57
DI 10.1006/phrs.2001.0833
PG 5
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 453UL
UT WOS:000169934800009
PM 11428911
DA 2024-02-19
ER

PT J
AU MASSIE, HR
   AIELLO, VR
AF MASSIE, HR
   AIELLO, VR
TI LEAD ACCUMULATION IN THE BONES OF AGING MALE-MICE
SO GERONTOLOGY
LA English
DT Article
DE LEAD; BONE; OSTEOPOROSIS; OSTEOPENIA
ID HUMAN TISSUES; OSTEOPOROSIS; EXPOSURE; CALCIUM; CADMIUM; COPPER
AB The lead content of mouse femurs increased by 83 % between 76 and 958 days of age with values ranging from 0.192 to 1.78 ng Pb/mg dry weight. These values are remarkably lower than in previous reports for the lead content of bone. The lead content of mouse liver showed no aging-related trend with values ranging from 0.00823 to 0.0149 ng/mg dry weight. Bone density, calcium and collagen content were not related to the lead content. We conclude that while bone lead content is very low in mice, it increases with aging but does not appear to be related to the osteopenia which develops in the C57BL/6J male mouse.
RP MASSIE, HR (corresponding author), MASONIC MED RES LAB,UTICA,NY 13501, USA.
CR ALI SF, 1989, J TOXICOL ENV HEALTH, V26, P235, DOI 10.1080/15287398909531248
   Barry P. S. I., 1978, BIOGEOCHEMISTRY LEAD, P97
   BARRY PSI, 1970, BRIT J IND MED, V27, P339
   FINE BP, 1988, TOXICOL APPL PHARM, V93, P388, DOI 10.1016/0041-008X(88)90041-5
   GILBERT SG, 1987, TOXICOL APPL PHARM, V91, P484, DOI 10.1016/0041-008X(87)90070-6
   GROSS SB, 1975, TOXICOL APPL PHARM, V32, P638, DOI 10.1016/0041-008X(75)90127-1
   HARLAN WR, 1988, ENVIRON HEALTH PERSP, V78, P9
   KOLLER LD, 1974, NATURE, V250, P148, DOI 10.1038/250148a0
   KOPP SJ, 1988, ENVIRON HEALTH PERSP, V78, P91, DOI 10.2307/3430507
   KROMHOUT D, 1988, ENVIRON HEALTH PERSP, V78, P43, DOI 10.2307/3430497
   MASSIE HR, 1990, EXP GERONTOL, V25, P469, DOI 10.1016/0531-5565(90)90035-Z
   MOORE S, 1954, J BIOL CHEM, V211, P907
   NEEDLEMAN HL, 1990, NEW ENGL J MED, V322, P83, DOI 10.1056/NEJM199001113220203
   PERRY HM, 1988, ENVIRON HEALTH PERSP, V78, P107, DOI 10.2307/3430509
   QUINLAN GJ, 1988, BIOCHIM BIOPHYS ACTA, V962, P196, DOI 10.1016/0005-2760(88)90159-2
   RACZ P, 1988, OPHTHALMIC RES, V20, P10, DOI 10.1159/000266248
   REVIS NW, 1981, P NATL ACAD SCI-BIOL, V78, P6494, DOI 10.1073/pnas.78.10.6494
   SCHROEDER HA, 1968, ARCH ENVIRON HEALTH, V17, P965, DOI 10.1080/00039896.1968.10665354
   SCHROEDER HA, 1965, J NUTR, V86, P51, DOI 10.1093/jn/86.1.51
   SCHROEDER HA, 1964, J NUTR, V83, P239, DOI 10.1093/jn/83.3.239
   SELEVAN SG, 1988, ENVIRON HEALTH PERSP, V78, P65, DOI 10.2307/3430502
   SETTLE DM, 1980, SCIENCE, V207, P1167, DOI 10.1126/science.6986654
   SHANNON M, 1988, VET HUM TOXICOL, V30, P586
   SILBERGELD EK, 1988, ENVIRON RES, V47, P79, DOI 10.1016/S0013-9351(88)80023-9
   VICTERY W, 1988, ENVIRON HEALTH PERSP, V78, P71, DOI 10.2307/3430504
NR 25
TC 9
Z9 9
U1 0
U2 2
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0304-324X
J9 GERONTOLOGY
JI Gerontology
PD JAN-APR
PY 1992
VL 38
IS 1-2
BP 13
EP 17
PG 5
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA HV966
UT WOS:A1992HV96600003
PM 1612459
DA 2024-02-19
ER

PT J
AU Hu, WL
   Dai, DH
   Li, W
AF Hu, Weilian
   Dai, Dehui
   Li, Wei
TI Anti-aging effect of <i>Blakeslea trispora</i> powder on adult mice
SO BIOTECHNOLOGY LETTERS
LA English
DT Article
DE Anti-aging; Anti-oxidation; Adult mice; Blakeslea trispora powder
ID ASSAY
AB Blakeslea trispora powder that contains 1.9 % lycopene was tested for its anti-aging effect on adult mice. 48 adult mice were administered with the powder at 0, 267, 534, 1,068 mg lycopene kg(-1) body daily for 30 days. The body weight, hematology, clinical chemical and antioxidant activities in major organs of adult mice were measured. The powder had no effect on the body weight, hematology, clinical chemical parameters of adult mice but improved the antioxidant activities in major organs of adult mice. Increased activities of superoxide dismutase, catalase and glutathione peroxidase and a decreased amount of malondialdehyde in liver, brain, kidney and skin of adult mice when a high-dose of the B. trispora powder was administered, suggests that it has the ability to enhance the antioxidation system and improve the anti-aging abilities of adult mice.
C1 [Hu, Weilian; Dai, Dehui] Zhejiang Univ Sci & Technol, Sch Biol & Chem Engn, Hangzhou 310023, Zhejiang, Peoples R China.
   [Li, Wei] Zhejiang Acad Med Sci, Zhejiang Ctr Lab Anim, Hangzhou 310013, Zhejiang, Peoples R China.
C3 Zhejiang University of Science & Technology; Zhejiang Academy of Medical
   Sciences
RP Hu, WL (corresponding author), Zhejiang Univ Sci & Technol, Sch Biol & Chem Engn, 318 Liu He Lu, Hangzhou 310023, Zhejiang, Peoples R China.
EM weilian89@yahoo.com
FU Science Technology Department of Zhejiang Province [2009C32072]
FX This work was funded by Science Technology Department of Zhejiang
   Province (2009C32072).
CR Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022
   Devaraj S, 2008, J AM COLL NUTR, V27, P267, DOI 10.1080/07315724.2008.10719699
   Dröge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   HARMAN D, 1991, P NATL ACAD SCI USA, V88, P5360, DOI 10.1073/pnas.88.12.5360
   Ibrahim HS, 2008, J MED FOOD, V11, P551, DOI 10.1089/jmf.2007.0517
   Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X
   Kiokias S, 2004, FOOD REV INT, V20, P99, DOI 10.1081/FRI-120037155
   Kumaran VS, 2009, NUTRITION, V25, P847, DOI 10.1016/j.nut.2009.02.005
   LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6
   Liu F, 2000, THESIS
   López-Nieto MJ, 2004, APPL MICROBIOL BIOT, V66, P153, DOI 10.1007/s00253-004-1669-4
   Luck H., 1965, Method of enzymatic analysis, P885, DOI [10.1016/B978-0-12-395630-9.50158-4, DOI 10.1016/B978-0-12-395630-9.50158-4]
   McClain RM, 2003, REGUL TOXICOL PHARM, V37, P274, DOI 10.1016/S0273-2300(03)00004-7
   Mehta BJ, 2003, APPL ENVIRON MICROB, V69, P4043, DOI 10.1128/AEM.69.7.4043-4048.2003
   NIKI E, 1993, BIOCHEM SOC T, V21, P313, DOI 10.1042/bst0210313
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Posadas SJ, 2009, EXP GERONTOL, V44, P383, DOI 10.1016/j.exger.2009.02.015
   Quiles-Rosillo MD, 2005, FUNGAL GENET BIOL, V42, P141, DOI 10.1016/j.fgb.2004.10.008
   Ramesh T, 2012, EXP GERONTOL, V47, P77, DOI 10.1016/j.exger.2011.10.007
   SUN Y, 1988, CLIN CHEM, V34, P497
NR 21
TC 11
Z9 12
U1 2
U2 40
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0141-5492
EI 1573-6776
J9 BIOTECHNOL LETT
JI Biotechnol. Lett.
PD AUG
PY 2013
VL 35
IS 8
BP 1309
EP 1315
DI 10.1007/s10529-013-1206-6
PG 7
WC Biotechnology & Applied Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology
GA 179JN
UT WOS:000321516600021
PM 23636861
DA 2024-02-19
ER

PT J
AU Miu, AC
   Olteanu, AI
   Miclea, M
AF Miu, AC
   Olteanu, AI
   Miclea, M
TI A behavioral and ultrastructural dissection of the interference of
   aluminum with aging
SO JOURNAL OF ALZHEIMERS DISEASE
LA English
DT Article
DE aluminum; aging; mitochondria; myelin; Alzheimer's disease
ID BLOOD-BRAIN-BARRIER; ALZHEIMERS-DISEASE; NEUROFIBRILLARY DEGENERATION;
   ENDOPLASMIC-RETICULUM; MEMBRANE FLUIDITY; INDUCED APOPTOSIS; DIETARY
   ALUMINUM; DRINKING-WATER; HIRANO BODIES; RATS
AB The persistence of neuroscientists in exploring aluminium's (Al) possible contribution to the pathogenesis of Alzheimer's disease (AD) has resulted in a wealth of researches detailing the biological toxicity of this metal. However, to date, there have been few accounts of the interference of Al with aging and its relevance to the pathogenesis of AD. We investigated the behavioral and the ultrastructural signatures of Al in the hippocampus on young and aging rats which were exposed for three months to aluminium gluconate. The aging animals displayed decreased scores of activity and emotionality, and the Al-exposed aging males had altered emotional reactivity behaviors. The electron-microscopic analysis indicated that Al promoted in the aging hippocampus a variety of cellular and ultrastructural degenerative signs, such as granulo-vacuolar degenerations, deposition of lipofuscin and amyloid in the cytoplasm of neurons and astrocytes, and in extracellular compartments, Hirano bodies, demyelination and the atrophy of the mitochondria. Moreover, the quantitation of myelin sheath width and the diameter of mitochondria measured on randomly selected samples confirmed that myelin and mitochondria are primary targets of Al's toxicity. Demyelination and mitochondrial atrophy seemed more advanced in the hippocampus of Al-exposed aging males, supporting the effect of sex suggested by the behavioral results. These findings and other collateral results also reported here are discussed in the context of a possible involvement of Al in AD, mediated by aging and catalyzed by hepatic morphopathology.
C1 Univ Babes Bolyai, Dept Psychol Neurosci Res Nucleus, Cluj Napoca 3400, Romania.
   Iuliu Hatieganu Univ Med & Pharm, Dept Physiol Neurosci Res Nucleus, Cluj Napoca 3400, Romania.
C3 Babes Bolyai University from Cluj; Iuliu Hatieganu University of
   Medicine & Pharmacy
RP Miu, AC (corresponding author), Univ Babes Bolyai, Dept Psychol Neurosci Res Nucleus, 37 Republ, Cluj Napoca 3400, Romania.
EM AndreiMiu@psychology.ro
RI Miu, Andrei C./C-5184-2011
OI Miu, Andrei C./0000-0002-6459-5010
CR ABREO K, 1991, J AM SOC NEPHROL, V1, P1299
   Ackley DC, 1998, TOXICOLOGY, V127, P59, DOI 10.1016/S0300-483X(98)00037-7
   ALFREY AC, 1976, NEW ENGL J MED, V294, P184, DOI 10.1056/NEJM197601222940402
   Andrasi E, 1996, MICROCHEM J, V54, P210, DOI 10.1006/mchj.1996.0097
   ANDREESCU CE, 2001, P ANN C IUL HAT U ME
   Atamna H, 2002, P NATL ACAD SCI USA, V99, P14807, DOI 10.1073/pnas.192585799
   BERTHOLF RL, 1989, TOXICOL APPL PHARM, V98, P58, DOI 10.1016/0041-008X(89)90134-8
   Campbell A, 2002, NEPHROL DIAL TRANSPL, V17, P17, DOI 10.1093/ndt/17.suppl_2.17
   Campbell A, 2001, BRAIN RES BULL, V55, P125, DOI 10.1016/S0361-9230(01)00455-5
   CASTER WO, 1981, SCI TOTAL ENVIRON, V17, P31, DOI 10.1016/0048-9697(81)90105-4
   Chaves S, 2003, J INORG BIOCHEM, V97, P161, DOI 10.1016/S0162-0134(03)00238-1
   Colomina MT, 2002, NEUROTOXICOLOGY, V23, P775, DOI 10.1016/S0161-813X(02)00008-6
   CONNOR DJ, 1989, BEHAV NEUROSCI, V103, P779, DOI 10.1037/0735-7044.103.4.779
   CONNOR DJ, 1988, PHARMACOL BIOCHEM BE, V31, P467, DOI 10.1016/0091-3057(88)90375-9
   Crichton RR, 2002, COORDIN CHEM REV, V228, P365, DOI 10.1016/S0010-8545(02)00038-3
   Cunat L, 2000, BIOL TRACE ELEM RES, V76, P31, DOI 10.1385/BTER:76:1:31
   Deloncle R, 2001, EXP GERONTOL, V36, P231, DOI 10.1016/S0531-5565(00)00214-X
   Demircan M, 1998, J PEDIATR GASTR NUTR, V26, P274, DOI 10.1097/00005176-199803000-00007
   DENENBERG VH, 1969, EXPT APPROACHES STUD, P852
   EICHHORN GL, 1979, MECH AGEING DEV, V9, P291, DOI 10.1016/0047-6374(79)90106-4
   Exley C, 1999, J INORG BIOCHEM, V76, P133, DOI 10.1016/S0162-0134(99)00125-7
   Farina M, 2002, TOXICOL LETT, V132, P131, DOI 10.1016/S0378-4274(02)00077-2
   FAVARATO M, 1992, BRAIN RES, V569, P330, DOI 10.1016/0006-8993(92)90647-R
   Fechheimer M, 2002, TRENDS MOL MED, V8, P590, DOI 10.1016/S1471-4914(02)02439-5
   Flaten TP, 2001, BRAIN RES BULL, V55, P187, DOI 10.1016/S0361-9230(01)00459-2
   FLORENCE AL, 1994, NEURODEGENERATION, V3, P315
   FONCIN JF, 1987, NATURE, V326, P136, DOI 10.1038/326136b0
   FULTON B, 1994, BIOL TRACE ELEM RES, V40, P9, DOI 10.1007/BF02916816
   Garbossa G, 1996, MINER ELECTROL METAB, V22, P214
   GEARING M, 1994, P NATL ACAD SCI USA, V91, P9382, DOI 10.1073/pnas.91.20.9382
   Ghribi O, 2002, NEUROSCI LETT, V324, P217, DOI 10.1016/S0304-3940(02)00147-7
   Ghribi O, 2001, BRAIN RES, V903, P66, DOI 10.1016/S0006-8993(01)02406-4
   Ghribi O, 2001, NEUROBIOL DIS, V8, P764, DOI 10.1006/nbdi.2001.0429
   Golub MS, 1999, NEUROTOXICOLOGY, V20, P953
   Gomez M, 1997, TOXICOLOGY, V116, P1, DOI 10.1016/S0300-483X(96)03512-3
   Gomez M, 1997, ARCH GERONTOL GERIAT, V24, P287, DOI 10.1016/S0167-4943(96)00766-2
   GOTOW T, 1995, NEUROSCIENCE, V64, P553, DOI 10.1016/0306-4522(94)00394-K
   Harris WR, 1996, J TOXICOL ENV HEALTH, V48, P543, DOI 10.1080/009841096161069
   HIRANO A, 1994, NEUROPATH APPL NEURO, V20, P3, DOI 10.1111/j.1365-2990.1994.tb00951.x
   JEANTET AY, 1992, CR ACAD SCI III-VIE, V315, P379
   Julka D, 1996, BBA-MOL BASIS DIS, V1315, P47, DOI 10.1016/0925-4439(95)00100-X
   Julka D, 1996, RES EXP MED, V196, P187, DOI 10.1007/BF02576841
   Kagan BL, 2002, PEPTIDES, V23, P1311, DOI 10.1016/S0196-9781(02)00067-0
   KANAYA K, 1987, MICRON MICROSC ACTA, V18, P131, DOI 10.1016/0739-6260(87)90048-7
   KARLIK SJ, 1989, J INORG BIOCHEM, V37, P259, DOI 10.1016/0162-0134(89)85001-9
   KLATZO I, 1965, J NEUROPATH EXP NEUR, V24, P187, DOI 10.1097/00005072-196504000-00002
   KLEIN GL, 1989, J PEDIATR GASTR NUTR, V9, P105, DOI 10.1097/00005176-198909010-00019
   LAL B, 1993, LIFE SCI, V42, P863
   Martyn C. N, 1992, CIBA F SYMP, V169, P79
   MARTYN CN, 1989, LANCET, V1, P59
   McLachlan DRC, 1996, NEUROLOGY, V46, P401, DOI 10.1212/WNL.46.2.401
   MCLACHLAN DRC, 1991, LANCET, V337, P1304, DOI 10.1016/0140-6736(91)92978-B
   Mecocci P, 1997, MOL CHEM NEUROPATHOL, V31, P53, DOI 10.1007/BF02815160
   Miu AC, 2003, INT J NEUROSCI, V113, P1197, DOI 10.1080/00207450390232292
   MIU AC, 2003, COGNITION BRAIN BEHA, V7, P219
   Neiva TJC, 1997, BRAZ J MED BIOL RES, V30, P599, DOI 10.1590/S0100-879X1997000500005
   Newman PE, 2000, MED HYPOTHESES, V54, P774, DOI 10.1054/mehy.1999.0948
   Nilsen J, 2003, P NATL ACAD SCI USA, V100, P2842, DOI 10.1073/pnas.0438041100
   NORDSTEDT C, 1991, P NATL ACAD SCI USA, V88, P8910, DOI 10.1073/pnas.88.20.8910
   Platt B, 2001, BRAIN RES BULL, V55, P257, DOI 10.1016/S0361-9230(01)00511-1
   Rao JKS, 1998, CLIN LAB MED, V18, P687
   Reusche E, 2001, HUM PATHOL, V32, P1136, DOI 10.1053/hupa.2001.28251
   Rogers MAM, 1999, AGE AGEING, V28, P205, DOI 10.1093/ageing/28.2.205
   ROSKAMS AJ, 1990, P NATL ACAD SCI USA, V87, P9024, DOI 10.1073/pnas.87.22.9024
   Savory J, 2003, J INORG BIOCHEM, V97, P151, DOI 10.1016/S0162-0134(03)00258-7
   Savory J, 1996, J TOXICOL ENV HEALTH, V48, P615, DOI 10.1080/009841096161104
   Savory J, 1999, ANN CLIN LAB SCI, V29, P118
   Shin RW, 2003, BRAIN RES, V961, P139, DOI 10.1016/S0006-8993(02)03893-3
   Smith DE, 1999, P NATL ACAD SCI USA, V96, P10893, DOI 10.1073/pnas.96.19.10893
   Smith MA, 1998, J CHEM NEUROANAT, V16, P35, DOI 10.1016/S0891-0618(98)00061-1
   SPENCER AJ, 1995, HUM EXP TOXICOL, V14, P787, DOI 10.1177/096032719501401002
   Strunecka A, 1999, Cesk Fysiol, V48, P9
   Struys-Ponsar C, 1994, J Neural Transm Suppl, V44, P111
   StruysPonsar C, 1997, PHARMACOL BIOCHEM BE, V56, P643, DOI 10.1016/S0091-3057(96)00515-1
   TERRY RD, 1965, J NEUROPATH EXP NEUR, V24, P200, DOI 10.1097/00005072-196504000-00003
   THORNE BM, 1987, B PSYCHONOMIC SOC, V25, P129
   TOGA M, 1974, CERVEAU TROISIEME AG, P7
   Torp R, 2000, NEUROSCIENCE, V96, P495, DOI 10.1016/S0306-4522(99)00568-0
   VANDERVOET GB, 1992, PHARMACOL TOXICOL, V70, P173, DOI 10.1111/j.1600-0773.1992.tb00451.x
   VANRENSBURG SJ, 1992, NEUROCHEM RES, V17, P825, DOI 10.1007/BF00969020
   VARMA PP, 2000, J ASSOC PHYSICIAN I, V48, P549
   Varner JA, 1998, BRAIN RES, V784, P284, DOI 10.1016/S0006-8993(97)01336-X
   VARNER JA, 1994, BEHAV NEURAL BIOL, V61, P233, DOI 10.1016/S0163-1047(05)80006-8
   Verstraeten SV, 1997, ARCH BIOCHEM BIOPHYS, V344, P289, DOI 10.1006/abbi.1997.0146
   WALKER PR, 1989, BIOCHEMISTRY-US, V28, P3911, DOI 10.1021/bi00435a043
   Ward RJ, 2001, J INORG BIOCHEM, V87, P9, DOI 10.1016/S0162-0134(01)00308-7
   WISNIEWSKI HM, 1973, NEUROBIOLOGICAL ASPE, P167
   YOKEL RA, 1991, TOXICOL APPL PHARM, V107, P153, DOI 10.1016/0041-008X(91)90339-G
   Yokel RA, 1999, J INORG BIOCHEM, V76, P127, DOI 10.1016/S0162-0134(99)00124-5
   Yokel RA, 2002, BRAIN RES, V930, P101, DOI 10.1016/S0006-8993(02)02234-5
   Yokel RA, 1998, NEUROTOXICOL TERATOL, V20, P55, DOI 10.1016/S0892-0362(97)00069-X
   Yumoto S, 2001, BRAIN RES BULL, V55, P229, DOI 10.1016/S0361-9230(01)00509-3
   Yumoto S, 1997, NUCL INSTRUM METH B, V123, P279, DOI 10.1016/S0168-583X(96)00429-6
   Zatta P, 2003, BRAIN RES BULL, V62, P15, DOI 10.1016/S0361-9230(03)00182-5
NR 94
TC 30
Z9 31
U1 0
U2 0
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1387-2877
EI 1875-8908
J9 J ALZHEIMERS DIS
JI J. Alzheimers Dis.
PD JUN
PY 2004
VL 6
IS 3
BP 315
EP 328
PG 14
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 862NR
UT WOS:000224498200012
PM 15201486
DA 2024-02-19
ER

PT J
AU Xing, CC
   Hang, ZC
   Guo, WH
   Li, YX
   Shah, RS
   Zhao, YH
   Zeng, ZH
   Du, HW
AF Xing, Cencan
   Hang, Zhongci
   Guo, Wenhuan
   Li, Yingxian
   Shah, Roshan
   Zhao, Yihan
   Zeng, Zehua
   Du, Hongwu
TI Stem cells from human exfoliated deciduous teeth rejuvenate the liver in
   naturally aged mice by improving ribosomal and mitochondrial proteins
SO CYTOTHERAPY
LA English
DT Article
DE aging; liver; mitochondria MSC; MSC; proteomic; proteomic ribosome; SHED
ID HUMAN DENTAL-PULP; LIFE-SPAN; TRANSLATION; PROTEOME; REGENERATION;
   HEPATOCYTES; HOMEOSTASIS; HALLMARKS; MEMBRANE; HEALTH
AB Background aims: Aging is accompanied by a decline in cellular proteome homeostasis, mitochondrial, and metabolic function. Mesenchymal stromal cell (MSC) therapies have been reported to extend lifespan and delay some age-related pathologies, yet the anti-aging rate and mechanisms remain unclear. Here, we investigated the effects and mechanism by transplantation of stem cells from human exfoliated deciduous teeth (SHED) into the naturally aged mice model. Methods: SHED were cultured in vitro and injected into mice by caudal vein. The in vivo imaging uncovered that SHED labeled by DiR dye mainly migrated to the liver, spleen, and lung organs of wild-type mice. As the main metabolic organ and SHED homing place, the liver was selected for proteomics and aging clock algorithm (LiverClock) analysis, which was constructed to estimate the proteomic pattern related to liver age state. Results: After 6 months of continuous SHED injections, the liver proteomic pattern was reversed from senescent (-30 months) to a youthful state (-3 months), accompanied with upregulation of hepatocytes marker genes, anti-aging protein Klotho, a global improvement of liver functional pathways proteins, and a dramatic regulation of ribosomal and mitochondrial proteins, including upregulation of translation elongation and ribosome-sparing proteins Rpsa and Rplp0; elongation factors Eif4a1, Eef1b2, Eif5a; protein-folding chaperones Hsp90aa and Hspe1; ATP synthesis proteins Atp5b, Atp5o, Atp5j; and downregulation of most ribosomal proteins, suggesting that the proteome homeostasis destruction and mitochondria dysfunction in the aged mice liver might be relieved after SHED treatment. Conclusions: SHED treatment could dramatically relieve the senescent state of the aged liver, affect ribosome component proteins and upregulate the ribosomal biogenesis proteins in the aged mice liver. These results may help understand the improvements and mechanisms of SHED treatment in anti-aging. (c) 2023 Published by Elsevier Inc. on behalf of International Society for Cell & Gene Therapy.
C1 [Xing, Cencan; Hang, Zhongci; Guo, Wenhuan; Shah, Roshan; Zhao, Yihan; Zeng, Zehua; Du, Hongwu] Univ Sci & Technol Beijing USTB, Daxing Res Inst, Sch Chem & Biol Engn, Beijing, Peoples R China.
   [Guo, Wenhuan] Peking Univ Third Hosp, Reprod Ctr, Beijing, Peoples R China.
   [Li, Yingxian] Univ Sci & Technol Beijing, Sch Mat Sci & Engn, Beijing, Peoples R China.
   [Zeng, Zehua; Du, Hongwu] 112 Lab,Lihua BLDG,30 Xueyuan Rd, Beijing 100083, Peoples R China.
C3 University of Science & Technology Beijing
RP Zeng, ZH; Du, HW (corresponding author), 112 Lab,Lihua BLDG,30 Xueyuan Rd, Beijing 100083, Peoples R China.
EM zehuazeng@xs.ustb.edu.cn; hongwudu@ustb.edu.cn
OI Shah, Roshan/0000-0001-8165-082X
FU Fundamental Research Funds for the Central Universities
   [FRF-TP-22-007A1]; National Natural Science Foundation of China
   [32300682]
FX This work was financially supported by the Fundamental Research Funds
   for the Central Universities (FRF-TP-22-007A1) and the National Natural
   Science Foundation of China (32300682 to CX) .
CR Almanzar N, 2020, NATURE, V583, P590, DOI 10.1038/s41586-020-2496-1
   Amin B, 2020, MECH AGEING DEV, V187, DOI 10.1016/j.mad.2020.111227
   [Anonymous], bioRxiv, DOI [DOI 10.1101/416511, 10.1101/416511, DOI 10.1101/416511V2]
   Barcena B, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10101535
   Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314
   Campisi J, 2019, NATURE, V571, P183, DOI 10.1038/s41586-019-1365-2
   Caplan AI, 2017, STEM CELL TRANSL MED, V6, P1445, DOI 10.1002/sctm.17-0051
   Chakravarti D, 2021, CELL, V184, P306, DOI 10.1016/j.cell.2020.12.028
   Cho YM, 2003, PROTEOMICS, V3, P1883, DOI 10.1002/pmic.200300562
   Covarrubias AJ, 2021, NAT REV MOL CELL BIO, V22, P119, DOI 10.1038/s41580-020-00313-x
   Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056
   Daum B, 2013, P NATL ACAD SCI USA, V110, P15301, DOI 10.1073/pnas.1305462110
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Dyakin VV, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23010285
   Finkel T, 2015, NAT MED, V21, P1416, DOI 10.1038/nm.3998
   Gong ZW, 2017, MOL CELL ENDOCRINOL, V455, P115, DOI 10.1016/j.mce.2016.12.022
   Gramignoli R, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms232314880
   Guo WH, 2022, CYTOTHERAPY, V24, P59, DOI 10.1016/j.jcyt.2021.07.018
   Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x
   Huang CH, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9091229
   Kamiyama Y, 2021, REGEN THER, V18, P202, DOI 10.1016/j.reth.2021.06.005
   Karunadharma PP, 2015, AGING CELL, V14, P547, DOI 10.1111/acel.12317
   Kim D, 2015, STEM CELL TRANSL MED, V4, P1144, DOI 10.5966/sctm.2015-0011
   Kuang R, 2016, ACTA BIOMATER, V33, P225, DOI 10.1016/j.actbio.2016.01.032
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Luecken MD, 2019, MOL SYST BIOL, V15, DOI 10.15252/msb.20188746
   Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261
   Mansilla E, 2016, REJUV RES, V19, P318, DOI 10.1089/rej.2015.1777
   Mao Jeremy J, 2008, N Y State Dent J, V74, P20
   Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100
   Mohammad RS, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11010156
   Neves J, 2017, CELL STEM CELL, V20, P161, DOI 10.1016/j.stem.2017.01.008
   O'Loghlen A, 2022, CELL CYCLE, V21, P111, DOI 10.1080/15384101.2021.2013612
   Olona A, 2018, MOL METAB, V11, P18, DOI 10.1016/j.molmet.2018.03.003
   Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x
   Petridis X, 2015, J CRANIO MAXILL SURG, V43, P483, DOI 10.1016/j.jcms.2015.02.003
   Prasad S, 2012, PREV MED, V54, pS29, DOI 10.1016/j.ypmed.2011.11.011
   Preston CC, 2008, MECH AGEING DEV, V129, P304, DOI 10.1016/j.mad.2008.02.010
   Pulkkinen HH, 2021, ANGIOGENESIS, V24, P129, DOI 10.1007/s10456-020-09748-4
   Puthiyedth N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152342
   Reis-Rodrigues P, 2012, AGING CELL, V11, P120, DOI 10.1111/j.1474-9726.2011.00765.x
   Seo H, 2016, ANIM CELLS SYST, V20, P157, DOI 10.1080/19768354.2016.1188855
   Shen JH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00067
   Shi WL, 2011, SCIENCE, V333, P1630, DOI 10.1126/science.1208813
   Skariah G, 2021, WIRES RNA, V12, DOI 10.1002/wrna.1628
   Sonoyama W, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000079
   Steffen KK, 2016, CELL METAB, V23, P1004, DOI 10.1016/j.cmet.2016.05.013
   Stein KC, 2022, NATURE, V601, P637, DOI 10.1038/s41586-021-04295-4
   Sugimura-Wakayama Y, 2015, STEM CELLS DEV, V24, P2687, DOI 10.1089/scd.2015.0104
   Szklarczyk D, 2021, NUCLEIC ACIDS RES, V49, pD605, DOI 10.1093/nar/gkaa1074
   Traag VA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41695-z
   Turi Z, 2019, AGING-US, V11, P2512, DOI 10.18632/aging.101922
   Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136
   Walther DM, 2015, CELL, V161, P919, DOI 10.1016/j.cell.2015.03.032
   Wang DT, 2020, J GERONTOL A-BIOL, V75, P2081, DOI 10.1093/gerona/glaa214
   Wei YL, 2021, SCIENCE, V371, P906, DOI 10.1126/science.abb1625
   Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0
   Yang HW, 2019, J GERONTOL A-BIOL, V74, P1015, DOI 10.1093/gerona/gly228
   Yang XT, 2019, THERANOSTICS, V9, P2694, DOI 10.7150/thno.31801
   Yanger K, 2014, CELL STEM CELL, V15, P340, DOI 10.1016/j.stem.2014.06.003
   Zhang XS, 2022, BIOMED PHARMACOTHER, V152, DOI 10.1016/j.biopha.2022.113169
   Zhang XS, 2021, CELL TRANSPLANT, V30, DOI 10.1177/09636897211042927
NR 62
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI London
PA 125 London Wall, London, ENGLAND
SN 1465-3249
EI 1477-2566
J9 CYTOTHERAPY
JI Cytotherapy
PD DEC
PY 2023
VL 25
IS 12
BP 1285
EP 1292
DI 10.1016/j.jcyt.2023.08.015
EA NOV 2023
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Hematology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Biotechnology & Applied Microbiology; Hematology; Research
   & Experimental Medicine
GA AV1Z4
UT WOS:001121149300001
PM 37815776
DA 2024-02-19
ER

PT J
AU Bysani, M
   Perfilyev, A
   de Mello, VD
   Rönn, T
   Nilsson, E
   Pihlajamäki, J
   Ling, C
AF Bysani, Madhusudhan
   Perfilyev, Alexander
   de Mello, Vanessa D.
   Ronn, Tina
   Nilsson, Emma
   Pihlajamaki, Jussi
   Ling, Charlotte
TI Epigenetic alterations in blood mirror age-associated DNA methylation
   and gene expression changes in human liver
SO EPIGENOMICS
LA English
DT Article
DE aging; blood; diabetes; DNA methylation; ELOVL2; epigenetics; FHL2; gene
   expression; KLF14; liver
ID TRANSCRIPTION FACTORS; ADIPOSE-TISSUE; IDENTIFICATION; BIOMARKERS;
   SIGNATURES; MARKER; IMPACT; LINK
AB Aim: To study the impact of aging on DNA methylation and mRNA expression in human liver. Experimental procedures: We analysed genome-wide DNA methylation and gene expression in human liver samples using Illumina 450K and HumanHT12 expression BeadChip arrays. Results: DNA methylation analysis of similar to 455,000 CpG sites in human liver revealed that age was significantly associated with altered DNA methylation of 20,396 CpG sites. Comparison of liver methylation data with published methylation data in other tissues showed that vast majority of the age-associated significant CpG sites overlapped between liver and blood, whereas a smaller overlap was found between liver and pancreatic islets or adipose tissue, respectively. We identified 151 genes whose liver expression also correlated with age. Conclusions: We identified age-associated DNA methylation and expression changes in human liver that are partly reflected by epigenetic alterations in blood.
C1 [Bysani, Madhusudhan; Perfilyev, Alexander; Ronn, Tina; Nilsson, Emma; Ling, Charlotte] Lund Univ, Ctr Diabet, Dept Clin Sci, Epigenet & Diabet Unit, Malmo, Sweden.
   [de Mello, Vanessa D.; Pihlajamaki, Jussi] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Dept Clin Nutr, Kuopio, Finland.
   [Pihlajamaki, Jussi] Kuopio Univ Hosp, Clin Nutr & Obes Ctr, Kuopio, Finland.
C3 Lund University; University of Eastern Finland; University of Eastern
   Finland; Kuopio University Hospital
RP Ling, C (corresponding author), Lund Univ, Ctr Diabet, Dept Clin Sci, Epigenet & Diabet Unit, Malmo, Sweden.
EM charlotte.ling@med.lu.se
RI Ling, Charlotte/Q-2432-2015
OI Ling, Charlotte/0000-0003-0587-7154; Perfilyev,
   Alexander/0000-0003-1136-8946; Pihlajamaki, Jussi/0000-0002-6241-6859;
   de Mello, Vanessa/0000-0003-3414-6983; Ronn, Tina/0000-0001-7622-800X
FU Academy of Finland [120,979, 138,005, 131,5931]; Finnish Diabetes
   Research Foundation; Finnish Cultural Foundation; Kuopio University
   Hospital EVO; VTR; Swedish Research Council; Region Skane (ALF); Knut
   and Alice Wallenberg Foundation; Novonordisk Foundation; EFSD/Lilly
   Fellowship; Soderberg Foundation; Swedish Diabetes Foundation; Pahlsson
   Foundation; EXODIAB; Linne grant
FX This study has been supported by grants from Academy of Finland
   (Contract numbers 120,979, 138,005 and 131,5931, the Finnish Diabetes
   Research Foundation, the Finnish Cultural Foundation and the Kuopio
   University Hospital EVO and VTR funding. The authors thank SCIBLU
   Genomics facility for microarray analysis. This work was financially
   supported by grants from the Swedish Research Council, Region Skane
   (ALF), Knut and Alice Wallenberg Foundation, Novonordisk Foundation,
   EFSD/Lilly Fellowship, Soderberg Foundation, The Swedish Diabetes
   Foundation, Pahlsson Foundation, EXODIAB and Linne grant. The authors
   have no other relevant affiliations or financial involvement with any
   organization or entity with a financial interest in or financial
   conflict with the subject matter or materials discussed in the
   manuscript apart from those disclosed.
CR Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   Bacos K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11089
   Bernal GM, 2014, AGING-US, V6, P931, DOI 10.18632/aging.100702
   Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007
   Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128
   Chen YA, 2013, EPIGENETICS-US, V8, P203, DOI 10.4161/epi.23470
   Costa RH, 2003, HEPATOLOGY, V38, P1331, DOI 10.1016/j.hep.2003.09.034
   Dayeh TA, 2013, DIABETOLOGIA, V56, P1036, DOI 10.1007/s00125-012-2815-7
   Dayeh T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004160
   De Zhu J, 2005, CELL RES, V15, P272
   Dedeurwaerder S, 2011, EPIGENOMICS-UK, V3, P771, DOI [10.2217/EPI.11.105, 10.2217/epi.11.105]
   Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224
   Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587
   Florath I, 2014, HUM MOL GENET, V23, P1186, DOI 10.1093/hmg/ddt531
   FOX J, 1992, J AM STAT ASSOC, V87, P178, DOI 10.2307/2290467
   Frith J, 2009, AGE AGEING, V38, P11, DOI 10.1093/ageing/afn242
   Garagnani P, 2012, AGING CELL, V11, P1132, DOI 10.1111/acel.12005
   Gillberg L, 2016, DIABETOLOGIA, V59, P799, DOI 10.1007/s00125-015-3852-9
   Glass D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r75
   Hernandez-Vargas H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009749
   Horvath S, 2014, P NATL ACAD SCI USA, V111, P15538, DOI 10.1073/pnas.1412759111
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Johansson Å, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067378
   Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037
   Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230
   Jump DB, 2013, ANNU REV NUTR, V33, P249, DOI 10.1146/annurev-nutr-071812-161139
   Kim SK, 2008, CARCINOGENESIS, V29, P1623, DOI 10.1093/carcin/bgn110
   Li QJ, 2011, HEPATOL RES, V41, P776, DOI 10.1111/j.1872-034X.2011.00827.x
   Ling C, 2007, J CLIN INVEST, V117, P3427, DOI 10.1172/JCI30938
   Ling C, 2009, DIABETES, V58, P2718, DOI 10.2337/db09-1003
   Männistö VT, 2014, J LIPID RES, V55, P2676, DOI 10.1194/jlr.P054387
   Nilsson E, 2015, J CLIN ENDOCR METAB, V100, pE1491, DOI 10.1210/jc.2015-3204
   Nitert MD, 2012, DIABETES, V61, P3322, DOI 10.2337/db11-1653
   Olsson AH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004735
   Pihlajamäki J, 2012, J HEPATOL, V56, P663, DOI 10.1016/j.jhep.2011.10.005
   Polager S, 2009, NAT REV CANCER, V9, P738, DOI 10.1038/nrc2718
   Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361
   Rönn T, 2015, EPIGENOMICS-UK, V7, P451, DOI 10.2217/epi.15.7
   Rönn T, 2015, HUM MOL GENET, V24, P3792, DOI 10.1093/hmg/ddv124
   Rönn T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003572
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Shen J, 2012, HEPATOLOGY, V55, P1799, DOI 10.1002/hep.25569
   Skinner MK, 2010, NATURE, V467, P922, DOI 10.1038/467922a
   Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461
   Steegenga WT, 2014, AGE, V36, P1523, DOI 10.1007/s11357-014-9648-x
   Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680
   Tobi EW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6592
   Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538
   Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609
   Yaghootkar H, 2015, DIABETES, V64, P2279, DOI 10.2337/db14-1456
NR 50
TC 40
Z9 43
U1 1
U2 11
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1750-1911
EI 1750-192X
J9 EPIGENOMICS-UK
JI Epigenomics
PD FEB
PY 2017
VL 9
IS 2
BP 105
EP 122
DI 10.2217/epi-2016-0087
PG 18
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA EJ8CR
UT WOS:000393452600004
PM 27911095
OA hybrid
DA 2024-02-19
ER

PT J
AU Howland, RH
AF Howland, Robert H.
TI Effects of Aging on Pharmacokinetic and Pharmacodynamic Drug Processes
SO JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES
LA English
DT Article
ID BODY-COMPOSITION; UNITED-STATES; PRESCRIPTION; AGE
AB Aging affects the pharmacokinetics and pharmacodynamics of drugs, which has potentially important implications for the use of psychotropic medication in older adults. The absorption of orally administered drugs may be impaired or delayed, the volume of distribution of most drugs is decreased, and over time, the distribution shifts toward greater drug accumulation in fat stores. Decrease in renal function with age is especially important regarding, the use of lithium but is also relevant for most drugs because they are eventually cleared through the kidneys after metabolism in the liver. Because pharmacodynamic changes associated with aging will make elderly patients more sensitive to the pharmacological effects of medication-especially adverse effects-nurses should be appropriately trained in pharmacology and therapeutics in older adults.
C1 Univ Pittsburgh, Sch Med, Western Psychiat Inst & Clin, Pittsburgh, PA 15213 USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); University
   of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC
RP Howland, RH (corresponding author), Univ Pittsburgh, Sch Med, Western Psychiat Inst & Clin, 3811 OHara St, Pittsburgh, PA 15213 USA.
EM HowlandRH@upmc.edu
RI Howland, Robert H/K-6937-2015
OI Howland, Robert H/0000-0002-6533-6010
CR Aparasu RR, 2003, J AM GERIATR SOC, V51, P671, DOI 10.1034/j.1600-0579.2003.00212.x
   Banning M., 2005, NURS OLDER PEOPLE, V17, P20, DOI [10.1016/j.ijnurstu.2008.02.009, DOI 10.1016/J.IJNURSTU.2008.02.009]
   BORKAN GA, 1983, J GERONTOL, V38, P673, DOI 10.1093/geronj/38.6.673
   ElDesoky Ehab S, 2007, Am J Ther, V14, P488, DOI 10.1097/01.mjt.0000183719.84390.4d
   GREENBLATT DJ, 1982, NEW ENGL J MED, V306, P1081
   Hilmer SN, 2007, FUND CLIN PHARMACOL, V21, P217, DOI 10.1111/j.1472-8206.2007.00473.x
   Hughes VA, 2002, AM J CLIN NUTR, V76, P473, DOI 10.1093/ajcn/76.2.473
   Pollock BG, 2009, CLIN PHARMACOL THER, V85, P89, DOI 10.1038/clpt.2008.229
   Qato DM, 2008, JAMA-J AM MED ASSOC, V300, P2867, DOI 10.1001/jama.2008.892
   Ritz P, 2000, ANN NY ACAD SCI, V904, P474
   ROBERTS J, 1998, CLIN GERIATR MED, V4, P127
   RUDORFER MV, 1993, J CLIN PSYCHIAT, V54, P50
NR 13
TC 3
Z9 3
U1 0
U2 2
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086 USA
SN 0279-3695
J9 J PSYCHOSOC NURS MEN
JI J. Psychosoc. Nurs. Ment. Health Serv.
PD OCT
PY 2009
VL 47
IS 10
BP 15
EP +
DI 10.3928/02793695-20090902-06
PG 4
WC Nursing
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Nursing
GA 509SI
UT WOS:000271038300007
PM 19835315
DA 2024-02-19
ER

PT J
AU Moffitt, TE
   Belsky, DW
   Danese, A
   Poulton, R
   Caspi, A
AF Moffitt, Terrie E.
   Belsky, Daniel W.
   Danese, Andrea
   Poulton, Richie
   Caspi, Avshalom
TI The Longitudinal Study of Aging in Human Young Adults: Knowledge Gaps
   and Research Agenda
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE Longitudinal cohort study; Health span; Geroscience; Young adults
ID ALL-CAUSE-MORTALITY; BIOLOGICAL AGE; DEVELOPMENTAL ORIGINS; LATER LIFE;
   BIOMARKERS; HEALTH; QUANTIFICATION; INTERVENTIONS; INTELLIGENCE; DISEASE
AB Background: To prevent onset of age-related diseases and physical and cognitive decline, interventions to slow human aging and extend health span must eventually be applied to people while they are still young and healthy. Yet most human aging research examines older adults, many with chronic disease, and little is known about aging in healthy young humans.
   Method: This article explains how this knowledge gap is a barrier to extending health span and puts forward the case that geroscience should invest in researching the pace of aging in young adults. As one illustrative example, we describe an initial effort to study the pace of aging in a young-adult birth cohort by using repeated waves of biomarkers collected across the third and fourth decades to quantify the pace of coordinated physiological deterioration across multiple organ systems (eg, pulmonary, periodontal, cardiovascular, renal, hepatic, metabolic, and immune function).
   Results: Findings provided proof of principle that it is possible to quantify individual variation in the pace of aging in young adults still free of age-related diseases.
   Conclusions: This article articulates research needs to improve longitudinal measurement of the pace of aging in young people, to pinpoint factors that slow or speed the pace of aging, to compare pace of aging against genomic clocks, to explain slow-aging young adults, and to apply pace of aging in preventive clinical trials of antiaging therapies. This article puts forward a research agenda to fill the knowledge gap concerning lifelong causes of aging.
C1 [Moffitt, Terrie E.; Caspi, Avshalom] Duke Univ, Dept Psychol & Neurosci, 2020 West Main St, Durham, NC 27708 USA.
   [Moffitt, Terrie E.; Caspi, Avshalom] Duke Univ, Dept Psychiat & Behav Sci, Durham, NC USA.
   [Moffitt, Terrie E.; Danese, Andrea; Caspi, Avshalom] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England.
   [Belsky, Daniel W.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA.
   [Belsky, Daniel W.] Duke Univ, Social Sci Res Inst, Durham, NC USA.
   [Poulton, Richie] Univ Otago, Dept Psychol, Dunedin, New Zealand.
C3 Duke University; Duke University; University of London; King's College
   London; Duke University; Duke University; University of Otago
RP Moffitt, TE (corresponding author), Duke Univ, Dept Psychol & Neurosci, 2020 West Main St, Durham, NC 27708 USA.
EM tem11@duke.edu
RI caspi, avshalom/AAJ-5874-2020; Belsky, Daniel/AAB-4785-2021; Moffitt,
   Terrie E/D-5295-2011; Belsky, Daniel/HDN-5118-2022; Danese,
   Andrea/ABF-1471-2020
OI caspi, avshalom/0000-0003-0082-4600; Belsky, Daniel/0000-0001-5463-2212;
   Moffitt, Terrie E/0000-0002-8589-6760; Danese,
   Andrea/0000-0001-8718-5412
FU U.S. National Institute on Aging (NIA) [AG032282, AG048895, AG049789];
   UK Medical Research Council [MR/K00381X]; ESRC [ES/M010309/1]; Jacobs
   Foundation; NIA [P30 AG028716]; NZ Health Research Council; New Zealand
   Ministry of Business, Innovation and Employment (MBIE); ESRC
   [ES/M010309/1] Funding Source: UKRI; MRC [MR/P005918/1] Funding Source:
   UKRI; Economic and Social Research Council [ES/M010309/1] Funding
   Source: researchfish; Medical Research Council [MR/P005918/1] Funding
   Source: researchfish
FX This work was supported by the U.S. National Institute on Aging (NIA;
   grants AG032282, AG048895, and AG049789); UK Medical Research Council
   (grant MR/K00381X); and ESRC (grant ES/M010309/1). Additional support
   was provided by the Jacobs Foundation. D.W.B. received support from the
   NIA through P30 AG028716. R.P. was supported by the NZ Health Research
   Council and New Zealand Ministry of Business, Innovation and Employment
   (MBIE).
CR [Anonymous], NIH C ADV GER IMP HE
   BARKER DJP, 1989, LANCET, V2, P577
   Barzilai N, 2012, NAT REV GENET, V13, P589, DOI 10.1038/nrg3290
   Belsky DW, 2015, P NATL ACAD SCI USA, V112, pE7164, DOI 10.1073/pnas.1518878112
   Belsky DW, 2015, P NATL ACAD SCI USA, V112, pE4104, DOI 10.1073/pnas.1506264112
   Brayne C, 2007, NAT REV NEUROSCI, V8, P233, DOI 10.1038/nrn2091
   Brooks-Wilson AR, 2013, HUM GENET, V132, P1323, DOI 10.1007/s00439-013-1342-z
   Burch JB, 2014, J GERONTOL A-BIOL, V69, pS1, DOI 10.1093/gerona/glu041
   Calvin CM, 2011, INT J EPIDEMIOL, V40, P626, DOI 10.1093/ije/dyq190
   Cohen AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116489
   Crimmins EM, 2004, ANNU REV PUBL HEALTH, V25, P79, DOI 10.1146/annurev.publhealth.25.102802.124401
   de Cabo R, 2014, CELL, V157, P1515, DOI 10.1016/j.cell.2014.05.031
   Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8
   Finch CE, 2004, SCIENCE, V305, P1736, DOI 10.1126/science.1092556
   Fontana L, 2014, NATURE, V511, P405, DOI 10.1038/511405a
   Gavrilov LA, 2004, ANN NY ACAD SCI, V1019, P496, DOI 10.1196/annals.1297.091
   Gillman MW, 2005, NEW ENGL J MED, V353, P1848, DOI 10.1056/NEJMe058187
   Glei DA, 2014, POPUL DEV REV, V40, P331, DOI 10.1111/j.1728-4457.2014.00676.x
   Gruenewald TL, 2006, P NATL ACAD SCI USA, V103, P14158, DOI 10.1073/pnas.0606215103
   Guarente L, 2014, CELL, V159, P15, DOI 10.1016/j.cell.2014.08.041
   Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016
   Hayden EC, 2015, NATURE, V522, P265, DOI 10.1038/522265a
   Hayflick L, 2000, NATURE, V408, P267, DOI 10.1038/35041709
   Heyn H, 2012, P NATL ACAD SCI USA, V109, P10522, DOI 10.1073/pnas.1120658109
   Hill PL, 2015, PSYCHOL AGING, V30, P529, DOI 10.1037/pag0000020
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Jackson SHD, 2003, ARCH GERONTOL GERIAT, V36, P103, DOI 10.1016/S0167-4943(02)00060-2
   Johnson TE, 2006, EXP GERONTOL, V41, P1243, DOI 10.1016/j.exger.2006.09.006
   Kaeberlein Matt, 2013, F1000Prime Rep, V5, P5, DOI 10.12703/P5-5
   Kennedy BK, 2014, CELL, V159, P708, DOI 10.1016/j.cell.2014.10.039
   Kirkland JL, 2013, EXP GERONTOL, V48, P1, DOI 10.1016/j.exger.2012.11.014
   Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682
   Klemera P, 2006, MECH AGEING DEV, V127, P240, DOI 10.1016/j.mad.2005.10.004
   Kuh D., 2014, A life course approach to healthy ageing
   Kwan CML, 2003, PSYCHOL AGING, V18, P3, DOI 10.1037/0882-7974.18.1.3
   Lara J, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0470-9
   Levine ME, 2014, J GERONTOL A-BIOL, V69, P297, DOI 10.1093/gerona/glt138
   Levine ME, 2013, J GERONTOL A-BIOL, V68, P667, DOI 10.1093/gerona/gls233
   Lixie E, 2015, GERONTOLOGY, V61, P526, DOI 10.1159/000381584
   Longo VD, 2015, AGING CELL, V14, P497, DOI 10.1111/acel.12338
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Mather KA, 2011, J GERONTOL A-BIOL, V66, P202, DOI 10.1093/gerona/glq180
   Mirzaei H, 2014, TRENDS ENDOCRIN MET, V25, P558, DOI 10.1016/j.tem.2014.07.002
   Mitnitski A, 2017, J GERONTOL A-BIOL, V72, P877, DOI 10.1093/gerona/glw089
   Mitnitski A, 2016, BIOGERONTOLOGY, V17, P199, DOI 10.1007/s10522-015-9583-y
   Munoz E, 2015, PSYCHOL AGING, V30, P487, DOI 10.1037/pag0000036
   Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805
   Peters MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9570
   Pitt JN, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002131
   Poulton R, 2015, SOC PSYCH PSYCH EPID, V50, P679, DOI 10.1007/s00127-015-1048-8
   Power C, 2013, ANNU REV PUBL HEALTH, V34, P7, DOI 10.1146/annurev-publhealth-031912-114423
   Rosso AL, 2015, J GERONTOL A-BIOL, V70, P317, DOI 10.1093/gerona/glu176
   Sayer AA, 1998, AGE AGEING, V27, P579, DOI 10.1093/ageing/27.5.579
   Simm A, 2008, BIOL CHEM, V389, P257, DOI 10.1515/BC.2008.034
   Sood S, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0750-x
   Sprott RL, 2010, EXP GERONTOL, V45, P2, DOI 10.1016/j.exger.2009.07.008
   Willett JB, 1998, DEV PSYCHOPATHOL, V10, P395, DOI 10.1017/S0954579498001667
   Wills AK, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000440
   Zhang WB, 2016, AGING CELL, V15, P39, DOI 10.1111/acel.12408
   Ziegler M, 2015, PSYCHOL AGING, V30, P573, DOI 10.1037/a0039493
NR 60
TC 75
Z9 82
U1 0
U2 17
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD FEB
PY 2017
VL 72
IS 2
BP 210
EP 215
DI 10.1093/gerona/glw191
PG 6
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA EP2EC
UT WOS:000397194800008
PM 28087676
OA Green Submitted, Green Published, Bronze
DA 2024-02-19
ER

PT J
AU ZOLFAGHARI, R
   ROSS, AC
AF ZOLFAGHARI, R
   ROSS, AC
TI CHRONIC VITAMIN-A INTAKE AFFECTS THE EXPRESSION OF MESSENGER-RNA FOR
   APOLIPOPROTEIN-A-I, BUT NOT FOR NUCLEAR RETINOID RECEPTORS, IN LIVER OF
   YOUNG AND AGING LEWIS RATS
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE RETINYL ESTERS; LEWIS RATS; AGING; APOLIPOPROTEIN A-I; NUCLEAR RETINOID
   RECEPTORS
ID MESSENGER-RNA; PLASMA RETINOL; X-RECEPTOR; RXR-ALPHA; ACID; GENE;
   CHOLESTEROL; TISSUE; POLYSACCHARIDE; TRANSCRIPTION
AB We have investigated the effects of chronic retinoid status and age on the steady-state levels in rat liver of the mRNAs for the retinoid-responsive gene apolipoprotein A-I (ape A-I), and for three nuclear retinoid receptors, RAR-alpha, RAR-beta, and RXR-alpha. Weanling male Lewis rats (five per age-diet group) were fed a semisynthetic diet with vitamin A at marginal, control, or supplemented levels until they were 2 or 8 months of age, The relative abundance of apo A-I mRNA (compared to beta-actin which did not differ among treatments) was about 50% lower in aging versus young rats, regardless of their vitamin A status. For both ages, apo A-I mRNA was approximately 40-50% higher (P < 0.05) for the vitamin A-marginal groups and 20-30% lower (P > 0.05) for the vitamin A-supplemented groups than the controls. Neither chronic diet nor age affected the levels of mRNA for RAR-alpha or RXR-alpha, two major retinoid receptors in liver, or for RAR-beta, a receptor known to be autoregulated by RA. Although vitamin A did not have a significant effect on the mRNA levels of the receptors examined in this study, they are still likely to be involved in regulating apo A-I gene expression because in vitro studies have shown that both RAR-alpha and RXR-alpha bind to the regulatory region of the apo A-I gene. (C) 1995 Academic Press, Inc.
C1 MED COLL PENN, DEPT BIOCHEM, PHILADELPHIA, PA 19129 USA.
C3 Drexel University
FU NIA NIH HHS [R01 AG-09839] Funding Source: Medline
CR APOSTOLOPOULOS JJ, 1987, J LIPID RES, V28, P642
   BERTHOU L, 1994, ARTERIOSCLER THROMB, V14, P1657, DOI 10.1161/01.ATV.14.10.1657
   DAVIDSON NO, 1988, J LIPID RES, V29, P1511
   ELSHOURBAGY NA, 1985, P NATL ACAD SCI USA, V82, P8242, DOI 10.1073/pnas.82.23.8242
   GARDNER EM, 1993, J NUTR, V123, P1435
   GO MF, 1988, J CLIN INVEST, V81, P1615, DOI 10.1172/JCI113496
   GOLDERNOVOSELSKY E, 1992, J BIOL CHEM, V267, P20787
   GREEN MH, 1987, J NUTR, V117, P694, DOI 10.1093/jn/117.4.694
   HADDAD IA, 1986, J BIOL CHEM, V261, P3268
   HARTZ SC, 1988, J AM COLL NUTR, V7, P119, DOI 10.1080/07315724.1988.10720228
   HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V
   JACOBSON A, 1987, METHOD ENZYMOL, V152, P254
   KAPTEIN A, 1993, ARTERIOSCLER THROMB, V13, P1505, DOI 10.1161/01.ATV.13.10.1505
   KATO S, 1992, BIOCHEM J, V286, P755, DOI 10.1042/bj2860755
   KRASINSKI SD, 1989, AM J CLIN NUTR, V49, P112, DOI 10.1093/ajcn/49.1.112
   LEID M, 1992, TRENDS BIOCHEM SCI, V17, P427, DOI 10.1016/0968-0004(92)90014-Z
   LEVIN AA, 1992, NATURE, V355, P359, DOI 10.1038/355359a0
   MALLIA A K, 1975, Journal of Lipid Research, V16, P180
   MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329
   NAGASAKI A, 1994, BIOCHEM BIOPH RES CO, V205, P1510, DOI 10.1006/bbrc.1994.2838
   OLSON JA, 1983, SEMIN ONCOL, V10, P290
   PASATIEMPO AMG, 1989, AM J CLIN NUTR, V49, P501, DOI 10.1093/ajcn/49.3.501
   PASATIEMPO AMG, 1990, FASEB J, V4, P2518, DOI 10.1096/fasebj.4.8.2110538
   RANDOLPH RK, 1991, J BIOL CHEM, V266, P16453
   RIAZULHAQ, 1991, P NATL ACAD SCI USA, V88, P8272, DOI 10.1073/pnas.88.18.8272
   ROTTMAN JN, 1991, MOL CELL BIOL, V11, P3814, DOI 10.1128/MCB.11.7.3814
   SMITH FR, 1976, NEW ENGL J MED, V294, P805, DOI 10.1056/NEJM197604082941503
   SORCITHOMAS M, 1989, J LIPID RES, V30, P1397
   STAELS B, 1989, J LIPID RES, V30, P1137
   STAUBER PM, 1991, AM J CLIN NUTR, V54, P878, DOI 10.1093/ajcn/54.5.878
   TANG J, 1989, BIOCHEM BIOPH RES CO, V181, P1407
   TZAMELI E, 1993, CIRCULATION, V88, P422
   VARMA VK, 1992, METABOLISM, V41, P1075, DOI 10.1016/0026-0495(92)90288-L
   WIDOM RL, 1992, MOL CELL BIOL, V12, P3380, DOI 10.1128/MCB.12.8.3380
   ZHANG XK, 1992, NATURE, V358, P587, DOI 10.1038/358587a0
   ZOLFAGHARI R, 1994, J LIPID RES, V35, P1985
   ZOLFAGHARI R, 1993, J BIOL CHEM, V268, P13532
   ZOLFAGHARI R, 1993, CLIN CHEM, V39, P1408
NR 38
TC 26
Z9 27
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 10
PY 1995
VL 323
IS 2
BP 258
EP 264
DI 10.1006/abbi.1995.9966
PG 7
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA TE643
UT WOS:A1995TE64300007
PM 7487086
DA 2024-02-19
ER

PT J
AU Basso, A
   Rossolini, G
   Piantanelli, A
   Amici, D
   Calzuola, I
   Mancinelli, L
   Marsili, V
   Gianfranceschi, G
AF Basso, A
   Rossolini, G
   Piantanelli, A
   Amici, D
   Calzuola, I
   Mancinelli, L
   Marsili, V
   Gianfranceschi, G
TI Aging reversibility: From thymus graft to vegetable extract treatment -
   application to cure an age-associated pathology
SO BIOGERONTOLOGY
LA English
DT Article
DE aging; antioxidant; DNA synthesis; primary cultures of hepatocytes;
   thymus extract; wheat sprout
ID SUB-MANDIBULAR GLANDS; DNA-SYNTHESIS; OXIDATIVE STRESS; ACIDIC PEPTIDES;
   WHEAT SPROUTS; FREE-RADICALS; HEPATOCYTES; MECHANISM; CHROMATIN;
   ANTIOXIDANTS
AB Neonatal thymus graft and thymus calf extract (TME) in vivo treatment exert similar corrective actions on different mouse age-related alterations. The aim of the present paper is to investigate whether a vegetal extract, wheat sprout extract (WESPRE), could mimic the thymus action on recovering age-related alterations and if this extract can cure an age-associated pathology, the cataract in dogs. Present experiments were carried out by using WESPRE and TME in vivo in old mice to check their ability to recover the altered DNA synthesis in hepatocyte primary cultures. Old mice treated with WESPRE and TME showed a recovery of hepatocyte DNA synthesis levels when compared with the old untreated ones. The increase of DNA and protein contents observed in aged animals is reduced by WESPRE treatments to levels observed in young mice hepatocytes. We measured also WESPRE phosphorylation activity by endogenous kinase: it was from 10 to 40 times higher with respect to wheat seeds. Old dogs were orally treated for a month and the lens opacity analysed before and after the treatment. Results showed a reduction from 25 to 40% of lens opacity. The efficacy of wheat sprouts in the recovery of age-related alterations and in treating age-associated pathologies could be due to the contemporary presence of small regulatory acid peptides, a remarkable level of highly energetic phosphoric radicals and antioxidant molecules, peculiarities that may be, to some extent, related to the aging process regulation.
C1 INRCA Ancona, Ctr Biochem, Gerontol Res Dept, I-60121 Ancona, Italy.
   Univ Camerino, Dept Biol, MCA, I-62032 Camerino, Italy.
   Univ Perugia, Dept Cellular & Environm Biol, I-06100 Perugia, Italy.
C3 IRCCS INRCA; University of Camerino; University of Perugia
RP Basso, A (corresponding author), INRCA Ancona, Ctr Biochem, Gerontol Res Dept, Via Birarelli 8, I-60121 Ancona, Italy.
EM a.basso@inrca.it
RI Rossolini, Giuliana/I-1619-2016
OI Rossolini, Giuliana/0000-0003-1840-599X; BASSO,
   ANDREA/0000-0001-5896-0854
CR AMICO D, 1983, P NATL ACAD SCI USA, V74, P3869
   ANDERSON RE, 1994, ADV EXP MED BIOL, V366, P73
   Basso A, 1998, J GERONTOL A-BIOL, V53, pB111, DOI 10.1093/gerona/53A.2.B111
   BASSO A, 1993, RECENT ADVANCES IN AGING SCIENCE, VOLS I AND II, P233
   Biesalski HK, 2002, CURR OPIN CLIN NUTR, V5, P5, DOI 10.1097/00075197-200201000-00002
   BURTON K, 1956, BIOCHEM J, V62, P315, DOI 10.1042/bj0620315
   Calzuola I, 2004, J AGR FOOD CHEM, V52, P5201, DOI 10.1021/jf0307752
   Dardenne M., 1990, PROGR NEURO ENDOCRIN, V3, P18
   Dröge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   FABRIS N, 1982, HORMONES AGEING, P186
   Falcioni G, 2002, J FOOD SCI, V67, P2918, DOI 10.1111/j.1365-2621.2002.tb08838.x
   FAUTZ R, 1993, MUTAT RES, V291, P21, DOI 10.1016/0165-1161(93)90013-P
   GIANFRANCESCHI GL, 1976, MOL BIOL REP, V3, P55, DOI 10.1007/BF00357209
   GIANFRANCESCHI GL, 1975, BIOCHIM BIOPHYS ACTA, V414, P9, DOI 10.1016/0005-2787(75)90121-5
   GIANFRANCESCHI GL, 1976, NATURE, V262, P622, DOI 10.1038/262622a0
   GIANFRANCESCHI GL, 1974, SPECTROPHOTOMETRICAL, V30, P1049
   Golden TR, 2002, AGING CELL, V1, P117, DOI 10.1046/j.1474-9728.2002.00015.x
   Goldstein AL, 2004, EXPERT OPIN BIOL TH, V4, P559, DOI 10.1517/eobt.4.4.559.29800
   Hannappel E, 2003, VITAM HORM, V66, P257, DOI 10.1016/S0083-6729(03)01007-0
   ISHIGAMI A, 1993, BIOCHEM BIOPH RES CO, V196, P181, DOI 10.1006/bbrc.1993.2232
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Mancinelli L, 1999, BIOL CHEM, V380, P31, DOI 10.1515/BC.1999.004
   MANCINELLI L, 1992, PHYSIOL CHEM PHYS M, V24, P97
   MANCINELLI L, 1998, GASTROENTEROL INT, V11, P50
   Marsili V, 2004, J CLIN GASTROENTEROL, V38, pS123, DOI 10.1097/01.mcg.0000128933.46296.0a
   Melov S, 2002, ANN NY ACAD SCI, V959, P330, DOI 10.1111/j.1749-6632.2002.tb02104.x
   Miquel J, 2002, ANN NY ACAD SCI, V959, P508, DOI 10.1111/j.1749-6632.2002.tb02120.x
   Niwa Y, 1998, INT J TISSUE REACT, V20, P63
   Orhan H, 1999, TOXICOLOGY, V139, P219, DOI 10.1016/S0300-483X(99)00128-6
   PERYT B, 1992, MUTAT RES, V269, P201, DOI 10.1016/0027-5107(92)90201-C
   PIANTANELLI L, 1980, MECH AGEING DEV, V14, P155, DOI 10.1016/0047-6374(80)90114-1
   PIANTANELLI L, 1991, ARCH GERONTOL GERIAT, V12, P291, DOI 10.1016/0167-4943(91)90035-O
   PIANTANELLI L, 1978, MECH AGEING DEV, V7, P163, DOI 10.1016/0047-6374(78)90062-3
   PIERI C, 1980, MECH AGEING DEV, V13, P275, DOI 10.1016/0047-6374(80)90040-8
   PIERI C, 1982, EXPERIENTIA, V38, P680, DOI 10.1007/BF01964092
   ROSSOLINI G, 1991, INT J NEUROSCI, V59, P143, DOI 10.3109/00207459108985457
   ROSSOLINI G, 1992, ARCH GERONTOL GERIAT, P311, DOI 10.1016/S0167-4943(05)80031-7
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   TAKAI S, 1988, J BIOCHEM-TOKYO, V103, P848, DOI 10.1093/oxfordjournals.jbchem.a122359
   TAYLOR A, 1995, AM J CLIN NUTR, V62, P1439, DOI 10.1093/ajcn/62.6.1439S
   TUDEK B, 1988, NEOPLASMA, V35, P515
   van der Pols JC, 1999, P NUTR SOC, V58, P295, DOI 10.1017/S0029665199001354
   VITICCHI C, 1989, ARCH GERONTOL GERIAT, V8, P13, DOI 10.1016/0167-4943(89)90065-4
   Zaia A, 1997, MECH AGEING DEV, V98, P37, DOI 10.1016/S0047-6374(97)00066-3
NR 44
TC 8
Z9 8
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD SEP
PY 2005
VL 6
IS 4
BP 245
EP 253
DI 10.1007/s10522-005-2620-5
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 991OR
UT WOS:000233823800003
PM 16333758
DA 2024-02-19
ER

PT J
AU Salama, A
   Elgohary, R
AF Salama, Abeer
   Elgohary, Rania
TI Influence of chrysin on D-galactose induced-aging in mice: Up regulation
   of AMP kinase/liver kinase B1/peroxisome proliferator-activated
   receptor-γ coactivator 1-α signaling pathway
SO FUNDAMENTAL & CLINICAL PHARMACOLOGY
LA English
DT Article; Early Access
DE aging; AMPK; chrysin; D-galactose; LKB1; NT-3; PGC1 alpha
ID OXIDATIVE STRESS; COGNITIVE DEFICITS; PGC-1 COACTIVATORS; PROTECTIVE
   ROLE; AGE; BRAIN; RAT; INCREASES; NEURODEGENERATION; INFLAMMATION
AB Adenosine monophosphate kinase/liver kinase B1/peroxisome proliferator-activated receptor-? coactivator 1-a (AMPK/LKB1/PGC1a) pathway has a vital role in regulating age-related diseases. It controls neurogenesis, cell proliferation, axon outgrowth, and cellular energy homeostasis. AMPK pathway also regulates mitochondrial synthesis. The current study evaluated the effect of chrysin on D-galactose (D-gal) induced-aging, neuron degeneration, mitochondrial dysfunction, oxidative stress, and neuroinflammation in mice. The mice were allocated randomly into four groups (10 each group): Group 1: normal control group, Group 2: D-gal group, Groups 3 and 4: chrysin (125 and 250 mg/kg, respectively). Groups 2-4 were injected with D-gal (200 mg/kg/day; s.c) for 8 weeks to induce aging. Groups 3 and 4 were orally gavaged every day concurrent with D-gal. At the end of experiment, behavioral, brain biochemical and histopathological changes were monitored. Chrysin administration elevated discrimination ratio in object recognition, Y Maze percentage alternation, locomotor activity and brain contents of AMPK, LKB1, PGC1a, NAD (P)H quinone oxidoreductase 1 (NQO1), heme oxygenase 1 (HO-1), nerve growth factor (NGF) (neurotrophin-3; NT-3), and seretonin as well as reduced brain contents of tumor necrosis factor-alpha (TNF-a), nuclear factor kappa B (NF-?B), advanced glycation end products (AGEs) and glial fibrillary acidic protein (GFAP) compared to D-gal-treated mice. Chrysin also alleviated cerebral cortex and white matter neurons degeneration. Chrysin protects against neurodegeneration, improves mitochondrial autophagy and biogenesis as well as activates antioxidant genes expression. In addition, chrysin ameliorates neuroinflammation and stimulates the release of NGF and serotonin neurotransmitter. So, chrysin has a neuroprotective effect in D-gal induced-aging in mice.
C1 [Salama, Abeer] Natl Res Ctr, Pharmacol Dept, El Buhouth St, Cairo 12622, Egypt.
   [Elgohary, Rania] Natl Res Ctr, Narcot Ergogen & Poisons Dept, El Buhouth St, Cairo 12622, Egypt.
   [Elgohary, Rania] Natl Res Ctr, Narcot Ergogen & Poisons Dept, 33 El Buhouth St, Giza 12622, Egypt.
C3 Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian
   Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge
   Bank (EKB); National Research Centre (NRC)
RP Elgohary, R (corresponding author), Natl Res Ctr, Narcot Ergogen & Poisons Dept, 33 El Buhouth St, Giza 12622, Egypt.
EM rony2003rania@gmail.com
FU National Research Centre, Egypt [20195]
FX ACKNOWLEDGMENTS This work was funded by the National Research Centre,
   Egypt (Grant Number 20195).
CR Anand KV, 2012, GERIATR GERONTOL INT, V12, P741, DOI 10.1111/j.1447-0594.2012.00843.x
   Avila J, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00626
   Baeta-Corral R, 2018, J GERONTOL A-BIOL, V73, P1147, DOI 10.1093/gerona/gly031
   Basha M, 2020, DRUG DEV IND PHARM, V46, P253, DOI 10.1080/03639045.2020.1716376
   Benkovic V, 2008, BIOL PHARM BULL, V31, P167, DOI 10.1248/bpb.31.167
   Bimonte HA, 2003, NEUROBIOL AGING, V24, P37, DOI 10.1016/S0197-4580(02)00015-5
   Borges Filho C, 2016, EUR J PHARMACOL, V791, P284, DOI 10.1016/j.ejphar.2016.09.005
   Burke SN, 2012, FRONT AGING NEUROSCI, V4, DOI 10.3389/fnagi.2012.00015
   Burke SN, 2010, BEHAV NEUROSCI, V124, P559, DOI 10.1037/a0020893
   Cai H, 2020, INT J MOL MED, V45, P715, DOI 10.3892/ijmm.2020.4453
   Cai ZY, 2012, NEUROMOL MED, V14, P1, DOI 10.1007/s12017-012-8173-2
   Çelik H, 2020, NEUROTOXICOLOGY, V81, P197, DOI 10.1016/j.neuro.2020.10.009
   Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873
   Chiroma SM, 2019, BIOMED PHARMACOTHER, V109, P853, DOI 10.1016/j.biopha.2018.10.111
   Ciftci O, 2012, TOXICOL IND HEALTH, V28, P947, DOI 10.1177/0748233711430978
   Dhalaria R, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9111123
   El-Baz FK, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/8843218
   ElShaheed AA., 2012, ARCH DIS CHILD, V97, DOI [10.1136/archdischild-2012-302724.0455, DOI 10.1136/ARCHDISCHILD]
   Fanibunda SE, 2019, P NATL ACAD SCI USA, V116, P11028, DOI 10.1073/pnas.1821332116
   Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794
   Funakoshi M, 2011, BIOCHEM BIOPH RES CO, V405, P667, DOI 10.1016/j.bbrc.2011.01.090
   Gao Y, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11010111
   Goudarzi M, 2019, NEUROL RES, V41, P419, DOI 10.1080/01616412.2019.1576319
   Guo B, 2020, BIOGERONTOLOGY, V21, P311, DOI 10.1007/s10522-020-09859-x
   Gustilo MC, 1999, J COMP NEUROL, V405, P491, DOI 10.1002/(SICI)1096-9861(19990322)405:4<491::AID-CNE4>3.0.CO;2-N
   Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311
   He XL, 2012, EUR J PHARMACOL, V680, P41, DOI 10.1016/j.ejphar.2012.01.025
   Hidaka N, 2011, ACTA MED OKAYAMA, V65, P269
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Huang DD, 2019, EXP GERONTOL, V119, P61, DOI 10.1016/j.exger.2019.01.022
   Hughes RN, 2004, NEUROSCI BIOBEHAV R, V28, P497, DOI 10.1016/j.neubiorev.2004.06.006
   Ingram T, 2016, AGING-US, V8, P3161, DOI 10.18632/aging.101131
   Jäger S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104
   Jing L, 2019, MOLECULES, V24, DOI 10.3390/molecules24183364
   Keller JN, 2006, AGEING RES REV, V5, P1, DOI 10.1016/j.arr.2005.06.002
   Kuipers SD, 2015, NEUROBIOL AGING, V36, P365, DOI 10.1016/j.neurobiolaging.2014.07.033
   Kumar Anil, 2011, Int J Alzheimers Dis, V2011, P347569, DOI 10.4061/2011/347569
   Lei M, 2008, BIOCHEM BIOPH RES CO, V369, P1082, DOI 10.1016/j.bbrc.2008.02.151
   Li MY, 2012, MECH AGEING DEV, V133, P655, DOI 10.1016/j.mad.2012.09.001
   LINDSAY RM, 1994, TRENDS NEUROSCI, V17, P182, DOI 10.1016/0166-2236(94)90099-X
   Liu C, 2011, ACTA BIOCH BIOPH SIN, V43, P248, DOI 10.1093/abbs/gmr007
   Liu FD, 2012, AGE, V34, P157, DOI 10.1007/s11357-011-9214-8
   Liu J, 2019, FOOD SCI NUTR, V7, P969, DOI 10.1002/fsn3.907
   Lu J, 2010, CEREB CORTEX, V20, P2540, DOI 10.1093/cercor/bhq002
   Lynch MA, 1998, PROG NEUROBIOL, V56, P571, DOI 10.1016/S0301-0082(98)00054-9
   Mao GX, 2010, BIOMED ENVIRON SCI, V23, P161, DOI 10.1016/S0895-3988(10)60047-5
   McGill-Carter T., 2020, J Psychiatry, V22, P21
   Mirouse V, 2011, FEBS LETT, V585, P981, DOI 10.1016/j.febslet.2010.12.025
   Miwa M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-153
   Murman Daniel L., 2015, Seminars in Hearing, V36, P111, DOI 10.1055/s-0035-1555115
   Nabavi SF, 2015, NEUROCHEM INT, V90, P224, DOI 10.1016/j.neuint.2015.09.006
   NAWA H, 1993, J NEUROCHEM, V60, P772, DOI 10.1111/j.1471-4159.1993.tb03216.x
   NICHOLS NR, 1993, NEUROBIOL AGING, V14, P421, DOI 10.1016/0197-4580(93)90100-P
   Pauly M, 2012, AM J PATHOL, V181, P583, DOI 10.1016/j.ajpath.2012.04.004
   Rehman IU, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9040408
   Sadowska-Bartosz I, 2015, MOLECULES, V20, P3309, DOI 10.3390/molecules20023309
   Salama A. A. A., 2015, African Journal of Pharmacy and Pharmacology, V9, P567
   Salama A, 2021, INT IMMUNOPHARMACOL, V101, DOI 10.1016/j.intimp.2021.107867
   Salama A, 2021, HELIYON, V7, DOI 10.1016/j.heliyon.2021.e07207
   Salama AAA, 2021, EUR J PHARMACOL, V892, DOI 10.1016/j.ejphar.2020.173763
   Salama RAA, 2019, J BIOCHEM MOL TOXIC, V33, DOI 10.1002/jbt.22256
   Salminen A, 2017, J MOL MED, V95, P123, DOI 10.1007/s00109-016-1477-1
   Samarghandian S, 2016, CAN J PHYSIOL PHARM, V94, P388, DOI 10.1139/cjpp-2014-0412
   Sharma Pushpa, 2009, J Emerg Trauma Shock, V2, P67, DOI 10.4103/0974-2700.50739
   Singhal G, 2020, BEHAV BRAIN RES, V383, DOI 10.1016/j.bbr.2020.112501
   Skaper Stephen D, 2012, Methods Mol Biol, V846, P1, DOI 10.1007/978-1-61779-536-7_1
   Skinner EA, 1996, J PERS SOC PSYCHOL, V71, P549, DOI 10.1037/0022-3514.71.3.549
   Souza LC, 2015, PHARMACOL BIOCHEM BE, V134, P22, DOI 10.1016/j.pbb.2015.04.010
   St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024
   Tian J, 2005, P NATL ACAD SCI USA, V102, P11846, DOI 10.1073/pnas.0504759102
   Tobina T, 2011, J SPORT MED PHYS FIT, V51, P683
   Ullah F, 2015, NEUROCHEM INT, V90, P114, DOI 10.1016/j.neuint.2015.07.001
   Vedagiri A., 2015, INT J PHARM RES, V7, P224
   Wang J., 1989, J TRADIT CHIN MED, V0
   Wang Y, 2017, AGEING RES REV, V34, P39, DOI 10.1016/j.arr.2016.11.002
   WETZEL W, 1980, PHARMACOL BIOCHEM BE, V12, P319, DOI 10.1016/0091-3057(80)90378-0
   Zhang Q, 2005, NEUROL RES, V27, P552, DOI 10.1179/016164105X25126
   Zhang YM, 2014, FREE RADICAL BIO MED, V71, P208, DOI 10.1016/j.freeradbiomed.2014.03.018
   Zhu JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101291
NR 79
TC 0
Z9 0
U1 1
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0767-3981
EI 1472-8206
J9 FUND CLIN PHARMACOL
JI Fundam. Clin. Pharmacol.
PD 2023 OCT
PY 2023
VL 37
IS 5
BP 947
EP 959
DI 10.1111/fcp.12895
EA APR 2023
PG 13
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA R6AI5
UT WOS:000972021300001
PM 36977287
DA 2024-02-19
ER

PT J
AU Allu, PKR
   Cardamone, MD
   Gomes, AS
   Dall'agnese, A
   Cederquist, C
   Pan, H
   Dreyfuss, JM
   Enerbäck, S
   Kahn, CR
AF Allu, Prasanna K. R.
   Cardamone, Maria Dafne
   Gomes, Antonio S.
   Dall'agnese, Alessandra
   Cederquist, Carly
   Pan, Hui
   Dreyfuss, Jonathan M.
   Enerback, Sven
   Kahn, C. Ronald
TI FoxK1 associated gene regulatory network in hepatic insulin action and
   its relationship to FoxO1 and insulin receptor mediated transcriptional
   regulation
SO MOLECULAR METABOLISM
LA English
DT Article
DE Insulin; FoxK1; FoxO1; IR; ChIP-seq; Promoters; Pathways
ID CHIP-SEQ; R/BIOCONDUCTOR PACKAGE; GLUCOSE-METABOLISM; EXPRESSION;
   BINDING; ENHANCERS; PROTEINS
AB Objective: Insulin acts on the liver via changes in gene expression to maintain glucose and lipid homeostasis. This study aimed to the Forkhead box protein K1 (FOXK1) associated gene regulatory network as a transcriptional regulator of hepatic insulin action and to determine its role versus FoxO1 and possible actions of the insulin receptor at the DNA level.Methods: Genome-wide analysis of FoxK1 binding were studied by chromatin immunoprecipitation sequencing and compared to those for IR and FoxO1. These were validated by knockdown experiments and gene expression analysis.Results: Chromatin immunoprecipitation (ChIP) sequencing shows that FoxK1 binds to the proximal promoters and enhancers of over 4000 genes, and insulin enhances this interaction for about 75% of them. These include genes involved in cell cycle, senescence, steroid biosynthesis, autophagy, and metabolic regulation, including glucose metabolism and mitochondrial function and are enriched in a TGTTTAC consensus motif. Some of these genes are also bound by FoxO1. Comparing this FoxK1 ChIP-seq data to that of the insulin receptor (IR) reveals that FoxK1 may act as the transcription factor partner for some of the previously reported roles of IR in gene regulation, including for LARS1 and TIMM22, which are involved in rRNA processing and cell cycle.Conclusion: These data demonstrate that FoxK1 is an important regulator of gene expression in response to insulin in liver and may act in concert with FoxO1 and IR in regulation of genes in metabolism and other important biological pathways.(c) 2023 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Allu, Prasanna K. R.; Gomes, Antonio S.; Cederquist, Carly; Kahn, C. Ronald] Harvard Med Sch, Joslin Diabet Ctr, Sect Integrat Physiol & Metab, Boston, MA 02115 USA.
   [Cardamone, Maria Dafne] Boston Univ, Biochem Dept, Sch Med, Boston, MA USA.
   [Dall'agnese, Alessandra] Whitehead Inst Biomed Res, Cambridge, MA USA.
   [Pan, Hui; Dreyfuss, Jonathan M.] Harvard Med Sch, Joslin Diabet Ctr, Bioinformat & Biostat Core, Boston, MA USA.
   [Enerback, Sven] Univ Gothenburg, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden.
C3 Harvard University; Harvard Medical School; Joslin Diabetes Center,
   Inc.; Boston University; Massachusetts Institute of Technology (MIT);
   Whitehead Institute; Harvard University; Harvard Medical School; Joslin
   Diabetes Center, Inc.; University of Gothenburg
RP Kahn, CR (corresponding author), Harvard Med Sch, Joslin Diabet Ctr, Sect Integrat Physiol & Metab, Boston, MA 02115 USA.
EM c.ronald.kahn@joslin.harvard.edu
OI Kahn, C. Ronald/0000-0002-7583-9228
FU Joslin Diabetes Research Center [R01DK31036, R01DK128429]; Mary K.
   Iacocca Pro-fessorship [P30DK036836]
FX This project was funded by National Institute of Diabetes and Digestive
   and Kidney Diseases (NIDDK) , National Institutes of Health (NIH) ,
   grantsR01DK31036, R01DK128429 to C.R.K. and the Joslin Diabetes Research
   Center grant P30DK036836 and the Mary K. Iacocca Professorship (to
   C.R.K.) .r R01DK31036, R01DK128429 to C.R.K. and the Joslin Diabetes
   Research Center grant P30DK036836 and the Mary K. Iacocca Pro-fessorship
   (to C.R.K.) .
CR Abdul-Wahed A, 2017, CELL METAB, V26, P324, DOI 10.1016/j.cmet.2017.07.004
   Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787
   Batista TM, 2021, DIABETOLOGIA, V64, P994, DOI 10.1007/s00125-021-05415-5
   Batista TM, 2019, CELL REP, V26, P3429, DOI 10.1016/j.celrep.2019.02.081
   Bowman CJ, 2014, NAT CELL BIOL, V16, P1202, DOI 10.1038/ncb3062
   Cardamone MD, 2018, JOVE-J VIS EXP, DOI 10.3791/58682
   Celton-Morizur S, 2009, J CLIN INVEST, V119, P1880, DOI 10.1172/JCI38677
   Chen SF, 2018, BIOINFORMATICS, V34, P884, DOI 10.1093/bioinformatics/bty560
   Collier JJ, 2004, MOL ENDOCRINOL, V18, P1051, DOI 10.1210/me.2003-0357
   Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107
   Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906
   Garcia-Martin R, 2022, CELL REP, V38, DOI 10.1016/j.celrep.2021.110277
   Hagenbuchner J, 2019, ELIFE, V8, DOI 10.7554/eLife.48876
   Hancock ML, 2019, CELL, V177, P722, DOI 10.1016/j.cell.2019.02.030
   Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001
   He L, 2018, MOL CELL, V70, P949, DOI 10.1016/j.molcel.2018.04.024
   Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004
   Hirota K, 2008, J BIOL CHEM, V283, P32432, DOI 10.1074/jbc.M806179200
   Horten P, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10071008
   Ji ZL, 2012, MOL CELL BIOL, V32, P385, DOI 10.1128/MCB.05504-11
   Kim JK, 2009, METHODS MOL BIOL, V560, P221, DOI 10.1007/978-1-59745-448-3_15
   Kitamoto T, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2102222118
   Langlet F, 2017, CELL, V171, P824, DOI 10.1016/j.cell.2017.09.045
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]
   Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017
   Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352
   Lu MJ, 2012, NAT MED, V18, P388, DOI 10.1038/nm.2686
   Matthews HK, 2022, NAT REV MOL CELL BIO, V23, P74, DOI 10.1038/s41580-021-00404-3
   Newell R, 2021, GENOMICS, V113, P1855, DOI 10.1016/j.ygeno.2021.04.026
   Noblet B, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102218
   O-Sullivan I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8079
   O'Neill BT, 2016, J CLIN INVEST, V126, P3433, DOI 10.1172/JCI86522
   Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]
   Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133
   Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730
   Sakaguchi M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09418-0
   Sheaffer KL, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008284
   Shi XZ, 2012, MOL CELL BIOCHEM, V366, P251, DOI 10.1007/s11010-012-1302-2
   Shimano H, 2017, NAT REV ENDOCRINOL, V13, P710, DOI 10.1038/nrendo.2017.91
   Shin DJ, 2012, NUCLEIC ACIDS RES, V40, P11499, DOI 10.1093/nar/gks932
   Stoffel M, 1997, P NATL ACAD SCI USA, V94, P13209, DOI 10.1073/pnas.94.24.13209
   Sukonina V, 2019, NATURE, V566, P279, DOI 10.1038/s41586-019-0900-5
   Thiel G, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11121886
   Tian J, 2016, P NATL ACAD SCI USA, V113, P8182, DOI 10.1073/pnas.1608987113
   Unterman TG, 2018, CURR TOP DEV BIOL, V127, P119, DOI 10.1016/bs.ctdb.2017.10.005
   van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22
   Villar D, 2015, CELL, V160, P554, DOI 10.1016/j.cell.2015.01.006
   Wang LH, 2019, DIABETES, V68, P1156, DOI 10.2337/db18-1236
   Wu WY, 2021, ONCOL LETT, V21, DOI 10.3892/ol.2021.12668
   Xie XF, 2009, MOL ENDOCRINOL, V23, P434, DOI 10.1210/me.2007-0531
   Yang Q, 2018, NAT REV MOL CELL BIO, V19, P654, DOI 10.1038/s41580-018-0044-8
   Yu GC, 2016, MOL BIOSYST, V12, P477, DOI 10.1039/c5mb00663e
   Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Zhang W, 2016, CELL REP, V15, P349, DOI 10.1016/j.celrep.2016.03.021
   Zhang YJ, 2018, J BIOL CHEM, V293, P7894, DOI 10.1074/jbc.RA117.000508
   Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137
   Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033
   Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237
   Zhu LJ, 2013, METHODS MOL BIOL, V1067, P105, DOI 10.1007/978-1-62703-607-8_8
NR 62
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2212-8778
J9 MOL METAB
JI Mol. Metab.
PD DEC
PY 2023
VL 78
AR 101825
DI 10.1016/j.molmet.2023.101825
EA OCT 2023
PG 15
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA Y3AK1
UT WOS:001104024500001
PM 37852413
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Chung, KW
   Lee, EK
   Kim, DH
   An, HJ
   Kim, ND
   Im, DS
   Lee, J
   Yu, BP
   Chung, HY
AF Chung, Ki Wung
   Lee, Eun Kyeong
   Kim, Dae Hyun
   An, Hye Jin
   Kim, Nam Deuk
   Im, Dong Soon
   Lee, Jaewon
   Yu, Byung Pal
   Chung, Hae Young
TI Age-related sensitivity to endotoxin-induced liver inflammation:
   Implication of inflammasome/IL-1β for steatohepatitis
SO AGING CELL
LA English
DT Article
DE aging; IL-1 beta; inflammasome; inflammation; lipid accumulation; LPS
ID IL-1 RECEPTOR ANTAGONIST; LIPID-ACCUMULATION; DISEASE; METABOLISM;
   LIPOPOLYSACCHARIDE; ACTIVATION; INDUCTION; SEPSIS; MICE
AB Aging is associated with increased vulnerability to inflammatory challenge. However, the effects of altered inflammatory response on the metabolic status of tissues or organs are not well documented. In this study, we present evidence demonstrating that lipopolysaccharide (LPS)-induced upregulation of the inflammasome/IL-1 beta pathway is accompanied with an increased inflammatory response and abnormal lipid accumulation in livers of aged rats. To monitor the effects of aging on LPS-induced inflammation, we administered LPS (2 mg kg(-1)) to young (6-month old) and aged (24-month old) rats and found abnormal lipid metabolism in only aged rats with increased lipid accumulation in the liver. This lipid accumulation in the liver was due to the dysregulation of PPAR alpha and SREBP1c. We also observed severe liver inflammation in aged rats as indicated by increased ALT levels in serum and increased Kupffer cells in the liver. Importantly, among many inflammation-associated factors, the aged rat liver showed chronically increased IL-1 beta production. Increased levels of IL-1 beta were caused by the upregulation of caspase-1 activity and inflammasome activation. In vitro studies with HepG2 cells demonstrated that treatment with IL-1 beta significantly induced lipid accumulation in hepatocytes through the regulation of PPAR alpha and SREBP1c. In summary, we demonstrated that LPS-induced liver inflammation and lipid accumulation were associated with a chronically overactive inflammasome/IL-1 beta pathway in aged rat livers. Based on the present findings, we propose a mechanism of aging-associated progression of steatohepatitis induced by endotoxin, delineating a pathogenic role of the inflammasome/IL-beta b pathway involved in lipid accumulation in the liver.
C1 [Chung, Ki Wung; Lee, Eun Kyeong; Kim, Dae Hyun; An, Hye Jin; Kim, Nam Deuk; Im, Dong Soon; Lee, Jaewon; Chung, Hae Young] Pusan Natl Univ, Mol Inflammat Res Ctr Aging Intervent MRCA, Coll Pharm, Busan 609735, South Korea.
   [Yu, Byung Pal] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA.
C3 Pusan National University; University of Texas System; University of
   Texas Health Science Center at San Antonio
RP Chung, HY (corresponding author), Pusan Natl Univ, Mol Inflammat Res Ctr Aging Intervent MRCA, Coll Pharm, 63 Beon Gil 2,Busandaehag Ro, Busan 609735, South Korea.
EM hyjung@pusan.ac.kr
RI Lee, Jaewon/N-9064-2013; Lee, Jaewon/IQR-8432-2023; Im,
   Dong-Soon/AAH-9104-2020
OI Lee, Jaewon/0000-0003-3203-2130; IM, DONG-SOON/0000-0001-8054-8946
FU National Research Foundation of Korea (NRF) grant - Korea government
   (MSIP) [2009-0083538]
FX This work was supported by the National Research Foundation of Korea
   (NRF) grant funded by the Korea government (MSIP) (No. 2009-0083538).
CR Affò S, 2014, GUT, V63, P1782, DOI 10.1136/gutjnl-2013-306098
   Carré JE, 2008, BBA-BIOENERGETICS, V1777, P763, DOI 10.1016/j.bbabio.2008.04.024
   Chen X, 2011, J PINEAL RES, V51, P416, DOI 10.1111/j.1600-079X.2011.00905.x
   da Silva FP, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-21
   Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005
   Dorshkind K, 2009, NAT REV IMMUNOL, V9, P57, DOI 10.1038/nri2471
   Febbraio MA, 2014, TRENDS ENDOCRIN MET, V25, P312, DOI 10.1016/j.tem.2014.02.004
   FEINGOLD KR, 1992, J LIPID RES, V33, P1765
   Fontana L, 2013, HEPATOLOGY, V57, P995, DOI 10.1002/hep.26099
   Frith J, 2009, GERONTOLOGY, V55, P607, DOI 10.1159/000235677
   GERSHONI JM, 1983, ANAL BIOCHEM, V131, P1, DOI 10.1016/0003-2697(83)90128-8
   Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001
   Gustot T, 2011, CURR OPIN CRIT CARE, V17, P153, DOI 10.1097/MCC.0b013e328344b446
   Hardardottir Ingibjorg, 1994, Current Opinion in Lipidology, V5, P207, DOI 10.1097/00041433-199405030-00008
   Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958
   Kamo N, 2013, HEPATOLOGY, V58, P351, DOI 10.1002/hep.26320
   Kwon HJ, 2001, J AM AGING ASSOC, V24, P163, DOI 10.1007/s11357-001-0017-1
   Ma KL, 2008, HEPATOLOGY, V48, P770, DOI 10.1002/hep.22423
   Martin GS, 2006, CRIT CARE MED, V34, P15, DOI 10.1097/01.CCM.0000194535.82812.BA
   Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848
   Miura K, 2010, GASTROENTEROLOGY, V139, P323, DOI 10.1053/j.gastro.2010.03.052
   Negash AA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003330
   Nesseler N, 2012, CRIT CARE, V16, DOI 10.1186/cc11381
   Opal SM, 2005, CLIN INFECT DIS, V41, pS504, DOI 10.1086/432007
   Petrasek J, 2012, J CLIN INVEST, V122, P3476, DOI 10.1172/JCI60777
   Petrasek J, 2011, GASTROENTEROLOGY, V140, P697, DOI 10.1053/j.gastro.2010.08.020
   Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237
   Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005
   Saito H, 2003, MECH AGEING DEV, V124, P1047, DOI 10.1016/j.mad.2003.08.002
   Szabo G, 2012, J HEPATOL, V57, P642, DOI 10.1016/j.jhep.2012.03.035
   Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001
   Turnbull IR, 2009, CRIT CARE MED, V37, P1018, DOI 10.1097/CCM.0b013e3181968f3a
   Vuppalanchi R, 2009, HEPATOLOGY, V49, P306, DOI 10.1002/hep.22603
   Wree A, 2014, HEPATOLOGY, V59, P898, DOI 10.1002/hep.26592
   Wree A, 2013, NAT REV GASTRO HEPAT, V10, P627, DOI 10.1038/nrgastro.2013.149
   Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002
NR 36
TC 32
Z9 33
U1 2
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD AUG
PY 2015
VL 14
IS 4
BP 524
EP 533
DI 10.1111/acel.12305
PG 10
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA CM8IC
UT WOS:000357941900003
PM 25847140
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Huang, YQ
   Chen, N
   Miao, DS
AF Huang, Yuanqing
   Chen, Ning
   Miao, Dengshun
TI Biological effects of pyrroloquinoline quinone on liver damage in Bmi-1
   knockout mice
SO EXPERIMENTAL AND THERAPEUTIC MEDICINE
LA English
DT Article
DE B cell-specific Moloney MLV insertion site-1; pyrroloquinoline quinone;
   liver; oxidative stress; antioxidants
ID MYOCARDIAL INFARCT SIZE; OXIDATIVE STRESS; PHYSIOLOGICAL IMPORTANCE;
   MITOCHONDRIAL-FUNCTION; PQQ; ANTIOXIDANT; INJURY; MODELS; GROWTH; PLAY
AB Pyrroloquinoline quinone (PQQ) has been demonstrated to function as an antioxidant by scavenging free radicals and subsequently protecting the mitochondria from oxidative stress-induced damage. The aim of the present study was to investigate whether PQQ is able to rescue premature senescence in the liver, induced by the deletion of B cell-specific Moloney MLV insertion site-1 (Bmi-1), by inhibiting oxidative stress. In vivo, the mice were allocated into three groups that underwent the following treatment protocols. WT mice received a normal diet, while BKO mice also received a normal diet. An additional group of BKO mice were fed a PQQ-supplemented diet (BKO + PQQ; 4 mg PQQ/kg in the normal diet). The results indicated that PQQ partially rescued the liver damage induced by the deletion of Bmi-1. PQQ was demonstrated to exhibit these therapeutic effects on liver damage through multiple aspects, including the promotion of proliferation, antiapoptotic effects, the inhibition of senescence, the upregulation of antioxidant ability, the downregulation of cell cycle protein expression, the scavenging of reactive oxygen species and the reduction of DNA damage. The results of these experiments indicated that treatment of BKO mice with a moderate dose of PQQ significantly protected the liver from deleterious effects by inhibiting oxidative stress and participating in DNA damage repair. Therefore, PQQ has great potential as a therapeutic agent against oxidative stress during liver damage.
C1 [Huang, Yuanqing; Chen, Ning; Miao, Dengshun] Nanjing Med Univ, State Key Lab Reprod Med, Res Ctr Bone & Stem Cells, Dept Anat Histol & Embryol, Nanjing 210029, Jiangsu, Peoples R China.
   [Huang, Yuanqing] Hunan Univ Med, Dept Stomatol, Huaihua 418000, Hunan, Peoples R China.
C3 Nanjing Medical University
RP Miao, DS (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Res Ctr Bone & Stem Cells, Dept Anat Histol & Embryol, 140 Han Zhong Rd, Nanjing 210029, Jiangsu, Peoples R China.
EM njcn@njmu.edu.cn; dengshunmiao@126.com
RI Huang, YQ/JOK-7580-2023
OI Miao, Dengshun/0000-0002-2682-3502; Chen, Ning/0000-0003-4785-5076
FU National Natural Science Foundation of China [81230009]
FX The study was supported by a grant from the National Natural Science
   Foundation of China (no. 81230009).
CR AIZENMAN E, 1992, J NEUROSCI, V12, P2362
   BAE IS, 1995, CANCER RES, V55, P2387
   Bauerly K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021779
   BISHOP A, 1994, FREE RADICAL BIO MED, V17, P311, DOI 10.1016/0891-5849(94)90017-5
   Cao GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032015
   Di Pietro C, 2006, APOPTOSIS, V11, P57, DOI 10.1007/s10495-005-3346-1
   Duine JA, 2001, CHEM REC, V1, P74
   Fan LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046472
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HAUGE JG, 1964, J BIOL CHEM, V239, P3630
   He K, 2003, BIOCHEM PHARMACOL, V65, P67, DOI 10.1016/S0006-2952(02)01453-3
   Ishii T, 2010, BIOSCI BIOTECH BIOCH, V74, P663, DOI 10.1271/bbb.90764
   Jin JL, 2014, AGING CELL, V13, P797, DOI 10.1111/acel.12236
   KILLGORE J, 1989, SCIENCE, V245, P850, DOI 10.1126/science.2549636
   Kumar N, 2014, CELL BIOCHEM FUNCT, V32, P538, DOI 10.1002/cbf.3048
   KUMAZAWA T, 1995, BIOCHEM J, V307, P331, DOI 10.1042/bj3070331
   Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040
   Misra HS, 2004, FEBS LETT, V578, P26, DOI 10.1016/j.febslet.2004.10.061
   Mitchell AE, 1999, ANAL BIOCHEM, V269, P317, DOI 10.1006/abio.1999.4039
   Muriel P, 2001, COMP BIOCHEM PHYS C, V130, P219, DOI 10.1016/S1532-0456(01)00237-X
   Ohwada K, 2008, J CLIN BIOCHEM NUTR, V42, P29, DOI 10.3164/jcbn.2008005
   Okuda M, 2002, GASTROENTEROLOGY, V122, P366, DOI 10.1053/gast.2002.30983
   Ouchi A, 2009, J AGR FOOD CHEM, V57, P450, DOI 10.1021/jf802197d
   Park CM, 2010, FOOD CHEM TOXICOL, V48, P1255, DOI 10.1016/j.fct.2010.02.019
   Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587
   Rucker R, 2009, ALTERN MED REV, V14, P268
   SALISBURY SA, 1979, NATURE, V280, P843, DOI 10.1038/280843a0
   Salmon AB, 2010, FREE RADICAL BIO MED, V48, P642, DOI 10.1016/j.freeradbiomed.2009.12.015
   Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028
   Shankar BS, 2010, REDOX REP, V15, P146, DOI 10.1179/174329210X12650506623762
   Srivastava A, 2010, FOOD CHEM, V118, P411, DOI 10.1016/j.foodchem.2009.05.014
   Steinberg F, 2003, EXP BIOL MED, V228, P160, DOI 10.1177/153537020322800205
   STEINBERG FM, 1994, J NUTR, V124, P744, DOI 10.1093/jn/124.5.744
   Stites T, 2006, J NUTR, V136, P390, DOI 10.1093/jn/136.2.390
   Stites TE, 2000, J NUTR, V130, P719, DOI 10.1093/jn/130.4.719
   Tang W, 2014, WORLD J GASTROENTERO, V20, P13079, DOI 10.3748/wjg.v20.i36.13079
   Tao R, 2007, BIOCHEM BIOPH RES CO, V363, P257, DOI 10.1016/j.bbrc.2007.08.041
   Weltman MD, 1998, HEPATOLOGY, V27, P128, DOI 10.1002/hep.510270121
   Xue YB, 2005, HUM MOL GENET, V14, P1515, DOI 10.1093/hmg/ddi160
   ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367
   Zhang HW, 2010, J BONE MINER RES, V25, P640, DOI 10.1359/jbmr.090812
   Zhang YM, 2002, EUR J NEUROSCI, V16, P1015, DOI 10.1046/j.1460-9568.2002.02169.x
   Zhang YH, 2006, BRAIN RES, V1094, P200, DOI 10.1016/j.brainres.2006.03.111
   Zhu BQ, 2006, J CARDIOVASC PHARM T, V11, P119, DOI 10.1177/1074248406288757
   Zhu BQ, 2004, CARDIOVASC DRUG THER, V18, P421, DOI 10.1007/s10557-004-6219-x
NR 45
TC 12
Z9 17
U1 1
U2 13
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1792-0981
EI 1792-1015
J9 EXP THER MED
JI Exp. Ther. Med.
PD AUG
PY 2015
VL 10
IS 2
BP 451
EP 458
DI 10.3892/etm.2015.2532
PG 8
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA CN8GZ
UT WOS:000358679400010
PM 26622336
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Hu, WS
   Zhu, SQ
   Fanai, ML
   Wang, J
   Cai, JR
   Feng, JW
AF Hu, Wansheng
   Zhu, Shengqian
   Fanai, Mimi Lalrimawii
   Wang, Jing
   Cai, Junrong
   Feng, Jingwei
TI 3D co-culture model of endothelial colony-forming cells (ECFCs) reverses
   late passage adipose-derived stem cell senescence for wound healing
SO STEM CELL RESEARCH & THERAPY
LA English
DT Article
DE Endothelial colony-forming cells; Adipose-derived stem cells; 3-D
   co-culture; Wound healing
ID PLATELET-RICH PLASMA; STROMAL-VASCULAR FRACTION; PROGENITOR CELLS;
   HYALURONIC-ACID; SELF-RENEWAL; CULTURE; SCARS
AB BackgroundExtensive passage of adipose-derived stem cells (ASCs) in vitro leads to loss of function. Endothelial colony-forming cells (ECFCs) can be isolated from adult peripheral blood. A 3D co-culture system may rescue in vitro ASC senescence.MethodsA 3D co-culture model was successfully established using hyaluronic acid (HA) gel and a 10:1 ratio of late-passage ASCs and ECFCs. Cell density and culture conditions were optimized. Stem cell phenotype was characterized by flow cytometry. ELISA was used to measure the trophic effect of angiogenic growth factors and compare the effects of these factors between the 3-D co-culture and single-cell culture. Therapeutic potential of ASC/ECFC 3-D co-cultures was evaluated in a mouse chronic injury model.ResultsFollowing incubation in a HA substrate 3D co-culture system, ASC morphology, phenotype, secretory profile, and differentiation capacity were restored. The ASC/ECFC co-culture increased the secretion of cytokines, such as hepatocyte growth factor, compared with single-cell 3D culture or monolayer culture. Mice radiation-ulcer wounds treated with ASC/ECFC 3-D co-cultures (spheroids) showed epithelialization and improved healing compared with wounds treated with ASCs or ECFCs alone. Further, transplanted ASC/ECFC spheroids exhibited superior angiogenic potential due to the ability of the ASCs to transdifferentiate into pericytes.Conclusion3D co-culture of ECFCs and ASCs in vitro restored native ASC properties by reversing cellular senescence and loss of trophic function. Transplant of ASC/ECFC 3D spheroids in vivo demonstrated pro-angiogenic capacity with improved therapeutic potential.
C1 [Hu, Wansheng; Zhu, Shengqian; Fanai, Mimi Lalrimawii; Wang, Jing; Cai, Junrong; Feng, Jingwei] Southern Med Univ, Nanfang Hosp, Dept Plast & Reconstruct Surg, Guangzhou 510515, Peoples R China.
C3 Southern Medical University - China
RP Cai, JR; Feng, JW (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Plast & Reconstruct Surg, Guangzhou 510515, Peoples R China.
EM drjunrongcai@outlook.com; feng.jingwei@gmail.com
FU National Nature Science Foundation of China [81601702, 81671931,
   81772101, 81701920, 81801933, 81801932, 81871573]; Natural Science
   Foundation of Guangdong Province of China [2017A030313900]
FX This work was supported by the National Nature Science Foundation of
   China (81601702, 81671931, 81772101, 81701920, 81801933, 81801932,
   81871573) and the Natural Science Foundation of Guangdong Province of
   China (2017A030313900).
CR [Anonymous], 2019, INT J MOL SCI
   Bauer G, 2018, STEM CELL TRANSL MED, V7, P676, DOI 10.1002/sctm.17-0282
   Bura A, 2014, CYTOTHERAPY, V16, P245, DOI 10.1016/j.jcyt.2013.11.011
   Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001
   Cervelli V, 2011, ADV SKIN WOUND CARE, V24, P176, DOI 10.1097/01.ASW.0000396302.05959.d3
   Cherubino M, 2009, REGEN MED, V4, P109, DOI 10.2217/17460751.4.1.109
   Darinskas A, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1243-3
   Feng JW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01528-3
   Galipeau J, 2018, CELL STEM CELL, V22, P824, DOI 10.1016/j.stem.2018.05.004
   GENTILE P, 2019, CELLS-BASEL, V8, DOI DOI 10.3390/CELLS8030282
   Gentile P, 2019, AESTHET SURG J
   Gentile P, 2020, EXPERT OPIN BIOL TH, V20, P711, DOI 10.1080/14712598.2020.1761322
   Gentile P, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/7397162
   Gentile P, 2019, J CLIN MED, V8, DOI 10.3390/jcm8060855
   Gentile P, 2019, J CLIN MED, V8, DOI 10.3390/jcm8040504
   Gentile P, 2017, REGEN MED, V12, P939, DOI 10.2217/rme-2017-0076
   Gentile P, 2015, PRS-GLOB OPEN, V3, DOI 10.1097/GOX.0000000000000285
   Gentile P, 2014, J CRANIOFAC SURG, V25, P267, DOI 10.1097/01.scs.0000436746.21031.ba
   Gentile P, 2010, J CRANIOFAC SURG, V21, P900, DOI 10.1097/SCS.0b013e3181d878e9
   Han SK, 2010, WOUND REPAIR REGEN, V18, P342, DOI 10.1111/j.1524-475X.2010.00593.x
   Hendrickx B, 2010, STEM CELLS, V28, P1165, DOI 10.1002/stem.445
   Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06
   Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396
   Kaigler D, 2005, FASEB J, V19, P665, DOI 10.1096/fj.04-2529fje
   Khatiwala R, 2016, STEM CELL REV REP, V12, P214, DOI 10.1007/s12015-016-9642-z
   Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344
   Legzdina D, 2016, INT J STEM CELLS, V9, P124, DOI 10.15283/ijsc.2016.9.1.124
   Lin RZ, 2014, P NATL ACAD SCI USA, V111, P10137, DOI 10.1073/pnas.1405388111
   Luu NT, 2013, STEM CELLS, V31, P2690, DOI 10.1002/stem.1511
   Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889
   Mckee Christina, 2017, COLLOID SURFACE B, V159
   Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471
   Mineda K, 2015, STEM CELL TRANSL MED, V4, P1511, DOI 10.5966/sctm.2015-0037
   Nicoli F, 2015, INT WOUND J, V12, P338, DOI 10.1111/iwj.12117
   Scioli MG, 2017, J TISSUE ENG REGEN M, V11, P2398, DOI 10.1002/term.2139
   Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505
NR 36
TC 7
Z9 7
U1 2
U2 14
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1757-6512
J9 STEM CELL RES THER
JI Stem Cell Res. Ther.
PD AUG 14
PY 2020
VL 11
IS 1
AR 355
DI 10.1186/s13287-020-01838-w
PG 11
WC Cell & Tissue Engineering; Cell Biology; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Research & Experimental Medicine
GA NG3VD
UT WOS:000563912800001
PM 32795343
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Minh Doan, V
   Chen, CX
   Lin, X
   Nguyen, VP
   Nong, ZH
   Li, WS
   Chen, QQ
   Ming, JJ
   Xie, QQ
   Huang, RB
AF Van Minh Doan
   Chen, Chunxia
   Lin, Xing
   Van Phuc Nguyen
   Nong, Zhihuan
   Li, Weisi
   Chen, Qingquan
   Ming, Jianjun
   Xie, Qiuqiao
   Huang, Renbin
TI Yulangsan polysaccharide improves redox homeostasis and immune
   impairment in D-galactose-induced mimetic aging
SO FOOD & FUNCTION
LA English
DT Article
ID AMELIORATES COGNITION DEFICITS; ATTENUATES OXIDATIVE DAMAGE; RAT-BRAIN;
   MICE; STRESS; PROTEIN; ACID
AB Yulangsan polysaccharide (YLSP) is a traditional Chinese medicine used in long-term treatment as a modulator of brain dysfunction and immunity. In this study, we evaluated the protective effect of YLSP against D-galactose-induced impairment of oxidative stress and the immune system and evaluated its possible mechanism of action. D-galactose was subcutaneously injected into the dorsal neck of mice daily for 8 weeks to establish the aging model. YLSP was simultaneously administered once daily. The results indicate that YLSP significantly improves the general appearance of the aging mice. YLSP significantly increased the levels of antioxidant enzymes, such as super oxide dismutase, glutathione peroxidase, catalase and total anti-oxidation capability, while decreasing the content of malondialdehyde in different tissues, including the liver, brain, and serum. YLSP also increased the interleukin-2 level while decreasing the interleukin-6 level. Moreover, YLSP significantly inhibited advanced glycation end product formation. Furthermore, YLSP decreased p21 and p53 gene expressions in the liver and brain of D-galactose-treated mice. These results suggest that YLSP may have a protective effect suppressing the aging process by enhancing antioxidant activity and immunity, as well as modulating aging-related gene expression.
C1 [Van Minh Doan; Chen, Chunxia; Lin, Xing; Van Phuc Nguyen; Nong, Zhihuan; Li, Weisi; Chen, Qingquan; Ming, Jianjun; Xie, Qiuqiao; Huang, Renbin] Guangxi Med Univ, Dept Pharmacol, Nanning 530021, Peoples R China.
   [Chen, Chunxia] Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Hyperbar Oxygen, Nanning 530021, Guangxi, Peoples R China.
C3 Guangxi Medical University
RP Minh Doan, V (corresponding author), Guangxi Med Univ, Dept Pharmacol, Nanning 530021, Peoples R China.
EM huangrenbin518@163.com
RI Huang, Ren/HJG-5652-2022
OI Huang, Ren/0000-0002-3068-8331
FU National Natural Science Fund [30960504]; Guangxi Scientific Research
   and Technology Development research projects [0630002-2A]; Guangxi
   Natural Science Foundation [2011GXNSFD018030]; Nanning Science and
   Technology Research and Production of New Products [201102084C]
FX This work was financially supported by the National Natural Science Fund
   (30960504), the Guangxi Scientific Research and Technology Development
   research projects (0630002-2A), the Guangxi Natural Science Foundation
   (2011GXNSFD018030), and the Nanning Science and Technology Research and
   Production of New Products (no. 201102084C).
CR Banji D, 2013, BRAIN RES, V1515, P1, DOI 10.1016/j.brainres.2013.03.023
   Barrientos R. M., 2015, NEUROSCIENCE, V15, P222
   Barroso-González J, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723556.2014.975075
   Bonafè M, 2001, EUR J IMMUNOL, V31, P2357, DOI 10.1002/1521-4141(200108)31:8<2357::AID-IMMU2357>3.0.CO;2-X
   Bucala R, 1992, Adv Pharmacol, V23, P1
   Cakatay Ufuk, 2013, Curr Aging Sci, V6, P135
   Calcutt NA, 2009, NAT REV DRUG DISCOV, V8, P417, DOI 10.1038/nrd2476
   Castillo C, 2005, BIOGERONTOLOGY, V6, P313, DOI 10.1007/s10522-005-4806-2
   Cebe T, 2014, AGE, V36, DOI 10.1007/s11357-014-9728-y
   Cebe T, 2014, EXP GERONTOL, V57, P132, DOI 10.1016/j.exger.2014.05.017
   Chen CX, 2014, NEUROSCI LETT, V570, P63, DOI 10.1016/j.neulet.2014.04.006
   Cui X, 2004, BIOGERONTOLOGY, V5, P317, DOI 10.1007/s10522-004-2570-3
   Dong YZ, 2014, J ETHNOPHARMACOL, V152, P201, DOI 10.1016/j.jep.2014.01.001
   ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P
   Han CH, 2014, FOOD FUNCT, V5, P2228, DOI 10.1039/c4fo00205a
   Han XQ, 2014, J HUAZHONG U SCI-MED, V34, P10, DOI 10.1007/s11596-014-1224-1
   HARPER JW, 1993, CELL, V75, P805
   Hsia CH, 2012, BRIT J NUTR, V107, P1787, DOI 10.1017/S0007114511005150
   Huang Z. S., 2008, CHINA PHARM, V19, P647
   Huang ZS, 2008, NEURAL REGEN RES, V3, P1099
   Kannarkat G. T., 2015, NEUROBIOL AGING, V13, P106
   Knight JA, 2001, ADV CLIN CHEM, V35, P1, DOI 10.1016/S0065-2423(01)35014-X
   Kumar A, 2010, FOOD CHEM TOXICOL, V48, P626, DOI 10.1016/j.fct.2009.11.043
   Larbi A, 2004, EXP GERONTOL, V39, P551, DOI 10.1016/j.exger.2003.10.031
   Li WJ, 2012, J AGR FOOD CHEM, V60, P1413, DOI 10.1021/jf204748a
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Lin X, 2014, CARBOHYD POLYM, V101, P533, DOI 10.1016/j.carbpol.2013.09.037
   Lu J, 2007, BIOCHEM PHARMACOL, V74, P1078, DOI 10.1016/j.bcp.2007.07.007
   Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178
   Münch G, 2012, AMINO ACIDS, V42, P1221, DOI 10.1007/s00726-010-0777-y
   Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034
   Munch G, 1997, BRAIN RES REV, V23, P134, DOI 10.1016/S0165-0173(96)00016-1
   Paradies G, 2011, NEUROCHEM INT, V58, P447, DOI 10.1016/j.neuint.2010.12.016
   Parameshwaran K, 2010, REJUV RES, V13, P729, DOI 10.1089/rej.2010.1020
   Peppa M, 2008, HORM-INT J ENDOCRINO, V7, P123, DOI 10.1007/BF03401503
   Ranaivo HR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-68
   Rosalia RA, 2014, CURR OPIN CHEM BIOL, V23, P39, DOI 10.1016/j.cbpa.2014.09.006
   Schneiders J., 2015, BRAIN BEHAV IMMUN, V23, P79
   SCHWARTZMAN RA, 1993, ENDOCRINOLOGY, V133, P591, DOI 10.1210/en.133.2.591
   Semba RD, 2010, J GERONTOL A-BIOL, V65, P963, DOI 10.1093/gerona/glq074
   Silva JP, 2010, DRUG DISCOV THER, V4, P144
   Srikanth V, 2011, NEUROBIOL AGING, V32, P763, DOI 10.1016/j.neurobiolaging.2009.04.016
   Tian Y, 2011, FOOD CHEM TOXICOL, V49, P1728, DOI 10.1016/j.fct.2011.04.018
   Tsai SJ, 2012, EUR J PHARMACOL, V689, P81, DOI 10.1016/j.ejphar.2012.05.018
   Wu DM, 2008, NEUROBIOL LEARN MEM, V90, P19, DOI 10.1016/j.nlm.2008.01.010
   Yanar K, 2011, BASIC CLIN PHARMACOL, V109, P423, DOI 10.1111/j.1742-7843.2011.00756.x
   Yi ZJ, 2009, EXP GERONTOL, V44, P760, DOI 10.1016/j.exger.2009.08.011
   Zhang Q, 2005, NEUROL RES, V27, P552, DOI 10.1179/016164105X25126
   Zhong SZ, 2009, J NEUROL SCI, V277, P58, DOI 10.1016/j.jns.2008.10.008
   Zhu JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101291
   黄忠仕, 2005, [中国老年学杂志, Chinese Journal of Gerontology], V25, P176
NR 51
TC 38
Z9 40
U1 1
U2 27
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PY 2015
VL 6
IS 5
BP 1712
EP 1718
DI 10.1039/c5fo00238a
PG 7
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA CI1SI
UT WOS:000354524300033
PM 25920068
DA 2024-02-19
ER

PT J
AU Albrahim, T
   Alonazi, M
AF Albrahim, Tarfa
   Alonazi, Mona
TI Effect of Blueberry Extract on Liver in Aged Rats
SO OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
LA English
DT Article
ID ANTIOXIDANT CAPACITY; INSULIN-RESISTANCE; METABOLIC SYNDROME;
   PHENOLIC-COMPOUNDS; OXIDATIVE STRESS; INFLAMMATION; BRAIN; POLYPHENOLS
AB Aging and age-related disorders are prominent issues. Aging is associated with a gradual impairment of physiology at the genetic, cellular, tissue, and whole organism level that directly influences the development of chronic diseases and organ failure. Blueberries, on the other hand, are well known for their high content of bioactive compounds and have demonstrated positive impacts on metabolic factors that influence health and general well-being. This study is aimed at evaluating the ameliorating the effects of blueberry on the liver of aged rats by monitoring changes in metabolic disturbances, oxidative stress, and inflammatory disruption. The aged group of rats was orally administered with blueberry extract (200 mg/kg) for a period of 4 weeks. The results revealed that aging was associated with an increase in body weight, liver weight, and metabolic parameters like serum insulin, triglycerides, total cholesterol, and liver function markers accompanied with a decrease in vitamin D levels. Furthermore, the results showed a significant diminish in the activities of antioxidant enzymes, glutathione content with an elevation in lipid peroxidation, inflammatory mediators (tumor necrosis factor alpha, interleukin 6, and nuclear factor kappa-light-chain-enhancer of activated B cells) as well as fibrotic markers (TGF-beta 1) in the liver of aged rats. Compared to the young rats (control group), blueberry effectively reversed age-mediated disruption of the aforementioned parameters. Hence, blueberries can be used as a potential therapeutic strategy for the management of age-related liver dysfunction and disease.
C1 [Albrahim, Tarfa] Princess Nourah Bint Abdulrahman Univ, Coll Hlth & Rehabil Sci, Dept Hlth Sci, Clin Nutr, POB 84428, Riyadh 11671, Saudi Arabia.
   [Alonazi, Mona] King Saud Univ, Sci Coll, Biochem Dept, POB 22452, Riyadh 11495, Saudi Arabia.
C3 Princess Nourah bint Abdulrahman University; King Saud University
RP Albrahim, T (corresponding author), Princess Nourah Bint Abdulrahman Univ, Coll Hlth & Rehabil Sci, Dept Hlth Sci, Clin Nutr, POB 84428, Riyadh 11671, Saudi Arabia.
EM tarfa.ibrahim21@gmail.com; moalonazi@ksu.edu.sa
FU Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia
   [PNURS2022R69]
FX AcknowledgmentsPrincess Nourah Bint Abdulrahman University Research
   Supporting Project number (PNURS2022R69), Princess Nourah Bint
   Abdulrahman University, Riyadh, Saudi Arabia, supported this study.
CR Aebi H., 1984, METHOD ENZYMOL, V105, P121, DOI 10.1016/s0076-6879(84)05016-3
   Aksic MF, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8070205
   Al Omairi NE, 2022, BIOLOGY-BASEL, V11, DOI 10.3390/biology11030354
   Azzini E, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/2740364
   Bechmann LP, 2012, J HEPATOL, V56, P952, DOI 10.1016/j.jhep.2011.08.025
   Beckman CH, 2000, PHYSIOL MOL PLANT P, V57, P101, DOI 10.1006/pmpp.2000.0287
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Cerezo AB, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9060478
   Chung HY, 2019, AGING DIS, V10, P367, DOI 10.14336/AD.2018.0324
   Correa-Betanzo J, 2014, FOOD CHEM, V165, P522, DOI 10.1016/j.foodchem.2014.05.135
   De Vega L, 2002, RENAL FAILURE, V24, P421, DOI 10.1081/JDI-120006769
   Debom G, 2016, BRAIN RES BULL, V127, P260, DOI 10.1016/j.brainresbull.2016.10.008
   Durazzo A, 2019, PHYTOTHER RES, V33, P2221, DOI 10.1002/ptr.6419
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   Fabregat I, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00357
   Forman HJ, 2021, NAT REV DRUG DISCOV, V20, P689, DOI 10.1038/s41573-021-00233-1
   Guarner V, 2015, INTERD T GERONT GERI, V40, P99, DOI 10.1159/000364934
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Istek N, 2017, J FUNCT FOODS, V38, P298, DOI 10.1016/j.jff.2017.09.039
   Kalt W, 2008, J AGR FOOD CHEM, V56, P705, DOI 10.1021/jf071998l
   Kalt W, 2020, ADV NUTR, V11, P224, DOI 10.1093/advances/nmz065
   Lee S, 2018, J NUTR, V148, P209, DOI 10.1093/jn/nxx027
   Li D, 2015, J NUTR, V145, P742, DOI 10.3945/jn.114.205674
   Li H, 2020, NUTR RES, V73, P83, DOI 10.1016/j.nutres.2019.09.005
   Liu WX, 2019, NUTR METAB, V16, DOI 10.1186/s12986-019-0363-6
   Loncaric A, 2020, FOODS, V9, DOI 10.3390/foods9111521
   Contreras-Zentella ML, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3529149
   Martineau LC, 2006, PHYTOMEDICINE, V13, P612, DOI 10.1016/j.phymed.2006.08.005
   Michalska A, 2015, INT J MOL SCI, V16, P18642, DOI 10.3390/ijms160818642
   Nair AR, 2017, FOOD FUNCT, V8, P4118, DOI [10.1039/c7fo00815e, 10.1039/C7FO00815E]
   NISHIKIMI M, 1972, BIOCHEM BIOPH RES CO, V46, P849, DOI 10.1016/S0006-291X(72)80218-3
   Nita M, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3164734
   Nowack R, 2008, PHYTOMEDICINE, V15, P653, DOI 10.1016/j.phymed.2008.07.009
   Nunes S, 2021, NUTRIENTS, V13, DOI 10.3390/nu13124192
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Othman MS, 2022, ENVIRON SCI POLLUT R, V29, P75043, DOI 10.1007/s11356-022-21092-2
   Othman MS, 2021, BIOMED PHARMACOTHER, V144, DOI 10.1016/j.biopha.2021.112287
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   Papandreou MA, 2009, BEHAV BRAIN RES, V198, P352, DOI 10.1016/j.bbr.2008.11.013
   Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024
   Samarghandian S, 2016, PHYTOTHER RES, V30, P1345, DOI 10.1002/ptr.5638
   Sellappan S, 2002, J AGR FOOD CHEM, V50, P2432, DOI 10.1021/jf011097r
   Serafini M, 2009, FREE RADICAL BIO MED, V46, P769, DOI 10.1016/j.freeradbiomed.2008.11.023
   Silva S, 2020, CRIT REV FOOD SCI, V60, P181, DOI 10.1080/10408398.2018.1518895
   Skupien K, 2006, CANCER LETT, V236, P282, DOI 10.1016/j.canlet.2005.05.018
   Taruscio TG, 2004, J AGR FOOD CHEM, V52, P3169, DOI 10.1021/jf0307595
   Wang YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058659
   Williams CM, 2008, FREE RADICAL BIO MED, V45, P295, DOI 10.1016/j.freeradbiomed.2008.04.008
   Wimalawansa SJ, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8020030
   Yi WG, 2005, J AGR FOOD CHEM, V53, P7320, DOI 10.1021/jf051333o
   Zhang B F, 2018, Zhonghua Gan Zang Bing Za Zhi, V26, P590, DOI 10.3760/cma.j.issn.1007-3418.2018.08.006
NR 51
TC 3
Z9 3
U1 3
U2 7
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1942-0900
EI 1942-0994
J9 OXID MED CELL LONGEV
JI Oxidative Med. Cell. Longev.
PD JUL 18
PY 2022
VL 2022
AR 3490776
DI 10.1155/2022/3490776
PG 11
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 3L9MA
UT WOS:000835083200003
PM 35898615
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Wang, Z
   Li, QQ
   Xu, LN
   Ma, J
   Wang, Y
   Wei, B
   Wu, WD
   Liu, SJ
AF Wang, Zhe
   Li, Qingqing
   Xu, Lining
   Ma, Juan
   Wang, Yan
   Wei, Bing
   Wu, Weidong
   Liu, Sijin
TI Ageing alters the physicochemical properties of silver nanoparticles and
   consequently compromises their acute toxicity in mammals
SO ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY
LA English
DT Article
DE Silver nanoparticles; Ageing process; Physicochemical alterations;
   Health impacts
ID HEMATOLOGICAL PARAMETERS; AQUATIC ENVIRONMENTS; OXIDE NANOPARTICLES;
   ORGANIC-MATTER; DRUG-DELIVERY; DISSOLUTION; TRANSFORMATIONS;
   NANOMATERIALS; TISSUE; CELLS
AB Despite numerous investigations into AgNP-induced toxicity, little has been taken into consideration the potential health impacts of aged AgNPs in comparison to fresh AgNPs. In the current study, we scrutinized the potential effects of aged AgNPs in animals. We first found that AgNPs underwent morphological transformations after natural ageing in aqueous solution upon exposure to air and sunlight for 9 days, as characterized by significant aggregation with increase of particle size approximately by 2 fold. Meanwhile, dissolved Ag ions from aged AgNPs increased by 33% compared to fresh AgNPs. Strikingly, the acute exposure results showed that aged AgNPs induced lower toxicity in mice relative to fresh AgNPs. Aged AgNPs caused milder local inflammation in the peritoneal cavity of mice, as evidenced by 63% reduction of tumor necrosis factor a (TNF-alpha) than that induced by fresh AgNPs. The deposition mass of aged AgNPs in the liver, spleen, lung and kidney was diminished by 69%, 39%, 83% and 40%, respectively, compared to the distribution profiles in response to fresh AgNPs. Whereby, milder splenic hyperemia was observed, and no significant hepatoxicity was found. Additionally, aged AgNPs provoked milder increase of periphery leukocytes and malondialdehyde (MDA) in mice in comparison to fresh AgNPs. Taken together, this study unraveled that the ageing process elicited remarkable alterations to physicochemical properties and toxic effects as well. This study would provide new insights into the potential health impacts of AgNPs under transformation-determined exposure scenarios.
C1 [Wang, Zhe; Li, Qingqing; Wang, Yan; Wei, Bing; Wu, Weidong] Xinxiang Med Univ, Sch Publ Hlth, Xinxiang 453003, Henan, Peoples R China.
   [Xu, Lining; Ma, Juan; Liu, Sijin] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Environm Chem & Ecotoxicol, Beijing 100085, Peoples R China.
   [Xu, Lining; Ma, Juan; Liu, Sijin] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
C3 Xinxiang Medical University; Chinese Academy of Sciences; Research
   Center for Eco-Environmental Sciences (RCEES); Chinese Academy of
   Sciences; University of Chinese Academy of Sciences, CAS
RP Wang, Z (corresponding author), Xinxiang Med Univ, Sch Publ Hlth, Xinxiang 453003, Henan, Peoples R China.
EM zhewang@xxmu.edu.cn
RI Xu, Lining/JCN-5595-2023
OI Wang, Zhe/0000-0003-1297-8252
FU National Natural Science Foundation of China [21407172, 81573112,
   21637004, 21920102007]; Beijing Natural Science Foundation [8191002];
   Chinese Academy of Sciences [121311KYSB20190010]; Key Project of Science
   and Technology of Henan Province [182102311051]
FX This work was supported by grants from the National Natural Science
   Foundation of China (grant numbers: 21407172, 81573112, 21637004 and
   21920102007), the Beijing Natural Science Foundation (grant number:
   8191002), the international collaboration key grant from the Chinese
   Academy of Sciences (grant number: 121311KYSB20190010), and the Key
   Project of Science and Technology of Henan Province (No. 182102311051).
CR Al-Abed SR, 2016, ENVIRON SCI-NANO, V3, P593, DOI 10.1039/c5en00250h
   Amde M, 2017, ENVIRON POLLUT, V230, P250, DOI 10.1016/j.envpol.2017.06.064
   Bergin IL, 2016, NANOTOXICOLOGY, V10, P352, DOI 10.3109/17435390.2015.1072588
   Diez-Ortiz M, 2015, ENVIRON POLLUT, V203, P191, DOI 10.1016/j.envpol.2015.03.033
   Dziendzikowska K, 2012, J APPL TOXICOL, V32, P920, DOI 10.1002/jat.2758
   El Badawy AM, 2011, ENVIRON SCI TECHNOL, V45, P283, DOI 10.1021/es1034188
   El Badawy AM, 2010, ENVIRON SCI TECHNOL, V44, P1260, DOI 10.1021/es902240k
   Fernández I, 2010, J AM ASSOC LAB ANIM, V49, P202
   Florek J, 2017, NANOSCALE, V9, P15252, DOI 10.1039/c7nr05762h
   Garza-Ocañas L, 2010, METALLOMICS, V2, P204, DOI 10.1039/b916107d
   Grillet N, 2013, J PHYS CHEM C, V117, P2274, DOI 10.1021/jp311502h
   Heydrnejad MS, 2015, BIOL TRACE ELEM RES, V165, P153, DOI 10.1007/s12011-015-0247-1
   Hsiao IL, 2015, ENVIRON SCI TECHNOL, V49, P3813, DOI 10.1021/es504705p
   Jang S, 2012, INT J NANOMED, V7, P1329, DOI 10.2147/IJN.S27159
   Jones AM, 2011, ENVIRON SCI TECHNOL, V45, P1428, DOI 10.1021/es103757c
   Karim MN, 2018, BIOSENS BIOELECTRON, V110, P8, DOI 10.1016/j.bios.2018.03.025
   Kifayatullah M, 2015, J ACUTE DIS, V4, P309, DOI 10.1016/j.joad.2015.06.010
   King W, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/6510842
   Kittler S, 2010, CHEM MATER, V22, P4548, DOI 10.1021/cm100023p
   Landsiedel R, 2012, ARCH TOXICOL, V86, P1021, DOI 10.1007/s00204-012-0858-7
   Lekamge S, 2019, J TOXICOL ENV HEAL A, V82, P1207, DOI 10.1080/15287394.2019.1710887
   Levard C, 2012, ENVIRON SCI TECHNOL, V46, P6900, DOI 10.1021/es2037405
   Li X, 2012, ENVIRON SCI TECHNOL, V46, P5378, DOI 10.1021/es204531y
   Li Y, 2013, ENVIRON SCI TECHNOL, V47, P10293, DOI 10.1021/es400945v
   Liu SJ, 2018, NANO TODAY, V23, P11, DOI 10.1016/j.nantod.2018.09.002
   Loeschner K, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-18
   Lowry GV, 2012, ENVIRON SCI TECHNOL, V46, P6893, DOI 10.1021/es300839e
   Lynch I, 2014, NANO TODAY, V9, P266, DOI 10.1016/j.nantod.2014.05.001
   Ma J, 2016, NANOSCALE, V8, P18070, DOI 10.1039/c6nr06041b
   Ma J, 2015, ACS NANO, V9, P10498, DOI 10.1021/acsnano.5b04751
   Ma R, 2012, ENVIRON SCI TECHNOL, V46, P752, DOI 10.1021/es201686j
   Mittal R, 2018, EXPERT OPIN DRUG DEL, V15, P301, DOI 10.1080/17425247.2018.1420055
   Mudunkotuwa IA, 2012, ENVIRON SCI TECHNOL, V46, P7001, DOI 10.1021/es203851d
   Nemzek JA, 2001, INFLAMM RES, V50, P523, DOI 10.1007/PL00000229
   Mendonça MCP, 2019, NANOTOXICOLOGY, V13, P326, DOI 10.1080/17435390.2018.1544302
   Park EJ, 2010, ENVIRON TOXICOL PHAR, V30, P162, DOI 10.1016/j.etap.2010.05.004
   Recordati C, 2016, PART FIBRE TOXICOL, V13, DOI 10.1186/s12989-016-0124-x
   Scheckel KG, 2010, ENVIRON SCI TECHNOL, V44, P1307, DOI 10.1021/es9032265
   Schrand AM, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/23/235104
   Schultz CL, 2018, ENVIRON SCI-NANO, V5, P2618, DOI [10.1039/c8en00054a, 10.1039/C8EN00054A]
   Shen XM, 2019, ENVIRON INT, V128, P146, DOI 10.1016/j.envint.2019.04.058
   Silva AH, 2017, TOXICOL IND HEALTH, V33, P147, DOI 10.1177/0748233715613224
   Smith JN, 2018, PART FIBRE TOXICOL, V15, DOI 10.1186/s12989-018-0283-z
   Sung JH, 2009, TOXICOL SCI, V108, P452, DOI 10.1093/toxsci/kfn246
   Orta-García ST, 2015, J APPL TOXICOL, V35, P1189, DOI 10.1002/jat.3190
   van der Zande M., 2012, ACS NANO, V6, P7427
   Vance ME, 2015, BEILSTEIN J NANOTECH, V6, P1769, DOI 10.3762/bjnano.6.181
   Wamucho A, 2019, ENVIRON POLLUT, V254, DOI 10.1016/j.envpol.2019.113078
   Wang MM, 2015, NANOTOXICOLOGY, V9, P972, DOI 10.3109/17435390.2014.992816
   Wang Z, 2015, NANOSCALE, V7, P7470, DOI 10.1039/c5nr01133g
   Wang Z, 2013, CURR PHARM DESIGN, V19, P6691
   Wang Z, 2013, ACS NANO, V7, P4171, DOI 10.1021/nn400594s
   Wei LY, 2015, DRUG DISCOV TODAY, V20, P595, DOI 10.1016/j.drudis.2014.11.014
   Wen RX, 2016, NANOIMPACT, V2, P18, DOI 10.1016/j.impact.2016.06.001
   Wen RX, 2016, J APPL TOXICOL, V36, P445, DOI 10.1002/jat.3260
   Xu M, 2018, ACS NANO, V12, P10104, DOI 10.1021/acsnano.8b04906
   Yang Y, 2018, SMALL METHODS, V2, DOI 10.1002/smtd.201700367
   Zhang J, 2018, ENVIRON SCI-NANO, V5, DOI 10.1039/c8en00688a
   Zhang WC, 2018, CHEMOSPHERE, V191, P324, DOI 10.1016/j.chemosphere.2017.10.016
   Zhang Z, 2015, J ENVIRON SCI, V35, P62, DOI 10.1016/j.jes.2015.03.007
   Zhao XC, 2017, ADV SCI, V4, DOI 10.1002/advs.201700296
   Zou XY, 2015, J HAZARD MATER, V292, P61, DOI 10.1016/j.jhazmat.2015.03.005
NR 62
TC 5
Z9 5
U1 2
U2 32
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0147-6513
EI 1090-2414
J9 ECOTOX ENVIRON SAFE
JI Ecotox. Environ. Safe.
PD JUN 15
PY 2020
VL 196
AR 110487
DI 10.1016/j.ecoenv.2020.110487
PG 9
WC Environmental Sciences; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology; Toxicology
GA LD1AE
UT WOS:000525763800003
PM 32229327
DA 2024-02-19
ER

PT J
AU Sera, LC
   McPherson, ML
AF Sera, Leah Church
   McPherson, Mary Lynn
TI Pharmacokinetics and Pharmacodynamic Changes Associated with Aging and
   Implications for Drug Therapy
SO CLINICS IN GERIATRIC MEDICINE
LA English
DT Article
DE Pharmacokinetics; Pharmacodynamics; Aging; Elderly; Polypharmacy; Drug
   therapy
ID CLINICAL-PHARMACOLOGY; ELDERLY-PATIENTS; P-GLYCOPROTEIN; RENAL-FUNCTION;
   AGE; LIVER; RISK; DISPOSITION; METABOLISM; GUIDELINES
AB Knowledge of the physiologic changes associated with aging is vital to providing optimal pharmaceutical care to geriatric patients. The absorption, distribution, metabolism, and excretion of medications are affected to varying extents by the normal aging process and by disease states commonly associated with increasing age. Additionally, altered pharmacodynamics in the elderly-the magnitude of a drug's pharmacologic effect-may increase the risk for adverse drug effects in this population. The altered action and disposition of drugs in the elderly patient should be taken into account by health care professionals to improve adherence, provide appropriate counseling, minimize side effects, and reduce medication errors.
C1 [Sera, Leah Church; McPherson, Mary Lynn] Univ Maryland, Sch Pharm, Dept Pharm Practice & Sci, Baltimore, MD 21201 USA.
C3 University System of Maryland; University of Maryland Baltimore
RP Sera, LC (corresponding author), Univ Maryland, Sch Pharm, Dept Pharm Practice & Sci, Baltimore, MD 21201 USA.
EM lsera@rx.umaryland.edu
RI Sera, Leah/S-6420-2019
OI Sera, Leah/0000-0002-1923-6721
CR ABERNETHY DR, 1986, ANN INTERN MED, V105, P329, DOI 10.7326/0003-4819-105-3-329
   Allen S, 2008, DRUG AGING, V25, P89, DOI 10.2165/00002512-200825020-00001
   [Anonymous], 2006, PATT MED US US REP S, P24
   Aronow Wilbert S, 2007, Cardiol Rev, V15, P195, DOI 10.1097/CRD.0b013e3180301b69
   Atkin PA, 1999, DRUG AGING, V14, P141, DOI 10.2165/00002512-199914020-00005
   Barrons R, 2011, AM J HEALTH-SYST PH, V68, P1221, DOI 10.2146/ajhp100452
   Benet LZ, 2002, CLIN PHARMACOL THER, V71, P115, DOI 10.1067/mcp.2002.121829
   Brenner SS, 2004, EUR J CLIN PHARMACOL, V60, P97, DOI 10.1007/s00228-004-0733-4
   Cepeda MS, 2003, CLIN PHARMACOL THER, V74, P102, DOI 10.1016/S0009-9236(03)00152-8
   CHUTKA DS, 1995, MAYO CLIN PROC, V70, P685, DOI 10.4065/70.7.685
   Cohen JS, 2000, GERIATRICS-US, V55, P54
   CONNOLLY MJ, 1995, CHEST, V108, P401, DOI 10.1378/chest.108.2.401
   COOK PJ, 1984, BRIT MED J, V289, P351, DOI 10.1136/bmj.289.6441.351
   Corsonello A, 2010, CURR MED CHEM, V17, P571, DOI 10.2174/092986710790416326
   DAVIES RO, 1984, BRIT J CLIN PHARMACO, V18, pS215, DOI 10.1111/j.1365-2125.1984.tb02601.x
   Delafuente Jeffrey C, 2008, Consult Pharm, V23, P324, DOI 10.4140/TCP.n.2008.324
   Desouza C, 2003, DIABETES CARE, V26, P1485, DOI 10.2337/diacare.26.5.1485
   DOCHERTY JR, 1990, PHARMACOL REV, V42, P103
   ElDesoky Ehab S, 2007, Am J Ther, V14, P488, DOI 10.1097/01.mjt.0000183719.84390.4d
   EWY GA, 1969, CIRCULATION, V39, P449, DOI 10.1161/01.CIR.39.4.449
   FLISER D, 1993, J AM SOC NEPHROL, V3, P1371
   Fliser D, 1997, NEPHROL DIAL TRANSPL, V12, P1553, DOI 10.1093/ndt/12.8.1553
   Fravel MA, 2011, AM J HEALTH-SYST PH, V68, P500, DOI 10.2146/ajhp080085
   Grossman Ehud, 2002, Curr Cardiol Rep, V4, P468, DOI 10.1007/s11886-002-0108-3
   Higami Y, 2000, CELL TISSUE RES, V301, P125, DOI 10.1007/s004419900156
   HOBSON M, 1992, WESTERN J MED, V157, P539
   Ickowicz E, 2003, J AM GERIATR SOC, V51, pS265
   Jesson Barbara, 2011, Nurs Older People, V23, P14
   Kaestli LZ, 2008, DRUG AGING, V25, P269, DOI 10.2165/00002512-200825040-00001
   Klotz U, 2009, DRUG METAB REV, V41, P67, DOI 10.1080/03602530902722679
   Lanza FL, 2009, AM J GASTROENTEROL, V104, P728, DOI 10.1038/ajg.2009.115
   Le Couteur David G, 2004, Aust Fam Physician, V33, P777
   Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003
   Leese GP, 2003, DIABETES CARE, V26, P1176, DOI 10.2337/diacare.26.4.1176
   LINDEMAN RD, 1984, KIDNEY INT, V26, P861, DOI 10.1038/ki.1984.229
   Lotrich FE, 2005, J CLIN PHARMACOL, V45, P1106, DOI 10.1177/0091270005280297
   Maixner SM, 1999, J CLIN PSYCHIAT, V60, P29
   Mangoni AA, 2003, AGE AGEING, V32, P326, DOI 10.1093/ageing/32.3.326
   Mangonis AA, 2003, BR J CLIN PHARM, V57, P6, DOI [DOI 10.1046/J.1365-2125.2003.02007.X, 10.1046/j.13652125.2003.02007.x, DOI 10.1046/J.13652125.2003.02007.X]
   McLean AJ, 2004, PHARMACOL REV, V56, P163, DOI 10.1124/pr.56.2.4
   MONTAMAT SC, 1989, CLIN PHARMACOL THER, V45, P682, DOI 10.1038/clpt.1989.90
   Mühlberg W, 1999, GERONTOLOGY, V45, P243, DOI 10.1159/000022097
   Nelson JM, 2007, J AM GERIATR SOC, V55, P2041, DOI 10.1111/j.1532-5415.2007.01430.x
   Orr WC, 2002, AM J PHYSIOL-GASTR L, V283, pG1226, DOI 10.1152/ajpgi.00276.2002
   Parker AL, 2004, J AM GERIATR SOC, V52, P388, DOI 10.1111/j.1532-5415.2004.52110.x
   Pergolizzi Joseph, 2008, Pain Pract, V8, P287, DOI 10.1111/j.1533-2500.2008.00204.x
   Platten HP, 1998, CLIN PHARMACOL THER, V63, P552, DOI 10.1016/S0009-9236(98)90106-0
   RICHTER C, 1995, INT J BIOCHEM CELL B, V27, P647, DOI 10.1016/1357-2725(95)00025-K
   Rissman RA, 2006, BRAIN RES, V1073, P120, DOI 10.1016/j.brainres.2005.12.036
   RUSSELL RM, 1992, AM J CLIN NUTR, V55, P1203
   SCHMUCKER DL, 1985, PHARMACOL REV, V37, P133
   Schmucker DL, 2001, DRUG AGING, V18, P837, DOI 10.2165/00002512-200118110-00005
   Shi S, 2008, EUR J CLIN PHARMACOL, V64, P183, DOI 10.1007/s00228-007-0422-1
   SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414
   Starner CI, 2008, PHARMACOTHERAPY PATH, P57
   Straus SMJM, 2006, J AM COLL CARDIOL, V47, P362, DOI 10.1016/j.jacc.2005.08.067
   Sulindac, DRUGDEX SYST
   Swedko P, 2003, ARCH INTERN MED, V163, P356, DOI 10.1001/archinte.163.3.356
   Toornvliet R, 2006, CLIN PHARMACOL THER, V79, P540, DOI 10.1016/j.clpt.2006.02.004
   Torn M, 2005, ARCH INTERN MED, V165, P1527, DOI 10.1001/archinte.165.13.1527
   WATKINS PB, 1989, J CLIN INVEST, V83, P688, DOI 10.1172/JCI113933
   WHITE M, 1994, CIRCULATION, V90, P1225, DOI 10.1161/01.CIR.90.3.1225
   Whitmer RA, 2009, JAMA-J AM MED ASSOC, V301, P1565, DOI 10.1001/jama.2009.460
   Wilkinson GR, 1997, ADV DRUG DELIVER REV, V27, P129, DOI 10.1016/S0169-409X(97)00040-9
NR 65
TC 67
Z9 76
U1 0
U2 19
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0749-0690
EI 1879-8853
J9 CLIN GERIATR MED
JI Clin. Geriatr. Med.
PD MAY
PY 2012
VL 28
IS 2
BP 273
EP +
DI 10.1016/j.cger.2012.01.007
PG 15
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 949JJ
UT WOS:000304572200009
PM 22500543
DA 2024-02-19
ER

PT J
AU Zhao, L
   Yang, HQ
   Xu, ML
   Wang, X
   Wang, CT
   Lian, YH
   Mehmood, A
   Dai, HC
AF Zhao, Lei
   Yang, Huaqing
   Xu, Meili
   Wang, Xin
   Wang, Chengtao
   Lian, Yunhe
   Mehmood, Arshad
   Dai, Haochen
TI <i>Stevia</i> residue extract ameliorates oxidative stress in
   D-galactose-induced aging mice via Akt/Nrf2/HO-1 pathway
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE Stevia; Chlorogenic acids; Hydroxycinnamate derivatives; D-galactose;
   Aging; Oxidative stress
ID CHLOROGENIC ACID; ANTIOXIDANT PROPERTIES; INDUCED TOXICITY; HEPG2 CELLS;
   IN-VITRO; HPLC-DAD; POLYPHENOLS; ACTIVATION; PROTECTS; LEAVES
AB The present study investigated the effect of Stevia residue extract (SRE) against oxidative stress in D-galactose (Dgal) induced aging mice. LC-MS/MS analysis revealed that SRE is a good source of chlorogenic acids. Biochemical results showed that SRE significantly increased the activities of superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) and total antioxidant capacity (T-AOC), and decreased acetylcholinesterase (AChE) activity and malondialdehyde (MDA) level in serum, liver or brain of D-gal induced aging mice. At 200 mg/kg, SRE up-regulated the mRNA expression of nuclear factor erythroid 2-related factor 2 (Nrf2) and its downstream target genes including GPx1, CAT, SOD1, quinone oxidoreductase-1 (NQO1) and heme oxygenase-1 (HO-1) in D-gal treated mice liver. SRE also up-regulated the protein expression of Nrf2, HO-1 and the ratio of phosphorylated Akt to Akt (pAkt/Akt) in D-gal treated mice liver. These findings suggest that SRE is able to protect against oxidative stress in D-gal induced aging model via activation of Akt/Nrf2/HO-1 pathway. In conclusion, SRE may provide a promising dietary approach for the prevention or alleviation of oxidative stress and age-related conditions.
C1 [Zhao, Lei; Yang, Huaqing; Wang, Xin; Wang, Chengtao; Mehmood, Arshad] Beijing Technol & Business Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing 100048, Peoples R China.
   [Zhao, Lei; Yang, Huaqing; Wang, Xin; Wang, Chengtao; Mehmood, Arshad] Beijing Technol & Business Univ, Beijing Engn & Technol Res Ctr Food Addit, Beijing 100048, Peoples R China.
   [Xu, Meili; Lian, Yunhe] Chenguang Biotech Grp Co Ltd, Handan 057250, Hebei, Peoples R China.
   [Dai, Haochen] Univ Massachusetts, Dept Food Sci, Amherst, MA 01003 USA.
C3 Beijing Technology & Business University; Beijing Technology & Business
   University; University of Massachusetts System; University of
   Massachusetts Amherst
RP Wang, CT; Lian, YH (corresponding author), Beijing Technol & Business Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing 100048, Peoples R China.
EM wangchengtaojs@163.com; lianyunhels@126.com
RI Qureshi, Arshad Mahmood/AAG-6954-2019; Zhao, Yi/JFA-7988-2023; Zhao,
   Lei/AAS-2428-2021; Mehmood, Arshad/W-5172-2017
OI Zhao, Lei/0000-0003-0813-6140; Dai, Haochen/0000-0003-3098-1826;
   Mehmood, Arshad/0000-0002-2022-375X
FU Project of High-level Teachers in Beijing Municipal Universities
   [CITTCD201704042, IDHT20180506]; National Key Research and Development
   Program [2016YFD0400802, 2016YFD0400502-02]; National Natural Science
   Foundation of China [31571801, 31701575]; construct of innovation
   service ability Science and technology achievement transformation
   Upgrade project [PXM2016-014213-000034]; Beijing Municipal Science and
   Technology Project [Z171100002217019]
FX This work was supported by the Support Project of High-level Teachers in
   Beijing Municipal Universities in the Period of 13th Five-year Plan (No.
   CIT&TCD201704042, IDHT20180506), the National Key Research and
   Development Program (No. 2016YFD0400802, 2016YFD0400502-02), the
   National Natural Science Foundation of China (No. 31571801, 31701575),
   the construct of innovation service ability Science and technology
   achievement transformation Upgrade project (PXM2016-014213-000034) and
   Beijing Municipal Science and Technology Project (No. Z171100002217019).
CR Aguiar AS, 2011, MECH AGEING DEV, V132, P560, DOI 10.1016/j.mad.2011.09.005
   Barroso M, 2016, IND CROP PROD, V90, P49, DOI 10.1016/j.indcrop.2016.06.013
   Cao W, 2016, FOOD FUNCT, V7, P2303, DOI [10.1039/C5FO01194A, 10.1039/c5fo01194a]
   Clifford MN, 2005, J AGR FOOD CHEM, V53, P3821, DOI 10.1021/jf050046h
   Dillard CJ, 2000, J SCI FOOD AGR, V80, P1744, DOI [10.1002/1097-0010(20000915)80:12<1744::AID-JSFA725>3.0.CO;2-W, 10.1002/1097-0010(20000915)80:12&lt;1744::AID-JSFA725&gt;3.0.CO;2-W]
   Dong FX, 2017, BIOCHEM BIOPH RES CO, V491, P636, DOI 10.1016/j.bbrc.2017.07.151
   Ena Gupta, 2013, Journal of Medicinal Plants Research, V7, P3343
   Feng Y, 2016, PHARM BIOL, V54, P1027, DOI 10.3109/13880209.2015.1093510
   Fu CW, 2011, J PHARMACEUT BIOMED, V55, P1067, DOI 10.1016/j.jpba.2011.03.011
   Giampieri F, 2017, FOOD CHEM, V234, P464, DOI 10.1016/j.foodchem.2017.05.017
   Han XZ, 2008, FOOD CHEM TOXICOL, V46, P3140, DOI 10.1016/j.fct.2008.06.086
   Hassan HA., 2018, LIVER, P121
   He WH, 2010, FOOD CHEM, V123, P521, DOI 10.1016/j.foodchem.2010.04.030
   Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074
   Jeong H, 2017, EXP GERONTOL, V95, P16, DOI 10.1016/j.exger.2017.05.004
   Jung UJ, 2006, J PHARMACOL EXP THER, V318, P476, DOI 10.1124/jpet.106.105163
   Lee YJ, 2012, FOOD CHEM TOXICOL, V50, P116, DOI 10.1016/j.fct.2011.10.035
   Li YR, 2018, BIOFACTORS, V44, P69, DOI 10.1002/biof.1400
   Liu J, 2010, FOOD BIOPROD PROCESS, V88, P215, DOI 10.1016/j.fbp.2009.12.005
   Liu XY, 2018, J FUNCT FOODS, V45, P110, DOI 10.1016/j.jff.2018.03.037
   Loboda A, 2016, CELL MOL LIFE SCI, V73, P3221, DOI 10.1007/s00018-016-2223-0
   Losada-Barreiro S, 2017, EUR J MED CHEM, V133, P379, DOI 10.1016/j.ejmech.2017.03.061
   Matés JM, 1999, CLIN BIOCHEM, V32, P595, DOI 10.1016/S0009-9120(99)00075-2
   Mattonai M, 2016, MICROCHEM J, V126, P220, DOI 10.1016/j.microc.2015.12.013
   Molina-Calle M, 2017, FOOD CHEM, V219, P329, DOI 10.1016/j.foodchem.2016.09.148
   Poniedzialek B, 2015, TOXICOL IN VITRO, V29, P926, DOI 10.1016/j.tiv.2015.03.023
   Prasad S, 2012, PREV MED, V54, pS29, DOI 10.1016/j.ypmed.2011.11.011
   Queen Brannon L, 2010, Curr Aging Sci, V3, P34
   Rogalska A., 2017, TOXICOLOGY, V47, P48
   Sato Y, 2011, INT J PHARMACEUT, V403, P136, DOI 10.1016/j.ijpharm.2010.09.035
   Shi AM, 2018, INT IMMUNOPHARMACOL, V54, P125, DOI 10.1016/j.intimp.2017.11.007
   Shivanna N, 2013, J DIABETES COMPLICAT, V27, P103, DOI 10.1016/j.jdiacomp.2012.10.001
   Shukla S, 2012, EXP TOXICOL PATHOL, V64, P807, DOI 10.1016/j.etp.2011.02.002
   Shwe T, 2018, EXP GERONTOL, V101, P13, DOI 10.1016/j.exger.2017.10.029
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Tadhani MB, 2007, J FOOD COMPOS ANAL, V20, P323, DOI 10.1016/j.jfca.2006.08.004
   Tian Y, 2011, FOOD CHEM TOXICOL, V49, P1728, DOI 10.1016/j.fct.2011.04.018
   van Velzen LS, 2017, PROG NEURO-PSYCHOPH, V76, P140, DOI 10.1016/j.pnpbp.2017.02.017
   Zhang L, 2015, FOOD RES INT, V70, P101, DOI 10.1016/j.foodres.2015.01.012
   Zhang Q, 2005, NEUROL RES, V27, P552, DOI 10.1179/016164105X25126
   Zhang ZF, 2009, FOOD CHEM TOXICOL, V47, P496, DOI 10.1016/j.fct.2008.12.005
   Zhuang CL, 2014, EUR J PHARMACOL, V740, P480, DOI 10.1016/j.ejphar.2014.06.040
   Zhuang YL, 2017, FOOD CHEM TOXICOL, V108, P554, DOI 10.1016/j.fct.2017.01.022
NR 43
TC 37
Z9 42
U1 4
U2 54
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1756-4646
J9 J FUNCT FOODS
JI J. Funct. Food.
PD JAN
PY 2019
VL 52
BP 587
EP 595
DI 10.1016/j.jff.2018.11.044
PG 9
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA HH4KR
UT WOS:000455691800062
DA 2024-02-19
ER

PT J
AU Li, TY
   Chen, SF
   Feng, T
   Dong, J
   Li, YY
   Li, H
AF Li, Tianyi
   Chen, Sufang
   Feng, Tao
   Dong, Jie
   Li, Yuanyuan
   Li, Hua
TI Rutin protects against aging-related metabolic dysfunction
SO FOOD & FUNCTION
LA English
DT Article
ID ENDOPLASMIC-RETICULUM STRESS; INSULIN-RESISTANCE; OXIDATIVE STRESS;
   LIPID-ACCUMULATION; MITOCHONDRIAL DYSFUNCTION; ADIPOSE-TISSUE;
   INFLAMMATION; DIETARY; CONTRIBUTES; LIVER
AB Aging is a complex process which is accompanied by multiple related chronic diseases. Among them, metabolic dysfunction is one of the most important aging-related disorders. In the present study, we aimed to investigate the effect of rutin on aging-related metabolic dysfunction. We found that the increase of fasting blood glucose, insulin levels, blood pressure and HOMA-IR in aged rats was significantly inhibited by rutin. In addition, rutin improved glucose and insulin tolerance in aged rats, as reflected by decreased glucose level in IPGTT and IPITT test. Rutin treatment notably increased Akt and IRS-1 phosphorylation in the livers of old rats. The increase of inflammatory markers, such as IL-1 beta and TNF alpha, was prevented by the rutin administration. Moreover, in circulation and livers of old rats, rutin treatment significantly decreased the content of TG. Rutin also inhibited the increase of serum AST and ALT levels. Furthermore, rutin treatment markedly inhibited aging-related mitochondrial dysfunction, ER stress, and oxidative stress, as evidenced by increased oxygen consumption rate and activities of Na+/K+-ATPase and Ca2+-ATPase, decreased expression of ATF3 and GRP78, decreased level of MDA, increased content of GSH and enhanced activity of SOD in aged rats. We show that the administration of rutin could effectively improve aging-related metabolic dysfunction. The amelioration of inflammation, lipid accumulation, mitochondrial dysfunction, ER stress, and oxidative stress may be involved in the effect of rutin on agingrelated metabolic dysfunction. These findings provide novel insights into the potential use of rutin in the intervention of aging and its related metabolic diseases.
C1 [Li, Tianyi; Chen, Sufang; Feng, Tao; Dong, Jie; Li, Yuanyuan; Li, Hua] Zhengzhou Univ, Affiliated Hosp 1, Dept Geriatr Endocrinol, Zhengzhou 450000, Henan Province, Peoples R China.
C3 Zhengzhou University
RP Li, H (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Geriatr Endocrinol, Zhengzhou 450000, Henan Province, Peoples R China.
EM hua_li15@126.com
RI li, yuanyuan/GZA-4435-2022
CR [Anonymous], J PHARM PHARM
   Dai Dao-Fu, 2014, Longev Healthspan, V3, P6, DOI 10.1186/2046-2395-3-6
   Dasuri K, 2016, BBA-MOL BASIS DIS, V1862, P274, DOI 10.1016/j.bbadis.2015.11.002
   El Assar M, 2013, FREE RADICAL BIO MED, V65, P380, DOI 10.1016/j.freeradbiomed.2013.07.003
   Rubio-Ruiz ME, 2014, ACTA PHARMACOL SIN, V35, P1364, DOI 10.1038/aps.2014.67
   Fabjan N, 2003, J AGR FOOD CHEM, V51, P6452, DOI 10.1021/jf034543e
   Fernández-Garcia JC, 2013, CURR VASC PHARMACOL, V11, P906, DOI 10.2174/15701611113116660175
   Ghosh AK, 2015, J GERONTOL A-BIOL, V70, P1320, DOI 10.1093/gerona/glu186
   Guebre-Egziabher F, 2013, BIOCHIMIE, V95, P1971, DOI 10.1016/j.biochi.2013.07.017
   Henis-Korenblit S, 2010, P NATL ACAD SCI USA, V107, P9730, DOI 10.1073/pnas.1002575107
   Honma T, 2011, J NUTR SCI VITAMINOL, V57, P123, DOI 10.3177/jnsv.57.123
   Hosseinzadeh H, 2014, J ENDOCRINOL INVEST, V37, P783, DOI 10.1007/s40618-014-0096-3
   Kamalakkannan N, 2006, BASIC CLIN PHARMACOL, V98, P97, DOI 10.1111/j.1742-7843.2006.pto_241.x
   Keith D, 2014, BIOCHEM BIOPH RES CO, V450, P324, DOI 10.1016/j.bbrc.2014.05.112
   Kong YH, 2014, INTERD T GERONT GERI, V39, P86, DOI 10.1159/000358901
   Kumar D, 2014, REJUV RES, V17, P446, DOI 10.1089/rej.2014.1573
   Kunchithapautham K, 2014, J BIOL CHEM, V289, P14534, DOI 10.1074/jbc.M114.564674
   Kuntic V, 2007, J PHARMACEUT BIOMED, V43, P718, DOI 10.1016/j.jpba.2006.07.019
   Lam D. W., 2000, METAB SYNDR, P1
   LeRoith D, 2002, AM J MED, V113, p3S
   Liu HW, 2015, J AGR FOOD CHEM, V63, P8407, DOI 10.1021/acs.jafc.5b02501
   MANACH C, 1995, J NUTR, V125, P1911, DOI 10.1093/jn/125.7.1911
   Nocchi L, 2014, AGING CELL, V13, P540, DOI 10.1111/acel.12208
   Nuzzo D, 2015, CURR ALZHEIMER RES, V12, P723, DOI 10.2174/1567205012666150710115506
   Panchal SK, 2011, J NUTR, V141, P1062, DOI 10.3945/jn.111.137877
   Pandey A, 2015, IUBMB LIFE, V67, P506, DOI 10.1002/iub.1396
   Park MH, 2014, ARCH PHARM RES, V37, P1507, DOI 10.1007/s12272-014-0474-6
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Phielix E, 2011, GERONTOLOGY, V57, P387, DOI 10.1159/000317691
   Pyrzanowska J, 2012, PHARMACOL REP, V64, P808, DOI 10.1016/S1734-1140(12)70876-9
   Seo E, 2015, NUTRIENTS, V7, P3038, DOI 10.3390/nu7043038
   Soprano M, 2016, CURR DIABETES REV, V12, P84, DOI 10.2174/1573399811666150722124701
   Tardif N, 2014, AGING CELL, V13, P1001, DOI 10.1111/acel.12263
   Wang X, 2012, BIOCHIMIE, V94, P1705, DOI 10.1016/j.biochi.2012.03.024
   Wang YB, 2015, EXP THER MED, V9, P451, DOI 10.3892/etm.2014.2090
   Yilancioglu K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091957
   Zhou YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132088
   Zuliani G, 2014, ATHEROSCLEROSIS, V235, P538, DOI 10.1016/j.atherosclerosis.2014.05.959
NR 38
TC 26
Z9 29
U1 1
U2 17
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PY 2016
VL 7
IS 2
BP 1147
EP 1154
DI 10.1039/c5fo01036e
PG 8
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA DE5SP
UT WOS:000370692900053
PM 26804783
DA 2024-02-19
ER

PT J
AU Chien, YC
   Chiang, HC
   Lin, PY
   Chen, YL
AF Chien, You-Chiuan
   Chiang, Heng-Chieh
   Lin, Ping-Yi
   Chen, Yao-Li
TI Erectile function in men with end-stage liver disease improves after
   living donor liver transplantation
SO BMC UROLOGY
LA English
DT Article
ID INTERNATIONAL INDEX; GONADAL DYSFUNCTION; ANDROGEN DEFICIENCY; AGING
   MALES; HYPOGONADISM; QUESTIONNAIRE; HEALTH
AB Background: Impaired liver function in men can result in erectile dysfunction or hypogonadism or both. We investigated whether living donor liver transplantation (LDLT) results in improvement in male sexual function.
   Methods: A total of 58 patients with end-stage liver disease (ESLD) were included in this prospective, cross-sectional study. Erectile function was measured before and after LDLT using a five-item modified version of the International Index of Erectile Function scale (IIEF-5) and hypogonadism was evaluated before and after LDLT using the Androgen Deficiency in the Aging Male (ADAM) questionnaire. Differences in mean values from the questionnaires before and after the operation were than evaluated to determine whether there is an association between LDLT and improvement in sexual function.
   Results: We found that mean IIEF-5 scores significantly increased after LDLT (from 11.7 +/- 7.7 before LDLT to 14.7 +/- 7.5 after LDLT, p < 0.01), indicating that the operation played a role in improving erectile function. In addition, the prevalence of hypogonadism among the patients with ESLD decreased markedly after liver transplantation (hypogonadism before LDLT, n = 41 versus hypogonadism after LDLT, n = 31, p = 0.03). Patients with hypogonadism reported a higher prevalence of erectile dysfunction after LDLT than patients without hypogonadism (p < 0.01).
   Conclusions: LDLT results in improvement in erectile function. In addition, improvement in erectile function is associated with self-reported absence of hypogonadism.
C1 [Chien, You-Chiuan; Chiang, Heng-Chieh] Changhua Christian Hosp, Dept Surg, Div Urol, Changhua 50006, Changhua County, Taiwan.
   [Lin, Ping-Yi] Changhua Christian Hosp, Transplant Med & Surg Res Ctr, Changhua, Taiwan.
   [Chen, Yao-Li] Kaohsiung Med Univ, Sch Med, Kaohsiung, Taiwan.
   [Chen, Yao-Li] Changhua Christian Hosp, Dept Gen Surg, Changhua 50006, Changhua County, Taiwan.
C3 Changhua Christian Hospital; Changhua Christian Hospital; Kaohsiung
   Medical University; Changhua Christian Hospital
RP Chen, YL (corresponding author), Kaohsiung Med Univ, Sch Med, Kaohsiung, Taiwan.
EM 31560@cch.org.tw
RI li, xinke/JTU-3633-2023
CR Akamatsu N, 2014, WORLD J HEPATOL, V6, P626, DOI 10.4254/wjh.v6.i9.626
   Bravata DM, 1999, LIVER TRANSPLANT SUR, V5, P318, DOI 10.1002/lt.500050404
   Burra P, 2013, BEST PRACT RES CL GA, V27, P553, DOI 10.1016/j.bpg.2013.06.014
   Burra P, 2010, TRANSPLANTATION, V89, P1425, DOI 10.1097/TP.0b013e3181e1f1f6
   Chen CL, 2013, NAT REV GASTRO HEPAT, V10, P746, DOI 10.1038/nrgastro.2013.194
   Durazzo M, 2010, J ENDOCRINOL INVEST, V33, P501, DOI 10.1007/BF03346632
   Foresta C, 2008, J ENDOCRINOL INVEST, V31, P470, DOI 10.1007/BF03346393
   GAVALER JS, 1988, GASTROENTEROLOGY, V95, P1680, DOI 10.1016/S0016-5085(88)80097-0
   Heidelbaugh JJ, 2010, AM FAM PHYSICIAN, V81, P305
   Ho JK, 2006, LIVER TRANSPLANT, V12, P1478, DOI 10.1002/lt.20831
   Huyghe E, 2008, AM J TRANSPLANT, V8, P2580, DOI 10.1111/j.1600-6143.2008.02424.x
   Karagiannis A, 2005, EUR J ENDOCRINOL, V152, P501, DOI 10.1530/eje.1.01886
   Klein J, 2013, ANN TRANSPL, V18, P136, DOI 10.12659/AOT.883860
   Madersbacher S, 1996, CLIN ENDOCRINOL, V44, P461, DOI 10.1046/j.1365-2265.1996.698519.x
   McMahon CG, 2013, J SEX MED, V10, P204, DOI 10.1111/j.1743-6109.2012.02824.x
   Morley JE, 2006, MATURITAS, V53, P424, DOI 10.1016/j.maturitas.2005.07.004
   Morley JE, 2000, METABOLISM, V49, P1239, DOI 10.1053/meta.2000.8625
   Rosen RC, 2002, INT J IMPOT RES, V14, P226, DOI 10.1038/sj.ijir.3900857
   Rosen RC, 1999, INT J IMPOT RES, V11, P319, DOI 10.1038/sj.ijir.3900472
   Rovira J, 2012, TRANSPLANTATION, V93, P874, DOI 10.1097/TP.0b013e31824bf1f0
   Sorrell JH, 2006, LIVER TRANSPLANT, V12, P1473, DOI 10.1002/lt.20812
   Tancredi A, 2004, EUR J ENDOCRINOL, V151, P355, DOI 10.1530/eje.0.1510355
   Wang GS, 2013, EXP CLIN TRANSPLANT, V11, P332, DOI 10.6002/ect.2012.0102
   Wu CJ, 2007, UROLOGY, V69, P743, DOI 10.1016/j.urology.2006.12.019
NR 24
TC 14
Z9 16
U1 0
U2 1
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2490
J9 BMC UROL
JI BMC Urol.
PD AUG 13
PY 2015
VL 15
AR 83
DI 10.1186/s12894-015-0078-6
PG 6
WC Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Urology & Nephrology
GA CO8ZE
UT WOS:000359460400001
PM 26268947
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Picca, A
   Pesce, V
   Fracasso, F
   Joseph, AM
   Leeuwenburgh, C
   Lezza, AMS
AF Picca, Anna
   Pesce, Vito
   Fracasso, Flavio
   Joseph, Anna-Maria
   Leeuwenburgh, Christiaan
   Lezza, Angela M. S.
TI Aging and Calorie Restriction Oppositely Affect Mitochondrial Biogenesis
   through TFAM Binding at Both Origins of Mitochondrial DNA Replication in
   Rat Liver
SO PLOS ONE
LA English
DT Article
ID TRANSCRIPTION FACTOR-A; HEAVY-STRAND PROMOTER; PEROXIREDOXIN-III;
   PHENOTYPIC ALTERATIONS; OXIDATIVE STRESS; SKELETAL-MUSCLE; AGE;
   EXPRESSION; BRAIN; NEURODEGENERATION
AB Aging affects mitochondria in a tissue-specific manner. Calorie restriction (CR) is, so far, the only intervention able to delay or prevent the onset of several age-related changes also in mitochondria. Using livers from middle age (18-month-old), 28-month-old and 32-month-old ad libitum-fed and 28-month-old calorie-restricted rats we found an age-related decrease in mitochondrial DNA (mtDNA) content and mitochondrial transcription factor A (TFAM) amount, fully prevented by CR. We revealed also an age-related decrease, completely prevented by CR, for the proteins PGC-1 alpha NRF-1 and cytochrome c oxidase subunit IV, supporting the efficiency of CR to forestall the age-related decrease in mitochondrial biogenesis. Furthermore, CR counteracted the age-related increase in oxidative damage to proteins, represented by the increased amount of oxidized peroxiredoxins (PRX-SO3) in the ad libitum-fed animals. An unexpected age-related decrease in the mitochondrial proteins peroxiredoxin III (Prx III) and superoxide dismutase 2 (SOD2), usually induced by increased ROS and involved in mitochondrial biogenesis, suggested a prevailing relevance of the age-reduced mitochondrial biogenesis above the induction by ROS in the regulation of expression of these genes with aging. The partial prevention of the decrease in Prx III and SOD2 proteins by CR also supported the preservation of mitochondrial biogenesis in the anti-aging action of CR. To investigate further the age- and CR-related effects on mitochondrial biogenesis we analyzed the in vivo binding of TFAM to specific mtDNA regions and demonstrated a marked increase in the TFAM-bound amounts of mtDNA at both origins of replication with aging, fully prevented by CR. A novel, positive correlation between the paired amounts of TFAM-bound mtDNA at these sub-regions was found in the joined middle age ad libitum-fed and 28-month-old calorie-restricted groups, but not in the 28-month-old ad libitum-fed counterpart suggesting a quite different modulation of TFAM binding at both origins of replication in aging and CR.
C1 [Picca, Anna; Joseph, Anna-Maria; Leeuwenburgh, Christiaan] Univ Florida, Div Biol Aging, Inst Aging, Dept Aging & Geriatr Res, Gainesville, FL USA.
   [Pesce, Vito; Fracasso, Flavio; Lezza, Angela M. S.] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy.
C3 State University System of Florida; University of Florida; Universita
   degli Studi di Bari Aldo Moro
RP Lezza, AMS (corresponding author), Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy.
EM angelamariaserena.lezza@uniba.it
RI Picca, Anna/K-2305-2018
OI Picca, Anna/0000-0001-7032-3487; PESCE, VITO/0000-0002-9148-3129;
   Leeuwenburgh, Christiaan/0000-0003-0826-4257
FU University of Florida Institute on Aging; Claude D. Pepper Older
   Americans Independence Center [1 P30 AG028740];  [NIA R01 AG17994]
FX This research was supported by grants to CL (NIA R01 AG17994), the
   University of Florida Institute on Aging and the Claude D. Pepper Older
   Americans Independence Center (1 P30 AG028740). The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Anderson RM, 2008, AGING CELL, V7, P101, DOI 10.1111/j.1474-9726.2007.00357.x
   Aspnes LE, 1997, FASEB J, V11, P573, DOI 10.1096/fasebj.11.7.9212081
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Barja G, 2007, REJUV RES, V10, P215, DOI 10.1089/rej.2006.0516
   Barrientos A, 1997, MOL BRAIN RES, V52, P284, DOI 10.1016/S0169-328X(97)00278-7
   Bua EA, 2004, FASEB J, V18, P582, DOI 10.1096/fj.03-0668fje
   Canugovi C, 2010, DNA REPAIR, V9, P1080, DOI 10.1016/j.dnarep.2010.07.009
   Cassano P, 2006, REJUV RES, V9, P211, DOI 10.1089/rej.2006.9.211
   Cassano P, 2004, ANN NY ACAD SCI, V1019, P269, DOI 10.1196/annals.1297.045
   Chang TS, 2004, J BIOL CHEM, V279, P41975, DOI 10.1074/jbc.M407707200
   Chiribau CB, 2008, J BIOL CHEM, V283, P8211, DOI 10.1074/jbc.M710610200
   Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076
   DAIRAGHI DJ, 1995, BBA-MOL BASIS DIS, V1271, P127, DOI 10.1016/0925-4439(95)00019-Z
   Dinardo MM, 2003, BIOCHEM BIOPH RES CO, V301, P187, DOI 10.1016/S0006-291X(02)03008-5
   Druzhyna NM, 2008, MECH AGEING DEV, V129, P383, DOI 10.1016/j.mad.2008.03.002
   FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496
   GADALETA MN, 1990, EUR J BIOCHEM, V187, P501, DOI 10.1111/j.1432-1033.1990.tb15331.x
   Gredilla R, 2001, J BIOENERG BIOMEMBR, V33, P279, DOI 10.1023/A:1010603206190
   Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024
   Huang JH, 2009, IUBMB LIFE, V61, P201, DOI 10.1002/iub.164
   Huh JY, 2012, ANTIOXID REDOX SIGN, V16, P229, DOI [10.1089/ars.2010.3766, 10.1089/ars.2011.3952]
   Hwang IK, 2010, FREE RADICAL BIO MED, V48, P1242, DOI 10.1016/j.freeradbiomed.2010.02.007
   Kang CM, 1998, FREE RADICAL BIO MED, V24, P148, DOI 10.1016/S0891-5849(97)00204-9
   Kanki T, 2004, MOL CELL BIOL, V24, P9823, DOI 10.1128/MCB.24.22.9823-9834.2004
   Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Lezza Angela M S, 2012, [Frontiers in Biology, 生物学前沿], V7, P30
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Lodeiro MF, 2012, P NATL ACAD SCI USA, V109, P6513, DOI 10.1073/pnas.1118710109
   López-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6
   Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X
   McInerny SC, 2009, MECH AGEING DEV, V130, P343, DOI 10.1016/j.mad.2009.01.008
   MIGUEL J, 1986, ALAN REV LISS, P51
   Musicco C, 2009, BBA-BIOENERGETICS, V1787, P890, DOI 10.1016/j.bbabio.2009.03.002
   Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006
   Navarro A, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00034
   Paradies G, 2010, FREE RADICAL BIO MED, V48, P1286, DOI 10.1016/j.freeradbiomed.2010.02.020
   PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027
   Pesce V, 2001, FREE RADICAL BIO MED, V30, P1223, DOI 10.1016/S0891-5849(01)00517-2
   Pesce V, 2005, J GERONTOL A-BIOL, V60, P715, DOI 10.1093/gerona/60.6.715
   Pesce V, 2012, REJUV RES, V15, P136, DOI 10.1089/rej.2011.1255
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   PICCA A, 2012, DORDR AGE       0904, DOI DOI 10.1007/S11357-012-9465-Z
   Sahin E, 2012, NAT REV MOL CELL BIO, V13, P397, DOI 10.1038/nrm3352
   Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3
   Shutt TE, 2011, TRANSCR-AUSTIN, V2, P55, DOI 10.4161/trns.2.2.14296
   St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024
   Storz P, 2005, MOL CELL BIOL, V25, P8520, DOI 10.1128/MCB.25.19.8520-8530.2005
   Stuart JA, 2004, FASEB J, V18, P595, DOI 10.1096/fj.03-0890fje
   Van Houten B, 2006, DNA REPAIR, V5, P145, DOI 10.1016/j.dnarep.2005.03.002
   Vercauteren K, 2006, MOL CELL BIOL, V26, P7409, DOI 10.1128/MCB.00585-06
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Woo DK, 2012, AM J PATHOL, V180, P24, DOI 10.1016/j.ajpath.2011.10.003
   Yoshida Y, 2002, BIOCHEM BIOPH RES CO, V295, P945, DOI 10.1016/S0006-291X(02)00757-X
   Zollo O, 2012, P NATL ACAD SCI USA, V109, P6508, DOI 10.1073/pnas.1118594109
NR 57
TC 59
Z9 65
U1 1
U2 19
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 13
PY 2013
VL 8
IS 9
AR e74644
DI 10.1371/journal.pone.0074644
PG 14
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 218BU
UT WOS:000324408400092
PM 24058615
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Lindvall, MO
   Hansson, L
   Klasson, S
   Lopez, MD
   Jern, C
   Stanne, TM
AF Lindvall, Martina Olsson
   Hansson, Lena
   Klasson, Sofia
   Lopez, Marcela Davila
   Jern, Christina
   Stanne, Tara M.
TI Hemostatic Genes Exhibit a High Degree of Allele-Specific Regulation in
   Liver
SO THROMBOSIS AND HAEMOSTASIS
LA English
DT Article
DE coagulation factors; gene regulation; hemostasis; single nucleotide
   polymorphisms; thrombosis
ID GENOME-WIDE ASSOCIATION; PROTEASE INHIBITOR GENE; VON-WILLEBRAND-FACTOR;
   ISCHEMIC-STROKE; RISK-FACTOR; F12 GENE; VENOUS THROMBOEMBOLISM; AGING
   RESEARCH; T-ALLELE; LOCI
AB Objective Elucidating the genetic basis underlying hepatic hemostatic gene expression variability may contribute to unraveling genetic factors contributing to thrombotic or bleeding disorders. We aimed to identify novel cis-regulatory variants involved in regulating hemostatic genes by analyzing allele-specific expression (ASE) in human liver samples. Study Design Biopsies of human liver tissue and blood were collected from adults undergoing liver surgery at the Sahlgrenska University Hospital (n =20). Genomic deoxyribonucleic acid (gDNA) and total ribonucleic acid (RNA) were isolated. A targeted approach was used to enrich and sequence 35 hemostatic genes for single nucleotide polymorphism (SNP) analysis (gDNAseq) and construct individualized genomes for transcript alignment. The allelic ratio of transcripts from targeted RNAseq was determined via ASE analysis. Public expression quantitative trait loci (eQTL) and genome-wide association study (GWAS) data were used to assess novelty and importance of the ASE SNPs (and proxies, r(2) >= 0.8) for relevant traits/diseases. Results Sixty percent of the genes studied showed allelic imbalance across 53 SNPs. Of these, 7 SNPs were previously validated in liver eQTL studies. For 32 with eQTLs in other cell/tissue types, this is the first time genotype-specific expression is demonstrated in liver, and for 14 ASE SNPs, this is the first ever reported genotype-expression association. A total of 29 ASE SNPs were previously associated with the respective plasma protein levels and 17 ASE SNPs to other relevant GWAS traits including venous thromboembolism, coronary artery disease, and stroke. Conclusion Our study provides a comprehensive ASE analysis of hemostatic genes and insights into the regulation of hemostatic genes in human liver.
C1 [Lindvall, Martina Olsson; Klasson, Sofia; Jern, Christina; Stanne, Tara M.] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Lab Med, Box 445, SE-40530 Gothenburg, Sweden.
   [Hansson, Lena] Novo Nordisk, Oxford, England.
   [Hansson, Lena] Sci Life Lab SciLifeLab, Stockholm, Sweden.
   [Lopez, Marcela Davila] Univ Gothenburg, Bioinformat Core Facil, Gothenburg, Sweden.
C3 University of Gothenburg; SciLifeLab; University of Gothenburg
RP Stanne, TM (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Lab Med, Box 445, SE-40530 Gothenburg, Sweden.
EM tara.stanne@gu.se
RI Lopez, Marcela Davila/I-5433-2019
OI Lopez, Marcela Davila/0000-0002-1619-6795; Stanne,
   Tara/0000-0001-9668-0407; Olsson Lindvall, Martina/0000-0002-8609-5607
FU Swedish Heart and Lung Foundation [20160316]; Swedish Research Council
   [2018-02543]; Swedish Stroke Association; Swedish government;
   ALF-agreement [ALFGBG-42]; Swedish Foundation for Strategic Research
   [RIF14-0081]; Rune and Ulla Amlovs Foundation for Neurologic Research;
   John and Brit Wennerstrom Foundation for Neurologic Research; Marcus
   Borgstroms Foundation for Neurologic Research; Nilsson-Ehle Endowments;
   Swedish Research Council [2018-02543] Funding Source: Swedish Research
   Council; Swedish Foundation for Strategic Research (SSF) [RIF14-0081]
   Funding Source: Swedish Foundation for Strategic Research (SSF)
FX This study was supported by the Swedish Heart and Lung Foundation
   (20160316), the Swedish Research Council (2018-02543), the Swedish
   Stroke Association, the Swedish state under the agreement between the
   Swedish government and the county councils (the ALF-agreement,
   ALFGBG-42), the Swedish Foundation for Strategic Research (RIF14-0081),
   the Rune and Ulla Amlovs Foundation for Neurologic Research, the John
   and Brit Wennerstrom Foundation for Neurologic Research, theMarcus
   Borgstroms Foundation for Neurologic Research, and the Nilsson-Ehle
   Endowments.
CR Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277
   AlShaikh FS, 2012, MOL HUM REPROD, V18, P156, DOI 10.1093/molehr/gar069
   Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110
   Campino S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004105
   Castel SE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0762-6
   Cochery-Nouvellon É, 2007, J THROMB HAEMOST, V5, P700, DOI 10.1111/j.1538-7836.2007.02423.x
   Danik JS, 2009, CIRC-CARDIOVASC GENE, V2, P134, DOI 10.1161/CIRCGENETICS.108.825273
   de Vries PS, 2016, HUM MOL GENET, V25, P358, DOI 10.1093/hmg/ddv454
   Dehghan A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144997
   del Río-Espínola A, 2012, ANN NEUROL, V72, P716, DOI 10.1002/ana.23664
   Dentali F, 2008, BRIT J HAEMATOL, V143, P284, DOI 10.1111/j.1365-2141.2008.07331.x
   Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148
   Eicher JD, 2015, NUCLEIC ACIDS RES, V43, pD799, DOI 10.1093/nar/gku1202
   Falcone GJ, 2017, STROKE, V48, P3420, DOI 10.1161/STROKEAHA.117.017072
   Franzén O, 2016, SCIENCE, V353, P827, DOI 10.1126/science.aad6970
   Hardison RC, 1997, GENOME RES, V7, P959, DOI 10.1101/gr.7.10.959
   Huang J, 2014, ARTERIOSCL THROM VAS, V34, P1093, DOI 10.1161/ATVBAHA.113.302088
   Innocenti F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002078
   Jood K, 2005, STROKE, V36, P2077, DOI 10.1161/01.STR.0000183617.54752.69
   Jood K, 2005, STROKE, V36, P1383, DOI 10.1161/01.STR.0000169944.46025.09
   Klarin D, 2017, CIRC-CARDIOVASC GENE, V10, DOI 10.1161/CIRCGENETICS.116.001643
   Konkle BA, 2018, HAEMOPHILIA, V24, P87, DOI 10.1111/hae.13506
   Kukurba KR, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004304
   Kumar S, 2017, NUCLEIC ACIDS RES, V45, pD139, DOI 10.1093/nar/gkw1064
   Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248
   Lovely RS, 2011, ARTERIOSCL THROM VAS, V31, P2345, DOI 10.1161/ATVBAHA.111.232710
   Malik R, 2018, NAT GENET, V50, P524, DOI 10.1038/s41588-018-0058-3
   Mercer TR, 2014, NAT PROTOC, V9, P989, DOI 10.1038/nprot.2014.058
   Morange PE, 2007, ARTERIOSCL THROM VAS, V27, P2250, DOI 10.1161/ATVBAHA.107.149468
   Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872
   Roldán V, 2005, THROMB HAEMOSTASIS, V94, P1294, DOI 10.1160/TH05-06-0453
   Santamaría A, 2004, STROKE, V35, P1795, DOI 10.1161/01.STR.0000133127.68041.a3
   Santamaria A, 2004, HAEMATOLOGICA, V89, P878
   Schalkwyk LC, 2010, AM J HUM GENET, V86, P196, DOI 10.1016/j.ajhg.2010.01.014
   Smith NL, 2010, CIRCULATION, V121, P1382, DOI 10.1161/CIRCULATIONAHA.109.869156
   Söderholm M, 2016, EUR J NEUROL, V23, P1722, DOI 10.1111/ene.13086
   Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955
   Staley JR, 2016, BIOINFORMATICS, V32, P3207, DOI 10.1093/bioinformatics/btw373
   Stanne TM, 2018, THROMB HAEMOSTASIS, V118, P298, DOI 10.1160/TH17-04-0249
   Tang WH, 2013, GENET EPIDEMIOL, V37, P512, DOI 10.1002/gepi.21731
   Tang WH, 2012, AM J HUM GENET, V91, P152, DOI 10.1016/j.ajhg.2012.05.009
   Thanassoulis G, 2013, NEW ENGL J MED, V368, P503, DOI 10.1056/NEJMoa1109034
   Van de Water N, 2004, BRIT J HAEMATOL, V127, P190, DOI 10.1111/j.1365-2141.2004.05189.x
   van der Harst P, 2018, CIRC RES, V122, P433, DOI [10.1161/CIRCRESAHA.117.312086, 10.1161/circresaha.117.312086]
   van Loon J, 2016, EUR J HUM GENET, V24, P1035, DOI 10.1038/ejhg.2015.222
   Ward LD, 2016, NUCLEIC ACIDS RES, V44, pD877, DOI 10.1093/nar/gkv1340
   Wassel CL, 2011, BLOOD, V117, P268, DOI 10.1182/blood-2010-06-289546
   Williams FMK, 2013, ANN NEUROL, V73, P16, DOI 10.1002/ana.23838
   Zi YZ, 2005, BLOOD COAGUL FIBRIN, V16, P79, DOI 10.1097/00001721-200501000-00013
NR 49
TC 2
Z9 2
U1 0
U2 2
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0340-6245
EI 2567-689X
J9 THROMB HAEMOSTASIS
JI Thromb. Haemost.
PD JUL
PY 2019
VL 119
IS 7
BP 1072
EP 1083
DI 10.1055/s-0039-1687879
PG 12
WC Hematology; Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology; Cardiovascular System & Cardiology
GA IH9SJ
UT WOS:000474846400007
PM 31035302
OA hybrid
DA 2024-02-19
ER

PT J
AU Garcia-Carrizo, F
   Priego, T
   Szostaczuk, N
   Palou, A
   Picó, C
AF Garcia-Carrizo, Francisco
   Priego, Teresa
   Szostaczuk, Nara
   Palou, Andreu
   Pico, Catalina
TI Sexual Dimorphism in the Age-Induced Insulin Resistance, Liver
   Steatosis, and Adipose Tissue Function in Rats
SO FRONTIERS IN PHYSIOLOGY
LA English
DT Article
DE sex-differences; white adipose tissue expandability; metabolic
   disturbances; leptin/adiponectin ratio; MEST
ID HIGH-FAT DIET; IMPAIRED GLUCOSE-TOLERANCE; GENE-EXPRESSION;
   OVARIECTOMIZED RATS; METABOLIC SYNDROME; HEPATIC STEATOSIS; LEPTIN
   RESISTANCE; LIPID-METABOLISM; OBESITY; MICE
AB Age-linked metabolic disturbances, such as liver steatosis and insulin resistance, show greater prevalence in men than in women. Thus, our aim was to analyze these sex-related differences in male and female Wistar rats (aged 26 days and 3, 7, and 14 months), and to assess their potential relationship with alterations in the capacity of adipose tissue expansion and the dysregulation of the main adipokines produced by the adipose tissue, leptin and adiponectin. Adiposity related parameters, blood parameters, the expression of genes related to expandability and inflammation (WAT), lipid metabolism (liver), and leptin and insulin signaling (both tissues) were measured. In females, adiposity index and WAT DNA content gradually increased with age, whereas males peaked at 7 months. A similar sex-dependent pattern was observed for leptin expression in WAT, while Mest expression levels decreased with age in males but not in females. Females also showed increased expression of the proliferation marker PCNA in the inguinal WAT compared to males. In males, leptin/adiponectin ratio greatly increased from 7 to 14 months in a more acute manner than in females, along with an increase in HOMA-IR index and hepatic triacylglyceride content, while no changes were observed in females. In liver, 14-month-old males displayed decreased mRNA levels of lnsr, Ampkor2, and Cptla compared with levels at 7 months. Males also showed decreased mRNA levels of Obrb (both tissues), and increased expression levels of Cd68 and Emrl (WAT) with age. In conclusion, females are more protected from age-related metabolic disturbances, such as insulin resistance, hepatic lipid deposition, and WAT inflammation compared to males. This may be related to their greater capacity for WAT expansion reflected by a greater Mest/leptin mRNA ratio and to their ability to maintain adiponectin levels and preserve leptin sensitivity with aging.
C1 [Garcia-Carrizo, Francisco; Priego, Teresa; Szostaczuk, Nara; Palou, Andreu; Pico, Catalina] Univ Balearic Isl, Lab Mol Biol Nutr & Biotechnol Nutrigen, Palma De Mallorca, Spain.
   [Garcia-Carrizo, Francisco; Priego, Teresa; Szostaczuk, Nara; Palou, Andreu; Pico, Catalina] CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Palma De Mallorca, Spain.
C3 Universitat de les Illes Balears; CIBER - Centro de Investigacion
   Biomedica en Red; CIBEROBN
RP Palou, A (corresponding author), Univ Balearic Isl, Lab Mol Biol Nutr & Biotechnol Nutrigen, Palma De Mallorca, Spain.; Palou, A (corresponding author), CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Palma De Mallorca, Spain.
EM andreu.palou@uib.es; cati.pieo@uib.es
RI Pico, Catalina/H-7115-2015; Palou, Andreu/K-9881-2014; Priego,
   Teresa/H-9880-2015
OI Pico, Catalina/0000-0001-6759-5844; Palou, Andreu/0000-0002-0295-4452;
   Priego, Teresa/0000-0001-5397-0877; Garcia-Carrizo,
   Francisco/0000-0002-2484-4000
FU EU's 7th Framework Programme FP7 [244995]; Institute de Salud Carlos
   III, Centro de Investigacion Biomedica en Red Fisiopatologla de la
   Obesidad y Nutrition, CIBERohn; "Direccio General d'Universitats,
   Recerca i Transferencia del Coneixement" of Regional Government (CAIB);
   FEDER funds (EU); European Nutrigenomics Organization, EU [FP6-506360];
   Regional Government (Conselleria d'Educacio, Cultura i Universitats,
   CAIB); European Social Fund (FSE)
FX This work was supported by the EU's 7th Framework Programme FP7
   2007-2013, no. 244995 (BIOCLAIMS Project) and the Institute de Salud
   Carlos III, Centro de Investigacion Biomedica en Red Fisiopatologla de
   la Obesidad y Nutrition, CIBERohn. Authors belong to the
   Nutrigenomics-group at UIB, awarded as "Group of Excellence" of the
   Autonomous Community of the Balearic Islands (CAIB) and supported by
   "Direccio General d'Universitats, Recerca i Transferencia del
   Coneixement" of Regional Government (CAIB) and FEDER funds (EU). The
   Laboratory is a member of the European Research Network of Excellence
   NuGO (The European Nutrigenomics Organization, EU Contract: no.
   FP6-506360). NS is granted with a Ph.D. fellowship entitled "beta para
   la formacion de personal investigador, co-funded by the Regional
   Government (Conselleria d'Educacio, Cultura i Universitats, CAIB) and
   the European Social Fund (FSE)."
CR Abreu-Vieira G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8433
   Arner E, 2010, DIABETES, V59, P105, DOI 10.2337/db09-0942
   Asterholm IW, 2010, AM J PATHOL, V176, P1364, DOI 10.2353/ajpath.2010.090647
   Awazawa M, 2009, BIOCHEM BIOPH RES CO, V382, P51, DOI 10.1016/j.bbrc.2009.02.131
   Bertolotti M, 2014, WORLD J GASTROENTERO, V20, P14185, DOI 10.3748/wjg.v20.i39.14185
   Carter S, 2013, CLIN INTERV AGING, V8, P829, DOI 10.2147/CIA.S36367
   Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200
   Côté I, 2012, CLIMACTERIC, V15, P594, DOI 10.3109/13697137.2011.637650
   Fishman S, 2007, FASEB J, V21, P53, DOI 10.1096/fj.06-6557com
   Frias JP, 2001, DIABETES, V50, P1344, DOI 10.2337/diabetes.50.6.1344
   Goodpaster BH, 2003, DIABETES CARE, V26, P372, DOI 10.2337/diacare.26.2.372
   Gunn PJ, 2016, CHRONOBIOL INT, V33, P39, DOI 10.3109/07420528.2015.1112396
   Guo KY, 2004, AM J PHYSIOL-REG I, V287, pR112, DOI 10.1152/ajpregu.00028.2004
   Hardy OT, 2012, CURR OPIN ENDOCRINOL, V19, P81, DOI 10.1097/MED.0b013e3283514e13
   HOSKER JP, 1985, DIABETOLOGIA, V28, P401, DOI 10.1007/BF00280882
   Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595
   Huan JN, 2003, J BIOL CHEM, V278, P45638, DOI 10.1074/jbc.M304165200
   Huynh FK, 2013, HEPATOLOGY, V57, P543, DOI 10.1002/hep.26043
   Karasek M, 2004, EXP GERONTOL, V39, P1723, DOI 10.1016/j.exger.2004.04.012
   Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021
   Kim SN, 2016, BIOL SEX DIFFER, V7, DOI 10.1186/s13293-016-0121-7
   KISSANE JM, 1958, J BIOL CHEM, V233, P184
   Kozak LP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011015
   KROTKIEWSKI M, 1983, J CLIN INVEST, V72, P1150, DOI 10.1172/JCI111040
   Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899
   Lee YH, 2014, BBA-MOL BASIS DIS, V1842, P358, DOI 10.1016/j.bbadis.2013.05.011
   Matafome P, 2014, ARCH PHYSIOL BIOCHEM, V120, P147, DOI 10.3109/13813455.2014.950590
   Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064
   Medrikova D, 2012, INT J OBESITY, V36, P262, DOI 10.1038/ijo.2011.87
   Nikonova L, 2008, FASEB J, V22, P3925, DOI 10.1096/fj.08-108266
   Oliver P, 2001, PFLUG ARCH EUR J PHY, V442, P383, DOI 10.1007/s004240100540
   Palou M, 2012, J NUTR BIOCHEM, V23, P1627, DOI 10.1016/j.jnutbio.2011.11.005
   Palou M, 2009, CELL PHYSIOL BIOCHEM, V24, P547, DOI 10.1159/000257511
   Paquette A, 2007, MATURITAS, V58, P182, DOI 10.1016/j.maturitas.2007.08.002
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Priego T, 2009, GENES NUTR, V4, P151, DOI 10.1007/s12263-009-0114-9
   Priego T, 2008, OBESITY, V16, P819, DOI 10.1038/oby.2007.117
   Priego T, 2009, HORM BEHAV, V55, P33, DOI 10.1016/j.yhbeh.2008.07.010
   Rodriguez A, 2005, METABOLISM, V54, P542, DOI 10.1016/j.metabol.2004.11.010
   Rosell M, 2014, AM J PHYSIOL-ENDOC M, V306, pE945, DOI 10.1152/ajpendo.00473.2013
   SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243
   Slawik M, 2006, AGEING RES REV, V5, P144, DOI 10.1016/j.arr.2006.03.004
   Stucchi P, 2011, BIOCHIMIE, V93, P1779, DOI 10.1016/j.biochi.2011.06.020
   Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x
   Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006
   Virtue S, 2008, PLOS BIOL, V6, P1819, DOI 10.1371/journal.pbio.0060237
   Völzke H, 2007, GUT, V56, P594, DOI 10.1136/gut.2006.115345
   Voigt A, 2013, MOL NUTR FOOD RES, V57, P1423, DOI 10.1002/mnfr.201200671
   Yamauchi T, 2013, CELL METAB, V17, P185, DOI 10.1016/j.cmet.2013.01.001
NR 49
TC 17
Z9 18
U1 0
U2 7
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-042X
J9 FRONT PHYSIOL
JI Front. Physiol.
PD JUL 11
PY 2017
VL 8
AR 445
DI 10.3389/fphys.2017.00445
PG 14
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA FA1AX
UT WOS:000405170800001
PM 28744221
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Bochkis, IM
   Przybylski, D
   Chen, J
   Regev, A
AF Bochkis, Irina M.
   Przybylski, Dariusz
   Chen, Jenny
   Regev, Aviv
TI Changes in Nucleosome Occupancy Associated with Metabolic Alterations in
   Aged Mammalian Liver
SO CELL REPORTS
LA English
DT Article
ID TRANSCRIPTION FACTOR-BINDING; SERUM RESPONSE FACTOR; GAMMA CONTRIBUTES;
   DNA-DAMAGE; PPAR-GAMMA; LAMIN A/C; HISTONE; EXPRESSION; RECEPTOR;
   HOMEOSTASIS
AB Aging is accompanied by physiological impairments, which, in insulin-responsive tissues, including the liver, predispose individuals to metabolic disease. However, the molecular mechanisms underlying these changes remain largely unknown. Here, we analyze genome-wide profiles of RNA and chromatin organization in the liver of young (3 months) and old (21 months) mice. Transcriptional changes suggest that derepression of the nuclear receptors PPAR alpha, PPAR gamma, and LXR alpha in aged mouse liver leads to activation of targets regulating lipid synthesis and storage, whereas age-dependent changes in nucleosome occupancy are associated with binding sites for both known regulators (forkhead factors and nuclear receptors) and candidates associated with nuclear lamina (Hdac3 and Srf) implicated to govern metabolic function of aging liver. Winged-helix transcription factor Foxa2 and nuclear receptor corepressor Hdac3 exhibit a reciprocal binding pattern at PPAR alpha targets contributing to gene expression changes that lead to steatosis in aged liver.
C1 [Bochkis, Irina M.; Przybylski, Dariusz; Chen, Jenny; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.
   [Chen, Jenny] MIT, Div Hlth Sci & Technol, Cambridge, MA 02142 USA.
   [Regev, Aviv] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA.
C3 Harvard University; Massachusetts Institute of Technology (MIT); Broad
   Institute; Massachusetts Institute of Technology (MIT); Massachusetts
   Institute of Technology (MIT); Howard Hughes Medical Institute
RP Bochkis, IM (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.
EM ibochkis@broadinstitute.org
RI Bochkis, Irina/AAR-8865-2020
OI Bochkis, Irina/0000-0001-8073-8408; Chen, Jenny/0000-0002-6664-2597
FU NHGRI CEGS [P50 HG006193]; HHMI; National Diabetes and Digestive and
   Kidney Diseases Institute K01 award [DK-101633]
FX We thank D. Thompson and R. Majovsky for critical reading of the
   manuscript and L. Gaffney, R. Raychowdhury, H. Whitton, and I. Wortman
   for technical assistance. This work was supported by NHGRI CEGS P50
   HG006193 and HHMI (A.R.). I.M.B. was supported by National Diabetes and
   Digestive and Kidney Diseases Institute K01 award DK-101633.
CR Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335
   Ballaré C, 2013, MOL CELL, V49, P67, DOI 10.1016/j.molcel.2012.10.019
   Bhaskara S, 2010, CANCER CELL, V18, P436, DOI 10.1016/j.ccr.2010.10.022
   Bochkis IM, 2008, NAT MED, V14, P828, DOI 10.1038/nm.1853
   Bochkis IM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002770
   Bochkis IM, 2013, MOL METAB, V2, P447, DOI 10.1016/j.molmet.2013.08.005
   Boergesen M, 2012, MOL CELL BIOL, V32, P852, DOI 10.1128/MCB.06175-11
   Celona B, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001086
   Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201
   Chen KF, 2013, GENOME RES, V23, P341, DOI 10.1101/gr.142067.112
   Ding W, 2001, J CELL SCI, V114, P1011
   Feser J, 2010, MOL CELL, V39, P724, DOI 10.1016/j.molcel.2010.08.015
   Fessler MB, 2009, CURR OPIN LIPIDOL, V20, P379, DOI 10.1097/MOL.0b013e32832fa5c4
   Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200
   Gong JY, 2009, CURR OPIN LIPIDOL, V20, P121, DOI 10.1097/MOL.0b013e328328d0bb
   Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001
   Hatta M, 2007, J BIOL CHEM, V282, P35583, DOI 10.1074/jbc.M704735200
   Henis-Korenblit S, 2010, P NATL ACAD SCI USA, V107, P9730, DOI 10.1073/pnas.1002575107
   Hillman-Jackson J., 2012, CURR PROTOC BIOINFOR, V5
   Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701
   Jin JL, 2011, HEPATOLOGY, V54, P989, DOI 10.1002/hep.24471
   Jin JL, 2010, AGING CELL, V9, P895, DOI 10.1111/j.1474-9726.2010.00617.x
   Kang MJ, 2005, BIOGERONTOLOGY, V6, P27, DOI 10.1007/s10522-004-7381-z
   Karakasilioti I, 2013, CELL METAB, V18, P403, DOI 10.1016/j.cmet.2013.08.011
   Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168
   Knutson SK, 2008, EMBO J, V27, P1017, DOI 10.1038/emboj.2008.51
   Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008
   Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li ZY, 2011, NAT STRUCT MOL BIOL, V18, P742, DOI 10.1038/nsmb.2060
   Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043
   Lund E, 2013, GENOME RES, V23, P1580, DOI 10.1101/gr.159400.113
   Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143
   McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630
   Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456
   Panasyuk G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1667
   Rakhshandehroo M, 2010, PPAR RES, V2010, DOI 10.1155/2010/612089
   Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Rodriguez A, 2007, J CLIN ENDOCR METAB, V92, P3568, DOI 10.1210/jc.2006-2764
   Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518
   Savage DB, 2009, DIS MODEL MECH, V2, P554, DOI 10.1242/dmm.002907
   Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168
   Schumacher B, 2009, MOL CELL ENDOCRINOL, V299, P112, DOI 10.1016/j.mce.2008.10.031
   Shackleton S, 2000, NAT GENET, V24, P153, DOI 10.1038/72807
   Sun K, 2009, HEPATOLOGY, V49, P1645, DOI 10.1002/hep.22834
   Sun Z, 2012, NAT MED, V18, P934, DOI 10.1038/nm.2744
   Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104
   Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861
   Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120
   Tropberger P, 2013, CELL, V152, P859, DOI 10.1016/j.cell.2013.01.032
   Umlauf David, 2004, Methods Mol Biol, V287, P99
   Vlieghe D, 2006, NUCLEIC ACIDS RES, V34, pD95, DOI 10.1093/nar/gkj115
   Willis-Martinez D, 2010, EXP GERONTOL, V45, P279, DOI 10.1016/j.exger.2009.10.001
   WORKMAN JL, 1992, SCIENCE, V258, P1780, DOI 10.1126/science.1465613
   Zambelli F, 2013, NUCLEIC ACIDS RES, V41, pW535, DOI 10.1093/nar/gkt448
NR 56
TC 54
Z9 59
U1 0
U2 6
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD NOV 6
PY 2014
VL 9
IS 3
BP 996
EP 1006
DI 10.1016/j.celrep.2014.09.048
PG 11
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA AS7ZI
UT WOS:000344470000022
PM 25437555
OA gold, Green Accepted, Green Published
DA 2024-02-19
ER

PT J
AU Lu, P
   Yan, M
   He, L
   Li, J
   Ji, YH
   Ji, JL
AF Lu, Peng
   Yan, Min
   He, Li
   Li, Jing
   Ji, Yuhua
   Ji, Juling
TI Crosstalk between Epigenetic Modulations in Valproic Acid Deactivated
   Hepatic Stellate Cells: An Integrated Protein and miRNA Profiling Study
SO INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES
LA English
DT Article
DE hepatic stellate cell; histone deacetylase inhibitor; valproic acid;
   miRNA; proteomics
ID HISTONE DEACETYLASE INHIBITOR; CANCER CELLS; ACTIVATION; SENESCENCE;
   APOPTOSIS; TARGET
AB Reverting activated hepatic stellate cells (HSCs) to less activation or quiescent status is a promising strategy for liver fibrosis. Histone deacetylase inhibitor (HDACI) could suppress HSCs activation. Our previous study demonstrated a critical role of miRNAs in HSCs activation. Here, we explored the involvement of miRNAs in HDACI induced HSCs deactivation. Human cell line LX2 that resembled activated HSCs was treated with an HDACI - valproic acid (VPA). The effects of VPA on the protein and miRNA profile of LX2 were comprehensively analyzed by iTraq quantitative proteomics and miRNA microarray. The interaction between miRNA and proteins was investigated systematically. The biofunctions of differentially expressed proteins and miRNA targeted proteins were annotated. VPA treatment attenuated the activation phenotype of LX2. In VPA treated LX2, among 1548 quantified proteins, only 86 proteins were differentially expressed (VPA-proteins). While among 282 high-abundance miRNAs, 123 were differentially expressed (VPA-miRNAs), with 104 down-regulated and 19 up-regulated. The top biofunctions of VPA-proteins were closely related to HSCs activation, including cell death and survival, cell movement, cellular growth and proliferation. Furthermore, 22 out of the 36 VPA-proteins involved in cell death and survival, and 19 out of the 30 VPA-proteins involved in cellular movement were predicted targets of VPA-miRNAs. A direct regulatory effect of histone acetylation on miRNA expression was also established. In conclusion, our data provided the molecular mechanisms for VPA induced HSCs deactivation at the protein level and suggested crosstalk between histone acetylation and miRNAs in the inhibitory effects of HDACI on HSCs activation.
C1 [Lu, Peng; Yan, Min; He, Li; Li, Jing; Ji, Juling] Nantong Univ, Dept Pathol, Med Sch, Nantong, Peoples R China.
   [Ji, Yuhua] Nantong Univ, Key Lab Neuroregenerat, Nantong, Peoples R China.
C3 Nantong University; Nantong University
RP Ji, JL (corresponding author), Nantong Univ, Dept Pathol, Med Sch, Nantong, Peoples R China.; Ji, YH (corresponding author), Nantong Univ, Key Lab Neuroregenerat, Nantong, Peoples R China.
EM jijuling@ntu.edu.cn; tjyh@ntu.edu.cn
RI Ji, Juling/AAT-2550-2021; Ji, Juling/AAU-1464-2020; Ji,
   Yuhua/GZL-8978-2022
OI Ji, Juling/0000-0001-6500-8052; Ji, Juling/0000-0001-6500-8052; Ji,
   Yuhua/0000-0002-6127-7287
FU National Natural Science Foundation of China [81761128018, 81572871,
   81141048, 81272027]; Natural Science Foundation of Jiangsu Province
   [BK20151277]
FX This research is supported by grants from the National Natural Science
   Foundation of China, No. 81761128018, 81572871 and 81141048 to JJL, No.
   81272027 to JYH, Natural Science Foundation of Jiangsu Province, No.
   BK20151277 to JJL. The funders had no role in study design, data
   collection, and analysis, decision to publish, or preparation of the
   manuscript.
CR Alarcón CR, 2015, CELL, V162, P1299, DOI 10.1016/j.cell.2015.08.011
   Armeanu S, 2005, J HEPATOL, V42, P210, DOI 10.1016/j.jhep.2004.10.020
   Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053
   Friedman SL, 2003, J HEPATOL, V38, pS38, DOI 10.1016/S0168-8278(02)00429-4
   Friedman SL, 2004, HEPATOLOGY, V40, P1041, DOI 10.1002/hep.20476
   Geerts A, 2001, SEMIN LIVER DIS, V21, P311, DOI 10.1055/s-2001-17550
   Guo CJ, 2009, J HEPATOL, V50, P766, DOI 10.1016/j.jhep.2008.11.025
   Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485
   He YW, 2009, CELL MOL LIFE SCI, V66, P1239, DOI 10.1007/s00018-008-8532-1
   Ji JL, 2012, HEPATOLOGY, V56, P332, DOI 10.1002/hep.25650
   Ji JL, 2009, FEBS LETT, V583, P759, DOI 10.1016/j.febslet.2009.01.034
   Ji YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108351
   Jin H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.92
   Krämer OH, 2003, EMBO J, V22, P3411, DOI 10.1093/emboj/cdg315
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   MACDONALD RL, 1993, EPILEPSIA, V34, pS1, DOI 10.1111/j.1528-1157.1993.tb05918.x
   Mann J, 2007, CELL DEATH DIFFER, V14, P275, DOI 10.1038/sj.cdd.4401979
   Mannaerts I, 2010, HEPATOLOGY, V51, P603, DOI 10.1002/hep.23334
   Mawatari T, 2015, INT J ONCOL, V47, P2073, DOI 10.3892/ijo.2015.3213
   Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823
   Mottamal M, 2015, MOLECULES, V20, P3898, DOI 10.3390/molecules20033898
   Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052
   Niki T, 1999, HEPATOLOGY, V29, P858, DOI 10.1002/hep.510290328
   Nilubol N, 2017, CLIN ENDOCRINOL, V86, P128, DOI 10.1111/cen.13154
   Paronetto MP, 2007, J CELL BIOL, V176, P929, DOI 10.1083/jcb.200701005
   Prince HM, 2009, CLIN CANCER RES, V15, P3958, DOI 10.1158/1078-0432.CCR-08-2785
   Rocca A, 2009, BRIT J CANCER, V100, P28, DOI 10.1038/sj.bjc.6604817
   Scott GK, 2006, CANCER RES, V66, P1277, DOI 10.1158/0008-5472.CAN-05-3632
   Treiber T, 2017, MOL CELL, V66, P270, DOI 10.1016/j.molcel.2017.03.014
   Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980
   Yauk CL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-330
   Yu XD, 2002, J NATL CANCER I, V94, P504
NR 33
TC 8
Z9 8
U1 3
U2 10
PU IVYSPRING INT PUBL
PI LAKE HAVEN
PA PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA
SN 1449-2288
J9 INT J BIOL SCI
JI Int. J. Biol. Sci.
PY 2019
VL 15
IS 1
BP 93
EP 104
DI 10.7150/ijbs.28642
PG 12
WC Biochemistry & Molecular Biology; Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA HE3LU
UT WOS:000453258300009
PM 30662350
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Tian, L
   Li, CM
   Li, YF
   Huang, TM
   Chao, NX
   Luo, GR
   Mo, FR
AF Tian Lin
   Li Chun-Mei
   Li Yan-Fei
   Huang Tian-Ming
   Chao Nai-Xia
   Luo Guo-Rong
   Mo Fa-Rong
TI Laminarin from Seaweed (<i>Laminaria japonica</i>) Inhibits
   Hepatocellular Carcinoma Through Upregulating Senescence Marker
   Protein-30
SO CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
LA English
DT Article
DE antitumor; apoptosis; hepatocellular carcinoma; laminarin;
   proliferation; senescence marker protein-30
ID HEPATITIS-B-VIRUS; APOPTOSIS; INDUCTION; CELLS
AB Objective: This study aimed at investigating the specific roles of laminarin from seaweed (Laminaria japonica) in hepatocellular carcinoma (HCC) and its potential mechanisms related to senescence marker protein-30 (SMP-30).
   Materials and Methods: Human HCC cell lines, including Bel-7404 and HepG2, were incubated with different concentrations of laminarin (0, 5, 15, 25, 35, and 45 mg/mL). The cell viability and apoptosis rates were detected by WST-8 cell proliferation assay and flow cytometry, respectively. Hepa 1-6 tumor-bearing mice were injected with different concentrations of laminarin (400, 800, and 1200 mg/kg center dot d), and tumor volume and weight were measured. The expression of SMP-30 was detected in laminarin-treated Bel-7404 and HepG2 HCC cells and LO2 normal liver cells by quantitative real-time PCR and Western blotting.
   Results: The treatment with laminarin (48 h) significantly decreased the viability and increased the apoptosis rates of Bel-7404 and HepG2 cells in a dose-dependent manner. The injection of laminarin also significantly decreased the tumor volumes (beginning on the 10th day) and tumor weights (30 d post-injection) of mice in a dose-dependent manner. In addition, the treatment with laminarin (35 mg/mL for 48 h) significantly upregulated SMP-30 in Bel-7404 and HepG2 cells but not in LO2 cells.
   Conclusion: Laminarin inhibited the proliferation of Bel-7404 and HepG2 cells and inhibited the growth of tumors in Hepa 1-6 tumor-bearing mice by upregulating SMP-30.
C1 [Tian Lin; Li Chun-Mei; Li Yan-Fei; Huang Tian-Ming; Chao Nai-Xia; Luo Guo-Rong; Mo Fa-Rong] Guangxi Med Univ, Sch Preclin Med, Shuangyong Rd 22, Nanning 530021, Peoples R China.
   [Tian Lin] Hubei Minzu Univ, Coll Sci & Technol, Enshi, Peoples R China.
   [Li Chun-Mei] Guilin Med Univ, Affiliated Hosp, Lab Hepatobiliary & Pancreat Surg, Guilin, Peoples R China.
   [Luo Guo-Rong; Mo Fa-Rong] Guangxi Med Univ, Guangxi Coll & Univ Key Lab Human Dev & Dis Res, Nanning, Peoples R China.
C3 Guangxi Medical University; Hubei Minzu University; Guilin Medical
   University; Guangxi Medical University
RP Mo, FR (corresponding author), Guangxi Med Univ, Sch Preclin Med, Shuangyong Rd 22, Nanning 530021, Peoples R China.
EM farongmo@126.com
FU Natural Science Foundation of Guangxi [2016GXNSFAA380267, 2017GXNSFA
   A198079, 2018GXNSFAA281071, 2018GXNSFAA13 8144]; Guangxi First-class
   Discipline Project for Basic Medicine Sciences [GXFCDP-BMS-2018]
FX This work was supported by the Natural Science Foundation of Guangxi
   (2016GXNSFAA380267, 2017GXNSFA A198079, 2018GXNSFAA281071, and
   2018GXNSFAA13 8144) and the Guangxi First-class Discipline Project for
   Basic Medicine Sciences (GXFCDP-BMS-2018).
CR Dhir M, 2016, ANN SURG, V263, P1112, DOI 10.1097/SLA.0000000000001556
   Fu JL, 2014, HEPATOL INT, V8, P1, DOI 10.1007/s12072-013-9493-5
   Fullerton SA, 2000, MOL UROL, V4, P7
   Han YF, 2011, WORLD J GASTROENTERO, V17, P4258, DOI 10.3748/wjg.v17.i38.4258
   Ji CF, 2014, ONCOL LETT, V7, P1728, DOI 10.3892/ol.2014.1952
   Ji YB, 2012, MOLECULES, V17, P9947, DOI 10.3390/molecules17089947
   Kawada M, 2018, J ANTIBIOT, V71, P39, DOI 10.1038/ja.2017.97
   KOJIMAYUASA A, 2015, CARCINOMA DIS, V3, P260, DOI DOI 10.3390/DISEASES304026028943624
   Kondo Y, 2016, GERIATR GERONTOL INT, V16, P4, DOI 10.1111/ggi.12722
   Lamarca A, 2016, CRIT REV ONCOL HEMAT, V105, P65, DOI 10.1016/j.critrevonc.2016.06.007
   Lee LJH, 2007, J SURG ONCOL, V95, P34, DOI 10.1002/jso.20374
   Menshova RV, 2014, CARBOHYD POLYM, V99, P101, DOI 10.1016/j.carbpol.2013.08.037
   Mo L, 2017, INT J BIOL MACROMOL, V95, P385, DOI 10.1016/j.ijbiomac.2016.10.106
   Mo ZJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep39376
   Nishijima K, 2017, J NUTR HEALTH AGING, V21, P573, DOI 10.1007/s12603-016-0841-8
   Park HK, 2013, INT J MOL MED, V32, P291, DOI 10.3892/ijmm.2013.1409
   Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013
   Singal AG, 2013, AM J GASTROENTEROL, V108, P425, DOI 10.1038/ajg.2012.449
   Xu H, 2017, ONCOTARGET, V8, P86693, DOI 10.18632/oncotarget.21411
   Zhang SC, 2014, ASIAN PAC J CANCER P, V15, P1193, DOI 10.7314/APJCP.2014.15.3.1193
   Zvyagintseva TN, 2000, COMP BIOCHEM PHYS C, V126, P209, DOI 10.1016/S0742-8413(00)00114-6
NR 21
TC 16
Z9 17
U1 4
U2 19
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1084-9785
EI 1557-8852
J9 CANCER BIOTHER RADIO
JI Cancer Biother. Radiopharm.
PD MAY 1
PY 2020
VL 35
IS 4
BP 277
EP 283
DI 10.1089/cbr.2019.3179
PG 7
WC Oncology; Medicine, Research & Experimental; Pharmacology & Pharmacy;
   Radiology, Nuclear Medicine & Medical Imaging
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Research & Experimental Medicine; Pharmacology & Pharmacy;
   Radiology, Nuclear Medicine & Medical Imaging
GA LN0SC
UT WOS:000532654400004
PM 32159381
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU Li, N
   Muthusamy, S
   Liang, RQ
   Sarojini, H
   Wang, E
AF Li, Na
   Muthusamy, Senthilkumar
   Liang, Ruiqiang
   Sarojini, Harshini
   Wang, Eugenia
TI Increased expression of miR-34a and miR-93 in rat liver during aging,
   and their impact on the expression of Mgst1 and Sirt1
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE microRNA; Aging; Liver; Sirt1; Mgst1
ID GLUTATHIONE-S-TRANSFERASE; OXIDATIVE STRESS; MICRORNA EXPRESSION; CELL;
   SP1; TRANSCRIPTION; INHIBITION; ACTIVATION; APOPTOSIS; PROTECTS
AB Age-dependent loss of oxidative defense is well recognized in rodent models, although the control mechanism is still obscure; a few studies have shown how microRNAs, a non-coding RNA species, regulate the expression of their target genes at the post-transcriptional level. In the current study, miR-34a and miR-93 are observed to increase in middle- and old-age rat liver, compared to young rats; the up-regulation of these two miRNAs is determined by qPCR through a grind-and-find approach, and histochemical in situ hybridization. Three commonly used miRNA target prediction programs suggest four candidate targets of miR-34a and miR-93: Sp1, Nrf2 (Nfe212), Sirt1 and Mgst1; their expression is found to be reduced inversely to the up-regulation of the two miRNAs by Western blotting of protein extracts, as well as immunofluorescence staining of intact liver tissues. Furthermore, the suppression of the four proteins by miR-34a/miR-93 is examined in HEK 293 cells by transfection and co-transfection; miR-34a represses all four proteins' expression, whereas miR-93 affects only Sp1,Sirt1 and Mgst1. Taken together, our study suggests a model of post-transcriptional repression, not only of genes involved in oxidative stress regulation and oxidative stress defense proteins, such as Sirt1 and Mgst1, but also of upstream transcription factors (TFs) regulating their activation, since Sp1 is the TF for both Sirt1 and Mgst1, and Nrf2 is the TF of Mgst1. Thus, up-regulation of both miR-34a and miR-93 constitutes an inescapable repression of two vital oxidative defense genes, by targeting not only the targets, but also transcription factors controlling their activation, a double dampening regulation at the post-transcriptional level. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
C1 [Li, Na; Muthusamy, Senthilkumar; Liang, Ruiqiang; Sarojini, Harshini; Wang, Eugenia] Univ Louisville, Sch Med, Dept Biochem & Mol Biol, Louisville, KY 40202 USA.
   [Li, Na; Muthusamy, Senthilkumar; Liang, Ruiqiang; Sarojini, Harshini; Wang, Eugenia] Univ Louisville, Sch Med, Gheens Ctr Aging, Louisville, KY 40202 USA.
C3 University of Louisville; University of Louisville
RP Wang, E (corresponding author), Univ Louisville, Sch Med, Dept Biochem & Mol Biol, 580 S Preston St, Louisville, KY 40202 USA.
EM Eugenia.Wang@Louisville.edu
RI Sarojini, Harshini/AAD-4870-2019; Muthusamy, Senthilkumar/G-7875-2015;
   Liang, Ruqiang/C-2326-2013; Muthusamy, Senthilkumar/Y-1353-2018
OI Sarojini, Harshini/0000-0002-3103-9712; Muthusamy,
   Senthilkumar/0000-0003-1603-9965; Liang, Ruqiang/0000-0002-3075-4554
FU U.S. National Aeronautics and Space Administration (NASA) [NNX08AP23G]
FX This work is supported by grant NNX08AP23G from the U.S. National
   Aeronautics and Space Administration (NASA) to E.W. The authors would
   like to thank Mr. Alan N. Bloch and Ms. Viktoriya Shekhovtsova for
   proofreading the manuscript, as well as Patrick R. Lyninger for
   computational services and Viktoriya Shekhovtsova for technical
   services.
CR ANDERSSON C, 1994, BBA-PROTEIN STRUCT M, V1204, P298, DOI 10.1016/0167-4838(94)90021-3
   Bates DJ, 2010, AGING CELL, V9, P1, DOI 10.1111/j.1474-9726.2009.00529.x
   Caito S, 2010, BIOCHEM BIOPH RES CO, V392, P264, DOI 10.1016/j.bbrc.2009.12.161
   Ciaudo C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000620
   de Jong Rob N., 2006, Journal of Structural and Functional Genomics, V7, P109, DOI 10.1007/s10969-006-9014-z
   Drummond MJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE1333, DOI 10.1152/ajpendo.90562.2008
   Ekström L, 2003, BBA-GENE STRUCT EXPR, V1627, P79, DOI 10.1016/S0167-4781(03)00077-0
   Finkel T, 2005, NAT REV MOL CELL BIO, V6, P971, DOI 10.1038/nrm1763
   Guo CJ, 2009, J HEPATOL, V50, P766, DOI 10.1016/j.jhep.2008.11.025
   Hanlon K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007169
   Hasegawa K, 2008, BIOCHEM BIOPH RES CO, V372, P51, DOI 10.1016/j.bbrc.2008.04.176
   Hasegawa K, 2010, J BIOL CHEM, V285, P13045, DOI 10.1074/jbc.M109.067728
   Kaddar T, 2009, BIOL CELL, V101, P511, DOI 10.1042/BC20080213
   Kelner MJ, 2000, J BIOL CHEM, V275, P13000, DOI 10.1074/jbc.275.17.13000
   Knight TR, 2008, TOXICOL SCI, V106, P329, DOI 10.1093/toxsci/kfn179
   Lee J, 2010, J BIOL CHEM, V285, P12604, DOI 10.1074/jbc.M109.094524
   Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010
   LI N, NEUROBIOL A IN PRESS
   Maeda A, 2005, BIOCHEMISTRY-US, V44, P480, DOI 10.1021/bi048016f
   Maes OC, 2008, MECH AGEING DEV, V129, P534, DOI 10.1016/j.mad.2008.05.004
   Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506
   Oh JE, 2007, BIOCHEM BIOPH RES CO, V353, P86, DOI 10.1016/j.bbrc.2006.11.118
   Okazaki M, 2010, ENDOCR J, V57, P403, DOI 10.1507/endocrj.K10E-004
   Pan YZ, 2009, DRUG METAB DISPOS, V37, P2112, DOI 10.1124/dmd.109.027680
   Shimoji M, 1996, BIOL PHARM BULL, V19, P209
   Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101
   Tsang WP, 2010, J NUTR BIOCHEM, V21, P140, DOI 10.1016/j.jnutbio.2008.12.003
   Ungvari Z, 2009, AM J PHYSIOL-HEART C, V297, pH1876, DOI 10.1152/ajpheart.00375.2009
   Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003
   Yu CH, 2009, DIGEST DIS SCI, V54, P2362, DOI 10.1007/s10620-008-0629-8
NR 30
TC 169
Z9 192
U1 1
U2 21
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD MAR
PY 2011
VL 132
IS 3
BP 75
EP 85
DI 10.1016/j.mad.2010.12.004
PG 11
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 751FZ
UT WOS:000289604200001
PM 21216258
DA 2024-02-19
ER

PT J
AU Kuai, Z
   Chao, X
   He, YT
   Ren, WY
AF Kuai, Zheng
   Chao, Xin
   He, Yuting
   Ren, Weiying
TI Metformin attenuates inflammation and boosts autophagy in the liver and
   intestine of chronologically aged rats
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Autophagy; Aging; Metformin; Pro-inflammatory cytokines; AMPK
ID ACTIVATED PROTEIN-KINASE; TARGETING SENESCENT CELLS; BARRIER
   DYSFUNCTION; PHOSPHORYLATION; INHIBITION; INJURY; ULK1
AB Background: Our previous studies found that autophagy levels in liver and intestinal segments of naturally aging rats were downregulated, and the expression of pro-inflammatory factors was increased. The increased expression of pro-inflammatory factors might be related to the downregulation of autophagy. AMPK is the most critical upstream targeting and regulating molecule of autophagy, and Metformin, as an agonist of AMPK, has the effects of anti-inflammation and anti-aging. We pretreated 29-month-old naturally aging rats with Metformin for a short period and observed the changes in autophagy levels and pro-inflammatory factors in the liver, ileum, and colon after 31 days of intervention and preliminarily investigated the mechanism of its action. Methods: 29-month-old SPF male Wistar rats were divided into three groups: The control group, the Metformin 100 mg/kg intervention group, and the Metformin 250 mg/kg intervention group, with eight rats in each group. At 29 months, different concentrations of Metformin (100 mg/kg, 250 mg/kg) were given by gavage once a day until 30 months, and the control group was kept generally until 30 months. Western Blot was used to assess the expression levels of AMPK, P-AMPK, LC3, and P62 proteins in the liver and intestinal tissues. Intestinal and liver tissues were immunofluorescence labeled for LC3 and P62 proteins. Moreover, RT-qPCR was conducted to detect the expression levels of pro-inflammatory factors IL-1 beta, TNF-alpha, IL-6, and MMP-9 mRNA in liver and intestinal tissues. Results: Short-term Metformin pretreatment (31 days) in naturally aging rats (29 months old) increased autophagy levels and down-regulated the expression of various pro-inflammatory cytokines (IL-1 beta, TNF-alpha, MMP-9, and IL-6) in various intestinal segments and the liver-the expression of LC3II protein enriched with the increase of Metformin concentration. The level of P62 protein decreased with the accumulation of Metformin concentration. And a higher concentration of Metformin was associated with increased expression of P-AMPK protein. Conclusions: Metformin intervention can boost the autophagy level in the liver and intestine and reduce the expression of aging-related inflammatory factors in aged rats, and these effects may be related to the increase of the AMPK phosphorylation level.
C1 [Kuai, Zheng; Chao, Xin; He, Yuting; Ren, Weiying] Fudan Univ, Zhongshan Hosp, Dept Geriatr, Shanghai 200032, Peoples R China.
C3 Fudan University
RP Ren, WY (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Geriatr, Shanghai 200032, Peoples R China.
EM Ren.weiying@zs-hospital.sh.cn
CR Cameron AR, 2016, CIRC RES, V119, P652, DOI 10.1161/CIRCRESAHA.116.308445
   Campisi J, 2019, NATURE, V571, P183, DOI 10.1038/s41586-019-1365-2
   Carmona-Gutierrez D, 2016, AGEING RES REV, V32, P2, DOI 10.1016/j.arr.2016.04.009
   Machado MCC, 2016, CURR PHARM DESIGN, V22, P4645, DOI 10.2174/1381612822666160510125331
   Chang NTC, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00138
   Chao X., 2020, Geriatr. Health Care, V26, P493
   Chen S, 2022, THERANOSTICS, V12, P2722, DOI 10.7150/thno.71360
   Deng J, 2018, J CELL MOL MED, V22, P546, DOI 10.1111/jcmm.13342
   Fernández AF, 2018, NATURE, V558, P136, DOI 10.1038/s41586-018-0162-7
   Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671
   Fu L, 2016, BRAIN RES, V1650, P103, DOI 10.1016/j.brainres.2016.08.035
   Garg G, 2017, REJUV RES, V20, P173, DOI 10.1089/rej.2016.1883
   Garg G, 2017, REJUV RES, V20, P16, DOI 10.1089/rej.2016.1826
   Gasek NS, 2021, NATURE AGING, V1, P870, DOI 10.1038/s43587-021-00121-8
   Gormsen LC, 2016, J NUCL MED, V57, P1920, DOI 10.2967/jnumed.116.177774
   Graham GG, 2011, CLIN PHARMACOKINET, V50, P81, DOI 10.2165/11534750-000000000-00000
   Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003
   Hasanvand A, 2022, INFLAMMOPHARMACOLOGY, V30, P775, DOI 10.1007/s10787-022-00980-6
   Horiuchi T, 2017, J BIOL CHEM, V292, P8436, DOI 10.1074/jbc.M116.769380
   Kavanagh K, 2019, GEROSCIENCE, V41, P923, DOI 10.1007/s11357-019-00112-z
   Kim JW, 2022, KOREAN J INTERN MED, V37, P13, DOI 10.3904/kjim.2021.363
   Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026
   Li YJ, 2019, ADV EXP MED BIOL, V1206, P85, DOI 10.1007/978-981-15-0602-4_4
   López-Otin C, 2023, CELL, V186, P243, DOI 10.1016/j.cell.2022.11.001
   Mallik R, 2018, DIABETES RES CLIN PR, V143, P409, DOI 10.1016/j.diabres.2018.05.023
   Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192
   McCreight LJ, 2016, DIABETOLOGIA, V59, P426, DOI 10.1007/s00125-015-3844-9
   Ravanan P, 2017, LIFE SCI, V188, P53, DOI 10.1016/j.lfs.2017.08.029
   Rena G, 2017, DIABETOLOGIA, V60, P1577, DOI 10.1007/s00125-017-4342-z
   Rera M, 2012, P NATL ACAD SCI USA, V109, P21528, DOI 10.1073/pnas.1215849110
   Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757
   Saavedra D, 2023, IMMUN AGEING, V20, DOI 10.1186/s12979-023-00352-w
   Shen PP, 2017, J NEUROCHEM, V140, P799, DOI 10.1111/jnc.13922
   Song Q, 2020, CELL BIOSCI, V10, DOI 10.1186/s13578-020-00467-3
   Sun LL, 2018, NAT MED, V24, P1919, DOI 10.1038/s41591-018-0222-4
   Tao Rong, 2010, J Mol Signal, V5, P1, DOI 10.1186/1750-2187-5-1
   Tian WL, 2015, FEBS LETT, V589, P1847, DOI 10.1016/j.febslet.2015.05.020
   Vellai T, 2009, TRENDS CELL BIOL, V19, P487, DOI 10.1016/j.tcb.2009.07.007
   von Kobbe C, 2019, AGING-US, V11, P12844, DOI 10.18632/aging.102557
   Wataya-Kaneda M, 2015, J DERMATOL SCI, V79, P93, DOI 10.1016/j.jdermsci.2015.04.005
   Wu WC, 2018, MOL PHARMACEUT, V15, P3272, DOI 10.1021/acs.molpharmaceut.8b00332
   Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505
NR 42
TC 0
Z9 0
U1 3
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD DEC
PY 2023
VL 184
AR 112331
DI 10.1016/j.exger.2023.112331
EA NOV 2023
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA Z8GW6
UT WOS:001114414300001
PM 37967593
OA hybrid
DA 2024-02-19
ER

PT J
AU Aoki, K
   Nakajima, A
   Mukasa, K
   Osawa, E
   Mori, Y
   Sekihara, H
AF Aoki, K
   Nakajima, A
   Mukasa, K
   Osawa, E
   Mori, Y
   Sekihara, H
TI Prevention of diabetes, hepatic injury, and colon cancer with
   dehydroepiandrosterone
SO JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
LA English
DT Article; Proceedings Paper
CT 11th International Congress on Hormonal Steroids/7th International
   Congress on Hormones and Cancer
CY OCT 21-25, 2002
CL FUKUOKA, JAPAN
DE dehydroepiandrosterone (DHEA); diabetes; troglitazone
ID C57BL/KSJ-DB/DB MICE; INSULIN SENSITIVITY; MESSENGER-RNA; DHEA; RATS;
   SULFATE; GLUCOSE-6-PHOSPHATASE; HYPERINSULINEMIA; TROGLITAZONE;
   SUPPRESSES
AB The levels of dehydroepiandrosterone (DHEA) and its sulfate (DHEA-S) peak in human in their twenties, then decrease gradually with age. The physiological importance of DHEA was not clear until recent research reports showing that DHEA has beneficial effects on preventing diabetes, malignancy, inflammation, osteoporosis, and collagen disease. We summarize our results concerning diabetes, hepatitis, and colon cancer.
   In 1982, Coleman et al. [Diabetes 31 (1982) 830] reported that DHEA decreased hyperglycemia in diabetic db/db mice, which become insulin resistant. We measured hepatic gluconeogenic enzymes in an attempt to elucidate the mechanical mechanism of DHEA action. The activity and gene expression of hepatic gluconeogenic enzyme such as glucose-6-phosphatase (G6Pase) was increased in db/db mice despite hyperinsulinemia compared to control db/+m mice. DHEA, like troglitazone, decreased these levels in db/db mice. We also showed that DHEA improved the insulin resistance caused by aging or obesity using the glucose clamp technique in another animal model. In humans, the serum DHEA concentration was shown to be associated with hyperinsulinemia in diabetes. It also became clear that DHEA increased insulin secretion in old-aged db/db mice. DHEA increases not only insulin sensitivity due to the effects in the liver and muscle, but also insulin secretion.
   As an effect of DHEA on T-cell mediated hepatitis induced by concanavalin A (ConA), DHEA reduced hepatic injury by inhibiting several inflammatory mediators and apoptosis. As an effect of DHEA on carcinogenesis, DHEA would be a potential chemopreventative agent against colon cancer because it decreases the number of azoxymethane (AOM) induced aberrant crypt foci, which is a possible precursor to adenoma and cancer in a murine model.
   Thus, since DHEA has many beneficial effects experimentally, we should consider administration of DHEA in the future, and common mechanisms among these actions of DHEA should be elucidated in further studies. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Yokohama City Univ, Sch Med, Dept Internal Med 3, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan.
C3 Yokohama City University
RP Aoki, K (corresponding author), Yokohama City Univ, Sch Med, Dept Internal Med 3, Kanazawa Ku, 3-9 Fuku Ura, Yokohama, Kanagawa 2360004, Japan.
CR Aoki K, 1999, DIABETES, V48, P1579, DOI 10.2337/diabetes.48.8.1579
   Aoki K, 2001, LIFE SCI, V69, P2543, DOI 10.1016/S0024-3205(01)01328-5
   Aoki K, 2000, ENDOCR J, V47, P799, DOI 10.1507/endocrj.47.799
   COLEMAN DL, 1984, DIABETES, V33, P26, DOI 10.2337/diabetes.33.1.26
   COLEMAN DL, 1982, DIABETES, V31, P830, DOI 10.2337/diabetes.31.9.830
   Dillon JS, 2000, DIABETES, V49, P2012, DOI 10.2337/diabetes.49.12.2012
   FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908
   GUNNARSSON R, 1975, DIABETOLOGIA, V11, P431, DOI 10.1007/BF00429912
   Ishizawa M, 2001, COMP BIOCHEM PHYS B, V130, P359, DOI 10.1016/S1096-4959(01)00444-4
   Kimura M, 1998, ENDOCRINOLOGY, V139, P3249, DOI 10.1210/en.139.7.3249
   Ladriere L, 1997, CELL BIOCHEM FUNCT, V15, P287, DOI 10.1002/(SICI)1099-0844(199712)15:4<287::AID-CBF753>3.0.CO;2-X
   Lasco A, 2001, EUR J ENDOCRINOL, V145, P457, DOI 10.1530/eje.0.1450457
   MCINTOSH MK, 1991, J NUTR, V121, P2037, DOI 10.1093/jn/121.12.2037
   Mukasa K, 1998, J STEROID BIOCHEM, V67, P355, DOI 10.1016/S0960-0760(98)00126-5
   NESTLER JE, 1995, J CLIN ENDOCR METAB, V80, P700, DOI 10.1210/jc.80.2.700
   NESTLER JE, 1987, J CLIN ENDOCR METAB, V64, P180, DOI 10.1210/jcem-64-1-180
   NYCE JW, 1984, CARCINOGENESIS, V5, P57, DOI 10.1093/carcin/5.1.57
   Osawa E, 2002, LIFE SCI, V70, P2623, DOI 10.1016/S0024-3205(02)01521-7
   PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321
   Yamaguchi Y, 1998, CLIN ENDOCRINOL, V49, P377, DOI 10.1046/j.1365-2265.1998.00533.x
   YOSHIDA S, 2001, P END SOC 83 ANN M P, P422
NR 21
TC 27
Z9 31
U1 0
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-0760
J9 J STEROID BIOCHEM
JI J. Steroid Biochem. Mol. Biol.
PD JUN
PY 2003
VL 85
IS 2-5
BP 469
EP 472
DI 10.1016/S0960-0760(03)00219-X
PG 4
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 724NM
UT WOS:000185493700046
PM 12943737
DA 2024-02-19
ER

PT J
AU Park, JK
   Jeong, DH
   Park, HY
   Son, KH
   Shin, DH
   Do, SH
   Yang, HJ
   Yuan, DW
   Hong, IH
   Goo, MJ
   Lee, HR
   Ki, MR
   Ishigami, A
   Jeong, KS
AF Park, Jin-Kyu
   Jeong, Da-Hee
   Park, Ho-Yong
   Son, Kwang-Hee
   Shin, Dong-Ha
   Do, Sun-Hee
   Yang, Hai-Jie
   Yuan, Dong-Wei
   Hong, Il-Hwa
   Goo, Moon-Jung
   Lee, Hye-Rim
   Ki, Mi-Ran
   Ishigami, Akihito
   Jeong, Kyu-Shik
TI Hepatoprotective effect of <i>Arazyme</i> on CCl<sub>4</sub>-induced
   acute hepatic injury in SMP30 knock-out mice
SO TOXICOLOGY
LA English
DT Article
DE Arazyme; SMP30; hepatoprotective effect; proteome; antioxidant protein
ID MARKER PROTEIN-30 SMP30; NITRIC-OXIDE SYNTHASE; RAT-LIVER INJURY;
   OXIDATIVE STRESS; CARBON-TETRACHLORIDE; STELLATE CELLS; FREE-RADICALS;
   EXPRESSION; ACID; APOPTOSIS
AB Arazyme is a novel protease produced by the HY-3 strain of Aranicola proteolyticus, which is a Gram-negative aerobic bacterium that has been isolated from the intestine of the spider Nephila clavata. This study focused on the hepatoprotective effect of Arazyme on carbon tetrachloride (CCl4)-induced acute hepatic injury in senescence marker protein 30 (SMP30) knock-out (KO) mice and SMP30 wild-type (WT) mice. WT mice and SMP30 KO mice were divided into eight groups as follows: (i) two negative control groups (G1, G5) which were treated with a single intraperitoneal (i.p.) olive oil injection. (ii) Two positive control groups (G2, G6) which received a single i.p. CCl4 (0.4 mL/kg) injection. (iii) Two vitamin C-treated groups (G3, G7) which received a single oral administration of vitamin C (100 mg/kg) and were injected with a single i.p. CCl4 (0.4 mL/kg). (iv) Two Arazyme-treated groups (G4, G8) which received a single oral administration of Arazyme (500 mg/kg) and were injected with a single i.p. CCl4 (0.4 mL/kg). Through present study, we could find that Arazyme-treated groups showed decreased degree of liver injury, increased expression of SMP30, decreased expression of phospho-Smad3 (p-Smad3), elevated expression of antioxidant proteins including sorbitol dehydrogenase, dihydropteridine reductase (DHPR), dehydrofolate reductase (DHFR), NADH dehydrogenase, glutathione S-transferase kappa I (GSTK1) and phospholipid hydroperoxide glutathione peroxidase (PHGPx) compared with non-Arazyme-treated groups. Therefore, it is concluded that Arazyme plays a significant role in protecting injured hepatocytes by increasing the expression of SMP30, inhibiting the transforming growth factor-beta (TGF-beta)/Smad pathway and elevating the expression of antioxidant proteins. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
C1 [Park, Jin-Kyu; Jeong, Da-Hee; Yang, Hai-Jie; Yuan, Dong-Wei; Hong, Il-Hwa; Goo, Moon-Jung; Lee, Hye-Rim; Ki, Mi-Ran; Jeong, Kyu-Shik] Kyungpook Natl Univ, Coll Vet Med, Dept Pathol, Taegu 702701, South Korea.
   [Park, Ho-Yong; Son, Kwang-Hee] Korea Res Inst Biosci & Biotechnol, Taejon 305333, South Korea.
   [Shin, Dong-Ha] Insect Biotech Co Ltd, Taejon 305811, South Korea.
   [Do, Sun-Hee] Konkuk Univ, Coll Vet Med, Dept Clin Pathol, Seoul 143701, South Korea.
   [Ishigami, Akihito] Tokyo Metropolitan Inst Gerontol, Tokyo 1730015, Japan.
C3 Kyungpook National University; Korea Research Institute of Bioscience &
   Biotechnology (KRIBB); Konkuk University; Konkuk University Medical
   Center; Tokyo Metropolitan Institute of Gerontology
RP Jeong, KS (corresponding author), Kyungpook Natl Univ, Coll Vet Med, Dept Pathol, Taegu 702701, South Korea.
EM jeongks@knu.ac.kr
RI PARK, HO-YONG/AAP-2225-2021
OI Do, Sun Hee/0000-0003-2372-5269; Ishigami, Akihito/0000-0001-7875-7482
CR Albano E, 2002, FREE RADICAL BIO MED, V32, P110, DOI 10.1016/S0891-5849(01)00773-0
   ANTUNES F, 1995, FREE RADICAL BIO MED, V19, P669, DOI 10.1016/0891-5849(95)00040-5
   Bersanetti PA, 2005, ENZYME MICROB TECH, V37, P574, DOI 10.1016/j.enzmictec.2005.01.041
   Bilska A, 2007, NEUROSCIENCE, V146, P1758, DOI 10.1016/j.neuroscience.2007.04.002
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Buettner GR, 1996, RADIAT RES, V145, P532, DOI 10.2307/3579271
   BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074
   Chalupsky K, 2005, P NATL ACAD SCI USA, V102, P9056, DOI 10.1073/pnas.0409594102
   Date M, 2000, GUT, V46, P719, DOI 10.1136/gut.46.5.719
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   Fujita T, 1999, BIOCHEM BIOPH RES CO, V254, P1, DOI 10.1006/bbrc.1998.9841
   Henneberger C, 2000, J NEUROSCI METH, V100, P123, DOI 10.1016/S0165-0270(00)00241-7
   Huang RB, 1995, JPN J PHARMACOL, V69, P325, DOI 10.1254/jjp.69.325
   HYUN J, 1995, BIOCHEM BIOPH RES CO, V206, P380, DOI 10.1006/bbrc.1995.1052
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   Jeong WI, 2004, LIVER INT, V24, P658, DOI 10.1111/j.1478-3231.2004.0961.x
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Kuzu N, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/36381
   Kwak J, 2007, J MICROBIOL BIOTECHN, V17, P761
   Liu XJ, 2006, LIVER INT, V26, P8, DOI 10.1111/j.1478-3231.2005.01192.x
   PESSAYRE D, 1995, J HEPATOL, V23, P16
   Sar P, 2007, MOL CELL BIOCHEM, V303, P239, DOI 10.1007/s11010-007-9462-1
   Son TG, 2006, MECH AGEING DEV, V127, P451, DOI 10.1016/j.mad.2006.01.005
   Sun F, 2001, BBA-MOL BASIS DIS, V1535, P186, DOI 10.1016/S0925-4439(00)00098-3
   Tahashi Y, 2002, HEPATOLOGY, V35, P49, DOI 10.1053/jhep.2002.30083
   Wu ZM, 2007, BASIC CLIN PHARMACOL, V100, P115, DOI 10.1111/j.1742-7835.2007.00020.x
   Yun HS, 2004, BIOCHEM BIOPH RES CO, V320, P852, DOI 10.1016/j.bbrc.2004.06.033
NR 27
TC 30
Z9 37
U1 0
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0300-483X
J9 TOXICOLOGY
JI Toxicology
PD APR 18
PY 2008
VL 246
IS 2-3
BP 132
EP 142
DI 10.1016/j.tox.2008.01.006
PG 11
WC Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Toxicology
GA 293FN
UT WOS:000255320800005
PM 18308447
DA 2024-02-19
ER

PT J
AU Parrado, J
   Bougria, M
   Ayala, A
   Castaño, A
   Machado, A
AF Parrado, J
   Bougria, M
   Ayala, A
   Castaño, A
   Machado, A
TI Effects of aging on the various steps of protein synthesis::
   Fragmentation of elongation factor 2
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE aging; oxidative stress; protein synthesis; elongation factor-2; free
   radical
ID FACTOR-II; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; ADP-RIBOSYLATION;
   TRANSFER-RNA; RAT-LIVER; DEGRADATION; CELLS; INHIBITORS; RIBOSOMES
AB The possible mechanism responsible for the in vivo protein synthesis decline during aging was studied. In order to determine the effect of aging on the various steps of protein synthesis, we determined the ribosomal state of aggregation and the time of assembly and release of polypeptide chains in the process of protein synthesis in rat Liver. The results suggest that elongation is the most sensitive step to aging. A molecular study of the Elongation Factor 2 (EF-2), the main protein involved in the elongation step, shows that this protein has a higher content of carbonyl groups and is less active in old rats. In addition, the molecular mass analysis of EF-2 shows that this protein becomes fragmented in old rats. A similar pattern of fragmentation is found in 3-month-old rats suffering oxidative stress, in that the decline in protein synthesis is similar to that found in old rats. These data suggest that: i) oxidative stress seems to be involved in the modifications of EF-2 observed during aging, and ii) the observed modifications (oxidation and fragmentation) of EF-2 could account for the decline in protein synthesis in old animals. (C) 1998 Elsevier Science Inc.
C1 Univ Sevilla, Dept Bioquim Bromatol Toxicol, Fac Farm, E-41012 Seville, Spain.
C3 University of Sevilla
RP Machado, A (corresponding author), Univ Sevilla, Dept Bioquim Bromatol Toxicol, Fac Farm, Prof Garcia Gonzalez S-N, E-41012 Seville, Spain.
EM Machado@cica.es
RI Castaño, Angelica/L-1938-2014; Ayala, Antonio/N-7591-2019; Parrado,
   Juan/E-6637-2010; IBIS, ENVEJECIMIENTO/O-9381-2015
OI Castaño, Angelica/0000-0002-4853-8980; Ayala,
   Antonio/0000-0001-9711-3711; Parrado, Juan/0000-0002-1462-408X; 
CR Ayala A, 1996, J BIOL CHEM, V271, P23105, DOI 10.1074/jbc.271.38.23105
   AYUSOPARRILLA MS, 1976, J BIOL CHEM, V251, P7785
   CABISCOL E, 1995, J BIOL CHEM, V270, P14742, DOI 10.1074/jbc.270.24.14742
   CLAESRECKINGER N, 1982, EXP GERONTOL, V17, P281, DOI 10.1016/0531-5565(82)90017-1
   COOK JR, 1981, MECH AGEING DEV, V17, P41, DOI 10.1016/0047-6374(81)90127-5
   DAVIES KJA, 1987, J BIOL CHEM, V262, P9895
   DEAN RT, 1993, TRENDS BIOCHEM SCI, V18, P437, DOI 10.1016/0968-0004(93)90145-D
   DEAN RT, 1997, BIOCHEM J, V32, P1
   ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407
   FENDRICK JL, 1989, P NATL ACAD SCI USA, V86, P554, DOI 10.1073/pnas.86.2.554
   GIOVANE A, 1987, BIOCHEM J, V244, P337, DOI 10.1042/bj2440337
   Grune T, 1996, J BIOL CHEM, V271, P15504, DOI 10.1074/jbc.271.26.15504
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441
   HYSLOP PA, 1988, J BIOL CHEM, V263, P1665
   KIMBALL SR, 1992, BIOCHEM J, V286, P263, DOI 10.1042/bj2860263
   KU Z, 1994, AM J PHYSIOL, V267, P115
   LAYMAN DK, 1976, ARCH BIOCHEM BIOPHYS, V173, P246, DOI 10.1016/0003-9861(76)90256-3
   LENZ AG, 1989, ANAL BIOCHEM, V177, P419, DOI 10.1016/0003-2697(89)90077-8
   MAKRIDES SC, 1984, MECH AGEING DEV, V27, P111, DOI 10.1016/0047-6374(84)90088-5
   MAKRIDES SC, 1983, BIOL REV, V58, P343, DOI 10.1111/j.1469-185X.1983.tb00394.x
   MOUDGIL PG, 1979, GERONTOLOGY, V25, P322, DOI 10.1159/000212360
   NYGARD O, 1990, EUR J BIOCHEM, V191, P1, DOI 10.1111/j.1432-1033.1990.tb19087.x
   OMURA F, 1989, EUR J BIOCHEM, V180, P1, DOI 10.1111/j.1432-1033.1989.tb14607.x
   PACIFICI RE, 1990, METHOD ENZYMOL, V186, P485
   PARRADO J, 1993, PEPTIDE RES, V6, P13
   PERENTESIS JP, 1992, BIOFACTORS, V3, P173
   Rattan SIS, 1996, EXP GERONTOL, V31, P33, DOI 10.1016/0531-5565(95)02022-5
   RATTAN SIS, 1991, MUTAT RES, V256, P115, DOI 10.1016/0921-8734(91)90005-V
   RATTAN SIS, 1991, MECH AGEING DEV, V6, P379
   REDPATH NT, 1992, ANAL BIOCHEM, V202, P340, DOI 10.1016/0003-2697(92)90115-N
   Richardson A, 1983, REV BIOL RES AGING, V1, P255
   RICHARDSON A, 1981, HDB BIOCH AGING, P79
   RIIS B, 1990, FEBS LETT, V266, P45, DOI 10.1016/0014-5793(90)81502-F
   RIIS B, 1989, J BIOCHEM BIOPH METH, V19, P319, DOI 10.1016/0165-022X(89)90063-8
   RIIS B, 1991, T AGING RES, V16, P115
   SAHAKIAN JA, 1995, ARCH BIOCHEM BIOPHYS, V318, P411, DOI 10.1006/abbi.1995.1248
   SCHRAUFSTATTER IU, 1986, P NATL ACAD SCI USA, V83, P4908, DOI 10.1073/pnas.83.13.4908
   SCORNIK OA, 1974, J BIOL CHEM, V249, P3876
   SHIKAMA N, 1994, P NATL ACAD SCI USA, V91, P4199, DOI 10.1073/pnas.91.10.4199
   STADTMAN ER, 1986, TRENDS BIOCHEM SCI, V11, P11, DOI 10.1016/0968-0004(86)90221-5
   STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   Tamarit J, 1998, J BIOL CHEM, V273, P3027, DOI 10.1074/jbc.273.5.3027
   VANDENHAUTE J, 1983, EXP GERONTOL, V18, P355, DOI 10.1016/0531-5565(83)90014-1
   VANNESS BG, 1980, J BIOL CHEM, V255, P710
   WEBSTER GC, 1985, MOL BIOL AGING GENE, P263
NR 47
TC 45
Z9 47
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0891-5849
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD FEB
PY 1999
VL 26
IS 3-4
BP 362
EP 370
DI 10.1016/S0891-5849(98)00202-0
PG 9
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 151BL
UT WOS:000077701000016
PM 9895228
DA 2024-02-19
ER

PT J
AU Toroser, D
   Sohal, RS
AF Toroser, Dikran
   Sohal, Rajindar S.
TI Age-associated perturbations in glutathione synthesis in mouse liver
SO BIOCHEMICAL JOURNAL
LA English
DT Article
DE aging; glutamate-cysteine ligase; glutathione; homocysteine; oxidative
   stress; redox state
ID GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; OXIDATIVE STRESS;
   DROSOPHILA-MELANOGASTER; REDOX STATE; CYSTEINE; METABOLISM; LIGASE;
   HOMOCYSTEINE; SUBUNIT; MECHANISMS
AB The nature of the mechanisms underlying the age-related decline in glutathione (GSH) synthetic capacity is at present unclear. Steady-state kinetic parameters of mouse liver GCL (glutamate-cysteine ligase), the rate-limiting enzyme in GSH synthesis, and levels of hepatic GSH synthesis precursors from the trans-sulfuration pathway, such as homocysteine, cystathionine and cysteine, were compared between young and old C57BL/ 6 mice (6- and 24-month-old respectively). There were no age-related differences in GCL V-max, but the apparent K. for its substrates, cysteine and glutamate, was higher in the old mice compared with the young mice (similar to 800 compared with similar to 300 mu M, and similar to 710 compared with 450 mu M, P < 0.05 for cysteine and glutamate in young and old mice respectively). Amounts of cysteine, cystathionine and Cys-Gly increased with age by 91, 24 and 28% respectively. Glutathione (GSH) levels remained unchanged with age, whereas GSSG content showed an 84% increase, suggesting a significant pro-oxidizing shift in the 2GSH/GSSG ratio. The amount of the toxic trans-sulfuration/ glutathione biosynthetic pathway intermediate, homocysteine, was 154 % higher (P < 0.005) in the liver of old mice compared with young mice. The conversion of homocysteine into cystathionine, a rate-limiting step in trans-sulfuration catalysed by cystathionine beta-synthase, was comparatively less efficient in the old mice, as indicated by eystathionine/homocysteine ratios. Incubation of tissue homogenates with physiological concentrations of homocysteine caused an up to 4.4-fold increase in the apparent K. of GCL for its glutamate substrate, but had no effect on V-max. The results suggest that perturbation of the catalytic efficiency of GCL and accumulation of homocysteine from the trans-sulfuration pathway may adversely affect de novo GSH synthesis during aging.
C1 Univ So Calif, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA.
C3 University of Southern California
RP Sohal, RS (corresponding author), Univ So Calif, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA.
EM sohal@usc.edu
RI Toroser, Dikran/AAT-9352-2021
FU NIA NIH HHS [R01AG13563, R01 AG013563] Funding Source: Medline
CR Abbott JJ, 2002, BIOCHEMISTRY-US, V41, P2741, DOI 10.1021/bi0159128
   Aguilar B, 2004, J THROMB THROMBOLYS, V18, P75, DOI 10.1007/s11239-004-0204-x
   Asensi M, 1999, METHOD ENZYMOL, V299, P267
   Chen Y, 2005, J BIOL CHEM, V280, P33766, DOI 10.1074/jbc.M504604200
   Cotgreave IA, 1998, BIOCHEM BIOPH RES CO, V242, P1, DOI 10.1006/bbrc.1997.7812
   Dröge W, 2005, PHILOS T R SOC B, V360, P2355, DOI 10.1098/rstb.2005.1770
   GRIFFITH OW, 1982, J BIOL CHEM, V257, P13704
   Hernanz A, 2000, LIFE SCI, V67, P1317, DOI 10.1016/S0024-3205(00)00722-0
   HUANG CS, 1993, J BIOL CHEM, V268, P20578
   Jacobsen DW, 2005, CLIN CHEM LAB MED, V43, P1076, DOI 10.1515/CCLM.2005.188
   Kelly BS, 2002, J BIOL CHEM, V277, P50, DOI 10.1074/jbc.M107961200
   Lee JI, 2006, BIOCHEM J, V393, P181, DOI 10.1042/BJ20051111
   Liu HL, 2004, ANN NY ACAD SCI, V1019, P346, DOI 10.1196/annals.1297.059
   Liu RM, 2000, FREE RADICAL BIO MED, V28, P566, DOI 10.1016/S0891-5849(99)00269-5
   Lu SC, 1999, FASEB J, V13, P1169, DOI 10.1096/fasebj.13.10.1169
   Lu SC, 1996, J CLIN INVEST, V97, P1488, DOI 10.1172/JCI118571
   MEISTER A, 1995, METHOD ENZYMOL, V251, P3, DOI 10.1016/0076-6879(95)51106-7
   MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431
   Mosoni L, 2004, EXP GERONTOL, V39, P203, DOI 10.1016/j.exger.2003.10.014
   Ookhtens M, 1998, SEMIN LIVER DIS, V18, P313, DOI 10.1055/s-2007-1007167
   ORLOWSKI M, 1971, J BIOL CHEM, V246, P7095
   Orr WC, 2005, J BIOL CHEM, V280, P37331, DOI 10.1074/jbc.M508272200
   Rebrin I, 2003, FREE RADICAL BIO MED, V35, P626, DOI 10.1016/S0891-5849(03)00388-5
   Rebrin I, 2004, BIOCHEM J, V382, P131, DOI 10.1042/BJ20040506
   Ristoff E, 2002, J INHERIT METAB DIS, V25, P577, DOI 10.1023/A:1022095324407
   Schwahn B, 2005, J INHERIT METAB DIS, V28, P99, DOI 10.1007/s10545-005-5084-5
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P575, DOI 10.1016/S0891-5849(02)00886-9
   Stipanuk MH, 2004, ANNU REV NUTR, V24, P539, DOI 10.1146/annurev.nutr.24.012003.132418
   STOKKE O, 1982, SCAND J CLIN LAB INV, V42, P361
   Suh JH, 2004, ARCH BIOCHEM BIOPHYS, V423, P126, DOI 10.1016/j.abb.2003.12.020
   Togawa T, 2000, BIOCHEM BIOPH RES CO, V277, P668, DOI 10.1006/bbrc.2000.3723
   Toroser D, 2006, BBA-GEN SUBJECTS, V1760, P233, DOI 10.1016/j.bbagen.2005.10.010
   Toroser D, 2005, BIOCHEM BIOPH RES CO, V326, P586, DOI 10.1016/j.bbrc.2004.11.066
   Tu ZH, 1998, BIOCHEM J, V336, P675, DOI 10.1042/bj3360675
   Voss P, 2006, FREE RADICAL RES, V40, P1339, DOI 10.1080/10715760600953859
   Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.10.2783S
NR 36
TC 44
Z9 45
U1 0
U2 5
PU PORTLAND PRESS LTD
PI LONDON
PA THIRD FLOOR, EAGLE HOUSE, 16 PROCTER STREET, LONDON WC1V 6 NX, ENGLAND
SN 0264-6021
J9 BIOCHEM J
JI Biochem. J.
PD AUG 1
PY 2007
VL 405
BP 583
EP 589
DI 10.1042/BJ20061868
PN 3
PG 7
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 196XN
UT WOS:000248516600022
PM 17461778
OA Green Published
DA 2024-02-19
ER

PT J
AU López-Diazguerrero, NE
   Luna-López, A
   Gutiérrez-Ruiz, MC
   Zentella, A
   Königsberg, M
AF López-Diazguerrero, NE
   Luna-López, A
   Gutiérrez-Ruiz, MC
   Zentella, A
   Königsberg, M
TI Susceptibility of DNA to oxidative stressors in young and aging mice
SO LIFE SCIENCES
LA English
DT Article
DE aging; DNA damage; oxidative stress; H2O2; carbon tetrachloride
ID AGE-RELATED-CHANGES; CARBON-TETRACHLORIDE; IN-VITRO; ANTIOXIDANT STATUS;
   COMET ASSAY; LIFE-SPAN; DAMAGE; REPAIR; OXYGEN; CELLS
AB The changes that accompany aging may be a result of oxidative damage to DNA that accumulates as a result of aging and age-related illnesses. Furthermore, a higher susceptibility is thought to be more common among elderly than young individuals. In the present study, we examined the severity of DNA damage caused by carbon tetrachloride (CCl4) and H2O2 in cells from young (2 month old) and older (14 month old) mice using both in vivo and in vitro exposures. CCl4 is known to generate radical oxidative species (ROS) throughout its biotransformation in the liver. Therefore, 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxdGuo) was quantified in liver DNA obtained from young and older mice treated with CCl4. In addition, DNA single-strand breaks were measured by the Comet assay in primary lung fibroblasts cultured from young and older mice and treated in vitro with H2O2. Intracellular ROS production and mitochondrial enzyme activity were determined in parallel. 8-oxodGuo levels were significantly higher in older mouse liver DNA than younger, and increased significantly with CCl4 treatment. When the basal DNA damage was subtracted, the net damage was almost equal for both. In addition, untreated cells cultured from older mice had significantly greater levels of strand breaks than cells derived from young mice. H2O2 increased the level of damage in both cell cultures. Our findings indicate that the DNA damage observed in older animals probably results from the accumulation of endogenous damage with age, perhaps due to insufficient repair, which enhances the injury caused by exposure to the toxic agents. (c) 2005 Elsevier Inc. All rights reserved.
C1 Univ Autonoma Metropolitana Iztapalapa, Div Ciencias Biol & Salud, Dept Ciencias Salud, Mexico City 09340, DF, Mexico.
   Univ Nacl Autonoma Mexico, Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Bioquim, Mexico City 04510, DF, Mexico.
   Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City 04510, DF, Mexico.
C3 Universidad Autonoma Metropolitana - Mexico; Instituto Nacional de
   Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad
   Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico
RP Univ Autonoma Metropolitana Iztapalapa, Div Ciencias Biol & Salud, Dept Ciencias Salud, AP 55-535, Mexico City 09340, DF, Mexico.
EM mkf@xanum.uam.mx
RI LUNA, ARMANDO/AAH-8128-2020
OI Gutierrez-Ruiz, Maria Concepcion/0000-0003-0501-7226; LOPEZ DIAZ
   GUERRERO, NORMA EDITH/0000-0001-7470-9360
CR AHMAD FF, 1987, LIFE SCI, V41, P2469, DOI 10.1016/0024-3205(87)90673-4
   ALTAMIRANO A, 1994, MANUAL MANEJO ANIMAL
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   BARNETT YA, 1995, MUTAT RES-DNAGING G, V338, P115, DOI 10.1016/0921-8734(95)00017-Z
   BASS DA, 1983, J IMMUNOL, V130, P1910
   Beddowes EJ, 2003, TOXICOLOGY, V187, P101, DOI 10.1016/S0300-483X(03)00058-1
   BETANCOURT M, 1995, MUTAT RES-FUND MOL M, V331, P65, DOI 10.1016/0027-5107(95)00052-K
   Bohr V, 1998, TOXICOL LETT, V103, P47
   Bohr VA, 2002, FREE RADICAL BIO MED, V32, P804, DOI 10.1016/S0891-5849(02)00787-6
   Boll M, 2001, Z NATURFORSCH C, V56, P649
   Campbell DH, 1900, ANN BOT-LONDON, V14, P1
   CATHCART R, 1983, ANAL BIOCHEM, V134, P111, DOI 10.1016/0003-2697(83)90270-1
   CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337
   Collins AR, 1997, MUTAT RES-FUND MOL M, V375, P183, DOI 10.1016/S0027-5107(97)00013-4
   DOYLE A, 1998, CELL TISSUE CULTUR B, V4, P7
   Effros RB, 2003, MECH AGEING DEV, V124, P71, DOI 10.1016/S0047-6374(02)00171-9
   Emerit J, 2004, BIOMED PHARMACOTHER, V58, P39, DOI 10.1016/j.biopha.2003.11.004
   FAIRBAIRN DW, 1995, MUTAT RES-REV GENET, V339, P37, DOI 10.1016/0165-1110(94)00013-3
   Giovannelli L, 2003, MUTAT RES-GEN TOX EN, V538, P71, DOI 10.1016/S1383-5718(03)00090-1
   Guillouzo A, 1998, ENVIRON HEALTH PERSP, V106, P511, DOI 10.2307/3433803
   Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341
   HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hashiguchi K, 2004, NUCLEIC ACIDS RES, V32, P5596, DOI 10.1093/nar/gkh863
   Helbock HJ, 1998, P NATL ACAD SCI USA, V95, P288, DOI 10.1073/pnas.95.1.288
   Ikura T, 2003, FRONT BIOSCI-LANDMRK, V8, pS149, DOI 10.2741/1013
   Issa JP, 2002, J NUTR, V132, p2388S, DOI 10.1093/jn/132.8.2388S
   Kim HG, 2003, MOL CELLS, V16, P278
   Königsberg M, 2004, CELL BIOL INT, V28, P641, DOI 10.1016/j.cellbi.2004.06.002
   Lezhava T, 2001, BIOGERONTOLOGY, V2, P253, DOI 10.1023/A:1013266411263
   Lueken A, 2004, TOXICOL LETT, V147, P35, DOI 10.1016/j.toxlet.2003.10.020
   Madesh M, 1998, INDIAN J BIOCHEM BIO, V35, P184
   Martinec E, 1996, CLASSICAL QUANT GRAV, V13, P1, DOI 10.1088/0264-9381/13/1/003
   Martinez GR, 2003, MUTAT RES-REV MUTAT, V544, P115, DOI 10.1016/j.mrrev.2003.05.005
   Matos HR, 2001, ARCH BIOCHEM BIOPHYS, V396, P171, DOI 10.1006/abbi.2001.2611
   McCord J M, 1993, New Horiz, V1, P70
   Melov S, 2001, J NEUROSCI, V21, P8348, DOI 10.1523/JNEUROSCI.21-21-08348.2001
   Mockett RJ, 2001, EXP GERONTOL, V36, P441, DOI 10.1016/S0531-5565(00)00258-8
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mosoni L, 2004, EXP GERONTOL, V39, P203, DOI 10.1016/j.exger.2003.10.014
   Mutlu-Türkoglu Ü, 2003, CLIN BIOCHEM, V36, P397, DOI 10.1016/S0009-9120(03)00035-3
   Park Y, 2005, ANNU REV MED, V56, P495, DOI 10.1146/annurev.med.56.082103.104546
   Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024
   Pouget JP, 2000, CHEM RES TOXICOL, V13, P541, DOI 10.1021/tx000020e
   Ramsay RE, 2004, NEUROLOGY, V62, pS24, DOI 10.1212/WNL.62.5_suppl_2.S24
   RUSSEL ES, 1964, BIOL LAB MOUSE, P685
   SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0
   Szczesny B, 2004, MECH AGEING DEV, V125, P755, DOI 10.1016/j.mad.2004.07.005
   Takahashi Y, 2005, J INVEST DERMATOL, V124, P435, DOI 10.1111/j.0022-202X.2004.23591.x
   Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J
   TICE RR, 1991, ADV EXP MED BIOL, V283, P157
   WANG L, 1994, NUCLEIC ACIDS RES, V22, P1774, DOI 10.1093/nar/22.9.1774
   Weyand CM, 2003, EXP GERONTOL, V38, P833, DOI 10.1016/S0531-5565(03)00090-1
   Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017
   Wolf FI, 2002, EXP GERONTOL, V37, P647, DOI 10.1016/S0531-5565(02)00005-0
   Wright RM, 2004, J AM PODIAT MED ASSN, V94, P90, DOI 10.7547/87507315-94-2-90
   YONEDA M, 1995, BIOCHEM BIOPH RES CO, V209, P723, DOI 10.1006/bbrc.1995.1559
   Zhang HJ, 2003, FASEB J, V17, P2293, DOI 10.1096/fj.03-0139fje
   Zimmerman JA, 2003, EXP GERONTOL, V38, P47, DOI 10.1016/S0531-5565(02)00149-3
   ZURCHER C, 1982, MOUSE BIOMEDICAL RES, V4
NR 62
TC 37
Z9 44
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
EI 1879-0631
J9 LIFE SCI
JI Life Sci.
PD OCT 14
PY 2005
VL 77
IS 22
BP 2840
EP 2854
DI 10.1016/j.lfs.2005.05.034
PG 15
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 969PA
UT WOS:000232245300011
PM 15979101
DA 2024-02-19
ER

PT J
AU Shimizu, S
   Iba, T
   Naito, H
   Rahmawati, FN
   Konishi, H
   Jia, WZ
   Muramatsu, F
   Takakura, N
AF Shimizu, Shota
   Iba, Tomohiro
   Naito, Hisamichi
   Rahmawati, Fitriana Nur
   Konishi, Hirotaka
   Jia, Weizhen
   Muramatsu, Fumitaka
   Takakura, Nobuyuki
TI Aging impairs the ability of vascular endothelial stem cells to generate
   endothelial cells in mice
SO ANGIOGENESIS
LA English
DT Article; Early Access
DE Endothelial cells; Aging; Stem cell aging; Vascular regeneration;
   Inflammation
ID SIDE POPULATION CELLS; IDENTIFICATION; EXPRESSION
AB Tissue-resident vascular endothelial stem cells (VESCs), marked by expression of CD157, possess long-term repopulating potential and contribute to vascular regeneration and homeostasis in mice. Stem cell exhaustion is regarded as one of the hallmarks of aging and is being extensively studied in several types of tissue-resident stem cells; however, how aging affects VESCs has not been clarified yet. In the present study, we isolated VESCs from young and aged mice to compare their potential to differentiate into endothelial cells in vitro and in vivo. Here, we report that the number of liver endothelial cells (ECs) including VESCs was lower in aged (27-28 month-old) than young (2-3 month-old) mice. In vitro culture of primary VESCs revealed that the potential to generate ECs is impaired in aged VESCs isolated from liver and lung relative to young VESCs. Orthotopic transplantation of VESCs showed that aged VESCs and their progeny expand less efficiently than their young counterparts when transplanted into aged mice, but they are equally functional in young recipients. Gene expression analysis indicated that inflammatory signaling was more activated in aged ECs including VESCs. Using single-cell RNA sequencing data from the Tabula Muris Consortium, we show that T cells and monocyte/macrophage lineage cells including Kupffer cells are enriched in the aged liver. These immune cells produce IL-1 & beta; and several chemokines, suggesting the possible involvement of age-associated inflammation in the functional decline of VESCs with age.
C1 [Shimizu, Shota; Iba, Tomohiro; Naito, Hisamichi; Rahmawati, Fitriana Nur; Konishi, Hirotaka; Jia, Weizhen; Muramatsu, Fumitaka; Takakura, Nobuyuki] Osaka Univ, Res Inst Microbial Dis, Dept Signal Transduct, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.
   [Shimizu, Shota] Keio Univ, Dept Anat, Sch Med, Tokyo, Japan.
   [Iba, Tomohiro; Naito, Hisamichi] Kanazawa Univ, Dept Physiol, Sch Med, Ishikawa, Japan.
   [Takakura, Nobuyuki] Osaka Univ, World Premier Inst, Immunol Frontier Res Ctr, Osaka, Japan.
   [Takakura, Nobuyuki] Osaka Univ, Inst Open & Transdisciplinary Res Initiat OTRI, Integrated Frontier Res Med Sci Div, Osaka, Japan.
   [Takakura, Nobuyuki] Osaka Univ, Ctr Infect Dis Educ & Res, Osaka, Japan.
C3 Osaka University; Keio University; Kanazawa University; Osaka
   University; Osaka University; Osaka University
RP Takakura, N (corresponding author), Osaka Univ, Res Inst Microbial Dis, Dept Signal Transduct, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.; Takakura, N (corresponding author), Osaka Univ, World Premier Inst, Immunol Frontier Res Ctr, Osaka, Japan.; Takakura, N (corresponding author), Osaka Univ, Inst Open & Transdisciplinary Res Initiat OTRI, Integrated Frontier Res Med Sci Div, Osaka, Japan.; Takakura, N (corresponding author), Osaka Univ, Ctr Infect Dis Educ & Res, Osaka, Japan.
EM ntakaku@biken.osaka-u.ac.jp
FU Japan Agency for Medical Research and Development (AMED) [JP21gm5010002,
   22ck0106727h0001]; Japan Society for the Promotion of Science (JSPS)
   [20H05698]
FX AcknowledgementsWe thank H. Morimoto, M. Ishida, N. Fujimoto, Y, Mori
   and N, Aikawa for technical assistance. This work was supported by the
   Japan Agency for Medical Research and Development (AMED) under Grant
   number (JP21gm5010002, 22ck0106727h0001) and the Japan Society for the
   Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (S)
   (20H05698).
CR Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465
   de Martin R, 2000, ARTERIOSCL THROM VAS, V20, pE83
   Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60
   Eelen G, 2020, CIRC RES, V127, P310, DOI 10.1161/CIRCRESAHA.120.316851
   Ermolaeva M, 2018, NAT REV MOL CELL BIO, V19, P594, DOI 10.1038/s41580-018-0020-3
   Fang ST, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001407
   Ge SX, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2486-6
   Hellström M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571
   Iba T, 2019, INFLAMM REGEN, V39, DOI 10.1186/s41232-019-0098-9
   Ingram DA, 2005, BLOOD, V105, P2783, DOI 10.1182/blood-2004-08-3057
   Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103
   Kalamakis G, 2019, CELL, V176, P1407, DOI 10.1016/j.cell.2019.01.040
   Kovtonyuk LV, 2022, BLOOD, V139, P44, DOI 10.1182/blood.2021011570
   Leins H, 2018, BLOOD, V132, P565, DOI 10.1182/blood-2018-02-831065
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Manavski Y, 2018, CIRC RES, V122, P670, DOI 10.1161/CIRCRESAHA.117.312310
   Márquez EJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14396-9
   Mihaylova MM, 2018, CELL STEM CELL, V22, P769, DOI 10.1016/j.stem.2018.04.001
   Mondor I, 2016, IMMUNITY, V45, P877, DOI 10.1016/j.immuni.2016.09.017
   Morinaga H, 2021, NATURE, V595, P266, DOI 10.1038/s41586-021-03624-x
   Naito H, 2020, NAT PROTOC, V15, P1066, DOI 10.1038/s41596-019-0276-x
   Naito H, 2019, DEV CELL, V48, P151, DOI 10.1016/j.devcel.2018.12.002
   Naito H, 2016, CANCER RES, V76, P3200, DOI 10.1158/0008-5472.CAN-15-2998
   Naito H, 2012, EMBO J, V31, P842, DOI 10.1038/emboj.2011.465
   Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593
   Pober JS, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01907
   Potente M, 2017, NAT REV MOL CELL BIO, V18, P477, DOI 10.1038/nrm.2017.36
   Rebo J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13363
   Revuelta M, 2017, AGING CELL, V16, P912, DOI 10.1111/acel.12655
   Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102
   Schaum N, 2020, NATURE, V583, P596, DOI 10.1038/s41586-020-2499-y
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Tabula Muris Consortium, 2020, Nature, V583, P590, DOI 10.1038/s41586-020-2496-1
   Takakura N, 2000, CELL, V102, P199, DOI 10.1016/S0092-8674(00)00025-8
   Theofilis P, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9070781
   Wakabayashi T, 2022, INVEST OPHTH VIS SCI, V63, DOI 10.1167/iovs.63.4.5
   Wakabayashi T, 2018, CELL STEM CELL, V22, P384, DOI 10.1016/j.stem.2018.01.010
   Wakabayashi T, 2013, INVEST OPHTH VIS SCI, V54, P6686, DOI 10.1167/iovs.13-12342
   Wang DL, 2023, HEPATOL COMMUN, V7, DOI 10.1097/HC9.0000000000000021
   Yamamoto R, 2018, CELL STEM CELL, V22, P600, DOI 10.1016/j.stem.2018.03.013
   Yu QC, 2016, CELL RES, V26, P1079, DOI 10.1038/cr.2016.85
   Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385
NR 44
TC 0
Z9 0
U1 5
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0969-6970
EI 1573-7209
J9 ANGIOGENESIS
JI Angiogenesis
PD 2023 NOV
PY 2023
VL 26
IS 4
BP 567
EP 580
DI 10.1007/s10456-023-09891-8
EA AUG 2023
PG 14
WC Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA S6RF6
UT WOS:001044984300001
PM 37563497
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU Ma, Y
   Liang, YH
   Liang, NJ
   Zhang, YJ
   Xiao, F
AF Ma, Yu
   Liang, Yuehui
   Liang, Ningjuan
   Zhang, Yujing
   Xiao, Fang
TI Identification and functional analysis of senescence-associated
   secretory phenotype of premature senescent hepatocytes induced by
   hexavalent chromium
SO ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY
LA English
DT Article; Early Access
DE Hexavalent chromium [Cr(VI)]; Premature senescence;
   Senescence-associated secretion phenotype (SASP); Alpha-enolase (ENO1);
   Peroxiredoxin 2 (PRDX2)
ID COACTOSIN-LIKE PROTEIN; ACTIN-BINDING-PROTEIN; DNA-DAMAGE; GLYCOLYSIS;
   CANCER; ACTIVATION; EXPRESSION
AB Hexavalent chromium [Cr(VI)] is a common heavy metal pollutant that can cause a number of human disease, including inflammation and cancer. Senescent cells can secrete a variety of molecules known as senescenceassociated secretory phenotype (SASP). Our previous studies have confirmed that Cr(VI) can induce premature senescence in L02 hepatocytes, but the composition and the function of the related SASP are still unknown. In order to understand the components of SASP secreted by senescent L02 hepatocytes under the action of Cr(VI), we applied LC-MS/MS-based label-free protein quantification. We found that three SASP components including Coactosin-like protein 1 (COTL1), Alpha-enolase (ENO1), and Peroxiredoxin 2 (PRDX2) were up-regulated, which were confirmed by western blotting and qRT-PCR. Evidence suggested that SASP may promote the development of tumor through chronic inflammatory response, therefore we identified and analyzed the potential biological functions and signaling pathways of these three SASP components using GO and KEGG methods. The interaction between SASP components was analyzed by STRING, and verified by Co-IP. We also found that ENO1 and PRDX2, which have direct interaction, can inhibit the growth and proliferation of wildtype hepatocytes and premature senescent hepatocytes, but can promote the proliferation and behavioral changes of liver tumor cells. The present study provides valuable clues for elucidation of the carcinogenic mechanism of Cr (VI), especially for further prevention and targeted treatment of Cr(VI)-related cancer.
C1 [Ma, Yu; Liang, Yuehui; Liang, Ningjuan; Zhang, Yujing; Xiao, Fang] Cent South Univ, Xiangya Sch Publ Hlth, Dept Hlth Toxicol, 238 Shangmayuanling Rd, Changsha 410078, Hunan, Peoples R China.
C3 Central South University
RP Xiao, F (corresponding author), Cent South Univ, Xiangya Sch Publ Hlth, Dept Hlth Toxicol, 238 Shangmayuanling Rd, Changsha 410078, Hunan, Peoples R China.
EM fangxiao@csu.edu.cn
RI Yang, Ying/ABD-2481-2022; yan, wang/JRW-9981-2023; zhang,
   yu/HNS-5948-2023; Zhang, Y J/HLG-1022-2023; Xiao, Fang/S-9283-2018
OI Xiao, Fang/0000-0002-6814-1227
FU National Natural Science Foundation of China [81773478]; Natural Science
   Foundation of Hunan Province, China [2020JJ3052]; Fundamental Research
   Funds for the Central Universities of Central South University
   [2019zzts749]
FX The current work was supported by National Natural Science Foundation of
   China (NO. 81773478), Natural Science Foundation of Hunan Province,
   China (NO. 2020JJ3052) and the Fundamental Research Funds for the
   Central Universities of Central South University (2019zzts749).
CR Akram M, 2013, J CANCER EDUC, V28, P454, DOI 10.1007/s13187-013-0486-9
   Alexander E, 2013, J CELL SCI, V126, P3738, DOI 10.1242/jcs.128835
   Bagchi D, 2002, TOXICOLOGY, V180, P5, DOI 10.1016/S0300-483X(02)00378-5
   Bai B, 2019, ONCOL REP, V41, P1539, DOI 10.3892/or.2019.6977
   Cai CY, 2015, EJSO-EUR J SURG ONC, V41, P228, DOI 10.1016/j.ejso.2014.11.037
   Chenbo, 2017, J CELL MOL MED, V12, P23
   Coppé JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009188
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   DEHOSTOS EL, 1993, CELL MOTIL CYTOSKEL, V26, P181, DOI 10.1002/cm.970260302
   Deng FW, 2020, AGING-US, V12, P3431, DOI 10.18632/aging.102820
   Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094
   Fumagalli M, 2009, NAT CELL BIOL, V11, P921, DOI 10.1038/ncb0809-921
   Giovanni P, 2007, BBA-MOL CELL RES, V1773, P1774, DOI 10.1016/j.bbamcr.2007.09.002
   Guo SQ, 2017, ONCOTARGET, V8, P644, DOI 10.18632/oncotarget.13501
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   INT AGCY RES CANC, 1990, IARC MONOG EVAL CARC, V49, P49
   Jeong HC, 2011, J PROTEOME RES, V10, P269, DOI 10.1021/pr100714b
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237
   Luo F, 2017, CARCINOGENESIS, V38, P615, DOI 10.1093/carcin/bgx034
   Luo WB, 2016, ONCOTARGET, V7, P6379, DOI 10.18632/oncotarget.7142
   Nadeem A, 2019, PROG NEURO-PSYCHOPH, V90, P204, DOI 10.1016/j.pnpbp.2018.12.002
   Olivieri F, 2015, ONCOTARGET, V6, P35509, DOI 10.18632/oncotarget.5899
   Ovadya Y, 2014, BIOGERONTOLOGY, V15, P627, DOI 10.1007/s10522-014-9529-9
   Park SJ, 2018, FREE RADICAL BIO MED, V123, P96, DOI 10.1016/j.freeradbiomed.2018.05.059
   Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007
   Provost P, 2001, BIOCHEM J, V359, P255, DOI 10.1042/0264-6021:3590255
   Ren PF, 2013, ONCOL REP, V30, P2297, DOI 10.3892/or.2013.2714
   Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529
   Thompson CM, 2013, CRIT REV TOXICOL, V43, P244, DOI 10.3109/10408444.2013.768596
   Xia L, 2018, ONCOGENE, V37, P323, DOI 10.1038/onc.2017.342
   Xiao F, 2012, MOL CELL BIOCHEM, V371, P65, DOI 10.1007/s11010-012-1423-7
   Xiao F, 2012, INT J MOL MED, V30, P629, DOI 10.3892/ijmm.2012.1031
   Zhang YJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34578
   Zhao S, 2017, TECHNOL CANCER RES T, V16, P1092, DOI 10.1177/1533034617732426
   Zhu WW, 2018, CANCER MANAG RES, V10, P5735, DOI 10.2147/CMAR.S182183
   Zhu XH, 2015, EXP CELL RES, V335, P216, DOI 10.1016/j.yexcr.2015.05.020
NR 38
TC 6
Z9 6
U1 3
U2 13
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0147-6513
EI 1090-2414
J9 ECOTOX ENVIRON SAFE
JI Ecotox. Environ. Safe.
PD 2021 MAR 15
PY 2021
VL 211
AR 111908
DI 10.1016/j.ecoenv.2021.111908
EA JAN 2021
PG 10
WC Environmental Sciences; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology; Toxicology
GA QG7RD
UT WOS:000617779900004
PM 33440265
OA gold
DA 2024-02-19
ER

PT J
AU Ghosh, S
   Thakur, MK
AF Ghosh, Swati
   Thakur, M. K.
TI Tissue-specific expression of receptor-interacting protein in aging
   mouse
SO AGE
LA English
DT Article
DE Receptor-interacting protein; Coregulator; Expression; Aging; Sex; Mouse
ID COREPRESSOR RIP140; REPRESSOR; GENE; ADIPOCYTES; ACTIVATION; PROTEASOME;
   ESTROGEN
AB Receptor-interacting protein ( RIP) is a well-characterized coregulator for nuclear receptors. Here, we report the expression of RIP as two isoforms with molecular weights of 140 kDa and 137 kDa in liver and kidney, but only as one isoform of 140 kDa in lung, adipose tissue, prostate and testis of mice. The levels of both the isoforms decreased in liver and kidney of old mice compared with adult mice. The expression of RIP140 in kidney was relatively lower in old males than females. In contrast, adipose tissue showed remarkably higher levels of RIP140 in old than adult mice of both sexes. Thus, the expression of RIP varied with the type of tissue, sex and age of mice, suggesting differences in its function as a coregulator.
C1 [Ghosh, Swati; Thakur, M. K.] Banaras Hindu Univ, Dept Zool, Biochem & Mol Biol Lab, Varanasi 221005, Uttar Pradesh, India.
C3 Banaras Hindu University (BHU)
RP Thakur, MK (corresponding author), Banaras Hindu Univ, Dept Zool, Biochem & Mol Biol Lab, Varanasi 221005, Uttar Pradesh, India.
EM mkt_bhu@yahoo.com
OI Ghosh, Swati/0000-0002-1902-8025
FU University Grants Commission, India; Department of Biotechnology,
   Government of India [BT/PR3593/Med/14/468/2003]
FX The authors would like to thank Dr Ngan Vo for providing RIP140
   antibody. Swati Ghosh is a recipient of Senior Research Fellowship from
   the University Grants Commission, India. This work was supported by
   grants from the Department of Biotechnology (BT/PR3593/Med/14/468/2003),
   Government of India to M. K. T.
CR Augereau P, 2006, MOL PHARMACOL, V69, P1338, DOI 10.1124/mol.105.017376
   AUGEREAU P, 2006, NUCL RECEPT SIGNAL, V4, P1
   Blouin K, 2005, METABOLISM, V54, P1034, DOI 10.1016/j.metabol.2005.03.006
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Carascossa S, 2006, MOL ENDOCRINOL, V20, P1506, DOI 10.1210/me.2005-0286
   CAVAILLES V, 1994, P NATL ACAD SCI USA, V91, P10009, DOI 10.1073/pnas.91.21.10009
   Christian M, 2005, MOL CELL BIOL, V25, P9383, DOI 10.1128/MCB.25.21.9383-9391.2005
   Christian M, 2006, TRENDS ENDOCRIN MET, V17, P243, DOI 10.1016/j.tem.2006.06.008
   Darling DL, 2005, CURR TOP DEV BIOL, V68, P281, DOI 10.1016/S0070-2153(05)68010-6
   DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475
   Farout L, 2006, ANTIOXID REDOX SIGN, V8, P205, DOI 10.1089/ars.2006.8.205
   Friguet B, 2000, ANN NY ACAD SCI, V908, P143
   Gupta P, 2005, MOL CELL PROTEOMICS, V4, P1776, DOI 10.1074/mcp.M500236-MCP200
   HEWISH DR, 1973, BIOCHEM BIOPH RES CO, V52, P504, DOI 10.1016/0006-291X(73)90740-7
   Huq MDM, 2005, MOL CELL PROTEOMICS, V4, P975, DOI 10.1074/mcp.M500015-MCP200
   Kerley JS, 2001, BIOCHEM BIOPH RES CO, V285, P969, DOI 10.1006/bbrc.2001.5274
   Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101
   Mattson MP, 2002, PHYSIOL REV, V82, P637, DOI 10.1152/physrev.00004.2002
   Parker MG, 2006, BIOCHEM SOC T, V34, P1103, DOI 10.1042/BST0341103
   Powelka AM, 2006, J CLIN INVEST, V116, P125, DOI 10.1172/JCI26040
   Steel JH, 2005, J ENDOCRINOL, V185, P1, DOI 10.1677/joe.1.05896
   Treuter E, 1998, MOL ENDOCRINOL, V12, P864, DOI 10.1210/me.12.6.864
   White R, 2008, FEBS LETT, V582, P39, DOI 10.1016/j.febslet.2007.11.017
   Zilliacus J, 2001, MOL ENDOCRINOL, V15, P501, DOI 10.1210/mend.15.4.0624
NR 24
TC 13
Z9 14
U1 0
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0161-9152
EI 1574-4647
J9 AGE
JI Age
PD DEC
PY 2008
VL 30
IS 4
BP 237
EP 243
DI 10.1007/s11357-008-9062-3
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 413LJ
UT WOS:000263794300006
PM 19424847
OA Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Szücs, A
   Paku, S
   Sebestyén, E
   Nagy, P
   Dezso, K
AF Szucs, Armanda
   Paku, Sandor
   Sebestyen, Endre
   Nagy, Peter
   Dezso, Katalin
TI Postnatal, ontogenic liver growth accomplished by biliary/oval cell
   proliferation and differentiation
SO PLOS ONE
LA English
DT Article
ID OVAL CELLS; DUCTULAR REACTIONS; STEM-CELLS; REGENERATION; HEPATOCYTES;
   SENESCENCE; EXPRESSION; 2-ACETYLAMINOFLUORENE; HOMEOSTASIS; RECEPTOR
AB Introduction
   The liver is well known for its enormous regenerative capacity. If the hepatocytes are compromised the reserve stem cells can regrow the lost tissue by means of oval cells differentiating into hepatocytes. We were curious whether this standby system was able to compensate for ontogenic liver growth arrested by 2-acetylaminofluorene (AAF) treatment or if it can be influenced by cholic acid, known to promote liver growth in several reactions.
   Methods
   (i) Four weeks-old (60-70g) male F344 rats were kept on standard chow and treated with solvent only, (ii) others were kept on 0,2% cholic acid (CA) enriched diet, (iii) treated with AAF, or (iiii) given a combination of CA diet and AAF treatment (AAF/CA).
   The proliferative response of epithelial cells was characterized by pulse bromodeoxyuridine labelling. The relative gene expression levels of senescence-related factors and bile acid receptors were determined by quantitative real-time polymerase chain reaction analysis.
   Results
   AAF administration efficiently inhibited the physiological proliferation of hepatocytes in young, male F344 rats after weaning. The activation of stem cells was indicated by the increased proliferation of periportal biliary/oval cells (B/OC). If the rats were fed additionally by cholic acid enriched diet, typical oval cell reaction emerged, subsequently the oval cells differentiated into hepatocytes restituting liver growth. This reaction was mediated by increased production of HGF, IL-6 and SCF by the damaged liver. Moreover, upregulation of FXR expression on B/OC made them competent for bile acids. Our results indicate that endogenous, autocrine mechanisms involved in liver ontogeny are also able to activate the backup regenerative machinery of stem cells.
C1 [Szucs, Armanda; Paku, Sandor; Sebestyen, Endre; Nagy, Peter; Dezso, Katalin] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, Budapest, Hungary.
C3 Semmelweis University
RP Dezso, K (corresponding author), Semmelweis Univ, Dept Pathol & Expt Canc Res 1, Budapest, Hungary.
EM dezso.katalin@med.semmelweis-univ.hu
RI Sebestyén, Endre/H-3999-2011
OI Sebestyén, Endre/0000-0001-5470-2161
FU National Excellence Program [TAMOP 4.2.4. A/1-11-12012-0001]; Janos
   Bolyai Scholarship of the Hungarian Academy of Sciences; Hungarian
   National Research, Development and Innovation Office, Development and
   Innovation Office [NVKP_16-1-2016-0004]; NFKIH [116301, FK135701,
   FK132666]; Semmelweis University Science and Innovation Fund
   [STIA_18_KF]
FX Supported by TAMOP 4.2.4. A/1-11-12012-0001'National Excellence Program'
   (K.D), Janos Bolyai Scholarship of the Hungarian Academy of Sciences
   (K.D), Hungarian National Research, Development and Innovation Office,
   Development and Innovation Office (grants: NVKP_16-1-2016-0004 (S.P,
   P.N) and NFKIH: 116301 (P.N), FK135701 (K.D), FK132666 (E.S)),
   Semmelweis University Science and Innovation Fund STIA_18_KF (E.S). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Anakk S, 2013, CELL REP, V5, P1060, DOI 10.1016/j.celrep.2013.10.030
   Barone M, 1996, HEPATOLOGY, V23, P1159, DOI 10.1053/jhep.1996.v23.pm0008621149
   BISGAARD HC, 1993, MOL CARCINOGEN, V7, P60, DOI 10.1002/mc.2940070110
   Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379
   EVARTS RP, 1987, CARCINOGENESIS, V8, P1737, DOI 10.1093/carcin/8.11.1737
   Fan MJ, 2015, BBA-GENE REGUL MECH, V1849, P196, DOI 10.1016/j.bbagrm.2014.05.021
   FUJIO K, 1994, LAB INVEST, V70, P511
   Guest I, 2010, HEPATOLOGY, V52, P1750, DOI 10.1002/hep.23880
   Guo M, 2017, BIOMED PHARMACOTHER, V96, P1527, DOI 10.1016/j.biopha.2017.11.075
   Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435
   Jensen CH, 2004, AM J PATHOL, V164, P1347, DOI 10.1016/S0002-9440(10)63221-X
   Katalin D, 2012, HEPATOLOGY, V56, P1457, DOI 10.1002/hep.25713
   KRIEK E, 1992, J CANCER RES CLIN, V118, P481, DOI 10.1007/BF01225261
   Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107
   Lu WY, 2015, NAT CELL BIOL, V17, P971, DOI 10.1038/ncb3203
   Michalopoulos GK, 2015, GASTROENTEROLOGY, V149, P876, DOI 10.1053/j.gastro.2015.08.004
   Miyajima A, 2014, CELL STEM CELL, V14, P561, DOI 10.1016/j.stem.2014.04.010
   NAGY P, 1994, J CELL BIOL, V126, P223, DOI 10.1083/jcb.126.1.223
   Nagy P, 1996, HEPATOLOGY, V23, P71, DOI 10.1053/jhep.1996.v23.pm0008550051
   Paku S, 2004, HEPATOLOGY, V39, P1353, DOI 10.1002/hep.20178
   Paku S, 2001, AM J PATHOL, V158, P1313, DOI 10.1016/S0002-9440(10)64082-5
   Papp V, 2009, LIVER TRANSPLANT, V15, P177, DOI 10.1002/lt.21665
   Roskams TA, 2004, HEPATOLOGY, V39, P1739, DOI 10.1002/hep.20130
   Stanger BZ, 2015, ANNU REV PHYSIOL, V77, P179, DOI 10.1146/annurev-physiol-021113-170255
   TATEMATSU M, 1984, AM J PATHOL, V114, P418
   Trautwein C, 1999, ONCOGENE, V18, P6443, DOI 10.1038/sj.onc.1203045
   Turányi E, 2010, HISTOPATHOLOGY, V57, P607, DOI 10.1111/j.1365-2559.2010.03668.x
   Vacca M, 2013, MOL CELL ENDOCRINOL, V368, P108, DOI 10.1016/j.mce.2012.06.025
   Yang SQ, 2004, HEPATOLOGY, V39, P403, DOI 10.1002/hep.20082
NR 31
TC 2
Z9 4
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 29
PY 2020
VL 15
IS 5
AR 0233736
DI 10.1371/journal.pone.0233736
PG 13
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA LU1WS
UT WOS:000537552800158
PM 32470002
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Edgar, D
   Trifunovic, A
AF Edgar, Daniel
   Trifunovic, Aleksandra
TI The mtDNA mutator mouse: Dissecting mitochondrial involvement in aging
SO AGING-US
LA English
DT Article
DE mtDNA mutator mice; mtDNA point mutations; mtDNA deletions; oxidative
   deficiency; premature aging
ID POINT MUTATIONS; DNA DELETIONS; MICE; AGE; ULTRASTRUCTURE; ACCUMULATION;
   DYSFUNCTION; MUSCLE; SITES; LIVER
AB The role of mtDNA mutations in aging has been intensely debated because of their low abundance and correlative connection with aging. The creation of mtDNA mutator mice provided the first evidence that somatic mtDNA mutations have the capacity to cause a variety of aging phenotypes in mammals, and they do so without inducing ROS production or increasing oxidative stress. We have recently provided evidence that the accumulation of point mutations in mtDNA leads to the synthesis of respiratory chain subunits with amino acid substitutions that impair complex stability in mtDNA mutator mice. Furthermore, we have demonstrated that the point mutations cause progressive respiratory chain deficiency, which, we propose, leads to premature aging. These results have been challenged by another group working on a similar model, who argues that the point mutations in mtDNA we found at very high levels in mtDNA mutator mice do not cause the phenotype. Instead, they argue that circular mtDNA molecules with large deletions, are the culprit. This intense debate about molecular mechanism of mitochondrial dysfunction that is causing progeroid phenotypes in the mtDNA mutator mice is the main topic of this research perspective.
C1 [Trifunovic, Aleksandra] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany.
   [Edgar, Daniel; Trifunovic, Aleksandra] Karolinska Inst, Div Metab Dis, Dept Lab Med, S-14186 Stockholm, Sweden.
C3 University of Cologne; Karolinska Institutet
RP Trifunovic, A (corresponding author), Univ Cologne, CECAD Cologne Excellent Aging Res, Inst Genet, Zulpicher Str 47, D-50674 Cologne, Germany.
EM aleksandra.trifunovic@ki.se
RI Trifunovic, Aleksandra/HHZ-1296-2022
OI Trifunovic, Aleksandra/0000-0002-5472-3517
FU Deutsche Forschungsgemeinschaft; Vetenskapradet; Angstromke Wiberg
   Foundation; Loo&Hans Ostermans Foundation
FX A. T. is supported by grants from the Deutsche Forschungsgemeinschaft,
   Vetenskapradet, angstrom ke Wiberg Foundation, and Loo&Hans Ostermans
   Foundation.
CR Bailey LJ, 2009, NUCLEIC ACIDS RES, V37, P2327, DOI 10.1093/nar/gkp091
   BATTEY J, 1978, CELL, V14, P143, DOI 10.1016/0092-8674(78)90309-4
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Greaves LC, 2009, AGING CELL, V8, P566, DOI 10.1111/j.1474-9726.2009.00505.x
   HERBENER GH, 1976, J GERONTOL, V31, P8, DOI 10.1093/geronj/31.1.8
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Kraytsberg Y, 2009, AGING CELL, V8, P502, DOI 10.1111/j.1474-9726.2009.00484.x
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   MICHAELS GS, 1982, DEV BIOL, V94, P246, DOI 10.1016/0012-1606(82)90088-4
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   SAMORAJSKI T, 1971, J GERONTOL, V26, P542, DOI 10.1093/geronj/26.4.542
   Sastre J, 1998, FREE RADICAL BIO MED, V24, P298, DOI 10.1016/S0891-5849(97)00228-1
   Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102
   Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010
   TATE EL, 1976, J GERONTOL, V31, P129, DOI 10.1093/geronj/31.2.129
   Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wallace D C, 2001, Novartis Found Symp, V235, P247
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   WILSON PD, 1975, BIOCHEM SOC T, V3, P126, DOI 10.1042/bst0030126
   WILSON PD, 1975, GERONTOLOGY, V21, P81, DOI 10.1159/000212035
NR 28
TC 47
Z9 54
U1 0
U2 6
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD DEC
PY 2009
VL 1
IS 12
BP 1028
EP 1032
DI 10.18632/aging.100109
PG 5
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 579VA
UT WOS:000276403100008
PM 20157586
OA Green Submitted, gold, Green Published
DA 2024-02-19
ER

PT J
AU Miquel, J
   Martinez, M
   Diez, A
   DeJuan, E
   Soler, A
   Ramirez, A
   Laborda, J
   Carrion, M
AF Miquel, J
   Martinez, M
   Diez, A
   DeJuan, E
   Soler, A
   Ramirez, A
   Laborda, J
   Carrion, M
TI Effects of turmeric on blood and liver lipoperoxide levels of mice: Lack
   of toxicity
SO AGE
LA English
DT Article
ID ANTIOXIDANT ACTIVITY; CURCUMA-LONGA; CURCUMINOIDS
AB We have investigated the effects on blood and liver lipoperoxide levels of turmeric, a potent antioxidant (from the rhizome of Curcuma Longa) which is extensively used as a food additive in India and other Asiatic and Central American countries, This study was performed on female Swiss mice that were 17 +/- 2 week old at the start of the experiment, A control group of 20 mice was fed the standard diet and another 20 animals received in their food 4 mg/Kg mouse/day of hydroalcoholic extract of turmeric, equivalent to 0.4 mg/Kg mouse/day of the phenolic antioxidant curcumin, This concentration is similar to that used in our current testing of turmeric on human subjects, The effects of the treatment were determined weekly by measuring food intake, body weight and muscular and CNS function (evaluating performance of mice subjected to string and T-maze tests), After four weeks of treatment, the mice were sacrificed and blood and liver samples were removed for determination of lipid peroxidation (measuring malondialdehyde content by the thiobarbituric acid method).
   The treatment with turmeric did not result in any toxic effects on the above physiological, behavioral and biochemical parameters, On the other hand, our data show a decrease in the level of both plasma and liver lipid peroxides, In our opinion, these preliminary data justify further animal investigations on the effects of treatment with this antioxidant not only on lipid peroxidation, but also on atherogenesis and senescence, since, according to the radical theory of aging, they man be linked to peroxidative changes.
C1 UNIV ALICANTE,SCH MED,E-03080 ALACANT,SPAIN.
   IBERMUTUA,ALACANT,SPAIN.
   ASAC PHARMACEUT INT AIE,ALACANT,SPAIN.
C3 Universitat d'Alacant
RI Martínez-Banaclocha, Marcos/AAG-5626-2020
OI Martínez-Banaclocha, Marcos/0000-0003-2639-7205
CR AMMON HPT, 1991, PLANTA MED, V57, P1, DOI 10.1055/s-2006-960004
   ARUNA K, 1990, INDIAN J EXP BIOL, V28, P1008
   AZUINE MA, 1992, NUTR CANCER, V17, P77, DOI 10.1080/01635589209514174
   BHAVANISHANKAR TN, 1980, INDIAN J EXP BIOL, V18, P73
   FLEMING JE, 1982, GERONTOLOGY, V28, P44, DOI 10.1159/000212510
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARMAN D, 1978, AGE, V1, P145
   Harman D., 1986, FREE RADICALS AGING, P3
   Harman D., 1992, FREE RADICALS AGING, P1
   HENNIG B, 1988, FREE RADICAL BIO MED, V4, P99, DOI 10.1016/0891-5849(88)90070-6
   JITOE A, 1992, J AGR FOOD CHEM, V40, P1337, DOI 10.1021/jf00020a008
   KLEINVELD HA, 1994, ARTERIOSCLER THROMB, V14, P1386, DOI 10.1161/01.ATV.14.8.1386
   LIPPMAN RD, 1989, HDB FREE RADICALS AN, V1, P187
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MASUDA T, 1992, PHYTOCHEMISTRY, V31, P3645, DOI 10.1016/0031-9422(92)83748-N
   MIQUEL J, 1992, MUTAT RES, V275, P209, DOI 10.1016/0921-8734(92)90024-J
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   MIQUEL J, 1978, EXP GERONTOL, V13, P389, DOI 10.1016/0531-5565(78)90049-9
   MIQUEL J, 1994, FACTS RES GERONTOL, V8, P28
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   SAMBAIAH K, 1982, J FOOD SCI TECH MYS, V19, P187
   SHARMA OP, 1976, BIOCHEM PHARMACOL, V25, P1811, DOI 10.1016/0006-2952(76)90421-4
   SONI KB, 1992, CANCER LETT, V66, P115, DOI 10.1016/0304-3835(92)90223-I
   TODA S, 1985, CHEM PHARM BULL, V33, P1725
   WEBER H, 1986, NUTR ASPECTS AGING, V1, P42
NR 25
TC 12
Z9 14
U1 0
U2 2
PU AMER AGING ASSOC
PI CHESTER
PA 2129 PROVIDENCE AVENUE, CHESTER, PA 19013
SN 0161-9152
J9 AGE
JI Age
PD OCT
PY 1995
VL 18
IS 4
BP 171
EP 174
DI 10.1007/BF02432632
PG 4
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA UF390
UT WOS:A1995UF39000004
DA 2024-02-19
ER

PT J
AU SRIVASTAVA, VK
   BUSBEE, DL
AF SRIVASTAVA, VK
   BUSBEE, DL
TI DECREASED FIDELITY OF DNA-POLYMERASES AND DECREASED DNA EXCISION REPAIR
   IN AGING MICE - EFFECTS OF CALORIC RESTRICTION
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
ID HUMAN-FIBROBLASTS; DIETARY RESTRICTION; MOLECULAR-BIOLOGY; LIFE-SPAN;
   ALPHA; REPLICATION; LYMPHOCYTES; DELTA; LIVER; CELLS
C1 TEXAS A&M UNIV SYST, COLL VET MED, DEPT ANAT & PUBL HLTH, DIV CELL BIOL, COLLEGE STN, TX 77843 USA.
   TEXAS A&M UNIV SYST, COLL MED, DEPT PHYSIOL, COLLEGE STN, TX 77843 USA.
C3 Texas A&M University System; Texas A&M University College Station; Texas
   A&M University System; Texas A&M University College Station
FU NIA NIH HHS [AG07739, AG06347] Funding Source: Medline
CR AGARWAL SS, 1978, J CELL PHYSIOL, V96, P235, DOI 10.1002/jcp.1040960212
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Burnet M., 1974, INTRINSIC MUTAGENESI
   BYRNES JJ, 1977, BIOCHEMISTRY-US, V16, P3740, DOI 10.1021/bi00636a002
   CURTINS JH, 1973, NATURE, V244, P441
   CURTIS HJ, 1971, ADV GENET, V16, P305, DOI 10.1016/S0065-2660(08)60361-2
   DIGIUSEPPE JA, 1989, BIOCHEMISTRY-US, V28, P9515, DOI 10.1021/bi00450a040
   DONALDSON RW, 1987, P NATL ACAD SCI USA, V84, P759, DOI 10.1073/pnas.84.3.759
   DOWNEY KM, 1990, BIOESSAYS, V12, P231, DOI 10.1002/bies.950120507
   FRY M, 1986, ANIMAL CELL DNA POLY, P13
   GROSS L, 1990, P NATL ACAD SCI USA, V87, P6795, DOI 10.1073/pnas.87.17.6795
   HART RW, 1974, P NATL ACAD SCI USA, V71, P2169, DOI 10.1073/pnas.71.6.2169
   HOLLIDAY R, 1972, NATURE, V238, P26, DOI 10.1038/238026a0
   KRAUSS SW, 1982, BIOCHEMISTRY-US, V21, P1002, DOI 10.1021/bi00534a027
   KRAUSS SW, 1987, J BIOL CHEM, V262, P3432
   KRAUSS SW, 1980, BIOCHEMISTRY-US, V19, P220, DOI 10.1021/bi00542a033
   LICASTRO F, 1986, MECH AGEING DEV, V35, P123, DOI 10.1016/0047-6374(86)90003-5
   LINDELL TJ, 1982, LIFE SCI, V31, P625, DOI 10.1016/0024-3205(82)90763-9
   LINN S, 1976, P NATL ACAD SCI USA, V73, P2818, DOI 10.1073/pnas.73.8.2818
   LINN S, 1991, CELL, V66, P185, DOI 10.1016/0092-8674(91)90608-2
   LIPMAN JM, 1989, MECH AGEING DEV, V48, P135, DOI 10.1016/0047-6374(89)90045-6
   MILLER RC, 1977, EXP CELL RES, V110, P63, DOI 10.1016/0014-4827(77)90270-1
   MODAK SP, 1972, CELL DIFFER, P439
   MURRAY V, 1981, J MOL BIOL, V146, P55, DOI 10.1016/0022-2836(81)90366-1
   OBENRADER M, 1974, EXP GERONTOL, V9, P181, DOI 10.1016/0531-5565(74)90035-7
   ORGEL LE, 1973, NATURE, V244, P441, DOI 10.1038/243441a0
   OVE P, 1972, BIOCHIM BIOPHYS ACTA, V277, P211, DOI 10.1016/0005-2787(72)90367-X
   PLESKO MM, 1984, BIOCHEM BIOPH RES CO, V118, P730, DOI 10.1016/0006-291X(84)91455-4
   REGAN JD, 1974, CANCER RES, V34, P3318
   RICHARDSON A, 1982, LIFE SCI, V31, P605, DOI 10.1016/0024-3205(82)90761-5
   SAXENA JK, 1990, NUCLEIC ACIDS RES, V18, P7425, DOI 10.1093/nar/18.24.7425
   SEGLEN PO, 1973, EXP CELL RES, V82, P391, DOI 10.1016/0014-4827(73)90357-1
   SO AG, 1988, BIOCHEMISTRY-US, V27, P4591, DOI 10.1021/bi00413a001
   SRIVASTAVA VK, 1991, EXP GERONTOL, V26, P453, DOI 10.1016/0531-5565(91)90034-J
   SRIVASTAVA VK, 1991, EXP GERONTOL, V26, P97, DOI 10.1016/0531-5565(91)90066-U
   SUZUKI F, 1980, EXP CELL RES, V127, P299, DOI 10.1016/0014-4827(80)90436-X
   SYLVIA V, 1988, CELL, V54, P651, DOI 10.1016/S0092-8674(88)80009-6
   SZILARD L, 1959, P NATL ACAD SCI USA, V45, P30, DOI 10.1073/pnas.45.1.30
   WEINDRUCH R, 1988, REDUCTION AGEING DIS
   WERAARCHAKUL N, 1989, EXP CELL RES, V181, P197, DOI 10.1016/0014-4827(89)90193-6
   WHELDON TE, 1973, J THEOR BIOL, V42, P107, DOI 10.1016/0022-5193(73)90150-1
NR 41
TC 27
Z9 28
U1 0
U2 0
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD JAN 31
PY 1992
VL 182
IS 2
BP 712
EP 721
DI 10.1016/0006-291X(92)91790-W
PG 10
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA HC397
UT WOS:A1992HC39700041
PM 1734878
DA 2024-02-19
ER

PT J
AU Li, JY
   Yu, YG
   Yang, YJ
   Liu, XW
   Zhang, JY
   Li, B
   Zhou, XZ
   Niu, JR
   Wei, XJ
AF Li, Jianyong
   Yu, Yuanguang
   Yang, Yajun
   Liu, Xiwang
   Zhang, Jiyu
   Li, Bing
   Zhou, Xuzheng
   Niu, Jianrong
   Wei, Xiaojuan
TI Antioxidant Activity of Aspirin Eugenol Ester for Aging Model of Mice by
   D-Galactose
SO JOURNAL OF ANIMAL AND VETERINARY ADVANCES
LA English
DT Article
DE Aspirin Eugenol Ester (AEE); antioxidant; mice; liver; heart; China
ID IN-VIVO; ANTIINFLAMMATORY DRUGS; XANTHINE-OXIDASE; BIOSYNTHESIS;
   MECHANISM; DAMAGE; RATS; CYCLOOXYGENASE; INHIBITION; VITRO
AB Antioxidant activity of Aspirin Eugenol Ester (AEE) for aging model of mice by D-galactose for 8 weeks was investigated. MICA and lipofuscin contents of mice serum and heart, liver were selected as indexes to reflect antioxidant activity. The results showed that the small doses of AEE can effectively remove free radicals caused by D-galactose and large doses of AEE can make free radicals level below the normal level. There were some relationships between dose and effect Compared with precursor drug aspirin and eugenol, AEE also has stronger antioxidant activity.
C1 [Li, Jianyong; Yang, Yajun; Liu, Xiwang; Zhang, Jiyu; Li, Bing; Zhou, Xuzheng; Niu, Jianrong; Wei, Xiaojuan] Inst Husb & Pharmaceut Sci CAAS, Minist Agr, Key Lab Vet Pharmaceut Dev, Key Lab New Anim Drug Project, Lanzhou 730050, Gansu, Peoples R China.
   [Yu, Yuanguang] Lanzhou Inst Vet Sci CAAS, Lanzhou 730030, Peoples R China.
C3 Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural
   Sciences; Lanzhou Institute of Husbandry & Pharmaceutical Sciences, CAAS
RP Li, JY (corresponding author), 335 Jiangouyan, Lanzhou 730050, Peoples R China.
RI Chen, Xin/JDN-2017-2023; WANG, JINGYI/GSJ-1241-2022
FU special project of fundamental scientific research professional fund for
   Central Public Welfare Scientific Research Institute [2012ZL085]; China
   Agriculture Research System [cars-38]
FX The project was supported by special project of fundamental scientific
   research professional fund for Central Public Welfare Scientific
   Research Institute (2012ZL085) and the earmarked fund for China
   Agriculture Research System (cars-38).
CR Bandyopadhyay U, 1999, CURR SCI INDIA, V77, P658
   Blander G, 2003, J BIOL CHEM, V278, P38966, DOI 10.1074/jbc.M307146200
   Chami N, 2005, ORAL MICROBIOL IMMUN, V20, P106, DOI 10.1111/j.1399-302X.2004.00202.x
   Chen Q., 2006, CHIN ANIM HUSBANDRY, V33, P106
   Chen Q., 1996, EXPT METHODS ANTIAGI
   Exner M, 2000, FEBS LETT, V470, P47, DOI 10.1016/S0014-5793(00)01289-8
   FENG J, 1987, NEUROPHARMACOLOGY, V26, P1775, DOI 10.1016/0028-3908(87)90131-6
   FLOWER R, 1972, NATURE-NEW BIOL, V238, P104, DOI 10.1038/newbio238104a0
   Gill AO, 2004, APPL ENVIRON MICROB, V70, P5750, DOI 10.1128/AEM.70.10.5750-5755.2004
   GRANGER DN, 1988, AM J PHYSIOL, V255, pH1269, DOI 10.1152/ajpheart.1988.255.6.H1269
   HASHIMOTO S, 1988, J DENT RES, V67, P1092, DOI 10.1177/00220345880670080601
   Hassan A, 1998, METHOD FIND EXP CLIN, V20, P849, DOI 10.1358/mf.1998.20.10.487540
   Li J, 2010, ANIM HUSBAND VET MED, V42, P20
   Li J., 2012, MED CHEM RES, V21, P995
   Li Jian-yong, 2011, Zhongguo Yaolixue Yu Dulixue Zazhi, V25, P57, DOI 10.3867/j.issn.1000-3002.2011.01.011
   Li JY, 2012, FOOD CHEM TOXICOL, V50, P1980, DOI 10.1016/j.fct.2012.03.080
   Nagababu E, 1997, MOL CELL BIOCHEM, V166, P65, DOI 10.1023/A:1006878315029
   Ogata M, 2000, CHEM PHARM BULL, V48, P1467
   PATRONO C, 1989, TRENDS PHARMACOL SCI, V10, P453, DOI 10.1016/S0165-6147(89)80010-0
   Raghavendra RH, 2009, PROSTAG LEUKOTR ESS, V81, P73, DOI 10.1016/j.plefa.2009.04.009
   Schoemaker RG, 1998, CARDIOVASC RES, V37, P108, DOI 10.1016/S0008-6363(97)00208-3
   SCHULZEOSTHOFF K, 1992, J BIOL CHEM, V267, P5317
   SUN Y, 1990, FREE RADICAL BIO MED, V8, P583, DOI 10.1016/0891-5849(90)90156-D
   Tragoolpua Y, 2007, PHYTOTHER RES, V21, P1153, DOI 10.1002/ptr.2226
   VANE J, 1987, FASEB J, V1, P89, DOI 10.1096/fasebj.1.2.3111928
   VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0
   Wallenburg H. C., 1986, LANCET, V327, P1
   Ye D., 2011, CHIN J PHARM TOXICOL, V25, P1
NR 28
TC 6
Z9 6
U1 0
U2 2
PU MEDWELL ONLINE
PI FAISALABAD
PA ANSINET BUILDING, 308-LASANI TOWN, SARGODHA RD, FAISALABAD, 38090,
   PAKISTAN
SN 1680-5593
J9 J ANIM VET ADV
JI J. Anim. Vet. Adv.
PY 2012
VL 11
IS 23
BP 4401
EP 4405
PG 5
WC Veterinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Veterinary Sciences
GA 129EC
UT WOS:000317820600018
DA 2024-02-19
ER

PT J
AU Oshida, K
   Vasani, N
   Waxman, DJ
   Corton, JC
AF Oshida, Keiyu
   Vasani, Naresh
   Waxman, David J.
   Corton, J. Christopher
TI Disruption of STAT5b-Regulated Sexual Dimorphism of the Liver
   Transcriptome by Diverse Factors Is a Common Event
SO PLOS ONE
LA English
DT Article
ID GROWTH-HORMONE-SECRETION; FEMALE MOUSE-LIVER; GENE-EXPRESSION; SIGNAL
   TRANSDUCER; GLUCOCORTICOID-RECEPTOR; NUCLEAR FACTOR-4-ALPHA; MICROARRAY
   ANALYSIS; BODY GROWTH; CROSS-TALK; GH ACTION
AB Signal transducer and activator of transcription 5b (STAT5b) is a growth hormone (GH)-activated transcription factor and a master regulator of sexually dimorphic gene expression in the liver. Disruption of the GH hypothalamo-pituitary-liver axis controlling STAT5b activation can lead to metabolic dysregulation, steatosis, and liver cancer. Computational approaches were developed to identify factors that disrupt STAT5b function in a mouse liver gene expression compendium. A biomarker comprised of 144 STAT5b-dependent genes was derived using comparisons between wild-type male and wild-type female mice and between STAT5b-null and wild-type mice. Correlations between the STAT5b biomarker gene set and a test set comprised of expression datasets (biosets) with known effects on STAT5b function were evaluated using a rank-based test (the Running Fisher algorithm). Using a similarity p-value <= 10(-4), the test achieved a balanced accuracy of 99% and 97% for detection of STAT5b activation or STAT5b suppression, respectively. The STAT5b biomarker gene set was then used to identify factors that activate (masculinize) or suppress (feminize) STAT5b function in an annotated mouse liver and primary hepatocyte gene expression compendium of similar to 1,850 datasets. Disruption of GH-regulated STAT5b is a common phenomenon in liver in vivo, with 5% and 29% of the male datasets, and 11% and 13% of the female datasets, associated with masculinization or feminization, respectively. As expected, liver STAT5b activation/masculinization occurred at puberty and suppression/feminization occurred during aging and in mutant mice with defects in GH signaling. A total of 70 genes were identified that have effects on STAT5b activation in genetic models in which the gene was inactivated or overexpressed. Other factors that affected liver STAT5b function were shown to include fasting, caloric restriction and infections. Together, these findings identify diverse factors that perturb the hypothalamo-pituitary-liver GH axis and disrupt GH-dependent STAT5b activation in mouse liver.
C1 [Oshida, Keiyu; Vasani, Naresh; Corton, J. Christopher] US EPA, Integrated Syst Toxicol Div, NHEERL ORD, Res Triangle Pk, NC 27711 USA.
   [Waxman, David J.] Boston Univ, Dept Biol, Div Cell & Mol Biol, Boston, MA 02215 USA.
   [Waxman, David J.] Boston Univ, Bioinformat Program, Boston, MA 02215 USA.
   [Oshida, Keiyu] Toray Industries Ltd, Kamakura, Kanagawa, Japan.
C3 United States Environmental Protection Agency; Boston University; Boston
   University; Toray Industries, Inc.
RP Corton, JC (corresponding author), US EPA, Integrated Syst Toxicol Div, NHEERL ORD, Res Triangle Pk, NC 27711 USA.
EM corton.chris@epa.gov
RI Vasani, Naresh B/K-9082-2019
OI Vasani, Naresh/0000-0003-4814-3310; Waxman, David/0000-0001-7982-9206
FU U.S. Environmental Protection Agency; NIH [DK33765]
FX The information in this document has been funded in part by the U.S.
   Environmental Protection Agency, and by NIH grant DK33765 (to DJW). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Barclay JL, 2010, MOL ENDOCRINOL, V24, P204, DOI 10.1210/me.2009-0233
   Bartke A, 2012, GERONTOLOGY, V58, P337, DOI 10.1159/000335166
   Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9
   Chia DJ, 2014, MOL ENDOCRINOL, V28, P1012, DOI 10.1210/me.2014-1099
   Choi HK, 1999, ENDOCRINOLOGY, V140, P5126, DOI 10.1210/en.140.11.5126
   Choi HK, 2000, ENDOCRINOLOGY, V141, P3245, DOI 10.1210/en.141.9.3245
   Choi HK, 2000, GROWTH HORM IGF RES, V10, P1, DOI 10.1016/S1096-6374(00)80002-7
   Clodfelter KH, 2007, PHYSIOL GENOMICS, V31, P63, DOI 10.1152/physiolgenomics.00055.2007
   Clodfelter KH, 2006, MOL ENDOCRINOL, V20, P1333, DOI 10.1210/me.2005-0489
   Collins LL, 2004, P NATL ACAD SCI USA, V101, P15058, DOI 10.1073/pnas.0405700101
   Conforto TL, 2012, MOL CELL BIOL, V32, P4611, DOI 10.1128/MCB.00886-12
   Conforto TL, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-9
   Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630
   Dhir RN, 2006, J PHARMACOL EXP THER, V316, P87, DOI 10.1124/jpet.105.093773
   Diczfalusy U, 2011, BRIT J CLIN PHARMACO, V71, P183, DOI 10.1111/j.1365-2125.2010.03773.x
   Fernando J, 2013, J IMMUNOL, V191, P4505, DOI 10.4049/jimmunol.1202723
   Frank SJ, 2001, GROWTH HORM IGF RES, V11, P201, DOI 10.1054/ghir.2001.0237
   Frijters R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-359
   FUJITA S, 1990, J PHARMACOL EXP THER, V253, P369
   Geter DR, 2014, TOXICOL SCI, V138, P425, DOI 10.1093/toxsci/kfu014
   Guo Q, 2012, EUR J IMMUNOL, V42, P1500, DOI 10.1002/eji.201142051
   Hand NJ, 2009, HEPATOLOGY, V49, P618, DOI 10.1002/hep.22656
   HARTMAN ML, 1993, HORM RES, V40, P37, DOI 10.1159/000183766
   Herrington J, 2001, TRENDS ENDOCRIN MET, V12, P252, DOI 10.1016/S1043-2760(01)00423-4
   Holloway MG, 2006, MOL ENDOCRINOL, V20, P647, DOI 10.1210/me.2005-0328
   Holloway MG, 2008, MOL ENDOCRINOL, V22, P1274, DOI 10.1210/me.2007-0564
   Holloway MG, 2007, ENDOCRINOLOGY, V148, P1977, DOI 10.1210/en.2006-1419
   Horvath CM, 2000, TRENDS BIOCHEM SCI, V25, P496, DOI 10.1016/S0968-0004(00)01624-8
   Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006
   JANSSON JO, 1985, ENDOCR REV, V6, P128, DOI 10.1210/edrv-6-2-128
   Jiang YJ, 2013, MECH AGEING DEV, V134, P407, DOI 10.1016/j.mad.2013.08.003
   Kang HS, 2011, DIABETES, V60, P177, DOI 10.2337/db10-0628
   Kim YD, 2012, J BIOL CHEM, V287, P37098, DOI 10.1074/jbc.M112.339887
   Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066
   Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939
   Laz EV, 2007, ENDOCRINOLOGY, V148, P3327, DOI 10.1210/en.2006-1192
   Lee C, 2012, CAN J PHYSIOL PHARM, V90, P1354, DOI [10.1139/y2012-099, 10.1139/Y2012-099]
   Lee JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024381
   Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098
   Lichanska AM, 2008, TRENDS GENET, V24, P41, DOI 10.1016/j.tig.2007.10.006
   Lin JX, 2000, ONCOGENE, V19, P2566, DOI 10.1038/sj.onc.1203523
   Ling GY, 2010, MOL CELL BIOL, V30, P5531, DOI 10.1128/MCB.00601-10
   Martinez CS, 2013, GROWTH HORM IGF RES, V23, P19, DOI 10.1016/j.ghir.2012.11.002
   Meinhardt UJ, 2007, ENDOCRIN METAB CLIN, V36, P57, DOI 10.1016/j.ecl.2006.11.009
   Mueller KM, 2012, MOL CELL ENDOCRINOL, V361, P1, DOI 10.1016/j.mce.2012.03.026
   Mugford CA, 1998, DRUG METAB REV, V30, P441, DOI 10.3109/03602539808996322
   Oberley CC, 2015, MOL CARCINOGEN, V54, P959, DOI 10.1002/mc.22165
   Oshida K, 2015, PLOS ONE UNPUB
   Oshida K, 2015, TOXICOLOGY, V336, P99, DOI 10.1016/j.tox.2015.07.005
   Oshida Keiyu, 2015, Nucl Recept Signal, V13, pe002, DOI 10.1621/nrs.13002
   Oshida K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0112655
   Park SH, 2001, J BIOL CHEM, V276, P43031, DOI 10.1074/jbc.M107597200
   Park SH, 2006, BIOCHEM J, V397, P159, DOI 10.1042/BJ20060332
   Parrish Rudolph S, 2004, J Biopharm Stat, V14, P575, DOI 10.1081/BIP-200025650
   Rowland JE, 2005, MOL CELL BIOL, V25, P66, DOI 10.1128/MCB.25.1.66-77.2005
   Schumacher B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000161
   Shi LM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S2-S12
   Shipley JM, 2004, TOXICOL APPL PHARM, V199, P275, DOI 10.1016/j.taap.2003.12.020
   Shipley JM, 2003, MOL PHARMACOL, V64, P355, DOI 10.1124/mol.64.2.355
   Steyn FJ, 2011, ENDOCRINOLOGY, V152, P3165, DOI 10.1210/en.2011-0253
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Sun K, 2009, HEPATOLOGY, V49, P1645, DOI 10.1002/hep.22834
   Tannenbaum GS, 2001, ENDOCRINOLOGY, V142, P4599, DOI 10.1210/en.142.11.4599
   Textoris J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012190
   Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498
   Veldhuis J D, 2001, Growth Horm IGF Res, V11 Suppl A, pS25, DOI 10.1016/S1096-6374(01)80005-8
   Waxman DJ, 2006, MOL ENDOCRINOL, V20, P2613, DOI 10.1210/me.2006-0007
   Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705
   WAXMAN DJ, 1995, J BIOL CHEM, V270, P13262, DOI 10.1074/jbc.270.22.13262
   Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605
   Woelfle J, 2003, J BIOL CHEM, V278, P51261, DOI 10.1074/jbc.M309486200
   Wolbold R, 2003, HEPATOLOGY, V38, P978, DOI 10.1053/jhep.2003.50393
   Yu JH, 2010, HEPATOLOGY, V52, P1808, DOI 10.1002/hep.23882
   Zhang YJ, 2012, MOL CELL BIOL, V32, P880, DOI 10.1128/MCB.06312-11
   Zhang Y, 2012, ELIFE, V1, DOI 10.7554/eLife.00065
   Zhang ZC, 2010, J BIOL CHEM, V285, P34718, DOI 10.1074/jbc.M110.126441
   Zhu P, 2007, MOL CELL, V27, P609, DOI 10.1016/j.molcel.2007.07.024
   Zhuang SG, 2013, CELL SIGNAL, V25, P1924, DOI 10.1016/j.cellsig.2013.05.007
NR 78
TC 36
Z9 39
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 9
PY 2016
VL 11
IS 3
AR e0148308
DI 10.1371/journal.pone.0148308
PG 27
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA DG3TF
UT WOS:000371992300002
PM 26959975
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT S
AU Goto, S
   Takahashi, R
   Kumiyama, A
   Radák, Z
   Hayashi, T
   Takenouchi, M
   Abe, R
AF Goto, S
   Takahashi, R
   Kumiyama, A
   Radák, Z
   Hayashi, T
   Takenouchi, M
   Abe, R
BE Park, SC
   Hwang, ES
   Kim, HS
   Park, WY
TI Implications of protein degradation in aging
SO HEALTHY AGING FOR FUNCTIONAL LONGEVITY: MOLECULAR AND CELLULAR
   INTERACTIONS IN SENESCENCE
SE Annals of the New York Academy of Sciences
LA English
DT Article; Proceedings Paper
CT Conference on Healthy Aging for Functional Longevity
CY FEB, 2000
CL KYONGJU, SOUTH KOREA
SP Federat Korean Gerontol Soc, Int Assoc BioMed Gerontol, Korea Sci & Engn Fdn, Korea Res Fdn, Korea Res Fdn Hlth Sci, Seoul Natl Univ
DE proteasomes; hepatocytes; dietary restriction; exercise; ubiquitin
ID BUTYL-ALPHA-PHENYLNITRONE; AGE-RELATED ACCUMULATION; RAT-LIVER;
   OXIDATIVE STRESS; GLUTAMINE-SYNTHETASE; DIETARY RESTRICTION; OXIDIZED
   PROTEINS; MAMMALIAN-CELLS; SKELETAL-MUSCLE; PROTEOLYSIS
AB Aging is characterized by accumulation of potentially harmful altered proteins that could lead to gradual deterioration of cellular functions and eventually result in increased probability of death. Metabolic turnover of proteins thus plays an essential role in maintaining the life of an organism. In this article we summarize our current knowledge on age-related changes in protein turnover with special reference to degradation. Increase in half-life of proteins with advancing age is well documented. Qualitative rather than quantitative changes of proteasomes appear to be responsible for this change. Dietary restriction and moderate long-term exercise seem to restore higher proteasome activity and turnover rate of proteins in aged animals.
C1 Toho Univ, Sch Pharmaceut Sci, Dept Biochem, Funabashi, Chiba 2748510, Japan.
   Hungarian Univ Phys Educ, Exercise Physiol Lab, Budapest, Hungary.
C3 Toho University; University of Physical Education
RP Goto, S (corresponding author), Toho Univ, Sch Pharmaceut Sci, Dept Biochem, 2-2-1 Miyama, Funabashi, Chiba 2748510, Japan.
EM goto@phar.toho-u.ac.jp
OI Radak, Zsolt/0000-0003-1297-6804
CR AGARWAL S, 1994, ARCH BIOCHEM BIOPHYS, V309, P24, DOI 10.1006/abbi.1994.1078
   Alves-Rodrigues A, 1998, TRENDS NEUROSCI, V21, P516, DOI 10.1016/S0166-2236(98)01276-4
   Arnold J, 1998, PROG BRAIN RES, V117, P23
   BLAIR SN, 1995, JAMA-J AM MED ASSOC, V273, P1093, DOI 10.1001/jama.273.14.1093
   Butterfield DA, 1997, P NATL ACAD SCI USA, V94, P674, DOI 10.1073/pnas.94.2.674
   CALOW P, 1978, GERONTOLOGY, V24, P448, DOI 10.1159/000212285
   CAO GH, 1995, ARCH BIOCHEM BIOPHYS, V320, P195, DOI 10.1006/abbi.1995.1359
   CARNEY JM, 1991, P NATL ACAD SCI USA, V88, P3633, DOI 10.1073/pnas.88.9.3633
   Conconi M, 1996, ARCH BIOCHEM BIOPHYS, V331, P232, DOI 10.1006/abbi.1996.0303
   Cotman CW, 1996, NEUROBIOL AGING, V17, P723
   Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101
   DAVIES KJA, 1982, BIOCHEM BIOPH RES CO, V107, P1198, DOI 10.1016/S0006-291X(82)80124-1
   ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6
   GERSHON D, 1979, MECH AGEING DEV, V9, P189, DOI 10.1016/0047-6374(79)90098-8
   Girotti AW, 1998, J LIPID RES, V39, P1529
   Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076
   Hayashi T, 1998, MECH AGEING DEV, V102, P55, DOI 10.1016/S0047-6374(98)00011-6
   Holliday R, 1996, EXP GERONTOL, V31, P449, DOI 10.1016/0531-5565(96)00008-3
   IKEDA T, 1992, ARCH GERONTOL GERIAT, V15, P181, DOI 10.1016/0167-4943(92)90017-X
   Iqbal K, 1998, J NEURAL TRANSM-SUPP, P169
   ISHIGAMI A, 1990, ARCH BIOCHEM BIOPHYS, V283, P362, DOI 10.1016/0003-9861(90)90655-I
   Keller JN, 2000, MECH AGEING DEV, V113, P61, DOI 10.1016/S0047-6374(99)00101-3
   LAVIE L, 1982, BIOCHEM J, V202, P47, DOI 10.1042/bj2020047
   LEVIS CM, 1972, MECH AGEING DEV, V1, P43
   Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897
   MEDVEDEV ZA, 1980, MECH AGEING DEV, V14, P1, DOI 10.1016/0047-6374(80)90102-5
   Medvedev Zhores A, 1962, BIOL ASPECTS AGEING, P255
   Mezey E, 1998, NAT MED, V4, P755, DOI 10.1038/nm0798-755
   MORI N, 1983, MECH AGEING DEV, V22, P1, DOI 10.1016/0047-6374(83)90002-7
   OHTSUKA H, 1995, J GERONTOL A-BIOL, V50, pB277, DOI 10.1093/gerona/50A.5.B277
   OKADA CY, 1982, CELL, V29, P33, DOI 10.1016/0092-8674(82)90087-3
   ORGEL LE, 1963, P NATL ACAD SCI USA, V49, P517, DOI 10.1073/pnas.49.4.517
   Ottonello S, 2000, OPHTHALMOLOGICA, V214, P78, DOI 10.1159/000027474
   Radák Z, 1998, PFLUG ARCH EUR J PHY, V435, P439, DOI 10.1007/s004240050537
   Radák Z, 2001, NEUROCHEM INT, V38, P17, DOI 10.1016/S0197-0186(00)00063-2
   Radák Z, 1999, FREE RADICAL BIO MED, V27, P69, DOI 10.1016/S0891-5849(99)00038-6
   Radak Z., 1998, OXIDATIVE STRESS SKE, P87
   REZNICK AZ, 1981, FEBS LETT, V128, P221, DOI 10.1016/0014-5793(81)80085-3
   REZNICK AZ, 1992, BIOCHEM BIOPH RES CO, V189, P801, DOI 10.1016/0006-291X(92)92273-Z
   RIVETT AJ, 1985, J BIOL CHEM, V260, P300
   ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6
   ROTHSTEIN M, 1983, ALTERED PROTEINS AGI, P2
   SAHAKIAN JA, 1995, ARCH BIOCHEM BIOPHYS, V318, P411, DOI 10.1006/abbi.1995.1248
   SARNA S, 1993, MED SCI SPORT EXER, V25, P237
   Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096
   SHARMA HK, 1979, ARCH BIOCHEM BIOPHYS, V194, P275, DOI 10.1016/0003-9861(79)90619-2
   Shibatani T, 1996, J GERONTOL A-BIOL, V51, pB316, DOI 10.1093/gerona/51A.5.B316
   STARKEREED PE, 1989, ARCH BIOCHEM BIOPHYS, V275, P559, DOI 10.1016/0003-9861(89)90402-5
   TAKAHASHI R, 1987, ARCH BIOCHEM BIOPHYS, V257, P200, DOI 10.1016/0003-9861(87)90559-5
   TAKAHASHI R, 1988, EUR J BIOCHEM, V178, P381, DOI 10.1111/j.1432-1033.1988.tb14461.x
   TANAKA K, 1986, J BIOL CHEM, V261, P5197
   Vittorini S, 1999, J GERONTOL A-BIOL, V54, pB318, DOI 10.1093/gerona/54.8.B318
   Weindruch R, 1996, SCI AM, V274, P46, DOI 10.1038/scientificamerican0196-46
   Yu Byung P., 1995, P613
NR 54
TC 66
Z9 70
U1 0
U2 5
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
BN 1-57331-285-1
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2001
VL 928
BP 54
EP 64
PG 11
WC Biochemistry & Molecular Biology; Geriatrics & Gerontology;
   Multidisciplinary Sciences
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Geriatrics & Gerontology; Science &
   Technology - Other Topics
GA BT10T
UT WOS:000171969700005
PM 11795528
DA 2024-02-19
ER

PT J
AU Hager, M
   Chang, P
   Lee, M
   Burns, CM
   Endicott, SJ
   Miller, RA
   Li, XN
AF Hager, Mary
   Chang, Peter
   Lee, Michael
   Burns, Calvin M.
   Endicott, S. Joseph
   Miller, Richard A.
   Li, Xinna
TI Recapitulation of anti-aging phenotypes by global overexpression of PTEN
   in mice
SO GEROSCIENCE
LA English
DT Article; Early Access
DE Slow-aging mice; Aging; Macrophage; Adipose tissue; Hippocampus; Liver;
   Phosphatase and tensin homolog (PTEN); Uncoupling protein 1 (UCP1);
   Fibronectin type III domain-containing protein 5 (FNDC5)/IRISIN;
   Glycosylphosphatidylinositol-specific phospholipase D1 (GPLD1);
   Brain-derived neurotrophic factor (BDNF); Doublecortin (DCX))
ID MICROTUBULE-ASSOCIATED PROTEIN; WHITE ADIPOSE-TISSUE; LIFE-SPAN;
   TUMOR-SUPPRESSOR; MACROPHAGE POLARIZATION; SNELL DWARF; BROWN-FAT;
   EXPRESSION; AGE; EXERCISE
AB The PTEN gene negatively regulates the oncogenic PI3K-AKT pathway by encoding a lipid and protein phosphatase that dephosphorylates lipid phosphatidylinositol-3,4,5-triphosphate (PIP3) resulting in the inhibition of PI3K and downstream inhibition of AKT. Overexpression of PTEN in mice leads to a longer lifespan compared to control littermates, although the mechanism is unknown. Here, we provide evidence that young adult PTENOE mice exhibit many characteristics shared by other slow-aging mouse models, including those with mutations that affect GH/IGF1 pathways, calorie-restricted mice, and mice treated with anti-aging drugs. PTENOE white adipose tissue (WAT) has increased UCP1, a protein linked to increased thermogenesis. WAT of PTENOE mice also shows a change in polarization of fat-associated macrophages, with elevated levels of arginase 1 (Arg1, characteristic of M2 macrophages) and decreased production of inducible nitric oxide synthase (iNOS, characteristic of M1 macrophages). Muscle and hippocampus showed increased expression of the myokine FNDC5, and higher levels of its cleavage product irisin in plasma, which has been linked to increased conversion of WAT to more thermogenic beige/brown adipose tissue. PTENOE mice also have an increase, in plasma and liver, of GPLD1, which is known to improve cognition in mice. Hippocampus of the PTENOE mice has elevation of both BDNF and DCX, indices of brain resilience and neurogenesis. These changes in fat, macrophages, liver, muscle, hippocampus, and plasma may be considered "aging rate indicators" in that they seem to be consistently changed across many of the long-lived mouse models and may help to extend lifespan by delaying many forms of late-life illness. Our new findings show that PTENOE mice can be added to the group of long-lived mice that share this multi-tissue suite of biochemical characteristics.
C1 [Hager, Mary; Chang, Peter; Lee, Michael] Univ Michigan, Coll Literature Sci & Arts, Ann Arbor, MI 48109 USA.
   [Burns, Calvin M.; Endicott, S. Joseph; Miller, Richard A.; Li, Xinna] Univ Michigan, Dept Pathol, Sch Med, Room 3160,BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.
   [Endicott, S. Joseph; Miller, Richard A.; Li, Xinna] Univ Michigan, Geriatr Ctr, Ann Arbor, MI 48109 USA.
C3 University of Michigan System; University of Michigan; University of
   Michigan System; University of Michigan; University of Michigan System;
   University of Michigan
RP Li, XN (corresponding author), Univ Michigan, Dept Pathol, Sch Med, Room 3160,BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.; Li, XN (corresponding author), Univ Michigan, Geriatr Ctr, Ann Arbor, MI 48109 USA.
EM xinna@umich.edu
FU National Institute on Aging
FX We are very grateful to Manuel Serrano (Institute for Research in
   Biomedicine, Barcelona, Spain) and Daniel Herranz (Rutgers University,
   New Brunswick, NJ, USA) for creating and sharing PTENOE mouse breeders,
   respectively. We thank Lori Roberts, Ilkim Erturk, Jacob Sheets, Robert
   Dilg, Trevor Davis, Micah Bush, and Lindsey Burger for expert animal
   care.
CR Altintas O, 2016, BMB REP, V49, P81, DOI 10.5483/BMBRep.2016.49.2.261
   Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937
   Boss Olivier, 2012, Front Endocrinol (Lausanne), V3, P14, DOI 10.3389/fendo.2012.00014
   Boström P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777
   BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0
   Buchman AS, 2016, NEUROLOGY, V86, P735, DOI 10.1212/WNL.0000000000002387
   Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240
   Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247
   Casaletto KB, 2020, J ALZHEIMERS DIS, V74, P363, DOI 10.3233/JAD-191114
   Chadborn NH, 2006, J CELL SCI, V119, P951, DOI 10.1242/jcs.02801
   Chen Y, 2019, INT REV IMMUNOL, V38, P249, DOI 10.1080/08830185.2019.1645138
   Conover CA, 2007, AGING CELL, V6, P727, DOI 10.1111/j.1474-9726.2007.00328.x
   Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608
   Costantini A, 2018, AGING-US, V10, P1268, DOI 10.18632/aging.101465
   Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x
   Dominick G, 2017, AGING CELL, V16, P52, DOI 10.1111/acel.12525
   Dominick G, 2015, ENDOCRINOLOGY, V156, P565, DOI 10.1210/en.2014-1690
   Dun SL, 2013, NEUROSCIENCE, V240, P155, DOI 10.1016/j.neuroscience.2013.02.050
   Endicott SJ, 2021, AUTOPHAGY, V17, P612, DOI 10.1080/15548627.2020.1725378
   Erickson CA, 2003, EXP GERONTOL, V38, P61, DOI 10.1016/S0531-5565(02)00160-2
   Erickson KI, 2012, NEUROSCIENTIST, V18, P82, DOI 10.1177/1073858410397054
   Exley MA, 2014, J ENDOCRINOL, V223, pR41, DOI 10.1530/JOE-13-0516
   Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014
   Ferrer-Martínez A, 2002, DEV DYNAM, V224, P154, DOI 10.1002/dvdy.10099
   Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898
   Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539
   Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1
   Fuentes L, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/219583
   Fujisaka S, 2016, DIABETOL INT, V7, P342, DOI 10.1007/s13340-016-0290-y
   Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030
   Germano G, 2013, CANCER CELL, V23, P249, DOI 10.1016/j.ccr.2013.01.008
   Ghahrizjani FA, 2015, GENE, V557, P123, DOI 10.1016/j.gene.2014.12.010
   Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3
   Grohmann U, 2001, J IMMUNOL, V167, P221, DOI 10.4049/jimmunol.167.1.221
   Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361
   Hofmann JW, 2015, CELL, V160, P477, DOI 10.1016/j.cell.2014.12.016
   Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037
   Horowitz AM, 2020, SCIENCE, V369, P167, DOI 10.1126/science.aaw2622
   Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677
   Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002
   Inokuma K, 2005, DIABETES, V54, P1385, DOI 10.2337/diabetes.54.5.1385
   Islam MR, 2021, NAT METAB, V3, P1058, DOI 10.1038/s42255-021-00438-z
   Itoh M, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/720926
   Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980
   Kraakman MJ, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00470
   Lachyankar MB, 2000, J NEUROSCI, V20, P1404
   Li XN, 2023, GEROSCIENCE, DOI 10.1007/s11357-023-00770-0
   Li XN, 2023, GEROSCIENCE, V45, P931, DOI 10.1007/s11357-022-00692-3
   Li XN, 2022, AGING CELL, V21, DOI 10.1111/acel.13685
   Li XN, 2022, FASEB J, V36, DOI 10.1096/fj.202200143R
   Li XN, 2020, AGING-US, V12, P8766, DOI 10.18632/aging.103380
   Li YJ, 2020, LIPIDS HEALTH DIS, V19, DOI 10.1186/s12944-020-01342-3
   Lichtnekert J, 2013, CURR OPIN PHARMACOL, V13, P555, DOI 10.1016/j.coph.2013.05.013
   Liu P, 2015, RESTOR NEUROL NEUROS, V33, P143, DOI 10.3233/RNN-140446
   Liu YQ, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.588958
   LONCAR D, 1988, J ULTRA MOL STRUCT R, V101, P199, DOI 10.1016/0889-1605(88)90010-9
   Lourenco MV, 2019, NAT MED, V25, P165, DOI 10.1038/s41591-018-0275-4
   Maehama T, 1999, TRENDS CELL BIOL, V9, P125, DOI 10.1016/S0962-8924(99)01519-6
   Mahbub S, 2012, J INTERF CYTOK RES, V32, P18, DOI 10.1089/jir.2011.0058
   Masse I, 2005, DEV BIOL, V286, P91, DOI 10.1016/j.ydbio.2005.07.010
   Matsuo Y, 2015, J CACHEXIA SARCOPENI, V6, P62, DOI 10.1002/jcsm.12006
   Mattson MP, 2004, TRENDS NEUROSCI, V27, P589, DOI 10.1016/j.tins.2004.08.001
   Mazur-Bialy AI, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040701
   Mihaylova VT, 1999, P NATL ACAD SCI USA, V96, P7427, DOI 10.1073/pnas.96.13.7427
   Miller RA, 2014, AGING CELL, V13, P468, DOI 10.1111/acel.12194
   Moon HS, 2013, METABOLISM, V62, P1131, DOI 10.1016/j.metabol.2013.04.007
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073
   Muzumdar R, 2008, AGING CELL, V7, P438, DOI 10.1111/j.1474-9726.2008.00391.x
   Nakashima N, 2000, J BIOL CHEM, V275, P12889, DOI 10.1074/jbc.275.17.12889
   O'Rourke RW, 2018, SURG OBES RELAT DIS, V14, P1755, DOI 10.1016/j.soard.2018.07.032
   Ortega-Molina A, 2013, TRENDS ENDOCRIN MET, V24, P184, DOI 10.1016/j.tem.2012.11.002
   Ortega-Molina A, 2012, CELL METAB, V15, P382, DOI 10.1016/j.cmet.2012.02.001
   Ozkurede U, 2019, J MOL ENDOCRINOL, V63, P123, DOI 10.1530/JME-19-0021
   Patsouris D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110653
   Pignataro P, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22041605
   Rao MS, 2006, AGING CELL, V5, P545, DOI 10.1111/j.1474-9726.2006.00243.x
   RICQUIER D, 1976, BIOCHEM BIOPH RES CO, V73, P577, DOI 10.1016/0006-291X(76)90849-4
   Rosenwald M, 2014, ADIPOCYTE, V3, P4, DOI 10.4161/adip.26232
   Shen ZQ, 2021, AGING CELL, V20, DOI 10.1111/acel.13345
   Shetty AK, 2011, HIPPOCAMPUS, V21, P631, DOI 10.1002/hipo.20776
   Simpson L, 2001, MOL CELL BIOL, V21, P3947, DOI 10.1128/MCB.21.12.3947-3958.2001
   Siteneski A, 2018, PROG NEURO-PSYCHOPH, V84, P294, DOI 10.1016/j.pnpbp.2018.03.004
   Siwak-Tapp CT, 2007, NEUROBIOL LEARN MEM, V88, P249, DOI 10.1016/j.nlm.2007.05.001
   Stout MB, 2014, AGING-US, V6, P575, DOI 10.18632/aging.100681
   Strong R, 2016, AGING CELL, V15, P872, DOI 10.1111/acel.12496
   Teufel A, 2002, GENE, V297, P79, DOI 10.1016/S0378-1119(02)00828-4
   Tu YM, 2023, FREE RADICAL BIO MED, V201, P98, DOI 10.1016/j.freeradbiomed.2023.03.014
   Van Diepen MT, 2008, DEV NEUROSCI-BASEL, V30, P59, DOI 10.1159/000109852
   Villarroya F, 2018, CELL METAB, V27, P954, DOI 10.1016/j.cmet.2018.04.006
   Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846
   Walker TL, 2007, J NEUROSCI, V27, P3734, DOI 10.1523/JNEUROSCI.5060-06.2007
   Wang YH, 2019, INT IMMUNOPHARMACOL, V70, P459, DOI 10.1016/j.intimp.2019.02.050
   Wink L, 2022, IMMUN AGEING, V19, DOI 10.1186/s12979-022-00264-1
   Wrann Christiane D, 2015, Brain Plast, V1, P55, DOI 10.3233/BPL-150019
   Wrann CD, 2013, CELL METAB, V18, P649, DOI 10.1016/j.cmet.2013.09.008
   Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112
   Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016
   Xiong XQ, 2018, METABOLISM, V83, P31, DOI 10.1016/j.metabol.2018.01.013
   YOUNG P, 1984, FEBS LETT, V167, P10, DOI 10.1016/0014-5793(84)80822-4
   Zhou J, 2012, CURR OPIN NEUROBIOL, V22, P873, DOI 10.1016/j.conb.2012.05.004
NR 101
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 2509-2715
EI 2509-2723
J9 GEROSCIENCE
JI GeroScience
PD 2023 DEC 19
PY 2023
DI 10.1007/s11357-023-01025-8
EA DEC 2023
PG 18
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA DA4Z3
UT WOS:001129312600001
PM 38114855
OA hybrid
DA 2024-02-19
ER

PT J
AU Jiang, ZR
   Zou, KX
   Liu, X
   Gu, HC
   Meng, YC
   Lin, J
   Shi, WH
   Yu, CJ
   Jin, L
   Wang, L
   Liu, XM
   Sheng, JZ
   Huang, HF
   Ding, GL
AF Jiang, Ziru
   Zou, Kexin
   Liu, Xia
   Gu, Hangchao
   Meng, Yicong
   Lin, Jing
   Shi, Weihui
   Yu, Chuanjin
   Jin, Li
   Wang, Li
   Liu, Xinmei
   Sheng, Jianzhong
   Huang, Hefeng
   Ding, Guolian
TI Aging attenuates the ovarian circadian rhythm
SO JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
LA English
DT Article; Early Access
DE Circadian rhythm; Ovary; Age; Fertility
ID CLOCK; BMAL1; GENES; EXPRESSION; PER2; MICE
AB Objective To study the effect of aging on ovarian circadian rhythm. Design Human and animal study. Setting University hospital and research laboratory. Patients/animals Human granulosa cells were obtained by follicular aspiration from women undergoing in vitro fertilization (IVF), and ovarian and liver tissues were obtained from female C57BL/6 mice. Intervention(s) None. Main outcome measure(s) Expression of circadian genes in young and older human granulosa cells and circadian rhythm in ovaries and livers of young and older mice. Result(s) All examined circadian clock genes in human granulosa cells showed a downward trend in expression with aging, and their mRNA expression levels were negatively correlated with age (P < 0.05). Older patients (>= 40 years of age) had significantly reduced serum anti-Mullerian hormone (AMH) levels. Except for Rev-erb alpha, all other examined circadian clock genes were positively correlated with the level of AMH (P < 0.05). The circadian rhythm in the ovaries of older mice (8 months) was changed significantly relative to that in ovaries of young mice (12 weeks), although the circadian rhythm in the livers of older mice was basically consistent with that of young mice. Conclusion(s) Lower ovarian reserve in older women is partially due to ovarian circadian dysrhythmia as a result of aging.
C1 [Jiang, Ziru; Zou, Kexin; Liu, Xia; Gu, Hangchao; Meng, Yicong; Lin, Jing; Shi, Weihui; Yu, Chuanjin; Jin, Li; Wang, Li; Liu, Xinmei; Huang, Hefeng; Ding, Guolian] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, 910 Hengshan Rd, Shanghai 200030, Peoples R China.
   [Jiang, Ziru; Zou, Kexin; Liu, Xia; Gu, Hangchao; Meng, Yicong; Lin, Jing; Shi, Weihui; Yu, Chuanjin; Jin, Li; Wang, Li; Liu, Xinmei; Huang, Hefeng; Ding, Guolian] Shanghai Key Lab Embryo Original Dis, Shanghai, Peoples R China.
   [Sheng, Jianzhong] Zhejiang Univ, Sch Med, Dept Pathol & Pathophysiol, Hangzhou, Peoples R China.
C3 Shanghai Jiao Tong University; Zhejiang University
RP Huang, HF; Ding, GL (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, 910 Hengshan Rd, Shanghai 200030, Peoples R China.; Huang, HF; Ding, GL (corresponding author), Shanghai Key Lab Embryo Original Dis, Shanghai, Peoples R China.
EM huanghefg@hotmail.com; dingguolian@hotmail.com
RI Huang, Hefeng/AAR-7184-2021; Huang, Hefeng/ABF-1117-2020; Ding,
   Guolian/GXG-7578-2022; Zhang, Yunyi/JHS-3626-2023; ZHOU,
   YUN/ISA-9160-2023
OI Ding, Guolian/0000-0002-0099-9980; ZHOU, YUN/0009-0003-5061-8730
FU Special Fund for the National Key Research and Development Plan Grant
   [2017YFC1001300]; Natural Science Foundation of China [81971458];
   Municipal Human Resources Development Program for Outstanding Young
   Talents in Medical and Health Sciences in Shanghai [2017YQ047];
   Scientific Research Project of Education Department of Zhejiang
   [Y201329380]; Innovative Research Team of Highlevel Local Universities
   in Shanghai; Shanghai Municipal Key Clinical Specialty, Shanghai, China
FX This work was supported by the Special Fund for the National Key
   Research and Development Plan Grant (2017YFC1001300 to Hefeng Huang,
   Guolian Ding, and Xinmei Liu), the Natural Science Foundation of China
   (81971458 to Guolian Ding), the Municipal Human Resources Development
   Program for Outstanding Young Talents in Medical and Health Sciences in
   Shanghai (2017YQ047 to Guolian Ding), Scientific Research Project of
   Education Department of Zhejiang (Y201329380 to Li Jin), the Innovative
   Research Team of Highlevel Local Universities in Shanghai, and Shanghai
   Municipal Key Clinical Specialty, Shanghai, China.
CR Alvarez JD, 2008, J BIOL RHYTHM, V23, P26, DOI 10.1177/0748730407311254
   Brzezinski A, 2018, J OVARIAN RES, V11, DOI 10.1186/s13048-018-0471-3
   Chang HC, 2013, CELL, V153, P1448, DOI 10.1016/j.cell.2013.05.027
   Chen HT, 2013, AM J PHYSIOL-CELL PH, V304, pC1131, DOI 10.1152/ajpcell.00008.2013
   Coccia ME, 2008, ANN NY ACAD SCI, V1127, P27, DOI 10.1196/annals.1434.011
   Evans JA, 2013, PROG MOL BIOL TRANSL, V119, P283, DOI 10.1016/B978-0-12-396971-2.00010-5
   Fahrenkrug J, 2006, ENDOCRINOLOGY, V147, P3769, DOI 10.1210/en.2006-0305
   Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394
   Hofmann GE, 2000, FERTIL STERIL, V74, P1192, DOI 10.1016/S0015-0282(00)01626-5
   Jiang ZR, 2019, SCI CHINA LIFE SCI, V62, P112, DOI 10.1007/s11427-018-9322-6
   Kennaway DJ, 2003, MOL HUM REPROD, V9, P503, DOI 10.1093/molehr/gag067
   Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206
   Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208
   Kushnir VA, 2018, REPROD SCI, V25, P893, DOI 10.1177/1933719117697130
   Liu Y, 2014, P NATL ACAD SCI USA, V111, P14295, DOI 10.1073/pnas.1209249111
   Mahoney MM, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/813764
   Menaker M, 2013, CURR OPIN NEUROBIOL, V23, P741, DOI 10.1016/j.conb.2013.03.003
   Moenter SM, 2003, FRONT NEUROENDOCRIN, V24, P79, DOI 10.1016/S0091-3022(03)00013-X
   Nakamura TJ, 2011, J NEUROSCI, V31, P10201, DOI 10.1523/JNEUROSCI.0451-11.2011
   NELSON JF, 1982, BIOL REPROD, V27, P327, DOI 10.1095/biolreprod27.2.327
   Pilorz V, 2008, REPRODUCTION, V135, P559, DOI 10.1530/REP-07-0434
   Ratajczak CK, 2009, ENDOCRINOLOGY, V150, P1879, DOI 10.1210/en.2008-1021
   Sato S, 2017, CELL, V170, P664, DOI 10.1016/j.cell.2017.07.042
   Sellix Michael T, 2013, Front Endocrinol (Lausanne), V4, P91, DOI 10.3389/fendo.2013.00091
   Sellix MT, 2012, J NEUROSCI, V32, P16193, DOI 10.1523/JNEUROSCI.3559-12.2012
   Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013
   Wiser A, 2012, REPROD BIOMED ONLINE, V24, P170, DOI 10.1016/j.rbmo.2011.11.007
   Yoshikawa T, 2009, ENDOCRINOLOGY, V150, P4338, DOI 10.1210/en.2008-1280
NR 28
TC 7
Z9 9
U1 3
U2 14
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1058-0468
EI 1573-7330
J9 J ASSIST REPROD GEN
JI J. Assist. Reprod. Genet.
PD 2021 JAN
PY 2021
VL 38
IS 1
BP 33
EP 40
DI 10.1007/s10815-020-01943-y
EA SEP 2020
PG 8
WC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Obstetrics & Gynecology; Reproductive Biology
GA PV6ZP
UT WOS:000569300400001
PM 32926298
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU Bartke, A
AF Bartke, A
TI Can growth hormone (GH) accelerate aging? Evidence from GH-transgenic
   mice
SO NEUROENDOCRINOLOGY
LA English
DT Article
DE growth hormone; insulin-like growth factors; insulin resistance; aging;
   transgenic mice
ID AMES DWARF MICE; PITUITARY-ADRENAL AXIS; LIFE-SPAN; FEMALE MICE;
   CORTICOSTERONE LEVELS; EXPRESSING HUMAN; FUSION GENES; FACTOR-I; BOVINE;
   LIVER
AB Overexpression of heterologous growth hormone (GH) in transgenic mice results in numerous phenotypic effects, including a drastically shortened life span. Early onset of pathological changes in the kidneys, glomerulosclerosis and glomerulonephritis, undoubtedly contributes to and perhaps accounts for reduced longevity of these animals. However, GH-transgenic mice exhibit various symptoms of accelerated aging, including increased astrogliosis, shortened reproductive life span, and early onset of age-related changes in cognitive function, hypothalamic neurotransmitter turnover, and plasma corticosterone levels. The hypothesis that supraphysiological levels of GH can accelerate aging derives indirect support from findings in GH-deficient and GH-resistant mutant mice in which aging is delayed and the life-span is increased and from the reciprocal relationship of body size and longevity within species. Copyright (C) 2003 S. Karger AG, Basel.
C1 So Illinois Univ, Sch Med, Dept Physiol, Springfield, IL 62794 USA.
   So Illinois Univ, Sch Med, Dept Med, Springfield, IL 62708 USA.
C3 Southern Illinois University System; Southern Illinois University;
   Southern Illinois University System; Southern Illinois University
RP Bartke, A (corresponding author), So Illinois Univ, Sch Med, Dept Physiol, POB 19628, Springfield, IL 62794 USA.
EM abartke@siumed.edu
RI Bartke, Andzej/D-6640-2017
OI Bartke, Andzej/0000-0002-2569-557X
CR BARTKE A, 1988, J EXP ZOOL, V248, P121, DOI 10.1002/jez.1402480116
   Bartke A, 2003, BIOGERONTOLOGY, V4, P1, DOI 10.1023/A:1022448532248
   Bartke A, 2002, NEUROPEPTIDES, V36, P201, DOI 10.1054/npep.2002.0889
   BARTKE A, 1994, P SOC EXP BIOL MED, V206, P345, DOI 10.3181/00379727-206-43771
   Bartke A, 2001, J GERONTOL A-BIOL, V56, pB340, DOI 10.1093/gerona/56.8.B340
   Bartke A, 1997, HORMONAL CONTROL SPE, P1
   BORG KE, 1995, P SOC EXP BIOL MED, V210, P126
   Brown-Borg HM, 1999, ENDOCRINE, V11, P41, DOI 10.1385/ENDO:11:1:41
   BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0
   CECIM M, 1991, NEUROENDOCRINOLOGY, V53, P313, DOI 10.1159/000125734
   Cecim M, 1996, TRANSGENIC RES, V5, P187, DOI 10.1007/BF01969708
   CECIM M, 1994, TRANSGENICS, V1, P431
   Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608
   DOI T, 1988, AM J PATHOL, V131, P398
   Dominici FP, 2002, J ENDOCRINOL, V173, P81, DOI 10.1677/joe.0.1730081
   Dominici FP, 1999, J ENDOCRINOL, V161, P383, DOI 10.1677/joe.0.1610383
   Dominici FP, 1999, AM J PHYSIOL-ENDOC M, V277, pE447, DOI 10.1152/ajpendo.1999.277.3.E447
   Dominici FP, 2000, J ENDOCRINOL, V166, P579, DOI 10.1677/joe.0.1660579
   FERRARO JS, 1994, BIOL RHYTHM RES, V25, P315, DOI 10.1080/09291019409360306
   Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898
   Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700
   HAMMER RE, 1985, NATURE, V315, P413, DOI 10.1038/315413a0
   Hauck SJ, 2001, J GERONTOL A-BIOL, V56, pB153, DOI 10.1093/gerona/56.4.B153
   Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298
   Ikeno Y, 2003, J GERONTOL A-BIOL, V58, P291
   KAJIURA LJ, 1994, CAN J ZOOL, V72, P1010, DOI 10.1139/z94-137
   Kajiura LJ, 1996, CAN J ZOOL, V74, P492, DOI 10.1139/z96-058
   Kinney BA, 2001, PHYSIOL BEHAV, V72, P653, DOI 10.1016/S0031-9384(01)00423-1
   Kinney BA, 2001, HORM BEHAV, V39, P277, DOI 10.1006/hbeh.2001.1654
   KLATZ R, 1997, AMAZING MED PROVEN P
   LACHMANSINGH E, 1994, CAN J ZOOL, V72, P2158, DOI 10.1139/z94-288
   MCGRANE MM, 1988, J BIOL CHEM, V263, P11443
   Meliska CJ, 1997, NEUROBIOL LEARN MEM, V68, P1, DOI 10.1006/nlme.1997.3772
   MILLER DB, 1995, EXP GERONTOL, V30, P383, DOI 10.1016/0531-5565(94)00064-A
   Miller RA, 2002, AGING CELL, V1, P22, DOI 10.1046/j.1474-9728.2002.00006.x
   MILTON S, 1992, ENDOCRINOLOGY, V131, P536, DOI 10.1210/en.131.1.536
   MORANO MI, 1994, MOL CELL NEUROSCI, V5, P400, DOI 10.1006/mcne.1994.1050
   Morley JE, 1999, J AM GERIATR SOC, V47, P1475, DOI 10.1111/j.1532-5415.1999.tb01572.x
   MULLER EE, 1993, J REPROD FERTIL, P99
   NAAR EM, 1991, BIOL REPROD, V45, P178, DOI 10.1095/biolreprod45.1.178
   OBERBAUER AM, 1994, GROWTH DEVELOP AGING, V58, P83
   OCALLAGHAN JP, 1991, NEUROBIOL AGING, V12, P171, DOI 10.1016/0197-4580(91)90057-Q
   ORIAN JM, 1989, ENDOCRINOLOGY, V124, P455, DOI 10.1210/endo-124-1-455
   Orme SM, 1998, J CLIN ENDOCR METAB, V83, P2730, DOI 10.1210/jc.83.8.2730
   PALMITER RD, 1982, NATURE, V300, P611, DOI 10.1038/300611a0
   PALMITER RD, 1983, SCIENCE, V222, P809, DOI 10.1126/science.6356363
   Patronek GJ, 1997, J GERONTOL A-BIOL, V52, pB171, DOI 10.1093/gerona/52A.3.B171
   PENDERGRASS WR, 1993, J CELL PHYSIOL, V156, P96, DOI 10.1002/jcp.1041560114
   PRINS GS, 1992, ENDOCRINOLOGY, V131, P2016, DOI 10.1210/en.131.4.2016
   QUAIFE CJ, 1989, ENDOCRINOLOGY, V124, P40, DOI 10.1210/endo-124-1-40
   Rollo CD, 1996, CAN J ZOOL, V74, P606, DOI 10.1139/z96-070
   Rollo CD, 2002, EVOL DEV, V4, P55, DOI 10.1046/j.1525-142x.2002.01053.x
   Rollo CD, 1999, CAN J ZOOL, V77, P1861, DOI 10.1139/cjz-77-12-1861
   Rollo CD, 1997, CAN J ZOOL, V75, P1020, DOI 10.1139/z97-123
   Rollo CD, 1999, CAN J ZOOL, V77, P1874, DOI 10.1139/cjz-77-12-1874
   RUDMAN D, 1990, NEW ENGL J MED, V323, P1, DOI 10.1056/NEJM199007053230101
   RUDMAN D, 1985, J AM GERIATR SOC, V33, P800, DOI 10.1111/j.1532-5415.1985.tb04195.x
   Samaras TT, 2002, J NATL MED ASSOC, V94, P88
   Savine R, 2000, HORM RES, V53, P37, DOI 10.1159/000023531
   SELDEN RF, 1989, J ENDOCRINOL, V122, P49, DOI 10.1677/joe.0.1220049
   SELDEN RF, 1988, P NATL ACAD SCI USA, V85, P8241, DOI 10.1073/pnas.85.21.8241
   SHEA BT, 1987, ENDOCRINOLOGY, V121, P1924, DOI 10.1210/endo-121-6-1924
   SONNTAG WE, 1980, ENDOCRINOLOGY, V107, P1875, DOI 10.1210/endo-107-6-1875
   Sonntag WE, 2000, J ANAT, V197, P575, DOI 10.1046/j.1469-7580.2000.19740575.x
   SOTELO A, 1993, ACTA ENDOCRINOL-COP, V129, P446, DOI 10.1530/acta.0.1290446
   STEFANEAU L, 1990, ENDOCRINOLOGY, V126, P608, DOI 10.1210/endo-126-1-608
   STEGER RW, 1993, J REPROD FERTIL, P61
   Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447
   VERGANI G, 1991, TISSUE CELL, V23, P607, DOI 10.1016/0040-8166(91)90017-N
   Wilkinson CW, 1997, NEUROENDOCRINOLOGY, V65, P79, DOI 10.1159/000127167
   WOLF E, 1993, MECH AGEING DEV, V68, P71, DOI 10.1016/0047-6374(93)90141-D
   Q J MED NS L1
   TRANSGENE
NR 73
TC 143
Z9 159
U1 1
U2 4
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0028-3835
EI 1423-0194
J9 NEUROENDOCRINOLOGY
JI Neuroendocrinology
PD OCT
PY 2003
VL 78
IS 4
BP 210
EP 216
DI 10.1159/000073704
PG 7
WC Endocrinology & Metabolism; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Endocrinology & Metabolism; Neurosciences & Neurology
GA 741LH
UT WOS:000186459200003
PM 14583653
DA 2024-02-19
ER

PT J
AU Zamuz, S
   García-Torres, S
   de Vaca, MC
   Tejerina, D
   Ortiz, A
   Olivan, M
   Sierra, V
   Diñeiro, Y
   Sentandreu, MA
   López-Pedrouso, M
   Purriños, L
   Lorenzo, JM
   Franco, D
AF Zamuz, Sol
   Garcia-Torres, Susana
   de Vaca, Maria Cabeza
   Tejerina, David
   Ortiz, Alberto
   Olivan, Mamen
   Sierra, Veronica
   Dineiro, Yolanda
   Sentandreu, Miguel A.
   Lopez-Pedrouso, Maria
   Purrinos, Laura
   Lorenzo, Jose M.
   Franco, Daniel
TI Impact of the pre-slaughter transport (mixing or no mixing with
   unfamiliar animals) of calves of As- turiana de los Valles and Retinta
   breeds on physicochemical and organoleptic attributes of the ageing
   meat. Consumers' acceptability and preference
SO ITEA-INFORMACION TECNICA ECONOMICA AGRARIA
LA English
DT Article; Early Access
DE Autochthonous breeds; pre-slaughter transport; QDA; hedonic analysis;
   preference; purchase decision and consumption habits
ID BEEF-CATTLE BREEDS; CARCASS CHARACTERISTICS; QUALITY ATTRIBUTES; EATING
   QUALITY; SPANISH BEEF; YOUNG BULLS; TIME; STRESS; PERCEPTION; LOIN
AB As ageing process is one of the main factors influencing the organoleptic characteristics of meat and its consumer acceptability, the objective of this research was to study the organoleptic attributes variation of meat from Asturiana de los Valles and Retinta breeds at two times of the ageing process (7 and 14 days) under different pre-slaughter transport conditions (mixing and non-mixing with unfamiliar animals). A descriptive sensory analysis was carried out with a trained panel and the acceptability and preference for ageing meat of these two breeds were analysed with 75 consumers, as well as a study on the factors that influence the purchase decision to this type of meat. The breed and mixing with unfamiliar animals before slaughter affected significantly at instrumental tenderness. The intensity of the attributes related to the texture showed significant differences among studied samples at 7 days of ageing, with an increase in tenderness, juiciness and fibrousness while at 14 days of ageing, odour, beef flavour, liver flavour and smoothness also showed significant differences. The results indicated that the organoleptic attributes changed in intensity during ageing time, therefore, we can conclude that the attributes of tenderness, juiciness, smoothness, fibrousness, odour, beef flavour and liver flavour showed significant differences among samples and could be considered sensory indicators of ageing. The type of pre-slaughter transport (with or without mixing with unknown animals) also influenced the intensity of the sensory attributes, but less markedly than the breed effect. It was also observed that consumers prefer the meat of the Asturiana de los Valles breed aged for 14 days, despite among the factors that most influence the meat purchase decision, the ageing time was not present. Regarding purchasing habits, a relationship was observed between the meat purchase format and sale point. Overall, it is necessary to promote greater knowledge among consumers about the importance of ageing in beef quality.
C1 [Zamuz, Sol; Purrinos, Laura; Lorenzo, Jose M.; Franco, Daniel] Ctr Tecnol Carne de Galicia, Ave Galicia 4,Parque Tecnol Galicia, San Cibrao Das Vinas, Ourense, Spain.
   [Garcia-Torres, Susana; de Vaca, Maria Cabeza; Tejerina, David; Ortiz, Alberto] CICYTEX Ctr Invest Cient & Tecnol Extremadura, Junta Extremadura, Ctra A-V,Km372, Guadajira 06187, Spain.
   [Olivan, Mamen; Sierra, Veronica; Dineiro, Yolanda] Serv Reg Invest & Desarrollo Agroalimentario SERI, Area Sistemas Prod Anim, Ctra AS 267,PK 19, Villaviciosa 33300, Asturias, Spain.
   [Olivan, Mamen; Sierra, Veronica; Dineiro, Yolanda] ISPA Inst Invest Sanitaria Principado Asturias, Avda Roma S-N, Oviedo 33011, Spain.
   [Sentandreu, Miguel A.] CSIC, Inst Agroquim & Tecnol Alimentos, Ave Agustin Escardino 7, Valencia 46980, Spain.
   [Lopez-Pedrouso, Maria] Univ Santiago de Compostela, Dept Zool Genet & Antropol Fis, Santiago De Compostela 15872, Spain.
   [Lorenzo, Jose M.] Univ Vigo, Fac Ciencias Ourense, Area Tecnol Alimentos, Orense 32004, Spain.
C3 Servicio Regional Investigacion Desarrollo Agroalimentario - SERIDA;
   Instituto de Investigacion Sanitaria del Principado de Asturias (ISPA);
   Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de
   Agroquimica y Tecnologia de los Alimentos (IATA); Universidade de
   Santiago de Compostela; Universidade de Vigo
RP Franco, D (corresponding author), Ctr Tecnol Carne de Galicia, Ave Galicia 4,Parque Tecnol Galicia, San Cibrao Das Vinas, Ourense, Spain.
EM danielfranco@ceteca.net
RI Lorenzo, Jose Manuel/K-6375-2014; García, Yolanda Diñeiro/ABH-4896-2020;
   Llerena, Alberto Ortiz/AAL-9314-2020; Sentandreu, Miguel A/L-3263-2017
OI Lorenzo, Jose Manuel/0000-0002-7725-9294; García, Yolanda
   Diñeiro/0000-0001-8091-6518; Llerena, Alberto Ortiz/0000-0003-2432-2373;
   Franco, Daniel/0000-0002-0093-7042; Sentandreu,
   M.A./0000-0001-5792-0148; Lopez-Pedrouso, Maria/0000-0003-1260-3485
CR Albertí P, 2008, LIVEST SCI, V114, P19, DOI 10.1016/j.livsci.2007.04.010
   Alberti P., 2017, VIANDES PRODUCITS CA, V33, P1
   [Anonymous], 85872010AMD12017 UNE
   [Anonymous], 85892010A12014 UNEEN
   [Anonymous], 85862014 UNEEN ISO
   Bethancourt-Garcia JA, 2019, LIVEST SCI, V222, P41, DOI 10.1016/j.livsci.2019.02.009
   Campo MM, 2006, MEAT SCI, V72, P303, DOI 10.1016/j.meatsci.2005.07.015
   Campo MM, 1999, MEAT SCI, V51, P383, DOI 10.1016/S0309-1740(98)00159-4
   Díaz-Luis A, 2021, ITEA-INF TEC ECON AG, V117, P3, DOI 10.12706/itea.2020.006
   Ferguson DM, 2008, MEAT SCI, V80, P12, DOI 10.1016/j.meatsci.2008.05.004
   Franco, 2018, 64 INT C MEAT SCI TE
   Franco D, 2012, MEAT SCI, V90, P871, DOI 10.1016/j.meatsci.2011.10.008
   Franco D, 2009, MEAT SCI, V83, P484, DOI 10.1016/j.meatsci.2009.06.030
   Garcia P, 2013, TECNOLOGIA AGROALIME, V12, P45
   García-Torres S, 2016, MEAT SCI, V114, P114, DOI 10.1016/j.meatsci.2015.12.019
   Glitsch K., 2000, British Food Journal, V102, P177, DOI 10.1108/00070700010332278
   Gomes CL, 2014, FOOD RES INT, V59, P76, DOI 10.1016/j.foodres.2014.01.061
   Gracia Royo A., 2004, Economia Agraria y Recursos Naturales, V4, P87
   Grunert KG, 1997, FOOD QUAL PREFER, V8, P157, DOI 10.1016/S0950-3293(96)00038-9
   Henchion MM, 2017, MEAT SCI, V128, P1, DOI 10.1016/j.meatsci.2017.01.006
   Honikel KO, 1998, MEAT SCI, V49, P447, DOI 10.1016/S0309-1740(98)00034-5
   HuffLonergan E, 1996, J ANIM SCI, V74, P993
   King DA, 2006, MEAT SCI, V74, P546, DOI 10.1016/j.meatsci.2006.05.004
   Koohmaraie M, 1996, Meat Sci, V43S1, P193, DOI 10.1016/0309-1740(96)00065-4
   la Lama GCMD, 2013, MEAT SCI, V94, P432, DOI 10.1016/j.meatsci.2013.03.026
   LEPETIT J, 1994, MEAT SCI, V36, P203, DOI 10.1016/0309-1740(94)90042-6
   López-Pedrouso M, 2020, FOODS, V9, DOI 10.3390/foods9020176
   Loudon KMW, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9090612
   MACFIE HJH, 1990, NUTR REV, V48, P87, DOI 10.1111/j.1753-4887.1990.tb02910.x
   Mach N, 2008, MEAT SCI, V78, P232, DOI 10.1016/j.meatsci.2007.06.021
   María GA, 2003, MEAT SCI, V65, P1335, DOI 10.1016/S0309-1740(03)00054-8
   Maza M. T., 2006, ITEA, V102, P360
   MEILGAARD M, 2006, SENSORY EVALUATION T
   MERCASA, 2019, DISTRIBUCION CONSUMO, V2, P34
   Minim V, 2013, ANALISE SENSORIAL ES, P332
   Miranda-de la Lama GC, 2013, VET MEXICO, V44, P31
   Morillo-Velarde M, 2006, CALIDAD CARNE RAZAS, P117
   Mottram DS, 1998, FOOD CHEM, V62, P415, DOI 10.1016/S0308-8146(98)00076-4
   Olaizola Tolosana A. M., 2005, Spanish Journal of Agricultural Research, V3, P418
   Pagliarini E, 2016, J SCI FOOD AGR, V96, P798, DOI 10.1002/jsfa.7151
   Panea B, 2019, ITEA-INF TEC ECON AG, V115, P149, DOI 10.12706/itea.2018.030
   Panea B, 2016, ITEA-INF TEC ECON AG, V112, P286, DOI 10.12706/itea.2016.018
   Panea B, 2018, J TEXTURE STUD, V49, P528, DOI 10.1111/jtxs.12350
   Peña F, 2014, MEAT SCI, V98, P718, DOI 10.1016/j.meatsci.2014.07.021
   Pensado-Leglise MD, 2018, REV MEX CIENC PECU, V9, P451, DOI 10.22319/rmcp.v9i3.4329
   Piedrafita J, 2003, LIVEST PROD SCI, V82, P1, DOI 10.1016/S0301-6226(03)00006-X
   Ponnampalam EN, 2017, COMPR REV FOOD SCI F, V16, P400, DOI 10.1111/1541-4337.12258
   Realini, 2015, 10 C AS ESP EC AGR 9
   Realini CE, 2004, MEAT SCI, V66, P567, DOI 10.1016/S0309-1740(03)00160-8
   Ripoll G, 2012, ITEA-INF TEC ECON AG, V108, P222
   SALIH AM, 1987, POULTRY SCI, V66, P1483, DOI 10.3382/ps.0661483
   Sánchez M, 2012, FOOD QUAL PREFER, V24, P30, DOI 10.1016/j.foodqual.2011.08.008
   Santolaria P., 1997, ITEA Produccion Animal, V93, P89
   Sanudo C, 2019, MARCAS CALIDAD CARNE, P259
   Serra X, 2008, MEAT SCI, V79, P98, DOI 10.1016/j.meatsci.2007.08.005
   Sierra V, 2010, MEAT SCI, V86, P343, DOI 10.1016/j.meatsci.2010.05.007
   Tadich N, 2005, LIVEST PROD SCI, V93, P223, DOI 10.1016/j.livprodsci.2004.10.004
   Troy DJ, 2010, MEAT SCI, V86, P214, DOI 10.1016/j.meatsci.2010.05.009
   Vitale M, 2016, INTEREMPRESAS
NR 59
TC 0
Z9 0
U1 0
U2 6
PU ASOCIACION INTERPROFESIONAL DESARROLLO AGARIO
PI ZARAGOZA
PA AVDA MONTANANA 930, APARTADO 727, ZARAGOZA, 50080, SPAIN
SN 1699-6887
EI 2386-3765
J9 ITEA-INF TEC ECON AG
JI ITEA-Inf. Tec. Econ. Agrar.
PD 2022 JUN
PY 2022
VL 118
IS 2
BP 213
EP 238
DI 10.12706/itea.2021.021
EA JUN 2021
PG 26
WC Agriculture, Dairy & Animal Science; Agronomy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture
GA 2D4BP
UT WOS:000729244400001
OA Bronze, Green Submitted
DA 2024-02-19
ER

PT J
AU Gao, ZG
   Zhang, J
   Kheterpal, I
   Kennedy, N
   Davis, RJ
   Ye, JP
AF Gao, Zhanguo
   Zhang, Jin
   Kheterpal, Indu
   Kennedy, Norm
   Davis, Roger J.
   Ye, Jianping
TI Sirtuin 1 (SIRT1) Protein Degradation in Response to Persistent c-Jun
   N-terminal Kinase 1 (JNK1) Activation Contributes to Hepatic Steatosis
   in Obesity
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID INSULIN-RECEPTOR SUBSTRATE-1; MULTIPLE SERINE KINASES; CALORIE
   RESTRICTION; GLUCOSE-HOMEOSTASIS; MAMMALIAN SIRTUIN-1; FATTY LIVER;
   RESISTANCE; PROMOTES; MICE; PHOSPHORYLATION
AB SIRT1 is involved in the pathogenesis of obesity, diabetes, and aging. However, it is not clear how SIRT1 activity is regulated by intracellular kinases in cells. In this study, we investigated SIRT1 phosphorylation and protein degradation in response to JNK1 activation in obese mice. Mouse SIRT1 is phosphorylated by JNK1 at Ser-46 (Ser-47 in human SIRT1), which is one of the four potential residues targeted by JNK1. The phosphorylation induces a brief activation of SIRT1 function and degradation of SIRT1 thereafter by the proteasome. Ubiquitination occurs in SIRT1 protein after the phosphorylation. Mutation of Ser-46 to alanine prevents the phosphorylation, ubiquitination, and degradation. In vivo, SIRT1 undergoes an extensive degradation in hepatocytes in obesity as a consequence of persistent activation of JNK1. The degradation leads to inhibition of SIRT1 function, which contributes to development of hepatic steatosis. The degradation disappears in obesity when JNK1 is inactivated in mice. JNK2 exhibits an opposite activity in the regulation of SIRT1 degradation. The JNK1-SIRT1 pathway provides a new molecular mechanism for the pathogenesis of hepatic steatosis in obesity.
C1 [Gao, Zhanguo; Zhang, Jin; Kheterpal, Indu; Ye, Jianping] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Antioxidant & Gene Regulat Lab, Baton Rouge, LA 70808 USA.
   [Kennedy, Norm; Davis, Roger J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Mol Med, Worcester, MA 01605 USA.
C3 Louisiana State University System; Louisiana State University;
   Pennington Biomedical Research Center; University of Massachusetts
   System; University of Massachusetts Worcester; Howard Hughes Medical
   Institute
RP Ye, JP (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Antioxidant & Gene Regulat Lab, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.
EM yej@pbrc.edu
RI Ye, Jianping/N-1998-2017
OI Ye, Jianping/0000-0003-3875-365X; Davis, Roger/0000-0002-0130-1652
FU National Institutes of Health [DK068036, DK085495]
FX This work was supported, in whole or in part, by National Institutes of
   Health Grants DK068036 and DK085495 (to J. Y.).
CR Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651
   Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200
   Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637
   Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200
   Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200
   Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196
   DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8
   Erion DM, 2009, P NATL ACAD SCI USA, V106, P11288, DOI 10.1073/pnas.0812931106
   Ford J, 2008, CELL CYCLE, V7, P3091, DOI 10.4161/cc.7.19.6799
   Gao ZG, 2006, J BIOL CHEM, V281, P4540, DOI 10.1074/jbc.M507784200
   Gao ZG, 2004, MOL ENDOCRINOL, V18, P2024, DOI 10.1210/me.2003-0383
   Gao ZG, 2003, J BIOL CHEM, V278, P24944, DOI 10.1074/jbc.M300423200
   Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200
   Gao ZG, 2008, BIOCHEM BIOPH RES CO, V376, P793, DOI 10.1016/j.bbrc.2008.09.079
   Gao ZG, 2007, AM J PHYSIOL-ENDOC M, V292, pE84, DOI 10.1152/ajpendo.00178.2006
   Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622
   Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043
   Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126
   Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349
   Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261
   Nakatani Y, 2004, J BIOL CHEM, V279, P45803, DOI 10.1074/jbc.M406963200
   Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414
   Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200
   Özcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294
   Özcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160
   Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583
   Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006
   Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104
   Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354
   Sabio G, 2010, GENE DEV, V24, P256, DOI 10.1101/gad.1878510
   Sabio G, 2009, CELL METAB, V10, P491, DOI 10.1016/j.cmet.2009.09.007
   Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200
   Sasaki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004020
   Schattenberg JM, 2006, HEPATOLOGY, V43, P163, DOI 10.1002/hep.20999
   Singh R, 2009, HEPATOLOGY, V49, P87, DOI 10.1002/hep.22578
   Xu F, 2010, ENDOCRINOLOGY, V151, P2504, DOI 10.1210/en.2009-1013
   Yang JQ, 2009, J BIOL CHEM, V284, P27042, DOI 10.1074/jbc.M109.047340
   Yang R, 2007, J BIOL CHEM, V282, P22765, DOI 10.1074/jbc.M700790200
   Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645
   You M, 2008, AM J PHYSIOL-GASTR L, V294, pG892, DOI 10.1152/ajpgi.00575.2007
   You M, 2008, J NUTR, V138, P497, DOI 10.1093/jn/138.3.497
NR 45
TC 145
Z9 162
U1 0
U2 13
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUN 24
PY 2011
VL 286
IS 25
BP 22227
EP 22234
DI 10.1074/jbc.M111.228874
PG 8
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 778QP
UT WOS:000291719900030
PM 21540183
OA Green Published, hybrid
DA 2024-02-19
ER

PT B
AU Smith, RG
   Sun, YX
   Jiang, H
   Albarran-Zeckler, R
   Timchenko, N
AF Smith, Roy G.
   Sun, Yuxiang
   Jiang, Hong
   Albarran-Zeckler, Rosie
   Timchenko, Nikolat
BE Gonos, ES
   Trougakos, IP
   Chondrogianni, N
TI Ghrelin receptor (GHS-R1A) agonists show potential as interventive
   agents during aging
SO MOLECULAR MECHANISMS AND MODELS OF AGING
SE Annals of the New York Academy of Sciences-Series
LA English
DT Article; Proceedings Paper
CT 12th Congress of the International-Association-of-Biomedical-Gerontology
CY MAY 20-24, 2007
CL Spetses Isl, GREECE
SP Int Assoc Biomed Gerontol
DE ghrelin; aging; MK0677; GHS-R; intervention; rejuvenation; ghrelin
   receptor; GHS-R agonists
ID GROWTH-HORMONE SECRETAGOGUE; C/EBP-ALPHA; UNCOUPLING PROTEIN-2;
   REGENERATING LIVER; ARCUATE NUCLEUS; MUSCLE STRENGTH; FACTOR-I;
   INTERLEUKIN-6; EXPRESSION; PROLIFERATION
AB Administration of an orally active agonist (MK-0677) of the growth hormone secretagogue receptor (GHS-R1a) to elderly subjects restored the amplitude of endogenous episodic growth hormone (GH) release to that of young adults. Functional benefits include increased lean mass and bone density and modest improvements in strength. In old mice, a similar agonist partially restored function to the thymus and reduced tumor cell growth and metastasis. Treatment of old mice with the endogenous GHS-R1 a agonist ghrelin restored a young liver phenotype. The mechanism involves inhibition of cyclin D3:cdk4/cdk6 activity and increased protein phosphatase-2A (PP2A) activity in liver nuclei, which stabilizes the dephosphorylated form of the transcription factor C/EBP alpha preventing the age-dependent formation of the C/EBP alpha-Rb-E2F4-Brm nuclear complex. By inhibiting formation of this complex, repression of E2F target genes is de-repressed and C/EBP alpha regulated expression of Pepck, a regulator of gluconeogenesis, is normalized, thereby restoring a young liver phenotype. In the brain, aging is associated with decline in dopamine function. We investigated the potential neuromodulatory role of GHS-R1a on dopamine action. Neurons were identified in the hippocampus, cortex, substantia nigra, and ventral tegmental areas that coexpressed GHS-R1a and dopamine receptor subtype-1 (DIR). Cell culture studies showed that, in the presence of ghrelin and dopamine, GHS-R and D1R form heterodimers, which modified G-protein signal transduction resulting in amplification of dopamine signaling. We speculate that aging is associated with deficient endogenous ghrelin signaling that can be rescued by intervention with GHS-R1a agonists to improve quality of life and maintain independence.
C1 [Smith, Roy G.; Sun, Yuxiang; Jiang, Hong; Albarran-Zeckler, Rosie; Timchenko, Nikolat] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA.
C3 Baylor College of Medicine
RP Smith, RG (corresponding author), Baylor Coll Med, Huffington Ctr Aging, 1 Baylor Plaza,MS BCM M230, Houston, TX 77030 USA.
EM rsmith@bcm.tmc.edu
CR ALOI JA, 1994, J CLIN ENDOCR METAB, V79, P943, DOI 10.1210/jc.79.4.943
   Andrews ZB, 2005, J NEUROSCI, V25, P184, DOI 10.1523/JNEUROSCI.4269-04.2005
   Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565
   Bach MA, 2004, J AM GERIATR SOC, V52, P516, DOI 10.1111/j.1532-5415.2004.52156.x
   Bach MA, 2000, CONT ENDOCRINOL, V19, P315
   BACH MA, 1996, P 78 ANN M END SOC 1
   Bailey ART, 1998, J NEUROENDOCRINOL, V10, P111
   Bailey ART, 2000, J NEUROENDOCRINOL, V12, P191
   Bailey ART, 2001, ENDOCRINE, V14, P15, DOI 10.1385/ENDO:14:1:015
   Baranowska B, 2006, J PHYSIOL PHARMACOL, V57, P55
   Barazzoni R, 2005, AM J PHYSIOL-ENDOC M, V288, pE228, DOI 10.1152/ajpendo.00115.2004
   BUCHER NLR, 1964, CANCER RES, V24, P509
   Cappola AR, 2003, J CLIN ENDOCR METAB, V88, P2019, DOI 10.1210/jc.2002-021694
   Cappola AR, 2001, J CLIN ENDOCR METAB, V86, P4139, DOI 10.1210/jc.86.9.4139
   Chapman IM, 2002, BIOGERONTOLOGY, V3, P67, DOI 10.1023/A:1015211530695
   Chapman IM, 1996, J CLIN ENDOCR METAB, V81, P4249, DOI 10.1210/jc.81.12.4249
   Chen HY, 2004, ENDOCRINOLOGY, V145, P2607, DOI 10.1210/en.2003-1596
   CLEETER MWJ, 1992, J NEUROCHEM, V58, P786, DOI 10.1111/j.1471-4159.1992.tb09789.x
   Dixit VD, 2004, J CLIN INVEST, V114, P57, DOI 10.1172/JCI200421134
   Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2
   Fausto Nelson, 1994, P1059
   FRY M, 1984, J CELL PHYSIOL, V118, P225, DOI 10.1002/jcp.1041180302
   Guan XM, 1997, MOL BRAIN RES, V48, P23, DOI 10.1016/S0169-328X(97)00071-5
   Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974
   Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0
   Inoue Y, 2004, J BIOL CHEM, V279, P44740, DOI 10.1074/jbc.M405177200
   Jiang H, 2006, MOL ENDOCRINOL, V20, P1772, DOI 10.1210/me.2005-0084
   KANDEL ER, 1982, SCIENCE, V218, P433, DOI 10.1126/science.6289442
   Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230
   Koo GC, 2001, J IMMUNOL, V166, P4195, DOI 10.4049/jimmunol.166.6.4195
   Krupczak-Hollis K, 2003, HEPATOLOGY, V38, P1552, DOI 10.1016/j.hep.2003.08.052
   Li AJ, 1997, BRAIN RES, V748, P30, DOI 10.1016/S0006-8993(96)01283-8
   Murphy MG, 2001, J CLIN ENDOCR METAB, V86, P1116, DOI 10.1210/jc.86.3.1116
   Nelsen CJ, 2001, CANCER RES, V61, P8564
   PATCHETT AA, 1995, P NATL ACAD SCI USA, V92, P7001, DOI 10.1073/pnas.92.15.7001
   Porse BT, 2001, CELL, V107, P247, DOI 10.1016/S0092-8674(01)00516-5
   Rigamonti AE, 2002, J ENDOCRINOL, V175, pR1, DOI 10.1677/joe.0.175R001
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   Schutte AE, 2007, REGUL PEPTIDES, V139, P65, DOI 10.1016/j.regpep.2006.10.006
   SMITH RG, 1993, SCIENCE, V260, P1640, DOI 10.1126/science.8503009
   Smith RG, 2005, ENDOCR REV, V26, P346, DOI 10.1210/er.2004-0019
   Smith RG, 1996, RECENT PROG HORM RES, V51, P261
   Smith RG, 1997, ENDOCR REV, V18, P621, DOI 10.1210/er.18.5.621
   Strum K, 2003, J CLIN ENDOCR METAB, V88, P3747, DOI 10.1210/jc.2002-021656
   Sun Y, 2006, CELL METAB, V3, P379, DOI 10.1016/j.cmet.2006.04.004
   Sun YX, 2003, MOL CELL BIOL, V23, P7973, DOI 10.1128/MCB.23.22.7973-7981.2003
   Sun YX, 2004, P NATL ACAD SCI USA, V101, P4679, DOI 10.1073/pnas.0305930101
   Timchenko NA, 1999, MOL CELL BIOL, V19, P2936
   Visser M, 2002, J GERONTOL A-BIOL, V57, pM326, DOI 10.1093/gerona/57.5.M326
   Wakabayashi H, 2002, J SURG RES, V106, P246, DOI 10.1006/jsre.2002.6462
   Wang GL, 2006, MOL CELL BIOL, V26, P2570, DOI 10.1128/MCB.26.7.2570-2582.2006
   Wang GL, 2004, GENE DEV, V18, P912, DOI 10.1101/gad.1183304
   Wang GL, 2007, J BIOL CHEM, V282, P1468, DOI 10.1074/jbc.M608226200
   Wang HM, 2002, EMBO J, V21, P930, DOI 10.1093/emboj/21.5.930
   Wang Y, 2001, BMC Mol Biol, V2, P8, DOI 10.1186/1471-2199-2-8
   Wellman PJ, 2005, REGUL PEPTIDES, V125, P151, DOI 10.1016/j.regpep.2004.08.013
   Ye SM, 1999, J NEUROIMMUNOL, V93, P139, DOI 10.1016/S0165-5728(98)00217-3
NR 57
TC 32
Z9 36
U1 0
U2 5
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER STREET, HOBOKEN, NJ, UNITED STATES
BN 978-1-57331-686-6
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2007
VL 1119
BP 147
EP 164
DI 10.1196/annals.1404.023
PG 18
WC Biochemistry & Molecular Biology; Geriatrics & Gerontology;
   Multidisciplinary Sciences; Physiology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Geriatrics & Gerontology; Science &
   Technology - Other Topics; Physiology
GA BHD15
UT WOS:000252263300015
PM 18056963
DA 2024-02-19
ER

PT J
AU IVY, GO
AF IVY, GO
TI PROTEASE INHIBITION CAUSES SOME MANIFESTATIONS OF AGING AND
   ALZHEIMERS-DISEASE IN RODENT AND PRIMATE BRAIN
SO ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
LA English
DT Article
ID PAIRED HELICAL FILAMENTS; ACTIVATED NEUTRAL PROTEASE; SENILE PLAQUES;
   RAT-LIVER; NEUROFIBRILLARY TANGLES; HUMAN-FIBROBLASTS; LEWY BODIES;
   TAU-PROTEIN; NEURODEGENERATIVE DISEASES; CEROID-LIPOFUSCINOSIS
RP IVY, GO (corresponding author), UNIV TORONTO,DIV LIFE SCI,SCARBOROUGH CAMPUS,1265 MIL TRAIL,SCARBOROUGH M1C 1A4,ON,CANADA.
CR AOYAGI T, 1969, J ANTIBIOT, V22, P558, DOI 10.7164/antibiotics.22.558
   BANCHER C, 1989, J NEUROPATH EXP NEUR, V48, P81, DOI 10.1097/00005072-198901000-00007
   BARRETT AJ, 1980, FED PROC, V39, P9
   BHACHATARRYA TK, 1983, BIOCHEM PHARMACOL, V32, P2965
   BIRCHENALLSPARKS MC, 1985, J NUTR, V115, P944, DOI 10.1093/jn/115.7.944
   BJORKERUD SOREN, 1964, ADVANCE GERONTOL RES, V1, P257
   BLASS JP, 1991, REV NEUROL, V147, P513
   CATALDO AM, 1990, BRAIN RES, V513, P181, DOI 10.1016/0006-8993(90)90456-L
   CATALDO AM, 1991, P NATL ACAD SCI USA, V88, P10998, DOI 10.1073/pnas.88.24.10998
   CIECHANOVER A, 1984, CELL, V37, P57, DOI 10.1016/0092-8674(84)90300-3
   COLE GM, 1987, NEUROSCI LETT, V79, P207, DOI 10.1016/0304-3940(87)90698-7
   DENNIS PA, 1985, ARCH BIOCHEM BIOPHYS, V240, P768, DOI 10.1016/0003-9861(85)90085-2
   DICE JF, 1982, J BIOL CHEM, V257, P4624
   DICKSON DW, 1989, ACTA NEUROPATHOL, V78, P572, DOI 10.1007/BF00691284
   DICKSON DW, 1990, LAB INVEST, V63, P87
   DICKSON DW, 1990, ACTA NEUROPATHOL, V79, P486, DOI 10.1007/BF00296107
   GOLDSTEIN S, 1976, MECH AGEING DEV, V5, P221, DOI 10.1016/0047-6374(76)90020-8
   GREENBERG SG, 1992, J BIOL CHEM, V267, P564
   GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913
   HANADA K, 1978, AGR BIOL CHEM TOKYO, V42, P537, DOI 10.1080/00021369.1978.10863016
   HASHIDA S, 1982, J BIOCHEM, V91, P1373, DOI 10.1093/oxfordjournals.jbchem.a133825
   HASHIDA S, 1980, J BIOCHEM-TOKYO, V88, P1805, DOI 10.1093/oxfordjournals.jbchem.a133155
   HENDLEY DD, 1963, J GERONTOL, V18, P144, DOI 10.1093/geronj/18.2.144
   HERSHKO A, 1980, P NATL ACAD SCI-BIOL, V77, P1783, DOI 10.1073/pnas.77.4.1783
   IHARA Y, 1986, J BIOCHEM-TOKYO, V99, P1807, DOI 10.1093/oxfordjournals.jbchem.a135662
   IHARA Y, 1988, BRAIN RES, V459, P138, DOI 10.1016/0006-8993(88)90293-4
   ISHIGAMI A, 1990, ARCH BIOCHEM BIOPHYS, V277, P189, DOI 10.1016/0003-9861(90)90568-J
   ISHIGAMI A, 1988, MECH AGEING DEV, V46, P125, DOI 10.1016/0047-6374(88)90120-0
   ISHIGAMI A, 1990, ARCH BIOCHEM BIOPHYS, V238, P362
   Ivy G.O., 1988, Lipofuscin-1987: State of the Art, V1st ed., P83
   IVY GO, 1989, BRAIN RES, V498, P360, DOI 10.1016/0006-8993(89)91117-7
   IVY GO, 1991, MECH AGEING DEV, V57, P213, DOI 10.1016/0047-6374(91)90048-5
   IVY GO, 1991, ARCH GERONTOL GERIAT, V12, P119, DOI 10.1016/0167-4943(91)90023-J
   IVY GO, 1984, SCIENCE, V226, P985, DOI 10.1126/science.6505679
   IVY GO, 1992, AM J MED GENET, V42, P555, DOI 10.1002/ajmg.1320420427
   IVY GO, 1990, LIPOFUSCIN CEROID PI, P31
   IVY GO, 1990, 4TH TOK S LIV AG, P109
   IVY GO, 1987, NEUROPLASTICITY LEAR, P125
   IVY GO, 1988, NEURAL PLASTICITY LI, P351
   KALRA J, 1988, MOL CELL BIOCHEM, V84, P233, DOI 10.1007/BF00421058
   KAREY KP, 1986, MECH AGEING DEV, V35, P169, DOI 10.1016/0047-6374(86)90007-2
   KIN NMKNY, 1983, J NEUROCHEM, V40, P1465, DOI 10.1111/j.1471-4159.1983.tb13592.x
   KITANI K, 1992, ARCH GERONTOL GERIAT, V14, P27, DOI 10.1016/0167-4943(92)90004-N
   KITANI K, 1990, LIPOFUSCIN CEROID PI, P75
   KONDO J, 1988, NEURON, V1, P827, DOI 10.1016/0896-6273(88)90130-4
   KOWALL NW, 1987, ANN NEUROL, V22, P639, DOI 10.1002/ana.410220514
   KSIEZAKREDING J, 1991, NEURON, V6, P1
   KUZUHARA S, 1988, ACTA NEUROPATHOL, V75, P345, DOI 10.1007/BF00687787
   LASZLO L, 1990, FEBS LETT, V261, P365, DOI 10.1016/0014-5793(90)80593-8
   LAVIE L, 1982, BIOCHEM J, V202, P47, DOI 10.1042/bj2020047
   LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488
   LENNOX G, 1988, NEUROSCI LETT, V94, P211, DOI 10.1016/0304-3940(88)90297-2
   LEWIS SEM, 1985, EXP GERONTOL, V20, P253, DOI 10.1016/0531-5565(85)90050-6
   LIBBY P, 1980, CELL, V19, P481, DOI 10.1016/0092-8674(80)90523-1
   LINDWALL G, 1984, J BIOL CHEM, V259, P5301
   LOVE S, 1988, J NEUROPATH EXP NEUR, V47, P393, DOI 10.1097/00005072-198807000-00001
   LOWE J, 1988, J PATHOL, V155, P9, DOI 10.1002/path.1711550105
   MANETTO V, 1988, P NATL ACAD SCI USA, V85, P4501, DOI 10.1073/pnas.85.12.4501
   MANETTO V, 1989, AM J PATHOL, V134, P505
   MIYAGISH.T, 1967, ACTA NEUROPATHOL, V9, P7, DOI 10.1007/BF00688154
   MORI H, 1987, SCIENCE, V235, P1641, DOI 10.1126/science.3029875
   NAKAMURA Y, 1991, NEUROSCI LETT, V130, P195, DOI 10.1016/0304-3940(91)90395-A
   NILSSON E, 1990, NEUROBIOL AGING, V11, P425, DOI 10.1016/0197-4580(90)90009-O
   OKADA AA, 1984, MECH AGEING DEV, V26, P341, DOI 10.1016/0047-6374(84)90105-2
   PALMER DN, 1986, J BIOL CHEM, V261, P1773
   PERCY ME, 1990, AM J MED GENET, V35, P459, DOI 10.1002/ajmg.1320350403
   PERRY G, 1987, P NATL ACAD SCI USA, V84, P3033, DOI 10.1073/pnas.84.9.3033
   RAO G, 1990, MECH AGEING DEV, V53, P49, DOI 10.1016/0047-6374(90)90033-C
   REZNICK AZ, 1979, MECH AGEING DEV, V11, P403, DOI 10.1016/0047-6374(79)90016-2
   ROTHSTEIN M, 1982, BIOCH APPROACHES AGI, P198
   ROTHSTEIN M, 1990, PROTEIN METABOLISM A, P3
   SCHULMAN H, 1984, J CELL BIOL, V99, P11, DOI 10.1083/jcb.99.1.11
   SHIMOHAMA S, 1991, BRAIN RES, V558, P105, DOI 10.1016/0006-8993(91)90722-8
   SMITH G M, 1988, Society for Neuroscience Abstracts, V14, P1292
   TAMAI M, 1981, J BIOCHEM, V90, P255, DOI 10.1093/oxfordjournals.jbchem.a133458
   TOYOOKA T, 1978, BIOCHEM BIOPH RES CO, V82, P484, DOI 10.1016/0006-291X(78)90900-2
   WANG GP, 1991, BRAIN RES, V566, P146, DOI 10.1016/0006-8993(91)91692-T
   WARD W, 1991, HEPATOLOGY, V14, P935, DOI 10.1002/hep.1840140529
   WARD WF, 1988, J GERONTOL, V43, pB121, DOI 10.1093/geronj/43.5.B121
   WARD WF, 1988, J GERONTOL, V43, pB50, DOI 10.1093/geronj/43.2.B50
   WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506
   WOLFE LS, 1987, CHEM SCRIPTA, V27, P79
   ZIMMERMAN UJP, 1984, PROG NEUROBIOL, V23, P63, DOI 10.1016/0301-0082(84)90012-1
NR 83
TC 21
Z9 23
U1 0
U2 1
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 E 63RD ST, NEW YORK, NY 10021
SN 0077-8923
J9 ANN NY ACAD SCI
JI Ann. N.Y. Acad. Sci.
PD DEC 31
PY 1992
VL 674
BP 89
EP 102
DI 10.1111/j.1749-6632.1992.tb27479.x
PG 14
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA KN661
UT WOS:A1992KN66100008
PM 1337691
DA 2024-02-19
ER

PT J
AU Larsen, K
   Kristensen, KK
   Momeni, J
   Farajzadeh, L
   Bendixen, C
AF Larsen, Knud
   Kristensen, Kaja Kjaer
   Momeni, Jamal
   Farajzadeh, Leila
   Bendixen, Christian
TI A-to-I RNA editing of the IGFBP7 transcript increases during aging in
   porcine brain tissues
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Brain; IGFBP7; RNA editing
ID EXPRESSION ANALYSIS; MOLECULAR-CLONING; RECEPTOR; MAC25; GENE;
   DIFFERENTIATION; IDENTIFICATION; METHYLATION; ACTIVATION; CARCINOMA
AB The IGFBP7 gene encodes insulin-like growth factor protein 7. IGFPB7 is involved in diverse biological functions including cell growth regulation, senescence and apoptosis, and also acts as a tumor suppressor in multiple cancers. The IGFBP7 mRNA is subject to A-to-I RNA editing mediated by adenosine deaminases acting on RNA 1 and 2 (ADAR1 and ADAR2). In the current study we have examined molecular characteristics of the porcine IGFBP7 gene, and determined the mRNA editing in different tissues. The A-to-I RNA editing of human IGFBP7 in positions Arg78 and Lys95 was shown to be conserved in the porcine homologue. In addition, a novel editing site was discovered in position Lys97 in the porcine IGFBP7 transcript. A differential editing was demonstrated at the three positions in the IGFBP7 transcript with very high degrees of editing in frontal cortex, cerebellum and lung. Interestingly, the degree of editing increased during aging in porcine frontal cortex and cerebellum. The IGFBP7 gene was mapped to pig chromosome 8. The porcine IGFBP7 gene was found to be ubiquitously expressed in examined organs and tissues. The methylation status of the IGFBP gene was examined in brain and liver by bisulfate sequencing and a high degree of methylation was found in the two tissues, 52% and 54%, respectively. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Larsen, Knud; Kristensen, Kaja Kjaer; Momeni, Jamal; Farajzadeh, Leila; Bendixen, Christian] Aarhus Univ, Dept Mol Biol & Genet, Blichers Alle 20,POB 50, DK-8830 Tjele, Denmark.
C3 Aarhus University
RP Larsen, K (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Blichers Alle 20,POB 50, DK-8830 Tjele, Denmark.
EM Knud.Larsen@mbg.au.dk
CR Agbemenyah HY, 2014, NEUROBIOL DIS, V62, P135, DOI 10.1016/j.nbd.2013.09.011
   Alic N, 2011, AGING CELL, V10, P137, DOI 10.1111/j.1474-9726.2010.00653.x
   An W, 2012, ANN SURG ONCOL, V19, P3971, DOI 10.1245/s10434-012-2407-2
   Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501
   Bjerre D, 2006, BIOCHEM BIOPH RES CO, V347, P803, DOI 10.1016/j.bbrc.2006.06.167
   Evdokimova V, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003184
   Farajzadeh L, 2013, BIOCHEM BIOPH RES CO, V438, P346, DOI 10.1016/j.bbrc.2013.07.074
   Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033
   Gambaro K, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1138-8
   Gommans WM, 2008, RNA, V14, P2074, DOI 10.1261/rna.816908
   Henriksen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079127
   Hochberg M, 2013, ARCH DERMATOL RES, V305, P519, DOI 10.1007/s00403-013-1338-5
   Holmes AP, 2013, BIOGERONTOLOGY, V14, P395, DOI 10.1007/s10522-013-9433-8
   Iwamoto K, 2009, RNA BIOL, V6, P248, DOI 10.4161/rna.6.3.8370
   Kato MV, 2000, MOL MED, V6, P126, DOI 10.1007/BF03401780
   Larsen K, 2016, BIOCHIMIE, V121, P189, DOI 10.1016/j.biochi.2015.12.011
   Larsen K, 2014, FEBS OPEN BIO, V4, P872, DOI 10.1016/j.fob.2014.10.001
   Levanon EY, 2005, NUCLEIC ACIDS RES, V33, P1162, DOI 10.1093/nar/gki239
   MURPHY M, 1993, CELL GROWTH DIFFER, V4, P715
   Nicholas A, 2010, MECH AGEING DEV, V131, P445, DOI 10.1016/j.mad.2010.06.001
   Nousbeck J, 2010, J INVEST DERMATOL, V130, P378, DOI 10.1038/jid.2009.265
   Oh YM, 1996, J BIOL CHEM, V271, P30322, DOI 10.1074/jbc.271.48.30322
   Pinto Y, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r5
   Riedmann EM, 2008, RNA, V14, P1110, DOI 10.1261/rna.923308
   Ruan Wen-jing, 2006, J Zhejiang Univ Sci B, V7, P929, DOI 10.1631/jzus.2006.B0929
   Schenck A, 2001, P NATL ACAD SCI USA, V98, P8844, DOI 10.1073/pnas.151231598
   Shtrichman R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041576
   Sie CG, 2012, FEBS LETT, V586, P2313, DOI 10.1016/j.febslet.2012.06.037
   St Laurent G, 2013, NAT STRUCT MOL BIOL, V20, P1333, DOI 10.1038/nsmb.2675
   Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101
   Sullivan L, 2012, J UROLOGY, V188, P1354, DOI 10.1016/j.juro.2012.06.002
   SWISSHELM K, 1995, P NATL ACAD SCI USA, V92, P4472, DOI 10.1073/pnas.92.10.4472
   Vizioli MG, 2010, ONCOGENE, V29, P3835, DOI 10.1038/onc.2010.136
   Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032
   Walker GE, 2006, ONCOGENE, V25, P1943, DOI 10.1038/sj.onc.1209213
   Yamanaka Y, 1997, J BIOL CHEM, V272, P30729, DOI 10.1074/jbc.272.49.30729
   Yamashita S, 2006, CANCER SCI, V97, P64, DOI 10.1111/j.1349-7006.2006.00136.x
   Zhu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043227
NR 38
TC 9
Z9 10
U1 0
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD OCT 21
PY 2016
VL 479
IS 3
BP 596
EP 601
DI 10.1016/j.bbrc.2016.09.125
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA EA8DO
UT WOS:000386865700029
PM 27687550
DA 2024-02-19
ER

PT J
AU Lee, AR
   Pechenino, AS
   Dong, H
   Hammock, BD
   Knowlton, AA
AF Lee, Alison R.
   Pechenino, Angela S.
   Dong, Hua
   Hammock, Bruce D.
   Knowlton, Anne A.
TI Aging, Estrogen Loss and Epoxyeicosatrienoic Acids (EETs)
SO PLOS ONE
LA English
DT Article
AB Inflammation is a key element in many cardiovascular diseases. Both estrogen loss, caused by menopause, and aging have inflammatory consequences. Epoxyeicosatrienoic acids (EETs) are anti-inflammatory molecules synthesized by various cytochrome P450 (Cyp) enzymes from arachidonic acid. EETs are in the third (Cytochrome P450) pathway of arachindonic acid metabolism, others being cyclooxygenases and lipoxygenases. We hypothesized that aging and estrogen loss would reduce levels of anti-inflammatory EETs. Adult (6 mo) and aged (22 mo) ovariectomized rats with (OP) and without (Ovx) 17-there exists-estradiol replacement were used in this study. Mass spectrometry was used to measure levels of EETs and their metabolites, dihydroxyeicosatrienoic acids (DHETs). Levels of Cyp2C2, Cyp2C6, and Cyp2J2, the principal Cyps responsible for EETs synthesis, as well as soluble epoxide hydrolase (sEH), which metabolizes EETS to DHETs, were determined via western blot. Overall Cyp levels decreased with age, though Cyp2C6 increased in the liver. sEH was increased in the kidney with estrogen replacement. Despite protein changes, no differences were measured in plasma or aortic tissue levels of EETs. However, plasma 14,15 DHET was increased in aged Ovx, and 5,6 DHET in adult OP. In conclusion neither aging nor estrogen loss decreased the anti-inflammatory EETs in the cardiovascular system.
C1 [Lee, Alison R.; Pechenino, Angela S.; Knowlton, Anne A.] Univ Calif Davis, Dept Med, Div Cardiovasc, Davis, CA 95616 USA.
   [Knowlton, Anne A.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA.
   [Dong, Hua; Hammock, Bruce D.] Univ Calif Davis, Dept Entymol, Davis, CA 95616 USA.
   [Knowlton, Anne A.] Northern Calif VA, Dept Vet Affairs, Sacramento, CA USA.
C3 University of California System; University of California Davis;
   University of California System; University of California Davis;
   University of California System; University of California Davis
RP Knowlton, AA (corresponding author), Univ Calif Davis, Dept Med, Div Cardiovasc, Davis, CA 95616 USA.
EM aaknowlton@ucdavis.edu
FU U.S. Department of Veterans' Affairs [5101BX000839]; Office of Research
   and Development; Biomedical Laboratory Research Program; NIH [T32
   86350]; HHMI-MIG
FX Supported by a Merit Award(5101BX000839) from the U.S. Department of
   Veterans' Affairs, Office of Research and Development, Biomedical
   Laboratory Research Program (AAK), NIH T32 86350(ARL and ASP) and
   HHMI-MIG (ARL). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Adams MR, 2002, ARTERIOSCL THROM VAS, V22, P1859, DOI 10.1161/01.ATV.0000042202.42136.D0
   Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701
   Csiszar A, 2002, CIRC RES, V90, P1159, DOI 10.1161/01.RES.0000020401.61826.EA
   Deng YM, 2011, FASEB J, V25, P703, DOI 10.1096/fj.10-171488
   Dhanasekaran A, 2008, AM J PHYSIOL-HEART C, V294, pH724, DOI 10.1152/ajpheart.00979.2007
   Douglas G, 2006, J PHYSIOL-LONDON, V571, P477, DOI 10.1113/jphysiol.2005.104125
   Ferrari AU, 2003, J APPL PHYSIOL, V95, P2591, DOI 10.1152/japplphysiol.00601.2003
   Fleming I, 2007, TRENDS PHARMACOL SCI, V28, P448, DOI 10.1016/j.tips.2007.08.002
   Fornage M, 2004, CIRCULATION, V109, P335, DOI 10.1161/01.CIR.0000109487.46725.02
   Gauthier KM, 2007, J CARDIOVASC PHARM, V50, P601, DOI 10.1097/FJC.0b013e318159cbe3
   Georgiadou P, 2009, ADV CLIN CHEM, V47, P59, DOI 10.1016/S0065-2423(09)47003-3
   Gross GJ, 2009, AM J PHYSIOL-HEART C, V297, pH47, DOI 10.1152/ajpheart.01084.2008
   Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605
   Imaoka Susumu, 2005, Drug Metab Pharmacokinet, V20, P478, DOI 10.2133/dmpk.20.478
   Imig JD, 2012, PHYSIOL REV, V92, P101, DOI 10.1152/physrev.00021.2011
   Jiang HL, 2011, AM J PHYSIOL-HEART C, V300, pH1990, DOI 10.1152/ajpheart.01267.2010
   Jung O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011979
   KARARA A, 1992, BIOCHEM BIOPH RES CO, V182, P1320, DOI 10.1016/0006-291X(92)91877-S
   KARARA A, 1991, J BIOL CHEM, V266, P7561
   Knowlton AA, 2012, PHARMACOL THERAPEUT, V135, P54, DOI 10.1016/j.pharmthera.2012.03.007
   Kozak W, 2003, EXP BIOL MED, V228, P786, DOI 10.1177/15353702-0322807-03
   LAETHEM RM, 1992, MOL PHARMACOL, V42, P958
   Lagranha CJ, 2010, CIRC RES, V106, P1681, DOI 10.1161/CIRCRESAHA.109.213645
   Lee CR, 2006, HUM MOL GENET, V15, P1640, DOI 10.1093/hmg/ddl085
   Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705
   Mahn K, 2005, FASEB J
   Michaelis UR, 2006, PHARMACOL THERAPEUT, V111, P584, DOI 10.1016/j.pharmthera.2005.11.003
   Minuz P, 2008, HYPERTENSION, V51, P1379, DOI 10.1161/HYPERTENSIONAHA.107.105395
   Morisseau C, 2005, ANNU REV PHARMACOL, V45, P311, DOI 10.1146/annurev.pharmtox.45.120403.095920
   Nagarajan S, 2008, J NUTR, V138, P332, DOI 10.1093/jn/138.2.332
   Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276
   Ogborn MR, 2010, EXP BIOL MED, V235, P1315, DOI 10.1258/ebm.2010.010059
   Oparil S, 1997, CIRCULATION, V95, P1301
   Ospina JA, 2004, AM J PHYSIOL-HEART C, V286, pH2010, DOI 10.1152/ajpheart.00481.2003
   Panigrahy D, 2012, J CLIN INVEST, V122, P178, DOI 10.1172/JCI58128
   Pechenino AS, 2011, PHYSIOL GENOMICS, V43, P1065, DOI 10.1152/physiolgenomics.00228.2010
   Pfister SL, 2011, HYPERTENSION, V57, P825, DOI 10.1161/HYPERTENSIONAHA.110.168716
   PINOT F, 1995, BIOCHEM PHARMACOL, V50, P501, DOI 10.1016/0006-2952(95)00167-X
   Przybyla-Zawislak BD, 2003, MOL PHARMACOL, V64, P482, DOI 10.1124/mol.64.2.482
   Register TC, 2005, J CLIN ENDOCR METAB, V90, P1734, DOI 10.1210/jc.2004-0939
   Revermann M, 2010, ARTERIOSCL THROM VAS, V30, P909, DOI 10.1161/ATVBAHA.110.204099
   Ross JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038425
   Schmelzer KR, 2006, P NATL ACAD SCI USA, V103, P13646, DOI 10.1073/pnas.0605908103
   Seubert JM, 2007, PROSTAG OTH LIPID M, V82, P50, DOI 10.1016/j.prostaglandins.2006.05.017
   Seubert JM, 2006, CIRC RES, V99, P442, DOI 10.1161/01.RES.0000237390.92932.37
   Shearer GC, 2008, PROSTAG LEUKOTR ESS, V79, P215, DOI 10.1016/j.plefa.2008.09.023
   Smith PJW, 2000, CIRCULATION, V102, P2983
   Spector AA, 2004, PROG LIPID RES, V43, P55, DOI 10.1016/S0163-7827(03)00049-3
   Spector AA, 2009, J LIPID RES, V50, pS52, DOI 10.1194/jlr.R800038-JLR200
   Spiecker M, 2004, CIRCULATION, V110, P2132, DOI 10.1161/01.CIR.0000143832.91812.60
   Stice JP, 2011, ENDOCRINOLOGY, V152, P1589, DOI 10.1210/en.2010-0627
   Stice JP, 2009, ENDOCRINOLOGY, V150, P212, DOI 10.1210/en.2008-0640
   Stice JP, 2008, FUTURE CARDIOLOGY, P151
   Sunday L, 2007, AM J PHYSIOL-HEART C, V292, pH2333, DOI 10.1152/ajpheart.01057.2006
   Turgeon JL, 2004, SCIENCE, V304, P1269, DOI 10.1126/science.1096725
   Ulu A, 2008, J CARDIOVASCULAR PHA, V52
   Vecera R, 2011, BIOPHARM DRUG DISPOS, V32, P482, DOI 10.1002/bdd.774
   Virdis A, 2010, PFLUG ARCH EUR J PHY, V459, P1015, DOI 10.1007/s00424-009-0783-7
   Voss MR, 2003, AM J PHYSIOL-HEART C, V285, pH687, DOI 10.1152/ajpheart.01000.2002
   VOSS MR, 2005, AM J PHYSIOL-HEART C, pH687
   Walsh BA, 1999, ARTERIOSCL THROM VAS, V19, P840, DOI 10.1161/01.ATV.19.4.840
   Webler AC, 2008, AM J PHYSIOL-CELL PH, V295, pC1292, DOI 10.1152/ajpcell.00230.2008
   Wright CD, 2008, CIRC RES, V103, P992, DOI 10.1161/CIRCRESAHA.108.176024
   Yan GJ, 2008, CARDIOVASC RES, V78, P308, DOI 10.1093/cvr/cvn006
   Yang J, 2009, ANAL CHEM, V81, P8085, DOI 10.1021/ac901282n
   Zhang LN, 2009, ARTERIOSCL THROM VAS, V29, P1265, DOI 10.1161/ATVBAHA.109.186064
   Zhao XY, 2004, J AM SOC NEPHROL, V15, P1244
   Zheng XP, 2011, INT J CARDIOL, V151, P290, DOI 10.1016/j.ijcard.2010.05.059
   Zhu P, 2011, J CHROMATOGR B, V879, P2487, DOI 10.1016/j.jchromb.2011.06.042
   Zivkovic AM, 2012, METABOLOMICS, V8, P1102, DOI 10.1007/s11306-012-0417-5
NR 70
TC 35
Z9 36
U1 1
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 13
PY 2013
VL 8
IS 8
AR e70719
DI 10.1371/journal.pone.0070719
PG 8
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 201BN
UT WOS:000323115800014
PM 23967089
OA gold, Green Submitted, Green Published
DA 2024-02-19
ER

PT J
AU Zhang, YL
   Li, B
   Wu, GL
AF Zhang, Yinglong
   Li, Bo
   Wu, Guangliang
TI Dandelion (<i>Taraxacum mongolicum</i> Hand.-Mazz.) suppresses the
   decrease in physical strength and exercise capacity caused by
   insufficient liver function
SO APPLIED BIOLOGICAL CHEMISTRY
LA English
DT Article
DE Dandelion; Aging; d-galactose; Exercise capacity; Liver function
ID ACID; ANTIOXIDANT; EXTRACT; BRAIN; FIBROSIS; KIDNEY; DIET
AB In this study, D-galactose was used to establish a model of liver dysfunction caused by oxidative stress in mice, and the effect of dandelion on improving the exercise capacity of mice with liver dysfunction was observed and its mechanism was expounded. This study examined the role and mechanism of dandelion in improving running ability, swimming endurance, blood biochemical indices, histopathological changes, and tissue mRNA expression changes. The animal results showed that dandelion extended the running and swimming time to exhaustion in liver dysfunctional mice, reduced the serum levels of blood urea nitrogen (BUN), blood lactic acid (BLA) and malondialdehyde (MDA) in the liver, and increased hepatic glycogen (HG) and muscle glycogen (MG) levels as well as uperoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) activities. Histopathological observations suggested that dandelion alleviated lesions in the liver. The quantitative polymerase chain reaction (qPCR) analysis results showed that dandelion downregulated inducible nitric oxide synthase (iNOS) and tumor necrosis factor-alpha (TNF-alpha) mRNA expression and neuronal nitric oxide synthase (nNOS), copper/zinc-superoxide dismutase (Cu/Zn-SOD), manganese-superoxide dismutase (Mn-SOD), and catalase (CAT) expression in the liver and skeletal muscle of the liver-dysfunctional mice. In contrast, dandelion downregulated syncytin-1 mRNA expression in skeletal muscle of mice with a dysregulated liver. The positional analysis showed that the main components of dandelion were gallic acid, protocatechuic acid, chlorogenic acid, caffeic acid, p-coumaric acid, rutin, myricitrin, isoquercitrin, isochlorogenic acid A, and luteolin.
C1 [Zhang, Yinglong] Yanan Univ, Sch Phys Educ, Yanan, Peoples R China.
   [Li, Bo] Xian Univ Finance & Econ, Sports Dept, Xian, Peoples R China.
   [Wu, Guangliang] Renmin Univ China, PE Dept, Beijing, Peoples R China.
C3 Yanan University; Xi'an University of Finance & Economics; Renmin
   University of China
RP Wu, GL (corresponding author), Renmin Univ China, PE Dept, Beijing, Peoples R China.
EM wuguangliangsx@163.com
CR Birman H, 2012, BALK MED J, V29, P188, DOI 10.5152/balkanmedj.2011.030
   Carvalho DZ, 2017, SLEEP MED, V32, P236, DOI 10.1016/j.sleep.2016.08.023
   [陈红玉 Chen Hongyu], 2021, [中华神经医学杂志, Chinese Journal of Neuromedicine], V20, P649
   Davaatseren M, 2013, FOOD CHEM TOXICOL, V58, P30, DOI 10.1016/j.fct.2013.04.023
   Gargouri M, 2012, FOOD CHEM TOXICOL, V50, P2303, DOI 10.1016/j.fct.2012.04.003
   Georgakouli K, 2015, EXP THER MED, V10, P2015, DOI 10.3892/etm.2015.2792
   Ghaima K. K., 2013, Journal of Applied Pharmaceutical Science, V3, P96
   González-Castejón M, 2012, NUTR REV, V70, P534, DOI 10.1111/j.1753-4887.2012.00509.x
   Hou CW, 2019, CHINESE MED J-PEKING, V132, P1005, DOI 10.1097/CM9.0000000000000185
   Hu P, 2012, BIOCONJUGATE CHEM, V23, P438, DOI 10.1021/bc200449k
   Hu TT, 2022, FOOD SCI HUM WELL, V11, P1362, DOI 10.1016/j.fshw.2022.04.036
   Jia L, 2010, J JILIN I PHYS ED, V26, P4
   Kandemir FM, 2022, MOL BIOL REP, V49, P6063, DOI 10.1007/s11033-022-07395-0
   Kim TW, 2009, J EXER REHABILIT, V15, P751
   Kristensen CM, 2017, EXP GERONTOL, V98, P124, DOI 10.1016/j.exger.2017.08.006
   Li F, 2021, FOOD FUNCT, V12, P12479, DOI [10.1039/D1FO00982F, 10.1039/d1fo00982f]
   Li XL, 2006, J GUANGZHOU PHYS ED, V26, P85
   Liu Jun, 2021, Chinese Journal of Sports Medicine, V40, P629, DOI 10.16038/j.1000-6710.2021.08.006
   Liu X, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00582
   Long XY, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.852012
   Luo XL, 2021, J FUNCT FOODS, V86, DOI 10.1016/j.jff.2021.104700
   Mahesh R, 2009, CELL BIOCHEM FUNCT, V27, P358, DOI 10.1002/cbf.1581
   Nakamura Y, 2001, J AGR FOOD CHEM, V49, P5674, DOI 10.1021/jf0106594
   Orita I., 2021, HEALTH-LONDON, V13, P1171, DOI [10.4236/health.2021.1311086, DOI 10.4236/HEALTH.2021.1311086]
   Ovadje P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030604
   Pari L, 2008, CHEM-BIOL INTERACT, V173, P77, DOI 10.1016/j.cbi.2008.02.010
   Qiu WM, 2014, J GUANGZHOU U TRADIT, V2014, P983
   Romani M, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2020.108660
   Shen YT, 2020, INT IMMUNOPHARMACOL, V89, DOI 10.1016/j.intimp.2020.107005
   Shi HT, 2013, TOXICOLOGY, V303, P107, DOI 10.1016/j.tox.2012.10.025
   Song YH, 2015, CHINESE J BIOCH PHAR, V2015, P119
   Wang J, 2014, CELL BIOCHEM BIOPHYS, V69, P21, DOI 10.1007/s12013-013-9761-y
   Wu JZ, 2022, FOOD SCI TECH-BRAZIL, V42, DOI 10.1590/fst.09822
   Xie WD, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/903258
   Xie WY, 2016, LIFE SCI, V152, P180, DOI 10.1016/j.lfs.2016.04.002
   Yi RK, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.573586
   Zhang JX, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/8013681
   Zhang Yuan, 2022, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V38, P47, DOI 10.12047/j.cjap.6209.2022.009
   Zhang Y, 2020, EXP GERONTOL, V131, DOI 10.1016/j.exger.2019.110824
   Zhang ZG, 2022, SCI TECHNOL FOOD IND, V43, P368
   Zhu KX, 2016, J AGR FOOD CHEM, V64, P1938, DOI 10.1021/acs.jafc.5b06103
NR 41
TC 1
Z9 1
U1 8
U2 21
PU SPRINGER SINGAPORE PTE LTD
PI SINGAPORE
PA #04-01 CENCON I, 1 TANNERY RD, SINGAPORE 347719, SINGAPORE
SN 2468-0834
EI 2468-0842
J9 APPL BIOL CHEM
JI Appl. Biol. Chem.
PD DEC
PY 2022
VL 65
IS 1
AR 89
DI 10.1186/s13765-022-00760-4
PG 10
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA 7L8JP
UT WOS:000906205300001
OA gold
DA 2024-02-19
ER

PT J
AU Kyritsi, K
   Wu, N
   Zhou, TH
   Carpino, G
   Baiocchi, L
   Kennedy, L
   Chen, LX
   Ceci, L
   Meyer, AA
   Barupala, N
   Franchitto, A
   Onori, P
   Ekser, B
   Gaudio, E
   Wu, CD
   Marakovits, C
   Chakraborty, S
   Francis, H
   Glaser, S
   Alpini, G
AF Kyritsi, Konstantina
   Wu, Nan
   Zhou, Tianhao
   Carpino, Guido
   Baiocchi, Leonardo
   Kennedy, Lindsey
   Chen, Lixian
   Ceci, Ludovica
   Meyer, Alison Ann
   Barupala, Nipuni
   Franchitto, Antonio
   Onori, Paolo
   Ekser, Burcin
   Gaudio, Eugenio
   Wu, Chaodong
   Marakovits, Corinn
   Chakraborty, Sanjukta
   Francis, Heather
   Glaser, Shannon
   Alpini, Gianfranco
TI Knockout of secretin ameliorates biliary and liver phenotypes during
   alcohol-induced hepatotoxicity
SO CELL AND BIOSCIENCE
LA English
DT Article
DE Biliary senescence; Ductular reaction; Fatty liver diseases; Hepatic
   steatosis; Lipogenesis
ID FUNCTIONAL-HETEROGENEITY; UP-REGULATION; BILE-ACIDS; CHOLANGIOCYTES;
   EXPRESSION; GROWTH; MICE; FIBROSIS; PROLIFERATION; METABOLISM
AB Background Alcohol-related liver disease (ALD) is characterized by ductular reaction (DR), liver inflammation, steatosis, fibrosis, and cirrhosis. The secretin (Sct)/secretin receptor (SR) axis (expressed only by cholangiocytes) regulates liver phenotypes in cholestasis. We evaluated the role of Sct signaling on ALD phenotypes. Methods We used male wild-type and Sct(-)(/-) mice fed a control diet (CD) or ethanol (EtOH) for 8 wk. Changes in liver phenotypes were measured in mice, female/male healthy controls, and patients with alcoholic cirrhosis. Since Cyp4a10 and Cyp4a11/22 regulate EtOH liver metabolism, we measured their expression in mouse/human liver. We evaluated: (i) the immunoreactivity of the lipogenesis enzyme elongation of very-long-chain fatty acids 1 (Elovl, mainly expressed by hepatocytes) in mouse/human liver sections by immunostaining; (ii) the expression of miR-125b (that is downregulated in cholestasis by Sct) in mouse liver by qPCR; and (iii) total bile acid (BA) levels in mouse liver by enzymatic assay, and the mRNA expression of genes regulating BA synthesis (cholesterol 7a-hydroxylase, Cyp27a1, 12a-hydroxylase, Cyp8b1, and oxysterol 7a-hydroxylase, Cyp7b11) and transport (bile salt export pump, Bsep, Na+-taurocholate cotransporting polypeptide, NTCP, and the organic solute transporter alpha (OSTa) in mouse liver by qPCR. Results In EtOH-fed WT mice there was increased biliary and liver damage compared to control mice, but decreased miR-125b expression, phenotypes that were blunted in EtOH-fed Sct(-/-) mice. The expression of Cyp4a10 increased in cholangiocytes and hepatocytes from EtOH-fed WT compared to control mice but decreased in EtOH-fed Sct(-/-) mice. There was increased immunoreactivity of Cyp4a11/22 in patients with alcoholic cirrhosis compared to controls. The expression of miR-125b decreased in EtOH-fed WT mice but returned at normal values in EtOH-fed Sct(-/-) mice. Elovl1 immunoreactivity increased in patients with alcoholic cirrhosis compared to controls. There was no difference in BA levels between WT mice fed CD or EtOH; BA levels decreased in EtOH-fed Sct(-/-) compared to EtOH-fed WT mice. There was increased expression of Cyp27a1, Cyp8b1, Cyp7b1, Bsep, NTCP and Osta in total liver from EtOH-fed WT compared to control mice, which decreased in EtOH-fed Sct(-/-) compared to EtOH-fed WT mice. Conclusions Targeting Sct/SR signaling may be important for modulating ALD phenotypes.
C1 [Kyritsi, Konstantina; Wu, Nan; Zhou, Tianhao; Kennedy, Lindsey; Chen, Lixian; Ceci, Ludovica; Meyer, Alison Ann; Barupala, Nipuni; Marakovits, Corinn; Francis, Heather; Alpini, Gianfranco] Indiana Univ Sch Med, Dept Med, Div Gastroenterol & Hepatol, Indianapolis, IN 46202 USA.
   [Carpino, Guido; Ceci, Ludovica; Onori, Paolo; Gaudio, Eugenio] Univ Roma La Sapienza, Dept Anat Histol Forens Med & Orthoped Sci, Rome, Italy.
   [Baiocchi, Leonardo] Tor Vergata Univ, Unit Hepatol, Rome, Italy.
   [Kennedy, Lindsey; Francis, Heather; Alpini, Gianfranco] Richard L Roudebush VA Med Ctr, Indiana Ctr Liver Res, Div Res, Gastroenterol,Med, 702 Rotary Circle, Rm 013C, Indianapolis, IN 46202 USA.
   [Kennedy, Lindsey; Francis, Heather; Alpini, Gianfranco] Indiana Univ, 702 Rotary Circle,Rm 013C, Indianapolis, IN 46202 USA.
   [Franchitto, Antonio] Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Rome, Italy.
   [Ekser, Burcin] Indiana Univ, Dept Surg, Div Transplant Surg, Indianapolis, IN USA.
   [Wu, Chaodong] Texas A&M Univ, Dept Nutr, College Stn, TX USA.
   [Chakraborty, Sanjukta; Glaser, Shannon] Texas A&M Univ, Dept Med Physiol, Sch Med, 8447 Riverside Pkwy,MREB II,Room 2342, Bryan, TX 77807 USA.
C3 Indiana University System; Indiana University Bloomington; Sapienza
   University Rome; University of Rome Tor Vergata; US Department of
   Veterans Affairs; Veterans Health Administration (VHA); Richard L.
   Roudebush VA Medical Center; Indiana University System; Indiana
   University-Purdue University Indianapolis; Foro Italico University of
   Rome; Indiana University System; Indiana University-Purdue University
   Indianapolis; Texas A&M University System; Texas A&M University College
   Station; Texas A&M University System; Texas A&M University College
   Station
RP Francis, H; Alpini, G (corresponding author), Indiana Univ Sch Med, Dept Med, Div Gastroenterol & Hepatol, Indianapolis, IN 46202 USA.; Francis, H; Alpini, G (corresponding author), Richard L Roudebush VA Med Ctr, Indiana Ctr Liver Res, Div Res, Gastroenterol,Med, 702 Rotary Circle, Rm 013C, Indianapolis, IN 46202 USA.; Francis, H; Alpini, G (corresponding author), Indiana Univ, 702 Rotary Circle,Rm 013C, Indianapolis, IN 46202 USA.; Glaser, S (corresponding author), Texas A&M Univ, Dept Med Physiol, Sch Med, 8447 Riverside Pkwy,MREB II,Room 2342, Bryan, TX 77807 USA.
EM heafranc@iu.edu; sglaser@tamu.edu; galpini@iu.edu
RI Carpino, Guido/AAB-9692-2019
OI CARPINO, Guido/0000-0001-8570-2519; Ekser, Burcin/0000-0003-0741-8007
FU Richard L. Roudebush VA Medical Center, Indianapolis, IN; Texas A&M
   University, Department of Medical Physiology, Medical Research Building,
   Bryan, TX
FX This material results from work supported by resources at the Richard L.
   Roudebush VA Medical Center, Indianapolis, IN, and Texas A & M
   University, Department of Medical Physiology, Medical Research Building,
   Bryan, TX. The views expressed in this article are those of the authors
   and do not necessarily represent the Department of Veterans Affairs
   views.
CR Affo S, 2021, CANCER CELL, V39, P866, DOI 10.1016/j.ccell.2021.03.012
   Alharshawi Khaled, 2021, J Cell Immunol, V3, P177, DOI 10.33696/immunology.3.096
   Alpini G, 2005, HEPATOLOGY, V41, P1037, DOI 10.1002/hep.20653
   Alpini G, 2002, HEPATOLOGY, V35, P1041, DOI 10.1053/jhep.2002.32712
   ALPINI G, 1988, J CLIN INVEST, V81, P569, DOI 10.1172/JCI113355
   ALPINI G, 1994, AM J PHYSIOL, V266, pG922, DOI 10.1152/ajpgi.1994.266.5.G922
   Alpini G, 1996, GASTROENTEROLOGY, V110, P1636, DOI 10.1053/gast.1996.v110.pm8613073
   Alpini Gianfranco, 1997, American Journal of Physiology, V272, pG1064
   Banales JM, 2012, HEPATOLOGY, V56, P687, DOI 10.1002/hep.25691
   Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5
   Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032
   Blaya D, 2016, GUT, V65, P1535, DOI 10.1136/gutjnl-2015-311314
   Bocca C, 2015, CELL MOL GASTROENTER, V1, P477, DOI 10.1016/j.jcmgh.2015.06.011
   Carbone M, 2018, LANCET GASTROENTEROL, V3, P626, DOI 10.1016/S2468-1253(18)30163-8
   Carpino G, 2020, HEPATOLOGY, V72, P470, DOI 10.1002/hep.31056
   Chen LX, 2021, HEPATOLOGY, V74, P1845, DOI 10.1002/hep.31871
   Chen YY, 2019, JHEP REP, V1, P369, DOI 10.1016/j.jhepr.2019.10.003
   García C, 1998, CELL TISSUE RES, V291, P481, DOI 10.1007/s004410051017
   Gaudio E, 2006, GASTROENTEROLOGY, V130, P1270, DOI 10.1053/j.gastro.2005.12.034
   Gaudio E, 1996, GASTROENTEROLOGY, V111, P1118, DOI 10.1016/S0016-5085(96)70081-1
   Glaser S, 2014, GASTROENTEROLOGY, V146, P1795, DOI 10.1053/j.gastro.2014.02.030
   Glaser T, 2020, J CELL MOL MED, V24, P5955, DOI 10.1111/jcmm.15182
   Govaere O, 2019, J PATHOL, V248, P66, DOI 10.1002/path.5228
   Jüngst C, 2013, EUR J CLIN INVEST, V43, P1069, DOI 10.1111/eci.12128
   Kanno N, 2000, HEPATOLOGY, V31, P555, DOI 10.1002/hep.510310302
   Kennedy L, 2023, J HEPATOL, V78, P99, DOI 10.1016/j.jhep.2022.07.034
   Kennedy L, 2020, LAB INVEST, V100, P837, DOI 10.1038/s41374-020-0405-8
   Kennedy L, 2019, FASEB J, V33, P10269, DOI 10.1096/fj.201802606R
   Kim SJ, 2019, HEPATOLOGY, V69, P1965, DOI 10.1002/hep.30525
   Korompokis K, 2021, COMPR REV FOOD SCI F, V20, P5965, DOI 10.1111/1541-4337.12847
   Kuba M, 2015, SCI REP-UK, V5, DOI 10.1038/srep17604
   Lam IPY, 2009, AM J PHYSIOL-GASTR L, V297, pG90, DOI 10.1152/ajpgi.00094.2009
   Lei L, 2021, J CLIN MED, V10, DOI 10.3390/jcm10071338
   LeSage GD, 1999, AM J PHYSIOL-GASTR L, V276, pG1289, DOI 10.1152/ajpgi.1999.276.5.G1289
   Li Q, 2018, HEPATOLOGY, V68, P187, DOI 10.1002/hep.29804
   Lleo A, 2020, LANCET, V396, P1915, DOI 10.1016/S0140-6736(20)31607-X
   Mandache E, 2002, J CELL MOL MED, V6, P59, DOI 10.1111/j.1582-4934.2002.tb00311.x
   Matsuzaka T, 2020, HEPATOLOGY, V71, P1609, DOI 10.1002/hep.30953
   Matsuzaka T, 2012, HEPATOLOGY, V56, P2199, DOI 10.1002/hep.25932
   Medina JF, 1997, HEPATOLOGY, V25, P12, DOI 10.1002/hep.510250104
   Muir K, 2013, CANCER RES, V73, P4722, DOI 10.1158/0008-5472.CAN-12-3797
   Prieto J, 1999, GASTROENTEROLOGY, V117, P167, DOI 10.1016/S0016-5085(99)70564-0
   Ramirez T, 2017, J HEPATOL, V66, P601, DOI 10.1016/j.jhep.2016.11.004
   Salas JT, 2008, GASTROENTEROLOGY, V134, P1482, DOI 10.1053/j.gastro.2008.02.020
   Sancho-Bru P, 2012, HEPATOLOGY, V55, P1931, DOI 10.1002/hep.25614
   Sasaki M, 2018, LAB INVEST, V98, P745, DOI 10.1038/s41374-018-0045-4
   Satishchandran A, 2018, GASTROENTEROLOGY, V154, P238, DOI 10.1053/j.gastro.2017.09.022
   Sato K, 2019, HEPATOLOGY, V69, P420, DOI 10.1002/hep.30150
   Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003
   Sekar R, 2014, FASEB J, V28, P3494, DOI 10.1096/fj.13-247536
   Singal AK, 2018, AM J GASTROENTEROL, V113, P175, DOI 10.1038/ajg.2017.469
   Tripathy S, 2014, J LIPID RES, V55, P1448, DOI 10.1194/jlr.M050062
   Trussoni CE, 2022, SEMIN IMMUNOPATHOL, DOI [10.1007/s00281-022-909-9, DOI 10.1007/S00281-022-909-9]
   van Niekerk J, 2018, CLIN LIVER DIS, V22, P457, DOI 10.1016/j.cld.2018.03.013
   Vogle A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59188-9
   von Meijenfeldt FA, 2022, HEPATOLOGY, V75, P623, DOI 10.1002/hep.32174
   Wan Y, 2017, HEPATOLOGY, V66, P528, DOI 10.1002/hep.29138
   Wu N, 2022, HEPATOLOGY, V75, P797, DOI 10.1002/hep.32233
   Wu N, 2020, HEPATOLOGY, V72, P2219, DOI 10.1002/hep.31484
   Wu N, 2018, AM J PATHOL, V188, P2264, DOI 10.1016/j.ajpath.2018.06.015
   Wu N, 2016, HEPATOLOGY, V64, P865, DOI 10.1002/hep.28622
   Yang ZH, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.140687
   Zhou JY, 2019, ACTA PHARM SIN B, V9, P526, DOI 10.1016/j.apsb.2018.11.004
   Zhou TH, 2019, EBIOMEDICINE, V48, P130, DOI 10.1016/j.ebiom.2019.09.013
   Zhou TH, 2018, LAB INVEST, V98, P1449, DOI 10.1038/s41374-018-0093-9
   Zhou X, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020373
NR 66
TC 1
Z9 1
U1 1
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2045-3701
J9 CELL BIOSCI
JI Cell Biosci.
PD JAN 9
PY 2023
VL 13
IS 1
AR 5
DI 10.1186/s13578-022-00945-w
PG 22
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 7T5DU
UT WOS:000911467400001
PM 36624475
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Lyuesfeldt, J
   Moos, T
AF Lyuesfeldt, J
   Moos, T
TI Age-dependent change in Vitamin C status: A phenomenon of maturation
   rather than of ageing
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE vitamin C; ageing; maturation; age-dependent; guinea pigs; humans
ID ASCORBIC-ACID CONCENTRATIONS; OLD RATS; MITOCHONDRIAL DECAY; OXIDATIVE
   DAMAGE; DIETARY; ANTIOXIDANTS; HEPATOCYTES; DECLINE; SUPPLEMENTATION;
   DEFICIENCY
AB Several reports have shown that Vitamin C is depleted in animals with age. Based mainly on comparisons between young animals that have not yet reached maturity and old animals, it appears to be the general assumption that the change in Vitamin C status occurs at a late stage in life and that this phenomenon may either contribute to or result from the ageing process. In the present study, young Q months old, n = 8) and old (36 months old, n = 8) female guinea pigs were followed for 6 months with monthly blood samplings and monitored for Vitamin C status as measured by plasma ascorbate and erythrocyte ascorbate recycling capacity after which the animals were euthanized. While remaining unchanged in the old animals, plasma Vitamin C status of the young animals significantly declined to that of the old animals within 3 months. During the following 3 months, the Vitamin C status of the young animals remained unchanged. Furthermore, post mortem Vitamin C analyses of the animals now aged 9 and 42 months, respectively, showed no effect of age on Vitamin C in plasma, liver, kidney, heart and brain between the groups while concentrations were significantly increased in cerebrospinal fluid and lung with age (p < 0.05). Moreover, a significantly elevated ascorbic acid oxidation ratio was observed in young compared to old animals (p < 0.05).
   The present data suggest that the decline in Vitamin C status with age occur early in life and is a phenomenon of maturation rather than of ageing. Data from other species and humans are discussed. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
C1 Royal Vet & Agr Univ, Dept Vet Pathobiol, Sect Biomed, DK-1870 Frederiksberg, Denmark.
   Univ Copenhagen, Dept Med Anat, Copenhagen, Denmark.
C3 University of Copenhagen; University of Copenhagen
RP Lyuesfeldt, J (corresponding author), Royal Vet & Agr Univ, Dept Vet Pathobiol, Sect Biomed, 9 Ridebanevej, DK-1870 Frederiksberg, Denmark.
EM jopl@kvl.dk
RI Lykkesfeldt, Jens/A-1072-2011
OI Lykkesfeldt, Jens/0000-0002-6514-8407; Moos, Torben/0000-0001-9989-0207
CR Ames BN, 1998, TOXICOL LETT, V103, P5, DOI 10.1016/S0378-4274(98)00282-3
   AMES BN, 1992, ANN NY ACAD SCI, V663, P85, DOI 10.1111/j.1749-6632.1992.tb38652.x
   AMES BN, 1995, BBA-MOL BASIS DIS, V1271, P165, DOI 10.1016/0925-4439(95)00024-X
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   AZHAR S, 1995, J CLIN INVEST, V96, P1414, DOI 10.1172/JCI118177
   Barja G, 1996, Subcell Biochem, V25, P157
   BERGER J, 1989, J NUTR, V119, P734, DOI 10.1093/jn/119.5.734
   DE AK, 1991, MECH AGEING DEV, V59, P123, DOI 10.1016/0047-6374(91)90078-E
   DICKINSON VA, 1994, J AM COLL NUTR, V13, P22
   Hagen TM, 1999, FASEB J, V13, P411, DOI 10.1096/fasebj.13.2.411
   Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064
   Hagen TM, 2002, P NATL ACAD SCI USA, V99, P7184
   Hampl JS, 2004, AM J PUBLIC HEALTH, V94, P870, DOI 10.2105/AJPH.94.5.870
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HERCBERG S, 1994, INT J VITAM NUTR RES, V64, P220
   HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2
   HUGHES RE, 1971, BRIT J NUTR, V25, P77, DOI 10.1079/BJN19710065
   KANUNGO MS, 1964, BIOCHEM J, V90, P637, DOI 10.1042/bj0900637
   Kume-Kick J, 1998, BRAIN RES, V803, P105, DOI 10.1016/S0006-8993(98)00628-3
   LEIBOVITZ BE, 1980, J GERONTOL, V35, P45, DOI 10.1093/geronj/35.1.45
   Leveque N, 2003, GERONTOLOGY, V49, P117, DOI 10.1159/000067951
   Lykkesfeldt J, 1999, METHOD ENZYMOL, V299, P83
   Lykkesfeldt J, 1998, FASEB J, V12, P1183, DOI 10.1096/fasebj.12.12.1183
   Lykkesfeldt J, 2002, FREE RADICAL RES, V36, P567, DOI 10.1080/1071576022411256
   Lykkesfeldt J, 2001, ANAL BIOCHEM, V291, P173, DOI 10.1006/abio.2001.5100
   LYKKESFELDT J, 2002, CURRENT PROTOCOLS TO
   Michels AJ, 2004, VITAMIN C: FUNCTION AND BIOCHEMISTRY IN ANIMALS AND PLANTS, P203
   Michels AJ, 2003, ARCH BIOCHEM BIOPHYS, V410, P112, DOI 10.1016/S0003-9861(02)00678-1
   O'Donnell E, 1998, NEUROBIOL AGING, V19, P461, DOI 10.1016/S0197-4580(98)00082-7
   ORRINGER EP, 1979, J CLIN INVEST, V63, P53, DOI 10.1172/JCI109277
   PATNAIK BK, 1966, BIOCHEM J, V100, P59, DOI 10.1042/bj1000059
   RIKANS LE, 1988, BIOCHIM BIOPHYS ACTA, V966, P269, DOI 10.1016/0304-4165(88)90076-1
   Rikans LE, 1996, MECH AGEING DEV, V91, P165, DOI 10.1016/S0047-6374(96)01784-8
   Sahoo A, 1997, INT J DEV NEUROSCI, V15, P939, DOI 10.1016/S0736-5748(97)00049-X
   Scrofano MM, 1998, MECH AGEING DEV, V105, P31, DOI 10.1016/S0047-6374(98)00077-3
   Suh JH, 2001, FASEB J, V15, P700, DOI 10.1096/fj.00-0176com
   SVENSSON L, 1993, BRAIN RES, V609, P36, DOI 10.1016/0006-8993(93)90851-D
   Villalpando S, 2003, SALUD PUBLICA MEXICO, V45, pS508
NR 38
TC 27
Z9 29
U1 0
U2 4
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD AUG
PY 2005
VL 126
IS 8
BP 892
EP 898
DI 10.1016/j.mad.2005.03.010
PG 7
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 947YN
UT WOS:000230683300008
PM 15992612
DA 2024-02-19
ER

PT J
AU Lee, OK
   Cha, HJ
   Lee, MJ
   Lim, KM
   Jung, JW
   Ahn, KJ
   An, IS
   An, S
   Bae, S
AF Lee, Ok-Kyu
   Cha, Hwa Jun
   Lee, Myung Joo
   Lim, Kyung Mi
   Jung, Jae Wook
   Ahn, Kyu Joong
   An, In-Sook
   An, Sungkwan
   Bae, Seunghee
TI Implication of microRNA regulation in
   <i>para</i>-phenylenediamine-induced cell death and senescence in normal
   human hair dermal papilla cells
SO MOLECULAR MEDICINE REPORTS
LA English
DT Article
DE para-phenylenediamine; human dermal papilla cells; microRNA
ID ALLERGIC CONTACT-DERMATITIS; CANINE KIDNEY-CELLS; P-PHENYLENEDIAMINE;
   DNA-DAMAGE; ACTIVATION; EXPRESSION; APOPTOSIS; CARCINOGENICITY;
   MORPHOGENESIS; MEDIATORS
AB Para-phenylenediamine (PPD) is a major component of hair coloring and black henna products. Although it has been largely demonstrated that PPD induces allergic reactions and increases the risk of tumors in the kidney, liver, thyroid gland and urinary bladder, the effect on dermal papilla cells remains to be elucidated. Therefore, the current study evaluated the effects of PPD on growth, cell death and senescence using cell-based assays and microRNA (miRNA) microarray in normal human hair dermal papilla cells (nHHDPCs). Cell viability and cell cycle analyses demonstrated that PPD exhibited a significant cytotoxic effect on nHHDPCs through inducing cell death and G(2) phase cell cycle arrest in a dose-dependent manner. It was additionally observed that treatment of nHHDPCs with PPD induced cellular senescence by promoting cellular oxidative stress. In addition, the results of the current study indicated that these PPD-mediated effects were involved in the alteration of miRNA expression profiles. Treatment of nHHDPCs with PPD altered the expression levels of 74 miRNAs by 2-fold (16 upregulated and 58 downregulated miRNAs). Further bioinformatics analysis determined that these identified miRNA target genes were likely to be involved in cell growth, cell cycle arrest, cell death, senescence and the induction of oxidative stress. In conclusion, the observations of the current study suggested that PPD was able to induce several cytotoxic effects through alteration of miRNA expression levels in nHHDPCs.
C1 [Lee, Ok-Kyu; Cha, Hwa Jun; Lee, Myung Joo; Lim, Kyung Mi; An, In-Sook; An, Sungkwan; Bae, Seunghee] Konkuk Univ, Korea Inst Skin & Clin Sci, Seoul 143701, South Korea.
   [Lee, Ok-Kyu; Cha, Hwa Jun; Lee, Myung Joo; Lim, Kyung Mi; An, In-Sook; An, Sungkwan; Bae, Seunghee] Konkuk Univ, Mol Targeted Drug Res Ctr, Seoul 143701, South Korea.
   [Jung, Jae Wook; Ahn, Kyu Joong] Konkuk Univ, Dept Dermatol, Sch Med, Seoul 143729, South Korea.
C3 Konkuk University; Konkuk University; Konkuk University; Konkuk
   University Medical Center
RP Bae, S (corresponding author), Konkuk Univ, Korea Inst Skin & Clin Sci, 120 Neungdong Ro, Seoul 143701, South Korea.
EM sbae@konkuk.ac.kr
FU Ministry of Health & Welfare, Republic of Korea [HN13C0075]; Konkuk
   University
FX The current study was supported by a grant from the Korean Health
   Technology R&D Project, Ministry of Health & Welfare, Republic of Korea
   (grant no. HN13C0075). Dr Seunghee Bae was additionally supported by the
   KU Research Professor Program of Konkuk University.
CR Akelma AZ, 2013, J ALLER CL IMM-PRACT, V1, P399, DOI 10.1016/j.jaip.2013.02.006
   Amelio I, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.426
   Anderson JS, 2000, J SOC DYERS COLOUR, V116, P193
   Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Beaudoin GMJ, 2005, P NATL ACAD SCI USA, V102, P14653, DOI 10.1073/pnas.0507609102
   Bhaumik D, 2009, AGING-US, V1, P402, DOI 10.18632/aging.100042
   Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242
   Chen SC, 2010, TOXICOL IN VITRO, V24, P1197, DOI 10.1016/j.tiv.2010.02.011
   Chen SC, 2006, TOXICOL IN VITRO, V20, P801, DOI 10.1016/j.tiv.2005.12.003
   Chye SM, 2014, ENVIRON TOXICOL, V29, P981, DOI 10.1002/tox.21828
   Colavitti R, 2005, IUBMB LIFE, V57, P277, DOI 10.1080/15216540500091890
   Corbett JF, 1999, DYES PIGMENTS, V41, P127, DOI 10.1016/S0143-7208(98)00075-8
   Coulter EM, 2007, J PHARMACOL EXP THER, V320, P885, DOI 10.1124/jpet.106.113803
   Demirci GT, 2012, CUTAN OCUL TOXICOL, V31, P250, DOI 10.3109/15569527.2011.641195
   Goebel C, 2014, TOXICOL APPL PHARM, V274, P480, DOI 10.1016/j.taap.2013.11.016
   Huang YC, 2011, TOXICOL IN VITRO, V25, P1630, DOI 10.1016/j.tiv.2011.06.013
   Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1
   Ishida Waka, 2011, ISRN Dermatol, V2011, P947284, DOI 10.5402/2011/947284
   Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104
   Marcoux D, 2002, PEDIATR DERMATOL, V19, P498, DOI 10.1046/j.1525-1470.2002.00218.x
   Mardaryev AN, 2010, FASEB J, V24, P3869, DOI 10.1096/fj.10-160663
   ROJANAPO W, 1986, CARCINOGENESIS, V7, P1997, DOI 10.1093/carcin/7.12.1997
   So YJ, 2011, MOL CELL TOXICOL, V7, P339, DOI [10.1007/s13273-011-0043-8, 10.1007/s13273-011-0040-y]
   SONTAG JM, 1981, JNCI-J NATL CANCER I, V66, P591
   Teo JL, 2010, ADV DRUG DELIVER REV, V62, P1149, DOI 10.1016/j.addr.2010.09.012
   Wan GH, 2011, TRENDS BIOCHEM SCI, V36, P478, DOI 10.1016/j.tibs.2011.06.002
   Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105
NR 28
TC 9
Z9 10
U1 0
U2 9
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1791-2997
EI 1791-3004
J9 MOL MED REP
JI Mol. Med. Rep.
PD JUL
PY 2015
VL 12
IS 1
BP 921
EP 936
DI 10.3892/mmr.2015.3487
PG 16
WC Oncology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Research & Experimental Medicine
GA CN0WJ
UT WOS:000358134400126
PM 25776079
OA Green Published, hybrid, Green Submitted
DA 2024-02-19
ER

PT J
AU Sanguino, E
   Roglans, N
   Rodríguez-Calvo, R
   Alegret, M
   Sánchez, RM
   Vázquez-Carrera, M
   Laguna, JC
AF Sanguino, Elena
   Roglans, Nuria
   Rodriguez-Calvo, Ricardo
   Alegret, Marta
   Sanchez, Rosa M.
   Vazquez-Carrera, Manuel
   Laguna, Juan C.
TI Ageing introduces a complex pattern of changes in several rat brain
   transcription factors depending on gender and anatomical localization
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE cortex; hippocampus; aged rat; NF kappa B; AP-1; LXR; PPAR
ID FACTOR-KAPPA-B; AGE-RELATED-CHANGES; LIVER-X-RECEPTOR; ACTIVATOR
   PROTEIN-1; OXIDATIVE STRESS; PPAR-ALPHA; CROSS-TALK; C-JUN; DISEASE; OLD
AB As ageing changes the activity of several transcription factors in the rat cortex, we were interested in determining whether similar changes also appear in the hippocampus of old rats. We determined by electrophoretic gel shift assays the binding activity of nuclear factor kappa B (NF kappa B), activator protein-1 (AP-1), peroxisome proliferator-activated receptor (PPAR), and liver X receptor (LXR) in cortex and hippocampus samples from young (3-month-old), and old (18-month-old) male and female Sprague-Dawley rats. NF kappa B activity increased in old male and female rats, though only in cortex samples, while AP-1 activity decreased only in the cortex and hippocampus of old female animals. LXR activity decreased in all conditions, except in old male cortexes; whereas PPAR activity only decreased in the hippocampus of old female rats. Decreases in AP-1 and PPAR activities restricted to old female rats did not result from an age-related decline in plasma 17 beta-estradiol concentration, as their activities did not change in samples obtained from ovariectomized young female rats. Our results indicate that ageing induces a complex pattern of changes in the brain-binding activity of NF kappa B, AP-1, PPAR and LXR, depending on the anatomical origin of the samples (cortex or hippocampus), and the sex of the animals studied. (c) 2006 Elsevier Inc. All rights reserved.
C1 Univ Barcelona, Fac Farm, Unidad Farmacol & Farmacognosia, E-08028 Barcelona, Spain.
C3 University of Barcelona
RP Laguna, JC (corresponding author), Univ Barcelona, Fac Farm, Unidad Farmacol & Farmacognosia, Avda Diagonal 643, E-08028 Barcelona, Spain.
EM jclagunae@ub.edu
RI Alegret, Marta/C-5086-2017; Rodriguez-Calvo, Ricardo/AAB-4054-2019;
   Rodriguez-Calvo, Ricardo/R-6645-2018; Roglans, Núria/ABH-1242-2020;
   Laguna, JCLaguna - Juan C./C-5481-2017; Vázquez-Carrera,
   Manuel/H-2612-2015
OI Alegret, Marta/0000-0002-5652-8651; Rodriguez-Calvo,
   Ricardo/0000-0001-7513-0983; Rodriguez-Calvo,
   Ricardo/0000-0001-7513-0983; Laguna, JCLaguna - Juan
   C./0000-0002-7082-0704; Vázquez-Carrera, Manuel/0000-0001-7138-8207;
   Roglans, Nuria/0000-0002-5018-021X
CR Basheer R, 2001, MOL BRAIN RES, V89, P153, DOI 10.1016/S0169-328X(01)00045-6
   Baum LW, 2005, J GERONTOL A-BIOL, V60, P736, DOI 10.1093/gerona/60.6.736
   Bowie A, 2000, BIOCHEM PHARMACOL, V59, P13, DOI 10.1016/S0006-2952(99)00296-8
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Cabrero A., 2002, Current Drug Targets - Inflammation and Allergy, V1, P243, DOI 10.2174/1568010023344616
   Cho KS, 2002, NEUROREPORT, V13, P285, DOI 10.1097/00001756-200203040-00008
   Constantinidis Christos, 2004, Cognitive Affective & Behavioral Neuroscience, V4, P444, DOI 10.3758/CABN.4.4.444
   Crestani M, 2004, BIOCHEM SOC T, V32, P92, DOI 10.1042/BST0320092
   Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048
   DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475
   Ferrari AU, 2003, J APPL PHYSIOL, V95, P2591, DOI 10.1152/japplphysiol.00601.2003
   Ham J, 2000, BIOCHEM PHARMACOL, V60, P1015, DOI 10.1016/S0006-2952(00)00372-5
   Helenius M, 1996, J MOL CELL CARDIOL, V28, P487, DOI 10.1006/jmcc.1996.0045
   Herdegen T, 1997, TRENDS NEUROSCI, V20, P227, DOI 10.1016/S0166-2236(96)01000-4
   Hüll M, 2002, CURR MED CHEM, V9, P83, DOI 10.2174/0929867023371292
   Ide T, 2003, MOL ENDOCRINOL, V17, P1255, DOI 10.1210/me.2002-0191
   Kálmán J, 2001, LIFE SCI, V68, P1495, DOI 10.1016/S0024-3205(01)00955-9
   Knight JA, 2001, ADV CLIN CHEM, V35, P1, DOI 10.1016/S0065-2423(01)35014-X
   Mattila PM, 1999, ACTA NEUROPATHOL, V98, P157, DOI 10.1007/s004010051064
   McGeer PL, 1995, BRAIN RES REV, V21, P195, DOI 10.1016/0165-0173(95)00011-9
   Pallottini V, 2003, BIOGERONTOLOGY, V4, P371, DOI 10.1023/B:BGEN.0000006557.92558.60
   Planavila A, 2005, J BIOL CHEM, V280, P17464, DOI 10.1074/jbc.M414220200
   Poynter ME, 1998, J BIOL CHEM, V273, P32833, DOI 10.1074/jbc.273.49.32833
   Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207
   Sanguino E, 2005, BRIT J PHARMACOL, V145, P853, DOI 10.1038/sj.bjp.0706260
   Sanguino E, 2004, EXP GERONTOL, V39, P1295, DOI 10.1016/j.exger.2004.06.007
   Sanguino E, 2004, BIOCHEM PHARMACOL, V68, P1411, DOI 10.1016/j.bcp.2004.06.008
   Sanguino E, 2003, LIFE SCI, V73, P2927, DOI 10.1016/j.lfs.2003.04.001
   Smith DR, 2001, NEUROBIOL AGING, V22, P773, DOI 10.1016/S0197-4580(01)00240-8
   SONNENBERG JL, 1989, NEURON, V3, P359, DOI 10.1016/0896-6273(89)90260-2
   Spencer NFL, 1997, INT IMMUNOL, V9, P1581, DOI 10.1093/intimm/9.10.1581
   Staels B, 1998, NATURE, V393, P790, DOI 10.1038/31701
   Stephenson D, 2000, J CEREBR BLOOD F MET, V20, P592, DOI 10.1097/00004647-200003000-00017
   Yudkin JS, 2000, ATHEROSCLEROSIS, V148, P209, DOI 10.1016/S0021-9150(99)00463-3
   Zhou L, 2003, EXP GERONTOL, V38, P1161, DOI 10.1016/S0531-5565(03)00170-0
NR 35
TC 8
Z9 11
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD APR
PY 2006
VL 41
IS 4
BP 372
EP 379
DI 10.1016/j.exger.2006.02.011
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 047OZ
UT WOS:000237889900005
PM 16600556
DA 2024-02-19
ER

PT J
AU Shima, T
   Seki, K
   Umemura, A
   Ogawa, R
   Horimoto, R
   Oya, H
   Sendo, R
   Mizuno, M
   Okanoue, T
AF Shima, Toshihide
   Seki, Kojiro
   Umemura, Atsushi
   Ogawa, Rie
   Horimoto, Ryuji
   Oya, Hirohisa
   Sendo, Rei
   Mizuno, Masayuki
   Okanoue, Takeshi
TI Influence of lifestyle-related diseases and age on the development and
   progression of non-alcoholic fatty liver disease
SO HEPATOLOGY RESEARCH
LA English
DT Article
DE aging; lifestyle-related disease; non-alcoholic fatty liver disease;
   non-alcoholic steatohepatitis
ID CLINICAL SCORING SYSTEM; HEPATOCELLULAR-CARCINOMA; FOLLOW-UP;
   STEATOHEPATITIS; FIBROSIS; JAPAN; RISK; CANCER; ELASTOGRAPHY;
   ASSOCIATION
AB AimAlthough non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome, the clinical association between non-alcoholic steatohepatitis (NASH) and lifestyle-related diseases such as obesity, type 2 diabetes mellitus (DM), hypertension (HT) and dyslipidemia (DL) has not been clarified. We studied the influence of lifestyle-related diseases and age on the development and progression of NAFLD.
   MethodsWe enrolled 550 patients with biopsy-proven NAFLD (284 men, 266 women; average age, 52 and 62 years, respectively). The effect of lifestyle-related diseases and age (49 vs 50 years) on the frequency of NASH and advanced fibrosis (stage 3) was studied.
   ResultsPrevalence of obesity, DM, HT and DL in male and female NASH patients was 75%/67%, 53%/54%, 66%/77% and 85/79%, respectively. DM patients had a higher frequency of NASH in the older male NAFLD group and a higher frequency of advanced fibrosis in the older female NASH group. With the increasing number of complicating lifestyle-related diseases, the rate of NASH increased in male NAFLD patients. In both sexes, aging resulted in the development of NASH and progression of liver fibrosis. Multivariate logistic regression analysis revealed that age and DM were significantly associated with the development of NASH in male NAFLD patients and progression of fibrosis in female NASH patients.
   ConclusionAge is strongly associated with the development and progression of NASH. Type 2 DM may play the most crucial role among lifestyle-related diseases in the development and progression of NASH.
C1 [Shima, Toshihide; Seki, Kojiro; Umemura, Atsushi; Ogawa, Rie; Horimoto, Ryuji; Oya, Hirohisa; Sendo, Rei; Mizuno, Masayuki; Okanoue, Takeshi] Saiseikai Suita Hosp, Dept Gastroenterol & Hepatol, Suita, Osaka 5640013, Japan.
RP Okanoue, T (corresponding author), Saiseikai Suita Hosp, Dept Gastroenterol & Hepatol, 1-2 Kawazonocho, Suita, Osaka 5640013, Japan.
EM okanoue@suita.saiseikai.or.jp
RI Shima, Toshihide/AAW-9215-2020
OI Shima, Toshihide/0000-0002-4120-9121; Umemura,
   Atsushi/0000-0002-7433-8501
FU Ministry of Labor and Welfare Japan [H20-Hepatitis general-008,
   H24-Hepatitis general-006]
FX THIS STUDY WAS supported by a grant from the Ministry of Labor and
   Welfare Japan (T. O. H20-Hepatitis general-008, H24-Hepatitis
   general-006].
CR Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014
   Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496
   Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1016/S0002-9270(99)00433-5
   Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762
   Chen J, 2011, RADIOLOGY, V259, P749, DOI 10.1148/radiol.11101942
   Eguchi Y, 2012, J GASTROENTEROL, V47, P586, DOI 10.1007/s00535-012-0533-z
   El-Serag HB, 2004, GASTROENTEROLOGY, V126, P460, DOI 10.1053/j.gastro.2003.10.065
   Fallo F, 2008, J HYPERTENS, V26, P2191, DOI 10.1097/HJH.0b013e32830dfe4b
   Fontana L, 2013, HEPATOLOGY, V57, P995, DOI 10.1002/hep.26099
   Harrison SA, 2008, GUT, V57, P1441, DOI 10.1136/gut.2007.146019
   Hotta Nigishi, 2007, Journal of the Japan Diabetes Society, V50, P47
   Ikai I, 2010, HEPATOL RES, V40, P1043, DOI 10.1111/j.1872-034X.2010.00731.x
   Kamada Y, 2011, AM J PHYSIOL-GASTR L, V301, pG1031, DOI 10.1152/ajpgi.00211.2011
   Kasuga M, 2013, CANCER SCI, V104, P965, DOI 10.1111/cas.12203
   Kawaguchi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038322
   Kawamura Y, 2012, AM J GASTROENTEROL, V107, P253, DOI 10.1038/ajg.2011.327
   Loomba R, 2012, HEPATOLOGY, V56, P943, DOI 10.1002/hep.25772
   Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8
   Miyaaki H, 2008, LIVER INT, V28, P519, DOI 10.1111/j.1478-3231.2007.01614.x
   Nettschwander-Tetri BA, 2010, HEPATOLOGY, V52, P913, DOI 10.1002/hep.23784
   Ochi H, 2012, HEPATOLOGY, V56, P1271, DOI 10.1002/hep.25756
   Okanoue T, 2013, NONALCOHOLIC FATTY L, P217
   Shiga T, 2009, J GASTROENTEROL, V44, P757, DOI 10.1007/s00535-009-0059-1
   Shima T, 2013, J GASTROENTEROL, V48, P515, DOI 10.1007/s00535-012-0653-5
   Speliotes EK, 2010, HEPATOLOGY, V51, P1979, DOI 10.1002/hep.23593
   Sumida Y, 2011, J GASTROENTEROL, V46, P257, DOI 10.1007/s00535-010-0305-6
   Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001
   Tobias DK, 2014, NEW ENGL J MED, V370, P233, DOI 10.1056/NEJMoa1304501
   Umemura T, 2009, J GASTROENTEROL, V44, P102, DOI 10.1007/s00535-008-2251-0
   Welzel TM, 2011, HEPATOLOGY, V54, P463, DOI 10.1002/hep.24397
   Yang JD, 2014, HEPATOLOGY, V59, P1406, DOI 10.1002/hep.26761
NR 31
TC 27
Z9 28
U1 1
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1386-6346
EI 1872-034X
J9 HEPATOL RES
JI Hepatol. Res.
PD MAY
PY 2015
VL 45
IS 5
BP 548
EP 559
DI 10.1111/hepr.12384
PG 12
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA CG6FZ
UT WOS:000353394200006
PM 24976563
DA 2024-02-19
ER

PT J
AU Tanami, S
   Ben-Moshe, S
   Elkayam, A
   Mayo, A
   Halpern, KB
   Itzkovitz, S
AF Tanami, Sivan
   Ben-Moshe, Shani
   Elkayam, Anat
   Mayo, Avi
   Halpern, Keren Bahar
   Itzkovitz, Shalev
TI Dynamic zonation of liver polyploidy
SO CELL AND TISSUE RESEARCH
LA English
DT Article
DE Liver zonation; Liver polyploidy; Systems biology; Single molecule
   imaging; Stem cells
ID GENE-EXPRESSION; MOUSE HEPATOCYTES; APOPTOSIS; REVERSAL; CELLS
AB The liver is a polyploid organ, consisting of hepatocytes with one or two nuclei each containing 2, 4, 8 or more haploid chromosome sets. The dynamic changes in the spatial distributions of polyploid classes across the liver lobule, its repeating anatomical unit, have not been characterized. Identifying these spatial patterns is important for understanding liver homeostatic and regenerative turnover, as well as potential division of labor among ploidy classes. Here, we use single molecule-based tissue imaging to reconstruct the spatial zonation profiles of liver polyploid classes in mice of different ages. We find that liver polyploidy proceeds in spatial waves, advancing more rapidly in the mid-lobule zone compared to the periportal and perivenous zones. We also measure the spatial zonation profiles of S-phase entry at different ages and identify more rapid S-phase entry in the mid-lobule zone at older ages. Our findings reveal fundamental features of liver spatial heterogeneity and highlight their dynamic changes during development and aging.
C1 [Tanami, Sivan; Ben-Moshe, Shani; Elkayam, Anat; Mayo, Avi; Halpern, Keren Bahar; Itzkovitz, Shalev] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel.
C3 Weizmann Institute of Science
RP Itzkovitz, S (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel.
EM shalev.itzkovitz@weizmann.ac.il
RI mayo, avi/N-3756-2019
OI mayo, avi/0000-0002-4479-3423; Itzkovitz, Shalev/0000-0003-0685-2522
FU Henry Chanoch Krenter Institute for Biomedical Imaging and Genomics;
   Leir Charitable Foundations; Richard Jakubskind Laboratory of Systems
   Biology; Lord Sieff of Brimpton Memorial Fund; Human Frontiers Science
   Program; I-CORE program of the Planning and Budgeting Committee; Israel
   Science Foundation; European Molecular Biology Organization Young
   Investigator Program; European Research Council under European Union/ERC
   [335122]; European Research Council (ERC) [335122] Funding Source:
   European Research Council (ERC)
FX We thank Shanie Landen for valuable comments on the manuscript. S.I. is
   supported by the Henry Chanoch Krenter Institute for Biomedical Imaging
   and Genomics, The Leir Charitable Foundations, Richard Jakubskind
   Laboratory of Systems Biology, Cymerman-Jakubskind Prize, The Lord Sieff
   of Brimpton Memorial Fund, The Human Frontiers Science Program, the
   I-CORE program of the Planning and Budgeting Committee and the Israel
   Science Foundation, the European Molecular Biology Organization Young
   Investigator Program and the European Research Council under the
   European Union's Seventh Framework Programme (FP7/2007-2013)/ ERC grant
   agreement number 335122. S.I. is the incumbent of the Philip Harris and
   Gerald Ronson Career Development Chair.
CR Achim K, 2015, NAT BIOTECHNOL, V33, P503, DOI 10.1038/nbt.3209
   Braeuning A, 2006, FEBS J, V273, P5051, DOI 10.1111/j.1742-4658.2006.05503.x
   BRALET MP, 1994, AM J PATHOL, V144, P896
   Celton-Morizur S, 2010, ADV EXP MED BIOL, V676, P123
   Celton-Morizur S, 2009, J CLIN INVEST, V119, P1880, DOI 10.1172/JCI38677
   Colnot S, 2011, MOL PATHOL LIB, V5, P7, DOI 10.1007/978-1-4419-7107-4_2
   Duncan AW, 2013, SEMIN CELL DEV BIOL, V24, P347, DOI 10.1016/j.semcdb.2013.01.003
   Duncan AW, 2010, NATURE, V467, P707, DOI 10.1038/nature09414
   EPSTEIN CJ, 1967, P NATL ACAD SCI USA, V57, P327, DOI 10.1073/pnas.57.2.327
   Font-Burgada J, 2015, CELL, V162, P766, DOI 10.1016/j.cell.2015.07.026
   GEBHARDT R, 1992, PHARMACOL THERAPEUT, V53, P275, DOI 10.1016/0163-7258(92)90055-5
   Gentric G, 2014, AM J PATHOL, V184, P322, DOI 10.1016/j.ajpath.2013.06.035
   Gujral JS, 2002, TOXICOL SCI, V67, P322, DOI 10.1093/toxsci/67.2.322
   Halpern KB, 2015, MOL CELL, V58, P147, DOI 10.1016/j.molcel.2015.01.027
   Jones BA, 1997, AM J PHYSIOL-GASTR L, V273, pG1174, DOI 10.1152/ajpgi.1997.273.6.G1174
   Jungermann K, 1996, ANNU REV NUTR, V16, P179, DOI 10.1146/annurev.nu.16.070196.001143
   Kanzler S, 2000, SEMIN CANCER BIOL, V10, P173, DOI 10.1006/scbi.2000.0318
   Lu P, 2007, MAMM GENOME, V18, P617, DOI 10.1007/s00335-007-9048-y
   Margall-Ducos G, 2007, J CELL SCI, V120, P3633, DOI 10.1242/jcs.016907
   Martin NC, 2002, J CELL PHYSIOL, V191, P138, DOI 10.1002/jcp.10057
   Morales-Navarrete H, 2015, ELIFE, V4, DOI 10.7554/eLife.11214
   Pandit SK, 2012, NAT CELL BIOL, V14, P1181, DOI 10.1038/ncb2585
   Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Wang B, 2015, NATURE, V524, P180, DOI 10.1038/nature14863
   Wang MJ, 2014, HEPATOLOGY, V60, P349, DOI 10.1002/hep.27094
NR 26
TC 49
Z9 54
U1 0
U2 22
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0302-766X
EI 1432-0878
J9 CELL TISSUE RES
JI Cell Tissue Res.
PD MAY
PY 2017
VL 368
IS 2
BP 405
EP 410
DI 10.1007/s00441-016-2427-5
PG 6
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA ES9YB
UT WOS:000399916800016
PM 27301446
DA 2024-02-19
ER

PT J
AU Kohen, R
   Fanberstein, D
   Tirosh, O
AF Kohen, R
   Fanberstein, D
   Tirosh, O
TI Reducing equivalents in the aging process
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
DE reducing equivalents; biological oxidative power; antioxidants; aging;
   non-invasive procedure; skin; tissues
ID OXIDATIVE DAMAGE; ANTIOXIDANT CAPACITY; CYCLIC VOLTAMMETRY; REDUCTIVE
   CAPACITY; LIFE-SPAN; PLASMA; HYPOTHESIS; EPIDERMIS; OXIDANTS; STRESS
AB Reducing equivalents may play a major role in the aging process. These metabolites are responsible for the endogenous redox potential in the living cell which is kept under tight regulation. Among their various roles is the ability to donate electrons to reactive oxygen species and by doing so to scavenge them. Most of the reducing equivalents in the cell are molecules with low molecular weights, such as glutathione and NADH which are synthesized by the cell. Other members of this group, such as uric acid are produced as waste products, while others, such as ascorbic acid and tocopherol, are derived from the diet. We studied the role of these equivalents in the aging process in various rat tissues. We demonstrated that the reducing power of tissue correlates with its antioxidant activity and that measurement of the total reducing power of a tissue may reflect its antioxidant activity. We used cyclic voltammeter methodology in order to evaluate the overall reducing power of tissue homogenates and other biological fluids. It was found that reducing power changes during the aging process in a bell-shaped manner in liver, lungs and kidneys, but not in heart and brain. We also showed that skin possesses strong reducing power which decreases dramatically with age. A non-invasive procedure to evaluate the oxidation status and the antioxidant activity of skin was developed. Using this method we demonstrated that there is an accumulation of organic peroxide in old skin compared to young skin, supporting the free radical hypothesis of aging. Copyright (C) 1997 Elsevier Science Ireland Ltd.
RP Kohen, R (corresponding author), HEBREW UNIV JERUSALEM, SCH PHARM, DEPT PHARMACEUT, POB 12065, IL-91120 JERUSALEM, ISRAEL.
RI Kohen, Ron/ABC-2281-2021
OI Kohen, Ron/0000-0001-7268-9845
CR ADELMAN R, 1988, P NATL ACAD SCI USA, V85, P2706, DOI 10.1073/pnas.85.8.2706
   AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858
   AMES BN, 1995, P NATL ACAD SCI USA, V92, P5258, DOI 10.1073/pnas.92.12.5258
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Berry EM, 1995, INT CONGR SER, V1100, P430
   CAO G, 1994, FREE RADICAL BIO MED, V16, P136, DOI 10.1016/0891-5849(94)90252-6
   CAO GH, 1993, FREE RADICAL BIO MED, V14, P303, DOI 10.1016/0891-5849(93)90027-R
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   Cutler R., 1984, Free Radicals in Biology, V6, P371
   EZRA R, 1996, IN PRESS EUR J PHARM
   FLOYD RA, 1993, TOXICOL IND HEALTH, V9, P197, DOI 10.1177/0748233793009001-214
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   FREI B, 1989, P NATL ACAD SCI USA, V86, P6377, DOI 10.1073/pnas.86.16.6377
   FUCHS J, 1994, SKIN PHARMACOL, V7, P278, DOI 10.1159/000211306
   GERSCHMAN R, 1954, SCIENCE, V119, P623, DOI 10.1126/science.119.3097.623
   GHISELLI A, 1995, FREE RADICAL BIO MED, V18, P29, DOI 10.1016/0891-5849(94)00102-P
   GHISELLI A, 1994, FREE RADICAL BIO MED, V16, P135, DOI 10.1016/0891-5849(94)90251-8
   HALLIWELL B, 1994, NUTR REV, V52, P253
   HALLIWELL B, 1995, FREE RADICAL BIO MED, V18, P125, DOI 10.1016/0891-5849(95)91457-3
   Halliwell B, 1989, FREE RADICAL BIO MED, P86
   HARMAN D, 1994, ANN NY ACAD SCI, V717, P1, DOI 10.1111/j.1749-6632.1994.tb12069.x
   HARMAN D, 1981, P NATL ACAD SCI USA, V78, P7122
   Harman D., 1956, J GERONTOL, V11, P198
   Jacobson MD, 1996, TRENDS BIOCHEM SCI, V21, P83, DOI 10.1016/S0968-0004(96)20008-8
   JOHANSON RM, 1970, DETERMINATIONS ORGAN, P15
   KOHEN R, 1992, EXP GERONTOL, V27, P161, DOI 10.1016/0531-5565(92)90040-7
   KOHEN R, 1992, FREE RADICAL RES COM, V17, P239, DOI 10.3109/10715769209079516
   KOHEN R, 1993, J PHARMACOL TOXICOL, V29, P185, DOI 10.1016/1056-8719(93)90024-9
   KOHEN R, 1988, P NATL ACAD SCI USA, V85, P3175, DOI 10.1073/pnas.85.9.3175
   KOHEN R, 1993, Patent No. 107220
   LOPEZTORRES M, 1994, J CLIN DERMATOL, V2, P476
   MASTUO M, 1993, FREE RADICAL BIO MED, P141
   POEGGELER B, 1993, J PINEAL RES, V14, P151, DOI 10.1111/j.1600-079X.1993.tb00498.x
   REITER RJ, 1995, FASEB J, V9, P526, DOI 10.1096/fasebj.9.7.7737461
   RICEEVANS C, 1994, METHOD ENZYMOL, V234, P279
   ROSSUM JP, 1991, EXP GERONTOL, V26, P37
   SCHALLREUTER KU, 1989, FREE RADICAL BIO MED, V6, P519, DOI 10.1016/0891-5849(89)90045-2
   SHAPIRO HM, 1972, J SURG RES, V3, P138
   SHINDO Y, 1994, J INVEST DERMATOL, V102, P122, DOI 10.1111/1523-1747.ep12371744
   SOHAL RS, 1990, MECH AGEING DEV, V53, P217, DOI 10.1016/0047-6374(90)90040-M
   SOHAL RS, 1990, EXP GERONTOL, V25, P499, DOI 10.1016/0531-5565(90)90017-V
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864
   Weindruch R., 1996, Scientific American, V274, P32
   WHITEHEAD TP, 1992, ANAL CHIM ACTA, V266, P265, DOI 10.1016/0003-2670(92)85052-8
NR 45
TC 43
Z9 48
U1 0
U2 8
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-4943
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PD MAR-APR
PY 1997
VL 24
IS 2
BP 103
EP 123
DI 10.1016/S0167-4943(96)00744-3
PG 21
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA WF651
UT WOS:A1997WF65100002
PM 15374118
DA 2024-02-19
ER

PT J
AU MIYAZAWA, T
   SUZUKI, T
   FUJIMOTO, K
AF MIYAZAWA, T
   SUZUKI, T
   FUJIMOTO, K
TI AGE-DEPENDENT ACCUMULATION OF PHOSPHATIDYLCHOLINE HYDROPEROXIDE IN THE
   BRAIN AND LIVER OF THE RAT
SO LIPIDS
LA English
DT Article
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; LOW-LEVEL CHEMILUMINESCENCE;
   HUMAN-BLOOD PLASMA; LIPID-PEROXIDATION; AGING RATS;
   DROSOPHILA-MELANOGASTER; CHEMI-LUMINESCENCE; ALPHA-TOCOPHEROL;
   VITAMIN-E; PHOSPHOLIPIDS
AB Age-related changes in phosphatidylcholine hydroperoxide (PCOOH) content as an index for oxidative membrane lipid damage were determined by high-performance liquid chromatography using chemiluminescence detection, Brain and liver PCOOH content increased significantly in male and female rats with age. The brain PCOOH content. of male 18-month-old rats was 4.4 times that of 1-month-old rats, and that of female 18-month-old rats was 3.5 times that of 1-month-old females. The liver PCOOH content of the male 18-month-old rats was 9.3 times that of the 1 month-old; and of the female 18-month-old rats was 4.7 times that of the 1-month-old. PCOOH levels in heart and lung did not show age dependency. In both brain and liver (but not in heart and lung), the phosphatidylcholine content significantly decreased upon aging. The results indicate that oxidative deterioration, such as phospholipid hydroperoxidation, is prevalent in the membrane lipids of brain and liver of the rat due to aging
RP MIYAZAWA, T (corresponding author), TOHOKU UNIV,DEPT APPL BIOL CHEM,SENDAI 981,JAPAN.
CR ABE K, 1976, Vitamins (Kyoto), V50, P453
   CAND F, 1989, FREE RADICAL BIO MED, V7, P59, DOI 10.1016/0891-5849(89)90101-9
   DEVASAGAYAM TPA, 1989, NEUROSCI LETT, V103, P92, DOI 10.1016/0304-3940(89)90491-6
   FAROOQUI MYH, 1987, COMP BIOCHEM PHYS B, V88, P177, DOI 10.1016/0305-0491(87)90097-6
   FREI B, 1988, ANAL BIOCHEM, V175, P120, DOI 10.1016/0003-2697(88)90369-7
   GUTTERIDGE JMC, 1981, FEBS LETT, V128, P343, DOI 10.1016/0014-5793(81)80113-5
   HAGIHARA M, 1984, J GERONTOL, V39, P269, DOI 10.1093/geronj/39.3.269
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HAZEL JR, 1985, LIPIDS, V20, P516, DOI 10.1007/BF02534892
   HEGNER D, 1979, MECH AGEING DEV, V10, P117, DOI 10.1016/0047-6374(79)90075-7
   HEGNER D, 1980, MECH AGEING DEV, V14, P101, DOI 10.1016/0047-6374(80)90109-8
   KASHIMA M, 1991, J AM OIL CHEM SOC, V68, P119, DOI 10.1007/BF02662331
   Kates M., 1986, TECHNIQUES LIPIDOLOG, P123
   Kates M., 1986, TECHNIQUES LIPIDOLOG, P100
   KOSUGI H, 1988, LIPIDS, V23, P1024, DOI 10.1007/BF02535647
   KRITCHEVSKY D, 1980, P SOC EXP BIOL MED, V165, P193, DOI 10.3181/00379727-165-40957
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P207, DOI 10.1016/0047-6374(89)90083-3
   LEIBOVITZ BE, 1980, J GERONTOL, V35, P45, DOI 10.1093/geronj/35.1.45
   MEYDANI M, 1986, LIPIDS, V21, P786, DOI 10.1007/BF02535413
   MEYDANI M, 1985, NUTR RES, V5, P1227, DOI 10.1016/S0271-5317(85)80066-X
   MIYAZAWA T, 1989, FREE RADICAL BIO MED, V7, P209, DOI 10.1016/0891-5849(89)90017-8
   MIYAZAWA T, 1988, J BIOCHEM-TOKYO, V103, P744, DOI 10.1093/oxfordjournals.jbchem.a122339
   MIYAZAWA T, 1987, ANAL LETT, V20, P915
   MIYAZAWA T, 1992, J LIPID RES, V33, P1051
   MIYAZAWA T, 1990, J BIOCHEM-TOKYO, V107, P689, DOI 10.1093/oxfordjournals.jbchem.a123109
   MIYAZAWA T, 1990, BIOMED CHROMATOGR, V4, P131, DOI 10.1002/bmc.1130040312
   MIYAZAWA T, 1985, LIPID PEROXIDE RES, V9, P5
   OBRIAN CA, 1988, BIOCHEM BIOPH RES CO, V155, P1374, DOI 10.1016/S0006-291X(88)81293-2
   PALUMBO EJ, 1992, BIOCHEM BIOPH RES CO, V187, P1439, DOI 10.1016/0006-291X(92)90463-U
   PARKER F, 1965, J LIPID RES, V6, P455
   RAO G, 1990, MECH AGEING DEV, V53, P49, DOI 10.1016/0047-6374(90)90033-C
   SAGAI M, 1980, LIFE SCI, V27, P731, DOI 10.1016/0024-3205(80)90326-4
   SATO T, 1992, GERONTOLOGY, V38, P50
   SATO T, 1991, MUTAT RES, V251, P91, DOI 10.1016/0027-5107(91)90218-D
   SAWADA M, 1987, MECH AGEING DEV, V41, P125, DOI 10.1016/0047-6374(87)90057-1
   SODERBERG M, 1991, LIPIDS, V26, P421, DOI 10.1007/BF02536067
   STEGE TE, 1982, EXP GERONTOL, V17, P273, DOI 10.1016/0531-5565(82)90016-X
   SUZUKI T, 1993, LIPIDS, V28, P775, DOI 10.1007/BF02536004
   TAPPEL A, 1973, J GERONTOL, V28, P415, DOI 10.1093/geronj/28.4.415
   UYSAL M, 1989, MECH AGEING DEV, V48, P85, DOI 10.1016/0047-6374(89)90028-6
   WANG JY, 1992, FEBS LETT, V310, P106
   YOSHIDA LS, 1990, LIPIDS, V25, P565, DOI 10.1007/BF02537166
   YOSHIKAWA M, 1967, J GERONTOL, V22, P162, DOI 10.1093/geronj/22.2.162
NR 44
TC 53
Z9 54
U1 0
U2 0
PU AMER OIL CHEMISTS SOC
PI CHAMPAIGN
PA 1608 BROADMOOR DRIVE, CHAMPAIGN, IL 61821-0489
SN 0024-4201
J9 LIPIDS
JI Lipids
PD SEP
PY 1993
VL 28
IS 9
BP 789
EP 793
DI 10.1007/BF02536232
PG 5
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA LX298
UT WOS:A1993LX29800003
PM 8231654
DA 2024-02-19
ER

PT J
AU Huang, LF
   Wu, HX
   Li, H
   Hou, YY
   Hu, JN
   Huang, L
   Lu, YQ
   Liu, XT
AF Huang, Liangfeng
   Wu, Hanxiao
   Li, Hu
   Hou, Yuanyuan
   Hu, Jianing
   Huang, Lin
   Lu, Yangqing
   Liu, Xingting
TI Hepatic glycerolipid metabolism is critical to the egg laying rate of
   Guangxi Ma chickens
SO GENE
LA English
DT Article; Early Access
DE Transcriptome; Yolk precursor; Liver; Laying rate; Guangxi Ma chickens
ID FATTY-ACIDS; LIVER; GENE; VITELLOGENIN; ACTIVATION; EXPRESSION;
   PRECURSOR; ESTROGEN; PACKAGE; PROTEIN
AB Yolk formation in liver is an important process for egg production in hens. The correlations between egg laying rate decline and liver function changes in Guangxi Ma chickens remain unclear. In this study, a total of 21,750 genes and 76,288 transcripts were identified in the RNA expression profiles isolated from liver tissues of 5 groups of Guangxi Ma chickens divided according to the age and egg laying rate. Numerous differential genes (DEGs) were identified after pairwise comparison among samples, and time series analysis categorization (age-related factors) revealed that down-regulated DEGs with aging were predominantly involved in lipid transportation and metabolic processes in the low egg laying rate groups. Notably, functional enrichment analysis confirmed that DGAT2, LIPG, PNPLA2, LPL, CEL, LIPC, DGKD, AGPAT2, AGPAT1 and AGPAT3 were highlighted as hub genes in glycerolipid metabolism pathway, which may be an essential non-age related factors of egg laying rate by regulating the synthesis of triacylglycerol (TAG) in liver. Finally, we categorized DEGs in Guangxi Ma chickens with different egg laying rate caused by age-related factors and found that DEGs with different expression patterns performing different biological functions. The analysis of DEGs with lower egg laying rate caused by non-age related factors and showed that the transportation of TAG was suppressed. Furthermore, critical genes and pathways involved in the synthesis of TAG in livers were identified, which dynamically regulated the formation of yolk precursors. Our results expanded the knowledge of the molecular mechanisms of the yolk precursor synthesis in chicken livers. The results will be helpful to explore the factors that affect egg laying rate from the perspective of yolk synthesis and provide a theoretical basis for improving the egg production of Guangxi Ma chickens.
C1 [Huang, Liangfeng; Wu, Hanxiao; Li, Hu; Hou, Yuanyuan; Hu, Jianing; Huang, Lin; Lu, Yangqing; Liu, Xingting] Guangxi Univ, Coll Anim Sci & Technol, State Key Lab Conservat & Utilizat Subtrop Agrobio, Nanning, Peoples R China.
C3 Guangxi University
RP Liu, XT (corresponding author), Guangxi Univ, Coll Anim Sci & Technol, State Key Lab Conservat & Utilizat Subtrop Agrobio, Nanning, Peoples R China.
EM xtliu@gxu.edu.cn
RI yuanyuan, Li/JEZ-6497-2023
OI Huang, Liangfeng/0000-0002-0977-9183
FU Natural Science Foundation of Guangxi [2020GXNSFBA297120]; Science and
   Technol-ogy Talent Base Special Project of Guangxi [GuikeAD21075035]
FX This study was supported by the Natural Science Foundation of Guangxi
   (Grant no.2020GXNSFBA297120) , and Science and Technol-ogy Talent Base
   Special Project of Guangxi (Grant no. GuikeAD21075035) .
CR Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28
   Ahn SE, 2012, GEN COMP ENDOCR, V175, P194, DOI 10.1016/j.ygcen.2011.11.013
   Alonso-Ayuso M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109587
   Amevor FK, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11071915
   Bhatt-Wessel B, 2018, ARCH BIOCHEM BIOPHYS, V655, P1, DOI 10.1016/j.abb.2018.08.001
   Bourin M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-457
   Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200
   Cerk IK, 2018, CURR PROTEIN PEPT SC, V19, P221, DOI 10.2174/1389203718666170918160110
   Chen K, 2013, CHINA POULT, V35, P31, DOI [10.16372/j.issn.1004-6364.2013.07.010, DOI 10.16372/J.ISSN.1004-6364.2013.07.010]
   Chin CH, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S4-S11
   Cui ZF, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10122348
   Dai HJ, 2021, POULTRY SCI, V100, DOI 10.1016/j.psj.2021.101499
   DEELEY RG, 1975, J BIOL CHEM, V250, P9060
   Denslow ND, 1999, ECOTOXICOLOGY, V8, P385, DOI 10.1023/A:1008986522208
   Fei WH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002201
   Futschik Matthias E., 2005, Journal of Bioinformatics and Computational Biology, V3, P965, DOI 10.1142/S0219720005001375
   Gloux A, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-6185-0
   GORDON DA, 1995, TRENDS CELL BIOL, V5, P317, DOI 10.1016/S0962-8924(00)89054-6
   Gu YF, 2021, POULTRY SCI, V100, DOI 10.1016/j.psj.2021.101478
   HILL EE, 1968, BIOCHIM BIOPHYS ACTA, V152, P645, DOI 10.1016/0005-2760(68)90109-4
   Johnson AL, 2015, POULTRY SCI, V94, P781, DOI 10.3382/ps/peu008
   Johnson AL, 2015, STURKIE'S AVIAN PHYSIOLOGY, 6TH EDITION, P635
   Khetarpal SA, 2021, PLOS GENET, V17, DOI 10.1371/journal.pgen.1009802
   Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]
   Kumar L, 2007, BIOINFORMATION, V2, P5, DOI 10.6026/97320630002005
   Li H, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1943-0
   Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656
   Liu XT, 2018, J ZHEJIANG UNIV-SC B, V19, P390, DOI [10.1631/jzus.B1700054, 10.1631/jzus.b1700054]
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Mann K, 2008, PROTEOMICS, V8, P178, DOI 10.1002/pmic.200700790
   MENTLEIN R, 1980, ARCH BIOCHEM BIOPHYS, V200, P547, DOI 10.1016/0003-9861(80)90386-0
   Miyazaki M, 2001, J LIPID RES, V42, P1018
   Moran ET, 2007, POULTRY SCI, V86, P1043, DOI 10.1093/ps/86.5.1043
   Ning CY, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00574
   Niu JL, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9110930
   Ntambi JM, 2004, PROG LIPID RES, V43, P91, DOI 10.1016/S0163-7827(03)00039-0
   Omer NA, 2020, POULTRY SCI, V99, P3121, DOI 10.1016/j.psj.2020.01.017
   Ong KT, 2011, HEPATOLOGY, V53, P116, DOI 10.1002/hep.24006
   Papackova Z, 2015, INT J MOL SCI, V16, P3831, DOI 10.3390/ijms16023831
   PIERINGER RA, 1962, J BIOL CHEM, V237, P653
   Pinent M, 2008, GENOMICS, V92, P26, DOI 10.1016/j.ygeno.2008.03.010
   Schneider WJ, 2016, J BIOMED RES, V30, P174, DOI 10.7555/JBR.30.20150048
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Shao F, 2020, POULTRY SCI, V99, P1813, DOI 10.1016/j.psj.2019.12.036
   SMITH SW, 1957, J BIOL CHEM, V228, P915
   Tumová L, 2017, ANIM REPROD SCI, V183, P21, DOI 10.1016/j.anireprosci.2017.06.006
   Van Every HA, 2021, BMC GENOMICS, V22, DOI 10.1186/s12864-021-07724-w
   von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005
   WAGNER MS, 1978, POULTRY SCI, V57, P959, DOI 10.3382/ps.0570959
   WALZEM RL, 1994, J LIPID RES, V35, P1354
   Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008
   Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484
   Willson NL, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4723-9
   Winter JN, 2010, AM J PHYSIOL-CELL PH, V299, pC335, DOI 10.1152/ajpcell.00039.2010
   Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019
   Worgall TS, 1998, J BIOL CHEM, V273, P25537, DOI 10.1074/jbc.273.40.25537
   Wu HX, 2022, THERIOGENOLOGY, V184, P13, DOI 10.1016/j.theriogenology.2022.02.020
   Xiao C, 2021, FUNCT INTEGR GENOMIC, V21, P113, DOI 10.1007/s10142-020-00764-7
   Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Zang YL, 2014, J ZHEJIANG UNIV-SC B, V15, P201, DOI 10.1631/jzus.B1300177
   Zhang JQ, 2010, BIOCHEM GENET, V48, P465, DOI 10.1007/s10528-009-9329-0
NR 63
TC 0
Z9 0
U1 0
U2 12
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0378-1119
EI 1879-0038
J9 GENE
JI Gene
PD 2022 JUL 1
PY 2022
VL 830
AR 146500
DI 10.1016/j.gene.2022.146500
EA APR 2022
PG 12
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 1N0XN
UT WOS:000800387000005
PM 35472624
DA 2024-02-19
ER

PT J
AU Kang, HK
   Kim, MS
   Kim, ND
   Yoo, MA
   Kim, KW
   Kim, J
   Ikeno, Y
   Yu, BP
   Chung, HY
AF Kang, HK
   Kim, MS
   Kim, ND
   Yoo, MA
   Kim, KW
   Kim, J
   Ikeno, Y
   Yu, BP
   Chung, HY
TI Downregulation of telomerase in rat during the aging process
SO MOLECULES AND CELLS
LA English
DT Article
DE aging; telomerase; testis; testosterone
ID MOUSE TELOMERASE; RNA COMPONENT; GERM-CELLS; DNA; IDENTIFICATION;
   LYMPHOCYTES; CHROMOSOME; HYPOTHESIS; CANCER
AB Telomerase is an RNA-dependent DNA polymerase that maintains the tandem arrays of telomeric repeats at the eukaryotic chromosome ends. Because of its ability to replenish lost telomeric sequences, telomerase is thought to be required for cell proliferation. At present, very little information on the role of telomerase in aging is available. In the present study, we tested the telomerase activity of Fischer 344 rat testis and liver at 6, 12, 18 and 24 months of age. As the testis is an androgen-dependent tissue, we also investigated the changes of testosterone and mRNA levels of androgen receptor in this tissue. Our results show that the telomerase activity of Fischer 344 rat testis significantly reduced at 24 months of age compared to 6 months of age, and that the mRNA level of telomerase protein component 1 (TLP-1) show a corresponding decrease with the telomerase activity. Interestingly, this downregulation was not observed in the liver. The testosterone level in testis increased until 18 months of age, but reduced by 50% at 24 months of age. Our conclusions are that the telomerase activity is age-dependent and its change is a tissue-specific phenomenon.
C1 Pusan Natl Univ, Dept Pharm, Coll Pharm, Pusan 609735, South Korea.
   Pusan Natl Univ, Dept Mol Biol, Pusan 609735, South Korea.
   Masan Coll, Masan 630729, South Korea.
   Univ Texas, Hlth Sci Ctr, San Antonio, TX 78284 USA.
C3 Pusan National University; Pusan National University; University of
   Texas System; University of Texas Health Science Center at San Antonio
RP Chung, HY (corresponding author), Pusan Natl Univ, Dept Pharm, Coll Pharm, Pusan 609735, South Korea.
CR Ahuja HS, 1996, J ANDROL, V17, P491
   ALLSHIRE RC, 1987, CELL, V50, P391, DOI 10.1016/0092-8674(87)90493-4
   BLASCO MA, 1995, SCIENCE, V269, P1267, DOI 10.1126/science.7544492
   BREMNER WJ, 1994, ENDOCRINOLOGY, V135, P1227, DOI 10.1210/en.135.3.1227
   CADENEAU C, 1995, ONCOGENE, V11, P893
   CAREY MF, 1986, MOL CELL BIOL, V6, P3068, DOI 10.1128/MCB.6.9.3068
   COUNTER CM, 1994, J VIROL, V68, P3410, DOI 10.1128/JVI.68.5.3410-3414.1994
   Eisenhauer KM, 1997, BIOL REPROD, V56, P1120, DOI 10.1095/biolreprod56.5.1120
   FEELISCH M, 1987, EUR J PHARMACOL, V139, P19, DOI 10.1016/0014-2999(87)90493-6
   FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491
   GRUNENEWALD DA, 1994, J GERONTOL, V49, pB42
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   HARLEY CB, 1992, EXP GERONTOL, V27, P375, DOI 10.1016/0531-5565(92)90068-B
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARRISON L, 1991, LECTIN REV, V1, P17
   Holt SE, 1996, NAT BIOTECHNOL, V14, P836, DOI 10.1038/nbt0796-836
   Holt SE, 1996, MOL CELL BIOL, V16, P2932
   ISHIKAWA F, 1993, MOL CELL BIOL, V13, P4301, DOI 10.1128/MCB.13.7.4301
   Jiang C, 1997, CARCINOGENESIS, V18, P2085, DOI 10.1093/carcin/18.11.2085
   KASUGA F, 1986, ENDOCRINOL JAPON, V33, P105
   KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428
   Kim NW, 1997, NUCLEIC ACIDS RES, V25, P2595, DOI 10.1093/nar/25.13.2595
   KIPLING D, 1991, GENOMICS, V11, P235, DOI 10.1016/0888-7543(91)90128-2
   KIPLING D, 1990, NATURE, V347, P347
   KRAMER K, 1993, CELL BIOL, V14, P961
   McClintock B, 1941, GENETICS, V26, P234
   MCEACHERN MJ, 1995, NATURE, V376, P403, DOI 10.1038/376403a0
   MEYER RB, 1993, J STEROID BIOCHEM, V31, P305
   Moon JI, 1998, MOL CELLS, V8, P359
   MORIN GB, 1989, CELL, V59, P512
   PROWSE KR, 1993, P NATL ACAD SCI USA, V90, P1493, DOI 10.1073/pnas.90.4.1493
   PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818
   QUINN PG, 1985, J BIOCH, V260, P2090
   Ravindranath N, 1997, ENDOCRINOLOGY, V138, P4026, DOI 10.1210/en.138.9.4026
   SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A
   SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955
   Skulachev VP, 1997, BIOCHEMISTRY-MOSCOW+, V62, P1191
   STCLAIR DK, 1993, P NATL ACAD SCI USA, V90, P3113
   VAZIRI H, 1993, AM J HUM GENET, V52, P661
   WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0
   ZHU Z, 1996, P NATL ACAD SCI USA, V93, P6091
   ZIRKIN BR, 1993, J ANDROL, V14, P118
NR 42
TC 10
Z9 11
U1 0
U2 2
PU SPRINGER-VERLAG SINGAPORE PTE LTD
PI SINGAPORE
PA #04-01 CENCON I, 1 TANNERY RD, SINGAPORE 347719, SINGAPORE
SN 1016-8478
J9 MOL CELLS
JI Mol. Cells
PD JUN 30
PY 1999
VL 9
IS 3
BP 286
EP 291
PG 6
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 210RP
UT WOS:000081118700009
PM 10420988
DA 2024-02-19
ER

PT J
AU Vinod, C
   Jagota, A
AF Vinod, Ch.
   Jagota, Anita
TI Daily <i>Socs1</i> rhythms alter with aging differentially in peripheral
   clocks in male Wistar rats: therapeutic effects of melatonin
SO BIOGERONTOLOGY
LA English
DT Article
DE Circadian rhythms; Peripheral clocks; Socs1; Melatonin; Aging
ID AGE-INDUCED ALTERATIONS; NF-KAPPA-B; CIRCADIAN CLOCK; SUPRACHIASMATIC
   NUCLEUS; INTERFERON-GAMMA; MAMMALIAN CLOCK; INNATE IMMUNITY;
   STRESS-RESPONSE; NITRIC-OXIDE; TNF-ALPHA
AB Suprachiasmatic nucleus (SCN) in synchronization with the peripheral clocks regulates the temporal oscillations leading to overt rhythms. Aging leads to attenuation of such circadian regulation, accompanied by increased inflammatory mediators prevalently the cytokines. Suppressors of cytokine signaling (SOCS) family of proteins such as SOCS 1, 3 and cytokine-inducible SH2-containing protein (CIS) negatively regulate the cytokine signaling pathway. The role of SOCS1 in aging and circadian system is obscure. We therefore studied the daily rhythms of rSocs1 mRNA expression at Zeitgeber time (ZT) -0, 6, 12 and 18 in peripheral clocks such as liver, kidney, intestine and heart of 3, 12 and 24 months (m) old male Wistar rats. Interestingly the peripheral clocks studied displayed a rhythmic rSocs1 gene expression in 3 months. In 12 months group, 12 h phase advance in liver and 12 h phase delay in kidney and heart was observed with abolition of rhythms in intestine. Aging (24 months group) resulted in a phase advance by 6 h in liver and heart with abolition of rhythms in intestine in 24 months group. Kidney was also significantly affected upon aging with significant decrease in the rSocs1 levels and abolition of rhythms. The decrease in melatonin levels with aging is associated with decreased immunity and increased oxidative stress. The exogenous administration of melatonin has been linked to play a role in re-synchronization of circadian rhythms, reducing oxidative stress and enhancing immune properties. We therefore had studied the effect of exogenous melatonin upon age induced changes in daily rSocs1 gene expression patterns. Melatonin treatment partially restored the rhythms and daily pulse (ratio of maximum:minimum levels) in liver and intestine in 12 months group. Melatonin administration resulted in a significant increase in mean 24 h rSocs1 expression in intestine and heart of 24 months group compared to that of 3 months. The melatonin administration resulted in differential restoration of rSocs1 rhythms and levels in various tissues of 24 months old group. The sensitivity of 24 months old animals to melatonin found in the present study is a step towards endorsing melatonin as an important anti-aging therapeutic drug.
C1 [Vinod, Ch.; Jagota, Anita] Univ Hyderabad, Sch Life Sci, Dept Anim Biol, Neurobiol & Mol Chronobiol Lab, Hyderabad 500046, Andhra Prades, India.
C3 University of Hyderabad
RP Jagota, A (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Anim Biol, Neurobiol & Mol Chronobiol Lab, Hyderabad 500046, Andhra Prades, India.
EM ajsl@uohyd.ernet.in
OI Ch, Vinod/0000-0003-3188-3750
FU ICMR [BMS/NTF/14/2006-2007, 55/7/2012-/BMS]; UGC [32-613/2006 (SR)]; UPE
FX The work is supported by ICMR (Ref. No. BMS/NTF/14/2006-2007;
   55/7/2012-/BMS), UGC (Ref: F. No.: 32-613/2006 (SR) and UPE Grants to
   AJ. Ch Vinod is thankful to UGC for fellowship.
CR Altara R, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0477-1
   Arboleya S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01204
   Bischoff SC, 2016, CURR OPIN CLIN NUTR, V19, P26, DOI 10.1097/MCO.0000000000000242
   Carter SJ, 2016, J LEUKOCYTE BIOL, V99, P549, DOI 10.1189/jlb.3RU1015-451R
   Cayetanot F, 2009, CHRONOBIOL INT, V26, P1587, DOI 10.3109/07420520903398518
   Cermakian N, 2013, CHRONOBIOL INT, V30, P870, DOI 10.3109/07420528.2013.782315
   Choi EY, 2011, J PINEAL RES, V50, P197, DOI 10.1111/j.1600-079X.2010.00829.x
   Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83
   Coogan AN, 2008, BRAIN RES, V1232, P104, DOI 10.1016/j.brainres.2008.07.087
   Curtis AM, 2014, IMMUNITY, V40, P178, DOI 10.1016/j.immuni.2014.02.002
   D'Souza AL, 2007, POSTGRAD MED J, V83, P44, DOI 10.1136/pgmj.2006.049361
   Dalpke A, 2008, IMMUNOBIOLOGY, V213, P225, DOI 10.1016/j.imbio.2007.10.008
   Delgado-Ortega M, 2011, VET IMMUNOL IMMUNOP, V144, P493, DOI 10.1016/j.vetimm.2011.08.002
   Dibner C, 2015, J INTERN MED, V277, P513, DOI 10.1111/joim.12347
   Duhart JM, 2013, J IMMUNOL, V191, P4656, DOI 10.4049/jimmunol.1300450
   Erion R, 2016, ELIFE, V5, DOI 10.7554/eLife.13552
   Gagnon J, 2007, CELL SIGNAL, V19, P806, DOI 10.1016/j.cellsig.2006.10.003
   Ganie SA, 2016, REJUV RES, V19, P21, DOI 10.1089/rej.2015.1704
   Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109
   Gibson EM, 2009, EXP GERONTOL, V44, P51, DOI 10.1016/j.exger.2008.05.007
   Golombek DA, 2004, NEUROCHEM INT, V45, P929, DOI 10.1016/j.neuint.2004.03.023
   González-Hernández T, 2006, J HISTOCHEM CYTOCHEM, V54, P427, DOI 10.1369/jhc.5A6845.2005
   Gubin Denis G, 2016, Curr Aging Sci, V9, P5
   Hardeland R, 2012, AGING DIS, V3, P194
   Hashiramoto A, 2010, J IMMUNOL, V184, P1560, DOI 10.4049/jimmunol.0903284
   Hurley JM, 2016, FUNGAL GENET BIOL, V90, P39, DOI 10.1016/j.fgb.2015.10.002
   Impey S, 2004, CELL, V119, P1041, DOI 10.1016/S0092-8674(04)01159-6
   Indo HP, 2015, J CLIN BIOCHEM NUTR, V56, P1, DOI 10.3164/jcbn.14-42
   Jagota A, 2012, BRAIN AGING THERAPEU, P111
   Jagota A., 2005, INDIAN J GERONTOL, V19, P415
   Jagota A, 2010, BIOGERONTOLOGY, V11, P299, DOI 10.1007/s10522-009-9248-9
   Karasek M, 2007, J PHYSIOL PHARMACOL, V58, P105
   Lee IT, 2015, NEURON, V85, P1086, DOI 10.1016/j.neuron.2015.02.006
   Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767
   Manikonda PK, 2012, BIOGERONTOLOGY, V13, P511, DOI 10.1007/s10522-012-9396-1
   Mate I, 2014, CURR PHARM DESIGN, V20, P4642
   Mattam U, 2014, BIOGERONTOLOGY, V15, P257, DOI 10.1007/s10522-014-9495-2
   Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128
   Monti JM, 2010, SLEEP MED REV, V14, P307, DOI 10.1016/j.smrv.2009.11.004
   Mukda S, 2016, NEUROSCI LETT, V621, P39, DOI 10.1016/j.neulet.2016.04.013
   Nelson RJ, 2004, TRENDS IMMUNOL, V25, P187, DOI 10.1016/j.it.2004.02.001
   Oxenkrug G, 2011, AGING DIS, V2, P474
   Paladino N, 2014, CHRONOBIOL INT, V31, P668, DOI 10.3109/07420528.2014.886588
   Palomba M, 2008, J BIOL RHYTHM, V23, P220, DOI 10.1177/0748730408316998
   Paredes SD, 2014, HORM MOL BIOL CLIN I, V18, P79, DOI 10.1515/hmbci-2014-0016
   Qin WW, 2012, J ENDOCRINOL, V214, P145, DOI 10.1530/JOE-12-0147
   Ramis MR, 2015, MECH AGEING DEV, V146, P28, DOI 10.1016/j.mad.2015.03.008
   Reddy MY, 2015, BIOGERONTOLOGY, V16, P285, DOI 10.1007/s10522-014-9545-9
   Reddy VDK, 2014, BIOGERONTOLOGY, V15, P245, DOI 10.1007/s10522-014-9494-3
   Reiter RJ, 2014, PHYSIOLOGY, V29, P325, DOI 10.1152/physiol.00011.2014
   Sadki A, 2007, NEUROBIOL AGING, V28, P296, DOI 10.1016/j.neurobiolaging.2005.12.007
   Shin IS, 2014, J PINEAL RES, V56, P398, DOI 10.1111/jpi.12127
   Su LY, 2015, AUTOPHAGY, V11, P1745, DOI 10.1080/15548627.2015.1082020
   Tang MK, 2009, PROTEOM CLIN APPL, V3, P1362, DOI 10.1002/prca.200900097
   Tortorella C, 2006, J GERONTOL A-BIOL, V61, P1111, DOI 10.1093/gerona/61.11.1111
   Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599
   Trufakin VA, 2016, MINI-REV MED CHEM, V16, P55, DOI 10.2174/1389557515666150909143515
   Tsai MJ, 2011, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2011-48
   Vinod C, 2016, BIOGERONTOLOGY, V17, P859, DOI 10.1007/s10522-016-9656-6
   Voderholzer U, 2012, J NEUROPSYCH CLIN N, V24, P354, DOI 10.1176/appi.neuropsych.11060142
   Willem K, 2005, BIOCHEM BIOPH RES CO, V330, P18
   Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093
   Zhang HQ, 2015, FREE RADICAL BIO MED, V88, P314, DOI 10.1016/j.freeradbiomed.2015.05.036
NR 63
TC 11
Z9 12
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD JUN
PY 2017
VL 18
IS 3
BP 333
EP 345
DI 10.1007/s10522-017-9687-7
PG 13
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA EV1YG
UT WOS:000401547300003
PM 28331994
DA 2024-02-19
ER

PT J
AU Ferioli, ME
   Sessa, A
   Tunici, P
   Pinotti, O
   Perin, A
AF Ferioli, ME
   Sessa, A
   Tunici, P
   Pinotti, O
   Perin, A
TI Aging and polyamine acetylation in rat kidney
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE aging; kidney (rat); polyamines; polyamine N-acetyltransferase;
   polyamine oxidase
ID ORNITHINE DECARBOXYLASE; METABOLISM; LIVER; OXIDASE; MOUSE
AB The acetylation of polyamines was investigated in rat kidney as a function of age. The activity of cytosolic spermidine/spermine N-1-acetyltransferase, the rate-limiting enzyme in polyamine interconversion, increased from 3 to 36 months of age. The activity of cytosolic spermidine N-8-acetyltransferase, an enzyme probably related to polyamine excretion, also increased. The activity of polyamine oxidase, which catalyzes the oxidative cleavage of polyamine N-1-acetyl derivatives into putrescine, decreased until 24 months, when an accumulation of N-1-acetylspermidine occurred. Subsequently, at 36 months, polyamine oxidase activity returned toward high values, in concomitance with the disappearance of N-1-acetylspermidine, an increase in spermidine and putrescine, and a decline in spermine was observed. Our results show that in rat kidney during aging there is an activation of the acetylation and interconversion of higher polyamines into putrescine, which is considered an alternative pathway of spermidine and putrescine formation.
C1 UNIV MILAN, IST PATOL GEN, I-20133 MILAN, ITALY.
C3 University of Milan
RP Ferioli, ME (corresponding author), UNIV MILAN, CNR, CTR STUDIO PATOL CELLULARE, VIA MANGIAGALLI 31, I-20133 MILAN, ITALY.
CR ANDERSON S, 1987, J AM GERIATR SOC, V35, P590, DOI 10.1111/j.1532-5415.1987.tb01407.x
   CAMPBELL RA, 1983, ADV POLYAMINE RES, V4, P107
   CASERO RA, 1993, FASEB J, V7, P653, DOI 10.1096/fasebj.7.8.8500690
   CHANG ZF, 1988, J BIOL CHEM, V263, P11431
   FERIOLI ME, 1975, EXP GERONTOL, V10, P13, DOI 10.1016/0531-5565(75)90010-8
   GEIGER PJ, 1972, ANAL BIOCHEM, V49, P467, DOI 10.1016/0003-2697(72)90450-2
   GOLDSTEIN RS, 1988, FASEB J, V2, P2241, DOI 10.1096/fasebj.2.7.3280378
   HAYASHI H, 1989, BIOCHIM BIOPHYS ACTA, V991, P310, DOI 10.1016/0304-4165(89)90121-9
   HEBY O, 1990, TRENDS BIOCHEM SCI, V15, P153, DOI 10.1016/0968-0004(90)90216-X
   JANNE J, 1964, ACTA PHYSIOL SCAND, V62, P352, DOI 10.1111/j.1748-1716.1964.tb10433.x
   JANNE J, 1991, ANN MED, V23, P241, DOI 10.3109/07853899109148056
   KHAN NA, 1991, CELL BIOL INT REP, V15, P9, DOI 10.1016/0309-1651(91)90078-W
   LEVILLAIN O, 1992, AM J PHYSIOL, V263, pF878, DOI 10.1152/ajprenal.1992.263.5.F878
   LIBBY PR, 1978, J BIOL CHEM, V253, P233
   LOSER C, 1988, J CHROMATOGR-BIOMED, V430, P249, DOI 10.1016/S0378-4347(00)83160-6
   MATSUI I, 1980, BIOCHIM BIOPHYS ACTA, V633, P87, DOI 10.1016/0304-4165(80)90040-9
   PEGG AE, 1986, BIOCHEM J, V234, P249, DOI 10.1042/bj2340249
   PEGG AE, 1982, SCIENCE, V217, P68, DOI 10.1126/science.6806900
   SCALABRINO G, 1984, MECH AGEING DEV, V26, P149, DOI 10.1016/0047-6374(84)90090-3
   SEILER N, 1990, DIGESTION, V46, P319, DOI 10.1159/000200405
   SEILER N, 1992, FALK SYMP, V62, P65
   SEILER N, 1987, CAN J PHYSIOL PHARM, V65, P2024, DOI 10.1139/y87-317
   Seiler N, 1991, Prog Drug Res, V37, P107
   SESSA A, 1994, AGENTS ACTIONS, V43, P69, DOI 10.1007/BF02005768
   SESSA A, 1991, CANCER LETT, V56, P159, DOI 10.1016/0304-3835(91)90091-U
   SESSA A, 1993, GEN PATHOLOGY PATHOP, P181
   SUZUKI O, 1984, EXPERIENTIA, V40, P838, DOI 10.1007/BF01951981
   WALLACE HM, 1992, FALK SYMP, V62, P87
   ZAGER RA, 1989, LAB INVEST, V61, P290
NR 29
TC 9
Z9 9
U1 1
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-4439
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD OCT 7
PY 1996
VL 1317
IS 1
BP 15
EP 18
DI 10.1016/0925-4439(96)00029-4
PG 4
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA VM832
UT WOS:A1996VM83200003
PM 8876622
DA 2024-02-19
ER

PT J
AU Keppler, D
   Sordat, B
   Sierra, F
AF Keppler, D
   Sordat, B
   Sierra, F
TI T-kininogen present in the liver of old rats is biologically active and
   readily forms complexes with endogenous cysteine proteinases
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE kininogen; aging; cysteine proteinase inhibitors; rat liver
ID ACUTE-PHASE RESPONSE; AFFINITY-CHROMATOGRAPHY; SUBMANDIBULAR-GLAND;
   TISSUE DISTRIBUTION; GENE-EXPRESSION; CATHEPSIN-B; INHIBITOR;
   DEGRADATION; PROTEASE; INACTIVATION
AB We have previously reported an increase in T-kininogen mRNA levels in the liver of ageing Sprague-Dawley rats. T-Kininogen functions both as a precursor to the vasoactive peptide T-kinin, and as a potent and specific inhibitor of cysteine proteinases. Under normal physiological conditions, the majority of cysteine proteinases are found intracellularly and we have shown that a significant proportion of T-kininogen also accumulates intracellularly in the liver of old rats. Therefore, our aim was to determine whether or not this T-kininogen is biologically active as an inhibitor of cysteine proteases. Titration of whole liver extracts indicates that old rats do indeed contain a 4-fold higher level of cysteine proteinase inhibitory activity than younger counterparts. Using gel permeation chromatography in conjunction with an enzyme inhibitor assay, we show that this difference is mainly due to the presence of a low level of free biologically active T-kininogen. However, Western blot analysis of the gel permeation chromatography fractions demonstrate that most of the intrahepatic T-kininogen is found as enzyme-inhibitor complexes. Alkaline inactivation of the cysteine proteinase component of these complexes leads to the release of biologically competent free T-kininogen. These findings are discussed with regard to the possible mechanisms responsible for the accumulation of T-kininogen within the aged rat liver. (C) 1997 Elsevier Science Ireland Ltd.
C1 ALLEGHENY UNIV HLTH SCI, CTR GERONTOL RES, PHILADELPHIA, PA 19129 USA.
   SWISS INST EXPT CANC RES, EXPT PATHOL UNIT, CH-1066 EPALINGES, LAUSANNE, SWITZERLAND.
C3 Drexel University; Swiss Institute Experimental Cancer Research
RI Keppler, Daniel/B-4309-2012
CR ABRAHAMSON M, 1990, BIOCHEM J, V268, P287, DOI 10.1042/bj2680287
   ADELI K, 1994, J BIOL CHEM, V269, P9166
   ADELMAN RC, 1983, ALTERED PROTEINS AGE
   AGARWAL S, 1994, ARCH BIOCHEM BIOPHYS, V309, P24, DOI 10.1006/abbi.1994.1078
   ANASTASI A, 1983, BIOCHEM J, V211, P129, DOI 10.1042/bj2110129
   ANDREU AL, 1995, NUTRITION, V11, P382
   BARLAS A, 1987, FEBS LETT, V218, P266, DOI 10.1016/0014-5793(87)81059-1
   BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189
   BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535
   BARRETT AJ, 1986, RES MONOG CELL TISSU, V12, P515
   BERG T, 1991, BIOCHEM J, V280, P19, DOI 10.1042/bj2800019
   Bohley P, 1995, NATURWISSENSCHAFTEN, V82, P544, DOI 10.1007/BF01140242
   BOND JS, 1987, ANNU REV BIOCHEM, V56, P333, DOI 10.1146/annurev.bi.56.070187.002001
   BRADFORD HN, 1993, J BIOL CHEM, V268, P26546
   CHAO J, 1988, BIOCHIM BIOPHYS ACTA, V964, P329, DOI 10.1016/0304-4165(88)90033-5
   CRAWFORD C, 1987, BIOCHEM J, V248, P589, DOI 10.1042/bj2480589
   EVANS B, 1983, J BIOL CHEM, V258, P227
   FRIGUET B, 1994, ARCH BIOCHEM BIOPHYS, V311, P168, DOI 10.1006/abbi.1994.1222
   GOUNARIS AD, 1984, BIOCHEM J, V221, P445, DOI 10.1042/bj2210445
   GUTMAN N, 1988, EUR J BIOCHEM, V171, P577, DOI 10.1111/j.1432-1033.1988.tb13827.x
   HASAN AAK, 1994, J BIOL CHEM, V269, P31822
   HASEGAWA A, 1993, BIOMED GERONTOL, V17, P144
   HERWALD H, 1995, J BIOL CHEM, V270, P14634
   ISHIGAMI A, 1990, ARCH BIOCHEM BIOPHYS, V277, P189, DOI 10.1016/0003-9861(90)90568-J
   ISHIGAMI A, 1988, MECH AGEING DEV, V46, P125, DOI 10.1016/0047-6374(88)90120-0
   IVY GO, 1989, BRAIN RES, V498, P360, DOI 10.1016/0006-8993(89)91117-7
   IVY GO, 1991, ARCH GERONTOL GERIAT, V12, P119, DOI 10.1016/0167-4943(91)90023-J
   KATUNUMA N, 1983, CURR TOP CELL REGUL, V22, P71
   KEP D, 1994, BIOCHEM SOC T, V22, P43
   KLENIEWSKI J, 1991, EUR J HAEMATOL, V46, P257
   KOMINAMI E, 1992, BIOL CHEM H-S, V373, P367, DOI 10.1515/bchm3.1992.373.2.367
   KUSHNER I, 1994, BAILLIERE CLIN RHEUM, V8, P513, DOI 10.1016/S0950-3579(05)80113-X
   KUSHNER I, 1982, ANN NY ACAD SCI, V389, P39, DOI 10.1111/j.1749-6632.1982.tb22124.x
   LAVIE L, 1982, BIOCHEM J, V202, P47, DOI 10.1042/bj2020047
   MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A
   MOREAU T, 1989, J BIOL CHEM, V264, P4298
   OHKUBO I, 1984, BIOCHEMISTRY-US, V23, P5691, DOI 10.1021/bi00319a005
   OKAMOTO H, 1983, BIOCHEM BIOPH RES CO, V112, P701, DOI 10.1016/0006-291X(83)91519-X
   PRASANNA HR, 1979, BIOCHEM BIOPH RES CO, V86, P552, DOI 10.1016/0006-291X(79)91749-2
   RATTAN SIS, 1992, ANN NY ACAD SCI, V663, P48, DOI 10.1111/j.1749-6632.1992.tb38648.x
   REZNICK AZ, 1979, MECH AGEING DEV, V11, P403, DOI 10.1016/0047-6374(79)90016-2
   SCHACHTER M, 1979, PHARMACOL REV, V31, P1
   SHARMA JN, 1988, GEN PHARMACOL, V19, P177, DOI 10.1016/0306-3623(88)90058-4
   SIERRA F, 1992, J BIOL CHEM, V267, P10665
   Sierra F, 1995, MECH AGEING DEV, V84, P127, DOI 10.1016/0047-6374(95)01639-2
   SIERRA F, 1989, MOL CELL BIOL, V9, P5610, DOI 10.1128/MCB.9.12.5610
   SIERRA F, 1995, ARCH BIOCHEM BIOPHYS, V322, P333, DOI 10.1006/abbi.1995.1472
   TSUSHIMA H, 1988, BIOL CHEM H-S, V369, P243
   TURK B, 1993, BIOCHEMISTRY-US, V32, P375, DOI 10.1021/bi00052a046
   TURK V, 1991, FEBS LETT, V285, P213, DOI 10.1016/0014-5793(91)80804-C
   XIONG W, 1990, J BIOL CHEM, V265, P2822
NR 51
TC 9
Z9 10
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD NOV
PY 1997
VL 98
IS 2
BP 151
EP 165
DI 10.1016/S0047-6374(97)00080-8
PG 15
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA XV405
UT WOS:A1997XV40500005
PM 9379711
DA 2024-02-19
ER

PT J
AU Lee, VK
   Tiwary, AK
   Sharma-Reddy, P
   Lieber, KA
   Taylor, DK
   Mook, DM
AF Lee, Vanessa K.
   Tiwary, Asheesh K.
   Sharma-Reddy, Prachi
   Lieber, Karen A.
   Taylor, Douglas K.
   Mook, Deborah M.
TI Moxidectin Toxicity in Senescence-Accelerated Prone and Resistant Mice
SO COMPARATIVE MEDICINE
LA English
DT Article
ID BLOOD-BRAIN-BARRIER; MDR1A P-GLYCOPROTEIN; AGE-RELATED-CHANGES;
   IVERMECTIN TOXICOSIS; MURINE MODEL; PERMEABILITY FEATURES;
   RESPIRATORY-FAILURE; DELETION MUTATION; OXIDATIVE STRESS; CYCLOSPORINE-A
AB Moxidectin has been used safely as an antiparasitic in many animal species, including for the eradication of the mouse fur mite, Mycoptes inusculinus. Although no side effects of moxidectin have previously been reported to occur in mice, 2 strains of the senescence-accelerated mouse (SAMP8 and SAMR1) sustained considerable mortality after routine prophylactic treatment. To investigate the mechanism underlying this effect, moxidectin toxicosis in these mice was evaluated in a controlled study. Moxidectin was applied topically (0.015 mg), and drug concentrations in both brain and serum were analyzed by using HPLC coupled with mass spectrometry. The moxidectin concentration in brain of SAMP8 mice was 18 times that in controls, and that in brain of SAMR1 mice was 14 times higher than in controls, whereas serum moxidectin concentrations did not differ significantly among the 3 strains. Because deficiency of the blood-brain barrier protein P-glycoprotein leads to sensitivity to this class of drugs in other SAM mice, Pgp immunohistochemistry of brain sections from a subset of mice was performed to determine whether this commercially available analysis could predict sensitivity to this class of drug. The staining analysis showed no difference among the strains of mice, indicating that this test does not correlate with sensitivity. In addition, no gross or histologic evidence of organ toxicity was found in brain, liver, lung, or kidney. This report shows that topically applied moxidectin at a standard dose accumulates in the CNS causing toxicosis in both SAMP8 and SAMR1 mice.
C1 [Lee, Vanessa K.; Lieber, Karen A.; Taylor, Douglas K.; Mook, Deborah M.] Emory Univ, Yerkes Reg Primate Res Ctr, Div Anim Resources, Atlanta, GA 30322 USA.
   [Taylor, Douglas K.; Mook, Deborah M.] Emory Univ, Yerkes Reg Primate Res Ctr, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.
   [Sharma-Reddy, Prachi] Emory Univ, Yerkes Reg Primate Res Ctr, Dept Pathol, Atlanta, GA 30322 USA.
   [Tiwary, Asheesh K.] Univ Calif Davis, Calif Anim Hlth & Food Safety Lab Syst, Sch Vet Med, Davis, CA 95616 USA.
C3 Emory University; Emory University; Emory University; University of
   California System; University of California Davis
RP Lee, VK (corresponding author), Emory Univ, Yerkes Reg Primate Res Ctr, Div Anim Resources, Atlanta, GA 30322 USA.
EM vlee@dar.emory.edu
RI Taylor, Doug/AAG-4670-2019
CR [Anonymous], IVERMECTIN ABAMECTIN
   Araya R, 2008, MOL CELL NEUROSCI, V38, P417, DOI 10.1016/j.mcn.2008.04.003
   Baars C, 2008, VET J, V177, P394, DOI 10.1016/j.tvjl.2007.05.020
   Banks WA, 2001, NEUROBIOL AGING, V22, P671, DOI 10.1016/S0197-4580(01)00220-2
   Banks WA, 2007, EXP NEUROL, V206, P248, DOI 10.1016/j.expneurol.2007.05.005
   Beal MW, 1999, J AM VET MED ASSOC, V215, P1813
   Beco L, 2001, VET REC, V149, P324, DOI 10.1136/vr.149.11.324
   Charney DS, 2004, AM J PSYCHIAT, V161, P1, DOI 10.1176/appi.ajp.161.1.1
   CHIBA Y, 2008, NEUROCHEM RES
   COURTNEY CH, 1995, VET PHARM THERAPEUTI
   Curry-Galvin E, 2005, JAVMA-J AM VET MED A, V226, P1280
   DeMarco JH, 2002, J ZOO WILDLIFE MED, V33, P147, DOI 10.1638/1042-7260(2002)033[0147:ITATAI]2.0.CO;2
   Dupuy J, 2006, J VET PHARMACOL THER, V29, P489, DOI 10.1111/j.1365-2885.2006.00780.x
   FASSLER PE, 1991, J AM VET MED ASSOC, V199, P457
   Fujibayashi Y, 1998, NEUROSCI LETT, V254, P109, DOI 10.1016/S0304-3940(98)00667-3
   Gallagher AE, 2008, J VET EMERG CRIT CAR, V18, P81, DOI 10.1111/j.1476-4431.2007.00248.x
   García-Matas S, 2008, AGING CELL, V7, P630, DOI 10.1111/j.1474-9726.2008.00410.x
   Hafezi-Moghadam A, 2007, AM J PHYSIOL-CELL PH, V292, pC1256, DOI 10.1152/ajpcell.00563.2005
   Hautekeete LA, 1998, VET HUM TOXICOL, V40, P29
   Hugnet C, 1996, VET HUM TOXICOL, V38, P31
   Jackson TA, 1998, LAB ANIM PRACT, V31, P37
   Johnson PJ, 1999, J AM VET MED ASSOC, V214, P678
   Jun K, 2000, MAMM GENOME, V11, P843, DOI 10.1007/s003350010176
   Kawamata T, 1998, MICROSC RES TECHNIQ, V43, P59, DOI 10.1002/(SICI)1097-0029(19981001)43:1<59::AID-JEMT9>3.0.CO;2-X
   Kerrick G P, 1995, Contemp Top Lab Anim Sci, V34, P78
   Khan SA, 2002, VET HUM TOXICOL, V44, P232
   Kuehn BM, 2004, JAVMA-J AM VET MED A, V225, P1157
   Kwei GY, 1999, DRUG METAB DISPOS, V27, P581
   Lankas GR, 1997, TOXICOL APPL PHARM, V143, P357, DOI 10.1006/taap.1996.8086
   Lespine A, 2007, EUR J PHARM SCI, V30, P84, DOI 10.1016/j.ejps.2006.10.004
   LEWIS DT, 1994, J AM VET MED ASSOC, V205, P584
   Marques-Santos LF, 1999, PHARMACOL TOXICOL, V84, P125, DOI 10.1111/j.1600-0773.1999.tb00887.x
   Mealey KL, 2001, PHARMACOGENETICS, V11, P727, DOI 10.1097/00008571-200111000-00012
   Mealey KL, 2003, J AM VET MED ASSOC, V223, P1453, DOI 10.2460/javma.2003.223.1453
   Mook DM, 2008, J AM ASSOC LAB ANIM, V47, P20
   Mori A, 1998, ANN NY ACAD SCI, V854, P239, DOI 10.1111/j.1749-6632.1998.tb09906.x
   Nishikawa T, 1998, NEUROSCI LETT, V254, P69, DOI 10.1016/S0304-3940(98)00646-6
   Novotny MJ, 2000, VET PARASITOL, V91, P377, DOI 10.1016/S0304-4017(00)00306-X
   Öge H, 2000, VET PARASITOL, V88, P299, DOI 10.1016/S0304-4017(99)00218-6
   Orion E, 2005, CLIN DERMATOL, V23, P182, DOI 10.1016/j.clindermatol.2004.06.013
   PAUL AJ, 1991, AM J VET RES, V52, P1922
   Paul AJ, 2000, AM J VET RES, V61, P482, DOI 10.2460/ajvr.2000.61.482
   Paul AJ, 2004, VET PARASITOL, V121, P285, DOI 10.1016/j.vetpar.2004.03.005
   PAUL AJ, 1987, AM J VET RES, V48, P684
   Pelegrí C, 2007, MECH AGEING DEV, V128, P522, DOI 10.1016/j.mad.2007.07.002
   PLUMB DC, 2005, PLUMBS VET DRUG HDB
   Pollicino P, 2008, VET PARASITOL, V151, P355, DOI 10.1016/j.vetpar.2007.10.018
   PULLIAM JD, 1985, VET MED-US, V80, P33
   Pullium JK, 2005, CONTEMP TOP LAB ANIM, V44, P26
   Reuss B, 2003, J NEUROSCI, V23, P6404
   Roulet A, 2003, EUR J PHARMACOL, V460, P85, DOI 10.1016/S0014-2999(02)02955-2
   Sakaeda T, 2002, BIOL PHARM BULL, V25, P1391, DOI 10.1248/bpb.25.1391
   Sartor LL, 2004, J VET INTERN MED, V18, P117, DOI 10.1892/0891-6640(2004)18&lt;117:LTIACW&gt;2.0.CO;2
   Sato E, 1996, MECH AGEING DEV, V86, P105, DOI 10.1016/0047-6374(95)01681-3
   Schinkel AH, 1996, J CLIN INVEST, V97, P2517, DOI 10.1172/JCI118699
   SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7
   SCHINKEL AH, 1995, J CLIN INVEST, V96, P1698, DOI 10.1172/JCI118214
   SEAMAN JT, 1987, AUST VET J, V64, P284, DOI 10.1111/j.1751-0813.1987.tb15963.x
   Skopets B, 1996, LAB ANIM SCI, V46, P111
   Snowden NJ, 2006, J SMALL ANIM PRACT, V47, P620, DOI 10.1111/j.1748-5827.2006.00081.x
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   Takeda T, 1997, EXP GERONTOL, V32, P105, DOI 10.1016/S0531-5565(96)00036-8
   TRANQUILLI WJ, 1989, AM J VET RES, V50, P769
   TRANQUILLI WJ, 1991, AM J VET RES, V52, P1170
   Tsai CE, 2002, BIOL NEONATE, V81, P58, DOI 10.1159/000047185
   Ueno M, 2001, MICROSC RES TECHNIQ, V53, P232, DOI 10.1002/jemt.1088
   Ueno M, 2001, NEUROBIOL AGING, V22, P469, DOI 10.1016/S0197-4580(01)00213-5
   UENO M, 1993, ARCH GERONTOL GERIAT, V16, P233, DOI 10.1016/0167-4943(93)90035-G
   Ueno M, 2000, ACTA NEUROPATHOL, V99, P385, DOI 10.1007/s004010051140
   Umbenhauer DR, 1997, TOXICOL APPL PHARM, V146, P88, DOI 10.1006/taap.1997.8225
   Villar D, 2007, J AM ASSOC LAB ANIM, V46, P8
   Watchko JF, 1998, PEDIATR RES, V44, P763, DOI 10.1203/00006450-199811000-00020
   YAGI H, 1988, BRAIN RES, V474, P86, DOI 10.1016/0006-8993(88)90671-3
   Zhang GH, 2008, EXP ANIM TOKYO, V57, P413, DOI 10.1538/expanim.57.413
NR 74
TC 10
Z9 10
U1 1
U2 3
PU AMER ASSOC LABORATORY ANIMAL SCIENCE
PI MEMPHIS
PA 9190 CRESTWYN HILLS DR, MEMPHIS, TN 38125 USA
SN 1532-0820
J9 COMPARATIVE MED
JI Comparative Med.
PD JUN
PY 2009
VL 59
IS 3
BP 227
EP 233
PG 7
WC Veterinary Sciences; Zoology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Veterinary Sciences; Zoology
GA 461GR
UT WOS:000267253200011
PM 19619412
DA 2024-02-19
ER

PT J
AU Wang, YF
   Brodin, E
   Nishii, K
   Frieboes, HB
   Mumenthaler, SM
   Sparks, JL
   Macklin, P
AF Wang, Yafei
   Brodin, Erik
   Nishii, Kenichiro
   Frieboes, Hermann B.
   Mumenthaler, Shannon M.
   Sparks, Jessica L.
   Macklin, Paul
TI Impact of tumor-parenchyma biomechanics on liver metastatic progression:
   a multi-model approach
SO SCIENTIFIC REPORTS
LA English
DT Article
AB Colorectal cancer and other cancers often metastasize to the liver in later stages of the disease, contributing significantly to patient death. While the biomechanical properties of the liver parenchyma (normal liver tissue) are known to affect tumor cell behavior in primary and metastatic tumors, the role of these properties in driving or inhibiting metastatic inception remains poorly understood, as are the longer-term multicellular dynamics. This study adopts a multi-model approach to study the dynamics of tumor-parenchyma biomechanical interactions during metastatic seeding and growth. We employ a detailed poroviscoelastic model of a liver lobule to study how micrometastases disrupt flow and pressure on short time scales. Results from short-time simulations in detailed single hepatic lobules motivate constitutive relations and biological hypotheses for a minimal agent-based model of metastatic growth in centimeter-scale tissue over months-long time scales. After a parameter space investigation, we find that the balance of basic tumor-parenchyma biomechanical interactions on shorter time scales (adhesion, repulsion, and elastic tissue deformation over minutes) and longer time scales (plastic tissue relaxation over hours) can explain a broad range of behaviors of micrometastases, without the need for complex molecular-scale signaling. These interactions may arrest the growth of micrometastases in a dormant state and prevent newly arriving cancer cells from establishing successful metastatic foci. Moreover, the simulations indicate ways in which dormant tumors could "reawaken" after changes in parenchymal tissue mechanical properties, as may arise during aging or following acute liver illness or injury. We conclude that the proposed modeling approach yields insight into the role of tumor-parenchyma biomechanics in promoting liver metastatic growth, and advances the longer term goal of identifying conditions to clinically arrest and reverse the course of late-stage cancer.
C1 [Wang, Yafei; Macklin, Paul] Indiana Univ, Dept Intelligent Syst Engn, Bloomington, IN 47405 USA.
   [Brodin, Erik; Nishii, Kenichiro; Sparks, Jessica L.] Miami Univ, Dept Chem Paper & Biomed Engn, Oxford, OH 45056 USA.
   [Frieboes, Hermann B.] Univ Louisville, Dept Bioengn, Louisville, KY 40292 USA.
   [Frieboes, Hermann B.] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA.
   [Frieboes, Hermann B.] Univ Louisville, Ctr Predict Med, Louisville, KY 40292 USA.
   [Mumenthaler, Shannon M.] Univ Southern Calif, Lawrence J Ellison Inst Transformat Med, Los Angeles, CA 90007 USA.
C3 Indiana University System; Indiana University Bloomington; University
   System of Ohio; Miami University; University of Louisville; University
   of Louisville; University of Louisville; University of Southern
   California
RP Macklin, P (corresponding author), Indiana Univ, Dept Intelligent Syst Engn, Bloomington, IN 47405 USA.; Sparks, JL (corresponding author), Miami Univ, Dept Chem Paper & Biomed Engn, Oxford, OH 45056 USA.
EM sparksj6@MiamiOH.edu; macklinp@iu.edu
RI Mumenthaler, Shannon M/AGY-8535-2022; Wang, Yafei/HHS-3355-2022
OI Mumenthaler, Shannon M/0000-0003-2687-3769; Wang,
   Yafei/0000-0001-6594-0608; Frieboes, Hermann/0000-0001-5959-4286;
   Sparks, Jessica/0000-0002-7800-6029; Macklin, Paul/0000-0002-9925-0151
FU National Science Foundation [1720625]; Breast Cancer Research
   Foundation; Jayne Koskinas Ted Giovanis Foundation for Health and
   Policy; National Cancer Institute [1R01CA180149, 1U01CA232137]; Div Of
   Engineering Education and Centers; Directorate For Engineering [1720625]
   Funding Source: National Science Foundation
FX The authors acknowledge funding by National Science Foundation (YW, PM:
   1720625), the Breast Cancer Research Foundation (PM), the Jayne Koskinas
   Ted Giovanis Foundation for Health and Policy (PM), the National Cancer
   Institute (EB, KN, HBF, SM, JLS, PM: 1R01CA180149; SM, PM:
   1U01CA232137). We would like to acknowledge the Miami Redhawk Cluster
   and the Ohio Supercomputer Center for access to computing resources to
   complete this work. We would also like to thank Dr. Jens Mueller of the
   Miami University Research Computing Center for assistance with Abaqus
   model development. The authors gratefully acknowledge access to
   FutureSystems at the Digital Science Center, Luddy School of
   Informatics, Computing, and Engineering, and to the Big Red II
   supercomputer at Indiana University, Bloomington. We would like to thank
   the USC Translational Pathology Core and Roy Lau (USC) for assistance
   with patient tissue processing, staining, and imaging. We thank Randy
   Heiland (IU) for support in creating and refining the nanoHUB liver app.
   We thank John Metzcar (IU) for helpful comments on the manuscript.
CR Ahmadzadeh H, 2017, P NATL ACAD SCI USA, V114, pE1617, DOI 10.1073/pnas.1617037114
   Ambrosi D, 2009, BIOMECH MODEL MECHAN, V8, P397, DOI 10.1007/s10237-008-0145-y
   Athanasiou K. A., 2008, SYNTH LECT BIOMED EN, V3, P1
   Banyard J, 2015, CONNECT TISSUE RES, V56, P403, DOI 10.3109/03008207.2015.1060970
   Barney LE, 2016, CURR OPIN CHEM ENG, V11, P85, DOI 10.1016/j.coche.2016.01.001
   Bertolotti M, 2014, WORLD J GASTROENTERO, V20, P14185, DOI 10.3748/wjg.v20.i39.14185
   Bethge A, 2015, J BIOMED INFORM, V57, P74, DOI 10.1016/j.jbi.2015.07.011
   Boire A, 2019, TRENDS CANCER, V5, P762, DOI 10.1016/j.trecan.2019.10.010
   Brás-Pereira C, 2018, CURR OPIN CELL BIOL, V51, P15, DOI 10.1016/j.ceb.2017.10.003
   Brodt P, 2016, CLIN CANCER RES, V22, P5971, DOI 10.1158/1078-0432.CCR-16-0460
   Brunt EM, 2014, HISTOPATHOLOGY, V64, P907, DOI 10.1111/his.12364
   Bull JA, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1007961
   Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544
   Byrne H, 2009, J MATH BIOL, V58, P657, DOI 10.1007/s00285-008-0212-0
   Campbell A, 2008, PHYS MED BIOL, V53, DOI 10.1088/0031-9155/53/24/015
   Carbrey JM, 2003, P NATL ACAD SCI USA, V100, P2945, DOI 10.1073/pnas.0437994100
   Cheng G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004632
   Chiang C.T, 2020, GIGASCIENCE
   Chiou WY, 2015, JPN J CLIN ONCOL, V45, P160, DOI 10.1093/jjco/hyu178
   Clark AM, 2017, LAB CHIP, V17, P156, DOI 10.1039/c6lc01171c
   Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077
   Curtis LT, 2016, PHARM RES-DORDR, V33, P2552, DOI 10.1007/s11095-016-1981-6
   D'Antonio G, 2013, MATH BIOSCI ENG, V10, P75, DOI 10.3934/mbe.2013.10.75
   Debbaut C, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4005545
   Deng J, 2019, MICROMACHINES-BASEL, V10, DOI 10.3390/mi10100676
   Dong YY, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0795-5
   Dutta-Moscato Joyeeta, 2014, Front Bioeng Biotechnol, V2, P18, DOI 10.3389/fbioe.2014.00018
   Evans DW, 2013, BIOMECH MODEL MECHAN, V12, P569, DOI 10.1007/s10237-012-0426-3
   Fane M, 2020, NAT REV CANCER, V20, P89, DOI 10.1038/s41568-019-0222-9
   Friedman A, 2017, MATH BIOSCI ENG, V14, P143, DOI [10.3034/mbe.2017010, 10.3934/mbe.2017010]
   Friedman SH, 2016, BIORXIV
   Gerlee P, 2008, J THEOR BIOL, V250, P705, DOI 10.1016/j.jtbi.2007.10.038
   Gerlee P, 2007, J THEOR BIOL, V246, P583, DOI 10.1016/j.jtbi.2007.01.027
   Getz M, 2020, RAPID COMMUNITY DRIV
   Ghaffarizadeh A, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005991
   Ghaffarizadeh A, 2016, BIOINFORMATICS, V32, P1256, DOI 10.1093/bioinformatics/btv730
   Haeno H, 2012, CELL, V148, P362, DOI 10.1016/j.cell.2011.11.060
   Haeno H, 2010, J THEOR BIOL, V263, P30, DOI 10.1016/j.jtbi.2009.11.005
   Heiland Randy, 2019, J Open Source Softw, V4, DOI 10.21105/joss.01408
   Helmlinger G, 1997, NAT BIOTECHNOL, V15, P778, DOI 10.1038/nbt0897-778
   Hoehme S, 2010, BIOINFORMATICS, V26, P2641, DOI 10.1093/bioinformatics/btq437
   Hoehme S, 2010, P NATL ACAD SCI USA, V107, P10371, DOI 10.1073/pnas.0909374107
   Hormuth DA, 2019, ANN BIOMED ENG, V47, P1539, DOI 10.1007/s10439-019-02262-9
   Hudson SV, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51249-y
   Hudson SV, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12691-y
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Ismail MF, 2009, INT J BIOL SCI, V5, P377
   Jiang D, 2016, CANCER MICROENVIRON, V9, P45, DOI 10.1007/s12307-016-0181-6
   Kaur A, 2019, CANCER DISCOV, V9, P64, DOI 10.1158/2159-8290.CD-18-0193
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Leonard F, 2020, CANCER IMMUNOL IMMUN, V69, P731, DOI 10.1007/s00262-020-02504-z
   Leonard F, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00693
   Leonard F, 2016, NANOSCALE, V8, P12544, DOI 10.1039/c5nr07796f
   Lettmann KA, 2014, J THEOR BIOL, V348, P33, DOI 10.1016/j.jtbi.2014.01.016
   Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027
   Lowengrub JS, 2010, NONLINEARITY, V23, pR1, DOI 10.1088/0951-7715/23/1/R01
   Macklin P, 2008, J SCI COMPUT, V35, P266, DOI 10.1007/s10915-008-9190-z
   Macklin P, 2007, J THEOR BIOL, V245, P677, DOI 10.1016/j.jtbi.2006.12.004
   Madhavan K, 2013, NANOTECHNOL REV, V2, P107, DOI 10.1515/ntrev-2012-0043
   Mahlbacher G, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-017-0313-7
   MAK AF, 1986, J BIOMECH ENG-T ASME, V108, P123, DOI 10.1115/1.3138591
   Marmottant P, 2009, P NATL ACAD SCI USA, V106, P17271, DOI 10.1073/pnas.0902085106
   Mavrogonatou E, 2019, MATRIX BIOL, V75-76, P27, DOI 10.1016/j.matbio.2017.10.004
   Metzcar J, 2019, JCO CLIN CANCER INFO, V3, DOI 10.1200/CCI.18.00069
   Meyer K, 2017, CELL SYST, V4, P277, DOI 10.1016/j.cels.2017.02.008
   Moran EC, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4007175
   MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202
   Newton PK, 2015, NPJ BREAST CANCER, V1, DOI 10.1038/npjbcancer.2015.18
   Newton PK, 2013, CANCER RES, V73, P2760, DOI 10.1158/0008-5472.CAN-12-4488
   Newton PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034637
   Nishii K, 2016, J MECH BEHAV BIOMED, V57, P201, DOI 10.1016/j.jmbbm.2015.11.033
   Patsenker E, 2011, AM J PHYSIOL-GASTR L, V301, pG425, DOI 10.1152/ajpgi.00050.2011
   Phillip JM, 2015, ANNU REV BIOMED ENG, V17, P113, DOI 10.1146/annurev-bioeng-071114-040829
   Pickup MW, 2014, EMBO REP, V15, P1243, DOI 10.15252/embr.201439246
   Preziosi L, 2010, J THEOR BIOL, V262, P35, DOI 10.1016/j.jtbi.2009.08.023
   Raghunathan S, 2010, ANN BIOMED ENG, V38, P1789, DOI 10.1007/s10439-010-9957-x
   Rahman MM, 2017, COMPUT METHOD APPL M, V320, P261, DOI 10.1016/j.cma.2017.03.021
   Ramia JM, 2011, HPB, V13, P320, DOI 10.1111/j.1477-2574.2010.00287.x
   Rani HP, 2006, J BIOMECH, V39, P551, DOI 10.1016/j.jbiomech.2004.11.029
   Reichel D, 2017, PHARM RES-DORDR, V34, P2385, DOI 10.1007/s11095-017-2245-9
   Ren HZ, 2013, LIVER INT, V33, P448, DOI 10.1111/liv.12088
   Ricken T, 2015, BIOMECH MODEL MECHAN, V14, P515, DOI 10.1007/s10237-014-0619-z
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Schwen LO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133653
   Scott JG, 2014, EUR J CANCER, V50, P3068, DOI 10.1016/j.ejca.2014.08.019
   Scott JG, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0011
   Shen Y, 2020, CANCER CELL, V37, P800, DOI 10.1016/j.ccell.2020.05.005
   Siggers JH, 2014, BIOMECH MODEL MECHAN, V13, P363, DOI 10.1007/s10237-013-0516-x
   Simon B.R., 1992, APPL MECH REV, V45, P191, DOI [DOI 10.1115/1.3121397, 10.1115/1.3121397]
   Sluka JP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162428
   Streichan SJ, 2014, P NATL ACAD SCI USA, V111, P5586, DOI 10.1073/pnas.1323016111
   Stylianopoulos T, 2013, CANCER RES, V73, P3833, DOI 10.1158/0008-5472.CAN-12-4521
   Suh JK, 1998, J BIOMECH ENG-T ASME, V120, P195, DOI 10.1115/1.2798302
   Swanson KR, 2002, ACTA BIOTHEOR, V50, P223, DOI 10.1023/A:1022644031905
   Swanson KR, 2011, CANCER RES, V71, P7366, DOI 10.1158/0008-5472.CAN-11-1399
   Trefts E, 2017, CURR BIOL, V27, pR1147, DOI 10.1016/j.cub.2017.09.019
   Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419
   Van Liedekerke P, 2018, 470559 BIORXIV, DOI [10.1101/470559, DOI 10.1101/470559]
   Van Liedekerke P, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006273
   Voutouri C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104717
   Wang HL, 2014, BIOPHYS J, V107, P2592, DOI 10.1016/j.bpj.2014.09.044
   Wang Y., 2019, PHYSICELL LIVER TISS, DOI [10.1038/s41598-020-78780-7, DOI 10.1038/S41598-020-78780-7]
   Wheeler SE, 2014, BRIT J CANCER, V111, P2342, DOI 10.1038/bjc.2014.533
   White D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162215
NR 104
TC 8
Z9 8
U1 2
U2 8
PU NATURE RESEARCH
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 18
PY 2021
VL 11
IS 1
AR 1710
DI 10.1038/s41598-020-78780-7
PG 20
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA RM1QQ
UT WOS:000639435500025
PM 33462259
OA gold, Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Li, JJ
   Mo, L
   Song, JL
AF Li, Jing-Jing
   Mo, Ling
   Song, Jia-Le
TI Improvement Effect of <i>Ficus vasculosa</i> Ethanol Extract on
   D-galactose-Induced Mice Aging
SO NATURAL PRODUCT COMMUNICATIONS
LA English
DT Article
DE Ficus vasculosa; D-galactose; aging; bioactive compounds
ID OXIDATIVE STRESS; ANTIOXIDANT ACTIVITY; STEM BARK; CONSTITUENTS; LEAVES;
   MODEL
AB This study was to investigate antioxidant activities of the ethanol extract from young edible leaves of Ficus vasculosa in vitro and in vivo. Ficus vasculosa ethanol extract (FVEE) showed significantly higher reducing power and alpha,alpha-diphenyl-beta-picrylhydrazyl (DPPH) radical scavenge activity than vitamin C (P < 0.05). FVEE also showed an activity to resist the D-galactose-induced aging in mice assessed by serum and tissue levels of superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH-Px). Total serum and tissue oxidative status, total antioxidantresponse, glutathione (GSH) and malondialdehyde (MDA) levels have been also measured. Pretreatment with FVEE at 200 mg/kg<bold> </bold>body weight significantly increased enzyme activity of SOD and CAT in serum and hepatic tissue<bold> </bold>(P < 0.05), as well as significantly increased enzyme activity of SOD in kidney (P < 0.05). Furthermore, high concentration of FVEE pretreatment significantly increased the level of GSH in serum, hepatic tissue and kidney (P < 0.05), meanwhile significantly decreased MDA production in hepatic tissue and kidney (P < 0.05). In addition, the phytochemical investigation discovered six previously described compounds from FVEE, naringenin (1), vanillic acid (2), 9, 16-dioxo-10, 12, 14-octadeca-trienoic acid (3), 2, 6-dimethoxy-1, 4-benzoquinone (4), apigenin (5) and norartocarpetin (6), and all compounds were isolated from this plant for the first time. Among the various compounds found, the rare highly unsaturated fatty acid 9, 16-dioxo-10, 12, 14-octadeca-trienoic acid (3) has been identified, which had been isolated only once before from F. vasculosa. Evaluation of the antioxidant activity of isolated compounds showed naringenin (1) to be the most active. According to our research, FVEE present very high antioxidant activity in vitro due to the presence of several compounds known for their antioxidant activity such as flavonoid and phenolic acid. In vivo, the ethanol extract had improvement effects against D-galactose-induced aging by reducing oxidative stress.
C1 [Li, Jing-Jing; Mo, Ling; Song, Jia-Le] Guilin Med Univ, Dept Nutr & Food Hyg, Sch Publ Hlth, 109 Huancheng North Rd 2, Guilin 541100, Guangxi, Peoples R China.
C3 Guilin Medical University
RP Li, JJ; Song, JL (corresponding author), Guilin Med Univ, Dept Nutr & Food Hyg, Sch Publ Hlth, 109 Huancheng North Rd 2, Guilin 541100, Guangxi, Peoples R China.
EM funnyazi@163.com; songjiale@glmc.edu.cn
OI Li, Jingjing/0000-0001-5872-5766
FU National Natural Science Foundation of China [31760530]; Natural Science
   Foundation of Guangxi Province [2016GXNSFA-A380031]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This
   research was supported by the National Natural Science Foundation of
   China (NO. 31760530) and Natural Science Foundation of Guangxi Province
   (NO. 2016GXNSFA-A380031).
CR Abbas GM, 2014, NAT PROD RES, V28, P952, DOI 10.1080/14786419.2014.900770
   Bast A, 2002, ENVIRON TOXICOL PHAR, V11, P251, DOI 10.1016/S1382-6689(01)00118-1
   Bhat AH, 2015, BIOMED PHARMACOTHER, V74, P101, DOI 10.1016/j.biopha.2015.07.025
   Bouriche H., 2011, Advances in Environmental Biology, V5, P281
   CASTORINA C, 1992, NEUROCHEM RES, V17, P599, DOI 10.1007/BF00968789
   [Du Zhangli 杜彰礼], 2008, [天然产物研究与开发, Natural Product R & D], V20, P630
   Erden-Inal M, 2002, CELL BIOCHEM FUNCT, V20, P61, DOI 10.1002/cbf.937
   Fatemi I, 2018, FUND CLIN PHARMACOL, V32, P392, DOI 10.1111/fcp.12364
   Fatemi I, 2018, IRAN J BASIC MED SCI, V21, P19, DOI 10.22038/IJBMS.2017.24331.6071
   [郭林新 Guo Linxin], 2017, [中成药, Chinese Traditional Patent Medicine], V39, P338
   HATANO T, 1988, CHEM PHARM BULL, V36, P2090
   Hermenean A, 2014, J MED FOOD, V17, P670, DOI 10.1089/jmf.2013.0007
   Ho E, 2013, REDOX BIOL, V1, P483, DOI 10.1016/j.redox.2013.07.006
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Jung WW, 2014, INT J MOL MED, V33, P1327, DOI 10.3892/ijmm.2014.1666
   Kaviani E, 2017, BEHAV BRAIN RES, V334, P55, DOI 10.1016/j.bbr.2017.07.029
   Kotur-Stevuljevic J, 2015, ATHEROSCLEROSIS, V241, P192, DOI 10.1016/j.atherosclerosis.2015.05.016
   Lee J, 2004, COMPR REV FOOD SCI F, V3, P21, DOI 10.1111/j.1541-4337.2004.tb00058.x
   Linn Ficus, 1998, FLOR REP POP SIN, V23, P117
   Linn Ficus, 1998, FLOR RELP POP SIN, V23, P66
   Nourazarian AR, 2014, ASIAN PAC J CANCER P, V15, P4745, DOI 10.7314/APJCP.2014.15.12.4745
   Rochette L, 2014, BBA-GEN SUBJECTS, V1840, P2709, DOI 10.1016/j.bbagen.2014.05.017
   Shi YX, 2011, FOOD CHEM, V128, P889, DOI 10.1016/j.foodchem.2011.03.113
   Siddhuraju P, 2002, FOOD CHEM, V79, P61, DOI 10.1016/S0308-8146(02)00179-6
   Wang LS, 2004, CHIN J CHIN MAT MED, V29, P58
   Wang XiaoMei, 2011, Zhongcaoyao = Chinese Traditional and Herbal Drugs, V42, P458
   [韦乾蔚 Wei Qianwei], 2016, [天然产物研究与开发, Natural Product Research and Development], V28, P1055
   WU TS, 1995, PHYTOCHEMISTRY, V40, P1247, DOI 10.1016/0031-9422(95)00427-9
   [徐立 XU Li], 2010, [食品科学, Food Science], V31, P101
   Xu YouKai, 2005, Journal of Wuhan Botanical Research, V23, P85
   Zhang L, 2002, CHIN WILD PLANT RESO, V23, P15
   Zhao Ting-zhou, 2001, Forest Research, V14, P441
   Zhao X, 2018, ONCOL REP, V39, P289, DOI 10.3892/or.2017.6065
   Zhu JF, 2017, J CHROMATOGR B, V1060, P262, DOI 10.1016/j.jchromb.2017.06.022
   陈胡兰, 2010, [中草药, Chinese Traditional and Herbal Drugs], V41, P874
NR 35
TC 4
Z9 5
U1 1
U2 6
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1934-578X
EI 1555-9475
J9 NAT PROD COMMUN
JI Nat. Prod. Commun.
PD DEC
PY 2019
VL 14
IS 12
DI 10.1177/1934578X19896676
PG 7
WC Chemistry, Medicinal; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Food Science & Technology
GA JY1TY
UT WOS:000504206100002
OA hybrid
DA 2024-02-19
ER

PT J
AU Chakravarti, B
   Oseguera, M
   Dalal, N
   Fathy, P
   Mallik, B
   Raval, A
   Chakravarti, DN
AF Chakravarti, Bulbul
   Oseguera, Melva
   Dalal, Neville
   Fathy, Pamela
   Mallik, Buddhadeb
   Raval, Alpan
   Chakravarti, Deb N.
TI Proteomic profiling of aging in the mouse heart: Altered expression of
   mitochondrial proteins
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE aging; mouse heart; proteomics
ID OXIDATIVE-PHOSPHORYLATION; CREATINE-KINASE; RAT-HEART; COMPLEX; ATP;
   DYSFUNCTION; MYOCARDIUM; METABOLISM; ACONITASE; LIVER
AB Using two-dimensional gel electrophoresis and liquid chromatography-tandem mass spectrometry, we have used a systems biology approach to study the molecular basis of aging of the mouse heart. We have identified 8 protein spots whose expression is up-regulated due to aging and 36 protein spots whose expression is down-regulated due to aging (p <= 0.05 as judged by Wilcoxon Rank Sum test). Among the up-regulated proteins, we have characterized 5 protein spots and 2 of them, containing 3 different enzymes, are mitochondrial proteins. Among the down-regulated proteins, we have characterized 27 protein spots and 16 of them are mitochondrial proteins. Mitochondrial damage is believed to be a key factor in the aging process. Our current study provides molecular evidence at the level of the proteome for the alteration of structural and functional parameters of the mitochondria that contribute to impaired activity of the mouse heart due to aging. (C) 2008 Elsevier Inc. All rights reserved.
C1 [Chakravarti, Bulbul; Oseguera, Melva; Dalal, Neville; Fathy, Pamela; Mallik, Buddhadeb; Raval, Alpan; Chakravarti, Deb N.] Prote Ctr, Keck Grad Inst Appl Life Sci, Claremont, CA 91711 USA.
   [Raval, Alpan] Claremont Grad Univ, Sch Math Sci, Claremont, CA 91711 USA.
C3 Claremont Colleges; Keck Graduate Institute; Keck Graduate Institute of
   Applied Life Sciences; Claremont Colleges; Claremont Graduate School
RP Chakravarti, B (corresponding author), Prote Ctr, Keck Grad Inst Appl Life Sci, 535 Watson Dr, Claremont, CA 91711 USA.
EM bulbul_chakravarti@kgi.edu
OI Raval, Alpan/0000-0002-2689-3594
CR BROSNAN MJ, 1991, AM J PHYSIOL, V260, pC1191, DOI 10.1152/ajpcell.1991.260.6.C1191
   CASTELLUCCIO C, 1994, MECH AGEING DEV, V76, P73, DOI 10.1016/0047-6374(94)91583-0
   Chakravarti B, 2007, GERONTOLOGY, V53, P128, DOI 10.1159/000097865
   Coligan J. E., 2004, CURRENT PROTOCOLS PR
   Davies SMK, 2001, FREE RADICAL BIO MED, V31, P181, DOI 10.1016/S0891-5849(01)00576-7
   Davydov VV, 1999, EXP GERONTOL, V34, P375, DOI 10.1016/S0531-5565(99)00020-0
   Delaval E, 2004, EUR J BIOCHEM, V271, P4559, DOI 10.1111/j.1432-1033.2004.04422.x
   Di Somma S, 2000, HEART, V84, P659, DOI 10.1136/heart.84.6.659
   FROLKIS VV, 1988, GERONTOLOGY, V34, P64, DOI 10.1159/000212932
   Grynberg A, 1996, J CARDIOVASC PHARM, V28, pS11
   Gustafsson ÅB, 2008, CARDIOVASC RES, V77, P334, DOI 10.1093/cvr/cvm005
   Hagen TM, 2002, ANN NY ACAD SCI, V959, P491, DOI 10.1111/j.1749-6632.2002.tb02119.x
   HANSFORD RG, 1982, MECH AGEING DEV, V19, P191, DOI 10.1016/0047-6374(82)90010-0
   IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.1080/10618600.1996.10474713, 10.2307/1390807, DOI 10.1080/10618600.1996.10474713]
   JACOBUS WE, 1986, J BIOL CHEM, V261, P6579
   KATZ AM, 1988, AM J CARDIOL, V62, pA3, DOI 10.1016/S0002-9149(88)80077-8
   KATZ AM, 1991, HOSP PRACT, V26, P78
   KEMP GJ, 1994, MAGNET RESON MED, V31, P248, DOI 10.1002/mrm.1910310303
   Kernec F, 2001, PHYSIOL GENOMICS, V6, P117, DOI 10.1152/physiolgenomics.2001.6.2.117
   Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495
   Lenaz G, 1997, MOL CELL BIOCHEM, V174, P329, DOI 10.1023/A:1006854619336
   Lenaz G, 2002, ANN NY ACAD SCI, V959, P199, DOI 10.1111/j.1749-6632.2002.tb02094.x
   Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P37, DOI 10.1006/jmcc.2000.1273
   Milner DJ, 2000, J CELL BIOL, V150, P1283, DOI 10.1083/jcb.150.6.1283
   Moreau R, 2004, BIOCHEM BIOPH RES CO, V325, P48, DOI 10.1016/j.bbrc.2004.10.011
   MORGAN JP, 1990, CIRCULATION, V81, P21
   NEELY JR, 1974, ANNU REV PHYSIOL, V36, P413, DOI 10.1146/annurev.ph.36.030174.002213
   NEGRETTI N, 1993, CARDIOVASC RES, V27, P1826, DOI 10.1093/cvr/27.10.1826
   Papa S, 1996, BBA-BIOENERGETICS, V1276, P87, DOI 10.1016/0005-2728(96)00077-1
   Rich MW, 2006, MED CLIN N AM, V90, P863, DOI 10.1016/j.mcna.2006.05.012
   Sadek HA, 2003, ARCH BIOCHEM BIOPHYS, V420, P201, DOI 10.1016/j.abb.2003.09.029
   VITORICA J, 1981, MECH AGEING DEV, V16, P105, DOI 10.1016/0047-6374(81)90087-7
   Yarian CS, 2005, BIOCHEM BIOPH RES CO, V330, P151, DOI 10.1016/j.bbrc.2005.02.135
NR 33
TC 30
Z9 31
U1 0
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN 1
PY 2008
VL 474
IS 1
BP 22
EP 31
DI 10.1016/j.abb.2008.02.001
PG 10
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 309KR
UT WOS:000256459800004
PM 18284913
DA 2024-02-19
ER

PT J
AU Manzano-Núñez, F
   Arámbul-Anthony, MJ
   Albiñana, AG
   Tassias, AL
   Umanzor, CA
   Gascó, IB
   Herrera, A
   Vila, JF
   Burks, DJ
   Noon, LA
AF Manzano-Nunez, Fatima
   Jose Arambul-Anthony, Maria
   Galan Albinana, Amparo
   Leal Tassias, Aranzazu
   Acosta Umanzor, Carlos
   Borreda Gasco, Irene
   Herrera, Antonio
   Forteza Vila, Jeronimo
   Burks, Deborah J.
   Noon, Luke A.
TI Insulin resistance disrupts epithelial repair and niche-progenitor Fgf
   signaling during chronic liver injury
SO PLOS BIOLOGY
LA English
DT Article
ID KERATINOCYTE GROWTH-FACTOR; RECEPTOR SUBSTRATE-1; CELL-PROLIFERATION;
   HEPATOCYTES; HEPATITIS; REGENERATION; ASSOCIATION; MECHANISMS;
   EXPRESSION; CONTRIBUTE
AB Insulin provides important information to tissues about feeding behavior and energy status. Defective insulin signaling is associated with ageing, tissue dysfunction, and impaired wound healing. In the liver, insulin resistance leads to chronic damage and fibrosis, but it is unclear how tissue-repair mechanisms integrate insulin signals to coordinate an appropriate injury response or how they are affected by insulin resistance. In this study, we demonstrate that insulin resistance impairs local cellular crosstalk between the fibrotic stroma and bipotent adult liver progenitor cells (LPCs), whose paracrine interactions promote epithelial repair and tissue remodeling. Using insulin-resistant mice deficient for insulin receptor substrate 2 (Irs2), we highlight dramatic impairment of proregenerative fibroblast growth factor 7 (Fgf7) signaling between stromal niche cells and LPCs during chronic injury. We provide a detailed account of the role played by IRS2 in promoting Fgf7 ligand and receptor (Fgfr2-IIIb) expression by the two cell compartments, and we describe an insulin/IRS2-dependent feed-forward loop capable of sustaining hepatic re-epithelialization by driving FGFR2-IIIb expression. Finally, we shed light on the regulation of IRS2 and FGF7 within the fibrotic stroma and show-using a human coculture system-that IRS2 silencing shifts the equilibrium away from paracrine epithelial repair in favor of fibrogenesis. Hence, we offer a compelling insight into the contribution of insulin resistance to the pathogenesis of chronic liver disease and propose IRS2 as a positive regulator of communication between cell types and the transition between phases of stromal to epithelial repair.
C1 [Manzano-Nunez, Fatima; Jose Arambul-Anthony, Maria; Acosta Umanzor, Carlos; Burks, Deborah J.; Noon, Luke A.] CIBERDEM Ctr Invest Biomed Red Diabet & Enfermeda, Madrid, Spain.
   [Manzano-Nunez, Fatima; Jose Arambul-Anthony, Maria; Galan Albinana, Amparo; Leal Tassias, Aranzazu; Acosta Umanzor, Carlos; Herrera, Antonio; Forteza Vila, Jeronimo; Burks, Deborah J.; Noon, Luke A.] Ctr Invest Principe Felipe, Valencia, Spain.
   [Borreda Gasco, Irene; Forteza Vila, Jeronimo] Univ Catolica Valencia San Vicente Martir, Inst Valenciano Patol, Valencia, Spain.
C3 CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Prince
   Felipe Research Center; Universidad Catolica de Valencia San Vicente
   Martir
RP Noon, LA (corresponding author), CIBERDEM Ctr Invest Biomed Red Diabet & Enfermeda, Madrid, Spain.; Noon, LA (corresponding author), Ctr Invest Principe Felipe, Valencia, Spain.
EM lnoon@cipf.es
RI Camacho, Antonio Herrera/G-2007-2016; Noon, Luke A/H-4141-2014; Galán,
   Amparo/ABG-8474-2020; Nuñez, Fatima Manzano/AAC-6806-2022
OI Camacho, Antonio Herrera/0000-0002-6248-1001; Noon, Luke
   A/0000-0002-0502-4322; Galán, Amparo/0000-0003-4265-8516; Nuñez, Fatima
   Manzano/0000-0001-9780-1792
FU Generalitat Valenciana [ACIF/2016/020]; Centro de Investigacion Principe
   Felipe [P.I.04/2017]; MINECO [BFU2014-58686-P, RYC-2012-11700,
   SAF2011-28331]; European Commission [FP7 HEALTH-F5-2008-223317]
FX Generalitat Valenciana http://www.ceice.gva.es/ca/web/ciencia (grant
   number ACIF/2016/020). Received by FMN. The funder had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript. Centro de Investigacion Principe Felipe
   http://www.cipf.es (grant number P.I.04/2017). Received by MJAA. The
   funder had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. MINECO
   http://www.mineco.gob.es (grant number BFU2014-58686-P). Received by
   LAN. The funder had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript. MINECO
   http://www.mineco.gob.es (grant number RYC-2012-11700). Received by LAN.
   The funder had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. MINECO
   http://www.mineco.gob.es (grant number SAF2011-28331). Received by DJB
   and LAN. The funder had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
   European Commission
   https://ec.europa.eu/eurostat/cros/content/research-project-sunder-frame
   work-programmes-0_en (grant number FP7 HEALTH-F5-2008-223317). Received
   by DJB. The funder had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376
   Berg T, 2007, HEPATOLOGY, V46, P1187, DOI 10.1002/hep.21814
   Böhm F, 2010, GASTROENTEROLOGY, V139, P1385, DOI 10.1053/j.gastro.2010.06.069
   Boissan M, 2005, AM J PATHOL, V167, P869, DOI 10.1016/S0002-9440(10)62058-5
   Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169
   Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012
   Cheetham SW, 2013, SCIENCE, V340, P817, DOI 10.1126/science.1238525
   Chell JM, 2010, CELL, V143, P1161, DOI 10.1016/j.cell.2010.12.007
   Fickert P, 2007, AM J PATHOL, V171, P525, DOI 10.2353/ajpath.2007.061133
   Font-Burgada J, 2015, CELL, V162, P766, DOI 10.1016/j.cell.2015.07.026
   Iseki S, 1999, DEVELOPMENT, V126, P5611
   Itoh N, 2016, FRONT CELL DEV BIOL, V4, P1, DOI DOI 10.3389/FCELL.2016.00110
   Jeong SH, 2018, J CLIN INVEST, V128, P1010, DOI 10.1172/JCI95802
   Kaneko K, 2015, HEPATOLOGY, V61, P2056, DOI 10.1002/hep.27685
   Katsumata LW, 2017, HEPATOL COMMUN, V1, P198, DOI 10.1002/hep4.1023
   Kawaguchi T, 2004, AM J PATHOL, V165, P1499, DOI 10.1016/S0002-9440(10)63408-6
   Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109
   Kubota N, 2008, CELL METAB, V8, P49, DOI 10.1016/j.cmet.2008.05.007
   Kubota N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12977
   Leclercq IA, 2007, J HEPATOL, V47, P142, DOI 10.1016/j.jhep.2007.04.002
   Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107
   Lu L, 2018, EXP MOL MED, V50, DOI 10.1038/emm.2017.205
   Nies VJM, 2016, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00193
   Padrissa-Altés S, 2015, GUT, V64, P1444, DOI 10.1136/gutjnl-2014-307874
   Parent R, 2004, GASTROENTEROLOGY, V126, P1147, DOI 10.1053/j.gastro.2004.01.002
   Peng C, 2011, PLAST RECONSTR SURG, V128, p673E, DOI 10.1097/PRS.0b013e318230c521
   Rametta R, 2013, INT J OBESITY, V37, P986, DOI 10.1038/ijo.2012.181
   Reuveni H, 2013, CANCER RES, V73, P4383, DOI 10.1158/0008-5472.CAN-12-3385
   Richardson MM, 2007, GASTROENTEROLOGY, V133, P80, DOI 10.1053/j.gastro.2007.05.012
   Sanchez-Lopez E, 2016, ONCOGENE, V35, P2634, DOI 10.1038/onc.2015.326
   Steiling H, 2004, AM J PATHOL, V165, P1233, DOI 10.1016/S0002-9440(10)63383-4
   Steiling H, 2003, ONCOGENE, V22, P4380, DOI 10.1038/sj.onc.1206499
   Steinberg Z, 2005, DEVELOPMENT, V132, P1223, DOI 10.1242/dev.01690
   Svegliati-Baroni G, 2011, GUT, V60, P108, DOI 10.1136/gut.2010.219741
   Takase HM, 2013, GENE DEV, V27, P169, DOI 10.1101/gad.204776.112
   Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780
   Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957
   Utley S, 2014, J HEPATOL, V60, P1002, DOI 10.1016/j.jhep.2013.12.017
   Valverde AM, 2003, DIABETES, V52, P2239, DOI 10.2337/diabetes.52.9.2239
   Walker A, 2018, IUBMB LIFE, V70, P1122, DOI 10.1002/iub.1920
   Wang B, 2015, NATURE, V524, P180, DOI 10.1038/nature14863
   Weiskirchen R, 2005, METH MOLEC MED, V117, P99
   Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835
   WERNER S, 1994, J INVEST DERMATOL, V103, P469, DOI 10.1111/1523-1747.ep12395564
   WERNER S, 1994, SCIENCE, V266, P819, DOI 10.1126/science.7973639
   Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089
   Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116
   Xu J, 2015, EXP BIOL MED, V240, P691, DOI 10.1177/1535370215584933
   YAN GC, 1993, MOL CELL BIOL, V13, P4513, DOI 10.1128/MCB.13.8.4513
   Yimlamai D, 2014, CELL, V157, P1324, DOI 10.1016/j.cell.2014.03.060
   Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026
NR 51
TC 9
Z9 9
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1544-9173
EI 1545-7885
J9 PLOS BIOL
JI PLoS. Biol.
PD JAN
PY 2019
VL 17
IS 1
AR e2006972
DI 10.1371/journal.pbio.2006972
PG 32
WC Biochemistry & Molecular Biology; Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA HK0NH
UT WOS:000457596000009
PM 30695023
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU ROGIERS, V
   COECKE, S
   VANDENBERGHE, Y
   MOREL, F
   CALLAERTS, A
   VERLEYE, G
   VANBEZOOIJEN, CFA
   GUILLOUZO, A
   VERCRUYSSE, A
AF ROGIERS, V
   COECKE, S
   VANDENBERGHE, Y
   MOREL, F
   CALLAERTS, A
   VERLEYE, G
   VANBEZOOIJEN, CFA
   GUILLOUZO, A
   VERCRUYSSE, A
TI EFFECT OF THE AGING PROCESS ON THE GENDER AND PHENOBARBITAL DEPENDENT
   EXPRESSION OF GLUTATHIONE-S-TRANSFERASE SUBUNITS IN BROWN NORWAY
   RAT-LIVER
SO BIOCHEMICAL PHARMACOLOGY
LA English
DT Article
AB The effect of age, gender and phenobarbital treatment on the hepatic cytosolic glutathione S-transferase subunit composition was studied in Brown Norway rats. Affinity chromatography followed by reversed phase HPLC was used in order to separate the various glutathione S-transferase subunits. Corresponding steady-state mRNA levels were measured by Northern Blot analysis using cDNA clones hybridizing to mRNA encoding glutathione S-transferase subunits 1/2, 3/4 and 7, respectively. In all the age groups studied (15, 25, 53, 99, 112 and 136 weeks) the total amount of glutathione S-transferase protein was in untreated rats significantly higher in males (132-mu-g/mg cytosolic protein) than in females (91-mu-g/mg cytosolic protein) and significant gender dependent differences in the subunit composition were demonstrated. Aging seemed to be of minor importance in untreated as well as in phenobarbital treated rats. Under control conditions, the subunit composition of male rats between 15 and 136 weeks old consisted of 28, 12, 11 and 49% of subunits 1, 2, 3 and 4 respectively and of female animals of the same age groups of 38, 26, 7 and 30%, respectively. In all the age groups studied phenobarbital administration (45 mg/kg body weight, i.p., once a day for 7 days) doubled total glutathione S-transferase protein in both genders and affected the subunit composition in a significant way, emphasizing the already existing differences between genders. Subunits 1, 2 and 3, especially, were increased in male rats in comparison to females resulting in the observation that levels of glutathione S-transferase subunits studied became higher in males than in their female counterparts. The HPLC results were confirmed by steady-state mRNA analysis. In untreated rats, higher levels of mRNA encoding glutathione S-transferase subunits 1/2 and 3/4 were present in male than in female livers. Phenobarbital treatment increased mRNA levels in both genders. Subunit 7 was never detected. These effects were demonstrated in both young and old rats.
C1 VRIJE UNIV BRUSSELS, DEPT STAT & OPERAT RES, B-1090 BRUSSELS, BELGIUM.
   HOP PONTCHAILLOU, INSERM, U49, UNITE RECH HEPATOL, F-35033 RENNES, FRANCE.
   TNO, INST EXPTL GERONTOL, 2280 HV RIJSWIJK, NETHERLANDS.
C3 Vrije Universiteit Brussel; CHU Rennes; Institut National de la Sante et
   de la Recherche Medicale (Inserm); Universite de Rennes; Netherlands
   Organization Applied Science Research
RP ROGIERS, V (corresponding author), VRIJE UNIV BRUSSELS, DEPT TOXICOL, LAARBEEKLAAN 103, B-1090 BRUSSELS, BELGIUM.
OI Rogiers, Vera/0000-0003-0635-7740
CR ABRAMOVITZ M, 1988, XENOBIOTICA, V18, P1249, DOI 10.3109/00498258809042248
   BENSON AM, 1977, P NATL ACAD SCI USA, V74, P158, DOI 10.1073/pnas.74.1.158
   BIRNBAUM L, 1987, GERIATRIC SCI, V35, P198
   BIRNBAUM LS, 1979, CHEM-BIOL INTERACT, V26, P245, DOI 10.1016/0009-2797(79)90028-0
   Chasseaud L F, 1979, Adv Cancer Res, V29, P175, DOI 10.1016/S0065-230X(08)60848-9
   CHENGELIS CP, 1988, XENOBIOTICA, V18, P1225, DOI 10.3109/00498258809042246
   CHENGELIS CP, 1988, XENOBIOTICA, V18, P1211, DOI 10.3109/00498258809042245
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   COECKE S, 1990, MECH AGEING DEV, V55, P189, DOI 10.1016/0047-6374(90)90026-C
   DARBY FJ, 1972, BIOCHEM J, V128, P175, DOI 10.1042/bj1280175
   DING VDH, 1985, ARCH BIOCHEM BIOPHYS, V240, P553, DOI 10.1016/0003-9861(85)90062-1
   FARRANTS AKO, 1987, BIOCHEM J, V245, P423, DOI 10.1042/bj2450423
   FUJITA S, 1985, BIOCHEM PHARMACOL, V34, P3891, DOI 10.1016/0006-2952(85)90440-X
   GORROD JW, 1974, GERONTOL CLIN, V16, P30, DOI 10.1159/000245483
   HALES BF, 1977, BIOCHEM PHARMACOL, V26, P555, DOI 10.1016/0006-2952(77)90337-9
   HAYAKAWA T, 1974, ARCH BIOCHEM BIOPHYS, V162, P223, DOI 10.1016/0003-9861(74)90122-2
   HOLLANDER CF, 1976, LAB ANIM SCI, V26, P320
   IGARASHI T, 1989, Drug Metabolism and Drug Interactions, V7, P191
   IGARASHI T, 1985, J BIOCHEM-TOKYO, V98, P117, DOI 10.1093/oxfordjournals.jbchem.a135249
   IGARASHI T, 1987, XENOBIOTICA, V17, P127, DOI 10.3109/00498258709043923
   KAPLOWITZ N, 1975, BIOCHEM J, V146, P351, DOI 10.1042/bj1460351
   KETTERER B, 1988, MUTAT RES, V202, P343, DOI 10.1016/0027-5107(88)90197-2
   KETTERER B, 1986, XENOBIOTICA, V16, P957, DOI 10.3109/00498258609038976
   KITAHARA A, 1982, LIVER AGING 1982, P135
   KLOTZ U, 1982, LIVER AGING 1982, P287
   KLOTZ U, 1978, LIVER AGING, P367
   MANNERVIK B, 1985, P NATL ACAD SCI USA, V82, P7202, DOI 10.1073/pnas.82.21.7202
   MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226
   MEYER BJ, 1989, 3RD INT GST C GLUT S
   MEYER DJ, 1984, FEBS LETT, V173, P327, DOI 10.1016/0014-5793(84)80799-1
   NORUSIS NJ, 1986, ADV STATISTICS, pB165
   PEMBLE SE, 1986, BIOCHEM J, V240, P885, DOI 10.1042/bj2400885
   SATOH K, 1985, P NATL ACAD SCI USA, V82, P3964, DOI 10.1073/pnas.82.12.3964
   SLATER TF, 1984, BIOCHEM J, V222, P1
   SOHAL RS, 1984, FREE RADICALS MOL BI, V27, P119
   SPEARMAN E, 1986, LIVER AGING, P45
   SPEARMAN ME, 1984, BIOCHEM PHARMACOL, V33, P1309, DOI 10.1016/0006-2952(84)90185-0
   STOHS SJ, 1982, BIOCHEM PHARMACOL, V31, P2113, DOI 10.1016/0006-2952(82)90429-4
   TAN KH, 1984, BIOCHEM J, V220, P243, DOI 10.1042/bj2200243
   TAYLOR JB, 1984, BIOCHEM J, V219, P223, DOI 10.1042/bj2190223
   van Bladeren P.J., 1988, METABOLISM XENOBIOTI, P267
   VANBEZOOIJEN CFA, 1981, MECH AGEING DEV, V17, P11, DOI 10.1016/0047-6374(81)90124-X
   VANBEZOOIJEN CFA, 1984, MECH AGEING DEV, V25, P1, DOI 10.1016/0047-6374(84)90126-X
   VANBEZOOIJEN CFA, 1987, MECH AGEING DEV, V35, P198
   VANDENBERGHE Y, 1990, MOL PHARMACOL, V37, P372
   VANDENBERGHE Y, 1988, BIOCHEM PHARMACOL, V37, P2482, DOI 10.1016/0006-2952(88)90378-4
   VANDERJAGT DL, 1985, J BIOL CHEM, V260, P1603
   VOS RME, 1988, BIOCHEM PHARMACOL, V37, P1077, DOI 10.1016/0006-2952(88)90513-8
NR 48
TC 18
Z9 18
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0006-2952
EI 1873-2968
J9 BIOCHEM PHARMACOL
JI Biochem. Pharmacol.
PD JUL 15
PY 1991
VL 42
IS 3
BP 491
EP 498
DI 10.1016/0006-2952(91)90310-2
PG 8
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA FY958
UT WOS:A1991FY95800007
PM 1859462
DA 2024-02-19
ER

PT J
AU Cao, ZY
   Xie, YY
   Yu, L
   Li, Y
   Wang, Y
AF Cao, Zeyuan
   Xie, Yunyi
   Yu, Le
   Li, Yi
   Wang, Yan
TI Hepatocyte growth factor (HGF) and stem cell factor (SCF) maintained the
   stemness of human bone marrow mesenchymal stem cells (hBMSCs) during
   long-term expansion by preserving mitochondrial function via the
   PI3K/AKT, ERK1/2, and STAT3 signaling pathways
SO STEM CELL RESEARCH & THERAPY
LA English
DT Article
DE Stem cells from human exfoliated deciduous teeth; Hepatocyte growth
   factor; Stem cell factor; Stemness; Senescence; Osteogenic
   differentiation; Mitochondrial function
ID CARTILAGE REPAIR; AGED MICE; PROLIFERATION; APOPTOSIS; ANGIOGENESIS;
   EXPRESSION
AB BackgroundMesenchymal stem cells (MSCs) have a limited self-renewal ability, impaired multi-differentiation potential, and undetermined cell senescence during in vitro series expansion. To address this concern, we investigated the effects of the microenvironment provided by stem cells from human exfoliated deciduous teeth (SHED) in maintaining the stemness of human bone marrow mesenchymal stem cells (hBMSCs) and identified the key factors and possible mechanisms responsible for maintaining the stemness of MSCs during long-term expansion in vitro.MethodsThe passage 3 (P3) to passage 8 (P8) hBMSCs were cultured in the conditioned medium from SHED (SHED-CM). The percentage of senescent cells was evaluated by beta -galactosidase staining. In addition, the osteogenic differentiation potential was analyzed by reverse transcription quantitative PCR (RT-qPCR), Western blot, alizarin red, and alkaline phosphatase (ALP) staining. Furthermore, RT-qPCR results identified hepatocyte growth factor (HGF) and stem cell factor (SCF) as key factors. Thus, the effects of HGF and SCF on mitochondrial function were assessed by measuring the ROS and mitochondrial membrane potential levels. Finally, selected mitochondrial-related proteins associated with the PI3K/AKT, ERK1/2, and STAT3 signaling pathways were investigated to determine the effects of HGF and SCF in preserving the mitochondrial function of hBMSCs during long-term expansion.ResultsSHED-CM had significantly enhanced the cell proliferation, reduced the senescent cells, and maintained the osteogenesis and pro-angiogenic capacity in P8 hBMSCs during long-term expansion. In addition, hBMSCs treated with 100ng/ml HGF and 10ng/ml SCF had reduced ROS levels and preserved mitochondrial membrane potential compared with P8 hBMSCs during long-term expansion. Furthermore, HGF and SCF upregulated the expression of mitochondrial-related proteins associated with the PI3K/AKT, ERK1/2, and STAT3 signaling pathways, possibly contributing to the maintenance of hBMSCs stemness by preserving mitochondrial function.ConclusionBoth HGF and SCF are key factors in maintaining the stemness of hBMSCs by preserving mitochondrial function through the expression of proteins associated with the PI3K/AKT, ERK1/2, and STAT3 signaling pathways. This study provides new insights into the anti-senescence capability of HGF and SCF, as well as new evidence for their potential application in optimizing the long-term culture of MSCs.
C1 [Cao, Zeyuan; Xie, Yunyi; Yu, Le; Li, Yi; Wang, Yan] Sun Yat Sen Univ, Guanghua Sch Stomatol, Hosp Stomatol, Guangdong Prov Key Lab Stomatol, 56 Lingyuanxi Rd, Guangzhou 510055, Peoples R China.
C3 Sun Yat Sen University
RP Wang, Y (corresponding author), Sun Yat Sen Univ, Guanghua Sch Stomatol, Hosp Stomatol, Guangdong Prov Key Lab Stomatol, 56 Lingyuanxi Rd, Guangzhou 510055, Peoples R China.
EM wang93@mail.sysu.edu.cn
RI zhang, lin/IZQ-4870-2023
OI Li, Yi/0000-0002-6484-1154
FU National Natural Science Foundation of China [81530069]; Guangdong
   Innovative Research Team program [2009010058]
FX This work was supported by the National Natural Science Foundation of
   China (No. 81530069) and the Guangdong Innovative Research Team program
   (No. 2009010058). The authors would also like to thank all the staff at
   the department of Guangdong Provincial Key Laboratory of Stomatology in
   Sun Yat-sen University.
CR Baker N, 2015, BONE, V70, P37, DOI 10.1016/j.bone.2014.10.014
   Bakopoulou A, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0705-0
   Bauer D, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.6
   Bunpetch V, 2019, BIOMATERIALS, V196, P67, DOI 10.1016/j.biomaterials.2017.11.023
   Chang PY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0222-1
   Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046
   Chen KY, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20167324
   Cheng YH, 2017, ACTA BIOCHIM POL, V64, P343, DOI 10.18388/abp.2016_1438
   Choudhery MS, 2012, CELL BIOL INT, V36, P747, DOI 10.1042/CBI20110183
   Ciccocioppo R, 2016, LANCET, V388, P1251, DOI 10.1016/S0140-6736(16)31209-0
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fu BB, 2017, BIOCHEM BIOPH RES CO, V486, P198, DOI 10.1016/j.bbrc.2017.03.027
   Ganta KK, 2017, CELL BIOL TOXICOL, V33, P69, DOI 10.1007/s10565-016-9362-9
   Gao L, 2016, J CLIN ONCOL, V34, P2843, DOI 10.1200/JCO.2015.65.3642
   Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220
   Gu LH, 2015, CELL MOL IMMUNOL, V12, P444, DOI 10.1038/cmi.2014.70
   Hall AE, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.91
   He NN, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0949-3
   Inglis S, 2019, FASEB J, V33, P3279, DOI 10.1096/fj.201801114R
   Jiang LT, 2018, BIOMATERIALS, V179, P15, DOI 10.1016/j.biomaterials.2018.06.035
   Konala VBR, 2016, CYTOTHERAPY, V18, P13, DOI 10.1016/j.jcyt.2015.10.008
   Kunimatsu R, 2018, BIOCHEM BIOPH RES CO, V501, P193, DOI 10.1016/j.bbrc.2018.04.213
   Lee HJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep44486
   Li X, 2017, J CELL MOL MED, V21, P265, DOI 10.1111/jcmm.12962
   Liang XT, 2019, FASEB J, V33, P4559, DOI 10.1096/fj.201801690R
   Lin H, 2019, BIOMATERIALS, V203, P96, DOI 10.1016/j.biomaterials.2018.06.026
   Lin L, 2016, INT J ONCOL, V49, P2265, DOI 10.3892/ijo.2016.3728
   Liu SY, 2015, CELL METAB, V22, P606, DOI 10.1016/j.cmet.2015.08.018
   Lu YY, 2020, AGING-US, V12, P844, DOI 10.18632/aging.102659
   Lu ZY, 2016, MOL MED REP, V14, P643, DOI 10.3892/mmr.2016.5314
   Matsushita Y, 2017, J TISSUE ENG REGEN M, V11, P1888, DOI 10.1002/term.2086
   McGonagle D, 2017, NAT REV RHEUMATOL, V13, P719, DOI 10.1038/nrrheum.2017.182
   Mesentier-Louro LA, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1226-9
   Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106
   Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100
   Mussano F, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051454
   Ning T, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1133-0
   Rayagiri SS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03425-3
   Rustad KC, 2012, BIOMATERIALS, V33, P80, DOI 10.1016/j.biomaterials.2011.09.041
   Scadden DT, 2014, CELL, V157, P41, DOI 10.1016/j.cell.2014.02.013
   Su N, 2017, BIOMATERIALS, V141, P74, DOI 10.1016/j.biomaterials.2017.06.028
   Tsai MJ, 2019, J CLIN MED, V8, DOI 10.3390/jcm8010023
   Verrier S, 2016, EUR CELLS MATER, V32, P87, DOI 10.22203/eCM.v032a06
   Vessey W, 2014, FERTIL STERIL, V102, P1576, DOI 10.1016/j.fertnstert.2014.09.009
   Wen L, 2016, STEM CELLS DEV, V25, P123, DOI 10.1089/scd.2015.0049
   Wen Q, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030734
   Wu LX, 2018, BIOMATERIALS, V186, P64, DOI 10.1016/j.biomaterials.2018.09.013
   Yin L, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0676-1
   Zhang SP, 2018, BIOMATERIALS, V156, P16, DOI 10.1016/j.biomaterials.2017.11.028
   Zhang Y, 2017, CANCER RES, V77, P3082, DOI 10.1158/0008-5472.CAN-16-1633
   Zhang Z, 2017, LEUKEMIA, V31, P403, DOI 10.1038/leu.2016.201
   Zhong W, 2018, ACTA BIOCH BIOPH SIN, V50, P701, DOI 10.1093/abbs/gmy048
NR 52
TC 20
Z9 20
U1 1
U2 15
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1757-6512
J9 STEM CELL RES THER
JI Stem Cell Res. Ther.
PD JUL 31
PY 2020
VL 11
IS 1
AR 329
DI 10.1186/s13287-020-01830-4
PG 15
WC Cell & Tissue Engineering; Cell Biology; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Research & Experimental Medicine
GA MZ7KQ
UT WOS:000559306600001
PM 32736659
OA gold, Green Submitted, Green Published
DA 2024-02-19
ER

PT J
AU Alferink, LJM
   Kiefte-de Jong, JC
   Erler, NS
   Veldt, BJ
   Schoufour, JD
   de Knegt, RJ
   Ikram, MA
   Metselaar, HJ
   Janssen, HLA
   Franco, OH
   Murad, SD
AF Alferink, Louise J. M.
   Kiefte-de Jong, Jessica C.
   Erler, Nicole S.
   Veldt, Bart J.
   Schoufour, Josje D.
   de Knegt, Robert J.
   Ikram, M. Arfan
   Metselaar, Herold J.
   Janssen, Harry L. A.
   Franco, Oscar H.
   Murad, Sarwa Darwish
TI Association of dietary macronutrient composition and non-alcoholic fatty
   liver disease in an ageing population: the Rotterdam Study
SO GUT
LA English
DT Article
ID FOOD FREQUENCY QUESTIONNAIRE; WEIGHT-LOSS; NAFLD; RISK; FRUCTOSE;
   GLUCOSE; STEATOHEPATITIS; REPRODUCIBILITY; INDIVIDUALS; PATTERN
AB Objective A healthy lifestyle is the first-line treatment in non-alcoholic fatty liver disease (NAFLD), but specific dietary recommendations are lacking. Therefore, we aimed to determine whether dietary macronutrient composition is associated with NAFLD.
   Design Participants from the Rotterdam Study were assessed on (1) average intake of macronutrients (protein, carbohydrate, fat, fibre) using a Food Frequency Questionnaire and (2) NAFLD presence using ultrasonography, in absence of excessive alcohol, steatogenic drugs and viral hepatitis. Macronutrients were analysed using the nutrient density method and ranked (Q1-Q4). Logistic regression analyses were adjusted for sociodemographic, lifestyle and metabolic covariates. Moreover, analyses were adjusted for and stratified by body mass index (BMI) (25 kg/m2). Also, substitution models were built.
   Results I n total, 3882 participants were included (age 70 +/- 9, 58% female). NAFLD was present in 1337 (34%) participants of whom 132 were lean and 1205 overweight. Total protein was associated with overweight NAFLD after adjustment for sociodemographic and lifestyle covariates (OR Q4vsQ1 1.40; 95% CI 1.11 to 1.77). This association was driven by animal protein (OR Q4vsQ1 1.54; 95% CI 1.20 to 1.98). After adjustment for metabolic covariates, only animal protein remained associated with overweight NAFLD (OR Q4vsQ1 1.36; 95% CI 1.05 to 1.77). Monosaccharides and disaccharides were associated with lower overall NAFLD prevalence (OR Q4vsQ1 0.66; 95% CI 0.52 to 0.83) but this effect diminished after adjustment for metabolic covariates and BMI. No consistent associations were observed for fat subtypes or fibre. There were no substitution effects.
   Conclusion T his large population-based study shows that high animal protein intake is associated with NAFLD in overweight, predominantly aged Caucasians, independently of well-known risk factors. Contrary to previous literature, our results do not support a harmful association of monosaccharides and disaccharides with NAFLD.
C1 [Alferink, Louise J. M.; Veldt, Bart J.; de Knegt, Robert J.; Metselaar, Herold J.; Janssen, Harry L. A.; Murad, Sarwa Darwish] Erasmus MC Univ, Med Ctr, Dept Gastroenterol & Hepatol, NL-3000 CA Rotterdam, Netherlands.
   [Kiefte-de Jong, Jessica C.; Schoufour, Josje D.; Ikram, M. Arfan; Franco, Oscar H.] Erasmus MC Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands.
   [Kiefte-de Jong, Jessica C.] Leiden Univ Coll, Dept Global Publ Hlth, The Hague, Netherlands.
   [Erler, Nicole S.] Erasmus MC Univ, Med Ctr, Dept Biostat, Rotterdam, Netherlands.
   [Veldt, Bart J.] Reinier de Graaf Hosp, Dept Gastroenterol & Hepatol, Delft, Netherlands.
   [Janssen, Harry L. A.] Univ Hlth Network, Toronto Gen Hosp, Toronto Ctr Liver Dis, Toronto, ON, Canada.
C3 Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam;
   Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Reinier de Graaf
   Hospital; University of Toronto; University Health Network Toronto;
   Toronto General Hospital
RP Murad, SD (corresponding author), Erasmus MC Univ, Med Ctr, Dept Gastroenterol & Hepatol, NL-3000 CA Rotterdam, Netherlands.
EM s.darwishmurad@erasmusmc.nl
RI Murad, Sarwa Darwish/AAO-5493-2020; Franco, Óscar H/ABE-2305-2020;
   Ikram, M. Arfan/AAM-5225-2021; De Knegt, Robert/X-4629-2019; Kiefte-de
   Jong, Jessica/GLV-3216-2022
OI Murad, Sarwa Darwish/0000-0003-2804-1165; Franco, Óscar
   H/0000-0002-4606-4929; De Knegt, Robert/0000-0003-0934-6975; Kiefte-de
   Jong, Jessica/0000-0002-8136-0918; Ikram, Mohammad
   Arfan/0000-0003-0372-8585; Erler, Nicole/0000-0002-9370-6832
FU Erasmus MC University Medical Centre and Erasmus University Rotterdam;
   Netherlands Organization for Scientific Research (NWO); Netherlands
   Organization for Health Research and Development (ZonMw); Research
   Institute for Diseases in the Elderly (RIDE); Ministry of Education,
   Culture and Science; Ministry of Health, Welfare and Sports; European
   Commission (DG XII); Municipality of Rotterdam; Den Dulk-Moermans
   foundation (Leiden University Fund)
FX The Rotterdam Study is supported by the Erasmus MC University Medical
   Centre and Erasmus University Rotterdam, the Netherlands Organization
   for Scientific Research (NWO), the Netherlands Organization for Health
   Research and Development (ZonMw), the Research Institute for Diseases in
   the Elderly (RIDE), the Ministry of Education, Culture and Science, the
   Ministry of Health, Welfare and Sports, the European Commission (DG XII)
   and by the Municipality of Rotterdam. JCK-dJ received a grant from the
   Den Dulk-Moermans foundation (Leiden University Fund).
CR Adeva MM, 2011, CLIN NUTR, V30, P416, DOI 10.1016/j.clnu.2011.03.008
   Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
   Bozzetto L, 2012, DIABETES CARE, V35, P1429, DOI 10.2337/dc12-0033
   Chan R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122406
   Chowdhury R, 2014, ANN INTERN MED, V160, P398, DOI 10.7326/M13-1788
   Cortez-Pinto H, 2006, CLIN NUTR, V25, P816, DOI 10.1016/j.clnu.2006.01.027
   Dasarathy S, 2009, J HEPATOL, V51, P1061, DOI 10.1016/j.jhep.2009.09.001
   de Souza RJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3978
   Donders-Engelen MR, 1997, VAKGROEP HUMANE VOED
   EASL, 2016, DIABETOLOGIA, V59, P1121, DOI 10.1007/s00125-016-3902-y
   Etemadi A, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1957
   Fallaize R, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010049
   Feunekes IJ, 1995, INT J FOOD SCI NUTR, V46, P117, DOI 10.3109/09637489509012539
   Fonseca J, 2017, J HEPATOL, V66, P465, DOI 10.1016/j.jhep.2016.10.036
   Freedman LS, 2011, J NATL CANCER I, V103, P1086, DOI 10.1093/jnci/djr189
   Freedman ND, 2010, J NATL CANCER I, V102, P1354, DOI 10.1093/jnci/djq301
   Galwey NW, 2009, GENET EPIDEMIOL, V33, P559, DOI 10.1002/gepi.20408
   Gemming L, 2014, EUR J CLIN NUTR, V68, P259, DOI 10.1038/ejcn.2013.242
   GOLDBOHM RA, 1995, EUR J CLIN NUTR, V49, P420
   GOLDBOHM RA, 1994, EUR J CLIN NUTR, V48, P253
   Ha V, 2015, ADV NUTR, V6, p504S, DOI 10.3945/an.114.007468
   Haghighatdoost F, 2016, J RES MED SCI, V21
   Hamaguchi M, 2007, AM J GASTROENTEROL, V102, P2708, DOI 10.1111/j.1572-0241.2007.01526.x
   Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849
   Ikram MA, 2017, EUR J EPIDEMIOL, V32, P807, DOI 10.1007/s10654-017-0321-4
   Johnston RD, 2013, GASTROENTEROLOGY, V145, P1016, DOI 10.1053/j.gastro.2013.07.012
   Kirk E, 2009, GASTROENTEROLOGY, V136, P1552, DOI 10.1053/j.gastro.2009.01.048
   Koehler EM, 2012, J HEPATOL, V57, P1305, DOI 10.1016/j.jhep.2012.07.028
   Krupp D, 2012, J NUTR, V142, P313, DOI 10.3945/jn.111.150540
   Kwok R, 2016, GUT, V65, P1359, DOI 10.1136/gutjnl-2015-309265
   LUDWIG J, 1980, MAYO CLIN PROC, V55, P434
   Markova M, 2017, GASTROENTEROLOGY, V152, P571, DOI 10.1053/j.gastro.2016.10.007
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Mosca A, 2017, J HEPATOL, V66, P1031, DOI 10.1016/j.jhep.2016.12.025
   Pais R, 2016, J HEPATOL, V65, P1245, DOI 10.1016/j.jhep.2016.07.033
   Pereira EC, 2008, CLIN BIOCHEM, V41, P1454, DOI 10.1016/j.clinbiochem.2008.08.074
   Promrat K, 2010, HEPATOLOGY, V51, P121, DOI 10.1002/hep.23276
   REBOLLEDO OR, 1978, AM J PHYSIOL, V234, pE426, DOI 10.1152/ajpendo.1978.234.4.E426
   Rietman A, 2018, EUR J CLIN NUTR, V72, P117, DOI 10.1038/ejcn.2017.148
   Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370
   Romero-Gómez M, 2017, J HEPATOL, V67, P829, DOI 10.1016/j.jhep.2017.05.016
   Romeu M, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-102
   Rothman KJG, 1951, MODERN EPIDEMIOLOGY
   Rubin DonaldB., 1987, MULTIPLE IMPUTATIONS
   Schoufour JD, 2018, MATURITAS, V107, P71, DOI 10.1016/j.maturitas.2017.10.010
   SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989
   Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393
   Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063
   van Lee L, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-49
   Vilar-Gomez E, 2015, GASTROENTEROLOGY, V149, P367, DOI 10.1053/j.gastro.2015.04.005
   Yasutake K, 2009, SCAND J GASTROENTERO, V44, P471, DOI 10.1080/00365520802588133
   Younossi ZM, 2012, MEDICINE, V91, P319, DOI 10.1097/MD.0b013e3182779d49
   Zelber-Sagi S, 2018, J HEPATOL, V68, P1239, DOI 10.1016/j.jhep.2018.01.015
   Zelber-Sagi S, 2017, LIVER INT, V37, P936, DOI 10.1111/liv.13435
   Zelber-Sagi S, 2016, THER ADV GASTROENTER, V9, P392, DOI 10.1177/1756283X16638830
   Zelber-Sagil S, 2007, J HEPATOL, V47, P711, DOI 10.1016/j.jhep.2007.06.020
NR 56
TC 87
Z9 89
U1 3
U2 15
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0017-5749
EI 1468-3288
J9 GUT
JI Gut
PD JUN
PY 2019
VL 68
IS 6
BP 1088
EP 1098
DI 10.1136/gutjnl-2017-315940
PG 11
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA ID7AF
UT WOS:000471832900018
PM 30064987
DA 2024-02-19
ER

PT J
AU Qin, X
   Zhang, YJ
   Lu, J
   Huang, SB
   Liu, ZJ
   Wang, X
AF Qin, Xuan
   Zhang, Yuanjin
   Lu, Jian
   Huang, Shengbo
   Liu, Zongjun
   Wang, Xin
TI CYP3A deficiency alters bile acid homeostasis and leads to changes in
   hepatic susceptibility in rats
SO TOXICOLOGY AND APPLIED PHARMACOLOGY
LA English
DT Article; Early Access
DE Cytochrome P450 3A; Bile acids; Cholesterol; Homeostasis regulator; Gene
   knockout rats
ID VITAMIN-D-RECEPTOR; SPECIES-DIFFERENCES; HUMAN HEPATOCYTES; LITHOCHOLIC
   ACID; CHOLESTEROL; METABOLISM; MOUSE; FXR; INHIBITION; EXPRESSION
AB Cytochrome P450 3A (CYP3A) as an important enzyme metabolizes many drugs and a variety of endogenous substances. Bile acids (BA) regulate physiological function by activating BA receptors. In this study, CYP3A1/2 gene knockout (KO) and wild-type (WT) rats were used to investigate the regulatory effects of CYP3A on BA homeostasis and liver function. Compared with WT rats, BA concentrations in serum, liver and small intestine of CYP3A1/2 KO rats increased significantly, which was due to the decrease of catabolism and the increase of synthesis. In particular, the composition of serum BA (overall hydrophobicity) presented an age- and CYP3Adependent manner. With the aging of WT rats, the serum BA became more hydrophobic, while this trend was delayed in CYP3A1/2 KO rats. Moreover, the level of serum total cholesterol, the precursor of BA synthesis, decreased by about 20% in CYP3A1/2 KO rats, which is due to the low synthesis but high biotransformation rate. The increase of BA pool further led to the change of transcription level of BA receptor in liver (pregnane X receptor) and small intestine (Takeda G-protein receptor 5), and affected the function and morphology of CYP3A1/ 2 KO rat liver. In conclusion, CYP3A is a key regulator of BA homeostasis in rats, especially in regulating BA pool size, composition and balance of anabolism, and prevents susceptibility to hepatotoxicity under BA overload.
C1 [Qin, Xuan; Zhang, Yuanjin; Lu, Jian; Huang, Shengbo; Wang, Xin] East China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai, Peoples R China.
   [Qin, Xuan; Zhang, Yuanjin; Lu, Jian; Huang, Shengbo; Wang, Xin] East China Normal Univ, Sch Life Sci, Shanghai, Peoples R China.
   [Qin, Xuan] Baylor Coll Med, Dept Pathol & Immunol, Ctr Drug Discovery, Houston, TX 77030 USA.
   [Liu, Zongjun] Shanghai Univ Tradit Chinese Med, Cent Hosp Shanghai Putuo Dist, Dept Cardiol, Shanghai, Peoples R China.
C3 East China Normal University; East China Normal University; Baylor
   College of Medicine; Shanghai University of Traditional Chinese Medicine
RP Wang, X (corresponding author), East China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai, Peoples R China.; Wang, X (corresponding author), East China Normal Univ, Sch Life Sci, Shanghai, Peoples R China.
EM lzj72@126.com; xwang@bio.ecnu.edu.cn
RI Wang, Xin/B-6572-2011; ZHU, BIN/IYJ-3847-2023
OI Wang, Xin/0000-0001-8079-8638; Qin, Xuan/0000-0003-3728-5911; Lu,
   Jian/0000-0002-0267-9243
FU National Natural Science Foundation of China [81773808]; Science and
   Technology Commission of Shanghai Municipality [18430760400];
   Fundamental Research Funds for the Central Universities; ECNU
   Multifunctional Platform for Innovation [011]; Instruments Sharing
   Platform of School of Life Sciences, East China Normal University
FX This work was supported in whole or part by grants from the Na-tional
   Natural Science Foundation of China (81773808) , the Science and
   Technology Commission of Shanghai Municipality (18430760400) , and the
   Fundamental Research Funds for the Central Universities. This work was
   also supported from ECNU Multifunctional Platform for Innovation (011)
   and the Instruments Sharing Platform of School of Life Sciences, East
   China Normal University.
CR Ahmad F, 2019, CANCERS, V11, DOI 10.3390/cancers11020146
   Bodin K, 2005, BBA-MOL CELL BIOL L, V1687, P84, DOI 10.1016/j.bbalip.2004.11.003
   Cheng J, 2014, J LIPID RES, V55, P455, DOI 10.1194/jlr.M044420
   Cheng Q, 2012, J BIOL CHEM, V287, P29554, DOI 10.1074/jbc.M112.390047
   Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200
   Dawson PA, 2009, J LIPID RES, V50, P2340, DOI 10.1194/jlr.R900012-JLR200
   Ferrell JM, 2016, J LIPID RES, V57, P1144, DOI 10.1194/jlr.M064709
   Fukumori S, 2007, DRUG METAB PHARMACOK, V22, P377, DOI 10.2133/dmpk.22.377
   Guo C, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00646
   Hashimoto M, 2013, J LIPID RES, V54, P2060, DOI 10.1194/jlr.M033464
   HEUMAN DM, 1989, J LIPID RES, V30, P719
   Joyce SA, 2016, ANNU REV FOOD SCI T, V7, P313, DOI 10.1146/annurev-food-041715-033159
   Khan AA, 2011, TOXICOL IN VITRO, V25, P80, DOI 10.1016/j.tiv.2010.09.011
   Landrier JF, 2006, AM J PHYSIOL-GASTR L, V290, pG476, DOI 10.1152/ajpgi.00430.2005
   Lee EA, 2018, BBA-MOL CELL BIOL L, V1863, P20, DOI 10.1016/j.bbalip.2017.08.007
   Lee JY, 2013, J LIPID RES, V54, P3062, DOI 10.1194/jlr.M039834
   Li JN, 2019, BBA-MOL BASIS DIS, V1865, P895, DOI 10.1016/j.bbadis.2018.05.011
   Li-Hawkins J, 2002, J CLIN INVEST, V110, P1191, DOI 10.1172/JCI200216309
   Lin QH, 2020, DRUG METAB DISPOS, V48, P499, DOI 10.1124/dmd.120.090464
   Lorbek G, 2012, FEBS J, V279, P1516, DOI 10.1111/j.1742-4658.2011.08432.x
   Lu J, 2017, SCI REP-UK, V7, DOI 10.1038/srep42922
   Ma XR, 2020, ACTA PHARMACOL SIN B, V10, P850, DOI 10.1016/j.apsb.2019.11.007
   Mao JL, 2017, DRUG METAB REV, V49, P18, DOI 10.1080/03602532.2016.1239630
   Martignoni M, 2006, EXPERT OPIN DRUG MET, V2, P875, DOI 10.1517/17425255.2.6.875
   Morgan RE, 2010, TOXICOL SCI, V118, P485, DOI 10.1093/toxsci/kfq269
   Nishioka T, 1999, BIOCHEM J, V340, P445, DOI 10.1042/0264-6021:3400445
   Pavek P, 2010, BIOCHEM PHARMACOL, V79, P277, DOI 10.1016/j.bcp.2009.08.017
   Pellicoro A, 2007, HEPATOLOGY, V45, P340, DOI 10.1002/hep.21528
   Petrov PD, 2020, ARCH TOXICOL, V94, P589, DOI 10.1007/s00204-019-02643-y
   Qin X, 2019, ACTA PHARM SIN B, V9, P1087, DOI 10.1016/j.apsb.2019.03.005
   Qin X, 2017, BIOCHEM PHARMACOL, V143, P129, DOI 10.1016/j.bcp.2017.07.013
   Qin X, 2016, PHARMACOL RES, V106, P114, DOI 10.1016/j.phrs.2016.02.021
   Rendic S, 2015, CHEM RES TOXICOL, V28, P38, DOI 10.1021/tx500444e
   Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003
   Singh M, 2013, BBA-BIOMEMBRANES, V1828, P1926, DOI 10.1016/j.bbamem.2013.04.003
   Slijepcevic D, 2017, HEPATOLOGY, V66, P1631, DOI 10.1002/hep.29251
   Song KH, 2009, HEPATOLOGY, V49, P297, DOI 10.1002/hep.22627
   Stenman LK, 2013, AM J PHYSIOL-GASTR L, V304, pG227, DOI 10.1152/ajpgi.00267.2012
   Vallim TQD, 2013, CELL METAB, V17, P657, DOI 10.1016/j.cmet.2013.03.013
   Volle DH, 2007, GENE DEV, V21, P303, DOI 10.1101/gad.409307
   Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705
   Woolbright BL, 2015, TOXICOL APPL PHARM, V283, P168, DOI 10.1016/j.taap.2015.01.015
   Xu Y, 2016, HEPATOLOGY, V64, P1072, DOI 10.1002/hep.28712
NR 43
TC 8
Z9 8
U1 1
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0041-008X
EI 1096-0333
J9 TOXICOL APPL PHARM
JI Toxicol. Appl. Pharmacol.
PD 2021 OCT 15
PY 2021
VL 429
AR 115703
DI 10.1016/j.taap.2021.115703
EA SEP 2021
PG 12
WC Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Toxicology
GA WH0MJ
UT WOS:000707383000001
PM 34461081
DA 2024-02-19
ER

PT J
AU Morrison, JP
   Coleman, MC
   Aunan, ES
   Walsh, SA
   Spitz, DR
   Kregel, KC
AF Morrison, JP
   Coleman, MC
   Aunan, ES
   Walsh, SA
   Spitz, DR
   Kregel, KC
TI Aging reduces responsiveness to BSO- and heat stress-induced
   perturbations of glutathione and antioxidant enzymes
SO AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE
   PHYSIOLOGY
LA English
DT Article
DE buthionine-L-sulfoximine; hyperthermia; reactive oxygen species
ID GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; OXIDATIVE STRESS; BUTHIONINE
   SULFOXIMINE; SUPEROXIDE-DISMUTASE; HYDROGEN-PEROXIDE;
   LIPID-PEROXIDATION; RATS; AGE; LIVER; EXPRESSION
AB Aging alters cellular responses to both heat and oxidative stress. Thiol-mediated metabolism of reactive oxygen species (ROS) is believed to be important in aging. To begin to determine the role of thiols in aging and heat stress, we depleted liver glutathione (GSH) by administering L-buthionine sulfoximine (BSO) in young (6 mo) and old (24 mo) Fisher 344 rats before heat stress. Animals were given BSO (4 mmol/kg ip) or saline (1 ml ip) 2 h before heat stress and subsequently heated to a core temperature of 41 degrees C over a 90-min period. Liver tissue was collected before and 0, 30, and 60 min after heat stress. BSO inhibited glutamate cysteine ligase (GCL, the rate-limiting enzyme in GSH synthesis) catalytic activity and resulted in a decline in liver GSH and GSSG that was more pronounced in young compared with old animals. Catalase activity did not change between groups until 60 min after heat stress in young BSO-treated rats. Young animals experienced a substantial and persistent reduction in Cu, Zn-SOD activity with BSO treatment. Mn-SOD activity increased with BSO but declined after heat stress. The differences in thiol depletion observed between young and old animals with BSO treatment may be indicative of age-related differences in GSH compartmentalization that could have an impact on maintenance of redox homeostasis and antioxidant balance immediately after a physiologically relevant stress. The significant changes in antioxidant enzyme activity after GSH depletion suggest that thiol status can influence the regulation of other antioxidant enzymes.
C1 Univ Iowa, Integrat Physiol Lab, Dept Exercise Sci, Iowa City, IA 52242 USA.
   Univ Iowa, Free Radical & Radiat Biol Program, Dept Radiat Oncol, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA.
C3 University of Iowa; University of Iowa
RP Kregel, KC (corresponding author), Univ Iowa, Integrat Physiol Lab, Dept Exercise Sci, 532 FH, Iowa City, IA 52242 USA.
EM kevin-kregel@uiowa.edu
OI Coleman, Mitchell/0000-0002-5116-801X; Cramer,
   Elizabeth/0000-0001-6205-9444; Morrison, Jo/0000-0001-7858-4876; Spitz,
   Douglas/0000-0002-1254-8765
FU NCI NIH HHS [P01-CA-66081, R01-CA-100045] Funding Source: Medline; NHLBI
   NIH HHS [R01-HL-51469] Funding Source: Medline; NIA NIH HHS
   [R01-AG-12350] Funding Source: Medline
CR Armeni T, 1998, MECH AGEING DEV, V101, P101, DOI 10.1016/S0047-6374(97)00167-X
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   BEERS RF, 1952, J BIOL CHEM, V195, P133
   Bejma J, 2000, ACTA PHYSIOL SCAND, V169, P343
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   Brown KE, 1998, FREE RADICAL BIO MED, V24, P545, DOI 10.1016/S0891-5849(97)00284-0
   Cao LC, 2004, J STEROID BIOCHEM, V88, P61, DOI 10.1016/j.jsbmb.2003.10.007
   Davidson JF, 2001, MOL CELL BIOL, V21, P8483, DOI 10.1128/MCB.21.24.8483-8489.2001
   DogruAbbasoglu S, 1997, MECH AGEING DEV, V98, P177, DOI 10.1016/S0047-6374(97)00082-1
   Erden-Inal M, 2002, CELL BIOCHEM FUNCT, V20, P61, DOI 10.1002/cbf.937
   FREEMAN ML, 1988, RADIAT RES, V115, P461, DOI 10.2307/3577295
   GOPALANKRICZKY P, 1994, CANCER LETT, V76, P25, DOI 10.1016/0304-3835(94)90130-9
   GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6
   Hall DM, 2000, FASEB J, V14, P78, DOI 10.1096/fasebj.14.1.78
   Hall DM, 2000, J APPL PHYSIOL, V89, P749, DOI 10.1152/jappl.2000.89.2.749
   HODGSON EK, 1975, BIOCHEMISTRY-US, V14, P5294, DOI 10.1021/bi00695a010
   Hu HL, 2000, MECH AGEING DEV, V121, P217
   HUANG CS, 1988, P NATL ACAD SCI USA, V85, P2464, DOI 10.1073/pnas.85.8.2464
   HUM S, 1991, CAN J PHYSIOL PHARM, V69, P581, DOI 10.1139/y91-085
   Jang IS, 2001, MECH AGEING DEV, V122, P561, DOI 10.1016/S0047-6374(01)00236-6
   Kang YJ, 1996, BIOCHEM PHARMACOL, V51, P567, DOI 10.1016/0006-2952(95)02221-X
   KERA Y, 1989, ALCOHOL ALCOHOLISM, V24, P519, DOI 10.1093/oxfordjournals.alcalc.a044954
   Kregel KC, 1996, J APPL PHYSIOL, V80, P547, DOI 10.1152/jappl.1996.80.2.547
   Leichtweis S, 2001, MECH AGEING DEV, V122, P503, DOI 10.1016/S0047-6374(00)00253-0
   Liu RM, 2000, FREE RADICAL BIO MED, V28, P566, DOI 10.1016/S0891-5849(99)00269-5
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MARTENSSON J, 1991, P NATL ACAD SCI USA, V88, P9360, DOI 10.1073/pnas.88.20.9360
   MEISTER A, 1995, METHOD ENZYMOL, V252, P26
   Mérad-Saïdoune M, 1999, EXP NEUROL, V158, P428, DOI 10.1006/exnr.1999.7108
   Mockett RJ, 1999, ARCH BIOCHEM BIOPHYS, V371, P260, DOI 10.1006/abbi.1999.1460
   Mockett RJ, 2003, FREE RADICAL BIO MED, V34, P207, DOI 10.1016/S0891-5849(02)01190-5
   Nakata K, 1996, MECH AGEING DEV, V90, P195, DOI 10.1016/0047-6374(96)01771-X
   NARDI G, 1990, J CHROMATOGR-BIOMED, V530, P122, DOI 10.1016/S0378-4347(00)82310-5
   Orr WC, 2003, EXP GERONTOL, V38, P227, DOI 10.1016/S0531-5565(02)00263-2
   Palomero J, 2001, FREE RADICAL BIO MED, V30, P836, DOI 10.1016/S0891-5849(01)00471-3
   Pansarasa O, 1999, FREE RADICAL BIO MED, V27, P617, DOI 10.1016/S0891-5849(99)00108-2
   Piwien-Pilipuk G, 2000, BBA-MOL CELL RES, V1495, P263, DOI 10.1016/S0167-4889(99)00166-4
   Ridnour LA, 2005, FREE RADICAL BIO MED, V38, P1361, DOI 10.1016/j.freeradbiomed.2005.01.023
   Roychowdhury S, 2003, NITRIC OXIDE-BIOL CH, V8, P39, DOI 10.1016/S1089-8603(02)00146-5
   Sancho P, 2003, MOL PHARMACOL, V63, P581, DOI 10.1124/mol.63.3.581
   Sanz N, 2002, BBA-MOL BASIS DIS, V1587, P12, DOI 10.1016/S0925-4439(02)00048-0
   Sanz N, 1997, J HEPATOL, V27, P525, DOI 10.1016/S0168-8278(97)80358-3
   SEN CK, 1994, J APPL PHYSIOL, V77, P2177, DOI 10.1152/jappl.1994.77.5.2177
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P575, DOI 10.1016/S0891-5849(02)00886-9
   SPITZ DR, 1990, ARCH BIOCHEM BIOPHYS, V279, P249, DOI 10.1016/0003-9861(90)90489-L
   SPITZ DR, 2001, CURRENT PROTOCOLS S, V8
   STANDEVEN AM, 1991, TOXICOL APPL PHARM, V107, P269, DOI 10.1016/0041-008X(91)90208-V
   STANDEVEN AM, 1991, PHARMACOL TOXICOL, V68, P469, DOI 10.1111/j.1600-0773.1991.tb01272.x
   Sun JT, 2002, GENETICS, V161, P661
   SUZUKI CAM, 1990, TOXICOLOGY, V64, P113, DOI 10.1016/0300-483X(90)90129-5
   Tsong TY, 1999, ANN NY ACAD SCI, V888, P211, DOI 10.1111/j.1749-6632.1999.tb07958.x
   TSUJI K, 1992, CANCER LETT, V66, P249, DOI 10.1016/0304-3835(92)90254-S
   Vergauwen B, 2003, J BACTERIOL, V185, P5555, DOI 10.1128/JB.185.18.5555-5562.2003
   YEUNG JHK, 1990, BIOCHEM PHARMACOL, V40, P1235, DOI 10.1016/0006-2952(90)90388-2
   Zhang HJ, 2004, FASEB J, V18, P1547, DOI 10.1096/fj.04-1629fje
   Zhang HJ, 2003, FASEB J, V17, P2293, DOI 10.1096/fj.03-0139fje
NR 56
TC 20
Z9 22
U1 0
U2 7
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0363-6119
EI 1522-1490
J9 AM J PHYSIOL-REG I
JI Am. J. Physiol.-Regul. Integr. Comp. Physiol.
PD OCT
PY 2005
VL 289
IS 4
BP R1035
EP R1041
DI 10.1152/ajpregu.00254.2005
PG 7
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA 966RC
UT WOS:000232037600015
PM 15947071
DA 2024-02-19
ER

PT J
AU Chang, RCC
   So, KF
AF Chang, Raymond Chuen-Chung
   So, Kwok-Fai
TI Use of anti-aging herbal medicine, <i>Lycium barbarum</i>, against
   aging-associated diseases.: What do we know so far?
SO CELLULAR AND MOLECULAR NEUROBIOLOGY
LA English
DT Article
DE Lycium barbsarum; anti-aging; neuroprotection; herbal medicine;
   polysaccharides
ID EUKARYOTIC INITIATION FACTOR-2-ALPHA; POLYSACCHARIDE-PROTEIN COMPLEX;
   OXIDATIVE STRESS; GANODERMA-LUCIDUM; NEURONAL DEGENERATION; STRUCTURAL
   FEATURES; INDUCED DAMAGE; FRUCTUS-LYCII; DNA-DAMAGE; ZEAXANTHIN
AB Lycium barbarum (Gouqizi, Fructus Lycii, Wolfberry) is well known for nourishing the liver, and in turn, improving the eyesight. However, many people have forgotten its anti-aging properties. Valuable components of L. barbarum are not limited to its colored components containing zeaxanthin and carotene, but include the polysaccharides and small molecules such as betaine, cerebroside, beta-sitosterol, p-coumaric, and various vitamins. Despite the fact that L. barbarum has been used for centuries, its beneficial effects to our bodies have not been comprehensively studied with modern technology to unravel its therapeutic effects at the biochemical level. Recently, our laboratory has demonstrated its neuroprotective effects to counter neuronal loss in neurodegenerative diseases. Polysaccharides extracted from L. barbarum can protect neurons against beta-amyloid peptide toxicity in neuronal cell cultures, and retinal ganglion cells in an experimental model of glaucoma. We have even isolated the active component of polysaccharide which can attenuate stress kinases and pro-apoptotic signaling pathways. We have accumulated scientific evidence for its anti-aging effects that should be highlighted for modern preventive medicine. This review is to provide background information and a new direction of study for the anti-aging properties of L. barbarum. We hope that new findings for L. barbarum will pave a new avenue for the use of Chinese medicine in modern evidence-based medicine.
C1 [Chang, Raymond Chuen-Chung; So, Kwok-Fai] Univ Hong Kong, LKS Fac Med, Dept Anat, Lab Neurodegenerat Dis, Pokfulam, Hong Kong, Peoples R China.
   [Chang, Raymond Chuen-Chung; So, Kwok-Fai] Univ Hong Kong, LKS Fac Med, Res Ctr Heart Brain Hormone & Healthy Aging, Pokfulam, Hong Kong, Peoples R China.
   [Chang, Raymond Chuen-Chung] Fac Med Building, Pokfulam, Hong Kong, Peoples R China.
C3 University of Hong Kong; University of Hong Kong
RP Chang, RCC (corresponding author), Univ Hong Kong, LKS Fac Med, Dept Anat, Lab Neurodegenerat Dis, Pokfulam, Hong Kong, Peoples R China.
EM rccchang@hkucc.hku.hk; hrmaskf@hkucc.hku.hk
RI Chang, Raymond Chuen-Chung/C-1107-2009
OI Chang, Raymond Chuen-Chung/0000-0001-8538-7993; So,
   Kwok-Fai/0000-0003-4039-4246
CR Bao XF, 2001, CARBOHYD RES, V332, P67, DOI 10.1016/S0008-6215(01)00075-1
   Bao XF, 2002, PHYTOCHEMISTRY, V59, P175, DOI 10.1016/S0031-9422(01)00450-2
   Benzie IFF, 2006, BRIT J NUTR, V96, P154, DOI 10.1079/BJN20061796
   Butovsky O, 2006, P NATL ACAD SCI USA, V103, P11784, DOI 10.1073/pnas.0604681103
   CAO GW, 1994, CHINESE J ONCOL, V16, P428
   Chan HC, 2007, EXP NEUROL, V203, P269, DOI 10.1016/j.expneurol.2006.05.031
   Chang RCC, 2002, NEUROREPORT, V13, P2429, DOI 10.1097/00001756-200212200-00011
   Chang RCC, 2002, J NEUROCHEM, V83, P1215, DOI 10.1046/j.1471-4159.2002.01237.x
   Chen HS, 2004, BIOORGAN MED CHEM, V12, P5595, DOI 10.1016/j.bmc.2004.08.003
   Cheng CY, 2005, BRIT J NUTR, V93, P123, DOI 10.1079/BJN20041284
   CHIU K, 2005, SOC NEUR ABSTR, V35, P977
   Choi S, 2002, PLANTA MED, V68, P330, DOI 10.1055/s-2002-26750
   DAI S, 1994, GERIATRIC ZA ZHI, V14, P33
   Deng HB, 2003, BIOMED ENVIRON SCI, V16, P267
   Duan Chang-ling, 2001, Yaoxue Xuebao, V36, P196
   Frasca D, 2005, SEMIN IMMUNOL, V17, P378, DOI 10.1016/j.smim.2005.05.005
   Gan L, 2004, INT IMMUNOPHARMACOL, V4, P563, DOI 10.1016/j.intimp.2004.01.023
   Gan L, 2003, EUR J PHARMACOL, V471, P217, DOI 10.1016/S0014-2999(03)01827-2
   [甘璐 Gan Lu], 2002, [营养学报, Acta Nutrimenta Sinica], V24, P67
   Go EK, 2005, J GERONTOL A-BIOL, V60, P1252, DOI 10.1093/gerona/60.10.1252
   Ha KT, 2005, J ETHNOPHARMACOL, V96, P529, DOI 10.1016/j.jep.2004.09.054
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Hu G., 1995, CHINESE J IMMUNOL, V11, P253
   Huang Lin-juan, 2001, Yaoxue Xuebao, V36, P108
   Huang Xiaolan, 2003, Wei Sheng Yan Jiu, V32, P599
   Huang YH, 1998, J GASTROENTEROL, V33, P512, DOI 10.1007/s005350050124
   Kanski J, 2002, J NUTR BIOCHEM, V13, P273, DOI 10.1016/S0955-2863(01)00215-7
   Kim SY, 1999, BIOL PHARM BULL, V22, P873, DOI 10.1248/bpb.22.873
   Knopman D, 2001, ALZ DIS ASSOC DIS, V15, P162, DOI 10.1097/00002093-200107000-00008
   Kuroiwa A, 2004, INT IMMUNOPHARMACOL, V4, P317, DOI 10.1016/j.intimp.2003.12.004
   Li XM, 2007, INT J BIOL MACROMOL, V40, P461, DOI 10.1016/j.ijbiomac.2006.11.002
   Li XM, 2007, J ETHNOPHARMACOL, V111, P504, DOI 10.1016/j.jep.2006.12.024
   Lin ZB, 2004, ACTA PHARMACOL SIN, V25, P1387
   Luo Q, 2004, LIFE SCI, V76, P137, DOI 10.1016/j.lfs.2004.04.056
   Luo Q, 2006, LIFE SCI, V79, P613, DOI 10.1016/j.lfs.2006.02.012
   Park Mi Jung, 1994, Archives of Pharmacal Research (Seoul), V17, P343, DOI 10.1007/BF02974174
   PENG XD, 2002, J NINGXIA MED COLL, V24, P79
   Peng XM, 2001, CHINESE J CHEM, V19, P1190
   Peng Y, 2005, PLANT FOOD HUM NUTR, V60, P161, DOI 10.1007/s11130-005-9550-5
   Poon HF, 2004, J GERONTOL A-BIOL, V59, P478
   Qin XM, 2001, CARBOHYD RES, V333, P79, DOI 10.1016/S0008-6215(01)00118-5
   Ren Binbin, 1995, Zhongguo Zhongyao Zazhi, V20, P303
   Schwartz M, 2005, J NEUROL SCI, V233, P163, DOI 10.1016/j.jns.2005.03.014
   SELKOE DJ, 1993, TRENDS NEUROSCI, V16, P403, DOI 10.1016/0166-2236(93)90008-A
   SO KF, 2005, P 4 AS PAC INT C AN, P37
   SONG Y, 1995, J NINGXIA MED COLL, V17, P12
   Squier TC, 2001, EXP GERONTOL, V36, P1539, DOI 10.1016/S0531-5565(01)00139-5
   Suen KC, 2003, J BIOL CHEM, V278, P49819, DOI 10.1074/jbc.M306503200
   Sullivan PG, 2005, PROG NEURO-PSYCHOPH, V29, P407, DOI 10.1016/j.pnpbp.2004.12.007
   Tan BKH, 2004, CURR MED CHEM, V11, P1423, DOI 10.2174/0929867043365161
   [王建华 Wang Jianhua], 2002, [营养学报, Acta Nutrimenta Sinica], V24, P189
   WANG L, 1995, ACAD J KUMMING MED C, V16, P29
   Wang YR, 2002, J ETHNOPHARMACOL, V82, P169, DOI 10.1016/S0378-8741(02)00169-1
   [汪朝阳 WANG Zhaoyang], 2003, [眼视光学杂志, Chinese Journal of Optometry & Ophthalmology], V5, P147
   Wu H, 2006, YAKUGAKU ZASSHI, V126, P365, DOI 10.1248/yakushi.126.365
   Wu SJ, 2004, PHYTOTHER RES, V18, P1008, DOI 10.1002/ptr.1617
   XIE C, 2001, J CHIN MAT MED, V26, P323
   Xu Rui-rong, 2004, Zhongguo Zhong Xi Yi Jie He Za Zhi, V24, P411
   Yankner BA, 1996, NEURON, V16, P921, DOI 10.1016/S0896-6273(00)80115-4
   Yu MS, 2007, INT J MOL MED, V20, P261
   Yu MS, 2006, INT J MOL MED, V17, P1157
   Zhao H, 2005, PHYTOMEDICINE, V12, P131, DOI 10.1016/j.phymed.2003.08.002
   ZHAO X, 2001, J NEUROCHEM, V76, P435
   Zhu J, 2007, CELL BIOL INT, V31, P615, DOI 10.1016/j.cellbi.2006.12.002
   Zou S, 2000, P NATL ACAD SCI USA, V97, P13726, DOI 10.1073/pnas.260496697
NR 65
TC 251
Z9 278
U1 7
U2 116
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0272-4340
EI 1573-6830
J9 CELL MOL NEUROBIOL
JI Cell. Mol. Neurobiol.
PD AUG
PY 2008
VL 28
IS 5
BP 643
EP 652
DI 10.1007/s10571-007-9181-x
PG 10
WC Cell Biology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Neurosciences & Neurology
GA 320HC
UT WOS:000257223300002
PM 17710531
DA 2024-02-19
ER

PT J
AU JORQUERA, F
   ALMAR, MM
   POZUELO, M
   SANSEGUNDO, D
   GONZALEZSASTRE, M
   GONZALEZGALLEGO, J
AF JORQUERA, F
   ALMAR, MM
   POZUELO, M
   SANSEGUNDO, D
   GONZALEZSASTRE, M
   GONZALEZGALLEGO, J
TI EFFECTS OF AGING ON ANTIPYRINE CLEARANCE - PREDICTIVE FACTORS OF
   METABOLIZING CAPACITY
SO JOURNAL OF CLINICAL PHARMACOLOGY
LA English
DT Article
ID LIVER-DISEASE; AGE; DRUG; DISPOSITION; KINETICS; SMOKING; ELIMINATION;
   VOLUNTEERS; PLASMA; SALIVA
AB The purpose of this study was to identify variables that can account for the decline of antipyrine clearance (Cl-AP) in elderly adults and that may help predict a reduction in metabolizing capacity, For comparison, Cl-AP was determined in 177 elderly (mean age 82 years) and 25 young (mean age 29 years) volunteers. Antipyrine (1 g) was administered orally and Cl-AP was determined by the one-sample saliva method. Mean Cl-AP was reduced by 38% and antipyrine half-life increased by 64% in old subjects. Multiple regression analysis of Cl-AP revealed an independent value for age, serum aspartate transaminase (AST), and height in the elderly. The independent variables collectively accounted for 27% of the variance explained, Age, high serum AST, use of diuretics, and no consumption of drugs known to stimulate oxidative metabolism were selected by multivariate analysis (logistic model) as independent predictors of a low metabolizing capacity. The findings indicate that factors other than age may contribute to impaired hepatic oxidative metabolism in the elderly.
C1 INSERSO,GERIATR UNIT,VALLADOLID,SPAIN.
   HOSP INSALUD,GASTROENTEROL UNIT,LEON,SPAIN.
RP JORQUERA, F (corresponding author), UNIV LEON,DEPT PHYSIOL PHARMACOL & TOXICOL,E-24071 LEON,SPAIN.
RI Gonzalez-Gallego, Javier/D-8219-2012; Jorquera, Francisco/ABH-3830-2020;
   Dufour, Jean Francois Jacques/AAL-9866-2020; Almar, Mar/L-3098-2017
OI Gonzalez-Gallego, Javier/0000-0002-4386-9342; Jorquera,
   Francisco/0000-0002-1799-2881; Dufour, Jean Francois
   Jacques/0000-0002-8062-1346; Almar, Mar/0000-0001-6131-7659
CR BACH B, 1981, CLIN PHARMACOKINET, V6, P389, DOI 10.2165/00003088-198106050-00005
   DANHOF M, 1979, PHARMACOLOGY, V18, P210, DOI 10.1159/000137254
   DOSSING M, 1982, CLIN PHARMACOL THER, V32, P392, DOI 10.1038/clpt.1982.177
   FRASER HS, 1976, BRIT J CLIN PHARMACO, V3, P321, DOI 10.1111/j.1365-2125.1976.tb00610.x
   FRASER HS, 1976, BRIT MED J, V8, P1507
   GREENBLATT DJ, 1982, NEW ENGL J MED, V306, P1081
   GREENBLATT DJ, 1982, J PHARMACOL EXP THER, V220, P120
   HUFFMAN DH, 1973, PHARMACOLOGY, V10, P338, DOI 10.1159/000136455
   LOFT S, 1988, HUM TOXICOL, V7, P277, DOI 10.1177/096032718800700309
   MUCKLOW JC, 1980, BRIT J CLIN PHARMACO, V9, P613, DOI 10.1111/j.1365-2125.1980.tb01089.x
   MURALI KV, 1983, CLIN EXP PHARMACOL P, V10, P7, DOI 10.1111/j.1440-1681.1983.tb00165.x
   OMALLEY K, 1971, BMJ-BRIT MED J, V3, P607, DOI 10.1136/bmj.3.5775.607
   POSNER J, 1987, BRIT J CLIN PHARMACO, V24, P51, DOI 10.1111/j.1365-2125.1987.tb03135.x
   POULSEN HE, 1988, J HEPATOL, V6, P374, DOI 10.1016/S0168-8278(88)80057-6
   REICHLING JJ, 1988, DIGEST DIS SCI, V33, P1601, DOI 10.1007/BF01535953
   SCHENKER S, 1994, J CLIN GASTROENTEROL, V18, P232, DOI 10.1097/00004836-199404000-00013
   SHOBHA JC, 1991, EUR J CLIN PHARMACOL, V41, P359, DOI 10.1007/BF00314968
   SIEGMUND W, 1991, INT J CLIN PHARM TH, V29, P469
   SOTANIEMI EA, 1983, ACTA ENDOCRINOL-COP, V262, P125
   STPETER JV, 1991, CLIN PHARMACOKINET, V20, P50, DOI 10.2165/00003088-199120010-00004
   SULTATOS LG, 1980, CLIN PHARMACOKINET, V5, P263, DOI 10.2165/00003088-198005030-00005
   TEUNISSEN MWE, 1983, J CHROMATOGR, V278, P367, DOI 10.1016/S0378-4347(00)84796-9
   TEUNISSEN MWE, 1982, CLIN PHARMACOL THER, V32, P240, DOI 10.1038/clpt.1982.154
   VESELL ES, 1971, CLIN PHARMACOL THER, V12, P192
   VESELL ES, 1993, CLIN PHARMACOL THER, V54, P150, DOI 10.1038/clpt.1993.126
   VESTAL RE, 1975, CLIN PHARMACOL THER, V18, P425
   VESTAL RE, 1980, CLIN PHARMACOKINET, V5, P309, DOI 10.2165/00003088-198005040-00001
   WOOD AJJ, 1979, CLIN PHARMACOL THER, V26, P16
NR 28
TC 9
Z9 9
U1 0
U2 0
PU LIPPINCOTT-RAVEN PUBL
PI PHILADELPHIA
PA 227 EAST WASHINGTON SQUARE, PHILADELPHIA, PA 19106
SN 0091-2700
J9 J CLIN PHARMACOL
JI J. Clin. Pharmacol.
PD SEP
PY 1995
VL 35
IS 9
BP 895
EP 901
DI 10.1002/j.1552-4604.1995.tb04134.x
PG 7
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA RX472
UT WOS:A1995RX47200006
PM 8786249
DA 2024-02-19
ER

PT J
AU Vujcic, M
   Terzic, N
   Ristic-Fira, A
   Kanazir, D
   Ruzdijic, S
AF Vujcic, M
   Terzic, N
   Ristic-Fira, A
   Kanazir, D
   Ruzdijic, S
TI Analysis of nuclear glucocorticoid receptor-DNA interaction in aged rat
   liver
SO JOURNAL OF THE SERBIAN CHEMICAL SOCIETY
LA English
DT Article
DE ageing; liver; glucocorticoid receptor; GRE; EMSA
ID MUTUAL INHIBITION; BINDING; PROTEIN; MECHANISMS; HORMONES
AB In order to contribute to the understanding of mechanisms by which regulatory proteins recognize genetic information stored in DNA, analyses of their interaction with specific nucleotides are usually performed. In this study, the electrophoretic mobility shift assay (EMSA) was applied to analyze the interaction of nuclear proteins from the liver of rats of different age i.e., young (3-month-old), middle-aged (12-month-old) and aged (24-month-old), with radioactively labelled synthetic oligonucleotide analogues, corresponding to GRE. The levels of GRE binding activity were assessed by quantitative densitometric scanning of the autoradiograms. The results showed statistically significant decreasing values of up to 78% and 49% in middle aged and old animals, respectively, compared to young animals (p < 0.05). The specificity of the nuclear proteins-GRE interaction was demonstrated by competition experiments with unlabelled GRE. In a supershift assay, using the antibody BuGR2, it was shown that the GR proteins present in nuclear extracts have a high affinity for the GRE probe. The stabilities of the protein-DNA complexes were analysed and it was concluded that they changed during ageing.
C1 Inst Chem Technol & Met, Dept Chem, Belgrade 11001, Serbia Monteneg.
   Vinca Inst Nucl Sci, Belgrade 11000, Serbia Monteneg.
   Serbian Acad Sci & Art, Belgrade 11000, Serbia Monteneg.
   Inst Biol Res Dr Sinisa Stankovic, Belgrade 11000, Serbia Monteneg.
C3 University of Belgrade; Serbian Academy of Sciences & Arts
RP Vujcic, M (corresponding author), Inst Chem Technol & Met, Dept Chem, Njegoseva 12,POB 473, Belgrade 11001, Serbia Monteneg.
EM mvujcic@chem.bg.ac.yu
RI Ristić-Fira, Aleksandra/AAX-8724-2020
OI Ristic-Fira, Aleksandra/0000-0002-8002-8470; Vujcic,
   Miroslava/0000-0001-6375-0309; Terzic-Jovanovic,
   Natasa/0000-0002-4127-525X
CR ARMANINI D, 1999, J STEROID BIOCHEM, V45, P191
   BEATO M, 1989, J STEROID BIOCHEM, V32, P737, DOI 10.1016/0022-4731(89)90521-9
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Chen SY, 1997, J BIOL CHEM, V272, P14087, DOI 10.1074/jbc.272.22.14087
   Djordjevic-Markovic R, 1999, EXP GERONTOL, V34, P971, DOI 10.1016/S0531-5565(99)00067-4
   DROUIN J, 1992, MOL ENDOCRINOL, V6, P1299, DOI 10.1210/me.6.8.1299
   ERLMANN T, 1990, J BIOL CHEM, V265, P17222
   FAGART J, 2002, MOL MECH ACTION STER, P77
   GARNER MM, 1981, NUCLEIC ACIDS RES, V9, P3047, DOI 10.1093/nar/9.13.3047
   GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2
   LARSON JC, 1996, BIOORGANIC CHEM NUCL, P324
   Lieberman BA, 1997, J BIOL CHEM, V272, P1061, DOI 10.1074/jbc.272.2.1061
   McKay LI, 1998, MOL ENDOCRINOL, V12, P45, DOI 10.1210/mend.12.1.0044
   Morin B, 2001, MOL ENDOCRINOL, V15, P458, DOI 10.1210/me.15.3.458
   Murphy EK, 2002, ENDOCRINOLOGY, V143, P1362, DOI 10.1210/en.143.4.1362
   Nichols NR, 1998, INTERD T GERONT GERI, V29, P1
   OKRET S, 1986, P NATL ACAD SCI USA, V83, P5899, DOI 10.1073/pnas.83.16.5899
   Roder K, 2001, BIOTECHNOL APPL BIOC, V33, P209, DOI 10.1042/BA20010007
   RUZDIJIC S, 2002, MOL MECH ACTION STER, P37
   Terzic N, 2003, J GERONTOL A-BIOL, V58, P297
   TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315
   YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V
NR 22
TC 2
Z9 2
U1 0
U2 0
PU SERBIAN CHEMICAL SOC
PI BELGRADE
PA KARNEGIJEVA 4, 11 120 BELGRADE, SERBIA
SN 0352-5139
J9 J SERB CHEM SOC
JI J. Serb. Chem. Soc.
PY 2005
VL 70
IS 5
BP 705
EP 712
DI 10.2298/JSC0505705V
PG 8
WC Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry
GA 943SY
UT WOS:000230375900004
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Xiong, ZW
   Yang, F
   Xu, TF
   Yang, Y
   Wang, FB
   Zhou, GB
   Wang, Q
   Guo, XW
   Xing, CH
   Bai, H
   Chen, J
   Wu, YH
   Yang, SQ
   Cao, HB
AF Xiong, Zhiwei
   Yang, Fan
   Xu, Tianfang
   Yang, Yan
   Wang, Feibing
   Zhou, Guangbin
   Wang, Qi
   Guo, Xiaowang
   Xing, Chenghong
   Bai, He
   Chen, Jing
   Wu, Yunhui
   Yang, Shuqiu
   Cao, Huabin
TI Selenium alleviates cadmium-induced aging via mitochondrial quality
   control in the livers of sheep
SO JOURNAL OF INORGANIC BIOCHEMISTRY
LA English
DT Article
DE Cadmium; Selenium; Liver; Aging; Mitochondrial quality control; Sheep
ID APOPTOSIS; CELLS
AB Cadmium (Cd) is a heavy metal with toxicity that induces mitochondrial dysfunction and aging, and selenium (Se) can alleviate its toxicity. However, the underlying mechanism of Se alleviating Cd-induced aging in sheep livers deserves further study. This study was to explore the protective mechanism of Se on the Cd-induced aging in the livers of sheep. A total of forty-eight sheep weighing about 10 kg were randomly divided into four groups: control group, Se group [0.34 mg Se center dot kg(-1)center dot body weight (BW)], Cd group (1 mg Cd center dot kg(-1)center dot BW), and Se + Cd group (0.34 mg Se center dot kg(-1)center dot BW +1 mg Cd center dot kg(-1)center dot BW). The results showed that Cd caused vacuolization, granule denaturation, and mitochondrial vacuolization in hepatocytes. Furthermore, the levels of catalase (CAT), total superoxide dismutase (T-SOD), glutathione (GSH) and adenosine triphosphate (ATP) in liver mitochondria were down regulated, but the levels of hydrogen peroxide (H2O2) and malonaldehyde (MDA) were up-regulated under Cd treatment. Besides, the cyclin-dependent kinase inhibitor 1 (P21) immunohistochemistry positive signal and the puncta of immunofluorescence co-locations of E3 ubiquitin ligase Parkin (Parkin)/ cytochrome c oxidase IV (COX IV) and light chain 3B (LC3B)/COX IV were increased under Cd stress. Moreover, Cd exposure decreased the levels of mitochondrial biogenesis and fusion related factors and minichromosome maintenance protein 2 (MCM2), but increased the levels of mitochondrial fission, mitophagy, and cell aging related factors. However, the variations mentioned above caused by Cd were effectively ameliorated by Se co-treatment. In conclusion, Se might alleviate Cd-induced aging via regulating mitochondrial quality control in sheep livers.
C1 [Xiong, Zhiwei; Yang, Fan; Xing, Chenghong; Bai, He; Chen, Jing; Wu, Yunhui; Yang, Shuqiu; Cao, Huabin] Jiangxi Agr Univ, Coll Anim Sci & Technol, Inst Anim Populat Hlth, Jiangxi Prov Key Lab Anim Hlth, 1101 Zhimin Ave, Nanchang 1101, Jiangxi, Peoples R China.
   [Xu, Tianfang; Yang, Yan] Jiangxi Agr Technol Extens Ctr, Nanchang 330096, Jiangxi, Peoples R China.
   [Wang, Feibing] Jinxi Cty Agr & Rural Bur, Agr Technol Extens Ctr, 89 Xiugu Middle Ave, Fuzhou 344800, Jiangxi, Peoples R China.
   [Zhou, Guangbin] Fengcheng Agr & Rural Bur, Anim Epidem Prevent & Quarantine Unit, Fengcheng 331100, Jiangxi, Peoples R China.
   [Wang, Qi] Nanchang Customs, Anim & Plant Quarantine Off, Nanchang 330009, Jiangxi, Peoples R China.
   [Guo, Xiaowang] Yichun Agr & Rural Affairs Bur, Yichun 336000, Jiangxi, Peoples R China.
C3 Jiangxi Agricultural University
RP Cao, HB (corresponding author), Jiangxi Agr Univ, Coll Anim Sci & Technol, Inst Anim Populat Hlth, Jiangxi Prov Key Lab Anim Hlth, 1101 Zhimin Ave, Nanchang 1101, Jiangxi, Peoples R China.
EM chbin20020804@jxau.edu.cn
RI Wang, lingyu/JLM-2013-2023; he, xi/JXN-3817-2024; peng,
   yan/JCO-1763-2023; li, wei/IUQ-2973-2023; Wang, Tianqi/JJD-7473-2023;
   li, bo/JJC-2664-2023; Wang, Luyao/JLL-2001-2023; Zhang,
   Lijun/JEZ-7925-2023; Yang, Fei/JLM-3367-2023; Yang, Tian/JFB-1008-2023;
   lin, qing/JED-5250-2023; Liu, Yujie/IWU-6535-2023; wang,
   KiKi/JFZ-3334-2023; wu, yunhui/JGD-6838-2023; zhang, zhi/HPH-4905-2023;
   liu, junyang/IXD-1252-2023; wang, chen/JED-7289-2023; Li,
   Xiaoli/JVZ-4089-2024; SUN, YANLING/JTT-9082-2023; liu,
   junyang/IXD-1201-2023; Gu, b/JNS-4761-2023; zhang, yimeng/JLL-7337-2023;
   Yang, Ying/ADL-4165-2022; Wu, Jiale/JQV-3750-2023; Li,
   Tao/IWU-9607-2023; wang, jiajun/JRW-6032-2023; CUI, XU/JYO-8134-2024
OI Liu, Yujie/0000-0002-1153-6156; Yang, Ying/0000-0002-3469-7681; 
FU program of Position System of Cattle and Sheep Diseases Prevention and
   Control of Jiangxi Province [JXRS13]; Education Department Science
   Foundation of Jiangxi Province [GJJ160349]; Key Research and Development
   Project of Jiangxi Province [20192BBF60035]
FX This work was supported by the program of Position System of Cattle and
   Sheep Diseases Prevention and Control of Jiangxi Province (JXRS13),
   Education Department Science Foundation of Jiangxi Province (No.
   GJJ160349) and Key Research and Development Project of Jiangxi Province
   (No. 20192BBF60035).
CR Aaseth J, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11081078
   Abdullah Saiful Arif, J DEV ECON, V77, P263, DOI [10.1016/j.landurbplan.2005.03.003, DOI 10.1016/J.JDEVECO.2009.07.004]
   Andjelkovic M, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16020274
   [Anonymous], 2020, BIOL TRACE ELEM RES, DOI DOI 10.1007/S12011-020-02112-Z
   Badiei K., 2009, Comparative Clinical Pathology, V18, P255, DOI 10.1007/s00580-008-0785-4
   Bai H, 2021, ECOTOX ENVIRON SAFE, V224, DOI 10.1016/j.ecoenv.2021.112618
   Benvenga S, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051222
   Bhardwaj JK, 2021, ENVIRON MOL MUTAGEN, V62, P374, DOI 10.1002/em.22450
   Bhargava P, 2017, NAT REV NEPHROL, V13, P629, DOI 10.1038/nrneph.2017.107
   Chen XM, 2022, J HAZARD MATER, V421, DOI 10.1016/j.jhazmat.2021.126704
   Dai ZY, 2020, ECOTOX ENVIRON SAFE, V204, DOI 10.1016/j.ecoenv.2020.111051
   EARLY JL, 1981, TOXICOL APPL PHARM, V58, P57, DOI 10.1016/0041-008X(81)90115-0
   Fletcher-Sananikone E, 2021, CANCER RES, V81, P5935, DOI 10.1158/0008-5472.CAN-21-0752
   Fu BB, 2017, BIOCHEM BIOPH RES CO, V486, P198, DOI 10.1016/j.bbrc.2017.03.027
   Gao PC, 2021, ECOTOX ENVIRON SAFE, V228, DOI 10.1016/j.ecoenv.2021.113018
   Ge J, 2022, J INORG BIOCHEM, V227, DOI 10.1016/j.jinorgbio.2021.111682
   Genchi G, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113782
   Gong ZG, 2022, J HAZARD MATER, V423, DOI 10.1016/j.jhazmat.2021.127110
   Guo HR, 2016, AGING-US, V8, P3009, DOI 10.18632/aging.101108
   Guo JM, 2021, ECOTOX ENVIRON SAFE, V209, DOI 10.1016/j.ecoenv.2020.111801
   Khan ZI, 2020, ENVIRON SCI POLLUT R, V27, P16339, DOI 10.1007/s11356-020-08140-5
   Kieliszek M, 2019, MOLECULES, V24, DOI 10.3390/molecules24071298
   Lai HH, 2021, BIOL TRACE ELEM RES, V199, P185, DOI 10.1007/s12011-020-02112-z
   Li J, 2018, COMP BIOCHEM PHYS C, V214, P17, DOI 10.1016/j.cbpc.2018.08.003
   Li PA, 2017, J NEUROSCI RES, V95, P2025, DOI 10.1002/jnr.24042
   Liao PC, 2020, METHOD CELL BIOL, V155, P3, DOI 10.1016/bs.mcb.2019.10.002
   Lim H, 2015, BIOCHEM PHARMACOL, V96, P337, DOI 10.1016/j.bcp.2015.06.013
   Liu JB, 2022, ENVIRON INT, V159, DOI 10.1016/j.envint.2021.107038
   Luczak MW, 2017, TOXICOL APPL PHARM, V331, P94, DOI 10.1016/j.taap.2017.05.029
   Luo HG, 2021, ENVIRON POLLUT, V290, DOI 10.1016/j.envpol.2021.118043
   Martino NA, 2017, REPROD TOXICOL, V69, P132, DOI 10.1016/j.reprotox.2017.02.005
   Miao ZR, 2022, ECOTOX ENVIRON SAFE, V231, DOI 10.1016/j.ecoenv.2022.113176
   Miura K, 2020, CHEM PHARM BULL, V68, P753, DOI 10.1248/cpb.c20-00194
   Mojapelo MM, 2019, THERIOGENOLOGY, V138, P9, DOI 10.1016/j.theriogenology.2019.06.044
   Picca A, 2018, NAT REV CARDIOL, V15, P543, DOI 10.1038/s41569-018-0059-z
   Rajput SA, 2021, ECOTOX ENVIRON SAFE, V220, DOI 10.1016/j.ecoenv.2021.112333
   Seo E, 2019, AGING CELL, V18, DOI 10.1111/acel.12895
   Shi X, 2021, ECOTOX ENVIRON SAFE, V225, DOI 10.1016/j.ecoenv.2021.112757
   Son SH, 2021, MAR DRUGS, V19, DOI 10.3390/md19040182
   Song N, 2021, J HAZARD MATER, V418, DOI 10.1016/j.jhazmat.2021.126172
   Sun K, 2021, AUTOPHAGY, V17, P2082, DOI 10.1080/15548627.2020.1822097
   Suzuki Y, 2019, GENES GENET SYST, V94, P123, DOI 10.1266/ggs.18-00062
   Wang JF, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16234665
   Wang K, 2021, SCI TOTAL ENVIRON, V756, DOI 10.1016/j.scitotenv.2020.143951
   Wang T, 2016, SCI REP-UK, V6, DOI 10.1038/srep38091
   Wang W, 2020, J HAZARD MATER, V386, DOI 10.1016/j.jhazmat.2019.121626
   Wang XY, 2022, ECOTOX ENVIRON SAFE, V235, DOI 10.1016/j.ecoenv.2022.113438
   Wang Y, 2018, ENVIRON SCI POLLUT R, V25, P18662, DOI 10.1007/s11356-018-2059-2
   Wu NN, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/9825061
   Xiong ZW, 2021, FRONT VET SCI, V8, DOI 10.3389/fvets.2021.756534
   Yoo SM, 2018, MOL CELLS, V41, P18, DOI 10.14348/molcells.2018.2277
   Zhang CY, 2022, ECOTOX ENVIRON SAFE, V230, DOI 10.1016/j.ecoenv.2021.113099
   Zhang C, 2020, ENVIRON POLLUT, V260, DOI 10.1016/j.envpol.2019.113873
   Zhang Fei, VACUUM, V656, P1133, DOI [10.1016/j.scitotenv.2018.11.444, DOI 10.1016/J.VACUUM.2018.05.012]
   Zhang JY, 2020, ECOTOX ENVIRON SAFE, V204, DOI 10.1016/j.ecoenv.2020.111049
   Zhang LW, 2021, ENVIRON POLLUT, V285, DOI 10.1016/j.envpol.2021.117301
   Zhang Q, 2020, FOOD FUNCT, V11, P1856, DOI [10.1039/C9FO02287B, 10.1039/c9fo02287b]
   Zhang SL, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1730-y
   Zhang YL, 2020, BIOL TRACE ELEM RES, V196, P103, DOI 10.1007/s12011-019-01908-y
   Zhang YM, 2020, ECOTOX ENVIRON SAFE, V202, DOI 10.1016/j.ecoenv.2020.110903
   Zhang YM, 2020, FOOD FUNCT, V11, P6467, DOI [10.1039/d0fo00394h, 10.1039/D0FO00394H]
   Zhang Yujing, 2020, Wei Sheng Yan Jiu, V49, P290, DOI 10.19813/j.cnki.weishengyanjiu.2020.02.021
   Zhao Y, 2022, ENVIRON POLLUT, V292, DOI 10.1016/j.envpol.2021.118390
   Zhao Y, 2021, ECOTOX ENVIRON SAFE, V208, DOI 10.1016/j.ecoenv.2020.111743
   Zheng SF, 2020, J HAZARD MATER, V389, DOI 10.1016/j.jhazmat.2019.121885
   Zheng YY, 2021, ANIM NUTR, V7, P997, DOI 10.1016/j.aninu.2021.05.005
   Zhong P, 2020, BIOL REPROD, V103, P608, DOI 10.1093/biolre/ioaa091
NR 67
TC 2
Z9 2
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0162-0134
EI 1873-3344
J9 J INORG BIOCHEM
JI J. Inorg. Biochem.
PD JUL
PY 2022
VL 232
AR 111818
DI 10.1016/j.jinorgbio.2022.111818
PG 12
WC Biochemistry & Molecular Biology; Chemistry, Inorganic & Nuclear
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA 7X1LL
UT WOS:000913964700001
PM 35405488
DA 2024-02-19
ER

PT J
AU Zhang, WT
   Chen, RY
   Yang, T
   Xu, N
   Chen, J
   Gao, YQ
   Stetler, RA
AF Zhang, Wenting
   Chen, Ruiying
   Yang, Tuo
   Xu, Na
   Chen, Jun
   Gao, Yanqin
   Stetler, R. Anne
TI Fatty acid transporting proteins: Roles in brain development, aging, and
   stroke
SO PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
LA English
DT Article
ID ALPHA-LINOLENIC ACID; ACYL-COA SYNTHETASE; ACTIVATED-RECEPTOR-GAMMA;
   LIVER PLASMA-MEMBRANES; N-3 PUFA DEPRIVATION; B SCAVENGER RECEPTOR; CD36
   KNOCKOUT MICE; BINDING-PROTEIN; DOCOSAHEXAENOIC ACID; ALZHEIMERS-DISEASE
AB Polyunsaturated fatty acids are required for the brain development and significantly impact aging and stroke. Due to the hydrophobicity of fatty acids, fatty acids transportation related proteins that include fatty acid binding proteins (FABPs), long chain acyl-coA synthase (ACS), fatty acid transportation proteins (FATPs), fatty acid translocase (FAT/CD36) and newly reported major facilitator superfamily domain-containing protein (Mfsd2a) play critical roles in the uptake of various fatty acids, especially polyunsaturated fatty acids. They are not only involved in neurodevelopment, but also have great impact on neurological disease, such as aging related dementia and stroke.
C1 [Zhang, Wenting; Chen, Ruiying; Xu, Na; Chen, Jun; Gao, Yanqin; Stetler, R. Anne] Fudan Univ, Inst Brain Sci, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China.
   [Zhang, Wenting; Chen, Ruiying; Xu, Na; Chen, Jun; Gao, Yanqin; Stetler, R. Anne] Fudan Univ, Collaborat Innovat Ctr Brain Sci, Shanghai 200032, Peoples R China.
   [Yang, Tuo; Chen, Jun; Gao, Yanqin; Stetler, R. Anne] Univ Pittsburgh, Pittsburgh Inst Brain Disorders, Sch Med, Pittsburgh, PA 15213 USA.
   [Yang, Tuo; Chen, Jun; Gao, Yanqin; Stetler, R. Anne] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15213 USA.
   [Chen, Jun; Stetler, R. Anne] Vet Affairs Pittsburgh Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Pittsburgh, PA 15261 USA.
C3 Fudan University; Fudan University; Pennsylvania Commonwealth System of
   Higher Education (PCSHE); University of Pittsburgh; Pennsylvania
   Commonwealth System of Higher Education (PCSHE); University of
   Pittsburgh; Geriatric Research Education & Clinical Center; US
   Department of Veterans Affairs; Veterans Health Administration (VHA); VA
   Pittsburgh Healthcare System
RP Gao, YQ (corresponding author), Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China.; Stetler, RA (corresponding author), Univ Pittsburgh, Pittsburgh Inst Brain Disorders & Recovery, Sch Med, S512 Biomed Sci Tower,3500 Terrace St, Pittsburgh, PA 15213 USA.
EM yqgao@shmu.edu.cn; stetler@pitt.edu
RI Yang, Tuo/J-5620-2019; Gao, Yanqin/I-6790-2016
OI Chen, Jun/0000-0002-8077-3403
FU National Natural Science Foundation of China [81471332, 81371306,
   81571285, 81529002]; Shanghai Committee of Science and Technology
   Support Program [14431907002]; US Department of Veterans Affairs (VA) RR
   D Merit Review [RX000420]; US National Institutes of Health [NS045048,
   NS091175, NS095671]
FX National Natural Science Foundation of China 81471332 (to W.Z.),
   81371306, 81571285 (to Y.G.) and 81529002 (to J.C.), the Shanghai
   Committee of Science and Technology Support Program 14431907002 (to
   Y.G.), US Department of Veterans Affairs (VA) RR & D Merit Review
   RX000420 (to J.C.), US National Institutes of Health grants NS045048,
   NS091175 and NS095671 (to J.C).
CR Abe T, 2010, STROKE, V41, P898, DOI 10.1161/STROKEAHA.109.572552
   Abumrad NA, 2005, PROSTAG OTH LIPID M, V77, P77, DOI 10.1016/j.prostaglandins.2004.09.012
   Alakbarzade V, 2015, NAT GENET, V47, P814, DOI 10.1038/ng.3313
   Angers M, 2008, BIOCHEM J, V416, P347, DOI 10.1042/BJ20080165
   Araki S, 2013, DIABETES CARE, V36, P1248, DOI 10.2337/dc12-1298
   Bao Y, 2012, J CEREBR BLOOD F MET, V32, P1567, DOI 10.1038/jcbfm.2012.52
   Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324
   Berger JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050629
   Berghaus TM, 1998, EUR J PEDIATR, V157, P763, DOI 10.1007/s004310050931
   BERK PD, 1990, P NATL ACAD SCI USA, V87, P3484, DOI 10.1073/pnas.87.9.3484
   Bonen A, 2007, PHYSIOLOGY, V22, P15, DOI 10.1152/physiologyonline.2007.22.1.15
   Boneva NB, 2012, HIPPOCAMPUS, V22, P896, DOI 10.1002/hipo.20951
   Boneva NB, 2011, HIPPOCAMPUS, V21, P162, DOI 10.1002/hipo.20732
   BOURRE JM, 1984, J NEUROCHEM, V43, P342, DOI 10.1111/j.1471-4159.1984.tb00906.x
   BOURRE JME, 1992, BIOCHIM BIOPHYS ACTA, V1124, P119, DOI 10.1016/0005-2760(92)90087-C
   Campbell FM, 1996, MOL CELL BIOCHEM, V155, P77, DOI 10.1007/BF00714336
   CAMPBELL FM, 1994, BBA-LIPID LIPID MET, V1214, P187, DOI 10.1016/0005-2760(94)90043-4
   Campbell FM, 1998, PLACENTA, V19, P409, DOI 10.1016/S0143-4004(98)90081-9
   CAMPBELL FM, 1995, FEBS LETT, V375, P227, DOI 10.1016/0014-5793(95)01216-2
   CAMPBELL FM, 1995, BIOCHEM BIOPH RES CO, V209, P1011, DOI 10.1006/bbrc.1995.1598
   Campbell FM, 1997, J LIPID RES, V38, P2558
   Campbell FM, 1998, LIFE SCI, V63, P235, DOI 10.1016/S0024-3205(98)00267-7
   Chen CT, 2008, PROSTAG LEUKOTR ESS, V79, P85, DOI 10.1016/j.plefa.2008.09.003
   Cheon MS, 2003, J NEURAL TRANSM-SUPP, P225
   Childs CE, 2008, P NUTR SOC, V67, P19, DOI 10.1017/S0029665108005983
   Cho S, 2005, J NEUROSCI, V25, P2504, DOI 10.1523/JNEUROSCI.0035-05.2005
   Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200
   Coe NR, 1999, J BIOL CHEM, V274, P36300, DOI 10.1074/jbc.274.51.36300
   Coraci IS, 2002, AM J PATHOL, V160, P101, DOI 10.1016/S0002-9440(10)64354-4
   Cutuli D, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00220
   DAS T, 1993, EUR J BIOCHEM, V211, P725, DOI 10.1111/j.1432-1033.1993.tb17602.x
   Delion S, 1997, J LIPID RES, V38, P680
   DeMar JC, 2005, J NEUROCHEM, V94, P1063, DOI 10.1111/j.1471-4159.2005.03258.x
   DEMAR JC, 1761, BIOCHIM BIOPHYS ACTA, V2006, P1050
   Denis I, 2013, AGEING RES REV, V12, P579, DOI 10.1016/j.arr.2013.01.007
   Ehehalt R, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-45
   El Khoury JB, 2003, J EXP MED, V197, P1657, DOI 10.1084/jem.20021546
   Esnault C, 2008, P NATL ACAD SCI USA, V105, P17532, DOI 10.1073/pnas.0807413105
   Extier A, 2010, J NUTR BIOCHEM, V21, P180, DOI 10.1016/j.jnutbio.2008.10.008
   Fang H, 2014, J IMMUNOL, V192, P5984, DOI 10.4049/jimmunol.1400054
   Febbraio M, 2007, INT J BIOCHEM CELL B, V39, P2012, DOI 10.1016/j.biocel.2007.03.012
   FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7
   Fitscher BA, 1998, BBA-GENE STRUCT EXPR, V1443, P381, DOI 10.1016/S0167-4781(98)00231-0
   Flores JJ, 2016, NEUROBIOL DIS, V87, P124, DOI 10.1016/j.nbd.2015.12.015
   Frohnert BI, 1999, J BIOL CHEM, V274, P3970, DOI 10.1074/jbc.274.7.3970
   Gamba P, 2011, AGING CELL, V10, P403, DOI 10.1111/j.1474-9726.2011.00681.x
   Gao F, 2013, AGE, V35, P597, DOI 10.1007/s11357-012-9390-1
   Garcia-Bonilla L, 2015, J NEUROSCI, V35, P14783, DOI 10.1523/JNEUROSCI.2980-15.2015
   Gerster H, 1998, INT J VITAM NUTR RES, V68, P159
   Gimeno RE, 2003, J BIOL CHEM, V278, P49512, DOI 10.1074/jbc.M309759200
   Giunta M, 2007, NEUROBIOL AGING, V28, P515, DOI 10.1016/j.neurobiolaging.2006.02.002
   GREENWALT DE, 1992, BLOOD, V80, P1105
   Guemez-Gamboa A, 2015, NAT GENET, V47, P809, DOI 10.1038/ng.3311
   Hall AM, 2005, J BIOL CHEM, V280, P11948, DOI 10.1074/jbc.M412629200
   Hall AM, 2003, J BIOL CHEM, V278, P43008, DOI 10.1074/jbc.M306575200
   Hamilton JA, 2007, J MOL NEUROSCI, V33, P12, DOI 10.1007/s12031-007-0050-3
   Hanhoff T, 2002, MOL CELL BIOCHEM, V239, P45, DOI 10.1023/A:1020502624234
   Hashimoto M., 2015, BIOCHIM BIOPHYS ACTA, P203
   Herrmann T, 2001, GENE, V270, P31, DOI 10.1016/S0378-1119(01)00489-9
   HEUCKEROTH RO, 1987, J BIOL CHEM, V262, P9709
   Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008
   Hui TY, 1998, J BIOL CHEM, V273, P27420, DOI 10.1074/jbc.273.42.27420
   Igarashi M., 2012, BIOCHIM BIOPHYS ACTA, P1235
   Igarashi M., 1791, BIOCHIM BIOPHYS ACTA, V2009, P132
   Igarashi M, 2007, J LIPID RES, V48, P2463, DOI 10.1194/jlr.M700315-JLR200
   Igarashi M, 2012, J NEUROCHEM, V120, P985, DOI 10.1111/j.1471-4159.2011.07597.x
   Kaduce TL, 2008, J NEUROCHEM, V105, P1525, DOI 10.1111/j.1471-4159.2008.05274.x
   Kim EH, 2015, CNS NEUROSCI THER, V21, P385, DOI 10.1111/cns.12326
   Kim E, 2008, J NEUROSCI, V28, P4661, DOI 10.1523/JNEUROSCI.0982-08.2008
   Kim E, 2012, ANN NEUROL, V71, P753, DOI 10.1002/ana.23569
   Kim H. W., 2011, BIOCHIM BIOPHYS ACTA, P111
   Kim HW, 2011, PROSTAG LEUKOTR ESS, V85, P361, DOI 10.1016/j.plefa.2011.08.002
   Knipp GT, 2000, PLACENTA, V21, P367, DOI 10.1053/plac.1999.0484
   Larqué E, 2006, AM J CLIN NUTR, V84, P853, DOI 10.1093/ajcn/84.4.853
   Lewis SE, 2001, J BIOL CHEM, V276, P37042, DOI 10.1074/jbc.M105556200
   Li F, 2015, J NEUROCHEM, V135, P445, DOI 10.1111/jnc.13239
   Liang CY, 2010, BIOL REPROD, V83, P387, DOI 10.1095/biolreprod.110.083915
   Lin LE, 2015, J LIPID RES, V56, P390, DOI 10.1194/jlr.M055590
   Little SJ, 2007, PROSTAG LEUKOTR ESS, V77, P155, DOI 10.1016/j.plefa.2007.08.009
   Liu Y, 2000, BRAIN RES, V852, P16, DOI 10.1016/S0006-8993(99)02158-7
   Ma D, 2008, HIPPOCAMPUS, V18, P326, DOI 10.1002/hipo.20393
   Ma DX, 2010, HIPPOCAMPUS, V20, P811, DOI 10.1002/hipo.20682
   MAKRIDES M, 1994, AM J CLIN NUTR, V60, P189, DOI 10.1093/ajcn/60.2.189
   Man MZ, 1996, MOL ENDOCRINOL, V10, P1021, DOI 10.1210/me.10.8.1021
   Martin G, 2000, J BIOL CHEM, V275, P12612, DOI 10.1074/jbc.275.17.12612
   McNamara RK, 2008, PROSTAG LEUKOTR ESS, V78, P293, DOI 10.1016/j.plefa.2008.04.001
   Mishima T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025865
   Mitchell DC, 2012, CHEM PHYS LIPIDS, V165, P393, DOI 10.1016/j.chemphyslip.2012.02.008
   Mitchell RW, 2011, J NEUROCHEM, V117, P735, DOI 10.1111/j.1471-4159.2011.07245.x
   Mollenhauer B, 2007, NEURODEGENER DIS, V4, P366, DOI 10.1159/000105157
   MOORE SA, 1990, J NEUROCHEM, V55, P391, DOI 10.1111/j.1471-4159.1990.tb04150.x
   MOORE SA, 1991, J NEUROCHEM, V56, P518, DOI 10.1111/j.1471-4159.1991.tb08180.x
   MOORE SA, 1993, ADV EXP MED BIOL, V331, P229
   Moriguchi T, 2001, J LIPID RES, V42, P419
   Murphy EJ, 2005, BIOCHEMISTRY-US, V44, P6350, DOI 10.1021/bi047292r
   MyersPayne SC, 1996, J NEUROCHEM, V66, P1648
   Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241
   Owada Y, 1996, J CHEM NEUROANAT, V12, P113, DOI 10.1016/S0891-0618(96)00192-5
   Pélerin H, 2014, PROSTAG LEUKOTR ESS, V91, P213, DOI 10.1016/j.plefa.2014.07.004
   Pelsers MMAL, 2005, CLIN CHIM ACTA, V352, P15, DOI 10.1016/j.cccn.2004.09.001
   Pelsers MMAL, 2004, CLIN CHEM, V50, P1568, DOI 10.1373/clinchem.2003.030361
   Pizza V, 2011, REV RECENT CLIN TRIA, V6, P189, DOI 10.2174/157488711796575577
   Pu LX, 1999, MOL CELL BIOCHEM, V198, P69, DOI 10.1023/A:1006946027619
   Raji CA, 2014, AM J PREV MED, V47, P444, DOI 10.1016/j.amepre.2014.05.037
   Rapoport S. I., 2009, ESSENT FAT ACIDS, V81, P119
   Rapoport SI, 2007, PROSTAG LEUKOTR ESS, V77, P251, DOI 10.1016/j.plefa.2007.10.023
   Ricciarelli R, 2004, FREE RADICAL BIO MED, V36, P1018, DOI 10.1016/j.freeradbiomed.2004.01.007
   Ring A., 2006, BIOCHIM BIOPHYS ACTA, P416
   SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6
   Schaiff WT, 2007, ENDOCRINOLOGY, V148, P3625, DOI 10.1210/en.2007-0211
   Schaiff WT, 2005, J CLIN ENDOCR METAB, V90, P4267, DOI 10.1210/jc.2004-2265
   SCOTT BL, 1989, P NATL ACAD SCI USA, V86, P2903, DOI 10.1073/pnas.86.8.2903
   Shie FS, 2004, AM J PATHOL, V164, P1173, DOI 10.1016/S0002-9440(10)63205-1
   Shimizu E, 2008, J IMMUNOL, V181, P6503, DOI 10.4049/jimmunol.181.9.6503
   Song BJ, 2010, LIPIDS, V45, P291, DOI 10.1007/s11745-010-3398-z
   Stahl A, 1999, MOL CELL, V4, P299, DOI 10.1016/S1097-2765(00)80332-9
   Steinacker P, 2004, NEUROSCI LETT, V370, P36, DOI 10.1016/j.neulet.2004.07.061
   STREMMEL W, 1992, BIOCHEM SOC T, V20, P814, DOI 10.1042/bst0200814
   STREMMEL W, 1983, BIOCHEM BIOPH RES CO, V112, P88, DOI 10.1016/0006-291X(83)91801-6
   STREMMEL W, 1985, P NATL ACAD SCI USA, V82, P4, DOI 10.1073/pnas.82.1.4
   Stremmel W, 2001, LIPIDS, V36, P981, DOI 10.1007/s11745-001-0809-2
   Stuhlsatz-Krouper SM, 1998, J BIOL CHEM, V273, P28642, DOI 10.1074/jbc.273.44.28642
   Teunissen CE, 2011, EUR J NEUROL, V18, P865, DOI 10.1111/j.1468-1331.2010.03273.x
   Toufaily C, 2013, PLACENTA, V34, P85, DOI 10.1016/j.placenta.2012.10.012
   Verdier Y, 2004, J PEPT SCI, V10, P229, DOI 10.1002/psc.573
   Virtanen JK, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000305
   Wada-Isoe K, 2008, J NEUROL SCI, V266, P20, DOI 10.1016/j.jns.2007.08.018
   Watanabe A, 2007, PLOS BIOL, V5, P2469, DOI 10.1371/journal.pbio.0050297
   Wolfrum C, 2007, CELL MOL LIFE SCI, V64, P2465, DOI 10.1007/s00018-007-7279-4
   Woo MS, 2012, ANN NEUROL, V72, P961, DOI 10.1002/ana.23727
   Wu TH, 2010, LAB INVEST, V90, P906, DOI 10.1038/labinvest.2009.33
   Wunderlich MT, 2005, J NEUROL, V252, P718, DOI 10.1007/s00415-005-0725-z
   Yamanaka W K, 1980, Prog Lipid Res, V19, P187, DOI 10.1016/0163-7827(80)90004-1
   Yamashima T, 2012, PROG LIPID RES, V51, P221, DOI 10.1016/j.plipres.2012.02.001
   YOUYOU A, 1986, J NEUROCHEM, V46, P224, DOI 10.1111/j.1471-4159.1986.tb12950.x
   Zanier ER, 2013, BRIT J ANAESTH, V111, P424, DOI 10.1093/bja/aet149
   Zhang SX, 2016, BEHAV BRAIN RES, V299, P90, DOI 10.1016/j.bbr.2015.11.027
   Zhang WT, 2015, EXP NEUROL, V272, P170, DOI 10.1016/j.expneurol.2015.03.005
   Zhang WT, 2010, STROKE, V41, P2341, DOI 10.1161/STROKEAHA.110.586081
   Zhao XR, 2015, CNS NEUROSCI THER, V21, P357, DOI 10.1111/cns.12350
   Zhao XR, 2007, ANN NEUROL, V61, P352, DOI 10.1002/ana.21097
   Zhao XR, 2009, STROKE, V40, pS92, DOI 10.1161/STROKEAHA.108.533158
NR 142
TC 39
Z9 44
U1 3
U2 33
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0952-3278
EI 1532-2823
J9 PROSTAG LEUKOTR ESS
JI Prostaglandins Leukot. Essent. Fatty Acids
PD SEP
PY 2018
VL 136
SI SI
BP 35
EP 45
DI 10.1016/j.plefa.2017.04.004
PG 11
WC Biochemistry & Molecular Biology; Cell Biology; Endocrinology &
   Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Endocrinology &
   Metabolism
GA GZ5GK
UT WOS:000449447000005
PM 28457600
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Cullen, JM
   Marion, PL
AF Cullen, JM
   Marion, PL
TI Non-neoplastic liver disease associated with chronic ground squirrel
   hepatitis virus infection
SO HEPATOLOGY
LA English
DT Article
ID WOODCHUCK MARMOTA-MONAX; B VIRUS; HEPATOCELLULAR-CARCINOMA; DUCKS
AB We examined 95 ground squirrel to compare the histological appearance of liver sections from animals that were chronically infected with ground squirrel hepatitis virus (GSHV) (n = 29), uninfected (n = 42), or had recovered from infection (n = 24), We studied the effects of long-term infection because these animals had been infected with GSHV for up to 10 years. Chronic infection generally produced a mild, persistent hepatitis characterized by light lymphocytic and plasmacytic portal infiltrates with occasional individual necrotic hepatocytes and small aggregates of Kupffer cells or mononuclear inflammatory cells in the parenchyma, In a few of the portal tracts from each of the more inflamed livers (grade 2), the inflammatory infiltrate penetrated the limiting plate and extended into the adjacent parenchyma, Hepatitis (grades 1 or 2) was detected more often in chronically infected animals (17 of 29) than in recovered (4 of 24) or uninfected ground squirrels (7 of 42). Fibrosis was generally not increased, but fine strands of collagen extended from the portal tracts and central veins into the parenchyma of about one quarter of the infected and recovered animals. Cytoplasmic pigment accumulation and variation in the size of hepatocyte nuclei appeared to be related to aging, not infection, Serum levels of aspartate and alanine transaminases (AST and ALT) were mildly elevated in samples from seven infected animals compared with seven control animals. Despite many years of chronic infection, liver injury was similar to that reported in previous studies on animals infected for shorter intervals, indicating that fiver injury is not progressive in GSHV-infected ground squirrels.
C1 STANFORD UNIV,SCH MED,DEPT MED,DIV GASTROENTEROL,PALO ALTO,CA 94304.
   STANFORD UNIV,SCH MED,DEPT MED,DIV INFECT DIS,PALO ALTO,CA 94304.
   STANFORD UNIV,SCH MED,DEPT MED,DIV GEOG MED,PALO ALTO,CA 94304.
C3 Stanford University; Stanford University; Stanford University
RP Cullen, JM (corresponding author), N CAROLINA STATE UNIV,COLL VET MED,DEPT MICROBIOL PATHOL & PARASITOL,4700 HILLSBOROUGH ST,RALEIGH,NC 27606, USA.
RI Cullen, John M/I-2051-2019
FU NIAID NIH HHS [AI20551] Funding Source: Medline
CR BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J
   CHADWICK RG, 1979, GUT, V20, P372, DOI 10.1136/gut.20.5.372
   CULLEN JM, 1989, VET PATHOL, V26, P164, DOI 10.1177/030098588902600210
   GERLICH WH, 1980, J VIROL, V36, P787, DOI 10.1128/JVI.36.3.787-795.1980
   GERLICH WH, 1979, J MED VIROL, V4, P227, DOI 10.1002/jmv.1890040308
   HORNBUCKLE WE, 1985, LAB ANIM SCI, V35, P376
   ISHAK KG, 1976, AM J CLIN PATHOL, V65, P787
   MARION PL, 1983, HEPATOLOGY, V3, P519
   MARION PL, 1980, P NATL ACAD SCI-BIOL, V77, P2941, DOI 10.1073/pnas.77.5.2941
   MARION PL, 1986, P NATL ACAD SCI USA, V83, P4543, DOI 10.1073/pnas.83.12.4543
   MARION PL, 1984, P NATL ACAD SCI-BIOL, V81, P898, DOI 10.1073/pnas.81.3.898
   OMATA M, 1983, GASTROENTEROLOGY, V85, P260
   POPPER H, 1982, HEPATOLOGY, V2, pS1
   POPPER H, 1987, P NATL ACAD SCI USA, V84, P866, DOI 10.1073/pnas.84.3.866
   POPPER H, 1981, HEPATOLOGY, V1, P91, DOI 10.1002/hep.1840010202
   ROBINSON WS, 1988, VIRAL HEPATITIS LIVE, P449
   ROTH L, 1985, VET PATHOL, V22, P338, DOI 10.1177/030098588502200407
   SEEGER C, 1991, J VIROL, V65, P1673, DOI 10.1128/JVI.65.4.1673-1679.1991
   SUMMERS J, 1978, P NATL ACAD SCI USA, V75, P4533, DOI 10.1073/pnas.75.9.4533
   THUNG SN, 1981, AM J PATHOL, V105, P328
   TYLER GV, 1986, LAB INVEST, V55, P51
   YOKOSUKA O, 1985, P NATL ACAD SCI USA, V82, P5180, DOI 10.1073/pnas.82.15.5180
NR 22
TC 6
Z9 7
U1 0
U2 0
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399
SN 0270-9139
J9 HEPATOLOGY
JI Hepatology
PD JUN
PY 1996
VL 23
IS 6
BP 1324
EP 1329
DI 10.1053/jhep.1996.v23.pm0008675146
PG 6
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA UQ898
UT WOS:A1996UQ89800005
PM 8675146
OA Bronze
DA 2024-02-19
ER

PT J
AU Wei, Q
   Zhou, JB
   Wang, K
   Zhang, XY
   Chen, JL
   Lu, D
   Wei, XY
   Zheng, SS
   Xu, X
AF Wei, Qiang
   Zhou, Junbin
   Wang, Kun
   Zhang, Xuanyu
   Chen, Junli
   Lu, Di
   Wei, Xuyong
   Zheng, Shusen
   Xu, Xiao
TI Combination of Early Allograft Dysfunction and Protein Expression
   Patterns Predicts Outcome of Liver Transplantation From Donation After
   Cardiac Death
SO FRONTIERS IN MEDICINE
LA English
DT Article
DE hepatic; liver transplant; EAD; protein profiles; prognosis
ID ISCHEMIA/REPERFUSION INJURY; REPERFUSION INJURY; ISCHEMIA; RISK;
   SENESCENCE; PROFILES; SYSTEM
AB Early allograft dysfunction (EAD) after liver transplantation (LT) accompanies poor prognosis. This study aims to explore the relationship between pretransplant intrahepatic proteins and the incidence of EAD, and the value of combined EAD and protein profiles for predicting recipient and graft survival prognosis. Liver biopsy specimens of 105 pretransplant grafts used for LT were collected and used for immunohistochemistry analysis of 5 proteins. And matched clinical data of donor, recipient, transplantation, and prognosis were analyzed. The incidence of EAD was 41.9% (44/105) in this cohort. Macrovesicular steatosis (P = 0.016), donor body mass index (P = 0.013), recipients' pretransplant serum creatinine (P = 0.036), and intrahepatic expression of heme oxygenase 1 (HO1) (P = 0.015) and tumor necrosis factor alpha (TNF-alpha) (P = 0.039) were independent predictors of EAD. Inferior graft and recipient prognosis were observed in patients who experienced EAD (P = 0.028 and 0.031) or received grafts with higher expression of sirtuin 1 (P = 0.005 and 0.013). The graft and recipient survival were worst in patients with both EAD and high expression of sirtuin 1 (P = 0.001 and 0.004). In conclusion, pretransplant intrahepatic expression of HO1 and TNF-alpha are associated with the incidence of EAD. The combination of EAD and EAD-unrelated proteins showed superiority in distinguishing recipients with worse prognosis.
C1 [Wei, Qiang; Zhou, Junbin; Lu, Di; Wei, Xuyong; Xu, Xiao] Zhejiang Univ, Ctr Integrated Oncol & Precis Med, Dept Hepatobiliary & Pancreat Surg, Affiliated Hangzhou Peoples Hosp 1,Sch Med, Hangzhou, Peoples R China.
   [Wei, Qiang; Zhou, Junbin; Zhang, Xuanyu; Lu, Di; Wei, Xuyong; Zheng, Shusen; Xu, Xiao] Zhejiang Univ, Inst Organ Transplantat, Hangzhou, Peoples R China.
   [Wei, Qiang; Zhou, Junbin; Zhang, Xuanyu; Lu, Di; Wei, Xuyong; Zheng, Shusen; Xu, Xiao] Natl Hlth Commiss Key Lab Combined Multiorgan Tra, Hangzhou, Peoples R China.
   [Wang, Kun] Nanjing Univ, Med Sch, Affiliated Hosp, Nanjing Drum Tower Hosp, Nanjing, Peoples R China.
   [Zhang, Xuanyu; Zheng, Shusen; Xu, Xiao] Nanjing Univ, Sch Med, Affiliated Hosp 1, Dept Hepatobiliary & Pancreat Surg, Hangzhou, Peoples R China.
   [Chen, Junli] China Liver Transplant Registery, Hangzhou, Peoples R China.
C3 Zhejiang University; Zhejiang University; Nanjing University; Nanjing
   University
RP Xu, X (corresponding author), Zhejiang Univ, Ctr Integrated Oncol & Precis Med, Dept Hepatobiliary & Pancreat Surg, Affiliated Hangzhou Peoples Hosp 1,Sch Med, Hangzhou, Peoples R China.; Xu, X (corresponding author), Zhejiang Univ, Inst Organ Transplantat, Hangzhou, Peoples R China.; Xu, X (corresponding author), Natl Hlth Commiss Key Lab Combined Multiorgan Tra, Hangzhou, Peoples R China.; Xu, X (corresponding author), Nanjing Univ, Sch Med, Affiliated Hosp 1, Dept Hepatobiliary & Pancreat Surg, Hangzhou, Peoples R China.
EM zjxu@zju.edu.cn
RI XIE, WANYING/JNR-9259-2023; Zhang, Jun/JPK-7723-2023; wang,
   zhiwen/JDV-9990-2023; wen, liang/JNR-7720-2023; WANG,
   JIAXUAN/JMP-8599-2023
FU National Natural Science Foundation of China [81800578, 81930016,
   81625003]; Key Research & Development Plan of Zhejiang Province
   [2019C03050, 2021C03118]; Projects of Medical and Health Technology
   Program in Zhejiang Province [WKJ-ZJ-2120]
FX Funding This work was supported by grants from the National Natural
   Science Foundation of China (Grant Numbers 81800578, 81930016, and
   81625003); the Key Research & Development Plan of Zhejiang Province
   (Grant Numbers 2019C03050 and 2021C03118); and the Projects of Medical
   and Health Technology Program in Zhejiang Province (Grant Number
   WKJ-ZJ-2120).
CR Agopian VG, 2018, JAMA SURG, V153, P436, DOI 10.1001/jamasurg.2017.5040
   Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Bankhead P, 2018, LAB INVEST, V98, P15, DOI 10.1038/labinvest.2017.131
   Berberat PO, 2006, TRANSPLANTATION, V82, P699, DOI 10.1097/01.tp.0000233377.14174.93
   Dar WA, 2019, LIVER INT, V39, DOI 10.1111/liv.14091
   Dhillon N, 2010, J HEPATOL, V53, P67, DOI 10.1016/j.jhep.2009.12.044
   Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197
   Friedman BH, 2012, LIVER TRANSPLANT, V18, P166, DOI 10.1002/lt.22451
   Geuken E, 2005, AM J TRANSPLANT, V5, P1875, DOI 10.1111/j.1600-6143.2005.00960.x
   Gorgen A, 2019, TRANSPLANTATION, V103, P944, DOI 10.1097/TP.0000000000002429
   Hu JF, 2016, J HEPATOL, V64, P146, DOI 10.1016/j.jhep.2015.08.021
   Kudoh K, 2014, ANN SURG, V260, P118, DOI 10.1097/SLA.0000000000000287
   Kurian SM, 2015, AM J TRANSPLANT, V15, P1605, DOI 10.1111/ajt.13145
   Lee DD, 2016, ANN HEPATOL, V15, P53, DOI 10.5604/16652681.1184212
   Lu L, 2018, HEPATOLOGY, V67, P1041, DOI 10.1002/hep.29593
   Lu L, 2016, TRANSPLANTATION, V100, P2601, DOI 10.1097/TP.0000000000001411
   Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517
   Nakagawa K, 2012, J HEPATOL, V56, P586, DOI 10.1016/j.jhep.2011.08.021
   Nakamura K, 2018, AM J TRANSPLANT, V18, P1110, DOI 10.1111/ajt.14586
   Nakamura K, 2017, J HEPATOL, V67, P1232, DOI 10.1016/j.jhep.2017.08.010
   Nanashima A, 2002, TRANSPL P, V34, P1231, DOI 10.1016/S0041-1345(02)02639-8
   Olthoff KM, 2010, LIVER TRANSPLANT, V16, P943, DOI 10.1002/lt.22091
   Pareja E, 2015, LIVER TRANSPLANT, V21, P38, DOI 10.1002/lt.23990
   PLOEG RJ, 1993, TRANSPLANTATION, V55, P807, DOI 10.1097/00007890-199304000-00024
   Pokorny H, 2005, CLIN TRANSPLANT, V19, P532, DOI 10.1111/j.1399-0012.2005.00384.x
   Selten JW, 2017, LIVER TRANSPLANT, V23, P946, DOI 10.1002/lt.24766
   Shen XD, 2007, LIVER TRANSPLANT, V13, P1435, DOI 10.1002/lt.21251
   Tekin K, 2004, TRANSPLANTATION, V77, P411, DOI 10.1097/01.TP.0000110318.70879.20
   Thomsen KL, 2019, J CLIN EXP HEPATOL, V9, P302, DOI 10.1016/j.jceh.2018.09.006
   Wang K, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2019.12.132
   Wang XZ, 2018, J HEPATOL, V68, P118, DOI 10.1016/j.jhep.2017.08.032
   Xie HY, 2020, TRANSPLANTATION, V104, P79, DOI 10.1097/TP.0000000000002787
   Yu A, 2013, MOL CELL ENDOCRINOL, V377, P23, DOI 10.1016/j.mce.2013.06.028
   Zhou JB, 2020, LIVER TRANSPLANT, V26, P1034, DOI 10.1002/lt.25779
NR 34
TC 0
Z9 0
U1 0
U2 6
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-858X
J9 FRONT MED-LAUSANNE
JI Front. Med.
PD DEC 8
PY 2021
VL 8
AR 775212
DI 10.3389/fmed.2021.775212
PG 10
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA XR9EU
UT WOS:000732524300001
PM 34957150
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU YAMADA, E
   WAKABAYASHI, Y
AF YAMADA, E
   WAKABAYASHI, Y
TI DEVELOPMENT OF PYRROLINE-5-CARBOXYLATE SYNTHASE AND N-ACETYLGLUTAMATE
   SYNTHASE AND THEIR CHANGES IN LACTATION AND AGING
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
ID PHOSPHATE SYNTHETASE-I; RAT-LIVER; ORNITHINE METABOLISM; MOUSE
   INTESTINE; UREA CYCLE; OLD RATS; ENZYMES; ARGININE; PREGNANCY; YOUNG
C1 KYOTO PREFECTURAL UNIV MED,DEPT BIOCHEM,465 KAJIICHO HIROKOJI,KAMIKYO KU,KYOTO 602,JAPAN.
   KYOTO PREFECTURAL UNIV MED,DEPT ANESTHESIOL,KAMIKYO KU,KYOTO 602,JAPAN.
C3 Kyoto Prefectural University of Medicine; Kyoto Prefectural University
   of Medicine
CR BARBER T, 1990, BIOCHEM J, V270, P77, DOI 10.1042/bj2700077
   CATHELINEAU L, 1981, ENZYME, V26, P245, DOI 10.1159/000459186
   GEOKAS MC, 1969, AM J SURG, V117, P881, DOI 10.1016/0002-9610(69)90078-6
   HARRIS JE, 1988, NUTR REP INT, V38, P349
   Herzfeld A, 1979, J Dev Physiol, V1, P315
   HERZFELD A, 1976, BIOCHIM BIOPHYS ACTA, V428, P600, DOI 10.1016/0304-4165(76)90188-4
   HITIER Y, 1983, AM J PHYSIOL, V244, pE548, DOI 10.1152/ajpendo.1983.244.6.E548
   HURWITZ R, 1986, AM J PHYSIOL, V251, pG103, DOI 10.1152/ajpgi.1986.251.1.G103
   Illnerova H, 1965, Biol Neonat, V9, P197
   JACKSON MJ, 1986, ANNU REV GENET, V20, P431, DOI 10.1146/annurev.ge.20.120186.002243
   JONES ME, 1985, J NUTR, V115, P509, DOI 10.1093/jn/115.4.509
   KMIEC Z, 1985, EXP GERONTOL, V20, P271, DOI 10.1016/0531-5565(85)90052-X
   LAMERS WH, 1982, UREA CYCLE DISEASES, P229
   MARTINEZRAMON A, 1990, J HISTOCHEM CYTOCHEM, V38, P371, DOI 10.1177/38.3.2303702
   MILLER SA, 1970, FED PROC, V29, P1497
   MILNER JA, 1978, J NUTR, V108, P1281, DOI 10.1093/jn/108.8.1281
   MOORE S, 1948, J BIOL CHEM, V176, P367
   PAULUS H, 1983, CURR TOP CELL REGUL, V22, P177
   PENZES L, 1970, DIGESTION, V3, P174, DOI 10.1159/000197028
   RABIER D, 1985, BIOCHIM BIOPHYS ACTA, V838, P1, DOI 10.1016/0304-4165(85)90242-9
   RAIHA NCR, 1976, UREA CYCLE, P261
   REMESAR X, 1980, ARCH INT PHYSIOL BIO, V88, P443, DOI 10.3109/13813458009092918
   RIBY JE, 1990, PEDIATR RES, V28, P261, DOI 10.1203/00006450-199009000-00022
   ROBERGE A, 1967, CAN J BIOCHEM CELL B, V45, P1371, DOI 10.1139/o67-161
   Rose WC, 1938, PHYSIOL REV, V18, P109, DOI 10.1152/physrev.1938.18.1.109
   RYALL JC, 1986, EUR J BIOCHEM, V156, P453, DOI 10.1111/j.1432-1033.1986.tb09603.x
   Schiller C. M., 1981, J APPL BIOCHEM, V3, P147
   SNELL K, 1973, ENZYME, V15, P40, DOI 10.1159/000481053
   TATIBANA M, 1976, UREA CYCLE, P301
   TUCHMAN M, 1990, PEDIATR RES, V27, P408, DOI 10.1203/00006450-199004000-00020
   VANDIJK M, 1984, BIOCHEM J, V222, P837, DOI 10.1042/bj2220837
   WAKABAYASHI Y, 1991, ARCH BIOCH BIOPHYS, V290
   WILLIAMS I, 1975, ANAL BIOCHEM, V64, P85, DOI 10.1016/0003-2697(75)90408-X
   WINICK M, 1965, DEV BIOL, V12, P451, DOI 10.1016/0012-1606(65)90009-6
   WRAIGHT C, 1988, AUST J BIOL SCI, V41, P435, DOI 10.1071/BI9880435
NR 35
TC 11
Z9 11
U1 0
U2 0
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0003-9861
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 15
PY 1991
VL 291
IS 1
BP 15
EP 23
DI 10.1016/0003-9861(91)90099-5
PG 9
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA GM200
UT WOS:A1991GM20000003
PM 1929426
DA 2024-02-19
ER

PT J
AU Sugiyama, S
AF Sugiyama, S
TI HMG CoA reductase inhibitor accelerates aging effect on diaphragm
   mitochondrial respiratory function in rats
SO BIOCHEMISTRY AND MOLECULAR BIOLOGY INTERNATIONAL
LA English
DT Article
DE HMG CoA reductase inhibitor; diaphragm; mitochondria; aging
ID CORONARY HEART-DISEASE; COENZYME-A REDUCTASE; SKELETAL-MUSCLE;
   PRAVASTATIN; DOXORUBICIN; THERAPY
AB We examined effects of pravastatin on age-related changes in mitochondrial function in rats. Decline in the activity of complex I of the mitochondrial electron transport chain was observed in diaphragm and psoai major in rats aged 35 and 55 weeks, and that of complex IV in rats aged 55 weeks. Pravastatin accelerated significantly age-related decline in the activity of complex I of diaphragm mitochondria, through pravastatin did not show significant effect on normally observed age-associated decline in the activities of complex IV of psoai major and diaphragm mitochondria. Aging effect on mitochondrial respiratory function was not observed on heart muscle and liver in rats up to 55 weeks old, and pravastatin did not effect significantly heart and liver mitochondrial respiratory function. From these results, careful clinical examination on respiratory muscle function should be necessary in patients treated with pravastatin particularly in elderly patients.
C1 Inst Appl Biochem, Dept Biomed Chem, Gifu 50501, Japan.
RP Sugiyama, S (corresponding author), Inst Appl Biochem, Dept Biomed Chem, Gifu 50501, Japan.
CR ABE K, 1978, J NUTR SCI VITAMINOL, V24, P555, DOI 10.3177/jnsv.24.555
   [Anonymous], 1993, Am J Cardiol, V72, P1031
   BUZDAR AU, 1985, CANCER, V55, P2761, DOI 10.1002/1097-0142(19850615)55:12<2761::AID-CNCR2820551206>3.0.CO;2-P
   BYINGTON RP, 1995, CIRCULATION, V92, P2419, DOI 10.1161/01.CIR.92.9.2419
   CRANE FL, 1957, BIOCHIM BIOPHYS ACTA, V25, P220, DOI 10.1016/0006-3002(57)90457-2
   ENGLAND JDF, 1995, AUST NZ J MED, V25, P374, DOI 10.1111/j.1445-5994.1995.tb01912.x
   GADBUT AP, 1995, J MOL CELL CARDIOL, V27, P2397, DOI 10.1016/S0022-2828(95)92163-X
   HOGEBOOM GH, 1948, J BIOL CHEM, V172, P619
   KANNEL WB, 1971, ANN INTERN MED, V74, P1, DOI 10.7326/0003-4819-74-1-1
   KRUMHOLZ HM, 1994, JAMA-J AM MED ASSOC, V272, P1335, DOI 10.1001/jama.272.17.1335
   NAGAI S, 1985, J MOL CELL CARDIOL, V17, P873, DOI 10.1016/S0022-2828(85)80101-2
   PACK AI, 1988, PULMONARY DISEASES D, V1, P79
   RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P351
   SATOH K, 1995, BRIT J PHARMACOL, V116, P1894, DOI 10.1111/j.1476-5381.1995.tb16679.x
   SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   SUGIYAMA S, 1993, BIOCHEM MOL BIOL INT, V30, P937
   SUGIYAMA S, 1980, EXPERIENTIA, V36, P1002, DOI 10.1007/BF01953847
   SUGIYAMA S, 1993, BIOCHEM MOL BIOL INT, V30, P797
   Sugiyama S, 1995, BIOCHEM MOL BIOL INT, V36, P1001
   Sugiyama S, 1995, BIOCHEM MOL BIOL INT, V37, P1111
   TORII K, 1992, AM J RESP CELL MOL, V6, P543, DOI 10.1165/ajrcmb/6.5.543
   TORII K, 1992, AM J RESP CELL MOL, V6, P88, DOI 10.1165/ajrcmb/6.1.88
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   TSUJITA Y, 1986, BIOCHIM BIOPHYS ACTA, V877, P50, DOI 10.1016/0005-2760(86)90117-7
NR 25
TC 18
Z9 19
U1 0
U2 5
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1039-9712
J9 BIOCHEM MOL BIOL INT
JI Biochem. Mol. Biol. Int.
PD DEC
PY 1998
VL 46
IS 5
BP 923
EP 931
PG 9
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 148MK
UT WOS:000077509000008
PM 9861446
DA 2024-02-19
ER

PT J
AU Singh, RK
   Lui, E
   Wright, D
   Taylor, A
   Bakovic, M
AF Singh, Ratnesh K.
   Lui, Edmund
   Wright, David
   Taylor, Adrian
   Bakovic, Marica
TI Alcohol extract of North American ginseng (<i>Panax quinquefolius</i>)
   reduces fatty liver, dyslipidemia, and other complications of metabolic
   syndrome in a mouse model
SO CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
LA English
DT Article
DE North American ginseng extract; root of Panax quinquefolius; fatty
   liver; intestine; lipoprotein secretion; hypertriglyceridemia
ID KOREAN RED GINSENG; INSULIN-RESISTANCE; PROTEIN-KINASE; HYPERGLYCEMIA;
   PATHOGENESIS; ACTIVATION; PREVENTS; DISEASE; DIET; RB1
AB We investigated whether North American ginseng (Panax quinquefolius) could reduce development of the metabolic syndrome phenotype in a mouse model (ETKO) of the disease. Young ETKO mice have no disease but similar to humans start to develop the fatty liver, hypertriglyceridemia, obesity, and insulin resistance at 25-30 weeks of age, and the disease continues to progress with ageing. ETKO mice were orally given an ethanol extract of ginseng roots at 4 and 32 weeks of age. Treatments with ginseng eliminated the ETKO fatty liver, reduced hepatic and intestinal lipoprotein secretion, and reduced the level of circulating lipids. Improvements by ginseng treatments were manifested as a reduction in the expression of genes involved in the regulation of fatty acid and triglyceride (fat) synthesis and secretion by the lipoproteins on one hand, and the stimulation of fatty acid oxidation and triglyceride degradation by lipolysis on the other hand. These processes altogether improved glucose, fatty acid, and triglyceride metabolism, reduced liver fat load, and reversed the progression of metabolic syndrome. These data confirm that treatments with North American ginseng could alleviate metabolic syndrome through the maintenance of a better balance between glucose and fatty acid metabolism, lipoprotein secretion, and energy homeostasis in disease-prone states.
C1 [Singh, Ratnesh K.; Wright, David; Taylor, Adrian; Bakovic, Marica] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada.
   [Lui, Edmund] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada.
C3 University of Guelph; Western University (University of Western Ontario)
RP Bakovic, M (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada.
EM mbakovic@uoguelph.ca
OI Wright, David/0000-0003-3867-8901
FU Ministry of Research and Innovation through an Ontario Research Fund
FX This study was financially supported by the Ministry of Research and
   Innovation through an Ontario Research Fund awarded to the Ontario
   Ginseng Innovation and Research Consortium (OGIRC).
CR Attele AS, 2002, DIABETES, V51, P1851, DOI 10.2337/diabetes.51.6.1851
   Azike CG, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-21
   Bang CS, 2014, J GINSENG RES, V38, P167, DOI 10.1016/j.jgr.2014.04.002
   Blasiole DA, 2007, MOL BIOSYST, V3, P608, DOI 10.1039/b700706j
   Ertunc ME, 2016, J LIPID RES, V57, P2099, DOI 10.1194/jlr.R066514
   Fullerton MD, 2007, MOL CELL BIOL, V27, P3327, DOI 10.1128/MCB.01527-06
   Fullerton MD, 2010, METABOLISM, V59, P1691, DOI 10.1016/j.metabol.2010.03.022
   Fullerton MD, 2009, J BIOL CHEM, V284, P25704, DOI 10.1074/jbc.M109.023846
   Geldenhuys WJ, 2017, DRUG DISCOV TODAY, V22, P352, DOI 10.1016/j.drudis.2016.10.007
   Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270
   Gyamfi MA, 2010, EXP BIOL MED, V235, P547, DOI 10.1258/ebm.2009.009249
   Helms Steve, 2004, Altern Med Rev, V9, P259
   Hong M, 2016, J GINSENG RES, V40, P203, DOI 10.1016/j.jgr.2015.07.006
   Joh EH, 2011, BIOCHEM PHARMACOL, V82, P278, DOI 10.1016/j.bcp.2011.05.003
   Julve J, 2016, CLIN CHIM ACTA, V455, P134, DOI 10.1016/j.cca.2016.02.004
   Kim DH, 2014, ARCH PHARM RES, V37, P813, DOI 10.1007/s12272-013-0223-2
   Komishon AM, 2016, J HUM HYPERTENS, V30, P619, DOI 10.1038/jhh.2016.18
   Kraegen EW, 2006, AM J PHYSIOL-ENDOC M, V290, pE471, DOI 10.1152/ajpendo.00316.2005
   Lee HJ, 2009, METABOLISM, V58, P1170, DOI 10.1016/j.metabol.2009.03.015
   Liu JP, 2011, FOOD CHEM TOXICOL, V49, P1718, DOI 10.1016/j.fct.2011.04.017
   Liu WS, 2016, CELL MOL LIFE SCI, V73, P1969, DOI 10.1007/s00018-016-2161-x
   Lund A, 2012, CURR MED RES OPIN, V28, P731, DOI 10.1185/03007995.2012.681639
   Mollah ML, 2009, PHYTOTHER RES, V23, P220, DOI 10.1002/ptr.2593
   Mucalo I, 2012, COLLEGIUM ANTROPOL, V36, P1435
   Murthy HN, 2014, J ETHNOPHARMACOL, V153, P917, DOI 10.1016/j.jep.2014.03.062
   Musso G, 2016, NAT REV DRUG DISCOV, V15, P249, DOI 10.1038/nrd.2015.3
   Tung NH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/173297
   Qiu YQ, 2008, J SEP SCI, V31, P3451, DOI 10.1002/jssc.200800253
   Sen S, 2013, PHYTOTHER RES, V27, P290, DOI 10.1002/ptr.4719
   Sen S, 2012, PHYTOMEDICINE, V19, P494, DOI 10.1016/j.phymed.2012.01.001
   Sen S, 2011, PHYTOMEDICINE, V18, P1110, DOI 10.1016/j.phymed.2011.06.013
   Shen L, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12543
   Shen L, 2013, J LIPID RES, V54, P1430, DOI 10.1194/jlr.M035907
   Shergis JL, 2013, PHYTOTHER RES, V27, P949, DOI 10.1002/ptr.4832
   Shishtar E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107391
   Singh RK, 2012, J LIPID RES, V53, P1811, DOI 10.1194/jlr.M021881
   Siri-Tarino PW, 2016, CURR OPIN LIPIDOL, V27, P323, DOI 10.1097/MOL.0000000000000310
   Visschers RGJ, 2013, CURR OPIN CLIN NUTR, V16, P576, DOI 10.1097/MCO.0b013e32836410a4
   Vos MB, 2017, J PEDIATR GASTR NUTR, V64, P319, DOI 10.1097/MPG.0000000000001482
   Wang CX, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/423287
   Yamada N, 2011, PSYCHOPHARMACOLOGY, V216, P589, DOI 10.1007/s00213-011-2252-1
   Yun SN, 2004, ARCH PHARM RES, V27, P790, DOI 10.1007/BF02980150
NR 42
TC 12
Z9 13
U1 2
U2 32
PU CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS
PI OTTAWA
PA 65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA
SN 0008-4212
EI 1205-7541
J9 CAN J PHYSIOL PHARM
JI Can. J. Physiol. Pharmacol.
PD SEP
PY 2017
VL 95
IS 9
BP 1046
EP 1057
DI 10.1139/cjpp-2016-0510
PG 12
WC Pharmacology & Pharmacy; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Physiology
GA FE6MC
UT WOS:000408322600008
PM 28666094
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Dai, CY
   Fang, TJ
   Hung, WW
   Tsai, HJ
   Tsai, YC
AF Dai, Chia-Yen
   Fang, Tzu-Jung
   Hung, Wei-Wen
   Tsai, Hui-Ju
   Tsai, Yi-Chun
TI The Determinants of Liver Fibrosis in Patients with Nonalcoholic Fatty
   Liver Disease and Type 2 Diabetes Mellitus
SO BIOMEDICINES
LA English
DT Article
DE liver fibrosis; type 2 diabetes mellitus; NAFLD; fibroscan
ID TRANSIENT ELASTOGRAPHY; GLOBAL EPIDEMIOLOGY; PREVALENCE;
   STEATOHEPATITIS; PATHOGENESIS; MANAGEMENT; STEATOSIS; DIAGNOSIS;
   STIFFNESS; DELIVERY
AB Liver fibrosis is a key pathophysiology process in chronic liver disease. It is still unclear whether the impact of liver fibrosis is not fully realized in type 2 diabetes mellitus (T2D) patients with nonalcoholic fatty liver disease (NAFLD), and the factors affecting nonalcoholic steatohepatitis (NASH) or liver stiffness also remain unclear. The aim of this study was to evaluate the determinants of liver fibrosis and in T2D patients with NAFLD. Liver fibrosis and steatosis were measured using transient elastography (FibroScan). Of 226 T2D patients with NAFLD, 50 with liver fibrosis had higher body mass index, serum uric acid, triglyceride and glycated hemoglobin levels and lower high density lipoprotein levels than 176 without liver fibrosis. Multivariate analysis revealed that aging, obesity, sulfonylurea usage and high levels of AST increased the risk of liver fibrosis in T2D patients with NAFLD. Our findings provide useful information to clinical physicians for earlier detection of liver fibrosis in T2D patients with NAFLD and to prevent liver fibrosis through controlling these risk factors.
C1 [Dai, Chia-Yen] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung 807, Taiwan.
   [Dai, Chia-Yen; Tsai, Hui-Ju; Tsai, Yi-Chun] Kaohsiung Med Univ, Coll Med, Sch Med, Kaohsiung 807, Taiwan.
   [Fang, Tzu-Jung] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Geriatr & Gerontol, Kaohsiung 807, Taiwan.
   [Hung, Wei-Wen] Kaohsiung Med Univ Hosp, Div Endocrinol & Metab, Kaohsiung 807, Taiwan.
   [Tsai, Hui-Ju] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Family Med, Kaohsiung 801, Taiwan.
   [Tsai, Hui-Ju] Kaohsiung Med Univ, Res Ctr Environm Med, Kaohsiung 807, Taiwan.
   [Tsai, Yi-Chun] Kaohsiung Med Univ Hosp, Div Gen Med, Kaohsiung 807, Taiwan.
   [Tsai, Yi-Chun] Kaohsiung Med Univ Hosp, Div Nephrol, Kaohsiung 807, Taiwan.
   [Tsai, Yi-Chun] Kaohsiung Med Univ, Liquid Biopsy & Cohort Res Ctr, Kaohsiung 807, Taiwan.
   [Tsai, Yi-Chun] Kaohsiung Med Univ, Drug Dev & Value Creat Res Ctr, Kaohsiung 807, Taiwan.
C3 Kaohsiung Medical University; Kaohsiung Medical University Hospital;
   Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung
   Medical University Hospital; Kaohsiung Medical University; Kaohsiung
   Medical University Hospital; Kaohsiung Medical University; Kaohsiung
   Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung
   Medical University; Kaohsiung Medical University Hospital; Kaohsiung
   Medical University; Kaohsiung Medical University Hospital; Kaohsiung
   Medical University; Kaohsiung Medical University
RP Tsai, HJ; Tsai, YC (corresponding author), Kaohsiung Med Univ, Coll Med, Sch Med, Kaohsiung 807, Taiwan.; Tsai, HJ (corresponding author), Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Family Med, Kaohsiung 801, Taiwan.; Tsai, HJ (corresponding author), Kaohsiung Med Univ, Res Ctr Environm Med, Kaohsiung 807, Taiwan.; Tsai, YC (corresponding author), Kaohsiung Med Univ Hosp, Div Gen Med, Kaohsiung 807, Taiwan.; Tsai, YC (corresponding author), Kaohsiung Med Univ Hosp, Div Nephrol, Kaohsiung 807, Taiwan.; Tsai, YC (corresponding author), Kaohsiung Med Univ, Liquid Biopsy & Cohort Res Ctr, Kaohsiung 807, Taiwan.; Tsai, YC (corresponding author), Kaohsiung Med Univ, Drug Dev & Value Creat Res Ctr, Kaohsiung 807, Taiwan.
EM daichiayen@gmail.com; 910062@ms.kmuh.org.tw; hung4488@ms57.hinet.net;
   bankin_0920@yahoo.com.tw; lidam65@yahoo.com.tw
RI Tsai, Hui-Ju/JVZ-2808-2024
OI Dai, Chia-Yen/0000-0003-2296-3054; tsai, yichun/0000-0003-4923-3342;
   Fang, Tzu-Jung/0000-0002-7318-5152
FU Ministry of Science and Technology [MOST 1102314-B-037-056-]; Kaohsiung
   Municipal Ta-Tung Hospital [KMTTH-110-R006]; National Pingtung
   University of Science and Technology and Kaohsiung Medical University
   [NPUST kmU-111-P009]
FX This study was funded by grants from Ministry of Science and Technology
   (MOST 1102314-B-037-056-), Kaohsiung Municipal Ta-Tung Hospital
   (KMTTH-110-R006), and National Pingtung University of Science and
   Technology and Kaohsiung Medical University (NPUST kmU-111-P009). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Alam MS, 2021, DIABET METAB SYND OB, V14, P3089, DOI 10.2147/DMSO.S317876
   Alexander M, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1321-x
   Almahmoud MH, 2021, ANN MED SURG, V68, DOI 10.1016/j.amsu.2021.102677
   Araújo AR, 2018, LIVER INT, V38, P47, DOI 10.1111/liv.13643
   Bhatt HB, 2015, HEPATOL SURG NUTR, V4, P101, DOI 10.3978/j.issn.2304-3881.2015.01.03
   Bril F, 2020, DIABETES CARE, V43, P290, DOI 10.2337/dc19-1071
   Chen KN, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236977
   Chiang DAJ, 2011, AM J PHYSIOL-GASTR L, V300, pG697, DOI 10.1152/ajpgi.00426.2010
   Ciardullo S, 2021, DIABETES CARE, V44, P519, DOI 10.2337/dc20-1778
   de Lédinghen V, 2014, J HEPATOL, V60, P1026, DOI 10.1016/j.jhep.2013.12.018
   Diehl AM, 2017, NEW ENGL J MED, V377, P2063, DOI 10.1056/NEJMra1503519
   Eddowes PJ, 2019, GASTROENTEROLOGY, V156, P1717, DOI 10.1053/j.gastro.2019.01.042
   Fujii H, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-93435-x
   Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752
   Kao WY, 2020, OBES SURG, V30, P1249, DOI 10.1007/s11695-019-04192-w
   Khunti K, 2018, LANCET DIABETES ENDO, V6, P821, DOI 10.1016/S2213-8587(18)30025-1
   Koehler EM, 2016, HEPATOLOGY, V63, P138, DOI 10.1002/hep.27981
   Kuchay MS, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9101346
   Kumar V, 2015, PHARM RES-DORDR, V32, P341, DOI 10.1007/s11095-014-1497-x
   Kwok R, 2016, GUT, V65, P1359, DOI 10.1136/gutjnl-2015-309265
   Lai LL, 2019, J GASTROEN HEPATOL, V34, P1396, DOI 10.1111/jgh.14577
   Lee HW, 2021, J DIABETES COMPLICAT, V35, DOI 10.1016/j.jdiacomp.2020.107747
   Lin CY, 2021, ADV DRUG DELIVER REV, V174, P127, DOI 10.1016/j.addr.2021.04.008
   Lomonaco R, 2021, DIABETES CARE, V44, P399, DOI 10.2337/dc20-1997
   Loomba R, 2019, CLIN GASTROENTEROL H, V17, P1867, DOI 10.1016/j.cgh.2018.11.004
   Makri E, 2021, ARCH MED RES, V52, P25, DOI 10.1016/j.arcmed.2020.11.010
   Mansour A, 2019, ACTA DIABETOL, V56, P1199, DOI 10.1007/s00592-019-01374-x
   Mofrad P, 2003, HEPATOLOGY, V37, P1286, DOI 10.1053/jhep.2003.50229
   Mota M, 2016, METABOLISM, V65, P1049, DOI 10.1016/j.metabol.2016.02.014
   Nascimbeni F, 2016, BMJ OPEN GASTROENTER, V3, DOI 10.1136/bmjgast-2015-000075
   Newsome PN, 2020, LANCET GASTROENTEROL, V5, P362, DOI 10.1016/S2468-1253(19)30383-8
   Phipps M, 2020, FRONTLINE GASTROENTE, V11, P478, DOI 10.1136/flgastro-2018-101119
   Pitisuttithum P, 2020, BMC GASTROENTEROL, V20, DOI 10.1186/s12876-020-01240-z
   Radaelli MG, 2018, J ENDOCRINOL INVEST, V41, P509, DOI 10.1007/s40618-017-0799-3
   Sanyal Debmalya, 2015, Indian J Endocrinol Metab, V19, P597, DOI 10.4103/2230-8210.163172
   Sberna AL, 2018, DIABETIC MED, V35, P368, DOI 10.1111/dme.13565
   Scheen AJ, 2014, EXPERT OPIN DRUG MET, V10, P839, DOI 10.1517/17425255.2014.902444
   Shima T, 2020, J GASTROENTEROL, V55, P100, DOI 10.1007/s00535-019-01626-1
   Siddiqui MT, 2020, WORLD J GASTROENTERO, V26, P3249, DOI 10.3748/wjg.v26.i23.3249
   Tada T, 2019, J GASTROEN HEPATOL, V34, P2011, DOI 10.1111/jgh.14734
   Takeshita Y, 2020, DIABETES THER, V11, P549, DOI 10.1007/s13300-020-00762-9
   Targher G, 2018, NAT REV ENDOCRINOL, V14, P99, DOI 10.1038/nrendo.2017.173
   Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132
   Tolman KG, 2007, DIABETES CARE, V30, P734, DOI 10.2337/dc06-1539
   Tomas TC, 2018, ACTA CHIM SLOV, V65, P253, DOI 10.17344/acsi.2018.4461
   Tuong TTK, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10030159
   Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x
   Vilar-Gomez E, 2018, GASTROENTEROLOGY, V155, P443, DOI 10.1053/j.gastro.2018.04.034
   Wild SH, 2016, J HEPATOL, V64, P1358, DOI 10.1016/j.jhep.2016.01.014
   Ye Q, 2020, LANCET GASTROENTEROL, V5, P739, DOI 10.1016/S2468-1253(20)30077-7
   Yen FS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243783
   Younossi ZM, 2019, J HEPATOL, V71, P793, DOI 10.1016/j.jhep.2019.06.021
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
   Zhao HL, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012356
   Zou ZY, 2020, J DIGEST DIS, V21, P372, DOI 10.1111/1751-2980.12871
NR 55
TC 7
Z9 7
U1 0
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2227-9059
J9 BIOMEDICINES
JI Biomedicines
PD JUL
PY 2022
VL 10
IS 7
AR 1487
DI 10.3390/biomedicines10071487
PG 12
WC Biochemistry & Molecular Biology; Medicine, Research & Experimental;
   Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Research & Experimental Medicine;
   Pharmacology & Pharmacy
GA 3H7VF
UT WOS:000832239600001
PM 35884792
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU TURINSKY, J
   BAYLY, BP
   OSULLIVAN, DM
AF TURINSKY, J
   BAYLY, BP
   OSULLIVAN, DM
TI 1,2-DIACYLGLYCEROL AND CERAMIDE LEVELS IN RAT-LIVER AND SKELETAL-MUSCLE
   INVIVO
SO AMERICAN JOURNAL OF PHYSIOLOGY
LA English
DT Article
DE FETAL GROWTH; POSTNATAL AGING; TISSUE ANOXIA; STRESS;
   LIPOPOLYSACCHARIDE; SALMONELLA-ENTERITIDIS
ID PROTEIN-KINASE-C; PHORBOL-MYRISTATE ACETATE; INSULIN-RESISTANT TISSUES;
   GLYCOGEN-SYNTHASE; GLUCOSE-TRANSPORT; PHOSPHOLIPASE-C; DIACYLGLYCEROL;
   HEPATOCYTES; VASOPRESSIN; STIMULATION
AB 1,2-Diacylglycerol and ceramide levels were measured in liver and skeletal muscle of rats under the following four experimental conditions:  1) during rapid fetal growth in the second half of gestation and during postnatal aging, 2) during tissue anoxia lasting up to 10 min, 3) during fasting for up to 6 days, and 4) during stress induced by injection of endotoxin (lipopolysaccharide from Salmonella enteritidis).  1,2-Diacylglycerol and ceramide levels in fetal liver were 77 and 58% lower, respectively, than those of young rats after weaning.  1,2-Diacylglycerol and ceramide concentrations in liver of postnatal rats were not influenced by aging.  Anoxia produced a 41-64% increase in liver 1,2-diacylglycerol levels and a 9-21% increase in liver ceramides.  Fasting of adult rats for up to 6 days had no effect on 1,2-diacylglycerol and ceramide levels in liver.  However, fasting increased skeletal muscle concentrations of 1,2-diacylglycerol and ceramides 88 and 44%, respectively.  Injection of endotoxin had a biphasic effect on liver 1,2-diacylglycerol levels, causing a transient 52% increase at 1 h, followed by a 24-38% decrease below the control level at 17 h after endotoxin administration.  Liver ceramide levels were increased 66, 52, and 27% at 1, 3, and 5 h after endotoxin, respectively, but did not differ from control at 17 h after injection.  Endotoxin had no effect on muscle 1,2-diacylglycerol and ceramide concentrations at any interval.
RP TURINSKY, J (corresponding author), UNION UNIV,DEPT PHYSIOL & CELL BIOL A-134,47 NEW SCOTLAND AVE,ALBANY,NY 12208, USA.
FU NIGMS NIH HHS [GM-22825] Funding Source: Medline
CR BARTLETT GR, 1959, J BIOL CHEM, V234, P466
   BLACKMORE PF, 1986, BIOCHEM J, V237, P235, DOI 10.1042/bj2370235
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   BOCCKINO SB, 1989, BIOCHEM BIOPH RES CO, V164, P290, DOI 10.1016/0006-291X(89)91716-6
   BOCCKINO SB, 1985, J BIOL CHEM, V260, P4201
   Boivin A, 1938, CR SOC BIOL, V128, P5
   BOUSCAREL B, 1986, BIOCHIM BIOPHYS ACTA, V888, P126, DOI 10.1016/0167-4889(86)90078-9
   BRACKETT DJ, 1985, CIRC SHOCK, V17, P273
   CORVERA S, 1984, BIOCHEM BIOPH RES CO, V119, P1128, DOI 10.1016/0006-291X(84)90892-1
   DETURCO EBR, 1988, BIOCHEM J, V253, P73
   FARESE RV, 1987, SCIENCE, V236, P586, DOI 10.1126/science.3107122
   GARCIA R, 1990, CIRC SHOCK, V30, P365
   GHOSH TK, 1990, SCIENCE, V248, P1653, DOI 10.1126/science.2163543
   HANNUN YA, 1986, J BIOL CHEM, V261, P2604
   HERION JC, 1964, AM J PHYSIOL, V206, P947, DOI 10.1152/ajplegacy.1964.206.5.947
   JONES SB, 1989, CIRC SHOCK, V28, P59
   KELLEHER DL, 1982, AM J PHYSIOL, V243, pR77, DOI 10.1152/ajpregu.1982.243.1.R77
   KIM JYH, 1986, J NEUROSCI RES, V15, P159, DOI 10.1002/jnr.490150205
   LYNCH CJ, 1985, J BIOL CHEM, V260, P2844
   MAVIS RD, 1972, J BIOL CHEM, V247, P2835
   NELSON DH, 1986, BIOCHEM BIOPH RES CO, V138, P463, DOI 10.1016/0006-291X(86)90303-7
   OKAZAKI T, 1990, J BIOL CHEM, V265, P15823
   PREISS JE, 1987, METHOD ENZYMOL, V141, P294
   ROACH PJ, 1983, P NATL ACAD SCI-BIOL, V80, P7170, DOI 10.1073/pnas.80.23.7170
   ROBERTSON DG, 1989, J BIOL CHEM, V264, P6773
   ROTH BL, 1987, AM J PHYSIOL, V252, pE699, DOI 10.1152/ajpendo.1987.252.5.E699
   ROZENGURT E, 1984, P NATL ACAD SCI-BIOL, V81, P5748, DOI 10.1073/pnas.81.18.5748
   RUITER DJ, 1981, LAB INVEST, V45, P38
   SMAL J, 1989, P NATL ACAD SCI USA, V86, P4705, DOI 10.1073/pnas.86.12.4705
   SOWELL MO, 1988, DIABETES, V37, P499, DOI 10.2337/diabetes.37.5.499
   STANDAERT ML, 1988, J BIOL CHEM, V263, P8696
   STERN I, 1953, J CLIN PATHOL, V6, P158, DOI 10.1136/jcp.6.2.158
   TURINSKY J, 1990, J BIOL CHEM, V265, P7933
   TURINSKY J, 1990, J BIOL CHEM, V265, P16880
   VANDEWERVE G, 1985, BIOCHEM J, V231, P511, DOI 10.1042/bj2310511
   VANDEWERVE G, 1987, DIABETES, V36, P310, DOI 10.2337/diabetes.36.3.310
NR 36
TC 24
Z9 25
U1 0
U2 2
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0002-9513
J9 AM J PHYSIOL
JI Am. J. Physiol.
PD NOV
PY 1991
VL 261
IS 5
BP E620
EP E627
DI 10.1152/ajpendo.1991.261.5.E620
PN 1
PG 8
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA GQ780
UT WOS:A1991GQ78000037
PM 1951687
DA 2024-02-19
ER

PT J
AU Pérez, S
   Rius-Pérez, S
   Tormos, AM
   Finamor, I
   Nebreda, AR
   Taléns-Visconti, R
   Sastre, J
AF Perez, Salvador
   Rius-Perez, Sergio
   Tormos, Ana M.
   Finamor, Isabela
   Nebreda, Angel R.
   Talens-Visconti, Raquel
   Sastre, Juan
TI Age-dependent regulation of antioxidant genes by p38α MAPK in the liver
SO REDOX BIOLOGY
LA English
DT Article
DE Nuclear factor kappa B; Glutathione; Glutamate cysteine ligase;
   Superoxide dismutase 1; Superoxide dismutase 2; And catalase
ID NF-KAPPA-B; ONCOGENE-INDUCED SENESCENCE; RIBOSOMAL S6 KINASE-1; P38
   MAPK; OXIDATIVE STRESS; CELL-PROLIFERATION; SIGNALING PATHWAY;
   ENDOTHELIAL-CELLS; REDOX REGULATION; SKELETAL-MUSCLE
AB p38 alpha is a redox sensitive MAPK activated by pro-inflammatory cytokines and environmental, genotoxic and endoplasmic reticulum stresses. The aim of this work was to assess whether p38 alpha controls the antioxidant defense in the liver, and if so, to elucidate the mechanism(s) involved and the age-related changes. For this purpose, we used liver-specific p38 alpha-deficient mice at two different ages: young-mice (4 months-old) and old-mice (24 months-old). The liver of young p38 alpha knock-out mice exhibited a decrease in GSH levels and an increase in GSSG/GSH ratio and malondialdehyde levels. However, old mice deficient in p38 alpha had higher hepatic GSH levels and lower GSSG/GSH ratio than young p38 alpha knock-out mice. Liver-specific p38 alpha deficiency triggered a dramatic down-regulation of the mRNAs of the key antioxidant enzymes glutamate cysteine ligase, superoxide dismutase 1, superoxide dismutase 2, and catalase in young mice, which seems mediated by the lack of p65 recruitment to their promoters. Nrf-2 nuclear levels did not change significantly in the liver of young mice upon p38 alpha deficiency, but nuclear levels of phospho-p65 and PGC-1 alpha decreased in these mice. p38 alpha-dependent activation of NF-kappa B seems to occur through classical I kappa B Kinase and via ribosomal S6 kinasel and AKT in young mice. However, unexpectedly the long-term deficiency in p38 alpha triggers a compensatory up-regulation of antioxidant enzymes via NF-kappa B activation and recruitment of p65 to their promoters. In conclusion, p38 alpha MAPK maintains the expression of antioxidant genes in liver of young animals via NF-kappa B under basal conditions, whereas its long-term deficiency triggers compensatory up-regulation of antioxidant enzymes through NF-kappa B.
C1 [Perez, Salvador; Rius-Perez, Sergio; Tormos, Ana M.; Finamor, Isabela; Sastre, Juan] Univ Valencia, Sch Pharm, Dept Physiol, Avda Vicente Andres Estelles S-N, E-46100 Burjassot, Valencia, Spain.
   [Nebreda, Angel R.] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain.
   [Nebreda, Angel R.] ICREA, Pg Lluis Co 23, Barcelona 08010, Spain.
   [Talens-Visconti, Raquel] Univ Valencia, Dept Pharm & Pharmaceut Technol & Parasitol, Sch Pharm, E-46100 Burjassot, Spain.
C3 University of Valencia; Barcelona Institute of Science & Technology;
   Institute for Research in Biomedicine - IRB Barcelona; ICREA; University
   of Valencia
RP Sastre, J (corresponding author), Univ Valencia, Sch Pharm, Dept Physiol, Avda Vicente Andres Estelles S-N, E-46100 Burjassot, Valencia, Spain.
EM juan.sastre@uv.es
RI Pérez, Salvador/N-5943-2014; PEREZ, SERGIO RIUS/T-7766-2017; Nebreda,
   Angel Rodriguez/R-9594-2019; Taléns-Visconti, Raquel/P-6621-2019
OI Pérez, Salvador/0000-0003-0766-1744; Taléns-Visconti,
   Raquel/0000-0002-9816-9693
FU FEDER funds from the Spanish Ministry of Economy and Competitiveness
   [SAF2012-39694, SAF2015-71208-R]; European Commission [ERC 294665];
   "Programa de Doutorado Sanduiche do Exterior (PDSE)", "Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)
FX This work was supported by Grant SAF2012-39694 and SAF2015-71208-R with
   FEDER funds from the Spanish Ministry of Economy and Competitiveness to
   J.S. ARN was funded by a grant from the European Commission (ERC
   294665). I.F. was recipient of a fellowship from "Programa de Doutorado
   Sanduiche do Exterior (PDSE)" that belongs to the "Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES).
CR Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5
   Andrusiak MG, 2016, J BIOL CHEM, V291, P7796, DOI 10.1074/jbc.R115.711101
   Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509
   Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465
   Blau HM, 2015, NAT MED, V21, P854, DOI 10.1038/nm.3918
   Bohuslav J, 2004, J BIOL CHEM, V279, P26115, DOI 10.1074/jbc.M313509200
   Bulavin DV, 2003, MOL CELL BIOL, V23, P3859, DOI 10.1128/MCB.23.11.3859-3871.2003
   Bundy RE, 2005, ANTIOXID REDOX SIGN, V7, P14, DOI 10.1089/ars.2005.7.14
   Cederbaum AI, 2015, ADV EXP MED BIOL, V815, P145, DOI 10.1007/978-3-319-09614-8_9
   Cherry AD, 2014, J BIOL CHEM, V289, P41, DOI 10.1074/jbc.M113.512483
   Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323
   Cuadrado A, 2015, FREE RADICAL BIO MED, V88, P147, DOI 10.1016/j.freeradbiomed.2015.04.029
   Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010
   Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013
   Escobedo J, 2004, FREE RADICAL BIO MED, V37, P1455, DOI 10.1016/j.freeradbiomed.2004.07.024
   Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Garrido C, 2006, CELL CYCLE, V5, P2592, DOI 10.4161/cc.5.22.3448
   Han JH, 2007, TRENDS BIOCHEM SCI, V32, P364, DOI 10.1016/j.tibs.2007.06.007
   Heinrichsdorff J, 2008, EMBO REP, V9, P1048, DOI 10.1038/embor.2008.149
   Hsieh CC, 2002, MECH AGEING DEV, V123, P1423, DOI 10.1016/S0047-6374(02)00084-2
   Hsieh CC, 2006, FASEB J, V20, P259, DOI 10.1096/fj.05-4376com
   Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033
   Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x
   Jha SK, 2015, INT J MOL CELL MED, V4, P67
   Kim SU, 2013, J NEUROIMMUNOL, V259, P26, DOI 10.1016/j.jneuroim.2013.03.006
   Kwong J, 2009, J BIOL CHEM, V284, P11237, DOI 10.1074/jbc.M808327200
   Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200
   Matsukawa J, 2004, J BIOCHEM, V136, P261, DOI 10.1093/jb/mvh134
   Mendelson KG, 1996, P NATL ACAD SCI USA, V93, P12908, DOI 10.1073/pnas.93.23.12908
   Nguyen A, 2004, FEBS LETT, V572, P307, DOI 10.1016/j.febslet.2004.06.061
   Nicke B, 2005, MOL CELL, V20, P673, DOI 10.1016/j.molcel.2005.10.038
   Olmos Y, 2013, ANTIOXID REDOX SIGN, V19, P1507, DOI 10.1089/ars.2012.4713
   Pereira L, 2013, EMBO MOL MED, V5, P1759, DOI 10.1002/emmm.201302732
   Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016
   Salvador JM, 2005, NAT IMMUNOL, V6, P390, DOI 10.1038/ni1177
   Sastre J, 2003, FREE RADICAL BIO MED, V35, P1, DOI 10.1016/S0891-5849(03)00184-9
   SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X
   Shao LJ, 2014, ANTIOXID REDOX SIGN, V20, P1447, DOI 10.1089/ars.2013.5635
   Soga Mayumi, 2012, Int J Cell Biol, V2012, P439587, DOI 10.1155/2012/439587
   Son Y, 2013, METHOD ENZYMOL, V528, P27, DOI 10.1016/B978-0-12-405881-1.00002-1
   Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046
   Tormos AM, 2013, HEPATOLOGY, V57, P1950, DOI 10.1002/hep.26174
   Torrnos A. M., 2017, PLOS ONE, V12, DOI [10.1371/journal.pone.0171738, DOI 10.1371/JOURNAL.PONE.0171738]
   Trempolec N, 2013, CELL, V152, P656, DOI [10.1016/j.cell.2013.01.029, 10.1016/j.cell.2013.01.047]
   Usatyuk PV, 2003, ANTIOXID REDOX SIGN, V5, P723, DOI 10.1089/152308603770380025
   Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037
   Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009
   Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694
   Wakabayashi N, 2015, FREE RADICAL BIO MED, V88, P158, DOI 10.1016/j.freeradbiomed.2015.05.017
   Wang SD, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071037
   Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002
   WONG SHY, 1987, CLIN CHEM, V33, P214
   Xu SQ, 2006, AM J PHYSIOL-CELL PH, V291, pC1336, DOI 10.1152/ajpcell.00552.2005
   Xu YX, 2014, TRENDS BIOCHEM SCI, V39, P268, DOI 10.1016/j.tibs.2014.04.004
   Yaswen P, 2007, CELL, V128, P233, DOI 10.1016/j.cell.2007.01.005
   Zaru R, 2015, J IMMUNOL, V195, P4264, DOI 10.4049/jimmunol.1501520
NR 57
TC 7
Z9 8
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2213-2317
J9 REDOX BIOL
JI Redox Biol.
PD JUN
PY 2018
VL 16
BP 276
EP 284
DI 10.1016/j.redox.2018.02.017
PG 9
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA GV8OR
UT WOS:000446404400027
PM 29567616
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Tanrikulu-Kucuk, S
   Ademoglu, E
AF Tanrikulu-Kucuk, Sevda
   Ademoglu, Evin
TI Dietary restriction of amino acids other than methionine prevents
   oxidative damage during aging: Involvement of telomerase activity and
   telomere length
SO LIFE SCIENCES
LA English
DT Article
DE Aging; Mitochondrial DNA; Dietary restriction; Free radicals; DNA
   damage; Oxidative damage
ID CALORIC RESTRICTION; LIFE-SPAN; MITOCHONDRIAL-DNA; COMPLEX-I; RAT-LIVER;
   RADICAL GENERATION; ROS GENERATION; F344 RATS; PROTEIN; STRESS
AB Aims: It has been suggested that variations in the proportions of some dietary amino acids can slow down aging. In this study, the influence of amino acids other than methionine on aging was investigated.
   Main methods: Rats were fed either with normal (ND) or except methionine, protein restricted diet (PREMD) for 4 months and oxygen radical production, oxidative protein and DNA damage along with telomere length and telomerase activity were evaluated in the liver.
   Key findings: Except mitochondrial superoxide production rate, feeding with PREMD significantly decreased the oxygen radical production rate and protein carbonyl levels in the homogenate and mitochondria of 16-month-old rats. Feeding with PREMD prevented 8-OHdG formation in mitochondria! DNA but not in the genomic DNA. Although liver telomerase activities of rats receiving either ND or PREMD seemed to have some variations, these did not reach a statistical significance. Feeding with PREMD conserved the telomere length in the liver. The telomere length of 8- and 16-month-old rats fed PREMD was similar, 16-month-old rats fed ND had telomeres shortened by 36% (p<0.05).
   Significance: Long-term restriction of the amino acids other than methionine may decrease oxygen radical generation and oxidative damage of cellular constituents, and may also prevent telomere shortening in rat liver. (c) 2012 Elsevier Inc. All rights reserved.
C1 [Ademoglu, Evin] Istanbul Univ, Istanbul Fac Med, Dept Biochem, TR-34093 Istanbul, Turkey.
   [Tanrikulu-Kucuk, Sevda] Istanbul Bilim Univ, Fac Med, Dept Biochem, Istanbul, Turkey.
C3 Istanbul University; Demiroglu Bilim University
RP Ademoglu, E (corresponding author), Istanbul Univ, Istanbul Fac Med, Dept Biochem, TR-34093 Istanbul, Turkey.
EM evin@istanbul.edu.tr
RI Ademoglu, Evin/AAD-8990-2020; KÜÇÜK, SEVDA TANRIKULU/AAJ-9738-2020
OI Ademoglu, Evin/0000-0003-2933-3119; 
FU Research Fund of Istanbul University [T-61/15122006]
FX This work was supported by The Research Fund of Istanbul University
   (project number: T-61/15122006). The authors thank Professor Ahmet
   Dirican, PhD Department of Public Health, for his contribution to the
   statistical analyses; and Professor Figen Gurdol, MD, Department of
   Biochemistry, for her invaluable comments on the manuscript.
CR ALLSOPP RC, 1995, EXP CELL RES, V220, P194, DOI 10.1006/excr.1995.1306
   Archer VE, 2003, MED HYPOTHESES, V60, P924, DOI 10.1016/S0306-9877(03)00097-5
   BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0
   Blackburn EH, 1991, NATURE, V350, P18
   Borrás C, 2004, J BIOL CHEM, V279, P34332, DOI 10.1074/jbc.M402425200
   Caro P, 2008, BIOGERONTOLOGY, V9, P183, DOI 10.1007/s10522-008-9130-1
   Caro Pilar, 2009, Rev Esp Geriatr Gerontol, V44, P194, DOI 10.1016/j.regg.2009.01.003
   Caro P, 2009, BIOGERONTOLOGY, V10, P579, DOI 10.1007/s10522-008-9200-4
   DeLaAsuncion JG, 1996, FASEB J, V10, P333, DOI 10.1096/fasebj.10.2.8641567
   Dubrana K, 2001, CURR OPIN CELL BIOL, V13, P281, DOI 10.1016/S0955-0674(00)00210-6
   Epel ES, 2009, HORM-INT J ENDOCRINO, V8, P7, DOI 10.14310/horm.2002.1217
   Everitt AV, 2005, AGE, V27, P39, DOI 10.1007/s11357-005-3284-4
   Greaves LC, 2009, BBA-GEN SUBJECTS, V1790, P1015, DOI 10.1016/j.bbagen.2009.04.018
   Gredilla R, 2001, FASEB J, V15, P1589, DOI 10.1096/fj.00-0764fje
   Haenold R, 2005, AGE, V27, P183, DOI 10.1007/s11357-005-2915-0
   Haklar G, 2001, CANCER LETT, V165, P219, DOI 10.1016/S0304-3835(01)00421-9
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   HARLEY CB, 1992, EXP GERONTOL, V27, P375, DOI 10.1016/0531-5565(92)90068-B
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Iwasaki K, 1988, J GERONTOL, V43, P13
   JACOBUS WE, 1982, ARCH BIOCHEM BIOPHYS, V219, P167, DOI 10.1016/0003-9861(82)90146-1
   Jin KL, 2010, AGING DIS, V1, P72
   KHORAKOVA M, 1990, Fiziologicheskii Zhurnal (Kiev), V36, P16
   Kurz DJ, 2004, J CELL SCI, V117, P2417, DOI 10.1242/jcs.01097
   LATORRE A, 1986, P NATL ACAD SCI USA, V83, P8649, DOI 10.1073/pnas.83.22.8649
   López-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6
   Mair W, 2005, PLOS BIOL, V3, P1305, DOI 10.1371/journal.pbio.0030223
   MCCAY CM, 1989, NUTRITION, V5, P155
   Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x
   Page MM, 2010, MECH AGEING DEV, V131, P242, DOI 10.1016/j.mad.2010.02.005
   Pamplona R, 2005, AGE, V27, P267, DOI 10.1007/s11357-005-4562-x
   Pamplona R, 2006, BBA-BIOENERGETICS, V1757, P496, DOI 10.1016/j.bbabio.2006.01.009
   Portero-Otín M, 2004, EXP GERONTOL, V39, P1527, DOI 10.1016/j.exger.2004.08.001
   REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357
   RICHIE JP, 1994, FASEB J, V8, P1302, DOI 10.1096/fasebj.8.15.8001743
   ROMERO DP, 1991, CELL, V67, P343, DOI 10.1016/0092-8674(91)90186-3
   Ruiz MC, 2005, MECH AGEING DEV, V126, P1106, DOI 10.1016/j.mad.2005.04.005
   Sanchez-Roman I, 2011, J BIOENERG BIOMEMBR, V43, P699, DOI 10.1007/s10863-011-9389-9
   Sanz A, 2004, J BIOENERG BIOMEMBR, V36, P545, DOI 10.1007/s10863-004-9001-7
   Shimokawa I, 1996, AGING-CLIN EXP RES, V8, P254, DOI 10.1007/BF03339576
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Soltow QA, 2010, INTEGR COMP BIOL, V50, P844, DOI 10.1093/icb/icq094
   Troen AM, 2007, AGE, V29, P29, DOI 10.1007/s11357-006-9018-4
   Viña J, 2007, IUBMB LIFE, V59, P249, DOI 10.1080/15216540601178067
   VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305
   Warner HR, 2005, AGE, V27, P321, DOI 10.1007/s11357-005-4556-8
   Weindruch R, 2003, ALZ DIS ASSOC DIS, V17, P58
   Wright JH, 1995, NUCLEIC ACIDS RES, V11, P1454
   YOUNGMAN LD, 1992, P NATL ACAD SCI USA, V89, P9112, DOI 10.1073/pnas.89.19.9112
NR 51
TC 8
Z9 9
U1 0
U2 24
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
J9 LIFE SCI
JI Life Sci.
PD JUN 14
PY 2012
VL 90
IS 23-24
BP 924
EP 928
DI 10.1016/j.lfs.2012.04.024
PG 5
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 962LO
UT WOS:000305546800007
PM 22564407
DA 2024-02-19
ER

PT J
AU Parkinson, JRC
   Emsley, R
   Adkins, JLT
   Longford, N
   Ozanne, SE
   Holmes, E
   Modi, N
AF Parkinson, James R. C.
   Emsley, Robby
   Adkins, Jane L. Tarry
   Longford, Nick
   Ozanne, Susan E.
   Holmes, Elaine
   Modi, Neena
TI Clinical and molecular evidence of accelerated ageing following very
   preterm birth
SO PEDIATRIC RESEARCH
LA English
DT Article
ID BLOOD-PRESSURE; GESTATIONAL-AGE; METABOLIC SYNDROME; ABDOMINAL OBESITY;
   CHILDREN BORN; VISCERAL FAT; ADIPOSITY; MORTALITY; PLASMA; GROWTH
AB Background The mechanisms responsible for the associations between very preterm birth and a higher risk of poor cardiovascular and metabolic health in adult life are unknown. Methods Here, we compare the clinical and molecular phenotypes of healthy, normal-weight young adults (18-27 years), born very preterm (<33 weeks gestational age (GA)) and at full-term (37-42 weeks GA). Outcomes included whole-body MRI, hepatic and muscle H-1 MRS, blood pressure measurements and telomere length. Results We recruited 156 volunteers, 69 preterm (45 women; 24 men) and 87 born at full-term (45 women; 42 men). Preterm individuals had a significantly altered blood pressure profile, including higher systolic blood pressure (SBP mmHg: preterm men 133.4 +/- 10.1, term men 23.0 +/- 6.9; preterm women 124.3 +/- 7.1, term women 118.4 +/- 8.0, p < 0.01 for all). Furthermore, preterm men had fewer long telomeres (145-48.5 kb: preterm men 14.1 +/- 0.9%, term men 17.8 +/- 1.1%, p < 0.05; 48.5-8.6 kb: preterm men 28.2 +/- 2.6, term men 37.0 +/- 2.4%, p < 0.001) and a higher proportion of shorter telomeres (4.2-1.3 kb: preterm men 40.4 +/- 3.5%, term men 29.9 +/- 3.2%, p < 0.01). Conclusion Our data indicate that healthy young adults born very preterm manifest clinical and molecular evidence of accelerated ageing.
C1 [Parkinson, James R. C.; Emsley, Robby; Longford, Nick; Modi, Neena] Imperial Coll London, Sect Neonatal Med, Dept Med, Chelsea & Westminster Campus,369 Fulham Rd, London SW10 9NH, England.
   [Parkinson, James R. C.] Univ Westminster, Dept Life Sci, Res Ctr Optimal Hlth, London W1W 6UW, England.
   [Adkins, Jane L. Tarry; Ozanne, Susan E.] Univ Cambridge, Metab Res Labs, Hills Rd, Cambridge CB2 OQQ, England.
   [Adkins, Jane L. Tarry; Ozanne, Susan E.] Addenbrookes Hosp, MRC Metab Dis Unit, Wellcome Trust MRC Inst Metab Sci, Hills Rd, Cambridge CB2 OQQ, England.
   [Holmes, Elaine] Imperial Coll London, Dept Surg & Canc, South Kensington Campus, London SW7 2AZ, England.
C3 Imperial College London; University of Westminster; University of
   Cambridge; Cambridge University Hospitals NHS Foundation Trust;
   Addenbrooke's Hospital; Imperial College London
RP Parkinson, JRC (corresponding author), Imperial Coll London, Sect Neonatal Med, Dept Med, Chelsea & Westminster Campus,369 Fulham Rd, London SW10 9NH, England.; Parkinson, JRC (corresponding author), Univ Westminster, Dept Life Sci, Res Ctr Optimal Hlth, London W1W 6UW, England.
EM j.parkinson@westminster.ac.uk
RI Holmes, Elaine/A-2189-2015; Holmes, Elaine/ABE-6606-2020
OI Holmes, Elaine/0000-0002-0556-8389; Ozanne, Susan/0000-0001-8753-5144
FU British Heart Foundation [FS/09/029/27902, PG/09/037/27387,
   PG/13/49/30307] Funding Source: Medline; Medical Research Council [(MC
   UU12012/04] Funding Source: Medline
CR Balaskó M, 2014, J CHEM NEUROANAT, V61-62, P248, DOI 10.1016/j.jchemneu.2014.08.006
   Bayrakci US, 2007, J PEDIATR-US, V151, P399, DOI 10.1016/j.jpeds.2007.04.003
   Cloarec O, 2005, ANAL CHEM, V77, P517, DOI 10.1021/ac048803i
   Crump C, 2011, JAMA-J AM MED ASSOC, V306, P1233, DOI 10.1001/jama.2011.1331
   de Jong F, 2012, HYPERTENSION, V59, P226, DOI 10.1161/HYPERTENSIONAHA.111.181784
   Delaney A, 2009, DIABETES CARE, V32, P165, DOI 10.2337/dc08-1319
   Després JP, 2008, ARTERIOSCL THROM VAS, V28, P1039, DOI 10.1161/ATVBAHA.107.159228
   Després JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488
   Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c
   Dona AC, 2014, ANAL CHEM, V86, P9887, DOI 10.1021/ac5025039
   Fabbrini E, 2009, P NATL ACAD SCI USA, V106, P15430, DOI 10.1073/pnas.0904944106
   Feldt K, 2007, J HUM HYPERTENS, V21, P401, DOI 10.1038/sj.jhh.1002176
   Harrington TAM, 2004, PEDIATR RES, V55, P437, DOI 10.1203/01.PDR.0000111202.29433.2D
   Heidinger BJ, 2012, P NATL ACAD SCI USA, V109, P1743, DOI 10.1073/pnas.1113306109
   Johansson S, 2005, CIRCULATION, V112, P3430, DOI 10.1161/CIRCULATIONAHA.105.540906
   Kajantie E, 2015, PAEDIATR PERINAT EP, V29, P515, DOI 10.1111/ppe.12219
   Kamarck TW, 2002, PHYSIOL BEHAV, V77, P699, DOI 10.1016/S0031-9384(02)00921-6
   Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402
   Kuk JL, 2006, OBESITY, V14, P336, DOI 10.1038/oby.2006.43
   Lewis MR, 2016, ANAL CHEM, V88, P9004, DOI 10.1021/acs.analchem.6b01481
   Littlejohns TJ, 2019, EUR HEART J, V40, P1158, DOI 10.1093/eurheartj/ehx254
   Martin CA, 2014, CLIN EXP PHARMACOL P, V41, P22, DOI 10.1111/1440-1681.12114
   Mathiasen R, 2009, DEV MED CHILD NEUROL, V51, P901, DOI 10.1111/j.1469-8749.2009.03331.x
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Möller P, 2009, AGING-US, V1, P733
   Neuhäuser M, 2004, PSYCHOL REP, V94, P189
   Odgers CL, 2012, J CHILD PSYCHOL PSYC, V53, P1009, DOI 10.1111/j.1469-7610.2012.02565.x
   Parkinson JRC, 2013, PEDIATRICS, V131, pE1240, DOI 10.1542/peds.2012-2177
   Riley K, 2008, ACTA PAEDIATR, V97, P159, DOI 10.1111/j.1651-2227.2007.00637.x
   Ritchie LD, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5644
   Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1
   Sardesai S, 2017, PEDIATR RES, V81, P240, DOI 10.1038/pr.2016.203
   Tarry-Adkins JL, 2009, FASEB J, V23, P1521, DOI 10.1096/fj.08-122796
   Thomas EL, 2011, PEDIATR RES, V70, P507, DOI 10.1203/PDR.0b013e31822d7860
   Thomas EL, 2005, GUT, V54, P122, DOI 10.1136/gut.2003.036566
   Uthaya S, 2005, PEDIATR RES, V57, P211, DOI 10.1203/01.PDR.0000148284.58934.1C
   VANDENBOOGAART A, 1995, NMR BIOMED, V8, P87, DOI 10.1002/nbm.1940080207
   Vorkas PA, 2015, ANAL CHEM, V87, P4184, DOI 10.1021/ac503775m
   Weis J, 2009, J MAGN RESON IMAGING, V30, P1124, DOI 10.1002/jmri.21900
   Wood NS, 2003, ARCH DIS CHILD-FETAL, V88, pF492, DOI 10.1136/fn.88.6.F492
NR 40
TC 19
Z9 19
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0031-3998
EI 1530-0447
J9 PEDIATR RES
JI Pediatr. Res.
PD MAY
PY 2020
VL 87
IS 6
BP 1005
EP 1010
DI 10.1038/s41390-019-0709-9
PG 6
WC Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Pediatrics
GA LI8WU
UT WOS:000529759500011
PM 31812156
OA Green Submitted
DA 2024-02-19
ER

PT J
AU Sundermann, EE
   Hussain, MA
   Moore, DJ
   Horvath, S
   Lin, DTS
   Kobor, MS
   Levine, A
AF Sundermann, Erin E.
   Hussain, Mariam A.
   Moore, David J.
   Horvath, Steven
   Lin, David T. S.
   Kobor, Michael S.
   Levine, Andrew
CA HNRP Grp
TI Inflammation-related genes are associated with epigenetic aging in HIV
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Article
DE HIV; Inflammation; Aging; Single nucleotide polymorphisms; Interleukin;
   HANA conditions
ID TUMOR-NECROSIS-FACTOR; C-REACTIVE PROTEIN; SINGLE NUCLEOTIDE
   POLYMORPHISMS; CORONARY-ARTERY-DISEASE; PLASMA IL-6 LEVELS; FACTOR-ALPHA
   GENE; INTERLEUKIN-10 GENE; ANTIINFLAMMATORY CYTOKINE; PROMOTER
   POLYMORPHISMS; MONONUCLEAR-CELLS
AB Chronic inflammation is characteristic of both HIV and aging ("inflammaging") and may contribute to the accelerated aging observed in people living with HIV (PLWH). We examined whether three inflammation-related single-nucleotide polymorphisms (SNPs) were risk factors for accelerated aging and HIV-associated, non-AIDS (HANA) conditions among PLWH. We examined 155 postmortem cases with HIV (mean age = 47.3, 81% male, 68% self-reported White) from the National NeuroAIDS Tissue Consortium who had pre-mortem neurobehavioral/medical/virologic data and epigenomic data from occipital cortex tissue. Accelerated aging was measured according to the Epigenetic Clock; an aging biomarker based on DNA methylation levels. Past or current age-associated HANA conditions including cerebrovascular, liver and kidney disease, chronic obstructive pulmonary disease, cancer, and diabetes were determined via self-report. Epigenetic Aging Z-scores and likelihood of past/current HANA conditions were compared between major allele homozygotes and minor allele carriers for each SNP (IL-6 - 174G>C, IL-10 - 592C>A, TNF-alpha - 308 G>A) separately. Analyses were adjusted for relevant demographic/clinical factors. Epigenetic aging (e.g., higher Z-scores) was significantly greater in IL-6 C allele carriers (p = .002) and IL-10 CC homozygotes (p = .02) compared to other genotype groups. The likelihood of any past/current HANA condition did not differ by IL-10 genotype but was 3.36 times greater in IL-6 C allele carriers versus others (OR = 3.36, 95%CI = 1.09-10.34, p = .03). TNF-alpha genotype was not associated with epigenetic aging or HANA conditions. IL-6 and IL-10 SNPs may help to identify PLWH who are at high risk for accelerated aging. These insights into pathophysiological pathways may inform interventional approaches to treat rapid aging among PLWH.
C1 [Sundermann, Erin E.; Hussain, Mariam A.; Moore, David J.] Univ Calif San Diego, Dept Psychiat, 9500 Gilman Dr, La Jolla, CA 92093 USA.
   [Hussain, Mariam A.] San Diego State Univ Univ Calif San Diego Joint D, 6363 Alvarado Ct, San Diego, CA 92120 USA.
   [Horvath, Steven] Univ Calif Los Angeles, David Geffen Sch Med, Human Genet, Los Angeles, CA 90095 USA.
   [Horvath, Steven] Univ Calif Los Angeles, Sch Publ Hlth, Biostat, Los Angeles, CA 90095 USA.
   [Lin, David T. S.; Kobor, Michael S.] Univ British Columbia, BC Childrens Hosp, Res Inst, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada.
   [Levine, Andrew] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.
C3 University of California System; University of California San Diego;
   California State University System; San Diego State University;
   University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA; University of California System; University of
   California Los Angeles; University of British Columbia; BC Childrens
   Hospital; University of California System; University of California Los
   Angeles; University of California Los Angeles Medical Center; David
   Geffen School of Medicine at UCLA
RP Sundermann, EE (corresponding author), Univ Calif San Diego, Dept Psychiat, 9500 Gilman Dr, La Jolla, CA 92093 USA.
EM esundermann@ucsd.edu
RI li, david/JXY-3562-2024; Hussain, Mariam/AAI-9460-2020; Levine,
   Andrew/ABD-7628-2021
OI Hussain, Mariam/0000-0002-3773-1785; Moore, David/0000-0001-9699-318X;
   Kobor, Michael/0000-0003-4140-1743; Horvath, Steve/0000-0002-4110-3589
FU National Institute of Health [P30MH062512, N01 MH22005,
   HHSN271201000036C, HHSN271201000030C, U24 MH100928, T32DA031098];
   Interdisciplinary Research Fellowship in NeuroAIDS [R25MH081482];
   Training in Research on Addictions in Interdisciplinary NeuroAIDS
   (TRAIN) [T32DA031098];  [R01MH096648];  [R01DA030913]
FX Primary funding was from R01MH096648 (MPIs: Levine and Moore).
   Additional funding was provided from R01DA030913 (MPIs: Levine and
   Horvath) as well as the following National Institute of Health awards
   [P30MH062512, N01 MH22005, HHSN271201000036C and HHSN271201000030C, U24
   MH100928, T32DA031098]. This work was further supported by salary
   support for Dr. E.E. Sundermann from the Interdisciplinary Research
   Fellowship in NeuroAIDS [R25MH081482] and support for Ms. M.A. Hussain
   from the Training in Research on Addictions in Interdisciplinary
   NeuroAIDS (TRAIN; T32DA031098).
CR Albani Diego, 2011, Aging Male, V14, P257, DOI 10.3109/13685538.2011.607521
   Altun B, 2005, TRANSPL INT, V18, P681, DOI 10.1111/j.1432-2277.2005.00118.x
   Alvarez V, 2002, AM J MED GENET, V114, P574, DOI 10.1002/ajmg.10515
   [Anonymous], 2017, HIV Surveillance Report
   Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b
   Barbieri M, 2003, AM J PHYSIOL-ENDOC M, V284, pE481, DOI 10.1152/ajpendo.00319.2002
   Bonafè M, 2001, EUR J IMMUNOL, V31, P2357, DOI 10.1002/1521-4141(200108)31:8<2357::AID-IMMU2357>3.0.CO;2-X
   Bruunsgaard H, 2001, CURR OPIN HEMATOL, V8, P131, DOI 10.1097/00062752-200105000-00001
   Cederholm T, 2007, J INTERN MED, V262, P215, DOI 10.1111/j.1365-2796.2007.01803.x
   Christiansen L, 2004, MECH AGEING DEV, V125, P391, DOI 10.1016/j.mad.2004.03.004
   Clifford RL, 2017, J ALLERGY CLIN IMMUN, V139, P112, DOI 10.1016/j.jaci.2016.03.046
   Cohen HJ, 1997, J GERONTOL A-BIOL, V52, pM201, DOI 10.1093/gerona/52A.4.M201
   Collins JS, 2000, AM J MED GENET, V96, P823, DOI 10.1002/1096-8628(20001204)96:6<823::AID-AJMG26>3.0.CO;2-I
   Culpan D, 2003, NEUROSCI LETT, V350, P61, DOI 10.1016/S0304-3940(03)00854-1
   Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756
   Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172
   Dunning MJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-85
   Durand M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2692-2
   ERSHLER WB, 1993, LYMPHOKINE CYTOK RES, V12, P225
   FAGIOLO U, 1993, EUR J IMMUNOL, V23, P2375, DOI 10.1002/eji.1830230950
   Ferrucci L, 1999, J AM GERIATR SOC, V47, P639, DOI 10.1111/j.1532-5415.1999.tb01583.x
   Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629
   Giovannini S, 2011, J AM GERIATR SOC, V59, P1679, DOI 10.1111/j.1532-5415.2011.03570.x
   Gross AM, 2016, MOL CELL, V62, P157, DOI 10.1016/j.molcel.2016.03.019
   Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2
   Herrmann SM, 1998, EUR J CLIN INVEST, V28, P59
   Hoffmann SC, 2002, AM J TRANSPLANT, V2, P560, DOI 10.1034/j.1600-6143.2002.20611.x
   Horvath S, 2015, J INFECT DIS, V212, P1563, DOI 10.1093/infdis/jiv277
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Hunt PW, 2016, J INFECT DIS, V214, pS44, DOI 10.1093/infdis/jiw275
   Hurme M, 2005, MECH AGEING DEV, V126, P417, DOI 10.1016/j.mad.2004.10.001
   Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463
   Jones SA, 2001, FASEB J, V15, P43, DOI 10.1096/fj.99-1003rev
   Kawanishi S, 2006, ANTIOXID REDOX SIGN, V8, P1047, DOI 10.1089/ars.2006.8.1047
   Kayaalti Z, 2011, ARCH GERONTOL GERIAT, V53, P354, DOI 10.1016/j.archger.2011.01.001
   Khabour OF, 2010, INT J IMMUNOGENET, V37, P293, DOI 10.1111/j.1744-313X.2010.00925.x
   Koch W, 2001, ATHEROSCLEROSIS, V159, P137, DOI 10.1016/S0021-9150(01)00467-1
   Kochanek Kenneth D, 2017, NCHS Data Brief, P1
   Kroeger KM, 1997, MOL IMMUNOL, V34, P391, DOI 10.1016/S0161-5890(97)00052-7
   Lagathu C, 2017, AIDS, V31, pS105, DOI [10.1097/QAD.0000000000001441, 10.1097/qad.0000000000001441]
   Lau A, 2005, NAT CELL BIOL, V7, P493, DOI 10.1038/ncb1250
   Lio D, 2002, GENES IMMUN, V3, P30, DOI 10.1038/sj.gene.6363827
   Mallat Z, 1999, CIRC RES, V85, pE17, DOI 10.1161/01.RES.85.8.e17
   Fragoso JM, 2011, CYTOKINE, V55, P29, DOI 10.1016/j.cyto.2011.03.021
   Morgello S, 2001, NEUROPATH APPL NEURO, V27, P326, DOI 10.1046/j.0305-1846.2001.00334.x
   Naicker DD, 2009, J INFECT DIS, V200, P448, DOI 10.1086/600072
   Nasi M, 2017, CLIN EXP IMMUNOL, V187, P44, DOI 10.1111/cei.12814
   Naumova E, 2004, EXP GERONTOL, V39, P637, DOI 10.1016/j.exger.2003.08.014
   Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749
   Nixon DE, 2010, CURR OPIN HIV AIDS, V5, P498, DOI 10.1097/COH.0b013e32833ed6f4
   Ohnishi S, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/387014
   Ohshima H, 2003, ARCH BIOCHEM BIOPHYS, V417, P3, DOI 10.1016/S0003-9861(03)00283-2
   Okayama N, 2005, J GERONTOL A-BIOL, V60, P1525, DOI 10.1093/gerona/60.12.1525
   Oslund LJP, 1999, ARTERIOSCL THROM VAS, V19, P2847, DOI 10.1161/01.ATV.19.12.2847
   Pathai S, 2014, J GERONTOL A-BIOL, V69, P833, DOI 10.1093/gerona/glt168
   Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3
   Pontillo A, 2012, JAIDS-J ACQ IMM DEF, V59, P121, DOI 10.1097/QAI.0b013e3182392ebe
   Posadas-Sánchez R, 2018, CYTOKINE, V106, P12, DOI 10.1016/j.cyto.2018.02.028
   Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327
   Rady PL, 2004, GENET TEST, V8, P194
   Rezer JFP, 2018, MICROB PATHOGENESIS, V114, P264, DOI 10.1016/j.micpath.2017.11.045
   Ross OA, 2003, MECH AGEING DEV, V124, P563, DOI 10.1016/S0047-6374(03)00037-X
   SCHINDLER R, 1990, BLOOD, V75, P40
   Seifart C, 2005, TISSUE ANTIGENS, V65, P93, DOI 10.1111/j.1399-0039.2005.00343.x
   Singh T, 2011, AGEING RES REV, V10, P319, DOI 10.1016/j.arr.2010.11.002
   Smith DA, 2001, CIRCULATION, V104, P746, DOI 10.1161/hc3201.094973
   So-Armah KA, 2016, JAIDS-J ACQ IMM DEF, V72, P206, DOI 10.1097/QAI.0000000000000954
   Sugimoto M, 2007, J GASTROEN HEPATOL, V22, P1443, DOI 10.1111/j.1440-1746.2006.04613.x
   Tachiwana H, 2006, CANCER RES, V66, P627, DOI 10.1158/0008-5472.CAN-05-3144
   Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680
   TILG H, 1994, BLOOD, V83, P113
   Trompet S, 2007, ANN NY ACAD SCI, V1100, P189, DOI 10.1196/annals.1395.018
   Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x
   Tuttolomondo A, 2012, CYTOKINE, V58, P398, DOI 10.1016/j.cyto.2012.02.012
   Vera JH, 2016, NEUROLOGY, V86, P1425, DOI 10.1212/WNL.0000000000002485
   Warriner AH, 2014, INFECT DIS CLIN N AM, V28, P457, DOI 10.1016/j.idc.2014.05.003
   Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368
   Yu GI, 2012, INFLAMM RES, V61, P899, DOI 10.1007/s00011-012-0482-2
   Yuen T, 2017, JAIDS-J ACQ IMM DEF, V76, P48, DOI 10.1097/QAI.0000000000001466
   Zimmerman ES, 2004, MOL CELL BIOL, V24, P9286, DOI 10.1128/MCB.24.21.9286-9294.2004
NR 80
TC 18
Z9 18
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD DEC
PY 2019
VL 25
IS 6
BP 853
EP 865
DI 10.1007/s13365-019-00777-4
PG 13
WC Neurosciences; Virology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Virology
GA KI9UO
UT WOS:000511704500012
PM 31286441
OA Green Accepted
DA 2024-02-19
ER

PT S
AU Yoon, YS
   Cho, H
   Lee, JH
   Yoon, G
AF Yoon, YS
   Cho, H
   Lee, JH
   Yoon, G
BE Lee, HK
   DiMauro, S
   Tanaka, M
   Wei, YH
TI Mitochondrial dysfunction via disruption of complex II activity during
   iron chelation-induced senescence-like growth arrest of Chang cells
SO MITOCHONDRIAL PATHOGENESIS: FROM GENES AND APOPTOSIS TO AGING AND
   DISEASE
SE Annals of the New York Academy of Sciences
LA English
DT Article; Proceedings Paper
CT 1st Scientific Meeting of the
   Asian-Society-for-Mitochondrial-Research-and-Medicine
CY FEB 05-06, 2003
CL Seoul, SOUTH KOREA
SP Asian Soc Mitochondrial Res & Med, Bukwang Pharmaceut, Dalim Pharmaceut, Mitocon Inc
DE mitochondrial dysfunction; disruption of complex II; deferoxamine
   mesylate-induced senescent arrest
ID HEPATOCELLULAR-CARCINOMA; IN-VITRO; G1 PHASE; INHIBITION; CYCLE;
   PROLIFERATION; LINES; ASSOCIATION; HEPATOCYTE; EXPRESSION
AB When cells are deprived of iron, their growth is invariably inhibited. However, the mechanism involved remains largely unclear. Recently, we have reported that subcytotoxic concentration of deferoxamine mesylate (DFO), an iron chelator, specifically inhibited transition of Chang cell, a normal hepatocyte cell line, from G1 to S phase, which was accompanied by irreversible appearance of senescent biomarkers. To investigate factors responsible for the irreversible arrest, we examined mitochondrial activities because they require several irons for their proper structure and function. After exposure to 1 M DFO, total cellular ATP level was irreversibly decreased with concurrent disruption of mitochondrial membrane potential (DeltaPsim), implying that it might be one of the crucial factors involved in the arrest. DFO did not directly inhibit the mitochondrial respiratory activities in vitro. Among the respiratory activities, complex II activity was specifically inhibited through a down-regulation of the expression of its iron-sulfur subunit. We also observed that mitochondrial morphology was drastically changed to highly elongated form. Our results suggest that mitochondrial function is sensitive to cellular iron level and iron deprivation might be involved in inducing the senescent arrest. In addition, complex II, which is a part of both oxidative phosphorylation and the Krebs cycle, could be one of the critical factors that regulate mitochondrial function by responding to iron levels.
C1 Ajou Univ, Sch Med, Dept Biochem & Mol Biol, Suwon 441721, South Korea.
C3 Ajou University
RP Yoon, YS (corresponding author), Ajou Univ, Sch Med, Dept Biochem & Mol Biol, Suwon 441721, South Korea.
EM ypeace@ajou.ac.kr
OI Cho, Hyeseong/0000-0002-4672-8887
CR Adams Paul C., 1998, Journal of Hepatology, V28, P19, DOI 10.1016/S0168-8278(98)80370-X
   ANDERSON GR, 1988, BIOCHEMISTRY-US, V27, P2187, DOI 10.1021/bi00406a056
   Boldt DH, 1999, AM J MED SCI, V318, P207, DOI 10.1097/00000441-199910000-00001
   BRODIE C, 1993, CANCER RES, V53, P3968
   Chenoufi N, 1998, LIVER, V18, P60
   Coates PJ, 2002, J PATHOL, V196, P371, DOI 10.1002/path.1073
   Deugnier Y, 2001, J GASTROEN HEPATOL, V16, P491, DOI 10.1046/j.1440-1746.2001.02430.x
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Esposti MD, 2001, METHOD CELL BIOL, V65, P75
   Fan LJ, 2001, CANCER RES, V61, P1073
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   HOYES KP, 1992, CANCER RES, V52, P4591
   Ito K, 1999, RADIOLOGY, V212, P235, DOI 10.1148/radiology.212.1.r99jl41235
   Kicic A, 2001, CANCER, V92, P3093, DOI 10.1002/1097-0142(20011215)92:12<3093::AID-CNCR10107>3.0.CO;2-B
   LUCAS JJ, 1995, BLOOD, V86, P2268, DOI 10.1182/blood.V86.6.2268.bloodjournal8662268
   NYHOLM S, 1993, J BIOL CHEM, V268, P26200
   Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116
   Renton FJ, 1996, BIOCHEM PHARMACOL, V51, P1553, DOI 10.1016/0006-2952(96)00099-8
   ROBBINS E, 1970, P NATL ACAD SCI USA, V66, P1244, DOI 10.1073/pnas.66.4.1244
   Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488
   Yoon G, 2002, BIOCHEM J, V366, P613, DOI 10.1042/BJ20011445
NR 21
TC 18
Z9 22
U1 1
U2 4
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
BN 1-57331-491-9; 1-57331-490-0
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2004
VL 1011
BP 123
EP 132
DI 10.1196/annals.1293.013
PG 10
WC Biochemistry & Molecular Biology; Multidisciplinary Sciences
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Science & Technology - Other Topics
GA BAE70
UT WOS:000221896100013
PM 15126290
DA 2024-02-19
ER

PT J
AU Marzook, F
   Marzook, E
   El-Sonbaty, S
AF Marzook, Fawzy
   Marzook, Ebtisam
   El-Sonbaty, Sawsan
TI Allantoin may modulate aging impairments, symptoms and cancers
SO PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE Allantoin; irradiation; physical activity; cancer; radiation protection
ID OXIDATIVE STRESS; FREE-RADICALS; PHYSICAL-ACTIVITY; ANTIOXIDANTS;
   CHOLESTEROL; EXERCISE; PREVENTION; SYSTEMS; PLASMA; REDOX
AB Allantoin increases in different stress conditions and environment such as physical activity, amniotic fluids and oxidative stress. So, we inspired to explore the role of allantoin as a metabolic by-product in health improvement and protection using irradiation as simulator for oxidative stress. Allantoin was injected i.p. (100 mg/kg) in senile male rats in irradiated and non-irradiated groups in comparison to sham operated group. The studied parameters were superoxide dismutase, Glutathione reductase, Glutathione, total antioxidant capacity, collagenase, urea, creatine kinase, alanine transaminase, aspartate aminotransferase, triglycerides, total cholesterol, and HDL and LDL cholesterol. Allantoin in vitro antitumor activity was MTT assayed for some age dependent cancers. Allantoin showed improvement in all in vivo studied oxidative stress parameters. Allantoin showed an increase in lipogenesis was recorded as a hepatic energy targeting muscles. Allantoin improves aging process indicated by its collagenase inhibitory effect. Allantoin showed cytotoxicity against prostate, colon, intestinal ovarian and breast cancers and weak inhibitory against larynx cancer. Allantoin may be the possible mysterious key factor involved in health and aging improvement and cancer protection in stress conditions such as physically activity and radiation hazards.
C1 [Marzook, Fawzy] Atom Energy Author, Labeled Compound Dept 1, Hot Lab Ctr, Cairo, Egypt.
   [Marzook, Ebtisam] Atom Energy Author, Biol Applicat Dept, Nucl Res Ctr, Cairo, Egypt.
   [El-Sonbaty, Sawsan] Atom Energy Author, Radiat Microbiol Dept, Natl Ctr Radiat Res & Technol, Cairo, Egypt.
C3 Egyptian Knowledge Bank (EKB); Egyptian Atomic Energy Authority (EAEA);
   Egyptian Knowledge Bank (EKB); Egyptian Atomic Energy Authority (EAEA);
   Egyptian Knowledge Bank (EKB); Egyptian Atomic Energy Authority (EAEA);
   National Center for Radiation Research & Technology
RP Marzook, F (corresponding author), Atom Energy Author, Labeled Compound Dept 1, Hot Lab Ctr, Cairo, Egypt.
EM fawzymarzouk@yahoo.com
RI Elsonbaty, sawsan/HKV-2611-2023
CR ALEKSANDROW D, 1964, J ATHEROSCLER RES, V4, P351, DOI 10.1016/S0368-1319(64)80046-6
   Amirthanathan A, 2011, J EXP SCI, V2, P01
   Bartges J, 2019, PHARMACOTHERAPEUTICS FOR VETERINARY DISPENSING, P297
   Battino M, 1999, CRIT REV ORAL BIOL M, V10, P458, DOI 10.1177/10454411990100040301
   BINDER C, 1992, BAILLIERE CLIN ENDOC, V6, P23, DOI 10.1016/S0950-351X(05)80329-5
   CARDOSO GC, 1994, CHEM PHYS LIPIDS, V67-8, P207, DOI 10.1016/0009-3084(94)90140-6
   de Bari O, 2014, ANN HEPATOL, V13, P728
   Fisher GJ, 1997, NEW ENGL J MED, V337, P1419, DOI 10.1056/NEJM199711133372003
   FOSSATI P, 1982, CLIN CHEM, V28, P2077
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Graham MR, 2009, AM J CARDIOVASC DRUG, V9, P371, DOI 10.2165/11312100-000000000-00000
   Gus'kov E P, 2004, Dokl Biochem Biophys, V398, P320, DOI 10.1023/B:DOBI.0000046649.11374.8d
   Kand'ár R, 2016, BIOMED CHROMATOGR, V30, P13, DOI 10.1002/bmc.3529
   Kruk J, 2019, FREE RADICAL RES, V53, P497, DOI 10.1080/10715762.2019.1612059
   LAWRENCE LM, 1990, VET CLIN N AM-EQUINE, V6, P393, DOI 10.1016/S0749-0739(17)30548-5
   LOPESVIRELLA MF, 1977, CLIN CHEM, V23, P882
   Ludwig B, 2012, P NATL ACAD SCI USA, V109, P5022, DOI 10.1073/pnas.1201868109
   MAVIS RD, 1968, J BIOL CHEM, V243, P809
   Mayneris-Perxachs J, 2019, EUR J NUTR, V58, P909, DOI 10.1007/s00394-018-1679-0
   Miles L, 2007, NUTR BULL, V32, P250, DOI 10.1111/j.1467-3010.2007.00653.x
   Milisav I, 2018, SUBCELL BIOCHEM, V90, P1, DOI 10.1007/978-981-13-2835-0_1
   Nageswari K, 1999, J NUTR BIOCHEM, V10, P338, DOI 10.1016/S0955-2863(99)00007-8
   Niki E, 2010, FREE RADICAL BIO MED, V49, P503, DOI 10.1016/j.freeradbiomed.2010.04.016
   Pal PB, 2015, BIOACTIVE NATURAL PRODUCTS: CHEMISTRY AND BIOLOGY, P199
   PATTON CJ, 1977, ANAL CHEM, V49, P464, DOI 10.1021/ac50011a034
   Reiter RJ, 2000, J BIOMED SCI, V7, P444, DOI 10.1007/BF02253360
   Ruiz-Casado A, 2017, TRENDS CANCER, V3, P423, DOI 10.1016/j.trecan.2017.04.007
   Saso L, 2014, CURR DRUG TARGETS, V15, P1177, DOI 10.2174/1389450115666141024113925
   Savini I., 2016, Obesity (Silver Spring), P65
   Seip RL, 1997, AM J PHYSIOL-ENDOC M, V272, pE255
   Shestopalov AV, 2006, BIOL BULL+, V33, P437, DOI 10.1134/S1062359006050037
   Torti DC, 2004, SPORTS MED, V34, P363, DOI 10.2165/00007256-200434060-00003
   Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Valko M, 2016, ARCH TOXICOL, V90, P1, DOI 10.1007/s00204-015-1579-5
   VANWART HE, 1981, ANAL BIOCHEM, V113, P356, DOI 10.1016/0003-2697(81)90089-0
   WIELAND H, 1983, J LIPID RES, V24, P904
   Zhou DN, 2018, CHEM ENG J, V346, P726, DOI 10.1016/j.cej.2018.04.016
NR 38
TC 2
Z9 3
U1 2
U2 12
PU UNIV KARACHI
PI KARACHI
PA UNIV CAMPUS, FAC PHARMACY, KARACHI, 75270, PAKISTAN
SN 1011-601X
J9 PAK J PHARM SCI
JI Pak. J. Pharm. Sci.
PD JUL
PY 2021
VL 34
IS 4
BP 1377
EP 1384
DI 10.36721/PJPS.2021.34.4.REG.1377-1384.1
PG 8
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA TA8QE
UT WOS:000667510100009
PM 34799310
DA 2024-02-19
ER

PT J
AU Wu, M
   Desai, DH
   Kakarla, SK
   Katta, A
   Paturi, S
   Gutta, AK
   Rice, KM
   Walker, EM
   Blough, ER
AF Wu, Miaozong
   Desai, Devashish H.
   Kakarla, Sunil K.
   Katta, Anjaiah
   Paturi, Satyanarayana
   Gutta, Anil K.
   Rice, Kevin M.
   Walker, Ernest M., Jr.
   Blough, Eric R.
TI Acetaminophen prevents aging-associated hyperglycemia in aged rats:
   effect of aging-associated hyperactivation of p38-MAPK and ERK1/2
SO DIABETES-METABOLISM RESEARCH AND REVIEWS
LA English
DT Article
DE acetaminophen; aging; hyperglycemia; glucose transporter-4;
   mitogen-activated protein kinase; reactive oxygen species
ID MAPK PATHWAY ACTIVATION; INDUCED GLUCOSE-UPTAKE; P38 MAPK;
   SKELETAL-MUSCLE; INSULIN-RESISTANCE; OXIDATIVE STRESS; KINASE;
   EXPRESSION; MYOCYTES
AB Background Aging-related hyperglycemia is associated with increased oxidative stress and diminished muscle glucose transporter-4 (Glut4) that may be regulated, at least in part, by the mitogen-activated protein kinases (MAPK).
   Methods To test the possibility that aging-related hyperglycemia can be prevented by pharmacological manipulation of MAPK hyperactivation, aged (27-month old) Fischer 344/NNiaHSD x Brown Norway/BiNia F1 (F344BN) rats were administered acetaminophen (30 mg/kg body weight/day) for 6 months in drinking water.
   Results Hepatic histopathology, serum aspartate aminotransferase and alanine aminotransferase analyses suggested that chronic acetaminophen did not cause hepatotoxicity. Compared with adult (6-month) and aged (27-month) rats, very aged rats (33-month) had higher levels of blood glucose, phosphorylation of soleus p38-MAPK and extracellular-regulated kinase 1/2 (ERK1/2), superoxide and oxidatively modified proteins (p < 0.05), and these changes were associated with decreased soleus Glut4 protein abundance (p < 0.05). Chronic acetaminophen treatment attenuated age-associated increase in blood glucose by 61.3% (p < 0.05) and increased soleus Glut4 protein by 157.2% (p < 0.05). These changes were accompanied by diminished superoxide levels, decrease in oxidatively modified proteins (-60.8%; p < 0.05) and reduced p38-MAPK and ERK1/2 hyperactivation (-50.4% and -35.4%, respectively; p < 0.05).
   Conclusions These results suggest that acetaminophen may be useful for the treatment of age-associated hyperglycemia. Copyright (c) 2009 John Wiley & Sons, Ltd.
C1 [Blough, Eric R.] Marshall Univ, Lab Mol Physiol, Dept Biol Sci, Huntington, WV 25755 USA.
   [Wu, Miaozong; Paturi, Satyanarayana; Blough, Eric R.] Marshall Univ, Cell Differentiat & Dev Ctr, Huntington, WV 25755 USA.
   [Desai, Devashish H.; Kakarla, Sunil K.; Katta, Anjaiah; Rice, Kevin M.; Blough, Eric R.] Marshall Univ, Dept Pharmacol Physiol & Toxicol, Huntington, WV 25755 USA.
   [Walker, Ernest M., Jr.] Marshall Univ, Dept Anat & Pathol, Huntington, WV 25755 USA.
C3 Marshall University; Marshall University; Marshall University; Marshall
   University
RP Blough, ER (corresponding author), Marshall Univ, Lab Mol Physiol, Dept Biol Sci, Byrd Biotechnol Bldg,1 John Marshall Dr, Huntington, WV 25755 USA.
EM blough@marshall.edu
RI Wu, Miaozong/C-1344-2009
OI Wu, Miaozong/0000-0002-2903-9625; Rice, Kevin/0000-0002-5785-3405
FU NIH [AG-027103-1]; McNeil Consumer Healthcare
FX This work was supported by grants provided by NIH Grant AG-027103-1 and
   McNeil Consumer Healthcare to E.R.B.
CR Bandyopadhyay G, 2001, J BIOL CHEM, V276, P35537, DOI 10.1074/jbc.M106042200
   Carlson CJ, 2003, DIABETES, V52, P634, DOI 10.2337/diabetes.52.3.634
   D'Alessandris C, 2007, DIABETOLOGIA, V50, P840, DOI 10.1007/s00125-006-0522-y
   de Alvaro C, 2004, J BIOL CHEM, V279, P17070, DOI 10.1074/jbc.M312021200
   DUBOIS RN, 1983, BIOCHEM PHARMACOL, V32, P2621, DOI 10.1016/0006-2952(83)90034-5
   Fujishiro M, 2001, J BIOL CHEM, V276, P19800, DOI 10.1074/jbc.M101087200
   GARRIDO A, 1991, PHARMACOL TOXICOL, V69, P9, DOI 10.1111/j.1600-0773.1991.tb00400.x
   Halseth AE, 2001, AM J PHYSIOL-ENDOC M, V280, pE994, DOI 10.1152/ajpendo.2001.280.6.E994
   HOUMARD JA, 1995, DIABETES, V44, P555, DOI 10.2337/diabetes.44.5.555
   Izawa Y, 2005, EXP CELL RES, V308, P291, DOI 10.1016/j.yexcr.2005.04.028
   Jeong Sun-Young, 2006, Physiological Chemistry and Physics and Medical NMR, V38, P77
   Kefaloyianni E, 2006, CELL SIGNAL, V18, P2238, DOI 10.1016/j.cellsig.2006.05.004
   Kim HJ, 2002, EXP GERONTOL, V37, P1041, DOI 10.1016/S0531-5565(02)00082-7
   Kurata S, 2000, J BIOL CHEM, V275, P23413, DOI 10.1074/jbc.C000308200
   Larkin LM, 2001, J GERONTOL A-BIOL, V56, pB486, DOI 10.1093/gerona/56.11.B486
   Merrill GF, 2001, BASIC RES CARDIOL, V96, P423, DOI 10.1007/s003950170023
   Montessuit C, 2004, CARDIOVASC RES, V64, P94, DOI 10.1016/j.cardiores.2004.06.005
   Nyholm B, 1997, DIABETES, V46, P1822, DOI 10.2337/diabetes.46.11.1822
   Suji G, 2004, BIOGERONTOLOGY, V5, P365, DOI 10.1007/s10522-004-3189-0
   THOMAS BH, 1977, RES COMMUN CHEM PATH, V17, P663
   Williamson D, 2003, J PHYSIOL-LONDON, V547, P977, DOI 10.1113/jphysiol.2002.036673
   Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4
   Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693
NR 23
TC 31
Z9 34
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1520-7552
EI 1520-7560
J9 DIABETES-METAB RES
JI Diabetes-Metab. Res. Rev.
PD MAR
PY 2009
VL 25
IS 3
BP 279
EP 286
DI 10.1002/dmrr.932
PG 8
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 425NC
UT WOS:000264643400011
PM 19177471
DA 2024-02-19
ER

PT J
AU WIMONWATWATEE, T
   HEYDARI, AR
   WU, WT
   RICHARDSON, A
AF WIMONWATWATEE, T
   HEYDARI, AR
   WU, WT
   RICHARDSON, A
TI EFFECT OF AGE ON THE EXPRESSION OF PHOSPHOENOLPYRUVATE CARBOXYKINASE IN
   RAT-LIVER
SO AMERICAN JOURNAL OF PHYSIOLOGY
LA English
DT Article
DE AGING; FASTING; TRANSCRIPTION
ID GENE-EXPRESSION; MESSENGER-RNA; CYCLIC-AMP; HEPATOCYTES; INSULIN; GTP;
   TRANSCRIPTION; DEGRADATION
AB The effect of age on the expression of phosphoenolpyruvate carboxykinase (PEPCK; EC 4.1.1.32) was studied using hepatocytes isolated from 6-, 15-, and 26-mo-old-male Fischer 344 rats fasted for 12 h. The activity of PEPCK in hepatocyte extracts decreased 40-50% (P < 0.05) between 6 and 26 mo of age. The age-related decrease in PEPCK activity was paralleled by a similar decrease (P < 0.05) in the level of PEPCK mRNA. Thus the decrease in PEPCK activity appears to arise from a decrease in level of the PEPCK transcript available for translation. The stability, i.e., half-life of PEPCK mRNA in hepatocytes isolated from 6- and 26-mo-old rats was similar; however, the nuclear transcription of PEPCK by hepatocytes isolated from 26-mo-old rats was 44% lower (P < 0.05) than the nuclear transcription of PEPCK by hepatocytes isolated from 6-mo-old rats. Thus the age-related decline in PEPCK mRNA levels in the liver of fasted rats appears to arise from a decrease in the transcription of PEPCK. A significant decrease (P < 0.05) in the activity and mRNA level of PEPCK also was observed with age in kidney tissue isolated from rats fasted for 12 h.
C1 ILLINOIS STATE UNIV,DEPT CHEM,NORMAL,IL 61761.
   ILLINOIS STATE UNIV,DEPT BIOL SCI,NORMAL,IL 61761.
C3 Illinois State University; Illinois State University
FU NIA NIH HHS [AG-06819] Funding Source: Medline
CR BALLARD FJ, 1969, J BIOL CHEM, V244, P5625
   BUTLER JA, 1989, J CELL PHYSIOL, V141, P400, DOI 10.1002/jcp.1041410222
   CASTLE T, 1978, MECH AGEING DEV, V8, P383, DOI 10.1016/0047-6374(78)90037-4
   CHANEZ M, 1988, DIABETES METAB, V14, P80
   CHANG H, 1966, J BIOL CHEM, V241, P2113
   CIMBALA MA, 1982, J BIOL CHEM, V257, P7629
   COLEMAN GL, 1977, J GERONTOL, V32, P258, DOI 10.1093/geronj/32.3.258
   FELDMAN D, 1977, AM J PHYSIOL, V233, pE147, DOI 10.1152/ajpendo.1977.233.3.E147
   GRANNER D, 1990, J BIOL CHEM, V265, P10173
   HOD Y, 1984, J BIOL CHEM, V259, P5609
   HOD Y, 1988, J BIOL CHEM, V263, P7747
   HOPGOOD MF, 1973, BIOCHEM J, V134, P445, DOI 10.1042/bj1340445
   KAMATAKI T, 1985, J PHARMACOL EXP THER, V233, P222
   KATZ MS, 1993, EXP GERONTOL, V28, P329, DOI 10.1016/0531-5565(93)90060-Q
   OBRIEN RM, 1991, BIOCHEM J, V278, P609, DOI 10.1042/bj2780609
   PARK GH, 1990, GERONTOLOGY, V36, P76
   RICHARDSON A, 1987, P467
   RICHARDSON A, 1982, LIFE SCI, V31, P605, DOI 10.1016/0024-3205(82)90761-5
   RICHARDSON A, 1982, J GERONTOL, V37, P666, DOI 10.1093/geronj/37.6.666
   RICHARDSON A, 1987, J BIOL CHEM, V262, P12821
   RICHARDSON A, 1985, MOL BIOL AGING GENE, P229
   RIKANS LE, 1991, BIOCHIM BIOPHYS ACTA, V1074, P195, DOI 10.1016/0304-4165(91)90061-K
   SASAKI K, 1988, P NATL ACAD SCI USA, V85, P2954, DOI 10.1073/pnas.85.9.2954
   Tilghman SM, 1976, GLUCONEOGENESIS ITS, P47
   VANREMMEN H, 1994, AM J PHYSIOL, V267, pG195, DOI 10.1152/ajpgi.1994.267.2.G195
   YOOWARREN H, 1981, J BIOL CHEM, V256, P224
NR 26
TC 12
Z9 13
U1 0
U2 3
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0002-9513
J9 AM J PHYSIOL
JI Am. J. Physiol.
PD AUG
PY 1994
VL 267
IS 2
BP G201
EP G206
DI 10.1152/ajpgi.1994.267.2.G201
PN 1
PG 6
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA PC439
UT WOS:A1994PC43900065
PM 8074221
DA 2024-02-19
ER

PT J
AU Ghafouri-Fard, S
   Abak, A
   Talebi, SF
   Shoorei, H
   Branicki, W
   Taheri, M
   Dilmaghani, NA
AF Ghafouri-Fard, Soudeh
   Abak, Atefe
   Talebi, Seyedeh Fahimeh
   Shoorei, Hamed
   Branicki, Wojciech
   Taheri, Mohammad
   Dilmaghani, Nader Akbari
TI Role of miRNA and lncRNAs in organ fibrosis and aging
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Article; Early Access
DE LncRNA; MiRNA; Aging; Organ fibrosis
ID PROMOTES MYOCARDIAL FIBROSIS; CARDIAC FIBROSIS; PULMONARY-FIBROSIS;
   NONCODING RNA; RENAL FIBROSIS; TGF-BETA; MESENCHYMAL TRANSITION;
   FIBROBLAST ACTIVATION; CELL-PROLIFERATION; SIGNALING PATHWAY
AB Fibrosis is the endpoint of pathological remodeling. This process contributes to the pathogenesis of several chronic disorders and aging-associated organ damage. Different molecular cascades contribute to this process. TGF-(i, WNT, and YAP/TAZ signaling pathways have prominent roles in this process. A number of long noncoding RNAs and microRNAs have been found to regulate organ fibrosis through modulation of the activity of related signaling pathways. miR-144-3p, miR-451, miR-200b, and miR-328 are among microRNAs that participate in the pathology of cardiac fibrosis. Meanwhile, miR-34a, miR-17-5p, miR-122, miR-146a, and miR-350 contribute to liver fibrosis in different situations. PVT1, MALAT1, GAS5, NRON, PFL, MIAT, HULC, ANRIL, and H19 are among long non-coding RNAs that participate in organ fibrosis. We review the impact of long noncoding RNAs and microRNAs in organ fibrosis and aging-related pathologies.
C1 [Ghafouri-Fard, Soudeh] Shahid Beheshti Univ Med Sci, Sch Med, Dept Med Genet, Tehran, Iran.
   [Abak, Atefe] Shahid Beheshti Univ Med Sci, Phytochem Res Ctr, Tehran, Iran.
   [Talebi, Seyedeh Fahimeh] Birjand Univ Med Sci, Dept Pharmacol, Birjand, Iran.
   [Shoorei, Hamed] Birjand Univ Med Sci, Fac Med, Dept Anat Sci, Birjand, Iran.
   [Branicki, Wojciech] Jagiellonian Univ, Malopolska Ctr Biotechnol, Krakow, Poland.
   [Taheri, Mohammad] Shahid Beheshti Univ Med Sci, Urol & Nephrol Res Ctr, Tehran, Iran.
   [Dilmaghani, Nader Akbari] Shahid Beheshti Univ Med Sci, Loghman Hakim Hosp, Skull Base Res Ctr, Tehran, Iran.
C3 Shahid Beheshti University Medical Sciences; Shahid Beheshti University
   Medical Sciences; Jagiellonian University; Shahid Beheshti University
   Medical Sciences; Shahid Beheshti University Medical Sciences
RP Branicki, W (corresponding author), Jagiellonian Univ, Malopolska Ctr Biotechnol, Krakow, Poland.; Taheri, M (corresponding author), Shahid Beheshti Univ Med Sci, Urol & Nephrol Res Ctr, Tehran, Iran.; Dilmaghani, NA (corresponding author), Shahid Beheshti Univ Med Sci, Loghman Hakim Hosp, Skull Base Res Ctr, Tehran, Iran.
EM wojciech.branicki@uj.edu.pl; mohammad_823@yahoo.com;
   nadakbari@sbmu.ac.ir
RI Branicki, Wojciech/ISA-2084-2023; Taheri, Mohammad/AAC-7307-2019;
   Shoorei, Hamed/J-5929-2019
OI Taheri, Mohammad/0000-0001-8381-0591; Shoorei,
   Hamed/0000-0002-7762-5362; Akbari Dilmaghani, Nader/0000-0002-5473-1904
FU shahid beheshti university of medical sciences
FX This study was financially supported by shahid beheshti university of
   medical sciences.
CR Ai P, 2018, J THROMB THROMBOLYS, V45, P264, DOI 10.1007/s11239-017-1596-8
   Ai Y, 2020, INT IMMUNOPHARMACOL, V86, DOI 10.1016/j.intimp.2020.106703
   Aydin Y, 2019, CANCERS, V11, DOI 10.3390/cancers11101407
   Bai L, 2021, HUM CELL, V34, P383, DOI 10.1007/s13577-020-00474-z
   Bardin P, 2018, J PATHOL, V245, P410, DOI 10.1002/path.5095
   Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026
   Burgy O, 2018, MATRIX BIOL, V68-69, P67, DOI 10.1016/j.matbio.2018.03.017
   Cao F., 2019, Mol. Med., V25, P1
   Cao GX, 2019, TOXICOL APPL PHARM, V385, DOI 10.1016/j.taap.2019.114769
   Cao YM, 2018, LAB INVEST, V98, P339, DOI 10.1038/labinvest.2017.123
   Capri M, 2017, AGING CELL, V16, P262, DOI 10.1111/acel.12549
   Che H, 2020, FASEB J, V34, P5282, DOI 10.1096/fj.201902692R
   Chen SL, 2014, J CELL MOL MED, V18, P415, DOI 10.1111/jcmm.12218
   Chen SJ, 2020, AGING DIS, V11, P1058, DOI 10.14336/AD.2019.0724
   Chen T, 2020, BIOCHEM BIOPH RES CO, V521, P921, DOI 10.1016/j.bbrc.2019.11.015
   Chen W, 2019, CELL SIGNAL, V54, P102, DOI 10.1016/j.cellsig.2018.10.016
   Chen X, 2020, THERANOSTICS, V10, P4851, DOI 10.7150/thno.42423
   Chen X, 2018, ONCOTARGET, V9, P1048, DOI 10.18632/oncotarget.23254
   Chen YY, 2020, MOL THER-NUCL ACIDS, V19, P350, DOI 10.1016/j.omtn.2019.11.018
   Chiabotto G., 2020, EXRNA, V2, P1
   Cui HM, 2019, MOL THER-NUCL ACIDS, V14, P114, DOI 10.1016/j.omtn.2018.11.006
   de Yébenes VG, 2020, ARTERIOSCL THROM VAS, V40, P2408, DOI 10.1161/ATVBAHA.120.314333
   Ding H, 2020, MOL THER-NUCL ACIDS, V19, P1276, DOI 10.1016/j.omtn.2020.01.002
   Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233
   Dong P, 2018, EUR REV MED PHARMACO, V22, P2052, DOI 10.26355/eurrev_201804_14735
   Dong ZH, 2019, AM J PHYSIOL-GASTR L, V316, pG539, DOI 10.1152/ajpgi.00249.2018
   Feng B, 2017, J MOL CELL CARDIOL, V105, P70, DOI 10.1016/j.yjmcc.2017.03.002
   Feng XZ, 2019, AM J TRANSL RES, V11, P5664
   Fierro-Fernández M, 2020, FASEB J, V34, P410, DOI 10.1096/fj.201901599RR
   Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290
   Na F, 2017, GENE, V618, P1, DOI 10.1016/j.gene.2017.03.008
   Fu XT, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00107
   Gao XM, 2020, EXP CELL RES, V388, DOI 10.1016/j.yexcr.2020.111878
   Ge XX, 2019, AGING-US, V11, P8745, DOI 10.18632/aging.102249
   Ge YN, 2019, MOL THER-NUCL ACIDS, V17, P741, DOI 10.1016/j.omtn.2019.07.007
   Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017
   Guan H, 2020, EXP CELL RES, V392, DOI 10.1016/j.yexcr.2020.112007
   Guan YJ, 2018, AGING CELL, V17, DOI 10.1111/acel.12752
   Guo JS, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-21
   Han YS, 2020, BIOCHEM BIOPH RES CO, V525, P354, DOI 10.1016/j.bbrc.2020.02.090
   Hao KL, 2019, THERANOSTICS, V9, P7282, DOI 10.7150/thno.33920
   Hofmann P, 2019, CARDIOVASC RES, V115, P230, DOI 10.1093/cvr/cvy206
   Hu HH, 2020, AGEING RES REV, V60, DOI 10.1016/j.arr.2020.101063
   Huang RX, 2018, TOXICOL RES-UK, V7, P415, DOI 10.1039/c8tx00031j
   Janku F, 2011, NAT REV CLIN ONCOL, V8, P528, DOI 10.1038/nrclinonc.2011.71
   Ji FH, 2019, J CELL BIOCHEM, V120, P4573, DOI 10.1002/jcb.27746
   Ji TT, 2020, J CELL MOL MED, V24, P13314, DOI 10.1111/jcmm.15949
   Jiang H, 2018, AM J PHYSIOL-LUNG C, V315, pL563, DOI 10.1152/ajplung.00434.2017
   Jin SS, 2019, EUR CYTOKINE NETW, V30, P98, DOI 10.1684/ecn.2019.0432
   Kim C, 2019, CELL REP, V29, P2202, DOI 10.1016/j.celrep.2019.10.044
   Kumar V, 2018, MOL THER, V26, P2798, DOI 10.1016/j.ymthe.2018.08.022
   Lee MJ, 2014, J INVEST DERMATOL, V134, P518, DOI 10.1038/jid.2013.339
   Lee S, 2014, AGE, V36, DOI 10.1007/s11357-014-9724-2
   Li AL, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0527-8
   Li H, 2015, SCI REP-UK, V5, DOI 10.1038/srep08527
   Li Q, 2019, MOL MED REP, V19, P3190, DOI 10.3892/mmr.2019.9986
   Li XL, 2018, FASEB J, V32, P5285, DOI 10.1096/fj.201800055R
   Liang C, 2019, LIFE SCI, V224, P12, DOI 10.1016/j.lfs.2019.02.059
   Liang HH, 2018, THERANOSTICS, V8, P1180, DOI 10.7150/thno.20846
   Lin CY, 2018, J FORMOS MED ASSOC, V117, P727, DOI 10.1016/j.jfma.2017.09.012
   Lin JW, 2020, LIFE-BASEL, V10, DOI 10.3390/life10080131
   Lin RZ, 2020, MOL THER-NUCL ACIDS, V20, P589, DOI 10.1016/j.omtn.2020.04.001
   Lin S, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02889-w
   Liu B, 2019, EUR REV MED PHARMACO, V23, P3478, DOI 10.26355/eurrev_201904_17713
   Liu F, 2015, AM J PHYSIOL-LUNG C, V308, pL344, DOI 10.1152/ajplung.00300.2014
   Liu HL, 2019, EUR REV MED PHARMACO, V23, P4414, DOI 10.26355/eurrev_201905_17949
   Liu HF, 2020, J CELL PHYSIOL, V235, P4520, DOI 10.1002/jcp.29329
   Liu JR, 2020, AGING-US, V12, P18052, DOI 10.18632/aging.103591
   Liu MN, 2018, BIOCHEM BIOPH RES CO, V495, P2324, DOI 10.1016/j.bbrc.2017.12.130
   Liu PH, 2020, AGING-US, V12, P5280, DOI 10.18632/aging.102950
   Liu Y, 2018, BBA-MOL BASIS DIS, V1864, P420, DOI 10.1016/j.bbadis.2017.11.003
   Lu QC, 2018, INFLAMMATION, V41, P896, DOI 10.1007/s10753-018-0744-4
   Lu QL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10116-0
   Luly FR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52770-w
   Ma J, 2019, INT J CLIN EXP PATHO, V12, P1174
   Mattick JS, 2010, TRENDS GENET, V26, P21, DOI 10.1016/j.tig.2009.11.002
   Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48
   Milito A, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111356
   Mo YQ, 2020, NANOTOXICOLOGY, V14, P1175, DOI 10.1080/17435390.2020.1808727
   Mutsaers HAM, 2016, FRONT MED-LAUSANNE, V3, DOI 10.3389/fmed.2016.00055
   Nagpal V, 2016, CIRCULATION, V133, P291, DOI 10.1161/CIRCULATIONAHA.115.018174
   Ni HE, 2019, INT J CARDIOL, V292, P188, DOI 10.1016/j.ijcard.2019.04.006
   Ou YL, 2020, IUBMB LIFE, V72, P2469, DOI 10.1002/iub.2375
   Ouyang F, 2020, AGING-US, V12, P996, DOI 10.18632/aging.102463
   Owczarz M, 2017, EXP BIOL MED, V242, P1453, DOI 10.1177/1535370217720884
   Piersma B, 2015, FRONT MED, V2, DOI 10.3389/fmed.2015.00059
   Pohlers D, 2009, BBA-MOL BASIS DIS, V1792, P746, DOI 10.1016/j.bbadis.2009.06.004
   Price NL, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.131102
   Quinn JJ, 2016, NAT REV GENET, V17, P47, DOI 10.1038/nrg.2015.10
   Rojano E, 2019, BRIEF BIOINFORM, V20, P1639, DOI 10.1093/bib/bby039
   Saito S, 2019, CLIN EXP NEPHROL, V23, P1345, DOI 10.1007/s10157-019-01783-w
   Shaker OG, 2019, IUBMB LIFE, V71, P1322, DOI 10.1002/iub.2039
   Shen XT, 2019, J CELL PHYSIOL, V234, P18169, DOI 10.1002/jcp.28450
   Shi H, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.534171
   Song L, 2019, BRIT J PHARMACOL, V176, P1619, DOI 10.1111/bph.14573
   Sun F, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20192215
   Sun F, 2019, J MOL CELL CARDIOL, V133, P188, DOI 10.1016/j.yjmcc.2019.06.011
   Sun J, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20190280
   Sun JT, 2020, BIOCHEM BIOPH RES CO, V521, P814, DOI 10.1016/j.bbrc.2019.10.175
   Sun JP, 2020, CLIN EXP PHARMACOL P, V47, P1850, DOI 10.1111/1440-1681.13371
   Sun SF, 2018, DIABETES, V67, P731, DOI 10.2337/db17-0816
   Sun YY, 2018, MOL THER-NUCL ACIDS, V11, P528, DOI 10.1016/j.omtn.2018.04.005
   Tao H, 2020, CELL SIGNAL, V74, DOI 10.1016/j.cellsig.2020.109705
   Tao H, 2017, TOXICOLOGY, V386, P11, DOI 10.1016/j.tox.2017.05.007
   Tao H, 2016, PFLUG ARCH EUR J PHY, V468, P1103, DOI 10.1007/s00424-016-1792-y
   Tao L, 2020, LIFE SCI, V253, DOI 10.1016/j.lfs.2020.117572
   Travers JG, 2016, CIRC RES, V118, P1021, DOI 10.1161/CIRCRESAHA.115.306565
   Ugalde AP, 2011, EMBO J, V30, P2219, DOI 10.1038/emboj.2011.124
   Vallée A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122537
   Vallée A, 2017, ONCOTARGET, V8, P90579, DOI 10.18632/oncotarget.21234
   Vasa-Nicotera M, 2011, ATHEROSCLEROSIS, V217, P326, DOI 10.1016/j.atherosclerosis.2011.03.034
   Nonaka CKV, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20164064
   Wang B, 2019, THERANOSTICS, V9, P1864, DOI 10.7150/thno.29579
   Wang B, 2013, J NUCLEIC ACIDS, V2013, DOI 10.1155/2013/951570
   Wang CQ, 2020, TOXICOL SCI, V177, P214, DOI 10.1093/toxsci/kfaa097
   Wang HD, 2019, MOL THER, V27, P571, DOI 10.1016/j.ymthe.2019.01.008
   Wang J, 2018, BIOMED PHARMACOTHER, V105, P37, DOI 10.1016/j.biopha.2018.05.104
   Wang J, 2018, MOL THER-NUCL ACIDS, V12, P741, DOI 10.1016/j.omtn.2018.07.012
   Wang W, 2020, BIOMED PHARMACOTHER, V121, DOI 10.1016/j.biopha.2019.109411
   Wang W, 2019, J CELL MOL MED, V23, P5486, DOI 10.1111/jcmm.14432
   Wang XL, 2018, DRUG DES DEV THER, V12, P2431, DOI 10.2147/DDDT.S170840
   Wang XNH, 2011, J AM SOC NEPHROL, V22, P2068, DOI 10.1681/ASN.2010121278
   Wang XX, 2018, MED SCI MONITOR, V24, P3958, DOI 10.12659/MSM.910000
   Wang YP, 2019, MOL CELL BIOCHEM, V457, P169, DOI 10.1007/s11010-019-03521-y
   Wei YC, 2020, J ETHNOPHARMACOL, V249, DOI 10.1016/j.jep.2019.112404
   Weng HL, 2009, HEPATOLOGY, V50, P230, DOI 10.1002/hep.22934
   Wu D, 2018, MOL HUM REPROD, V24, P357, DOI 10.1093/molehr/gay019
   Wu J, 2018, BIOCHEM BIOPH RES CO, V503, P977, DOI 10.1016/j.bbrc.2018.06.105
   Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277
   Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015
   Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807
   Xiao B, 2019, BIOL OPEN, V8, DOI 10.1242/bio.039958
   Xu XW, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m606, 10.1136/bmj.m792]
   Yan Y, 2019, MOL THER-NUCL ACIDS, V16, P494, DOI 10.1016/j.omtn.2019.04.002
   Yang JJ, 2020, J CELL MOL MED, V24, P2677, DOI 10.1111/jcmm.14987
   Yang K, 2019, CLIN SCI, V133, P1845, DOI 10.1042/CS20190203
   Yang SZ, 2012, AM J PATHOL, V180, P484, DOI 10.1016/j.ajpath.2011.10.005
   Yang XC, 2018, J GERONTOL A-BIOL, V73, P1010, DOI 10.1093/gerona/gly020
   Ye ZS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03085-3
   Yeh CH, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0857-2
   Ying HZ, 2017, MOL MED REP, V16, P7879, DOI 10.3892/mmr.2017.7641
   Yu FJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1068-x
   Yu SY, 2019, EUR REV MED PHARMACO, V23, P3760, DOI 10.26355/eurrev_201905_17802
   Yuan XL, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00249
   Zang XJ, 2019, EUR REV MED PHARMACO, V23, P7519, DOI 10.26355/eurrev_201909_18867
   Zarjou A, 2011, AM J PHYSIOL-RENAL, V301, pF793, DOI 10.1152/ajprenal.00273.2011
   Zhang H, 2021, OPEN MED-WARSAW, V16, P481, DOI 10.1515/med-2021-0231
   Zhang K, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2323-5
   Zhang Q, 2017, MOL THER, V25, P728, DOI 10.1016/j.ymthe.2016.12.017
   Zhang TP, 2019, J HEPATOL, V70, P87, DOI 10.1016/j.jhep.2018.08.026
   Zhang Z, 2018, FASEB J, V32, P5967, DOI 10.1096/fj.201800183R
   Zhao DD, 2018, CELL PHYSIOL BIOCHEM, V46, P1555, DOI 10.1159/000489201
   Zhao XG, 2018, MOL THER, V26, P2206, DOI 10.1016/j.ymthe.2018.06.020
   Zhao XD, 2018, INFLAMM RES, V67, P681, DOI 10.1007/s00011-018-1159-2
   Zhao Y., 2019, CELL DEATH DIS, V10, P1
   Zhou B, 2017, BIOCHEM BIOPH RES CO, V487, P769, DOI 10.1016/j.bbrc.2017.04.044
   Zhou H, 2019, NEPHROLOGY, V24, P472, DOI 10.1111/nep.13394
   Zhou LX, 2020, CHEMOSPHERE, V241, DOI 10.1016/j.chemosphere.2019.125075
   Zhou SG, 2018, EUR REV MED PHARMACO, V22, P166, DOI 10.26355/eurrev_201801_14114
   Zhu YQ, 2020, FASEB J, V34, P14371, DOI 10.1096/fj.202001337R
   Zhu YJ, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00564
   Zou YT, 2019, CELL SIGNAL, V58, P1, DOI 10.1016/j.cellsig.2019.01.012
NR 162
TC 56
Z9 58
U1 1
U2 32
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD 2021 NOV
PY 2021
VL 143
AR 112132
DI 10.1016/j.biopha.2021.112132
EA SEP 2021
PG 21
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA UR8IE
UT WOS:000696985100004
PM 34481379
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Castillo, C
   Salazar, V
   Ariznavarreta, C
   Vara, E
   Tresguerres, JAF
AF Castillo, C.
   Salazar, V.
   Ariznavarreta, C.
   Vara, E.
   Tresguerres, J. A. F.
TI Effect of isoflavone administration on age-related hepatocyte changes in
   old ovariectomized femal Wistar rats
SO PHYTOMEDICINE
LA English
DT Article
DE isoflavone; aging; hepatocyte model
ID NITRIC-OXIDE SYNTHASE; ESTROGEN REPLACEMENT THERAPY; SOYBEAN
   PHYTOESTROGEN INTAKE; SEPSIS-RELATED CYTOKINES; OXIDATIVE DNA-DAMAGE;
   HEME OXYGENASE; GROWTH-HORMONE; VASCULAR REACTIVITY; ANTIOXIDANT ACTION;
   LIPID-SYNTHESIS
AB Aging seems to be due to the accumulation of oxidative damage in cells and molecules. On the other hand, menopause and ovariectomy induce deleterious effects on different organs and systems that have been shown to be counteracted by estrogens and in a not so evident form also with phytoestrogens. The present study has investigated whether the administration of a commercial soy extract that contains similar to 10% isoflavones was able to modify some parameters related to oxidative stress and inflammation in hepatocytes isolated from old ovariectomized female Wistar rats. Eighteen 22-month-old animals that had been previously ovariectomized at 12 months of age were divided into four groups: ovariectomized control rats, estradiol-treated ovariectomized females and ovariectomized rats treated with isoflavones. Six intact female rats of 2 months of age were used as reference group. Hepatocytes were isolated and cultured, and carbon monoxide (CO) and nitric oxide (NO) release, as well as adenosyl triphosphate (ATP), cyclic guanosyl monophosphate (cGMP), phosphatidylcholine (PC) and lipid peroxide (LPO) content of cells were evaluated. Uterus was also removed and weighed. Hepatocytes isolated from old ovariectomized rats showed a decrease in ATP content as compared to young animals. Age also induced an increase in LPO cell content. NO, CO and cGMP were augmented with age, and PC synthesis showed a dramatic reduction. Treatment with either estradiol or isoflavones were able to improve all the mentioned parameters altered in hepatocytes isolated from old ovariectomized rats, and the magnitude of the improvement was similar for both treatments. Ovariectomy induced a significant reduction in uterine weight, which was significantly counteracted by estradiol treatment but not by isoflavone administration. In conclusion, the administration of a soy extract containing isoflavones seems to prevent oxidative changes in hepatocytes isolated from old ovariectomized female rats, without modifying uterus weight. (c) 2005 Elsevier GmbH. All rights reserved.
C1 Univ Complutense, Sch Med, Lab Expt Endocrinol, Dept Physiol, E-28040 Madrid, Spain.
   Univ Complutense, Sch Med, Dept Biochem & Mol Biol, E-28040 Madrid, Spain.
C3 Complutense University of Madrid; Complutense University of Madrid
RP Tresguerres, JAF (corresponding author), Univ Complutense, Sch Med, Lab Expt Endocrinol, Dept Physiol, E-28040 Madrid, Spain.
EM guerres@med.ucm.es
CR ADLERCREUTZ CHT, 1995, J NUTR, V125, pS757, DOI 10.1093/jn/125.3_Suppl.757S
   Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   ARIASDIAZ J, 1993, EUR J SURG, V159, P535
   Arora A, 1998, ARCH BIOCHEM BIOPHYS, V356, P133, DOI 10.1006/abbi.1998.0783
   Barañano DE, 2001, P NATL ACAD SCI USA, V98, P10996, DOI 10.1073/pnas.191351298
   Bejma J, 2000, ACTA PHYSIOL SCAND, V169, P343
   Boveris A, 2002, FREE RADICAL BIO MED, V33, P1186, DOI 10.1016/S0891-5849(02)01009-2
   BRUNE B, 1987, MOL PHARMACOL, V32, P497
   Castillo C, 2004, ENDOCRINE, V25, P33, DOI 10.1385/ENDO:25:1:33
   Castillo C, 2005, BIOGERONTOLOGY, V6, P49, DOI 10.1007/s10522-004-7383-x
   Chung HY, 2001, ANN NY ACAD SCI, V928, P327
   Clarkson TB, 1998, BAILLIERE CLIN ENDOC, V12, P589, DOI 10.1016/S0950-351X(98)80006-2
   Compston JE, 2001, PHYSIOL REV, V81, P419, DOI 10.1152/physrev.2001.81.1.419
   Cuzzocrea S, 2001, MOL MED, V7, P478, DOI 10.1007/BF03401853
   Gasbarrini A, 1998, SCAND J GASTROENTERO, V33, P1107
   Green PS, 2000, INT J DEV NEUROSCI, V18, P347, DOI 10.1016/S0736-5748(00)00017-4
   Guo X, 2001, LIFE SCI, V69, P3113, DOI 10.1016/S0024-3205(01)01417-5
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   Henningsson R, 2001, AM J PHYSIOL-CELL PH, V280, pC1242, DOI 10.1152/ajpcell.2001.280.5.C1242
   Hodgson JM, 1999, ATHEROSCLEROSIS, V145, P167, DOI 10.1016/S0021-9150(99)00029-5
   Jeon TI, 2001, LIPIDS, V36, P589, DOI 10.1007/s11745-001-0761-1
   Kris-Etherton Penny M., 2002, American Journal of Medicine, V113, p71S
   LACORT M, 1995, LIPIDS, V30, P141, DOI 10.1007/BF02538267
   Leal AM, 1998, BIOCHEM PHARMACOL, V56, P1463, DOI 10.1016/S0006-2952(98)00248-2
   Liu Y, 2002, WORLD J GASTROENTERO, V8, P363
   Mikkola TS, 2002, CARDIOVASC RES, V53, P605, DOI 10.1016/S0008-6363(01)00466-7
   Mitchell JH, 1998, ARCH BIOCHEM BIOPHYS, V360, P142, DOI 10.1006/abbi.1998.0951
   Mizutani K, 2000, J HYPERTENS, V18, P1833, DOI 10.1097/00004872-200018120-00018
   Morito K, 2001, BIOL PHARM BULL, V24, P351, DOI 10.1248/bpb.24.351
   Nagao T, 2001, REPROD TOXICOL, V15, P399, DOI 10.1016/S0890-6238(01)00141-1
   Nasr A, 1998, GYNECOL ENDOCRINOL, V12, P43, DOI 10.3109/09513599809024970
   Nathan L, 1998, SEMIN REPROD ENDOCR, V16, P309, DOI 10.1055/s-2007-1016289
   Ohlsson C, 1998, ENDOCR REV, V19, P55, DOI 10.1210/er.19.1.55
   Palomero J, 2001, FREE RADICAL BIO MED, V30, P836, DOI 10.1016/S0891-5849(01)00471-3
   Persky AM, 2000, P SOC EXP BIOL MED, V223, P59, DOI 10.1046/j.1525-1373.2000.22308.x
   Pfeilschifter J, 2002, ENDOCR REV, V23, P90, DOI 10.1210/er.23.1.90
   Pinzani M, 2001, J HEPATOL, V34, P764, DOI 10.1016/S0168-8278(01)00055-1
   Reiter RJ, 1998, PROG NEUROBIOL, V56, P359, DOI 10.1016/S0301-0082(98)00052-5
   Reiter RJ, 1999, BIOL SIGNAL RECEPT, V8, P56
   Röhrdanz E, 2002, J NUTR, V132, P370, DOI 10.1093/jn/132.3.370
   RuizLarrea MB, 1997, J PHYSIOL BIOCHEM, V53, P225
   Ryter SW, 2002, MOL CELL BIOCHEM, V234, P249, DOI 10.1023/A:1015957026924
   Sader MA, 2002, CARDIOVASC RES, V53, P597, DOI 10.1016/S0008-6363(01)00473-4
   Sastre J, 2000, IUBMB LIFE, V49, P427
   Sierens J, 2001, MUTAT RES-DNA REPAIR, V485, P169, DOI 10.1016/S0921-8777(00)00069-0
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P575, DOI 10.1016/S0891-5849(02)00886-9
   SUGIOKA K, 1987, FEBS LETT, V210, P37, DOI 10.1016/0014-5793(87)81293-0
   Szabó C, 2003, TOXICOL LETT, V140, P105, DOI 10.1016/S0378-4274(02)00507-6
   Tikkanen MJ, 1998, P NATL ACAD SCI USA, V95, P3106, DOI 10.1073/pnas.95.6.3106
   Van Remmen H, 2001, EXP GERONTOL, V36, P957
   Vara E, 1996, AM J PHYSIOL-LUNG C, V271, pL359, DOI 10.1152/ajplung.1996.271.3.L359
   VARA E, 1994, HEPATOLOGY, V20, P924, DOI 10.1002/hep.1840200422
   Vedavanam K, 1999, PHYTOTHER RES, V13, P601, DOI 10.1002/(SICI)1099-1573(199911)13:7&lt;601::AID-PTR550&gt;3.0.CO;2-O
   Vom Saal Frederick S., 1994, P1213
   Wang J, 2001, J NEUROCHEM, V77, P804, DOI 10.1046/j.1471-4159.2001.00271.x
   Wight E, 2000, J SOC GYNECOL INVEST, V7, P106, DOI 10.1016/S1071-5576(00)00036-8
   Wuttke W, 2002, J STEROID BIOCHEM, V83, P133, DOI 10.1016/S0960-0760(02)00259-5
   Xu JW, 2002, WORLD J GASTROENTERO, V8, P883, DOI 10.3748/wjg.v8.i5.883
NR 59
TC 16
Z9 17
U1 0
U2 5
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0944-7113
J9 PHYTOMEDICINE
JI Phytomedicine
PD JUL
PY 2006
VL 13
IS 7
BP 468
EP 476
DI 10.1016/j.phymed.2005.03.012
PG 9
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA 067EP
UT WOS:000239284800002
PM 16785039
DA 2024-02-19
ER

PT J
AU Kono, N
   Inoue, T
   Yoshida, Y
   Sato, H
   Matsusue, T
   Itabe, H
   Niki, E
   Aoki, J
   Arai, H
AF Kono, Nozomu
   Inoue, Takao
   Yoshida, Yasukazu
   Sato, Hiroyuki
   Matsusue, Tomokazu
   Itabe, Hiroyuki
   Niki, Etsuo
   Aoki, Junken
   Arai, Hiroyuki
TI Protection against oxidative stress-induced hepatic injury by
   intracellular type II platelet-activating factor acetylhydrolase by
   metabolism of oxidized phospholipids <i>in vivo</i>
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID TETRACHLORIDE-INDUCED HEPATOTOXICITY; CARBON-TETRACHLORIDE;
   HUMAN-PLASMA; PAF-ACETYLHYDROLASE; LIPID-PEROXIDATION;
   CAENORHABDITIS-ELEGANS; MISSENSE MUTATION; RECEPTOR-GAMMA; LIVER-INJURY;
   RISK-FACTOR
AB Membrane phospholipids are susceptible to oxidation, which is involved in various pathological processes such as inflammation, atherogenesis, neurodegeneration, and aging. One enzyme that may help to remove oxidized phospholipids from cells is intracellular type II platelet-activating factor acetylhydrolase (PAF-AH (II)), which hydrolyzes oxidatively fragmented fatty acyl chains attached to phospholipids. Overexpression of PAF-AH (II) in cells or tissues was previously shown to suppress oxidative stress-induced cell death. In this study we investigated the functions of PAF-AH (II) by generating PAF-AH (II)-deficient (Pafah2(-/-)) mice. PAF-AH (II) was predominantly expressed in epithelial cells such as kidney proximal and distal tubules, intestinal column epithelium, and hepatocytes. Although PAF- AH activity was almost abolished in the liver and kidney of Pafah2(-/-) mice, Pafah2(-/-) mice developed normally and were phenotypically indistinguishable from wild- type mice. However, mouse embryonic fibroblasts derived from Pafah2(-/-) mice were more sensitive to tert- butylhydroperoxide treatment than those derived from wild- type mice. When carbon tetrachloride (CCl4) was injected into mice, Pafah2(-/-) mice showed a delay in hepatic injury recovery. Moreover, after CCl4 administration, liver levels of the esterified form of 8-iso-PGF(2 alpha), a known in vitro substrate of PAF-AH (II), were higher in Pafah2(-/-) mice than in wild-type mice. These results indicate that PAF-AH (II) is involved in the metabolism of esterified 8-isoprostaglandin F-2 alpha and protects tissue from oxidative stress-induced injury.
C1 [Kono, Nozomu; Inoue, Takao; Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan.
   [Yoshida, Yasukazu; Niki, Etsuo] Natl Inst Adv Ind Sci & Technol, Human Stress Signal Res Ctr, Osaka 5638577, Japan.
   [Sato, Hiroyuki; Matsusue, Tomokazu] Mochida Pharmaceut Co Ltd, Pharmaceut Res Ctr, Shizuoka 4128524, Japan.
   [Itabe, Hiroyuki] Showa Univ, Sch Pharmaceut Sci, Dept Biol Chem, Shinagawa Ku, Tokyo 1428555, Japan.
   [Aoki, Junken] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan.
   [Kono, Nozomu; Inoue, Takao; Arai, Hiroyuki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan.
   [Kono, Nozomu; Inoue, Takao; Arai, Hiroyuki] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan.
C3 University of Tokyo; National Institute of Advanced Industrial Science &
   Technology (AIST); Mochida Pharmaceutical Co Ltd; Showa University;
   Tohoku University; Japan Science & Technology Agency (JST); Japan
   Science & Technology Agency (JST)
RP Arai, H (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.
EM harai@mol.f.u-tokyo.ac.jp
RI KONO, nozomu/AAM-3178-2020; YOSHIDA, YASUKAZU/H-8510-2016; 板部板部,
   洋之/ABC-7746-2020
OI YOSHIDA, YASUKAZU/0000-0001-6034-2502; Aoki, Junken/0000-0001-9435-1896
CR AMES BN, 1983, SCIENCE, V221, P1256, DOI 10.1126/science.6351251
   Bae KA, 2000, J BIOL CHEM, V275, P26704
   BIASI F, 1991, CELL BIOCHEM FUNCT, V9, P111, DOI 10.1002/cbf.290090208
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Campo GM, 2001, FREE RADICAL RES, V34, P379, DOI 10.1080/10715760100300321
   Chen R, 2007, J BIOL CHEM, V282, P24842, DOI 10.1074/jbc.M702865200
   Davies SS, 2001, J BIOL CHEM, V276, P16015, DOI 10.1074/jbc.M100878200
   DENNIS EA, 1994, J BIOL CHEM, V269, P13057
   Fruhwirth GO, 2007, BBA-MOL BASIS DIS, V1772, P718, DOI 10.1016/j.bbadis.2007.04.009
   Fukuda Y, 2000, EUR J PHARMACOL, V390, P203, DOI 10.1016/S0014-2999(99)00920-6
   HALL BH, 1990, BROOKINGS PAP ECO AC, P85
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HATTORI M, 1993, J BIOL CHEM, V268, P18748
   Henderson WR, 2000, J IMMUNOL, V164, P3360, DOI 10.4049/jimmunol.164.6.3360
   Hiramoto M, 1997, STROKE, V28, P2417, DOI 10.1161/01.STR.28.12.2417
   Hofbauer B, 1998, GASTROENTEROLOGY, V115, P1238, DOI 10.1016/S0016-5085(98)70096-4
   HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0
   Inoue T, 2004, P NATL ACAD SCI USA, V101, P13233, DOI 10.1073/pnas.0405507101
   ITABE H, 1988, BIOCHIM BIOPHYS ACTA, V962, P8
   Karabina SA, 2006, BBA-MOL CELL BIOL L, V1761, P1351, DOI 10.1016/j.bbalip.2006.05.008
   Karasawa K, 2006, BBA-MOL CELL BIOL L, V1761, P1359, DOI 10.1016/j.bbalip.2006.06.017
   KAYGANICHHARRISON KA, 1993, J LIPID RES, V34, P1229
   KINNUNEN PKJ, 1991, CHEM PHYS LIPIDS, V57, P375, DOI 10.1016/0009-3084(91)90087-R
   Kriska T, 2007, J BIOL CHEM, V282, P100, DOI 10.1074/jbc.M608135200
   Kruse S, 2000, AM J HUM GENET, V66, P1522, DOI 10.1086/302901
   Lawson JA, 1999, J BIOL CHEM, V274, P24441, DOI 10.1074/jbc.274.35.24441
   Liu P, 2001, LIVER, V21, P384, DOI 10.1034/j.1600-0676.2001.210604.x
   Marques M, 2002, J INVEST DERMATOL, V119, P913, DOI 10.1046/j.1523-1747.2002.01859.x
   Matsuzawa A, 1997, J BIOL CHEM, V272, P32315, DOI 10.1074/jbc.272.51.32315
   Min JH, 1999, BIOCHEMISTRY-US, V38, P12935, DOI 10.1021/bi991149u
   Min JH, 2001, BIOCHEMISTRY-US, V40, P4539, DOI 10.1021/bi002600g
   MIWA M, 1988, J CLIN INVEST, V82, P1983, DOI 10.1172/JCI113818
   Montuschi P, 2004, FASEB J, V18, P1791, DOI 10.1096/fj.04-2330rev
   MORROW JD, 1994, BBA-LIPID LIPID MET, V1210, P244, DOI 10.1016/0005-2760(94)90128-7
   MORROW JD, 1992, P NATL ACAD SCI USA, V89, P10721, DOI 10.1073/pnas.89.22.10721
   MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383
   Nigam S, 2000, BBA-MOL CELL BIOL L, V1488, P167, DOI 10.1016/S1388-1981(00)00119-0
   Oberley TD, 2001, FREE RADICAL BIO MED, V30, P412, DOI 10.1016/S0891-5849(00)00486-X
   Ohshima N, 2002, J BIOL CHEM, V277, P9722, DOI 10.1074/jbc.M112406200
   Prescott SM, 2000, ANNU REV BIOCHEM, V69, P419, DOI 10.1146/annurev.biochem.69.1.419
   Quarck R, 2001, CIRCULATION, V103, P2495
   Satoh N, 1999, AM J RESP CRIT CARE, V159, P974, DOI 10.1164/ajrccm.159.3.9807093
   SATOUCHI K, 1993, LIPIDS, V28, P837, DOI 10.1007/BF02536239
   Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0
   Sotelo-Félix JI, 2002, EUR J GASTROEN HEPAT, V14, P1001, DOI 10.1097/00042737-200209000-00011
   SOUTHORN PA, 1988, MAYO CLIN PROC, V63, P390, DOI 10.1016/S0025-6196(12)64862-9
   Stafforini DM, 2006, J BIOL CHEM, V281, P4616, DOI 10.1074/jbc.M507340200
   Stafforini DM, 1999, J CLIN INVEST, V103, P989, DOI 10.1172/JCI5574
   Stafforini DM, 1996, J CLIN INVEST, V97, P2784, DOI 10.1172/JCI118733
   Stafforini DM, 1997, J BIOL CHEM, V272, P17895, DOI 10.1074/jbc.272.29.17895
   STAFFORINI DM, 1987, J BIOL CHEM, V262, P4223
   Stafforini DM, 1996, BBA-LIPID LIPID MET, V1301, P161, DOI 10.1016/0005-2760(96)00040-9
   STAFFORINI DM, 1987, J BIOL CHEM, V262, P4215
   STREMLER KE, 1989, J BIOL CHEM, V264, P5331
   STREMLER KE, 1991, J BIOL CHEM, V266, P11095
   TAKAHASHI K, 1992, J CLIN INVEST, V90, P136, DOI 10.1172/JCI115826
   Tanaka M, 2004, FEBS LETT, V571, P197, DOI 10.1016/j.febslet.2004.06.083
   Theilmeier G, 2000, FASEB J, V14, P2032, DOI 10.1096/fj.99-1029com
   Tjoelker LW, 2000, BBA-MOL CELL BIOL L, V1488, P102, DOI 10.1016/S1388-1981(00)00114-1
   TJOELKER LW, 1995, NATURE, V374, P549, DOI 10.1038/374549a0
   TSELEPIS AD, 1995, ARTERIOSCL THROM VAS, V15, P1764, DOI 10.1161/01.ATV.15.10.1764
   Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6
   Umemura K, 2007, STROKE, V38, P1063, DOI 10.1161/01.STR.0000257981.09329.d2
   Wang XS, 2003, J BIOL CHEM, V278, P25179, DOI 10.1074/jbc.M302706200
   Weber LWD, 2003, CRIT REV TOXICOL, V33, P105, DOI 10.1080/713611034
   Wong FWY, 1998, TOXICOL APPL PHARM, V153, P109, DOI 10.1006/taap.1998.8547
   Wu Y, 2007, TOXICOLOGY, V232, P50, DOI 10.1016/j.tox.2006.12.013
   Yamada Y, 1997, BIOCHEM BIOPH RES CO, V236, P772, DOI 10.1006/bbrc.1997.7047
   Yamada Y, 1998, METABOLISM, V47, P177, DOI 10.1016/S0026-0495(98)90216-5
   Yoshida Y, 2005, TOXICOL APPL PHARM, V208, P87, DOI 10.1016/j.taap.2005.01.015
   Zhang QW, 2005, J BIOL CHEM, V280, P73, DOI 10.1074/jbc.M409795200
NR 71
TC 63
Z9 71
U1 3
U2 15
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JAN 18
PY 2008
VL 283
IS 3
BP 1628
EP 1636
DI 10.1074/jbc.M708622200
PG 9
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 250EL
UT WOS:000252282700049
PM 18024956
OA hybrid
DA 2024-02-19
ER

PT J
AU Zou, ZY
   Cai, J
   Zhong, AG
   Zhou, Y
   Wang, ZX
   Wu, ZM
   Yang, Y
   Li, X
   Cheng, X
   Tan, J
   Fan, YH
   Zhang, XT
   Lu, Y
   Zhou, Y
   Yang, L
   Zhang, C
   Zhao, Q
   Fu, D
   Shen, Q
   Chen, J
   Bai, S
   Wu, L
   Chen, Y
   Chen, X
   Chen, J
   Zheng, H
   Wang, H
   Lou, Y
   Ding, Y
   Shen, S
   Ye, Y
   Chen, L
   Lin, Y
   Huang, J
   Zou, K
   Zhang, J
   Bian, B
   Huang, C
   Rong, C
   Dai, L
   Xu, Y
   Cheng, L
   Chen, Y
   Luo, Y
   Zhang, S
   Li, L
AF Zou, Zhenyou
   Cai, Jing
   Zhong, Aiguo
   Zhou, Yong
   Wang, Zengxian
   Wu, Zhongmin
   Yang, Yue
   Li, Xin
   Cheng, Xiaoying
   Tan, Jie
   Fan, Yihao
   Zhang, Xiaotong
   Lu, Yuxiang
   Zhou, Yaping
   Yang, Liu
   Zhang, Chengliang
   Zhao, Qiang
   Fu, Derong
   Shen, Qiqiong
   Chen, Jie
   Bai, Shi
   Wu, Lijuan
   Chen, Yongfeng
   Chen, Xin
   Chen, Jiaren
   Zheng, Hongjie
   Wang, Hongdian
   Lou, Yingjie
   Ding, Yarong
   Shen, Shiyi
   Ye, Ying
   Chen, Lifen
   Lin, Yukai
   Huang, Jue
   Zou, Kechun
   Zhang, Jianxing
   Bian, Baohua
   Huang, Chengbo
   Rong, Cuiping
   Dai, Limiao
   Xu, Yali
   Cheng, Lin
   Chen, Ye
   Luo, Yewen
   Zhang, Shanshan
   Li, Liangxian
TI Using the synthesized peptide HAYED (5) to protect the brain against
   iron catalyzed radical attack in a naturally senescence Kunming mouse
   model
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE HAYED (5) peptide; Alzheimer's disease; Senescence; Free iron ions;
   Radicals; Amyloid beta peptide
ID AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; CHELATION-THERAPY; BETA;
   BINDING; DEFERIPRONE; HIPPOCAMPUS; EXPRESSION; REDUCTION; SITE
AB Alzheimer's disease (AD) is a progressive neurodegenerative disease of the brain. It cannot be cured currently, and those suffering from AD place a great burden on their caregivers and society. AD is characterized by high levels of iron ions in the brain, which catalyze radicals that damage the neurons. Knowing that the A beta 42 peptide precipitates iron by binding iron ions at amino acid residues D1, E3, H11, H13, and H14, we synthesized a 5-repeat (HAYED) sequence peptide. By treating iron-stressed SH-SY5Y cells with it and injecting it into the cerebrospinal fluid (CSF) of naturally senescence Kunming mouse, which displaying AD-similar symptoms such as learning and memory dysfunction, neuron degeneration and high level of iron in brain, we found that HAYED (5) decreased the iron and radical levels in the cell culture medium and in the CSF. Specially, the synthesized peptide prevented cell and brain damage. Furthermore, functional magnetic resonance imaging (fMRI), Morris water maze and passive avoidance tests demonstrated that the peptide ameliorated brain blood-oxygen metabolism and slowed cognitive loss in the experimental senescence mice, and clinical and blood tests showed that HAYED (5) was innoxious to the kidney, the liver and blood and offset the AD-associated inflammation and anemia.
C1 [Zou, Zhenyou; Tan, Jie; Rong, Cuiping; Li, Liangxian] Guilin Med Univ, Guangxi Key Lab Brain & Cognit Neurosci, 1 Zhiyuan Rd, Guilin 541199, GX, Peoples R China.
   [Zou, Zhenyou; Zhong, Aiguo; Wu, Zhongmin; Yang, Yue; Li, Xin; Cheng, Xiaoying; Fan, Yihao; Zhang, Xiaotong; Lu, Yuxiang; Zhou, Yaping; Yang, Liu; Zhang, Chengliang; Zhao, Qiang; Fu, Derong; Shen, Qiqiong; Chen, Jie; Bai, Shi; Wu, Lijuan; Chen, Yongfeng; Chen, Xin; Chen, Jiaren; Zheng, Hongjie; Wang, Hongdian; Lou, Yingjie; Ding, Yarong; Shen, Shiyi; Ye, Ying; Chen, Lifen; Lin, Yukai; Huang, Jue; Zhang, Jianxing; Bian, Baohua; Huang, Chengbo; Dai, Limiao; Xu, Yali; Cheng, Lin; Chen, Ye; Luo, Yewen; Zhang, Shanshan] Taizhou Univ, Med Sch, Taizhou 318000, ZJ, Peoples R China.
   [Cai, Jing] Nanjing Med Univ, Genet Dept, Nanjing 210000, JS, Peoples R China.
   [Zhou, Yong] Taizhou Univ, Affiliated Hosp, Clin Lab, Taizhou 318000, ZJ, Peoples R China.
   [Wang, Zengxian] Taizhou Univ, Affiliated Hosp, Med Image Ctr, Taizhou 318000, ZJ, Peoples R China.
   [Zou, Kechun] Shangli Teacher Training Sch, Pingxiang 337009, JX, Peoples R China.
   [Zou, Zhenyou] Purdue Univ, Biochem Dept, W Lafayette, IN 47906 USA.
C3 Guilin Medical University; Taizhou University; Nanjing Medical
   University; Taizhou University; Taizhou University; Purdue University
   System; Purdue University West Lafayette Campus; Purdue University
RP Zou, ZY (corresponding author), Guilin Med Univ, Guangxi Key Lab Brain & Cognit Neurosci, 1 Zhiyuan Rd, Guilin 541199, GX, Peoples R China.; Zhou, Y (corresponding author), Taizhou Univ, Affiliated Hosp, Clin Lab, Taizhou 318000, ZJ, Peoples R China.; Wang, ZX (corresponding author), Taizhou Univ, Affiliated Hosp, Med Image Ctr, Taizhou 318000, ZJ, Peoples R China.
EM zouzy@glmc.edu.cn; zhouy5077@tzzxyy.com; wangzx@tzzxyy.com
RI Li, Yuting/IVH-4108-2023; Tan, Jie/IVV-5250-2023; wang,
   KiKi/JFZ-3334-2023; Wu, Lijuan/JJG-0701-2023; WANG, HUI/JFA-9683-2023;
   Zhang, Xiaotong/HIR-6204-2022
FU Public Welfare Technology Research Grant for Zhejiang Social
   Development, China [2015C33248]; Natural Science Foundation of Zhejiang
   Province, China [Y17H160027, LY15H090002]; Taizhou Science and
   Technology Program, China [1501KY32]; Medical and Health Science Program
   of Zhejiang Province, China [2019ky246]; Taizhou University Research
   Fund, China [0104010004]; Taizhou University Talent Fostering Fund,
   China [2015PY028]; Public Applied Technology Research Project of
   Zhejiang Province, China [2015C37081]; Guangxi Key Laboratory of Brain
   and Cognitive Neuroscience, China [GKLBCN20180101]
FX This study was supported by the Public Welfare Technology Research Grant
   for Zhejiang Social Development, China [2015C33248], the Natural Science
   Foundation of Zhejiang Province, China [Y17H160027], the Taizhou Science
   and Technology Program, China [1501KY32], Medical and Health Science
   Program of Zhejiang Province, China [2019ky246], Taizhou University
   Research Fund, China [0104010004], Taizhou University Talent Fostering
   Fund, China [2015PY028], the Public Applied Technology Research Project
   of Zhejiang Province, China [2015C37081], the Natural Science Foundation
   of Zhejiang Province, China [LY15H090002], and Guangxi Key Laboratory of
   Brain and Cognitive Neuroscience, China [GKLBCN20180101].
CR Abbott A, 2018, NATURE, V556, P426, DOI 10.1038/d41586-018-04930-7
   Atwood CS, 2000, J NEUROCHEM, V75, P1219, DOI 10.1046/j.1471-4159.2000.0751219.x
   Baruch-Suchodolsky R, 2009, BIOCHEMISTRY-US, V48, P4354, DOI 10.1021/bi802361k
   Bergeron R.J., 1994, DEV IRON CHELATORS C, P353
   Bogoyevitch MA, 2004, BBA-PROTEINS PROTEOM, V1697, P89, DOI 10.1016/j.bbapap.2003.11.016
   Bousejra-ElGarah F, 2011, INORG CHEM, V50, P9024, DOI 10.1021/ic201233b
   Choi EY, 2004, J IMMUNOL, V172, P7069, DOI 10.4049/jimmunol.172.11.7069
   Conrad ME, 2000, NEW ENGL J MED, V342, P1293
   CROWE A, 1994, NEUROCHEM RES, V19, P71, DOI 10.1007/BF00966731
   Fenton H. J. H., 1894, J CHEM SOC, V65, P899, DOI [DOI 10.1039/CT8946500899, 10.1039/CT8946500899]
   Fernández T, 2018, ACS CHEM NEUROSCI, V9, P912, DOI 10.1021/acschemneuro.7b00260
   Gabathuler R, 2010, NEUROBIOL DIS, V37, P48, DOI 10.1016/j.nbd.2009.07.028
   Galanello R, 2009, ACTA HAEMATOL-BASEL, V122, P155, DOI 10.1159/000243800
   Gassen M, 1997, PHARMACOL TOXICOL, V80, P159, DOI 10.1111/j.1600-0773.1997.tb00390.x
   Ghiso J, 2002, ADV DRUG DELIVER REV, V54, P1539, DOI 10.1016/S0169-409X(02)00149-7
   Ghosh D, 2014, AGING CELL, V13, P631, DOI 10.1111/acel.12216
   Gumienna-Kontecka E., 2014, CURR MED CHEM
   HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V
   Harrill AH, 2012, TOXICOL SCI, V130, P416, DOI 10.1093/toxsci/kfs238
   Housecroft C. E., 2005, INORG CHEM, P741
   Huang JT, 2018, NEUROSCIENCE, V385, P90, DOI 10.1016/j.neuroscience.2018.06.011
   Igbavboa U, 2009, NEUROSCIENCE, V162, P328, DOI 10.1016/j.neuroscience.2009.04.049
   Ingelsson M, 2004, NEUROLOGY, V62, P925, DOI 10.1212/01.WNL.0000115115.98960.37
   Jang SM, 2010, FEBS J, V277, P4054, DOI 10.1111/j.1742-4658.2010.07801.x
   Jin UH, 2007, J ETHNOPHARMACOL, V109, P271, DOI 10.1016/j.jep.2006.07.030
   KIMURA H, 1992, J CELL BIOL, V116, P777, DOI 10.1083/jcb.116.3.777
   KOJIMA S, 1993, FEBS LETT, V329, P125, DOI 10.1016/0014-5793(93)80207-B
   KONTOGHIORGHES GJ, 1995, ANALYST, V120, P845, DOI 10.1039/an9952000845
   Lee HJ, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-176
   Letiembre M, 2009, NEUROBIOL AGING, V30, P759, DOI 10.1016/j.neurobiolaging.2007.08.018
   Li QS, 2018, BRAIN RES BULL, V137, P311, DOI 10.1016/j.brainresbull.2018.01.007
   Lin YT, 2018, J CLIN MED, V7, DOI 10.3390/jcm7100329
   Liu G, 2010, METHODS MOL BIOL, V610, P123, DOI 10.1007/978-1-60327-029-8_8
   Liu JL, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00632
   Mazzaccara C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003772
   MCLACHLAN DRC, 1991, CAN MED ASSOC J, V145, P793
   Mudher A, 2002, TRENDS NEUROSCI, V25, P22, DOI 10.1016/S0166-2236(00)02031-2
   Multhaup G, 1996, SCIENCE, V271, P1406, DOI 10.1126/science.271.5254.1406
   Multhaup G, 1998, BIOCHEMISTRY-US, V37, P7224, DOI 10.1021/bi980022m
   Nam SM, 2014, NEUROCHEM RES, V39, P1702, DOI 10.1007/s11064-014-1362-7
   National Heat Lung and Blood Institute, 2013, ARE THAL TREAT
   Olivieri NF, 1997, BLOOD, V89, P739, DOI 10.1182/blood.V89.3.739
   OLIVIERI NF, 1992, AM J PEDIAT HEMATOL, V14, P48
   Pardridge WM, 2007, DRUG DISCOV TODAY, V12, P54, DOI 10.1016/j.drudis.2006.10.013
   Pardridge William M, 2003, Mol Interv, V3, P90, DOI 10.1124/mi.3.2.90
   Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142
   Raha AA, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-55
   Sarkar G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028881
   Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5
   SLATER TF, 1984, BIOCHEM J, V222, P1
   SOLBERG HE, 1987, CLIN CHIM ACTA, V165, P111, DOI 10.1016/0009-8981(87)90224-5
   Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505
   Su DH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32948-4
   Tabaton M, 2010, EXP NEUROL, V221, P18, DOI 10.1016/j.expneurol.2009.09.002
   Tao YL, 2014, J ALZHEIMERS DIS, V42, P679, DOI 10.3233/JAD-140396
   Thompson Carl A, 2007, BMC Geriatr, V7, P18, DOI 10.1186/1471-2318-7-18
   Tiraboschi P, 2004, NEUROLOGY, V62, P1984, DOI 10.1212/01.WNL.0000129697.01779.0A
   Vivekanandan S, 2011, BIOCHEM BIOPH RES CO, V411, P312, DOI 10.1016/j.bbrc.2011.06.133
   Walker T, 2016, AGING-US, V8, P2488, DOI 10.18632/aging.101069
   Ward R, 2014, LANCET NEUROL, V13, P1045, DOI 10.1016/S1474-4422(14)70117-6
   Wiwanitkit V, 2006, INT J NANOMED, V1, P111, DOI 10.2147/nano.2006.1.1.111
   WOZNIAK A, 1989, IMMUNOLOGY, V68, P359
   Wuthrich K., 1986, NMR PROTEINS NUCL AC, P61
   Yang Qiuhong, 2013, JILIN J TRADIT CHIN, V33, P206
   Yao ZX, 2002, FASEB J, V16, P1677, DOI 10.1096/fj.02-0285fje
   Zhang W, 1998, ACTA NEUROPATHOL, V96, P395, DOI 10.1007/s004010050910
   Zou K, 2002, J NEUROSCI, V22, P4833, DOI 10.1523/JNEUROSCI.22-12-04833.2002
   [邹珍友 ZOU Zhenyou], 2007, [南京农业大学学报, Journal of Nanjing Agricultural University], V30, P116
NR 68
TC 8
Z9 8
U1 0
U2 28
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD JAN
PY 2019
VL 130
BP 458
EP 470
DI 10.1016/j.freeradbiomed.2018.11.014
PG 13
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA HG9RR
UT WOS:000455347000042
PM 30448512
DA 2024-02-19
ER

PT J
AU Cha, HN
   Kim, YW
   Kim, JY
   Kim, YD
   Song, IH
   Min, KN
   Park, SY
AF Cha, Hye-Na
   Kim, Yong-Woon
   Kim, Jong-Yeon
   Kim, Yong-Dae
   Song, In Hwan
   Min, Ki-Nam
   Park, So-Young
TI Lack of inducible nitric oxide synthase does not prevent
   aging-associated insulin resistance
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Aging; Insulin resistance; iNOS; Cytokines; Knockout
ID NECROSIS-FACTOR-ALPHA; IN-VIVO; GLUCOSE-TOLERANCE; SKELETAL-MUSCLE;
   WISTAR RATS; OBESE MICE; TNF-ALPHA; FAT; EXPRESSION; LIVER
AB Inducible nitric oxide synthase (iNOS) is involved in obesity-induced insulin resistance. Since aging is accompanied by increased iNOS expression, the effect of iNOS gene deletion on aging-associated insulin resistance was investigated in 7-month-old (adult) and 22-month-old (old) iNOS knockout and wild-type mice using the hyperinsulinemic-euglycemic clamp. While body weight and fat mass were increased, muscle mass was reduced with aging in wild-type mice. However, body composition was not changed with aging in iNOS knockout mice due to increased locomotor activity. NO metabolites in plasma, and protein levels of iNOS and nitrotyrosine in skeletal muscle increased with aging in wild-type mice. Deletion of iNOS gene attenuated NO metabolites and nitrotyrosine with aging in iNOS knockout mice. Glucose uptake in whole body and skeletal muscle was reduced with aging in both wild-type and iNOS knockout mice and there was no difference between two groups. Plasma level of tumor necrosis factor-et and gene expression of proinflammatory cytokines in peripheral tissues were increased with aging in both groups, and that was more heightened in iNOS knockout mice. These results suggest that lack of iNOS does not prevent aging-associated insulin resistance in mice and heightened production of proinflammatory cytokines may be involved. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Cha, Hye-Na; Kim, Yong-Woon; Kim, Jong-Yeon; Park, So-Young] Yeungnam Univ, Coll Med, Dept Physiol, Taegu 705717, South Korea.
   [Kim, Yong-Dae; Park, So-Young] Yeungnam Univ, Coll Med, Dept Otorhinolaryngol, Taegu 705717, South Korea.
   [Song, In Hwan] Yeungnam Univ, Coll Med, Dept Anat, Taegu 705717, South Korea.
   [Cha, Hye-Na] Yeungnam Univ, Coll Med, Aging Associated Vasc Dis Res Ctr, Taegu 705717, South Korea.
   [Min, Ki-Nam] Mazence Inc, R&D Ctr, Suwon, South Korea.
C3 Yeungnam University; Yeungnam University; Yeungnam University; Yeungnam
   University; Samsung
RP Park, SY (corresponding author), Yeungnam Univ, Coll Med, Dept Physiol, Taegu 705717, South Korea.
EM sypark@med.yu.ac.kr
RI Park, So-Young/AAC-5528-2022
OI Park, So-Young/0000-0002-6018-0440
FU Korea Science and Engineering Foundation (KOSEF); Korea government
   [R13-2005-005-03002-0]
FX This work was supported by the Korea Science and Engineering Foundation
   (KOSEF) grant funded by the Korea government (R13-2005-005-03002-0).
CR Ahima RS, 2009, NAT MED, V15, P996, DOI 10.1038/nm0909-996
   Alexandraki K, 2006, ANN NY ACAD SCI, V1084, P89, DOI 10.1196/annals.1372.039
   Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424
   BODEN G, 1995, J CLIN INVEST, V96, P1261, DOI 10.1172/JCI118160
   Borst SE, 2004, ENDOCRINE, V23, P177, DOI 10.1385/ENDO:23:2-3:177
   Bruunsgaard H, 2001, CURR OPIN HEMATOL, V8, P131, DOI 10.1097/00062752-200105000-00001
   Carvalho MA, 2009, DIABETOLOGIA, V52, P2425, DOI 10.1007/s00125-009-1498-1
   CEFALU WT, 1995, METABOLISM, V44, P954, DOI 10.1016/0026-0495(95)90251-1
   Chauhan SD, 2003, FASEB J, V17, P773, DOI 10.1096/fj.02-0668fje
   Cheung AT, 1998, ENDOCRINOLOGY, V139, P4928, DOI 10.1210/en.139.12.4928
   CRAIG BW, 1989, MECH AGEING DEV, V49, P147, DOI 10.1016/0047-6374(89)90098-5
   Csiszar A, 2003, FASEB J, V17, P1183, DOI 10.1096/fj.02-1049fje
   Cuzzocrea S, 2003, ENDOCRINOLOGY, V144, P1098, DOI 10.1210/en.2002-220597
   Dallaire P, 2008, DIABETES, V57, P1999, DOI 10.2337/db08-0540
   DESPRES JP, 1989, DIABETES, V38, P304, DOI 10.2337/diabetes.38.3.304
   Escriva F, 1997, ENDOCRINOLOGY, V138, P49, DOI 10.1210/en.138.1.49
   Escrivá F, 2007, J ENDOCRINOL, V194, P131, DOI 10.1677/joe.1.07043
   Ferrini M, 2001, NEUROENDOCRINOLOGY, V74, P1, DOI 10.1159/000054665
   Ferrini M, 2001, BIOL REPROD, V64, P974, DOI 10.1095/biolreprod64.3.974
   Gabriely I, 2002, DIABETES, V51, P2951, DOI 10.2337/diabetes.51.10.2951
   Gnacinska M, 2009, ADV MED SCI-POLAND, V54, P150, DOI 10.2478/v10039-009-0035-2
   Kim HJ, 2004, DIABETES, V53, P1060, DOI 10.2337/diabetes.53.4.1060
   Kireev RA, 2010, BIOGERONTOLOGY, V11, P229, DOI 10.1007/s10522-009-9242-2
   Lees SJ, 2009, AGING CELL, V8, P26, DOI 10.1111/j.1474-9726.2008.00445.x
   Li QX, 2009, BASIC RES CARDIOL, V104, P269, DOI 10.1007/s00395-008-0754-8
   Manetta J, 2001, METABOLISM, V50, P349, DOI 10.1053/meta.2001.20205
   Marzetti E, 2009, MECH AGEING DEV, V130, P272, DOI 10.1016/j.mad.2008.12.008
   Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750
   Nathan C, 1997, J CLIN INVEST, V100, P2417, DOI 10.1172/JCI119782
   Noronha BT, 2005, DIABETES, V54, P1082, DOI 10.2337/diabetes.54.4.1082
   Paolisso G, 1998, AM J PHYSIOL-ENDOC M, V275, pE294, DOI 10.1152/ajpendo.1998.275.2.E294
   Park SY, 2005, DIABETES, V54, P2514, DOI 10.2337/diabetes.54.9.2514
   Perreault M, 2001, NAT MED, V7, P1138, DOI 10.1038/nm1001-1138
   Ryan AS, 2000, SPORTS MED, V30, P327, DOI 10.2165/00007256-200030050-00002
   Sass G, 2001, J CLIN INVEST, V107, P439, DOI 10.1172/JCI10613
   Song W, 2009, J GERONTOL A-BIOL, V64, P540, DOI 10.1093/gerona/glp021
   STENHOLM S, 2009, CLIN ENDOCRINOL 1031
   Tomonaga S, 2005, EUR J PHARMACOL, V524, P84, DOI 10.1016/j.ejphar.2005.09.008
   Torres SH, 2004, J ENDOCRINOL, V181, P419, DOI 10.1677/joe.0.1810419
   Tripathi P, 2007, FEMS IMMUNOL MED MIC, V51, P443, DOI 10.1111/j.1574-695X.2007.00329.x
   Tsuchiya K, 2007, ENDOCRINOLOGY, V148, P4548, DOI 10.1210/en.2006-1371
   Wang HR, 2004, NEUROPSYCHOPHARMACOL, V29, P2126, DOI 10.1038/sj.npp.1300502
   Xu AW, 2005, PLOS BIOL, V3, P2168, DOI 10.1371/journal.pbio.0030415
   Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200
   Zeidler PC, 2004, TOXICOL APPL PHARM, V195, P45, DOI 10.1016/j.taap.2003.10.005
   Zingarelli B, 2002, FASEB J, V16, DOI 10.1096/fj.01-0533com
NR 46
TC 18
Z9 20
U1 1
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD SEP
PY 2010
VL 45
IS 9
BP 711
EP 718
DI 10.1016/j.exger.2010.05.004
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 651HL
UT WOS:000281918500010
PM 20493940
DA 2024-02-19
ER

PT J
AU MORITA, A
   KIMURA, M
   ITOKAWA, Y
AF MORITA, A
   KIMURA, M
   ITOKAWA, Y
TI THE EFFECT OF AGING ON THE MINERAL STATUS OF FEMALE MICE
SO BIOLOGICAL TRACE ELEMENT RESEARCH
LA English
DT Article
DE AGING; FEMALE MICE; IRON; ZINC; COPPER; CALCIUM; MAGNESIUM; SODIUM;
   POTASSIUM
ID BLOOD-BRAIN-BARRIER; SUPEROXIDE-DISMUTASE; C57BL-6J MICE; AGE; CALCIUM;
   COPPER; RATS; ZINC; METALLOTHIONEIN; METABOLISM
AB To clarify the effect of aging on the mineral status of female mice, mineral concentrations in their tissues were determined. Five 2-mo-old, five 6-mo-old, and five 10-mo-old female B10BR mice were fed a commercial diet. Iron, zinc, copper, calcium, magnesium, sodium, and potassium concentrations in the blood, liver, kidney, heart, brain, lung, and spleen of the mice were determined using a flame atomic absorption spectrophotometer. Iron concentrations in the liver, kidney, heart, brain, and spleen increased with age. Significant differences were detected between mice 2 and 6 mo of age and between mice 2 and 10 mo of age. Zinc concentrations in the heart and lung decreased significantly with age. Zinc concentrations in the heart and lung of 10-mo-old mice were significantly lower than those of 2-mo-old mice. It is noteworthy that the copper concentration in the brain of 10-mo-old mice was markedly higher compared with that of younger mice. Calcium accumulation was apparent in the kidney of mice at 10 mo.
RP MORITA, A (corresponding author), KYOTO UNIV, GRAD SCH MED, DEPT ENVIRONM MED, KYOTO 606, JAPAN.
OI Morita, Akemi/0000-0001-7942-6415
CR Aust SD, 1982, FREE RADICALS BIOL, V5
   BERGMAN B, 1974, ACTA PHYSIOL SCAND, V92, P440, DOI 10.1111/j.1748-1716.1974.tb05765.x
   BOGDEN JD, 1991, J NUTR, V121, P718, DOI 10.1093/jn/121.5.718
   BULLAMORE JR, 1970, LANCET, V2, P535
   COUSINS RJ, 1985, PHYSIOL REV, V65, P238, DOI 10.1152/physrev.1985.65.2.238
   DANIEL PM, 1978, J PHYSIOL-LONDON, V274, P141, DOI 10.1113/jphysiol.1978.sp012139
   DAVSON H, 1976, J PHYSIOL-LONDON, V255, P1
   DUNN MA, 1987, P SOC EXP BIOL MED, V185, P107
   GRINNA LS, 1973, BIOCHEM BIOPH RES CO, V55, P773, DOI 10.1016/0006-291X(73)91211-4
   HAMBIDGE KM, 1986, TRACE ELEMENTS HUMAN, V2, P83
   HANSARD SL, 1957, J NUTR, V62, P325
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   ITOKAWA Y, 1974, J APPL PHYSIOL, V37, P835, DOI 10.1152/jappl.1974.37.6.835
   LABBE MR, 1984, J NUTR, V114, P823, DOI 10.1093/jn/114.5.823
   LINDEMAN RD, 1982, J AM COLL NUTR, V1, P49
   MAMEESH MS, 1958, J NUTR, V65, P161, DOI 10.1093/jn/65.1.161
   MASSIE HR, 1983, EXP GERONTOL, V18, P277, DOI 10.1016/0531-5565(83)90038-4
   MASSIE HR, 1979, MECH AGEING DEV, V10, P93, DOI 10.1016/0047-6374(79)90073-3
   MASSIE HR, 1990, EXP GERONTOL, V25, P469, DOI 10.1016/0531-5565(90)90035-Z
   MASSIE HR, 1979, MECH AGEING DEV, V11, P219, DOI 10.1016/0047-6374(79)90001-0
   MATSUDA A, 1989, Japanese Journal of Hygiene, V44, P887
   MCELROY ST, 1991, J NUTR, V121, P492, DOI 10.1093/jn/121.4.492
   MEEMA HE, 1969, J AM GERIATR SOC, V17, P120, DOI 10.1111/j.1532-5415.1969.tb03167.x
   MEEMA HE, 1966, J BONE JOINT SURG AM, VA 48, P1138, DOI 10.2106/00004623-196648060-00011
   MEEMA S, 1973, CALC TISS RES, V12, P101, DOI 10.1007/BF02013725
   Pilch S M., 1984, Assessment of Iron Nutrition Status of the U.S. Population Based on Data Collected in the Second National Health and Nutrition Examination Survey
   Pinkham C S, 1988, Magnes Res, V1, P147
   POMMER G, 1885, UNTERSUCHUNGEN OSTEO
   RAPOPORT SI, 1979, J GERONTOL, V34, P162, DOI 10.1093/geronj/34.2.162
   REDDY BS, 1972, J NUTR, V102, P299, DOI 10.1093/jn/102.2.299
   REISS U, 1976, BIOCHEM BIOPH RES CO, V73, P255, DOI 10.1016/0006-291X(76)90701-4
   SINAKI M, 1974, ARCH PHYS MED REHAB, V55, P508
   TANAKA Y, 1986, HDB STATISTICAL ANAL, V3
   TAYLOR DM, 1962, BIOCHEM J, V83, P25, DOI 10.1042/bj0830025
   UENO M, 1991, ARCH GERONTOL GERIAT, V13, P201, DOI 10.1016/0167-4943(91)90062-U
   USA American Institute of Nutrition, 1977, Journal of Nutrition, V107, P1340
   Wisniewski H, 1966, Neuropatol Pol, V4, P33
   WOODWARD WD, 1984, J GERONTOL, V39, P521, DOI 10.1093/geronj/39.5.521
   YOSHIKAWA M, 1967, J GERONTOL, V22, P162, DOI 10.1093/geronj/22.2.162
NR 39
TC 67
Z9 74
U1 2
U2 8
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0163-4984
EI 1559-0720
J9 BIOL TRACE ELEM RES
JI Biol. Trace Elem. Res.
PD AUG
PY 1994
VL 42
IS 2
BP 165
EP 177
DI 10.1007/BF02785387
PG 13
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA PB808
UT WOS:A1994PB80800007
PM 7981006
DA 2024-02-19
ER

PT J
AU Kim, LB
   Putyatina, AN
   Russkikh, GS
   Shkurupy, VA
AF Kim, L. B.
   Putyatina, A. N.
   Russkikh, G. S.
   Shkurupy, V. A.
TI Peculiarities of Collagen Turnover in Aging BALB/c Mice
SO BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Article; Early Access
DE hydroxyproline; collagen; hyaluronidase activity; age; mouse organs
ID MATRIX; FIBROSIS
AB Examination of collagen turnover in the liver, lungs, and spleen of BALB/c mice revealed the age-related differences in the levels of hydroxyproline and its fractions. The highest level of total hydroxyproline was observed in the lungs and spleen of young (2-month-old) mice. In the liver, this level attained maximum at the age of 6 months at the expense of elevation of protein-bound hydroxyproline relatively its level in 2-month-old mice. At the age of 12 months, the levels of total hydroxyproline in the liver and spleen were lower than in 6-month-old mice. The decrease in the collagen turnover rate in the liver of 12-month-old mice reflected lower levels of hydroxyproline fractions in comparison with the corresponding values in 6-month-old mice. The rates of collagen turnover in organs differed in mice of different ages: it was maximum in the lungs and spleen of young animals and in the liver of middle-aged mice.
C1 [Kim, L. B.; Putyatina, A. N.; Russkikh, G. S.; Shkurupy, V. A.] Fed Res Ctr Fundamental & Translat Med, Novosibirsk, Russia.
   [Shkurupy, V. A.] Novosibirsk State Med Univ, Minist Hlth Russian Federat, Novosibirsk, Russia.
C3 Novosibirsk State Medical University; Ministry of Health of the Russian
   Federation
RP Kim, LB (corresponding author), Fed Res Ctr Fundamental & Translat Med, Novosibirsk, Russia.
EM lenkim@centercem.ru
OI Russkikh, Galina/0000-0003-1565-5248
CR Biernacka A, 2011, AGING DIS, V2, P158
   Calabresi C, 2007, EXP GERONTOL, V42, P1003, DOI 10.1016/j.exger.2007.06.016
   Didenko VI, 2014, GASTROENTEROLOGIYA, P37
   Dworatzek E, 2016, PROTEOM CLIN APPL, V10, P84, DOI 10.1002/prca.201500031
   Gagliano N, 2002, MECH AGEING DEV, V123, P413, DOI 10.1016/S0047-6374(01)00398-0
   Gordon MK, 2010, CELL TISSUE RES, V339, P247, DOI 10.1007/s00441-009-0844-4
   Horn MA, 2016, J MOL CELL CARDIOL, V93, P175, DOI 10.1016/j.yjmcc.2015.11.005
   Hu JC, 2017, ARTICULAR CARTILAGE, P585
   Isman FK, 2007, J INT MED RES, V35, P346, DOI 10.1177/147323000703500309
   Karsdal MA, 2016, J HEPATOL, V64, P103, DOI 10.1016/j.jhep.2015.08.014
   Kim L B, 2017, Adv Gerontol, V30, P332
   Kim LB, 2016, B EXP BIOL MED+, V161, P32, DOI 10.1007/s10517-016-3338-x
   Omel'yanenko NP, 2009, CONNECTIVE TISSUE GI, V1
   Siddiqi NJ, 2012, INDIAN J BIOCHEM BIO, V49, P130
   Stefanska A, 2015, AGING-US, V7, P370, DOI 10.18632/aging.100756
NR 15
TC 0
Z9 0
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0007-4888
EI 1573-8221
J9 B EXP BIOL MED+
JI Bull. Exp. Biol. Med.
PD 2020 MAY
PY 2020
VL 169
IS 1
BP 100
EP 103
DI 10.1007/s10517-020-04833-6
EA JUN 2020
PG 4
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA LW6LO
UT WOS:000537646000004
PM 32495166
DA 2024-02-19
ER

PT J
AU Gurau, F
   Silvestrini, A
   Matacchione, G
   Fazioli, F
   Bonfigli, AR
   Olivieri, F
   Sabbatinelli, J
AF Gurau, Felicia
   Silvestrini, Andrea
   Matacchione, Giulia
   Fazioli, Francesca
   Bonfigli, Anna Rita
   Olivieri, Fabiola
   Sabbatinelli, Jacopo
TI Plasma levels of interleukin-38 in healthy aging and in type 2 diabetes
SO DIABETES RESEARCH AND CLINICAL PRACTICE
LA English
DT Article; Early Access
DE Type 2 diabetes; Interleukin-38; Inflammation; Age-related diseases;
   Aging
ID AGE; DISEASE; IL-38
AB Plasma levels of interleukin (IL)-38 were evaluated in patients with type 2 diabetes (T2DM) and healthy controls. Plasma IL-38 was higher in T2DM patients and positively related to waist/hip ratio, HbA1c, uric acid, liver function tests, triglycerides and total proteins. Patients suffering from diabetic nephropathy had the highest IL-38 levels. (C) 2020 Elsevier B.V. All rights reserved.
C1 [Gurau, Felicia; Silvestrini, Andrea; Matacchione, Giulia; Fazioli, Francesca; Olivieri, Fabiola; Sabbatinelli, Jacopo] Univ Politecn Marche, DISCLIMO, Dept Clin & Mol Sci, Via Tronto 10-A, Ancona, Italy.
   [Bonfigli, Anna Rita] IRCCS INRCA, Sci Direct, Ancona, Italy.
   [Olivieri, Fabiola] IRCCS INRCA, Ctr Clin Pathol & Innovat Therapy, Ancona, Italy.
C3 Marche Polytechnic University; IRCCS INRCA; IRCCS INRCA
RP Matacchione, G (corresponding author), Univ Politecn Marche, DISCLIMO, Dept Clin & Mol Sci, Via Tronto 10-A, Ancona, Italy.
EM g.matacchione@pm.univpm.it
RI Bonfigli, Anna Rita R/J-7248-2016; Matacchione, Giulia/AAC-2682-2019;
   Sabbatinelli, Jacopo/U-1851-2018; Olivieri, Fabiola/K-6465-2016
OI Bonfigli, Anna Rita R/0000-0002-9619-0181; Matacchione,
   Giulia/0000-0002-1840-3903; Sabbatinelli, Jacopo/0000-0001-9947-6778;
   Olivieri, Fabiola/0000-0002-9606-1144; Silvestrini,
   Andrea/0000-0002-3586-6635
FU Italian Ministry of Health [Ricerca Corrente]; Universita Politecnica
   delle Marche (UNIVPM) [RSA grants]
FX This work was supported by the Italian Ministry of Health [Ricerca
   Corrente grant to IRCCS INRCA] and by Universita Politecnica delle
   Marche (UNIVPM) [RSA grants to FO].
CR American Diabetes Association, 2020, Diabetes Care, V43, pS14, DOI 10.2337/dc20-S002
   Bautista-Niño PK, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050748
   Bonora E, 2011, DIABETES CARE, V34, P1038, DOI 10.2337/dc10-1180
   Boutet MA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061257
   Franceschi C, 2007, NUTR REV, V65, pS173, DOI 10.1301/nr.2007.dec.S173-S176
   Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4
   Franceschi C, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00061
   Fulop T, 2018, SEMIN IMMUNOL, V40, P17, DOI 10.1016/j.smim.2018.09.003
   Garraud T, 2018, CYTOKINE GROWTH F R, V39, P26, DOI 10.1016/j.cytogfr.2018.01.001
   Jylhävä J, 2017, EBIOMEDICINE, V21, P29, DOI 10.1016/j.ebiom.2017.03.046
   Liu Y, 2020, INT IMMUNOPHARMACOL, V82, DOI 10.1016/j.intimp.2020.106264
   Mensà E, 2019, MECH AGEING DEV, V180, P1, DOI 10.1016/j.mad.2019.03.001
   Prattichizzo F, 2020, DIABET OBES METAB
   Prattichizzo F, 2018, AGEING RES REV, V41, P1, DOI 10.1016/j.arr.2017.10.003
   Rea IM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00586
   Rudloff I, 2015, ARTHRITIS RHEUMATOL, V67, P3219, DOI 10.1002/art.39328
   Targher G, 2018, NAT REV ENDOCRINOL, V14, P99, DOI 10.1038/nrendo.2017.173
   Testa R, 2011, DIABETIC MED, V28, P1388, DOI 10.1111/j.1464-5491.2011.03370.x
   van de Veerdonk FL, 2012, P NATL ACAD SCI USA, V109, P3001, DOI 10.1073/pnas.1121534109
   Wang X, 2013, DIABETES CARE, V36, P166, DOI 10.2337/dc12-0702
   Xu KY, 2019, BIOCHEM BIOPH RES CO, V508, P198, DOI 10.1016/j.bbrc.2018.11.114
   Yu ZY, 2017, J REPROD IMMUNOL, V124, P8, DOI 10.1016/j.jri.2017.09.011
NR 22
TC 11
Z9 11
U1 0
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-8227
EI 1872-8227
J9 DIABETES RES CLIN PR
JI Diabetes Res. Clin. Pract.
PD 2021 JAN
PY 2021
VL 171
AR 108585
DI 10.1016/j.diabres.2020.108585
EA JAN 2021
PG 6
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA QE1RN
UT WOS:000615988000035
PM 33310128
DA 2024-02-19
ER

PT J
AU Cen, JP
   Zhang, HY
   Liu, YW
   Deng, M
   Tang, SS
   Liu, WH
   Zhang, ZF
AF Cen, Jiaping
   Zhang, Hongyan
   Liu, Yuanwei
   Deng, Miao
   Tang, Shanshan
   Liu, Wenhua
   Zhang, Zhifen
TI Anti-aging effect of estrogen on telomerase activity in ovariectomised
   rats - animal model for menopause
SO GYNECOLOGICAL ENDOCRINOLOGY
LA English
DT Article
DE Aging; estrogen; menopause; telomerase; telomere
ID DISEASE; CANCER; LIFE
AB Objective: The aim of this study was to investigate the anti-aging effects of exogenous estrogen on telomerase activity in ovariectomized female Sprague-Dawley rats.
   Methods: Thirty-three 12-week-old female rats were divided into three groups: the ovariectomized-Treated group (Treated, n = 11), the ovariectomized control group (OVX, n = 11) and the Sham-operated group (Sham, n = 11). The rats in the Treated group were given 0.21 mg/kg estradiol valerate intragastric administration while other two groups were given the amount of physiological saline daily. All of the animals were euthanized 12 weeks after treatment, and abdominal aortic blood samples were taken to assess the level of estradiol (E-2), follicle stimulating hormone (FSH). Telomerase activity and telomerase reverse transcriptase (TERT) mRNA expression in the heart, liver, brain tissues of all rats were measured by reverse transcriptional polymerase chain reaction (RT-PCR) and competitive enzyme-linked immunosorbent assay (ELISA).
   Results: Compared to the OVX and Sham group, telomerase activity and TERT mRNA levels were significantly increased in the heart, liver and brain tissues of rats in the Treated group (p<0.05). The telomerase expression was significantly higher in the heart than in liver and brain tissues in the Treated group (p<0.05).
   Conclusion: Based on the findings in the ovariectomized female rats model, exogenous estrogen can significantly up-regulate telomerase activity and TERT mRNA expression to exert the effects of anti-aging.
C1 [Cen, Jiaping] Tianchang Peoples Hosp, Dept Obstet & Gynecol, Chuzhou, Peoples R China.
   [Zhang, Hongyan; Liu, Yuanwei; Deng, Miao; Tang, Shanshan; Liu, Wenhua; Zhang, Zhifen] Nanjing Med Univ, Affiliated Hangzhou Peoples Hosp, Dept Obstet & Gynecol, Hangzhou 310006, Zhejiang, Peoples R China.
C3 Nanjing Medical University
RP Zhang, ZF (corresponding author), Nanjing Med Univ, Affiliated Hangzhou Peoples Hosp, Dept Obstet & Gynecol, Hangzhou 310006, Zhejiang, Peoples R China.
EM zhangzf@zju.edu.cn
FU Science and Technology Department of Zhejiang Province, Hangzhou, China
   [WKJ-ZJ-024, 2014C03044-1]; Hangzhou Municipal Science and Technology
   Bureau, Hangzhou, China [20142013A58]
FX The present study was funded by the Science and Technology Department of
   Zhejiang Province, Hangzhou, China (WKJ-ZJ-024 and 2014C03044-1) and
   Hangzhou Municipal Science and Technology Bureau, Hangzhou, China
   (20142013A58). The authors report no conflicts of interest. The authors
   alone are responsible for the content and writing of the article.
CR Amore M, 2007, MATURITAS, V56, P303, DOI 10.1016/j.maturitas.2006.09.006
   Armanios M, 2013, J CLIN INVEST, V123, P996, DOI 10.1172/JCI66370
   de Jesus BB, 2013, TRENDS GENET, V29, P513, DOI 10.1016/j.tig.2013.06.007
   de Jesus BB, 2012, EMBO MOL MED, V4, P691, DOI 10.1002/emmm.201200245
   Blasco MA, 2003, CANCER LETT, V194, P183, DOI 10.1016/S0304-3835(02)00705-X
   Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349
   Bonetti D, 2014, CHROMOSOMA, V123, P57, DOI 10.1007/s00412-013-0440-y
   Carulli L, 2014, WORLD J GASTROENTERO, V20, P6287, DOI 10.3748/wjg.v20.i20.6287
   Cha Y, 2008, MOL CELLS, V26, P454
   Cui J, 2013, TRENDS MOL MED, V19, P197, DOI 10.1016/j.molmed.2012.12.007
   Dosi R, 2014, J CLIN DIAGN RES, V8, P62, DOI 10.7860/JCDR/2014/6457.4009
   Finch CE, 2014, J STEROID BIOCHEM, V142, P132, DOI 10.1016/j.jsbmb.2013.03.010
   Gallagher JC, 2007, MENOPAUSE, V14, P567, DOI 10.1097/gme.0b013e31804c793d
   Gladych M, 2011, BIOCHEM CELL BIOL, V89, P359, DOI 10.1139/O11-037
   Hathcock KS, 2005, IMMUNOL REV, V205, P104, DOI 10.1111/j.0105-2896.2005.00267.x
   Imanishi T, 2005, J HYPERTENS, V23, P1699, DOI 10.1097/01.hjh.0000176788.12376.20
   Kyo S, 1999, CANCER RES, V59, P5917
   Moilanen JM, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-8
   Oeseburg H, 2010, PFLUG ARCH EUR J PHY, V459, P259, DOI 10.1007/s00424-009-0728-1
   Sfeir AJ, 2005, MOL CELL, V18, P131, DOI 10.1016/j.molcel.2005.02.035
   Soerensen M, 2012, AGING CELL, V11, P223, DOI 10.1111/j.1474-9726.2011.00775.x
   Sturdee DW, 2011, CLIMACTERIC, V14, P302, DOI 10.3109/13697137.2011.570590
   Suzuki T, 2009, J REPROD DEVELOP, V55, P491, DOI 10.1262/jrd.09-069A
   Xi HJ, 2013, AGING CLIN EXP RES, V25, P139, DOI 10.1007/s40520-013-0021-1
   Zhou C, 2013, PLOS ONE, V8, P30
NR 25
TC 14
Z9 16
U1 0
U2 14
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0951-3590
EI 1473-0766
J9 GYNECOL ENDOCRINOL
JI Gynecol. Endocrinol.
PY 2015
VL 31
IS 7
BP 582
EP 585
DI 10.3109/09513590.2015.1065478
PG 4
WC Endocrinology & Metabolism; Obstetrics & Gynecology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Obstetrics & Gynecology
GA CR4RF
UT WOS:000361324100019
PM 26340354
DA 2024-02-19
ER

PT J
AU Zhao, HD
   Li, J
   Zhao, J
   Chen, Y
   Ren, CP
   Chen, YX
AF Zhao, Huandong
   Li, Jian
   Zhao, Juan
   Chen, Yang
   Ren, Caiping
   Chen, Yuxiang
TI Antioxidant effects of compound walnut oil capsule in mice aging model
   induced by D-galactose
SO FOOD & NUTRITION RESEARCH
LA English
DT Article
DE walnut oil capsule; oxidative stress; antioxidant; D-galactose; aging
   model
ID OXIDATIVE STRESS; IN-VITRO; NITRIC-OXIDE; HEME OXYGENASE; FREE-RADICALS;
   KLOTHO; PATHWAY; KIDNEY; CELLS; BRAIN
AB Background: Many plant original foods have been shown beneficial effects in humans. In the previous work, we have developed a compound capsule which contains major constituents of walnut oil and grape seed extract.
   Objective: To investigate the antioxidant effects of the Compound Walnut Oil Capsule (WOC) in aging model induced by D-gal.
   Design: 70 C57BL/6J mice were randomly divided into seven groups. Mice in normal group received daily subcutaneous injection of saline while the control group, WOC groups, Vitamin C (VC) group and pure walnut oil group received daily subcutaneous injection of D-galactose (D-gal) for 8 weeks. Total antioxidant capacity (T-AOC), super dismutase (SOD), glutathione peroxidase (GSH-Px) and malondialdehyde (MDA) in serum, liver and brain were determined. The expression of Heme Oxygenase (HO-1), iNOS and Klotho in liver and brain were obtained.
   Results: WOC could improve the pathologic lesions caused by oxidative stress and significantly enhance the T-AOC, increase the activities of SOD, GSH-Px and decrease the contents of MDA in serum, liver and brain. Also, the WOC could obviously up-regulate the expression of HO-1 and Klotho and down-regulate the expression of iNOS.
   Conclusion: WOC can be used as an anti-aging food for its effectively eliminating free radicals. enhancing the antioxidant capacity and alleviating the damages of oxidative stress.
C1 [Zhao, Huandong] Cent S Univ, Xiangya Hosp, Chinese Minist Hlth, Key Lab Nanobiol Technol, Changsha, Hunan, Peoples R China.
   [Zhao, Huandong; Chen, Yuxiang] Cent S Univ, Sch Pharmaceut Sci, Changsha, Hunan, Peoples R China.
   [Li, Jian; Chen, Yang] Cent S Univ, Xiangya Hosp, Inst Biomed Engn, Changsha, Hunan, Peoples R China.
   [Zhao, Juan] Cent S Univ, Xiangya Hosp, Dept Clin Lab, Changsha, Hunan, Peoples R China.
   [Ren, Caiping] Cent S Univ, Sch Basic Med Sci, Chinese Minist Hlth,Canc Res Inst, Key Lab Carcinogenesis,Collaborat Innovat Ctr Can, Changsha, Hunan, Peoples R China.
C3 Central South University; Central South University; Central South
   University; Central South University; Central South University
RP Li, J (corresponding author), 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China.; Chen, YX (corresponding author), 172 Tongzipo Rd, Changsha 410013, Hunan, Peoples R China.
EM lijian869@126.com; Yuxiangchen@csu.edu.cn
RI chen, yu-cheng/IQT-1648-2023; Chen, Yu/Y-3292-2019; chen, ye
   Xiao/HSF-9650-2023; Chen, Yi/HIR-2608-2022; Chen, Yi/HPD-0595-2023
FU Development and Research of Compound Walnut Oil Soft Capsule
   [2014.10-2018.09]; National Basic Research Program of China
   [2010CB833605]; Hunan Provincial Science Department Program [2014FJ6006]
FX This work was supported by the Development and Research of Compound
   Walnut Oil Soft Capsule (2014.10-2018.09), National Basic Research
   Program of China (2010CB833605), and Hunan Provincial Science Department
   Program (2014FJ6006).
CR Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042
   Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593
   An F, 2012, NEURAL REGEN RES, V7, P2565, DOI 10.3969/j.issn.1673-5374.2012.33.001
   Arranz S, 2008, EUR FOOD RES TECHNOL, V227, P425, DOI 10.1007/s00217-007-0737-2
   Bickford PC, 2017, EXP GERONTOL, V94, P4, DOI 10.1016/j.exger.2017.01.027
   Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907
   Chen JM, 2017, MECH AGEING DEV, V164, P1, DOI 10.1016/j.mad.2017.03.007
   da Cunha NV, 2017, CLIN EXP HYPERTENS, V39, P50, DOI 10.1080/10641963.2016.1210628
   Diamanti-Kandarakis E, 2017, EUR J ENDOCRINOL, V176, pR283, DOI 10.1530/EJE-16-1061
   Dias AS, 2005, J NUTR, V135, P2299, DOI 10.1093/jn/135.10.2299
   Dillin A, 2014, CURR OPIN CELL BIOL, V26, P107, DOI 10.1016/j.ceb.2013.12.003
   Forman HJ, 2016, FREE RADICAL BIO MED, V97, P398, DOI 10.1016/j.freeradbiomed.2016.07.003
   Glassock RJ, 2017, J NEPHROL, V30, P477, DOI 10.1007/s40620-016-0362-x
   Go YM, 2017, CLIN SCI, V131, P1669, DOI 10.1042/CS20160897
   Gong G.Q., 1991, J CHINA PHARM U, V22, P101
   Jayaprakasha GK, 2001, FOOD CHEM, V73, P285, DOI 10.1016/S0308-8146(00)00298-3
   Jyoti A, 2016, CURR SCI INDIA, V111, P1787, DOI 10.18520/cs/v111/i11/1787-1793
   Kokkinaki M, 2013, J NEUROSCI, V33, P16346, DOI 10.1523/JNEUROSCI.0402-13.2013
   Kuo PC, 1997, BIOCHEM BIOPH RES CO, V234, P289, DOI 10.1006/bbrc.1997.6562
   Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285
   Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766
   Laubertová L, 2015, EUR J NUTR, V54, P291, DOI 10.1007/s00394-014-0710-3
   Lei LH, 2016, J CHIN MED ASSOC, V79, P205, DOI 10.1016/j.jcma.2015.06.023
   Li GL, 2012, REJUV RES, V15, P257, DOI 10.1089/rej.2011.1259
   Luo Y, 2017, APOPTOSIS, V22, P1013, DOI 10.1007/s10495-017-1381-3
   Maher J, 2010, TOXICOL APPL PHARM, V244, P4, DOI 10.1016/j.taap.2010.01.011
   Maines MD, 2000, CELL MOL BIOL, V46, P573
   Marí M, 2009, ANTIOXID REDOX SIGN, V11, P2685, DOI [10.1089/ars.2009.2695, 10.1089/ARS.2009.2695]
   Martin GM, 1981, HUM PATHOL, V14, P96
   Mathew S, 2006, FOOD CHEM TOXICOL, V44, P198, DOI 10.1016/j.fct.2005.06.013
   Pannese E, 2013, REND LINCEI-SCI FIS, V24, P101, DOI 10.1007/s12210-012-0218-9
   Park M, 2014, J FOOD BIOCHEM, V38, P259, DOI 10.1111/jfbc.12044
   Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005
   Selvaratnam JS, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.141671
   Sharma OP, 2009, FOOD CHEM, V113, P1202, DOI 10.1016/j.foodchem.2008.08.008
   St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200
   Szeto YT, 2013, APPL PHYSIOL NUTR ME, V38, P275, DOI 10.1139/apnm-2012-0296
   TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748
   Thiab NR, 2016, AIMS MOL SCI, V3, P125, DOI 10.3934/molsci.2016.2.125
   Tian L, 2017, PROG NEURO-PSYCHOPH, V79, P27, DOI 10.1016/j.pnpbp.2017.01.007
   Wang PP, 2016, PHYTOMEDICINE, V23, P460, DOI 10.1016/j.phymed.2016.02.014
   Wang YH, 2012, AGING CELL, V11, P410, DOI 10.1111/j.1474-9726.2012.00796.x
   Wei HF, 2005, BEHAV BRAIN RES, V157, P245, DOI 10.1016/j.bbr.2004.07.003
   Yao Y, 2017, INTELL SYST SER, P1, DOI 10.1016/B978-0-12-812013-2.00001-0
   Yonny ME, 2016, MICROCHEM J, V129, P281, DOI 10.1016/j.microc.2016.07.010
   Yu XM, 2016, J DAIRY SCI, V99, P903, DOI 10.3168/jds.2015-10265
   Zhu Ya-zhen, 2007, Fudan Xuebao (Yixueban), V34, P617
NR 47
TC 24
Z9 26
U1 3
U2 39
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1654-6628
EI 1654-661X
J9 FOOD NUTR RES
JI Food Nutr. Res.
PD APR 20
PY 2018
VL 62
AR 1371
DI 10.29219/fnr.v62.1371
PG 10
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA GG2MI
UT WOS:000432526600001
PM 29720929
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Supakar, PC
   Roy, AK
AF Supakar, PC
   Roy, AK
TI Role of transcription factors in the age-dependent regulation of the
   androgen receptor gene in rat liver
SO BIOLOGICAL SIGNALS
LA English
DT Article
DE androgen receptor; transcription factor; aging; age-dependent factor
ID NF-KAPPA-B; DNA-BINDING; RESPONSE ELEMENT; NUCLEAR FACTOR; PROMOTER;
   ACTIVATION; EXPRESSION; ENHANCER; PROTEIN; IDENTIFICATION
AB Androgen receptor (AR) is a ligand-activated transcription factor involved in mediating male reproductive functions, The high expression of the AR gene in target tissues of young-adult animals is generally followed by an age-dependent decline during the postreproductive life. The liver of male rats shows about a 50- to 100-fold decline in androgen sensitivity during old age due to a concomitant decline of the AR gene expression. This decline corresponds to changes in the nuclear level of several transcription factors that bind to the AR gene promoter. The positively acting factors that control the AR gene and undergo an age-dependent decline include the age-dependent transcription factor (ADF), Sp1 and the serum response factor (SRF). Nuclear factor kappa B, which functions as a negative regulator of the AR promoter, undergoes about a 10-fold increase during the age-dependent loss of the hepatic androgen sensitivity. Additionally, AP3, which can potentially function as a regulator of the AR gene, shows a marked increase during old age. Thus, a coordinated interaction among a number of positive and negative regulators appears to guide the downregulation of the AR gene during aging.
C1 UNIV TEXAS, HLTH SCI CTR, DEPT CELLULAR & STRUCT BIOL, SAN ANTONIO, TX 78284 USA.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio
FU NIA NIH HHS [R01 AG 10486] Funding Source: Medline; NIDDK NIH HHS [R37
   DK 14744] Funding Source: Medline
CR AMMENDOLA R, 1992, J BIOL CHEM, V267, P17944
   BAARENDS WM, 1990, MOL CELL ENDOCRINOL, V74, P75, DOI 10.1016/0303-7207(90)90207-O
   BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0
   BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.iy.12.040194.001041
   BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394
   COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4
   COURTOIS G, 1987, SCIENCE, V238, P688, DOI 10.1126/science.3499668
   FRIEDMAN AD, 1989, GENE DEV, V3, P1314, DOI 10.1101/gad.3.9.1314
   GIL G, 1988, P NATL ACAD SCI USA, V85, P8963, DOI 10.1073/pnas.85.23.8963
   GONZALEZ GA, 1991, MOL CELL BIOL, V11, P1306, DOI 10.1128/MCB.11.3.1306
   HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0
   JONES KA, 1987, CELL, V48, P79, DOI 10.1016/0092-8674(87)90358-8
   JOST A, 1970, PHILOS T ROY SOC B, V259, P119, DOI 10.1098/rstb.1970.0052
   KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4
   KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0
   MERCURIO F, 1989, EMBO J, V8, P1455, DOI 10.1002/j.1460-2075.1989.tb03528.x
   MIZOKAMI A, 1994, MOL ENDOCRINOL, V8, P77, DOI 10.1210/me.8.1.77
   NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9
   NURRISH SJ, 1995, MOL CELL BIOL, V15, P4076
   POLLOCK R, 1991, GENE DEV, V5, P2327, DOI 10.1101/gad.5.12a.2327
   Prins GS, 1996, DEV GENET, V18, P99
   ROY AK, 1995, CRIT REV EUKAR GENE, V5, P157, DOI 10.1615/CritRevEukarGeneExpr.v5.i2.30
   Roy AK, 1996, EXP GERONTOL, V31, P83, DOI 10.1016/0531-5565(95)00020-8
   ROY AK, 1983, RECENT PROG HORM RES, V39, P425
   SESHADRI T, 1990, SCIENCE, V247, P205, DOI 10.1126/science.2104680
   SHARROCKS AD, 1993, MOL CELL BIOL, V13, P123, DOI 10.1128/MCB.13.1.123
   SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353
   SONG CS, 1993, BIOCHEM J, V294, P779, DOI 10.1042/bj2940779
   SONG CS, 1991, ENDOCRINOLOGY, V128, P349, DOI 10.1210/endo-128-1-349
   SUN SC, 1994, P NATL ACAD SCI USA, V91, P1346, DOI 10.1073/pnas.91.4.1346
   SUPAKAR PC, 1995, J BIOL CHEM, V270, P837, DOI 10.1074/jbc.270.2.837
   SUPAKAR PC, 1993, J BIOL CHEM, V268, P26400
   TILLEY WD, 1990, J BIOL CHEM, V265, P13776
   TRAENCKNER EBM, 1994, EMBO J, V13, P5433, DOI 10.1002/j.1460-2075.1994.tb06878.x
   VELLANOWETH RL, 1994, LAB INVEST, V70, P784
   YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0
   YU YT, 1992, GENE DEV, V6, P1783, DOI 10.1101/gad.6.9.1783
NR 37
TC 26
Z9 27
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1016-0922
J9 BIOL SIGNAL
JI Biol. Signals
PD MAY-JUN
PY 1996
VL 5
IS 3
BP 170
EP 179
PG 10
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA VE292
UT WOS:A1996VE29200006
PM 8864062
DA 2024-02-19
ER

PT J
AU Wu, JZ
   Chen, HJ
   Wang, D
   Zhao, X
AF Wu, Jianzhong
   Chen, Hongjiang
   Wang, Dan
   Zhao, Xin
TI Effect of <i>Clerodendranthus spicatus</i> (Thunb.) C. Y. Wu on the
   exercise ability of D-galactose-induced oxidative aging mice
SO FOOD SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Clerodendranthus spicatus (Thunb.) C. Y. Wu; D-galactose; oxidative;
   exercise; mRNA
ID ANTIOXIDANT; STRESS; PERFORMANCE; FATIGUE; DISEASE; DAMAGE; ALPHA;
   RUTIN; RISK; ACID
AB The Clerodendranthus spicatus (Thunb.) C. Y. Wu extract (CSTCYWE) was administered to D-galactose-induced aging mice to investigate the effect and mechanism of CSTCYWE on exercise endurance in aging mice. The effect of CSTCYWE on the improvement of exercise capacity in aging mice was evaluated by detecting serum biochemical indicators, pathological changes in tissues, and expression by qPCR. The composition of CSTCYWE was analyzed by HPLC. The experiment showed that CSTCYWE increased the running time and the exhaustive swimming time of aging mice to improve their exercise endurance. CSTCYWE also reduced the levels of BUN, BLA, and MDA and increased the levels of HG, MG, SOD, and GSH-Px in the serum of aging mice. Pathological observation found that CSTCYWE alleviated the liver and kidney tissue lesions and damage caused by aging. Meanwhile, CSTCYWE could down-regulate the relative mRNA expressions of nNOS, iNOS, TNF-alpha, and syncrin-1 and up-regulate the relative mRNA expressions of Cu/Zn-SOD, Mn-SOD, and CAT in the mouse liver tissue and skeletal muscle tissue. The results of component analysis showed that CSTCYWE contained caffeic acid, hypericin, isoquercetin, dihydroquercetin, rosmarinic acid, baicalin, luteolin, and baicalein. These active ingredients enable CSTCYWE to act on aging mice and improve their exercise capacity.
C1 [Wu, Jianzhong] Beijing Sport Univ, Sports Coaching Coll, Beijing, Peoples R China.
   [Chen, Hongjiang; Zhao, Xin] Chongqing Univ Educ, Coll Biol & Chem Engn, Chongqing, Peoples R China.
   [Wang, Dan] China Univ Geosci, Dept Phys Educ, Beijing, Peoples R China.
C3 Beijing Sport University; Chongqing University of Education; China
   University of Geosciences - Beijing
RP Wang, D (corresponding author), China Univ Geosci, Dept Phys Educ, Beijing, Peoples R China.
EM wuwang199709@163.com
CR Aschner M., FREE RADICAL BIO MED
   Bakkaloglu Z, 2021, FOOD SCI TECH-BRAZIL, V41, P687, DOI 10.1590/fst.14520
   Bloomer RJ, 2009, INT J SPORT NUTR EXE, V19, P457, DOI 10.1123/ijsnem.19.5.457
   Cao N, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.316
   Chen H, 2021, INT J FATIGUE, V146, DOI 10.1016/j.ijfatigue.2021.106150
   Chen YF, 2009, CHEM-BIOL INTERACT, V182, P7, DOI 10.1016/j.cbi.2009.06.007
   Cho YA, 2011, PHARMACOL REP, V63, P1066, DOI 10.1016/S1734-1140(11)70624-7
   Cruz-Zúñiga JM, 2016, FOOD CHEM, V204, P420, DOI 10.1016/j.foodchem.2016.02.130
   Dimitrov VG, 2012, EUR J APPL PHYSIOL, V112, P1399, DOI 10.1007/s00421-011-2095-9
   Eor JY, 2020, INT J DAIRY TECHNOL, V73, P743, DOI 10.1111/1471-0307.12708
   Fan LM, 2017, FREE RADICAL BIO MED, V108, P940, DOI 10.1016/j.freeradbiomed.2017.05.008
   Fujii N, 2016, J APPL PHYSIOL, V120, P318, DOI 10.1152/japplphysiol.00714.2015
   Gao Y, 2020, REDOX BIOL, V36, DOI 10.1016/j.redox.2020.101635
   Grandi N, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0301-x
   Hill AM, 2007, AM J CLIN NUTR, V85, P1267, DOI 10.1093/ajcn/85.5.1267
   Hsu YJ, 2016, NUTRIENTS, V8, DOI 10.3390/nu8100648
   López-Cruz RI, 2010, COMP BIOCHEM PHYS A, V156, P50, DOI 10.1016/j.cbpa.2009.12.017
   Iwansyah AC, 2021, FOOD SCI TECH-BRAZIL, V41, P987, DOI 10.1590/fst.15420
   Izquierdo MC, 2012, NEPHROL DIAL TRANSPL, V27, piv6, DOI 10.1093/ndt/gfs426
   Kaska A, 2021, FOOD SCI TECH-BRAZIL, V41, P505, DOI 10.1590/fst.08620
   Katzman WB, 2017, OSTEOPOROSIS INT, V28, P2831, DOI 10.1007/s00198-017-4109-x
   Kazemi S. Y., 2012, J LUMIN
   Kim TW, 2019, J EXERC REHABIL, V15, P751, DOI 10.12965/jer.1938712.356
   Lanza IR, 2009, AM J CLIN NUTR, V89, p467S, DOI 10.3945/ajcn.2008.26717D
   Laura V, 2011, RES AUTISM SPECT DIS, V5, P286, DOI 10.1016/j.rasd.2010.04.010
   Lee CS, 2020, INT J DAIRY TECHNOL, V73, P706, DOI 10.1111/1471-0307.12701
   Leung FP, 2008, SPORTS MED, V38, P1009, DOI 10.2165/00007256-200838120-00005
   Li N, 2013, FOOD CHEM, V139, P1161, DOI 10.1016/j.foodchem.2013.01.084
   Maleki BH, 2018, CYTOKINE, V102, P18, DOI 10.1016/j.cyto.2017.12.016
   MPHAHLELE MJ, 2021, J MOL STRUCT, V1245
   Ogura Y, 2011, ACTA PHYSIOL, V202, P683, DOI 10.1111/j.1748-1716.2011.02284.x
   Oluwole OSA, 2007, AMYOTROPH LATERAL SC, V8, P67, DOI 10.1080/17482960600864207
   Park JH, 2018, EXP DERMATOL, V27, P378, DOI 10.1111/exd.13437
   Petersen KF, 2004, J CLIN ENDOCR METAB, V89, P4656, DOI 10.1210/jc.2004-0408
   Seon HY, 2021, FOOD SCI TECH-BRAZIL, V41, P1025, DOI 10.1590/fst.21720
   Shiose K., 2012, OPEN J MOL INTEGR PH, V2, P119, DOI [10.4236/ojmip.2012.24017, DOI 10.4236/OJMIP.2012.24017]
   Singh AK, 2016, J POSTGRAD MED, V62, P96, DOI 10.4103/0022-3859.180555
   Tepe B, 2007, FOOD CHEM, V100, P985, DOI 10.1016/j.foodchem.2005.10.062
   Uygur B, 2019, MOL CANCER RES, V17, P806, DOI 10.1158/1541-7786.MCR-18-0500
   Vitale G, 2013, NAT REV ENDOCRINOL, V9, P228, DOI 10.1038/nrendo.2013.29
   Waisundara VY, 2011, LIFE SCI, V88, P1016, DOI 10.1016/j.lfs.2011.03.009
   Wang L, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/9623957
   Wille CM, 2014, J ORTHOP SPORT PHYS, V44, P825, DOI 10.2519/jospt.2014.5367
   Yano H, 2010, EUR J APPL PHYSIOL, V110, P797, DOI 10.1007/s00421-010-1560-1
   Yi RK, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.641544
   Yoon GA, 2014, NUTR RES PRACT, V8, P618, DOI 10.4162/nrp.2014.8.6.618
   Yu XL, 2015, FOOD FUNCT, V6, P3296, DOI 10.1039/c5fo00500k
   Zhang YC, 2013, FOOD CHEM TOXICOL, V59, P272, DOI 10.1016/j.fct.2013.05.058
   Zhou CC, 2016, BRIT J PHARMACOL, V173, P2352, DOI 10.1111/bph.13513
NR 49
TC 3
Z9 3
U1 4
U2 13
PU SOC BRASILEIRA CIENCIA TECNOLOGIA ALIMENTOS
PI CAMPINAS
PA AV BRASIL 2880, CAXIA POSTAL 271 CEP 13001-970, CAMPINAS, SAO PAULO
   00000, BRAZIL
SN 0101-2061
EI 1678-457X
J9 FOOD SCI TECH-BRAZIL
JI Food Sci. Technol.
PY 2022
VL 42
AR e09822
DI 10.1590/fst.09822
PG 12
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA 0Z3RR
UT WOS:000790998800010
OA gold
DA 2024-02-19
ER

PT J
AU Floreani, A
AF Floreani, Annarosa
TI Liver disorders in the elderly
SO BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY
LA English
DT Article
DE Liver diseases; Elderly; Chronic hepatitis; Ageing
ID HEPATITIS-C VIRUS; PRIMARY BILIARY-CIRRHOSIS; I AUTOIMMUNE HEPATITIS;
   HEPATOCELLULAR-CARCINOMA; NATURAL-HISTORY; GENERAL-POPULATION;
   RISK-FACTORS; FATTY LIVER; NONALCOHOLIC STEATOHEPATITIS; COMBINATION
   THERAPY
AB Although there are no specific age-related liver diseases, it is increasingly recognized that the percentage and the actual number of elderly will increase substantially over the next twenty years. Moreover, the developments of new emerging conditions (e.g. non-alcoholic steatohepatitis) and novel therapeutic approaches have provoked increasing enthusiasm among hepatologists. Some liver diseases are particularly frequent in the elderly, e.g. chronic hepatitis C and hepatocellular carcinoma. The clinical course and management of liver disease in the elderly may differ in several aspects from those of younger adults. The problem of whether to offer antiviral treatment to a wide range of patients with chronic hepatitis C has arisen over the last eight to ten years, since the reduction in the risk of hepatocellular carcinoma was analyzed. Selected patients aged 65 and older have a chance of treatment with pegylated interferon plus ribavirin, despite a higher likelihood of side effects. The diagnosis of autoimmune hepatitis should be suspected in a patient over 65 years of age in case of 'acute' presentation with 10-fold increase in transaminases, jaundice and hyper-gammaglobulinemia, to avoid any delay in starting immunosuppressive therapy. The age of an end stage liver disease will increase over the next years, thus we will expects an increasing number of decompensated liver disease and hepatocellular carcinomas. (C) 2009 Elsevier Ltd. All rights reserved.
C1 Univ Padua, Dept Surg & Gastroenterol Sci, I-35128 Padua, Italy.
C3 University of Padua
RP Floreani, A (corresponding author), Univ Padua, Dept Surg & Gastroenterol Sci, Via Giustiniani 2, I-35128 Padua, Italy.
EM annarosa.floreani@unipd.it
CR Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014
   Alessi Nunziata, 2003, Infez Med, V11, P208
   Allen JR, 1996, JAMA-J AM MED ASSOC, V275, P797
   Allocca M, 2006, GUT, V55, P1795, DOI 10.1136/gut.2005.079814
   Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753
   Andrade RJ, 2005, GASTROENTEROLOGY, V129, P512, DOI 10.1053/j.gastro.2005.05.006
   Ansaldi F, 2005, J MED VIROL, V76, P327, DOI 10.1002/jmv.20376
   Antonucci G, 2007, AM J GASTROENTEROL, V102, P1383, DOI 10.1111/j.1572-0241.2007.01201.x
   Bacosi M, 2002, HEPATOL RES, V22, P231, DOI 10.1016/S1386-6346(01)00140-1
   Baldo V, 2000, GERONTOLOGY, V46, P194, DOI 10.1159/000022159
   BALDO V, 2008, CURR PHARM DESIGN, V103, P1959
   Bedogni G, 2007, HEPATOLOGY, V46, P1387, DOI 10.1002/hep.21827
   Benvegnù L, 2004, GUT, V53, P744, DOI 10.1136/gut.2003.020263
   BIORNSSON E, 2005, HEPATOLOGY, V42, P481
   Bruno S, 2005, BMJ-BRIT MED J, V330, P932, DOI 10.1136/bmj.38391.663287.E0
   Cavazza A, 2009, J HEPATOL, V50, pS26, DOI 10.1016/S0168-8278(09)60063-5
   Chiaramonte M, 1999, CANCER-AM CANCER SOC, V85, P2132, DOI 10.1002/(SICI)1097-0142(19990515)85:10<2132::AID-CNCR6>3.0.CO;2-H
   Chiaramonte M, 1996, J HEPATOL, V24, P129, DOI 10.1016/S0168-8278(96)80020-1
   CHIARAMONTE M, 1987, BIOMED PHARMACOTHER, V41, P121
   Conti F, 2009, J HEPATOL, V50, pS222, DOI 10.1016/S0168-8278(09)60605-X
   Coppola RC, 2000, J VIRAL HEPATITIS, V7, P130
   Czaja AJ, 2006, HEPATOLOGY, V43, P532, DOI 10.1002/hep.21074
   Czaja AJ, 2008, DRUG AGING, V25, P219, DOI 10.2165/00002512-200825030-00005
   Di Stefano R, 2002, J MED VIROL, V67, P339, DOI 10.1002/jmv.10081
   El-Serag HB, 2006, J HEPATOL, V44, P158, DOI 10.1016/j.jhep.2005.10.002
   FABRIS P, 2008, J CLIN GASTROENTEROL
   Fattovich G, 2008, J HEPATOL, V48, P335, DOI 10.1016/j.jhep.2007.11.011
   FLOREANI A, 1992, EUR J EPIDEMIOL, V8, P808, DOI 10.1007/BF00145324
   Floreani A, 2006, ALIMENT PHARM THER, V24, P1051, DOI 10.1111/j.1365-2036.2006.03104.x
   Floreani A, 2006, J AM GERIATR SOC, V54, P549, DOI 10.1111/j.1532-5415.2006.00643_4.x
   Floreani A, 1999, HEPATOLOGY, V29, P1425, DOI 10.1002/hep.510290501
   FLOREANI A, 1991, Recenti Progressi in Medicina, V82, P259
   Floreani A, 2007, DIGEST DIS, V25, P138, DOI 10.1159/000099478
   Forrest EH, 2005, GUT, V54, P1174, DOI 10.1136/gut.2004.050781
   Giannini EG, 2009, CLIN GASTROENTEROL H, V7, P580, DOI 10.1016/j.cgh.2009.01.001
   Guadagnino V, 1997, HEPATOLOGY, V26, P1006, DOI 10.1053/jhep.1997.v26.pm0009328327
   Hislop W S, 1982, Age Ageing, V11, P153, DOI 10.1093/ageing/11.3.153
   Hoofnagle JH, 1999, J HEPATOL, V31, P264, DOI 10.1016/S0168-8278(99)80414-0
   Iwasaki Y, 2006, HEPATOLOGY, V43, P54, DOI 10.1002/hep.20984
   JOHN W, 2006, GERIATRICS, V61, P23
   Jones DEJ, 1997, HEPATOLOGY, V26, P1138
   Junaidi O, 2007, CLIN GERIATR MED, V23, P889, DOI 10.1016/j.cger.2007.06.006
   Kumada T, 2005, INTERVIROLOGY, V49, P112, DOI 10.1159/000087273
   Lavanchy D, 2008, BEST PRACT RES CL GA, V22, P991, DOI 10.1016/j.bpg.2008.11.002
   LEHMANN AB, 1985, GERONTOLOGY, V31, P186, DOI 10.1159/000212701
   Lobello S, 2009, J HEPATOL, V50, pS365, DOI 10.1016/S0168-8278(09)61010-2
   Maddrey WC, 2005, J CLIN GASTROENTEROL, V39, pS83, DOI 10.1097/01.mcg.0000155548.91524.6e
   Maio G, 2000, J HEPATOL, V33, P116, DOI 10.1016/S0168-8278(00)80167-1
   Marcus EL, 1997, J AM GERIATR SOC, V45, P755, DOI 10.1111/j.1532-5415.1997.tb01484.x
   Meier P, 2008, CURR OPIN CLIN NUTR, V11, P21, DOI 10.1097/MCO.0b013e3282f30564
   Minola E, 2002, BLOOD, V99, P4588, DOI 10.1182/blood-2001-12-0192
   Monica F, 2006, DIGEST LIVER DIS, V38, P336, DOI 10.1016/j.dld.2005.12.014
   Monto A, 2004, HEPATOLOGY, V39, P826, DOI 10.1002/hep.20127
   Navarro VJ, 2006, NEW ENGL J MED, V354, P731, DOI 10.1056/NEJMra052270
   Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193
   Newton JL, 1997, AGE AGEING, V26, P441, DOI 10.1093/ageing/26.6.441
   Newton JL, 2000, AGE AGEING, V29, P305, DOI 10.1093/ageing/29.4.305
   Nomura H, 2004, J GASTROEN HEPATOL, V19, P1312, DOI 10.1111/j.1440-1746.2004.03459.x
   NOUSBAUM JB, 1995, ANN INTERN MED, V122, P161, DOI 10.7326/0003-4819-122-3-199502010-00001
   Oneta CM, 2001, Z GASTROENTEROL, V39, P783, DOI 10.1055/s-2001-17196
   Pagliaro L, 1999, ITAL J GASTROENTEROL, V31, P28
   Paradis V, 2009, HEPATOLOGY, V49, P851, DOI 10.1002/hep.22734
   Parker DR, 1997, QJM-MON J ASSOC PHYS, V90, P289, DOI 10.1093/qjmed/90.4.289
   Pendino GM, 2005, HEPATOLOGY, V41, P1151, DOI 10.1002/hep.20689
   POTTER CL, 1987, GERONTOLOGY, V33, P77, DOI 10.1159/000212857
   Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8
   Puoti C, 2002, J HEPATOL, V37, P117, DOI 10.1016/S0168-8278(02)00101-0
   Raffaele A, 2001, EUR J EPIDEMIOL, V17, P41, DOI 10.1023/A:1010932832190
   Ribes J, 2008, J HEPATOL, V49, P233, DOI 10.1016/j.jhep.2008.04.016
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Schramm C, 2001, AM J GASTROENTEROL, V96, P1587
   Seitz HK, 2007, CLIN GERIATR MED, V23, P905, DOI 10.1016/j.cger.2007.06.010
   Serfaty L, 1996, GASTROENTEROLOGY, V110, P291, DOI 10.1053/gast.1996.v110.pm8536870
   Siegel SM, 2008, GERONTOLOGY, V54, P193, DOI 10.1159/000138335
   Simmonds P, 1996, J HEPATOL, V24, P517, DOI 10.1016/S0168-8278(96)80135-8
   STROFFOLINI T, 1995, ITAL J GASTROENTEROL, V27, P235
   Takaki S, 2004, J GASTROENTEROL, V39, P668, DOI 10.1007/s00535-003-1363-9
   Thabut D, 2006, AM J GASTROENTEROL, V101, P1260, DOI 10.1111/j.1572-0241.2006.00556.x
   Thomas M, 2009, J GASTROENTEROL, V44, P136, DOI 10.1007/s00535-008-2252-z
   WIESNER RH, 1992, HEPATOLOGY, V16, P1290, DOI 10.1016/0270-9139(92)90026-6
   Yeh CN, 2004, HEPATO-GASTROENTEROL, V51, P219
   Zelber-Sagil S, 2007, J HEPATOL, V47, P711, DOI 10.1016/j.jhep.2007.06.020
NR 82
TC 14
Z9 15
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1521-6918
EI 1532-1916
J9 BEST PRACT RES CL GA
JI Best Pract. Res. Clin. Gastroenterol.
PD DEC
PY 2009
VL 23
IS 6
BP 909
EP 917
DI 10.1016/j.bpg.2009.10.005
PG 9
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 537NZ
UT WOS:000273121000011
PM 19942167
DA 2024-02-19
ER

PT J
AU COCHARY, EF
   GERSHOFF, SN
   SADOWSKI, JA
AF COCHARY, EF
   GERSHOFF, SN
   SADOWSKI, JA
TI EFFECTS OF VITAMIN-B6 DEFICIENCY AND AGING ON PYRIDOXAL 5'-PHOSPHATE
   LEVELS AND GLYCOGEN-PHOSPHORYLASE ACTIVITY IN RATS
SO JOURNAL OF NUTRITIONAL BIOCHEMISTRY
LA English
DT Article
DE VITAMIN-B6; AGING; PYRIDOXAL 5'-PHOSPHATE; GLYCOGEN PHOSPHORYLASE;
   MUSCLE; LIVER; BRAIN
ID NUTRITIONAL-STATUS; SENESCENT MICE; YOUNG-ADULT; METABOLISM; PHOSPHATE;
   TISSUES; PLASMA; LIVER; ERYTHROCYTE; DIETARY
AB Muscle, liver, brain, and plasma pyridoxal 5'-phosphate (PLP) concentration and muscle, liver, and brain glycogen phosphorylase (GPase) activity were determined during vitamin B-6 deficiency and aging. Fischer 344, male rats, aged 15 weeks, and 6, 15, and 25.5 months at the end of the 12-week study, were divided into diet groups of ad libitum controls, deficient or pair-fed controls. Plasma PLP levels in 25.5-month-old control rats were lower (P less-than-or-equal-to 0.05) than the other three age groups which were slightly, but not significantly different from each other. Plasma PLP of deficient rats was dramatically decreased (P less-than-or-equal-to 0.05) in all age groups. Muscle PLP was decreased (P less-than-or-equal-to 0.05) in all vitamin B-6 deficient rats. Liver and brain PLP concentrations were decreased (P less-than-or-equal-to 0.05) in 15 week, 6 month, and 15 month deficient rats only. Tissue PLP levels were correlated (P less-than-or-equal-to 0.01) with plasma PLP. Vitamin B-6 deficiency resulted in decreased glycogen phosphorylase activity (P less-than-or-equal-to 0.05) in muscle, liver, and brain of 15 week rats, and in muscle and liver of 6 month rats. Reduction in food intake did not account for the reported changes during vitamin B-6 deficiency. A significant correlation between tissue glycogen phosphorylase activity and tissue PLP levels was observed. Vitamin B-6 deficiency significantly lowered tissue PLP and phosphorylase activity, but the decrease in each was less marked with increasing age.
C1 TUFTS UNIV, USDA, HUMAN NUTR RES CTR AGING, BOSTON, MA 02111 USA.
   TUFTS UNIV, SCH NUTR, MEDFORD, MA 02155 USA.
C3 United States Department of Agriculture (USDA); Tufts University; Tufts
   University
CR [Anonymous], 1980, J NUTR, V110, P1726
   BAYOUMI RA, 1976, CLIN CHEM, V22, P327
   BOSRON WF, 1978, J BIOL CHEM, V253, P1488
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BRIN M, 1960, J NUTR, V71, P416, DOI 10.1093/jn/71.4.416
   CHABNER B, 1970, ANAL BIOCHEM, V34, P413, DOI 10.1016/0003-2697(70)90126-0
   COCHARY EF, 1990, AM J CLIN NUTR, V51, P446, DOI 10.1093/ajcn/51.3.446
   Cori GT, 1938, J BIOL CHEM, V123, P375
   DRUMMOND GI, 1964, ARCH BIOCHEM BIOPHYS, V105, P156, DOI 10.1016/0003-9861(64)90247-4
   DRUMMOND GI, 1970, J NEUROCHEM, V17, P475, DOI 10.1111/j.1471-4159.1970.tb00524.x
   EISENSTEIN AB, 1962, BIOCHIM BIOPHYS ACTA, V58, P244, DOI 10.1016/0006-3002(62)91005-3
   FONDA ML, 1980, EXP GERONTOL, V15, P457, DOI 10.1016/0531-5565(80)90053-4
   FONDA ML, 1980, EXP GERONTOL, V15, P465, DOI 10.1016/0531-5565(80)90054-6
   GARRY PJ, 1982, AM J CLIN NUTR, V36, P319, DOI 10.1093/ajcn/36.2.319
   GILBOE DP, 1972, ANAL BIOCHEM, V47, P20, DOI 10.1016/0003-2697(72)90274-6
   GUILLAND JC, 1984, INT J VITAM NUTR RES, V54, P185
   HAMFELT A, 1964, CLIN CHIM ACTA, V10, P48, DOI 10.1016/0009-8981(64)90214-1
   HODKINSON M, 1984, CLIN BIOCH ELDERLY, P1
   KANT AK, 1988, AM J CLIN NUTR, V48, P1284, DOI 10.1093/ajcn/48.5.1284
   KREBS EG, 1964, VIT HORMOONES, V22, P339
   LEKLEM JE, 1987, FED PROC, V46, P1487
   LI TK, 1974, BIOCHEM BIOPH RES CO, V61, P677, DOI 10.1016/0006-291X(74)91010-9
   LUMENG L, 1978, J NUTR, V108, P545, DOI 10.1093/jn/108.4.545
   LUMENG L, 1980, METHODS VITAMIN B6 N, P57
   LYON JB, 1962, BIOCHIM BIOPHYS ACTA, V58, P248, DOI 10.1016/0006-3002(62)91006-5
   MCGANDY RB, 1986, NUTR RES, V6, P785, DOI 10.1016/S0271-5317(86)80161-0
   MCIIWAIN H, 1985, BIOCH CTR NERVOUS SY, P30
   MEISLER NT, 1980, J NUTR, V110, P1965, DOI 10.1093/jn/110.10.1965
   NELSON SR, 1968, J NEUROCHEM, V15, P1271, DOI 10.1111/j.1471-4159.1968.tb05904.x
   PATNAIK SK, 1974, BIOCHEM BIOPH RES CO, V56, P845, DOI 10.1016/S0006-291X(74)80265-2
   REYNOLDS RD, 1987, CLIN CHEM
   ROSE CS, 1976, AM J CLIN NUTR, V29, P847, DOI 10.1093/ajcn/29.8.847
   RUSSELL LE, 1985, J NUTR, V115, P1124, DOI 10.1093/jn/115.9.1124
   TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913
   USA American Institute of Nutrition, 1977, Journal of Nutrition, V107, P1340
   VALADARES JR, 1967, BIOCHIM BIOPHYS ACTA, V136, P296, DOI 10.1016/0304-4165(67)90075-X
   WILSON JE, 1977, MOL CELL BIOCHEM, V18, P39, DOI 10.1007/BF00215278
   WU C, 1977, BIOCHEM BIOPH RES CO, V75, P879, DOI 10.1016/0006-291X(77)91464-4
   1980, AOAC OFFICIAL METHOD, P768
NR 39
TC 6
Z9 7
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0955-2863
EI 1873-4847
J9 J NUTR BIOCHEM
JI J. Nutr. Biochem.
PD MAR
PY 1991
VL 2
IS 3
BP 135
EP 141
DI 10.1016/0955-2863(91)90005-P
PG 7
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA EZ832
UT WOS:A1991EZ83200004
DA 2024-02-19
ER

PT J
AU Alper, G
   Girgin, FK
   Ozgönül, M
   Mentes, G
   Ersöz, B
AF Alper, G
   Girgin, FK
   Ozgönül, M
   Mentes, G
   Ersöz, B
TI MAO inhibitors and oxidant stress in aging brain tissue
SO EUROPEAN NEUROPSYCHOPHARMACOLOGY
LA English
DT Article
DE monoamine oxidase inhibitors; lipid peroxidation; antioxidant enzymes;
   brain tissue; aging
ID MONOAMINE-OXIDASE; RAT-BRAIN; SUPEROXIDE-DISMUTASE; SYSTEMS; FRACTIONS;
   LONGEVITY; CATALASE; INJURY; LIVER
AB The process of aging presents itself with various alterations in physiological events. Among many theories, the free radical (FR) theory of aging which reflects the FR damage to cellular components is accepted as one of the most important theories. Recently, the increases in catecholamine metabolism in aging have also attracted attention, and monoamine oxidase (MAO), a key enzyme in this process has been extensively studied. The aim of this study was to assess the role of FR species via MAO, a possible source of FRs, in physiological aging by determining the lipid peroxidation products (LPP) (malondialdehyde, diene conjugates) and antioxidant enzyme levels (superoxide dismutase (SOD) and catalase (CAT) in young (3 months old, n=10) and aging (16-18 months old, n=10) rat brain tissues of Swiss male albino rats. In the second part of the study, the same parameters were determined after the acute administration of MAO inhibitors (deprenyl and pargyline, 25 mg/kg i.p.) to investigate whether these agents have any beneficial effects in reducing oxidant stress via inhibition of MAO. In old rat brains, MAO activities showed a significant increase (P=0.000) in addition to an insignificant increase in LPP, while SOD (P=0.007) and CAT activities showed a decrease with advancing age. After the acute administration of both deprenyl and pargyline, a significant decrease in the MAO activities of both young (P=0.0002 for each) and aging rats (P=0.0002 for deprenyl and P=0.0001 for pargyline) were observed. It was noted that deprenyl causes a significant increase in CAT activity (P<0.05) but a significant decrease in SOD activity (P<0.05) in young rats, while it causes only a significant increase in SOD activity in aging rats (P<0.05). Both deprenyl and pargyline cause a significant decrease in conjugated diene levels of aging rats (P<0.05). These results confirm the role of catecholamine oxidation and MAO activity as one of the causative factors in increased oxidant stress during aging. By reducing the oxidant stress observed in aging brain, MAO inhibitors, especially deprenyl, may contribute to the control of the aging process. (C) 1999 Elsevier Science B.V. All rights reserved.
C1 Ege Univ, Sch Med, Dept Biochem, TR-35100 Izmir, Turkey.
C3 Ege University
RP Alper, G (corresponding author), Ege Univ, Sch Med, Dept Biochem, TR-35100 Izmir, Turkey.
CR ABRASS IB, 1990, WESTERN J MED, V153, P641
   AEBI H, 1984, METHOD ENZYMOL, V105, P121
   BENEDETTI MS, 1989, BIOCHEM PHARMACOL, V38, P555, DOI 10.1016/0006-2952(89)90198-6
   Buege J A, 1978, Methods Enzymol, V52, P302
   FRACKOWIAK RSJ, 1986, MENTAL HLTH ELDERLY, P146
   GEOKAS MC, 1990, ANN INTERN MED, V113, P455, DOI 10.7326/0003-4819-113-6-455
   GEREMIA E, 1990, NEUROCHEM RES, V15, P719, DOI 10.1007/BF00973653
   GLOVER V, 1986, CELL BIOCHEM FUNCT, V4, P89, DOI 10.1002/cbf.290040203
   HARMAN D, 1968, J GERONTOL, V23, P476, DOI 10.1093/geronj/23.4.476
   HARMAN D, 1993, DRUG AGING, V3, P60, DOI 10.2165/00002512-199303010-00006
   JOSSAN SS, 1991, BRAIN RES, V547, P69
   KALARIA RN, 1988, BRAIN, V111, P1441, DOI 10.1093/brain/111.6.1441
   KRAML M, 1965, BIOCHEM PHARMACOL, V14, P1684
   LAUX G, 1995, CNS DRUGS, V3, P145, DOI 10.2165/00023210-199503020-00006
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Luck H., 1965, Method of enzymatic analysis, P885, DOI [10.1016/B978-0-12-395630-9.50158-4, DOI 10.1016/B978-0-12-395630-9.50158-4]
   MANN JJ, 1984, ACTA PSYCHIAT SCAND, V69, P135, DOI 10.1111/j.1600-0447.1984.tb02477.x
   MANN JJ, 1986, J NEURAL TRANSM, V65, P277, DOI 10.1007/BF01249088
   MCCORD JM, 1985, NEW ENGL J MED, V312, P159
   MISRA HP, 1972, J BIOL CHEM, V247, P3170
   ORELAND L, 1986, PROG NEURO-PSYCHOPH, V10, P533, DOI 10.1016/0278-5846(86)90023-0
   Saura J, 1994, J Neural Transm Suppl, V41, P89
   SEMSEI I, 1991, MECH AGEING DEV, V58, P13, DOI 10.1016/0047-6374(91)90116-H
   SEVANIAN A, 1985, ANNU REV NUTR, V5, P365, DOI 10.1146/annurev.nu.05.070185.002053
   SIMONSON SG, 1993, J CEREBR BLOOD F MET, V13, P125, DOI 10.1038/jcbfm.1993.15
   SLATER TF, 1971, BIOCHEM J, V123, P805, DOI 10.1042/bj1230805
   SOHAL RS, 1990, MECH AGEING DEV, V53, P217, DOI 10.1016/0047-6374(90)90040-M
   SOHAL RS, 1993, BIOCHEM BIOPH RES CO, V196, P7, DOI 10.1006/bbrc.1993.2208
   VERTECHY M, 1989, EXP GERONTOL, V24, P211, DOI 10.1016/0531-5565(89)90012-0
   VOITENKO NN, 1991, VOP MED KHIM, V37, P28
   WU RM, 1993, EUR J PHARMACOL, V243, P241, DOI 10.1016/0014-2999(93)90181-G
   ZHANG J, 1991, AM PHYSL SOC, P1057
NR 32
TC 63
Z9 70
U1 0
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0924-977X
EI 1873-7862
J9 EUR NEUROPSYCHOPHARM
JI Eur. Neuropsychopharmacol.
PD MAR
PY 1999
VL 9
IS 3
BP 247
EP 252
DI 10.1016/S0924-977X(98)00035-2
PG 6
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry
GA 178AW
UT WOS:000079244100010
PM 10208295
DA 2024-02-19
ER

PT J
AU An, T
   Zhang, XY
   Gao, X
   Zhang, XY
   Shen, T
   Li, HX
   Dou, L
   Huang, XQ
   Man, Y
   Li, GP
   Tang, WQ
   Li, J
AF An, Tong
   Zhang, Xiaoyi
   Gao, Xin
   Zhang, Xiyue
   Shen, Tao
   Li, Hongxia
   Dou, Lin
   Huang, Xiuqing
   Man, Yong
   Li, Guoping
   Tang, Weiqing
   Li, Jian
TI Phosphoenolpyruvate induces endothelial dysfunction and cell senescence
   through stimulation of metabolic reprogramming
SO JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
LA English
DT Article; Early Access
DE Phosphoenolpyruvate; Endothelial dysfunction; Cell senescence; Metabolic
   reprogramming
ID REPERFUSION INJURY; TELOMERE; ISCHEMIA; PROTECTS; DEATH; ATP
AB Endothelial dysfunction is a key early link in the pathogenesis of atherosclerosis, and the accumulation of senescent vascular endothelial cells causes endothelial dysfunction. Phosphoenolpyruvate (PEP), which is a high-energy glycolytic intermediate, protects against ischemia-reperfusion injury in isolated rat lung, heart, and liver tissue by quickly providing ATP. However, it was reported that serum PEP concentrations are 13-fold higher in healthy elderly compare to the young. Unlike that of other cell types, the energy required for the physiological function of endothelial cells is mainly derived from glycolysis. Recently, it is unclear whether circulating accumulation of PEP affects endothelial cell function. In this study, we found for the first time that 50-250 mu M of PEP significantly promoted THP-1 monocyte adhesion to human umbilical vein endothelial cells (HUVECs) through increased expression of vascular endothelial adhesion factor 1 (VCAM1) and intercellular adhesion factor 1 (ICAM1) in HUVECs. Meanwhile, 50-250 mu M of PEP decreased the expression of endothelial nitric oxide synthase (eNOS) and cellular level of nitric oxide (NO) in HUVECs. Moreover, PEP increased levels of ROS, enhanced the numbers of SA-beta-Gal-positive cells and upregulated the expression of cell cycle inhibitors such as p21, p16 and the phosphorylation level of p53 on Ser15, and the expression of proinflammatory factors including TNF-alpha, IL-1 beta, IL-6, IL-8, IL-18 and MCP-1 in HUVECs. Furthermore, PEP increased both oxygen consumption rate (OCR) and glycolysis rate, and was accompanied by reduced NAD(+)/NADH ratios and enhanced phosphorylation levels of AMPK alpha (Thr172), p38 MAPK (T180/Y182) and NF-kappa B p65 (Ser536) in HUVECs. Notably, PEP had no significant effect on hepG2 cells. In conclusion, these results demonstrated that PEP induced dysfunction and senescence in vascular endothelial cells through stimulation of metabolic reprogramming.
C1 [An, Tong; Zhang, Xiaoyi; Li, Jian] Peking Univ, Sch Clin Med 5, Beijing 100730, Peoples R China.
   [An, Tong; Zhang, Xiaoyi; Zhang, Xiyue; Shen, Tao; Li, Hongxia; Dou, Lin; Huang, Xiuqing; Man, Yong; Li, Guoping; Tang, Weiqing; Li, Jian] Chinese Acad Med Sci, Beijing Hosp, Beijing Inst Geriatr, Inst Geriatr Med,Key Lab Geriatr,Natl Ctr Gerontol, Beijing 100730, Peoples R China.
   [Gao, Xin] Chinese Acad Med Sci, Beijing Hosp, Inst Geriatr Med, Clin Trial Ctr,Natl Ctr Gerontol Natl Hlth Commiss, Beijing 100730, Peoples R China.
C3 Peking University; Chinese Academy of Medical Sciences - Peking Union
   Medical College; Beijing Hospital; Chinese Academy of Medical Sciences -
   Peking Union Medical College; Beijing Hospital
RP Li, J (corresponding author), Peking Univ, Sch Clin Med 5, Beijing 100730, Peoples R China.; Tang, WQ; Li, J (corresponding author), Chinese Acad Med Sci, Beijing Hosp, Beijing Inst Geriatr, Inst Geriatr Med,Key Lab Geriatr,Natl Ctr Gerontol, Beijing 100730, Peoples R China.
EM tangweiqing2365@bjhmoh.cn; lijian@bjhmoh.cn
RI Shen, Tao/AGP-6511-2022
OI Shen, Tao/0000-0001-5856-0818
FU Beijing Natural Science Foundation [7212086, 7232141]; National Key R&D
   Program of China [2021YFE0114200]; Chinese Academy of Medical Sciences
   (CAMS) Innovation Fund for Medical Sciences [2021-I2M-1-050]
FX This work was supported by the Beijing Natural Science Foundation
   (7212086, 7232141), the National Key R&D Program of China
   (2021YFE0114200) and the Chinese Academy of Medical Sciences (CAMS)
   Innovation Fund for Medical Sciences (grant no. 2021-I2M-1-050)
CR Abulizi A, 2020, CELL METAB, V32, P751, DOI 10.1016/j.cmet.2020.10.006
   Andrew PJ, 1999, CARDIOVASC RES, V43, P521, DOI 10.1016/S0008-6363(99)00115-7
   Birch J, 2020, GENE DEV, V34, P1565, DOI 10.1101/gad.343129.120
   CHANG E, 1995, P NATL ACAD SCI USA, V92, P11190, DOI 10.1073/pnas.92.24.11190
   Cuollo L, 2020, BIOLOGY-BASEL, V9, DOI 10.3390/biology9120485
   Feletou M, 2011, INTEGRATED SYSTEMS P
   Förstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304
   Gao MQ, 2020, J BIOENERG BIOMEMBR, V52, P17, DOI 10.1007/s10863-019-09819-2
   Geng XK, 2021, MOL NEUROBIOL, V58, P2309, DOI 10.1007/s12035-020-02251-3
   Gimbrone MA, 2016, CIRC RES, V118, P620, DOI 10.1161/CIRCRESAHA.115.306301
   Gomes AP, 2020, NATURE, V585, P283, DOI 10.1038/s41586-020-2630-0
   Grasmann G, 2019, BBA-REV CANCER, V1872, P24, DOI 10.1016/j.bbcan.2019.05.006
   Libby P, 2021, NATURE, V592, P524, DOI 10.1038/s41586-021-03392-8
   Luengo A, 2021, MOL CELL, V81, P691, DOI 10.1016/j.molcel.2020.12.012
   Matacchione G, 2021, BIOGERONTOLOGY, V22, P297, DOI 10.1007/s10522-021-09915-0
   Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17
   Nacarelli T, 2019, NAT CELL BIOL, V21, P397, DOI 10.1038/s41556-019-0287-4
   Okuda K, 2000, ATHEROSCLEROSIS, V152, P391, DOI 10.1016/S0021-9150(99)00482-7
   Oshima Yoshiaki, 2005, Japanese Journal of Anesthesiology, V54, P1234
   Oshima Y, 2015, J ANESTH, V29, P635, DOI 10.1007/s00540-014-1972-x
   Saiki S, 1997, J SURG RES, V73, P59, DOI 10.1006/jsre.1997.5177
   Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262
   Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011
   Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672
   Zhao WW, 2014, VASC PHARMACOL, V63, P162, DOI 10.1016/j.vph.2014.06.008
   Zhou CY, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.655687
NR 26
TC 1
Z9 1
U1 3
U2 8
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0145-479X
EI 1573-6881
J9 J BIOENERG BIOMEMBR
JI J. Bioenerg. Biomembr.
PD 2023 APR
PY 2023
VL 55
IS 2
BP 103
EP 114
DI 10.1007/s10863-023-09965-8
EA APR 2023
PG 12
WC Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biophysics; Cell Biology
GA AV8I0
UT WOS:000968213600001
PM 37046136
DA 2024-02-19
ER

PT J
AU Martin, H
   Staedtler, F
   Lamboley, C
   Adrian, M
   Schumacher, MM
   Chibout, SD
   Laurant, P
   Richert, L
   Berthelot, A
AF Martin, Helene
   Staedtler, Frank
   Lamboley, Christelle
   Adrian, Markus
   Schumacher, Martin M.
   Chibout, Salah-Dine
   Laurant, Pascal
   Richert, Lysiane
   Berthelot, Alain
TI Effects of long-term dietary intake of magnesium on rat liver
   transcriptome
SO MAGNESIUM RESEARCH
LA English
DT Article
DE magnesium; rat liver; mRNA expression
ID GENE-EXPRESSION PROFILES; OXIDATIVE STRESS; CDNA ARRAY; VITAMIN-E;
   DEFICIENCY; CELLS; MICE; HEPATOCYTES; MODULATION; INDUCTION
AB In the present study we investigated the effect of a two-year treatment period with a diet containing 3.2g, 0.8 g and 0.15 g Mg/kg, on the rat liver transcriptome. At the end of the study, a treatment-dependent decrease in plasmatic Mg concentration was found (0.86 +/- 0.02 mmoVL, 0.70 +/- 0.02 mmol/L and 0.52 +/- 0.03 mmoVL for groups receiving 3.2g, 0.8 g and 0.15 g Mg/kg diet, respectively). No significant treatment-related effect on body and liver weights was observed, however a dietary Mg intake-dependent increase in mortality rate occurred in animals (11%, 25% and 38% death of animals). Mg content in the diet affected gene expression in rat livers, as assessed by rat specific DNA microarrays. We identified 11 genes up-regulated and 39 genes down-regulated by at least two-fold by a decrease in Mg content and grouped them within five functional pathways: metabolism 20%, cytoarchitecture (connective tissue/cell adhesion/cytoskeleton) 12%, channels/ transporters 20%, turn-over (nucleic acid and protein) 16%, and homeostasis (stress/DNA damage/apoptosis/ageing) 32%. The results of the present study confirm the pleiotropic effects of Mg and provide further evidence that a Mg decrease in the diet may be considered as a promoting factor for pathologies, especially in the liver, during ageing.
C1 [Martin, Helene; Richert, Lysiane] UFR Sci Med & Pharmaceut, EA 3921, Lab Biol Cellulaire, OMC, F-25030 Besancon, France.
   [Staedtler, Frank; Lamboley, Christelle; Schumacher, Martin M.; Chibout, Salah-Dine] Novartis Pharma AG, Biomarker Dev Investigat Toxicol, Basel, Switzerland.
   [Adrian, Markus; Laurant, Pascal; Berthelot, Alain] OMC, EA 3921, UFR Sci Med & Pharmaceut, Physiol Lab, Besancon, France.
C3 Novartis
RP Martin, H (corresponding author), UFR Sci Med & Pharmaceut, EA 3921, Lab Biol Cellulaire, OMC, Pl St Jacques, F-25030 Besancon, France.
EM helene.martin@univ-fcomte.fr
OI MARTIN, helene/0000-0001-8318-3858
CR ALTURA BM, 1982, ELECTROLYTES HEART, P41
   ARSENIAN MA, 1993, PROG CARDIOVASC DIS, V35, P271, DOI 10.1016/0033-0620(93)90008-2
   Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200
   Bussiere FI, 2002, MAGNESIUM RES, V15, P37
   CERAFATTI C, 2000, J BIOL CHEM, V275, P3772
   CHAUDHARY DP, 2007, IN PRESS EUR J NUTR
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Durlach J, 1998, MAGNESIUM RES, V11, P25
   Eymin B, 1997, CANCER RES, V57, P686
   Fischer A, 2001, BIOCHEM BIOPH RES CO, V285, P470, DOI 10.1006/bbrc.2001.5171
   GUNTHER T, 1992, MAGNESIUM-B, V14, P57
   Guyton KZ, 1996, BIOCHEM J, V314, P547, DOI 10.1042/bj3140547
   Hartwig A, 2001, MUTAT RES-FUND MOL M, V475, P113, DOI 10.1016/S0027-5107(01)00074-4
   Kim S, 2005, J NUTR, V135, P33, DOI 10.1093/jn/135.1.33
   Kim TH, 2000, J BIOL CHEM, V275, P39474, DOI 10.1074/jbc.M003370200
   KUMMEROW FA, 1992, J AM COLL NUTR, V11, P410
   Li YW, 2003, J NUTR, V133, P1011, DOI 10.1093/jn/133.4.1011
   Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675
   Martin H, 2003, J NUTR, V133, P2505, DOI 10.1093/jn/133.8.2505
   Menon B, 2001, INDIAN J BIOCHEM BIO, V38, P159
   Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141
   *NAT RES COUNC, 1995, NUTR REQ LAB AN, P11
   Ozgo M, 2007, MAGNESIUM RES, V20, P148
   Pagès N, 2003, MAGNESIUM RES, V16, P43
   Panov A, 1996, BIOCHEMISTRY-US, V35, P427, DOI 10.1021/bi952101t
   Petrault I, 2002, BBA-MOL BASIS DIS, V1586, P92, DOI 10.1016/S0925-4439(01)00089-8
   Rimbach G, 1999, FOOD CHEM TOXICOL, V37, P37, DOI 10.1016/S0278-6915(98)00103-3
   RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439
   Rubin H, 2005, MAGNESIUM RES, V18, P268
   Van Orden R, 2006, MAGNESIUM RES, V19, P93
NR 30
TC 6
Z9 6
U1 0
U2 2
PU JOHN LIBBEY EUROTEXT LTD
PI MONTROUGE
PA 127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE
SN 0953-1424
J9 MAGNESIUM RES
JI Magnes. Res.
PD DEC
PY 2007
VL 20
IS 4
BP 259
EP 265
PG 7
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 248PF
UT WOS:000252165700006
PM 18271497
DA 2024-02-19
ER

PT J
AU Covington, MD
   Arrington, DD
   Schnellmann, RG
AF Covington, Marisa D.
   Arrington, David D.
   Schnellmann, Rick G.
TI Calpain 10 is required for cell viability and is decreased in the aging
   kidney
SO AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY
LA English
DT Article
DE apoptosis; calpain 1; calpain 2; caloric restriction
ID ACUTE-RENAL-FAILURE; NEUTRAL PROTEINASE CALPAIN; CALORIE RESTRICTION;
   IN-VITRO; APOPTOSIS; AGE; DISEASE; DEATH; DEGRADATION; PROTEASOME
AB Covington MD, Arrington DD, Schnellmann RG. Calpain 10 is required for cell viability and is decreased in the aging kidney. Am J Physiol Renal Physiol 296: F478-F486, 2009. First published January 14, 2009; doi:10.1152/ajprenal.90477.2008.-Aging is associated with abnormalities in kidney function, but the exact mechanisms are unknown. We examined calpains 1, 2, and 10 protein levels in kidneys from rats, mice, and humans of various ages and determined whether calpain 10 is required for cell viability. Calpain 10 protein expression decreased in the kidney, but not in the liver, of aging Fischer 344 rats, and this decrease was attenuated with caloric restriction. There was no change in calpains 1 or 2 levels in the kidney or liver in control and caloric-restricted aging rats. Aging mice also exhibited decreased calpain 10 protein levels. Calpain 10 protein and mRNA levels decreased linearly in human kidney samples with age in the absence of changes in calpains 1 or 2. Our laboratory previously found calpain 10 to be expressed in both the cytosol and mitochondria of rabbit renal proximal tubular cells (RPTC). Adenoviral-delivered shRNA to rabbit RPTC decreased mitochondrial calpain 10 expression below detectable levels by 3 days while cytosolic calpain 10 levels remained unchanged at 3 days and decreased to similar to 20% of control by 5 days. Knockdown of mitochondrial calpain 10 resulted in nuclear condensation and cleaved procaspase 3, markers of apoptosis. In summary, mitochondrial calpain 10 is required for cell viability and calpain 10 levels specifically decrease in aging rat, mice, and human kidney tissues when renal function decreases, suggesting that calpain 10 is required for renal function and is a biomarker of the aging kidney.
C1 [Covington, Marisa D.; Arrington, David D.; Schnellmann, Rick G.] Med Univ S Carolina, Dept Pharmaceut & Biomed Sci, Ctr Cell Death Injury & Regenerat, S Carolina Coll Pharm, Charleston, SC 29425 USA.
C3 Medical University of South Carolina
RP Schnellmann, RG (corresponding author), Med Univ S Carolina, Dept Pharmaceut & Biomed Sci, Ctr Cell Death Injury & Regenerat, S Carolina Coll Pharm, 280 Calhoun St,POB 250140, Charleston, SC 29425 USA.
EM schnell@musc.edu
FU National Institutes of Health (NIH) Sciences [ES-012239, GM-084147,
   T32-HL-007260]
FX This study was supported by National Institutes of Health (NIH) Sciences
   Grants ES-012239 and GM-084147, and NIH Training Grant T32-HL-007260.
CR Adachi T, 2001, CLIN EXP PHARMACOL P, V28, P877, DOI 10.1046/j.1440-1681.2001.03536.x
   Altznauer F, 2004, J BIOL CHEM, V279, P5947, DOI 10.1074/jbc.M308576200
   Arrington DD, 2008, AM J PHYSIOL-CELL PH, V294, pC641, DOI 10.1152/ajpcell.00400.2007
   Arrington DD, 2006, AM J PHYSIOL-CELL PH, V291, pC1159, DOI 10.1152/ajpcell.00207.2006
   AZUMA M, 1992, FEBS LETT, V307, P313, DOI 10.1016/0014-5793(92)80703-J
   BAYLIS C, 1994, J CLIN INVEST, V94, P1823, DOI 10.1172/JCI117531
   Benuck M, 1996, J NEUROCHEM, V67, P2019
   Bizat N, 2003, J NEUROSCI, V23, P5020
   BREZIS M, 1989, NEW ENGL J MED, V320, P179, DOI 10.1056/NEJM198901193200309
   Chen M, 2001, J BIOL CHEM, V276, P30724, DOI 10.1074/jbc.M103701200
   Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200
   Cummings BS, 2004, J PHARMACOL EXP THER, V308, P921, DOI 10.1124/jpet.103.060541
   DAVID LL, 1992, BIOCHIM BIOPHYS ACTA, V1139, P210, DOI 10.1016/0925-4439(92)90136-B
   FILLIT H, 1992, AGING KIDNEY
   Friguet B, 2000, ANN NY ACAD SCI, V908, P143
   Giguere CJ, 2008, BIOCHEM BIOPH RES CO, V366, P258, DOI 10.1016/j.bbrc.2007.11.133
   Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002
   GOYAL VK, 1982, EXP GERONTOL, V17, P321, DOI 10.1016/0531-5565(82)90032-8
   Harriman JF, 2002, CELL DEATH DIFFER, V9, P734, DOI 10.1038/sj.cdd.4401029
   Harris F, 2004, MOL CELL BIOCHEM, V261, P161, DOI 10.1023/B:MCBI.0000028751.10560.dc
   Inserte J, 2004, CARDIOVASC RES, V64, P105, DOI 10.1016/j.cardiores.2004.06.001
   Joaquin AM, 2001, J AM GERIATR SOC, V49, P1234, DOI 10.1046/j.1532-5415.2001.04990.x
   Johnson JD, 2004, J BIOL CHEM, V279, P24794, DOI 10.1074/jbc.M401216200
   Jung KY, 2004, MECH AGEING DEV, V125, P445, DOI 10.1016/j.mad.2004.04.001
   Keller JN, 2000, MECH AGEING DEV, V113, P61, DOI 10.1016/S0047-6374(99)00101-3
   KELLEY MJ, 1993, J BIOL CHEM, V268, P18844
   Lee JH, 2004, EXP GERONTOL, V39, P1361, DOI 10.1016/j.exger.2004.06.015
   Leosco D, 1996, J AM SOC NEPHROL, V7, P1045
   Liu XL, 2004, ANNU REV PHARMACOL, V44, P349, DOI 10.1146/annurev.pharmtox.44.101802.121804
   Ma H, 1999, EXP EYE RES, V68, P447, DOI 10.1006/exer.1998.0625
   Ma H, 2001, J BIOL CHEM, V276, P28525, DOI 10.1074/jbc.M100603200
   Ma LJ, 2000, KIDNEY INT, V58, P2425, DOI 10.1046/j.1523-1755.2000.00426.x
   Maddox DA, 2002, KIDNEY INT, V62, P208, DOI 10.1046/j.1523-1755.2002.00412.x
   Manya H, 2002, J BIOL CHEM, V277, P35503, DOI 10.1074/jbc.M206033200
   Mulder W J., 2001, Eur J Intern Med, V12, P86, DOI 10.1016/S0953-6205(01)00121-2
   NIXON RA, 1994, ANN NY ACAD SCI, V747, P77
   NOWAK G, 1995, AM J PHYSIOL-CELL PH, V268, pC1053, DOI 10.1152/ajpcell.1995.268.4.C1053
   Pariat M, 1997, MOL CELL BIOL, V17, P2806, DOI 10.1128/MCB.17.5.2806
   PASCUAL J, 1990, J AM GERIATR SOC, V38, P25, DOI 10.1111/j.1532-5415.1990.tb01592.x
   Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200
   Qiao X, 2005, J GERONTOL A-BIOL, V60, P830, DOI 10.1093/gerona/60.7.830
   Sabbatini M, 2004, J AM SOC NEPHROL, V15, P901, DOI 10.1097/01.ASN.0000119573.01290.AE
   SAITO KI, 1993, P NATL ACAD SCI USA, V90, P2628, DOI 10.1073/pnas.90.7.2628
   Shringarpure R, 2001, CELL MOL LIFE SCI, V58, P1442, DOI 10.1007/PL00000787
   Silva Fred G., 2005, International Urology and Nephrology, V37, P185, DOI 10.1007/s11255-004-0873-6
   Stern JS, 2001, J NUTR, V131, p913S, DOI 10.1093/jn/131.3.913S
   Tiao JYH, 2002, CARDIOVASC SURG, V10, P445, DOI 10.1016/S0967-2109(02)00056-X
   Wang CH, 2004, J BIOMED SCI, V11, P571, DOI 10.1159/000079668
   Wiggins JE, 2005, J AM SOC NEPHROL, V16, P2953, DOI 10.1681/ASN.2005050488
   Wu SH, 2005, PROSTAG LEUKOTR ESS, V73, P127, DOI 10.1016/j.plefa.2005.02.005
   Xue JL, 2006, J AM SOC NEPHROL, V17, P1135, DOI 10.1681/ASN.2005060668
   Yamashima T, 2004, CELL CALCIUM, V36, P285, DOI 10.1016/j.ceca.2004.03.001
   Zhang JH, 2003, AGEING RES REV, V2, P357, DOI 10.1016/S1568-1637(03)00026-6
NR 53
TC 20
Z9 24
U1 0
U2 4
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 1931-857X
EI 1522-1466
J9 AM J PHYSIOL-RENAL
JI Am. J. Physiol.-Renal Physiol.
PD MAR
PY 2009
VL 296
IS 3
BP F478
EP F486
DI 10.1152/ajprenal.90477.2008
PG 9
WC Physiology; Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology; Urology & Nephrology
GA 410CB
UT WOS:000263552400004
PM 19144693
OA Green Published
DA 2024-02-19
ER

PT J
AU Idobe-Fujii, Y
   Omoso, R
   Fujii, S
   Fujiwara, H
   Nakamura, Y
   Nomi, T
   Sasaki, Y
   Sasaki, H
   Isomoto, H
   Murawaki, Y
AF Idobe-Fujii, Yoko
   Omoso, Ryoko
   Fujii, Shinya
   Fujiwara, Hiromitsu
   Nakamura, Yuki
   Nomi, Takahiro
   Sasaki, Yuichiro
   Sasaki, Hiroyuki
   Isomoto, Hajime
   Murawaki, Yoshikazu
TI Normal values of combinational elastography in adult liver: the
   influence of age
SO JOURNAL OF MEDICAL ULTRASONICS
LA English
DT Article; Early Access
DE Ultrasound elastography; RTE; Liver fibrosis index; Shear wave imaging;
   Strain imaging
ID TIME TISSUE ELASTOGRAPHY; SHEAR-WAVE ELASTOGRAPHY; ULTRASOUND
   ELASTOGRAPHY; NONALCOHOLIC STEATOHEPATITIS; TRANSIENT ELASTOGRAPHY;
   NONINVASIVE EVALUATION; STRAIN ELASTOGRAPHY; HEPATIC-FIBROSIS;
   CLINICAL-USE; STIFFNESS
AB Purpose We aimed to clarify the normal values obtained by simultaneous use of shear wave imaging and strain imaging (combinational elastography) in liver and reveal how aging influences them. Methods In our checkup center, 257 examinees were diagnosed with normal liver based on questionnaires about liver disease and their drinking history, liver function test results, and ultrasound B-mode study findings. We estimated the values of combinational elastography and considered the correlation between the values and age. A multivariate analysis was performed concerning several features and the liver fibrosis (LF) index. We divided examinees into a younger group (< 65 years old) and an older group (>= 65 years old), and assessed the effect of age on the LF index. Results The mean shear wave velocity (Vs) of shear wave measurement (SWM) was 1.10 +/- 0.17 m/s (range 0.84-1.93), and the mean LF index of real-time tissue elastography (RTE) was 1.371 +/- 0.458 (range 0.258-3.173). There was no significant correlation between Vs and age. However, the LF index increased significantly with age. The multivariate analysis showed that age (P < 0.001) and BMI (P < 0.05) significantly affected the LF index. Indeed, the LF index in the older group was significantly higher than that in the younger group (P < 0.001). Conclusion In adult liver, the normal Vs of SWM was 1.10 +/- 0.17 m/s, and the normal LF index of RTE was 1.371 +/- 0.458. The LF index increased significantly with age in contrast to Vs; therefore, the influence of age should be considered when using combinational elastography.
C1 [Idobe-Fujii, Yoko; Sasaki, Hiroyuki] Saiseikai Sakaiminato Gen Hosp, Checkup Ctr, 44 Yonegawa Cho, Tottori 6848555, Japan.
   [Omoso, Ryoko; Fujiwara, Hiromitsu] Saiseikai Sakaiminato Gen Hosp, Clin Lab, Tottori, Japan.
   [Fujii, Shinya] Tottori Univ, Fac Med, Dept Multidisciplinary Internal Med, Div Radiol, Tottori, Japan.
   [Nakamura, Yuki; Nomi, Takahiro; Sasaki, Yuichiro; Murawaki, Yoshikazu] Saiseikai Sakaiminato Gen Hosp, Dept Gastroenterol, Tottori, Japan.
   [Isomoto, Hajime] Tottori Univ, Fac Med, Div Gastroenterol & Nephrol, Dept Multidisciplinary Internal Med, Tottori, Japan.
C3 Tottori University; Tottori University
RP Idobe-Fujii, Y (corresponding author), Saiseikai Sakaiminato Gen Hosp, Checkup Ctr, 44 Yonegawa Cho, Tottori 6848555, Japan.
EM yok.fujii@sakaiminato-saiseikai.jp
CR [Anonymous], 2015, J HEPATOL, V63, P237, DOI 10.1016/j.jhep.2015.04.006
   Barr RG, 2020, RADIOLOGY, V296, P263, DOI 10.1148/radiol.2020192437
   Bende F, 2018, ULTRASOUND MED BIOL, V44, P332, DOI 10.1016/j.ultrasmedbio.2017.10.013
   Cobbold JFL, 2008, HEPATOLOGY, V47, P370, DOI 10.1002/hep.22200
   Cogger VC, 2003, EXP GERONTOL, V38, P1101, DOI 10.1016/j.exger.2003.07.002
   Colli A, 2010, RADIOLOGY, V257, P872, DOI 10.1148/radiol.10100013
   Dietrich CF, 2017, ULTRASCHALL MED, V38, pE16, DOI 10.1055/s-0043-103952
   Enomoto M, 2014, WORLD J GASTROENTERO, V20, P12031, DOI 10.3748/wjg.v20.i34.12031
   Ferraioli G, 2018, ULTRASOUND MED BIOL, V44, P2419, DOI 10.1016/j.ultrasmedbio.2018.07.008
   Ferraioli G, 2015, ULTRASOUND MED BIOL, V41, P1161, DOI 10.1016/j.ultrasmedbio.2015.03.007
   Ferraioli G, 2012, AM J ROENTGENOL, V199, P19, DOI 10.2214/AJR.11.7517
   Fujimoto K, 2013, ONCOLOGY-BASEL, V84, P3, DOI 10.1159/000345883
   Gagliano N, 2002, MECH AGEING DEV, V123, P413, DOI 10.1016/S0047-6374(01)00398-0
   Gersak MM, 2016, MED ULTRASON, V18, P481, DOI 10.11152/mu-877
   Hu Y, 2015, J ULTRAS MED, V34, P1895, DOI 10.7863/ultra.14.10001
   Huang ZP, 2014, ULTRASOUND MED BIOL, V40, P2549, DOI 10.1016/j.ultrasmedbio.2014.05.008
   Iijima H, 2019, HEPATOL RES, V49, P676, DOI 10.1111/hepr.13319
   Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244
   Kobayashi K, 2015, EUR RADIOL, V25, P230, DOI 10.1007/s00330-014-3364-x
   Kudo M, 2013, J MED ULTRASON, V40, P325, DOI 10.1007/s10396-013-0460-5
   Kwo PY, 2017, AM J GASTROENTEROL, V112, P18, DOI 10.1038/ajg.2016.517
   Mathurin P, 2015, J HEPATOL, V62, pS38, DOI 10.1016/j.jhep.2015.03.006
   Millonig G, 2008, HEPATOLOGY, V48, P1718, DOI 10.1002/hep.22577
   Petzold G, 2019, J ULTRAS MED, V38, P1769, DOI 10.1002/jum.14866
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Sebastiani G, 2014, WORLD J GASTROENTERO, V20, P11033, DOI 10.3748/wjg.v20.i32.11033
   Shiina T, 2013, J MED ULTRASON, V40, P309, DOI 10.1007/s10396-013-0490-z
   Singh S, 2015, CLIN GASTROENTEROL H, V13, P643, DOI 10.1016/j.cgh.2014.04.014
   Sirli R, 2009, J GASTROINTEST LIVER, V18, P57
   SUGIMOTO K, 2020, RADIOLOGY
   Sugimoto K, 2018, ULTRASOUND MED BIOL, V44, P2018, DOI 10.1016/j.ultrasmedbio.2018.05.008
   Tatsumi C, 2010, INTERVIROLOGY, V53, P76, DOI 10.1159/000252789
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   Yada N, 2017, DIGEST DIS, V35, P515, DOI 10.1159/000480140
   Yada N, 2017, ONCOLOGY-BASEL, V92, P10, DOI 10.1159/000451011
   Yada N, 2013, ONCOLOGY-BASEL, V84, P13, DOI 10.1159/000345884
   Yano M, 1996, HEPATOLOGY, V23, P1334, DOI 10.1053/jhep.1996.v23.pm0008675148
   You CR, 2014, WORLD J GASTROENTERO, V20, P13293, DOI 10.3748/wjg.v20.i37.13293
   Younossi ZM, 2011, HEPATOLOGY, V53, P1874, DOI 10.1002/hep.24268
NR 39
TC 0
Z9 1
U1 1
U2 1
PU SPRINGER JAPAN KK
PI TOKYO
PA SHIROYAMA TRUST TOWER 5F, 4-3-1 TORANOMON, MINATO-KU, TOKYO, 105-6005,
   JAPAN
SN 1346-4523
EI 1613-2254
J9 J MED ULTRASON
JI J. Med. Ultrason.
PD 2021 APR
PY 2021
VL 48
IS 2
BP 207
EP 213
DI 10.1007/s10396-021-01082-6
EA MAR 2021
PG 7
WC Radiology, Nuclear Medicine & Medical Imaging
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Radiology, Nuclear Medicine & Medical Imaging
GA RU6JP
UT WOS:000624383500001
PM 33651239
DA 2024-02-19
ER

PT J
AU Massip, L
   Garand, C
   Paquet, ER
   Cogger, VC
   O'Reilly, JN
   Tworek, L
   Hatherell, A
   Taylor, CG
   Thorin, E
   Zahradka, P
   Le Couteur, DG
   Lebel, M
AF Massip, Laurent
   Garand, Chantal
   Paquet, Eric R.
   Cogger, Victoria C.
   O'Reilly, Jennifer N.
   Tworek, Leslee
   Hatherell, Avril
   Taylor, Carla G.
   Thorin, Eric
   Zahradka, Peter
   Le Couteur, David G.
   Lebel, Michel
TI Vitamin C restores healthy aging in a mouse model for Werner syndrome
SO FASEB JOURNAL
LA English
DT Article
DE ascorbate; metabolism; microarrays; liver; adipocyte; inflammation
ID GENE-EXPRESSION PROFILES; L-ASCORBIC-ACID; INSULIN-RESISTANCE; SYNDROME
   PROTEIN; OXIDATIVE STRESS; POLY(ADP-RIBOSE) POLYMERASE-1; DWARF MICE;
   LIFE-SPAN; KAPPA-B; CELLS
AB Werner syndrome (WS) is a premature aging disorder caused by mutations in a RecQ-like DNA helicase. Mice lacking the helicase domain of the WRN homologue exhibit many phenotypic features of WS, including a prooxidant status and a shorter mean life span compared to wild-type animals. Here, we show that Wrn mutant mice also develop premature liver sinusoidal endothelial defenestration along with inflammation and metabolic syndrome. Vitamin C supplementation rescued the shorter mean life span of Wrn mutant mice and reversed several age-related abnormalities in adipose tissues and liver endothelial defenestration, genomic integrity, and inflammatory status. At the molecular level, phosphorylation of age-related stress markers like Akt kinase-specific substrates and the transcription factor NF-kappa B, as well as protein kinase C delta and Hif-1 alpha transcription factor levels, which are increased in the liver of Wrn mutants, were normalized by vitamin C. Vitamin C also increased the transcriptional regulator of lipid metabolism PPAR alpha. Finally, microarray and gene set enrichment analyses on liver tissues revealed that vitamin C decreased genes normally up-regulated in human WS fibroblasts and cancers, and it increased genes involved in tissue injury response and adipocyte dedifferentiation in obese mice. Vitamin C did not have such effect on wild-type mice. These results indicate that vitamin C supplementation could be beneficial for patients with WS.-Massip, L., Garand, C., Paquet, E. R., Cogger, V. C., O'Reilly, J. N., Tworek, L., Hatherell, A., Taylor, C. G., Thorin, E., Zahradka, P., Le Couteur, D. G., Lebel, M. Vitamin C restores healthy aging in a mouse model for Werner syndrome. FASEB J. 24, 158-172 ( 2010). www.fasebj.org
C1 [Massip, Laurent; Garand, Chantal; Paquet, Eric R.; Lebel, Michel] Univ Laval, Ctr Rech Cancerol, Hop Hotel Dieu, Quebec City, PQ, Canada.
   [Cogger, Victoria C.; O'Reilly, Jennifer N.; Le Couteur, David G.] Univ Sydney, Ctr Educ & Res Ageing, Sydney, NSW 2006, Australia.
   [Cogger, Victoria C.; O'Reilly, Jennifer N.; Le Couteur, David G.] Univ Sydney, ANZAC Res Inst, Sydney, NSW 2006, Australia.
   [Cogger, Victoria C.; O'Reilly, Jennifer N.; Le Couteur, David G.] Concord RG Hosp, Sydney, NSW, Australia.
   [Tworek, Leslee; Hatherell, Avril; Taylor, Carla G.; Zahradka, Peter] Univ Manitoba, Canadian Ctr Agri Food Res Hlth & Med, Winnipeg, MB, Canada.
   [Tworek, Leslee; Hatherell, Avril; Taylor, Carla G.; Zahradka, Peter] St Boniface Gen Hosp, Res Ctr, Winnipeg, MB, Canada.
   [Thorin, Eric] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada.
C3 Laval University; University of Sydney; University of Sydney; ANZAC
   Research Institute; Concord Repatriation General Hospital; University of
   Manitoba; University of Manitoba; Children's Hospital Research Institute
   of Manitoba; Universite de Montreal
RP Lebel, M (corresponding author), Hop HoDieu Quebec, Ctr Rech Cancerol, 9 McMahon St, Quebec City, PQ G1R 2J6, Canada.
EM michel.lebel@crhdq.ulaval.ca
RI Thorin, Eric/K-3978-2013; Research Institute, ANZAC/CAE-9030-2022
OI Thorin, Eric/0000-0001-5827-8935; Le Couteur, David/0000-0002-4227-5817;
   Garand, Chantal/0000-0003-0716-6487; Paquet, Eric/0000-0001-9194-1655;
   Zahradka, Peter/0000-0002-7814-0658; Taylor, Carla
   G./0000-0003-3358-6418
FU Canadian Institutes of Health Research; National Sciences and
   Engineering Research Council of Canada; The National Health and Medical
   Research Council of Australia; Aging and Alzheimers Research Foundation
FX We thank Dr. O. Neyret-Djossou of the functional genomic platform of the
   Institut de Recherche Clinique de Montreal (Montreal, QC, Canada) for
   the microarray services. We are also grateful to M. Sild and A. Labbe
   for real-time RT-PCRs ( Centre de Recherche en Cancerologie de
   l'Universite Laval). This work was supported in part by grants from the
   Canadian Institutes of Health Research and from the National Sciences
   and Engineering Research Council of Canada to M. L. and from The
   National Health and Medical Research Council of Australia and from the
   Aging and Alzheimers Research Foundation ( a Division of the Medical
   Foundation of the University of Sydney) to D. G. L. M. L. is a senior
   scholar of the Fonds de la Recherche en Sante du Quebec.
CR Adler AS, 2007, GENE DEV, V21, P3244, DOI 10.1101/gad.1588507
   Balajee AS, 1999, MOL BIOL CELL, V10, P2655, DOI 10.1091/mbc.10.8.2655
   Bokko PB, 2007, MOL BIOL CELL, V18, P1874, DOI 10.1091/mbc.E06-09-0881
   BORGESE N, 1986, BIOCHEM J, V239, P393, DOI 10.1042/bj2390393
   Chang S, 2004, NAT GENET, V36, P877, DOI 10.1038/ng1389
   Cooper MP, 2000, GENE DEV, V14, P907
   Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619
   Cummins EP, 2005, PFLUG ARCH EUR J PHY, V450, P363, DOI 10.1007/s00424-005-1413-7
   Davis T, 2005, J GERONTOL A-BIOL, V60, P1386, DOI 10.1093/gerona/60.11.1386
   Deschênes F, 2005, HUM MOL GENET, V14, P3293, DOI 10.1093/hmg/ddi362
   Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7
   EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001
   Flechner SM, 2004, AM J TRANSPLANT, V4, P1475, DOI 10.1111/j.1600-6143.2004.00526.x
   Hilmer SN, 2005, HEPATOLOGY, V42, P1349, DOI 10.1002/hep.20937
   Hoffmann R, 2002, GENOME RES, V12, P98, DOI 10.1101/gr.201501
   Honjo S, 2008, J AM GERIATR SOC, V56, P173, DOI 10.1111/j.1532-5415.2007.01484.x
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Hsieh CC, 2006, FASEB J, V20, P259, DOI 10.1096/fj.05-4376com
   Huang SR, 2006, HUM MUTAT, V27, P558, DOI 10.1002/humu.20337
   Ichiba T, 2003, BLOOD, V102, P763, DOI 10.1182/blood-2002-09-2748
   Kashino G, 2003, FREE RADICAL BIO MED, V35, P438, DOI 10.1016/S0891-5849(03)00326-5
   Kipling D, 2004, SCIENCE, V305, P1426, DOI 10.1126/science.1102587
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kuo SM, 2004, J NUTR, V134, P2216
   Kyng KJ, 2003, P NATL ACAD SCI USA, V100, P12259, DOI 10.1073/pnas.2130723100
   Lam TKT, 2002, AM J PHYSIOL-ENDOC M, V283, pE682, DOI 10.1152/ajpendo.00038.2002
   Le Couteur DG, 2008, ANAT REC, V291, P672, DOI 10.1002/ar.20661
   Lebel M, 2003, AM J PATHOL, V162, P1559, DOI 10.1016/S0002-9440(10)64290-3
   Lebel M, 1999, J BIOL CHEM, V274, P37795, DOI 10.1074/jbc.274.53.37795
   Lebel M, 1998, P NATL ACAD SCI USA, V95, P13097, DOI 10.1073/pnas.95.22.13097
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481
   Linster CL, 2007, FEBS J, V274, P1, DOI 10.1111/j.1742-4658.2006.05607.x
   Lloret A, 2008, FREE RADICAL BIO MED, V44, P495, DOI 10.1016/j.freeradbiomed.2007.10.046
   Lombard DB, 2000, MOL CELL BIOL, V20, P3286, DOI 10.1128/MCB.20.9.3286-3291.2000
   Maeda N, 2000, P NATL ACAD SCI USA, V97, P841, DOI 10.1073/pnas.97.2.841
   Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009
   MASSIE HR, 1984, GERONTOLOGY, V30, P370, DOI 10.1159/000212659
   Massip L, 2006, EXP GERONTOL, V41, P157, DOI 10.1016/j.exger.2005.10.011
   Masternak MM, 2007, PPAR RES, V2007, DOI 10.1155/2007/28436
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   McLachlan JL, 2005, BBA-MOL BASIS DIS, V1741, P271, DOI 10.1016/j.bbadis.2005.03.007
   Moore G, 2008, MECH AGEING DEV, V129, P201, DOI 10.1016/j.mad.2007.12.009
   MORI S, 2001, INT J OBESITY, V25, P29229
   Nadler ST, 2000, P NATL ACAD SCI USA, V97, P11371, DOI 10.1073/pnas.97.21.11371
   Otsuka M, 1999, J NUTR SCI VITAMINOL, V45, P163, DOI 10.3177/jnsv.45.163
   Ozgenc A, 2005, MUTAT RES-FUND MOL M, V577, P237, DOI 10.1016/j.mrfmmm.2005.03.020
   Pagano G, 2005, FREE RADICAL RES, V39, P529, DOI 10.1080/10715760500092683
   Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530
   Saintigny Y, 2002, MOL CELL BIOL, V22, P6971, DOI 10.1128/MCB.22.20.6971-6978.2002
   SALK D, 1982, HUM GENET, V62, P1, DOI 10.1007/BF00295598
   Schumacher B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000161
   Shen JC, 2000, TRENDS GENET, V16, P213, DOI 10.1016/S0168-9525(99)01970-8
   Shepard JL, 2005, P NATL ACAD SCI USA, V102, P13194, DOI 10.1073/pnas.0506583102
   SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Swindell WR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-353
   Taylor CT, 2008, J PHYSIOL-LONDON, V586, P4055, DOI 10.1113/jphysiol.2008.157669
   Villalba JM, 2000, ANTIOXID REDOX SIGN, V2, P213, DOI 10.1089/ars.2000.2.2-213
   Wang CX, 2004, MECH AGEING DEV, V125, P629, DOI 10.1016/j.mad.2004.07.003
   Warren A, 2005, EXP GERONTOL, V40, P807, DOI 10.1016/j.exger.2005.06.012
   Wieland S, 2004, P NATL ACAD SCI USA, V101, P6669, DOI 10.1073/pnas.0401771101
   Yamamoto H, 2007, CLIN CHIM ACTA, V379, P167, DOI 10.1016/j.cca.2007.01.009
   Yokote K, 2008, J AM GERIATR SOC, V56, P1770, DOI 10.1111/j.1532-5415.2008.01817.x
   Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258
   Yu DN, 2005, ANN NY ACAD SCI, V1059, P145, DOI 10.1196/annals.1339.047
   Fokko ZA, 2007, BBA-MOL CELL BIOL L, V1771, P972, DOI 10.1016/j.bbalip.2007.04.021
   Zhu H, 1998, P NATL ACAD SCI USA, V95, P14470, DOI 10.1073/pnas.95.24.14470
NR 69
TC 80
Z9 80
U1 0
U2 17
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD JAN
PY 2010
VL 24
IS 1
BP 158
EP 172
DI 10.1096/fj.09-137133
PG 15
WC Biochemistry & Molecular Biology; Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 539DL
UT WOS:000273233600018
PM 19741171
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Vigneswara, V
   Cass, S
   Wayne, D
   Bolt, EL
   Ray, DE
   Carter, WG
AF Vigneswara, Vasanthy
   Cass, Simon
   Wayne, Declan
   Bolt, Edward L.
   Ray, David E.
   Carter, Wayne G.
TI Molecular Ageing of Alpha- and Beta-Synucleins: Protein Damage and
   Repair Mechanisms
SO PLOS ONE
LA English
DT Article
ID L-ISOASPARTYL METHYLTRANSFERASE; POSTTRANSLATIONAL MODIFICATIONS;
   O-METHYLTRANSFERASE; SYNAPSIN-I; RAT-LIVER; ACCUMULATION; PEPTIDES;
   GENE; DEAMIDATION; BRAIN
AB Abnormal alpha-synuclein aggregates are hallmarks of a number of neurodegenerative diseases. Alpha synuclein and beta-synucleins are susceptible to post-translational modification as isoaspartate protein damage, which is regulated in vivo by the action of the repair enzyme protein L-isoaspartyl O-methyltransferase (PIMT). We aged in vitro native alpha-synuclein, the alpha-synuclein familial mutants A30P and A53T that give rise to Parkinsonian phenotypes, and beta-synuclein, at physiological pH and temperature for a time course of up to 20 days. Resolution of native alpha-synuclein and beta-synuclein by two dimensional techniques showed the accumulation of a number of post-translationally modified forms of both proteins. The levels of isoaspartate formed over the 20 day time course were quantified by exogenous methylation with PIMT using S-Adenosyl-L-[H-3-methyl]methionine as a methyl donor, and liquid scintillation counting of liberated H-3-methanol. All alpha-synuclein proteins accumulated isoaspartate at similar to 1% of molecules/day, similar to 20 times faster than for beta-synuclein. This disparity between rates of isoaspartate was confirmed by exogenous methylation of synucleins by PIMT, protein resolution by one-dimensional denaturing gel electrophoresis, and visualisation of H-3-methyl esters by autoradiography. Protein silver staining and autoradiography also revealed that alpha-synucleins accumulated stable oligomers that were resistant to denaturing conditions, and which also contained isoaspartate. Co-incubation of approximately equimolar beta-synuclein with alpha-synuclein resulted in a significant reduction of isoaspartate formed in all alpha-synucleins after 20 days of ageing. Co-incubated alpha- and beta-synucleins, or alpha, or beta synucleins alone, were resolved by non-denaturing size exclusion chromatography and all formed oligomers of similar to 57.5 kDa; consistent with tetramerization. Direct association of alpha-synuclein with beta-synuclein in column fractions or from in vitro ageing co-incubations was demonstrated by their co-immunoprecipitation. These results provide an insight into the molecular differences between alpha- and beta-synucleins during ageing, and highlight the susceptibility of alpha-synuclein to protein damage, and the potential protective role of beta-synuclein.
C1 [Vigneswara, Vasanthy; Cass, Simon; Bolt, Edward L.; Ray, David E.] Univ Nottingham, Queens Med Ctr, Sch Biomed Sci, Nottingham NG7 2RD, England.
   [Wayne, Declan; Carter, Wayne G.] Univ Nottingham, Sch Med, Royal Derby Hosp, Sch Grad Entry Med & Hlth, Derby, England.
C3 University of Nottingham; University of Nottingham
RP Carter, WG (corresponding author), Univ Nottingham, Sch Med, Royal Derby Hosp, Sch Grad Entry Med & Hlth, Derby, England.
EM Wayne.Carter@nottingham.ac.uk
OI Bolt, Edward/0000-0002-5656-7706; Vigneswara,
   Vasanthy/0009-0005-7461-8190
FU Medical Research Council program grant; University of Nottingham
FX Financial support was gratefully received from a Medical Research
   Council program grant, and the University of Nottingham. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200
   Beyer K, 2010, BRAIN, V133, P3724, DOI 10.1093/brain/awq275
   Beyer K, 2008, CURR MED CHEM, V15, P2748, DOI 10.2174/092986708786242868
   Böhme L, 2008, BIOL CHEM, V389, P1055, DOI 10.1515/BC.2008.125
   BRENNAN TV, 1994, J BIOL CHEM, V269, P24586
   Brennan TV, 1995, DEAMIDATION ISOASPAR, P65
   Carter WG, 2008, BIOCHEMISTRY-US, V47, P10757, DOI 10.1021/bi8013467
   Carter WG, 2010, J CHROMATOGR B, V878, P1312, DOI 10.1016/j.jchromb.2009.10.018
   Farrar C, 2005, AGING CELL, V4, P1, DOI 10.1111/j.1474-9728.2004.00136.x
   Farrar CE, 2005, J COMP NEUROL, V493, P524, DOI 10.1002/cne.20780
   GEIGER T, 1987, J BIOL CHEM, V262, P785
   George JM, 2002, GENOME BIOL, V3
   Ghandour H, 2002, J NUTR, V132, P1357, DOI 10.1093/jn/132.6.1357
   Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564
   Hashimoto M, 2004, GENE THER, V11, P1713, DOI 10.1038/sj.gt.3302349
   Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7
   Ikegaya Y, 2001, HIPPOCAMPUS, V11, P287, DOI 10.1002/hipo.1043
   Israeli E, 2009, J NEUROCHEM, V108, P465, DOI 10.1111/j.1471-4159.2008.05776.x
   JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5
   JOHNSON BA, 1987, J BIOL CHEM, V262, P12283
   JOHNSON BA, 1993, J BIOL CHEM, V268, P6174
   JOHNSON BA, 1993, NEUROCHEM RES, V18, P87, DOI 10.1007/BF00966926
   JOHNSON BA, 1987, J BIOL CHEM, V262, P5622
   Kharbanda KK, 2007, J HEPATOL, V46, P1119, DOI 10.1016/j.jhep.2007.01.026
   Kharbanda KK, 2009, BIOCHEM BIOPH RES CO, V381, P523, DOI 10.1016/j.bbrc.2009.02.082
   Kim E, 1997, P NATL ACAD SCI USA, V94, P6132, DOI 10.1073/pnas.94.12.6132
   Kim E, 1999, J BIOL CHEM, V274, P20671, DOI 10.1074/jbc.274.29.20671
   Krüger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106
   Kuo YM, 1998, BBA-MOL BASIS DIS, V1406, P291, DOI 10.1016/S0925-4439(98)00014-3
   Lowenson JD, 2001, J BIOL CHEM, V276, P20695, DOI 10.1074/jbc.M100987200
   Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265
   MCFADDEN PN, 1987, P NATL ACAD SCI USA, V84, P2595, DOI 10.1073/pnas.84.9.2595
   Najbauer J, 1996, BIOCHEMISTRY-US, V35, P5183, DOI 10.1021/bi953063g
   NAJBAUER J, 1990, J BIOL CHEM, V265, P12717
   Obeid R, 2009, CLIN CHEM, V55, P1852, DOI 10.1373/clinchem.2009.125021
   Ohtake H, 2004, NEUROLOGY, V63, P805, DOI 10.1212/01.WNL.0000139870.14385.3C
   Oueslati A, 2010, PROG BRAIN RES, V183, P115, DOI 10.1016/S0079-6123(10)83007-9
   PARANANDI MV, 1995, BIOCHEM BIOPH RES CO, V212, P442, DOI 10.1006/bbrc.1995.1989
   Park JY, 2003, BIOCHEMISTRY-US, V42, P3696, DOI 10.1021/bi020604a
   Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045
   Reissner KJ, 2006, J BIOL CHEM, V281, P8389, DOI 10.1074/jbc.M510716200
   Robinson NE, 2004, J PEPT RES, V63, P426, DOI 10.1111/j.1399-3011.2004.00151.x
   Robinson NE, 2009, PROTEIN SCI, V18, P1766, DOI 10.1002/pro.183
   Shaltiel-Karyo R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013863
   Shimizu T, 2005, BIOL PHARM BULL, V28, P1590, DOI 10.1248/bpb.28.1590
   Shimizu T, 2002, J NEUROSCI RES, V69, P341, DOI 10.1002/jnr.10301
   Shimizu T, 2002, J NEUROSCI RES, V70, P451, DOI 10.1002/jnr.10350
   Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278
   Tarhoni MH, 2011, MOLECULES, V16, P8535, DOI 10.3390/molecules16108535
   Tsigelny IF, 2007, FEBS J, V274, P1862, DOI 10.1111/j.1742-4658.2007.05733.x
   Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200
   Vigneswara V, 2006, J BIOL CHEM, V281, P32619, DOI 10.1074/jbc.M605421200
   Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n
   Yamamoto A, 1998, J NEUROSCI, V18, P2063
   Young AL, 2001, J BIOL CHEM, V276, P37161, DOI 10.1074/jbc.M106682200
   Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795
   Zhu JX, 2006, J BIOL CHEM, V281, P33802, DOI 10.1074/jbc.M606958200
NR 57
TC 27
Z9 30
U1 0
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 22
PY 2013
VL 8
IS 4
AR e61442
DI 10.1371/journal.pone.0061442
PG 12
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 130JR
UT WOS:000317911500037
PM 23630590
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Kämppä, N
   Mäkelä, KM
   Lyytikäinen, LP
   Peltonen, N
   Hautamäki, J
   Seppälä, I
   Mononen, N
   Goebeler, S
   Karhunen, PJ
   Hervonen, A
   Hurme, M
   Jylhä, M
   Lehtimäki, T
AF Kamppa, Niko
   Makela, Kari-Matti
   Lyytikainen, Leo-Pekka
   Peltonen, Nina
   Hautamaki, Jussi
   Seppala, Ilkka
   Mononen, Nina
   Goebeler, Sirkka
   Karhunen, Pekka J.
   Hervonen, Antti
   Hurme, Mikko
   Jylha, Marja
   Lehtimaki, Terho
TI Vascular cell adhesion molecule 1, soluble Fas and hepatocyte growth
   factor as predictors of mortality in nonagenarians: The Vitality
   90+study
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Hepatocyte growth factor; Vascular cell adhesion molecule 1; Soluble
   Fas; Nonagenarians; Mortality
ID C-REACTIVE PROTEIN; CONGESTIVE-HEART-FAILURE; FOLLOW-UP; POPULATION;
   VCAM-1; ACTIVATION; EXPRESSION; LONGEVITY; COMMUNITY; RECEPTOR
AB Background: Ageing is characteristically accompanied by changes in vascular endothelial markers and growth factor as well as increased cellular death. We analysed the associations of the plasma levels of vascular cell adhesion molecule-1 (VCAM-1), hepatocyte growth factor (HGF) and soluble Fas (sFAS), and their combinations, with 4-year mortality to identify new biomarkers.
   Methods: A total of 238 individuals, both community-dwelling and institutionalised, aged 89 91 years and participating in the Vitality 90+ study were included. Biomarkers of endothelial function (VCAM-1), growth factor (HGF) and a marker of apoptosis (sFAS) were determined from plasma using Luminex (R) technology. This newly-determined data was combined with earlier data, e. g., 4-year mortality and medical history.
   Results: Subjects who died during the follow-up had higher baseline plasma levels of VCAM-1, sFas, and HGF. When other known risk factors were adjusted for, subjects in the highest concentration tertile for VCAM-1 (HR 1.85; 95% CI, 1.12-3.05) and HGF (HR 2.22; 95% CI, 1.33-3.71) had higher mortality compared to those in the lowest tertile. In the adjusted analyses, when compared to subjects with none of the biomarkers in the highest concentration tertile, mortality was also higher when sFas and VCAM-1 were simultaneously (HR 2.03; 95% CI, 1.13-3.64) or all three were simultaneously (HR 3.63; 95% CI, 1.65-7.97) in the highest concentration tertile.
   Conclusions: Our results suggest that increased concentrations of these biomarkers, separately and in combination, associate with mortality among the aged and are prognostic markers of death. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Kamppa, Niko; Makela, Kari-Matti; Lyytikainen, Leo-Pekka; Peltonen, Nina; Hautamaki, Jussi; Seppala, Ilkka; Mononen, Nina; Lehtimaki, Terho] Univ Tampere, Sch Med, Dept Clin Chem, FIN-33101 Tampere, Finland.
   [Goebeler, Sirkka; Karhunen, Pekka J.] Univ Tampere, Sch Med, Dept Forens Med, FIN-33101 Tampere, Finland.
   [Hurme, Mikko] Univ Tampere, Sch Med, Dept Microbiol & Immunol, FIN-33101 Tampere, Finland.
   [Goebeler, Sirkka; Hervonen, Antti; Jylha, Marja] Univ Tampere, Sch Hlth Sci, FIN-33101 Tampere, Finland.
   [Kamppa, Niko; Makela, Kari-Matti; Lyytikainen, Leo-Pekka; Peltonen, Nina; Hautamaki, Jussi; Seppala, Ilkka; Mononen, Nina; Karhunen, Pekka J.; Hurme, Mikko; Lehtimaki, Terho] Fimlab Labs, FI-33101 Tampere, Finland.
   [Goebeler, Sirkka] Natl Inst Hlth & Welf, Dept Forens Med, Helsinki, Finland.
   [Jylha, Marja] Univ Tampere, Gerontol Res Ctr, FIN-33101 Tampere, Finland.
   [Jylha, Marja] Univ Jyvaskyla, SF-40351 Jyvaskyla, Finland.
C3 Tampere University; Tampere University; Tampere University; Tampere
   University; Finland National Institute for Health & Welfare; Tampere
   University; University of Jyvaskyla
RP Kämppä, N (corresponding author), Fimlab Labs, Dept Clin Chem, FM 2,3rd Floor,POB 66, FI-33101 Tampere, Finland.
EM niko.kamppa@uta.fi
RI Lehtimäki, Terho/AAD-1094-2022; Lyytikäinen, Leo-Pekka/C-8544-2016
OI Lehtimäki, Terho/0000-0002-2555-4427; Lyytikäinen,
   Leo-Pekka/0000-0002-7200-5455; Hurme, Mikko/0000-0002-8614-1044; Makela,
   Kari-Matti/0000-0002-8318-8584
FU Medical Research Fund of Tampere University Hospital [9M048, 9N035];
   Emil Aaltonen Foundation
FX This study was supported with grants from the Medical Research Fund of
   Tampere University Hospital (grants 9M048 and 9N035) and the Emil
   Aaltonen Foundation (T.L.). The Gerontology Research Centre is a joint
   effort between the University of Tampere and the University of
   Jyvaskyla.
CR Abbasova SG, 2009, B EXP BIOL MED+, V148, P638, DOI 10.1007/s10517-010-0784-8
   Blankenberg S, 2001, CIRCULATION, V104, P1336, DOI 10.1161/hc3701.095949
   Cook-Mills JM, 2011, ANTIOXID REDOX SIGN, V15, P1607, DOI 10.1089/ars.2010.3522
   DAVIES MJ, 1993, J PATHOL, V171, P223, DOI 10.1002/path.1711710311
   Ezeh AC, 2012, LANCET, V380, P142, DOI 10.1016/S0140-6736(12)60696-5
   Funakoshi H, 2003, CLIN CHIM ACTA, V327, P1, DOI 10.1016/S0009-8981(02)00302-9
   Goebeler S, 2003, AGING CLIN EXP RES, V15, P154
   Huffman KM, 2011, J GERONTOL A-BIOL, V66, P1369, DOI 10.1093/gerona/glr121
   Hurme M, 2007, MECH AGEING DEV, V128, P574, DOI 10.1016/j.mad.2007.07.004
   Jylhä M, 1999, SCAND J PUBLIC HEALT, V27, P106, DOI 10.1177/14034948990270021001
   Jylha M, 2007, J GERONTOL A-BIOL, V62, P1016, DOI 10.1093/gerona/62.9.1016
   Kawanami D, 2006, ATHEROSCLEROSIS, V185, P39, DOI 10.1016/j.atherosclerosis.2005.01.057
   Lamblin N, 2005, AM HEART J, V150, P137, DOI 10.1016/j.ahj.2005.03.047
   Lettau M, 2011, EUR J CELL BIOL, V90, P456, DOI 10.1016/j.ejcb.2010.10.006
   Lisko I, 2012, REJUV RES, V15, P445, DOI 10.1089/rej.2011.1310
   Malik I, 2001, LANCET, V358, P971, DOI 10.1016/S0140-6736(01)06104-9
   Maulik G, 2002, CYTOKINE GROWTH F R, V13, P41, DOI 10.1016/S1359-6101(01)00029-6
   Meller I, 1999, EUR ARCH PSY CLIN N, V249, P180, DOI 10.1007/s004060050085
   Nishigaki K, 1997, J AM COLL CARDIOL, V29, P1214, DOI 10.1016/S0735-1097(97)00055-7
   Nybo H, 2003, J AM GERIATR SOC, V51, P1365, DOI 10.1046/j.1532-5415.2003.51453.x
   Ohtsuka T, 1999, CORONARY ARTERY DIS, V10, P221, DOI 10.1097/00019501-199906000-00003
   Rontu R, 2006, CLIN ENDOCRINOL, V64, P265, DOI 10.1111/j.1365-2265.2006.02455.x
   Schmidt C, 2009, ANGIOLOGY, V60, P108, DOI 10.1177/0003319708316899
   Toyozaki T, 1998, AM J CARDIOL, V81, P798, DOI 10.1016/S0002-9149(97)01032-1
NR 24
TC 7
Z9 8
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD NOV
PY 2013
VL 48
IS 11
BP 1167
EP 1172
DI 10.1016/j.exger.2013.07.009
PG 6
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 235WD
UT WOS:000325750900004
PM 23911532
DA 2024-02-19
ER

PT J
AU Klein, RS
AF Klein, Robert S.
TI Trends Related to Aging and Co-Occurring Disorders in HIV-Infected Drug
   Users
SO SUBSTANCE USE & MISUSE
LA English
DT Article
DE HIV; renal disease; aging; hepatitis; comorbidities; cancer;
   dyslipidemia; neurocognitive dysfunction; cardiovascular risk;
   depression
ID IMMUNODEFICIENCY-VIRUS-INFECTION; ACTIVE ANTIRETROVIRAL THERAPY;
   BONE-MINERAL DENSITY; CD4 CELL RECOVERY; INSULIN-RESISTANCE; OLDER MEN;
   CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; MEDICINE-ASSOCIATION;
   GLUCOSE-METABOLISM
AB Drug users with HIV infection successfully treated with highly active antiretroviral therapy are now living to older ages. As persons with HIV infection age, they become at risk for comorbidities that occur in any group of aging individuals. However, some of these conditions occur at increased rates, with increasing severity, or pose special problems in older persons with HIV infection. This article discusses the epidemiology of HIV infection in aging drug users, and hormonal, cardiovascular, liver, renal, bone, and cognitive disorders and depression and cancer in these individuals, as well as problems related to taking multiple medications and HIV disease progression.
C1 [Klein, Robert S.] Mt Sinai Sch Med, Dis Prevent & Publ Hlth Inst, New York, NY 10029 USA.
   [Klein, Robert S.] Mt Sinai Sch Med, Div Infect Dis, New York, NY 10029 USA.
C3 Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at
   Mount Sinai
RP Klein, RS (corresponding author), Mt Sinai Sch Med, Dis Prevent & Publ Hlth Inst, 1 Gustave L Levy Pl, New York, NY 10029 USA.
EM robert.klein@mssm.edu
CR Adler WH, 1997, MECH AGEING DEV, V96, P137, DOI 10.1016/S0047-6374(97)01888-5
   Alexander J, 2006, Minerva Ginecol, V58, P35
   Alexapoulos GS, 2005, LANCET, V365, P1961, DOI 10.1016/S0140-6736(05)66665-2
   Alexopoulos GS, 2002, BIOL PSYCHIAT, V52, P543, DOI 10.1016/S0006-3223(02)01468-3
   Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004
   [Anonymous], 1992, MMWR Recomm Rep, V41, P1
   [Anonymous], 2006, NAT SURV DRUG US HLT
   Anthony IC, 2008, FRONT BIOSCI-LANDMRK, V13, P1294, DOI 10.2741/2762
   Appel G, 2007, CLEV CLIN J MED, V74, P353, DOI 10.3949/ccjm.74.5.353
   Araujo AB, 2004, J CLIN ENDOCR METAB, V89, P5920, DOI 10.1210/jc.2003-031719
   Arnsten JH, 2006, CLIN INFECT DIS, V42, P1014, DOI 10.1086/501015
   Arnsten JH, 2002, J GEN INTERN MED, V17, P377, DOI 10.1046/j.1525-1497.2002.10644.x
   Arnsten JH, 2007, AIDS, V21, P617, DOI 10.1097/QAD.0b013e3280148c05
   Bangsberg DR, 2008, J INFECT DIS, V197, pS272, DOI 10.1086/533415
   Bartlett JA, 2001, AIDS, V15, P1369, DOI 10.1097/00002030-200107270-00006
   Becker JT, 2004, AIDS, V18, pS11, DOI 10.1097/00002030-200401001-00003
   Behrens G, 1999, AIDS, V13, pF63, DOI 10.1097/00002030-199907090-00001
   Bell JE, 2006, J NEUROIMMUNE PHARM, V1, P182, DOI 10.1007/s11481-006-9018-2
   Bertolote Jose Manoel, 2004, Crisis, V25, P147, DOI 10.1027/0227-5910.25.4.147
   Bing EG, 2001, ARCH GEN PSYCHIAT, V58, P721, DOI 10.1001/archpsyc.58.8.721
   Bozzette SA, 2003, NEW ENGL J MED, V348, P702, DOI 10.1056/NEJMoa022048
   Brown TT, 2006, AIDS, V20, P2165, DOI 10.1097/QAD.0b013e32801022eb
   Buckner RL, 2004, NEURON, V44, P195, DOI 10.1016/j.neuron.2004.09.006
   Carr A, 1999, LANCET, V353, P2093, DOI 10.1016/S0140-6736(98)08468-2
   CASEY DA, 1994, SOUTHERN MED J, V87, P559
   *CDCP, 1999, HIV AIDS SURVEILLANC, V5, P1
   *CDCP, 2006, HIV AIDS SURVEILLA S, V12, P1
   Centers for Disease Control and Prevention, 2006, HIV AIDS SURVEILLANC, V18, P1
   Centers for Disease Control (CDC), 1981, MMWR Morb Mortal Wkly Rep, V30, P305
   Chapman Daniel P, 2008, Prev Chronic Dis, V5, pA22
   CHERUBIN CE, 1993, ANN INTERN MED, V119, P1017, DOI 10.7326/0003-4819-119-10-199311150-00009
   Cheruvu Srinivas, 2007, Clin Liver Dis, V11, P917, DOI 10.1016/j.cld.2007.08.007
   Chesney MA, 2000, CLIN INFECT DIS, V30, pS171, DOI 10.1086/313849
   Chiesi A, 1996, J NEUROL SCI, V144, P107, DOI 10.1016/S0022-510X(96)00192-X
   CICERO TJ, 1980, FED PROC, V39, P2551
   Ciesla JA, 2001, AM J PSYCHIAT, V158, P725, DOI 10.1176/appi.ajp.158.5.725
   Cooper OB, 2003, CLIN INFECT DIS, V37, pS132, DOI 10.1086/375879
   Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9
   Davis L, 2008, CURR OPIN PSYCHIATR, V21, P14, DOI 10.1097/YCO.0b013e3282f32408
   DeCarli C, 2003, NEUROLOGIST, V9, P123, DOI 10.1097/00127893-200305000-00001
   Dobs AS, 1996, J CLIN ENDOCR METAB, V81, P4108, DOI 10.1210/jc.81.11.4108
   DOBS AS, 1988, AM J MED, V84, P611, DOI 10.1016/0002-9343(88)90144-1
   Dubé MP, 2003, CLIN INFECT DIS, V37, P613, DOI 10.1086/378131
   Ettinger B, 2006, MENOPAUSE, V13, P340, DOI 10.1097/01.gme.0000222475.93345.b3
   Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218
   Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744
   Frishman William H, 2003, Heart Dis, V5, P187, DOI 10.1097/01.hdx.0000074519.43281.fa
   Frishman William H, 2003, Heart Dis, V5, P253, DOI 10.1097/01.hdx.0000080713.09303.a6
   Ganem D, 1998, CURR CLIN TOPICS INF, V18, P237
   Geiss Linda S., 1993, Morbidity and Mortality Weekly Report, V42, P1
   Gibbie T, 2006, HIV MED, V7, P112, DOI 10.1111/j.1468-1293.2006.00350.x
   Gkrania-Klotsas E, 2007, BRIT MED BULL, V84, P49, DOI 10.1093/bmb/ldm030
   Gorard DA, 2006, QJM-INT J MED, V99, P797, DOI 10.1093/qjmed/hcl109
   Gougeon ML, 2004, ANTIVIR THER, V9, P161
   Grabar S, 2004, AIDS, V18, P2029, DOI 10.1097/00002030-200410210-00007
   Grimes RM, 2002, CLIN INFECT DIS, V34, P1530, DOI 10.1086/340404
   Grinspoon S, 1996, J CLIN ENDOCR METAB, V81, P4051, DOI 10.1210/jc.81.11.4051
   Gupta SK, 2005, CLIN INFECT DIS, V40, P1559, DOI 10.1086/430257
   Hadigan C, 2001, CLIN INFECT DIS, V32, P130, DOI 10.1086/317541
   Hartel DM, 2006, CLIN INFECT DIS, V43, P525, DOI 10.1086/505978
   Hinkin CH, 2004, AIDS, V18, pS19, DOI 10.1097/00002030-200418001-00004
   Howard AA, 2006, HIV MED, V7, P389, DOI 10.1111/j.1468-1293.2006.00398.x
   Howard AA, 2005, CLIN INFECT DIS, V40, P1492, DOI 10.1086/429824
   Hu SX, 2005, J INFECT DIS, V191, P886, DOI 10.1086/427830
   Ickovics JR, 2001, JAMA-J AM MED ASSOC, V285, P1466, DOI 10.1001/jama.285.11.1466
   JAFFE HW, 1983, J INFECT DIS, V148, P339, DOI 10.1093/infdis/148.2.339
   Jaffe JA, 2006, CLIN J AM SOC NEPHRO, V1, P655, DOI 10.2215/CJN.00300106
   Justice AC, 2004, AIDS, V18, pS49, DOI 10.1097/00002030-200401001-00008
   Kaarbo M, 2007, BIOESSAYS, V29, P1227, DOI 10.1002/bies.20676
   Kanis JA, 2000, OSTEOPOROSIS INT, V11, P192, DOI 10.1007/s001980050281
   Klein RS, 2005, CLIN INFECT DIS, V41, P1794, DOI 10.1086/498311
   Langford D, 2004, J NEUROVIROL, V10, P327, DOI 10.1080/13550280490520961
   Law MR, 1997, BMJ-BRIT MED J, V315, P841, DOI 10.1136/bmj.315.7112.841
   Lee GA, 2004, AIDS, V18, P641, DOI 10.1097/00002030-200403050-00008
   Leibson C L, 1997, Ann N Y Acad Sci, V826, P422, DOI 10.1111/j.1749-6632.1997.tb48496.x
   Liu H, 2008, ANN INTERN MED, V148, P685, DOI 10.7326/0003-4819-148-9-200805060-00009
   Macdonald S, 2003, DRUG ALCOHOL DEPEN, V72, P99, DOI 10.1016/S0376-8716(03)00202-3
   MCARTHUR JC, 1993, NEUROLOGY, V43, P2245, DOI 10.1212/WNL.43.11.2245
   McGinnis JM, 1999, P ASSOC AM PHYSICIAN, V111, P109, DOI 10.1046/j.1525-1381.1999.09256.x
   McLean AJ, 2004, PHARMACOL REV, V56, P163, DOI 10.1124/pr.56.2.4
   Michelson D, 1996, NEW ENGL J MED, V335, P1176, DOI 10.1056/NEJM199610173351602
   Moore RD, 1999, AIDS, V13, P1933, DOI 10.1097/00002030-199910010-00017
   Mulligan K, 2000, J ACQ IMMUN DEF SYND, V23, P35, DOI 10.1097/00042560-200001010-00005
   Murata H, 2000, J BIOL CHEM, V275, P20251, DOI 10.1074/jbc.C000228200
   National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2008, OST
   New York City Department of Health and Mental Hygiene, 2008, NEW YORK CIT HIV AID
   Niaura R, 2000, CLIN INFECT DIS, V31, P808, DOI 10.1086/314048
   Nogueras M, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-159
   Noor MA, 2001, AIDS, V15, pF11, DOI 10.1097/00002030-200105040-00001
   Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299
   Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301
   *PAN ANT GUID AD A, 2009, GUID US ANT AG HIV 1, P1, DOI DOI 10.1111/J.1468-1293.2008.00636.X
   Pan F, 2008, J GEN INTERN MED, V23, P611, DOI 10.1007/s11606-008-0544-x
   Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005
   PEDRAZZONI M, 1993, ACTA ENDOCRINOL-COP, V129, P42, DOI 10.1530/acta.0.1290042
   Perez JL, 2003, CLIN INFECT DIS, V36, P212, DOI 10.1086/345669
   PHILLIPS AN, 1991, J ACQ IMMUN DEF SYND, V4, P970
   Phillips AN, 2008, ANTIVIR THER, V13, P177
   Rabkin JG, 2006, AM J PSYCHIAT, V163, P59, DOI 10.1176/appi.ajp.163.1.59
   RAO TKS, 1984, NEW ENGL J MED, V310, P669, DOI 10.1056/NEJM198403153101101
   Raskind MA, 1998, J CLIN PSYCHIAT, V59, P9
   Riddler SA, 2003, JAMA-J AM MED ASSOC, V289, P2978, DOI 10.1001/jama.289.22.2978
   Rietschel P, 2000, CLIN INFECT DIS, V31, P1240, DOI 10.1086/317457
   Rivlin RS, 2007, AM J CLIN NUTR, V86, p1559S, DOI 10.1093/ajcn/86.5.1559S
   ROTHENBERG R, 1987, NEW ENGL J MED, V317, P1297, DOI 10.1056/NEJM198711193172101
   Sacktor N, 2001, NEUROLOGY, V56, P257, DOI 10.1212/WNL.56.2.257
   Salazar JA, 2007, EXPERT OPIN DRUG SAF, V6, P695, DOI 10.1517/14740338.6.6.695
   Santoro N, 2007, MENOPAUSE, V14, P859, DOI 10.1097/gme.0b013e31802f7369
   Schoenbaum EE, 2005, CLIN INFECT DIS, V41, P1517, DOI 10.1086/497270
   Shah SS, 2002, CLIN INFECT DIS, V35, P1238, DOI 10.1086/343048
   Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214
   Shuter J, 2008, J ANTIMICROB CHEMOTH, V61, P769, DOI 10.1093/jac/dkn020
   Singh N, 1996, AIDS CARE, V8, P261, DOI 10.1080/09540129650125696
   Sulkowski MS, 2008, J INFECT DIS, V197, pS279, DOI 10.1086/533414
   Sulkowski MS, 2003, ANN INTERN MED, V138, P197, DOI 10.7326/0003-4819-138-3-200302040-00012
   Szczech LA, 2004, KIDNEY INT, V66, P1145, DOI 10.1111/j.1523-1755.2004.00865.x
   Triant VA, 2008, J CLIN ENDOCR METAB, V93, P3499, DOI 10.1210/jc.2008-0828
   Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190
   Tumbarello M, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-46
   Tyor WR, 1999, J LEUKOCYTE BIOL, V65, P475, DOI 10.1002/jlb.65.4.475
   United States Renal Data System, 2007, ANN DAT REP 2007 ADR
   Valcour V, 2004, NEUROLOGY, V63, P822, DOI 10.1212/01.WNL.0000134665.58343.8D
   Viard JP, 2001, J INFECT DIS, V183, P1290, DOI 10.1086/319678
   VILLETTE JM, 1990, J CLIN ENDOCR METAB, V70, P572, DOI 10.1210/jcem-70-3-572
   Walli R, 1998, AIDS, V12, pF167, DOI 10.1097/00002030-199815000-00001
   Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632
   Wyles DL, 2005, CLIN INFECT DIS, V40, P174, DOI 10.1086/426021
   Yun LWH, 2005, JAIDS-J ACQ IMM DEF, V38, P432, DOI 10.1097/01.qai.0000147524.19122.fd
   Zhang L, 1998, J NEUROVIROL, V4, P619, DOI 10.3109/13550289809114228
NR 129
TC 9
Z9 10
U1 0
U2 3
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1082-6084
EI 1532-2491
J9 SUBST USE MISUSE
JI Subst. Use Misuse
PY 2011
VL 46
IS 2-3
BP 233
EP 244
DI 10.3109/10826084.2011.522843
PG 12
WC Substance Abuse; Psychiatry; Psychology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Substance Abuse; Psychiatry; Psychology
GA 718DZ
UT WOS:000287102100012
PM 21303243
DA 2024-02-19
ER

PT J
AU Guan, QJ
   Gong, TT
   Lu, ZM
   Geng, Y
   Duan, WH
   Ren, YL
   Zhang, XJ
   Chai, LJ
   Shi, JS
   Xu, ZH
AF Guan, Qijie
   Gong, Tingting
   Lu, Zhen-Ming
   Geng, Yan
   Duan, Wenhui
   Ren, Yi-Lin
   Zhang, Xiao-Juan
   Chai, Li-Juan
   Shi, Jin-Song
   Xu, Zheng-Hong
TI Hepatoprotective Effect of Cereal Vinegar Sediment in Acute Liver Injury
   Mice and Its Influence on Gut Microbiota
SO FRONTIERS IN NUTRITION
LA English
DT Article
DE cereal vinegar sediment; composition analysis; liver injury prevention;
   gut microbiota; CCl4 induced liver injury
ID KUROZU MOROMI POWDER; SHANXI AGED VINEGAR; FLAVONOIDS; IDENTIFICATION;
   DAMAGE; DIET
AB Cereal vinegar sediment (CVS) is a natural precipitate formed during the aging process of traditional grain vinegar. It has been used as Chinese traditional medicine, while its composition and function are reported minimally. In this study, we measured CVS in terms of saccharide, protein, fat and water content, and polyphenol and flavonoid content. Furthermore, we determined the amino acids, organic acids, and other soluble metabolites in CVS using reverse-phase high-performance liquid chromatography (RP-HPLC), HPLC, and liquid chromatography with tandem mass spectrometry (LC-MS/MS) platforms. The hepatoprotective effect of CVS was evaluated in acute CCl4-induced liver injury mice. Administration of CVS for 7 days prior to the CCl4 treatment can significantly decrease liver alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels and reactive oxygen species (ROS) levels, compared with those in the hepatic injury model group. The gut microbiota was changed by CCl4 administration and was partly shifted by the pretreatment of CVS, particularly the Muribaculaceae family, which was increased in CVS-treated groups compared with that in the CCl4 administration group. Moreover, the abundances of Alistipes genus and Muribaculaceae family were correlated with the liver ALT, AST, and malondialdehyde (MDA) levels. Our results illustrated the composition of CVS and its hepatoprotective effect in mice, suggested that CVS could be developed as functional food to prevent acute liver injury.
C1 [Guan, Qijie; Xu, Zheng-Hong] Jiangnan Univ, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Jiangsu, Peoples R China.
   [Guan, Qijie; Lu, Zhen-Ming; Zhang, Xiao-Juan; Chai, Li-Juan; Xu, Zheng-Hong] Jiangnan Univ, Natl Engn Lab Cereal Fermentat Technol, Wuxi, Jiangsu, Peoples R China.
   [Gong, Tingting; Geng, Yan; Duan, Wenhui; Ren, Yi-Lin; Shi, Jin-Song] Jiangnan Univ, Sch Pharmaceut Sci, Wuxi, Jiangsu, Peoples R China.
   [Lu, Zhen-Ming; Zhang, Xiao-Juan; Chai, Li-Juan; Xu, Zheng-Hong] Jiangnan Univ, Jiangsu Engn Res Ctr Bioact Prod Proc Technol, Wuxi, Jiangsu, Peoples R China.
   [Ren, Yi-Lin] Jiangnan Univ, Affiliated Hosp, Dept Gastroenterol, Wuxi, Jiangsu, Peoples R China.
C3 Jiangnan University; Jiangnan University; Jiangnan University; Jiangnan
   University; Jiangnan University
RP Xu, ZH (corresponding author), Jiangnan Univ, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Jiangsu, Peoples R China.; Xu, ZH (corresponding author), Jiangnan Univ, Natl Engn Lab Cereal Fermentat Technol, Wuxi, Jiangsu, Peoples R China.; Xu, ZH (corresponding author), Jiangnan Univ, Jiangsu Engn Res Ctr Bioact Prod Proc Technol, Wuxi, Jiangsu, Peoples R China.
EM zhenghxu@jiangnan.edu.cn
RI Geng, Yan/ABH-7789-2022; Guan, Qijie/IQW-7165-2023; Shi,
   JIn/JYP-1805-2024; shi, jin/GQZ-1206-2022; Chai, Li-Juan/GLN-3794-2022
OI Guan, Qijie/0000-0002-8441-9604; Ren, Yilin/0000-0001-6339-8579; Geng,
   Yan/0000-0001-8861-7686
FU National Key R&D Program of China [2018YFC1603800, 2018YFC1603802];
   National Natural Science Foundation of China [31771967]; National
   First-Class Discipline Program of Light Industry Technology and
   Engineering [LITE2018-11]
FX This study was supported by the National Key R&D Program of China (Grant
   Nos. 2018YFC1603800 and 2018YFC1603802), the National Natural Science
   Foundation of China (Grant No. 31771967), and National First-Class
   Discipline Program of Light Industry Technology and Engineering (Grant
   No. LITE2018-11).
CR Adolph TE, 2018, TRENDS IMMUNOL, V39, P712, DOI 10.1016/j.it.2018.05.002
   Albillos A, 2020, J HEPATOL, V72, P558, DOI 10.1016/j.jhep.2019.10.003
   AOAC, 1990, OFFICIAL METHODS ANA, V15th
   Asshauer KP, 2015, BIOINFORMATICS, V31, P2882, DOI 10.1093/bioinformatics/btv287
   Aykin E, 2015, J AM COLL NUTR, V34, P80, DOI 10.1080/07315724.2014.896230
   Betrapally NS, 2016, GASTROENTEROLOGY, V150, P1745, DOI 10.1053/j.gastro.2016.02.073
   Boursier J, 2016, HEPATOLOGY, V63, P764, DOI 10.1002/hep.28356
   Chen SJ., 2014, FOOD SCI, V11
   Cho S, 2015, ASIAN AUSTRAL J ANIM, V28, P1362, DOI 10.5713/ajas.15.0078
   Compare D, 2012, NUTR METAB CARDIOVAS, V22, P471, DOI 10.1016/j.numecd.2012.02.007
   Corradini E, 2011, NAT PROD RES, V25, P469, DOI 10.1080/14786419.2010.482054
   Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]
   Fujino T., 1990, KENKO KAGAKU, V12, P139
   Fukuyama N, 2007, NUTRITION, V23, P81, DOI 10.1016/j.nut.2006.10.004
   Gardner W. H., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P493
   Geng Y, 2021, MOL NUTR FOOD RES, V65, DOI 10.1002/mnfr.202001227
   Guan QJ, 2021, J PROTEOMICS, V231, DOI 10.1016/j.jprot.2020.104019
   Hayashi T, 2007, FOOD SCI TECHNOL RES, V13, P385, DOI 10.3136/fstr.13.385
   Hu YY, 2015, FOOD FUNCT, V6, P3359, DOI 10.1039/c5fo00581g
   Kanouchi H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150796
   Kedia S, 2016, J GASTROENTEROL, V51, P660, DOI 10.1007/s00535-016-1193-1
   Koyu A, 2006, MOL CELL BIOCHEM, V284, P81, DOI 10.1007/s11010-005-9017-2
   Martin M., 2011, EMBnet. J., V17, P10, DOI [DOI 10.14806/EJ.17.1.200, 10.14806/ej.17.1.200]
   Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001
   Nagano M., 2001, Journal of Japanese Society of Nutrition and Food Science, V54, P171
   Nagano M., 2001, JPN PHARMACOL THER, V29, P635
   Nagano M, 2010, J JPN SOC FOOD SCI, V57, P346
   Nie Y, 2015, FOOD FUNCT, V6, P513, DOI [10.1039/C4FO00557K, 10.1039/c4fo00557k]
   Ohkura N., 2018, Food and Nutrition Sciences, V9, P235, DOI 10.4236/fns.2018.93018
   Parker BJ, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00906
   Pihlava JM, 2014, J CEREAL SCI, V60, P645, DOI 10.1016/j.jcs.2014.07.002
   Qiu J, 2010, J SCI FOOD AGR, V90, P1951, DOI 10.1002/jsfa.4040
   Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219
   Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584
   Sandri M, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-0981-z
   Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60
   Shibayama Y, 2019, FUNCT FOODS HEALTH D, V9, P276, DOI 10.31989/ffhd.v9i4.596
   Shizuma T, 2011, J CLIN BIOCHEM NUTR, V49, P31, DOI [10.3164/jcbn.10-112., 10.3164/jcbn.10-112]
   Shizuma T, 2011, DIGEST DIS SCI, V56, P1387, DOI 10.1007/s10620-010-1432-x
   Smith BJ, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1494-7
   Song J, 2020, J FUNCT FOODS, V74, DOI 10.1016/j.jff.2020.104152
   Song ZT, 2014, LIVEST SCI, V167, P292, DOI 10.1016/j.livsci.2014.05.030
   Taniguchi M, 2004, LIFE SCI, V75, P1539, DOI 10.1016/j.lfs.2004.02.030
   Tripathi A, 2018, NAT REV GASTRO HEPAT, V15, P397, DOI 10.1038/s41575-018-0011-z
   Walker A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10369-z
   Wang YL, 2015, GENET MOL RES, V14, P10973, DOI 10.4238/2015.September.21.9
   Wu JJ, 2012, FOOD MICROBIOL, V30, P289, DOI 10.1016/j.fm.2011.08.010
   Xia T, 2020, FOOD FUNCT, V11, P2898, DOI [10.1039/c9fo03015h, 10.1039/C9FO03015H]
   Xia T, 2019, J FUNCT FOODS, V60, DOI 10.1016/j.jff.2019.103448
   Xia T, 2018, NUTRIENTS, V10, DOI 10.3390/nu10070805
   Xie XL, 2017, J FOOD SCI, V82, P2479, DOI 10.1111/1750-3841.13914
   Zhang XL, 2019, INT J FOOD SCI TECH, V54, P2927, DOI 10.1111/ijfs.14185
   Zhu SH, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.585582
NR 53
TC 2
Z9 2
U1 5
U2 49
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-861X
J9 FRONT NUTR
JI Front. Nutr.
PD DEC 24
PY 2021
VL 8
AR 798273
DI 10.3389/fnut.2021.798273
PG 13
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA YI6SK
UT WOS:000743976200001
PM 35004825
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Angelini, D
   Konkle, BA
   Sood, SL
AF Angelini, Dana
   Konkle, Barbara A.
   Sood, Suman L.
TI Aging among persons with hemophilia: contemporary concerns
SO SEMINARS IN HEMATOLOGY
LA English
DT Article
DE Hemophilia; Elderly; Cardiovascular; Cancer; Arthropathy; Renal
ID CORONARY-ARTERY CALCIFICATION; HEART-DISEASE; RISK-FACTORS;
   CARDIOVASCULAR-DISEASE; MORTALITY-RATES; KIDNEY-DISEASE; PREVALENCE;
   MANAGEMENT; COMORBIDITIES; PATIENT
AB The life expectancy of persons with hemophilia (PWH) has increased almost 10-fold over the past seven decades, largely due to access to safe factor replacement products. Concomitant with this success, however, comes the burden of aging. Older PWH are developing similar comorbidities as the general population, including increasing rates of hypertension, obesity, and diabetes, which predispose them to chronic diseases such as cardiovascular disease (CVD) and chronic kidney disease (CKD). How their coagulopathy affects the expression of these conditions remains unclear. In addition, the elderly hemophilia population must cope with chronic joint arthropathy, which provokes falls and fractures, and complications related to human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infections, which greatly impact the incidence of cancer and liver disease. With a dearth of evidence based guidelines to direct therapy, a new challenge has arisen for hematologists to optimally manage these complex age-related issues. This review will focus on common complications affecting the older hemophilia population, including joint disease, CVD, malignancy, renal insufficiency, and liver disease. (c) 2016 Elsevier Inc. All rights reserved.
C1 [Angelini, Dana; Sood, Suman L.] Univ Michigan, Hemophilia & Coagulat Disorders Program, Ann Arbor, MI 48109 USA.
   [Konkle, Barbara A.] Univ Washington, Bloodworks Northwest, Seattle, WA 98195 USA.
   [Konkle, Barbara A.] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA.
C3 University of Michigan System; University of Michigan; University of
   Washington; University of Washington Seattle; University of Washington;
   University of Washington Seattle
RP Sood, SL (corresponding author), Univ Michigan, Hemophilia & Coagulat Disorders Program, Ann Arbor, MI 48109 USA.
EM sumisood@med.umich.edu
RI Konkle, Barbara/GPX-3325-2022; Konkle, Barbara A/AAD-7712-2022
OI Konkle, Barbara A/0000-0002-3959-8797
CR Biere-Rafi S, 2010, NETH J MED, V68, P207
   Biere-Rafi S, 2011, THROMB HAEMOSTASIS, V105, P274, DOI 10.1160/TH10-07-0460
   Bilora F, 2006, CLIN APPL THROMB-HEM, V12, P193, DOI 10.1177/107602960601200207
   Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199
   Coppola A, 2010, SEMIN THROMB HEMOST, V36, P91, DOI 10.1055/s-0030-1248728
   Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038
   Darby SC, 2007, BLOOD, V110, P815, DOI 10.1182/blood-2006-10-050435
   Esposito P, 2013, EUR J HAEMATOL, V91, P287, DOI 10.1111/ejh.12134
   Ewenstein BM, 2004, HAEMOPHILIA, V10, P629, DOI 10.1111/j.1365-2516.2004.00943.x
   Ferrario C, 2007, HAEMOPHILIA, V13, P763, DOI 10.1111/j.1365-2516.2007.01530.x
   Ferraris VA, 2015, CARDIOL REV, V23, P53, DOI 10.1097/CRD.0000000000000045
   Foley CJ, 2010, J THROMB HAEMOST, V8, P208, DOI 10.1111/j.1538-7836.2009.03669.x
   FORBES CD, 1977, SCAND J HAEMATOL, P43
   Forsyth AL, 2011, HAEMOPHILIA, V17, pE870, DOI 10.1111/j.1365-2516.2011.02514.x
   Franchini M, 2009, CANCER TREAT REV, V35, P374, DOI 10.1016/j.ctrv.2009.01.001
   Gay ND, 2015, BRIT J HAEMATOL, V170, P584, DOI 10.1111/bjh.13312
   Hsue PY, 2010, CIRC-HEART FAIL, V3, P132, DOI 10.1161/CIRCHEARTFAILURE.109.854943
   Jackson Shannon C, 2015, BMC Hematol, V15, P4, DOI 10.1186/s12878-015-0022-8
   Konkle BA, 2012, AM J HEMATOL, V87, pS27, DOI 10.1002/ajh.23161
   Kulkarni R, 2005, AM J HEMATOL, V79, P36, DOI 10.1002/ajh.20339
   Kulkarni R, 2003, HAEMOPHILIA, V9, P703, DOI 10.1046/j.1351-8216.2003.00821.x
   Lövdahl S, 2013, HAEMOPHILIA, V19, P362, DOI 10.1111/hae.12092
   Mannucci PM, 2009, BLOOD, V114, P5256, DOI 10.1182/blood-2009-07-215665
   Miesbach W, 2009, HAEMOPHILIA, V15, P894, DOI 10.1111/j.1365-2516.2009.02030.x
   Morgan RL, 2013, ANN INTERN MED, V158, P329, DOI 10.7326/0003-4819-158-5-201303050-00005
   Philipp C, 2010, HEMATOL-AM SOC HEMAT, P191, DOI 10.1182/asheducation-2010.1.191
   Plug I, 2006, J THROMB HAEMOST, V4, P510, DOI 10.1111/j.1538-7836.2006.01808.x
   Pocoski J, 2014, HAEMOPHILIA, V20, P472, DOI 10.1111/hae.12339
   PRENTICE CR, 1971, Q J MED, V40, P47
   Ragni MV, 2011, HAEMOPHILIA, V17, P867, DOI 10.1111/j.1365-2516.2011.02501.x
   ROSENDAAL FR, 1989, BRIT J HAEMATOL, V71, P71, DOI 10.1111/j.1365-2141.1989.tb06277.x
   Schutgens REG, 2009, HAEMOPHILIA, V15, P952, DOI 10.1111/j.1365-2516.2009.02020.x
   Siboni SM, 2009, J THROMB HAEMOST, V7, P780, DOI 10.1111/j.1538-7836.2009.03318.x
   Small S, 1982, Br Med J (Clin Res Ed), V285, P1609
   Sood SL, 2014, ASH ANN M, V124, P2863
   Soucie JM, 2000, BLOOD, V96, P437
   Tonelli M, 2007, ANNU REV MED, V58, P123, DOI 10.1146/annurev.med.58.071105.111123
   TRIEMSTRA M, 1995, ANN INTERN MED, V123, P823, DOI 10.7326/0003-4819-123-11-199512010-00002
   Tuinenburg A, 2012, ARTERIOSCL THROM VAS, V32, P799, DOI 10.1161/ATVBAHA.111.238162
   van de Putte DEF, 2012, EUR J HAEMATOL, V89, P336, DOI 10.1111/j.1600-0609.2012.01835.x
   von Drygalski A, 2013, HYPERTENSION, V62, P209, DOI 10.1161/HYPERTENSIONAHA.113.01174
   Zwiers M, 2012, J THROMB HAEMOST, V10, P23, DOI 10.1111/j.1538-7836.2011.04514.x
NR 42
TC 29
Z9 31
U1 0
U2 8
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0037-1963
EI 1532-8686
J9 SEMIN HEMATOL
JI Semin. Hematol.
PD JAN
PY 2016
VL 53
IS 1
BP 35
EP 39
DI 10.1053/j.seminhematol.2015.10.004
PG 5
WC Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology
GA DD4GG
UT WOS:000369879900006
PM 26805905
DA 2024-02-19
ER

PT J
AU Beaufrère, B
   Morio, B
AF Beaufrère, B
   Morio, B
TI Fat and protein redistribution with aging:: metabolic considerations
SO EUROPEAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article; Proceedings Paper
CT Workshop of the International-Dietary-Energy-Consultative-Group
CY MAY, 1999
CL TUFS UNIV, USDA HUMAN NUTRIT RES CTR, BOSTON, MA
SP Int Dietary Energy Consultat Grp
HO TUFS UNIV, USDA HUMAN NUTRIT RES CTR
DE aging; fat distribution; lean body mass
ID HORMONE-REPLACEMENT THERAPY; INDUCED INSULIN-RESISTANCE; SIMPLE
   ANTHROPOMETRIC MEASUREMENTS; CARDIOVASCULAR RISK-FACTORS;
   IDENTICAL-TWINS DISCORDANT; VISCERAL ADIPOSE-TISSUE;
   AGE-RELATED-CHANGES; GLUCOSE-TOLERANCE; BODY-COMPOSITION;
   SKELETAL-MUSCLE
AB Aging is associated with a redistribution of both fat and lean tissue within the body. Intra-abdominal Fat (IAF) accumulates more rapidly than total fat while the loss of lean body mass is mostly due to sarcopenia. Increase of visceral fat plays a major role in the pathogenesis of insulin resistance, which leads to type II diabetes and also to cardiovascular diseases. This review is focussed on the relationships that exist between the accumulation of IAF and insulin resistance during aging. The various methods available for assessing IAF are briefly reviewed; imaging techniques are the only reference methods, and their availability is limited. Insulin resistance that appears with aging is caused by accumulation of IAF, rather than by aging per se. Studies done in type II diabetic patients suggest that the metabolic link between increased IAF and insulin resistance could well be the increased availability and/or oxidation of free fatty acids. Physical inactivity certainly enhances both IAF accumulation and, more directly, insulin resistance. Independent and significant effects of menopause or of sarcopenia on insulin resistance remain to be established. The influence of hormonal changes, reduced Fatty acid utilization, and resistance to leptin on IAF accumulation are also discussed. Although it is difficult to determine the independent influence of each of these factors, IAF accumulation seems to be a central and important determinant of cardiovascular risk. The last part of this review is devoted to protein metabolism and focused on the preservation of protein metabolism in the liver during aging.
C1 Univ Auvergne, INRA, Lab Nutr Humaine, F-63009 Clermont Ferrand, France.
   CRNH Auvergne, F-63009 Clermont Ferrand, France.
C3 INRAE; Universite Clermont Auvergne (UCA)
RP Univ Auvergne, INRA, Lab Nutr Humaine, 58 Montalembert,BP 321, F-63009 Clermont Ferrand, France.
EM beaufrer@clermont.inra.fr
RI Morio, Béatrice/G-3571-2018
OI Morio, Béatrice/0000-0002-2418-1438
CR Barzilai N, 1997, J CLIN INVEST, V100, P3105, DOI 10.1172/JCI119865
   Barzilai N, 1998, J CLIN INVEST, V101, P1353, DOI 10.1172/JCI485
   Barzilai N, 1999, DIABETES, V48, P94, DOI 10.2337/diabetes.48.1.94
   BARZILAI N, 1996, AM J PHYSIOL, V270, pF930
   Bjorntorp P, 1997, NUTRITION, V13, P795, DOI 10.1016/S0899-9007(97)00191-3
   BODEN G, 1994, J CLIN INVEST, V93, P2438, DOI 10.1172/JCI117252
   Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3
   Boirie Y, 1997, AM J CLIN NUTR, V65, P489
   BOIRIE Y, 1998, CLIN NUTR, V17, P68
   BONADONNA RC, 1994, AM J PHYSIOL, V266, pE501
   Bonora E, 1995, METABOLISM, V44, P1617, DOI 10.1016/0026-0495(95)90084-5
   CALLESESCANDON J, 1995, J APPL PHYSIOL, V78, P266, DOI 10.1152/jappl.1995.78.1.266
   CEFALU WT, 1995, METABOLISM, V44, P954, DOI 10.1016/0026-0495(95)90251-1
   Cefalu WT, 1998, METABOLISM, V47, P401, DOI 10.1016/S0026-0495(98)90050-6
   COLBERG SR, 1995, J CLIN INVEST, V95, P1846, DOI 10.1172/JCI117864
   COON PJ, 1992, J CLIN ENDOCR METAB, V75, P1125, DOI 10.1210/jc.75.4.1125
   Crook D, 1997, BRIT J OBSTET GYNAEC, V104, P298, DOI 10.1111/j.1471-0528.1997.tb11457.x
   DESPRES J, 1991, AGE NUTR, V44, P741
   EVANS WJ, 1995, J GERONTOL A-BIOL, V50, P5, DOI 10.1093/gerona/50A.Special_Issue.5
   FABRIS F, 1994, INT ANGIOL, V13, P52
   Ferrannini E, 1996, DIABETES, V45, P947, DOI 10.2337/diabetes.45.7.947
   Fu AZ, 1998, AM J PHYSIOL-ENDOC M, V275, pE1023, DOI 10.1152/ajpendo.1998.275.6.E1023
   GERSOVITZ M, 1980, METABOLISM, V29, P1087, DOI 10.1016/0026-0495(80)90220-6
   GIRARD J, 1995, DIABETES METAB, V21, P79
   GOLDSPINK DF, 1984, BIOCHEM J, V217, P507, DOI 10.1042/bj2170507
   Goodyear LJ, 1998, ANNU REV MED, V49, P235, DOI 10.1146/annurev.med.49.1.235
   Gower BA, 1998, INT J OBESITY, V22, P605, DOI 10.1038/sj.ijo.0800633
   GUMBINER B, 1992, METABOLISM, V41, P1115, DOI 10.1016/0026-0495(92)90296-M
   Hawkins M, 1997, J CLIN INVEST, V99, P2173, DOI 10.1172/JCI119390
   Hjeltnes N, 1998, FASEB J, V12, P1701, DOI 10.1096/fasebj.12.15.1701
   Horber FF, 1997, NUTRITION, V13, P524, DOI 10.1016/S0899-9007(97)00031-2
   Horber FF, 1996, EUR J CLIN INVEST, V26, P279, DOI 10.1046/j.1365-2362.1996.124281.x
   Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665
   Howard G, 1997, STROKE, V28, P1693, DOI 10.1161/01.STR.28.9.1693
   Hunter GR, 1996, INT J OBESITY, V20, P860
   ITOH H, 1997, CLIN EXP PHARM PHYSL, V26, P558
   Ivy J L, 1997, Sports Med, V24, P321
   KAHN SE, 1990, AM J PHYSIOL, V258, pE937, DOI 10.1152/ajpendo.1990.258.6.E937
   KELLEY DE, 1994, J CLIN INVEST, V94, P2349, DOI 10.1172/JCI117600
   Kim YB, 1999, BIOCHEM BIOPH RES CO, V254, P720, DOI 10.1006/bbrc.1998.9940
   KOHRT WM, 1995, J GERONTOL A-BIOL, V50, P68
   LAVILLE M, 1995, METABOLISM, V44, P639, DOI 10.1016/0026-0495(95)90122-1
   MAYS PK, 1991, HEPATOLOGY, V14, P1224
   MERRY BJ, 1987, MECH AGEING DEV, V39, P189, DOI 10.1016/0047-6374(87)90008-X
   Morio B, 1999, INT J OBESITY, V23, P706, DOI 10.1038/sj.ijo.0800909
   MOSONI L, 1993, AM J PHYSIOL, V264, pE614, DOI 10.1152/ajpendo.1993.264.4.E614
   MOSONI L, 1993, MECH AGEING DEV, V68, P209, DOI 10.1016/0047-6374(93)90152-H
   Mourier A, 1997, DIABETES CARE, V20, P385, DOI 10.2337/diacare.20.3.385
   MYKKANEN L, 1992, INT J OBESITY, V16, P695
   Nolte LA, 1998, DIABETES, V47, P721, DOI 10.2337/diabetes.47.5.721
   Obisesan TO, 1997, EXP GERONTOL, V32, P643, DOI 10.1016/S0531-5565(97)00052-1
   Owens S, 1999, OBES RES, V7, P16, DOI 10.1002/j.1550-8528.1999.tb00386.x
   PaganiniHill A, 1996, AM J OBSTET GYNECOL, V174, P897, DOI 10.1016/S0002-9378(96)70322-8
   Paolisso G, 1998, AM J PHYSIOL-ENDOC M, V275, pE294, DOI 10.1152/ajpendo.1998.275.2.E294
   Poehlman ET, 1998, CORONARY ARTERY DIS, V9, P799, DOI 10.1097/00019501-199809120-00004
   POEHLMAN ET, 1995, ANN INTERN MED, V123, P673, DOI 10.7326/0003-4819-123-9-199511010-00005
   Ronnemaa T, 1997, ANN INTERN MED, V126, P26, DOI 10.7326/0003-4819-126-1-199701010-00004
   Ronnemaa T, 1997, J CLIN ENDOCR METAB, V82, P383, DOI 10.1210/jc.82.2.383
   SEIDELL JC, 1990, AM J CLIN NUTR, V51, P953, DOI 10.1093/ajcn/51.6.953
   Tchernof A, 1998, CORONARY ARTERY DIS, V9, P503, DOI 10.1097/00019501-199809080-00006
   Toth MJ, 2000, EUR J CLIN NUTR, V54, pS121, DOI 10.1038/sj.ejcn.1601033
   TREUTH MS, 1995, J APPL PHYSIOL, V78, P2140, DOI 10.1152/jappl.1995.78.6.2140
   WANG QL, 1994, AM J CLIN NUTR, V60, P843, DOI 10.1093/ajcn/60.6.843
   WARD W, 1991, HEPATOLOGY, V14, P935, DOI 10.1002/hep.1840140529
   Willeit J, 1997, ATHEROSCLEROSIS, V130, P183, DOI 10.1016/S0021-9150(96)06038-8
   YAMANOUCHI K, 1992, J APPL PHYSIOL, V73, P2241, DOI 10.1152/jappl.1992.73.6.2241
   Zamboni M, 1997, AM J CLIN NUTR, V66, P111, DOI 10.1093/ajcn/66.1.111
NR 67
TC 175
Z9 207
U1 0
U2 13
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 0954-3007
EI 1476-5640
J9 EUR J CLIN NUTR
JI Eur. J. Clin. Nutr.
PD JUN
PY 2000
VL 54
SU 3
BP S48
EP S53
DI 10.1038/sj.ejcn.1601025
PG 6
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Nutrition & Dietetics
GA 333FG
UT WOS:000088118600008
PM 11041075
DA 2024-02-19
ER

PT J
AU Carrillo, MC
   Kitarii, K
   Minami, C
   Maruyama, W
AF Carrillo, Maria-Cristina
   Kitarii, Kenichi
   Minami, Chiyoko
   Maruyama, Wakako
TI Age-related changes in antioxidant enzyme activities in the brain and
   liver of BN/Bi rats: Striking differences from those in F344 rats
   emphasize the need for "public observations" for generating a general
   theory of aging
SO GERIATRICS & GERONTOLOGY INTERNATIONAL
LA English
DT Article
DE age; BN/BiHsd rats; brain; catalase; liver; superoxide dismutase
ID SUPEROXIDE-DISMUTASE; LIFE-SPAN; CATALASE; SEX; OVEREXPRESSION;
   EXPRESSION; EXTENSION; LONGEVITY; MOUSE
AB Objective: Age-related changes in endogenous antioxidant enzyme activities have been widely discussed in relation to mechanisms of organismic aging. However, some discrepancies in this regard can be seen in the Published work. The present study aimed to clarify past discrepancies using BN/Bi rats in which no Study has been reported in the past.
   Methods: Antioxidant enzyme activities such as superoxide dismutase (SOD) and catalase (CAT) were compared in several brain regions and the liver between young (8-9 months) and old (27-29 months) BN/BiRijHsd rats of both sexes.
   Results: CAT activities in brain regions were quite comparable between young, and old rats of both sexes. SOD activity changes with age also were not remarkable, with the exception of significantly lower Mn-SOD activities in substantia nigra and hippocampus of old male rats and significantly higher activities of Cu/Zn-SOD in substantia nigra of old female rats in comparison with respective values in Young rats. CAT activities in the liver tended to be lower in old male rats, while in females the opposite was observed. SOD activities in the liver stayed essentially unchanged with age in males, while in females total as well as Cu/Zn-SOD activities were more than twofold higher in old animals.
   Conclusion: These data coupled with previously reported results, indicate that no generalization can be made in terms of age-related changes in antioxidant enzyme activities. These differences emphasize the need of "public observations" in any attempt to generate a theory for mechanisms of aging based on antioxidant enzyme activity changes with age.
C1 [Carrillo, Maria-Cristina; Kitarii, Kenichi; Minami, Chiyoko; Maruyama, Wakako] Natl Inst Logev Sci, Aichi 4748522, Japan.
   [Carrillo, Maria-Cristina] Natl Univ Rosario, Inst Expt Physiol, Rosario, Argentina.
C3 National University of Rosario
RP Kitarii, K (corresponding author), Natl Inst Logev Sci, 36-3 Geno Moriokacho, Aichi 4748522, Japan.
EM kitani@nils.go.jp
CR [Anonymous], 1978, PATHOLOGY AGING RATS
   BEERS RF, 1952, J BIOL CHEM, V195, P133
   CARRILLO MC, 1992, MECH AGEING DEV, V65, P187, DOI 10.1016/0047-6374(92)90035-C
   CIRIOLO MR, 1991, MECH AGEING DEV, V61, P287, DOI 10.1016/0047-6374(91)90061-4
   GUPTA A, 1991, GERONTOLOGY, V37, P305, DOI 10.1159/000213277
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARMAN D, 1994, ANN NY ACAD SCI, V717, P1, DOI 10.1111/j.1749-6632.1994.tb12069.x
   KAMATAKI T, 1985, J PHARMACOL EXP THER, V233, P222
   KELLOGG EW, 1976, J GERONTOL, V31, P405, DOI 10.1093/geronj/31.4.405
   Kitani K, 1998, ARCH GERONTOL GERIAT, V26, P257, DOI 10.1016/S0167-4943(98)00008-9
   Martin GM, 1997, MOL MED, V3, P356, DOI 10.1007/BF03401682
   MCCORD JM, 1969, J BIOL CHEM, V244, P6049
   NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   RAO G, 1990, MECH AGEING DEV, V53, P49, DOI 10.1016/0047-6374(90)90033-C
   REISS U, 1978, LIVER AGING 1978, P55
   RIKANS LE, 1991, BIOCHIM BIOPHYS ACTA, V1074, P195, DOI 10.1016/0304-4165(91)90061-K
   SANTIAGO LA, 1993, NEUROCHEM RES, V18, P711, DOI 10.1007/BF00966786
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   SEMSEI I, 1991, MECH AGEING DEV, V58, P13, DOI 10.1016/0047-6374(91)90116-H
   Tanaka S, 2000, ARCH GERONTOL GERIAT, V30, P215, DOI 10.1016/S0167-4943(00)00053-4
   WILLIAMS LR, 1995, ADV BEHAV BIOL, V44, P641
   WULF JH, 1975, EXP GERONTOL, V10, P101, DOI 10.1016/0531-5565(75)90040-6
   XIA EN, 1995, J NUTR, V125, P195
NR 24
TC 1
Z9 1
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1444-1586
EI 1447-0594
J9 GERIATR GERONTOL INT
JI Geriatr. Gerontol. Int.
PD SEP
PY 2007
VL 7
IS 3
BP 279
EP 284
DI 10.1111/j.1447-0594.2007.00404.x
PG 6
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 273TZ
UT WOS:000253955900011
DA 2024-02-19
ER

PT J
AU Erhuma, A
   Salter, AM
   Sculley, DV
   Langley-Evans, SC
   Bennett, AJ
AF Erhuma, Aml
   Salter, Andrew M.
   Sculley, Dean V.
   Langley-Evans, Simon C.
   Bennett, Andrew J.
TI Prenatal exposure to a low-protein diet programs disordered regulation
   of lipid metabolism in the aging rat
SO AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
LA English
DT Article
DE pregnancy; lipids; transcription factors; insulin resistance; metabolic
   syndrome
ID EARLY GROWTH; NONALCOHOLIC STEATOHEPATITIS; EXPRESSION; OBESITY; GENE;
   LIFE; HYPERTENSION; ASSOCIATION; RESISTANCE; NONOBESE
AB The nutritional environment encountered during fetal life is strongly implicated as a determinant of lifelong metabolic capacity and risk of disease. Pregnant rats were fed a control or low- protein ( LP) diet, targeted to early ( LPE), mid-( LPM), or late ( LPL) pregnancy, or throughout gestation ( LPA). The offspring were studied at 1, 9, and 18 mo of age. All LP- exposed groups had similar plasma triglyceride, cholesterol, glucose, and insulin concentrations to those of controls at 1 and 9 mo of age, but by 18 mo there was evidence of LP- programmed hypertri-glyceridemia and insulin resistance. All LP- exposed groups exhibited histological evidence of hepatic steatosis and were found to have two-to threefold more hepatic triglyceride than control animals. These phenotypic changes were accompanied by age- related changes in mRNA and protein expression of the transcription factors SREBP-1c, ChREBP, PPAR gamma, and PPAR alpha and their respective downstream target genes ACC1, FAS, L- PK, and MCAD. At 9 mo of age, the LP groups exhibited suppression of the SREBP-1c-related lipogenic pathway but between 9 and 18 mo underwent a switch to increased lipogenic capacity with a lower expression of PPAR gamma and MCAD, consistent with reduced lipid oxidation. The findings indicate that prenatal protein restriction programs development of a metabolic syndrome- like phenotype that develops only with senescence. The data implicate altered expression of SREBP- 1c and ChREBP as key mediators of the programmed phenotype, but the basis of the switch in metabolic status that occurred between 9 and 18 mo of age is, as yet, unidentified.
C1 Univ Nottingham, Sch Biosci, Loughborough LE12 5RD, Leics, England.
   Univ Nottingham, Sch Biomed Sci, Queens Med Ctr, Nottingham NG7 2RD, England.
C3 University of Nottingham; University of Nottingham
RP Langley-Evans, SC (corresponding author), Univ Nottingham, Sch Biosci, Loughborough LE12 5RD, Leics, England.
EM Simon.Langley-Evans@nottingham.ac.uk
RI Salter, Andrew/JYQ-4173-2024; Sculley, Dean Vincent/ABD-4789-2021;
   Langley-Evans, Simon C/F-3564-2012; Langley-Evans, Simon/AAR-4181-2020
OI Sculley, Dean Vincent/0000-0003-3972-8309; Langley-Evans, Simon
   C/0000-0002-1969-8416; Salter, Andrew/0000-0002-8922-673X; bennett,
   andrew/0000-0003-3829-0309
FU British Heart Foundation [PG/03/034/15234] Funding Source: Medline
CR Bellinger L, 2006, INT J OBESITY, V30, P729, DOI 10.1038/sj.ijo.0803205
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Dong XC, 2006, J CLIN INVEST, V116, P101, DOI 10.1172/JCI25735
   Erhuma AM, 2005, P NUTR SOC, V64, p81A
   Eriksson J, 2001, INT J OBESITY, V25, P735, DOI 10.1038/sj.ijo.0801602
   Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949
   Fernandez-Twinn DS, 2006, PHYSIOL BEHAV, V88, P234, DOI 10.1016/j.physbeh.2006.05.039
   Fernandez-Twinn DS, 2005, AM J PHYSIOL-REG I, V288, pR368, DOI 10.1152/ajpregu.00206.2004
   Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292
   Hirashima Y, 2003, J ENDOCRINOL, V179, P253, DOI 10.1677/joe.0.1790253
   Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593
   Jackson L, 2003, GUT, V52, P1317, DOI 10.1136/gut.52.9.1317
   Jump DB, 2005, J NUTR, V135, P2503, DOI 10.1093/jn/135.11.2503
   Kim HJ, 2004, ARCH INTERN MED, V164, P2169, DOI 10.1001/archinte.164.19.2169
   LANGLEY SC, 1994, COMP BIOCHEM PHYS A, V109, P223, DOI 10.1016/0300-9629(94)90124-4
   Langley-Evans SC, 2006, P NUTR SOC, V65, P97, DOI 10.1079/PNS2005478
   Langley-Evans SC, 1999, LIFE SCI, V64, P965, DOI 10.1016/S0024-3205(99)00022-3
   Langley-Evans SC, 2005, MATERN CHILD NUTR, V1, P142, DOI 10.1111/j.1740-8709.2005.00015.x
   Langley-Evans SC, 2006, FEBS LETT, V580, P4150, DOI 10.1016/j.febslet.2006.06.062
   LangleyEvans SC, 1996, J REPROD FERTIL, V106, P307, DOI 10.1530/jrf.0.1060307
   Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Lucas A, 1996, BRIT J NUTR, V76, P605, DOI 10.1079/BJN19960066
   Maloney CA, 2003, OBES RES, V11, P461, DOI 10.1038/oby.2003.63
   McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003
   Musso G, 2005, AM J GASTROENTEROL, V100, P2438, DOI 10.1111/j.1572-0241.2005.00297.x
   Neuschwander-Tetri BA, 2005, AM J MED SCI, V330, P326, DOI 10.1097/00000441-200512000-00011
   Nogalska A, 2005, METABOLISM, V54, P1041, DOI 10.1016/j.metabol.2005.03.007
   Ozanne SE, 1998, METABOLISM, V47, P1450, DOI 10.1016/S0026-0495(98)90068-3
   Ozanne SE, 2003, J ENDOCRINOL, V177, P235, DOI 10.1677/joe.0.1770235
   Palekar NA, 2006, LIVER INT, V26, P151, DOI 10.1111/j.1478-3231.2005.01209.x
   Petry C J, 2001, Int J Exp Diabetes Res, V2, P139
   Schadinger SE, 2005, AM J PHYSIOL-ENDOC M, V288, pE1195, DOI 10.1152/ajpendo.00513.2004
   Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028
   Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656
   Tobe K, 2001, J BIOL CHEM, V276, P38337, DOI 10.1074/jbc.C100160200
   Tollet-Egnell P, 2004, PHYSIOL GENOMICS, V16, P261, DOI 10.1152/physiolgenomics.00093.2002
   Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83
   White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001
   Zhang JL, 2005, AM J PHYSIOL-REG I, V288, pR104, DOI 10.1152/ajpregu.00343.2004
NR 40
TC 130
Z9 140
U1 0
U2 21
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1849
EI 1522-1555
J9 AM J PHYSIOL-ENDOC M
JI Am. J. Physiol.-Endocrinol. Metab.
PD JUN
PY 2007
VL 292
IS 6
BP E1702
EP E1714
DI 10.1152/ajpendo.00605.2006
PG 13
WC Endocrinology & Metabolism; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Physiology
GA 188SH
UT WOS:000247939100024
PM 17299084
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Glaser, J
   Stienecker, K
AF Glaser, J
   Stienecker, K
TI Pancreas and aging: A study using ultrasonography
SO GERONTOLOGY
LA English
DT Article
DE pancreas; ultrasonography; aging; echogenicity; pancreatic duct
ID SONOGRAPHIC SECRETIN TEST; ULTRASONIC EVALUATION; DUCT; DIAGNOSIS
AB Background: The pancreas undergoes a continuous aging process leading to alterations such as atrophy, fatty infiltration and fibrosis. Objective: The aim of this study was to determine the normal ultrasonic aspect of the pancreas and any relationship to age with special regard to pancreatic echogenicity and pancreatic duct diameter. Methods: In the study on pancreatic echogenicity 131 patients (56 male, 75 female), aged 18-92 (median 52) years, with normal weight were examined prospectively, The echogenicity of the pancreas was compared with the normal liver and divided into four different categories. The prospective investigation into any age relationship of pancreatic duct diameter was performed on 101 patients (44 male, 57 female), ages 18-91 (median 53) years, with normal weight. In both studies, the patients were split into seven age groups. For statistical analysis the chi-square test for independence was used. Results: With advancing age, ultrasonography demonstrated an increasing echogenicity of the pancreas, beginning in the 4th decade of life. Most patients over 50 years, and all patients over 80 had a marked echogenicity, distinctly higher than that found in the liver. The mean pancreatic duct diameter of all patients in the second study was 1.9 mm. Younger subjects had a smaller diameter - average 1.5 mm in the group 18-29 years - but with advancing age a distinct duct enlargement was observed: mean 1.9 mm in the group 40-49 years; mean 2.3 mm in patients over 80 years, but not exceeding 3 mm. Conclusion: On ultrasonography, the aging process of the pancreas leads to an increase of echogenicity. In the aged, a very high echogenicity is a normal ultrasonic finding. The pancreatic duct diameter also increases with advancing age. Even in advanced age, a diameter of more than 3 mm, however, should be regarded as a pathological finding. Copyright (C) 2000 S.Karger AG, Basel.
C1 Gen Dist Hosp, Dept Internal Med & Gastroenterol, Fulda, Germany.
RP Glaser, J (corresponding author), Herz Jesu Krankenhaus Fulda, Dept Internal Med & Gastroenterol, Buttlarstr 74, D-36039 Fulda, Germany.
CR Becker V, 1973, SPEZIELLE PATHOLOGIS
   BOLONDI L, 1984, DIGEST DIS SCI, V29, P802, DOI 10.1007/BF01318422
   BRYAN PJ, 1982, J CLIN ULTRASOUND, V10, P63, DOI 10.1002/jcu.1870100206
   FIKRY ME, 1968, J AM GERIATR SOC, V16, P463, DOI 10.1111/j.1532-5415.1968.tb02827.x
   GLASER J, 1994, INT J PANCREATOL, V15, P195
   GLASER J, 1989, SCAND J GASTROENTERO, V24, P179, DOI 10.3109/00365528909093034
   GLASER J, 1990, DEUT MED WOCHENSCHR, V115, P1361, DOI 10.1055/s-2008-1065166
   HADIDI A, 1983, J CLIN ULTRASOUND, V11, P17, DOI 10.1002/jcu.1870110105
   Kolbel G, 1987, Rofo, V146, P415, DOI 10.1055/s-2008-1048513
   MARKS WM, 1980, RADIOLOGY, V137, P475, DOI 10.1148/radiology.137.2.7433680
   PARULEKAR SG, 1980, J CLIN ULTRASOUND, V8, P457, DOI 10.1002/jcu.1870080603
   ROSENBERG IR, 1966, GASTROENTEROLOGY, V50, P191
   SCHMITZMOORMANN P, 1979, Z GASTROENTEROL, V17, P256
   WORTHEN NJ, 1982, AM J ROENTGENOL, V139, P1095, DOI 10.2214/ajr.139.6.1095
NR 14
TC 64
Z9 78
U1 1
U2 4
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0304-324X
J9 GERONTOLOGY
JI Gerontology
PD MAR-APR
PY 2000
VL 46
IS 2
BP 93
EP 96
DI 10.1159/000022141
PG 4
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 289CC
UT WOS:000085600900007
PM 10671806
DA 2024-02-19
ER

PT J
AU Moorthy, K
   Yadav, UCS
   Siddiqui, MR
   Sharma, D
   Basir, SF
   Baquer, NZ
AF Moorthy, K
   Yadav, UCS
   Siddiqui, MR
   Sharma, D
   Basir, SF
   Baquer, NZ
TI Effect of estradiol and progesterone treatment on carbohydrate
   metabolizing enzymes in tissues of aging female rats
SO BIOGERONTOLOGY
LA English
DT Article
DE aging; carbohydrate metabolism; enzymes; glucose; hormone; replacement
   therapy
ID EARLY ESTROGEN ACTION; GROWTH-FACTOR-I; POSTMENOPAUSAL WOMEN;
   REPLACEMENT THERAPY; INSULIN SENSITIVITY; GLUCOSE-METABOLISM;
   PLASMA-INSULIN; HORMONE; GLUCOSE-6-PHOSPHATASE; SECRETION
AB The aim of this study was to determine the effect of administration of estradiol (E-2), progesterone (P-4), and combination of estradiol and progesterone (EP) in aging female rats. The changes in the activities of hexokinase (HK), glucose-6-phosphatase (G6P'tase) and glucose-6-phosphate dehydrogenase (G6PDH) enzymes, and in protein levels in tissues of rats namely brain ( cerebral hemisphere), heart, liver, kidney and uterus have been measured in different age groups. The random blood sugar level was measured in serum and liver. The different age groups of rats were given 0.1 mug/g body weight estradiol, 2.5 mug/g body weight progesterone and a similar concentration of both in a combined treatment for 1 month. This dose was selected after determining estrogen and progesterone levels in 3 month adult female animals so that the aging female animals had circulating hormone levels nearly the same as those of young female animals. The random sugar level was determined in serum and liver cytosolic fractions, and it was increased by combination treatment. The protein content in tissues showed significant changes only with combined hormone administration when compared with age-matched controls. The activity of HK decreased in aged animals and significantly increased by hormone treatments in all the tissues of the aged rats studied. The activity of G6P'tase increased with age up to 1.5 years and decreased in 2 years. Treatment with E-2 and EP further decreased the activity significantly in all the tissues. G6PDH showed a similar pattern as was observed in HK in all the age groups. Therefore, the E-2 and EP treatments caused an entire series of growth-related responses, including an increased uptake of glucose, increased the protein level in the tissues of aging rats, thereby reducing the risk factors associated with aging by normalizing hormone levels which decreased with aging and resulted in diseases such as Alzheimer's diseases and diabetes.
C1 Jawaharlal Nehru Univ, Sch Life Sci, Hormone & Drug Res Lab, New Delhi 110067, India.
   Jamia Millia Islamia, Dept Biosci, New Delhi 110025, India.
C3 Jawaharlal Nehru University, New Delhi; Jamia Millia Islamia
RP Baquer, NZ (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Hormone & Drug Res Lab, New Delhi 110067, India.
EM nzbaquer@hotmail.com
RI Basir, Seemi Farhat/GOE-4171-2022; Yadav, Umesh/C-7858-2012
CR AJABOR LN, 1972, AM J OBSTET GYNECOL, V113, P383, DOI 10.1016/0002-9378(72)90689-8
   ALKA MK, 2003, ANN INTERN MED, V138, P1
   ARONICA SM, 1994, P NATL ACAD SCI USA, V91, P8517, DOI 10.1073/pnas.91.18.8517
   BAGINSKY ES, 1975, METHOD ENZYMAT AN, V2, P876
   BAILEY CJ, 1972, HORM METAB RES, V4, P266, DOI 10.1055/s-0028-1094063
   BAQUER NZ, 1993, BIOCHEM MOL BIOL INT, V31, P509
   BAQUER NZ, 1972, BIOCHEM BIOPH RES CO, V48, P729, DOI 10.1016/0006-291X(72)90667-5
   BAQUER NZ, 1973, BIOCHEM BIOPH RES CO, V52, P263, DOI 10.1016/0006-291X(73)90982-0
   BELLANTONI MF, 1991, J CLIN ENDOCR METAB, V72, P172, DOI 10.1210/jcem-72-1-172
   BLASS JP, 1980, BIOCH DEMENTIA, P121
   Brown SA, 2003, MED CLIN N AM, V87, P1039, DOI 10.1016/S0025-7125(03)00065-8
   Casper RF, 2000, MATURITAS, V34, P97, DOI 10.1016/S0378-5122(99)00076-6
   CELESTINO G, 2001, J PANE, V2, P140
   COSTRINI NV, 1971, J CLIN INVEST, V50, P992, DOI 10.1172/JCI106593
   DAVIDSON MB, 1987, ENDOCR REV, V8, P115, DOI 10.1210/edrv-8-2-115
   DENA BD, 2001, ENDOCRINOLOGY, V142, P43, DOI DOI 10.1210/EN.142.1.43
   DIXIT A, 1991, BIOCHEM INT, V24, P649
   ECKSTEIN B, 1966, ENDOCRINOLOGY, V78, P409, DOI 10.1210/endo-78-2-409
   Fiske CH, 1925, J BIOL CHEM, V66, P375
   Gamberucci A, 1996, MOL MEMBR BIOL, V13, P103, DOI 10.3109/09687689609160583
   GODSLAND IF, 1992, J CLIN ENDOCR METAB, V74, P64, DOI 10.1210/jc.74.1.64
   GRODSTEIN F, 1995, PROG CARDIOVASC DIS, V38, P192
   Gumma KA, 1972, FEBS LETT, V27, P293
   JAY WP, 1994, NEUROBIOL AGING, V15, P117
   JIMENEZDEASUA L, 1974, NATURE, V251, P624, DOI 10.1038/251624a0
   KAUR G, 1981, J BIOSCIENCE, V3, P125, DOI 10.1007/BF02702654
   Keller JN, 1997, J NEUROSCI RES, V50, P522, DOI 10.1002/(SICI)1097-4547(19971115)50:4<522::AID-JNR3>3.0.CO;2-G
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MARCUS DL, 1989, ANN NEUROL, V26, P91, DOI 10.1002/ana.410260114
   MATUTE ML, 1973, ENDOCRINOLOGY, V92, P762, DOI 10.1210/endo-92-3-762
   MEIERRUGE W, 1984, ARCH GERONTOL GERIAT, V3, P161, DOI 10.1016/0167-4943(84)90007-4
   Migliaccio A, 1996, EMBO J, V15, P1292, DOI 10.1002/j.1460-2075.1996.tb00471.x
   MORLEY P, 1992, ENDOCRINOLOGY, V131, P1305, DOI 10.1210/en.131.3.1305
   MUELLER GC, 1961, P NATL ACAD SCI USA, V47, P164, DOI 10.1073/pnas.47.2.164
   NUUTILA P, 1995, DIABETES, V44, P31, DOI 10.2337/diabetes.44.1.31
   Plewka A, 2000, MECH AGEING DEV, V113, P49, DOI 10.1016/S0047-6374(99)00097-4
   PUAH JA, 1985, ENDOCRINOLOGY, V117, P1336, DOI 10.1210/endo-117-4-1336
   ROY DW, 1999, ENDOCRINOLOGY, V140, P3602, DOI DOI 10.1210/EN.140.8.3602
   SHARMA C, 1963, J BIOL CHEM, V238, P3840
   SMITH CB, 1980, BRAIN, V103, P351, DOI 10.1093/brain/103.2.351
   TERRENCE MD, 1983, BIOCHIM BIOPHYS ACTA, V739, P148
   THOMAS DK, 1986, PHYSIOL BEHAV, V36, P567, DOI 10.1016/0031-9384(86)90332-X
   UI H, 1963, P NATL ACAD SCI USA, V50, P256, DOI 10.1073/pnas.50.2.256
   VALADARES JR, 1968, SCIENCE, V159, P990, DOI 10.1126/science.159.3818.990
   VALDES CT, 1991, J CLIN ENDOCR METAB, V72, P642, DOI 10.1210/jcem-72-3-642
   Wagner JD, 1996, METABOLISM, V45, P1254, DOI 10.1016/S0026-0495(96)90244-9
   WEISSBERGER AJ, 1991, J CLIN ENDOCR METAB, V72, P374, DOI 10.1210/jcem-72-2-374
NR 47
TC 19
Z9 25
U1 0
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD AUG
PY 2004
VL 5
IS 4
BP 249
EP 259
DI 10.1023/B:BGEN.0000038026.89337.02
PG 11
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 846RE
UT WOS:000223332700005
PM 15314275
DA 2024-02-19
ER

PT J
AU SRIVASTAVA, V
   TILLEY, R
   MILLER, S
   HART, R
   BUSBEE, D
AF SRIVASTAVA, V
   TILLEY, R
   MILLER, S
   HART, R
   BUSBEE, D
TI EFFECTS OF AGING AND DIETARY RESTRICTION ON DNA-POLYMERASES -
   GENE-EXPRESSION, ENZYME FIDELITY, AND DNA EXCISION REPAIR
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE DIETARY RESTRICTION; AGING; DNA POLYMERASE; GENE EXPRESSION; ENZYMES;
   DNA REPAIR
ID ALPHA CATALYTIC POLYPEPTIDE; PROTEIN KINASE-C; HUMAN-FIBROBLASTS;
   DECREASED FIDELITY; REGENERATING LIVER; CELL-PROLIFERATION; SYNTHESIS
   INVITRO; ACTIVITY FORM; LIFE-SPAN; REPLICATION
AB Hepatic DNA polymerases isolated from young and old C57BL/6N mice fed ad libitum or calorically restricted differed in chromatographic characteristics, binding affinity for DNA template-primer, specific activity, and fidelity of synthesis. DNA polymerase alpha-total and specific activity declined slightly, while the nucleotide misincorporation frequency increased dramatically, with increased age of the donor animals. A positive correlation was observed between polymerase alpha-specific activity and the affinity of enzyme binding to activated DNA template-primer. Both the age-associated decline in enzyme activity and the decrease in fidelity of synthesis were modified by dietary restriction, with higher specific activity levels and lower misincorporation frequencies for DNA polymerases from dietarily restricted animals compared with ad libitum animals of all ages. Fidelity of both DNA polymerase alpha and beta-increased following treatment with the phosphoinositide hydrolysis product inositol-1,4-bisphoshate. The data suggest that dietary restriction could play an important role in decreasing the age-associated decline in function of physiological systems sensitive to decreased or defective DNA synthesis.
C1 TEXAS A&M UNIV SYST,COLL VET MED,COLL STN,TX 77843.
   NATL CTR TOXICOL RES,JEFFERSON,AR 72079.
C3 Texas A&M University System; Texas A&M University College Station; US
   Food & Drug Administration (FDA)
RP SRIVASTAVA, V (corresponding author), TEXAS A&M UNIV SYST,COLL MED,CTR MOLEC AGING,COLL STN,TX 77843, USA.
FU NIA NIH HHS [AG07739, AG06347] Funding Source: Medline
CR ABBOTTS J, 1984, J BIOL CHEM, V259, P6712
   AGARWAL SS, 1978, J CELL PHYSL, V106, P235
   Barrows C H, 1980, Rev Pure Appl Pharmacol Sci, V1, P293
   BARTON RW, 1974, FED PROC, V33, P1419
   BATTULA N, 1974, J BIOL CHEM, V249, P4086
   BERRIDGE MJ, 1985, SCI AM, V253, P142, DOI 10.1038/scientificamerican1085-142
   BHATTACHARYA P, 1981, P NATL ACAD SCI-BIOL, V78, P2683, DOI 10.1073/pnas.78.5.2683
   Bollum F J, 1975, Prog Nucleic Acid Res Mol Biol, V15, P109, DOI 10.1016/S0079-6603(08)60118-X
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BROWN M, 1981, P NATL ACAD SCI-BIOL, V78, P3049, DOI 10.1073/pnas.78.5.3049
   Burnet M., 1974, INTRINSIC MUTAGENESI
   BUSBEE D, 1987, J NATL CANCER I, V79, P1231
   BYRNES JJ, 1977, BIOCHEMISTRY-US, V16, P3740, DOI 10.1021/bi00636a002
   CAMPBELL JL, 1986, ANNU REV BIOCHEM, V55, P733, DOI 10.1146/annurev.biochem.55.1.733
   CHAN JYH, 1979, P NATL ACAD SCI USA, V76, P814, DOI 10.1073/pnas.76.2.814
   CHEN YC, 1979, J BIOL CHEM, V254, P1678
   CONAWAY RC, 1982, P NATL ACAD SCI-BIOL, V79, P2523, DOI 10.1073/pnas.79.8.2523
   COTTERILL SM, 1987, EUKARYOTIC REPLICATI, P147
   CRAIG RK, 1975, BIOCHEM J, V145, P225, DOI 10.1042/bj1450225
   CRISTOFALO VJ, 1973, EXP CELL RES, V76, P419, DOI 10.1016/0014-4827(73)90394-7
   CUTLER RG, 1975, EXP GERONTOL, V10, P7
   DANSE JM, 1981, FEBS LETT, V124, P84, DOI 10.1016/0014-5793(81)80059-2
   DELFINI C, 1985, P NATL ACAD SCI USA, V82, P2220, DOI 10.1073/pnas.82.8.2220
   DOWNEY KM, 1990, BIOESSAYS, V12, P231, DOI 10.1002/bies.950120507
   FERSHT AR, 1983, J MOL BIOL, V165, P663
   FERSHT AR, 1979, P NATL ACAD SCI USA, V76, P4996
   FICHOT O, 1979, BIOCHIM BIOPHYS ACTA, V561, P29, DOI 10.1016/0005-2787(79)90487-8
   FISHER PA, 1981, BIOCHEMISTRY-US, V20, P4560, DOI 10.1021/bi00519a008
   FOSTER DN, 1976, J BIOL CHEM, V251, P7893
   FRY M, 1976, BIOCHEMISTRY-US, V15, P4319, DOI 10.1021/bi00664a028
   FRY M, 1984, J CELL PHYSIOL, V118, P225, DOI 10.1002/jcp.1041180302
   FRY M, 1986, ANIMAL CELL DNA POLY
   FULDER SJ, 1975, CELL, V6, P67, DOI 10.1016/0092-8674(75)90075-6
   GILLIN FD, 1976, J BIOL CHEM, V251, P5225
   GROSS F, 1987, EUKARYOTIC REPLICATI, P151
   GROSS L, 1990, P NATL ACAD SCI USA, V87, P6795, DOI 10.1073/pnas.87.17.6795
   HARLEY CB, 1980, P NATL ACAD SCI-BIOL, V77, P1885, DOI 10.1073/pnas.77.4.1885
   HART RW, 1976, MECH AGEING DEV, V5, P67, DOI 10.1016/0047-6374(76)90009-9
   HESSLEWOOD IP, 1978, EUR J BIOCHEM, V84, P123, DOI 10.1111/j.1432-1033.1978.tb12148.x
   HOLLIDAY R, 1981, J THEOR BIOL, V93, P627, DOI 10.1016/0022-5193(81)90225-3
   HOLMES AM, 1976, EUR J BIOCHEM, V62, P229, DOI 10.1111/j.1432-1033.1976.tb10152.x
   HSI KL, 1990, NUCLEIC ACIDS RES, V18, P6231, DOI 10.1093/nar/18.21.6231
   HUBSCHER U, 1983, EXPERIENTIA, V39, P1
   HUBSCHER U, 1983, EMBO J, V2, P133, DOI 10.1002/j.1460-2075.1983.tb01394.x
   KARAWYA E, 1984, P NATL ACAD SCI-BIOL, V81, P7777, DOI 10.1073/pnas.81.24.7777
   KEYSE SM, 1985, MUTAT RES, V146, P109, DOI 10.1016/0167-8817(85)90061-6
   KIRKWOOD TBL, 1980, J THEOR BIOL, V82, P363, DOI 10.1016/0022-5193(80)90243-X
   KRAUSS SW, 1987, J BIOL CHEM, V262, P3432
   KRAUSS SW, 1986, J CELL PHYSIOL, V126, P99, DOI 10.1002/jcp.1041260114
   KRAUSS SW, 1980, BIOCHEMISTRY-US, V19, P220, DOI 10.1021/bi00542a033
   KUNKEL TA, 1979, P NATL ACAD SCI USA, V76, P6331, DOI 10.1073/pnas.76.12.6331
   KUNKEL TA, 1981, SCIENCE, V213, P765, DOI 10.1126/science.6454965
   LAKS MS, 1980, BIOCHEM BIOPH RES CO, V96, P697, DOI 10.1016/0006-291X(80)91411-4
   LINDELL TJ, 1982, MECH AGEING DEV, V19, P63, DOI 10.1016/0047-6374(82)90051-3
   LINN S, 1976, P NATL ACAD SCI USA, V73, P2818, DOI 10.1073/pnas.73.8.2818
   LOEB LA, 1986, PROG NUCLEIC ACID RE, V33, P57, DOI 10.1016/S0079-6603(08)60020-3
   LOEB LA, 1974, ENZYMES, V10, P173
   LOEB LA, 1982, ANNU REV BIOCHEM, V52, P429
   MAJERUS PW, 1986, SCIENCE, V234, P1519, DOI 10.1126/science.3024320
   MECHALI M, 1983, NEW APPROACHES EUKAR
   MURRAY V, 1981, J MOL BIOL, V146, P55, DOI 10.1016/0022-2836(81)90366-1
   MURRAY V, 1981, MECH AGEING DEV, V16, P327, DOI 10.1016/0047-6374(81)90017-8
   NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651
   NOGUCHI H, 1983, CELL, V32, P443, DOI 10.1016/0092-8674(83)90464-6
   ORGEL LE, 1970, P NATL ACAD SCI USA, V67, P1476, DOI 10.1073/pnas.67.3.1476
   ORGEL LE, 1963, P NATL ACAD SCI USA, V49, P517, DOI 10.1073/pnas.49.4.517
   OTTIGER HP, 1984, P NATL ACAD SCI-BIOL, V81, P3993, DOI 10.1073/pnas.81.13.3993
   PRITCHARD CG, 1983, J BIOL CHEM, V258, P9801
   RICHARDSON A, 1982, LIFE SCI, V31, P605, DOI 10.1016/0024-3205(82)90761-5
   SCHONHERR OT, 1977, BIOCHIM BIOPHYS ACTA, V232, P83
   SHELDRAKE AR, 1974, NATURE, V250, P381, DOI 10.1038/250381a0
   SHOCK NW, 1970, J AM DIET ASSOC, V56, P491
   SILBER JR, 1985, J BIOL CHEM, V260, P1304
   SIROVER MA, 1976, SCIENCE, V194, P1434, DOI 10.1126/science.1006310
   SLOAN DL, 1975, J BIOL CHEM, V250, P8913
   SO AG, 1988, BIOCHEMISTRY-US, V27, P4591, DOI 10.1021/bi00413a001
   SRIVASTAVA VK, 1991, EXP GERONTOL, V26, P453, DOI 10.1016/0531-5565(91)90034-J
   SYLVIA V, 1988, CELL, V54, P651, DOI 10.1016/S0092-8674(88)80009-6
   SYLVIA VL, 1989, INT J BIOCHEM, V21, P347, DOI 10.1016/0020-711X(89)90357-1
   SZILARD L, 1959, P NATL ACAD SCI USA, V45, P30, DOI 10.1073/pnas.45.1.30
   TANABE K, 1976, J BIOCHEM-TOKYO, V79, P85, DOI 10.1093/oxfordjournals.jbchem.a131061
   WAHL AF, 1988, MOL CELL BIOL, V8, P5016, DOI 10.1128/MCB.8.11.5016
   WANG TSF, 1989, FASEB J, V3, P14, DOI 10.1096/fasebj.3.1.2642867
   WANG TSF, 1982, BIOCHEMISTRY-US, V21, P1597, DOI 10.1021/bi00536a021
   WANG TSF, 1980, BIOCHEMISTRY-US, V19, P1792
   WEINDRUCH R, 1982, SCIENCE, V215, P1415, DOI 10.1126/science.7063854
   WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641
   WEINDRUCH R, 1988, RETARDATION AGING DI
   WONG SW, 1988, EMBO J, V7, P37, DOI 10.1002/j.1460-2075.1988.tb02781.x
   YAGURA T, 1982, J BIOCHEM-TOKYO, V91, P607, DOI 10.1093/oxfordjournals.jbchem.a133732
   YU BP, 1982, J GERONTOL, V37, P130, DOI 10.1093/geronj/37.2.130
   ZHANG SJ, 1987, ARCH BIOCHEM BIOPHYS, V252, P24, DOI 10.1016/0003-9861(87)90004-X
NR 92
TC 14
Z9 14
U1 1
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0531-5565
J9 EXP GERONTOL
JI Exp. Gerontol.
PD SEP-DEC
PY 1992
VL 27
IS 5-6
BP 593
EP 613
DI 10.1016/0531-5565(92)90014-Q
PG 21
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA JP128
UT WOS:A1992JP12800014
PM 1426092
DA 2024-02-19
ER

PT J
AU López-Navarro, ME
   Jarquín-Martínez, M
   Sánchez-Labastida, LA
   Ramírez-Rosales, D
   Godínez-Victoria, M
   Quintas-Granados, LI
   Trujillo-Ferrara, JG
AF Lopez-Navarro, Maria E.
   Jarquin-Martinez, Mariana
   Sanchez-Labastida, Luis A.
   Ramirez-Rosales, Daniel
   Godinez-Victoria, Marycarmen
   Quintas-Granados, Laura Itzel
   Trujillo-Ferrara, Jose Guadalupe
TI Decoding Aging: Understanding the Complex Relationship among Aging, Free
   Radicals, and GSH
SO OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
LA English
DT Article
ID RAT EMBRYOS; GLUTATHIONE
AB N-aryl maleimides can undergo a 1,4-Michael-type addition reaction with reduced glutathione (GSH), leading to a decreased concentration of GSH and an increased concentration of free radicals (FRs) in cells. GSH is a critical scavenging molecule responsible for protecting cells from oxidation and for maintaining redox homeostasis. N-aryl maleimides disturb redox homeostasis in cells because they scavenge thiol-containing molecules, especially GSH. This study aimed at measuring the concentrations of GSH and FRs by electronic paramagnetic resonance (EPR), in the brain and liver tissue of male Wistar rats (ex vivo) at different ages and after treatment with 3,5-dimaleimylbenzoic acid (3,5-DMB). Our results showed a relationship between age and the concentrations of GSH and FRs in cells. In young rats, the concentration of GSH was higher than in old rats, while the concentration of FRs was higher in adult rats than in young rats, suggesting an inverse relationship between GSH and FRs. On the other hand, the reaction of 3,5-DMB (an electrophilic maleimide) with cellular GSH increased the FR content. The results of this study contribute to the awareness that the process of aging implies not only a loss of tissue function but also essential changes in the molecular contents of cells, especially the concentrations of FRs and GSH.
C1 [Lopez-Navarro, Maria E.; Jarquin-Martinez, Mariana; Sanchez-Labastida, Luis A.; Godinez-Victoria, Marycarmen; Trujillo-Ferrara, Jose Guadalupe] Inst Politecn Nacl, Escuela Super Med, Dept Bioquim, Plan San Luis y Salvador Diaz Miron S-N, Mexico City 11340, DF, Mexico.
   [Lopez-Navarro, Maria E.; Jarquin-Martinez, Mariana; Sanchez-Labastida, Luis A.; Godinez-Victoria, Marycarmen; Trujillo-Ferrara, Jose Guadalupe] Inst Politecn Nacl, Escuela Super Med, Secc Estudios Posgrad & Invest, Plan San Luis y Salvador Diaz Miron S-N, Mexico City 11340, DF, Mexico.
   [Ramirez-Rosales, Daniel] Inst Politecn Nacl, ESFM, Ave Inst Politecn Nacl S-N,Edif 9 UP Zacatenco, Mexico City 07738, DF, Mexico.
   [Quintas-Granados, Laura Itzel] Univ Mexiquense Bicentenario, Unidad Estudios Super Tultitlan, Ave Ex Hacienda Portales S-N, Tultitlan 54910, Estado De Mexic, Mexico.
C3 Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional
   - Mexico; Instituto Politecnico Nacional - Mexico
RP Trujillo-Ferrara, JG (corresponding author), Inst Politecn Nacl, Escuela Super Med, Dept Bioquim, Plan San Luis y Salvador Diaz Miron S-N, Mexico City 11340, DF, Mexico.; Trujillo-Ferrara, JG (corresponding author), Inst Politecn Nacl, Escuela Super Med, Secc Estudios Posgrad & Invest, Plan San Luis y Salvador Diaz Miron S-N, Mexico City 11340, DF, Mexico.; Quintas-Granados, LI (corresponding author), Univ Mexiquense Bicentenario, Unidad Estudios Super Tultitlan, Ave Ex Hacienda Portales S-N, Tultitlan 54910, Estado De Mexic, Mexico.
EM elinorelo@gmail.com; majajarquin@gmail.com; lsanchezl1404@alumno.ipn.mx;
   rosales@esfm.ipn.mx; maric_27@yahoo.com; litquingra@gmail.com;
   jtrujillo@ipn.mx
RI Godínez-Victoria, Marycarmen/AFQ-2983-2022; Quintas-Granados, Laura
   Itzel/GSM-8815-2022
OI Quintas-Granados, Laura Itzel/0000-0002-8622-2004; JARQUIN MARTINEZ,
   MARIANA/0000-0002-5807-311X; Godinez-Victoria,
   Marycarmen/0000-0003-3317-7980
FU CONACYT; Instituto Politecnico Nacional (Mexico); SIP; COFAA
FX This research received financial support from CONACYT, SIP, COFAA, and
   the Instituto Politecnico Nacional (Mexico). J. G. Trujillo-Ferrara is
   EDI-IPN, COFAA, and SNI-CONACYT fellow.
CR Andrade-Jorge E, 2016, ANTI-CANCER AGENT ME, V16, P1615, DOI 10.2174/1871520615666160504094417
   Baltaci SB, 2016, BIOMED REP, V5, P525, DOI 10.3892/br.2016.777
   Blomgren K, 2006, FREE RADICAL BIO MED, V40, P388, DOI 10.1016/j.freeradbiomed.2005.08.040
   CARRASCOTORRES G, 2017, OXID MED CELL LONGEV, V2017, DOI DOI 10.1155/2017/2734976
   Elajaili HB, 2019, JOVE-J VIS EXP, DOI 10.3791/58461
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   Erecinska M, 2004, PROG NEUROBIOL, V73, P397, DOI 10.1016/j.pneurobio.2004.06.003
   HARRIS C, 1987, TOXICOL APPL PHARM, V88, P141, DOI 10.1016/0041-008X(87)90278-X
   Holmström KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801
   Hosseinzadeh R, 2018, J BIOMOL STRUCT DYN, V36, P2216, DOI 10.1080/07391102.2017.1345698
   Jiang M, 2020, BIORESOURCES, V15, P1384, DOI 10.15376/biores.15.1.1384-1396
   LoPachin RM, 2019, TOXICOLOGY, V418, P62, DOI 10.1016/j.tox.2019.02.005
   MACHLIN LJ, 1987, FASEB J, V1, P441, DOI 10.1096/fasebj.1.6.3315807
   MCNUTT TL, 1994, REPROD TOXICOL, V8, P351, DOI 10.1016/0890-6238(94)90051-5
   Phaniendra A, 2015, INDIAN J CLIN BIOCHE, V30, P11, DOI 10.1007/s12291-014-0446-0
   Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432
   Schwöbel JAH, 2010, CHEM RES TOXICOL, V23, P1576, DOI 10.1021/tx100172x
   Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624
   Shih H, 2011, J AM COLL CARDIOL, V57, P9, DOI 10.1016/j.jacc.2010.08.623
   Sies H., 1985, INTRO REMARKS, P1
   Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X
   Trujillo-Ferrara J, 1999, MAGN RESON CHEM, V37, P682, DOI 10.1002/(SICI)1097-458X(199909)37:9<682::AID-MRC500>3.0.CO;2-#
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Weil J. A., 1994, ELECT PARARNAGNETIC
NR 24
TC 10
Z9 10
U1 0
U2 4
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1942-0900
EI 1942-0994
J9 OXID MED CELL LONGEV
JI Oxidative Med. Cell. Longev.
PD OCT 13
PY 2020
VL 2020
AR 3970860
DI 10.1155/2020/3970860
PG 11
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA OQ0BR
UT WOS:000588458300002
PM 33110472
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Xiao, YM
   Word, B
   Starlard-Davenport, A
   Haefele, A
   Lyn-Cook, BD
   Hammons, G
AF Xiao, Yongmei
   Word, Beverly
   Starlard-Davenport, Atena
   Haefele, Aaron
   Lyn-Cook, Beverly D.
   Hammons, George
TI Age and gender affect DNMT3a and DNMT3b expression in human liver
SO CELL BIOLOGY AND TOXICOLOGY
LA English
DT Article
DE ageing; DNMT3a; DNMT3b; gender; human liver
ID METHYLTRANSFERASE GENE-EXPRESSION; CPG ISLAND HYPERMETHYLATION; DE-NOVO
   METHYLATION; DNA-METHYLTRANSFERASE; TUMOR-SUPPRESSOR; MAINTENANCE;
   INHIBITION; SP1; 5-AZA-2'-DEOXYCYTIDINE; TRANSFORMATION
AB DNA methylation is catalyzed by a family of DNA methyltransferases (DNMTs) including the maintenance enzyme DNMT 1 and de novo methyltransferases DNMT 3a and DNMT 3b. Elevated levels of DNMTs have been found in cancer cells and in several types of human tumors. A polymorphism found in DNMT3b has been associated with increased risk for several cancers. The factors influencing DNMT expression in human tissues have not been clearly determined. he present study examined TDNMT3a and DNMT3b levels in human liver tissue samples and compared the effect of ageing, cigarette smoking, and gender. DNMT3a and DNMT3b expression levels in the samples from older individuals (56-78 years, n = 28) were both significantly higher than those of the younger group (16-48 years, n = 27) (73.2 +/- 3.4 vs 8.3 +/- 2.8 and 56.1 +/- 1.9 vs 17.5 +/- 5.7, respectively; p < 0.05). Levels of DNMT3b in females were significantly higher than those in males (75.4 +/- 2.2 vs 16.3 +/- 4.7; p < 0.05); however, DNMT3a levels were similar for females and males (52.7 +/- 2.7 vs 48.4 +/- 2.0). Expression levels of DNMT3a and DNMT3b were similar in smokers and nonsmokers (58.1 +/- 3.5 vs 60.8 +/- 3.1 and 54.5 +/- 2.3 vs 48.3 +/- 1.8, respectively). Genotyping for DNMT3b (C -> T) variant in this sample pool showed a frequency distribution of CC (41%), CT (50%), and TT (9%). The findings from this study suggest that ageing and gender may be important factors influencing DNA methylation status.
C1 [Hammons, George] Natl Ctr Toxicol Res, Jefferson, AR 72079 USA.
   [Xiao, Yongmei; Word, Beverly; Starlard-Davenport, Atena; Haefele, Aaron; Lyn-Cook, Beverly D.; Hammons, George] Natl Ctr Toxicol Res, Div Personalized Nutr & Med, Jefferson, AR 72079 USA.
C3 US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)
RP Hammons, G (corresponding author), Natl Ctr Toxicol Res, HFT-100, Jefferson, AR 72079 USA.
EM ghammons@nctr.fda.gov
RI Starlard-Davenport, Athena/Q-3866-2017
OI Starlard-Davenport, Athena/0000-0002-8938-237X
CR Abdelrahim M, 2002, J BIOL CHEM, V277, P28815, DOI 10.1074/jbc.M203828200
   [Anonymous], 1994, Basic and clinical biostatistics
   Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200
   Bakin AV, 1999, SCIENCE, V283, P387, DOI 10.1126/science.283.5400.387
   Belinsky SA, 1996, P NATL ACAD SCI USA, V93, P4045, DOI 10.1073/pnas.93.9.4045
   Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395
   Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102
   Boivin AJ, 2002, ANTI-CANCER DRUG, V13, P869, DOI 10.1097/00001813-200209000-00013
   Casillas MA, 2003, MOL CELL BIOCHEM, V252, P33, DOI 10.1023/A:1025548623524
   Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996
   Cui X, 2006, HUM PATHOL, V37, P298, DOI 10.1016/j.humpath.2005.10.013
   Egger G, 2007, CANCER RES, V67, P346, DOI 10.1158/0008-5472.CAN-06-2845
   Eng C, 2000, NAT GENET, V24, P101, DOI 10.1038/72730
   Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600
   Estève PO, 2005, P NATL ACAD SCI USA, V102, P1000, DOI 10.1073/pnas.0407729102
   Fiala ES, 1998, CARCINOGENESIS, V19, P597, DOI 10.1093/carcin/19.4.597
   Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536
   Hammons GJ, 1999, CELL BIOL TOXICOL, V15, P389, DOI 10.1023/A:1007658000971
   Jinawath A, 2005, BIOCHEM J, V385, P557, DOI 10.1042/BJ20040684
   Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816
   Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852
   JUE K, 1995, BIOL REPROD, V52, P1364, DOI 10.1095/biolreprod52.6.1364
   Kim YI, 2004, CANCER EPIDEM BIOMAR, V13, P511
   Kishikawa S, 2002, EUR J BIOCHEM, V269, P2961, DOI 10.1046/j.1432-1033.2002.02972.x
   Laird PW, 1996, ANNU REV GENET, V30, P441, DOI 10.1146/annurev.genet.30.1.441
   LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F
   LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0
   Liang GG, 2002, MOL CELL BIOL, V22, P480, DOI 10.1128/MCB.22.2.480-491.2002
   Lopatina N, 2002, J CELL BIOCHEM, V84, P324, DOI 10.1002/jcb.10015
   MACLEOD AR, 1995, J BIOL CHEM, V270, P11327, DOI 10.1074/jbc.270.19.11327
   Nagai M, 2003, HEPATOL RES, V26, P186, DOI 10.1016/S1386-6346(03)00091-3
   Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5
   Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890
   Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6
   Oue N, 2001, ONCOL REP, V8, P1085
   Pradhan S, 1999, J BIOL CHEM, V274, P33002, DOI 10.1074/jbc.274.46.33002
   Raiche J, 2004, BIOCHEM BIOPH RES CO, V325, P39, DOI 10.1016/j.bbrc.2004.10.002
   REDDY PMS, 1988, BIOCHEM INT, V16, P543
   Reu FJ, 2006, CANCER RES, V66, P2785, DOI 10.1158/0008-5472.CAN-05-2303
   Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a
   Richardson B, 2003, AGEING RES REV, V2, P245, DOI 10.1016/S1568-1637(03)00010-2
   Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291
   ROULEAU J, 1995, J BIOL CHEM, V270, P1595, DOI 10.1074/jbc.270.4.1595
   Saito Y, 2003, INT J CANCER, V105, P527, DOI 10.1002/ijc.11127
   Shen HB, 2002, CANCER RES, V62, P4992
   Slack A, 1999, EUR J BIOCHEM, V264, P191, DOI 10.1046/j.1432-1327.1999.00603.x
   Slack A, 1999, J BIOL CHEM, V274, P10105, DOI 10.1074/jbc.274.15.10105
   STEWART CL, 1982, P NATL ACAD SCI-BIOL, V79, P4098, DOI 10.1073/pnas.79.13.4098
   Sun JM, 2005, EXP CELL RES, V302, P96, DOI 10.1016/j.yexcr.2004.08.015
   Sun L, 1997, JPN J CANCER RES, V88, P1165, DOI 10.1111/j.1349-7006.1997.tb00345.x
   SZYF M, 1994, TRENDS PHARMACOL SCI, V15, P233, DOI 10.1016/0165-6147(94)90317-4
   Tsai CL, 2006, CANCER RES, V66, P11668, DOI 10.1158/0008-5472.CAN-06-2194
   VERTINO PM, 1994, CELL GROWTH DIFFER, V5, P1395
   Vertino PM, 1996, MOL CELL BIOL, V16, P4555, DOI 10.1128/mcb.16.8.4555
   Wang L, 2004, INT J ONCOL, V25, P993
   Wang R, 2006, J NEUROCHEM, V99, P1543, DOI 10.1111/j.1471-4159.2006.04201.x
   Xie SP, 1999, GENE, V236, P87, DOI 10.1016/S0378-1119(99)00252-8
   Xiong YN, 2005, GYNECOL ONCOL, V96, P601, DOI 10.1016/j.ygyno.2004.11.047
NR 58
TC 45
Z9 53
U1 1
U2 9
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0742-2091
EI 1573-6822
J9 CELL BIOL TOXICOL
JI Cell Biol. Toxicol.
PD JUN
PY 2008
VL 24
IS 3
BP 265
EP 272
DI 10.1007/s10565-007-9035-9
PG 8
WC Cell Biology; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Toxicology
GA 291IO
UT WOS:000255190400007
PM 17929180
DA 2024-02-19
ER

PT J
AU Mitchell, SJ
   Madrigal-Matute, J
   Scheibye-Knudsen, M
   Fang, E
   Aon, M
   González-Reyes, JA
   Cortassa, S
   Kaushik, S
   Gonzalez-Freire, M
   Patel, B
   Wahl, D
   Ali, A
   Calvo-Rubio, M
   Burón, MI
   Guiterrez, V
   Ward, TM
   Palacios, HH
   Cai, H
   Frederick, DW
   Hine, C
   Broeskamp, F
   Habering, L
   Dawson, J
   Beasley, TM
   Wan, JX
   Ikeno, Y
   Hubbard, G
   Becker, KG
   Zhang, YQ
   Bohr, VA
   Longo, DL
   Navas, P
   Ferrucci, L
   Sinclair, DA
   Cohen, P
   Egan, JM
   Mitchell, JR
   Baur, JA
   Allison, DB
   Anson, RM
   Villalba, JM
   Madeo, F
   Cuervo, AM
   Pearson, KJ
   Ingram, DK
   Bernier, M
   de Cabo, R
AF Mitchell, Sarah J.
   Madrigal-Matute, Julio
   Scheibye-Knudsen, Morten
   Fang, Evandro
   Aon, Miguel
   Gonzalez-Reyes, Jose A.
   Cortassa, Sonia
   Kaushik, Susmita
   Gonzalez-Freire, Marta
   Patel, Bindi
   Wahl, Devin
   Ali, Ahmed
   Calvo-Rubio, Miguel
   Buron, Maria I.
   Guiterrez, Vincent
   Ward, Theresa M.
   Palacios, Hector H.
   Cai, Huan
   Frederick, David W.
   Hine, Christopher
   Broeskamp, Filomena
   Habering, Lukas
   Dawson, John
   Beasley, T. Mark
   Wan, Junxiang
   Ikeno, Yuji
   Hubbard, Gene
   Becker, Kevin G.
   Zhang, Yongqing
   Bohr, Vilhelm A.
   Longo, Dan L.
   Navas, Placido
   Ferrucci, Luigi
   Sinclair, David A.
   Cohen, Pinchas
   Egan, Josephine M.
   Mitchell, James R.
   Baur, Joseph A.
   Allison, David B.
   Anson, R. Michael
   Villalba, Jose M.
   Madeo, Frank
   Cuervo, Ana Maria
   Pearson, Kevin J.
   Ingram, Donald K.
   Bernier, Michel
   de Cabo, Rafael
TI Effects of Sex, Strain, and Energy Intake on Hallmarks of Aging in Mice
SO CELL METABOLISM
LA English
DT Article
ID EXTENDS LIFE-SPAN; CHAPERONE-MEDIATED AUTOPHAGY; SHORT-TERM CALORIE;
   BODY-MASS INDEX; DIETARY RESTRICTION; NORDIHYDROGUAIARETIC ACID;
   MITOCHONDRIAL BIOGENESIS; INSULIN SENSITIVITY; PROTEIN RESTRICTION;
   OXIDATIVE STRESS
AB Calorie restriction (CR) is the most robust non-genetic intervention to delay aging. However, there are a number of emerging experimental variables that alter CR responses. We investigated the role of sex, strain, and level of CR on health and survival in mice. CR did not always correlate with lifespan extension, although it consistently improved health across strains and sexes. Transcriptional and metabolomics changes driven by CR in liver indicated anaplerotic filling of the Krebs cycle together with fatty acid fueling of mitochondria. CR prevented ageassociated decline in the liver proteostasis network while increasing mitochondrial number, preserving mitochondrial ultrastructure and function with age. Abrogation of mitochondrial function negated life-prolonging effects of CR in yeast and worms. Our data illustrate the complexity of CR in the context of aging, with a clear separation of outcomes related to health and survival, highlighting complexities of translation of CR into human interventions.
C1 [Mitchell, Sarah J.; Scheibye-Knudsen, Morten; Gonzalez-Freire, Marta; Wahl, Devin; Ali, Ahmed; Guiterrez, Vincent; Ward, Theresa M.; Palacios, Hector H.; Ferrucci, Luigi; Anson, R. Michael; Pearson, Kevin J.; Bernier, Michel; de Cabo, Rafael] NIA, Translat Gerontol Branch, Intramural Res Program, NIH, 251 Bayview Blvd,Suite 100, Baltimore, MD 21224 USA.
   [Madrigal-Matute, Julio; Kaushik, Susmita; Patel, Bindi; Cuervo, Ana Maria] Albert Einstein Coll Med, Inst Aging Studies, Dept Dev & Mol Biol, Bronx, NY 10461 USA.
   [Scheibye-Knudsen, Morten; Fang, Evandro; Bohr, Vilhelm A.] NIA, Lab Mol Gerontol, Intramural Res Program, NIH, 251 Bayview Blvd,Suite 100, Baltimore, MD 21224 USA.
   [Scheibye-Knudsen, Morten] Univ Copenhagen, Dept Cellular & Mol Med, Ctr Hlth Aging, DK-2200 Copenhagen, Denmark.
   [Aon, Miguel; Cortassa, Sonia] NIA, Lab Cardiovasc Sci, Intramural Res Program, NIH, 251 Bayview Blvd,Suite 100, Baltimore, MD 21224 USA.
   [Gonzalez-Reyes, Jose A.; Calvo-Rubio, Miguel; Buron, Maria I.; Villalba, Jose M.] Univ Cordoba, Dept Cell Biol Physiol & Immunol, Agrifood Campus Int Excellence,CeiA3, E-14071 Cordoba, Spain.
   [Cai, Huan; Egan, Josephine M.] NIA, Lab Clin Invest, Intramural Res Program, NIH, 251 Bayview Blvd,Suite 100, Baltimore, MD 21224 USA.
   [Frederick, David W.; Baur, Joseph A.] Univ Penn, Dept Physiol, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA.
   [Hine, Christopher; Mitchell, James R.] Harvard Univ, Dept Genet & Complex Dis, Boston, MA 02115 USA.
   [Broeskamp, Filomena; Habering, Lukas; Madeo, Frank] Graz Univ, NAWI Graz, Inst Mol Biosci, A-8010 Graz, Austria.
   [Broeskamp, Filomena; Habering, Lukas; Madeo, Frank] BioTechMed Graz, A-8010 Graz, Austria.
   [Dawson, John; Beasley, T. Mark; Allison, David B.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA.
   [Dawson, John; Beasley, T. Mark; Allison, David B.] Birmingham Atlanta Vet Adm Hosp, GRECC, Birmingham, AL 35294 USA.
   [Wan, Junxiang; Cohen, Pinchas] Univ So Calif, Leonard Davis Sch Gerontol, Los Angeles, CA 90089 USA.
   [Ikeno, Yuji; Hubbard, Gene] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78245 USA.
   [Becker, Kevin G.; Zhang, Yongqing; Longo, Dan L.] NIA, Lab Genet, Intramural Res Program, NIH, 251 Bayview Blvd,Suite 100, Baltimore, MD 21224 USA.
   [Navas, Placido] Univ Pablo de Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Seville 41013, Spain.
   [Navas, Placido] Univ Pablo de Olavide, CIBERER, Inst Salud Carlos III, Seville 41013, Spain.
   [Sinclair, David A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.
   [Pearson, Kevin J.] Univ Kentucky, Grad Ctr Nutr Sci, CT Wethington Bldg,Room 591,900 South Limestone, Lexington, KY 40536 USA.
   [Ingram, Donald K.] Pennington Biomed Res Ctr, Baton Rouge, LA 70809 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute on
   Aging (NIA); Yeshiva University; Albert Einstein College of Medicine;
   National Institutes of Health (NIH) - USA; NIH National Institute on
   Aging (NIA); University of Copenhagen; National Institutes of Health
   (NIH) - USA; NIH National Institute on Aging (NIA); Universidad de
   Cordoba; National Institutes of Health (NIH) - USA; NIH National
   Institute on Aging (NIA); University of Pennsylvania; Harvard
   University; University of Graz; University of Alabama System; University
   of Alabama Birmingham; Geriatric Research Education & Clinical Center;
   University of Southern California; University of Texas System;
   University of Texas Health Science Center at San Antonio; National
   Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA);
   Consejo Superior de Investigaciones Cientificas (CSIC); Universidad
   Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology
   (CABD); Universidad Pablo de Olavide; CIBER - Centro de Investigacion
   Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Harvard
   University; Harvard Medical School; University of Kentucky; Louisiana
   State University System; Louisiana State University; Pennington
   Biomedical Research Center
RP de Cabo, R (corresponding author), NIA, Translat Gerontol Branch, Intramural Res Program, NIH, 251 Bayview Blvd,Suite 100, Baltimore, MD 21224 USA.
EM decabora@mail.nih.gov
RI Beasley, Mark/AAG-6173-2019; Dawson, John/HDM-6702-2022; Bernier,
   Michel/AAO-3983-2021; Longo, Dan L./F-6022-2011; Cortassa,
   Sonia/AAO-1633-2020; Gonzalez-Freire, Marta/ABG-1197-2020; Bohr,
   Vilhelm/AAP-5931-2020; de Cabo, Rafael Carlos/E-7996-2010; Kaushik,
   Susmita/GVS-3186-2022; Barrera, Miguel Calvo-Rubio/G-8790-2015; Fang,
   Evandro Fei/AAV-4653-2020; Fang, Evandro Fei/AAC-5511-2019; Aon, Miguel
   Antonio/A-6564-2008; González-Reyes, José A/K-1367-2014; Wahl,
   Devin/R-9621-2018; NAVAS, PLACIDO/R-5943-2019; Bernier,
   Michel/Y-7139-2019
OI Bernier, Michel/0000-0002-5948-368X; Cortassa,
   Sonia/0000-0001-7224-9858; de Cabo, Rafael Carlos/0000-0003-2830-5693;
   Kaushik, Susmita/0000-0002-6096-5387; Aon, Miguel
   Antonio/0000-0002-4355-5431; González-Reyes, José A/0000-0003-1918-5490;
   Wahl, Devin/0000-0003-2794-0185; NAVAS, PLACIDO/0000-0002-4115-7966;
   Madeo, Frank/0000-0002-5070-1329; Broeskamp,
   Filomena/0000-0002-6955-3901; Fang, Evandro Fei/0000-0003-0355-7202;
   Madrigal-Matute, Julio/0000-0002-0894-5450; Villalba Montoro, Jose
   Manuel/0000-0001-8554-3802; Anson, Robert/0000-0002-7913-3644; Hine,
   Christopher/0000-0003-1926-7939; Cuervo, Ana Maria/0000-0002-0771-700X;
   Gonzalez-Freire, Marta/0000-0001-9741-2826; Calvo-Rubio Barrera,
   Miguel/0000-0003-3760-4118; Sinclair, David/0000-0002-9936-436X;
   Scheibye-Knudsen, Morten/0000-0002-6637-1280
FU Intramural Research Program of the National Institute on Aging, NIH; NIH
   [R01 AG043483, R01 DK098656, AG031782, 1P01AG034906, 1R01GM090311,
   1R01ES 020812]; Proteostasis of Aging Core [AG038072]; American Diabetes
   Association [1-15-MI-03]; FWF [I1000, P27893, P29203, P24381-B20]; BMWFW
   [80.109/0001-WF/V/3b/2015]; Spanish Ministerio de Economia y
   Competitividad [BFU2011-23578, BFU2015-64630-R]; Austrian Science Fund
   (FWF) [P29203] Funding Source: Austrian Science Fund (FWF)
FX This work was supported in part by the Intramural Research Program of
   the National Institute on Aging, NIH, and by NIH grants R01 AG043483 and
   R01 DK098656 (J.A.B.), NIH grant AG031782 (A.M.C.), and the Proteostasis
   of Aging Core AG038072 (A.M.C.). J.M.M. was supported by a postdoctoral
   fellowship from the American Diabetes Association, grant 1-15-MI-03.
   P.C. was supported by NIH grants (1P01AG034906, 1R01GM090311, and 1R01ES
   020812). F.M. is grateful to the FWF for grants LIPOTOX, I1000, P27893,
   P29203, and P24381-B20 and the BMWFW for grants "Unconventional
   Research" and "Flysleep" (80.109/0001-WF/V/3b/2015). J.M.V. was
   supported by the Spanish Ministerio de Economia y Competitividad (grants
   BFU2011-23578 and BFU2015-64630-R). The authors thank the personnel from
   the Servicio Centralizado de Apoyo a la Investigacion (SCAI; University
   of Cordoba) for technical support. Special thanks to the members of the
   Translational Gerontology Branch and the Comparative Medicine Section of
   the National Institute on Aging. In particular we acknowledge Paul
   Bastian, Elin Lehrmann, Frances Fan, Robin Minor, Dawn Nines, and Dawn
   Boyer.
CR Abu-Bakar A, 2007, DRUG METAB DISPOS, V35, P787, DOI 10.1124/dmd.106.014423
   Adamovich Y, 2013, MOL CELL BIOL, V33, P2603, DOI 10.1128/MCB.01672-12
   Anisimov VN, 2008, CELL CYCLE, V7, P2769, DOI 10.4161/cc.7.17.6625
   [Anonymous], PATHOBIOL AGING AGE
   Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100
   Artal-Sanz M, 2009, NATURE, V461, P793, DOI 10.1038/nature08466
   Bartke Andrzej, 2007, V35, P69
   Barzilai N, 1998, J CLIN INVEST, V101, P1353, DOI 10.1172/JCI485
   BERG BN, 1960, J NUTR, V71, P255
   Bergamini E, 2003, BIOMED PHARMACOTHER, V57, P203, DOI 10.1016/S0753-3322(03)00048-9
   BREESE CR, 1991, J GERONTOL, V46, pB180, DOI 10.1093/geronj/46.5.B180
   Bruss MD, 2010, AM J PHYSIOL-ENDOC M, V298, pE108, DOI 10.1152/ajpendo.00524.2009
   Cantó C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023
   Chang HW, 2015, FREE RADICAL BIO MED, V78, P168, DOI 10.1016/j.freeradbiomed.2014.10.576
   Chattopadhyay M, 2012, BIOCHEM PHARMACOL, V83, P733, DOI 10.1016/j.bcp.2011.12.020
   CHENEY KE, 1980, EXP GERONTOL, V15, P237, DOI 10.1016/0531-5565(80)90029-7
   Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552
   Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635
   Cuervo AM, 1997, J BIOL CHEM, V272, P5606, DOI 10.1074/jbc.272.9.5606
   Cuervo AM, 2008, TRENDS GENET, V24, P604, DOI 10.1016/j.tig.2008.10.002
   De Cabo R, 2004, EXP GERONTOL, V39, P297, DOI 10.1016/j.exger.2003.12.003
   DeBalsi KL, 2014, J BIOL CHEM, V289, P8106, DOI 10.1074/jbc.M113.511535
   DUFFY PH, 1989, MECH AGEING DEV, V48, P117, DOI 10.1016/0047-6374(89)90044-4
   FERNANDES G, 1976, P NATL ACAD SCI USA, V73, P1279, DOI 10.1073/pnas.73.4.1279
   FIGUEROA CD, 1994, INT J BIOCHEM, V26, P1299, DOI 10.1016/0020-711X(94)90099-X
   Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905
   Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898
   Flurkey K, 2002, MECH AGEING DEV, V123, P121, DOI 10.1016/S0047-6374(01)00339-6
   Fontana L, 2016, AGING CELL, V15, P22, DOI 10.1111/acel.12400
   Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020
   Fontana L, 2014, NATURE, V511, P405, DOI 10.1038/511405a
   Forster MJ, 2003, FASEB J, V17, P690, DOI 10.1096/fj.02-0533fje
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220
   GOODRICK CL, 1990, MECH AGEING DEV, V55, P69, DOI 10.1016/0047-6374(90)90107-Q
   Grabowski DC, 2001, J AM GERIATR SOC, V49, P968, DOI 10.1046/j.1532-5415.2001.49189.x
   Gregg SQ, 2012, HEPATOLOGY, V55, P609, DOI 10.1002/hep.24713
   GROSS L, 1984, P NATL ACAD SCI-BIOL, V81, P7596, DOI 10.1073/pnas.81.23.7596
   Guan KL, 2011, TRENDS BIOCHEM SCI, V36, P108, DOI 10.1016/j.tibs.2010.09.003
   Guevara-Aguirre J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001845
   Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024
   Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724
   Harper JM, 2006, AGING CELL, V5, P441, DOI 10.1111/j.1474-9726.2006.00236.x
   Harrison DE, 2014, AGING CELL, V13, P273, DOI 10.1111/acel.12170
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   HARRISON DE, 1987, J NUTR, V117, P376, DOI 10.1093/jn/117.2.376
   Hine C, 2015, CELL, V160, P132, DOI 10.1016/j.cell.2014.11.048
   Hsieh CC, 2002, MECH AGEING DEV, V123, P1245, DOI 10.1016/S0047-6374(02)00037-4
   Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720
   Kaushik S, 2015, NAT MED, V21, P1406, DOI 10.1038/nm.4001
   Khraiwesh H, 2014, EXP GERONTOL, V56, P77, DOI 10.1016/j.exger.2014.03.023
   Khraiwesh H, 2013, J GERONTOL A-BIOL, V68, P1023, DOI 10.1093/gerona/glt006
   Kirkwood TBL, 2002, MECH AGEING DEV, V123, P737, DOI 10.1016/S0047-6374(01)00419-5
   Kritchevsky D, 2002, HYBRIDOMA HYBRIDOM, V21, P147, DOI 10.1089/153685902317401753
   Kuhla A, 2014, J GERONTOL A-BIOL, V69, P915, DOI 10.1093/gerona/glt160
   LANE MA, 1995, AM J PHYSIOL-ENDOC M, V268, pE941, DOI 10.1152/ajpendo.1995.268.5.E941
   Liao CY, 2011, AGING CELL, V10, P629, DOI 10.1111/j.1474-9726.2011.00702.x
   Liao CY, 2010, AGING CELL, V9, P92, DOI 10.1111/j.1474-9726.2009.00533.x
   Longo VD, 2015, AGING CELL, V14, P497, DOI 10.1111/acel.12338
   López-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103
   Madrigal-Matute J, 2016, GASTROENTEROLOGY, V150, P328, DOI 10.1053/j.gastro.2015.09.042
   Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192
   MASORO EJ, 1990, P SOC EXP BIOL MED, V193, P31, DOI 10.3181/00379727-193-42985
   Masternak MM, 2009, J GERONTOL A-BIOL, V64, P516, DOI 10.1093/gerona/glp024
   Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432
   McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63
   Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708
   Miller DL, 2007, P NATL ACAD SCI USA, V104, P20618, DOI 10.1073/pnas.0710191104
   Miller RA, 2014, AGING CELL, V13, P468, DOI 10.1111/acel.12194
   Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178
   Milman S, 2014, AGING CELL, V13, P769, DOI 10.1111/acel.12213
   Mitchell SE, 2015, ONCOTARGET, V6, P23213, DOI 10.18632/oncotarget.4003
   Mitchell SE, 2015, ONCOTARGET, V6, P18314, DOI 10.18632/oncotarget.4506
   Moreschi C., 1909, Z IMMUNITATSFORSCH, V2, P651
   Moscovitz O, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7609
   MURTAGHMARK CM, 1995, J GERONTOL A-BIOL, V50, pB148, DOI 10.1093/gerona/50A.3.B148
   Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728
   Olzmann JA, 2008, AUTOPHAGY, V4, P85, DOI 10.4161/auto.5172
   Osborne TB, 1917, SCIENCE, V45, P294, DOI 10.1126/science.45.1160.294
   Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011
   Pearson KJ, 2008, P NATL ACAD SCI USA, V105, P2325, DOI 10.1073/pnas.0712162105
   Qiao SX, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8014
   Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015
   Rikke BA, 2003, MECH AGEING DEV, V124, P663, DOI 10.1016/S0047-6374(03)00003-4
   Rikke BA, 2007, AM J PHYSIOL-REG I, V293, pR1522, DOI 10.1152/ajpregu.00215.2007
   Rikke BA, 2010, EXP GERONTOL, V45, P691, DOI 10.1016/j.exger.2010.04.008
   Rous P, 1914, J EXP MED, V20, P433, DOI 10.1084/jem.20.5.433
   Sadagurski M, 2014, AM J PHYSIOL-ENDOC M, V306, pE1305, DOI 10.1152/ajpendo.00031.2014
   Schneider JL, 2014, CELL METAB, V20, P417, DOI 10.1016/j.cmet.2014.06.009
   Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x
   Shang ZX, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-23
   Sharples AP, 2015, AGING CELL, V14, P511, DOI 10.1111/acel.12342
   Sheth SS, 2005, J LIPID RES, V46, P123, DOI 10.1194/jlr.M400341-JLR200
   Shimokawa I, 2015, AGING CELL, V14, P707, DOI 10.1111/acel.12340
   Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976
   Soare A, 2011, AGING-US, V3, P374, DOI 10.18632/aging.100280
   Solon-Biet SM, 2015, CELL REP, V11, P1529, DOI 10.1016/j.celrep.2015.05.007
   Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001
   Strong R, 2008, AGING CELL, V7, P641, DOI 10.1111/j.1474-9726.2008.00414.x
   Strong R, 2013, J GERONTOL A-BIOL, V68, P6, DOI 10.1093/gerona/gls070
   Sun LY, 2013, ELIFE, V2, DOI 10.7554/eLife.01098
   Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320
   TANNENBAUM A., 1940, Amer. F. Cancer, V38, P335
   Tauriainen E, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/525094
   Turturro A, 2002, J GERONTOL A-BIOL, V57, pB379, DOI 10.1093/gerona/57.11.B379
   TURTURRO A, 1991, ANN NY ACAD SCI, V621, P363
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Weindruch R, 1997, NEW ENGL J MED, V337, P986, DOI 10.1056/NEJM199710023371407
   WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641
   WEINDRUCH RH, 1979, FED PROC, V38, P2007
   Yang GD, 2013, ANTIOXID REDOX SIGN, V18, P1906, DOI 10.1089/ars.2012.4645
   Yang L, 2016, CELL REP, V14, P422, DOI 10.1016/j.celrep.2015.12.042
   Yuan R, 2009, AGING CELL, V8, P277, DOI 10.1111/j.1474-9726.2009.00478.x
   Zee RS, 2010, ANTIOXID REDOX SIGN, V13, P1023, DOI 10.1089/ars.2010.3251
   Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851
NR 115
TC 294
Z9 315
U1 1
U2 38
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1550-4131
EI 1932-7420
J9 CELL METAB
JI Cell Metab.
PD JUN 14
PY 2016
VL 23
IS 6
BP 1093
EP 1112
DI 10.1016/j.cmet.2016.05.027
PG 20
WC Cell Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Endocrinology & Metabolism
GA DO7ZA
UT WOS:000378000600021
PM 27304509
OA Green Accepted, hybrid, Green Submitted
DA 2024-02-19
ER

PT J
AU Endicott, SJ
   Boynton, DN 
   Beckmann, LJ
   Miller, RA
AF Endicott, S. Joseph
   Boynton, Dennis N., Jr.
   Beckmann, Logan J.
   Miller, Richard A.
TI Long-lived mice with reduced growth hormone signaling have a
   constitutive upregulation of hepatic chaperone-mediated autophagy
SO AUTOPHAGY
LA English
DT Article; Early Access
DE Aging; chaperone-mediated autophagy; endocrine control of autophagy;
   endocrine signaling; growth hormone
ID LIFE-SPAN EXTENSION; SNELL DWARF; GLYCERALDEHYDE-3-PHOSPHATE
   DEHYDROGENASE; CYTOSOLIC PROTEINS; MUTANT MICE; RECEPTOR; GENE;
   DEGRADATION; MOUSE; LONGEVITY
AB Chaperone-mediated autophagy (CMA) is the most selective form of lysosomal proteolysis. CMA modulates proteomic organization through selective protein degradation, with targets including metabolic enzymes, cell growth regulators, and neurodegeneration-related proteins. CMA activity is low in ad libitum-fed rodents but is increased by prolonged fasting. AKT negatively regulates CMA at the lysosomal membrane by phosphorylating and inhibiting the CMA regulator GFAP. We have previously reported that long-lived Pou1f1/Pit1 mutant (Snell) mice and ghr (growth hormone receptor) knockout mice (ghr KO) have lower AKT activity when fed compared to littermate controls, suggesting the hypothesis that these mice have increased baseline CMA activity. Here, we report that liver lysosomes from fed Snell dwarf mice and ghr KO mice have decreased GFAP phosphorylation and increased CMA substrate uptake activity. Liver lysosomes isolated from fed Snell dwarf mice and ghr KO mice injected with the protease inhibitor leupeptin had increased accumulation of endogenous CMA substrates, compared to littermate controls, suggesting an increase in CMA in vivo. Mice with liver-specific ablation of GH (growth hormone) signaling did not have increased liver CMA, suggesting that a signaling effect resulting from a loss of growth hormone in another tissue causes enhanced CMA in Snell dwarf and ghr KO mice. Finally, we find Snell dwarf mice have decreased protein levels (in liver and kidney) of CIP2A, a well-characterized CMA target protein, without an associated change in Cip2a mRNA. Collectively, these data suggest that CMA is enhanced downstream of an endocrine change resulting from whole-body ablation of GH signaling.
C1 [Endicott, S. Joseph; Miller, Richard A.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.
   [Boynton, Dennis N., Jr.; Beckmann, Logan J.] Univ Michigan, Coll Literature Sci & Arts, Ann Arbor, MI 48109 USA.
   [Miller, Richard A.] Univ Michigan, Inst Gerontol, Geriatr Ctr, Ann Arbor, MI 48109 USA.
C3 University of Michigan System; University of Michigan; University of
   Michigan System; University of Michigan; University of Michigan System;
   University of Michigan
RP Miller, RA (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.
EM millerr@umich.edu
OI Endicott, S. Joseph/0000-0002-8237-9784
FU NIH [AG024824, 5T32AG000114-34]; Paul F. Glenn Center for Biology of
   Aging Research
FX This work was supported by NIH grant AG024824 and training grant
   5T32AG000114-34 and by the Paul F. Glenn Center for Biology of Aging
   Research
CR Agarraberes FA, 2001, J CELL SCI, V114, P2491
   Al-Regaiey KA, 2005, ENDOCRINOLOGY, V146, P851, DOI 10.1210/en.2004-1120
   ANIENTO F, 1993, J BIOL CHEM, V268, P10463
   Anisimov VN, 2013, CRIT REV ONCOL HEMAT, V87, P201, DOI 10.1016/j.critrevonc.2013.01.005
   Arias E, 2015, MOL CELL, V59, P270, DOI 10.1016/j.molcel.2015.05.030
   Bandyopadhyay U, 2008, MOL CELL BIOL, V28, P5747, DOI 10.1128/MCB.02070-07
   Bandyopadhyay U, 2010, MOL CELL, V39, P535, DOI 10.1016/j.molcel.2010.08.004
   Bartke Andrzej, 2012, Frontiers in Genetics, V3, P288, DOI 10.3389/fgene.2012.00288
   Brooks NL, 2007, J BIOL CHEM, V282, P35069, DOI 10.1074/jbc.M700484200
   Chen SY, 2012, J POLYM RES, V19, DOI 10.1007/s10965-011-9800-6
   CHIANG HL, 1989, SCIENCE, V246, P382, DOI 10.1126/science.2799391
   Côme C, 2009, CLIN CANCER RES, V15, P5092, DOI 10.1158/1078-0432.CCR-08-3283
   Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608
   Coschigano KT, 2003, ENDOCRINOLOGY, V144, P3799, DOI 10.1210/en.2003-0374
   Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200
   CUERVO AM, 1994, J BIOL CHEM, V269, P26374
   Cuervo AM, 2000, TRAFFIC, V1, P570, DOI 10.1034/j.1600-0854.2000.010707.x
   Cuervo AM, 1997, J BIOL CHEM, V272, P5606, DOI 10.1074/jbc.272.9.5606
   CUERVO AM, 1995, AM J PHYSIOL-CELL PH, V269
   Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017
   DICE JF, 1990, TRENDS BIOCHEM SCI, V15, P305, DOI 10.1016/0968-0004(90)90019-8
   DOMINICK G, 2016, AGING CELL, V16, P1
   Dominick G, 2015, ENDOCRINOLOGY, V156, P565, DOI 10.1210/en.2014-1690
   Drake JC, 2015, AGING CELL, V14, P474, DOI 10.1111/acel.12329
   Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168
   Fernandez Alvaro F, 2018, Nature, V558, P136, DOI 10.1038/s41586-018-0162-7
   Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898
   Gomes LR, 2017, AUTOPHAGY, V13, P928, DOI 10.1080/15548627.2017.1293767
   Haspel J, 2011, AUTOPHAGY, V7, P629, DOI 10.4161/auto.7.6.15100
   Hauck SJ, 2001, EXP BIOL MED, V226, P552
   Hofmann JW, 2015, CELL, V160, P477, DOI 10.1016/j.cell.2014.12.016
   Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044
   Kaushik S, 2006, EMBO J, V25, P3921, DOI 10.1038/sj.emboj.7601283
   Kaushik S, 2018, NAT REV MOL CELL BIO, V19, P365, DOI 10.1038/s41580-018-0001-6
   Kaushik S, 2016, AUTOPHAGY, V12, P432, DOI 10.1080/15548627.2015.1124226
   Kaushik S, 2011, J CELL SCI, V124, P495, DOI 10.1242/jcs.073874
   Kiffin R, 2007, J CELL SCI, V120, P782, DOI 10.1242/jcs.001073
   Kundra R, 1999, J BIOL CHEM, V274, P31039, DOI 10.1074/jbc.274.43.31039
   Lescat L, 2018, AUTOPHAGY, V14, P1267, DOI 10.1080/15548627.2018.1460021
   Li WW, 2012, CELL MOL LIFE SCI, V69, P1125, DOI 10.1007/s00018-011-0865-5
   LIN SC, 1994, DEVELOPMENT, V120, P515
   List EO, 2014, ENDOCRINOLOGY, V155, P1793, DOI 10.1210/en.2013-2086
   Liu Y, 2015, DIABETES, V64, P36, DOI 10.2337/db14-0267
   Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103
   Meléndez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782
   Miller RA, 1999, J GERONTOL A-BIOL, V54, pB358, DOI 10.1093/gerona/54.8.B358
   Miller RA, 2007, AGING CELL, V6, P565, DOI 10.1111/j.1474-9726.2007.00311.x
   Murakami S, 2003, FASEB J, V17, P1565, DOI 10.1096/fj.02-1092fje
   Paquette M, 2018, CANCERS, V10, DOI 10.3390/cancers10010018
   Pyo JO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3300
   Rodriguez-Navarro JA, 2012, P NATL ACAD SCI USA, V109, pE705, DOI 10.1073/pnas.1113036109
   Sahu R, 2011, DEV CELL, V20, P131, DOI 10.1016/j.devcel.2010.12.003
   Schneider JL, 2014, CELL METAB, V20, P417, DOI 10.1016/j.cmet.2014.06.009
   Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269
   Sinha RA, 2017, ENDOCR REV, V38, P69, DOI 10.1210/er.2016-1103
   Sinha RA, 2012, J CLIN INVEST, V122, P2428, DOI 10.1172/JCI60580
   SMITH RE, 1966, J CELL BIOL, V31, P319, DOI 10.1083/jcb.31.2.319
   Tóth ML, 2008, AUTOPHAGY, V4, P330, DOI 10.4161/auto.5618
   Troncoso R, 2012, CARDIOVASC RES, V93, P320, DOI 10.1093/cvr/cvr321
   Ujvári A, 2001, J BIOL CHEM, V276, P5924, DOI 10.1074/jbc.M009203200
   Wang M, 2012, AGING CELL, V11, P668, DOI 10.1111/j.1474-9726.2012.00833.x
   Wendeler M, 2009, GLYCOCONJUGATE J, V26, P945, DOI 10.1007/s10719-008-9137-5
   Westbrook R, 2009, J GERONTOL A-BIOL, V64, P443, DOI 10.1093/gerona/gln075
   Westermarck J, 2008, TRENDS MOL MED, V14, P152, DOI 10.1016/j.molmed.2008.02.001
   Xilouri M, 2016, AGEING RES REV, V32, P13, DOI 10.1016/j.arr.2016.07.001
   Xilouri M, 2016, AUTOPHAGY, V12, P2230, DOI 10.1080/15548627.2016.1214777
   Xilouri M, 2013, BRAIN, V136, P2130, DOI 10.1093/brain/awt131
   Young JA, 2016, PROG MOL BIOL TRANSL, V138, P27, DOI 10.1016/bs.pmbts.2015.10.014
   Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851
   Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215
NR 70
TC 22
Z9 24
U1 0
U2 9
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1554-8627
EI 1554-8635
J9 AUTOPHAGY
JI Autophagy
PD 2021 MAR 4
PY 2021
VL 17
IS 3
BP 612
EP 625
DI 10.1080/15548627.2020.1725378
EA FEB 2020
PG 14
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA RJ0QV
UT WOS:000513751800001
PM 32013718
OA Bronze, Green Published
DA 2024-02-19
ER

PT J
AU Polat, KY
   Aydinli, B
   Yilmaz, O
   Aslan, S
   Gursan, N
   Ozturk, G
   Onbas, O
AF Polat, K. Yalcin
   Aydinli, Bulent
   Yilmaz, Omer
   Aslan, Sahin
   Gursan, Nesrin
   Ozturk, Gurkan
   Onbas, Omer
TI Intestinal tuberculosis and secondary liver abscess
SO MOUNT SINAI JOURNAL OF MEDICINE
LA English
DT Article
DE intestinal tuberculosis; tuberculous liver abscesses; surgical treatment
ID ABDOMINAL TUBERCULOSIS; BOWEL OBSTRUCTION; COMPLICATIONS; PERFORATIONS;
   FEATURES
AB The incidence of intestinal tuberculosis (ITB) has been increasing in the West, due to the AIDS epidemic, transglobal immigration, IV drug abuse, an aging population, and an increase in the number of immunocompromised patients. Obstruction and perforation of the intestine are the most common and serious complications of ITB. Another complication, tuberculous liver abscess (TLA), is rare and usually associated with foci of infection in the lung or gastrointestinal tract. We report a case of a 17-year-old boy with Down syndrome who presented with multiple TLAs secondary to obstructive and multiple perforated ileal tuberculosis.
C1 Ataturk Univ, Sch Med, Dept Gen Surg, Erzurum, Turkey.
   Ataturk Univ, Sch Med, Dept Gastroenterol, Erzurum, Turkey.
   Ataturk Univ, Sch Med, Dept Emergency Med, Erzurum, Turkey.
   Ataturk Univ, Sch Med, Dept Pathol, Erzurum, Turkey.
   Ataturk Univ, Sch Med, Dept Radiol, Erzurum, Turkey.
C3 Ataturk University; Ataturk University; Ataturk University; Ataturk
   University; Ataturk University
RP Aydinli, B (corresponding author), Ataturk Univ, Tip Fak, Cerrahi AD, Erzurum, Turkey.
EM bulentaydinli@gmail.com
RI Aydinli, Bulent/K-7597-2018
OI Ozturk, Gurkan/0000-0001-8662-636X
CR Akçay MN, 2004, INT J CLIN PRACT, V58, P625, DOI 10.1111/j.1368-5031.2004.00105.x
   Ara C, 2005, J GASTROINTEST SURG, V9, P514, DOI 10.1016/j.gassur.2004.09.034
   Balsarkar D, 2000, J Postgrad Med, V46, P108
   Brandt MM, 2002, AM J SURG, V183, P290, DOI 10.1016/S0002-9610(02)00788-2
   Chen HC, 2003, LIVER INT, V23, P346, DOI 10.1034/j.1478-3231.2003.00861.x
   Engin G, 2005, J COMPUT ASSIST TOMO, V29, P37, DOI 10.1097/01.rct.0000151935.52808.0c
   Ha HK, 1999, ABDOM IMAGING, V24, P32, DOI 10.1007/s002619900436
   Hayashi M, 2004, INTERNAL MED, V43, P521, DOI 10.2169/internalmedicine.43.521
   Kim MP, 2005, J AM COLL SURGEONS, V201, P478, DOI 10.1016/j.jamcollsurg.2005.02.032
   Kok K Y, 1999, J Hepatobiliary Pancreat Surg, V6, P195, DOI 10.1007/s005340050106
   LEVINE C, 1990, GASTROINTEST RADIOL, V15, P307, DOI 10.1007/BF01888805
   Makanjuola D, 1998, EUR J RADIOL, V26, P261, DOI 10.1016/S0720-048X(96)01091-1
   MUSTARD RA, 1986, CAN J SURG, V29, P449
   Nagi B, 2004, ABDOM IMAGING, V29, P335, DOI 10.1007/s00261-003-0115-x
   Nagi B, 2002, ACTA RADIOL, V43, P501, DOI 10.1034/j.1600-0455.2002.430510.x
   Patel N, 2004, J GASTROEN HEPATOL, V19, P1240, DOI 10.1111/j.1440-1746.2004.03485.x
   Pereira JM, 2005, EUR J RADIOL, V55, P173, DOI 10.1016/j.ejrad.2005.04.015
   Rahmatulla RH, 2001, EUR J GASTROEN HEPAT, V13, P437, DOI 10.1097/00042737-200104000-00024
   Sefr R, 2001, DIGEST SURG, V18, P475
   Settbas Y, 2003, WORLD J GASTROENTERO, V9, P2382
   Sharma MP, 2004, INDIAN J MED RES, V120, P305
   Suri S, 1999, BRIT J RADIOL, V72, P92, DOI 10.1259/bjr.72.853.10341698
   Uygur-Bayramiçli O, 2003, WORLD J GASTROENTERO, V9, P1098
   Yilmaz T, 2002, COMPUT MED IMAG GRAP, V26, P321, DOI 10.1016/S0895-6111(02)00029-0
NR 24
TC 12
Z9 13
U1 1
U2 3
PU MOUNT SINAI HOSPITAL
PI NEW YORK
PA BOX 1094 ONE GUSTAVE L LEVY PLACE ATTN: CIRCULATION ASST, NEW YORK, NY
   10029-6574 USA
SN 0027-2507
J9 MT SINAI J MED
JI Mt. Sinai J. Med.
PD OCT
PY 2006
VL 73
IS 6
BP 887
EP 890
PG 4
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 100NF
UT WOS:000241675100010
PM 17117317
DA 2024-02-19
ER

PT J
AU NIEDERMULLER, H
   HOFECKER, G
   SKALICKY, M
AF NIEDERMULLER, H
   HOFECKER, G
   SKALICKY, M
TI THE CHANGE IN THE SUPPLY WITH REDUCTION EQUIVALENTS IN DIFFERENT ORGANS
   OF THE RAT DURING AGING
SO ZEITSCHRIFT FUR GERONTOLOGIE
LA English
DT Article
DE AGING; GLUCOSE METABOLISM; REDUCTION EQUIVALENTS
ID METABOLISM
AB The rate of metabolic kinetics and the frequency of biological cycles may be correlated with the rate of aging and the maximum life-span potential.  Therefore, investigation either into changes with age of such parameters within one species or into differences between species may give some information about the genetic programming of the aging process.  Male Sprague-Dawley rats aged 3.5, 7, 12, 17, 23, and 33 months (m) were used to determine the changes with age of those metabolic pathways mentioned in the title, using the liver (LI), kidney (KI), brain (BR), heart (HE) and the skeletal muscle (SM).  The maximum percentage of glucose utilization via the pentose pathway, compared to the total glucose utilization, was calculated after intravenous administration of D-[1-C-14]- and D-[6-C-14]glucose by the determination of the trioses (as lipids) 3 hours after the application.  Furthermore, in rats aged 13 and 25 m the kinetics of both glucoses was measured in liver, kidney, heart, brain, skeletal muscle, spleen (SP), and testes (TE) during the first 3 hours after application.  Pentose pathway values were calculated.
   The results indicate a decrease in the glucose utilization via the pentose pathway in the course of aging in liver, kidney, heart and skeletal muscle and a decrease from 3.5 months on in brain, younger rats exhibit a higher rate of glucose utilization via the pentose pathway as do old ones.  the reduction of the pentose pathway may possibly be the cause of higher lipofuscin accumulation in the cells of some organs, lacking sufficient reduction equivalents for lipid metabolism.
RP NIEDERMULLER, H (corresponding author), VET UNIV VIENNA,INST PHYSIOL,DEPT GERONTOL,LINKE BAHNGASSE 11,A-1030 VIENNA,AUSTRIA.
CR BEIER W, 1973, BIOPHYSIKALISCHE ASP, P69
   BENJAMIN W, 1961, AM J PHYSIOL, V201, P540, DOI 10.1152/ajplegacy.1961.201.3.540
   CRISTOFALO VJ, 1970, AGING CELL TISSUE CU, P83
   CRISTOFALO VJ, 1970, ORGANIC BIOL MED CHE, V2, P95
   HOFECKER G, 1990, Z GERONTOL, V23, P136
   KATZ J, 1960, J BIOL CHEM, V235, P2165
   KATZ J, 1961, KUNSTLICHE RADIOAKTI, V1, P705
   MASORO EJ, 1985, HDB BIOL AGING, P540
   NEELY RJ, 1974, ANN REV PHYSL, P413
   Niedermuller H., 1976, Wiener Tierarztliche Monatsschrift, V63, P388
   PATEL MS, 1977, J GERONTOL, V32, P643, DOI 10.1093/geronj/32.6.643
   SOHAL RS, 1980, AGE PIGEMENTS, P394
   TOMLINSON TO, 1985, MECH AGEING DEV, V30, P33
   VITORICA J, 1981, MECH AGEING DEV, V16, P105, DOI 10.1016/0047-6374(81)90087-7
   WOOD HG, 1958, J BIOL CHEM, V233, P1279
NR 15
TC 1
Z9 1
U1 0
U2 1
PU DR DIETRICH STEINKOPFF VERLAG
PI BERLIN 33
PA C/O SPRINGER-VERLAG, HEIDELBERGER PLATZ 3, 1000 BERLIN 33, GERMANY
SN 0044-281X
J9 Z GERONTOL
PD MAR-APR
PY 1991
VL 24
IS 2
BP 61
EP 65
PG 5
WC Geriatrics & Gerontology
WE Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA FN695
UT WOS:A1991FN69500002
PM 1877288
DA 2024-02-19
ER

PT J
AU Allison, DB
   Ren, G
   Peliciari-Garcia, RA
   Mia, S
   McGinnis, GR
   Davis, J
   Gamble, KL
   Kim, JA
   Young, ME
AF Allison, David B.
   Ren, Guang
   Peliciari-Garcia, Rodrigo A.
   Mia, Sobuj
   McGinnis, Graham R.
   Davis, Jennifer
   Gamble, Karen L.
   Kim, Jeong-A
   Young, Martin E.
TI Diurnal, metabolic and thermogenic alterations in a murine model of
   accelerated aging
SO CHRONOBIOLOGY INTERNATIONAL
LA English
DT Article; Early Access
DE Aging; chronobiology; metabolism; thermogenesis
ID CIRCADIAN-RHYTHMS; OXIDATIVE STRESS; CONTRACTILE FUNCTION; TARGETED
   DISRUPTION; SKELETAL-MUSCLE; GENE-EXPRESSION; CLOCK; HEART; SAMP8; MICE
AB Senescence-Accelerated Mouse-Prone 8 (SAMP8) mice exhibit characteristics of premature aging, including hair loss, cognitive dysfunction, reduced physical activity, impaired metabolic homeostasis, cardiac dysfunction and reduced lifespan. Interestingly, circadian disruption can induce or augment many of these same pathologies. Moreover, previous studies have reported that SAMP8 mice exhibit abnormalities in circadian wheel-running behavior, indicating possible alterations in circadian clock function. These observations led to the hypothesis that 24 h rhythms in behavior and/or circadian clock function are altered in SAMP8 mice and that these alterations may contribute to perturbations in whole-body metabolism. Here, we report that 6-month-old SAMP8 mice exhibit a more prominent biphasic pattern in daily behaviors (food intake and physical activity) and whole-body metabolism (energy expenditure, respiratory exchange ratio), relative to SAMR1 control mice. Consistent with a delayed onset of food intake at the end of the light phase, SAMP8 mice exhibit a phase delay (1.3-1.9 h) in 24 h gene expression rhythms of major circadian clock components (bmal1, rev-erb alpha, per2, dbp) in peripheral tissues (liver, skeletal muscle, white adipose tissue [WAT], brown adipose tissue [BAT]). Forcing mice to consume food only during the dark period improved alignment of both whole-body metabolism and oscillations in expression of clock genes in peripheral tissues between SAMP8 and SAMR1 mice. Next, interrogation of metabolic genes revealed altered expression of thermogenesis mediators (ucp1, pgc1 alpha, dio2) in WAT and/or BAT in SAMP8 mice. Interestingly, SAMP8 mice exhibit a decreased tolerance to an acute (5 h) cold challenge. Moreover, SAMP8 and SAMR1 mice exhibited differential responses to a chronic (1 week) decrease in ambient temperature; the greatest response in whole-body substrate selection was observed in SAMR1 mice. Collectively, these observations reveal differential behaviors (e.g. 24 h food intake patterns) in SAMP8 mice that are associated with perturbations in peripheral circadian clocks, metabolism and thermogenesis.
C1 [Allison, David B.] Indiana Univ, Sch Publ Hlth, Bloomington, IN USA.
   [Ren, Guang; Kim, Jeong-A] Univ Alabama Birmingham, Dept Med, Div Endocrinol Diabet & Metab, Birmingham, AL 35294 USA.
   [Peliciari-Garcia, Rodrigo A.] Univ Fed Sao Paulo, Dept Biol Sci, Morphophysiol & Pathol Sect, Diadema, SP, Brazil.
   [Mia, Sobuj; McGinnis, Graham R.; Young, Martin E.] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, 703 19th St S,ZRB 308, Birmingham, AL 35294 USA.
   [Davis, Jennifer; Gamble, Karen L.] Univ Alabama Birmingham, Dept Psychiat, Birmingham, AL 35294 USA.
C3 Indiana University System; Indiana University Bloomington; University of
   Alabama System; University of Alabama Birmingham; Universidade Federal
   de Sao Paulo (UNIFESP); University of Alabama System; University of
   Alabama Birmingham; University of Alabama System; University of Alabama
   Birmingham
RP Young, ME (corresponding author), Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, 703 19th St S,ZRB 308, Birmingham, AL 35294 USA.
EM martinyoung@uabmc.edu
RI Peliciari-Garcia, Rodrigo Antonio/K-7803-2012; Peliciari-Garcia, Rodrigo
   Antonio/Y-7533-2019
OI Peliciari-Garcia, Rodrigo Antonio/0000-0003-1752-1593; Peliciari-Garcia,
   Rodrigo Antonio/0000-0003-1752-1593; Ren, Guang/0000-0001-7871-2110
FU National Institute of Aging [R01AG043972, R03AG058078]; National Heart,
   Lung, and Blood Institute [R01HL142216, R01 HL128695]
FX This work was supported by the National Institute of Aging [R01AG043972
   [DBA]; R03AG058078 [JK]] and the National Heart, Lung, and Blood
   Institute [R01HL142216 [MEY]; R01 HL128695 [JK]].
CR Akiguchi I, 2017, NEUROPATHOLOGY, V37, P293, DOI 10.1111/neup.12373
   Bailey SM, 2014, J ENDOCRINOL, V222, pR75, DOI 10.1530/JOE-14-0200
   Barquissau V, 2017, FREE RADICAL BIO MED, V113, P267, DOI 10.1016/j.freeradbiomed.2017.10.012
   Bray MS, 2013, INT J OBESITY, V37, P843, DOI 10.1038/ijo.2012.137
   Bray MS, 2008, AM J PHYSIOL-HEART C, V294, pH1036, DOI 10.1152/ajpheart.01291.2007
   Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1
   Bunger MK, 2005, GENESIS, V41, P122, DOI 10.1002/gene.20102
   Chen CY, 2016, P NATL ACAD SCI USA, V113, P206, DOI 10.1073/pnas.1508249112
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Christoffolete MA, 2004, DIABETES, V53, P577, DOI 10.2337/diabetes.53.3.577
   Cox KH, 2019, J MOL ENDOCRINOL, V63, pR93, DOI 10.1530/JME-19-0153
   Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500
   Darcy J, 2019, GEROSCIENCE, V41, P285, DOI 10.1007/s11357-019-00076-0
   Durgan DJ, 2011, CHRONOBIOL INT, V28, P187, DOI 10.3109/07420528.2010.550406
   Edery I, 2000, PHYSIOL GENOMICS, V3, P59, DOI 10.1152/physiolgenomics.2000.3.2.59
   Evans JA, 2013, PROG MOL BIOL TRANSL, V119, P283, DOI 10.1016/B978-0-12-396971-2.00010-5
   Fernández-Sánchez A, 2011, INT J MOL SCI, V12, P3117, DOI 10.3390/ijms12053117
   Förstermann U, 2008, NAT CLIN PRACT CARD, V5, P338, DOI 10.1038/ncpcardio1211
   Gerhart-Hines Z, 2013, NATURE, V503, P410, DOI 10.1038/nature12642
   Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995
   Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986
   Hood S, 2017, J CLIN INVEST, V127, P437, DOI 10.1172/JCI90328
   Karuppagounder V, 2017, AGEING RES REV, V35, P291, DOI 10.1016/j.arr.2016.10.006
   Kim KH, 1997, ANNU REV NUTR, V17, P77, DOI 10.1146/annurev.nutr.17.1.77
   Kohsaka A, 2007, TRENDS ENDOCRIN MET, V18, P4, DOI 10.1016/j.tem.2006.11.005
   Lassmann H, 2011, J NEURAL TRANSM, V118, P747, DOI 10.1007/s00702-011-0607-8
   Lefta M, 2012, AM J PHYSIOL-HEART C, V303, pH475, DOI 10.1152/ajpheart.00238.2012
   Longo VD, 2016, CELL METAB, V23, P1048, DOI 10.1016/j.cmet.2016.06.001
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253
   Martino TA, 2008, AM J PHYSIOL-REG I, V294, pR1675, DOI 10.1152/ajpregu.00829.2007
   Morley JE, 2012, BBA-MOL BASIS DIS, V1822, P650, DOI 10.1016/j.bbadis.2011.11.015
   Nomura Y, 1999, NEUROBIOL AGING, V20, P111, DOI 10.1016/S0197-4580(99)00006-8
   O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702
   Pang KCH, 2006, AGE, V28, P283, DOI 10.1007/s11357-006-9013-9
   Peliciari-Garcia RA, 2018, CHRONOBIOL INT, V35, P147, DOI 10.1080/07420528.2017.1388253
   Peliciari-Garcia RA, 2016, CHRONOBIOL INT, V33, P1444, DOI 10.1080/07420528.2016.1229673
   Portaluppi F, 2010, CHRONOBIOL INT, V27, P1911, DOI 10.3109/07420528.2010.516381
   Riera CE, 2015, NAT CELL BIOL, V17, P196, DOI 10.1038/ncb3107
   Silva JE, 2006, PHYSIOL REV, V86, P435, DOI 10.1152/physrev.00009.2005
   Sreedhar R, 2016, BIOFACTORS, V42, P368, DOI 10.1002/biof.1280
   Stavinoha MA, 2004, AM J PHYSIOL-ENDOC M, V287, pE878, DOI 10.1152/ajpendo.00189.2004
   Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744
   Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   Tsai JY, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.077800
   Yamazaki S, 2002, P NATL ACAD SCI USA, V99, P10801, DOI 10.1073/pnas.152318499
   Young ME, 2014, J BIOL RHYTHM, V29, P257, DOI 10.1177/0748730414543141
   Young ME, 2001, CIRC RES, V89, P1199, DOI 10.1161/hh2401.100741
   Young ME, 2001, CIRC RES, V88, P1142, DOI 10.1161/hh1101.091190
NR 52
TC 7
Z9 7
U1 0
U2 2
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0742-0528
EI 1525-6073
J9 CHRONOBIOL INT
JI Chronobiol. Int.
PD 2020 AUG 2
PY 2020
VL 37
IS 8
BP 1119
EP 1139
DI 10.1080/07420528.2020.1796699
EA AUG 2020
PG 21
WC Biology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics; Physiology
GA NV0TG
UT WOS:000561166900001
PM 32819176
OA Green Accepted, hybrid
DA 2024-02-19
ER

PT J
AU Chen, LH
   SaxonKelley, DM
   Snyder, DL
AF Chen, LH
   SaxonKelley, DM
   Snyder, DL
TI Effects of age and dietary restriction on liver endogenous antioxidant
   defenses in male Lobund-Wistar rats
SO AGE
LA English
DT Article
ID FOOD RESTRICTION; SUPEROXIDE-DISMUTASE; LIPID-PEROXIDATION; LIFE-SPAN;
   DROSOPHILA-MELANOGASTER; ENZYME-ACTIVITIES; OXIDATIVE STRESS;
   DT-DIAPHORASE; AGING RATS; CATALASE
AB Dietary restriction (DR) of 30% in caloric intake extends both median and maximum life span by about 30%. DR retards the aging process, but the mechanism of action is not clearly understood. The effects of DR on major endogenous antioxidant defenses were studied in 80 male Lobund-Wistar (LW) rats at various ages throughout the life span. Two groups of rats were fed ad libitum (AL) or restricted diet (DR) from 6 weeks of age. Adult DR rats received 30% less diet with regard to calories per day when compared to adult AL rats. Eight rats in each diet group were killed at 6, 12, 18, 24 and 30 months of age. The livers were excised and prepared for the determinations of major endogenous antioxidant defense parameters. Hepatic reduced glutathione (GSH) levels were decreased at old age in the AL group, however, DR eliminated this decrease. Activities of glutathione reductase (GR) and Se-dependent glutathione peroxidase (GPx) were not affected by age nor by DR. Superoxide dismutase (SOD) activity decreased from 6 to 12 months of age and catalase activity decreased with aging in the AL group, while DR maintained the enzyme activities at similar levels for all ages. Quinone reductase (QR) activity increased with increasing age in the AL group, and DR further increased the enzyme activity at all ages. The results suggest that 30% DR may contribute to the delaying of the aging process by improving endogenous antioxidant defense capability which decreases by 20 to 30% during aging.
C1 UNIV KENTUCKY, LEXINGTON, KY 40506 USA.
   UNIV NOTRE DAME, LOBUND LAB, NOTRE DAME, IN 46556 USA.
C3 University of Kentucky; University of Notre Dame
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   AMSTAD P, 1991, BIOCHEMISTRY-US, V30, P9305, DOI 10.1021/bi00102a024
   CHEN LH, 1993, ARCH GERONTOL GERIAT, V16, P69, DOI 10.1016/0167-4943(93)90028-G
   CHEN LH, 1994, AGE, V17, P65, DOI 10.1007/BF02434896
   CHIPALKATTI S, 1983, J NUTR, V113, P944, DOI 10.1093/jn/113.5.944
   CHOI JH, 1989, AGE, V12, P133, DOI 10.1007/BF02432350
   CHUNG MH, 1992, FREE RADICAL BIO MED, V12, P523, DOI 10.1016/0891-5849(92)90105-P
   DAVIS LJ, 1993, MECH AGEING DEV, V72, P155, DOI 10.1016/0047-6374(93)90097-B
   ENESCO HE, 1981, EXP GERONTOL, V16, P357, DOI 10.1016/0531-5565(81)90056-5
   Ernster L, 1967, Methods in enzymology, P309, DOI DOI 10.1016/0076-6879(67)10059-1
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   HABIB MP, 1990, J APPL PHYSIOL, V68, P2588, DOI 10.1152/jappl.1990.68.6.2588
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Harman D., 1986, FREE RADICALS AGING, P3
   IYANAGI T, 1970, BIOCHIM BIOPHYS ACTA, V216, P282, DOI 10.1016/0005-2728(70)90220-3
   KOIZUMI A, 1987, J NUTR, V117, P361, DOI 10.1093/jn/117.2.361
   LAGANIERE S, 1987, BIOCHEM BIOPH RES CO, V145, P1185, DOI 10.1016/0006-291X(87)91562-2
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P221, DOI 10.1016/0047-6374(89)90084-5
   LEAKEY JEA, 1991, BIOL EFFECTS DIETARY, P207
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   LUHTALA TA, 1994, J GERONTOL, V49, pB231, DOI 10.1093/geronj/49.5.B231
   MASORO EJ, 1992, AM J CLIN NUTR, V55, P1250
   MATSUO M, 1993, J GERONTOL, V48, pB133, DOI 10.1093/geronj/48.4.B133
   MCCORD JM, 1969, J BIOL CHEM, V244, P6049
   MOTE PL, 1991, J GERONTOL, V46, pB95, DOI 10.1093/geronj/46.3.B95
   Mune M, 1995, AGE, V18, P43, DOI 10.1007/BF02432518
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   ORR WC, 1993, ARCH BIOCHEM BIOPHYS, V301, P34, DOI 10.1006/abbi.1993.1111
   OWENS CWI, 1965, BIOCHEM J, V94, P705, DOI 10.1042/bj0940705
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   PIERI C, 1992, ARCH GERONTOL GERIAT, V14, P93, DOI 10.1016/0167-4943(92)90010-2
   POLLARD M, 1971, GERONTOLOGY, V17, P333, DOI 10.1159/000211839
   PROCHASKA HJ, 1991, OXIDATIVE STRESS OXI, P195
   RACKER E, 1955, METHOD ENZYMOL, V2, P722, DOI 10.1016/S0076-6879(55)02291-X
   RAO G, 1990, J NUTR, V120, P602, DOI 10.1093/jn/120.6.602
   RIKANS LE, 1991, BIOCHIM BIOPHYS ACTA, V1074, P195, DOI 10.1016/0304-4165(91)90061-K
   ROSS MH, 1969, J NUTR, V97, P565, DOI 10.1093/jn/97.suppl_4.565
   SEMSEI I, 1989, BIOCHEM BIOPH RES CO, V164, P620, DOI 10.1016/0006-291X(89)91505-2
   SNYDER DL, 1990, J GERONTOL, V45, pB52, DOI 10.1093/geronj/45.2.B52
   SNYDER DL, 1987, LAB ANIM SCI, V37, P320
   SNYDER DL, 1989, DIETARY RESTRICTION, P135
   VAN DER RIJST M. P. J., 1955, Voeding, V16, P708
   WERAARCHAKUL N, 1989, EXP CELL RES, V181, P197, DOI 10.1016/0014-4827(89)90193-6
   XIA EN, 1995, J NUTR, V125, P195
   YOUNGMAN LD, 1992, P NATL ACAD SCI USA, V89, P9112, DOI 10.1073/pnas.89.19.9112
NR 45
TC 7
Z9 7
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0161-9152
EI 1574-4647
J9 AGE
JI Age
PD JUL
PY 1996
VL 19
IS 3
BP 101
EP 109
DI 10.1007/BF02434089
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA WH863
UT WOS:A1996WH86300004
DA 2024-02-19
ER

PT J
AU Jedlicka, J
   Tuma, Z
   Razak, K
   Kunc, R
   Kala, A
   Peña, SP
   Lerchner, T
   Jezek, K
   Kuncová, J
AF Jedlicka, Jan
   Tuma, Zdenek
   Razak, Karim
   Kunc, Radovan
   Kala, Annu
   Pena, Stephanie Proskauer
   Lerchner, Tobias
   Jezek, Karel
   Kuncova, Jitka
TI Impact of Aging on Mitochondrial Respiration in Various Organs
SO PHYSIOLOGICAL RESEARCH
LA English
DT Article
DE Aging; Mitochondria; Gender differences; High-resolution respirometry
ID AGE-RELATED-CHANGES; SKELETAL-MUSCLE; OXIDATIVE-PHOSPHORYLATION;
   LIVER-MITOCHONDRIA; GENDER DIMORPHISM; QUALITY-CONTROL; SEX-DIFFERENCES;
   COMPLEX-I; BIOENERGETICS; STRESS
AB Mitochondria are considered central regulator of the aging process; however, majority of studies dealing with the impact of age on mitochondrial oxygen consumption focused on skeletal muscle concluding (although not uniformly) a general declining trend with advancing age. In addition, gender related differences in mitochondrial respiration have not been satisfactorily described yet. The aim of the present study was to evaluate mitochondrial oxygen consumption in various organs of aging male and female Fischer 344 rats at the ages of 6, 12 and 24 months. Mitochondrial respiration of homogenized (skeletal muscle, left and right heart ventricle, hippocampus, cerebellum, kidney cortex), gently mechanically permeabilized (liver) tissue or intact cells (platelets) was determined using high-resolution respirometry (oxygraphs O2k, Oroboros, Austria). The pattern of age-related changes differed in each tissue: in the skeletal muscle and kidney cortex of both sexes and in female heart, parameters of mitochondrial respiration significantly declined with age. Resting respiration of intact platelets displayed an increasing trend and it did not correlate with skeletal muscle respiratory states. In the heart of male rats and brain tissues of both sexes, respiratory states remained relatively stable over analyzed age categories with few exceptions of lower mitochondrial oxygen consumption at the age of 24 months. In the liver, OXPHOS capacity was higher in females than in males with either no difference between the ages of 6 and 24 months or even significant increase at the age of 24 months in the male rats. In conclusion, the results of our study indicate that the concept of general pattern of age-dependent decline in mitochondrial oxygen consumption across different organs and tissues could be misleading. Also, the statement of higher mitochondrial respiration in females seems to be conflicting, since the gender - related differences may vary with the tissue studied, combination of substrates used and might be better detectable at younger ages than in old animals.
C1 [Jedlicka, Jan; Razak, Karim; Kunc, Radovan; Lerchner, Tobias; Kuncova, Jitka] Charles Univ Prague, Inst Physiol, Fac Med Plzen, Plzen, Czech Republic.
   [Tuma, Zdenek; Kala, Annu; Pena, Stephanie Proskauer; Jezek, Karel; Kuncova, Jitka] Charles Univ Prague, Biomed Ctr, Fac Med Plzen, Plzen, Czech Republic.
   [Kunc, Radovan] Charles Univ Prague, Inst Social Med, Fac Med Plzen, Plzen, Czech Republic.
   [Jedlicka, Jan] Charles Univ Prague, Inst Physiol, Fac Med Plzen, Alej Svobody 76, Plzen 32300, Czech Republic.
C3 Charles University Prague; Charles University Prague; Charles University
   Prague; Charles University Prague
RP Jedlicka, J (corresponding author), Charles Univ Prague, Inst Physiol, Fac Med Plzen, Alej Svobody 76, Plzen 32300, Czech Republic.
EM jan.jedlicka@lfp.cuni.cz
RI Jedlička, Jan/AAR-4751-2021; Jezek, Karel/A-9581-2012
OI Jedlička, Jan/0000-0001-5999-6875; Jezek, Karel/0000-0001-7559-3689
FU Project of the Grant Agency of the Charles University [966120]; Charles
   University Cooperation Program [Z.02.1.01/0.0/0.0/16_019/0000787]; MEYS
   CR; EFRR; Specific Student Research Project of the Charles University
   [260538/2020]
FX This research was funded by the project of the Grant Agency of the
   Charles University No. 966120, the Charles University Cooperation
   Program (research area Immunity and Infection) , project No.
   Z.02.1.01/0.0/0.0/16_019/0000787 Fighting Infectious Diseases awarded by
   the MEYS CR, financed from EFRR, and the Specific Student Research
   Project Nr. 260538/2020 of the Charles University.
CR Anton SD, 2015, AGEING RES REV, V24, P304, DOI 10.1016/j.arr.2015.09.005
   Braganza A, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.128248
   Brierley EJ, 1997, ANN NEUROL, V41, P114, DOI 10.1002/ana.410410120
   Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x
   Colom B, 2007, CELL PHYSIOL BIOCHEM, V19, P205, DOI 10.1159/000099208
   Crescenzo R, 2015, INT J MOL SCI, V16, P10674, DOI 10.3390/ijms160510674
   Distefano G, 2017, J GERONTOL A-BIOL, V72, P535, DOI 10.1093/gerona/glw102
   Ehinger JK, 2015, J NEUROL, V262, P1493, DOI 10.1007/s00415-015-7737-0
   Esselun C, 2021, NEUROMOL MED, V23, P140, DOI 10.1007/s12017-020-08639-7
   Farhat F, 2017, REDOX REP, V22, P508, DOI 10.1080/13510002.2017.1296637
   Fisar Z, 2016, CURR ALZHEIMER RES, V13, P930, DOI 10.2174/1567205013666160314150856
   Gómez-Pérez Y, 2008, CELL PHYSIOL BIOCHEM, V22, P539, DOI 10.1159/000185538
   Havlenova T, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-96618-8
   Hedges CP, 2019, J APPL PHYSIOL, V126, P454, DOI 10.1152/japplphysiol.00777.2018
   Hepple RT, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00211
   Holmes DJ., 2003, SCI AGING KNOWL ENV, V36, pas2, DOI [10.1126/sageke.2003.36.as2, DOI 10.1126/SAGEKE.2003.36.AS2]
   Jang JY, 2018, J CLIN INVEST, V128, P3662, DOI 10.1172/JCI120842
   Jedlicka J, 2021, PHYSIOL RES, V70, pS369, DOI 10.33549/physiolres.934812
   Junker A, 2022, FASEB J, V36, DOI 10.1096/fj.202101628R
   Justo R, 2005, AM J PHYSIOL-CELL PH, V289, pC372, DOI 10.1152/ajpcell.00035.2005
   Khalifa ARM, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13125
   Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495
   Lalia AZ, 2017, AGING-US, V9, P1096, DOI 10.18632/aging.101210
   Larsen RG, 2012, APPL PHYSIOL NUTR ME, V37, P88, DOI [10.1139/h11-135, 10.1139/H11-135]
   Lenaz G, 1997, MOL CELL BIOCHEM, V174, P329, DOI 10.1023/A:1006854619336
   Martin C, 2007, AGING CELL, V6, P165, DOI 10.1111/j.1474-9726.2007.00271.x
   Navarro A, 2004, AM J PHYSIOL-REG I, V287, pR1244, DOI 10.1152/ajpregu.00226.2004
   Navarro A, 2008, AM J PHYSIOL-REG I, V294, pR501, DOI 10.1152/ajpregu.00492.2007
   No MH, 2020, PFLUG ARCH EUR J PHY, V472, P179, DOI 10.1007/s00424-020-02357-6
   O'Toole JF, 2010, BIOCHEM J, V427, P105, DOI 10.1042/BJ20091373
   Pandya Jignesh D, 2020, J Aging Res, V2020, P7232614, DOI 10.1155/2020/7232614
   Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3
   Petrus AT, 2019, PHYSIOL RES, V68, P347, DOI 10.33549/physiolres.934032
   Picard M, 2011, AGING CELL, V10, P1047, DOI 10.1111/j.1474-9726.2011.00745.x
   Pokkunuri I, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6135319
   Popa-Wagner A, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00032
   Reijne AC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149419
   Rose S, 2019, AM J PHYSIOL-ENDOC M, V317, pE503, DOI 10.1152/ajpendo.00084.2019
   Sanz A, 2007, EXP GERONTOL, V42, P173, DOI 10.1016/j.exger.2006.10.003
   Sjövall F, 2010, CRIT CARE, V14, DOI 10.1186/cc9337
   Son JM, 2021, SEMIN CELL DEV BIOL, V116, P160, DOI 10.1016/j.semcdb.2021.02.006
   Son JM, 2019, BMB REP, V52, P13, DOI 10.5483/BMBRep.2019.52.1.300
   Svíglerová J, 2012, EXP BIOL MED, V237, P1056, DOI 10.1258/ebm.2012.012045
   Tichanek F, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62308-0
   Tieland M, 2018, J CACHEXIA SARCOPENI, V9, P3, DOI 10.1002/jcsm.12238
   Tyrrell DJ, 2016, REDOX BIOL, V10, P65, DOI 10.1016/j.redox.2016.09.009
   Ventura B, 2002, BBA-BIOENERGETICS, V1553, P249, DOI 10.1016/S0005-2728(01)00246-8
   Ventura-Clapier R, 2017, CLIN SCI, V131, P803, DOI 10.1042/CS20160485
   Wang Y, 2019, CNS NEUROSCI THER, V25, P816, DOI 10.1111/cns.13116
   Weber TA, 2010, EXP GERONTOL, V45, P503, DOI 10.1016/j.exger.2010.03.018
   Wu YS, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.714320
   Zhou KI, 2011, AGING-US, V3, P733, DOI 10.18632/aging.100367
NR 52
TC 4
Z9 4
U1 1
U2 8
PU ACAD SCIENCES CZECH REPUBLIC, INST PHYSIOLOGY
PI PRAGUE 4
PA VIDENSKA 1083, PRAGUE 4 142 20, CZECH REPUBLIC
SN 0862-8408
EI 1802-9973
J9 PHYSIOL RES
JI Physiol. Res.
PD DEC
PY 2022
VL 71
SU 2
BP S227
EP S236
DI 10.33549/physiolres.934995
PG 10
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA 8N0RU
UT WOS:000924861700008
PM 36647911
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU KASTEN, TP
   DUNAWAY, GA
AF KASTEN, TP
   DUNAWAY, GA
TI FRUCTOSE 2,6-BISPHOSPHATE - CHANGES DURING NEONATAL MATURATION AND AGING
   OF RAT AND POTENTIAL ROLE IN REGULATION OF GLUCOSE-UTILIZATION
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE AGING; DEVELOPMENT; 6-PHOSPHOFRUCTO-1-KINASE; FRUCTOSE-2,6-BISPHOSPHATE;
   ENERGY METABOLISM; METABOLIC REGULATION
ID 6-PHOSPHOFRUCTO-1-KINASE ISOZYME POOLS; FRUCTOSE-2,6-BISPHOSPHATE
   CONTENT; PHOSPHOFRUCTOKINASE ACTIVITY; LIVER PHOSPHOFRUCTOKINASE;
   SUBUNIT COMPOSITION; BRAIN; HEART; METABOLISM; GLYCOLYSIS
AB During the 6 days following birth, tissue levels of fructose-2,6-P2 in rat brain, liver, muscle, heart and kidney did not significantly change. However, by the tenth day postpartum fructose-2,6-P2 levels in brain, heart, and skeletal muscle increased approximately 50% and attained adult values. During maturation of liver, adult levels of fructose-2,6-P2 were not achieved until 3-4 weeks after birth or approximately at the time of maximum rates of gluconeogenesis. Renal fructose-2,6-P2 levels in the neonate were initially elevated and 2-3 weeks after birth decreased approximately 2.5-fold to adult values. With the exception of the pons-medulla, which showed no significant changes in fructose-2,6-P2 amounts, levels of this regulatory sugar from aging brain regions were generally decreased. The fructose-2,6-P2 levels from heart atria of old rats (24-30 month) were also significantly decreased. In diaphragm, the fructose-2,6-P2 levels were increased at 12 months of age and at 27 months of age were twice the level at 3 months. The fructose-2,6-P2 levels during the aging of liver, skeletal muscle (EDL and soleus), spleen, thymus, kidney, testis and lung were not significantly altered.
C1 SO ILLINOIS UNIV,SCH MED,DEPT PHARMACOL,SPRINGFIELD,IL 62794.
C3 Southern Illinois University System; Southern Illinois University
FU NIA NIH HHS [AG08014] Funding Source: Medline; NICHD NIH HHS [HD 16 666]
   Funding Source: Medline
CR AMBROSIO S, 1991, J NEUROCHEM, V57, P200, DOI 10.1111/j.1471-4159.1991.tb02116.x
   CLAUS TH, 1984, CURR TOP CELL REGUL, V23, P57
   CLAUS TH, 1980, P NATL ACAD SCI-BIOL, V77, P6501, DOI 10.1073/pnas.77.11.6501
   DUNAWAY GA, 1986, J BIOL CHEM, V261, P7170
   DUNAWAY GA, 1988, BRAIN RES, V456, P310, DOI 10.1016/0006-8993(88)90233-8
   DUNAWAY GA, 1989, MOL CELL BIOCHEM, V87, P71, DOI 10.1007/BF00421084
   DUNAWAY GA, 1986, MECH AGEING DEV, V36, P13, DOI 10.1016/0047-6374(86)90135-1
   DUNAWAY GA, 1985, J BIOL CHEM, V260, P4180
   DUNAWAY GA, 1990, BIOCHEM J, V266, P823
   DUNAWAY GA, 1983, MOL CELL BIOCHEM, V52, P75
   FURUYA E, 1980, P NATL ACAD SCI-BIOL, V77, P5861, DOI 10.1073/pnas.77.10.5861
   HUE L, 1982, J BIOL CHEM, V257, P4308
   HUE L, 1987, BIOCHEM J, V245, P313, DOI 10.1042/bj2450313
   LAWSON JWR, 1987, J BIOL CHEM, V262, P3165
   MARGOLIS RN, 1983, ENDOCRINOLOGY, V113, P893, DOI 10.1210/endo-113-3-893
   MHASKAR Y, 1991, MOL CELL BIOCHEM, V107, P39, DOI 10.1007/BF02424574
   NARABAYASHI H, 1985, J BIOL CHEM, V260, P9750
   OGUSHI S, 1990, J BIOL CHEM, V265, P10943
   PILKIS SJ, 1981, J BIOL CHEM, V256, P3619
   REINHART GD, 1980, BIOCHEMISTRY-US, V19, P1491, DOI 10.1021/bi00548a036
   SARTIN J, 1980, FED PROC, V39, P3163
   SCHUBERT C, 1983, BIOCHEM BIOPH RES CO, V113, P672, DOI 10.1016/0006-291X(83)91779-5
   UYEDA K, 1982, MOL CELL BIOCHEM, V48, P97
   VANSCHAFTINGEN E, 1980, BIOCHEM J, V192, P263, DOI 10.1042/bj1920263
   VANSCHAFTINGEN E, 1982, EUR J BIOCHEM, V129, P191
NR 25
TC 4
Z9 4
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD MAY
PY 1993
VL 68
IS 1-3
BP 37
EP 45
DI 10.1016/0047-6374(93)90138-H
PG 9
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA LG147
UT WOS:A1993LG14700004
PM 8350662
DA 2024-02-19
ER

PT J
AU Raza, MH
   Kim, MH
   Ding, L
   Fong, TL
   Romero, C
   Genyk, Y
   Sher, L
   Emamaullee, J
AF Raza, Muhammad H.
   Kim, Michelle H.
   Ding, Li
   Fong, Tse-Ling
   Romero, Christian
   Genyk, Yuri
   Sher, Linda
   Emamaullee, Juliet
TI Long-Term Financial, Psychosocial, and Overall it Check for updates
   Health-Related Quality of Life After Living Liver Donation
SO JOURNAL OF SURGICAL RESEARCH
LA English
DT Article
DE living liver donation; Living donor liver transplantation; Quality of
   life
ID DONOR HEPATIC LOBECTOMY; TRANSPLANTATION; ADULT; COMPLICATIONS;
   MORBIDITY; OUTCOMES; DEATH; HEPATECTOMY; PREDICTORS; MORTALITY
AB Background: To assess the impact of living liver donation (LD) in a diverse and aging population up to 20 y after donation, particularly with regard to medical, financial, psychosocial, and overall health-related quality of life (HRQOL).
   Methods: Patients undergoing LD between 1999 and 2009 were recruited to respond to the Short-Form 36 and a novel Donor Quality of Life Survey at two time points (2010 and 2018).
   Results: Sixty-eight living liver donors (LLDs) completed validated surveys, with a mean follow-up of 11.5 +/- 5.1 y. Per Donor Quality of Life Survey data, physical activity or strength was not impacted by LD in most patients. All respondents returned to school or employment, and 82.4% reported that LD had no impact on school or work performance. LD did not impact health insurability in 95.6% of donors, and only one patient experienced difficulty obtaining life insurance. Overall, 97.1% of respondents did not regret LD. Short-Form 36 survey-measured outcomes were similar between LLDs and the general U.S. population. LLDs who responded in both 2010 and 2018 were followed for an overall average of 15.4 +/- 2.4 y and HRQOL outcomes in these donors also remained statistically equivalent to U.S. population norms.
   Conclusions: This study represents the longest postdonation follow-up and offers unique insight related to HRQOL in a highly diverse patient population. Although LLDs continue to maintain excellent HRQOL outcomes up to 20 y after donation, continued lifetime follow-up is required to accurately provide young, healthy potential donors with an accurate description of the risks that they may incur on aging. (C) 2020 Elsevier Inc. All rights reserved.
C1 [Raza, Muhammad H.; Kim, Michelle H.; Fong, Tse-Ling; Genyk, Yuri; Sher, Linda; Emamaullee, Juliet] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90033 USA.
   [Kim, Michelle H.; Genyk, Yuri; Sher, Linda; Emamaullee, Juliet] Univ Southern Calif, Dept Surg, Div Hepatobiliary & Abdominal Transplant Surg, Los Angeles, CA 90033 USA.
   [Ding, Li] Univ Southern Calif, Dept Prevent Med, Los Angeles, CA 90033 USA.
   [Fong, Tse-Ling] Univ Southern Calif, Dept Gastrointestinal & Liver Dis, Los Angeles, CA 90033 USA.
   [Romero, Christian] Univ Southern Calif, Dept Surg, 1510 San Pablo St,Suite 412, Los Angeles, CA 90033 USA.
C3 University of Southern California; University of Southern California;
   University of Southern California; University of Southern California;
   University of Southern California
RP Emamaullee, J (corresponding author), Univ Southern Calif, Dept Surg, 1510 San Pablo St,Suite 412, Los Angeles, CA 90033 USA.
EM Juliet.emamaullee@med.usc.edu
RI Ding, Li/G-4031-2019; DING, LI/ABI-1989-2020; Emamaullee,
   Juliet/Q-9249-2019
OI Ding, Li/0000-0001-8565-430X; DING, LI/0000-0001-8565-430X; Emamaullee,
   Juliet/0000-0003-4238-3057; Kim, Michelle/0000-0002-7094-9938
FU National Center for Advancing Translational Science (NCATS) of the U.S.
   National Institutes of Health [UL1TR001855, UL1TR000130];  [R01
   HL1418570-01]
FX This work was supported by grants UL1TR001855 and UL1TR000130 from the
   National Center for Advancing Translational Science (NCATS) of the U.S.
   National Institutes of Health. The content is solely the responsibility
   of the authors and does not necessarily represent the official views of
   the National Institutes of Health.; J.E. was supported by an
   Investigator Research Supplement from the National Heart, Lung, and
   Blood Institute of the National Institutes of Health under award number
   R01 HL1418570-01.
CR Abecassis MM, 2012, AM J TRANSPLANT, V12, P1208, DOI 10.1111/j.1600-6143.2011.03972.x
   Abu-Gazala S, 2019, ANNU REV MED, V70, P225, DOI 10.1146/annurev-med-051517-125454
   Adcock L, 2010, AM J TRANSPLANT, V10, P364, DOI 10.1111/j.1600-6143.2009.02950.x
   Azoulay D, 2011, AM J TRANSPLANT, V11, P101, DOI 10.1111/j.1600-6143.2010.03284.x
   Berg CL, 2011, HEPATOLOGY, V54, P1313, DOI 10.1002/hep.24494
   Bernard H.R., 2017, INTRO TEXT QUALITATI
   Bonanno AP, 2008, TRANSPL P, V40, P720, DOI 10.1016/j.transproceed.2008.02.068
   Botha JF, 2010, LIVER TRANSPLANT, V16, P649, DOI 10.1002/lt.22043
   Brige P, 2018, J GASTROINTEST LIVER, V27, P169, DOI 10.15403/jgld.2014.1121.272.mor
   Castedal M, 2010, TRANSPL P, V42, P4449, DOI 10.1016/j.transproceed.2010.09.114
   Cheah YL, 2013, LIVER TRANSPLANT, V19, P499, DOI 10.1002/lt.23575
   Dew MA, 2018, TRANSPLANTATION, V102, P105, DOI 10.1097/TP.0000000000001942
   Dew MA, 2016, TRANSPLANTATION, V100, P1257, DOI 10.1097/TP.0000000000001144
   Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae
   Dubay DA, 2009, AM J TRANSPLANT, V9, P1169, DOI 10.1111/j.1600-6143.2009.02614.x
   Erim Y, 2007, LIVER TRANSPLANT, V13, P886, DOI 10.1002/lt.21168
   Farivar SS, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-54
   Fisher RA, 2017, NAT REV GASTRO HEPAT, V14, P373, DOI 10.1038/nrgastro.2017.2
   Ghobrial RM, 2008, GASTROENTEROLOGY, V135, P468, DOI 10.1053/j.gastro.2008.04.018
   Hall EC, 2014, JAMA SURG, V149, P288, DOI 10.1001/jamasurg.2013.3835
   Hashikura Y, 2009, TRANSPLANTATION, V88, P110, DOI 10.1097/TP.0b013e3181aaccb0
   Humphreville VR, 2016, LIVER TRANSPLANT, V22, P53, DOI 10.1002/lt.24304
   Janik MK, 2019, ANN TRANSPL, V24, P45, DOI 10.12659/AOT.911109
   Kim PTW, 2016, HEPATOBIL SURG NUTR, V5, P133, DOI 10.3978/j.issn.2304-3881.2015.06.01
   Kim W R, 2019, Am J Transplant, V19 Suppl 2, P184, DOI 10.1111/ajt.15276
   Kim-Schluger L, 2002, TRANSPLANTATION, V73, P1593, DOI 10.1097/00007890-200205270-00012
   Ladner DP, 2015, J HEPATOL, V62, P346, DOI 10.1016/j.jhep.2014.08.043
   Laucis NC, 2015, J BONE JOINT SURG AM, V97A, P1628, DOI 10.2106/JBJS.O.00030
   Laurence JM, 2015, LIVER TRANSPLANT, V21, P1082, DOI 10.1002/lt.24180
   Muzaale AD, 2012, GASTROENTEROLOGY, V142, P273, DOI 10.1053/j.gastro.2011.11.015
   Narasimhan G, 2016, TRANSPLANTATION, V100, P1251, DOI 10.1097/TP.0000000000001246
   Olthoff KM, 2015, ANN SURG, V262, P465, DOI 10.1097/SLA.0000000000001383
   Parikh ND, 2010, LIVER TRANSPLANT, V16, P1352, DOI 10.1002/lt.22181
   Rand Corporation, 36 IT SHORT FORM SUR
   Roll GR, 2013, LIVER TRANSPLANT, V19, P472, DOI 10.1002/lt.23608
   Rudow DL, 2019, LIVER TRANSPLANT, V25, P724, DOI 10.1002/lt.25402
   Takada Y, 2012, LIVER TRANSPLANT, V18, P1343, DOI 10.1002/lt.23509
   Trotter JF, 2007, TRANSPLANTATION, V83, P1506, DOI 10.1097/01.tp.0000263343.21714.3b
   Uchiyama H, 2014, AM J TRANSPLANT, V14, P367, DOI 10.1111/ajt.12559
   Umeshita K, 2003, LANCET, V362, P687, DOI 10.1016/S0140-6736(03)14230-4
   Wachs ME, 1998, TRANSPLANTATION, V66, P1313, DOI 10.1097/00007890-199811270-00008
   Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X
NR 42
TC 10
Z9 11
U1 2
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0022-4804
EI 1095-8673
J9 J SURG RES
JI J. Surg. Res.
PD SEP
PY 2020
VL 253
BP 41
EP 52
DI 10.1016/j.jss.2020.03.025
PG 12
WC Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery
GA MN5VN
UT WOS:000550908900008
PM 32320896
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Anticoli, S
   Arciello, M
   Mancinetti, A
   De Martinis, M
   Ginaldi, L
   Iuliano, L
   Balsano, C
AF Anticoli, Simona
   Arciello, Mario
   Mancinetti, Adriano
   De Martinis, Massimo
   Ginaldi, Lia
   Iuliano, Luigi
   Balsano, Clara
TI 7-Ketocholesterol and 5,6-Secosterol Modulate Differently the
   Stress-Activated Mitogen-Activated Protein Kinases (MAPKs) in Liver
   Cells
SO JOURNAL OF CELLULAR PHYSIOLOGY
LA English
DT Article
ID HEPATITIS-C VIRUS; OXIDATIVE STRESS; FREE-RADICALS; SENESCENCE;
   REGENERATION; APOPTOSIS; JNK; PATHOGENESIS; OXYSTEROLS; MECHANISMS
AB Enhanced oxidative stress is a common feature of liver diseases and contributes to chronic liver disease (CLD) progression by inducing fibrogenesis during liver regeneration. Peroxidation products of cholesterol metabolism, named oxysterols, are new and reliable markers of oxidative stress in vivo. Patients affected by CLDs present high plasma levels of oxysterols, raising the question of the origin and biological relevance of these compounds in the pathophysiology of chronic liver damage. The aim of this study was to examine the molecular basis of the biological effects of oxysterols on liver-derived cells, HepG2 and Huh7. Cells were treated with different concentrations (10(-9) to 10(-5) M) of 7-ketocholesterol used as a reference, and 5,6-secosterol, a recently discovered oxysterol. FACS investigations, caspase-3 activation, and Sytox Green immunofluorescent assay showed that pathological concentrations of oxysterols induced necrosis (30-50%) after 48 h of treatment. The two analyzed compounds displayed a similar, but not identical, behavior. In fact, 5,6-secosterol, but not 7-ketocholesterol, induced cell senescence. Notably, low concentrations of 5,6-secosterol caused a sustained activation of ERK 1/2, inducing cell proliferation, this unexpected behavior should be better characterized by further studies. Since enhanced oxidative stress is known to worsen liver chronic hepatitis and frequently results in overall decreased cellular survival, our data suggest the important and different role oxysterols may have in interfering with physiological liver tissue regeneration in injured human liver. Antioxidant treatment may provide a highly specific and effective mean to counteract the common consequences of oxidative stress on chronic hepatitis, such as fibrosis/cirrhosis and liver failure. J. Cell. Physiol. 222: 586-595, 2010. (C) 2009 Wiley-Liss, Inc.
C1 [Balsano, Clara] Fdn A Cesalpino, Med Clin 1, Policlin Umberto I, Lab Mol Virol & Oncol, I-00161 Rome, Italy.
   [Anticoli, Simona; Arciello, Mario; Mancinetti, Adriano; De Martinis, Massimo; Ginaldi, Lia; Balsano, Clara] Univ Aquila, Dept Internal Med, I-67100 Laquila, Italy.
   [Iuliano, Luigi] Univ Roma La Sapienza, Unit Vasc Med, Latina, Italy.
   [Iuliano, Luigi] Univ Roma La Sapienza, Dept Expt Med, Atherothrombosis Lab, Latina, Italy.
C3 Sapienza University Rome; University Hospital Sapienza Rome; University
   of L'Aquila; Sapienza University Rome; Sapienza University Rome
RP Balsano, C (corresponding author), Fdn A Cesalpino, Med Clin 1, Policlin Umberto I, Lab Mol Virol & Oncol, Viale Policlin 155, I-00161 Rome, Italy.
EM clara.balsano@cc.univaq.it
RI DE MARTINIS, MASSIMO/N-8725-2015; Anticoli, Simona/M-9940-2017; Balsano,
   Clara/AAK-9870-2020; Arciello, Mario/G-9278-2016; Anticoli,
   Simona/AAH-8838-2021; Iuliano, Luigi/A-5266-2008
OI DE MARTINIS, MASSIMO/0000-0003-4253-1312; Balsano,
   Clara/0000-0002-9615-7031; Arciello, Mario/0000-0001-8599-6297; Iuliano,
   Luigi/0000-0002-0027-9326; Ginaldi, Lia/0000-0003-1841-2807; Anticoli,
   Simona/0000-0003-3238-3280
FU Andrea Cesalpino Foundation [CB0100]
FX Contract grant sponsor: Andrea Cesalpino Foundation;; Contract grant
   number: CB0100.
CR Albano E, 2008, MOL ASPECTS MED, V29, P9, DOI 10.1016/j.mam.2007.09.004
   Arca M, 2007, FREE RADICAL BIO MED, V42, P698, DOI 10.1016/j.freeradbiomed.2006.12.013
   Barkla DH, 1999, PATHOLOGY, V31, P230, DOI 10.1080/003130299105043
   Beyer TA, 2008, EMBO J, V27, P212, DOI 10.1038/sj.emboj.7601950
   Biasi F, 2004, FASEB J, V18, P693, DOI 10.1096/fj.03-0401fje
   Choi J, 2006, AM J PHYSIOL-GASTR L, V290, pG847, DOI 10.1152/ajpgi.00522.2005
   Corradini SG, 2005, LIVER TRANSPLANT, V11, P1494, DOI 10.1002/lt.20524
   Das M, 2007, P NATL ACAD SCI USA, V104, P15759, DOI 10.1073/pnas.0707782104
   Diehl AM, 2002, FRONT BIOSCI-LANDMRK, V7, pE301, DOI 10.2741/diehl
   Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2
   Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x
   Javitt NB, 2008, STEROIDS, V73, P149, DOI 10.1016/j.steroids.2007.10.004
   Jung-Hynes B, 2009, CELL CYCLE, V8, P1478, DOI 10.4161/cc.8.10.8408
   Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041
   Kim DE, 2009, NEUROCHEM RES, V34, P1433, DOI 10.1007/s11064-009-9930-y
   Kwong J, 2009, J BIOL CHEM, V284, P11237, DOI 10.1074/jbc.M808327200
   Lemaire S, 1998, FEBS LETT, V440, P434, DOI 10.1016/S0014-5793(98)01496-3
   Leonarduzzi G, 2006, ANTIOXID REDOX SIGN, V8, P375, DOI 10.1089/ars.2006.8.375
   Lu T, 2008, EXP CELL RES, V314, P1918, DOI 10.1016/j.yexcr.2008.01.011
   Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1
   Mantena SK, 2008, FREE RADICAL BIO MED, V44, P1259, DOI 10.1016/j.freeradbiomed.2007.12.029
   Maruyama J, 2009, CURR MED CHEM, V16, P1229, DOI 10.2174/092986709787846613
   Matés JM, 2000, TOXICOLOGY, V153, P83, DOI 10.1016/S0300-483X(00)00306-1
   Matsuzawa A, 2008, BBA-GEN SUBJECTS, V1780, P1325, DOI 10.1016/j.bbagen.2007.12.011
   McConnell BB, 1998, CURR BIOL, V8, P351, DOI 10.1016/S0960-9822(98)70137-X
   McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775
   Miguet C, 2001, CELL DEATH DIFFER, V8, P83, DOI 10.1038/sj.cdd.4400792
   Moreira EF, 2001, J BIOL CHEM, V276, P18570, DOI 10.1074/jbc.M011259200
   O'Callaghan YC, 1999, EUR J NUTR, V38, P255, DOI 10.1007/s003940050075
   Okuda M, 2002, GASTROENTEROLOGY, V122, P366, DOI 10.1053/gast.2002.30983
   Pinzani M, 2004, DIGEST LIVER DIS, V36, P231, DOI 10.1016/j.dld.2004.01.003
   Reid AE, 2001, GASTROENTEROLOGY, V121, P710, DOI 10.1053/gast.2001.27126
   Roninson IB, 2001, DRUG RESIST UPDATE, V4, P303, DOI 10.1054/drup.2001.0213
   Savouret JF, 2001, J BIOL CHEM, V276, P3054, DOI 10.1074/jbc.M005988200
   Schroepfer GJ, 2000, PHYSIOL REV, V80, P361, DOI 10.1152/physrev.2000.80.1.361
   Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005
   Tanikawa K, 2006, MED MOL MORPHOL, V39, P22, DOI 10.1007/s00795-006-0313-z
   Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009
   Wada T, 2008, CELL DEATH DIFFER, V15, P89, DOI 10.1038/sj.cdd.4402222
   Weymann A, 2009, HEPATOLOGY, V50, P207, DOI 10.1002/hep.22979
NR 40
TC 22
Z9 23
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-9541
EI 1097-4652
J9 J CELL PHYSIOL
JI J. Cell. Physiol.
PD MAR
PY 2010
VL 222
IS 3
BP 586
EP 595
DI 10.1002/jcp.21972
PG 10
WC Cell Biology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Physiology
GA 552FM
UT WOS:000274273700014
PM 19937729
DA 2024-02-19
ER

PT J
AU Horvath, S
   Haghani, A
   Zoller, JA
   Naderi, A
   Soltanmohammadi, E
   Farmaki, E
   Kaza, V
   Chatzistamou, I
   Kiaris, H
AF Horvath, Steve
   Haghani, Amin
   Zoller, Joseph A.
   Naderi, Asieh
   Soltanmohammadi, Elham
   Farmaki, Elena
   Kaza, Vimala
   Chatzistamou, Ioulia
   Kiaris, Hippokratis
TI Methylation studies in <i>Peromyscus</i>: aging, altitude adaptation,
   and monogamy
SO GEROSCIENCE
LA English
DT Article; Early Access
DE Deer mouse; Aging; Epigenetic clock; DNA methylation
ID DNA METHYLATION; BRAIN; AGE; EVOLUTION; DISEASE
AB DNA methylation-based biomarkers of aging have been developed for humans and many other mammals and could be used to assess how stress factors impact aging. Deer mice (Peromyscus) are long-living rodents that have emerged as an informative model to study aging, adaptation to extreme environments, and monogamous behavior. In the present study, we have undertaken an exhaustive, genome-wide analysis of DNA methylation in Peromyscus, spanning different species, stocks, sexes, tissues, and age cohorts. We describe DNA methylation-based estimators of age for different species of deer mice based on novel DNA methylation data generated on highly conserved mammalian CpGs measured with a custom array. The multi-tissue epigenetic clock for deer mice was trained on 3 tissues (tail, liver, and brain). Two human-Peromyscus clocks accurately measure age and relative age, respectively. We present CpGs and enriched pathways that relate to different conditions such as chronological age, high altitude, and monogamous behavior. Overall, this study provides a first step towards studying the epigenetic correlates of monogamous behavior and adaptation to high altitude in Peromyscus. The human-Peromyscus epigenetic clocks are expected to provide a significant boost to the attractiveness of Peromyscus as a biological model.
C1 [Horvath, Steve; Haghani, Amin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.
   [Horvath, Steve; Zoller, Joseph A.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Biostat, Los Angeles, CA USA.
   [Naderi, Asieh; Soltanmohammadi, Elham; Farmaki, Elena; Kiaris, Hippokratis] Univ South Carolina, Coll Pharm, Dept Drug Discovery & Biomed Sci, Columbia, SC 29208 USA.
   [Kaza, Vimala; Kiaris, Hippokratis] Univ South Carolina, Peromyscus Genet Stock Ctr, Columbia, SC 29208 USA.
   [Chatzistamou, Ioulia] Univ South Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.
C3 University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA; University of California System; University of
   California Los Angeles; University of South Carolina System; University
   of South Carolina Columbia; University of South Carolina System;
   University of South Carolina Columbia; University of South Carolina
   System; University of South Carolina Columbia
RP Horvath, S (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.; Kiaris, H (corresponding author), Univ South Carolina, Coll Pharm, Dept Drug Discovery & Biomed Sci, Columbia, SC 29208 USA.
EM shorvath@mednet.ucla.edu; ahaghani@g.ucla.edu; jaz18@g.ucla.edu;
   elhams@email.sc.edu; efarmaki@coh.org; kaza@email.sc.edu;
   chatzistamou@uscmed.sc.edu; hk@sc.edu
RI Haghani, Amin/C-5543-2015
OI Haghani, Amin/0000-0002-6052-8793; Zoller, Joseph/0000-0001-6309-0291;
   Horvath, Steve/0000-0002-4110-3589; Naderi, Asieh/0000-0001-9911-5841
FU Paul G. Allen Frontiers Group; NSF [OIA-1736150, DBI-1755670]
FX This work was supported by the Paul G. Allen Frontiers Group (PI
   Horvath) and by the NSF (OIA-1736150) (PI H. Kiaris). The PGSC is
   supported by a grant from the NSF (DBI-1755670) (PI H. Kiaris). The
   funders had no role in the study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Abraham MA, 2016, DIABETOLOGIA, V59, P1367, DOI 10.1007/s00125-016-3950-3
   Bedford NL, 2015, ELIFE, V4, DOI 10.7554/eLife.06813
   Bell CG, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1824-y
   Bendesky A, 2017, NATURE, V544, P434, DOI 10.1038/nature22074
   CEDAR H, 1988, CELL, V53, P3, DOI 10.1016/0092-8674(88)90479-5
   Curtis JT, 2006, BRAIN RES, V1126, P76, DOI 10.1016/j.brainres.2006.07.126
   de Magalhaes JP, 2007, J GERONTOL A-BIOL, V62, P149
   Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01
   Hannon E, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007544
   Havighorst A, 2017, SEMIN CELL DEV BIOL, V61, P150, DOI 10.1016/j.semcdb.2016.06.020
   Hegarty SV, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08900-3
   Horvath S, 2021, GEROSCIENCE, V43, P2413, DOI 10.1007/s11357-021-00438-7
   Horvath S, 2018, AIDS, V32, P1465, DOI [10.1097/QAD.0000000000001854, 10.1097/qad.0000000000001854]
   Horvath S, 2018, NAT REV GENET, V19, P371, DOI 10.1038/s41576-018-0004-3
   Horvath S, 2015, AGING-US, V7, P1130, DOI 10.18632/aging.100859
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Jasarevic E, 2013, J COMP PSYCHOL, V127, P91, DOI 10.1037/a0027936
   Jung M, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0118-4
   Kabacik S, 2018, AGING-US, V10, P2800, DOI 10.18632/aging.101588
   Kellar D, 2020, LANCET NEUROL, V19, P758, DOI 10.1016/S1474-4422(20)30231-3
   KLEIMAN DG, 1977, Q REV BIOL, V52, P39, DOI 10.1086/409721
   Klug H, 2018, FRONT ECOL EVOL, V6, DOI 10.3389/fevo.2018.00030
   Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559
   Mazzeo RS, 2005, EXERC IMMUNOL REV, V11, P6
   McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630
   MEEHAN RT, 1987, ANN EMERG MED, V16, P974, DOI 10.1016/S0196-0644(87)80743-6
   Meer MV, 2018, ELIFE, V7, DOI 10.7554/eLife.40675
   Morgello S, 2001, NEUROPATH APPL NEURO, V27, P326, DOI 10.1046/j.0305-1846.2001.00334.x
   Nowak RM., 1999, WALKERS MAMMALS WORL
   Oliver SJ, 2013, HIGH ALT MED BIOL, V14, P144, DOI 10.1089/ham.2012.1070
   Petkovich DA, 2017, CELL METAB, V25, P954, DOI 10.1016/j.cmet.2017.03.016
   Prado NA, 2021, AGING CELL, V20, DOI 10.1111/acel.13414
   Raj K, 2021, GEROSCIENCE, V43, P2363, DOI 10.1007/s11357-021-00445-8
   Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109
   Schachtschneider KM, 2021, GEROSCIENCE, V43, P2467, DOI 10.1007/s11357-021-00439-6
   Scribner JL, 2020, P NATL ACAD SCI USA, V117, P11076, DOI 10.1073/pnas.1917287117
   Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354
   Soltanmohammadi E, 2021, EXP GERONTOL, V144, DOI 10.1016/j.exger.2020.111191
   Steinman MQ, 2017, SEMIN CELL DEV BIOL, V61, P92, DOI 10.1016/j.semcdb.2016.06.021
   Storz JF, 2007, PLOS GENET, V3, P448, DOI 10.1371/journal.pgen.0030045
   Stouffer S.A., 1949, The American Soldier: Adjustment during Army Life. (Studies in Social Psychology in World War II), VVolume 1, P87
   Stubbs TM, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1203-5
   Sugrue VJ, 2021, ELIFE, V10, DOI 10.7554/eLife.64932
   Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109
   Thompson MJ, 2018, AGING-US, V10, P2832, DOI 10.18632/aging.101590
   Vrana PB, 2014, WIRES DEV BIOL, V3, P211, DOI 10.1002/wdev.132
   Vrana PB, 1998, NAT GENET, V20, P362, DOI 10.1038/3833
   Vu, 2021, MAMMALIAN METHYLATIO
   Wang TN, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1186-2
   Weigl R., 2005, Longevity of mammals in captivity; from the living collections of the world
   Zhou WD, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gky691
NR 51
TC 3
Z9 4
U1 2
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 2509-2715
EI 2509-2723
J9 GEROSCIENCE
JI GeroScience
PD 2022 FEB
PY 2022
VL 44
IS 1
SI SI
BP 447
EP 461
DI 10.1007/s11357-021-00472-5
EA OCT 2021
PG 15
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA YR7XN
UT WOS:000711289100002
PM 34698996
OA hybrid, Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Kim, KH
   Park, GT
   Lim, YB
   Rue, SW
   Jung, JC
   Sonn, JK
   Bae, YS
   Park, JW
   Lee, YS
AF Kim, KH
   Park, GT
   Lim, YB
   Rue, SW
   Jung, JC
   Sonn, JK
   Bae, YS
   Park, JW
   Lee, YS
TI Expression of connective tissue growth factor, a biomarker in senescence
   of human diploid fibroblasts, is up-regulated by a transforming growth
   factor-β-mediated signaling pathway
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE senescence; TGF-beta; CTGF; human diploid fibroblasts
ID FACTOR INDUCES APOPTOSIS; FACTOR GENE-EXPRESSION; REPLICATIVE
   SENESCENCE; FIBROSIS; STRESS; CELLS; SKIN; RAT; P53; PROLIFERATION
AB Molecular changes associated with cellular senescence in human diploid fibroblasts (HDF), IMR-90, were analyzed by two-dimensional differential proteome analysis. A high percentage of replicative senescent cells were positive for senescence-associated beta-galactosidase activity, and displayed elevated levels of p21 and p53 proteins. Comparison of early population doubling level (PDL) versus replicative senescent cells among the 1000 spots resolved on gels revealed that the signal intensities of six spots were increased fivefold, whereas those of four spots were decreased. Proteome analysis data demonstrated that connective tissue growth factor (CTGF) is an age-associated protein. Up-regulation of CTGF expression in senescent cells was further confirmed by Western blotting and RT-PCR. We postulate that CTGF expression is controlled, in part, by transforming growth factor-beta (TGF-beta), in view of the high levels of TGF-beta isoforms as well as type I and II receptors detected only in late PDL of HDF cells. To verify this hypothesis, we stimulated early PDL cells with TGF-beta1 as well as stress inducing agents such as hydrogen peroxide. As expected, CTGF expression and Smad protein phosphorylation were dramatically increased up to observed levels in normal replicative senescent cells. In vivo experiments disclosed that CTGF, pSmad, and p53 were constitutively expressed at basal levels in up to 18-month-old rat liver, and expression was significantly up-regulated in 24-month-old rat tissue. However, expression patterns were not altered at all periods examined in livers of caloric-restricted rats. In view of both in vitro and in vivo data, we propose that the TGF-beta/Smad pathway functions in the induction of CTGF, a novel biomarker protein of cellular senescence in human fibroblasts. (C) 2004 Elsevier Inc. All rights reserved.
C1 Kyungpook Natl Univ, Coll Nat Sci, Dept Biochem, Taegu 702701, South Korea.
   Kyungpook Natl Univ, Coll Nat Sci, Dept Biol, Taegu 702701, South Korea.
   Kyungpook Natl Univ, Teachers Coll, Dept Biol, Taegu 702701, South Korea.
C3 Kyungpook National University; Kyungpook National University; Kyungpook
   National University
RP Lee, YS (corresponding author), Kyungpook Natl Univ, Coll Nat Sci, Dept Biochem, Taegu 702701, South Korea.
EM yselee@kyungpook.ac.kr
RI Park, Ji Won/JCD-9105-2023; Kim, Hyung-Kwan/ITU-6159-2023; Kim,
   Hyung-Kwan/R-8375-2019
OI Park, Ji Won/0000-0003-0046-8175; Bae, Young-Seuk/0000-0002-5520-4444
FU NIA NIH HHS [AG 01188] Funding Source: Medline
CR ABRASS CK, 1995, AM J PATHOL, V146, P742
   BarcellosHoff MH, 1996, MOL ENDOCRINOL, V10, P1077, DOI 10.1210/me.10.9.1077
   Benvenuti S, 2002, MOL CELL PROTEOMICS, V1, P280, DOI 10.1074/mcp.M100028-MCP200
   BRADHAM DM, 1991, J CELL BIOL, V114, P1285, DOI 10.1083/jcb.114.6.1285
   Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189
   Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169
   Caldini R, 1998, MECH AGEING DEV, V105, P137, DOI 10.1016/S0047-6374(98)00085-2
   Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1
   Chang BD, 1999, ONCOGENE, V18, P4808, DOI 10.1038/sj.onc.1203078
   CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337
   Chen QM, 2000, BIOCHEM J, V347, P543, DOI 10.1042/0264-6021:3470543
   Chen QM, 1998, BIOCHEM J, V332, P43, DOI 10.1042/bj3320043
   Coyle B, 2003, J BIOL CHEM, V278, P5920, DOI 10.1074/jbc.M211300200
   Dierick JF, 2002, FEBS LETT, V531, P499, DOI 10.1016/S0014-5793(02)03604-9
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Dumont P, 2000, FREE RADICAL BIO MED, V28, P361, DOI 10.1016/S0891-5849(99)00249-X
   Frazier K, 1996, J INVEST DERMATOL, V107, P404, DOI 10.1111/1523-1747.ep12363389
   Frippiat C, 2001, J BIOL CHEM, V276, P2531, DOI 10.1074/jbc.M006809200
   Gagliano N, 2000, J GERONTOL A-BIOL, V55, pB365, DOI 10.1093/gerona/55.8.B365
   GENG Y, 1994, P NATL ACAD SCI USA, V91, P8602, DOI 10.1073/pnas.91.18.8602
   Grotendorst GR, 1996, CELL GROWTH DIFFER, V7, P469
   Ha HJ, 2000, KIDNEY INT, V58, pS19, DOI 10.1046/j.1523-1755.2000.07704.x
   Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   Hishikawa K, 2000, EUR J PHARMACOL, V392, P19, DOI 10.1016/S0014-2999(00)00115-1
   Hishikawa K, 1999, J BIOL CHEM, V274, P37461, DOI 10.1074/jbc.274.52.37461
   Hishikawa K, 1999, EUR J PHARMACOL, V385, P287, DOI 10.1016/S0014-2999(99)00763-3
   Holmes A, 2003, J BIOL CHEM, V278, P41728, DOI 10.1074/jbc.M305019200
   IGARASHI A, 1995, J INVEST DERMATOL, V105, P280, DOI 10.1111/1523-1747.ep12318465
   IGARASHI A, 1993, MOL BIOL CELL, V4, P637, DOI 10.1091/mbc.4.6.637
   Ito Y, 1998, KIDNEY INT, V53, P853, DOI 10.1046/j.1523-1755.1998.00820.x
   Kretzschmar M, 1998, CURR OPIN GENET DEV, V8, P103, DOI 10.1016/S0959-437X(98)80069-5
   KULJU KS, 1995, EXP CELL RES, V217, P336, DOI 10.1006/excr.1995.1095
   Lee EH, 1999, INVEST OPHTH VIS SCI, V40, P2025
   Massagué J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753
   Mawal-Dewan M, 2002, J BIOL CHEM, V277, P7857, DOI 10.1074/jbc.M104515200
   MILLIS AJT, 1992, EXP CELL RES, V201, P373, DOI 10.1016/0014-4827(92)90286-H
   Mori T, 1999, J CELL PHYSIOL, V181, P153, DOI 10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K
   Moussad EEDA, 2000, MOL GENET METAB, V71, P276, DOI 10.1006/mgme.2000.3059
   Paradis V, 1999, HEPATOLOGY, V30, P968, DOI 10.1002/hep.510300425
   Park SK, 2001, BIOCHEM BIOPH RES CO, V284, P966, DOI 10.1006/bbrc.2001.5058
   Razzaque MS, 2003, PATHOL INT, V53, P133, DOI 10.1046/j.1440-1827.2003.01446.x
   Smith JR, 1996, SCIENCE, V273, P63, DOI 10.1126/science.273.5271.63
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Stratton R, 2002, FASEB J, V16, P1949, DOI 10.1096/fj.02-0204fje
   Stratton R, 2001, J CLIN INVEST, V108, P241, DOI 10.1172/JCI12020
   Thannickal VJ, 1995, J BIOL CHEM, V270, P30334, DOI 10.1074/jbc.270.51.30334
   Toussaint O, 2000, EXP GERONTOL, V35, P927, DOI 10.1016/S0531-5565(00)00180-7
   Tremain R, 2000, ONCOGENE, V19, P1698, DOI 10.1038/sj.onc.1203471
   VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305
NR 50
TC 53
Z9 64
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD JUN 11
PY 2004
VL 318
IS 4
BP 819
EP 825
DI 10.1016/j.bbrc.2004.04.108
PG 7
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 825RQ
UT WOS:000221776400003
PM 15147944
DA 2024-02-19
ER

PT J
AU OKAMOTO, M
   KITA, T
   OKUDA, H
   TANAKA, T
   NAKASHIMA, T
AF OKAMOTO, M
   KITA, T
   OKUDA, H
   TANAKA, T
   NAKASHIMA, T
TI EFFECTS OF AGING ON ACUTE TOXICITY OF NICOTINE IN RATS
SO PHARMACOLOGY & TOXICOLOGY
LA English
DT Article
ID BINDING-SITES; BRAIN; CORTICOSTERONE; ALZHEIMERS; MECHANISMS; SECRETION;
   DOPAMINE; INVIVO; SYSTEM
AB Acute toxicity of nicotine was examined in old (24 months) and young (6 weeks) Wistar rats. There were no significant age differences in the mortality and convulsive responses induced by an intraperitoneal injection of nicotine (24.5 mg/kg). The lethal nicotine levels in blood and cortex and the latent period to death in old rats were larger than those in young rats. Cortical and blood nicotine levels 15 min, after the nicotine injection in old rats were also higher than those in young rats. Nicotine significantly increased dopamine, 3,4-dihydroxyphenylacetic acid and homovanillic acid levels in striatum and hippocampus in young rats, but not those in old rats. Moreover, nicotine-induced elevations in blood levels of corticosterone in old rats were also less than those in young rats. On the other hand, the cytochrome P-450 content, the nicotine oxidase activity and the flavin-containing monooxygenase activity in liver showed age-related decreases in the young, the middle-aged (12 months) and the old rats. These results indicate that the acute toxicity of nicotine in old rats reflects the decreases in hepatic nicotine metabolism and in brain sensitivity to nicotine.
RP OKAMOTO, M (corresponding author), NARA MED UNIV,DEPT PHARMACOL,KASHIHARA,NARA 634,JAPAN.
CR ARAUJO DM, 1990, J NEUROSCI, V10, P3069
   AUBERT I, 1992, J NEUROCHEM, V58, P529, DOI 10.1111/j.1471-4159.1992.tb09752.x
   BENWELL MEM, 1992, BRIT J PHARMACOL, V105, P849, DOI 10.1111/j.1476-5381.1992.tb09067.x
   CLARKE PBS, 1990, BIOCHEM PHARMACOL, V40, P1427, DOI 10.1016/0006-2952(90)90436-O
   CONTEDEVOLX B, 1981, LIFE SCI, V28, P1067, DOI 10.1016/0024-3205(81)90755-4
   FLYNN DD, 1986, J NEUROCHEM, V47, P1948, DOI 10.1111/j.1471-4159.1986.tb13113.x
   FUNG YK, 1989, PHARMACOL BIOCHEM BE, V32, P221, DOI 10.1016/0091-3057(89)90237-2
   GIORGUIEFFCHESSELET MF, 1979, LIFE SCI, V25, P1257, DOI 10.1016/0024-3205(79)90469-7
   GLOWINSKI J, 1966, J NEUROCHEM, V13, P655, DOI 10.1111/j.1471-4159.1966.tb09873.x
   HICKS CS, 1947, AUST J EXP BIOL MED, V25, P83, DOI 10.1038/icb.1947.12
   HUCKER HB, 1960, J PHARMACOL EXP THER, V129, P94
   KATO R, 1968, JPN J PHARMACOL, V18, P389, DOI 10.1254/jjp.18.389
   KATO R, 1964, BIOCHEM PHARMACOL, V13, P1037, DOI 10.1016/0006-2952(64)90100-5
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MAYER GS, 1983, J CHROMATOGR, V255, P533, DOI 10.1016/S0021-9673(01)88308-4
   OKAMOTO M, 1992, JPN J PHARMACOL, V59, P449, DOI 10.1254/jjp.59.449
   OMURA T, 1964, J BIOL CHEM, V239, P2370
   PETTIT FH, 1963, BIOCHEM BIOPH RES CO, V13, P193, DOI 10.1016/0006-291X(63)90280-8
   POMERLEAU OF, 1989, PSYCHONEUROENDOCRINO, V14, P407, DOI 10.1016/0306-4530(89)90040-1
   POMERLEAU OF, 1992, AM J MED, V93, pS2, DOI 10.1016/0002-9343(92)90619-M
   PONZIO F, 1982, NEUROBIOL AGING, V3, P23, DOI 10.1016/0197-4580(82)90057-4
   PRADHAN SN, 1980, LIFE SCI, V26, P1643, DOI 10.1016/0024-3205(80)90172-1
   ROWELL PP, 1987, TOBACCO SMOKING NICO, P191
   SHIMIZU K, 1983, J CHROMATOGR, V272, P170, DOI 10.1016/S0378-4347(00)86114-9
   SILVETTE H, 1962, PHARMACOL REV, V14, P137
   SLOAN JW, 1989, PHARMACOL BIOCHEM BE, V34, P559, DOI 10.1016/0091-3057(89)90558-3
   SONNTAG WE, 1987, ENDOCRINOLOGY, V120, P2308, DOI 10.1210/endo-120-6-2308
   STALHANDSKE T, 1969, ACTA PHARMACOL TOX, V27, P363
   STALHANDSKE T, 1970, ACTA PHARMACOL TOX, V28, P233
   TEPPER JM, 1979, PHARMACOL BIOCHEM BE, V10, P349, DOI 10.1016/0091-3057(79)90196-5
   Thomas JE, 1928, J PHARMACOL EXP THER, V34, P111
   YAMAMOTO I, 1966, JPN J PHARMACOL, V16, P295, DOI 10.1254/jjp.16.295
   ZHANG X, 1990, INT J DEV NEUROSCI, V8, P715, DOI 10.1016/0736-5748(90)90065-A
NR 33
TC 46
Z9 53
U1 0
U2 12
PU MUNKSGAARD INT PUBL LTD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0901-9928
J9 PHARMACOL TOXICOL
JI Pharmacol. Toxicol.
PD JUL
PY 1994
VL 75
IS 1
BP 1
EP 6
DI 10.1111/j.1600-0773.1994.tb00316.x
PG 6
WC Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Toxicology
GA NV666
UT WOS:A1994NV66600001
PM 7971729
DA 2024-02-19
ER

PT J
AU Rabek, JP
   Boylston, WH
   Papaconstantinou, J
AF Rabek, JP
   Boylston, WH
   Papaconstantinou, J
TI Carbonylation of ER chaperone proteins in aged mouse liver
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE endoplasmic reticulum; oxidative damage; carbonylation; aging; chaperone
   proteins
ID OXIDATIVE STRESS; POSTTRANSCRIPTIONAL REGULATION; ENDOPLASMIC-RETICULUM;
   MITOCHONDRIAL DISEASE; DAMAGE; GENERATION; EXPRESSION; ALPHA
AB Progressive accumulation of oxidative damage to macromolecules in aged tissues is thought to contribute to the decline in tissue function characteristic of the aged phenotype. Mitochondria are a major intracellular source of reactive oxygen species (ROS); however, other organelles are also endogenous sources of oxyradicals and oxidants, which can damage macromolecules. We, therefore, sought to examine the relationship between aging and oxidative damage to ER resident proteins, which exist in a strongly oxidizing environment necessary for disulfide bond formation. In these studies, we have fractionated young and aged liver homogenates, resolved the proteins by 2D gel electrophoresis, assayed for oxidative damage as indicated by protein carbonylation, and identified BiP/Grp78, protein disulfide isomerase (PDI), and calreticulin as exhibiting an age-associated increase in oxidative damage. Increased carbonylation of these key proteins in aged liver suggests an age-associated impairment in protein folding, disulfide crosslinking, and glycosylation in the aged mouse liver. (C) 2003 Elsevier Science (USA). All rights reserved.
C1 Univ Texas, Med Branch, Dept Human Biol Chem & Genet, Galveston, TX 77550 USA.
C3 University of Texas System; University of Texas Medical Branch Galveston
RP Papaconstantinou, J (corresponding author), Univ Texas, Med Branch, Dept Human Biol Chem & Genet, Galveston, TX 77550 USA.
EM jpapacon@utmb.edu
RI Papaconstantinou, John/E-3312-2010
FU NIA NIH HHS [P30 AG024832, P02 AG10514] Funding Source: Medline
CR An MR, 1996, MOL CELL BIOL, V16, P2295
   Barja G, 2002, FREE RADICAL BIO MED, V33, P1167, DOI 10.1016/S0891-5849(02)00910-3
   Barja G, 1999, J BIOENERG BIOMEMBR, V31, P347, DOI 10.1023/A:1005427919188
   Beal MF, 2002, FREE RADICAL BIO MED, V32, P797, DOI 10.1016/S0891-5849(02)00780-3
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   Dhahbi JM, 1997, J NUTR, V127, P1758, DOI 10.1093/jn/127.9.1758
   Drew B, 2002, ANN NY ACAD SCI, V959, P66, DOI 10.1111/j.1749-6632.2002.tb02084.x
   Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820
   Fewell SW, 2001, ANNU REV GENET, V35, P149, DOI 10.1146/annurev.genet.35.102401.090313
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   GETHING MJ, 1997, GUIDEBOOK MOL CHAPER, P59
   Golden TR, 2001, MECH AGEING DEV, V122, P1577, DOI 10.1016/S0047-6374(01)00288-3
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   Hsieh CC, 1998, MOL BIOL CELL, V9, P1479, DOI 10.1091/mbc.9.6.1479
   Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4
   Levine RL, 2001, EXP GERONTOL, V36, P1495, DOI 10.1016/S0531-5565(01)00135-8
   Levine RL, 2000, METH MOL B, V99, P15
   Ma YJ, 2002, CELL STRESS CHAPERON, V7, P222, DOI 10.1379/1466-1268(2002)007<0222:TMERAA>2.0.CO;2
   Ma YJ, 2001, CELL, V107, P827, DOI 10.1016/S0092-8674(01)00623-7
   Mandavilli BS, 2002, MUTAT RES-FUND MOL M, V509, P127, DOI 10.1016/S0027-5107(02)00220-8
   Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846
   Mouradian MM, 2002, NEUROLOGY, V58, P179, DOI 10.1212/WNL.58.2.179
   Mueller S, 2002, BIOCHEM J, V363, P483, DOI 10.1042/0264-6021:3630483
   PARODI AJ, 2002, ANNU REV BIOCHEM, V69, P69
   Rajapakse N, 2001, BRAIN RES PROTOC, V8, P176, DOI 10.1016/S1385-299X(01)00108-8
   Rakhit R, 2002, J BIOL CHEM, V277, P47551, DOI 10.1074/jbc.M207356200
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P37, DOI 10.1016/S0891-5849(02)00856-0
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   Stadtman ER, 2001, ANN NY ACAD SCI, V928, P22
   Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191
   Tien M, 1999, P NATL ACAD SCI USA, V96, P7809, DOI 10.1073/pnas.96.14.7809
   Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571
   Tu BP, 2002, MOL CELL, V10, P983, DOI 10.1016/S1097-2765(02)00696-2
   Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168
   Yan LJ, 1998, P NATL ACAD SCI USA, V95, P12896, DOI 10.1073/pnas.95.22.12896
NR 35
TC 119
Z9 138
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD JUN 6
PY 2003
VL 305
IS 3
BP 566
EP 572
DI 10.1016/S0006-291X(03)00826-X
PG 7
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 687BG
UT WOS:000183355500020
PM 12763031
DA 2024-02-19
ER

PT J
AU Mura, CV
   Gong, X
   Taylor, A
   VillalobosMolina, R
   Scrofano, MM
AF Mura, CV
   Gong, X
   Taylor, A
   VillalobosMolina, R
   Scrofano, MM
TI Effects of calorie restriction and aging on the expression of
   antioxidant enzymes and ubiquitin in the liver of Emory mice
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE aging; caloric restriction; catalase; glutathione peroxidase; mice;
   superoxide dismutase; ubiquitin
ID SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; DIETARY RESTRICTION;
   GLUTATHIONE-PEROXIDASE; CATARACT FORMATION; FOOD RESTRICTION; DELAYS
   CATARACT; FREE-RADICALS; LIFE-SPAN; RAT-LIVER
AB We studied the effect of age and calorie restriction on the expression of genes involved in antioxidant defenses in livers of young (4.5-6 months) and old (22 months) Emory mice fed a control (C) or restricted (R) diet. Specifically examined were catalase (CAT), glutathione peroxidase (Gpx), Cu/Zn and Mn superoxide dismutase (Cu/ZnSOD and MnSOD). As an indicator of oxidative damage to the tissues we measured lipid peroxidation. As indicators of oxidative stress we determined ubiquitin mRNA levels and endogenous high molecular weight (HMW) ubiquitin conjugates. Lower mRNA levels of ubiquitin (P < 0.05), CAT (P < 0.01) and Gpx (P < 0.01) were observed in tissues from young R versus C animals. The old C group had a lower CAT mRNA level (P < 0.0001) compared with young C. In the R group, age did not affect the CAT mRNA levels or Gpx mRNA levels; however, ubiquitin mRNA levels were higher (P < 0.05). No significant changes in Cu/Zn or MnSOD mRNA were observed with age or diet. Cu/ZnSOD protein levels were lower in the young R at 4.5 months (P < 0.05) than young C, and higher in the old R group versus old C (P < 0.05). CAT protein levels were higher in the old C versus old R (P < 0.05). Changes of HMW ubiquitin conjugates with age or diet were not significant. Of the four groups, the old R group showed the highest levels of lipid peroxidation.
C1 CINVESTAV IPN,DEPT PHARMACOL & TOXICOL,MEXICO CITY 14000,DF,MEXICO.
C3 CINVESTAV - Centro de Investigacion y de Estudios Avanzados del
   Instituto Politecnico Nacional
RP Mura, CV (corresponding author), TUFTS UNIV,JEAN MAYER USDA HUMAN NUTR RES CTR AGING,LAB NUTR & VIS RES,BOSTON,MA 02111, USA.
CR AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   AMSTAD P, 1991, BIOCHEMISTRY-US, V30, P9305, DOI 10.1021/bi00102a024
   BRONSON RT, 1991, GROWTH DEVELOP AGING, V55, P169
   CEBALLOS I, 1988, BIOCHIM BIOPHYS ACTA, V949, P5864
   CHIPALKATTI S, 1983, J NUTR, V113, P944, DOI 10.1093/jn/113.5.944
   CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4
   ELSTNER EF, 1976, ANAL BIOCHEM, V70, P616, DOI 10.1016/0003-2697(76)90488-7
   FEUERS RJ, 1993, MUTAT RES, V295, P191, DOI 10.1016/0921-8734(93)90020-4
   FINCH JS, 1992, CELL GROWTH DIFFER, V3, P269
   FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2
   FLOHE L, 1984, METHOD ENZYMOL, V105, P114
   FORNACE AJ, 1989, NUCLEIC ACIDS RES, V17, P1215, DOI 10.1093/nar/17.3.1215
   HALLIWELL B, 1994, NUTR REV, V52, P253
   HARRIS ED, 1992, FASEB J, V6, P2675, DOI 10.1096/fasebj.6.9.1612291
   HARRISON DE, 1987, J NUTR, V117, P376, DOI 10.1093/jn/117.2.376
   HEYDARI AR, 1995, J NUTR, V125, P410
   IMRE S, 1987, MECH AGEING DEV, V38, P259, DOI 10.1016/0047-6374(87)90094-7
   JENTSCH S, 1992, ANNU REV GENET, V26, P179, DOI 10.1146/annurev.ge.26.120192.001143
   JI LL, 1990, AM J PHYSIOL, V258, pR918, DOI 10.1152/ajpregu.1990.258.4.R918
   JONES PL, 1995, GENE, V153, P155, DOI 10.1016/0378-1119(94)00666-G
   Kehrer JP, 1994, NATURAL ANTIOXIDANTS, P25
   KELLNER MJ, 1995, FREE RADIC BIOL MED, V18, P497
   KELLNER MJ, 1990, J BIOL CHEM, V265, P10872
   KOISUMI A, 1987, J NUTR, V117, P361
   KRINSKY NI, 1992, P SOC EXP BIOL MED, V200, P248
   KRISTAL BS, 1994, MODULATION AGING PRO, P1
   KUCK JFR, 1990, EXP EYE RES, V50, P659, DOI 10.1016/0014-4835(90)90110-G
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   MASORO EJ, 1991, ANN NY ACAD SCI, V621, P337
   MAYER RJ, 1991, BIOCHIM BIOPHYS ACTA, V1089, P141, DOI 10.1016/0167-4781(91)90002-4
   MICHIELS C, 1994, FREE RADICAL BIO MED, V17, P235, DOI 10.1016/0891-5849(94)90079-5
   MOTE PL, 1990, MECH AGEING DEV, V53, P101, DOI 10.1016/0047-6374(90)90038-H
   MOTE PL, 1991, J GERONTOL, V46, pB95, DOI 10.1093/geronj/46.3.B95
   MURA CV, 1993, CURR EYE RES, V12, P1081, DOI 10.3109/02713689309033506
   NOHL H, 1993, BRIT MED BULL, V49, P653, DOI 10.1093/oxfordjournals.bmb.a072638
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   PACIFICI RE, 1991, GERONTOLOGY, V37, P166
   PLACER ZA, 1966, ANAL BIOCHEM, V16, P359, DOI 10.1016/0003-2697(66)90167-9
   RAO G, 1990, J NUTR, V120, P602, DOI 10.1093/jn/120.6.602
   RIKANS LE, 1991, BIOCHIM BIOPHYS ACTA, V1074, P195, DOI 10.1016/0304-4165(91)90061-K
   SEMSEI I, 1989, BIOCHEM BIOPH RES CO, V164, P620, DOI 10.1016/0006-291X(89)91505-2
   SHANG F, 1995, BIOCHEM J, V307, P297, DOI 10.1042/bj3070297
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Sies H., 1994, NATURAL ANTIOXIDANTS, P107
   STADTMAN ER, 1992, FREE RADICALS AGING, P65
   TAYLOR A, 1995, MECH AGEING DEV, V79, P33, DOI 10.1016/0047-6374(94)01541-S
   TAYLOR A, 1995, EXP EYE RES, V61, P55, DOI 10.1016/S0014-4835(95)80058-1
   TAYLOR A, 1987, FREE RADICAL BIO MED, V3, P371, DOI 10.1016/0891-5849(87)90015-3
   TAYLOR A, 1989, FASEB J, V3, P1741, DOI 10.1096/fasebj.3.6.2703107
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Weindruch R., 1988, RETARDATION AGING DI, P231
   YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139
NR 52
TC 32
Z9 32
U1 0
U2 1
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD OCT 25
PY 1996
VL 91
IS 2
BP 115
EP 129
DI 10.1016/0047-6374(96)01780-0
PG 15
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA VM783
UT WOS:A1996VM78300003
PM 8905609
DA 2024-02-19
ER

PT J
AU Hunt, NJ
   Lockwood, GP
   Kang, SWS
   Westwood, LJ
   Limantoro, C
   Chrzanowski, W
   McCourt, PAG
   Kuncic, Z
   Le Couteur, DG
   Cogger, VC
AF Hunt, Nicholas J.
   Lockwood, Glen P.
   Kang, Sun W. S.
   Westwood, Lara J.
   Limantoro, Christina
   Chrzanowski, Wojciech
   McCourt, Peter A. G.
   Kuncic, Zdenka
   Le Couteur, David G.
   Cogger, Victoria C.
TI Quantum Dot Nanomedicine Formulations Dramatically Improve
   Pharmacological Properties and Alter Uptake Pathways of Metformin and
   Nicotinamide Mononucleotide in Aging Mice
SO ACS NANO
LA English
DT Article; Early Access
DE pharmaceutical; drug development; nanocrystals; liver; pharmacokinetics;
   pharmacodynamics
ID CLINICAL TRANSLATION; NANOPARTICLE SIZE; CELLULAR UPTAKE; PROTEIN
   CORONA; LIVER; DELIVERY; PHARMACOKINETICS; NANOCRYSTALS; CLEARANCE;
   MECHANISM
AB Orally administered Ag2S quantum dots (QDs) rapidly cross the small intestine and are taken up by the liver. Metformin and nicotinamide mononucleotide (NMN) target metabolic and aging processes within the liver. This study examined the pharmacology and toxicology of QD-based nanomedicines as carriers of metformin and NMN in young and old mice, determining if their therapeutic potency and reduced effects associated with aging could be improved. Pharmacokinetic studies demonstrated that QD-conjugated metformin and NMN have greater bioavailability, with selective accumulation in the liver following oral administration compared to unconjugated formulations. Pharmacodynamic data showed that the QD-conjugated medicines had increased physiological, metabolic, and cellular potency compared to unconjugated formulations (25x metformin; 100x NMN) and highlighted a shift in the peak induction of, and greater metabolic response to, glucose tolerance testing. Two weeks of treatment with low-dose QD-NMN (0.8 mg/kg/day) improved glucose tolerance tests in young (3 months) mice, whereas old (18 and 24 months) mice demonstrated improved fasting and fed insulin levels and insulin resistance. High-dose unconjugated NMN (80 mg/kg/day) demonstrated improvements in young mice but not in old mice. After 100 days of QD (320 mu g/kg/day) treatment, there was no evidence of cellular necrosis, fibrosis, inflammation, or accumulation. Ag2S QD nanomedicines improved the pharmacokinetic and pharmacodynamic properties of metformin and NMN by increasing their therapeutic potency, bypassing classical cellular uptake pathways, and demonstrated efficacy when drug alone was ineffective in aging mice.
C1 [Hunt, Nicholas J.; Lockwood, Glen P.; Kang, Sun W. S.; Le Couteur, David G.; Cogger, Victoria C.] Concord Repatriat Gen Hosp, Ageing & Alzheimers Inst, Ctr Educ & Res Ageing, ANZAC Res Inst, Concord, NSW 2139, Australia.
   [Hunt, Nicholas J.] Univ Sydney, Fac Med & Hlth, Charles Perkins Ctr, Sydney, NSW 2006, Australia.
   [Hunt, Nicholas J.; Limantoro, Christina; Chrzanowski, Wojciech; Kuncic, Zdenka] Univ Sydney, Sydney Nano Inst, Sydney, NSW 2006, Australia.
   [Lockwood, Glen P.; Le Couteur, David G.; Cogger, Victoria C.] Univ Sydney, Fac Med & Hlth, Sydney, NSW 2006, Australia.
   [Kang, Sun W. S.] NCI, Cell Biol & Imaging Sect, Thorac & Gastrointestinal Oncol Branch, NIH, Bethesda, MD 20892 USA.
   [Westwood, Lara J.] Univ Technol Sydney, Fac Sci, Sydney, NSW 2000, Australia.
   [Limantoro, Christina; Chrzanowski, Wojciech] Univ Sydney, Fac Med & Hlth, Sydney Pharm Sch, Sydney, NSW 2006, Australia.
   [McCourt, Peter A. G.; Kuncic, Zdenka; Le Couteur, David G.; Cogger, Victoria C.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia.
   [McCourt, Peter A. G.] Arctic Univ Norway, Dept Med Biol, Univ Tromso, N-9037 Tromso, Norway.
   [Kuncic, Zdenka] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia.
C3 Concord Repatriation General Hospital; University of Sydney; ANZAC
   Research Institute; University of Sydney; University of Sydney;
   University of Sydney; National Institutes of Health (NIH) - USA; NIH
   National Cancer Institute (NCI); University of Technology Sydney;
   University of Sydney; University of Sydney; UiT The Arctic University of
   Tromso; University of Sydney
RP Cogger, VC (corresponding author), Concord Repatriat Gen Hosp, Ageing & Alzheimers Inst, Ctr Educ & Res Ageing, ANZAC Res Inst, Concord, NSW 2139, Australia.; Cogger, VC (corresponding author), Univ Sydney, Fac Med & Hlth, Sydney, NSW 2006, Australia.; Cogger, VC (corresponding author), Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia.
EM victoria.cogger@sydney.edu.au
RI Research Institute, ANZAC/CAE-9030-2022; McCourt, Peter/B-3043-2009;
   Hunt, Nicholas/AAD-6084-2019; Kuncic, Zdenka/B-4464-2008
OI McCourt, Peter/0000-0001-5072-4590; Hunt, Nicholas/0000-0002-9001-0602;
   Lockwood, Glen/0000-0001-5966-0191; Chrzanowski,
   Wojciech/0000-0001-8050-8821; Kuncic, Zdenka/0000-0001-6765-3215
FU NHMRC [1141234]; University of Sydney DVCR Research Equity Fellowship;
   University of Sydney Seed Grant; University of Tromso Faculty of Health
   Sciences travel grant; Sydney Medical School Foundation McKnight
   Bequest; National Health and Medical Research Council of Australia
   [1141234] Funding Source: NHMRC
FX NHMRC project Grant No. 1141234; Sydney Medical School Foundation
   McKnight Bequest, The University of Sydney DVCR Research Equity
   Fellowship, The University of Sydney Seed Grant and the University of
   Tromso Faculty of Health Sciences travel grant to P.M. Australian Centre
   for Microscopy and Microanalysis and the Sydney Analytical Vibrational
   Spectrometry Facility, the University of Sydney. The Microscopy and Flow
   Cytometry Core Facility, ANZAC Research Institute. Concord RG Hospital
   Electron Microscopy Unit.
CR Alfaras I, 2017, NPJ AGING MECH DIS, V3, DOI 10.1038/s41514-017-0018-7
   Anas A, 2009, ACS NANO, V3, P2419, DOI 10.1021/nn900663r
   Aprà E, 2020, J CHEM PHYS, V152, DOI 10.1063/5.0004997
   Pereira ADBF, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113488
   Barzilai N, 2016, CELL METAB, V23, P1060, DOI 10.1016/j.cmet.2016.05.011
   Behzadi S, 2017, CHEM SOC REV, V46, P4218, DOI 10.1039/c6cs00636a
   Bobo D, 2016, PHARM RES-DORDR, V33, P2373, DOI 10.1007/s11095-016-1958-5
   Boles MA, 2016, NAT MATER, V15, P141, DOI [10.1038/NMAT4526, 10.1038/nmat4526]
   Chinnaiyan Santhosh Kumar, 2018, Pharmaceutical Nanotechnology, V6, P253, DOI 10.2174/2211738507666181221142406
   Choi YH, 2018, JOVE-J VIS EXP, DOI 10.3791/56241
   Cogger VC, 2020, LIVER: BIOLOGY AND PATHOBIOLOGY, 6TH EDITION, 6 EDITION, P435
   Cogger VC, 2015, JOVE-J VIS EXP, DOI 10.3791/52698
   Dai Q, 2018, ACS NANO, V12, P8423, DOI 10.1021/acsnano.8b03900
   Desmoulière A, 2003, LAB INVEST, V83, P1689, DOI 10.1097/01.LAB.0000101911.53973.90
   Dong SP, 2014, BIOMACROMOLECULES, V15, P1560, DOI 10.1021/bm401593n
   Dujic T, 2015, DIABETES, V64, P1786, DOI 10.2337/db14-1388
   Fischer HC, 2006, ADV FUNCT MATER, V16, P1299, DOI 10.1002/adfm.200500529
   Fraser JA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25854-2
   Friedman SL, 2003, J HEPATOL, V38, pS38, DOI 10.1016/S0168-8278(02)00429-4
   Gao L, 2012, J CONTROL RELEASE, V160, P418, DOI 10.1016/j.jconrel.2012.03.013
   Glancy D, 2019, J CONTROL RELEASE, V304, P102, DOI 10.1016/j.jconrel.2019.04.023
   Grozio A, 2019, NAT METAB, V1, P47, DOI 10.1038/s42255-018-0009-4
   Hassan S, 2017, NANO TODAY, V15, P91, DOI 10.1016/j.nantod.2017.06.008
   Hua S, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00790
   Hunt NJ, 2020, ACS NANO, V14, P1492, DOI 10.1021/acsnano.9b06071
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Hunt NJ, 2020, J GERONTOL A-BIOL, V75, P278, DOI 10.1093/gerona/glz153
   Hunt NJ, 2019, AM J PHYSIOL-GASTR L, V316, pG144, DOI 10.1152/ajpgi.00179.2018
   Hunt NJ, 2018, ADV DRUG DELIVER REV, V135, P39, DOI 10.1016/j.addr.2018.09.006
   Isin EM, 2007, BBA-GEN SUBJECTS, V1770, P314, DOI 10.1016/j.bbagen.2006.07.003
   Jose P, 2015, CELL BIOCHEM BIOPHYS, V71, P627, DOI 10.1007/s12013-014-0242-8
   Kang SWS, 2019, AM J PHYSIOL-CELL PH, V317, pC942, DOI 10.1152/ajpcell.00051.2019
   Katsyuba E, 2020, NAT METAB, V2, P9, DOI 10.1038/s42255-019-0161-5
   Kermanizadeh A, 2020, J TOXICOL ENV HEAL B, V23, P137, DOI 10.1080/10937404.2020.1751756
   Kim HJ, 2016, ADV DRUG DELIVER REV, V104, P61, DOI 10.1016/j.addr.2016.06.011
   Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512
   Kumar S, 2017, J PHARM PHARMACOL, V69, P143, DOI 10.1111/jphp.12672
   Lammers T, 2020, NANO TODAY, V31, DOI 10.1016/j.nantod.2020.100853
   Loeschner K, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-18
   Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105
   McCreight LJ, 2016, DIABETOLOGIA, V59, P426, DOI 10.1007/s00125-015-3844-9
   McReynolds MR, 2020, EXP GERONTOL, V134, DOI 10.1016/j.exger.2020.110888
   Miller DL, 2016, INT J TOXICOL, V35, P47, DOI 10.1177/1091581815616602
   Mills KF, 2016, CELL METAB, V24, P795, DOI 10.1016/j.cmet.2016.09.013
   Mohamad M, 2016, AGING CELL, V15, P706, DOI 10.1111/acel.12481
   Murakami M, 2015, SCI REP-UK, V5, DOI 10.1038/srep17035
   Nies AT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022163
   Ortega-Ribera M, 2020, HEPATOL COMMUN, V4, P1087, DOI 10.1002/hep4.1517
   Padwal RS, 2011, DIABETES CARE, V34, P1295, DOI 10.2337/dc10-2140
   Panda B.P., 2018, NANO BIOMED ENG, V10, P343
   Park K, 2019, J CONTROL RELEASE, V305, P221, DOI 10.1016/j.jconrel.2019.05.044
   Patel S, 2019, ADV DRUG DELIVER REV, V144, P90, DOI 10.1016/j.addr.2019.08.004
   Patiño-Herrera R, 2019, EUR J PHARM SCI, V131, P1, DOI 10.1016/j.ejps.2019.02.003
   Pelaz B, 2017, ACS NANO, V11, P2313, DOI 10.1021/acsnano.6b06040
   Poisson J, 2017, J HEPATOL, V66, P212, DOI 10.1016/j.jhep.2016.07.009
   Poon W, 2019, ACS NANO, V13, P5785, DOI 10.1021/acsnano.9b01383
   Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8
   Ratajczak J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13103
   Rosario D, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00775
   Sambol NC, 1996, J CLIN PHARMACOL, V36, P1012, DOI 10.1177/009127009603601105
   Schlender L, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0574-5
   Tang R, 2015, ACS NANO, V9, P220, DOI 10.1021/nn5071183
   Tsoi KM, 2016, NAT MATER, V15, P1212, DOI [10.1038/NMAT4718, 10.1038/nmat4718]
   Wagner AM, 2019, ACTA BIOMATER, V94, P44, DOI 10.1016/j.actbio.2019.05.022
   Walkey CD, 2012, J AM CHEM SOC, V134, P2139, DOI 10.1021/ja2084338
   Warren A, 2005, EXP GERONTOL, V40, P807, DOI 10.1016/j.exger.2005.06.012
   Wong XY, 2020, ACS NANO, V14, P2585, DOI 10.1021/acsnano.9b08133
   Xu HL, 2011, J MATER CHEM, V21, P18227, DOI 10.1039/c1jm11163a
   Yoshino J, 2018, CELL METAB, V27, P513, DOI 10.1016/j.cmet.2017.11.002
   Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014
   Zhang YR, 2019, GEN PSYCHIAT, V32, DOI 10.1136/gpsych-2019-100069
   Zrazhevskiy P, 2009, NANO TODAY, V4, P414, DOI 10.1016/j.nantod.2009.07.004
NR 72
TC 13
Z9 13
U1 6
U2 49
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
EI 1936-086X
J9 ACS NANO
JI ACS Nano
PD 2021 MAR 23
PY 2021
VL 15
IS 3
BP 4710
EP 4727
DI 10.1021/acsnano.0c09278
EA FEB 2021
PG 18
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA RF0WQ
UT WOS:000634569100084
PM 33626869
OA Green Published
DA 2024-02-19
ER

PT J
AU Fang, YF
   Yang, WJ
   Wu, LX
   Yao, LY
   Cao, XH
   Chen, HT
AF Fang, Yanfei
   Yang, Wenjing
   Wu, Lexi
   Yao, Lingya
   Cao, Xianghan
   Chen, Haotian
TI An aging-related gene signature to predict the prognosis of
   hepatocellular carcinoma
SO MEDICINE
LA English
DT Article
DE aging; gene; hepatocellular carcinoma; prediction; prognosis
ID CANCER; LIVER; METHYLATION; SUPPRESSOR; HEPATITIS; DEATH
AB Aging increases the susceptibility of various diseases, including hepatocellular carcinoma (HCC). This study aimed to establish an aging-related prognostic model for HCC and to investigate the role of aging-related genes in HCC progression. Transcriptome and clinical information of HCC cases were obtained from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. Aging-related prognostic genes were identified through univariate Cox regression analysis, protein-protein interaction analysis, and least absolute shrinkage and selection operator (LASSO) analysis. An aging-related risk signature was then constructed, including LDHA, MMP12, ATAD3A, CD8A, TPI1, CST3, and TPM1. The risk score was inversely associated with the overall survival of patients with HCC and correlated well with known prognostic factors. The area under the curve of 1-, 3-, and 5-year survival in the training dataset was 0.83, 0.83, and 0.84, respectively. Univariate and multivariate cox regression analysis verified that the aging-related risk signature independently predicted the overall survival in HCC. To increase the clinical utility of the prognostic model, a nomogram was developed by incorporating the risk score with key clinical features. Finally, single-cell transcriptomes of HCC were analyzed to elucidate the expression pattern of the prognostic genes across different tissues, pathologic stages, and cell types. Collectively, the aging-related prognostic model shed light on HCC pathogenesis and held potential for optimizing the management of HCC.
C1 [Fang, Yanfei; Yang, Wenjing; Wu, Lexi; Yao, Lingya; Cao, Xianghan; Chen, Haotian] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Gastroenterol, Hangzhou 310016, Peoples R China.
C3 Zhejiang University
RP Chen, HT (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Gastroenterol, Hangzhou 310016, Peoples R China.
EM fyanfei@sina.com; yangwenjing@zju.edu.cn; wulx@zju.edu.cn;
   11918256@zju.edu.cn; 12218697@zju.edu.cn; 3414288@zju.edu.cn
CR Aunan JR, 2017, AGING DIS, V8, P628, DOI 10.14336/AD.2017.0103
   Baudier J, 2018, BIOL REV, V93, P827, DOI 10.1111/brv.12373
   Bharadwaj S, 2002, CANCER LETT, V183, P205, DOI 10.1016/S0304-3835(02)00119-2
   Blokzijl F, 2016, NATURE, V538, P260, DOI 10.1038/nature19768
   Brayford S, 2016, CURR BIOL, V26, P1312, DOI 10.1016/j.cub.2016.03.028
   Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096
   Cagigas ML, 2022, NAT MATER, V21, P120, DOI 10.1038/s41563-021-01087-z
   Chen XT, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.661988
   Dandachi N, 2017, AM J RESP CRIT CARE, V196, P353, DOI 10.1164/rccm.201606-1150OC
   Fane M, 2020, NAT REV CANCER, V20, P89, DOI 10.1038/s41568-019-0222-9
   Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809
   Jeske SS, 2020, IMMUN AGEING, V17, DOI 10.1186/s12979-020-0174-7
   Jiang H, 2017, BIOCHEM BIOPH RES CO, V482, P1048, DOI 10.1016/j.bbrc.2016.11.156
   Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015
   Kim HJ, 2009, CLIN CHEM, V55, P1022, DOI 10.1373/clinchem.2008.102996
   Kokudo T, 2016, J HEPATOL, V65, P938, DOI 10.1016/j.jhep.2016.05.044
   Li X, 2021, NAT REV CANCER, V21, P541, DOI 10.1038/s41568-021-00383-9
   Liu J, 2022, NAT METAB, V4, P1830, DOI 10.1038/s42255-022-00708-4
   Llovet JM, 2021, NAT REV DIS PRIMERS, V7, DOI 10.1038/s41572-020-00240-3
   López-Otin C, 2023, CELL, V186, P243, DOI 10.1016/j.cell.2022.11.001
   Lu YM, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-32283-3
   Ng KTP, 2011, EUR J CANCER, V47, P2299, DOI 10.1016/j.ejca.2011.05.032
   Nishida N, 2008, HEPATOLOGY, V47, P908, DOI 10.1002/hep.22110
   Park JW, 2015, LIVER INT, V35, P2155, DOI 10.1111/liv.12818
   Pierre P, 1998, CELL, V93, P1135, DOI 10.1016/S0092-8674(00)81458-0
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Rozhok A, 2019, ELIFE, V8, DOI 10.7554/eLife.39950
   Simon N, 2011, J STAT SOFTW, V39, P1
   Srour B, 2022, EUR J EPIDEMIOL, V37, P49, DOI 10.1007/s10654-021-00828-3
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Sun YF, 2021, CELL, V184, P404, DOI 10.1016/j.cell.2020.11.041
   Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660
   Tyson GL, 2011, CLIN GASTROENTEROL H, V9, P989, DOI 10.1016/j.cgh.2011.07.026
   Vogel A, 2022, LANCET, V400, P1345, DOI 10.1016/S0140-6736(22)01200-4
   Wolpaw AJ, 2018, TRENDS CELL BIOL, V28, P201, DOI 10.1016/j.tcb.2017.11.006
   Xie XQ, 2023, CELL RES, V33, P215, DOI 10.1038/s41422-022-00766-z
   Yang JD, 2019, NAT REV GASTRO HEPAT, V16, P589, DOI 10.1038/s41575-019-0186-y
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Zhang ZM, 2015, INT J SURG, V20, P8, DOI 10.1016/j.ijsu.2015.05.009
   Zhao J., 2023, Anal Cell Pathol, V2023, P1
NR 40
TC 0
Z9 0
U1 4
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD DEC 22
PY 2023
VL 102
IS 51
AR e36715
DI 10.1097/MD.0000000000036715
PG 10
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA DE9X8
UT WOS:001130483000027
PM 38134103
OA gold
DA 2024-02-19
ER

PT J
AU Wang, N
   Yu, QY
   Wang, DL
   Ren, HT
   Xu, C
   Ning, CC
   Li, N
   Fan, HP
   Ai, ZL
AF Wang, Na
   Yu, Qiuying
   Wang, Dongliang
   Ren, Hongtao
   Xu, Chao
   Ning, Cancan
   Li, Na
   Fan, Huiping
   Ai, Zhilu
TI Synergistic antiaging effects of jujube polysaccharide and flavonoid in
   D-Galactose-Induced aging mice
SO FOOD SCIENCE AND TECHNOLOGY
LA English
DT Article
DE jujube polysaccharide; jujube flavonoid; antiaging; chinese jujube; red
   jujube; neurotransmitter enhancement; free radical damage
ID OXIDATIVE STRESS; ANTIOXIDANT; PURIFICATION; METABOLITES; MODEL
AB In this study, the synergistic effects of jujube polysaccharide (JP) and flavonoid (JF) on aging mice were investigated. Sub-acutely aging mouse models were established using D-galactose. Eighty experimental mice were randomly assigned to normal, model, vitamin C (200 mg/kg), JP (200 mg/kg), JF (200 mg/kg) and JP + JF (low (100 mg/kg), medium (200 mg/kg), and high-dose (300 mg/kg)) groups (10 mice in per group). After 35 days, the physiological aging indices of mice were measured. JP and JF displayed significantly positive synergistic antiaging effects. Compared with an aging model control group, groups administered JP and JF showed increased indices for the thymus and spleen and significantly increased activities of SOD and GSH-PX in the heart, liver, spleen, and brain (R-2 > 0.99, P < 0.01; R-2 > 0.98, P < 0.01). The contents of MDA in heart, liver, spleen, brain and serum were significantly decreased (R-2 > 0.95, P < 0.01), while those of HYP in skin and serum were significantly increased. The concentrations of neurotransmitters (NE, DA, 5-HT, 5-HIAA) in the brain and serum of mice were significantly increased (P < 0.01). These results indicated that JP and JF acted not only on relevant tissues or organs of mice, but on all body systems.
C1 [Wang, Na] Henan Agr Univ, Coll Anim Med, Zhengzhou, Henan, Peoples R China.
   [Wang, Na; Yu, Qiuying; Ren, Hongtao; Xu, Chao; Ning, Cancan; Fan, Huiping; Ai, Zhilu] Key Lab Nutr & Hlth Food Zhengzhou, Zhengzhou, Peoples R China.
   [Wang, Na; Ren, Hongtao; Xu, Chao; Li, Na] Minist Agr, Key Lab Staple Grain Proc, Zhengzhou, Peoples R China.
   [Yu, Qiuying; Ren, Hongtao; Xu, Chao; Ning, Cancan; Li, Na; Fan, Huiping; Ai, Zhilu] Henan Agr Univ, Coll Food Sci & Technol, Zhengzhou, Peoples R China.
   [Wang, Dongliang] Zhengzhou Chunzhilan Commercial & Trading Co Ltd, Zhengzhou, Peoples R China.
C3 Henan Agricultural University; Ministry of Agriculture & Rural Affairs;
   Henan Agricultural University
RP Ai, ZL (corresponding author), Key Lab Nutr & Hlth Food Zhengzhou, Zhengzhou, Peoples R China.; Ai, ZL (corresponding author), Henan Agr Univ, Coll Food Sci & Technol, Zhengzhou, Peoples R China.
EM zhila@163.com
CR Abdelhafidh K, 2018, BIOMARKERS, V23, P167, DOI [10.1080/1354750X.2017.1390609, 10.1080/1354750x.2017.1390609]
   Chen H, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/6049083
   Damiano S, 2017, FOOD CHEM, V230, P24, DOI 10.1016/j.foodchem.2017.02.141
   Fimbres-Olivarria D, 2018, FOOD HYDROCOLLOID, V75, P229, DOI 10.1016/j.foodhyd.2017.08.002
   Hou L, 2019, PLANTA, V249, P815, DOI 10.1007/s00425-018-3020-9
   Ji XL, 2018, FOOD CHEM, V245, P1124, DOI 10.1016/j.foodchem.2017.11.058
   Ji XL, 2017, FOOD CHEM, V227, P349, DOI 10.1016/j.foodchem.2017.01.074
   Jiao R, 2016, AM J CHINESE MED, V44, P463, DOI 10.1142/S0192415X16500269
   Koley TK, 2016, ARAB J CHEM, V9, pS1044, DOI 10.1016/j.arabjc.2011.11.005
   Kou XH, 2015, FOOD CHEM, V173, P1037, DOI 10.1016/j.foodchem.2014.10.110
   Li Q, 2022, FOOD SCI TECH-BRAZIL, V42, DOI 10.1590/fst.44621
   Li Y, 2017, SAUDI J BIOL SCI, V24, P718, DOI 10.1016/j.sjbs.2017.01.047
   Lin XM, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9020127
   Liu XX, 2020, LWT-FOOD SCI TECHNOL, V117, DOI 10.1016/j.lwt.2019.108645
   Mu XY, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/3508907
   Mubaraki MA, 2017, MICROB PATHOGENESIS, V107, P69, DOI 10.1016/j.micpath.2017.03.017
   Chavez-Santiago JO, 2022, FOOD SCI TECH-BRAZIL, V42, DOI 10.1590/fst.02221
   Qi QC, 2018, MOLECULES, V23, DOI 10.3390/molecules23102668
   Rashwan AK, 2020, J FUNCT FOODS, V75, DOI 10.1016/j.jff.2020.104205
   Ribeiro D, 2018, CURR MED CHEM, V25, P3374, DOI 10.2174/0929867325666180214121734
   Rostami H, 2016, CARBOHYD POLYM, V143, P100, DOI 10.1016/j.carbpol.2016.01.075
   Shergis JL, 2017, PHYTOMEDICINE, V34, P38, DOI 10.1016/j.phymed.2017.07.004
   Sutedja AM, 2022, FOOD SCI TECH-BRAZIL, V42, DOI 10.1590/fst.11521
   Tian S, 2017, SAUDI PHARM J, V25, P537, DOI 10.1016/j.jsps.2017.04.020
   Wu JZ, 2022, FOOD SCI TECH-BRAZIL, V42, DOI 10.1590/fst.09822
   Zhao LS, 2015, J CHROMATOGR B, V988, P59, DOI 10.1016/j.jchromb.2015.02.029
   Zhu XL, 2018, EXP THER MED, V16, P3651, DOI 10.3892/etm.2018.6596
NR 27
TC 0
Z9 0
U1 6
U2 32
PU SOC BRASILEIRA CIENCIA TECNOLOGIA ALIMENTOS
PI CAMPINAS
PA AV BRASIL 2880, CAXIA POSTAL 271 CEP 13001-970, CAMPINAS, SAO PAULO
   00000, BRAZIL
SN 0101-2061
EI 1678-457X
J9 FOOD SCI TECH-BRAZIL
JI Food Sci. Technol.
PY 2022
VL 42
AR e46222
DI 10.1590/fst.46222
PG 9
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA 6B7SA
UT WOS:000881527600006
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Xu, Y
   Wu, T
   Jin, YX
   Fu, ZW
AF Xu, Yang
   Wu, Tao
   Jin, Yuanxiang
   Fu, Zhengwei
TI Effects of age and jet lag on d-galactose induced aging process
SO BIOGERONTOLOGY
LA English
DT Article
DE Aging model; D-galactose; Jet lag; Real-time RT-PCR
ID AMELIORATES COGNITION DEFICITS; ATTENUATES OXIDATIVE DAMAGE; ANTIOXIDANT
   ENZYMES; MEMORY IMPAIRMENT; MICE; BRAIN; STRESS; MELATONIN; METABOLITES;
   EXPRESSION
AB Chronic administration of d-galactose (d-gal) is a useful method for establishing a model of natural aging. However, whether animal age or jet lag influences the d-gal-induced aging process has not been investigated. To clarify these issues, ICR male mice were given a daily injection of d-gal (500 mg/kg bw) for 7 wks. d-gal-treatment caused a significant decrease only in the transcript level of Cat gene in the 6-wk-old mice, whereas it significantly reduced the expression of Cat and Sod1 genes and of Cat, Gpx1, Sod1 and Sod2 genes in the 12- and 22-wk-old group, respectively, suggesting that d-gal induced aging process was greatly dependent on the age of mice. Mice receiving both d-gal and jet lag exhibited larger decreases in the expression levels of above four genes in liver as compared with that of either group singly, indicating a synergistic effect of jet lag and d-gal on the aging process.
C1 [Xu, Yang; Wu, Tao; Jin, Yuanxiang; Fu, Zhengwei] Zhejiang Univ Technol, Coll Biol & Environm Engn, Hangzhou 310032, Zhejiang, Peoples R China.
C3 Zhejiang University of Technology
RP Fu, ZW (corresponding author), Zhejiang Univ Technol, Coll Biol & Environm Engn, 6 Dist, Hangzhou 310032, Zhejiang, Peoples R China.
EM azwfu2003@yahoo.com.cn
RI Fu, Zhengwei/G-3162-2011; Wu, Tao/A-7783-2012
OI Fu, Zhengwei/0000-0003-3351-3075; Jin, Yuanxiang/0000-0003-4135-553X
FU Program for Changjiang Scholars and Innovative Research Team in
   University [IRT 0653]; Science Foundation of Zhejiang Province, China
   [2004C14003]; Natural Science Foundation of Zhejiang Province for
   Distinguished Young Students [2007R40G2020043]
FX This study was supported by the Program for Changjiang Scholars and
   Innovative Research Team in University (No. IRT 0653), Science
   Foundation of Zhejiang Province, China (No. 2004C14003), and Natural
   Science Foundation of Zhejiang Province for Distinguished Young Students
   (No. 2007R40G2020043).
CR Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8
   Chen CF, 2006, PSYCHONEUROENDOCRINO, V31, P805, DOI 10.1016/j.psyneuen.2006.03.004
   CUATRECASAS P, 1966, SCIENCE, V153, P549, DOI 10.1126/science.153.3735.549
   Cui X, 2004, BIOGERONTOLOGY, V5, P317, DOI 10.1007/s10522-004-2570-3
   Cui X, 2006, J NEUROSCI RES, V83, P1584, DOI 10.1002/jnr.20845
   Cutler RG, 2006, AGEING RES REV, V5, P221, DOI 10.1016/j.arr.2006.05.002
   Davidson AJ, 2006, CURR BIOL, V16, pR914, DOI 10.1016/j.cub.2006.09.058
   Davies KJA, 2000, IUBMB LIFE, V50, P279, DOI 10.1080/15216540051081010
   Deng HB, 2003, BIOMED ENVIRON SCI, V16, P267
   GIBSON JB, 1995, EUR J PEDIATR, V154, pS14, DOI 10.1007/BF02143797
   GITZELMANN R, 1995, EUR J PEDIATR, V154, pS45, DOI 10.1007/BF02143803
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Holton JB, 2001, METABOLIC MOL BASES, V8th
   Hua XD, 2007, LIFE SCI, V80, P1897, DOI 10.1016/j.lfs.2007.02.030
   Kireev RA, 2007, J PINEAL RES, V42, P64, DOI 10.1111/j.1600-079X.2006.00385.x
   Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206
   Kong WJ, 2006, EXP GERONTOL, V41, P628, DOI 10.1016/j.exger.2006.04.008
   Kong WJ, 2006, BIOCHEM BIOPH RES CO, V344, P425, DOI 10.1016/j.bbrc.2006.03.060
   Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lu J, 2006, BEHAV BRAIN RES, V171, P251, DOI 10.1016/j.bbr.2006.03.043
   Lu J, 2007, BIOCHEM PHARMACOL, V74, P1078, DOI 10.1016/j.bcp.2007.07.007
   Melchiorri D, 1996, BIOCHEM PHARMACOL, V51, P1095, DOI 10.1016/0006-2952(96)00055-X
   PETRY K, 1991, BIOCHEM MED METAB B, V46, P93, DOI 10.1016/0885-4505(91)90054-O
   PIERPAOLI W, 1987, IMMUNOL LETT, V16, P355, DOI 10.1016/0165-2478(87)90169-6
   QUANMA R, 1966, AM J DIS CHILD, V112, P477, DOI 10.1001/archpedi.1966.02090140149018
   Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x
   Salhab M, 2006, INT J FERTIL WOMEN M, V51, P205
   Schadewaldt P, 2003, RAPID COMMUN MASS SP, V17, P2833, DOI 10.1002/rcm.1272
   Shen YX, 2002, J PINEAL RES, V32, P173, DOI 10.1034/j.1600-079x.2002.1o850.x
   Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6
   Sun SW, 2007, NUTR RES, V27, P169, DOI 10.1016/j.nutres.2007.01.010
   VANHEYNINGEN R, 1959, NATURE, V184, P194, DOI 10.1038/184194b0
   Wang H, 2008, FOOD CHEM, V106, P888, DOI 10.1016/j.foodchem.2007.05.068
   Wang ZYJ, 2001, ANN NEUROL, V50, P266, DOI 10.1002/ana.1102
   Wei HF, 2005, BEHAV BRAIN RES, V157, P245, DOI 10.1016/j.bbr.2004.07.003
   Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901
   XU FB, 1985, P 2 NAT C AG RES HAR
   Yager CT, 2003, MOL GENET METAB, V80, P283, DOI 10.1016/j.ymgme.2003.08.021
   Zhang D, 2006, J ETHNOPHARMACOL, V104, P250, DOI 10.1016/j.jep.2005.09.010
   Zhang HX, 2007, CHEM-BIOL INTERACT, V170, P145, DOI 10.1016/j.cbi.2007.07.009
   Zhang XL, 2007, PHARMACOL BIOCHEM BE, V88, P64, DOI 10.1016/j.pbb.2007.07.004
NR 42
TC 37
Z9 37
U1 0
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD APR
PY 2009
VL 10
IS 2
BP 153
EP 161
DI 10.1007/s10522-008-9158-2
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 413HY
UT WOS:000263785400004
PM 18622715
DA 2024-02-19
ER

PT J
AU Wu, LX
   Liu, XY
   Hu, RK
   Chen, YX
   Xiao, MF
   Liu, B
   Zeng, F
AF Wu, Linxiu
   Liu, Xiaoyan
   Hu, Rongkang
   Chen, Yixuan
   Xiao, Meifang
   Liu, Bin
   Zeng, Feng
TI Prebiotic <i>Agrocybe cylindracea</i> crude polysaccharides combined
   with <i>Lactobacillus rhamnosus</i> GG postpone aging-related oxidative
   stress in mice
SO FOOD & FUNCTION
LA English
DT Article; Early Access
ID CHOLESTEROL-METABOLISM; INTESTINAL MICROBIOTA; ANTIOXIDANT ACTIVITY;
   RECEPTOR; SUPPLEMENTATION; LOCALIZATION; MODEL
AB This study aimed to investigate the potential anti-aging mechanisms of Agrocybe cylindracea crude polysaccharides (APS), when used synergistically with Lactobacillus rhamnosus GG (APS + LGG) in a d-galactose-induced aging mouse model. In the Morris water maze test, APS + LGG showed a significantly higher memory and learning capacity compared to untreated, APS only treated and LGG treated mice. This was thought to be mediated by increased levels of brain-derived neurotrophic factor, which decreased escape latency. In addition to this, in the aging mouse model, APS + LGG co-treatment markedly alleviated liver oxidation and metabolism by enhancing the antioxidant activity of enzymes; this decreased the lipid metabolism and peroxidation levels. Furthermore, high throughput sequencing analysis revealed that an APS + LGG supplemented feed increased the relative abundance of positive bacteria in the gut microbiota such as Alloprevotella and Parvibacter. Importantly, Alloprevotella and Parvibacter showed a negative relationship with low density lipoprotein-cholesterol in the Spearman correlation analysis. These results illustrate that APS, in combination with LGG, postponed aging related oxidative stress when used as a prebiotic. The proposed mechanism for this is the reduction in liver oxidation and lipid metabolism, as well as the regulation of gut microbiota.
C1 [Wu, Linxiu; Liu, Xiaoyan; Hu, Rongkang; Chen, Yixuan; Xiao, Meifang; Liu, Bin; Zeng, Feng] Fujian Agr & Forestry Univ, Coll Food Sci, Fuzhou 350002, Fujian, Peoples R China.
   [Wu, Linxiu] South China Univ Technol, Sch Med, Guangzhou 510006, Guangdong, Peoples R China.
   [Liu, Xiaoyan] Beijing Technol & Business Univ, Beijing Engn & Technol Res Ctr Food Addit, Sch Food & Hlth, Beijing 100048, Peoples R China.
   [Hu, Rongkang] South China Univ Technol, Sch Food Sci & Engn, Guangzhou 510640, Guangdong, Peoples R China.
   [Liu, Bin; Zeng, Feng] Fujian Agr & Forestry Univ, Natl Engn Res Ctr JUNCAO Technol, Fuzhou 350002, Fujian, Peoples R China.
C3 Fujian Agriculture & Forestry University; South China University of
   Technology; Beijing Technology & Business University; South China
   University of Technology; Fujian Agriculture & Forestry University
RP Liu, B; Zeng, F (corresponding author), Fujian Agr & Forestry Univ, Coll Food Sci, Fuzhou 350002, Fujian, Peoples R China.; Liu, B; Zeng, F (corresponding author), Fujian Agr & Forestry Univ, Natl Engn Res Ctr JUNCAO Technol, Fuzhou 350002, Fujian, Peoples R China.
EM liubin618@hotmail.com; fengzengfz@163.com
RI zhang, xu/JEO-4879-2023; liu, xiao/HMD-7454-2023; Liu,
   XiaoYan/GQA-7216-2022; liang, shuang/JOK-5869-2023; liu,
   xiao/HKE-9880-2023; LU, Li/JFJ-9011-2023; He, Chen/JLM-5059-2023; wu,
   yi/JEP-1581-2023; LI, XIAO/IQV-9318-2023; JIN, LIYING/JFB-1980-2023;
   Jiang, Yuan/JED-3759-2023; Wu, linxiu/IQU-5333-2023; Zhang,
   Zhentao/JQV-7389-2023
FU Key Research and Development Program of Jiangxi Province
   [20192ACB60008]; Interdisciplinary Integration to Promote the
   High-quality Development of Juncao Science and Industry
   [XKJC-712021030]; Major Special Project of Fujian Province [2021NZ0101];
   Science and Technology Planning Project of Fujian Province [2021L3007];
   Ji'an Major Science and Technology Project [[2019]55]
FX This work was supported by the Key Research and Development Program of
   Jiangxi Province (20192ACB60008), Interdisciplinary Integration to
   Promote the High-quality Development of Juncao Science and Industry
   (XKJC-712021030), Major Special Project of Fujian Province (2021NZ0101),
   Science and Technology Planning Project of Fujian Province (2021L3007)
   and the Ji'an Major Science and Technology Project ([2019]55).
CR BARKER SA, 1954, J CHEM SOC, P4550, DOI 10.1039/jr9540004550
   Barzilai N., 2019, PUBLIC POLICY AGING, V29, P128
   Ben Romdhane M, 2017, FOOD CHEM, V216, P355, DOI 10.1016/j.foodchem.2016.08.056
   Biagi G, 2013, AM J VET RES, V74, P90, DOI 10.2460/ajvr.74.1.90
   Blagosklonny MV, 2007, DRUG DISCOV TODAY, V12, P218, DOI 10.1016/j.drudis.2007.01.004
   Chen P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19732-0
   Chen YX, 2016, INT J BIOL MACROMOL, V91, P505, DOI 10.1016/j.ijbiomac.2016.05.086
   Clavel T, 2013, INT J SYST EVOL MICR, V63, P2642, DOI 10.1099/ijs.0.045344-0
   Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101
   de Pablos RM, 2019, PHARMACOL RES, V143, P58, DOI 10.1016/j.phrs.2019.03.005
   Du BX, 2019, INT J BIOL MACROMOL, V128, P724, DOI 10.1016/j.ijbiomac.2019.01.159
   Dumitrescu L, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2406594
   Gamba P, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00119
   Goyal N, 2013, WORLD J MICROB BIOT, V29, P1049, DOI 10.1007/s11274-013-1268-6
   He ZM, 2015, INT J FOOD SCI TECH, V50, P1673, DOI 10.1111/ijfs.12824
   Higuchi H, 2003, EMBO J, V22, P1790, DOI 10.1093/emboj/cdg177
   Hindu SV, 2019, AQUACULT INT, V27, P227, DOI 10.1007/s10499-018-0318-3
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Hu RK, 2019, FOOD FUNCT, V10, P2935, DOI 10.1039/c9fo00475k
   Jing HJ, 2018, INT J BIOL MACROMOL, V106, P1270, DOI 10.1016/j.ijbiomac.2017.08.138
   Kacuráková M, 2000, CARBOHYD POLYM, V43, P195, DOI 10.1016/S0144-8617(00)00151-X
   Khan A, 2019, NEUROTOXICOLOGY, V72, P38, DOI 10.1016/j.neuro.2019.02.002
   Lambeth Stacey M, 2015, J Diabetes Obes, V2, P1
   Lee JE, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020363
   Li CL, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/3878740
   Li SP, 2009, POULTRY SCI, V88, P519, DOI 10.3382/ps.2008-00365
   Li XH, 2012, NEUROSCI LETT, V514, P46, DOI 10.1016/j.neulet.2012.02.054
   Li XY, 2017, NEUROCHEM RES, V42, P3268, DOI 10.1007/s11064-017-2366-x
   Liu L, 2018, LWT-FOOD SCI TECHNOL, V95, P99, DOI 10.1016/j.lwt.2018.04.053
   Liu M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160799
   Liu XY, 2020, CARBOHYD POLYM, V236, DOI 10.1016/j.carbpol.2020.116056
   Massey JB, 2006, CURR OPIN LIPIDOL, V17, P296, DOI 10.1097/01.mol.0000226123.17629.ab
   Matt SM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01832
   Min F, 2020, EUR J PHARMACOL, V881, DOI 10.1016/j.ejphar.2020.173214
   Morgan AE, 2017, P NUTR SOC, V76, P378, DOI 10.1017/S0029665116002822
   Özkarakas H, 2017, TURK J MED SCI, V47, P1165, DOI 10.3906/sag-1604-60
   Pang PT, 2004, AGEING RES REV, V3, P407, DOI 10.1016/j.arr.2004.07.002
   Pereira DB, 2007, J NEUROSCI, V27, P4859, DOI 10.1523/JNEUROSCI.4587-06.2007
   Petzold A, 2015, NEUROBIOL LEARN MEM, V120, P52, DOI 10.1016/j.nlm.2015.02.009
   Prabawati, 2014, J FOOD NUTR RES, V2, P1015
   Sanborn V, 2020, NEUROPSYCH DIS TREAT, V16, P2765, DOI 10.2147/NDT.S270035
   Sharma D, 2019, J NEUROCHEM, V148, P238, DOI 10.1111/jnc.14609
   Shu GW, 2017, MOLECULES, V22, DOI 10.3390/molecules22101764
   Suzuki S, 2004, J CELL BIOL, V167, P1205, DOI 10.1083/jcb.200404106
   Ulziijargal E, 2011, INT J MED MUSHROOMS, V13, P343, DOI 10.1615/IntJMedMushr.v13.i4.40
   Wang MX, 2018, FOOD FUNCT, V9, P1864, DOI [10.1039/C7FO01507K, 10.1039/c7fo01507k]
   Wang MX, 2018, RSC ADV, V8, P5042, DOI 10.1039/c7ra12067b
   Wei HF, 2005, BEHAV BRAIN RES, V157, P245, DOI 10.1016/j.bbr.2004.07.003
   Yu XH, 2017, CARBOHYD POLYM, V156, P9, DOI 10.1016/j.carbpol.2016.08.092
   Yu Yin-hang, 2014, Yaoxue Xuebao, V49, P1000
   Zhang J. H., 2018, MOD FOOD SCI TECHNOL, V34, P143
   Zhang YKJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016683
   Zhao HJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30104-6
NR 53
TC 14
Z9 14
U1 9
U2 65
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD 2022 FEB 7
PY 2022
VL 13
IS 3
BP 1218
EP 1231
DI 10.1039/d1fo02079j
EA DEC 2021
PG 14
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA YU3XU
UT WOS:000741631200001
PM 35019929
DA 2024-02-19
ER

PT J
AU Zhao, YY
   Yang, DH
   Yan, YQ
   Zhang, XX
   Yang, NN
   Guo, Y
   Yu, CH
AF Zhao, Yuanyuan
   Yang, Donghui
   Yan, Yaqiong
   Zhang, Xiaoxia
   Yang, Niannian
   Guo, Yan
   Yu, Chuanhua
TI Secular Trends of Liver Cancer Mortality and Years of Life Lost in
   Wuhan, China 2010-2019
SO CURRENT ONCOLOGY
LA English
DT Article
DE liver cancer; disease burden; trend; decomposition; Wuhan
ID HEPATOCELLULAR-CARCINOMA; DIAGNOSIS; HBV
AB Background: Liver cancer has caused a heavy burden worldwide. This study aimed to estimate the trends in the mortality and years of life lost (YLL) due to liver cancer and decompose the total deaths into three contributors: population growth, population aging, and mortality change. Methods: Our study used data from the cause-of-death surveillance system in Wuhan. The mortality and YLL rates were standardized according to the sixth national population census in China. This study calculated the estimated annual percentage change (EAPC) to estimate the trends in the age-standardized mortality rate (ASMR) and age-standardized YLL rate (ASYR). Meanwhile, a decomposition analysis was used to explore the effect of population growth, population aging, and age-specific mortality change on the change in liver cancer deaths. Results: The ASMR of liver cancer declined at an annual rate of 4.6% from 30.87 per 100,000 people in 2010 to 20.29 per 100,000 people in 2019, while the ASYR was at an annual rate of 5.6% from 969.35 per 100,000 people in 2010 to 581.82 per 100,000 people in 2019. Similar downward trends were seen in men and women. The decomposition analysis found that total deaths number changed by -12.42% from 2010 to 2019, of which population growth and population aging caused the total death numbers to increase by 9.75% and 21.15%, while the age-specific mortality change caused the total death numbers to decrease by 43.32%. Conclusion: Although the ASMR of liver cancer has declined in recent years in Wuhan, it still causes a heavy burden with the increasing population and rapid population aging and remains an essential public health issue. The government should take measures to reduce the burden of liver cancer, especially among men.
C1 [Zhao, Yuanyuan; Yan, Yaqiong; Zhang, Xiaoxia; Yang, Niannian; Guo, Yan] Wuhan Ctr Dis Control & Prevent, Wuhan 430024, Peoples R China.
   [Yang, Donghui; Yu, Chuanhua] Wuhan Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430072, Peoples R China.
C3 Wuhan University
RP Guo, Y (corresponding author), Wuhan Ctr Dis Control & Prevent, Wuhan 430024, Peoples R China.; Yu, CH (corresponding author), Wuhan Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430072, Peoples R China.
EM swallow315@whcdc.org; yuchua@whu.edu.cn
OI Yang, Donghui/0000-0002-4296-783X
FU Health Commission of the Hubei Province scientific research project
   [WJ2019H304]; National Natural Science Foundation of China [82173626];
   Wuhan Medical Research Project [WG20B07]
FX This research was funded by the Health Commission of the Hubei Province
   scientific research project (Grant No. WJ2019H304), the National Natural
   Science Foundation of China (Grant No. 82173626), and the Wuhan Medical
   Research Project (Grant No. WG20B07).
CR Akinyemiju T, 2017, JAMA ONCOL, V3, P1683, DOI 10.1001/jamaoncol.2017.3055
   An L, 2019, Zhonghua Zhong Liu Za Zhi, V41, P721, DOI 10.3760/cma.j.issn.0253-3766.2019.10.001
   [Anonymous], 2017, CHIN J VACCINES IMMU
   Beijing: Department of Disease Prevention and Control NHCotPsRoC, CHIN HAS ACH REM RES
   Cao MM, 2019, CHINA CANC, V28, P643
   Chai KC, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00008
   Chang MH, 2016, GASTROENTEROLOGY, V151, P472, DOI 10.1053/j.gastro.2016.05.048
   [陈万青 Chen Wanqing], 2019, [中国肿瘤, Bulletin of Chinese Cancer], V28, P23
   Chuang SC, 2009, CANCER LETT, V286, P9, DOI 10.1016/j.canlet.2008.10.040
   Das Gupta P, 1994, Genus, V50, P171
   Esteve J, 1994, IARC Sci Publ, P1
   Fang EF, 2020, AGEING RES REV, V64, DOI 10.1016/j.arr.2020.101174
   Fang Y H, 2018, Zhonghua Liu Xing Bing Xue Za Zhi, V39, P1432, DOI 10.3760/cma.j.issn.0254-6450.2018.11.003
   Fang Y H, 2018, Zhonghua Liu Xing Bing Xue Za Zhi, V39, P280, DOI 10.3760/cma.j.issn.0254-6450.2018.03.006
   Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0
   Gebo KA, 2002, HEPATOLOGY, V36, pS84, DOI 10.1053/jhep.2002.36817
   He HJ, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00177
   Hollebecque A, 2015, EUR J CANCER, V51, P327, DOI 10.1016/j.ejca.2014.12.005
   Islami F, 2017, CA-CANCER J CLIN, V67, P273, DOI 10.3322/caac.21402
   Jing WZ, 2020, FRONT MED-PRC, V14, P21, DOI 10.1007/s11684-020-0744-2
   Kocarnik JM., 2022, JAMA ONCOL, V8, P420, DOI [10.1001/jamaoncol.2021.6987, DOI 10.1001/JAMAONCOL.2021.6987]
   Liang XF, 2009, J INFECT DIS, V200, P39, DOI 10.1086/599332
   Lin LF, 2020, LIVER CANCER, V9, P563, DOI 10.1159/000508568
   Liu J, 2019, Zhonghua Liu Xing Bing Xue Za Zhi, V40, P605, DOI 10.3760/cma.j.issn.0254-6450.2019.06.001
   Long Z, 2022, INT J CANCER, V151, P684, DOI 10.1002/ijc.33998
   Man XB, 2005, LIVER INT, V25, P962, DOI 10.1111/j.1478-3231.2005.01100.x
   Mohammadian M, 2020, J Prev Med Hyg, V61, pE259, DOI 10.15167/2421-4248/jpmh2020.61.2.1244
   Professional Committee for Prevention and Control of Hepatobiliary and Pancreatic Diseases of Chinese Preventive Medicine Association, 2021, Zhonghua Zhong Liu Za Zhi, V43, P60, DOI 10.3760/cma.j.cn112152-20201109-00970
   Prospective suRveillance for very Early hepatoCellular cARcinoma(PreCar) expert panel, 2021, Zhonghua Gan Zang Bing Za Zhi, V29, P515, DOI 10.3760/cma.j.cn501113-20210605-00264
   Shen QJ, 2012, LANCET ONCOL, V13, P817, DOI 10.1016/S1470-2045(12)70233-4
   Sung H., 2021, CA Cancer J. Clin, V71, P209, DOI DOI 10.3322/caac.21660
   UN DESA. Population Division, 2022, World Population Prospects
   Wang F, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16162878
   Wang H, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4428-y
   Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443
   Yang JQ, 2022, CANCER MED-US, V11, P1357, DOI 10.1002/cam4.4530
   Yang ZX, 2017, CHINESE J CANCER RES, V29, P385, DOI 10.21147/j.issn.1000-9604.2017.05.02
   Zeng HM, 2018, LANCET GLOB HEALTH, V6, pE555, DOI 10.1016/S2214-109X(18)30127-X
   Zheng B, 2017, SCI CHINA LIFE SCI, V60, P575, DOI 10.1007/s11427-016-9043-9
   Zhou J, 2011, J CLIN ONCOL, V29, P4781, DOI 10.1200/JCO.2011.38.2697
NR 40
TC 0
Z9 0
U1 2
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1198-0052
EI 1718-7729
J9 CURR ONCOL
JI Curr. Oncol.
PD JAN
PY 2023
VL 30
IS 1
BP 938
EP 948
DI 10.3390/curroncol30010071
PG 11
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA 7X8WS
UT WOS:000914476000001
PM 36661720
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Weindruch, R
   Kayo, T
   Lee, CK
   Prolla, TA
AF Weindruch, R
   Kayo, T
   Lee, CK
   Prolla, TA
TI Microarray profiling of gene expression in aging and its alteration by
   caloric restriction in mice
SO JOURNAL OF NUTRITION
LA English
DT Article; Proceedings Paper
CT Experimental Biology 2000 Meeting
CY APR 14-18, 2000
CL SAN DIEGO, CALIFORNIA
SP Amer Soc Nutr Sci
DE caloric restriction; aging; gene expression; oligonucleotide
   microarrays; muscle
ID MESSENGER-RNA EXPRESSION; SKELETAL-MUSCLE; CAENORHABDITIS-ELEGANS;
   OXIDATIVE STRESS; DNA METHYLATION; PROTEIN; TRANSCRIPTION; CELLS;
   DAMAGE; LIVER
AB An active research area in biological gerontology concerns the mechanisms by which caloric restriction (CR) retards the aging process in laboratory rodents. We used high density oligonucleotide arrays representing 6347 genes to determine the gene expression profile of the aging process in gastrocnemius muscle of male C57BL/6 mice. Aging resulted in a differential gene expression pattern indicative of a marked stress response and lower expression of metabolic and biosynthetic genes. Most alterations were completely or partially prevented by CR. Transcriptional patterns of muscle from calorie-restricted animals suggest that CR retards the aging process by causing a metabolic shift toward increased protein turnover and decreased macromolecular damage. The use of high density oligonucleotide microarrays provides a new tool to measure biological age on a tissue-specific basis and to evaluate at the molecular level the efficacy of nutritional interventions designed to retard the aging process.
C1 Univ Wisconsin, Dept Med, Madison, WI 53705 USA.
   Univ Wisconsin, Ctr Geriatr Res Educ & Clin, Madison, WI 53705 USA.
   Univ Wisconsin, Wisconsin Reg Primate Res Ctr, Madison, WI 53715 USA.
   Univ Wisconsin, Ctr Environm Toxicol, Madison, WI 53706 USA.
   Univ Wisconsin, Dept Genet & Med Genet, Madison, WI 53706 USA.
C3 University of Wisconsin System; University of Wisconsin Madison;
   Geriatric Research Education & Clinical Center; University of Wisconsin
   System; University of Wisconsin Madison; University of Wisconsin System;
   University of Wisconsin Madison; University of Wisconsin System;
   University of Wisconsin Madison; University of Wisconsin System;
   University of Wisconsin Madison
RP Weindruch, R (corresponding author), Univ Wisconsin, Dept Med, Madison, WI 53705 USA.
RI Lee, Cheol-Koo/F-2103-2013
OI Lee, Cheol-Koo/0000-0003-3927-9195
FU NCI NIH HHS [R01 CA78723] Funding Source: Medline; NIA NIH HHS [P01
   AG11915, R01 AG18922] Funding Source: Medline
CR Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349
   Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462
   COONEY CA, 1993, GROWTH DEVELOP AGING, V57, P261
   Copray JCVM, 1997, NEUROSCI LETT, V236, P41, DOI 10.1016/S0304-3940(97)00747-7
   DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680
   Dhahbi JM, 1999, AM J PHYSIOL-ENDOC M, V277, pE352, DOI 10.1152/ajpendo.1999.277.2.E352
   Dhahbi JM, 1997, J NUTR, V127, P1758, DOI 10.1093/jn/127.9.1758
   Dhahbi JM, 1998, J GERONTOL A-BIOL, V53, pB180, DOI 10.1093/gerona/53A.3.B180
   DISTERHOFT JF, 1994, CALCIUM HYPOTHESIS A
   DUTTA C, 1995, J GERONTOL A-BIOL, V50, P1, DOI 10.1093/gerona/50A.Special_Issue.1
   ENGELMAN RW, 1991, CANCER RES, V51, P5123
   Fishbein L, 1991, BIOL EFFECTS DIETARY
   FORNACE AJ, 1989, MOL CELL BIOL, V9, P851, DOI 10.1128/MCB.9.2.851
   Fraichard A, 1997, EMBO J, V16, P4412, DOI 10.1093/emboj/16.14.4412
   Fujita H, 1998, J BIOL CHEM, V273, P26516, DOI 10.1074/jbc.273.41.26516
   KRISTAL BS, 1992, J GERONTOL, V47, pB107, DOI 10.1093/geronj/47.4.B107
   Lander ES, 1999, NAT GENET, V21, P3, DOI 10.1038/4427
   LARSSON L, 1995, J GERONTOL A-BIOL, V50, P91
   Lass A, 1998, FREE RADICAL BIO MED, V25, P1089, DOI 10.1016/S0891-5849(98)00144-0
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046
   Lengauer C, 1997, P NATL ACAD SCI USA, V94, P2545, DOI 10.1073/pnas.94.6.2545
   LI WC, 1994, EXP EYE RES, V59, P179, DOI 10.1006/exer.1994.1096
   Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447
   Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486
   MARAZZI G, 1993, DEV DYNAM, V197, P115, DOI 10.1002/aja.1001970205
   MOTE PL, 1991, J GERONTOL, V46, pB95, DOI 10.1093/geronj/46.3.B95
   Mura CV, 1996, MECH AGEING DEV, V91, P115, DOI 10.1016/0047-6374(96)01780-0
   Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764
   NELSON JF, 1995, NEUROBIOL AGING, V16, P837, DOI 10.1016/0197-4580(95)00072-M
   Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194
   PAYNE A, 1994, MUTAT RES-FUND MOL M, V310, P89, DOI 10.1016/0027-5107(94)90012-4
   Pennisi E, 2000, SCIENCE, V288, P1146, DOI 10.1126/science.288.5469.1146
   Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212
   Peterson CA, 1997, J NUTR, V127, pS1007
   Petrini JHJ, 1999, AM J HUM GENET, V64, P1264, DOI 10.1086/302391
   Schwartz AL, 1999, ANNU REV MED, V50, P57
   SHIELDS BA, 1991, P NATL ACAD SCI USA, V88, P11138, DOI 10.1073/pnas.88.24.11138
   Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6
   SOHAL RS, 1991, MECH AGEING DEV, V57, P187, DOI 10.1016/0047-6374(91)90034-W
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   SPINDLER SR, 1990, J NUTR, V120, P1412, DOI 10.1093/jn/120.11.1412
   SPINDLER SR, 1991, J GERONTOL, V46, pB233, DOI 10.1093/geronj/46.6.B233
   Stachowiak O, 1998, J BIOL CHEM, V273, P16694, DOI 10.1074/jbc.273.27.16694
   Tillman JB, 1996, J BIOL CHEM, V271, P3500, DOI 10.1074/jbc.271.7.3500
   Tillman JB, 1996, J NUTR, V126, P416, DOI 10.1093/jn/126.2.416
   Tissenbaum HA, 1998, GENETICS, V148, P703
   Tomoyasu T, 1998, MOL MICROBIOL, V30, P567, DOI 10.1046/j.1365-2958.1998.01090.x
   Van Remmen Holly, 1995, P171
   Walford RL, 1997, J GERONTOL A-BIOL, V52, pB179, DOI 10.1093/gerona/52A.4.B179
   Wang S, 1996, MECH AGEING DEV, V92, P121, DOI 10.1016/S0047-6374(96)01814-3
   WEINDRUCH R, 1988, RETARDATION AGING DI
   Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8
   Yu BP, 1994, MODULATION AGING PRO
   Zainal TA, 2000, FASEB J, V14, P1825, DOI 10.1096/fj.99-0881com
   Zierath JR, 1998, ENDOCRINOLOGY, V139, P5034, DOI 10.1210/en.139.12.5034
NR 58
TC 184
Z9 211
U1 0
U2 11
PU AMER INST NUTRITION
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-3166
J9 J NUTR
JI J. Nutr.
PD MAR
PY 2001
VL 131
IS 3
BP 918S
EP 923S
DI 10.1093/jn/131.3.918S
PG 6
WC Nutrition & Dietetics
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 409VB
UT WOS:000167405400040
PM 11238786
OA hybrid
DA 2024-02-19
ER

PT J
AU Anand, RS
   Ganesan, D
   Selvam, S
   Rajasekaran, S
   Jayavelu, T
AF Anand, Ramaian Santhaseela
   Ganesan, Dhasarathan
   Selvam, Senthilraja
   Rajasekaran, Sudarshana
   Jayavelu, Tamilselvan
TI Distinct utilization of biotin in and between adipose and brain during
   aging is associated with a lipogenic shift in Wistar rat brain
SO NUTRITION RESEARCH
LA English
DT Article
DE Biotin; Biotinylation; Wistar rat; Adipose; Brain
ID COA CARBOXYLASE; LIFE-SPAN; METABOLISM; LIVER; DEFICIENCY; PROTEINS;
   RECEPTOR; ENZYME; LIPIDS; ACIDS
AB Tissue-specific metabolism determines their functions that collectively sense and respond to numerous stress cues to achieve systemic homeostasis. Chronic stress skews such metabolic profiles and leads to failure of organs as evidenced by a bias towards lipid synthesis and storage in the aging brain, muscle, and liver under Alzheimer's disease, sarcopenia, and non-alcoholic fatty liver disease, respectively. In contrast, the tissue destined for lipid synthesis and storage, such as adipose, limits its threshold and develops diabetes mellitus. However, the underlying factors that contribute to this lipogenic shift between organs are unknown. From this perspective, differential biotin utilization between lipid-rich tissues such as adipose and brain during aging was hypothesized owing to the established role of biotin in lipogenesis. The same was tested using young and aged Wistar rats. We found that adipose-specific biotin content was much higher than the brain irrespective of aging status, as well as its associated cues. However, within tissues, the adipose fails to maintain its biotinylation levels during aging whereas the brain seizes more biotin and exhibits lipid accumulation. Furthermore, mimicking the age-related stress cues in vitro such as high glucose and endoplasmic reticulum stress deprive the astroglial biotin content, but not that of adipocytes. Lipid accumulation in the aging brain was also correlated with increased S-adenosylmethionine levels and biotin utilization by astrocytes. In summary, differential biotin utilization between adipose and brain under aging and their respective cell types like adipocytes and astrocytes under age-associated stress cues connects well with the lipogenic shift in rat brain. (C) 2020 Elsevier Inc. All rights reserved.
C1 [Anand, Ramaian Santhaseela; Ganesan, Dhasarathan; Selvam, Senthilraja; Rajasekaran, Sudarshana; Jayavelu, Tamilselvan] Anna Univ, Ctr Biotechnol, Chennai 600025, Tamil Nadu, India.
C3 Anna University; Anna University Chennai
RP Jayavelu, T (corresponding author), Anna Univ, Ctr Biotechnol, Chennai 600025, Tamil Nadu, India.
EM tamilselvan@annauniv.edu
RI RS, Anand/GPK-0913-2022
OI RS, Anand/0000-0003-3513-9224; Jayavelu,
   Tamilselvan/0000-0002-7143-352X; Ganesan,
   Dhasarathan/0000-0002-5593-6290
FU Department of Biotechnology, India [BT/PR15162/GBD/27/348/2011,
   BT/PR12153/INF/22/200/2014]; University Grants Commission, India
   [F.5-6/2015/DSA-I(SAP-II)]; Indian Council of Medical Research
   [2015-25060]
FX This work was funded by the Department of Biotechnology, India
   [BT/PR15162/GBD/27/348/2011] and the University Grants Commission, India
   [F.5-6/2015/DSA-I(SAP-II)]. We thank the Indian Council of Medical
   Research for research fellowship awarded to Anand R.S.
   [IRIS-ID:2015-25060]. We thank the Department of Science and Technology,
   IndiaPURSE, FIST and Department of Biotechnology, IndiaBUILDER
   [BT/PR12153/INF/22/200/2014] programs for chemiluminescence, confocal
   microscope and HPLC instrumentation support, respectively. The authors
   declare no conflict of interest.
CR Ames BN, 2006, P NATL ACAD SCI USA, V103, P17589, DOI 10.1073/pnas.0608757103
   Banerjee R, 2008, TRENDS BIOCHEM SCI, V33, P413, DOI 10.1016/j.tibs.2008.06.006
   Baumgartner M.R., 2012, INBORN METABOLIC DIS, P375
   Blüher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223
   BRAMWELL ME, 1987, J BIOCHEM BIOPH METH, V15, P125, DOI 10.1016/0165-022X(87)90111-4
   Buch A, 2016, EXP GERONTOL, V76, P25, DOI 10.1016/j.exger.2016.01.008
   CHANDLER CS, 1988, BIOCHEM J, V251, P749, DOI 10.1042/bj2510749
   COLLINS JC, 1988, J BIOL CHEM, V263, P11280
   Ferris HA, 2017, P NATL ACAD SCI USA, V114, P1189, DOI 10.1073/pnas.1620506114
   Ganesan D, 2020, J NEUROCHEM, V154, P562, DOI 10.1111/jnc.14979
   Gao S, 2007, P NATL ACAD SCI USA, V104, P17358, DOI 10.1073/pnas.0708385104
   Gómez-Ramos P, 2007, J ALZHEIMERS DIS, V11, P53
   Hamilton JA, 2007, J MOL NEUROSCI, V33, P2, DOI 10.1007/s12031-007-0060-1
   HARIHARAN M, 1993, J CHROMATOGR-BIOMED, V621, P15, DOI 10.1016/0378-4347(93)80071-B
   Hoffmann J, 2013, AGING-US, V5, P315, DOI 10.18632/aging.100553
   JACOBS R, 1970, J BIOL CHEM, V245, P6462
   Järvinen E, 2016, INT J OBESITY, V40, P788, DOI 10.1038/ijo.2015.237
   Kant HR, 2014, J BIOTECHNOL, V188, P112, DOI 10.1016/j.jbiotec.2014.08.017
   Kim Hyemin, 2012, Immune Netw, V12, P18, DOI 10.4110/in.2012.12.1.18
   Kitada M, 2019, EBIOMEDICINE, V43, P632, DOI 10.1016/j.ebiom.2019.04.005
   Kuhla A, 2011, J GERONTOL A-BIOL, V66, P1192, DOI 10.1093/gerona/glr124
   Landenberger A, 2004, J NUTR BIOCHEM, V15, P591, DOI 10.1016/j.jnutbio.2004.04.006
   LAU EP, 1979, P NATL ACAD SCI USA, V76, P214, DOI 10.1073/pnas.76.1.214
   MAEBASHI M, 1993, J CLIN BIOCHEM NUTR, V14, P211
   Martínez-Uña M, 2013, HEPATOLOGY, V58, P1296, DOI 10.1002/hep.26399
   Mentch SJ, 2016, ANN NY ACAD SCI, V1363, P91, DOI 10.1111/nyas.12956
   Miller KN, 2017, AGING CELL, V16, P497, DOI 10.1111/acel.12575
   Moore SA, 2001, J MOL NEUROSCI, V16, P195, DOI 10.1385/JMN:16:2-3:195
   Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024
   Obata F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9332
   Pacheco-Alvarez D, 2004, J BIOL CHEM, V279, P52312, DOI 10.1074/jbc.M407056200
   Piperi C, 2012, J CLIN ENDOCR METAB, V97, P2231, DOI 10.1210/jc.2011-3408
   Rao ZJ, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e01494
   Selvam S, 2019, CELL STRESS CHAPERON, V24, P343, DOI 10.1007/s12192-018-00967-9
   Shimabukuro MK, 2016, SCI REP-UK, V6, DOI 10.1038/srep23795
   SHRIVER BJ, 1993, J NUTR, V123, P1140
   THONG KW, 1987, PARASITOL RES, V73, P193, DOI 10.1007/BF00578503
   Varela-Rey M, 2014, NEURON, V81, P1024, DOI 10.1016/j.neuron.2014.01.037
   Wongkittichote P, 2017, MOL GENET METAB, V122, P145, DOI 10.1016/j.ymgme.2017.10.002
   Zempleni J, 2011, EPIGENETICS-US, V6, P892, DOI 10.4161/epi.6.7.15544
NR 40
TC 1
Z9 1
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0271-5317
EI 1879-0739
J9 NUTR RES
JI Nutr. Res.
PD JUL
PY 2020
VL 79
BP 68
EP 76
DI 10.1016/j.nutres.2020.06.004
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA MU5FD
UT WOS:000555698200007
PM 32650222
DA 2024-02-19
ER

PT J
AU Catera, M
   Borelli, V
   Malagolini, N
   Chiricolo, M
   Venturi, G
   Reis, C
   Osorio, H
   Abruzzo, PM
   Capri, M
   Monti, D
   Ostan, R
   Franceschi, C
   Dall'Olio, F
AF Catera, Mariangela
   Borelli, Vincenzo
   Malagolini, Nadia
   Chiricolo, Mariella
   Venturi, Giulia
   Reis, Celso
   Osorio, Hugo
   Abruzzo, Provvidenza M.
   Capri, Miriam
   Monti, Daniela
   Ostan, Rita
   Franceschi, Claudio
   Dall'Olio, Fabio
TI Identification of novel plasma glycosylation-associated markers of aging
SO ONCOTARGET
LA English
DT Article
DE antibody glycosylation; inflammaging; plasma galactosyltransferases;
   plasma sialyltransferases; soluble glycosyltransferases; Gerotarget
ID BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE; RHEUMATOID-ARTHRITIS
   PATIENTS; N-LINKED OLIGOSACCHARIDES; INTRAVENOUS IMMUNOGLOBULIN;
   ANTIINFLAMMATORY ACTIVITY; AGALACTOSYL IGG; SERUM IGG; ALPHA-2,6
   SIALYLTRANSFERASE; ST6GAL-1 SIALYLTRANSFERASE; AFFINITY-CHROMATOGRAPHY
AB The pro-or anti-inflammatory activities of immunoglobulins G (IgGs) are controlled by the structure of the glycan N-linked to Asn297 of their heavy chain. The age-associated low grade inflammation (inflammaging) is associated with increased plasmatic levels of agalactosylated IgGs terminating with N-acetylglucosamine (IgG-G0) whose biogenesis has not been fully explained. Although the biosynthesis of glycans is in general mediated by glycosyltransferases associated with internal cell membranes, the extracellular glycosylation of circulating glycoproteins mediated by plasmatic glycosyltransferases has been recently demonstrated. In this study we have investigated the relationship between plasmatic glycosyltransferases, IgG glycosylation and inflammatory and aging markers. In cohorts of individuals ranging from infancy to centenarians we determined the activity of plasmatic beta 4 galactosyltransferase(s) (B4GALTs) and of alpha 2,6-sialyltransferase ST6GAL1, the glycosylation of IgG, the GlycoAge test (a glycosylation-based marker of aging) and the plasma level of inflammatory and liver damage markers. Our results show that: 1) plasmatic B4GALTs activity is a new marker of aging, showing a linear increase throughout the whole age range. 2) plasmatic ST6GAL1 was high only in children and in people above 80, showing a quadratic relationship with age. 3) Neither plasmatic glycosyltransferase correlated with markers of liver damage. 4) plasmatic ST6GAL1 showed a positive association with acute phase proteins in offspring of short lived parents, but not in centenarians or in their offspring. 5) Although the glycosylation of IgGs was not correlated with the level of the two plasmatic glycosyltransferases, it showed progressive age-associated changes consistent with a shift toward a pro-inflammatory glycotype.
C1 [Catera, Mariangela; Borelli, Vincenzo; Malagolini, Nadia; Chiricolo, Mariella; Venturi, Giulia; Abruzzo, Provvidenza M.; Capri, Miriam; Ostan, Rita; Franceschi, Claudio; Dall'Olio, Fabio] Univ Bologna, Dipartimento Med Specialist Diagnost & Sperimenta, Bologna, Italy.
   [Reis, Celso; Osorio, Hugo] Univ Porto, Inst Res & Innovat Hlth, Inst Invest & Inovacao Saude, Rua Campo Alegre 823, P-4100 Oporto, Portugal.
   [Reis, Celso; Osorio, Hugo] Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal.
   [Reis, Celso] Univ Porto, Inst Biomed Sci Abel Salazar ICBAS, Rua Campo Alegre 823, P-4100 Oporto, Portugal.
   [Reis, Celso; Osorio, Hugo] Univ Porto, Fac Med, Rua Campo Alegre 823, P-4100 Oporto, Portugal.
   [Monti, Daniela] Univ Florence, Dipartimento Sci Biomed Sperimentali & Clin Mario, Florence, Italy.
C3 University of Bologna; Universidade do Porto; i3S - Instituto de
   Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do
   Porto; Universidade do Porto; Universidade do Porto; University of
   Florence
RP Dall'Olio, F (corresponding author), Univ Bologna, Dipartimento Med Specialist Diagnost & Sperimenta, Bologna, Italy.
EM fabio.dallolio@unibo.it
RI Abruzzo, Provvidenza Maria/G-7009-2015; REIS, Celso A/B-9969-2008;
   Capri, Miriam/K-4700-2016; Franceschi, Claudio/L-4484-2017; Ostan,
   Rita/K-3074-2018; Monti, Daniela/G-9556-2012; Osorio, Hugo/A-7847-2012
OI Abruzzo, Provvidenza Maria/0000-0001-5242-9448; REIS, Celso
   A/0000-0002-0286-6639; Capri, Miriam/0000-0001-9077-0401; Ostan,
   Rita/0000-0002-0299-2811; Monti, Daniela/0000-0001-8651-8123; Osorio,
   Hugo/0000-0002-6362-8255; VENTURI, GIULIA/0000-0002-1624-8946
FU European Union [259679, 305280]; MIUR (PRIN); University of Florence;
   University of Bologna [FARB2-2014]; University of Bologna; FCT, the
   Portuguese Foundation for Science and Technology; FEDER funds through
   the Operational Program for Competitiveness Factors-COMPETE; National
   Funds through the FCT [PEst-C/SAU/LA0003/2013, PTDC/BBB-EBI/0786/2012]
FX The research leading to these results has received funding from the
   European Union's Seventh Framework Program under grant agreement n.
   259679 (IDEAL) to CF, n. 305280 (MIMOmics) to CF, from MIUR (PRIN 2006)
   to DM and CF, from grant of University of Florence to DM and FARB2-2014
   -University of Bologna-to MCap.; M. Cat. VB and GV were supported by PhD
   grants from the University of Bologna.; CR and HO acknowledges IPATIMUP
   / I3S Research Unit, which is partially supported by FCT, the Portuguese
   Foundation for Science and Technology. This work is funded by FEDER
   funds through the Operational Program for Competitiveness
   Factors-COMPETE and National Funds through the FCT, under the projects:
   PEst-C/SAU/LA0003/2013, PTDC/BBB-EBI/0786/2012
CR ALAVI A, 1995, ADV EXP MED BIOL, V376, P185
   Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315
   Appenheimer MM, 2003, GLYCOBIOLOGY, V13, P591, DOI 10.1093/glycob/cwg066
   AXFORD JS, 1987, LANCET, V2, P1486
   AXFORD JS, 1992, J CLIN INVEST, V89, P1021, DOI 10.1172/JCI115643
   Blagosklonny MV, 2013, CELL CYCLE, V12, P3736, DOI 10.4161/cc.27188
   BODMAN KB, 1992, CLIN EXP IMMUNOL, V88, P420
   Böhm S, 2012, SEMIN IMMUNOPATHOL, V34, P443, DOI 10.1007/s00281-012-0308-x
   Callewaert N, 2001, GLYCOBIOLOGY, V11, P275, DOI 10.1093/glycob/11.4.275
   Campbell IK, 2014, J IMMUNOL, V192, P5031, DOI 10.4049/jimmunol.1301611
   Cevenini E, 2010, CURR PHARM DESIGN, V16, P609, DOI 10.2174/138161210790883840
   Collin M, 2013, EXP DERMATOL, V22, P511, DOI 10.1111/exd.12171
   Dall'Olio F, 2011, SPR CARB CH, V37, P21, DOI 10.1039/9781849732765-00021
   Dall'Olio F, 2004, GLYCOBIOLOGY, V14, P39, DOI 10.1093/glycob/cwh002
   Dall'Olio F, 2001, GLYCOCONJUGATE J, V18, P841, DOI 10.1023/A:1022288022969
   Dall'Olio F, 2001, EUR J BIOCHEM, V268, P5876, DOI 10.1046/j.0014-2956.2001.02536.x
   Dall'Olio F, 2014, BBA-GEN SUBJECTS, V1840, P2752, DOI 10.1016/j.bbagen.2014.06.006
   Dall'Olio F, 2013, AGEING RES REV, V12, P685, DOI 10.1016/j.arr.2012.02.002
   Dall'Olio F, 2012, FRONT BIOSCI-LANDMRK, V17, P670, DOI 10.2741/3951
   Dall'Olio Fabio, 2000, Glycoconjugate Journal, V17, P669, DOI 10.1023/A:1011077000164
   Dalziel M, 1999, GLYCOBIOLOGY, V9, P1003, DOI 10.1093/glycob/9.10.1003
   DELMOTTE FM, 1980, EUR J BIOCHEM, V112, P219, DOI 10.1111/j.1432-1033.1980.tb07197.x
   DELVES PJ, 1990, ARTHRITIS RHEUM-US, V33, P1655, DOI 10.1002/art.1780331108
   Dong X, 1999, J IMMUNOL, V163, P5427
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Franceschi C, 2007, NUTR REV, V65, pS173, DOI 10.1301/nr.2007.dec.S173-S176
   Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016
   FURUKAWA K, 1990, INT IMMUNOL, V2, P105, DOI 10.1093/intimm/2.1.105
   Gornik O, 2012, BBA-GEN SUBJECTS, V1820, P1318, DOI 10.1016/j.bbagen.2011.12.004
   Goulabchand R, 2014, AUTOIMMUN REV, V13, P742, DOI 10.1016/j.autrev.2014.02.005
   Gueresi P, 2013, EXP GERONTOL, V48, P395, DOI 10.1016/j.exger.2013.02.004
   Hess C, 2013, J CLIN INVEST, V123, P3788, DOI 10.1172/JCI65938
   IGLESIAS JL, 1982, EUR J BIOCHEM, V123, P247, DOI 10.1111/j.1432-1033.1982.tb19760.x
   Jeddi PA, 1996, IMMUNOLOGY, V87, P654, DOI 10.1046/j.1365-2567.1996.474593.x
   Jones MB, 2012, J BIOL CHEM, V287, P15365, DOI 10.1074/jbc.M112.345710
   Jones MB, 2010, J BIOL CHEM, V285, P25009, DOI 10.1074/jbc.M110.104406
   Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594
   KAPLAN HA, 1983, J BIOL CHEM, V258, P1505
   Keusch J, 1998, GLYCOCONJUGATE J, V15, P1093, DOI 10.1023/A:1006957711557
   Kitazume S, 2003, GLYCOCONJUGATE J, V20, P59, DOI 10.1023/B:GLYC.0000016743.25495.45
   Kitazume S, 2003, J BIOL CHEM, V278, P14865, DOI 10.1074/jbc.M206262200
   Kitazume S, 2001, P NATL ACAD SCI USA, V98, P13554, DOI 10.1073/pnas.241509198
   Knezevic A, 2010, GLYCOBIOLOGY, V20, P959, DOI 10.1093/glycob/cwq051
   Knezevic A, 2009, J PROTEOME RES, V8, P694, DOI 10.1021/pr800737u
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Leader KA, 1996, BRIT J RHEUMATOL, V35, P335
   LEAVITT RD, 1977, J BIOL CHEM, V252, P2961
   Lee MM, 2014, J BIOL CHEM, V289, P8742, DOI 10.1074/jbc.C113.546713
   Leontyev D, 2012, TRANSFUSION, V52, P1799, DOI 10.1111/j.1537-2995.2011.03517.x
   Malagolini N, 2013, APOPTOSIS, V18, P373, DOI 10.1007/s10495-013-0812-z
   Nasirikenari M, 2006, BLOOD, V108, P3397, DOI 10.1182/blood-2006-04-014779
   Nasirikenari M, 2014, J BIOL CHEM, V289, P7178, DOI 10.1074/jbc.M113.508457
   Nimmerjahn F, 2008, ANNU REV IMMUNOL, V26, P513, DOI 10.1146/annurev.immunol.26.021607.090232
   Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206
   Nimmerjahn F, 2007, P NATL ACAD SCI USA, V104, P8433, DOI 10.1073/pnas.0702936104
   Oefner CM, 2012, J ALLERGY CLIN IMMUN, V129, P1647, DOI 10.1016/j.jaci.2012.02.037
   Osorio Hugo, 2013, Methods Mol Biol, V1007, P301, DOI 10.1007/978-1-62703-392-3_13
   Ostan R, 2013, AGE, V35, P1995, DOI 10.1007/s11357-012-9483-x
   Othy S, 2014, EUR J IMMUNOL, V44, P2059, DOI 10.1002/eji.201444440
   PAREKH R, 1988, J EXP MED, V167, P1731, DOI 10.1084/jem.167.5.1731
   PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0
   Peipp M, 2008, BLOOD, V112, P2390, DOI 10.1182/blood-2008-03-144600
   PEREIRA MEA, 1978, ARCH BIOCHEM BIOPHYS, V185, P108, DOI 10.1016/0003-9861(78)90149-2
   Pucic M, 2012, GLYCOBIOLOGY, V22, P975, DOI 10.1093/glycob/cws062
   Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370
   Ruhaak LR, 2011, J PROTEOME RES, V10, P1667, DOI 10.1021/pr1009959
   Ruhaak LR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012566
   Salvioli S, 2013, CURR PHARM DESIGN, V19, P1675
   Schwab I, 2014, EUR J IMMUNOL, V44, P1444, DOI 10.1002/eji.201344230
   Sharma M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05672
   SHIBUYA N, 1987, J BIOL CHEM, V262, P1596
   Vanhooren V, 2008, BIOGERONTOLOGY, V9, P351, DOI 10.1007/s10522-008-9140-z
   Vanhooren V, 2007, REJUV RES, V10, P521, DOI 10.1089/rej.2007.0556
   Vanhooren V, 2010, EXP GERONTOL, V45, P738, DOI 10.1016/j.exger.2010.08.009
   Vanhooren V, 2009, MECH AGEING DEV, V130, P92, DOI 10.1016/j.mad.2008.11.008
   Wandall HH, 2012, BLOOD, V120, P626, DOI 10.1182/blood-2012-02-409235
   Yabe R, 2010, FEBS J, V277, P4010, DOI 10.1111/j.1742-4658.2010.07792.x
   Yu XJ, 2013, J MOL BIOL, V425, P1253, DOI 10.1016/j.jmb.2013.02.006
NR 78
TC 33
Z9 35
U1 0
U2 9
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
EI 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD FEB 16
PY 2016
VL 7
IS 7
BP 7455
EP 7468
DI 10.18632/oncotarget.7059
PG 14
WC Oncology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Cell Biology
GA DE0PD
UT WOS:000370325900010
PM 26840264
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Yamamoto, N
   Tamura, T
   Maeda, M
   Ando, M
   Shinkai, T
   Eguchi, K
   Ohe, Y
   Oshita, F
   Shiraishi, J
   Katsumata, N
   Saijo, N
AF Yamamoto, N
   Tamura, T
   Maeda, M
   Ando, M
   Shinkai, T
   Eguchi, K
   Ohe, Y
   Oshita, F
   Shiraishi, J
   Katsumata, N
   Saijo, N
TI The influence of ageing on cisplatin pharmacokinetics in lung cancer
   patients with normal organ function
SO CANCER CHEMOTHERAPY AND PHARMACOLOGY
LA English
DT Article
DE cisplatin; ageing; pharmacokinetics
ID NEPHROTOXICITY; DISPOSITION
AB This study was performed to identify any relationship between age and cisplatin (CDDP) pharmacokinetics in lung cancer patients. CDDP was given at a dose of 80 mg/m(2) by l-h intravenous infusion to 23 lung cancer patients. All patients had normal renal, hepatic, and bone marrow functions. We measured ultrafilterable platinum (U-Pt) and total plasma platinum (T-Pt) using atomic absorption spectrometry. There was significant correlation between the age of the patients and U-Pt pharmacokinetic parameters such as the area under the plasma concentration versus time curve (AUG), total clearance(Cl), and peak plasma concentration (Cmax) as well as the AUC of T-Pt (P < 0.05). We performed univariate regression analysis to examine the influence of factors aside from age on the AUC of U-Pt and T-Pt. Creatinine and GPT levels were significantly related to the AUC of U-Pt, and creatinine clearance and creatinine concentrations were significantly related to the AUC of T-Pt. Therefore, stepwise multiple-regression models for the AUC of U-Pt and T-Pt were developed to assess an age effect. Age was consistently an independent and significant predictor of the AUC of U-Pt and T-Pt.
C1 NATL CANC CTR,RES INST,DIV PHARMACOL,CHUO KU,TOKYO 104,JAPAN.
   NATL CANC CTR,RES INST,CHEMOTHERAPY & DIV,CHUO KU,TOKYO 104,JAPAN.
   NATL CANC CTR,DEPT MED ONCOL,CHUO KU,TOKYO 104,JAPAN.
C3 National Cancer Center - Japan; National Cancer Center - Japan; National
   Cancer Center - Japan
CR BORKOWSKI JM, 1994, CANCER CHEMOTH PHARM, V33, P493, DOI 10.1007/BF00686507
   BUNN PA, 1989, SEMIN ONCOL, V16, P10
   GREENBLATT DJ, 1975, NEW ENGL J MED, V293, P702, DOI 10.1056/NEJM197510022931406
   MIYA T, 1992, JPN J CANCER RES, V83, P1382, DOI 10.1111/j.1349-7006.1992.tb02773.x
   OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014
   POWIS G, 1985, CANCER CHEMOTH PHARM, V14, P177
   REECE PA, 1987, J CLIN ONCOL, V5, P304, DOI 10.1200/JCO.1987.5.2.304
   SCHMUCKER DL, 1985, PHARMACOL REV, V37, P133
   TREGASKIS BF, 1990, BRIT MED BULL, V46, P9, DOI 10.1093/oxfordjournals.bmb.a072397
   WEINER MW, 1983, FED PROC, V42, P2974
   YAMAOKA K, 1978, J PHARMACOKINET BIOP, V6, P165, DOI 10.1007/BF01117450
   YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879, DOI 10.1248/bpb1978.4.879
NR 12
TC 31
Z9 32
U1 1
U2 2
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0344-5704
J9 CANCER CHEMOTH PHARM
JI Cancer Chemother. Pharmacol.
PD JUN
PY 1995
VL 36
IS 2
BP 102
EP 106
DI 10.1007/BF00689192
PG 5
WC Oncology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Pharmacology & Pharmacy
GA QY585
UT WOS:A1995QY58500002
PM 7767944
DA 2024-02-19
ER

PT J
AU Daneshi-Maskooni, M
   Keshavarz, SA
   Qorbani, M
   Mansouri, S
   Alavian, SM
   Badri-Fariman, M
   Jazayeri-Tehrani, SA
   Sotoudeh, G
AF Daneshi-Maskooni, Milad
   Keshavarz, Seyed Ali
   Qorbani, Mostafa
   Mansouri, Siavash
   Alavian, Seyed Moayed
   Badri-Fariman, Mahtab
   Jazayeri-Tehrani, Seyed Ali
   Sotoudeh, Gity
TI Green cardamom increases Sirtuin-1 and reduces inflammation in
   overweight or obese patients with non-alcoholic fatty liver disease: a
   double-blind randomized placebo-controlled clinical trial
SO NUTRITION & METABOLISM
LA English
DT Article
DE Non-alcoholic fatty liver disease; Green cardamom; Overweight or
   obesity; Sirtuin-1; Inflammatory factors
ID NF-KAPPA-B; ELETTARIA-CARDAMOMUM; OXIDATIVE STRESS; DIETARY POLYPHENOLS;
   HEPATIC STEATOSIS; DOWN-REGULATION; POTENTIAL ROLE; AGING PROCESS;
   WEIGHT-LOSS; IN-VITRO
AB Background: Non-alcoholic fatty liver disease (NAFLD) is the hepatic component of metabolic syndrome. Despite the beneficial health effects of cardamom on dyslipidemia, hepatomegaly, and fasting hyperglycemia, no previous human study has been conducted on the efficacy of cardamom in NAFLD. The aim of this study was to assess the effects of green cardamom (GC) on serum Sirtuin-1 (Sirt1), inflammatory factors, and liver enzymes in overweight or obese NAFLD patients.
   Methods: The recruitment of subjects was conducted at the polyclinic of the central hospital of National Iranian Oil Company (NIOC), Tehran. Eighty-seven patients who participated were divided randomly into two groups according to the ultrasonography and eligibility criteria as cardamom (n = 43) or placebo (n = 44). The intervention involves taking two 500 mg capsules three times per day with meals for 3 months. General characteristics, dietary intake and physical activity status, weight and height were determined. In addition, serum Sirt1, tumor necrosis factor-alpha (TNF-alpha), high sensitive c-reactive protein (hs-CRP), interleukin-6 (IL-6), alanine transaminase (ALT), and aspartate transaminase (AST) were measured. The degree of fatty liver was determined at beginning and end of the study.
   Results: In comparison with placebo, GC significantly increased Sirt1 and decreased hs-CRP, TNF-alpha, IL-6, ALT, and the degree of fatty liver (P < 0.05). The differences in weight, BMI, and AST were not significant (P> 0.05).
   Conclusion: GC supplementation could improve some biomarkers related to fatty liver including inflammation, ALT, and Sirt1 in overweight/obese NAFLD patients. Further trials on cardamom's potential are suggested.
C1 [Daneshi-Maskooni, Milad; Badri-Fariman, Mahtab; Sotoudeh, Gity] Univ Tehran Med Sci, Dept Community Nutr, Sch Nutr Sci & Dietet, 44 Hojjatdoust Alley,Naderi Ave,Keshavarz Blvd, Tehran 1416643931, Iran.
   [Keshavarz, Seyed Ali; Jazayeri-Tehrani, Seyed Ali] Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Clin Nutr, Tehran, Iran.
   [Qorbani, Mostafa] Alborz Univ Med Sci, Noncommunicable Dis Res Ctr, Karaj, Iran.
   [Mansouri, Siavash] NIOC, Gastroenterohepatol Dept, Cent Hosp, Tehran, Iran.
   [Alavian, Seyed Moayed] Baqiyatallah Univ Med Sci, Baqiyatallah Res Ctr Gastroenterol & Liver Dis BR, Tehran, Iran.
C3 Tehran University of Medical Sciences; Tehran University of Medical
   Sciences; National Iranian Oil Company (NIOC); Baqiyatallah University
   of Medical Sciences (BMSU)
RP Sotoudeh, G (corresponding author), Univ Tehran Med Sci, Dept Community Nutr, Sch Nutr Sci & Dietet, 44 Hojjatdoust Alley,Naderi Ave,Keshavarz Blvd, Tehran 1416643931, Iran.; Keshavarz, SA (corresponding author), Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Clin Nutr, Tehran, Iran.
EM s_akeshavarz@yahoo.com
RI Daneshi-Maskooni, Milad/AAC-6834-2021; keshavarz, Seyed
   Ali/AAD-3261-2019; Qorbani, Mostafa/M-8171-2017; Daneshi-Maskooni,
   Milad/C-1139-2019
OI Daneshi-Maskooni, Milad/0000-0003-1373-1358; Keshavarz, Seyyed
   Ali/0000-0002-5173-7665
FU Tehran University of Medical Sciences [30123-161-03-94]
FX Funding was supported by the Tehran University of Medical Sciences
   (Code: 30123-161-03-94).
CR Aboelnaga S. M. H., 2015, World Applied Sciences Journal, V33, P854
   Aboubakr M., 2016, International Journal of Basic and Applied Sciences, V5, P1, DOI DOI 10.14419/IJBAS.V5I1.5435
   Adibi A, 2013, OPEN J MED IMAGING, V3, P97, DOI DOI 10.4236/OJMI.2013.33015
   Aggarwal BB, 2009, EXP BIOL MED, V234, P825, DOI 10.3181/0902-MR-78
   Ajami M, 2017, NEUROSCI BIOBEHAV R, V73, P39, DOI 10.1016/j.neubiorev.2016.11.022
   Al-Othman A. M., 2006, IJP - International Journal of Pharmacology, V2, P60
   Amirkalali B, 2014, IRAN J PUBLIC HEALTH, V43, P1275
   Asimi O.A., 2016, JFishLivestProd, V04, P1, DOI [10.4172/2332-2608.1000157, DOI 10.4172/2332-2608.1000157]
   Azimi Paria, 2014, Rev Diabet Stud, V11, P258, DOI 10.1900/RDS.2014.11.258
   Badkook MM, 2013, INT J NUTR FOOD SCI, V2, P280, DOI [10.11648/j.ijnfs.20130206.13, DOI 10.11648/J.IJNFS.20130206.13]
   Baghiani-Moghaddam MH, 2013, J HLTH SYST RES, V9, P605
   Berman AY, 2017, NPJ PRECIS ONCOL, V1, DOI 10.1038/s41698-017-0038-6
   Bhaswant M, 2015, NUTRIENTS, V7, P7691, DOI 10.3390/nu7095360
   Bhat GMN, 2015, J ADV PHARM TECHNOL, V6, P136, DOI 10.4103/2231-4040.157981
   Bhattacharjee B, 2013, ASIAN PAC J CANCER P, V14, P3735, DOI 10.7314/APJCP.2013.14.6.3735
   Bo S, 2018, ACTA DIABETOL, V55, P331, DOI 10.1007/s00592-017-1097-4
   Brglez Mojzer Eva, 2016, Molecules, V21, DOI 10.3390/molecules21070901
   Chung SW, 2010, ARCH BIOCHEM BIOPHYS, V501, P79, DOI 10.1016/j.abb.2010.05.003
   Colak Y, 2014, J GASTROINTEST LIVER, V23, P311, DOI [10.15403/jgld.2014.1121.233.yck, 10.1543/jgld.20l4.1121.233.yck]
   Colak Y, 2011, MED SCI MONITOR, V17, pHY5, DOI 10.12659/MSM.881749
   Da-Silva WS, 2007, DIABETES, V56, P767, DOI 10.2337/db06-1488
   Daneshi-Maskooni M, 2017, TRIALS, V18, DOI 10.1186/s13063-017-1979-3
   Darwish MM, 2013, ARAB J NUCL SCI APPL, V46, P232
   Das I, 2012, BRIT J NUTR, V108, P984, DOI 10.1017/S0007114511006283
   Davis JM, 2009, CURR SPORT MED REP, V8, P206, DOI 10.1249/JSR.0b013e3181ae8959
   Del Campo JA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030911
   Deng YJ, 2016, CHIN HERB MED, V8, P359, DOI 10.1016/S1674-6384(16)60063-1
   Ding RB, 2017, INT J BIOL SCI, V13, P852, DOI 10.7150/ijbs.19370
   Dixon JB, 2004, HEPATOLOGY, V39, P1647, DOI 10.1002/hep.20251
   Duarte DA, 2015, J NUTR BIOCHEM, V26, P64, DOI 10.1016/j.jnutbio.2014.09.003
   Ekhlasi G., 2013, Razi Journal of Medical Sciences, V20, P30
   Elguindy NM, 2016, S AFR J BOT, V105, P251, DOI 10.1016/j.sajb.2016.04.001
   Elliott PJ, 2008, CURR OPIN INVEST DR, V9, P371
   Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280
   Farris PK, 2011, SEMIN CUTAN MED SURG, V30, P163, DOI 10.1016/j.sder.2011.05.004
   Gaharwar Rakesh, 2015, J Assoc Physicians India, V63, P12
   Ghane Z, 2016, J MAZANDARAN U MED S, V26, P1
   González R, 2011, CRIT REV FOOD SCI, V51, P331, DOI 10.1080/10408390903584094
   Hämäläinen M, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/45673
   Hamzaa RG, 2012, BIOCH ANAL BIOCH, V1, P2161, DOI [10.4172/2161-1009.1000113, DOI 10.4172/2161-1009.1000113]
   Han XZ, 2007, INT J MOL SCI, V8, P950, DOI 10.3390/i8090950
   Han XueSheng, 2017, Cogent Medicine, V4, P1308066, DOI 10.1080/2331205x.2017.1308066
   Ho SuChen, 2012, American Journal of Plant Sciences, V3, P995
   Hussain T, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/7432797
   Islam MA, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/5137431
   Jazayeri S, 2005, IRAN J DIAB LIPID, V1, P81
   Jazayeri-Tehrani SA, 2018, NANOMED J, V5, P67, DOI 10.22038/nmj.2018.005.003
   Jazayeri-Tehrani SA, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016914
   Kandikattu HK, 2017, BIOMED PHARMACOTHER, V91, P191, DOI 10.1016/j.biopha.2017.04.049
   Katan MB, 2009, NEW ENGL J MED, V360, P923, DOI 10.1056/NEJMe0810291
   Kazemi S, 2017, J SCI FOOD AGR, V97, P5296, DOI 10.1002/jsfa.8414
   Kelly GS, 2010, ALTERN MED REV, V15, P313
   Kim HK, 2007, BIOGERONTOLOGY, V8, P399, DOI 10.1007/s10522-007-9083-9
   Kim JA, 2005, INT IMMUNOPHARMACOL, V5, P209, DOI 10.1016/j.intimp.2004.09.027
   Lankarani KB, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.9248
   Lau E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/979515
   Majdalawieh AF, 2010, J MED FOOD, V13, P371, DOI 10.1089/jmf.2009.1131
   McCullough Arthur J, 2004, Clin Liver Dis, V8, P521, DOI 10.1016/j.cld.2004.04.004
   Musso G, 2013, NONALCOHOLIC FATTY L, P293
   Musso G, 2010, HEPATOLOGY, V52, P79, DOI 10.1002/hep.23623
   National Guideline Centre (UK), 2016, NON FATT LIV DIS ASS
   Natsume M, 2018, CURR PHARM DESIGN, V24, P191, DOI 10.2174/1381612823666171109104141
   Nishioji K, 2015, J GASTROENTEROL, V50, P95, DOI 10.1007/s00535-014-0948-9
   Pandey KB, 2009, CURR NUTR FOOD SCI, V5, P249, DOI 10.2174/157340109790218058
   Park MJ, 2015, CELL SIGNAL, V27, P1831, DOI 10.1016/j.cellsig.2015.04.010
   Qaffarpour M, 2000, GUIDES HOME SCALES C
   Radomska- Lesniewska DM, 2013, MEDIAT INFLAMM, V2013
   Rahman MM, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0539-x
   Sadeek E. A., 2010, J AM SCI, V6, P7
   Sahebkar A, 2011, WORLD J GASTROENTERO, V17, P271, DOI 10.3748/wjg.v17.i2.271
   Salminen A, 2013, INT J MOL SCI, V14, P3834, DOI 10.3390/ijms14023834
   Salminen A, 2012, CURR OPIN CLIN NUTR, V15, P23, DOI 10.1097/MCO.0b013e32834d3ae7
   Sengupta A, 2009, MOL TARGETS THERAPEU, P65, DOI DOI 10.1142/9789812837912_0003
   Shah K, 2009, OBESITY, V17, P2162, DOI 10.1038/oby.2009.126
   Sherlock S, 2002, DIS LIVER BILIARY SY, P423
   Suen J, 2016, HEALTHCARE-BASEL, V4, DOI 10.3390/healthcare4030069
   Suneetha WJ, 2005, PHYTOTHER RES, V19, P437, DOI 10.1002/ptr.1681
   The IPAQ group, 2017, INT PHYS ACT QUEST
   The lab tests online, 2012, LAB METH US MED LAB
   Torre E, 2017, PHYTOCHEM REV, V16, P1183, DOI 10.1007/s11101-017-9529-x
   Upadhyay S, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/504253
   Vafai-Najar A, 2015, IRAN J HLTH ED HLTH, V3, P116
   Vaidya A., 2014, AM INT J RES FORMAL, V8, P18
   Verma S. K., 2012, Asian Pacific Journal of Tropical Disease, pS739
   Verma SK, 2009, INDIAN J BIOCHEM BIO, V46, P503
   Vijayan KK, 2002, 12 PROPERTIES END US
   Winarsi H, 2016, AGRIC AGRIC SCI PROC, V9, P264, DOI 10.1016/j.aaspro.2016.02.147
   Wu T, 2014, ANN CLIN LAB SCI, V44, P410
   Yanagisawa S, 2017, CHEST, V152, P343, DOI 10.1016/j.chest.2017.05.004
   Yashin A, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6030070
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
   Zelber-Sagi S, 2011, WORLD J GASTROENTERO, V17, P3377, DOI 10.3748/wjg.v17.i29.3377
NR 92
TC 29
Z9 32
U1 0
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1743-7075
J9 NUTR METAB
JI Nutr. Metab.
PD SEP 25
PY 2018
VL 15
AR 63
DI 10.1186/s12986-018-0297-4
PG 12
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA GV1FG
UT WOS:000445814800001
PM 30263038
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Jensen, MR
   Factor, VM
   Fantozzi, A
   Helin, K
   Huh, CG
   Thorgeirsson, SS
AF Jensen, MR
   Factor, VM
   Fantozzi, A
   Helin, K
   Huh, CG
   Thorgeirsson, SS
TI Reduced hepatic tumor incidence in cyclin G1-deficient mice
SO HEPATOLOGY
LA English
DT Article
ID RETROVIRAL VECTOR; DNA-DAMAGE; CHROMOSOMAL LOCALIZATION; G2/M ARREST;
   G1; GROWTH; P53; EXPRESSION; CELLS; LIVER
AB Cyclin G1 is a transcriptional target of the tumor suppressor p53, and its expression is increased after DNA damage. Recent data show that cyclin G1 can regulate the levels of p53 by a mechanism that involves dephosphorylation of Mdm2 by protein phosphatase 2A. To understand the biologic role of cyclin G1, we have generated cyclin G1-deficient mice. In agreement with previous results, we showed that these mice develop normally, and that proliferation and induction of cellular senescence in cyclin G1-deficient mouse embryo fibroblasts are indistinguishable from wild-type fibroblasts. However, we found that the p53 levels in the cyclin G1-deficient mice are 2-fold higher that in wild-type mice. Moreover, we showed that treatment of mice with the alkylating agent 1,4-bis [N,N'-di(ethylene)-phosphamide]piperazine (Dipin), followed by partial hepatectomy, decreased G1-S transition in cyclin G1-null hepatocytes as compared with wild type. Finally, we found a significant decrease in tumor incidence, mass, and malignancy in both male and female cyclin G1-null mice after treatment with the potent hepatocarcinogen N-diethylnitrosamine. Taken with recent published data, our results suggest that cyclin G1, together with Mdm2, constitute a part of a negative feedback system that attenuates the activity of p53. In conclusion, our data suggest that the decreased tumor susceptibility after loss of cyclin G1 function is caused by the increased tumor suppressor action of p53.
C1 NCI, Expt Carcinogenesis Lab, Canc Res Ctr, NIH, Bethesda, MD 20892 USA.
   European Inst Oncol, Dept Expt Oncol, Milan, Italy.
C3 National Institutes of Health (NIH) - USA; NIH National Cancer Institute
   (NCI); IRCCS European Institute of Oncology (IEO)
RP Thorgeirsson, SS (corresponding author), NCI, Expt Carcinogenesis Lab, Canc Res Ctr, NIH, 37 Convent Dr,MSC 4262,Bldg 37,Room 4146, Bethesda, MD 20892 USA.
EM snorri_thorgeirsson@nih.gov
RI Helin, Kristian/K-2526-2019; Jensen, Michael R/E-9677-2011; Helin,
   Kristian/HDM-8306-2022
OI Helin, Kristian/0000-0003-1975-6097
CR Bates S, 1996, ONCOGENE, V13, P1103
   Campagne MV, 1998, NEUROSCIENCE, V84, P1097, DOI 10.1016/S0306-4522(97)00580-0
   Campagne MV, 1999, MOL BRAIN RES, V64, P1
   Chen DS, 1997, HUM GENE THER, V8, P1667, DOI 10.1089/hum.1997.8.14-1667
   DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0
   FACTOR VM, 1994, AM J PATHOL, V145, P409
   Factor VM, 1997, CANCER RES, V57, P2089
   FAKTOR VM, 1980, VIRCHOWS ARCH B, V33, P187, DOI 10.1007/BF02899181
   Gordon EM, 2001, HUM GENE THER, V12, P193, DOI 10.1089/104303401750061258
   Gordon EM, 2000, CANCER RES, V60, P3343
   HARVEY M, 1993, ONCOGENE, V8, P2457
   Higgins GM, 1931, ARCH PATHOL, V12, P186
   HOLLSTEIN M, 1994, NUCLEIC ACIDS RES, V22, P3551
   Horne MC, 1996, J BIOL CHEM, V271, P6050, DOI 10.1074/jbc.271.11.6050
   JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6
   Jensen MR, 1998, HEPATOLOGY, V28, P537, DOI 10.1002/hep.510280235
   Jensen MR, 1997, GENOMICS, V45, P297, DOI 10.1006/geno.1997.4947
   Jensen MR, 2000, GENE, V256, P59, DOI 10.1016/S0378-1119(00)00361-9
   Jensen MR, 1999, GENE, V230, P171, DOI 10.1016/S0378-1119(99)00057-8
   Kamijo T, 1999, CANCER RES, V59, P2217
   Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292
   Kimura SH, 1997, GENOMICS, V46, P483, DOI 10.1006/geno.1997.5034
   Kimura SH, 2001, ONCOGENE, V20, P3290, DOI 10.1038/sj.onc.1204270
   KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770
   LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293
   LEE GH, 1991, CANCER RES, V51, P3257
   Morita N, 1996, J NEUROSCI, V16, P5961
   NAKAMURA T, 1995, EXP CELL RES, V221, P534, DOI 10.1006/excr.1995.1406
   Nakatani T, 2001, JPN J CANCER RES, V92, P249, DOI 10.1111/j.1349-7006.2001.tb01089.x
   Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173
   OKAMOTO K, 1994, EMBO J, V13, P4816, DOI 10.1002/j.1460-2075.1994.tb06807.x
   Okamoto K, 1996, MOL CELL BIOL, V16, P6593
   Okamoto K, 2002, MOL CELL, V9, P761, DOI 10.1016/S1097-2765(02)00504-X
   Quelle DE, 1997, P NATL ACAD SCI USA, V94, P669, DOI 10.1073/pnas.94.2.669
   ROBERTSON EJ, 1991, BIOL REPROD, V44, P238, DOI 10.1095/biolreprod44.2.238
   Shimizu A, 1998, BIOCHEM BIOPH RES CO, V242, P529, DOI 10.1006/bbrc.1997.8004
   SKOTZKO M, 1995, CANCER RES, V55, P5493
   SUSKOVA V S, 1970, Voprosy Onkologii (St. Petersburg), V16, P58
   TAMURA K, 1993, ONCOGENE, V8, P2113
   TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299
   Yardley G, 1998, FEBS LETT, V430, P171, DOI 10.1016/S0014-5793(98)00650-4
   ZAUBERMAN A, 1995, ONCOGENE, V10, P2361
   Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005
NR 43
TC 57
Z9 69
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD APR
PY 2003
VL 37
IS 4
BP 862
EP 870
DI 10.1053/jhep.2003.50137
PG 9
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 663KK
UT WOS:000182004600019
PM 12668979
DA 2024-02-19
ER

PT J
AU Lykkesfeldt, J
   Morgan, E
   Christen, S
   Skovgaard, LT
   Moos, T
AF Lykkesfeldt, Jens
   Morgan, Evan
   Christen, Stephan
   Skovgaard, Lene Theil
   Moos, Torben
TI Oxidative stress and damage in liver, but not in brain, of Fischer 344
   rats subjected to dietary iron supplementation with lipid-soluble
   [(3,5,5-trimethylhexainoyl)ferrocene]
SO JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
LA English
DT Article
DE antioxidant; ferritin; glutathione; hemeoxygenase; malondialdehyde
ID FERROCENE-LOADED RAT; DIVALENT METAL TRANSPORTER-1; PARKINSONS-DISEASE;
   HEME OXYGENASE; BELGRADE RAT; MOUSE-BRAIN; BARRIER; TRANSFERRIN;
   METABOLISM; FERRITIN
AB Accumulation of iron probably predisposes the aging brain to progressive neuronal loss. We examined various markers of oxidative stress and damage in the brain and liver of 3- and 24-monthold rats following supplementation with the lipophilic iron derivative [(3,5,5-trimethylhexanoyl)ferrocene] (TMHF), which is capable of crossing the blood-brain barrier. At both ages, iron concentration increased markedly in the liver but failed to increase in the brain. In the liver of TMHF-treated young rats, levels of (alpha-and gamma-tocopherols and glutathione (GSH) were also higher. In contrast, the brain displayed unaltered levels of the tocopherols and GSH. Malondialdehyde (MDA) level was also higher in the cerebrospinal. fluid (CSF) and the liver but not in the brain. In old rats, the absence of an increase in iron concentration in the brain was reflected by unaltered concentrations of GSH, tocopherols, and MDA as compared to that in untreated rats. In the aging liver, concentrations of GSH and MDA increased with TMHF treatment. Morphological studies revealed unaltered levels of iron, ferritin, heme oxygenase-1 (HO-1), nitrotyrosine (NT), or MDA in the brains of both young and old rats treated with TMHE In contrast, TMHF treatment increased the level of HO-1 in Kupffer cells, NT in hepatic endothelial cells, and MDA and ferritin in hepatocytes. Although these results demonstrated an increase in the biochemical markers of oxidative stress and damage in response to increasing concentrations of iron in the liver, they also demonstrated that the brain is well protected against dietary iron overload by using iron in a lipid-soluble formulation. (C) 2007 Wiley Periodicals, Inc.
C1 Univ Copenhagen, Panum Inst, Dept Med Anat, DK-2200 Copenhagen, Denmark.
   Univ Copenhagen, Sect Biomed, Dept Vet Pathobiol, DK-2200 Copenhagen, Denmark.
   Univ Western Australia, Dept Physiol, Crawley, WA, Australia.
   Univ Bern, Inst Infect Dis, Bern, Switzerland.
   Univ Copenhagen, Dept Biostat, Copenhagen, Denmark.
C3 University of Copenhagen; University of Copenhagen; University of
   Western Australia; University of Bern; University of Copenhagen
RP Moos, T (corresponding author), Univ Copenhagen, Panum Inst, Dept Med Anat, DK-2200 Copenhagen, Denmark.
EM TMoos@mai.ku.dk
RI Kummer, Juerg/B-3322-2011; Christen, Stephan/B-8602-2009; Lykkesfeldt,
   Jens/A-1072-2011
OI Lykkesfeldt, Jens/0000-0002-6514-8407; Moos, Torben/0000-0001-9989-0207
FU NINDS NIH HHS [R01 NS33997] Funding Source: Medline
CR Asare GA, 2006, TOXICOLOGY, V219, P41, DOI 10.1016/j.tox.2005.11.006
   BARTZOKIS G, 1994, AM J NEURORADIOL, V15, P1129
   Bartzokis G, 1999, MAGN RESON IMAGING, V17, P213, DOI 10.1016/S0730-725X(98)00155-6
   BENKOVIC SA, 1993, J COMP NEUROL, V338, P97, DOI 10.1002/cne.903380108
   Burdo JR, 2001, J NEUROSCI RES, V66, P1198, DOI 10.1002/jnr.1256.abs
   Cable EE, 1999, DRUG METAB DISPOS, V27, P255
   Choi J H, 1998, J Nutr Health Aging, V2, P133
   Cook CI, 1998, MECH AGEING DEV, V102, P1, DOI 10.1016/S0047-6374(98)00005-0
   Cooperman SS, 2005, BLOOD, V106, P1084, DOI 10.1182/blood-2004-12-4703
   Crossgrove JS, 2004, NEUROTOXICOLOGY, V25, P451, DOI 10.1016/j.neuro.2003.10.005
   Dexter DT, 1999, BIOCHEM PHARMACOL, V58, P151, DOI 10.1016/S0006-2952(99)00079-9
   Floor E, 2000, CELL MOL BIOL, V46, P709
   FLORENCE A, 1992, BIOCHEM PHARMACOL, V44, P1023, DOI 10.1016/0006-2952(92)90363-N
   Focht SJ, 1997, NEUROSCIENCE, V79, P255, DOI 10.1016/S0306-4522(96)00607-0
   HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2
   Jeong SY, 2006, J NEUROSCI, V26, P9810, DOI 10.1523/JNEUROSCI.2922-06.2006
   LAMBRECHT RW, 1994, BIOCHEM PHARMACOL, V47, P1669, DOI 10.1016/0006-2952(94)90546-0
   Lykkesfeldt J, 2001, CLIN CHEM, V47, P1725
   Malecki EA, 1999, J NEUROL SCI, V170, P112, DOI 10.1016/S0022-510X(99)00203-8
   Malecki EA, 2002, BIOL TRACE ELEM RES, V86, P73, DOI 10.1385/BTER:86:1:73
   Moos T, 2004, ANN NY ACAD SCI, V1012, P14, DOI 10.1196/annals.1306.002
   Moos T, 2004, J NEUROCHEM, V88, P233, DOI 10.1046/j.1471-4159.2003.02142.x
   Moos T, 2001, J NEUROCHEM, V79, P119, DOI 10.1046/j.1471-4159.2001.00541.x
   Moos T, 2000, CELL MOL BIOL, V46, P549
   NIELSEN P, 1993, BIOCHEM PHARMACOL, V45, P385, DOI 10.1016/0006-2952(93)90074-7
   Pardridge WM, 1998, J NEUROCHEM, V70, P1781
   Rouault Tracey A, 2006, Semin Pediatr Neurol, V13, P142, DOI 10.1016/j.spen.2006.08.002
   Russo N, 2004, J NEUROL, V251, P849, DOI 10.1007/s00415-004-0445-9
   Sayre LM, 2000, CELL MOL BIOL, V46, P731
   TAYLOR EM, 1991, J NEUROCHEM, V57, P1584, DOI 10.1111/j.1471-4159.1991.tb06355.x
   Vymazal J, 1999, RADIOLOGY, V211, P489, DOI 10.1148/radiology.211.2.r99ma53489
   WARD RJ, 1991, EUR J BIOCHEM, V202, P405, DOI 10.1111/j.1432-1033.1991.tb16389.x
   WARD RJ, 1995, BIOCHEM PHARMACOL, V49, P1821, DOI 10.1016/0006-2952(94)00521-M
   WHITTAKER P, 1994, J TRACE ELEM EXP MED, V7, P19
   Wu LJC, 2004, BRAIN RES, V1001, P108, DOI 10.1016/j.brainres.2003.10.066
   Yokel RA, 2006, J ALZHEIMERS DIS, V10, P223
   ZAMARRENO MMD, 1992, J CHROMATOGR, V623, P69, DOI 10.1016/0021-9673(92)85300-I
   Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537
   Zheng W, 2003, TOXICOL APPL PHARM, V192, P1, DOI 10.1016/S0041-008X(03)00251-5
NR 39
TC 11
Z9 13
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1095-6670
EI 1099-0461
J9 J BIOCHEM MOL TOXIC
JI J. Biochem. Mol. Toxicol.
PY 2007
VL 21
IS 3
BP 145
EP 155
DI 10.1002/jbt.20170
PG 11
WC Biochemistry & Molecular Biology; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Toxicology
GA 191VX
UT WOS:000248161200008
PM 17623885
DA 2024-02-19
ER

PT J
AU Goto, S
   Lin, YC
   Lai, CY
   Lee, CM
   Pan, TL
   Lord, R
   Chiang, KC
   Tseng, HP
   Lin, CL
   Cheng, YF
   Yokoyama, H
   Kitano, S
   Chen, CL
AF Goto, S
   Lin, YC
   Lai, CY
   Lee, CM
   Pan, TL
   Lord, R
   Chiang, KC
   Tseng, HP
   Lin, CL
   Cheng, YF
   Yokoyama, H
   Kitano, S
   Chen, CL
TI Telomerase activity in rat liver allografts
SO TRANSPLANTATION
LA English
DT Article
ID CELLS
AB Background Telomerase activity in grafts may be involved in the alteration of cellular senescence after transplantation or its relevant immunological events.
   Methods. At the age of 20 weeks, donor livers harvested from DA (RT1(a)) were orthotopically transplanted into PVG (RTIc) or LEW (RT1(1)) rats. Rats having undergone orthotopic liver transplantation (OLT; DA-PVG) naturally overcome rejection, whereas all OLT (DA-LEW) rats die from acute rejection within 14 days. Telomerase activity in liver allografts was measured at various intervals post OLT.
   Results. At day 7 when the most severe rejection episode was observed in OLT (DA-LEW) and OLT (DA-PVG), the telomerase activity was significantly higher than in syngeneic OLT (DA-DA) rats, in which no rejection occurred. Telomerase activity in tolerogenic OLT (DA-PVG) livers remained elevated for at least 2 months.
   Conclusion. These results suggest that telomerase activity in allogeneic OLT livers may reflect regenerating hepatocytes or activation of lymphocytes and/or hematopoietic stem cells, associated with rejection or tolerance.
C1 Chang Gung Mem Hosp, Dept Surg, Liver Transplantat Program, Kaohsiung, Taiwan.
   Univ Wales Coll Cardiff, Coll Med, Dept Cardiol, Cardiff CF1 3NS, S Glam, Wales.
   Oita Med Univ, Dept Surg 1, Oita, Japan.
C3 Chang Gung Memorial Hospital; Cardiff University; Oita University
RP Chen, CL (corresponding author), Chang Gung Mem Hosp, Dept Surg, Liver Transplantat Program, 123 Ta Pei Rd, Kaohsiung, Taiwan.
EM clcltf@ms17.hinet.net
RI Lord, Roger/F-8135-2014
OI Lord, Roger/0000-0002-4789-9864
CR Bessa X, 1997, Gastroenterol Hepatol, V20, P442
   Fossel M, 1998, JAMA-J AM MED ASSOC, V279, P1732, DOI 10.1001/jama.279.21.1732
   HIYAMA K, 1995, J IMMUNOL, V155, P3711
   Holt SE, 1996, NAT BIOTECHNOL, V14, P836, DOI 10.1038/nbt0796-836
   KAMADA N, 1983, SURGERY, V93, P64
   KAMADA N, 1985, IMMUNOLOGY, V55, P369
   Olver S, 1998, TRANSPLANTATION, V66, P132, DOI 10.1097/00007890-199807150-00023
   Shay JW, 1998, LANCET, V351, P153, DOI 10.1016/S0140-6736(05)78218-0
   TERAMOTO K, 1990, TRANSPLANTATION, V50, P199, DOI 10.1097/00007890-199008000-00005
   Yamaguchi Y, 1998, EXP CELL RES, V242, P120, DOI 10.1006/excr.1998.4102
NR 10
TC 5
Z9 5
U1 1
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0041-1337
EI 1534-6080
J9 TRANSPLANTATION
JI Transplantation
PD MAR 15
PY 2000
VL 69
IS 5
BP 1013
EP 1015
PG 3
WC Immunology; Surgery; Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Surgery; Transplantation
GA 298NG
UT WOS:000086145600061
PM 10755570
DA 2024-02-19
ER

PT J
AU Akusjaervi, SS
   Neogi, U
AF Akusjaervi, Sara Svensson
   Neogi, Ujjwal
TI Biological Aging in People Living with HIV on Successful Antiretroviral
   Therapy: Do They Age Faster?
SO CURRENT HIV/AIDS REPORTS
LA English
DT Article; Early Access
DE People living with HIV; Antiretroviral therapy; Biological aging;
   Immunometabolism
ID T-CELL-ACTIVATION; GLUTAMINE-METABOLISM; RISK-FACTORS; LACTIC-ACID;
   INFECTION; GLUCOSE; INFLAMMATION; REPLICATION; GLYCOLYSIS; MTORC1
AB Purpose of Review In the absence of a prophylactic/therapeutic vaccine or cure, the most amazing achievement in the battle against HIV was the discovery of effective, well-tolerated combination antiretroviral therapy (cART). The primary research question remains whether PLWH on prolonged successful therapy has accelerated, premature, or accentuated biological aging. In this review, we discuss the current understanding of the immunometabolic profile in PLWH, potentially associated with biological aging, and a better understanding of the mechanisms and temporal dynamics of biological aging in PLWH.
   Recent Findings Biological aging, defined by the epigenetic alterations analyzed by the DNA methylation pattern, has been reported in PLWH with cART that points towards epigenetic age acceleration.
   Summary The hastened development of specific clinical geriatric syndromes like cardiovascular diseases, metabolic syndrome, cancers, liver diseases, neurocognitive diseases, persistent low-grade inflammation, and a shift toward glutamate metabolism in PLWH may potentiate a metabolic profile at-risk for accelerated aging.
C1 [Akusjaervi, Sara Svensson; Neogi, Ujjwal] Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Syst Virol Lab, Stockholm, Sweden.
C3 Karolinska Institutet
RP Akusjaervi, SS; Neogi, U (corresponding author), Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Syst Virol Lab, Stockholm, Sweden.
EM sara.svensson.akusjarvi@ki.se; ujjwal.neogi@ki.se
OI Neogi, Ujjwal/0000-0002-0844-3338
FU Karolinska Institute; Swedish Research Council [2017-01330, 2018-06156,
   2021-01756]; Swedish Research Council [2018-06156, 2021-01756] Funding
   Source: Swedish Research Council
FX Open access funding provided by Karolinska Institute. Authors
   acknowledge the support received from the Swedish Research Council
   grants 2017-01330, 2018-06156, and 2021-01756.
CR Ambikan AT, 2022, LIFE SCI ALLIANCE, V5, DOI 10.26508/lsa.202201405
   Angin M, 2019, NAT METAB, V1, P704, DOI 10.1038/s42255-019-0081-4
   Aso H, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107887
   Atkuri KR, 2007, P NATL ACAD SCI USA, V104, P4547, DOI 10.1073/pnas.0611732104
   Babu H, 2019, METABOLITES, V9, DOI 10.3390/metabo9100210
   Barrero CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068376
   Besnard E, 2016, CELL HOST MICROBE, V20, P785, DOI 10.1016/j.chom.2016.11.001
   Boyko M, 2012, NEUROTHERAPEUTICS, V9, P649, DOI 10.1007/s13311-012-0129-6
   Burgi A, 2005, CANCER-AM CANCER SOC, V104, P1505, DOI 10.1002/cncr.21334
   Castellano P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39898-5
   Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016
   Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684
   Chowdhury FZ, 2018, AIDS, V32, P2669, DOI [10.1097/QAD.0000000000002007, 10.1097/qad.0000000000002007]
   Clerc I, 2019, NAT METAB, V1, P717, DOI 10.1038/s42255-019-0084-1
   Datta PK, 2016, CELL CYCLE, V15, P2288, DOI 10.1080/15384101.2016.1190054
   DeBerardinis RJ, 2012, CELL, V148, P1132, DOI 10.1016/j.cell.2012.02.032
   Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756
   Desquilbet L, 2007, J GERONTOL A-BIOL, V62, P1279, DOI 10.1093/gerona/62.11.1279
   Dhillon BK, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01683
   Dietl K, 2010, J IMMUNOL, V184, P1200, DOI 10.4049/jimmunol.0902584
   Durán RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043
   Esteban-Cantos A, 2021, LANCET HIV, V8, pe197, DOI 10.1016/S2352-3018(21)00006-0
   Ferrucci L, 2020, AGING CELL, V19, DOI 10.1111/acel.13080
   Fischer K, 2007, BLOOD, V109, P3812, DOI 10.1182/blood-2006-07-035972
   Gelpi M, 2021, AGING-US, V13, P22732, DOI 10.18632/aging.203622
   Golumbeanu M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36135-3
   Gross AM, 2016, MOL CELL, V62, P157, DOI 10.1016/j.molcel.2016.03.019
   Guo HT, 2021, NAT IMMUNOL, V22, P423, DOI 10.1038/s41590-021-00898-1
   Hasin Y, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1215-1
   Hegedus A, 2017, AIDS RES HUM RETROV, V33, P1236, DOI [10.1089/AID.2017.0165, 10.1089/aid.2017.0165]
   Hegedus A, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0098-4
   Hollenbaugh JA, 2011, VIROLOGY, V415, P153, DOI 10.1016/j.virol.2011.04.007
   Holzscheck N, 2021, NPJ AGING MECH DIS, V7, DOI 10.1038/s41514-021-00068-5
   Horvath S, 2015, J INFECT DIS, V212, P1563, DOI 10.1093/infdis/jiv277
   Johmura Y, 2021, SCIENCE, V371, P265, DOI 10.1126/science.abb5916
   Kishimoto N, 2020, RETROVIROLOGY, V17, DOI 10.1186/s12977-020-00539-9
   Kishimoto N, 2017, BIOCHEM BIOPH RES CO, V484, P278, DOI 10.1016/j.bbrc.2017.01.096
   Lan XQ, 2013, J LEUKOCYTE BIOL, V94, P769, DOI 10.1189/jlb.0313142
   Liu SJ, 2021, MEDIAT INFLAMM, V2021, DOI 10.1155/2021/5577577
   Loisel-Meyer S, 2012, P NATL ACAD SCI USA, V109, P2549, DOI 10.1073/pnas.1121427109
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Luo YT, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7838647
   Magalhaes I, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02309
   Malmström S, 2022, AIDS, V36, P447, DOI 10.1097/QAD.0000000000003117
   Martin AR, 2017, J CLIN INVEST, V127, P651, DOI 10.1172/JCI89552
   Masoud GN, 2015, ACTA PHARM SIN B, V5, P378, DOI 10.1016/j.apsb.2015.05.007
   Massanella M, 2016, CURR OPIN HIV AIDS, V11, P234, DOI 10.1097/COH.0000000000000230
   Masson JJR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183931
   Mayer KA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01533
   Meyer DH, 2021, AGING CELL, V20, DOI 10.1111/acel.13320
   Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329
   Mikaeloff F, 2022, COMMUN BIOL, V5, DOI 10.1038/s42003-021-02985-3
   Minhas PS, 2021, NATURE, V590, P122, DOI 10.1038/s41586-020-03160-0
   Mracica TB, 2020, BIOGERONTOLOGY, V21, P763, DOI 10.1007/s10522-020-09892-w
   Ohta A, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00027
   Omenn GS., 2012, EVOLUTION TRANSLATIO
   Oursler KK, 2006, AIDS RES HUM RETROV, V22, P1113, DOI 10.1089/aid.2006.22.1113
   Palmer CS, 2014, J IMMUNOL, V193, P5595, DOI 10.4049/jimmunol.1303092
   Palmer CS, 2014, AIDS, V28, P297, DOI 10.1097/QAD.0000000000000128
   Pan XY, 2013, CELL RES, V23, P876, DOI 10.1038/cr.2013.74
   Pathai S, 2014, J GERONTOL A-BIOL, V69, P833, DOI 10.1093/gerona/glt168
   Pollizzi KN, 2015, J CLIN INVEST, V125, P2090, DOI 10.1172/JCI77746
   Ros J, 2001, J NEUROSCI RES, V66, P790, DOI 10.1002/jnr.10043
   Sáez-Cirión A, 2021, NAT REV IMMUNOL, V21, P5, DOI 10.1038/s41577-020-0381-7
   Sanchez Lopez de Nava A, STATPEARLS
   Scarpelini B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161920
   Schmauck-Medina T, 2022, AGING-US, V14, P6829, DOI 10.18632/aging.204248
   Smit M, 2015, LANCET INFECT DIS, V15, P810, DOI 10.1016/S1473-3099(15)00056-0
   Sorbara LR, 1996, J VIROL, V70, P7275, DOI 10.1128/JVI.70.10.7275-7279.1996
   Sperk M, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102111
   STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x
   Sun RC, 2014, CELL METAB, V19, P285, DOI 10.1016/j.cmet.2013.11.022
   Svensson Akusjarvi S, 2022, THESIS KAROLINSKA I
   Tarancon-Diez L, 2019, EBIOMEDICINE, V42, P86, DOI 10.1016/j.ebiom.2019.03.004
   Toschi A, 2008, J BIOL CHEM, V283, P34495, DOI 10.1074/jbc.C800170200
   Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190
   Valle-Casuso JC, 2019, CELL METAB, V29, P611, DOI 10.1016/j.cmet.2018.11.015
   van den Akker EB, 2020, CIRC-GENOM PRECIS ME, V13, P541, DOI 10.1161/CIRCGEN.119.002610
   Vázquez-Santiago FJ, 2014, J NEUROVIROL, V20, P315, DOI 10.1007/s13365-014-0258-2
   Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021
   Yu L, 2018, J CANCER, V9, P3699, DOI 10.7150/jca.27279
   Zdzisinska B, 2017, ARCH IMMUNOL THER EX, V65, P21, DOI 10.1007/s00005-016-0406-x
   Zhang W, 2018, EBIOMEDICINE, V27, P40, DOI 10.1016/j.ebiom.2017.11.031
   Zuo H, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010005
NR 84
TC 2
Z9 2
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1548-3568
EI 1548-3576
J9 CURR HIV-AIDS REP
JI Curr. Hiv/Aids Rep.
PD 2023 JAN 25
PY 2023
DI 10.1007/s11904-023-00646-0
EA JAN 2023
PG 9
WC Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases
GA 8G8MD
UT WOS:000920596000002
PM 36695947
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU Navarro, A
   López-Cepero, JM
   Bández, MJ
   Sánchez-Pino, MJ
   Gómez, C
   Cadenas, E
   Boveris, A
AF Navarro, Ana
   Lopez-Cepero, Jose M.
   Bandez, Manuel J.
   Sanchez-Pino, Maria-Jesus
   Gomez, Carmen
   Cadenas, Enrique
   Boveris, Alberto
TI Hippocampal mitochondrial dysfunction in rat aging
SO AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE
   PHYSIOLOGY
LA English
DT Article
DE mitochondrial nitric oxide synthase; reduced nicotinamide adenide
   dinucleotide dehydrogenase; cytochrome oxidase; oxidative damage
ID NITRIC-OXIDE SYNTHASE; AGE-RELATED-CHANGES; ALZHEIMERS-DISEASE;
   OXIDATIVE STRESS; LIVER-MITOCHONDRIA; BRAIN MITOCHONDRIA;
   ELECTRON-TRANSFER; MICE; BIOGENESIS; SURVIVAL
AB Hippocampus mitochondrial dysfunction with impaired electron transfer and increased oxidative damage was observed upon rat aging. Hippocampal mitochondria of aged (12 mo) and senescent (20 mo) rats showed, compared with young (4 mo) rats, marked decreases in the rate of state 3 respiration with NAD-dependent substrates (32-51%) and in the activities of mitochondrial complexes I (57-73%) and IV (33-54%). The activity of mitochondrial nitric oxide synthase was also decreased, 53-66%, with age. These losses in enzymatic activity were more marked in the hippocampus than in brain cortex or in whole brain. The histochemical assay of mitochondrial complex IV in the hippocampus showed decreased staining upon aging. Oxidative damage, determined as the mitochondrial content of thiobarbituric-acid reactive substances (TBARS) and protein carbonyls, increased in aged and senescent hippocampus (66-74% in TBARS and 48-96% in carbonyls). A significant statistical correlation was observed between mitochondrial oxidative damage and enzymatic activity. Mitochondrial dysfunction with shortage of energy supply is considered a likely cause of dysfunction in aged hippocampus.
C1 [Navarro, Ana; Bandez, Manuel J.; Sanchez-Pino, Maria-Jesus; Gomez, Carmen] Univ Cadiz, Fac Med, Sch Med, Dept Biochem & Mol Biol, Cadiz 11003, Spain.
   [Lopez-Cepero, Jose M.] Univ Cadiz, Sch Med, Dept Cell Biol & Histol, Cadiz 11003, Spain.
   [Cadenas, Enrique] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA USA.
   [Boveris, Alberto] Univ Buenos Aires, Sch Pharm & Biochem, Buenos Aires, DF, Argentina.
C3 Universidad de Cadiz; Universidad de Cadiz; University of Southern
   California; University of Buenos Aires
RP Navarro, A (corresponding author), Univ Cadiz, Fac Med, Sch Med, Dept Biochem & Mol Biol, Plaza Fragela 9, Cadiz 11003, Spain.
EM ana.navarro@uca.es
RI Gómez-Gómez, Carmen/AAN-2273-2020
OI Gomez Gomez, Carmen/0000-0002-9619-5927; Bandez Ruiz, Manuel
   Jesus/0000-0002-6128-8752
CR Abramoff M.D., 2004, Biophotonics Int, V11, P36, DOI DOI 10.1201/9781420005615.AX4
   AMES BN, 1995, BBA-MOL BASIS DIS, V1271, P165, DOI 10.1016/0925-4439(95)00024-X
   Antunes F, 2004, P NATL ACAD SCI USA, V101, P16774, DOI 10.1073/pnas.0405368101
   Baloyannis SJ, 2006, J ALZHEIMERS DIS, V9, P119
   Bancroft J.D., 2002, THEORY PRACTICE HIST, V5th
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Bertoni-Freddari C, 2004, ANN NY ACAD SCI, V1019, P33, DOI 10.1196/annals.1297.007
   BOOTH RFG, 1978, BIOCHEM J, V176, P365, DOI 10.1042/bj1760365
   Boveris A, 2002, METHOD ENZYMOL, V359, P328
   Boveris A, 1999, METHOD ENZYMOL, V301, P188
   CLARK JB, 1970, J BIOL CHEM, V245, P4724
   Cocco T, 2005, FREE RADICAL BIO MED, V38, P796, DOI 10.1016/j.freeradbiomed.2004.11.034
   Cohen RM, 2006, NEUROBIOL AGING, V27, P1385, DOI 10.1016/j.neurobiolaging.2005.07.018
   Colas D, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-81
   Conrad CD, 2007, J NEUROSCI, V27, P8278, DOI 10.1523/JNEUROSCI.2121-07.2007
   deLeon MJ, 1997, NEUROBIOL AGING, V18, P1, DOI 10.1016/S0197-4580(96)00213-8
   FRAGA CG, 1988, FREE RADICAL BIO MED, V4, P155, DOI 10.1016/0891-5849(88)90023-8
   GERSCHMAN R, 1954, SCIENCE, V119, P623, DOI 10.1126/science.119.3097.623
   GILAD GM, 1995, MECH AGEING DEV, V78, P75, DOI 10.1016/0047-6374(94)01529-U
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Harman D, 2006, ANN NY ACAD SCI, V1067, P10, DOI 10.1196/annals.1354.003
   Hensley K, 2000, CARCINOGENESIS, V21, P983, DOI 10.1093/carcin/21.5.983
   Itoh K, 1996, NEUROBIOL AGING, V17, P843, DOI 10.1016/S0197-4580(96)00168-6
   JACK CR, 1992, NEUROLOGY, V42, P183, DOI 10.1212/WNL.42.1.183
   Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604
   KILLIANY RJ, 1993, ARCH NEUROL-CHICAGO, V50, P949, DOI 10.1001/archneur.1993.00540090052010
   Liu JK, 2002, P NATL ACAD SCI USA, V99, P2356, DOI 10.1073/pnas.261709299
   Lores-Arnaiz S, 2005, NEUROCHEM INT, V47, P362, DOI 10.1016/j.neuint.2005.05.006
   McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006
   Miller DB, 2005, AGEING RES REV, V4, P123, DOI 10.1016/j.arr.2005.03.002
   MullerHocker J, 1996, MECH AGEING DEV, V86, P197, DOI 10.1016/0047-6374(95)01692-9
   Navarro A, 2005, AM J PHYSIOL-REG I, V289, pR1392, DOI 10.1152/ajpregu.00834.2004
   Navarro A, 2004, AM J PHYSIOL-REG I, V286, pR505, DOI 10.1152/ajpregu.00208.2003
   Navarro A, 2002, AM J PHYSIOL-REG I, V282, pR985, DOI 10.1152/ajpregu.00537.2001
   Navarro A, 2004, AM J PHYSIOL-REG I, V287, pR1244, DOI 10.1152/ajpregu.00226.2004
   Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006
   Navarro A, 2007, ANTIOXID REDOX SIGN, V9, P131, DOI 10.1089/ars.2007.9.131
   Nisoli E, 2004, P NATL ACAD SCI USA, V101, P16507, DOI 10.1073/pnas.0405432101
   Nisoli E, 2006, J CELL SCI, V119, P2855, DOI 10.1242/jcs.03062
   OLIVER CN, 1987, J BIOL CHEM, V262, P5488
   PALKOVITS M, 1983, BRAIN MICRODISSECTIO, P1
   Schönfeld P, 2006, J BIOL CHEM, V281, P7136, DOI 10.1074/jbc.M513198200
   SCOPSI L, 1986, MED BIOL, V64, P139
   SELIGMAN AM, 1968, J CELL BIOL, V38, P1, DOI 10.1083/jcb.38.1.1
   Siqueira IR, 2005, LIFE SCI, V78, P271, DOI 10.1016/j.lfs.2005.04.044
   Valdez LB, 2005, METHOD ENZYMOL, V396, P444, DOI 10.1016/S0076-6879(05)96037-0
   Viña J, 2003, ANTIOXID REDOX SIGN, V5, P549, DOI 10.1089/152308603770310194
   VITORICA J, 1985, MECH AGEING DEV, V29, P255, DOI 10.1016/0047-6374(85)90066-1
NR 48
TC 81
Z9 89
U1 0
U2 15
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0363-6119
J9 AM J PHYSIOL-REG I
JI Am. J. Physiol.-Regul. Integr. Comp. Physiol.
PD FEB
PY 2008
VL 294
IS 2
BP R501
EP R509
DI 10.1152/ajpregu.00492.2007
PG 9
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA 257AY
UT WOS:000252772800027
PM 18077512
DA 2024-02-19
ER

PT J
AU Ribas-Aulinas, F
   Ribo, S
   Casas, E
   Mourin-Fernandez, M
   Ramon-Krauel, M
   Diaz, R
   Lerin, C
   Kalko, SG
   Vavouri, T
   Jimenez-Chillaron, JC
AF Ribas-Aulinas, Francesc
   Ribo, Silvia
   Casas, Eduard
   Mourin-Fernandez, Marta
   Ramon-Krauel, Marta
   Diaz, Ruben
   Lerin, Carles
   Kalko, Susana G. G.
   Vavouri, Tanya
   Jimenez-Chillaron, Josep C. C.
TI Intergenerational Inheritance of Hepatic Steatosis in a Mouse Model of
   Childhood Obesity: Potential Involvement of Germ-Line microRNAs
SO NUTRIENTS
LA English
DT Article
DE circadian rhythm; intergenerational epigenetic inheritance; childhood
   obesity; litter size reduction; DNA methylation; small non-coding RNAs
ID TRANSGENERATIONAL EPIGENETIC INHERITANCE; HIGH-FAT DIET;
   LIPID-METABOLISM; NUTRITION; RISK; TRANSCRIPTION; RESPONSES;
   SPERMATOZOA; PATHWAYS; PROGRAM
AB Childhood obesity increases the risk of developing metabolic syndrome later in life. Moreover, metabolic dysfunction may be inherited into the following generation through non-genomic mechanisms, with epigenetics as a plausible candidate. The pathways involved in the development of metabolic dysfunction across generations in the context of childhood obesity remain largely unexplored. We have developed a mouse model of early adiposity by reducing litter size at birth (small litter group, SL: 4 pups/dam; control group, C: 8 pups/dam). Mice raised in small litters (SL) developed obesity, insulin resistance and hepatic steatosis with aging. Strikingly, the offspring of SL males (SL-F1) also developed hepatic steatosis. Paternal transmission of an environmentally induced phenotype strongly suggests epigenetic inheritance. We analyzed the hepatic transcriptome in C-F1 and SL-F1 mice to identify pathways involved in the development of hepatic steatosis. We found that the circadian rhythm and lipid metabolic process were the ontologies with highest significance in the liver of SL-F1 mice. We explored whether DNA methylation and small non-coding RNAs might be involved in mediating intergenerational effects. Sperm DNA methylation was largely altered in SL mice. However, these changes did not correlate with the hepatic transcriptome. Next, we analyzed small non-coding RNA content in the testes of mice from the parental generation. Two miRNAs (miR-457 and miR-201) appeared differentially expressed in the testes of SL-F0 mice. They are known to be expressed in mature spermatozoa, but not in oocytes nor early embryos, and they may regulate the transcription of lipogenic genes, but not clock genes, in hepatocytes. Hence, they are strong candidates to mediate the inheritance of adult hepatic steatosis in our murine model. In conclusion, litter size reduction leads to intergenerational effects through non-genomic mechanisms. In our model, DNA methylation does not seem to play a role on the circadian rhythm nor lipid genes. However, at least two paternal miRNAs might influence the expression of a few lipid-related genes in the first-generation offspring, F1.
C1 [Ribas-Aulinas, Francesc; Ribo, Silvia; Mourin-Fernandez, Marta; Ramon-Krauel, Marta; Diaz, Ruben; Lerin, Carles; Jimenez-Chillaron, Josep C. C.] Inst Recerca St Joan Deu IRSJD, Barcelona 08950, Spain.
   [Casas, Eduard; Vavouri, Tanya] Josep Carreras Leukemia Res Inst IJC, Badalona 08916, Spain.
   [Ramon-Krauel, Marta; Lerin, Carles] Inst Salud Carlos III, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid 28029, Spain.
   [Kalko, Susana G. G.] Vall dHebron Res Inst VHIR, Barcelona 08035, Spain.
   [Jimenez-Chillaron, Josep C. C.] Univ Barcelona, Sch Med, Barcelona 08907, Spain.
   [Casas, Eduard] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.
C3 Institut de Recerca Contra la Leucemia Josep Carreras (IJC); CIBER -
   Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud
   Carlos III; Autonomous University of Barcelona; Hospital Universitari
   Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); University of
   Barcelona; University of Colorado System; University of Colorado Boulder
RP Jimenez-Chillaron, JC (corresponding author), Inst Recerca St Joan Deu IRSJD, Barcelona 08950, Spain.; Jimenez-Chillaron, JC (corresponding author), Univ Barcelona, Sch Med, Barcelona 08907, Spain.
EM josep.jimenez@ub.edu
RI Ribas Aulinas, Francesc/B-7677-2018
OI Ribas Aulinas, Francesc/0000-0001-7672-4775; Ramon-Krauel,
   Marta/0000-0003-3027-9105; Kalko, Susana/0000-0002-6701-0233
FU European Foundation; Ministerio de Economia y Competitividad, Spain
   (MINECO) [SAF2017-84542-R]; Templeton Foundation [62167]
FX J.C.J.-C. received researching funding from The European Foundation for
   the Study of Diabetes/Lilly, year grant 2016; Ministerio de Economia y
   Competitividad, Spain (MINECO), grant number SAF2017-84542-R; and The
   Templeton Foundation, grant number 62167.
CR Barbosa TD, 2016, MOL METAB, V5, P184, DOI 10.1016/j.molmet.2015.12.002
   Billah MM, 2022, INT J OBESITY, V46, P901, DOI 10.1038/s41366-021-01042-7
   Block T, 2017, ATHEROSCLEROSIS, V266, P31, DOI 10.1016/j.atherosclerosis.2017.09.003
   Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055
   Bygren LO, 2013, ANNU REV PUBL HEALTH, V34, P49, DOI 10.1146/annurev-publhealth-031912-114419
   Campos EI, 2014, TRENDS CELL BIOL, V24, P664, DOI 10.1016/j.tcb.2014.08.004
   Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008
   Casas E, 2020, REPRODUCTION, V159, pR251, DOI 10.1530/REP-19-0340
   Champagne FA, 2016, DEV PSYCHOPATHOL, V28, P1219, DOI 10.1017/S0954579416000808
   Chen Q, 2016, SCIENCE, V351, P397, DOI 10.1126/science.aad7977
   Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188
   Donkin I, 2018, MOL METAB, V14, P1, DOI 10.1016/j.molmet.2018.02.006
   Donkin I, 2016, CELL METAB, V23, P369, DOI 10.1016/j.cmet.2015.11.004
   Donohoe DR, 2012, J CELL PHYSIOL, V227, P3169, DOI 10.1002/jcp.24054
   Dupont C, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00337
   Ferrari A, 2012, MOL MEMBR BIOL, V29, P257, DOI 10.3109/09687688.2012.729094
   Gapp K, 2014, BIOESSAYS, V36, P491, DOI 10.1002/bies.201300116
   Gong PF, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11050751
   Grandjean V, 2009, GYNECOL OBSTET FERTI, V37, P558, DOI 10.1016/j.gyobfe.2009.04.005
   Grandjean V, 2015, SCI REP-UK, V5, DOI 10.1038/srep18193
   Guerrero-Bosagna C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100194
   Guerrero-Bosagna C, 2012, MOL CELL ENDOCRINOL, V354, P3, DOI 10.1016/j.mce.2011.10.004
   Hammoud SS, 2014, CELL STEM CELL, V15, P239, DOI 10.1016/j.stem.2014.04.006
   Houfflyn Sam, 2017, Curr Mol Biol Rep, V3, P288, DOI 10.1007/s40610-017-0083-5
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249
   Jimenez-Chillaron JC, 2016, P NUTR SOC, V75, P78, DOI 10.1017/S0029665115004231
   Jiménez-Chillarón JC, 2012, BIOCHIMIE, V94, P2242, DOI 10.1016/j.biochi.2012.06.012
   Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859
   Kaati G, 2007, EUR J HUM GENET, V15, P784, DOI 10.1038/sj.ejhg.5201832
   Kaspar D, 2020, MAMM GENOME, V31, P119, DOI 10.1007/s00335-020-09839-z
   Kawano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044542
   Keyhan S, 2021, CLIN EPIGENETICS, V13, DOI 10.1186/s13148-020-00997-0
   King SE, 2020, TRENDS ENDOCRIN MET, V31, P478, DOI 10.1016/j.tem.2020.02.009
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Li XZG, 2013, MOL CELL, V50, P67, DOI 10.1016/j.molcel.2013.02.016
   Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656
   Lloyd LJ, 2012, INT J OBESITY, V36, P1, DOI 10.1038/ijo.2011.186
   Logue J, 2011, CLIN PHARMACOL THER, V90, P174, DOI 10.1038/clpt.2011.88
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955
   Martin M., 2011, EMBnet. J., V17, P10, DOI [DOI 10.14806/EJ.17.1.200, 10.14806/ej.17.1.200]
   Martínez D, 2014, CELL METAB, V19, P941, DOI 10.1016/j.cmet.2014.03.026
   Nätt D, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000559
   Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491
   Ou XH, 2019, J CELL PHYSIOL, V234, P7847, DOI 10.1002/jcp.27847
   Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5
   Panneerdoss S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041146
   Parra-Vargas M, 2020, CELL METAB, V32, P334, DOI 10.1016/j.cmet.2020.07.014
   Pembrey M, 2014, J MED GENET, V51, P563, DOI 10.1136/jmedgenet-2014-102577
   Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538
   Pentinat T, 2010, ENDOCRINOLOGY, V151, P5617, DOI 10.1210/en.2010-0684
   Raad G, 2021, ELIFE, V10, DOI 10.7554/eLife.61736
   Radford EJ, 2018, NAT REV ENDOCRINOL, V14, P345, DOI 10.1038/s41574-018-0005-5
   Radford EJ, 2014, SCIENCE, V345, P785, DOI 10.1126/science.1255903
   Ramon-Krauel M, 2018, FASEB J, V32, P6025, DOI 10.1096/fj.201700717RR
   Rando OJ, 2012, CELL, V151, P702, DOI 10.1016/j.cell.2012.10.020
   Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222
   Reinke H, 2016, GASTROENTEROLOGY, V150, P574, DOI 10.1053/j.gastro.2015.11.043
   Ribas-Aulinas F, 2021, NUTRIENTS, V13, DOI 10.3390/nu13103579
   Ribas-Aulinas F, 2021, MOL METAB, V45, DOI 10.1016/j.molmet.2021.101162
   Seki Y, 2012, ENDOCRINOLOGY, V153, P1031, DOI 10.1210/en.2011-1805
   Sharma U, 2016, SCIENCE, V351, P391, DOI 10.1126/science.aad6780
   Shea JM, 2015, DEV CELL, V35, P750, DOI 10.1016/j.devcel.2015.11.024
   Shi DM, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00423
   Soubry A, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.625204
   Soubry A, 2018, ENVIRON EPIGENETICS, V4, DOI 10.1093/eep/dvy007
   Soubry A, 2018, BIOESSAYS, V40, DOI 10.1002/bies.201700113
   Soubry A, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0217-2
   Takabatake M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164194
   The NS, 2010, JAMA-J AM MED ASSOC, V304, P2042, DOI 10.1001/jama.2010.1635
   Watkins AJ, 2018, P NATL ACAD SCI USA, V115, P10064, DOI [10.1161/CIRCULATIONAHA.118.038158, 10.1073/pnas.1806333115]
   Whitelaw E, 2015, DEV CELL, V35, P668, DOI 10.1016/j.devcel.2015.12.005
   Whitelaw E, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0626-0
   Zhang Y, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-04436-7
   Zhang YF, 2019, NAT REV ENDOCRINOL, V15, P489, DOI 10.1038/s41574-019-0226-2
NR 76
TC 0
Z9 0
U1 4
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD MAR
PY 2023
VL 15
IS 5
AR 1241
DI 10.3390/nu15051241
PG 17
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 9V1ON
UT WOS:000948169600001
PM 36904241
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Hor, YY
   Ooi, CH
   Khoo, BY
   Choi, SB
   Seeni, A
   Shamsuddin, S
   Oon, CE
   Ong, KL
   Jeong, WS
   Liong, MT
AF Hor, Yan-Yan
   Ooi, Cheong-Hwa
   Khoo, Boon-Yin
   Choi, Sy-Bing
   Seeni, Azman
   Shamsuddin, Shaharum
   Oon, Chern-Ein
   Ong, Kee-Leong
   Jeong, Woo-Sik
   Liong, Min-Tze
TI <i>Lactobacillus</i> Strains Alleviated Aging Symptoms and Aging-Induced
   Metabolic Disorders in Aged Rats
SO JOURNAL OF MEDICINAL FOOD
LA English
DT Article
DE AMPK; antiaging; bone; LAB; metabolism; muscle; probiotic; telomere
ID AMPK; BIFIDOBACTERIA; RESTRICTION
AB Aging is an inevitable and ubiquitous progress that affects all living organisms. A total of 18 strains of lactic acid bacteria (LAB) were evaluated on the activation of adenosine monophosphate-activated protein kinase (AMPK), an intracellular energy sensor mediating lifespan extension. The cell-free supernatant (CFS) of Lactobacillus fermentum DR9 (LF-DR9), Lactobacillus paracasei OFS 0291 (LP-0291), and Lactobacillus helveticus OFS 1515 (LH-1515) showed the highest activation of AMPK and was further evaluated. The phosphorylation of AMPK by these three LAB strains was more evident in U2OS and C2C12 cells, compared to the other cell lines and control (P < .05). Using premature senescent Sprague-Dawley rats induced by D-galactose (D-gal), the administration of LAB (10 log CFU/rat/day) for 12 weeks prevented the shortening of telomere length in D-gal-treated rats compared to the untreated control (P < .05). LF-DR9 lowered gene expression of p53, a known senescent biomarker, in gastrocnemius muscle and tibia compared to the control. The selected LAB strains also enhanced lipid, renal, and liver profile of rats, suggesting added potential of the strains in preventing aging-induced metabolic diseases. Strain LP-0291 and LH-1515 showed ability to adhere to mucin, no antibiotic resistance, tolerated and proliferated under gastric and intestinal simulated conditions, and inhibited the growth of pathogens Escherichia coli, Staphylococcus aureus, and Staphylococcus epidermidis, comparable to commercial probiotic LF-DR9 and Lactobacillus sakei Probio 65. This study provided an insight into the potential of LAB for exhibiting antisenescence effects, with potentials as new medicinal foods for targeted antiaging therapies.
C1 [Hor, Yan-Yan; Liong, Min-Tze] Univ Sains Malaysia, Sch Ind Technol, Div Bioproc Technol, George Town 11800, Malaysia.
   [Khoo, Boon-Yin; Oon, Chern-Ein] Univ Sains Malaysia, Inst Res Mol Med, George Town, Malaysia.
   [Hor, Yan-Yan; Shamsuddin, Shaharum; Liong, Min-Tze] Univ Sains Malaysia, USM RIKEN Int Ctr Aging Sci URICAS, George Town, Malaysia.
   [Ooi, Cheong-Hwa; Seeni, Azman] Univ Sains Malaysia, Adv Med & Dent Inst, Cluster Lifestyle Sci, Kepala Batas, Penang, Malaysia.
   [Choi, Sy-Bing] Perdana Univ, Sch Data Sci, MARDI Complex, Selangor, Malaysia.
   [Shamsuddin, Shaharum] Univ Sains Malaysia, Sch Med Sci, Div Biomed, Kubang Kerian, Malaysia.
   [Ong, Kee-Leong] Clin Nutr Intl M Sdn Bhd, Selangor, Malaysia.
   [Jeong, Woo-Sik] Inje Univ, Dept Food & Life Sci, Gimhae 50834, South Korea.
C3 Universiti Sains Malaysia; Universiti Sains Malaysia; Universiti Sains
   Malaysia; Universiti Sains Malaysia; Perdana University; Universiti
   Sains Malaysia; Inje University
RP Liong, MT (corresponding author), Univ Sains Malaysia, Sch Ind Technol, Div Bioproc Technol, George Town 11800, Malaysia.; Jeong, WS (corresponding author), Inje Univ, Dept Food & Life Sci, Gimhae 50834, South Korea.
EM jeongws@inje.ac.kr; mintze.liong@usm.my
RI Hor, YY/ACW-4325-2022; Khoo, Boon Yin/A-9256-2011; Ooi, Cheong
   Hwa/J-9230-2012; Shamsuddin, Shaharum/A-7907-2011; Jeong,
   Woo-Sik/AAN-6885-2020; Seeni, Azman/I-3837-2012; Choi, Sy
   Bing/AGZ-6475-2022; Oon, Chern E/B-3684-2013; Khoo, Boon
   Yin/AAF-2783-2019; Liong, Min Tze/F-4726-2010; Liong,
   Min-Tze/GVT-7267-2022
OI Ooi, Cheong Hwa/0000-0002-7013-267X; Shamsuddin,
   Shaharum/0000-0001-9997-7740; Jeong, Woo-Sik/0000-0002-7717-3626; Seeni,
   Azman/0000-0002-3680-4006; Oon, Chern E/0000-0002-4685-6408; Liong,
   Min-Tze/0000-0002-4471-8271; Khoo, Boon Yin/0000-0003-1915-6606; Hor,
   Yan Yan/0000-0003-1224-4056; Choi, Sy Bing/0000-0003-3189-904X
CR Agostoni C, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2815
   Aliper A, 2017, AGING-US, V9, P2245, DOI 10.18632/aging.101319
   Bi PP, 2016, ELIFE, V5, DOI 10.7554/eLife.17355
   Cantó C, 2011, PHYSIOLOGY, V26, P214, DOI 10.1152/physiol.00010.2011
   Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027
   Chen HK, 2012, EXP CELL RES, V318, P867, DOI 10.1016/j.yexcr.2012.02.022
   Chong YK, 2015, HONG KONG MED J, V21, P201, DOI 10.12809/hkmj144373
   Colman RJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4557
   Dao MC, 2018, EUR J INTERN MED, V48, P18, DOI 10.1016/j.ejim.2017.10.005
   FAO/WHO, 2018, EV HLTH NUTR PROP PR
   Firouzi S, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0952-5
   Greer EL, 2009, ANN NY ACAD SCI, V1170, P688, DOI 10.1111/j.1749-6632.2009.04019.x
   He Wan, WORLDS OLDER POPULAT
   Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Hor YY, 2014, DERMATOL SIN, V32, P141, DOI 10.1016/j.dsi.2014.03.001
   Huang RX, 2016, NUTRIENTS, V8, DOI 10.3390/nu8080483
   Klare I, 2007, J ANTIMICROB CHEMOTH, V59, P900, DOI 10.1093/jac/dkm035
   Kobilo T, 2014, LEARN MEMORY, V21, P119, DOI 10.1101/lm.033332.113
   Lew LC, 2011, J SCI FOOD AGR, V91, P1406, DOI 10.1002/jsfa.4325
   Li W.B., 1995, CHIN J PHARM TOXICOL, V9, P93
   Lin TH, 2019, J MICROBIOL IMMUNOL, V52, P409, DOI 10.1016/j.jmii.2017.08.003
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lu J, 2006, BEHAV BRAIN RES, V171, P251, DOI 10.1016/j.bbr.2006.03.043
   Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192
   Nie YH, 2016, FASEB J, V30, P3745, DOI 10.1096/fj.201600529R
   Novotny SA, 2015, PHYSIOLOGY, V30, P8, DOI 10.1152/physiol.00033.2014
   Pandey KR, 2015, J FOOD SCI TECH MYS, V52, P7577, DOI 10.1007/s13197-015-1921-1
   Qian Yingjuan, 2013, Methods Mol Biol, V965, P37, DOI 10.1007/978-1-62703-239-1_3
   Shammas MA, 2011, CURR OPIN CLIN NUTR, V14, P28, DOI 10.1097/MCO.0b013e32834121b1
   Smith DL, 2010, J GERONTOL A-BIOL, V65, P468, DOI 10.1093/gerona/glq033
   Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6
   Tham CSC, 2012, ANN MICROBIOL, V62, P1079, DOI 10.1007/s13213-011-0349-8
   Thevaranjan N, 2017, CELL HOST MICROBE, V21, P455, DOI 10.1016/j.chom.2017.03.002
   Tokatli M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/315819
   Ulgherait M, 2014, CELL REP, V8, P1767, DOI 10.1016/j.celrep.2014.08.006
   Zhou YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132088
NR 37
TC 25
Z9 32
U1 3
U2 37
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1096-620X
EI 1557-7600
J9 J MED FOOD
JI J. Med. Food
PD JAN 1
PY 2019
VL 22
IS 1
BP 1
EP 13
DI 10.1089/jmf.2018.4229
PG 13
WC Chemistry, Medicinal; Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Food Science & Technology; Nutrition &
   Dietetics
GA HR8EY
UT WOS:000463390400001
PM 30592688
DA 2024-02-19
ER

PT J
AU Mo, ZJ
   Zheng, SX
   Lv, ZL
   Zhuang, Y
   Lan, XW
   Wang, F
   Lu, XL
   Zhao, YX
   Zhou, SF
AF Mo, Zhijing
   Zheng, Shunxin
   Lv, Zhilue
   Zhuang, Yuan
   Lan, Xiuwan
   Wang, Feng
   Lu, Xiaoling
   Zhao, Yongxiang
   Zhou, Sufang
TI Senescence marker protein 30 (SMP30) serves as a potential prognostic
   indicator in hepatocellular carcinoma
SO SCIENTIFIC REPORTS
LA English
DT Article
ID GENE-EXPRESSION; CELL-ADHESION; CANCER; METASTASIS; OVEREXPRESSION;
   PROLIFERATION; APOPTOSIS; ANTIGEN
AB Senescence marker protein 30 (SMP30) has been identified as a tumor-related molecule of hepatocellular carcinoma (HCC). Its clinical significance and underlying mechanisms in HCC tissues, however, remain largely unexplored. We have demonstrated a preferentially expressed SMP30 in normal liver using a tissue microarray. By employing real-time quantitative PCR, two tissue microarrays and Oncomine database analysis, we have also shown that the SMP30 in HCC tissues has significantly reduced when compared with that in paired adjacent non-tumor tissues (P = 0.0037). The reduced expression of SMP30 is very noticeably related to larger tumor size (P = 0.012), enhanced TNM (P = 0.009) and worse survival (P < 0.0001) in HCC patients. The analyses using Cox regression have indicated that the decreased SMP30 expression is an independent risk to the reduced overall survival rate of HCC patients (P = 0.001), and the down-regulation of SMP30 in HCC might be mediated by DNA methylation. Moreover, genes co-expressed with SMP30 may affect the prognosis through apoptotic process, biological adhesion and blood coagulation by PANTHER analyses. Our studies have indicated that the SMP30 may serve as a candidate of HCC clinical prognostic marker and a potential therapeutic target.
C1 [Mo, Zhijing; Zheng, Shunxin; Lv, Zhilue; Zhuang, Yuan; Lan, Xiuwan; Wang, Feng; Zhou, Sufang] Guangxi Med Univ, Dept Biochem & Mol Biol, Nanning 530021, Peoples R China.
   [Lu, Xiaoling; Zhao, Yongxiang; Zhou, Sufang] Guangxi Med Univ, Guangxi Key Lab Biol Targeting Diag & Therapy Res, Nanning 530021, Peoples R China.
C3 Guangxi Medical University; Guangxi Medical University
RP Zhou, SF (corresponding author), Guangxi Med Univ, Dept Biochem & Mol Biol, Nanning 530021, Peoples R China.; Zhao, YX; Zhou, SF (corresponding author), Guangxi Med Univ, Guangxi Key Lab Biol Targeting Diag & Therapy Res, Nanning 530021, Peoples R China.
EM yongxiang_zhao@126.com; zsf200000@163.com
RI Lan, xiuwan/GWV-7422-2022; lu, xl/HDO-8340-2022
FU National Natural Science Foundation of China [81460432, 81572994];
   Natural Science Foundation of Guangxi Province [2015GXNSFDA139017];
   Programs for Department of Education of Guangxi Zhuang Autonomous Region
   [2013ZD011]; Guangxi science and technology research and technology
   development project [15104001-7]; Guangxi Nanning Qingxiu District
   Science and Technology Research and Technology Development Project
   [2014S03]
FX This work is supported by National Natural Science Foundation of China
   (grant number 81460432,81572994); Natural Science Foundation of Guangxi
   Province (grant number 2015GXNSFDA139017); Programs for Department of
   Education of Guangxi Zhuang Autonomous Region (grant number 2013ZD011);
   Guangxi science and technology research and technology development
   project (grant number 15104001-7); and Guangxi Nanning Qingxiu District
   Science and Technology Research and Technology Development Project
   (grant number 2014S03).
CR [Anonymous], ANAL BIOCH
   Bapu D, 2016, CANCER LETT, V375, P367, DOI 10.1016/j.canlet.2016.03.019
   Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095
   Chang RM, 2014, HEPATOLOGY, V60, P1251, DOI 10.1002/hep.27221
   Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023
   Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914
   Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0
   Fu Y, 2014, ONCOTARGET, V5, P6701, DOI 10.18632/oncotarget.2239
   Kikkawa Y, 2016, EXP CELL RES, V344, P76, DOI 10.1016/j.yexcr.2016.04.002
   Li HL, 2015, ONCOTARGET, V6, P21406, DOI 10.18632/oncotarget.4011
   Li PQ, 2016, CELL PHYSIOL BIOCHEM, V38, P1915, DOI 10.1159/000445553
   Li X, 2015, ONCOTARGET, V6, P11547, DOI 10.18632/oncotarget.3413
   Oh JK, 2014, ANN GLOB HEALTH, V80, P384, DOI 10.1016/j.aogh.2014.09.013
   Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112
   Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2
   Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607
   Stenner-Liewen F, 2000, CANCER EPIDEM BIOMAR, V9, P285
   Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403
   Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262
   Tsurusaki Y, 2003, J CELL BIOCHEM, V90, P619, DOI 10.1002/jcb.10652
   Vestjens JHMJ, 2007, PATHOPHYSIOL HAEMO T, V36, P113, DOI 10.1159/000175149
   Wojtukiewicz MZ, 2016, CANCER METAST REV, V35, P213, DOI 10.1007/s10555-016-9626-0
   Yaacoub K, 2016, CANCER LETT, V378, P150, DOI 10.1016/j.canlet.2016.05.012
   Yamaguchi M, 2005, J CELL BIOCHEM, V95, P1169, DOI 10.1002/jcb.20490
   Zhang SC, 2014, ASIAN PAC J CANCER P, V15, P1193, DOI 10.7314/APJCP.2014.15.3.1193
   Zhang SC, 2013, ASIAN PAC J CANCER P, V14, P2383, DOI 10.7314/APJCP.2013.14.4.2383
   Zhou SF, 2006, CLIN CHIM ACTA, V366, P274, DOI 10.1016/j.cca.2005.10.026
   Zhou SF, 2011, CLIN BIOCHEM, V44, P331, DOI 10.1016/j.clinbiochem.2010.10.008
NR 28
TC 17
Z9 18
U1 0
U2 12
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD DEC 19
PY 2016
VL 6
AR 39376
DI 10.1038/srep39376
PG 10
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA EE8LJ
UT WOS:000389876800001
PM 27991558
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Song, XY
   Wu, WF
   Dai, YB
   Warner, M
   Nalvarte, I
   Antonson, P
   Varshney, M
   Gustafsson, JÅ
AF Song, Xiaoyu
   Wu, Wanfu
   Dai, Yubing
   Warner, Margaret
   Nalvarte, Ivan
   Antonson, Per
   Varshney, Mukesh
   Gustafsson, Jan-Ake
TI Loss of ERβ in Aging LXRαβ Knockout Mice Leads to Colitis
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE liver X receptor; estrogen receptor beta; colitis; inflammatory bowel
   diseases; plectin
ID LIVER X RECEPTORS; NONNEURONAL CHOLINERGIC SYSTEM; COLON; INFLAMMATION;
   PROTECTS
AB Liver X receptors (LXR alpha and LXR beta) are oxysterol-activated nuclear receptors that play key roles in cholesterol homeostasis, the central nervous system, and the immune system. We have previously reported that LXR fffi-deficient mice are more susceptible to dextran sodium sulfate (DSS)induced colitis than their WT littermates, and that an LXR agonist protects against colitis in mice mainly via the regulation of the immune system in the gut. We now report that both LXRff and LXRfi are expressed in the colonic epithelium and that in aging LXR alpha beta (-/-) mice there is a reduction in the intensity of goblet cells, mucin (MUC2), TFF3, and estrogen receptor beta (ER beta) levels. The cytoplasmic compartment of the surface epithelial cells was markedly reduced and there was a massive invasion of macrophages in the lamina propria. The expression and localization of beta-catenin, alpha-catenin, and E-cadherin were not changed, but the shrinkage of the cytoplasm led to an appearance of an increase in staining. In the colonic epithelium there was a reduction in the expression of plectin, a hemidesmosome protein whose loss in mice leads to spontaneous colitis, ELOVL1, a fatty acid elongase protein coding gene whose overexpression is found in colorectal cancer, and non-neuronal choline acetyltransferase (ChAT) involved in the regulation of epithelial cell adhesion. We conclude that in aging LXR alpha beta (-/-) mice, the phenotype in the colon is due to loss of ER beta expression.
C1 [Song, Xiaoyu; Wu, Wanfu; Dai, Yubing; Warner, Margaret; Gustafsson, Jan-Ake] Univ Houston, Ctr Nucl Receptors & Cell Signaling, Dept Biol & Biochem, Houston, TX 77204 USA.
   [Nalvarte, Ivan; Antonson, Per; Varshney, Mukesh; Gustafsson, Jan-Ake] Karolinska Inst, Dept Biosci & Nutr, S-14186 Huddinge, Sweden.
C3 University of Houston System; University of Houston; Karolinska
   Institutet
RP Gustafsson, JÅ (corresponding author), Univ Houston, Ctr Nucl Receptors & Cell Signaling, Dept Biol & Biochem, Houston, TX 77204 USA.; Gustafsson, JÅ (corresponding author), Karolinska Inst, Dept Biosci & Nutr, S-14186 Huddinge, Sweden.
EM xsong7@central.uh.edu; wwu16@central.uh.edu; daifengdb555@yahoo.com;
   mwarner@central.uh.edu; ivan.nalvarte@ki.se; per.antonson@ki.se;
   mukesh.varshney@ki.se; jgustafsson@uh.edu
RI Antonson, Per/ISV-1520-2023; Song, Xiaoyu/AGF-1522-2022
OI Antonson, Per/0000-0001-9335-9941; Song, Xiaoyu/0000-0001-9485-977X
FU Swedish Research Council; Robert A. Welch Foundation [E-0004]
FX This work was supported by the Swedish Research Council and the Robert
   A. Welch Foundation (grant E-0004).
CR Aihara E, 2017, ANNU REV PHYSIOL, V79, P357, DOI 10.1146/annurev-physiol-021115-105447
   Alberti S, 2001, J CLIN INVEST, V107, P565, DOI 10.1172/JCI9794
   Andersen V, 2011, WORLD J GASTROENTERO, V17, P197, DOI 10.3748/wjg.v17.i2.197
   Andersson S, 2005, P NATL ACAD SCI USA, V102, P3857, DOI 10.1073/pnas.0500634102
   Bader S, 2019, PFLUG ARCH EUR J PHY, V471, P605, DOI 10.1007/s00424-018-2236-7
   Bader S, 2018, PFLUG ARCH EUR J PHY, V470, P669, DOI 10.1007/s00424-017-2104-x
   Bader S, 2014, EUR J PHARMACOL, V733, P23, DOI 10.1016/j.ejphar.2014.03.036
   BARIBAULT H, 1994, GENE DEV, V8, P2964, DOI 10.1101/gad.8.24.2964
   Beckmann J, 2013, PHARMACOLOGY, V92, P286, DOI 10.1159/000355835
   Castañón MJ, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10092453
   Dai YB, 2016, MOL PSYCHIATR, V21, P844, DOI 10.1038/mp.2015.133
   Dai YB, 2016, P NATL ACAD SCI USA, V113, P7614, DOI 10.1073/pnas.1607590113
   Dai YB, 2012, P NATL ACAD SCI USA, V109, P13112, DOI 10.1073/pnas.1210833109
   De Arcangelis A, 2017, GUT, V66, P1748, DOI 10.1136/gutjnl-2015-310847
   de Freitas FA, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11081251
   Fan X, 2008, P NATL ACAD SCI USA, V105, P13445, DOI 10.1073/pnas.0806974105
   Garcia-Villatoro EL, 2021, ESSAYS BIOCHEM, V65, P1003, DOI 10.1042/EBC20210010
   Guillemot-Legris O, 2022, BRIT J PHARMACOL, V179, P4917, DOI 10.1111/bph.15479
   Hases L, 2022, ADV EXP MED BIOL, V1390, P213, DOI 10.1007/978-3-031-11836-4_12
   Hases L, 2020, CANCER LETT, V492, P54, DOI 10.1016/j.canlet.2020.06.021
   Jakobsson T, 2014, MUCOSAL IMMUNOL, V7, P1416, DOI 10.1038/mi.2014.31
   Jakobsson T, 2012, TRENDS PHARMACOL SCI, V33, P394, DOI 10.1016/j.tips.2012.03.013
   Jin Y, 2018, AM J PHYSIOL-GASTR L, V315, pG966, DOI 10.1152/ajpgi.00087.2018
   Jönsson M, 2007, INFLAMM BOWEL DIS, V13, P1347, DOI 10.1002/ibd.20224
   Kalabis J, 2006, J BIOL CHEM, V281, P6434, DOI 10.1074/jbc.M512905200
   Kim HJ, 2009, P NATL ACAD SCI USA, V106, P558, DOI 10.1073/pnas.0811295106
   Kiritsi D, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10102738
   Korach-Andre Marion, 2015, BioMolecular Concepts, V6, P177, DOI 10.1515/bmc-2015-0007
   Krausova A, 2021, MUCOSAL IMMUNOL, V14, P691, DOI 10.1038/s41385-021-00380-z
   Lesko S, 2013, CELLS TISSUES ORGANS, V197, P411, DOI 10.1159/000345437
   Li H, 2022, FASEB J, V36, DOI 10.1096/fj.202101529R
   Ma YY, 2022, MICROBIOME, V10, DOI 10.1186/s40168-022-01356-2
   Miao YF, 2015, P NATL ACAD SCI USA, V112, P14006, DOI 10.1073/pnas.1519358112
   Miranda-Bautista J, 2021, INFLAMM BOWEL DIS, V27, P1661, DOI 10.1093/ibd/izab034
   Polari L, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20123007
   Qin TF, 2021, J CELL PHYSIOL, V236, P6507, DOI 10.1002/jcp.30325
   Sassa T, 2013, MOL CELL BIOL, V33, P2787, DOI 10.1128/MCB.00192-13
   Soderholm AT, 2019, IMMUNOLOGY, V158, P267, DOI 10.1111/imm.13117
   Song CH, 2018, GUT LIVER, V12, P682, DOI 10.5009/gnl18221
   Song XY, 2022, HEARING RES, V422, DOI 10.1016/j.heares.2022.108534
   Song XY, 2019, P NATL ACAD SCI USA, V116, P16507, DOI 10.1073/pnas.1904719116
   Song XY, 2022, BIOMEDICINES, V10, DOI 10.3390/biomedicines10092165
   Steffensen KR, 2013, EXPERT OPIN THER TAR, V17, P977, DOI 10.1517/14728222.2013.806490
   Tao Y, 2022, PHYTOTHER RES, V36, P3248, DOI 10.1002/ptr.7495
   Wada-Hiraike O, 2006, P NATL ACAD SCI USA, V103, P2959, DOI 10.1073/pnas.0511271103
   Wu WF, 2023, INT J BIOL SCI, V19, P2848, DOI 10.7150/ijbs.85164
   Yip JLK, 2021, CELL MOL GASTROENTER, V12, P1701, DOI 10.1016/j.jcmgh.2021.08.021
   Yu S, 2016, FASEB J, V30, P2570, DOI 10.1096/fj.201600244R
NR 48
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-6596
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD AUG
PY 2023
VL 24
IS 15
AR 12461
DI 10.3390/ijms241512461
PG 12
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA O9FG5
UT WOS:001046798700001
PM 37569842
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU DEANS, SG
   NOBLE, RC
   PENZES, L
   IMRE, SG
AF DEANS, SG
   NOBLE, RC
   PENZES, L
   IMRE, SG
TI PROMOTIONAL EFFECTS OF PLANT VOLATILE OILS ON THE POLYUNSATURATED
   FATTY-ACID STATUS DURING AGING
SO AGE
LA English
DT Article
ID CBA/CA INBRED MICE; INDEXES
AB Protection of polyunsaturated fatty acids within the liver of old mice was realized by the ingestion of culinary and medicinal plant volatile oils containing natural antioxidants obtained by hydrodistillation. This protection effectively reversed the normal trend in polyunsaturated fatty acid metabolism during aging wherein a decrease in levels is concomitant with a reduction in tissue function and integrity. Volatile oil from thyme was overall the most effective in this protective capacity.
C1 SEMMELWEIS UNIV MED,INST GERONTOL,H-1085 BUDAPEST 8,HUNGARY.
   UNIV MED SCH DEBRECEN,INST PATHOPHYSIOL,DEBRECEN,HUNGARY.
C3 Semmelweis University; University of Debrecen
RP DEANS, SG (corresponding author), SCOTTISH AGR COLL,DEPT BIOCHEM SCI,AUCHINCRUIVE K46 5HW,AYR,SCOTLAND.
CR ALJALAY B, 1987, J FOOD PROTECT, V50, P25, DOI 10.4315/0362-028X-50.1.25
   ARAUJO J M A, 1985, Ciencia e Tecnologia de Alimentos, V5, P57
   Christie WW, 1982, LIPID ANAL
   DEANS S G, 1990, Flavour and Fragrance Journal, V5, P187, DOI 10.1002/ffj.2730050311
   DEANS SG, 1987, INT J FOOD MICROBIOL, V5, P165, DOI 10.1016/0168-1605(87)90034-1
   DEANS SG, 1990, NEWS INFORMATION, V2, P211
   ELANDTJOHNSTON RC, 1980, SURVIVAL MODELS DATA, P225
   GALLI C, 1989, DIETARY W3 W6 FATTY
   GURR MI, 1969, EUR J BIOCHEM, V9, P70, DOI 10.1111/j.1432-1033.1969.tb00577.x
   HALL DA, 1975, BIOCHEM SOC T, V3, P42
   PENZES L, 1989, Z GERONTOL, V22, P170
   PENZES L, 1988, MECH AGEING DEV, V45, P75, DOI 10.1016/0047-6374(88)90021-8
   STRICKLAND KP, 1973, FORM FUNCTION PHOSPH, P9
   SUMMERFIELD FW, 1984, ARCH BIOCHEM BIOPHYS, V233, P408, DOI 10.1016/0003-9861(84)90462-4
   WADA E, 1984, MECH AGEING DEV, V27, P287, DOI 10.1016/0047-6374(84)90053-8
   WILBUR KM, 1949, ARCH BIOCHEM, V24, P305
NR 16
TC 29
Z9 32
U1 0
U2 0
PU AMER AGING ASSOC
PI CHESTER
PA 2129 PROVIDENCE AVENUE, CHESTER, PA 19013
SN 0161-9152
J9 AGE
JI Age
PD APR
PY 1993
VL 16
IS 2
BP 71
EP 74
DI 10.1007/BF02435040
PG 4
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA LF967
UT WOS:A1993LF96700011
DA 2024-02-19
ER

PT J
AU Hu, TT
   Chen, R
   Qian, Y
   Ye, K
   Long, X
   Park, KY
   Zhao, X
AF Hu, Tiantian
   Chen, Rui
   Qian, Yu
   Ye, Ke
   Long, Xingyao
   Park, Kun-Young
   Zhao, Xin
TI Antioxidant effect of<i> Lactobacillus</i><i> fermentum</i>
   HFY02-fermented soy milk on <i>D</i>-galactose-induced aging mouse model
SO FOOD SCIENCE AND HUMAN WELLNESS
LA English
DT Article
DE Lactobacillus fermentum HFY02; Fermented soybean milk; D-galactose;
   Antioxidant; Aging
ID END-PRODUCTS AGES; SUPEROXIDE-DISMUTASE; COLONIC MUCOSA; ISOFLAVONE;
   INVOLVEMENT; ACTIVATION; AGLYCONES; SYSTEM; INJURY; FOODS
AB This study aimed to investigate the antioxidant effect of soybean milk fermented by a new type of Lactobacillus fermentum (LF-HFY02) by using D-galactose induced aging mice model. Firstly, the optimal fermentation conditions was screened out by detecting the effects of different fermentation temperature and time on the active components and antioxidant activity of soybean milk in vitro. And then unfermented soybean milk and the soybean milk fermented by different Lactobacillus was given by gavage to D-galactose-induced aging mouse. The activities of GSH, GSH-Px, SOD, CAT and T-AOC in serum, brain and liver of soybean milk fermented by LF-HFY02 were significantly increased, while the content of MDA and the level of AGEs in hippocampal were significantly decreased compared with D-galactose induced group. Further more, the mRNA expression of GSH and SOD in mouse liver were obviously up-regulated by soybean milk fermented by LF-HFY02. The skin tissue structure of mice in the LF-HFY02 fermented soybean milk group was more complete, the collagen fibers were increased and arranged orderly and liver inflammation has improved compared with the model group. And Western blot analysis showed that LF-HFY02 effectively upregulated EGFR, SOD and GSH protein expression in mouse liver. These findings suggest that LF-HFY02 can effectively prevent D-galactose-induced oxidation and aging in mice, and the effect was even better than that of the Lactobacillus delbruechii subsp. bulgaricus and vitamin C. Thus, LF-HFY02 may be potentially employed as a probiotic strain. In conclusion, soybean milk fermented by LF-HFY02 can increase the content of antioxidant factors and the activity of antioxidant enzymes by regulating gene and protein expression, and finally inhibit the process of tissue cell peroxidation, and improve the oxidative damage of mouse skin and liver. The results could provide a basis for the research and development and industrial production of probiotic-related fermented soybean milk products. (c) 2022 Beijing Academy of Food Sciences. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Hu, Tiantian; Qian, Yu; Ye, Ke; Long, Xingyao; Park, Kun-Young; Zhao, Xin] Chongqing Univ Educ, Chongqing Collaborat Innovat Ctr Funct Food, Chongqing Engn Res Ctr Funct Food, Chongqing Engn Lab Res & Dev Funct Food, Chongqing 400067, Peoples R China.
   [Chen, Rui] Third Peoples Hosp Chengdu, Dept Gen Practice, Chengdu 610036, Peoples R China.
   [Long, Xingyao; Park, Kun-Young] Cha Univ, Dept Food Sci & Biotechnol, Seongnam 13488, South Korea.
C3 Chongqing University of Education; Pochon Cha University
RP Park, KY; Zhao, X (corresponding author), Chongqing Univ Educ, Chongqing 400067, Peoples R China.
EM kunypark@cha.ac.kr; zhaoxin@cque.edu.cn
FU Chongqing University Innovation Research Group Project [CXQTP20033];
   Science and Technology Project of Chongqing [cstc2021jcyj-msxmX0408];
   Scientific and Technological Innovation Project of Construction of
   Double City Economic Circle in Chengdu-Chongqing Area of Chongqing
   Education Commission [KJCX2020052]
FX This research was funded by Chongqing University Innovation Research
   Group Project (CXQTP20033) , the Science and Technology Project of
   Chongqing (cstc2021jcyj-msxmX0408) , and Scientific and Technological
   Innovation Project of Construction of Double City Economic Circle in
   Chengdu-Chongqing Area of Chongqing Education Commission (KJCX2020052) .
CR Abernathy LM, 2015, J THORAC ONCOL, V10, P1703, DOI 10.1097/JTO.0000000000000677
   Azman KF, 2019, BIOGERONTOLOGY, V20, P763, DOI 10.1007/s10522-019-09837-y
   Cao ZH, 2019, BIOTECHNOL ADV, V37, P223, DOI 10.1016/j.biotechadv.2018.12.001
   Chen HL, 2011, BRIT J NUTR, V105, P805, DOI 10.1017/S000711451000437X
   Chen XY, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060545
   Divya JB, 2012, ENG LIFE SCI, V12, P377, DOI 10.1002/elsc.201100179
   Feng Y, 2016, PHARM BIOL, V54, P1027, DOI 10.3109/13880209.2015.1093510
   Gao JQ, 2018, CLIN INTERV AGING, V13, P1859, DOI 10.2147/CIA.S173838
   Gao P, 2019, EXP GERONTOL, V118, P9, DOI 10.1016/j.exger.2018.12.018
   Gerber PA, 2016, SUPPORT CARE CANCER, V24, P4241, DOI 10.1007/s00520-016-3254-7
   Grillo MA, 2008, AMINO ACIDS, V35, P29, DOI 10.1007/s00726-007-0606-0
   Hartog JWL, 2007, EUR J HEART FAIL, V9, P1146, DOI 10.1016/j.ejheart.2007.09.009
   Hernández-Ruiz J, 2001, BIOCHEM J, V354, P107, DOI 10.1042/0264-6021:3540107
   Huang CC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/275431
   Ighodaro OM, 2018, ALEX J MED, V54, P287, DOI 10.1016/j.ajme.2017.09.001
   Inoguchi S, 2012, INT J FOOD SCI NUTR, V63, P402, DOI 10.3109/09637486.2011.630992
   Iwayama K, 2017, BMC PHARMACOL TOXICO, V18, DOI 10.1186/s40360-017-0119-8
   Izumi T, 2000, J NUTR, V130, P1695, DOI 10.1093/jn/130.7.1695
   Jang HH, 2020, FOOD CHEM, V330, DOI 10.1016/j.foodchem.2020.127317
   Kapila Suman, 2006, Indian J Med Sci, V60, P361
   Lee JH, 2018, J FOOD DRUG ANAL, V26, P1054, DOI 10.1016/j.jfda.2017.12.003
   Liu BH, 2019, FOOD SCI NUTR, V7, P2068, DOI 10.1002/fsn3.1048
   Liu BH, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/3152324
   Liu J, 2020, RSC ADV, V10, P4607, DOI 10.1039/c9ra09863a
   Lv M, 2015, DRUG DISCOV TODAY, V20, P332, DOI 10.1016/j.drudis.2014.10.007
   Majumdar APN, 2003, INTERD T GERONT GERI, V32, P40
   Masilamani M, 2012, IMMUNOL RES, V54, P95, DOI 10.1007/s12026-012-8331-5
   Masilamani M, 2011, J ALLERGY CLIN IMMUN, V128, P1242, DOI 10.1016/j.jaci.2011.05.009
   McFarland LV, 2015, CLIN INFECT DIS, V60, pS85, DOI 10.1093/cid/civ054
   Meng X, 2016, APPL BIOL CHEM, V59, P143, DOI 10.1007/s13765-015-0135-6
   Mishra BK, 2019, FOOD TECHNOL BIOTECH, V57, P399, DOI 10.17113/ftb.57.03.19.6103
   Nautiyal J, 2010, CURR PROTEIN PEPT SC, V11, P436, DOI 10.2174/138920310791824110
   Ollberding NJ, 2012, JNCI-J NATL CANCER I, V104, P67, DOI 10.1093/jnci/djr475
   Parvez S, 2006, J APPL MICROBIOL, V100, P1171, DOI 10.1111/j.1365-2672.2006.02963.x
   Rekha CR, 2010, J APPL MICROBIOL, V109, P1198, DOI 10.1111/j.1365-2672.2010.04745.x
   RELAN NK, 1995, BBA-GEN SUBJECTS, V1244, P368, DOI 10.1016/0304-4165(95)00024-6
   Röhrdanz E, 2002, J NUTR, V132, P370, DOI 10.1093/jn/132.3.370
   Shor Audrey C, 2008, Cancer Control, V15, P47
   Shu GW, 2019, PROBIOTICS ANTIMICRO, V11, P723, DOI 10.1007/s12602-018-9410-2
   Song LH, 2006, J RADIAT RES, V47, P157, DOI 10.1269/jrr.47.157
   Steinkraus KH, 1997, FOOD CONTROL, V8, P311, DOI 10.1016/S0956-7135(97)00050-9
   Suo HY, 2018, J DAIRY SCI, V101, P10664, DOI 10.3168/jds.2018-14758
   Suo HY, 2016, J FOOD BIOCHEM, V40, P294, DOI 10.1111/jfbc.12223
   Wang Y.L., 2016, MOL NEUROBIOL, V54
   Wang YL, 2016, TOXICOL APPL PHARM, V308, P91, DOI 10.1016/j.taap.2016.07.006
   WARNER HR, 1994, FREE RADICAL BIO MED, V17, P249, DOI 10.1016/0891-5849(94)90080-9
   Xia JH, 2019, J SCI FOOD AGR, V99, P6841, DOI 10.1002/jsfa.9969
   Xiao ZQ, 2001, AM J PHYSIOL-GASTR L, V281, pG111, DOI 10.1152/ajpgi.2001.281.1.G111
   Yi RK, 2019, J MED FOOD, V22, P1208, DOI 10.1089/jmf.2019.4467
   Yi RK, 2019, MOLECULES, V24, DOI 10.3390/molecules24061016
   Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X
   Zhang RF, 2011, J AGR FOOD CHEM, V59, P5935, DOI 10.1021/jf201593n
   Zhao X, 2019, J DAIRY SCI, V102, P5899, DOI 10.3168/jds.2018-16033
   Zhao X, 2018, INT J BIOCHEM CELL B, V103, P1, DOI 10.1016/j.biocel.2018.07.010
   Zhao X, 2018, MOLECULES, V23, DOI 10.3390/molecules23010204
   Zoumpopoulou G, 2018, PROBIOTICS ANTIMICRO, V10, P313, DOI 10.1007/s12602-017-9311-9
NR 56
TC 18
Z9 23
U1 17
U2 95
PU TSINGHUA UNIV PRESS
PI BEIJING
PA B605D, XUE YAN BUILDING, BEIJING, 100084, PEOPLES R CHINA
EI 2213-4530
J9 FOOD SCI HUM WELL
JI Food Sci. Human Wellness
PD SEP
PY 2022
VL 11
IS 5
BP 1362
EP 1372
DI 10.1016/j.fshw.2022.04.036
PG 11
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA 2O5UG
UT WOS:000819122400030
OA gold
DA 2024-02-19
ER

PT J
AU Ueda, M
   Ando, Y
   Haraoka, K
   Katsuragi, S
   Terasaki, Y
   Sugimoto, M
   Sun, XG
   Uchino, M
AF Ueda, Mitsuharu
   Ando, Yukio
   Haraoka, Katsuki
   Katsuragi, Shoichi
   Terasaki, Yasuhiro
   Sugimoto, Mineharu
   Sun, Xuguo
   Uchino, Makoto
TI Aging and transthyretin-related amyloidosis: Pathologic examinations in
   pulmonary amyloidosis
SO AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
LA English
DT Article
DE pulmonary amyloidosis; aging; FAP; SSA; TTR
ID SENILE SYSTEMIC AMYLOIDOSIS; POLYNEUROPATHY TYPE-I;
   LIVER-TRANSPLANTATION; FAMILIAL AMYLOIDOSIS; PRE-ALBUMIN; AUTONOMIC
   DYSFUNCTION; CARDIAC AMYLOIDOSIS; JAPANESE PATIENTS; FIBRIL; PREALBUMIN
AB Although aging is closely related with the onset of senile systemic amyloidosis (SSA) caused by wild-type transthyretin (TTR), the effect of aging on amyloid formation has remained unclear in familial amyloidotic polyneuropathy (FAP), caused by variant- and wild-type TTR. The aim of this study was to elucidate the effects of aging and/or other factors in FAP on amyloid formation in the lung, one of the most important target organs of amyloid deposition in SSA. Pulmonary amyloid distribution was determined using 19 autopsied lung samples from patients with FAP amyloidogenic TTR (ATTR) V30M, the most common type of FAP. Amyloid deposition was observed around the walls of the bronchi/ bronchioles, the pulmonary arteries, and the pulmonary veins, while no amyloid deposits could be found around the lymphatics. In addition, amyloid deposition in the alveolar regions was a characteristic finding in aged patients with FAP ATTR V30M (average ages of the patients with amyloid positive vs. negative: 50.55 +/- 8.75 vs. 39.75 +/- 4.17 years old, p < 0.005), similar to the finding in one SSA patient. These results suggest that aging could play an important role in the progression of pulmonary amyloid formation in FAP ATTR V30M.
C1 Kumamoto Univ, Grad Sch Med Sci, Dept Diagnost Med, Kumamoto 8600811, Japan.
   Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, Kumamoto 8600811, Japan.
   Kumamoto Univ, Grad Sch Med Sci, Dept Gastroenterol & Hepatol, Kumamoto 8600811, Japan.
   Kumamoto Univ, Grad Sch Med Sci, Dept Pathol 2, Kumamoto 8600811, Japan.
   Kikuchi Natl Hosp, Dept Pathol, Kumamoto, Japan.
   Saishunso Natl Hosp, Dept Resp Med, Kumamoto, Japan.
C3 Kumamoto University; Kumamoto University; Kumamoto University; Kumamoto
   University
RP Ando, Y (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Diagnost Med, 1-1-1 Honjo, Kumamoto 8600811, Japan.
EM yukio@kaiju.medic.kumamoto-u.ac.jp
RI Ando, Yasumasa/F-3264-2015; Ueda, Mitsuharu/Q-8595-2019
OI Ueda, Mitsuharu/0000-0002-6814-0582; Terasaki,
   Yasuhiro/0000-0003-4495-7982; Ando, Yukio/0000-0001-7115-9105
CR Abe M, 1996, J AUTONOM NERV SYST, V60, P71, DOI 10.1016/0165-1838(96)00033-1
   Ando E, 1997, BRIT J OPHTHALMOL, V81, P295, DOI 10.1136/bjo.81.4.295
   Ando E, 2001, ANN INTERN MED, V135, P931, DOI 10.7326/0003-4819-135-10-200111200-00026
   Ando Y, 1996, MUSCLE NERVE, V19, P1640
   Ando Y, 1997, LANCET, V350, P593, DOI 10.1016/S0140-6736(05)63185-6
   ANDO Y, 1995, BIOCHEM BIOPH RES CO, V211, P354, DOI 10.1006/bbrc.1995.1820
   Ando Y, 1998, AMYLOID, V5, P288, DOI 10.3109/13506129809007303
   Ando Y, 1996, TRANSPLANTATION, V62, P1037, DOI 10.1097/00007890-199610150-00028
   ANDO Y, 1995, LANCET, V345, P195, DOI 10.1016/S0140-6736(95)90201-5
   ANDO Y, 1993, INTERNAL MED, V32, P920, DOI 10.2169/internalmedicine.32.920
   ARAKI S, 1984, BRAIN DEV-JPN, V6, P128, DOI 10.1016/S0387-7604(84)80061-3
   Benson MD, 1996, AMYLOID, V3, P44, DOI 10.3109/13506129609014354
   BLAKE CCF, 1974, J MOL BIOL, V88, P1, DOI 10.1016/0022-2836(74)90291-5
   CHRISTMANSON L, 1991, FEBS LETT, V281, P177, DOI 10.1016/0014-5793(91)80387-I
   CONNORS LH, 2002, AMYLOID, V10, P160
   COSTA PP, 1978, P NATL ACAD SCI USA, V75, P4499, DOI 10.1073/pnas.75.9.4499
   Dubrey SW, 1997, TRANSPLANTATION, V64, P74, DOI 10.1097/00007890-199707150-00014
   DWULET FE, 1984, P NATL ACAD SCI-BIOL, V81, P694, DOI 10.1073/pnas.81.3.694
   EANES ED, 1968, J HISTOCHEM CYTOCHEM, V16, P673, DOI 10.1177/16.11.673
   ERIKSSON A, 1983, ACTA PATH MICRO IM A, V91, P343
   ERIKSSON P, 1984, PACE, V7, P702, DOI 10.1111/j.1540-8159.1984.tb05599.x
   GUSTAVSSON A, 1991, BIOCHEM BIOPH RES CO, V175, P1159, DOI 10.1016/0006-291X(91)91687-8
   GUSTAVSSON A, 1995, LAB INVEST, V73, P703
   HODKINSON HM, 1997, Q J MED, V46, P381
   HOLMGREN G, 1993, LANCET, V341, P113
   NOY N, 1992, BIOCHEMISTRY-US, V31, P11118, DOI 10.1021/bi00160a023
   Olofsson BO, 2002, TRANSPLANTATION, V73, P745, DOI 10.1097/00007890-200203150-00015
   PITKANEN P, 1984, AM J PATHOL, V117, P391
   SARAIVA MJM, 1983, T ASSOC AM PHYSICIAN, V96, P261
   SKINNER M, 1994, ANN INTERN MED, V120, P133, DOI 10.7326/0003-4819-120-2-199401150-00006
   SLETTEN K, 1980, SCAND J IMMUNOL, V12, P503, DOI 10.1111/j.1365-3083.1980.tb00098.x
   SMITH TJ, 1984, MAYO CLIN PROC, V59, P547, DOI 10.1016/S0025-6196(12)61493-1
   Stangou AJ, 1998, TRANSPLANTATION, V66, P229, DOI 10.1097/00007890-199807270-00016
   Strege RJ, 1998, VIRCHOWS ARCH, V433, P19, DOI 10.1007/s004280050211
   TAKAHASHI K, 1991, HUM PATHOL, V22, P519, DOI 10.1016/0046-8177(91)90227-G
   Tashima K, 1999, AMYLOID, V6, P124, DOI 10.3109/13506129909007313
   TAWARA S, 1983, BIOCHEM BIOPH RES CO, V116, P880, DOI 10.1016/S0006-291X(83)80224-1
   WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843
   Westermark P, 2003, AMYLOID, V10, P48
   Westermark P, 2002, AMYLOID, V9, P197
NR 40
TC 22
Z9 24
U1 0
U2 3
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1350-6129
EI 1744-2818
J9 AMYLOID
JI Amyloid-J. Protein Fold. Disord.
PD MAR
PY 2006
VL 13
IS 1
BP 24
EP 30
DI 10.1080/13506120500537194
PG 7
WC Biochemistry & Molecular Biology; Medicine, General & Internal;
   Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; General & Internal Medicine; Research
   & Experimental Medicine
GA 048FG
UT WOS:000237932400005
PM 16690497
DA 2024-02-19
ER

PT J
AU Gonzalo-Gobernado, R
   Perucho, J
   Vallejo-Muñoz, M
   Casarejos, MJ
   Reimers, D
   Jiménez-Escrig, A
   Gómez, A
   de Asanza, GMU
   Bazán, E
AF Gonzalo-Gobernado, Rafael
   Perucho, Juan
   Vallejo-Munoz, Manuela
   Jose Casarejos, Maria
   Reimers, Diana
   Jimenez-Escrig, Adriano
   Gomez, Ana
   Ulzurrun de Asanza, Gonzalo M.
   Bazan, Eulalia
TI Liver Growth Factor "LGF" as a Therapeutic Agent for Alzheimer's Disease
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE liver growth factor; Alzheimer&#8217; s disease; inflammation;
   neuroprotection; microglia; Tg2576 transgenic mice; amyloid-beta
ID NEURAL STEM-CELLS; AMYLOID-BETA; MOUSE MODEL; NEURONAL SURVIVAL;
   OXIDATIVE STRESS; MICROGLIA; BRAIN; PATHOLOGY; RECEPTOR; PROTEIN
AB Alzheimer's disease (AD) is a progressive degenerative disorder and the most common cause of dementia in aging populations. Although the pathological hallmarks of AD are well defined, currently no effective therapy exists. Liver growth factor (LGF) is a hepatic albumin-bilirubin complex with activity as a tissue regenerating factor in several neurodegenerative disorders such as Parkinson's disease and Friedreich's ataxia. Our aim here was to analyze the potential therapeutic effect of LGF on the APPswe mouse model of AD. Twenty-month-old mice received intraperitoneal (i.p.) injections of 1.6 mu g LGF or saline, twice a week during three weeks. Mice were sacrificed one week later, and the hippocampus and dorsal cortex were prepared for immunohistochemical and biochemical studies. LGF treatment reduced amyloid-beta (A beta) content, phospho-Tau/Tau ratio and the number of A beta plaques with diameter larger than 25 mu m. LGF administration also modulated protein ubiquitination and HSP70 protein levels, reduced glial reactivity and inflammation, and the expression of the pro-apoptotic protein Bax. Because the administration of this factor also restored cognitive damage in APPswe mice, we propose LGF as a novel therapeutic tool that may be useful for the treatment of AD.
C1 [Gonzalo-Gobernado, Rafael; Perucho, Juan; Vallejo-Munoz, Manuela; Jose Casarejos, Maria; Reimers, Diana; Jimenez-Escrig, Adriano; Gomez, Ana; Ulzurrun de Asanza, Gonzalo M.; Bazan, Eulalia] Inst Ramon Y Cajal Invest Sanitaria IRYCIS, Serv Neurobiol, Madrid 28034, Spain.
   [Gonzalo-Gobernado, Rafael] Natl Ctr Biotechnol CNB, CSIC, Madrid 28049, Spain.
   [Jimenez-Escrig, Adriano] Hosp Ramon & Cajal, Serv Neurol, Madrid 28034, Spain.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro
   Nacional de Biotecnologia (CNB); Hospital Universitario Ramon y Cajal
RP Bazán, E (corresponding author), Inst Ramon Y Cajal Invest Sanitaria IRYCIS, Serv Neurobiol, Madrid 28034, Spain.
EM rd.gonzalo@cnb.csic.es; juan.perucho@outlook.com;
   manuela.vmqm@gmail.com; m.jose.casarejos@hrc.es; diana.reimers@hrc.es;
   adriano.jimenez@hrc.es; go.s6506@hotmail.com; gonzalo.munoz@hrc.es;
   eulalia.bazan@hrc.es
RI Gómez, Ana Lara/IST-3355-2023; Gomez, Ana Maria/B-5376-2013; Casarejos,
   María jose/AAA-9629-2019; Gonzalo-Gobernado, Rafael/F-2675-2016
OI Gómez, Ana Lara/0000-0002-5324-5584; Gomez, Ana
   Maria/0000-0003-0009-2884; Casarejos, María jose/0000-0003-1288-1717;
   Gonzalo-Gobernado, Rafael/0000-0002-6357-105X; Bazan,
   Eulalia/0000-0002-0126-250X
FU Research Supporting Staff Grant Contract (Spanish Health Research Fund
   (FIS))
FX R.G.-G. was the recipient of a Research Supporting Staff Grant Contract
   (Spanish Health Research Fund (FIS)).
CR Ameen-Ali KE, 2017, NEUROPATH APPL NEURO, V43, P553, DOI 10.1111/nan.12440
   Arbor Sage C., 2016, Yale Journal of Biology and Medicine, V89, P5
   Avila J, 2010, NAT REV NEUROL, V6, P587, DOI 10.1038/nrneurol.2010.157
   Bird TD, 1993, ALZHEIMER DIS OVERVI
   Butterfield DA, 2013, ANTIOXID REDOX SIGN, V19, P823, DOI 10.1089/ars.2012.5027
   Calatrava-Ferreras L, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122066
   Calatrava-Ferreras L, 2014, INT J MOL SCI, V15, P19056, DOI 10.3390/ijms151019056
   Carro E, 2002, NAT MED, V8, P1390, DOI 10.1038/nm793
   Casarejos MJ, 2013, J ALZHEIMERS DIS, V35, P525, DOI 10.3233/JAD-130050
   Chong ZZ, 2005, HISTOL HISTOPATHOL, V20, P299, DOI 10.14670/HH-20.299
   Conde JR, 2006, J NEUROPATH EXP NEUR, V65, P199, DOI 10.1097/01.jnen.0000202887.22082.63
   Coraci IS, 2002, AM J PATHOL, V160, P101, DOI 10.1016/S0002-9440(10)64354-4
   Couturier J, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0477-y
   De-Paula Vanessa J, 2012, Subcell Biochem, V65, P329, DOI 10.1007/978-94-007-5416-4_14
   Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2
   Díaz-Gil JJ, 1999, J HEPATOL, V30, P1065, DOI 10.1016/S0168-8278(99)80261-X
   Díaz-Gil JJ, 2008, HISTOL HISTOPATHOL, V23, P583, DOI 10.14670/HH-23.583
   DIAZGIL JJ, 1986, BIOCHEM J, V235, P49, DOI 10.1042/bj2350049
   DIAZGIL JJ, 1988, HEPATOLOGY, V8, P484, DOI 10.1002/hep.1840080308
   Doens D, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-48
   Dossi E, 2018, BRAIN RES BULL, V136, P139, DOI 10.1016/j.brainresbull.2017.02.001
   Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499
   Eckert A, 2003, ANN NY ACAD SCI, V1010, P604, DOI 10.1196/annals.1299.113
   Feng Z, 2006, FREE RADICAL BIO MED, V40, P101, DOI 10.1016/j.freeradbiomed.2005.08.014
   Franklin BM, 2007, SECOND EDUC CHANG WO, P3
   Franklin BS, 2014, NAT IMMUNOL, V15, P727, DOI 10.1038/ni.2913
   Frebel K, 2006, BIOCHEM SOC T, V34, P1287, DOI 10.1042/BST0341287
   Friker LL, 2020, CELL REP, V30, P3743, DOI 10.1016/j.celrep.2020.02.025
   Gandy S, 2013, ANNU REV MED, V64, P367, DOI 10.1146/annurev-med-092611-084441
   Gardai SJ, 2004, J BIOL CHEM, V279, P21085, DOI 10.1074/jbc.M400063200
   GIL JJD, 1994, GROWTH REGULAT, V4, P113
   Girón-Martínez A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112995
   Gonzalo-Gobernado R, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10050315
   Gonzalo-Gobernado Rafael, 2014, Recent Pat CNS Drug Discov, V9, P173
   Gonzalo-Gobernado R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067771
   Gonzalo-Gobernado R, 2009, J HISTOCHEM CYTOCHEM, V57, P491, DOI 10.1369/jhc.2009.952275
   Heneka MT, 2010, J NEURAL TRANSM, V117, P919, DOI 10.1007/s00702-010-0438-z
   Hernández F, 2007, CELL MOL LIFE SCI, V64, P2219, DOI 10.1007/s00018-007-7220-x
   Hoshino T, 2011, J NEUROSCI, V31, P5225, DOI 10.1523/JNEUROSCI.5478-10.2011
   Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99
   Huang WJ, 2016, BIOMED REP, V4, P519, DOI 10.3892/br.2016.630
   Itoh K, 2004, MOL CELL BIOL, V24, P36, DOI 10.1128/MCB.24.1.36-45.2004
   Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943
   Joshi G, 2015, NEUROBIOL AGING, V36, P664, DOI 10.1016/j.neurobiolaging.2014.09.004
   Kakimura J, 2002, FASEB J, V16, P601, DOI 10.1096/fj.01-0530fje
   Kerr F, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006593
   Kim TK, 2012, EXP MOL MED, V44, P740, DOI 10.3858/emm.2012.44.12.082
   King DL, 2002, PHYSIOL BEHAV, V75, P627, DOI 10.1016/S0031-9384(02)00639-X
   Kobayashi EH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11624
   Lee YW, 2013, EUR J PHARMACOL, V704, P70, DOI 10.1016/j.ejphar.2013.02.015
   Lu RC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/435203
   Martin E, 2017, AGING CELL, V16, P27, DOI 10.1111/acel.12522
   Martínez-Galán L, 2010, ARCH BRONCONEUMOL, V46, P20, DOI 10.1016/j.arbres.2009.10.006
   Matsuda Satoru, 2018, Diseases, V6, DOI 10.3390/diseases6020028
   Miyata Y, 2011, FUTURE MED CHEM, V3, P1523, DOI [10.4155/fmc.11.88, 10.4155/FMC.11.88]
   Mosher KI, 2014, BIOCHEM PHARMACOL, V88, P594, DOI 10.1016/j.bcp.2014.01.008
   Noshita N, 2001, J CEREBR BLOOD F MET, V21, P1442, DOI 10.1097/00004647-200112000-00009
   Obulesu M, 2014, NEUROCHEM RES, V39, P2301, DOI 10.1007/s11064-014-1454-4
   Park IH, 2004, MOL IMMUNOL, V40, P1203, DOI 10.1016/j.molimm.2003.11.027
   Perucho J, 2012, CURR ALZHEIMER RES, V9, P334, DOI 10.2174/156720512800107573
   Perucho J, 2010, EXP NEUROL, V221, P54, DOI 10.1016/j.expneurol.2009.09.029
   Reimers D, 2006, J HISTOCHEM CYTOCHEM, V54, P457, DOI 10.1369/jhc.5A6805.2005
   Reimers D, 2012, CURR STEM CELL RES T, V7, P15, DOI 10.2174/157488812798483421
   Ricciarelli R, 2004, FREE RADICAL BIO MED, V36, P1018, DOI 10.1016/j.freeradbiomed.2004.01.007
   Rojo AI, 2018, REDOX BIOL, V18, P173, DOI 10.1016/j.redox.2018.07.006
   Sagare AP, 2011, J NEUROSCI RES, V89, P967, DOI 10.1002/jnr.22670
   Sarlus H, 2017, J CLIN INVEST, V127, P3240, DOI 10.1172/JCI90606
   Scott XO, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21134674
   Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189
   SINGH J, 1986, J CHROMATOGR, V380, P321, DOI 10.1016/S0378-4347(00)83660-9
   Surra JC, 2010, HISTOL HISTOPATHOL, V25, P609, DOI 10.14670/HH-25.609
   Suzuki T, 2019, CELL REP, V28, P746, DOI 10.1016/j.celrep.2019.06.047
   Taipa R, 2018, NEUROPATH APPL NEURO, V44, P298, DOI 10.1111/nan.12445
   Takeuchi A, 2000, AM J PATHOL, V157, P331, DOI 10.1016/S0002-9440(10)64544-0
   Thornalley PJ, 1998, CELL MOL BIOL, V44, P1013
   Uruno A, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00467-19
   Venegas C, 2017, NATURE, V552, P355, DOI 10.1038/nature25158
   Von Bernhardi R, 2001, BIOL RES, V34, P123
   von Bernhardi R, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00124
   Wang CY, 2014, ANTIOXID REDOX SIGN, V21, P2208, DOI 10.1089/ars.2014.5845
   Wilkinson K, 2011, J BIOL CHEM, V286, P34914, DOI 10.1074/jbc.M111.232116
   Yan YF, 2012, NEUROSCI LETT, V531, P160, DOI 10.1016/j.neulet.2012.10.043
   Youssef P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29770-3
   Zhao H, 2006, MOL NEUROBIOL, V34, P249, DOI 10.1385/MN:34:3:249
NR 84
TC 9
Z9 9
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD DEC
PY 2020
VL 21
IS 23
AR 9201
DI 10.3390/ijms21239201
PG 21
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA PD4AA
UT WOS:000597628300001
PM 33276671
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Gabriely, I
   Ma, XH
   Yang, XM
   Atzmon, G
   Rajala, MW
   Berg, AH
   Scherer, P
   Rossetti, L
   Barzilai, N
AF Gabriely, I
   Ma, XH
   Yang, XM
   Atzmon, G
   Rajala, MW
   Berg, AH
   Scherer, P
   Rossetti, L
   Barzilai, N
TI Removal of visceral fat prevents insulin resistance and glucose
   intolerance of aging - An adipokine-mediated process?
SO DIABETES
LA English
DT Article
ID TYPE-2 DIABETES-MELLITUS; NECROSIS-FACTOR-ALPHA; CALORIC RESTRICTION;
   INDUCED INHIBITION; GENE-EXPRESSION; ADIPOSE-TISSUE; LIFE-STYLE;
   TNF-ALPHA; OBESITY; RISK
AB Age-dependent changes in insulin action and body fat distribution are risk factors for the development of type 2 diabetes. To examine whether the accumulation of visceral fat (VF) could play a direct role in the pathophysiology of insulin resistance and type 2 diabetes, we monitored insulin action, glucose tolerance, and the expression of adipo-derived peptides after surgical removal of VF in aging (20-month-old) F344/Brown Norway (FBN) and in Zucker Diabetic Fatty (ZDF) rats. As expected, peripheral and hepatic insulin action were markedly impaired in aging FBN rats, and extraction of VF (accounting for similar to18% of their total body fat) was sufficient to restore peripheral and hepatic insulin action to the levels of young rats. When examined at the mechanistic level, removal of VF in ZDF rats prevented the progressive decrease in insulin action and delayed the onset of diabetes, but VF extraction did not alter plasma free fatty acid levels. However, the expression of tumor necrosis factor-alpha and leptin in subcutaneous (SC) adipose tissue were markedly decreased after VF removal (by approximately three- and twofold, respectively). Finally, extracted VF retained similar to15-fold higher resistin mRNA compared with SC fat. Our data suggest that insulin resistance and the development of diabetes can be significantly reduced in aging rats by preventing the age-dependent accumulation of VF. This study documents a cause-and-effect relationship between VF and major components of the metabolic syndrome.
C1 Albert Einstein Coll Med, Inst Aging Res, Bronx, NY 10461 USA.
   Albert Einstein Coll Med, Div Endocrinol, Dept Med, Bronx, NY 10461 USA.
   Albert Einstein Coll Med, Ctr Diabet Res & Training, Bronx, NY 10461 USA.
   Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA.
C3 Yeshiva University; Albert Einstein College of Medicine; Yeshiva
   University; Albert Einstein College of Medicine; Yeshiva University;
   Albert Einstein College of Medicine; Yeshiva University; Albert Einstein
   College of Medicine
RP Barzilai, N (corresponding author), Albert Einstein Coll Med, Inst Aging Res, Belfer Bldg No 701,1300 Morris Pk Ave, Bronx, NY 10461 USA.
EM barzilai@aecom.yu.edu
RI Scherer, Philipp E/K-7819-2012
OI Scherer, Philipp E/0000-0003-0680-3392
FU NIA NIH HHS [R01-AG18381] Funding Source: Medline; NIDDK NIH HHS
   [R01-DK45024, R01-DK 48321, DK 20541] Funding Source: Medline
CR Abbasi F, 2000, METABOLISM, V49, P151, DOI 10.1016/S0026-0495(00)91065-5
   ADER M, 1990, AM J PHYSIOL, V258, pE1020, DOI 10.1152/ajpendo.1990.258.6.E1020
   BARZILAI N, 1995, AM J PHYSIOL-ENDOC M, V269, pE591, DOI 10.1152/ajpendo.1995.269.3.E591
   Barzilai N, 1999, J GERONTOL A-BIOL, V54, pB89, DOI 10.1093/gerona/54.3.B89
   Barzilai N, 1996, DIABETES, V45, P1329, DOI 10.2337/diabetes.45.10.1329
   Barzilai N, 1998, J CLIN INVEST, V101, P1353, DOI 10.1172/JCI485
   Barzilai N, 1999, DIABETES, V48, P94, DOI 10.2337/diabetes.48.1.94
   Barzilai N, 1999, ANN NY ACAD SCI, V892, P58, DOI 10.1111/j.1749-6632.1999.tb07785.x
   BJORNTORP P, 1990, ARTERIOSCLEROSIS, V10, P493, DOI 10.1161/01.ATV.10.4.493
   BODEN G, 1994, J CLIN INVEST, V93, P2438, DOI 10.1172/JCI117252
   Boden G, 2001, DIABETES, V50, P1612, DOI 10.2337/diabetes.50.7.1612
   Carey DG, 1996, DIABETES, V45, P633, DOI 10.2337/diabetes.45.5.633
   CEFALU WT, 1995, METABOLISM, V44, P954, DOI 10.1016/0026-0495(95)90251-1
   Cefalu WT, 1999, TOXICOL SCI, V52, P49, DOI 10.1093/toxsci/52.2.49
   Ferrannini E, 1997, HYPERTENSION, V30, P1144, DOI 10.1161/01.HYP.30.5.1144
   Fujimoto WY, 1999, DIABETES CARE, V22, P1808, DOI 10.2337/diacare.22.11.1808
   Gabriely I, 2001, MECH AGEING DEV, V122, P1565, DOI 10.1016/S0047-6374(01)00287-1
   Gupta G, 2000, AM J PHYSIOL-REG I, V278, pR111, DOI 10.1152/ajpregu.2000.278.1.R111
   Hawkins M, 1997, J CLIN INVEST, V99, P2173, DOI 10.1172/JCI119390
   HOFMANN C, 1994, ENDOCRINOLOGY, V134, P264, DOI 10.1210/en.134.1.264
   Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665
   HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936
   Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492
   Lamarche B, 1998, CORONARY ARTERY DIS, V9, P473, DOI 10.1097/00019501-199809080-00002
   Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X
   Masoro EJ, 1996, TOXICOL PATHOL, V24, P738, DOI 10.1177/019262339602400617
   Moller DE, 2000, TRENDS ENDOCRIN MET, V11, P212, DOI 10.1016/S1043-2760(00)00272-1
   OSHAUGHNESSY IM, 1995, HYPERTENSION, V26, P186, DOI 10.1161/01.HYP.26.1.186
   REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595
   Rebrin K, 1996, J CLIN INVEST, V98, P741, DOI 10.1172/JCI118846
   SHIMOKATA H, 1989, J GERONTOL, V44, pM66, DOI 10.1093/geronj/44.2.M66
   Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000
   Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801
   vanZwieten PA, 1996, PHARMACOL RES, V33, P95, DOI 10.1006/phrs.1996.0015
   Wang JL, 1999, NAT MED, V5, P895, DOI 10.1038/11335
   Wang JL, 1998, NATURE, V393, P684, DOI 10.1038/31474
   Weindruch R, 1996, TOXICOL PATHOL, V24, P742, DOI 10.1177/019262339602400618
   WILLIAMSON JR, 1966, P NATL ACAD SCI USA, V56, P247, DOI 10.1073/pnas.56.1.247
   YORK DA, 1972, METABOLISM, V21, P277, DOI 10.1016/0026-0495(72)90070-4
NR 39
TC 443
Z9 486
U1 0
U2 18
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0012-1797
EI 1939-327X
J9 DIABETES
JI Diabetes
PD OCT
PY 2002
VL 51
IS 10
BP 2951
EP 2958
DI 10.2337/diabetes.51.10.2951
PG 8
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 599LT
UT WOS:000178336600011
PM 12351432
OA Bronze
DA 2024-02-19
ER

PT J
AU Nguyen, V
   Huang, JC
   Doan, V
   Lin, X
   Tang, XN
   Huang, YH
   Tang, AC
   Yang, X
   Huang, RB
AF Vanphuc Nguyen
   Huang, Jianchun
   Vanminh Doan
   Lin, Xing
   Tang, Xiuneng
   Huang, Yuanheng
   Tang, Aicun
   Yang, Xin
   Huang, Renbin
TI Hepatoprotective effects of Yulangsan polysaccharide against
   nimesulide-induced liver injury in mice
SO JOURNAL OF ETHNOPHARMACOLOGY
LA English
DT Article
DE Yulangsan polysaccharide; Nimesulide; Hepatoprotection
ID MITOCHONDRIAL PERMEABILITY TRANSITION; HEPATOTOXICITY; MECHANISMS;
   IMPAIRMENT; HEPATITIS; APOPTOSIS; FAILURE; DDB
AB Ethnopharmacological relevance: Yulangsan polysaccharide (YLSPS) is often used in popular folk medicine in the Guangxi Zhuang Autonomous Region of China as a chief ingredient of Millettia pulchra, which is used as a hepatic protection, anti-aging and memory improving agent.
   Aim of the study: This study was designed to investigate the protective effects of polysaccharides from Millettia pulchra Kurz var.laxior (Dunn) (Yulangsan polysaecharide, YLSPS) against nimesulide-induced hepatotoxicities in mice.
   Materials and methods: Liver injury was induced in mice by administering nimesulide. Simultaneously, YLSPS was administered 2 h prior to the administration of nimesulide. Dimethyl diphenyl bicarboxylate (DDB) was used as a reference drug.
   Results: Compared with the nimesulide group, YLSPS significantly decreased the activities of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP) and the content of bilirubin in the serum. The anti-oxidative effect of YLSPS was observed from the increase of the superoxide dismutase (SOD) and catalase and glutathione peroxidase (GSH-Px) activities in the liver, both of which were decreased by nimesulide. Moreover, the content of malondialdehyde (MBA) was reduced, and histological findings also confirmed the anti-hepatotoxic activity. In addition, YLSPS significantly inhibited proinflammatory mediators, such as tumor necrosis factor-alpha (TNF-alpha) and interleukin 6 (IL-6). Additionally, YLSPS also enhanced the mitochondrial antioxidant and inhibited dead cells by preventing the down-regulation of BcI-2, up-regulation and release of Bax along with caspase 9 and 3 activity, confirming the involvement of mitochondria in the nimesulide-induced apoptosis.
   Conclusion: The protective effect of YLSPS against nimesulide-induced hepatic injury may rely on its ability to reduce oxidative stress and prevent nimesulide-induced hepatotoxicity by inhibiting critical control points of apoptosis. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
C1 [Vanphuc Nguyen; Huang, Jianchun; Vanminh Doan; Lin, Xing; Tang, Xiuneng; Huang, Yuanheng; Tang, Aicun; Yang, Xin; Huang, Renbin] Guangxi Med Univ, Dept Pharmacol, Nanning 530021, Peoples R China.
C3 Guangxi Medical University
RP Huang, RB (corresponding author), Guangxi Med Univ, Dept Pharmacol, Nanning 530021, Peoples R China.
EM huangrenbin518@163.com
RI Huang, Ren/HJG-5652-2022
OI Huang, Ren/0000-0002-3068-8331
FU Science and Technology Research Development of Guangxi Province
   [2012GXNSFBA053094]; Scientific Research and Technology Development
   research projects of Guangxi Province [0630002-2A, 10124008-6]; Science
   and Technology foundation platform construction project of Guangxi
   Province [12-97-20]
FX The authors gratefully acknowledge financial support from the Science
   and Technology Research Development of Guangxi Province (No.
   2012GXNSFBA053094), Scientific Research and Technology Development
   research projects of Guangxi Province (No. 0630002-2A, No. 10124008-6),
   and Science and Technology foundation platform construction project of
   Guangxi Province (No. 12-97-20).
CR Boelsterli UA, 2002, DRUG SAFETY, V25, P633, DOI 10.2165/00002018-200225090-00003
   Boelsterli UA, 2006, CURR DRUG METAB, V7, P715, DOI 10.2174/138920006778520606
   Dai B, 2009, CHINESE MODERN YAO M, P401
   Dastis SN, 2007, EUR J GASTROEN HEPAT, V19, P919, DOI 10.1097/MEG.0b013e3282eeb4cc
   Dong YZ, 2014, J ETHNOPHARMACOL, V152, P201, DOI 10.1016/j.jep.2014.01.001
   Duan X., 2007, LISHIZHEN MED MAT ME, V18, P1592
   [段小群 DUAN Xiaoqun], 2008, [中国现代医学杂志, China Journal of Modern Medicine], V18, P423
   Galati G, 2002, CHEM-BIOL INTERACT, V142, P25, DOI 10.1016/S0009-2797(02)00052-2
   Gao M, 2005, LIVER INT, V25, P904, DOI 10.1111/j.1478-3231.2005.01140.x
   Guangxi Food and Drug Administration, 2008, STAND GUANGX ZHUANG, P72
   Hassan AA, 2010, LIFE SCI J, V7, P148
   Holt MP, 2006, AAPS J, V8, pE48, DOI 10.1208/aapsj080106
   [黄仁彬 Huang Renbin], 2003, [中国医院药学杂志, Chinese Journal of Hospital Pharmacy], V23, P321
   [黄媛恒 HUANG Yuan-heng], 2008, [中国新药杂志, Chinese Journal New Drugs], V17, P1764
   Iqbal M, 2003, PHARMACOL TOXICOL, V92, P33, DOI 10.1034/j.1600-0773.2003.920106.x
   Korsmeyer SJ, 1999, CANCER RES, V59, p1693S
   Lee WM, 2003, NEW ENGL J MED, V349, P474, DOI 10.1056/NEJMra021844
   Leone A, 2014, TOXICOL APPL PHARM, V275, P189, DOI 10.1016/j.taap.2014.01.017
   Lin X, 2014, INT IMMUNOPHARMACOL, V19, P365, DOI 10.1016/j.intimp.2014.02.009
   Lin X, 2014, CARBOHYD POLYM, V101, P533, DOI 10.1016/j.carbpol.2013.09.037
   [林兴 LIN Xing], 2009, [中成药, Chinese Traditional Patent Medicine], V31, P903
   Malhi H, 2006, HEPATOLOGY, V43, pS31, DOI 10.1002/hep.21062
   Merlani G, 2001, EUR J CLIN PHARMACOL, V57, P321, DOI 10.1007/s002280100312
   Mingatto FE, 2002, J PHARMACOL EXP THER, V303, P601, DOI 10.1124/jpet.102.038620
   O'connor N, 2003, QJM-INT J MED, V96, P787, DOI 10.1093/qjmed/hcg138
   Ong MMK, 2006, FREE RADICAL BIO MED, V40, P420, DOI 10.1016/j.freeradbiomed.2005.08.038
   Park EY, 2005, CHEM-BIOL INTERACT, V155, P82, DOI 10.1016/j.cbi.2005.04.006
   Reed JC, 2006, CELL DEATH DIFFER, V13, P1378, DOI 10.1038/sj.cdd.4401975
   Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867
   Romero-Gómez M, 1999, LIVER, V19, P164, DOI 10.1111/j.1478-3231.1999.tb00027.x
   Singh BK, 2010, TOXICOLOGY, V275, P1, DOI 10.1016/j.tox.2010.05.001
   Tay VKS, 2005, FREE RADICAL BIO MED, V39, P949, DOI 10.1016/j.freeradbiomed.2005.05.013
   Traversa G, 2003, BMJ-BRIT MED J, V327, P18, DOI 10.1136/bmj.327.7405.18
   Tripathi M, 2011, J ETHNOPHARMACOL, V136, P94, DOI 10.1016/j.jep.2011.04.014
   Tripathi M, 2010, TOXICOL IN VITRO, V24, P495, DOI 10.1016/j.tiv.2009.09.011
   Vitaglione P, 2004, CRIT REV FOOD SCI, V44, P575, DOI 10.1080/10408690490911701
   Wang Y, 2011, PHARMACOEPIDEM DR S, V20, P778, DOI 10.1002/pds.2161
NR 37
TC 17
Z9 18
U1 1
U2 29
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-8741
J9 J ETHNOPHARMACOL
JI J. Ethnopharmacol.
PD AUG 22
PY 2015
VL 172
BP 273
EP 280
DI 10.1016/j.jep.2015.06.048
PG 8
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA CP4TQ
UT WOS:000359875900031
PM 26144697
DA 2024-02-19
ER

PT J
AU Sutton, GM
   Ptitsyn, AA
   Floyd, ZE
   Yu, G
   Wu, XY
   Hamel, K
   Shah, FS
   Centanni, A
   Eilertsen, K
   Kheterpal, I
   Newman, S
   Leonardi, C
   Freitas, MA
   Bunnell, BA
   Gimble, JM
AF Sutton, Gregory M.
   Ptitsyn, Andrey A.
   Floyd, Z. Elizabeth
   Yu, Gang
   Wu, Xiying
   Hamel, Katie
   Shah, Forum S.
   Centanni, Armand
   Eilertsen, Kenneth
   Kheterpal, Indu
   Newman, Susan
   Leonardi, Claudia
   Freitas, Michael A.
   Bunnell, Bruce A.
   Gimble, Jeffrey M.
TI Biological aging alters circadian mechanisms in murine adipose tissue
   depots
SO AGE
LA English
DT Article
DE Brown adipose; Circadian; Liver; Oscillation; Transcriptomics; White
   adipose
ID LIPOPROTEIN-LIPASE ACTIVITY; REV-ERB-ALPHA; GENE-EXPRESSION; CALORIC
   RESTRICTION; REGULATED GENE; ANATOMIC SITE; LEPTIN LEVELS; CLOCK GENES;
   BODY-WEIGHT; LITHIUM
AB Biological aging alters the metabolism and volume of adipose tissue depots. Recent evidence suggests that circadian mechanisms play a role in promoting adipogenesis, obesity, and lipodystrophy. The current study compared cohorts of younger (5-9 months) and older (24-28 months) C57BL/6 mice as a function of biological age and circadian time. Advanced age significantly reduced the weight of the brown, epididymal, inguinal, and retroperitoneal adipose depots but not total body weight. The older mice reduced their physical activity by > 50% and delayed their activity initiation after light offset. The expressed transcriptome in brown and white adipose depots and liver of both cohorts displayed evidence of circadian rhythmicity; however, the oscillating mRNAs differed significantly between age groups and across tissues. The amplitude of Cry1, a component of the negative arm of the circadian apparatus, and downstream regulators such as Rev-erb alpha were elevated in the older relative to the younger cohorts as a function of circadian time. Overall, transcript levels differed significantly for 557 (inguinal adipose), 1,016 (liver), and 1,021 (brown adipose) expressed sequences between the cohorts as a function of age. These included transcripts encoding proteins within the canonical and non-canonical Wnt pathways. Since the Wnt pathway regulates adipose stem cell differentiation and shares a critical enzyme, glycogen synthase kinase 3 beta, with the circadian mechanism, the intersection between these two fundamental regulatory mechanisms merits further investigation with respect to biological aging of adipose tissues.
C1 [Sutton, Gregory M.; Centanni, Armand] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Prot Deficiency & Dev Biol Lab, Baton Rouge, LA 70808 USA.
   [Ptitsyn, Andrey A.] Univ Florida, Whitney Lab Marine Biosci, St Augustine, FL 32080 USA.
   [Floyd, Z. Elizabeth; Yu, Gang; Wu, Xiying; Hamel, Katie; Shah, Forum S.; Newman, Susan; Gimble, Jeffrey M.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA.
   [Eilertsen, Kenneth] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Epigenet & Nucl Reprogramming, Baton Rouge, LA 70808 USA.
   [Kheterpal, Indu] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Prot Struct Biol Labs, Baton Rouge, LA 70808 USA.
   [Leonardi, Claudia] Louisiana State Univ Syst, Biostat Core Facil, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA.
C3 Louisiana State University System; Louisiana State University;
   Pennington Biomedical Research Center; State University System of
   Florida; University of Florida; Louisiana State University System;
   Louisiana State University; Pennington Biomedical Research Center;
   Louisiana State University System; Louisiana State University;
   Pennington Biomedical Research Center; Louisiana State University
   System; Louisiana State University; Pennington Biomedical Research
   Center; Louisiana State University System; Louisiana State University;
   Pennington Biomedical Research Center
RP Sutton, GM (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Prot Deficiency & Dev Biol Lab, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.
EM Gregory.Sutton@pbrc.edu
RI Eilertsen, Kenneth/N-1960-2017; Floyd, Elizabeth/N-1962-2017; Floyd,
   Elizabeth/W-2758-2019; Freitas, Michael/C-8953-2009
OI Floyd, Elizabeth/0000-0002-3002-6186; Floyd,
   Elizabeth/0000-0002-3002-6186; Freitas, Michael/0000-0002-3103-8410;
   Bunnell, Bruce/0000-0001-6196-3722; Ptitsyn, Andrey/0000-0003-1196-8757;
   Hamel, Katie/0000-0001-5639-9776
FU NORC Center [1P30 DK072476]; NIDDK; COBRE [NIH-P20-RR021945]; American
   Diabetes Association; Pennington Biomedical Research Foundation;
   NIH/NCRR [P50RR00164]; Louisiana Gene Therapy Research Consortium
FX The investigators express their appreciation to Barry Robert DVM, Ph.D.,
   Cindy Kloster, MS, and the staff of the Comparative Biology Core
   Facility for providing outstanding care for the animals used in this
   study; the Genomics Core Facility staff for assistance in performing the
   microarrays with support in part from the NORC Center Grant # 1P30
   DK072476 entitled "Nutritional Programming: Environmental and Molecular
   Interactions" sponsored by NIDDK and COBRE grant NIH-P20-RR021945; Laura
   Dallam for administrative assistant supporting this work; and Jeffrey
   Keller, Ph.D. for logistical assistance. The study was supported in part
   through funding from the American Diabetes Association (GMS, AC, ZEF),
   Pennington Biomedical Research Foundation (YG, XW, JMG), COBRE grant
   NIH-P20-RR021945 (GMS, ZEF), the NIH/NCRR P50RR00164 (BAB), and the
   Louisiana Gene Therapy Research Consortium (BAB).
CR Ahmad AM, 2001, J CLIN ENDOCR METAB, V86, P3499, DOI 10.1210/jc.86.8.3499
   Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5
   Ando H, 2005, ENDOCRINOLOGY, V146, P5631, DOI 10.1210/en.2005-0771
   Arasaradnam MP, 2002, ANN CLIN BIOCHEM, V39, P136, DOI 10.1258/0004563021901883
   Atmaca M, 2002, NEUROPSYCHOBIOLOGY, V46, P67, DOI 10.1159/000065414
   BAPTISTA T, 1995, PHARMACOPSYCHIATRY, V28, P35, DOI 10.1055/s-2007-979586
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102
   Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200
   Bray MS, 2009, OBES REV, V10, P6, DOI 10.1111/j.1467-789X.2009.00684.x
   Calvani M, 2004, DIABETES, V53, P939, DOI 10.2337/diabetes.53.4.939
   Cartwright MJ, 2007, EXP GERONTOL, V42, P463, DOI 10.1016/j.exger.2007.03.003
   Cartwright MJ, 2010, J GERONTOL A-BIOL, V65, P242, DOI 10.1093/gerona/glp213
   Chengappa KNR, 2002, CLIN THER, V24, P1576, DOI 10.1016/S0149-2918(02)80061-3
   Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780
   Davies K, 1994, Br J Nurs, V3, P256
   Duffield GE, 2002, CURR BIOL, V12, P551, DOI 10.1016/S0960-9822(02)00765-0
   Elabd C, 2009, STEM CELLS, V27, P2753, DOI 10.1002/stem.200
   Elmslie JL, 2001, J CLIN PSYCHIAT, V62, P486, DOI 10.4088/JCP.v62n0614
   Fagiolini A, 2003, AM J PSYCHIAT, V160, P112, DOI 10.1176/appi.ajp.160.1.112
   Fagiolini A, 2002, J CLIN PSYCHIAT, V63, P528, DOI 10.4088/JCP.v63n0611
   Fonjallaz P, 1996, EMBO J, V15, P351, DOI 10.1002/j.1460-2075.1996.tb00365.x
   Froy O, 2008, REJUV RES, V11, P467, DOI 10.1089/rej.2008.0669
   Froy O, 2007, PROG NEUROBIOL, V82, P142, DOI 10.1016/j.pneurobio.2007.03.002
   Froy O, 2006, AM J PHYSIOL-ENDOC M, V291, pE1017, DOI 10.1152/ajpendo.00140.2006
   Fu CX, 2006, MECH AGEING DEV, V127, P905, DOI 10.1016/j.mad.2006.09.006
   Garg A, 2009, BBA-MOL CELL BIOL L, V1791, P507, DOI 10.1016/j.bbalip.2008.12.014
   Gavi S, 2007, J GERONTOL A-BIOL, V62, P997, DOI 10.1093/gerona/62.9.997
   Gavrila A, 2003, J CLIN ENDOCR METAB, V88, P2838, DOI 10.1210/jc.2002-021721
   Gimble JM, 2009, OBES REV, V10, P1, DOI 10.1111/j.1467-789X.2009.00672.x
   Gimble JM, 2009, J APPL PHYSIOL, V107, P1629, DOI 10.1152/japplphysiol.00090.2009
   Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777
   GOUBERN M, 1981, HORM METAB RES, V13, P73, DOI 10.1055/s-2007-1019177
   Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022
   Green CB, 1996, P NATL ACAD SCI USA, V93, P14884, DOI 10.1073/pnas.93.25.14884
   Hernandez L, 2010, DEV CELL, V19, P413, DOI 10.1016/j.devcel.2010.08.013
   Higami Y, 2003, FASEB J, V17, P415, DOI 10.1096/fj.03-0678fje
   Hirota T, 2004, ZOOL SCI, V21, P359, DOI 10.2108/zsj.21.359
   Hogenesch John B, 2003, Novartis Found Symp, V253, P171
   Holmbäck U, 2003, EUR J NUTR, V42, P75, DOI 10.1007/s00394-003-0386-6
   Holmbäck U, 2002, J NUTR, V132, P1892, DOI 10.1093/jn/132.7.1892
   HOUSTEK J, 1990, BIOCHIM BIOPHYS ACTA, V1018, P243, DOI 10.1016/0005-2728(90)90258-6
   Huffman DM, 2009, BBA-GEN SUBJECTS, V1790, P1117, DOI 10.1016/j.bbagen.2009.01.008
   Iwahana E, 2004, EUR J NEUROSCI, V19, P2281, DOI 10.1111/j.0953-816X.2004.03322.x
   Jiang ZY, 2008, BIOCHEMISTRY-US, V47, P14028, DOI 10.1021/bi801073p
   Kawai M, 2010, P NATL ACAD SCI USA, V107, P10508, DOI 10.1073/pnas.1000788107
   KIRKLAND JL, 1990, AM J PHYSIOL, V258, pC206, DOI 10.1152/ajpcell.1990.258.2.C206
   KIRKLAND JL, 1993, BIOCHEM CELL BIOL, V71, P556, DOI 10.1139/o93-079
   KIRKLAND JL, 1994, J GERONTOL, V49, pB31, DOI 10.1093/geronj/49.1.B31
   Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455
   Kondratov RV, 2007, AGEING RES REV, V6, P12, DOI 10.1016/j.arr.2007.02.003
   Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206
   Koska J, 2007, DIABETES, V56, pA338
   KOTLAR TJ, 1977, AM J PHYSIOL, V233, pE316, DOI 10.1152/ajpendo.1977.233.4.E316
   Kromkowski J, 2008, NEUROSCI LETT, V438, P121, DOI 10.1016/j.neulet.2008.04.001
   Kruger C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008978
   Kumar N, 2010, ENDOCRINOLOGY, V151, P3015, DOI 10.1210/en.2009-0800
   LAFONTAN M, 1985, INT J OBESITY, V9, P117
   Lemberger T, 1996, J BIOL CHEM, V271, P1764, DOI 10.1074/jbc.271.3.1764
   Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718
   Liew AWC, 2009, PATTERN RECOGN, V42, P549, DOI 10.1016/j.patcog.2008.09.022
   Linford NJ, 2007, AGING CELL, V6, P673, DOI 10.1111/j.1474-9726.2007.00319.x
   Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925
   Marcheva B, 2009, J APPL PHYSIOL, V107, P1638, DOI 10.1152/japplphysiol.00698.2009
   Mastronardi CA, 2002, P NATL ACAD SCI USA, V99, P5721, DOI 10.1073/pnas.082098499
   MEUNIER P, 1971, CLIN ORTHOP RELAT R, P147, DOI 10.1097/00003086-197110000-00021
   Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501
   Monk TH, 2005, J BIOL RHYTHM, V20, P366, DOI 10.1177/0748730405277378
   Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006
   Oishi K, 2003, J BIOL CHEM, V278, P41519, DOI 10.1074/jbc.M304564200
   Padiath QS, 2004, CHRONOBIOL INT, V21, P43, DOI 10.1081/CBI-120027981
   Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5
   Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a
   Patel DD, 2001, J LIPID RES, V42, P328
   Ptitsyn A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001842
   Ptitsyn AA, 2007, PLOS COMPUT BIOL, V3, P1108, DOI 10.1371/journal.pcbi.0030120
   Ptitsyn AA, 2006, PLOS COMPUT BIOL, V2, P126, DOI 10.1371/journal.pcbi.0020016
   Ptitsyn AA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S8
   Ptitsyn AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S10
   REHNMARK S, 1990, J BIOL CHEM, V265, P16464
   ROSS SE, 2000, SCIENCE, V289, P950, DOI [DOI 10.1126/SCIENCE.289.5481.950, 10.1126/science.289.5481.950]
   Ruge T, 2004, INT J BIOCHEM CELL B, V36, P320, DOI 10.1016/S1357-2725(03)00256-5
   Saad MF, 1998, J CLIN ENDOCR METAB, V83, P453, DOI 10.1210/jc.83.2.453
   Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018
   Sato TK, 2003, J BIOL RHYTHM, V18, P96, DOI 10.1177/0748730403252245
   SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047
   Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102
   Shimba S, 2004, J BIOL CHEM, V279, P40946, DOI 10.1074/jbc.M400840200
   Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008
   Sutton GM, 2008, J NEUROSCI, V28, P12946, DOI 10.1523/JNEUROSCI.3615-08.2008
   Swindell WR, 2008, MECH AGEING DEV, V129, P138, DOI 10.1016/j.mad.2007.11.003
   Swindell WR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-585
   Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x
   Torra IP, 2000, ENDOCRINOLOGY, V141, P3799, DOI 10.1210/en.141.10.3799
   Trayhurn P, 2005, ACTA PHYSIOL SCAND, V184, P285, DOI 10.1111/j.1365-201X.2005.01468.x
   Trayhurn P, 2001, P NUTR SOC, V60, P329, DOI 10.1079/PNS200194
   Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906
   Valentinuzzi VS, 1997, AM J PHYSIOL-REG I, V273, pR1957, DOI 10.1152/ajpregu.1997.273.6.R1957
   Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949
   Weinert D, 1999, PHYSIOL BEHAV, V66, P605, DOI 10.1016/S0031-9384(98)00342-4
   Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246
   Wichert S, 2004, BIOINFORMATICS, V20, P5, DOI 10.1093/bioinformatics/btg364
   Yang XL, 2003, OBES RES, V11, P1182, DOI 10.1038/oby.2003.163
   Yang XL, 2004, BIOCHEM BIOPH RES CO, V317, P1045, DOI 10.1016/j.bbrc.2004.03.152
   Yildiz BO, 2004, P NATL ACAD SCI USA, V101, P10434, DOI 10.1073/pnas.0403465101
   Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179
   Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873
   Zvonic S, 2007, J BONE MINER RES, V22, P357, DOI 10.1359/jbmr.061114
NR 108
TC 12
Z9 14
U1 1
U2 16
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0161-9152
EI 1574-4647
J9 AGE
JI Age
PD JUN
PY 2013
VL 35
IS 3
BP 533
EP 547
DI 10.1007/s11357-012-9389-7
PG 15
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 133XL
UT WOS:000318174100002
PM 22411258
OA Green Published
DA 2024-02-19
ER

PT J
AU Li, XP
   Sutherland, S
   Takeda, K
   Fong, GH
   Lee, FS
AF Li, Xiping
   Sutherland, Scott
   Takeda, Kotaro
   Fong, Guo-Hua
   Lee, Frank S.
TI Integrity of the prolyl hydroxylase domain protein 2:erythropoietin
   pathway in aging mice
SO BLOOD CELLS MOLECULES AND DISEASES
LA English
DT Article
DE Erythropoietin; Prolyl hydroxylase domain protein; Hypoxia inducible
   factor; Prolyl hydroxylation; Gene regulation
ID FACTOR-I ACTIVITY; IRON HOMEOSTASIS; PHD2 MUTATION; HYPOXIA; OXYGEN;
   ERYTHROCYTOSIS; AGE; EXPRESSION; ANEMIA; ERYTHROPOIETIN
AB The central transcriptional response to hypoxia is mediated by the prolyl hydroxylase domain protein (PHD):hypoxia inducible factor (HIF) pathway. In this pathway, PHD prolyl hydroxylates and thereby negatively regulates the alpha-subunit of the transcription factor HIF (HIF-alpha). An important HIF target gene is that for erythropoietin (EPO), which controls red cell mass. Recent studies have identified PHD2 as the critical PHD isoform regulating the EPO gene. Other studies have shown that the inducibility of the HIF pathway diminishes as a function of age. Thus, an important question is whether the PHD2:EPO pathway is altered in the aging. Here, we employed a mouse line with a globally-inducible Phd2 conditional knockout allele to examine the integrity of the Phd2:Epo axis in young (six to eight months old) and aging (sixteen to twenty months old) mice. We find that acute global deletion of Phd2 results in a robust erythrocytosis in both young and aging mice, with both age groups showing marked extramedullary hematopoiesis in the spleen. Epo mRNA is dramatically upregulated in the kidney, but not in the liver, in both age groups. Conversely, other Hif targets, including Vegf, Pgk1, and Phd3 are upregulated in the liver but not in the kidney in both age groups. These findings have implications for targeting this pathway in the aging. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Li, Xiping; Sutherland, Scott; Lee, Frank S.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
   [Takeda, Kotaro; Fong, Guo-Hua] Univ Connecticut, Ctr Hlth, Dept Cell Biol, Ctr Vasc Biol, Farmington, CT 06030 USA.
C3 University of Pennsylvania; University of Connecticut
RP Lee, FS (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, 605 Stellar Chance Labs,422 Curie Blvd, Philadelphia, PA 19104 USA.
EM franklee@mail.med.upenn.edu
OI Lee, Frank/0000-0003-2511-1834
FU NIH [R01-CA090261]; University of Pennsylvania Institute of Aging; Roche
   Foundation for Anemia Research (RoFAR)
FX We thank Dr. Celeste Simon and Dr. Michaela Gruber for advice on the
   tamoxifen treatment. This work was supported by NIH grant R01-CA090261,
   a Pilot Project Grant from the University of Pennsylvania Institute of
   Aging, and a grant from the Roche Foundation for Anemia Research
   (RoFAR).
CR Agarwal N, 2008, SEMIN HEMATOL, V45, P267, DOI 10.1053/j.seminhematol.2008.06.007
   Al-Sheikh M, 2008, BLOOD CELL MOL DIS, V40, P160, DOI 10.1016/j.bcmd.2007.07.017
   Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540
   Bosch-Marce M, 2007, CIRC RES, V101, P1310, DOI 10.1161/CIRCRESAHA.107.153346
   Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002
   Bunn HF, 2007, BLOOD, V109, P868, DOI 10.1182/blood-2006-08-019083
   Chang EI, 2007, CIRCULATION, V116, P2818, DOI 10.1161/CIRCULATIONAHA.107.715847
   Di Giulio C, 2005, RESP PHYSIOL NEUROBI, V147, P31, DOI 10.1016/j.resp.2005.01.006
   Eisenstaedt R, 2006, BLOOD REV, V20, P213, DOI 10.1016/j.blre.2005.12.002
   Fandrey J, 2004, AM J PHYSIOL-REG I, V286, pR977, DOI 10.1152/ajpregu.00577.2003
   Frenkel-Denkberg G, 1999, FEBS LETT, V462, P341, DOI 10.1016/S0014-5793(99)01552-5
   GOODNOUGH LT, 1995, J LAB CLIN MED, V126, P57
   Guralnik JM, 2004, BLOOD, V104, P2263, DOI 10.1182/blood-2004-05-1812
   Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001
   Hodges VA, 2007, CRIT REV ONCOL HEMAT, V64, P139, DOI 10.1016/j.critrevonc.2007.06.006
   Hwang ISS, 2007, J GERONTOL A-BIOL, V62, P41, DOI 10.1093/gerona/62.1.41
   Jelkmann W, 2007, EUR J HAEMATOL, V78, P183, DOI 10.1111/j.1600-0609.2007.00818.x
   Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142
   Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009
   Ladroue C, 2008, NEW ENGL J MED, V359, P2685, DOI 10.1056/NEJMoa0806277
   Lee FS, 2008, BLOOD REV, V22, P321, DOI 10.1016/j.blre.2008.04.003
   Lee PL, 2009, ANNU REV PATHOL-MECH, V4, P489, DOI 10.1146/annurev.pathol.4.110807.092205
   Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003
   Minamishima YA, 2008, BLOOD, V111, P3236, DOI 10.1182/blood-2007-10-117812
   Ndubuizu OI, 2009, AM J PHYSIOL-REG I, V297, pR158, DOI 10.1152/ajpregu.90829.2008
   Pappalardi MB, 2008, BIOCHEMISTRY-US, V47, P11165, DOI 10.1021/bi801624f
   Percy MJ, 2008, HAEMATOL-HEMATOL J, V93, P963, DOI 10.3324/haematol.13250
   Percy MJ, 2007, BLOOD, V110, P2193, DOI 10.1182/blood-2007-04-084434
   Percy MJ, 2006, P NATL ACAD SCI USA, V103, P654, DOI 10.1073/pnas.0508423103
   Peyssonnaux C, 2007, J CLIN INVEST, V117, P1926, DOI 10.1172/JCI31370
   Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117
   Rivard A, 2000, J BIOL CHEM, V275, P29643, DOI 10.1074/jbc.M001029200
   Rohrbach S, 2005, BIOGERONTOLOGY, V6, P165, DOI 10.1007/s10522-005-7950-9
   Rohrbach S, 2008, BIOGERONTOLOGY, V9, P169, DOI 10.1007/s10522-008-9126-x
   Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366
   Scortegagna M, 2003, BLOOD, V102, P1634, DOI 10.1182/blood-2003-02-0448
   Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012
   Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949
   Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561
   Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06
   Wrighting DM, 2008, CURR TOP DEV BIOL, V82, P141, DOI 10.1016/S0070-2153(07)00006-3
   Yamashita T, 2008, BLOOD, V112, P1482, DOI 10.1182/blood-2007-11-122648
NR 42
TC 14
Z9 14
U1 0
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1079-9796
EI 1096-0961
J9 BLOOD CELL MOL DIS
JI Blood Cells Mol. Dis.
PD JUN 15
PY 2010
VL 45
IS 1
BP 9
EP 19
DI 10.1016/j.bcmd.2010.03.003
PG 11
WC Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology
GA 607EB
UT WOS:000278480600002
PM 20400342
OA Green Published, Green Accepted
DA 2024-02-19
ER

PT J
AU Yan, YQ
   Salazar, TE
   Dominguez, JM
   Nguyen, DV
   Calzi, SL
   Bhatwadekar, AD
   Qi, XP
   Busik, JV
   Boulton, ME
   Grant, MB
AF Yan, Yuanqing
   Salazar, Tatiana E.
   Dominguez, James M., II
   Nguyen, Dung V.
   Calzi, Sergio Li
   Bhatwadekar, Ashay D.
   Qi, Xiaoping
   Busik, Julia V.
   Boulton, Michael E.
   Grant, Maria B.
TI Dicer Expression Exhibits a Tissue-Specific Diurnal Pattern That Is Lost
   during Aging and in Diabetes
SO PLOS ONE
LA English
DT Article
ID CIRCADIAN-RHYTHMS; ENZYME DICER; MICRORNAS; CLOCK; DELETION; DISRUPTION;
   GENETICS; RELEASE; LIVER; HEART
AB Dysregulation of circadian rhythmicity is identified as a key factor in disease pathogenesis. Circadian rhythmicity is controlled at both a transcriptional and post-transcriptional level suggesting the role of microRNA (miRNA) and double-stranded RNA (dsRNA) in this process. Endonuclease Dicer controls miRNA and dsRNA processing, however the role of Dicer in circadian regulation is not known. Here we demonstrate robust diurnal oscillations of Dicer expression in central and peripheral clock control systems including suprachiasmatic nucleolus (SCN), retina, liver, and bone marrow (BM). The Dicer oscillations were either reduced or phase shifted with aging and Type 2 diabetes. The decrease and phase shift of Dicer expression was associated with a similar decrease and phase shift of miRNAs 146a and 125a-5p and with an increase in toxic Alu RNA. Restoring Dicer levels and the diurnal patterns of Dicer-controlled miRNA and RNA expression may provide new therapeutic strategies for metabolic disease and aging-associated complications.
C1 [Yan, Yuanqing; Salazar, Tatiana E.] Univ Florida, Genet & Genom Grad Program, Gainesville, FL USA.
   [Yan, Yuanqing; Salazar, Tatiana E.; Dominguez, James M., II; Nguyen, Dung V.; Calzi, Sergio Li; Bhatwadekar, Ashay D.; Grant, Maria B.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL USA.
   [Yan, Yuanqing; Salazar, Tatiana E.; Grant, Maria B.] Univ Florida, Genet Inst, Gainesville, FL USA.
   [Qi, Xiaoping; Boulton, Michael E.] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL USA.
   [Busik, Julia V.] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA.
C3 State University System of Florida; University of Florida; State
   University System of Florida; University of Florida; State University
   System of Florida; University of Florida; State University System of
   Florida; University of Florida; Michigan State University
RP Busik, JV (corresponding author), Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA.
EM grantma@ufl.edu
RI Busik, Julia V/A-2698-2010; Bhatwadekar, Ashay/AAT-5933-2020
OI Busik, Julia V/0000-0003-3453-7124; Salazar, Tatiana/0009-0006-9315-1685
FU National Institutes of Health (NIH) [EY007739, EY012601, DK090730-02,
   U01HL087366, EY018358]
FX These studies were partially supported by National Institutes of Health
   (NIH) - EY007739, EY012601, DK090730-02, and U01HL087366 to MBG and
   EY018358 to MEB. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Babak T, 2004, RNA, V10, P1813, DOI 10.1261/rna.7119904
   Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253
   Boon RA, 2013, NATURE, V495, P107, DOI 10.1038/nature11919
   Brown SA, 2011, AGING-US, V3, P813, DOI 10.18632/aging.100366
   Busik JV, 2009, J EXP MED, V206, P2897, DOI 10.1084/jem.20090889
   Caballero S, 2007, DIABETES, V56, P960, DOI 10.2337/db06-1254
   Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105
   Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017
   Debono M, 2013, CLIN ENDOCRINOL, V78, P659, DOI 10.1111/cen.12117
   Fernández-Hernando C, 2013, ARTERIOSCL THROM VAS, V33, P178, DOI 10.1161/ATVBAHA.112.300144
   Frezzetti D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027648
   Froy O, 2011, PHYSIOLOGY, V26, P225, DOI 10.1152/physiol.00012.2011
   Froy O, 2011, CLIN SCI, V120, P65, DOI 10.1042/CS20100327
   Froy O, 2010, ENDOCR REV, V31, P1, DOI 10.1210/er.2009-0014
   Gale JE, 2011, J BIOL RHYTHM, V26, P423, DOI 10.1177/0748730411416341
   Gibson EM, 2009, EXP GERONTOL, V44, P51, DOI 10.1016/j.exger.2008.05.007
   Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107
   Hansen KF, 2011, GENOME MED, V3, DOI 10.1186/gm224
   Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102
   Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103
   Hazra S, 2012, DIABETES, V61, P3270, DOI 10.2337/db11-1596
   Ho JJD, 2012, J BIOL CHEM, V287, P29003, DOI 10.1074/jbc.M112.373365
   Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936
   Iyer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044789
   Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830
   Kawase-Koga Y, 2009, DEV DYNAM, V238, P2800, DOI 10.1002/dvdy.22109
   Kojima S, 2011, J CELL SCI, V124, P311, DOI 10.1242/jcs.065771
   Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208
   Korhonen HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024821
   Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6
   Leproult R, 2010, ENDOCR DEV, V17, P11, DOI 10.1159/000262524
   Li Calzi S, 2010, EPMA J, V1, P88, DOI 10.1007/s13167-010-0011-8
   Lu FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004144
   Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355
   Mehta N, 2013, J MOL BIOL, V425, P3609, DOI 10.1016/j.jmb.2012.10.022
   Méndez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685
   Morita S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004212
   Nakamura TJ, 2011, J NEUROSCI, V31, P10201, DOI 10.1523/JNEUROSCI.0451-11.2011
   Paddison PJ, 2008, CURR TOP MICROBIOL, V320, P1
   Pegoraro M, 2008, J GENET, V87, P505, DOI 10.1007/s12041-008-0073-8
   Peirson SN, 2006, BIOCHEM BIOPH RES CO, V351, P800, DOI 10.1016/j.bbrc.2006.10.118
   Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965
   Sekine S, 2009, J PATHOL, V219, P365, DOI 10.1002/path.2606
   Sellix MT, 2012, J NEUROSCI, V32, P16193, DOI 10.1523/JNEUROSCI.3559-12.2012
   Sequeira-Lopez MLS, 2010, J AM SOC NEPHROL, V21, P460, DOI 10.1681/ASN.2009090964
   Shende VR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022586
   Starega-Roslan J, 2011, CELL MOL LIFE SCI, V68, P2859, DOI 10.1007/s00018-011-0726-2
   Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430
   Tao JF, 2011, J NEUROSCI, V31, P8306, DOI 10.1523/JNEUROSCI.0567-11.2011
   Wei QQ, 2010, J AM SOC NEPHROL, V21, P756, DOI 10.1681/ASN.2009070718
   Yamazaki S, 2002, P NATL ACAD SCI USA, V99, P10801, DOI 10.1073/pnas.152318499
   Yang M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-83
   Zhang L, 2010, STEM CELLS, V28, P1260, DOI 10.1002/stem.455
NR 53
TC 40
Z9 43
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 7
PY 2013
VL 8
IS 11
AR e80029
DI 10.1371/journal.pone.0080029
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 254KD
UT WOS:000327162900059
PM 24244599
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU LEE, CY
   HWANG, JH
   LEE, YS
   CHO, KS
AF LEE, CY
   HWANG, JH
   LEE, YS
   CHO, KS
TI PURIFICATION AND CHARACTERIZATION OF MOUSE-LIVER RHODANESE
SO JOURNAL OF BIOCHEMISTRY AND MOLECULAR BIOLOGY
LA English
DT Article
DE AGING; ENZYME ACTIVITY; MOUSE LIVER; RHODANESE
ID ENZYME; COVALENT; FORMS
AB Rhodanese from mouse liver was purified to near homogeneity by ammonium sulfate precipitation, CM-Sephadex ion exchange, hydroxyapatite and Sephacryl S-200-HR gel filtration chromatographies with a purification of 776 folds. The molecular weight was determined by Sephadex G-150 gel filtration and found to be 34.8 KDa. SDS-PAGE showed molecular weight 34 KDa and two identical subunits splitting by aging for 3 weeks at -70 degrees C the molecular weight of which was 17 KDa. The optimal pH of enzyme activity was 9.4 and the pI value of the enzyme was 6.6. Rhodanese showed the optimal reaction temperature of 25 degrees C and near linear increasing pattern until 10 min. incubation. K-M values of rhodanese for KCN and Na2S2O3 as substrates were 12.5 mM and 8.3 mM, respectively. Rhodanese activity was inhibited by more than 70% at a concentration of 100 mu M of Ni2+, Zn2+, Cd2+, Hg2+ and CU2+. Other metal ions, such as Mn2+, Mg2+, Ca2+, and Fe2+ showed no effect on rhodanese activity.
C1 HANYANG UNIV, COLL SCI, DEPT BIOCHEM, ANSAN 425791, SOUTH KOREA.
C3 Hanyang University
CR AIRD BA, 1988, BIOCHIM BIOPHYS ACTA, V956, P30, DOI 10.1016/0167-4838(88)90294-4
   BLUMENTHAL KM, 1971, J BIOL CHEM, V246, P2430
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   HOROWITZ P, 1970, J BIOL CHEM, V245, P984
   HOROWITZ PM, 1987, J BIOL CHEM, V262, P8728
   HOROWITZ PM, 1978, ANAL BIOCHEM, V86, P751, DOI 10.1016/0003-2697(78)90803-5
   Lang K, 1933, BIOCHEM Z, V259, P243
   LEININGER KR, 1968, J BIOL CHEM, V243, P1892
   MINTEL R, 1966, J BIOL CHEM, V241, P3386
   OGATA K, 1986, J PROTEIN CHEM, V5, P239, DOI 10.1007/BF01025422
   OGATA K, 1989, J BIOL CHEM, V262, P2718
   PALLINI R, 1987, NEUROLOGY, V37, P1878, DOI 10.1212/WNL.37.12.1878
   PLOEGMAN JH, 1978, NATURE, V273, P124, DOI 10.1038/273124a0
   RUSSELL J, 1978, J BIOL CHEM, V253, P8102
   Sorbo B., 1975, METABOLIC PATHWAYS, VVII, P433
   SORBO BH, 1953, ACTA CHEM SCAND, V7, P1137, DOI 10.3891/acta.chem.scand.07-1137
   SORBO BH, 1953, ACTA CHEM SCAND, V7, P1129, DOI 10.3891/acta.chem.scand.07-1129
   Stokinger H. E., 1981, PATTYS IND HYGIENE A, V2A, P1493
   VALLEE BL, 1972, ANNU REV BIOCHEM, V41, P91, DOI 10.1146/annurev.bi.41.070172.000515
   VOLINI M, 1978, J BIOL CHEM, V253, P7591
   VOLINI M, 1967, J BIOL CHEM, V242, P5520
   WANG SF, 1968, J BIOL CHEM, V243, P5465
   WENG L, 1978, J BIOL CHEM, V253, P8109
   WESTLEY J, 1973, ADV ENZYMOL RAMB, V39, P327
   WESTLEY J, 1959, J BIOL CHEM, V243, P2325
   WESTLEY J, 1959, J BIOL CHEM, V243, P1857
NR 26
TC 14
Z9 16
U1 0
U2 0
PU SPRINGER SINGAPORE PTE LTD
PI SINGAPORE
PA #04-01 CENCON I, 1 TANNERY RD, SINGAPORE 347719, SINGAPORE
SN 1225-8687
J9 J BIOCHEM MOL BIOL
JI J. Biochem. Mol. Biol.
PD MAR 31
PY 1995
VL 28
IS 2
BP 170
EP 176
PG 7
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA QW387
UT WOS:A1995QW38700014
DA 2024-02-19
ER

PT J
AU Carrio, R
   Altman, NH
   Lopez, DM
AF Carrio, Roberto
   Altman, Norman H.
   Lopez, Diana M.
TI Downregulation of interleukin-7 and hepatocyte growth factor in the
   thymic microenvironment is associated with thymus involution in
   tumor-bearing mice
SO CANCER IMMUNOLOGY IMMUNOTHERAPY
LA English
DT Article
DE Tumor-bearing mice; IL-7; Hepatocyte growth factor; Vascular endothelial
   growth factor; Thymus
ID T-CELL DEVELOPMENT; MAMMARY-TUMOR; MARROW-TRANSPLANTATION; TISSUE
   DISTRIBUTION; HYBRID CYTOKINE; EXPRESSION; IL-7; RECONSTITUTION;
   KERATINOCYTES; REGENERATION
AB During mammary tumorigenesis, there is a profound thymic involution associated with severe depletion of the most abundant subset of thymocytes, CD4(+)CD8(+) immature cells, and an early arrest in at least two steps of T cell differentiation. Thymic atrophy that is normally related with aging has been observed in other model systems, including graft-vs-host disease (GVHD) and tumor development. However, the mechanisms involved in this phenomenon remain to be elucidated. Vascular endothelial growth factor (VEGF) has been associated with thymic involution, when expressed at high levels systemically. In thymuses of D1-DMBA-3 tumor-bearing mice, this growth factor is diminished relative to the level of normal thymuses. Interestingly, the expression of hepatocyte growth factor (HGF), which has been associated with proliferation, cell survival, angiogenesis and B-cell differentiation, is profoundly down-regulated in thymuses of tumor bearers. In parallel, IL-7 and IL-15 mRNA, crucial cytokines involved in thymocytes development and cellular homeostasis, respectively, are also down-regulated in the thymuses of tumor hosts as compared to those of normal mice. Injection of HGF into mice implanted with mammary tumors resulted in normalization of thymic volume and levels of VEGF, IL-7 and IL-15. While, injections of IL-7 partially restored the thymic involution observed in the thymuses of tumor-bearing mice, injection of IL-15 did not have any significant effects. Our data suggest that the downregulation of HGF and IL-7 may play an important role in the thymic involution observed in tumor-bearing hosts.
C1 [Carrio, Roberto; Lopez, Diana M.] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33101 USA.
   [Altman, Norman H.] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA.
C3 University of Miami; University of Miami
RP Lopez, DM (corresponding author), Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, POB 016960, Miami, FL 33101 USA.
EM dlopez@med.miami.edu
OI Carrio, Roberto/0000-0001-5527-8403
FU National Institutes of Health [RO1 CA25583]
FX The authors would like to thank to Dr. Howard T. Petrie for giving us
   his unpublished data cited in this paper as a personal communication. We
   thank Mantley Dorsey, Jr. for his technical assistance in the tumor
   implantation procedures and Dan Ilkovitch and Lynn Herbert for the
   helpful comments and discussions in preparing the manuscript. We thank
   Dr. Thomas R. Malek and Dr. Becky Adkins for critical reading of this
   manuscript. This research was supported by National Institutes of Health
   Grant RO1 CA25583.
CR Adkins B, 2000, J IMMUNOL, V164, P5635, DOI 10.4049/jimmunol.164.11.5635
   AHERNE WA, 1980, CELL TISSUE KINET, V13, P485, DOI 10.1111/j.1365-2184.1980.tb00489.x
   Anderson G, 2000, SEMIN IMMUNOL, V12, P457, DOI 10.1006/smim.2000.0260
   Aspinall R, 2000, J CLIN IMMUNOL, V20, P250, DOI 10.1023/A:1006611518223
   Boyd E, 1932, AM J DIS CHILD, V43, P1162
   CALDERON C, 1994, J EXP MED, V180, P945, DOI 10.1084/jem.180.3.945
   Carrio R, 2004, J IMMUNOL, V172, P7315, DOI 10.4049/jimmunol.172.12.7315
   Carrio R, 1996, AM J PATHOL, V149, P2133
   Carrio R, 2007, EUR J IMMUNOL, V37, P3078, DOI 10.1002/eji.200737585
   Carrio R, 2009, INT J MOL MED, V23, P89, DOI 10.3892/ijmm_00000105
   FU Y, 1989, In Vivo (Attiki), V3, P1
   FU YX, 1989, J IMMUNOL, V143, P4300
   FU YX, 1990, CANCER RES, V50, P227
   Gill J, 2003, IMMUNOL REV, V195, P28, DOI 10.1034/j.1600-065X.2003.00077.x
   Gille J, 1998, J INVEST DERMATOL, V111, P1160, DOI 10.1046/j.1523-1747.1998.00418.x
   Hadden JW, 1998, ANN NY ACAD SCI, V840, P352, DOI 10.1111/j.1749-6632.1998.tb09574.x
   Haynes BF, 2000, ANNU REV IMMUNOL, V18, P529, DOI 10.1146/annurev.immunol.18.1.529
   Huang YH, 2007, BLOOD, V110, P624, DOI 10.1182/blood-2007-01-065714
   Imado T, 2004, BLOOD, V104, P1542, DOI 10.1182/blood-2003-12-4309
   Jin HL, 2004, J IMMUNOL, V173, P657, DOI 10.4049/jimmunol.173.1.657
   Ladi E, 2006, NAT IMMUNOL, V7, P338, DOI 10.1038/ni1323
   Lai LJ, 2006, BLOOD, V107, P1776, DOI 10.1182/blood-2005-08-3470
   Lai LJ, 2001, J IMMUNOL, V167, P3550, DOI 10.4049/jimmunol.167.7.3550
   LAPP WS, 1985, IMMUNOL REV, V88, P107, DOI 10.1111/j.1600-065X.1985.tb01155.x
   Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033
   LOPEZ DM, 1991, CANCER INVEST, V9, P643, DOI 10.3109/07357909109039876
   Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727
   MEDINA D, 1969, J NATL CANCER I, V42, P303
   Metcalf D, 1967, Clin Exp Immunol, V2, P109
   Min H, 2006, CLIN IMMUNOL, V118, P117, DOI 10.1016/j.clim.2005.08.015
   MIYAZAWA K, 1989, BIOCHEM BIOPH RES CO, V163, P967, DOI 10.1016/0006-291X(89)92316-4
   Montecino-Rodriquez E, 2005, SEMIN IMMUNOL, V17, P356, DOI 10.1016/j.smim.2005.05.006
   Ohm JE, 2003, BLOOD, V101, P4878, DOI 10.1182/blood-2002-07-1956
   Osaka G, 1996, J PHARM SCI, V85, P612, DOI 10.1021/js9504494
   Owen JL, 2003, J IMMUNOL, V171, P4340, DOI 10.4049/jimmunol.171.8.4340
   Portman RJ, 2000, PEDIATR NEPHROL, V15, P2, DOI 10.1007/s004670000435
   Sun QL, 2002, ANTICANCER RES, V22, P91
   Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781
   Taub DD, 2005, IMMUNOL REV, V205, P72, DOI 10.1111/j.0105-2896.2005.00275.x
   Van Belle E, 1998, CIRCULATION, V97, P381
   WATSON GA, 1991, J LEUKOCYTE BIOL, V49, P126, DOI 10.1002/jlb.49.2.126
   Wojta J, 1999, LAB INVEST, V79, P427
   Yang J, 2001, GENE THER, V8, P1470, DOI 10.1038/sj.gt.3301545
   Zamisch M, 2005, J IMMUNOL, V174, P60, DOI 10.4049/jimmunol.174.1.60
   ZARNEGAR R, 1995, J CELL BIOL, V129, P1177, DOI 10.1083/jcb.129.5.1177
NR 45
TC 17
Z9 22
U1 0
U2 8
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0340-7004
EI 1432-0851
J9 CANCER IMMUNOL IMMUN
JI Cancer Immunol. Immunother.
PD DEC
PY 2009
VL 58
IS 12
BP 2059
EP 2072
DI 10.1007/s00262-009-0714-7
PG 14
WC Oncology; Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Immunology
GA 498UE
UT WOS:000270168800017
PM 19421751
DA 2024-02-19
ER

PT J
AU Vinué, A
   Andrés-Blasco, I
   Herrero-Cervera, A
   Piqueras, L
   Andrés, V
   Burks, DJ
   Sanz, MJ
   González-Navarro, H
AF Vinue, Angela
   Andres-Blasco, Irene
   Herrero-Cervera, Andrea
   Piqueras, Laura
   Andres, Vicente
   Burks, Deborah J.
   Jesus Sanz, Maria
   Gonzalez-Navarro, Herminia
TI <i>Ink4</i>/<i>Arf</i> locus restores glucose tolerance and insulin
   sensitivity by reducing hepatic steatosis and inflammation in mice with
   impaired IRS2-dependent signalling
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE CDKN2A/2B; Diabetes; Insulin resistance; Inflammation; Steatosis;
   Macrophage
ID GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; METABOLIC SYNDROME;
   FATTY LIVER; RESISTANCE; IRS-2; ATHEROSCLEROSIS; SUSCEPTIBILITY;
   MACROPHAGE; RECEPTOR
AB Single nucleotide polymorphisms near the Ink4/Arf locus have been associated with type-2 diabetes mellitus. Previous studies indicate a protective role of the locus in the carbohydrate metabolism derangement associated with ageing in wild-type mice. The present study demonstrates that the increased Ink4/Arf locus expression in 1-year-old mice, partially-deficient for the insulin receptor substrate (IRS)2 (Irs2 +/-SuperInk4/Arf mice) ameliorates hepatic steatosis, inflammation and insulin resistance. Irs2 +/-SuperInk4/Arf mice displayed improved glucose tolerance and insulin sensitivity compared with Irs2 +/- mice which were glucose intolerant and insulin resistant compared with age-matched wild-type mice. These changes in Irs2 +/- mice were accompanied by enhanced hepatic steatosis, proinflammatory macrophage phenotype, increased Ly6C(hi)-monocyte percentage, T-lymphocyte activation and MCP1 and TNF-alpha cytokine levels. In Irs2 +/- SuperInk4/Arf mice, steatosis and inflammatory parameters were markedly reduced and similar to those of wild-type counterparts. In vivo insulin signalling also revealed reduced activation of the IRS/ART-dependent signalling in Irs2 mice. This was restored upon increased locus expression in Irs2 +/- SuperInk4/Arf mice which display similar activation levels as those for wild-type mice. In vivo treatment of Irs2 +/- SuperInk4/Arf mice with TNF-alpha diminished insulin canonical IRS/AKT-signalling and enhanced the stress SAPMNK-phosphoSer307IRS1-pathway suggesting that cytokine levels might potentially affect glucose homeostasis through changes in these insulin-signalling pathways. Altogether, these results indicate that enhanced Ink4/Arf locus expression restores glucose homeostasis and that this is associated with diminished hepatic steatosis and inflammation in mice with insulin resistance. Therefore, pharmacological interventions targeted to modulate the Ink4/Arf locus expression could be a tentative therapeutic approach to alleviate the inflammation associated with insulin resistance. Published by Elsevier B.V.
C1 [Vinue, Angela; Andres-Blasco, Irene; Herrero-Cervera, Andrea; Piqueras, Laura; Jesus Sanz, Maria; Gonzalez-Navarro, Herminia] Hlth Res Inst INCLIVA, Valencia 46010, Spain.
   [Andres, Vicente] CNIC, Dept Atherothrombosis Imaging & Epidemiol, Madrid 28029, Spain.
   [Burks, Deborah J.] CIPF, Valencia 46012, Spain.
   [Burks, Deborah J.; Gonzalez-Navarro, Herminia] CIBERDEM, Madrid, Spain.
   [Jesus Sanz, Maria] Univ Valencia, Dept Farmacol, Valencia 46010, Spain.
C3 Centro Nacional de Investigaciones Cardiovasculares (CNIC); Prince
   Felipe Research Center; CIBER - Centro de Investigacion Biomedica en
   Red; CIBERDEM; University of Valencia
RP González-Navarro, H (corresponding author), Hlth Res Inst INCLIVA, Avd Menendez Pelayo 4, Valencia 46010, Spain.
EM gonzaleh@uv.es
RI Andres, Vicente/I-6440-2014
OI Andres, Vicente/0000-0002-0125-7209; PIQUERAS,
   LAURA/0000-0001-8010-5168; , Andrea/0000-0001-6490-6504; Sanz, Maria
   Jesus/0000-0002-8885-294X; Gonzalez-Navarro,
   Herminia/0000-0001-6883-3808
FU Carlos III Health Institute [FIS: PI-CP10/00555, PI13/00834,
   RD12/0042/0028]; Spanish Ministry of the Economy and Competitiveness;
   Generalitat Valenciana [SAF2011-23777, GVACOMP2014-16]; European
   Regional Development Fund (FEDER); 'Miguel Servet' programme
   [CP10/00555]; Proyecto Paula; CIBERDEM, a Carlos III Health Institute
   initiative; Spanish Ministry of Economy and Competitiveness; Pro-CNIC
   Foundation
FX This study was supported by grants from the Carlos III Health Institute
   (FIS: PI-CP10/00555 and PI13/00834 to H.G.-N.; and RD12/0042/0028 to
   V.A.), from the Spanish Ministry of the Economy and Competitiveness and
   from the Generalitat Valenciana (SAF2011-23777 and GVACOMP2014-16,
   respectively, to MJS) and from the European Regional Development Fund
   (FEDER). H.G.-N. is an investigator from the 'Miguel Servet' programme
   (CP10/00555). I.A-B. and A.V. received salary support from Proyecto
   Paula. This work was also supported by the CIBERDEM, a Carlos III Health
   Institute initiative. The CNIC is supported by the Spanish Ministry of
   Economy and Competitiveness and the Pro-CNIC Foundation.
CR Bochenek G, 2013, HUM MOL GENET, V22, P4516, DOI 10.1093/hmg/ddt299
   Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911
   Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071
   Cunnington MS, 2011, CURR ATHEROSCLER REP, V13, P193, DOI 10.1007/s11883-011-0178-z
   Doria A, 2008, JAMA-J AM MED ASSOC, V300, P2389, DOI 10.1001/jama.2008.649
   El Mkadem SA, 2001, DIABETES, V50, P2164, DOI 10.2337/diabetes.50.9.2164
   Fuentes L, 2011, DIABETOLOGIA, V54, P3150, DOI 10.1007/s00125-011-2324-0
   Gonzalez S, 2006, CELL CYCLE, V5, P1382, DOI 10.4161/cc.5.13.2901
   González-Navarro H, 2008, ARTERIOSCL THROM VAS, V28, P2187, DOI 10.1161/ATVBAHA.108.175299
   González-Navarro H, 2013, AGING CELL, V12, P102, DOI 10.1111/acel.12023
   González-Navarro H, 2010, J AM COLL CARDIOL, V55, P2258, DOI 10.1016/j.jacc.2010.01.026
   Gruben N, 2014, BBA-MOL BASIS DIS, V1842, P2329, DOI 10.1016/j.bbadis.2014.08.004
   Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027
   Hamsten A, 2008, J INTERN MED, V263, P538, DOI 10.1111/j.1365-2796.2008.01958.x
   Hribal ML, 2011, DIABETOLOGIA, V54, P795, DOI 10.1007/s00125-010-2038-8
   Kido Y, 2000, J CLIN INVEST, V105, P199, DOI 10.1172/JCI7917
   Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092
   Kuo CL, 2011, ARTERIOSCL THROM VAS, V31, P2483, DOI 10.1161/ATVBAHA.111.234492
   Lee BC, 2014, BBA-MOL BASIS DIS, V1842, P446, DOI 10.1016/j.bbadis.2013.05.017
   Martínez-Hervás S, 2014, CARDIOVASC RES, V103, P324, DOI 10.1093/cvr/cvu115
   Matheu A, 2004, GENE DEV, V18, P2736, DOI 10.1101/gad.310304
   Matheu A, 2009, AGING CELL, V8, P152, DOI 10.1111/j.1474-9726.2009.00458.x
   Melzer D, 2007, MECH AGEING DEV, V128, P370, DOI 10.1016/j.mad.2007.03.005
   Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091
   Nasu K, 2000, J IMMUNOL, V165, P7246, DOI 10.4049/jimmunol.165.12.7246
   Nio Y, 2012, DIABETOLOGIA, V55, P3350, DOI 10.1007/s00125-012-2710-2
   Norris AW, 2003, J CLIN INVEST, V112, P608, DOI 10.1172/JCI200317305
   Nunn AVW, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-16
   Pello OM, 2011, IMMUNOBIOLOGY, V216, P1172, DOI 10.1016/j.imbio.2011.05.010
   Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345
   Ruchat SM, 2009, ACTA DIABETOL, V46, P217, DOI 10.1007/s00592-008-0080-5
   Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794
   Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358
   Schreyer SA, 1998, J CLIN INVEST, V102, P402, DOI 10.1172/JCI2849
   Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382
   Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241
   Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070
   Stancáková A, 2009, DIABETES, V58, P2129, DOI 10.2337/db09-0117
   Stefan N, 2003, DIABETES, V52, P1544, DOI 10.2337/diabetes.52.6.1544
   Tanti JF, 2009, CURR OPIN PHARMACOL, V9, P753, DOI 10.1016/j.coph.2009.07.004
   Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645
   Vidal A, 2000, GENE, V247, P1, DOI 10.1016/S0378-1119(00)00092-5
   Villuendas G, 2005, HUM REPROD, V20, P3184, DOI 10.1093/humrep/dei205
   Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022
   Withers DJ, 1999, NAT GENET, V23, P32, DOI 10.1038/12631
   Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116
   Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005
   Zambon S, 2009, DIABETES CARE, V32, P153, DOI 10.2337/dc08-1256
   Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364
NR 49
TC 8
Z9 9
U1 0
U2 9
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 1879-260X
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD SEP
PY 2015
VL 1852
IS 9
BP 1729
EP 1742
DI 10.1016/j.bbadis.2015.05.013
PG 14
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA CP5XQ
UT WOS:000359959100005
PM 26022372
OA hybrid
DA 2024-02-19
ER

PT J
AU Zhou, ZY
   Wang, J
   Song, YN
   He, YM
   Zhang, CC
   Liu, CQ
   Zhao, HX
   Dun, YY
   Yuan, D
   Wang, T
AF Zhou, Zhiyong
   Wang, Jiao
   Song, Yanan
   He, Yumin
   Zhang, Changcheng
   Liu, Chaoqi
   Zhao, Haixia
   Dun, Yaoyan
   Yuan, Ding
   Wang, Ting
TI Panax notoginseng saponins attenuate cardiomyocyte apoptosis through
   mitochondrial pathway in natural aging rats
SO PHYTOTHERAPY RESEARCH
LA English
DT Article
DE cardiomyocyte apoptosis; heart aging; mitochondrial function pathway;
   oxidative stress; saponins from Panax notoginseng
ID OXIDATIVE STRESS; HEART-FAILURE; AUTOPHAGY; DYSFUNCTION; DEATH; CELLS;
   LIVER
AB Panax notoginseng saponins (PNS) have been widely used in the cardiovascular system for the treatment of cardiovascular diseases and stroke in China. In this study, we investigated the anti-apoptotic effect of PNS on cardiomyocytes in the natural aging rat and explored the potential mechanisms regarding oxidative stress and mitochondrial function signaling pathways. Male Sprague-Dawley rats were randomly divided into five groups: adult control (3-month old), aging control (24-month old), and different doses of PNS-treated aging rat groups (10, 30, 60 mg/kg/day, orally). After treatment of PNS or saline for 6 months, the effects of PNS on the cardiomyocytes were evaluated. Results showed that PNS significantly improved the morphological changes in myocardium, prevented the increase of cardiomyocyte apoptosis in the aging rats, and improved mitochondrial dysfunction associated aging in a dose-dependent manner. PNS also significantly reversed the down-regulation of FoxO3a and Mn-SOD and up-regulated PGC-1 alpha, LC3 beta, and Beclin-1 levels. Our data demonstrated that during aging, mitochondrial dysfunction caused an increase of oxidative damage, which played a key role in cardiomyocyte apoptosis. PNS exerted an anti-apoptotic effect via attenuating oxidative damage through oxidative stress- and mitochondrial function-related signaling pathways.
C1 [Zhou, Zhiyong; Wang, Jiao; Song, Yanan; He, Yumin; Zhang, Changcheng; Liu, Chaoqi; Zhao, Haixia; Dun, Yaoyan; Wang, Ting] China Three Gorges Univ, Med Coll, 8 Univ Rd, Yichang 443002, Hubei, Peoples R China.
   [Yuan, Ding] China Three Gorges Univ, RENHE Hosp, 410 Yiling Rd, Yichang 443002, Hubei, Peoples R China.
C3 China Three Gorges University; China Three Gorges University
RP Wang, T (corresponding author), China Three Gorges Univ, Med Coll, 8 Univ Rd, Yichang 443002, Hubei, Peoples R China.; Yuan, D (corresponding author), China Three Gorges Univ, RENHE Hosp, 410 Yiling Rd, Yichang 443002, Hubei, Peoples R China.
EM yxyydyd@126.com; tingting0301@126.com
RI zhang, hao/JOJ-7093-2023
FU Open Foundation of Yichang Key Laboratory of ischemic cardiovascular and
   cerebrovascular disease translational medicine (Three Gorges University)
   [2016xnxg201, 2017KXN07 2017KXN07]; National Natural Science Foundation
   of China [31570329, 81273895]
FX Open Foundation of Yichang Key Laboratory of ischemic cardiovascular and
   cerebrovascular disease translational medicine (Three Gorges
   University), Grant/Award Number: No.2016xnxg201, No.2017KXN07 2017KXN07
   and 2016xnxg201; National Natural Science Foundation of China,
   Grant/Award Number: No.31570329 No.81273895
CR Boyle AJ, 2011, EXP GERONTOL, V46, P549, DOI 10.1016/j.exger.2011.02.010
   Centurione L, 2002, MECH AGEING DEV, V123, P341, DOI 10.1016/S0047-6374(01)00378-5
   Chan P, 2002, ACTA PHARMACOL SIN, V23, P1157
   Chen SX, 2011, J ETHNOPHARMACOL, V137, P263, DOI 10.1016/j.jep.2011.05.011
   De Meyer GRY, 2009, BBA-MOL CELL RES, V1793, P1485, DOI 10.1016/j.bbamcr.2008.12.011
   Fan JS, 2012, J ETHNOPHARMACOL, V142, P732, DOI 10.1016/j.jep.2012.05.053
   Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408
   Guo S, 2015, MOL CELL ENDOCRINOL, V412, P85, DOI 10.1016/j.mce.2015.05.034
   Hepple RT, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00211
   Hoshino A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3308
   Kajstura J, 1996, AM J PHYSIOL-HEART C, V271, pH1215, DOI 10.1152/ajpheart.1996.271.3.H1215
   Karamanlidis G, 2011, CIRC-HEART FAIL, V4, P707, DOI 10.1161/CIRCHEARTFAILURE.111.961474
   Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036
   Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023
   Lavandero S, 2013, AUTOPHAGY, V9, P1455, DOI 10.4161/auto.25969
   Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261
   Luo SS, 2016, FREE RADICAL BIO MED, V92, P1, DOI 10.1016/j.freeradbiomed.2015.12.026
   Misra MK, 2009, MED SCI MONITOR, V15, pRA209
   North BJ, 2012, CIRC RES, V110, P1097, DOI 10.1161/CIRCRESAHA.111.246876
   Qi XF, 2015, J MOL CELL CARDIOL, V81, P114, DOI 10.1016/j.yjmcc.2015.01.022
   Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194
   Silva-Palacios A, 2016, AGEING RES REV, V26, P81, DOI 10.1016/j.arr.2015.12.005
   Taneike M, 2010, AUTOPHAGY, V6, P600, DOI 10.4161/auto.6.5.11947
   Toblli JE, 2016, INT J CARDIOL, V212, P84, DOI 10.1016/j.ijcard.2016.03.039
   Tocchi A, 2015, BBA-BIOENERGETICS, V1847, P1424, DOI 10.1016/j.bbabio.2015.07.009
   Tsutsui H, 2009, CARDIOVASC RES, V81, P449, DOI 10.1093/cvr/cvn280
   Wohlgemuth SE, 2007, REJUV RES, V10, P281, DOI 10.1089/rej.2006.0535
   Wohlgemuth SE, 2014, J MOL CELL CARDIOL, V71, P62, DOI 10.1016/j.yjmcc.2014.03.007
   陈军, 2002, [中草药, Chinese Traditional and Herbal Drugs], V33, P640
NR 29
TC 32
Z9 36
U1 2
U2 26
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0951-418X
EI 1099-1573
J9 PHYTOTHER RES
JI Phytother. Res.
PD FEB
PY 2018
VL 32
IS 2
BP 243
EP 250
DI 10.1002/ptr.5961
PG 8
WC Chemistry, Medicinal; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA FV0YI
UT WOS:000424287300005
PM 29130614
DA 2024-02-19
ER

PT J
AU Gusarov, I
   Nudler, E
AF Gusarov, Ivan
   Nudler, Evgeny
TI Glycogen at the Crossroad of Stress Resistance, Energy Maintenance, and
   Pathophysiology of Aging
SO BIOESSAYS
LA English
DT Article
DE aging; AMPK; glucose; glutathione; glycogen; oxidative stress
ID ACTIVATED PROTEIN-KINASE; METABOLIC LIVER-DISEASE; OXIDATIVE STRESS;
   LIFE-SPAN; CAENORHABDITIS-ELEGANS; SUPEROXIDE-DISMUTASE;
   STORAGE-DISEASE; HISTOPATHOLOGIC APPROACH; LIPID-METABOLISM; GLYCEMIC
   INDEX
AB Glycogen is synthesized and stored to maintain postprandial blood glucose homeostasis and to ensure an uninterrupted energy supply between meals. Although the regulation of glycogen turnover has been well studied, the effects of glycogen on aging and disease development have been largely unexplored. In Caenorhabditis elegans fed a high sugar diet, glycogen potentiates resistance to oxidants, but paradoxically, shortens lifespan. Depletion of glycogen by oxidants or inhibition of glycogen synthesis extends the lifespan of worms by an AMPK-dependent mechanism. Thus, glycogen is not merely an inert storage molecule, but also an active regulator of energy balance and aging. Its depletion by oxidants may be beneficial in the treatment of hyperglycemia and glycogen-related diseases.
C1 [Gusarov, Ivan; Nudler, Evgeny] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA.
   [Nudler, Evgeny] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA.
C3 New York University; New York University; Howard Hughes Medical
   Institute
RP Nudler, E (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA.; Nudler, E (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA.
EM evgeny.nudler@nyumc.org
RI Gusarov, Ivan/AAJ-6282-2020
OI Nudler, Evgeny/0000-0002-8811-3071
FU Blavatnik Family Foundation; Howard Hughes Medical Institute
FX The authors thank Timur Artemev for his contribution. This work was
   supported by the Blavatnik Family Foundation and Howard Hughes Medical
   Institute (E.N.).
CR Alexandre Benedetto T. B., 2017, BIORXIV
   Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404
   Aschenbach WG, 2002, DIABETES, V51, P567, DOI 10.2337/diabetes.51.3.567
   Aston LM, 2006, P NUTR SOC, V65, P125, DOI 10.1079/PNS2005485
   Bandsma RHJ, 2002, EUR J PEDIATR, V161, pS65, DOI 10.1007/s00431-002-1007-8
   Bansal A, 2015, P NATL ACAD SCI USA, V112, pE277, DOI 10.1073/pnas.1412192112
   Batchuluun B, 2014, ATHEROSCLEROSIS, V232, P156, DOI 10.1016/j.atherosclerosis.2013.10.025
   Blair AS, 1999, J BIOL CHEM, V274, P36293, DOI 10.1074/jbc.274.51.36293
   Brose Stephen A, 2016, Front Neurosci, V10, P546
   BUS JS, 1984, ENVIRON HEALTH PERSP, V55, P37, DOI 10.2307/3429690
   Chevion S, 2003, P NATL ACAD SCI USA, V100, P5119, DOI 10.1073/pnas.0831097100
   Depuydt G, 2014, J PROTEOME RES, V13, P1938, DOI 10.1021/pr401081b
   Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083
   Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039
   Floettmann E, 2010, TOXICOL PATHOL, V38, P393, DOI 10.1177/0192623310362707
   Forman HJ, 2009, MOL ASPECTS MED, V30, P1, DOI 10.1016/j.mam.2008.08.006
   Frazier HN, 2009, CURR BIOL, V19, P859, DOI 10.1016/j.cub.2009.03.066
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]
   Garcia D, 2017, MOL CELL, V66, P789, DOI 10.1016/j.molcel.2017.05.032
   Gögüs S, 2002, PEDIATR DEVEL PATHOL, V5, P299, DOI 10.1007/s10024-001-0139-6
   Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047
   Gusarov I, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15868
   Hicks J, 2011, ULTRASTRUCT PATHOL, V35, P183, DOI 10.3109/01913123.2011.601404
   HINSON JA, 1983, BIOCHEM PHARMACOL, V32, P1979, DOI 10.1016/0006-2952(83)90415-X
   Hirst J, 2008, BIOCHEM SOC T, V36, P976, DOI 10.1042/BST0360976
   Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385
   Hudson ER, 2003, CURR BIOL, V13, P861, DOI 10.1016/S0960-9822(03)00249-5
   Hunt PR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021922
   Hwang AB, 2014, P NATL ACAD SCI USA, V111, pE4458, DOI 10.1073/pnas.1411199111
   Jevon GP, 1998, PEDIATR DEVEL PATHOL, V1, P261, DOI 10.1007/s100249900038
   JEVON GP, 1994, PEDIATR PATHOL, V14, P709, DOI 10.3109/15513819409023343
   Jevon GP, 1998, PEDIATR DEVEL PATHOL, V1, P179, DOI 10.1007/s100249900026
   Joseph AM, 2016, J PHYSIOL-LONDON, V594, P5105, DOI 10.1113/JP270659
   Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003
   Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482
   Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472
   Lee D, 2015, GENE DEV, V29, P2490, DOI 10.1101/gad.266304.115
   Lee SJ, 2009, CELL METAB, V10, P379, DOI 10.1016/j.cmet.2009.10.003
   Luptak I, 2007, J CLIN INVEST, V117, P1432, DOI 10.1172/JCI30658
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Mankowski RT, 2015, MED SCI SPORT EXER, V47, P1857, DOI 10.1249/MSS.0000000000000620
   McBride A, 2009, CELL METAB, V9, P23, DOI 10.1016/j.cmet.2008.11.008
   Mlekusch W, 1996, MECH AGEING DEV, V92, P43, DOI 10.1016/S0047-6374(96)01801-5
   Nomura T, 2010, GENES NUTR, V5, P17, DOI 10.1007/s12263-009-0157-y
   Otaegui PJ, 2000, HUM GENE THER, V11, P1543, DOI 10.1089/10430340050083270
   Pang SS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6048
   Perry RJ, 2015, SCIENCE, V347, P1253, DOI 10.1126/science.aaa0672
   Quagliaro L, 2003, DIABETES, V52, P2795, DOI 10.2337/diabetes.52.11.2795
   Ralser M., 2007, J BIOL, V6, P10, DOI DOI 10.1186/jbiol61
   Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014
   Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416
   Romero-Aristizabal C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6020
   Rossetti L, 2000, ENDOCRINOLOGY, V141, P1922, DOI 10.1210/en.141.6.1922
   Ruff JS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3245
   Schlotterer A, 2009, DIABETES, V58, P2450, DOI 10.2337/db09-0567
   Schmeisser S, 2013, AGING CELL, V12, P508, DOI 10.1111/acel.12076
   Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011
   Sciarretta S, 2015, CLIN SCI, V128, P387, DOI 10.1042/CS20140336
   Seo Y, 2018, P NATL ACAD SCI USA, V115, pE2791, DOI 10.1073/pnas.1714178115
   Sindhu RK, 2004, CLIN EXP HYPERTENS, V26, P43, DOI 10.1081/CEH-120027330
   Stapleton D, 2010, PROTEOMICS, V10, P2320, DOI 10.1002/pmic.200900628
   Steinbacher P, 2015, BIOMOLECULES, V5, P356, DOI 10.3390/biom5020356
   Tangvarasittichai S, 2015, WORLD J DIABETES, V6, P456, DOI 10.4239/wjd.v6.i3.456
   Tauffenberger A, 2012, AGING CELL, V11, P856, DOI 10.1111/j.1474-9726.2012.00855.x
   Van Raamsdonk JM, 2012, P NATL ACAD SCI USA, V109, P5785, DOI 10.1073/pnas.1116158109
   VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605
   Venn BJ, 2007, EUR J CLIN NUTR, V61, pS122, DOI 10.1038/sj.ejcn.1602942
   Weinstein DA, 2006, MOL GENET METAB, V87, P284, DOI 10.1016/j.ymgme.2005.10.006
   WILLIAMSON JR, 1993, DIABETES, V42, P801, DOI 10.2337/diabetes.42.6.801
   Wojtaszewski JFP, 2002, DIABETES, V51, P284, DOI 10.2337/diabetes.51.2.284
   Wojtaszewski JFP, 2003, AM J PHYSIOL-ENDOC M, V284, pE813, DOI 10.1152/ajpendo.00436.2002
   Wu JZ, 2016, DIABET METAB SYND OB, V9, P145, DOI 10.2147/DMSO.S106087
   Yan LJ, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/137919
   Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556
   Yee C, 2014, CELL, V157, P897, DOI 10.1016/j.cell.2014.02.055
NR 75
TC 11
Z9 12
U1 1
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0265-9247
EI 1521-1878
J9 BIOESSAYS
JI Bioessays
PD SEP
PY 2018
VL 40
IS 9
AR 1800033
DI 10.1002/bies.201800033
PG 6
WC Biochemistry & Molecular Biology; Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA GR1VJ
UT WOS:000442340600005
PM 29897131
DA 2024-02-19
ER

PT J
AU Yu, BP
AF Yu, BP
TI Membrane alteration as a basis of aging and the protective effects of
   calorie restriction
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE biological membranes; oxidative stress; lipid peroxidation; calorie
   restriction; mitochondria; reactive aldehydes
ID LIPID-PEROXIDATION; LIFE-SPAN; DIETARY-RESTRICTION; FOOD RESTRICTION;
   MODULATION; AGE; LIVER; DAMAGE; MITOCHONDRIA; RATS
AB As has been experimentally determined, oxidative modification to biological systems can be extensive, although the identification and stochiometric relation of the reactive species that cause these alterations have not been fully elucidated. In this review, arguments are presented to support the notion that the combined effects of membrane lipid peroxidation and its by-products, reactive aldehydes are likely responsible for membrane-associated functional declines during aging. As evidence for a systemic response to overall oxidative stress, the molecular inflammation hypothesis of aging is discussed by considering that the activation of inflammatory genes act as a bridge linking normal aging to pathological processes. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
C1 Univ Texas, Hlth Sci Ctr, Dept Physiol, San Antonio, TX 78284 USA.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio
RP Yu, BP (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Physiol, San Antonio, TX 78284 USA.
EM bpyu@earthlink.net
CR Brand MD, 2003, BIOCHEM J, V376, P741, DOI 10.1042/BJ20030984
   Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2
   Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598
   Cho CG, 2003, EXP GERONTOL, V38, P539, DOI 10.1016/S0531-5565(03)00005-6
   CHOE M, 1995, FREE RADICAL BIO MED, V18, P977, DOI 10.1016/0891-5849(94)00217-8
   Chung HY, 2001, ANN NY ACAD SCI, V928, P327
   Chung HY, 2000, REV CLIN GERONTOL, V10, P207, DOI DOI 10.1017/S0959259800010327
   Cook CI, 1998, MECH AGEING DEV, V102, P1, DOI 10.1016/S0047-6374(98)00005-0
   Crompton M, 2004, AGING CELL, V3, P3, DOI 10.1046/j.1474-9728.2003.00073.x
   Else PL, 2003, CLIN EXP PHARMACOL P, V30, P559, DOI 10.1046/j.1440-1681.2003.03883.x
   Franceschi C, 2003, BIOCHEM SOC T, V31, P457, DOI 10.1042/BST0310457
   Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064
   HEGNER D, 1980, MECH AGEING DEV, V14, P101, DOI 10.1016/0047-6374(80)90109-8
   HEIDRICK ML, 1984, MECH AGEING DEV, V27, P341, DOI 10.1016/0047-6374(84)90057-5
   Hoffmann S, 2004, FREE RADICAL BIO MED, V36, P765, DOI 10.1016/j.freeradbiomed.2003.12.019
   Hulbert AJ, 2004, EXP GERONTOL, V39, P1137, DOI 10.1016/j.exger.2004.04.006
   Hulbert AJ, 2003, J EXP BIOL, V206, P2303, DOI 10.1242/jeb.00399
   Iverson SL, 2004, ARCH BIOCHEM BIOPHYS, V423, P37, DOI 10.1016/j.abb.2003.12.002
   Je JH, 2004, FEBS LETT, V566, P183, DOI 10.1016/j.febslet.2004.04.037
   KIKUGAWA K, 1991, MEMBRANE LIPID OXIDA, V2, P171
   Kim HJ, 2002, MECH AGEING DEV, V123, P1589, DOI 10.1016/S0047-6374(02)00094-5
   Klotz L.-O., 2000, ANTIOXIDANT REDOX RE, P3
   Kristal BS, 1996, J BIOL CHEM, V271, P6033, DOI 10.1074/jbc.271.11.6033
   Kristal BS, 1998, FREE RADICAL BIO MED, V24, P1269, DOI 10.1016/S0891-5849(97)00444-9
   KRISTAL BS, 1994, MODULATION AGING PRO, P1
   LAGANIERE S, 1993, GERONTOLOGY, V39, P7, DOI 10.1159/000213509
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P207, DOI 10.1016/0047-6374(89)90083-3
   Lambert AJ, 2004, AM J PHYSIOL-REG I, V286, pR71, DOI 10.1152/ajpregu.00341.2003
   Lee JY, 2004, EUR J BIOCHEM, V271, P1339, DOI 10.1111/j.1432-1033.2004.04042.x
   Levenson CW, 2004, AGEING RES REV, V3, P251, DOI 10.1016/j.arr.2004.03.001
   LOSCHEN G, 1974, FEBS LETT, V42, P68, DOI 10.1016/0014-5793(74)80281-4
   Lucas DT, 1998, P NATL ACAD SCI USA, V95, P510, DOI 10.1073/pnas.95.2.510
   MATSUO M, 1993, J GERONTOL, V48, pB133, DOI 10.1093/geronj/48.4.B133
   Merry BJ, 2002, INT J BIOCHEM CELL B, V34, P1340, DOI 10.1016/S1357-2725(02)00038-9
   Nisoli E, 2004, BIOCHEM PHARMACOL, V67, P1, DOI 10.1016/j.bcp.2003.10.015
   Pamplona R, 2004, EXP GERONTOL, V39, P725, DOI 10.1016/j.exger.2004.01.006
   Pamplona R, 1998, J LIPID RES, V39, P1989
   Penzo D, 2002, BBA-BIOENERGETICS, V1555, P160, DOI 10.1016/S0005-2728(02)00272-4
   Pepe S, 1999, AM J PHYSIOL-HEART C, V276, pH149, DOI 10.1152/ajpheart.1999.276.1.H149
   Pieri C, 1997, AGE, V20, P71, DOI 10.1007/s11357-997-0007-z
   Porter NA, 1990, Membrane lipid oxidation, VI, P33
   Rabini RA, 2002, EXP GERONTOL, V37, P657, DOI 10.1016/S0531-5565(02)00006-2
   Rasmussen UF, 2003, EXP GERONTOL, V38, P877, DOI 10.1016/S0531-5565(03)00092-5
   Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536
   SCHROEDER F, 1984, NEUROBIOL AGING, V5, P323, DOI 10.1016/0197-4580(84)90010-1
   SHIGENAGA MK, 1994, NATURAL ANTIOXIDANTS, P63
   Sies H, 1997, EXP PHYSIOL, V82, P291, DOI 10.1113/expphysiol.1997.sp004024
   Speakman JR, 2004, AGING CELL, V3, P87, DOI 10.1111/j.1474-9728.2004.00097.x
   Spiteller G, 2002, ANN NY ACAD SCI, V959, P30, DOI 10.1111/j.1749-6632.2002.tb02080.x
   Spiteller G, 2001, EXP GERONTOL, V36, P1425, DOI 10.1016/S0531-5565(01)00131-0
   STADTMAN ER, 1988, J GERONTOL, V43, pB112, DOI 10.1093/geronj/43.5.B112
   Sung B, 2004, J GERONTOL A-BIOL, V59, P997
   TRACY RP, 2003, INT J OBESITY, V3, P29
   Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6
   Vereb G, 2003, P NATL ACAD SCI USA, V100, P8053, DOI 10.1073/pnas.1332550100
   Warner H, 1997, OXYGEN GENE EXPRESSI, P139
   Yu B.P., 1993, FREE RADICALS AGING, P57
   YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139
   Yu BP, 1996, ANN NY ACAD SCI, V786, P1, DOI 10.1111/j.1749-6632.1996.tb39047.x
   Yu BP, 2001, ANN NY ACAD SCI, V928, P39
   Yu BP, 1996, FREE RADICAL BIO MED, V21, P651, DOI 10.1016/0891-5849(96)00162-1
   Yu BP, 2005, AGING INTERVENTIONS AND THERAPIES, P193, DOI 10.1142/9789812701329_0010
   Zou Y, 2003, FASEB J, V17, P320, DOI 10.1096/fj.03-0849fje
   Zs-Nagy I., 1994, MEMBRANE HYPOTHESIS
NR 64
TC 45
Z9 50
U1 0
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD SEP
PY 2005
VL 126
IS 9
BP 1003
EP 1010
DI 10.1016/j.mad.2005.03.020
PG 8
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 956YC
UT WOS:000231335000012
PM 15893361
DA 2024-02-19
ER

PT J
AU Kalandarishvili, F
   Wheeler, KT
AF Kalandarishvili, F
   Wheeler, KT
TI Accumulation of DNA damage in pre- and posthepatectomized liver of aged
   rats
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE DNA damage; DNA repair; pre- and posthepatectomized rat liver; DNA
   damage hypothesis of aging; ionizing radiation; aged Fisher 344 rats
ID REPAIR; CELLS; BREAKS; BRAIN; CHROMATIN; TISSUE; ALKALI; MICE
AB Although the majority of the literature supports the concept that an accumulation of DNA damage or a modification in the DNA structure of postmitotic cells occurs with increasing age, there are also several reports that show no DNA changes in these cells with increasing age. In the study reported here, two components of the DNA damage hypothesis of aging were tested. Young (4-6 months) and old (18-20 month) unirradiated or irradiated, pre- and posthepatectomized male Fisher 344 rats were killed, and the posterior lateral lobe of the liver removed. Single cell/nuclei suspensions were made, and the DNA damage accumulated with age or remaining at various times after irradiation was measured using the alkaline elution technique. The results demonstrate that, 1) DNA damage accumulates in rat liver cells with age, and 2) liver cells repair their radiation-induced DNA damage slower in posthepatectomized, but not prehepatectomized aged rats. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
C1 Wake Forest Univ, Sch Med, Dept Radiol, Winston Salem, NC 27157 USA.
C3 Wake Forest University
RP Wheeler, KT (corresponding author), Wake Forest Univ, Sch Med, Dept Radiol, Med Ctr Blvd, Winston Salem, NC 27157 USA.
FU NCI NIH HHS [CA-45156, CA-12197] Funding Source: Medline
CR Al-Nabulsi I, 1999, RADIAT RES, V151, P188, DOI 10.2307/3579769
   ALEXANDER P, 1957, GERONTOLOGY, V1, P174, DOI 10.1159/000210696
   Alexander P, 1967, Symp Soc Exp Biol, V21, P29
   AlNabulsi I, 1997, RADIAT RES, V148, P568, DOI 10.2307/3579732
   BERGTOLD DS, 1985, MOL BIOL AGING GENE, P23
   BERKOWITZ EM, 1983, J NEUROCHEM, V41, P516, DOI 10.1111/j.1471-4159.1983.tb04769.x
   CESARONE CF, 1979, ANAL BIOCHEM, V100, P188, DOI 10.1016/0003-2697(79)90131-3
   CURTIS HJ, 1966, J GERONTOL, V21, P268, DOI 10.1093/geronj/21.2.268
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   FU CS, 1991, J GERONTOL, V46, pB78, DOI 10.1093/geronj/46.2.B78
   GAUBATZ J, 1979, FED PROC, V38, P1973
   GENZLER HL, 1981, Q REV BIOL, V56, P279
   HIGAMI Y, 1994, LAB INVEST, V71, P650
   Higgins GM, 1931, ARCH PATHOL, V12, P186
   HOLMES GE, 1992, MUTAT RES, V275, P305, DOI 10.1016/0921-8734(92)90034-M
   JABERABOANSARI A, 1989, MECH AGEING DEV, V50, P257, DOI 10.1016/0047-6374(89)90104-8
   JOHNSON R, 1972, NATURE, V240, P412, DOI 10.1038/240412a0
   KHILOBOCK IY, 1983, GERONTOLOGY, V29, P9, DOI 10.1159/000213089
   KOHN KW, 1981, DNA REPAIR LABORATOR, P379
   MEYN RE, 1983, CANCER RES, V43, P5668
   MODAK SP, 1978, EXPERIENTIA, V34, P949
   MULLAART E, 1988, MECH AGEING DEV, V45, P41, DOI 10.1016/0047-6374(88)90017-6
   MULLAART E, 1990, MUTAT RES, V237, P9, DOI 10.1016/0921-8734(90)90027-O
   PARK JW, 1988, P NATL ACAD SCI USA, V85, P7467, DOI 10.1073/pnas.85.20.7467
   PRICE GB, 1971, SCIENCE, V171, P917, DOI 10.1126/science.171.3974.917
   STCLAIR WH, 1991, EXP CELL RES, V197, P323
   VANANKEREN SC, 1984, BIOPHYS J, V45, P421, DOI 10.1016/S0006-3495(84)84165-X
   Walburg HE., 1975, ADV RADIAT BIOL, V5, P145
   WHEELER KT, 1974, P NATL ACAD SCI USA, V71, P1862, DOI 10.1073/pnas.71.5.1862
   WHEELER KT, 1981, RADIAT RES, V85, P465, DOI 10.2307/3575417
   WHEELER KT, 1983, RADIAT ENVIRON BIOPH, V22, P3, DOI 10.1007/BF01323757
   ZHANG H, 1993, RADIAT RES, V136, P77, DOI 10.2307/3578643
   ZONGZA V, 1979, BIOCHEM J, V179, P291, DOI 10.1042/bj1790291
NR 33
TC 4
Z9 4
U1 0
U2 3
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD OCT 1
PY 1999
VL 110
IS 1-2
BP 25
EP 35
DI 10.1016/S0047-6374(99)00039-1
PG 11
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 249DW
UT WOS:000083318400003
PM 10580689
DA 2024-02-19
ER

PT J
AU Asahina, Y
   Tsuchiya, K
   Tamaki, N
   Hirayama, I
   Tanaka, T
   Sato, M
   Yasui, Y
   Hosokawa, T
   Ueda, K
   Kuzuya, T
   Nakanishi, H
   Itakura, J
   Takahashi, Y
   Kurosaki, M
   Enomoto, N
   Izumi, N
AF Asahina, Yasuhiro
   Tsuchiya, Kaoru
   Tamaki, Nobuharu
   Hirayama, Itsuko
   Tanaka, Tomohiro
   Sato, Mitsuaki
   Yasui, Yutaka
   Hosokawa, Takanori
   Ueda, Ken
   Kuzuya, Teiji
   Nakanishi, Hiroyuki
   Itakura, Jun
   Takahashi, Yuka
   Kurosaki, Masayuki
   Enomoto, Nobuyuki
   Izumi, Namiki
TI Effect of Aging on Risk for Hepatocellular Carcinoma in Chronic
   Hepatitis C Virus Infection
SO HEPATOLOGY
LA English
DT Article
ID SUSTAINED VIROLOGICAL RESPONSE; HCV-RELATED CIRRHOSIS; INTERFERON
   THERAPY; LIVER-DISEASE; CANCER; COFFEE; JAPAN; METAANALYSIS;
   CONSUMPTION; STEATOSIS
AB An increase in the aging population is an impending problem. A large cohort study was carried out to determine the influence of aging and other factors on hepatocarcinogenesis in patients treated with interferon. Biopsy-proven 2547 chronic hepatitis C patients registered at our referral center since 1992 were included. Of these, 2166 were treated with interferon-based therapy. Incidences of hepatocellular carcinoma (HCC) associated with interferon were analyzed by Kaplan-Meier and person-years methods for an average follow-up of 7.5 years. Factors associated with HCC risk were determined by Cox proportional hazard analysis. HCC developed in 177 interferon-treated patients. The risk for HCC depended on age at primary biopsy and increased more than 15-fold after 65 years of age. Even when stratified by stage of fibrosis, the cumulative and annual incidences of HCC were significantly higher in older patients than in younger patients (P < 0.001) at the same stage of fibrosis, except for cirrhosis. Progression of fibrosis over time was significantly accelerated in older patients. The impact of viral eradication on HCC prevention was less significant in older patients than in younger patients. Multivariate analysis confirmed that age, gender, liver fibrosis, liver steatosis, total cholesterol level, fasting blood sugar level, baseline and postinterferon alpha-fetoprotein level, and virological response to interferon were independent risk factors associated with HCC. Aging was the strongest risk factor for a nonvirological response to interferon-based antiviral therapy. Conclusion: Elderly patients are at a higher risk for HCC. Hepatitis C viral eradication had a smaller effect on hepatocarcinogenesis in older patients. Patients should therefore be identified at an earlier age and treatment should be initiated. (HEPATOLOGY 2010;52:518-527)
C1 [Asahina, Yasuhiro; Tsuchiya, Kaoru; Tamaki, Nobuharu; Hirayama, Itsuko; Tanaka, Tomohiro; Sato, Mitsuaki; Yasui, Yutaka; Hosokawa, Takanori; Ueda, Ken; Kuzuya, Teiji; Nakanishi, Hiroyuki; Itakura, Jun; Takahashi, Yuka; Kurosaki, Masayuki; Izumi, Namiki] Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Musashino, Tokyo 1808610, Japan.
   [Sato, Mitsuaki; Enomoto, Nobuyuki] Univ Yamanashi, Fac Med, Dept Internal Med 1, Yamanashi, Japan.
C3 Musashino RedCross Hospital; University of Yamanashi
RP Izumi, N (corresponding author), Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, 1-26-1 Kyonan Cho, Musashino, Tokyo 1808610, Japan.
EM nizumi@musashino.jrc.or.jp
RI Nakanishi, Hiroyuki/AAD-9324-2020; Kuzuya, Teiji/ABG-8786-2021
OI Nakanishi, Hiroyuki/0000-0003-3982-3314; Yasui,
   Yutaka/0000-0002-6117-4990; Tamaki, Nobuharu/0000-0003-4634-6616
CR Bravi F, 2007, HEPATOLOGY, V46, P430, DOI 10.1002/hep.21708
   Bruno S, 2007, HEPATOLOGY, V45, P579, DOI 10.1002/hep.21492
   DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629
   DIBISCEGLIE AM, 1995, SEMIN LIVER DIS, V15, P64, DOI 10.1055/s-2007-1007263
   Freedman ND, 2009, HEPATOLOGY, V50, P1360, DOI 10.1002/hep.23162
   Hamada H, 2002, CANCER, V95, P331, DOI 10.1002/cncr.10662
   Hiraoka T, 2003, INTERVIROLOGY, V46, P171, DOI 10.1159/000071458
   Ikeda K, 1999, HEPATOLOGY, V29, P1124, DOI 10.1002/hep.510290439
   Ikeda K, 2007, ANN INTERN MED, V146, P649, DOI 10.7326/0003-4819-146-9-200705010-00008
   Imai Y, 1998, ANN INTERN MED, V129, P94, DOI 10.7326/0003-4819-129-2-199807150-00005
   Inoue M, 2009, CANCER EPIDEM BIOMAR, V18, P1746, DOI 10.1158/1055-9965.EPI-08-0923
   KIYOSAWA K, 1990, HEPATOLOGY, V12, P671, DOI 10.1002/hep.1840120409
   Koike K, 2005, J GASTROENTEROL, V40, P329, DOI 10.1007/s00535-005-1586-z
   Koike K, 2010, HEPATOL RES, V40, P69, DOI 10.1111/j.1872-034X.2009.00593.x
   Kumar D, 2002, HEPATOLOGY, V36, P1266, DOI 10.1053/jhep.2002.36370
   Larsson SC, 2007, GASTROENTEROLOGY, V132, P1740, DOI 10.1053/j.gastro.2007.03.044
   Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1
   Miki D, 2008, J GASTROENTEROL, V43, P550, DOI 10.1007/s00535-008-2194-5
   Monto A, 2002, HEPATOLOGY, V36, P729, DOI 10.1053/jhep.2002.35064
   Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053
   Ohishi W, 2003, SCAND J GASTROENTERO, V38, P894, DOI 10.1080/00365520310004434
   Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7
   Stroffolini T, 2008, AM J GASTROENTEROL, V103, P1966, DOI 10.1111/j.1572-0241.2008.01912.x
   Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P15584, DOI 10.1073/pnas.242608099
   Tokita H, 2005, J GASTROEN HEPATOL, V20, P752, DOI 10.1111/j.1440-1746.2005.03800.x
   Toyoda H, 2000, J VIRAL HEPATITIS, V7, P414, DOI 10.1046/j.1365-2893.2000.00241.x
   United States Census Bureau, POP PROJ US INT PROJ
   Veldt BJ, 2007, ANN INTERN MED, V147, P677, DOI 10.7326/0003-4819-147-10-200711200-00003
   Yancik R, 2005, CANCER J, V11, P437, DOI 10.1097/00130404-200511000-00002
   Yoshida H, 1999, ANN INTERN MED, V131, P174, DOI 10.7326/0003-4819-131-3-199908030-00003
NR 30
TC 229
Z9 233
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD AUG
PY 2010
VL 52
IS 2
BP 518
EP 527
DI 10.1002/hep.23691
PG 10
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 633OZ
UT WOS:000280513900014
PM 20683951
OA hybrid
DA 2024-02-19
ER

PT J
AU Bajaj, JS
   Duarte-Rojo, A
   Xie, JJ
   Acharya, C
   Wade, JB
   Robles, C
   Thacker, LR
   Flud, C
   Fagan, A
   Garcia-Saenz-de-Sicilia, M
   White, MB
   Kelly, M
   Nguyen, V
   Gavis, EA
   Vargas, HE
AF Bajaj, Jasmohan S.
   Duarte-Rojo, Andres
   Xie, Jesse J.
   Acharya, Chathur
   Wade, James B.
   Robles, Carlos
   Thacker, Leroy R.
   Flud, Christopher
   Fagan, Andrew
   Garcia-Saenz-de-Sicilia, Mauricio
   White, Melanie B.
   Kelly, Megan
   Nguyen, Vy
   Gavis, Edith A.
   Vargas, Hugo E.
TI Minimal Hepatic Encephalopathy and Mild Cognitive Impairment Worsen
   Quality of Life in Elderly Patients With Cirrhosis
SO CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
LA English
DT Article
DE Dementia; Aging; Memory; Daily Function; Transplant Selection
ID LIVER-DISEASE; DIAGNOSIS; HEALTH; ENCEPHALAPP; IMPACT; RBANS
AB BACKGROUND & AIMS: Patients with cirrhosis are growing older. The overlap between minimal hepatic encephalop-athy (MHE) and predementia mild cognitive impairment (MCI) could affect quality of life (QOL). We investigated the performance of elderly patients with cirrhosis on tests for MHE and MCI and their effects on QOL.
   METHODS: We recruited outpatients with cirrhosis (n = 109) and without cirrhosis (controls, n = 100), 65 years or older, at 4 centers (derivation cohort). All study participants were assessed for psychometric hepatic encephalopathy score (PHES), EncephalApp score, and QOL. MCI was tested in patients with cirrhosis using the repeatable battery for assessment of neuropsychological status and assigned to the following groups: unimpaired, MCI only, MHE only, and MCI+MHE. We created adjusted norms to detect MHE using PHES and EncephalApp scores from the controls. Findings were validated using data from a separate cohort of 77 patients with cirrhosis (mean age, 69.49 - 4.36 y; 72% men) at the same study sites.
   RESULTS: Controls were older but were more educated, performed better cognitively, and had better QOL. Among patients with cirrhosis, age, education, model for end-stage liver disease score, EncephalApp score, and QOL were similar, but PHES and repeatable battery for assessment of neuropsychological status differed among sites. In the derivation cohort, the presence of MHE, with or without MCI, was associated with poor QOL, which was lowest in the MCI+MHE group. When we adjusted for age, sex, and education, 49% of patients with cirrhosis had MHE based on the EncephalApp and 8% had MHE based on the PHES. A similar pattern (49% MHE based on EncephalApp and 6% MHE based on PHES) was found in a validation cohort.
   CONCLUSIONS: In a multicenter study of patients with cirrhosis (>65 y) and controls, the presence of MHE, regardless of MCI, was associated with poor cognition and QOL. We created adjusted norms that defined the high sensitivity of EncephalApp for the detection of MHE in older individuals and validated it in a separate cohort.
C1 [Bajaj, Jasmohan S.; Acharya, Chathur; Wade, James B.; Thacker, Leroy R.; Fagan, Andrew; White, Melanie B.; Gavis, Edith A.] Virginia Commonwealth Univ, Med Ctr, Richmond, VA USA.
   [Bajaj, Jasmohan S.; Acharya, Chathur; Fagan, Andrew; White, Melanie B.; Gavis, Edith A.] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA.
   [Duarte-Rojo, Andres; Xie, Jesse J.; Flud, Christopher; Garcia-Saenz-de-Sicilia, Mauricio] Univ Arkansas, Sch Med Sci, Little Rock, AR 72204 USA.
   [Robles, Carlos; Kelly, Megan; Nguyen, Vy; Vargas, Hugo E.] Mayo Clin, Phoenix, AZ USA.
C3 Virginia Commonwealth University; Hunter Holmes McGuire Veterinary
   Affairs Medical Center; University of Arkansas System; University of
   Arkansas Little Rock; University of Arkansas Fayetteville; Mayo Clinic;
   Mayo Clinic Phoenix
RP Bajaj, JS (corresponding author), Virginia Commonwealth Univ, McGuire Vet Affairs Med Ctr, Div Gastroenterol Hepatol & Nutr, Richmond, VA 23249 USA.
EM jasmohan.bajaj@vcuhealth.org
RI Vargas, Hugo E./K-1562-2019; Garcia Saenz de Sicilia,
   Mauricio/J-6550-2014
OI Vargas, Hugo E./0000-0002-7802-688X; wade, james/0000-0003-1759-0337;
   Jesse, Xie/0000-0003-4896-7715; Garcia Saenz de Sicilia,
   Mauricio/0000-0003-0886-5175; Duarte-Rojo, Andres/0000-0002-5377-9295
FU Veterans Affairs Merit Review grants [2I0CX001076, RO1HS025412,
   R21TR002024]
FX Supported in part by Veterans Affairs Merit Review grants 2I0CX001076,
   RO1HS025412, and R21TR002024 (J.S.B.).
CR Ahluwalia V, 2015, HEPATOLOGY
   Ahluwalia V., 2012, Hepatology, V56, p162A
   Allampati S, 2016, AM J GASTROENTEROL, V111, P78, DOI 10.1038/ajg.2015.377
   Amodio P, 2002, AGING CLIN EXP RES, V14, P117, DOI 10.1007/BF03324425
   Arguedas MR, 2003, DIGEST DIS SCI, V48, P1622, DOI 10.1023/A:1024784327783
   Asrani SK, 2019, J HEPATOL, V70, P151, DOI 10.1016/j.jhep.2018.09.014
   Bajaj JS, 2016, SCI REP-UK, V6, DOI 10.1038/srep38481
   Bajaj JS, 2016, LIVER TRANSPLANT, V22, P1319, DOI 10.1002/lt.24521
   Bajaj JS, 2015, CLIN GASTROENTEROL H, V13, P1828, DOI 10.1016/j.cgh.2014.05.011
   Bajaj JS, 2013, HEPATOLOGY, V58, P1122, DOI 10.1002/hep.26309
   Bajaj JS, 2012, LIVER TRANSPLANT, V18, P1179, DOI 10.1002/lt.23484
   BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001
   Blazer DG, 2009, AM J PSYCHIAT, V166, P1162, DOI 10.1176/appi.ajp.2009.09010016
   Butterworth RF, 2003, J HEPATOL, V39, P278, DOI 10.1016/S0168-8278(03)00267-8
   Corrias M, 2014, J CLIN EXP HEPATOL, V4, P89, DOI 10.1016/j.jceh.2013.12.005
   Duarte-Rojo A, 2011, DIGEST DIS SCI, V56, P3014, DOI 10.1007/s10620-011-1684-0
   Duff K, 2010, ARCH CLIN NEUROPSYCH, V25, P429, DOI 10.1093/arclin/acq045
   Goldbecker A, 2013, GUT, V62, P1497, DOI 10.1136/gutjnl-2012-303262
   Kanwal F, 2009, CLIN GASTROENTEROL H, V7, P793, DOI 10.1016/j.cgh.2009.03.013
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Koehler EM, 2012, J HEPATOL, V57, P1305, DOI 10.1016/j.jhep.2012.07.028
   Montagnese S, 2019, DRUGS, V79, P11, DOI 10.1007/s40265-018-1019-y
   Montagnese S, 2015, J CLIN EXP HEPATOL, V5, pS49, DOI 10.1016/j.jceh.2014.06.006
   Mooney S, 2007, ARCH CLIN NEUROPSYCH, V22, P175, DOI 10.1016/j.acn.2006.12.005
   Morgan MY, 2016, METAB BRAIN DIS, V31, P1217, DOI 10.1007/s11011-015-9726-5
   Ortiz M, 2005, J HEPATOL, V42, pS45, DOI 10.1016/j.jhep.2004.11.028
   Perez-Matos MC, 2018, CLIN GASTROENTEROL H, V16, P1836, DOI 10.1016/j.cgh.2018.03.010
   Rakoski MO, 2012, HEPATOLOGY, V55, P184, DOI 10.1002/hep.24616
   Sanford AM, 2017, CLIN GERIATR MED, V33, P325, DOI 10.1016/j.cger.2017.02.005
   Van Belle G., 2002, STAT RULES THUMB
   Vilstrup H, 2014, HEPATOLOGY, V60, P715, DOI 10.1002/hep.27210
   Weissenborn K, 2001, J HEPATOL, V34, P768, DOI 10.1016/S0168-8278(01)00026-5
   Zhang XD, 2014, WORLD J GASTROENTERO, V20, P11262, DOI 10.3748/wjg.v20.i32.11262
NR 33
TC 37
Z9 39
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1542-3565
EI 1542-7714
J9 CLIN GASTROENTEROL H
JI Clin. Gastroenterol. Hepatol.
PD DEC
PY 2020
VL 18
IS 13
BP 3008
EP +
DI 10.1016/j.cgh.2020.03.033
PG 11
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA OR9ZX
UT WOS:000589825300029
PM 32205222
OA Green Accepted
DA 2024-02-19
ER

PT J
AU BROUGHTON, DL
   JAMES, OWF
   ALBERTI, KGMM
   TAYLOR, R
AF BROUGHTON, DL
   JAMES, OWF
   ALBERTI, KGMM
   TAYLOR, R
TI PERIPHERAL AND HEPATIC INSULIN SENSITIVITY IN HEALTHY ELDERLY
   HUMAN-SUBJECTS
SO EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article
DE BODY WEIGHT; EXERCISE TEST; GERONTOLOGY; GLUCOSE TOLERANCE TEST;
   INSULIN; INSULIN RESISTANCE
ID GLUCOSE-INTOLERANCE; DIABETES-MELLITUS; BODY POTASSIUM; AGE; RESISTANCE;
   UNDERESTIMATION; METABOLISM; MEN; SECRETION; CLEARANCE
AB Insulin resistance has been reported in normal ageing but discrepancies between such studies may be related to compounding factors such as body composition and exercise patterns.  We employed a two-step hyperinsulinaemic euglycaemic clamp to assess peripheral and hepatic tissue insulin sensitivity and glucose recycling in 13 elderly (E) and 14 young (Y) healthy subjects controlling for the above factors.  There was no difference in basal hepatic glucose production (E:  2.36 +/- 0.06, Y:  2.47 +/- 0.1 mg kg-1 min-1; P = 0.4).  At step 1 (insulin infusion 15 mU kg-1 h-1) glucose turnover was similar (E:  2.65 +/- 0.13, Y:  2.88 +/- 0.22 mg kg-1 min-1; P = 0.4) but hepatic glucose production was lower in the elderly group (0.20 +/- 0.16 vs 0.64 +/- 0.10 mg kg-1 min-1; P = 0.03).  At step 2 (insulin infusion 50 mU kg-1 h-1) glucose turnover was similar (E:  7.60 +/- 0.24, Y:  8.05 +/- 0.34 mg kg-1 min-1; P = 0.3) and hepatic glucose production was equal but negative (E:  -1.35 +/- 0.18, Y:  -1.34 +/- 0.22 mg kg-1 min-1; P = 0.9).  Glucose recycling did not differ between the groups at any stage.  Similar serum insulin levels were achieved in both groups at each step.  Decreased glucose tolerance was confirmed in E with a higher 2 h blood glucose after an OGTT (5.3 +/- 0.4 vs 4.1 +/- 0.3 mmol l-1; P = 0.03) but incremental insulin response was similar (E:  3236 +/- 289, Y:  3586 +/- 463 mU l-1 min-1; P = 0.5).  We conclude that changes in hepatic tissue insulin sensitivity do not cause the deterioration in glucose tolerance observed with age.  A small reduction in both peripheral tissue insulin sensitivity and late insulin secretion may be responsible.
RP BROUGHTON, DL (corresponding author), UNIV NEWCASTLE UPON TYNE,SCH MED,DEPT MED & GERIATR MED,NEWCASTLE TYNE NE2 4HH,ENGLAND.
CR ANDRES R, 1977, HDB BIOL AGING, P357
   ARGOUD GM, 1987, AM J PHYSIOL, V252, pE606, DOI 10.1152/ajpendo.1987.252.5.E606
   ASTRAND PO, 1976, PROG CARDIOVASC DIS, V19, P51, DOI 10.1016/0033-0620(76)90008-6
   BELL PM, 1986, J CLIN INVEST, V78, P1479, DOI 10.1172/JCI112739
   BODDY K, 1972, J CLIN PATHOL, V25, P512, DOI 10.1136/jcp.25.6.512
   BODDY K, 1973, CLIN SCI, V44, P622, DOI 10.1042/cs0440622
   BROUGHTON DL, 1987, GERONTOLOGY, V33, P357, DOI 10.1159/000212903
   BURRIN JM, 1980, CLIN CHIM ACTA, V106, P45, DOI 10.1016/0009-8981(80)90373-3
   CHEN M, 1985, J CLIN ENDOCR METAB, V60, P13, DOI 10.1210/jcem-60-1-13
   DAVIDSON MB, 1979, METABOLISM, V28, P688, DOI 10.1016/0026-0495(79)90024-6
   DEFRONZO RA, 1979, DIABETES, V28, P1095, DOI 10.2337/diab.28.12.1095
   Diabetes mellitus, 1985, WHO TECHNICAL REPORT, V727
   DONALDSON SM, 1980, ERGONOMICS, V23, P469, DOI 10.1080/00140138008924760
   DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060
   FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908
   FINK RI, 1985, DIABETES, V34, P275, DOI 10.2337/diabetes.34.3.275
   HEDING LG, 1975, DIABETOLOGIA, V11, P541, DOI 10.1007/BF01222104
   JACKSON RA, 1988, DIABETES, V37, P119, DOI 10.2337/diabetes.37.1.119
   JACKSON RA, 1982, J CLIN ENDOCR METAB, V55, P840, DOI 10.1210/jcem-55-5-840
   KALANT N, 1980, J AM GERIATR SOC, V28, P304, DOI 10.1111/j.1532-5415.1980.tb00620.x
   KIMMERLING G, 1977, J AM GERIATR SOC, V25, P349, DOI 10.1111/j.1532-5415.1977.tb00658.x
   KNOX DP, 1984, J AUTOM CHEM, V6, P152, DOI 10.1155/S1463924684000286
   LLOYD B, 1978, CLIN CHEM, V24, P1724
   LONDON ED, 1986, J GERONTOL, V41, P599, DOI 10.1093/geronj/41.5.599
   MCGUIRE EA, 1979, DIABETES, V28, P110, DOI 10.2337/diabetes.28.2.110
   MCMAHON MM, 1989, DIABETES, V38, P97, DOI 10.2337/diabetes.38.1.97
   MINAKER KL, 1982, DIABETES, V31, P851, DOI 10.2337/diabetes.31.10.851
   ORSKOV H, 1968, NATURE, V219, P193, DOI 10.1038/219193b0
   PACINI G, 1988, J AM GERIATR SOC, V36, P317, DOI 10.1111/j.1532-5415.1988.tb02358.x
   REAVEN GM, 1982, DIABETES, V31, P670, DOI 10.2337/diabetes.31.8.670
   ROBERT JJ, 1982, DIABETES, V31, P203, DOI 10.2337/diabetes.31.3.203
   ROSENTHAL M, 1983, DIABETES, V32, P408, DOI 10.2337/diabetes.32.5.408
   ROSENTHAL M, 1982, J AM GERIATR SOC, V30, P562, DOI 10.1111/j.1532-5415.1982.tb05662.x
   ROWE JW, 1983, J CLIN INVEST, V71, P1581, DOI 10.1172/JCI110914
   SOELDNER JS, 1965, DIABETES, V14, P771, DOI 10.2337/diab.14.12.771
   STEELE R, 1956, AM J PHYSIOL, V187, P15, DOI 10.1152/ajplegacy.1956.187.1.15
   YKIJARVINEN H, 1989, DIABETES, V38, P744, DOI 10.2337/diabetes.38.6.744
   ZAWADZKI JK, 1988, DIABETES, V37, P154, DOI 10.2337/diabetes.37.2.154
NR 38
TC 53
Z9 54
U1 0
U2 1
PU BLACKWELL SCIENCE LTD
PI OXFORD
PA OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL
SN 0014-2972
J9 EUR J CLIN INVEST
JI Eur. J. Clin. Invest.
PD FEB
PY 1991
VL 21
IS 1
BP 13
EP 21
DI 10.1111/j.1365-2362.1991.tb01352.x
PG 9
WC Medicine, General & Internal; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine; Research & Experimental Medicine
GA FA830
UT WOS:A1991FA83000003
PM 1907550
DA 2024-02-19
ER

PT J
AU Pascua, P
   Camello-Almaraz, C
   Pozo, MJ
   Martin-Cano, FE
   Vara, E
   Fernández-Tresguerres, JA
   Camello, PJ
AF Pascua, P.
   Camello-Almaraz, C.
   Pozo, M. J.
   Martin-Cano, F. E.
   Vara, E.
   Fernandez-Tresguerres, J. A.
   Camello, P. J.
TI Aging-induced alterations in female rat colon smooth muscle: the
   protective effects of hormonal therapy
SO JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
LA English
DT Article
DE Aging; Colon smooth muscle; Estrogens; Inflammation; Melatonin;
   Oxidative stress
ID PIG URINARY-BLADDER; ENDOTHELIAL DYSFUNCTION; NATURAL ANTIOXIDANTS;
   LIPID-PEROXIDATION; OXIDATIVE STRESS; GROWTH-HORMONE; MELATONIN;
   ESTROGENS; SYSTEM; LIVER
AB Aging is associated to oxidative damage and alterations in inflammatory and apoptotic pathways. Aging impairs secretion of several hormones, including melatonin and estrogens. However, the mechanisms involved in aging of smooth muscle are poorly known. We have studied the changes induced by aging in the colonic smooth muscle layer of female rats and the protective effect of hormonal therapy. We used young, aged, and ovariectomized aged female rats. Two groups of ovariectomized rats (22 months old) were treated either with melatonin or with estrogen for 10 weeks before sacrifice. Aging induced oxidative imbalance, evidenced by H2O2 accumulation, lipid peroxidation, and decreased catalase activity. The oxidative damage was enhanced by ovariectomy. In addition, aged colonic muscle showed enhanced expression of the pro-inflammatory enzyme cyclooxygenase 2. Expression of the activated forms of caspases 3 and 9 was also enhanced in aged colon. Melatonin and estrogen treatment prevented the oxidative damage and the activation of caspases. In conclusion, aging of colonic smooth muscle induces oxidative imbalance and activation of apoptotic and pro-inflammatory pathways. Hormonal therapy has beneficial effects on the oxidative and apoptotic changes associated to aging in this model.
C1 [Camello, P. J.] Fac Vet Sci & Nursing Sch, Dept Physiol, Caceres 10003, Spain.
   [Pascua, P.; Camello-Almaraz, C.; Pozo, M. J.; Martin-Cano, F. E.; Camello, P. J.] Univ Extremadura, Dept Physiol, Sch Nursing, Caceres 10071, Spain.
   [Vara, E.] Univ Complutense Madrid, Dept Biochem, Sch Med, E-28040 Madrid, Spain.
   [Fernandez-Tresguerres, J. A.] Univ Complutense Madrid, Dept Physiol, Sch Med, E-28040 Madrid, Spain.
C3 Universidad de Extremadura; Complutense University of Madrid;
   Complutense University of Madrid
RP Camello, PJ (corresponding author), Fac Vet Sci & Nursing Sch, Dept Physiol, Avda Univ S-N, Caceres 10003, Spain.
EM pcamello@unex.es
RI Camello, Cristina/K-8238-2014; CAMELLO, PEDRO J J/K-8237-2014; Pozo,
   Maria J/K-8277-2014; Cano, Francisco Eduardo Martín/K-1112-2014; Cano,
   Francisco Eduardo Martín/W-8892-2019
OI Camello, Cristina/0000-0003-0882-8497; CAMELLO, PEDRO J
   J/0000-0001-5026-7166; Pozo, Maria J/0000-0002-4137-6798; Cano,
   Francisco Eduardo Martín/0000-0003-4971-4883; 
FU Ministerio de Educacion y Ciencia [BFU2011-24365]; Instituto de Salud
   Carlos III [RETICEF: RD06/0013/0002, RD06/0013/1012]; Junta de
   Extremadura [GR100009]; FEDER
FX The authors thank Purificacion Delgado and Fatima Barriga for technical
   assistance. This work was supported by Ministerio de Educacion y Ciencia
   (BFU2011-24365), Instituto de Salud Carlos III (RETICEF: RD06/0013/0002
   and RD06/0013/1012), Junta de Extremadura (GR100009), and FEDER.
CR Ayres S, 1996, J LAB CLIN MED, V128, P367, DOI 10.1016/S0022-2143(96)80008-4
   Bernard CE, 2009, NEUROGASTROENT MOTIL, V21, P746, DOI 10.1111/j.1365-2982.2008.01245.x
   Bitar KN, 2003, AM J PHYSIOL-GASTR L, V284, pG1, DOI 10.1152/ajpgi.00264.2002
   Camilleri M, 2008, NEUROGASTROENT MOTIL, V20, P185, DOI 10.1111/j.1365-2982.2007.01072.x
   Castillo C, 2005, BIOGERONTOLOGY, V6, P49, DOI 10.1007/s10522-004-7383-x
   CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P471, DOI 10.1016/0735-1097(94)90305-0
   Díaz-Flores M, 1999, LIFE SCI, V65, P2481, DOI 10.1016/S0024-3205(99)00514-7
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Franceschi C, 1997, Aging (Milano), V9, P30
   Gomez-Pinilla PJ, 2008, J PINEAL RES, V44, P416, DOI 10.1111/j.1600-079X.2007.00544.x
   Gomez-Pinilla PJ, 2007, BIOCHEM PHARMACOL, V74, P860, DOI 10.1016/j.bcp.2007.06.037
   Gómez-Pinilla PJ, 2007, AM J PHYSIOL-REG I, V293, pR793, DOI 10.1152/ajpregu.00034.2007
   Gomez-Pinilla PJ, 2006, J PHARMACOL EXP THER, V319, P847, DOI 10.1124/jpet.106.109256
   HARMAN D, 1993, DRUG AGING, V3, P60, DOI 10.2165/00002512-199303010-00006
   Kawagoe J, 2007, ENDOCRINOLOGY, V148, P6092, DOI 10.1210/en.2007-0188
   KAY L, 1994, AGE AGEING, V23, P146, DOI 10.1093/ageing/23.2.146
   Kireev RA, 2007, J PINEAL RES, V42, P64, DOI 10.1111/j.1600-079X.2006.00385.x
   Kireev RA, 2007, BIOGERONTOLOGY, V8, P469, DOI 10.1007/s10522-007-9089-3
   Kireev RA, 2010, BIOGERONTOLOGY, V11, P229, DOI 10.1007/s10522-009-9242-2
   Li M, 2007, J BIOCHEM MOL BIOL, V40, P72
   Lopes GS, 2006, EXP GERONTOL, V41, P55, DOI 10.1016/j.exger.2005.10.004
   LU KH, 1979, BIOL REPROD, V21, P193, DOI 10.1095/biolreprod21.1.193
   Madsen JL, 2004, AGE AGEING, V33, P154, DOI 10.1093/ageing/afh040
   Mukai Y, 2002, ARTERIOSCL THROM VAS, V22, P1445, DOI 10.1161/01.ATV.0000029121.63691.CE
   Ospina JA, 2004, AM J PHYSIOL-HEART C, V286, pH2010, DOI 10.1152/ajpheart.00481.2003
   Pascua P, 2011, J PINEAL RES, V51, P405, DOI 10.1111/j.1600-079X.2011.00904.x
   Peck CJ, 2009, NEUROGASTROENT MOTIL, V21, DOI 10.1111/j.1365-2982.2009.01349.x
   Pfeilschifter J, 2002, ENDOCR REV, V23, P90, DOI 10.1210/er.23.1.90
   Phillips RJ, 2001, J COMP NEUROL, V434, P358, DOI 10.1002/cne.1182
   Pollack M, 2002, ANN NY ACAD SCI, V959, P93, DOI 10.1111/j.1749-6632.2002.tb02086.x
   Pozo MJ, 2010, CURR MED CHEM, V17, P4150
   RECKNAGEL RO, 1984, METHOD ENZYMOL, V105, P331
   SUBBIAH MTR, 1993, J CLIN ENDOCR METAB, V77, P1095, DOI 10.1210/jc.77.4.1095
   SUGIOKA K, 1987, FEBS LETT, V210, P37, DOI 10.1016/0014-5793(87)81293-0
   Touitou Y, 2000, CHRONOBIOL INT, V17, P369, DOI 10.1081/CBI-100101052
   Tresguerres JAF, 2008, J STEROID BIOCHEM, V108, P318, DOI 10.1016/j.jsbmb.2007.09.010
   Valles SL, 2010, BRAIN RES, V1312, P138, DOI 10.1016/j.brainres.2009.11.044
   Viña J, 2003, ANTIOXID REDOX SIGN, V5, P549, DOI 10.1089/152308603770310194
   Vural P, 2005, ANN CLIN BIOCHEM, V42, P220, DOI 10.1258/0004563053857941
   Yagi K, 1997, ACTA BIOCHIM POL, V44, P701, DOI 10.18388/abp.1997_4372
NR 40
TC 5
Z9 6
U1 0
U2 7
PU SERVICIO PUBLICACIONES UNIVERSIDAD NAVARRA
PI PAMPLONA
PA CAMPUS UNIV, CARRETERA DEL SADAR S-N, APARTADO 177, 31080 PAMPLONA,
   SPAIN
SN 1138-7548
J9 J PHYSIOL BIOCHEM
JI J. Physiol. Biochem.
PD JUN
PY 2012
VL 68
IS 2
BP 255
EP 262
DI 10.1007/s13105-011-0138-7
PG 8
WC Biochemistry & Molecular Biology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Physiology
GA 940CG
UT WOS:000303867000011
PM 22167661
DA 2024-02-19
ER

PT J
AU BIN, QH
   GARFINKEL, D
AF BIN, QH
   GARFINKEL, D
TI THE CADMIUM TOXICITY HYPOTHESIS OF AGING - A POSSIBLE EXPLANATION FOR
   THE ZINC-DEFICIENCY HYPOTHESIS OF AGING
SO MEDICAL HYPOTHESES
LA English
DT Article
ID HAMSTER CELLS; RAT-LIVER; DNA; CARCINOGENESIS; INHIBITION; INDUCTION;
   MECHANISM; INVITRO
AB Although cadmium and zinc have similar chemical properties, they affect living organisms diversely: while zinc is an essential element for growth, development and functioning of all living cells, cadmium is a highly toxic material. Cadmium has an extremely long biological half-life and may be considered a cumulative toxin. It has been shown to have sterilizing, teratogenic and carcinogenic effects and most of these effects could be reduced or even prevented by zinc administration.
   An increase in cadmium concentration with age has been proven in various species and in different tissues and these facts led some investigators to the assumption that cadmium accumulation might play an important role in senescense. Zinc essentiality and the lack of a reliable index of intracellular zinc status, formed the rationale for the zinc deficiency hypothesis of aging. This hypothesis suggests a gradual time related zinc deficiency occuring in each living cell, making zinc less available for its metalloenzymes. The sum of all deleterious effects resulting from the distorted function of different zinc enzymes, is later manifested as aging processes (1).
   When cadmium concentration increases, zinc concentration in various tissues decreases. Cadmium may inhibit zinc activities at many stages, interfering with zinc absorption, distribution to different tissues and transport into cells or into several intracellular structures. Therefore, it is reasonable to assume that a slowly developing cadmium toxicity may result in a gradual time related zinc deficiency.
C1 E WOLFSON MED CTR,IL-58100 HOLON,ISRAEL.
   MA WANG DUI SANATORIUM,CHANG SHA 410001,PEOPLES R CHINA.
CR [Anonymous], TRACE ELEMENTS HLTH
   BLAKLEY BR, 1986, J APPL TOXICOL, V6, P425, DOI 10.1002/jat.2550060608
   BURNET FM, 1981, LANCET, V1, P186
   DEGRAEVE N, 1981, MUTAT RES, V86, P115, DOI 10.1016/0165-1110(81)90035-X
   DIPAOLO JA, 1979, CANCER RES, V39, P1008
   FOULKES EC, 1991, TOXICOLOGY, V70, P261, DOI 10.1016/0300-483X(91)90001-H
   FRENIAL JM, 1986, CELL BIOL TOXICOL, V2, P1, DOI 10.1007/BF00117702
   FRIBERG L, 1976, CADMIUM ENV, P59
   GARFINKEL D, 1990, METAL IONS BIOL MED, P57
   GARFINKEL D, 1986, MED HYPOTHESES, V19, P117, DOI 10.1016/0306-9877(86)90053-8
   GIRIDHAR J, 1991, TOXICOLOGY, V70, P185, DOI 10.1016/0300-483X(91)90045-3
   GROTEN JP, 1991, FOOD CHEM TOXICOL, V29, P249, DOI 10.1016/0278-6915(91)90022-Y
   Guille E, 1979, Biol Trace Elem Res, V1, P299, DOI 10.1007/BF02778832
   GUNN SA, 1964, P SOC EXP BIOL MED, V115, P653
   GUNN SA, 1963, J NATL CANCER I, V31, P745
   HARTSFIELD JK, 1992, BIOCHEM MED METAB B, V48, P159, DOI 10.1016/0885-4505(92)90061-3
   HILL CH, 1970, FED PROC, V29, P1474
   JAMALL IS, 1985, TOXICOL APPL PHARM, V80, P33, DOI 10.1016/0041-008X(85)90098-5
   KAJI T, 1993, TOXICOL LETT, V66, P247
   KING JC, 1986, J AM DIET ASSOC, V86, P1523
   KOOOP SJ, 1982, SCIENCE, V217, P837
   KUDO N, 1991, TOXICOLOGY, V68, P133, DOI 10.1016/0300-483X(91)90016-T
   MASSIE HR, 1983, GERONTOLOGY, V29, P226, DOI 10.1159/000213121
   MASSIE HR, 1981, EXP GERONTOL, V16, P337, DOI 10.1016/0531-5565(81)90053-X
   MASSIE HR, 1979, MECH AGEING DEV, V11, P214
   MERALI Z, 1976, BRIT J PHARMACOL, V57, P573, DOI 10.1111/j.1476-5381.1976.tb10387.x
   MEYER SA, 1982, J NUTR, V112, P954, DOI 10.1093/jn/112.5.954
   MITRA RS, 1978, J BACTERIOL, V133, P75, DOI 10.1128/JB.133.1.75-80.1978
   NEWSOME DA, 1988, ARCH OPHTHALMOL-CHIC, V106, P192
   NOCENTINI S, 1987, NUCLEIC ACIDS RES, V15, P4211, DOI 10.1093/nar/15.10.4211
   OCHI T, 1983, MUTAT RES, V111, P69, DOI 10.1016/0027-5107(83)90009-X
   OLDIGES H, 1989, TOXICOL ENVIRON CHEM, V23, P35
   OTSUKA F, 1991, CHEM-BIOL INTERACT, V78, P193, DOI 10.1016/0009-2797(91)90014-X
   Piscator M, 1981, Prog Clin Biol Res, V77, P209
   Rhodes D., 1993, Scientific American, V268, P32
   ROE FJC, 1964, BRIT J CANCER, V18, P674, DOI 10.1038/bjc.1964.77
   STOWE HD, 1972, ARCH PATHOL, V94, P389
   UDOM AO, 1980, BIOCHEM J, V187, P329, DOI 10.1042/bj1870329
   Vorobeeva RS, 1980, GIG SANIT, V10, P22
   WAALKES MP, 1990, METAL IONS BIOL MED, P279
   WAALKES MP, 1989, CANCER RES, V49, P4282
   WAALKES MP, 1991, TOXICOL APPL PHARM, V108, P448, DOI 10.1016/0041-008X(91)90091-R
   1980, NUTR REV, V38, P286
   1981, BRIT MED J, V282, P1098
NR 44
TC 15
Z9 16
U1 1
U2 5
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH, MIDLOTHIAN, SCOTLAND EH1 3AF
SN 0306-9877
J9 MED HYPOTHESES
JI Med. Hypotheses
PD JUN
PY 1994
VL 42
IS 6
BP 380
EP 384
DI 10.1016/0306-9877(94)90157-0
PG 5
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA NV141
UT WOS:A1994NV14100007
PM 7935085
DA 2024-02-19
ER

PT J
AU Al-Bahrani, R
   Tuertcher, D
   Zailaie, S
   Abuetabh, Y
   Nagamori, S
   Zetouni, N
   Bahitham, W
   Sergi, C
AF Al-Bahrani, Redha
   Tuertcher, Dominika
   Zailaie, Samar
   Abuetabh, Yasser
   Nagamori, Seishi
   Zetouni, Nikolas
   Bahitham, Wesam
   Sergi, Consolato
TI Differential SIRT1 Expression in Hepatocellular Carcinomas and
   Cholangiocarcinoma of the Liver
SO ANNALS OF CLINICAL AND LABORATORY SCIENCE
LA English
DT Article
ID ACTIVATING TRANSCRIPTION FACTOR-3; BONE MORPHOGENETIC PROTEINS;
   COLON-CANCER; CALORIE RESTRICTION; TUMOR-SUPPRESSOR; PROSTATE-CANCER;
   BETA-CATENIN; FACTOR ATF3; DNA-DAMAGE; P53
AB Hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) are two major liver malignancies. Although some phenotypic overlap is known, HCC and CCA are usually different with regard to etiology, histology, and prognosis. Gene expression and deacetylase activity of the class III histone deacetylase SIRT1 are up-regulated in cancer cells due to oncogene overexpression or loss of function of tumor suppressor genes. SIRT1 may play a critical role in tumor initiation, progression, and drug resistance by blocking senescence and apoptosis, and promoting cell growth and angiogenesis, but pleiotropic effects (synchronous or metachronous anti-proliferation and anti-apoptotic mechanisms) have been suggested in some cancers. Our aim was to investigate the expression of SIRT1 in liver epithelial malignancies. Thirty carcinomas of the liver, including 16 HCC and 14 CCA cases, were investigated by immunohistochemistry using monoclonal antibodies against SIRT1 and p53. Western blot analysis (WBA) was carried out for expression of SIRT1 in three CCA cell lines, one HCC cell line, and one cell line of Papova-immortalized normal hepatocytes. An expression of SIRT1 was found in 11 of 16 (68.75%) HCC and in 5 of 14 (35.71%) CCA. Moreover, we found an expression of p53 in 8 out of 16 (50%) HCC and 13 out of 14 (92.86%) CCA. WBA showed expression of SIRT1 in all cell lines studied, although a stronger signal was seen in the HCC cell line. Immunohistochemical data did not correlate to clinical stage or other clinical or histopathological parameters. Sirtuin 1 is a phylogenetically-conserved family of deacetylases and our data seem to indicate that (1) pleiotropic effects may be present in hepatic epithelial malignancies, and (2) there is no specificity of SIRT1 for either HCC or CCA.
C1 [Al-Bahrani, Redha; Zailaie, Samar; Abuetabh, Yasser; Zetouni, Nikolas; Bahitham, Wesam; Sergi, Consolato] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada.
   [Tuertcher, Dominika; Sergi, Consolato] Med Univ Innsbruck, Inst Pathol, A-6020 Innsbruck, Austria.
C3 University of Alberta; Medical University of Innsbruck
RP Sergi, C (corresponding author), Univ Alberta Hosp, Dept Lab Med & Pathol, 8440 112 St NW, Edmonton, AB T6G 2B7, Canada.
EM sergi@ualberta.ca
RI Sergi, Consolato/A-1126-2009; Zailaie, Samar Abdullah/AAY-2979-2020; P,
   Niranjan/D-2188-2015
OI Zailaie, Samar Abdullah/0009-0006-8336-111X; P,
   Niranjan/0000-0002-7010-8442; Sergi, Consolato/0000-0002-2779-7879
FU Saudi Cultural Bureau, Ottawa, ON, Canada
FX The authors are very grateful to the Saudi Cultural Bureau, Ottawa, ON,
   Canada, for the financial support of RA, SZ, YA, and WB, Laboratory
   Medicine and Pathology at the University of Alberta, Edmonton, AB,
   Canada.
CR Abuetabh Y, 2011, ANN CLIN LAB SCI, V41, P217
   Anastasiou D, 2006, PHYSIOLOGY, V21, P404, DOI 10.1152/physiol.00031.2006
   Aquilano K, 2010, J BIOL CHEM, V285, P21590, DOI 10.1074/jbc.M109.070169
   Bandyopadhyay S, 2006, CANCER RES, V66, P11983, DOI 10.1158/0008-5472.CAN-06-0943
   Bernier M, 2011, J BIOL CHEM, V286, P19270, DOI 10.1074/jbc.M110.200311
   Björnsson E, 1999, LIVER, V19, P501, DOI 10.1111/j.1478-3231.1999.tb00083.x
   Blonski W, 2010, WORLD J GASTROENTERO, V16, P3603, DOI 10.3748/wjg.v16.i29.3603
   Bottone FG, 2005, MOL CANCER THER, V4, P693, DOI 10.1158/1535-7163.MCT-04-0337
   Brunner TB, 2010, STRAHLENTHER ONKOL, V186, P672, DOI 10.1007/s00066-010-2161-y
   Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357
   Chen J, 2011, CANCER RES, V71, P4138, DOI 10.1158/0008-5472.CAN-10-4274
   Chung SW, 2010, ARCH BIOCHEM BIOPHYS, V501, P79, DOI 10.1016/j.abb.2010.05.003
   de Martel C, 2010, GASTROEN CLIN BIOL, V34, P173, DOI 10.1016/j.gcb.2010.01.008
   Dragani TA, 2010, J HEPATOL, V52, P252, DOI 10.1016/j.jhep.2009.11.015
   Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020
   Fisher DE, 2001, APOPTOSIS, V6, P7, DOI 10.1023/A:1009659708549
   Hackl C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-668
   Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057
   Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778
   Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5
   Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085
   Ishiguro T, 2000, ONCOL RES, V12, P343, DOI 10.3727/096504001108747792
   Johnston J, 2012, J CLIN PATHOL
   Kabra N, 2009, J BIOL CHEM, V284, P18210, DOI 10.1074/jbc.M109.000034
   Kapoor M, 1998, P NATL ACAD SCI USA, V95, P2834, DOI 10.1073/pnas.95.6.2834
   Khan SA, 2005, LANCET, V366, P1303, DOI 10.1016/S0140-6736(05)67530-7
   Lain S, 2008, CANCER CELL, V13, P454, DOI 10.1016/j.ccr.2008.03.004
   Li Y, 2008, CELL METAB, V8, P38, DOI 10.1016/j.cmet.2008.05.004
   Lowe SW, 1999, ENDOCR-RELAT CANCER, V6, P45, DOI 10.1677/erc.0.0060045
   Maddocks ODK, 2011, J MOL MED, V89, P237, DOI 10.1007/s00109-011-0735-5
   Motola-Kuba Daniel, 2006, Ann Hepatol, V5, P16
   Muraoka RS, 2000, DEV BIOL, V225, P322, DOI 10.1006/dbio.2000.9824
   Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026
   Olnes MJ, 2004, ONCOLOGY-BASEL, V66, P167, DOI 10.1159/000077991
   Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74
   Passa O, 2011, IMMUNOLOGY, V134, P349, DOI 10.1111/j.1365-2567.2011.03495.x
   Picard F, 2005, INT J OBESITY, V29, pS36, DOI 10.1038/sj.ijo.0802912
   Rasbach KA, 2010, P NATL ACAD SCI USA, V107, P21866, DOI 10.1073/pnas.1016089107
   Regateiro FS, 2011, CURR OPIN IMMUNOL, V23, P660, DOI 10.1016/j.coi.2011.07.003
   Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831
   Salminen A, 2009, J CLIN IMMUNOL, V29, P397, DOI 10.1007/s10875-009-9296-6
   Senawong T, 2005, ARCH BIOCHEM BIOPHYS, V434, P316, DOI 10.1016/j.abb.2004.10.028
   Sergi C, 2000, AM J PATHOL, V156, P1589, DOI 10.1016/S0002-9440(10)65031-6
   Smith JS, 2002, TRENDS CELL BIOL, V12, P404, DOI 10.1016/S0962-8924(02)02342-5
   Soussi T, 2007, CANCER CELL, V12, P303, DOI 10.1016/j.ccr.2007.10.001
   Taniguchi K, 2002, ONCOGENE, V21, P4863, DOI 10.1038/sj.onc.1205591
   Vashishta Aruna, 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P385
   Wang AJ, 2007, MOL CARCINOGEN, V46, P476, DOI 10.1002/mc.20298
   WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309
   Yi JJ, 2010, BBA-PROTEINS PROTEOM, V1804, P1684, DOI 10.1016/j.bbapap.2010.05.002
   Yin X, 2008, ONCOGENE, V27, P2118, DOI 10.1038/sj.onc.1210861
   Zhang S, 2013, ANN CLIN LAB SCI, V43, P373
   Zhao G, 2011, GENE THER, V18, P920, DOI 10.1038/gt.2011.81
   Zhu DH, 2009, J BIOL CHEM, V284, P9529, DOI 10.1074/jbc.M809393200
   Zörnig M, 2001, BBA-REV CANCER, V1551, pF1, DOI 10.1016/S0304-419X(01)00031-2
NR 55
TC 14
Z9 16
U1 0
U2 231
PU ASSOC CLINICAL SCIENTISTS
PI MIDDLEBURY
PA PO BOX 1287, MIDDLEBURY, VT 05753 USA
SN 0091-7370
EI 1550-8080
J9 ANN CLIN LAB SCI
JI Ann. Clin. Lab. Sci.
PD WIN
PY 2015
VL 45
IS 1
BP 3
EP 9
PG 7
WC Medical Laboratory Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Medical Laboratory Technology
GA CB8IT
UT WOS:000349872900001
PM 25696003
DA 2024-02-19
ER

PT J
AU Sato, A
   Takino, Y
   Yano, T
   Fukui, K
   Ishigami, A
AF Sato, Ayami
   Takino, Yuka
   Yano, Tomohiro
   Fukui, Koji
   Ishigami, Akihito
TI Determination of tissue-specific interaction between vitamin C and
   vitamin E <i>in vivo</i> using senescence marker protein-30 knockout
   mice as a vitamin C synthesis deficiency model
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article; Early Access
DE Ascorbic acid; alpha-tocopherol; Liver; Mice; SMP30; Vitamin C; Vitamin
   E
ID FREE-RADICAL INTERACTION; RRR-ALPHA-TOCOPHEROL; ASCORBIC-ACID; OXIDATIVE
   STRESS; DEHYDROASCORBIC ACID; MOUSE-LIVER; AGE; BIOSYNTHESIS;
   REGENERATION; PLASMA
AB Vitamin E (alpha-tocopherol; VE) is known to be regenerated from VE radicals by vitamin C (L-ascorbic acid; VC) in vitro. However, their in vivo interaction in various tissues is still unclear. Therefore, we alternatively examined the in vivo interaction of VC and VE by measurement of their concentrations in various tissues of senescence marker protein-30 (SMP30) knockout (KO) mice as a VC synthesis deficiency model. Male SMP30-KO mice were divided into four groups (VC+/VE+, VC+/VE-, VC-/VE+ and VC-/VE-), fed diets with or without 500 mg/kg VE and given water with or without 1.5 g/l VC ad libitum. Then, VC and VE concentrations in the plasma and various tissues were determined. Further, gene expression levels of transporters associated with VC and VE, such as alpha-tocopherol transfer protein (alpha-TTP) and sodium-dependent vitamin C transporters (SVCTs), were examined. These results showed that the VE levels in the VC-depleted (VC-/VE+) group were significantly lower than those in the VC+/VE+ group in the liver and heart; the VC levels in the VE-depleted (VC+/VE-) group were significantly lower than those in the VC+/VE+ group in the kidneys. The alpha-TTP gene expression in the liver and kidneys was decreased by VC and/or VE depletion. Moreover, SVCT1 gene expression in the liver was decreased by both VC and VE depletion. In conclusion, these results indicate that VC spares VE mainly in the liver and heart and that VE spares VC in the kidneys of SMP30-KO mice. Thus, interaction between VC and VE is likely to be tissue specific.
C1 [Sato, Ayami; Takino, Yuka; Ishigami, Akihito] Tokyo Metropolitan Inst Gerontol, Mol Regulat Aging, Tokyo 1730015, Japan.
   [Sato, Ayami; Yano, Tomohiro] Toyo Univ, Inst Life Innovat Studies, Itakura, Gunma 3740193, Japan.
   [Fukui, Koji] Shibaura Inst Technol, Grad Sch Engn & Sci, Coll Syst Engn & Sci, Mol Cell Biol Lab, Saitama 3378570, Japan.
   [Ishigami, Akihito] Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 1920397, Japan.
C3 Tokyo Metropolitan Institute of Gerontology; Toyo University; Shibaura
   Institute of Technology; Tokyo Metropolitan University
RP Ishigami, A (corresponding author), Tokyo Metropolitan Inst Gerontol, Mol Regulat Aging, Tokyo 1730015, Japan.; Ishigami, A (corresponding author), Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 1920397, Japan.
EM ishigami@tmig.or.jp
RI ; Yano, Tomohiro/J-2166-2016
OI Ishigami, Akihito/0000-0001-7875-7482; Fukui, Koji/0000-0003-2748-3228;
   Yano, Tomohiro/0000-0002-9490-3424
FU Japan Society for the Promotion of Science (JSPS) KAKENHI [19H04043,
   21K17697]; Grants-in-Aid for Scientific Research [21K17697, 19H04043]
   Funding Source: KAKEN
FX This study was supported by the Japan Society for the Promotion of
   Science (JSPS) KAKENHI Grant Number 19H04043 (AI) and 21K17697 (AS). The
   ascorbic acid powder was kindly provided by DSM Japan K.K. (Tokyo,
   Japan).
CR Abdoulhossein D, 2018, ANN MED SURG, V36, P152, DOI 10.1016/j.amsu.2018.10.026
   Amano A, 2010, ARCH BIOCHEM BIOPHYS, V496, P38, DOI 10.1016/j.abb.2010.01.012
   Babaev VR, 2010, ARTERIOSCL THROM VAS, V30, P1751, DOI 10.1161/ATVBAHA.110.209502
   BISBY RH, 1995, ARCH BIOCHEM BIOPHYS, V317, P170, DOI 10.1006/abbi.1995.1150
   Boudouris G, 2013, INT UROL NEPHROL, V45, P1137, DOI 10.1007/s11255-012-0334-6
   BURTON GW, 1990, LIPIDS, V25, P199, DOI 10.1007/BF02535748
   CHAN AC, 1991, J BIOL CHEM, V266, P17290
   Chepda T, 2001, LIFE SCI, V69, P1587, DOI 10.1016/S0024-3205(01)01240-1
   Christiansen-Weber TA, 2000, AM J PATHOL, V157, P1017, DOI 10.1016/S0002-9440(10)64614-7
   Dadheech G, 2006, INDIAN J CLIN BIOCHE, V21, P34, DOI 10.1007/BF02912908
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Fouladvand Faezeh, 2020, Prev Nutr Food Sci, V25, P1, DOI 10.3746/pnf.2020.25.1.1
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   Fukui K, 2002, ANN NY ACAD SCI, V959, P275, DOI 10.1111/j.1749-6632.2002.tb02099.x
   Furusawa H, 2008, BIOL PHARM BULL, V31, P1673, DOI 10.1248/bpb.31.1673
   Glascott PA, 1996, BIOCHEM PHARMACOL, V52, P1245, DOI 10.1016/0006-2952(96)00478-9
   Halpner AD, 1998, ARCH BIOCHEM BIOPHYS, V359, P305, DOI 10.1006/abbi.1998.0914
   Hamilton ITJ, 2000, BRIT J NUTR, V84, P261, DOI 10.1017/S0007114500001537
   Hill KE, 2003, AM J CLIN NUTR, V77, P1484, DOI 10.1093/ajcn/77.6.1484
   Hosomi A, 1997, FEBS LETT, V409, P105, DOI 10.1016/S0014-5793(97)00499-7
   HRUBA F, 1982, EXPERIENTIA, V38, P1454, DOI 10.1007/BF01955766
   Huang JJ, 2003, MOL CELL BIOCHEM, V247, P171, DOI 10.1023/A:1024167731074
   IGARASHI O, 1991, J NUTR SCI VITAMINOL, V37, P359, DOI 10.3177/jnsv.37.359
   Ikeda S, 1998, J NUTR, V128, P832, DOI 10.1093/jn/128.5.832
   Ishida Y, 2020, BRIT J NUTR, V123, P537, DOI 10.1017/S0007114519003118
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   Ishigami A, 2015, GERIATR GERONTOL INT, V15, P804, DOI 10.1111/ggi.12347
   Kadoma Y, 2006, IN VIVO, V20, P61
   KAGAN VE, 1992, J LIPID RES, V33, P385
   Khadangi F, 2019, IUBMB LIFE, V71, P411, DOI 10.1002/iub.1990
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Lee KJ, 2003, BRIT J NUTR, V89, P589, DOI 10.1079/BJN2003819
   Leng XL, 2015, BIOPHYS J, V109, P1608, DOI 10.1016/j.bpj.2015.08.032
   Linster CL, 2007, FEBS J, V274, P1, DOI 10.1111/j.1742-4658.2006.05607.x
   Lykkesfeldt J, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102412
   Magiorkinis E, 2011, EUR J INTERN MED, V22, P147, DOI 10.1016/j.ejim.2010.10.006
   May JM, 2004, J BIOL CHEM, V279, P14975, DOI 10.1074/jbc.M312548200
   May JM, 1998, ARCH BIOCHEM BIOPHYS, V349, P281, DOI 10.1006/abbi.1997.0473
   Michels AJ, 2003, ARCH BIOCHEM BIOPHYS, V410, P112, DOI 10.1016/S0003-9861(02)00678-1
   Monacelli F, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070670
   MUKAI K, 1991, J BIOL CHEM, V266, P274
   OUAHCHI K, 1995, NAT GENET, V9, P141, DOI 10.1038/ng0295-141
   PACKER JE, 1979, NATURE, V278, P737, DOI 10.1038/278737a0
   Pierce MR, 2013, NUTR NEUROSCI, V16, P160, DOI 10.1179/1476830512Y.0000000042
   Ruiz-Ramos M, 2010, J NUTR HEALTH AGING, V14, P467, DOI 10.1007/s12603-010-0099-5
   Salonen RM, 2003, CIRCULATION, V107, P947, DOI 10.1161/01.CIR.0000050626.25057.51
   Sato Y, 2010, BIOL PHARM BULL, V33, P364, DOI 10.1248/bpb.33.364
   Shichiri M, 2010, J NUTR BIOCHEM, V21, P451, DOI 10.1016/j.jnutbio.2009.02.002
   Takahashi K, 2019, ARCH BIOCHEM BIOPHYS, V663, P120, DOI 10.1016/j.abb.2019.01.003
   Takahashi K, 2017, EUR J NUTR, V56, P1317, DOI 10.1007/s00394-016-1182-4
   Takahashi K, 2014, BBA-GEN SUBJECTS, V1840, P2289, DOI 10.1016/j.bbagen.2014.03.019
   Tanaka K, 1997, J NUTR, V127, P2060, DOI 10.1093/jn/127.10.2060
   TRABER MG, 1990, J LIPID RES, V31, P675
   Uchida T, 2011, J NUTR SCI VITAMINOL, V57, P326, DOI 10.3177/jnsv.57.326
   VERA JC, 1994, BLOOD, V84, P1628
   WELCH RW, 1995, J BIOL CHEM, V270, P12584, DOI 10.1074/jbc.270.21.12584
   Zhu QY, 2000, J NUTR BIOCHEM, V11, P14, DOI 10.1016/S0955-2863(99)00065-0
NR 57
TC 4
Z9 4
U1 0
U2 6
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD 2022 SEP 28
PY 2022
VL 128
IS 6
BP 993
EP 1003
DI 10.1017/S0007114521004384
EA NOV 2021
PG 11
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 3U1FJ
UT WOS:000744748000001
PM 34725010
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU Mori, N
   Kawasumi, K
   Arai, T
AF Mori, Nobuko
   Kawasumi, Koh
   Arai, Toshiro
TI Comparison of the Plasma Insulin and Adiponectin Concentrations as
   Metabolic Markers in Clinically Healthy Dogs with Ageing
SO JOURNAL OF ANIMAL AND VETERINARY ADVANCES
LA English
DT Article
DE Adiponectin; dog; insulin; metabolic disorder; plasma; Japan
ID DIABETES-MELLITUS; WEIGHT-LOSS; RESISTANCE; OBESITY; ASSOCIATION;
   EXPRESSION; HORMONE; DISEASE; TISSUE; LIVER
AB Plasma metabolite concentrations reflect changes in the energy metabolic and physical conditions of animals with metabolic disorders. A reduced adiponectin level in humans and rodents is the critical factor associated with the pathogenesis of obesity-associated atherosclerosis, insulin resistance and type 2 diabetes mellitus. Appropriate plasma metabolic markers appear to be useful for the early diagnosis of latent metabolic disorders with no clinical signs in animals. The aim of this study was to assess changes in the values of plasma metabolic markers in healthy ageing dogs. Significant differences were observed in the plasma insulin and total cholesterol concentrations in healthy dogs of different genders and ages. Adiponectin concentrations peaked at a young age and decreased with ageing. Apparently, insulin increased according to age. Plasma insulin concentrations were particularly influenced significantly by age as well as glucose and triglyceride levels whereas adiponectin concentrations were affected by gender on multiple linear regressions for all factors. No criteria exist for the early diagnosis of latent metabolic disorders without remarkable signs regarding age and gender in dogs. Thus, in case of dogs, it may be necessary to set up improved age-dependent criteria for metabolic disorders with changes in plasma insulin concentrations.
C1 [Mori, Nobuko; Kawasumi, Koh; Arai, Toshiro] Nippon Vet & Life Sci Univ, Sch Vet Med, Dept Vet Sci, Vet Biochem Lab, Musashino, Tokyo 1808602, Japan.
C3 Nippon Veterinary & Life Science University
RP Arai, T (corresponding author), Nippon Vet & Life Sci Univ, Sch Vet Med, Dept Vet Sci, Vet Biochem Lab, 1-7-1 Kyonancho, Musashino, Tokyo 1808602, Japan.
RI Arai, Toshiro/HTP-2574-2023
FU Ministry of Education, Culture, Sports, Science and Technology of Japan
   (MEXT); MEXT [21380195]; Grants-in-Aid for Scientific Research
   [21380195] Funding Source: KAKEN
FX Researchers thank the seven veterinary clinics (Hiroo Animal Hospital,
   Tokyo; Cherry Avenue Animal Hospital, Tokyo; Ichikawa Animal Hospital,
   Saitama; Hirano Animal Hospital, Chiba; Togashira Animal Hospital,
   Ibaraki; Grandmama Animal Hospital, Osaka and Muromi Animal Hospital,
   Fukuoka) in Japan for their assistance in obtaining blood samples from
   dogs. This study was supported, in part by the Strategic Research Base
   Development Program for Private Universities from the Ministry of
   Education, Culture, Sports, Science and Technology of Japan (MEXT),
   2008-2012 and a Grant in Aid for Scientific Research (No. 21380195 to T.
   Arai) from MEXT.
CR Asako O., 2004, VET BIOCH, V41, P31
   Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34
   Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992
   Chandran M, 2003, DIABETES CARE, V26, P2442, DOI 10.2337/diacare.26.8.2442
   Downs LG, 1997, RES VET SCI, V63, P35, DOI 10.1016/S0034-5288(97)90155-7
   German AJ, 2007, J VET INTERN MED, V21, P1174, DOI 10.1892/06-280.1
   Ghazanfari S, 2011, ASIAN J ANIM VET ADV, V6, P429, DOI 10.3923/ajava.2011.429.439
   Hsiao PJ, 2007, J GASTROEN HEPATOL, V22, P2118, DOI 10.1111/j.1440-1746.2006.04698.x
   Iacobellis G, 2008, OBESITY, V16, P179, DOI 10.1038/oby.2007.50
   International Diabetes Federation [IDF], 2005, The IDF Consensus Worldwide Definition of the Metabolic Syndrome
   Ishioka K, 2006, RES VET SCI, V80, P127, DOI 10.1016/j.rvsc.2005.05.011
   Kondo H, 2002, DIABETES, V51, P2325, DOI 10.2337/diabetes.51.7.2325
   Kumada M, 2004, CIRCULATION, V109, P2046, DOI 10.1161/01.CIR.0000127953.98131.ED
   Lund E. M., 2006, International Journal of Applied Research in Veterinary Medicine, V4, P177
   Magori E, 2005, RES VET SCI, V78, P39, DOI 10.1016/j.rvsc.2004.06.001
   Mori N, 2011, ASIAN J ANIM VET ADV, V6, P844, DOI 10.3923/ajava.2011.844.850
   Neumann S, 2008, RES VET SCI, V84, P178, DOI 10.1016/j.rvsc.2007.05.014
   Pasarica M, 2009, OBESITY, V17, P1976, DOI 10.1038/oby.2009.219
   Pitkänen OM, 1999, SCAND J CLIN LAB INV, V59, P607, DOI 10.1080/00365519950185094
   Saltiel AR, 2001, NAT MED, V7, P887, DOI 10.1038/90911
   Verkest KR, 2011, DOMEST ANIM ENDOCRIN, V41, P24, DOI 10.1016/j.domaniend.2011.02.001
   Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930
   Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788
NR 23
TC 3
Z9 3
U1 0
U2 5
PU MEDWELL ONLINE
PI FAISALABAD
PA ANSINET BUILDING, 308-LASANI TOWN, SARGODHA RD, FAISALABAD, 38090,
   PAKISTAN
SN 1680-5593
J9 J ANIM VET ADV
JI J. Anim. Vet. Adv.
PY 2012
VL 11
IS 7
BP 971
EP 974
PG 4
WC Veterinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Veterinary Sciences
GA 931GG
UT WOS:000303203700017
DA 2024-02-19
ER

PT J
AU Agostinucci, K
   Manfredi, TG
   Cosmas, A
   Martin, K
   Han, SN
   Wu, D
   Sastre, J
   Meydani, SN
   Meydani, M
AF Agostinucci, K
   Manfredi, TG
   Cosmas, A
   Martin, K
   Han, SN
   Wu, D
   Sastre, J
   Meydani, SN
   Meydani, M
TI Vitamin E and age alter liver mitochondrial morphometry
SO JOURNAL OF ANTI-AGING MEDICINE
LA English
DT Article
ID PHYSICOCHEMICAL PROPERTIES; OXIDATIVE DAMAGE; MEGAMITOCHONDRIA; HEART;
   RAT; ANTIOXIDANTS; HEPATOCYTES; MEMBRANES; HYDRAZINE
AB Oxidative damage to mitochondrial. membranes caused by free radical production during respiration plays a major role in tissue dysfunction. It has been hypothesized that aging is associated with mitochondrial enlargement and elongation. These changes may be enhanced by deficiencies in vitamin E and selenium. Vitamin E supplementation minimizes the age-related mitochondrial enlargement and elongation in the mouse liver. This study investigated the effects of vitamin E supplementation (500 IU/kg) on "old" (760 days) and "older" (827 days) C57BL/6 mice liver mitochondrial. (Mt morphometry. Fixed mitochondria from homogenized liver samples taken from control and vitamin E-supplemented mice were examined by transmission electron microscopy and measured by image analysis. Morphometric measurements included Mt area, short and long axis, and size distributions. "Old" vitamin E-supplemented mice had significantly smaller (p < 0.0001) liver mitochondria than age-matched controls. While age had no significant effect on Mt area and short axis in the vitamin E-supplemented mice, it had a significant effect (p < 0.002) on the long axis. Analysis of the long axis to short axis ratio indicated that age had a significant effect of mitochondrial elongation in the vitamin E fed mice. Vitamin E supplementation results in smaller mouse liver mitochondria as compared to age-matched cohorts and aging results in elongation but does not alter the size of liver mitochondria in mice supplemented with vitamin E. These results suggest that vitamin E provides a protective effect against age-related mitochondrial enlargement.
C1 Univ Rhode Isl, Exercise Sci Lab, Kingston, RI 02881 USA.
   Univ Connecticut, Sch Allied Hlth Prof, Storrs, CT USA.
   Tufts Univ, JM USDA, Human Nutr Res Ctr, Boston, MA USA.
   Univ Valencia, Dept Pharm, Valencia, Spain.
C3 University of Rhode Island; University of Connecticut; United States
   Department of Agriculture (USDA); Tufts University; University of
   Valencia
RP Manfredi, TG (corresponding author), Univ Rhode Isl, Exercise Sci Lab, 25 W Independence Way, Kingston, RI 02881 USA.
CR ADACHI K, 1994, EXP MOL PATHOL, V61, P134, DOI 10.1006/exmp.1994.1032
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   BAUDHUIN P, 1967, J CELL BIOL, V35, P631, DOI 10.1083/jcb.35.3.631
   BERTONIFREDDARI C, 1993, BRAIN RES, V628, P193, DOI 10.1016/0006-8993(93)90955-M
   Cosmas Arthur, 1994, Age (Chester), V17, P158
   Essig D A, 1996, Exerc Sport Sci Rev, V24, P289
   FRIGG M, 1976, EXP MOL PATHOL, V24, P236, DOI 10.1016/0014-4800(76)90008-3
   Herrero A, 2001, J AM AGING ASSOC, V24, P45, DOI 10.1007/s11357-001-0006-4
   Lipman RD, 1998, MECH AGEING DEV, V103, P269, DOI 10.1016/S0047-6374(98)00048-7
   Losonczy KG, 1996, AM J CLIN NUTR, V64, P190, DOI 10.1093/ajcn/64.2.190
   Matsuhashi T, 1996, TOXICOL LETT, V86, P47, DOI 10.1016/0378-4274(96)83964-6
   McBride JM, 1998, MED SCI SPORT EXER, V30, P67, DOI 10.1097/00005768-199801000-00010
   MEYDANI SN, 1995, AM J CLIN NUTR, V62, P1462
   PARAIDATHATHU T, 1994, TOXICOLOGY, V90, P103, DOI 10.1016/0300-483X(94)90209-7
   Pedersen P L, 1978, Methods Cell Biol, V20, P411, DOI 10.1016/S0091-679X(08)62030-0
   SANTORO CJ, 2000, P AM AGING ASS A JUN, P50
   Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Sternlieb I, 1995, HEPATOLOGY, V22, P1782, DOI 10.1016/0270-9139(95)90206-6
   Teranishi M, 2000, EXP MOL PATHOL, V68, P104, DOI 10.1006/exmp.1999.2288
   VANVLEET JF, 1977, AM J VET RES, V38, P1399
   VANVLEET JF, 1976, AM J VET RES, V37, P1081
   WAKABAYASHI T, 1987, TOXICOL APPL PHARM, V87, P235, DOI 10.1016/0041-008X(87)90285-7
   WAKABAYASHI T, 1997, MOL ASPECTS MED, V18, P51
NR 25
TC 5
Z9 6
U1 1
U2 2
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1094-5458
J9 J ANTI-AGING MED
JI J. Anti-Aging Med.
PD SUM
PY 2002
VL 5
IS 2
BP 173
EP 178
DI 10.1089/10945450260195612
PG 6
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 585FY
UT WOS:000177515800005
DA 2024-02-19
ER

PT J
AU Franke, K
   Ristow, M
   Gaser, C
AF Franke, Katja K
   Ristow, Michael
   Gaser, Christian
CA Alzheimer's Dis Neuroimaging Initi
TI Gender-specific impact of personal health parameters on individual brain
   aging in cognitively unimpaired elderly subjects
SO FRONTIERS IN AGING NEUROSCIENCE
LA English
DT Article
DE aging; Alzheimer's disease (AD); BrainAGE; lifestyle; magnetic resonance
   imaging (MRI); voxel-based morphometry (VBM)
ID MENTAL-STATE-EXAMINATION; AGE-RELATED-CHANGES; GRAY-MATTER VOLUME;
   ALZHEIMERS-DISEASE; RISK-FACTORS; OLDER-ADULTS; CARDIOVASCULAR-HEALTH;
   MEDITERRANEAN DIET; TOTAL HOMOCYSTEINE; PHYSICAL-ACTIVITY
AB Aging alters brain structure and function. Personal health markers and modifiable lifestyle factors are related to individual brain aging as well as to the risk of developing Alzheimer's disease (AD). This study used a novel magnetic resonance imaging (MRI)-based biomarker to assess the effects of 17 health markers on individual brain aging in cognitively unimpaired elderly subjects. By employing kernel regression methods, the expression of normal brain-aging patterns forms the basis to estimate the brain age of a given new subject. If the estimated age is higher than the chronological age, a positive brain age gap estimation (BrainAGE) score indicates accelerated atrophy and is considered a risk factor for developing AD. Within this cross-sectional, multi-center study 228 cognitively unimpaired elderly subjects (118 males) completed an MRI at 1.5Tesla, physiological and blood parameter assessments. The multivariate regression model combining all measured parameters was capable of explaining 39% of BrainAGE variance in males (p < 0.001) and 32% in females (p < 0.01). Furthermore, markers of the metabolic syndrome as well as markers of liver and kidney functions were profoundly related to BrainAGE scores in males (p < 0.05). In females, markers of liver and kidney functions as well as supply of vitamin B-12 were significantly related to BrainAGE (p < 0.05). In conclusion, in cognitively unimpaired elderly subjects several clinical markers of poor health were associated with subtle structural changes in the brain that reflect accelerated aging, whereas protective effects on brain aging were observed for markers of good health. Additionally, the relations between individual brain aging and miscellaneous health markers show gender-specific patterns. The BrainAGE approach may thus serve as a clinically relevant biomarker for the detection of subtly abnormal patterns of brain aging probably preceding cognitive decline and development of AD.
C1 [Franke, Katja K; Gaser, Christian] Jena Univ Hosp, Dept Psychiat, Struct Brain Mapping Grp, Jena, Germany.
   [Franke, Katja K; Gaser, Christian] Jena Univ Hosp, Dept Neurol, Jena, Germany.
   [Ristow, Michael] Univ Jena, Dept Human Nutr, D-07743 Jena, Germany.
   [Ristow, Michael] Swiss Fed Inst Technol, Swiss Fed Inst Technol, Energy Metab Lab, Zurich, Switzerland.
C3 Friedrich Schiller University of Jena; Friedrich Schiller University of
   Jena; Friedrich Schiller University of Jena; Swiss Federal Institutes of
   Technology Domain; ETH Zurich
RP Franke, K (corresponding author), Univ Jena, Dept Psychiat, Struct Brain Mapping Grp, Jahnstr 3, D-07743 Jena, Germany.
EM katja.franke@uni-jena.de
RI Gaser, Christian/F-5103-2010; Franke, Katja/S-7577-2017; Ristow,
   Michael/O-9858-2014
OI Gaser, Christian/0000-0002-9940-099X; Franke, Katja/0000-0003-1859-5738;
   Ristow, Michael/0000-0003-2109-2453
FU German Ministry for Education and Research (Bundesministerium fur
   Bildung und Forschung - BMBF) [01EV0709]; European Community [279281];
   European Foundation for the Study of Diabetes; Jena Centre for Systems
   Biology of Ageing (JenAge) - BMBF [0315581]; Alzheimer's Disease
   Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01
   AG024904]; National Institute on Aging; National Institute of Biomedical
   Imaging and Bioengineering; NIH [P30 AG010129, K01 AG030514]; Dana
   Foundation
FX We are grateful to Dr. Rachel Yotter and Dr. Alissa Winkler for their
   comments on the manuscript. This work was supported in part by the
   German Ministry for Education and Research (Bundesministerium fur
   Bildung und Forschung - BMBF) [01EV0709 to Christian Gaser] and the
   European Community [FP7 HEALTH, Project 279281 (BrainAge) to Katja
   Franke]. Additionally, this work is supported by the European Foundation
   for the Study of Diabetes, and the Jena Centre for Systems Biology of
   Ageing (JenAge) funded by the BMBF [0315581 to Michael Ristow]. The
   sponsors had no role in the design and conduct of the study; collection,
   management, analysis, and interpretation of the data; and preparation,
   review, or approval of the manuscript. Data collection and sharing for
   this project was funded by the Alzheimer's Disease Neuroimaging
   Initiative (ADNI) (National Institutes of Health Grant U01 AG024904).
   ADNI is funded by the National Institute on Aging, the National
   Institute of Biomedical Imaging and Bioengineering, and through generous
   contributions from the following: Abbott, AstraZeneca AB, Bayer Schering
   Pharma AG, Bristol-Myers Squibb, Eisai Global Clinical Development, Elan
   Corporation, Genentech, GE Healthcare, GlaxoSmithKline, Innogenetics,
   Johnson and Johnson, Eli Lilly and Co., Medpace, Inc., Merck and Co.,
   Inc., Novartis AG, Pfizer Inc., E Hoffman-La Roche, Schering-Plough,
   Synarc, Inc., as well as non-profit partners the Alzheimer's Association
   and Alzheimer's Drug Discovery Foundation, with participation from the
   U.S. Food and Drug Administration. Private sector contributions to ADNI
   are facilitated by the Foundation for the National Institutes of Health
   (www.fnih.org). The grantee organization is the Northern California
   Institute for Research and Education, and the study is coordinated by
   the Alzheimer's Disease Cooperative Study at the University of
   California, San Diego. ADNI data are disseminated by the Laboratory for
   Neuro Imaging at the University of California, Los Angeles. This
   research was also supported by NIH grants P30 AG010129, K01 AG030514,
   and the Dana Foundation.
CR Aisen PS, 2008, JAMA-J AM MED ASSOC, V300, P1774, DOI 10.1001/jama.300.15.1774
   Ashburner J, 2003, LANCET NEUROL, V2, P79, DOI 10.1016/S1474-4422(03)00304-1
   Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018
   Azad NA, 2007, GENDER MED, V4, P120, DOI 10.1016/S1550-8579(07)80026-X
   Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381
   Cao KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013098
   Chen JH, 2009, J FORMOS MED ASSOC, V108, P754, DOI 10.1016/S0929-6646(09)60402-2
   Clark VH, 2012, NEUROBIOL AGING, V33, P2733, DOI 10.1016/j.neurobiolaging.2012.01.010
   Clarke R, 2006, NEW ENGL J MED, V354, P2817, DOI 10.1056/NEJMe068086
   Clarke R, 1998, ARCH NEUROL-CHICAGO, V55, P1449, DOI 10.1001/archneur.55.11.1449
   Clarke R, 2007, AM J CLIN NUTR, V86, P1384, DOI 10.1093/ajcn/86.5.1384
   COCKRELL JR, 1988, PSYCHOPHARMACOL BULL, V24, P689
   Cuadra MB, 2005, IEEE T MED IMAGING, V24, P1548, DOI 10.1109/TMI.2005.857652
   Czapski GA, 2012, ACTA NEUROBIOL EXP, V72, P397, DOI 10.55782/ane-2012-1911
   Debette S, 2010, ANN NEUROL, V68, P136, DOI 10.1002/ana.22062
   Douaud G, 2013, P NATL ACAD SCI USA, V110, P9523, DOI 10.1073/pnas.1301816110
   Driscoll I, 2009, NEUROLOGY, V72, P1906, DOI 10.1212/WNL.0b013e3181a82634
   Dukart J, 2013, NEUROIMAGE-CLIN, V3, P84, DOI 10.1016/j.nicl.2013.07.005
   Dukart J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002987
   Dukart J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022193
   Ellinson M, 2004, J HUM NUTR DIET, V17, P371, DOI 10.1111/j.1365-277X.2004.00532.x
   Enzinger C, 2005, NEUROLOGY, V64, P1704, DOI 10.1212/01.WNL.0000161871.83614.BB
   Erickson KI, 2010, NEUROLOGY, V75, P1415, DOI 10.1212/WNL.0b013e3181f88359
   Féart C, 2010, CURR OPIN CLIN NUTR, V13, P14, DOI 10.1097/MCO.0b013e3283331fe4
   Fitzpatrick AL, 2009, ARCH NEUROL-CHICAGO, V66, P336, DOI 10.1001/archneurol.2008.582
   Fotenos AF, 2008, ARCH NEUROL-CHICAGO, V65, P113, DOI 10.1001/archneurol.2007.27
   Franke K, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00090
   Franke K, 2012, GEROPSYCH, V25, P235, DOI 10.1024/1662-9647/a000074
   Franke K, 2012, NEUROIMAGE, V63, P1305, DOI 10.1016/j.neuroimage.2012.08.001
   Franke K, 2010, NEUROIMAGE, V50, P883, DOI 10.1016/j.neuroimage.2010.01.005
   Frisardi V, 2010, J ALZHEIMERS DIS, V22, P715, DOI 10.3233/JAD-2010-100942
   Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215
   Gaser C., 2009, NEUROIMAGE, V47, pS121, DOI DOI 10.1016/S1053-8119(09)71151-6
   Gaser C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067346
   Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786
   Grossi Enzo, 2005, Gend Med, V2, P106, DOI 10.1016/S1550-8579(05)80017-8
   Gu YA, 2010, ARCH NEUROL-CHICAGO, V67, P699, DOI 10.1001/archneurol.2010.84
   Hinterberger M, 2013, J NEURAL TRANSM, V120, P211, DOI 10.1007/s00702-012-0822-y
   HOLM S, 1979, SCAND J STAT, V6, P65
   Hughes TF, 2009, CURR PSYCHIATRY REV, V5, P73, DOI 10.2174/157340009788167347
   Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6
   Jones DT, 2011, NEUROLOGY, V77, P1524, DOI 10.1212/WNL.0b013e318233b33d
   Kim G, 2013, J ALZHEIMERS DIS, V33, P853, DOI 10.3233/JAD-2012-121345
   Langan RC, 2011, AM FAM PHYSICIAN, V83, P1425
   Lebel C, 2011, J NEUROSCI, V31, P10937, DOI 10.1523/JNEUROSCI.5302-10.2011
   Lenroot Rhoshel K, 2006, Neurosci Biobehav Rev, V30, P718, DOI 10.1016/j.neubiorev.2006.06.001
   Luchsinger JA, 2005, NEUROLOGY, V65, P545, DOI 10.1212/01.wnl.0000172914.08967.dc
   Luchsinger JA, 2009, CURR OPIN CLIN NUTR, V12, P15, DOI 10.1097/MCO.0b013e32831c8c71
   Mangialasche F, 2013, J INTERN MED, V273, P602, DOI 10.1111/joim.12037
   McMahon JA, 2006, NEW ENGL J MED, V354, P2764, DOI 10.1056/NEJMoa054025
   Middleton LE, 2009, ARCH NEUROL-CHICAGO, V66, P1210, DOI 10.1001/archneurol.2009.201
   Mohs R C, 1996, Int Psychogeriatr, V8, P195, DOI 10.1017/S1041610296002578
   MOHS RC, 1988, PSYCHOPHARMACOL BULL, V24, P627
   MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a
   Morris MS, 2012, ADV NUTR, V3, P801, DOI 10.3945/an.112.002535
   Morris MS, 2012, J AM GERIATR SOC, V60, P1457, DOI 10.1111/j.1532-5415.2012.04076.x
   Nepal B, 2010, AUSTRALAS J AGEING, V29, P111, DOI 10.1111/j.1741-6612.2010.00392.x
   Oulhaj A, 2010, INT J GERIATR PSYCH, V25, P82, DOI 10.1002/gps.2303
   Peters Ruth, 2008, BMC Geriatr, V8, P36, DOI [10.1186/1471-2318-8-18, 10.1186/1471-2318-8-36]
   PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012
   Pinn VW, 2003, JAMA-J AM MED ASSOC, V289, P397, DOI 10.1001/jama.289.4.397
   Querbes O, 2009, BRAIN, V132, P2036, DOI 10.1093/brain/awp105
   Rajapakse JC, 1997, IEEE T MED IMAGING, V16, P176, DOI 10.1109/42.563663
   Raz N, 2006, NEUROSCI BIOBEHAV R, V30, P730, DOI 10.1016/j.neubiorev.2006.07.001
   Resnick SM, 2003, J NEUROSCI, V23, P3295
   Saetre P, 2011, SYNAPSE, V65, P971, DOI 10.1002/syn.20933
   Scarmeas N, 2009, JAMA-J AM MED ASSOC, V302, P627, DOI 10.1001/jama.2009.1144
   Scholkopf B, 2001, Learning With Kernels: Support Vector Machines, Regularization, Optimization, and Beyond
   Sluimer JD, 2009, EUR RADIOL, V19, P2826, DOI 10.1007/s00330-009-1512-5
   Snowdon DA, 2003, ANN INTERN MED, V139, P450, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00014
   Solfrizzi Vincenzo, 2008, Expert Rev Neurother, V8, P133, DOI 10.1586/14737175.8.1.133
   Spulber G, 2010, NEUROBIOL AGING, V31, P1601, DOI 10.1016/j.neurobiolaging.2008.08.018
   Steele M, 2007, EXP GERONTOL, V42, P28, DOI 10.1016/j.exger.2006.06.002
   Taki Y, 2008, OBESITY, V16, P119, DOI 10.1038/oby.2007.4
   Terribilli D, 2011, NEUROBIOL AGING, V32, P354, DOI 10.1016/j.neurobiolaging.2009.02.008
   Tipping ME, 2001, J MACH LEARN RES, V1, P211, DOI 10.1162/15324430152748236
   Tohka J, 2004, NEUROIMAGE, V23, P84, DOI 10.1016/j.neuroimage.2004.05.007
   Wang PN, 2009, PSYCHIAT RES-NEUROIM, V171, P221, DOI 10.1016/j.pscychresns.2008.05.002
   Wilke M, 2003, MAGN RESON MED, V50, P749, DOI 10.1002/mrm.10606
   Xu GL, 2009, PSYCHIAT CLIN NEUROS, V63, P43, DOI 10.1111/j.1440-1819.2008.01904.x
   Zylberstein DE, 2011, NEUROBIOL AGING, V32, P380, DOI 10.1016/j.neurobiolaging.2009.02.024
NR 81
TC 61
Z9 66
U1 2
U2 22
PU FRONTIERS RESEARCH FOUNDATION
PI LAUSANNE
PA PO BOX 110, LAUSANNE, 1015, SWITZERLAND
SN 1663-4365
J9 FRONT AGING NEUROSCI
JI Front. Aging Neurosci.
PD MAY 23
PY 2014
VL 6
AR 94
DI 10.3389/fnagi.2014.00094
PG 14
WC Geriatrics & Gerontology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Neurosciences & Neurology
GA AL9BY
UT WOS:000339435800001
PM 24904408
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Bozhkov, AI
   Nikitchenko, YV
AF Bozhkov, A. I.
   Nikitchenko, Yu. V.
TI Thermogenesis and longevity in mammals. Thyroxin model of accelerated
   aging
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Thermogenesis; Life span; Epigenotype; Thyroid status
ID CALORIE RESTRICTION; THYROID-HORMONE; RAT-LIVER; LIFE-SPAN;
   MITOCHONDRIAL; HYPERTHYROIDISM; METABOLISM; RADICALS; GROWTH
AB Development of experimental models of life span regulation is an important goal of modern gerontology. We proposed a thyroxin model of accelerated aging. Male Wistar rats at the age of 17 months received thyroxin in drinking water at a concentration of 6 mg/L for 2 months as a model of induced hyperthyroidism (IH). Administration of thyroxin resulted in a decrease in life span and a 2 degrees C increase in body temperature that was accompanied by a 2 fold increase in thyroxin level and a 40% increase in triiodothyronine in blood serum. Induced hyperthyroidism can be used as a model of accelerated aging. We also found that thyroxin administration acts as uncoupler of oxidative phosphorylation as treatment was accompanied by an increase in the generation of superoxide radicals by 50%. Antioxidant enzyme activity remained unchanged (glutathione peroxidase, glutathione reductase mitochondrial) or was reduced (glutathione-S-transferase by 1.7 times) as compared with the control. The activity of glucose-6-transferase was increased by 2.8 times as compared with control, and malate dehydrogenase activity in liver increased by 6.8 times. Induced hyperthyroidism in rats resulted in distinct epigenotype which was accompanied by a decrease in life span. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Bozhkov, A. I.; Nikitchenko, Yu. V.] V N Karazin Kharkov Natl Univ, Res Inst Biol, UA-61022 Kharkov, Ukraine.
C3 Ministry of Education & Science of Ukraine; VN Karazin Kharkiv National
   University
RP Bozhkov, AI (corresponding author), V N Karazin Kharkov Natl Univ, Res Inst Biol, UA-61022 Kharkov, Ukraine.
EM bozhkov@univer.kharkov.ua
OI Bozhkov, Anatoly/0009-0007-0971-8763; Nikitchenko,
   Yuri/0009-0001-9075-1179
CR Adjeitey CNK, 2013, AM J PHYSIOL-ENDOC M, V305, pE405, DOI 10.1152/ajpendo.00057.2013
   Aggarwal N, 2013, J THROID RES, V2013, DOI 10.1155/2013/481287
   Alva-Sánchez C, 2012, NEUROENDOCRINOL LETT, V33, P703
   ASAKAWA T, 1980, LIPIDS, V15, P137, DOI 10.1007/BF02540959
   Barja G, 2004, BIOL REV, V79, P235, DOI 10.1017/S1464793103006213
   BAUMAN DE, 1970, ARCH BIOCHEM BIOPHYS, V140, P237, DOI 10.1016/0003-9861(70)90028-7
   Bonkowski MS, 2006, P NATL ACAD SCI USA, V103, P7901, DOI 10.1073/pnas.0600161103
   Bozhkov A.I., 2001, USPECHY GERONTOL, P89
   CARLBERG I, 1975, J BIOL CHEM, V250, P5475
   Crosas-Molist E, 2014, FREE RADICAL BIO MED, V69, P338, DOI 10.1016/j.freeradbiomed.2014.01.040
   DENSCKA WD, 1974, J CLIN INVEST, V53, P572
   Frijhoff J, 2014, FREE RADICAL BIO MED, V68, P268, DOI 10.1016/j.freeradbiomed.2013.12.022
   GUSKOVA RA, 1980, BIOFIZIKA+, V25, P102
   JOHNSON HD, 1963, J GERONTOL, V18, P29, DOI 10.1093/geronj/18.1.29
   KAMATH SA, 1972, ANAL BIOCHEM, V48, P53, DOI 10.1016/0003-2697(72)90169-8
   LEVINE RL, 1994, METHOD ENZYMOL, V233, P346
   Little AG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-26
   Maity S, 2013, J ENDOCRINOL, V217, P215, DOI 10.1530/JOE-12-0304
   Marrazzo G, 2014, CRIT REV FOOD SCI, V54, P1599, DOI 10.1080/10408398.2011.644874
   MASSIE HR, 1983, EXP GERONTOL, V18, P277, DOI 10.1016/0531-5565(83)90038-4
   McCarthy DA, 2013, J BIOL CHEM, V288, P32149, DOI 10.1074/jbc.M113.493841
   McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63
   Merry BJ, 2002, INT J BIOCHEM CELL B, V34, P1340, DOI 10.1016/S1357-2725(02)00038-9
   MILLER GL, 1959, ANAL CHEM, V31, P964, DOI 10.1021/ac60149a611
   MISRA HP, 1972, J BIOL CHEM, V247, P3170
   Niforou K, 2014, REDOX BIOL, V2, P323, DOI 10.1016/j.redox.2014.01.017
   Nikitchenko YuV., 2013, J NUTR THER, V2, P30
   NIKITIN VN, 1960, P RES I BIOL BIOL FA, V29, P111
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   OOKA H, 1986, MECH AGEING DEV, V33, P275, DOI 10.1016/0047-6374(86)90052-7
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015
   RAVIN HA, 1956, LANCET, V270, P726
   Reddy PA, 2012, INDIAN J MED RES, V135, P277
   Silva JE, 2003, ANN INTERN MED, V139, P205, DOI 10.7326/0003-4819-139-3-200308050-00010
   SKULACHEV VP, 1969, ACCUMULATION ENERGY
   Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002
   USATENKO MS, 1974, VOP MED KHIM, V20, P401
   Vidali S, 2014, J INVEST DERMATOL, V134, P33, DOI 10.1038/jid.2013.286
   Vitetta L, 2014, INFLAMMOPHARMACOLOGY, V22, P69, DOI 10.1007/s10787-014-0199-7
   Walford RL, 1988, THE RETARDATION OF A
   Walrand S, 2014, FASEB J, V28, P1499, DOI 10.1096/fj.13-239806
   Yap CS, 2013, BIOCHEM BIOPH RES CO, V440, P635, DOI 10.1016/j.bbrc.2013.09.116
   YOUNES M, 1980, PHARMACOL RES COMMUN, V12, P115, DOI 10.1016/S0031-6989(80)80069-5
   ZAHEER N, 1967, ARCH BIOCHEM BIOPHYS, V120, P22, DOI 10.1016/0003-9861(67)90593-0
   1986, OFFICIAL J L, V358
NR 46
TC 7
Z9 9
U1 0
U2 11
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD DEC
PY 2014
VL 60
BP 173
EP 182
DI 10.1016/j.exger.2014.10.017
PG 10
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA AW1RW
UT WOS:000346068300025
PM 25446982
DA 2024-02-19
ER

PT J
AU Yang, ZJ
   Gao, SS
   Wong, CC
   Liu, WX
   Chen, HR
   Shang, HY
   Wu, ZY
   Xu, LX
   Zhang, X
   Wong, N
   Kuang, M
   Yu, J
AF Yang, Zhenjie
   Gao, Shanshan
   Wong, Chi Chun
   Liu, Weixin
   Chen, Huarong
   Shang, Haiyun
   Wu, Zoe Yuet
   Xu, Lixia
   Zhang, Xiang
   Wong, Nathalie
   Kuang, Ming
   Yu, Jun
TI TUBB4B is a novel therapeutic target in non-alcoholic fatty liver
   disease-associated hepatocellular carcinoma
SO JOURNAL OF PATHOLOGY
LA English
DT Article; Early Access
DE CRISPR-Cas9 knockout screening; non-alcoholic fatty liver disease; liver
   neoplasms; TUBB4B; cellular senescence; apoptosis
ID SCALE CRISPR-CAS9 KNOCKOUT; SENESCENT CELLS; MEBENDAZOLE
AB Non-alcoholic fatty liver disease-associated hepatocellular carcinoma (NAFLD-HCC) is an emerging malignancy due to the rising prevalence of NAFLD. However, no drug is available to target NAFLD-HCC. In this study, we aim to unravel novel therapeutic targets of NAFLD-HCC utilizing a high-throughput CRISPR/Cas9 screening strategy. We utilized the Epi-drug CRISPR/Cas9 library consisting of single-guide RNAs (sgRNAs) targeting over 1,000 genes representing the FDA-approved drug targets and epigenetic regulators to perform loss-of-function screening in two NAFLD-HCC cell lines (HKCI2 and HKCI10). CRISPR/Cas9 library screening unraveled TUBB4B as an essential gene for NAFLD-HCC cell growth. TUBB4B was overexpressed in NAFLD-HCC tumors compared with adjacent normal tissues (N = 17) and was associated with poor survival (p < 0.01). RNA-sequencing and functional assays revealed that TUBB4B knockout in NAFLD-HCC promoted cell apoptosis, cell cycle arrest, and cellular senescence, leading to suppressed NAFLD-HCC growth in vitro and in vivo. We identified that TUBB4B inhibitor mebendazole (MBZ), an FDA-approved drug, inhibited NAFLD-HCC growth by inducing apoptosis and cellular senescence. Since protein expression of pro-survival Bcl-xL was induced in TUBB4B knockout NAFLD-HCC cells, we examined combination of TUBB4B inhibition with navitoclax, a Bcl-xL inhibitor that selectively targets senescent cells. Consistent with our hypothesis, either TUBB4B knockout or MBZ synergized with navitoclax to inhibit NAFLD-HCC cell growth via the induction of intrinsic and extrinsic apoptosis pathways. In summary, TUBB4B is a novel therapeutic target in NAFLD-HCC. Inhibition of TUBB4B with MBZ in combination with navitoclax synergistically inhibited NAFLD-HCC cell growth, representing a promising strategy for the treatment of NAFLD-HCC. (c) 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
C1 [Yang, Zhenjie; Gao, Shanshan; Wong, Chi Chun; Liu, Weixin; Chen, Huarong; Shang, Haiyun; Wu, Zoe Yuet; Zhang, Xiang; Yu, Jun] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, CUHK Shenzhen Res Inst, Dept Med & Therapeut,State Key Lab Digest Dis, Hong Kong, Peoples R China.
   [Yang, Zhenjie; Gao, Shanshan; Wong, Chi Chun; Liu, Weixin; Chen, Huarong; Shang, Haiyun; Wu, Zoe Yuet; Zhang, Xiang; Yu, Jun] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Peoples R China.
   [Xu, Lixia] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Oncol, Guangzhou, Peoples R China.
   [Wong, Nathalie] Univ Hong Kong, Dept Surg, Hong Kong, Peoples R China.
   [Kuang, Ming] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Surg, Guangzhou, Peoples R China.
   [Yu, Jun] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Peoples R China.
   [Yu, Jun] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Peoples R China.
C3 Chinese University of Hong Kong; CUHK Shenzhen Research Institute;
   Chinese University of Hong Kong; Sun Yat Sen University; University of
   Hong Kong; Sun Yat Sen University; Chinese University of Hong Kong;
   Prince of Wales Hospital; Chinese University of Hong Kong
RP Yu, J (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Peoples R China.; Yu, J (corresponding author), Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Peoples R China.
EM junyu@cuhk.edu.hk
RI chen, huarong/ABH-8561-2020
OI chen, huarong/0000-0003-2192-1864
FU HMRF Hong Kong [09202626]; RGC Theme-based Research Scheme
   [T12-703/19-R]; RGC Collaborative Research Fund [C4041-17GF]; RGC
   Research Impact Fund [R4017-18F]; Kingboard Precision Oncology Program,
   The Chinese University of Hong Kong; RGC-General Research Fund; CUHK; 
   [14108718];  [24100520];  [4930775]
FX We thank Professor Housheng Hansen He for kindly providing the Epi-drug
   sgRNA library. This project was supported by HMRF Hong Kong (09202626);
   RGC Theme-based Research Scheme (T12-703/19-R); RGC Collaborative
   Research Fund (C4041-17GF); RGC Research Impact Fund (R4017-18F); The
   Kingboard Precision Oncology Program, The Chinese University of Hong
   Kong; RGC-General Research Fund (14108718, 24100520); Vice-Chancellor's
   Discretionary Fund CUHK (4930775).
CR Ally A, 2017, CELL, V169, P1327, DOI 10.1016/j.cell.2017.05.046
   Ascha MS, 2010, HEPATOLOGY, V51, P1972, DOI 10.1002/hep.23527
   Bai RY, 2015, CLIN CANCER RES, V21, P3462, DOI 10.1158/1078-0432.CCR-14-2681
   Basu A, 2022, PHARMACOL THERAPEUT, V230, DOI 10.1016/j.pharmthera.2021.107943
   Chen HR, 2021, GASTROENTEROLOGY, V160, P1284, DOI 10.1053/j.gastro.2020.11.013
   Chen HR, 2019, THERANOSTICS, V9, P5246, DOI 10.7150/thno.34713
   Corsello SM, 2020, NAT CANCER, V1, P235, DOI 10.1038/s43018-019-0018-6
   Dharmapal D, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.788024
   Eggert T, 2016, CANCER CELL, V30, P533, DOI 10.1016/j.ccell.2016.09.003
   Estes C, 2018, J HEPATOL, V69, P896, DOI 10.1016/j.jhep.2018.05.036
   Fan JG, 2017, J HEPATOL, V67, P862, DOI 10.1016/j.jhep.2017.06.003
   Gao SS, 2021, ONCOGENE, V40, P6601, DOI 10.1038/s41388-021-01882-7
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Guerini AE, 2019, CANCERS, V11, DOI 10.3390/cancers11091284
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   Joung J, 2017, NAT PROTOC, V12, P828, DOI 10.1038/nprot.2017.016
   Kwan SY, 2020, HEPATOLOGY, V71, P275, DOI 10.1002/hep.30807
   Lee S, 2019, NAT CELL BIOL, V21, P94, DOI 10.1038/s41556-018-0249-2
   Li W, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0843-6
   Llovet JM, 2018, NAT REV CLIN ONCOL, V15, P599, DOI 10.1038/s41571-018-0073-4
   Milanovic M, 2018, NATURE, V553, P96, DOI 10.1038/nature25167
   Nardella C, 2011, NAT REV CANCER, V11, P503, DOI 10.1038/nrc3057
   Pribluda A, 2013, CANCER CELL, V24, P242, DOI 10.1016/j.ccr.2013.06.005
   Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252
   Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005
   Shi J, 2011, CANCER RES, V71, P4518, DOI 10.1158/0008-5472.CAN-10-4336
   Sobierajska K, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080810
   van Meerloo J, 2011, METHODS MOL BIOL, V731, P237, DOI 10.1007/978-1-61779-080-5_20
   Villanueva A, 2019, NEW ENGL J MED, V380, P1450, DOI 10.1056/NEJMra1713263
   Wang C, 2019, NATURE, V574, P268, DOI 10.1038/s41586-019-1607-3
   Wang R, 2017, AGING CELL, V16, P564, DOI 10.1111/acel.12587
   Williamson T, 2016, ONCOTARGET, V7, P68571, DOI 10.18632/oncotarget.11851
   Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD1074, DOI 10.1093/nar/gkx1037
   Xiong SM, 2019, TRENDS CELL BIOL, V29, P623, DOI 10.1016/j.tcb.2019.05.001
   Xu MJ, 2022, CANCER LETT, V548, DOI 10.1016/j.canlet.2022.215898
   Yau EH, 2017, CANCER RES, V77, P6330, DOI 10.1158/0008-5472.CAN-17-2043
   Yosef R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11190
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Yu J, 2013, SEMIN CANCER BIOL, V23, P483, DOI 10.1016/j.semcancer.2013.07.003
   Zucman-Rossi J, 2015, GASTROENTEROLOGY, V149, P1226, DOI 10.1053/j.gastro.2015.05.061
NR 40
TC 2
Z9 2
U1 4
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3417
EI 1096-9896
J9 J PATHOL
JI J. Pathol.
PD 2023 MAY
PY 2023
VL 260
IS 1
BP 71
EP 83
DI 10.1002/path.6065
EA MAR 2023
PG 13
WC Oncology; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Pathology
GA C2IM6
UT WOS:000950498700001
PM 36787097
OA hybrid
DA 2024-02-19
ER

PT J
AU Wauthier, V
   Verbeeck, RK
   Calderon, PB
AF Wauthier, V
   Verbeeck, RK
   Calderon, PB
TI Age-related changes in the protein and mRNA levels of CYP2E1 and CYP3A
   isoforms as well as in their hepatic activities in Wistar rats. What
   role for oxidative stress?
SO ARCHIVES OF TOXICOLOGY
LA English
DT Article
DE cytochrome P450; ageing; oxidative stress; proteasome
ID DRUG-METABOLISM; LIVER-MICROSOMES; PROTEOLYSIS; CYTOCHROME-P-450;
   DEGRADATION; PHARMACOKINETICS; EXPRESSION; MIDAZOLAM; SYSTEMS; PLASMA
AB Drug biotransformation and its therapeutic effect may be modified during ageing. Among different causative factors of ageing, the impairment of normal cellular functions by free radicals has been evoked as playing a critical role. The effect of age on the expression and activity of CYP2E1 and CYP3A was investigated in male Wistar rats of 3, 8, 11 and 18 months old. The total cytochrome P450 as well as the expression and the activity (midazolam oxidation) of CYP3A isoforms did not change until 18 months of age. Chlorzoxazone hydroxylation (CYP2E1 activity) increased from 3 to 8 months, remained constant between 8 and 11 months and then progressively decreased until 18 months. Interestingly, CYP2E1 microsomal protein followed the same enzyme activity profile from 3 to 8 months, but remained constant thereafter. The level of CYP2E1 mRNA did not change over the whole period. While the amount of proteins did not change after 8 months, their functionality may be affected by oxidative stress (increase in thiobarbituric acid reactive substances, decrease in reduced glutathione level). However, no changes in carbonyl protein content were observed. The decrease in CYP2E1 activity in rats after 11 months is most probably due to post-translational modifications of CYP2E1 proteins. Indeed, it may be correlated with an accumulation of oxidative damage. Since no change was observed in CYP3A activity or in their protein and mRNA content, it seems that such isoforms should be less affected by oxidative stress.
C1 Catholic Univ Louvain, Unite Pharmacocinet Metab Nutr & Toxicol, Dept Pharmaceut Sci, B-1200 Brussels, Belgium.
C3 Universite Catholique Louvain
RP Calderon, PB (corresponding author), Catholic Univ Louvain, Unite Pharmacocinet Metab Nutr & Toxicol, Dept Pharmaceut Sci, Ave E Mounier 73, B-1200 Brussels, Belgium.
EM calderon@pmnt.ucl.ac.be
OI Verbeeck, Roger/0000-0003-3009-2826
CR Balducci L, 2000, EUR J CANCER, V36, P1741, DOI 10.1016/S0959-8049(00)00169-6
   BIRNBAUM LS, 1980, EXP GERONTOL, V15, P259, DOI 10.1016/0531-5565(80)90030-3
   Bogdanov M, 2000, FREE RADICAL BIO MED, V29, P652, DOI 10.1016/S0891-5849(00)00349-X
   Bulteau AL, 2002, ARCH BIOCHEM BIOPHYS, V397, P298, DOI 10.1006/abbi.2001.2663
   Bulteau AL, 2000, EXP GERONTOL, V35, P767, DOI 10.1016/S0531-5565(00)00136-4
   DODDS C, 1995, PHARMACOL THERAPEUT, V66, P369, DOI 10.1016/0163-7258(94)00070-J
   Dukan S, 2000, P NATL ACAD SCI USA, V97, P5746, DOI 10.1073/pnas.100422497
   Eeckhoudt SL, 1998, J CHROMATOGR B, V710, P165, DOI 10.1016/S0378-4347(98)00137-6
   EKSTROM G, 1989, BIOCHEM PHARMACOL, V38, P1313, DOI 10.1016/0006-2952(89)90338-9
   ELIASSON E, 1992, J BIOL CHEM, V267, P15765
   Espínola EB, 1999, PHARMACOL BIOCHEM BE, V62, P419, DOI 10.1016/S0091-3057(98)00192-0
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   FRIGUET B, 1994, ARCH BIOCHEM BIOPHYS, V311, P168, DOI 10.1006/abbi.1994.1222
   GEORGE J, 1995, BIOCHEM PHARMACOL, V50, P727, DOI 10.1016/0006-2952(95)00192-3
   Goasduff T, 1999, ARCH BIOCHEM BIOPHYS, V370, P258, DOI 10.1006/abbi.1999.1399
   Goasduff T, 2000, ARCH BIOCHEM BIOPHYS, V379, P321, DOI 10.1006/abbi.2000.1870
   Grune T, 2001, J GERONTOL A-BIOL, V56, pB459, DOI 10.1093/gerona/56.11.B459
   Guengrich FP, 1999, ANNU REV PHARMACOL, V39, P1, DOI 10.1146/annurev.pharmtox.39.1.1
   HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2
   HUNT CM, 1990, BIOCHEM PHARMACOL, V40, P1666, DOI 10.1016/0006-2952(90)90470-6
   IMAOKA S, 1991, BIOCHIM BIOPHYS ACTA, V1097, P187, DOI 10.1016/0925-4439(91)90034-7
   KAMATAKI T, 1985, J PHARMACOL EXP THER, V233, P222
   Kobayashi K, 2002, BIOCHEM PHARMACOL, V63, P889, DOI 10.1016/S0006-2952(01)00843-7
   Leclercq I, 1998, J CHROMATOGR A, V828, P291, DOI 10.1016/S0021-9673(98)00588-3
   Leclercq I, 1997, HEPATOLOGY, V26, P1182
   LEVINE RL, 1990, METHOD ENZYMOL, V186, P464
   Levine RL, 2001, EXP GERONTOL, V36, P1495, DOI 10.1016/S0531-5565(01)00135-8
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Mahnke Z, 1997, ARCH BIOCHEM BIOPHYS, V337, P62, DOI 10.1006/abbi.1996.9752
   NAKAJIMA T, 1992, J PHARMACOL EXP THER, V261, P869
   Oesch-Bartlomowicz B, 2003, ARCH BIOCHEM BIOPHYS, V409, P228, DOI 10.1016/S0003-9861(02)00558-1
   OMURA T, 1964, J BIOL CHEM, V239, P2370
   RIKANS LE, 1989, DRUG METAB DISPOS, V17, P114
   RIKANS LE, 1982, J PHARMACOL EXP THER, V220, P574
   Ronis M.J.J., 1996, CYTOCHROMES P, V450, P211
   SCHMUCKER DL, 1990, CLIN PHARMACOL THER, V48, P365, DOI 10.1038/clpt.1990.164
   Schmucker DL, 2001, DRUG AGING, V18, P837, DOI 10.2165/00002512-200118110-00005
   SCHMUCKER DL, 1981, MECH AGEING DEV, V15, P189, DOI 10.1016/0047-6374(81)90074-9
   Smorenburg CH, 2003, EUR J CANCER, V39, P196, DOI 10.1016/S0959-8049(02)00611-1
   Sotaniemi EA, 1997, CLIN PHARMACOL THER, V61, P331, DOI 10.1016/S0009-9236(97)90166-1
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   Stadtman ER, 2002, FREE RADICAL BIO MED, V33, P597, DOI 10.1016/S0891-5849(02)00904-8
   STARKEREED PE, 1989, ARCH BIOCHEM BIOPHYS, V275, P559, DOI 10.1016/0003-9861(89)90402-5
   Szweda PA, 2002, FREE RADICAL BIO MED, V33, P29, DOI 10.1016/S0891-5849(02)00837-7
   Tanira MOM, 1997, LIFE SCI, V60, P413, DOI 10.1016/S0024-3205(96)00666-2
   TAPER HS, 1988, ARCH TOXICOL, V61, P406, DOI 10.1007/BF00334622
   THOMAS PE, 1987, BIOCHEMISTRY-US, V26, P2280, DOI 10.1021/bi00382a031
   VANBEZOOIJEN RL, 1994, EXP GERONTOL, V29, P187, DOI 10.1016/0531-5565(94)90050-7
   Warrington JS, 2000, J PHARMACOL EXP THER, V292, P1024
NR 49
TC 33
Z9 36
U1 0
U2 0
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5761
EI 1432-0738
J9 ARCH TOXICOL
JI Arch. Toxicol.
PD MAR
PY 2004
VL 78
IS 3
BP 131
EP 138
DI 10.1007/s00204-003-0526-z
PG 8
WC Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Toxicology
GA 804KX
UT WOS:000220298700002
PM 14600803
DA 2024-02-19
ER

PT J
AU Cavallini, G
   Donati, A
   Taddei, M
   Bergamini, E
AF Cavallini, Gabriella
   Donati, Alessio
   Taddei, Michele
   Bergamini, Ettore
TI Evidence for selective mitochondrial autophagy and failure in aging
SO AUTOPHAGY
LA English
DT Article
DE autophagy; mitophagy; 8-OHdG; cytocrome c oxidase; antilipolytic agents;
   rat liver
ID PROTEIN-DEGRADATION; OXIDATIVE STRESS; RAT-LIVER; HEPATOCYTES;
   IMPAIRMENT; MECHANISMS; MICE; DNA
AB Autophagy is a major intracellular degradation/recycling system ubiquitous in eukaryotic cells. It contributes to the turnover of cellular components by delivering portions of the cytoplasm and organelles to lysosomes, where they are digested. Starvation-induced autophagy is required for maintaining an amino acid pool for gluconeogenesis and for the synthesis of proteins essential to survival under starvation conditions. In addition, autophagy plays an important role in the degradation of excess or injured organelles, including mitochondria. To test the hypothesis of an involvement of a decrease in autophagy in the process of aging, we explored the antiaging effects of pharmacological stimulation of autophagy on the age-dependent accumulation of 8-OHdG-rich mitochondria in rat liver. Male 3-month and 16-month-old 24 hours-fasted Sprague Dawley rats were injected with the antilipolytic agent [3,5-dimethylpyrazole (DMP)] intraperitoneally. Results showed that drug injection rescued older cells from the accumulation of 8-OHdG in the mtDNA in less than 6 hours, but no significant decrease in the level of cytocrome c oxidase activity was observed. Together, these data provide indirect evidence that 8-OHdG might accumulate in a small pool of mitochondria with increasing age rather than be degraded by the autophagic machinery selectively.
C1 Univ Pisa, Ctr Ric Biol & Patol Invecchiamento, I-56126 Pisa, Italy.
C3 University of Pisa
RP Bergamini, E (corresponding author), Univ Pisa, Ctr Ric Biol & Patol Invecchiamento, Via Roma 55, I-56126 Pisa, Italy.
EM ebergami@med.unipi.it
CR Alexeyev MF, 2004, CLIN SCI, V107, P355, DOI 10.1042/CS20040148
   BERGAMINI E, 1993, EXP MOL PATHOL, V59, P13, DOI 10.1006/exmp.1993.1023
   Cuervo AM, 2004, MOL CELL BIOCHEM, V263, P55, DOI 10.1023/B:MCBI.0000041848.57020.57
   Donati A, 2001, J GERONTOL A-BIOL, V56, pB288, DOI 10.1093/gerona/56.7.B288
   Donati A, 2006, REJUV RES, V9, P408, DOI 10.1089/rej.2006.9.408
   Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje
   GLAUMANN H, 1981, INT REV CYTOL, V73, P149, DOI 10.1016/S0074-7696(08)61288-7
   Gu YP, 2004, FEBS LETT, V577, P357, DOI 10.1016/j.febslet.2004.10.040
   Kissová I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200
   Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717
   Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022
   Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3
   Majeski AE, 2004, INT J BIOCHEM CELL B, V36, P2435, DOI 10.1016/j.biocel.2004.02.013
   Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704
   MORTIMORE GE, 1989, DIABETES METAB REV, V5, P49, DOI 10.1002/dmr.5610050105
   PFEIFER U, 1978, J CELL BIOL, V78, P152, DOI 10.1083/jcb.78.1.152
   Seglen P O, 1990, Semin Cell Biol, V1, P441
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
NR 20
TC 53
Z9 63
U1 3
U2 12
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1554-8627
EI 1554-8635
J9 AUTOPHAGY
JI Autophagy
PD JAN-FEB
PY 2007
VL 3
IS 1
BP 26
EP 27
DI 10.4161/auto.3268
PG 2
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 126FY
UT WOS:000243499200006
PM 16963838
OA Bronze
DA 2024-02-19
ER

PT J
AU Amelina, H
   Sjödin, MOD
   Bergquist, J
   Cristobal, S
AF Amelina, Hanna
   Sjodin, Marcus O. D.
   Bergquist, Jonas
   Cristobal, Susana
TI Quantitative subproteomic analysis of age-related changes in mouse liver
   peroxisomes by iTRAQ LC-MS/MS
SO JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL
   AND LIFE SCIENCES
LA English
DT Article
DE Liquid chromatography; Tandem mass spectrometry; Peroxisomes; Aging;
   Liver; iTRAQ
ID RAT-LIVER; MITOCHONDRIAL PROTEOME; GENE-EXPRESSION; MESSENGER-RNA;
   KIDNEY; POLLUTANTS; PROTEINS; SPECTRA; BINDING; TISSUE
AB Aging is a complex multifactorial phenomenon, which is believed to result from the accumulation of cellular damage to biological macromolecules. Peroxisomes recently emerged as another important source of reactive oxygen species (ROS) production in addition to mitochondria. However, the role of these organelles in the process of aging is still not clear. The aim of this study was to characterize the changes in protein expression profiles of young (10 weeks old) versus old (18 months old) mouse liver peroxisome-enriched fractions. We have applied shotgun proteomic approach based on liquid chromatography and tandem mass spectrometry (LC-MS/MS) combined with iTRAQ (isobaric tags for relative and absolute quantitation) labeling that allows comparative quantitative multiplex analysis. Our analysis led to identification and quantification of 150 proteins, 8 out of which were differentially expressed between two age groups at a statistically significant level (p < 0.05), with folds ranging from 1.2 to 4.1. These proteins involved in peroxisornal beta-oxidation, detoxification of xenobiotics and production of ROS. Noteworthy, differences in liver proteome have been observed between as well as within different age groups. In conclusion, our subproteomic quantitative study suggests that mouse liver proteome is sufficiently maintained until certain age. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Amelina, Hanna; Cristobal, Susana] Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.
   [Sjodin, Marcus O. D.; Bergquist, Jonas] Uppsala Univ, Dept Phys & Analyt Chem, SE-75124 Uppsala, Sweden.
   [Cristobal, Susana] Linkoping Univ, Dept Clin & Expt Med, SE-58103 Linkoping, Sweden.
   [Cristobal, Susana] Univ Basque Country, Dept Physiol, Basque Fdn Sci, IKERBASQUE, Leioa 48940, Spain.
C3 Stockholm University; Uppsala University; Linkoping University;
   University of Basque Country; Basque Foundation for Science
RP Amelina, H (corresponding author), Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.
EM hanna.amelina@dbb.su.se
RI Bergquist, Jonas/C-5894-2015
OI Amelina, Hanna/0000-0002-9006-9217; Bergquist,
   Jonas/0000-0002-4597-041X; Cristobal, Susana/0000-0002-3894-2218
FU Swedish Research Council - Medicine; Swedish Research Council - Natural
   Science; Carl Trygger Foundation; VINNOVA - Vinnmer program; Magnus
   Bergvalls Foundation; Oscar and Lilli Lamms Minne Foundation;
   IKERBASQUE; CBR-SSF
FX This work was supported by grants from the Swedish Research Council -
   Medicine and Swedish Research Council - Natural Science (VR-M and VR-N),
   Carl Trygger Foundation, VINNOVA - Vinnmer program, Magnus Bergvalls
   Foundation, Oscar and Lilli Lamms Minne Foundation, IKERBASQUE, CBR-SSF.
CR Amelina H, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-16
   Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333
   Apraiz I, 2006, MOL CELL PROTEOMICS, V5, P1274, DOI 10.1074/mcp.M500333-MCP200
   Artal-Sanz M, 2009, NATURE, V461, P793, DOI 10.1038/nature08466
   BEIER K, 1993, VIRCHOWS ARCH B, V63, P139, DOI 10.1007/BF02899254
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Carrette O, 2006, PROTEOMICS, V6, P4940, DOI 10.1002/pmic.200600084
   Chang J, 2007, J GERONTOL A-BIOL, V62, P223, DOI 10.1093/gerona/62.3.223
   Dencher NA, 2006, ANN NY ACAD SCI, V1067, P116, DOI 10.1196/annals.1354.014
   DiMauro T, 2009, AGING-US, V1, P182, DOI 10.18632/aging.100023
   Djojosubroto MW, 2003, MOL CELLS, V15, P164
   Dollé MET, 2000, P NATL ACAD SCI USA, V97, P8403, DOI 10.1073/pnas.97.15.8403
   Fu CX, 2006, MECH AGEING DEV, V127, P905, DOI 10.1016/j.mad.2006.09.006
   GHOSH MK, 1986, ANAL BIOCHEM, V159, P169, DOI 10.1016/0003-2697(86)90323-4
   Jing Z, 2005, NEUROBIOL AGING, V26, P207, DOI 10.1016/j.neurobiolaging.2004.03.012
   KIM SK, 1992, ARCH ORAL BIOL, V37, P349, DOI 10.1016/0003-9969(92)90017-3
   Kiri Ajay N, 2005, J Biomol Tech, V16, P371
   Koepke JI, 2008, TOXICOL APPL PHARM, V232, P99, DOI 10.1016/j.taap.2008.06.004
   Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P37, DOI 10.1006/jmcc.2000.1273
   Li M, 2007, J BIOCHEM MOL BIOL, V40, P72
   Melk A, 2005, KIDNEY INT, V68, P2667, DOI 10.1111/j.1523-1755.2005.00738.x
   Mi J, 2005, PROTEOMICS, V5, P3954, DOI 10.1002/pmic.200401243
   Mi J, 2007, PROTEOME SCI, V5, DOI 10.1186/1477-5956-5-19
   Mi J, 2007, PROTEOMICS, V7, P1916, DOI 10.1002/pmic.200600638
   Morley A, 1998, ANN NY ACAD SCI, V854, P20, DOI 10.1111/j.1749-6632.1998.tb09888.x
   O'Connell K, 2009, PROTEOMICS, V9, P5509, DOI 10.1002/pmic.200900472
   Prolla TA, 2002, CHEM SENSES, V27, P299, DOI 10.1093/chemse/27.3.299
   Ryazanov AG, 2002, MECH AGEING DEV, V123, P207, DOI 10.1016/S0047-6374(01)00337-2
   Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200
   Sohal RS, 2008, MECH AGEING DEV, V129, P558, DOI 10.1016/j.mad.2008.04.006
   Terlecky SR, 2006, BBA-MOL CELL RES, V1763, P1749, DOI 10.1016/j.bbamcr.2006.08.017
   THOMPSON SL, 1990, J BIOL CHEM, V265, P5731
   Tollet-Egnell P, 2001, MOL ENDOCRINOL, V15, P308, DOI 10.1210/me.15.2.308
   VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105
   VOLKL A, 1985, EUR J BIOCHEM, V149, P257, DOI 10.1111/j.1432-1033.1985.tb08920.x
   Walther DM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004523
   Weindruch R, 2001, J NUTR, V131, p918S, DOI 10.1093/jn/131.3.918S
NR 37
TC 11
Z9 12
U1 0
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1570-0232
EI 1873-376X
J9 J CHROMATOGR B
JI J. Chromatogr. B
PD NOV 15
PY 2011
VL 879
IS 30
BP 3393
EP 3400
DI 10.1016/j.jchromb.2011.08.044
PG 8
WC Biochemical Research Methods; Chemistry, Analytical
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA 852ZO
UT WOS:000297396200006
PM 21963482
DA 2024-02-19
ER

PT J
AU Koo, JS
   Seong, JK
   Park, C
   Yu, DY
   Oh, BK
   Oh, SH
   Park, YN
AF Koo, JS
   Seong, JK
   Park, C
   Yu, DY
   Oh, BK
   Oh, SH
   Park, YN
TI Large liver cell dysplasia in hepatitis B virus X transgenic mouse liver
   and human chronic hepatitis B virus-infected liver
SO INTERVIROLOGY
LA English
DT Article; Proceedings Paper
CT Japan-Korea Liver Symposium on the Prevention of the Occurence and
   Recurrence of Human Hepatocarcinogenesis in Japan and South Korea
CY JAN 10, 2004
CL Kobe, JAPAN
DE large liver cell dysplasia; hepatitis B virus; HBX transgenic mouse;
   proliferation; apoptosis
ID HEPATOCELLULAR-CARCINOMA; SURFACE-ANTIGEN; CIRRHOSIS; GENE; APOPTOSIS;
   ASSOCIATION; CANCER; MICE; P53
AB Objectives: Large liver cell dysplasia (LCD) is frequently associated with hepatitis B virus (HBV), but it remains uncertain whether it is reactive, senescent or preneoplastic. Methods: The HBX transgenic mice and normal control mice were sacrificed at 1, 3, 5, 7, 9, 11, 13 and 15 months after birth. Twenty-three cases of human B viral chronic hepatitis/cirrhosis with prominent LCD were selected. The immunohistochemical stain of proliferating cell nuclear antigen (PCNA), transferase-mediated dUTP-biotin nick end labeling (TUNEL) assay and senescence-associated beta-galactosidase (SA-beta-Gal) were evaluated. Results: In HBX transgenic mice, LCD was developed since 3 months and formed small nodules of hepatocellular adenoma, which progressed to hepatocellular carcinoma. The hepatocytes with LCD in HBX transgenic mice showed significantly higher PCNA-labeling index (LI) and lower TUNEL-LI than normal hepatocytes of control mice (p < 0.05). In the majority of human B viral chronic hepatitis/cirrhosis, the hepatocytes with LCD revealed higher PCNA-LI and lower TUNEL-LI than those without, when compared in each case using the same tissue block. SA-beta-Gal staining showed no difference between hepatocytes with and without LCD. Conclusion: It is suggested that LCD, related to HBV, might not be just an innocent bystander, but closely related to hepatocarcinogenesis. Copyright (C) 2005 S. Karger AG, Basel.
C1 Yonsei Univ, Coll Med, Ctr Chron Metab Dis Res, Dept Pathol, Seoul, South Korea.
   Yonsei Univ, Coll Med, Inst Gastroenterol, Dept Pathol, Seoul, South Korea.
   Yonsei Univ, Coll Med, Brain Korea 21 Project Med Sci, Seoul, South Korea.
   Seoul Natl Univ, Coll Vet Med, Inst Lab, Seoul, South Korea.
   Seoul Natl Univ, Coll Vet Med, Dept Biol & Genom, Seoul, South Korea.
   Korea Res Inst Biosci & Biotechnol, Taejon, South Korea.
C3 Yonsei University; Yonsei University Health System; Yonsei University;
   Yonsei University Health System; Yonsei University; Yonsei University
   Health System; Seoul National University (SNU); Seoul National
   University (SNU); Korea Research Institute of Bioscience & Biotechnology
   (KRIBB)
RP Park, YN (corresponding author), Yonsei Univ, Coll Med, Ctr Chron Metab Dis Res, Dept Pathol, CPO Box 8044, Seoul, South Korea.
EM young0608@yumc.yonsei.ac.kr
RI Park, Jun Yong/H-7127-2019
OI Seong, Je Kyung/0000-0003-1177-6958; Park, Young
   Nyun/0000-0003-0357-7967; koo, ja seung/0000-0003-4546-4709
CR ADACHI E, 1993, CANCER, V72, P2902, DOI 10.1002/1097-0142(19931115)72:10<2902::AID-CNCR2820721008>3.0.CO;2-2
   AKAGI G, 1984, CANCER, V54, P315, DOI 10.1002/1097-0142(19840715)54:2<315::AID-CNCR2820540223>3.0.CO;2-6
   ANTHONY PP, 1976, CANCER RES, V36, P2579
   ANTHONY PP, 1973, J CLIN PATHOL, V26, P217, DOI 10.1136/jcp.26.3.217
   BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J
   BORZIO M, 1995, GASTROENTEROLOGY, V108, P812, DOI 10.1016/0016-5085(95)90455-7
   Chirillo P, 1997, P NATL ACAD SCI USA, V94, P8162, DOI 10.1073/pnas.94.15.8162
   DIMIRI GP, 1995, P NATL ACAD SCI USA, V92, P9363
   FEITELSON MA, 1993, ONCOGENE, V8, P1109
   GanneCarrie N, 1996, HEPATOLOGY, V23, P1112
   GraslKraupp B, 1997, HEPATOLOGY, V25, P906, DOI 10.1002/hep.510250420
   HENMI A, 1985, CANCER, V55, P2594, DOI 10.1002/1097-0142(19850601)55:11<2594::AID-CNCR2820551111>3.0.CO;2-7
   Hino N, 1996, LIVER, V16, P123
   HO JCI, 1981, INT J CANCER, V28, P571, DOI 10.1002/ijc.2910280507
   KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0
   LeBail B, 1997, J HEPATOL, V27, P835, DOI 10.1016/S0168-8278(97)80321-2
   Lee RG, 1997, HEPATOLOGY, V26, P1415
   Libbrecht L, 2001, HISTOPATHOLOGY, V39, P66, DOI 10.1046/j.1365-2559.2001.01172.x
   Natarajan S, 1997, AM J SURG PATHOL, V21, P312, DOI 10.1097/00000478-199703000-00007
   OMATA M, 1982, Liver, V2, P125
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   RONCALLI M, 1989, INT J CANCER, V44, P204, DOI 10.1002/ijc.2910440203
   RUBIN EM, 1994, MODERN PATHOL, V7, P677
   SAKURAI M, 1978, ACTA PATHOL JAPON, V28, P705
   Takada S, 1997, ONCOGENE, V15, P1895, DOI 10.1038/sj.onc.1201369
   Terris B, 1997, J HEPATOL, V27, P313, DOI 10.1016/S0168-8278(97)80177-8
   THOMAS RM, 1992, HUM PATHOL, V23, P496, DOI 10.1016/0046-8177(92)90126-N
   WANG XW, 1995, CANCER RES, V55, P6012
   WATANABE S, 1983, CANCER, V51, P2197, DOI 10.1002/1097-0142(19830615)51:12<2197::AID-CNCR2820511208>3.0.CO;2-5
   Yu DY, 1999, J HEPATOL, V31, P123, DOI 10.1016/S0168-8278(99)80172-X
NR 30
TC 21
Z9 25
U1 0
U2 3
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0300-5526
EI 1423-0100
J9 INTERVIROLOGY
JI Intervirology
PY 2005
VL 48
IS 1
BP 16
EP 22
DI 10.1159/000082090
PG 7
WC Virology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Virology
GA 909UW
UT WOS:000227887200004
PM 15785085
DA 2024-02-19
ER

PT J
AU Chen, WJ
   Kung, GP
   Gnana-Prakasam, JP
AF Chen, William J.
   Kung, George P.
   Gnana-Prakasam, Jaya P.
TI Role of Iron in Aging Related Diseases
SO ANTIOXIDANTS
LA English
DT Article
DE iron; aging; oxidative stress; chronic diseases; iron chelator
ID LIFE-SPAN; HEREDITARY HEMOCHROMATOSIS; LIPID-PEROXIDATION; OXIDATIVE
   STRESS; SERUM FERRITIN; LIVER-INJURY; MOUSE MODEL; ACCUMULATION;
   CHELATION; HEPCIDIN
AB Iron progressively accumulates with age and can be further exacerbated by dietary iron intake, genetic factors, and repeated blood transfusions. While iron plays a vital role in various physiological processes within the human body, its accumulation contributes to cellular aging in several species. In its free form, iron can initiate the formation of free radicals at a cellular level and contribute to systemic disorders. This is most evident in high iron conditions such as hereditary hemochromatosis, when accumulation of iron contributes to the development of arthritis, cirrhosis, or cardiomyopathy. A growing body of research has further identified iron's contributory effects in neurodegenerative diseases, ocular disorders, cancer, diabetes, endocrine dysfunction, and cardiovascular diseases. Reducing iron levels by repeated phlebotomy, iron chelation, and dietary restriction are the common therapeutic considerations to prevent iron toxicity. Chelators such as deferoxamine, deferiprone, and deferasirox have become the standard of care in managing iron overload conditions with other potential applications in cancer and cardiotoxicity. In certain animal models, drugs with iron chelating ability have been found to promote health and even extend lifespan. As we further explore the role of iron in the aging process, iron chelators will likely play an increasingly important role in our health.
C1 [Chen, William J.; Kung, George P.; Gnana-Prakasam, Jaya P.] St Louis Univ, Dept Ophthalmol, St Louis, MO 63104 USA.
   [Gnana-Prakasam, Jaya P.] St Louis Univ, Dept Biochem & Mol Biol, St Louis, MO 63104 USA.
C3 Saint Louis University; Saint Louis University
RP Gnana-Prakasam, JP (corresponding author), St Louis Univ, Dept Ophthalmol, St Louis, MO 63104 USA.; Gnana-Prakasam, JP (corresponding author), St Louis Univ, Dept Biochem & Mol Biol, St Louis, MO 63104 USA.
EM william.j.chen@health.slu.edu; george.kung@health.slu.edu;
   jaya.gnanaprakasam@health.slu.edu
FU National Eye Institute [R01-EY031008]; American Heart Association
   [14SDG20510062]
FX The financial support from the National Eye Institute (R01-EY031008) and
   the American Heart Association (14SDG20510062) is kindly acknowledged.
CR Agrawal S, 2018, FREE RADICAL BIO MED, V120, P317, DOI 10.1016/j.freeradbiomed.2018.04.002
   Ali MK, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01340-2019
   [Anonymous], 2019, Reference Range Values for Pediatric Care, DOI DOI 10.1542/9781610022811
   Aregbesola A, 2017, ANN CLIN BIOCHEM, V54, P113, DOI 10.1177/0004563216646397
   AXFORD JS, 1991, BAILLIERE CLIN RHEUM, V5, P351, DOI 10.1016/S0950-3579(05)80287-0
   Ayyadevara S, 2013, ANTIOXID REDOX SIGN, V18, P481, DOI 10.1089/ars.2011.4151
   Bloomer SA, 2021, AM J PHYSIOL-GASTR L, V320, pG496, DOI 10.1152/ajpgi.00286.2020
   Boddaert N, 2007, BLOOD, V110, P401, DOI 10.1182/blood-2006-12-065433
   Botelho FV, 2007, J INORG BIOCHEM, V101, P935, DOI 10.1016/j.jinorgbio.2007.03.007
   Brandstädt S, 2013, AGING-US, V5, P270, DOI 10.18632/aging.100548
   Chaston TB, 2003, CLIN CANCER RES, V9, P402
   Chaudhary K, 2019, AM J PHYSIOL-RENAL, V317, pF512, DOI 10.1152/ajprenal.00184.2019
   Chaudhary K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21276-2
   Chua ACG, 2010, WORLD J GASTROENTERO, V16, P663, DOI 10.3748/wjg.v16.i6.663
   Cloonan SM, 2016, NAT MED, V22, P163, DOI 10.1038/nm.4021
   Cook CI, 1998, MECH AGEING DEV, V102, P1, DOI 10.1016/S0047-6374(98)00005-0
   Cornelissen A, 2019, EBIOMEDICINE, V47, P598, DOI 10.1016/j.ebiom.2019.08.014
   Cozzi A, 2019, STEM CELL REP, V13, P832, DOI 10.1016/j.stemcr.2019.09.002
   Crielaard BJ, 2017, NAT REV DRUG DISCOV, V16, P400, DOI 10.1038/nrd.2016.248
   Cross AJ, 2003, CANCER RES, V63, P2358
   DAVALOS A, 1994, STROKE, V25, P1543, DOI 10.1161/01.STR.25.8.1543
   Demeo DL, 2009, AM J HUM GENET, V85, P493, DOI 10.1016/j.ajhg.2009.09.004
   Deschemin JC, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00804
   Dexter DT, 2011, J NEURAL TRANSM, V118, P223, DOI 10.1007/s00702-010-0531-3
   Dhanasekaran M, 2008, PHYTOTHER RES, V22, P6, DOI 10.1002/ptr.2109
   Doherty CP, 2007, J NUTR, V137, P1341, DOI 10.1093/jn/137.5.1341
   Dröge W, 2007, AGING CELL, V6, P361, DOI 10.1111/j.1474-9726.2007.00294.x
   Elalfy MS, 2018, AM J HEMATOL, V93, P262, DOI 10.1002/ajh.24966
   Evangelista AS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/164671
   Fairweather-Tait SJ, 2014, MECH AGEING DEV, V136, P22, DOI 10.1016/j.mad.2013.11.005
   FARAAWI R, 1993, J RHEUMATOL, V20, P448
   Farombi EO, 2005, CLIN EXP PHARMACOL P, V32, P667, DOI 10.1111/j.0305-1870.2005.04248.x
   Faure ME, 2021, INT J ANTIMICROB AG, V58, DOI 10.1016/j.ijantimicag.2021.106438
   Fleming DJ, 2001, AM J CLIN NUTR, V74, P219
   Fonseca-Nunes A, 2014, CANCER EPIDEM BIOMAR, V23, P12, DOI 10.1158/1055-9965.EPI-13-0733
   Gardenghi S, 2010, J CLIN INVEST, V120, P4466, DOI 10.1172/JCI41717
   Geissler C, 2011, NUTRIENTS, V3, P283, DOI 10.3390/nu3030283
   Gkouvatsos K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085530
   GORDEUK VR, 1992, BLOOD, V79, P1855
   GREENBERG G, 1976, BRIT MED J, V1, P1508, DOI 10.1136/bmj.1.6024.1508-a
   Gujja P, 2010, J AM COLL CARDIOL, V56, P1001, DOI 10.1016/j.jacc.2010.03.083
   Gulati V, 2014, CARDIOL REV, V22, P56, DOI 10.1097/CRD.0b013e3182a67805
   Guo ML, 2007, DALTON T, P4951, DOI 10.1039/b705136k
   Guo SL, 2013, J CLIN INVEST, V123, P1531, DOI 10.1172/JCI66969
   Guo ZL, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0330-x
   Hahn P, 2003, ARCH OPHTHALMOL-CHIC, V121, P1099, DOI 10.1001/archopht.121.8.1099
   Hahn P, 2006, NEUROREPORT, V17, P1803, DOI 10.1097/WNR.0b013e3280107776
   Hahn P, 2009, EXP GERONTOL, V44, P594, DOI 10.1016/j.exger.2009.06.006
   HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001
   Hare DJ, 2017, NPJ PARKINSONS DIS, V3, DOI 10.1038/s41531-016-0004-y
   Harrison SA, 2005, MED CLIN N AM, V89, P391, DOI 10.1016/j.mcna.2004.08.005
   Huang HL, 2002, TOXICOL APPL PHARM, V180, P118, DOI 10.1006/taap.2002.9378
   Huang X, 2008, LANCET ONCOL, V9, P803, DOI 10.1016/S1470-2045(08)70200-6
   HURRELL RF, 1992, AM J CLIN NUTR, V56, P573, DOI 10.1093/ajcn/56.3.573
   Ichikawa Y, 2014, J CLIN INVEST, V124, P617, DOI 10.1172/JCI72931
   Jacomin AC, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00142
   James SA, 2015, CHEM SCI, V6, P2952, DOI 10.1039/c5sc00233h
   Jiang R, 2004, JAMA-J AM MED ASSOC, V291, P711, DOI 10.1001/jama.291.6.711
   Jiao Y, 2006, FREE RADICAL BIO MED, V40, P1152, DOI 10.1016/j.freeradbiomed.2005.11.003
   Kalpouzos G, 2021, NEUROPSYCHOPHARM REP, V41, P393, DOI 10.1002/npr2.12197
   Kastman EK, 2010, J NEUROSCI, V30, P7940, DOI 10.1523/JNEUROSCI.0835-10.2010
   KENNEDY TP, 1990, J CLIN INVEST, V86, P1565, DOI 10.1172/JCI114876
   Killilea DW, 2004, ANN NY ACAD SCI, V1019, P365, DOI 10.1196/annals.1297.063
   Kim MK, 2012, AM J HYPERTENS, V25, P492, DOI 10.1038/ajh.2011.241
   Klang IM, 2014, AGING-US, V6, P975, DOI 10.18632/aging.100689
   Kohgo Y, 2008, INT J HEMATOL, V88, P7, DOI 10.1007/s12185-008-0120-5
   Kratz A, 2004, NEW ENGL J MED, V351, P1548, DOI 10.1056/NEJMcpc049016
   Lakhal-Littleton S, 2015, P NATL ACAD SCI USA, V112, P3164, DOI 10.1073/pnas.1422373112
   Lee SC, 2001, HYPERTENSION, V38, P166, DOI 10.1161/01.HYP.38.2.166
   Levi S, 2005, BEST PRACT RES CL HA, V18, P265, DOI 10.1016/j.beha.2004.08.021
   Levi S, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00099
   Li XY, 2019, G3-GENES GENOM GENET, V9, P513, DOI 10.1534/g3.118.200803
   Liu JL, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00632
   Lunova M, 2014, J HEPATOL, V61, P633, DOI 10.1016/j.jhep.2014.04.034
   Mandala A, 2021, AM J PHYSIOL-GASTR L, V321, pG262, DOI 10.1152/ajpgi.00129.2021
   Mandala A, 2020, NPJ AGING MECH DIS, V6, DOI 10.1038/s41514-020-00050-7
   Martin-Bastida A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01402-2
   Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192
   Masaldan S, 2018, REDOX BIOL, V14, P100, DOI 10.1016/j.redox.2017.08.015
   MASSIE HR, 1983, EXP GERONTOL, V18, P277, DOI 10.1016/0531-5565(83)90038-4
   MASSIE HR, 1985, MECH AGEING DEV, V29, P215, DOI 10.1016/0047-6374(85)90020-X
   Mayr R, 2010, J HEPATOL, V53, P941, DOI 10.1016/j.jhep.2010.05.016
   McDermott JH, 2005, J CLIN ENDOCR METAB, V90, P2451, DOI 10.1210/jc.2004-0980
   Millan M, 2007, STROKE, V38, P90, DOI 10.1161/01.STR.0000251798.25803.e0
   Minor RK, 2010, J GERONTOL A-BIOL, V65, P695, DOI 10.1093/gerona/glq042
   Mleczko-Sanecka K, 2014, BLOOD, V123, P1574, DOI 10.1182/blood-2013-07-515957
   Montella-Manuel S, 2021, BIOCHEM J, V478, P811, DOI 10.1042/BCJ20200849
   Neves J, 2017, EBIOMEDICINE, V20, P230, DOI 10.1016/j.ebiom.2017.04.036
   Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683
   Nishina S, 2021, BMC GASTROENTEROL, V21, DOI 10.1186/s12876-021-01674-z
   Nogueira-Recalde U, 2019, EBIOMEDICINE, V45, P588, DOI 10.1016/j.ebiom.2019.06.049
   Olynyk JK, 2005, AM J GASTROENTEROL, V100, P837, DOI 10.1111/j.1572-0241.2005.41287.x
   Ostrerova-Golts N, 2000, J NEUROSCI, V20, P6048, DOI 10.1523/JNEUROSCI.20-16-06048.2000
   Perez CA, 2009, J INORG BIOCHEM, V103, P326, DOI 10.1016/j.jinorgbio.2008.11.003
   Petillon C, 2019, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.01031
   Phiwchai I, 2018, EUR J PHARM SCI, V114, P64, DOI 10.1016/j.ejps.2017.12.004
   Pietrangelo A, 2005, GASTROENTEROLOGY, V128, P470, DOI 10.1053/j.gastro.2004.11.057
   Polla AS, 2003, AGEING RES REV, V2, P25, DOI 10.1016/S1568-1637(02)00048-X
   Preza GC, 2011, J CLIN INVEST, V121, P4880, DOI 10.1172/JCI57693
   Ramos P, 2014, J TRACE ELEM MED BIO, V28, P13, DOI 10.1016/j.jtemb.2013.08.001
   Rao VA, 2009, CANCER RES, V69, P948, DOI 10.1158/0008-5472.CAN-08-1437
   Reverter-Branchat G, 2004, J BIOL CHEM, V279, P31983, DOI 10.1074/jbc.M404849200
   RICHMOND HG, 1959, BMJ-BRIT MED J, V1, P947, DOI 10.1136/bmj.1.5127.947
   Rottkamp CA, 2001, FREE RADICAL BIO MED, V30, P447, DOI 10.1016/S0891-5849(00)00494-9
   Saito H, 2014, NAGOYA J MED SCI, V76, P235
   SALONEN JT, 1992, CIRCULATION, V86, P803, DOI 10.1161/01.CIR.86.3.803
   Santos EL, 2009, BIOCHEM PHARMACOL, V78, P951, DOI 10.1016/j.bcp.2009.06.018
   Santos PCJL, 2012, INT J MOL SCI, V13, P1497, DOI 10.3390/ijms13021497
   Sayre LM, 2000, J NEUROCHEM, V74, P270, DOI 10.1046/j.1471-4159.2000.0740270.x
   SCHAFER AI, 1985, ARCH INTERN MED, V145, P1217, DOI 10.1001/archinte.145.7.1217
   Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046
   Seravalle G, 2020, HYPERTENSION, V76, P1444, DOI 10.1161/HYPERTENSIONAHA.120.15511
   Simcox JA, 2013, CELL METAB, V17, P329, DOI 10.1016/j.cmet.2013.02.007
   Simunek T, 2005, J MOL CELL CARDIOL, V39, P345, DOI 10.1016/j.yjmcc.2005.05.008
   Sirlin CB, 2010, MAGN RESON IMAGING C, V18, P359, DOI 10.1016/j.mric.2010.08.014
   STROHMEYER G, 1988, ANN NY ACAD SCI, V526, P245, DOI 10.1111/j.1749-6632.1988.tb55510.x
   Sukumaran A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05810-2
   Tang LL, 2007, J INT MED RES, V35, P517, DOI 10.1177/147323000703500411
   Tasevska N, 2009, AM J CLIN NUTR, V89, P1884, DOI 10.3945/ajcn.2008.27272
   THELANDER L, 1983, J BIOL CHEM, V258, P4063
   Timmers PRHJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17312-3
   Ugarte M, 2018, BIOMETALS, V31, P1061, DOI 10.1007/s10534-018-0147-x
   Utzschneider KM, 2010, NAT REV ENDOCRINOL, V6, P26, DOI 10.1038/nrendo.2009.241
   van Vulpen LFD, 2015, J CLIN PATHOL, V68, P592, DOI 10.1136/jclinpath-2015-202967
   Vashchenko G, 2013, NUTRIENTS, V5, P2289, DOI 10.3390/nu5072289
   Wang Y, 2009, J BIOL CHEM, V284, P314, DOI 10.1074/jbc.M807579200
   Weber S, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.627662
   Weinreb O, 2009, GENES NUTR, V4, P283, DOI 10.1007/s12263-009-0143-4
   Wessling-Resnick M, 2010, ANNU REV NUTR, V30, P105, DOI 10.1146/annurev.nutr.012809.104804
   Wiener Edith, 2003, Hematology, V8, P35, DOI 10.1080/1024533031000081414
   Xu JZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002865
   Xu JZ, 2010, MECH AGEING DEV, V131, P487, DOI 10.1016/j.mad.2010.04.007
   Yang LPH, 2007, DRUGS, V67, P2211, DOI 10.2165/00003495-200767150-00007
   Yu YC, 2022, CANCER EPIDEM BIOMAR, V31, P230, DOI 10.1158/1055-9965.EPI-21-0754
   Zhen AW, 2013, HEPATOLOGY, V58, P1315, DOI 10.1002/hep.26490
   Zhou XY, 1998, P NATL ACAD SCI USA, V95, P2492, DOI 10.1073/pnas.95.5.2492
   Zhu YM, 2021, AM J RESP CELL MOL, V65, P189, DOI 10.1165/rcmb.2020-0279OC
NR 137
TC 11
Z9 11
U1 3
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3921
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD MAY
PY 2022
VL 11
IS 5
AR 865
DI 10.3390/antiox11050865
PG 13
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science
   & Technology
GA 1O5JP
UT WOS:000801368700001
PM 35624729
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Mak, KM
   Chen, LL
   Lee, TF
AF Mak, Ki M.
   Chen, Lucy L.
   Lee, Ting-Fang
TI Codistribution of Collagen Type IV and Laminin in Liver Fibrosis of
   Elderly Cadavers: Immunohistochemical Marker of Perisinusoidal Basement
   Membrane Formation
SO ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY
   BIOLOGY
LA English
DT Article
DE elderly cadavers; liver fibrosis; perisinusoidal basement membranes;
   collagen type IV; laminin
ID HEPATIC SINUSOIDS; INDUCED CIRRHOSIS; RAT-LIVER; CAPILLARIZATION;
   TRANSFORMATION; LOCALIZATION; DISEASE; AGE
AB Liver sinusoids are lined by a fenestrated endothelium that lacks a basement membrane. Formation of perisinusoidal basement membranes beneath the endothelium is an integral feature of capillarization of sinusoids that is a significant pathology found in advanced fibrosis. Liver fibrosis is prevalent in elderly cadavers; however, basement membrane formation in these liver samples has yet to be studied. Collagen type IV and laminin are major basement membrane proteins and their codistribution around sinusoids provides an immunohistochemical marker of basement membrane formation. Here, we examined the intralobular sites of perisinusoidal basement membrane formation in elderly cadaveric livers having various stages of fibrosis. Collagen IV and laminin codistributed in basement membranes of portal and septal ductular and vascular structures, providing a positive control. In the parenchyma, collagen IV immunostaining of sinusoids was panlobular in all stages of fibrosis, and the stain was continuous along the sinusoids. In contrast, laminin was not detected in livers, showing minimal fibrotic change. It was rarely seen in perisinusoidal/pericellular fibrosis, but frequently in septa formation, bridging fibrosis, and cirrhosis. The laminin stain was patchy, occurring principally in sinusoids of periportal and periseptal areas, less commonly in midlobular and rarely in centrilobular areas. Consecutive sections revealed that laminin codistributed with collagen IV in these sinusoidal locations, thus marking the sites of perisinusoidal basement membrane formation in aged fibrotic livers. This development is presumably related to aging of the liver and exacerbated by liver injury caused by advanced liver fibrosis, possibly resulting in sinusoidal capillarization. (C) 2013 Wiley Periodicals, Inc.
C1 [Mak, Ki M.; Chen, Lucy L.] Mt Sinai, Icahn Sch Med, Ctr Anat & Funct Morphol, Dept Med Educ, New York, NY 10029 USA.
   [Lee, Ting-Fang] Mt Sinai, Icahn Sch Med, Div Liver Dis, New York, NY 10029 USA.
C3 Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at
   Mount Sinai
RP Mak, KM (corresponding author), Mt Sinai, Icahn Sch Med, Ctr Anat & Funct Morphol, Dept Med Educ, 1 Gustave L Levy Pl,Box 1007, New York, NY 10029 USA.
EM ki.mak@mssm.edu
RI Lee, Ting-Fang/IUM-2995-2023
OI Lee, Ting-Fang/0000-0003-2693-9510
FU National Science Council, Taiwan [NSC 100-2917-1-564-006)]; Center for
   Anatomy and Functional Morphology, Icahn School of Medicine at Mount
   Sinai, New York
FX Ting-Fang Lee was a recipient of the Postdoctoral Research Abroad
   Program (NSC 100-2917-1-564-006) of the National Science Council,
   Taiwan. We wish to acknowledge the support by the Research Fund of the
   Center for Anatomy and Functional Morphology, Icahn School of Medicine
   at Mount Sinai, New York.
CR BABBS C, 1990, HEPATOLOGY, V11, P723, DOI 10.1002/hep.1840110503
   BHUNCHET E, 1993, HEPATOLOGY, V18, P1450
   CHEVALLIER M, 1994, HEPATOLOGY, V20, P349, DOI 10.1002/hep.1840200213
   DUBUISSON L, 1995, HEPATOLOGY, V21, P805, DOI 10.1002/hep.1840210330
   HAHN E, 1980, GUT, V21, P63, DOI 10.1136/gut.21.1.63
   HORN T, 1987, HEPATOLOGY, V7, P77, DOI 10.1002/hep.1840070117
   JEZEQUEL AM, 1990, J HEPATOL, V11, P206, DOI 10.1016/0168-8278(90)90115-8
   Le Couteur DG, 2008, ANAT REC, V291, P672, DOI 10.1002/ar.20661
   Mak KM, 2012, ANAT REC, V295, P1159, DOI 10.1002/ar.22504
   Mak KM, 2012, ANAT REC, V295, P40, DOI 10.1002/ar.21525
   MAK KM, 1984, HEPATOLOGY, V4, P386, DOI 10.1002/hep.1840040306
   MARTINEZHERNANDEZ A, 1991, HEPATOLOGY, V14, P864, DOI 10.1002/hep.1840140519
   McLean AJ, 2003, J PATHOL, V200, P112, DOI 10.1002/path.1328
   NAKAYAMA Y, 1991, LIVER, V11, P260
   POPPER H, 1970, AM J MED, V49, P707, DOI 10.1016/S0002-9343(70)80135-8
   SCHAFFNER F, 1963, GASTROENTEROLOGY, V44, P239
   Simionescu N., 1988, CELL TISSUE BIOL, P355
   TIMPL R, 1979, J BIOL CHEM, V254, P9933
   TSUTSUMI M, 1993, ALCOHOL ALCOHOLISM, V28, P45, DOI 10.1093/alcalc/28.Supplement_1A.45
   URASHIMA S, 1993, ALCOHOL ALCOHOLISM, V28, P77, DOI 10.1093/alcalc/28.Supplement_1B.77
   Wells RG., 2007, TXB HEPATOLOGY, P264
   Xu B, 2003, AM J PATHOL, V163, P1275, DOI 10.1016/S0002-9440(10)63487-6
NR 22
TC 47
Z9 51
U1 0
U2 6
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-8486
J9 ANAT REC
JI Anat. Rec.
PD JUN
PY 2013
VL 296
IS 6
BP 953
EP 964
DI 10.1002/ar.22694
PG 12
WC Anatomy & Morphology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Anatomy & Morphology
GA 164DD
UT WOS:000320388100010
PM 23596149
DA 2024-02-19
ER

PT S
AU Friedman, RSC
   Krause, DS
AF Friedman, Rachel S. C.
   Krause, Diane S.
BE Bushell, WC
   Olivo, EL
   Theise, ND
TI Regeneration and Repair New Findings in Stem Cell Research and Aging
SO LONGEVITY, REGENERATION, AND OPTIMAL HEALTH: INTEGRATING EASTERN AND
   WESTEN PERSPECTIVES
SE Annals of the New York Academy of Sciences
LA English
DT Article; Proceedings Paper
CT Conference on Longevity, Regeneration and Optimal Health
CY SEP 18-21, 2006
CL Phoenicia, NY
DE regeneration; repair; stem cells; aging
ID BONE-MARROW-CELLS; MUSCLE SATELLITE CELLS; SKELETAL-MUSCLE;
   MYOCARDIAL-INFARCTION; STROMAL CELLS; RISK-FACTORS; TRANSPLANTATION;
   HEPATOCYTES; PLASTICITY; LIVER
AB When it comes to the capacity to regenerate damaged parts of the body, humans are by no means the most advanced among animal species. At the level of single cell populations, humans do exhibit some degree of regenerative potential-for example, hepatocytes have the ability to restore up to 75% of a surgically removed or damaged liver. However, as every schoolchild knows, salamanders and starfish can regrow entire amputated appendages, a remarkable feat well beyond the scope of human capacity. Accordingly, the standing consensus position of the scientific community has deemed mammals fundamentally and unalterably different from those more "primitive" yet regeneration-competent species.' Current approaches for the restoration of organ function in humans have therefore been limited to allogeneic organ or cell transplantation-strategies that, while effective, nonetheless exhibit major limitations based on availability of donor tissues and the risk of rejection unless extensive immunosuppression is induced.
C1 [Friedman, Rachel S. C.] Sutter Med Ctr Santa Rosa, Santa Rose, CA 95404 USA.
   [Krause, Diane S.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA.
   [Krause, Diane S.] Yale Univ, Sch Med, Dept Pathol & Cell Biol, New Haven, CT USA.
C3 Yale University; Yale University
RP Friedman, RSC (corresponding author), Sutter Med Ctr Santa Rosa, 3325 Chanate Rd, Santa Rose, CA 95404 USA.
EM rscfriedman@gmail.com
FU NHLBI NIH HHS [P01 HL063357] Funding Source: Medline
CR Alison MR, 2000, NATURE, V406, P257, DOI 10.1038/35018642
   Austin TW, 2003, MECH DEVELOP, V120, P131, DOI 10.1016/S0925-4773(02)00339-8
   Ball ED, 2003, ANN INTERN MED, V139, P916, DOI 10.7326/0003-4819-139-11-200312020-00010
   Beeres SLMA, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.07.018
   Bushell WC, 2005, ANN NY ACAD SCI, V1057, P28, DOI 10.1196/annals.1322.002
   CARLSON BM, 1989, AM J PHYSIOL, V256, pC1262
   Carlson BM, 2001, J GERONTOL A-BIOL, V56, pB224, DOI 10.1093/gerona/56.5.B224
   Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573
   Dallari D, 2006, J ORTHOP RES, V24, P877, DOI 10.1002/jor.20112
   Gao LR, 2006, AM J CARDIOL, V98, P597, DOI 10.1016/j.amjcard.2006.03.034
   Grove JE, 2004, STEM CELLS, V22, P487, DOI 10.1634/stemcells.22-4-487
   Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534
   Herzog EL, 2003, BLOOD, V102, P3483, DOI 10.1182/blood-2003-05-1664
   Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870
   Jyotsna M, 2006, CARDIOVASC REVASCULA, V7, P217, DOI 10.1016/j.carrev.2006.06.004
   Kollman C, 2001, BLOOD, V98, P2043, DOI 10.1182/blood.V98.7.2043
   Korbling M, 2002, NEW ENGL J MED, V346, P738, DOI 10.1056/NEJMoa3461002
   Krause DS, 2002, GENE THER, V9, P754, DOI 10.1038/sj.gt.3301760
   Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2
   Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326
   Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9
   Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706
   Machida S, 2004, EXP GERONTOL, V39, P1521, DOI 10.1016/j.exger.2004.08.009
   Machida S, 2006, ANN NY ACAD SCI, V1067, P349, DOI 10.1196/annals.1354.049
   MCCAY CM, 1957, GERONTOLOGY, V1, P7, DOI 10.1159/000210677
   Morrison SJ, 1996, IMMUNITY, V5, P207, DOI 10.1016/S1074-7613(00)80316-7
   Nardo B, 2004, AM J TRANSPLANT, V4, P1139, DOI 10.1111/j.1600-6143.2004.00472.x
   Niggemann B, 2006, J ALLERGY CLIN IMMUN, V118, P569, DOI 10.1016/j.jaci.2006.06.021
   Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898
   Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587
   PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081
   Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958
   SCHULTZ E, 1982, MECH AGEING DEV, V20, P377, DOI 10.1016/0047-6374(82)90105-1
   Stocum DL, 1999, SEMIN CELL DEV BIOL, V10, P433, DOI 10.1006/scdb.1999.0330
   Tausk FA, 1998, ARCH DERMATOL, V134, P1422, DOI 10.1001/archderm.134.11.1422
   Theise ND, 2000, HEPATOLOGY, V32, P11, DOI 10.1053/jhep.2000.9124
   Theise ND, 2002, SEMIN CELL DEV BIOL, V13, P411, DOI 10.1016/S1084952102001283
   Theise ND, 1999, HEPATOLOGY, V30, P1425, DOI 10.1002/hep.510300614
   van Laar JM, 2006, RHEUMATOLOGY, V45, P1187, DOI 10.1093/rheumatology/kel158
NR 43
TC 6
Z9 6
U1 2
U2 18
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN STREET, MALDEN 02148, MA USA
SN 0077-8923
BN 978-1-57331-677-4
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2009
VL 1172
BP 88
EP 94
DI 10.1111/j.1749-6632.2009.04411.x
PG 7
WC Integrative & Complementary Medicine; Multidisciplinary Sciences
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Integrative & Complementary Medicine; Science & Technology - Other
   Topics
GA BLE67
UT WOS:000270023800009
PM 19735242
DA 2024-02-19
ER

PT S
AU LEPAGNOL, JM
   HEIDET, V
AF LEPAGNOL, JM
   HEIDET, V
BE Nitsch, RM
   Growdon, JH
   Corkin, S
   Wurtman, RJ
TI COMPARATIVE EFFECTS OF AGING PROCESS ON PHOSPHATIDYLCHOLINE BIOSYNTHESIS
   PATHWAY - A KEY ROLE FOR CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE
SO ALZHEIMERS DISEASE: AMYLOID PRECUSOR PROTEINS, SIGNAL TRANSDUCTION, AND
   NEURONAL TRANSPLANTATION
SE ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
LA English
DT Article; Proceedings Paper
CT 7th Meeting of the
   International-Study-Group-on-the-Pharmacology-of-Memory-Disorders-Associ
   ated-with-Aging: Alzheimers Disease
CY FEB 12-14, 1993
CL ZURICH, SWITZERLAND
SP INT STUDY GRP PHARM MEMORY DISORDERS ASSOC AGING
ID CHOLINERGIC NEURONS
AB The effects of aging on phosphatidylcholine (PtdCho) biosynthesis were investigated in Liver and brain subcellular fractions of the rat, by studying the activity and regulation of CTP phosphocholine cytidylyltransferase (CT), the rate limiting enzyme in PtdCho biosyntheses. With both tissues, CT activity was present in cytosolic and microsomal fractions, but in brain, CT activity seemed to escape to an inhibiting feed back mechanism. In brain, CT activity was greater in the microsomal fraction, whilst in liver, a higher CT activity was seen in the cytosolic fraction.
   In liver fractions of aged animals, there was no significant change in CT activity or its sensitivity to negative feedback regulation, as compared to young animals. In contrast, a progressive age related decline in CT activity was observed in the brain microsomal fraction. Furthermore, the incorporation of newly formed CDPCho into PtdCho was also reduced in aged animals, and paralleled the decreased incorporation of choline in PtdCho. The age-related decrease in CT activity cannot be explained by product feed back inhibition or decreased diacylglycerol levels.
   Since PtdCho is a major membrane lipid, the reduction in CT activity may lead to a decreased membrane integrity and fluidity during the aging process, and these effects may be greater in neuronal cells.
RP LEPAGNOL, JM (corresponding author), INST RECH SERVIER,DEPT CEREBRAL PATHOL,11 RUE MOULINEAUX,F-92150 SURESNES,FRANCE.
CR Banner C, 1990, Int Psychogeriatr, V2, P135, DOI 10.1017/S1041610290000394
   BLUSZTAJN JK, 1983, SCIENCE, V221, P614, DOI 10.1126/science.6867732
   BOWEN DM, 1979, LANCET, V1, P11
   VANCE DE, 1991, BIOCH LIPIDS LIPOPRO, P205
   WEILER MH, 1990, NEUROBIOL AGING, V11, P401, DOI 10.1016/0197-4580(90)90006-L
   WURTMAN RJ, 1992, TRENDS NEUROSCI, V15, P117, DOI 10.1016/0166-2236(92)90351-8
NR 6
TC 2
Z9 2
U1 0
U2 1
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021
SN 0077-8923
BN 0-89766-853-7
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 1993
VL 695
BP 86
EP 90
DI 10.1111/j.1749-6632.1993.tb23034.x
PG 5
WC Biochemistry & Molecular Biology; Multidisciplinary Sciences;
   Neurosciences
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Science & Technology - Other Topics;
   Neurosciences & Neurology
GA BZ92T
UT WOS:A1993BZ92T00017
PM 8239319
DA 2024-02-19
ER

PT J
AU Lee, SW
   Baek, SM
   Kang, KK
   Lee, AR
   Kim, TU
   Choi, SK
   Roh, YS
   Hong, IH
   Park, SJ
   Kim, TH
   Jeong, KS
   Park, JK
AF Lee, Seoung-Woo
   Baek, Su-Min
   Kang, Kyung-Ku
   Lee, A-Rang
   Kim, Tae-Un
   Choi, Seong-Kyoon
   Roh, Yoon-Seok
   Hong, Il-Hwa
   Park, Sang-Joon
   Kim, Tae-Hwan
   Jeong, Kyu-Shik
   Park, Jin-Kyu
TI Vitamin C Deficiency Inhibits Nonalcoholic Fatty Liver Disease
   Progression through Impaired <i>de Novo</i> Lipogenesis
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article; Early Access
ID HEPATIC STEATOSIS; GENE-EXPRESSION; CHOLESTEROL; MICE; NAFLD; ACID;
   SUPPLEMENTATION; BIOSYNTHESIS; EPIDEMIOLOGY; ANTIOXIDANT
AB Despite the increasing clinical importance of nonalcoholic fatty liver disease (NAFLD), little is known about its underlying pathogenesis or specific treatment. The senescence marker protein 30 (SMP30), which regulates the biosynthesis of vitamin C (VC) in many mammals, except primates and humans, was recently recognized as a gluconolactonase. However, the precise relation between VC and lipid metabolism in NAFLD is not completely understood. Therefore, this study aimed to clearly reveal the role of VC in NAFLD progression. SMP30 knockout (KO) mice were used as a VC-deficient mouse model. To investigate the precise role of VC on lipid metabolism, 13- to 15-week-old SMP30 KO mice and wild-type mice fed a 60% high-fat diet were exposed to tap water or VC-containing water (1.5 g/L) ad libitum for 11 weeks. Primary mouse hepatocytes isolated from the SMP30 KO and wild-type mice were used to demonstrate the relation between VC and lipid metabolism in hepatocytes. Long-term VC deficiency significantly suppressed the progression of simple steatosis. The high-fat diet-fed VC-deficient SMP30 KO mice exhibited impaired sterol regulatory element-binding protein-1c activation because of excessive cholesterol accumulation in hepatocytes. Long-term VC deficiency inhibits de novo Lipogenesis through impaired sterol regulatory element-binding protein-1c activation.
C1 [Lee, Seoung-Woo; Baek, Su-Min; Lee, A-Rang; Kim, Tae-Un; Kim, Tae-Hwan; Jeong, Kyu-Shik; Park, Jin-Kyu] Kyungpook Natl Univ, Coll Vet Med, Dept Vet Pathol, Daegu 41566, South Korea.
   [Park, Sang-Joon] Kyungpook Natl Univ, Coll Vet Med, Lab Vet Histol, Daegu, South Korea.
   [Jeong, Kyu-Shik; Park, Jin-Kyu] Kyungpook Natl Univ, Stem Cell Therapeut Res Inst, Daegu, South Korea.
   [Kang, Kyung-Ku] Daegu Gyeongbuk Med Innovat Fdn, Lab Anim Ctr, Daegu, South Korea.
   [Choi, Seong-Kyoon] Daegu Gyeongbuk Inst Sci & Technol, Core Prot Resources Ctr, Daegu, South Korea.
   [Roh, Yoon-Seok] Chungbuk Natl Univ, Coll Pharm, Cheongju, South Korea.
   [Hong, Il-Hwa] Gyeongsang Natl Univ, Coll Vet Med, Dept Vet Pathol, Jinju, South Korea.
C3 Kyungpook National University; Kyungpook National University; Kyungpook
   National University; Daegu Gyeongbuk Institute of Science & Technology
   (DGIST); Chungbuk National University; Gyeongsang National University
RP Park, JK (corresponding author), Kyungpook Natl Univ, Coll Vet Med, Dept Vet Pathol, Daegu 41566, South Korea.
EM jinkyu820@knu.ac.kr
FU National Research Foundation of Korea [2017R1C1B5015716,
   2019R1I1A2A01060031]
FX Supported in part by the National Research Foundation of Korea grants
   2017R1C1B5015716 (J.K.P) and 2019R1I1A2A01060031 (J.K.P.) .
CR Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41
   Arulanandan Ahilan, 2015, Curr Hepatol Rep, V14, P109
   Baran B, 2014, WORLD J GASTROENTERO, V20, P14219, DOI 10.3748/wjg.v20.i39.14219
   Benedict M, 2017, WORLD J HEPATOL, V9, P715, DOI 10.4254/wjh.v9.i16.715
   Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5
   Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466
   BURNS JJ, 1957, NATURE, V180, P552, DOI 10.1038/180553a0
   Buzzetti E, 2016, METABOLISM, V65, P1038, DOI 10.1016/j.metabol.2015.12.012
   Canbakan B, 2007, ACTA GASTRO-ENT BELG, V70, P277
   Carr AC, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111211
   Chiang JYL, 2015, HEPATOLOGY, V62, P1315, DOI 10.1002/hep.27964
   Curcio A, 2020, MEDICINA-LITHUANIA, V56, DOI 10.3390/medicina56100544
   Dal S, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7019573
   Denechaud PD, 2008, J CLIN INVEST, V118, P956, DOI 10.1172/JCI34314
   Dubuquoy C, 2011, J HEPATOL, V55, P145, DOI 10.1016/j.jhep.2010.10.024
   Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315
   Ferré P, 2010, DIABETES OBES METAB, V12, P83, DOI 10.1111/j.1463-1326.2010.01275.x
   Frikke-Schmidt H, 2010, ANAL BIOCHEM, V397, P135, DOI 10.1016/j.ab.2009.09.040
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   GINTER E, 1973, SCIENCE, V179, P702, DOI 10.1126/science.179.4074.702
   Gui YZ, 2016, ACTA PHARMACOL SIN, V37, P1337, DOI 10.1038/aps.2016.46
   Hashimoto E, 2013, J GASTROEN HEPATOL, V28, P64, DOI 10.1111/jgh.12271
   Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809
   Ipsen DH, 2014, NUTRIENTS, V6, P5473, DOI 10.3390/nu6125473
   JENKINS SA, 1977, BIOCHEM BIOPH RES CO, V77, P1030, DOI 10.1016/S0006-291X(77)80081-8
   Kim JY, 2018, CELL, V175, P133, DOI 10.1016/j.cell.2018.08.020
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   KOTHARI LK, 1988, ACTA BIOL HUNG, V39, P49
   Lazo M, 2008, SEMIN LIVER DIS, V28, P339, DOI 10.1055/s-0028-1091978
   Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814
   Li G, 2012, METABOLISM, V61, P823, DOI 10.1016/j.metabol.2011.11.008
   Madan K, 2006, J CLIN GASTROENTEROL, V40, P930, DOI 10.1097/01.mcg.0000212608.59090.08
   Maeda N, 2000, P NATL ACAD SCI USA, V97, P841, DOI 10.1073/pnas.97.2.841
   Maruyama N, 2010, GERIATR GERONTOL INT, V10, pS88, DOI 10.1111/j.1447-0594.2010.00586.x
   McRae MP, 2008, J CHIROPR MED, V7, P48, DOI 10.1016/j.jcme.2008.01.002
   McRae MP, 2006, J CHIROPR MED, V5, P2, DOI 10.1016/S0899-3467(07)60127-X
   Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183
   Michels AJ, 2009, AM J PHYSIOL-CELL PH, V297, pC1220, DOI 10.1152/ajpcell.00348.2009
   Musso G, 2003, HEPATOLOGY, V37, P909, DOI 10.1053/jhep.2003.50132
   Padayatty SJ, 2003, J AM COLL NUTR, V22, P18, DOI 10.1080/07315724.2003.10719272
   Perumpail BJ, 2017, WORLD J GASTROENTERO, V23, P8263, DOI 10.3748/wjg.v23.i47.8263
   Rezazadeh A, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-26
   Scott Stephanie H, 2011, Biomol Concepts, V2, P469
   Strable MS, 2010, CRIT REV BIOCHEM MOL, V45, P199, DOI 10.3109/10409231003667500
   Swinnen JV, 1997, P NATL ACAD SCI USA, V94, P12975, DOI 10.1073/pnas.94.24.12975
   Tamm C, 2008, APOPTOSIS, V13, P354, DOI 10.1007/s10495-007-0172-7
   Tomita Y, 2020, ANGIOGENESIS, V23, P385, DOI 10.1007/s10456-020-09717-x
   Trauner M, 2010, BBA-MOL CELL BIOL L, V1801, P299, DOI 10.1016/j.bbalip.2009.10.007
   Vos MB, 2012, J PEDIATR GASTR NUTR, V54, P90, DOI 10.1097/MPG.0b013e318229da1a
   WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8
NR 51
TC 11
Z9 11
U1 0
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0002-9440
EI 1525-2191
J9 AM J PATHOL
JI Am. J. Pathol.
PD 2021 SEP
PY 2021
VL 191
IS 9
BP 1550
EP 1563
DI 10.1016/j.ajpath.2021.05.020
EA AUG 2021
PG 14
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA UE5UF
UT WOS:000687952200001
PM 34126083
OA hybrid
DA 2024-02-19
ER

PT S
AU Guerrieri, F
   Vendemiale, G
   Turturro, N
   Fratello, A
   Furio, A
   Muolo, L
   Grattagliano, I
   Papa, S
AF Guerrieri, F
   Vendemiale, G
   Turturro, N
   Fratello, A
   Furio, A
   Muolo, L
   Grattagliano, I
   Papa, S
BE Kitani, K
   Aoba, A
   Goto, S
TI Alteration of mitochondrial F0F1 ATP synthase during aging possible
   involvement of oxygen free radicals - Possible involvement of oxygen
   free radicals
SO PHARMACOLOGICAL INTERVENTION IN AGING AND AGE-ASSOCIATED DISORDERS:
   PROCEEDINGS OF THE SIXTH CONGRESS OF THE INTERNATIONAL ASSOCIATION OF
   BIOMEDICAL GERONTOLOGY
SE ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
LA English
DT Article; Proceedings Paper
CT 6th Congress for the International-Association-of-Biomedical-Gerontology
CY AUG 20-23, 1995
CL TOKYO, JAPAN
SP Int Assoc Biomed Gerontol
ID AGE-RELATED-CHANGES; RAT-HEART MITOCHONDRIA; LIVER MITOCHONDRIA;
   DEPENDENT CHANGES; L-CARNITINE; GLUTATHIONE; BIOENERGETICS; CARRIER
C1 UNIV BARI,INST RADIOL,I-70121 BARI,ITALY.
   UNIV BARI,INST CLIN MED,I-70121 BARI,ITALY.
C3 Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari
   Aldo Moro
RP Guerrieri, F (corresponding author), UNIV BARI POLICLIN,INST MED BIOCHEM & CHEM,PIAZZA G CESARE,I-70124 BARI,ITALY.
OI Papa, Sergio/0000-0002-4417-1763
CR [Anonymous], 2012, FREE RADICALS BIOL
   BENZI G, 1990, MECH AGEING DEV, V56, P155, DOI 10.1016/0047-6374(90)90006-2
   BRIGELIUS R, 1983, BIOCHEM PHARMACOL, V32, P2529, DOI 10.1016/0006-2952(83)90014-X
   BUSTAMANTE E, 1977, ANAL BIOCHEM, V80, P401, DOI 10.1016/0003-2697(77)90661-3
   CAPOZZA G, 1994, ARCH GERONTOL GERI S, V4, P31
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   GADALETA MN, 1990, EUR J BIOCHEM, V187, P501, DOI 10.1111/j.1432-1033.1990.tb15331.x
   GOLDBERG AL, 1992, EUR J BIOCHEM, V203, P9, DOI 10.1111/j.1432-1033.1992.tb19822.x
   GUERRIERI F, 1989, ORGANELLES IN EUKARYOTIC CELLS, P197
   GUERRIERI F, 1992, ANN NY ACAD SCI, V671, P395, DOI 10.1111/j.1749-6632.1992.tb43813.x
   GUERRIERI F, 1992, ARCH GERONTOL GERIAT, V14, P299, DOI 10.1016/0167-4943(92)90029-4
   GUERRIERI F, 1993, CARDIOSCIENCE, V4, P93
   HANSFORD RG, 1983, BIOCHIM BIOPHYS ACTA, V726, P41, DOI 10.1016/0304-4173(83)90010-1
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HAZELTON GA, 1980, BIOCHEM J, V188, P25, DOI 10.1042/bj1880025
   KIM JH, 1988, MECH AGEING DEV, V46, P279, DOI 10.1016/0047-6374(88)90130-3
   LAKATTA EG, 1982, AM J PHYSIOL, V242, pH927, DOI 10.1152/ajpheart.1982.242.6.H927
   LEE CP, 1968, EUR J BIOCHEM, V3, P391, DOI 10.1111/j.1432-1033.1967.tb19542.x
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   LIPPE G, 1991, BIOCHEM BIOPH RES CO, V181, P746
   LOW H, 1963, BIOCHIM BIOPHYS ACTA, V69, P361, DOI 10.1016/0006-3002(63)91269-1
   MIQUEL J, 1992, FREE RADICALS AGING, P47
   MIQUEL J, 1986, FREE RADICALS AGING, P51
   MULLERHOCKER J, 1992, BRAIN PATHOL, V2, P149, DOI 10.1111/j.1750-3639.1992.tb00683.x
   NOHL H, 1980, MECH AGEING DEV, V14, P137, DOI 10.1016/0047-6374(80)90112-8
   OLAFSDOTTIR K, 1988, BIOCHIM BIOPHYS ACTA, V964, P377, DOI 10.1016/0304-4165(88)90038-4
   PAPA S, 1969, BIOCHIM BIOPHYS ACTA, V172, P184, DOI 10.1016/0005-2728(69)90106-6
   PARADIES G, 1990, BIOCHIM BIOPHYS ACTA, V1016, P207, DOI 10.1016/0005-2728(90)90060-H
   PARADIES G, 1992, BIOCHIM BIOPHYS ACTA, V1103, P324, DOI 10.1016/0005-2736(92)90103-S
   RICHIE JP, 1992, EXP GERONTOL, V27, P615, DOI 10.1016/0531-5565(92)90015-R
   TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5
   Vifia J., 1990, GLUTATHIONE METABOLI
   ZHANG Y, 1990, J BIOL CHEM, V265, P16330
   ZSNAGY I, 1978, J THEOR BIOL, V75, P189, DOI 10.1016/0022-5193(78)90230-8
NR 34
TC 16
Z9 18
U1 0
U2 1
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021
SN 0077-8923
BN 1-57331-030-1
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 1996
VL 786
BP 62
EP 71
DI 10.1111/j.1749-6632.1996.tb39052.x
PG 10
WC Geriatrics & Gerontology; Multidisciplinary Sciences; Pharmacology &
   Pharmacy
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Science & Technology - Other Topics;
   Pharmacology & Pharmacy
GA BF92J
UT WOS:A1996BF92J00006
PM 8687044
DA 2024-02-19
ER

PT J
AU PODOLIN, DA
   PAGLIASSOTTI, MJ
   GLEESON, TT
   MAZZEO, RS
AF PODOLIN, DA
   PAGLIASSOTTI, MJ
   GLEESON, TT
   MAZZEO, RS
TI INFLUENCE OF ENDURANCE TRAINING ON THE AGE-RELATED DECLINE IN HEPATIC
   GLYCONEOGENESIS
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE GLUCONEOGENESIS; LACTATE; FRUCTOSE; AGING
ID GLUCONEOGENESIS-INHIBITED RATS; INSULIN RESISTANCE; GLUCOSE-INTOLERANCE;
   ENZYME-ACTIVITIES; BETA-CELL; EXERCISE; MUSCLE; METABOLISM; GLYCOLYSIS;
   LACTATE
AB Hepatic gluconeogenic and glyconeogenic capabilities were investigated in Fischer 344 rat livers (ages 7, 15 and 25 months; n = 66) to determine if endurance training affected age related decrements in these hepatic functions. Animals were trained 1 h/day, 5 days/week for 10 weeks at treadmill speeds of 75% of age-specific maximal capacity. After training, rats were injected (300 mg/kg) with a known gluconeogenic inhibitor, 3-mercaptopicolinic acid (MPA). Two endurance tests were performed to help assess the contribution of gluconeogenesis to exercise performance, an initial test 4 days prior to injection and a final test immediately postinjection. MPA significantly (P < 0.05) reduced running times in all trained groups compared to their control test: 89%, 81%, and 51% in the young, middle-aged, and old, respectively. MPA reduced running times in the untrained animals 19%, 11%, and 8%, respectively. Three days after the last exercise bout, the animals were anesthetized and liver sections were sliced and incubated in [C-14]lactic acid or [C-14]fructose. An age-related decline was found in [C-14]lactate incorporation (middle-aged down arrow 66%, old down arrow 54%) and in [C-14]fructose incorporation (middle-aged down arrow 51%, old down arrow 48%) into glycogen. Differences existed in lactate incorporation in trained compared to untrained animals for the young, middle-aged, and old groups: 150.1 +/- 11.3 vs. 102.1 +/- 10.0; 75.3 +/- 6.2 vs. 34.9 +/- 6.4; and 69.3 +/- 14.9 vs. 47.0 +/- 4.7 nmol/g/h, respectively. No differences were found with training in any of the age groups for fructose; Phosphoenolpyruvate carboxykinase (PEPCK) activity and messenger RNA (mRNA) were significantly reduced in the old compared to the young rats (down arrow 64% and down arrow 58%, respectively).
C1 UNIV COLORADO,DEPT KINESIOL & ENVIRONM POPULAT & ORGANISM BIOL,BOULDER,CO 80309.
   UNIV COLORADO,HLTH SCI CTR,DENVER,CO 80262.
C3 University of Colorado System; University of Colorado Boulder;
   University of Colorado System; University of Colorado Denver; University
   of Colorado Anschutz Medical Campus
FU NIA NIH HHS [AG 07180] Funding Source: Medline
CR BOISJOYEUX B, 1990, DIABETES METAB, V16, P504
   CARDIN S, 1991, AM J PHYSIOL, V260, pR67, DOI 10.1152/ajpregu.1991.260.1.R67
   CHEN M, 1985, J CLIN ENDOCR METAB, V60, P13, DOI 10.1210/jcem-60-1-13
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   DAVIDSON MB, 1979, METABOLISM, V28, P687
   DEFRONZO RA, 1979, DIABETES, V28, P1095, DOI 10.2337/diab.28.12.1095
   DOHM GL, 1985, AM J PHYSIOL, V249, pE6, DOI 10.1152/ajpendo.1985.249.1.E6
   DONOVAN CM, 1989, AM J PHYSIOL, V257, pE782, DOI 10.1152/ajpendo.1989.257.5.E782
   DONOVAN CM, 1990, AM J PHYSIOL, V258, pR770, DOI 10.1152/ajpregu.1990.258.3.R770
   FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908
   HASSID WZ, 1957, METHOD ENZYMOL, V3, P34, DOI 10.1016/S0076-6879(57)03345-5
   HISSIN PJ, 1982, J CLIN INVEST, V70, P780, DOI 10.1172/JCI110674
   HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831
   HUSTON RL, 1975, LIFE SCI, V17, P369, DOI 10.1016/0024-3205(75)90486-5
   JOHNALDER HB, 1986, AM J PHYSIOL, V251, pR137, DOI 10.1152/ajpregu.1986.251.1.R137
   KAHN SE, 1990, AM J PHYSIOL, V258, pE937, DOI 10.1152/ajpendo.1990.258.6.E937
   KERN M, 1992, AM J PHYSIOL, V263, pE362, DOI 10.1152/ajpendo.1992.263.2.E362
   KHANDELWAL RL, 1984, MECH AGEING DEV, V28, P13, DOI 10.1016/0047-6374(84)90149-0
   Masoro E J, 1991, Aging (Milano), V3, P117
   MAZZEO RS, 1984, J APPL PHYSIOL, V57, P1369, DOI 10.1152/jappl.1984.57.5.1369
   PETRESCU I, 1979, ANAL BIOCHEM, V96, P279, DOI 10.1016/0003-2697(79)90582-7
   REAVEN EP, 1979, J CLIN INVEST, V64, P591, DOI 10.1172/JCI109498
   ROWE JW, 1983, J CLIN INVEST, V71, P1581, DOI 10.1172/JCI110914
   SASAKI K, 1984, J BIOL CHEM, V259, P5242
   SATRUSTEGUI J, 1986, FEBS LETT, V197, P159, DOI 10.1016/0014-5793(86)80318-0
   Srere P.A., 1969, METHOD ENZYMOL, V13, P3, DOI DOI 10.1016/0076-6879(69)13005-0
   STITH RD, 1985, MECH AGEING DEV, V30, P73, DOI 10.1016/0047-6374(85)90060-0
   SUMIDA KD, 1993, J APPL PHYSIOL, V74, P782, DOI 10.1152/jappl.1993.74.2.782
   TONINO RP, 1989, AM J PHYSIOL, V256, pE352, DOI 10.1152/ajpendo.1989.256.3.E352
   TURCOTTE LP, 1990, J APPL PHYSIOL, V68, P944, DOI 10.1152/jappl.1990.68.3.944
   TURCOTTE LP, 1990, AM J PHYSIOL, V258, pE203, DOI 10.1152/ajpendo.1990.258.1.E203
   WINDER WW, 1985, EXERCISE SPORT SCI R, P1
NR 32
TC 18
Z9 18
U1 0
U2 2
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD JUL
PY 1994
VL 75
IS 1
BP 81
EP 93
DI 10.1016/0047-6374(94)90030-2
PG 13
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA PB062
UT WOS:A1994PB06200008
PM 9128756
DA 2024-02-19
ER

PT J
AU Massey, AC
   Kiffin, R
   Cuervo, AM
AF Massey, Ashish C.
   Kiffin, Roberta
   Cuervo, Ana Maria
TI Autophagic defects in aging - Looking for an "emergency exit"?
SO CELL CYCLE
LA English
DT Article
DE aging; autophagy; cell death; chaperones; macroautophagy; oxidative
   stress; stress response
ID CHAPERONE-MEDIATED AUTOPHAGY; LYSOSOMAL PROTEIN-DEGRADATION;
   UBIQUITIN-PROTEASOME SYSTEM; RAT-LIVER; ALPHA-SYNUCLEIN; MEMBRANE;
   STARVATION; YEAST; MICROAUTOPHAGY; NOMENCLATURE
AB The ability of cells to renew their intracellular components and get rid of undesired or altered molecules decreases with age. Failure of autophagy is considered one of the main reasons for the build up of damaged components in the tissues of old organisms. We have recently shown that, declined activity of chaperone-mediated autophagy, a selective type of autophagy particularly impaired in aging, increases cell's vulnerability to stressors. This finding supports that, added to its role in cellular clean up, chaperone-mediated autophagy is an essential component of the cellular response to stress. Failure to perform this function with age could underlie the inability of old cells to adapt to stress conditions, and explain the accelerated course of some protein conformational disorders, such as Parkinson's disease, as affected individuals age.
C1 Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA.
C3 Yeshiva University; Albert Einstein College of Medicine
RP Cuervo, AM (corresponding author), 1300 Morris Pk Ave, Bronx, NY 10461 USA.
EM amcuervo@aecom.yu.edu
OI Cuervo, Ana Maria/0000-0002-0771-700X
CR Agarraberes FA, 2001, J CELL SCI, V114, P2491
   Agarraberes FA, 1997, J CELL BIOL, V137, P825, DOI 10.1083/jcb.137.4.825
   ANIENTO F, 1993, J BIOL CHEM, V268, P10463
   Betarbet R, 2005, EXP NEUROL, V191, pS17, DOI 10.1016/j.expneurol.2004.08.021
   CHIANG HL, 1989, SCIENCE, V246, P382, DOI 10.1126/science.2799391
   Cuervo AM, 1999, KIDNEY INT, V55, P529, DOI 10.1046/j.1523-1755.1999.00268.x
   Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200
   Cuervo AM, 2000, TRAFFIC, V1, P570, DOI 10.1034/j.1600-0854.2000.010707.x
   Cuervo AM, 2004, MOL CELL BIOCHEM, V263, P55, DOI 10.1023/B:MCBI.0000041848.57020.57
   Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738
   CUERVO AM, 1995, EUR J BIOCHEM, V227, P792, DOI 10.1111/j.1432-1033.1995.tb20203.x
   Cuervo AM, 2003, EMBO J, V22, P47, DOI 10.1093/emboj/cdg002
   CUERVO AM, 1995, AM J PHYSIOL-CELL PH, V269, pC1200, DOI 10.1152/ajpcell.1995.269.5.C1200
   Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002
   Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501
   Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017
   Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3
   Debnath J, 2005, AUTOPHAGY, V1, P66, DOI 10.4161/auto.1.2.1738
   DICE JF, 1982, J BIOL CHEM, V257, P4624
   DICE JF, 1990, TRENDS BIOCHEM SCI, V15, P305, DOI 10.1016/0968-0004(90)90019-8
   Donati A, 2001, J GERONTOL A-BIOL, V56, pB375, DOI 10.1093/gerona/56.9.B375
   Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020
   Eskelinen EL, 2005, TRAFFIC, V6, P1058, DOI 10.1111/j.1600-0854.2005.00337.x
   Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9
   Finn PF, 2005, J BIOL CHEM, V280, P25864, DOI 10.1074/jbc.M502456200
   Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102
   Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200
   Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477
   Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X
   Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022
   Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1
   Longo VD, 2002, CELL MOL LIFE SCI, V59, P903, DOI 10.1007/s00018-002-8477-8
   Maguire-Zeiss KA, 2005, MOL BRAIN RES, V134, P18, DOI 10.1016/j.molbrainres.2004.09.014
   Majeski AE, 2004, INT J BIOCHEM CELL B, V36, P2435, DOI 10.1016/j.biocel.2004.02.013
   Martinez-Vicente M, 2005, EXP GERONTOL, V40, P622, DOI 10.1016/j.exger.2005.07.005
   Massey A, 2004, INT J BIOCHEM CELL B, V36, P2420, DOI 10.1016/j.biocel.2004.04.010
   Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103
   Mizushima N, 2005, CELL DEATH DIFFER, V12, P1535, DOI 10.1038/sj.cdd.4401728
   Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704
   Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421
   Moore DJ, 2003, NEUROMOL MED, V4, P95, DOI 10.1385/NMM:4:1-2:95
   MORTIMORE GE, 1988, J BIOL CHEM, V263, P2506
   Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002
   Salvador N, 2000, J BIOL CHEM, V275, P27447
   SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889
   Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993
   TERLECKY SR, 1993, J BIOL CHEM, V268, P23490
   Terman A, 2004, INT J BIOCHEM CELL B, V36, P2365, DOI 10.1016/j.biocel.2004.03.009
   Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200
   Zhou DL, 2005, IMMUNITY, V22, P571, DOI 10.1016/j.immuni.2005.03.009
NR 50
TC 33
Z9 37
U1 0
U2 4
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1538-4101
EI 1551-4005
J9 CELL CYCLE
JI Cell Cycle
PD JUN 15
PY 2006
VL 5
IS 12
BP 1292
EP 1296
DI 10.4161/cc.5.12.2865
PG 5
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 057FH
UT WOS:000238581200011
PM 16760669
OA Bronze
DA 2024-02-19
ER

PT J
AU Cook, CI
   Yu, BP
AF Cook, CI
   Yu, BP
TI Iron accumulation in aging: modulation by dietary restriction
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE tissue iron content; lipid peroxidation; oxidative stress; dietary
   restriction; aging
ID LIPID-PEROXIDATION; OXIDATIVE STRESS; LONGEVITY; MICE; AGE;
   QUANTITATION; METABOLISM; HYPOTHESIS; RATS
AB Male Fischer 344 rats fed ad libitum or dietary restricted (maintained on 60% of ad libitum food intake) were sacrificed at 6, 12 and 24 months of age. Portions of kidney, liver and brain were removed for total iron content analysis and oxidative stress assessment. Total iron content was measured directly and lipid peroxidation (LPO) was assayed as an index of oxidative stress. Tissue total iron content was shown to increase significantly with age in animals fed ad libitum (AL). At 24 months, these animals showed comparable iron content increases in the liver and kidney, but were significantly greater than measurements found in brain. This age-related iron accumulation, however, was found to be markedly suppressed by dietry restriction (DR) in all tissues. Similarly, LPO measurements increased in an age-related, tissue-specific fashion. At 24 months of age, measurements of LPO in AL rats brain and liver exceeded measurements in kidney. Again, we found DR to markedly suppress age-related LPO in all tissues. Reported here are our findings on the ability of DR to modulate iron status at the tissue level. Consistent with the proposed anti-oxidative mechanism of DR, these findings further suggest that the modulation of tissue total iron content is an important component of that mechanism. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
C1 Univ Texas, Hlth Sci Ctr, Dept Physiol, San Antonio, TX 78284 USA.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio
RP Yu, BP (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Physiol, San Antonio, TX 78284 USA.
FU NIA NIH HHS [AG-0118] Funding Source: Medline
CR BAKER GT, 1994, J AGING PHYS ACTIV, V2, P304
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CHOI JH, 1994, AGE, V17, P93, DOI 10.1007/BF02435012
   DAVIS LJ, 1993, MECH AGEING DEV, V72, P155, DOI 10.1016/0047-6374(93)90097-B
   DJURIC Z, 1993, MUTAT RES, V295, P181, DOI 10.1016/0921-8734(93)90019-Y
   DRAPER HH, 1990, METHOD ENZYMOL, V186, P421
   DUNFORD HB, 1987, FREE RADICAL BIO MED, V3, P405, DOI 10.1016/0891-5849(87)90019-0
   FEUERS RJ, 1993, MUTAT RES, V295, P191, DOI 10.1016/0921-8734(93)90020-4
   FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9
   Fishbein L, 1991, BIOL EFFECTS DIETARY
   FLOYD RA, 1993, TOXICOL IND HEALTH, V9, P197, DOI 10.1177/0748233793009001-214
   FONTECAVE M, 1993, BIOCHIMIE, V75, P767, DOI 10.1016/0300-9084(93)90126-D
   Ghio AJ, 1997, J LAB CLIN MED, V129, P53, DOI 10.1016/S0022-2143(97)90161-X
   GRINNA LS, 1973, BIOCHEM BIOPH RES CO, V55, P773, DOI 10.1016/0006-291X(73)91211-4
   JANERO DR, 1990, FREE RADICAL BIO MED, V9, P515, DOI 10.1016/0891-5849(90)90131-2
   KOIZUMI A, 1987, J NUTR, V117, P361, DOI 10.1093/jn/117.2.361
   LASH A, 1995, ANN CLIN LAB SCI, V25, P20
   MASSIE HR, 1983, EXP GERONTOL, V18, P277, DOI 10.1016/0531-5565(83)90038-4
   MASSIE HR, 1985, MECH AGEING DEV, V29, P215, DOI 10.1016/0047-6374(85)90020-X
   MINOTTI G, 1992, LIPIDS, V27, P219, DOI 10.1007/BF02536182
   OLANOW CW, 1993, TRENDS NEUROSCI, V16, P439, DOI 10.1016/0166-2236(93)90070-3
   SHARMA OP, 1977, BIOCHEM BIOPH RES CO, V78, P469, DOI 10.1016/0006-291X(77)90202-9
   WENDELL TC, 1962, AM J CLIN PATHOL, V37, P445
   YAGI K, 1987, CHEM PHYS LIPIDS, V45, P337, DOI 10.1016/0009-3084(87)90071-5
   YOSHIKAWA M, 1967, J GERONTOL, V22, P162, DOI 10.1093/geronj/22.2.162
   Yu BP, 1996, ANN NY ACAD SCI, V786, P1, DOI 10.1111/j.1749-6632.1996.tb39047.x
   YU BP, 1982, J GERONTOL, V37, P130, DOI 10.1093/geronj/37.2.130
   YU BP, 1995, MCBU, P331
   Yu BP, 1996, FREE RADICAL BIO MED, V21, P651, DOI 10.1016/0891-5849(96)00162-1
   YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657
NR 30
TC 109
Z9 121
U1 0
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD MAY 1
PY 1998
VL 102
IS 1
BP 1
EP 13
DI 10.1016/S0047-6374(98)00005-0
PG 13
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA ZT633
UT WOS:000074107400001
PM 9663787
DA 2024-02-19
ER

PT J
AU Ding, QY
   Yang, D
   Zhang, WN
   Lu, YM
   Zhang, MZ
   Wang, LM
   Li, XH
   Zhou, LY
   Wu, QX
   Pan, WJ
   Chen, Y
AF Ding, Qiuying
   Yang, Dan
   Zhang, Wenna
   Lu, Yongming
   Zhang, Mingzhu
   Wang, Liming
   Li, Xuehui
   Zhou, Liyuan
   Wu, Qingxi
   Pan, Wenjuan
   Chen, Yan
TI Antioxidant and anti-aging activities of the polysaccharide TLH-3 from
   <i>Tricholoma lobayense</i>
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Antioxidant activity; Anti-aging activity; Tricholoma lobayense
   polysaccharide TLH-3
ID INDUCED CELL-DAMAGE; OXIDATIVE STRESS; EXTRACTS; PURIFICATION;
   APOPTOSIS; MICE
AB Polysaccharides from edible fungi usually exhibit many bioactivities. Our previous studies found that polysaccharide TLH-3 extracted from Tricholoma lobayense possessed noticeable antioxidant activity. To further explore its biological activities, the antioxidant and anti-aging activities of TLH-3 were evaluated in vitro and in vivo. The results of antioxidant activity in vitro showed that TLH-3 could enhance the cell viability, reduce the production of reactive oxygen species (ROS) and inhibit oxidative damage induced by tert-butylhydroperoxide (t-BHP) in human embryonic lung fibroblasts (HELF) cells. The anti-aging capability was measured in D-galactose (D-gal)-induced aged mice model, and the experimental data showed that TLH-3 significantly inhibited the formation of malondialdehyde (MDA) and raised the activities of superoxide dismutase (SOD) and catalase (CAT) in mice liver and serum (p < 0.05). This study suggested that TLH-3 possessed apparent antioxidant and anti-aging activities and could be exploited as a potent dietary supplement to attenuate aging and prevent age-related diseases in humans. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Ding, Qiuying; Yang, Dan; Zhang, Wenna; Lu, Yongming; Zhang, Mingzhu; Wang, Liming; Li, Xuehui; Zhou, Liyuan; Wu, Qingxi; Pan, Wenjuan; Chen, Yan] Anhui Univ, Sch Life Sci, Key Lab Ecol Engn & Biotechnol Anhui Prov, Hefei 230601, Anhui, Peoples R China.
C3 Anhui University
RP Chen, Y (corresponding author), Anhui Univ, Sch Life Sci, Hefei 230601, Anhui, Peoples R China.
EM chenyan91030@yahoo.com
RI Zhang, Wenna Zhang/HJZ-2313-2023; Wu, Qing-Xi/AAA-4724-2020; Lu,
   Yong-Ming/Q-5305-2018
OI Wu, Qing-Xi/0000-0003-2388-2344; Lu, Yong-Ming/0000-0002-4023-0500
FU National Natural Science Foundation of China [31271817]; Key Project of
   Science and Technology of Anhui Province [1501031099]
FX This research was supported by the National Natural Science Foundation
   of China (31271817) and the Key Project of Science and Technology of
   Anhui Province (1501031099).
CR Arur S, 2003, DEV CELL, V4, P587, DOI 10.1016/S1534-5807(03)00090-X
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   CARMICHAEL J, 1987, CANCER RES, V47, P936
   Cui HX, 2008, CARBOHYD POLYM, V74, P771, DOI 10.1016/j.carbpol.2008.04.034
   Fernandez-Tome S, 2014, FOOD RES INT, V62, P793, DOI 10.1016/j.foodres.2014.04.054
   Ge Y, 2009, CARBOHYD POLYM, V77, P188, DOI 10.1016/j.carbpol.2008.12.020
   GOTZ ME, 1994, PHARMACOL THERAPEUT, V63, P37, DOI 10.1016/0163-7258(94)90055-8
   Hampton MB, 1997, FEBS LETT, V414, P552, DOI 10.1016/S0014-5793(97)01068-5
   HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9
   Harman D, 2006, ANN NY ACAD SCI, V1067, P10, DOI 10.1196/annals.1354.003
   Hsieh HM, 2009, FOOD CHEM TOXICOL, V47, P625, DOI 10.1016/j.fct.2008.12.026
   Ishaque A, 1998, J IMMUNOL METHODS, V221, P43, DOI 10.1016/S0022-1759(98)00166-5
   Kim DB, 2016, FOOD CHEM, V194, P920, DOI 10.1016/j.foodchem.2015.08.094
   Kim YS, 2013, BIOTECHNOL BIOPROC E, V18, P819, DOI 10.1007/s12257-012-0623-z
   Kim YS, 2012, FOOD CHEM TOXICOL, V50, P4191, DOI 10.1016/j.fct.2012.08.015
   KIRKMAN HN, 1984, P NATL ACAD SCI-BIOL, V81, P4343, DOI 10.1073/pnas.81.14.4343
   Kumar KH, 2013, CELL MOL NEUROBIOL, V33, P5, DOI 10.1007/s10571-012-9865-8
   Li GL, 2012, FOOD CHEM TOXICOL, V50, P363, DOI 10.1016/j.fct.2011.10.036
   Li SJ, 2015, INT J BIOL MACROMOL, V80, P16, DOI 10.1016/j.ijbiomac.2015.06.024
   Li X., 2015, INT J BIOL MACROMOL
   Liu F, 1996, GEN PHARMACOL, V27, P621, DOI 10.1016/0306-3623(95)02058-6
   Liu L, 2015, PROCESS BIOCHEM, V50, P1146, DOI 10.1016/j.procbio.2015.04.011
   Martino R, 2013, LEUKEMIA RES, V37, P1137, DOI 10.1016/j.leukres.2013.06.004
   Matkowski A, 2008, J MED PLANTS RES, V2, P321
   NOHL H, 1993, BRIT MED BULL, V49, P653, DOI 10.1093/oxfordjournals.bmb.a072638
   Senevirathne M, 2011, CARBOHYD POLYM, V83, P995, DOI 10.1016/j.carbpol.2010.09.016
   Sies H, 1997, EXP PHYSIOL, V82, P291, DOI 10.1113/expphysiol.1997.sp004024
   Singh RP., 2004, J INDIAN ACAD CLIN M, V5, P218
   Sun SW, 2007, NUTR RES, V27, P169, DOI 10.1016/j.nutres.2007.01.010
   Sun YX, 2010, CARBOHYD POLYM, V82, P510, DOI 10.1016/j.carbpol.2010.05.010
   Wang C, 2012, INT J BIOL MACROMOL, V50, P534, DOI 10.1016/j.ijbiomac.2012.01.005
   White J, 2005, STEM CELL REV, V1, P131, DOI 10.1385/SCR:1:2:131
   Wu DM, 2006, J GASTROEN HEPATOL, V21, pS26, DOI 10.1111/j.1440-1746.2006.04589.x
   Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9
   Yuan JF, 2008, CARBOHYD POLYM, V74, P822, DOI 10.1016/j.carbpol.2008.04.040
   Zhang H, 2011, CARBOHYD POLYM, V84, P638, DOI 10.1016/j.carbpol.2010.12.044
   Zhang ZF, 2012, INT J BIOL MACROMOL, V51, P1140, DOI 10.1016/j.ijbiomac.2012.09.002
   Zhao KS, 2005, BIOCHEM PHARMACOL, V70, P1796, DOI 10.1016/j.bcp.2005.08.022
   Zheng L, 2015, J SCI FOOD AGR, V95, P3117, DOI 10.1002/jsfa.7048
   Zhong WQ, 2013, INT J BIOL MACROMOL, V60, P355, DOI 10.1016/j.ijbiomac.2013.06.018
   Zhou Y, 2014, ARCH GERONTOL GERIAT, V58, P293, DOI 10.1016/j.archger.2013.10.005
   Zhu MY, 2009, CARBOHYD POLYM, V78, P497, DOI 10.1016/j.carbpol.2009.05.008
NR 42
TC 63
Z9 68
U1 5
U2 123
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD APR
PY 2016
VL 85
BP 133
EP 140
DI 10.1016/j.ijbiomac.2015.12.058
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA DE8LF
UT WOS:000370886800016
PM 26721384
DA 2024-02-19
ER

PT J
AU Dominguez, LJ
   Barbagallo, M
AF Dominguez, Ligia J.
   Barbagallo, Mario
TI The biology of the metabolic syndrome and aging
SO CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
LA English
DT Article
DE aging; inflammation; insulin resistance; metabolic syndrome; obesity
ID TELOMERE LENGTH; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; SARCOPENIC
   OBESITY; MEDITERRANEAN DIET; OLDER-ADULTS; FETUIN-A; PREVALENCE;
   MAGNESIUM; HEALTH
AB Purpose of reviewAging of the world population is a major contributor to the growing prevalence of the metabolic syndrome, as older persons are frequently affected by the constellation of cardiovascular and metabolic risk factors that constitute the syndrome. The metabolic syndrome has been related to the increasing prevalence of obesity, which is escalating even among older age groups. The present review covers data on the novel proposed biological mediators of the metabolic syndrome, which are as well linked to the aging process.Recent findingsRelevant biological mediators of metabolic syndrome and unhealthy aging include sarcopenic obesity, insulin resistance with ectopic fat accumulation, magnesium metabolism alterations, systemic and hypothalamic inflammation, shortening of telomeres length, epigenetics, and circadian rhythm disturbances.SummaryMetabolic syndrome is related to increased accumulation of central adiposity and ectopic fat infiltration in the skeletal muscle and the liver, linked to overeating and sedentarism with deleterious consequences in late life. Obesity may be complicated with sarcopenia, which refers to loss of muscle mass, strength, and quality in older populations. Prevention of obesity and metabolic syndrome is a priority through the promotion of healthier lifestyles and policies for sugar and saturated fats, which might be widely implemented.
C1 [Dominguez, Ligia J.; Barbagallo, Mario] Univ Palermo, Dept Internal Med & Geriatr, Geriatr Unit, I-90144 Palermo, Italy.
C3 University of Palermo
RP Dominguez, LJ (corresponding author), Univ Palermo, Dept Internal Med & Geriatr, Geriatr Unit, Viale F Scaduto 6-C, I-90144 Palermo, Italy.
EM ligia.dominguez@unipa.it
RI BARBAGALLO, MARIO/K-4794-2017
OI BARBAGALLO, MARIO/0000-0002-1349-6530
CR Aguilar M, 2015, JAMA-J AM MED ASSOC, V313, P1973, DOI 10.1001/jama.2015.4260
   Arellanes-Licea E, 2014, AGING DIS, V5, P406, DOI 10.14336/AD.2014.0500406
   Atkins JL, 2014, J AM GERIATR SOC, V62, P253, DOI 10.1111/jgs.12652
   Barbagallo M, 2014, METABOLISM, V63, P502, DOI 10.1016/j.metabol.2013.12.003
   Batsis JA, 2013, J AM GERIATR SOC, V61, P974, DOI 10.1111/jgs.12260
   Belancio VP, 2015, FRONT GENET, V5, DOI 10.3389/fgene.2014.00455
   Cederholm T, 2015, CURR OPIN CLIN NUTR, V18, P1, DOI 10.1097/MCO.0000000000000119
   Crous-Bou M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6674
   Daniele G, 2014, ACTA DIABETOL, V51, P123, DOI 10.1007/s00592-013-0543-1
   DeWeerdt S, 2014, NATURE, V508, pS61, DOI 10.1038/508S61a
   Dibaba DT, 2014, DIABETIC MED, V31, P1301, DOI 10.1111/dme.12537
   Dominguez LJ, 2006, AM J CLIN NUTR, V84, P419
   García-Calzón S, 2014, INT J OBESITY, V38, P177, DOI 10.1038/ijo.2013.68
   Grant RW, 2015, OBESITY, V23, P512, DOI 10.1002/oby.21003
   Haycock PC, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4227
   Hinnouho GM, 2015, EUR HEART J, V36, P551, DOI 10.1093/eurheartj/ehu123
   HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183
   Jia GH, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0434-z
   Johnson RJ, 2013, OBESITY, V21, P659, DOI 10.1002/oby.20026
   Kalyani RR, 2014, LANCET DIABETES ENDO, V2, P819, DOI 10.1016/S2213-8587(14)70034-8
   La SA, 2015, BIOL TRACE ELEM RES
   Li JX, 2014, MOL METAB, V3, P313, DOI 10.1016/j.molmet.2014.01.012
   Liu ML, 2014, BEST PRACT RES CL EN, V28, P25, DOI 10.1016/j.beem.2013.06.003
   Lopez-Garcia E, 2014, AM J CLIN NUTR, V99, P172, DOI 10.3945/ajcn.113.068106
   Magkos F, 2012, GASTROENTEROLOGY, V142, P1444, DOI 10.1053/j.gastro.2012.03.003
   de Morentin PBM, 2014, CURR MOL MED, V14, P3, DOI 10.2174/1566524013666131118103706
   Moore AZ, 2014, J AM GERIATR SOC, V62, P230, DOI 10.1111/jgs.12653
   Morley JE, 2004, J GERONTOL A-BIOL, V59, P139
   Mukhopadhyay S, 2014, ENDOCR PRACT, V20, P1345, DOI 10.4158/EP14421.RA
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Pahor M, 2014, JAMA-J AM MED ASSOC, V311, P2387, DOI 10.1001/jama.2014.5616
   Perry RJ, 2014, NAT MED, V20, P759, DOI 10.1038/nm.3579
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Révész D, 2014, J CLIN ENDOCR METAB, V99, P4607, DOI 10.1210/jc.2014-1851
   Riera CE, 2015, NAT CELL BIOL, V17, P196, DOI 10.1038/ncb3107
   Samocha-Bonet D, 2014, DIABETES CARE, V37, pE15, DOI 10.2337/dc13-1728
   Sepúlveda J, 2014, SCIENCE, V345, P1275, DOI 10.1126/science.1257099
   Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479
   Shulman GI, 2014, NEW ENGL J MED, V371, P1131, DOI 10.1056/NEJMra1011035
   Szendroedi J, 2014, P NATL ACAD SCI USA, V111, P9597, DOI 10.1073/pnas.1409229111
   Szic KSV, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0068-2
   Tang YZ, 2015, TRENDS NEUROSCI, V38, P36, DOI 10.1016/j.tins.2014.10.002
   Thomsen M, 2014, JAMA INTERN MED, V174, P15, DOI 10.1001/jamainternmed.2013.10522
   Velloso LA, 2015, ENDOCR REV, V36, P245, DOI 10.1210/er.2014-1100
   Wannamethee SG, 2015, P NUTR SOC, V74, P405, DOI 10.1017/S002966511500169X
   Yan JQ, 2014, NAT MED, V20, P1001, DOI 10.1038/nm.3616
   Yang Z, 2014, MED CARE, V52, P658, DOI 10.1097/MLR.0000000000000154
NR 47
TC 97
Z9 103
U1 0
U2 45
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1363-1950
EI 1473-6519
J9 CURR OPIN CLIN NUTR
JI Curr. Opin. Clin. Nutr. Metab. Care
PD JAN
PY 2016
VL 19
IS 1
BP 5
EP 11
DI 10.1097/MCO.0000000000000243
PG 7
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA CY4CU
UT WOS:000366357000002
PM 26560521
DA 2024-02-19
ER

PT J
AU Hunt, NJ
   Lockwood, GP
   Kang, SW
   Pulpitel, T
   Clark, X
   Mao, H
   McCourt, PAG
   Cooney, GJ
   Wali, JA
   Le Couteur, FH
   Le Couteur, DG
   Cogger, VC
AF Hunt, Nicholas J.
   Lockwood, Glen P.
   Kang, Sun Woo (Sophie)
   Pulpitel, Tamara
   Clark, Ximonie
   Mao, Hong
   McCourt, Peter A. G.
   Cooney, Gregory J.
   Wali, Jibran A.
   Le Couteur, Frank H.
   Le Couteur, David G.
   Cogger, Victoria C.
TI The Effects of Metformin on Age-Related Changes in the Liver Sinusoidal
   Endothelial Cell
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE NOS; LSEC; dSTORM; Aging; Insulin
ID ACTIVATED PROTEIN-KINASE; PSEUDOCAPILLARIZATION; PHOSPHORYLATION;
   HOMEOSTASIS; MECHANISMS; ACTIN; AMPK
AB Age-related changes in the liver sinusoidal endothelium, particularly the reduction in fenestrations, contribute to insulin resistance in old age. Metformin impacts on the aging process and improves insulin resistance. Therefore, the effects of metformin on the liver sinusoidal endothelium were studied. Metformin increased fenestrations in liver sinusoidal endothelial cells isolated from both young and old mice. Mice administered metformin in the diet for 12 months had increased fenestrations and this was associated with lower insulin levels. The effect of metformin on fenestrations was blocked by inhibitors of AMP-activated protein kinase (AMPK), endothelial nitric oxide synthase, and myosin light chain kinase phosphorylation. Metformin led to increased transgelin expression and structural changes in the actin cytoskeleton but had no effect on lactate production. Metformin also generated fenestration-like structures in SK-Hep1 cells, a liver endothelial cell line, and this was associated with increased ATP, cGMP, and mitochondrial activity. In conclusion, metformin ameliorates age-related changes in the liver sinusoidal endothelial cell via AMPK and endothelial nitric oxide pathways, which might promote insulin sensitivity in the liver, particularly in old age.
C1 [Hunt, Nicholas J.; Lockwood, Glen P.; Kang, Sun Woo (Sophie); Le Couteur, Frank H.; Le Couteur, David G.; Cogger, Victoria C.] Concord Repatriat Gen Hosp, ANZAC Res Inst, Biogerontol Lab, Sydney, NSW, Australia.
   [Hunt, Nicholas J.; Lockwood, Glen P.; Kang, Sun Woo (Sophie); Wali, Jibran A.; Le Couteur, David G.; Cogger, Victoria C.] Concord Repatriat Gen Hosp, Aging & Alzheimers Inst, Sydney, NSW, Australia.
   [Hunt, Nicholas J.; Lockwood, Glen P.; Kang, Sun Woo (Sophie); Wali, Jibran A.; Le Couteur, David G.; Cogger, Victoria C.] Concord Repatriat Gen Hosp, Ctr Educ & Res Ageing, Sydney, NSW, Australia.
   [Hunt, Nicholas J.; Le Couteur, David G.; Cogger, Victoria C.] Univ Sydney, Sydney Med Sch, Concord Clin Sch, Sydney, NSW, Australia.
   [Hunt, Nicholas J.; Lockwood, Glen P.; Kang, Sun Woo (Sophie); Pulpitel, Tamara; Clark, Ximonie; McCourt, Peter A. G.; Cooney, Gregory J.; Wali, Jibran A.; Le Couteur, David G.; Cogger, Victoria C.] Univ Sydney, Charles Perkins Ctr, Nutr Ecol & Physiol Lab, Sydney, NSW, Australia.
   [Mao, Hong; McCourt, Peter A. G.] Univ Tromso, Dept Med Biol, Tromso, Norway.
   [Wali, Jibran A.] Univ Sydney, Sch Life & Environm Sci, Fac Sci, Sydney, NSW, Australia.
C3 University of Sydney; ANZAC Research Institute; Concord Repatriation
   General Hospital; Concord Repatriation General Hospital; Concord
   Repatriation General Hospital; University of Sydney; University of
   Sydney; UiT The Arctic University of Tromso; University of Sydney
RP Cogger, VC (corresponding author), Concord Repatriat Gen Hosp, Ctr Educ & Res Ageing, Sydney, NSW, Australia.
EM victoria.cogger@sydney.edu.au
RI Hunt, Nicholas/AAD-6084-2019; Wali, Jibran/K-9843-2019; McCourt,
   Peter/B-3043-2009; Research Institute, ANZAC/CAE-9030-2022; Mao,
   Hong/AAS-3541-2020; Ekanayake, Kanchana/P-8817-2016
OI Hunt, Nicholas/0000-0002-9001-0602; Wali, Jibran/0000-0002-8524-5773;
   McCourt, Peter/0000-0001-5072-4590; Mao, Hong/0000-0003-4266-3550;
   Lockwood, Glen/0000-0001-5966-0191
FU Australian National Health and Medical Research Council [1141234,
   1101913]; Ageing and Alzheimer's Research Foundation (a Division of the
   Medical Foundation of the University of Sydney); Sydney Medical School
   Foundation McKnight Bequest; University of Sydney DVCR Research Equity
   Fellowship; University of Tromso Faculty of Health Sciences travel
   grants; National Health and Medical Research Council of Australia
   [1141234, 1101913] Funding Source: NHMRC
FX The study was supported by the Australian National Health and Medical
   Research Council Projects #1141234 and #1101913; the Ageing and
   Alzheimer's Research Foundation (a Division of the Medical Foundation of
   the University of Sydney); Sydney Medical School Foundation McKnight
   Bequest; the University of Sydney DVCR Research Equity Fellowship; and
   the University of Tromso Faculty of Health Sciences travel grants to
   P.M. and H.M.
CR Alfaras I, 2017, NPJ AGING MECH DIS, V3, DOI 10.1038/s41514-017-0018-7
   Barzilai N. R., 2017, Innovation in Aging, V1, P743, DOI [10.1093/geroni/igx004.2682, DOI 10.1093/GERONI/IGX004.2682]
   Barzilai N, 2016, CELL METAB, V23, P1060, DOI 10.1016/j.cmet.2016.05.011
   Braet F, 2003, HEPATOLOGY, V38, P394, DOI 10.1053/jhep.2003.50347
   Cogger VC, 2008, AM J PHYSIOL-GASTR L, V295, pG137, DOI 10.1152/ajpgi.00069.2008
   Cogger VC, 2015, JOVE-J VIS EXP, DOI 10.3791/52698
   DeLeve LD, 2008, HEPATOLOGY, V48, P920, DOI 10.1002/hep.22351
   DeLeve LD, 2015, HEPATOLOGY, V61, P1740, DOI 10.1002/hep.27376
   Detaille D, 2005, DIABETES, V54, P2179, DOI 10.2337/diabetes.54.7.2179
   Ford RJ, 2015, BIOCHEM J, V468, P125, DOI 10.1042/BJ20150125
   Fu D, 2013, P NATL ACAD SCI USA, V110, P7288, DOI 10.1073/pnas.1304285110
   Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372
   Han M, 2009, LIFE SCI, V84, P394, DOI 10.1016/j.lfs.2008.11.017
   Hilmer SN, 2005, HEPATOLOGY, V42, P1349, DOI 10.1002/hep.20937
   Howell JJ, 2017, CELL METAB, V25, P463, DOI 10.1016/j.cmet.2016.12.009
   Hunt NJ, 2019, AM J PHYSIOL-GASTR L, V316, pG144, DOI 10.1152/ajpgi.00179.2018
   Hunt NJ, 2018, ADV DRUG DELIVER REV, V135, P39, DOI 10.1016/j.addr.2018.09.006
   Jamieson HA, 2007, EXP GERONTOL, V42, P374, DOI 10.1016/j.exger.2006.11.004
   Kane DA, 2010, FREE RADICAL BIO MED, V49, P1082, DOI 10.1016/j.freeradbiomed.2010.06.022
   Kang SWS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165638
   Lazarus B, 2018, JAMA INTERN MED, V178, P903, DOI 10.1001/jamainternmed.2018.0292
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   Liang ZX, 2017, ONCOTARGET, V8, P62780, DOI 10.18632/oncotarget.19376
   Madiraju AK, 2018, NAT MED, V24, P1384, DOI 10.1038/s41591-018-0125-4
   Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192
   Maslak E, 2015, PHARMACOL REP, V67, P689, DOI 10.1016/j.pharep.2015.04.010
   Mitchell SJ, 2011, J GERONTOL A-BIOL, V66, P400, DOI 10.1093/gerona/glq221
   Mohamad M, 2016, AGING CELL, V15, P706, DOI 10.1111/acel.12481
   Novelle MG, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a025932
   Rena G, 2017, DIABETOLOGIA, V60, P1577, DOI 10.1007/s00125-017-4342-z
   Rhee CM, 2017, NEPHRON, V135, P147, DOI 10.1159/000450862
   Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781
   Svistounov D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046134
   Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05
   Vítecek J, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/318087
   Warren A, 2005, EXP GERONTOL, V40, P807, DOI 10.1016/j.exger.2005.06.012
   Wolter S, 2012, NAT METHODS, V9, P1040, DOI 10.1038/nmeth.2224
   Xie GH, 2012, GASTROENTEROLOGY, V142, P918, DOI 10.1053/j.gastro.2011.12.017
   Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505
   Zolotarevsky Y, 2002, GASTROENTEROLOGY, V123, P163, DOI 10.1053/gast.2002.34235
NR 40
TC 24
Z9 25
U1 0
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD FEB
PY 2020
VL 75
IS 2
BP 278
EP 285
DI 10.1093/gerona/glz153
PG 8
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA LU0FZ
UT WOS:000537440500011
PM 31198956
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU Chen, F
   Pan, JN
   Yu, LL
   Wang, SH
   Zhang, CC
   Zhao, JX
   Narbad, A
   Zhai, QX
   Tian, FW
AF Chen, Feng
   Pan, Jiani
   Yu, Leilei
   Wang, Shunhe
   Zhang, Chengcheng
   Zhao, Jianxin
   Narbad, Arjan
   Zhai, Qixiao
   Tian, Fengwei
TI Lactiplantibacillus plantarum CCFM8661 alleviates d-galactose-induced
   brain aging in mice by the regulation of the gut microbiota
SO FOOD & FUNCTION
LA English
DT Article; Early Access
ID INTESTINAL MICROBIOTA; OXIDATIVE STRESS
AB Aging is characterized by a decline in biological functions, leading to various health issues. There is significant interest in mitigating age and age-related health issues. Gut microbiota has emerged as a crucial target for combating aging and influencing host health. This study evaluated the anti-aging effects of Lactiplantibacillus plantarum CCFM8661 in mice and the role of the gut microbiota in mediating its effects. Aging was induced in mice using d-galactose, and L. plantarum CCFM8661 was orally administered for 8 weeks to evaluate its effects on age-related decline and the gut microbiota. The results demonstrated that supplementation with L. plantarum CCFM8661 effectively alleviated cognitive impairment and oxidative stress in the aging brain, as well as liver oxidation and bone damage, and impaired intestinal barrier function in aging mice. Furthermore, L. plantarum CCFM8661 modulated the gut microbiota of aging mice, increasing the abundance of beneficial bacteria, such as Ruminococcaceae, and influenced the functionality of the gut microbiota to promote the production of active metabolites. These findings suggest that L. plantarum CCFM8661 has a mitigating effect on organismal aging, especially brain aging.
C1 [Chen, Feng; Pan, Jiani; Yu, Leilei; Wang, Shunhe; Zhang, Chengcheng; Zhao, Jianxin; Zhai, Qixiao; Tian, Fengwei] Jiangnan Univ, State Key Lab Food Sci & Resources, Wuxi 214122, Jiangsu, Peoples R China.
   [Chen, Feng; Pan, Jiani; Yu, Leilei; Wang, Shunhe; Zhang, Chengcheng; Zhao, Jianxin; Zhai, Qixiao; Tian, Fengwei] Jiangnan Univ, Sch Food Sci & Technol, Wuxi 214122, Jiangsu, Peoples R China.
   [Yu, Leilei; Zhao, Jianxin; Narbad, Arjan; Zhai, Qixiao; Tian, Fengwei] Jiangnan Univ, Int Joint Res Lab Probiot, Wuxi 214122, Jiangsu, Peoples R China.
   [Narbad, Arjan] Quadram Inst Biosci, Gut Hlth & Microbiome Inst Strateg Programme, Norwich 16, England.
C3 Jiangnan University; Jiangnan University; Jiangnan University; UK
   Research & Innovation (UKRI); Biotechnology and Biological Sciences
   Research Council (BBSRC); Quadram Institute
RP Yu, LL (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Resources, Wuxi 214122, Jiangsu, Peoples R China.; Yu, LL (corresponding author), Jiangnan Univ, Sch Food Sci & Technol, Wuxi 214122, Jiangsu, Peoples R China.; Yu, LL (corresponding author), Jiangnan Univ, Int Joint Res Lab Probiot, Wuxi 214122, Jiangsu, Peoples R China.
EM edyulei@126.com
RI Liu, Zhihao/JUF-7651-2023
OI Yu, Leilei/0000-0002-3191-3123
FU This research was funded by the Natural Science Foundation of Jiangsu
   Province [BE2021623, BK20220155], the National Natural Science
   Foundation of China [32001665, U1903205], the Key Scientific and
   Technological Research Projects in the Key Areas of the Xi [BE2021623,
   BK20220155]; Natural Science Foundation of Jiangsu Province [32001665,
   U1903205]; National Natural Science Foundation of China [2018AB010]; Key
   Scientific and Technological Research Projects in the Key Areas of the
   Xinjiang Production and Construction Corps; Collaborative Innovation
   Center of Food Safety and Quality Control in Jiangsu Province; Animal
   Ethics Committee of Jiangnan University
FX This research was funded by the Natural Science Foundation of Jiangsu
   Province [BE2021623, BK20220155], the National Natural Science
   Foundation of China [32001665, U1903205], the Key Scientific and
   Technological Research Projects in the Key Areas of the Xinjiang
   Production and Construction Corps [2018AB010], and the Collaborative
   Innovation Center of Food Safety and Quality Control in Jiangsu
   Province. The Animal Ethics Committee of Jiangnan University has
   approved all the experimental protocols. The ethics number is
   JN.No20220315c1200620 [038].
CR Ali T, 2015, J PINEAL RES, V58, P71, DOI 10.1111/jpi.12194
   Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836
   Bogicevic B, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw012
   Boskey AL, 2010, J DENT RES, V89, P1333, DOI 10.1177/0022034510377791
   Burton DGA, 2018, BIOGERONTOLOGY, V19, P447, DOI 10.1007/s10522-018-9763-7
   Chen YJ, 2018, J GASTROEN HEPATOL, V33, P1844, DOI 10.1111/jgh.14281
   Chen YF, 2020, AGING-US, V12, P4778, DOI 10.18632/aging.102872
   Cheng LH, 2022, FOOD FUNCT, V13, P5240, DOI [10.1039/d2fo00165a, 10.1039/D2FO00165A]
   Chiodini RJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134382
   Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107
   DeJong EN, 2020, CELL HOST MICROBE, V28, P180, DOI 10.1016/j.chom.2020.07.013
   den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012
   Dhanjal DS, 2020, NUTRIENTS, V12, DOI 10.3390/nu12103008
   Ge QF, 2021, BMC MICROBIOL, V21, DOI 10.1186/s12866-021-02248-5
   Ghosh TS, 2022, NAT REV GASTRO HEPAT, V19, P565, DOI 10.1038/s41575-022-00605-x
   Han B, 2017, CELL, V169, P1249, DOI 10.1016/j.cell.2017.05.036
   Henneke L, 2022, GUT MICROBES, V14, DOI 10.1080/19490976.2022.2057778
   Ho ST, 2019, J DAIRY SCI, V102, P1901, DOI 10.3168/jds.2018-15811
   Huang CL, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00776
   Humbel F, 2020, CLIN GASTROENTEROL H, V18, P2019, DOI 10.1016/j.cgh.2019.09.022
   Kritsilis M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19102937
   Kumar Manish, 2016, Nutr Healthy Aging, V4, P3, DOI 10.3233/NHA-150002
   Kushkevych I, 2018, OPEN LIFE SCI, V13, P481, DOI 10.1515/biol-2018-0057
   Lee J, 2020, GUT MICROBES, V12, DOI 10.1080/19490976.2020.1814107
   Li Z, 2021, BIOGERONTOLOGY, V22, P165, DOI 10.1007/s10522-021-09910-5
   Lin SW, 2021, NUTRIENTS, V13, DOI 10.3390/nu13082860
   Liu YR, 2023, IMETA, V2, DOI 10.1002/imt2.136
   Lushchak O, 2023, BIOMOLECULES, V13, DOI 10.3390/biom13060966
   Marquez-Exposito L, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11020301
   Murros KE, 2021, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.652617
   Ni YH, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201900603
   Palmer AK, 2019, DIABETOLOGIA, V62, P1835, DOI 10.1007/s00125-019-4934-x
   Peng Jiang, 2020, Food and Fermentation Industries, V46, P13, DOI 10.13995/j.cnki.11-1802/ts.024120
   Pingali U, 2022, PHYTOMEDICINE, V105, DOI 10.1016/j.phymed.2022.154334
   Pomatto LCD, 2018, FREE RADICAL BIO MED, V124, P420, DOI 10.1016/j.freeradbiomed.2018.06.016
   Qi DS, 2016, BRAIN RES, V1653, P67, DOI 10.1016/j.brainres.2016.10.017
   Rondanelli M, 2015, WORLD J CLIN CASES, V3, P156, DOI 10.12998/wjcc.v3.i2.156
   Shemtov SJ, 2023, FEBS J, V290, P4163, DOI 10.1111/febs.16558
   Shi X, 2022, APPL MICROBIOL BIOT, V106, P5349, DOI 10.1007/s00253-022-12089-5
   Song P, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030671
   Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x
   Teodori L, 2019, MECH AGEING DEV, V182, DOI 10.1016/j.mad.2019.111127
   Tuikhar N, 2019, MECH AGEING DEV, V179, P23, DOI [10.1016/j.mad.2019.02.001, 10.1016/j.mad.2019.02.00]
   Vemuri R, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061297
   Vemuri R, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091255
   Wang B, 2022, FRONT AGING NEUROSCI, V14, DOI 10.3389/fnagi.2022.777700
   Wang G, 2017, FOOD FUNCT, V8, P3155, DOI 10.1039/c7fo00593h
   Wang JJ, 2022, GUT MICROBES, V14, DOI 10.1080/19490976.2022.2107288
   Wang MX, 2018, RSC ADV, V8, P5042, DOI 10.1039/c7ra12067b
   Wang W, 2022, J AGR FOOD CHEM, V70, P8619, DOI 10.1021/acs.jafc.2c01950
   Wang W, 2021, J AGR FOOD CHEM, V69, P2745, DOI 10.1021/acs.jafc.0c06730
   Warman DJ, 2022, NUTRIENTS, V14, DOI 10.3390/nu14040747
   Xi Y, 2022, FOOD FUNCT, V13, P1535, DOI [10.1039/D1FO03334D, 10.1039/d1fo03334d]
   Xia CF, 2020, J FUNCT FOODS, V69, DOI 10.1016/j.jff.2020.103938
   Xiao Y, 2021, MICROBIOME, V9, DOI 10.1186/s40168-021-01108-8
   Xu GD, 2018, BIOL PHARM BULL, V41, P1024, DOI 10.1248/bpb.b17-00978
   Yao JX, 2023, FRONT NEUROSCI-SWITZ, V17, DOI 10.3389/fnins.2023.1093180
   Yeung SSY, 2021, NUTRIENTS, V13, DOI 10.3390/nu13124310
   Yu XM, 2023, PROBIOTICS ANTIMICRO, V15, P1193, DOI 10.1007/s12602-022-09933-5
   Zhang D, 2023, J MICROBIOL BIOTECHN, V33, P1030, DOI 10.4014/jmb.2209.09021
   Zhao JC, 2018, FOOD FUNCT, V9, P917, DOI [10.1039/c7fo01574g, 10.1039/C7FO01574G]
   Zhao L, 2019, J FUNCT FOODS, V52, P587, DOI 10.1016/j.jff.2018.11.044
   Zheng SY, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59055-7
NR 63
TC 0
Z9 0
U1 19
U2 19
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD 2023 NOV 13
PY 2023
VL 14
IS 22
BP 10135
EP 10150
DI 10.1039/d3fo03377e
EA OCT 2023
PG 16
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA X2VY4
UT WOS:001092378500001
PM 37901912
DA 2024-02-19
ER

PT J
AU Poirier, H
   Mathieu, Y
   Besnard, P
   Bernard, A
AF Poirier, H
   Mathieu, Y
   Besnard, P
   Bernard, A
TI Intestinal lipid esterification and aging in mice and rats
SO COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-PHYSIOLOGY
LA English
DT Article
DE absorption; acyltransferases; aging; esterification; intestine; fatty
   acids; mice; rats
ID UNSATURATED FATTY-ACIDS; LIVER MICROSOMES; ABSORPTION; AGE;
   ACYLTRANSFERASE; METABOLISM; DIET
AB The effects of aging on lipid absorption, particularly on fatty acid glycerophospholipid and triacylglycerol esterification, were investigated in 2.5-,12- and 24-month-old mice and rats. Two intestinal mucosa microsomal enzymes, involved in the dietary fatty acid absorption, were assayed:acylCoA:2-monoacylglycerol acyltransferase and acylCoA:1-lysophosphatidylcholine acyltransferase. In both mice and rats, the activities of both enzymes varied with the nature of the acyl-CoA. Indeed acylCoa:2-monoacylglycerol acyltransferase activities were significantly higher with oleoyl-CoA and linoleoyl-CoA than with palmitoyl-CoA and arachidonoyl-CoA, while acylCoA:1-lysophosphatidylcholine acyltransferase activities were highest with arachidonoyl-CoA. AcylCoA:2-monoacylglycerol acyltransferase activity did not decrease significantly with aging in mice or rats, whatever the acyl-CoA used. In contrast, acylCoA:1-lysophosphatidylcholine acyltransferase activity in the 24-month-old rats was significantly lower (-47 %) than in 2.5-month-old rats, with oleoyl-CoA, linoleoyl-CoA and arachidonoyl-CoA. Simultaneously we observed that less glycerophospholipid esterification of oleic and linoleic acid occurs in older rats than in 2.5-month-old rats. Copyright (C) 1997 Elsevier Science Inc.
C1 UNIV BOURGOGNE,LAB PHYSIOL NUTR,ECOLE NATL SUPER BIOL APPL NUTR & ALIMENTAT,EA DRED 580,F-21000 DIJON,FRANCE.
C3 Universite de Bourgogne
CR ARORA S, 1989, GASTROENTEROLOGY, V96, P1560, DOI 10.1016/0016-5085(89)90527-1
   BERNARD A, 1991, ANN NUTR METAB, V35, P98, DOI 10.1159/000177632
   BERNARD A, 1989, REPROD NUTR DEV, V29, P63, DOI 10.1051/rnd:19890104
   BERNARD A, 1992, COMP BIOCHEM PHYS A, V101, P607, DOI 10.1016/0300-9629(92)90515-R
   BRASITUS TA, 1984, BIOCHIM BIOPHYS ACTA, V778, P341, DOI 10.1016/0005-2736(84)90378-X
   Brindley D N, 1974, Biomembranes, V4B, P621
   CARLIER H, 1991, REPROD NUTR DEV, V31, P475, DOI 10.1051/rnd:19910501
   . Delsal J. L., 1944, BULL SOC CHIM BIOL, V26, P99
   ECKANUER R, 1982, J GERONTOL, V37, P151
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   GOODNIGHT SH, 1982, ARTERIOSCLEROSIS, V2, P87, DOI 10.1161/01.ATV.2.2.87
   HOLT PR, 1981, DIGEST DIS SCI, V26, P1109, DOI 10.1007/BF01295977
   HOLT PR, 1985, GASTROENTEROLOGY, V89, P1026, DOI 10.1016/0016-5085(85)90204-5
   HOLT PR, 1993, AM J PHYSIOL, V264, pG1, DOI 10.1152/ajpgi.1993.264.1.G1
   HOLT PR, 1984, J GERONTOL, V39, P642, DOI 10.1093/geronj/39.6.642
   KAWASHIMA Y, 1986, BIOCHIM BIOPHYS ACTA, V875, P549
   LANDS WEM, 1982, J BIOL CHEM, V257, P4968
   LEHNER R, 1993, LIPIDS, V28, P29, DOI 10.1007/BF02536356
   MANSBACH CM, 1973, BIOCHIM BIOPHYS ACTA, V296, P386, DOI 10.1016/0005-2760(73)90097-0
   MATHIEU Y, 1994, ANN NUTR METAB, V38, P48, DOI 10.1159/000177793
   MUKHERJEE JJ, 1992, BIOCHIM BIOPHYS ACTA, V1123, P27, DOI 10.1016/0005-2760(92)90167-T
   PAVERO C, 1992, J NUTR, V122, P1672, DOI 10.1093/jn/122.8.1672
   QUAFORDT SH, 1966, BIOCHIM BIOPHYS ACTA, V116, P382
   REDGRAVE TG, 1988, J BIOL CHEM, V263, P5118
   RODGERS JB, 1969, J LIPID RES, V10, P427
   RODGERS JB, 1972, BIOCHIM BIOPHYS ACTA, V270, P453, DOI 10.1016/0005-2760(72)90110-5
   SIMKO V, 1989, ARCH INTERN MED, V149, P557, DOI 10.1001/archinte.149.3.557
   SINGH A, 1972, BIOCHIM BIOPHYS ACTA, V260, P708, DOI 10.1016/0005-2760(72)90019-7
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   ULMANN L, 1991, LIPIDS, V26, P127, DOI 10.1007/BF02544006
NR 30
TC 4
Z9 6
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0300-9629
J9 COMP BIOCHEM PHYS A
JI Comp. Biochem. Physiol. A-Physiol.
PD MAR
PY 1997
VL 116
IS 3
BP 253
EP 260
DI 10.1016/S0300-9629(96)00212-5
PG 8
WC Biochemistry & Molecular Biology; Physiology; Zoology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Physiology; Zoology
GA WJ673
UT WOS:A1997WJ67300008
PM 9102187
DA 2024-02-19
ER

PT J
AU Hubbard, RE
   O'Mahony, MS
   Calver, BL
   Woodhouse, KW
AF Hubbard, Ruth E.
   O'Mahony, M. Sinead
   Calver, Brian L.
   Woodhouse, Ken W.
TI Plasma esterases and inflammation in ageing and frailty
SO EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
LA English
DT Article
DE esterases; frailty; inflammation
ID ASPIRIN ESTERASE; OLDER-ADULTS; CLINICAL PHARMACOKINETICS;
   DRUG-METABOLISM; HUMAN-LIVER; AGE; HEALTH; WOMEN; COMMUNITY; DISABILITY
AB Objectives Esterases are enzymes of drug metabolism known to be reduced in frail older people and during acute illness. The mechanism for this is unknown. The aim of this study was to examine esterase activity and inflammation in ageing and frailty.
   Methods Thirty frail patients (mean age 84.9 years) dependent on continuing inpatient care, 40 patients of intermediate frailty attending Day Hospital (84.2 years), 40 fit older controls (82.7 years) and 30 young controls (23.3 years) were studied. Frailty indicators, plasma esterase activities and markers of inflammation were measured.
   Results With increasing patient frailty, C-reactive protein (CRP), interleukin-6 (IL-6) and tumour necrosis factor-alpha (TNF-alpha) increased significantly and esterase activity, with the exception of aspirin esterase, fell significantly (p < 0.005). There were significant negative correlations between log-transformed IL-6 and acetylcholinesterase (r=-0.354, p < 0.01), butyrylcholinesterase (r=-0.392, p < 0.01) and benzoyl-cholinesterase activity (r=-0.241, p < 0.05) and significant negative correlations between TNF-alpha and acetylcholinesterase (r=-0.223, p < 0.01), butyrylcholinesterase (r=-0.279, p < 0.01) and benzoylcholinesterase activity (r=-0.253, p < 0.01). Aspirin esterase activity did not correlate with IL-6 or TNF- alpha.
   Conclusion Frailty was associated with higher inflammatory markers and lower esterase activity. There was a weak but significant negative correlation between both IL-6 and TNF-alpha and the activity of three of four esterases. The negative correlation between esterase activity and inflammatory markers may have a causal basis, comparable to the inflammatory suppression of cytochrome P-450 enzymes.
C1 [Hubbard, Ruth E.; O'Mahony, M. Sinead; Calver, Brian L.; Woodhouse, Ken W.] Cardiff Univ, Sch Med, Dept Geriatr Med, Llandough Hosp,Acad Ctr, Penarth CF64 2XX, S Glam, Wales.
C3 Cardiff University
RP Hubbard, RE (corresponding author), Cardiff Univ, Sch Med, Dept Geriatr Med, Llandough Hosp,Acad Ctr, 3rd Floor,Penlan Rd, Penarth CF64 2XX, S Glam, Wales.
EM Ruth.Hubbard@cdha.nshealth.ca
RI Calver, Brian L/JSL-4590-2023; Hubbard, Ruth/G-5414-2010
OI Hubbard, Ruth/0000-0002-8688-5836
CR Abou-Hatab K, 2001, EUR J CLIN PHARMACOL, V57, P55, DOI 10.1007/s002280000259
   Abou-Hatab K, 2001, AGE AGEING, V30, P41, DOI 10.1093/ageing/30.1.41
   Bandeen-Roche K, 2006, J GERONTOL A-BIOL, V61, P262, DOI 10.1093/gerona/61.3.262
   Bergman H, 2007, J GERONTOL A-BIOL, V62, P731, DOI 10.1093/gerona/62.7.731
   BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160
   Bruunsgaard H, 2003, AM J MED, V115, P278, DOI 10.1016/S0002-9343(03)00329-2
   Cesari M, 2004, J GERONTOL A-BIOL, V59, P242
   ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9
   Ershler WB, 2000, ANNU REV MED, V51, P245, DOI 10.1146/annurev.med.51.1.245
   Ershler WB, 2007, J APPL PHYSIOL, V103, P3, DOI 10.1152/japplphysiol.00375.2007
   Ferrucci L, 1999, J AM GERIATR SOC, V47, P639, DOI 10.1111/j.1532-5415.1999.tb01583.x
   Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146
   Hamerman D, 1999, ANN INTERN MED, V130, P945, DOI 10.7326/0003-4819-130-11-199906010-00022
   Hogan DB, 1999, J GERONTOL A-BIOL, V54, pM77, DOI 10.1093/gerona/54.2.M77
   Howard C, 2007, J APPL PHYSIOL, V103, P17, DOI 10.1152/japplphysiol.00133.2007
   KALOW W, 1955, CAN J BIOCHEM PHYS, V33, P568
   KAMPMANN JP, 1981, CLIN PHARMACOKINET, V6, P401, DOI 10.2165/00003088-198106060-00001
   KUBO SH, 1985, CLIN PHARMACOKINET, V10, P377, DOI 10.2165/00003088-198510050-00001
   Lally F, 2007, POSTGRAD MED J, V83, P16, DOI 10.1136/pgmj.2006.048587
   Leng SX, 2007, J AM GERIATR SOC, V55, P864, DOI 10.1111/j.1532-5415.2007.01186.x
   Maggio M, 2005, J ENDOCRINOL INVEST, V28, P711, DOI 10.1007/BF03347554
   Michelon E, 2006, J GERONTOL A-BIOL, V61, P600, DOI 10.1093/gerona/61.6.600
   Morgan ET, 1997, DRUG METAB REV, V29, P1129, DOI 10.3109/03602539709002246
   Morley JE, 2004, J GERONTOL A-BIOL, V59, P924
   OMAHONEY MS, 1994, AGE AGEING, V23, P338, DOI 10.1093/ageing/23.4.338
   Pedersen A N, 2002, J Nutr Health Aging, V6, P413
   Roubenoff R, 2003, AM J MED, V115, P429, DOI 10.1016/j.amjmed.2003.05.001
   Simonsick EM, 2000, AGING-CLIN EXP RES, V12, P274, DOI 10.1007/BF03339847
   Walston J, 2002, ARCH INTERN MED, V162, P2333, DOI 10.1001/archinte.162.20.2333
   Walston J, 2006, J AM GERIATR SOC, V54, P991, DOI 10.1111/j.1532-5415.2006.00745.x
   White S, 2005, AGE AGEING, V34, P603, DOI 10.1093/ageing/afi189
   WILLIAMS FM, 1987, PHARMACOL THERAPEUT, V34, P99, DOI 10.1016/0163-7258(87)90094-5
   WILLIAMS FM, 1989, AGE AGEING, V18, P39, DOI 10.1093/ageing/18.1.39
   WILLIAMS FM, 1989, J PHARM PHARMACOL, V41, P407, DOI 10.1111/j.2042-7158.1989.tb06487.x
   YELLAND C, 1991, AGE AGEING, V20, P16, DOI 10.1093/ageing/20.1.16
   PUBLICATIONS PARLIAM
NR 36
TC 102
Z9 106
U1 0
U2 15
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0031-6970
EI 1432-1041
J9 EUR J CLIN PHARMACOL
JI Eur. J. Clin. Pharmacol.
PD SEP
PY 2008
VL 64
IS 9
BP 895
EP 900
DI 10.1007/s00228-008-0499-1
PG 6
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 343VH
UT WOS:000258882900011
PM 18506436
DA 2024-02-19
ER

PT J
AU Dollé, MET
   Vijg, J
AF Dollé, MET
   Vijg, J
TI Genome dynamics in aging mice
SO GENOME RESEARCH
LA English
DT Article
ID TRANSGENIC MOUSE MODEL; SOMATIC MUTATIONS; AGE; REARRANGEMENTS;
   RECOMBINATION; FREQUENCY; BRAIN; CELLS; GENE
AB Random spontaneous genome rearrangements are difficult to detect in vivo, especially in postmitotic tissues. Using a lacZ-plasmid reporter mouse model, we have previously presented evidence for the accumulation of large genome rearrangements in various tissues, including postmitotic tissues, during aging. These rearrangements, which were found to be organ-specific and to increase with age, have one breakpoint in the lacZ-reporter locus and the second elsewhere in the mouse genome. In this present work, we have used a mouse genome sequence database to physically characterize a total of 49 genome rearrangements in the brain, heart, and liver from young and old mice at two lacZ-plasmid reporter loci. Half of all breakpoints in the mouse genome occurred in chromosomes 3 and 4, each carrying a lacZ-reporter cluster, at distances varying from <100 kb to 66 Mb, indicating intrachromosomal deletions or inversions. The other half of the breakpoints in the mouse genome was found randomly on any of the other chromosomes, indicating translocations. Alternatively, part of the intra- and extrachromosomal events could involve transpositions. Regions of extended homology were not found at the breakpoints. These results lead us to postulate potential mechanisms for the origin of large genome rearrangements in mouse tissues and to predict their possible impact as a potential cause of aging.
C1 Univ Texas, Hlth Sci Ctr, Sam & Ann Barshop Ctr Longev & Aging Studies, San Antonio, TX 78245 USA.
   SW Texas Vet Hlth Care Syst, Ctr Geriatr Res Educ & Clin, San Antonio, TX 78229 USA.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio; Geriatric Research Education & Clinical Center
EM dolle@uthscsa.edu
FU NIA NIH HHS [1PO1AG17242, P01 AG017242] Funding Source: Medline
CR Albertini RJ, 2001, MUTAT RES-REV MUTAT, V489, P1, DOI 10.1016/S1383-5742(01)00064-3
   BOERRIGTER METI, 1995, NATURE, V377, P657, DOI 10.1038/377657a0
   Colgin LM, 2002, P NATL ACAD SCI USA, V99, P1437, DOI 10.1073/pnas.032655699
   deBoer JG, 1997, MUTAT RES-FUND MOL M, V375, P79, DOI 10.1016/S0027-5107(96)00255-2
   DEMPSEY JL, 1993, MUTAT RES, V291, P141, DOI 10.1016/0165-1161(93)90153-Q
   DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694
   Dolle MET, 1996, MUTAGENESIS, V11, P111, DOI 10.1093/mutage/11.1.111
   Dolle MET, 1997, NAT GENET, V17, P431, DOI 10.1038/ng1297-431
   Dollé MET, 1999, ENVIRON MOL MUTAGEN, V34, P112, DOI 10.1002/(SICI)1098-2280(1999)34:2/3&lt;112::AID-EM9&gt;3.0.CO;2-W
   Dollé MET, 1999, MUTAGENESIS, V14, P287, DOI 10.1093/mutage/14.3.287
   Dollé MET, 2000, P NATL ACAD SCI USA, V97, P8403, DOI 10.1073/pnas.97.15.8403
   Dollé MET, 2002, NUCLEIC ACIDS RES, V30, P545, DOI 10.1093/nar/30.2.545
   GOSSEN J, 1993, TRENDS GENET, V9, P27, DOI 10.1016/0168-9525(93)90069-T
   GRIST SA, 1992, MUTAT RES, V266, P189, DOI 10.1016/0027-5107(92)90186-6
   Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682
   Liang L, 2000, ENVIRON MOL MUTAGEN, V35, P150, DOI 10.1002/(SICI)1098-2280(2000)35:2<150::AID-EM10>3.3.CO;2-S
   Marshall E, 2001, SCIENCE, V292, P822, DOI 10.1126/science.292.5518.822
   Martin GM, 1996, HUM MOL GENET, V5, P215, DOI 10.1093/hmg/5.2.215
   Martin SL, 2001, MECH AGEING DEV, V122, P1321, DOI 10.1016/S0047-6374(01)00267-6
   MATSUOKA M, 1991, SCIENCE, V254, P81, DOI 10.1126/science.1925563
   Pastink A, 2001, MUTAT RES-FUND MOL M, V480, P37, DOI 10.1016/S0027-5107(01)00167-1
   Richardson C, 2000, NATURE, V405, P697, DOI 10.1038/35015097
   Sandoval A, 2002, DNA REPAIR, V1, P397, DOI 10.1016/S1568-7864(02)00013-7
   SCHATZ DG, 1992, NEW BIOL, V4, P188
   Slovak ML, 2001, CANCER RES, V61, P831
   Stambrook PJ, 1996, ENVIRON MOL MUTAGEN, V28, P471
   Sugawara N, 2000, MOL CELL BIOL, V20, P5300, DOI 10.1128/MCB.20.14.5300-5309.2000
   Vijg J, 2002, MECH AGEING DEV, V123, P907, DOI 10.1016/S0047-6374(02)00028-3
   VUJG J, 2000, MUTAT RES, V447, P117
   Warner HR, 1997, NAT GENET, V17, P368, DOI 10.1038/ng1297-368
NR 30
TC 54
Z9 63
U1 0
U2 1
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 1088-9051
EI 1549-5469
J9 GENOME RES
JI Genome Res.
PD NOV
PY 2002
VL 12
IS 11
BP 1732
EP 1738
DI 10.1101/gr.125502
PG 7
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA 612DB
UT WOS:000179058300012
PM 12421760
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Deugnier, Y
AF Deugnier, Y
TI Iron and liver cancer
SO ALCOHOL
LA English
DT Article; Proceedings Paper
CT Symposium on Role of Iron in Alcoholic Liver Disease
CY OCT, 2002
CL BETHESDA, MD
DE iron; cancer; liver cancer; hemochromatosis; HFE mutations; oxidative
   stress
ID PORPHYRIA-CUTANEA-TARDA; PRIMARY HEPATOCELLULAR-CARCINOMA; MATCHED
   CONTROL PATIENTS; GENETIC HEMOCHROMATOSIS; HEREDITARY HEMOCHROMATOSIS;
   NONCIRRHOTIC LIVER; DIETARY IRON; PROGNOSTIC FACTORS; DNA-DAMAGE; BOUND
   IRON
AB Mechanisms whereby iron may act in carcinogenesis are induction of oxidative stress, facilitation of tumor growth, and modification of the immune system. Results of clinical and epidemiologic studies demonstrate a strong association between iron excess (even at mild levels) and the development of cancer at any site, but they do not indicate whether this reflects a causal link or an indirect association through other factors (i.e., aging, alcohol consumption, and insulin resistance). Findings obtained from experimental work are not conclusive with respect to a direct carcinogenic role of iron, but they support a carcinogenic or co-carcinogenic role of iron in chemically induced carcinogenesis. (C) 2003 Elsevier Inc. All rights reserved.
C1 CHU Pontchaillou, Clin Malad Foie, F-35033 Rennes, France.
   CHU Pontchaillou, Ctr Invest Clin, F-35033 Rennes, France.
C3 CHU Rennes; Universite de Rennes; Universite de Rennes; CHU Rennes;
   Institut National de la Sante et de la Recherche Medicale (Inserm)
RP Deugnier, Y (corresponding author), CHU Pontchaillou, Clin Malad Foie, F-35033 Rennes, France.
EM yves.deugnier@univ-rennes1.fr
CR ARUOMA OI, 1988, BLOOD, V72, P1416
   Blanc JF, 2000, J HEPATOL, V32, P805, DOI 10.1016/S0168-8278(00)80250-0
   BLUMBERG RS, 1988, GASTROENTEROLOGY, V95, P1399, DOI 10.1016/0016-5085(88)90379-4
   BRADBEAR RA, 1985, J NATL CANCER I, V75, P81
   Bralet MP, 1998, J HEPATOL, V28, P740, DOI 10.1016/S0168-8278(98)80303-6
   BREIMER LH, 1991, FREE RADICAL RES COM, V14, P159, DOI 10.3109/10715769109088945
   Britto MRC, 2000, SCAND J GASTROENTERO, V35, P889
   CARTHEW P, 1991, HEPATOLOGY, V13, P534, DOI 10.1002/hep.1840130322
   Chenoufi N, 1997, J HEPATOL, V26, P650, DOI 10.1016/S0168-8278(97)80432-1
   de Sousa M, 2000, HEMOCHROMATOSIS: GENETICS, PATHOPHYSIOLOGY, DIAGNOSIS AND TREATMENT, P396
   Deugnier Y, 2000, HEMOCHROMATOSIS: GENETICS, PATHOPHYSIOLOGY, DIAGNOSIS AND TREATMENT, P239
   DEUGNIER YM, 1992, GASTROENTEROLOGY, V102, P2050, DOI 10.1016/0016-5085(92)90331-R
   DEUGNIER YM, 1993, HEPATOLOGY, V18, P1363, DOI 10.1016/0270-9139(93)90225-C
   DEUGNIER YM, 1993, GASTROENTEROLOGY, V104, P228, DOI 10.1016/0016-5085(93)90856-8
   DJEHA A, 1992, BRIT J HAEMATOL, V80, P235, DOI 10.1111/j.1365-2141.1992.tb08906.x
   FARGION S, 1992, HEPATOLOGY, V15, P655, DOI 10.1002/hep.1840150417
   FARGION S, 1994, HEPATOLOGY, V20, P1426, DOI 10.1002/hep.1840200608
   FELLOWS IW, 1988, GUT, V29, P1603, DOI 10.1136/gut.29.11.1603
   Fracanzani AL, 2001, J HEPATOL, V35, P498, DOI 10.1016/S0168-8278(01)00160-X
   Fracanzani AL, 2001, HEPATOLOGY, V33, P647, DOI 10.1053/jhep.2001.22506
   Ganne-Carrié N, 2000, GUT, V46, P277, DOI 10.1136/gut.46.2.277
   Glei M, 2002, MUTAT RES-GEN TOX EN, V519, P151, DOI 10.1016/S1383-5718(02)00135-3
   Goh J, 1999, EUR J GASTROEN HEPAT, V11, P915, DOI 10.1097/00042737-199908000-00019
   GONZALES J, 1984, ZOO BIOL, V3, P255, DOI 10.1002/zoo.1430030308
   Grando-Lemaire V, 1999, J HEPATOL, V31, P508, DOI 10.1016/S0168-8278(99)80044-0
   GREEN R, 1988, ANN NY ACAD SCI, V526, P301, DOI 10.1111/j.1749-6632.1988.tb55514.x
   Halliday JW, 1996, BIOMETALS, V9, P205, DOI 10.1007/BF00144626
   HANN HWL, 1989, INT J CANCER, V43, P376, DOI 10.1002/ijc.2910430304
   HANN HWL, 1990, HEPATOLOGY, V11, P566, DOI 10.1002/hep.1840110407
   HARADA T, 1987, CELL IMMUNOL, V109, P75, DOI 10.1016/0008-8749(87)90293-0
   Houglum K, 1997, HEPATOLOGY, V26, P605, DOI 10.1053/jhep.1997.v26.pm0009303489
   Hussain SP, 2000, P NATL ACAD SCI USA, V97, P12770, DOI 10.1073/pnas.220416097
   Kato J, 1996, J CLIN INVEST, V98, P923, DOI 10.1172/JCI118875
   Le NTV, 2002, BBA-REV CANCER, V1603, P31, DOI 10.1016/S0304-419X(02)00068-9
   Lemmer ER, 1999, CANCER LETT, V146, P207, DOI 10.1016/S0304-3835(99)00274-8
   Linet MS, 1999, AM J EPIDEMIOL, V149, P1010
   LOEB LA, 1988, P NATL ACAD SCI USA, V85, P3918, DOI 10.1073/pnas.85.11.3918
   Loréal O, 2000, J HEPATOL, V32, P727, DOI 10.1016/S0168-8278(00)80240-8
   MADRA S, 1995, CARCINOGENESIS, V16, P719, DOI 10.1093/carcin/16.4.719
   Mendler MH, 1999, GASTROENTEROLOGY, V117, P1155, DOI 10.1016/S0016-5085(99)70401-4
   MERK K, 1990, INT J EPIDEMIOL, V19, P505, DOI 10.1093/ije/19.3.505
   Moirand R, 1997, LANCET, V349, P95, DOI 10.1016/S0140-6736(96)06034-5
   Moirand R, 2002, AM J MED GENET, V111, P356, DOI 10.1002/ajmg.10547
   NELSON RL, 1995, CANCER, V76, P875, DOI 10.1002/1097-0142(19950901)76:5<875::AID-CNCR2820760523>3.0.CO;2-Q
   Niederau C, 1996, GASTROENTEROLOGY, V110, P1107, DOI 10.1053/gast.1996.v110.pm8613000
   NIEDERAU C, 1985, NEW ENGL J MED, V313, P1256, DOI 10.1056/NEJM198511143132004
   Okada S, 1996, PATHOL INT, V46, P311, DOI 10.1111/j.1440-1827.1996.tb03617.x
   PIETRANGELO A, 1990, HEPATOLOGY, V11, P798, DOI 10.1002/hep.1840110513
   Pigeon C, 1999, J HEPATOL, V30, P926, DOI 10.1016/S0168-8278(99)80149-4
   Pirisi M, 2000, CANCER, V89, P297, DOI 10.1002/1097-0142(20000715)89:2<297::AID-CNCR14>3.0.CO;2-N
   RANDELL MG, 1981, J AM VET MED ASSOC, V179, P1214
   Roberts AG, 1997, LANCET, V349, P321, DOI 10.1016/S0140-6736(96)09436-6
   Rothenberg BE, 1996, P NATL ACAD SCI USA, V93, P1529, DOI 10.1073/pnas.93.4.1529
   SALATA H, 1985, J HEPATOL, V1, P477, DOI 10.1016/S0168-8278(85)80746-7
   SELIGMAN PA, 1987, MOL BASIS BLOOD DIS, V1, P219
   SMITH AG, 1993, CARCINOGENESIS, V14, P1381, DOI 10.1093/carcin/14.7.1381
   Smith PGJ, 1996, AM J PATHOL, V149, P389
   STAL P, 1995, HEPATOLOGY, V21, P521, DOI 10.1016/0270-9139(95)90115-9
   TERADA T, 1990, CANCER, V65, P1994, DOI 10.1002/1097-0142(19900501)65:9<1994::AID-CNCR2820650919>3.0.CO;2-B
   TERADA T, 1989, HEPATOLOGY, V10, P851, DOI 10.1002/hep.1840100517
   TOYOKUNI S, 1994, INT J CANCER, V57, P123, DOI 10.1002/ijc.2910570122
   Toyokuni S, 1996, FREE RADICAL BIO MED, V20, P553, DOI 10.1016/0891-5849(95)02111-6
   TURLIN B, 1995, HEPATOLOGY, V22, P446, DOI 10.1002/hep.1840220212
   Vautier G, 1999, GASTROENTEROLOGY, V117, P154, DOI 10.1016/S0016-5085(99)70562-7
   WILLIAMS GM, 1972, J NATL CANCER I, V49, P685
   YOUNG IS, 1994, FREE RADICAL BIO MED, V16, P393, DOI 10.1016/0891-5849(94)90041-8
   ZHOU XD, 1987, CANCER, V59, P1430, DOI 10.1002/1097-0142(19870415)59:8<1430::AID-CNCR2820590808>3.0.CO;2-A
NR 67
TC 44
Z9 48
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0741-8329
EI 1873-6823
J9 ALCOHOL
JI Alcohol
PD JUN
PY 2003
VL 30
IS 2
BP 145
EP 150
DI 10.1016/S0741-8329(03)00129-0
PG 6
WC Substance Abuse; Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Substance Abuse; Pharmacology & Pharmacy; Toxicology
GA 721PR
UT WOS:000185325200010
PM 12957299
DA 2024-02-19
ER

PT J
AU Natarajan, Y
   White, DL
   El-Serag, HB
   Ramsey, D
   Richardson, P
   Kuzniarek, J
   Shukla, R
   Tansel, A
   Kanwal, F
AF Natarajan, Yamini
   White, Donna L.
   El-Serag, Hashem B.
   Ramsey, David
   Richardson, Peter
   Kuzniarek, Jill
   Shukla, Richa
   Tansel, Aylin
   Kanwal, Fasiha
TI Role of Non-hepatic Medical Comorbidity and Functional Limitations in
   Predicting Mortality in Patients with HCV
SO DIGESTIVE DISEASES AND SCIENCES
LA English
DT Article
DE Epidemiology; Hepatology; Hepatitis C; Comorbidity; Prognosis; Natural
   history; Mortality
ID C VIRUS-INFECTION; COMMUNITY; OLDER; VALIDATION; LIVER; RISK; INDEXES;
   HEALTH; ELDERS; ADULTS
AB Medical comorbidities and functional status limitations are determinants of mortality in many chronic diseases. The extent to which survival in the rapidly aging cohort of patients with HCV is affected by these competing causes of mortality remains unclear.
   We sought to determine the effect of medical/functional comorbidities on survival after adjusting for liver disease severity in a cohort of patients with HCV infection.
   We prospectively recruited consecutive patients from an HCV clinic 2009-2014. We calculated an index of survival (Schonberg Index, SI) based on age, gender, medical comorbidities, and functional status variables. We defined cirrhosis with the FibroSure test (F3/4-F4). We used multivariable Cox modeling to assess association between functional/survival measure and survival after adjustment for severity of liver disease.
   The cohort consisted of 1052 HCV patients. The average age was 56.8 years; 36 % had cirrhosis. The mean SI was 8.2 (SD = 2.7). During a mean follow-up of 5610 person-years, 102 (9.7 %) patients died. In unadjusted analysis, higher baseline SI predicted mortality (HR 1.17; 95 % CI 1.09-1.25). SI similarly predicted mortality in cirrhotic patients (HR 1.23, 95 % CI 1.13-1.34) and non-cirrhotic patients (HR 1.21, 95 % CI 1.08-1.36). This did not change after adjusting for age, drug use, or coronary artery disease.
   Comorbidities and functional limitations predict higher mortality in patients with HCV; this relationship is independent of cirrhosis. Use of general prognostic indices may help identify HCV patients at high risk for mortality, which could further guide clinical care in a manner not achievable with assessment of liver disease alone.
C1 [Natarajan, Yamini; White, Donna L.; El-Serag, Hashem B.; Shukla, Richa; Tansel, Aylin; Kanwal, Fasiha] Michael E DeBakey VA Med Ctr, Sect Gastroenterol & Hepatol, Houston, TX 77030 USA.
   [Natarajan, Yamini; White, Donna L.; El-Serag, Hashem B.; Shukla, Richa; Tansel, Aylin; Kanwal, Fasiha] Baylor Coll Med, Houston, TX 77030 USA.
   [White, Donna L.; El-Serag, Hashem B.; Ramsey, David; Richardson, Peter; Kuzniarek, Jill; Kanwal, Fasiha] Michael E DeBakey VA Med Ctr, Clin Epidemiol & Comparat Effectiveness Program, Sect Hlth Serv Res IQuESt, Houston, TX USA.
   [White, Donna L.; El-Serag, Hashem B.; Kanwal, Fasiha] Texas Med Ctr, Ctr Digest Dis, Houston, TX USA.
   [White, Donna L.; El-Serag, Hashem B.; Kanwal, Fasiha] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA.
   [White, Donna L.] Michael E DeBakey VA Med Ctr, CTRID, Houston, TX USA.
C3 Baylor College of Medicine; Baylor College of Medicine; Baylor College
   of Medicine; Baylor College of Medicine; University of Texas System;
   University of Texas Health Science Center Houston; Baylor College of
   Medicine; Baylor College of Medicine
RP Natarajan, Y (corresponding author), Michael E DeBakey VA Med Ctr, Sect Gastroenterol & Hepatol, Houston, TX 77030 USA.; Natarajan, Y (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.
EM Yamini.Natarajan@va.gov
RI White, Donna/AAZ-9349-2021
OI White, Donna/0000-0003-0297-2949; Ramsey, David/0000-0002-5504-812X
FU U.S. Department of Veterans Affairs; Houston Veterans Affairs Health
   Services Research Center of Innovations [CIN13-413]; National Institute
   of Diabetes Digestive and Kidney Diseases [K01 DK081736, K24 DK04-107]
FX This research was funded in part by the U.S. Department of Veterans
   Affairs (CSR&D Merit Review H-22934, PI: El-Serag), and the Houston
   Veterans Affairs Health Services Research Center of Innovations
   (CIN13-413). Drs. El-Serag's and White's effort was supported in part by
   the National Institute of Diabetes Digestive and Kidney Diseases (K01
   DK081736 and K24 DK04-107, respectively).
CR Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802
   [Anonymous], 1997, ABSTR BIOL REPR, V56, P83
   Bernacki RE, 2014, JAMA INTERN MED, V174, P1994, DOI 10.1001/jamainternmed.2014.5271
   Carey EC, 2004, J GEN INTERN MED, V19, P1027, DOI 10.1111/j.1525-1497.2004.40016.x
   Drazer MW, 2014, CANCER-AM CANCER SOC, V120, P1491, DOI 10.1002/cncr.28600
   Duberg AS, 2008, J VIRAL HEPATITIS, V15, P538, DOI 10.1111/j.1365-2893.2008.00982.x
   Eng JA, 2015, J AM GERIATR SOC, V63, P757, DOI 10.1111/jgs.13340
   Fried LP, 1998, JAMA-J AM MED ASSOC, V279, P585, DOI 10.1001/jama.279.8.585
   Guiltinan AM, 2008, AM J EPIDEMIOL, V167, P743, DOI 10.1093/aje/kwm370
   Jepsen P, 2014, GASTROENTEROLOGY, V146, P147, DOI 10.1053/j.gastro.2013.09.019
   Kerr KF, 2014, EPIDEMIOLOGY, V25, P114, DOI 10.1097/EDE.0000000000000018
   Lee MH, 2012, J INFECT DIS, V206, P469, DOI 10.1093/infdis/jis385
   Omland LH, 2011, CLIN GASTROENTEROL H, V9, P71, DOI 10.1016/j.cgh.2010.09.014
   Saliba D, 2001, J AM GERIATR SOC, V49, P1691, DOI 10.1046/j.1532-5415.2001.49281.x
   Schonberg MA, 2011, J AM GERIATR SOC, V59, P1444, DOI 10.1111/j.1532-5415.2011.03523.x
   Schonberg MA, 2009, J GEN INTERN MED, V24, P1115, DOI 10.1007/s11606-009-1073-y
   Sharabiani MTA, 2012, MED CARE, V50, P1109, DOI 10.1097/MLR.0b013e31825f64d0
   Sohn Min-Woong, 2006, Popul Health Metr, V4, P2, DOI 10.1186/1478-7954-4-2
   Szabo SM, 2015, ANN HEPATOL, V14, P618, DOI 10.1016/S1665-2681(19)30756-2
   Tetsche MS, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-31
   White DL, 2012, HEPATOLOGY, V55, P759, DOI 10.1002/hep.24618
NR 21
TC 6
Z9 7
U1 0
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0163-2116
EI 1573-2568
J9 DIGEST DIS SCI
JI Dig. Dis. Sci.
PD JAN
PY 2017
VL 62
IS 1
BP 76
EP 83
DI 10.1007/s10620-016-4303-2
PG 8
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Gastroenterology & Hepatology
GA EI2JE
UT WOS:000392312200014
PM 27655101
DA 2024-02-19
ER

PT J
AU Aghajan, M
   Li, N
   Karin, M
AF Aghajan, Mariam
   Li, Ning
   Karin, Michael
TI Obesity, autophagy and the pathogenesis of liver and pancreatic cancers
SO JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
LA English
DT Article
DE autophagy; hepatocellular carcinoma; nuclear factor-kappa B; p62;
   pancreatic ductal adenocarcinoma
ID NF-KAPPA-B; HEPATOCELLULAR-CARCINOMA; DEFICIENT MICE; P62;
   TUMORIGENESIS; ACTIVATION; INFLAMMATION; STRESS; SENESCENCE; DISEASE
AB Liver and pancreatic cancers are both highly lethal diseases with limited to no therapeutic options for patients. Recent studies suggest that deregulated autophagy plays a role in the pathogenesis of these diseases by perturbing cellular homeostasis and laying the foundation for disease development. While accumulation of p62 upon impaired autophagy has been implicated in hepatocellular carcinoma, its role in pancreatic ductal adenocarcinoma remains less clear. This review will focus on recent studies illustrating the role of autophagy in liver and pancreatic cancers. The relationships between autophagy, nuclear factor-kappa B signaling and obesity in hepatocellular carcinoma will be discussed, as well as the dual role of autophagy in pancreatic ductal adenocarcinoma.
C1 Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, San Diego, CA 92103 USA.
   Univ Calif San Diego, Sch Med, Dept Pathol, Lab Gene Regulat & Signal Transduct, San Diego, CA 92103 USA.
C3 University of California System; University of California San Diego;
   University of California System; University of California San Diego
RP Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr,MC 0723, La Jolla, CA 92093 USA.
EM karinoffice@ucsd.edu
FU NCI NIH HHS [R01 CA155120-02, R01 CA118165, F32 CA162773, R01
   CA118165-05, R01 CA155120-01A1, F32-CA162773, R01 CA155120] Funding
   Source: Medline; NIAAA NIH HHS [P50 AA011999] Funding Source: Medline;
   NIEHS NIH HHS [ES006376, R01 ES006376] Funding Source: Medline
CR Burhans WC, 2007, NUCLEIC ACIDS RES, V35, P7545, DOI 10.1093/nar/gkm1059
   Caldwell SH, 2004, GASTROENTEROLOGY, V127, pS97, DOI 10.1053/j.gastro.2004.09.021
   Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006
   Criollo A, 2010, EMBO J, V29, P619, DOI 10.1038/emboj.2009.364
   De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189
   Ding ZB, 2008, CANCER RES, V68, P9167, DOI 10.1158/0008-5472.CAN-08-1573
   Duran A, 2008, CANCER CELL, V13, P343, DOI 10.1016/j.ccr.2008.02.001
   El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061
   Elgendy M, 2011, MOL CELL, V42, P23, DOI 10.1016/j.molcel.2011.02.009
   Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934
   Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012
   Guerra C, 2011, CANCER CELL, V19, P728, DOI 10.1016/j.ccr.2011.05.011
   Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311
   He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910
   He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183
   He GB, 2010, CANCER CELL, V17, P286, DOI 10.1016/j.ccr.2009.12.048
   Inami Y, 2011, J CELL BIOL, V193, P275, DOI 10.1083/jcb.201102031
   Inokuchi S, 2010, P NATL ACAD SCI USA, V107, P844, DOI 10.1073/pnas.0909781107
   Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041
   Kimmelman AC, 2011, GENE DEV, V25, P1999, DOI 10.1101/gad.17558811
   Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022
   Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035
   Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017
   Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021
   Koorstra JBM, 2009, MODERN PATHOL, V22, P1439, DOI 10.1038/modpathol.2009.114
   Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481
   Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018
   Lock R, 2011, MOL BIOL CELL, V22, P165, DOI 10.1091/mbc.E10-06-0500
   Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016
   Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014
   Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305
   Mareninova OA, 2009, J CLIN INVEST, V119, P3340, DOI 10.1172/JCI38674
   Mariño G, 2011, MOL CELL, V42, P1, DOI 10.1016/j.molcel.2011.03.003
   Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048
   Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899
   Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107
   Parekh S, 2007, GASTROENTEROLOGY, V132, P2191, DOI 10.1053/j.gastro.2007.03.055
   Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052
   Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2
   Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039
   Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976
   Stumptner C, 2002, HEPATOLOGY, V35, P1053, DOI 10.1053/jhep.2002.32674
   Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211
   Villeneuve NF, 2010, ANTIOXID REDOX SIGN, V13, P1699, DOI 10.1089/ars.2010.3211
   White E, 2009, GENE DEV, V23, P784, DOI 10.1101/gad.1795309
   Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005
   Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111
   Yen WL, 2008, PHYSIOLOGY, V23, P248, DOI 10.1152/physiol.00013.2008
   Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709
   Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6
NR 50
TC 35
Z9 39
U1 2
U2 11
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0815-9319
J9 J GASTROEN HEPATOL
JI J. Gastroenterol. Hepatol.
PD MAR
PY 2012
VL 27
SU 2
SI SI
BP 10
EP 14
DI 10.1111/j.1440-1746.2011.07008.x
PG 5
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 889AX
UT WOS:000300047000003
PM 22320909
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Melo, DD
   Pereira, LC
   Santos, CS
   Mendes, BF
   Konig, IFM
   Garcia, BCC
   Queiroz, IP
   Moreno, LG
   Cassilhas, RC
   Esteves, EA
   Vieira, ER
   Magalhaes, FD
   Capettini, LDA
   De Sousa, RAL
   Sampaio, KH
   Peixoto, MFD
AF Melo, Dirceu de Sousa
   Pereira, Liliane Costa
   Santos, Carina Sousa
   Mendes, Bruno Ferreira
   Konig, Isaac Filipe Moreira
   Garcia, Bruna Caroline Chaves
   Queiroz, Ilkilene Pinheiro
   Moreno, Lauane Gomes
   Cassilhas, Ricardo Cardoso
   Esteves, Elizabethe Adriana
   Vieira, Etel Rocha
   Magalhaes, Flavio de Castro
   Capettini, Luciano dos Santos Aggum
   De Sousa, Ricardo Augusto Leoni
   Sampaio, Kinulpe Honorato
   Peixoto, Marco Fabricio Dias
TI Intense Caloric Restriction from Birth Prevents Cardiovascular Aging in
   Rats
SO REJUVENATION RESEARCH
LA English
DT Article
DE diet; food restriction; cardiovascular diseases; elderly; senescence
ID DIASTOLIC DYSFUNCTION; REDOX HOMEOSTASIS; OXIDATIVE STRESS; PLASMA;
   DAMAGE
AB We previously demonstrated that a 50% caloric restriction (CR) from birth improves several cardiometabolic risk factors in young rats. In this study, we investigated in middle-aged rats the consequences of a 50% CR from birth on cardiometabolic risk factors, heart function/morphology, ventricular arrhythmia, and fibrillation incidence, and cardiac intracellular proteins involved with redox status and cell survival. From birth to the age of 18 months, rats were divided into an Ad Libitum (AL18) group, which had free access to food, and a CR18 group, which had food limited to 50% of that consumed by the AL18. Resting metabolic rate, blood pressure, and heart rate were recorded, and oral glucose and intraperitoneal insulin tolerance tests were performed. Blood was collected for biochemical analyses, and visceral fat and liver were harvested and weighed. Hearts were harvested for cardiac function, histological, redox status, and western blot analyses. The 50% CR from birth potentially reduced several cardiometabolic risk factors in 18-month-old rats. Moreover, compared with AL18, the CR18 group showed a similar to 50% increase in cardiac contractility and relaxation, nearly three to five times less incidence of ventricular arrhythmia and fibrillation, similar to 18% lower cardiomyocyte diameter, and similar to 60% lower cardiac fibrosis. CR18 hearts also improved biomarkers of antioxidant defense and cell survival. Collectively, these results reveal several metabolic and cardiac antiaging effects of a 50% CR from birth in middle-aged rats.
C1 [Melo, Dirceu de Sousa; Pereira, Liliane Costa; Santos, Carina Sousa; Mendes, Bruno Ferreira; Garcia, Bruna Caroline Chaves; Moreno, Lauane Gomes; Cassilhas, Ricardo Cardoso; Esteves, Elizabethe Adriana; Vieira, Etel Rocha; Magalhaes, Flavio de Castro; De Sousa, Ricardo Augusto Leoni; Sampaio, Kinulpe Honorato; Peixoto, Marco Fabricio Dias] Univ Fed Vales Jequitinhonha & Mucuri UFVJM, Programa Posgrad Multicentr Ciencias Fisiol, Rodovia MGT 367,Km 583, BR-39100000 Diamantina, Brazil.
   [Konig, Isaac Filipe Moreira] Univ Fed Lavras UFLA, Dept Med Vet, Lavras, Brazil.
   [Queiroz, Ilkilene Pinheiro; Cassilhas, Ricardo Cardoso; Esteves, Elizabethe Adriana; Vieira, Etel Rocha; Magalhaes, Flavio de Castro; Sampaio, Kinulpe Honorato; Peixoto, Marco Fabricio Dias] Univ Fed Vales Jequitinhonha & Mucuri UFVJM, Programa Posgrad Ciencias Saude, Diamantina, Brazil.
   [Capettini, Luciano dos Santos Aggum] Univ Fed Minas Gerais UFMG, Programa Posgrad Fisiol & Farmacol, Belo Horizonte, Brazil.
C3 Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM);
   Universidade Federal de Lavras; Universidade Federal dos Vales do
   Jequitinhonha e Mucuri (UFVJM); Universidade Federal de Minas Gerais
RP Peixoto, MFD (corresponding author), Univ Fed Vales Jequitinhonha & Mucuri UFVJM, Programa Posgrad Multicentr Ciencias Fisiol, Rodovia MGT 367,Km 583, BR-39100000 Diamantina, Brazil.
EM marcofabri@ufvjm.edu.br
RI Cassilhas, Ricardo C/E-5920-2012; Magalhaes, Flavio/AAB-5540-2022
OI Cassilhas, Ricardo C/0000-0001-6970-2551; Magalhaes,
   Flavio/0000-0002-1963-982X
FU Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)
   [APQ-00214-21, APQ-01049-21, APQ-00938-18, APQ-03855-16]; Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
   [438498/2018-6]; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES) [001]
FX We thank the Centro Integrado de Pos-Graduacao e Pesquisa em Saude,
   (CIPq-Saude) from the Universidade Federal dos Vales do Jequitinhonha e
   Mucuri (UFVJM) for providing equipment and technical support for
   experiments. We thank the Fundacao de Amparo a Pesquisa do Estado de
   Minas Gerais (FAPEMIG) (Nos. APQ-00214-21, APQ-01049-21, APQ-00938-18,
   APQ-03855-16), Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) (No. 438498/2018-6), and Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)-Finance code 001
   for providing financial support.
CR Ahmet I, 2011, J MOL CELL CARDIOL, V51, P263, DOI 10.1016/j.yjmcc.2011.04.015
   Al-Rasheed NM, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/1092015
   Almeida JNFQ, 2020, EXP PHYSIOL, V105, P1172, DOI 10.1113/EP088434
   Anderson RM, 2010, TRENDS ENDOCRIN MET, V21, P134, DOI 10.1016/j.tem.2009.11.005
   Andersson C, 2018, NAT REV CARDIOL, V15, P230, DOI 10.1038/nrcardio.2017.154
   Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI [10.1161/CIR.0000000000000530, 10.1161/CIR.0000000000000558, 10.1161/CIR.0000000000000485]
   Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Bruss MD, 2010, AM J PHYSIOL-ENDOC M, V298, pE108, DOI 10.1152/ajpendo.00524.2009
   Cebe T, 2014, AGE, V36, DOI 10.1007/s11357-014-9728-y
   Cebe T, 2014, EXP GERONTOL, V57, P132, DOI 10.1016/j.exger.2014.05.017
   Ferguson DP, 2019, J PHYSIOL-LONDON, V597, P1855, DOI 10.1113/JP277637
   Fontana L, 2018, NAT REV CARDIOL, V15, P566, DOI 10.1038/s41569-018-0026-8
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Guo ZM, 2002, MECH AGEING DEV, V123, P1121, DOI 10.1016/S0047-6374(02)00008-8
   Han XF, 2010, ACTA PHARMACOL SIN, V31, P1111, DOI 10.1038/aps.2010.146
   He LH, 2003, J BIOL CHEM, V278, P16755, DOI 10.1074/jbc.M300153200
   Heilbronn LK, 2006, JAMA-J AM MED ASSOC, V295, P1539, DOI 10.1001/jama.295.13.1539
   Kayali R, 2007, MECH AGEING DEV, V128, P365, DOI 10.1016/j.mad.2007.03.003
   Lu ZM, 2006, IUBMB LIFE, V58, P621, DOI 10.1080/15216540600957438
   MARKLUND S, 1974, EUR J BIOCHEM, V47, P469
   Martin CK, 2007, OBESITY, V15, P2964, DOI 10.1038/oby.2007.354
   Mattison JA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14063
   Melo DD, 2019, NUTRITION, V66, P87, DOI 10.1016/j.nut.2019.03.022
   Melo DS, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00106
   Melo DS, 2013, APPL PHYSIOL NUTR ME, V38, P879, DOI 10.1139/apnm-2012-0387
   Most J, 2020, EXP GERONTOL, V133, DOI 10.1016/j.exger.2020.110875
   Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350
   Muruganandan S, 2005, J ETHNOPHARMACOL, V97, P497, DOI 10.1016/j.jep.2004.12.010
   National Research Council, 2011, GUIDE CARE USE LAB A, DOI 10.17226/12910
   NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Overton JM, 2004, PHYSIOL BEHAV, V81, P749, DOI 10.1016/j.physbeh.2004.04.025
   Park HS, 2002, MOL CELL BIOL, V22, P7721, DOI 10.1128/MCB.22.22.7721-7730.2002
   Redman LM, 2018, CELL METAB, V27, P805, DOI 10.1016/j.cmet.2018.02.019
   Rodrigues CM, 2021, LIFE SCI, V275, DOI 10.1016/j.lfs.2021.119411
   Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009
   Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624
   Seymour EM, 2006, J MOL CELL CARDIOL, V41, P661, DOI 10.1016/j.yjmcc.2006.07.012
   Shinmura K, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/528935
   Shinmura K, 2011, GERIATR GERONTOL INT, V11, P143, DOI 10.1111/j.1447-0594.2010.00675.x
   Shinmura K, 2011, J MOL CELL CARDIOL, V50, P117, DOI 10.1016/j.yjmcc.2010.10.018
   Skrzypiec-Spring Monika, 2007, Journal of Pharmacological and Toxicological Methods, V55, P113, DOI 10.1016/j.vascn.2006.05.006
   Taylor BA, 1996, GENOMICS, V34, P389, DOI 10.1006/geno.1996.0302
   Ungvari Z, 2008, CIRC RES, V102, P519, DOI 10.1161/CIRCRESAHA.107.168369
   Willis BL, 2015, AM J PREV MED, V49, P678, DOI 10.1016/j.amepre.2015.03.034
   Yamada Y, 2013, EXP GERONTOL, V48, P1226, DOI 10.1016/j.exger.2013.08.002
   Yan LJ, 2002, EMBO J, V21, P5164, DOI 10.1093/emboj/cdf528
NR 48
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1549-1684
EI 1557-8577
J9 REJUV RES
JI Rejuv. Res.
PD OCT 1
PY 2023
VL 26
IS 5
BP 194
EP 205
DI 10.1089/rej.2023.0032
PG 12
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA U5PU5
UT WOS:001085330300003
PM 37694594
DA 2024-02-19
ER

PT J
AU Wang, L
   Liu, XL
   Nie, J
   Zhang, J
   Kimball, SR
   Zhang, H
   Zhang, WPJ
   Jefferson, LS
   Cheng, ZN
   Ji, QH
   Shi, YG
AF Wang, Li
   Liu, Xiaolei
   Nie, Jia
   Zhang, Jun
   Kimball, Scot R.
   Zhang, Hai
   Zhang, Weiping J.
   Jefferson, Leonard S.
   Cheng, Zeneng
   Ji, Qiuhe
   Shi, Yuguang
TI ALCAT1 Controls Mitochondrial Etiology of Fatty Liver Diseases, Linking
   Defective Mitophagy to Steatosis
SO HEPATOLOGY
LA English
DT Article
ID INSULIN-RESISTANCE; OXIDATIVE STRESS; SKELETAL-MUSCLE; MITOFUSIN 2;
   CARDIOLIPIN; AUTOPHAGY; OBESITY; MFN2; ELIMINATION; DYSFUNCTION
AB Defective autophagy is implicated in the pathogenesis of nonalcoholic fatty liver diseases (NAFLD) through poorly defined mechanisms. Cardiolipin is a mitochondrial phospholipid required for bioenergetics and mitophagy from yeast to mammals. Here we investigated a role for ALCAT1 in the development of NAFLD. ALCAT1 is a lysocardiolipin acyltransferase that catalyzes pathological cardiolipin remodeling in several aging-related diseases. We show that the onset of diet-induced NAFLD caused autophagic arrest in hepatocytes, leading to oxidative stress, mitochondrial dysfunction, and insulin resistance. In contrast, targeted deletion of ALCAT1 in mice prevented the onset of NAFLD. ALCAT1 deficiency also restored mitophagy, mitochondrial architecture, mitochondrial DNA (mtDNA) fidelity, and oxidative phosphorylation. In support of a causative role of the enzyme in a mitochondrial etiology of the disease, hepatic ALCAT1 expression was significantly up-regulated in mouse models of NAFLD. Conclusion: Forced expression of ALCAT1 in primary hepatocytes led to multiple defects that are highly reminiscent of NAFLD, including steatosis, defective autophagy, and mitochondrial dysfunction, linking pathological cardiolipin remodeling by ALCAT1 to the pathogenesis of NAFLD. (Hepatology 2015;61:486-496)
C1 [Wang, Li; Ji, Qiuhe] Fourth Mil Med Univ, Xijing Hosp, Dept Endocrinol & Metab, Xian 710032, Peoples R China.
   [Wang, Li; Liu, Xiaolei; Nie, Jia; Zhang, Jun; Kimball, Scot R.; Zhang, Hai; Jefferson, Leonard S.; Shi, Yuguang] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA.
   [Zhang, Hai; Zhang, Weiping J.; Shi, Yuguang] Second Mil Med Univ, Dept Pathophysiol, Shanghai, Peoples R China.
   [Cheng, Zeneng] Cent S Univ, Sch Pharmaceut Sci, Dept Pharmacol, Changsha, Hunan, Peoples R China.
C3 Air Force Military Medical University; Pennsylvania Commonwealth System
   of Higher Education (PCSHE); Pennsylvania State University; Penn State
   Health; Naval Medical University; Central South University
RP Shi, YG (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, 500 Univ Dr,H166, Hershey, PA 17033 USA.
EM jqiuhe@fmmu.edu.cn; yus11@psu.edu
RI Zhou, Lu/KAM-1449-2024; nie, jia/AAE-8355-2019; Zhang, Jun/W-5146-2019
OI nie, jia/0000-0001-9085-7224; Zhang, Jun/0000-0002-8489-3699
FU NIH [DK076685, DK13499]; National Natural Science Foundation of China
   [31371192, 81100606]
FX Supported in part by grants from NIH (DK076685 to Y.S., and DK13499 to
   L.S.J.) and National Natural Science Foundation of China (31371192, to
   Y.S. and 81100606 to L.W.).
CR Bach D, 2005, DIABETES, V54, P2685, DOI 10.2337/diabetes.54.9.2685
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen S, 2008, MOL BIOL CELL, V19, P5047, DOI 10.1091/mbc.E08-05-0486
   Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031
   Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837
   Chu CT, 2010, HUM MOL GENET, V19, pR28, DOI 10.1093/hmg/ddq143
   Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009
   Hamasaki M, 2013, NATURE
   Huang WJ, 2012, CELL RES, V22, P473, DOI 10.1038/cr.2012.24
   Ibdah JA, 2005, GASTROENTEROLOGY, V128, P1381, DOI 10.1053/j.gastro.2005.02.001
   Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727
   Li J, 2012, P NATL ACAD SCI USA, V109, P6975, DOI 10.1073/pnas.1120043109
   Li J, 2010, CELL METAB, V12, P154, DOI 10.1016/j.cmet.2010.07.003
   Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002
   Liu XL, 2012, MOL CELL BIOL, V32, P4493, DOI 10.1128/MCB.01092-12
   Molina AJA, 2009, DIABETES, V58, P2303, DOI 10.2337/db07-1781
   Petrosillo G, 2007, BBA-BIOENERGETICS, V1767, P1260, DOI 10.1016/j.bbabio.2007.07.011
   Sanyal AJ, 2005, NAT CLIN PRACT GASTR, V2, P46, DOI 10.1038/ncpgasthep0084
   Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007
   Sebastián D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109
   Shi YG, 2010, J BIOMED RES, V24, P6, DOI 10.1016/S1674-8301(10)60003-6
   Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976
   Taylor WA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048628
   Taylor WA, 2009, J BIOL CHEM, V284, P30360, DOI 10.1074/jbc.M109.048322
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005
NR 26
TC 104
Z9 119
U1 4
U2 58
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD FEB
PY 2015
VL 61
IS 2
BP 486
EP 496
DI 10.1002/hep.27420
PG 11
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA AZ9UX
UT WOS:000348563200014
PM 25203315
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Cassano, M
   Offner, S
   Planet, E
   Piersigilli, A
   Jang, SM
   Henry, H
   Geuking, MB
   Mooser, C
   McCoy, KD
   Macpherson, AJ
   Trono, D
AF Cassano, Marco
   Offner, Sandra
   Planet, Evarist
   Piersigilli, Alessandra
   Jang, Suk Min
   Henry, Hugues
   Geuking, Markus B.
   Mooser, Catherine
   McCoy, Kathy D.
   Macpherson, Andrew J.
   Trono, Didier
TI Polyphenic Trait Promotes Liver Cancer in a Model of Epigenetic
   Instability in Mice
SO HEPATOLOGY
LA English
DT Article
ID FARNESOID-X RECEPTOR; HIGH-FAT-DIET; HEPATOCELLULAR-CARCINOMA;
   BETA-CATENIN; GUT MICROBIOTA; OBESITY; MECHANISMS; GENE; METABOLISM;
   PHOSPHORYLATION
AB Hepatocellular carcinoma (HCC) represents the fifth-most common form of cancer worldwide and carries a high mortality rate attributed to lack of effective treatment. Males are 8 times more likely to develop HCC than females, an effect largely driven by sex hormones, albeit through still poorly understood mechanisms. We previously identified TRIM28 (tripartite protein 28), a scaffold protein capable of recruiting a number of chromatin modifiers, as a crucial mediator of sexual dimorphism in the liver. Trim28(hep-/-) mice display sex-specific transcriptional deregulation of a wide range of bile and steroid metabolism genes and development of liver adenomas in males. We now demonstrate that obesity and aging precipitate alterations of TRIM28-dependent transcriptional dynamics, leading to a metabolic infection state responsible for highly penetrant male-restricted hepatic carcinogenesis. Molecular analyses implicate aberrant androgen receptor stimulation, biliary acid disturbances, and altered responses to gut microbiota in the pathogenesis of Trim28(hep-/-)-associated HCC. Correspondingly, androgen deprivation markedly attenuates the frequency and severity of tumors, and raising animals under axenic conditions completely abrogates their abnormal phenotype, even upon high-fat diet challenge. Conclusion: This work underpins how discrete polyphenic traits in epigenetically metastable conditions can contribute to a cancer-prone state and more broadly provides new evidence linking hormonal imbalances, metabolic disturbances, gut microbiota, and cancer.
C1 [Cassano, Marco; Offner, Sandra; Planet, Evarist; Piersigilli, Alessandra; Jang, Suk Min; Trono, Didier] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland.
   [Piersigilli, Alessandra] Univ Bern, Vetsuisse Fac, Inst Anim Pathol, Bern, Switzerland.
   [Henry, Hugues] Univ Lausanne, Fac Biol & Med, Lausanne Univ Hosp, Clin Chem Lab, Lausanne, Switzerland.
   [Geuking, Markus B.; Mooser, Catherine; McCoy, Kathy D.; Macpherson, Andrew J.] Univ Bern, Dept Clin Res, Mucosal Immunol Lab, Bern, Switzerland.
C3 Swiss Federal Institutes of Technology Domain; Ecole Polytechnique
   Federale de Lausanne; University of Bern; University of Lausanne; Centre
   Hospitalier Universitaire Vaudois (CHUV); University of Bern
RP Trono, D (corresponding author), EPFL SV, Stn 19, CH-1015 Lausanne, Switzerland.
EM Didier.Trono@epfl.ch
RI Cassano, Marco/T-3473-2019; McCoy, Kathy/ABD-5814-2021
OI McCoy, Kathy/0000-0002-3900-9227; Cassano, Marco/0000-0002-8526-1319
FU Swiss National Science Foundation; European Research Council [ERC
   268721, ERC 694658]
FX Supported by grants from the Swiss National Science Foundation and the
   European Research Council (ERC 268721 and ERC 694658).
CR Asarian L, 2006, PHILOS T R SOC B, V361, P1251, DOI 10.1098/rstb.2006.1860
   Bäckhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104
   Bernstein H, 2005, MUTAT RES-REV MUTAT, V589, P47, DOI 10.1016/j.mrrev.2004.08.001
   Bojkowska K, 2012, HEPATOLOGY, V56, P1279, DOI 10.1002/hep.25767
   Cadoret A, 2002, ONCOGENE, V21, P8293, DOI 10.1038/sj.onc.1206118
   Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408
   Chassaing B, 2014, HEPATOLOGY, V59, P328, DOI 10.1002/hep.26494
   Dalgaard K, 2016, CELL, V164, P353, DOI 10.1016/j.cell.2015.12.025
   Dao MC, 2016, GUT, V65, P426, DOI 10.1136/gutjnl-2014-308778
   Dorak M. Tevfik, 2012, Frontiers in Genetics, V3, P268, DOI 10.3389/fgene.2012.00268
   Ecco G, 2016, DEV CELL, V36, P611, DOI 10.1016/j.devcel.2016.02.024
   Font-Burgada J, 2016, CELL METAB, V23, P48, DOI 10.1016/j.cmet.2015.12.015
   Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067
   Cano PG, 2013, OBESITY, V21, P2310, DOI 10.1002/oby.20330
   Gluckman PD, 2009, NAT REV ENDOCRINOL, V5, P401, DOI 10.1038/nrendo.2009.102
   GOODRICK CL, 1975, J GERONTOL, V30, P257, DOI 10.1093/geronj/30.3.257
   Gougelet A, 2014, HEPATOLOGY, V59, P2344, DOI 10.1002/hep.26924
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9
   Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809
   Horvath S, 2014, P NATL ACAD SCI USA, V111, P15538, DOI 10.1073/pnas.1412759111
   Huggins C, 1972, CA Cancer J Clin, V22, P232, DOI 10.3322/canjclin.22.4.232
   Karantanos T, 2013, ONCOGENE, V32, P5501, DOI 10.1038/onc.2013.206
   Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36
   Kim I, 2007, CARCINOGENESIS, V28, P940, DOI 10.1093/carcin/bgl249
   Kondo Y, 1999, JPN J CANCER RES, V90, P1301, DOI 10.1111/j.1349-7006.1999.tb00712.x
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]
   Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29
   Li Z, 2012, CELL, V148, P72, DOI 10.1016/j.cell.2011.11.026
   Ma CL, 2008, GASTROENTEROLOGY, V135, P947, DOI 10.1053/j.gastro.2008.05.046
   MCCARTHY N, 2011, NAT REV CANC, V11, P386
   Nault JC, 2014, J HEPATOL, V60, P224, DOI 10.1016/j.jhep.2013.08.019
   Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052
   Rauwel B, 2015, ELIFE, V4, DOI 10.7554/eLife.06068
   Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674
   Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003
   Schulz MD, 2014, NATURE, V514, P508, DOI 10.1038/nature13398
   Serino M, 2012, GUT, V61, P543, DOI 10.1136/gutjnl-2011-301012
   Sharma D, 2010, HEPATOLOGY, V52, P1713, DOI 10.1002/hep.23892
   Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522
   Singh K, 2015, GENE DEV, V29, P513, DOI 10.1101/gad.254532.114
   Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122
   Wands J, 2007, NEW ENGL J MED, V357, P1974, DOI 10.1056/NEJMcibr075652
   White D, 2012, MOL CANCER RES, V10, P401, DOI 10.1158/1541-7786.MCR-11-0134
   Yang F, 2007, CANCER RES, V67, P863, DOI 10.1158/0008-5472.CAN-06-1078
   Yang FJ, 2002, J BIOL CHEM, V277, P11336, DOI 10.1074/jbc.M111962200
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Zhan L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105930
   Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137
NR 49
TC 11
Z9 12
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD JUL
PY 2017
VL 66
IS 1
BP 235
EP 251
DI 10.1002/hep.29182
PG 17
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA EY3OX
UT WOS:000403883100021
PM 28370258
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Tower, J
   Landis, G
   Gao, R
   Luan, A
   Lee, J
   Sun, YY
AF Tower, John
   Landis, Gary
   Gao, Rebecca
   Luan, Albert
   Lee, Jonathan
   Sun, Yuanyue
TI Variegated Expression of <i>Hsp22</i> Transgenic Reporters Indicates
   Cell-specific Patterns of Aging in <i>Drosophila</i> Oenocytes
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE Mitochondria; Age pigment; Mosaic; Cell lineage; Prepattern
ID LIFE-SPAN EXTENSION; MITOCHONDRIAL-DNA; GENE-EXPRESSION; OXIDATIVE
   STRESS; SUPEROXIDE-DISMUTASE; GENOME-WIDE; RNA LEVELS; LIPOFUSCIN;
   OVEREXPRESSION; ACCUMULATION
AB The cytoplasmic chaperone gene Hsp70 and the mitochondrial chaperone gene Hsp22 are upregulated during normal aging in Drosophila in tissue-general patterns. In addition, Hsp22 reporters are dramatically upregulated during aging in a subset of the oenocytes (liver-like cells). Hsp22 reporter expression varied dramatically between individual oenocytes and between groups of oenocytes located in adjacent body segments, and was negatively correlated with accumulation of age pigment, indicating cell-specific and cell-lineage-specific patterns of oenocyte aging. Conditional transgenic systems were used to express 88 transgenes to search for trans-regulators of the Hsp70 and Hsp22 reporters during aging. The wingless gene increased tissue-general upregulation of both Hsp70 and Hsp22 reporters. In contrast, the mitochondrial genes MnSOD and Hsp22 increased expression of Hsp22 reporters in the oenocytes and decreased accumulation of age pigment in these cells. The data suggest that cell-specific and cell lineage-specific patterns of mitochondrial malfunction contribute to oenocyte aging.
C1 [Tower, John; Landis, Gary; Gao, Rebecca; Luan, Albert; Lee, Jonathan; Sun, Yuanyue] Univ So Calif, Mol & Computat Biol Program, Dept Biol Sci, Los Angeles, CA 90089 USA.
C3 University of Southern California
RP Tower, J (corresponding author), Univ So Calif, Mol & Computat Biol Program, 1050 Childs Way,RRI 201, Los Angeles, CA 90089 USA.
EM jtower@usc.edu
FU Department of Health and Human Services [AG011833]
FX This work was supported by a grant from the Department of Health and
   Human Services to J.T. (AG011833).
CR Amador-Noguez D, 2005, BIOCHEM BIOPH RES CO, V332, P1086, DOI 10.1016/j.bbrc.2005.05.063
   Ameur A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002028
   Ardekani R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040506
   Augustin H, 2009, BBA-GEN SUBJECTS, V1790, P1084, DOI 10.1016/j.bbagen.2009.06.011
   Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495
   Bonduriansky R, 2009, TRENDS ECOL EVOL, V24, P280, DOI 10.1016/j.tree.2008.12.005
   Cabreiro F, 2011, FREE RADICAL BIO MED, V51, P1575, DOI 10.1016/j.freeradbiomed.2011.07.020
   Chen SJ, 2012, GENETICS, V192, P483, DOI 10.1534/genetics.112.143719
   CHEN X, 1993, B MOL BIOL MED, V18, P57
   Cho J, 2011, EXP GERONTOL, V46, P331, DOI 10.1016/j.exger.2010.08.010
   Conboy IM, 2012, CELL CYCLE, V11, P2260, DOI 10.4161/cc.20437
   Cortright RN, 2000, CAN J APPL PHYSIOL, V25, P288, DOI 10.1139/h00-023
   Curtis C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r262
   DeCarolis NA, 2008, BIOESSAYS, V30, P102, DOI 10.1002/bies.20709
   Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007
   Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016
   Fedina TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049799
   Ford D, 2007, EXP GERONTOL, V42, P483, DOI 10.1016/j.exger.2007.01.004
   Gould AP, 2001, J ANAT, V199, P25, DOI 10.1017/S0021878201008317
   Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382
   Haag-Liautard C, 2008, PLOS BIOL, V6, P1706, DOI 10.1371/journal.pbio.0060204
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135
   Hughes BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026116
   Jacobson J, 2010, AGING CELL, V9, P466, DOI 10.1111/j.1474-9726.2010.00573.x
   Jarrett SG, 2010, OPHTHALMIC RES, V44, P179, DOI 10.1159/000316480
   Jokinen Riikka, 2011, Small GTPases, V2, P31
   Jung T, 2010, METHODS MOL BIOL, V594, P173, DOI 10.1007/978-1-60761-411-1_13
   Khraiwesh H, 2013, J GERONTOL A-BIOL, V68, P1023, DOI 10.1093/gerona/glt006
   Kim HJ, 2010, EXP GERONTOL, V45, P611, DOI 10.1016/j.exger.2009.12.012
   King V, 1999, DEV BIOL, V207, P107, DOI 10.1006/dbio.1998.9147
   Kirkwood TBL, 2005, MECH AGEING DEV, V126, P439, DOI 10.1016/j.mad.2004.09.008
   Krupp Joshua J, 2010, J Vis Exp, DOI 10.3791/2242
   Kuo TH, 2012, PLOS GENET, V8, P640, DOI 10.1371/journal.pgen.1002684
   Kuo TH, 2012, J EXP BIOL, V215, P814, DOI 10.1242/jeb.064980
   Kurapati R, 2000, J GERONTOL A-BIOL, V55, pB552, DOI 10.1093/gerona/55.11.B552
   Landis G, 2012, AGING-US, V4, P768, DOI 10.18632/aging.100499
   Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101
   LAWRENCE PA, 1982, J EMBRYOL EXP MORPH, V72, P197
   LAWRENCE PA, 1986, J EMBRYOL EXP MORPH, V91, P251
   Liu DM, 2013, J GERONTOL A-BIOL, V68, P1035, DOI 10.1093/gerona/glt015
   Magwire MM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001037
   Martin GM, 2012, MECH AGEING DEV, V133, P107, DOI 10.1016/j.mad.2011.09.001
   Meissner C, 2007, Z GERONTOL GERIATR, V40, P325, DOI 10.1007/s00391-007-0481-z
   Morrow G, 2000, J BIOL CHEM, V275, P31204, DOI 10.1074/jbc.M002960200
   Naito AT, 2010, CIRC RES, V107, P1295, DOI 10.1161/CIRCRESAHA.110.223776
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Pincus Z, 2010, DEV DYNAM, V239, P1306, DOI 10.1002/dvdy.22224
   Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4
   Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608
   Rera M, 2011, CELL METAB, V14, P623, DOI 10.1016/j.cmet.2011.09.013
   Schmucker DL, 2002, ARCH GERONTOL GERIAT, V34, P249, DOI 10.1016/S0167-4943(01)00218-7
   Schwarze SR, 1998, MUTAT RES-GENOMICS, V382, P99, DOI 10.1016/S1383-5726(97)00013-7
   Shen Jie, 2009, BMC Geriatr, V9, P56, DOI 10.1186/1471-2318-9-56
   Shen J, 2009, AGING-US, V1, P191, DOI 10.18632/aging.100018
   Shirangi TR, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000168
   Sun JT, 2002, GENETICS, V161, P661
   Tower J, 2006, MECH AGEING DEV, V127, P705, DOI 10.1016/j.mad.2006.05.001
   Tower J, 2011, EXP GERONTOL, V46, P355, DOI 10.1016/j.exger.2010.09.002
   WHEELER JC, 1995, P NATL ACAD SCI USA, V92, P10408, DOI 10.1073/pnas.92.22.10408
   Wheeler JC, 1999, NEUROBIOL AGING, V20, P545, DOI 10.1016/S0197-4580(99)00088-3
   Yang JS, 2009, J GERONTOL A-BIOL, V64, P828, DOI 10.1093/gerona/glp054
   Yin DZ, 1996, FREE RADICAL BIO MED, V21, P871, DOI 10.1016/0891-5849(96)00175-X
   Yui R, 2006, MUTAT RES-FUND MOL M, V594, P155, DOI 10.1016/j.mrfmmm.2005.08.003
   Zhan M, 2007, GENOME RES, V17, P1236, DOI 10.1101/gr.6216607
   Zou S, 2000, P NATL ACAD SCI USA, V97, P13726, DOI 10.1073/pnas.260496697
NR 66
TC 13
Z9 17
U1 0
U2 7
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD MAR
PY 2014
VL 69
IS 3
BP 253
EP 259
DI 10.1093/gerona/glt078
PG 7
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA AD6QB
UT WOS:000333384800002
PM 23723429
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Picca, A
   Pesce, V
   Fracasso, F
   Joseph, AM
   Leeuwenburgh, C
   Lezza, AMS
AF Picca, Anna
   Pesce, Vito
   Fracasso, Flavio
   Joseph, Anna-Maria
   Leeuwenburgh, Christiaan
   Lezza, Angela Maria Serena
TI A comparison among the tissue-specific effects of aging and calorie
   restriction on TFAM amount and TFAM-binding activity to mtDNA in rat
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
LA English
DT Article
DE Mitochondrial Transcription Factor A; Mitochondrial Transcription
   Factor; A-mitochondrial deoxyribonucleic acid binding;
   Tissue-specificity; Aging rat; Calorie restriction
ID MITOCHONDRIAL TRANSCRIPTION FACTOR; DNA DELETIONS; FACTOR-A; PHENOTYPIC
   ALTERATIONS; OXIDATIVE STRESS; LIVER; AGE; BRAIN; ABNORMALITIES;
   MAINTENANCE
AB Background: Mitochondria Transcription Factor A (TFAM) is regarded as a histone-like protein of mitochondrial DNA (mtDNA), performing multiple functions for this genome. Aging affects mitochondria in a tissue-specific manner and only calorie restriction (CR) is able to delay or prevent the onset of several age-related changes also in mitochondria.
   Methods: Samples of the frontal cortex and soleus skeletal muscle from 6- and 26-month-old ad libitum-fed and 26-month-old calorie-restricted rats and of the livers from 18- and 28-month-old ad libitum-fed and 28-month-old calorie-restricted rats were used to detect TFAM amount, TFAM-binding to mtDNA and mtDNA content.
   Results: We found an age-related increase in TFAM amount in the frontal cortex, not affected by CR, versus an age-related decrease in the soleus and liver, fully prevented by CR. The semi-quantitative analysis of in vivo binding of TFAM to specific mtDNA regions, by mtDNA immunoprecipitation assay and following PCR, showed a marked age-dependent decrease in TFAM-binding activity in the frontal cortex, partially prevented by CR. An age-related increase in TFAM-binding to mtDNA, fully prevented by CR, was found in the soleus and liver. MtDNA content presented a common age-related decrease, completely prevented by CR in the soleus and liver, but not in the frontal cortex.
   Conclusions: The modulation of TFAM expression, TFAM-binding to mtDNA and mtDNA content with aging and CR showed a trend shared by the skeletal muscle and liver, but not by the frontal cortex counterpart.
   General significance: Aging and CR appear to induce similar mitochondrial molecular mechanisms in the skeletal muscle and liver, different from those elicited in the frontal cortex. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Picca, Anna; Joseph, Anna-Maria; Leeuwenburgh, Christiaan] Univ Florida, Div Biol Aging, Inst Aging, Dept Aging & Geriatr Res, Gainesville, FL 32611 USA.
   [Pesce, Vito; Fracasso, Flavio; Lezza, Angela Maria Serena] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, I-70125 Bari, Italy.
C3 State University System of Florida; University of Florida; Universita
   degli Studi di Bari Aldo Moro
RP Lezza, AMS (corresponding author), Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Via Orabona 4, I-70125 Bari, Italy.
EM angelamariaserena.lezza@uniba.it
RI Picca, Anna/K-2305-2018
OI Picca, Anna/0000-0001-7032-3487; PESCE, VITO/0000-0002-9148-3129;
   Leeuwenburgh, Christiaan/0000-0003-0826-4257
FU National Institute on Aging (NIA) [R01 AG17994]; University of Florida
   Institute on Aging; Claude D. Pepper Older Americans Independence Center
   [1 P30 AG028740]
FX This research was supported by grants to CL (National Institute on Aging
   (NIA) R01 AG17994), the University of Florida Institute on Aging and the
   Claude D. Pepper Older Americans Independence Center (1 P30 AG028740).
   We thank Isabella Maiellaro, MS, for assisting with the experiments.
CR Anderson R, 2009, BBA-GEN SUBJECTS, V1790, P1059, DOI 10.1016/j.bbagen.2009.04.005
   Anderson RM, 2010, TRENDS ENDOCRIN MET, V21, P134, DOI 10.1016/j.tem.2009.11.005
   Aspnes LE, 1997, FASEB J, V11, P573, DOI 10.1096/fasebj.11.7.9212081
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Barja G, 2007, REJUV RES, V10, P215, DOI 10.1089/rej.2006.0516
   Bestwick ML, 2013, TRENDS BIOCHEM SCI, V38, P283, DOI 10.1016/j.tibs.2013.03.006
   Bua EA, 2004, FASEB J, V18, P582, DOI 10.1096/fj.03-0668fje
   Canugovi C, 2010, DNA REPAIR, V9, P1080, DOI 10.1016/j.dnarep.2010.07.009
   Cassano P, 2006, REJUV RES, V9, P211, DOI 10.1089/rej.2006.9.211
   Cassano P, 2004, ANN NY ACAD SCI, V1019, P269, DOI 10.1196/annals.1297.045
   Dinardo MM, 2003, BIOCHEM BIOPH RES CO, V301, P187, DOI 10.1016/S0006-291X(02)03008-5
   Escrivá H, 1999, BIOCHIMIE, V81, P965, DOI 10.1016/S0300-9084(99)00223-0
   Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909
   FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496
   Fontana L, 2009, CURR OPIN GASTROEN, V25, P144, DOI 10.1097/MOG.0b013e32831ef1ba
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   GADALETA MN, 1990, EUR J BIOCHEM, V187, P501, DOI 10.1111/j.1432-1033.1990.tb15331.x
   Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007
   Kang CM, 1998, FREE RADICAL BIO MED, V24, P148, DOI 10.1016/S0891-5849(97)00204-9
   Kanki T, 2004, MOL CELL BIOL, V24, P9823, DOI 10.1128/MCB.24.22.9823-9834.2004
   Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Larsson NG, 1996, NAT GENET, V13, P296, DOI 10.1038/ng0796-296
   Lezza Angela M S, 2012, [Frontiers in Biology, 生物学前沿], V7, P30
   López-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6
   Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012
   McInerny SC, 2009, MECH AGEING DEV, V130, P343, DOI 10.1016/j.mad.2009.01.008
   Navarro A, 2004, AM J PHYSIOL-REG I, V287, pR1244, DOI 10.1152/ajpregu.00226.2004
   PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027
   Pesce V, 2001, FREE RADICAL BIO MED, V30, P1223, DOI 10.1016/S0891-5849(01)00517-2
   Pesce V, 2005, J GERONTOL A-BIOL, V60, P715, DOI 10.1093/gerona/60.6.715
   Pesce V, 2012, REJUV RES, V15, P136, DOI 10.1089/rej.2011.1255
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Picca A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074644
   Picca A, 2013, AGE, V35, P1607, DOI 10.1007/s11357-012-9465-z
   Stuart JA, 2004, FASEB J, V18, P595, DOI 10.1096/fj.03-0890fje
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Wang CH, 2013, EXP BIOL MED, V238, P450, DOI 10.1177/1535370213493069
   Yoshida Y, 2002, BIOCHEM BIOPH RES CO, V295, P945, DOI 10.1016/S0006-291X(02)00757-X
NR 40
TC 27
Z9 31
U1 2
U2 8
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0304-4165
EI 1872-8006
J9 BBA-GEN SUBJECTS
JI Biochim. Biophys. Acta-Gen. Subj.
PD JUL
PY 2014
VL 1840
IS 7
BP 2184
EP 2191
DI 10.1016/j.bbagen.2014.03.004
PG 8
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA AK4NW
UT WOS:000338402400009
PM 24631828
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Kuenstner, A
   Schilf, P
   Busch, H
   Ibrahim, SM
   Hirose, M
AF Kuenstner, Axel
   Schilf, Paul
   Busch, Hauke
   Ibrahim, Saleh M.
   Hirose, Misa
TI Changes of Gut Microbiota by Natural mtDNA Variant Differences Augment
   Susceptibility to Metabolic Disease and Ageing
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE mitochondrial DNA polymorphisms; natural variants; gut microbiota;
   complex I; proteobacteria; glucose metabolism; ageing
ID MITOCHONDRIAL; DIVERSITY; DYSBIOSIS
AB We recently reported on two mouse strains carrying different single nucleotide variations in the mitochondrial complex I gene, i.e., B6-mt(BPL) mice carrying m.11902T>C and B6-mt(ALR) carrying m.4738C>A. B6-mt(BPL) mice exhibited a longer lifespan and a lower metabolic disease susceptibility despite mild mitochondrial functional differences in steady-state. As natural polymorphisms in the mitochondrial DNA (mtDNA) are known to be associated with distinct patterns of gut microbial composition, we further investigated the gut microbiota composition in these mice strains. In line with mouse phenotypes, we found a significantly lower abundance of Proteobacteria, which is positively associated with pathological conditions, in B6-mt(BPL) compared to B6-mt(ALR) mice. A prediction of functional profile of significantly differential bacterial genera between these strains revealed an involvement of glucose metabolism pathways. Whole transcriptome analysis of liver samples from B6-mt(BPL) and B6-mt(ALR) mice confirmed these findings. Thus, both host gene expression and gut microbial changes caused by the mtDNA variant differences may contribute to the ageing and metabolic phenotypes observed in these mice strains. Since gut microbiota are easier to modulate, compared with mtDNA variants, identification of such mtDNA variants, specific gut bacterial species and bacterial metabolites may be a potential intervention to modulate common diseases, which are differentially susceptible to individuals with different mtDNA variants.
C1 [Kuenstner, Axel; Schilf, Paul; Busch, Hauke; Ibrahim, Saleh M.; Hirose, Misa] Univ Lubeck, Lubeck Inst Expt Dermatol, D-23562 Lubeck, Germany.
   [Kuenstner, Axel; Busch, Hauke] Univ Lubeck, Inst Cardiogenet, D-23562 Lubeck, Germany.
   [Ibrahim, Saleh M.] Univ Sharjah, Coll Med, Sharjah 27272, U Arab Emirates.
   [Ibrahim, Saleh M.] Univ Sharjah, Sharjah Inst Med Res, Sharjah 27272, U Arab Emirates.
C3 University of Lubeck; University of Lubeck; University of Sharjah;
   University of Sharjah
RP Hirose, M (corresponding author), Univ Lubeck, Lubeck Inst Expt Dermatol, D-23562 Lubeck, Germany.
EM axel.kuenstner@uni-luebeck.de; Paul.Schilf@uksh.de;
   hauke.busch@uni-luebeck.de; Saleh.Ibrahim@uksh.de; Misa.Hirose@uksh.de
RI Busch, Hauke/R-6452-2016; Hirose, Misa/A-2858-2014
OI Busch, Hauke/0000-0003-4763-4521; Kunstner, Axel/0000-0003-0692-2105;
   Ibrahim, Saleh/0000-0001-7827-2290
CR Aitchison John, 1986, STAT ANAL COMPOSITIO, DOI [10.1111/j.2517-6161.1982.tb01195.x, DOI 10.1007/978-94-009-4109-0]
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Badal VD, 2020, NUTRIENTS, V12, DOI 10.3390/nu12123759
   Brown MD, 2000, J BIOL CHEM, V275, P39831, DOI 10.1074/jbc.M006476200
   Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]
   Davis NM, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0605-2
   Douglas GM, 2020, NAT BIOTECHNOL, V38, P685, DOI 10.1038/s41587-020-0548-6
   Fernandes AD, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-15
   Hirose M, 2019, GENES-BASEL, V10, DOI 10.3390/genes10070532
   Hirose M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092359
   Hirose M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24290-6
   Hirose M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15377-7
   Hirose M, 2016, NATURE, V540, pE13, DOI 10.1038/nature20778
   Houghton D, 2018, J GERONTOL A-BIOL, V73, P571, DOI 10.1093/gerona/glx197
   Indo HP, 2015, J CLIN BIOCHEM NUTR, V56, P1, DOI 10.3164/jcbn.14-42
   Kaur H, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01365
   Kim S, 2015, COMMUN STAT APPL MET, V22, P665, DOI 10.5351/CSAM.2015.22.6.665
   Latorre-Pellicer A, 2016, NATURE, V535, P561, DOI 10.1038/nature18618
   Lin CS, 2012, P NATL ACAD SCI USA, V109, P20065, DOI 10.1073/pnas.1217113109
   Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266
   Martin BD, 2020, ANN APPL STAT, V14, P94, DOI [10.1214/19-AOAS1283, 10.1214/19-aoas1283]
   McManus MJ, 2019, CELL METAB, V29, P78, DOI 10.1016/j.cmet.2018.08.002
   Murali A, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0521-5
   O'Toole PW, 2015, SCIENCE, V350, P1214, DOI 10.1126/science.aac8469
   Parks DH, 2022, NUCLEIC ACIDS RES, V50, pD785, DOI 10.1093/nar/gkab776
   Rivera-Pinto J, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00053-18
   Schilf P, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22031006
   Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Willis A, 2015, BIOMETRICS, V71, P1042, DOI 10.1111/biom.12332
   Willis AD, 2022, BIOSTATISTICS, V23, P207, DOI 10.1093/biostatistics/kxaa015
   Yardeni T, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aaw3159
   Yonova-Doing E, 2021, NAT GENET, V53, P982, DOI 10.1038/s41588-021-00868-1
   Yu X, 2009, GENOME RES, V19, P159, DOI 10.1101/gr.078865.108
   Zhou LY, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00516
NR 35
TC 2
Z9 2
U1 0
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD FEB
PY 2022
VL 23
IS 3
AR 1056
DI 10.3390/ijms23031056
PG 13
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA YZ5BP
UT WOS:000755491500001
PM 35162979
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Jin, JL
   Wang, GL
   Salisbury, E
   Timchenko, L
   Timchenko, NA
AF Jin, Jingling
   Wang, Guo-Li
   Salisbury, Elizabeth
   Timchenko, Lubov
   Timchenko, Nikolai A.
TI GSK3β-cyclin D3-CUGBP1-eIF2 pathway in aging and in myotonic dystrophy
SO CELL CYCLE
LA English
DT Article
DE aging; myotonic dystrophy 2; CUGBP1-eIF2; liver; proliferation; CCUG RNA
   repeats; cyclin D3/C/EBP; GSK3
ID BINDING PROTEIN-BETA; INCREASES TRANSLATION; CTG REPEATS; CUGBP1; MICE;
   DIFFERENTIATION; PROLIFERATION; EXPRESSION; COMPLEX; LIVER
AB Epigenetic silencing of the cell cycle proteins is one of the major pathways of the inhibition of liver proliferation in old mice. We recently identified glycogen synthase 3 beta, GSK3 beta, as an enzyme which controls the epigenetic regulation of the liver proliferation via reduction of cyclin D3-cdk4. The elevation of cyclin D3 in livers of old mice leads to the accumulation of a transcriptional C/EBP alpha-HDAC1-Brm complex and translational CUGBP1-eIF2 complex. The accumulation of the CUGBP1-eIF2 increases translation of HDAC1 and C/EBP beta in livers of old mice leading to formation of C/EBP beta-HDAC1 complex which represses C/EBP beta-dependent genes by interacting with their promoters. The translational CUGBP1-eIF2 complex also plays critical role in the regulation of biological processes in young livers and needs to be tightly regulated. Our recent paper showed that this complex is un-appropriately upregulated in skeletal muscle precursors of patients affected with multisystemic disease, Myotonic Dystrophy 2 (DM2) leading to translational elevation of several proteins. These data suggest that the age-specific translational dysfunctions might be involved in DM2 pathogenesis. Our data also suggest that the regulation of translation is conserved in liver and skeletal muscle. In this review, we discuss biological consequences of the age-associated alterations of translation in the liver and a possible role of the elevation of the CUGBP1-eIF2 complex in development of DM2 pathology.
C1 [Timchenko, Nikolai A.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA.
   Baylor Coll Med, Dept Physiol & Mol Biophys, Houston, TX 77030 USA.
   Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA.
C3 Baylor College of Medicine; Baylor College of Medicine; Baylor College
   of Medicine
RP Timchenko, NA (corresponding author), Baylor Coll Med, Dept Pathol, 1 Baylor Plaza, Houston, TX 77030 USA.
EM nikolait@bcm.tmc.edu
OI Salisbury, Elizabeth/0000-0003-3607-2367; Jin,
   Jingling/0000-0002-4365-1837
FU National Institutes of Health [AR052791, NS063298, GM55188, CA100070,
   AG025477]
FX This work was supported by National Institutes of Health Grants
   AR052791, NS063298 (to L. T. T.), and GM55188, CA100070, AG025477 (to N.
   A. T.).
CR Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5
   Harper PS, 2001, Myotonic dystrophy
   Ho TH, 2005, HUM MOL GENET, V14, P1539, DOI 10.1093/hmg/ddi162
   JIN J, 2009, MOL CELL BI IN PRESS
   JIN J, 2009, AGING IN PRESS
   Karagiannides I, 2006, J BIOL CHEM, V281, P23025, DOI 10.1074/jbc.M513187200
   KAWAKAMI K, 2008, BIOGERONTOLOGY, DOI DOI 10.1007/S10522-008-9176-80
   Kuyumcu-Martinez NM, 2007, MOL CELL, V28, P68, DOI 10.1016/j.molcel.2007.07.027
   Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125
   Mahadevan MS, 2006, NAT GENET, V38, P1066, DOI 10.1038/ng1857
   Orengo JP, 2008, P NATL ACAD SCI USA, V105, P2646, DOI 10.1073/pnas.0708519105
   Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737
   SALISBURY E, 2009, AM J PATHOL IN PRESS
   Salisbury E, 2008, EXP CELL RES, V314, P2266, DOI 10.1016/j.yexcr.2008.04.018
   Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704
   Schara Ulrike, 2006, Semin Pediatr Neurol, V13, P71
   Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407
   Timchenko LT, 1996, HUM MOL GENET, V5, P115, DOI 10.1093/hmg/5.1.115
   Timchenko LT, 1999, AM J HUM GENET, V64, P360, DOI 10.1086/302268
   Timchenko LT, 2006, J BIOL CHEM, V281, P32806, DOI 10.1074/jbc.M605701200
   Timchenko NA, 2005, J BIOL CHEM, V280, P20549, DOI 10.1074/jbc.M409563200
   Timchenko NA, 2004, J BIOL CHEM, V279, P13129, DOI 10.1074/jbc.M312923200
   Timchenko NA, 2001, J BIOL CHEM, V276, P7820, DOI 10.1074/jbc.M005960200
   Timchenko NA, 2001, MOL CELL BIOL, V21, P6927, DOI 10.1128/MCB.21.20.6927-6938.2001
   Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005
   Wang GL, 2008, J BIOL CHEM, V283, P26169, DOI 10.1074/jbc.M803544200
   Wang GL, 2008, J BIOL CHEM, V283, P26179, DOI 10.1074/jbc.M803545200
   Wang GL, 2007, J BIOL CHEM, V282, P1468, DOI 10.1074/jbc.M608226200
NR 28
TC 21
Z9 26
U1 0
U2 2
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1538-4101
EI 1551-4005
J9 CELL CYCLE
JI Cell Cycle
PD AUG 1
PY 2009
VL 8
IS 15
BP 2356
EP 2359
DI 10.4161/cc.8.15.9248
PG 4
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 477RH
UT WOS:000268535700018
PM 19571675
OA Bronze
DA 2024-02-19
ER

PT J
AU Jiang, T
   Zhan, F
   Rao, ZQ
   Pan, XX
   Zhong, WZ
   Sun, Y
   Wang, P
   Lu, L
   Zhou, HM
   Wang, XH
AF Jiang, Tao
   Zhan, Feng
   Rao, Zhuqing
   Pan, Xiongxiong
   Zhong, Weizhe
   Sun, Yu
   Wang, Ping
   Lu, Ling
   Zhou, Haoming
   Wang, Xuehao
TI Combined ischemic and rapamycin preconditioning alleviated liver
   ischemia and reperfusion injury by restoring autophagy in aged mice
SO INTERNATIONAL IMMUNOPHARMACOLOGY
LA English
DT Article
DE Liver ischemia and reperfusion injury; Ischemic preconditioning;
   Rapamycin preconditioning; Autophagy; Aging
ID ISCHEMIA/REPERFUSION INJURY; MOUSE-LIVER; OLDER; ACTIVATION; INDUCTION;
   PROTECTS; BENCH
AB Old livers are more damaged by hepatic ischemia and reperfusion (IR) injury than young livers. The aim of this study was to investigate the effects of ischemic and rapamycin preconditioning on IR injury in old livers. Young (8-week-old) and aged (60-week-old) mice were subjected to IR or a sham control procedure. The aged mice were randomly divided into six groups: IR (CON), IR with ischemic preconditioning (IPC), IR with rapamycin preconditioning (RAPA), IR with combined ischemic and rapamycin preconditioning (IPC + RAPA), IR with 3-methyladenine (3-MA), IR with combined ischemic and rapamycin preconditioning with 3-MA pretreatment (IPC + RAPA +3-MA). Liver injury was evaluated 6 h after reperfusion. Hepatocellular autophagy induction was also analyzed by western blotting. The results revealed that aged mice had aggravated liver IR injury as compared to young mice. In aged mice following IR, IPC + RAPA but not IPC or RAPA alleviated liver injury, as evidenced by lower levels of serum ALT, improved preservation of liver architecture with lower Suzuki scores, and decreased caspase-3 activity compared with CON. In addition, western blot analysis revealed increased LC3B II but decreased p62 protein expression levels in the IPC + RAPA group, indicating that autophagic flux was restored by combined ischemic and rapamycin preconditioning. Furthermore, autophagy inhibition by the inhibitor 3-MA abrogated the protective role in the IPC + RAPA group, while no significant effects were observed in the CON group. In conclusions, our results demonstrated that combined ischemic and rapamycin preconditioning protected old livers against IR injury, which was likely attributed to restored autophagy activation.
C1 [Jiang, Tao; Zhan, Feng; Zhong, Weizhe; Sun, Yu; Wang, Ping; Lu, Ling; Zhou, Haoming; Wang, Xuehao] Nanjing Med Univ, Affiliated Hosp 1, Hepatobiliary Liver Transplantat Ctr, Nanjing 210029, Jiangsu, Peoples R China.
   [Jiang, Tao] Nanjing Univ Chinese Med, Bayi Hosp, Dept Surg Oncol, Nanjing, Jiangsu, Peoples R China.
   [Rao, Zhuqing; Pan, Xiongxiong] Nanjing Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Nanjing, Jiangsu, Peoples R China.
C3 Nanjing Medical University; Nanjing University of Chinese Medicine;
   Nanjing Medical University
RP Zhou, HM; Wang, XH (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Hepatobiliary Liver Transplantat Ctr, Nanjing 210029, Jiangsu, Peoples R China.
EM hmzhou@njmu.edu.cn; wangxh@njmu.edu.cn
RI luo, yuan/JLS-6416-2023; LU, LU/JEZ-4760-2023; xiongxiong,
   pan/GPP-4500-2022; lu, lu/HII-7530-2022; zhou, haoming/HMV-1715-2023
OI xiongxiong, pan/0000-0002-2747-3241; Sun, Yu/0000-0003-3620-7268
FU National Natural Science Foundation of China [81600450, 81530048,
   81470901]; Six Talent Peaks Project in Jiangsu Province [2018-WSN-011];
   Jiangsu Science and Technology Association Young Science and Technology
   Talents Lifting Project [DG000D4007]; PAPD
FX This study was supported by the National Natural Science Foundation of
   China (No. 81600450, 81530048 and 81470901), Six Talent Peaks Project in
   Jiangsu Province (No. 2018-WSN-011), Jiangsu Science and Technology
   Association Young Science and Technology Talents Lifting Project (No.
   DG000D4007) and A Project Funded by the PAPD.
CR Chun SK, 2018, AGING CELL, V17, DOI 10.1111/acel.12761
   Clavien PA, 2003, ANN SURG, V238, P843, DOI 10.1097/01.sla.0000098620.27623.7d
   Czaja MJ, 2013, AUTOPHAGY, V9, P1131, DOI 10.4161/auto.25063
   Desai KK, 2008, LIVER TRANSPLANT, V14, P1569, DOI 10.1002/lt.21630
   Johnson SR, 2007, AM J TRANSPLANT, V7, P1003, DOI 10.1111/j.1600-6143.2006.01702.x
   Kan CY, 2018, TRANSPLANTATION, V102, P368, DOI 10.1097/TP.0000000000001999
   Lee SC, 2016, AM J TRANSPLANT, V16, P2042, DOI 10.1111/ajt.13729
   Lee WY, 2006, BIOCHEM BIOPH RES CO, V349, P1087, DOI 10.1016/j.bbrc.2006.08.140
   Limani P, 2016, ANN SURG, V264, P797, DOI 10.1097/SLA.0000000000001765
   Liu AD, 2014, CRIT CARE MED, V42, pE762, DOI 10.1097/CCM.0000000000000659
   Mariño G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735
   Mather M, 2000, BIOCHEM BIOPH RES CO, V273, P603, DOI 10.1006/bbrc.2000.2994
   Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006
   Okaya T, 2005, SHOCK, V24, P421, DOI 10.1097/01.shk.0000181282.14050.11
   Park Y, 2007, J SURG RES, V137, P96, DOI 10.1016/j.jss.2006.08.013
   Rao ZQ, 2017, ANESTH ANALG, V125, P1355, DOI 10.1213/ANE.0000000000002385
   Rautou PE, 2010, J HEPATOL, V53, P1123, DOI 10.1016/j.jhep.2010.07.006
   Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053
   Selzner M, 2007, LIVER TRANSPLANT, V13, P382, DOI 10.1002/lt.21100
   Selzner M, 2009, LIVER TRANSPLANT, V15, P1594, DOI 10.1002/lt.21864
   Tejima K, 2004, GASTROENTEROLOGY, V127, P1488, DOI 10.1053/j.gastro.2004.07.023
   van den Munckhof I, 2013, AM J PHYSIOL-HEART C, V304, pH1727, DOI 10.1152/ajpheart.00054.2013
   Wang JH, 2011, GASTROENTEROLOGY, V141, P2188, DOI 10.1053/j.gastro.2011.08.005
   Zhai Y, 2013, NAT REV GASTRO HEPAT, V10, P79, DOI 10.1038/nrgastro.2012.225
   Zhou HM, 2018, J HEPATOL, V69, P99, DOI 10.1016/j.jhep.2018.01.036
   Zhou HM, 2016, TRANSPLANTATION, V100, P365, DOI 10.1097/TP.0000000000001032
   Zhu JJ, 2015, TRANSPLANTATION, V99, P48, DOI 10.1097/TP.0000000000000476
   Zhu Q, 2018, CELL DEATH DIS, V9
NR 28
TC 17
Z9 18
U1 2
U2 9
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-5769
EI 1878-1705
J9 INT IMMUNOPHARMACOL
JI Int. Immunopharmacol.
PD SEP
PY 2019
VL 74
AR 105711
DI 10.1016/j.intimp.2019.105711
PG 6
WC Immunology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Pharmacology & Pharmacy
GA IY0OQ
UT WOS:000486093000072
PM 31302450
OA hybrid
DA 2024-02-19
ER

PT J
AU Brand, MD
AF Brand, MD
TI Uncoupling to survive? The role of mitochondrial inefficiency in ageing
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article; Proceedings Paper
CT Biological Aging - Euroconference on Molecular, Cellular and Tissue
   Gerontology
CY MAY 06-10, 2000
CL SPA, BELGIUM
SP Int Assoc Gerontol, UN Programme Ageing
DE mitochondria; proton conductance; proton leak; uncoupling; efficiency;
   protonmotive force; quinones; superoxide; reactive oxygen species
ID INNER MEMBRANE; LIVER-MITOCHONDRIA; HEART-MITOCHONDRIA; PROTON LEAK;
   HYDROGEN-PEROXIDE; METABOLIC-RATE; GENERATION; OXYGEN; RESPIRATION;
   PERMEABILITY
AB Mitochondria are incompletely coupled, and during oxidative phosphorylation some of the redox energy in substrates is lost as heat. Incomplete coupling is mostly due to a natural leak of protons across the mitochondrial inner membrane. In rat hepatocytes the futile cycle of proton pumping and proton leak is responsible for 20-25% of respiration; in perfused rat muscle the value is 35-50%. Mitochondrial proton cycling is estimated to cause 20-25% of basal metabolic rate in rats. Proton cycling is equally prominent in hepatocytes from several different mammalian and ectotherm species, so it may be a general pathway of ecologically significant energy loss in all aerobes. Because it occurs in ectotherms, thermogenesis cannot be its primary function. Instead, an attractive candidate fur the function of the universal and expensive energy-dissipating proton cycle is to decrease the production of superoxide and other reactive oxygen species (ROS). This could be important in helping to minimise oxidative damage to DNA and in slowing ageing. Mitochondria are the major source of cellular ROS, and increased mitochondrial proton conductance leads to oxidation of ubiquinone and decreased ROS production in isolated mitochondria. However, to date there is no direct evidence in cells or organisms that mitochondrial proton cycling lowers ROS production or oxidative damage or that it increases lifespan. (C) 2000 Elsevier Science Inc. All rights reserved.
C1 MRC, Dunn Human Nutr Unit, Cambridge CB2 2XY, England.
C3 UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC
   Human Nutrition Research
RP Brand, MD (corresponding author), MRC, Dunn Human Nutr Unit, Hills Rd, Cambridge CB2 2XY, England.
EM martin.brand@mrc-dunn.cam.ac.uk
RI Brand, Martin D/A-9423-2012
OI Brand, Martin D/0000-0003-4418-6153
CR ANDREYEV AY, 1989, EUR J BIOCHEM, V182, P585, DOI 10.1111/j.1432-1033.1989.tb14867.x
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707
   BOVERIS A, 1976, BIOCHEM J, V156, P435, DOI 10.1042/bj1560435
   BRAND MD, 1991, BIOCHEM J, V275, P81, DOI 10.1042/bj2750081
   BRAND MD, 1994, BBA-BIOENERGETICS, V1187, P132, DOI 10.1016/0005-2728(94)90099-X
   Brand MD, 1999, INT J OBESITY, V23, pS4, DOI 10.1038/sj.ijo.0800936
   BRAND MD, 1990, BIOCHIM BIOPHYS ACTA, V1018, P128, DOI 10.1016/0005-2728(90)90232-S
   BRAND MD, 2000, IN PRESS LIFE COLD
   Brookes PS, 1998, COMP BIOCHEM PHYS B, V119, P325, DOI 10.1016/S0305-0491(97)00357-X
   CASTRESANA J, 1995, TRENDS BIOCHEM SCI, V20, P443, DOI 10.1016/S0968-0004(00)89098-2
   Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908
   Herrero A, 1998, MECH AGEING DEV, V103, P133, DOI 10.1016/S0047-6374(98)00035-9
   Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9
   Liu SS, 1997, BIOSCIENCE REP, V17, P259, DOI 10.1023/A:1027328510931
   NICHOLLS DG, 1974, EUR J BIOCHEM, V50, P305, DOI 10.1111/j.1432-1033.1974.tb03899.x
   NOBES CD, 1990, J BIOL CHEM, V265, P12903
   NOHL H, 1994, ANN BIOL CLIN-PARIS, V52, P199
   Nohl H, 1996, FREE RADICAL BIO MED, V20, P207, DOI 10.1016/0891-5849(95)02038-1
   PORTER RK, 1993, NATURE, V362, P628, DOI 10.1038/362628a0
   PORTER RK, 1995, AM J PHYSIOL-REG I, V269, pR1213, DOI 10.1152/ajpregu.1995.269.5.R1213
   Ricquier D, 2000, BIOCHEM J, V345, P161, DOI 10.1042/0264-6021:3450161
   Rolfe DFS, 1997, BIOSCIENCE REP, V17, P9, DOI 10.1023/A:1027327015957
   Rolfe DFS, 1996, AM J PHYSIOL-CELL PH, V271, pC1380, DOI 10.1152/ajpcell.1996.271.4.C1380
   Rolfe DFS, 1999, AM J PHYSIOL-CELL PH, V276, pC692, DOI 10.1152/ajpcell.1999.276.3.C692
   Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488
   Skulachev VP, 1996, Q REV BIOPHYS, V29, P169, DOI 10.1017/S0033583500005795
   Stuart JA, 1999, J BIOENERG BIOMEMBR, V31, P517, DOI 10.1023/A:1005456725549
   TRUMPOWER BL, 1990, MICROBIOL REV, V54, P101, DOI 10.1128/MMBR.54.2.101-129.1990
   Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60
NR 30
TC 605
Z9 698
U1 1
U2 60
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD SEP
PY 2000
VL 35
IS 6-7
SI SI
BP 811
EP 820
DI 10.1016/S0531-5565(00)00135-2
PG 10
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Geriatrics & Gerontology
GA 367ZQ
UT WOS:000090093100018
PM 11053672
DA 2024-02-19
ER

PT J
AU Koyanagi, T
   Nakanishi, Y
   Murayama, N
   Yamaura, Y
   Ikeda, K
   Yano, K
   Uehara, S
   Utoh, M
   Kim, S
   Uno, Y
   Yamazaki, H
AF Koyanagi, Takashi
   Nakanishi, Yasuharu
   Murayama, Norie
   Yamaura, Yoshiyuki
   Ikeda, Kanami
   Yano, Koji
   Uehara, Shotaro
   Utoh, Masahiro
   Kim, Soonih
   Uno, Yasuhiro
   Yamazaki, Hiroshi
TI Age-related changes of hepatic clearances of cytochrome P450 probes,
   midazolam and <i>R-/S-</i>warfarin in combination with caffeine,
   omeprazole and metoprolol in cynomolgus monkeys using <i>in vitro-in
   vivo</i> correlation
SO XENOBIOTICA
LA English
DT Article
DE Cynomolgus monkey; hepatic clearance; in vitro-in vivo correlation;
   liver microsomes; P450 substrates
ID DRUG-METABOLISM; LIVER-MICROSOMES; PROTEIN-BINDING; PHARMACOKINETICS;
   ENZYMES; POLYMORPHISMS; VARIABILITY; PARAMETERS; DIAZEPAM; ANIMALS
AB 1. Pharmacokinetics of human cytochrome P450 probes (caffeine, racemic warfarin, omeprazole, metoprolol and midazolam) were investigated after single intravenous and oral administrations at doses of 0.20 and 1.0 mgkg(-1), respectively, in combination to three young (3-year-old) and three aged (16-year-old) cynomolgus monkeys.
   2. The plasma concentrations of caffeine and R-/S-warfarin decreased slowly in a monophasic manner, but those of omeprazole, metoprolol and midazolam decreased rapidly, in a similar manner to those as reported for pharmacokinetics in humans.
   3. The mean maximum concentrations of R- and S-warfarin (4.6 and 3.7 mu g/mL, respectively) in aged monkeys after oral administration were significantly higher than those in young monkeys (3.3 and 2.7 mu g/mL). The mean clearance (CL) values of midazolam in aged monkeys (9.5 mL/min/kg) were significantly lower than those in young monkeys (13 mL/min/kg).
   4. Individual intrinsic CL values for omeprazole (r = 0.29) and metoprolol (r = 0.30) of individual monkey livers were inversely correlated with their ages significantly (p < 0.05) in liver microsomes prepared from 55 cynomolgus monkeys.
   5. These results suggest that cynomolgus monkeys could be a good model for humans, especially with particular characteristics in reduced CLs of some human P450 substrates by aging.
C1 [Koyanagi, Takashi; Yamaura, Yoshiyuki; Yano, Koji; Kim, Soonih] Ono Pharmaceut Co Ltd, Shimamoto, Osaka, Japan.
   [Nakanishi, Yasuharu; Utoh, Masahiro; Uno, Yasuhiro] Shin Nippon Biomed Labs Ltd, Wakayama, Japan.
   [Murayama, Norie; Ikeda, Kanami; Uehara, Shotaro; Yamazaki, Hiroshi] Showa Pharmaceut Univ, Lab DMPK, Machida, Tokyo 1948543, Japan.
C3 Ono Pharmaceutical Co Ltd; Shin Nippon Biomedical Laboratories Ltd.;
   Showa Pharmaceutical University
RP Yamazaki, H (corresponding author), Showa Pharmaceut Univ, Lab DMPK, 3-3165 Higashi Tamagawa Gakuen, Machida, Tokyo 1948543, Japan.
EM hyamazak@ac.shoyaku.ac.jp
RI Yamazaki, Hiroshi/A-6081-2011
OI Yamazaki, Hiroshi/0000-0002-1068-4261; Uehara,
   Shotaro/0000-0002-1359-8828; Uno, Yasuhiro/0000-0001-9040-1681
FU Takeda Science Foundation
FX This work was supported, in part, by the Takeda Science Foundation (H.
   Y.).
CR Corsonello A, 2010, CURR MED CHEM, V17, P571, DOI 10.2174/092986710790416326
   DAVIES B, 1993, PHARMACEUT RES, V10, P1093, DOI 10.1023/A:1018943613122
   Gorski JC, 2003, CLIN PHARMACOL THER, V74, P275, DOI 10.1016/S0009-9236(03)00187-5
   GREENBLATT DJ, 1984, ANESTHESIOLOGY, V61, P27, DOI 10.1097/00000542-198461010-00006
   HARPER KW, 1985, BRIT J ANAESTH, V57, P866, DOI 10.1093/bja/57.9.866
   Hosoi Y, 2012, BIOCHEM PHARMACOL, V84, P1691, DOI 10.1016/j.bcp.2012.09.026
   HOUSTON JB, 1994, BIOCHEM PHARMACOL, V47, P1469
   Ishizawa Y, 2005, CLIN PHARMACOKINET, V44, P1179, DOI 10.2165/00003088-200544110-00005
   Iwasaki K, 2010, DRUG METAB PHARMACOK, V25, P388, DOI 10.2133/dmpk.DMPK-10-NT-022
   Jensen BP, 2012, BRIT J CLIN PHARMACO, V74, P797, DOI 10.1111/j.1365-2125.2012.04259.x
   Johnson JA, 1996, DRUG METAB DISPOS, V24, P350
   Klotz U, 2004, BASIC CLIN PHARMACOL, V95, P2, DOI 10.1111/j.1600-0773.2004.pto950102.x
   Klotz U, 2009, DRUG METAB REV, V41, P67, DOI 10.1080/03602530902722679
   Koyanagi T, 2014, XENOBIOTICA, V44, P893, DOI 10.3109/00498254.2014.903532
   LARSSON M, 1984, EUR J CLIN PHARMACOL, V27, P217, DOI 10.1007/BF00544048
   McLachlan AJ, 2012, J GERONTOL A-BIOL, V67, P175, DOI 10.1093/gerona/glr118
   Mogi M, 2012, J TOXICOL SCI, V37, P1157, DOI 10.2131/jts.37.1157
   Naritomi Y, 2001, DRUG METAB DISPOS, V29, P1316
   Obach RS, 2008, DRUG METAB DISPOS, V36, P1385, DOI 10.1124/dmd.108.020479
   Parkinson A, 2004, TOXICOL APPL PHARM, V199, P193, DOI 10.1016/j.taap.2004.01.010
   Platten HP, 1998, CLIN PHARMACOL THER, V63, P552, DOI 10.1016/S0009-9236(98)90106-0
   Rendic S, 2012, CHEM RES TOXICOL, V25, P1316, DOI 10.1021/tx300132k
   Takahashi H, 1998, PHARMACOGENETICS, V8, P365, DOI 10.1097/00008571-199810000-00001
   Turpault S, 2009, BRIT J CLIN PHARMACO, V68, P928, DOI 10.1111/j.1365-2125.2009.03548.x
   Uehara S, 2011, J PHARMACOL EXP THER, V339, P654, DOI 10.1124/jpet.111.185009
   Uno Y, 2015, DRUG METAB PHARMACOK, V30, P130, DOI 10.1016/j.dmpk.2014.10.002
   Uno Y, 2014, BIOCHEM PHARMACOL, V91, P242, DOI 10.1016/j.bcp.2014.07.004
   Uno Y, 2014, DRUG METAB DISPOS, V42, P1407, DOI 10.1124/dmd.114.059220
   Uno Y, 2010, DRUG METAB DISPOS, V38, P1486, DOI 10.1124/dmd.110.033274
   Utoh M, 2013, XENOBIOTICA, V43, P1037, DOI 10.3109/00498254.2013.793874
   VIANI A, 1992, BRIT J CLIN PHARMACO, V33, P299, DOI 10.1111/j.1365-2125.1992.tb04039.x
NR 31
TC 20
Z9 20
U1 0
U2 8
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0049-8254
EI 1366-5928
J9 XENOBIOTICA
JI Xenobiotica
PD APR
PY 2015
VL 45
IS 4
BP 312
EP 321
DI 10.3109/00498254.2014.979271
PG 10
WC Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Toxicology
GA CE5JQ
UT WOS:000351869200004
PM 25364857
DA 2024-02-19
ER

PT J
AU Cuervo, AM
   Huffman, DM
   Vijg, J
   Milman, S
   Singh, R
   Barzilai, N
AF Cuervo, Ana Maria
   Huffman, Derek M.
   Vijg, Jan
   Milman, Sofiya
   Singh, Rajat
   Barzilai, Nir
TI Einstein-Nathan Shock Center: translating the hallmarks of aging to
   extend human health span
SO GEROSCIENCE
LA English
DT Article; Early Access
DE Health span; Metabolism; Parabiosis; Proteostasis; Autophagy;
   Proteomics; Genomics
ID HEPATIC INSULIN-RESISTANCE; BODY-COMPOSITION; DIETARY RESTRICTION;
   COGNITIVE DEFICITS; FAT DISTRIBUTION; FOOD-INTAKE; AUTOPHAGY; LEPTIN;
   PARABIOSIS; RATS
AB The overarching mission of the Einstein-Nathan Shock Center (E-NSC) is to make scientific discoveries in geroscience, leveraging on the expertise in our center in 6 out of the 7 pillars of aging, and to translate their effects towards drug discovery. The relevance of this basic biology of aging discoveries to humans will be confirmed through the unique gero-human resource at E-NSC. This is achieved through services provided by E-NSC, connectivity among its members, attracting worldwide investigators, and providing them with the opportunities to become future leaders. The two central components of the E-NSC are (a) cutting-edge research programs and (b) unique E-NSC research support cores. E-NSC scientists lead NIH-supported cutting-edge research programs that integrate key hallmarks of aging including proteostasis/autophagy, metabolism/inflammaging, genetic/epigenetics, stem cells/regeneration, and translational aging/longevity. Since the inception of the E-NSC, the well-integrated, collaborative, and innovative nature of the multiple supporting state-of-the-art E-NSC research cores form the bedrock of research success at the E-NSC. The three state-of-the-art E-NSC research cores, (i) Proteostasis of Aging Core (PAC), (ii) the Health Span Core (HSC), and (iii) the Human Multi-Omics Core (HMOC), have allowed impressive expansion of translational biological research programs. Expansion was facilitated through the wealth of data coming from genomics/proteomics and metabolomic analysis on human longevity studies, due to access to a variety of biological samples from elderly subjects in clinical trials with aging-targeting drugs, and new drug design services via the PAC to target the hallmarks of aging.
C1 [Cuervo, Ana Maria; Huffman, Derek M.; Milman, Sofiya; Singh, Rajat; Barzilai, Nir] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA.
   [Cuervo, Ana Maria; Singh, Rajat] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA.
   [Cuervo, Ana Maria; Huffman, Derek M.; Vijg, Jan; Milman, Sofiya; Singh, Rajat; Barzilai, Nir] Albert Einstein Coll Med, Inst Aging Res, Bronx, NY 10467 USA.
   [Cuervo, Ana Maria; Huffman, Derek M.; Vijg, Jan; Milman, Sofiya; Singh, Rajat; Barzilai, Nir] Paul F Glenn Ctr Biol Human Aging, Einstein Nathan Shock Ctr Excellence Biol Aging, Bronx, NY USA.
   [Huffman, Derek M.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA.
   [Vijg, Jan; Barzilai, Nir] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA.
C3 Yeshiva University; Albert Einstein College of Medicine; Yeshiva
   University; Albert Einstein College of Medicine; Yeshiva University;
   Albert Einstein College of Medicine; Yeshiva University; Albert Einstein
   College of Medicine; Yeshiva University; Albert Einstein College of
   Medicine
RP Barzilai, N (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA.
EM Nir.Barzilai@einsteinmed.org
RI SINGH, RAJAT/JPK-6888-2023
OI SINGH, RAJAT/0000-0001-9389-8574; Huffman, Derek/0000-0001-9520-3449;
   Barzilai, Nir/0000-0002-7787-6268; vijg, jan/0000-0002-8457-9595;
   Milman, Sofiya/0000-0001-9247-0082; Cuervo, Ana
   Maria/0000-0002-0771-700X
FU NIH NIA [P30AG038072]
FX The Einstein-Nathan Shock Center of Excellence for the basic Biology of
   Aging is supported by the NIH NIA grant P30AG038072.
CR Aja S, 2001, AM J PHYSIOL-REG I, V281, pR1862, DOI 10.1152/ajpregu.2001.281.6.R1862
   AUTERI JS, 1983, J CELL PHYSIOL, V115, P167, DOI 10.1002/jcp.1041150210
   BARZILAI N, 1995, AM J PHYSIOL-ENDOC M, V269, pE591, DOI 10.1152/ajpendo.1995.269.3.E591
   Barzilai N, 2003, JAMA-J AM MED ASSOC, V290, P2030, DOI 10.1001/jama.290.15.2030
   Barzilai N, 1997, J CLIN INVEST, V100, P3105, DOI 10.1172/JCI119865
   Barzilai N, 1996, AM J PHYSIOL-ENDOC M, V270, pE930, DOI 10.1152/ajpendo.1996.270.6.E930
   Barzilai N, 1998, J CLIN INVEST, V101, P1353, DOI 10.1172/JCI485
   Bejarano E, 2018, AGING CELL, V17, DOI 10.1111/acel.12777
   Bernier M, 2020, CELL METAB, V32, P203, DOI 10.1016/j.cmet.2020.04.019
   Bi S, 2001, AM J PHYSIOL-REG I, V281, pR254, DOI 10.1152/ajpregu.2001.281.1.R254
   Blouet C, 2008, CELL METAB, V8, P459, DOI 10.1016/j.cmet.2008.10.004
   Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090
   Caballero B, 2018, AGING CELL, V17, DOI 10.1111/acel.12692
   Carey M, 2020, DIABETES, V69, P1140, DOI 10.2337/db19-1256
   Cases JA, 2000, INT J OBESITY, V24, pS63, DOI 10.1038/sj.ijo.0801508
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Conboy MJ, 2013, AGING CELL, V12, P525, DOI 10.1111/acel.12065
   Dai MX, 2010, MICROBES INFECT, V12, P1198, DOI 10.1016/j.micinf.2010.08.006
   de Wall EV, 2008, ENDOCRINOLOGY, V149, P1773, DOI 10.1210/en.2007-1132
   Einstein FH, 2008, FASEB J, V22, P3450, DOI 10.1096/fj.08-109041
   Esteban-Martínez L, 2017, EMBO J, V36, P1688, DOI 10.15252/embj.201695916
   Gabriely I, 2002, DIABETES, V51, P1016, DOI 10.2337/diabetes.51.4.1016
   Gabriely I, 2002, DIABETES, V51, P2951, DOI 10.2337/diabetes.51.10.2951
   Gong ZW, 2018, J CELL BIOL, V217, P635, DOI 10.1083/jcb.201606095
   Gontier G, 2018, CELL REP, V22, P1974, DOI 10.1016/j.celrep.2018.02.001
   Greussing R, 2012, JOVE-J VIS EXP, DOI 10.3791/3327
   Gubbi S, 2017, AM J CARDIOL, V120, P2170, DOI 10.1016/j.amjcard.2017.08.040
   Gulinello M, 2008, BEHAV BRAIN RES, V193, P315, DOI 10.1016/j.bbr.2008.06.016
   Gulinello M, 2010, MICROBES INFECT, V12, P528, DOI 10.1016/j.micinf.2010.03.009
   Gupta G, 2000, AM J PHYSIOL-ENDOC M, V278, pE985, DOI 10.1152/ajpendo.2000.278.6.E985
   Gupta G, 2000, AM J PHYSIOL-REG I, V278, pR111, DOI 10.1152/ajpregu.2000.278.1.R111
   Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024
   Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724
   HARRIS RBS, 1984, AM J PHYSIOL, V247, pR380, DOI 10.1152/ajpregu.1984.247.2.R380
   HARRIS RBS, 1987, INT J OBESITY, V11, P275
   Harris RBS, 1999, ENDOCRINOLOGY, V140, P138, DOI 10.1210/en.140.1.138
   Harris RBS, 2013, BBA-MOL BASIS DIS, V1832, P1449, DOI 10.1016/j.bbadis.2013.02.021
   Hars ES, 2007, AUTOPHAGY, V3, P93, DOI 10.4161/auto.3636
   Hernandez I, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat3005
   Huang Q, 2018, J GERONTOL A-BIOL, V73, P421, DOI 10.1093/gerona/glx183
   Huffman DM, 2008, AM J PHYSIOL-REG I, V294, pR1618, DOI 10.1152/ajpregu.00890.2007
   Huffman DM, 2016, AGING CELL, V15, P181, DOI 10.1111/acel.12415
   Jia KL, 2007, AUTOPHAGY, V3, P597, DOI 10.4161/auto.4989
   Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013
   Kaushik S, 2015, NAT MED, V21, P1406, DOI 10.1038/nm.4001
   Kaushik S, 2011, CELL METAB, V14, P173, DOI 10.1016/j.cmet.2011.06.008
   Kaushik S, 2009, METHOD ENZYMOL, V452, P297, DOI 10.1016/S0076-6879(08)03619-7
   Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021
   Kiss T, 2020, GEROSCIENCE, V42, P727, DOI 10.1007/s11357-020-00180-6
   Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496
   Koga H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1393
   Kulkarni AS, 2018, AGING CELL, V17, DOI 10.1111/acel.12723
   Ladiges W, 2019, PATHOBIOL AGING AGE, V9, DOI 10.1080/20010001.2019.1593786
   Ladiges W, 2017, J GERONTOL A-BIOL, V72, P760, DOI 10.1093/gerona/glx019
   Ladiges W, 2017, PATHOBIOL AGING AGE, V7, DOI [10.1080/20010001.2017.304005, 10.1080/20010001.2017.1304005]
   Lehallier B, 2019, NAT MED, V25, P1843, DOI 10.1038/s41591-019-0673-2
   Lei CB, 2020, AGING-US, V12, P12285, DOI 10.18632/aging.103421
   Li Y, 2015, PHARMACOL BIOCHEM BE, V135, P70, DOI 10.1016/j.pbb.2015.05.013
   Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lusk G, 1976, NUTR BULL, V3, P401
   Ma XH, 2002, J GERONTOL A-BIOL, V57, pB225, DOI 10.1093/gerona/57.6.B225
   Mann SN, 2020, ELIFE, V9, DOI 10.7554/eLife.59616
   Mao K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04805-5
   Meléndez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782
   Milman S, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a025098
   Morrison EJ, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061337
   Muzumdar RH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006334
   Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574
   Ozek C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35716-6
   Pajares M, 2018, AUTOPHAGY, V14, P1310, DOI 10.1080/15548627.2018.1474992
   Pollack RM, 2017, J GERONTOL A-BIOL, V72, P1703, DOI 10.1093/gerona/glx041
   Pyo JO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3300
   Quipildor GEF, 2019, GEROSCIENCE, V41, P185, DOI 10.1007/s11357-019-00065-3
   Raz Y, 2017, J GERONTOL A-BIOL, V72, P1201, DOI 10.1093/gerona/glx020
   Rebo J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13363
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Sathyan S, 2020, AGING CELL, V19, DOI 10.1111/acel.13250
   Schneider JL, 2014, NAT REV GASTRO HEPAT, V11, P187, DOI 10.1038/nrgastro.2013.211
   Schwartz GJ, 2002, ENDOCRINOLOGY, V143, P3779, DOI 10.1210/en.2002-220352
   Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269
   Smith LK, 2015, NAT MED, V21, P932, DOI 10.1038/nm.3898
   Snyder JM, 2019, GEROSCIENCE, V41, P455, DOI 10.1007/s11357-019-00088-w
   Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697
   Tomé WA, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150762
   Vijayanathan V, 2011, BEHAV BRAIN RES, V225, P491, DOI 10.1016/j.bbr.2011.08.006
   Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357
   Walters RO, 2018, CELL REP, V25, P663, DOI 10.1016/j.celrep.2018.09.065
   Wen J, 2018, NEUROPHARMACOLOGY, V139, P76, DOI 10.1016/j.neuropharm.2018.07.007
   Whitehead JC, 2014, J GERONTOL A-BIOL, V69, P621, DOI 10.1093/gerona/glt136
   Yousefzadeh MJ, 2020, GEROSCIENCE, V42, P951, DOI 10.1007/s11357-020-00185-1
   Zhang JZ, 2017, J BIOL CHEM, V292, P10328, DOI 10.1074/jbc.M116.764076
   Zhang WB, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9061368
   Zhang ZD, 2020, NAT METAB, V2, P663, DOI 10.1038/s42255-020-0247-0
   Zizola CF, 2008, AM J PHYSIOL-ENDOC M, V295, pE1358, DOI 10.1152/ajpendo.90464.2008
NR 95
TC 2
Z9 2
U1 0
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 2509-2715
EI 2509-2723
J9 GEROSCIENCE
JI GeroScience
PD 2021 OCT
PY 2021
VL 43
IS 5
SI SI
BP 2167
EP 2182
DI 10.1007/s11357-021-00428-9
EA AUG 2021
PG 16
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA WZ5BL
UT WOS:000691639100002
PM 34463901
OA Green Published
DA 2024-02-19
ER

PT J
AU DEHAAN, JB
   CRISTIANO, F
   IANNELLO, RC
   KOLA, I
AF DEHAAN, JB
   CRISTIANO, F
   IANNELLO, RC
   KOLA, I
TI CU/ZN-SUPEROXIDE DISMUTASE AND GLUTATHIONE-PEROXIDASE DURING AGING
SO BIOCHEMISTRY AND MOLECULAR BIOLOGY INTERNATIONAL
LA English
DT Article
ID SYNDROME FETAL BRAIN; DOWNS-SYNDROME; NEUROMUSCULAR-JUNCTIONS; OXYGEN
   RADICALS; PROTEIN; INVITRO; DAMAGE; GENE; MICE
AB During oxidative metabolism harmful reactive oxygen species (ROS) are generated. These species are neutralized by antioxidant enzymes. Firstly, superoxide dismutase (Sod) converts superoxide radicals (O2(-)) to hydrogen peroxide (H2O2). Thereafter catalase (Cat) and glutathione peroxidase (Gpx) independently convert this to water. An imbalance in the ratio of Sod to Gpx and Cat results in the accumulation of H2O2 which may participate in the Fenton reaction, resulting in the formation of noxious hydroxyl radicals. These ROS are highly reactive and cause damage to macromolecules such as DNA, protein and lipids. We propose that it is the balance in the activity of the Sod to Gpx plus Cat ratio (Sod/(Gpx plus Cat)) that is an important determinant of cellular aging. This is based on our observation that an altered Cu/Zn-superoxide dismutase (Sod1)/(Gpx1 plus Cat) ratio exists in the brain of aging mice and that this correlates with increased lipid damage. Conversely, aging liver and kidney have an unaffected Sod1/(Gpx1 plus Cat) ratio and lipid damage is not increased with aging. We also examine the Sod1 to Gpx1 ratio in Down syndrome tissue and show that all organs have an altered ratio. This may contribute to the premature aging seen in these individuals. We show that binding of a p50/p65 complex to an NF-KB consensus sequence is enhanced by H2O2 treatment in NIH3T3 cells. Thus an altered Sod1/(Gpx1 plus Cat) ratio may also affect gene expression by altering the binding and/or availability of transcription factors to DNA.
RP DEHAAN, JB (corresponding author), MONASH UNIV,CTR EARLY HUMAN DEV,INST REPROD & DEV,CLAYTON,VIC 3168,AUSTRALIA.
RI de Haan, Judy B/E-8778-2010; Kola, Ismail/C-5254-2013
OI de Haan, Judy B./0000-0002-2749-7833
CR ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682
   AMSTAD P, 1994, J BIOL CHEM, V269, P1606
   AVRAHAM KB, 1991, J NEUROCYTOL, V20, P208, DOI 10.1007/BF01186993
   BRAWN K, 1981, ARCH BIOCHEM BIOPHYS, V206, P414, DOI 10.1016/0003-9861(81)90108-9
   BROOKSBANK BWL, 1985, J NEUROCHEM, V44, P869, DOI 10.1111/j.1471-4159.1985.tb12896.x
   BROOKSBANK BWL, 1984, DEV BRAIN RES, V16, P37, DOI 10.1016/0165-3806(84)90060-9
   BROOKSBANK BWL, 1989, MOL CHEM NEUROPATHOL, V11, P157, DOI 10.1007/BF03160049
   CEBALLOS I, 1991, FREE RADICAL RES COM, V12-3, P581
   CHADA S, 1990, GENOMICS, V6, P268, DOI 10.1016/0888-7543(90)90566-D
   DAVIES KJA, 1987, J BIOL CHEM, V262, P9895
   DEHAAN JB, 1994, PEDIATR RES, V35, P188, DOI 10.1203/00006450-199402000-00013
   DEHAAN JB, 1992, MOL BRAIN RES, V13, P179, DOI 10.1016/0169-328X(92)90025-7
   FAHIM MA, 1982, J NEUROCYTOL, V11, P641, DOI 10.1007/BF01262429
   Halliwell B, 1985, FREE RADICALS BIOL M, DOI 10.1016/0748-5514(85)90140-0
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HAYFLICK L, 1985, EXP GERONTOL, V20, P145, DOI 10.1016/0531-5565(85)90032-4
   IANELLO RC, 1993, J BIOL CHEM, V268, P22581
   IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821
   KOLA I, 1994, ADV HUMAN REPRODUCTI, P309
   PERIERASMITH OM, 1988, P NATL ACAD SCI USA, V85, P6042
   SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x
   SOHAL RS, 1990, EXP GERONTOL, V25, P499, DOI 10.1016/0531-5565(90)90017-V
   TAN YH, 1973, J EXP MED, V137, P317, DOI 10.1084/jem.137.2.317
   WANG CY, 1994, MOL CELL BIOL, V14, P1153, DOI 10.1128/MCB.14.2.1153
   WIEACKER P, 1980, ANN GENET-PARIS, V23, P73
   YAROM R, 1988, J NEUROL SCI, V88, P41, DOI 10.1016/0022-510X(88)90204-3
NR 26
TC 110
Z9 119
U1 0
U2 4
PU ACADEMIC PRESS AUST
PI MARRICKVILLE
PA LOCKED BAG 16, MARRICKVILLE NSW 2204, AUSTRALIA
SN 1039-9712
J9 BIOCHEM MOL BIOL INT
JI Biochem. Mol. Biol. Int.
PD MAY
PY 1995
VL 35
IS 6
BP 1281
EP 1297
PG 17
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA TB591
UT WOS:A1995TB59100016
PM 7492966
DA 2024-02-19
ER

PT J
AU MOORADIAN, AD
   DEEBAJ, L
   WONG, NCW
AF MOORADIAN, AD
   DEEBAJ, L
   WONG, NCW
TI AGE-RELATED ALTERATIONS IN THE RESPONSE OF HEPATIC LIPOGENIC ENZYMES TO
   ALTERED THYROID STATES IN THE RAT
SO JOURNAL OF ENDOCRINOLOGY
LA English
DT Article
ID RIBONUCLEIC-ACID; MESSENGER-RNA; HORMONE; TRIIODOTHYRONINE;
   DIFFERENTIATION; TISSUE; LIVER
AB To determine the age-related alterations in tissue-responsiveness to thyroid hormone action, the mRNA levels and the enzyme activities of hepatic cytosolic malate dehydrogenase (ME) and mitochondrial alpha-glycerophosphate dehydrogenase (alpha-GPD) were determined in groups of euthyroid, hypothyroid and hyperthyroid male Fischer 344 rats at various ages.  The basal alpha-GPD level (change in optical density/min per mg) in 2-month-old rats (0.163 +/- 0.003) (S.E.M.) was significantly (P < 0.001) higher than that in 6-month-old and 26-month-old rats (0.116 +/- 0.012 and 0.098 +/- 0.013 respectively).  The basal ME activity (mU/mg) was significantly (P < 0.001) reduced in aged rats (9.2 +/- 0.89) compared with younger rats (54.2 +/- 3.4 and 17.1 +/- 2.3 for 2-month-old and 6-month-old rats respectively).  The response of ME to tri-iodothyronine (T3) in aged rats compared with young rats was reduced approximately 50%.  This age-related reduction in ME response to T3 could not be attributed to reduced food intake with ageing.  Northern blot analysis showed that ME mRNA levels in hyperthyroid aged rats were 50% of those of young hyperthyroid rats.  There were no significant differences in either basal or T3-stimulated alpha-GPD mRNA levels.  The proportional reduction in steady-state ME mRNA levels and ME activity in aged rats indicates that this age-related change is modulated at a pretranslational level.
C1 UNIV CALGARY,DEPT ENDOCRINOL,CALGARY T2N 4N1,ALBERTA,CANADA.
C3 University of Calgary
RP MOORADIAN, AD (corresponding author), UNIV ARIZONA,DIV RESTORAT MED,1821 E ELM ST,TUCSON,AZ 85719, USA.
RI Mooradian, Arshag/IAP-5640-2023
CR BAGCHI S, 1987, J BIOL CHEM, V262, P1558
   BULOS B, 1971, J GERONTOL, V26, P13, DOI 10.1093/geronj/26.1.13
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   COLE GM, 1982, HORMONES DEV AGING, P477
   DENCKLA WD, 1974, J CLIN INVEST, V43, P572
   DOBSON DE, 1987, J BIOL CHEM, V262, P1804
   DOZIN B, 1985, BIOCHEMISTRY-US, V24, P5581, DOI 10.1021/bi00341a044
   FORCIEA MA, 1981, J CLIN INVEST, V67, P1729
   GAMBERT SR, 1981, ENDOCRINOLOGY, V108, P27, DOI 10.1210/endo-108-1-27
   GRAD B, 1969, J GERONTOL, V23, P5
   Hsu RY., 1969, Methods in Enzymology, V13, P230, DOI DOI 10.1016/0076-6879(69)13042-6
   KAISER FE, 1980, METABOLISM, V29, P767, DOI 10.1016/0026-0495(80)90201-2
   KAISER FE, 1983, METABOLISM, V32, P838, DOI 10.1016/0026-0495(83)90116-6
   KATZ MS, 1987, BIOCH BIOPHYSICAL RE, V147, P726
   KINLAW WB, 1984, J CLIN INVEST, V74, P1934, DOI 10.1172/JCI111613
   LEE YP, 1965, J BIOL CHEM, V240, P1427
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Maniatis T., 1982, MOL CLONING
   MOORADIAN AD, 1990, J GERONTOL, V45, pB24, DOI 10.1093/geronj/45.1.B24
   MOORADIAN AD, 1989, HORM METAB RES, V21, P638, DOI 10.1055/s-2007-1009307
   MOORADIAN AD, 1990, EXP GERONTOL, V25, P29, DOI 10.1016/0531-5565(90)90006-N
   MOORADIAN AD, 1990, IN PRESS BIOCH BIOPH
   MOORADIAN AD, 1987, MECHANISMS AGEING DE, V61, P189
   MOORADIAN AD, 1988, DISEASE MONTH, V34, P398
   OCHOA S, 1955, METHOD ENZYMOL, V1, P739, DOI 10.1016/0076-6879(55)01129-4
   OPPENHEIMER JH, 1987, ENDOCR REV, V8, P288, DOI 10.1210/edrv-8-3-288
   SCARPACE PJ, 1981, ENDOCRINOLOGY, V108, P1276, DOI 10.1210/endo-108-4-1276
   SCHAPIRO S, 1977, ENDOCRINOLOGY, V79, P1075
   SCHWARTZ HL, 1979, ENDOCRINOLOGY, V105, P41, DOI 10.1210/endo-105-1-41
   SEGAL J, 1986, J ENDOCRINOL, V110, P511, DOI 10.1677/joe.0.1100511
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   TSUJIMOTO G, 1987, AM J PHYSIOL, V252, pH513, DOI 10.1152/ajpheart.1987.252.3.H513
NR 32
TC 25
Z9 25
U1 0
U2 1
PU J ENDOCRINOLOGY LTD
PI BRISTOL
PA 17/18 THE COURTYARD, WOODLANDS, ALMONDSBURY, BRISTOL, ENGLAND BS12 4NQ
SN 0022-0795
J9 J ENDOCRINOL
JI J. Endocrinol.
PD JAN
PY 1991
VL 128
IS 1
BP 79
EP 84
DI 10.1677/joe.0.1280079
PG 6
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA EU021
UT WOS:A1991EU02100010
PM 1999678
DA 2024-02-19
ER

PT J
AU Peters, EC
   Safayan, L
   Marx, TJ
   Ngu, E
   Vasileva, A
   Zappia, I
   Powell, WH
   Duca, FA
   Stern, JH
AF Peters, Emily C.
   Safayan, Luke
   Marx, Tyler J.
   Ngu, Emily
   Vasileva, Anastasiia
   Zappia, India
   Powell, William H.
   Duca, Frank A.
   Stern, Jennifer H.
TI Metabolic and physical function are improved with lifelong 15% calorie
   restriction in aging male mice
SO BIOGERONTOLOGY
LA English
DT Article; Early Access
DE Calorie restriction; Liver fat; Glucose homeostasis; Insulin
   sensitivity; Healthspan
ID FATTY LIVER-DISEASE; IMPAIRED FASTING GLUCOSE; INSULIN SENSITIVITY;
   DIETARY RESTRICTION; AGE; RESISTANCE; ADIPOSITY; TOLERANCE; PROTECTS;
   OBESITY
AB Chronic calorie restriction (CR) results in lengthened lifespan and reduced disease risk. Many previous studies have implemented 30-40% calorie restriction to investigate these benefits. The goal of our study was to investigate the effects of calorie restriction, beginning at 4 months of age, on metabolic and physical changes induced by aging. Male C57BL/6NCrl calorie restricted and ad libitum fed control mice were obtained from the National Institute on Aging (NIA) and studied at 10, 18, 26, and 28 months of age to better understand the metabolic changes that occur in response to CR in middle age and advanced age. Food intake was measured in ad libitum fed controls to assess the true degree of CR (15%) in these mice. We found that 15% CR decreased body mass and liver triglyceride content, improved oral glucose clearance, and increased all limb grip strength in 10- and 18-month-old mice. Glucose clearance in ad libitum fed 26- and 28-month-old mice is enhanced relative to younger mice but was not further improved by CR. CR decreased basal insulin concentrations in all age groups and improved insulin sensitivity and rotarod time to fall in 28-month-old mice. The results of our study demonstrate that even a modest reduction (15%) in caloric intake may improve metabolic and physical health. Thus, moderate calorie restriction may be a dietary intervention to promote healthy aging with improved likelihood for adherence in human populations.
C1 [Peters, Emily C.; Safayan, Luke; Powell, William H.; Stern, Jennifer H.] Univ Arizona, Dept Physiol, Coll Med, Tucson, AZ 85724 USA.
   [Marx, Tyler J.; Ngu, Emily; Vasileva, Anastasiia; Zappia, India; Stern, Jennifer H.] Univ Arizona, Div Endocrinol, Coll Med, Tucson, AZ 85724 USA.
   [Duca, Frank A.] Univ Arizona, Coll Agr & Life Sci, Sch Anim & Comparat Biomed Sci, Tucson, AZ 85721 USA.
   [Duca, Frank A.; Stern, Jennifer H.] Univ Arizona, BIO5 Inst, Tucson, AZ 85724 USA.
C3 University of Arizona; University of Arizona; University of Arizona;
   University of Arizona
RP Stern, JH (corresponding author), Univ Arizona, Dept Physiol, Coll Med, Tucson, AZ 85724 USA.
EM jhstern@email.arizona.edu
FU National Institutes of Health [R00-AG055649]; University of Arizona
   Healthy Aging Seed Grant
FX This work was supported by grants from the National Institutes of Health
   grant R00-AG055649 [to J.H.S.] and from the University of Arizona
   Healthy Aging Seed Grant [to J.H.S.].
CR Anderson RM, 2009, TOXICOL PATHOL, V37, P47, DOI 10.1177/0192623308329476
   Bertolotti M, 2014, WORLD J GASTROENTERO, V20, P14185, DOI 10.3748/wjg.v20.i39.14185
   Borel AL, 2015, INT J OBESITY, V39, P495, DOI 10.1038/ijo.2014.163
   Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009
   CDC, 2017, NAT DIAB STAT REP 20
   CDC, 2014, NAT DIAB STAT REP ES
   Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296
   Das SK, 2017, AM J CLIN NUTR, V105, P913, DOI 10.3945/ajcn.116.137232
   Derby CA, 2009, AM J EPIDEMIOL, V169, P1352, DOI 10.1093/aje/kwp043
   Ehrhardt N, 2019, OBESITY, V27, P434, DOI 10.1002/oby.22418
   Fabbrini E, 2009, P NATL ACAD SCI USA, V106, P15430, DOI 10.1073/pnas.0904944106
   Fan Amy Z, 2007, Atherosclerosis, V195, pe191, DOI 10.1016/j.atherosclerosis.2007.03.045
   Flurkey K., 2007, The Mouse in Biomedical Research, P637
   Fontana L, 2013, HEPATOLOGY, V57, P995, DOI 10.1002/hep.26099
   Frith J, 2009, GERONTOLOGY, V55, P607, DOI 10.1159/000235677
   Fritschi C, 2017, J DIABETES COMPLICAT, V31, P347, DOI 10.1016/j.jdiacomp.2016.06.022
   Frohnert BI, 2013, DIABETES, V62, P3163, DOI 10.2337/db12-1122
   Garcia D, 2019, CELL REP, V26, P192, DOI 10.1016/j.celrep.2018.12.036
   Geisler CE, 2019, AM J PHYSIOL-GASTR L, V316, pG623, DOI 10.1152/ajpgi.00415.2017
   Gresl TA, 2003, AM J PHYSIOL-REG I, V285, pR1340, DOI 10.1152/ajpregu.00651.2002
   Gutiérrez-Casado E, 2019, J GERONTOL A-BIOL, V74, P760, DOI 10.1093/gerona/gly161
   Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518
   Justice JN, 2014, AGE, V36, P583, DOI 10.1007/s11357-013-9589-9
   Karunadharma PP, 2015, AGING CELL, V14, P547, DOI 10.1111/acel.12317
   Kim CW, 2017, CELL METAB, V26, P394, DOI 10.1016/j.cmet.2017.07.009
   Kraus WE, 2019, LANCET DIABETES ENDO, V7, P673, DOI 10.1016/S2213-8587(19)30151-2
   Krebs S, 2009, ANAL BIOCHEM, V387, P136, DOI 10.1016/j.ab.2008.12.020
   Kuhla A, 2014, J GERONTOL A-BIOL, V69, P915, DOI 10.1093/gerona/glt160
   Lally JSV, 2019, CELL METAB, V29, P174, DOI 10.1016/j.cmet.2018.08.020
   Li WD, 2015, WORLD J GASTROENTERO, V21, P9607, DOI 10.3748/wjg.v21.i32.9607
   LINDHEIM SR, 1994, J SOC GYNECOL INVEST, V1, P150, DOI 10.1177/107155769400100210
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lomonaco R, 2016, DIABETES CARE, V39, P632, DOI 10.2337/dc15-1876
   Mantovani A, 2018, DIABETES CARE, V41, P372, DOI 10.2337/dc17-1902
   Mezhnina V, 2020, AGING CELL, V19, DOI 10.1111/acel.13266
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Oh YS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159689
   Orenduff MC, 2022, EXP GERONTOL, V165, DOI 10.1016/j.exger.2022.111841
   Penninx BWJH, 2009, J GERONTOL A-BIOL, V64, P96, DOI 10.1093/gerona/gln005
   Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4
   Romero-Aleshire MJ, 2009, AM J PHYSIOL-REG I, V297, pR587, DOI 10.1152/ajpregu.90762.2008
   Rossi R, 2004, DIABETES CARE, V27, P645, DOI 10.2337/diacare.27.3.645
   Rusli F, 2015, MOL NUTR FOOD RES, V59, P533, DOI 10.1002/mnfr.201400621
   Ryan AS, 2002, DIABETES CARE, V25, P127, DOI 10.2337/diacare.25.1.127
   Sarafidis PA, 2007, J HUM HYPERTENS, V21, P709, DOI 10.1038/sj.jhh.1002201
   SHIMOKATA H, 1991, DIABETES, V40, P44, DOI 10.2337/diabetes.40.1.44
   Stern JH, 2019, J ENDOCRINOL, V243, P149, DOI 10.1530/JOE-19-0201
   THAMPY KG, 1988, J BIOL CHEM, V263, P6454
   Turturro A, 2002, J GERONTOL A-BIOL, V57, pB379, DOI 10.1093/gerona/57.11.B379
   Vasileva A., 2022, BIORXIV, DOI [10.1101/2022.03.20.485051, DOI 10.1101/2022.03.20.485051]
   Wang Q, 2009, HEPATOLOGY, V49, P1166, DOI 10.1002/hep.22774
   Wang ZL, 2013, EXP GERONTOL, V48, P705, DOI 10.1016/j.exger.2013.05.059
   WEINDRUCH R, 1982, SCIENCE, V215, P1415, DOI 10.1126/science.7063854
   WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641
   Willcox BJ, 2007, ANN NY ACAD SCI, V1114, P434, DOI 10.1196/annals.1396.037
   Woodard GA, 2011, MENOPAUSE, V18, P376, DOI 10.1097/gme.0b013e3181f6480e
   Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992
NR 57
TC 3
Z9 3
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD 2022 DEC
PY 2022
VL 23
IS 6
SI SI
BP 741
EP 755
DI 10.1007/s10522-022-09996-5
EA OCT 2022
PG 15
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 6U4YV
UT WOS:000876847500002
PM 36315375
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Ma, LL
   Ma, C
   Shi, ZM
   Li, WM
   Xu, L
   Hu, F
   Li, HX
AF Ma, L. L.
   Ma, C.
   Shi, Z. M.
   Li, W. M.
   Xu, L.
   Hu, F.
   Li, H. X.
TI Effects of fluoranthene on the growth, bioavailability and anti-oxidant
   system of <i>Eisenia fetida</i> during the ageing process
SO EUROPEAN JOURNAL OF SOIL BIOLOGY
LA English
DT Article
DE Fluoranthene; Ageing; Bioavailability; Fluoranthene accumulation in
   earthworms; Enzyme activities; MDA
ID POLYCYCLIC AROMATIC-HYDROCARBONS; PERSISTENT ORGANIC POLLUTANTS; PREDICT
   BIOAVAILABILITY; PEROXIDASE-ACTIVITY; ANDREI OLIGOCHAETA; EARTHWORM;
   SOIL; PAHS; AVAILABILITY; LIVER
AB Studies were conducted to assess the effects of certain concentrations of fluoranthene on the growth, bioavailability, and anti-oxidant system of Eisenia fetida during the ageing process. The concentration of fluoranthene in the soil decreased rapidly during the first: 25 days (27.0% decrease) followed by a slower decrease in the next 90 days (11.2% decrease). The increase in the weight ratio (WR) was initially rapid and then slowed with ageing in a manner consistent with the rate of decrease in fluoranthene concentration. The bioconcentration factor (BCF) and the concentration of fluoranthene in the earthworms' epidermis and intestines increased prior to 25 days but decreased thereafter. This result confirmed that the bioavailability of fluoranthene decreases as time increases, except when increased toxicity caused the earthworms to die at the beginning of the experiment. The fluoranthene concentration and the BCF in earthworms' intestines were higher than those in the epidermis throughout the whole experiment, which suggested that earthworms accumulate fluoranthene mainly by ingesting it with soil particles rather than by penetrating it through their epidermis. The effects of fluoranthene on anti-oxidative enzyme activity (superoxide dismutase, SOD; catalase, CAT; guaiacol peroxidase. POD and polyphenol oxidase. PPO) and malondialdehyde (MDA) content in earthworms were also investigated. The activities of SOD, POD, and PPO and the content of MDA decreased gradually, but the activity of CAT decreased initially and then increased thereafter. The WR, POD, and PPO sensitivities of the earthworms were closely related to the decrease in fluoranthene concentration, while the sensitivity to SOD lagged behind. (C) 2011 Elsevier Masson SAS. All rights reserved.
C1 [Ma, L. L.; Ma, C.; Shi, Z. M.; Li, W. M.; Xu, L.; Hu, F.; Li, H. X.] Nanjing Agr Univ, Coll Resources & Environm Sci, Soil Ecol Lab, Nanjing 210095, Jiangsu, Peoples R China.
C3 Nanjing Agricultural University
RP Li, HX (corresponding author), Nanjing Agr Univ, Coll Resources & Environm Sci, Soil Ecol Lab, Nanjing 210095, Jiangsu, Peoples R China.
EM malifeng19830615@126.com; machao.0910@163.com; 2008103020@njau.edu.cn;
   2010103100@njau.edu.cn; xuli602@njau.edu.cn; fenghu@njau.edu.cn;
   huixinli@njau.edu.cn
RI Li, huixin/H-5573-2011; Hu, Feng/IAN-4009-2023
OI Shi, Zhiming/0000-0003-0365-7377
FU Environmental public welfare project [201009032]
FX This research was financially supported by Environmental public welfare
   project (No. 201009032). We thank Wendy Moreno and Shanmei Wu, in
   Berkeley, University of California for language improvement.
CR Alexander M, 2000, ENVIRON SCI TECHNOL, V34, P4259, DOI 10.1021/es001069+
   Apitz SE, 1999, ORG GEOCHEM, V30, P891, DOI 10.1016/S0146-6380(99)00073-X
   Arnaud C, 2000, SOIL BIOL BIOCHEM, V32, P67, DOI 10.1016/S0038-0717(99)00130-3
   BOLZAN AD, 1995, EXP GERONTOL, V30, P169, DOI 10.1016/0531-5565(94)00053-0
   Burgeot T, 1996, MAR ECOL PROG SER, V131, P125, DOI 10.3354/meps131125
   Conell D.W., 1990, CHEMOSPHERE, V20, P91
   Contreras-Ramos SM, 2005, BIOL FERT SOILS, V41, P190, DOI 10.1007/s00374-004-0821-8
   Ding Ai-fang, 2007, Journal of Ecology and Rural Environment, V23, P71
   Fatima M, 2007, AQUAT TOXICOL, V81, P159, DOI 10.1016/j.aquatox.2006.11.013
   Gevao B, 2001, ENVIRON SCI TECHNOL, V35, P501, DOI 10.1021/es000144d
   GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P309, DOI 10.1104/pp.59.2.309
   Goldman R, 2001, CANCER RES, V61, P6367
   HENNY H, 2003, CHEMOSPHERE, V53, P1097
   Holovská K, 2005, EXP TOXICOL PATHOL, V56, P377, DOI 10.1016/j.etp.2005.01.002
   Jager T, 2000, ENVIRON TOXICOL CHEM, V19, P953, DOI [10.1897/1551-5028(2000)019&lt;0953:TOPAHI&gt;2.3.CO;2, 10.1002/etc.5620190424]
   Jager T, 2003, ENVIRON SCI TECHNOL, V37, P3399, DOI 10.1021/es0340578
   Johnson DL, 2002, SOIL BIOL BIOCHEM, V34, P1363, DOI 10.1016/S0038-0717(02)00081-0
   Jones KC, 1999, ENVIRON POLLUT, V100, P209, DOI 10.1016/S0269-7491(99)00098-6
   JONES KC, 1996, LAND CONTAMINATION R, V3, P189
   Kelsey JW, 1997, ENVIRON SCI TECHNOL, V31, P214, DOI 10.1021/es960354j
   KOCHBA J, 1977, PLANT CELL PHYSIOL, V18, P463, DOI 10.1093/oxfordjournals.pcp.a075455
   Krauss M, 2000, ENVIRON SCI TECHNOL, V34, P4335, DOI 10.1021/es001137s
   LANDRUM PF, 1989, ENVIRON SCI TECHNOL, V23, P588, DOI 10.1021/es00063a012
   Liste HH, 2002, CHEMOSPHERE, V46, P1011, DOI 10.1016/S0045-6535(01)00165-5
   LIVINGSTONE DR, 1993, J CHEM TECHNOL BIOT, V57, P195
   Lu R.K., 1999, Soil Agrochemical Analysis Method
   Macleod CJA, 2000, ENVIRON SCI TECHNOL, V34, P4952, DOI 10.1021/es000061x
   Matscheko N, 2002, ENVIRON TOXICOL CHEM, V21, P1724, DOI 10.1897/1551-5028(2002)021<1724:AAEOPA>2.0.CO;2
   NAIMJ G, 2007, COMP BIOCH PHYSL C, V145, P678
   Nayak SB, 1999, EXP GERONTOL, V34, P365, DOI 10.1016/S0531-5565(99)00021-2
   PORTER NA, 1984, METHOD ENZYMOL, V105, P273
   Reid BJ, 2000, ENVIRON SCI TECHNOL, V34, P3174, DOI 10.1021/es990946c
   Reid BJ, 2000, ENVIRON POLLUT, V108, P103, DOI 10.1016/S0269-7491(99)00206-7
   Sabljic A, 2001, CHEMOSPHERE, V43, P363, DOI 10.1016/S0045-6535(00)00084-9
   Saint-Denis M, 1998, ARCH ENVIRON CON TOX, V35, P602, DOI 10.1007/s002449900422
   Shi HH, 2005, COMP BIOCHEM PHYS C, V140, P115, DOI 10.1016/j.cca.2005.01.009
   Song YuFang, 2003, Rural Eco-Environment, V19, P36
   Stroo HF, 2000, ENVIRON SCI TECHNOL, V34, P3831, DOI 10.1021/es990623g
   Tang JX, 2002, CHEMOSPHERE, V48, P35, DOI 10.1016/S0045-6535(02)00046-2
   Xu J.B., 1997, ENVIRON CHEM, V18, P73
   Zelikoff Judith T., 1996, P287
   [张宝旭 Zhang Baoxu], 2002, [环境科学学报, Acta Scientic Circumstantance], V22, P764
   Zhang W., 2009, J LIAONING TECH U NA, V28, P846
   [张薇 ZHANG Wei], 2007, [环境化学, Environmental Chemistry], V26, P202
NR 44
TC 27
Z9 30
U1 3
U2 70
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 1164-5563
J9 EUR J SOIL BIOL
JI Eur. J. Soil Biol.
PD MAY-JUN
PY 2012
VL 50
BP 21
EP 27
DI 10.1016/j.ejsobi.2011.11.005
PG 7
WC Ecology; Soil Science
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology; Agriculture
GA 948NJ
UT WOS:000304509600004
DA 2024-02-19
ER

PT J
AU Lei, SW
   Zhang, ZF
   Xie, GH
   Zhao, CY
   Miao, Y
   Chen, DH
   Zhang, GR
   Liu, H
   Peng, CX
   Hou, Y
   Gong, JS
AF Lei, Shuwen
   Zhang, Zhifang
   Xie, Guihua
   Zhao, Chunyan
   Miao, Yue
   Chen, Dehong
   Zhang, Guangren
   Liu, Hao
   Peng, Chunxiu
   Hou, Yan
   Gong, Jiashun
TI Theabrownin modulates the gut microbiome and serum metabolome in aging
   mice induced by <i>D</i>-galactose
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article; Early Access
DE Theabrownin; Aging; Gut microbiota; Metabolites
ID PU-ERH TEA; INTESTINAL MICROBIOTA; ANTIOXIDANT ACTIVITY; LACTOBACILLUS;
   INFLAMMATION; POLYPHENOLS; SIGNATURES; MECHANISM; OBESITY; RAT
AB Theabrownin (TB) is a complex oxidized polyphenol formed during the microbial fermentation of Pu-erh tea. It offers some health benefits such as weight loss, blood glucose reduction, and oxidation resistance; however, the anti-aging effect and the related mechanism have not yet been explored. In this study, symptoms of aging were induced in mice using D-galactose. Morris water maze test, hematoxylin-eosin staining, 16S rDNA high-throughput sequencing, and UHPLC-QE-MS metabolomics were used to reveal the anti-aging effects and potential mechanism of TB. TB improved the learning and memory ability, the liver oxidative stress (SOD, GSH-Px, and MDA), inflammation (IL-2, IL-6, and TNF-alpha), and degeneration of the small intestine in the aging mice. Further analysis showed that TB pretreatment increased the relative abundance of Lactobacillus_murinus and Bacteroides_acidifaciens, and regulated 19 metabolites in the serum. In addition, TB treatment increased the relative abundance of Akkermansia_muciniphila, and regulated 12 metabolites. In conclusion, the anti-aging effect of TB is exerted by the targeted regulation of intestinal microorganisms, which could prevent and delay aging.
C1 [Lei, Shuwen; Zhang, Zhifang; Zhao, Chunyan; Miao, Yue; Hou, Yan; Gong, Jiashun] Yunnan Agr Univ, Coll Food Sci & Technol, Kunming 650201, Yunnan, Peoples R China.
   [Xie, Guihua; Hou, Yan] Yunnan Agr Univ, Coll Tea, Kunming 650201, Yunnan, Peoples R China.
   [Chen, Dehong; Zhang, Guangren; Liu, Hao] Yunnan Agr Univ, Coll Vet Med, Kunming 650201, Yunnan, Peoples R China.
   [Peng, Chunxiu] Yunnan Agr Univ, Coll Hort & Landscape, Kunming 650201, Yunnan, Peoples R China.
C3 Yunnan Agricultural University; Yunnan Agricultural University; Yunnan
   Agricultural University; Yunnan Agricultural University
RP Hou, Y; Gong, JS (corresponding author), Yunnan Agr Univ, Coll Food Sci & Technol, Kunming 650201, Yunnan, Peoples R China.
EM zgynndhy@163.com; gong199@163.com
FU National Natural Science Foundation of China [81860608]; Yunling Scholar
   Program [YNWR-YLXZ-2018-026]; Yunnan Province National Fund
   [2017FG001(-011)]
FX This research was funded by the National Natural Science Foundation of
   China (81860608), Yunling Scholar Program (YNWR-YLXZ-2018-026) and
   Yunnan Province National Fund (2017FG001(-011)).
CR An R, 2018, GUT, V67, P2213, DOI 10.1136/gutjnl-2017-315542
   BAILEY RG, 1992, J SCI FOOD AGR, V59, P365, DOI 10.1002/jsfa.2740590314
   Bajaj JS, 2018, HEPATOLOGY, V68, P234, DOI 10.1002/hep.29791
   Bárcena C, 2019, NAT MED, V25, P1234, DOI 10.1038/s41591-019-0504-5
   Bauer ME, 2016, MECH AGEING DEV, V158, P27, DOI 10.1016/j.mad.2016.01.001
   Biagi E, 2017, MECH AGEING DEV, V165, P180, DOI 10.1016/j.mad.2016.12.013
   Biagi E, 2016, CURR BIOL, V26, P1480, DOI 10.1016/j.cub.2016.04.016
   Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667
   Bischoff SC, 2016, CURR OPIN CLIN NUTR, V19, P26, DOI 10.1097/MCO.0000000000000242
   Blacher E, 2019, NATURE, V572, P474, DOI 10.1038/s41586-019-1443-5
   Bruunsgaard H, 2006, DAN MED BULL, V53, P285
   Chen TL, 2018, ANAL CHEM, V90, P2475, DOI 10.1021/acs.analchem.7b02859
   Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107
   De la Fuente M, 2002, EUR J CLIN NUTR, V56, pS5, DOI 10.1038/sj.ejcn.1601476
   Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4
   Fraumene C, 2018, GUT MICROBES, V9, P104, DOI 10.1080/19490976.2017.1371894
   Frei B, 2003, J NUTR, V133, p3275S, DOI 10.1093/jn/133.10.3275S
   Giovannini S, 2011, J AM GERIATR SOC, V59, P1679, DOI 10.1111/j.1532-5415.2011.03570.x
   Gong JS, 2010, J FOOD SCI, V75, pH182, DOI 10.1111/j.1750-3841.2010.01675.x
   Goulet O, 2015, NUTR REV, V73, P32, DOI 10.1093/nutrit/nuv039
   Grompone G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052493
   Han M, 2021, MOLECULES, V26, DOI 10.3390/molecules26071887
   Harandi S, 2015, BASIC CLIN NEUROSCI, V6, P91
   He Q., 2016, CHIN J AESTH MED, V25, P101
   Hébuterne X, 2003, CURR OPIN CLIN NUTR, V6, P49, DOI 10.1097/00075197-200301000-00008
   Huang FJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12896-x
   Inoue T, 2008, ATHEROSCLEROSIS, V201, P385, DOI 10.1016/j.atherosclerosis.2008.03.010
   Jadoon S, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/709628
   Jiao JJ, 2017, J FUNCT FOODS, V30, P63, DOI 10.1016/j.jff.2016.12.039
   Jin WD, 2018, J CELL MOL MED, V22, P4423, DOI 10.1111/jcmm.13742
   Komura T, 2013, BIOGERONTOLOGY, V14, P73, DOI 10.1007/s10522-012-9411-6
   Kong FL, 2016, CURR BIOL, V26, pR832, DOI 10.1016/j.cub.2016.08.015
   Konturek PC, 2015, J PHYSIOL PHARMACOL, V66, P483
   Krall AS, 2021, CELL METAB, V33, P1013, DOI 10.1016/j.cmet.2021.02.001
   Kundu P, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau4760
   Lagkouvardos I, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0637-2
   Lakshminarayanan B, 2014, J NUTR HEALTH AGING, V18, P773, DOI [10.1007/s12603-014-0549-6, 10.1007/s12603-014-0513-5]
   Lan HaiJing, 2019, Shipin Kexue / Food Science, V40, P196
   Li W, 2019, CARBOHYD POLYM, V223, DOI 10.1016/j.carbpol.2019.115065
   Liang YR, 2005, J SCI FOOD AGR, V85, P381, DOI 10.1002/jsfa.1857
   Liu J, 2016, J SCI FOOD AGR, V96, P3708, DOI 10.1002/jsfa.7556
   Liu R, 2020, FOOD SCI HUM WELL, V9, P184, DOI 10.1016/j.fshw.2020.02.003
   Margalef M, 2016, J NUTR BIOCHEM, V29, P90, DOI 10.1016/j.jnutbio.2015.11.007
   Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123
   Matsumoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023652
   Nakagawa H, 2016, AGING CELL, V15, P227, DOI 10.1111/acel.12431
   Nakajima A, 2020, APPL ENVIRON MICROB, V86, DOI 10.1128/AEM.00405-20
   Odamaki T, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0708-5
   Pan FW, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0440-5
   Passarino G, 2016, IMMUN AGEING, V13, DOI 10.1186/s12979-016-0066-z
   Patel P, 2015, EXP GERONTOL, V67, P1, DOI 10.1016/j.exger.2015.04.011
   Qasim M, 2016, PAK J BOT, V48, P621
   Qi L, 2021, CELL STEM CELL, V28, P1982, DOI 10.1016/j.stem.2021.07.011
   Qin Yi, 2009, Chemistry and Industry of Forest Products, V29, P95
   Salazar N, 2017, GUT MICROBES, V8, P82, DOI 10.1080/19490976.2016.1256525
   Shen X, 2018, GUT PATHOG, V10, DOI 10.1186/s13099-018-0231-3
   Sullivan LB, 2018, NAT CELL BIOL, V20, P782, DOI 10.1038/s41556-018-0125-0
   Tanaka R, 2009, BIOCHEM BIOPH RES CO, V378, P851, DOI 10.1016/j.bbrc.2008.11.152
   Tu Y. Y., 2021, TEA HLTH
   Wang Q. H., 2020, CHIN ARCH TRADIT CHI, V38, P26
   Westfall S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25382-z
   Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380
   Xiang WL, 2019, J SCI FOOD AGR, V99, P5577, DOI 10.1002/jsfa.9831
   Xiao J, 2020, J AGR FOOD CHEM, V68, P1237, DOI 10.1021/acs.jafc.9b04961
   Xiao Y, 2018, FOOD CHEM TOXICOL, V119, P141, DOI 10.1016/j.fct.2018.05.017
   Xu LQ, 2016, FOOD FUNCT, V7, P4545, DOI 10.1039/c6fo01057a
   Yang JY, 2017, MUCOSAL IMMUNOL, V10, P104, DOI 10.1038/mi.2016.42
   Yue SuiJuan, 2016, Journal of Tea Science, V36, P261
   Zhai SX, 2018, MICROBIOLOGYOPEN, V7, DOI 10.1002/mbo3.612
   Zhang CH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3163
   Zhang Q, 2005, NEUROREPORT, V16, P1297, DOI 10.1097/01.wnr.0000174405.24763.bc
   Zhang X, 2021, GEROSCIENCE, V43, P709, DOI 10.1007/s11357-020-00188-y
   Zhao ZJ, 2010, J FOOD SAFETY, V30, P769, DOI 10.1111/j.1745-4565.2010.00240.x
NR 73
TC 9
Z9 12
U1 17
U2 65
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1756-4646
EI 2214-9414
J9 J FUNCT FOODS
JI J. Funct. Food.
PD 2022 FEB
PY 2022
VL 89
AR 104941
DI 10.1016/j.jff.2022.104941
EA JAN 2022
PG 13
WC Food Science & Technology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Nutrition & Dietetics
GA 1R0LC
UT WOS:000803069800002
OA gold
DA 2024-02-19
ER

PT S
AU Zhu, M
   de Cabo, R
   Lane, MA
   Ingram, DK
AF Zhu, M
   de Cabo, R
   Lane, MA
   Ingram, DK
BE DeGrey, ADN
TI Caloric restriction modulates early events in insulin signaling in liver
   and skeletal muscle of rat
SO STRATEGIES FOR ENGINEERED NEGLIGIBLE SENESCENCE: WHY GENUINE CONTROL OF
   AGING MAY BE FORESEEABLE
SE Annals of the New York Academy of Sciences
LA English
DT Article; Proceedings Paper
CT 10th Congress of the International-Association-of-Biomedical-Gerontology
CY SEP 19-23, 2003
CL Cambridge, ENGLAND
SP Int Assoc Biomed Gerontol
DE caloric restriction; aging; insulin signaling pathway; PTP-1B
ID PROTEIN-TYROSINE PHOSPHATASE-1B; RECEPTOR; SENSITIVITY; OBESITY; MICE
AB Mutations that extend life span in C elegans suggest that the insulin/IGF-1 signaling (IS) pathway may play a key role in retarding aging and extending life span by caloric restriction (CR). To evaluate this hypothesis, male rats were subjected to either AL (ad libitum) or CR (40% from AL) for 2 and 25 months, and then the effects of CR on the early events in the IS pathway in liver and muscle were assessed. The results indicated that aging was accompanied by a significant decline in insulin receptor tyrosine phosphorylation (pY-IR) upon insulin stimulation in both tissues, which was correlated with a significant increase in the activity of protein tyrosine phosphatase 1B (PTP-1B). However, these alterations with age were attenuated by 25CR. Parallel changes observed in liver mRNA of CR rats were upregulated insulin receptor (1R), IGF-1R and IRS-1, but increased expression of IR mRNA was dissociated with the IR protein in 25CR rats. The expression of liver mRNAs involved in lipid metabolism was also analyzed. In contrast to 25AL rats, the expression of mRNAs for PPARs (alpha, beta, and gamma) was significantly increased in 25CR rats. SREBP-1c and fatty acid synthase were reduced, and other genes were increased, including hormone-sensitive lipase and PGC-1 by CR. The data suggest that the normal function of insulin receptor in liver and muscle is required for successful aging. An altered expression of transcription of a number of genes involved in lipid metabolism may also contribute to modulation of the IS pathway by CR.
C1 NIA, Gerontol Res Ctr, Lab Expt Gerontol, Intramural Res Program,NIH, Baltimore, MD 21224 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Institute on
   Aging (NIA)
RP Ingram, DK (corresponding author), NIA, Gerontol Res Ctr, Lab Expt Gerontol, Intramural Res Program,NIH, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.
EM doni@vax.grc.nia.nih.gov
RI de Cabo, Rafael Carlos/E-7996-2010; de Cabo, Rafael/J-5230-2016
OI de Cabo, Rafael Carlos/0000-0003-2830-5693; de Cabo,
   Rafael/0000-0002-3354-2442
CR Byon JCH, 1998, MOL CELL BIOCHEM, V182, P101, DOI 10.1023/A:1006868409841
   Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544
   Friedman JE, 1997, AM J PHYSIOL-ENDOC M, V273, pE1014, DOI 10.1152/ajpendo.1997.273.5.E1014
   HANSEN BC, 1993, DIABETES, V42, P1809, DOI 10.2337/diabetes.42.12.1809
   Kennedy BP, 2000, BIOCHEM PHARMACOL, V60, P877, DOI 10.1016/S0006-2952(00)00305-1
   Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000
   Liu F, 1997, BIOCHEM J, V327, P139, DOI 10.1042/bj3270139
   Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X
   Roth GS, 2001, ANN NY ACAD SCI, V928, P305
   Youngren JF, 2001, J APPL PHYSIOL, V91, P2240, DOI 10.1152/jappl.2001.91.5.2240
   ZHU M, 2004, IN PRESS EXP GERONTO
NR 11
TC 13
Z9 15
U1 0
U2 2
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
BN 1-57331-497-8; 1-57331-496-X
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2004
VL 1019
BP 448
EP 452
DI 10.1196/annals.1297.082
PG 5
WC Biochemistry & Molecular Biology; Cell Biology; Geriatrics &
   Gerontology; Multidisciplinary Sciences
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Geriatrics &
   Gerontology; Science & Technology - Other Topics
GA BAN77
UT WOS:000223002700082
PM 15247064
DA 2024-02-19
ER

PT J
AU Liu, ZQ
   Jiang, YF
   Fang, QW
   Yuan, HB
   Cai, N
   Suo, C
   Ye, WM
   Chen, XD
   Zhang, TJ
AF Liu, Zhenqiu
   Jiang, Yanfeng
   Fang, Qiwen
   Yuan, Huangbo
   Cai, Ning
   Suo, Chen
   Ye, Weimin
   Chen, Xingdong
   Zhang, Tiejun
TI Future of cancer incidence in Shanghai, China: Predicting the burden
   upon the ageing population
SO CANCER EPIDEMIOLOGY
LA English
DT Article
DE Cancer incidence; Projections; Ageing population; Shanghai
ID BREAST-CANCER; TRENDS; MORTALITY; PROJECTIONS; STATISTICS; SMOKING;
   IMPACT; LIVER; RATES
AB Aim: The age-specific cancer patterns have changed significantly over the last few decades in urban Shanghai. Predicting the cancer incidence in an ageing population can help to anticipate future resource needs, evaluate primary prevention strategies, and inform further research studies.
   Materials and Methods: Annual cancer cases and population data from 1988 to 2013 were collected from Shanghai Cancer Registry. A Bayesian age-period-cohort model was applied to project the future cancer incidence with demographical changes from 2014 to 2025.
   Results: From 1988 through 2013, the urban population aged < 65 years decreased by 19.5%, while the population aged >= 65 years increased by 58.4%. In the same period, cancer cases increased by 66.0% (from 8315 to 13,806) and 88.6% (from 7448 to 14,048) in these two populations, respectively. From 2014-2025, the population size is expected to decrease by an additional 29.6% in people aged < 65 years, while it will increase by an additional 68.3% in people aged >= 65 years. Correspondingly, the model predicts an 87.5% and 143.4% increase in cancer cases for these two populations, respectively. The most pronounced increase was found in thyroid cancer in both sexes, followed by prostate, kidney, and colon cancer in men. In women, lung, kidney, and cervical cancer in women was expected to increase.
   Conclusions: The number of cancer cases in urban Shanghai, especially in older people, is expected to significantly increase in the next decade. Particular strategies targeting the elderly are required to combat the cancers.
C1 [Liu, Zhenqiu; Jiang, Yanfeng; Cai, Ning; Suo, Chen; Chen, Xingdong] Fudan Univ, State Key Lab Genet Engn, Sch Life Sci, Shanghai, Peoples R China.
   [Liu, Zhenqiu; Jiang, Yanfeng; Cai, Ning; Suo, Chen; Chen, Xingdong] Fudan Univ, Collaborat Innovat Ctr Genet & Dev, Sch Life Sci, Shanghai, Peoples R China.
   [Liu, Zhenqiu; Fang, Qiwen; Yuan, Huangbo; Cai, Ning; Suo, Chen; Zhang, Tiejun] Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai, Peoples R China.
   [Liu, Zhenqiu; Fang, Qiwen; Yuan, Huangbo; Cai, Ning; Suo, Chen; Zhang, Tiejun] Fudan Univ, Key Lab Publ Hlth Safety, Minist Educ, Shanghai, Peoples R China.
   [Liu, Zhenqiu; Jiang, Yanfeng; Cai, Ning; Suo, Chen; Chen, Xingdong] Fudan Univ, Taizhou Inst Hlth Sci, Taizhou, Peoples R China.
   [Ye, Weimin] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.
C3 Fudan University; Fudan University; Fudan University; Fudan University;
   Fudan University; Karolinska Institutet
RP Zhang, TJ (corresponding author), Fudan Univ, Sch Publ Hlth, Shanghai 200032, Peoples R China.; Chen, XD (corresponding author), Fudan Univ, Sch Life Sci, Shanghai 200438, Peoples R China.
EM xingdongchen@fudan.edu.cn; tjzhang@shmu.edu.cn
RI zhang, Tiejun/HGD-6858-2022; Yuan, Huangbo/AAU-1977-2020; Zhang,
   Tiejun/HDM-7091-2022
OI Liu, Zhenqiu/0000-0002-5244-6894; Yuan, Huangbo/0000-0002-7065-2974
FU National Natural Science Foundation of China [81772170, 81502870];
   National Key Research and Development program of China [2017YFC0907002,
   2017YFC0907501, 2017YFC211700]; Science and Technology Commission of
   Shanghai Municipality [16JC1400500]; International S&T Cooperation
   Program of China [2015DFE32790]; Shanghai Municipal Science and
   Technology Major Project [2017SHZDZX01]
FX This work was supported by the National Natural Science Foundation of
   China (grant numbers: 81772170, 81502870); the National Key Research and
   Development program of China (grant number: 2017YFC0907002,
   2017YFC0907501, 2017YFC211700); the key basic research grants from
   Science and Technology Commission of Shanghai Municipality (grant
   number: 16JC1400500); the International S&T Cooperation Program of China
   (grant number: 2015DFE32790); and Shanghai Municipal Science and
   Technology Major Project (2017SHZDZX01).
CR [Anonymous], LANCET
   [Anonymous], J STAT SOFTW
   [Anonymous], J NATL CANC I
   [Anonymous], SHANGH STAT YB
   [Anonymous], EUR J EPIDEMIOL
   Bai L, 2018, CLIN EPIDEMIOL, V10, P277, DOI 10.2147/CLEP.S153951
   Baker A, 2005, AM J EPIDEMIOL, V162, P798, DOI 10.1093/aje/kwi273
   Bao PP, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2313-2
   Bartelink H, 2001, NEW ENGL J MED, V345, P1378, DOI 10.1056/NEJMoa010874
   Bill-Axelson A, 2011, NEW ENGL J MED, V364, P1708, DOI 10.1056/NEJMoa1011967
   Boes S, 2015, HEALTH ECON, V24, P1502, DOI 10.1002/hec.3108
   Bray F, 2006, NAT REV CANCER, V6, P63, DOI 10.1038/nrc1781
   Chaturvedi AK, 2013, J CLIN ONCOL, V31, P4550, DOI 10.1200/JCO.2013.50.3870
   Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338
   Doubeni CA, 2018, CA-CANCER J CLIN, V68, P199, DOI 10.3322/caac.21452
   Gallagher EJ, 2013, DIABETES CARE, V36, pS233, DOI 10.2337/dcS13-2001
   Gong P, 2012, LANCET, V379, P843, DOI 10.1016/S0140-6736(11)61878-3
   Gorlia T, 2008, LANCET ONCOL, V9, P29, DOI 10.1016/S1470-2045(07)70384-4
   Hankey BF, 2000, CANCER CAUSE CONTROL, V11, P31, DOI 10.1023/A:1008953201688
   Huang Z, 2016, ANN ONCOL, V27, P1129, DOI 10.1093/annonc/mdw069
   Jiang XX, 2014, ANN HUM BIOL, V41, P469, DOI 10.3109/03014460.2014.910270
   Kairouz S, 2015, NICOTINE TOB RES, V17, P41, DOI 10.1093/ntr/ntu125
   Leung WK, 2018, GASTROENTEROLOGY, V155, P67, DOI 10.1053/j.gastro.2018.03.028
   Mistry M, 2011, BRIT J CANCER, V105, P1795, DOI 10.1038/bjc.2011.430
   Ormiston-Smith Nicholas, 2006, Popul Trends, P37
   Pearson-Stuttard J, 2016, CIRCULATION, V133, P967, DOI 10.1161/CIRCULATIONAHA.115.019904
   Qi D, 2015, PROSTATE, V75, P1662, DOI 10.1002/pros.23046
   Qin YC, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13050512
   Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155
   Riebler A, 2017, BIOMETRICAL J, V59, P531, DOI 10.1002/bimj.201500263
   Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208
   Smith BD, 2009, J CLIN ONCOL, V27, P2758, DOI 10.1200/JCO.2008.20.8983
   Smittenaar CR, 2016, BRIT J CANCER, V115, P1147, DOI 10.1038/bjc.2016.304
   Vaccarella S, 2016, LANCET ONCOL, V17, P1445, DOI 10.1016/S1470-2045(16)30275-3
   Van de Velde N, 2012, JNCI-J NATL CANCER I, V104, P1712, DOI 10.1093/jnci/djs395
   Wang TG, 2013, J DIABETES, V5, P378, DOI 10.1111/1753-0407.12057
   Wang WL, 2012, ARCH VIROL, V157, P901, DOI 10.1007/s00705-012-1251-9
   Weir HK, 2015, CANCER-AM CANCER SOC, V121, P1827, DOI 10.1002/cncr.29258
   Welch HG, 2018, ANN INTERN MED, V168, P143, DOI 10.7326/M17-2792
NR 39
TC 23
Z9 27
U1 3
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1877-7821
EI 1877-783X
J9 CANCER EPIDEMIOL
JI Cancer Epidemiol.
PD JUN
PY 2019
VL 60
BP 8
EP 15
DI 10.1016/j.canep.2019.03.004
PG 8
WC Oncology; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Public, Environmental & Occupational Health
GA HY4UL
UT WOS:000468123300002
PM 30878799
DA 2024-02-19
ER

PT J
AU Geller, AM
   Zenick, H
AF Geller, AM
   Zenick, H
TI Aging and the environment: A research framework
SO ENVIRONMENTAL HEALTH PERSPECTIVES
LA English
DT Article
DE aging; environmental health; exposure; frailty; microenvironment; older
   adults; pharmacodynamics; pharmacokinetics; polypharmacy
ID AGE-RELATED-CHANGES; EPIDERMAL PERMEABILITY BARRIER; DRUG-METABOLISM;
   PHARMACOKINETIC DIFFERENCES; ACTIVITY PATTERNS; POTENTIAL IMPACT;
   AIR-POLLUTION; LIVER; EXPOSURES; NEUROTOXICITY
AB The rapid growth in the number of older Americans has many implications for public health, including the need to better understand the risks posed to older adults by environmental exposures. Biologic capacity declines with normal aging; this may be exacerbated in individuals with pre-existing health conditions. This decline can result in compromised pharmacokinetic and pharmacodynamic responses to environmental exposures encountered in daily activities. In recognition of this issue, the U.S. Environmental Protection Agency (EPA) is developing a research agenda on the environment and older adults. The U.S. EPA proposes to apply an environmental public health paradigm to better understand the relationships between external pollution sources -> human exposures -> internal dose -> early biologic effect -> adverse health effects for older adults. The initial challenge will be using information about aging-related changes in exposure, pharmacokinetic, and pharmacodynamic factors to identify susceptible subgroups within the diverse population of older adults. These changes may interact with specific diseases of aging or medications used to treat these conditions. Constructs such as "frailty" may help to capture some of the diversity in the older adult population. Data are needed regarding a) behavior/activity patterns and exposure to the pollutants in the microenvironments of older adults; b) changes in absorption, distribution, metabolism, and excretion with aging; c) alterations in reserve capacity that alter the body's ability to compensate for the effects of environmental exposures; and a) strategies for effective communication of risk and risk reduction methods to older individuals and communities. This article summarizes the U.S. EPA's development of a framework to address and prioritize the exposure, health effects, and risk communications concerns for the U.S. EPA's evolving research program on older adults as a susceptible subpopulation.
C1 US EPA, Natl Hlth & Environm Effects Lab, Off Res & Dev, Res Triangle Pk, NC 27711 USA.
C3 United States Environmental Protection Agency
RP Geller, AM (corresponding author), US EPA, Natl Hlth & Environm Effects Lab, Off Res & Dev, 109 TW Alexander Dr,MD B305-02, Res Triangle Pk, NC 27711 USA.
EM geller.andrew@epa.gov
CR AKMAN S, 2003, CRITICAL REV OXIDATI, P925
   APRK DC, 2002, DIFFERENTIAL SUSCEPT
   Baker S. R., 1987, ENV TOXICITY AGING P
   Bateson TF, 2004, EPIDEMIOLOGY, V15, P143, DOI 10.1097/01.ede.0000112210.68754.fa
   BIRNBAUM LS, 1991, ANNU REV PHARMACOL, V31, P101
   BORLAKOGLU JT, 1991, COMP BIOCHEM PHYS C, V100, P327, DOI 10.1016/0742-8413(91)90004-D
   Bortz WM, 2002, J GERONTOL A-BIOL, V57, pM283, DOI 10.1093/gerona/57.5.M283
   Brooks AI, 1999, BRAIN RES, V823, P1, DOI 10.1016/S0006-8993(98)01192-5
   Brown JS, 2002, AM J RESP CRIT CARE, V166, P1240, DOI 10.1164/rccm.200205-399OC
   Buratti FM, 2003, TOXICOL APPL PHARM, V186, P143, DOI 10.1016/S0041-008X(02)00027-3
   Butler AM, 1997, J PHARMACOL EXP THER, V280, P966
   Clewell HJ, 2004, TOXICOL SCI, V79, P381, DOI 10.1093/toxsci/kfh109
   Clewell HJ, 2002, CRIT REV TOXICOL, V32, P329, DOI 10.1080/20024091064264
   Crome P, 2003, TOXICOLOGY, V192, P49, DOI 10.1016/S0300-483X(03)00253-1
   Elias PM, 2002, CLIN GERIATR MED, V18, P103, DOI 10.1016/S0749-0690(03)00037-5
   Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146
   FROHMAN LA, 1994, NEUROBIOL AGING, V15, P479, DOI 10.1016/0197-4580(94)90083-3
   GHADIALLY R, 1995, J CLIN INVEST, V95, P2281, DOI 10.1172/JCI117919
   GOLDMAN JE, 1994, CURR OPIN NEUROL, V7, P287, DOI 10.1097/00019052-199408000-00002
   GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P391, DOI 10.1021/tx00022a001
   GUPTA S, 1995, DRUG AGING, V7, P19, DOI 10.2165/00002512-199507010-00003
   HELMUTH L, 2003, ENVIRON, V8, P3
   Herrlinger C, 2001, BEST PRACT RES CL GA, V15, P897, DOI 10.1053/bega.2001.0249
   *IPCS, 1993, ENV HLTH CRIT, V144
   JENKINS PL, 1992, ATMOS ENVIRON A-GEN, V26, P2141, DOI 10.1016/0960-1686(92)90402-7
   JOHANSSON BB, 1998, INTRO BLOOD BRAIN BA, P427
   Kim CS, 1997, AM J RESP CRIT CARE, V155, P899, DOI 10.1164/ajrccm.155.3.9117024
   Kinirons MT, 2004, BRIT J CLIN PHARMACO, V57, P540, DOI 10.1111/j.1365-2125.2004.02096.x
   Kinney PL, 2002, ENVIRON HEALTH PERSP, V110, P539, DOI 10.1289/ehp.02110s4539
   KLEPEIS NE, 1996, EPA600R96074 US
   Kodavanti P.R.S., 1999, TARGET ORGAN TOXICIT, P157
   Lippmann M, 2003, ENVIRON HEALTH PERSP, V111, P1074, DOI 10.1289/ehp.5750
   Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661
   MAYERSOHN M, 1994, ENVIRON HEALTH PERSP, V102, P119, DOI 10.1289/ehp.94102s11119
   MCCORD JM, 2003, CRITICAL REV OXIDATI, P883
   McLean AJ, 2004, PHARMACOL REV, V56, P163, DOI 10.1124/pr.56.2.4
   MICHALEK H, 1990, ACTA NEUROBIOL EXP, V50, P237
   Mooradian AD, 1997, BRAIN RES REV, V23, P210, DOI 10.1016/S0165-0173(97)00003-9
   *NAS, 2003, DIFF SUSC OLD PERS E
   *NAT RES COUNC, 1987, AG TOD ENV
   Naumova EN, 2003, EMERG INFECT DIS, V9, P418, DOI 10.3201/eid0904.020260
   OMAHONY S, 2000, DRUGS OLDER POPULATI, P58
   PRYBYS KM, 2002, EMERG MED REP, V23
   Rea AW, 2001, J AIR WASTE MANAGE, V51, P1271, DOI 10.1080/10473289.2001.10464351
   REAVEN P, 2003, CRITICAL REV OXIDATI, P896
   Rehman HU, 2001, AGE AGEING, V30, P279, DOI 10.1093/ageing/30.4.279
   Rodes CE, 2001, J EXPO ANAL ENV EPID, V11, P103, DOI 10.1038/sj.jea.7500155
   ROLAN PE, 1994, BRIT J CLIN PHARMACO, V37, P125, DOI 10.1111/j.1365-2125.1994.tb04251.x
   Saarela K, 2003, ATMOS ENVIRON, V37, P5563, DOI 10.1016/j.atmosenv.2003.09.031
   Sams C, 2000, TOXICOL LETT, V116, P217, DOI 10.1016/S0378-4274(00)00221-6
   SCHMUCKER DL, 1985, PHARMACOL REV, V37, P133
   Schmucker DL, 2001, DRUG AGING, V18, P837, DOI 10.2165/00002512-200118110-00005
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   Schuurmans H, 2004, J GERONTOL A-BIOL, V59, P962
   Shah GN, 1997, EXP GERONTOL, V32, P501, DOI 10.1016/S0531-5565(96)00158-1
   SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414
   Smith RG, 2005, ENDOCR REV, V26, P203, DOI 10.1210/er.2002-0017
   SPENCER PS, 1990, BEHAVIORAL MEASURES, P268
   SPENGLER JD, 1985, ENVIRON SCI TECHNOL, V19, P700, DOI 10.1021/es00138a008
   Starr JM, 2003, J NEUROL NEUROSUR PS, V74, P70, DOI 10.1136/jnnp.74.1.70
   Thiruchelvam M, 2003, EUR J NEUROSCI, V18, P589, DOI 10.1046/j.1460-9568.2003.02781.x
   Thummel KE, 1998, ANNU REV PHARMACOL, V38, P389, DOI 10.1146/annurev.pharmtox.38.1.389
   *US AOA, 2004, PROF OLD AM 2003
   *US DOC, 1996, CURR POP REP
   US Environmental Protection Agency (US EPA), 1997, EXP FACT HDB
   *US EPA, 2000, EPA600R00068 US
   *US EPA, 2003, 600R03050 US EPA
   *US EPA, 2005, AG IN PUBL LIST SESS
   *US EPA, 2005, P AG AM IMP EC ENV Q
   *US EPA, 1998, EPA600N98002 US
   *US EPA, 2003, EPA600R02050 US
   *US FDA, 2002, PREV ADV DRUG REACT
   VESTAL RE, 1989, HEPATOLOGY, V9, P331, DOI 10.1002/hep.1840090228
   Vestal RE, 1997, CANCER, V80, P1302, DOI 10.1002/(SICI)1097-0142(19971001)80:7<1302::AID-CNCR16>3.0.CO;2-B
   Von Moltke Lisa L., 1995, P1461
   Walston J, 2002, ARCH INTERN MED, V162, P2333, DOI 10.1001/archinte.162.20.2333
   Walston Jeremy, 2004, Sci Aging Knowledge Environ, V2004, ppe4
   WEISS B, 1990, NEUROTOXICOLOGY, V11, P305
   Williams R, 2000, J EXPO ANAL ENV EPID, V10, P533, DOI 10.1038/sj.jea.7500108
   WILLIAMS R, 2002, EPA600R01086 US
   WILLIAMS R, 2000, ATMOS ENVIRON, V34, P4139
   WISNIEWSKI H, 2002, INTRO BLOOD BRAIN BA, P409
   Ye J, 2002, EXP DERMATOL, V11, P209, DOI 10.1034/j.1600-0625.2002.110303.x
   Youssef J, 1999, ENVIRON HEALTH PERSP, V107, P791, DOI 10.2307/3454575
   Zanobetti A, 2000, ENVIRON HEALTH PERSP, V108, P841, DOI 10.2307/3434991
   2003, FED REG, V68, P10238
NR 86
TC 83
Z9 92
U1 2
U2 12
PU US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE
PI RES TRIANGLE PK
PA NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA
SN 0091-6765
EI 1552-9924
J9 ENVIRON HEALTH PERSP
JI Environ. Health Perspect.
PD SEP
PY 2005
VL 113
IS 9
BP 1257
EP 1262
DI 10.1289/ehp.7569
PG 6
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Toxicology
GA 961QU
UT WOS:000231677700050
PM 16140638
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Goto, S
   Naito, H
   Kaneko, T
   Chung, H
   Radák, Z
AF Goto, Sataro
   Naito, Hisashi
   Kaneko, Takao
   Chung, HaeYoung
   Radak, Zsolt
TI Hormetic effects of regular exercise in aging:: correlation with
   oxidative stress
SO APPLIED PHYSIOLOGY NUTRITION AND METABOLISM
LA English
DT Article; Proceedings Paper
CT 13th Annual Conference on Biochemistry of Exercise
CY OCT 20-23, 2006
CL Seoul, SOUTH KOREA
SP Korean Natl Sport Univ, Korean Soc Exercise Physiol, Seoul Natl Univ, Aging & Apoptosis Res Ctr
DE rat; aging; regular exercise; liver; brain; protein carbonyl; NF-kappa
   B; 8-oxodG; OGG1; hormesis
ID FACTOR-KAPPA-B; PROTEIN OXIDATION; SKELETAL-MUSCLE; DNA-DAMAGE;
   ANTIOXIDANT; RISK; AGE; MECHANISMS; EXPRESSION; HORMESIS
AB To explore mechanisms of the beneficial consequences of regular exercise, we studied the effects of regular swimming and treadmill exercise on oxidative stress in the brain and liver of rats. Protein carbonyl was significantly reduced and the activity of proteasome was upregulated in the brain extracts of young and middle-aged animals after 9 weeks of swimming training. Furthermore, their cognitive functions were significantly improved. In separate experiments, the activation of transcription nuclear factor kappa B was attenuated in the liver of old rats after 8 weeks of regular treadmill exercise and the DNA binding activity of glucocorticoid receptor reduced with age was restored, suggesting that inflammatory reactions are alleviated by the regimen. This was accompanied by upregulation of the glutathione level and reduced reactive oxygen species generation. Similar training reduced the 8-oxodeoxyguanosine content in the nuclear and mitochondrial DNA of the liver of old rats. Thus, these findings, together with reports of other investigators, suggest that moderate regular exercise attenuates oxidative stress. The mild oxidative stress possibly elicited by regular exercise appears to manifest a hormesis-like effect in nonmuscular tissues, constituting beneficial mechanisms of exercise by adaptively upregulating various antioxidant mechanisms, including antioxidative and repair-degradation enzymes for damaged molecules. Importantly, the adaptation induced by regular exercise was effective even if initiated late in life.
C1 Tokyo Metropolitan Inst Gerontol, Tokyo 1730015, Japan.
   Juntendo Univ, Sch Sports Sci, Chiba 2701695, Japan.
   Pusan Natl Univ, Sch Pharm, Pusan 609735, South Korea.
   Semmelweis Univ, Fac Phys Educ & Sport Sci, H-1123 Budapest, Hungary.
C3 Tokyo Metropolitan Institute of Gerontology; Juntendo University; Pusan
   National University; University of Physical Education; Semmelweis
   University
RP Goto, S (corresponding author), Tokyo Metropolitan Inst Gerontol, Tokyo 1730015, Japan.
EM goto@tmig.or.jp
RI Kaneko, Takao/Q-8779-2019; Naito, Hisashi/F-5655-2011
OI Naito, Hisashi/0000-0002-0522-9512; Radak, Zsolt/0000-0003-1297-6804
CR Abbott RD, 2004, JAMA-J AM MED ASSOC, V292, P1447, DOI 10.1001/jama.292.12.1447
   Adcock IM, 2000, PULM PHARMACOL THER, V13, P115, DOI 10.1006/pupt.2000.0243
   Adlard PA, 2005, J NEUROSCI, V25, P4217, DOI 10.1523/JNEUROSCI.0496-05.2005
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395
   Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x
   Calabrese EJ, 2004, EMBO REP, V5, pS37, DOI 10.1038/sj.embor.7400222
   CARNEY JM, 1991, P NATL ACAD SCI USA, V88, P3633, DOI 10.1073/pnas.88.9.3633
   Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715
   CHENG KC, 1992, J BIOL CHEM, V267, P166
   Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552
   Dangour AD, 2004, J GERONTOL A-BIOL, V59, P659
   DAVIES KJA, 1982, BIOCHEM BIOPH RES CO, V107, P1198, DOI 10.1016/S0006-291X(82)80124-1
   Demetrius L, 2006, ANN NY ACAD SCI, V1067, P66, DOI 10.1196/annals.1354.010
   Floyd RA, 2002, ANN NY ACAD SCI, V959, P321, DOI 10.1111/j.1749-6632.2002.tb02103.x
   Fontana L, 2004, P NATL ACAD SCI USA, V101, P6659, DOI 10.1073/pnas.0308291101
   Goto S, 1999, MECH AGEING DEV, V107, P245, DOI 10.1016/S0047-6374(98)00133-X
   Goto S, 2004, ANN NY ACAD SCI, V1019, P471, DOI 10.1196/annals.1297.085
   Goto S., 2004, GERIATR GERONTOL INT, V4, pS79, DOI DOI 10.1111/J.1447-0594.2004.00254.X
   Haddad JJ, 2002, CELL SIGNAL, V14, P879, DOI 10.1016/S0898-6568(02)00053-0
   Hadley EC, 2005, CELL, V120, P557, DOI 10.1016/j.cell.2005.01.030
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hershko A, 2005, CELL DEATH DIFFER, V12, P1191, DOI 10.1038/sj.cdd.4401702
   Hollander J, 1999, AM J PHYSIOL-REG I, V277, pR856, DOI 10.1152/ajpregu.1999.277.3.R856
   Howes RM, 2006, ANN NY ACAD SCI, V1067, P22, DOI 10.1196/annals.1354.004
   Hunt ND, 2006, AGEING RES REV, V5, P125, DOI 10.1016/j.arr.2006.03.006
   Ji LL, 2006, ANN NY ACAD SCI, V1067, P425, DOI 10.1196/annals.1354.061
   JI LL, 1993, MED SCI SPORT EXER, V25, P225
   Judge S, 2005, AM J PHYSIOL-REG I, V289, pR1564, DOI 10.1152/ajpregu.00396.2005
   Kakarla P, 2005, J EXP ZOOL PART A, V303A, P203, DOI 10.1002/jez.a.149
   Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870
   Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004
   Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015
   LEBOURG EL, 2006, BIOGERONTOLOGY, V123, P135
   LEEUWENBURGH C, 1995, ARCH BIOCHEM BIOPHYS, V316, P941, DOI 10.1006/abbi.1995.1125
   LEW H, 1985, FEBS LETT, V185, P262, DOI 10.1016/0014-5793(85)80919-4
   Loft S, 1996, J MOL MED, V74, P297, DOI 10.1007/s001090050031
   Maemura K, 2005, IMMUNOL CELL BIOL, V83, P336, DOI 10.1111/j.1440-1711.2005.01323.x
   Martin GM, 1996, NAT GENET, V13, P25, DOI 10.1038/ng0596-25
   Nakamoto H, 2007, EXP GERONTOL, V42, P287, DOI 10.1016/j.exger.2006.11.006
   Navarro A, 2004, AM J PHYSIOL-REG I, V286, pR505, DOI 10.1152/ajpregu.00208.2003
   Olshansky SJ, 2002, SCI AM, V286, P92, DOI 10.1038/scientificamerican0602-92
   Pang TYC, 2006, NEUROSCIENCE, V141, P569, DOI 10.1016/j.neuroscience.2006.04.013
   Piva R, 2006, ANTIOXID REDOX SIGN, V8, P478, DOI 10.1089/ars.2006.8.478
   Pryor WA, 2006, AM J PHYSIOL-REG I, V291, pR491, DOI 10.1152/ajpregu.00614.2005
   Quindry JC, 2003, MED SCI SPORT EXER, V35, P1139, DOI 10.1249/01.MSS.0000074568.82597.0B
   Radak Z, 2005, BIOGERONTOLOGY, V6, P71, DOI 10.1007/s10522-004-7386-7
   Radák Z, 2004, FASEB J, V18, P749, DOI 10.1096/fj.03-0509fje
   Radák Z, 2001, NEUROCHEM INT, V38, P17, DOI 10.1016/S0197-0186(00)00063-2
   Radák Z, 1999, FREE RADICAL BIO MED, V27, P69, DOI 10.1016/S0891-5849(99)00038-6
   RAY A, 1994, P NATL ACAD SCI USA, V91, P752, DOI 10.1073/pnas.91.2.752
   Rinaldi B, 2006, EXP GERONTOL, V41, P764, DOI 10.1016/j.exger.2006.05.008
   Schaffer S, 2006, FORUM NUTR, V59, P86, DOI 10.1159/000095209
   Singh MAF, 2002, J GERONTOL A-BIOL, V57, pM262, DOI 10.1093/gerona/57.5.M262
   Smoak KA, 2004, MECH AGEING DEV, V125, P697, DOI 10.1016/j.mad.2004.06.010
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   Tillerson JL, 2003, NEUROSCIENCE, V119, P899, DOI 10.1016/S0306-4522(03)00096-4
   van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368
   Vollaard NBJ, 2005, SPORTS MED, V35, P1045, DOI 10.2165/00007256-200535120-00004
NR 62
TC 66
Z9 70
U1 0
U2 8
PU CANADIAN SCIENCE PUBLISHING
PI OTTAWA
PA 65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA
SN 1715-5312
EI 1715-5320
J9 APPL PHYSIOL NUTR ME
JI Appl. Physiol. Nutr. Metab.
PD OCT
PY 2007
VL 32
IS 5
BP 948
EP 953
DI 10.1139/H07-092
PG 6
WC Nutrition & Dietetics; Physiology; Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Nutrition & Dietetics; Physiology; Sport Sciences
GA 229QB
UT WOS:000250818000016
PM 18059621
DA 2024-02-19
ER

PT J
AU CARTER, KC
   POST, DJ
   PAPACONSTANTINOU, J
AF CARTER, KC
   POST, DJ
   PAPACONSTANTINOU, J
TI DIFFERENTIAL EXPRESSION OF THE MOUSE ALPHA-1-ACID GLYCOPROTEIN GENES
   (AGP-1 AND AGP-2) DURING INFLAMMATION AND AGING
SO BIOCHIMICA ET BIOPHYSICA ACTA
LA English
DT Article
DE ALPHA-1-ACID GLYCOPROTEIN GENE; MESSENGER RNA; ACUTE PHASE RESPONSE;
   GENE REGULATION; AGING
ID HEPATOCYTE-STIMULATING FACTOR; ACUTE PHASE REACTANTS; MESSENGER-RNA;
   RAT-LIVER; TRANSCRIPTIONAL REGULATION; PLASMA-PROTEINS; CELLS;
   GLUCOCORTICOIDS; INDUCTION; SEQUENCE
AB In this study we investigated the expression of the Balb/c mouse alpha-1-acid glycoprotein genes.  Mice, like humans, have two distinct alpha-1-acid glycoprotein mRNAs.  As in humans and rats, mouse alpha-1-acid glycoprotein is a strong acute-phase reactant and its expression can be induced by acute-phase stimulatory agents such as bacterial lipopolysaccharides.  Southern analysis and partial sequencing of different alpha-1-acid glycoprotein genomic clones indicated the existence of three distinct alpha-1-acid glycoprotein genes in the Balb/c genome.  Using oligonucleotide hybridization, we showed that two of the three genes were expressed while the third gene was either not expressed or expressed at extremely low levels.  The mRNA levels for the two expressed genes, alpha-1-acid glycoprotein-1 and alpha-1-acid glycoprotein-2, were both induced during the acute-phase response.  However, alpha-1-acid glycoprotein-2 mRNA was present in at least 10-fold higher levels in both induced and uninduced mice.  There were also differences in the development patterns of the two mRNAs in that the constitutive alpha-1-acid glycoprotein-1 mRNA levels increased 20-fold between 2 and 7 months, while alpha-1-acid glycoprotein-2 mRNA pools remained constant.  During the acute-phase response in aged animals, there was an increase in the time required for both mRNAs to respond, and the maximum induced level of both mRNAs decreased.  These studies set the stage for future experiments to determine the mechanisms by which the different alpha-1-acid glycoprotein genes are regulated during the acute-phase response and how aging affects these regulatory processes.
C1 UNIV TEXAS,MED BRANCH,DEPT HUMAN BIOL CHEM & GENET,GALVESTON,TX 77550.
   SHRINERS BURN INST,GALVESTON,TX 77550.
C3 University of Texas System; University of Texas Medical Branch Galveston
RI Papaconstantinou, John/E-3312-2010
CR ANDUS T, 1988, EUR J IMMUNOL, V18, P739, DOI 10.1002/eji.1830180513
   Ausubel FM, 1995, SHORT PROTOCOLS MOL
   BAUMANN H, 1983, J CELL BIOL, V97, P866, DOI 10.1083/jcb.97.3.866
   BAUMANN H, 1984, J BIOL CHEM, V259, P566
   BAUMANN H, 1983, J BIOL CHEM, V258, P563
   BENNETT M, 1980, P NATL ACAD SCI-BIOL, V77, P6109, DOI 10.1073/pnas.77.10.6109
   BIRCH HE, 1986, J BIOL CHEM, V261, P8077
   CARTER KC, 1989, J BIOL CHEM, V264, P515
   CARTER KC, 1989, J BIOL CHEM, V264, P4112
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   CLAWSON AG, 1985, NUCLEAR ENVELOPE STR, P507
   COOPER R, 1987, BIOCHEMISTRY-US, V26, P5244, DOI 10.1021/bi00391a006
   COOPER R, 1986, J BIOL CHEM, V261, P1849
   DENTE L, 1985, NUCLEIC ACIDS RES, V13, P3941, DOI 10.1093/nar/13.11.3941
   DENTE L, 1987, EMBO J, V6, P2289, DOI 10.1002/j.1460-2075.1987.tb02503.x
   DENTE L, 1988, GENE DEV, V2, P259, DOI 10.1101/gad.2.2.259
   KLEIN ES, 1988, MOL ENDOCRINOL, V2, P1343, DOI 10.1210/mend-2-12-1343
   KOJ A, 1984, ACUTE PHASE RESPONSE, P139
   KULKARNI AB, 1985, J BIOL CHEM, V260, P5386
   LEE SC, 1989, DNA-J MOLEC CELL BIO, V8, P245, DOI 10.1089/dna.1.1989.8.245
   LIAO YCJ, 1985, MOL CELL BIOL, V5, P3634, DOI 10.1128/MCB.5.12.3634
   LOWELL CA, 1986, J BIOL CHEM, V261, P8453
   Maniatis T., 1982, MOL CLONING
   MORRONE G, 1989, EMBO J, V8, P3767, DOI 10.1002/j.1460-2075.1989.tb08553.x
   MURTY CVR, 1988, BIOCHIM BIOPHYS ACTA, V949, P27, DOI 10.1016/0167-4781(88)90050-4
   PROWSE KR, 1990, J BIOL CHEM, V265, P10201
   PROWSE KR, 1988, MOL CELL BIOL, V8, P42, DOI 10.1128/MCB.8.1.42
   REINKE R, 1985, J BIOL CHEM, V260, P4397
   ROY A, 1984, 57TH P NOB S STER HO, P439
   ROY AK, 1983, J BIOL CHEM, V258, P123
   SCHREIBER G, 1986, INFLAMMATION, V10, P59, DOI 10.1007/BF00916041
   SHIELS BR, 1987, J BIOL CHEM, V262, P12826
   SIERRA F, 1989, MOL CELL BIOL, V9, P5610, DOI 10.1128/MCB.9.12.5610
   STONE RT, 1987, DEV GENET, V8, P295, DOI 10.1002/dvg.1020080411
   THOMAS T, 1989, J BIOL CHEM, V264, P5784
   VANNICE JL, 1984, P NATL ACAD SCI-BIOL, V81, P4241, DOI 10.1073/pnas.81.14.4241
   VANNICE JL, 1983, DNA-J MOLEC CELL BIO, V2, P205, DOI 10.1089/dna.1983.2.205
   WALLACE RB, 1987, METHOD ENZYMOL, V152, P432
   WON KA, 1990, MOL CELL BIOL, V10, P3965, DOI 10.1128/MCB.10.8.3965
   YAMAMOTO K, 1986, SCIENCE, V232, P227, DOI 10.1126/science.3456645
NR 40
TC 27
Z9 27
U1 1
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0006-3002
J9 BIOCHIM BIOPHYS ACTA
PD JUN 13
PY 1991
VL 1089
IS 2
BP 197
EP 205
DI 10.1016/0167-4781(91)90008-A
PG 9
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA FU400
UT WOS:A1991FU40000008
PM 2054382
DA 2024-02-19
ER

PT J
AU SANCHEZARIAS, JA
   SANCHEZGUTIERREZ, JC
   GUADANO, A
   ALVAREZ, JF
   SAMPER, B
   MATO, JM
   FELIU, JE
AF SANCHEZARIAS, JA
   SANCHEZGUTIERREZ, JC
   GUADANO, A
   ALVAREZ, JF
   SAMPER, B
   MATO, JM
   FELIU, JE
TI CHANGES IN THE INSULIN-SENSITIVE GLYCOSYL-PHOSPHATIDYL-INOSITOL
   SIGNALING SYSTEM WITH AGING IN RAT HEPATOCYTES
SO EUROPEAN JOURNAL OF BIOCHEMISTRY
LA English
DT Article
ID POLAR HEAD GROUP; PHOSPHO-OLIGOSACCHARIDE; PYRUVATE-DEHYDROGENASE;
   GLUCOCORTICOID TREATMENT; GLYCOGEN-PHOSPHORYLASE; RECEPTOR KINASE;
   HEPATOMA-CELLS; GLYCAN; ADIPOCYTES; MIMICS
AB An inositol-phosphate glycan (InsP glycan), which is the polar head group of an insulin-sensitive glycosyl-phosphatidylinositol (glycosyl-PtdIns). has been reported to mimic some insulin actions when added to different types of cells. In connection with this, a specific. time-dependent and energy-dependent transport system for this InsP glycan has been identified in isolated rat hepatocytes [Alvarez, J. F., Sanchez-Arias, J. A., Guadano, A., Estevez, F., Varela, I., Feliu, J. E. & Mato, J. M. (1991) Biochem. J. 274, 369- 374]. Here we have investigated the glycosyl-PtdIns-dependent insulin-signalling system in hepatocytes isolated from either 3-month-old or 24-month-old rats. Aging reduced the stimulatory effect of insulin on [U-C-14]glucose incorporation into glycogen, caused a significant decrease in basal glycosyl-PtdIns levels and blocked the insulin-mediated hydrolysis of this lipid. In 24-month-old rats, we also observed a diminution in the rate of hepatocyte InsP-glycan uptake and a marked reduction of the stimulatory effect of this compound on glycogen synthesis. These results support the hypothesis that insulin resistance associated with aging is accompanied by an impairment of the glycosyl-PtdIns-dependent cellular signalling system.
C1 UNIV AUTONOMA MADRID,HOSP PUERTA HIERRO,SERV ENDOCRINOL EXPTL,SAN MARTIN PORRES 4,E-28035 MADRID,SPAIN.
   INST INVEST BIOMED,MADRID,SPAIN.
C3 Autonomous University of Madrid; Hospital Puerta de Hierro-Majadahonda
RI MATO, JOSE/A-5187-2011; Sanchez-Arias, Juan A./H-6165-2017
OI MATO, JOSE/0000-0003-1264-3153; Sanchez-Arias, Juan
   A./0000-0001-7164-3386
CR ALEMANY S, 1987, NATURE, V330, P77, DOI 10.1038/330077a0
   ALVAREZ JF, 1987, BIOCHEM BIOPH RES CO, V147, P765, DOI 10.1016/0006-291X(87)90996-X
   ALVAREZ JF, 1991, BIOCHEM J, V274, P369, DOI 10.1042/bj2740369
   ALVAREZ L, 1991, MOL ENDOCRINOL, V5, P1062, DOI 10.1210/mend-5-8-1062
   CABELLO MA, 1990, MOL CELL ENDOCRINOL, V68, pR1, DOI 10.1016/0303-7207(90)90173-6
   CARRASCOSA JM, 1989, BIOCHEM BIOPH RES CO, V160, P303, DOI 10.1016/0006-291X(89)91656-2
   DEFRONZO RA, 1981, DIABETES CARE, V4, P493, DOI 10.2337/diacare.4.4.493
   FELIU JE, 1983, ENDOCRINOLOGY, V112, P2120, DOI 10.1210/endo-112-6-2120
   FERGUSON MAJ, 1988, ANNU REV BIOCHEM, V57, P285
   FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908
   GOTTSCHALK WK, 1988, ARCH BIOCHEM BIOPHYS, V261, P175, DOI 10.1016/0003-9861(88)90116-6
   HOWARD AD, 1987, P NATL ACAD SCI USA, V84, P6055, DOI 10.1073/pnas.84.17.6055
   JUHL H, 1990, 4TH INT S INS REC IN, P98
   KELLY KL, 1986, FEBS LETT, V209, P238, DOI 10.1016/0014-5793(86)81119-X
   KELLY KL, 1987, P NATL ACAD SCI USA, V84, P6404, DOI 10.1073/pnas.84.18.6404
   KONO S, 1990, AM J PHYSIOL, V259, pE27, DOI 10.1152/ajpendo.1990.259.1.E27
   Lamprecht W, 1965, METHOD ENZYMAT AN, P543
   LARNER J, 1988, BIOCHEM BIOPH RES CO, V151, P1416, DOI 10.1016/S0006-291X(88)80520-5
   LOW MG, 1988, SCIENCE, V239, P268, DOI 10.1126/science.3276003
   LOW MG, 1987, BIOCHEM J, V244, P1
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MACAULAY SL, 1990, BIOCHEM J, V271, P427, DOI 10.1042/bj2710427
   MACHICAO F, 1990, BIOCHEM J, V266, P909
   MATO JM, 1987, BIOCHEM BIOPH RES CO, V146, P764, DOI 10.1016/0006-291X(87)90595-X
   MATO JM, 1987, J BIOL CHEM, V262, P2131
   MATO JM, 1989, CELL SIGNAL, V1, P143, DOI 10.1016/0898-6568(89)90003-X
   MERIDA I, 1988, FEBS LETT, V236, P251, DOI 10.1016/0014-5793(88)80325-9
   MOJENA M, 1989, METABOLISM, V38, P466, DOI 10.1016/0026-0495(89)90200-X
   NADIV O, 1992, ENDOCRINOLOGY, V130, P1515, DOI 10.1210/en.130.3.1515
   NARIMIYA M, 1984, AM J PHYSIOL, V246, pE397, DOI 10.1152/ajpendo.1984.246.5.E397
   ROMERO G, 1988, SCIENCE, V240, P509, DOI 10.1126/science.3282305
   ROMERO G, 1990, P NATL ACAD SCI USA, V87, P1476, DOI 10.1073/pnas.87.4.1476
   ROWE JW, 1983, J CLIN INVEST, V71, P1581, DOI 10.1172/JCI110914
   RUIZ P, 1991, DIABETES S1, V40, pA108
   SALTIEL AR, 1990, DIABETES CARE, V13, P244, DOI 10.2337/diacare.13.3.244
   SALTIEL AR, 1987, BIOCHEM BIOPH RES CO, V149, P1084, DOI 10.1016/0006-291X(87)90519-5
   SALTIEL AR, 1987, ENDOCRINOLOGY, V120, P967, DOI 10.1210/endo-120-3-967
   SALTIEL AR, 1986, SCIENCE, V233, P967, DOI 10.1126/science.3016898
   SANCHEZARIAS JA, 1992, ENDOCRINOLOGY, V131, P1727, DOI 10.1210/en.131.4.1727
   STRALFORS P, 1990, FEBS LETT, V268, P169, DOI 10.1016/0014-5793(90)81000-E
   THEW CM, 1991, DIABETES S1, V40, pA186
   VARELA I, 1990, BIOCHEM J, V267, P541, DOI 10.1042/bj2670541
   VARELA I, 1990, EUR J BIOCHEM, V188, P213, DOI 10.1111/j.1432-1033.1990.tb15392.x
   VILLALBA M, 1988, BIOCHIM BIOPHYS ACTA, V968, P69, DOI 10.1016/0167-4889(88)90045-6
   Villalba M, 1990, GROWTH FACTORS, V2, P91, DOI 10.3109/08977199009071496
   WHITELEY NM, 1974, J MOL BIOL, V84, P543
   WITTERS LA, 1988, J BIOL CHEM, V263, P8027
NR 47
TC 11
Z9 11
U1 0
U2 2
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0014-2956
J9 EUR J BIOCHEM
JI Eur. J. Biochem.
PD FEB 1
PY 1993
VL 211
IS 3
BP 431
EP 436
DI 10.1111/j.1432-1033.1993.tb17568.x
PG 6
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA KM326
UT WOS:A1993KM32600008
PM 8436106
DA 2024-02-19
ER

PT J
AU García-Fernández, M
   Delgado, G
   Puche, JE
   González-Barón, S
   Cortázar, IC
AF Garcia-Fernandez, Maria
   Delgado, Gloria
   Puche, Juan Enrique
   Gonzalez-Baron, Salvador
   Cortazar, Inma Castilla
TI Low doses of insulin-like growth factor I improve insulin resistance,
   lipid metabolism, and oxidative damage in aging rats
SO ENDOCRINOLOGY
LA English
DT Article
ID ADVANCED LIVER-CIRRHOSIS; IGF-I; HORMONE; BRAIN; EXPRESSION; AGE;
   MITOCHONDRIA; HIPPOCAMPUS; DYSFUNCTION; TRANSPORT
AB GH and IGF-I concentrations decline with age. Age-related changes appear to be linked to decreases in the anabolic hormones, GH and IGF-I. The aim of this study was to investigate the antioxidant, anabolic, and metabolic effects of the IGF-I replacement therapy, at low doses, in aging rats. Three experimental groups were included in this protocol: young healthy controls (17 wk old); untreated old (O) rats (103 wk old); and aging rats (103 wk old) treated with IGF-I during 1 month (2.25 mu g IGF-I/100 g body weight(-1).d(-1)). Compared with young controls, untreated aging rats showed a reduction of IGF-I and testosterone levels, and a decrease of serum total antioxidant status, which were corrected by IGF-I therapy. In addition, untreated O presented increased levels of serum glucose with hyperinsulinemia, cholesterol, and triglycerides, and a reduction of free fatty acid concentrations. IGF-I therapy was able to revert insulin resistance, and to reduce cholesterol and triglycerides levels increasing significantly free fatty acid concentrations. The O group showed higher oxidative damage in brain and liver tissues associated with alterations in antioxidant enzyme activities. IGF-I therapy reduced oxidative damage in brain and liver, normalizing antioxidant enzyme activities and mitochondrial dysfunction. In conclusion, low doses of IGF-I restore circulating IGF-I, improve glucose and lipid metabolism, increase testosterone levels and serum total antioxidant capability, and reduce oxidative damage in brain and liver associated with a normalization of antioxidant enzyme activities and mitochondrial function.
C1 [Puche, Juan Enrique; Cortazar, Inma Castilla] Univ CEU San Pablo, Dept Med Physiol, Sch Med, Madrid 28668, Spain.
   [Garcia-Fernandez, Maria; Delgado, Gloria; Puche, Juan Enrique; Gonzalez-Baron, Salvador; Cortazar, Inma Castilla] Univ Malaga, Dept Physiol, Sch Med, E-29071 Malaga, Spain.
C3 San Pablo CEU University; Universidad de Malaga
RP Cortázar, IC (corresponding author), Univ CEU San Pablo, Dept Med Physiol, Sch Med, Madrid 28668, Spain.
EM iccortazar@uma.es
RI María, garcia-fernandez/H-8196-2017; Puche, Juan E/HMP-2853-2023;
   Castilla-Cortazar, Inma/K-7883-2017; Puche, Juan/L-9132-2014
OI María, garcia-fernandez/0000-0002-6436-1361; Castilla-Cortazar,
   Inma/0000-0002-2230-5927; 
CR Åberg ND, 2006, THESCIENTIFICWORLDJO, V6, P53, DOI 10.1100/tsw.2006.22
   Adamo ML, 2006, AGEING RES REV, V5, P310, DOI 10.1016/j.arr.2006.05.001
   [Anonymous], 1983, METHODS ENZYMATIC AN
   Cardoso SM, 1999, FREE RADICAL BIO MED, V26, P3, DOI 10.1016/S0891-5849(98)00205-6
   CASTILLA C, 1999, AM J PHYSL 1, V276, P37
   Castilla-Cortazar I, 2000, HEPATOLOGY, V31, P592, DOI 10.1002/hep.510310308
   Castilla-Cortázar I, 2004, BMC GASTROENTEROL, V4, DOI 10.1186/1471-230X-4-12
   Castilla-Cortázar I, 2001, LIVER, V21, P405, DOI 10.1034/j.1600-0676.2001.210607.x
   Castilla-Cortázar I, 2004, WORLD J GASTROENTERO, V10, P2529, DOI 10.3748/wjg.v10.i17.2529
   CastillaCortazar I, 1997, GASTROENTEROLOGY, V113, P1682, DOI 10.1053/gast.1997.v113.pm9352873
   CastillaCortazar I, 1997, GASTROENTEROLOGY, V113, P1180, DOI 10.1053/gast.1997.v113.pm9322513
   Ceda G P, 2005, J Endocrinol Invest, V28, P96
   Cemborain A, 1998, J HEPATOL, V28, P122, DOI 10.1016/S0168-8278(98)80211-0
   ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6
   Fernandez S, 2007, GROWTH HORM IGF RES, V17, P89, DOI 10.1016/j.ghir.2007.01.006
   García-Fernández M, 2005, BMC GASTROENTEROL, V5, DOI 10.1186/1471-230X-5-7
   García-Fernández M, 2003, J PHYSIOL BIOCHEM, V59, P145, DOI 10.1007/BF03179879
   Garcia-Segura LM, 2006, NEUROENDOCRINOLOGY, V84, P275, DOI 10.1159/000097485
   Groban L, 2006, J GERONTOL A-BIOL, V61, P28, DOI 10.1093/gerona/61.1.28
   HARRIS ED, 1992, FASEB J, V6, P2675, DOI 10.1096/fasebj.6.9.1612291
   HOGEBOOM GH, 1950, NATURE, V166, P302, DOI 10.1038/166302a0
   Holzenberger M, 2004, EUR J ENDOCRINOL, V151, pS23, DOI 10.1530/eje.0.151S023
   KLINGER B, 1995, J PEDIATR ENDOCR MET, V8, P149
   Kowaltowski AJ, 1999, FREE RADICAL BIO MED, V26, P463, DOI 10.1016/S0891-5849(98)00216-0
   Laron Z, 1996, NEW ENGL J MED, V334, P463, DOI 10.1056/NEJM199602153340711
   LARON Z, 1966, ISRAEL J MED SCI, V2, P152
   LEVINE RL, 1990, METHOD ENZYMOL, V186, P464
   Li Q, 2007, AM J PHYSIOL-HEART C, V292, pH1398, DOI 10.1152/ajpheart.01036.2006
   Maggio M, 2007, AM J PHYSIOL-ENDOC M, V292, pE353, DOI 10.1152/ajpendo.00339.2006
   Maher FO, 2006, J NEUROCHEM, V96, P1560, DOI 10.1111/j.1471-4159.2006.03664.x
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Messier Claude, 2005, Neural Plasticity, V12, P311, DOI 10.1155/NP.2005.311
   Miller Nicholas J., 1993, Biochemical Society Transactions, V21, p95S
   Mirpuri E, 2002, INT J BIOCHEM CELL B, V34, P242, DOI 10.1016/S1357-2725(01)00123-6
   *NAT AC SCI, 1991, GUID PRINC RES INV A
   Navarro A, 2004, AM J PHYSIOL-REG I, V287, pR1244, DOI 10.1152/ajpregu.00226.2004
   OCONNOR JE, 1988, BIOCHEM BIOPH RES CO, V151, P568, DOI 10.1016/0006-291X(88)90632-8
   Perez R, 2001, J HEPATOL, V34, P79
   Picardi A, 1997, J HEPATOL, V26, P191, DOI 10.1016/S0168-8278(97)80026-8
   RICHTER C, 1995, BBA-MOL BASIS DIS, V1271, P67, DOI 10.1016/0925-4439(95)00012-S
   Shimokawa I, 2003, FASEB J, V17, P1108, DOI 10.1096/fj.02-0819fje
   Sonntag WE, 2005, ENDOCRINOLOGY, V146, P2920, DOI 10.1210/en.2005-0058
   Sonntag WE, 1997, ENDOCRINOLOGY, V138, P3515, DOI 10.1210/en.138.8.3515
   Sonntag WE, 2006, AM J PHYSIOL-ENDOC M, V291, pE604, DOI 10.1152/ajpendo.00012.2006
   Sun LY, 2005, NEUROBIOL AGING, V26, P929, DOI 10.1016/j.neurobiolaging.2004.07.010
   Svensson J, 2006, J ENDOCRINOL, V189, P617, DOI 10.1677/joe.1.06631
   Thum T, 2007, CIRC RES, V100, P434, DOI 10.1161/01.RES.0000257912.78915.af
   Tollet-Egnell P, 2000, ENDOCRINOLOGY, V141, P910, DOI 10.1210/en.141.3.910
   Trejo JL, 2004, GROWTH HORM IGF RES, V14, pS39, DOI 10.1016/j.ghir.2004.03.010
   VegaNunez E, 1997, ENDOCRINOLOGY, V138, P3771, DOI 10.1210/en.138.9.3771
   Voss P, 2006, FREE RADICAL RES, V40, P1339, DOI 10.1080/10715760600953859
   Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487
   WU A, 1974, CLIN SCI MOL MED, V47, P359, DOI 10.1042/cs0470359
   ZENOBI PD, 1992, J CLIN INVEST, V90, P2234, DOI 10.1172/JCI116109
NR 54
TC 70
Z9 80
U1 0
U2 11
PU ENDOCRINE SOC
PI WASHINGTON
PA 2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA
SN 0013-7227
EI 1945-7170
J9 ENDOCRINOLOGY
JI Endocrinology
PD MAY
PY 2008
VL 149
IS 5
BP 2433
EP 2442
DI 10.1210/en.2007-1190
PG 10
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 291LX
UT WOS:000255200000043
PM 18187555
OA Bronze
DA 2024-02-19
ER

PT J
AU Cieslak, KP
   Baur, O
   Verheij, J
   Bennink, RJ
   van Gulik, TM
AF Cieslak, Kasia P.
   Baur, Onno
   Verheij, Joanne
   Bennink, Roelof J.
   van Gulik, Thomas M.
TI Liver function declines with increased age
SO HPB
LA English
DT Article
ID FUTURE REMNANT LIVER; ELDERLY-PATIENTS; HEPATOBILIARY SCINTIGRAPHY;
   PREOPERATIVE ASSESSMENT; GRAFT FUNCTION; DONOR AGE; RESECTION;
   HEPATECTOMY; TRANSPLANTATION; OLDER
AB Introduction: Age itself is not considered a contraindication for high impact surgery. However, the aging process of the liver remains largely unknown. This study evaluates age-dependent changes in liver function using a quantitative liver function test.
   Methods: Between January 2005 and December 2014, 508 patients underwent Tc-99m-mebrofenin hepatobiliary scintigraphy (HBS) for the assessment of liver function. These included 203 patients with healthy livers (group A) and 57 patients with HCC and Child-Pugh A (group B). Tc-99m-mebrofenin-uptakerate of the whole liver corrected for body surface area (cMUR) was calculated for all patients. Linear regression analysis was performed to assess the relationship between age and cMUR.
   Results: The mean cMUR was 8.50 +/- 2.05%/min/m(2) and 6.94 +/- 2.03%/min/m(2) in group A and B, respectively. A negative linear correlation was found between patient's age and cMUR in group A, r = 0.244, p = 0.000. In group B, there was no correlation between age and cMUR, however, a trend in decline of liver function with age was noted.
   Conclusion: This study shows that liver function deteriorates with age. Since the regenerative capacity of the liver correlates with liver function, this finding should be taken into account when assessing surgical risk in patients considered for major liver resection.
C1 [Cieslak, Kasia P.; Baur, Onno; van Gulik, Thomas M.] Acad Med Ctr, Dept Surg, IWO 1-A1-113-1, NL-1100 DD Amsterdam, Netherlands.
   [Bennink, Roelof J.] Acad Med Ctr, Dept Nucl Med, Amsterdam, Netherlands.
   [Verheij, Joanne] Acad Med Ctr, Dept Pathol, Amsterdam, Netherlands.
C3 University of Amsterdam; Academic Medical Center Amsterdam; University
   of Amsterdam; Academic Medical Center Amsterdam; University of
   Amsterdam; Academic Medical Center Amsterdam
RP Cieslak, KP; van Gulik, TM (corresponding author), Acad Med Ctr, Dept Surg, IWO 1-A1-113-1, NL-1100 DD Amsterdam, Netherlands.
EM k.p.cieslak@amc.uva.nl; t.m.vangulik@amc.uva.nl
OI Verheij, Joanne/0000-0003-1283-630X
FU National Institutes of Health; Wellcome Trust; Howard Hughes Medical
   Institute (HHMI)
FX None of the authors has received funding related to this subject from
   the following organizations: National Institutes of Health; Wellcome
   Trust; Howard Hughes Medical Institute (HHMI); and other(s).
CR Adam R, 2010, BRIT J SURG, V97, P366, DOI 10.1002/bjs.6889
   Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   Bennink RJ, 2004, J NUCL MED, V45, P965
   Borchert D, 2005, TRANSPL INT, V18, P709, DOI 10.1111/j.1432-2277.2005.00128.x
   Cescon M, 2003, ARCH SURG-CHICAGO, V138, P547, DOI 10.1001/archsurg.138.5.547
   Cieslak KP, 2014, DIGEST SURG, V31, P255, DOI 10.1159/000364836
   Cieslak KP, CASE REP GASTROENTER, V9, P353
   de Graaf W, 2011, BRIT J SURG, V98, P825, DOI 10.1002/bjs.7456
   de Graaf W, 2010, J GASTROINTEST SURG, V14, P369, DOI 10.1007/s11605-009-1085-2
   Ekman M, 1996, NUCL MED COMMUN, V17, P235, DOI 10.1097/00006231-199603000-00011
   Enkhbold C, J GASTROENTEROL HEPA, V30, P1217
   Erdogan D, 2004, LIVER INT, V24, P117, DOI 10.1111/j.1478-3231.2004.00901.x
   Ettorre GM, 2001, BRIT J SURG, V88, P73, DOI 10.1046/j.1365-2168.2001.01629.x
   Ferrero A, 2005, WORLD J SURG, V29, P1101, DOI 10.1007/s00268-005-7768-2
   Huang J, 2009, J GASTROINTEST SURG, V13, P1627, DOI 10.1007/s11605-009-0933-4
   Ikegami T, 2000, TRANSPLANTATION, V70, P1703, DOI 10.1097/00007890-200012270-00007
   Menon KV, 2006, J AM COLL SURGEONS, V203, P677, DOI 10.1016/j.jamcollsurg.2006.07.025
   Poos MJJC, WAT IS NEDERLAND LEV
   Reddy SK, 2011, J AM COLL SURGEONS, V212, P787, DOI 10.1016/j.jamcollsurg.2010.12.048
   Schiergens TS, 2014, J GASTROINTEST SURG, V18, P1161, DOI 10.1007/s11605-014-2516-2
   Serra MP, 2015, J HEPATOL, V62, P1341, DOI 10.1016/j.jhep.2015.01.015
   Shirabe K, 2009, WORLD J SURG, V33, P1927, DOI 10.1007/s00268-009-0122-3
   TSUKAMOTO I, 1993, BIOCHEM MOL BIOL INT, V30, P773
   van den Broek MAJ, 2008, LIVER INT, V28, P767, DOI 10.1111/j.1478-3231.2008.01777.x
   Washburn WK, 1996, TRANSPLANTATION, V61, P1062, DOI 10.1097/00007890-199604150-00013
   YERSIZ H, 1995, TRANSPLANTATION, V60, P790, DOI 10.1097/00007890-199510270-00005
   Zacharias T, 2004, ANN SURG, V240, P858, DOI 10.1097/01.sla.0000143272.52505.d6
NR 27
TC 52
Z9 53
U1 1
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1365-182X
EI 1477-2574
J9 HPB
JI HPB
PD AUG
PY 2016
VL 18
IS 8
BP 691
EP 696
DI 10.1016/j.hpb.2016.05.011
PG 6
WC Gastroenterology & Hepatology; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Surgery
GA DT0XI
UT WOS:000381205900008
PM 27485064
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Davydov, VV
   Zakharchenko, IV
   Ovsyannikov, VG
AF Davydov, VV
   Zakharchenko, IV
   Ovsyannikov, VG
TI Free radical processes in the liver of adult and old rats during stress
SO BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Article
DE oxidative stress; immobilization; aging; liver
ID OXIDATIVE STRESS; LIPID-PEROXIDATION; EXERCISE
AB We measured the content of free radical lipid peroxidation products, intensity of induced lipid peroxidation, and concentration of carbonylated proteins in the liver of adult (10-12 months) and old rats (22-25 months) subjected to 30-min immobilization. Changes in the intensity of induced lipid peroxidation in homogenates and accumulation of carbonylated proteins in subcellular liver fractions indicate that immobilization stimulates free radical generation in the liver of both adult and old rats. The intensity of this process in old rats surpassed that in adult animals.
C1 Ukraine Acad Med Sci, Inst Child & Adolescent Welf, Lab Age Specif Endocrinol & Metab, Kharkov, Ukraine.
   Rostov State Med Univ, Dept Pathophysiol, Rostov Na Donu, Russia.
C3 National Academy of Medical Sciences of Ukraine; Rostov State Medical
   University
RP Davydov, VV (corresponding author), Ukraine Acad Med Sci, Inst Child & Adolescent Welf, Lab Age Specif Endocrinol & Metab, Kharkov, Ukraine.
RI Davydov, Vadim/ISU-9984-2023
OI Davydov, Vadim/0000-0002-3347-1832; Ovsyannikov,
   Viktor/0000-0002-8775-0781
CR Allen RG, 2000, FREE RADICAL BIO MED, V28, P463, DOI 10.1016/S0891-5849(99)00242-7
   Barbieri M, 2003, EXP GERONTOL, V38, P137, DOI 10.1016/S0531-5565(02)00153-5
   Bejma J, 2000, ACTA PHYSIOL SCAND, V169, P343
   DUBININ EE, 2000, VOPR MED KHIM, P36
   Dunlop RA, 2002, FREE RADICAL BIO MED, V33, P894, DOI 10.1016/S0891-5849(02)00958-9
   ESTERBAUER H, 1985, BIOCHEM J, V228, P363, DOI 10.1042/bj2280363
   Faff J, 1997, EUR J APPL PHYSIOL O, V75, P413, DOI 10.1007/s004210050181
   MENSHIKOVA EV, 1994, BIOCH OXIDATIVE STRE
   Muller G., 1986, GZAMTE UM MED GRENZG, V41, P673
   NOHL H, 1990, AGE, V13, P104
   PARAMONOVA GI, 1994, DOKL AKAD NAUK UKRAN, P174
   RECKNAGEL RO, 1966, NATURE, V210, P1162, DOI 10.1038/2101162a0
   Rice-Evans CA, 1991, LAB TECHNIQUES BIOCH
   SCHMUCKER DL, 1998, J GERONTOL, V53, P15
NR 14
TC 9
Z9 13
U1 0
U2 1
PU CONSULTANTS BUREAU
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0007-4888
J9 B EXP BIOL MED+
JI Bull. Exp. Biol. Med.
PD FEB
PY 2004
VL 137
IS 2
BP 139
EP 142
DI 10.1023/B:BEBM.0000028123.70410.cf
PG 4
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 844ES
UT WOS:000223140900010
PM 15273758
DA 2024-02-19
ER

PT J
AU Zhao, FF
   Chang, YF
   Gao, L
   Qin, XM
   Du, GH
   Zhang, X
   Zhou, YZ
AF Zhao, Fanfan
   Chang, Yanfen
   Gao, Li
   Qin, Xuemei
   Du, Guanhua
   Zhang, Xiang
   Zhou, Yuzhi
TI Protective effects of <i>Scutellaria baicalensis</i> Georgi extract on
   D-galactose induced aging rats
SO METABOLIC BRAIN DISEASE
LA English
DT Article
DE Scutellaria baicalensis; Aging; D-galactose; Metabolomics
ID NMR-BASED METABONOMICS; COGNITIVE IMPAIRMENT; GLUTATHIONE SYNTHESIS;
   METABOLOMICS APPROACH; MEMORY IMPAIRMENTS; ALZHEIMERS-DISEASE; OXIDATIVE
   DAMAGE; BRAIN; MICE; STRESS
AB Scutellaria baicalensis Georgi (SBG), a traditional Chinese herb, has attracted considerable attention for its wide range of pharmacological activities. This study aimed to investigate the intervention effects of SBG ethanol extract on aging rats induced by D-galactose (D-gal) and to explore potential mechanisms by serum and liver metabolic profiles. The aging rats were induced by the D-gal (100 mg/kg) for 10 weeks continuously with subcutaneous injection, while the control rats received physiological saline. Two other groups of rats were administered with 100 mg/kg/day and 200 mg/kg/day of SBG by oral route following D-gal injections. The abilities of spatial and learning memory were evaluated by open-field test and Morris water maze test. Then, some biochemical indexes related to cognitive ability and aging were measured. Histopathological feature in hippocampal region was observed by Hematoxylin and eosin (HE) staining. The changes of metabolic profiles were evaluated using proton nuclear magnetic resonance (H-1 NMR) spectroscopy coupled with multivariate data analysis. Results showed that SBG could significantly improve the learning and memory functions, reducing oxidative damage and histological abnormalities of hippocampus neurons. In addition, significant differences in the metabolic profiles were observed both in serum and liver between the model group and the control group. After the treatment using SBG, the levels of these metabolites are significantly changed back to their similar levels in the control group. These metabolic changes are related to the disturbance in amino acid metabolism, glycometabolism and choline metabolism. Hence, SBG may have the potential to improve neurodegeneration and provide brain protection.
C1 [Zhao, Fanfan; Gao, Li; Qin, Xuemei; Du, Guanhua; Zhang, Xiang; Zhou, Yuzhi] Shanxi Univ, Modern Res Ctr Tradit Chinese Med, 92 Wucheng Rd, Taiyuan, Shanxi, Peoples R China.
   [Zhao, Fanfan] Shanxi Univ, Coll Chem & Chem Engn, 92 Wucheng Rd, Taiyuan, Shanxi, Peoples R China.
   [Chang, Yanfen] Shanxi Prov Children Hosp, Matern & Child Care Hosp, Taiyuan, Shanxi, Peoples R China.
   [Du, Guanhua] Chinese Acad Med Sci, Inst Mat Med, Beijing, Peoples R China.
   [Du, Guanhua] Peking Union Med Coll, Beijing, Peoples R China.
   [Zhang, Xiang] Univ Louisville, Dept Chem, Louisville, KY 40292 USA.
C3 Shanxi University; Shanxi University; Chinese Academy of Medical
   Sciences - Peking Union Medical College; Institute of Materia Medica -
   CAMS; Chinese Academy of Medical Sciences - Peking Union Medical
   College; Peking Union Medical College; University of Louisville
RP Zhou, YZ (corresponding author), Shanxi Univ, Modern Res Ctr Tradit Chinese Med, 92 Wucheng Rd, Taiyuan, Shanxi, Peoples R China.
EM zhouyuzhi@sxu.edu.cn
RI liu, jingwen/JQW-9270-2023
FU Applied basic research project of Shanxi Province [201601D021164];
   Innovation project of higher education institutions in Shanxi Province
   [2016120]; Construction of the Science and Technology Basic Condition
   Platform of Shanxi Province [2014091022]; Program of Science and
   Technology of Shanxi Province [20140313008-14]
FX We acknowledge financial supports from the Applied basic research
   project of Shanxi Province (No. 201601D021164), the Innovation project
   of higher education institutions in Shanxi Province (No. 2016120), the
   Construction of the Science and Technology Basic Condition Platform of
   Shanxi Province (No. 2014091022), and the Program of Science and
   Technology of Shanxi Province (No. 20140313008-14).
CR An L, 2015, RSC ADV, V5, P84048, DOI 10.1039/c5ra16563f
   An YP, 2013, J PROTEOME RES, V12, P3755, DOI 10.1021/pr400398b
   Anisimov VN, 2013, CRIT REV ONCOL HEMAT, V87, P201, DOI 10.1016/j.critrevonc.2013.01.005
   Aydin AF, 2016, METAB BRAIN DIS, V31, P337, DOI 10.1007/s11011-015-9755-0
   Baranyi A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160542
   Bouatra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073076
   Budni J, 2016, BEHAV BRAIN RES, V302, P35, DOI 10.1016/j.bbr.2015.12.041
   Chang Yan-fen, 2016, Yaoxue Xuebao, V51, P86, DOI 10.16438/j.0513-4870.2015-0597
   Chaung HC, 2013, FOOD CHEM, V138, P342, DOI 10.1016/j.foodchem.2012.10.082
   Chiu CY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149823
   Chu H, 2016, J CHROMATOGR B, V1015, P50, DOI 10.1016/j.jchromb.2016.02.007
   Figueira J, 2016, MOL BIOSYST, V12, P2562, DOI 10.1039/c6mb00233a
   Fu CW, 2011, J PHARMACEUT BIOMED, V55, P1067, DOI 10.1016/j.jpba.2011.03.011
   Gao J, 2015, BEHAV BRAIN RES, V293, P27, DOI 10.1016/j.bbr.2015.06.045
   Gao L, 2016, REJUV RES, V19, P414, DOI 10.1089/rej.2015.1760
   Gong YS, 2016, EXP GERONTOL, V74, P21, DOI 10.1016/j.exger.2015.11.020
   Haider S, 2015, LIFE SCI, V124, P110, DOI 10.1016/j.lfs.2015.01.016
   Haider S, 2014, AGE, V36, P1291, DOI 10.1007/s11357-014-9653-0
   Hwang YK, 2011, J ETHNOPHARMACOL, V137, P681, DOI 10.1016/j.jep.2011.06.025
   Iriondo-DeHond A, 2016, MOLECULES, V21, DOI 10.3390/molecules21060721
   Jamwal S, 2016, PHYSIOL BEHAV, V155, P180, DOI 10.1016/j.physbeh.2015.12.015
   Jeong K, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-14
   Kojima-Yuasa A, 2016, CHEM-BIOL INTERACT, V257, P101, DOI 10.1016/j.cbi.2016.07.031
   Lin XD, 2016, SCI REP-UK, V6, DOI 10.1038/srep36474
   Lin ZH, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI 10.1155/2012/692621
   Lu J, 2007, BIOCHEM PHARMACOL, V74, P1078, DOI 10.1016/j.bcp.2007.07.007
   Luo L, 2016, J ETHNOPHARMACOL, V186, P257, DOI 10.1016/j.jep.2016.03.059
   Qu Z, 2016, PHYSIOL BEHAV, V154, P114, DOI 10.1016/j.physbeh.2015.11.016
   Tomassini A, 2014, J PROTEOME RES, V13, P5848, DOI 10.1021/pr500748r
   Toroser D, 2007, BIOCHEM J, V405, P583, DOI 10.1042/BJ20061868
   Wang HF, 2015, J FUNCT FOODS, V17, P459, DOI 10.1016/j.jff.2015.04.014
   Wang T, 2015, J PHARM PHARMACOL, V67, P1284, DOI 10.1111/jphp.12413
   Wiest R, 2012, GUT, V61, P297, DOI 10.1136/gutjnl-2011-300779
   Wijeyesekera A, 2012, J PROTEOME RES, V11, P2224, DOI 10.1021/pr2010154
   Xian YF, 2014, NEUROCHEM INT, V76, P42, DOI 10.1016/j.neuint.2014.06.011
   Xie SW, 2016, FISH SHELLFISH IMMUN, V55, P233, DOI 10.1016/j.fsi.2016.05.033
   Xu LQ, 2016, FOOD FUNCT, V7, P4545, DOI 10.1039/c6fo01057a
NR 37
TC 16
Z9 17
U1 1
U2 52
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0885-7490
EI 1573-7365
J9 METAB BRAIN DIS
JI Metab. Brain Dis.
PD OCT
PY 2018
VL 33
IS 5
BP 1401
EP 1412
DI 10.1007/s11011-018-0229-z
PG 12
WC Endocrinology & Metabolism; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Neurosciences & Neurology
GA GU3DD
UT WOS:000445154200004
PM 29855978
DA 2024-02-19
ER

PT J
AU Zhao, F
   Yuan, J
   Lu, G
   Zhang, LH
   Chen, ZY
   Wáng, YXJ
AF Zhao, Feng
   Yuan, Jing
   Lu, Gang
   Zhang, Li H.
   Chen, Zhi Y.
   Wang, Yi-Xiang J.
TI T1ρ relaxation time in brain regions increases with ageing: an
   experimental MRI observation in rats
SO BRITISH JOURNAL OF RADIOLOGY
LA English
DT Article
ID ACUTE CEREBRAL-ISCHEMIA; SPIN-LOCK; HYPERTENSIVE-RATS; LIVER FIBROSIS;
   T-1-RHO; T1RHO; DISEASE; QUANTIFICATION; DISPERSION; PERFUSION
AB Objective: T1 rho variation is associated with neurodegenerative diseases. This study aims to observe T1 rho relaxation time changes in rat brains associated with normal ageing in Sprague-Dawley (SD) rats, Wistar Kyoto (WKY) rats and spontaneously hypertension rats (SHRs).
   Methods: 18 male SD rats, 11 male WKY rats and 11 male SHRs were used. T1 rho measurement was performed at 3-T MR with a spin-lock frequency of 500Hz. SD rats were scanned at the ages of 5, 8, 10 and 15 months. SHRs and WKY rats were scanned at the ages of 6, 9 and 12 months.
   Results: For SD rats, T1r at the thalamus, hippocampus and frontal cortices increased significantly from 5 to 15 months (p < 0.05). For the WKY rats and SHRs, the T1 rho values in the thalamus, hippocampus and frontal cortices also increased significantly from 6 to 12 months (p < 0.05). Furthermore, T1 rho in the thalamus, hippocampus and frontal cortices of SHRs were consistently higher than those of WKY rats at the ages of 6, 9 and 12 months (p < 0.05). The percentage regional T1 rho differences between WKY rats and SHRs did not change during ageing.
   Conclusion: An increase in T1 rho was associated with agerelated changes of the rat brain.
   Advances in knowledge: An age-related and hypertensionrelated T1 rho increase in rat brain regions was observed in the thalamus, hippocampus and frontal cortical regions of the rat brain.
C1 [Zhao, Feng; Yuan, Jing; Wang, Yi-Xiang J.] Chinese Univ Hong Kong, Prince Wales Hosp, Fac Med, Dept Imaging & Intervent Radiol, Shatin, Hong Kong, Peoples R China.
   [Yuan, Jing] Hong Kong Sanat & Hosp, Med Phys & Res Dept, Hong Kong, Hong Kong, Peoples R China.
   [Lu, Gang] Chinese Univ Hong Kong, Prince Wales Hosp, Fac Med, Div Neurosurg, Shatin, Hong Kong, Peoples R China.
   [Zhang, Li H.] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China.
   [Chen, Zhi Y.] Guangzhou Med Univ, Affiliated Hosp 3, Lab Ultrasound Mol Imaging, Guangzhou, Guangdong, Peoples R China.
C3 Chinese University of Hong Kong; Prince of Wales Hospital; Chinese
   University of Hong Kong; Prince of Wales Hospital; Chinese University of
   Hong Kong; Guangzhou Medical University
RP Wáng, YXJ (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Fac Med, Dept Imaging & Intervent Radiol, Shatin, Hong Kong, Peoples R China.
EM yixiang_wang@cuhk.edu.hk
RI Wang, Yi Xiang/I-5952-2016; Yuan, Jing/E-4236-2013
OI Wang, Yi Xiang/0000-0001-5697-0717; Yuan, Jing/0000-0001-8112-3608
FU Hong Kong Research Grants Council General Research Fund [475911];
   Natural Science Foundation of China [81201076];  [SEG_CUHK02]
FX This study was supported by Hong Kong Research Grants Council General
   Research Fund 475911, SEG_CUHK02 and Natural Science Foundation of China
   grant 81201076.
CR Allkemper T, 2014, RADIOLOGY, V271, P408, DOI 10.1148/radiol.13130342
   Amenta Francesco, 2010, Italian Journal of Anatomy and Embryology, V115, P13
   BENDEL P, 1992, BRAIN RES, V574, P224, DOI 10.1016/0006-8993(92)90820-Y
   Borthakur A, 2008, NEUROIMAGE, V41, P1199, DOI 10.1016/j.neuroimage.2008.03.030
   Borthakur A, 2006, J MAGN RESON IMAGING, V24, P1011, DOI 10.1002/jmri.20751
   Charagundla SR, 2003, J MAGN RESON, V162, P113, DOI 10.1016/S1090-7807(02)00197-0
   Chen W, 2015, QUANT IMAGING MED SU, V5, P583, DOI 10.3978/j.issn.2223-4292.2015.08.05
   Deng M, 2012, BRIT J RADIOL, V85, pE590, DOI 10.1259/bjr/98745548
   Gonyea JV, 2015, J MAGN RESON IMAGING, V42, P1623, DOI 10.1002/jmri.24954
   Gröhn OHJ, 1999, MAGNET RESON MED, V42, P268, DOI 10.1002/(SICI)1522-2594(199908)42:2<268::AID-MRM8>3.0.CO;2-A
   Gröhn OHJ, 2000, J CEREBR BLOOD F MET, V20, P1457
   Haris M, 2011, J NEUROIMAGING, V21, pe86, DOI 10.1111/j.1552-6569.2010.00467.x
   Haris M, 2011, J NEUROL, V258, P380, DOI 10.1007/s00415-010-5762-6
   Haris M, 2009, J MAGN RESON IMAGING, V29, P1008, DOI 10.1002/jmri.21735
   Heiland S, 2002, NEUROSCI LETT, V334, P157, DOI 10.1016/S0304-3940(02)01073-X
   Hughes EJ, 2012, NEUROIMAGE, V63, P1134, DOI 10.1016/j.neuroimage.2012.07.043
   Johnson CP, 2015, J MAGN RESON IMAGING, V41, P242, DOI 10.1002/jmri.24518
   Jokivarsi KT, 2010, STROKE, V41, P2335, DOI 10.1161/STROKEAHA.110.587394
   Jokivarsi KT, 2009, J CEREBR BLOOD F MET, V29, P206, DOI 10.1038/jcbfm.2008.113
   KNOX CA, 1980, ACTA NEUROPATHOL, V51, P1, DOI 10.1007/BF00688844
   LAMMINEN AE, 1993, BRIT J RADIOL, V66, P783, DOI 10.1259/0007-1285-66-789-783
   Lee TH, 2011, EXP NEUROL, V227, P314, DOI 10.1016/j.expneurol.2010.12.003
   Mäkelä HI, 2002, J CEREBR BLOOD F MET, V22, P547
   Markkola AT, 1996, RADIOLOGY, V200, P369, DOI 10.1148/radiology.200.2.8685328
   NAPOLEONE P, 1990, ARCH GERONTOL GERIAT, V10, P173, DOI 10.1016/0167-4943(90)90017-Z
   Nestrasil I, 2010, J NEUROL, V257, P964, DOI 10.1007/s00415-009-5446-2
   Nobler Mitchell S, 2002, Curr Psychiatry Rep, V4, P51, DOI 10.1007/s11920-002-0013-x
   Regatte RR, 2006, J MAGN RESON IMAGING, V23, P547, DOI 10.1002/jmri.20536
   TAJIMA A, 1993, HYPERTENSION, V21, P105, DOI 10.1161/01.HYP.21.1.105
   Tomassoni D, 2010, BRAIN RES, V1325, P155, DOI 10.1016/j.brainres.2010.02.023
   Virta A, 1998, ACAD RADIOL, V5, P104, DOI 10.1016/S1076-6332(98)80130-X
   Wang YXJ, 2014, QUANT IMAGING MED SU, V4, P152, DOI 10.3978/j.issn.2223-4292.2014.04.04
   Wang YXJ, 2013, QUANT IMAGING MED SU, V3, P54, DOI 10.3978/j.issn.2223-4292.2013.02.09
   Wang YXJ, 2013, EUR RADIOL, V23, P228, DOI 10.1007/s00330-012-2591-2
   Wang YXJ, 2011, RADIOLOGY, V259, P712, DOI 10.1148/radiol.11101638
   Watts R, 2014, J MAGN RESON IMAGING, V40, P376, DOI 10.1002/jmri.24358
   Wells JA, 2015, NEUROIMAGE, V111, P369, DOI 10.1016/j.neuroimage.2015.02.023
   Witschey WRT, 2008, J MAGN RESON IMAGING, V28, P744, DOI 10.1002/jmri.21444
   Witschey WRT, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-37
   Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044
   Yuan J., 2013, MED IMAGING TECHNOLO, P565
   Yuan J, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/24/8185
   Yuan J, 2012, PHYS MED BIOL, V57, P1631, DOI 10.1088/0031-9155/57/6/1631
   Zhang YF, 2009, J MAGN RESON IMAGING, V30, P1139, DOI 10.1002/jmri.21954
   Zhao F, 2013, QUANT IMAG MED SURG, V3, P308, DOI 10.3978/j.issn.2223-4292.2013.12.10
   Zhao F, 2012, KOREAN J RADIOL, V13, P736, DOI 10.3348/kjr.2012.13.6.736
   Zhao F, 2012, EUR RADIOL, V22, P1709, DOI 10.1007/s00330-012-2419-0
   Zhu YJ, 2015, MAGN RESON MED, V73, P263, DOI 10.1002/mrm.25130
NR 48
TC 12
Z9 12
U1 0
U2 11
PU BRITISH INST RADIOLOGY
PI LONDON
PA 36 PORTLAND PLACE, LONDON W1N 4AT, ENGLAND
SN 0007-1285
EI 1748-880X
J9 BRIT J RADIOL
JI Br. J. Radiol.
PY 2016
VL 89
IS 1057
AR 20140704
DI 10.1259/bjr.20140704
PG 8
WC Radiology, Nuclear Medicine & Medical Imaging
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Radiology, Nuclear Medicine & Medical Imaging
GA DB3NN
UT WOS:000368418500002
PM 26529226
OA Green Published
DA 2024-02-19
ER

PT J
AU MIYAMURA, Y
   OHTSU, H
   NIWA, O
   KURISHITA, A
   WATANABE, H
   SADO, T
   ONO, T
AF MIYAMURA, Y
   OHTSU, H
   NIWA, O
   KURISHITA, A
   WATANABE, H
   SADO, T
   ONO, T
TI COMPARISON OF THE AGE- AND TUMOR-ASSOCIATED CHANGES IN THE C-MYC GENE
   METHYLATION IN MOUSE-LIVER
SO GERONTOLOGY
LA English
DT Article
DE C-MYC GENE; DNA METHYLATION; LIVER; TUMOR
ID HUMAN HEPATOCELLULAR-CARCINOMA; DNA METHYLATION; COLORECTAL
   TUMORIGENESIS; AGING PROCESS; RAS ONCOGENE; H-RAS; HYPOMETHYLATION;
   MICE; CANCER; EXPRESSION
AB Study of DNA methylation of the c-myc gene in liver tumors of BCF1 mice treated with various agents revealed frequent alteration from that in normal liver. The alteration, however, was complex and showed either an increase or a decrease of methylation to various degrees. On the other hand, the tumors obtained from middle-aged C3H/He mice, which develop liver tumors spontaneously at a high incidence rate starting in middle age, showed predominantly increases of methylation in the c-myc gene, while the large tumors found in older mice revealed decreases. The normal part of the liver showed a slight gradual age-dependent increase. These suggest that hypermethylation of the c-myc gene is common to aging and early tumor development in liver. Thus the alteration of DNA methylation seems to be a good clue to investigate why the tumor incidence rate increases rapidly as individuals grow older.
C1 TOHOKU UNIV, SCH MED, DEPT RADIAT RES, 2-1 SEIRYOMACHI, SENDAI, MIYAGI 980, JAPAN.
   NATL INST RADIOL SCI, DEPT PHYSIOL & PATHOL, CHIBA 260, JAPAN.
   HIROSHIMA UNIV, NUCL MED & BIOL RES INST, DEPT PATHOL, HIROSHIMA 730, JAPAN.
   HIROSHIMA UNIV, NUCL MED & BIOL RES INST, DEPT CANC RES, HIROSHIMA 730, JAPAN.
C3 Tohoku University; National Institutes for Quantum Science & Technology;
   Hiroshima University; Hiroshima University
CR BESTOR TH, 1992, EMBO J, V11, P2611, DOI 10.1002/j.1460-2075.1992.tb05326.x
   BHAVE MR, 1988, CARCINOGENESIS, V9, P343, DOI 10.1093/carcin/9.3.343
   BUCHMANN A, 1991, P NATL ACAD SCI USA, V88, P911, DOI 10.1073/pnas.88.3.911
   CONI P, 1992, CARCINOGENESIS, V13, P497, DOI 10.1093/carcin/13.3.497
   DIZIK M, 1991, CARCINOGENESIS, V12, P1307, DOI 10.1093/carcin/12.7.1307
   ENGLER P, 1991, CELL, V65, P939, DOI 10.1016/0092-8674(91)90546-B
   FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I
   FEINBERG AP, 1988, CANCER RES, V48, P1159
   FOX TR, 1990, CANCER RES, V50, P4014
   GARCEA R, 1989, CARCINOGENESIS, V10, P1183, DOI 10.1093/carcin/10.7.1183
   GOELZ SE, 1985, SCIENCE, V228, P187, DOI 10.1126/science.2579435
   HOLLIDAY R, 1987, MUTAT RES, V181, P215, DOI 10.1016/0027-5107(87)90098-4
   Jones P A, 1990, Adv Cancer Res, V54, P1, DOI 10.1016/S0065-230X(08)60806-4
   KANEKO Y, 1985, JPN J CANCER RES, V76, P1136
   KOHN RR, 1971, AGING ANIMALS OBSERV, P105
   MAKOS M, 1992, P NATL ACAD SCI USA, V89, P1929, DOI 10.1073/pnas.89.5.1929
   MAYSHOOPES LL, 1989, INT REV CYTOL, V114, P181
   MIYAMURA Y, 1993, MUTAT RES, V295, P63, DOI 10.1016/0921-8734(93)90002-K
   NAMBU S, 1987, JPN J CANCER RES, V78, P695
   NIWA O, 1989, JPN J CANCER RES, V80, P212, DOI 10.1111/j.1349-7006.1989.tb02294.x
   ONO T, 1993, AGE AGEING, V22, pS34, DOI 10.1093/ageing/22.suppl_1.S34
   ONO T, 1990, MUTAT RES, V237, P239, DOI 10.1016/0921-8734(90)90005-C
   ONO T, 1989, MECH AGEING DEV, V50, P27, DOI 10.1016/0047-6374(89)90056-0
   ONO T, 1985, MECH AGEING DEV, V32, P227, DOI 10.1016/0047-6374(85)90082-X
   ONO T, 1989, MUTAT RES, V219, P39, DOI 10.1016/0921-8734(89)90039-8
   PITOT HC, 1990, PROG CLIN BIOL RES, V331, P311
   POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0
   RAO PM, 1989, CARCINOGENESIS, V10, P933, DOI 10.1093/carcin/10.5.933
   REIK W, 1990, DEVELOPMENT, P99
   RUMSBY PC, 1991, CARCINOGENESIS, V12, P2331, DOI 10.1093/carcin/12.12.2331
   SAPIENZA C, 1987, NATURE, V328, P251, DOI 10.1038/328251a0
   SHARRARD RM, 1992, BRIT J CANCER, V65, P667, DOI 10.1038/bjc.1992.142
   SILVERMAN AL, 1989, CANCER RES, V49, P3468
   SMITH GS, 1973, J NATL CANCER I, V50, P1195, DOI 10.1093/jnci/50.5.1195
   UEHARA Y, 1989, ONCOGENE, V4, P1023
   VORCE RL, 1991, J TOXICOL ENV HEALTH, V34, P367, DOI 10.1080/15287399109531574
   WAINFAN E, 1992, CANCER RES, V52, pS2071
   YASUZAWA K, 1992, CANCER LETT, V67, P157, DOI 10.1016/0304-3835(92)90139-M
NR 38
TC 9
Z9 9
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0304-324X
EI 1423-0003
J9 GERONTOLOGY
JI Gerontology
PY 1993
VL 39
SU 1
BP 3
EP 10
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA LP544
UT WOS:A1993LP54400002
PM 8365669
DA 2024-02-19
ER

PT J
AU Song, HD
   Zhang, L
   Luo, YK
   Zhang, SQ
   Li, B
AF Song, Hongdong
   Zhang, Ling
   Luo, Yongkang
   Zhang, Siqi
   Li, Bo
TI Effects of collagen peptides intake on skin ageing and platelet release
   in chronologically aged mice revealed by cytokine array analysis
SO JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
LA English
DT Article
DE collagen peptides; action mechanism; chronologically aged mice; cytokine
   array; anti-skin ageing; platelet release
ID ENDOTHELIAL GROWTH-FACTOR; PROLIFERATION; MODULATION; EXPRESSION;
   MECHANISM; PATHWAY; DISEASE; IGFBP-2
AB Action mechanisms underlying various biological activities of collagen peptides (CPs) remained to be elucidated. Cytokines may play an important role in mediating these health benefits of CPs. This study aimed to systemically examine the cytokines in skin and blood regulated by CPs intake. Thirteen-month-old female Kunming mice were administered with CPs for 2months (0 or 400mg/kg bodyweight/day). The cytokines in skin and plasma were analysed using a 53-cytokine array and corresponding ELISA kits. In skin, CPs intake significantly down-regulated placenta growth factor (PIGF-2), insulin-like growth factor (IGF)-binding protein (IGFBP) -2 and IGFBP-3, and up-regulated platelet factor 4 (PF4), serpin E1 and transforming growth factor (TGF)-(1). CPs treatment also increased the type I collagen mRNA and protein levels and improved the aged skin collagen fibres. In plasma, nine cytokines were significantly down-regulated by CPs intake compared to the model group: fibroblast growth factor (FGF)-2, heparin-binding (HB) epidermal growth factor (EGF)-like growth factor (HB-EGF), hepatocyte growth factor (HGF), platelet-derived growth factor (PDGF)-AB/BB, vascular endothelial growth factor (VEGF), chemokine (C-X-C motif) ligand 1 (KC), matrix metalloproteinase (MMP)-9, interleukin (IL)-1 and IL-10; 2 cytokines were significantly up-regulated, including TGF-(1) and serpin F1. Furthermore, CPs intake significantly decreased the level of platelet release indicators in the plasma and washed platelets, including PF4, granule membrane protein (GMP)-140, -thromboglobulin and serotonin. These results provide a mechanism underlying anti-skin ageing by CPs intake and highlight potential application of CPs as a healthcare supplement to combat cancer and cardiovascular disease by inhibiting platelet release.
C1 [Song, Hongdong; Zhang, Ling; Zhang, Siqi; Li, Bo] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing, Peoples R China.
   [Luo, Yongkang; Li, Bo] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing, Peoples R China.
   [Li, Bo] Beijing Higher Inst Engn Res Ctr Anim Prod, Beijing, Peoples R China.
C3 China Agricultural University; China Agricultural University
RP Li, B (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing, Peoples R China.; Li, B (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, Beijing, Peoples R China.; Li, B (corresponding author), Beijing Higher Inst Engn Res Ctr Anim Prod, Beijing, Peoples R China.
EM libo@cau.edu.cn
FU National Key Technology Research and development Program of the Ministry
   of Science and Technology of China [2015BAD16B00, 2015BAD16B01]; China
   Agriculture Research System [CARS-46]
FX This study was supported by the National Key Technology Research and
   development Program of the Ministry of Science and Technology of China
   (2015BAD16B00; 2015BAD16B01) and the China Agriculture Research System
   (CARS-46). H.S. and B.L. designed research. H.S., L.Z. and S.Z.
   conducted research; H.S., Y.L. and B.L. analysed data; H.S. and B.L.
   wrote the manuscript; B.L. had primary responsibility for final content.
   All authors read and approved the final manuscript.
CR Badimon L, 2014, J INTERN MED, V276, P618, DOI 10.1111/joim.12296
   Battinelli EM, 2011, BLOOD, V118, P1359, DOI 10.1182/blood-2011-02-334524
   Borg M, 2013, CLIMACTERIC, V16, P514, DOI 10.3109/13697137.2013.802303
   Brandt K, 2015, GROWTH HORM IGF RES, V25, P34, DOI 10.1016/j.ghir.2014.11.001
   Bredella MA, 2013, BONE, V53, P336, DOI 10.1016/j.bone.2012.12.046
   Chacko BK, 2013, LAB INVEST, V93, P690, DOI 10.1038/labinvest.2013.53
   Chung HY, 2009, AGEING RES REV, V8, P18, DOI 10.1016/j.arr.2008.07.002
   Chung JH, 2001, J INVEST DERMATOL, V117, P1218, DOI 10.1046/j.0022-202x.2001.01544.x
   Flurkey K, 2004, BEST PRACT RES CL EN, V18, P407, DOI 10.1016/j.beem.2004.02.001
   Fowler DM, 2014, NAT METHODS, V11, P801, DOI [10.1038/nmeth.3027, 10.1038/NMETH.3027]
   Fu P, 2006, J AM SOC NEPHROL, V17, P3105, DOI 10.1681/ASN.2005121366
   Haratake A, 2015, J FUNCT FOODS, V16, P174, DOI 10.1016/j.jff.2015.04.017
   He T, 2009, J INVEST DERMATOL, V129, pS41
   Heijnen H, 2015, J THROMB HAEMOST, V13, P2141, DOI 10.1111/jth.13147
   Higgins Paul J, 2014, J Mol Genet Med, V8, P101
   HITIHARPER J, 1978, SCIENCE, V199, P991, DOI 10.1126/science.203038
   Hubatsch I, 2007, NAT PROTOC, V2, P2111, DOI 10.1038/nprot.2007.303
   Iacomino G, 2016, FOOD CHEM, V212, P537, DOI 10.1016/j.foodchem.2016.06.014
   Inoue N, 2016, J SCI FOOD AGR, V96, P4077, DOI 10.1002/jsfa.7606
   Jung SK, 2016, J CELL MOL MED, V20, P909, DOI 10.1111/jcmm.12780
   Kim HK, 2014, FOOD FUNCT, V5, P573, DOI 10.1039/c3fo60509d
   Kuespert S, 2015, J CELL MOL MED, V19, P1010, DOI 10.1111/jcmm.12492
   Kyllönen H, 2004, BRIT J DERMATOL, V150, P1174, DOI 10.1111/j.1365-2133.2004.06017.x
   Leem KH, 2013, J MED FOOD, V16, P447, DOI 10.1089/jmf.2012.2461
   Li F, 2016, BIOCHEM BIOPH RES CO, V478, P1106, DOI 10.1016/j.bbrc.2016.08.076
   Li X., 2017, J CELL MOL MED
   Liang JA, 2010, J MED FOOD, V13, P757, DOI 10.1089/jmf.2009.1279
   Middleton RK, 2007, J VASC SURG, V45, P574, DOI 10.1016/j.jvs.2006.11.020
   Minekus M, 2014, FOOD FUNCT, V5, P1113, DOI 10.1039/c3fo60702j
   Mohebali D, 2014, J AM GERIATR SOC, V62, P529, DOI 10.1111/jgs.12700
   Neri M, 2015, CURR VASC PHARMACOL, V13, P26, DOI 10.2174/15701611113119990003
   Nissinen LM, 2015, J INVEST DERMATOL, V135, P2350, DOI 10.1038/jid.2015.246
   Odorisio T, 2006, J DERMATOL SCI, V41, P11, DOI 10.1016/j.jdermsci.2005.08.008
   Ohara H, 2010, J DERMATOL, V37, P330, DOI 10.1111/j.1346-8138.2010.00827.x
   Oliveira SM, 2016, ACTA BIOMATER, V32, P129, DOI 10.1016/j.actbio.2015.12.028
   Palomo I, 2008, MOL MED REP, V1, P179
   Papiewska-Pajak I, 2017, J CELL MOL MED, V21, P1139, DOI 10.1111/jcmm.13045
   Passaretti F, 2014, PLATELETS, V25, P252, DOI 10.3109/09537104.2013.809060
   PEPPER MS, 1993, EXP CELL RES, V204, P356, DOI 10.1006/excr.1993.1043
   Proksch E, 2014, SKIN PHARMACOL PHYS, V27, P113, DOI 10.1159/000355523
   Ren QS, 2007, MOL BIOL CELL, V18, P24, DOI 10.1091/mbc.E06-09-0785
   Song HD, 2017, FOOD FUNCT, V8, P1538, DOI [10.1039/C6FO01397J, 10.1039/c6fo01397j]
   Südel KM, 2005, PHOTOCHEM PHOTOBIOL, V81, P581, DOI 10.1562/2004-06-16-RA-202.1
   Sun Z, 2017, J CELL MOL MED, V21, P336, DOI 10.1111/jcmm.12968
   Tang LH, 2015, J BIOSCI BIOENG, V119, P558, DOI 10.1016/j.jbiosc.2014.10.011
   Varani J, 2006, AM J PATHOL, V168, P1861, DOI 10.2353/ajpath.2006.051302
   Varani J, 2000, J INVEST DERMATOL, V114, P480, DOI 10.1046/j.1523-1747.2000.00902.x
   Wang C, 2016, FOOD RES INT, V81, P188, DOI 10.1016/j.foodres.2015.12.013
   Yang HL, 2016, J CELL MOL MED, V20, P1542, DOI 10.1111/jcmm.12847
   Zhu ZQ, 2015, MOL MED REP, V12, P1157, DOI 10.3892/mmr.2015.3535
NR 50
TC 29
Z9 32
U1 3
U2 37
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1582-1838
EI 1582-4934
J9 J CELL MOL MED
JI J. Cell. Mol. Med.
PD JAN
PY 2018
VL 22
IS 1
BP 277
EP 288
DI 10.1111/jcmm.13317
PG 12
WC Cell Biology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Research & Experimental Medicine
GA FR0NQ
UT WOS:000418759200026
PM 28922541
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Kramar, B
   Suput, D
   Milisav, I
AF Kramar, Barbara
   Suput, Dusan
   Milisav, Irina
TI Differential p16 expression levels in the liver, hepatocytes and
   hepatocellular cell lines
SO PEERJ
LA English
DT Article
DE p16; Gene expression; Hepatocytes; HepG2; Liver; FaO; Hepatoma
ID TUMOR-SUPPRESSOR P16(INK4A); APOPTOSIS; PROTEIN; GENE; PHOSPHORYLATION;
   STRESS; GROWTH; CDKN2A; S6K1; BETA
AB Background: One of the most frequently deleted genes in cancer is CDKN2A encoding p16. This protein is often overexpressed in senescent cells, while its suppression can bypass the oncogene-induced senescence to enable transformation and tumorigenesis. The roles of the protein p16 are recently being expanded from the cell cycle progression regulator to the cellular regulator interacting in several different pathways. Yet data on its liver and liver cells' expression are inconclusive. Methods: The expression of the p16 gene in liver and liver cells was determined by RT-qPCR and compared to its protein amounts by western blotting. Results: p16 is expressed at low levels in the liver and rat hepatocytes. Its expression varies from none to the considerable levels in the examined hepatocellular carcinoma cell lines (FaO and HepG2) and in immortalized mouse hepatocytes. Such significant expression differences of an important cellular regulator warrant the need to closely examine the differences in biochemical pathways correlated with the p16 expression when using hepatocytes and hepatoma liver models.
C1 [Kramar, Barbara; Suput, Dusan; Milisav, Irina] Univ Ljubljana, Inst Pathophysiol, Fac Med, Zaloska 4, Ljubljana, Slovenia.
   [Milisav, Irina] Univ Ljubljana, Lab Oxidat Stress Res, Fac Hlth Sci, Zdravstvena Pot 5, Ljubljana, Slovenia.
C3 University of Ljubljana; University of Ljubljana
RP Milisav, I (corresponding author), Univ Ljubljana, Inst Pathophysiol, Fac Med, Zaloska 4, Ljubljana, Slovenia.; Milisav, I (corresponding author), Univ Ljubljana, Lab Oxidat Stress Res, Fac Hlth Sci, Zdravstvena Pot 5, Ljubljana, Slovenia.
EM irina.milisav@mf.uni-lj.si
OI Kramar, Barbara/0000-0002-4913-5462
FU TREATMENT project [H2020-MSCA-ITN:721236]; Slovenian Research Agency
   [P3-0019]; Word Federation of Scientists
FX This research was funded by H2020-MSCA-ITN:721236 TREATMENT project and
   from the Slovenian Research Agency (research core funding No. P3-0019) .
   BK acknowledges the financial support of the Word Federation of
   Scientists within the framework of the Slovenian Science Foundation. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Angelico G, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11040713
   Atlas, 2021, THP HUM PROT ATL CDK
   Banic B, 2011, CELL MOL BIOL LETT, V16, P328, DOI 10.2478/s11658-011-0007-y
   Buj R, 2019, MOL CELL ONCOL, V6, DOI 10.1080/23723556.2019.1677140
   Buj R, 2019, CELL REP, V28, P1971, DOI 10.1016/j.celrep.2019.07.084
   Caja L, 2007, CELL SIGNAL, V19, P683, DOI 10.1016/j.cellsig.2006.09.002
   Choi BY, 2005, NAT STRUCT MOL BIOL, V12, P699, DOI 10.1038/nsmb960
   Csárdi G, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005206
   Csepregi A, 2008, Z GASTROENTEROL, V46, DOI [10.1055/s-2008-1037553, DOI 10.1055/S-2008-1037553]
   Cui CH, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0819-6
   González-Rodriguez A, 2009, HEPATOLOGY, V50, P216, DOI 10.1002/hep.22915
   Gump J, 2003, J BIOL CHEM, V278, P6619, DOI 10.1074/jbc.C200622200
   Huang JZ, 2003, WORLD J GASTROENTERO, V9, P84, DOI 10.3748/wjg.v9.i1.84
   Jenkins NC, 2011, ONCOGENE, V30, P265, DOI 10.1038/onc.2010.419
   Jiao Y, 2018, BIOCHEMISTRY-MOSCOW+, V83, P1289, DOI 10.1134/S0006297918110019
   Kita R, 1996, INT J CANCER, V67, P176, DOI 10.1002/(SICI)1097-0215(19960717)67:2<176::AID-IJC4>3.0.CO;2-Q
   Lee MH, 2013, J CELL SCI, V126, P1744, DOI 10.1242/jcs.113613
   Li JN, 2011, BIOCHEMISTRY-US, V50, P5566, DOI 10.1021/bi200642e
   Liu YS, 2016, CELL, V165, P535, DOI 10.1016/j.cell.2016.03.014
   Lv XY, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008106
   Marolt TP, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240754
   Matsuda Y, 2006, MED MOL MORPHOL, V39, P169, DOI 10.1007/s00795-006-0339-2
   Murai Y, 2005, PATHOL RES PRACT, V201, P109, DOI 10.1016/j.prp.2005.01.002
   Nipic D, 2010, HEPATOLOGY, V51, P2140, DOI 10.1002/hep.23598
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Pardo V, 2015, FOOD CHEM TOXICOL, V80, P298, DOI 10.1016/j.fct.2015.03.029
   Pascal LE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-246
   Proell Verena, 2007, Comp Hepatol, V6, P1, DOI 10.1186/1476-5926-6-1
   Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370
   Sanchez A, 1996, J BIOL CHEM, V271, P7416, DOI 10.1074/jbc.271.13.7416
   Sancho P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045285
   STONE S, 1995, CANCER RES, V55, P2988
   Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262
   Tyagi E, 2017, ONCOTARGET, V8, P55848, DOI 10.18632/oncotarget.19862
   Wolff B, 1999, ONCOGENE, V18, P2663, DOI 10.1038/sj.onc.1202617
   Zhao R, 2016, EBIOMEDICINE, V8, P30, DOI 10.1016/j.ebiom.2016.04.017
NR 36
TC 2
Z9 2
U1 0
U2 3
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
J9 PEERJ
JI PeerJ
PD NOV 2
PY 2021
VL 9
AR 12358
DI 10.7717/peerj.12358
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA YJ5ED
UT WOS:000744554200001
PM 34760375
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Ohishi, S
   Toshinai, K
   Kizaki, T
   Haga, S
   Fukuda, K
   Nagata, N
   Ohno, H
AF Ohishi, S
   Toshinai, K
   Kizaki, T
   Haga, S
   Fukuda, K
   Nagata, N
   Ohno, H
TI Effects of aging and/or training on antioxidant enzyme system in
   diaphragm of mice
SO RESPIRATION PHYSIOLOGY
LA English
DT Article
DE aging; enzyme, SOD; exercise, diaphragm; mammals, mouse; muscle,
   diaphragm; superoxide dismutase, SOD
ID SKELETAL-MUSCLE; SUPEROXIDE-DISMUTASE; ACUTE EXERCISE; LIVER
AB We investigated the effects of aging and/or swimming training on the antioxidant enzyme system in diaphragm of mice. Young (2 months old) and old (26 months old) male mice were swimming-trained for 6 weeks (1 h/day, 5 days/week). Cu,Zn-Superoxide dismutase (Cu,Zn-SOD) activity was significantly upregulated with aging, and swimming training definitely enhanced the activity only in young mice. Neither aging nor swimming training had overt effect on Mn-SOD activity. Glutathione peroxidase activity in young mice was significantly increased after training, but not in old mice. Both of immunoreactive Cu,Zn-SOD and Mn-SOD were significantly increased with aging but were unaffected by swimming training, Consequently, physical training significantly enhanced the specific activity of Cu,Zn-SOD in young mice, but not in old mice, Meanwhile, swimming training significantly increased xanthine oxidase activity in both age groups, the extent of the increase being greater in old mice than in young mice. We concluded that the antioxidant enzyme system in mouse diaphragm trends to be upregulated with aging, but that swimming training improved the system only in young mouse diaphragm.
C1 NATL DEF MED COLL, DEPT HYG, TOKOROZAWA, SAITAMA 359, JAPAN.
   UNIV TSUKUBA, INST HLTH & SPORT SCI, TSUKUBA, IBARAKI 305, JAPAN.
   NATL DEF MED COLL, CTR LAB ANIM SCI, TOKOROZAWA, SAITAMA 359, JAPAN.
   NATL DEF MED COLL, DEPT INTERNAL MED 3, TOKOROZAWA, SAITAMA 359, JAPAN.
C3 National Defense Medical College - Japan; University of Tsukuba;
   National Defense Medical College - Japan; National Defense Medical
   College - Japan
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Crapo J D, 1978, Methods Enzymol, V53, P382
   CRISWELL D, 1993, MED SCI SPORT EXER, V25, P1135
   FRIED R, 1974, METHOD ENZYMAT AN, V2, P664
   GERSHON H, 1973, P NATL ACAD SCI USA, V70, P909, DOI 10.1073/pnas.70.3.909
   HARDT H, 1985, BIOCHIM BIOPHYS ACTA, V831, P13, DOI 10.1016/0167-4838(85)90143-8
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HELLSTENWESTING Y, 1993, HISTOCHEMISTRY, V100, P215, DOI 10.1007/BF00269094
   JENKINS RR, 1988, SPORTS MED, V5, P156, DOI 10.2165/00007256-198805030-00003
   JI LL, 1988, ARCH BIOCHEM BIOPHYS, V263, P150, DOI 10.1016/0003-9861(88)90623-6
   LAWLER JM, 1994, RESP PHYSIOL, V96, P139, DOI 10.1016/0034-5687(94)90122-8
   LEEUWENBURGH C, 1994, AM J PHYSIOL, V267, pR439, DOI 10.1152/ajpregu.1994.267.2.R439
   NOHL H, 1978, EUR J BIOCHEM, V82, P563, DOI 10.1111/j.1432-1033.1978.tb12051.x
   OhIshi S, 1995, MECH AGEING DEV, V84, P65, DOI 10.1016/0047-6374(95)01637-F
   Ohno H., 1994, EXERCISE OXYGEN TOXI, P127
   ORGEL LE, 1970, P NATL ACAD SCI USA, V67, P1476, DOI 10.1073/pnas.67.3.1476
   POWERS SK, 1994, RESP PHYSIOL, V95, P227, DOI 10.1016/0034-5687(94)90118-X
   POWERS SK, 1992, J APPL PHYSIOL, V72, P1068, DOI 10.1152/jappl.1992.72.3.1068
   Saltin B, 1983, HDB PHYSL 10, P555, DOI DOI 10.1007/S00421-005-0088-2
   Shepherd D., 1969, CITRATE SYNTHASE RAT, V13, P11
   SOHAL RS, 1994, FREE RADICAL BIO MED, V16, P621, DOI 10.1016/0891-5849(94)90062-0
   SUZUKI K, 1993, CARCINOGENESIS, V14, P1881, DOI 10.1093/carcin/14.9.1881
   Tappel A L, 1978, Methods Enzymol, V52, P506
   TOLMASOFF JM, 1980, P NATL ACAD SCI-BIOL, V77, P2777, DOI 10.1073/pnas.77.5.2777
   VANLUNTEREN E, 1995, RESP PHYSIOL, V99, P113, DOI 10.1016/0034-5687(94)00077-D
NR 25
TC 24
Z9 28
U1 0
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0034-5687
J9 RESP PHYSIOL
JI Respir. Physiol.
PD SEP
PY 1996
VL 105
IS 3
BP 195
EP 202
DI 10.1016/0034-5687(96)00057-6
PG 8
WC Physiology; Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology; Respiratory System
GA VQ420
UT WOS:A1996VQ42000005
PM 8931179
DA 2024-02-19
ER

PT J
AU Wong, AM
   Ding, XF
   Wong, AM
   Xu, MJ
   Zhang, LY
   Leung, HHW
   Chan, AWH
   Song, QX
   Kwong, J
   Chan, LKY
   Man, MT
   He, M
   Chen, JN
   Zhang, Z
   You, WX
   Lau, C
   Yu, AL
   Wei, YY
   Yuan, YF
   Lai, PBS
   Zhao, JM
   Man, K
   Yu, J
   Kahn, M
   Wong, NTL
AF Wong, Alissa Michelle
   Ding, Xiaofan
   Wong, Aikha Melissa
   Xu, Mingjing
   Zhang, Luyao
   Leung, Howard Ho-Wai
   Chan, Anthony Wing-Hung
   Song, Qi Xiu
   Kwong, Joseph
   Chan, Loucia Kit-Ying
   Man, Matthew
   He, Mian
   Chen, Jinna
   Zhang, Zhe
   You, Wenxing
   Lau, Coleen
   Yu, Allen
   Wei, Yingying
   Yuan, Yunfei
   Lai, Paul Bo-San
   Zhao, Jingmin
   Man, Kwan
   Yu, Jun
   Kahn, Michael
   Wong, Nathalie
TI Unique molecular characteristics of NAFLD-associated liver cancer
   accentuate β-catenin/TNFRSF19-mediated immune evasion
SO JOURNAL OF HEPATOLOGY
LA English
DT Article; Early Access
DE Hepatocellular carcinoma; NAFLD; somatic variants; beta Catenin; immune
   escape
ID CELLULAR SENESCENCE; MUTATIONAL SIGNATURES; CATENIN; ACTIVATION;
   EXPRESSION; DISEASE; OBESITY; TARGET; FUTURE; REPAIR
AB Background & Aims: The hepatic manifestation of the metabolic syndrome, non-alcoholic fatty liver disease (NAFLD), can lead to the development of hepatocellular carcinoma (HCC). Despite a strong causative link, NAFLD-HCC is often underrepresented in systematic genome explorations.
   Methods: Herein, tumor-normal pairs from 100 patients diagnosed with NAFLD-HCC were subject to next-generation sequencing. Bioinformatic analyses were performed to identify key genomic, epigenomic and transcriptomic events associated with the pathogenesis of NAFLD-HCC. Establishment of primary patient-derived NAFLD-HCC culture was used as a representative human model for downstream in vitro investigations of the underlying CTNNB1 S45P driver mutation. A syngeneic immuno-competent mouse model was used to further test the involvement of CTNNB1(mut) and TNFRSF19 in reshaping the tumor microenvironment.
   Results: Mutational processes operative in the livers of patients with NAFLD inferred susceptibility to tumor formation through defective DNA repair pathways. Dense promoter mutations and dysregulated transcription factors accentuated activated transcriptional regulation in NAFLD-HCC, in particular the enrichment of MAZ-MYC activities. Somatic events common in HCCs arising from NAFLD and viral hepatitis B infection underscore similar driver pathways, although an incidence shift highlights CTNNB1(mut) dominance in NAFLD-HCC (33%). Immune exclusion correlated evidently with CTNNB1(mut). Chromatin immunoprecipitation-sequencing integrated with transcriptome and immune profiling revealed a unique transcriptional axis, wherein CTNNB1(mut) leads to an upregulation of TNFRSF19 which subsequently represses senescence-associated secretory phenotype-like cytokines (including IL6 and CXCL8). This phenomenon could be reverted by the Wnt-modulator ICG001.
   Conclusions: The unique mutational processes in the livers of patients with NAFLD and NAFLD-HCC allude to a "field effect" involving a gain-of-function role of CTNNB1 mutations in immune exclusion.
   Lay summary: The increasing prevalence of metabolic syndrome in adult populations means that NAFLD is poised to be the major cause of liver cancer in the 21st century. We showed a strong "field effect" in the livers of patients with NAFLD, wherein activated beta-catenin was involved in reshaping the tumor-immune microenvironment. (c) 2022 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).
C1 [Wong, Alissa Michelle; Ding, Xiaofan; Wong, Aikha Melissa; Xu, Mingjing; Zhang, Luyao; You, Wenxing; Lai, Paul Bo-San; Wong, Nathalie] Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Dept Surg, Shatin NT, Hong Kong, Peoples R China.
   [Leung, Howard Ho-Wai; Chan, Anthony Wing-Hung; Song, Qi Xiu; Man, Matthew; He, Mian; Chen, Jinna; Zhang, Zhe; Lau, Coleen; Wong, Nathalie] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Shatin NT, Hong Kong, Peoples R China.
   [Kwong, Joseph; Chan, Loucia Kit-Ying] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Shatin NT, Hong Kong, Peoples R China.
   [Yu, Allen] Chinese Univ Hong Kong, Sch Life Sci, Shatin NT, Hong Kong, Peoples R China.
   [Wei, Yingying] Chinese Univ Hong Kong, Dept Stat, Shatin NT, Hong Kong, Peoples R China.
   [Yuan, Yunfei] Sun Yat sen Univ, Canc Ctr, Dept Hepatobiliary Surg, Guangzhou, Peoples R China.
   [Zhao, Jingmin] Beijing 302 Hosp, Dept Pathol & Hepatol, Beijing, Peoples R China.
   [Man, Kwan] Univ Hong Kong, LKS Fac Med, Dept Surg, Pokfulam, Hong Kong, Peoples R China.
   [Yu, Jun] Chinese Univ Hong Kong, State Key Lab Digest Dis, Shatin NT, Hong Kong, Peoples R China.
   [Yu, Jun; Wong, Nathalie] Chinese Univ Hong Kong, Dept Med & Therapeut, Shatin NT, Hong Kong, Peoples R China.
   [Kahn, Michael] Beckman Res Inst City Hope, Dept Mol Med, Duarte, CA 91010 USA.
   [Wong, Nathalie] Chinese Univ Hong Kong, State Key Lab Translat Oncol, Shatin NT, Hong Kong, Peoples R China.
   [Wong, Nathalie] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Shatin, Hong Kong, Peoples R China.
C3 Chinese University of Hong Kong; Chinese University of Hong Kong;
   Chinese University of Hong Kong; Chinese University of Hong Kong;
   Chinese University of Hong Kong; Sun Yat Sen University; Fifth Medical
   Center of Chinese PLA General Hospital; University of Hong Kong; Chinese
   University of Hong Kong; Chinese University of Hong Kong; City of Hope;
   Beckman Research Institute of City of Hope; Chinese University of Hong
   Kong; Chinese University of Hong Kong; Prince of Wales Hospital
RP Wong, NTL (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Shatin, Hong Kong, Peoples R China.
EM natwong@cuhk.edu.hk
RI Wei, Yingying/HLW-6638-2023; Yu, Jun/D-8569-2015; DING,
   Xiaofan/GLS-2274-2022; zhou, chuyue/JOJ-9001-2023; Xu,
   Mingjing/AIA-3151-2022; Lai, Paul BS/K-8556-2015; Chan, Anthony Wing
   Hung/HGB-4311-2022; XU, Mingjing/AAF-9230-2021; Chen,
   Jinna/GXM-9165-2022; Kwong, Joseph/H-2368-2013
OI Yu, Jun/0000-0001-5008-2153; Xu, Mingjing/0000-0001-7499-4448; Lai, Paul
   BS/0000-0002-9469-6728; Chan, Anthony Wing Hung/0000-0002-1771-163X; XU,
   Mingjing/0000-0002-9128-1172; Chen, Jinna/0000-0002-6244-8009; Kwong,
   Joseph/0000-0002-3380-6882; Wong, Alissa/0000-0001-7858-1368; HE,
   MIAN/0000-0002-4813-5487; DING, Xiaofan/0000-0003-2565-7757; Yuan,
   Yunfei/0000-0003-2467-3683; Man, Ka-Hou/0000-0001-8388-1541; Yu, Allen
   Chi-Shing/0000-0002-9568-8316; Leung, Howard Ho Wai/0000-0001-9930-1783
FU Hong Kong Research Grants Council Collaborative Research Fund
   [C4041-17]; Area of Excellence Scheme [AoE/M-401/20]; Theme-based
   Research Schemes [T12-403/11, T12-703/19R]; Research Impact Fund
   [R4017-18]; Chinese University of Hong Kong
FX This work was supported by the Hong Kong Research Grants Council
   Collaborative Research Fund (Ref. C4041-17) , Area of Excellence Scheme
   (Ref. AoE/M-401/20) , Theme-based Research Schemes (Ref. T12-403/11;
   T12-703/19R) , Research Impact Fund (Ref. R4017-18) and Direct Grant
   from The Chinese University of Hong Kong. The authors are thankful to
   the Charlie Lee Foundation.
CR Alexandrov LB, 2020, NATURE, V578, P94, DOI 10.1038/s41586-020-1943-3
   Ally A, 2017, CELL, V169, P1327, DOI 10.1016/j.cell.2017.05.046
   Anstee QM, 2019, NAT REV GASTRO HEPAT, V16, P411, DOI 10.1038/s41575-019-0145-7
   Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Canovas B, 2021, NAT REV MOL CELL BIO, V22, P346, DOI 10.1038/s41580-020-00322-w
   Chen B, 2020, NAT REV GASTRO HEPAT, V17, P238, DOI 10.1038/s41575-019-0240-9
   Chiappini F, 2017, SCI REP-UK, V7, DOI 10.1038/srep46658
   Curtius K, 2018, NAT REV CANCER, V18, P19, DOI 10.1038/nrc.2017.102
   de Galarreta MR, 2019, CANCER DISCOV, V9, P1124, DOI 10.1158/2159-8290.CD-19-0074
   Deng CC, 2018, CANCER RES, V78, P3469, DOI 10.1158/0008-5472.CAN-17-3205
   Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101
   Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083
   Estes C, 2018, HEPATOLOGY, V67, P123, DOI 10.1002/hep.29466
   Faget DV, 2019, NAT REV CANCER, V19, P439, DOI 10.1038/s41568-019-0156-2
   Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69
   Frey N, 2018, NAT REV GASTRO HEPAT, V15, P81, DOI 10.1038/nrgastro.2017.146
   Gordon SR, 2017, NATURE, V545, P495, DOI 10.1038/nature22396
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732
   Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025
   Huang DIQ, 2021, NAT REV GASTRO HEPAT, V18, P223, DOI 10.1038/s41575-020-00381-6
   Huby T, 2022, NAT REV IMMUNOL, V22, P429, DOI 10.1038/s41577-021-00639-3
   Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Letouzé E, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01358-x
   Li FL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13839
   Li X, 2021, NAT REV CANCER, V21, P541, DOI 10.1038/s41568-021-00383-9
   Liu HJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001249
   Llovet JM, 2021, NAT REV DIS PRIMERS, V7, DOI 10.1038/s41572-020-00240-3
   Luke JJ, 2019, CLIN CANCER RES, V25, P3074, DOI 10.1158/1078-0432.CCR-18-1942
   Ma C, 2016, NATURE, V531, P253, DOI 10.1038/nature16969
   Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822
   Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016
   Papatheodoridi AM, 2020, HEPATOLOGY, V71, P363, DOI 10.1002/hep.30834
   Perera D, 2016, NATURE, V532, P259, DOI 10.1038/nature17437
   Pfister D, NATURE, V592, P450
   Pinter M, 2021, GUT, V70, P204, DOI 10.1136/gutjnl-2020-321702
   Pinyol R, 2021, J HEPATOL, V75, P865, DOI 10.1016/j.jhep.2021.04.049
   Puri P, 2009, HEPATOLOGY, V50, P1827, DOI 10.1002/hep.23229
   Remondini D, 2005, P NATL ACAD SCI USA, V102, P6902, DOI 10.1073/pnas.0502081102
   Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252
   Setten RL, 2019, NAT REV DRUG DISCOV, V18, P421, DOI 10.1038/s41573-019-0017-4
   Singh VK, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01119-5
   Stauffer JK, 2012, HEPATOLOGY, V56, P1567, DOI 10.1002/hep.25674
   Tang YC, 2021, THERANOSTICS, V11, P5232, DOI 10.7150/thno.53417
   Totoki Y, 2014, NAT GENET, V46, P1267, DOI 10.1038/ng.3126
   Wolf MJ, 2014, CANCER CELL, V26, P549, DOI 10.1016/j.ccell.2014.09.003
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Yu J, 2013, SEMIN CANCER BIOL, V23, P483, DOI 10.1016/j.semcancer.2013.07.003
   Zeller KI, 2001, J BIOL CHEM, V276, P48285, DOI 10.1074/jbc.M108506200
   Zhao LH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12992
NR 53
TC 12
Z9 12
U1 11
U2 27
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0168-8278
EI 1600-0641
J9 J HEPATOL
JI J. Hepatol.
PD 2022 AUG
PY 2022
VL 77
IS 2
BP 410
EP 423
DI 10.1016/j.jhep.2022.03.015
EA JUL 2022
PG 15
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 3O9YR
UT WOS:000837192900021
PM 35351523
OA Green Accepted, hybrid
DA 2024-02-19
ER

PT J
AU Nishimura, K
   Shiina, R
   Kashiwagi, K
   Igarashi, K
AF Nishimura, K
   Shiina, R
   Kashiwagi, K
   Igarashi, K
TI Decrease in polyamines with aging and their ingestion from food and
   drink
SO JOURNAL OF BIOCHEMISTRY
LA English
DT Article
DE aging; food; health; polyamines; tissue
ID SPERMIDINE/SPERMINE N-1-ACETYLTRANSFERASE;
   ALPHA-DIFLUOROMETHYLORNITHINE; CELL-GROWTH; ORNITHINE DECARBOXYLASE;
   POLYPEPTIDE-SYNTHESIS; BOVINE LYMPHOCYTES; ESCHERICHIA-COLI; SPERMINE;
   RATS; INHIBITION
AB Changes in polyamine levels during aging were measured in 3-, 10- and 26-week-old female mice. The level of polyamines in pancreas, brain, and uterus was maintained during these periods.. The level of spermidine slightly decreased in intestine, and decreased significantly in thymus, spleen, ovary, liver, stomach, lung, kidney, heart and muscle during these periods. In skin, the level of spermidine was maximal in 10-week-old mice and markedly reduced in 26-week-old mice. The results suggest that maintenance of polyamine levels may play important roles in the function of the pancreas, brain and uterus in 3- to 26-week-old mice. We next looked for polyamine-rich food materials as a dietary source of polyamines. Foods found to be rich in polyamines included wheat germ, rice bran, black rice, Philippine mango, green pepper, Japanese pumpkin, nuts, fermented pickles, pond smelt, turban shell viscera, whelk viscera, salted salmon roe, salted cod roe, beef intestine (boiled) and liver of eel, beef, pork and chicken; and, as previously reported, soybean, fermented soybean (natto), mushrooms, orange and green tea leaf. These results offer useful information when it becomes necessary to ingest polyamines from food.
C1 Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba 2608675, Japan.
C3 Chiba University
RP Igarashi, K (corresponding author), Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 1-8-1 Inohana, Chiba 2608675, Japan.
EM iga16077@p.chiba-u.ac.jp
OI Igarashi, Kazuei/0000-0003-3751-3187; Nishimura,
   Kazuhiro/0000-0002-6209-5522
CR AIHARA H, 1983, BIOCHEM PHARMACOL, V32, P1733
   BARDOCZ S, 1993, J NUTR BIOCHEM, V4, P66, DOI 10.1016/0955-2863(93)90001-D
   Cason AL, 2003, EUR J HUM GENET, V11, P937, DOI 10.1038/sj.ejhg.5201072
   Cohen S.S., 1998, GUIDE POLYAMINES
   COOPER KD, 1976, CLIN CHIM ACTA, V73, P71, DOI 10.1016/0009-8981(76)90307-7
   DAS R, 1982, EXP GERONTOL, V17, P95, DOI 10.1016/0531-5565(82)90042-0
   Higashi K, 2004, J BIOCHEM, V136, P533, DOI 10.1093/jb/mvh150
   IGARASHI K, 1975, BIOCHEM BIOPH RES CO, V64, P897, DOI 10.1016/0006-291X(75)90132-1
   IGARASHI K, 1984, CANCER RES, V44, P5332
   IGARASHI K, 1986, J BACTERIOL, V166, P128, DOI 10.1128/jb.166.1.128-134.1986
   Igarashi K, 1999, BIOCHEM J, V344, P633, DOI 10.1042/0264-6021:3440633
   Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601
   JANNE J, 1964, ACTA PHYSIOL SCAND, V62, P352, DOI 10.1111/j.1748-1716.1964.tb10433.x
   Kaasinen SK, 2004, PHARMACOL BIOCHEM BE, V78, P35, DOI 10.1016/j.pbb.2004.02.001
   KAKEGAWA T, 1988, ARCH BIOCHEM BIOPHYS, V261, P250, DOI 10.1016/0003-9861(88)90339-6
   KAKINUMA Y, 1987, ARCH BIOCHEM BIOPHYS, V259, P171, DOI 10.1016/0003-9861(87)90483-8
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Masuko T, 1999, MOL PHARMACOL, V55, P957, DOI 10.1124/mol.55.6.957
   MIYAMOTO S, 1993, ARCH BIOCHEM BIOPHYS, V300, P63, DOI 10.1006/abbi.1993.1009
   NAKAIKE S, 1988, JPN J CANCER RES, V79, P501, DOI 10.1111/j.1349-7006.1988.tb01619.x
   Nie LP, 2005, J BIOL CHEM, V280, P15097, DOI 10.1074/jbc.M409856200
   Nishimura K, 2005, BIOCHEM J, V385, P779, DOI 10.1042/BJ20041477
   OGASAWARA T, 1989, J BIOCHEM-TOKYO, V105, P164, DOI 10.1093/oxfordjournals.jbchem.a122633
   Okamoto A, 1997, BIOSCI BIOTECH BIOCH, V61, P1582, DOI 10.1271/bbb.61.1582
   Park MH, 1997, BIOL SIGNAL, V6, P115
   PEGG AE, 1988, CANCER RES, V48, P759
   Peulen O, 2004, REPROD NUTR DEV, V44, P353, DOI 10.1051/rnd:2004040
   Peulen O, 1998, PUBLIC HEALTH NUTR, V1, P181, DOI 10.1079/PHN19980028
   Pietila M, 1997, J BIOL CHEM, V272, P18746, DOI 10.1074/jbc.272.30.18746
   Räsänen TL, 2003, SCAND J GASTROENTERO, V38, P787, DOI 10.1080/00365520310003273
   SPLINTER TAW, 1986, EUR J CANCER CLIN ON, V22, P61, DOI 10.1016/0277-5379(86)90343-3
   Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327
   WATANABE S, 1991, J BIOL CHEM, V266, P20803
   Wery I, 1996, HEPATOLOGY, V24, P1206
   Williams K, 1997, BIOCHEM J, V325, P289, DOI 10.1042/bj3250289
   Yoshida M, 2004, J BIOL CHEM, V279, P46008, DOI 10.1074/jbc.M404393200
NR 36
TC 206
Z9 217
U1 1
U2 34
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0021-924X
EI 1756-2651
J9 J BIOCHEM
JI J. Biochem.
PD JAN
PY 2006
VL 139
IS 1
BP 81
EP 90
DI 10.1093/jb/mvj003
PG 10
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 010SU
UT WOS:000235219000010
PM 16428322
DA 2024-02-19
ER

PT J
AU Kwekel, JC
   Desai, VG
   Moland, CL
   Branham, WS
   Fuscoe, JC
AF Kwekel, Joshua C.
   Desai, Varsha G.
   Moland, Carrie L.
   Branham, William S.
   Fuscoe, James C.
TI Age and sex dependent changes in liver gene expression during the life
   cycle of the rat
SO BMC GENOMICS
LA English
DT Article
ID DRUG-METABOLIZING-ENZYMES; TRANSCRIPTION FACTORS; MOUSE-LIVER;
   CLINICAL-PHARMACOLOGY; UNITED-STATES; GROWTH; INJURY; CYTOCHROME-P450;
   CARCINOGENICITY; POLYMORPHISMS
AB Background: Age-and sex-related susceptibility to adverse drug reactions and disease is a key concern in understanding drug safety and disease progression. We hypothesize that the underlying suite of hepatic genes expressed at various life cycle stages will impact susceptibility to adverse drug reactions. Understanding the basal liver gene expression patterns is a necessary first step in addressing this hypothesis and will inform our assessments of adverse drug reactions as the liver plays a central role in drug metabolism and biotransformation. Untreated male and female F344 rats were sacrificed at 2, 5, 6, 8, 15, 21, 52, 78, and 104 weeks of age. Liver tissues were collected for histology and gene expression analysis. Whole-genome rat microarrays were used to query global expression profiles.
   Results: An initial list of differentially expressed genes was selected using criteria based upon p-value (p < 0.05) and fold-change (+/- 1.5). Three dimensional principal component analyses revealed differences between males and females beginning at 2 weeks with more divergent profiles beginning at 5 weeks. The greatest sex-differences were observed between 8 and 52 weeks before converging again at 104 weeks. K-means clustering identified groups of genes that displayed age-related patterns of expression. Various adult aging-related clusters represented gene pathways related to xenobiotic metabolism, DNA damage repair, and oxidative stress.
   Conclusions: These results suggest an underlying role for genes in specific clusters in potentiating age-and sex-related differences in susceptibility to adverse health effects. Furthermore, such a comprehensive picture of life cycle changes in gene expression deepens our understanding and informs the utility of liver gene expression biomarkers.
C1 [Kwekel, Joshua C.; Desai, Varsha G.; Moland, Carrie L.; Branham, William S.; Fuscoe, James C.] US FDA, Ctr Funct Genom, Div Syst Biol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA.
C3 US Food & Drug Administration (FDA)
RP Kwekel, JC (corresponding author), US FDA, Ctr Funct Genom, Div Syst Biol, Natl Ctr Toxicol Res, 3900 NCTR Rd, Jefferson, AR 72079 USA.
EM joshua.kwekel@fda.hhs.gov; james.fuscoe@fda.hhs.gov
OI Desai, Varsha/0000-0002-5285-3801
FU U.S. Department of Energy; U.S. Food and Drug Administration
FX The thoughtful comments and critical reviews from Drs. Tao Han, Leming
   Shi, and William Salminen are greatly appreciated. JCK was supported in
   part by an appointment to the Research Participation Program at the
   National Center for Toxicological Research administered by the Oak Ridge
   Institute for Science and Education through an interagency agreement
   between the U.S. Department of Energy and the U.S. Food and Drug
   Administration. The findings and conclusions presented in this article
   are the authors and do not necessarily reflect those of the Food and
   Drug Administration.
CR Abraham NG, 2007, CURR GENE THER, V7, P89, DOI 10.2174/156652307780363134
   Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   Andrade RJ, 2005, GASTROENTEROLOGY, V129, P512, DOI 10.1053/j.gastro.2005.05.006
   [Anonymous], GENE EXPRESSION OMNI
   BIRNBAUM LS, 1994, ENVIRON HEALTH PERSP, V102, P676, DOI 10.2307/3432197
   Boedigheimer MJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-285
   Butler AA, 2001, ENDOCRINOLOGY, V142, P1685, DOI 10.1210/en.142.5.1685
   CAMERON TP, 1985, FUND APPL TOXICOL, V5, P526, DOI 10.1016/0272-0590(85)90100-9
   Carey EJ, 2008, DIGEST DIS SCI, V53, P1977, DOI 10.1007/s10620-008-0250-x
   Chen David P, 2008, Pac Symp Biocomput, P243
   Choudhuri S, 2006, INT J TOXICOL, V25, P231, DOI 10.1080/10915810600746023
   Claudel T, 2007, FEBS LETT, V581, P3626, DOI 10.1016/j.febslet.2007.04.009
   Clodfelter KH, 2006, MOL ENDOCRINOL, V20, P1333, DOI 10.1210/me.2005-0489
   Doria G, 2001, MECH AGEING DEV, V122, P985, DOI 10.1016/S0047-6374(01)00251-2
   Du HL, 2010, REPRODUCTION, V139, P237, DOI 10.1530/REP-08-0376
   Fang H, 2009, METHODS MOL BIOL, V563, P379, DOI 10.1007/978-1-60761-175-2_20
   Fielden MR, 2005, AM J PHARMACOGENOMIC, V5, P161, DOI 10.2165/00129785-200505030-00003
   Finn RD, 2008, J BIOL CHEM, V283, P31385, DOI 10.1074/jbc.M803496200
   Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015
   Hart SN, 2008, EXPERT OPIN DRUG MET, V4, P439, DOI [10.1517/17425255.4.4.439, 10.1517/17425255.4.4.439 ]
   Haseman JK, 1998, TOXICOL PATHOL, V26, P428, DOI 10.1177/019262339802600318
   Hofman MA, 2006, AGEING RES REV, V5, P33, DOI 10.1016/j.arr.2005.07.001
   Lucena MI, 2009, HEPATOLOGY, V49, P2001, DOI 10.1002/hep.22895
   Jeffery B, 2004, ARCH BIOCHEM BIOPHYS, V429, P231, DOI 10.1016/j.abb.2004.06.025
   Kacew S, 1996, J TOXICOL ENV HEALTH, V47, pR5
   Kaina B, 2007, DNA REPAIR, V6, P1079, DOI 10.1016/j.dnarep.2007.03.008
   Laz EV, 2007, ENDOCRINOLOGY, V148, P3327, DOI 10.1210/en.2006-1192
   Lee JS, 2008, TOXICOL SCI, V106, P263, DOI 10.1093/toxsci/kfn144
   Lee MD, 2006, XENOBIOTICA, V36, P1013, DOI 10.1080/00498250600861785
   Lord PG, 2006, BASIC CLIN PHARMACOL, V98, P537, DOI 10.1111/j.1742-7843.2006.pto_444.x
   Maes OC, 2008, MECH AGEING DEV, V129, P534, DOI 10.1016/j.mad.2008.05.004
   McConnell E E, 1983, Toxicol Pathol, V11, P60
   McLean AJ, 2004, PHARMACOL REV, V56, P163, DOI 10.1124/pr.56.2.4
   MEEKS RHS, 1991, HEPATOTOXICITY
   Mikhailova ON, 2005, TOXICOLOGY, V210, P189, DOI 10.1016/j.tox.2005.01.018
   Mori K, 2007, TOXICOL PATHOL, V35, P242, DOI 10.1080/01926230601156286
   Moslen MT, 1996, CASARETT DOULLS TOXI, P403
   Muller DN, 2007, BIOCHEM J, V403, P109, DOI 10.1042/BJ20061328
   Murray M, 2006, CURR DRUG METAB, V7, P67, DOI 10.2174/138920006774832569
   Neafsey P, 2009, J TOXICOL ENV HEAL B, V12, P334, DOI 10.1080/10937400903158342
   Ostapowicz G, 2002, ANN INTERN MED, V137, P947, DOI 10.7326/0003-4819-137-12-200212170-00007
   Perucca E, 2000, EPILEPSY RES, V41, P107, DOI 10.1016/S0920-1211(00)00124-8
   Phan VH, 2009, EXPERT OPIN DRUG MET, V5, P243, DOI [10.1517/17425250902800153, 10.1517/17425250902800153 ]
   Quinn R, 2005, NUTRITION, V21, P775, DOI 10.1016/j.nut.2005.04.002
   RAO GN, 1990, TOXICOL PATHOL, V18, P61, DOI 10.1177/019262339001800109
   Rinn JL, 2004, DEV CELL, V6, P791, DOI 10.1016/j.devcel.2004.05.005
   Russo MW, 2004, LIVER TRANSPLANT, V10, P1018, DOI 10.1002/lt.20204
   Schwartz JB, 2007, CLIN PHARMACOL THER, V82, P87, DOI 10.1038/sj.clpt.6100226
   Shekunova EV, 2004, EUR J PHARMACOL, V486, P259, DOI 10.1016/j.ejphar.2004.01.012
   Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239
   SNELL K, 1986, BIOCHEM J, V233, P617, DOI 10.1042/bj2330617
   Wauthier V, 2004, ARCH TOXICOL, V78, P131, DOI 10.1007/s00204-003-0526-z
   Wauthier V, 2008, MOL ENDOCRINOL, V22, P1962, DOI 10.1210/me.2007-0549
   Waxman DJ, 2006, MOL ENDOCRINOL, V20, P2613, DOI 10.1210/me.2006-0007
   Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705
   Wood RD, 2005, MUTAT RES-FUND MOL M, V577, P275, DOI 10.1016/j.mrfmmm.2005.03.007
   Zhang YKJ, 2009, DRUG METAB DISPOS, V37, P106, DOI 10.1124/dmd.108.024174
   TABLE VALID GENOMIC
NR 58
TC 60
Z9 69
U1 0
U2 4
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2164
J9 BMC GENOMICS
JI BMC Genomics
PD NOV 30
PY 2010
VL 11
AR 675
DI 10.1186/1471-2164-11-675
PG 15
WC Biotechnology & Applied Microbiology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 700TD
UT WOS:000285766300001
PM 21118493
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Bulteau, AL
   Szweda, LI
   Friguet, B
AF Bulteau, Anne-Laure
   Szweda, Luke I.
   Friguet, Bertrand
TI Mitochondrial protein oxidation and degradation in response to oxidative
   stress and aging
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article; Proceedings Paper
CT 4th Conference on Mitochondrial Physiology
CY SEP 16-20, 2005
CL Schroecken, AUSTRIA
DE mitochondrial protein degradation; Lon protease; aging; oxidative
   stress; ischemia-reperfusion
ID ATP-DEPENDENT PROTEASE; LON PROTEASE; CRYSTAL-STRUCTURE; RAT-LIVER;
   ACONITASE; MODULATION; DOMAIN; PROTEOLYSIS; EXPRESSION; SUBSTRATE
AB Mitochondria are a major Source of intracellular reactive oxygen species (ROS). the production of which increases with age. These organelles are also targets of oxidative damage. The deleterious effects of ROS may be responsible for impairment of mitochondrial function observed during various pathophysiological states associated with oxidative stress and aging. An important factor for protein maintenance in the presence of oxidative stress is enzymatic reversal of oxidative modifications and/or protein degradation. Failure of these protein maintenance systems is likely a critical component of the aging process. Mitochondrial matrix proteins are sensitive to oxidative inactivation and oxidized proteins are known to accumulate during aging. The ATP-stimulated mitochondrial Lon protease is a highly conserved protease found in prokaryotes and the mitochondrial compartment of eukaryotes and is believed to play an important role in the degradation of oxidized mitochondrial matrix proteins. Age-dependent declines in the activity and regulation of this proteolytic system may underlie accumulation of oxidatively modified and dysfunctional protein and loss in mitochondrial viability. (c) 2006 Elsevier Inc. All rights reserved.
C1 Univ Denis Diderot Paris 7, Lab Biol & Biochim Cellulaire Vieillissement, EA 3106, IFR 117, F-75251 Paris 05, France.
   Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA.
C3 Universite Paris Cite; Oklahoma Medical Research Foundation
RP Friguet, B (corresponding author), Univ Denis Diderot Paris 7, Lab Biol & Biochim Cellulaire Vieillissement, EA 3106, IFR 117, Case Courrier 7128,2 Pl Jussieu, F-75251 Paris 05, France.
EM bfriguet@paris7.jussieu.fr
RI bulteau, anne-laure/AAN-4004-2020
OI Friguet, Bertrand/0000-0001-8085-1961
FU NIA NIH HHS [AG-19357-03] Funding Source: Medline
CR AMERIK AY, 1990, BIOORG KHIM+, V16, P869
   AMERIK AY, 1991, FEBS LETT, V287, P211, DOI 10.1016/0014-5793(91)80053-6
   Bakala H, 2003, EUR J BIOCHEM, V270, P2295, DOI 10.1046/j.1432-1033.2003.03598.x
   Besche H, 2004, EUR J BIOCHEM, V271, P4361, DOI 10.1111/j.1432-1033.2004.04421.x
   Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836
   Bota DA, 2005, FREE RADICAL BIO MED, V38, P665, DOI 10.1016/j.freeradbiomed.2004.11.017
   Bota DA, 2002, FEBS LETT, V532, P103, DOI 10.1016/S0014-5793(02)03638-4
   Botos I, 2004, J STRUCT BIOL, V146, P113, DOI 10.1016/j.jsb.2003.09.003
   Botos I, 2004, J BIOL CHEM, V279, P8140, DOI 10.1074/jbc.M312243200
   Bulteau AL, 2005, P NATL ACAD SCI USA, V102, P5987, DOI 10.1073/pnas.0501519102
   Bulteau AL, 2003, BIOCHEMISTRY-US, V42, P14846, DOI 10.1021/bi0353979
   Das N, 2001, BIOCHEM J, V360, P209, DOI 10.1042/0264-6021:3600209
   Delaval E, 2004, EUR J BIOCHEM, V271, P4559, DOI 10.1111/j.1432-1033.2004.04422.x
   FRIGUET B, 1994, ARCH BIOCHEM BIOPHYS, V311, P168, DOI 10.1006/abbi.1994.1222
   Friguet B, 1997, FEBS LETT, V405, P21, DOI 10.1016/S0014-5793(97)00148-8
   Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076
   Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010
   Käser M, 2000, SEMIN CELL DEV BIOL, V11, P181, DOI 10.1006/scdb.2000.0166
   Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   Lenaz G, 2002, ANN NY ACAD SCI, V959, P199, DOI 10.1111/j.1749-6632.2002.tb02094.x
   Li M, 2005, PROTEIN SCI, V14, P2895, DOI 10.1110/ps.051736805
   Liu T, 2004, J BIOL CHEM, V279, P13902, DOI 10.1074/jbc.M309642200
   Lupas AN, 2002, CURR OPIN STRUC BIOL, V12, P746, DOI 10.1016/S0959-440X(02)00388-3
   MARCILLAT O, 1988, BIOCHEM J, V254, P677, DOI 10.1042/bj2540677
   Mogk A, 2004, J STRUCT BIOL, V146, P90, DOI 10.1016/j.jsb.2003.10.009
   Nulton-Persson AC, 2001, J BIOL CHEM, V276, P23357, DOI 10.1074/jbc.M100320200
   Ondrovicová G, 2005, J BIOL CHEM, V280, P25103, DOI 10.1074/jbc.M502796200
   Rasulova FS, 1998, FEBS LETT, V432, P179, DOI 10.1016/S0014-5793(98)00859-X
   Sastre J, 2003, FREE RADICAL BIO MED, V35, P1, DOI 10.1016/S0891-5849(03)00184-9
   Shringarpure R, 2001, CELL MOL LIFE SCI, V58, P1442, DOI 10.1007/PL00000787
   Thomas-Wohlever J, 2002, BIOCHEMISTRY-US, V41, P9418, DOI 10.1021/bi0255470
   Van Dyck L, 1999, CELL MOL LIFE SCI, V56, P825, DOI 10.1007/s000180050029
   WANG N, 1993, P NATL ACAD SCI USA, V90, P11247, DOI 10.1073/pnas.90.23.11247
NR 34
TC 115
Z9 138
U1 1
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD JUL
PY 2006
VL 41
IS 7
BP 653
EP 657
DI 10.1016/j.exger.2006.03.013
PG 5
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Geriatrics & Gerontology
GA 060JN
UT WOS:000238798600001
PM 16677792
DA 2024-02-19
ER

PT J
AU Zhao, SM
   Luo, H
   Kan, GH
   Zhao, Y
   Lin, LF
   Tang, Q
   Yu, CL
   Sun, W
   Cai, LP
   Cui, SF
AF Zhao, Shanmin
   Luo, Hong
   Kan, Guanghan
   Zhao, Yong
   Lin, Lifang
   Tang, Qiu
   Yu, Chenlin
   Sun, Wei
   Cai, Liping
   Cui, Shufang
TI The Protective Role of Autophagy in <i>Heterocephalus</i> <i>glaber</i>
   Hepatic Stellate Cells Exposed to H<sub>2</sub>O<sub>2</sub> or
   Nutritional Stress
SO CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
LA English
DT Article
DE Heterocephalus glaber; Hepatic Stellate Cells; Autophagy; H2O2;
   Nutritional Stress
ID NAKED MOLE-RAT; LONGEST-LIVING RODENT; MAMMALIAN-CELLS; GOOD HEALTH;
   DUAL ROLE; APOPTOSIS; INHIBITION; DEATH; DISEASE; MACROAUTOPHAGY
AB Background/Aims: Naked mole rats (NMRs) survive and thrive in dark, dank environments with low levels of oxygen and poor quality nutrition. Their long lifespan is attributed to sustained good health and pronounced resistance to cancer. Physiological and biochemical processes, such as autophagy, may contribute to the successful aging of this exceptionally long-lived species. We demonstrated that NMRs have higher levels of autophagy than short-lived C57BL/6 mice, and this may play an important role in the maintenance of cellular protein quality and the defense of cells against intracellular and extracellular aggressors in NMRs. The present study assesses autophagy as a means for cells to flexibly respond to environmental changes (H2O2 treatment and a shortage of nutrients). Methods: Primary NMR HSCs were isolated from liver and treated with serum-free medium. Cells in the experimental group were incubated with different concentrations of hydrogen peroxide (H2O2) in the presence and / or absence of 3-MA (5 mM).The LC3-II/LC3-I ratio was determined by western blot analysis. Western blotting was performed to analyze the expression level of Beclin 1 protein. Apoptosis and cell-cycle progression were analyzed by flow cytometry. Results: Our data reveal that both poor quality nutrition and H2O2 treatment induces apoptosis and autophagy in NMR hepatic stellate cells(HSCs). Conclusion: NMR cells have the capacity to induce cell death through apoptosis and downregulate the energy consuming processes through inhibition of proliferation when they become superfluous or irreversibly damaged. Copyright (C) 2014 S. Karger AG, Basel
C1 [Zhao, Shanmin; Lin, Lifang; Tang, Qiu; Yu, Chenlin; Sun, Wei; Cai, Liping; Cui, Shufang] Secondary Med Univ, Lab Anim Ctr, Shanghai 200433, Peoples R China.
   [Luo, Hong] Second Mil Med Univ, Ctr Educ Technol, Shanghai, Peoples R China.
   [Kan, Guanghan] China Astronaut Res & Training Ctr, Beijing, Peoples R China.
   [Zhao, Yong] Shanghai Lab Anim Res Ctr, Shanghai, Peoples R China.
C3 Naval Medical University; Shanghai Academy of Science & Technology
RP Cui, SF (corresponding author), Secondary Med Univ, Lab Anim Ctr, 800 Xiangyin Rd, Shanghai 200433, Peoples R China.
EM youngstrar_sf@163.com
RI chen, jia/JLM-4733-2023
OI Cui, Shufang/0000-0001-8571-6830
CR BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3
   Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005
   Burscha W, 2008, TOXICOLOGY, V254, P147, DOI 10.1016/j.tox.2008.07.048
   Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78
   Edrey YH, 2011, ILAR J, V52, P41, DOI 10.1093/ilar.52.1.41
   Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33
   Eskelinen EL, 2011, CURR OPIN PHARMACOL, V11, P294, DOI 10.1016/j.coph.2011.03.009
   Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007
   Ge Jun-Na, 2008, Ai Zheng, V27, P788
   Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720
   Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131
   Kim EH, 2007, CANCER RES, V67, P6314, DOI 10.1158/0008-5472.CAN-06-4217
   Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263
   Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338
   Kues WA, 2000, BIOL REPROD, V62, P412, DOI 10.1095/biolreprod62.2.412
   Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842
   Labinskyy N, 2006, AM J PHYSIOL-HEART C, V291, pH2698, DOI 10.1152/ajpheart.00534.2006
   Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018
   Li XS, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-26
   Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257
   Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046
   Luo S, 2010, CELL DEATH DIFFER, V17, P268, DOI 10.1038/cdd.2009.121
   Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002
   Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421
   Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639
   Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585
   Ramm GA, 1998, J GASTROEN HEPATOL, V13, P846, DOI 10.1111/j.1440-1746.1998.tb00747.x
   Rodriguez KA, 2011, CURR PHARM DESIGN, V17, P2290
   Strecker V, 2010, MECH AGEING DEV, V131, P48, DOI 10.1016/j.mad.2009.11.005
   Thorburn A, 2008, APOPTOSIS, V13, P1, DOI 10.1007/s10495-007-0154-9
   Toh PPC, 2013, HUM MOL GENET, V22, P5237, DOI 10.1093/hmg/ddt381
   Wang Y, 2008, AUTOPHAGY, V4, P214, DOI 10.4161/auto.5369
   Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895
   Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814
   Yin J, 2010, MICROBIOL-SGM, V156, P665, DOI 10.1099/mic.0.033944-0
   Zhao SM, 2014, CELL PHYSIOL BIOCHEM, V33, P321, DOI 10.1159/000356672
NR 38
TC 10
Z9 13
U1 0
U2 13
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1015-8987
EI 1421-9778
J9 CELL PHYSIOL BIOCHEM
JI Cell. Physiol. Biochem.
PY 2014
VL 34
IS 2
BP 463
EP 473
DI 10.1159/000363015
PG 11
WC Cell Biology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Physiology
GA AR7MT
UT WOS:000343764600022
PM 25096031
OA gold
DA 2024-02-19
ER

PT J
AU Hagopian, K
   Ramsey, JJ
   Weindruch, R
AF Hagopian, Kevork
   Ramsey, Jon J.
   Weindruch, Richard
TI Enzymes of glycerol and glyceraldehyde metabolism in mouse liver:
   effects of caloric restriction and age on activities
SO BIOSCIENCE REPORTS
LA English
DT Article
DE aging; caloric restriction; energy source; glyceralclehyde metabolism;
   glycerol metabolism; liver
ID KETO REDUCTASE SUPERFAMILY; ALDEHYDE DEHYDROGENASE-ACTIVITY;
   ALCOHOL-DEHYDROGENASE; RAT-LIVER; FRUCTOSE METABOLISM; THYROID-HORMONES;
   FOOD RESTRICTION; LIFE-SPAN; MUSCLE; OXIDATION
AB The influence of caloric restriction on hepatic glyceraldehyde- and glycerol-metabolizing enzyme activities of young and old mice were studied. Glycerol kinase and cytoplasmic glycerol-3-phosphate dehydrogenase activities were increased in both young and old CR (calorie-restricted) mice when compared with controls, whereas triokinase increased only in old CR mice. Aldehyde dehydrogenase and aldehyde reductase activities in both young and old CR mice were unchanged by caloric restriction. Mitochondrial glycerol-3-phosphate dehydrogenase showed a trend towards an increased activity in old CR mice, whereas a trend towards a decreased activity in alcohol dehydrogenase was observed in both young and old CR mice. Serum glycerol levels decreased in young and old CR mice. Therefore increases in glycerol kinase and glycerol-3-phosphate dehydrogenase were associated with a decrease in fasting blood glycerol levels in CR animals. A prominent role for triokinase in glyceraldehyde metabolism with CR was also observed. The results indicate that long-term caloric restriction induces sustained increases in the capacity for gluconeogenesis from glycerol.
C1 [Hagopian, Kevork; Ramsey, Jon J.] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA.
   [Weindruch, Richard] Univ Wisconsin, Sch Med, Dept Med, Madison, WI 53706 USA.
   [Weindruch, Richard] William S Middleton Mem Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, Madison, WI 53705 USA.
C3 University of California System; University of California Davis;
   University of Wisconsin System; University of Wisconsin Madison; US
   Department of Veterans Affairs; Veterans Health Administration (VHA);
   William S Middleton Memorial Veterans Hospital; Geriatric Research
   Education & Clinical Center
RP Hagopian, K (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA.
EM khagopian@ucdavis.edu
FU NIA NIH HHS [P01 AG011915-06A1, P01 AG11915, R01 AG028125, P01 AG011915,
   R01 AG28125, R01 AG028125-01A1] Funding Source: Medline
CR ALGAR EM, 1983, EUR J BIOCHEM, V137, P139, DOI 10.1111/j.1432-1033.1983.tb07807.x
   BABA H, 1995, NUTRITION, V11, P149
   BALAK KJ, 1982, J BIOL CHEM, V257, P5000
   Barron JT, 1998, J MOL CELL CARDIOL, V30, P1571, DOI 10.1006/jmcc.1998.0722
   Barzilai N, 2001, J NUTR, V131, p903S, DOI 10.1093/jn/131.3.903S
   BERGMEYER HU, 1983, METHOD ENZYMAT AN, V2, P216
   BERGMEYER HU, 1983, METHOD ENZYMAT AN, V2, P215
   BISMUT H, 1993, EUR J BIOCHEM, V213, P721, DOI 10.1111/j.1432-1033.1993.tb17812.x
   BOHREN KM, 1989, J BIOL CHEM, V264, P9547
   Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616
   BORTZ WM, 1972, J CLIN INVEST, V51, P1537, DOI 10.1172/JCI106950
   BOSRON WF, 1984, ALCOHOL CLIN EXP RES, V8, P196, DOI 10.1111/j.1530-0277.1984.tb05837.x
   BRAGGINS TJ, 1981, EUR J BIOCHEM, V119, P633, DOI 10.1111/j.1432-1033.1981.tb05654.x
   Brisson D, 2001, BIOESSAYS, V23, P534, DOI 10.1002/bies.1073
   CLAUS TH, 1982, J BIOL CHEM, V257, P7541
   DANH HC, 1983, J NEUROCHEM, V41, P618, DOI 10.1111/j.1471-4159.1983.tb04786.x
   DANH HC, 1984, GERONTOLOGY, V30, P159, DOI 10.1159/000212624
   Dhahbi JM, 1999, AM J PHYSIOL-ENDOC M, V277, pE352, DOI 10.1152/ajpendo.1999.277.2.E352
   Dhahbi JM, 2001, MECH AGEING DEV, V122, P1033, DOI 10.1016/S0047-6374(01)00230-5
   ELIA M, 1993, CLIN SCI, V84, P99, DOI 10.1042/cs0840099
   ESTABROOK RW, 1958, J BIOL CHEM, V233, P1014
   FLYNN TG, 1982, BIOCHEM PHARMACOL, V31, P2705, DOI 10.1016/0006-2952(82)90123-X
   FRANK MSB, 1981, PHARMACOTHERAPY, V1, P147
   Guarente L, 2005, MECH AGEING DEV, V126, P923, DOI 10.1016/j.mad.2005.03.013
   Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029
   Hagopian K, 2005, FEBS LETT, V579, P2009, DOI 10.1016/j.febslet.2005.02.062
   Hagopian K, 2003, EXP GERONTOL, V38, P267, DOI 10.1016/S0531-5565(02)00202-4
   Hagopian K, 2003, EXP GERONTOL, V38, P253, DOI 10.1016/S0531-5565(02)00203-6
   Hagopian K, 2005, BBA-GEN SUBJECTS, V1721, P37, DOI 10.1016/j.bbagen.2004.10.001
   HARDING JW, 1975, BIOCHEM J, V146, P223, DOI 10.1042/bj1460223
   HENLEY KS, 1968, LAB CLIN MED CLIN EX, V71, P183
   HERLIHY JT, 1990, MECH AGEING DEV, V53, P9, DOI 10.1016/0047-6374(90)90030-J
   HORTON AA, 1979, MECH AGEING DEV, V11, P363, DOI 10.1016/0047-6374(79)90011-3
   Iemitsu M, 2002, AM J PHYSIOL-HEART C, V283, pH1750, DOI 10.1152/ajpheart.01051.2001
   JEFFERY J, 1983, P NATL ACAD SCI-BIOL, V80, P901, DOI 10.1073/pnas.80.4.901
   Jez JM, 1997, BIOCHEM J, V326, P625, DOI 10.1042/bj3260625
   Jez JM, 1997, BIOCHEM PHARMACOL, V54, P639, DOI 10.1016/S0006-2952(97)84253-0
   KATTERMANN R, 1961, BIOCHEM Z, V334, P218
   Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000
   Kevork HA, 2004, EXP GERONTOL, V39, P1145, DOI 10.1016/j.exger.2004.04.009
   KORIEH A, 1991, ARCH INT PHYSIOL BIO, V99, P455
   Lang G., 1984, METHOD ENZYMAT AN, VVI, P525
   LEE YP, 1965, J BIOL CHEM, V240, P1427
   Lehninger A. L., 1993, PRINCIPLES BIOCH
   LIEPA GU, 1980, AM J PHYSIOL, V238, pE253, DOI 10.1152/ajpendo.1980.238.3.E253
   LIN ECC, 1977, ANNU REV BIOCHEM, V46, P765, DOI 10.1146/annurev.bi.46.070177.004001
   LINDAHL R, 1992, CRIT REV BIOCHEM MOL, V27, P283, DOI 10.3109/10409239209082565
   LINDROS KO, 1979, BIOCHEM PHARMACOL, V28, P2313
   LUMENG L, 1979, BIOCHEM PHARMACOL, V28, P1547, DOI 10.1016/0006-2952(79)90471-4
   MacDonald MJ, 2000, ARCH BIOCHEM BIOPHYS, V384, P143, DOI 10.1006/abbi.2000.2107
   Masoro EJ, 2006, J GERONTOL A-BIOL, V61, P14, DOI 10.1093/gerona/61.1.14
   McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63
   MULLER S, 1994, P NATL ACAD SCI USA, V91, P10581, DOI 10.1073/pnas.91.22.10581
   OSCAI LB, 1990, J APPL PHYSIOL, V69, P1571, DOI 10.1152/jappl.1990.69.5.1571
   OWEN OE, 1969, J CLIN INVEST, V48, P574, DOI 10.1172/JCI106016
   Patsouris D, 2004, J CLIN INVEST, V114, P94, DOI 10.1172/JC1200420468
   PILKIS SJ, 1995, ANNU REV BIOCHEM, V64, P799, DOI 10.1146/annurev.bi.64.070195.004055
   Poynter ME, 1998, J BIOL CHEM, V273, P32833, DOI 10.1074/jbc.273.49.32833
   PRIDHAM JB, 1979, SUGAR SCI TECHNOLOGY, P437
   Pugh TD, 1999, NEUROBIOL AGING, V20, P157, DOI 10.1016/S0197-4580(99)00043-3
   RINGLER RL, 1959, J BIOL CHEM, V234, P2211
   Robergs RA, 1998, SPORTS MED, V26, P145, DOI 10.2165/00007256-199826030-00002
   SHAFRIR E, 1984, COMP BIOCHEM PHYS B, V78, P493, DOI 10.1016/0305-0491(84)90064-6
   SILLERO MAG, 1969, EUR J BIOCHEM, V10, P345, DOI 10.1111/j.1432-1033.1969.tb00696.x
   SMOLEN A, 1981, COMP BIOCHEM PHYS C, V69, P199, DOI 10.1016/0306-4492(81)90129-5
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Sung B, 2004, J GERONTOL A-BIOL, V59, P997
   TURNER AJ, 1980, BIOCHIM BIOPHYS ACTA, V613, P256, DOI 10.1016/0005-2744(80)90081-9
   VENEZIALE CM, 1972, EUR J BIOCHEM, V31, P59, DOI 10.1111/j.1432-1033.1972.tb02500.x
   Weindruch R., 1988, RETARDATION AGING DI
   WIELAND OH, 1984, METHOD ENZYMAT AN, V6, P504
   Wolf G, 2006, NUTR REV, V64, P89, DOI [10.1301/nr.2006.feb.89-92, 10.1111/j.1753-4887.2006.tb00192.x]
   Yoon M, 2006, TOXICOL SCI, V89, P386, DOI 10.1093/toxsci/kfj045
NR 73
TC 31
Z9 40
U1 0
U2 5
PU PORTLAND PRESS LTD
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND
SN 0144-8463
EI 1573-4935
J9 BIOSCIENCE REP
JI Biosci. Rep.
PD APR
PY 2008
VL 28
IS 2
BP 107
EP 115
DI 10.1042/BSR20080015
PG 9
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 317KS
UT WOS:000257019700006
PM 18429748
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Lavrovsky, Y
   Song, CS
   Chatterjee, B
   Roy, AK
AF Lavrovsky, Y
   Song, CS
   Chatterjee, B
   Roy, AK
TI Age-dependent increase of heme oxygenase-1 gene expression in the liver
   mediated by NFκB
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE aging; nuclear factor kappa B; heme oxygenase-1; reactive oxidative
   species; transcriptional regulation
ID ANDROGEN RECEPTOR GENE; OXIDATIVE STRESS; TRANSCRIPTION FACTORS; PROTEIN
   OXIDATION; PROMOTER REGION; BINDING; IDENTIFICATION; TOXICITY; ELEMENTS;
   CELLS
AB Heme, the iron-porphyrin coordination complex, released from the degradation of hemoproteins, is a strong prooxidant. It is enzymatically degraded by heme oxygenase to free iron, carbon monoxide and biliverdin. Biliverdin and its reduced metabolite bilirubin are two potent physiological antioxidants. Here we show a progressive increase of steady-state levels of the mRNA encoding the inducible isoform of this enzyme (heme oxygenase-1) in the rat liver during aging. We had previously reported that aging is associated with increased activation of the nuclear factor kappa B (NF kappa B). We now provide evidence to establish that overexpression of NF kappa B in transfected liver-derived HepG2 cells can cause a marked induction of the endogenous heme oxygenase-1 (HO-1) mRNA and activation of the cotransfected HO-1 gene promoter. Taken together, these results support the conclusion that enhanced oxidative stress during aging is accompanied by compensatory induction of the antioxidant enzyme HO-1 through activation of the NF kappa B pathway. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
C1 Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78284 USA.
   Audie L Murphy Mem Vet Adm Med Ctr, San Antonio, TX 78284 USA.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); Audie L. Murphy Memorial Veterans Hospital
RP Lavrovsky, Y (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, 7703 Floyd Curl Dr, San Antonio, TX 78284 USA.
EM lavrosky@uthscsa.edu
FU NIA NIH HHS [R37AG10486] Funding Source: Medline
CR ABRAHAM NG, 1995, P NATL ACAD SCI USA, V92, P6798, DOI 10.1073/pnas.92.15.6798
   Barlow C, 1999, P NATL ACAD SCI USA, V96, P9915, DOI 10.1073/pnas.96.17.9915
   Bergeron M, 1998, DEV BRAIN RES, V105, P181, DOI 10.1016/S0165-3806(97)00169-7
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Dennery PA, 1998, J CLIN INVEST, V101, P1001, DOI 10.1172/JCI448
   Doré S, 1999, P NATL ACAD SCI USA, V96, P2445, DOI 10.1073/pnas.96.5.2445
   EISENSTEIN RS, 1991, P NATL ACAD SCI USA, V88, P688, DOI 10.1073/pnas.88.3.688
   Fogg S, 1999, AM J RESP CELL MOL, V20, P797, DOI 10.1165/ajrcmb.20.4.3477
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   Helenius M, 1996, J MOL CELL CARDIOL, V28, P487, DOI 10.1006/jmcc.1996.0045
   Iijima N, 1999, NEUROSCI LETT, V271, P113, DOI 10.1016/S0304-3940(99)00543-1
   Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331
   KHAN AU, 1995, CHEM BIOL, V2, P437
   Lavrovsky Y, 1996, BIOCHEM BIOPH RES CO, V218, P759, DOI 10.1006/bbrc.1996.0135
   LAVROVSKY Y, 1994, P NATL ACAD SCI USA, V91, P5987, DOI 10.1073/pnas.91.13.5987
   Li NX, 1999, FASEB J, V13, P1137, DOI 10.1096/fasebj.13.10.1137
   Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517
   McCoubrey WK, 1997, J BIOL CHEM, V272, P12568, DOI 10.1074/jbc.272.19.12568
   Mireles LC, 1999, PEDIATR RES, V45, P355, DOI 10.1203/00006450-199903000-00011
   Muller JM, 1997, METHODS, V11, P301, DOI 10.1006/meth.1996.0424
   Ni AG, 1998, J BIOL CHEM, V273, P2784, DOI 10.1074/jbc.273.5.2784
   OLIVER CN, 1987, J BIOL CHEM, V262, P5488
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925
   Poynter ME, 1998, J BIOL CHEM, V273, P32833, DOI 10.1074/jbc.273.49.32833
   Rahman A, 1999, J IMMUNOL, V162, P5466
   Reeve VE, 1999, P NATL ACAD SCI USA, V96, P9317, DOI 10.1073/pnas.96.16.9317
   Roy AK, 1997, MOL MED, V3, P496, DOI 10.1007/BF03401696
   SHIBAHARA S, 1989, EUR J BIOCHEM, V179, P557, DOI 10.1111/j.1432-1033.1989.tb14583.x
   Sohal R. S., 1997, P91
   SONG CS, 1993, BIOCHEM J, V294, P779, DOI 10.1042/bj2940779
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864
   SUPAKAR PC, 1995, J BIOL CHEM, V270, P837, DOI 10.1074/jbc.270.2.837
   Suttner DM, 1999, AM J PHYSIOL-LUNG C, V276, pL443, DOI 10.1152/ajplung.1999.276.3.L443
   ToliverKinsky T, 1997, J NEUROSCI RES, V48, P580, DOI 10.1002/(SICI)1097-4547(19970615)48:6<580::AID-JNR11>3.0.CO;2-Z
   TYRRELL RM, 1993, CARCINOGENESIS, V14, P761, DOI 10.1093/carcin/14.4.761
   Verma IM, 1997, P NATL ACAD SCI USA, V94, P11758, DOI 10.1073/pnas.94.22.11758
   Walter R, 1998, J GERONTOL A-BIOL, V53, pB172
   Walter R, 1998, J GERONTOL A-BIOL, V53, pB102, DOI 10.1093/gerona/53A.2.B102
   WU RL, 1994, J BIOL CHEM, V269, P28450
   Yamada N, 1999, AM J RESP CELL MOL, V21, P428, DOI 10.1165/ajrcmb.21.3.3501
NR 43
TC 71
Z9 76
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD FEB 22
PY 2000
VL 114
IS 1
BP 49
EP 60
DI 10.1016/S0047-6374(00)00087-7
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 304GR
UT WOS:000086475800006
PM 10731581
DA 2024-02-19
ER

PT J
AU Morrison, SJ
   Wandycz, AM
   Akashi, K
   Globerson, A
   Weissman, IL
AF Morrison, SJ
   Wandycz, AM
   Akashi, K
   Globerson, A
   Weissman, IL
TI The aging of hematopoietic stem cells
SO NATURE MEDICINE
LA English
DT Article
ID BONE-MARROW CELLS; PROLIFERATIVE CAPACITY; REPOPULATING ABILITY;
   IRRADIATED MICE; MITOTIC CLOCK; FETAL LIVER; B-CELLS; AGE; PROGENITORS;
   INVITRO
AB We have purified hematopoietic stem cells (HSCs) from the bone marrow of old mice and compared their properties to HSCs in young and middle-aged mice. Single, reconstituting HSCs (by limit dilution) from old and young mice exhibited indistinguishable progenitor activities in vivo. HSCs were five times as frequent in the bone marrow of old mice; however, HSCs from old mice were only one-quarter as efficient at homing to and engrafting the bone marrow of irradiated recipients. HSCs in young and middle-aged mice rarely were in the S/C-2/M phases of the cell cycle, but HSCs in old mice were frequently in cycle. We speculate that the unexpected proliferation of HSCs in old mice might be related to the increased incidence of leukemia in old mice. HSCs change with age, but it is unknown whether these changes are determined intrinsically or caused by the aging of their environment.
C1 STANFORD UNIV,DEPT PATHOL,STANFORD,CA 94305.
   STANFORD UNIV,DEPT DEV BIOL,STANFORD,CA 94305.
   WEIZMANN INST SCI,DEPT IMMUNOL,IL-76100 REHOVOT,ISRAEL.
C3 Stanford University; Stanford University; Weizmann Institute of Science
RI Morrison, Sean/ABD-5326-2021
OI Morrison, Sean/0000-0003-1587-8329
FU NCI NIH HHS [CA 42551] Funding Source: Medline
CR ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114
   Chiu CP, 1996, STEM CELLS, V14, P239, DOI 10.1002/stem.140239
   CUMANO A, 1992, NATURE, V356, P612, DOI 10.1038/356612a0
   FARRAR JJ, 1974, J IMMUNOL, V112, P1244
   FRANCUS T, 1986, J IMMUNOL, V137, P2411
   HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7
   HARRISON DE, 1983, J EXP MED, V157, P1496, DOI 10.1084/jem.157.5.1496
   HARRISON DE, 1978, J EXP MED, V147, P1526, DOI 10.1084/jem.147.5.1526
   HARRISON DE, 1982, J EXP MED, V156, P1767, DOI 10.1084/jem.156.6.1767
   HARRISON DE, 1979, MECH AGEING DEV, V9, P409, DOI 10.1016/0047-6374(79)90082-4
   HARRISON DE, 1987, J NUTR, V117, P376, DOI 10.1093/jn/117.2.376
   HARRISON DE, 1989, J IMMUNOL, V142, P3833
   HARRISON DE, 1984, J EXP MED, V160, P759, DOI 10.1084/jem.160.3.759
   HARRISON DE, 1973, P NATL ACAD SCI USA, V70, P4184
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   HEIMFELD S, 1991, P NATL ACAD SCI USA, V88, P9902, DOI 10.1073/pnas.88.21.9902
   MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X
   MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302
   MULLERSIEBURG CE, 1986, CELL, V44, P653, DOI 10.1016/0092-8674(86)90274-6
   NAKAHATA T, 1982, P NATL ACAD SCI-BIOL, V79, P3843, DOI 10.1073/pnas.79.12.3843
   OGDEN DA, 1976, TRANSPLANTATION, V22, P287, DOI 10.1097/00007890-197609000-00010
   PAPAYANNOPOULOU T, 1995, P NATL ACAD SCI USA, V92, P9647, DOI 10.1073/pnas.92.21.9647
   Peters SO, 1996, BLOOD, V87, P30
   REINCKE U, 1982, SCIENCE, V215, P1619, DOI 10.1126/science.7071580
   ROLINK A, 1993, BLOOD, V81, P2290
   SCHNEIDER EL, 1976, P NATL ACAD SCI USA, V73, P3584, DOI 10.1073/pnas.73.10.3584
   SHARP A, 1989, MECH AGEING DEV, V48, P91, DOI 10.1016/0047-6374(89)90029-8
   SIMINOVITCH L, 1964, J CELL COMPAR PHYSL, V64, P23, DOI 10.1002/jcp.1030640104
   SMITH LG, 1991, P NATL ACAD SCI USA, V88, P2788, DOI 10.1073/pnas.88.7.2788
   SPANGRUDE GJ, 1995, BLOOD, V85, P1006, DOI 10.1182/blood.V85.4.1006.bloodjournal8541006
   SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810
   TSUJI K, 1992, BLOOD, V79, P2855
   UCHIDA N, 1994, BLOOD, V83, P3758
   UCHIDA N, 1992, J EXP MED, V175, P175, DOI 10.1084/jem.175.1.175
   VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857
NR 35
TC 619
Z9 699
U1 1
U2 27
PU NATURE PUBLISHING CO
PI NEW YORK
PA 345 PARK AVE SOUTH, NEW YORK, NY 10010-1707
SN 1078-8956
J9 NAT MED
JI Nat. Med.
PD SEP
PY 1996
VL 2
IS 9
BP 1011
EP 1016
DI 10.1038/nm0996-1011
PG 6
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA VF497
UT WOS:A1996VF49700036
PM 8782459
DA 2024-02-19
ER

PT J
AU Mitchell, SJ
   Hilmer, SN
   Murnion, BP
   Matthews, S
AF Mitchell, S. J.
   Hilmer, S. N.
   Murnion, B. P.
   Matthews, S.
TI Hepatotoxicity of therapeutic short-course paracetamol in hospital
   inpatients: impact of ageing and frailty
SO JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
LA English
DT Article
DE ageing; frailty; hospital inpatients; paracetamol hepatotoxicity;
   therapeutic
ID ACETAMINOPHEN; AGE; ADULTS; STATE
AB Background:
   Paracetamol, a commonly used simple analgesic, can be fatal in overdose. Case reports suggest liver damage may occur at therapeutic doses. In older and particularly frail patients, dose reduction of therapeutic paracetamol is recommended due to concerns of an increased risk of hepatotoxicity.
   Aims:
   This study aimed to investigate the effects of ageing and frailty on the safety of paracetamol in hospital inpatients commenced on short courses of the drug.
   Methods:
   An observational cohort study of young (18-55 years, n = 19), older (>= 70 years) fit (n = 24) and older frail (n = 28) hospital inpatients. Treatment group participants commenced regular paracetamol (3-4 g/day) during their hospital admission, whereas the control group was not exposed to paracetamol. In both groups, plasma alanine aminotransferase (ALT) was measured at baseline and day 5, and risk factors for raised ALT were recorded. A random serum paracetamol concentration was measured at day 5 in the treatment group.
   Results:
   No older frail treatment participants had an abnormal day 5 ALT. Odds ratios for having a day 5 ALT above the upper limit of normal (ULN) with paracetamol use, compared with unexposed controls, were 3 center dot 7 [95% confidence intervals (CI): 0 center dot 32, 41 center dot 59] for older not frail participants and 2 center dot 5 (95% CI: 0 center dot 34, 18 center dot 3) for younger participants. Decreasing frailty score independently predicted a day 5 ALT above the ULN (P < 0 center dot 05). Day 5 serum paracetamol concentrations were highest in older frail participants (P < 0 center dot 005).
   Conclusion:
   Higher paracetamol concentrations observed in frail older patients after 5 days of therapeutic paracetamol do not necessarily indicate an increased risk of hepatotoxicity.
C1 [Mitchell, S. J.; Hilmer, S. N.; Murnion, B. P.] Royal N Shore Hosp, Dept Clin Pharmacol, St Leonards, NSW 2065, Australia.
   [Mitchell, S. J.; Hilmer, S. N.; Murnion, B. P.] Royal N Shore Hosp, Dept Aged Care, St Leonards, NSW 2065, Australia.
   [Mitchell, S. J.; Hilmer, S. N.; Murnion, B. P.; Matthews, S.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.
C3 Royal North Shore Hospital; Royal North Shore Hospital; University of
   Sydney
RP Mitchell, SJ (corresponding author), Royal N Shore Hosp, Dept Clin Pharmacol, Ward 11C Main Bldg,Pacific Highway, St Leonards, NSW 2065, Australia.
EM shilmer@med.usyd.edu.au
RI Matthews, Slade/J-4939-2019; Hilmer, Sarah/AAW-8554-2020; murnion,
   Bridin/AAK-3057-2020
OI Matthews, Slade/0000-0002-1652-543X; Hilmer, Sarah/0000-0002-5970-1501;
   murnion, Bridin/0000-0001-7791-3025
FU Geoff and Elaine Penney Ageing Research Unit, Royal North Shore Hospital
FX We gratefully acknowledge the contributions of Dr D. Chesher,
   Biochemistry, PaLMS, Royal North Shore Hospital for the measurements of
   ALT and paracetamol concentrations in this study, and the Geoff and
   Elaine Penney Ageing Research Unit, Royal North Shore Hospital for
   financial support. Authors have no industrial links or affiliations.
CR Bannwarth B, 2001, J RHEUMATOL, V28, P182
   BRIANT RH, 1976, J AM GERIATR SOC, V24, P359, DOI 10.1111/j.1532-5415.1976.tb03312.x
   CUMMINGS AJ, 1967, BRIT J PHARM CHEMOTH, V29, P150, DOI 10.1111/j.1476-5381.1967.tb01948.x
   Daly FFS, 2008, MED J AUSTRALIA, V188, P296, DOI 10.5694/j.1326-5377.2008.tb01625.x
   Dart RC, 2007, PHARMACOTHERAPY, V27, P1219, DOI 10.1592/phco.27.9.1219
   DIVOLL M, 1982, J AM GERIATR SOC, V30, P240, DOI 10.1111/j.1532-5415.1982.tb07093.x
   Donohoo E, 2003, MIMS ONLINE
   Ferrell B, 2002, J AM GERIATR SOC, V50, pS205, DOI 10.1046/j.1532-5415.50.6s.1.x
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146
   Gnjidic D, 2008, AGE AGEING, V37, P699, DOI 10.1093/ageing/afn152
   Hilmer S. N., 2009, HAZZARDS GERIATRIC M, P99
   Hilmer SN, 2009, AUSTRALAS J AGEING, V28, P182, DOI 10.1111/j.1741-6612.2009.00367.x
   Kurtovic J, 2003, J INTERN MED, V253, P240, DOI 10.1046/j.1365-2796.2003.01097.x
   Lazo M, 2008, ANN INTERN MED, V148, P348, DOI 10.7326/0003-4819-148-5-200803040-00005
   Lubel JS, 2007, MED J AUSTRALIA, V186, P371, DOI 10.5694/j.1326-5377.2007.tb00943.x
   McLean AJ, 2004, PHARMACOL REV, V56, P163, DOI 10.1124/pr.56.2.4
   Mitchell Sarah J., 2009, Journal of Pharmacy Practice and Research, V39, P122
   New South Wales (NSW) Health, 2006, PAR US PD2006 004
   Nuttall SL, 1998, LANCET, V351, P645, DOI 10.1016/S0140-6736(05)78428-2
   Pacific Medicine Laboratory Services (PaLMS), 2007, LIV FUNCT TESTS PLAS
   Perera V, 2009, AGE AGEING, V38, P156, DOI 10.1093/ageing/afn293
   PRESCOTT LF, 1971, LANCET, V1, P519
   REGAL RE, 1986, DRUG INTEL CLIN PHAR, V20, P507, DOI 10.1177/106002808602000620
   RUMACK BH, 1975, PEDIATRICS, V55, P871
   Vellas B, 1999, NUTRITION, V15, P116, DOI 10.1016/S0899-9007(98)00171-3
   Vitols S, 2003, J INTERN MED, V253, P95, DOI 10.1046/j.1365-2796.2003.01107.x
   Ward B, 1999, ACUTE PAIN, V2, P139, DOI [DOI 10.1016/S1366-0071(99)80006-0, 10.1016/S1366-0071(99)80006-0]
   Watkins PB, 2006, JAMA-J AM MED ASSOC, V296, P87, DOI 10.1001/jama.296.1.87
   WYNNE HA, 1990, AGE AGEING, V19, P419, DOI 10.1093/ageing/19.6.419
   Yuan CS, 1998, CLIN PHARMACOL THER, V63, P379, DOI 10.1016/S0009-9236(98)90169-2
NR 31
TC 33
Z9 38
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0269-4727
EI 1365-2710
J9 J CLIN PHARM THER
JI J. Clin. Pharm. Ther.
PD JUN
PY 2011
VL 36
IS 3
BP 327
EP 335
DI 10.1111/j.1365-2710.2010.01193.x
PG 9
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 760GQ
UT WOS:000290313200007
PM 21545612
OA gold
DA 2024-02-19
ER

PT J
AU THAKUR, MK
   PRASAD, S
AF THAKUR, MK
   PRASAD, S
TI ANALYSIS OF AGE-ASSOCIATED ALTERATION IN THE SYNTHESIS OF HMG NONHISTONE
   PROTEINS OF THE RAT-LIVER
SO MOLECULAR BIOLOGY REPORTS
LA English
DT Article
DE AGING; HMG PROTEINS; MODULATORS; SYNTHESIS
ID MOBILITY-GROUP PROTEINS; SODIUM-BUTYRATE; CHROMATIN; DNA;
   PHOSPHORYLATION; TRANSCRIPTION; METHYLATION; CELLS; GENES
AB HMG proteins were extracted with 5% PCA or 0.35 M NaCl from whole tissue, nuclei or chromatin of the liver of young (19 weeks) and old (118 weeks) male rats.  They were resolved on acetic acid-urea polyacrylamide gel.  The electrophoretic patterns of the major HMG proteins 1, 2, 14 and 17 of both ages are similar.  The in vitro synthesis of HMG 1 and 2 decreases, but that of HMG 14 and 17 increases considerably in the liver of old rats.  The synthesis of different HMG proteins is modulated differentially by spermine, butyrate, dexamethasone and 3-aminobenzamide in the liver of young and old rats.  These findings suggest that HMG proteins contribute to alterations in the organization of chromatin and expression of genes during aging.
RP THAKUR, MK (corresponding author), BANARAS HINDU UNIV,CTR ADV STUDY ZOOL,BIOCHEM & MOLEC BIOL,VARANASI 221005,UTTAR PRADESH,INDIA.
CR ABRAHAM AK, 1970, FEBS LETT, V101, P93
   ALEXANDROVA EA, 1988, BIOCHEM BIOPH RES CO, V154, P918, DOI 10.1016/0006-291X(88)90227-6
   AXEL R, 1973, P NATL ACAD SCI USA, V70, P2029, DOI 10.1073/pnas.70.7.2029
   BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595
   BOFFA LC, 1981, J BIOL CHEM, V256, P9612
   BUCCI LR, 1984, J BIOL CHEM, V259, P8840
   BURGOYNE LA, 1974, BIOCHEM J, V143, P67, DOI 10.1042/bj1430067
   CARBALLO M, 1984, EMBO J, V3, P1255, DOI 10.1002/j.1460-2075.1984.tb01960.x
   DORBIC T, 1987, EMBO J, V6, P2393, DOI 10.1002/j.1460-2075.1987.tb02517.x
   EINCK L, 1985, EXP CELL RES, V156, P295, DOI 10.1016/0014-4827(85)90539-7
   GARRETT HE, 1966, STATISTICS PSYCHOL E, P43
   GIANCOTTI V, 1989, EXP CELL RES, V184, P538, DOI 10.1016/0014-4827(89)90352-2
   GOODWIN GH, 1977, FEBS LETT, V80, P413, DOI 10.1016/0014-5793(77)80488-2
   ISACKSON PJ, 1981, FEBS LETT, V125, P30, DOI 10.1016/0014-5793(81)80989-1
   Johns EW., 1982, HMG CHROMOSOMAL PROT, P1
   KANUNGO MS, 1980, BIOCH AGING, P18
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MACIEIRACOELHO A, 1988, BIOL NORMAL PROLIFER, P22
   MEDVEDEV ZA, 1986, EXP GERONTOL, V21, P277, DOI 10.1016/0531-5565(86)90037-9
   NICOLAS RH, 1983, NUCLEIC ACIDS RES, V11, P753, DOI 10.1093/nar/11.3.753
   NICOLAS RH, 1982, HMG CHROMOSOMAL PROT, P41
   PRASAD S, 1987, MOL BIOL REP, V12, P273, DOI 10.1007/BF00444679
   PRASAD S, 1988, BIOCHEM INT, V16, P375
   PRASAD S, 1990, BIOCHEM INT, V20, P687
   TANUMA S, 1983, J BIOL CHEM, V258, P4067
   THAKUR MK, 1989, MUTAT RES, V219, P107, DOI 10.1016/0921-8734(89)90021-0
   THAKUR MK, 1990, MECH AGEING DEV, V53, P91, DOI 10.1016/0047-6374(90)90037-G
   THAKUR MK, 1984, MECH AGEING DEV, V27, P263, DOI 10.1016/0047-6374(84)90052-6
   TREMETHICK DJ, 1989, FEBS LETT, V242, P346, DOI 10.1016/0014-5793(89)80499-5
   WAGA S, 1989, BIOCHIM BIOPHYS ACTA, V1007, P209, DOI 10.1016/0167-4781(89)90041-9
   WEISBROD S, 1982, NATURE, V297, P289, DOI 10.1038/297289a0
   YAU P, 1988, NUCLEIC ACIDS RES, V11, P2651
NR 32
TC 6
Z9 6
U1 0
U2 2
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0301-4851
J9 MOL BIOL REP
JI Mol. Biol. Rep.
PD FEB
PY 1991
VL 15
IS 1
BP 19
EP 24
DI 10.1007/BF00369896
PG 6
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA FK762
UT WOS:A1991FK76200003
PM 1908550
DA 2024-02-19
ER

PT J
AU BENEDETTI, MS
   CINI, M
   FUSI, R
   MARRARI, P
   DOSTERT, P
AF BENEDETTI, MS
   CINI, M
   FUSI, R
   MARRARI, P
   DOSTERT, P
TI THE EFFECTS OF AGING ON MAO ACTIVITY AND AMINO-ACID LEVELS IN RAT-BRAIN
SO JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION
LA English
DT Article
ID METHYLENE-DL-ASPARTATE; HEPATIC-ENCEPHALOPATHY; REGIONAL DISTRIBUTION;
   DIFFERENTIAL CHANGES; METABOLISM; AMMONIA; TAURINE; CYCLE; AGE;
   GLUTAMINE
AB The possibility that age-related changes in amino acid levels in various rat brain areas might correlate with modifications of monoamine oxidase (MAO) activity, already found with aging, has been examined.
   Taurine, aspartic acid and glutamic acid levels were found to be unchanged or decreased with age, whereas GABA and glutamine concentrations increased or remained unchanged. Serine and glycine (except in pons-medulla) levels were found to be unaffected by age. The increase in total MAO activity with aging in some brain areas might contribute to the changes in amino acid levels. Likewise, the possible influence of age-induced changes in activity of various enzymes involved in H2O2 and NH3 detoxication and in amino acid biosynthesis on rat brain amino acid levels are considered. Oral administration of clorgyline or 1-deprenyl to young rats did not significantly modify the concentrations of most brain amino acids.
C1 FARMITALIA CARLO ERBA SPA, RES & DEV ERBAMONT GRP, I-20159 MILAN, ITALY.
CR ALLEN IC, 1986, J NEUROCHEM, V46, P1582, DOI 10.1111/j.1471-4159.1986.tb01780.x
   ALVAREZ JG, 1983, BIOL REPROD, V29, P548, DOI 10.1095/biolreprod29.3.548
   Aprison M. H., 1978, AMINO ACIDS CHEM TRA, P531
   APRISON MH, 1969, COMP BIOCHEM PHYSIOL, V28, P1345, DOI 10.1016/0010-406X(69)90571-4
   Aprison MH, 1978, ADV NEUROCHEM, V3, P203
   BENEDETTI MS, 1989, BIOCHEM PHARMACOL, V38, P555, DOI 10.1016/0006-2952(89)90198-6
   BENEDETTI MS, 1986, MODULATION CENTRAL P, P255
   BUTTERWORTH RF, 1988, J NEUROCHEM, V51, P486, DOI 10.1111/j.1471-4159.1988.tb01064.x
   COOPER AJL, 1987, NEUROCHEM PATHOL, V6, P67, DOI 10.1007/BF02833601
   COOPER AJL, 1983, BIOCHEM PHARMACOL, V32, P679, DOI 10.1016/0006-2952(83)90493-8
   COOPER AJL, 1987, PHYSIOL REV, V67, P440, DOI 10.1152/physrev.1987.67.2.440
   DANH HC, 1985, GERONTOLOGY, V31, P95, DOI 10.1159/000212686
   DANH HC, 1983, J NEUROCHEM, V40, P1003, DOI 10.1111/j.1471-4159.1983.tb08084.x
   DANH HC, 1984, MONOAMINE OXIDASE DI, P301
   DAVIS J, 1975, ADV BEHAV BIOL, V16, P329
   DEKONINGVEREST IF, 1980, MECH AGEING DEV, V13, P83, DOI 10.1016/0047-6374(80)90132-3
   FITZPATRICK SM, 1988, J NEUROCHEM, V51, P1197, DOI 10.1111/j.1471-4159.1988.tb03087.x
   FONDA ML, 1973, ARCH BIOCHEM BIOPHYS, V159, P622, DOI 10.1016/0003-9861(73)90499-2
   GLOWINSKI J, 1966, J NEUROCHEM, V13, P655, DOI 10.1111/j.1471-4159.1966.tb09873.x
   HINDFELT B, 1977, J CLIN INVEST, V59, P386, DOI 10.1172/JCI108651
   HORN AS, 1974, J NEUROCHEM, V22, P265, DOI 10.1111/j.1471-4159.1974.tb11589.x
   HUXTABLE RJ, 1986, TRENDS PHARMACOL SCI, V7, P481, DOI 10.1016/0165-6147(86)90433-5
   JONES BN, 1983, J CHROMATOGR, V266, P471, DOI 10.1016/S0021-9673(01)90918-5
   KANUNGO MS, 1969, 8TH P INT C GER, V1, P356
   LAI JCK, 1986, J NEUROCHEM, V47, P1376, DOI 10.1111/j.1471-4159.1986.tb00768.x
   LAI JCK, 1981, J NEUROCHEM, V36, P1443, DOI 10.1111/j.1471-4159.1981.tb00585.x
   LAVOIE J, 1987, J NEUROCHEM, V49, P692, DOI 10.1111/j.1471-4159.1987.tb00949.x
   NAKASHIMA T, 1982, JPN J PHARMACOL, V32, P583, DOI 10.1254/jjp.32.583
   RAJESWARI TS, 1984, MECH AGEING DEV, V24, P139, DOI 10.1016/0047-6374(84)90066-6
   RATNAKUMARI L, 1986, NEUROCHEM INT, V8, P115, DOI 10.1016/0197-0186(86)90108-7
   RECORD CO, 1976, EUR J CLIN INVEST, V6, P387, DOI 10.1111/j.1365-2362.1976.tb00533.x
   SCHULTZ V, 1976, J BIOL CHEM, V251, P485
   SEILER N, 1974, BIOCHEM J, V144, P29, DOI 10.1042/bj1440029
   Timiras P S, 1973, Prog Brain Res, V40, P267
   VANDERHEYDEN JAM, 1978, J NEUROCHEM, V31, P197
   WESTERINK BHC, 1976, EUR J PHARMACOL, V40, P131, DOI 10.1016/0014-2999(76)90362-9
   WRIGHT CE, 1986, ANNU REV BIOCHEM, V55, P427, DOI 10.1146/annurev.bi.55.070186.002235
   YUDKOFF M, 1988, J NEUROCHEM, V51, P843, DOI 10.1111/j.1471-4159.1988.tb01820.x
NR 38
TC 0
Z9 1
U1 0
U2 0
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0300-9564
J9 J NEURAL TRANSM-GEN
JI J. Neural Transm.-Gen. Sect.
PY 1990
SU 29
BP 259
EP 268
PG 10
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA DK611
UT WOS:A1990DK61100026
DA 2024-02-19
ER

PT J
AU Segatto, M
   Trapani, L
   Marino, M
   Pallottini, V
AF Segatto, Marco
   Trapani, Laura
   Marino, Maria
   Pallottini, Valentina
TI Age- and Sex-Related Differences in Extra-hepatic Low-Density
   Lipoprotein Receptor
SO JOURNAL OF CELLULAR PHYSIOLOGY
LA English
DT Article
ID HMG-COA REDUCTASE; O-LINKED GLYCOSYLATION; LDL RECEPTOR; CHOLESTEROL
   HOMEOSTASIS; PLASMA-CHOLESTEROL; HYPERCHOLESTEROLEMIA; BIOSYNTHESIS;
   EXPRESSION; STABILITY; PROTEINS
AB To determine whether differences in LDLr behavior in extra-hepatic tissues and whether extra-hepatic receptors could differentially contribute to cholesterol homeostasis under physiological conditions, we evaluated the presence and regulation of LDLr from both a gender and an aging perspective. We used the brain cortex, the gastrocnemius, and the heart ventricle of 3- and 12-month-old male and female rats. We observed a protein decrease of total LDLr in 12-month-old female rat brains that was completely restored by 17-beta estradiol treatment. In the gastrocnemius, LDLr accumulates in the skeletal muscle in both male and female aged rats as a precursor probably due to a glycosylation impairment. In the heart, no modifications were observed in either older rats or rats of a specific gender. These data highlight a tissue-specific dysregulation of LDLr that is age-and gender-dependent. J. Cell. Physiol. 226: 2610-2616, 2011. (C) 2010 Wiley-Liss, Inc.
C1 [Segatto, Marco; Trapani, Laura; Marino, Maria; Pallottini, Valentina] Univ Roma Tre, Dept Biol, I-00146 Rome, Italy.
C3 Roma Tre University
RP Pallottini, V (corresponding author), Univ Roma Tre, Dept Biol, Viale Marconi 446, I-00146 Rome, Italy.
EM vpallott@uniroma3.it
RI Pallottini, Valentina/AAA-3218-2021; Segatto, Marco/HJY-2706-2023;
   Segatto, Marco/AHD-3607-2022; Segatto, Marco/IQV-0900-2023
OI Pallottini, Valentina/0000-0003-2511-6168; Segatto,
   Marco/0000-0003-0465-9470
FU University of Roma Tre
FX Contract grant sponsor: CLAR 2008-2009 from University of Roma Tre to VP
   and MM.
CR Alberts B., 2002, Molecular Biology of the Cell, V4th ed.
   ALLALOUF D, 1988, MECH AGEING DEV, V44, P45, DOI 10.1016/0047-6374(88)90078-4
   Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059
   Andersen K, 1999, NEUROLOGY, V53, P1992, DOI 10.1212/WNL.53.9.1992
   Andreasen N, 1998, J NEUROL NEUROSUR PS, V64, P298, DOI 10.1136/jnnp.64.3.298
   Atkins D, 2000, J Am Med Womens Assoc (1972), V55, P234
   Bar PR, 1997, BIOCHEM SOC T, V25, P50
   BARZEL US, 1988, AM J MED, V85, P847
   BELLOSTA S, 1995, J BIOL CHEM, V270, P27063, DOI 10.1074/jbc.270.45.27063
   Benarroch EE, 2008, NEUROLOGY, V71, P1368, DOI 10.1212/01.wnl.0000333215.93440.36
   Björnström L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486
   BROWN MS, 1983, J CLIN INVEST, V72, P743, DOI 10.1172/JCI111044
   BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311
   Brown MS, 2004, ATHEROSCLEROSIS SUPP, V5, P57, DOI 10.1016/j.atherosclerosissup.2004.08.024
   Carnes BA, 2003, BIOGERONTOLOGY, V4, P31, DOI 10.1023/A:1022425317536
   CUMMINGS RD, 1983, J BIOL CHEM, V258, P5261
   De Marinis E, 2008, J ENDOCRINOL, V198, P635, DOI 10.1677/JOE-08-0242
   DiCroce L, 1996, BIOCHEM BIOPH RES CO, V224, P345, DOI 10.1006/bbrc.1996.1031
   Farhat MY, 1996, FASEB J, V10, P615, DOI 10.1096/fasebj.10.5.8621060
   FILIPOVIC I, 1989, J BIOL CHEM, V264, P8815
   Finch CE, 1997, SCIENCE, V278, P407, DOI 10.1126/science.278.5337.407
   Fodor J.G., 2004, The Journal of Men's Health & Gender, V1, P32, DOI DOI 10.1016/J.JMHG.2004.03.005
   GOLDSTEIN JL, 1984, J LIPID RES, V25, P1450
   Holliday R, 2000, BIOGERONTOLOGY, V1, P97, DOI 10.1023/A:1010068604446
   KOUSVELARI EE, 1988, MECH AGEING DEV, V42, P173, DOI 10.1016/0047-6374(88)90072-3
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Marino M, 2002, MECH AGEING DEV, V123, P1183, DOI 10.1016/S0047-6374(02)00009-X
   Martini C, 2007, GENES NUTR, V2, P181, DOI 10.1007/s12263-007-0049-y
   Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399
   Pallottini V, 2007, MECH AGEING DEV, V128, P688, DOI 10.1016/j.mad.2007.10.001
   Pallottini V, 2006, J CELL BIOCHEM, V98, P1044, DOI 10.1002/jcb.20951
   Pfrieger FW, 2003, CELL MOL LIFE SCI, V60, P1158, DOI 10.1007/s00018-003-3018-7
   REDDY P, 1989, J BIOL CHEM, V264, P17329
   Skafar DF, 1997, J CLIN ENDOCR METAB, V82, P3913, DOI 10.1210/jc.82.12.3913
   SPADY DK, 1983, J LIPID RES, V24, P303
   TOLLESHAUG H, 1982, CELL, V30, P715, DOI 10.1016/0092-8674(82)90276-8
   TOLLESHAUG H, 1983, CELL, V32, P941, DOI 10.1016/0092-8674(83)90079-X
   TRAPANI L, 2010, CURR GERONTOL GERIAT, P1
   Trapani L, 2010, EXP GERONTOL, V45, P119, DOI 10.1016/j.exger.2009.10.014
   Vance JE, 2005, SEMIN CELL DEV BIOL, V16, P193, DOI 10.1016/j.semcdb.2005.01.005
   Vanhooren V, 2007, REJUV RES, V10, P521, DOI 10.1089/rej.2007.0556
   YOSHIMURA A, 1987, J BIOL CHEM, V262, P13299
   Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348
NR 43
TC 30
Z9 35
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-9541
EI 1097-4652
J9 J CELL PHYSIOL
JI J. Cell. Physiol.
PD OCT
PY 2011
VL 226
IS 10
BP 2610
EP 2616
DI 10.1002/jcp.22607
PG 7
WC Cell Biology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Physiology
GA 811MF
UT WOS:000294214400018
PM 21792919
DA 2024-02-19
ER

PT J
AU Sharma, R
   Kapila, R
   Kapasiya, M
   Saliganti, V
   Dass, G
   Kapila, S
AF Sharma, Rohit
   Kapila, Rajeev
   Kapasiya, Meena
   Saliganti, Vamshi
   Dass, Gulshan
   Kapila, Suman
TI Dietary supplementation of milk fermented with probiotic
   <i>Lactobacillus fermentum</i> enhances systemic immune response and
   antioxidant capacity in aging mice
SO NUTRITION RESEARCH
LA English
DT Article
DE Immunosenescence; Lactobacillus; Infection; Antioxidant; Mice;
   Inflammaging
ID LACTIC-ACID; T-CELLS; AGE; IMMUNOSENESCENCE; ACIDOPHILUS; CYTOKINE;
   CASEI; RATS; DAHI; TH2
AB Although probiotics are known to enhance the host immune response, their roles in modulating immunosenescence, resisting infection, and improving redox homeostasis during aging remain unclear. Therefore, the present study was devised in aging mice to assess the antiimmunosenescence potential from the consumption of milk that is fermented with probiotic Lactobacillus fermentum MTCC 5898 (LF). We hypothesized that probiotic supplementation would boost immunity, improve antioxidant capacity, and resist severity of pathogenic infection in aging mice. To test this hypothesis, during a trial period of 2 months, 16-month-old male Swiss mice were kept on 3 experimental diets: basal diet (BD), BD supplemented with skim milk, and BD supplemented with probiotic LF-fermented milk. A concurrent analysis of several immunosenescence markers that include neutrophil functions, interleukins profile, inflammation and antibody responses in the intestine as well as analysis of antioxidant enzymes in the liver and red blood cells was performed. Neutrophil respiratory burst enzymes and phagocytosis increased significantly in probiotic LF-fed groups, whereas no exacerbation in plasma levels of monocyte chemotactic protein 1 and tumor necrosis factor a was observed. Splenocytes registered increased interferon-gamma but decreased interleukin 4 and interleukin 10 production, whereas humoral antibodies registered decreases in immunoglobulin G1 (IgG1)/IgG2a ratio and IgE levels in the probiotic-fed groups. Antioxidant enzymes (superoxide dismutase, catalase, and glutathione peroxidase) in LF-fed groups showed increased activities, which were more pronounced in the liver than in red blood cell. An Escherichia coli based infection model in aging mice was also designed to validate the protective attributes of LF. Administration of probiotic LF significantly reduced E coli population in organs (intestine, liver, spleen, and peritoneal fluid), as compared with control groups, by enhancing E colt-specific antibodies and inflammatory proteins. Based on these results, it appears that LF supplementation alleviated immunosenescence, enhanced antioxidant enzyme activities, and resisted E coli infection in aging mice; thereby, signifying its potential in augmenting healthy aging. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Sharma, Rohit; Kapila, Rajeev; Kapasiya, Meena; Saliganti, Vamshi; Dass, Gulshan; Kapila, Suman] Natl Dairy Res Inst, Anim Biochem Div, Karnal 132001, Haryana, India.
C3 Indian Council of Agricultural Research (ICAR); ICAR - National Dairy
   Research Institute
RP Kapila, R (corresponding author), Natl Dairy Res Inst, Anim Biochem Div, Karnal 132001, Haryana, India.
EM rkapila69@rediffmail.com
RI Kapila, Suman/O-5288-2019; Kapila, Rajeev/AAN-1602-2021; Sharma,
   Rohit/AAC-8355-2020
OI Kapila, Suman/0000-0003-2627-773X; Sharma, Rohit/0000-0001-6209-3845;
   KAPILA, RAJEEV/0000-0002-2795-3720
FU Department of Biotechnology; Government of India
FX The financial assistance provided by the Department of Biotechnology and
   the Government of India are appreciated. The laboratory facilities
   provided by NDRI, Karnal, are also acknowledged.
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Moro-García MA, 2013, AGE, V35, P1311, DOI 10.1007/s11357-012-9434-6
   AOAC, 2005, OFFICIAL METHODS ANA, P75
   Aw D, 2007, IMMUNOLOGY, V120, P435, DOI 10.1111/j.1365-2567.2007.02555.x
   BERNET MF, 1993, APPL ENVIRON MICROB, V59, P4121, DOI 10.1128/AEM.59.12.4121-4128.1993
   BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462
   Braga PC, 1998, GERONTOLOGY, V44, P192, DOI 10.1159/000022009
   Brüünsgaard H, 2003, IMMUNOL ALLERGY CLIN, V23, P15, DOI 10.1016/S0889-8561(02)00056-5
   Chagnaud P, 2001, J MICROBIOL METH, V44, P139, DOI 10.1016/S0167-7012(00)00244-X
   Costa D, 2006, FREE RADICAL BIO MED, V40, P632, DOI 10.1016/j.freeradbiomed.2005.09.017
   CUTLER RG, 1991, AM J CLIN NUTR, V53, pS373, DOI 10.1093/ajcn/53.1.373S
   Dorrington MG, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00171
   Ellis TN, 2004, IMMUNOLOGY, V112, P2, DOI 10.1111/j.1365-2567.2004.01849.x
   Engwall E, 1971, J IMMUNOL, V109, P129
   Feili-Hariri M, 2005, J LEUKOCYTE BIOL, V78, P656, DOI 10.1189/jlb.1104631
   Ferreira CD, 2012, CELL BIOCHEM FUNCT, V30, P604, DOI 10.1002/cbf.2840
   Festing Michael F W, 2002, ILAR J, V43, P244
   Ghosh S, 2004, GUT, V53, P620, DOI 10.1136/gut.2003.034249
   Ginaldi L, 1999, IMMUNOL RES, V20, P109, DOI 10.1007/BF02786467
   Gionchetti P, 2003, GASTROENTEROLOGY, V124, P1202, DOI 10.1016/S0016-5085(03)00171-9
   Guamer F, 2008, WORLD GASTROENTEROL
   Hay FC, 2002, PRACTICAL IMMUNOLOGY, P203
   Jain S, 2008, INT J IMMUNOPATH PH, V21, P1021, DOI 10.1177/039463200802100428
   Kapila R, 2013, MICROBIOL IMMUNOL, V57, P778, DOI 10.1111/1348-0421.12092
   Kapila R, 2012, PROBIOTICS ANTIMICRO, V4, P173, DOI 10.1007/s12602-012-9107-x
   Kapila S, 2007, FOOD AGR IMMUNOL, V18, P75, DOI 10.1080/09540100701317618
   Kaushal D, 2012, MOL BIOL REP, V39, P1791, DOI 10.1007/s11033-011-0920-1
   Kekkonen RA, 2008, WORLD J GASTROENTERO, V14, P2029, DOI 10.3748/wjg.14.2029
   Kiernan J.A., 2008, HISTOLOGICAL HISTOCH
   Kovacs EJ, 2004, MECH AGEING DEV, V125, P121, DOI 10.1016/j.mad.2003.11.007
   LIM TS, 1981, IMMUNOLOGY, V43, P401
   Lin Shu-peng, 2010, Nan Fang Yi Ke Da Xue Xue Bao, V30, P584
   Lord JM, 2001, MECH AGEING DEV, V122, P1521, DOI 10.1016/S0047-6374(01)00285-8
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Lutgendorff F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004512
   Maneerat S, 2013, J NUTR SCI, V2, DOI 10.1017/jns.2013.31
   MARKLUND S, 1974, EUR J BIOCHEM, V47, P469
   Martarelli D, 2011, CURR MICROBIOL, V62, P1689, DOI 10.1007/s00284-011-9915-3
   Matsumoto M, 2011, MED HYPOTHESES, V77, P469, DOI 10.1016/j.mehy.2011.06.011
   Mocchegiani E, 2009, J CLIN IMMUNOL, V29, P416, DOI 10.1007/s10875-009-9298-4
   Mohamadzadeh M, 2005, P NATL ACAD SCI USA, V102, P2880, DOI 10.1073/pnas.0500098102
   Mohamadzadeh M, 2008, EXPERT REV VACCINES, V7, P1155, DOI 10.1586/14760584.7.8.1155
   Ogawa Kishiko, 2008, Immun Ageing, V5, P13, DOI 10.1186/1742-4933-5-13
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Roessler A, 2008, CLIN EXP ALLERGY, V38, P93, DOI 10.1111/j.1365-2222.2007.02876.x
   Schiavi E, 2011, ALLERGY, V66, P499, DOI 10.1111/j.1398-9995.2010.02501.x
   Sharma R, 2014, AGING CLIN EXP RES, V26, P353, DOI 10.1007/s40520-013-0190-y
   Sharma R, 2013, FOOD REV INT, V29, P201, DOI 10.1080/87559129.2012.751547
   Shearer GM, 1997, MECH AGEING DEV, V94, P1
   Shih PH, 2007, BIOGERONTOLOGY, V8, P71, DOI 10.1007/s10522-006-9033-y
   Stadlbauer V, 2008, J HEPATOL, V48, P945, DOI 10.1016/j.jhep.2008.02.015
   Tan M, 2011, CRIT CARE, V15, DOI 10.1186/cc10579
   Tortorella C, 2000, MECH AGEING DEV, V119, P69, DOI 10.1016/S0047-6374(00)00171-8
   Uciechowski P, 2008, EXP GERONTOL, V43, P493, DOI 10.1016/j.exger.2007.11.006
   Verna Elizabeth C, 2010, Therap Adv Gastroenterol, V3, P307, DOI 10.1177/1756283X10373814
   Whorwell PJ, 2006, AM J GASTROENTEROL, V101, P1581, DOI 10.1111/j.1572-0241.2006.00734.x
   Yadav H, 2008, J DAIRY RES, V75, P189, DOI 10.1017/S0022029908003129
   Zhou XX, 2010, FISH PHYSIOL BIOCHEM, V36, P501, DOI 10.1007/s10695-009-9320-z
   Zommara M, 1998, BIOSCI BIOTECH BIOCH, V62, P710, DOI 10.1271/bbb.62.710
NR 60
TC 57
Z9 61
U1 1
U2 38
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0271-5317
EI 1879-0739
J9 NUTR RES
JI Nutr. Res.
PD NOV
PY 2014
VL 34
IS 11
BP 968
EP 981
DI 10.1016/j.nutres.2014.09.006
PG 14
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA AT5JX
UT WOS:000344980600007
PM 25311611
DA 2024-02-19
ER

PT J
AU Liu, YY
   Hung, TC
   Lee, CW
   Wu, YJ
AF Liu, Yen -Yu
   Hung, Ta-Chuan
   Lee, Chun-Wei
   Wu, Yih-Jer
TI Early Signs of Cardiovascular Senescence in a Patient with Hereditary
   Hemorrhagic Telangiectasia
SO INTERNATIONAL JOURNAL OF GERONTOLOGY
LA English
DT Article
DE atrial fibrillation; telangiectasia hereditary hemorrhagic; hypertension
   pulmonary; varicose veins
ID ATRIAL-FIBRILLATION; HEART-FAILURE; RISK; COMPLICATIONS; HYPERTENSION
AB Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant genetic disease with manifesta-tions of epistaxis, mucocutaneous telangiectasias, and arteriovenous malformations of multiple or-gans, including the lungs, liver, and brain. It can also lead to fatal events such as high-output cardiac fail-ure, respiratory failure, stroke, sepsis, and other hemodynamic complications. Therefore, early aware-ness of HHT is essential. We describe a 55-year-old man highly suspected of HHT with a rare initial pre-sentation of atrial fibrillation (AF) and remarkable varicose veins at an unusually young age. AF occur-ring at a young age and refractory varicose veins caused by high-output heart failure might be a whistle -blower for HHT, and early awareness may help diagnosis and appropriate management.Copyright (c) 2023, Taiwan Society of Geriatric Emergency & Critical Care Medicine.
C1 [Liu, Yen -Yu; Hung, Ta-Chuan; Lee, Chun-Wei; Wu, Yih-Jer] MacKay Mem Hosp, Dept Internal Med, Cardiovasc Div, Taipei, Taiwan.
   [Liu, Yen -Yu; Hung, Ta-Chuan; Lee, Chun-Wei; Wu, Yih-Jer] MacKay Mem Hosp, Dept Crit Care Med, Taipei, Taiwan.
   [Hung, Ta-Chuan; Lee, Chun-Wei] MacKay Jr Coll Med Nursing & Management, Taipei, Taiwan.
   [Liu, Yen -Yu; Hung, Ta-Chuan; Wu, Yih-Jer] MacKay Med Coll, Dept Med, 46,Sec 3, Zhongzhen Rd, New Taipei City, Taiwan.
   [Liu, Yen -Yu; Hung, Ta-Chuan; Wu, Yih-Jer] MacKay Med Coll, Inst Biomed Sci, New Taipei City, Taiwan.
C3 Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Junior
   College of Medicine, Nursing & Management; Mackay Medical College;
   Mackay Medical College
RP Wu, YJ (corresponding author), MacKay Med Coll, Dept Med, 46,Sec 3, Zhongzhen Rd, New Taipei City, Taiwan.
EM jacobyjwu@gmail.com
CR Anter E, 2009, CIRCULATION, V119, P2516, DOI 10.1161/CIRCULATIONAHA.108.821306
   Anwar MA, 2012, CIRC-CARDIOVASC GENE, V5, P460, DOI 10.1161/CIRCGENETICS.112.963439
   Blanco FJ, 2011, AGING CELL, V10, P896, DOI 10.1111/j.1474-9726.2011.00727.x
   Blanco FJ, 2008, CIRC RES, V103, P1383, DOI 10.1161/CIRCRESAHA.108.176552
   Cartin-Ceba R, 2013, CHEST, V144, P1033, DOI 10.1378/chest.12-0924
   Droege F, 2018, VASC MED, V23, P377, DOI 10.1177/1358863X18767761
   Dupuis-Girod S, 2012, JAMA-J AM MED ASSOC, V307, P948, DOI 10.1001/jama.2012.250
   Farhan A, 2022, AM J MED GENET A, V188, P199, DOI 10.1002/ajmg.a.62522
   Faughnan ME, 2011, J MED GENET, V48, P73, DOI 10.1136/jmg.2009.069013
   Faughnan ME, 2009, EUR RESPIR J, V33, P1186, DOI 10.1183/09031936.00061308
   GUTTMACHER AE, 1995, NEW ENGL J MED, V333, P918, DOI 10.1056/NEJM199510053331407
   Mäkivaara LA, 2009, INT ANGIOL, V28, P452
   Piazza G, 2014, CIRCULATION, V130, P582, DOI 10.1161/CIRCULATIONAHA.113.008331
   Sankaranarayanan R, 2013, CARDIOL RES PRACT, V2013, DOI 10.1155/2013/976976
   Strait JB, 2012, HEART FAIL CLIN, V8, P143, DOI 10.1016/j.hfc.2011.08.011
   Velthuis S, 2013, CHEST, V144, P542, DOI 10.1378/chest.12-1599
   Vorselaars VMM, 2015, WORLD J CARDIOL, V7, P230, DOI 10.4330/wjc.v7.i5.230
   WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983
   Wooderchak-Donahue WL, 2013, AM J HUM GENET, V93, P530, DOI 10.1016/j.ajhg.2013.07.004
   Wu SH, 2022, ACTA CARDIOL SIN, V38, P113, DOI 10.6515/ACS.202203_38(2).20211005A
NR 20
TC 0
Z9 0
U1 0
U2 0
PU TAIWAN SOC GERIATRIC EMERGENCY & CRITICAL CARE MEDICINE-TSGECM
PI TAIPEI
PA 12F-14, NO 42, SEC 1, MINSHENG E RD, ZHONGSHAN DIST, TAIPEI, 104, TAIWAN
SN 1873-9598
EI 1873-958X
J9 INT J GERONTOL
JI Int. J. Gerontol.
PD APR
PY 2023
VL 17
IS 2
BP 141
EP 143
DI 10.6890/IJGE.202304_17(2).0012
PG 3
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA G4JV7
UT WOS:000988846900014
DA 2024-02-19
ER

PT J
AU Alvarez, CF
   Debeljuk, L
   Rodríguez, ED
   López, BD
AF Alvarez, CF
   Debeljuk, L
   Rodríguez, ED
   López, BD
TI Developmental pattern of tachykinins during aging in several organs::
   effect of exogenous melatonin
SO PEPTIDES
LA English
DT Article
DE NKA; SP; aging; melatonin; ovary; pancreas; liver; spleen
ID VASOACTIVE INTESTINAL POLYPEPTIDE; P-LIKE IMMUNOREACTIVITY; GENE-RELATED
   PEPTIDE; NEUROKININ-A LEVELS; SUBSTANCE-P; ANTERIOR-PITUITARY;
   INSULIN-SECRETION; NEUROPEPTIDE-Y; DIABETIC RATS; HYPOTHALAMUS
AB Mammalian neurokinin A (NKA) and substance P (SP) are neuropeptides widely distributed in the body; they are potential regulators of the basal blood flow and therefore of the function of many organs and tissues. In the present investigation, we studied the age-dependent changes in NKA and SP in ovary, liver, pancreas and spleen as well as the role of exogenous melatonin on these changes. Female rats of 5, 15 or 25 months of age were studied. In the ovary, NKA concentrations did not change during aging. SP concentrations in the control group were significantly higher (P < 0.01) in old rats than in the other two age groups studied. Melatonin treatment resulted in reduced concentrations as compared with those of the control old rats. In the pancreas, NKA and SP concentrations increased during aging, the young rats showing significantly lower values (P < 0.01) than middle-aged and old rats for NKA and significantly lower (P < 0.01) than the old rats for SP. After melatonin treatment the differences in NKA concentrations disappeared and SP decreased in middle-aged as compared with those in old rats. In the liver, NKA and SP concentrations in the control and melatonin-treated groups did not differ significantly for the three age groups studied. Splenic NKA in control and melatonin-treated groups increased from young to middle-age up to old ages. SP concentrations showed similar values at all ages except in melatonin-treated old rats; in these animals there were significantly higher concentrations than in young melatonin-treated rats. The effect of melatonin was mainly observed on the ovary and pancreas in old rats, with a reduction in the concentrations as compared with those observed in the young groups. (C) 2002 Elsevier Science Inc. All rights reserved.
C1 Univ Oviedo, Dpto Biol Funct, Area Fisiol, Fac Med, E-33006 Oviedo, Spain.
   So Illinois Univ, Dept Physiol & Hlth Care Profess, Carbondale, IL 62901 USA.
C3 University of Oviedo; Southern Illinois University System; Southern
   Illinois University
RP López, BD (corresponding author), Univ Oviedo, Dpto Biol Funct, Area Fisiol, Fac Med, C Julian Claveria 6, E-33006 Oviedo, Spain.
OI Diaz-Rodriguez, Elena/0000-0002-0075-8191
CR Adeghate E, 2001, PEPTIDES, V22, P99, DOI 10.1016/S0196-9781(00)00361-2
   Adeghate E, 1999, NEUROPEPTIDES, V33, P227, DOI 10.1054/npep.1999.0022
   BAILEY CJ, 1974, HORM RES, V5, P21, DOI 10.1159/000178615
   BROWN GM, 1979, LIFE SCI, V25, P929, DOI 10.1016/0024-3205(79)90498-3
   CSABA G, 1971, EXPERIENTIA, V27, P962, DOI 10.1007/BF02135774
   DEBELJUK L, 1990, BRAIN RES BULL, V25, P717, DOI 10.1016/0361-9230(90)90048-5
   DEBELJUK L, 1991, NEUROENDOCRINOL LETT, V13, P5
   DEBELJUK L, 1995, PEPTIDES, V16, P827, DOI 10.1016/0196-9781(95)00031-E
   Debeljuk L, 1999, PEPTIDES, V20, P285, DOI 10.1016/S0196-9781(98)00159-4
   DEPALATIS LR, 1982, ENDOCRINOLOGY, V110, P282, DOI 10.1210/endo-110-1-282
   Di Sebastiano P, 2000, GUT, V47, P423, DOI 10.1136/gut.47.3.423
   DIAZ B, 1986, HORM METAB RES, V18, P225, DOI 10.1055/s-2007-1012279
   Diaz E, 2000, J REPROD FERTIL, V119, P151, DOI 10.1530/reprod/119.1.151
   Duval P, 1998, J NEUROENDOCRINOL, V10, P823
   Duval P, 1996, J NEUROSCI RES, V45, P598, DOI 10.1002/(SICI)1097-4547(19960901)45:5<598::AID-JNR9>3.0.CO;2-7
   EGLEZOS A, 1991, IMMUNOL CELL BIOL, V69, P285, DOI 10.1038/icb.1991.39
   El-Sokkary GH, 1999, SHOCK, V12, P402, DOI 10.1097/00024382-199911000-00009
   FERNANDEZ C, IN PRESS PEPTIDES
   Goehler LE, 1996, PEPTIDES, V17, P209, DOI 10.1016/0196-9781(95)02126-4
   GONKA AK, 1999, GERONTOLOGY, V45, P67
   GORNI RC, 1993, J PHARMACOL EXP THER, V266, P1536
   Karbownik M, 2000, INT J CANCER, V88, P7, DOI 10.1002/1097-0215(20001001)88:1<7::AID-IJC2>3.0.CO;2-T
   KIRKWOOD KS, 1999, AM J PHYSIOL, V277, P14
   la Fleur SE, 2001, J NEUROENDOCRINOL, V13, P1025, DOI 10.1046/j.1365-2826.2001.00717.x
   Lima FB, 1998, AM J PHYSIOL-ENDOC M, V275, pE934
   Milcu S, 1971, PINEAL GLAND, P345
   Mileusnic D, 1999, NEUROBIOL AGING, V20, P19, DOI 10.1016/S0197-4580(99)00019-6
   MOREL G, 1982, NEUROENDOCRINOLOGY, V35, P86, DOI 10.1159/000123360
   Nakane A, 1998, FEMS IMMUNOL MED MIC, V20, P159
   OTSUKA M, 1993, PHYSIOL REV, V73, P229, DOI 10.1152/physrev.1993.73.2.229
   Özbek E, 2000, BJU INT, V85, P742, DOI 10.1046/j.1464-410x.2000.00531.x
   Payne CM, 2001, J VIROL, V75, P10467, DOI 10.1128/JVI.75.21.10467-10471.2001
   Peschke E, 2000, J PINEAL RES, V28, P156
   PICARD P, 1994, BRIT J PHARMACOL, V112, P240, DOI 10.1111/j.1476-5381.1994.tb13058.x
   Pompei P, 1999, MOL BRAIN RES, V64, P132, DOI 10.1016/S0169-328X(98)00317-9
   Ponery AS, 2000, PEPTIDES, V21, P1503, DOI 10.1016/S0196-9781(00)00304-1
   Rameshwar P, 1997, LEUKEMIA LYMPHOMA, V28, P1
   Reiter R J, 1980, Endocr Rev, V1, P109
   Reubi JC, 1998, BLOOD, V92, P191, DOI 10.1182/blood.V92.1.191.413k12_191_197
   REUSS S, 1994, BRAIN RES, V638, P189, DOI 10.1016/0006-8993(94)90649-1
   SKENE DJ, 1990, BRAIN RES, V528, P170, DOI 10.1016/0006-8993(90)90214-V
   SODER O, 1989, INT ARCH ALLER A IMM, V90, P91, DOI 10.1159/000235006
   STOESSL AJ, 1993, BRAIN RES, V632, P21
   Stones RW, 1996, EUR J OBSTET GYN R B, V67, P191, DOI 10.1016/0301-2115(96)02466-9
   VILLANUA MA, 1992, PEPTIDES, V13, P377, DOI 10.1016/0196-9781(92)90124-L
NR 45
TC 7
Z9 7
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0196-9781
J9 PEPTIDES
JI Peptides
PD SEP
PY 2002
VL 23
IS 9
BP 1617
EP 1623
AR PII S0196-9781(02)00099-2
PG 7
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism;
   Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism;
   Pharmacology & Pharmacy
GA 599MR
UT WOS:000178339300011
PM 12217422
DA 2024-02-19
ER

PT S
AU PARADIES, G
   RUGGIERO, FM
   PETROSILLO, G
   GADALETA, MN
   QUAGLIARIELLO, E
AF PARADIES, G
   RUGGIERO, FM
   PETROSILLO, G
   GADALETA, MN
   QUAGLIARIELLO, E
BE ZsNagy, I
   Harman, D
   Kitani, K
TI THE EFFECT OF AGING AND ACETYL-L-CARNITINE ON THE FUNCTION AND ON THE
   LIPID-COMPOSITION OF RAT-HEART MITOCHONDRIA
SO PHARMACOLOGY OF AGING PROCESSES: METHODS OF ASSESSMENT AND POTENTIAL
   INTERVENTIONS
SE ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
LA English
DT Article; Proceedings Paper
CT 5th International Congress of the
   International-Association-of-Biomedical-Gerontology
CY JUL 01-03, 1993
CL BUDAPEST, HUNGARY
SP INT ASSOC BIOMED GERONTOL, VERZIR INT LAB EXPTL GERONTOL, BIOGAL PHARM WORKSLTD, GLENN FDN MED RES, SANDOZ FDN GERONTOL RES
ID AGE-DEPENDENT CHANGES; CYTOCHROME-C-OXIDASE; PHOSPHATE CARRIER;
   SENESCENT RATS; CARDIAC MITOCHONDRIA; LIVER-MITOCHONDRIA; ATP SYNTHESIS;
   CARDIOLIPIN; PHOSPHORYLATION; RESPIRATION
C1 UNIV BARI,CNR,STUDY MITOCHONDRIA & BIOENERGET UNIT,BARI,ITALY.
C3 Consiglio Nazionale delle Ricerche (CNR); Universita degli Studi di Bari
   Aldo Moro
RP PARADIES, G (corresponding author), UNIV BARI,DEPT BIOCHEM & MOLEC BIOL,BARI,ITALY.
OI PETROSILLO, GIUSEPPE/0000-0001-8035-8368
CR ABRAMOVITCH DA, 1990, BIOCHIM BIOPHYS ACTA, V1020, P34, DOI 10.1016/0005-2728(90)90090-Q
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   CLANDININ MT, 1983, MECH AGEING DEV, V22, P205, DOI 10.1016/0047-6374(83)90076-3
   CURTI D, 1989, MECH AGEING DEV, V47, P39, DOI 10.1016/0047-6374(89)90005-5
   DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4
   DOUSSIERE J, 1984, BIOCHIM BIOPHYS ACTA, V766, P492, DOI 10.1016/0005-2728(84)90265-2
   ERECINSKA M, 1982, J MEMBRANE BIOL, V70, P1, DOI 10.1007/BF01871584
   FRY M, 1980, J BIOL CHEM, V255, P9967
   GADALETA MN, 1990, EUR J BIOCHEM, V187, P501, DOI 10.1111/j.1432-1033.1990.tb15331.x
   HANSFORD RG, 1983, BIOCHIM BIOPHYS ACTA, V726, P41, DOI 10.1016/0304-4173(83)90010-1
   HANSFORD RG, 1978, BIOCHEM J, V170, P285, DOI 10.1042/bj1700285
   HOCH FL, 1992, BIOCHIM BIOPHYS ACTA, V1113, P71, DOI 10.1016/0304-4157(92)90035-9
   KADENBACH B, 1986, J BIOENERG BIOMEMBR, V18, P39, DOI 10.1007/BF00743611
   KIM JH, 1988, MECH AGEING DEV, V46, P279, DOI 10.1016/0047-6374(88)90130-3
   KLINGENBERG M, 1980, J MEMBRANE BIOL, V56, P97, DOI 10.1007/BF01875961
   KUBOYAMA M, 1972, J BIOL CHEM, V247, P6375
   LEWIN MB, 1984, MECH AGEING DEV, V24, P343, DOI 10.1016/0047-6374(84)90119-2
   MARSH D, 1988, BIOELECTROCH BIOENER, V20, P73, DOI 10.1016/S0302-4598(98)80006-8
   NOHL H, 1980, MECH AGEING DEV, V14, P137, DOI 10.1016/0047-6374(80)90112-8
   NOHL H, 1982, GERONTOLOGY, V28, P354, DOI 10.1159/000212556
   PARADIES G, 1990, BIOCHIM BIOPHYS ACTA, V1016, P207, DOI 10.1016/0005-2728(90)90060-H
   PARADIES G, 1991, ARCH BIOCHEM BIOPHYS, V284, P332, DOI 10.1016/0003-9861(91)90304-2
   PARADIES G, 1992, BIOCHIM BIOPHYS ACTA, V1103, P324, DOI 10.1016/0005-2736(92)90103-S
   PARADIES G, 1988, BIOCHIM BIOPHYS ACTA, V935, P79, DOI 10.1016/0005-2728(88)90110-7
   PARADIES G, 1992, INT J BIOCHEM, V24, P783, DOI 10.1016/0020-711X(92)90012-P
   PETRUZZELLA V, 1992, ARCH GERONTOL GERIAT, V14, P131, DOI 10.1016/0167-4943(92)90048-9
   POWELL GL, 1987, BIOCHEMISTRY-US, V26, P8138, DOI 10.1021/bi00399a018
   ROBINSON NC, 1980, BIOCHEMISTRY-US, V19, P3656, DOI 10.1021/bi00557a003
   RUGGIERO FM, 1984, LIPIDS, V19, P171, DOI 10.1007/BF02534794
   RUGGIERO FM, 1990, BIOCHEM BIOPH RES CO, V170, P621, DOI 10.1016/0006-291X(90)92137-O
   SILIPRAN.N, 1965, BIOCHEM J, V96, P777, DOI 10.1042/bj0960777
   TAYER WS, 1981, J BIOL CHEM, V256, P6090
NR 32
TC 33
Z9 34
U1 0
U2 0
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021
SN 0077-8923
BN 0-89766-881-2
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 1994
VL 717
BP 233
EP 243
DI 10.1111/j.1749-6632.1994.tb12093.x
PG 11
WC Multidisciplinary Sciences; Pharmacology & Pharmacy
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA BA67F
UT WOS:A1994BA67F00025
PM 8030840
DA 2024-02-19
ER

PT J
AU Castilla-Cortázar, I
   García-Fernández, M
   Delgado, G
   Puche, JE
   Sierra, I
   Barhoum, R
   González-Barón, S
AF Castilla-Cortazar, Inma
   Garcia-Fernandez, Maria
   Delgado, Gloria
   Puche, Juan E.
   Sierra, Inma
   Barhoum, Rima
   Gonzalez-Baron, Salvador
TI Hepatoprotection and neuroprotection induced by low doses of IGF-II in
   aging rats
SO JOURNAL OF TRANSLATIONAL MEDICINE
LA English
DT Article
ID GROWTH-FACTOR-I; ADVANCED LIVER-CIRRHOSIS; INSULIN-RESISTANCE; BRAIN;
   TRANSPORT; ATROPHY
AB Background: GH and IGFs serum levels decline with age. Age-related changes appear to be associated to decreases in these anabolic hormones. We have previously demonstrated that IGF-I replacement therapy improves insulin resistance, lipid metabolism and reduces oxidative damage (in brain and liver) in aging rats. Using the same experimental model, the aim of this work was to study whether the exogenous administration of IGF-II, at low doses, acts analogous to IGF-I in aging rats.
   Methods: Three experimental groups were included in this study: young healthy controls (yCO, 17 weeks old); untreated old rats (O, 103 weeks old); and aging rats treated with IGF-II (O+IGF-II, 2 mu g * 100 g body weight(-1) * day(-1)) for 30 days. Analytical parameters were determined in serum by routine laboratory methods using an autoanalyzer (Cobas Mira; Roche Diagnostic System, Basel, Switzerland). Serum levels of hormones (testosterone, IGF-I and insulin) were assessed by RIA. Serum Total Antioxidant Status was evaluated using a colorimetric assay. Mitochondrial membrane potential was evaluated using rhodamine 123 dye (adding different substrates to determine the different states). ATP synthesis in isolated mitochondria was determined by an enzymatic method.
   Results: Compared with young controls, untreated old rats showed a reduction of IGF-I and testosterone levels with a decrease of serum total antioxidant status (TAS). IGF-II therapy improved serum antioxidant capability without modifying testosterone and IGF-I circulating concentrations. In addition, IGF-II treatment reduced oxidative damage in brain and liver, improving antioxidant enzyme activities and mitochondrial function. IGF-II was also able to reduce cholesterol and triglycerides levels increasing free fatty acids concentrations.
   Conclusions: We demonstrate that low doses of IGF-II induce hepatoprotective, neuroprotective and metabolic effects, improving mitochondrial function, without affecting testosterone and IGF-I levels.
C1 [Castilla-Cortazar, Inma; Puche, Juan E.; Sierra, Inma; Barhoum, Rima] CEU San Pablo Univ, Sch Med, Dept Med Physiol, Inst Appl Mol Med IMMA Boadilla del Monte, Madrid 28668, Spain.
   [Garcia-Fernandez, Maria; Delgado, Gloria; Gonzalez-Baron, Salvador] Univ Malaga, Sch Med, Dept Physiol, E-29071 Malaga, Spain.
C3 San Pablo CEU University; Universidad de Malaga
RP Castilla-Cortázar, I (corresponding author), CEU San Pablo Univ, Sch Med, Dept Med Physiol, Inst Appl Mol Med IMMA Boadilla del Monte, Madrid 28668, Spain.
EM iccortazar@ceu.es
RI Puche, Juan/L-9132-2014; Puche, Juan E/HMP-2853-2023; María,
   garcia-fernandez/H-8196-2017; Castilla-Cortazar, Inma/K-7883-2017
OI María, garcia-fernandez/0000-0002-6436-1361; Castilla-Cortazar,
   Inma/0000-0002-2230-5927
FU CICYT of the Spanish government [SAF-2009-08319]; ISCIII [ADE09/90041];
   Lilly Laboratories (Madrid, Spain)
FX This work was supported in part by grants from the CICYT of the Spanish
   government (SAF-2009-08319), and the ISCIII (ADE09/90041). We thank Ms
   Yolanda Rico and Mr Jose Maria Garrido for their generous help. We also
   thank Drs. Jesus Hernandez Cabrero and Jose A Sacristan from Lilly
   Laboratories (Madrid, Spain), for providing research grants and the
   recombinant IGF-II used in this study.
CR Aebi HE., 1983, Methods of enzymatic analysis, P273
   Cardoso SM, 1999, FREE RADICAL BIO MED, V26, P3, DOI 10.1016/S0891-5849(98)00205-6
   Castilla-Cortazar I, 2000, HEPATOLOGY, V31, P592, DOI 10.1002/hep.510310308
   Castilla-Cortázar I, 2004, BMC GASTROENTEROL, V4, DOI 10.1186/1471-230X-4-12
   Castilla-Cortázar I, 2004, WORLD J GASTROENTERO, V10, P2529, DOI 10.3748/wjg.v10.i17.2529
   CASTILLACORTAZA.I, 1999, AM J PHYSIOL, V276, P37
   CastillaCortazar I, 1997, GASTROENTEROLOGY, V113, P1682, DOI 10.1053/gast.1997.v113.pm9352873
   CastillaCortazar I, 1997, GASTROENTEROLOGY, V113, P1180, DOI 10.1053/gast.1997.v113.pm9322513
   Ceda GP, 1998, J CLIN ENDOCR METAB, V83, P499, DOI 10.1210/jc.83.2.499
   Cemborain A, 1998, J HEPATOL, V28, P122, DOI 10.1016/S0168-8278(98)80211-0
   Chen DY, 2011, NATURE, V469, P491, DOI 10.1038/nature09667
   Clemmons David R., 1997, Cytokine and Growth Factor Reviews, V8, P45, DOI 10.1016/S1359-6101(96)00053-6
   D'Ercole AJ, 2002, NEUROPEPTIDES, V36, P209, DOI 10.1054/npep.2002.0893
   Dupont Joelle, 2003, Birth Defects Research, V69, P257, DOI 10.1002/bdrc.10022
   ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6
   Fernandez S, 2007, GROWTH HORM IGF RES, V17, P89, DOI 10.1016/j.ghir.2007.01.006
   García-Fernández M, 2005, BMC GASTROENTEROL, V5, DOI 10.1186/1471-230X-5-7
   García-Fernández M, 2003, J PHYSIOL BIOCHEM, V59, P145, DOI 10.1007/BF03179879
   García-Fernández M, 2008, ENDOCRINOLOGY, V149, P2433, DOI 10.1210/en.2007-1190
   Garcia-Segura LM, 2006, NEUROENDOCRINOLOGY, V84, P275, DOI 10.1159/000097485
   GLUCKMAN PD, 1993, MOL CELL ENDOCRINOL, V92, pC1, DOI 10.1016/0303-7207(93)90067-T
   HARRIS ED, 1992, FASEB J, V6, P2675, DOI 10.1096/fasebj.6.9.1612291
   HOGEBOOM GH, 1950, NATURE, V166, P302, DOI 10.1038/166302a0
   LEVINE RL, 1990, METHOD ENZYMOL, V186, P464
   Li Q, 2007, AM J PHYSIOL-HEART C, V292, pH1398, DOI 10.1152/ajpheart.01036.2006
   LLorens-Martín M, 2009, NEUROSCIENTIST, V15, P134, DOI 10.1177/1073858408331371
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Miller Nicholas J., 1993, Biochemical Society Transactions, V21, p95S
   Mirpuri E, 2002, INT J BIOCHEM CELL B, V34, P242, DOI 10.1016/S1357-2725(01)00123-6
   *NAT AC SCI, 1991, GUID PRINC RES INV A
   OCONNOR JE, 1988, BIOCHEM BIOPH RES CO, V151, P568, DOI 10.1016/0006-291X(88)90632-8
   Picardi A, 1997, J HEPATOL, V26, P191, DOI 10.1016/S0168-8278(97)80026-8
   Puche JE, 2008, ENDOCRINOLOGY, V149, P2620, DOI 10.1210/en.2007-1563
   RICHTER C, 1995, BBA-MOL BASIS DIS, V1271, P67, DOI 10.1016/0925-4439(95)00012-S
   Sullivan KA, 2008, ENDOCRINOLOGY, V149, P5963, DOI 10.1210/en.2008-1020
   Thum T, 2007, CIRC RES, V100, P434, DOI 10.1161/01.RES.0000257912.78915.af
   Trejo JL, 2004, GROWTH HORM IGF RES, V14, pS39, DOI 10.1016/j.ghir.2004.03.010
   VegaNunez E, 1997, ENDOCRINOLOGY, V138, P3771, DOI 10.1210/en.138.9.3771
   Voss P, 2006, FREE RADICAL RES, V40, P1339, DOI 10.1080/10715760600953859
   Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487
NR 40
TC 35
Z9 38
U1 0
U2 12
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1479-5876
J9 J TRANSL MED
JI J. Transl. Med.
PD JUL 6
PY 2011
VL 9
AR 103
DI 10.1186/1479-5876-9-103
PG 9
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 803ZF
UT WOS:000293621300001
PM 21733157
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU NAVEAU, S
   PERRIER, C
   INK, O
   MORY, B
   POYNARD, T
   CHAPUT, JC
AF NAVEAU, S
   PERRIER, C
   INK, O
   MORY, B
   POYNARD, T
   CHAPUT, JC
TI ARE ALCOHOLIC BEVERAGES EQUIVALENT IN THEIR POTENTIAL TO CAUSE ALCOHOLIC
   LIVER-DISEASE
SO EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
LA English
DT Article
DE ALCOHOLIC CIRRHOSIS; LIVER STEATOSIS; ALCOHOLIC BEVERAGES
AB The aim of this study was to assess the relationship between the type of beverage ingested and the presence of cirrhosis and liver steatosis in 1114 alcoholic patients. In a first analysis, four variables were positively correlated with the presence of cirrhosis when all variables were considered together - age, female gender, total duration of alcohol abuse and daily consumption of wine as a percentage of daily alcohol intake over the previous 5 years. In the second analysis, the daily consumption of aperitifs as a percentage of the daily total alcohol intake over the previous 5 years correlated positively with liver steatosis grade; the duration of alcohol abuse correlated negatively with liver steatosis grade. The relationship between the daily consumption of wine and the presence of cirrhosis could be explained by the effect of liver disease and ageing, which may have contributed to the change of drinking habits. On the other hand, the consumption of aperitifs could be a factor in the early stages of alcoholic liver disease.
RP NAVEAU, S (corresponding author), HOP ANTOINE BECLERE, SERV HEPATO GASTROENTEROL, 157 RUE PORTE TRIVAUX, F-92141 CLAMART, FRANCE.
RI Poynard, Thierry/C-1355-2010
OI Poynard, Thierry/0000-0002-3726-7230; Poynard,
   Thierry/0000-0002-2050-640X
NR 0
TC 6
Z9 6
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0954-691X
EI 1473-5687
J9 EUR J GASTROEN HEPAT
JI Eur. J. Gastroenterol. Hepatol.
PD MAR
PY 1991
VL 3
IS 3
BP 265
EP 269
PG 5
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA FE078
UT WOS:A1991FE07800014
DA 2024-02-19
ER

PT J
AU Swindell, WR
AF Swindell, William R.
TI Gene expression profiling of long-lived dwarf mice: longevity-associated
   genes and relationships with diet, gender and aging
SO BMC GENOMICS
LA English
DT Article
ID GROWTH-HORMONE; LIFE-SPAN; RESTRICTION MIMETICS; STRESS RESISTANCE;
   OXIDATIVE STRESS; IGF-I; INSULIN; MOUSE; RECEPTOR; SNELL
AB Background: Long-lived strains of dwarf mice carry mutations that suppress growth hormone (GH) and insulin-like growth factor I (IGF-I) signaling. The downstream effects of these endocrine abnormalities, however, are not well understood and it is unclear how these processes interact with aging mechanisms. This study presents a comparative analysis of microarray experiments that have measured hepatic gene expression levels in long- lived strains carrying one of four mutations (PropI(df/) (df), PitI(dw/) (dw), Ghrhr(lit/ lit), GHR-KO) and describes how the effects of these mutations relate to one another at the transcriptional level. Points of overlap with the effects of calorie restriction (CR), CR mimetic compounds, low fat diets, gender dimorphism and aging were also examined.
   Results: All dwarf mutations had larger and more consistent effects on IGF-l expression than dietary treatments. In comparison to dwarf mutations, however, the transcriptional effects of CR (and some CR mimetics) overlapped more strongly with those of aging. Surprisingly, the Ghrhr(lit/lit) mutation had much larger effects on gene expression than the GHR-KO mutation, even though both mutations affect the same endocrine pathway. Several genes potentially regulated or co-regulated with the IGF-I transcript in liver tissue were identified, including a DNA repair gene (SnmI) that is upregulated in proportion to IGF-I inhibition. A total of 13 genes exhibiting parallel differential expression patterns among all four strains of long-lived dwarf mice were identified, in addition to 30 genes with matching differential expression patterns in multiple long- lived dwarf strains and under CR.
   Conclusion: Comparative analysis of microarray datasets can identify patterns and consistencies not discernable from any one dataset individually. This study implements new analytical approaches to provide a detailed comparison among the effects of life-extending mutations, dietary treatments, gender and aging. This comparison provides insight into a broad range of issues relevant to the study of mammalian aging. In this context, 43 longevity-associated genes are identified and individual genes with the highest level of support among all microarray experiments are highlighted. These results provide promising targets for future experimental investigation as well as potential clues for understanding the functional basis of lifespan extension in mammalian systems.
C1 Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.
C3 University of Michigan System; University of Michigan
RP Swindell, WR (corresponding author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.
EM wswindel@med.umich.edu
FU Intramural NIH HHS [Z01 AG000114] Funding Source: Medline; NIA NIH HHS
   [T32 AG000114] Funding Source: Medline
CR Adamo ML, 2006, ENDOCRINOLOGY, V147, P2944, DOI 10.1210/en.2005-0742
   Ahkter S, 2005, MOL CELL BIOL, V25, P10071, DOI 10.1128/MCB.25.22.10071-10078.2005
   Amador-Noguez D, 2005, BIOCHEM BIOPH RES CO, V332, P1086, DOI 10.1016/j.bbrc.2005.05.063
   Amador-Noguez D, 2004, AGING CELL, V3, P423, DOI 10.1111/j.1474-9728.2004.00125.x
   Anisimov VN, 2005, EXP GERONTOL, V40, P685, DOI 10.1016/j.exger.2005.07.007
   Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887
   Bartke A, 2005, ENDOCRINOLOGY, V146, P3718, DOI 10.1210/en.2005-0411
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   BIELSCHOWSKY F, 1961, BRIT J CANCER, V15, P257, DOI 10.1038/bjc.1961.32
   Bonkowski MS, 2006, P NATL ACAD SCI USA, V103, P7901, DOI 10.1073/pnas.0600161103
   Boylston WH, 2006, AGE, V28, P125, DOI 10.1007/s11357-006-9008-6
   BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0
   Butler AA, 2001, ENDOCRINOLOGY, V142, P1685, DOI 10.1210/en.142.5.1685
   Carter CS, 2002, TRENDS GENET, V18, P295, DOI 10.1016/S0168-9525(02)02696-3
   Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821
   CONOVER CA, IN PRESS AGING CELL
   Corton JC, 2004, J BIOL CHEM, V279, P46204, DOI 10.1074/jbc.M406739200
   Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608
   Dhahbi JM, 2005, PHYSIOL GENOMICS, V23, P343, DOI 10.1152/physiolgenomics.00069.2005
   DiMarco A, 1997, J BIOL CHEM, V272, P23069, DOI 10.1074/jbc.272.37.23069
   Dozmorov I, 2002, J GERONTOL A-BIOL, V57, pB99, DOI 10.1093/gerona/57.3.B99
   Dozmorov I, 2001, J GERONTOL A-BIOL, V56, pB72, DOI 10.1093/gerona/56.2.B72
   Dronkert MLG, 2000, MOL CELL BIOL, V20, P4553, DOI 10.1128/MCB.20.13.4553-4561.2000
   DUESCHER RJ, 1994, J BIOL CHEM, V269, P17525
   Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567
   Fisher RA, 1948, American Statistician, V2, P30, DOI [DOI 10.2307/2681650, 10.2307/2681650]
   Flowers MT, 2006, J LIPID RES, V47, P2668, DOI 10.1194/jlr.M600203-JLR200
   FLURKEY C, 2007, MOUSE BIOMEDICAL RES, V3, P637
   Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898
   Flurkey K, 2002, MECH AGEING DEV, V123, P121, DOI 10.1016/S0047-6374(01)00339-6
   GELMAN R, 1988, GENETICS, V118, P693
   Gems D, 2005, MECH AGEING DEV, V126, P381, DOI 10.1016/j.mad.2004.09.001
   GODFREY P, 1993, NAT GENET, V4, P227, DOI 10.1038/ng0793-227
   Goya L, 2002, EUR J ENDOCRINOL, V147, P417, DOI 10.1530/eje.0.1470417
   Harper JM, 2006, MECH AGEING DEV, V127, P687, DOI 10.1016/j.mad.2006.04.002
   Heishi M, 2006, DIABETOLOGIA, V49, P1647, DOI 10.1007/s00125-006-0271-y
   HENRIQUES JAP, 1990, CURR GENET, V18, P387, DOI 10.1007/BF00309906
   Hill K, 2001, J HUM EVOL, V40, P437, DOI 10.1006/jhev.2001.0469
   Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298
   Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476
   Hsieh CC, 2002, MECH AGEING DEV, V123, P1229, DOI 10.1016/S0047-6374(02)00036-2
   Ikeno Y, 2003, J GERONTOL A-BIOL, V58, P291
   Ingram DK, 2006, AGING CELL, V5, P97, DOI 10.1111/j.1474-9726.2006.00202.x
   Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249
   Ito O, 2006, MOL CELL BIOCHEM, V284, P141, DOI 10.1007/s11010-005-9038-x
   Jones JM, 2000, J BIOL CHEM, V275, P12590, DOI 10.1074/jbc.275.17.12590
   Kinney BA, 2001, HORM BEHAV, V39, P277, DOI 10.1006/hbeh.2001.1654
   Krause RJ, 1996, ARCH BIOCHEM BIOPHYS, V333, P109, DOI 10.1006/abbi.1996.0370
   Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766
   Larsson O, 2006, OMICS, V10, P381, DOI 10.1089/omi.2006.10.381
   Liang HY, 2003, EXP GERONTOL, V38, P1353, DOI 10.1016/j.exger.2003.10.019
   MAITER D, 1989, ENDOCRINOLOGY, V124, P2604, DOI 10.1210/endo-124-5-2604
   Masubachi Y, 2003, BIOCHEM BIOPH RES CO, V304, P207, DOI 10.1016/S0006-291X(03)00572-2
   McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200
   Metcalf D, 2003, STEM CELLS, V21, P5, DOI 10.1634/stemcells.21-1-5
   Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311
   Miller RA, 2005, J AM GERIATR SOC, V53, pS284, DOI 10.1111/j.1532-5415.2005.53490.x
   Miller RA, 2002, MOL ENDOCRINOL, V16, P2657, DOI 10.1210/me.2002-0142
   Miller RA, 2001, J GERONTOL A-BIOL, V56, pB52, DOI 10.1093/gerona/56.2.B52
   Murakami S, 2003, FASEB J, V17, P1565, DOI 10.1096/fj.02-1092fje
   Nakashima K, 1998, SEMIN HEMATOL, V35, P210
   Nicholson SE, 1999, EMBO J, V18, P375, DOI 10.1093/emboj/18.2.375
   Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456
   Nonogaki K, 1996, AM J PHYSIOL-ENDOC M, V271, pE521, DOI 10.1152/ajpendo.1996.271.3.E521
   Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103
   OSTER MH, 1995, J CLIN INVEST, V95, P2258, DOI 10.1172/JCI117916
   Park SK, 2005, AGEING RES REV, V4, P55, DOI 10.1016/j.arr.2004.09.003
   Park T, 2006, BIOINFORMATICS, V22, P1682, DOI 10.1093/bioinformatics/btl183
   Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995
   Recinos A, 2004, PHYSIOL GENOMICS, V19, P131, DOI 10.1152/physiolgenomics.00146.2003
   RENNELS EG, 1965, TEX REP BIOL MED, V23, P776
   Robledo O, 1997, J BIOL CHEM, V272, P4855, DOI 10.1074/jbc.272.8.4855
   Rowland JE, 2005, MOL CELL BIOL, V25, P66, DOI 10.1128/MCB.25.1.66-77.2005
   Salmon AB, 2005, AM J PHYSIOL-ENDOC M, V289, pE23, DOI 10.1152/ajpendo.00575.2004
   SILBERBERG R, 1972, PATHOL MICROBIOL, V38, P417, DOI 10.1159/000162458
   Smid M, 2003, BIOINFORMATICS, V19, P2065, DOI 10.1093/bioinformatics/btg282
   Smyth GK., 2004, Stat Appl Genet Mol Biol, V3, P1, DOI DOI 10.2202/1544-6115.1027
   Spencer CC, 2003, AGING CELL, V2, P123, DOI 10.1046/j.1474-9728.2003.00044.x
   Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206
   Stevens JR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-57
   STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0
   Tsuchiya T, 2004, PHYSIOL GENOMICS, V17, P307, DOI 10.1152/physiolgenomics.00039.2004
   Uthus EO, 2006, MECH AGEING DEV, V127, P444, DOI 10.1016/j.mad.2006.01.001
   van de Ven Marieke, 2006, PLoS Genet, V2, pe192, DOI 10.1371/journal.pgen.0020192
   Vergara M, 2004, J GERONTOL A-BIOL, V59, P1244, DOI 10.1093/gerona/59.12.1244
   Waxman DJ, 2006, MOL ENDOCRINOL, V20, P2613, DOI 10.1210/me.2006-0007
   Williams RBH, 2006, NAT GENET, V38, P855, DOI 10.1038/ng0806-855
   Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147
   Ye XQ, 1997, BIOCHEM BIOPH RES CO, V239, P660, DOI 10.1006/bbrc.1997.7529
   Yip AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-22
   Zhou JH, 2006, MUTAT RES-REV MUTAT, V612, P165, DOI 10.1016/j.mrrev.2005.09.001
NR 91
TC 60
Z9 66
U1 0
U2 7
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2164
J9 BMC GENOMICS
JI BMC Genomics
PD OCT 3
PY 2007
VL 8
AR 353
DI 10.1186/1471-2164-8-353
PG 22
WC Biotechnology & Applied Microbiology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 234NK
UT WOS:000251170600001
PM 17915019
OA Green Accepted, gold, Green Published
DA 2024-02-19
ER

PT J
AU HO, ST
   WANG, JJ
   HU, OYP
   HU, TM
AF HO, ST
   WANG, JJ
   HU, OYP
   HU, TM
TI THE EFFECT OF AGING ON THE PHARMACOKINETICS OF NALBUPHINE IN RABBITS
SO BIOPHARMACEUTICS & DRUG DISPOSITION
LA English
DT Article
DE NALBUPHINE; PHARMACOKINETIC; AGING EFFECT; ANIMAL MODEL
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; AGE-RELATED-CHANGES;
   HEALTHY-VOLUNTEERS; SURGICAL PATIENTS; ELDERLY PATIENTS; PLASMA;
   DISPOSITION; METABOLISM; LIVER
AB For the purpose of selecting an animal model for the study of the aging effect on the pharmacokinetics of nalbuphine, the pharmacokinetic properties in young and in aged rabbits were reported. Thirty-one healthy New Zealand white rabbits ranging in ages (mean) from three months to 43 months (six three months old, group I; nine eight months old, group II; nine 18 months old, group III; and seven 43 months old, group IV) were included in the study. After intravenous bolus injection of nalbuphine (10 mg kg(-1)) to each rabbit, plasma samples were collected and analysed for nalbuphine by a high-performance liquid chromatography method. The plasma concentration-time data regarding nalbuphine were successfully fitted to a linear two-compartment open model. The elimination half-life of nalbuphine in rabbits increased significantly with age. Consequently, clearance decreased significantly with age. The parameter AUC(0-infinity), which is derived from dose/clearance, increased significantly with age. The effect of aging on the pharmacokinetics of nalbuphine in rabbits is quite similar to that in humans. From the present study, it is concluded that rabbits may be suitable for the study of aging effects on the pharmacokinetics of nalbuphine.
C1 NATL DEF MED CTR, SCH PHARM, TAIPEI, TAIWAN.
C3 National Defense Medical Center
RP HO, ST (corresponding author), TRISERV GEN HOSP, NATL DEF MED CTR, DEPT ANAESTHESIOL, TAIPEI, TAIWAN.
OI Hu, Teh-Min/0000-0001-6350-3180
CR Bivin W. S., 1974, The biology of the laboratory rabbit,, P73
   BORTOLOTTI A, 1989, LAB ANIM SCI, V39, P437
   CROOKS J, 1976, Clinical Pharmacokinetics, V1, P280
   FICK TE, 1986, LAB ANIM, V20, P138, DOI 10.1258/002367786780865179
   GIBALDI M, 1982, PHARMACOKINETICS, P67
   GREENBLATT DJ, 1979, J AM GERIATR SOC, V27, P20, DOI 10.1111/j.1532-5415.1979.tb01715.x
   HO ST, 1991, J CHROMATOGR-BIOMED, V570, P339, DOI 10.1016/0378-4347(91)80537-M
   JAILLON P, 1989, CLIN PHARMACOL THER, V46, P226, DOI 10.1038/clpt.1989.130
   KLEIN-SCHWARTZ W, 1991, Drugs and Aging, V1, P67
   Kozma C., 1974, The biology of the laboratory rabbit,, P49
   Kraus A. L., 1984, Laboratory animal medicine, P207
   LAKE CL, 1982, J CHROMATOGR, V233, P410, DOI 10.1016/S0378-4347(00)81777-6
   LO MW, 1984, RES COMMUN CHEM PATH, V43, P159
   LO MW, 1987, J CLIN PHARMACOL, V27, P866, DOI 10.1002/j.1552-4604.1987.tb05581.x
   LO MW, 1987, EUR J CLIN PHARMACOL, V33, P297, DOI 10.1007/BF00637566
   METZLER CM, 1989, PCNONLIN USERS GUIDE
   OWEN JA, 1983, CLIN PHARMACOL THER, V34, P364, DOI 10.1038/clpt.1983.180
   Pang K S, 1977, J Pharmacokinet Biopharm, V5, P625, DOI 10.1007/BF01059688
   PICK CG, 1992, J PHARMACOL EXP THER, V262, P1044
   SCHMIDT WK, 1985, DRUG ALCOHOL DEPEN, V14, P339, DOI 10.1016/0376-8716(85)90066-3
   SCHMUCKER DL, 1987, GERIATRIC CLIN PHARM, P159
   SEDMAN AJ, 1976, J PHARM SCI, V65, P1006, DOI 10.1002/jps.2600650713
   SITAR DS, 1989, CAN J ANAESTH, V36, P149, DOI 10.1007/BF03011438
   WALLACE S, 1976, BRIT J CLIN PHARMACO, V3, P327, DOI 10.1111/j.1365-2125.1976.tb00611.x
   WOODHOUSE K, 1992, BIOPHARM DRUG DISPOS, V13, P311, DOI 10.1002/bdd.2510130502
   WOODHOUSE K, 1992, DRUG AGING, V2, P243, DOI 10.2165/00002512-199202030-00007
   WOODHOUSE KW, 1988, CLIN PHARMACOKINET, V15, P287, DOI 10.2165/00003088-198815050-00002
NR 27
TC 5
Z9 5
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0142-2782
EI 1099-081X
J9 BIOPHARM DRUG DISPOS
JI Biopharm. Drug Dispos.
PD NOV
PY 1995
VL 16
IS 8
BP 695
EP 703
DI 10.1002/bdd.2510160808
PG 9
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA TC827
UT WOS:A1995TC82700006
PM 8573688
DA 2024-02-19
ER

PT J
AU Raffaele, M
   Kovacovicova, K
   Frohlich, J
   Lo Re, O
   Giallongo, S
   Oben, JA
   Faldyna, M
   Leva, L
   Giannone, AG
   Cabibi, D
   Vinciguerra, M
AF Raffaele, Marco
   Kovacovicova, Kristina
   Frohlich, Jan
   Lo Re, Oriana
   Giallongo, Sebastiano
   Oben, Jude A.
   Faldyna, Martin
   Leva, Lenka
   Giannone, Antonino Giulio
   Cabibi, Daniela
   Vinciguerra, Manlio
TI Mild exacerbation of obesity- and age-dependent liver disease
   progression by senolytic cocktail dasatinib plus quercetin
SO CELL COMMUNICATION AND SIGNALING
LA English
DT Article
DE Senolytics; Liver diseases; Inflammation; Cancer; Obesity
ID CELLULAR SENESCENCE; CELLS; CHEMOTHERAPY; FIBROSIS; DIETARY
AB Background Nonalcoholic fatty liver disease (NAFLD) is increasingly prevalent and represents a growing challenge in terms of prevention and treatment. A minority of affected patients develops inflammation, subsequently fibrosis, cirrhosis and hepatocellular carcinoma (HCC). HCC is a leading cause of cancer-related death. An increased number of senescent cells correlate with age-related tissue degeneration during NAFLD-induced HCC. Senolytics are promising agents that target selectively senescent cells. Previous studies showed that whereas a combination of the senolytic drugs dasatinib and quercetin (D + Q) reduced NAFLD in mice, D + Q lacked efficacy in removing doxorubicin-induced beta-gal-positive senescent cells in human HCC xenografted mice. Whether D + Q has an effect on the age-associated spectrum of NAFLD-inflammation-HCC remains unknown. Methods Here, we utilized an established model of age- and obesity-associated HCC, the low dose diethylnitrosamine (DEN)/high fat diet (HFD), a regimen promoting liver inflammation and tumorigenesis over a long period of 9 months. Four groups of mice each were created: group 1 included control untreated mice; group 2 included mice treated with D + Q; group 3 included mice undergoing the DEN/HFD protocol; group 4 included mice undergoing the DEN/HFD protocol with the administration of D + Q. At the end of the chemical/dietary regimen, we analyzed liver damage and cell senescence by histopathology, qPCR and immunoblotting approaches. Results Unexpectedly, D + Q worsened liver disease progression in the DEN/HFD mouse model, slightly increasing histological damage and tumorigenesis, while having no effect on senescent cells removal. Conclusions In summary, using an animal model that fully recapitulates NAFLD, we demonstrate that these compounds are ineffective against age-associated NAFLD-induced HCC.
C1 [Raffaele, Marco; Kovacovicova, Kristina; Frohlich, Jan; Lo Re, Oriana; Giallongo, Sebastiano; Vinciguerra, Manlio] St Annes Univ Hosp, Int Clin Res Ctr, Brno, Czech Republic.
   [Giallongo, Sebastiano] Masaryk Univ, Fac Med, Dept Biol, Brno, Czech Republic.
   [Oben, Jude A.; Vinciguerra, Manlio] Univ Coll London UCL, Inst Liver & Digest Hlth ILDH, Div Med, London, England.
   [Faldyna, Martin; Leva, Lenka] Vet Res Inst, Brno, Czech Republic.
   [Giannone, Antonino Giulio; Cabibi, Daniela] Univ Palermo, Dept Hlth Promot, Internal Med & Med Specialties, Mother & Child Care,Pathol Anat Unit, Palermo, Italy.
   [Vinciguerra, Manlio] Med Univ Varna, Era Chair Translat Stem Cell Biol, Varna, Bulgaria.
C3 St Anne's University Hospital Brno (FNUSA-ICRC); Masaryk University
   Brno; University of London; University College London; Czech Veterinary
   Research Institute; University of Palermo; Medical University Varna
RP Raffaele, M; Vinciguerra, M (corresponding author), St Annes Univ Hosp, Int Clin Res Ctr, Brno, Czech Republic.
EM marco.raffaele@fnusa.cz; manlio.vinciguerra@fnusa.cz
RI Giannone, Antonino Giulio/JHU-7235-2023; cabibi, daniela/D-7438-2013;
   Raffaele, Marco/AAQ-2895-2020; Lo Re, Oriana/ACC-4425-2022; Frohlich,
   Jan/AAI-4184-2021; Vinciguerra, Manlio/N-1309-2015
OI cabibi, daniela/0000-0001-6571-6577; Lo Re, Oriana/0000-0002-4798-6802;
   Frohlich, Jan/0000-0002-8312-0483; Vinciguerra,
   Manlio/0000-0002-1768-3894; Giallongo, Sebastiano/0000-0002-5047-7515;
   Oben, Jude/0000-0003-3350-8356; Raffaele, Marco/0000-0001-9232-4587
FU European Social Fund; European Regional Development Fund-Project MAGNET
   [CZ.02.1.01/0.0/0.0/15_003/00004 92]; Ministry of Health of the Czech
   Republic [NV18-03-00058]; Ministry of Agriculture of the Czech Republic
   [RO0518]; European Commission Horizon 2020 Framework Program
   [856871-TRANSTEM]
FX This work was supported by the European Social Fund and European
   Regional Development Fund-Project MAGNET (No.
   CZ.02.1.01/0.0/0.0/15_003/00004 92 (MV), by the Ministry of Health of
   the Czech Republic (No. NV18-03-00058) (MV), by the Ministry of
   Agriculture of the Czech Republic (project RO0518) (MF), and by the
   European Commission Horizon 2020 Framework Program (Project
   856871-TRANSTEM) (MV).
CR Alves-Bezerra M, 2018, COMPR PHYSIOL, V8, P1, DOI 10.1002/cphy.c170012
   Araújo AR, 2018, LIVER INT, V38, P47, DOI 10.1111/liv.13643
   Arayinthan AD, 2016, J HEPATOL, V65, P825, DOI 10.1016/j.jhep.2016.05.030
   Benegiamo G, 2012, DIGEST DIS SCI, V57, P1598, DOI 10.1007/s10620-012-2160-1
   Biddinger SB, 2005, DIABETES, V54, P1314, DOI 10.2337/diabetes.54.5.1314
   Borghesan M, 2016, CANCER RES, V76, P594, DOI 10.1158/0008-5472.CAN-15-1336
   Calimport SRG, 2019, SCIENCE, V366, P576, DOI 10.1126/science.aay7319
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Cazanave S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17370-6
   Childs BG, 2017, NAT REV DRUG DISCOV, V16, P718, DOI 10.1038/nrd.2017.116
   Frohlich J, 2020, AGING-US, V12, P20024, DOI 10.18632/aging.104182
   Fuhrmann-Stroissnigg H, 2019, DRUGS J VIS EXP
   Fuhrmann-Stroissnigg H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00314-z
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Grosse L, 2020, CELL METAB, V32, P87, DOI 10.1016/j.cmet.2020.05.002
   Hickson LJ, 2019, EBIOMEDICINE, V47, P446, DOI 10.1016/j.ebiom.2019.08.069
   Hodes RJ, 2016, ANN NY ACAD SCI, V1386, P45, DOI 10.1111/nyas.13299
   Inouye SK, 2007, J AM GERIATR SOC, V55, P780, DOI 10.1111/j.1532-5415.2007.01156.x
   Kirkland JL, 2017, J AM GERIATR SOC, V65, P2297, DOI 10.1111/jgs.14969
   Kirkland JL, 2017, EBIOMEDICINE, V21, P21, DOI 10.1016/j.ebiom.2017.04.013
   Kovacovicova K, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00459
   McHugh D, 2018, J CELL BIOL, V217, P65, DOI 10.1083/jcb.201708092
   Ogrodnik M, 2019, CELL METAB, V29, P1061, DOI [10.1016/j.cmet.2018.12.008, 10.1016/j.cmet.2019.01.013]
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Papatheodoridi AM, 2020, HEPATOLOGY, V71, P363, DOI 10.1002/hep.30834
   Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052
   Pignolo RJ, 2020, TRENDS MOL MED, V26, P630, DOI 10.1016/j.molmed.2020.03.005
   Raffaele M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155469
   Raffaele M, 2020, AGING-US, V12, P13979, DOI 10.18632/aging.103637
   Raffaele M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102593
   Raffaele M, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/5310961
   Rappa F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054458
   Schafer MJ, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.133668
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Shen HH, 2020, J FOOD BIOCHEM, V44, DOI 10.1111/jfbc.13522
   Sierra-Ramirez A, 2020, AGING-US, V12, P11337, DOI 10.18632/aging.103607
   Takeda D, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-65
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344
NR 39
TC 25
Z9 25
U1 1
U2 12
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1478-811X
J9 CELL COMMUN SIGNAL
JI Cell Commun. Signal.
PD APR 8
PY 2021
VL 19
IS 1
AR 44
DI 10.1186/s12964-021-00731-0
PG 9
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA RL7ED
UT WOS:000639130700003
PM 33832488
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Cho, J
   Kim, H
   Song, J
   Cheong, JW
   Shin, JW
   Yang, WI
   Kim, HO
AF Cho, Jooyoung
   Kim, Hyunkyung
   Song, Jaewoo
   Cheong, June-Won
   Shin, Jeong Won
   Yang, Woo Ick
   Kim, Hyun Ok
TI Platelet storage induces accelerated desialylation of platelets and
   increases hepatic thrombopoietin production
SO JOURNAL OF TRANSLATIONAL MEDICINE
LA English
DT Article
DE Platelet storage lesion (PSL); Desialylation; Thrombopoietin (TPO);
   Ashwell-Morell receptor (AMR)
ID CHILLED BLOOD-PLATELETS; HEMOSTATIC FUNCTION; CLEARANCE; REFRIGERATION;
   CRYOPRESERVATION; TRANSFUSION; RECOVERY; CELLS
AB Background: Stored platelets undergo deleterious changes, referred to as platelet storage lesions (PSLs), which accelerate the desialylation of platelets and result in their phagocytosis and clearance by hepatic macrophages. Recent studies have reported that Ashwell-Morell receptor binds to desialylated platelets, thereby inducing hepatic thrombopoietin (TPO) production in a mouse model. Therefore, this study aimed to demonstrate these relationships between PSL and hepatic TPO production in human study.
   Methods: Platelet concentrates (PCs) were obtained from 5 healthy volunteers and the remaining were discarded samples from the blood bank. PCs were divided into two halves, and stored either at 22 or 4 degrees C. Experiments were conducted using serial samples. Desialylation was assessed using flow cytometry, and structural changes were visualized using electron microscopy. Following co-culture of HepG2 cells (HB-8065, ATCC) with isolated platelets, hepatic TPO production was determined using real-time quantitative polymerase chain reaction and the supernatant TPO level was measured using a Luminex kit.
   Results: For 5 days of storage duration, platelet counts were not influenced by the storage conditions, but the degree of desialylation was proportional to the storage duration. Significant changes in the platelet surface and structure according to storage conditions were noted in electron microscopy. HepG2 cells incubated with aged platelets expressed more TPO mRNA, and supernatant TPO levels were proportional to the storage duration. Refrigeration also influenced on the results of this study, but they were not statistically significant.
   Conclusions: This is the first study to demonstrate that, in vitro, aging and refrigeration affect the integrity of human platelets, resulting in induction of hepatic TPO mRNA and protein expression.
C1 [Cho, Jooyoung; Song, Jaewoo; Kim, Hyun Ok] Yonsei Univ, Dept Lab Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
   [Cho, Jooyoung] Yonsei Univ, Dept Lab Med, Wonju Coll Med, Wonju, South Korea.
   [Kim, Hyunkyung] Yonsei Univ, Gangnam Severance Hosp, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea.
   [Cheong, June-Won] Yonsei Univ, Coll Med, Dept Internal Med, Seoul 03722, South Korea.
   [Shin, Jeong Won] Soonchunhyang Univ, Dept Lab Med, Sch Med, Seoul, South Korea.
   [Yang, Woo Ick] Yonsei Univ, Dept Pathol, Coll Med, Seoul, South Korea.
C3 Yonsei University; Yonsei University Health System; Yonsei University;
   Yonsei University; Yonsei University Health System; Yonsei University;
   Yonsei University Health System; Soonchunhyang University; Yonsei
   University; Yonsei University Health System
RP Kim, HO (corresponding author), Yonsei Univ, Dept Lab Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea.
EM hyunok1019@yuhs.ac
RI Kim, Jie-Hyun/Q-9061-2019
OI Kim, Jie-Hyun/0000-0002-9198-3326; CHEONG, JUNE-WON/0000-0002-1744-0921;
   Song, Jaewoo/0000-0002-1877-5731; Kim, Hyun Ok/0000-0002-4964-1963; Kim,
   HyunKyung/0000-0002-2528-6231
CR Almhanawi Bahaa Hadi, 2017, Porto Biomed J, V2, P23, DOI 10.1016/j.pbj.2016.11.002
   Bergmeier W, 2003, BLOOD, V102, P4229, DOI 10.1182/blood-2003-04-1305
   Canault M, 2010, BLOOD, V115, P1835, DOI 10.1182/blood-2009-03-211706
   Cap AP, 2016, TRANSFUSION, V56, P13, DOI 10.1111/trf.13433
   Cookson P, 2012, TRANSFUSION, V52, P983, DOI 10.1111/j.1537-2995.2011.03388.x
   de Graaf CA, 2011, CELL CYCLE, V10, P1582, DOI 10.4161/cc.10.10.15619
   Egidi MG, 2010, BLOOD TRANSFUS-ITALY, V8, pS73, DOI 10.2450/2010.012S
   Ellies LG, 2002, P NATL ACAD SCI USA, V99, P10042, DOI 10.1073/pnas.142005099
   Folman CC, 2001, TRANSFUSION, V41, P517, DOI 10.1046/j.1537-2995.2001.41040517.x
   Geddis AE, 2002, CYTOKINE GROWTH F R, V13, P61, DOI 10.1016/S1359-6101(01)00030-2
   Grozovsky R, 2015, NAT MED, V21, P47, DOI 10.1038/nm.3770
   Hoffmeister KM, 2016, THROMB RES, V141, pS68, DOI 10.1016/S0049-3848(16)30370-X
   Hoffmeister KM, 2003, SCIENCE, V301, P1531, DOI 10.1126/science.1085322
   Hoffmeister KM, 2003, CELL, V112, P87, DOI 10.1016/S0092-8674(02)01253-9
   Inaba K, 2011, J TRAUMA, V71, P1766, DOI 10.1097/TA.0b013e31823bdbf9
   Jansen AJG, 2012, BLOOD, V119, P1263, DOI 10.1182/blood-2011-05-355628
   Johnson L, 2016, TRANSFUSION, V56, P1807, DOI 10.1111/trf.13630
   Kaplan C, 2012, BLOOD, V119, P1100, DOI 10.1182/blood-2011-12-394502
   Kile BT, 2015, NAT MED, V21, P11, DOI 10.1038/nm.3780
   Kreuger AL, 2017, VOX SANG, V112, P291, DOI 10.1111/vox.12494
   Mittal Kshitija, 2015, Asian J Transfus Sci, V9, P1, DOI 10.4103/0973-6247.150933
   NasrEldin E., 2017, PEDIATR HEMAT ONCOL, V2, P29, DOI DOI 10.1016/J.PH0J.2017.07.001
   Rumjantseva V, 2009, NAT MED, V15, P1273, DOI 10.1038/nm.2030
   Shrivastava M, 2009, TRANSFUS APHER SCI, V41, P105, DOI 10.1016/j.transci.2009.07.002
   Waters L, 2018, VOX SANG, V113, P317, DOI 10.1111/vox.12640
   Wolber EM, 2000, J INTERF CYTOK RES, V20, P499, DOI 10.1089/10799900050023915
   ZILLA P, 1987, TEX HEART I J, V14, P13
NR 27
TC 22
Z9 26
U1 0
U2 7
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1479-5876
J9 J TRANSL MED
JI J. Transl. Med.
PD JUL 18
PY 2018
VL 16
AR 199
DI 10.1186/s12967-018-1576-6
PG 9
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA GN5YE
UT WOS:000439144400001
PM 30021591
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Duran-Ortiz, S
   Young, JA
   List, EO
   Basu, R
   Krejsa, J
   Kearns, JK
   Berryman, DE
   Kopchick, JJ
AF Duran-Ortiz, Silvana
   Young, Jonathan A. A.
   List, Edward O. O.
   Basu, Reetobrata
   Krejsa, Jackson
   Kearns, John K. K.
   Berryman, Darlene E. E.
   Kopchick, John J. J.
TI GHR disruption in mature adult mice alters xenobiotic metabolism gene
   expression in the liver
SO PITUITARY
LA English
DT Article; Early Access
DE Growth hormone; Aging; Liver; RNAseq; 6mGHRKO mice; Xenobiotic
   metabolism
ID NUCLEAR RECEPTORS CAR; GROWTH-HORMONE; SIGNAL TRANSDUCER;
   SEXUAL-DIMORPHISM; TRANSCRIPTION 5B; CROSS-TALK; PXR; ACTIVATION;
   BINDING
AB BackgroundLifelong reduction of growth hormone (GH) action extends lifespan and improves healthspan in mice. Moreover, congenital inactivating mutations of GH receptor (GHR) in mice and humans impart resistance to age-associated cancer, diabetes, and cognitive decline. To investigate the consequences of GHR disruption at an adult age, we recently ablated the GHR at 6-months of age in mature adult (6mGHRKO) mice. We found that both, male and female 6mGHRKO mice have reduced oxidative damage, with males 6mGHRKO showing improved insulin sensitivity and cancer resistance. Importantly, 6mGHRKO females have an extended lifespan compared to controls.Objective and MethodsTo investigate the possible mechanisms leading to health improvements, we performed RNA sequencing using livers from male and female 6mGHRKO mice and controls.ResultsWe found that disrupting GH action at an adult age reduced the gap in liver gene expression between males and females, making gene expression between sexes more similar. However, there was still a 6-fold increase in the number of differentially expressed genes when comparing male 6mGHRKO mice vs controls than in 6mGHRKO female vs controls, suggesting that GHR ablation affects liver gene expression more in males than in females. Finally, we found that lipid metabolism and xenobiotic metabolism pathways are activated in the liver of 6mGHRKO mice.ConclusionThe present study shows for the first time the specific hepatic gene expression profile, cellular pathways, biological processes and molecular mechanisms that are driven by ablating GH action at a mature adult age in males and females. Importantly, these results and future studies on xenobiotic metabolism may help explain the lifespan extension seen in 6mGHRKO mice.
C1 [Duran-Ortiz, Silvana; Young, Jonathan A. A.; List, Edward O. O.; Basu, Reetobrata; Krejsa, Jackson; Kearns, John K. K.; Berryman, Darlene E. E.; Kopchick, John J. J.] Ohio Univ, Edison Biotechnol Inst, Athens, OH 45701 USA.
   [Duran-Ortiz, Silvana; Berryman, Darlene E. E.; Kopchick, John J. J.] Ohio Univ, Mol & Cellular Biol Program, Athens, OH 45701 USA.
   [Duran-Ortiz, Silvana] Ohio Univ, Coll Arts & Sci, Dept Biol Sci, Athens, OH 45701 USA.
   [Young, Jonathan A. A.; Berryman, Darlene E. E.; Kopchick, John J. J.] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA.
C3 University System of Ohio; Ohio University; University System of Ohio;
   Ohio University; University System of Ohio; Ohio University; University
   System of Ohio; Ohio University
RP Kopchick, JJ (corresponding author), Ohio Univ, Edison Biotechnol Inst, Athens, OH 45701 USA.; Kopchick, JJ (corresponding author), Ohio Univ, Mol & Cellular Biol Program, Athens, OH 45701 USA.; Kopchick, JJ (corresponding author), Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA.
EM kopchick@ohio.edu
OI Young, Jonathan/0000-0003-1770-1391
FU NIH; Glenn Foundation for Medical Research; American Federation for
   Aging Research (AFAR); Diabetes Institute at Ohio University; AMVETS; 
   [R01AG059779]
FX This work was supported by the State of Ohio's Eminent Scholar Program
   that includes a gift from Milton and Lawrence Goll, by NIH grant
   R01AG059779 to JJK, by the Glenn Foundation for Medical Research and the
   American Federation for Aging Research (AFAR) to SD, the AMVETS, and by
   the Diabetes Institute at Ohio University.
CR Al-Regaiey KA, 2005, ENDOCRINOLOGY, V146, P851, DOI 10.1210/en.2004-1120
   Amador-Noguez D, 2005, BIOCHEM BIOPH RES CO, V332, P1086, DOI 10.1016/j.bbrc.2005.05.063
   Bartke A, 2021, WORLD J MENS HEALTH, V39, P454, DOI 10.5534/wjmh.200201
   Bartke A, 2008, CLIN INTERV AGING, V3, P659, DOI 10.2147/CIA.S3697
   Choi HK, 2000, ENDOCRINOLOGY, V141, P3245, DOI 10.1210/en.141.9.3245
   Clodfelter KH, 2006, MOL ENDOCRINOL, V20, P1333, DOI 10.1210/me.2005-0489
   Connerney J, 2017, ENDOCRINOLOGY, V158, P1386, DOI 10.1210/en.2017-00060
   Duran-Ortiz S, 2021, AGING CELL, V20, DOI 10.1111/acel.13506
   Duran-Ortiz S, 2018, GROWTH HORM IGF RES, V42-43, P52, DOI 10.1016/j.ghir.2018.08.003
   Fang YM, 2018, P NATL ACAD SCI USA, V115, pE1495, DOI 10.1073/pnas.1717065115
   Fukuda I, 2002, ENDOCR J, V49, P379, DOI 10.1507/endocrj.49.379
   Goldfarb CN, 2022, ENDOCRINOLOGY, V163, DOI 10.1210/endocr/bqac059
   Guevara-Aguirre J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001845
   Hagan C., 2020, ARE MICE CONSIDERED
   Holloway MG, 2006, MOL ENDOCRINOL, V20, P647, DOI 10.1210/me.2005-0328
   Holloway MG, 2007, ENDOCRINOLOGY, V148, P1977, DOI 10.1210/en.2006-1419
   JANSSON JO, 1985, ENDOCR REV, V6, P128, DOI 10.1210/edrv-6-2-128
   Jo JR, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-98537-0
   Junnila RK, 2016, ENDOCRINOLOGY, V157, P4502, DOI 10.1210/en.2016-1649
   Junnila RK, 2013, NAT REV ENDOCRINOL, V9, P366, DOI 10.1038/nrendo.2013.67
   Kodama S, 2004, MOL CELL BIOL, V24, P7931, DOI 10.1128/MCB.24.18.7931-7940.2004
   Konno Y, 2008, DRUG METAB PHARMACOK, V23, P8, DOI 10.2133/dmpk.23.8
   Kopchick JJ, 2000, MOL GENET METAB, V71, P293, DOI 10.1006/mgme.2000.3068
   Koutsounas I, 2013, CURR DRUG METAB, V14, P341, DOI 10.2174/1389200211314030009
   Lau-Corona D, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00301-17
   LEGRAVEREND C, 1992, FASEB J, V6, P711, DOI 10.1096/fasebj.6.2.1537461
   Leung KC, 2003, P NATL ACAD SCI USA, V100, P1016, DOI 10.1073/pnas.0337600100
   Li XN, 2013, AM J PHYSIOL-ENDOC M, V305, pE942, DOI 10.1152/ajpendo.00304.2013
   List EO, 2014, ENDOCRINOLOGY, V155, P1793, DOI 10.1210/en.2013-2086
   List EO, 2013, MOL ENDOCRINOL, V27, P524, DOI 10.1210/me.2012-1330
   Longo VD, 2015, AGING CELL, V14, P497, DOI 10.1111/acel.12338
   Miao J, 2006, J BIOL CHEM, V281, P14537, DOI 10.1074/jbc.M510713200
   Pilcher H., 2003, NATURE, DOI DOI 10.1038/NEWS030915-13
   Rahmani J, 2022, AGING CELL, V21, DOI 10.1111/acel.13540
   Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698
   Steinbaugh MJ, 2012, AM J PHYSIOL-ENDOC M, V303, pE488, DOI 10.1152/ajpendo.00110.2012
   Stout MB, 2014, AGING-US, V6, P575, DOI 10.18632/aging.100681
   Tannenbaum GS, 2001, ENDOCRINOLOGY, V142, P4599, DOI 10.1210/en.142.11.4599
   Timsit YE, 2007, STEROIDS, V72, P231, DOI 10.1016/j.steroids.2006.12.006
   Turnley AM, 2005, TRENDS ENDOCRIN MET, V16, P53, DOI 10.1016/j.tem.2005.01.006
   Vijayakumar A, 2010, GROWTH HORM IGF RES, V20, P1, DOI 10.1016/j.ghir.2009.09.002
   Wauthier V, 2008, MOL ENDOCRINOL, V22, P1962, DOI 10.1210/me.2007-0549
   Wauthier Valerie, 2010, Mol Endocrinol, V24, P667, DOI 10.1210/me.2009-0454
   Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705
   Yokobori K, 2022, BIOCHEM BIOPH RES CO, V615, P75, DOI 10.1016/j.bbrc.2022.05.055
NR 45
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1386-341X
EI 1573-7403
J9 PITUITARY
JI Pituitary
PD 2023 AUG
PY 2023
VL 26
IS 4
BP 437
EP 450
DI 10.1007/s11102-023-01331-6
EA JUN 2023
PG 14
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA N6WY2
UT WOS:001014659800001
PM 37353704
DA 2024-02-19
ER

PT J
AU Tetrault, JM
   Tate, JP
   McGinnis, KA
   Goulet, JL
   Sullivan, LE
   Bryant, K
   Justice, AC
   Fiellin, DA
AF Tetrault, Jeanette M.
   Tate, Janet P.
   McGinnis, Kathleen A.
   Goulet, Joseph L.
   Sullivan, Lynn E.
   Bryant, Kendall
   Justice, Amy C.
   Fiellin, David A.
CA Vet Aging Cohort Study Team
TI Hepatic Safety and Antiretroviral Effectiveness in HIV-Infected Patients
   Receiving Naltrexone
SO ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
LA English
DT Article
DE HIV; Naltrexone; Alcoholism; Opioid-Related Disorders
ID HUMAN-IMMUNODEFICIENCY-VIRUS; RANDOMIZED CONTROLLED-TRIAL; HIGH-DOSE
   NALTREXONE; ILLICIT DRUG-USE; ALCOHOL DEPENDENCE; MEDICATION ADHERENCE;
   RELEASE NALTREXONE; OPIOID DEPENDENCE; THERAPY; DRINKING
AB Background: We sought to determine the impact of naltrexone on hepatic enzymes and HIV biomarkers in HIV-infected patients.
   Methods: We used data from the Veterans Aging Cohort Study-Virtual Cohort, an electronic database of administrative, pharmacy, and laboratory data. We restricted our sample to HIV-infected patients who received an initial oral naltrexone prescription of at least 7 days duration. We examined aspartate aminotransferase (AST) and alanine aminotransferase (ALT) and HIV biomarker (CD4 and HIV RNA) values for the 365 days prior to, during, and for the 365 days post-naltrexone prescription. We also examined cases of liver enzyme elevation (LEE; defined as > 5 times baseline ALT or AST or > 3.5 times baseline if baseline ALT or AST was > 40 IU/l).
   Results: Of 114 HIV-infected individuals, 97% were men, 45% white, 57% Hepatitis C co-infected; median age was 49 years; 89% of the sample had a history of alcohol dependence and 32% had opioid dependence. Median duration of naltrexone prescription was 49 (interquartile range 30 to 83) days, representing 9,525 person-days of naltrexone use. Mean ALT and AST levels remained below the upper limit of normal. Two cases of LEE occurred. Mean CD4 count remained stable and mean HIV RNA decreased after naltrexone prescription.
   Conclusions: In HIV-infected patients, oral naltrexone is rarely associated with clinically significant ALT or AST changes and does not have a negative impact on biologic parameters. Therefore, HIV-infected patients with alcohol or opioid dependence can be treated with naltrexone.
C1 [Tetrault, Jeanette M.; Goulet, Joseph L.; Sullivan, Lynn E.; Justice, Amy C.; Fiellin, David A.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.
   [Tate, Janet P.; McGinnis, Kathleen A.; Goulet, Joseph L.; Justice, Amy C.; Fiellin, David A.] Vet Aging Cohort Study, West Haven, CT USA.
   [Tate, Janet P.; Goulet, Joseph L.; Justice, Amy C.] VA Connecticut Healthcare Syst, West Haven, CT USA.
   [McGinnis, Kathleen A.] VA Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, Pittsburgh, PA USA.
   [Bryant, Kendall] NIAAA, Rockville, MD 20852 USA.
C3 Yale University; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); VA Connecticut Healthcare System; US Department of
   Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh
   Healthcare System; National Institutes of Health (NIH) - USA; NIH
   National Institute on Alcohol Abuse & Alcoholism (NIAAA)
RP Tetrault, JM (corresponding author), 367 Cedar St,4th Floor, New Haven, CT 06510 USA.
EM jeanette.tetrault@yale.edu
OI Goulet, Joseph Lucien/0000-0002-0842-804X; Fiellin,
   David/0000-0002-4006-010X
FU National Institute on Alcohol Abuse and Alcoholism [U10 AA 13566]; VHA
   Public Health Strategic Health Core Group; National Institute on Alcohol
   and Alcohol Abuse [U01 AA 13566]; National Institute on Drug Abuse
   (NIDA) [R01 DA019511-03, R01 DA025991, R01 DA020576-01A1, K23
   DA024050-02]
FX The Veterans Aging Cohort Study is funded by the National Institute on
   Alcohol Abuse and Alcoholism (U10 AA 13566) and the VHA Public Health
   Strategic Health Core Group. The material presented in this study is
   based upon work supported in part by funding from the National Institute
   on Alcohol and Alcohol Abuse (U01 AA 13566) and the National Institute
   on Drug Abuse (NIDA R01 DA019511-03, R01 DA025991, R01 DA020576-01A1,
   K23 DA024050-02).
CR [Anonymous], POSTGRADUATE MED
   Anton RF, 2008, NEW ENGL J MED, V359, P715, DOI 10.1056/NEJMct0801733
   Anton RF, 2006, JAMA-J AM MED ASSOC, V295, P2003, DOI 10.1001/jama.295.17.2003
   Arnsten JH, 2002, J GEN INTERN MED, V17, P377, DOI 10.1046/j.1525-1497.2002.10644.x
   ATKINSON RL, 1985, CLIN PHARMACOL THER, V38, P419, DOI 10.1038/clpt.1985.197
   Berg BJ, 1996, DRUG SAFETY, V15, P274, DOI 10.2165/00002018-199615040-00005
   BRAHEN LS, 1988, J CLIN PHARMACOL, V28, P64, DOI 10.1002/j.1552-4604.1988.tb03102.x
   Braithwaite RS, 2005, ALCOHOL CLIN EXP RES, V29, P1190, DOI 10.1097/01.ALC.0000171937.87731.28
   Brewer C, 2004, ADDICT BIOL, V9, P81, DOI 10.1080/13556210410001674130
   Celentano DD, 1998, JAMA-J AM MED ASSOC, V280, P544, DOI 10.1001/jama.280.6.544
   Centers for Disease Control and Prevention, 2009, HIV AIDS SURV REP
   Cicconi P, 2007, AIDS, V21, P599, DOI 10.1097/QAD.0b013e328013db9c
   Comer SD, 2006, ARCH GEN PSYCHIAT, V63, P210, DOI 10.1001/archpsyc.63.2.210
   Cook RL, 2001, J GEN INTERN MED, V16, P83, DOI 10.1046/j.1525-1497.2001.00122.x
   Croop RS, 1997, ARCH GEN PSYCHIAT, V54, P1130
   Diehl AM, 2010, GASTROENTEROL CLIN N, V39, P57, DOI 10.1016/j.gtc.2009.12.001
   Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280
   Faragon John J, 2003, AIDS Read, V13, P433
   Fultz SL, 2006, MED CARE, V44, pS25, DOI 10.1097/01.mlr.0000223670.00890.74
   Galvan FH, 2002, J STUD ALCOHOL, V63, P179, DOI 10.15288/jsa.2002.63.179
   Garbutt JC, 2005, JAMA-J AM MED ASSOC, V293, P1617, DOI 10.1001/jama.293.13.1617
   Gekker G, 2001, DRUG ALCOHOL DEPEN, V64, P257, DOI 10.1016/S0376-8716(01)00140-5
   Hernandez-Avila CA, 2006, ALCOHOL CLIN EXP RES, V30, P860, DOI 10.1111/j.1530-0277.2006.00101.x
   Hulse GK, 2009, ARCH GEN PSYCHIAT, V66, P1108, DOI 10.1001/archgenpsychiatry.2009.130
   Kim SW, 2006, CLIN NEUROPHARMACOL, V29, P77, DOI 10.1097/00002826-200603000-00004
   Kranzler HR, 2009, J CLIN PSYCHOPHARM, V29, P350, DOI 10.1097/JCP.0b013e3181ac5213
   Lucas GM, 2002, AIDS, V16, P767, DOI 10.1097/00002030-200203290-00012
   Lucas GM, 2001, J ACQ IMMUN DEF SYND, V27, P251, DOI 10.1097/00126334-200107010-00006
   Lucey MR, 2008, ALCOHOL CLIN EXP RES, V32, P498, DOI 10.1111/j.1530-0277.2007.00593.x
   MALCOLM R, 1985, INT J OBESITY, V9, P347
   Marrazzi MA, 1997, AM J ADDICTION, V6, P21
   McCance-Katz EF, 2001, AM J ADDICTION, V10, P296
   Minozzi S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001333.pub2
   OMalley SS, 1996, ALCOHOL ALCOHOLISM, V31, P77
   Panel on Antiretroviral Guidelines for Adults and Adolescents, 2011, GUID US ANT AG HIV 1, P1
   Pfohl D N, 1986, NIDA Res Monogr, V67, P66
   PINI L-A, 1991, Drug Metabolism and Drug Interactions, V9, P161
   Polo JLL, 1997, REV CLIN ESP, V197, P479
   Samet JH, 2003, ALCOHOL CLIN EXP RES, V27, P862, DOI 10.1097/01.ALC.0000065438.80967.56
   Samet JH, 2004, AIDS RES HUM RETROV, V20, P151, DOI 10.1089/088922204773004860
   Soto B, 1997, J HEPATOL, V26, P1, DOI 10.1016/S0168-8278(97)80001-3
   Stein MD, 2000, AM J DRUG ALCOHOL AB, V26, P195, DOI 10.1081/ADA-100100600
   Streeton C, 2001, ALCOHOL ALCOHOLISM, V36, P544, DOI 10.1093/alcalc/36.6.544
   Sulkowski MS, 2000, CLIN INFECT DIS, V30, pS77, DOI 10.1086/313842
   Wang X, 2006, J LEUKOCYTE BIOL, V79, P1166, DOI 10.1189/jlb.1105642
   Yen MH, 2006, ALCOHOL, V38, P117, DOI 10.1016/j.alcohol.2006.05.003
NR 46
TC 28
Z9 29
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0145-6008
EI 1530-0277
J9 ALCOHOL CLIN EXP RES
JI Alcoholism (NY)
PD FEB
PY 2012
VL 36
IS 2
BP 318
EP 324
DI 10.1111/j.1530-0277.2011.01601.x
PG 7
WC Substance Abuse
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Substance Abuse
GA 883DS
UT WOS:000299614700018
PM 21797892
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Kalfalah, F
   Janke, L
   Schiavi, A
   Tigges, J
   Ix, A
   Ventura, N
   Boege, F
   Reinke, H
AF Kalfalah, Faiza
   Janke, Linda
   Schiavi, Alfonso
   Tigges, Julia
   Ix, Alexander
   Ventura, Natascia
   Boege, Fritz
   Reinke, Hans
TI Crosstalk of clock gene expression and autophagy in aging
SO AGING-US
LA English
DT Article
DE aging; circadian clock; autophagy; primary human skin fibroblasts;
   lin-42; C. elegans
ID LIFE-SPAN EXTENSION; CIRCADIAN CLOCK; SIGNALING PATHWAYS; DERMAL
   FIBROBLASTS; LIVER; OSCILLATORS; BIOGENESIS; DEFICIENCY; PROTEIN; CANCER
AB Autophagy and the circadian clock counteract tissue degeneration and support longevity in many organisms. Accumulating evidence indicates that aging compromises both the circadian clock and autophagy but the mechanisms involved are unknown. Here we show that the expression levels of transcriptional repressor components of the circadian oscillator, most prominently the human Period homologue PER2, are strongly reduced in primary dermal fibroblasts from aged humans, while raising the expression of PER2 in the same cells partially restores diminished autophagy levels. The link between clock gene expression and autophagy is corroborated by the finding that the circadian clock drives cell-autonomous, rhythmic autophagy levels in immortalized murine fibroblasts, and that siRNA-mediated downregulation of PER2 decreases autophagy levels while leaving core clock oscillations intact. Moreover, the Period homologue lin-42 regulates autophagy and life span in the nematode Caenorhabditis elegans, suggesting an evolutionarily conserved role for Period proteins in autophagy control and aging. Taken together, this study identifies circadian clock proteins as set-point regulators of autophagy and puts forward a model, in which age-related changes of clock gene expression promote declining autophagy levels.
C1 [Kalfalah, Faiza; Janke, Linda; Schiavi, Alfonso; Ix, Alexander; Ventura, Natascia; Boege, Fritz; Reinke, Hans] Univ Dusseldorf, Fac Med, Inst Clin Chem & Lab Diagnost, D-40225 Dusseldorf, Germany.
   [Janke, Linda; Schiavi, Alfonso; Tigges, Julia; Ventura, Natascia; Reinke, Hans] IUF Leibniz Res Inst Environm Med, D-40225 Dusseldorf, Germany.
C3 Heinrich Heine University Dusseldorf; Leibniz Institut fur
   Umweltmedizinische Forschung (IUF)
RP Reinke, H (corresponding author), Univ Dusseldorf, Fac Med, Inst Clin Chem & Lab Diagnost, D-40225 Dusseldorf, Germany.; Reinke, H (corresponding author), IUF Leibniz Res Inst Environm Med, D-40225 Dusseldorf, Germany.
EM hans.reinke@med.uni-duesseldorf.de
RI Boege, Fritz/H-3261-2019; Ventura, Natascia/ABF-4279-2020
OI Kalfalah, Faiza/0000-0002-5186-8059; ventura,
   natascia/0000-0001-8718-4321; Tigges, Julia/0000-0002-0847-9939;
   Schiavi, Alfonso/0000-0002-6563-8035
FU Deutsche Forschungsgemeinschaft [SFB 728, GK 1033, Re 3046/2-1]; Human
   Frontier Science Program [CDA00009/2009-C]; German Ministry of Research
   and Education [GerontoSys Network on Stromal Aging]; Italian Association
   for Cancer Research [MFAG11509]; Strategic Research Funding of the
   Heinrich Heine University [701301988]
FX The authors gratefully acknowledge funding by the Deutsche
   Forschungsgemeinschaft [SFB 728 to F.B. and H.R., GK 1033 to F.B., Re
   3046/2-1 to H.R.], the Human Frontier Science Program [CDA00009/2009-C
   to H.R.], the German Ministry of Research and Education [GerontoSys
   Network on Stromal Aging to F.B.], the Italian Association for Cancer
   Research (MFAG11509 to N.V.) and the Strategic Research Funding of the
   Heinrich Heine University (701301988 to N.V.).
CR Alers S, 2011, AUTOPHAGY, V7, P1424, DOI 10.4161/auto.7.12.18027
   Antoch MP, 2013, CELL CYCLE, V12, P3673, DOI 10.4161/cc.26614
   Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050
   Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2
   Bonaconsa M, 2014, EXP GERONTOL, V55, P70, DOI 10.1016/j.exger.2014.03.011
   Chang HC, 2013, CELL, V153, P1448, DOI 10.1016/j.cell.2013.05.027
   Demirovic D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126546
   Dibner C, 2015, J INTERN MED, V277, P513, DOI 10.1111/joim.12347
   Gaddameedhi S, 2011, P NATL ACAD SCI USA, V108, P18790, DOI 10.1073/pnas.1115249108
   Guo B, 2014, EMBO REP, V15, P705, DOI 10.1002/embr.201338310
   Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024
   Jeon M, 1999, SCIENCE, V286, P1141, DOI 10.1126/science.286.5442.1141
   Kalfalah F, 2015, AGING-US, V7, P110, DOI 10.18632/aging.100723
   Kalfalah F, 2014, EXP GERONTOL, V56, P59, DOI 10.1016/j.exger.2014.03.017
   Khapre RV, 2014, AGING-US, V6, P675, DOI 10.18632/aging.100686
   Khapre RV, 2014, AGING-US, V6, P48, DOI 10.18632/aging.100633
   Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496
   Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339
   Kondratov RV, 2007, COLD SPRING HARB SYM, V72, P477, DOI 10.1101/sqb.2007.72.050
   Krishnan N, 2009, AGING-US, V1, P937, DOI 10.18632/aging.100103
   Lee S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010995
   Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023
   Liu H, 2013, SEMIN CANCER BIOL, V23, P352, DOI 10.1016/j.semcancer.2013.06.008
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lupa DMW, 2015, J INVEST DERMATOL, V135, P1954, DOI 10.1038/jid.2015.120
   Ma D, 2011, EMBO J, V30, P4642, DOI 10.1038/emboj.2011.322
   Madeo F, 2015, J CLIN INVEST, V125, P85, DOI 10.1172/JCI73946
   Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822
   Meléndez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782
   Metz P, 2015, J VIROL, V89, P8026, DOI 10.1128/JVI.00787-15
   Monsalve GC, 2011, CURR BIOL, V21, P2033, DOI 10.1016/j.cub.2011.10.054
   Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2
   Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002
   Oishi K, 2011, EXP GERONTOL, V46, P994, DOI 10.1016/j.exger.2011.09.003
   Pagani L, 2011, P NATL ACAD SCI USA, V108, P7218, DOI 10.1073/pnas.1008882108
   Pilorz V, 2008, REPRODUCTION, V135, P559, DOI 10.1530/REP-07-0434
   Pyo JO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3300
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Schiavi A, 2015, CURR BIOL, V25, P1810, DOI 10.1016/j.cub.2015.05.059
   Schiavi A, 2013, EXP GERONTOL, V48, P191, DOI 10.1016/j.exger.2012.12.002
   Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744
   Thiaville MM, 2008, BIOCHEM J, V410, P473, DOI 10.1042/BJ20071252
   Tian Y, 2010, CELL, V141, P1042, DOI 10.1016/j.cell.2010.04.034
   Tóth ML, 2008, AUTOPHAGY, V4, P330, DOI 10.4161/auto.5618
   Tsukamoto S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04533
   Wallach T, 2015, FEBS LETT, V589, P1530, DOI 10.1016/j.febslet.2015.04.059
   Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213
   Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542
   Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682
   Yen WL, 2008, PHYSIOLOGY, V23, P248, DOI 10.1152/physiol.00013.2008
   Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851
   Zhang H, 2015, AUTOPHAGY, V11, P9, DOI 10.1080/15548627.2014.1003478
NR 52
TC 35
Z9 39
U1 1
U2 18
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD SEP
PY 2016
VL 8
IS 9
BP 1876
EP 1895
DI 10.18632/aging.101018
PG 20
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA EF4OY
UT WOS:000390311600008
PM 27574892
OA gold, Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Chu, WH
   Wang, P
   Ma, Z
   Peng, L
   Wang, ZM
   Chen, ZL
AF Chu, Wenhui
   Wang, Pan
   Ma, Zhe
   Peng, Lin
   Wang, Zongmin
   Chen, Zilin
TI Ultrasonic treatment of <i>Dendrobium officinale</i> polysaccharide
   enhances antioxidant and anti-inflammatory activity in a mouse
   D-galactose-induced aging model
SO FOOD SCIENCE & NUTRITION
LA English
DT Article; Early Access
DE anti-inflammatory activity; antioxidant activity; Dendrobium officinale;
   D-galactose; polysaccharide
ID OXIDATIVE STRESS; DEGRADATION; INFLAMMATION; EXTRACTION; DAMAGE; LIVER
AB Utilization of the biological macromolecule Dendrobium officinale polysaccharide (DOP) as a functional ingredient is limited by its high intrinsic viscosity and molecular weight. The goal of the present study was to improve rheological properties of DOP by ultrasonic treatment. Such a treatment resulted in the degradation of DOP and consequent reduction of rheological properties. Among DOP samples treated with ultrasonication at low (L), medium (M), and high (H) power intensities (25, 50, 75 w/cm(2)), M-DOP displayed the highest reactive oxygen species (ROS) and reactive nitrogen species (RNS) radical scavenging activity in vitro. In a mouse D-galactose (D-Gal)induced aging model, M-DOP significantly increased activities of antioxidant enzymes and reduced levels of pro-inflammatory cytokines in liver. Real-time polymerase chain reaction (RT-PCR) analysis indicated that M-DOP upregulated messenger RNA (mRNA) expression of anti-inflammatory/antioxidant proteins such as Nrf2 (nuclear factor erythroid 2-related factor), hemeoxygenase-1 (HO-1), and NAD(P)H:quinone oxidoreductase (NQO1) in liver. In summary, M-DOP displayed a strong radical scavenging activity in vitro, and ameliorated liver injury in the mouse aging model through the promotion of Nrf2/HO-1/NQO1 signaling pathway.
C1 [Chu, Wenhui; Ma, Zhe; Peng, Lin] Taizhou Univ, Sch Life Sci, 1139 Shifu Ave, Taizhou 318000, Peoples R China.
   [Wang, Pan; Chen, Zilin] Tradit Chinese Med Ind Dev & Promot Ctr Panan Cty, Panan, Peoples R China.
   [Wang, Zongmin] Shandong Univ Technol, Sch Agr & Food Engn, Zibo, Peoples R China.
C3 Taizhou University; Shandong University of Technology
RP Peng, L (corresponding author), Taizhou Univ, Sch Life Sci, 1139 Shifu Ave, Taizhou 318000, Peoples R China.
EM leogard2005@163.com
OI Chu, Wenhui/0009-0005-7694-8249
FU Natural Science Foundation of Zhejiang Province [Q21C200006]; National
   Natural Science Foundation of China [31701584]; Taizhou Science and
   Technology Plan Project [2001xg06, 21ywa67]
FX This study was supported by the Natural Science Foundation of Zhejiang
   Province (Q21C200006), National Natural Science Foundation of China
   (31701584), Taizhou Science and Technology Plan Project (2001xg06,
   21ywa67)
CR Agarwal A, 2005, REPROD BIOMED ONLINE, V11, P641, DOI 10.1016/S1472-6483(10)61174-1
   Aydin S, 2012, BIOGERONTOLOGY, V13, P251, DOI 10.1007/s10522-011-9370-3
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Byun K, 2017, PHARMACOL THERAPEUT, V177, P44, DOI 10.1016/j.pharmthera.2017.02.030
   Chen B, 2010, BRAIN RES, V1344, P43, DOI 10.1016/j.brainres.2010.04.082
   Chen P, 2020, RSC ADV, V10, P8027, DOI 10.1039/d0ra00774a
   Çoban J, 2015, METAB BRAIN DIS, V30, P793, DOI 10.1007/s11011-014-9643-z
   DODGSON KS, 1962, BIOCHEM J, V84, P106, DOI 10.1042/bj0840106
   DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017
   Fan LM, 2014, J PHARMACOL TOX MET, V70, P40, DOI 10.1016/j.vascn.2014.03.173
   He LA, 2018, CARBOHYD POLYM, V198, P101, DOI 10.1016/j.carbpol.2018.06.073
   Hipkiss AR, 1998, ANN NY ACAD SCI, V854, P37, DOI 10.1111/j.1749-6632.1998.tb09890.x
   Hou Y, 2012, CARBOHYD POLYM, V87, P153, DOI 10.1016/j.carbpol.2011.07.031
   Huang KW, 2016, MOLECULES, V21, DOI 10.3390/molecules21060701
   Li HZ, 2004, FOOD RES INT, V37, P731, DOI 10.1016/j.foodres.2004.02.016
   Li L, 2016, NEURAL REGEN RES, V11, P807, DOI 10.4103/1673-5374.182709
   Liu J, 2021, IND CROP PROD, V168, DOI 10.1016/j.indcrop.2021.113605
   Mzoughi Z, 2017, INT J BIOL MACROMOL, V105, P1315, DOI 10.1016/j.ijbiomac.2017.07.151
   Naik E, 2011, J EXP MED, V208, P417, DOI 10.1084/jem.20110367
   Palma-Duran SA, 2018, METABOLISM, V83, P120, DOI 10.1016/j.metabol.2018.01.023
   Pan LH, 2014, INT J BIOL MACROMOL, V64, P420, DOI 10.1016/j.ijbiomac.2013.12.024
   Peng L, 2015, CARBOHYD POLYM, V133, P104, DOI 10.1016/j.carbpol.2015.07.014
   Qiu JQ, 2019, LWT-FOOD SCI TECHNOL, V113, DOI 10.1016/j.lwt.2019.108266
   Saleh DO, 2019, EUR J PHARMACOL, V855, P40, DOI 10.1016/j.ejphar.2019.04.043
   Salmon AB, 2010, FREE RADICAL BIO MED, V48, P642, DOI 10.1016/j.freeradbiomed.2009.12.015
   Salzano S, 2014, P NATL ACAD SCI USA, V111, P12157, DOI 10.1073/pnas.1401712111
   Wang B, 2013, FOOD CHEM, V138, P1713, DOI 10.1016/j.foodchem.2012.12.002
   Wang C, 2017, POSTHARVEST BIOL TEC, V131, P31, DOI 10.1016/j.postharvbio.2017.04.012
   Xing X., 2013, Bioactive Carbohydrates and Dietary Fibre, V1, P131, DOI 10.1016/j.bcdf.2013.04.001
   Yan JK, 2009, FOOD CHEM, V117, P641, DOI 10.1016/j.foodchem.2009.04.068
   Yan JK, 2016, ULTRASON SONOCHEM, V29, P251, DOI 10.1016/j.ultsonch.2015.10.005
   Yan SL, 2021, INT J BIOL MACROMOL, V182, P129, DOI 10.1016/j.ijbiomac.2021.03.193
   Yan X, 2018, INT J POLYM SCI, V2018, DOI 10.1155/2018/6464051
   YANG LY, 2018, BIOMED RES INT, V2018, DOI DOI 10.1155/2018/8584136
   Yang Q, 2019, BIOMED PHARMACOTHER, V117, DOI 10.1016/j.biopha.2019.109177
   Yao Y, 2015, INT J BIOL MACROMOL, V80, P246, DOI 10.1016/j.ijbiomac.2015.06.033
   Yen GC, 2001, FOOD CHEM, V74, P471, DOI 10.1016/S0308-8146(01)00165-0
   Yu GY, 2021, FOODS, V10, DOI 10.3390/foods10010197
   Zhou YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132088
   Zhu ZY, 2014, CARBOHYD POLYM, V114, P12, DOI 10.1016/j.carbpol.2014.07.068
NR 40
TC 12
Z9 12
U1 10
U2 61
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2048-7177
J9 FOOD SCI NUTR
JI Food Sci. Nutr.
PD 2022 AUG
PY 2022
VL 10
IS 8
BP 2620
EP 2630
DI 10.1002/fsn3.2867
EA APR 2022
PG 11
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA 3P7DT
UT WOS:000776989700001
PM 35959255
OA Green Published
DA 2024-02-19
ER

PT J
AU Du, HM
   Wang, YJ
   Liu, X
   Wang, SL
   Wu, SM
   Yuan, Z
   Zhu, XK
AF Du, H. M.
   Wang, Y. J.
   Liu, X.
   Wang, S. L.
   Wu, S. M.
   Yuan, Z.
   Zhu, X. K.
TI Defective Central Immune Tolerance Induced by High-Dose D-Galactose
   Resembles Aging
SO BIOCHEMISTRY-MOSCOW
LA English
DT Article
DE D-galactose; oxidative stress; thymic aging; central immune tolerance;
   negative selection
ID AUTOREACTIVE T-CELLS; NEGATIVE SELECTION; HYDROGEN-PEROXIDE; OXIDATIVE
   STRESS; REDOX THEORY; THYMUS; LIVER; 1A
AB D-Galactose (D-Gal) promotes accumulation of reactive oxygen species and formation of advanced glycation end-products, ultimately resulting in oxidative stress. D-Gal has been widely used to induce accelerated aging in anti-aging medical research. Although thymic epithelial cells are particularly sensitive to oxidative stress, there are few reports on the thymus changes accompanying D-Gal-induced aging in mice. To study the effect of D-Gal on rodent thymus, we investigated the degree of thymus atrophy and changes in the atrophy relative index in C57BL/6J mice following subcutaneous injection of D-Gal at different doses (200, 500, 1000 mg/kg per day) for 60 days. Compared with the vehicle-treated (0.9% saline) and young controls, D-Gal at doses of 500 and 1000 mg/kg per day led to a significant thymic atrophy; the latter dose caused atrophy similar to that observed in naturally aged (18-20-month-old) mice. Mice treated with high-dose D-Gal exhibited greater immunosenescence, defective central immune tolerance, increased levels of activated splenic immune cell, and chronic low-grade inflammation, i.e., outcomes similar to those observed in natural aging in mice. Taken together, our results indicate that mice treated with high-dose D-Gal may be a valid model for studying induced thymic atrophy and effects of aging on the immune system.
C1 [Du, H. M.; Wang, Y. J.; Liu, X.; Zhu, X. K.] China Med Univ, Shengjing Hosp, Res Ctr, Benxi 117000, Peoples R China.
   [Du, H. M.; Wang, S. L.] China Med Univ, Shengjing Hosp, Dept Oncol, Shenyang 110022, Liaoning, Peoples R China.
   [Wu, S. M.; Yuan, Z.] China Med Univ, Shengjing Hosp, Dept Blood Transfus, Shenyang 110022, Liaoning, Peoples R China.
C3 China Medical University; China Medical University
RP Zhu, XK (corresponding author), China Med Univ, Shengjing Hosp, Res Ctr, Benxi 117000, Peoples R China.
EM dhmcmu@163.com; 742032002@qq.com; Sherryliu779122290@qq.com;
   doctorwangsl@hotmail.com; smwu@cmu.edu.cn; yuan._zhe@163.com;
   zhuxk@sj-hospital.org
RI yuan, zhe/GYE-0922-2022
FU National Natural Science Foundation of China [81270430]
FX This work was supported by the National Natural Science Foundation of
   China (grant no. 81270430).
CR Abramson J, 2017, ANNU REV IMMUNOL, V35, P85, DOI 10.1146/annurev-immunol-051116-052320
   Bo-Htay C, 2018, J CELL MOL MED, V22, P1392, DOI 10.1111/jcmm.13472
   Cebe T, 2014, AGE, V36, DOI 10.1007/s11357-014-9728-y
   Cepeda S, 2018, EXP GERONTOL, V105, P113, DOI 10.1016/j.exger.2017.12.022
   Chaudhry MS, 2016, IMMUNOL REV, V271, P56, DOI 10.1111/imr.12418
   Coder BD, 2015, J IMMUNOL, V194, P5825, DOI 10.4049/jimmunol.1500082
   Currais A, 2018, J GERONTOL A-BIOL, V73, P299, DOI 10.1093/gerona/glx104
   de Toda IM, 2015, BIOGERONTOLOGY, V16, P709, DOI 10.1007/s10522-015-9607-7
   DeVoss JJ, 2010, J IMMUNOL, V184, P4236, DOI 10.4049/jimmunol.0902434
   Dixit VD, 2010, CURR OPIN IMMUNOL, V22, P521, DOI 10.1016/j.coi.2010.06.010
   Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057
   Go YM, 2017, CLIN SCI, V131, P1669, DOI 10.1042/CS20160897
   Griffith AV, 2015, CELL REP, V12, P1071, DOI 10.1016/j.celrep.2015.07.008
   Guzik TJ, 2018, ANTIOXID REDOX SIGN, V29, P257, DOI 10.1089/ars.2017.7299
   Hubert FX, 2009, J IMMUNOL, V182, P3902, DOI 10.4049/jimmunol.0802124
   Jones DP, 2016, ARCH BIOCHEM BIOPHYS, V595, P13, DOI 10.1016/j.abb.2015.10.022
   Jones DP, 2015, ANTIOXID REDOX SIGN, V23, P734, DOI 10.1089/ars.2015.6247
   Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667
   Kurd N, 2016, IMMUNOL REV, V271, P114, DOI 10.1111/imr.12398
   Li MY, 2016, PAK VET J, V36, P356
   Li M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020183
   Li W, 2017, EXP THER MED, V14, P5045, DOI 10.3892/etm.2017.5163
   Majumdar S, 2018, SCAND J IMMUNOL, V87, P4, DOI 10.1111/sji.12618
   Malchow S, 2016, IMMUNITY, V44, P1102, DOI 10.1016/j.immuni.2016.02.009
   Markle JG, 2014, TRENDS IMMUNOL, V35, P97, DOI 10.1016/j.it.2013.10.006
   Mo ZZ, 2017, REJUV RES, V20, P231, DOI 10.1089/rej.2016.1870
   Morava E, 2014, MOL GENET METAB, V112, P275, DOI 10.1016/j.ymgme.2014.06.002
   Oh J, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2003352
   Purton JF, 2004, J IMMUNOL, V173, P3816, DOI 10.4049/jimmunol.173.6.3816
   Rehman SU, 2017, MOL NEUROBIOL, V54, P255, DOI 10.1007/s12035-015-9604-5
   Sander M, 2015, AGE AGEING, V44, P185, DOI 10.1093/ageing/afu189
   Shwe T, 2018, EXP GERONTOL, V101, P13, DOI 10.1016/j.exger.2017.10.029
   Sies H, 2017, REDOX BIOL, V11, P613, DOI 10.1016/j.redox.2016.12.035
   Takaba H, 2017, TRENDS IMMUNOL, V38, P805, DOI 10.1016/j.it.2017.07.010
   Uddin MN, 2010, J IMMUNOTOXICOL, V7, P165, DOI 10.3109/15476910903510806
   Wang HF, 2018, SCI CHINA LIFE SCI, V61, P24, DOI 10.1007/s11427-017-9207-x
   Xing Y, 2016, NAT IMMUNOL, V17, P565, DOI 10.1038/ni.3419
NR 37
TC 8
Z9 12
U1 1
U2 22
PU MAIK NAUKA/INTERPERIODICA/SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013-1578 USA
SN 0006-2979
EI 1608-3040
J9 BIOCHEMISTRY-MOSCOW+
JI Biochem.-Moscow
PD JUN
PY 2019
VL 84
IS 6
BP 617
EP 626
DI 10.1134/S000629791906004X
PG 10
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA ID3TW
UT WOS:000471601000004
PM 31238861
DA 2024-02-19
ER

PT J
AU Arthur, L
   Esaulova, E
   Mogilenko, DA
   Tsurinov, P
   Burdess, S
   Laha, A
   Presti, R
   Goetz, B
   Watson, MA
   Goss, CW
   Gurnett, CA
   Mudd, PA
   Beers, C
   O'Halloran, JA
   Artyomov, MN
AF Arthur, Laura
   Esaulova, Ekaterina
   Mogilenko, Denis A.
   Tsurinov, Petr
   Burdess, Samantha
   Laha, Anwesha
   Presti, Rachel
   Goetz, Brian
   Watson, Mark A.
   Goss, Charles W.
   Gurnett, Christina A.
   Mudd, Philip A.
   Beers, Courtney
   O'Halloran, Jane A.
   Artyomov, Maxim N.
TI Cellular and plasma proteomic determinants of COVID-19 and non-COVID-19
   pulmonary diseases relative to healthy aging
SO NATURE AGING
LA English
DT Article
ID PATTERNS; AGE; SIGNATURES; PNEUMONIA; PROFILES; CELLS
AB We examine the cellular and soluble determinants of coronavirus disease 2019 (COVID-19) relative to aging by performing mass cytometry in parallel with clinical blood testing and plasma proteomic profiling of similar to 4,700 proteins from 71 individuals with pulmonary disease and 148 healthy donors (25-80 years old). Distinct cell populations were associated with age (GZMK(+)CD8(+) T cells and CD25(low) CD4(+) T cells) and with COVID-19 (TBET-EOMES- CD4(+) T cells, HLA-DR(+)CD38(+) CD8(+) T cells and CD27(+)CD38(+) B cells). A unique population of TBET+EOMES+ CD4(+) T cells was associated with individuals with COVID-19 who experienced moderate, rather than severe or lethal, disease. Disease severity correlated with blood creatinine and urea nitrogen levels. Proteomics revealed a major impact of age on the disease-associated plasma signatures and highlighted the divergent contribution of hepatocyte and muscle secretomes to COVID-19 plasma proteins. Aging plasma was enriched in matrisome proteins and heart/aorta smooth muscle cell-specific proteins. These findings reveal age-specific and disease-specific changes associated with COVID-19, and potential soluble mediators of the physiological impact of COVID-19.
C1 [Arthur, Laura; Esaulova, Ekaterina; Mogilenko, Denis A.; Tsurinov, Petr; Burdess, Samantha; Laha, Anwesha; Watson, Mark A.; Artyomov, Maxim N.] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63130 USA.
   [Tsurinov, Petr] JetBrains Res, St Petersburg, Russia.
   [Presti, Rachel; O'Halloran, Jane A.] Washington Univ, Dept Med, Sch Med, St Louis, MO USA.
   [Goetz, Brian; Beers, Courtney] Washington Univ, Siteman Canc Ctr, Sch Med, St Louis, MO USA.
   [Goss, Charles W.] Washington Univ, Div Biostat, Sch Med, St Louis, MO USA.
   [Gurnett, Christina A.] Washington Univ, Dept Neurol, Sch Med, St Louis, MO USA.
   [Mudd, Philip A.] Washington Univ, Dept Emergency Med, Sch Med, St Louis, MO USA.
C3 Washington University (WUSTL); Washington University (WUSTL); Washington
   University (WUSTL); Siteman Cancer Center; Washington University
   (WUSTL); Washington University (WUSTL); Washington University (WUSTL)
RP Artyomov, MN (corresponding author), Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63130 USA.
EM martyomov@wustl.edu
RI Goss, Charles W/R-7296-2019; Mogilenko, Denis/H-4436-2013
OI Mogilenko, Denis/0000-0001-5427-5243; Presti, Rachel/0000-0002-5469-0727
FU Aging Biology Foundation; Barnes Jewish Hospital Foundation; Siteman
   Cancer Center [P30 CA091842]; Washington University Institute of
   Clinical and Translational Sciences from the National Center for
   Advancing Translational Sciences of the NIH [UL1TR002345]
FX This research was supported by a grant from Aging Biology Foundation to
   the laboratory of M.N.A. This study utilized samples obtained from the
   Washington University School of Medicine's COVID-19 biorepository
   supported by the Barnes Jewish Hospital Foundation, the Siteman Cancer
   Center (grant P30 CA091842 from the NCI of NIH) and the Washington
   University Institute of Clinical and Translational Sciences (grant
   UL1TR002345 from the National Center for Advancing Translational
   Sciences of the NIH). The content is solely the responsibility of the
   authors and does not necessarily represent the views of the NIH.
CR Aizarani N, 2019, NATURE, V572, P199, DOI 10.1038/s41586-019-1373-2
   [Anonymous], 2021, Weekly Epidemiological Record = Releve Epidemiologique Hebdomadaire 97
   [Anonymous], 2020, EBIOMEDICINE, DOI [DOI 10.1016/J.EBIOM.2020.102763, 10.1016/j.ebiom.2020.102763(2020]
   Arevalo-Rodriguez I, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242958
   Badawi O, 2018, CRIT CARE MED, V46, P361, DOI 10.1097/CCM.0000000000002904
   Blackburn J, 2021, ANN INTERN MED, V174, P135, DOI 10.7326/M20-5352
   Bodenheimer T, 2020, bioRxiv, DOI [10.1101/2020.06.19.159749, 10.1101/2020.06.19.159749, DOI 10.1101/2020.06.19.159749]
   Carissimo G, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19080-6
   Chen J, 2018, ENDOCR J, V65, P1075, DOI 10.1507/endocrj.EJ18-0113
   Chen XH, 2020, CLIN INFECT DIS, V71, P1937, DOI 10.1093/cid/ciaa449
   Conte M, 2019, J GERONTOL A-BIOL, V74, P600, DOI 10.1093/gerona/gly153
   Costela-Ruiz VJ, 2020, CYTOKINE GROWTH F R, V54, P62, DOI 10.1016/j.cytogfr.2020.06.001
   Cummings MJ, 2020, LANCET, V395, P1763, DOI 10.1016/S0140-6736(20)31189-2
   Del Valle DM, 2020, NAT MED, V26, P1636, DOI [10.1038/s41591-020-1051-9, 10.1101/2020.05.28.20115758]
   Di Filippo L, 2020, ENDOCRINE, V68, P475, DOI 10.1007/s12020-020-02383-5
   Diao B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00827
   Foy BH, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.22058
   Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313
   Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI 10.1056/NEJMc2005203
   Hashimoto K, 2019, P NATL ACAD SCI USA, V116, P24242, DOI 10.1073/pnas.1907883116
   KAIRISTO V, 1994, EUR J CLIN CHEM CLIN, V32, P789
   Ko GTC, 2006, CROAT MED J, V47, P709
   Kong M, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820001557
   Kuri-Cervantes L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd7114
   Lackner I, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01920
   Lara PC, 2020, AGING DIS, V11, P756, DOI 10.14336/AD.2020.0601
   Lee JS, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd1554
   Lehallier B, 2019, NAT MED, V25, P1843, DOI 10.1038/s41591-019-0673-2
   Leisman DE, 2020, LANCET RESP MED, V8, P1233, DOI 10.1016/S2213-2600(20)30404-5
   Li YM, 2020, CIRCULATION, V142, P1374, DOI 10.1161/CIRCULATIONAHA.120.046528
   Liu JY, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02374-0
   Liu X, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1917-7
   Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y
   Maggio M, 2015, J STEROID BIOCHEM, V145, P281, DOI 10.1016/j.jsbmb.2014.03.014
   Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511
   McInnes L., 2018, ARXIV, V3, P861, DOI [arXiv:1802.03426, DOI 10.21105/JOSS.00861, 10.21105/joss.00861]
   Mengos AE, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01147
   Menni C, 2015, J GERONTOL A-BIOL, V70, P809, DOI 10.1093/gerona/glu121
   Meyerowitz-Katz G, 2020, INT J INFECT DIS, V101, P138, DOI 10.1016/j.ijid.2020.09.1464
   Milner JJ, 2012, P NUTR SOC, V71, P298, DOI 10.1017/S0029665112000158
   Mogilenko DA, 2021, IMMUNITY, V54, P99, DOI 10.1016/j.immuni.2020.11.005
   Monaco G, 2019, CELL REP, V26, P1627, DOI 10.1016/j.celrep.2019.01.041
   Müller-Durovic B, 2019, AGING-US, V11, P724, DOI 10.18632/aging.101774
   Nakamura T, 2017, BIOCHEM BIOPH RES CO, V487, P653, DOI 10.1016/j.bbrc.2017.04.110
   Nikolich-Zugich J, 2018, NAT IMMUNOL, V19, P10, DOI 10.1038/s41590-017-0006-x
   Palaiodimos L, 2020, METABOLISM, V108, DOI 10.1016/j.metabol.2020.154262
   Remy KE, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.140329
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x
   Ryu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019245
   Salje H, 2020, SCIENCE, V369, P208, DOI 10.1126/science.abc3517
   Salvagno GL, 2015, CRIT REV CL LAB SCI, V52, P86, DOI 10.3109/10408363.2014.992064
   Schuyler RP, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02367
   Sergushichev A. A., 2016, bioRxiv, DOI DOI 10.1101/060012
   Shchukina I, 2021, NATURE AGING, V1, P124, DOI 10.1038/s43587-020-00002-6
   Silvin A, 2020, CELL, V182, P1401, DOI 10.1016/j.cell.2020.08.002
   Singh T, 2011, AGEING RES REV, V10, P319, DOI 10.1016/j.arr.2010.11.002
   Strioga M, 2011, IMMUNOLOGY, V134, P17, DOI 10.1111/j.1365-2567.2011.03470.x
   Takahashi T., 2020, NATURE, V588, P315, DOI DOI 10.1038/s41586-020-2700-3
   Tanaka T, 2018, AGING CELL, V17, DOI 10.1111/acel.12799
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wang J, 2019, CELL, V176, P334, DOI 10.1016/j.cell.2018.11.010
   Williams SA, 2019, NAT MED, V25, P1851, DOI 10.1038/s41591-019-0665-2
   Yin JB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06765-2
   Zhang F, 2019, NAT IMMUNOL, V20, P928, DOI 10.1038/s41590-019-0378-1
   Zhang JY, 2020, NAT IMMUNOL, V21, P1107, DOI 10.1038/s41590-020-0762-x
   Zhao QW, 2020, INT J INFECT DIS, V96, P131, DOI 10.1016/j.ijid.2020.04.086
NR 67
TC 18
Z9 18
U1 0
U2 5
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
EI 2662-8465
J9 NATURE AGING
JI Nature Aging
PD JUN
PY 2021
VL 1
IS 6
BP 535
EP +
DI 10.1038/s43587-021-00067-x
PG 26
WC Cell Biology; Geriatrics & Gerontology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology; Neurosciences & Neurology
GA 9J1WI
UT WOS:000939985700008
PM 37117829
OA Bronze
DA 2024-02-19
ER

PT J
AU Zhu, RX
   Mok, MTS
   Kang, W
   Lau, SSK
   Yip, WK
   Chen, YC
   Lai, PBS
   Wong, VWS
   To, KF
   Sung, JJY
   Cheng, ASL
   Chan, HLY
AF Zhu, Ranxu
   Mok, Myth T. S.
   Kang, Wei
   Lau, Suki S. K.
   Yip, Wing-Kit
   Chen, Yangchao
   Lai, Paul B. S.
   Wong, Vincent W. S.
   To, Ka-Fai
   Sung, Joseph J. Y.
   Cheng, Alfred S. L.
   Chan, Henry L. Y.
TI Truncated HBx-dependent silencing of GAS2 promotes hepatocarcinogenesis
   through deregulation of cell cycle, senescence and p53-mediated
   apoptosis
SO JOURNAL OF PATHOLOGY
LA English
DT Article
DE HBV; truncated HBx; GAS2; cell cycle; apoptosis; senescence;
   hepatocellular carcinoma
ID HEPATITIS-B-VIRUS; ARREST-SPECIFIC PROTEIN; X-PROTEIN;
   HEPATOCELLULAR-CARCINOMA; GROWTH ARREST; MICROFILAMENT REORGANIZATION;
   DOWN-REGULATION; IN-VITRO; GENE; EXPRESSION
AB Hepatocellular carcinoma (HCC) is a worldwide threat to public health, especially in China, where chronic hepatitis B virus (HBV) infection is found in 80-90% of all HCCs. The HBV-encoded X antigen (HBx) is a trans-regulatory protein involved in virus-induced hepatocarcinogenesis. Although the carboxyl-terminus-truncated HBx, rather than the full-length counterpart, is frequently overexpressed in human HCCs, its functional mechanisms are not fully defined. We investigated the molecular function of a naturally occurring HBx variant which has 35 amino acids deleted at the C-terminus (HBx35). Genome-wide scanning analysis and PCR validation identified growth arrest-specific 2 (GAS2) as a direct target of HBx35 at transcriptional level in human immortalized liver cells. HBx35 was found to bind the promoter region of GAS2 and attenuate its expression to promote hepatocellular proliferation and tumourigenicity. Further functional assays demonstrated that GAS2 induces p53-dependent apoptosis and senescence to counteract HBx35-mediated tumourigenesis. Notably, GAS2 expression was significantly down-regulated in HCCs compared with the corresponding normal tissues. In conclusion, our integrated study uncovered a novel viral mechanism in hepatocarcinogenesis, wherein HBx35 deregulates cell growth via direct silencing of GAS2 and thereby provides a survival advantage for pre-neoplastic hepatocytes to facilitate cancer development. Copyright (c) 2015 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
C1 [Zhu, Ranxu; Lau, Suki S. K.; Chen, Yangchao; Lai, Paul B. S.; Wong, Vincent W. S.; To, Ka-Fai; Sung, Joseph J. Y.; Cheng, Alfred S. L.; Chan, Henry L. Y.] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China.
   [Zhu, Ranxu; Lau, Suki S. K.; Chen, Yangchao; Lai, Paul B. S.; Wong, Vincent W. S.; To, Ka-Fai; Sung, Joseph J. Y.; Cheng, Alfred S. L.; Chan, Henry L. Y.] Chinese Univ Hong Kong, State Key Lab Digest Dis, Hong Kong, Hong Kong, Peoples R China.
   [Zhu, Ranxu; Wong, Vincent W. S.; Chan, Henry L. Y.] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.
   [Zhu, Ranxu] Univ Hong Kong, Shenzhen Hosp, Dept Gastroenterol, Shenzhen, Peoples R China.
   [Mok, Myth T. S.; Chen, Yangchao; Cheng, Alfred S. L.] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China.
   [Mok, Myth T. S.; Cheng, Alfred S. L.] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China.
   [Kang, Wei; To, Ka-Fai] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China.
   [Lai, Paul B. S.] Chinese Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China.
C3 Chinese University of Hong Kong; Chinese University of Hong Kong;
   Chinese University of Hong Kong; University of Hong Kong; Chinese
   University of Hong Kong; The Chinese University of Hong Kong, Shenzhen;
   CUHK Shenzhen Research Institute; Chinese University of Hong Kong;
   Chinese University of Hong Kong
RP Cheng, ASL (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China.
EM alfredcheng@cuhk.edu.hk; hlychan@cuhk.edu.hk
RI Wong, Grace L. H./L-8586-2014; Chan, Henry Lik-Yuen/B-9636-2008; Sung,
   Joseph J. Y./R-3203-2018; Chen, Yangchao/AAG-2127-2019; Chan,
   Henry/JKI-4211-2023; Lai, Paul BS/K-8556-2015; Wong, Vincent
   WS/K-3864-2014; Cheng, Alfred SL/C-3327-2014; KANG, Wei/C-5451-2016;
   Mok, Myth T/M-2958-2013; To, Ka Fai/JTT-7693-2023
OI Wong, Grace L. H./0000-0002-2863-9389; Sung, Joseph J.
   Y./0000-0003-3125-5199; Chen, Yangchao/0000-0002-0249-3414; Lai, Paul
   BS/0000-0002-9469-6728; Wong, Vincent WS/0000-0003-2215-9410; Cheng,
   Alfred SL/0000-0003-2345-6951; KANG, Wei/0000-0002-4651-677X; Mok, Myth
   T/0000-0003-3156-4944; To, Ka Fai/0000-0003-4919-3707
FU Food and Health Bureau Health and Medical Research Fund [08070332,
   12110532, 01120216]; Research Grants Council - Collaborative Research
   Fund [CUHK8/CRF/11R]; National Natural Science Foundation of China
   [373492, 81302167]; Chinese University of Hong Kong [1907301]
FX This study was funded by the Food and Health Bureau Health and Medical
   Research Fund (08070332, 12110532, and 01120216), the Research Grants
   Council - Collaborative Research Fund (CUHK8/CRF/11R), the National
   Natural Science Foundation of China (373492 and 81302167), and the
   Focused Investment Scheme - Scheme B (1907301) of the Chinese University
   of Hong Kong.
CR Benetti R, 2001, EMBO J, V20, P2702, DOI 10.1093/emboj/20.11.2702
   Bouchard MJ, 2001, SCIENCE, V294, P2376, DOI 10.1126/science.294.5550.2376
   Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467
   BRANCOLINI C, 1992, J CELL BIOL, V117, P1251, DOI 10.1083/jcb.117.6.1251
   BRANCOLINI C, 1995, EMBO J, V14, P5179, DOI 10.1002/j.1460-2075.1995.tb00202.x
   BRANCOLINI C, 1994, J CELL BIOL, V124, P743, DOI 10.1083/jcb.124.5.743
   Brancolini C, 1997, CELL DEATH DIFFER, V4, P247, DOI 10.1038/sj.cdd.4400232
   Chen YC, 2007, HEPATOLOGY, V46, P200, DOI 10.1002/hep.21668
   Cheng ASL, 2008, BIOCHEM BIOPH RES CO, V374, P175, DOI 10.1016/j.bbrc.2008.06.098
   Cheng ASL, 2007, CANCER LETT, V253, P43, DOI 10.1016/j.canlet.2007.01.004
   Cheng ASL, 2004, MODERN PATHOL, V17, P1169, DOI 10.1038/modpathol.3800196
   Cheng ASL, 2006, MOL CELL, V21, P393, DOI 10.1016/j.molcel.2005.12.016
   Cougot D, 2007, J BIOL CHEM, V282, P4277, DOI 10.1074/jbc.M606774200
   Feitelson MA, 2014, EXPERT OPIN THER TAR, V18, P293, DOI 10.1517/14728222.2014.867947
   Feng H, 2011, J CLIN INVEST, V121, P3159, DOI 10.1172/JCI45967
   Gong DY, 2013, VIRUSES-BASEL, V5, P1261, DOI 10.3390/v5051261
   Iavarone M, 2003, J HEPATOL, V39, P253, DOI 10.1016/S0168-8278(03)00217-4
   Janssen JJWM, 2005, LEUKEMIA, V19, P998, DOI 10.1038/sj.leu.2403735
   JEMAL A, 2011, CA-CANCER J CLIN, V61, P69, DOI DOI 10.3322/CAAC.20107
   Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159
   Lee DK, 2001, GENE DEV, V15, P455, DOI 10.1101/gad.856201
   Lee SW, 2000, BIOCHEM BIOPH RES CO, V268, P456, DOI 10.1006/bbrc.2000.2093
   Li XJ, 2014, J HEPATOL, V60, P975, DOI 10.1016/j.jhep.2013.12.014
   Liu LP, 2014, BRIT J CANCER, V110, P1066, DOI 10.1038/bjc.2013.787
   Ma NF, 2008, CLIN CANCER RES, V14, P5061, DOI 10.1158/1078-0432.CCR-07-5082
   Matsuda Y, 2009, MED MOL MORPHOL, V42, P138, DOI 10.1007/s00795-009-0457-8
   Murata M, 2009, HEPATOLOGY, V49, P1203, DOI 10.1002/hep.22765
   Norton PA, 2004, J VIRAL HEPATITIS, V11, P332, DOI 10.1111/j.1365-2893.2004.00555.x
   Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013
   Petroulakis E, 2009, CANCER CELL, V16, P439, DOI 10.1016/j.ccr.2009.09.025
   SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3
   Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000
   Sgorbissa A, 1999, J CELL SCI, V112, P4475
   Shih WL, 2003, J BIOL CHEM, V278, P31807, DOI 10.1074/jbc.M302580200
   Sir D, 2010, P NATL ACAD SCI USA, V107, P4383, DOI 10.1073/pnas.0911373107
   Sirma H, 1999, ONCOGENE, V18, P4848, DOI 10.1038/sj.onc.1202867
   Sung WK, 2009, J BIOL CHEM, V284, P21941, DOI 10.1074/jbc.M109.014563
   Sze KMF, 2013, HEPATOLOGY, V57, P131, DOI 10.1002/hep.25979
   Tian Y, 2013, MOL CELL BIOL, V33, P2810, DOI 10.1128/MCB.00205-13
   Tu H, 2001, CANCER RES, V61, P7803
   Wang JD, 2005, ONCOGENE, V24, P5637, DOI 10.1038/sj.onc.1208720
   Wang Y, 2004, ONCOGENE, V23, P142, DOI 10.1038/sj.onc.1206889
   Weber RG, 2007, ONCOGENE, V26, P1088, DOI 10.1038/sj.onc.1209851
   Yip WK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022888
   Yu Z, 2014, GUT, V63, P1793, DOI 10.1136/gutjnl-2013-305584
   Zhang ZS, 2004, J VIROL, V78, P4566, DOI 10.1128/JVI.78.9.4566-4572.2004
NR 46
TC 28
Z9 29
U1 0
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3417
EI 1096-9896
J9 J PATHOL
JI J. Pathol.
PD SEP
PY 2015
VL 237
IS 1
BP 38
EP 49
DI 10.1002/path.4554
PG 12
WC Oncology; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Pathology
GA CO7DB
UT WOS:000359317200005
PM 25925944
DA 2024-02-19
ER

PT J
AU EDLUND, C
   SODERBERG, M
   KRISTENSSON, K
   DALLNER, G
AF EDLUND, C
   SODERBERG, M
   KRISTENSSON, K
   DALLNER, G
TI UBIQUINONE, DOLICHOL, AND CHOLESTEROL-METABOLISM IN AGING AND
   ALZHEIMERS-DISEASE
SO BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE
LA English
DT Article; Proceedings Paper
CT SATELLITE CONF ON DOLICHOL AND OTHER LIPIDS RELATED TO GLYCOCONJUGATE
   METABOLISM, AT THE 11TH INTERNATIONAL SYMP ON GLYCOCONJUGATES
CY JUN 26-29, 1991
CL KIMBERLY, CANADA
SP MERCK FROSST CANADA, MED RES COUNCIL CANADA
DE UBIQUINONE; DOLICHOL; CHOLESTEROL; AGING; ALZHEIMERS DISEASE
ID EMBRYONIC-DEVELOPMENT; HUMAN-BRAIN; RAT-LIVER; ENDOPLASMIC-RETICULUM;
   PHOSPHATE; BIOSYNTHESIS; INHIBITION; MEMBRANES; PROTEINS; ACCUMULATION
AB The lipid compositions of various regions of the human brain were investigated during aging and in Alzheimer's disease. The phospholipid amounts and compositions remained unchanged during aging. There were, however, considerable differences both in phospholipid composition and amount when the various regions were compared. The level of dolichol increased severalfold in all regions up to the age of 70, but there was no further elevation thereafter. The ubiquinone level decreased significantly in all parts of the brain upon aging. In Alzheimer's disease, the dolichol level was decreased in all regions, and particularly, in those affected by the disease. In contrast, the dolichyl-P concentration increased in those regions that exhibited morphological changes. There was no modification in cholesterol distribution, but a significant elevation in ubiquinone content was observed in most regions. The only phospholipid whose level was elevated was phosphatidylinositol, and only in those parts of the brain that were affected. The content of polyunsaturated fatty acids in phosphatidylethanolamine was greatly decreased in connection with the disease, with a parallel increase in the saturated portion. The results indicate that Alzheimer's disease results in specific and significant changes in the levels of lipid products of the mevalonate pathway in the brain.
RP EDLUND, C (corresponding author), KAROLINSKA INST,HUDDINGE HOSP,CLIN RES CTR,DIV BASIC RES DEMENTIA,S-14186 HUDDINGE,SWEDEN.
CR ANDERSSON M, 1987, J NEUROCHEM, V49, P685, DOI 10.1111/j.1471-4159.1987.tb00948.x
   ASTRAND IM, 1986, EUR J BIOCHEM, V155, P447, DOI 10.1111/j.1432-1033.1986.tb09511.x
   BERLET HH, 1980, AGING BRAIN DEMENTIA, P81
   BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311
   CARSON DD, 1979, P NATL ACAD SCI USA, V76, P5709, DOI 10.1073/pnas.76.11.5709
   CARSON DD, 1981, J BIOL CHEM, V256, P4679
   CHOJNACKI T, 1988, BIOCHEM J, V251, P1
   DEGIER J, 1969, 4TH P INT C PHARM, V4, P102
   DEROPP JS, 1985, J BIOL CHEM, V260, P5669
   EDLUND C, 1986, CHEM-BIOL INTERACT, V57, P255, DOI 10.1016/0009-2797(86)90001-3
   EDLUND C, 1987, CHEM-BIOL INTERACT, V62, P191, DOI 10.1016/0009-2797(87)90090-1
   EGGENS I, 1988, CANCER RES, V48, P3418
   EKSTROM TJ, 1987, J BIOL CHEM, V262, P4090
   EKSTROM TJ, 1984, J BIOL CHEM, V259, P460
   ELMBERGER PG, 1989, BIOMED CHROMATOGR, V3, P20, DOI 10.1002/bmc.1130030106
   ERICSSON J, 1991, FASEB J, V5, pA798
   FAUST JR, 1979, ARCH BIOCHEM BIOPHYS, V192, P86, DOI 10.1016/0003-9861(79)90074-2
   FORSMARK P, 1991, FEBS LETT, V285, P39, DOI 10.1016/0014-5793(91)80720-N
   FREI B, 1990, P NATL ACAD SCI USA, V87, P4879, DOI 10.1073/pnas.87.12.4879
   GLOMSET JA, 1990, TRENDS BIOCHEM SCI, V15, P139, DOI 10.1016/0968-0004(90)90213-U
   Horrocks L. A., 1981, MOL BASIS NEUROPATHO, P601
   KALEN A, 1990, CHEM-BIOL INTERACT, V73, P221, DOI 10.1016/0009-2797(90)90005-8
   LOW MG, 1989, BIOCHIM BIOPHYS ACTA, V988, P427, DOI 10.1016/0304-4157(89)90014-2
   LOW P, 1992, LIPIDS, V27, P1, DOI 10.1007/BF02537050
   POTTER JER, 1981, J BIOL CHEM, V256, P2371
   PULLARKAT RK, 1987, CHEM SCRIPTA, V27, P85
   PULLARKAT RK, 1982, J BIOL CHEM, V257, P5991
   Quinn P. J. K., 1985, COENZYME Q, P107
   ROSSIGNOL DP, 1981, J BIOL CHEM, V256, P538
   Rouser G, 1972, Adv Lipid Res, V10, P261
   SAKAKIHARA Y, 1985, J NEUROCHEM, V44, P1535, DOI 10.1111/j.1471-4159.1985.tb08792.x
   SODERBERG M, 1991, LIPIDS, V26, P421, DOI 10.1007/BF02536067
   SODERBERG M, 1990, J NEUROCHEM, V54, P415, DOI 10.1111/j.1471-4159.1990.tb01889.x
   SODERBERG M, 1991, IN PRESS J NEUROCHEM
   SVENNERHOLM L, 1968, J LIPID RES, V9, P570
   THELIN A, 1991, EUR J BIOCHEM, V195, P755, DOI 10.1111/j.1432-1033.1991.tb15763.x
   VALTERSSON C, 1985, J BIOL CHEM, V260, P2742
   White D., 1973, FORM FUNCTION PHOSPH, P441
   WHITE DA, 1981, ARCH BIOCHEM BIOPHYS, V208, P30, DOI 10.1016/0003-9861(81)90119-3
   WOLFE LS, 1982, LANCET, V2, P99
   WOLFE LS, 1987, CHEM SCRIPTA, V27, P79
NR 41
TC 58
Z9 60
U1 1
U2 8
PU NATL RESEARCH COUNCIL CANADA
PI OTTAWA
PA RESEARCH JOURNALS, MONTREAL RD, OTTAWA ON K1A 0R6, CANADA
SN 0829-8211
J9 BIOCHEM CELL BIOL
JI Biochem. Cell Biol.
PD JUN
PY 1992
VL 70
IS 6
BP 422
EP 428
DI 10.1139/o92-065
PG 7
WC Biochemistry & Molecular Biology; Cell Biology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA JP919
UT WOS:A1992JP91900009
PM 1449707
DA 2024-02-19
ER

PT J
AU Czarkowska-Paczek, B
   Wyczalkowska-Tomasik, A
   Paczek, L
AF Czarkowska-Paczek, Bozena
   Wyczalkowska-Tomasik, Aleksandra
   Paczek, Leszek
TI Laboratory blood test results beyond normal ranges could not be
   attributed to healthy aging
SO MEDICINE
LA English
DT Article
DE aging; cardiovascular risk; laboratory reference values
ID GELATINASE-ASSOCIATED LIPOCALIN; CHRONIC KIDNEY-DISEASE; PLATELET COUNT;
   LIVER; AGE; COHORT; SEX; REGENERATION; PREVALENCE; BIOMARKER
AB Aging is related to a decline in the function of many organs. The results of blood tests are essential for clinical management and could change over a lifespan reflecting aging. The aim of this study was to examine serum levels of liver, kidney, and bone marrow function and to study their dynamics as a function of age and sex.
   The cross-sectional study conducted in Poland included 180 healthy individuals (20-90 years) divided into subgroups by sex and decade. These included subgroups of >= 65 or <65 years (men and women). We investigated serum levels of creatinine, estimated glomerular filtration rate, estimated effective renal blood/plasma flow, urine pH, urine neutrophil gelatinase-associated lipocalin (NGAL) as well as serum levels of transaminases, bilirubin, total cholesterol (TC), international normalized ratio (INR), and blood morphology.
   All parameters were within normal range in all groups. Urine NGAL was higher in men aged >= 65 years than women (25.67 +/- 53.65 vs 16.49 +/- 34.66, P=.001); serum levels of TC and platelet (PLT) count were higher in women than men aged >= 65 years (221.0 +/- 41.7 vs 188.4 +/- 48.2 and 250.3 +/- 47.8 vs 202.5 +/- 57.9, P=.003 and P=.038, respectively). The INR was lower in women (0.97 +/-.06 vs 1.19 +/- 0.48, P=.03).
   These blood tests were normal in healthy people aged >= 65 years. Higher PLT and TC and lower INR in women might indicate a higher risk of cardiovascular diseases. These changes in blood tests were not attributed to aging itself.
C1 [Czarkowska-Paczek, Bozena] Med Univ Warsaw, Dept Clin Nursing, E Ciolka Str 27, PL-01445 Warsaw, Poland.
   [Wyczalkowska-Tomasik, Aleksandra; Paczek, Leszek] Med Univ Warsaw, Dept Immunol Transplantol & Internal Dis, Warsaw, Poland.
C3 Medical University of Warsaw; Medical University of Warsaw
RP Czarkowska-Paczek, B (corresponding author), Med Univ Warsaw, Dept Clin Nursing, E Ciolka Str 27, PL-01445 Warsaw, Poland.
EM bozena.czarkowska-paczek@wum.edu.pl
OI Czarkowska-Paczek, Bozena/0000-0002-1023-3057; Paczek,
   Leszek/0000-0003-0160-3009
CR Andrawes WF, 2005, DRUG AGING, V22, P859, DOI 10.2165/00002512-200522100-00005
   Balduini CL, 2014, HAEMATOLOGICA, V99, P953, DOI 10.3324/haematol.2014.106260
   Cieslak KP, 2016, HPB, V18, P691, DOI 10.1016/j.hpb.2016.05.011
   Danielsson J, 2014, WORLD J GASTROENTERO, V20, P11743, DOI 10.3748/wjg.v20.i33.11743
   Denic A, 2016, ADV CHRONIC KIDNEY D, V23, P19, DOI 10.1053/j.ackd.2015.08.004
   Devarajan P, 2010, NEPHROLOGY, V15, P419, DOI 10.1111/j.1440-1797.2010.01317.x
   Enkhbold C, 2015, J GASTROEN HEPATOL, V30, P1217, DOI 10.1111/jgh.12930
   Giasson Janice, 2011, Inflammation & Allergy Drug Targets, V10, P272
   Jenne CN, 2013, INT J LAB HEMATOL, V35, P254, DOI 10.1111/ijlh.12084
   Kurokawa T, 2017, WORLD J GASTROENTERO, V23, P3228, DOI 10.3748/wjg.v23.i18.3228
   Musso CG, 2016, POSTGRAD MED, V128, P716, DOI 10.1080/00325481.2016.1209963
   Nitta K, 2013, KIDNEY BLOOD PRESS R, V38, P109, DOI 10.1159/000355760
   Rocca WA, 2014, MAYO CLIN PROC, V89, P1336, DOI 10.1016/j.mayocp.2014.07.010
   Segal JB, 2006, ANN EPIDEMIOL, V16, P123, DOI 10.1016/j.annepidem.2005.06.052
   Starr JM, 2011, MATURITAS, V69, P373, DOI 10.1016/j.maturitas.2011.05.007
   Tsai MT, 2015, BLOOD, V126, P1633, DOI 10.1182/blood-2015-06-654764
   Verdoia M, 2015, EXP GERONTOL, V62, P32, DOI 10.1016/j.exger.2014.12.019
   Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269
   Wyczalkowska-Tomasik A, 2017, GERIATR GERONTOL INT, V17, P1022, DOI 10.1111/ggi.12811
NR 19
TC 2
Z9 2
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD JUL
PY 2018
VL 97
IS 28
AR e11414
DI 10.1097/MD.0000000000011414
PG 6
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA GO0AE
UT WOS:000439577500039
PM 29995788
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Panda, H
   Pandey, RS
   Debata, PR
   Supakar, PC
AF Panda, Harekrushna
   Pandey, Ravi Shankar
   Debata, Priya Ranjan
   Supakar, Prakash Chandra
TI Age-dependent differential expression and activity of rat liver
   cytosolic inorganic pyrophosphatase gene
SO BIOGERONTOLOGY
LA English
DT Article
DE differential display PCR; gene expression; aging; in-gel assay;
   inorganic pyrophosphatase
ID ANDROGEN RECEPTOR GENE; NUCLEOSIDE TRIPHOSPHATE; PROTEIN EXPRESSION;
   PROTEOMIC ANALYSIS; CALCIFICATION; IDENTIFICATION; PRECIPITATION;
   PROFILE
AB Besides epigenetic factors, the genetic make-up and differential gene expression not only determines aging and disease susceptibility but also the functional activity of cells in an individual. Analysis of a variety of mammalian tissues revealed that the age-associated differentially expressed genes mainly belong to inflammation, stress, and metabolism. Intracellular PPi is a by-product of multiple biosynthetic reactions and its hydrolysis by cytosolic inorganic pyrophosphatase (iPPase) has long been considered as an important homeostatic mechanism favoring biosynthesis. In this paper we report an age-associated increase (similar to 2-fold) in the expression of rat liver cytosolic iPPase gene by differential display PCR and northern blot analysis. Expression profiling of iPPase by RNA slot blot analysis in several other tissues revealed no significant change with aging. A comparative spectrophotometric and in-gel analysis of iPPase activity in whole cell lysate (WCL) of liver, brain, skeletal muscle, heart, spleen and kidney exhibited that liver of old rats (24 months ) has similar to 2-fold more activity than the adult (4 months) ones and also its activity is highest among the tissues. The specificity of iPPase activity in the spectrophotometric assay and in-gel analysis was confirmed by specific iPPase inhibitors like CaCl2 and NaF.
C1 Inst Life Sci, Bhubaneswar 751023, Orissa, India.
C3 Department of Biotechnology (DBT) India; Institute of Life Sciences
   India (ILS)
RP Supakar, PC (corresponding author), Inst Life Sci, Nalco Sq Chandrasekharpur, Bhubaneswar 751023, Orissa, India.
EM pcsupakar@hotmail.com
RI Debata, Priya Ranjan/AAY-7142-2021
CR Block GA, 2000, CLIN NEPHROL, V54, P318
   Chen GA, 2002, CLIN CANCER RES, V8, P2298
   Childress AM, 1996, MICROBIOL-UK, V142, P2289, DOI 10.1099/13500872-142-8-2289
   Dhahbi JM, 1999, AM J PHYSIOL-ENDOC M, V277, pE352, DOI 10.1152/ajpendo.1999.277.2.E352
   Felkai S, 1999, EMBO J, V18, P1783, DOI 10.1093/emboj/18.7.1783
   FLEISCH H, 1965, NATURE, V207, P1300, DOI 10.1038/2071300b0
   FRIEDMAN DB, 1988, J GERONTOL, V43, pB102, DOI 10.1093/geronj/43.4.B102
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   Giachelli CM, 1999, AM J PATHOL, V154, P671, DOI 10.1016/S0002-9440(10)65313-8
   Gulick PJ, 2005, GENOME, V48, P913, DOI 10.1139/g05-039
   GUYNN RW, 1974, BIOCHEMISTRY-US, V140, P369, DOI 10.1042/bj1400369
   Hathout Y, 2002, J PROTEOME RES, V1, P435, DOI 10.1021/pr020006i
   James OFW, 1997, GUT, V41, P430, DOI 10.1136/gut.41.4.430
   Johnson K, 2001, J RHEUMATOL, V28, P2681
   KAR M, 1975, CAN J BOT, V53, P503, DOI 10.1139/b75-061
   LAHTI R, 1983, MICROBIOL REV, V47, P169, DOI 10.1128/MMBR.47.2.169-178.1983
   Lavery LW, 2002, BIOGERONTOLOGY, V3, P207, DOI 10.1023/A:1016251929165
   Lavery WL, 2002, GERONTOLOGY, V48, P369, DOI 10.1159/000065505
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   Lexander H, 2005, ANAL QUANT CYTOL, V27, P263
   MANSUROVA SE, 1989, BIOCHIM BIOPHYS ACTA, V977, P237, DOI 10.1016/S0005-2728(89)80078-7
   Michels PAM, 1997, EUR J BIOCHEM, V250, P698, DOI 10.1111/j.1432-1033.1997.00698.x
   NORDLIE RC, 1965, J BIOL CHEM, V240, P2155
   Orr WC, 2003, J BIOL CHEM, V278, P26418, DOI 10.1074/jbc.M303095200
   Panda H, 2004, J BIOMED SCI, V11, P528, DOI 10.1159/000077903
   PATRA HK, 1979, PLANT PHYSIOL, V63, P318, DOI 10.1104/pp.63.2.318
   RACHOW JW, 1988, RHEUM DIS CLIN N AM, V14, P289
   Debata PR, 2007, BIOGERONTOLOGY, V8, P25, DOI 10.1007/s10522-006-9032-z
   Rayn LM., 1997, ARTHRITIS ALLIED CON, V2, P2103
   ROY AK, 1983, J BIOL CHEM, V258, P123
   Rumsfeld J, 2000, PROTEIN EXPRES PURIF, V18, P303, DOI 10.1006/prep.1999.1189
   Seroude Laurent, 2002, ScientificWorldJournal, V2, P618
   SHATTON JB, 1983, CANCER RES, V43, P3742
   SIERRA F, 1989, MOL CELL BIOL, V9, P5610, DOI 10.1128/MCB.9.12.5610
   Simonovic AD, 2004, ANAL BIOCHEM, V334, P312, DOI 10.1016/j.ab.2004.07.010
   SONG CS, 1991, ENDOCRINOLOGY, V128, P349, DOI 10.1210/endo-128-1-349
   Sun JT, 1999, MOL CELL BIOL, V19, P216
   SUPAKAR PC, 1995, J BIOL CHEM, V270, P837, DOI 10.1074/jbc.270.2.837
   SUPAKAR PC, 1993, J BIOL CHEM, V268, P26400
   Supakar PC, 1996, BIOL SIGNAL, V5, P170
   Terkeltaub RA, 2001, AM J PHYSIOL-CELL PH, V281, pC1, DOI 10.1152/ajpcell.2001.281.1.C1
   Tollet-Egnell P, 2001, MOL ENDOCRINOL, V15, P308, DOI 10.1210/me.15.2.308
   Tomonaga T, 2004, CLIN CANCER RES, V10, P2007, DOI 10.1158/1078-0432.CCR-03-0321
   Weindruch R, 2001, J NUTR, V131, p918S, DOI 10.1093/jn/131.3.918S
   WUTHIER RE, 1972, CALC TISS RES, V10, P198, DOI 10.1007/BF02012549
NR 45
TC 10
Z9 10
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD OCT
PY 2007
VL 8
IS 5
BP 517
EP 525
DI 10.1007/s10522-007-9094-6
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 206UJ
UT WOS:000249208100006
PM 17415680
DA 2024-02-19
ER

PT J
AU Gopalakrishnan, S
   Cheung, NKM
   Yip, BWP
   Au, DWT
AF Gopalakrishnan, Singaram
   Cheung, Napo K. M.
   Yip, Bill W. P.
   Au, Doris W. T.
TI Medaka fish exhibits longevity gender gap, a natural drop in estrogen
   and telomere shortening during aging: a unique model for studying
   sex-dependent longevity
SO FRONTIERS IN ZOOLOGY
LA English
DT Article
DE Lifespan; Aging; Telomerase and telomere; Estrogen profile; Sex
   difference and medaka O. latipes
ID GAMBUSIA-HOLBROOKI PISCES; LIFE-HISTORY; DROSOPHILA-MELANOGASTER; HTERT
   EXPRESSION; LIVE LONGER; AGE; POPULATION; MECHANISMS; POECILIIDAE;
   DIMORPHISM
AB Introduction: Females having a longer telomere and lifespan than males have been documented in many animals. Such linkage however has never been reported in fish. Progressive shortening of telomere length is an important aging mechanism. Mounting in vitro evidence has shown that telomere shortening beyond a critical length triggered replicative senescence or cell death. Estrogen has been postulated as a key factor contributing to maintenance of telomere and sex-dependent longevity in animals. This postulation remains unproven due to the lack of a suitable animal system for testing. Here, we introduce a teleost model, the Japanese medaka Oryzias latipes, which shows promise for research into the molecular mechanism(s) controlling sex difference in aging.
   Results: Using the medaka, we demonstrate for the first time in teleost that (i) sex differences (female > male) in telomere length and longevity also exist in fish, and (ii) a natural, 'menopause'-like decline of plasma estrogen was evident in females during aging. Estrogen levels significantly correlated with telomerase activity as well as telomere length in female organs (not in males), suggesting estrogen could modulate telomere length via telomerase activation in a sex - specific manner. A hypothetical in vivo 'critical' terminal restriction fragment (TRF, representing telomere) length of approximately 4 kb was deduced in medaka liver for prediction of organismal mortality, which is highly comparable with that for human cells. An age conversion model was also established to enable age translation between medaka (in months) and human (in years). These novel tools are useful for future research on comparative biology of aging using medaka.
   Conclusion: The striking similarity in estrogen profile between aging female O. latipes and women enables studying the influence of "postmenopausal" decline of estrogen on telomere and longevity without the need of invasive ovariectomy. Medaka fish is advantageous for studying the direct effect of increased estrogen on telomere length and longevity without the breast cancer complications reported in rodents. The findings strongly support the notion that O. latipes is a unique non-mammalian model for validation of estrogenic influence on telomere and longevity in vertebrates. This laboratory model fish is of potential significance for deciphering the ostensibly conserved mechanism(s) of sex-associated longevity in vertebrates.
C1 [Gopalakrishnan, Singaram; Cheung, Napo K. M.; Yip, Bill W. P.; Au, Doris W. T.] City Univ Hong Kong, Dept Biol & Chem, State Key Lab Marine Pollut, Kowloon, Hong Kong, Peoples R China.
C3 City University of Hong Kong
RP Au, DWT (corresponding author), City Univ Hong Kong, Dept Biol & Chem, State Key Lab Marine Pollut, 83 Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
EM bhdwtau@cityu.edu.hk
RI Gopalakrishnan, Singaram/AEB-6454-2022
OI AU, Wai Ting Doris/0000-0003-4490-5971
FU Research Grants Council of the Hong Kong Special Administrative Region,
   China [9041468, CityU 160009]; University Grants Committee, Area of
   Excellence Grant [AoE/P-04/04]; State Key Laboratory in Marine Pollution
FX The work described in this paper was supported by grants from the
   Research Grants Council of the Hong Kong Special Administrative Region,
   China (Project No. 9041468; CityU 160009), the University Grants
   Committee, Area of Excellence Grant (AoE/P-04/04) and the State Key
   Laboratory in Marine Pollution. The authors greatly appreciated Jun Bo,
   Roy R. Ye, Andy C. K. Cheung and Hong-Lin Ren for their assistance on
   fish sampling, and Joseph L. Humble for proofreading the manuscript.
CR Allman J, 1998, P NATL ACAD SCI USA, V95, P6866, DOI 10.1073/pnas.95.12.6866
   ASDELL SA, 1967, J REPROD FERTIL, V14, P113, DOI 10.1530/jrf.0.0140113
   Austad SN, 1997, ZEUS SALMON BIODEMOG
   Austad Steven N, 2006, Gend Med, V3, P79, DOI 10.1016/S1550-8579(06)80198-1
   Aviv A, 2005, SCI AGING KNOWLEDGE, V23, P1
   BALLINGER RE, 1981, J NAT HIST, V15, P213, DOI 10.1080/00222938100770171
   Barrett ELB, 2011, AGING CELL, V10, P913, DOI 10.1111/j.1474-9726.2011.00741.x
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Blackburn EH, 2005, FEBS LETT, V579, P859, DOI 10.1016/j.febslet.2004.11.036
   Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4
   Bolis CL, 2001, PHARMACOL RES, V44, P265, DOI 10.1006/phrs.2001.0845
   Cabral JA, 1999, ACTA OECOL, V20, P607, DOI 10.1016/S1146-609X(99)00102-2
   Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373
   Callard GV, 2011, J STEROID BIOCHEM, V127, P176, DOI 10.1016/j.jsbmb.2011.03.022
   Carvalho Cory T. De, 1995, Revista Brasileira de Zoologia, V12, P627, DOI 10.1590/S0101-81751995000300018
   CASTILHO R, 1993, FISH RES, V16, P339, DOI 10.1016/0165-7836(93)90145-W
   Cherif H, 2003, NUCLEIC ACIDS RES, V31, P1576, DOI 10.1093/nar/gkg208
   Cheung NKM, 2012, COMP BIOCHEM PHYS C, V155, P18, DOI 10.1016/j.cbpc.2011.05.010
   Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002
   Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528
   Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723
   DAS G. M., 1959, BULL ENT RES, V50, P265, DOI 10.1017/S0007485300054572
   Davis T, 2007, ANN NY ACAD SCI, V1100, P455, DOI 10.1196/annals.1395.051
   Ding LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013287
   Gerhard GS, 2007, AGEING RES REV, V6, P64, DOI 10.1016/j.arr.2007.02.007
   Grabherr H, 2009, AMPHIBIA-REPTILIA, V30, P389, DOI 10.1163/156853809788795218
   Guo CH, 2003, J UROLOGY, V170, P615, DOI 10.1097/01.ju.0000074653.22766.c8
   Han S, 2010, AQUAT TOXICOL, V98, P256, DOI 10.1016/j.aquatox.2010.02.013
   Harley CB, 2011, REJUV RES, V14, P45, DOI 10.1089/rej.2010.1085
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   Hatakeyama H, 2008, MECH AGEING DEV, V129, P550, DOI 10.1016/j.mad.2008.05.006
   Haussmann MF, 2008, MOL ECOL RESOUR, V8, P264, DOI 10.1111/j.1471-8286.2007.01973.x
   Hill K, 2001, J HUM EVOL, V40, P437, DOI 10.1006/jhev.2001.0469
   Holldobler B., 1990, pi
   Howell A, 1997, ENDOCR-RELAT CANCER, V4, P371, DOI 10.1677/erc.0.0040371
   Imamura S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003364
   Jemielity S, 2007, AGING CELL, V6, P225, DOI 10.1111/j.1474-9726.2007.00279.x
   KALU DN, 1991, BONE MINER, V15, P175, DOI 10.1016/0169-6009(91)90124-I
   Khosla S, 1998, J CLIN ENDOCR METAB, V83, P2266, DOI 10.1210/jc.83.7.2266
   Kimura M, 2010, NAT PROTOC, V5, P1596, DOI 10.1038/nprot.2010.124
   KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0
   Kyo S, 1999, CANCER RES, V59, P5917
   Lauck B, 2005, AUST J ZOOL, V53, P21, DOI 10.1071/ZO04028
   LeBourg E, 1996, J GERONTOL A-BIOL, V51, pB280, DOI 10.1093/gerona/51A.4.B280
   LILES J. N., 1960, ANN ENT SOC AMER, V53, P277, DOI 10.1093/aesa/53.2.277
   LINTS FA, 1993, EXP GERONTOL, V28, P611, DOI 10.1016/0531-5565(93)90050-N
   Maklakov AA, 2007, AGING CELL, V6, P739, DOI 10.1111/j.1474-9726.2007.00333.x
   Marzona E, 2004, ITAL J ZOOL, V71, P117, DOI 10.1080/11250000409356620
   Mayer S, 2006, CYTOGENET GENOME RES, V112, P194, DOI 10.1159/000089870
   MEYNE J, 1989, P NATL ACAD SCI USA, V86, P7049, DOI 10.1073/pnas.86.18.7049
   Misiti S, 2000, MOL CELL BIOL, V20, P3764, DOI 10.1128/MCB.20.11.3764-3771.2000
   Mok HOL, 2008, THESIS CITY U HONG K
   Nappi RE, 1999, GYNECOL OBSTET INVES, V47, P29, DOI 10.1159/000010058
   PATNAIK BK, 1994, GERONTOLOGY, V40, P113, DOI 10.1159/000213582
   Richard AF, 2002, J ZOOL, V256, P421, DOI 10.1017/S0952836902000468
   Russo IH, 1998, J MAMMARY GLAND BIOL, V3, P49, DOI 10.1023/A:1018770218022
   RYAN MJ, 1983, ECOLOGY, V64, P1456, DOI 10.2307/1937500
   Scott JA, 1974, J RES LEPIDOPTERA, V12, P225
   Simpson ER, 2001, ENDOCRINOLOGY, V142, P4589, DOI 10.1210/en.142.11.4589
   Soda H, 2000, PROSTATE, V43, P161, DOI 10.1002/(SICI)1097-0045(20000515)43:3<161::AID-PROS1>3.0.CO;2-O
   Stewart SA, 2003, NAT GENET, V33, P492, DOI 10.1038/ng1127
   Stindl R, 2004, MED HYPOTHESES, V62, P151, DOI 10.1016/S0306-9877(03)00316-5
   STRIJBOSCH H, 1988, OECOLOGIA, V76, P20, DOI 10.1007/BF00379595
   Terzibasi E, 2007, EXP GERONTOL, V42, P81, DOI 10.1016/j.exger.2006.06.039
   TINKLE D W, 1972, Herpetologica, V28, P351
   Vargas MJ, 1996, HYDROBIOLOGIA, V341, P215, DOI 10.1007/BF00014686
   Viña J, 2003, ANTIOXID REDOX SIGN, V5, P549, DOI 10.1089/152308603770310194
   Vina J, 2005, SCI AGING KNOWL ENV, V2005, P1
   Viña J, 2010, ANTIOXID REDOX SIGN, V13, P269, DOI 10.1089/ars.2009.2952
   Yip BWP, 2011, THESIS CITY U HONG K
NR 70
TC 42
Z9 45
U1 2
U2 47
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1742-9994
J9 FRONT ZOOL
JI Front. Zool.
PD DEC 23
PY 2013
VL 10
AR 78
DI 10.1186/1742-9994-10-78
PG 11
WC Zoology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Zoology
GA 287EJ
UT WOS:000329523500001
PM 24364913
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Tatoli, R
   Tirelli, S
   Lampignano, L
   Castellana, F
   Bortone, I
   Zupo, R
   Sborgia, G
   Lozupone, M
   Panza, F
   Giannelli, G
   Quaranta, N
   Boeing, H
   Sardone, R
AF Tatoli, Rossella
   Tirelli, Sarah
   Lampignano, Luisa
   Castellana, Fabio
   Bortone, Ilaria
   Zupo, Roberta
   Sborgia, Giancarlo
   Lozupone, Madia
   Panza, Francesco
   Giannelli, Gianluigi
   Quaranta, Nicola
   Boeing, Heiner
   Sardone, Rodolfo
TI Liver Fibrosis and Hearing Loss in an Older Mediterranean Population:
   Results from the Salus in Apulia Study
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Article
DE liver fibrosis; hearing loss; older Mediterranean population;
   inflammation; oxidative stress
ID MARROW-DERIVED CELLS; PROINFLAMMATORY CYTOKINES; AMERICAN ASSOCIATION;
   RISK-FACTORS; DISEASE; AGE; PREVALENCE; DIAGNOSIS; INTERLEUKIN-6;
   DYSFUNCTION
AB Background: Aging is the main negative prognostic factor for various chronic diseases, such as liver fibrosis, and clinical disorders such as hearing loss. This study aimed to investigate the association between age-related hearing loss (ARHL) and age-related central auditory processing disorder (CAPD), and the risk for liver fibrosis in a cross-sectional study on an aging population. Methods: Liver fibrosis risk was judged on the fibrosis-4 (FIB-4) score. Peripheral ARHL was evaluated with pure tone audiometry using a calibrated audiometer. The pure tone average (PTA), calculated as a threshold <= 40 dB (HL) in the better ear, was measured at the frequencies 0.5-4 kHz. For age-related CAPD assessment, we employed the Synthetic Sentence Identification with an Ipsilateral Competitive Message test (SSI-ICM). General linear Logistic regression models were used to estimate the association. Results: The increase in the PTA 0.5-2 kHz (coefficient: 0.02, SE: 0.01, CI 95%: 0.01 to 0.03) was directly associated with a higher risk of liver fibrosis (FIB-4 >= 2.67). Moreover, the reduction in SSI (coefficient: -0.02, SE: 0.01, CI 95%: -0.03 to -0.01) was inversely associated with FIB-4 values < 2.67. Conclusion: Our results show an association between liver fibrosis and both ARHL and CAPD, linked by the typical consequence of aging. We also assume a role of inflammatory responses and oxidative stress.
C1 [Tatoli, Rossella; Tirelli, Sarah; Lampignano, Luisa; Castellana, Fabio; Bortone, Ilaria; Zupo, Roberta; Sardone, Rodolfo] Natl Inst Gastroenterol Saverio de Bellis, Res Hosp, Dept Basic Med, Unit Data Sci & Technol Innovat Populat Hlth, I-70013 Castellana Grotte, Italy.
   [Sborgia, Giancarlo; Lozupone, Madia; Panza, Francesco; Quaranta, Nicola] Univ Bari Aldo Moro, Dept Basic Med Neurosci & Sense Organs, Neurodegenerat Dis Unit, I-70013 Bari, Italy.
   [Giannelli, Gianluigi] Sci Direct Natl Inst Gastroenterol Saverio de Bell, Res Hosp, I-70013 Castellana Grotte, Italy.
   [Boeing, Heiner] German Inst Human Nutr Potsdam Rehbruecke DIfE, Arthur Scheunert Allee 114-116, D-14558 Nuthetal, Germany.
C3 Universita degli Studi di Bari Aldo Moro; Deutsches Institut fur
   Ernahrungsforschung Potsdam-Rehbrucke (DIfE)
RP Lampignano, L (corresponding author), Natl Inst Gastroenterol Saverio de Bellis, Res Hosp, Dept Basic Med, Unit Data Sci & Technol Innovat Populat Hlth, I-70013 Castellana Grotte, Italy.
EM luisa.lampignano@irccsdebellis.it
RI Bortone, Ilaria/HPE-3696-2023; Sardone, Rodolfo/AAM-2727-2020; Panza,
   Francesco/M-6804-2017; lozupone, madia/F-7262-2018
OI Sardone, Rodolfo/0000-0003-1383-1850; Sborgia,
   Giancarlo/0000-0001-7271-0536; Quaranta, Nicola/0000-0001-6214-2336;
   Zupo, Roberta/0000-0001-9885-1185; Lampignano,
   Luisa/0000-0001-9299-3211; Tatoli, Rossella/0000-0002-7891-6057; Panza,
   Francesco/0000-0002-7220-0656; lozupone, madia/0000-0002-1674-9724;
   Bortone, Ilaria/0000-0002-4767-5334; Castellana,
   Fabio/0000-0002-6439-8228
FU Italian Ministry of Health; Apulia Government; Italian Ministry of
   Health under the Studies on Aging Network, at Italian Research Hospitals
   (IRCCS)
FX This study was funded by the Italian Ministry of Health with the
   "Ricerca Corrente 2019" Grant and by the Apulia Government with the
   "Regione Puglia Grant 2018". The Salus in Apulia Study was funded by the
   Apulia Government and Italian Ministry of Health, under the Studies on
   Aging Network, at Italian Research Hospitals (IRCCS).
CR [Anonymous], 1981, Br J Audiol, V15, P213
   Antonelli A, 1970, SPEECH AUDIOMETRY, P130
   Ballestri S, 2016, J GASTROEN HEPATOL, V31, P936, DOI 10.1111/jgh.13264
   Castellana F, 2020, NUTRIENTS, V12, DOI 10.3390/nu12103097
   Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367
   Chalasani N, 2012, AM J GASTROENTEROL, V107, P811, DOI 10.1038/ajg.2012.128
   Collins BH, 2013, LIVER INT, V33, P1175, DOI 10.1111/liv.12202
   Dalton DS, 1998, DIABETES CARE, V21, P1540, DOI 10.2337/diacare.21.9.1540
   Dirchwolf M, 2016, CYTOKINE, V77, P14, DOI 10.1016/j.cyto.2015.10.006
   Evans MB, 2006, OTOL NEUROTOL, V27, P609, DOI 10.1097/01.mao.0000226286.19295.34
   Finch CE., 2011, HDB BIOL AGING, P275, DOI DOI 10.1016/B978-0-12-378638-8.00012-9
   Fransen E, 2008, JARO-J ASSOC RES OTO, V9, P264, DOI 10.1007/s10162-008-0123-1
   Fujioka M, 2006, J NEUROSCI RES, V83, P575, DOI 10.1002/jnr.20764
   Gates GA, 2005, LANCET, V366, P1111, DOI 10.1016/S0140-6736(05)67423-5
   GATES GA, 1993, ARCH OTOLARYNGOL, V119, P156
   Gates GA, 2002, J AM GERIATR SOC, V50, P482, DOI 10.1046/j.1532-5415.2002.50114.x
   Genesca J, 1999, AM J GASTROENTEROL, V94, P169
   Johnston SC, 2005, ARTERIOSCL THROM VAS, V25, P2648, DOI 10.1161/01.ATV.0000189157.88630.d1
   Kabbany MN, 2017, AM J GASTROENTEROL, V112, P581, DOI 10.1038/ajg.2017.5
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kloke J, 2014, Nonparametric statistical methods using R. Chapman and Hall/CRC, P288, DOI DOI 10.1201/B17501
   Koehler EM, 2012, J HEPATOL, V57, P1305, DOI 10.1016/j.jhep.2012.07.028
   Ladrech S, 2007, J NEUROSCI RES, V85, P1970, DOI 10.1002/jnr.21335
   Le Couteur DG, 2008, ANAT REC, V291, P672, DOI 10.1002/ar.20661
   Li S, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4234061
   Liu XZ, 2007, J PATHOL, V211, P188, DOI 10.1002/path.2102
   Lurie Y, 2015, WORLD J GASTROENTERO, V21, P11567, DOI 10.3748/wjg.v21.i41.11567
   Mahrouf-Yorgov M, 2011, REJUV RES, V14, P353, DOI 10.1089/rej.2010.1146
   Martínez-Esparza M, 2015, WORLD J GASTROENTERO, V21, P11522, DOI 10.3748/wjg.v21.i41.11522
   Okano T, 2008, J NEUROSCI RES, V86, P1758, DOI 10.1002/jnr.21625
   Poulose N, 2014, AGING DIS, V5, P101, DOI 10.14336/AD.2014.0500101
   Ratziu V, 2010, J HEPATOL, V53, P372, DOI 10.1016/j.jhep.2010.04.008
   Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370
   Sardone R, 2021, JAMA OTOLARYNGOL, V147, P561, DOI 10.1001/jamaoto.2020.5334
   Sardone R, 2020, OTOLARYNG HEAD NECK, V163, P348, DOI 10.1177/0194599820913635
   Sardone R, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00619
   Schreiner AD, 2021, DIABETES-METAB RES, V37, DOI 10.1002/dmrr.3452
   Shah AG, 2009, CLIN GASTROENTEROL H, V7, P1104, DOI 10.1016/j.cgh.2009.05.033
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Singh S, 2017, GASTROENTEROLOGY, V152, P1544, DOI 10.1053/j.gastro.2017.03.016
   So H, 2007, JARO-J ASSOC RES OTO, V8, P338, DOI 10.1007/s10162-007-0084-9
   Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178
   Tan BTG, 2008, J COMP NEUROL, V509, P167, DOI 10.1002/cne.21729
   Tomczak M, 2014, TRENDS SPORT SCI, V21, DOI DOI 10.1186/S13054-016-1208-6
   Upmeier E, 2011, AGE AGEING, V40, P280, DOI 10.1093/ageing/afq180
   Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669
   Wakabayashi K, 2010, NEUROSCI RES, V66, P345, DOI 10.1016/j.neures.2009.12.008
   Watson N, 2017, AGEING RES REV, V40, P142, DOI 10.1016/j.arr.2017.10.002
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
NR 49
TC 1
Z9 1
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD DEC
PY 2022
VL 11
IS 23
AR 7213
DI 10.3390/jcm11237213
PG 11
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 6Y8AD
UT WOS:000897310400001
PM 36498787
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Chen, TH
AF Chen, T-H
TI GENDER-SPECIFIC EFFECTS OF OBESITY ON ALCOHOLIC LIVER DISEASE IN OLDER
   ADULTS OF DIFFERENT GROUPS AGED 65 AND OVER: A CASECONTROL STUDY
SO APPLIED ECOLOGY AND ENVIRONMENTAL RESEARCH
LA English
DT Article
DE alcoholic liver disease; aging society; gender physiological effects;
   obesity diseases; alcoholism
ID RISK-FACTORS; MANAGEMENT; PREVALENCE; NUTRITION
AB Alcoholic liver disease is a common liver disease caused by chronic alcohol consumption and is categorized into fatty liver, alcoholic hepatitis, and alcoholic cirrhosis. This study aimed to examine the relationship between alcoholic liver disease and overweight in older adults, focusing on age and gender differences The study was designed as a retrospective age-matched case-control study using the Chang Gung Research Database (CGRD). The data of this study were collected from January 1, 2018 to December 31, 2022. The subjects were aged over 65 years old with a primary diagnosis of alcoholic liver disease. The experimental group matched gender and age group to conduct a case- control study with a ratio of 1:2 for the control group. The relationship between overweight and alcoholic liver disease was analyzed by logistic regression. The study found that the prevalence of alcoholic liver disease was significantly higher in male than in female. The prevalence of overweight in male with alcoholic liver disease decreased with age distribution. For female, age did not matter much. However, among female aged 65 to 69 years, those who were overweight were more likely to develop alcoholic liver disease than those who were of normal weight. These findings provide guidance for population-specific prevention and treatment strategies and highlight the importance of weight control in aged 65 and over. Particularly in the aging population, attention to weight control and aging, as well as the development of alcoholic liver disease, may improve patient health and quality of life.
C1 [Chen, T-H] Linkou Chang Gung Mem Hosp, Dept Healthcare Adm, Taoyuan, Taiwan.
C3 Chang Gung Memorial Hospital
RP Chen, TH (corresponding author), Linkou Chang Gung Mem Hosp, Dept Healthcare Adm, Taoyuan, Taiwan.
EM shawn@cgmh.org.tw
CR Abidov M, 2010, DIABETES OBES METAB, V12, P72, DOI 10.1111/j.1463-1326.2009.01132.x
   Agabio R, 2017, CURR MED CHEM, V24, P2661, DOI 10.2174/0929867323666161202092908
   Ahmed T, 2010, CLIN INTERV AGING, V5, P207
   An J., 2022, Sex/Gender-Specific Medicine in the Gastrointestinal Diseases, P197, DOI [10.1007/978-981-19-0120-1_13, DOI 10.1007/978-981-19-0120-1_13]
   Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   Covarrubias AJ, 2021, NAT REV MOL CELL BIO, V22, P119, DOI 10.1038/s41580-020-00313-x
   Després JP, 2009, ARTERIOSCL THROM VAS, V29, P416, DOI 10.1161/ATVBAHA.108.176362
   Ding HR, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1287127
   Dyson J, 2014, J HEPATOL, V60, P110, DOI 10.1016/j.jhep.2013.08.011
   Ebadi M, 2020, ALIMENT PHARM THER, V52, P600, DOI 10.1111/apt.15927
   Ezhilarasan D, 2020, HEPATOB PANCREAT DIS, V19, P429, DOI 10.1016/j.hbpd.2020.03.011
   French MT, 2010, HEALTH ECON, V19, P814, DOI 10.1002/hec.1521
   Johnson TM, 2013, NUTR CLIN PRACT, V28, P15, DOI 10.1177/0884533612469027
   Kamran U, 2020, WORLD J GASTROENTERO, V26, P2916, DOI 10.3748/wjg.v26.i22.2916
   Nielson CM, 2012, J BONE MINER RES, V27, P1, DOI 10.1002/jbmr.1486
   Park SH, 2006, J GASTROEN HEPATOL, V21, P138, DOI 10.1111/j.1440-1746.2005.04086.x
   Saberi B, 2016, J CLIN TRANSL HEPATO, V4, P113, DOI 10.14218/JCTH.2016.00006
   Shida T, 2018, J GASTROENTEROL, V53, P535, DOI 10.1007/s00535-017-1377-3
   Sivakrishnan S., 2019, WORLD J PHARM PHARM, V8, P1385, DOI DOI 10.20959/WJPPS20175-9192
   Stanhope KL, 2016, CRIT REV CL LAB SCI, V53, P52, DOI 10.3109/10408363.2015.1084990
   Torruellas C, 2014, WORLD J GASTROENTERO, V20, P11684, DOI 10.3748/wjg.v20.i33.11684
   Zhou YJ, 2007, WORLD J GASTROENTERO, V13, P6419, DOI 10.3748/wjg.13.6419
NR 22
TC 0
Z9 0
U1 3
U2 3
PU ALOKI Applied Ecological Research and Forensic Inst Ltd
PI Budapest
PA Kassa u. 118, Budapest, HUNGARY
SN 1589-1623
EI 1785-0037
J9 APPL ECOL ENV RES
JI Appl. Ecol. Environ. Res.
PY 2023
VL 21
IS 5
BP 4605
EP 4614
DI 10.15666/aeer/2105_46054614
PG 10
WC Ecology; Environmental Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology
GA Y3XV4
UT WOS:001104638200019
OA gold
DA 2024-02-19
ER

PT J
AU Li, HP
   Zhao, HJ
   Gao, Z
   Song, XL
   Wang, WS
   Yuan, FF
   Feng, YB
   Zhang, YW
   Zhang, JJ
   Zhang, SL
   Jia, L
AF Li, Huaping
   Zhao, Huajie
   Gao, Zheng
   Song, Xinling
   Wang, Wenshuai
   Yuan, Fangfang
   Feng, Yanbo
   Zhang, Yiwen
   Zhang, Jianjun
   Zhang, Shuliang
   Jia, Le
TI The Antioxidant and Anti-Aging Effects of Acetylated Mycelia
   Polysaccharides from Pleurotus djamor
SO MOLECULES
LA English
DT Article
DE acetylated mycelia polysaccharides; Pleurotus djamor; antioxidant
   effects; anti-aging effects
ID OXIDATIVE STRESS; IN-VITRO; ZINC POLYSACCHARIDES; ANTITUMOR; EXTRACT;
   BIOLOGY
AB The present work mainly describes the preparation of acetylated mycelia polysaccharides (AMPS) from Pleurotus djamor and investigates the antioxidant and anti-aging effects in d-galactose-induced aging mice. The optimized procedure indicates the acetyl substitution degree of AMPS is 0.54 +/- 0.04 under the conditions of a reaction time of 56 h, a reaction temperature of 37 degrees C, and 4 mL of added acetic anhydride. The in vitro analysis and in vivo animal experiments indicate that the AMPS could alleviate the aging properties by scavenging the radicals, elevating the enzyme activities, and reducing the lipid contents. As for serum levels, the AMPS can improve the serum biochemical indices and enhance immunological activity. The histopathological observations indicate that the injuries to the liver, kidney, and brain can be remitted by AMPS intervention. The characterization showed that AMPS was one kind of beta-pyranose with the weight-average molecular weights of 3.61 x 10(5) Da and the major monosaccharides of mannose and glucose. The results suggest that AMPS can be used as a dietary supplement and functional food for the prevention of aging and age-related diseases.
C1 [Li, Huaping; Zhang, Shuliang] Dezhou Acad Agr Sci, Dezhou 253015, Peoples R China.
   [Li, Huaping; Zhao, Huajie; Gao, Zheng; Song, Xinling; Wang, Wenshuai; Yuan, Fangfang; Feng, Yanbo; Zhang, Yiwen; Zhang, Jianjun; Jia, Le] Shandong Agr Univ, Coll Life Sci, Tai An 271018, Shandong, Peoples R China.
C3 Shandong Agricultural University
RP Zhang, SL (corresponding author), Dezhou Acad Agr Sci, Dezhou 253015, Peoples R China.; Jia, L (corresponding author), Shandong Agr Univ, Coll Life Sci, Tai An 271018, Shandong, Peoples R China.
EM dzzhshl@126.com; jiale0525@163.com
RI Zhang, Yanchao/JMB-7717-2023; zhan, y/ISA-2807-2023; zhang,
   jian/HPD-1712-2023; wu, yi/JEP-1581-2023; jin, li/IWU-4648-2023; Wang,
   Shuai/JAZ-0277-2023; li, wl/JJC-0768-2023
FU Mushroom Technology System of Shandong Province [SDAIT-07-05]
FX This work was supported by grants from Mushroom Technology System of
   Shandong Province (SDAIT-07-05).
CR Bovera F, 2007, TROP ANIM HEALTH PRO, V39, P265, DOI 10.1007/s11250-007-9008-2
   Chang Yan-fen, 2016, Yaoxue Xuebao, V51, P86, DOI 10.16438/j.0513-4870.2015-0597
   Chen Y, 2014, FOOD CHEM, V156, P279, DOI 10.1016/j.foodchem.2014.01.111
   Connolly MK, 2010, J IMMUNOL, V185, P2200, DOI 10.4049/jimmunol.1000332
   Ding QY, 2016, INT J BIOL MACROMOL, V85, P133, DOI 10.1016/j.ijbiomac.2015.12.058
   Fan Yan-ling, 2015, Zhongguo Zhong Yao Za Zhi, V40, P4229
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Gao Li, 2010, Chinese Journal of Immunology, V26, P901
   Govindan S, 2016, EXP TOXICOL PATHOL, V68, P329, DOI 10.1016/j.etp.2016.04.001
   Huang SZ, 2005, WORLD J GASTROENTERO, V11, P132, DOI 10.3748/wjg.v11.i1.132
   Huangfu JQ, 2013, J AGR FOOD CHEM, V61, P7800, DOI 10.1021/jf402224w
   Jia H.Q., 2018, FOOD IND TECHNOL, V39, P39
   Jin ML, 2012, CARBOHYD POLYM, V89, P713, DOI 10.1016/j.carbpol.2012.04.049
   Kumar A, 2010, FOOD CHEM TOXICOL, V48, P626, DOI 10.1016/j.fct.2009.11.043
   Li SS, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/7298683
   Liang Z.Y., 1996, CHIN J PHARM, V10, P37
   Lin L, 2016, CARBOHYD POLYM, V146, P388, DOI 10.1016/j.carbpol.2016.03.071
   Lin RS, 2012, INT J BIOL MACROMOL, V51, P153, DOI 10.1016/j.ijbiomac.2012.04.011
   Liu M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160799
   Liu X, 2019, J ETHNOPHARMACOL, V234, P36, DOI 10.1016/j.jep.2019.01.008
   Ma LS, 2012, CARBOHYD POLYM, V89, P371, DOI 10.1016/j.carbpol.2012.03.016
   Metwally Ibrahim Samah E L, 2018, Pathophysiology, V25, P307, DOI 10.1016/j.pathophys.2018.05.001
   Miao SS, 2013, INT J BIOL MACROMOL, V60, P235, DOI 10.1016/j.ijbiomac.2013.05.033
   [莫睿 Mo Rui], 2017, [解放军医学杂志, Medical Journal of Chinese People's Liberation Army], V42, P743
   Mu XY, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/3508907
   Pan C.Y., 2013, 2 MIL MED U ACAD J, V32, P349, DOI [10.3724/SP.J.1008.2012.00349, DOI 10.3724/SP.J.1008.2012.00349]
   Pang F., 2017, AUG FIR LAND RECLAM, V29, P42
   Peng XB, 2010, INT J BIOL MACROMOL, V47, P304, DOI 10.1016/j.ijbiomac.2010.03.018
   Rui X, 2017, FOOD FUNCT, V8, P1323, DOI [10.1039/c6fo01656a, 10.1039/C6FO01656A]
   Sies H, 2015, REDOX BIOL, V4, P180, DOI 10.1016/j.redox.2015.01.002
   SMIRNOFF N, 1989, PHYTOCHEMISTRY, V28, P1057, DOI 10.1016/0031-9422(89)80182-7
   Song XL, 2018, INT J BIOL MACROMOL, V114, P979, DOI 10.1016/j.ijbiomac.2018.04.001
   Song Y, 2013, CARBOHYD POLYM, V98, P686, DOI 10.1016/j.carbpol.2013.06.049
   Spada TC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205791
   Su J, 2016, INT J BIOL MACROMOL, V87, P597, DOI 10.1016/j.ijbiomac.2016.03.022
   Sun T, 2005, FOOD CHEM, V90, P743, DOI 10.1016/j.foodchem.2004.04.035
   Takeda M, 2018, INT J BIOL MACROMOL, V109, P323, DOI 10.1016/j.ijbiomac.2017.12.065
   Tao YZ, 2009, INT J BIOL MACROMOL, V45, P109, DOI 10.1016/j.ijbiomac.2009.04.010
   Wasser SP, 2002, APPL MICROBIOL BIOT, V60, P258, DOI 10.1007/s00253-002-1076-7
   Yan LJ, 2014, REDOX BIOL, V2, P165, DOI 10.1016/j.redox.2014.01.002
   [杨春瑜 Yang Chunyu], 2015, [食品工业科技, Science & Technology of Food Industry], V36, P105
   Yuan HM, 2005, CARBOHYD RES, V340, P685, DOI 10.1016/j.carres.2004.12.026
   Zeng WC, 2012, CARBOHYD POLYM, V89, P694, DOI 10.1016/j.carbpol.2012.03.078
   Zhang C, 2017, INT J BIOL MACROMOL, V95, P778, DOI 10.1016/j.ijbiomac.2016.12.003
   Zhang JJ, 2016, CARBOHYD POLYM, V136, P588, DOI 10.1016/j.carbpol.2015.09.075
   Zhang Wei, 2007, Wei Sheng Yan Jiu, V36, P164
   Zhang ZF, 2013, CARBOHYD POLYM, V98, P1524, DOI 10.1016/j.carbpol.2013.07.052
   Zhao HJ, 2016, CARBOHYD POLYM, V151, P1227, DOI 10.1016/j.carbpol.2016.06.058
   Zhu XY, 2016, BRAIN RES BULL, V124, P295, DOI 10.1016/j.brainresbull.2016.06.010
NR 49
TC 16
Z9 19
U1 1
U2 21
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD AUG
PY 2019
VL 24
IS 15
AR 2698
DI 10.3390/molecules24152698
PG 20
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA IS9AP
UT WOS:000482441100021
PM 31344969
OA gold, Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Schmelzer, C
   Kubo, H
   Mori, M
   Sawashita, J
   Kitano, M
   Hosoe, K
   Boomgaarden, I
   Döring, F
   Higuchi, K
AF Schmelzer, Constance
   Kubo, Hiroshi
   Mori, Masayuki
   Sawashita, Jinko
   Kitano, Mitsuaki
   Hosoe, Kazunori
   Boomgaarden, Inka
   Doering, Frank
   Higuchi, Keiichi
TI Supplementation with the reduced form of Coenzyme Q<sub>10</sub>
   decelerates phenotypic characteristics of senescence and induces a
   peroxisome proliferator-activated receptor-α gene expression signature
   in SAMP1 mice
SO MOLECULAR NUTRITION & FOOD RESEARCH
LA English
DT Article
DE CoQ(10); Gene expression; Inflammation; Lipid metabolism; Peroxisome
   proliferator-activated receptor-alpha
ID PPAR-ALPHA; MURINE MODEL; TNF-ALPHA; Q PREVENTS; VITAMIN-E; MOUSE; RAT;
   METABOLISM; PLASMA; CHOLESTEROL
AB Our present study reveals significant decelerating effects on senescence processes in middle-aged SAMP1 mice supplemented for 6 or 14 months with the reduced form (Q(10)H(2), 500 mg/kg BW/day) of coenzyme Q(10) (CoQ(10)). To unravel molecular mechanisms of these CoQ(10) effects, a genome-wide transcript profiling in liver, heart, brain and kidney of SAMP1 mice supplemented with the reduced (Q(10)H(2)) or oxidized form of CoQ(10) (Q(10)) was performed. Liver seems to be the main target tissue of CoQ(10) intervention, followed by kidney, heart and brain. Stringent evaluation of the resulting data revealed that Q(10)H(2) has a stronger impact on gene expression than Q(10), primarily due to differences in the bioavailability. Indeed, Q(10)H(2) supplementation was more effective than Q(10) to increase levels of CoQ(10) in the liver of SAMP1 mice. To identify functional and regulatory connections of the "top 50" (p<0.05) Q(10)H(2)-sensitive transcripts in liver, text mining analysis was used. Hereby, we identified Q(10)H(2)-sensitive genes which are regulated by peroxisome proliferator-activated receptor-alpha and are primarily involved in cholesterol synthesis (e.g. HMGCS1, HMGCL and HMGCR), fat assimilation (FABP5), lipoprotein metabolism (PLTP) and inflammation (STAT-1). These data may explain, at least in part, the decelerating effects on degenerative processes observed in Q(10)H(2)-supplemented SAMP1 mice.
C1 [Schmelzer, Constance; Boomgaarden, Inka; Doering, Frank] Univ Kiel, Inst Human Nutr & Food Sci, D-24118 Kiel, Germany.
   [Kubo, Hiroshi; Kitano, Mitsuaki] Kaneka Corp, Frontier Biochem Lab, Takasago, Hyogo, Japan.
   [Kubo, Hiroshi; Kitano, Mitsuaki] Kaneka Corp, Med Res Lab, Takasago, Hyogo, Japan.
   [Mori, Masayuki; Sawashita, Jinko; Higuchi, Keiichi] Shinshu Univ, Grad Sch Med, Inst Aging & Adaptat, Dept Aging Biol, Matsumoto, Nagano 390, Japan.
   [Hosoe, Kazunori] Kaneka Corp, Funct Food Ingredients Div, Osaka, Japan.
C3 University of Kiel; Kaneka Corporation; Kaneka Corporation; Shinshu
   University; Kaneka Corporation
RP Döring, F (corresponding author), Univ Kiel, Inst Human Nutr & Food Sci, Heinrich Hecht Pl 10, D-24118 Kiel, Germany.
EM sek@molprev.uni-kiel.de
RI Döring, Frank/E-9483-2010
OI Sawashita, Jinko/0000-0001-8016-6649
FU Grants-in-Aid for Scientific Research [21650097] Funding Source: KAKEN
CR Bello RI, 2005, EXP GERONTOL, V40, P694, DOI 10.1016/j.exger.2005.07.003
   Beyer RE, 1996, P NATL ACAD SCI USA, V93, P2528, DOI 10.1073/pnas.93.6.2528
   Carmona MC, 2009, INT J OBESITY, V33, P204, DOI 10.1038/ijo.2008.265
   Chiba Y, 2009, NEUROCHEM RES, V34, P679, DOI 10.1007/s11064-008-9812-8
   Chinetti G, 2000, INFLAMM RES, V49, P497, DOI 10.1007/s000110050622
   Cook WS, 2000, BIOCHEM BIOPH RES CO, V278, P250, DOI 10.1006/bbrc.2000.3739
   Costet P, 1998, J BIOL CHEM, V273, P29577, DOI 10.1074/jbc.273.45.29577
   Cummins CL, 2006, BIOCHEM SOC T, V34, P1110, DOI 10.1042/BST0341110
   Cuzzocrea S, 2006, J LEUKOCYTE BIOL, V79, P999, DOI 10.1189/jlb.0605341
   Delayre-Orthez C, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-91
   Farooqui T, 2009, MECH AGEING DEV, V130, P203, DOI 10.1016/j.mad.2008.11.006
   Fusco D, 2007, CLIN INTERV AGING, V2, P377
   Galinier A, 2004, FEBS LETT, V578, P53, DOI 10.1016/j.febslet.2004.10.067
   Gelinas DS, 2005, NEUROCHEM RES, V30, P1369, DOI 10.1007/s11064-005-8341-y
   Gervois P, 2000, CLIN CHEM LAB MED, V38, P3, DOI 10.1515/CCLM.2000.002
   Groneberg DA, 2005, INT J BIOCHEM CELL B, V37, P1208, DOI 10.1016/j.biocel.2004.11.017
   Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593
   Hosokawa M, 2002, MECH AGEING DEV, V123, P1553, DOI 10.1016/S0047-6374(02)00091-X
   HOSOKAWA M, 1984, MECH AGEING DEV, V26, P91, DOI 10.1016/0047-6374(84)90168-4
   HUA XX, 1995, GENOMICS, V25, P667, DOI 10.1016/0888-7543(95)80009-B
   Ide T, 2003, MOL ENDOCRINOL, V17, P1255, DOI 10.1210/me.2002-0191
   Kaikkonen J, 2002, FREE RADICAL RES, V36, P389, DOI 10.1080/10715760290021234
   KALEN A, 1989, LIPIDS, V24, P579, DOI 10.1007/BF02535072
   Kaliora AC, 2006, ATHEROSCLEROSIS, V187, P1, DOI 10.1016/j.atherosclerosis.2005.11.001
   Kamzalov S, 2004, EXP GERONTOL, V39, P1199, DOI 10.1016/j.exger.2004.04.007
   König B, 2007, BIOCHEM PHARMACOL, V73, P574, DOI 10.1016/j.bcp.2006.10.027
   Kunitomo M, 2008, J PHARMACOL SCI, V107, P128, DOI 10.1254/jphs.FP0072365
   Lankin VZ, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1081, DOI 10.1134/S0006297907100069
   Lankin VZ, 2003, MOL CELL BIOCHEM, V249, P129, DOI 10.1023/A:1024742907379
   Lee JH, 2005, NEUROREPORT, V16, P829
   Littarru GP, 2007, MITOCHONDRION, V7, pS168, DOI 10.1016/j.mito.2007.03.002
   Navarro F, 1998, FASEB J, V12, P1665, DOI 10.1096/fasebj.12.15.1665
   NAVARRO F, 1995, BIOCHEM BIOPH RES CO, V212, P138, DOI 10.1006/bbrc.1995.1947
   Novo E, 2008, FIBROGENESIS TISSUE, V1, DOI 10.1186/1755-1536-1-5
   Osborne TF, 2000, J BIOL CHEM, V275, P32379, DOI 10.1074/jbc.R000017200
   Pich MM, 2002, FREE RADICAL RES, V36, P429, DOI 10.1080/10715760290021289
   Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900
   Scherf M, 2005, BRIEF BIOINFORM, V6, P287, DOI 10.1093/bib/6.3.287
   Schmelzer C, 2009, J CLIN BIOCHEM NUTR, V44, P62, DOI 10.3164/jcbn.08-182
   Schmelzer C, 2007, BIOFACTORS, V31, P35, DOI 10.1002/biof.5520310104
   Schmelzer C, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/415437
   Schmelzer C, 2007, BIOFACTORS, V31, P211, DOI 10.1002/biof.5520310308
   Schoonjans K, 1996, J LIPID RES, V37, P907
   Shimomura I, 1998, J BIOL CHEM, V273, P35299, DOI 10.1074/jbc.273.52.35299
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   Takeda T, 1997, EXP GERONTOL, V32, P105, DOI 10.1016/S0531-5565(96)00036-8
   TAKEDA T, 1994, ARCH GERONTOL GERIAT, V19, P185, DOI 10.1016/0167-4943(94)90039-6
   Thomas SR, 1996, ARTERIOSCL THROM VAS, V16, P687, DOI 10.1161/01.ATV.16.5.687
   Thomas SR, 2001, ARTERIOSCL THROM VAS, V21, P585, DOI 10.1161/01.ATV.21.4.585
   VALLS V, 1994, BIOCHEM MOL BIOL INT, V33, P633
   Vasiliou Vasilis, 2006, Human Genomics, V2, P329
   Yamashita S, 1997, ANAL BIOCHEM, V250, P66, DOI 10.1006/abio.1997.2187
   Yan J, 2006, EXP GERONTOL, V41, P130, DOI 10.1016/j.exger.2005.11.007
   Zambon A, 2006, ARTERIOSCL THROM VAS, V26, P977, DOI 10.1161/01.ATV.0000204327.96431.9a
NR 54
TC 41
Z9 43
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1613-4125
EI 1613-4133
J9 MOL NUTR FOOD RES
JI Mol. Nutr. Food Res.
PD JUN
PY 2010
VL 54
IS 6
BP 805
EP 815
DI 10.1002/mnfr.200900155
PG 11
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA 619IK
UT WOS:000279423400007
PM 19960455
DA 2024-02-19
ER

PT J
AU CAPUTI, M
   MELO, CA
   BARALLE, FE
AF CAPUTI, M
   MELO, CA
   BARALLE, FE
TI REGULATION OF FIBRONECTIN EXPRESSION IN RAT REGENERATING LIVER
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID PRE-MESSENGER-RNA; CELLULAR FIBRONECTIN; MOLECULAR-BIOLOGY;
   GENE-EXPRESSION; CELLS; GROWTH; EXON; PATTERNS; EMBRYOS; HEART
AB Fibronectin (FN) expression displays a complex regulation that results in precisely defined isoform patterns during different developmental stages, ageing and injury. The qualitative and quantitative changes that are observed derive from modulation of the rate of transcription of the single FN pre-mRNA and its specific differential processing in the EIIIA, EIIIB and V regions of rat FN. The liver is the major source of plasma FN which is characterised by the absence of the EIIIA and EIIIB exons. Here we show that in the rat regenerating liver there is a significant reprogramming of the splicing machinery that results in the synthesis by the liver of up to 17% of EIIIA+ FN linked with all the three V forms. On the other hand the EIIIB+ form is totally absent both in normal and regenerating liver. Furthermore there is a variation of the V pattern observed in the regenerating tissue, the V120 form (linked to both EIIIA+ and EIIIA- messengers) increases from 11 to 32%. The quantitative RT-PCR method was used to estimate the FN transcription rate, before and after partial hepatectomy. We have shown a 3-fold increase in FN mRNA in liver that is specifically linked to the regeneration process and not to the surgical stress.
C1 INT CTR GENET ENGN & BIOTECHNOL, UNIDO, I-34012 TRIESTE, ITALY.
C3 International Center for Genetic Engineering & Biotechnology (ICGEB)
OI Baralle, Francisco/0000-0002-4645-2809
CR BARONE MV, 1989, EMBO J, V8, P1079, DOI 10.1002/j.1460-2075.1989.tb03476.x
   BERNATH VA, 1990, J BIOL CHEM, V265, P18219
   CAPUTI M, 1994, NUCLEIC ACIDS RES, V22, P1018, DOI 10.1093/nar/22.6.1018
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   DEAN DC, 1988, J CELL BIOL, V106, P2159, DOI 10.1083/jcb.106.6.2159
   FFRENCHCONSTANT C, 1988, DEVELOPMENT, V104, P369
   FFRENCHCONSTANT C, 1989, J CELL BIOL, V109, P909
   GILLILAND G, 1990, PCR PROTOCOLS GUIDE
   GUTMAN A, 1987, P NATL ACAD SCI USA, V84, P7179, DOI 10.1073/pnas.84.20.7179
   HUH GS, 1993, MOL CELL BIOL, V13, P5301, DOI 10.1128/MCB.13.9.5301
   HYNES R, 1985, ANNU REV CELL BIOL, V1, P67, DOI 10.1146/annurev.cb.01.110185.000435
   INGBER DE, 1990, J CELL BIOL, V110, P1803, DOI 10.1083/jcb.110.5.1803
   KNOWLTON AA, 1992, J CLIN INVEST, V89, P1060, DOI 10.1172/JCI115685
   KORNBLIHTT AR, 1983, P NATL ACAD SCI-BIOL, V80, P3218, DOI 10.1073/pnas.80.11.3218
   KORNBLIHTT AR, 1988, BIOL REV, V63, P465, DOI 10.1111/j.1469-185X.1988.tb00668.x
   KORNBLIHTT AR, 1985, EMBO J, V4, P1755, DOI 10.1002/j.1460-2075.1985.tb03847.x
   LOCKWOOD CJ, 1991, NEW ENGL J MED, V325, P669, DOI 10.1056/NEJM199109053251001
   MAGNUSON VL, 1991, J BIOL CHEM, V266, P14654
   MAMUYA WS, 1992, J CLIN INVEST, V89, P392, DOI 10.1172/JCI115598
   MENZO S, 1992, J CLIN MICROBIOL, V30, P1752, DOI 10.1128/JCM.30.7.1752-1757.1992
   MURATA Y, 1990, MOL ENDOCRINOL, V4, P693, DOI 10.1210/mend-4-5-693
   MURPHYULLRICH JE, 1986, CONNECTIVE TISSUE DI, P455
   NORTON PA, 1987, MOL CELL BIOL, V7, P4297, DOI 10.1128/MCB.7.12.4297
   ODENTHAL M, 1992, EXP CELL RES, V203, P289, DOI 10.1016/0014-4827(92)90001-O
   OYAMA F, 1989, BIOCHEMISTRY-US, V28, P1428, DOI 10.1021/bi00429a072
   PAGANI F, 1991, J CELL BIOL, V113, P1223, DOI 10.1083/jcb.113.5.1223
   PATEL RS, 1987, EMBO J, V6, P2565, DOI 10.1002/j.1460-2075.1987.tb02545.x
   RAMADORI G, 1992, GASTROENTEROLOGY, V103, P1313, DOI 10.1016/0016-5085(92)91522-6
   SAKAMAKI K, 1989, J BIOL CHEM, V264, P16828
   Sambrook J., 1989, MOL CLONING LABORATO, V2nd
   SCHWARTZ MA, 1991, EXP CELL RES, V195, P533, DOI 10.1016/0014-4827(91)90407-L
   WAYNFORTH HB, 1992, EXPT SURGICAL TECHNI
   Yamada KM, 1989, FIBRONECTIN, P47
   ZARDI L, 1987, EMBO J, V6, P2337, DOI 10.1002/j.1460-2075.1987.tb02509.x
NR 34
TC 31
Z9 38
U1 0
U2 0
PU OXFORD UNIV PRESS UNITED KINGDOM
PI OXFORD
PA WALTON ST JOURNALS DEPT, OXFORD, ENGLAND OX2 6DP
SN 0305-1048
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JAN 25
PY 1995
VL 23
IS 2
BP 238
EP 243
DI 10.1093/nar/23.2.238
PG 6
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA QJ418
UT WOS:A1995QJ41800007
PM 7862527
OA Green Published
DA 2024-02-19
ER

PT J
AU Garrido, A
   Cruces, J
   Ceprián, N
   Corpas, I
   Tresguerres, JA
   De la Fuente, M
AF Garrido, Antonio
   Cruces, Julia
   Ceprian, Noemi
   Corpas, Isabel
   Tresguerres, Jesus A.
   De la Fuente, Monica
TI Social environment improves immune function and redox state in several
   organs from prematurely aging female mice and increases their lifespan
SO BIOGERONTOLOGY
LA English
DT Article
DE Social environment; Prematurely aging mice; Immunosenescence; Oxidative
   stress balance; Lifespan
ID OXIDATIVE STRESS; PSYCHOLOGICAL STRESS; GUT MICROBIOTA;
   CLINICAL-RELEVANCE; INNATE IMMUNITY; BIOLOGICAL AGE; STYLE FACTORS; 2
   STRAINS; T-CELL; SYSTEM
AB Aging is associated with a chronic oxidative stress (increase of oxidants and decrease of antioxidants), which contributes to immunosenescence and therefore shorter longevity. Nevertheless, a positive social network has been related to the adequate maintenance of health and deceleration of aging. Adult prematurely aging mice (PAM) are characterized by their inadequate stress response to a T-maze, showing premature immunosenescence and oxidative stress establishment. These impairments contribute to shorter life spans in comparison to exceptional non-PAM (ENPAM). However, it is not known whether these characteristics of PAM could be prevented by a positive cohabitation. Therefore, the aim of the present work was to determine if the premature immunosenescence and oxidative stress shown by PAM could be avoided by the cohabitation with ENPAM, increasing their life span. Female CD1 PAM and ENPAM were divided into three experimental groups: PAM controls, ENPAM controls and a social environment experimental group, containing in the same cage ENPAM and PAM (proportion 5/2, respectively). After 2months, mice were sacrificed and spleen, thymus, liver and heart removed. Later, several immune functions as well as oxidative stress parameters were assessed in spleen and thymus leukocytes. Also, several oxidative stress parameters were analyzed in liver and heart. The results showed that PAM, after co-housing with ENPAM, had improved immune functions and redox balance in spleen and thymus leukocytes. This improvement of redox state was also observed in liver and heart. Furthermore, all these positive effects seem to be related to the increased life span of PAM.
C1 [Garrido, Antonio; Cruces, Julia; Ceprian, Noemi; Corpas, Isabel; De la Fuente, Monica] Complutense Univ Madrid UCM, Fac Biol, Anim Physiol Unit, Dept Genet Physiol & Microbiol, C Jose Antonio Novais 12, Madrid 28040, Spain.
   [Garrido, Antonio; Cruces, Julia; Ceprian, Noemi; De la Fuente, Monica] Hosp 12 Octubre I 12, Inst Invest, Madrid, Spain.
   [Tresguerres, Jesus A.] Complutense Univ Madrid UCM, Fac Med, Dept Physiol, Av Complutense S-N, Madrid 28040, Spain.
C3 Complutense University of Madrid; Hospital Universitario 12 de Octubre;
   Complutense University of Madrid
RP Garrido, A (corresponding author), Complutense Univ Madrid UCM, Fac Biol, Anim Physiol Unit, Dept Genet Physiol & Microbiol, C Jose Antonio Novais 12, Madrid 28040, Spain.
EM antoniogarridobio@gmail.com
RI DE LA FUENTE, MONICA/ABG-6991-2020; Ceprian, Noemi/S-5661-2018
OI Ceprian, Noemi/0000-0001-7028-3083; De la Fuente,
   Monica/0000-0002-5969-097X; Cruces, Julia/0009-0004-5536-9814; Garrido,
   Antonio/0000-0003-3026-3330
FU Grants of the Research Group of UCM [910379]; FIS from the ISCIII-FEDER
   of the European Union [PI15/01787]
FX This work was supported by the Grants of the Research Group of UCM
   (910379) and FIS (PI15/01787) from the ISCIII-FEDER of the European
   Union.
CR Alexander AD, 2006, MAMM GENOME, V17, P1093, DOI 10.1007/s00335-006-0063-1
   Alvarado C, 2006, DEV COMP IMMUNOL, V30, P1168, DOI 10.1016/j.dci.2006.03.004
   Alvarado C, 2006, NUTRITION, V22, P767, DOI 10.1016/j.nut.2006.05.007
   Arranz L, 2010, REJUV RES, V13, P415, DOI 10.1089/rej.2009.0989
   Arranz L, 2010, J GERONTOL A-BIOL, V65, P941, DOI 10.1093/gerona/glq101
   Baeza I, 2010, J NEUROIMMUNOL, V219, P90, DOI 10.1016/j.jneuroim.2009.12.008
   Bauer ME, 2016, MECH AGEING DEV, V158, P27, DOI 10.1016/j.mad.2016.01.001
   Bauer ME, 2008, NEUROIMMUNOMODULAT, V15, P241, DOI 10.1159/000156467
   BEERS RF, 1952, J BIOL CHEM, V195, P133
   Beery AK, 2015, NEUROBIOL STRESS, V1, P116, DOI 10.1016/j.ynstr.2014.10.004
   Benaroya-Milshtein N, 2004, EUR J NEUROSCI, V20, P1341, DOI 10.1111/j.1460-9568.2004.03587.x
   Besedovsky HO, 2007, BRAIN BEHAV IMMUN, V21, P34, DOI 10.1016/j.bbi.2006.09.008
   BORKAN GA, 1980, J GERONTOL, V35, P177, DOI 10.1093/geronj/35.2.177
   BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453
   Bugajski J, 1999, J PHYSIOL PHARMACOL, V50, P367
   Bulpitt Christopher J, 2009, Curr Aging Sci, V2, P193
   Castle SC, 2000, CLIN INFECT DIS, V31, P578, DOI 10.1086/313947
   Cheng YJ, 2017, AGING-US, V9, P1359, DOI 10.18632/aging.101232
   Cohen S, 2007, JAMA-J AM MED ASSOC, V298, P1685, DOI 10.1001/jama.298.14.1685
   Cruces J, 2014, CURR PHARM DESIGN, V20, P4608
   Cutler RG, 2005, REJUV RES, V8, P138, DOI 10.1089/rej.2005.8.138
   De la Fuente M, 2004, CELL MOL BIOL, V50, P683, DOI 10.1170/82
   De la Fuente M, 1998, MECH AGEING DEV, V104, P213, DOI 10.1016/S0047-6374(98)00071-2
   De la Fuente M, 2009, CURR PHARM DESIGN, V15, P3003, DOI 10.2174/138161209789058110
   De la Fuente M, 2011, CURR PHARM DESIGN, V17, P3966, DOI 10.2174/138161211798764861
   De Martinis M, 2006, EXP MOL PATHOL, V80, P219, DOI 10.1016/j.yexmp.2005.11.004
   De Palma G, 2014, J NEUROIMMUNOL, V276, P47, DOI 10.1016/j.jneuroim.2014.08.007
   DelaRosa O, 2006, BIOGERONTOLOGY, V7, P471, DOI 10.1007/s10522-006-9062-6
   DELRIO M, 1994, PEPTIDES, V15, P15, DOI 10.1016/0196-9781(94)90164-3
   Detillion CE, 2004, PSYCHONEUROENDOCRINO, V29, P1004, DOI 10.1016/j.psyneuen.2003.10.003
   DeVries AC, 2002, HORM BEHAV, V41, P405, DOI 10.1006/hbeh.2002.1780
   Dröge W, 2003, ADV EXP MED BIOL, V543, P191
   Enns LC, 2008, CRIT REV EUKAR GENE, V18, P81, DOI 10.1615/CritRevEukarGeneExpr.v18.i1.60
   Feldman N, 2015, AGEING RES REV, V24, P29, DOI 10.1016/j.arr.2015.01.003
   FERGUSON FG, 1995, J GERONTOL A-BIOL, V50, pB378, DOI 10.1093/gerona/50A.6.B378
   Ferrández MD, 1999, EXP GERONTOL, V34, P675, DOI 10.1016/S0531-5565(99)00009-1
   Finkel JC, 2006, ANESTHESIOLOGY, V105, P360, DOI 10.1097/00000542-200608000-00020
   Foster JA, 2017, NEUROBIOL STRESS, V7, P124, DOI 10.1016/j.ynstr.2017.03.001
   Fulop T, 2004, AGING CELL, V3, P217, DOI 10.1111/j.1474-9728.2004.00110.x
   Garrido A, 2018, BRAIN BEHAV IMMUN, V69, P440, DOI 10.1016/j.bbi.2018.01.003
   Garrido A, 2018, J GERONTOL A-BIOL, V73, P873, DOI 10.1093/gerona/gly043
   Garrido Antonio, 2017, Rev Esp Geriatr Gerontol, V52, P20, DOI 10.1016/j.regg.2016.01.002
   Geuking MB, 2014, GUT MICROBES, V5, P411, DOI 10.4161/gmic.29330
   Glasper ER, 2005, BRAIN BEHAV IMMUN, V19, P61, DOI 10.1016/j.bbi.2004.03.002
   Gouin JP, 2008, NEUROIMMUNOMODULAT, V15, P251, DOI 10.1159/000156468
   Gruver AL, 2007, J PATHOL, V211, P144, DOI 10.1002/path.2104
   GUAN XB, 1994, BEHAV BRAIN RES, V61, P87, DOI 10.1016/0166-4328(94)90011-6
   Guayerbas N, 2003, DEV COMP IMMUNOL, V27, P339, DOI 10.1016/S0145-305X(02)00103-9
   Guayerbas N, 2002, CLIN EXP PHARMACOL P, V29, P1009, DOI 10.1046/j.1440-1681.2002.03758.x
   Guayerbas N, 2002, BEHAV BRAIN RES, V134, P41, DOI 10.1016/S0166-4328(01)00449-1
   HALLGREN HM, 1988, MECH AGEING DEV, V43, P175, DOI 10.1016/0047-6374(88)90045-0
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   Hashimoto Y, 2006, BRIT J DERMATOL, V154, P28, DOI 10.1111/j.1365-2133.2005.06879.x
   Hazeldine J, 2015, BIOGERONTOLOGY, V16, P187, DOI 10.1007/s10522-014-9514-3
   Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108
   Hildebrand F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r4
   HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2
   Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316
   Hufeldt MR, 2010, COMPARATIVE MED, V60, P336
   Irie M, 2001, JPN J CANCER RES, V92, P367, DOI 10.1111/j.1349-7006.2001.tb01104.x
   Johansson SE, 1999, INT J EPIDEMIOL, V28, P1073, DOI 10.1093/ije/28.6.1073
   Kand'ár R, 2016, BIOMED CHROMATOGR, V30, P13, DOI 10.1002/bmc.3529
   Kasapoglu M, 2001, EXP GERONTOL, V36, P209, DOI 10.1016/S0531-5565(00)00198-4
   Kumar Manish, 2016, Nutr Healthy Aging, V4, P3, DOI 10.3233/NHA-150002
   Lutgendorf SK, 2005, J CLIN ONCOL, V23, P7105, DOI 10.1200/JCO.2005.10.015
   Maffei VJ, 2017, J GERONTOL A-BIOL, V72, P1474, DOI 10.1093/gerona/glx042
   Martinez de Toda I, 2018, J GERONTOL A
   de Toda IM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071598
   de Toda IM, 2016, AGING-US, V8, P3110, DOI 10.18632/aging.101116
   Miller RA, 1996, SCIENCE, V273, P70, DOI 10.1126/science.273.5271.70
   Molarius A, 2007, EUR J PUBLIC HEALTH, V17, P125, DOI 10.1093/eurpub/ckl070
   Moller P, 1996, CHEM-BIOL INTERACT, V102, P17, DOI 10.1016/0009-2797(96)03729-5
   Morgulis MSFA, 2004, NEUROIMMUNOMODULAT, V11, P49, DOI 10.1159/000072969
   Osada K, 2003, P ROY SOC B-BIOL SCI, V270, P929, DOI 10.1098/rspb.2002.2308
   Palermo-Neto J, 2014, CURR PHARM DESIGN, V20, P4629
   Pawelec G, 1997, MECH AGEING DEV, V93, P35, DOI 10.1016/S0047-6374(96)01812-X
   Pawelec G, 2002, FRONT BIOSCI-LANDMRK, V7, pD1056
   Plowden J, 2004, AGING CELL, V3, P161, DOI 10.1111/j.1474-9728.2004.00102.x
   Rikans LE, 1997, BBA-MOL BASIS DIS, V1362, P116, DOI 10.1016/S0925-4439(97)00067-7
   Russo SJ, 2012, NAT NEUROSCI, V15, P1475, DOI 10.1038/nn.3234
   Salchner P, 2004, BEHAV BRAIN RES, V151, P1, DOI 10.1016/j.bbr.2003.07.002
   Salminen A, 2008, AGEING RES REV, V7, P83, DOI 10.1016/j.arr.2007.09.002
   Saxton KB, 2011, BRAIN BEHAV IMMUN, V25, P1617, DOI 10.1016/j.bbi.2011.05.010
   Seeman TE, 2001, ANN NY ACAD SCI, V954, P88
   Sharon G, 2016, CELL, V167, P915, DOI 10.1016/j.cell.2016.10.027
   SOHAL RS, 1994, MECH AGEING DEV, V76, P215, DOI 10.1016/0047-6374(94)91595-4
   Solana R, 2012, SEMIN IMMUNOL, V24, P331, DOI 10.1016/j.smim.2012.04.008
   Takeda T, 2009, NEUROCHEM RES, V34, P639, DOI 10.1007/s11064-009-9922-y
   Tiihonen K, 2010, AGEING RES REV, V9, P107, DOI 10.1016/j.arr.2009.10.004
   Tu WJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02111
   Turner VM, 2017, IMMUNOLOGY, V151, P349, DOI 10.1111/imm.12737
   Uchino BN, 2006, J BEHAV MED, V29, P377, DOI 10.1007/s10865-006-9056-5
   Vida C, 2017, REDOX BIOL, V12, P423, DOI 10.1016/j.redox.2017.03.005
   Vida C, 2011, J PHYSIOL BIOCHEM, V67, P551, DOI 10.1007/s13105-011-0100-8
   Viveros MP, 2007, NEUROIMMUNOMODULAT, V14, P157, DOI 10.1159/000110640
   WAYNE SJ, 1990, J GERONTOL, V45, pM45, DOI 10.1093/geronj/45.2.M45
   Weinberger B, 2017, CLIN EXP IMMUNOL, V187, P1, DOI 10.1111/cei.12879
   Weyand CM, 2016, ANN AM THORAC SOC, V13, pS422, DOI 10.1513/AnnalsATS.201602-095AW
NR 98
TC 9
Z9 10
U1 0
U2 14
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD FEB
PY 2019
VL 20
IS 1
BP 49
EP 69
DI 10.1007/s10522-018-9774-4
PG 21
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA HG2FK
UT WOS:000454778400004
PM 30255225
DA 2024-02-19
ER

PT J
AU Mladenovic, D
   Radosavljevic, T
   Hrncic, D
   Rasic-Markovic, A
   Stanollovic, O
AF Mladenovic, Dusan
   Radosavljevic, Tatjana
   Hrncic, Dragan
   Rasic-Markovic, Aleksandra
   Stanollovic, Olivera
TI The effects of dietary methionine restriction on the function and
   metabolic reprogramming in the liver and brain - implications for
   longevity
SO REVIEWS IN THE NEUROSCIENCES
LA English
DT Article
DE brain; liver; longevity; metabolic changes; methionine restriction;
   oxidative stress
ID CHOLINE-DEFICIENT DIET; PROTEIN-KINASE GCN2; CENTRAL-NERVOUS-SYSTEM;
   FATTY-ACID-METABOLISM; LIFE-SPAN; OXIDATIVE STRESS; HEPATIC STEATOSIS;
   SUPPLEMENTATION REVERSES; INSULIN SENSITIVITY; CALORIC RESTRICTION
AB Methionine is an essential sulphur-containing amino acid involved in protein synthesis, regulation of protein function and methylation reactions. Dietary methionine restriction (0.12-0.17% methionine in food) extends the life span of various animal species and delays the onset of aging-associated diseases and cancers. In the liver, methionine restriction attenuates steatosis and delays the development of non-alcoholic steatohepatitis due to antioxidative action and metabolic reprogramming. The limited intake of methionine stimulates the fatty acid oxidation in the liver and the export of lipoproteins as well as inhibits de novo lipogenesis. These effects are mediated by various signaling pathways and effector molecules, including sirtuins, growth hormone/insulin-like growth factor-1 axis, sterol regulatory element binding proteins, adenosine monophosphate-dependent kinase and general control nonderepressible 2 pathway. Additionally, methionine restriction stimulates the synthesis of fibroblast growth factor-21 in the liver, which increases the insulin sensitivity of peripheral tissues. In the brain, methionine restriction delays the onset of neurodegenerative diseases and increases the resistance to various forms of stress through antioxidative effects and alterations in lipid composition. This review aimed to summarize the morphological, functional and molecular changes in the liver and brain caused by the methionine restriction, with possible implications in the prolongation of maximal life span.
C1 [Hrncic, Dragan; Rasic-Markovic, Aleksandra; Stanollovic, Olivera] Univ Belgrade, Inst Med Physiol Richard Burian, Fac Med, Visegradska 26-2, Belgrade 11000, Serbia.
   [Mladenovic, Dusan; Radosavljevic, Tatjana] Univ Belgrade, Fac Med, Inst Pathophysiol Ljubodrag Buba Mihailovic, Dr Subotica 9, Belgrade 11000, Serbia.
C3 University of Belgrade; University of Belgrade
RP Stanollovic, O (corresponding author), Univ Belgrade, Inst Med Physiol Richard Burian, Fac Med, Visegradska 26-2, Belgrade 11000, Serbia.
EM solja@afrodita.rcub.bg.ac.rs
RI Rasic-Markovic, Aleksandra/AAT-5675-2021; Rasic Markovic,
   Aleksandra/AAA-9441-2022; Hrncic, Dragan/AAT-2544-2021; Radosavljević,
   Tatjana/AAE-2792-2020
OI Rasic Markovic, Aleksandra/0000-0003-1131-2328; Hrncic,
   Dragan/0000-0003-0806-444X; Radosavljević, Tatjana/0000-0002-1701-3313;
   Mladenovic, Dusan/0000-0002-8921-6232; Stanojlovic,
   Olivera/0000-0001-5317-3827
FU Ministry of Education, Science and Technological Development of Serbia
   [175032]
FX This work was supported by the Ministry of Education, Science and
   Technological Development of Serbia [Grant No 175032].
CR Ables GP, 2016, ANN NY ACAD SCI, V1363, P68, DOI 10.1111/nyas.13014
   Ables GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051357
   Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x
   Anthony TG, 2004, J BIOL CHEM, V279, P36553, DOI 10.1074/jbc.M404559200
   Antosh M, 2011, CELL CYCLE, V10, P904, DOI 10.4161/cc.10.6.14912
   Aoki Y, 2016, J PHARMACOL SCI, V130, P38, DOI 10.1016/j.jphs.2015.12.009
   Arriazu E, 2010, CELL PHYSIOL BIOCHEM, V26, P281, DOI 10.1159/000320551
   Barja G, 2014, PROG MOL BIOL TRANSL, V127, P1, DOI 10.1016/B978-0-12-394625-6.00001-5
   Bauernfeind F, 2016, J IMMUNOL, V197, P2900, DOI 10.4049/jimmunol.1501336
   Berks D, 2015, EUR J OBSTET GYN R B, V194, P199, DOI 10.1016/j.ejogrb.2015.09.021
   Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188
   Bonetti F, 2016, NEURODEGENER DIS MAN, V6, P133, DOI 10.2217/nmt-2015-0008
   Bukharaeva E, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00391
   Calvert S, 2016, AGING CELL, V15, P256, DOI 10.1111/acel.12432
   Caro P, 2009, REJUV RES, V12, P421, DOI 10.1089/rej.2009.0902
   Castellano R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130514
   Castilho BA, 2014, BBA-MOL CELL RES, V1843, P1948, DOI 10.1016/j.bbamcr.2014.04.006
   Chitnis NS, 2012, MOL CELL, V48, P353, DOI 10.1016/j.molcel.2012.08.025
   CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701
   Corbin KD, 2012, CURR OPIN GASTROEN, V28, P159, DOI 10.1097/MOG.0b013e32834e7b4b
   DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G
   Djuric D, 2000, Am J Ther, V7, P381, DOI 10.1097/00045391-200007060-00007
   Durando X, 2008, NUTR CANCER, V60, P23, DOI 10.1080/01635580701525877
   Elshorbagy AK, 2011, J LIPID RES, V52, P104, DOI 10.1194/jlr.M010215
   Fang P, 2014, DIABETES, V63, P4275, DOI 10.2337/db14-0809
   Fang R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163667
   Foretz M, 1998, J BIOL CHEM, V273, P14767, DOI 10.1074/jbc.273.24.14767
   Forney LA, 2017, OBESITY, V25, P730, DOI 10.1002/oby.21806
   Gallinetti J, 2013, BIOCHEM J, V449, P1, DOI 10.1042/BJ20121098
   Gárriz A, 2009, MOL CELL BIOL, V29, P1592, DOI 10.1128/MCB.01446-08
   Gomez A, 2015, J BIOENERG BIOMEMBR, V47, P199, DOI 10.1007/s10863-015-9608-x
   de Carvalho CMRG, 2017, EUR J CLIN NUTR, V71, P434, DOI 10.1038/ejcn.2016.177
   Grant L, 2016, MECH AGEING DEV, V157, P35, DOI 10.1016/j.mad.2016.07.003
   Guéant JL, 2014, PFLUG ARCH EUR J PHY, V466, P833, DOI 10.1007/s00424-013-1339-4
   Guo YJ, 2017, J MOL ENDOCRINOL, V59, P205, DOI 10.1530/JME-16-0179
   Hamilton R, 2016, J NEUROL SCI, V370, P47, DOI 10.1016/j.jns.2016.09.021
   Hasek BE, 2013, DIABETES, V62, P3362, DOI 10.2337/db13-0501
   Hens JR, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2367-1
   Hrncic D, 2016, CAN J PHYSIOL PHARM, V94, P1074, DOI 10.1139/cjpp-2015-0581
   Jeon H, 2016, ONCOTARGET, V7, P67223, DOI 10.18632/oncotarget.11615
   Johnson JI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106014
   Jorgacevic B, 2014, HUM EXP TOXICOL, V33, P701, DOI 10.1177/0960327113506723
   Jové M, 2013, J PROTEOME RES, V12, P2679, DOI 10.1021/pr400064a
   Junnila RK, 2016, ENDOCRINOLOGY, V157, P4502, DOI 10.1210/en.2016-1649
   Korai M, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0634-3
   Kramer P, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00165
   Krishnamoorthy T, 2001, MOL CELL BIOL, V21, P5018, DOI 10.1128/MCB.21.15.5018-5030.2001
   Latimer M, 2017, J EXP BIOL, V220, P2932, DOI 10.1242/jeb.154484
   Latimer MN, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00217
   Leach NV, 2014, EUR J INTERN MED, V25, P762, DOI 10.1016/j.ejim.2014.09.007
   Lee BC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4592
   Lee G, 2017, MUSCLE NERVE, V55, P262, DOI 10.1002/mus.25221
   Lee JW, 2012, J LIPID RES, V53, P1277, DOI 10.1194/jlr.M022897
   Lees EK, 2014, AGING CELL, V13, P817, DOI 10.1111/acel.12238
   Liu H, 2015, TOXICOL LETT, V232, P349, DOI 10.1016/j.toxlet.2014.11.011
   Maddineni S, 2013, EXP BIOL MED, V238, P392, DOI 10.1177/1535370213477988
   Malik R, 2016, BRAIN RES, V1633, P1, DOI 10.1016/j.brainres.2015.12.029
   Malloy VL, 2013, METABOLISM, V62, P1651, DOI 10.1016/j.metabol.2013.06.012
   Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404
   Mattocks DAL, 2017, EXP GERONTOL, V88, P1, DOI 10.1016/j.exger.2016.12.003
   McIsaac RS, 2016, ANN NY ACAD SCI, V1363, P155, DOI 10.1111/nyas.13032
   Mentch SJ, 2015, CELL METAB, V22, P861, DOI 10.1016/j.cmet.2015.08.024
   Miller JW, 2000, NUTRITION, V16, P675, DOI 10.1016/S0899-9007(00)00307-5
   Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x
   Miousse IR, 2018, CARCINOGENESIS, V39, P1117, DOI 10.1093/carcin/bgy085
   Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998
   Najim N, 2009, ANTICANCER RES, V29, P3103
   Naudí A, 2007, REJUV RES, V10, P473, DOI 10.1089/rej.2007.0538
   Nicken P, 2016, FOOD CHEM TOXICOL, V95, P196, DOI 10.1016/j.fct.2016.07.014
   ORENTREICH N, 1993, J NUTR, V123, P269
   Pamplona R, 2006, BBA-BIOENERGETICS, V1757, P496, DOI 10.1016/j.bbabio.2006.01.009
   Pang XM, 2014, ATHEROSCLEROSIS, V236, P73, DOI 10.1016/j.atherosclerosis.2014.06.021
   Payne BAI, 2015, BBA-BIOENERGETICS, V1847, P1347, DOI 10.1016/j.bbabio.2015.05.022
   Peng Wei, 2012, Sci Transl Med, V4, p118ra11, DOI 10.1126/scitranslmed.3002629
   Pereira CM, 2005, J BIOL CHEM, V280, P28316, DOI 10.1074/jbc.M408571200
   Pérez-Martí A, 2017, HORM MOL BIOL CLIN I, V30, DOI 10.1515/hmbci-2016-0034
   Perrone CE, 2008, J LIPID RES, V49, P12, DOI 10.1194/jlr.M700194-JLR200
   Perrone CE, 2010, METABOLISM, V59, P1000, DOI 10.1016/j.metabol.2009.10.023
   Plaisance EP, 2011, J CLIN ENDOCR METAB, V96, pE836, DOI 10.1210/jc.2010-2493
   Plummer J, 2017, J CELL BIOCHEM, V118, P31, DOI 10.1002/jcb.25604
   Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006
   Rasic-Markovic A, 2009, MOL CELL BIOCHEM, V327, P39, DOI 10.1007/s11010-009-0040-6
   Richie JP, 2004, NUTRITION, V20, P800, DOI 10.1016/j.nut.2004.05.009
   Romero Y, 2016, AGING CELL, V15, P1103, DOI 10.1111/acel.12514
   Russo C, 2008, J NEUROL, V255, P64, DOI 10.1007/s00415-007-0668-7
   Salmon AB, 2009, FASEB J, V23, P3601, DOI 10.1096/fj.08-127415
   Sanchez-Roman I, 2013, EXP GERONTOL, V48, P1030, DOI 10.1016/j.exger.2013.02.021
   Sanchez-Roman I, 2012, BIOGERONTOLOGY, V13, P399, DOI 10.1007/s10522-012-9384-5
   Sanz A, 2006, FASEB J, V20, P1064, DOI 10.1096/fj.05-5568com
   Sattlegger E, 2000, EMBO J, V19, P6622, DOI 10.1093/emboj/19.23.6622
   Selhub J, 2016, ANN NY ACAD SCI, V1363, P18, DOI 10.1111/nyas.12962
   Sen U, 2014, NITRIC OXIDE-BIOL CH, V41, P27, DOI 10.1016/j.niox.2014.06.006
   Sinha R, 2014, PROSTATE, V74, P1663, DOI 10.1002/pros.22884
   Stankovic MN, 2014, J MED FOOD, V17, P254, DOI 10.1089/jmf.2013.0111
   Stanojlovic O, 2009, CELL MOL NEUROBIOL, V29, P329, DOI 10.1007/s10571-008-9324-8
   Stone KP, 2015, OBESITY, V23, P1836, DOI 10.1002/oby.21177
   Stone KP, 2014, DIABETES, V63, P3721, DOI 10.2337/db14-0464
   Tahara EB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056388
   Takizawa D, 2011, CARCINOGENESIS, V32, P576, DOI 10.1093/carcin/bgq277
   Thivat E, 2009, ANTICANCER RES, V29, P5235
   Toriguchi K, 2014, J GASTROEN HEPATOL, V29, P1109, DOI 10.1111/jgh.12481
   Troen AM, 2007, AGE, V29, P29, DOI 10.1007/s11357-006-9018-4
   Vucevic D, 2013, HUM EXP TOXICOL, V32, P698, DOI 10.1177/0960327112467045
   Wanders D, 2016, DIABETES, V65, P1499, DOI 10.2337/db15-1324
   WEK SA, 1995, MOL CELL BIOL, V15, P4497
   Xie D, 2015, SCI REP-UK, V5, DOI 10.1038/srep16268
   Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392
   Yu DY, 2018, FASEB J, V32, P3471, DOI 10.1096/fj.201701211R
   Zhang ZY, 2016, J STROKE CEREBROVASC, V25, P1254, DOI 10.1016/j.jstrokecerebrovasdis.2016.01.037
   Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009
   Zhou XH, 2016, AMINO ACIDS, V48, P1533, DOI 10.1007/s00726-016-2247-7
NR 111
TC 13
Z9 14
U1 2
U2 26
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0334-1763
EI 1607-8470
J9 REV NEUROSCIENCE
JI Rev. Neurosci.
PD AUG
PY 2019
VL 30
IS 6
BP 581
EP 593
DI 10.1515/revneuro-2018-0073
PG 13
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA IM0DZ
UT WOS:000477657000002
PM 30817309
DA 2024-02-19
ER

PT J
AU Chen, P
   Chen, FC
   Zhou, BH
AF Chen, Peng
   Chen, Fuchao
   Zhou, Ben-hong
TI Leonurine ameliorates D-galactose-induced aging in mice through
   activation of the Nrf2 signalling pathway
SO AGING-US
LA English
DT Article
DE aging; D-galactose; leonurine; oxidative stress; Nrf2 pathway
ID INDUCED OXIDATIVE STRESS; MEMORY IMPAIRMENT; GENE-EXPRESSION; MOUSE
   MODEL; STEM-CELLS; ANTIOXIDANT; APOPTOSIS; DYSFUNCTION; LIVER; RATS
AB Aging is a complex physiological phenomenon associated with oxidative stress damage. The objective of this study was to investigate the potential effects of leonurine on D-galactose-induced aging in mice and its possible mechanisms. In this study, we first tested the antioxidant activity of leonurine in vitro. A subcutaneous injection of D-galactose in mice for 8 weeks was used to establish the aging model to evaluate the protective effects of leonurine. The results showed that treatment with 150 mg.kg(-1) leonurine could improve the mental condition, organic index, and behavioural impairment; significantly increase the activities of antioxidative enzymes including SOD, CAT, and T-AOC; and ameliorate the advanced glycation end product (AGE) level and histopathological injury. Furthermore, the Western blotting data revealed that leonurine supplementation noticeably modulated the suppression of the Nrf2 pathway and upregulated the downstream expression of HO-1 and NOQ1 in aging mice. Additionally, leonurine treatment activated Nrf2 nuclear translocation in both aging mice and normal young mice, and the expression levels of Nrf2 in normal young mice was higher than those in naturally aging mice. In conclusion, our findings suggest that leonurine is a promising agent for attenuating the aging process, and the underlying molecular mechanisms depend on activating the Nrf2 pathway.
C1 [Chen, Peng; Zhou, Ben-hong] Wuhan Univ, Renmin Hosp, Dept Pharm, Wuhan 430060, Hubei, Peoples R China.
   [Chen, Fuchao] Hubei Univ Med, Dongfeng Hosp, Dept Pharm, Shiyan 442008, Hubei, Peoples R China.
   [Zhou, Ben-hong] Wuhan Univ, Sch Pharmaceut Sci, Wuhan 430071, Hubei, Peoples R China.
C3 Wuhan University; Hubei University of Medicine; Wuhan University
RP Zhou, BH (corresponding author), Wuhan Univ, Renmin Hosp, Dept Pharm, Wuhan 430060, Hubei, Peoples R China.; Zhou, BH (corresponding author), Wuhan Univ, Sch Pharmaceut Sci, Wuhan 430071, Hubei, Peoples R China.
EM benhongzh@whu.edu.cn
OI chen, fuchao/0000-0001-9738-6744; Zhou, Benhong/0000-0002-6129-0182
CR Arlt A, 2013, ONCOGENE, V32, P4825, DOI 10.1038/onc.2012.493
   Balasubramanian P, 2010, AGING-US, V2, P632, DOI 10.18632/aging.100219
   Blagosklonny MV, 2008, CELL CYCLE, V7, P3344, DOI 10.4161/cc.7.21.6965
   Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8
   Camandola S, 2017, EMBO J, V36, P1474, DOI 10.15252/embj.201695810
   Castillo-Quan JI, 2016, CELL REP, V15, P638, DOI 10.1016/j.celrep.2016.03.041
   Cha HJ, 2016, NEUROSCI LETT, V619, P79, DOI 10.1016/j.neulet.2016.03.017
   Chapple SJ, 2012, INT J BIOCHEM CELL B, V44, P1315, DOI 10.1016/j.biocel.2012.04.021
   Chen P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19732-0
   Cheung KL, 2014, MOL CARCINOGEN, V53, P77, DOI 10.1002/mc.21950
   Dey A. B., 2017, Indian Journal of Medical Research, V145, P150, DOI [DOI 10.4103/0971-5916.207249, 10.4103/0971-5916, DOI 10.4103/0971-5916, 10.4103/0971-5916.207249]
   Dong ZY, 2017, EXP THER MED, V14, P616, DOI 10.3892/etm.2017.4514
   Du ZD, 2015, MOL MED REP, V12, P7883, DOI 10.3892/mmr.2015.4430
   Dulcy CP, 2012, J NEUROSCI RES, V90, P2053, DOI 10.1002/jnr.23080
   Fivenson EM, 2017, NEUROCHEM INT, V109, P202, DOI 10.1016/j.neuint.2017.02.007
   Floegel A, 2011, J FOOD COMPOS ANAL, V24, P1043, DOI 10.1016/j.jfca.2011.01.008
   Gómez LA, 2012, SEMIN CELL DEV BIOL, V23, P758, DOI 10.1016/j.semcdb.2012.04.002
   Gouzi H, 2013, INT J MED MUSHROOMS, V15, P471, DOI 10.1615/IntJMedMushr.v15.i5.50
   Harman D, 2006, ANN NY ACAD SCI, V1067, P10, DOI 10.1196/annals.1354.003
   Inal ME, 2001, CLIN CHIM ACTA, V305, P75, DOI 10.1016/S0009-8981(00)00422-8
   Jia MM, 2017, INT J NEUROPSYCHOPH, V20, P886, DOI 10.1093/ijnp/pyx062
   Kim EN, 2018, AGING-US, V10, P83, DOI 10.18632/aging.101361
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385
   Koh YH, 2000, FREE RADICAL RES, V33, P739, DOI 10.1080/10715760000301261
   Kou XJ, 2016, ONCOTARGET, V7, P74484, DOI 10.18632/oncotarget.12811
   Kubben N, 2016, CELL, V165, P1361, DOI 10.1016/j.cell.2016.05.017
   Li L, 2016, CELL MOL NEUROBIOL, V36, P103, DOI 10.1007/s10571-015-0224-4
   Li XY, 2017, NEUROCHEM RES, V42, P3268, DOI 10.1007/s11064-017-2366-x
   Liaquat L, 2017, PAK J PHARM SCI, V30, P647
   Nunes GBL, 2015, LIFE SCI, V121, P57, DOI 10.1016/j.lfs.2014.11.018
   Liu JH, 2011, FOOD RES INT, V44, P133, DOI 10.1016/j.foodres.2010.10.050
   Liu MW, 2016, INT J MOL MED, V38, P1419, DOI 10.3892/ijmm.2016.2749
   Loboda A, 2016, CELL MOL LIFE SCI, V73, P3221, DOI 10.1007/s00018-016-2223-0
   Long M, 2017, ENVIRON SCI POLLUT R, V24, P26724, DOI 10.1007/s11356-017-0123-y
   Lu MC, 2016, MED RES REV, V36, P924, DOI 10.1002/med.21396
   Luo C, 2011, MED HYPOTHESES, V77, P174, DOI 10.1016/j.mehy.2011.04.002
   Ma B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174530
   Ma KS, 2014, PAK J ZOOL, V46, P215
   Maltese G, 2017, J CELL MOL MED, V21, P621, DOI 10.1111/jcmm.12996
   Musa KH, 2016, FOOD CHEM, V194, P705, DOI 10.1016/j.foodchem.2015.08.038
   Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200
   Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200
   Pan HZ, 2016, CELL RES, V26, P190, DOI 10.1038/cr.2016.4
   Park JH, 2016, CENT EUR J IMMUNOL, V41, P324, DOI 10.5114/ceji.2016.63134
   Patros KM, 2017, J PHYS CHEM A, V121, P5459, DOI 10.1021/acs.jpca.7b05124
   Péczely L, 2014, BEHAV BRAIN RES, V274, P211, DOI 10.1016/j.bbr.2014.07.031
   Qi J, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00284
   Qi J, 2010, BIOL PHARM BULL, V33, P1958, DOI 10.1248/bpb.33.1958
   Ruan QW, 2013, MECH AGEING DEV, V134, P89, DOI 10.1016/j.mad.2012.12.005
   RUMMANS TA, 1993, MAYO CLIN PROC, V68, P731, DOI 10.1016/S0025-6196(12)60628-4
   Sang Y, 2017, FOOD FUNCT, V8, P2331, DOI [10.1039/c7fo00037e, 10.1039/C7FO00037E]
   Sastre J, 2000, IUBMB LIFE, V49, P427
   Schatten H, 2018, HISTOCHEM CELL BIOL, V150, P303, DOI 10.1007/s00418-018-1698-1
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P37, DOI 10.1016/S0891-5849(02)00856-0
   Sun YN, 2016, EUR J DRUG METAB PH, V41, P423, DOI 10.1007/s13318-015-0268-3
   Tsunoda M, 2016, BIOL PHARM BULL, V39, P1419, DOI 10.1248/bpb.b15-00896
   Wang T, 2015, J PHARM PHARMACOL, V67, P1284, DOI 10.1111/jphp.12413
   Wang X, 2010, J ETHNOPHARMACOL, V127, P424, DOI 10.1016/j.jep.2009.10.022
   Wu HQ, 2017, J MOL NEUROSCI, V61, P449, DOI 10.1007/s12031-017-0885-1
   Yan WH, 2017, BIOL PHARM BULL, V40, P1174, DOI 10.1248/bpb.b16-00777
   Yang C, 2015, J CELL PHYSIOL, V230, P2403, DOI 10.1002/jcp.24970
   Yang D, 2016, NAT PROD COMMUN, V11, P1757
   Yang HG, 2016, INT J FOOD SCI NUTR, V67, P806, DOI 10.1080/09637486.2016.1198890
   Yu YH, 2015, MOL CELL BIOCHEM, V403, P287, DOI 10.1007/s11010-015-2358-6
   Zhang Y, 2017, REJUV RES, V20, P462, DOI 10.1089/rej.2017.1960
   Zhou CL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163571
   Zhou L, 2018, REDOX BIOL, V14, P35, DOI 10.1016/j.redox.2017.08.014
   Zhuang CL, 2017, MEDCHEMCOMM, V8, P286, DOI 10.1039/c6md00500d
NR 69
TC 37
Z9 40
U1 0
U2 32
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD SEP 30
PY 2019
VL 11
IS 18
BP 7339
EP 7356
DI 10.18632/aging.101733
PG 18
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA JB0VH
UT WOS:000488275300005
PM 31527304
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Preuss, HG
   Mrvichin, N
   Kaats, GR
   Bagchi, D
   Clouatre, D
AF Preuss, Harry G.
   Mrvichin, Nate
   Kaats, Gilbert R.
   Bagchi, Debasis
   Clouatre, Dallas
TI Reflecting on Concepts Relevant to Contemplating the Relationships
   Between Glucose-Insulin Perturbations, Nutrition, and Aging
SO JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
LA English
DT Article
DE Continuum of risk; aging paradox; deadly triangle; aging; insulin
   resistance
ID FATTY LIVER-DISEASE; LIFE-SPAN; METABOLIC SYNDROME; DIABETES-MELLITUS;
   RESISTANCE; AGE; SUCROSE; PHENFORMIN; TOLERANCE; DENSITY
AB Background: Medical professionals attribute a crucial role in the development of several age-related, chronic health maladies to glucose-insulin perturbations - particularly, discernible insulin resistance (IR). However, little information is available concerning the degree to which relatively minor changes in IR participate over time in overall aging population, e.g., when circulating glucose and/or insulin concentrations are consistently within the higher end of normally accepted ranges. Objective: Obtaining precise knowledge is important, because proper nutritional management has the distinct capability of ameliorating the consequences. Methods: Five key concepts are suggested to underpin current thinking as to the applicable mechanisms and these are (1) the practical use of fasting blood glucose (FBG) levels as an estimate of IR, (2) the potential role of even slightly aberrant insulin regulation over time in the aging process, (3) the implementation of "continuum of risks" rather than checkpoints in considering prevention, (4) the presence and meaning of an aging paradox discovered in a recent study, and (5) the importance nutritional considerations in the "deadly triangle" as key factors in aging. Conclusions: Maintaining relatively low levels of FBG representing IR during aging via nutritional means has the potential to deliver a longer, more healthful lifespan as well as ameliorate many adverse manifestations of aging.
C1 [Preuss, Harry G.] Georgetown Univ, Med Ctr, Dept Biochem, Washington, DC 20007 USA.
   [Mrvichin, Nate; Kaats, Gilbert R.] Integrat Hlth Technol, San Antonio, TX USA.
   [Bagchi, Debasis] Univ Houston, Dept Pharmacol & Pharmaceut Serv, Houston, TX USA.
   [Clouatre, Dallas] Glykon Technol Grp LLC, Seattle, WA USA.
C3 Georgetown University; University of Houston System; University of
   Houston
RP Preuss, HG (corresponding author), 231B Basic Sci Bldg,3900 Reservoir RD NW, Washington, DC 20057 USA.
EM preusshg@georgetown.edu
CR Anisimov VN, 2003, BIOGERONTOLOGY, V4, P297, DOI 10.1023/A:1026299318315
   [Anonymous], HYPERTENSION, DOI DOI 10.1161/01.HYP.0000107251.49515.C2
   Banting FG, 1922, CAN MED ASSOC J, V7, P141
   BROUGHTON DL, 1991, AGE AGEING, V20, P221, DOI 10.1093/ageing/20.3.221
   BUYSSCHAERT M, 1992, DIABETES METAB, V18, P32
   Carey E, NONALCOHOLIC FATTY L
   Darwin C., 1987, ORIGIN SPECIES MEANS, P1
   DAVIDSON MB, 1979, METABOLISM, V28, P688, DOI 10.1016/0026-0495(79)90024-6
   DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173
   DEFRONZO RA, 1981, DIABETES CARE, V4, P493, DOI 10.2337/diacare.4.4.493
   DILMAN VM, 1980, GERONTOLOGY, V26, P241, DOI 10.1159/000212423
   Dong MH, 2012, CLIN GASTROENTEROL H, V10, P285, DOI 10.1016/j.cgh.2011.10.014
   Dong MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014254
   FERRANNINI E, 1990, J CARDIOVASC PHARM, V15, pS18, DOI 10.1097/00005344-199000005-00004
   FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908
   GINSBERG H, 1974, DIABETES, V23, P674, DOI 10.2337/diab.23.8.674
   HARMAN D, 1994, AGE, V17, P119, DOI 10.1007/BF02435819
   Himsworth HP, 1936, LANCET, V1, P127
   KNIGHT JA, 1995, ANN CLIN LAB SCI, V25, P1
   KREISBERG RA, 1987, GERIATRICS, V42, P67
   Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192
   MASORO EJ, 1992, J GERONTOL, V47, pB202, DOI 10.1093/geronj/47.6.B202
   MCCARTY MF, 1993, MED HYPOTHESES, V41, P316, DOI 10.1016/0306-9877(93)90073-Y
   Mofrad P, 2003, HEPATOLOGY, V37, P1286, DOI 10.1053/jhep.2003.50229
   Musso G, 2008, DIABETES CARE, V31, P562, DOI 10.2337/dc07-1526
   Porter SA, 2013, ARTERIOSCL THROM VAS, V33, P139, DOI 10.1161/ATVBAHA.112.300075
   Preuss H, 1999, WOMENS HLTH ALTERNAT, V1, P5
   Preuss H G, 1997, Geriatr Nephrol Urol, V7, P81, DOI 10.1023/A:1008249001782
   Preuss HG, 2017, J AM COLL NUTR, V36, P556, DOI 10.1080/07315724.2017.1322545
   Preuss HG, 2011, J INORG BIOCHEM, V105, P1344, DOI 10.1016/j.jinorgbio.2011.01.005
   Preuss HG, 1997, J AM COLL NUTR, V16, P397, DOI 10.1080/07315724.1997.10718704
   Preuss HG, 1998, J AM COLL NUTR, V17, P36, DOI 10.1080/07315724.1998.10720453
   Preuss HG, 1997, J AM COLL NUTR, V16, P393, DOI 10.1080/07315724.1997.10718702
   Preuss HG, 2016, ORIG INTERN, V23, P78
   Preuss HG, 2018, NUTR THERAPEUTIC INT
   Preuss HG, 2016, ORIGINAL INTERNIST, V23, P13
   Preuss HG, 2001, ADV GUIDE LONGEVITY, P239
   Preuss HG, 1998, AGING RELATIONSHIP I, V1, P12
   Preuss HG., 2017, BITTER SWEET, P1
   Preuss HG, 2011, ORIG INTERNIST, V18, P92
   Preuss HG, 2018, J AM COLL NUTR, V13, P1
   Preuss HG, 2015, NUTR INTEGRATIVE STR, P148
   REAVEN GM, 1989, HYPERTENSION, V14, P117, DOI 10.1161/01.HYP.14.2.117
   REAVEN GM, 1989, J AM GERIATR SOC, V37, P735, DOI 10.1111/j.1532-5415.1989.tb02235.x
   REID IR, 1993, AM J PHYSIOL, V265, pE655, DOI 10.1152/ajpendo.1993.265.4.E655
   REISER S, 1979, AM J CLIN NUTR, V32, P2206, DOI 10.1093/ajcn/32.11.2206
   Ryan AS, 2000, SPORTS MED, V30, P327, DOI 10.2165/00007256-200030050-00002
   Saltiel AR, 1996, DIABETES, V45, P1661, DOI 10.2337/diabetes.45.12.1661
   SHIMOKATA H, 1991, DIABETES, V40, P44, DOI 10.2337/diabetes.40.1.44
   Sung KC, 2012, DIABETES CARE, V35, P717, DOI 10.2337/dc11-1853
   SZANTO S, 1969, POSTGRAD MED J, V45, P602, DOI 10.1136/pgmj.45.527.602
   Whelton PK, 2017, JAMA-J AM MED ASSOC, V318, P2073, DOI 10.1001/jama.2017.18209
   YUDKIN J, 1964, P NUTR SOC, V23, P149, DOI 10.1079/PNS19640028
   YUDKIN J, 1971, BRIT MED J, V1, P349, DOI 10.1136/bmj.1.5744.349
   YUDKIN J, 1988, AM HEART J, V115, P493, DOI 10.1016/0002-8703(88)90508-X
   YUDKIN J, 1967, AM J CLIN NUTR, V20, P503, DOI 10.1093/ajcn/20.5.503
   YUDKIN J, 1957, LANCET, V2, P154
   YUDKIN J, 1978, LIPIDS, V13, P370, DOI 10.1007/BF02533732
NR 58
TC 8
Z9 8
U1 0
U2 0
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0731-5724
EI 1541-1087
J9 J AM COLL NUTR
JI J. Am. Coll. Nutr.
PD JUL 4
PY 2019
VL 38
IS 5
BP 463
EP 469
DI 10.1080/07315724.2018.1529640
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA IF3GV
UT WOS:000472969800010
PM 30810506
DA 2024-02-19
ER

PT J
AU Li, GF
   Ji, T
   Chen, J
   Fu, YF
   Hou, LD
   Feng, Y
   Zhang, TY
   Song, TY
   Zhao, J
   Endo, Y
   Lin, H
   Cai, XJ
   Cang, Y
AF Li, Gaofeng
   Ji, Tong
   Chen, Jiang
   Fu, Yufei
   Hou, Lidan
   Feng, Yan
   Zhang, Tingyue
   Song, Tianyu
   Zhao, Jie
   Endo, Yoko
   Lin, Hui
   Cai, Xiujun
   Cang, Yong
TI CRL4<SUP>DCAF8</SUP> Ubiquitin Ligase Targets Histone H3K79 and Promotes
   H3K9 Methylation in the Liver
SO CELL REPORTS
LA English
DT Article
ID DNA METHYLATION; GENE-TRANSCRIPTION; ALPHA-FETOPROTEIN; S PHASE;
   CHROMATIN; DDB1; HETEROCHROMATIN; DAMAGE; H2A; UBIQUITYLATION
AB Transcription from chromosomes is regulated by posttranslational modifications to histones, such as methylation and ubiquitination. Monoubiquitination of histones H2A and H2B influences H3 methylation to reinforce the activation or repression of gene expression. Here, we provide evidence that H3 polyubiquitination represses transcription of fetal and cell-cycle genes in postnatal mouse liver by crosstalk with H3K9 methylation. We found that the CRL4 ubiquitin ligase targets H3 for polyubiquitination at K79 via the DCAF8 substrate receptor in hepatocytes. Genetic inactivation of DCAF8 and overexpression of an H3K79 mutant in cells or inducible deletion of CRL4 in mouse liver abrogates H3 ubiquitination, reactivates the expression of fetal liver and cellcycle genes by interfering with methylated H3K9 occupancy, and leads to cell senescence. Restoring CRL4 DCAF8 expression in cells with decreased H3 ubiquitination reinstates the epigenetic gene silencing. Our results suggest that progressive H3 ubiquitination plays an important role in postnatal liver maturation.
C1 [Li, Gaofeng; Fu, Yufei; Hou, Lidan; Feng, Yan; Zhang, Tingyue; Song, Tianyu; Cang, Yong] Zhejiang Univ, Sir Run Run Shaw Hosp, Coll Med, Dept Gen Surg, Zhejiang 310058, Peoples R China.
   [Ji, Tong; Chen, Jiang; Zhao, Jie; Lin, Hui; Cai, Xiujun] Zhejiang Univ, Sir Run Run Shaw Hosp, Coll Med, Dept Gen Surg, Hangzhou 310058, Zhejiang, Peoples R China.
   [Endo, Yoko] Sanford Burnham Med Res Inst, Signal Transduct Program, La Jolla, CA 92121 USA.
   [Fu, Yufei] Zhejiang Hosp Tradit Chinese Med, Zhejiang Key Lab Gastro Intestinal Pathophysiol, Zhejiang 310058, Peoples R China.
C3 Zhejiang University; Zhejiang University; Sanford Burnham Prebys Medical
   Discovery Institute; Zhejiang Chinese Medical University
RP Cang, Y (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Coll Med, Dept Gen Surg, Zhejiang 310058, Peoples R China.; Cai, XJ (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Coll Med, Dept Gen Surg, Hangzhou 310058, Zhejiang, Peoples R China.
EM cxjzu@hotmail.com; cangyong@zju.edu.cn
RI Song, Tian-Yu/AAN-3792-2020
OI Song, Tian-Yu/0000-0001-9834-6795; Cang, Yong/0000-0002-1148-7008
FU National 973 Plan for Basic Research [2015CB553803]; Zhejiang Provincial
   Natural Science Foundation of China [LZ14H160002]; National Natural
   Science Foundation of China [31671334]; Science Technology Department of
   Zhejiang Province [2015C03026]; Fundamental Research Funds for the
   Central Universities; National "985'' Project
FX We thank Zhengang Peng for technical support and Abcam Trading
   (Shanghai) Company for supplying the H3K79ub antibody. We also thank Xin
   Yan and Shaobing Gao for proofreading. This research was supported by
   the National 973 Plan for Basic Research (2015CB553803), Zhejiang
   Provincial Natural Science Foundation of China (LZ14H160002), National
   Natural Science Foundation of China (31671334), Science Technology
   Department of Zhejiang Province (2015C03026), and Fundamental Research
   Funds for the Central Universities and Key Construction Program of the
   National "985'' Project.
CR Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014
   Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175
   Nguyen AT, 2011, GENE DEV, V25, P1345, DOI 10.1101/gad.2057811
   Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22
   Bhatnagar S, 2014, NATURE, V516, P116, DOI 10.1038/nature13955
   BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0
   Bondar T, 2006, MOL CELL BIOL, V26, P2531, DOI 10.1128/MCB.26.7.2531-2539.2006
   Braun S, 2012, EMBO REP, V13, P619, DOI 10.1038/embor.2012.78
   Braun S, 2011, CELL, V144, P41, DOI 10.1016/j.cell.2010.11.051
   Buscaino A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002499
   Cang Y, 2007, P NATL ACAD SCI USA, V104, P2733, DOI 10.1073/pnas.0611311104
   Cang Y, 2006, CELL, V127, P929, DOI 10.1016/j.cell.2006.09.045
   Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015
   Endo Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031846
   Gao J, 2015, ELIFE, V4, DOI 10.7554/eLife.07539
   Grazini U, 2010, MOL CELL, V37, P282, DOI 10.1016/j.molcel.2009.12.035
   Han JH, 2013, CELL, V155, P817, DOI 10.1016/j.cell.2013.10.014
   Havens CG, 2011, GENE DEV, V25, P1568, DOI 10.1101/gad.2068611
   Henikoff S, 2007, CANCER CELL, V12, P407, DOI 10.1016/j.ccr.2007.10.024
   Hewawasam G, 2010, MOL CELL, V40, P444, DOI 10.1016/j.molcel.2010.10.014
   Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490
   Horn PJ, 2005, GENE DEV, V19, P1705, DOI 10.1101/gad.1328005
   Iovine B, 2011, INT J BIOCHEM CELL B, V43, P1664, DOI 10.1016/j.biocel.2011.09.001
   Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002
   Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127
   Jia ST, 2005, NAT CELL BIOL, V7, P1007, DOI 10.1038/ncb1300
   Kapetanaki MG, 2006, P NATL ACAD SCI USA, V103, P2588, DOI 10.1073/pnas.0511160103
   Klein CJ, 2014, NEUROLOGY, V82, P873, DOI 10.1212/WNL.0000000000000206
   Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159
   Kuscu C, 2014, P NATL ACAD SCI USA, V111, P1795, DOI 10.1073/pnas.1313096111
   Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001
   Liu JY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4924
   Morford LA, 2007, HEPATOLOGY, V46, P1541, DOI 10.1002/hep.21825
   Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200
   Nishiyama A, 2013, NATURE, V502, P249, DOI 10.1038/nature12488
   Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011
   Perincheri S, 2005, P NATL ACAD SCI USA, V102, P396, DOI 10.1073/pnas.0408555102
   Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506
   Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501
   Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966
   Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202
   Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07
   Suganuma T, 2008, CELL, V135, P604, DOI 10.1016/j.cell.2008.10.036
   Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883
   Tachibana M, 2008, EMBO J, V27, P2681, DOI 10.1038/emboj.2008.192
   Tamayo AG, 2015, NAT STRUCT MOL BIOL, V22, P759, DOI 10.1038/nsmb.3076
   Thorslund T, 2015, NATURE, V527, P389, DOI 10.1038/nature15401
   Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985
   Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035
   Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014
   Wright DE, 2011, EPIGENETICS-US, V6, P1165, DOI 10.4161/epi.6.10.17745
   Wu FQ, 2012, FEBS LETT, V586, P1079, DOI 10.1016/j.febslet.2012.02.053
   Xie Z, 2008, P NATL ACAD SCI USA, V105, P10859, DOI 10.1073/pnas.0800647105
   Yamaji S, 2010, P NATL ACAD SCI USA, V107, P22237, DOI 10.1073/pnas.1015793108
NR 54
TC 22
Z9 23
U1 0
U2 17
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD FEB 7
PY 2017
VL 18
IS 6
BP 1499
EP 1511
DI 10.1016/j.celrep.2017.01.039
PG 13
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA EP4AR
UT WOS:000397323400014
PM 28178526
OA gold
DA 2024-02-19
ER

PT J
AU Manikonda, PK
   Jagota, A
AF Manikonda, Pavan Kumar
   Jagota, Anita
TI Melatonin administration differentially affects age-induced alterations
   in daily rhythms of lipid peroxidation and antioxidant enzymes in male
   rat liver
SO BIOGERONTOLOGY
LA English
DT Article
DE Aging; Peripheral clock; Lipid peroxidation; Antioxidant enzymes;
   Melatonin
ID PREVENTS OXIDATIVE STRESS; SUPRACHIASMATIC NUCLEUS; CIRCADIAN
   VARIATIONS; WISTAR RATS; MICE; RESTRICTION; NETWORK; TISSUES; SYSTEM;
   BRAIN
AB A central clock/pacemaker, suprachiasmatic nuclei of the hypothalamus coordinates and entrains circadian oscillations in the peripheral tissues such as the liver, kidney, heart, lungs etc. called peripheral clocks. These also have endogenous circadian oscillations. The circadian rhythms of antioxidants present in cytosol signify redox state of the cell during day/night cycle. The liver has a major impact on homeostasis through its control on serum protein composition and plays a pivotal role in the metabolism of nutrients, drugs, hormones, and metabolic waste products and undergoes substantial changes in structure and function upon aging. In present study, the temporal patterns of oxidative stress indicators in liver were studied. Daily rhythms of lipid peroxidation end products, reduced glutathione (GSH), oxidized glutathione (GSSG) and antioxidant enzymes such as glutathione peroxidase (GPx), superoxide dismutase (SOD) and catalase (CAT) were studied in liver at variable time points (Zeitgeber Time (ZT) 0, 6, 12 and 18) in three age groups: 3 (adult), 12 and 24 months old male Wistar rats. There was increase in oxidative stress in 12 and 24 months old rats indicated through a significant increase in lipid peroxidation, decrease in GSH/GSSG ratio and antioxidant enzyme activities. In 3 months old rats, lipid peroxidation was maximum at ZT-12 whereas GSH, SOD and CAT activities were minimum at ZT-12. The maximum level in 24 h i.e., acrophases of lipid peroxidation, GPx, SOD and CAT activities in liver cell free extracts altered upon aging. As melatonin, messenger of darkness, an endogenous synchronizer of rhythm, an antioxidant and an antiaging drug, declines with aging we studied the effects of melatonin on activities of these antioxidant enzymes in aging rats. Melatonin administration resulted in differential restoration of acrophases, amplitude, mean as well as daily rhythms of lipid peroxidation and antioxidants in liver of 12 and 24 months old rats.
C1 [Manikonda, Pavan Kumar; Jagota, Anita] Univ Hyderabad, Sch Life Sci, Dept Anim Sci, Neurobiol & Mol Chronobiol Lab, Hyderabad 500046, Andhra Pradesh, India.
C3 University of Hyderabad
RP Jagota, A (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Anim Sci, Neurobiol & Mol Chronobiol Lab, Hyderabad 500046, Andhra Pradesh, India.
EM ajsl@uohyd.ernet.in
FU UGC [32-613/2006(SR)]; DST [SR/SO/AS-47/2004]; DST-Nano [8.18]; ICMR
   [BMS/NTF/14/2006-2007]; DBT-CREBB
FX This work is supported by UGC (Ref: F. No.: 32-613/2006(SR), DST (Do
   No.: SR/SO/AS-47/2004), DST-Nano (Ref: 8.18), ICMR (Ref. No.
   BMS/NTF/14/2006-2007) Grants to AJ. PKM is thankful to DBT-CREBB for
   Post Doctoral Fellowship.
CR Baeza I, 2010, BIOGERONTOLOGY, V11, P687, DOI 10.1007/s10522-010-9282-7
   Baydas G, 2002, NEUROSCI LETT, V323, P195, DOI 10.1016/S0304-3940(02)00144-1
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Cardinali DP, 2011, NEUROENDOCRINOL LETT, V32, P588
   Carnes BA, 2011, BIOGERONTOLOGY, V12, P367, DOI 10.1007/s10522-011-9338-3
   Contini MD, 2011, BIOL TRACE ELEM RES, V144, P924, DOI 10.1007/s12011-011-9060-7
   Delezie J, 2011, ANN NY ACAD SCI, V1243, P30, DOI 10.1111/j.1749-6632.2011.06246.x
   Hardeland R, 2012, J PINEAL RES, V52, P139, DOI 10.1111/j.1600-079X.2011.00934.x
   Jagota A, 2000, NAT NEUROSCI, V3, P372, DOI 10.1038/73943
   Jagota A., 2005, INDIAN J GERONTOL, V19, P415
   Jagota A, 2006, P INDIAN NATL SCI B, VB71, P275
   Jagota A, 2008, BIOGERONTOLOGY, V9, P229, DOI 10.1007/s10522-008-9132-z
   Jagota A, 2010, BIOGERONTOLOGY, V11, P299, DOI 10.1007/s10522-009-9248-9
   Kakarla P, 2005, J EXP ZOOL PART A, V303A, P203, DOI 10.1002/jez.a.149
   Kaya H, 1999, STRAHLENTHER ONKOL, V175, P285, DOI 10.1007/BF02743581
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   Kwon Ilmin, 2011, Exp Neurobiol, V20, P18, DOI 10.5607/en.2011.20.1.18
   LAPENNA D, 1992, FREE RADICAL RES COM, V17, P187, DOI 10.3109/10715769209068165
   Lebel Michel, 2011, Curr Gerontol Geriatr Res, V2011, P859415, DOI 10.1155/2011/859415
   Li XM, 1997, TOXICOL APPL PHARM, V143, P281, DOI 10.1006/taap.1996.8088
   Manoharan S., 2005, SMJ Singapore Medical Journal, V46, P184
   Mauriz JL, 2007, J PINEAL RES, V42, P222, DOI 10.1111/j.1600-079X.2006.00409.x
   Mayo JC, 2002, CELL MOL LIFE SCI, V59, P1706, DOI 10.1007/PL00012498
   Muradian KK, 2002, FREE RADICAL BIO MED, V33, P1736, DOI 10.1016/S0891-5849(02)01196-6
   Nachiyar RK, 2011, BIOL RHYTHM RES, V42, P147, DOI 10.1080/09291016.2010.491243
   Pandi-Perumal SR, 2008, PROG NEUROBIOL, V85, P335, DOI 10.1016/j.pneurobio.2008.04.001
   Pevet P, 2011, J PHYSIOL-PARIS, V105, P170, DOI 10.1016/j.jphysparis.2011.07.001
   PIERI C, 1992, ARCH GERONTOL GERIAT, V14, P93, DOI 10.1016/0167-4943(92)90010-2
   Rattan SIS, 2012, EXPERT OPIN DRUG DIS, V7, P439, DOI 10.1517/17460441.2012.677430
   Rebrin I, 2011, FREE RADICAL BIO MED, V51, P225, DOI 10.1016/j.freeradbiomed.2011.04.006
   Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x
   Sanchez-Hidalgo M, 2009, EXP GERONTOL, V44, P328, DOI 10.1016/j.exger.2009.02.002
   Sani M, 2007, CHRONOBIOL INT, V24, P671, DOI 10.1080/07420520701535720
   Sobocanec S, 2008, BIOGERONTOLOGY, V9, P335, DOI 10.1007/s10522-008-9145-7
   Tsutsui K, 2009, GEN COMP ENDOCR, V163, P117, DOI 10.1016/j.ygcen.2009.04.005
   Urata Y, 1999, FREE RADICAL BIO MED, V27, P838, DOI 10.1016/S0891-5849(99)00131-8
   Vinatier V, 2010, ANAL BIOCHEM, V405, P255, DOI 10.1016/j.ab.2010.06.006
   Von Gall C, 2008, NEUROBIOL AGING, V29, P464, DOI 10.1016/j.neurobiolaging.2006.10.015
   Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919
   Yonei Y., 2010, ANTIAGING MED, V7, P85
NR 40
TC 44
Z9 45
U1 0
U2 12
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD OCT
PY 2012
VL 13
IS 5
BP 511
EP 524
DI 10.1007/s10522-012-9396-1
PG 14
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 014AI
UT WOS:000309347000005
PM 22960749
DA 2024-02-19
ER

PT J
AU Chen, HY
   Dong, L
   Chen, XY
   Ding, CB
   Hao, MQ
   Peng, XJ
   Zhang, Y
   Zhu, HY
   Liu, WC
AF Chen, Huiying
   Dong, Ling
   Chen, Xueyan
   Ding, Chuanbo
   Hao, Mingqian
   Peng, Xiaojuan
   Zhang, Yue
   Zhu, Hongyan
   Liu, Wencong
TI Anti-aging effect of phlorizin on D-galactose-induced aging in mice
   through antioxidant and anti-inflammatory activity, prevention of
   apoptosis, and regulation of the gut microbiota
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article; Early Access
DE Phlorizin; Antioxidant; Anti-inflammatory; Apoptosis; Gut microbiota
ID OXIDATIVE STRESS; ALZHEIMERS-DISEASE; IMMUNE-RESPONSE; REACTIVE OXYGEN;
   PHLORETIN; BRAIN; IMPAIRMENT; EXPRESSION; HEALTH; RATS
AB Aging is an inevitable and complicated process involving many physiological changes. Screening of natural biologically active anti-aging substances is a current research hotspot. Phlorizin (PZ), an important dihydrochalcone phytoconstituent, has been demonstrated to have antioxidant and anti-tumor effects. In this paper, different doses of PZ (20 and 40 mg/kg) were used to research the protective effect on D-galactose (D-gal) induced aging mice. Following hematoxylin and eosin staining and by observing the hippocampus, we found that PZ alleviated the damage caused by D-gal in neuronal cells, while PZ enhanced the learning and memory abilities of aging mice in a radical eight-arm maze. In order to explain the reasons for these anti-aging effects, we tested the antioxidant enzyme activity and malonic dialdehyde concentration in mouse serum, liver, and brain tissue. The contents of proteins related to anti-inflammation and apoptosis in brain tissue were analyzed, and the gut microbiota was also analyzed. The results indicated that PZ improved antioxidant enzyme activity while significantly reducing the malonic dialdehyde content. Western blotting analysis suggested that PZ effectively alleviated neuro-apoptosis via regulating the expressions of Bax, Bcl-2, and caspase-3. PZ also exerted anti inflammation effects by regulating the interleukin-1 beta/inhibitor of nuclear factor kappa B alpha/nuclear factor kappa-light-chain-enhancer of activated B-cells signaling pathways in brain tissues. Importantly, PZ improved the structure and diversity of the gut microbiota, and the microbiota-gut-brain axis may hold a key role in PZinduced anti-aging effects. In conclusion, PZ can be used as a potential drug candidate to combat aging.
C1 [Chen, Huiying; Dong, Ling; Chen, Xueyan; Ding, Chuanbo; Hao, Mingqian; Peng, Xiaojuan; Zhang, Yue; Zhu, Hongyan; Liu, Wencong] Jilin Agr Univ, Coll Chinese Med Mat, Changchun, Peoples R China.
   [Liu, Wencong] Jilin Agr Univ, Coll Resources & Environm Sci, Changchun, Peoples R China.
C3 Jilin Agricultural University; Jilin Agricultural University
RP Liu, WC (corresponding author), Jilin Agr Univ, Coll Chinese Med Mat, Changchun, Peoples R China.; Liu, WC (corresponding author), Jilin Agr Univ, Coll Resources & Environm Sci, Changchun, Peoples R China.
EM wencongliu123123@163.com
RI zhang, xueying/JMB-7808-2023; yang, zhou/JKI-3744-2023; cao,
   yutong/JJF-4531-2023
OI Hao, Mingqian/0000-0001-6156-7578
FU Jilin Province Innovation Capacity Building Fund Project [2021C041-1]
FX This work was supported by Jilin Province Innovation Capacity Building
   Fund Project (No. 2021C041-1) .
CR Ali A, 2021, NEUROCHEM INT, V142, DOI 10.1016/j.neuint.2020.104893
   Almalki WH, 2021, CHEM-BIOL INTERACT, V333, DOI 10.1016/j.cbi.2020.109328
   Azman KF, 2019, BIOGERONTOLOGY, V20, P763, DOI 10.1007/s10522-019-09837-y
   Bhardwaj N, 2018, DRUG DISCOVERY TODAY, V28, P51
   Bieghs V, 2013, TRENDS IMMUNOL, V34, P446, DOI 10.1016/j.it.2013.04.005
   Borrelli RC, 2005, MOL NUTR FOOD RES, V49, P673, DOI 10.1002/mnfr.200500011
   Cai JZ, 2021, TOXICOLOGY, V453, DOI 10.1016/j.tox.2021.152720
   Carmona J.J., 2016, BIOL AGING LONGEVITY
   Chang YM, 2021, J ETHNOPHARMACOL, V264, DOI 10.1016/j.jep.2020.113297
   Chen P, 2019, AGING-US, V11, P7339, DOI 10.18632/aging.101733
   Choudhary GS, 2015, METHODS MOL BIOL, V1219, P1, DOI 10.1007/978-1-4939-1661-0_1
   Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319
   Conway J, 2021, AGEING RES REV, V68, DOI 10.1016/j.arr.2021.101323
   Dinan TG, 2017, J PHYSIOL-LONDON, V595, P489, DOI 10.1113/JP273106
   Ehrenkranz JRL, 2005, DIABETES-METAB RES, V21, P31, DOI 10.1002/dmrr.532
   Ferreira JPS, 2021, EUR J MED CHEM, V221, DOI 10.1016/j.ejmech.2021.113492
   Furlan JC, 2020, EXP NEUROL, V332, DOI 10.1016/j.expneurol.2020.113401
   García-Peña C, 2017, ARCH MED RES, V48, P681, DOI 10.1016/j.arcmed.2017.11.005
   Gosch C, 2010, PHYTOCHEMISTRY, V71, P838, DOI 10.1016/j.phytochem.2010.03.003
   Grajeda-lglesias C., 2021, AGING
   Grossberg GT, 2003, CURR THER RES CLIN E, V64, P216, DOI 10.1016/S0011-393X(03)00059-6
   Gungor O, 2019, J MOL STRUCT, V1196, P491, DOI 10.1016/j.molstruc.2019.06.104
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   He SD, 2019, FOOD CHEM TOXICOL, V125, P62, DOI 10.1016/j.fct.2018.12.045
   Hsieh HM, 2009, FOOD CHEM TOXICOL, V47, P625, DOI 10.1016/j.fct.2008.12.026
   Jaeschke H, 2011, J GASTROEN HEPATOL, V26, P173, DOI 10.1111/j.1440-1746.2010.06592.x
   Kamdi SP, 2021, CYTOKINE, V139, DOI 10.1016/j.cyto.2020.155408
   Karimani Asieh, 2021, Toxicol Rep, V8, P1280, DOI 10.1016/j.toxrep.2021.06.017
   Khalifa MMA, 2017, BIOMED PHARMACOTHER, V95, P529, DOI 10.1016/j.biopha.2017.08.121
   Kobori M, 2012, FOOD CHEM TOXICOL, V50, P2547, DOI 10.1016/j.fct.2012.04.017
   Kolodziejczyk AA, 2019, NAT REV MICROBIOL, V17, P742, DOI 10.1038/s41579-019-0256-8
   Kou XD, 2021, J MOL STRUCT, V1239, DOI 10.1016/j.molstruc.2021.130459
   Léveillé M, 2020, MOL METAB, V34, P72, DOI 10.1016/j.molmet.2020.01.004
   Li L, 2016, NEURAL REGEN RES, V11, P807, DOI 10.4103/1673-5374.182709
   Li MX, 2019, PHYTOTHER RES, V33, P2692, DOI 10.1002/ptr.6443
   Liochev SI, 2013, FREE RADICAL BIO MED, V60, P1, DOI 10.1016/j.freeradbiomed.2013.02.011
   Liu EYL, 2020, ACTA PHARMACOL SIN B, V10, P1926, DOI 10.1016/j.apsb.2020.05.005
   Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322
   Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123
   OLTON DS, 1979, BEHAV BRAIN SCI, V2, P313, DOI 10.1017/S0140525X00062713
   Pan SJ, 2021, BIOMATERIALS, V275, DOI 10.1016/j.biomaterials.2021.120946
   Parameshwaran K, 2010, REJUV RES, V13, P729, DOI 10.1089/rej.2010.1020
   Pellanda P, 2021, CURR OPIN BIOTECH, V70, P48, DOI 10.1016/j.copbio.2020.11.001
   Peng XY, 2014, INT DAIRY J, V34, P80, DOI 10.1016/j.idairyj.2013.08.004
   PubChem, 2000, PHLORIZIN
   Rehman SU, 2017, MOL NEUROBIOL, V54, P255, DOI 10.1007/s12035-015-9604-5
   Rezk BM, 2002, BIOCHEM BIOPH RES CO, V295, P9, DOI 10.1016/S0006-291X(02)00618-6
   Rodríguez-Lavado J, 2020, EUR J MED CHEM, V198, DOI 10.1016/j.ejmech.2020.112368
   Salminen A, 2008, AGEING RES REV, V7, P83, DOI 10.1016/j.arr.2007.09.002
   Salminen A, 2009, J CLIN IMMUNOL, V29, P397, DOI 10.1007/s10875-009-9296-6
   Sharma R, 2014, NUTR RES, V34, P968, DOI 10.1016/j.nutres.2014.09.006
   Shen X, 2017, DRUG DES DEV THER, V11, P313, DOI 10.2147/DDDT.S127010
   Shou Y, 2002, J NEUROCHEM, V81, P842, DOI 10.1046/j.1471-4159.2002.00880.x
   Sivamaruthi B.S., 2018, Int J Appl Pharm, V10, P23
   Sochocka M, 2019, MOL NEUROBIOL, V56, P1841, DOI 10.1007/s12035-018-1188-4
   Stepien A., 2007, POSTEPY HIG MED DOSW
   Sukhorukov VL, 2001, BIOPHYS J, V81, P1006, DOI 10.1016/S0006-3495(01)75758-X
   Ugan RA, 2020, EURASIAN J MED, V52, P265, DOI 10.5152/eurasianjmed.2020.20022
   Un H, 2021, LIFE SCI, V266, DOI 10.1016/j.lfs.2020.118869
   Valenta C., 2001, J PHARM SCI-US, DOI [10.1002/1520-6017(200104)90:43.0.co;2-%23, DOI 10.1002/1520-6017(200104)90:43.0.CO;2-%23]
   van der Lugt B, 2019, IMMUN AGEING, V16, DOI 10.1186/s12979-019-0145-z
   van Empel VPM, 2005, CARDIOVASC RES, V67, P21, DOI 10.1016/j.cardiores.2005.04.012
   Viña J, 2007, IUBMB LIFE, V59, P249, DOI 10.1080/15216540601178067
   Wang H, 2019, J FOOD BIOCHEM, V43, DOI 10.1111/jfbc.12744
   Wen J, 2020, BRAIN RES BULL, V164, P249, DOI 10.1016/j.brainresbull.2020.08.017
   Woo JY, 2014, ANAEROBE, V27, P22, DOI 10.1016/j.anaerobe.2014.03.003
   Yu LZ, 2013, INT J MOL MED, V32, P717, DOI 10.3892/ijmm.2013.1436
   Zapata HJ, 2015, J AM GERIATR SOC, V63, P776, DOI 10.1111/jgs.13310
   Zhang XY, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00359
   Zhang XL, 2007, PHARMACOL BIOCHEM BE, V88, P64, DOI 10.1016/j.pbb.2007.07.004
   Zhao L, 2017, FOOD FUNCT, V8, P4644, DOI [10.1039/C7FO01383C, 10.1039/c7fo01383c]
   Zhao LL, 2017, THER CLIN RISK MANAG, V13, DOI 10.2147/TCRM.S141738
   Zhong JJ, 2020, INT IMMUNOPHARMACOL, V83, DOI 10.1016/j.intimp.2020.106491
   Zhu BL, 2010, PROTEIN CELL, V1, P718, DOI 10.1007/s13238-010-0093-z
NR 74
TC 23
Z9 23
U1 6
U2 49
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD 2022 JUN 15
PY 2022
VL 163
AR 111769
DI 10.1016/j.exger.2022.111769
EA MAR 2022
PG 13
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 1C1RB
UT WOS:000792903900003
PM 35337894
OA hybrid
DA 2024-02-19
ER

PT J
AU SAITO, K
   NOJI, M
   OHMORI, S
   IMAI, Y
   MURAKOSHI, I
AF SAITO, K
   NOJI, M
   OHMORI, S
   IMAI, Y
   MURAKOSHI, I
TI INTEGRATION AND EXPRESSION OF A RABBIT LIVER CYTOCHROME-P-450 GENE IN
   TRANSGENIC NICOTIANA-TABACUM
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE SENESCENCE; METABOLISM OF NICOTINE; AGROBACTERIUM-TUMEFACIENS;
   TI-PLASMID VECTOR; PROMOTER FOR MANNOPINE SYNTHASE
ID AGROBACTERIUM-TUMEFACIENS; TI PLASMID; LIPID-PEROXIDATION; PLANTS;
   TRANSFORMATION; QUANTITATION; SUPERFAMILY; SUPPRESSION; EVOLUTION;
   MUTATIONS
AB Cytochrome P-450 is involved in the oxidative metabolism of a broad range of substrates. We have made a chimeric construct, pSN002, containing the cDNA for rabbit liver cytochrome P-450 (IIC14) under the control of the TR2' promoter for mannopine synthase in the Agrobacterium Ti plasmid. Nicotiana tabacum was transformed with Agrobacterium tumefaciens harboring a cointegrated plasmid pSN002::pGV2260. The presence of mRNA and of the translated protein from the chimeric cytochrome P-450 gene in transgenic plants was confirmed by RNA blot hybridization and by Western blot and immunohistochemical analyses, respectively. The transformants in which the foreign cytochrome P-450 protein is expressed show marked phenotypic changes, notably a tendency rapidly to senesce. We detected 2-propenylpyrrolidine, a degradative metabolite of nicotine alkaloids, in transgenic tobacco showing this pronounced phenotypic change. Such metabolism is likely to be due to the effect of senescence and not directly to the presence of the cytochrome P-450.
C1 UNIV OSAKA PREFECTURE,FAC AGR,SAKAI,OSAKA 591,JAPAN.
C3 Osaka Metropolitan University
RP SAITO, K (corresponding author), CHIBA UNIV,FAC PHARMACEUT SCI,YAYOI CHO 1-33,CHIBA 260,JAPAN.
RI Saito, Kazuki/D-2670-2009
OI Saito, Kazuki/0000-0001-6310-5342
CR BOZAK KR, 1990, P NATL ACAD SCI USA, V87, P3904, DOI 10.1073/pnas.87.10.3904
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   DEBLAERE R, 1987, METHOD ENZYMOL, V153, P277
   DEBLAERE R, 1985, NUCLEIC ACIDS RES, V13, P4777, DOI 10.1093/nar/13.13.4777
   DEBLOCK M, 1987, EMBO J, V6, P2513, DOI 10.1002/j.1460-2075.1987.tb02537.x
   DHAESE P, 1979, NUCLEIC ACIDS RES, V7, P1837, DOI 10.1093/nar/7.7.1837
   DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93
   DITTA G, 1980, P NATL ACAD SCI-BIOL, V77, P7347, DOI 10.1073/pnas.77.12.7347
   DOMINGO A, 1989, ANAL BIOCHEM, V182, P176, DOI 10.1016/0003-2697(89)90738-0
   ECKES P, 1989, MOL GEN GENET, V217, P63
   GILLETTE JR, 1982, DRUG METAB REV, V13, P941, DOI 10.3109/03602538208991371
   GONZALEZ FJ, 1990, TRENDS GENET, V6, P182, DOI 10.1016/0168-9525(90)90174-5
   GUENGERICH PF, 1982, BIOCHEMISTRY-US, V21, P1689
   HAMILL JD, 1990, PLANT MOL BIOL, V15, P27, DOI 10.1007/BF00017721
   HELLER SR, 1978, EPA NIH MASS SPECTRA, V1
   IMAI Y, 1989, BIOCHEM BIOPH RES CO, V158, P717, DOI 10.1016/0006-291X(89)92780-0
   IMAI Y, 1987, J BIOCHEM-TOKYO, V101, P1129, DOI 10.1093/oxfordjournals.jbchem.a121977
   Jakoby W.B., 1980, ENZYMATIC BASIS DETO, V1 & 2 1
   JAKOBY WB, 1982, METABOLIC BASIS DETO
   KAMATAKI T, 1983, ARCH BIOCHEM BIOPHYS, V225, P758, DOI 10.1016/0003-9861(83)90087-5
   LANGRIDGE WHR, 1989, P NATL ACAD SCI USA, V86, P3219, DOI 10.1073/pnas.86.9.3219
   LANGRIMINI LM, 1980, PLANT CELL, V2, P7
   Leete E., 1983, ALKALOIDS CHEM BIOL, V1, P85
   LOGEMANN J, 1987, ANAL BIOCHEM, V163, P1
   Maniatis T., 1982, MOL CLONING
   NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279
   NEBERT DW, 1987, ANNU REV BIOCHEM, V56, P945, DOI 10.1146/annurev.bi.56.070187.004501
   NEBERT DW, 1989, DNA-J MOLEC CELL BIO, V8, P1, DOI 10.1089/dna.1.1989.8.1
   OKEEFE DP, 1989, PLANT PHYSIOL, V89, P1141, DOI 10.1104/pp.89.4.1141
   PELEMAN J, 1989, GENE, V84, P359, DOI 10.1016/0378-1119(89)90510-6
   SAITO K, 1989, PLANT CELL REP, V7, P607, DOI 10.1007/BF00272040
   SAITO K, 1990, PLANT CELL REP, V8, P718, DOI 10.1007/BF00272102
   SAITO K, 1991, PLANTA, V184, P40, DOI 10.1007/BF00208234
   SAITO K, 1990, PLANT CELL REP, V9, P121, DOI 10.1007/BF00232085
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   SLIGAR SG, 1986, CYTOCHROME P450 STRU, P429
   SVINGEN BA, 1979, J BIOL CHEM, V254, P5892
   TRIPPI VS, 1989, PLANT CELL PHYSL, V30, P6157
   VANDERKROL AR, 1990, PLANT CELL, V2, P291, DOI 10.1105/tpc.2.4.291
   VELTEN J, 1984, EMBO J, V3, P2723, DOI 10.1002/j.1460-2075.1984.tb02202.x
   VELTEN J, 1985, NUCLEIC ACIDS RES, V13, P6981, DOI 10.1093/nar/13.19.6981
   WEST CA, 1980, BIOCH PLANTS, V2, P317
   WHITE RE, 1980, ANNU REV BIOCHEM, V49, P315, DOI 10.1146/annurev.bi.49.070180.001531
NR 43
TC 41
Z9 53
U1 0
U2 2
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG
PY 1991
VL 88
IS 16
BP 7041
EP 7045
DI 10.1073/pnas.88.16.7041
PG 5
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA GB701
UT WOS:A1991GB70100029
PM 1714583
OA Green Published
DA 2024-02-19
ER

PT J
AU Siddiqi, KA
   Ostermann, J
   Zhang, JJ
   Khan, MM
   Olatosi, B
AF Siddiqi, Khairul A.
   Ostermann, Jan
   Zhang, Jiajia
   Khan, M. Mahmud
   Olatosi, Bankole
TI Ageing with HIV in the United States: Changing trends in inpatient
   hospital stays and comorbidities, 2003-2015
SO HIV MEDICINE
LA English
DT Article; Early Access
DE ageing; chronic conditions; comorbidities; HIV; hospitalizations
ID HUMAN-IMMUNODEFICIENCY-VIRUS; INFECTED PATIENTS; ANTIRETROVIRAL THERAPY;
   CARE; AGE; MULTIMORBIDITY; INDIVIDUALS; MORTALITY; REASONS
AB Introduction As people with HIV (PWH) age, they experience prolonged exposure to HIV and antiretroviral therapy, increased risks of developing age-related HIV-associated non-AIDS (HANA) comorbidities and higher rates of hospitalization. Few studies have explored the ageing of PWH and its impact on hospital stays in the US. This study examined trends, characteristics and comorbidities associated with hospital stays with HIV (HSWH) as compared with hospital stays without HIV (HSWOH). Methods Thirteen years of pooled National Inpatient Sample (NIS) data from 2003 through 2015 were analysed to describe yearly trends. Trends were evaluated for eight major HANA conditions (cardiovascular disease, cancer, diabetes, liver disease, bone loss, kidney disease, pulmonary disease and neurological disease) across four age groups (18-34, 35-49, 50-64, 65+ years). Results Although overall rates of hospitalization reduced across all age groups, the proportion of HIV-related hospitalization increased among older Americans. The average number of chronic conditions was higher for HSWH among all age groups and disproportionately increased for older PWH. Although age-adjusted rates of cardiovascular disease, cancer, bone loss and pulmonary disease were lower for HSWH relative to HSWOH, rates increased disproportionately over the study period. The prevalence of all major HANA conditions except cancer and diabetes increased among the elderly (65+), and the prevalence of cardiovascular disease, cancer, bone loss, kidney disease and pulmonary disease also increased among patients aged 50-64 years. Conclusions Higher rates of hospitalizations and HANA comorbidities were observed among older HIV patients. The ageing of PWH suggests increased future hospital resource utilization for HSWH. Appropriate training of healthcare providers is essential to managing increased comorbidity burdens of older PWH during hospital stays in the US.
C1 [Siddiqi, Khairul A.] Univ Florida, Coll Med, Room 188,2197 Mowry Rd, Gainesville, FL 32608 USA.
   [Ostermann, Jan; Zhang, Jiajia; Olatosi, Bankole] Univ South Carolina, Columbia, SC 29208 USA.
   [Khan, M. Mahmud] Univ Georgia, Athens, GA 30602 USA.
C3 State University System of Florida; University of Florida; University of
   South Carolina System; University of South Carolina Columbia; University
   System of Georgia; University of Georgia
RP Siddiqi, KA (corresponding author), Univ Florida, Coll Med, Room 188,2197 Mowry Rd, Gainesville, FL 32608 USA.
EM ksiddiqi@ufl.edu
RI Olatosi, Bankole/ABU-8851-2022; Ostermann, Jan/GQB-4743-2022; Siddiqi,
   Khairul Alam/IQS-1625-2023
OI Olatosi, Bankole/0000-0002-8295-8735; Siddiqi, Khairul
   Alam/0000-0002-6780-7621; Ostermann, Jan/0000-0002-8236-9500
FU Office of the Vice President for Research at the University of South
   Carolina; University of South Carolina
FX Office of the Vice President for Research at the University of South
   Carolina; University of South Carolina
CR Ahn MY, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25228
   Akgün KM, 2014, JAIDS-J ACQ IMM DEF, V67, P397, DOI 10.1097/QAI.0000000000000341
   Alfano G, 2019, J CLIN MED, V8, DOI 10.3390/jcm8081254
   [Anonymous], 2021, 2018 INTRO NIS
   [Anonymous], 2015, HCUP USING MULTIPLE
   [Anonymous], 2018, Producing National HCUP Estimates-Accessible Version. Healthcare Cost and Utilization Project (HCUP)
   Asrani SK, 2018, GASTROENTEROLOGY, V155, P719, DOI 10.1053/j.gastro.2018.05.032
   Baynes HW, 2017, HIV AIDS-RES PALLIAT, V9, P1, DOI 10.2147/HIV.S120979
   Berry SA, 2012, JAIDS-J ACQ IMM DEF, V59, P368, DOI 10.1097/QAI.0b013e318246b862
   Bigna JJ, 2018, LANCET GLOB HEALTH, V6, pE182, DOI 10.1016/S2214-109X(17)30451-5
   Bradley H, 2014, MMWR-MORBID MORTAL W, V63, P1113
   Center for Disease Control and Prevention, 2020, HIV SURVEILLANCE REP, P16
   Centers for Disease Control and Prevention, 2018, HIV PEOPL AG 50 OV
   Chawla A, 2018, INFECT DIS THER, V7, P183, DOI 10.1007/s40121-018-0201-6
   Crowell TA, 2015, J INFECT DIS, V211, P1692, DOI 10.1093/infdis/jiu809
   Crum-Cianflone NF, 2010, JAIDS-J ACQ IMM DEF, V54, P248, DOI 10.1097/QAI.0b013e3181c8ef22
   Desai Seema, 2010, Curr HIV/AIDS Rep, V7, P4, DOI 10.1007/s11904-009-0038-4
   Fleishman JA, 2005, MED CARE, V43, P40
   Fleming J., 2019, AIDS CARE, V5, P1
   Gallant J, 2017, J INFECT DIS, V216, P1525, DOI 10.1093/infdis/jix518
   Guaraldi G., 2016, MANAGING OLDER ADULT, P19
   Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627
   Guardigni V., 2018, INFECT DIS SPECIAL I, P77
   Harris CM, 2015, J COMMUNITY HOSP INT, V5, DOI 10.3402/jchimp.v5.29428
   Hashimoto Robin E, 2014, Evid Based Spine Care J, V5, P74, DOI 10.1055/s-0034-1390027
   HCUP, 2008, NIS DESCR DAT EL
   Heslin, 2016, HCUP STAT BRIEF 206
   High KP, 2012, JAIDS-J ACQ IMM DEF, V60, pS1, DOI 10.1097/QAI.0b013e31825a3668
   Hirode G, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.1997
   Houchens R., 2014, Nationwide Inpatient Sample (NIS) resdesign final report
   Institute of Medicine Committee on the Future Health Care Workforce for Older Americans, 2008, RET AG AM BUILD HLTH, DOI [10.17226/12089, DOI 10.17226/12089]
   Kim DJ, 2012, JAIDS-J ACQ IMM DEF, V61, P600, DOI 10.1097/QAI.0b013e31827303d5
   King JT, 2015, JAMA SURG, V150, P343, DOI 10.1001/jamasurg.2014.2257
   Maciel RA, 2018, INT J INFECT DIS, V70, P30, DOI 10.1016/j.ijid.2018.02.009
   Mayer KH, 2018, PUBLIC HEALTH REP, V133, P109, DOI 10.1177/0033354917748670
   National Institute of Allergy and Infectious Diseases, 2018, ANT VIRL DRUG DIS DE
   Nguyen N, 2008, CLIN INTERV AGING, V3, P453
   Pathai S, 2014, J GERONTOL A-BIOL, V69, P833, DOI 10.1093/gerona/glt168
   Pebody R., 2019, TREATMENT OUTCOMES L
   Rodriguez-Penney AT, 2013, AIDS PATIENT CARE ST, V27, P5, DOI 10.1089/apc.2012.0329
   Ruzicka DJ, 2019, J INFECT CHEMOTHER, V25, P89, DOI 10.1016/j.jiac.2018.10.006
   Sarrazin MSV, 2012, JAMA-J AM MED ASSOC, V307, P1433, DOI 10.1001/jama.2012.404
   Schouten J, 2014, CLIN INFECT DIS, V59, P1787, DOI 10.1093/cid/ciu701
   Smit M, 2015, LANCET INFECT DIS, V15, P810, DOI 10.1016/S1473-3099(15)00056-0
   Tadros A, 2012, J EMERG MED, V43, P1138, DOI 10.1016/j.jemermed.2012.02.028
   U.S. Census Bureau, 2019, INT DAT BAS
   U.S. Census Bureau, 2020, AGE SEX COMPOSITION
   United States Senate, 2013, OLD AM CHANG FAC HIV
   Wing EJ., 2017, T AM CLIN CLIMAT ASS, V128, P131, DOI DOI 10.1016/J.IJID.2016.10.004
   Wong C, 2018, CLIN INFECT DIS, V66, P1230, DOI 10.1093/cid/cix998
   Zhao Y., 2007, HEALTHCARE COST UTIL
NR 51
TC 3
Z9 3
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1464-2662
EI 1468-1293
J9 HIV MED
JI HIV Med.
PD 2023 JAN
PY 2023
VL 24
IS 1
BP 93
EP 103
DI 10.1111/hiv.13325
EA JUN 2022
PG 11
WC Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases
GA 8B3TK
UT WOS:000807479300001
PM 35674220
DA 2024-02-19
ER

PT J
AU Wang, YQ
   Cui, XJ
   Lin, QL
   Cai, J
   Tang, LH
   Liang, Y
AF Wang, Yuqian
   Cui, Xiaoji
   Lin, Qinlu
   Cai, Jie
   Tang, Liuhuan
   Liang, Ying
TI Active Peptide KF-8 from Rice Bran Attenuates Oxidative Stress in a
   Mouse Model of Aging Induced by D-Galactose
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE KF-8; oxidative stress; aging NF-kappa B; Nrf2
AB This study investigated the effects of a physiologically active peptide derived from rice bran (KF-8) on oxidative stress in D-galactose (D-gal)-induced aging mice and the underlying molecular mechanisms. The aging model was developed by subcutaneously injecting Institute of Cancer Research mice with 250 mg/kg D-gal daily for 12 weeks and simultaneously treating them with 30 mg/kg KF-8. The relative expression levels of Nrf2 and NF-kappa B in the liver were determined by the western blot. The regulation of Nrf2 and NF-kappa Bp65 by KF-8 was further validated in NIH/3T3 cells. Compared with the control mice, the aging mice had significantly decreased body weights as well as superoxide dismutase and GSH-Px levels (p < 0.05); however, they had increased serum reactive oxygen species and malondialdehyde and 8-hydroxydeoxyguanosine levels accompanied by aortic and brain injuries. They also had elevated RAGE, TLR4, I kappa B, Box, and caspase-8 expressions and NF-kappa B/p65 phosphorylation but reduced BcL-2 expression in the liver. Moreover, in vitro experiments demonstrated that the pretreatment of H2O2 -treated NIH/3T3 cells with KF8 significantly mitigated the NF-kappa B signaling and attenuated the Nrf2 nuclear transport (both p < 0.05). In conclusion, KF-8 treatment inhibited aging-induced oxidative stress-related organ injury in mice by attenuating NF-kappa B/p38 signaling and preserving Nrf2 activity.
C1 [Wang, Yuqian; Cui, Xiaoji; Lin, Qinlu; Cai, Jie; Tang, Liuhuan; Liang, Ying] Cent South Univ Forestry & Technol, Coll Food Sci & Engn, Mol Nutr Branch, Natl Engn Lab Rice & Byprod Deep Proc, Changsha 410004, Hunan, Peoples R China.
C3 Central South University of Forestry & Technology
RP Liang, Y (corresponding author), Cent South Univ Forestry & Technol, Coll Food Sci & Engn, Mol Nutr Branch, Natl Engn Lab Rice & Byprod Deep Proc, Changsha 410004, Hunan, Peoples R China.
EM liangying498@163.com
OI Liang, Ying/0000-0002-6216-4743
FU Natural Science Foundation of Hunan Province [2020JJ4138]; National
   Natural Science Foundation of China [31201348]; Hunan Furong Scholars
   Program; Huxiang Youth Talents Supporting Program [2016RS3033];
   Scientific Research Foundation of Hunan Provincial Education Department
   [18A160]; Grain-oil Process and Quality Control 2011 Collaborative and
   Innovative Grant from Hunan Province
FX This work was supported by funding from the Natural Science Foundation
   of Hunan Province (no. 2020JJ4138), the National Natural Science
   Foundation of China (no. 31201348), Hunan Furong Scholars Program,
   Huxiang Youth Talents Supporting Program (no. 2016RS3033), Scientific
   Research Foundation of Hunan Provincial Education Department (no.
   18A160), and Grain-oil Process and Quality Control 2011 Collaborative
   and Innovative Grant from Hunan Province.
CR Abrahams S, 2019, NEUROSCIENCE, V406, P1, DOI 10.1016/j.neuroscience.2019.02.020
   Ariga T, 2004, BIOFACTORS, V21, P197, DOI 10.1002/biof.552210140
   Barrera G, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7080102
   BAUER CH, 1976, BIOCHEM J, V154, P141, DOI 10.1042/bj1540141
   Tung BT, 2015, EXP GERONTOL, V64, P1, DOI 10.1016/j.exger.2015.02.004
   Campisi J, 2019, NATURE, V571, P183, DOI 10.1038/s41586-019-1365-2
   CERAMI A, 1985, J AM GERIATR SOC, V33, P626, DOI 10.1111/j.1532-5415.1985.tb06319.x
   Cheng X, 2019, NEUROCHEM INT, V122, P149, DOI 10.1016/j.neuint.2018.09.003
   da Costa JP, 2016, AGEING RES REV, V29, P90, DOI 10.1016/j.arr.2016.06.005
   Das J., Antiepileptic effect of fisetin in iron-induced experimental model of traumatic epilepsy in rats in the light of electrophysiological, biochemical, and behavioral observations
   Dehghani A, 2019, AGING CLIN EXP RES, V31, P1195, DOI 10.1007/s40520-018-1075-x
   Dong FX, 2017, BIOCHEM BIOPH RES CO, V491, P636, DOI 10.1016/j.bbrc.2017.07.151
   Dong ZY, 2017, EXP THER MED, V14, P616, DOI 10.3892/etm.2017.4514
   Finkel T, 1998, CURR OPIN CELL BIOL, V10, P248, DOI 10.1016/S0955-0674(98)80147-6
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016
   Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057
   Fu W, 2017, BEHAV BRAIN RES, V328, P81, DOI 10.1016/j.bbr.2017.04.012
   Gaona-Gaona L, 2011, TOXICOLOGY, V286, P20, DOI 10.1016/j.tox.2011.04.014
   Gebicki JM, 2016, ARCH BIOCHEM BIOPHYS, V595, P33, DOI 10.1016/j.abb.2015.10.021
   Ginés C, 2017, EXP GERONTOL, V90, P61, DOI 10.1016/j.exger.2017.01.021
   Grilli M, 1999, CELL DEATH DIFFER, V6, P22, DOI 10.1038/sj.cdd.4400463
   Guo Y, 2018, BBA-MOL BASIS DIS, V1864, P238, DOI 10.1016/j.bbadis.2017.09.029
   Hagl S, 2015, J ALZHEIMERS DIS, V43, P927, DOI 10.3233/JAD-132084
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hayyan M, 2016, CHEM REV, V116, P3029, DOI 10.1021/acs.chemrev.5b00407
   He M, 2009, BIOL PHARM BULL, V32, P55, DOI 10.1248/bpb.32.55
   Helenius M, 1996, J MOL CELL CARDIOL, V28, P487, DOI 10.1006/jmcc.1996.0045
   Horie K., INHIBITION CANONICAL
   Horie K, 2014, ONCOL RES, V22, P105, DOI 10.3727/096504014X14146137738628
   Hosseini M, 2018, DRUG CHEM TOXICOL, V41, P175, DOI 10.1080/01480545.2017.1336173
   Jeong H, 2017, EXP GERONTOL, V95, P16, DOI 10.1016/j.exger.2017.05.004
   Jing HJ, 2018, INT J BIOL MACROMOL, V106, P1270, DOI 10.1016/j.ijbiomac.2017.08.138
   Kaviani E, 2017, BEHAV BRAIN RES, V334, P55, DOI 10.1016/j.bbr.2017.07.029
   Ki YW, 2013, TOXICOL LETT, V218, P235, DOI 10.1016/j.toxlet.2013.02.003
   Kong SZ, 2018, MAR DRUGS, V16, DOI 10.3390/md16060181
   Kumar A, 2011, J ASIAN NAT PROD RES, V13, P42, DOI 10.1080/10286020.2010.544253
   Lampiasi N, 2009, MOL PHARMACOL, V76, P290, DOI 10.1124/mol.109.055418
   Li F, 2015, CARDIOLOGY, V130, P55, DOI 10.1159/000369126
   Liang Y, 2018, J AGR FOOD CHEM, V66, P440, DOI 10.1021/acs.jafc.7b04036
   Lobo V, 2010, Pharmacogn Rev, V4, P118, DOI 10.4103/0973-7847.70902
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Ma YJ, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/8938207
   Manosroi A, 2012, PHARM BIOL, V50, P208, DOI 10.3109/13880209.2011.596206
   Mecocci P, 2018, J ALZHEIMERS DIS, V62, P1319, DOI 10.3233/JAD-170732
   Moon JM, 2018, MOLECULES, V23, DOI 10.3390/molecules23092254
   Nishimura D., INT J-TORONTO
   Park C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082308
   Poynter ME, 1998, J BIOL CHEM, V273, P32833, DOI 10.1074/jbc.273.49.32833
   Qiu WJ, 2020, FOOD CHEM TOXICOL, V135, DOI 10.1016/j.fct.2019.110881
   Raina AK, 2000, CLIN CHEM LAB MED, V38, P93, DOI 10.1515/CCLM.2000.015
   Saleh DO, 2019, EUR J PHARMACOL, V855, P40, DOI 10.1016/j.ejphar.2019.04.043
   Schmitt W, 2008, TOXICOL IN VITRO, V22, P457, DOI 10.1016/j.tiv.2007.09.010
   Singh A, 2016, ACS CHEM BIOL, V11, P3214, DOI 10.1021/acschembio.6b00651
   Sivandzade F, 2019, REDOX BIOL, V21, DOI 10.1016/j.redox.2018.11.017
   Suji G., 2008, TOXICOL IN VITRO, DOI DOI 10.1016/j.tiv.2007.12.003
   SUPAKAR PC, 1995, J BIOL CHEM, V270, P837, DOI 10.1074/jbc.270.2.837
   Takahashi T, 2016, YONAGO ACTA MED, V59, P188
   Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684
   Wakeman D, 2012, AM J PHYSIOL-GASTR L, V302, pG997, DOI 10.1152/ajpgi.00485.2011
   Wang HL, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/9741369
   Wang ZL, 2018, MOL MED REP, V17, P6269, DOI 10.3892/mmr.2018.8659
   Wu F, 2013, NEUROCHEM INT, V63, P133, DOI 10.1016/j.neuint.2013.05.006
   Xiao DF, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/9719618
   Yang YC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/980276
   Yi R, 2013, AFR J TRADIT COMPLEM, V10, P171
   Zhang H.-f., OXID MED CELL LONGEV
   Zhang HQ, 2015, FREE RADICAL BIO MED, V88, P314, DOI 10.1016/j.freeradbiomed.2015.05.036
   Zhang RF, 2014, ECOTOXICOLOGY, V23, P641, DOI 10.1007/s10646-014-1228-4
   Zhang ZF, 2010, FOOD CHEM TOXICOL, V48, P2500, DOI 10.1016/j.fct.2010.06.023
   Zhu JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101291
   Zhu SY, 2017, BIOMED ENVIRON SCI, V30, P623, DOI 10.3967/bes2017.083
NR 72
TC 23
Z9 23
U1 3
U2 39
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD NOV 4
PY 2020
VL 68
IS 44
BP 12271
EP 12283
DI 10.1021/acs.jafc.0c04358
PG 13
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Chemistry; Food Science & Technology
GA OR3NA
UT WOS:000589379300010
PM 32942847
DA 2024-02-19
ER

PT J
AU Hernández-Breijo, B
   Monserrat, J
   Román, ID
   González-Rodríguez, A
   Fernández-Moreno, MD
   Lobo, MVT
   Valverde, AM
   Gisbert, JP
   Guijarro, LG
AF Hernandez-Breijo, Borja
   Monserrat, Jorge
   Roman, Irene D.
   Gonzalez-Rodriguez, Agueda
   Dolores Fernandez-Moreno, Ma
   Lobo, Ma Val T.
   Valverde, Angela M.
   Gisbert, Javier P.
   Guijarro, Luis G.
TI Azathioprine desensitizes liver cancer cells to insulin-like growth
   factor 1 and causes apoptosis when it is combined with bafilomycin A1
SO TOXICOLOGY AND APPLIED PHARMACOLOGY
LA English
DT Article
DE Senescence; Apoptosis; Autophagy; Thiopurine; Cancer; Desensitization
ID CELLULAR SENESCENCE; SIGNALING PATHWAY; HUMAN HEPATOMA; UP-REGULATION;
   FACTOR-I; AUTOPHAGY; ACTIVATION; EXPRESSION; RECEPTOR; KINASE
AB Hepatoblastoma is a primary liver cancer that affects children, due to the sensitivity of this tumor to insulin-like growth factor 1 (IGF-1). In this paper we show that azathioprine (AZA) is capable of inhibiting IGF1-mediated signaling cascade in HepG2 cells. The efficiency of AZA on inhibition of proliferation differs in the evaluated cell lines as follows: HepG2 (an experimental model of hepatoblastoma) > Hep3B (derived from a hepatocellular carcinoma) > HuH6 (derived from a hepatoblastoma) >> HuH7 (derived from a hepatocellular carcinoma) = Chang Liver cells (a non-malignant cellular model). The effect of AZA in HepG2 cells has been proven to derive from activation of Ras/ERK/TSC2, leading to activation of mTOR/p70S6K in a sustained manner. p70S6K phosphorylates IRS-1 in serine 307 which leads to the uncoupling between IRS-1 and p85 (the regulatory subunit of PI3K) and therefore causing the lack of response of HepG2 to IGF-1. As a consequence, proliferation induced by IGF-1 is inhibited by AZA and autophagy increases leading to senescence of HepG2 cells. Our results suggest that AZA induces the autophagic process in HepG2 activating senescence, and driving to deceleration of cell cycle but not to apoptosis. However, when simultaneous to AZA treatment the autophagy was inhibited by bafilomycin A1 and the degradation of regulatory proteins of cell cycle (e.g. Rb, E2F, and cyclin D1) provoked apoptosis. In conclusion, AZA induces resistance in hepatoblastoma cells to IGF-1, which leads to autophagy activation, and causes apoptosis when it is combined with bafilomycin A1. We are presenting here a novel mechanism of action of azathioprine, which could be useful in treatment of IGF-1 dependent tumors, especially in its combination with other drugs. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Hernandez-Breijo, Borja; Roman, Irene D.; Dolores Fernandez-Moreno, Ma; Guijarro, Luis G.] Univ Alcala, Dept Biol Sistemas, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Alcala De Henares 28871, Spain.
   [Monserrat, Jorge] Univ Alcala, Dept Med & Especialidades Med, E-28871 Alcala De Henares, Spain.
   [Gonzalez-Rodriguez, Agueda; Valverde, Angela M.] Univ Alcala, Inst Ramon & Cajal Invest Sanitaria IRYCIS, Dept Biomed & Biotecnol, Alcala De Henares 28871, Spain.
   [Lobo, Ma Val T.] ISCIII, Ctr Invest Biomed Red Diabet & Enfermedade Metab, Inst Invest Biomed Alberto Sols CSIC UAM, Madrid 28029, Spain.
   [Gisbert, Javier P.] Hosp Univ La Princesa, Unidad Gastroenterol, Inst Invest Sanitaria Princesa, Madrid 28006, Spain.
   [Gisbert, Javier P.] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid 28006, Spain.
C3 Universidad de Alcala; CIBER - Centro de Investigacion Biomedica en Red;
   CIBEREHD; Universidad de Alcala; Universidad de Alcala; Consejo Superior
   de Investigaciones Cientificas (CSIC); CSIC - Instituto de
   Investigaciones Biomedicas Alberto Sols (IIBM); Instituto de Salud
   Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD
RP Guijarro, LG (corresponding author), Univ Alcala, Dept Biol Sistemas, E-28871 Alcala De Henares, Spain.
EM luis_guijarro@telefonica.net
RI Gisbert, Javier P/GRY-2719-2022; Hernández-Breijo, Borja/M-2508-2019;
   Gisbert, Javier P/ABB-7531-2021; Gonzalez-Rodriguez, Agueda/D-7651-2012
OI Gisbert, Javier P/0000-0003-2090-3445; Roman, Irene
   D/0000-0002-4897-1549; Gonzalez-Rodriguez, Agueda/0000-0003-2851-2318;
   Gonzalez-Rodriguez, Agueda/0000-0001-6559-0847; Martinez Valverde,
   Angela/0000-0003-1192-9045
FU Spanish Science and Education Ministry [SAF2008-05355]; Comunidad de
   Madrid [CCG10-UAH/BlO-5971, S2010/BMD-2423]
FX The authors thank Dr. Vicente Barrios for advising on the
   immunoprecipitation of IRS1. The authors thank Dr. Patricia Boya for
   providing LC-3 antibody for immunocytochemistry. We thank Instalacion
   Radiactiva and Unidad de Cultivos Celulares from Universidad de Alcala
   for the technical help. The authors also thank M. Galan for linguistic
   assistance. This work was supported by the Spanish Science and Education
   Ministry [Grant SAF2008-05355] and by the Comunidad de Madrid [Grants
   CCG10-UAH/BlO-5971, S2010/BMD-2423].
CR Abe K, 2000, NEUROSCI RES, V38, P325, DOI 10.1016/S0168-0102(00)00188-7
   Adesina AM, 2009, HUM PATHOL, V40, P843, DOI 10.1016/j.humpath.2008.10.022
   Afshari CA, 1996, CELL GROWTH DIFFER, V7, P979
   Alexia C, 2004, ANN NY ACAD SCI, V1030, P219, DOI 10.1196/annals.1329.028
   Arvisais E, 2010, MOL ENDOCRINOL, V24, P632, DOI 10.1210/me.2009-0312
   BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320
   Bose SK, 2012, J VIROL, V86, P6315, DOI 10.1128/JVI.00050-12
   Cantarini MC, 2006, HEPATOLOGY, V44, P446, DOI 10.1002/hep.21272
   Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7
   Cheng YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030437
   Cuevas EP, 2007, J HEPATOL, V46, P1089, DOI 10.1016/j.jhep.2007.01.031
   Cuevas EP, 2009, J CELL BIOCHEM, V108, P1292, DOI 10.1002/jcb.22359
   de Keizer PLJ, 2010, CANCER RES, V70, P8526, DOI 10.1158/0008-5472.CAN-10-1563
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   El-Serag H, 2003, ANN INTERN MED, V139, P817, DOI 10.7326/0003-4819-139-10-200311180-00009
   Gong K, 2012, J BIOL CHEM, V287, P35576, DOI 10.1074/jbc.M112.370585
   González-Rodriguez A, 2009, HEPATOLOGY, V50, P216, DOI 10.1002/hep.22915
   Guijarro LG, 2012, CURR DRUG METAB, V13, P1267
   Hernández-Breijo B, 2011, WORLD J GASTROENTERO, V17, P3899, DOI 10.3748/wjg.v17.i34.3899
   Hewish M, 2009, RECENT PAT ANTI-CANC, V4, P54, DOI 10.2174/157489209787002515
   Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010
   Jia GH, 2006, IMMUNOL CELL BIOL, V84, P448, DOI 10.1111/j.1440-1711.2006.01454.x
   Kanazawa Shinichiro, 1994, Kobe Journal of Medical Sciences, V40, P165
   Kanazawa T, 2004, J BIOL CHEM, V279, P8452, DOI 10.1074/jbc.M306337200
   Kanematsu S, 2010, ANTICANCER RES, V30, P3381
   Kashima H, 2009, ENDOCR-RELAT CANCER, V16, P113, DOI 10.1677/ERC-08-0117
   Kawaguchi T, 2011, INT J ONCOL, V38, P643, DOI 10.3892/ijo.2010.882
   Kim SY, 2009, ONCOLOGIST, V14, P83, DOI 10.1634/theoncologist.2008-0189
   Kim TR, 2010, BIOCHEM BIOPH RES CO, V400, P100, DOI 10.1016/j.bbrc.2010.08.018
   Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857
   Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660
   Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031
   Malogolowkin MH, 2008, J CLIN ONCOL, V26, P2379, DOI 10.1200/JCO.2006.09.7204
   Menor C, 2004, J PHARMACOL EXP THER, V311, P668, DOI 10.1124/jpet.104.069286
   Niu J, 2008, J CANCER RES CLIN, V134, P503, DOI 10.1007/s00432-007-0314-x
   Park SH, 2011, CANCER LETT, V310, P232, DOI 10.1016/j.canlet.2011.07.009
   Rosenzweig SA, 2010, BIOCHEM PHARMACOL, V80, P1115, DOI 10.1016/j.bcp.2010.06.013
   Scharf JG, 2001, J CLIN PATHOL-MOL PA, V54, P138, DOI 10.1136/mp.54.3.138
   Schmitz-Peiffer C, 2003, IUBMB LIFE, V55, P367, DOI 10.1080/1521654031000138569
   Shin E, 2011, VIRCHOWS ARCH, V458, P453, DOI 10.1007/s00428-011-1043-8
   Sivaprakasam P, 2011, J PEDIAT HEMATOL ONC, V33, pE226, DOI 10.1097/MPH.0b013e31821f0eaf
   SU TS, 1989, CANCER RES, V49, P1773
   Takeda S, 1996, ONCOGENE, V12, P1589
   Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013
   Wu J, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-30
   Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1
   Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709
   Zeng XH, 2008, CANCER RES, V68, P2384, DOI 10.1158/0008-5472.CAN-07-6163
   Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200
NR 49
TC 11
Z9 15
U1 0
U2 24
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0041-008X
EI 1096-0333
J9 TOXICOL APPL PHARM
JI Toxicol. Appl. Pharmacol.
PD NOV 1
PY 2013
VL 272
IS 3
BP 568
EP 578
DI 10.1016/j.taap.2013.07.024
PG 11
WC Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Toxicology
GA 241BM
UT WOS:000326141400002
PM 23958494
DA 2024-02-19
ER

PT J
AU Lee, BS
   So, WY
   Kim, SH
   Yoon, JH
AF Lee, Bang Sub
   So, Wi-Young
   Kim, Sang-Hoon
   Yoon, Jin-Ho
TI EXPRESSION PROFILES OF CYTOCHROME P450S FOLLOWING SWIMMING EXERCISE IN
   AGING RATS
SO JOURNAL OF MENS HEALTH
LA English
DT Article
DE aging; cytochrome P450s; exercise; nuclear receptors; rat; swimming
ID DRUG-METABOLISM; ANTIPYRINE CLEARANCE; PHYSICAL-EXERCISE;
   SKELETAL-MUSCLE; GENE-EXPRESSION; LIVER; ENZYMES; TRANSPORTERS;
   BIOCHEMISTRY; INTESTINE
AB Background and Objective
   Cytochrome P450s (CYPs) are the major drug-metabolizing enzymes responsible for the clearance of approximately 75% of all drugs in clinical use. Drug clearance may be reduced with aging, resulting in increased drug toxicity in the elderly. Here, we evaluated changes in CYP expression following exercise in an aging rat model.
   Materials and Methods
   Sixteen male Sprague-Dawley rats were grouped into control (n = 5), short-term exercise (SE) (n = 4), and long-term exercise (LE) (n = 7) groups and changes in CYPs and nuclear receptors (NRs) were measured with aging.
   Results
   CYP2C22, CYP3A1, and CYP2C11 mRNAs were up-regulated, whereas CYP26B1 was downregulated in the SE and LE groups compared with the control group. Moreover, mRNA levels of the NRs, constitutive androstane receptor, retinoid X receptor a, peroxisome proliferator-activated receptor, and pregnane X receptor, were significantly increased in the LE group compared with those in the control group. As an indicator of more long-term changes, protein levels of CYP2C11, CYP2B, CYP1A, CYP2C, and CYP2C22 were significantly up-regulated in the LE group compared with the control group. Overall, our data show that CYP and NR expression increased in rats with forced long-term exercise during aging.
   Conclusion
   Therefore, we propose that regular swimming exercise may increase CYP levels, resulting in enhanced drug clearance and thereby reducing age-related drug toxicity in elderly individuals.
C1 [Lee, Bang Sub; So, Wi-Young] Korea Natl Univ Transportat, Coll Humanities & Arts, Sports & Hlth Care Major, Chungju Si 27469, South Korea.
   [Kim, Sang-Hoon] Korea Athlet Training Res Inst, Seoul 05392, South Korea.
   [Yoon, Jin-Ho] Far East Univ, Dept Sport & Leisure Studies, Chungbuk 27601, South Korea.
C3 Korea National University of Transportation
RP Yoon, JH (corresponding author), Far East Univ, Dept Sport & Leisure Studies, Chungbuk 27601, South Korea.
EM tkd97@daum.net
CR BOEL J, 1984, CLIN PHARMACOL THER, V36, P121, DOI 10.1038/clpt.1984.149
   Cuciureanu Magdalena, 2010, Rev Med Chir Soc Med Nat Iasi, V114, P885
   De Stefano F, 2015, J NUTR HEALTH AGING, V19, P785, DOI 10.1007/s12603-015-0482-3
   FABBRI A, 1991, ITAL J GASTROENTEROL, V23, P74
   FRENKL R, 1976, ACTA MED HUNG, V33, P95
   FRENKL R, 1980, EUR J APPL PHYSIOL O, V44, P135, DOI 10.1007/BF00421091
   FRENKL R, 1980, J SPORT MED PHYS FIT, V20, P371
   Fu ZD, 2014, TOXICOL APPL PHARM, V274, P137, DOI 10.1016/j.taap.2013.11.003
   GUENGERICH FP, 1994, ENVIRON HEALTH PERSP, V102, P49, DOI 10.1289/ehp.94102s949
   Habano W, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-81
   Iemitsu M, 2002, AM J PHYSIOL-HEART C, V283, pH1750, DOI 10.1152/ajpheart.01051.2001
   JORQUERA F, 1995, J CLIN PHARMACOL, V35, P895, DOI 10.1002/j.1552-4604.1995.tb04134.x
   Kochanska-Dziurowicz AA, 2015, J SPORT MED PHYS FIT, V55, P158
   Kvernmo HD, 1997, THROMB RES, V87, P559, DOI 10.1016/S0049-3848(97)00185-0
   Lee CM, 2008, J BIOL CHEM, V283, P889, DOI 10.1074/jbc.M708821200
   Lee JS, 2008, TOXICOL SCI, V106, P263, DOI 10.1093/toxsci/kfn144
   Liptrott NJ, 2009, BRIT J PHARMACOL, V156, P497, DOI 10.1111/j.1476-5381.2008.00050.x
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Makanae Y, 2015, EXP PHYSIOL, V100, P1168, DOI 10.1113/EP085207
   Martignoni M, 2006, DRUG METAB DISPOS, V34, P1047, DOI 10.1124/dmd.105.009035
   Mauriz JL, 2000, EUR J APPL PHYSIOL, V81, P62, DOI 10.1007/PL00013798
   ORIOLI S, 1990, J SPORT MED PHYS FIT, V30, P261
   Paterson DH, 2007, APPL PHYSIOL NUTR ME, V32, pS69, DOI 10.1139/H07-111
   PIATKOWSKI TS, 1993, DRUG METAB DISPOS, V21, P474
   Pinto PR, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0093-3
   Sato K, 2015, J STEROID BIOCHEM, V145, P200, DOI 10.1016/j.jsbmb.2014.03.009
   SCHMUCKER DL, 1990, HEPATOLOGY, V12, P1216, DOI 10.1002/hep.1840120523
   Smith DA, 1998, XENOBIOTICA, V28, P1095, DOI 10.1080/004982598238859
   Staskin DR, 2005, DRUG AGING, V22, P1013, DOI 10.2165/00002512-200522120-00003
   Stupans I, 2001, FOOD CHEM TOXICOL, V39, P1119, DOI 10.1016/S0278-6915(01)00060-6
   Takizawa D, 2011, CARCINOGENESIS, V32, P576, DOI 10.1093/carcin/bgq277
   Testa B, 2007, CHEM BIODIVERS, V4, P2031, DOI 10.1002/cbdv.200790169
   Testa B, 2007, CHEM BIODIVERS, V4, P257, DOI 10.1002/cbdv.200790032
   VANBEZOOIJEN RL, 1994, EXP GERONTOL, V29, P187, DOI 10.1016/0531-5565(94)90050-7
   Villa JG, 1998, EUR J APPL PHYSIOL O, V77, P106
   Vyskocilová E, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/408573
   Wada T, 2009, TRENDS ENDOCRIN MET, V20, P273, DOI 10.1016/j.tem.2009.03.003
   WANG P, 1980, ARCH BIOCHEM BIOPHYS, V199, P206, DOI 10.1016/0003-9861(80)90274-X
   Ware WR, 2009, INTEGR CANCER THER, V8, P22, DOI 10.1177/1534735408328573
   Warrington JS, 2004, J PHARMACOL EXP THER, V309, P720, DOI 10.1124/jpet.103.061077
   Wauthier V, 2007, CURR MED CHEM, V14, P745, DOI 10.2174/092986707780090981
   Yun KU, 2010, ARCH TOXICOL, V84, P939, DOI 10.1007/s00204-010-0520-1
NR 42
TC 2
Z9 2
U1 0
U2 8
PU DOUGMAR PUBLISHING GROUP INC
PI HAMILTON
PA 1 HUNTER ST E STE G-100, HAMILTON, ONTARIO L8N-3W1, CANADA
SN 1875-6859
J9 J MENS HEALTH
JI J. Mens Health
PY 2017
VL 13
IS 2
BP E25
EP E33
DI 10.22374/1875-6859.13.2.4
PG 9
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA FR2EL
UT WOS:000418879700004
OA gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Haynes, V
   Traaseth, NJ
   Elfering, S
   Fujisawa, Y
   Giulivi, C
AF Haynes, Virginia
   Traaseth, Nathaniel J.
   Elfering, Sarah
   Fujisawa, Yasuko
   Giulivi, Cecilia
TI Nitration of specific tyrosines in F<sub>o</sub>F<sub>1</sub> ATP
   synthase and activity loss in aging
SO AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
LA English
DT Article
DE adenosine 5 '-triphosphate; adenosine 5 '-triphosphatase; mitochondria;
   bioenergetics; biomarker
ID NUCLEOTIDE BINDING-SITES; METHIONINE SULFOXIDE RESIDUES; NITRIC-OXIDE
   REGULATION; RAT-LIVER MITOCHONDRIA; BEEF-HEART F1-ATPASE;
   ADENOSINE-TRIPHOSPHATASE; OXIDATIVE-PHOSPHORYLATION; ENERGY-METABOLISM;
   BETA-SUBUNIT; IDENTIFICATION
AB Haynes V, Traaseth NJ, Elfering S, Fujisawa Y, Giulivi C. Nitration of specific tyrosines in FoF1 ATP synthase and activity loss in aging. Am J Physiol Endocrinol Metab 298: E978-E987, 2010. First published February 16, 2010; doi: 10.1152/ajpendo.00739.2009.-It has been reported that C-nitration of proteins occurs under nitrative/oxidative stress; however, its role in pathophysiological situations is not fully understood. In this study, we determined that nitration of Tyr(345) and Tyr(368) in the beta-subunit of the mitochondrial FoF1-ATPase is a major target for nitrative stress in rat liver under in vivo conditions. The chemical characteristics of these Tyr make them suitable for a facilitated nitration (solvent accessibility, consensus sequence, and pK(a)). Moreover, beta-subunit nitration increased significantly with the age of the rats (from 4 to 80 weeks old) and correlated with decreased ATP hydrolysis and synthesis rates. Although its affinity for ATP binding was unchanged, maximal ATPase activity decreased between young and old rats by a factor of two. These changes directly impacted the available ATP concentration in vivo, and it was expected that they would affect multiple cellular ATP-dependent processes. For instance, at least 50% of available [ATP] in the liver of older rats would have to be committed to sustain maximal Na+-K+-ATPase activity, whereas only 30% would be required for young rats. If this requirement was not fulfilled, the osmoregulation and Na+-nutrient cotransport in liver of older rats would be compromised. On the basis of our studies, we propose that targeted nitration of the beta-subunit is an early marker for nitrative stress and aging.
C1 [Fujisawa, Yasuko; Giulivi, Cecilia] Univ Calif Davis, Dept Mol Biosci, Davis, CA 95616 USA.
   [Haynes, Virginia; Traaseth, Nathaniel J.; Elfering, Sarah] Univ Minnesota, Dept Biochem & Chem, Duluth, MN 55812 USA.
C3 University of California System; University of California Davis;
   University of Minnesota System; University of Minnesota Duluth
RP Giulivi, C (corresponding author), Univ Calif Davis, Dept Mol Biosci, 1120 Haring Hall,1 Shields Ave, Davis, CA 95616 USA.
EM cgiulivi@ucdavis.edu
RI Giulivi, Cecilia/AAV-6774-2021; Giulivi, Cecilia/ABB-7809-2020;
   Traaseth, Nathaniel/B-4751-2010
OI Giulivi, Cecilia/0000-0003-1033-7435; 
FU National Institute of Environmental Health Sciences [012691, 005707]
FX This study was supported by National Institute of Environmental Health
   Sciences Grants 012691 and 005707.
CR Abello N, 2009, J PROTEOME RES, V8, P3222, DOI 10.1021/pr900039c
   ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0
   Arivazhagan P, 2004, ANN NY ACAD SCI, V1019, P350, DOI 10.1196/annals.1297.060
   Baines A, 2002, AM J PHYSIOL-RENAL, V283, pF286, DOI 10.1152/ajprenal.00330.2001
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424
   Bota DA, 2001, MITOCHONDRION, V1, P33, DOI 10.1016/S1567-7249(01)00005-8
   BROT N, 1991, BIOFACTORS, V3, P91
   BROT N, 1983, ARCH BIOCHEM BIOPHYS, V223, P271, DOI 10.1016/0003-9861(83)90592-1
   BULLOUGH DA, 1986, J BIOL CHEM, V261, P5722
   BULLOUGH DA, 1988, J BIOL CHEM, V263, P14053
   BULLOUGH DA, 1986, J BIOL CHEM, V261, P14171
   Byrne CD, 2009, CLIN SCI, V116, P539, DOI 10.1042/CS20080253
   Cadenas Enrique, 2004, Molecular Aspects of Medicine, V25, P17, DOI 10.1016/j.mam.2004.02.005
   Catterall W A, 1979, Methods Enzymol, V55, P320
   CATTERALL WA, 1971, J BIOL CHEM, V246, P4987
   CHANCE B, 1956, ADV ENZYMOL REL S BI, V17, P65
   Cooper CE, 2007, AM J PHYSIOL-CELL PH, V292, pC1993, DOI 10.1152/ajpcell.00310.2006
   CROSS RL, 1987, P NATL ACAD SCI USA, V84, P5715, DOI 10.1073/pnas.84.16.5715
   CROSS RL, 1982, J BIOL CHEM, V257, P2874
   CROSS RL, 1988, J BIOENERG BIOMEMBR, V20, P395, DOI 10.1007/BF00762200
   Davies KJA, 2006, NEUROLOGY, V66, pS93, DOI 10.1212/01.wnl.0000192308.43151.63
   DAVIES KJA, 1987, J BIOL CHEM, V262, P9902
   DRAHOTA Z, 1977, BIOCHIM BIOPHYS ACTA, V460, P541, DOI 10.1016/0005-2728(77)90093-7
   Elfering SL, 2004, AM J PHYSIOL-HEART C, V286, pH22, DOI 10.1152/ajpheart.00766.2003
   FANTES KH, 1967, NATURE, V216, P71, DOI 10.1038/216071a0
   Fujisawa Y, 2009, BIOCHEM J, V423, P219, DOI 10.1042/BJ20090594
   GALEOTTI T, 1976, CANCER RES, V36, P4175
   Giulivi C, 1998, BIOCHEM J, V332, P673, DOI 10.1042/bj3320673
   Giulivi C, 1998, J BIOL CHEM, V273, P11038, DOI 10.1074/jbc.273.18.11038
   Giulivi C, 2006, AM J PHYSIOL-CELL PH, V291, pC1225, DOI 10.1152/ajpcell.00307.2006
   Gole MD, 2000, AM J PHYSIOL-LUNG C, V278, pL961, DOI 10.1152/ajplung.2000.278.5.L961
   Goto S, 1999, MECH AGEING DEV, V107, P245, DOI 10.1016/S0047-6374(98)00133-X
   GUERRIERI F, 1981, J BIOENERG BIOMEMBR, V13, P393, DOI 10.1007/BF00743212
   Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064
   Halliwell B, 1999, FREE RADICAL RES, V31, P651, DOI 10.1080/10715769900301221
   Irie Y, 2003, P NATL ACAD SCI USA, V100, P5634, DOI 10.1073/pnas.1131756100
   Ischiropoulos H, 1998, ARCH BIOCHEM BIOPHYS, V356, P1, DOI 10.1006/abbi.1998.0755
   ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P431, DOI 10.1016/0003-9861(92)90431-U
   Kang M, 2008, FEBS LETT, V582, P3033, DOI 10.1016/j.febslet.2008.07.042
   Kaur J, 2001, NEUROSCI LETT, V301, P1, DOI 10.1016/S0304-3940(01)01576-2
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   López-Sánchez LM, 2009, PROTEOMICS, V9, P808, DOI 10.1002/pmic.200800546
   Lossa S, 2001, Horm Metab Res, V33, P343
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762
   NAIR KS, 2000, MAYO CLIN P, V75, P14
   NALIN CM, 1982, J BIOL CHEM, V257, P8055
   Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006
   Ngo JK, 2007, ANN NY ACAD SCI, V1119, P78, DOI 10.1196/annals.1404.015
   OKAMOTO H, 1977, J BIOL CHEM, V252, P6125
   Panzenböck U, 2005, BBA-PROTEINS PROTEOM, V1703, P171, DOI 10.1016/j.bbapap.2004.11.003
   PATTERSON SD, 1995, ELECTROPHORESIS, V16, P1791, DOI 10.1002/elps.11501601299
   PATTERSON SD, 1995, ELECTROPHORESIS, V16, P1104, DOI 10.1002/elps.11501601187
   Pedersen P L, 1979, Methods Enzymol, V55, P736
   PEDERSEN PL, 1978, J BIOL CHEM, V253, P2176
   PEDERSEN PL, 1981, J BIOL CHEM, V256, P1362
   PULLMAN ME, 1956, SCIENCE, V123, P1105, DOI 10.1126/science.123.3208.1105
   PULLMAN ME, 1963, J BIOL CHEM, V238, P3762
   RACKER E, 1967, J BIOL CHEM, V242, P2547
   Sandhu SK, 2003, BIOGERONTOLOGY, V4, P19, DOI 10.1023/A:1022473219044
   SCHNAITMAN C, 1968, J CELL BIOL, V38, P158, DOI 10.1083/jcb.38.1.158
   Skulachev VP, 2006, APOPTOSIS, V11, P473, DOI 10.1007/s10495-006-5881-9
   Smallwood HS, 2007, BIOCHEMISTRY-US, V46, P10498, DOI 10.1021/bi7009713
   Solien J, 2005, COMP BIOCHEM PHYS A, V142, P111, DOI 10.1016/j.cbpb.2005.05.004
   Stadtman ER, 2002, MOL CELL BIOCHEM, V234, P3, DOI 10.1023/A:1015916831583
   Steen H, 2001, J AM SOC MASS SPECTR, V12, P228, DOI 10.1016/S1044-0305(00)00219-1
   Sun HY, 1999, BIOCHEMISTRY-US, V38, P105, DOI 10.1021/bi981295k
   THAYER WS, 1979, J BIOL CHEM, V254, P7717
   TUMMINO PJ, 1991, MECH AGEING DEV, V59, P177, DOI 10.1016/0047-6374(91)90083-C
   VANROSSUM GDV, 1976, BIOCHIM BIOPHYS ACTA, V423, P111, DOI 10.1016/0005-2728(76)90105-5
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
NR 72
TC 50
Z9 51
U1 0
U2 2
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1849
EI 1522-1555
J9 AM J PHYSIOL-ENDOC M
JI Am. J. Physiol.-Endocrinol. Metab.
PD MAY
PY 2010
VL 298
IS 5
BP E978
EP E987
DI 10.1152/ajpendo.00739.2009
PG 10
WC Endocrinology & Metabolism; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Physiology
GA 582XX
UT WOS:000276635200009
PM 20159857
OA Green Published
DA 2024-02-19
ER

PT J
AU El-Far, AH
   Mohamed, HH
   Elsabagh, DA
   Mohamed, SA
   Noreldin, AE
   Al Jaouni, SK
   Alsenosy, AA
AF El-Far, Ali H.
   Mohamed, Hadeer H.
   Elsabagh, Doaa A.
   Mohamed, Shymaa A.
   Noreldin, Ahmed E.
   Al Jaouni, Soad K.
   Alsenosy, Abdelwahab A.
TI Eugenol and carvacrol attenuate brain d-galactose-induced aging-related
   oxidative alterations in rats
SO ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
LA English
DT Article; Early Access
DE Aging; Apoptosis; Anti-aging; Eugenol; Carvacrol
ID INDUCED LIVER; ANTIOXIDANT; TISSUE; STRESS; DAMAGE; PERFORMANCE;
   IMPAIRMENT; APOPTOSIS; THYMOL; INJURY
AB Aging represents the accumulation of progressive changes in a human being over time and can cover physical, psychological, and social changes. It is an oxidative stress-associated process that progresses with age. The antioxidant activity of either eugenol (EU) or carvacrol (CAR) for aging in rats induced by d-gal for 42 days was investigated in the current study using 10 and 20 mg of EU/kg/day/orally, while CAR was supplemented by 40 and 80 mg /kg/day/orally. Biochemical, mRNA expression, and histopathological assessments of brain samples evaluated the oxidative alterations induced by d-gal and the protective role of EU and CAR. Results showed that d-gal was causing oxidative alternation of the brain that was recognized via upregulation of p53 and p21 mRNA expression levels, as aging markers and Bax mRNA expression level, as an apoptotic marker. Also, the results observed alterations in the levels of biochemical markers as creatine phosphokinase (CPK) and triacylglycerol (TAG), besides, enhancement of brain antioxidant capacity. Finally, these results compared with the groups treated with EU and CAR to observe that the EU and CAR potentially attenuate these aging-related oxidative alterations in a dose-dependent manner. Finally, we can conclude that EU and CAR supplementations are considered promising natural protective compounds that could delay aging and maintain health.
C1 [El-Far, Ali H.; Mohamed, Hadeer H.; Elsabagh, Doaa A.; Alsenosy, Abdelwahab A.] Damanhour Univ, Fac Vet Med, Dept Biochem, Damanhour 22511, Egypt.
   [Mohamed, Shymaa A.] Alexandria Univ, Med Technol Ctr, Med Res Inst, Mol Biol Unit,Mol Biol, Alexandria, Egypt.
   [Noreldin, Ahmed E.] Damanhour Univ, Fac Vet Med, Histol & Cytol Dept, Damanhour 22511, Egypt.
   [Al Jaouni, Soad K.] King Abdulaziz Univ, Fac Med, Dept Hematol Pediat Oncol, Yousef Abdulatif Jameel Sci Chair Prophet Med App, Jeddah 21589, Saudi Arabia.
C3 Egyptian Knowledge Bank (EKB); Damanhour University; Egyptian Knowledge
   Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB);
   Damanhour University; King Abdulaziz University
RP El-Far, AH (corresponding author), Damanhour Univ, Fac Vet Med, Dept Biochem, Damanhour 22511, Egypt.
EM ali.elfar@damanhour.edu.eg; doctor.hadeer.98dr@gmail.com;
   doaaelsabagh43@gmail.com; shymaa.abdullah@alexu.edu.eg;
   ahmed.elsayed@damanhour.edu.eg; saljaouni@kau.edu.sa;
   dr_alsenosy_2010@yahoo.com
RI Noreldin, Ahmed E./S-1130-2017; El-Far, Prof Dr/Ali H./L-7946-2017
OI Noreldin, Ahmed E./0000-0002-8344-0807; El-Far, Prof Dr/Ali
   H./0000-0001-9721-4360
FU Science, Technology & Innovation Funding Authority (STDF); Egyptian
   Knowledge Bank (EKB)
FX Open access funding provided by The Science, Technology & Innovation
   Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank
   (EKB).
CR Abadi AJ, 2022, PHYTOTHER RES, V36, P189, DOI 10.1002/ptr.7305
   ACOSTA PB, 1995, EUR J PEDIATR, V154, pS87, DOI 10.1007/BF02143811
   Ahmadifar E, 2011, J APPL ICHTHYOL, V27, P1057, DOI 10.1111/j.1439-0426.2011.01763.x
   Aristatile B, 2009, FUND CLIN PHARMACOL, V23, P757, DOI 10.1111/j.1472-8206.2009.00721.x
   Ashrafizadeh M, 2021, CANCER CELL INT, V21, DOI 10.1186/s12935-021-01773-7
   Ashrafizadeh M, 2020, LIFE SCI, V256, DOI 10.1016/j.lfs.2020.117984
   Atanasov AG, 2021, NAT REV DRUG DISCOV, V20, P200, DOI 10.1038/s41573-020-00114-z
   Bancroft J.D., 2013, Theory and Practice of Histological Techniques, V7th, P173, DOI DOI 10.1016/B978-0-7020-4226-3.00010-X
   Baranauskaite J, 2020, MOLECULES, V25, DOI 10.3390/molecules25081807
   Baskaran Y, 2010, TOXICOLOGY, V268, P204, DOI 10.1016/j.tox.2009.12.018
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Bucala R, 1992, Adv Pharmacol, V23, P1
   Çakatay U, 2010, OXID STRESS APPL BAS, P3, DOI 10.1007/978-1-60761-602-3_1
   Chen P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19732-0
   Chiroma SM, 2018, BIOMED PHARMACOTHER, V103, P1602, DOI 10.1016/j.biopha.2018.04.152
   Coelho AI, 2015, CURR OPIN CLIN NUTR, V18, P422, DOI 10.1097/MCO.0000000000000189
   Davalli P, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3565127
   de Sa PL, 2016, PHYTOMEDICINE, V23, P725, DOI 10.1016/j.phymed.2016.03.014
   El-Far AH, 2021, INTEGR CANCER THER, V20, DOI 10.1177/15347354211035450
   El-Far AH, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124348
   El-Far AH, 2020, INTEGR CANCER THER, V19, DOI 10.1177/1534735419901160
   El-Far AH, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101369
   El-Far Ali H, 2015, Curr Drug Discov Technol, V12, P80
   Elbahy D.A., 2015, Int. J. Res. Stud. Biosci, V3, P19
   Fan JJ, 2017, ONCOTARGET, V8, P17475, DOI [10.18632/oncotarget.15420, 10.18632/oncotarget.15728]
   GROSS KC, 1991, J INHERIT METAB DIS, V14, P253, DOI 10.1007/BF01800599
   Gülçin I, 2011, J MED FOOD, V14, P975, DOI 10.1089/jmf.2010.0197
   Harb AA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50352-4
   Hashemipour H, 2013, POULTRY SCI, V92, P2059, DOI 10.3382/ps.2012-02685
   Herranz N, 2018, J CLIN INVEST, V128, P1238, DOI 10.1172/JCI95148
   Karam I, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0523-5
   Krafts KP, 2010, ORGANOGENESIS, V6, P225, DOI 10.4161/org.6.4.12555
   Liu C, 2018, J MED FOOD, V21, P678, DOI 10.1089/jmf.2017.4090
   Liu ZB, 2013, J TRADIT CHIN MED, V33, P399, DOI 10.1016/S0254-6272(13)60186-7
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180
   Manikandan P, 2011, INVEST NEW DRUG, V29, P110, DOI 10.1007/s10637-009-9345-2
   Manikandan P, 2010, LIFE SCI, V86, P936, DOI 10.1016/j.lfs.2010.04.010
   Manouchehrabadi M, 2020, NEUROTOX RES, V37, P156, DOI 10.1007/s12640-019-00088-w
   Mateen S, 2019, PHYTOMEDICINE, V53, P70, DOI 10.1016/j.phymed.2018.09.004
   Mesole SB, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/8425643
   Mohammadi Z, 2014, EUR POULTRY SCI, V78, DOI 10.1399/eps.2014.51
   Mohsen E., 2022, PHYTOMED PLUS, V2, DOI [10.1016/j.phyplu.2021.100209, DOI 10.1016/J.PHYPLU.2021.100209]
   Mondal A, 2021, ADV STRUCTURED MAT, P437, DOI 10.1007/978-3-030-54027-2_13
   Neki NS, 2015, BANGLADESH J MED SCI, V14, P221, DOI 10.3329/bjms.v14i3.23468
   Parameshwaran K, 2010, REJUV RES, V13, P729, DOI 10.1089/rej.2010.1020
   Potocnjak I, 2016, FOOD CHEM TOXICOL, V98, P251, DOI 10.1016/j.fct.2016.11.004
   Rajan B., 2015, Food Science and Human Wellness, V4, P66, DOI [10.1016/j.fshw.2015.04.002, DOI 10.1016/J.FSHW.2015.04.002]
   Rehman SU, 2017, MOL NEUROBIOL, V54, P255, DOI 10.1007/s12035-015-9604-5
   Rodier F, 2007, NUCLEIC ACIDS RES, V35, P7475, DOI 10.1093/nar/gkm744
   Sadeghzadeh S, 2018, PHYSIOL PHARMACOL, V22, P54
   Sander M, 2015, AGE AGEING, V44, P185, DOI 10.1093/ageing/afu189
   Shahroudi MJ, 2017, J PHARMACOPUNCT, V20, P29, DOI 10.3831/KPI.2017.20.006
   Sharifi-Rad M, 2018, PHYTOTHER RES, V32, P1675, DOI 10.1002/ptr.6103
   Shoorei H, 2019, BIOMED PHARMACOTHER, V111, P568, DOI 10.1016/j.biopha.2018.12.054
   Shwe T, 2018, EXP GERONTOL, V101, P13, DOI 10.1016/j.exger.2017.10.029
   Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6
   Stojanovic NM, 2019, FOOD CHEM TOXICOL, V128, P280, DOI 10.1016/j.fct.2019.04.010
   Sun KY, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7108604
   Suo HY, 2018, J DAIRY SCI, V101, P10664, DOI 10.3168/jds.2018-14758
   Wei HF, 2005, BEHAV BRAIN RES, V157, P245, DOI 10.1016/j.bbr.2004.07.003
   Williams C. A., 2003, Encyclopedia of Food Sciences and Nutrition (Second Edition), P2843, DOI [10.1016/B0-12-227055-X/00544-7, DOI 10.1016/B0-12-227055-X/00544-7]
   Xu LQ, 2016, FOOD FUNCT, V7, P4545, DOI 10.1039/c6fo01057a
   Xu XX, 2020, AGING-US, V12, P18501, DOI 10.18632/aging.103819
   Xu Y, 2009, BIOGERONTOLOGY, V10, P153, DOI 10.1007/s10522-008-9158-2
NR 65
TC 9
Z9 9
U1 0
U2 9
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0944-1344
EI 1614-7499
J9 ENVIRON SCI POLLUT R
JI Environ. Sci. Pollut. Res.
PD 2022 JUL
PY 2022
VL 29
IS 31
BP 47436
EP 47447
DI 10.1007/s11356-022-18984-8
EA FEB 2022
PG 12
WC Environmental Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology
GA 2J2OC
UT WOS:000758313700001
PM 35182345
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Yan, Y
   Li, XD
   Yao, PF
AF Yan, Y
   Li, XD
   Yao, PF
TI Anti-aging effects of Bao-Chun-Wan on rats: A morphological
   ultrastructure study
SO AMERICAN JOURNAL OF CHINESE MEDICINE
LA English
DT Article
AB Bao-Chun-Wan, a Chinese prescription, is formulated according to the principle of tonifying the kidney for treatment of aging. Morphological study on the ultrastructure of laboratory albino rats treated with this formula showed an increase in thymic lymphocytes, which play an important role in the production of T cells. As to the liver cells, the formula has a protective effect and may induce enzymes enhancing oxidation and excretion of toxic substances. An increase in the Leydig's cell, which promotes reproductive hormone secretion, was also observed, but there was no obvious change in germinal cells. The above findings reported in this article have not been cited in any previous studies and are suggesting that the kidney tonifying formula may act through the mechanism of promoting body immune function, metabolism and biotransformation, and, therefore, result in anti-aging.
C1 Shanghai Univ Tradit Chinese Med, Longhua Hosp, Shanghai, Peoples R China.
C3 Shanghai University of Traditional Chinese Medicine
RP Yan, Y (corresponding author), Shanghai Univ Tradit Chinese Med, Longhua Hosp, Shanghai, Peoples R China.
CR CAO J, 1984, MODERN GERONTOLOGY, P18
   JUNQUEIRA LC, 1971, BASIC HISTOLOGY, P267
   LI CP, 1986, TRADITIONAL CHINESE, P206
   WANG XM, 1991, PATHOPHYSIOLOGY, P16
   XU SK, 1987, PHARM ACTION APPL AN, P18
   YAO PF, 1982, SHANGHAI J TRAD CHIN, V6, P2
NR 6
TC 1
Z9 1
U1 0
U2 2
PU INST ADV RES ASIAN SCI & MED
PI CHESTNUT HILL
PA PO BOX 67336, CHESTNUT HILL, MA 02167 USA
SN 0192-415X
J9 AM J CHINESE MED
JI Am. J. Chin. Med.
PY 1998
VL 26
IS 2
BP 143
EP 151
DI 10.1142/S0192415X98000191
PG 9
WC Integrative & Complementary Medicine; Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Integrative & Complementary Medicine; General & Internal Medicine
GA 127XV
UT WOS:000076376600004
PM 9799966
DA 2024-02-19
ER

PT J
AU Chen, TH
AF Chen, T. -H
TI GENDER-SPECIFIC EFFECTS OF OBESITY ON ALCOHOLIC LIVER DISEASE IN OLDER
   ADULTS OF DIFFERENT GROUPS AGED 65 AND OVER: A CASE-CONTROL STUDY
SO APPLIED ECOLOGY AND ENVIRONMENTAL RESEARCH
LA English
DT Article; Early Access
DE alcoholic liver disease; aging society; gender physiological effects;
   obesity diseases; alcoholism
ID RISK-FACTORS; MANAGEMENT; PREVALENCE; NUTRITION
AB Alcoholic liver disease is a common liver disease caused by chronic alcohol consumption and is categorized into fatty liver, alcoholic hepatitis, and alcoholic cirrhosis. This study aimed to examine the relationship between alcoholic liver disease and overweight in older adults, focusing on age and gender differences The study was designed as a retrospective age-matched case-control study using the Chang Gung Research Database (CGRD). The data of this study were collected from January 1, 2018 to December 31, 2022. The subjects were aged over 65 years old with a primary diagnosis of alcoholic liver disease. The experimental group matched gender and age group to conduct a case-control study with a ratio of 1:2 for the control group. The relationship between overweight and alcoholic liver disease was analyzed by logistic regression. The study found that the prevalence of alcoholic liver disease was significantly higher in male than in female. The prevalence of overweight in male with alcoholic liver disease decreased with age distribution. For female, age did not matter much. However, among female aged 65 to 69 years, those who were overweight were more likely to develop alcoholic liver disease than those who were of normal weight. These findings provide guidance for population-specific prevention and treatment strategies and highlight the importance of weight control in aged 65 and over. Particularly in the aging population, attention to weight control and aging, as well as the development of alcoholic liver disease, may improve patient health and quality of life.
C1 [Chen, T. -H] Linkou Chang Gung Mem Hosp, Dept Healthcare Adm, Taoyuan, Taiwan.
C3 Chang Gung Memorial Hospital
RP Chen, TH (corresponding author), Linkou Chang Gung Mem Hosp, Dept Healthcare Adm, Taoyuan, Taiwan.
EM shawn@cgmh.org.tw
CR Abidov M, 2010, DIABETES OBES METAB, V12, P72, DOI 10.1111/j.1463-1326.2009.01132.x
   Agabio R, 2017, CURR MED CHEM, V24, P2661, DOI 10.2174/0929867323666161202092908
   Ahmed T, 2010, CLIN INTERV AGING, V5, P207
   An J., 2022, Sex/Gender-Specific Medicine in the Gastrointestinal Diseases, P197, DOI [10.1007/978-981-19-0120-1_13, DOI 10.1007/978-981-19-0120-1_13]
   Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   Covarrubias AJ, 2021, NAT REV MOL CELL BIO, V22, P119, DOI 10.1038/s41580-020-00313-x
   Després JP, 2009, ARTERIOSCL THROM VAS, V29, P416, DOI 10.1161/ATVBAHA.108.176362
   Ding HR, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1287127
   Dyson J, 2014, J HEPATOL, V60, P110, DOI 10.1016/j.jhep.2013.08.011
   Ebadi M, 2020, ALIMENT PHARM THER, V52, P600, DOI 10.1111/apt.15927
   Ezhilarasan D, 2020, HEPATOB PANCREAT DIS, V19, P429, DOI 10.1016/j.hbpd.2020.03.011
   French MT, 2010, HEALTH ECON, V19, P814, DOI 10.1002/hec.1521
   Johnson TM, 2013, NUTR CLIN PRACT, V28, P15, DOI 10.1177/0884533612469027
   Kamran U, 2020, WORLD J GASTROENTERO, V26, P2916, DOI 10.3748/wjg.v26.i22.2916
   Nielson CM, 2012, J BONE MINER RES, V27, P1, DOI 10.1002/jbmr.1486
   Park SH, 2006, J GASTROEN HEPATOL, V21, P138, DOI 10.1111/j.1440-1746.2005.04086.x
   Saberi B, 2016, J CLIN TRANSL HEPATO, V4, P113, DOI 10.14218/JCTH.2016.00006
   Shida T, 2018, J GASTROENTEROL, V53, P535, DOI 10.1007/s00535-017-1377-3
   Sivakrishnan S., 2019, WORLD J PHARM PHARM, V8, P1385, DOI DOI 10.20959/WJPPS20175-9192
   Stanhope KL, 2016, CRIT REV CL LAB SCI, V53, P52, DOI 10.3109/10408363.2015.1084990
   Torruellas C, 2014, WORLD J GASTROENTERO, V20, P11684, DOI 10.3748/wjg.v20.i33.11684
   Zhou YJ, 2007, WORLD J GASTROENTERO, V13, P6419, DOI 10.3748/wjg.13.6419
NR 22
TC 0
Z9 0
U1 3
U2 3
PU ALOKI Applied Ecological Research and Forensic Inst Ltd
PI Budapest
PA Kassa u. 118, Budapest, HUNGARY
SN 1589-1623
EI 1785-0037
J9 APPL ECOL ENV RES
JI Appl. Ecol. Environ. Res.
PD 2023 AUG 1
PY 2023
BP 4605
EP 4614
DI 10.15666/aeer/2105_46054614
EA AUG 2023
PG 10
WC Ecology; Environmental Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology
GA T7WI9
UT WOS:001080045900001
OA gold
DA 2024-02-19
ER

PT J
AU Baumgart, M
   Di Cicco, E
   Rossi, G
   Cellerino, A
   Tozzini, ET
AF Baumgart, Mario
   Di Cicco, Emiliano
   Rossi, Giacomo
   Cellerino, Alessandro
   Tozzini, Eva Terzibasi
TI Comparison of captive lifespan, age-associated liver neoplasias and
   age-dependent gene expression between two annual fish species:
   <i>Nothobranchius furzeri and Nothobranchius korthause</i>
SO BIOGERONTOLOGY
LA English
DT Article
DE Animal model; Liver neoplasia; Ageing; Annual fish
ID MODEL; LOCOMOTOR
AB Nothobranchius is a genus of annual fish broadly distributed in South-Eastern Africa and found into temporary ponds generated during the rain seasons and their lifespan is limited by the duration of their habitats. Here we compared two Nothobranchius species from radically different environments: N. furzeri and N. korthausae. We found a large difference in life expectancy (29- against 71-weeks of median life span, 40- against 80-weeks of maximum lifespan, respectively), which correlates with a diverse timing in the onset of several age dependent processes: our data show that N. korthause longer lifespan is associated to retarded onset of age-dependent liver-neoplasia and slower down-regulation of collagen 1 alpha 2 (COL1A2) expression in the skin. On the other hand, the expression of cyclin B1 (CCNB1) in the brain was strongly age-regulated, but with similar profiles in N. furzeri and N. korthausae. In conclusion, our data suggest that the different ageing rate of two species of the same genus could be used as novel tool to investigate and better understand the genetic bases of some general mechanism leading to the complex ageing process, providing a strategy to unravel some of the genetic mechanisms regulating longevity and age-associate pathologies including neoplasias.
C1 [Baumgart, Mario] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany.
   [Di Cicco, Emiliano; Rossi, Giacomo; Cellerino, Alessandro] Univ Camerino, Dept Vet Sci, Fac Vet Med, I-62032 Camerino, Italy.
   [Cellerino, Alessandro; Tozzini, Eva Terzibasi] Scuola Normale Super Pisa, I-56127 Pisa, Italy.
C3 Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI);
   University of Camerino; Scuola Normale Superiore di Pisa
RP Tozzini, ET (corresponding author), Scuola Normale Super Pisa, Piazza Cavalieri 7, I-56127 Pisa, Italy.
EM eva.terzibasi@sns.it
RI Tozzini, Eva/JQI-3406-2023; Cellerino, Alessandro/AAJ-7453-2020;
   Cellerino, Alessandro/AAB-4398-2020; Rossi, Giacomo/HCI-9726-2022;
   Tozzini, Eva Terzibasi/J-9466-2016; terzibasi tozzini, eva/AEA-0204-2022
OI Cellerino, Alessandro/0000-0003-3834-0097; Cellerino,
   Alessandro/0000-0003-3834-0097; Tozzini, Eva
   Terzibasi/0000-0003-3317-1538; terzibasi tozzini,
   eva/0000-0003-3317-1538; rossi, giacomo/0000-0001-8617-5984; Baumgart,
   Mario/0000-0001-8172-1595
FU AIRC Foundation [MFAG-11511]; DFG Foundation [CE 46/6-1]; German
   Ministry for Education and Research (JenAge; BMBF) [0315581A]
FX We wish to thank Sabine Matz and Julia Bluhm for technical assistance;
   Alexander Dorn for providing us the eggs of N. korthausae; the AIRC
   Foundation (Grant MFAG-11511 to E.T.T.), the DFG Foundation (Grant CE
   46/6-1 to A.C.) and the German Ministry for Education and Research
   (JenAge; BMBF, support code: 0315581A) for the financial support. The
   animal work was approved by the State of Thuringia (Auth. Nr.
   03-001/09).
CR Baumgart M, 2012, MECH AGEING DEV, V133, P226, DOI 10.1016/j.mad.2012.03.015
   COOPER EL, 1983, EXP GERONTOL, V18, P29, DOI 10.1016/0531-5565(83)90048-7
   Di Cicco E, 2011, EXP GERONTOL, V46, P249, DOI 10.1016/j.exger.2010.10.011
   Genade T, 2005, AGING CELL, V4, P223, DOI 10.1111/j.1474-9726.2005.00165.x
   Genade T, 2013, EXP GERONTOL, V48, P202, DOI 10.1016/j.exger.2012.11.013
   Hartmann N, 2011, AGING CELL, V10, P824, DOI 10.1111/j.1474-9726.2011.00723.x
   Hartmann N, 2009, MECH AGEING DEV, V130, P290, DOI 10.1016/j.mad.2009.01.003
   Herrera M, 2004, J GERONTOL A-BIOL, V59, P101
   Hsu CY, 2009, AGING CELL, V8, P726, DOI 10.1111/j.1474-9726.2009.00525.x
   Hsu CY, 2008, J GERONTOL A-BIOL, V63, P1267, DOI 10.1093/gerona/63.12.1267
   Kirschner J, 2012, AGING CELL, V11, P252, DOI 10.1111/j.1474-9726.2011.00780.x
   Liu CS, 2012, BIOGERONTOLOGY, V13, P501, DOI 10.1007/s10522-012-9395-2
   Lucas-Sánchez A, 2011, EXP GERONTOL, V46, P970, DOI 10.1016/j.exger.2011.08.009
   Lucas-Sánchez A, 2014, J GERONTOL A-BIOL, V69, P142, DOI 10.1093/gerona/glt066
   Petzold A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-185
   Reichwald K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r16
   Terzibasi E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003866
   Tozzini ET, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-77
   Tozzini ET, 2012, AGING CELL, V11, P241, DOI 10.1111/j.1474-9726.2011.00781.x
   Valdesalicil S, 2003, P ROY SOC B-BIOL SCI, V270, pS189, DOI 10.1098/rsbl.2003.0048
   Valenzano DR, 2006, AGING CELL, V5, P275, DOI 10.1111/j.1474-9726.2006.00212.x
   Valenzano DR, 2009, GENETICS, V183, P1385, DOI 10.1534/genetics.109.108670
   Wildekamp R. H., 2004, WORLD KILLIES ATLAS
NR 23
TC 18
Z9 20
U1 0
U2 13
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD FEB
PY 2015
VL 16
IS 1
BP 63
EP 69
DI 10.1007/s10522-014-9535-y
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA AZ7EJ
UT WOS:000348381400006
PM 25315356
DA 2024-02-19
ER

PT J
AU MACHADO, A
   AYALA, A
   GORDILLO, E
   REVILLA, E
   MARIA, CS
AF MACHADO, A
   AYALA, A
   GORDILLO, E
   REVILLA, E
   MARIA, CS
TI RELATIONSHIP BETWEEN ENZYMATIC-ACTIVITY LOSS AND POSTTRANSLATIONAL
   PROTEIN MODIFICATION IN AGING
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article; Proceedings Paper
CT INTERNATIONAL SYMP : FRITZ VERZAR PROJECT - 2000
CY SEP 30-OCT 03, 1990
CL ANCONA, ITALY
SP IST NAZL RICOVERO & CURA ANZIANI, SANDOZ FDN GERONTOL RES, BIOGAL PHARM WORKS
DE AGING; MALIC ENZYME, 6-PHOSPHOGLUCONATE DEHYDROGENASE; SUPEROXIDE
   DISMUTASE; HISTIDINE MODIFICATION; LYSINE MODIFICATION; PROTEIN
   MODIFICATION
ID LIVER SUPEROXIDE-DISMUTASE; RAT-LIVER; TURBATRIX-ACETI;
   HYDROGEN-PEROXIDE; MALIC ENZYME; INACTIVATION; NEMATODE; AGE;
   INVOLVEMENT; OXIDATION
AB During aging, there is a decrease in the activity of many enzymes. The mechanism causing the loss of activity is still not well understood in most cases. We have studied the decrease in the activities of the malic, 6-phosphogluconate dehydrogenase and superoxide dismutase enzymes. The old malic enzyme is about 36% less active than the young enzyme and the old 6-phosphogluconic dehydrogenase enzyme is about 26% less active than the young enzyme. In this paper, some chemical properties of these enzymes are studied. Diethyl pyrocarbonate measurements indicate that the old malic enzyme has 1 histidine residue less than the young malic enzyme. Moreover, the treatment of the young malic enzyme with ascorbate for 15 min produces the loss of 36% of enzymatic activity and the loss of 1.2 histidine residues. 2,4,6-trinitrobenzenesulfonic acid measurements indicate that the old 6-phosphogluconate dehydrogenase enzyme has 11 lysine residues less than the young 6-phosphogluconate dehydrogenase enzyme. The proteolysis with trypsin produces more peptides in the young 6-phosphogluconate dehydrogenase enzyme than in the old one. However, similar numbers of peptides were produced when endoproteinase Arg-C was used in both enzymes, young and old 6-phosphogluconate dehydrogenase. Moreover, the treatment of young 6-phosphogluconate dehydrogenase enzyme with ascorbate for 15 min produces the loss of 8 lysine residues. These results suggest that during aging the modification of histidine residue could be involved in the loss of malic enzyme activity, and the modification of lysine residues could be involved in the loss of 6-phosphogluconate dehydrogenase activity. These results could also suggest that the modification of histidine and lysine residues during aging could be produced by oxidation. This could be a general process in aging, with an increase in the oxidation of many proteins. The relevance of this process in the aging effects must be related to the kind of proteins that are susceptible of oxidation and that this oxidation affects their enzymatic or biological function. We have also studied other enzymes one of which is the superoxide dismutase enzyme involved in the protection against oxidative damage. Our results are similar to those described for malic enzyme. In the latter case, the failure to measure one of the histidines in the Cu/Zn SOD is due to a chemical modification, probably caused by oxidation of the residue.
RP MACHADO, A (corresponding author), UNIV SEVILLA,DEPT BIOQUIM BROMATOL & TOXICOL,E-41012 SEVILLE,SPAIN.
RI Ayala, Antonio/N-7591-2019; IBIS, ENVEJECIMIENTO/O-9381-2015; Torres, Mª
   Elisa Revilla/K-5897-2014
OI Ayala, Antonio/0000-0001-9711-3711; Torres, Mª Elisa
   Revilla/0000-0001-8867-8446
CR BRAY RC, 1974, BIOCHEM J, V139, P43, DOI 10.1042/bj1390043
   CHANG GG, 1980, BIOCHIM BIOPHYS ACTA, V611, P217, DOI 10.1016/0005-2744(80)90058-3
   FUCCI L, 1983, P NATL ACAD SCI-BIOL, V80, P1521, DOI 10.1073/pnas.80.6.1521
   GORDILLO E, 1988, J BIOL CHEM, V263, P8053
   GORDILLO E, 1989, J BIOL CHEM, V264, P17014
   GOREN P, 1977, FEBS LETT, V84, P83, DOI 10.1016/0014-5793(77)81062-4
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HODGSON EK, 1975, BIOCHEMISTRY-US, V14, P5294, DOI 10.1021/bi00695a010
   LEVINE RL, 1983, J BIOL CHEM, V258, P1828
   Lewin S., 1976, VITAMIN C ITS MOL BI
   MACHADO A, 1983, CARDIOLOGY AGING, P65
   REISS U, 1976, EUR J BIOCHEM, V63, P617, DOI 10.1111/j.1432-1033.1976.tb10266.x
   REVILLA E, 1990, UNPUB CHANGES HISTID
   REZNICK AZ, 1979, MECH AGEING DEV, V11, P403, DOI 10.1016/0047-6374(79)90016-2
   ROTHSTEIN M, 1982, BIOCH APPROACHES AGI, P213
   SHARMA HK, 1980, J BIOL CHEM, V255, P5043
   SHARMA HK, 1980, P NATL ACAD SCI-BIOL, V77, P5865, DOI 10.1073/pnas.77.10.5865
   SHARMA HK, 1976, ARCH BIOCHEM BIOPHYS, V174, P324, DOI 10.1016/0003-9861(76)90351-9
   STADTMAN ER, 1986, TRENDS BIOCHEM SCI, V11, P11, DOI 10.1016/0968-0004(86)90221-5
   VITORICA J, 1981, ENZYME, V26, P144
   WINTERBOURN CC, 1981, BIOCHEM J, V198, P125, DOI 10.1042/bj1980125
NR 21
TC 14
Z9 17
U1 0
U2 5
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0167-4943
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PD MAR-JUN
PY 1991
VL 12
IS 2-3
BP 187
EP 197
DI 10.1016/0167-4943(91)90027-N
PG 11
WC Geriatrics & Gerontology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA FT598
UT WOS:A1991FT59800008
PM 15374447
DA 2024-02-19
ER

PT J
AU Mima, K
   Hayashi, H
   Yumoto, S
   Matsumoto, T
   Tsukamoto, M
   Miyata, T
   Nakagawa, S
   Nitta, H
   Baba, H
AF Mima, Kosuke
   Hayashi, Hiromitsu
   Yumoto, Shinsei
   Matsumoto, Takashi
   Tsukamoto, Masayo
   Miyata, Tatsunori
   Nakagawa, Shigeki
   Nitta, Hidetoshi
   Baba, Hideo
TI Disability in perioperative activities of daily living is associated
   with worse survival outcomes following hepatic resection in patients
   with intrahepatic cholangiocarcinoma
SO HEPATOLOGY RESEARCH
LA English
DT Article; Early Access
DE frail; geriatrics; morbidity; oncology; rehabilitation; vulnerability
ID PRIMARY LIVER-CANCER; UP SURVEY; COMPLICATIONS; FRAILTY; BYPASS; IMPACT
AB Aim Intrahepatic cholangiocarcinoma (ICC) is a rare disease; however, its incidence and mortality are increasing worldwide. The rapid aging of populations around the world is leading to an increased number of patients with cancer who develop disability in activities of daily living (ADL). This study was conducted to investigate the associations of perioperative ADL with patient survival after hepatic resection for ICC. Methods We included 70 consecutive patients who underwent hepatectomy for ICC from 2010 to 2021 in the current study. Preoperative and postoperative ADL were evaluated based on the Barthel index, which yields a score of 0-100 points, with higher scores indicating greater independence. A preoperative or postoperative Barthel index score of Among the 70 patients, seven (10%) had a preoperative Barthel index score of <100, and 23 (33%) showed a postoperative Barthel index score of <100. Multivariate analyses revealed that disability in perioperative ADL was associated with shorter recurrence-free survival (multivariable hazard ratios 2.38, 95% confidence interval 1.22-4.57; p = 0.011) and overall survival (multivariable hazard ratio 2.49, 95% confidence interval 1.09-5.70; p = 0.031). Conclusions Disability in perioperative ADL is associated with shorter recurrence-free and overall survival after hepatic resection for ICC. Upon validation, perioperative measurement of ADL may improve risk assessment, and improvement of perioperative ADL may lead to favorable clinical outcomes in patients with ICC.
C1 [Mima, Kosuke; Hayashi, Hiromitsu; Yumoto, Shinsei; Matsumoto, Takashi; Tsukamoto, Masayo; Miyata, Tatsunori; Nakagawa, Shigeki; Nitta, Hidetoshi; Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, 1-1-1 Honjo,Chuo Ku, Kumamoto 8608556, Japan.
C3 Kumamoto University
RP Baba, H (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, 1-1-1 Honjo,Chuo Ku, Kumamoto 8608556, Japan.
EM hdobaba@kumamoto-u.ac.jp
FU SGH Foundation; Medical Research Encouragement Prize of The Japan
   Medical Association; Shinnihon Foundation of Advanced Medical Treatment
   Research
FX The SGH Foundation; The Medical Research Encouragement Prize of The
   Japan Medical Association; Shinnihon Foundation of Advanced Medical
   Treatment Research
CR Beppu T, 2011, J GASTROENTEROL, V46, P938, DOI 10.1007/s00535-011-0406-x
   Brindley PJ, 2021, NAT REV DIS PRIMERS, V7, DOI 10.1038/s41572-021-00300-2
   Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2
   Ethun CG, 2017, CA-CANCER J CLIN, V67, P363, DOI 10.3322/caac.21406
   Florio AA, 2020, CANCER-AM CANCER SOC, V126, P2666, DOI 10.1002/cncr.32803
   GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005
   Hewitt DB, 2022, EXPERT REV ANTICANC, V22, P27, DOI 10.1080/14737140.2022.1999809
   Higashi T, 2015, ANN SURG ONCOL, V22, pS1041, DOI 10.1245/s10434-015-4796-5
   Imai K, 2019, SURGERY, V165, P696, DOI 10.1016/j.surg.2018.10.023
   Kaibori M, 2021, HEPATOL RES, V51, P890, DOI 10.1111/hepr.13676
   Kaibori M, 2021, CANCERS, V13, DOI 10.3390/cancers13040842
   Kaneko S, 2021, HEPATOL RES, V51, P902, DOI 10.1111/hepr.13673
   KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016
   Kermansaravi M, 2021, SURG OBES RELAT DIS, V17, P1489, DOI 10.1016/j.soard.2021.04.013
   Kodama A, 2018, CIRC J, V82, P267, DOI 10.1253/circj.CJ-17-0369
   Kudo M, 2022, HEPATOL RES, V52, P5, DOI 10.1111/hepr.13675
   Kudo M, 2015, DIGEST DIS, V33, P765, DOI 10.1159/000439101
   Kurebayashi Y, 2021, HEPATOL RES, V51, P5, DOI 10.1111/hepr.13539
   Marubashi S, 2021, ANN GASTROENT SURG, V5, P639, DOI 10.1002/ags3.12462
   Mavros MN, 2014, JAMA SURG, V149, P565, DOI 10.1001/jamasurg.2013.5137
   Mima K, 2014, BRIT J SURG, V101, P269, DOI 10.1002/bjs.9343
   Mima K, 2022, J SURG ONCOL, V126, P995, DOI 10.1002/jso.26996
   Mima K, 2021, INT J CLIN ONCOL, V26, P1938, DOI 10.1007/s10147-021-01983-z
   Mima K, 2021, J GASTROINTEST SURG, V25, P2628, DOI 10.1007/s11605-021-04990-7
   Mima K, 2020, ANN GASTROENT SURG, V4, P405, DOI 10.1002/ags3.12337
   Miyata T, 2017, ANTICANCER RES, V37, P2673, DOI 10.21873/anticanres.11615
   Nakao Y, 2019, ANTICANCER RES, V39, P2641, DOI 10.21873/anticanres.13388
   Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051
   Rouge-Bugat ME, 2013, J NUTR HEALTH AGING, V17, P473, DOI 10.1007/s12603-012-0435-z
   Spolverato G, 2015, CANCER-AM CANCER SOC, V121, P2730, DOI 10.1002/cncr.29419
   Tanaka S, 2018, J HEPATO-BIL-PAN SCI, V25, P377, DOI 10.1002/jhbp.568
   Thomalla G, 2018, NEW ENGL J MED, V379, P611, DOI 10.1056/NEJMoa1804355
   Yamada S, 2021, ANN SURG ONCOL, V28, P439, DOI 10.1245/s10434-020-08742-w
   Yamashita Y, 2017, ANN GASTROENT SURG, V1, P136, DOI 10.1002/ags3.12018
   Zhang XF, 2018, BRIT J SURG, V105, P848, DOI 10.1002/bjs.10676
NR 35
TC 1
Z9 1
U1 1
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1386-6346
EI 1872-034X
J9 HEPATOL RES
JI Hepatol. Res.
PD 2023 FEB
PY 2023
VL 53
IS 2
BP 135
EP 144
DI 10.1111/hepr.13849
EA NOV 2022
PG 10
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 9C1UK
UT WOS:000883024700001
PM 36305859
DA 2024-02-19
ER

PT J
AU Ota, A
   Nakao, H
   Sawada, Y
   Karnan, S
   Wahiduzzaman, M
   Inoue, T
   Kobayashi, Y
   Yamamoto, T
   Ishii, N
   Ohashi, T
   Nakade, Y
   Sato, K
   Itoh, K
   Konishi, H
   Hosokawa, Y
   Yoneda, M
AF Ota, Akinobu
   Nakao, Haruhisa
   Sawada, Yumi
   Karnan, Sivasundaram
   Wahiduzzaman, Md
   Inoue, Tadahisa
   Kobayashi, Yuji
   Yamamoto, Takaya
   Ishii, Norimitsu
   Ohashi, Tomohiko
   Nakade, Yukiomi
   Sato, Ken
   Itoh, Kiyoaki
   Konishi, Hiroyuki
   Hosokawa, Yoshitaka
   Yoneda, Masashi
TI Δ40p53α suppresses tumor cell proliferation and induces cellular
   senescence in hepatocellular carcinoma cells
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE Delta 40p53; Gene targeting; Liver cancer; Tumorigenesis; Gene
   expression
ID P53 ISOFORMS; EXPRESSION; GENERATION; LACKING; MICE
AB Splice variants of certain genes impact on genetic biodiversity in mammals. The tumor suppressor TP53 gene (encoding p53) plays an important role in the regulation of tumorigenesis in hepatocellular carcinoma (HCC). Delta 40p53 alpha is a naturally occurring p53 isoform that lacks the N-terminal transactivation domain, yet little is known about the role of Delta 40p53 alpha in the development of HCC. Here, we first report on the role of Delta 40p53 alpha in HCC cell lines. In the TP53(+/Delta 40) cell clones, clonogenic activity and cell survival dramatically decreased, whereas the percentage of senescence-associated beta-galactosidase (SA-beta-gal)-positive cells and p21 (also known as WAF1, CIP1 and CDKN1A) expression significantly increased. These observations were clearly attenuated in the TP53(+/Delta 40) cell clones after Delta 40p53 alpha knockdown. In addition, exogenous Delta 40p53 expression significantly suppressed cell growth in HCC cells with wild-type TP53, and in those that were mutant or null for TP53. Notably, Delta 40p53 alpha-induced tumor suppressor activity was markedly attenuated in cells expressing the hot-spot mutant Delta 40p53 alpha-R175H, which lacks the transcription factor activity of p53. Moreover, Delta 40p53 alpha expression was associated with increased full-length p53 protein expression. These findings enhance the understanding of the molecular pathogenesis of HCC and show that Delta 40p53 alpha acts as an important tumor suppressor in HCC cells.
C1 [Ota, Akinobu; Karnan, Sivasundaram; Wahiduzzaman, Md; Konishi, Hiroyuki; Hosokawa, Yoshitaka] Aichi Med Univ, Sch Med, Dept Biochem, Nagakute, Aichi, Japan.
   [Nakao, Haruhisa; Sawada, Yumi; Inoue, Tadahisa; Kobayashi, Yuji; Yamamoto, Takaya; Ishii, Norimitsu; Ohashi, Tomohiko; Nakade, Yukiomi; Sato, Ken; Itoh, Kiyoaki; Yoneda, Masashi] Aichi Med Univ, Sch Med, Div Hepatol & Pancreatol, Dept Internal Med, Nagakute, Aichi, Japan.
C3 Aichi Medical University; Aichi Medical University
RP Nakao, H (corresponding author), Aichi Med Univ, Sch Med, Div Hepatol & Pancreatol, Dept Internal Med, Nagakute, Aichi, Japan.
EM hnakao@aichi-med-u.ac.jp
RI Inoue, Tadahisa/AFK-7576-2022; Ota, Akinobu/CAC-5999-2022; Ota,
   Akinobu/H-4510-2019; Ota, Akinobu/AAI-9396-2020; Wahiduzzaman,
   Md/HHZ-2205-2022
OI Inoue, Tadahisa/0000-0003-0718-9099; Ota, Akinobu/0000-0002-6296-2921;
   Ota, Akinobu/0000-0002-6296-2921; Konishi, Hiroyuki/0000-0003-1131-4905;
   Wahiduzzaman, Md/0000-0001-5915-8935
FU Grants-in-Aid for Scientific Research [25460395, 16K09381, 17K09442,
   15K19561] Funding Source: KAKEN
CR Attardi LD, 2004, ONCOGENE, V23, P973, DOI 10.1038/sj.onc.1207026
   BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0
   Candeias MM, 2006, ONCOGENE, V25, P6936, DOI 10.1038/sj.onc.1209996
   Courtois S, 2002, ONCOGENE, V21, P6722, DOI 10.1038/sj.onc.1205874
   Cui HJ, 2002, MOL CANCER THER, V1, P679
   Hafsi H, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-134
   Hossain E, 2015, MOL CELL BIOCHEM, V400, P29, DOI 10.1007/s11010-014-2259-0
   HSU IC, 1993, CARCINOGENESIS, V14, P987, DOI 10.1093/carcin/14.5.987
   Katz SF, 2012, GASTROENTEROLOGY, V142, P1229, DOI 10.1053/j.gastro.2012.02.009
   Konishi H, 2007, NAT PROTOC, V2, P2865, DOI 10.1038/nprot.2007.409
   Lanigan F, 2011, ONCOGENE, V30, P2901, DOI 10.1038/onc.2011.34
   Larsson LG, 2011, SEMIN CANCER BIOL, V21, P367, DOI 10.1016/j.semcancer.2011.10.005
   Liu M, 2014, PROTEIN CELL, V5, P673, DOI 10.1007/s13238-014-0065-9
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404
   Marcel V, 2011, CELL DEATH DIFFER, V18, P1815, DOI 10.1038/cdd.2011.120
   Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355
   Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6
   Morris SM, 2012, HEPATOLOGY, V55, P121, DOI 10.1002/hep.24653
   Nishida N, 2011, CURR GENOMICS, V12, P130, DOI 10.2174/138920211795564359
   Ohki R, 2007, CANCER SCI, V98, P189, DOI 10.1111/j.1349-7006.2006.00375.x
   Olivares-Illana V, 2010, ONCOGENE, V29, P5113, DOI 10.1038/onc.2010.266
   Ozturk M, 2009, CANCER LETT, V286, P103, DOI 10.1016/j.canlet.2008.10.048
   Qian Yingjuan, 2013, Methods Mol Biol, V965, P37, DOI 10.1007/978-1-62703-239-1_3
   Rago C, 2007, NAT PROTOC, V2, P2734, DOI 10.1038/nprot.2007.408
   Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Takahashi M, 2013, CANCER SCI, V104, P165, DOI 10.1111/cas.12053
   Takahashi R, 2014, J INVEST DERMATOL, V134, P791, DOI 10.1038/jid.2013.391
   Thomas SE, 2013, J BIOL CHEM, V288, P7606, DOI 10.1074/jbc.M112.424655
   Topaloglu O, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni160
   Wei JX, 2012, J NUCLEIC ACIDS, V2012, DOI 10.1155/2012/687359
   Weiss MB, 2010, ONCOGENE, V29, P4715, DOI 10.1038/onc.2010.220
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Yin YL, 2002, NAT CELL BIOL, V4, P462, DOI 10.1038/ncb801
NR 35
TC 28
Z9 28
U1 0
U2 2
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0021-9533
EI 1477-9137
J9 J CELL SCI
JI J. Cell Sci.
PD FEB 1
PY 2017
VL 130
IS 3
BP 614
EP 625
DI 10.1242/jcs.190736
PG 12
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA EL2LB
UT WOS:000394450100010
PM 27980070
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU Anchelin, M
   Alcaraz-Pérez, F
   Martínez, CM
   Bernabé-García, M
   Mulero, V
   Cayuela, ML
AF Anchelin, Monique
   Alcaraz-Perez, Francisca
   Martinez, Carlos M.
   Bernabe-Garcia, Manuel
   Mulero, Victoriano
   Cayuela, Maria L.
TI Premature aging in telomerase-deficient zebrafish
SO DISEASE MODELS & MECHANISMS
LA English
DT Article
ID DOMINANT DYSKERATOSIS-CONGENITA; REVERSE-TRANSCRIPTASE; IN-VIVO;
   CAENORHABDITIS-ELEGANS; HUMAN-DISEASE; DANIO-RERIO; MICE; MOUSE; MODEL;
   DYSFUNCTION
AB The study of telomere biology is crucial to the understanding of aging and cancer. In the pursuit of greater knowledge in the field of human telomere biology, the mouse has been used extensively as a model. However, there are fundamental differences between mouse and human cells. Therefore, additional models are required. In light of this, we have characterized telomerase-deficient zebrafish (Danio rerio) as the second vertebrate model for human telomerase-driven diseases. We found that telomerase-deficient zebrafish show p53-dependent premature aging and reduced lifespan in the first generation, as occurs in humans but not in mice, probably reflecting the similar telomere length in fish and humans. Among these aging symptoms, spinal curvature, liver and retina degeneration, and infertility were the most remarkable. Although the second-generation embryos died in early developmental stages, restoration of telomerase activity rescued telomere length and survival, indicating that telomerase dosage is crucial. Importantly, this model also reproduces the disease anticipation observed in humans with dyskeratosis congenita (DC). Thus, telomerase haploinsufficiency leads to anticipation phenomenon in longevity, which is related to telomere shortening and, specifically, with the proportion of short telomeres. Furthermore, p53 was induced by telomere attrition, leading to growth arrest and apoptosis. Importantly, genetic inhibition of p53 rescued the adverse effects of telomere loss, indicating that the molecular mechanisms induced by telomere shortening are conserved from fish to mammals. The partial rescue of telomere length and longevity by restoration of telomerase activity, together with the feasibility of the zebrafish for high-throughput chemical screening, both point to the usefulness of this model for the discovery of new drugs able to reactivate telomerase in individuals with DC.
C1 [Anchelin, Monique; Alcaraz-Perez, Francisca; Martinez, Carlos M.; Bernabe-Garcia, Manuel; Cayuela, Maria L.] Univ Hosp Virgen de la Arrixaca, Telomerase Aging & Canc Grp, CIBERehd, Res Unit,Dept Surg, Murcia, Spain.
   [Anchelin, Monique; Alcaraz-Perez, Francisca; Martinez, Carlos M.; Bernabe-Garcia, Manuel; Mulero, Victoriano; Cayuela, Maria L.] IMIB, Murcia, Spain.
   [Mulero, Victoriano] Univ Murcia, Fac Biol, Dept Biol Celular & Histol, Murcia, Spain.
C3 Hospital Clinico Universitario Virgen de la Arrixaca; CIBER - Centro de
   Investigacion Biomedica en Red; CIBEREHD; University of Murcia
RP Cayuela, ML (corresponding author), Univ Hosp Virgen de la Arrixaca, Telomerase Aging & Canc Grp, CIBERehd, Res Unit,Dept Surg, Murcia, Spain.
EM marial.cayuela@carm.es
RI Mulero, Victoriano/L-2730-2014; Martinez, Carlos M./E-4986-2016
OI Mulero, Victoriano/0000-0001-9527-0211; Martinez, Carlos
   M./0000-0003-3307-1326; Alcaraz Perez, Francisca/0000-0003-1802-4943;
   Bernabe Garcia, Manuel/0000-0003-4334-0059
FU Spanish Ministry of Science and Innovation [PI10/00878]; Fundacion
   Seneca from the regional government of Murcia, Spain (CARM)
   [08760/PI/08]; Fundacion para la Formacion e Investigacion Sanitarias de
   la Region de Murcia, Spain; RED RTICC [RD07/0020/0023]
FX This work was supported by the Spanish Ministry of Science and
   Innovation (PI10/00878), Fundacion Seneca from the regional government
   of Murcia, Spain (CARM, grant 08760/PI/08), Fundacion para la Formacion
   e Investigacion Sanitarias de la Region de Murcia, Spain (fellowships to
   F.A.-P.), and RED RTICC (RD07/0020/0023).
CR Anchelin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016955
   Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102
   Autexier C, 2008, GENE DEV, V22, P1731, DOI 10.1101/gad.1695808
   Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102
   de Jesus BB, 2012, EMBO MOL MED, V4, P691, DOI 10.1002/emmm.201200245
   BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0
   Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656
   Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4
   Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373
   Canela A, 2007, P NATL ACAD SCI USA, V104, P5300, DOI 10.1073/pnas.0609367104
   Cheung I, 2006, NUCLEIC ACIDS RES, V34, P96, DOI 10.1093/nar/gkj417
   Chiang YJ, 2004, MOL CELL BIOL, V24, P7024, DOI 10.1128/MCB.24.16.7024-7031.2004
   Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X
   COHN M, 1995, SCIENCE, V269, P396, DOI 10.1126/science.7618104
   Fitzgerald MS, 1999, P NATL ACAD SCI USA, V96, P14813, DOI 10.1073/pnas.96.26.14813
   Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025
   Flores I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004934
   Gerhard GS, 2002, AGING CELL, V1, P104, DOI 10.1046/j.1474-9728.2002.00012.x
   Gerhard GS, 2002, EXP GERONTOL, V37, P1055, DOI 10.1016/S0531-5565(02)00088-8
   González-Suárez E, 2000, NAT GENET, V26, P114, DOI 10.1038/79089
   Goytisolo FA, 2002, ONCOGENE, V21, P584, DOI 10.1038/sj.onc.1205085
   Hemann MT, 2001, MOL BIOL CELL, V12, P2023, DOI 10.1091/mbc.12.7.2023
   Henriques CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003214
   Herbert BS, 2006, NAT PROTOC, V1, P1583, DOI 10.1038/nprot.2006.239
   Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950
   Imamura S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003364
   Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603
   Kirwan M, 2009, BBA-MOL BASIS DIS, V1792, P371, DOI 10.1016/j.bbadis.2009.01.010
   Kishi S, 2009, GERONTOLOGY, V55, P430, DOI 10.1159/000228892
   Kishi S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000152
   Knudson M, 2005, BLOOD, V105, P682, DOI 10.1182/blood-2004-04-1673
   Lau BWM, 2008, J MOL NEUROSCI, V34, P63, DOI 10.1007/s12031-007-0072-x
   Lee C, 2004, METHOD CELL BIOL, V77, P241
   Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345
   Leri A, 2003, EMBO J, V22, P131, DOI 10.1093/emboj/cdg013
   Liu Y, 2000, CURR BIOL, V10, P1459, DOI 10.1016/S0960-9822(00)00805-8
   Martínez P, 2009, GENE DEV, V23, P2060, DOI 10.1101/gad.543509
   Maser RS, 2004, DNA REPAIR, V3, P979, DOI 10.1016/j.dnarep.2004.05.009
   Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141
   Pereboom TC, 2011, BLOOD, V118, P5458, DOI 10.1182/blood-2011-04-351460
   Samper E, 2001, EMBO REP, V2, P800, DOI 10.1093/embo-reports/kve174
   Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021
   Swanberg SE, 2010, EXP GERONTOL, V45, P647, DOI 10.1016/j.exger.2010.04.002
   Vera E, 2012, CELL REP, V2, P732, DOI 10.1016/j.celrep.2012.08.023
   Vulliamy T, 2004, NAT GENET, V36, P447, DOI 10.1038/ng1346
   Westerfield M., 2000, The Zebrafish Book, a Guide for the Laboratory Use of Zebrafish (Danio rerio) OR, V4th ed.
   Wicky C, 1996, P NATL ACAD SCI USA, V93, P8983, DOI 10.1073/pnas.93.17.8983
   Xie MY, 2008, J BIOL CHEM, V283, P2049, DOI 10.1074/jbc.M708032200
   Yuan XM, 1999, GENES CELLS, V4, P563, DOI 10.1046/j.1365-2443.1999.00284.x
   Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030188
   Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606
NR 51
TC 68
Z9 71
U1 0
U2 37
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 1754-8403
EI 1754-8411
J9 DIS MODEL MECH
JI Dis. Model. Mech.
PD SEP
PY 2013
VL 6
IS 5
BP 1101
EP 1112
DI 10.1242/dmm.011635
PG 12
WC Cell Biology; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Pathology
GA 236IV
UT WOS:000325789600006
PM 23744274
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Verbeke, P
   Clark, BFC
   Rattan, SIS
AF Verbeke, P
   Clark, BFC
   Rattan, SIS
TI Modulating cellular aging in vitro: Hormetic effects of repeated mild
   heat stress on protein oxidation and glycation
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article; Proceedings Paper
CT Biological Aging - Euroconference on Molecular, Cellular and Tissue
   Gerontology
CY MAY 06-10, 2000
CL SPA, BELGIUM
SP Int Assoc Gerontol, UN Programme Ageing
DE anti-aging; gerontogenes; heat shock; hormesis; protein modification;
   stress
ID AGE-RELATED-CHANGES; MOLECULAR CHAPERONES; CALORIC RESTRICTION; OXIDIZED
   PROTEINS; SHOCK PROTEINS; EXTENDED LIFE; LIVER; CELLS; INACTIVATION;
   BIOCHEMISTRY
AB Intracellular and extracellular proteins are subject to a variety of spontaneous non-enzymatic modifications which affect their structure, function and stability. Protein oxidation and glycation are tightly linked and are implicated in the development of many pathological consequences of aging. Although multiple endogenous pathways in the cell can prevent the formation of oxidized and glycated proteins, and repair and degrade abnormal proteins, such abnormal proteins do accumulate during aging. The heat shock response involving the family of stress-proteins or the so-called heat shock proteins (HSP), represents the quickest and highly conserved response to proteotoxic insults. Since repeated mild heat stress is able to prevent the onset of various age-related changes during cellular aging in vitro, we suggest that treatments which increase HSP expression should reduce the extent of accumulation of abnormal proteins during aging. Such modulation of aging is an example of hormesis, which is characterized by the beneficial effects resulting from the cellular responses to mild repeated stress. (C) 2000 Elsevier Science Inc. All rights reserved.
C1 Aarhus Univ, Dept Biol Mol & Struct, Lab Cellular Ageing, Danish Ctr Mol Gerontol, DK-8000 Aarhus, Denmark.
C3 Aarhus University
RP Rattan, SIS (corresponding author), Aarhus Univ, Dept Biol Mol & Struct, Lab Cellular Ageing, Danish Ctr Mol Gerontol, Gustav Wieds Vej 10-C, DK-8000 Aarhus, Denmark.
EM rattan@imsb.au.dk
OI Rattan, Suresh I.S./0000-0002-3478-1381
CR BAYNES JW, 2000, IN PRESS BIOGERONTOL
   Benjamin IJ, 1998, CIRC RES, V83, P117, DOI 10.1161/01.RES.83.2.117
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   CEFALU WT, 1995, J GERONTOL A-BIOL, V50, pB337, DOI 10.1093/gerona/50A.6.B337
   Conconi M, 1998, BIOCHEM J, V333, P407, DOI 10.1042/bj3330407
   Conconi M, 1996, ARCH BIOCHEM BIOPHYS, V331, P232, DOI 10.1006/abbi.1996.0303
   Dean RT, 1997, BIOCHEM J, V324, P1
   Faccio L, 2000, J BIOL CHEM, V275, P2581, DOI 10.1074/jbc.275.4.2581
   Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243
   Furth AJ, 1997, BRIT J BIOMED SCI, V54, P192
   Gabai VL, 1998, FEBS LETT, V438, P1, DOI 10.1016/S0014-5793(98)01242-3
   Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076
   Grune T, 2000, BIOGERONTOLOGY, V1, P31, DOI 10.1023/A:1010037908060
   Hall DM, 2000, FASEB J, V14, P78, DOI 10.1096/fasebj.14.1.78
   Hayashi T, 1998, MECH AGEING DEV, V102, P55, DOI 10.1016/S0047-6374(98)00011-6
   JAKOB U, 1999, CELL, P96
   Kajimoto Y, 1999, DIABETOLOGIA, V42, P1417, DOI 10.1007/s001250051313
   Kasper M, 1999, BIOCHEM BIOPH RES CO, V261, P175, DOI 10.1006/bbrc.1999.0902
   LEE AT, 1992, ANN NY ACAD SCI, V663, P63, DOI 10.1111/j.1749-6632.1992.tb38649.x
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   Levine RL, 1999, MECH AGEING DEV, V107, P323, DOI 10.1016/S0047-6374(98)00152-3
   Liao DF, 2000, J BIOL CHEM, V275, P189, DOI 10.1074/jbc.275.1.189
   LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540
   MIFFLIN LC, 1994, J BIOL CHEM, V269, P15710
   Minois N, 2000, BIOGERONTOLOGY, V1, P15, DOI 10.1023/A:1010085823990
   Miyata T, 1999, KIDNEY INT, V55, P389, DOI 10.1046/j.1523-1755.1999.00302.x
   OLIVER CN, 1987, J BIOL CHEM, V262, P5488
   Rattan S I, 2000, Indian J Exp Biol, V38, P1
   Rattan SIS, 1996, EXP GERONTOL, V31, P33, DOI 10.1016/0531-5565(95)02022-5
   Rattan SIS, 1995, MOL ASPECTS MED, V16, P441, DOI 10.1016/0098-2997(95)00005-2
   Rattan SIS, 1998, BIOCHEM MOL BIOL INT, V45, P753
   Rikans LE, 1998, GERONTOLOGY, V44, P72, DOI 10.1159/000021987
   Scrofano MM, 1998, MECH AGEING DEV, V105, P273, DOI 10.1016/S0047-6374(98)00097-9
   Sell DR, 1998, MECH AGEING DEV, V105, P221, DOI 10.1016/S0047-6374(98)00090-6
   Sun HY, 1999, BIOCHEMISTRY-US, V38, P105, DOI 10.1021/bi981295k
   Tatar M, 1997, NATURE, V390, P30, DOI 10.1038/36237
   Terman A, 1998, MECH AGEING DEV, V100, P145, DOI 10.1016/S0047-6374(97)00129-2
   Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109
NR 38
TC 60
Z9 65
U1 0
U2 14
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD SEP
PY 2000
VL 35
IS 6-7
SI SI
BP 787
EP 794
DI 10.1016/S0531-5565(00)00143-1
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Geriatrics & Gerontology
GA 367ZQ
UT WOS:000090093100015
PM 11053669
DA 2024-02-19
ER

PT J
AU TAKAHASHI, N
   DASHWOOD, RH
   BJELDANES, LF
   BAILEY, GS
   WILLIAMS, DE
AF TAKAHASHI, N
   DASHWOOD, RH
   BJELDANES, LF
   BAILEY, GS
   WILLIAMS, DE
TI REGULATION OF HEPATIC CYTOCHROME P4501A BY INDOLE-3-CARBINOL - TRANSIENT
   INDUCTION WITH CONTINUOUS FEEDING IN RAINBOW-TROUT
SO FOOD AND CHEMICAL TOXICOLOGY
LA English
DT Article
ID ACID REACTION-PRODUCTS; BETA-NAPHTHOFLAVONE; AH RECEPTOR; AFLATOXIN-B1
   METABOLISM; ENZYME-INDUCTION; CELL LINE; INVIVO; CARCINOGENESIS; RAT;
   2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN
AB This study investigated the kinetics of hepatic cytochrome P-4501A (CYP1A) induction in rainbow trout by indole-3-carbinol (I3C), a natural tumour modulator from cruciferous vegetables, and its low pH reaction products 3,3'-diindolylmethane (I33'), 5,6,11,12,17,18-hexahydrocyclononal[1,2-b:4,5-b':7,8-b'']triindole cyclic trimer (CT), and the unresolved I3C acid reaction mixture (RXM). RXM, CT and I33' were potent inducers of total embryonic CYP1A following direct microinjection, and of fingerling hepatic CYP1A following ip exposure, whereas I3C itself produced only a transient and relatively weak induction. It is also reported for the first time that dietary I3C induced hepatic CYP1A and its associated ethoxyresorufin O-deethylase (EROD) activity in trout but, again, the induction was weak and transient even with continuous I3C feeding. Mechanism studies and mixed exposures with the Ah agonist beta-naphthoflavone indicated that transient induction by I3C was not due to diet ageing, but appears to involve inactivation of the Ah inductive pathway and irreversible inactivation of CYP1A-mediated EROD activity by DC-derived metabolites. Thus, I3C derivatives exhibit dual capacities for CYP1A induction and inhibition in trout.
C1 OREGON STATE UNIV, DEPT FOOD SCI & TECHNOL, CORVALLIS, OR 97331 USA.
   OREGON STATE UNIV, CTR MARINE FRESHWATER BIOMED SCI, CORVALLIS, OR 97331 USA.
   UNIV HAWAII, DEPT ENVIRONM BIOCHEM, HONOLULU, HI 96822 USA.
   UNIV CALIF BERKELEY, DEPT NUTR SCI, BERKELEY, CA 94720 USA.
C3 Oregon State University; Oregon State University; University of Hawaii
   System; University of California System; University of California
   Berkeley
RI Dashwood, Roderick/AAF-2025-2020; Dashwood, Roderick H/E-9090-2011
OI Takahashi-Ando, Naoko/0000-0001-8997-0772; Dashwood,
   Roderick/0000-0003-0351-4034
FU NCI NIH HHS [CA34732] Funding Source: Medline; NIEHS NIH HHS [ES00210,
   ES03850] Funding Source: Medline
CR BERNDTSON AK, 1994, ARCH BIOCHEM BIOPHYS, V310, P187, DOI 10.1006/abbi.1994.1156
   BJELDANES LF, 1991, P NATL ACAD SCI USA, V88, P9543, DOI 10.1073/pnas.88.21.9543
   BOOBIS AR, 1977, MOL PHARMACOL, V13, P259
   BRADFIELD CA, 1987, J TOXICOL ENV HEALTH, V21, P311, DOI 10.1080/15287398709531021
   BRADLOW HL, 1991, CARCINOGENESIS, V12, P1571, DOI 10.1093/carcin/12.9.1571
   BURKE MD, 1977, DRUG METAB DISPOS, V5, P1
   BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5
   DASHWOOD RH, 1989, FOOD CHEM TOXICOL, V27, P385, DOI 10.1016/0278-6915(89)90144-0
   DASHWOOD RH, 1989, CARCINOGENESIS, V10, P175, DOI 10.1093/carcin/10.1.175
   DEKRUIF CA, 1991, CHEM-BIOL INTERACT, V80, P303, DOI 10.1016/0009-2797(91)90090-T
   DEMONTELLANO PRO, 1983, ANNU REV PHARMACOL, V23, P481
   EISELE TA, 1983, TOXICOL LETT, V19, P133, DOI 10.1016/0378-4274(83)90273-4
   EISEN HJ, 1983, BIOCHEM ACTION HORM, V10, P227
   FONG AT, 1990, BIOCHEM PHARMACOL, V39, P19, DOI 10.1016/0006-2952(90)90643-Y
   GOEGER DE, 1988, CARCINOGENESIS, V9, P1793, DOI 10.1093/carcin/9.10.1793
   GOOCH JW, 1989, TOXICOL APPL PHARM, V98, P422, DOI 10.1016/0041-008X(89)90171-3
   HAASCH ML, 1993, FUND APPL TOXICOL, V20, P72, DOI 10.1006/faat.1993.1009
   HAHN ME, 1994, TOXICOL APPL PHARM, V127, P187, DOI 10.1006/taap.1994.1153
   HAHN ME, 1993, AQUAT TOXICOL, V26, P185, DOI 10.1016/0166-445X(93)90030-5
   HAHN ME, 1992, MAR ENVIRON RES, V34, P87, DOI 10.1016/0141-1136(92)90088-4
   HEILMANN LJ, 1988, DNA-J MOLEC CELL BIO, V7, P379, DOI 10.1089/dna.1.1988.7.379
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LORENZEN A, 1990, TOXICOL APPL PHARM, V106, P53, DOI 10.1016/0041-008X(90)90105-4
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   NEBERT DW, 1987, ANNU REV BIOCHEM, V56, P945, DOI 10.1146/annurev.bi.56.070187.004501
   NEBERT DW, 1991, DNA CELL BIOL, V10, P1, DOI 10.1089/dna.1991.10.1
   QUATTROCHI LC, 1994, J BIOL CHEM, V269, P6949
   Sinnhuber R O, 1978, Ann N Y Acad Sci, V298, P389, DOI 10.1111/j.1749-6632.1977.tb19280.x
   STRESSER DM, 1994, DRUG METAB DISPOS, V22, P392
   SWANSON HI, 1991, TOXICOL LETT, V58, P85, DOI 10.1016/0378-4274(91)90194-B
   VALSTA LM, 1988, FOOD CHEM TOXICOL, V26, P129, DOI 10.1016/0278-6915(88)90109-3
   WATTENBERG LW, 1985, CANCER RES, V45, P1
   WILLIAMS DE, 1982, BIOCHIM BIOPHYS ACTA, V717, P398, DOI 10.1016/0304-4165(82)90280-X
   WILLIAMS DE, 1983, ARCH BIOCHEM BIOPHYS, V225, P55, DOI 10.1016/0003-9861(83)90006-1
   WILLIAMS DE, 1984, BIOCHEM PHARMACOL, V33, P3743, DOI 10.1016/0006-2952(84)90035-2
   WORTELBOER HM, 1992, FOOD CHEM TOXICOL, V30, P589, DOI 10.1016/0278-6915(92)90193-O
   WORTELBOER HM, 1992, BIOCHEM PHARMACOL, V43, P1439, DOI 10.1016/0006-2952(92)90200-3
   1993, J VET MED ASSOCIATIO, V202, P229
NR 38
TC 28
Z9 31
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0278-6915
EI 1873-6351
J9 FOOD CHEM TOXICOL
JI Food Chem. Toxicol.
PD FEB
PY 1995
VL 33
IS 2
BP 111
EP 120
DI 10.1016/0278-6915(94)00117-7
PG 10
WC Food Science & Technology; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Toxicology
GA QQ759
UT WOS:A1995QQ75900003
PM 7867998
DA 2024-02-19
ER

PT J
AU URYVAEVA, IV
   DELONE, GV
AF URYVAEVA, IV
   DELONE, GV
TI AN IMPROVED METHOD OF MOUSE-LIVER MICRONUCLEUS ANALYSIS - AN APPLICATION
   TO AGE-RELATED GENETIC ALTERATION AND POLYPLOIDY STUDY
SO MUTATION RESEARCH-ENVIRONMENTAL MUTAGENESIS AND RELATED SUBJECTS
LA English
DT Article
DE MICRONUCLEUS TEST; MOUSE LIVER; AGING; POLYPLOIDY
ID UNSCHEDULED DNA-SYNTHESIS; RAT-LIVER; CELL POLYPLOIDY; HEPATOCYTES;
   INVIVO; ASSAY; CARCINOGENS; INDUCTION; DAMAGE; ETHYLNITROSOUREA
AB The performance of a micronucleus test in liver cells in vivo requires two laborious procedures: stimulation of hepatocytes to division and dissociation of liver tissue into a single-cell suspension. We propose the method of inhalation treatment of mice with carbon tetrachloride to induce cell proliferation and alkaline dissociation of previously fixed tissue. The micronucleus incidence and ploidy classes in terms of cytophotometric DNA content were determined in liver of mice of three age groups (around 2.5, 5.0 and 7.0 months old) after CCl4 treatment or partial hepatectomy. The data obtained show that both methods give the same results. The fraction of micronucleated hepatocytes was 0.69% at the age of 2.5 months; it increased to 8.5% and then to 13.5% at 5.0 and 7.0 months respectively. Simultaneously, the ploidy classes changed both with the aging of the animal and after induced liver regeneration. The percentage distribution of micronucleated cells by ploidy class showed that cells carrying micronuclei were the higher ploidies rather than the population in general. Since polyploid cells contain multiple molecular targets for genetic damage, the micronucleation index per genome unit was estimated. Then the real rate of accumulation of bath intrinsic endogenous (and probably the exogenously induced) preclastogenic genetic alterations in hepatocytes during the adulthood of mice was evaluated to be 0.03% per diploid genome per day. This seems to be the first description of the phenomenon of liver cell aging in terms of micronuclear aberrations.
RP URYVAEVA, IV (corresponding author), RUSSIAN ACAD SCI,INST DEV BIOL,VAVILOV STR 26,MOSCOW 117808,RUSSIA.
CR ALBERT MD, 1960, CANCER RES, V20, P1514
   AMES BN, 1989, MUTAT RES, V214, P41, DOI 10.1016/0027-5107(89)90196-6
   ASHBY J, 1989, ENVIRON MOL MUTAGEN, V14, P221, DOI 10.1002/em.2850140403
   ASHBY J, 1986, MUTAT RES, V172, P271, DOI 10.1016/0165-1218(86)90065-0
   BELOV LN, 1973, TSITOLOGIYA, V17, P1332
   BENNING V, 1992, MUTAT RES, V271, P159, DOI 10.1016/0165-1161(92)91190-3
   BRAITHWAITE I, 1988, MUTAT RES, V203, P23, DOI 10.1016/0165-1161(88)90004-0
   Brodsky V.Y., 1985, GENOME MULTIPLICATIO
   Brodsky W Y, 1977, Int Rev Cytol, V50, P275
   BUTTERWORTH BE, 1989, CANCER RES, V49, P1075
   CLIET I, 1989, MUTAT RES, V216, P321, DOI 10.1016/0165-1161(89)90042-3
   CROWLEY C, 1963, P NATL ACAD SCI USA, V49, P626, DOI 10.1073/pnas.49.5.626
   CURTIS HJ, 1963, SCIENCE, V141, P686, DOI 10.1126/science.141.3582.686
   DAS RK, 1988, STAIN TECHNOL, V63, P71, DOI 10.3109/10520298809107164
   ECKL PM, 1991, CARCINOGENESIS, V12, P643, DOI 10.1093/carcin/12.4.643
   GEORGE E, 1989, CARCINOGENESIS, V10, P2329, DOI 10.1093/carcin/10.12.2329
   GERHARD H, 1970, VIRCHOWS ARCH B, V6, P38
   HEDDLE JA, 1983, MUTAT RES, V123, P61, DOI 10.1016/0165-1110(83)90047-7
   MEDVEDEV ZA, 1990, BIOL REV, V65, P375, DOI 10.1111/j.1469-185X.1990.tb01428.x
   MIRSALIS JC, 1980, CARCINOGENESIS, V1, P621, DOI 10.1093/carcin/1.7.621
   MIRSALIS JC, 1982, ENVIRON MUTAGEN, V4, P553, DOI 10.1002/em.2860040506
   ONO K, 1990, RADIAT RES, V123, P345, DOI 10.2307/3577742
   ROSSI AM, 1987, MUTAT RES, V182, P75, DOI 10.1016/0165-1161(87)90056-2
   SAKAHARA H, 1992, INT J RADIAT BIOL, V62, P443, DOI 10.1080/09553009214552321
   SAWADA S, 1991, MUTAT RES, V251, P59, DOI 10.1016/0027-5107(91)90215-A
   SCHULTZE B, 1973, VIRCHOWS ARCH B, V14, P329
   STEINMETZ KL, 1989, CARCINOGENESIS, V9, P959
   TATES AD, 1980, MUTAT RES, V74, P11, DOI 10.1016/0165-1161(80)90187-9
   TATES AD, 1982, MUTAT RES, V92, P275, DOI 10.1016/0027-5107(82)90231-7
   TATES AD, 1989, MUTAT RES, V210, P271, DOI 10.1016/0027-5107(89)90088-2
   TATES AD, 1986, CARCINOGENESIS, V7, P1053, DOI 10.1093/carcin/7.7.1053
   TATES AD, 1990, CHROMOSOMAL ABERRATI, P242
   Uryvaeva I N, 1992, Ontogenez, V23, P370
   URYVAEVA IV, 1982, TSITOLOGIYA+, V24, P911
   URYVAEVA IV, 1976, TSITOLOGIYA+, V18, P1354
   URYVAEVA IV, 1981, J THEOR BIOL, V89, P557, DOI 10.1016/0022-5193(81)90028-X
   VANDEPOLL MLM, 1989, CARCINOGENESIS, V10, P717, DOI 10.1093/carcin/10.4.717
NR 37
TC 27
Z9 30
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-1161
J9 MUTAT RES-ENVIR MUTA
JI Mutat. Res.-Environ. Mutagen. Rel. Subj.
PD FEB
PY 1995
VL 334
IS 1
BP 71
EP 80
DI 10.1016/0165-1161(95)90032-2
PG 10
WC Environmental Sciences; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology; Genetics & Heredity
GA QA449
UT WOS:A1995QA44900009
PM 7528339
DA 2024-02-19
ER

PT J
AU Dkhar, P
   Sharma, R
AF Dkhar, Preeticia
   Sharma, Ramesh
TI Attenuation of age-related increase of protein carbonylation in the
   liver of mice by melatonin and curcumin
SO MOLECULAR AND CELLULAR BIOCHEMISTRY
LA English
DT Article
DE Aging; Protein carbonyls; Melatonin; Curcumin; Liver; Mice
ID OXIDATIVE STRESS; RAT-BRAIN; KAPPA-B; DIMETHYLSULFOXIDE; DISEASE
AB Protein carbonyls are formed as a consequence of the oxidative modification of proteins by reactive oxygen species and are commonly used as a marker of protein oxidation in cells and tissues. Melatonin has free radical scavenging ability besides its classical role as a hormonal signaling agent. Curcumin, a phytochemical, has a wide variety of biological actions including anti-inflammatory and antioxidative. In the present study, the effects of melatonin and curcumin on age-related carbonyl content of liver in mice were investigated. Young (1 month) and aged (18 month) were administered with melatonin (10 mg/kg body weight) and curcumin (90 mg/kg body weight) in dimethyl sulfoxide intraperitoneally. Livers were excised from each experimental group and processed. The level of protein carbonylation was assessed spectrophotometrically and further confirmed by Western blotting analysis. Protein carbonyls of liver have been found to be significantly higher in 18-month-old mice as compared to 1-month-old mice. The carbonyl content in 1- and 18-month-old mice decreases significantly upon administrations of melatonin and curcumin. This study thus suggests that the formation of protein carbonyls in the liver of the aging mice can be prevented by the antioxidative effects of melatonin and curcumin, which may provide health benefits in aging animals.
C1 [Dkhar, Preeticia; Sharma, Ramesh] NE Hill Univ, Dept Biochem, Shillong 793022, Meghalaya, India.
C3 North Eastern Hill University
RP Sharma, R (corresponding author), NE Hill Univ, Dept Biochem, Shillong 793022, Meghalaya, India.
EM sharamesh@gmail.com
FU UGC [34-288/2008(SR)]; UGC-RGNFS [F.14-2(ST)/2007(SA-III)]
FX Financial support to RS from UGC under Major Research Project (F. No.
   34-288/2008(SR)) and the fellowship support from UGC-RGNFS
   (F.14-2(ST)/2007(SA-III) to PD are gratefully acknowledged. Authors
   thank the Department of Biochemistry, North-Eastern Hill University,
   Shillong for providing research facilities under UGC-UPE and DRS, and
   DST-FIST, New Delhi.
CR Adams S, 2001, FRONT BIOSCI, V6, pA17, DOI 10.2741/Adams
   Aggarwal BB, 2009, INT J BIOCHEM CELL B, V41, P40, DOI 10.1016/j.biocel.2008.06.010
   Bala K, 2006, BIOGERONTOLOGY, V7, P81, DOI 10.1007/s10522-006-6495-x
   Balogun E, 2003, BIOCHEM J, V371, P887, DOI 10.1042/BJ20021619
   Benot S, 1999, J PINEAL RES, V27, P59, DOI 10.1111/j.1600-079X.1999.tb00597.x
   Boukhtouche F, 2006, J NEUROCHEM, V96, P1778, DOI 10.1111/j.1471-4159.2006.03708.x
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Breusing N, 2008, BIOL CHEM, V389, P203, DOI 10.1515/BC.2008.029
   Cankurtaran M, 2006, ARCH GERONTOL GERIAT, V42, P35, DOI 10.1016/j.archger.2005.05.004
   Ceriello A, 2006, CURR OPIN LIPIDOL, V17, P510, DOI 10.1097/01.mol.0000245256.17764.fb
   Dkhar P, 2011, NEUROCHEM INT, V59, P996, DOI 10.1016/j.neuint.2011.08.019
   Dkhar P, 2010, INT J DEV NEUROSCI, V28, P351, DOI 10.1016/j.ijdevneu.2010.04.005
   El-Missiry MA, 2007, ECOTOX ENVIRON SAFE, V66, P278, DOI 10.1016/j.ecoenv.2006.03.008
   Friguet Bertrand, 2002, TheScientificWorldJOURNAL, V2, P248
   Fu SL, 1997, BIOCHEM J, V324, P41, DOI 10.1042/bj3240041
   GOEL A, 2008, BIOCHEM PHARMACOL, V75, P907
   Goto S, 2007, ANN NY ACAD SCI, V1100, P431, DOI 10.1196/annals.1395.048
   Harman D, 2000, J AM AGING ASSOC, V23, P25, DOI 10.1007/s11357-000-0004-y
   Helenius M, 2001, ANTIOXID REDOX SIGN, V3, P147, DOI 10.1089/152308601750100669
   KELLY KA, 1994, INFECT IMMUN, V62, P3122, DOI 10.1128/IAI.62.8.3122-3128.1994
   Krause D.N., 2000, IUPHAR COMPENDIUM RE, V2nd, P270
   Kregel KC, 2007, AM J PHYSIOL-REG I, V292, pR18, DOI 10.1152/ajpregu.00327.2006
   Lavrovsky Y, 2000, EXP GERONTOL, V35, P521, DOI 10.1016/S0531-5565(00)00118-2
   LEVINE RL, 1994, METHOD ENZYMOL, V233, P346
   Levine RL, 2002, FREE RADICAL BIO MED, V32, P790, DOI 10.1016/S0891-5849(02)00765-7
   Li WX, 2004, J NEUROSCI, V24, P7400, DOI 10.1523/JNEUROSCI.1370-04.2004
   Liu XF, 2005, ANN NY ACAD SCI, V1054, P136, DOI 10.1196/annals.1345.016
   Martín M, 2002, INT J BIOCHEM CELL B, V34, P348, DOI 10.1016/S1357-2725(01)00138-8
   OXIDATIVE P, 1934, INT J BIOCHEM CELL B, P348
   Rao CV, 2007, ADV EXP MED BIOL, V595, P213
   REDDY ACP, 1994, MOL CELL BIOCHEM, V137, P1, DOI 10.1007/BF00926033
   Reiter RJ, 2003, BEST PRACT RES CL EN, V17, P273, DOI 10.1016/S1521-690X(03)00016-2
   SRIMAL RC, 1973, J PHARM PHARMACOL, V25, P447, DOI 10.1111/j.2042-7158.1973.tb09131.x
   Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191
   YU ZW, 1994, BIOSCIENCE REP, V14, P259, DOI 10.1007/BF01199051
   Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974
   Zhang HJ, 2003, FASEB J, V17, P2293, DOI 10.1096/fj.03-0139fje
NR 37
TC 11
Z9 11
U1 0
U2 19
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0300-8177
EI 1573-4919
J9 MOL CELL BIOCHEM
JI Mol. Cell. Biochem.
PD AUG
PY 2013
VL 380
IS 1-2
BP 153
EP 160
DI 10.1007/s11010-013-1668-9
PG 8
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 174CP
UT WOS:000321131100015
PM 23613230
DA 2024-02-19
ER

PT J
AU JI, LL
   DILLON, D
   WU, E
AF JI, LL
   DILLON, D
   WU, E
TI MYOCARDIAL AGING - ANTIOXIDANT ENZYME-SYSTEMS AND RELATED
   BIOCHEMICAL-PROPERTIES
SO AMERICAN JOURNAL OF PHYSIOLOGY
LA English
DT Article
DE MYOCARDIUM; LIPID PEROXIDATION; EXERCISE
ID RAT SKELETAL-MUSCLE; FREE-RADICALS; SUPEROXIDE-DISMUTASE; REPERFUSION
   INJURY; OXYGEN RADICALS; EXERCISE; LIVER; HEART; CATALASE; ISCHEMIA
AB The effects of aging on myocardial antioxidant enzyme activity, lipid peroxidation, and other related biochemical properties were investigated in male Wistar-Furth rats at 4,26, and 31 mo of age at rest and after an acute exercise bout. The results showed that resting heart cytosolic superoxide dismutase (CuZn SOD) activity was significantly decreased in the heart with aging (66 +/- 6.5 U/mg protein at 4 mo vs. 49 +/- 3.8 U/mg protein at 31 mo) and was elevated in all age groups after exercise. Mitochondrial Mn SOD activity was almost doubled in both 26- and 31-mo-old rats compared with that at 4 mo. Myocardial catalase and cytosolic glutathione peroxidase (GPX) activities were significantly decreased with age, whereas mitochondrial GPX was 29% higher (P < 0.05) in 31- than 4-mo-old rats. Glutathione S-transferase activity in the heart also declined with age (P < 0.05 at 31 mo). Malondialdehyde contents in both heart homogenate and mitochondria were significantly increased at old age. Activity of several enzymes related to myocardial energy production, e.g., citrate synthase, malate dehydrogenase, and lactate dehydrogenase, as well as myocardial protein content showed an age-related decline. These data indicate that myocardial antioxidant capacity is weakened during aging and that the compensatory increases of mitochondrial SOD and GPX may be an important mechanism in coping with free radical damage in senescent heart. Findings in the present investigation seem to support the free radical theory of aging.
C1 UNIV ILLINOIS, DIV NUTR SCI, URBANA, IL 61801 USA.
C3 University of Illinois System; University of Illinois Urbana-Champaign
RP JI, LL (corresponding author), UNIV ILLINOIS, DEPT KINESIOL, 125 FREER HALL, 906 S GOODWIN AVE, URBANA, IL 61801 USA.
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   DAS DK, 1987, BIOL NEONATE, V51, P156, DOI 10.1159/000242647
   DAVIES KJA, 1982, BIOCHEM BIOPH RES CO, V107, P1198, DOI 10.1016/S0006-291X(82)80124-1
   DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478
   FLOHE L, 1984, METHOD ENZYMOL, V105, P114
   GAUDUEL Y, 1984, J MOL CELL CARDIOL, V16, P459, DOI 10.1016/S0022-2828(84)80617-3
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   HANSFORD RG, 1983, BIOCHIM BIOPHYS ACTA, V726, P41, DOI 10.1016/0304-4173(83)90010-1
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Harman D., 1986, FREE RADICALS AGING, P3
   HERBENER GH, 1976, J GERONTOL, V31, P8, DOI 10.1093/geronj/31.1.8
   HESS ML, 1984, J MOL CELL CARDIOL, V16, P969, DOI 10.1016/S0022-2828(84)80011-5
   JI LL, 1988, ARCH BIOCHEM BIOPHYS, V263, P150, DOI 10.1016/0003-9861(88)90623-6
   JI LL, 1987, BIOCHEM PHARMACOL, V36, P3411, DOI 10.1016/0006-2952(87)90319-4
   JI LL, 1990, AM J PHYSIOL, V258, pR918, DOI 10.1152/ajpregu.1990.258.4.R918
   JI LL, 1988, ARCH BIOCHEM BIOPHYS, V263, P137, DOI 10.1016/0003-9861(88)90622-4
   Johnson N.P., 1986, BIOCH MECHANISMS PLA, P1
   LAKATTA EG, 1982, AM J PHYSIOL, V242, pH927, DOI 10.1152/ajpheart.1982.242.6.H927
   Ling K., 1966, METHODS ENZYMOLOGY, V9, P425
   MISRA HP, 1972, J BIOL CHEM, V247, P3170
   NOHL H, 1978, EUR J BIOCHEM, V90, P385, DOI 10.1111/j.1432-1033.1978.tb12615.x
   NOHL H, 1979, MECH AGEING DEV, V11, P145, DOI 10.1016/0047-6374(79)90050-2
   NOHL H, 1978, EUR J BIOCHEM, V82, P563, DOI 10.1111/j.1432-1033.1978.tb12051.x
   OHNO H, 1986, CAN J PHYSIOL PHARM, V64, P1263, DOI 10.1139/y86-213
   PACKER L, 1986, BIOCH ASPECTS PHYSIC, P73
   SIMPSON PJ, 1987, J LAB CLIN MED, V110, P13
   TATE EL, 1976, J GERONTOL, V31, P129, DOI 10.1093/geronj/31.2.129
   UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1
   WERNS SW, 1986, CIRCULATION, V74, P1, DOI 10.1161/01.CIR.74.1.1
NR 30
TC 76
Z9 83
U1 0
U2 2
PU AMER PHYSIOLOGICAL SOC
PI Rockville
PA 6120 Executive Blvd, Suite 600, Rockville, MD, UNITED STATES
SN 0002-9513
J9 AM J PHYSIOL
JI Am. J. Physiol.
PD AUG
PY 1991
VL 261
IS 2
BP R386
EP R392
DI 10.1152/ajpregu.1991.261.2.R386
PN 2
PG 7
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA GC252
UT WOS:A1991GC25200063
PM 1877697
DA 2024-02-19
ER

PT J
AU Yamamoto, K
   Kitano, Y
   Shuang, E
   Hatakeyama, Y
   Sakamoto, Y
   Honma, T
   Tsuduki, T
AF Yamamoto, Kazushi
   Kitano, Yasuna
   Shuang, E.
   Hatakeyama, Yu
   Sakamoto, Yu
   Honma, Taro
   Tsuduki, Tsuyoshi
TI Decreased lipid absorption due to reduced pancreatic lipase activity in
   aging male mice
SO BIOGERONTOLOGY
LA English
DT Article
DE Aging; Enzyme activity; Lipid absorption; Mice; Pancreatic lipase
ID INSULIN-RESISTANCE; OXIDATIVE STATUS; IN-VITRO; ACID; ACCUMULATION;
   EXPRESSION; TISSUE; RATS; UNDERNUTRITION; PEROXIDATION
AB Malnutrition due to aging is partly caused by decreased absorption of nutrients by the gastrointestinal tract. However, the underlying mechanism is unclear and changes in lipid absorption with aging are poorly understood. In this study, changes in lipid absorption with aging were examined in mice aged 3 and 25 months. After overnight fasting, blood samples were collected from snipped tails and then soybean oil was administered orally. Three hours later, mice were sacrificed by decapitation and the liver, pancreas, small intestine and blood were collected. The increase in serum triacylglycerol after soybean oil administration was significantly lower in the older mice, indicating a decrease in lipid absorption with aging. Measurement of mRNA levels for triacylglycerol absorption-related genes showed that mRNA for pancreatic lipase tended to decrease in 25-month-old mice. There was no significant difference in the protein level of pancreatic lipase, but the enzyme activity showed a significant decrease in the older mice. To examine this mechanism, expression levels of mRNA for protein turnover-related genes in the pancreas were measured. The level of a proteasomal mRNA showed a significant decrease in 25-month-old mice. This suggests that the ability to degrade unfolded protein decreases in the aging pancreas, and that this leads to reduction of pancreatic lipase activity and a decrease in lipid absorption.
C1 [Yamamoto, Kazushi; Kitano, Yasuna; Shuang, E.; Hatakeyama, Yu; Sakamoto, Yu; Honma, Taro; Tsuduki, Tsuyoshi] Tohoku Univ, Grad Sch Agr Sci, Lab Food & Biomol Sci, Aoba Ku, Sendai, Miyagi 9818555, Japan.
C3 Tohoku University
RP Tsuduki, T (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Lab Food & Biomol Sci, Aoba Ku, 1-1 Tsutsumidori Amamiyamachi, Sendai, Miyagi 9818555, Japan.
EM tsuzukit@biochem.tohoku.ac.jp
RI Tsuduki, Tsuyoshi/C-2254-2016; Tsuduki, Tsuyoshi/T-2697-2019
OI Tsuduki, Tsuyoshi/0000-0001-7810-0528
FU Ministry of Education, Culture, Sports, Science and Technology, Japan
   [20780099]; Grants-in-Aid for Scientific Research [20780099] Funding
   Source: KAKEN
FX This study was supported by Grant-in-Aid for Young Scientists (B)
   (20780099) from the Ministry of Education, Culture, Sports, Science and
   Technology, Japan.
CR Aw TY, 1997, COMP BIOCHEM PHYS B, V118, P479, DOI 10.1016/S0305-0491(97)00220-4
   Benkovic V, 2014, CLIN NUTR, V33, P689, DOI 10.1016/j.clnu.2013.09.006
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Chondrogianni N, 2014, FREE RADICAL BIO MED, V71, P303, DOI 10.1016/j.freeradbiomed.2014.03.031
   Choudhery MS, 2012, CELL BIOL INT, V36, P747, DOI 10.1042/CBI20110183
   Cirilo CP, 2013, NUTRITION, V29, P673, DOI 10.1016/j.nut.2012.09.004
   CLEMENT G, 1964, J PHYSIOLOGY PARIS, V56, P111
   Coudray C, 2006, J TRACE ELEM MED BIO, V20, P73, DOI 10.1016/j.jtemb.2005.10.007
   Cuesta S, 2013, AGE, V35, P659, DOI 10.1007/s11357-012-9397-7
   D'Souza AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056890
   Drozdowski L, 2005, AM J PHYSIOL-GASTR L, V288, pG125, DOI 10.1152/ajpgi.00311.2003
   Drozdowski L, 2006, WORLD J GASTROENTERO, V12, P7578, DOI 10.3748/wjg.v12.i47.7578
   FEIBUSCH JM, 1982, DIGEST DIS SCI, V27, P1095, DOI 10.1007/BF01391447
   FERRARIS RP, 1993, AM J PHYSIOL, V264, pG285, DOI 10.1152/ajpgi.1993.264.2.G285
   Schoffen JPF, 2014, EXP GERONTOL, V51, P54, DOI 10.1016/j.exger.2014.01.001
   Han LK, 2006, YAKUGAKU ZASSHI, V126, P43, DOI 10.1248/yakushi.126.43
   Hasty P, 2005, MECH AGEING DEV, V126, P71, DOI 10.1016/j.mad.2004.09.036
   Hedemann MS, 2006, J ANIM SCI, V84, P3310, DOI 10.2527/jas.2005-701
   Honma T, 2013, J CLIN BIOCHEM NUTR, V52, P234, DOI 10.3164/jcbn.12-85
   Honma T, 2012, BIOGERONTOLOGY, V13, P93, DOI 10.1007/s10522-011-9363-2
   Honma T, 2011, J NUTR SCI VITAMINOL, V57, P123, DOI 10.3177/jnsv.57.123
   Ishibashi T, 1999, OKAYAMA IGAKKAI ZASS, V111, P3
   Jia JX, 2010, MOL CELL BIOCHEM, V335, P127, DOI 10.1007/s11010-009-0249-4
   Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1
   Kovacs D, 2013, ARCH BIOCHEM BIOPHYS, V531, P80, DOI 10.1016/j.abb.2012.09.010
   Kwak MK, 2007, LIFE SCI, V80, P2411, DOI 10.1016/j.lfs.2007.04.014
   Manikonda PK, 2012, BIOGERONTOLOGY, V13, P511, DOI 10.1007/s10522-012-9396-1
   Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587
   Murashita K, 2013, COMP BIOCHEM PHYS A, V166, P361, DOI 10.1016/j.cbpa.2013.07.015
   Naidoo N, 2008, J NEUROSCI, V28, P6539, DOI 10.1523/JNEUROSCI.5685-07.2008
   Naidoo N, 2009, AGEING RES REV, V8, P150, DOI 10.1016/j.arr.2009.03.001
   Oh S, 2011, NEUROBIOL AGING, V32, P1331, DOI 10.1016/j.neurobiolaging.2009.08.004
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Pérez VI, 2009, P NATL ACAD SCI USA, V106, P3059, DOI 10.1073/pnas.0809620106
   Peter L, 2011, GEN COMP ENDOCR, V172, P39, DOI 10.1016/j.ygcen.2011.02.005
   Ren JK, 2011, J NUTR BIOCHEM, V22, P691, DOI 10.1016/j.jnutbio.2010.06.002
   Sheng L, 2006, EUR J PHARMACOL, V543, P116, DOI 10.1016/j.ejphar.2006.05.038
   Shibata H, 2013, OLEOSCIENCE, V13, P17
   Shibata Hiroshi, 1992, Nutrition and Health (Bicester), V8, P165
   Shinohara N, 2012, BBA-MOL CELL BIOL L, V1821, P980, DOI 10.1016/j.bbalip.2012.04.001
   Sugawara S, 2013, J CLIN BIOCHEM NUTR, V52, P139, DOI 10.3164/jcbn.12-88
   THOMPSON JS, 1988, MECH AGEING DEV, V46, P135, DOI 10.1016/0047-6374(88)90121-2
   Tsuduki T, 2013, J OLEO SCI, V62, P825, DOI 10.5650/jos.62.825
   Tsuzuki T, 2004, CARCINOGENESIS, V25, P1417, DOI 10.1093/carcin/bgh109
   Tsuzuki T, 2008, CARCINOGENESIS, V29, P797, DOI 10.1093/carcin/bgm298
   Tsuzuki T, 2007, BBA-MOL CELL BIOL L, V1771, P20, DOI 10.1016/j.bbalip.2006.11.006
   Uchida A, 2013, METHOD CELL BIOL, V116, P151, DOI 10.1016/B978-0-12-408051-5.00014-0
   Venold FF, 2013, COMP BIOCHEM PHYS A, V164, P229, DOI 10.1016/j.cbpa.2012.09.009
   Villeneuve NF, 2009, CELL CYCLE, V8, P3255, DOI 10.4161/cc.8.20.9565
   Vincent M, 2013, OBESITY, V21, P553, DOI 10.1002/oby.20276
   WATSON TDG, 1995, RES VET SCI, V58, P256, DOI 10.1016/0034-5288(95)90113-2
   Wijnhoven HAH, 2012, CLIN NUTR, V31, P351, DOI 10.1016/j.clnu.2011.10.013
   Winter TA, 2007, NUTRITION, V23, P29, DOI 10.1016/j.nut.2006.10.005
   Woudstra T, 2002, BEST PRACT RES CL GA, V16, P1, DOI 10.1053/bega.2001.0262
   Wu D, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-11
   Zhou Y, 2014, ARCH GERONTOL GERIAT, V58, P293, DOI 10.1016/j.archger.2013.10.005
   Zhu YF, 2012, TOXICOL LETT, V211, P172, DOI 10.1016/j.toxlet.2012.03.801
NR 57
TC 18
Z9 20
U1 3
U2 19
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD OCT
PY 2014
VL 15
IS 5
BP 463
EP 473
DI 10.1007/s10522-014-9512-5
PG 11
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA AP4WM
UT WOS:000342080300005
PM 25033985
DA 2024-02-19
ER

PT J
AU MATSUO, M
   GOMI, F
   DOOLEY, MM
AF MATSUO, M
   GOMI, F
   DOOLEY, MM
TI AGE-RELATED ALTERATIONS IN ANTIOXIDANT CAPACITY AND LIPID-PEROXIDATION
   IN BRAIN, LIVER, AND LUNG HOMOGENATES OF NORMAL AND VITAMIN-E-DEFICIENT
   RATS
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE AGING; CATALASE; CONJUGATED-DIENE FORMATION; GLUTATHIONE PEROXIDASE;
   OXYGEN ABSORPTION; LIPID PEROXIDATION; SUPEROXIDE DISMUTASE; TBA VALUE;
   VITAMIN-E
ID SUPEROXIDE-DISMUTASE ACTIVITIES; GLUTATHIONE-PEROXIDASE; AGING RATS;
   CATALASE; ENZYMES; TISSUES; EXPRESSION; SYSTEM; AUTOXIDATION;
   RESTRICTION
AB Age-related alterations in both antioxidant capacity and lipid peroxidation in the cerebrum, lung and liver homogenates of normal and vitamin E-deficient rats were investigated. The antioxidant capacity, which includes superoxide dismutase, catalase and glutathione peroxidase activities and vitamin E (alpha-tocopherol) concentration, was relatively stable throughout the lifespan. It was observed, however, that catalase and glutathione peroxidase activities in livers of old rats decreased and that vitamin E concentration in lung and liver increased with age. In vitamin E-deficient animals, catalase activity in liver increased and glutathione peroxidase activity in liver and lung decreased. Lipid peroxidation was monitored by use of three different indices, i.e. the thiobarbituric acid (TBA) value, oxygen absorption and conjugated-diene formation. In the absence of any initiator, neither oxygen absorption into tissue homogenates nor conjugated-diene formation in lipid extracts from the homogenates occurred. The TBA value of each cerebrum homogenate incubated under air or an oxygen atmosphere was larger than that of the corresponding unincubated cerebrum homogenate. From comparison between the TBA value and oxygen absorption, this increase in the TBA value was suggested to be due to some reactions other than lipid peroxidation. Although tissue homogenates examined contained TBA-reacting materials, no lipid peroxidation seems to arise during incubation of them. No age-related alterations in the TBA value and oxygen absorption in rat tissue homogenates were observed. Vitamin E deficiency had no effect on the TBA values of cerebrum and lung homogenates, while it seemed to increase the TBA values of liver homogenates. Vitamin E deficiency had no effect on oxygen absorption in these tissue homogenates. The induction period of initiator-induced conjugated-diene formation in lipid extracts from liver and lung homogenates from normal and vitamin E-deficient rats tended to be extended with age. Vitamin E deficiency decreased the induction period of initiator-induced conjugated-diene formation. As a result, the length of the induction period was found to be proportional to vitamin E concentration in lipid extracts. The overall antioxidant capacity of rat tissues appears to be maintained without large variation during ageing. Decreases in the capacity of some antioxidant factors may be compensated by increases in the capacity of other factors.
RP MATSUO, M (corresponding author), TOKYO METROPOLITAN GERIATR HOSP & INST GERONTOL, 35-2 SAKAECHO, ITABASHI KU, TOKYO 173, JAPAN.
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   ANSARI KA, 1989, GROWTH DEVELOP AGING, V53, P117
   BENZI G, 1989, EXP GERONTOL, V24, P137, DOI 10.1016/0531-5565(89)90024-7
   BRAUGHLER JM, 1987, FREE RADICAL BIO MED, V3, P362
   BURTON GW, 1985, LIPIDS, V20, P29, DOI 10.1007/BF02534359
   CAND F, 1989, FREE RADICAL BIO MED, V7, P59, DOI 10.1016/0891-5849(89)90101-9
   CHEN LH, 1980, NUTR REP INT, V22, P873
   CHOW CK, 1973, J NUTR, V103, P618, DOI 10.1093/jn/103.4.618
   COMOLLI R, 1971, Experientia (Basel), V27, P1166, DOI 10.1007/BF02286903
   DEQUIROGA GB, 1990, BIOCHEM J, V272, P247
   DEVASAGAYAM TPA, 1986, FEBS LETT, V205, P246, DOI 10.1016/0014-5793(86)80906-1
   FLOHE L, 1984, METHOD ENZYMOL, V105, P114
   FRANKEL EN, 1983, BIOCHIM BIOPHYS ACTA, V754, P264, DOI 10.1016/0005-2760(83)90141-8
   GRINNA LS, 1973, BIOCHEM BIOPH RES CO, V55, P773, DOI 10.1016/0006-291X(73)91211-4
   HALLIWELL B, 1985, FREE RADICAL BIO MED, P228
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HEIKKILA RE, 1976, ANAL BIOCHEM, V75, P356, DOI 10.1016/0003-2697(76)90089-0
   INGOLD KU, 1987, LIPIDS, V22, P163, DOI 10.1007/BF02537297
   ISCHIROPOULOS H, 1990, MECH AGEING DEV, V52, P11, DOI 10.1016/0047-6374(90)90141-2
   KELLOGG EW, 1976, J GERONTOL, V31, P405, DOI 10.1093/geronj/31.4.405
   KUROBE N, 1990, BIOMED RES-TOKYO, V11, P187, DOI 10.2220/biomedres.11.187
   KWON TW, 1963, J FOOD SCI, V28, P627, DOI 10.1111/j.1365-2621.1963.tb01666.x
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P221, DOI 10.1016/0047-6374(89)90084-5
   LAMMIKEEFE CJ, 1984, GERONTOLOGY, V30, P153, DOI 10.1159/000212623
   MARIA CS, 1987, MECH AGEING DEV, V37, P183
   MASUGI F, 1976, INT J VITAM NUTR RES, V46, P187
   MATSUO M, 1977, CHEM PHARM BULL, V25, P3381
   McCay P. B., 1980, Vitamin E, P289
   MORROW JD, 1990, ANAL BIOCHEM, V184, P1, DOI 10.1016/0003-2697(90)90002-Q
   MULLER DPR, 1987, CLIN NUTRITIONAL ASP, P183
   MURTY HS, 1970, J BIOL CHEM, V245, P5498
   NILSSON JLG, 1968, ACTA CHEM SCAND, V22, P3160, DOI 10.3891/acta.chem.scand.22-3160
   NODA Y, 1982, NEUROBIOL AGING, V3, P173, DOI 10.1016/0197-4580(82)90037-9
   NOHL H, 1979, MECH AGEING DEV, V11, P145, DOI 10.1016/0047-6374(79)90050-2
   PEREZ R, 1991, FREE RADICAL BIO MED, V10, P35, DOI 10.1016/0891-5849(91)90019-Y
   PINTO RE, 1969, BIOCHEM J, V112, P109, DOI 10.1042/bj1120109
   PLAYER TJ, 1977, BIOCHEM BIOPH RES CO, V78, P1397, DOI 10.1016/0006-291X(77)91447-4
   PRYOR WA, 1976, LIPIDS, V11, P370, DOI 10.1007/BF02532843
   RAO G, 1990, MECH AGEING DEV, V53, P49, DOI 10.1016/0047-6374(90)90033-C
   REISS U, 1976, BIOCHEM BIOPH RES CO, V73, P255, DOI 10.1016/0006-291X(76)90701-4
   RIKANS LE, 1988, BIOCHIM BIOPHYS ACTA, V966, P269, DOI 10.1016/0304-4165(88)90076-1
   SAWADA M, 1987, MECH AGEING DEV, V41, P125, DOI 10.1016/0047-6374(87)90057-1
   SEMSEI I, 1989, BIOCHEM BIOPH RES CO, V164, P620, DOI 10.1016/0006-291X(89)91505-2
   SEMSEI I, 1991, MECH AGEING DEV, V58, P13, DOI 10.1016/0047-6374(91)90116-H
   SOHAL RS, 1986, ADV FREE RADICAL BIO, V2, P117, DOI 10.1016/S8755-9668(86)80026-6
   UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1
   VANELLA A, 1982, GERONTOLOGY, V28, P108, DOI 10.1159/000212519
   VATASSERY GT, 1984, J NEUROCHEM, V43, P409, DOI 10.1111/j.1471-4159.1984.tb00916.x
   WEGLICKI WB, 1969, NATURE, V221, P185, DOI 10.1038/221185a0
   YAMAMOTO Y, 1982, B CHEM SOC JPN, V55, P1548, DOI 10.1246/bcsj.55.1548
   YOSHIKAWA M, 1967, J GERONTOL, V22, P162, DOI 10.1093/geronj/22.2.162
NR 51
TC 66
Z9 69
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD JUL 15
PY 1992
VL 64
IS 3
BP 273
EP 292
DI 10.1016/0047-6374(92)90084-Q
PG 20
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA JF084
UT WOS:A1992JF08400005
PM 1405785
DA 2024-02-19
ER

PT J
AU Lipman, RD
   Dallal, GE
   Bronson, RT
AF Lipman, RD
   Dallal, GE
   Bronson, RT
TI Lesion biomarkers of aging in B6C3F1 hybrid mice
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
ID DIETARY RESTRICTION; CALORIC RESTRICTION; AGE; RATS; FISCHER-344
AB This study of B6C3F1 hybrid mice was designed to determine the effects of caloric restriction (CR) oil age-related pathologic changes. These changes accompany and may, in part, account for the apparent effect of CR in slowing the rate of aging. The study also explored whether lesions observed in groups of animals killed at 6 month intervals can serve as biomarkers of aging. Approximately 30 mice of each sex and each of two diet groups-CR and ad libitum fed (AL)-and each of six age groups-6, 12, 18, 24, 30, and 36 months of age-from the Biomarkers of Aging Program of the National Institute on Aging were killed and all tissues from each were examined for the histological presence or absence of lesions. A total of 209 distinct lesions were observed, of which 51 occurred in at least 10% of the AL or CR mice. The average number of lesions per mouse increased linearly with age in all diet-sex groups except in male CR mice. This increase was significantly smaller in CR than in AL mice of both sexes. The number of distinct lesions also increased with age in both diet groups but much less rapidly in CR mice. Nearly all lesions, including neoplastic, and nonneoplastic proliferative and degenerative ones, occurred significantly less often in CR than in AL mice at all ages. Foci of leukocytes ill the liver however, occurred more frequently in CR mice. Lung adenomas in old female mice occurred with equal frequency hi both diet groups. A parsimonious classification tree analysis showed that diet groups could have been distinguished at each age by an evaluation of relatively few lesions and tissues. Altogether, this study suggests strongly that the prevalence of many individual lesions, the total lesion burden, and the total types of lesions are good biomarkers of aging because they increase with age and reflect the effect of CR in slowing the aging process. The study also shows that lesions occur stochastically randomly and independently in genetically homogeneous mice raised in a notvariable environment.
C1 Tufts Univ, USDA, Human Nutr Res Ctr Aging, Boston, MA 02111 USA.
C3 United States Department of Agriculture (USDA); Tufts University
RP Lipman, RD (corresponding author), Tufts Univ, USDA, Human Nutr Res Ctr Aging, 711 Washington St, Boston, MA 02111 USA.
RI Lipman, Ruth/HHN-7864-2022
OI Lipman, Ruth/0000-0001-8632-3895
FU NIA NIH HHS [AG 07747] Funding Source: Medline
CR AHRONHEIM JC, 1983, JAMA-J AM MED ASSOC, V250, P1182, DOI 10.1001/jama.250.9.1182
   BAKER GT, 1988, EXP GERONTOL, V23, P223, DOI 10.1016/0531-5565(88)90025-3
   BRONSON RT, 1991, GROWTH DEVELOP AGING, V55, P169
   CHENEY KE, 1983, J GERONTOL, V38, P420, DOI 10.1093/geronj/38.4.420
   FERNANDES G, 1995, P NATL ACAD SCI USA, V92, P6494, DOI 10.1073/pnas.92.14.6494
   GELMAN R, 1988, GENETICS, V118, P693
   HARRISON DE, 1987, J NUTR, V117, P376, DOI 10.1093/jn/117.2.376
   HAUCK WW, 1979, BIOMETRICS, V35, P817, DOI 10.2307/2530114
   JAMES SJ, 1994, CANCER RES, V54, P5508
   Klima MP, 1997, J GERONTOL A-BIOL, V52, pM247, DOI 10.1093/gerona/52A.4.M247
   KLURFELD DM, 1989, INT J CANCER, V43, P922, DOI 10.1002/ijc.2910430532
   Lipman RD, 1997, EXP GERONTOL, V32, P215, DOI 10.1016/S0531-5565(96)00037-X
   Lipman RD, 1996, J GERONTOL A-BIOL, V51, pB54, DOI 10.1093/gerona/51A.1.B54
   MAEDA H, 1985, J GERONTOL, V40, P671, DOI 10.1093/geronj/40.6.671
   OGURA M, 1989, P NATL ACAD SCI USA, V86, P4225, DOI 10.1073/pnas.86.11.4225
   Roecker EB, 1996, J GERONTOL A-BIOL, V51, pB276, DOI 10.1093/gerona/51A.4.B276
   SHELDON WG, 1995, TOXICOL PATHOL, V23, P458, DOI 10.1177/019262339502300403
   SHIMOKAWA I, 1993, J GERONTOL, V48, pB68, DOI 10.1093/geronj/48.2.B68
   SMITH BJ, 1992, ANAT HISTOL EMBRYOL, V21, P32, DOI 10.1111/j.1439-0264.1992.tb00316.x
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Taffet GE, 1997, J GERONTOL A-BIOL, V52, pB285, DOI 10.1093/gerona/52A.6.B285
   TANNENBAUM ALBERT, 1942, CANCER RES, V2, P460
   WEINDRUCH R, 1989, RETARDATION AGING DI
   WITT WM, 1989, LAB ANIM, V18, P37
NR 24
TC 29
Z9 30
U1 0
U2 0
PU GERONTOLOGICAL SOCIETY AMER
PI WASHINGTON
PA 1275 K STREET NW SUITE 350, WASHINGTON, DC 20005-4006 USA
SN 1079-5006
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD NOV
PY 1999
VL 54
IS 11
BP B466
EP B477
DI 10.1093/gerona/54.11.B466
PG 12
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 331XL
UT WOS:000088043900003
PM 10619310
OA Bronze
DA 2024-02-19
ER

PT J
AU Kil, IS
   Lee, YS
   Bae, YS
   Huh, TL
   Park, JW
AF Kil, IS
   Lee, YS
   Bae, YS
   Huh, TL
   Park, JW
TI Modulation of NADP<SUP>+</SUP>-dependent isocitrate dehydrogenase in
   aging
SO REDOX REPORT
LA English
DT Article
DE NADP(+)-dependent isocitrate dehydrogenase; aging; tissues
ID SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; DIETARY RESTRICTION;
   LIPID-PEROXIDATION; LIFE-SPAN; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE;
   DAMAGE; OVEREXPRESSION; GLUTATHIONE; CATALASE
AB NADPH is an important cofactor in many biosynthesis pathways and the regeneration of reduced glutathione, critically important in cellular defense against oxidative damage. It is mainly produced by glucose-6-phosphate dehydrogenase, malic enzyme, and NADP(+)-specific isocitrate dehydrogenases (ICDHs). Here, we investigated age-related changes in ICDH activity and protein expression in IMR-90 human diploid fibroblast cells and tissues from Fischer 344 rats. We found that in IMR-90 cells the activity of cytosolic ICDH (IDPc) gradually increased with age up to the 46-48 population doubling level (PDL) and then gradually decreased at later PDL. 2',7'-Dichlorofluorescein fluorescence which reflects intracellular ROS generation was increased with aging in IMR-90 cells. In ad libitum-fed rats, we noted age-related, tissue-specific modulations of IDPc and mitochondrial ICDH (IDPm) activities and protein expression in the liver, kidney and testes. In contrast, ICDH activities and protein expression were not significantly modulated in diet-restricted rats. These data suggest that modulation of ICDH is an age-dependent and a tissue-specific phenomenon.
C1 Kyungpook Natl Univ, Coll Nat Sci, Dept Biochem, Taegu 702701, South Korea.
   Kyungpook Natl Univ, Coll Nat Sci, Dept Genet Engn, Taegu 702701, South Korea.
C3 Kyungpook National University; Kyungpook National University
RP Park, JW (corresponding author), Kyungpook Natl Univ, Coll Nat Sci, Dept Biochem, Taegu 702701, South Korea.
EM parkjw@knu.ac.kr
OI Bae, Young-Seuk/0000-0002-5520-4444
CR AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Blander G, 2003, J BIOL CHEM, V278, P38966, DOI 10.1074/jbc.M307146200
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   Holmgren A, 2000, ANTIOXID REDOX SIGN, V2, P811, DOI 10.1089/ars.2000.2.4-811
   HUH TL, 1993, BIOCHEM J, V292, P705, DOI 10.1042/bj2920705
   JENNINGS GT, 1990, BIOCHIM BIOPHYS ACTA, V1034, P219, DOI 10.1016/0304-4165(90)90080-G
   Jo SH, 2001, J BIOL CHEM, V276, P16168, DOI 10.1074/jbc.M010120200
   KOIZUMI A, 1987, J NUTR, V117, P361, DOI 10.1093/jn/117.2.361
   Lee SM, 2002, FREE RADICAL BIO MED, V32, P1185, DOI 10.1016/S0891-5849(02)00815-8
   Lithgow GJ, 1996, SCIENCE, V273, P80, DOI 10.1126/science.273.5271.80
   Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311
   Oh IU, 1996, GENOMICS, V38, P104, DOI 10.1006/geno.1996.0602
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   Öztürk O, 2004, EXP GERONTOL, V39, P211, DOI 10.1016/j.exger.2003.10.015
   PANDOLFI PP, 1995, EMBO J, V14, P5209, DOI 10.1002/j.1460-2075.1995.tb00205.x
   ROSIERS CD, 1995, J BIOL CHEM, V270, P10027, DOI 10.1074/jbc.270.17.10027
   Salvemini F, 1999, J BIOL CHEM, V274, P2750, DOI 10.1074/jbc.274.5.2750
   SCHWARZ MA, 1994, J BIOL CHEM, V269, P15238
   STEIN AM, 1967, BIOCHEMISTRY-US, V6, P1370, DOI 10.1021/bi00857a020
   Sun LJ, 1999, J BIOL CHEM, V274, P17334, DOI 10.1074/jbc.274.24.17334
   TIMIRAS PS, 1998, PHYSL BASIS GERIATRI
   Yu BP, 1996, FREE RADICAL BIO MED, V21, P651, DOI 10.1016/0891-5849(96)00162-1
   YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657
NR 25
TC 16
Z9 23
U1 0
U2 4
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1351-0002
EI 1743-2928
J9 REDOX REP
JI Redox Rep.
PY 2004
VL 9
IS 5
BP 271
EP 277
DI 10.1179/135100004225006056
PG 7
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 882VE
UT WOS:000225966200005
PM 15606980
OA Bronze
DA 2024-02-19
ER

PT J
AU JENA, BS
   MOHANTY, MK
   PATNAIK, BK
AF JENA, BS
   MOHANTY, MK
   PATNAIK, BK
TI EFFECT OF AGE ON THERMAL INACTIVATION OF
   GLUCOSE-6-PHOSPHATE-DEHYDROGENASE IN LIVER AND KIDNEY OF THE MALE GARDEN
   LIZARD
SO GERONTOLOGY
LA English
DT Article
DE LIZARD; GLUCOSE-6-PHOSPHATE DEHYDROGENASE; THERMOLABILITY
ID ALTERED GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; HUMAN-FIBROBLASTS;
   HEAT-LABILITY; MECHANISMS; ENZYMES; CELLS
AB A comparison between middle-aged and old lizards revealed no significant age change in glucose-6-phosphate dehydrogenase activity of liver and kidney. Thermal inactivation at 51 +/- 1-degrees-C induced a significantly higher degree of decline in enzyme activity of tissues of old than that of middle-aged lizards. The increase in thermolability of enzyme in liver and kidney of ageing lizards suggests an accumulation of altered enzyme molecules.
C1 BERHAMPUR UNIV,DEPT ZOOL,BERHAMPUR 760007,ORISSA,INDIA.
C3 Berhampur University
CR BENZI G, 1989, EXP GERONTOL, V24, P137, DOI 10.1016/0531-5565(89)90024-7
   CERAMI A, 1987, SCI AM, V256, P90, DOI 10.1038/scientificamerican0587-90
   DAS DK, 1987, BASIC RES CARDIOL, V82, P36, DOI 10.1007/BF01907051
   DOVRAT A, 1986, EXP EYE RES, V42, P489, DOI 10.1016/0014-4835(86)90008-4
   ELLS HA, 1961, P SOC EXP BIOL MED, V106, P607
   EVANS HC, 1977, EXP GERONTOL, V12, P169
   FUNFU DLM, 1985, MECH AGEING DEV, V32, P249
   GERSHON D, 1979, MECH AGEING DEV, V9, P189, DOI 10.1016/0047-6374(79)90098-8
   GERSHON D, 1979, AGING, V8, P21
   GOLDSTEIN S, 1976, INTERDISCIP TOP GERO, V10, P24
   HIRSCH G, 1976, INTERDISCIPL TOPICS, V10, P1
   HOLLIDAY R, 1983, GERONTOLOGY, V29, P89, DOI 10.1159/000213098
   JENA BS, 1990, GERONTOLOGY, V36, P12
   KAHN A, 1977, BIOCHEM BIOPH RES CO, V77, P760, DOI 10.1016/S0006-291X(77)80043-0
   KARA TC, 1981, GERONTOLOGY, V27, P187, DOI 10.1159/000212472
   LEWIS CM, 1976, INTERDISCIPL TOP GER, V9, P198
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MARTINS RN, 1986, J NEUROCHEM, V46, P1042, DOI 10.1111/j.1471-4159.1986.tb00615.x
   MAYES PA, 1988, BIOCHEMISTRY-US, P130
   OLIVER CN, 1987, J BIOL CHEM, V262, P5488
   ORGEL LE, 1963, P NATL ACAD SCI USA, V49, P517, DOI 10.1073/pnas.49.4.517
   ORGEL LE, 1973, NATURE, V243, P441
   PENDERGRASS WR, 1976, J CELL PHYSIOL, V87, P3, DOI 10.1002/jcp.1040870103
   POPP RA, 1976, INTERDISCIPLINARY TO, V9, P209
   ROSE KJW, 1977, EXP GERONTOL, V12, P117
   SCHMUCKER DL, 1983, MECH AGEING DEV, V21, P137, DOI 10.1016/0047-6374(83)90070-2
   SCHOFIELD JD, 1978, EXP GERONTOL, V13, P147, DOI 10.1016/0531-5565(78)90007-4
   SHUKLA SP, 1968, EXP GERONTOL, V3, P31, DOI 10.1016/0531-5565(68)90053-3
   WILSON PD, 1972, GERONTOLOGY, V18, P36, DOI 10.1159/000211918
   WULF JH, 1975, EXP GERONTOL, V10, P101, DOI 10.1016/0531-5565(75)90040-6
   YAGIL G, 1976, EXP GERONTOL, V11, P73, DOI 10.1016/0531-5565(76)90016-4
NR 31
TC 6
Z9 6
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0304-324X
J9 GERONTOLOGY
JI Gerontology
PD NOV-DEC
PY 1991
VL 37
IS 6
BP 299
EP 304
PG 6
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA GQ472
UT WOS:A1991GQ47200002
PM 1765279
DA 2024-02-19
ER

PT J
AU Olsen, K
   Suri, DJ
   Davis, C
   Sheftel, J
   Nishimoto, K
   Yamaoka, Y
   Toya, Y
   Welham, NV
   Tanumihardjo, SA
AF Olsen, Kiersten
   Suri, Devika J.
   Davis, Christopher
   Sheftel, Jesse
   Nishimoto, Kohei
   Yamaoka, Yusuke
   Toya, Yutaka
   Welham, Nathan V.
   Tanumihardjo, Sherry A.
TI Serum retinyl esters are positively correlated with analyzed total liver
   vitamin A reserves collected from US adults at time of death
SO AMERICAN JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
DE aging; alpha-retinol; hypervitaminosis A; toxicity; vitamin A biomarkers
ID NUTRITION EXAMINATION SURVEY; BINDING-PROTEIN; ISOTOPE-DILUTION;
   NATIONAL-HEALTH; PLASMA RETINOL; BETA-CAROTENE; INFLAMMATION;
   SUPPLEMENT; POPULATION; DEFICIENCY
AB Background: Minimal human data exist on liver vitamin A (VA) compared with serum biomarkers. Cutoffs of 5% and 10% total serum VA as retinyl esters (REs) suggest a VA intoxication diagnosis.
   Objectives: We compared total liver VA reserves (TLRs) with the percentage of total serum VA as REs to evaluate hypervitaminosis with the use of US adult autopsy samples. Secondary objectives evaluated serum retinol sensitivity, TLRs among lobes, and hepatic alpha-retinol concentrations, an alpha-carotene cleavage product.
   Design: Matched serum and liver samples were procured from cadavers (n = 27; mean +/- SD age: 70.7 +/- 14.9 y; range: 49-101 y). TLRs and alpha-REs were quantified by ultra-performance liquid chromatography. Pearson correlations showed liver and serum associations. Sensitivity and specificity were calculated for >5%, 7.5%, and 10% total serum VA as REs to predict TLRs and for serum retinol <0.7 and 1 mu mol/L to predict deficiency.
   Results: Serum RE concentrations were correlated with TLRs (r = 0.497, P < 0.001). Nine subjects (33%) had hypervitaminosis A (>= 1.0 mu mol VA/g liver), 2 of whom had >7.5% total serum VA as REs; histologic indicators corroborated toxicity at 3 mu mol/g liver. No subject had >10% total serum VA as REs. Serum retinol sensitivity to determine deficiency (TLRs <0.1 mu mol VA/g) was 83% at 0.7 and 1 mu mol/L. Hepatic alpha-retinol was positively correlated with age (P = 0.047), but removing an outlier nullified significance.
   Conclusions: This study evaluated serum REs as a biomarker of VA status against TLRs (gold standard), and abnormal histology suggested that 7.5% total serum VA as REs is diagnostic for toxicity at the individual level in adults. The long-term impact of VA supplements and fortificants on VA status is currently unknown. Considering the high prevalence of hypervitaminotic TLRs in this cohort, and given that many countries are adding preformed VA to processed products, population biomarkers diagnosing hypervitaminosis before toxicity are urgently needed.
C1 [Olsen, Kiersten; Suri, Devika J.; Davis, Christopher; Sheftel, Jesse; Tanumihardjo, Sherry A.] Univ Wisconsin, Interdept Grad Program Nutr Sci, Madison, WI 53706 USA.
   [Nishimoto, Kohei; Yamaoka, Yusuke; Toya, Yutaka; Welham, Nathan V.] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Div Otolaryngol, Madison, WI USA.
   [Nishimoto, Kohei; Toya, Yutaka] Kumamoto Univ, Sch Med, Dept Otolaryngol, Kumamoto, Japan.
   [Yamaoka, Yusuke] Kyoto Univ, Fac Med, Kyoto, Japan.
C3 University of Wisconsin System; University of Wisconsin Madison;
   University of Wisconsin System; University of Wisconsin Madison;
   Kumamoto University; Kyoto University
RP Tanumihardjo, SA (corresponding author), Univ Wisconsin, Interdept Grad Program Nutr Sci, Madison, WI 53706 USA.
EM sherry@nutrisci.wisc.edu
FU NIH from the National Institute on Deafness and Other Communication
   Disorders [R01 DC004428, T32DC009401]; Global Health Funds at the
   University of Wisconsin-Madison
FX Supported by NIH grants R01 DC004428 (toNVW) and T32DC009401 (to KO),
   both from the National Institute on Deafness and Other Communication
   Disorders, and Global Health Funds at the University of
   Wisconsin-Madison.
CR [Anonymous], BULLETIN
   [Anonymous], 2012, Report: Priorities in the assessment of vitamin A and iron status in populations: 15-17 September 2010
   [Anonymous], 2009, GLOBAL PREVALENCE VI
   [Anonymous], 2011, Serum retinol concentrations for determining the prevalence of vitamin A deficiency in populations
   [Anonymous], 2010, Encyclopedia of Dietary Supplements
   [Anonymous], 2011, Guideline: vitamin A supplementation in infants and children 6-59 months of age
   Bailey RL, 2011, J NUTR, V141, P261, DOI 10.3945/jn.110.133025
   Ballew C, 2001, J BONE MINER RES, V16, P2306, DOI 10.1359/jbmr.2001.16.12.2306
   Chow Clement C, 2014, Retin Cases Brief Rep, V8, P164, DOI 10.1097/ICB.0000000000000031
   Dary O, 2002, J NUTR, V132, p2927S, DOI 10.1093/jn/132.9.2927S
   Davis C, 2008, BRIT J NUTR, V100, P786, DOI 10.1017/S0007114508944123
   Dietary Guidelines Advisory Committee, 2015, SCI REP 2015 DIET GU
   Drammeh BS, 2008, CLIN CHEM, V54, P1883, DOI 10.1373/clinchem.2008.108761
   DUITSMAN PK, 1995, NUTR RES, V15, P1263, DOI 10.1016/0271-5317(95)02002-D
   Fujita MQ, 2002, FORENSIC SCI INT, V130, P160, DOI 10.1016/S0379-0738(02)00381-X
   Gahche Jamie, 2011, NCHS Data Brief, P1
   Gannon B, 2014, AM J CLIN NUTR, V100, P1541, DOI 10.3945/ajcn.114.087379
   HATHCOCK JN, 1990, AM J CLIN NUTR, V52, P183, DOI 10.1093/ajcn/52.2.183
   Hui D, 2015, CURR OPIN SUPPORT PA, V9, P346, DOI 10.1097/SPC.0000000000000171
   KRASINSKI SD, 1989, AM J CLIN NUTR, V49, P112, DOI 10.1093/ajcn/49.1.112
   Larson LM, 2017, AM J CLIN NUTR, V106, p390S, DOI 10.3945/ajcn.116.142166
   Li CY, 2011, ARCH INTERN MED, V171, P507, DOI 10.1001/archinternmed.2010.440
   Mondloch S, 2015, AM J CLIN NUTR, V102, P497, DOI 10.3945/ajcn.115.112383
   MUHILAL H, 1975, BIOCHEM SOC T, V3, P744, DOI 10.1042/bst0030744
   OLSON JA, 1984, J NATL CANCER I, V73, P1439
   OLSON JA, 1979, AM J CLIN NUTR, V32, P2500, DOI 10.1093/ajcn/32.12.2500
   Penniston KL, 2006, AM J CLIN NUTR, V83, P191
   Penniston KL, 2003, J AM DIET ASSOC, V103, P1185, DOI 10.1016/S0002-8223(03)00978-7
   Penniston KL, 2005, AM J CLIN NUTR, V81, P851, DOI 10.1093/ajcn/81.4.851
   Penniston KL, 2003, J NUTR, V133, P4202, DOI 10.1093/jn/133.12.4202
   Penniston KL, 2001, J NUTR, V131, P2904, DOI 10.1093/jn/131.11.2904
   Penniston KL, 2006, AM J CLIN NUTR, V84, P1350, DOI 10.1093/ajcn/84.6.1350
   Radimer K, 2004, AM J EPIDEMIOL, V160, P339, DOI 10.1093/aje/kwh207
   Riabroy N, 2014, J NUTR, V144, P1188, DOI 10.3945/jn.114.191668
   Riabroy N, 2014, BRIT J NUTR, V111, P1373, DOI 10.1017/S0007114513003851
   Ross AC, 2004, J NUTR, V134, p269S, DOI 10.1093/jn/134.1.269S
   Rubin LP, 2017, ADV NUTR, V8, P197, DOI 10.3945/an.116.014167
   SMITH FR, 1976, NEW ENGL J MED, V294, P805, DOI 10.1056/NEJM197604082941503
   Suri DJ, 2015, AM J CLIN NUTR, V102, P1259, DOI 10.3945/ajcn.115.113050
   SUTHUTVORAVOOT S, 1974, AM J CLIN NUTR, V27, P883, DOI 10.1093/ajcn/27.8.883
   Tanumihardjo SA, 2005, J NUTR, V135, P2622, DOI 10.1093/jn/135.11.2622
   Tanumihardjo SA, 2012, J AGING RES CLIN PRA, V1, P23
   Tanumihardjo SA, 2016, J NUTR, V146, P1816, DOI 10.3945/jn.115.229708
   Tanumihardjo SA, 2015, PROCEDIA CHEM, V14, P398, DOI 10.1016/j.proche.2015.03.054
   Tanumihardjo SA, 2013, J CLIN DENSITOM, V16, P414, DOI 10.1016/j.jocd.2013.08.016
   Thurnham DI, 2003, LANCET, V362, P2052, DOI 10.1016/S0140-6736(03)15099-4
   Valentine AR, 2013, AM J CLIN NUTR, V98, P1192, DOI 10.3945/ajcn.113.063867
   WAKE K, 1974, J CELL BIOL, V63, P683, DOI 10.1083/jcb.63.2.683
   WHO, 1996, Indicators for Assessing Vitamin A Deficiency and their Application in Monitoring and Evaluating Intervention Programmes
   Yoshizumi T, 2003, TRANSPLANT P, V35, P1415, DOI 10.1016/S0041-1345(03)00482-2
NR 50
TC 21
Z9 24
U1 0
U2 7
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0002-9165
EI 1938-3207
J9 AM J CLIN NUTR
JI Am. J. Clin. Nutr.
PD NOV
PY 2018
VL 108
IS 5
BP 997
EP 1005
DI 10.1093/ajcn/nqy190
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA HH9XK
UT WOS:000456094800012
PM 30475970
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Crowe, J
   Lumb, FE
   Doonan, J
   Broussard, M
   Tarafdar, A
   Pineda, MA
   Landabaso, C
   Mulvey, L
   Hoskisson, PA
   Babayan, SA
   Selman, C
   Harnett, W
   Harnett, MM
AF Crowe, Jenny
   Lumb, Felicity E.
   Doonan, James
   Broussard, Margaux
   Tarafdar, Anuradha
   Pineda, Miguel A.
   Landabaso, Carmen
   Mulvey, Lorna
   Hoskisson, Paul A.
   Babayan, Simon A.
   Selman, Colin
   Harnett, William
   Harnett, Margaret M.
TI The parasitic worm product ES-62 promotes health- and life-span in a
   high calorie diet-accelerated mouse model of ageing
SO PLOS PATHOGENS
LA English
DT Article
ID INNATE LYMPHOID TYPE-2; REGULATORY B-CELLS; INTESTINAL INFLAMMATION;
   INSULIN-RESISTANCE; INDUCED OBESITY; GUT MICROBIOTA; BODY-WEIGHT;
   HIGH-FAT; ADIPOSE; GLUCOSE
AB Author summary
   Infection with parasitic worms is increasingly considered to protect against chronic inflammatory disorders, including obesity, type-2 diabetes and cardiovascular disease. Although previously associated with old age, these ailments are ever more prevalent even in young people, due to the global adoption of the "Western" lifestyle and high calorie diet (HCD; high sugar and high fat). Rather than developing live worm therapies, our approach focuses on the potential of ES-62, a molecule secreted by the parasitic worm Acanthocheilonema viteae that we have previously shown to protect against inflammatory conditions like allergic asthma and arthritis in mice. We found that a small weekly dose of ES-62 promoted late-life wellbeing in HCD-fed mice of both sexes and substantially extended the life of obese male mice (by over 70 days; >10%). Machine learning modelling of its impact on the complex immunometabolic networks underpinning obesity showed that health-promoting effects of ES-62 could not simply be explained by its anti-inflammatory actions but encompassed protection against adipose, liver and gut pathology. The target signatures identified may thus represent a starting point for developing novel ES-62-based approaches to improving health during ageing and increasing lifespan in humans.
   Improvements in hygiene and health management have driven significant increases in human lifespan over the last 50 years. Frustratingly however, this extension of lifespan has not been matched by equivalent improvements in late-life health, not least due to the global pandemic in type-2 diabetes, obesity and cardiovascular disease, all ageing-associated conditions exacerbated and accelerated by widespread adoption of the high calorie Western diet (HCD). Recently, evidence has begun to emerge that parasitic worm infection might protect against such ageing-associated co-morbidities, as a serendipitous side-effect of their evolution of pro-survival, anti-inflammatory mechanisms. As a novel therapeutic strategy, we have therefore investigated the potential of ES-62, an anti-inflammatory secreted product of the filarial nematode Acanthocheilonema viteae, to improve healthspan (the period of life before diseases of ageing appear) by targeting the chronic inflammation that drives metabolic dysregulation underpinning ageing-induced ill-health. We administered ES-62 subcutaneously (at a dose of 1 mu g/week) to C57BL/6J mice undergoing HCD-accelerated ageing throughout their lifespan, while subjecting the animals to analysis of 120 immunometabolic responses at various time-points. ES-62 improved a number of inflammatory parameters, but markedly, a range of pathophysiological, metabolic and microbiome parameters of ageing were also successfully targeted. Notably, ES-62-mediated promotion of healthspan in male and female HCD-mice was associated with different mechanisms and reflecting this, machine learning modelling identified sex-specific signatures predictive of ES-62 action against HCD-accelerated ageing. Remarkably, ES-62 substantially increased the median survival of male HCD-mice. This was not the case with female animals and unexpectedly, this difference between the two sexes could not be explained in terms of suppression of the chronic inflammation driving ageing, as ES-62 tended to be more effective in reducing this in female mice. Rather, the difference appeared to be associated with ES-62's additional ability to preferentially promote a healthier gut-metabolic tissue axis in male animals.
C1 [Crowe, Jenny; Broussard, Margaux; Tarafdar, Anuradha; Pineda, Miguel A.; Landabaso, Carmen; Harnett, Margaret M.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.
   [Lumb, Felicity E.; Doonan, James; Hoskisson, Paul A.; Harnett, William] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland.
   [Mulvey, Lorna; Babayan, Simon A.; Selman, Colin] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow Ageing Res Network GARNER, Glasgow, Lanark, Scotland.
C3 University of Glasgow; University of Strathclyde; University of Glasgow
RP Harnett, MM (corresponding author), Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.; Harnett, W (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland.
EM w.harnett@strath.ac.uk; Margaret.Harnett@glasgow.ac.uk
RI Babayan, Simon A/E-1807-2011
OI Babayan, Simon A/0000-0002-4949-1117; Mulvey, Lorna/0000-0002-6706-6114;
   Pineda, Miguel/0000-0001-5678-7752; Landabaso,
   Carmen/0000-0002-9276-7916; Hoskisson, Paul/0000-0003-4332-1640; Selman,
   Colin/0000-0002-8727-0593; Crowe, Jenny/0000-0002-7976-2993; Doonan,
   James/0000-0001-6933-4840
FU Biotechnology and Biological Sciences Research Council [BB/M029727/1,
   BB/M029662/1]; BBSRC [BB/M029662/1, BB/M029727/1] Funding Source: UKRI
FX The study was funded by linked awards to MMH and CS (BB/M029727/1) and
   WH (BB/M029662/1) from the Biotechnology and Biological Sciences
   Research Council (https://bbsrc.ukri.org).The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362
   [Anonymous], ARTERIOSCLER THROMB
   [Anonymous], 2017, DIABETES CARE S1, V39, pS33
   [Anonymous], SEXUAL DIMORPHISM HU
   [Anonymous], 2018, CURR OPIN TOXICOL
   Aprahamian TR, 2015, INT J PARASITOL, V45, P203, DOI 10.1016/j.ijpara.2014.12.006
   Bach JF, 2018, NAT REV IMMUNOL, V18, P105, DOI 10.1038/nri.2017.111
   Bennett PH, 2016, LANCET DIABETES ENDO, V4, P815, DOI 10.1016/S2213-8587(16)30220-0
   Berbudi A, 2016, J INNATE IMMUN, V8, P601, DOI 10.1159/000448401
   Bhargava P, 2012, NAT MED, V18, P1665, DOI 10.1038/nm.2962
   Binder CJ, 2007, J AM COLL CARDIOL, V50, P547, DOI 10.1016/j.jacc.2007.04.054
   Blain A, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu044
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Brooks LRK, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01366
   Bupp MRG, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01269
   Cheng J, 2013, CURR TOP MICROBIOL, V358, P323, DOI 10.1007/82_2011_189
   Christ A, 2018, CELL, V172, P162, DOI 10.1016/j.cell.2017.12.013
   Chuang YH, 2011, J IMMUNOL, V186, P4687, DOI 10.4049/jimmunol.1003659
   Chusyd DE, 2016, FRONT NUTR, V3, DOI 10.3389/fnut.2016.00010
   Clark RI, 2015, CELL REP, V12, P1656, DOI 10.1016/j.celrep.2015.08.004
   Cohen CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066477
   Coltherd JC, 2016, SCI REP-UK, V6, DOI 10.1038/srep19224
   Crowe J, 2017, PARASITE IMMUNOL, V39, DOI 10.1111/pim.12410
   de Guinoa JS, 2018, EMBO J, V37, DOI 10.15252/embj.201797537
   Doonan J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09361-0
   Elderman M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01018
   Erben U, 2014, INT J CLIN EXP PATHO, V7, P4557
   Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020
   Fujio-Vejar S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01221
   Gallois M, 2005, REPROD NUTR DEV, V45, P109, DOI 10.1051/rnd:2005008
   Garcia-Carrizo F, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00445
   Griffin C, 2018, J BIOL CHEM, V293, P8775, DOI 10.1074/jbc.RA117.001526
   Guzik TJ, 2017, CARDIOVASC RES, V113, P1009, DOI 10.1093/cvr/cvx108
   Hams E, 2013, J IMMUNOL, V191, P5349, DOI 10.4049/jimmunol.1301176
   Harnett MM, 2017, TRENDS PARASITOL, V33, P694, DOI 10.1016/j.pt.2017.05.007
   Harnett W, 2014, MOL BIOCHEM PARASIT, V195, P130, DOI 10.1016/j.molbiopara.2014.03.007
   He W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20909-w
   Heintz C, 2014, CELL, V156, P408, DOI 10.1016/j.cell.2014.01.025
   Helmby H, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0074-3
   Hempenstall S, 2010, MECH AGEING DEV, V131, P111, DOI 10.1016/j.mad.2009.12.008
   Hotamisligil GS, 2017, IMMUNITY, V47, P406, DOI 10.1016/j.immuni.2017.08.009
   Hussaarts L, 2015, FASEB J, V29, P3027, DOI 10.1096/fj.14-266239
   Jialal I, 2014, J CLIN ENDOCR METAB, V99, P39, DOI 10.1210/jc.2013-3092
   Jin CC, 2013, CELL METAB, V17, P873, DOI 10.1016/j.cmet.2013.05.011
   Kadel S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01653
   Kowalski GM, 2017, J ENDOCRINOL, V233, P269, DOI 10.1530/JOE-17-0004
   Lam YY, 2011, OBESITY, V19, P2113, DOI 10.1038/oby.2011.68
   LaMarche NM, 2018, J IMMUNOL, V201, P1827, DOI 10.4049/jimmunol.1800556
   Lee YS, 2018, CELL, V172, P22, DOI 10.1016/j.cell.2017.12.025
   Lobo PI, 2019, NEPHRON, V143, P166, DOI 10.1159/000501639
   Lobo PI, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00974
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Marais GAB, 2018, BIOL SEX DIFFER, V9, DOI 10.1186/s13293-018-0181-y
   Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   McInnes IB, 2003, J IMMUNOL, V171, P2127, DOI 10.4049/jimmunol.171.4.2127
   Miller RA, 2002, AGING CELL, V1, P22, DOI 10.1046/j.1474-9728.2002.00006.x
   Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964
   Mulvey L, 2017, MOL CELL ENDOCRINOL, V455, P41, DOI 10.1016/j.mce.2016.09.001
   Naradikian MS, 2016, IMMUNOL REV, V269, P118, DOI 10.1111/imr.12380
   Nieuwenhuis EES, 2009, J CLIN INVEST, V119, P1241, DOI 10.1172/JCI36509
   O'Toole JF, 2010, BIOCHEM J, V427, P105, DOI 10.1042/BJ20091373
   Olszak T, 2014, NATURE, V509, P497, DOI 10.1038/nature13150
   Park YJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01311
   Pedregosa F, 2011, J MACH LEARN RES, V12, P2825
   Phalke S, 2018, CURR OPIN IMMUNOL, V55, P75, DOI 10.1016/j.coi.2018.09.007
   Pomatto LCD, 2018, J GERONTOL A-BIOL, V73, P141, DOI 10.1093/gerona/glx083
   Prescott SL, 2013, J ALLERGY CLIN IMMUN, V131, P23, DOI 10.1016/j.jaci.2012.11.019
   Rastelli M, 2018, OBESITY, V26, P792, DOI 10.1002/oby.22175
   Regan JC, 2016, ELIFE, V5, DOI 10.7554/eLife.10956
   Rera M, 2013, AGING-US, V5, P586, DOI 10.18632/aging.100589
   Rera M, 2013, AGEING RES REV, V12, P436, DOI 10.1016/j.arr.2012.05.003
   Riley RL, 2017, CELL IMMUNOL, V321, P61, DOI 10.1016/j.cellimm.2017.04.008
   Rodgers DT, 2015, ARTHRITIS RHEUMATOL, V67, P1023, DOI 10.1002/art.39004
   Rosser EC, 2015, IMMUNITY, V42, P607, DOI 10.1016/j.immuni.2015.04.005
   Rosser EC, 2014, NAT MED, V20, P1334, DOI 10.1038/nm.3680
   Satoh M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01314
   Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com
   Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221
   Selvanantham T, 2016, J IMMUNOL, V197, P4464, DOI 10.4049/jimmunol.1601410
   Shaikh SR, 2015, CLIN EXP IMMUNOL, V179, P90, DOI 10.1111/cei.12444
   Tower J, 2017, TRENDS ENDOCRIN MET, V28, P735, DOI 10.1016/j.tem.2017.07.002
   Vaiserman AM, 2017, AGEING RES REV, V35, P36, DOI 10.1016/j.arr.2017.01.001
   van der Heijden RA, 2015, AGING-US, V7, P256, DOI 10.18632/aging.100738
   van Eijkeren RJ, 2018, IMMUNOLOGY, V153, P179, DOI 10.1111/imm.12839
   Vemuri R, 2019, SEMIN IMMUNOPATHOL, V41, P265, DOI 10.1007/s00281-018-0716-7
   Versini M, 2014, AUTOIMMUN REV, V13, P981, DOI 10.1016/j.autrev.2014.07.001
   Waskom M., 2018, MWASKOM SEABORN V0 9, DOI DOI 10.5281/ZENODO.1313201
   Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475
   Yang ZH, 2013, INFECT IMMUN, V81, P1905, DOI 10.1128/IAI.00053-13
   Zhang CH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3163
NR 91
TC 18
Z9 19
U1 1
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD MAR
PY 2020
VL 16
IS 3
AR e1008391
DI 10.1371/journal.ppat.1008391
PG 33
WC Microbiology; Parasitology; Virology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology; Parasitology; Virology
GA LA1HP
UT WOS:000523706200041
PM 32163524
OA Green Published, Green Submitted, Green Accepted, gold
DA 2024-02-19
ER

PT J
AU Teillet, L
   Ribière, P
   Gouraud, S
   Bakala, H
   Corman, B
AF Teillet, L
   Ribière, P
   Gouraud, S
   Bakala, H
   Corman, B
TI Cellular signaling, AGE accumulation and gene expression in hepatocytes
   of lean aging rats fed ad libitum or food-restricted
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE aging; glucagon receptor; cAMP; AGEs; gene expression; liver; WAG Rij
   rats
ID GLYCOSYLATION END-PRODUCTS; ACID-BINDING PROTEIN; CALORIC RESTRICTION;
   MESSENGER-RNA; KINASE-C; GLYCATION; GROWTH; LIVER; ACTIVATION; BRAIN
AB The effects of food restriction on liver glucagous and vasopressin V I a receptors on AGE accumulation and on gene expression were investigated in 10- and 30-month-old WAG/Rij female rats fed ad libitum or chronically food-restricted by 30%. The age-related increase in glucagon and vasopressin Via receptor density, as well as the rise in glucagon-induced cAMP generation was prevented by the restriction. AGE accumulation, characteristic of the aging process, was normalized in food-restricted animals. Gene expression determined with rat Atlas(TM) cDNA Expression Arrays containing 1176 cDNA indicates that a few genes exhibited a greater than twofold change in mRNA ratios with age. Most down-regulated genes were related to oxidative metabolism of lipids, and most of the up-regulated genes were concerned with the cell cycle and transcription factors. Chronic food restriction partially prevents these changes in gene expression and induces up- and down-regulation of several mRNAs which are not modified with age in ad libitum fed rats. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
C1 CEA, Ctr Etud Saclay, Serv Biol Cellulaire, F-91191 Gif Sur Yvette, France.
   Assistance Publ Hop Paris, AP HP, Hop St Perine, F-75016 Paris, France.
   Univ Paris 07, Fac Sci, F-75005 Paris, France.
C3 CEA; Universite Paris Saclay; Hopital Universitaire Sainte-Perine -
   APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite;
   Hopital Universitaire Hotel-Dieu - APHP; Hopital Universitaire
   Paul-Brousse - APHP; Aix-Marseille Universite; Assistance
   Publique-Hopitaux de Marseille; Universite Paris Cite
RP Corman, B (corresponding author), CEA, Ctr Etud Saclay, Serv Biol Cellulaire, F-91191 Gif Sur Yvette, France.
RI Gouraud, Sabine S. S/N-3395-2018
OI Gouraud, Sabine S. S/0000-0002-4917-0647
CR AKMAL SN, 1995, HUM PATHOL, V26, P846, DOI 10.1016/0046-8177(95)90005-5
   Bergman I, 1970, Clin Chim Acta, V27, P347, DOI 10.1016/0009-8981(70)90355-4
   BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506
   CANTLEY LG, 1995, J AM SOC NEPHROL, V5, P1872
   CEFALU WT, 1995, J GERONTOL A-BIOL, V50, pB337, DOI 10.1093/gerona/50A.6.B337
   CERAMI A, 1985, J AM GERIATR SOC, V33, P626, DOI 10.1111/j.1532-5415.1985.tb06319.x
   Corman B, 1998, P NATL ACAD SCI USA, V95, P1301, DOI 10.1073/pnas.95.3.1301
   CORMAN B, 1987, AM J PHYSIOL, V253, pR555, DOI 10.1152/ajpregu.1987.253.4.R555
   GalveRoperh I, 1996, MECH AGEING DEV, V92, P21, DOI 10.1016/S0047-6374(96)01799-X
   Glatz JFC, 1998, ADV EXP MED BIOL, V441, P207
   Grillari J, 2000, EXP GERONTOL, V35, P187, DOI 10.1016/S0531-5565(00)00080-2
   Han ES, 2000, MECH AGEING DEV, V115, P157, DOI 10.1016/S0047-6374(00)00119-6
   HUANG RP, 1995, CANCER RES, V55, P5054
   KATZ MS, 1988, AM J PHYSIOL, V254, pE54, DOI 10.1152/ajpendo.1988.254.1.E54
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046
   MAKITA Z, 1992, J BIOL CHEM, V267, P5133
   MASORO EJ, 1989, J GERONTOL, V44, pB20, DOI 10.1093/geronj/44.1.B20
   MASORO EJ, 1992, J GERONTOL, V47, pB202, DOI 10.1093/geronj/47.6.B202
   MONDER C, 1989, J STEROID BIOCHEM, V32, P77, DOI 10.1016/0022-4731(89)90017-4
   Mooradian AD, 1997, METABOLISM, V46, P1132, DOI 10.1016/S0026-0495(97)90204-3
   NAKANISHI H, 1993, J BIOL CHEM, V268, P13
   Nose K, 1996, BIOCHEM J, V316, P381, DOI 10.1042/bj3160381
   Novelli M, 1998, J GERONTOL A-BIOL, V53, pB94, DOI 10.1093/gerona/53A.2.B94
   PAPANASTASIOU P, 1994, KIDNEY INT, V46, P216, DOI 10.1038/ki.1994.262
   Perlman H, 1999, GENE THER, V6, P758, DOI 10.1038/sj.gt.3300893
   PRADELLES P, 1989, ANAL CHEM, V61, P447, DOI 10.1021/ac00180a014
   Reichel C, 1997, MOL PHARMACOL, V51, P576, DOI 10.1124/mol.51.4.576
   REISER KM, 1994, J GERONTOL, V49, P71
   SAKAI M, 1989, CANCER RES, V49, P5633
   SAPOLSKY RM, 1992, NEUROBIOL AGING, V13, P171, DOI 10.1016/0197-4580(92)90025-S
   SEGLEN PO, 1973, EXP CELL RES, V82, P391, DOI 10.1016/0014-4827(73)90357-1
   Sell DR, 1996, P NATL ACAD SCI USA, V93, P485, DOI 10.1073/pnas.93.1.485
   Singer SS, 1996, J AM COLL NUTR, V15, P169
   SLAGBOOM PE, 1990, MECH AGEING DEV, V53, P243, DOI 10.1016/0047-6374(90)90042-E
   Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519
   Teillet L, 2001, MECH AGEING DEV, V122, P385, DOI 10.1016/S0047-6374(00)00251-7
   Teillet L, 2000, J AM SOC NEPHROL, V11, P1488, DOI 10.1681/ASN.V1181488
   Troyanovskaya M, 2000, AM J PHYSIOL-REG I, V278, pR413, DOI 10.1152/ajpregu.2000.278.2.R413
   Ulrich P, 2001, RECENT PROG HORM RES, V56, P1, DOI 10.1210/rp.56.1.1
   van der Leij FR, 1999, ADV EXP MED BIOL, V466, P377
   Verbeke P, 1997, J HISTOCHEM CYTOCHEM, V45, P1059, DOI 10.1177/002215549704500804
   Vlassara H, 1996, KIDNEY INT, V49, P1795, DOI 10.1038/ki.1996.270
   Vlassara H, 1996, Adv Nephrol Necker Hosp, V25, P303
   Wang HM, 1997, ARCH BIOCHEM BIOPHYS, V344, P365, DOI 10.1006/abbi.1997.0230
   Weindruch R, 2001, J NUTR, V131, p918S, DOI 10.1093/jn/131.3.918S
NR 46
TC 9
Z9 10
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD FEB
PY 2002
VL 123
IS 4
BP 427
EP 439
AR PII S0047-6374(01)00400-6
DI 10.1016/S0047-6374(01)00400-6
PG 13
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 578NR
UT WOS:000177125000015
PM 11744052
DA 2024-02-19
ER

PT J
AU RANDERATH, E
   HART, RW
   TURTURRO, A
   DANNA, TF
   REDDY, R
   RANDERATH, K
AF RANDERATH, E
   HART, RW
   TURTURRO, A
   DANNA, TF
   REDDY, R
   RANDERATH, K
TI EFFECTS OF AGING AND CALORIC RESTRICTION ON I-COMPOUNDS IN LIVER, KIDNEY
   AND WHITE BLOOD-CELL DNA OF MALE BROWN-NORWAY RATS
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE I-COMPOUNDS; DNA; CALORIC RESTRICTION; CARCINOGENESIS;
   P-32-POST-LABELING
ID DRUG-METABOLIZING ENZYMES; MALE FISCHER-344 RAT; SPRAGUE-DAWLEY RATS;
   DIETARY RESTRICTION; FOOD RESTRICTION; ADDUCT FORMATION; MAMMARY-TUMORS;
   AGE; MICE; EXPRESSION
AB Rodent tissues display species-, strain-, sex- and tissue-specific adduct-like DNA modifications termed I-compounds, which increase with age, are modulated by diet and are presumably derived from indigenous metabolic intermediates. We have explored whether I-compounds are affected by caloric restriction, which is known to extend life span and retard age-related degenerative and neoplastic diseases. Male Brown-Norway rats were fed NIH-31 diet ad libitum (AL). Calorically restricted (CR) rats received 60% of AL consumption, starting at 3.5 months. DNA was analyzed by P-32-postlabeling at 1, 4, 8, 12, 16 and 24 months of age in liver, kidney and white blood cells. I-compounds in AL liver and kidney exhibited complex tissue-specific profiles; I-compound levels increased with age, plateaued between 8 and 18 months depending on tissue and diet and were 8.7 (liver) and 27.4 (kidney) modifications in 10(8) nucleotides at 24 months, thereby exceeding the corresponding 1-month values by 3.7- and 16.6-fold. CR resulted in similar profiles but did not diminish age-related increases, rather I-compound levels in CR liver and kidney were increased by about 70% and 30% versus age-matched AL rats. White blood cells exhibited few I-compounds and at low levels; age-related increases were small overall but more pronounced in CR rats. Higher I-compound levels in CR animals, which were presumably a consequence of metabolic effects elicited by CR, thus correlated with extended life span and, therefore, may be beneficial, in agreement with previous findings showing an association between reduced I-compound levels and hepatocarcinogenesis as well as organ susceptibility to diseases.
C1 NATL CTR TOXICOL RES,JEFFERSON,AR 72079.
C3 US Food & Drug Administration (FDA)
RP RANDERATH, E (corresponding author), BAYLOR UNIV,DEPT PHARMACOL,DIV TOXICOL,HOUSTON,TX 77030, USA.
FU NIA NIH HHS [R01 AG 07750] Funding Source: Medline
CR ARMARIO A, 1987, ANN NUTR METAB, V31, P81, DOI 10.1159/000177254
   BUETOW D E, 1971, P87
   CHATTERJEE B, 1989, FASEB J, V3, P169, DOI 10.1096/fasebj.3.2.2464518
   CHIPALKATTI S, 1983, J NUTR, V113, P944, DOI 10.1093/jn/113.5.944
   DUFFY PH, 1989, MECH AGEING DEV, V48, P117, DOI 10.1016/0047-6374(89)90044-4
   FEUERS RJ, 1989, MECH AGEING DEV, V48, P179, DOI 10.1016/0047-6374(89)90049-3
   GOODMAN MN, 1980, AM J PHYSIOL, V239, pE269
   GUPTA KP, 1990, MUTAT RES, V237, P17, DOI 10.1016/0921-8734(90)90028-P
   GUPTA RC, 1984, P NATL ACAD SCI-BIOL, V81, P6943, DOI 10.1073/pnas.81.22.6943
   GUPTA RC, 1982, CARCINOGENESIS, V3, P1081, DOI 10.1093/carcin/3.9.1081
   KASAI H, 1989, CANCER RES, V49, P2603
   KOIZUMI A, 1987, J NUTR, V117, P361, DOI 10.1093/jn/117.2.361
   LEAKEY JEA, 1989, MECH AGEING DEV, V48, P157, DOI 10.1016/0047-6374(89)90047-X
   LEAKEY JEA, 1989, MECH AGEING DEV, V48, P145, DOI 10.1016/0047-6374(89)90046-8
   LI D, 1989, CARCINOGENESIS, V10, P605, DOI 10.1093/carcin/10.3.605
   LI D, 1990, Proceedings of the American Association for Cancer Research Annual Meeting, V31, P94
   LI DH, 1990, CARCINOGENESIS, V11, P251, DOI 10.1093/carcin/11.2.251
   LI DH, 1990, CANCER RES, V50, P3991
   Masoro E J, 1984, Physiologist, V27, P98
   MASORO EJ, 1988, J GERONTOL, V43, pB59, DOI 10.1093/geronj/43.3.B59
   McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63
   MERRY BJ, 1985, EXP GERONTOL, V20, P15, DOI 10.1016/0531-5565(85)90005-1
   PEGRAM RA, 1989, MECH AGEING DEV, V48, P167, DOI 10.1016/0047-6374(89)90048-1
   POLLARD M, 1985, J NATL CANCER I, V74, P1347
   RANDERATH E, 1991, MUTAT RES, V247, P65, DOI 10.1016/0027-5107(91)90034-L
   RANDERATH K, 1988, CARCINOGENESIS, V9, P2285, DOI 10.1093/carcin/9.12.2285
   RANDERATH K, 1966, J CHROMATOGR, V22, P110, DOI 10.1016/S0021-9673(01)97076-1
   RANDERATH K, 1989, CARCINOGENESIS, V10, P1231, DOI 10.1093/carcin/10.7.1231
   RANDERATH K, 1981, P NATL ACAD SCI-BIOL, V78, P6126, DOI 10.1073/pnas.78.10.6126
   RANDERATH K, 1988, CARCINOGENESIS, V9, P1843, DOI 10.1093/carcin/9.10.1843
   RANDERATH K, 1985, ENVIRON HEALTH PERSP, V62, P57, DOI 10.2307/3430093
   RANDERATH K, 1990, MUTAT RES, V238, P245, DOI 10.1016/0165-1110(90)90016-5
   RANDERATH K, 1990, CARCINOGENESIS, V11, P1041, DOI 10.1093/carcin/11.6.1041
   RANDERATH K, 1989, MUTAT RES, V219, P121, DOI 10.1016/0921-8734(89)90023-4
   RANDERATH K, 1986, CARCINOGENESIS, V7, P1615, DOI 10.1093/carcin/7.9.1615
   RANDERATH K, 1990, TOXICOL APPL PHARM, V103, P271, DOI 10.1016/0041-008X(90)90229-N
   RAO MS, 1987, CARCINOGENESIS, V8, P631
   REDDY MV, 1986, CARCINOGENESIS, V7, P1543, DOI 10.1093/carcin/7.9.1543
   REDDY MV, 1990, MUTAT RES, V241, P37
   RICHARDSON A, 1987, J BIOL CHEM, V262, P12821
   ROSS MH, 1972, AM J CLIN NUTR, V25, P834
   RUGGERI BA, 1987, BIOCHIM BIOPHYS ACTA, V929, P239, DOI 10.1016/0167-4889(87)90249-7
   SACHER GA, 1977, HDB BIOL AGING, P582
   SARKAR NH, 1982, P NATL ACAD SCI-BIOL, V79, P7758, DOI 10.1073/pnas.79.24.7758
   Tice R.R., 1985, HDB BIOL AGING, P173
   TICE RR, 1979, J EXP MED, V149, P1029, DOI 10.1084/jem.149.5.1029
   WARNER HR, 1987, MODERN BIOL THEORIES, V31
   WAXMAN DJ, 1985, BIOCHEMISTRY-US, V24, P4409, DOI 10.1021/bi00337a023
NR 48
TC 29
Z9 29
U1 0
U2 1
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD MAY
PY 1991
VL 58
IS 2-3
BP 279
EP 296
DI 10.1016/0047-6374(91)90099-L
PG 18
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA FP286
UT WOS:A1991FP28600014
PM 1875735
DA 2024-02-19
ER

PT J
AU Jansen, D
   Janssen, CIF
   Vanmierlo, T
   Dederen, PJ
   van Rooij, D
   Zinnhardt, B
   Nobelen, CLM
   Janssen, AL
   Hafkemeijer, A
   Mutsaers, MPC
   Doedée, AMCM
   Kuipers, AAM
   Broersen, LM
   Mulder, M
   Kiliaan, AJ
AF Jansen, Diane
   Janssen, Carola I. F.
   Vanmierlo, Tim
   Dederen, Pieter J.
   van Rooij, Daan
   Zinnhardt, Bastian
   Nobelen, Cindy L. M.
   Janssen, Anna-Lena
   Hafkemeijer, Anne
   Mutsaers, Martina P. C.
   Doedee, Anne M. C. M.
   Kuipers, Almar A. M.
   Broersen, Laus M.
   Mulder, Monique
   Kiliaan, Amanda J.
TI Cholesterol and Synaptic Compensatory Mechanisms in Alzheimer's Disease
   Mice Brain During Aging
SO JOURNAL OF ALZHEIMERS DISEASE
LA English
DT Article
DE Aging; Alzheimer's disease; amyloid-beta; cholesterol; glucose
   transporter type-1; hippocampus; liver X receptor; synapse;
   synaptophysin; T0901317; transgenic mice
ID AMYLOID PRECURSOR PROTEIN; CENTRAL-NERVOUS-SYSTEM; TRANSGENIC MOUSE
   MODEL; VASCULAR RISK-FACTORS; GLUCOSE-TRANSPORTER PROTEINS;
   POLYUNSATURATED FATTY-ACIDS; HIPPOCAMPAL DENTATE GYRUS; CEREBRAL
   BLOOD-VOLUME; COGNITIVE IMPAIRMENT; IN-VIVO
AB Research into the development of Alzheimer's disease (AD) provides increasing evidence that vascular risk factors, including high serum cholesterol, might influence the progression of cognitive impairment and neural degeneration. In this study, we investigated the effects of high dietary cholesterol intake and the cholesterol-lowering liver X receptor-agonist T0901317 on capillary density, amyloid-beta deposition, and presynaptic boutons in the hippocampus of adult (8 months) and aged (15 months) A beta PPswe-PS1dE9 and wild-type mice to elucidate how cholesterol may affect neurodegenerative processes in aging and AD. Our results show increased number of presynaptic boutons in 15-month-old A beta PP-PS1 mice compared to age-matched wild-type animals, but no difference at 8 months of age. High cholesterol intake accelerated this response by increasing the amount of presynaptic boutons at 8 and 15 months of age, while T0901317 intake decreased the amount of presynaptic boutons in 15-month-old A beta PP-PS1 mice. These findings suggest a synaptic compensatory response to maintain connectivity during aging. We hypothesize that high cholesterol intake may cause impaired cerebral blood flow inducing ischemia, fortifying the above mentioned hypothesis of a compensatory mechanism. Contrarily, cholesterol-lowering agents may positively influence cerebral circulation, thereby diminishing aggravation of AD-like pathology.
C1 [Jansen, Diane; Janssen, Carola I. F.; Dederen, Pieter J.; van Rooij, Daan; Zinnhardt, Bastian; Nobelen, Cindy L. M.; Janssen, Anna-Lena; Hafkemeijer, Anne; Mutsaers, Martina P. C.; Doedee, Anne M. C. M.; Kiliaan, Amanda J.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Anat, NL-6500 HB Nijmegen, Netherlands.
   [Vanmierlo, Tim] Maastricht Univ, Dept Neurosci, Maastricht, Netherlands.
   [Kuipers, Almar A. M.; Broersen, Laus M.] Ctr Specialised Nutr, Danone Res, Nutricia Adv Med Nutr, Wageningen, Netherlands.
   [Mulder, Monique] Erasmus MC, Div Pharmacol Vasc & Metab Dis, Dept Internal Med, Rotterdam, Netherlands.
C3 Radboud University Nijmegen; Maastricht University; Danone Nutricia;
   Erasmus University Rotterdam; Erasmus MC
RP Kiliaan, AJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Anat, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM A.Kiliaan@anat.umcn.nl
RI Dederen, Pieter.J.W.C/E-1899-2016; Kiliaan, Amanda J/D-8778-2012;
   Mulder, Monique/JDW-8433-2023; van Rooij, Daan/AAC-3526-2020; Vanmierlo,
   Tim/C-7773-2013
OI Vanmierlo, Tim/0000-0003-2912-0578; Butscher,
   Anna-Lena/0000-0001-5556-4610; Hafkemeijer, Anne/0000-0002-2940-4768;
   Zinnhardt, Bastian/0000-0002-8274-9108
FU EU [QLRT-2002-172, 211696]
FX We would like to thank Henk Arnts and Janneke Mulders for their
   excellent care giving of our mice. The authors would also like to
   acknowledge Dr. Carlijn Hooijmans, Dr. Carmen Capone, and Valerio Zerbi
   for their scientific input. This study was partly supported by an EU 5th
   framework project (no: QLRT-2002-172), and an EU 7th framework project
   (FP7/2007-2013) under grant agreement no211696.
CR Arendt T, 2001, NEUROSCIENCE, V102, P723, DOI 10.1016/S0306-4522(00)00516-9
   Bartoo GT, 1997, J NEUROPATH EXP NEUR, V56, P531, DOI 10.1097/00005072-199705000-00009
   Bishop GM, 2002, NEUROBIOL AGING, V23, P1101, DOI 10.1016/S0197-4580(02)00050-7
   Björkhem I, 2006, J INTERN MED, V260, P493, DOI 10.1111/j.1365-2796.2006.01725.x
   Boncristiano S, 2005, NEUROBIOL AGING, V26, P607, DOI 10.1016/j.neurobiolaging.2004.06.010
   BOXERMAN JL, 1995, MAGNET RESON MED, V34, P555, DOI 10.1002/mrm.1910340412
   Breteler MMB, 2000, NEUROBIOL AGING, V21, P153, DOI 10.1016/S0197-4580(99)00110-4
   Breteler MMB, 2000, ANN NY ACAD SCI, V903, P457, DOI 10.1111/j.1749-6632.2000.tb06399.x
   Bronfman FC, 2000, NEUROBIOL DIS, V7, P152, DOI 10.1006/nbdi.2000.0283
   Calon F, 2005, EUR J NEUROSCI, V22, P617, DOI 10.1111/j.1460-9568.2005.04253.x
   Calon F, 2007, PROSTAG LEUKOTR ESS, V77, P287, DOI 10.1016/j.plefa.2007.10.019
   Canevari L, 2007, NEUROCHEM RES, V32, P739, DOI 10.1007/s11064-006-9200-1
   Casserly I, 2004, LANCET, V363, P1139, DOI 10.1016/S0140-6736(04)15900-X
   Choeiri C, 2002, NEUROSCIENCE, V111, P19, DOI 10.1016/S0306-4522(01)00619-4
   Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372
   Cummings BJ, 1996, NEUROBIOL AGING, V17, P921, DOI 10.1016/S0197-4580(96)00170-4
   Davis DG, 1999, J NEUROPATH EXP NEUR, V58, P376, DOI 10.1097/00005072-199904000-00008
   de la Torre JC, 2004, LANCET NEUROL, V3, P184, DOI 10.1016/S1474-4422(04)00683-0
   DeKosky ST, 1996, NEURODEGENERATION, V5, P417, DOI 10.1006/neur.1996.0056
   DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502
   Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003
   Dong HX, 2007, J COMP NEUROL, V500, P311, DOI 10.1002/cne.21176
   Dosunmu Remi, 2007, Expert Rev Neurother, V7, P887, DOI 10.1586/14737175.7.7.887
   Eckert GP, 2007, NEUROSCI LETT, V423, P47, DOI 10.1016/j.neulet.2007.05.063
   Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098
   Fernando MS, 2004, J NEUROL SCI, V226, P13, DOI 10.1016/j.jns.2004.09.004
   Franklin KB, 2008, Paxinos and Franklin's The mouse brain in stereotaxic coordinates
   Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017
   GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106
   HAMOS JE, 1989, NEUROLOGY, V39, P355, DOI 10.1212/WNL.39.3.355
   Harris GJ, 1998, AM J NEURORADIOL, V19, P1727
   Hirsch-Reinshagen V, 2009, MOL CELL BIOCHEM, V326, P121, DOI 10.1007/s11010-008-0012-2
   Hooijmans CR, 2007, NEUROBIOL DIS, V28, P16, DOI 10.1016/j.nbd.2007.06.007
   Hooijmans CR, 2009, NEUROBIOL DIS, V33, P482, DOI 10.1016/j.nbd.2008.12.002
   Hooijmans CR, 2008, EUR J PHARMACOL, V585, P176, DOI 10.1016/j.ejphar.2007.11.081
   Hooijmans CR, 2007, BRAIN RES, V1181, P93, DOI 10.1016/j.brainres.2007.08.063
   HORWOOD N, 1994, VIRCHOWS ARCH, V425, P69
   Irizarry MC, 1997, J NEUROSCI, V17, P7053
   JAHN R, 1993, J NEUROCHEM, V61, P12, DOI 10.1111/j.1471-4159.1993.tb03533.x
   Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019
   Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3
   Julien C, 2010, NEUROBIOL AGING, V31, P1516, DOI 10.1016/j.neurobiolaging.2008.08.022
   KALARIA RN, 1989, J NEUROCHEM, V53, P1083, DOI 10.1111/j.1471-4159.1989.tb07399.x
   Kalmijn S, 1997, AM J EPIDEMIOL, V145, P33, DOI 10.1093/oxfordjournals.aje.a009029
   Kalmijn S, 1997, ANN NEUROL, V42, P776, DOI 10.1002/ana.410420514
   Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026
   King DL, 2002, BRAIN RES, V926, P58, DOI 10.1016/S0006-8993(01)03294-2
   Kivipelto M, 2001, BMJ-BRIT MED J, V322, P1447, DOI 10.1136/bmj.322.7300.1447
   Kivipelto M, 2002, ANN INTERN MED, V137, P149, DOI 10.7326/0003-4819-137-3-200208060-00006
   Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556
   Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009
   Koldamova RP, 2003, J BIOL CHEM, V278, P13244, DOI 10.1074/jbc.M300044200
   Koldamova T, 2005, J BIOL CHEM, V280, P4079, DOI 10.1074/jbc.M411420200
   Kouznetsova E, 2006, INT J DEV NEUROSCI, V24, P187, DOI 10.1016/j.ijdevneu.2005.11.011
   Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x
   Lesné S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533
   Leuba G, 2008, J ALZHEIMERS DIS, V15, P139
   Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X
   Lütjohann D, 2006, ACTA NEUROL SCAND, V114, P33, DOI 10.1111/j.1600-0404.2006.00683.x
   MAHER F, 1994, FASEB J, V8, P1003, DOI 10.1096/fasebj.8.13.7926364
   Masliah E, 1996, J NEUROSCI, V16, P5795
   MASLIAH E, 1994, NEUROSCI LETT, V174, P67, DOI 10.1016/0304-3940(94)90121-X
   Masliah E, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P91
   Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621
   Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354
   McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M
   Meyer JS, 1998, EUR NEUROL, V39, P7, DOI 10.1159/000052064
   Mintun MA, 2006, NEUROLOGY, V67, P446, DOI 10.1212/01.wnl.0000228230.26044.a4
   Mitter D, 2003, J NEUROCHEM, V84, P35, DOI 10.1046/j.1471-4159.2003.01258.x
   Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P194, DOI 10.1001/archneur.60.2.194
   Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000
   Mukaetova-Ladinska EB, 2000, AM J PATHOL, V157, P623, DOI 10.1016/S0002-9440(10)64573-7
   Mulder M, 2007, NEUROSCI RES, V59, P251, DOI 10.1016/j.neures.2007.07.004
   Oksman M, 2006, NEUROBIOL DIS, V23, P563, DOI 10.1016/j.nbd.2006.04.013
   Pfrieger FW, 2003, CELL MOL LIFE SCI, V60, P1158, DOI 10.1007/s00018-003-3018-7
   Refolo LM, 2001, NEUROBIOL DIS, V8, P890, DOI 10.1006/nbdi.2001.0422
   Refolo LM, 2000, NEUROBIOL DIS, V7, P321, DOI 10.1006/nbdi.2000.0304
   Riddell DR, 2007, MOL CELL NEUROSCI, V34, P621, DOI 10.1016/j.mcn.2007.01.011
   Rutten BPF, 2005, AM J PATHOL, V167, P161, DOI 10.1016/S0002-9440(10)62963-X
   Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012
   Scheff SW, 2003, NEUROBIOL AGING, V24, P1029, DOI 10.1016/j.neurobiolaging.2003.08.002
   Scheff SW, 1996, DEMENTIA, V7, P226, DOI 10.1159/000106884
   Scheff SW, 1998, J NEUROPATH EXP NEUR, V57, P1146, DOI 10.1097/00005072-199812000-00006
   Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400
   Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248
   Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069
   Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782
   Shie FS, 2002, NEUROREPORT, V13, P455, DOI 10.1097/00001756-200203250-00019
   Shukla C, 1999, NEUROREPORT, V10, P3785, DOI 10.1097/00001756-199912160-00012
   Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460
   SIMPSON IA, 1994, ANN NEUROL, V35, P546, DOI 10.1002/ana.410350507
   Skoog I, 2002, ANN NY ACAD SCI, V977, P29, DOI 10.1111/j.1749-6632.2002.tb04796.x
   Skoog I, 2003, NEUROL RES, V25, P675, DOI 10.1179/016164103101201986
   Skoog I, 2006, NEUROL RES, V28, P605, DOI 10.1179/016164106X130506
   Sun Y, 2003, J BIOL CHEM, V278, P27688, DOI 10.1074/jbc.M300760200
   TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410
   Terry RD, 1996, J NEUROPATH EXP NEUR, V55, P1023, DOI 10.1097/00005072-199655100-00001
   Thiele C, 2000, NAT CELL BIOL, V2, P42, DOI 10.1038/71366
   Tohgi H, 1998, NEURORADIOLOGY, V40, P131, DOI 10.1007/s002340050553
   Vanmierlo T, 2011, NEUROBIOL AGING, V32, P1262, DOI 10.1016/j.neurobiolaging.2009.07.005
   Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C
   Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a
   Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x
   Wang L, 2002, P NATL ACAD SCI USA, V99, P13878, DOI 10.1073/pnas.172510899
   Wojcicka Grazyna, 2007, Postepy Hig Med Dosw (Online), V61, P736
   Yao PJ, 2005, BIOCHEM BIOPH RES CO, V330, P34, DOI 10.1016/j.bbrc.2005.02.121
NR 108
TC 23
Z9 24
U1 0
U2 9
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1387-2877
EI 1875-8908
J9 J ALZHEIMERS DIS
JI J. Alzheimers Dis.
PY 2012
VL 31
IS 4
BP 813
EP 826
DI 10.3233/JAD-2012-120298
PG 14
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 006HD
UT WOS:000308809200014
PM 22717611
DA 2024-02-19
ER

PT J
AU Roy, AK
   Vellanoweth, RL
   Chen, S
   Supakar, PC
   Jung, MH
   Song, CS
   Chatterjee, B
AF Roy, AK
   Vellanoweth, RL
   Chen, S
   Supakar, PC
   Jung, MH
   Song, CS
   Chatterjee, B
TI The evolutionary tangle of aging, sex, and reproduction and an
   experimental approach to its molecular dissection
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE evolution of aging; aging and sex; androgen receptor; transcription
   factor; NF-KB; ADF; reproductive aging
ID ANDROGEN RECEPTOR GENE; DNA-SYNTHESIS; EXPRESSION; MATURATION; PROMOTER;
   CELLS; AGE; RECOMBINATION; ACTIVATION; MUTATION
AB Exchange of genetic materials by two individual members of the same species is considered to be the origin of primitive sex. During evolution, this primitive form of molecular sex has been transformed into a complex biological function involving specialized sexual structures and multiple hormonal interactions. Development and maintenance of these reproductive structures are also dependent on hormones and hormone receptors. Furthermore, reproductive specialization in higher forms of life has led to customized species specific rates of aging and life-span potentials that are commensurate with the reproductive needs of the particular type of organism. Because of this reproductive imposition on aging of the organism, temporal regulation of the hormone response is a significant component of the genetics of aging. We have observed a marked age-dependent alteration in the hepatic expression of the rat androgen receptor (rAR) gene. Among the large number of transcription factors that control the rAR gene, at least three appear to participate in its age-dependent regulation. Two of these are positively acting and yet/to be characterized transcription factors, while the third is a negative regulator the nuclear factor kappa B (NF-kappa B). NF-kappa B is the major tr ans-regulator for genes involved in the immune response, inflammation, and oxidative stress. Involvement of NF-kappa B in the modulation of both oxidative stress and sex function provides the first example of a common molecular link between sex and aging.
RP Roy, AK (corresponding author), UNIV TEXAS,HLTH SCI CTR,DEPT CELLULAR & STRUCT BIOL,SAN ANTONIO,TX 78284, USA.
FU NIA NIH HHS [5T32 AG00165, R01 AG10486] Funding Source: Medline; NIDDK
   NIH HHS [R-37 DK14744] Funding Source: Medline
CR AGARWAL S, 1994, P NATL ACAD SCI USA, V91, P12332, DOI 10.1073/pnas.91.25.12332
   [Anonymous], 1990, Longevity, senescence and the genome
   BAARENDS WM, 1990, MOL CELL ENDOCRINOL, V74, P75, DOI 10.1016/0303-7207(90)90207-O
   BERNSTEIN, 1991, AGING SEX DNA REPAIR
   BERNSTEIN H, 1985, SCIENCE, V229, P1277, DOI 10.1126/science.3898363
   BRAZILL JL, 1978, EXP CELL RES, V112, P121, DOI 10.1016/0014-4827(78)90532-3
   CHARLESWORTH B, 1993, GENETICA, V91, P11, DOI 10.1007/BF01435984
   Charlesworth B., 1994, EVOLUTION AGE STRUCT, V2
   CHATTERJEE B, 1990, J STEROID BIOCHEM, V37, P437, DOI 10.1016/0960-0760(90)90495-7
   COOGAN TP, 1988, MUTAT RES, V194, P183, DOI 10.1016/0167-8817(88)90020-X
   Darwin C., 1859, ORIGIN SPECIES
   GOLDING DW, 1994, P NATL ACAD SCI USA, V91, P11777, DOI 10.1073/pnas.91.25.11777
   GONZALEZCADAVID NF, 1991, ENDOCRINOLOGY, V129, P1671, DOI 10.1210/endo-129-3-1671
   GUMUCIO DL, 1993, P NATL ACAD SCI USA, V90, P6018, DOI 10.1073/pnas.90.13.6018
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HOTTA Y, 1985, CHROMOSOMA, V93, P140, DOI 10.1007/BF00293161
   JOST A, 1970, PHILOS T ROY SOC B, V259, P119, DOI 10.1098/rstb.1970.0052
   Liou HC, 1993, CURR OPIN CELL BIOL, V5, P477, DOI 10.1016/0955-0674(93)90014-H
   MIZOKAMI A, 1994, MOL ENDOCRINOL, V8, P77, DOI 10.1210/me.8.1.77
   PARTRIDGE L, 1993, NATURE, V362, P305, DOI 10.1038/362305a0
   ROEHRBORN CG, 1987, J CLIN INVEST, V79, P44, DOI 10.1172/JCI112805
   ROY AK, 1983, J BIOL CHEM, V258, P123
   ROY AK, 1983, ANNU REV PHYSIOL, V45, P37, DOI 10.1146/annurev.ph.45.030183.000345
   ROY AK, 1984, MOL BASIS AGING
   ROY AK, IN PRESS CRIT REV EU
   SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   SONG CS, 1993, BIOCHEM J, V294, P779, DOI 10.1042/bj2940779
   SONG CS, 1991, ENDOCRINOLOGY, V128, P349, DOI 10.1210/endo-128-1-349
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   STUBBS L, 1986, CHROMOSOMA, V93, P529, DOI 10.1007/BF00386795
   SUPAKAR PC, 1995, J BIOL CHEM, V270, P837, DOI 10.1074/jbc.270.2.837
   SUPAKAR PC, 1993, J BIOL CHEM, V268, P26400
   SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8
   TILLEY WD, 1990, J BIOL CHEM, V265, P13776
   ZHANG YL, 1988, J ENDOCRINOL, V117, P361, DOI 10.1677/joe.0.1170361
NR 36
TC 14
Z9 16
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0531-5565
J9 EXP GERONTOL
JI Exp. Gerontol.
PD JAN-APR
PY 1996
VL 31
IS 1-2
BP 83
EP 94
DI 10.1016/0531-5565(95)00020-8
PG 12
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA TX426
UT WOS:A1996TX42600010
PM 8706808
DA 2024-02-19
ER

PT J
AU Llibre-Rodríguez, JD
   Valhuerdi-Cepero, A
   López-Medina, AM
   Noriega-Fernández, L
   Porto-Alvarez, R
   Guerra-Hernández, MA
   Bosch-Bayard, RI
   Zayas-Llerena, T
   Hernandez-Ulloa, E
   Rodríguez-Blanco, AL
   Salazar-Pérez, E
   Llibre-Guerra, JC
   Llibre-Guerra, JJ
   Marcheco-Teruel, B
AF de Jesus Llibre-Rodriguez, Juan
   Valhuerdi-Cepero, Adolfo
   Lopez-Medina, Ana M.
   Noriega-Fernandez, Lisseth
   Porto-Alvarez, Rutbeskia
   Guerra-Hernandez, Milagros A.
   Bosch-Bayard, Rodolfo I.
   Zayas-Llerena, Tania
   Hernandez-Ulloa, Elaine
   Rodriguez-Blanco, Ana L.
   Salazar-Perez, Enrique
   Llibre-Guerra, Juan C.
   Llibre-Guerra, Jorge J.
   Marcheco-Teruel, Beatriz
TI Cuba's Aging and Alzheimer Longitudinal Study
SO MEDICC REVIEW
LA English
DT Article
DE Dementia; Alzheimer disease; chronic disease; aging; chronic illness;
   frailty; dependency; cohort studies; Cuba
ID DEMENTIA; PREVALENCE
AB Aging and Alzheimer is a prospective, longitudinal cohort study involving 2944 adults aged >= 65 years from selected areas in Cuba's Havana and Matanzas Provinces. This door-to-door study, which began in 2003, includes periodic assessments of the cohort based on an interview; physical exam; anthropometric measurements; and diagnosis of dementia and its subtypes, other mental disorders, and other chronic non-communicable diseases and their risk factors. Information was gathered on sociodemographic characteristics; disability, dependency and frailty; use of health services; and characteristics of care and caregiver burden. The first assessment also included blood tests: complete blood count, blood glucose, kidney and liver function, lipid profile and ApoE4 genotype (a susceptibility marker). In 2007-2011, the second assessment was done of 2010 study subjects aged >= 65 years who were still alive. The study provides data on prevalence and incidence of dementia and its risk factors, and of related conditions that affect the health of older adults. It also contributes valuable experiences from field work and interactions with older adults and their families. Building on lessons learned, a third assessment to be done in 2016-2018 will incorporate a community intervention strategy to respond to diseases and conditions that predispose to dementia, frailty and dependency in older adults.
C1 [de Jesus Llibre-Rodriguez, Juan] Med Univ Havana, UCMH, Finlay Albarran Fac Med Sci, Alzheimer Studies Ctr, Havana, Cuba.
   [Valhuerdi-Cepero, Adolfo] Faustino Perez Clin Surg Univ Hosp, Matanzas, Cuba.
   [Lopez-Medina, Ana M.] Heroes Corynthia Univ Polyclin, Havana, Cuba.
   [Noriega-Fernandez, Lisseth] Marianao Mental Hlth Ctr, Havana, Cuba.
   [Porto-Alvarez, Rutbeskia] Faustino Perez Clin Surg Univ Hosp, Matanzas, Cuba.
   [Guerra-Hernandez, Milagros A.] 27 Noviembre Univ Polyclin, Havana, Cuba.
   [Bosch-Bayard, Rodolfo I.; Zayas-Llerena, Tania; Hernandez-Ulloa, Elaine] UCMH, Finlay Albarran Fac Med Sci, Havana, Cuba.
   [Rodriguez-Blanco, Ana L.; Salazar-Perez, Enrique] Cristobal Labra Polyclin, Havana, Cuba.
   [Llibre-Guerra, Juan C.; Llibre-Guerra, Jorge J.] Neurol & Neurosurg Inst, Havana, Cuba.
   [Marcheco-Teruel, Beatriz] UCMH, Natl Med Genet Ctr, Havana, Cuba.
RP Llibre-Rodríguez, JD (corresponding author), Med Univ Havana, UCMH, Finlay Albarran Fac Med Sci, Alzheimer Studies Ctr, Havana, Cuba.
EM mguerra@infomed.sld.cu
RI Rodriguez, Juan J Llibre/D-2380-2010
OI Rodriguez, Juan J Llibre/0000-0002-8215-3160; Llibre Guerra, Jorge
   Jesus/0000-0002-2137-7750
CR Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1
   [Anonymous], 2016, WORLD ALZH REP 2016
   COPELAND JRM, 1986, PSYCHOL MED, V16, P89, DOI 10.1017/S0033291700057779
   Llibre JD, 2014, MEDICC REV, V16, P24, DOI 10.37757/MR2014.V16.N1.6
   Dewey ME, 2001, INT J GERIATR PSYCH, V16, P912, DOI 10.1002/gps.446
   Gorry C, 2013, MEDICC REV, V15, P5, DOI 10.37757/MR2013V15.N2.2
   HALL KS, 1993, INT J METHOD PSYCH, V3, P1
   Kaufer DI, 2000, J NEUROPSYCH CLIN N, V12, P233, DOI 10.1176/appi.neuropsych.12.2.233
   McDowell I, 2000, NEUROLOGY, V55, P66
   MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457
   National Council of Scientifi c Societies (CU). Libro Premio Anual de la Salud, 2011, LIBR PREM AN SAL 201, P54
   National Health Statistics and Medical Records Division (CU), 2015, AN EST SAL 2015
   Prince M., 2015, WORLD ALZHEIMER REPO
   Prince M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-165
   Prince MJ, 2015, LANCET, V385, P549, DOI 10.1016/S0140-6736(14)61347-7
   Rehm J., 1999, INT J METH PSYCH RES, V8, P110, DOI DOI 10.1002/MPR.61
   Rodríguez JL, 2008, NEUROEPIDEMIOLOGY, V31, P243, DOI 10.1159/000165362
   Rodriguez JJL, 2008, LANCET, V372, P464, DOI 10.1016/S0140-6736(08)61002-8
   Smith SC, 2005, HEALTH TECHNOL ASSES, V9, P1
   United Nations Department of Economic and Social Affairs (UNDESA) Population Division, 2013, ESAPWP228 UNDESA POP
   Wimo A., 2010, World Alzheimer Report 2010: The Global Economic Impact of Dementia
NR 21
TC 6
Z9 10
U1 0
U2 6
PU MEDICC-MED EDUC COOPERATION CUBA
PI DECATUR
PA 1902 CLAIRMONT RD, STE 250, DECATUR, GEORGIA 30033-3406 USA
SN 1555-7960
J9 MEDICC REV
JI MEDICC Rev.
PD JAN
PY 2017
VL 19
IS 1
BP 31
EP 35
PG 5
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA EO0LU
UT WOS:000396390100006
PM 28225543
OA hybrid, Green Submitted
DA 2024-02-19
ER

PT J
AU Cai, YS
   Xiong, MZ
   Xin, ZJ
   Liu, CY
   Ren, J
   Yang, XY
   Lei, JH
   Li, W
   Liu, FF
   Chu, Q
   Zhang, YY
   Yin, J
   Ye, YX
   Liu, DY
   Fan, YL
   Sun, SH
   Jing, YB
   Zhao, Q
   Zhao, LY
   Che, SS
   Zheng, YD
   Yan, HT
   Ma, S
   Wang, S
   Belmonte, JCI
   Qu, J
   Zhang, WQ
   Liu, GH
AF Cai, Yusheng
   Xiong, Muzhao
   Xin, Zijuan
   Liu, Chengyu
   Ren, Jie
   Yang, Xiying
   Lei, Jinghui
   Li, Wei
   Liu, Feifei
   Chu, Qun
   Zhang, Yiyuan
   Yin, Jian
   Ye, Yanxia
   Liu, Dingyi
   Fan, Yanling
   Sun, Shuhui
   Jing, Yaobin
   Zhao, Qian
   Zhao, Liyun
   Che, Shanshan
   Zheng, Yandong
   Yan, Haoteng
   Ma, Shuai
   Wang, Si
   Belmonte, Juan Carlos Izpisua
   Qu, Jing
   Zhang, Weiqi
   Liu, Guang-Hui
TI Decoding aging-dependent regenerative decline across tissues at
   single-cell resolution
SO CELL STEM CELL
LA English
DT Article
ID MUSCLE STEM-CELLS; MACROPHAGE PLASTICITY; PARTIAL-HEPATECTOMY;
   LIVER-INJURY; REPAIR; ANGIOGENESIS; INFLAMMATION; MECHANISMS;
   REJUVENATION; POLARIZATION
AB Regeneration across tissues and organs exhibits significant variation throughout the body and undergoes a progressive decline with age. To decode the relationships between aging and regenerative capacity, we conducted a comprehensive single-cell transcriptome analysis of regeneration in eight tissues from young and aged mice. We employed diverse analytical models to study tissue regeneration and unveiled the intricate cellular and molecular mechanisms underlying the attenuated regenerative processes observed in aged tissues. Specifically, we identified compromised stem cell mobility and inadequate angiogenesis as prominent contributors to this age-associated decline in regenerative capacity. Moreover, we discovered a unique subset of Arg1(+) macrophages that were activated in young tissues but suppressed in aged regenerating tissues, suggesting their important role in age-related immune response disparities during regeneration. This study provides a comprehensive single-cell resource for identifying potential targets for interventions aimed at enhancing regenerative outcomes in the aging population.
C1 [Cai, Yusheng; Xin, Zijuan; Liu, Feifei; Zhang, Yiyuan; Yin, Jian; Sun, Shuhui; Jing, Yaobin; Ma, Shuai; Liu, Guang-Hui] Chinese Acad Sci, State Key Lab Membrane Biol, Inst Zool, Beijing 100101, Peoples R China.
   [Liu, Chengyu; Chu, Qun; Ye, Yanxia; Liu, Dingyi; Zheng, Yandong; Qu, Jing] Chinese Acad Sci, State Key Lab Stem Cell & Reprod Biol, Inst Zool, Beijing 100101, Peoples R China.
   [Ren, Jie] Chinese Acad Sci, Beijing Inst Genom, Key Lab RNA Sci & Engn, Beijing 100101, Peoples R China.
   [Xiong, Muzhao; Ren, Jie; Fan, Yanling; Che, Shanshan; Zhang, Weiqi] China Natl Ctr Bioinformat, Beijing 100101, Peoples R China.
   [Xiong, Muzhao; Ren, Jie; Fan, Yanling; Che, Shanshan; Zhang, Weiqi] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genom & Precis Med, Beijing 100101, Peoples R China.
   [Xiong, Muzhao; Liu, Chengyu; Yin, Jian; Liu, Dingyi; Jing, Yaobin; Che, Shanshan; Zheng, Yandong; Qu, Jing; Zhang, Weiqi; Liu, Guang-Hui] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
   [Cai, Yusheng; Xin, Zijuan; Liu, Chengyu; Liu, Feifei; Chu, Qun; Zhang, Yiyuan; Yin, Jian; Ye, Yanxia; Liu, Dingyi; Sun, Shuhui; Jing, Yaobin; Zheng, Yandong; Ma, Shuai; Qu, Jing; Zhang, Weiqi; Liu, Guang-Hui] Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing 100101, Peoples R China.
   [Cai, Yusheng; Xin, Zijuan; Liu, Chengyu; Liu, Feifei; Chu, Qun; Zhang, Yiyuan; Yin, Jian; Ye, Yanxia; Liu, Dingyi; Sun, Shuhui; Jing, Yaobin; Zheng, Yandong; Ma, Shuai; Qu, Jing; Liu, Guang-Hui] Beijing Inst Stem Cell & Regenerat Med, Beijing 100101, Peoples R China.
   [Lei, Jinghui; Li, Wei; Zhao, Qian; Zhao, Liyun; Yan, Haoteng; Wang, Si; Liu, Guang-Hui] Capital Med Univ, Xuanwu Hosp, Adv Innovat Ctr Human Brain Protect, Beijing 100053, Peoples R China.
   [Lei, Jinghui; Li, Wei; Zhao, Qian; Zhao, Liyun; Yan, Haoteng; Wang, Si; Liu, Guang-Hui] Capital Med Univ, Xuanwu Hosp, Natl Clin Res Ctr Geriatr Disorders, Beijing 100053, Peoples R China.
   [Lei, Jinghui; Li, Wei; Zhao, Qian; Zhao, Liyun; Yan, Haoteng; Wang, Si; Liu, Guang-Hui] Capital Med Univ, Beijing Municipal Geriatr Med Res Ctr, Aging Translat Med Ctr, Int Ctr Aging & Canc,Xuanwu Hosp, Beijing 100053, Peoples R China.
   [Yang, Xiying] Weifang Med Univ, Lab Anesthesia & Crit Care Med Coll & Univ Shandon, Sch Anesthesiol, Weifang 261053, Peoples R China.
   [Belmonte, Juan Carlos Izpisua] Altos Labs Inc, San Diego, CA 94022 USA.
   [Ren, Jie; Ma, Shuai; Wang, Si; Qu, Jing; Zhang, Weiqi; Liu, Guang-Hui] Aging Biomarker Consortium, Wuhan, Peoples R China.
C3 Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy
   of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences;
   Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; Beijing
   Institute of Genomics, CAS; Chinese Academy of Sciences; University of
   Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Capital
   Medical University; Capital Medical University; Capital Medical
   University; Shandong Second Medical University
RP Cai, YS; Liu, GH (corresponding author), Chinese Acad Sci, State Key Lab Membrane Biol, Inst Zool, Beijing 100101, Peoples R China.; Qu, J (corresponding author), Chinese Acad Sci, State Key Lab Stem Cell & Reprod Biol, Inst Zool, Beijing 100101, Peoples R China.; Zhang, WQ (corresponding author), Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genom & Precis Med, Beijing 100101, Peoples R China.; Qu, J; Zhang, WQ; Liu, GH (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.; Cai, YS; Qu, J; Zhang, WQ; Liu, GH (corresponding author), Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing 100101, Peoples R China.; Cai, YS; Qu, J; Liu, GH (corresponding author), Beijing Inst Stem Cell & Regenerat Med, Beijing 100101, Peoples R China.; Liu, GH (corresponding author), Capital Med Univ, Xuanwu Hosp, Adv Innovat Ctr Human Brain Protect, Beijing 100053, Peoples R China.; Liu, GH (corresponding author), Capital Med Univ, Xuanwu Hosp, Natl Clin Res Ctr Geriatr Disorders, Beijing 100053, Peoples R China.; Liu, GH (corresponding author), Capital Med Univ, Beijing Municipal Geriatr Med Res Ctr, Aging Translat Med Ctr, Int Ctr Aging & Canc,Xuanwu Hosp, Beijing 100053, Peoples R China.; Qu, J; Zhang, WQ; Liu, GH (corresponding author), Aging Biomarker Consortium, Wuhan, Peoples R China.
EM qujing@ioz.ac.cn; zhangwq@big.ac.cn; ghliu@ioz.ac.cn
RI Xiong, Muzhao/IYJ-1377-2023
FU National Natural Science Foundation of China [92149301, 91949209,
   92049304, 92049116, 32121001, 82192863, 82122024, 31970597, 82071588,
   32000500, 82271600, 82201727, 32000510, 82001477, YSBR-076,
   2021ZD0202400, 11000023T000002036310]; CAS Project for Young Scientists
   in Basic Research [2020YFA0804000, 2020YFA0112200]; National Key
   Research and Development Program of China [2021YFF1201005,
   2019YFA0802202, 2020YFA0803401, 2022YFA1103800, 2022YFC3602500,
   2022YFA1104700, Z190019, 2021-1045, XDA16000000]; Program of the Beijing
   Natural Science Foundation [E1CAZW0401]; Tencent Foundation [2022083];
   Youth Innovation Promotion Association of CAS [2023092, YESS20200012,
   YESS20210002]; Young Elite Scientists Sponsorship Program by CAST
   [CAS-WX2021SF-0301, CAS-WX2022SDC-XK14]; Informatization Plan of Chinese
   Academy of Sciences [CAS-WX2021SF-0101, 12300927, BPHR202203105];
   Excellent Young Talents Program of Capital Medical University
   [QML20230806]; STI2030-Major Projects; Excellent Young Talents Training
   Program for the Construction of Beijing Municipal University Teacher
   Team [81921006]; Project for Technology Development of
   Beijing-affiliated Medical Research Institutes; Beijing Hospitals
   Authority Youth Programme [2022YFA1103700]; Strategic Priority Research
   Program of the Chinese Academy of Sciences;  [82125011];  [YSBR-012]; 
   [92168201]
FX We thank J. Jia for assisting with the animal experiments; J. Ping, J.
   Li, and X. Wang for his help with the bioinformatic analysis; and L.
   Bai, R. Bai, Q. Chu, J. Lu, J. Chen, Y. Yang, L. Tian, and X. Li for
   their administrative assistance. We are also grateful to J. Jia from the
   Institute of Biophysics, Chinese Academy of Sciences for FACS and to S.
   Li from the Institute of Zoology, Chinese Academy of Sciences for image
   scanning. This work was supported by the National Key Research and
   Development Program of China (2022YFA1103700) , the National Natural
   Science Foundation of China (92168201 and 81921006) , CAS Project for
   Young Scientists in Basic Research (YSBR-076 and YSBR-012) , the
   National Key Research and Development Program of China (2020YFA0804000,
   2020YFA0112200, 2021YFF1201005, 2019YFA0802202, 2020YFA0803401,
   2022YFA1103800, 2022YFC3602500, 2022YFA1104700, and the STI2030-Major
   Projects-2021ZD0202400) , the National Natural Science Foundation of
   China (82125011, 92149301, 91949209, 92049304, 92049116, 32121001,
   82192863, 82122024, 31970597, 82071588, 32000500, 82271600, 82201727,
   32000510, and 82001477) , the <STRONG>Strategic Priority Research
   Program of the Chinese Academy of Sciences (XDA16000000) ,</STRONG> the
   Program of the Beijing Natural Science Foundation (Z190019) , the
   Tencent Foundation (2021-1045) , Youth Innovation Promotion Association
   of CAS (E1CAZW0401, 2022083, and 2023092) , Young Elite Scientists
   Sponsorship Program by CAST (YESS20200012 and YESS20210002) , the
   Informatization Plan of Chinese Academy of Sciences (CAS-WX2021SF-0301,
   CAS-WX2022SDC-XK14, and CAS-WX2021SF-0101) , Excellent Young Talents
   Program of Capital Medical University (12300927) , The Project for
   Technology Development of Beijing-affiliated Medical Research Institutes
   (11000023T000002036310) , Excellent Young Talents Training Program for
   the Construction of Beijing Municipal University Teacher Team
   (BPHR202203105) , and Beijing Hospitals Authority Youth Pro-gramme
   (QML20230806) .
CR Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]
   Antelo-Iglesias L, 2021, MECH AGEING DEV, V198, DOI 10.1016/j.mad.2021.111528
   Bao HN, 2023, SCI CHINA LIFE SCI, DOI 10.1007/s11427-023-2305-0
   Ben-Moshe S, 2022, CELL STEM CELL, V29, P973, DOI 10.1016/j.stem.2022.04.008
   Blanpain C, 2014, SCIENCE, V344, P1243, DOI 10.1126/science.1242281
   Bonnet CS, 2005, RHEUMATOLOGY, V44, P7, DOI 10.1093/rheumatology/keh344
   Borselli C, 2010, P NATL ACAD SCI USA, V107, P3287, DOI 10.1073/pnas.0903875106
   Brunet A, 2023, NAT REV MOL CELL BIO, V24, P45, DOI 10.1038/s41580-022-00510-w
   Cai Y., 2022, Life Med., V1, P307, DOI [10.1093/lifemedi/lnac054, DOI 10.1093/LIFEMEDI/LNAC054]
   Cai YS, 2022, SCI CHINA LIFE SCI, V65, P2354, DOI 10.1007/s11427-022-2161-3
   Cai YS, 2022, INNOVATION-AMSTERDAM, V3, DOI 10.1016/j.xinn.2022.100276
   Cai YS, 2022, STEM CELL TRANSL MED, V11, P231, DOI 10.1093/stcltm/szab012
   Cai YS, 2020, CELL RES, V30, P574, DOI 10.1038/s41422-020-0314-9
   Campana L, 2021, NAT REV MOL CELL BIO, V22, P608, DOI 10.1038/s41580-021-00373-7
   Campbell L, 2013, J INVEST DERMATOL, V133, P2461, DOI 10.1038/jid.2013.164
   Campisi J, 2019, NATURE, V571, P183, DOI 10.1038/s41586-019-1365-2
   Chembazhi UV, 2021, GENOME RES, V31, P576, DOI 10.1101/gr.267013.120
   Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012
   Conboy IM, 2005, CELL CYCLE, V4, P407, DOI 10.4161/cc.4.3.1518
   Cooke JP, 2019, CIRC RES, V124, P1166, DOI 10.1161/CIRCRESAHA.118.314669
   Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464
   De Micheli AJ, 2020, CELL REP, V30, P3583, DOI 10.1016/j.celrep.2020.02.067
   Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930
   Eming SA, 2017, SCIENCE, V356, P1026, DOI 10.1126/science.aam7928
   Flach J, 2014, NATURE, V512, P198, DOI 10.1038/nature13619
   Fleming SJ, 2019, CELLBENDER REMOVE BA, DOI [DOI 10.1101/791699, 10.1101/791699]
   Forbes SJ, 2016, NAT REV GASTRO HEPAT, V13, P473, DOI 10.1038/nrgastro.2016.97
   Gadd VL, 2020, CELL STEM CELL, V27, P557, DOI 10.1016/j.stem.2020.08.016
   Galliot B, 2017, DEVELOPMENT, V144, P357, DOI 10.1242/dev.144279
   Gao Y, 2020, J INVEST DERMATOL, V140, P455, DOI 10.1016/j.jid.2019.06.143
   Goldman JA, 2020, NAT REV GENET, V21, P511, DOI 10.1038/s41576-020-0239-7
   Goodell MA, 2015, SCIENCE, V350, P1199, DOI 10.1126/science.aab3388
   Gorbunova V, 2021, NATURE, V596, P43, DOI 10.1038/s41586-021-03542-y
   Hao YH, 2021, CELL, V184, P3573, DOI 10.1016/j.cell.2021.04.048
   He LJ, 2021, SCIENCE, V371, P905, DOI 10.1126/science.abc4346
   He XJ, 2020, NAT METAB, V2, P293, DOI 10.1038/s42255-020-0196-7
   Huang DY, 2023, PROTEIN CELL, V14, P888, DOI 10.1093/procel/pwac057
   Huber R, 2012, CELL SIGNAL, V24, P1287, DOI 10.1016/j.cellsig.2012.02.007
   Iismaa SE, 2018, NPJ REGEN MED, V3, DOI 10.1038/s41536-018-0044-5
   Imhof BA, 2006, NAT MED, V12, P171, DOI 10.1038/nm0206-171
   Jiang MM, 2023, FEBS J, V290, P5674, DOI 10.1111/febs.16930
   Jin SQ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21246-9
   Jing Y, 2023, CELL PROLIFERAT, V56, DOI 10.1111/cpr.13455
   Josephson AM, 2019, P NATL ACAD SCI USA, V116, P6995, DOI 10.1073/pnas.1810692116
   Kang W, 2022, NUCLEIC ACIDS RES, V50, pD1085, DOI 10.1093/nar/gkab870
   Kikuchi K, 2012, ANNU REV CELL DEV BI, V28, P719, DOI 10.1146/annurev-cellbio-101011-155739
   Lei JH, 2024, PROTEIN CELL, V15, P36, DOI 10.1093/procel/pwad027
   Lei JH, 2021, PROTEIN CELL, V12, P145, DOI 10.1007/s13238-020-00779-7
   Leng Sean X, 2022, Life Med, V1, P67, DOI 10.1093/lifemedi/lnac013
   Liu BB, 2022, CELL REP, V41, DOI 10.1016/j.celrep.2022.111451
   Liu XQ, 2023, CELL, V186, P287, DOI 10.1016/j.cell.2022.12.017
   Liu ZP, 2022, CELL DISCOV, V8, DOI 10.1038/s41421-021-00361-3
   Locati M, 2020, ANNU REV PATHOL-MECH, V15, P123, DOI 10.1146/annurev-pathmechdis-012418-012718
   Ma SA, 2023, ANNU REV BIOMED DA S, V6, DOI 10.1146/annurev-biodatasci-020722-120642
   Ma S, 2022, CELL STEM CELL, V29, P990, DOI 10.1016/j.stem.2022.04.017
   Ma S, 2020, CELL, V180, P984, DOI 10.1016/j.cell.2020.02.008
   Mahmoudi S, 2019, NAT CELL BIOL, V21, P32, DOI 10.1038/s41556-018-0206-0
   Mascharak S, 2022, CELL STEM CELL, V29, P315, DOI 10.1016/j.stem.2021.12.011
   McGinnis CS, 2019, CELL SYST, V8, P329, DOI 10.1016/j.cels.2019.03.003
   McKellar DW, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02810-x
   Meizlish ML, 2021, ANNU REV IMMUNOL, V39, P557, DOI 10.1146/annurev-immunol-061020-053734
   Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Neves J, 2017, CELL STEM CELL, V20, P161, DOI 10.1016/j.stem.2017.01.008
   Nevzorova YA, 2015, LAB ANIM-UK, V49, P81, DOI 10.1177/0023677215572000
   Ning S, 2011, GENES IMMUN, V12, P399, DOI 10.1038/gene.2011.21
   Oh J, 2014, NAT MED, V20, P870, DOI 10.1038/nm.3651
   Oishi Y, 2018, INT IMMUNOL, V30, P511, DOI 10.1093/intimm/dxy054
   Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371
   Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]
   Qiu XJ, 2017, NAT METHODS, V14, P309, DOI [10.1038/NMETH.4150, 10.1038/nmeth.4150]
   Rando TA, 2021, CSH PERSPECT BIOL, V13, DOI 10.1101/cshperspect.a040907
   Ren J, 2023, NAT MED, V29, P2162, DOI 10.1038/s41591-023-02444-y
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Schultz MB, 2016, DEVELOPMENT, V143, P3, DOI 10.1242/dev.130633
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Shi XZ, 2006, GENE DEV, V20, P1692, DOI 10.1101/gad.1419406
   Sica A, 2014, HEPATOLOGY, V59, P2034, DOI 10.1002/hep.26754
   Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643
   Skinnider MA, 2021, NAT BIOTECHNOL, V39, P30, DOI 10.1038/s41587-020-0605-1
   Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013
   Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0
   Strunz M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17358-3
   Sun GQ, 2023, PROTEIN CELL, V14, P180, DOI 10.1093/procel/pwac058
   Sun SH, 2023, INNOVATION-AMSTERDAM, V4, DOI 10.1016/j.xinn.2023.100380
   Sun Yu, 2022, Life Med, V1, P103, DOI 10.1093/lifemedi/lnac030
   Sutti S, 2018, CLIN SCI, V132, P609, DOI 10.1042/CS20171313
   Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   Vannella KM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004372
   Velders M, 2013, SPORTS MED, V43, P1089, DOI 10.1007/s40279-013-0081-6
   Wang C, 2023, RESEARCH-CHINA, V6, DOI 10.34133/research.0192
   Wells JM, 2018, NATURE, V557, P322, DOI 10.1038/s41586-018-0073-7
   Willet SG, 2018, EMBO J, V37, DOI 10.15252/embj.201798311
   Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0
   Wu XK, 2021, CARDIOVASC RES, V117, P1257, DOI 10.1093/cvr/cvaa287
   Wu Z., 2023, Life Metab., V2, DOI [DOI 10.1093/LIFEMETA/LOAD012, 10.1093/lifemeta/load012]
   Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015
   Xia HM, 2018, NAT REV MATER, V3, P174, DOI 10.1038/s41578-018-0027-6
   Xiang CG, 2019, SCIENCE, V364, P399, DOI 10.1126/science.aau7307
   Yan Pengze, 2020, Cell Regen, V9, P22, DOI 10.1186/s13619-020-00064-2
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Zhang B., 2023, Life Med., V2, DOI [10.1093/lifemedi/lnad022, DOI 10.1093/LIFEMEDI/LNAD022]
   Zhang F., 2022, Life Medicine, V1, P179, DOI [10.1093/lifemedi/lnac002, DOI 10.1093/LIFEMEDI/LNAC002]
   Zhang H, 2023, CELL REP, V42, DOI 10.1016/j.celrep.2023.112593
   Zhang JY, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20193031
   Zhang L., 2023, Life Med, DOI [10.1093/lifemedi/lnad033, DOI 10.1093/LIFEMEDI/LNAD033]
   Zhang WQ, 2020, NAT REV MOL CELL BIO, V21, P137, DOI 10.1038/s41580-019-0204-5
   Zhao Q, 2023, PROTEIN CELL, V14, P398, DOI 10.1093/procel/pwac062
   Zhao Y, 2023, NAT REV IMMUNOL, V23, P75, DOI 10.1038/s41577-022-00751-y
   Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6
   Zhu F., 2023, Life Med., V2, DOI [10.1093/lifemedi/lnad027, DOI 10.1093/LIFEMEDI/LNAD027]
NR 112
TC 1
Z9 1
U1 20
U2 20
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1934-5909
EI 1875-9777
J9 CELL STEM CELL
JI Cell Stem Cell
PD DEC 7
PY 2023
VL 30
IS 12
DI 10.1016/j.stem.2023.09.014
EA DEC 2023
PG 27
WC Cell & Tissue Engineering; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA EK8Z2
UT WOS:001138924400001
PM 37898124
DA 2024-02-19
ER

PT J
AU Sato, T
   Shapiro, JS
   Chang, HC
   Miller, RA
   Ardehali, H
AF Sato, Tatsuya
   Shapiro, Jason Solomon
   Chang, Hsiang-Chun
   Miller, Richard A.
   Ardehali, Hossein
TI Aging is associated with increased brain iron through cortex-derived
   hepcidin expression
SO ELIFE
LA English
DT Article
DE Aging; Iron; oxidative stress; Mouse
ID ALZHEIMERS-DISEASE; SUBSTANTIA-NIGRA; ACCUMULATION; FERRITIN;
   TRANSFERRIN
AB Iron is an essential molecule for biological processes, but its accumulation can lead to oxidative stress and cellular death. Due to its oxidative effects, iron accumulation is implicated in the process of aging and neurodegenerative diseases. However, the mechanism for this increase in iron with aging, and whether this increase is localized to specific cellular compartment(s), are not known. Here, we measured the levels of iron in different tissues of aged mice, and demonstrated that while cytosolic non-heme iron is increased in the liver and muscle tissue, only the aged brain cortex exhibits an increase in both the cytosolic and mitochondrial non-heme iron. This increase in brain iron is associated with elevated levels of local hepcidin mRNA and protein in the brain. We also demonstrate that the increase in hepcidin is associated with increased ubiquitination and reduced levels of the only iron exporter, ferroportin-1 (FPN1). Overall, our studies provide a potential mechanism for iron accumulation in the brain through increased local expression of hepcidin, and subsequent iron accumulation due to decreased iron export. Additionally, our data support that aging is associated with mitochondrial and cytosolic iron accumulation only in the brain and not in other tissues.
C1 [Sato, Tatsuya; Shapiro, Jason Solomon; Chang, Hsiang-Chun; Ardehali, Hossein] Northwestern Univ, Feinberg Cardiovasc & Renal Res Inst, Sch Med, Chicago, IL 60611 USA.
   [Miller, Richard A.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA.
C3 Northwestern University; University of Michigan System; University of
   Michigan
RP Ardehali, H (corresponding author), Northwestern Univ, Feinberg Cardiovasc & Renal Res Inst, Sch Med, Chicago, IL 60611 USA.
EM h-ardehali@northwestern.edu
OI Chang, Hsiang-Chun/0000-0002-9201-4500
FU American Heart Association; NIH [R01 HL127646, R01 HL140973, R01
   HL138982, U01-AG022303-17, P30-AG024824]; Leducq foundation
FX The authors would like to thank Chunlei Chen for technical help. TS was
   supported by American Heart Association. HA is supported by NIH R01
   HL127646, R01 HL140973, and R01 HL138982, and a grant from Leducq
   foundation. RAM was supported by NIH grants U01-AG022303-17 and
   P30-AG024824.
CR BARTZOKIS G, 1994, AM J NEURORADIOL, V15, P1129
   BARTZOKIS G, 1994, BIOL PSYCHIAT, V35, P480, DOI 10.1016/0006-3223(94)90047-7
   Bartzokis G, 2010, J ALZHEIMERS DIS, V20, P333, DOI 10.3233/JAD-2010-1368
   Bayeva M, 2012, CELL METAB, V16, P645, DOI 10.1016/j.cmet.2012.10.001
   BENKOVIC SA, 1993, J COMP NEUROL, V338, P97, DOI 10.1002/cne.903380108
   Berg D, 2001, J NEUROCHEM, V79, P225, DOI 10.1046/j.1471-4159.2001.00608.x
   Chang HC, 2021, ELIFE, V10, DOI 10.7554/eLife.65158
   Chang HC, 2016, EMBO MOL MED, V8, P247, DOI 10.15252/emmm.201505748
   Chaudhary S, 2021, J ALZHEIMERS DIS, V82, P1487, DOI 10.3233/JAD-210221
   Flurkey K., 2007, The Mouse in Biomedical Research, P637
   Gutschow P, 2015, HAEMATOLOGICA, V100, P167, DOI 10.3324/haematol.2014.116723
   Hahn P, 2009, EXP GERONTOL, V44, P594, DOI 10.1016/j.exger.2009.06.006
   Harrison DE, 2021, AGING CELL, V20, DOI 10.1111/acel.13328
   Kandlur A, 2020, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.00041
   Kawabata H, 1999, J BIOL CHEM, V274, P20826, DOI 10.1074/jbc.274.30.20826
   Koleini N, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI148671
   Lakhal-Littleton S, 2016, ELIFE, V5, DOI 10.7554/eLife.19804
   Lei P, 2012, NAT MED, V18, P291, DOI 10.1038/nm.2613
   Liang T, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101284
   Lieblein-Boff JC, 2013, J NEUROSCI, V33, P16334, DOI 10.1523/JNEUROSCI.0708-13.2013
   Lu LN, 2017, MOL NEUROBIOL, V54, P5213, DOI 10.1007/s12035-016-0067-0
   Mastroberardino PG, 2009, NEUROBIOL DIS, V34, P417, DOI 10.1016/j.nbd.2009.02.009
   Noster J, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00762
   Nyberg L, 2010, P NATL ACAD SCI USA, V107, P22682, DOI 10.1073/pnas.1012651108
   Pellegrino RM, 2016, SCI REP-UK, V6, DOI 10.1038/srep30725
   Qian ZM, 1998, BRAIN RES REV, V27, P257, DOI 10.1016/S0165-0173(98)00012-5
   Qiao B, 2012, CELL METAB, V15, P918, DOI 10.1016/j.cmet.2012.03.018
   ROSKAMS AJI, 1994, J NEUROCHEM, V63, P709
   Samavati L, 2008, J BIOL CHEM, V283, P21134, DOI 10.1074/jbc.M801954200
   Sato T, 2018, P NATL ACAD SCI USA, V115, pE6291, DOI 10.1073/pnas.1804701115
   Sawicki KT, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.95948
   Schwartz AJ, 2021, NAT METAB, V3, P969, DOI 10.1038/s42255-021-00406-7
   Silvestri L, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00093
   Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866
   Sun YY, 2018, ACS CHEM NEUROSCI, V9, P1118, DOI 10.1021/acschemneuro.7b00478
   Wang J, 2004, MOL CELL BIOL, V24, P954, DOI 10.1128/MCB.24.3.954-965.2004
   Wang Q, 2008, ENDOCRINOLOGY, V149, P3920, DOI 10.1210/en.2007-1626
   Xiong XY, 2016, CIRCULATION, V134, P1025, DOI 10.1161/CIRCULATIONAHA.116.021881
   Xu JH, 2021, FRONT AGING NEUROSCI, V13, DOI 10.3389/fnagi.2021.656626
   Xu JZ, 2012, INT J MOL SCI, V13, P2368, DOI 10.3390/ijms13022368
   Zecca L, 2001, J NEUROCHEM, V76, P1766, DOI 10.1046/j.1471-4159.2001.00186.x
   Zhang XW, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-00346-3
NR 42
TC 19
Z9 20
U1 0
U2 5
PU eLIFE SCIENCES PUBL LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD JAN 11
PY 2022
VL 11
AR e73456
DI 10.7554/eLife.73456; 10.7554/eLife.73456.sa0; 10.7554/eLife.73456.sa1;
   10.7554/eLife.73456.sa2
PG 15
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA YM2AQ
UT WOS:000746382400001
PM 35014607
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Skarupski, KA
   Gross, A
   Schrack, JA
   Deal, JA
   Eber, GB
AF Skarupski, Kimberly A.
   Gross, Alden
   Schrack, Jennifer A.
   Deal, Jennifer A.
   Eber, Gabriel B.
TI The Health of America's Aging Prison Population
SO EPIDEMIOLOGIC REVIEWS
LA English
DT Article
DE aging; epidemiology; gerontology; health status; incarcerated
   individuals
ID MENTAL-HEALTH; SUICIDAL IDEATION; PREVALENCE; CARE; OLD; INCARCERATION;
   DISABILITY; COMMUNITY; INMATES; OBESITY
AB Older incarcerated individuals comprise the fastest growing demographic in the US prison system. Unhealthy lifestyles among incarcerated individuals and inadequate health care lead to earlier onset and more rapid progression of many chronic conditions that are prevalent among community-living older adults. There are limited peer-reviewed epidemiologic data in this area; however, there is growing interest in identifying strategies for housing aging incarcerated individuals, delivering appropriate health care in prisons, and coordinating after-release health care. In this systematic review, we summarize the epidemiologic evidence of the health challenges facing the aging US prison population. Our comprehensive literature search focused on health outcomes, including diseases, comorbid conditions, mental health, cognition, and mobility. From 12,486 articles identified from the literature search, we reviewed 21 studies published between 2007 and 2017. All the studies were observational and cross-sectional, and most (n = 17) were based on regional samples. Sample sizes varied widely, ranging from 25 to 14,499 incarcerated people (median, 258). In general, compared with their younger counterparts, older incarcerated individuals reported high rates of diabetes mellitus, cardiovascular conditions, and liver disease. Mental health problems were common, especially anxiety, fear of desire for death or suicide, and depression. Activities of daily living were challenging for up to one-fifth of the population. We found no empirical data on cognition among older incarcerated individuals. The findings of this review reveal few empirical data in this area and highlight the need for new data to drive policy and practice patterns that address critical health issues related to the aging prison population.
C1 [Skarupski, Kimberly A.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA.
   [Skarupski, Kimberly A.; Gross, Alden; Schrack, Jennifer A.; Deal, Jennifer A.; Eber, Gabriel B.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.
   [Skarupski, Kimberly A.; Gross, Alden; Schrack, Jennifer A.; Deal, Jennifer A.] Johns Hopkins Univ, Ctr Aging & Hlth, Baltimore, MD USA.
   [Eber, Gabriel B.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Baltimore, MD USA.
   Amer Civil Liberties Fdn, Natl Prison Project, Washington, DC USA.
C3 Johns Hopkins University; Johns Hopkins University; Johns Hopkins
   Bloomberg School of Public Health; Johns Hopkins University; Johns
   Hopkins University; Johns Hopkins Bloomberg School of Public Health
RP Gross, A (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, 2024 E Monument St, Baltimore, MD 21205 USA.
EM agross14@jhu.edu
RI Schrack, Jennifer/AAJ-1772-2021
OI Schrack, Jennifer/0000-0001-9244-9267
FU National Institute on Aging [K01-AG050699, K01AG048765, R21AG053198,
   P30AG021334]
FX A.G. was supported by grant K01-AG050699 from the National Institute on
   Aging. J.A.S. was supported by grants K01AG048765, R21AG053198, and
   P30AG021334 from the National Institute on Aging.
CR Aday R.H., 2011, Women Aging in Prison. A Neglected Population in the Correctional System
   Aday R.H., 2003, Aging prisoners crisis in American corrections
   ADAY RH, 1994, INT J OFFENDER THER, V38, P79, DOI 10.1177/0306624X9403800108
   Ahalt C, 2015, ANN INTERN MED, V162, P345, DOI 10.7326/M14-2161
   Ahalt C, 2013, J AM GERIATR SOC, V61, P2013, DOI 10.1111/jgs.12510
   Ahalt C, 2012, J GEN INTERN MED, V27, P160, DOI 10.1007/s11606-011-1858-7
   Allen RS, 2008, GERONTOLOGIST, V48, P692, DOI 10.1093/geront/48.5.692
   Allen RS, 2013, INT J GERIATR PSYCH, V28, P710, DOI 10.1002/gps.3874
   [Anonymous], 0808 US DEP JUST OFF
   [Anonymous], J CORRECT HLTH CARE
   [Anonymous], NURS HOM QUAL IN
   [Anonymous], 2014, Corrections Today
   [Anonymous], 2012, OLD BARS AGING PRISO
   [Anonymous], CORRECTIONAL HLTH CA
   [Anonymous], GROWTH INC US EXPL C
   [Anonymous], PRISONERS 2009
   [Anonymous], SPEC REP AG STAT PRI
   [Anonymous], 0603 US DEP JUST OFF
   [Anonymous], BUR JUST STAT PART P
   [Anonymous], NAT INM SURV 2011 20
   [Anonymous], STAT PRIS EXP 2001
   [Anonymous], AMA J ETHICS
   [Anonymous], 2012, POS STAT SEGR PRIS M
   [Anonymous], QUICK START CORRECTI
   [Anonymous], MED PROBL PRIS
   [Anonymous], MENTAL HLTH TREATMEN
   [Anonymous], MENT HLTH SCREENS CO
   [Anonymous], ABC EVENING NEW 1008
   [Anonymous], MAY URB I ROUNDT NEW
   [Anonymous], 2012, AM EXPENSE MASS INCA
   [Anonymous], PUBLIC HLTH BARS
   [Anonymous], PRISONERS IN 2000
   [Anonymous], 2013, ESSENTIALS CORRECTIO
   [Anonymous], HLTH STAT SOON REL P
   [Anonymous], ETH CONS RES INV PRI
   [Anonymous], PRIS HLTH CAR COSTS
   [Anonymous], J BIOETH INQ
   [Anonymous], CLIN PRACTICE CORREC
   Bai JR, 2015, J CORRECT HEALTH CAR, V21, P255, DOI 10.1177/1078345815587510
   BARAK Y, 1995, INT J GERIATR PSYCH, V10, P511, DOI 10.1002/gps.930100611
   Barry LC, 2017, INT J GERIATR PSYCH, V32, P1141, DOI 10.1002/gps.4578
   Barry LC, 2016, CRISIS, V37, P88, DOI 10.1027/0227-5910/a000350
   Binswanger IA, 2009, J EPIDEMIOL COMMUN H, V63, P912, DOI 10.1136/jech.2009.090662
   Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115
   Bishop AJ, 2014, J APPL GERONTOL, V33, P998, DOI 10.1177/0733464812456632
   Bishop Alex J, 2011, J Correct Health Care, V17, P34, DOI 10.1177/1078345810385912
   Chutka DS, 2004, MAYO CLIN PROC, V79, P122, DOI 10.4065/79.1.122
   Deaton D, 2009, OMEGA-J DEATH DYING, V60, P51, DOI 10.2190/OM.60.1.c
   Fazel S, 2001, BRIT J PSYCHIAT, V179, P535, DOI 10.1192/bjp.179.6.535
   Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723
   Gallagher EM, 2001, INT J LAW PSYCHIAT, V24, P325, DOI 10.1016/S0160-2527(00)00080-7
   Gates ML, 2017, J HEALTH CARE POOR U, V28, P132, DOI 10.1353/hpu.2017.0057
   HEINIK J, 1994, INT J GERIATR PSYCH, V9, P491, DOI 10.1002/gps.930090608
   KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016
   Leigey ME, 2015, J CORRECT HEALTH CAR, V21, P276, DOI 10.1177/1078345815588171
   Leigey ME, 2012, WOMEN CRIM JUSTICE, V22, P289, DOI 10.1080/08974454.2012.716358
   Liem M, 2013, INT J LAW PSYCHIAT, V36, P333, DOI 10.1016/j.ijlp.2013.04.012
   Loeb SJ, 2008, WESTERN J NURS RES, V30, P234, DOI 10.1177/0193945907302981
   Loeb SJ, 2006, RES NURS HEALTH, V29, P556, DOI 10.1002/nur.20177
   Loeb SJ, 2011, RES GERONTOL NURS, V4, P185, DOI 10.3928/19404921-20100730-01
   Mallik-Kane K, 2008, HLTH PRISONER REENTR
   Martin MS, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-275
   Maschi T, 2015, J CRIME JUSTICE, V38, P113, DOI 10.1080/0735648X.2013.808853
   Merten MJ, 2012, AM J HEALTH BEHAV, V36, P275, DOI 10.5993/AJHB.36.2.12
   Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.i4086, 10.1186/2046-4053-4-1, 10.1136/bmj.b2700, 10.1016/j.ijsu.2010.07.299, 10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]
   Nowotny KM, 2016, J AGING HEALTH, V28, P935, DOI 10.1177/0898264315614007
   Phillips LL, 2009, CRIM JUSTICE BEHAV, V36, P620, DOI 10.1177/0093854809334442
   Rich JD, 2011, NEW ENGL J MED, V364, P2081, DOI 10.1056/NEJMp1102385
   ROSNER R, 1991, J FORENSIC SCI, V36, P1722
   SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420
   Torrey E.F., 2010, More Mentally Ill Persons are in Jails and Prisons that Hospitals: A Survey of the States
   Visher C. A., 2007, Public health behind bars, P434
   Visher CA, 2003, ANNU REV SOCIOL, V29, P89, DOI 10.1146/annurev.soc.29.010202.095931
   Wagner P., 2016, Mass incarceration: The whole pie 2016
   Williams BA, 2006, J AM GERIATR SOC, V54, P702, DOI 10.1111/j.1532-5415.2006.00662.x
   Williams BA, 2012, AM J PUBLIC HEALTH, V102, P1475, DOI 10.2105/AJPH.2012.300704
   Williams BA, 2010, AM J PUBLIC HEALTH, V100, P756, DOI 10.2105/AJPH.2008.154591
   Williams BA, 2009, J AM GERIATR SOC, V57, P1286, DOI 10.1111/j.1532-5415.2009.02286.x
   Wilper AP, 2009, AM J PUBLIC HEALTH, V99, P666, DOI 10.2105/AJPH.2008.144279
NR 79
TC 87
Z9 95
U1 3
U2 20
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0193-936X
EI 1478-6729
J9 EPIDEMIOL REV
JI Epidemiol. Rev.
PY 2018
VL 40
IS 1
BP 157
EP 165
DI 10.1093/epirev/mxx020
PG 9
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA GI1UI
UT WOS:000434155700014
PM 29584869
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Choi, J
   Min, K
   Jeon, S
   Kim, N
   Pack, JK
   Song, K
AF Choi, Jisu
   Min, Kyeongrae
   Jeon, Sangbong
   Kim, Nam
   Pack, Jeong-Ki
   Song, Kiwon
TI Continuous Exposure to 1.7GHz LTE Electromagnetic Fields Increases
   Intracellular Reactive Oxygen Species to Decrease Human Cell
   Proliferation and Induce Senescence
SO SCIENTIFIC REPORTS
LA English
DT Article
ID CANCER STEM-CELLS; RF-EMF EXPOSURE; RADIOFREQUENCY RADIATION;
   DNA-DAMAGE; PHONE USE; MECHANISMS; TUMOR
AB Due to the rapid development of mobile phone technology, we are continuously exposed to 1.7GHz LTE radio frequency electromagnetic fields (RF-EMFs), but their biological effects have not been clarified. Here, we investigated the non-thermal cellular effects of these RF-EMFs on human cells, including human adipose tissue-derived stem cells (ASCs), Huh7 and Hep3B liver cancer stem cells (CSCs), HeLa and SH-SY5Y cancer cells, and normal fibroblast IMR-90 cells. When continuously exposed to 1.7GHz LTE RF-EMF for 72h at 1 and 2 SAR, cell proliferation was consistently decreased in all the human cells. The anti-proliferative effect was higher at 2 SAR than 1 SAR and was less severe in ASCs. The exposure to RF-EMF for 72h at 1 and 2 SAR did not induce DNA double strand breaks or apoptotic cell death, but did trigger a slight delay in the G1 to S cell cycle transition. Cell senescence was also clearly observed in ASC and Huh7 cells exposed to RF-EMF at 2 SAR for 72h. Intracellular ROS increased in these cells and the treatment with an ROS scavenger recapitulated the anti-proliferative effect of RF-EMF. These observations strongly suggest that 1.7GHz LTE RF-EMF decrease proliferation and increase senescence by increasing intracellular ROS in human cells.
C1 [Choi, Jisu; Min, Kyeongrae; Song, Kiwon] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 03722, South Korea.
   [Jeon, Sangbong] Elect & Telecommun Res Inst ETRI, Broadcasting Media Res Lab, Radio & Satellite Res Div, Daejon 34129, South Korea.
   [Kim, Nam] Chungbuk Natl Univ, Sch Informat & Commun Engn, Cheongju 28644, Chungbuk, South Korea.
   [Pack, Jeong-Ki] Chungnam Natl Univ, Dept Radio & Informat Commun Engn, Daejon 34134, South Korea.
C3 Yonsei University; Electronics & Telecommunications Research Institute -
   Korea (ETRI); Chungbuk National University; Chungnam National University
RP Song, K (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 03722, South Korea.
EM bc5012@yonsei.ac.kr
OI JEON, Sangbong/0000-0001-8059-9700
FU Bio & Medical Technology Development Program of the National Research
   Foundation (NRF) - Korean government (MSIT) [NRF-2016M3A9C6918275];
   Korea Mobile EMF consortium; Brain Korea (BK) 21 PLUS
FX The authors appreciate Anna Song in the lab for editing English of this
   manuscript. This work was supported by the Bio & Medical Technology
   Development Program of the National Research Foundation (NRF) funded by
   the Korean government (MSIT) [No. NRF-2016M3A9C6918275], and by Korea
   Mobile EMF consortium. J. Choi was partially supported by Brain Korea
   (BK) 21 PLUS of 2018-2019.
CR Ammari M, 2008, TOXICOLOGY, V250, P70, DOI 10.1016/j.tox.2008.05.019
   Baan R, 2011, LANCET ONCOL, V12, P624, DOI 10.1016/S1470-2045(11)70147-4
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Challis LJ, 2005, BIOELECTROMAGNETICS, pS98, DOI 10.1002/bem.20119
   Chen CH, 2014, SCI REP-UK, V4, DOI 10.1038/srep05103
   Chen JJ, 2019, ONCOL REP, V42, P1101, DOI 10.3892/or.2019.7229
   Chen XL, 2011, J HEPATOL, V55, P838, DOI 10.1016/j.jhep.2010.12.043
   Falcioni L, 2018, ENVIRON RES, V165, P496, DOI 10.1016/j.envres.2018.01.037
   Gläser K, 2016, RADIAT RES, V186, P455, DOI 10.1667/RR14405.1
   Hansen JW, 2020, IEEE REV BIOMED ENG, V13, P340, DOI 10.1109/RBME.2019.2912023
   Hardell L, 2008, INT J ONCOL, V32, P1097
   Houston BJ, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00270
   IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2013, IARC Monogr Eval Carcinog Risks Hum, V102, P1
   ICNIRP, 2020, HEALTH PHYS, V118, P525, DOI 10.1097/HP.0000000000001137
   Kan P, 2008, J NEURO-ONCOL, V86, P71, DOI 10.1007/s11060-007-9432-1
   Kazemi E, 2015, J Biomed Phys Eng, V5, P105
   Kehrer JP, 2000, TOXICOLOGY, V149, P43, DOI 10.1016/S0300-483X(00)00231-6
   Lee KY, 2011, BIOELECTROMAGNETICS, V32, P169, DOI 10.1002/bem.20618
   Lee SS, 2014, J CRANIOFAC SURG, V25, P1902, DOI 10.1097/SCS.0000000000000939
   Ma YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091947
   Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076
   Moros EG, 1999, BIOELECTROMAGNETICS, V20, P65, DOI 10.1002/(SICI)1521-186X(1999)20:2<65::AID-BEM1>3.0.CO;2-W
   Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184
   Ni S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072370
   (NTP) N. T. P., 2018, 595 NTP TR, V595, P1
   Park J, 2016, SCI REP-UK, V6, DOI 10.1038/srep39298
   Pickard WF, 2000, IEEE T BIO-MED ENG, V47, P202, DOI 10.1109/10.821756
   Rao VS, 2008, RADIAT RES, V169, P319, DOI 10.1667/RR1118.1
   Schatton T, 2009, BIOESSAYS, V31, P1038, DOI 10.1002/bies.200900058
   Sefidbakht Y, 2014, PHOTOCH PHOTOBIO SCI, V13, P1082, DOI 10.1039/c3pp50451d
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Shahbazi-Gahrouei D, 2016, J Biomed Phys Eng, V6, P243
   Soffritti M, 2019, BASIC CLIN PHARMACOL, V125, P58, DOI 10.1111/bcpt.13215
   Su LL, 2018, INT J RADIAT BIOL, V94, P295, DOI 10.1080/09553002.2018.1432913
   Su LL, 2017, BIOELECTROMAGNETICS, V38, P175, DOI 10.1002/bem.22032
   Valle-Prieto A, 2010, STEM CELLS DEV, V19, P1885, DOI 10.1089/scd.2010.0093
   Vijayalaxmi, 2012, MUTAT RES-GEN TOX EN, V749, P1, DOI 10.1016/j.mrgentox.2012.09.007
   Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007
   Xu SC, 2010, BRAIN RES, V1311, P189, DOI 10.1016/j.brainres.2009.10.062
   Xu SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054906
   Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004
   Zhao R, 2007, TOXICOLOGY, V235, P167, DOI 10.1016/j.tox.2007.03.015
NR 42
TC 23
Z9 24
U1 1
U2 8
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUN 8
PY 2020
VL 10
IS 1
AR 9238
DI 10.1038/s41598-020-65732-4
PG 15
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA NB4BZ
UT WOS:000560461000016
PM 32514068
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Menthena, A
   Koehler, CI
   Sandhu, JS
   Yovchev, MI
   Hurston, E
   Shafritz, DA
   Oertel, M
AF Menthena, Anuradha
   Koehler, Christoph I.
   Sandhu, Jaswinderpal S.
   Yovchev, Mladen I.
   Hurston, Ethel
   Shafritz, David A.
   Oertel, Michael
TI Activin A, p15INK4b Signaling, and Cell Competition Promote
   Stem/Progenitor Cell Repopulation of Livers in Aging Rats
SO GASTROENTEROLOGY
LA English
DT Article
DE p16INK4a; p19ARF; p21/CIP1; Stem Cell Therapy
ID CDK INHIBITORS; GROWTH ARREST; FETAL LIVER; TGF-BETA; DNA-SYNTHESIS;
   CYCLE ARREST; C/EBP-ALPHA; STEM-CELLS; IN-VIVO; HEPATOCYTES
AB BACKGROUND & AIMS: Highly proliferative fetal liver stem/progenitor cells (FLSPCs) repopulate livers of normal recipients by cell competition. We investigated the mechanisms by which FLSPCs repopulate livers of older compared with younger rats. METHODS: Fetal liver cells were transplanted from DPPIV+ F344 rats into DPPIV- rats of different ages (2, 6, 14, or 18 months); liver tissues were analyzed 6 months later. Cultured cells and liver tissues were analyzed by reverse transcription polymerase chain reaction, immunoblot, histochemistry, laser-capture microscopy, and terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling analyses. RESULTS: We observed 4- to 5-fold increases in liver repopulation when FLSPCs were transplanted into older compared with younger rats. Messenger RNA levels of cyclin-dependent kinase inhibitors increased progressively in livers of older rats; hepatocytes from 20-month-old rats had 6.1-fold higher expression of p15INK4b and were less proliferative in vitro than hepatocytes from 2-month-old rats. Expression of p15INK4b in cultured hepatocytes was up-regulated by activin A, which increased in liver during aging. Activin A inhibited proliferation of adult hepatocytes, whereas FLSPCs were unresponsive because they had reduced expression of activin receptors (eg, ALK-4). In vivo, expanding cell clusters derived from transplanted FLSPCs had lower levels of ALK-4 and p15INK4b and increased levels of Ki-67 compared with the host parenchyma. Liver tissue of older rats had 3-fold more apoptotic cells than that of younger rats. CONCLUSIONS: FLSPCs, resistant to activin A signaling, repopulate livers of older rats; hepatocytes in older rats have less proliferation because of increased activin A and p15INK4b levels and increased apoptosis than younger rats. These factors and cell types might be manipulated to improve liver cell transplantation strategies in patients with liver diseases in which activin A levels are increased.
C1 [Menthena, Anuradha; Koehler, Christoph I.; Sandhu, Jaswinderpal S.; Yovchev, Mladen I.; Hurston, Ethel; Shafritz, David A.; Oertel, Michael] Yeshiva Univ, Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Div Gastroenterol & Liver Dis,Dept Med, Bronx, NY 10461 USA.
C3 Yeshiva University; Albert Einstein College of Medicine
RP Oertel, M (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Div Gastroenterol & Liver Dis,Dept Med, 1300 Morris Pk Ave,Ullmann 603B, Bronx, NY 10461 USA.
EM michael.oertel@einstein.yu.edu
FU National Institutes of Health [R01 DK17609, P30 DK41296]; American
   Federation for Aging Research (AFAR)
FX Research reported from the author's laboratories was supported in part
   by National Institutes of Health grants R01 DK17609 and P30 DK41296 to
   D.A.S. and AFAR Research Grant from the American Federation for Aging
   Research (AFAR) to M.O.
CR Aikata H, 2000, EXP CELL RES, V256, P578, DOI 10.1006/excr.2000.4862
   Awad MM, 2000, FEBS LETT, V483, P160, DOI 10.1016/S0014-5793(00)02108-6
   Awad MM, 2000, CELL GROWTH DIFFER, V11, P325
   BUCHER NLR, 1964, CANCER RES, V24, P509
   Bucher NRL, 1971, REGENERATION LIVER K, P17
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Cánepa ET, 2007, IUBMB LIFE, V59, P419, DOI 10.1080/15216540701488358
   Chen YG, 2006, EXP BIOL MED, V231, P534
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884
   de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4
   Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969
   Funakoshi F, 2004, INT J MOL MED, V13, P779
   HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Herbig U, 2006, MECH AGEING DEV, V127, P16, DOI 10.1016/j.mad.2005.09.002
   Ho J, 2004, CELL SIGNAL, V16, P693, DOI 10.1016/j.cellsig.2003.11.002
   Hughes RD, 2003, EUR J GASTROEN HEPAT, V15, P127, DOI 10.1097/00042737-200302000-00004
   HULLY JR, 1994, HEPATOLOGY, V20, P854, DOI 10.1002/hep.1840200413
   Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0
   Johnston LA, 2009, SCIENCE, V324, P1679, DOI 10.1126/science.1163862
   Kawashita Y, 2005, SURG TODAY, V35, P705, DOI 10.1007/s00595-005-3024-5
   Koyama M, 2007, MOL CANCER THER, V6, P1579, DOI 10.1158/1535-7163.MCT-06-0814
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1
   Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172
   Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4
   Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338
   Niimi S, 2002, BIOL PHARM BULL, V25, P437, DOI 10.1248/bpb.25.437
   Oertel M, 2006, GASTROENTEROLOGY, V130, P507, DOI 10.1053/j.gastro.2005.10.049
   Oertel M, 2008, GASTROENTEROLOGY, V134, P823, DOI 10.1053/j.gastro.2008.01.007
   Oertel M, 2008, BBA-MOL BASIS DIS, V1782, P61, DOI 10.1016/j.bbadis.2007.12.004
   Ozturk M, 2009, CANCER LETT, V286, P103, DOI 10.1016/j.canlet.2008.10.048
   Pajalunga D, 2007, J CELL BIOL, V176, P807, DOI 10.1083/jcb.200608109
   Pasciu D, 2006, AGING CELL, V5, P373, DOI 10.1111/j.1474-9726.2006.00230.x
   Patella S, 2001, J HEPATOL, V34, P576, DOI 10.1016/S0168-8278(00)00029-5
   Perera MTPR, 2009, J GASTROEN HEPATOL, V24, pS124, DOI 10.1111/j.1440-1746.2009.06081.x
   Premoli A, 2009, Minerva Gastroenterol Dietol, V55, P71
   REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831
   Sandhu JS, 2001, AM J PATHOL, V159, P1323, DOI 10.1016/S0002-9440(10)62519-9
   Schmelzer E, 2006, STEM CELLS, V24, P1852, DOI 10.1634/stemcells.2006-0036
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   SCHWALL RH, 1993, HEPATOLOGY, V18, P347, DOI 10.1016/0270-9139(93)90018-I
   Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501
   Stocker E, 1971, Beitr Pathol, V144, P400
   Sugiyama M, 1998, GASTROENTEROLOGY, V114, P550, DOI 10.1016/S0016-5085(98)70539-6
   Timchenko NA, 1998, NUCLEIC ACIDS RES, V26, P3293, DOI 10.1093/nar/26.13.3293
   Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005
   Tosh D, 2005, J HEPATOL, V42, pS75, DOI 10.1016/j.jhep.2004.12.009
   Wang XH, 2001, P NATL ACAD SCI USA, V98, P11468, DOI 10.1073/pnas.201360898
   YASUDA H, 1993, J CLIN INVEST, V92, P1491, DOI 10.1172/JCI116727
   Yndestad A, 2009, AM J GASTROENTEROL, V104, P2196, DOI 10.1038/ajg.2009.318
   Yuen MF, 2002, SCAND J GASTROENTERO, V37, P233, DOI 10.1080/003655202753416939
   Zauberman A, 1997, ONCOGENE, V15, P1705, DOI 10.1038/sj.onc.1201348
   Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178
NR 56
TC 51
Z9 58
U1 1
U2 10
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0016-5085
EI 1528-0012
J9 GASTROENTEROLOGY
JI Gastroenterology
PD MAR
PY 2011
VL 140
IS 3
BP 1009
EP U450
DI 10.1053/j.gastro.2010.12.003
PG 20
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 730EC
UT WOS:000288014700041
PM 21147108
OA Green Accepted, Bronze
DA 2024-02-19
ER

PT J
AU Chen, Q
   Jin, MX
   Wang, SM
   Wang, KX
   Chen, LQ
   Zhu, XJ
   Zhang, Y
   Wang, Y
   Li, Y
   Li, S
   Zeng, YM
   Feng, L
   Yang, WR
   Gao, Y
   Zhou, SQ
   Peng, Q
AF Chen, Qi
   Jin, Meixian
   Wang, Simin
   Wang, Kexin
   Chen, Liqin
   Zhu, Xiaojuan
   Zhang, Ying
   Wang, Yi
   Li, Yang
   Li, Shao
   Zeng, Youmin
   Feng, Lei
   Yang, Wanren
   Gao, Yi
   Zhou, Shuqin
   Peng, Qing
TI Establishing an hTERT-driven immortalized umbilical cord-derived
   mesenchymal stem cell line and its therapeutic application in mice with
   liver failure
SO JOURNAL OF TISSUE ENGINEERING
LA English
DT Article
DE Umbilical cord mesenchymal stem cell; telomerase; TERT; immortalization;
   acute liver failure; treatment
ID TRANSPLANTATION; SENESCENCE; EXOSOMES; EFFICACY; TELOMERE; DISEASE;
   INJURY; MODEL
AB Acute liver failure (ALF) is characterized by rapid liver cell destruction. It is a multi-etiological and fulminant complication with a clinical mortality of over 80%. Therapy using mesenchymal stem cells (MSCs) or MSCs-derived exosomes can alleviate acute liver injury, which has been demonstrated in animal experiments and clinical application. However, similar to other stem cells, different cell sources, poor stability, cell senescence and other factors limit the clinical application of MSCs. To achieve mass production and quality control on stem cells and their exosomes, transfecting umbilical cord mesenchymal stem cell (UCMSC) with lentivirus overexpressing human telomerase reverse transcriptase (hTERT) gene, the hTERT-UCMSC was constructed as an immortalized MSC cell line. Compared with the primary UCMSC (P3) and immortalized cell line hTERT-UCMSC at early passage (P10), the hTERT-UCMSC retained the key morphological and physiological characteristics of UCMSC at the 35th passage (P35), and showed no signs of carcinogenicity and toxic effect in mice. There was no difference in either exosome production or characteristics of exosomes among cultures from P3 primary cells, P10 and P35 immortalized hTERT-UCMSCs. Inoculation of either hTERT-UCMSC (P35) or its exosomes improved the survival rate and liver function of ALF mice induced by thioacetamide (TAA). Our findings suggest that this immortalized cell line can maintain its characteristics in long-term culture. Inoculation of hTERT-UCMSC and its exosomes could potentially be used in clinics for the treatment of liver failure in the future.
C1 [Chen, Qi; Jin, Meixian; Wang, Simin; Chen, Liqin; Zeng, Youmin; Zhou, Shuqin] Southern Med Univ, Zhujiang Hosp, Dept Anesthesiol, Guangzhou, Guangdong, Peoples R China.
   [Chen, Qi] Jinan Univ, Dept Anesthesiol, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.
   [Wang, Kexin; Zhang, Ying; Wang, Yi; Li, Yang; Li, Shao; Feng, Lei; Yang, Wanren; Gao, Yi; Peng, Qing] Southern Med Univ, Zhujiang Hosp, Inst Regenerat Med, Gen Surg Ctr,Dept Hepatobiliary Surg 2,Guangzhou C, Guangzhou, Guangdong, Peoples R China.
   [Zhu, Xiaojuan] First Peoples Hosp Kashi, Dept Anesthesiol, Kashgar, Xinjiang, Peoples R China.
   [Zhou, Shuqin] Southern Med Univ, Zhujiang Hosp, Dept Anesthesiol, 253 Ind Ave Ctr, Guangzhou 510515, Guangdong, Peoples R China.
   [Peng, Qing] Southern Med Univ, Zhujiang Hosp, Inst Regenerat Med, Gen Surg Ctr,Dept Hepatobiliary Surg 2,Guangzhou C, Guangzhou 510515, Guangdong, Peoples R China.
C3 Southern Medical University - China; Jinan University; Southern Medical
   University - China; Southern Medical University - China; Southern
   Medical University - China
RP Zhou, SQ (corresponding author), Southern Med Univ, Zhujiang Hosp, Dept Anesthesiol, 253 Ind Ave Ctr, Guangzhou 510515, Guangdong, Peoples R China.; Peng, Q (corresponding author), Southern Med Univ, Zhujiang Hosp, Inst Regenerat Med, Gen Surg Ctr,Dept Hepatobiliary Surg 2,Guangzhou C, Guangzhou 510515, Guangdong, Peoples R China.
EM zhoushuqin@smu.edu.cn; zhujiangzhuanhua@163.com
OI Feng, Lei/0000-0001-6053-8417
FU National Key Ramp;D Program of China [2022YFA1104900, 2018YFA0108200];
   Natural Science Foundation of Xinjiang Uygur Autonomous Region
   [2021D01C011]; National Natural Science Foundation of China [82072627,
   81760664]; Guangdong Basic and Applied Basic Research Foundation
   [2023A1515012452, 2021B1515230011]; President Foundation of Zhujiang
   Hospital, Southern Medical University [yzjj2022ms13]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: The
   authors are grateful for the financial support by the National Key R & D
   Program of China (2022YFA1104900, 2018YFA0108200), the Natural Science
   Foundation of Xinjiang Uygur Autonomous Region (2021D01C011), the
   National Natural Science Foundation of China (82072627, 81760664), the
   Guangdong Basic and Applied Basic Research Foundation (2023A1515012452,
   2021B1515230011), and the President Foundation of Zhujiang Hospital,
   Southern Medical University (yzjj2022ms13).
CR Akiyama K, 2012, CELL STEM CELL, V10, P544, DOI 10.1016/j.stem.2012.03.007
   Bernal W, 2015, J HEPATOL, V62, pS112, DOI 10.1016/j.jhep.2014.12.016
   Cai YJ, 2015, INT J CLIN EXP PATHO, V8, P107
   Campisi J, 1997, EUR J CANCER, V33, P703, DOI 10.1016/S0959-8049(96)00058-5
   Chen GF, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0040-2
   Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657
   Cristofalo VJ, 2004, MECH AGEING DEV, V125, P827, DOI 10.1016/j.mad.2004.07.010
   Doyle LM, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070727
   Estrada JC, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.211
   Fang XQ, 2018, J GASTROEN HEPATOL, V33, P774, DOI 10.1111/jgh.14081
   Gilsanz C, 2017, BIOMED PHARMACOTHER, V91, P776, DOI 10.1016/j.biopha.2017.04.117
   Gu YZ, 2013, HUM IMMUNOL, V74, P267, DOI 10.1016/j.humimm.2012.12.011
   Guo G, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1184-2
   He J, 2017, CELL PHYSIOL BIOCHEM, V43, P891, DOI 10.1159/000481639
   Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4
   Hu CX, 2020, INT J BIOL SCI, V16, P893, DOI 10.7150/ijbs.39725
   Huang B, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0792-1
   Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977
   Kelland LR, 2005, EUR J CANCER, V41, P971, DOI 10.1016/j.ejca.2004.11.024
   Kolodziejczyk AA, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1102-2
   Kostallari E, 2021, ADV DRUG DELIVER REV, V175, DOI 10.1016/j.addr.2021.05.026
   Levine BL, 2006, P NATL ACAD SCI USA, V103, P17372, DOI 10.1073/pnas.0608138103
   Lin H, 2011, CELL MOL IMMUNOL, V8, P19, DOI 10.1038/cmi.2010.57
   Liu QW, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1063-2
   Markov A, 2021, STEM CELL RES THER, V12, DOI 10.1186/s13287-021-02265-1
   Milosavljevic N, 2017, LIVER TRANSPLANT, V23, P1040, DOI 10.1002/lt.24784
   Roefs MT, 2020, TRENDS CELL BIOL, V30, P990, DOI 10.1016/j.tcb.2020.09.009
   Shao MY, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-1550-0
   Shi LL, 2011, AM J MED SCI, V342, P212, DOI 10.1097/MAJ.0b013e3182112b90
   Shokravi S, 2022, STEM CELL RES THER, V13, DOI 10.1186/s13287-022-02825-z
   Shu SL, 2020, J EXTRACELL VESICLES, V9, DOI 10.1080/20013078.2019.1692401
   Stravitz RT, 2019, LANCET, V394, P869, DOI 10.1016/S0140-6736(19)31894-X
   Tautenhahn HM, 2016, ANN SURG, V263, P546, DOI 10.1097/SLA.0000000000001155
   Trachana V, 2017, CYTOTHERAPY, V19, P808, DOI 10.1016/j.jcyt.2017.03.078
   Tsai CC, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-64
   Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343
   Wang C, 2023, BIOMED PHARMACOTHER, V157, DOI 10.1016/j.biopha.2022.114040
   Wang HY, 2022, J EXTRACELL VESICLES, V11, DOI 10.1002/jev2.12222
   Wang YM, 2021, ACTA BIOMATER, V136, P184, DOI 10.1016/j.actbio.2021.09.021
   Wang YH, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0972-4
   Wu LL, 2022, J NANOBIOTECHNOL, V20, DOI 10.1186/s12951-022-01407-8
   Xiao JQ, 2013, ARCH MED RES, V44, P370, DOI 10.1016/j.arcmed.2013.06.004
   Yeo RWY, 2013, ADV DRUG DELIVER REV, V65, P336, DOI 10.1016/j.addr.2012.07.001
   Yi YW, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020665
   Zhang HL, 2016, THERIOGENOLOGY, V85, P1446, DOI 10.1016/j.theriogenology.2016.01.006
   Zhang Y., 2016, Biomed Res Int, V2016, P1
   Zhang Y, 2014, HEPATOLOGY, V59, P671, DOI 10.1002/hep.26670
   Zhang YT, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/7159465
   Zhang YX, 2022, STEM CELLS INT, V2022, DOI 10.1155/2022/6430565
   Zheng S, 2015, INT J CLIN EXP PATHO, V8, P15854
   Zhou W, 2019, CELL TRANSPLANT, V28, P1116, DOI 10.1177/0963689719859262
   Zhu MM, 2021, STEM CELLS INT, V2021, DOI 10.1155/2021/6546780
   Zhu XS, 2013, CELL TISSUE RES, V351, P477, DOI 10.1007/s00441-012-1524-3
NR 53
TC 0
Z9 0
U1 9
U2 9
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 2041-7314
J9 J TISSUE ENG
JI J. Tissue Eng.
PY 2023
VL 14
AR 20417314231200328
DI 10.1177/20417314231200328
PG 22
WC Cell & Tissue Engineering
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA S0AU7
UT WOS:001067893300001
PM 37736245
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Zhang, D
   Tang, J
   Xu, YH
   Huang, XJ
   Wang, YL
   Jin, X
   Wu, G
   Liu, PA
AF Zhang, Dan
   Tang, Jing
   Xu, Yunhong
   Huang, Xiaoju
   Wang, Yilin
   Jin, Xin
   Wu, Gang
   Liu, Pian
TI Global crotonylome reveals hypoxia-mediated lamin A crotonylation
   regulated by HDAC6 in liver cancer
SO CELL DEATH & DISEASE
LA English
DT Article
ID HISTONE CROTONYLATION
AB Lysine crotonylation is a recently discovered post-translation modification involved in transcription regulation, cell signal transduction, and other processes. Scientists have identified several crotonylases and decrotonylases of histones, including P300/CBP, HDACs, and SIRTs. However, the regulation of non-histone protein crotonylation remains unclear. In the current study, we verified that crotonylation was upregulated in hypoxia and promoted liver cancer cell growth. We performed TMT-labeled quantitative lysine crotonylome analysis in 12 pairs of hepatocellular carcinoma and adjacent liver tissue and identified 3,793 lysine crotonylation sites in 1,428 proteins. We showed that crotonylation of lamin A at the site of K265/270 maintains its subcellular position, promotes liver cancer cell proliferation, and prevents cellular senescence. Our data indicate that HDAC6 is the decrotonylase of lamin A and downregulated in response to hypoxia, resulting in lamin A K265/270cr. Taken together, our study reveals the lamin A crotonylation in liver cancer progression and fills the research gap in non-histone protein crotonylation function.
C1 [Zhang, Dan; Tang, Jing; Xu, Yunhong; Huang, Xiaoju; Wu, Gang; Liu, Pian] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Canc Ctr, Wuhan 430022, Peoples R China.
   [Zhang, Dan; Tang, Jing; Xu, Yunhong; Huang, Xiaoju; Wang, Yilin; Wu, Gang; Liu, Pian] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Radiat Oncol, Wuhan 430022, Peoples R China.
   [Jin, Xin] Cent South Univ, Xiangya Hosp 2, Dept Urol, Changsha 410011, Hunan, Peoples R China.
   [Jin, Xin] Cent South Univ, Urooncol Inst, Changsha 410011, Hunan, Peoples R China.
C3 Huazhong University of Science & Technology; Huazhong University of
   Science & Technology; Central South University; Central South University
RP Wu, G; Liu, PA (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Canc Ctr, Wuhan 430022, Peoples R China.; Wu, G; Liu, PA (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Radiat Oncol, Wuhan 430022, Peoples R China.; Jin, X (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Urol, Changsha 410011, Hunan, Peoples R China.; Jin, X (corresponding author), Cent South Univ, Urooncol Inst, Changsha 410011, Hunan, Peoples R China.
EM jinxinxy2@csu.edu.cn; xhzlwg@163.com; liupianamazing@126.com
OI Jin, Xin/0000-0001-6461-6005
FU National Natural Science Foundation of China [82072945, 81772800,
   82073321]; Beijing CSCO Clinical Oncology Research Foundation
   [Y-HS202102-0152]; Hubei Provincial Key Laboratory of Biological
   Targeted Therapy Open Foundation [F016.02004.21003.082]; National Key
   Research and Development Plan of China [2020YFC2006000]
FX This work was supported by grants from the National Natural Science
   Foundation of China (Grant No. 82072945, 81772800 (PL) and 82073321
   (XJ)), Beijing CSCO Clinical Oncology Research Foundation (Grant No.
   Y-HS202102-0152 (GW)), Hubei Provincial Key Laboratory of Biological
   Targeted Therapy Open Fundation (Grant No.F016.02004.21003.082(DZ)) and
   National Key Research and Development Plan of China (Grant numbers.
   2020YFC2006000).
CR Ao Y, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav5078
   Bao XC, 2019, MOL CELL, V76, P660, DOI 10.1016/j.molcel.2019.08.018
   Bertrand AT, 2012, HUM MOL GENET, V21, P1037, DOI 10.1093/hmg/ddr534
   Capo-chichi CD, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-28
   Caron M, 2007, CELL DEATH DIFFER, V14, P1759, DOI 10.1038/sj.cdd.4402197
   Cenni V, 2020, AGEING RES REV, V62, DOI 10.1016/j.arr.2020.101073
   Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200
   Choi SJ, 2016, EMBO J, V35, P429, DOI 10.15252/embj.201592586
   Fang Y, 2021, CELL STEM CELL, V28, P748, DOI 10.1016/j.stem.2020.12.009
   Fellows R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02651-5
   Gowans GJ, 2019, MOL CELL, V76, P909, DOI 10.1016/j.molcel.2019.09.029
   Jiang GY, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03987-z
   Jiang GC, 2018, J CLIN INVEST, V128, P1190, DOI 10.1172/JCI98071
   Lazar I, 2020, MOL CANCER RES, V18, P1560, DOI 10.1158/1541-7786.MCR-20-0291
   Liu H, 2020, J CELL MOL MED, V24, P12008, DOI 10.1111/jcmm.15829
   Liu YQ, 2019, BIOL PSYCHIAT, V85, P635, DOI 10.1016/j.biopsych.2018.11.025
   Lv Y, 2021, GENOM PROTEOM BIOINF, V19, P80, DOI 10.1016/j.gpb.2021.01.004
   Mattioli E, 2018, AGING CELL, V17, DOI 10.1111/acel.12824
   Maynard S, 2019, NUCLEIC ACIDS RES, V47, P11709, DOI 10.1093/nar/gkz912
   Narita T, 2019, NAT REV MOL CELL BIO, V20, P156, DOI 10.1038/s41580-018-0081-3
   Sabari BR, 2015, MOL CELL, V58, P203, DOI 10.1016/j.molcel.2015.02.029
   Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047
   Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008
   Tang XQ, 2021, CIRCULATION, V143, P1066, DOI 10.1161/CIRCULATIONAHA.120.049438
   Wan JH, 2019, BIOMED PHARMACOTHER, V111, P976, DOI 10.1016/j.biopha.2018.12.148
   Wei W, 2017, CELL RES, V27, P898, DOI 10.1038/cr.2017.68
   Xie ZY, 2016, MOL CELL, V62, P194, DOI 10.1016/j.molcel.2016.03.036
   Xu WZ, 2017, CELL RES, V27, P946, DOI 10.1038/cr.2017.60
   Yu HJ, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay4697
   Zhang YA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05808-y
   Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI 10.1038/NCHEMBIO.495
NR 31
TC 8
Z9 9
U1 5
U2 19
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD AUG 17
PY 2022
VL 13
IS 8
AR 717
DI 10.1038/s41419-022-05165-1
PG 11
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 3V7DK
UT WOS:000841820300003
PM 35977926
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Soltanmohammadi, E
   Farmaki, E
   Zhang, Y
   Naderi, A
   Kaza, V
   Chatzistamou, I
   Kiaris, H
AF Soltanmohammadi, E.
   Farmaki, E.
   Zhang, Y.
   Naderi, A.
   Kaza, V.
   Chatzistamou, I.
   Kiaris, H.
TI Coordination in the unfolded protein response during aging in outbred
   deer mice
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE ER stress; Aging; Peromyscus
ID ENDOPLASMIC-RETICULUM STRESS; QUALITY-CONTROL; CHAPERONES; PEROMYSCUS
AB Endoplasmic reticulum (ER) stress has been linked to various metabolic pathologies, neurodegeneration and aging. Although various mechanistic aspects of the resulting unfolded protein response (UPR) have been elucidated, its regulation in genetically diverse populations remains elusive. In the present study we evaluated the expression of chaperones BiP/GRP78, GRP94 and calnexin (CANX) in the lungs, liver and brain of 7 months old and 2-3 years old outbred deer mice P. maniculatus and P. leucopus. Chaperones' expression was highly variable between species, tissues and ages suggesting that levels of expression of individual chaperones do not change consistently during aging. Despite this variation, a high degree of coordination was maintained between chaperones' expression indicating the tight regulation of the UPR which is consistent with its adaptive activity to maintain homeostasis. In the brain though of older P. maniculatus, at which neurodegenerative changes were detected, loss of coordination was revealed, especially between BiP and either of GRP94 or calnexin which indicates that de-coordination rather than aberrant expression is linked to deregulation of the UPR in aging. These findings underscore the involvement of UPR in the onset of aging-related pathologies and suggest that beyond levels of expression, concerted activation may be of significance to attain homeostasis. These findings emphasize the value of genetically diverse models and suggest that beyond levels of expression of individual targets the coordination of transcriptional networks should be considered when links to pathology are explored.
C1 [Soltanmohammadi, E.; Farmaki, E.; Zhang, Y.; Naderi, A.; Kiaris, H.] Univ South Carolina, Coll Pharm, Dept Drug Discovery & Biomed Sci, Columbia, SC 29208 USA.
   [Kaza, V.; Kiaris, H.] Univ South Carolina, Peromyscus Genet Stock Ctr, Columbia, SC 29208 USA.
   [Chatzistamou, I.] Univ South Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.
C3 University of South Carolina System; University of South Carolina
   Columbia; University of South Carolina System; University of South
   Carolina Columbia; University of South Carolina System; University of
   South Carolina Columbia
RP Kiaris, H (corresponding author), Univ South Carolina, Coll Pharm, Dept Drug Discovery & Biomed Sci, Columbia, SC 29208 USA.
EM kiarish@cop.sc.edu
RI Zhang, Youwen/AHC-2007-2022; Zhang, Youwen/AHC-2035-2022
OI Zhang, Youwen/0000-0002-0957-4276; Naderi, Asieh/0000-0001-9911-5841
FU NSF [1755670]; Direct For Biological Sciences; Div Of Biological
   Infrastructure [1755670] Funding Source: National Science Foundation
FX This study was supported by NSF (Award Number: 1736150). The PGSC is
   supported by a grant from NSF (Award Number: 1755670).
CR Ain Q, 2018, AGING-US, V10, P3397, DOI 10.18632/aging.101655
   Almanza A., 2018, FEBS J, DOI [10.1111/febs.1460, DOI 10.1111/FEBS.1460]
   Chen BH, 2016, AGING-US, V8, P1844, DOI 10.18632/aging.101020
   Doyle KM, 2011, J CELL MOL MED, V15, P2025, DOI 10.1111/j.1582-4934.2011.01374.x
   Eletto D, 2010, SEMIN CELL DEV BIOL, V21, P479, DOI 10.1016/j.semcdb.2010.03.004
   Görlach A, 2006, ANTIOXID REDOX SIGN, V8, P1391, DOI 10.1089/ars.2006.8.1391
   Gorbunova V, 2007, NUCLEIC ACIDS RES, V35, P7466, DOI 10.1093/nar/gkm756
   Havighorst A, 2019, DIS MODEL MECH, V12, DOI 10.1242/dmm.037242
   Havighorst A, 2017, SEMIN CELL DEV BIOL, V61, P150, DOI 10.1016/j.semcdb.2016.06.020
   Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976
   Higuchi-Sanabria R, 2018, DEV CELL, V44, P139, DOI 10.1016/j.devcel.2017.12.020
   Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117
   Lempradl A, 2015, NAT REV GENET, V16, P665, DOI 10.1038/nrg3941
   Levine ME, 2018, AGING-US, V10, P573, DOI 10.18632/aging.101414
   Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824
   Naidoo N, 2008, J NEUROSCI, V28, P6539, DOI 10.1523/JNEUROSCI.5685-07.2008
   Nuss JE, 2008, BIOCHEM BIOPH RES CO, V365, P355, DOI 10.1016/j.bbrc.2007.10.194
   Schröder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5
   Shi WJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep42648
   Soti C, 2007, EXP GERONTOL, V42, P113, DOI 10.1016/j.exger.2006.05.017
   Tannous A, 2015, SEMIN CELL DEV BIOL, V41, P79, DOI 10.1016/j.semcdb.2014.12.001
   Vaidya A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004511
   Vrana PB, 2014, WIRES DEV BIOL, V3, P211, DOI 10.1002/wdev.132
   Zhang YW, 2020, AGING-US, V12, P4222, DOI 10.18632/aging.102875
   Zhang YW, 2019, DNA CELL BIOL, V38, P969, DOI 10.1089/dna.2019.4910
   Zhu GY, 2015, J CELL PHYSIOL, V230, P1413, DOI 10.1002/jcp.24923
NR 26
TC 7
Z9 9
U1 0
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD FEB
PY 2021
VL 144
AR 111191
DI 10.1016/j.exger.2020.111191
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA PT6TV
UT WOS:000608746800008
PM 33290861
DA 2024-02-19
ER

PT J
AU Baldensperger, T
   Eggen, M
   Kappen, J
   Winterhalter, PR
   Pfirrmann, T
   Glomb, MA
AF Baldensperger, Tim
   Eggen, Michael
   Kappen, Jonas
   Winterhalter, Patrick R.
   Pfirrmann, Thorsten
   Glomb, Marcus A.
TI Comprehensive analysis of posttranslational protein modifications in
   aging of subcellular compartments
SO SCIENTIFIC REPORTS
LA English
DT Article
ID GLYCATION END-PRODUCTS; OXIDATIVE STRESS; LYSINE;
   1-DEOXY-D-ERYTHRO-HEXO-2,3-DIULOSE; PROTEOSTASIS; DEGRADATION;
   FORMYLATION; PATHWAYS; RESIDUES; RECEPTOR
AB Enzymatic and non-enzymatic posttranslational protein modifications by oxidation, glycation and acylation are key regulatory mechanisms in hallmarks of aging like inflammation, altered epigenetics and decline in proteostasis. In this study a mouse cohort was used to monitor changes of posttranslational modifications in the aging process. A protocol for the extraction of histones, cytosolic and mitochondrial proteins from mouse liver was developed and validated. In total, 6 lysine acylation structures, 7 advanced glycation endproducts, 6 oxidative stress markers, and citrullination were quantitated in proteins of subcellular compartments using HPLC-MS/MS. Methionine sulfoxide, acetylation, formylation, and citrullination were the most abundant modifications. Histone proteins were extraordinary high modified and non-enzymatic modifications accumulated in all subcellular compartments during the aging process. Compared to acetylation of histone proteins which gave between 350 and 305 mu mol/mol leucine equivalents in young and old animals, modifications like acylation, glycation, and citrullination raised to 43%, 20%, and 18% of acetylation, respectively. On the other hand there was an age related increase of selected oxidative stress markers by up to 150%. The data and patterns measured in this study are mandatory for further studies and will strongly facilitate understanding of the molecular mechanisms in aging.
C1 [Baldensperger, Tim; Eggen, Michael; Kappen, Jonas; Glomb, Marcus A.] Martin Luther Univ Halle Wittenberg, Food Chem, Inst Chem, Kurt Mothes Str 2, D-06120 Halle, Germany.
   [Winterhalter, Patrick R.] Martin Luther Univ Halle Wittenberg, Clin Heart Surg, Ernst Grube Str 40, D-06120 Halle, Germany.
   [Pfirrmann, Thorsten] Martin Luther Univ Halle Wittenberg, Inst Physiol Chem, Hollystr 1, D-06114 Halle, Germany.
C3 Martin Luther University Halle Wittenberg; Martin Luther University
   Halle Wittenberg; Martin Luther University Halle Wittenberg
RP Glomb, MA (corresponding author), Martin Luther Univ Halle Wittenberg, Food Chem, Inst Chem, Kurt Mothes Str 2, D-06120 Halle, Germany.
EM marcus.glomb@chemie.uni-halle.de
RI Pfirrmann, Thorsten/HTQ-6239-2023
OI Pfirrmann, Thorsten/0000-0002-9474-9535; Baldensperger,
   Tim/0000-0002-9653-3156; Kappen, Jonas/0000-0002-4669-586X
FU Deutsche Forschungsgemeinschaft (DFG, Germany) Research Training Group,
   ProMoAge [2155]
FX Funding was supported by the Deutsche Forschungsgemeinschaft (DFG,
   Germany) Research Training Group 2155, ProMoAge.
CR Aebersold R, 2018, NAT CHEM BIOL, V14, P206, DOI [10.1038/nchembio.2576, 10.1038/NCHEMBIO.2576]
   Ali I, 2018, CHEM REV, V118, P340, DOI 10.1021/acs.chemrev.7b00181
   ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786
   Anderson KA, 2014, CELL, V159, DOI 10.1016/j.cell.2014.10.045
   Baldensperger T, 2019, ANAL CHEM, V91, P12336, DOI 10.1021/acs.analchem.9b02656
   Baldensperger T, 2018, J AGR FOOD CHEM, V66, P1898, DOI 10.1021/acs.jafc.7b05813
   Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7
   Carrico C, 2018, CELL METAB, V27, P497, DOI 10.1016/j.cmet.2018.01.016
   Chaudhuri J, 2018, CELL METAB, V28, P337, DOI 10.1016/j.cmet.2018.08.014
   COMMERFORD SL, 1982, P NATL ACAD SCI-BIOL, V79, P1163, DOI 10.1073/pnas.79.4.1163
   Edrissi B, 2013, CHEM RES TOXICOL, V26, P1421, DOI 10.1021/tx400320u
   Feser J, 2011, FEBS LETT, V585, P2041, DOI 10.1016/j.febslet.2010.11.016
   Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478
   Glomb MA, 2001, J AGR FOOD CHEM, V49, P1493, DOI 10.1021/jf001082d
   Glomb MA, 2001, J BIOL CHEM, V276, P41638, DOI 10.1074/jbc.M103557200
   Henning C, 2018, J AGR FOOD CHEM, V66, P4692, DOI 10.1021/acs.jafc.8b00558
   Henning C, 2011, J BIOL CHEM, V286, P44350, DOI 10.1074/jbc.M111.282442
   Höhn A, 2013, J PROTEOMICS, V92, P132, DOI 10.1016/j.jprot.2013.01.004
   Hong SY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168752
   Jiang T, 2007, P NATL ACAD SCI USA, V104, P60, DOI 10.1073/pnas.0606775103
   JOHANSEN JT, 1976, CARLSBERG RES COMMUN, V41, P1, DOI 10.1007/BF02908689
   Kislinger T, 1999, J BIOL CHEM, V274, P31740, DOI 10.1074/jbc.274.44.31740
   Korovila I, 2017, REDOX BIOL, V13, P550, DOI 10.1016/j.redox.2017.07.008
   LEDL F, 1990, ANGEW CHEM INT EDIT, V29, P565, DOI 10.1002/anie.199005653
   Leeuwenburgh C, 1999, AM J PHYSIOL-REG I, V276, pR128, DOI 10.1152/ajpregu.1999.276.1.R128
   Lin HN, 2018, CHEM REV, V118, P11, DOI 10.1021/acs.chemrev.7b00756
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Moldogazieva N.T.Mokhosoev, 2019, MED CELL LONGEV, P1
   Nie LT, 2017, MOL CELL PROTEOMICS, V16, P1324, DOI [10.1074/mcp.M117.067553, 10.1074/mcp.m117.067553]
   Nishida Y, 2015, MOL CELL, V59, P321, DOI 10.1016/j.molcel.2015.05.022
   POGO AO, 1966, P NATL ACAD SCI USA, V56, P550, DOI 10.1073/pnas.56.2.550
   Rabbani N, 2015, BIOCHEM BIOPH RES CO, V458, P221, DOI 10.1016/j.bbrc.2015.01.140
   Rardin MJ, 2013, CELL METAB, V18, P920, DOI 10.1016/j.cmet.2013.11.013
   Rosca MG, 2005, AM J PHYSIOL-RENAL, V289, pF420, DOI 10.1152/ajprenal.00415.2004
   Sabari BR, 2017, NAT REV MOL CELL BIO, V18, P90, DOI 10.1038/nrm.2016.140
   Smuda M, 2015, BIOCHEMISTRY-US, V54, P2500, DOI 10.1021/bi5013194
   Smuda M, 2013, ANGEW CHEM INT EDIT, V52, P4887, DOI 10.1002/anie.201300399
   Smuda M, 2010, J AGR FOOD CHEM, V58, P6458, DOI 10.1021/jf100334r
   SONG S, 2019, FRONT ONCOL, V9, P113, DOI DOI 10.3389/fonc.2019.00113
   Tsakiri EN, 2013, FREE RADICAL BIO MED, V65, P1155, DOI 10.1016/j.freeradbiomed.2013.08.186
   Uchiki T, 2012, AGING CELL, V11, P1, DOI 10.1111/j.1474-9726.2011.00752.x
   VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G
   Voigt M, 2009, J AGR FOOD CHEM, V57, P4765, DOI 10.1021/jf900459x
   WACHSMUTH ED, 1966, BIOCHEMISTRY-US, V5, P169, DOI 10.1021/bi00865a022
   Wagner GR, 2014, MOL CELL, V54, P5, DOI 10.1016/j.molcel.2014.03.027
   Wisniewski JR, 2008, NUCLEIC ACIDS RES, V36, P570, DOI 10.1093/nar/gkm1057
   Xie L, 2018, HISTONE MODIFICATION, V13
   Zheng QF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09192-z
NR 48
TC 25
Z9 27
U1 1
U2 9
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 5
PY 2020
VL 10
IS 1
AR 7596
DI 10.1038/s41598-020-64265-0
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA LM7YW
UT WOS:000532466200008
PM 32371922
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Vaanholt, LM
   Speakman, JR
   Garland, T
   Lobley, GE
   Visser, GH
AF Vaanholt, Lobke M.
   Speakman, John R.
   Garland, Theodore, Jr.
   Lobley, Gerald E.
   Visser, G. Henk
TI Protein synthesis and antioxidant capacity in aging mice: Effects of
   long-term voluntary exercise
SO PHYSIOLOGICAL AND BIOCHEMICAL ZOOLOGY
LA English
DT Article
ID WHEEL-RUNNING BEHAVIOR; AGE-RELATED-CHANGES; RESISTANCE EXERCISE;
   METABOLIC-RATE; SUPEROXIDE-DISMUTASE; DIETARY-RESTRICTION; OXIDATIVE
   STRESS; WHOLE-BODY; LIFE-SPAN; DROSOPHILA-MELANOGASTER
AB Exercise increases metabolic rate and the production of reactive oxygen species (ROS) but also elevates protein turnover. ROS cause damage to macromolecules (e. g., proteins) and thereby contribute to aging. Protein turnover removes and replaces damaged proteins. The balance between these two responses may underlie beneficial effects of physical activity on aging. Effects of lifelong exercise on antioxidant enzyme activities and fractional synthesis rate of protein (FSRP) were examined at various ages (2-26 mo) in heart, liver, and muscle of mice that had been selectively bred for high wheel-running activity, housed with (S+) or without (S+) a running wheel, and their random-bred controls (C+) housed with running wheels. FSRP decreased with age and increased in muscle of young, but not old, activity-selected mice. Enzyme activity of superoxide dismutase and glutathione peroxidase decreased with age and showed a peak at 10 mo of age in liver. Selection for wheel-running activity did not affect antioxidant enzyme activity. Daily energy expenditure correlated positively with antioxidant levels in liver. This might indicate that oxidative stress (ROS production) increases with metabolic rate, driving upregulation of antioxidant enzymes. Alternatively, the elevated energy expenditure may reflect the energetic cost of elevated protection, consistent with the disposable-soma hypothesis and with other studies showing positive links between energy expenditure and life span. Long-term elevations in voluntary exercise did not result in elevations in antioxidant enzyme activities or protein synthesis rates.
C1 [Vaanholt, Lobke M.; Visser, G. Henk] Univ Groningen, Dept Behav Biol, NL-9750 AA Haren, Netherlands.
   [Vaanholt, Lobke M.; Speakman, John R.] Univ Aberdeen, Sch Biol Sci, Aberdeen Ctr Energy Regulat & Obes, Aberdeen AB24 2TZ, Scotland.
   [Garland, Theodore, Jr.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.
   [Lobley, Gerald E.] Rowett Res Inst, Aberdeen AB21 9SB, Scotland.
C3 University of Groningen; University of Aberdeen; University of
   California System; University of California Riverside; University of
   Aberdeen
RP Vaanholt, LM (corresponding author), Univ Groningen, Dept Behav Biol, POB 14, NL-9750 AA Haren, Netherlands.
EM l.vaanholt@abdn.ac.uk
RI John, Speakman R/A-9494-2008
OI Vaanholt, Lobke M./0000-0002-5102-7970; Garland,
   Theodore/0000-0002-7916-3552
CR Arch JRS, 2006, INT J OBESITY, V30, P1322, DOI 10.1038/sj.ijo.0803280
   Barja G, 2004, TRENDS NEUROSCI, V27, P595, DOI 10.1016/j.tins.2004.07.005
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   BIOLO G, 1995, AM J PHYSIOL-ENDOC M, V268, pE514
   Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2
   Bronikowski AM, 2006, EVOLUTION, V60, P1494, DOI 10.1554/05-590.1
   Bronikowski AM, 2002, GENETICS, V161, P1763
   Calder A G, 1988, Rapid Commun Mass Spectrom, V2, P14, DOI 10.1002/rcm.1290020105
   CALDER AG, 1992, RAPID COMMUN MASS SP, V6, P421, DOI 10.1002/rcm.1290060704
   CHESLEY A, 1992, J APPL PHYSIOL, V73, P1383, DOI 10.1152/jappl.1992.73.4.1383
   DAVIES KJA, 1982, BIOCHEM BIOPH RES CO, V107, P1198, DOI 10.1016/S0006-291X(82)80124-1
   Dorrens J, 2003, SCAND J MED SCI SPOR, V13, P26, DOI 10.1034/j.1600-0838.2003.00306.x
   GARLICK PJ, 1980, BIOCHEM J, V192, P719, DOI 10.1042/bj1920719
   Greenberg JA, 2000, MECH AGEING DEV, V113, P37, DOI 10.1016/S0047-6374(99)00094-9
   Gündüz F, 2004, PHYSIOL RES, V53, P171, DOI 10.33549/physiolres.930384
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HAYASE K, 1992, BIOSCI BIOTECH BIOCH, V56, P1637, DOI 10.1271/bbb.56.1637
   Hernandez JM, 2000, J APPL PHYSIOL, V88, P1142, DOI 10.1152/jappl.2000.88.3.1142
   HILL RW, 1972, J APPL PHYSIOL, V33, P261, DOI 10.1152/jappl.1972.33.2.261
   HOLLOSZY JO, 1988, J GERONTOL, V43, pB149, DOI 10.1093/geronj/43.6.B149
   Hulbert AJ, 2004, EXP GERONTOL, V39, P1137, DOI 10.1016/j.exger.2004.04.006
   Ji LL, 1999, P SOC EXP BIOL MED, V222, P283, DOI 10.1046/j.1525-1373.1999.d01-145.x
   Kakarla P, 2005, J EXP ZOOL PART A, V303A, P203, DOI 10.1002/jez.a.149
   KATZEFF HL, 1994, AM J PHYSIOL, V267, pE63, DOI 10.1152/ajpendo.1994.267.1.E63
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   KIRKWOOD TBL, 1992, AM J CLIN NUTR, V55, P1191
   LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6
   LEWIS SEM, 1985, EXP GERONTOL, V20, P253, DOI 10.1016/0531-5565(85)90050-6
   MARKLUND S, 1974, EUR J BIOCHEM, V47, P469
   Masoro EJ, 2006, J GERONTOL A-BIOL, V61, P14, DOI 10.1093/gerona/61.1.14
   MCCARTER R, 1985, AM J PHYSIOL, V248, pE488
   McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63
   McEwen JE, 2005, CURR OPIN CARDIOL, V20, P399, DOI 10.1097/01.hco.0000175517.50181.89
   Mecocci P, 1999, FREE RADICAL BIO MED, V26, P303, DOI 10.1016/S0891-5849(98)00208-1
   Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846
   Morgan TJ, 2003, EVOLUTION, V57, P646, DOI 10.1111/j.0014-3820.2003.tb01556.x
   MOSONI L, 1995, AM J PHYSIOL-ENDOC M, V268, pE328, DOI 10.1152/ajpendo.1995.268.2.E328
   Navarro A, 2004, AM J PHYSIOL-REG I, V286, pR505, DOI 10.1152/ajpregu.00208.2003
   Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006
   Oklejewicz M, 1997, J BIOL RHYTHM, V12, P413, DOI 10.1177/074873049701200503
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   Phillips SM, 1997, AM J PHYSIOL-ENDOC M, V273, pE99, DOI 10.1152/ajpendo.1997.273.1.E99
   RAO G, 1990, MECH AGEING DEV, V53, P49, DOI 10.1016/0047-6374(90)90033-C
   Rattan SIS, 1996, EXP GERONTOL, V31, P33, DOI 10.1016/0531-5565(95)02022-5
   RENNIE MJ, 1981, CLIN SCI, V61, P627, DOI 10.1042/cs0610627
   ROMIJN C, 1961, P 2 S EN MET EUR ASS, P49
   Ryazanov AG, 2002, MECH AGEING DEV, V123, P207, DOI 10.1016/S0047-6374(01)00337-2
   Selman C, 2005, MECH AGEING DEV, V126, P783, DOI 10.1016/j.mad.2005.02.004
   Selman C, 2002, ARCH BIOCHEM BIOPHYS, V401, P255, DOI 10.1016/S0003-9861(02)00050-4
   Sheffield-Moore M, 2005, AM J PHYSIOL-ENDOC M, V288, pE922, DOI 10.1152/ajpendo.00358.2004
   Sheffield-Moore M, 2004, AM J PHYSIOL-ENDOC M, V287, pE513, DOI 10.1152/ajpendo.00334.2003
   Short KR, 2004, AM J PHYSIOL-ENDOC M, V286, pE92, DOI 10.1152/ajpendo.00366.2003
   SLATER C, 1995, J MASS SPECTROM, V30, P1325, DOI 10.1002/jms.1190300917
   SOHAL RS, 1990, FREE RADICAL BIO MED, V9, P495, DOI 10.1016/0891-5849(90)90127-5
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P37, DOI 10.1016/S0891-5849(02)00856-0
   Speakman JR, 2005, J EXP BIOL, V208, P1717, DOI 10.1242/jeb.01556
   Speakman JR, 2004, AGING CELL, V3, P87, DOI 10.1111/j.1474-9728.2004.00097.x
   Speakman JR, 2003, AGING CELL, V2, P265, DOI 10.1046/j.1474-9728.2003.00061.x
   Swallow JG, 1998, BEHAV GENET, V28, P227, DOI 10.1023/A:1021479331779
   Tsay HJ, 2000, J BIOMED SCI, V7, P466
   TYLER DD, 1975, FEBS LETT, V51, P180, DOI 10.1016/0014-5793(75)80882-9
   Vaanholt LM, 2007, J COMP PHYSIOL B, V177, P109, DOI 10.1007/s00360-006-0113-8
   Van Voorhies WA, 2004, J APPL PHYSIOL, V97, P1915, DOI 10.1152/japplphysiol.00505.2004
   Volpi E, 2001, JAMA-J AM MED ASSOC, V286, P1206, DOI 10.1001/jama.286.10.1206
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641
   Wester TJ, 2004, BRIT J NUTR, V92, P401, DOI 10.1079/BJN20041226
   Yamamoto T, 2002, COMP BIOCHEM PHYS C, V132, P437, DOI 10.1016/S1532-0456(02)00097-2
   Yarasheski KE, 2003, J GERONTOL A-BIOL, V58, P918
   YARASHESKI KE, 1993, AM J PHYSIOL, V265, pE210, DOI 10.1152/ajpendo.1993.265.2.E210
NR 70
TC 29
Z9 32
U1 0
U2 4
PU UNIV CHICAGO PRESS
PI CHICAGO
PA 1427 E 60TH ST, CHICAGO, IL 60637-2954 USA
SN 1522-2152
EI 1537-5293
J9 PHYSIOL BIOCHEM ZOOL
JI Physiol. Biochem. Zool.
PD MAR-APR
PY 2008
VL 81
IS 2
BP 148
EP 157
DI 10.1086/525289
PG 10
WC Physiology; Zoology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology; Zoology
GA 256WC
UT WOS:000252759600003
PM 18199000
OA Green Published
DA 2024-02-19
ER

PT J
AU Chaturvedi, P
   Neelamraju, Y
   Arif, W
   Kalsotra, A
   Janga, SC
AF Chaturvedi, Praneet
   Neelamraju, Yaseswini
   Arif, Waqar
   Kalsotra, Auinash
   Janga, Sarath Chandra
TI Uncovering RNA binding proteins associated with age and gender during
   liver maturation
SO SCIENTIFIC REPORTS
LA English
DT Article
ID P53 TARGET WIG-1; GENE-EXPRESSION; SEX-DIFFERENCES; TRANSCRIPTOME;
   STABILITY; NETWORKS; PROFILE; BRAIN; BLOOD
AB In the present study, we perform an association analysis focusing on the expression changes of 1344 RNA Binding proteins (RBPs) as a function of age and gender in human liver. We identify 88 and 45 RBPs to be significantly associated with age and gender respectively. Experimental verification of several of the predicted associations in mice confirmed our findings. Our results suggest that a small fraction of the gender-associated RBPs (similar to 40%) are expressed higher in males than females. Altogether, these observations show that several of these RBPs are important and conserved regulators in maintaining liver function. Further analysis of the protein interaction network of RBPs associated with age and gender based on the centrality measures like degree, betweenness and closeness revealed that several of these RBPs might be prominent players in aging liver and impart gender specific alterations in gene expression via the formation of protein complexes. Indeed, both age and gender-associated RBPs in liver were found to show significantly higher clustering coefficients and network centrality measures compared to non-associated RBPs. The compendium of RBPs and this study will help us gain insight into the role of post-transcriptional regulatory molecules in aging and gender specific expression of genes.
C1 [Chaturvedi, Praneet; Neelamraju, Yaseswini; Janga, Sarath Chandra] Indiana Univ Purdue Univ, Sch Informat & Comp, Dept BioHlth Informat, Indianapolis, IN 46202 USA.
   [Arif, Waqar; Kalsotra, Auinash] Univ Illinois, Dept Biochem & Med Biochem, Urbana, IL 61801 USA.
   [Janga, Sarath Chandra] Indiana Univ, Sch Med, Ctr Computat Biol & Bioinformat, Hlth Informat & Translat Sci 5021, Indianapolis, IN 46202 USA.
   [Janga, Sarath Chandra] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA.
C3 Indiana University System; Indiana University-Purdue University
   Indianapolis; University of Illinois System; University of Illinois
   Urbana-Champaign; Indiana University System; Indiana University-Purdue
   University Indianapolis; Indiana University System; Indiana
   University-Purdue University Indianapolis
RP Janga, SC (corresponding author), Indiana Univ Purdue Univ, Sch Informat & Comp, Dept BioHlth Informat, 719 Indiana Ave Ste 319,Walker Plaza Bldg, Indianapolis, IN 46202 USA.
EM scjanga@iupui.edu
RI Neelamraju, Yaseswini/AIA-0734-2022; CHATURVEDI, PRANEET/S-3184-2019
OI Kalsotra, Auinash/0000-0002-1011-0006; Janga, Sarath
   Chandra/0000-0001-7351-6268; Arif, Waqar/0000-0002-9252-0200
FU School of Informatics and Computing at IUPUI; Basil O'Connor Starter
   Scholar Research Award from March of Dimes; Roy J. Carver Charitable
   Trust Young Investigator Award; University of Illinois
FX Funding SCJ acknowledges support from the School of Informatics and
   Computing at IUPUI in the form of start-up funds. AK is supported by the
   Basil O'Connor Starter Scholar Research Award from March of Dimes, Roy
   J. Carver Charitable Trust Young Investigator Award and the start-up
   funds from the University of Illinois.
CR Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Blech-Hermoni Y, 2013, INT J BIOCHEM CELL B, V45, P2467, DOI 10.1016/j.biocel.2013.08.008
   Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249
   Buckberry S, 2014, MOL HUM REPROD, V20, P810, DOI 10.1093/molehr/gau035
   Castello A, 2013, NAT PROTOC, V8, P491, DOI 10.1038/nprot.2013.020
   Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031
   Charoensawan V, 2010, NUCLEIC ACIDS RES, V38, P7364, DOI 10.1093/nar/gkq617
   Colegrove-Otero LJ, 2005, CRIT REV BIOCHEM MOL, V40, P21, DOI 10.1080/10409230590918612
   Collins LJ, 2009, J HERED, V100, P597, DOI 10.1093/jhered/esp064
   Cook KB, 2011, NUCLEIC ACIDS RES, V39, pD301, DOI 10.1093/nar/gkq1069
   Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224
   Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311
   Glass D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r75
   Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004
   Innocenti F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002078
   Jansen R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-33
   Jessen HM, 2011, EPIGENETICS-US, V6, P857, DOI 10.4161/epi.6.7.16517
   Kalsotra A, 2014, CELL REP, V6, P336, DOI 10.1016/j.celrep.2013.12.025
   Katsanou V, 2009, MOL CELL BIOL, V29, P2762, DOI 10.1128/MCB.01393-08
   Koschützki D, 2008, GENE REGUL SYST BIO, V2, P193, DOI 10.4137/GRSB.S702
   Kwon SC, 2013, NAT STRUCT MOL BIOL, V20, P1122, DOI 10.1038/nsmb.2638
   Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531
   Leeds P, 1997, ONCOGENE, V14, P1279, DOI 10.1038/sj.onc.1201093
   Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661
   Lv J., 2014, J VIRAL HEPATITUS, V22, P199
   Masuda K, 2012, AGEING RES REV, V11, P423, DOI 10.1016/j.arr.2012.01.005
   McKnight NC, 2012, EMBO J, V31, P1931, DOI 10.1038/emboj.2012.36
   Mili S, 2003, MOL CELL BIOL, V23, P4972, DOI 10.1128/MCB.23.14.4972-4982.2003
   Mittal N, 2009, P NATL ACAD SCI USA, V106, P20300, DOI 10.1073/pnas.0906940106
   Nepusz T, 2012, NAT METHODS, V9, P471, DOI [10.1038/nmeth.1938, 10.1038/NMETH.1938]
   Nigro P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.410
   Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311
   Rodwell GEJ, 2004, PLOS BIOL, V2, P2191, DOI 10.1371/journal.pbio.0020427
   Schröder A, 2013, PHARMACOGENOMICS J, V13, P12, DOI 10.1038/tpj.2011.44
   Shibayama M, 2009, FEBS J, V276, P6658, DOI 10.1111/j.1742-4658.2009.07380.x
   Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109
   Suckale J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016992
   Thomas RP, 2002, J GASTROINTEST SURG, V6, P445, DOI 10.1016/S1091-255X(01)00010-5
   Thoren LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011650
   Torres-Padilla ME, 2001, MECH DEVELOP, V109, P183, DOI 10.1016/S0925-4773(01)00521-4
   Vilborg A, 2011, CELL DEATH DIFFER, V18, P1434, DOI 10.1038/cdd.2011.20
   Vilborg A, 2009, P NATL ACAD SCI USA, V106, P15756, DOI 10.1073/pnas.0900862106
   Wakamatsu Y, 1997, DEVELOPMENT, V124, P3449
   Xie XD, 2007, MOL CELL BIOCHEM, V301, P115, DOI 10.1007/s11010-006-9402-5
NR 45
TC 6
Z9 8
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 31
PY 2015
VL 5
AR 9512
DI 10.1038/srep09512
PG 10
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA CE6LI
UT WOS:000351947500001
PM 25824884
OA gold, Green Submitted, Green Published
DA 2024-02-19
ER

PT J
AU de Haan, G
   Van Zant, G
AF de Haan, G
   Van Zant, G
TI Dynamic changes in mouse hematopoietic stem cell numbers during aging
SO BLOOD
LA English
DT Article
ID ADULT BONE-MARROW; LONG-TERM; FETAL LIVER; GENETIC-CONTROL; IN-VIVO;
   REPOPULATING ABILITY; TELOMERASE ACTIVITY; ALLOPHENIC MICE; COMPLEX
   TRAITS; GROWTH-FACTORS
AB To address the fundamental question of whether or not stem cell populations age, we performed quantitative measurements of the cycling status and frequency of hematopoietic stem cells in long-lived C57BL/6 (B6) and short-lived DBA/2 (DBA) mice at different developmental and aging stages. The frequency of cobblestone area-forming cells (CAFC) day-35 in DBA fetal liver was twofold to threefold higher than in B6 mice, and by late gestation, the total stem cell number was nearly as large as that of young DBA adults. Following a further approximate to 50% increase in stem cells between 6 weeks and 1 year of age, numbers in old DBA mice dropped precipitously between 12 and 20 months of age. In marked contrast, this stem cell population in B6 mice increased at a constant rate from late gestation to 20 months of age with no signs of abatement, Throughout development an inverse correlation was observed between stem cell numbers and the percentage of cells in S-phase. Because a strong genetic component contributed to the changes in stem cell numbers during aging, we quantified stem cells of 20-month old BXD recombinant inbred (RI) mice, derived from B6 and DBA progenitor strains, thus permitting detailed Interstrain genetic analysis. For each BXD strain we calculated the stem cell increase or decrease as mice aged from 2 to 20 months. Net changes in CAFC-day 35 numbers among BXD strains ranged from an approximate to 10-fold decrease to an approximate to 10-fold increase. A genome wide search for loci associated with this quantitative trait was performed. Several loci contribute to the trait-putative loci map to chromosomes X, 2, and 14. We conclude that stem cell numbers fluctuate widely during aging and that this has a strong genetic basis. (C) 1999 by The American Society of Hematology.
C1 Univ Kentucky, Lucille P Markey Canc Ctr, Div Hematol Oncol, Blood & Marrow Transplant Program, Lexington, KY 40536 USA.
   Univ Groningen, Dept Physiol Chem, Groningen, Netherlands.
C3 University of Kentucky; University of Groningen
RP Van Zant, G (corresponding author), Univ Kentucky, Lucille P Markey Canc Ctr, Div Hematol Oncol, Blood & Marrow Transplant Program, 800 Rose St, Lexington, KY 40536 USA.
RI de Haan, Gerald/AAF-8963-2019; de Haan, Gerald/D-2081-2015
OI de Haan, Gerald/0000-0001-9706-0138; de Haan, Gerald/0000-0001-9706-0138
CR Abkowitz JL, 1998, P NATL ACAD SCI USA, V95, P3862, DOI 10.1073/pnas.95.7.3862
   ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114
   Belknap JK, 1996, BEHAV GENET, V26, P149, DOI 10.1007/BF02359892
   Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349
   BOGGS DR, 1984, TRANSPLANTATION, V37, P300, DOI 10.1097/00007890-198403000-00017
   Champion KM, 1997, BRIT J HAEMATOL, V97, P920, DOI 10.1046/j.1365-2141.1997.1933010.x
   CHERVENICK PA, 1968, AM J PHYSIOL, V215, P353, DOI 10.1152/ajplegacy.1968.215.2.353
   CHURCHILL GA, 1994, GENETICS, V138, P963
   De Haan G, 1999, FASEB J, V13, P707, DOI 10.1096/fasebj.13.6.707
   deHaan G, 1997, BLOOD, V89, P1543, DOI 10.1182/blood.V89.5.1543.1543_1543_1550
   deHaan G, 1997, J EXP MED, V186, P529, DOI 10.1084/jem.186.4.529
   deHaan G, 1996, BLOOD, V87, P4581, DOI 10.1182/blood.V87.11.4581.bloodjournal87114581
   DESTGROTH F, 1982, J IMMUNOL METHODS, V49, pR11, DOI DOI 10.1016/0022-1759(82)90269-1
   DOWN JD, 1993, EXP HEMATOL, V21, P913
   Engelhardt M, 1997, BLOOD, V90, P182
   Gale RE, 1997, BRIT J HAEMATOL, V98, P512, DOI 10.1046/j.1365-2141.1997.2573078.x
   GELMAN R, 1988, GENETICS, V118, P693
   HARRISON DE, 1972, NATURE-NEW BIOL, V237, P220, DOI 10.1038/newbio237220a0
   HARRISON DE, 1983, J EXP MED, V157, P1496, DOI 10.1084/jem.157.5.1496
   Harrison DE, 1997, EXP HEMATOL, V25, P293
   Harrison DE, 1997, BLOOD, V90, P174
   HARRISON DE, 1988, EXP HEMATOL, V16, P213
   HARRISON DE, 1989, J IMMUNOL, V142, P3833
   Iscove NN, 1997, CURR BIOL, V7, P805, DOI 10.1016/S0960-9822(06)00341-1
   LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241
   LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226
   LANSDORP PM, 1993, J EXP MED, V178, P787, DOI 10.1084/jem.178.3.787
   MANLY KF, 1993, MAMM GENOME, V4, P303, DOI 10.1007/BF00357089
   Marcos MAR, 1997, J IMMUNOL, V158, P2627
   MAUCH P, 1982, BLOOD, V60, P245
   MICKLEM HS, 1972, J CELL PHYSIOL, V79, P293, DOI 10.1002/jcp.1040790214
   Morrison SJ, 1996, IMMUNITY, V5, P207, DOI 10.1016/S1074-7613(00)80316-7
   MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302
   Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011
   *MOUS GEN DAT, 1998, MOUS GEN INF
   MullerSieburg CE, 1996, J EXP MED, V183, P1141, DOI 10.1084/jem.183.3.1141
   NEBEN S, 1994, EXP HEMATOL, V22, P353
   Notaro R, 1997, P NATL ACAD SCI USA, V94, P13782, DOI 10.1073/pnas.94.25.13782
   Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242
   PHILLIPS RL, 1992, P NATL ACAD SCI USA, V89, P11607, DOI 10.1073/pnas.89.23.11607
   PLOEMACHER RE, 1993, LEUKEMIA, V7, P120
   PLOEMACHER RE, 1991, BLOOD, V78, P2527
   POTTEN CS, 1990, DEVELOPMENT, V110, P1001
   Rebel VI, 1996, BLOOD, V87, P3500, DOI 10.1182/blood.V87.8.3500.bloodjournal8783500
   Rebel VI, 1996, EXP HEMATOL, V24, P638
   Rubin H, 1997, MECH AGEING DEV, V98, P1, DOI 10.1016/S0047-6374(97)00067-5
   Silver LM, 1995, MOUSE GENETICS CONCE
   SIMINOVITCH L, 1964, J CELL COMPAR PHYSL, V64, P23, DOI 10.1002/jcp.1030640104
   TEJERO C, 1989, EXP HEMATOL, V17, P66
   VANZANT G, 1983, CELL, V35, P639, DOI 10.1016/0092-8674(83)90096-X
   VANZANT G, 1990, J EXP MED, V171, P1547, DOI 10.1084/jem.171.5.1547
   VanZant G, 1997, EXP HEMATOL, V25, P187
   VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857
   Yui J, 1998, BLOOD, V91, P3255, DOI 10.1182/blood.V91.9.3255.3255_3255_3262
NR 54
TC 162
Z9 180
U1 0
U2 8
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 1200 19TH ST, NW, STE 300, WASHINGTON, DC 20036-2422 USA
SN 0006-4971
J9 BLOOD
JI Blood
PD MAY 15
PY 1999
VL 93
IS 10
BP 3294
EP 3301
DI 10.1182/blood.V93.10.3294.410k07_3294_3301
PG 8
WC Hematology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology
GA 194JY
UT WOS:000080190100015
PM 10233881
DA 2024-02-19
ER

PT J
AU Nakajima, T
   Karino, Y
   Hige, S
   Suii, H
   Tatsumi, R
   Yamaguchi, M
   Arakawa, T
   Kuwata, Y
   Toyota, J
AF Nakajima, Tomoaki
   Karino, Yoshiyasu
   Hige, Shuhei
   Suii, Hirokazu
   Tatsumi, Ryoji
   Yamaguchi, Masakatsu
   Arakawa, Tomohiro
   Kuwata, Yasuaki
   Toyota, Joji
TI Aging impairs fibrosis-4 index after sustained virologic response by
   direct-acting antivirals in chronic hepatitis C infection
SO ANNALS OF HEPATOLOGY
LA English
DT Article; Early Access
DE HCV; FIB-4 (Fibrosis-4) index; DAA (direct acting antivirals); SVR;
   Aging
ID PLUS RIBAVIRIN; HEPATOCELLULAR-CARCINOMA; ALL-CAUSE; THERAPY; CIRRHOSIS;
   FIB-4; DACLATASVIR; ASUNAPREVIR; SOFOSBUVIR; MORTALITY
AB Introduction and objectives: Sustained virologic response (SVR) is achieved in most cases of C-type liver disease after direct-acting antiviral (DAA) therapy. Although liver fibrosis improves, the degree of improvement is different. This study aimed to analyze the factors involved in improving liver fibrosis using the fibrosis 4 (FIB-4) index.
   Material and methods: Patients were monitored for >3 years after SVR. At the start of therapy (SOT), liver fibrosis was categorized as either mild (<1.45 n = 28), moderate (1.45-3.25 n = 139), or advanced (>3.25 n = 236) based on the FIB-4 index. The FIB-4 index in the advanced group decreased significantly compared to that of the other two, so we selected the advanced group as the analysis target. SOT and end of therapy (EOT) factors that contributed to the FIB-4 index <= 3.25 at 3 years after therapy were examined using a multivariate analysis.
   Results: Among the SOT factors, age (<72 years old), absence of liver cirrhosis (LC), alanine transferase (ALT) (>= 50 U/L), platelet (PLT) (>= 10.2 x 10(4)/mm(3)), and total bilirubin (T.Bil) (<0.8 mg/dl) were the significant factors contributing to the improvement of the FIB-4 index. Among the EOT factors, age (<72 years), PLT (>= 12.0 x 10(4)/mm(3)), and hemoglobin (Hb) (>= 12.1 g/dl) were the significant factors contributing to the improvement of FIB-4 index.
   Conclusions: Factors involved in the improvement of liver fibrosis after SVR were young age, absence of LC, low T.Bil., high ALT, high PLT, and high Hb levels. The levels of T.Bil, PLT, and Hb were considered to be related to portal hypertension. Aging strongly impaired the improvement in liver fibrosis. (C) 2021 Fundacion Clinica Medica Sur, A.C. Published by Elsevier Espana, S.L.U.
C1 [Nakajima, Tomoaki; Karino, Yoshiyasu; Hige, Shuhei; Suii, Hirokazu; Tatsumi, Ryoji; Yamaguchi, Masakatsu; Arakawa, Tomohiro; Kuwata, Yasuaki; Toyota, Joji] Sapporo Kosei Gen Hosp, Dept Hepatol, Sapporo, Hokkaido, Japan.
   [Karino, Yoshiyasu] Keiyukai Sapporo Hosp, Dept Gastroenterol, Sapporo, Hokkaido, Japan.
C3 Sapporo Kosei General Hospital
RP Karino, Y (corresponding author), Keiyukai Sapporo Hosp, Dept Gastroenterol, Shiroishi Ku, South 1-1,Hondouri 9, Sapporo, Hokkaido, Japan.
EM ykarino@keiyukaisapporo.or.jp
CR Akahane T, 2019, HEPATOL RES, V49, P264, DOI 10.1111/hepr.13246
   Bachofner JA, 2017, LIVER INT, V37, P369, DOI 10.1111/liv.13256
   Chayama K, 2012, HEPATOLOGY, V55, P742, DOI 10.1002/hep.24724
   Chen QS, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.21173
   Child C G, 1964, Major Probl Clin Surg, V1, P1
   Chindamo MC, 2017, WORLD J HEPATOL, V9, P310, DOI 10.4254/wjh.v9.i6.310
   El-Kamary SS, 2011, CLIN INFECT DIS, V53, P150, DOI 10.1093/cid/cir306
   El-Sherif O, 2018, GASTROENTEROLOGY, V154, P2111, DOI 10.1053/j.gastro.2018.03.022
   Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047
   Güzelbulut F, 2011, TURK J GASTROENTEROL, V22, P279, DOI 10.4318/tjg.2011.0213
   Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141
   Hsu WF, 2019, BMC GASTROENTEROL, V19, DOI 10.1186/s12876-019-0973-5
   Huang R, 2020, DIGEST DIS SCI, V65, P1491, DOI 10.1007/s10620-019-05886-y
   Ioannou GN, 2019, GASTROENTEROLOGY, V157, P1264, DOI 10.1053/j.gastro.2019.07.033
   Johnson PJ, 2015, J CLIN ONCOL, V33, P550, DOI 10.1200/JCO.2014.57.9151
   Kanwal F, 2020, HEPATOLOGY, V71, P44, DOI 10.1002/hep.30823
   Knop V, 2020, J VIRAL HEPATITIS, V27, P690, DOI 10.1111/jvh.13280
   Koyama R, 2006, INTERVIROLOGY, V49, P121, DOI 10.1159/000089372
   Kumada H, 2015, HEPATOLOGY, V62, P1037, DOI 10.1002/hep.27972
   Kumada H, 2014, HEPATOLOGY, V59, P2083, DOI 10.1002/hep.27113
   Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5
   Nakajima T, 2021, J GASTROEN HEPATOL, V36, P367, DOI 10.1111/jgh.15280
   Ouchi Y, 2017, GERIATR GERONTOL INT, V17, P1045, DOI 10.1111/ggi.13118
   Oze T, 2011, J GASTROENTEROL, V46, P944, DOI 10.1007/s00535-011-0403-0
   Reddy KR, 2015, HEPATOLOGY, V62, P79, DOI 10.1002/hep.27826
   Roche B, 2018, LIVER INT, V38, P139, DOI 10.1111/liv.13659
   Seko Y, 2019, HEPATOL RES, V49, P473, DOI 10.1111/hepr.13296
   Singh S, 2018, CLIN GASTROENTEROL H, V16, P27, DOI 10.1016/j.cgh.2017.04.038
   Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178
   Tada T, 2017, J GASTROEN HEPATOL, V32, P687, DOI 10.1111/jgh.13589
   Takehara T, 2019, J GASTROENTEROL, V54, P87, DOI 10.1007/s00535-018-1503-x
   Tanaka J, 2011, INTERVIROLOGY, V54, P185, DOI 10.1159/000324525
   Thiele M, 2018, GASTROENTEROLOGY, V154, P1369, DOI 10.1053/j.gastro.2018.01.005
   Tmu N, 2019, J CLIN EXP HEPATOL, V9, P4, DOI 10.1016/j.jceh.2018.02.009
   Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669
   Velosa J, 2011, DIGEST DIS SCI, V56, P1853, DOI 10.1007/s10620-011-1621-2
   Verna EC, 2020, J HEPATOL, V73, P540, DOI 10.1016/j.jhep.2020.03.031
NR 37
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER ESPANA
PI MADRID
PA CALLE DE ZURBANO, 76-4TH FLR LEFT, MADRID, 28010, SPAIN
SN 1665-2681
J9 ANN HEPATOL
JI Ann. Hepatol.
PD 2022 JAN-FEB
PY 2022
VL 27
IS 1
AR 100566
DI 10.1016/j.aohep.2021.100566
EA NOV 2021
PG 9
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA WZ2AO
UT WOS:000719774400001
PM 34688887
OA gold
DA 2024-02-19
ER

PT J
AU YAO, KN
   WU, XM
   THOMPSON, JE
   CARLSON, JC
AF YAO, KN
   WU, XM
   THOMPSON, JE
   CARLSON, JC
TI ISOLATION AND CHARACTERIZATION OF DETERIOSOMES FROM RAT-LIVER
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Article
DE MEMBRANE BREAKDOWN; PERMEABILITY; NONSEDIMENTABLE MICROVESICLES;
   PHOSPHOLIPASE-A2; CALCIUM
ID POLYPHOSPHOINOSITIDE PHOSPHODIESTERASE; BEAN COTYLEDONS;
   PLASMA-MEMBRANE; PHOSPHOLIPASE; MICROVESICLES; SENESCENCE; BREAKDOWN;
   VESICLES; PROTEINS; CELLS
AB Deteriosomes, a new class of microvesicles, have been isolated from rat liver tissue. These microvesicles are similar to those isolated previously from plant tissue [Yao et al., Proc Natl Acad Sci USA 88:2269-2273,1991] in that they are nonsedimentable and enriched in membrane catabolites, particularly products of phospholipid degradation. Liver deteriosomes range in size from 0.05 mum to 0.11 mum in radius. They are also much more permeable than microsomal membrane vesicles indicating that the deteriosome bilayer is perturbed. The data are consistent with the proposal that deteriosomes are formed from membranes by microvesiculation and that they represent an intermediate stage of membrane deterioration. Furthermore, liver deteriosomes were found to contain phospholipase A2 activity. This suggests that they not only serve as a means of moving destabilizing macromolecular catabolites out of membranes into the cytosol but also possess enzymatic activity. The fact that the specific activity of phospholipase A2 is higher in deteriosomes than in deteriosome-free cytosol suggests that some of the enzymatic activity traditionally assumed to be cytosolic may in fact be associated with deteriosomes.
C1 UNIV WATERLOO,DEPT BIOL,WATERLOO N2L 3G1,ONTARIO,CANADA.
C3 University of Waterloo
RI Li, Jiaai/JCO-0168-2023; li, jian/IAQ-2794-2023
CR ALLAN D, 1975, BIOCHIM BIOPHYS ACTA, V413, P309, DOI 10.1016/0005-2736(75)90116-9
   ALLAN D, 1976, NATURE, V261, P58, DOI 10.1038/261058a0
   BARBER RF, 1980, J EXP BOT, V31, P1305, DOI 10.1093/jxb/31.5.1305
   BLINKS JR, 1982, PROG BIOPHYS MOL BIO, V40, P1, DOI 10.1016/0079-6107(82)90011-6
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E
   COCKCROFT S, 1984, BIOCHEM J, V221, P477, DOI 10.1042/bj2210477
   DAS S, 1984, BIOCHEM BIOPH RES CO, V124, P491, DOI 10.1016/0006-291X(84)91580-8
   DOWNES CP, 1981, BIOCHEM J, V198, P133, DOI 10.1042/bj1980133
   DOWNES CP, 1982, BIOCHEM J, V202, P53, DOI 10.1042/bj2020053
   FISHMAN HM, 1990, BIOCHIM BIOPHYS ACTA, V1023, P421, DOI 10.1016/0005-2736(90)90135-B
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   HALLETT FR, 1989, CAN J SPECTROSC, V34, P63
   JIAN MK, 1977, J MEMBRANE BIOL, V34, P157
   KANTOR HL, 1975, BIOCHEMISTRY-US, V14, P1790, DOI 10.1021/bi00679a035
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LAPETINA EG, 1973, BIOCHEM J, V131, P433, DOI 10.1042/bj1310433
   MAGGIO B, 1975, BIOCHEM J, V149, P5947
   PALIYATH G, 1987, PLANT PHYSIOL, V83, P63, DOI 10.1104/pp.83.1.63
   PEARCE RS, 1985, PLANTA, V166, P1, DOI 10.1007/BF00397380
   PERSOON NLM, 1987, BIOCHIM BIOPHYS ACTA, V917, P186, DOI 10.1016/0005-2760(87)90299-2
   PETKOVA DH, 1986, EXP GERONTOL, V21, P187, DOI 10.1016/0531-5565(86)90072-0
   RILEY JCM, 1987, ENDOCRINOLOGY, V121, P776, DOI 10.1210/endo-121-2-776
   SCHUMAKER KS, 1986, J BIOL CHEM, V261, P2172
   THOMPSON JE, 1987, NEW PHYTOL, V105, P317, DOI 10.1111/j.1469-8137.1987.tb00871.x
   WALLACE MA, 1989, BIOCHIM BIOPHYS ACTA, V1006, P311, DOI 10.1016/0005-2760(89)90018-0
   WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2
   WU XM, 1990, ENDOCRINOLOGY, V127, P2646
   YAO K, 1991, P NATL ACAD SCI USA, V88, P2269, DOI 10.1073/pnas.88.6.2269
   YAO K, 1991, THESIS U GUELPH GUEL
   YAO KN, 1991, PLANT PHYSIOL, V97, P502, DOI 10.1104/pp.97.2.502
NR 31
TC 7
Z9 7
U1 0
U2 3
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0730-2312
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PD APR
PY 1993
VL 51
IS 4
BP 488
EP 494
DI 10.1002/jcb.2400510414
PG 7
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA KW487
UT WOS:A1993KW48700014
PM 8496249
DA 2024-02-19
ER

PT J
AU Metzendorf, C
   Wineberger, K
   Rausch, J
   Cigliano, A
   Peters, K
   Sun, BD
   Mennerich, D
   Kietzmann, T
   Calvisi, DF
   Dombrowski, F
   Ribback, S
AF Metzendorf, Christoph
   Wineberger, Katharina
   Rausch, Jenny
   Cigliano, Antonio
   Peters, Kristin
   Sun, Baodong
   Mennerich, Daniela
   Kietzmann, Thomas
   Calvisi, Diego F.
   Dombrowski, Frank
   Ribback, Silvia
TI Transcriptomic and Proteomic Analysis of Clear Cell Foci (CCF) in the
   Human Non-Cirrhotic Liver Identifies Several Differentially Expressed
   Genes and Proteins with Functions in Cancer Cell Biology and Glycogen
   Metabolism
SO MOLECULES
LA English
DT Article
DE clear cell foci; liver; hepatocellular carcinoma; pre-neoplastic lesions
ID PANCREATIC-ISLET TRANSPLANTS; HEPATOCELLULAR-CARCINOMA; CENTROSOME LOSS;
   HEPATIC FOCI; GROWTH; USP28; ACTIVATION; REQUIREMENT; SENESCENCE;
   RECEPTORS
AB Clear cell foci (CCF) of the liver are considered to be pre-neoplastic lesions of hepatocellular adenomas and carcinomas. They are hallmarked by glycogen overload and activation of AKT (v-akt murine thymoma viral oncogene homolog)/mTOR (mammalian target of rapamycin)-signaling. Here, we report the transcriptome and proteome of CCF extracted from human liver biopsies by laser capture microdissection. We found 14 genes and 22 proteins differentially expressed in CCF and the majority of these were expressed at lower levels in CCF. Using immunohistochemistry, the reduced expressions of STBD1 (starch-binding domain-containing protein 1), USP28 (ubiquitin-specific peptidase 28), monad/WDR92 (WD repeat domain 92), CYB5B (Cytochrome b5 type B), and HSPE1 (10 kDa heat shock protein, mitochondrial) were validated in CCF in independent specimens. Knockout of Stbd1, the gene coding for Starch-binding domain-containing protein 1, in mice did not have a significant effect on liver glycogen levels, indicating that additional factors are required for glycogen overload in CCF. Usp28 knockout mice did not show changes in glycogen storage in diethylnitrosamine-induced liver carcinoma, demonstrating that CCF are distinct from this type of cancer model, despite the decreased USP28 expression. Moreover, our data indicates that decreased USP28 expression is a novel factor contributing to the pre-neoplastic character of CCF. In summary, our work identifies several novel and unexpected candidates that are differentially expressed in CCF and that have functions in glycogen metabolism and tumorigenesis.
C1 [Metzendorf, Christoph; Wineberger, Katharina; Rausch, Jenny; Cigliano, Antonio; Peters, Kristin; Calvisi, Diego F.; Dombrowski, Frank; Ribback, Silvia] Univ Med Greifswald, Inst Pathol, Friedrich Loeffler Str 23e, D-17475 Greifswald, Germany.
   [Sun, Baodong] Duke Univ, Dept Pediat, Div Med Genet, Med Ctr, Durham, NC 27710 USA.
   [Mennerich, Daniela; Kietzmann, Thomas] Univ Oulu, Fac Biochem & Mol Med, Oulu 90570, Finland.
   [Mennerich, Daniela; Kietzmann, Thomas] Univ Oulu, Bioctr Oulu, Oulu 90570, Finland.
   [Metzendorf, Christoph] Uppsala Univ, Dept Immunol Genet & Pathol, BMC, Husargatan 3, S-75124 Uppsala, Sweden.
   [Cigliano, Antonio; Calvisi, Diego F.] Regensburg Univ Klinikum, Inst Pathol, Franz Josef Str Allee 11, D-93053 Regensburg, Germany.
C3 Greifswald Medical School; Duke University; University of Oulu;
   University of Oulu; Uppsala University
RP Ribback, S (corresponding author), Univ Med Greifswald, Inst Pathol, Friedrich Loeffler Str 23e, D-17475 Greifswald, Germany.
EM christoph.metzendorf@igp.uu.se; katharina.wineberger@hotmail.de;
   jesora@web.de; antonio.cigliano@klinik.uni-regensburg.de;
   kristin.peters@med.uni-greifswald.de; baodong.sun@duke.edu;
   daniela.mennerich@oulu.fi; thomas.kietzmann@oulu.fi;
   diego.calvisi@klinik.uni-regensburg.de;
   frank.dombrowski@uni-greifswald.de; silvia.ribback@med.uni-greifswald.de
RI Metzendorf, Christoph/GWZ-6968-2022; Cigliano, Antonio/J-4660-2017
OI Metzendorf, Christoph/0000-0003-3891-2809; Cigliano,
   Antonio/0000-0002-6408-3613; Mennerich, Daniela/0000-0001-9017-3009;
   Sun, Baodong/0000-0002-2191-0025; Kietzmann, Thomas/0000-0003-0242-8636
FU Deutsche Forschungsgemeinschaft (DFG) [RI2695/1-1]
FX This research was funded by grant RI2695/1-1 from the Deutsche
   Forschungsgemeinschaft (DFG).
CR Andergassen U, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/792672
   Bannasch P, 1996, Prog Liver Dis, V14, P161
   BANNASCH P, 1980, BIOCHIM BIOPHYS ACTA, V605, P217, DOI 10.1016/0304-419X(80)90005-0
   Bannasch P, 2017, HEPATOB PANCREAT DIS, V16, P570, DOI 10.1016/S1499-3872(17)60071-7
   Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185
   Bouju S, 1998, BIOCHEM J, V335, P549, DOI 10.1042/bj3350549
   Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006
   Calvisi DF, 2011, GASTROENTEROLOGY, V140, P1071, DOI 10.1053/j.gastro.2010.12.006
   Che L, 2017, CELL CYCLE, V16, P499, DOI 10.1080/15384101.2017.1282586
   Chen GX, 2019, ONCOL REP, V41, P405, DOI 10.3892/or.2018.6783
   Chu X, 2013, J MED GENET, V50, P479, DOI 10.1136/jmedgenet-2013-101595
   Davila JA, 2005, GUT, V54, P533, DOI 10.1136/gut.2004.052167
   Dombrowski F, 2005, CANCER RES, V65, P7013, DOI 10.1158/0008-5472.CAN-05-0122
   Dombrowski F, 1996, AM J PATHOL, V148, P1249
   Dombrowski F, 2006, CANCER RES, V66, P1833, DOI 10.1158/0008-5472.CAN-05-2787
   Dombrowski F, 1997, AM J PATHOL, V150, P1071
   Evert M, 2008, PATHOLOGE, V29, P47, DOI 10.1007/s00292-007-0953-3
   Evert M, 2012, HEPATOLOGY, V55, P1473, DOI 10.1002/hep.25600
   Favaro E, 2012, CELL METAB, V16, P751, DOI 10.1016/j.cmet.2012.10.017
   Flügel D, 2012, BLOOD, V119, P1292, DOI 10.1182/blood-2011-08-375014
   Fong CS, 2016, ELIFE, V5, DOI [10.7554/eLite.16270, 10.7554/eLife.16270]
   Franco LM, 2005, J INHERIT METAB DIS, V28, P153, DOI 10.1007/s10545-005-7500-2
   Han H, 2013, HEPATOLOGY, V57, P2378, DOI 10.1002/hep.26302
   Janecek S, 2002, BIOINFORMATICS, V18, P1534, DOI 10.1093/bioinformatics/18.11.1534
   Jiang SX, 2011, BIOCHEM BIOPH RES CO, V413, P420, DOI 10.1016/j.bbrc.2011.08.106
   Jiang SX, 2010, J BIOL CHEM, V285, P34960, DOI 10.1074/jbc.M110.150839
   KLIMEK F, 1984, CARCINOGENESIS, V5, P265, DOI 10.1093/carcin/5.2.265
   Lambrus BG, 2016, J CELL BIOL, V214, P143, DOI 10.1083/jcb.201604054
   Latgé G, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010123
   Li FZ, 2019, EXP CELL RES, V379, P11, DOI 10.1016/j.yexcr.2019.03.026
   Li L, 2016, HEPATOLOGY, V63, P1900, DOI 10.1002/hep.28508
   Libbrecht L, 2005, LIVER INT, V25, P16, DOI 10.1111/j.1478-3231.2005.01016.x
   Lin JY, 2017, NEOPLASIA, V19, P43, DOI 10.1016/j.neo.2016.11.007
   Lin TC, 2017, ONCOTARGET, V8, P42588, DOI 10.18632/oncotarget.16585
   Makide K, 2014, J LIPID RES, V55, P1986, DOI 10.1194/jlr.R046920
   Mao YG, 2019, INT J BIOL SCI, V15, P169, DOI 10.7150/ijbs.29048
   Marengo A, 2016, ANNU REV MED, V67, P103, DOI 10.1146/annurev-med-090514-013832
   Mazzucco AE, 2017, GENE DEV, V31, P1933, DOI 10.1101/gad.304857.117
   Meitinger F, 2016, J CELL BIOL, V214, P155, DOI 10.1083/jcb.201604081
   Napier C, 2015, J CLIN ENDOCR METAB, V100, pE187, DOI 10.1210/jc.2014-2694
   Paul NR, 2015, J CELL BIOL, V210, P1013, DOI 10.1083/jcb.201502040
   PITOT HC, 1990, ANNU REV PHARMACOL, V30, P465
   Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601
   Prats C, 2018, J BIOL CHEM, V293, P7089, DOI 10.1074/jbc.R117.802843
   Ribback S, 2017, ONCOTARGET, V8, P104315, DOI 10.18632/oncotarget.22234
   Ribback S, 2015, ONCOTARGET, V6, P13036, DOI 10.18632/oncotarget.3675
   Ribback S, 2013, J HEPATOL, V58, P1147, DOI 10.1016/j.jhep.2013.01.013
   Richter K, 2018, MOL CANCER RES, V16, P1000, DOI 10.1158/1541-7786.MCR-17-0452
   Saeki M, 2006, BIOCHEM BIOPH RES CO, V342, P568, DOI 10.1016/j.bbrc.2006.02.009
   Saeki M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067326
   Sun T, 2016, J BIOL CHEM, V291, P16479, DOI 10.1074/jbc.C116.741397
   Tarhan YE, 2016, NEOPLASIA, V18, P265, DOI 10.1016/j.neo.2016.03.005
   Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321
   Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507
   Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419
   Uwamizu A, 2015, J BIOCHEM, V157, P151, DOI 10.1093/jb/mvu060
   Valero R, 2001, GENOME BIOL, V2
   Vigneri R, 2016, J ENDOCRINOL INVEST, V39, P1365, DOI 10.1007/s40618-016-0508-7
   Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185
   von Morgen P, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00069
   Wang XF, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0208-z
   WILLIAMS GM, 1980, BIOCHIM BIOPHYS ACTA, V605, P167, DOI 10.1016/0304-419X(80)90003-7
   Wu YD, 2013, CELL REP, V5, P224, DOI 10.1016/j.celrep.2013.08.030
   Yi HQ, 2012, DIS MODEL MECH, V5, P804, DOI 10.1242/dmm.009712
   Youssef I, 2019, MOL CANCER RES, V17, P1961, DOI 10.1158/1541-7786.MCR-19-0125
   Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039
   Zhao C, 2008, ONCOGENE, V27, P63, DOI 10.1038/sj.onc.1210637
NR 67
TC 3
Z9 3
U1 0
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD SEP
PY 2020
VL 25
IS 18
AR 4141
DI 10.3390/molecules25184141
PG 22
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA OF7CC
UT WOS:000581359800001
PM 32927708
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU KITANI, K
   ZSNAGY, I
   OHTA, M
   KANAI, S
   SATO, Y
   IVY, GO
AF KITANI, K
   ZSNAGY, I
   OHTA, M
   KANAI, S
   SATO, Y
   IVY, GO
TI EFFECT OF LEUPEPTIN ON THE LATERAL MOBILITY OF PROTEINS IN THE
   PLASMA-MEMBRANE OF HEPATOCYTES OF C57BL/6 MICE - FRAP STUDIES ON LIVER
   SMEARS
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
DE LEUPEPTIN; PROTEASE INHIBITOR MODEL OF AGING; LATERAL DIFFUSION
   CONSTANT; FRACTIONAL RECOVERY; HEPATOCYTE MEMBRANES; FRAP
ID AGE-DEPENDENT DECREASE; FLUORESCENCE RECOVERY; DIFFUSION CONSTANT; RAT;
   AUTOFLUORESCENCE; ACCUMULATION; DEGRADATION; MECHANISMS; INHIBITORS;
   OUABAIN
AB Four groups of male C57BL/6 mice (ages 2, 3.8, 11.8-12.5 and 24 months) were administered leupeptin at 5 mg/100 g body weight/day via intraperitoneally implanted osmotic minipumps. Both untreated and saline-treated mice served as controls. The time and dose-dependence of the effects of leupeptin on the lateral mobility of proteins in hepatocyte surface membranes were analyzed first in mice treated for 2, 5, 8, 11 and 14 days, respectively, by using the fluorescence recovery after photobleaching (FRAP) technique. The age dependence of the response to this treatment was also studied after 14 days of treatment in mice of various ages. The average lateral diffusion constant (D) and the fractional recovery (FR) were measured, and D x FR calculated. Leupeptin treatment at a daily dose of 5 mg/100 g for 2 weeks increased plasma glutamic-pyruvic transaminase levels 2-fold in all age groups. Leupeptin treatment caused a linear increase of D and a decrease of FR with respect to the duration of the treatment in adult mice. In all age groups about 30% of the membrane proteins became immobile after 14 days of treatment, whereas the still mobile fraction displayed a large increase of D. The values of D x FR in the leupeptin-treated groups were slightly higher than those in the untreated mice until the age of 15 months but decreased after this age. The results are interpreted in terms of the known inhibitory effect of leupeptin on cytoplasmic and lysosomal thiol proteases, causing a general slowing down of the protein turnover and, specifically, of proteins in the hepatocyte membrane.
RP KITANI, K (corresponding author), TOKYO METROPOLITAN GERIATR HOSP & INST GERONTOL, DEPT CLIN PHYSIOL, 35-2 SAKAECHO, ITABASHI KU, TOKYO 173, JAPAN.
CR AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4
   DAWSON RMC, 1969, DATA BIOCH RES, P507
   ELDRED GE, 1988, LIPOFUSCIN 1987 STAT, P185
   HARE JF, 1988, J BIOL CHEM, V263, P8759
   HARE JF, 1990, BIOCHIM BIOPHYS ACTA, V1031, P71, DOI 10.1016/0304-4157(90)90003-U
   Ivy G.O., 1988, Lipofuscin-1987: State of the Art, V1st ed., P83
   IVY GO, 1989, BRAIN RES, V498, P360, DOI 10.1016/0006-8993(89)91117-7
   IVY GO, 1991, MECH AGEING DEV, V57, P213, DOI 10.1016/0047-6374(91)90048-5
   IVY GO, 1989, ADV EXP MED BIOL, V266, P31
   IVY GO, 1984, SCIENCE, V226, P985, DOI 10.1126/science.6505679
   IVY GO, 1986, LIVER AGING 1986, P389
   IVY GO, 1987, NEUROPLASTICITY LEAR, P125
   KIKUGAWA K, 1988, LIPOFUSCIN 1987 STAT, P51
   KITANI K, 1991, INT CONGR SER, V940, P305
   KITANI K, 1988, HEPATOLOGY, V8, P125, DOI 10.1002/hep.1840080124
   KITANI K, 1990, LIPOFUSCIN CEROID PI, P75
   KOMINAMI E, 1981, BIOCHIM BIOPHYS ACTA, V659, P378, DOI 10.1016/0005-2744(81)90064-4
   LIBBY P, 1978, SCIENCE, V199, P534, DOI 10.1126/science.622552
   LUSTYIK G, 1987, BIOCHIM BIOPHYS ACTA, V896, P57, DOI 10.1016/0005-2736(87)90356-7
   NAGY VZ, 1988, TISSUE CELL, V20, P229, DOI 10.1016/0040-8166(88)90044-4
   NOKUBO M, 1988, BIOCHIM BIOPHYS ACTA, V939, P441, DOI 10.1016/0005-2736(88)90090-9
   NOKUBO M, 1989, BIOCHIM BIOPHYS ACTA, V981, P303, DOI 10.1016/0005-2736(89)90041-2
   OHTA M, 1990, BIOCHEM PHARMACOL, V39, P1223, DOI 10.1016/0006-2952(90)90266-N
   PORTA EA, 1990, LIPOFUSCIN CEROID PI, P169
   SMITH GM, 1989, 14 INT C GER AC, P195
   Snedecor GW, 1980, STAT METHODOL, V7th, P39
   TANAKA K, 1979, ARCH BIOCHEM BIOPHYS, V208, P102
   WOLFE LS, 1988, LIPOFUSCIN 1987 STAT, P389
   YGUERABIDE J, 1982, BIOPHYS J, V40, P69, DOI 10.1016/S0006-3495(82)84459-7
   ZSNAGY I, 1990, ARCH GERONTOL GERIAT, V11, P243, DOI 10.1016/0167-4943(90)90068-H
   ZSNAGY I, 1988, BIOCHIM BIOPHYS ACTA, V939, P551, DOI 10.1016/0005-2736(88)90102-2
   ZSNAGY I, 1989, EXP GERONTOL, V24, P317, DOI 10.1016/0531-5565(89)90004-1
   ZSNAGY I, 1986, EXP GERONTOL, V21, P555, DOI 10.1016/0531-5565(86)90007-0
   ZSNAGY I, 1986, ARCH GERONTOL GERIAT, V5, P131, DOI 10.1016/0167-4943(86)90016-6
   ZSNAGY I, 1984, MIKROSKOPIE, V41, P12
   ZSNAGY I, 1987, BIOL AGE AGING RISK, P147
   ZSNAGY I, 1989, J GERONTOL BIOL SCI, V44, pB85
   ZSNAGY I, 1989, CRC HDB FREE RADICAL, V1, P199
NR 38
TC 10
Z9 10
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-4943
EI 1872-6976
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PD JAN-FEB
PY 1992
VL 14
IS 1
BP 27
EP 45
DI 10.1016/0167-4943(92)90004-N
PG 19
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA HK365
UT WOS:A1992HK36500003
PM 15374407
DA 2024-02-19
ER

PT J
AU Agirregoitia, N
   Gil, J
   Ruiz, F
   Irazusta, J
   Casis, L
AF Agirregoitia, N
   Gil, J
   Ruiz, F
   Irazusta, J
   Casis, L
TI Effect of aging on rat tissue peptidase activities
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
ID THYROTROPIN-RELEASING-HORMONE; PROLYL ENDOPEPTIDASE INHIBITOR;
   ALZHEIMERS-DISEASE; ENZYME-ACTIVITIES; OXIDATIVE STRESS;
   AMINOPEPTIDASE-M; GENE-EXPRESSION; BOVINE BRAIN; CATHEPSIN-B;
   BODY-FLUIDS
AB The process of aging is known to involve alterations in the activity of peptidases and proteases. However, the precise changes in the activity of many peptidases in aged tissues have not yet been fully characterized, and both decreases and increases in both peptidase activity and peptide levels have been reported to occur during the aging process. In the present study, we measured the activity of several peptidases in selected tissues (brain cortex, brain stem, liver, kidney, heart, and lung) of the young adult (3 months old) and aged (18 months old and 22 months old) rat. The activities of prolyl endopeptidase, pyroglutamyl peptidase I, puromycin sensitive aminopeptidase, and aminopeptidase N were assayed using beta-naphthylamine aminoacidic derivatives as substrates. The activity of the soluble fractions of prolyl endopeptidase was found to be reduced in the lungs of aged animals, while reduced activity of soluble pyroglutamyl peptidase I and also aminopeptidase N was measured in the aged kidney and heart, respectively. In contrast, increased activity of particulate prolyl endopeptidase was measured in the brain stem of older animals. Since most of these changes can be correlated with known alterations in the levels of peptides controlled by each enzyme, the results of the present study indicate that the studied peptidases may play an important role in regulating tissue peptide levels during aging.
C1 Univ Basque Country, Sch Med, Dept Physiol, Bilbao, Bizkaia, Spain.
C3 University of Basque Country
RP Irazusta, J (corresponding author), Univ Basque Country, Sch Med, Dept Physiol, POB 699, Bilbao, Bizkaia, Spain.
EM ofpirasj@lg.ehu.es
RI Irazusta, Jon/ABB-1237-2020
OI CASIS SAENZ, LUIS/0000-0001-9968-3216; Irazusta, Jon/0000-0002-6763-8602
CR AHOTUPA M, 1992, ACTA PHYSIOL SCAND, V145, P151, DOI 10.1111/j.1748-1716.1992.tb09350.x
   Alba F, 1989, Arch Neurobiol (Madr), V52, P169
   ALBA F, 1995, NEUROPEPTIDES, V29, P103, DOI 10.1016/0143-4179(95)90092-6
   AMENTA F, 1988, ARCH GERONTOL GERIAT, V7, P215, DOI 10.1016/0167-4943(88)90004-0
   Ansari MA, 1997, PEDIATR RES, V42, P709, DOI 10.1203/00006450-199711000-00025
   AOYAGI T, 1990, EXPERIENTIA, V46, P94, DOI 10.1007/BF01955428
   BOLUYT MO, 1993, AM J PHYSIOL, V265, pH212, DOI 10.1152/ajpheart.1993.265.1.H212
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CAFFREY JL, 1994, J MOL CELL CARDIOL, V26, P701, DOI 10.1006/jmcc.1994.1085
   Campisi J, 2000, IN VIVO, V14, P183
   Conconi M, 1997, MOL BIOL REP, V24, P45, DOI 10.1023/A:1006852506884
   Cummins PM, 1996, INT J BIOCHEM CELL B, V28, P883, DOI 10.1016/1357-2725(96)00034-9
   Cunningham DF, 1997, BBA-PROTEIN STRUCT M, V1343, P160, DOI 10.1016/S0167-4838(97)00134-9
   DYER SH, 1990, J NEUROCHEM, V54, P547, DOI 10.1111/j.1471-4159.1990.tb01906.x
   Fernández D, 2002, PEPTIDES, V23, P461, DOI 10.1016/S0196-9781(01)00622-2
   FRIEDMAN TC, 1986, J NEUROCHEM, V46, P1231, DOI 10.1111/j.1471-4159.1986.tb00643.x
   FUSE Y, 1990, AM J PHYSIOL, V259, pE787, DOI 10.1152/ajpendo.1990.259.6.E787
   García SI, 2001, HYPERTENSION, V37, P365, DOI 10.1161/01.HYP.37.2.365
   GIROS B, 1986, MOL PHARMACOL, V29, P281
   GOLDSTEIN DJ, 1983, EUR J PHARMACOL, V93, P293, DOI 10.1016/0014-2999(83)90153-X
   Goossens F, 1996, EUR J CLIN CHEM CLIN, V34, P17
   GROS C, 1985, BIOCHEMISTRY-US, V24, P2179, DOI 10.1021/bi00330a011
   Hayashi T, 1998, MECH AGEING DEV, V102, P55, DOI 10.1016/S0047-6374(98)00011-6
   HERSH LB, 1982, MOL CELL BIOCHEM, V47, P35
   Irazusta J, 2002, NEUROCHEM INT, V40, P337, DOI 10.1016/S0197-0186(01)00078-X
   Jiang CH, 2001, P NATL ACAD SCI USA, V98, P1930, DOI 10.1073/pnas.98.4.1930
   Keller JN, 2000, MECH AGEING DEV, V113, P61, DOI 10.1016/S0047-6374(99)00101-3
   Keppler D, 2000, CELL TISSUE RES, V302, P181, DOI 10.1007/s004410000269
   Laitinen KSM, 2001, NEUROREPORT, V12, P3309, DOI 10.1097/00001756-200110290-00032
   Mantle D, 1996, CLIN CHIM ACTA, V249, P129, DOI 10.1016/0009-8981(96)06282-1
   McLaughlin PJ, 1998, DEV DYNAM, V211, P153, DOI 10.1002/(SICI)1097-0177(199802)211:2<153::AID-AJA4>3.3.CO;2-O
   MIYAMOTO M, 1994, EUR J PHARMACOL, V271, P357
   NAKANO M, 1988, MECH AGEING DEV, V45, P51, DOI 10.1016/0047-6374(88)90018-8
   OCUINN G, 1990, J NEUROCHEM, V54, P1, DOI 10.1111/j.1471-4159.1990.tb13276.x
   OLEARY RM, 1995, EUR J BIOCHEM, V227, P277, DOI 10.1111/j.1432-1033.1995.tb20385.x
   Saido TC, 1998, NEUROBIOL AGING, V19, pS69, DOI 10.1016/S0197-4580(98)00033-5
   SEDO A, 1991, J CANCER RES CLIN, V117, P249, DOI 10.1007/BF01625433
   Shaw PJ, 1996, J NEUROL SCI, V139, P71, DOI 10.1016/0022-510X(96)00103-7
   SHINODA M, 1995, JPN J PHARMACOL, V69, P273, DOI 10.1254/jjp.69.273
   Takahashi A, 2002, EXP LUNG RES, V28, P275, DOI 10.1080/01902140252964366
   Terwel D, 1998, J NEUROL SCI, V161, P47, DOI 10.1016/S0022-510X(98)00240-8
   TOIDE K, 1995, J NEUROCHEM, V65, P234
   Toide K, 1996, N-S ARCH PHARMACOL, V353, P355, DOI 10.1007/BF00168640
   TSUKAHARA T, 1990, J BIOL CHEM, V265, P21448
   VENTURA C, 1992, CIRC RES, V70, P66, DOI 10.1161/01.RES.70.1.66
   WILK S, 1989, ANN NY ACAD SCI, V553, P556
   YOSHIMOTO T, 1979, BIOCHIM BIOPHYS ACTA, V569, P184, DOI 10.1016/0005-2744(79)90053-6
   ZOLI M, 1993, J CHEM NEUROANAT, V6, P131, DOI 10.1016/0891-0618(93)90023-W
NR 48
TC 19
Z9 19
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD SEP
PY 2003
VL 58
IS 9
BP 792
EP 797
PG 6
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 729UL
UT WOS:000185793100006
PM 14528034
DA 2024-02-19
ER

PT J
AU Rattan, SIS
AF Rattan, SIS
TI Synthesis, modifications, and turnover of proteins during aging
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE translation; posttranslational modifications; protein degradation;
   accuracy; initiation factors; elongation factors; aging
ID HUMAN-DIPLOID FIBROBLASTS; SENESCENT HUMAN-FIBROBLASTS; INITIATION
   FACTOR-II; MESSENGER-RNA LEVELS; ELONGATION FACTOR-II; RAT-LIVER; HUMAN
   LENS; AGED RATS; ACCUMULATION; BRAIN
AB Slowing down of bulk protein synthesis is one of the most commonly observed biochemical changes during aging. The implications and consequences of slower rates of protein synthesis are manifold, including a decrease in the availability of enzymes for the maintenance, repair, and normal metabolic functioning of the cell, an inefficient removal of inactive, abnormal, and damaged macromolecules in the cell, the inefficiency of the intracellular and intercellular signalling pathways, and a decrease in the production and secretion of hormones, antibodies, neurotransmitters, and the components of the extracellular matrix. Age-related changes in the activity, specificity, and stability of a large number of proteins have been reported. However, the molecular mechanisms responsible for such alterations are still poorly understood. Studies on various components of the protein synthetic machinery have revealed a decline in the efficiency and accuracy of ribosomes, an increase in the levels of rRNA and tRNA, and a decrease in the amounts and activities of elongation factors. Because posttranslational modifications of proteins determine their activity and stability, alterations in the extent and level of various modifications such as phosphorylation, methylation, ADP-ribosylation, oxidation, glycation, and conformational changes during aging are being studied. Changes in the regulation of protein synthesis, posttranslational modifications, and protein turnover are crucial determinants of age-related decline in the maintenance, repair, and survival of the organism.
RP Rattan, SIS (corresponding author), AARHUS UNIV, DEPT CHEM, LAB CELLULAR AGEING, LANGELANDSGADE 140, DK-8000 AARHUS C, DENMARK.
OI Rattan, Suresh I.S./0000-0002-3478-1381
CR BAUER EA, 1985, EXP CELL RES, V161, P484, DOI 10.1016/0014-4827(85)90103-X
   BJORKSTEN J, 1990, EXP GERONTOL, V25, P91, DOI 10.1016/0531-5565(90)90039-5
   BLUMENTHAL EJ, 1993, MECH AGEING DEV, V72, P13, DOI 10.1016/0047-6374(93)90127-D
   BRUNAUER LS, 1986, J BIOL CHEM, V261, P2538
   BUCHANAN JH, 1987, EUR J CELL BIOL, V43, P141
   CALES C, 1986, MECH AGEING DEV, V33, P147, DOI 10.1016/0047-6374(86)90023-0
   CARNEY JM, 1991, P NATL ACAD SCI USA, V88, P3633, DOI 10.1073/pnas.88.9.3633
   CINI JK, 1986, ARCH BIOCHEM BIOPHYS, V249, P500, DOI 10.1016/0003-9861(86)90027-5
   DELLORCO RT, 1991, J CELL PHYSIOL, V146, P216, DOI 10.1002/jcp.1041460205
   DERVENTZI A, 1993, MECH AGEING DEV, V69, P193, DOI 10.1016/0047-6374(93)90023-K
   DETATA V, 1993, EXP CELL RES, V205, P261, DOI 10.1006/excr.1993.1085
   DIPAOLO BR, 1992, EXP CELL RES, V201, P500, DOI 10.1016/0014-4827(92)90300-W
   DUDAS SP, 1994, EXP GERONTOL, V29, P645, DOI 10.1016/0531-5565(94)90076-0
   DULIC V, 1993, P NATL ACAD SCI USA, V90, P11034, DOI 10.1073/pnas.90.23.11034
   FILION AM, 1985, MECH AGEING DEV, V29, P125, DOI 10.1016/0047-6374(85)90013-2
   GAFNI A, 1990, REV BIOL RES AGING, V4, P315
   GRACY RW, 1985, MODIFICATION PROTEIN, P1
   GRUBE K, 1992, P NATL ACAD SCI USA, V89, P11759, DOI 10.1073/pnas.89.24.11759
   HARLEY CB, 1980, P NATL ACAD SCI-BIOL, V77, P1885, DOI 10.1073/pnas.77.4.1885
   HEARN MG, 1994, EXP GERONTOL, V29, P611, DOI 10.1016/0531-5565(94)90074-4
   HEBERT L, 1994, EXP CELL RES, V210, P10, DOI 10.1006/excr.1994.1002
   Holliday R, 1984, Monogr Dev Biol, V17, P221
   Holliday R, 1995, Understanding ageing
   JOHNSON TE, 1985, MECH AGEING DEV, V30, P285, DOI 10.1016/0047-6374(85)90118-6
   KAY MMB, 1990, GWUMC DEPT, P147
   KHASIGOV PZ, 1987, BIOCHEM INT, V15, P1171
   KIMBALL SR, 1992, BIOCHEM J, V286, P263, DOI 10.1042/bj2860263
   KIRKLAND JL, 1993, EXP GERONTOL, V28, P557, DOI 10.1016/0531-5565(93)90044-E
   KNUDSEN SM, 1993, EUR J BIOCHEM, V215, P549, DOI 10.1111/j.1432-1033.1993.tb18064.x
   KOWALD A, 1993, J THEOR BIOL, V160, P493, DOI 10.1006/jtbi.1993.1032
   LAUGHREA M, 1988, MECH AGEING DEV, V45, P137, DOI 10.1016/0047-6374(88)90103-0
   LEE AT, 1992, ANN NY ACAD SCI, V663, P63, DOI 10.1111/j.1749-6632.1992.tb38649.x
   LIS H, 1993, EUR J BIOCHEM, V218, P1, DOI 10.1111/j.1432-1033.1993.tb18347.x
   LUCE MC, 1989, EXP GERONTOL, V24, P113, DOI 10.1016/0531-5565(89)90022-3
   LUTHRA M, 1994, J BIOL CHEM, V269, P22678
   MAKITA Z, 1992, SCIENCE, V258, P651, DOI 10.1126/science.1411574
   MAYSHOOPES LL, 1985, REV BIOL AGING, V2, P361
   MCFADDEN PN, 1986, MECH AGEING DEV, V34, P91, DOI 10.1016/0047-6374(86)90107-7
   Medvedev ZA, 1986, DRUGS AGING, P1
   MERRICK WC, 1992, MICROBIOL REV, V56, P291, DOI 10.1128/MMBR.56.2.291-315.1992
   MERRY BJ, 1991, MECH AGEING DEV, V58, P139, DOI 10.1016/0047-6374(91)90088-H
   MIKSIK I, 1991, J GERONTOL, V46, pB111, DOI 10.1093/geronj/46.3.B111
   MILLER RA, 1994, EXP GERONTOL, V29, P21, DOI 10.1016/0531-5565(94)90060-4
   MORI N, 1983, MECH AGEING DEV, V22, P1, DOI 10.1016/0047-6374(83)90002-7
   NAGARAJ RH, 1991, P NATL ACAD SCI USA, V88, P10257, DOI 10.1073/pnas.88.22.10257
   NAKAZAWA T, 1984, MECH AGEING DEV, V26, P241, DOI 10.1016/0047-6374(84)90097-6
   OIMOMI M, 1988, J GERONTOL, V43, pB98, DOI 10.1093/geronj/43.4.B98
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   PAN JX, 1993, EXP GERONTOL, V28, P39, DOI 10.1016/0531-5565(93)90018-9
   PARK MH, 1993, BIOFACTORS, V4, P95
   PORTER MB, 1992, J CELL PHYSIOL, V150, P545, DOI 10.1002/jcp.1041500315
   Rattan S.I.S., 1995, MOL BASIS AGING, P389
   RATTAN SIS, 1992, ANN NY ACAD SCI, V663, P48, DOI 10.1111/j.1749-6632.1992.tb38648.x
   RATTAN SIS, 1991, MUTAT RES, V256, P115, DOI 10.1016/0921-8734(91)90005-V
   RATTAN SIS, 1992, EUR J GERONTOL, V1, P128
   RICHARDSON A, 1987, REV BIOL RES AGING, V3, P467
   RICHTER KH, 1991, CANCER RES, V51, P6010
   RIIS B, 1990, FEBS LETT, V266, P45, DOI 10.1016/0014-5793(90)81502-F
   RIIS B, 1990, TRENDS BIOCHEM SCI, V15, P420, DOI 10.1016/0968-0004(90)90279-K
   RIIS B, 1995, BIOCHEM MOL BIOL INT, V35, P855
   RIIS B, 1993, BIOCHEM BIOPH RES CO, V192, P1210, DOI 10.1006/bbrc.1993.1545
   RYAZANOV AG, 1991, FEBS LETT, V285, P170, DOI 10.1016/0014-5793(91)80798-8
   SAUNDERS NA, 1993, BIOCHEM BIOPH RES CO, V197, P46, DOI 10.1006/bbrc.1993.2439
   SCHRODER HC, 1992, EUR J GERONTOL, V1, P452
   SELKOE DJ, 1992, SCI AM, V267, P135, DOI 10.1038/scientificamerican0992-134
   SELLINGER OZ, 1988, MECH AGEING DEV, V43, P161, DOI 10.1016/0047-6374(88)90044-9
   SESHADRI T, 1990, SCIENCE, V247, P205, DOI 10.1126/science.2104680
   SHEPHERD JCW, 1989, P NATL ACAD SCI USA, V86, P7520, DOI 10.1073/pnas.86.19.7520
   SHIGEOKA H, 1990, MECH AGEING DEV, V55, P49, DOI 10.1016/0047-6374(90)90105-O
   SHIKAMA N, 1994, P NATL ACAD SCI USA, V91, P4199, DOI 10.1073/pnas.91.10.4199
   SILAR P, 1994, J MOL BIOL, V235, P231, DOI 10.1016/S0022-2836(05)80029-4
   SOHAL RS, 1993, BIOCHEM BIOPH RES CO, V196, P7, DOI 10.1006/bbrc.1993.2208
   SOHAL RS, 1993, P NATL ACAD SCI USA, V90, P7255, DOI 10.1073/pnas.90.15.7255
   SOJAR HT, 1986, MECH AGEING DEV, V35, P47, DOI 10.1016/0047-6374(86)90065-5
   SOTTILE J, 1989, J CELL PHYSIOL, V138, P281, DOI 10.1002/jcp.1041380209
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   STEIN GH, 1990, SCIENCE, V249, P666, DOI 10.1126/science.2166342
   STREHLER B, 1971, J THEOR BIOL, V33, P429, DOI 10.1016/0022-5193(71)90091-9
   TAKAHASHI R, 1985, MECH AGEING DEV, V33, P67, DOI 10.1016/0047-6374(85)90109-5
   TAKAHASHI R, 1985, EXP GERONTOL, V20, P325, DOI 10.1016/0531-5565(85)90012-9
   THELIN A, 1994, MECH AGEING DEV, V76, P165, DOI 10.1016/0047-6374(94)91591-1
   Van Remmen Holly, 1995, P171
   VINAYAK M, 1987, BIOCHEM INT, V15, P279
   WARD W, 1991, HEPATOLOGY, V14, P935, DOI 10.1002/hep.1840140529
   Webster G.C., 1986, P207
   WEBSTER GC, 1985, MOL BIOL AGING GENE, P263
   WELLSKNECHT MC, 1993, J BIOL CHEM, V268, P12348
   WICK M, 1994, J BIOL CHEM, V269, P18953
NR 88
TC 167
Z9 191
U1 0
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD JAN-APR
PY 1996
VL 31
IS 1-2
BP 33
EP 47
DI 10.1016/0531-5565(95)02022-5
PG 15
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA TX426
UT WOS:A1996TX42600006
PM 8706803
DA 2024-02-19
ER

PT J
AU Iwasa, M
   Kaito, M
   Gabazza, EC
   Ikoma, J
   Nakagawa, N
   Fujita, N
   Watanabe, S
   Adachi, Y
AF Iwasa, M
   Kaito, M
   Gabazza, EC
   Ikoma, J
   Nakagawa, N
   Fujita, N
   Watanabe, S
   Adachi, Y
TI Quantitative analysis of magnetic resonance signal intensity of the
   vertebral body bone marrow in patients with liver cirrhosis
SO MEDICAL SCIENCE RESEARCH
LA English
DT Article
DE bone marrow; liver cirrhosis; magnetic resonance imaging
ID AGE; MR; DISORDERS
AB We have semiquantified the signal intensity of the vertebral body bone marrow using magnetic resonance imaging, and evaluated its clinical significance in patients with liver cirrhosis. 30 subjects with normal liver function and 35 patients with liver cirrhosis were enrolled in the study. On fat-suppressed T2-weighted images, the signal intensity ratio of bone marrow to spinal erector muscle deceased concomitantly with ageing in subjects with normal liver function. In patients with early liver cirrhosis, there was a significant correlation between the ratio and the peripheral erythrocyte count. The ratio was significantly higher in patients with advanced cirrhosis. Measurement of bone marrow signal intensity by abdominal magnetic resonance imaging with fat-suppression techniques may provide important information about the bone marrow cellularity and haemodynamic state in patients with liver cirrhosis. Med Sci Res 27:735-737 (C) 1999 Lippincott Williams & Wilkins.
C1 Mie Univ, Sch Med, Dept Internal Med 3, Tsu, Mie 5148507, Japan.
   Mie Univ, Hlth Adm Ctr, Tsu, Mie 5148507, Japan.
C3 Mie University; Mie University
RP Iwasa, M (corresponding author), Mie Univ, Sch Med, Dept Internal Med 3, 2-174 Edobashi, Tsu, Mie 5148507, Japan.
RI Gabazza, Esteban/HTO-2503-2023
CR DAWSON KL, 1992, RADIOLOGY, V183, P47, DOI 10.1148/radiology.183.1.1549693
   DIXON WT, 1984, RADIOLOGY, V153, P189, DOI 10.1148/radiology.153.1.6089263
   DOOMS GC, 1985, RADIOLOGY, V155, P429, DOI 10.1148/radiology.155.2.3983394
   GUCKEL F, 1990, J COMPUT ASSIST TOMO, V14, P633
   IWASAKI T, 1991, JPN J MAGNET RESON M, V11, P420
   JENSEN KE, 1990, ACTA RADIOL, V31, P361
   JONES KM, 1992, MAGN RESON IMAGING, V10, P169, DOI 10.1016/0730-725X(92)90477-H
   Kakitsubata Yousuke, 1993, Nippon Acta Radiologica, V53, P1267
   MOORE SG, 1990, RADIOLOGY, V175, P219, DOI 10.1148/radiology.175.1.2315484
   PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817
   Sherlock S, 1993, DIS LIVER BILIARY SY, P44
   SMITH SR, 1989, RADIOLOGY, V172, P805, DOI 10.1148/radiology.172.3.2772192
   UEDA H, 1998, JPN J MAGNET RESON M, V18, P57
   VOGLER JB, 1988, RADIOLOGY, V168, P679, DOI 10.1148/radiology.168.3.3043546
NR 14
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0269-8951
J9 MED SCI RES
JI Med. Sci. Res.
PD NOV
PY 1999
VL 27
IS 11
BP 735
EP 737
PG 3
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 252QR
UT WOS:000083514200004
DA 2024-02-19
ER

PT J
AU Rieck, S
   Zhang, J
   Li, ZY
   Liu, CY
   Naji, A
   Takane, KK
   Fiaschi-Taesch, NM
   Stewart, AF
   Kushner, JA
   Kaestner, KH
AF Rieck, Sebastian
   Zhang, Jia
   Li, Zhaoyu
   Liu, Chengyang
   Naji, Ali
   Takane, Karen K.
   Fiaschi-Taesch, Nathalie M.
   Stewart, Andrew F.
   Kushner, Jake A.
   Kaestner, Klaus H.
TI Overexpression of Hepatocyte Nuclear Factor-4α Initiates Cell Cycle
   Entry, but Is not Sufficient to Promote β-Cell Expansion in Human Islets
SO MOLECULAR ENDOCRINOLOGY
LA English
DT Article
ID DNA-DAMAGE RESPONSE; ONCOGENE-INDUCED SENESCENCE; INSULIN-SECRETION;
   IN-VITRO; REPLICATION; PROLIFERATION; P53; HNF-4-ALPHA; CHECKPOINTS;
   EXPRESSION
AB The transcription factor HNF4 alpha ( hepatocyte nuclear factor-4 alpha) is required for increased beta-cell proliferation during metabolic stress in vivo. We hypothesized that HNF4 alpha could induce proliferation of human beta-cells. We employed adenoviral-mediated overexpression of an isoform of HNF4 alpha (HNF4 alpha 8) alone, or in combination with cyclin-dependent kinase (Cdk) 6 and Cyclin D3, in human islets. Heightened HNF4 alpha 8 expression led to a 300-fold increase in the number of beta-cells in early S-phase. When we overexpressed HNF4 alpha 8 together with Cdk6 and Cyclin D3, beta-cell cycle entry was increased even further. However, the punctate manner of bromodeoxyuridine incorporation into HNF4 alpha(High) beta-cells indicated an uncoupling of the mechanisms that control the concise timing and execution of each cell cycle phase. Indeed, in HNF4 alpha 8-induced bromodeoxyuridine(+,punctate) beta-cells we observed signs of dysregulated DNA synthesis, cell cycle arrest, and activation of a double stranded DNA damage-associated cell cycle checkpoint mechanism, leading to the initiation of loss of beta-cell lineage fidelity. However, a substantial proportion of beta-cells stimulated to enter the cell cycle by Cdk6 and Cyclin D3 alone also exhibited a DNA damage response. HNF4 alpha 8 is a mitogenic signal in the human beta-cell but is not sufficient for completion of the cell cycle. The DNA damage response is a barrier to efficient beta-cell proliferation in vitro, and we suggest its evaluation in all attempts to stimulate beta-cell replication as an approach to diabetes treatment. (Molecular Endocrinology 26: 1590-1602, 2012)
C1 [Rieck, Sebastian; Zhang, Jia; Li, Zhaoyu; Kaestner, Klaus H.] Univ Penn, Sch Med, Dept Genet, Translat Res Ctr 12 126, Philadelphia, PA 19104 USA.
   [Rieck, Sebastian; Zhang, Jia; Li, Zhaoyu; Kaestner, Klaus H.] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Translat Res Ctr 12 126, Philadelphia, PA 19104 USA.
   [Liu, Chengyang; Naji, Ali] Univ Penn, Sch Med, Dept Transplantat, Philadelphia, PA 19104 USA.
   [Takane, Karen K.; Fiaschi-Taesch, Nathalie M.; Stewart, Andrew F.] Univ Pittsburgh, Sch Med, Div Endocrinol & Metab, Pittsburgh, PA 15261 USA.
   [Kushner, Jake A.] Baylor Coll Med, Dept Pediat Diabet & Endocrinol, Houston, TX 77030 USA.
C3 University of Pennsylvania; University of Pennsylvania; University of
   Pennsylvania; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); University of Pittsburgh; Baylor College of Medicine
RP Kaestner, KH (corresponding author), Univ Penn, Sch Med, Dept Genet, Translat Res Ctr 12 126, 3400 Civ Ctr Blvd,Buildingg 421, Philadelphia, PA 19104 USA.
EM kaestner@mail.med.upenn.edu
RI Kushner, Jake A/AFJ-8198-2022; Kushner, Jake A/AAF-5049-2022
OI Kushner, Jake A/0000-0002-3646-1744; Kushner, Jake
   A/0000-0002-3646-1744; Li, Zhaoyu/0000-0002-1136-2758
FU National Institutes of Health (NIH) Pharmacology training grant [T32
   GM008076-25, DK R01-055342]; Juvenile Diabetes Research Foundation
   (JDRF) Postdoctoral Fellowship Award [U01 DK 089538,
   1-2008-39/34-2008-7630, 17-2011-262]
FX This work was supported by National Institutes of Health (NIH)
   Pharmacology training grant (T32 GM008076-25) (to S.R.), Juvenile
   Diabetes Research Foundation (JDRF) Postdoctoral Fellowship Award (to
   Z.L.), U01 DK 089538 and JDRF grants 1-2008-39/34-2008-7630 (to A.F.S.),
   and NIH (DK R01-055342) and JDRF grants (17-2011-262) (to K.H.K.).
CR Aggarwal P, 2007, GENE DEV, V21, P2908, DOI 10.1101/gad.1586007
   Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482
   Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268
   Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663
   Blow JJ, 2002, TRENDS CELL BIOL, V12, P72, DOI 10.1016/S0962-8924(01)02203-6
   CHARTIER FL, 1994, GENE, V147, P269, DOI 10.1016/0378-1119(94)90079-5
   Cozar-Castellano I, 2008, DIABETES, V57, P3056, DOI 10.2337/db08-0393
   Davidson IF, 2006, MOL CELL, V24, P433, DOI 10.1016/j.molcel.2006.09.010
   Davis DB, 2010, MOL ENDOCRINOL, V24, P1822, DOI 10.1210/me.2010-0082
   Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327
   Dimitrova DS, 2000, NAT CELL BIOL, V2, P686, DOI 10.1038/35036309
   Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520
   Fiaschi-Taesch N, 2009, DIABETES, V58, P882, DOI 10.2337/db08-0631
   Fiaschi-Taesch NM, 2010, DIABETES, V59, P1926, DOI 10.2337/db09-1776
   Gupta RK, 2007, GENE DEV, V21, P756, DOI 10.1101/gad.1535507
   Gupta RK, 2005, J CLIN INVEST, V115, P1006, DOI 10.1172/JCI22365
   Halvorsen TL, 2000, J ENDOCRINOL, V166, P103, DOI 10.1677/joe.0.1660103
   Hansen SK, 2002, J CLIN INVEST, V110, P827, DOI 10.1172/JCI200215085
   Harb G, 2009, DIABETES, V58, P1852, DOI 10.2337/db08-0759
   Hardy OT, 2007, MOL ENDOCRINOL, V21, P765, DOI 10.1210/me.2006-0411
   Hohmeier HE, 2005, NAT BIOTECHNOL, V23, P1231, DOI 10.1038/nbt1005-1231
   Karslioglu E, 2011, MOL ENDOCRINOL, V25, P1760, DOI 10.1210/me.2011-1074
   Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097
   Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Lavine JA, 2010, MOL ENDOCRINOL, V24, P464, DOI 10.1210/me.2009-0384
   Laybutt DR, 2002, DIABETES, V51, P1793, DOI 10.2337/diabetes.51.6.1793
   Lee SH, 2011, ISLETS, V3, P358, DOI 10.4161/isl.3.6.17923
   Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008
   Matsuoka TA, 2007, MOL ENDOCRINOL, V21, P2764, DOI 10.1210/me.2007-0028
   Matsuoka T, 2010, DIABETES, V59, P1709, DOI 10.2337/db08-0693
   Murray-Zmijewski F, 2008, NAT REV MOL CELL BIO, V9, P702, DOI 10.1038/nrm2451
   Nelson SB, 2007, DEVELOPMENT, V134, P2491, DOI 10.1242/dev.002691
   PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x
   Pang LZ, 2003, J CELL PHYSIOL, V197, P251, DOI 10.1002/jcp.10357
   Perl S, 2010, J CLIN ENDOCR METAB, V95, pE234, DOI 10.1210/jc.2010-0932
   Rieck S, 2009, MOL ENDOCRINOL, V23, P1702, DOI 10.1210/me.2009-0144
   Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858
   Russ HA, 2008, DIABETES, V57, P1575, DOI 10.2337/db07-1283
   Sage J, 2010, GENE DEV, V24, P1329, DOI 10.1101/gad.1948010
   Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723
   Sengupta S, 2003, EMBO J, V22, P1210, DOI 10.1093/emboj/cdg114
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401
   Shibuya EK, 1996, CELL GROWTH DIFFER, V7, P235
   Sladek FM, 2011, MOL CELL ENDOCRINOL, V334, P3, DOI 10.1016/j.mce.2010.06.018
   Soleimanpour SA, J BIOL CHEM, V285, P40050
   Takane KK, 2012, DIABETES, V61, P418, DOI 10.2337/db11-0580
   Tavana O, 2010, DIABETES, V59, P135, DOI 10.2337/db09-0792
   Thomson AM, 2010, J CELL BIOL, V188, P209, DOI 10.1083/jcb.200911037
   Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005
NR 51
TC 42
Z9 48
U1 0
U2 3
PU ENDOCRINE SOC
PI CHEVY CHASE
PA 8401 CONNECTICUT AVE, SUITE 900, CHEVY CHASE, MD 20815-5817 USA
SN 0888-8809
J9 MOL ENDOCRINOL
JI Mol. Endocrinol.
PD SEP
PY 2012
VL 26
IS 9
BP 1590
EP 1602
DI 10.1210/me.2012-1019
PG 13
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 999VI
UT WOS:000308342700011
PM 22798294
OA Bronze, Green Published, Green Accepted
DA 2024-02-19
ER

PT J
AU Mandal, S
   Dasmahapatra, AK
AF Mandal, Suvendu
   Dasmahapatra, Ashok Kumar
TI Effect of aging on the microstructure and physical properties of
   Poly(vinyl alcohol) hydrogel
SO JOURNAL OF POLYMER RESEARCH
LA English
DT Article
DE Physical aging; Poly(vinyl alcohol) hydrogel; Hydrogen bonding;
   Molecular rearrangement
ID MECHANICAL-PROPERTIES; FREE-VOLUME; RHEOLOGICAL CHARACTERIZATION;
   STRUCTURAL-PROPERTIES; CRYSTALLIZATION; POLYPROPYLENE; SPECTROSCOPY;
   KINETICS; GELATION; PHASE
AB Physical aging is a fundamental phenomenon for any polymeric material and is essential to understand correctly, especially to foretell the long-term behavior of the material. Change in properties with time has a great influence on its applicability and usability. Polyvinyl alcohol (PVA), one of the most widely used polymers especially in biomedical industries, due to its biocompatibility and biodegradability nature. Moreover, PVA hydrogel is widely used in tissue engineering applications because of its high porosity and water retention capacity. The influence of aging (viz., real-time aging) on the physical properties of PVA hydrogel is poorly understood. Herein, we present an aging (viz., real-time) study of PVA hydrogel over a long period, from 3-days to 300-days. The detailed morphological analysis based on FESEM reveals a significant change in microstructure, with coarsening of pores. The rheological study shows that the material becomes more elastic with aging. After 300 days of aging the PVA hydrogel becomes thermally more stable with a shift in the transition temperature based on DSC/TGA analysis. The change in macroscopic properties is linked with the change in microscopic structure, which is governed by the extensive hydrogen bonding (both intra- and inter-molecular) between hydroxyl groups, as is evident from FTIR studies. This extensive hydrogen bonding leads to the formation of a crosslinked three-dimensional network structure, which evolves with the aging time. The 300 days aged hydrogel microstructure resembles to the porcine liver structure, indicating that it may be useful as a scaffold for tissue engineering research purposes.
C1 [Mandal, Suvendu; Dasmahapatra, Ashok Kumar] Indian Inst Technol Guwahati, Ctr Nanotechnol, Gauhati 781039, Assam, India.
   [Dasmahapatra, Ashok Kumar] Indian Inst Technol Guwahati, Dept Chem Engn, Gauhati 781039, Assam, India.
C3 Indian Institute of Technology System (IIT System); Indian Institute of
   Technology (IIT) - Guwahati; Indian Institute of Technology System (IIT
   System); Indian Institute of Technology (IIT) - Guwahati
RP Dasmahapatra, AK (corresponding author), Indian Inst Technol Guwahati, Ctr Nanotechnol, Gauhati 781039, Assam, India.; Dasmahapatra, AK (corresponding author), Indian Inst Technol Guwahati, Dept Chem Engn, Gauhati 781039, Assam, India.
EM suven176153002@iitg.ac.in; akdm@iitg.ac.in
FU Ministry of Electronics and Information Technology, Government of India
   [5(9)/2012-NANO (Vol. II)]; Department of Science and Technology
   Government of India [SR/FST/ETII-028/2010, EMR/2017/003610]
FX The authors wish to acknowledge the Ministry of Electronics and
   Information Technology (No. 5(9)/2012-NANO (Vol. II)), and the
   Department of Science and Technology (No. SR/FST/ETII-028/2010 and
   EMR/2017/003610), Government of India, for funding support. We highly
   acknowledge the Centre for Nanotechnology, Department of Biosciences and
   Bioengineering, Department of Chemical engineering and CIF, IIT
   Guwahati, for providing characteristics measurements and
   characterizations facilities.
CR Aamer KA, 2004, BIOMATERIALS, V25, P1087, DOI 10.1016/S0142-9612(03)00632-X
   Abdullah OG, 2016, RESULTS PHYS, V6, P1103, DOI 10.1016/j.rinp.2016.11.050
   ARIGA O, 1987, J FERMENT BIOENG, V65, P651, DOI 10.1016/0385-6380(87)90007-0
   Bercea M, 2015, EUR POLYM J, V70, P147, DOI 10.1016/j.eurpolymj.2015.07.013
   Bercea M, 2013, SOFT MATTER, V9, P1244, DOI 10.1039/c2sm26094h
   Bin-Dahman OA, 2017, STARCH-STARKE, V69, DOI 10.1002/star.201600005
   Cangialosi D, 2003, MACROMOLECULES, V36, P142, DOI 10.1021/ma021214z
   Chen YN, 2016, ACS APPL MATER INTER, V8, P27199, DOI 10.1021/acsami.6b08374
   CHOW TS, 1984, MACROMOLECULES, V17, P2336, DOI 10.1021/ma00141a024
   Curley C, 2014, J MECH BEHAV BIOMED, V40, P13, DOI 10.1016/j.jmbbm.2014.08.003
   Dong WF, 2014, J THERM ANAL CALORIM, V115, P1661, DOI 10.1007/s10973-013-3419-2
   DOOLITTLE AK, 1951, J APPL PHYS, V22, P1471, DOI 10.1063/1.1699894
   Draper ER, 2015, CHEM COMMUN, V51, P6595, DOI 10.1039/c5cc01334h
   Elkebir Y, 2020, ELECTROCHIM ACTA, V337, DOI 10.1016/j.electacta.2020.135766
   Gao HW, 2010, J APPL POLYM SCI, V116, P1459, DOI 10.1002/app.31677
   Grattoni CA, 2001, J COLLOID INTERF SCI, V240, P601, DOI 10.1006/jcis.2001.7633
   Gupta S, 2011, J MATER SCI-MATER M, V22, P1763, DOI 10.1007/s10856-011-4343-2
   Hassan CM, 2000, MACROMOLECULES, V33, P2472, DOI 10.1021/ma9907587
   Hassan CM, 2000, ADV POLYM SCI, V153, P37
   Hayes JC, 2016, MAT SCI ENG C-MATER, V59, P894, DOI 10.1016/j.msec.2015.10.052
   Hecksher T, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3487646
   Holloway JL, 2013, ACTA BIOMATER, V9, P5013, DOI 10.1016/j.actbio.2012.09.018
   Holloway JL, 2013, SOFT MATTER, V9, P826, DOI 10.1039/c2sm26763b
   Hu WX, 2019, J POLYM RES, V26, DOI 10.1007/s10965-019-1773-x
   HUTCHINSON JM, 1995, PROG POLYM SCI, V20, P703, DOI 10.1016/0079-6700(94)00001-I
   Jiang S, 2011, J MECH BEHAV BIOMED, V4, P1228, DOI 10.1016/j.jmbbm.2011.04.005
   Kamoun EA, 2015, ARAB J CHEM, V8, P1, DOI 10.1016/j.arabjc.2014.07.005
   Karami M, 2009, FOOD CHEM, V112, P539, DOI 10.1016/j.foodchem.2008.06.003
   Kenawy E, 2014, ARAB J CHEM, V7, P372, DOI 10.1016/j.arabjc.2013.05.026
   KENNEY JF, 1966, J POLYM SCI A1, V4, P699, DOI 10.1002/pol.1966.150040322
   Law A, 2008, POLYM ENG SCI, V48, P627, DOI 10.1002/pen.20987
   Lee EJ, 2006, J APPL POLYM SCI, V101, P465, DOI 10.1002/app.23256
   Li JK, 1998, J CONTROL RELEASE, V56, P117, DOI 10.1016/S0168-3659(98)00089-3
   Liu YR, 2010, J MECH BEHAV BIOMED, V3, P203, DOI 10.1016/j.jmbbm.2009.07.001
   Mansur HS, 2008, MAT SCI ENG C-BIO S, V28, P539, DOI 10.1016/j.msec.2007.10.088
   Mansur HS, 2004, POLYMER, V45, P7193, DOI 10.1016/j.polymer.2004.08.036
   Merrick MM, 2020, POLYMER, V211, DOI 10.1016/j.polymer.2020.123176
   Mota R. C. A. G., 2018, MAT SCI APPL, V09, P473, DOI DOI 10.4236/MSA.2018.95033
   Moura MJ, 2007, BIOMACROMOLECULES, V8, P3823, DOI 10.1021/bm700762w
   Noori S, 2015, PROC MAT SCI, V11, P152, DOI 10.1016/j.mspro.2015.11.023
   Orienti I, 2001, DRUG DEV IND PHARM, V27, P877, DOI 10.1081/DDC-100107253
   Othman N., 2011, Malays. Polym. J, V6, P147
   Ozer BH, 1998, J TEXTURE STUD, V29, P67, DOI 10.1111/j.1745-4603.1998.tb00154.x
   Pan PJ, 2007, MACROMOLECULES, V40, P9664, DOI 10.1021/ma071737c
   Park JS, 2001, POLYMER, V42, P4271, DOI 10.1016/S0032-3861(00)00768-0
   Pavia DL., 2015, INTRO SPECTROSCOPY
   Peng M, 2014, MACROMOLECULES, V47, P8411, DOI 10.1021/ma501590x
   PEPPAS NA, 1980, BIOMATERIALS, V1, P158, DOI 10.1016/0142-9612(80)90039-3
   Qi XL, 2015, CARBOHYD POLYM, V118, P60, DOI 10.1016/j.carbpol.2014.11.021
   Ramli M, 2013, COMPOS PART B-ENG, V55, P221, DOI 10.1016/j.compositesb.2013.06.022
   Reena, 2020, J MOL LIQ, V301, DOI 10.1016/j.molliq.2020.112472
   ROBERTSON RE, 1984, MACROMOLECULES, V17, P911, DOI 10.1021/ma00134a064
   Schwarz I, 2001, COLLOID POLYM SCI, V279, P506, DOI 10.1007/s003960100488
   Stolte I, 2013, J PHYS CHEM B, V117, P15196, DOI 10.1021/jp4093404
   STRUIK LCE, 1976, ANN NY ACAD SCI, V279, P78, DOI 10.1111/j.1749-6632.1976.tb39695.x
   STRUIK LCE, 1977, POLYM ENG SCI, V17, P165, DOI 10.1002/pen.760170305
   Tang YF, 2007, CARBOHYD POLYM, V67, P491, DOI 10.1016/j.carbpol.2006.06.015
   Teodorescu M, 2016, RSC ADV, V6, P39718, DOI 10.1039/c6ra04319d
   Uddin AJ, 2011, COMPOS PART A-APPL S, V42, P741, DOI 10.1016/j.compositesa.2011.02.012
   Volynskii AL, 2007, POLYM SCI SER C+, V49, P301, DOI 10.1134/S1811238207040017
   Wang B, 2003, POLYMER, V44, P4047, DOI 10.1016/S0032-3861(03)00306-9
   White RP, 2016, MACROMOLECULES, V49, P3987, DOI 10.1021/acs.macromol.6b00215
   Xinqiu Hong, 2018, IOP Conference Series: Materials Science and Engineering, V439, DOI 10.1088/1757-899X/439/4/042011
   Yan CQ, 2010, CHEM SOC REV, V39, P3528, DOI 10.1039/b919449p
   Yang J, 2013, ACS APPL MATER INTER, V5, P3199, DOI 10.1021/am4001997
   Yang N, 2013, J RHEOL, V57, P1739, DOI 10.1122/1.4824428
   Yu LC, 2018, J POLYM RES, V25, DOI 10.1007/s10965-018-1642-z
   Zhang TP, 2011, J PHYS CHEM B, V115, P13835, DOI 10.1021/jp2087863
   Zhao J, 2002, MACROMOLECULES, V35, P3097, DOI 10.1021/ma011333z
   Zu YG, 2012, INT J BIOL MACROMOL, V50, P82, DOI 10.1016/j.ijbiomac.2011.10.006
NR 70
TC 7
Z9 7
U1 4
U2 29
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1022-9760
EI 1572-8935
J9 J POLYM RES
JI J. Polym. Res.
PD JUL
PY 2021
VL 28
IS 7
AR 269
DI 10.1007/s10965-021-02624-9
PG 12
WC Polymer Science
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Polymer Science
GA UJ7GR
UT WOS:000691450500002
DA 2024-02-19
ER

PT J
AU Hamada, T
   Miyakawa, K
   Kushige, H
   Shibata, S
   Kurachi, S
AF Hamada, Toshiyuki
   Miyakawa, Kazuko
   Kushige, Hiroko
   Shibata, Shigenobu
   Kurachi, Sumiko
TI Age-related expression analysis of mouse liver nuclear protein binding
   to 3'-untranslated region of <i>Period2</i> gene
SO JOURNAL OF PHYSIOLOGICAL SCIENCES
LA English
DT Article
DE Period 2; hnRNP; Circadian rhythm; Aging; Homeostasis
ID MESSENGER-RNA DEGRADATION; CIRCADIAN OSCILLATION; ARGININE METHYLATION;
   PROTEOMIC ANALYSIS; BLOOD-COAGULATION; FACTOR-IX; HNRNP A1;
   PHOSPHORYLATION; TRANSLATION; MAINTENANCE
AB In mammals, both circadian rhythm and aging play important roles in regulating time-dependent homeostasis. We previously discovered an age-related increase element binding protein, hnRNP A3, which binds to the 3'-untranslated region (UTR) of blood coagulation factor IX (FIX). Here, we describe other members of this protein family, hnRNP C and hnRNP H, which bind to the 3'-UTR of the mouse circadian clock gene Period 2 (mPer2). RNA electrophoretic mobility shift assays using a P-32-labeled Per2 RNA probe coupled with two-dimensional gel electrophoresis followed by MALDI-TOF/MS peptide mass fingerprint analysis was used to analyze these proteins. Western blotting suggested that the total expression of these proteins in mouse liver cell nuclei does not increase with age. Two-dimensional gel electrophoresis analysis of age-related protein expression showed that many isoforms of these proteins exist in the liver and that each protein exhibits a complex age-related expression pattern. These results suggest that many isoforms of proteins are regulated by different aging systems and that many age regulation systems function in the liver.
C1 [Hamada, Toshiyuki] Hokkaido Univ, Appl Mol Imaging Phys, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan.
   [Hamada, Toshiyuki] Hakujikai Inst Gerontol, Adachi Ward, Tokyo 1230864, Japan.
   [Miyakawa, Kazuko; Shibata, Shigenobu] Waseda Univ, Sch Adv Sci & Engn, Lab Physiol & Pharmacol, Shinjuku Ward, Tokyo 1628480, Japan.
   [Kushige, Hiroko] Natl Inst Adv Ind Sci & Technol, AIST Tsukuba Ctr 6 13, Age Dimens Res Ctr, Tsukuba, Ibaraki 3058566, Japan.
   [Kurachi, Sumiko] Univ Washington, Div Med Genet, Dept Med, Seattle, WA 98195 USA.
C3 Hokkaido University; Waseda University; National Institute of Advanced
   Industrial Science & Technology (AIST); University of Washington;
   University of Washington Seattle
RP Hamada, T (corresponding author), Hokkaido Univ, Appl Mol Imaging Phys, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan.
EM toshi-ha@med.hokudai.ac.jp; hiroko.kushige@aist.go.jp
RI Hamada, Toshiyuki/AAZ-2258-2020
OI Hamada, Toshiyuki/0000-0002-3998-2916
FU internal research fund from AIST; JSPS KAKENHI [24621001]; Suhara
   Memorial Foundation; Grants-in-Aid for Scientific Research [24621001]
   Funding Source: KAKEN
FX This research was supported in part by an internal research fund from
   AIST, JSPS KAKENHI (Grant Number 24621001), and by a research fund from
   The Suhara Memorial Foundation. We thank Dr. Kenneth Sutherland for
   comments on drafts of this manuscript.
CR Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003
   Buxadé M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009
   Hamada T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012971
   Heintzen C, 1997, P NATL ACAD SCI USA, V94, P8515, DOI 10.1073/pnas.94.16.8515
   HONORE B, 1995, J BIOL CHEM, V270, P28780
   Hüttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115
   Kim TD, 2007, GENE DEV, V21, P797, DOI 10.1101/gad.1519507
   Kim TD, 2005, MOL CELL BIOL, V25, P3232, DOI 10.1128/MCB.25.8.3232-3246.2005
   Kojima S, 2007, P NATL ACAD SCI USA, V104, P1859, DOI 10.1073/pnas.0607567104
   Kurachi Kotoku, 2008, Nihon Ronen Igakkai Zasshi, V45, P126
   Kurachi Kotoku, 2008, P427, DOI 10.1007/978-4-431-78847-8_30
   Kurachi S, 1999, SCIENCE, V285, P739, DOI 10.1126/science.285.5428.739
   Kurachi S, 2009, P NATL ACAD SCI USA, V106, P7921, DOI 10.1073/pnas.0902191106
   Li TW, 2004, P NATL ACAD SCI USA, V101, P8551, DOI 10.1073/pnas.0402889101
   LIU Q, 1995, MOL CELL BIOL, V15, P2800
   Mittag M, 1996, P NATL ACAD SCI USA, V93, P14401, DOI 10.1073/pnas.93.25.14401
   MITTAG M, 1994, P NATL ACAD SCI USA, V91, P5257, DOI 10.1073/pnas.91.12.5257
   Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X
   Ostareck-Lederer A, 2002, MOL CELL BIOL, V22, P4535, DOI 10.1128/MCB.22.13.4535-4543.2002
   Shetty S, 2005, MOL CELL BIOCHEM, V272, P107, DOI 10.1007/s11010-005-7644-2
   Tamaru T, 2003, NEUROSCI LETT, V341, P111, DOI 10.1016/S0304-3940(03)00181-2
   Villén J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104
   WEIGHARDT F, 1995, J CELL SCI, V108, P545
   Woo KC, 2010, MOL CELL BIOL, V30, P197, DOI 10.1128/MCB.01154-09
   Woo KC, 2009, NUCLEIC ACIDS RES, V37, P26, DOI 10.1093/nar/gkn893
   Yamaoka K, 2006, BIOCHEM BIOPH RES CO, V345, P1240, DOI 10.1016/j.bbrc.2006.04.183
   YOSHITAKE S, 1985, BIOCHEMISTRY-US, V24, P3736, DOI 10.1021/bi00335a049
   Zhang KZ, 2002, J BIOL CHEM, V277, P4532, DOI 10.1074/jbc.M109524200
   Ziemienowicz A, 2003, PLANT MOL BIOL, V53, P201, DOI 10.1023/B:PLAN.0000009288.46713.1f
NR 29
TC 0
Z9 0
U1 0
U2 7
PU SPRINGER JAPAN KK
PI TOKYO
PA CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065,
   JAPAN
SN 1880-6546
EI 1880-6562
J9 J PHYSIOL SCI
JI J. Physiol. Sci.
PD JUL
PY 2015
VL 65
IS 4
BP 349
EP 357
DI 10.1007/s12576-015-0373-8
PG 9
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA CL1UJ
UT WOS:000356730100006
PM 25846207
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Grigoras, ML
   Citu, IM
   Citu, C
   Chiriac, VD
   Gorun, F
   Levai, MC
   Manolescu, D
   Rosca, O
   Bratosin, F
   Gurumurthy, S
   Wulandari, PH
   Cretu, OM
AF Grigoras, Mirela Loredana
   Citu, Ioana Mihaela
   Citu, Cosmin
   Chiriac, Veronica Daniela
   Gorun, Florin
   Levai, Mihaela Codrina
   Manolescu, Diana
   Rosca, Ovidiu
   Bratosin, Felix
   Gurumurthy, Srivathsava
   Wulandari, Prima Hapsari
   Cretu, Octavian Marius
TI Evaluation of FIB-4, NFS, APRI and Liver Function Tests as Predictors
   for SARS-CoV-2 Infection in the Elderly Population: A Matched
   Case-Control Analysis
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Article
DE SARS-CoV-2; COVID-19; FIB-4; NFS; APRI; inflammatory markers; liver
   function
ID RISK-FACTORS; COMPLICATIONS; EXPRESSION; MORTALITY; FIBROSIS; AGE
AB Several investigations have revealed that COVID-19 causes a significant death rate due to acute respiratory distress syndrome, alterations in the quantity of ACE2 receptor expression, or the intensity of cytokine storm. Similarly, patients with hepatic impairment that are co-infected with SARS-CoV-2 are more likely to display upregulations of ACE2 receptors and cytokine storm overload, which exacerbates hepatic impairment, potentially increasing the death rate. Moreover, it is expected that the aging population develops a higher degree of hepatic fibrosis in association with other comorbid conditions that are likely to influence the course of COVID-19. Therefore, this research was developed to describe the differences in liver test parameters in elderly individuals with COVID-19 in relation to other inflammatory markers and outcomes. This current observational single-center research followed a case-control design of elderly patients hospitalized for SARS-CoV-2 infection. The research was conducted at a tertiary emergency hospital in western Romania during a two-year period. There were 632 patients included in the analysis that were split into two equal groups matched 1:1 based on gender and body mass index. Three hundred sixteen patients made the group of cases with COVID-19 patients older than 65 years, while the other half were the 316 patient controls with COVID-19 that were younger than 65 years old. Disease outcomes showed a higher prevalence of ICU admissions (22.8% vs. 12.7%, p-value < 0.001) and in-hospital mortality (17.1% vs. 8.9%, p-value = 0.002) in the group of cases. Specific and non-specific liver biomarkers were identified as risk factors for mortality in the elderly, such as ALP (OR = 1.26), LDH (OR = 1.68), AST (OR = 1.98), and ALT (OR = 2.34). Similarly, patients with APRI and NFS scores higher than 1.5 were, respectively, 2.69 times and, 3.05 times more likely to die from COVID-19, and patients with FIB-4 scores higher than 3.25 were 3.13 times more likely to die during hospitalization for SARS-CoV-2 infection. Our research indicates that abnormally increased liver biomarkers and high liver fibrosis scores are related to a worse prognosis in SARS-CoV-2 infected individuals.
C1 [Grigoras, Mirela Loredana] Victor Babes Univ Med & Pharm Timisoara, Dept Anat & Embryol, Eftimie Murgu Sq 2, Timisoara 300041, Romania.
   [Citu, Ioana Mihaela] Victor Babes Univ Med & Pharm Timisoara, Dept Internal Med 1, Eftimie Murgu Sq 2, Timisoara 300041, Romania.
   [Citu, Cosmin; Chiriac, Veronica Daniela; Gorun, Florin] Victor Babes Univ Med & Pharm Timisoara, Dept Obstet & Gynecol, Eftimie Murgu Sq 2, Timisoara 300041, Romania.
   [Levai, Mihaela Codrina] Victor Babes Univ Med & Pharm Timisoara, Res Ctr Med Commun, Eftimie Murgu Sq 2, Timisoara 300041, Romania.
   [Manolescu, Diana] Victor Babes Univ Med & Pharm Timisoara, Dept Radiol, Eftimie Murgu Sq 2, Timisoara 300041, Romania.
   [Rosca, Ovidiu; Bratosin, Felix] Victor Babes Univ Med & Pharm Timisoara, Methodol & Infect Dis Res Ctr, Dept Infect Dis, Timisoara 300041, Romania.
   [Gurumurthy, Srivathsava] Rajiv Gandhi Univ Hlth Sci, Mysore Med Coll & Res Inst, Irwin Rd, Mysuru 570001, India.
   [Wulandari, Prima Hapsari] Harvard Med Sch, Massachusetts Gen Hosp, 55 Fruit St, Boston, MA 02114 USA.
   [Cretu, Octavian Marius] Victor Babes Univ Med & Pharm Timisoara, Fac Med, Dept Surg, Eftimie Murgu Sq 2, Timisoara 300041, Romania.
C3 Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes
   University of Medicine & Pharmacy, Timisoara; Victor Babes University of
   Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine &
   Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy,
   Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara;
   Harvard University; Massachusetts General Hospital; Harvard Medical
   School; Victor Babes University of Medicine & Pharmacy, Timisoara
RP Chiriac, VD (corresponding author), Victor Babes Univ Med & Pharm Timisoara, Dept Obstet & Gynecol, Eftimie Murgu Sq 2, Timisoara 300041, Romania.
EM chiriac.veronica@umft.ro
RI Wulandari, Prima/AEQ-4233-2022; GORUN, FLORIN/ABB-4540-2020; Citu,
   Cosmin Ioan/AGY-4889-2022; CITU, IOANA/AHC-8035-2022; Bratosin,
   Felix/HDN-8724-2022
OI Wulandari, Prima/0000-0002-5341-507X; GORUN, FLORIN/0000-0002-8882-7381;
   CITU, IOANA/0000-0001-8728-5413; Bratosin, Felix/0000-0003-4711-4315;
   Rosca, Ovidiu/0000-0001-8236-2205; Gurumurthy,
   Srivathsava/0000-0002-7535-2313; Chiriac, Daniela/0000-0001-8076-8885;
   Citu, Ioan Cosmin/0000-0002-3730-6527
CR Accorsi EK, 2022, JAMA-J AM MED ASSOC, V327, P639, DOI 10.1001/jama.2022.0470
   Ali FEM, 2021, WORLD J GASTROENTERO, V27, DOI 10.3748/wjg.v27.i15.1531
   Cabibbo G, 2021, J VIRAL HEPATITIS, V28, P4, DOI 10.1111/jvh.13440
   Cerbu B, 2022, J CLIN MED, V11, DOI 10.3390/jcm11030652
   Cerbu B, 2021, MEDICINA-LITHUANIA, V57, DOI 10.3390/medicina57060597
   Citu C, 2022, DIAGNOSTICS, V12, DOI 10.3390/diagnostics12030703
   Citu IM, 2022, J CLIN MED, V11, DOI 10.3390/jcm11061698
   Citu IM, 2022, J CLIN MED, V11, DOI 10.3390/jcm11051382
   Citu IM, 2022, VIRUSES-BASEL, V14, DOI 10.3390/v14020307
   Citu IM, 2022, VACCINES-BASEL, V10, DOI 10.3390/vaccines10020275
   De Matteis C, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-94277-3
   Dehelean L, 2021, BRAIN SCI, V11, DOI 10.3390/brainsci11101287
   Dehelean L, 2019, ROM J MORPHOL EMBRYO, V60, P1105
   Dehelean L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228648
   Docherty AB, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1985
   Fan GH, 2022, ONE HEALTH-AMSTERDAM, V14, DOI 10.1016/j.onehlt.2022.100402
   Folescu R, 2018, ROM J MORPHOL EMBRYO, V59, P227
   Franssen T, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09208-0
   Fruh SM, 2017, J AM ASSOC NURSE PRA, V29, pS3, DOI 10.1002/2327-6924.12510
   Gkoufa Aikaterini, 2021, World J Crit Care Med, V10, P278, DOI 10.5492/wjccm.v10.i5.278
   Götz G, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9070788
   Grigoras ML, 2017, ROM J MORPHOL EMBRYO, V58, P1317
   Kang SJ, 2020, INFECT CHEMOTHER, V52, P154, DOI 10.3947/ic.2020.52.2.154
   Lazarus JV, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-31441-x
   Lee K, 2009, GLOB INST, P1
   Limpawattana P, 2016, ARCH GERONTOL GERIAT, V62, P97, DOI 10.1016/j.archger.2015.08.016
   Liu ML, 2022, CAN J GASTROENTEROL, V2022, DOI 10.1155/2022/7235860
   Marincu I, 2022, J PERS MED, V12, DOI 10.3390/jpm12020259
   Marincu I, 2021, MEDICINA-LITHUANIA, V57, DOI 10.3390/medicina57090986
   Marincu I, 2021, J CLIN MED, V10, DOI 10.3390/jcm10122652
   Mathieu E, 2021, NAT HUM BEHAV, V5, P947, DOI 10.1038/s41562-021-01122-8
   Pazgan-Simon M, 2022, J CLIN MED, V11, DOI 10.3390/jcm11020308
   Peckham H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19741-6
   Pilut CN, 2022, DIAGNOSTICS, V12, DOI 10.3390/diagnostics12040824
   Popescu A, 2022, DIAGNOSTICS, V12, DOI 10.3390/diagnostics12040907
   Popescu A, 2022, HEALTHCARE-BASEL, V10, DOI 10.3390/healthcare10040639
   Shinan-Altman S, 2019, INT J AGING HUM DEV, V88, P3, DOI 10.1177/0091415017752941
   Singhal S, 2021, BMC GERIATR, V21, DOI 10.1186/s12877-021-02261-3
   Statista Romania, AG STRUCT 2011 2021
   Timircan M, 2021, MEDICINA-LITHUANIA, V57, DOI 10.3390/medicina57101113
   Timircan M, 2021, MEDICINA-LITHUANIA, V57, DOI 10.3390/medicina57080796
   Treeprasertsuk S, 2013, WORLD J GASTROENTERO, V19, P1219, DOI 10.3748/wjg.v19.i8.1219
   Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669
   Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4
   Wong DWL, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10081900
   Yadav DK, 2021, GUT, V70, P807, DOI 10.1136/gutjnl-2020-322072
   Yanez ND, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09826-8
   Yao RL, 2021, J CLIN LAB ANAL, V35, DOI 10.1002/jcla.23880
   Yoo HW, 2021, J KOREAN MED SCI, V36, DOI 10.3346/jkms.2021.36.e291
   Yu DD, 2021, VIROL J, V18, DOI 10.1186/s12985-021-01593-1
   Yuki K, 2020, CLIN IMMUNOL, V215, DOI 10.1016/j.clim.2020.108427
   Zghal M, 2022, PAN AFR MED J, V41, DOI 10.11604/pamj.2022.41.56.31114
   Zhang QQ, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00653-w
   Zhao WB, 2022, J MED VIROL, V94, P1886, DOI 10.1002/jmv.27627
   Zhu X, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-06450-8
NR 55
TC 5
Z9 5
U1 2
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD SEP
PY 2022
VL 11
IS 17
AR 5149
DI 10.3390/jcm11175149
PG 14
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 4K4WA
UT WOS:000851950800001
PM 36079087
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Armeni, T
   Principato, G
   Quiles, JL
   Pieri, C
   Bompadre, S
   Battino, M
AF Armeni, T
   Principato, G
   Quiles, JL
   Pieri, C
   Bompadre, S
   Battino, M
TI Mitochondrial dysfunctions during aging: Vitamin E deficiency or caloric
   restriction - Two different ways of modulating stress
SO JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
LA English
DT Article
DE coenzyme Q; respiratory chain activities; hydroperoxides;
   polyunsaturated fatty acids
ID OXIDATIVE DNA-DAMAGE; HYDROGEN-PEROXIDE RELEASE; AGE-RELATED
   ALTERATIONS; RAT-LIVER MITOCHONDRIA; FEMALE WISTAR RATS; COENZYME-Q
   CONTENT; DIETARY RESTRICTION; LIPID-PEROXIDATION; FOOD RESTRICTION;
   LIFE-SPAN
AB Caloric restriction (CR), which has been demonstrated to offset the age-associated accrual of oxidative injury, involves a reduction in calory intake while maintaining adequate nutrition, preserves the activities of antioxidant enzymes in postmitotic tissues, maintains organ function, opposes the development of spontaneous diseases, and prolongs maximum life span in laboratory rodents. It has been proposed that reductions in Reactive Oxygen Species (ROS) production and cellular oxidative injury are central to the positive effects of CR. In the present investigation we studied the effect of CR and of a vitamin E deprived diet on mitochondrial structure and features in the liver of rats during aging, in order to ascertain the extent of modifications induced by these experimental conditions. CR rats displayed structural and functional mitochondrial properties (fatty acid pattern, respiratory chain activities, antioxidant levels, and hydroperoxide contents) similar to those of younger rats whilst vitamin E deficient rats appeared older than their own age. The mitochondria of the former, together with those of young rats, possessed the lowest Coenzyme Q(9), hydroperoxide, and cytochrome contents as well as a suitable fatty acid membrane composition. Our study confirms that CR is a valuable tool in limiting aging-related free-radical damage also at mitochondrial liver level.
C1 Univ Ancona, Fac Med, Inst Biochem, I-60100 Ancona, Italy.
   Univ Ancona, Inst Biol & Genet, Ancona, Italy.
   Univ Granada, Dept Physiol, INYTA, Granada, Spain.
   INRCA, Gerontol Res Dept, Cytol Ctr, Ancona, Italy.
   Univ Ancona, Inst Microbiol & Biomed Sci, Ancona, Italy.
C3 Marche Polytechnic University; Marche Polytechnic University; University
   of Granada; IRCCS INRCA; Marche Polytechnic University
RP Battino, M (corresponding author), Univ Ancona, Fac Med, Inst Biochem, Via Ranieri 65, I-60100 Ancona, Italy.
RI Armeni, Tatiana/J-8228-2013; Battino, Maurizio/E-6103-2012; Quiles, José
   L./C-6911-2013
OI Armeni, Tatiana/0000-0003-0931-1342; Battino,
   Maurizio/0000-0002-7250-1782; Quiles, José L./0000-0002-9048-9086;
   PRINCIPATO, Giovanni/0000-0001-8800-0301
CR AGARWAL S, 1994, P NATL ACAD SCI USA, V91, P12332, DOI 10.1073/pnas.91.25.12332
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   [Anonymous], HDB BIOL AGING
   [Anonymous], COENZYME Q MOL MECH
   Anson RM, 1999, FREE RADICAL BIO MED, V27, P456, DOI 10.1016/S0891-5849(99)00091-X
   Armeni T, 1998, MECH AGEING DEV, V101, P101, DOI 10.1016/S0047-6374(97)00167-X
   ASSONBATRES MA, 1991, J BIOL CHEM, V266, P9932
   BALL JC, 1979, ANAL BIOCHEM, V98, P472, DOI 10.1016/0003-2697(79)90169-6
   Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646
   BARZANTI V, 1994, BRIT J NUTR, V71, P193, DOI 10.1079/BJN19940126
   BATTINO M, 1991, J BIOENERG BIOMEMBR, V23, P345, DOI 10.1007/BF00762227
   Battino M, 2000, J BIOENERG BIOMEMBR, V32, P163, DOI 10.1023/A:1005559930210
   Battino M, 1999, CRIT REV ORAL BIOL M, V10, P458, DOI 10.1177/10454411990100040301
   Battino M, 2002, J BIOENERG BIOMEMBR, V34, P127, DOI 10.1023/A:1015128009826
   BATTINO M, 1995, MECH AGEING DEV, V78, P173, DOI 10.1016/0047-6374(94)01535-T
   Battino M, 2001, BIOL CHEM, V382, P925, DOI 10.1515/BC.2001.115
   BATTINO M, 2001, MITOCHONDRIAL UBIQUI, V1, P151
   BEYER RE, 1985, MECH AGEING DEV, V32, P267, DOI 10.1016/0047-6374(85)90085-5
   BURDON RH, 1989, FREE RADICAL RES COM, V7, P149, DOI 10.3109/10715768909087937
   CHEN LH, 1995, ARCH GERONTOL GERIAT, V14, P17
   Claiborne A.J.F.C.P., 1985, HDB METHODS OXYGEN R, DOI DOI 10.1016/0531-5565(85)90021-X
   DARNOLD JR, 1990, MECH AGEING DEV, V53, P157, DOI 10.1016/0047-6374(90)90067-P
   DAVIS LJ, 1993, MECH AGEING DEV, V72, P155, DOI 10.1016/0047-6374(93)90097-B
   Desai VG, 1996, ARCH BIOCHEM BIOPHYS, V333, P145, DOI 10.1006/abbi.1996.0375
   DJURIC Z, 1993, MUTAT RES, V295, P181, DOI 10.1016/0921-8734(93)90019-Y
   Ebadi M., 2001, MITOCHONDRIAL UBIQUI, V2
   EBADI M, 2001, MITOCHONDRIAL UBIQUI, V1
   EKWALL K, 1970, ARCH BIOCHEM BIOPHYS, V137, P128, DOI 10.1016/0003-9861(70)90419-4
   Feuers RJ, 1998, ANN NY ACAD SCI, V854, P192, DOI 10.1111/j.1749-6632.1998.tb09902.x
   Gabbita SP, 1997, FREE RADICAL BIO MED, V23, P191, DOI 10.1016/S0891-5849(97)00043-9
   Goto S, 2002, ANN NY ACAD SCI, V959, P50, DOI 10.1111/j.1749-6632.2002.tb02082.x
   Gredilla R, 2001, FASEB J, V15, P1589, DOI 10.1096/fj.00-0764fje
   Gredilla R, 2001, J BIOENERG BIOMEMBR, V33, P279, DOI 10.1023/A:1010603206190
   Habig W H, 1981, Methods Enzymol, V77, P398
   HUERTAS JR, 1992, LIFE SCI, V50, P2111, DOI 10.1016/0024-3205(92)90577-C
   HUERTAS JR, 1991, BIOCHEM BIOPH RES CO, V181, P375, DOI 10.1016/S0006-291X(05)81429-9
   HUERTAS JR, 1991, FEBS LETT, V287, P89, DOI 10.1016/0014-5793(91)80022-U
   JIANG ZY, 1992, ANAL BIOCHEM, V202, P384, DOI 10.1016/0003-2697(92)90122-N
   KU HH, 1993, FREE RADICAL BIO MED, V15, P621, DOI 10.1016/0891-5849(93)90165-Q
   Lass A, 1999, BIOFACTORS, V9, P199, DOI 10.1002/biof.5520090215
   LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6
   LEPAGE G, 1986, J LIPID RES, V27, P114
   López-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MASORO EJ, 1994, CLIN J SPORT MED, V4, P262
   Mataix J, 1998, FREE RADICAL BIO MED, V24, P511, DOI 10.1016/S0891-5849(97)00288-8
   MCLELLAN AC, 1992, ANAL BIOCHEM, V206, P17, DOI 10.1016/S0003-2697(05)80005-3
   Miquel J, 2001, PUBLIC HEALTH NUTR, V4, P1385, DOI 10.1079/PHN2001224
   MODE CJ, 1984, J GERONTOL, V39, P36, DOI 10.1093/geronj/39.1.36
   NOUROOZZADEH J, 1994, ANAL BIOCHEM, V220, P403, DOI 10.1006/abio.1994.1357
   PIERI C, 1992, ARCH GERONTOL GERIAT, V14, P93, DOI 10.1016/0167-4943(92)90010-2
   PIERI C, 1990, ARCH GERONTOL GERIAT, V11, P99, DOI 10.1016/0167-4943(90)90001-M
   PRINCIPATO GB, 1987, BIOCHIM BIOPHYS ACTA, V911, P349, DOI 10.1016/0167-4838(87)90076-8
   Quiles JL, 1999, BRIT J NUTR, V81, P21, DOI 10.1017/S0007114599000094
   Quiles JL, 2001, J BIOENERG BIOMEMBR, V33, P127, DOI 10.1023/A:1010700515071
   Quiles JL, 1999, INT J VITAM NUTR RES, V69, P243, DOI 10.1024/0300-9831.69.4.243
   RAMOSMARTINEZ JI, 1983, COMP BIOCHEM PHYS B, V75, P689, DOI 10.1016/0305-0491(83)90117-7
   REITMAN S, 1957, AM J CLIN PATHOL, V28, P56, DOI 10.1093/ajcp/28.1.56
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   SOHAL RS, 1991, MECH AGEING DEV, V57, P187, DOI 10.1016/0047-6374(91)90034-W
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   SOHAL RS, 1994, FREE RADICAL BIO MED, V16, P621, DOI 10.1016/0891-5849(94)90062-0
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   SOHAL RS, 1995, FREE RADICAL BIO MED, V19, P499, DOI 10.1016/0891-5849(95)00037-X
   SOHAL RS, 1994, MECH AGEING DEV, V76, P215, DOI 10.1016/0047-6374(94)91595-4
   VANDERJAGT DL, 1975, BIOCHEMISTRY-US, V14, P3669, DOI 10.1021/bi00687a024
   VENKATRAMAN J, 1992, MECH AGEING DEV, V63, P27, DOI 10.1016/0047-6374(92)90014-5
   WRZESZCZYNSKI KO, 1994, BIOCHEMISTRY-US, V33, P11544, DOI 10.1021/bi00204a017
   XIA EN, 1995, J NUTR, V125, P195
   YOUNGMAN LD, 1992, P NATL ACAD SCI USA, V89, P9112, DOI 10.1073/pnas.89.19.9112
   YU BP, 1982, J GERONTOL, V37, P130, DOI 10.1093/geronj/37.2.130
   YU BP, 1992, MECH AGEING DEV, V65, P17, DOI 10.1016/0047-6374(92)90123-U
   Yu BP, 1996, FREE RADICAL BIO MED, V21, P651, DOI 10.1016/0891-5849(96)00162-1
NR 73
TC 38
Z9 46
U1 1
U2 4
PU KLUWER ACADEMIC/PLENUM PUBL
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0145-479X
J9 J BIOENERG BIOMEMBR
JI J. Bioenerg. Biomembr.
PD APR
PY 2003
VL 35
IS 2
BP 181
EP 191
DI 10.1023/A:1023754305218
PG 11
WC Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biophysics; Cell Biology
GA 678DX
UT WOS:000182850700008
PM 12887016
DA 2024-02-19
ER

PT J
AU Sharma, R
   Kapila, R
   Dass, G
   Kapila, S
AF Sharma, Rohit
   Kapila, Rajeev
   Dass, Gulshan
   Kapila, Suman
TI Improvement in Th1/Th2 immune homeostasis, antioxidative status and
   resistance to pathogenic <i>E</i>. <i>coli</i> on consumption of
   probiotic <i>Lactobacillus rhamnosus</i> fermented milk in aging mice
SO AGE
LA English
DT Article
DE Immunosenescence; Lactobacillus; Infection; Antioxidant; Th1/Th2;
   Inflamm-aging
ID SALMONELLA-ENTERITIDIS INFECTION; INTESTINAL EPITHELIAL-CELLS; DENDRITIC
   CELLS; T-CELLS; INHIBITION; RESPONSES; MURINE; CASEI; DAHI;
   IMMUNOSENESCENCE
AB Imbalance in Th1/Th2 immune pathways and cellular antioxidant systems with progressive aging are among the leading causes of increased risk of morbidity and mortality in elderly. Although probiotics have been considered to boost immune system, there is a lack of comprehensive analysis of probiotic effects on aging physiology. The present study aimed at determining anti-immunosenescence potential of milk fermented with probiotic Lactobacillus rhamnosus (LR) in 16 months old mice by concurrent analysis of immunosenescence markers associated with Th1/Th2 profile of splenocytes, inflamm-aging in plasma, neutrophil functions and antibody response in intestine along with analysis of antioxidant enzymes in liver and red blood cells (RBCs) after feeding trials of 1 and 2 months, respectively. An enteropathogenic Escherichia coli (ATCC 14948)-based infection model in aging mice was also designed to validate protective attributes of LR. Splenocytes registered increased IFN-gamma and decreased IL-4 and IL-10 production in LR-fed animals. Neutrophil respiratory burst enzymes and phagocytosis increased significantly while no aggravation in plasma levels of MCP-1 and TNF-alpha was observed. Further, owing to increased Th1 response, antibodies registered a decrease in IgG1/IgG2a ratio and IgE levels in LR groups. No significant variations were observed in secretory IgA and IgA + cells in the intestine. Antioxidant enzymes (superoxide dismutase, catalase, glutathione peroxidase) in LR-fed groups recorded increased activities which were more pronounced in the liver than in RBCs. LR supplementation significantly reduced E. coli translocation to organs (intestine, liver, spleen, peritoneal fluid) by enhancing E. coli-specific antibodies (IgA and IgG1) and inflammatory proteins. In conclusion, LR supplementation alleviated immunosenescence-associated Th1/Th2 imbalance, improved antioxidant capacity, and enhanced resistance of aged mice to E. coli infection thereby signifying its potential in augmenting healthy aging.
C1 [Sharma, Rohit; Kapila, Rajeev; Dass, Gulshan; Kapila, Suman] Natl Dairy Res Inst, Anim Biochem Div, Karnal 132001, Haryana, India.
C3 Indian Council of Agricultural Research (ICAR); ICAR - National Dairy
   Research Institute
RP Kapila, R (corresponding author), Natl Dairy Res Inst, Anim Biochem Div, Karnal 132001, Haryana, India.
EM rkapila69@rediffmail.com
RI Sharma, Rohit/AAC-8355-2020; Kapila, Suman/O-5288-2019; Kapila,
   Rajeev/AAN-1602-2021
OI Kapila, Suman/0000-0003-2627-773X; Sharma, Rohit/0000-0001-6209-3845;
   KAPILA, RAJEEV/0000-0002-2795-3720
FU Department of Biotechnology, Government of India
FX The financial assistance provided by the Department of Biotechnology,
   Government of India, and laboratory facilities provided by National
   Dairy Research Institute are thankfully acknowledged.
CR Aebi H, 1984, Methods Enzymol, V105, P121
   Aw D, 2007, IMMUNOLOGY, V120, P435, DOI 10.1111/j.1365-2567.2007.02555.x
   Azcárate-Peril MA, 2011, AM J PHYSIOL-GASTR L, V301, pG401, DOI 10.1152/ajpgi.00110.2011
   BERNET MF, 1993, APPL ENVIRON MICROB, V59, P4121, DOI 10.1128/AEM.59.12.4121-4128.1993
   BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462
   Braga PC, 1998, GERONTOLOGY, V44, P192, DOI 10.1159/000022009
   Brüünsgaard H, 2003, IMMUNOL ALLERGY CLIN, V23, P15, DOI 10.1016/S0889-8561(02)00056-5
   Costa D, 2006, FREE RADICAL BIO MED, V40, P632, DOI 10.1016/j.freeradbiomed.2005.09.017
   Dorrington MG, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00171
   Effros Rita B, 2005, Immun Ageing, V2, P7, DOI 10.1186/1742-4933-2-7
   Ellis TN, 2004, IMMUNOLOGY, V112, P2, DOI 10.1111/j.1365-2567.2004.01849.x
   Engwall E, 1971, J IMMUNOL, V109, P129
   Feili-Hariri M, 2005, J LEUKOCYTE BIOL, V78, P656, DOI 10.1189/jlb.1104631
   Ghosh S, 2004, GUT, V53, P620, DOI 10.1136/gut.2003.034249
   Ginaldi L, 1999, IMMUNOL RES, V20, P109, DOI 10.1007/BF02786467
   Hawkley LC, 2004, BRAIN BEHAV IMMUN, V18, P114, DOI 10.1016/j.bbi.2003.09.005
   Hay FC, 2002, PRACTICAL IMMUNOLOGY, P203
   Jain S, 2008, INT J IMMUNOPATH PH, V21, P1021, DOI 10.1177/039463200802100428
   Jain S, 2009, J MED FOOD, V12, P576, DOI 10.1089/jmf.2008.0246
   Jijon H, 2004, GASTROENTEROLOGY, V126, P1358, DOI 10.1053/j.gastro.2004.02.003
   Kapila R, 2013, MICROBIOL IMMUNOL, V57, P778, DOI 10.1111/1348-0421.12092
   Kapila R, 2012, PROBIOTICS ANTIMICRO, V4, P173, DOI 10.1007/s12602-012-9107-x
   Kapila S, 2007, FOOD AGR IMMUNOL, V18, P75, DOI 10.1080/09540100701317618
   Kaushal D, 2012, MOL BIOL REP, V39, P1791, DOI 10.1007/s11033-011-0920-1
   Kekkonen RA, 2008, WORLD J GASTROENTERO, V14, P2029, DOI 10.3748/wjg.14.2029
   Kiernan J.A., 2008, HISTOLOGICAL HISTOCH
   Kovacs EJ, 2004, MECH AGEING DEV, V125, P121, DOI 10.1016/j.mad.2003.11.007
   Kullisaar T, 2002, INT J FOOD MICROBIOL, V72, P215, DOI 10.1016/S0168-1605(01)00674-2
   Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1
   LIM TS, 1981, IMMUNOLOGY, V43, P401
   Lin Shu-peng, 2010, Nan Fang Yi Ke Da Xue Xue Bao, V30, P584
   Lord JM, 2001, MECH AGEING DEV, V122, P1521, DOI 10.1016/S0047-6374(01)00285-8
   Lutgendorff F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004512
   MARKLUND S, 1974, EUR J BIOCHEM, V47, P469
   Martarelli D, 2011, CURR MICROBIOL, V62, P1689, DOI 10.1007/s00284-011-9915-3
   Matsumoto M, 2011, MED HYPOTHESES, V77, P469, DOI 10.1016/j.mehy.2011.06.011
   McElhaney Janet E, 2003, Conn Med, V67, P469
   Melton-Witt JA, 2012, INFECT IMMUN, V80, P720, DOI 10.1128/IAI.05958-11
   Mocchegiani E, 2009, J CLIN IMMUNOL, V29, P416, DOI 10.1007/s10875-009-9298-4
   Mohamadzadeh M, 2005, P NATL ACAD SCI USA, V102, P2880, DOI 10.1073/pnas.0500098102
   Mohamadzadeh M, 2008, EXPERT REV VACCINES, V7, P1155, DOI 10.1586/14760584.7.8.1155
   Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560
   Neish AS, 2004, IMMUNOL RES, V29, P175, DOI 10.1385/IR:29:1-3:175
   Ogawa Kishiko, 2008, Immun Ageing, V5, P13, DOI 10.1186/1742-4933-5-13
   Otte JM, 2004, AM J PHYSIOL-GASTR L, V286, pG613, DOI 10.1152/ajpgi.00341.2003
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   RAMMELSBERG M, 1990, J APPL BACTERIOL, V69, P177, DOI 10.1111/j.1365-2672.1990.tb01507.x
   Roessler A, 2008, CLIN EXP ALLERGY, V38, P93, DOI 10.1111/j.1365-2222.2007.02876.x
   Ruiz PA, 2005, IMMUNOLOGY, V115, P441, DOI 10.1111/j.1365-2567.2005.02176.x
   Schiavi E, 2011, ALLERGY, V66, P499, DOI 10.1111/j.1398-9995.2010.02501.x
   Sharma R, 2014, AGING CLIN EXP RES, V26, P353, DOI 10.1007/s40520-013-0190-y
   Sharma R, 2013, FOOD REV INT, V29, P201, DOI 10.1080/87559129.2012.751547
   Shearer GM, 1997, MECH AGEING DEV, V94, P1
   Sheil B, 2004, GUT, V53, P694, DOI 10.1136/gut.2003.027789
   Shih PH, 2007, BIOGERONTOLOGY, V8, P71, DOI 10.1007/s10522-006-9033-y
   Shu Q, 2002, FEMS IMMUNOL MED MIC, V34, P59, DOI 10.1016/S0928-8244(02)00340-1
   SNAPPER CM, 1988, J EXP MED, V167, P183, DOI 10.1084/jem.167.1.183
   Stadlbauer V, 2008, J HEPATOL, V48, P945, DOI 10.1016/j.jhep.2008.02.015
   Tan M, 2011, CRIT CARE, V15, DOI 10.1186/cc10579
   Tortorella C, 2000, MECH AGEING DEV, V119, P69, DOI 10.1016/S0047-6374(00)00171-8
   Uciechowski P, 2008, EXP GERONTOL, V43, P493, DOI 10.1016/j.exger.2007.11.006
   Yadav H, 2008, J DAIRY RES, V75, P189, DOI 10.1017/S0022029908003129
   Zhou XX, 2010, FISH PHYSIOL BIOCHEM, V36, P501, DOI 10.1007/s10695-009-9320-z
   Zommara M, 1998, BIOSCI BIOTECH BIOCH, V62, P710, DOI 10.1271/bbb.62.710
NR 64
TC 51
Z9 55
U1 3
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0161-9152
EI 1574-4647
J9 AGE
JI Age
PD AUG
PY 2014
VL 36
IS 4
AR 9686
DI 10.1007/s11357-014-9686-4
PG 17
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA AR8BR
UT WOS:000343801100023
PM 25037247
OA Green Published
DA 2024-02-19
ER

PT J
AU Hegab, AE
   Ozaki, M
   Meligy, FY
   Kagawa, S
   Ishii, M
   Betsuyaku, T
AF Hegab, Ahmed E.
   Ozaki, Mani
   Meligy, Fatma Y.
   Kagawa, Shizuko
   Ishii, Makoto
   Betsuyaku, Tomoko
TI High fat diet activates adult mouse lung stem cells and accelerates
   several aging-induced effects
SO STEM CELL RESEARCH
LA English
DT Article
DE High fat diet; Aging; Alveolar cells; Lung stem cells; Mitochondria;
   Calorie restriction
ID INFLAMMATION; MECHANISMS; MITOCHONDRIA; DYSFUNCTION; COMPONENTS; REPAIR;
   LIVER
AB High fat diet (HFD) decreases the lifespan of mice, and is a risk factor for several human diseases. Here, we investigated the effects of a HFD on lung epithelial and stem cells and its interaction with aging. Young and old mice were fed with either a standard diet (SD) or a HFD then their trachea and lung were examined for histological changes, inflammation, and mitochondrial function. Their stem cell function was examined using the in vitro organoid/colony forming efficiency (CFE) assay. Aging reduced the number of tracheal basal and alveolar type-2 (AT2) cells. HFD significantly increased the number of AT2 cells. Aging also caused a significant increase in lung inflammation, and HFD caused a similar increase, in young mice. Aging reduced mitochondrial mass and function, and increased reactive oxygen species. In young mice, HFD caused mitochondrial changes similar to the aging-induced changes. Organoid culture of tracheal and lung epithelial cells collected from both young and old HFD-fed mice showed higher CFE compared to SD-fed mice. Switching the HFD to low calorie/fat diet (LCD) efficiently reversed several of the HFD-induced effects. Thus, HFD induces several histological, inflammatory, and functional changes in the lung, and exacerbates the aging-induced lung inflammation and mitochondrial deterioration. LCD can reverse many of the HFD-induced effects.
C1 [Hegab, Ahmed E.; Ozaki, Mani; Meligy, Fatma Y.; Kagawa, Shizuko; Ishii, Makoto; Betsuyaku, Tomoko] Keio Univ, Dept Med, Div Pulm Med, Sch Med, Tokyo, Japan.
   [Meligy, Fatma Y.] Assiut Univ, Fac Med, Dept Histol, Assiut, Egypt.
C3 Keio University; Egyptian Knowledge Bank (EKB); Assiut University
RP Hegab, AE (corresponding author), Keio Univ, Dept Med, Div Pulm Med, Sch Med,Shinjuku Ku, Shinanomachi 35, Tokyo 1608582, Japan.
EM ahegab@a2.keio.jp
RI Meligy, Fatma/AAO-9926-2021
OI Meligy, Fatma/0000-0002-6372-8731; Ozaki, Mari/0000-0003-0649-7882;
   Ishii, Makoto/0000-0003-4396-1664
FU JSPS, Japan
FX We would like to thank Junko Hamamoto, Mari Fujiwara, Miyuki Yamamoto
   and Mikiko Shibuya for technical support and the Collaborative Research
   Resources, Keio University, School of Medicine, Japan for technical
   support. This work was supported by JSPS, Japan Grant-in-Aid for
   Scientific Research (A.E.H. and M.O.). All authors have no conflict of
   interest to declare.
CR Aoshiba K, 2007, FEBS LETT, V581, P3512, DOI 10.1016/j.febslet.2007.06.075
   Bae Ju Yong, 2016, J Exerc Nutrition Biochem, V20, P28, DOI 10.20463/jenb.2016.06.20.2.4
   Beyaz S, 2016, NATURE, V531, P53, DOI 10.1038/nature17173
   Bhardwaj P, 2013, CANCER PREV RES, V6, P282, DOI 10.1158/1940-6207.CAPR-12-0467
   Bueno M., 2015, FASEB J S, V29
   Canan CH, 2014, J LEUKOCYTE BIOL, V96, P473, DOI 10.1189/jlb.4A0214-093RR
   Choi JW, 2018, METABOLISM, V78, P43, DOI 10.1016/j.metabol.2017.09.005
   Clark-Knowles KV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112406
   Efeyan A, 2015, NATURE, V517, P302, DOI 10.1038/nature14190
   Franks Teri J, 2008, Proc Am Thorac Soc, V5, P763, DOI 10.1513/pats.200803-025HR
   Gereke M, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-47
   Gomes M, 2014, ADV EXP MED BIOL, V816, P1, DOI 10.1007/978-3-0348-0837-8_1
   GOODMAN MT, 1992, EPIDEMIOLOGY, V3, P288, DOI 10.1097/00001648-199207000-00004
   Guillemot-Legris O, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0666-8
   Hegab A. E., 2018, CALORIE RESTRI UNPUB
   Hegab AE, 2015, STEM CELLS BIOL REG, P97, DOI 10.1007/978-3-319-21082-7_6
   Hegab AE, 2015, STEM CELL RES, V15, P109, DOI 10.1016/j.scr.2015.05.005
   Hurley MS, 2006, BRIT J NUTR, V95, P623, DOI 10.1079/BJN20051711
   Kakimoto PA, 2016, REDOX BIOL, V8, P216, DOI 10.1016/j.redox.2016.01.009
   Ketonen J, 2010, HEART VESSELS, V25, P254, DOI 10.1007/s00380-009-1182-x
   Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713
   Kuroda A, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0554-5
   Lee CY, 2013, CLIN TRANSL GASTROEN, V4, DOI 10.1038/ctg.2013.11
   Lee D, 2015, AGING CELL, V14, P8, DOI 10.1111/acel.12277
   Liu L, 2011, J CELL BIOL, V193, P257, DOI 10.1083/jcb.201010131
   Malley CO, 2016, BBA CLIN, V5, P29, DOI 10.1016/j.bbacli.2015.11.003
   Mazucanti CH, 2015, CURR TOP MED CHEM, V15, P2116, DOI 10.2174/1568026615666150610125715
   Meiners S, 2015, EUR RESPIR J, V45, P807, DOI 10.1183/09031936.00186914
   Meydani S, 2014, FASEB J, V28
   Mock JR, 2014, MUCOSAL IMMUNOL, V7, P1440, DOI 10.1038/mi.2014.33
   Moldoveanu B, 2009, J INFLAMM RES, V2, P1
   Muller Alexandre Pastoris, 2013, Longev Healthspan, V2, P10, DOI 10.1186/2046-2395-2-10
   Oldham S, 2011, TRENDS ENDOCRIN MET, V22, P45, DOI 10.1016/j.tem.2010.11.002
   Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105
   Randall TD, 2010, ADV IMMUNOL, V107, P187, DOI [10.1016/S0065-2776(10)07002-1, 10.1016/B978-0-12-381300-8.00007-1]
   Schumacker PT, 2014, AM J PHYSIOL-LUNG C, V306, pL962, DOI 10.1152/ajplung.00073.2014
   Sverdlov AL, 2015, J MOL CELL CARDIOL, V78, P165, DOI 10.1016/j.yjmcc.2014.07.018
   Szeto HH, 2016, KIDNEY INT, V90, P997, DOI 10.1016/j.kint.2016.06.013
   van der Heijden RA, 2015, AGING-US, V7, P256, DOI 10.18632/aging.100738
   Villarroya J, 2015, J NUTR BIOCHEM, V26, P1328, DOI 10.1016/j.jnutbio.2015.07.029
   Wagener A, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.4
   Wansleeben C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093496
   Wick G, 1997, FASEB J, V11, P1199, DOI 10.1096/fasebj.11.13.9367355
   Yamada M, 2016, INFLAMM REGEN, V36, DOI 10.1186/s41232-016-0020-7
   Yin L, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0116-z
NR 45
TC 22
Z9 23
U1 1
U2 10
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1873-5061
EI 1876-7753
J9 STEM CELL RES
JI Stem Cell Res.
PD DEC
PY 2018
VL 33
BP 25
EP 35
DI 10.1016/j.scr.2018.10.006
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Biotechnology & Applied Microbiology
GA HD6IH
UT WOS:000452639700006
PM 30308415
OA gold
DA 2024-02-19
ER

PT J
AU FROLKIS, VV
   GRIGOROV, YG
   PISARCHUK, KL
AF FROLKIS, VV
   GRIGOROV, YG
   PISARCHUK, KL
TI LONG-TERM EFFECTS OF LITTER SIZE IN EARLY POSTNATAL-PERIOD ON
   METABOLISM, AGING AND LIFE-SPAN IN RATS
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
DE POSTNATAL OVERNUTRITION; METABOLISM; HORMONE LEVEL; LYSOSOMAL ACTIVITY;
   AGING
ID DIETARY RESTRICTION; NUTRITION; LONGEVITY; MICE
AB Some indices of aging, metabolism and life span were studied in the male Wistar rats, raised during the suckling period (up to 21 days) in nests of 8-10 pups (control) and 2 pups/dam (experiment). The milk intake of the rat pups was controlled by adjusting litter size at birth. After weaning, the rats of both groups each received the same standard diet ad libitum. Postnatal overfed rats had higher values of body weight, epididymal fat pads and lipid metabolism (total cholesterol, triglycerides, etc.) throughout their whole life. Rats from small nests had increased levels of insulin, thyroxine and decreased proteinase activity of hepatic lysosomes. Overfeeding in the early postnatal period was found to influence the dynamics of mortality and survival rates. It may be concluded that the modification of nutrition in the early period of life may influence an organism's aging process and the dynamics of age-related changes in metabolism and its regulation during an animal's life.
RP FROLKIS, VV (corresponding author), UKRAINE ACAD MED SCI,INST GERONTOL,VYSHGORODSKAYA ST 67,KIEV 254114,UKRAINE.
CR AUBERT R, 1980, J NUTR, V110, P649, DOI 10.1093/jn/110.4.649
   AUST L, 1986, EXP CLIN ENDOCRINOL, V87, P299, DOI 10.1055/s-0029-1210558
   Barret A.G., 1980, LIZOSOMY METODY ISSL, P25
   BEAUCHENE RE, 1986, J GERONTOL, V41, P13, DOI 10.1093/geronj/41.1.13
   DRORI D, 1986, EXP AGING RES, V12, P59
   FAUST IM, 1980, J NUTR, V110, P2027, DOI 10.1093/jn/110.10.2027
   FERLAND G, 1992, MECH AGEING DEV, V64, P49, DOI 10.1016/0047-6374(92)90095-U
   FROLKIS VV, 1982, AGING LIFE PROLONGIN, P378
   FROLKIS VV, 1981, AGING NEUORHUMORAL M, P360
   GIGOROV YG, 1982, VOP PITANIYA, V5, P15
   GOODRICK CL, 1984, AGE, V7, P1, DOI 10.1007/BF02431887
   GUPTA D, 1990, NEUROENDOCRINOLOGY N
   JANE S, 1991, J NEUROENDOCRINOL, V3, P85
   KIRJAKOV A, 1979, LAB DELO, V7, P398
   MACHO L, 1973, ENDOCRINOLOGIE, V6, P194
   MASORO EJ, 1984, J AM GERIATR SOC, V32, P296, DOI 10.1111/j.1532-5415.1984.tb02025.x
   McCAY CLIVE M., 1956, BULL NEW YORK ACAD MED, V32, P91
   MILLWARD DJ, 1981, REPROD NUTR DEV, V21, P265, DOI 10.1051/rnd:19810210
   OLEFSKY JM, 1976, J CLIN INVEST, V57, P1165, DOI 10.1172/JCI108384
   PETZKE K, 1988, CLIN NUTR, V7, P69
   RICHARDSON A, 1985, REV BIOL RES AGING, V2, P395
   SJOSTOM L, 1972, ACTA MED SCAND S, V5, P1
   STERN JS, 1972, LANCET, V2, P948
   TUTELYAN VA, 1987, VOP MED KHIM, V33, P65
   VASILJEV AV, 1983, VOPR MED KHIM, V3, P127
   Waterlow J.C., 1978, PROTEIN TURNOVER MAM
   WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641
   WURTMAN JJ, 1976, J NUTR, V106, P697, DOI 10.1093/jn/106.5.697
   Wyndham J R, 1983, Arch Gerontol Geriatr, V2, P317, DOI 10.1016/0167-4943(83)90005-5
NR 29
TC 3
Z9 3
U1 0
U2 2
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0167-4943
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PD JUL-AUG
PY 1993
VL 17
IS 1
BP 65
EP 73
DI 10.1016/0167-4943(93)90018-D
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA LZ585
UT WOS:A1993LZ58500006
PM 15374332
DA 2024-02-19
ER

PT J
AU Güney, S
   Cumaoglu, A
   Öztürk, G
   Akbulut, KG
   Karasu, Ç
AF Guney, Sevin
   Cumaoglu, Ahmet
   Ozturk, Guler
   Akbulut, K. Gonca
   Karasu, Cimen
TI Comparison of Melatonin Effect on Oxidant Status and Antioxidant
   Capacity in Liver and Heart of Young and Aged Rats
SO INTERNATIONAL JOURNAL OF GERONTOLOGY
LA English
DT Article
DE aging; antioxidant; melatonin; oxidant
ID SUPEROXIDE-DISMUTASE ACTIVITY; OXIDATIVE DAMAGE; CALORIC RESTRICTION;
   LIPID-PEROXIDATION; HYDROGEN-PEROXIDE; GENE-EXPRESSION; PINEAL CONTROL;
   STRESS; ENZYMES; MITOCHONDRIA
AB Background: Oxidative stress is involved in several pathologic conditions such as metabolic or cardiovascular disease, and in aging. Oxidative damage of biomolecules increases with age. Melatonin is the main neurohormone of the pineal gland and specific antioxidants may act against age-related oxidative damage.
   Objective: This study investigated the effects of administration of melatonin on aging-related parameters such as total oxidant status (TOS), hydrogen peroxide (H2O2) and lipid hydroperoxide (LOOH) levels and total antioxidant capacity (TAC) in the heart and liver in a rat model of aging.
   Methods: Young (3-month-old) and aged (24-month-old) male Wistar rats were divided into control and melatonin-treated groups. Melatonin was given for 21 days (10 mg/kg/day). At the end of the treatment period, TOS, TAC, H2O2, and LOOH levels were measured.
   Results: H2O2 in the liver, but not in the heart, was found to be increased in aged rats. Melatonin treatment diminished H2O2 in the heart of both group of rats compared with those of untreated control rats. Melatonin treatment also led to a decrease in H2O2 in the liver of aged rats. LOOH were found to be increased in both tissues of aged rats whereas melatonin treatment decreased LOOH levels in heart and liver tissues of aged rats. In the young rats melatonin also inhibited LOOH in liver. TAC in heart and liver was not found to be statistically different between young and aged rats. In young rats, melatonin treatment resulted in an increase in TAC that was associated with increased H2O2. In the liver and heart of the rats, TOS was increased with age and was ameliorated by melatonin treatment.
   Conclusion: Our results demonstrate that there is no dramatic overall decline in the antioxidant system with age. However, total oxidant status increased with age. Melatonin has a restorative effect on oxidative status. Copyright (C) 2012, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
C1 [Guney, Sevin; Akbulut, K. Gonca] Gazi Univ, Fac Med, Dept Physiol, Ankara, Turkey.
   [Karasu, Cimen] Gazi Univ, Fac Med, Dept Med Pharmacol, Ankara, Turkey.
   [Cumaoglu, Ahmet] Batman Univ, Sch Hlth, Dept Nutr & Dietet, Batman, Turkey.
   [Ozturk, Guler] Maltepe Univ, Fac Med, Dept Physiol, TR-34843 Istanbul, Turkey.
C3 Gazi University; Gazi University; Batman University; Maltepe University
RP Öztürk, G (corresponding author), Maltepe Univ, Fac Med, Dept Physiol, Feyzullah Caddesi 39, TR-34843 Istanbul, Turkey.
EM gulerturk@yahoo.co.uk
RI Akbulut, K Gonca/Z-2938-2019; Güney, Şevin/AAA-6223-2021; Öztürk,
   Güler/HJA-3266-2022; Karasu, Çimen/JVZ-4637-2024
OI Karasu, Çimen/0000-0002-0954-8465; Guney, Sevin/0000-0001-6968-5472
CR Akbulut KG, 1999, GERONTOLOGY, V45, P67, DOI 10.1159/000022065
   Albarrán MT, 2001, J PINEAL RES, V30, P227, DOI 10.1034/j.1600-079X.2001.300406.x
   Anisimov VN, 1997, MECH AGEING DEV, V97, P81, DOI 10.1016/S0047-6374(97)01897-6
   Antolin I, 1996, FASEB J, V10, P882, DOI 10.1096/fasebj.10.8.8666165
   Bokov A, 2004, MECH AGEING DEV, V125, P811, DOI 10.1016/j.mad.2004.07.009
   CAND F, 1989, FREE RADICAL BIO MED, V7, P59, DOI 10.1016/0891-5849(89)90101-9
   Ceylan-Isik Asli F, 2011, Curr Aging Sci, V4, P150
   Dai DF, 2009, TRENDS CARDIOVAS MED, V19, P213, DOI 10.1016/j.tcm.2009.12.004
   Drew B, 2003, AM J PHYSIOL-REG I, V284, pR474, DOI 10.1152/ajpregu.00455.2002
   Eaton P, 2001, CARDIOVASC RES, V51, P294, DOI 10.1016/S0008-6363(01)00303-0
   El-Sokkary GH, 1999, ALCOHOL ALCOHOLISM, V34, P842, DOI 10.1093/alcalc/34.6.842
   Gredilla R, 2001, FASEB J, V15, P1589, DOI 10.1096/fj.00-0764fje
   Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   Judge S, 2005, FASEB J, V19, P419, DOI 10.1096/fj.04-2622fje
   Jung K, 1996, FREE RADICAL BIO MED, V20, P613, DOI 10.1016/0891-5849(95)02090-X
   Karasu Cimen, 2010, Open Cardiovasc Med J, V4, P240, DOI 10.2174/1874192401004010240
   Kotler M, 1998, J PINEAL RES, V24, P83, DOI 10.1111/j.1600-079X.1998.tb00371.x
   MUSCARI C, 1990, BASIC RES CARDIOL, V85, P172, DOI 10.1007/BF01906970
   Öztürk G, 2000, JPN J PHYSIOL, V50, P149, DOI 10.2170/jjphysiol.50.149
   Pamplona R, 2002, ANN NY ACAD SCI, V959, P475, DOI 10.1111/j.1749-6632.2002.tb02118.x
   PIERPAOLI W, 1991, ANN NY ACAD SCI, V621, P291
   PIERPAOLI W, 1994, P NATL ACAD SCI USA, V91, P787, DOI 10.1073/pnas.91.2.787
   POEGGELER B, 1993, J PINEAL RES, V14, P151, DOI 10.1111/j.1600-079X.1993.tb00498.x
   Pollack M, 2001, J GERONTOL A-BIOL, V56, pB475, DOI 10.1093/gerona/56.11.B475
   Pollack M., 2000, HDB OXIDANTS ANTIOXI, P881, DOI [10.1016/b978-044482650-3/50030-4, DOI 10.1016/B978-044482650-3/50030-4, 10.1016/B978-044482650-3/50030-4]
   REITER RJ, 1995, J PINEAL RES, V18, P1, DOI 10.1111/j.1600-079X.1995.tb00133.x
   Reiter RJ, 1998, ANN NY ACAD SCI, V854, P410, DOI 10.1111/j.1749-6632.1998.tb09920.x
   REITER RJ, 1995, AGING-CLIN EXP RES, V7, P340, DOI 10.1007/BF03324344
   REITER RJ, 1981, ENDOCRINOLOGY, V109, P1295, DOI 10.1210/endo-109-4-1295
   REITER RJ, 1995, FASEB J, V9, P526, DOI 10.1096/fasebj.9.7.7737461
   REITER RJ, 1994, ANN NY ACAD SCI, V719, P1, DOI 10.1111/j.1749-6632.1994.tb56817.x
   Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x
   SOHAL RS, 1992, ANN NY ACAD SCI, V663, P74, DOI 10.1111/j.1749-6632.1992.tb38651.x
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   SOHAL RS, 1995, MECH AGEING DEV, V81, P15, DOI 10.1016/0047-6374(94)01578-A
   Sumien N, 2003, EXP GERONTOL, V38, P699, DOI 10.1016/S0531-5565(03)00068-8
   Tan DX, 2000, FREE RADICAL BIO MED, V29, P1177, DOI 10.1016/S0891-5849(00)00435-4
   Thollon C, 1995, CARDIOVASC RES, V30, P648, DOI 10.1016/S0008-6363(95)00075-5
   Tomás-Zapico C, 2005, J PINEAL RES, V39, P99, DOI 10.1111/j.1600-079X.2005.00248.x
   TOUITOU Y, 1985, ACTA ENDOCRINOL-COP, V108, P135, DOI 10.1530/acta.0.1080135
   TRENTINI GP, 1992, NEUROENDOCRINOLOGY, V56, P364, DOI 10.1159/000126250
   Troen BR, 2003, MT SINAI J MED, V70, P3
   Yildirim Z, 2011, INT J GERONTOL, V5, P166, DOI 10.1016/j.ijge.2011.09.019
NR 45
TC 11
Z9 11
U1 0
U2 12
PU TAIWAN SOC GERIATRIC EMERGENCY & CRITICAL CARE MEDICINE-TSGECM
PI TAIPEI
PA 12F-14, NO 42, SEC 1, MINSHENG E RD, ZHONGSHAN DIST, TAIPEI, 104, TAIWAN
SN 1873-9598
EI 1873-958X
J9 INT J GERONTOL
JI Int. J. Gerontol.
PD MAR
PY 2013
VL 7
IS 1
BP 45
EP 49
DI 10.1016/j.ijge.2012.11.010
PG 5
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 130UO
UT WOS:000317945800009
DA 2024-02-19
ER

PT J
AU Renault, V
   Thorne, LE
   Eriksson, PO
   Butler-Browne, G
   Mouly, V
AF Renault, V
   Thorne, LE
   Eriksson, PO
   Butler-Browne, G
   Mouly, V
TI Regenerative potential of human skeletal muscle during aging
SO AGING CELL
LA English
DT Article
DE aging; human; satellite cells; skeletal muscle; telomere
ID HEAVY-CHAIN COMPOSITION; SATELLITE CELL; TELOMERE LENGTH; HUMAN LIVER;
   AGE; FIBERS; DENERVATION; MYONUCLEAR; BIOLOGY; TISSUES
AB In this study, we have investigated the consequences of aging on the regenerative capacity of human skeletal muscle by evaluating two parameters: (i) variation in telomere length which was used to evaluate the in vivo turn-over and (h) the proportion of satellite cells calculated as compared to the total number of nuclei in a muscle fibre. Two skeletal muscles which have different types of innervation were analysed: the biceps brachii, a limb muscle, and the masseter, a masticatory muscle. The biopsies were obtained from two groups: young adults (23 +/- 1.15 years old) and aged adults (74 +/- 4.25 years old). Our results showed that during adult life, minimum telomere lengths and mean telomere lengths remained stable in the two muscles. The mean number of myonuclei per fibre was lower in the biceps brachii than in the masseter but no significant change was observed in either muscle with increasing age. However, the number of satellite cells, expressed as a proportion of myonuclei, decreased with age in both muscles. Therefore, normal aging of skeletal muscle in vivo is reflected by the number of satellite cells available for regeneration, but not by the mean number of myonuclei per fibre or by telomere lengths. We conclude that a decrease in regenerative capacity with age may be partially explained by a reduced availability of satellite cells.
C1 Univ Paris 06, UMR CNRS 7000, F-75634 Paris, France.
   Umea Univ, Dept Integrat Med Biol Anat & Odontol, S-90187 Umea, Sweden.
   Umea Univ, Dept Clin & Oral Physiol, S-90187 Umea, Sweden.
   Natl Inst Working Life, Ctr Musculoskeletal Res, S-90713 Umea, Sweden.
C3 Sorbonne Universite; Umea University; Umea University
RP Butler-Browne, G (corresponding author), Univ Paris 06, UMR CNRS 7000, 105 Bvd Hop, F-75634 Paris, France.
EM butlerb@ext.jussieu.fr
RI Mouly, Gillian/G-6595-2017
OI butler-browne, gillian/0000-0002-3431-242X; Mouly,
   Vincent/0000-0003-3809-4033
CR Aikata H, 2000, EXP CELL RES, V256, P578, DOI 10.1006/excr.2000.4862
   Bilodeau M, 2001, J APPL PHYSIOL, V91, P2654, DOI 10.1152/jappl.2001.91.6.2654
   BISCHOFF R, 1994, DEV DYNAM, V201, P41, DOI 10.1002/aja.1002010105
   Campisi J, 2001, EXP GERONTOL, V36, P1619, DOI 10.1016/S0531-5565(01)00160-7
   Carlson BM, 2001, J GERONTOL A-BIOL, V56, pB224, DOI 10.1093/gerona/56.5.B224
   CASHMAN NR, 1987, ANN NEUROL, V21, P481, DOI 10.1002/ana.410210512
   Decary S, 2000, NEUROMUSCULAR DISORD, V10, P113, DOI 10.1016/S0960-8966(99)00093-0
   Decary S, 1997, HUM GENE THER, V8, P1429, DOI 10.1089/hum.1997.8.12-1429
   Degens H, 1998, ADV EXP MED BIOL, V454, P343
   DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518
   ERIKSSON PO, 1980, HISTOCHEMISTRY, V65, P193, DOI 10.1007/BF00493169
   Fanò G, 2001, J MUSCLE RES CELL M, V22, P345, DOI 10.1023/A:1013122805060
   Fardeau M, 1981, ELECTRON MICROS, V4, P257
   Ferrannini E, 1996, DIABETES, V45, P947, DOI 10.2337/diabetes.45.7.947
   Friedrich U, 2000, MECH AGEING DEV, V119, P89, DOI 10.1016/S0047-6374(00)00173-1
   Goyns MH, 2002, MECH AGEING DEV, V123, P791, DOI 10.1016/S0047-6374(01)00424-9
   HABER JE, 1984, GENETICS, V106, P207
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   ISHIMOTO S, 1983, J NEUROL SCI, V62, P303, DOI 10.1016/0022-510X(83)90207-1
   Kadi F, 2000, HISTOCHEM CELL BIOL, V113, P99, DOI 10.1007/s004180050012
   Kallainen LK, 2002, MUSCLE NERVE, V25, P31, DOI 10.1002/mus.1216
   Klapper W, 2001, MECH AGEING DEV, V122, P695, DOI 10.1016/S0047-6374(01)00223-8
   KLITGAARD H, 1990, ACTA PHYSIOL SCAND, V140, P55, DOI 10.1111/j.1748-1716.1990.tb08975.x
   LARSSON L, 1978, ACTA PHYSIOL SCAND, V103, P31, DOI 10.1111/j.1748-1716.1978.tb06187.x
   Larsson L, 1998, ACTA PHYSIOL SCAND, V163, pS27, DOI 10.1046/j.1365-201x.1998.00375.x
   LEXELL J, 1995, J GERONTOL A-BIOL, V50, P11
   LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3
   LINDSEY J, 1991, MUTAT RES, V256, P45, DOI 10.1016/0921-8734(91)90032-7
   Luff AR, 1998, ANN NY ACAD SCI, V854, P92, DOI 10.1111/j.1749-6632.1998.tb09895.x
   Maier F, 1999, MUSCLE NERVE, V22, P578, DOI 10.1002/(SICI)1097-4598(199905)22:5<578::AID-MUS5>3.3.CO;2-K
   MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493
   Melk A, 2000, J AM SOC NEPHROL, V11, P444, DOI 10.1681/ASN.V113444
   Monemi M, 1999, J MUSCLE RES CELL M, V20, P351, DOI 10.1023/A:1005421604314
   MULLERFELBER W, 1993, VIRCHOWS ARCH A, V422, P277, DOI 10.1007/BF01608336
   Nakamura K, 2000, CANCER LETT, V158, P179, DOI 10.1016/S0304-3835(00)00521-8
   ORRWEAVER TL, 1981, P NATL ACAD SCI-BIOL, V78, P6354, DOI 10.1073/pnas.78.10.6354
   Renault V, 2000, EXP GERONTOL, V35, P711, DOI 10.1016/S0531-5565(00)00151-0
   RENAULT V, 2002, IN PRESS EXP GERONTO
   Roth SM, 2000, ANAT REC, V260, P351, DOI 10.1002/1097-0185(200012)260:4<350::AID-AR30>3.0.CO;2-6
   SCHMALBRUCH H, 1976, ANAT REC, V185, P279, DOI 10.1002/ar.1091850303
   SCHMALBRUCH H, 1991, RES NEUROL, V5, P3
   SCHUBERT W, 1989, P NATL ACAD SCI USA, V86, P307, DOI 10.1073/pnas.86.1.307
   Squier TC, 2001, EXP GERONTOL, V36, P1539, DOI 10.1016/S0531-5565(01)00139-5
   Takubo K, 2000, J GERONTOL A-BIOL, V55, pB533, DOI 10.1093/gerona/55.11.B533
   VAZIRI H, 1993, AM J HUM GENET, V52, P661
   WATKINS SC, 1988, ANAT REC, V222, P6, DOI 10.1002/ar.1092220103
NR 48
TC 253
Z9 292
U1 0
U2 13
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1474-9718
J9 AGING CELL
JI Aging Cell
PD DEC
PY 2002
VL 1
IS 2
BP 132
EP 139
DI 10.1046/j.1474-9728.2002.00017.x
PG 8
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 678YZ
UT WOS:000182895400009
PM 12882343
DA 2024-02-19
ER

PT J
AU Qiang, W
   Weiqiang, K
   Qing, Z
   Pengju, Z
   Yi, L
AF Qiang, Wan
   Weiqiang, Kang
   Qing, Zhu
   Pengju, Zhang
   Yi, Liu
TI Aging impairs insulin-stimulated glucose uptake in rat skeletal muscle
   via suppressing AMPKα
SO EXPERIMENTAL AND MOLECULAR MEDICINE
LA English
DT Article
DE 5'-AMP-activated protein kinase; aging; glucose transporter type 4;
   insulin resistance; muscle; skeletal; rat
ID ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; CARBOHYDRATE-METABOLISM;
   FEEDING IMPAIRS; EXERCISE; GLUT-4; LIVER; RESISTANCE; OBESITY; MEN
AB Insufficient intracellular fat oxidation is an important contributor to aging-related insulin resistance, while the precise mechanism underlying is unclear. AMP-activated protein kinase (AMPK) is an important regulator of intracellular fat oxidation and was evidenced to play a key role in high-glucose and high-fat induced glucose intolerance. In the present study, we investigated whether altered AMPK expression or activity was also involved in aging-related insulin resistance. Insulin sensitivity of rats' skeletal muscles was evaluated using in-vitro glucose uptake assay. Activity of a subunit of AMPK (AMPK alpha) was evaluated by measuring the phosphorylation of both AMPKa ((P-AMPK alpha) and acetyl-CoA carboxylase (P-ACC), while expression of AMPKa was assessed by determining the mRNA levels of AMPK(alpha 1 and AMPK alpha 2, and protein contents of AMPKa. Compared with 4-month old rats, 24-month old rats exhibited obviously impaired insulin sensitivity. At the same time, AMPK alpha activity significantly decreased, while AMPKa expression did not alter during aging. Glucose transporter 4 expression also decreased in old rats. Compared with 24-month old rats, administration of the specific activator of AMPK, 5-aminolmidazole-4-carboxamide riboside (AICAR), significantly elevated AMPKa activity and GluT4 expression. Also, aging-related insulin resistance was significantly ameliorated by AICAR treatment. In conclusion, aging-related insulin resistance is associated with impaired AMPKa activity and could be ameliorated by AICAR, thus indicating a possible role of AMPK in aging-induced insulin resistance.
C1 Shandong Univ, Shandong Provincial Hosp, Dept Internal Med, Jinan 250021, Peoples R China.
   Qingdao Municipal Hoap, Dept Municipal Hosp, Qingdao 266011, Peoples R China.
   Qingdao Haici Hosp, Dept Internal Med, Qingdao 266033, Peoples R China.
   Shandong Univ, Dept Biochem, Jinan 250012, Peoples R China.
C3 Shandong University; Shandong First Medical University & Shandong
   Academy of Medical Sciences; Shandong University
RP Yi, L (corresponding author), Shandong Univ, Shandong Provincial Hosp, Dept Internal Med, Jinan 250021, Peoples R China.
EM liuyishanyi@yahoo.com.cn
OI Liu, Yi/0000-0002-4094-2663; Wan, Qiang/0000-0001-9173-2941
CR Abu-Elheiga L, 2003, P NATL ACAD SCI USA, V100, P10207, DOI 10.1073/pnas.1733877100
   Boirie Y, 2001, J CLIN ENDOCR METAB, V86, P638, DOI 10.1210/jc.86.2.638
   CallesEscandon J, 1997, METABOLISM, V46, P1312, DOI 10.1016/S0026-0495(97)90236-5
   CALLESESCANDON J, 1995, J APPL PHYSIOL, V78, P266, DOI 10.1152/jappl.1995.78.1.266
   Carvalho CRO, 1996, ENDOCRINOLOGY, V137, P151, DOI 10.1210/en.137.1.151
   Cox JH, 1999, J APPL PHYSIOL, V86, P2019, DOI 10.1152/jappl.1999.86.6.2019
   Cree MG, 2004, J CLIN ENDOCR METAB, V89, P3864, DOI 10.1210/jc.2003-031986
   Curtis R, 2006, AGING CELL, V5, P119, DOI 10.1111/j.1474-9726.2006.00205.x
   Dobbins RL, 2001, DIABETES, V50, P123, DOI 10.2337/diabetes.50.1.123
   Fryer LGD, 2002, BIOCHEM J, V363, P167, DOI 10.1042/0264-6021:3630167
   Holmes BF, 2005, AM J PHYSIOL-ENDOC M, V289, pE1071, DOI 10.1152/ajpendo.00606.2004
   HOUMARD JA, 1995, DIABETES, V44, P555, DOI 10.2337/diabetes.44.5.555
   Iossa S, 2004, DIABETES, V53, P2861, DOI 10.2337/diabetes.53.11.2861
   Jessen N, 2003, J APPL PHYSIOL, V94, P1373, DOI 10.1152/japplphysiol.00250.2002
   Kraegen EW, 2006, AM J PHYSIOL-ENDOC M, V290, pE471, DOI 10.1152/ajpendo.00316.2005
   Larkin LM, 2001, J GERONTOL A-BIOL, V56, pB486, DOI 10.1093/gerona/56.11.B486
   Liu Y, 2006, BIOCHEM BIOPH RES CO, V339, P701, DOI 10.1016/j.bbrc.2005.11.068
   McCarty MF, 2004, MED HYPOTHESES, V63, P334, DOI 10.1016/j.mehy.2004.01.043
   McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7
   Menshikova EV, 2006, J GERONTOL A-BIOL, V61, P534, DOI 10.1093/gerona/61.6.534
   Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a
   Park SY, 2006, LIFE SCI, V79, P2228, DOI 10.1016/j.lfs.2006.07.014
   Perdomo G, 2004, J BIOL CHEM, V279, P27177, DOI 10.1074/jbc.M403566200
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048
   Scheen AJ, 2005, DIABETES METAB, V31, pS27
   SEALS DR, 1984, JAMA-J AM MED ASSOC, V252, P645, DOI 10.1001/jama.252.5.645
   Short KR, 2003, DIABETES, V52, P1888, DOI 10.2337/diabetes.52.8.1888
   Sial S, 1996, AM J PHYSIOL-ENDOC M, V271, pE983, DOI 10.1152/ajpendo.1996.271.6.E983
   Sial S, 1998, AM J PHYSIOL-ENDOC M, V274, pE785, DOI 10.1152/ajpendo.1998.274.5.E785
   Slawik M, 2006, AGEING RES REV, V5, P144, DOI 10.1016/j.arr.2006.03.004
   Wan Q, 2005, ALCOHOL CLIN EXP RES, V29, P1450, DOI 10.1097/01.alc.0000174768.78427.f6
   Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788
   Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505
NR 34
TC 104
Z9 123
U1 0
U2 11
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1226-3613
EI 2092-6413
J9 EXP MOL MED
JI Exp. Mol. Med.
PD AUG 31
PY 2007
VL 39
IS 4
BP 535
EP 543
DI 10.1038/emm.2007.59
PG 9
WC Biochemistry & Molecular Biology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Research & Experimental Medicine
GA 206ZA
UT WOS:000249220200013
PM 17934342
OA gold
DA 2024-02-19
ER

PT J
AU Ju, SH
   Ku, BJ
AF Ju, Sang Hyeon
   Ku, Bon Jeong
TI Effects of rosuvastatin/ezetimibe on senescence of CD8+T-cell in type 2
   diabetic patients with hypercholesterolemia: A study protocol
SO MEDICINE
LA English
DT Article
DE ezetimibe; senescent CD8+T cells; statin; type 2 diabetes mellitus
ID CD8(+) T-CELLS; ENDOTHELIAL FUNCTION; MECHANISMS; INFLAMMATION;
   PATHOGENESIS; LYMPHOCYTES; EXHAUSTION; EZETIMIBE; STATINS; DISEASE
AB Background:A decade ago, systemic inflammation became widely recognized as an etiology of type 2 diabetes mellitus (T2DM) and complications thereof. Senescent CD8 + T cells of T2DM patients exhibit increased secretion of pro-inflammatory cytokines and enhanced expression of cytotoxic molecules, contributing to systemic inflammation. Recently, many anti-inflammatory roles played by statins and ezetimibe (cholesterol-lowering drugs) have been reported. We will explore the effects of statin/ezetimibe therapy on CD8 + T cell senescence in patients with T2DM and hypercholesterolemia. Methods:This 2-group, parallel, randomized, controlled clinical trial will recruit 108 subjects with T2DM and low-density lipoprotein-cholesterol (LDL-C) levels >= 100 mg/dL and randomly assign them to rosuvastatin/ezetimibe and rosuvastatin groups at a 1:1 ratio. Blood samples will be drawn at baseline and after 12 weeks of medication. The primary outcomes will be the LDL-C-lowering effects after 12 weeks. The secondary outcomes will be changes in the senescent (CD28 - CD57+) CD8 + T cell proportions; the levels of circulating pro-inflammatory cytokines, cytotoxic molecules, interleukin-1, transforming growth factor-beta, fasting glucose, and HbA1c; and biochemical indices of kidney, liver, and muscle function. Symptoms and signs of predictable adverse events (myopathy and hepatitis) will be routinely monitored. Discussion:We will evaluate the effects of statin/ezetimibe on CD8 + T cell senescence. Statin/ezetimibe may exert a beneficial immunomodulatory effect.
C1 [Ju, Sang Hyeon; Ku, Bon Jeong] Chungnam Natl Univ Hosp, Dept Internal Med, Daejeon, South Korea.
   [Ku, Bon Jeong] Chungnam Natl Univ, Dept Internal Med, Sch Med, Daejeon, South Korea.
   [Ku, Bon Jeong] Chungnam Natl Univ, Dept Internal Med, Sch Med, 282 Munhwa ro, Daejeon 35015, South Korea.
C3 Chungnam National University; Chungnam National University Hospital;
   Chungnam National University; Chungnam National University
RP Ku, BJ (corresponding author), Chungnam Natl Univ, Dept Internal Med, Sch Med, 282 Munhwa ro, Daejeon 35015, South Korea.
EM jshsignal@cnuh.co.kr; bonjeong@cnu.ac.kr
OI Ku, Bon Jeong/0000-0002-3414-8949
FU Chungnam National University Hospital [2018-10-030]; Yuhan
   Pharmaceutical Company [IIT-009]
FX This study supported by Chungnam National University Hospital
   (2018-10-030) and Yuhan Pharmaceutical Company (IIT-009).CRIS
   registration number: KCT0003477
CR Akash MSH, 2013, J CELL BIOCHEM, V114, P525, DOI 10.1002/jcb.24402
   Amer Diabet Assoc Professional Pra, 2022, DIABETES CARE, V45, pS17, DOI 10.2337/dc22-S002
   Bass A, 2009, ANN PHARMACOTHER, V43, P2021, DOI 10.1345/aph.1M302
   Bennaceur K, 2014, ATHEROSCLEROSIS, V236, P312, DOI 10.1016/j.atherosclerosis.2014.07.020
   Bird L, 2018, NAT REV IMMUNOL, V18, P669, DOI 10.1038/s41577-018-0076-5
   Blanco-Colio LM, 2003, KIDNEY INT, V63, P12, DOI 10.1046/j.1523-1755.2003.00744.x
   Blum A, 2009, ATHEROSCLEROSIS, V203, P325, DOI 10.1016/j.atherosclerosis.2008.08.022
   Bu DX, 2010, J CLIN INVEST, V120, P1961, DOI 10.1172/JCI41384
   Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489
   Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583
   DeFronzo RA, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.19
   DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028
   Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925
   Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011
   Ganda Om P, 2016, F1000Res, V5, DOI 10.12688/f1000research.8629.1
   Ghittoni Raffaella, 2007, Inflammation & Allergy Drug Targets, V6, P3, DOI 10.2174/187152807780077291
   Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545
   Giubilato S, 2011, EUR HEART J, V32, P1214, DOI 10.1093/eurheartj/ehq499
   Grigore L, 2013, EUR J CLIN PHARMACOL, V69, P341, DOI 10.1007/s00228-012-1345-z
   Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Kang YE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154003
   Laakso M, 2001, J INTERN MED, V249, P225, DOI 10.1046/j.1365-2796.2001.00789.x
   Lau EYM, 2019, CLIN EXP IMMUNOL, V197, P205, DOI 10.1111/cei.13344
   Libby P, 2003, AM J CARDIOL, V91, p4B, DOI 10.1016/S0002-9149(02)03267-8
   Link A, 2011, CLIN RES CARDIOL, V100, P147, DOI 10.1007/s00392-010-0225-8
   Ma XZ, 2019, CELL METAB, V30, P143, DOI 10.1016/j.cmet.2019.04.002
   Moher D, 2010, BMJ-BRIT MED J, V340, DOI [10.1136/bmj.c869, 10.1136/bmj.c332, 10.1016/j.ijsu.2011.09.004, 10.1186/1741-7015-8-18, 10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352]
   Moller DE, 2000, TRENDS ENDOCRIN MET, V11, P212, DOI 10.1016/S1043-2760(00)00272-1
   Mondal AM, 2013, J CLIN INVEST, V123, P5247, DOI 10.1172/JCI70355
   Nakanjako D, 2015, TROP MED INT HEALTH, V20, P380, DOI 10.1111/tmi.12442
   Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964
   Okoye I, 2017, ONCOTARGET, V8, P98215, DOI 10.18632/oncotarget.21003
   Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812
   Strioga M, 2011, IMMUNOLOGY, V134, P17, DOI 10.1111/j.1365-2567.2011.03470.x
   Tedeschi V, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23063374
   Yi HS, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1494-4
   Youn JC, 2013, HYPERTENSION, V62, P126, DOI 10.1161/HYPERTENSIONAHA.113.00689
   Yu HT, 2015, CELL MOL IMMUNOL, V12, P466, DOI 10.1038/cmi.2014.74
   Yuan JJ, 2021, PROTEIN CELL, V12, P240, DOI 10.1007/s13238-021-00821-2
   Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010
NR 41
TC 1
Z9 1
U1 1
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD NOV 25
PY 2022
VL 101
IS 47
DI 10.1097/MD.0000000000031691
PG 5
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 6W5AK
UT WOS:000895740900023
PM 36451471
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Park, JH
   Choi, TS
AF Park, Ji-Hun
   Choi, Tae-Saeng
TI Polycystic ovary syndrome (PCOS)-like phenotypes in the
   D-galactose-induced aging mouse model
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Anti-Mullerian hormone; D-Galactose induced aging; Polycystic ovary
   syndrome; Testosterone
ID ANTI-MULLERIAN HORMONE; GLYCATION END-PRODUCTS;
   FOLLICLE-STIMULATING-HORMONE; ANTIMULLERIAN HORMONE; SENSITIVITY;
   MARKER; WOMEN; MICE
AB The D-galactose (D-gal)-induced animal model, which is established by consecutive subcutaneous D-gal injections for approximately 6 weeks, has been frequently used for aging research. This animal model has been shown to accelerate aging of the brain, kidneys, liver, and blood cells. However, aging of the female reproductive organs in this animal model has not been reported. The aim of this study was to investigate changes in the ovary in the D-gal-induced aging mouse model. First, we evaluated anti-Mullerian hormone (AMH) as a marker of ovarian aging in blood plasma. We speculated there would be lower AMH levels in D-gal-treated mice because ovarian aging would be induced by D-gal, as reported for other tissues. However, the results showed that AMH levels in D-gal-treated mice were approximately four-fold higher than control mice. Abnormally high AMH levels are detected in ovarian cancer and polycystic ovary syndrome (PCOS) patients. Therefore, we examined PCOS-related markers in this mouse model. Total testosterone levels were high and abnormal estrous cycles were induced in D-gal-treated mice. These changes, including AMH levels, in D-gal-treated mice were inhibited by aminoguanidine treatment, an advanced glycation end product reducer. In addition, ovarian cysts were observed in some D-gal-treated mice. These results indicate that with respect to female reproduction, D-gal-treated mice are suitable for PCOS studies, rather than aging studies. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Park, Ji-Hun] Dankook Univ, WCU Res Ctr Nanobiomed Sci, Cheonan 330714, South Korea.
   [Park, Ji-Hun; Choi, Tae-Saeng] Dankook Univ, Dept Microbiol, Coll Med, Anseo 330714, Cheonan, South Korea.
C3 Dankook University; Dankook University
RP Choi, TS (corresponding author), Dankook Univ, Dept Microbiol, Coll Med, Room 403, Anseo 330714, Cheonan, South Korea.
EM tschoi@dankook.ac.kr
FU Institute of Bio-Science and Technology (IBST) of Dankook University,
   Republic of Korea [2010]
FX This study was supported by grants 2010 from the Institute of
   Bio-Science and Technology (IBST) of Dankook University, Republic of
   Korea.
CR Chapman JC, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-47
   Chen HL, 2011, BRIT J NUTR, V105, P805, DOI 10.1017/S000711451000437X
   Chu MC, 2005, FERTIL STERIL, V84, P1685, DOI 10.1016/j.fertnstert.2005.06.026
   Cui X, 2006, J NEUROSCI RES, V84, P647, DOI 10.1002/jnr.20899
   Diamanti-Kandarakis E, 2005, CLIN ENDOCRINOL, V62, P37, DOI 10.1111/j.1365-2265.2004.02170.x
   Diamanti-Kandarakis E, 2007, HISTOCHEM CELL BIOL, V127, P581, DOI 10.1007/s00418-006-0265-3
   Dumesic DA, 2008, OBSTET GYNECOL SURV, V63, P39, DOI 10.1097/OGX.0b013e31815e85fc
   Feyereisen E, 2006, REPROD BIOMED ONLINE, V12, P695, DOI 10.1016/S1472-6483(10)61081-4
   Geerts I, 2009, INT J GYNECOL CANCER, V19, P847, DOI 10.1111/IGC.0b013e3181a702d1
   Kevenaar ME, 2006, ENDOCRINOLOGY, V147, P3228, DOI 10.1210/en.2005-1588
   Kumar A, 2011, INT J RADIAT BIOL, V87, P1086, DOI 10.3109/09553002.2011.605417
   Lei M, 2008, BIOCHEM BIOPH RES CO, V369, P1082, DOI 10.1016/j.bbrc.2008.02.151
   Li Y, 2011, FERTIL STERIL, V95, P2354, DOI 10.1016/j.fertnstert.2011.03.047
   Lin N, 2012, DIABETES METAB, V38, P250, DOI 10.1016/j.diabet.2012.01.003
   Liu AJ, 2009, BIOSCI BIOTECH BIOCH, V73, P1461, DOI 10.1271/bbb.80558
   Mao GX, 2010, BIOMED ENVIRON SCI, V23, P161, DOI 10.1016/S0895-3988(10)60047-5
   NELSON JF, 1982, BIOL REPROD, V27, P327, DOI 10.1095/biolreprod27.2.327
   Parco S, 2011, INT J GEN MED, V4, P759, DOI 10.2147/IJGM.S25639
   Pellatt L, 2011, FERTIL STERIL, V96, P1246, DOI 10.1016/j.fertnstert.2011.08.015
   Pigny P, 2003, J CLIN ENDOCR METAB, V88, P5957, DOI 10.1210/jc.2003-030727
   Roland AV, 2010, J ENDOCRINOL, V207, P213, DOI 10.1677/JOE-10-0217
   Seifer DB, 2011, FERTIL STERIL, V95, P747, DOI 10.1016/j.fertnstert.2010.10.011
   Semba RD, 2010, J GERONTOL A-BIOL, V65, P963, DOI 10.1093/gerona/glq074
   Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6
   Soto N, 2009, HUM REPROD, V24, P2838, DOI 10.1093/humrep/dep276
   Visser JA, 2006, REPRODUCTION, V131, P1, DOI 10.1530/rep.1.00529
   Walters KA, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097808
   Zhu JQ, 2010, MOL HUM REPROD, V16, P260, DOI 10.1093/molehr/gap089
NR 28
TC 38
Z9 42
U1 1
U2 27
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD NOV 2
PY 2012
VL 427
IS 4
BP 701
EP 704
DI 10.1016/j.bbrc.2012.09.099
PG 4
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 037VN
UT WOS:000311134700003
PM 23022527
DA 2024-02-19
ER

PT J
AU Jeong, H
   Liu, Y
   Kim, HS
AF Jeong, Heesoo
   Liu, Yanan
   Kim, Hyun-Sook
TI Dried plum and chokeberry ameliorate D-galactose-induced aging in mice
   by regulation of PI3k/Akt-mediated Nrf2 and Nf-κB pathways
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
ID OXIDATIVE STRESS; ARONIA-MELANOCARPA; MOLECULAR-MECHANISMS;
   TRANSCRIPTION FACTOR; CALORIC RESTRICTION; ANTIOXIDANT ENZYMES;
   ACTIVATING NRF2; FREE-RADICALS; POLYPHENOLS; LIVER
C1 [Jeong, Heesoo; Liu, Yanan; Kim, Hyun-Sook] Sookmyung Womens Univ, Coll Human Ecol, Food & Nutr, Seoul 04310, South Korea.
C3 Sookmyung Women's University
RP Kim, HS (corresponding author), Sookmyung Womens Univ, Coll Human Ecol, Food & Nutr, Seoul 04310, South Korea.
EM hskim@sookmyung.ac.kr
FU Medical Research Center Program through National Research Foundation of
   Korea (NRF) grant - Korea government (MSIP) [2011-0030074]
FX This work was supported by the Medical Research Center Program (No.
   2011-0030074) through National Research Foundation of Korea (NRF) grant
   funded by the Korea government (MSIP).
CR Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042
   Ali T, 2015, J PINEAL RES, V58, P71, DOI 10.1111/jpi.12194
   [Anonymous], BIOCHEMISTRY
   Appel K, 2015, FITOTERAPIA, V105, P73, DOI 10.1016/j.fitote.2015.06.009
   Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907
   Bu SY, 2008, CALCIFIED TISSUE INT, V82, P475, DOI 10.1007/s00223-008-9139-0
   CAND F, 1989, FREE RADICAL BIO MED, V7, P59, DOI 10.1016/0891-5849(89)90101-9
   Chapple SJ, 2012, INT J BIOCHEM CELL B, V44, P1315, DOI 10.1016/j.biocel.2012.04.021
   Chen HL, 2011, BRIT J NUTR, V105, P805, DOI 10.1017/S000711451000437X
   Chen Z, 2015, PHYTOTHER RES, V29, P1768, DOI 10.1002/ptr.5431
   Conner EM, 1996, NUTRITION, V12, P274, DOI 10.1016/S0899-9007(96)00000-8
   Csiszar A, 2008, J APPL PHYSIOL, V105, P1333, DOI 10.1152/japplphysiol.90470.2008
   Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004
   Denev PN, 2012, COMPR REV FOOD SCI F, V11, P471, DOI 10.1111/j.1541-4337.2012.00198.x
   Elkhamisy A. E., 2014, World Journal of Dairy & Food Sciences, V9, P220
   Fernández AF, 2011, EPIGENETICS-US, V6, P870, DOI 10.4161/epi.6.7.16499
   Gallaher CM, 2009, BRIT J NUTR, V101, P233, DOI 10.1017/S0007114508995684
   Gasiorowski K, 1997, CANCER LETT, V119, P37, DOI 10.1016/S0304-3835(97)00248-6
   Hadzi-Petrushev N, 2015, PHYSIOL RES, V64, P61, DOI 10.33549/physiolres.932786
   HALLFRISCH J, 1990, J GERONTOL, V45, pM186, DOI 10.1093/geronj/45.6.M186
   Han CH, 2014, FOOD FUNCT, V5, P2228, DOI 10.1039/c4fo00205a
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Helenius M, 1996, J MOL CELL CARDIOL, V28, P487, DOI 10.1006/jmcc.1996.0045
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Hooshmand S, 2015, FOOD FUNCT, V6, P1719, DOI [10.1039/c5fo00173k, 10.1039/C5FO00173K]
   Hooshmand S, 2014, BRIT J NUTR, V112, P55, DOI 10.1017/S0007114514000671
   Hsia C., 2012, FRUCTO OLIGOSACCHARI, P1787
   Jayasooriya RGPT, 2014, FOOD CHEM TOXICOL, V65, P82, DOI 10.1016/j.fct.2013.12.011
   Kasapoglu M, 2001, EXP GERONTOL, V36, P209, DOI 10.1016/S0531-5565(00)00198-4
   Kim B, 2013, NUTR RES, V33, P406, DOI 10.1016/j.nutres.2013.03.001
   Kim DH, 2008, BIOGERONTOLOGY, V9, P33, DOI 10.1007/s10522-007-9114-6
   Kim HJ, 2002, EXP GERONTOL, V37, P1041, DOI 10.1016/S0531-5565(02)00082-7
   Knight JA, 2000, ANN CLIN LAB SCI, V30, P145
   Kulling SE, 2008, PLANTA MED, V74, P1625, DOI 10.1055/s-0028-1088306
   Li DY, 2006, J SURG RES, V131, P64, DOI 10.1016/j.jss.2005.06.038
   Li YN, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/320513
   Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433
   Mateos R, 2005, J CHROMATOGR B, V827, P76, DOI 10.1016/j.jchromb.2005.06.035
   Matsuda S., 2013, ISRN ENDOCRINOLOGY
   Munch G, 1997, BRAIN RES REV, V23, P134, DOI 10.1016/S0165-0173(96)00016-1
   Nakatani N, 2000, J AGR FOOD CHEM, V48, P5512, DOI 10.1021/jf000422s
   Obrenovich ME, 2010, REJUV RES, V13, P631, DOI 10.1089/rej.2010.1043
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Papandreou MA, 2009, BEHAV BRAIN RES, V198, P352, DOI 10.1016/j.bbr.2008.11.013
   Peppa M, 2008, HORM-INT J ENDOCRINO, V7, P123, DOI 10.1007/BF03401503
   Piper MDW, 2008, CELL METAB, V8, P99, DOI 10.1016/j.cmet.2008.06.012
   Radák Z, 2004, FASEB J, V18, P749, DOI 10.1096/fj.03-0509fje
   Reinisalo M, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/340520
   Rendina E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060569
   Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982
   Salminen A, 2008, CELL MOL LIFE SCI, V65, P1049, DOI 10.1007/s00018-008-7461-3
   Salminen A, 2009, J CLIN IMMUNOL, V29, P397, DOI 10.1007/s10875-009-9296-6
   Sarady JK, 2004, FASEB J, V18, P854, DOI 10.1096/fj.03-0643fje
   Shukitt-Hale B, 2009, NUTRITION, V25, P567, DOI 10.1016/j.nut.2008.10.018
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Stacewicz-Sapuntzakis M, 2013, CRIT REV FOOD SCI, V53, P1277, DOI 10.1080/10408398.2011.563880
   Sun HZ, 2010, J ENDOCRINOL, V204, P311, DOI 10.1677/JOE-09-0270
   Sykiotis GP, 2011, CURR OPIN CLIN NUTR, V14, P41, DOI 10.1097/MCO.0b013e32834136f2
   Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x
   Tian LQ, 1998, FREE RADICAL BIO MED, V24, P1477, DOI 10.1016/S0891-5849(98)00025-2
   Tilstra JS, 2011, AGING DIS, V2, P449
   Tomobe K, 2012, ARCH GERONTOL GERIAT, V54, pE1, DOI 10.1016/j.archger.2011.06.006
   Valcheva-Kuzmanova S, 2004, EXP TOXICOL PATHOL, V56, P195, DOI 10.1016/j.etp.2004.04.012
   Valls-Pedret C, 2012, J ALZHEIMERS DIS, V29, P773, DOI 10.3233/JAD-2012-111799
   Minh Doan V, 2015, FOOD FUNCT, V6, P1712, DOI [10.1039/C5FO00238A, 10.1039/c5fo00238a]
   Willcox BJ, 2007, ANN NY ACAD SCI, V1114, P434, DOI 10.1196/annals.1396.037
   Woo JY, 2014, ANAEROBE, V27, P22, DOI 10.1016/j.anaerobe.2014.03.003
   Xie YX, 2013, CURR DRUG METAB, V14, P414, DOI 10.2174/1389200211314040005
   Yang YQ, 2005, NUTR CANCER, V53, P117, DOI 10.1207/s15327914nc5301_14
   Yeh SL, 2014, EUR J NUTR, V53, P449, DOI 10.1007/s00394-013-0545-3
   Yu YH, 2015, PHARMACOL BIOCHEM BE, V133, P122, DOI 10.1016/j.pbb.2015.03.020
   Yu YH, 2015, MOL CELL BIOCHEM, V403, P287, DOI 10.1007/s11010-015-2358-6
   Zhou Y, 2013, FOOD CHEM TOXICOL, V59, P412, DOI 10.1016/j.fct.2013.06.009
NR 73
TC 22
Z9 23
U1 0
U2 34
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD SEP
PY 2017
VL 95
BP 16
EP 25
DI 10.1016/j.exger.2017.05.004
PG 10
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA EZ1TK
UT WOS:000404493500003
PM 28502776
DA 2024-02-19
ER

PT J
AU Fountoulakis, M
   de Vera, MC
   Crameri, F
   Boess, F
   Gasser, R
   Albertini, S
   Suter, L
AF Fountoulakis, M
   de Vera, MC
   Crameri, F
   Boess, F
   Gasser, R
   Albertini, S
   Suter, L
TI Modulation of gene and protein expression by carbon tetrachloride in the
   rat liver
SO TOXICOLOGY AND APPLIED PHARMACOLOGY
LA English
DT Article
DE toxicogenomics; proteomics; hepatotoxicty; gene expression; microarray
ID NECROSIS-FACTOR-ALPHA; INDUCED HEPATOTOXICITY; MICROVESICULAR STEATOSIS;
   MESSENGER-RNAS; TOXICITY; IDENTIFICATION; ACETAMINOPHEN; INDUCTION;
   INJURY; ELECTROPHORESIS
AB The gene and protein expression changes after exposure to a toxic compound might help elucidate its mechanism of action. In this paper we investigated the effect of carbon tetrachloride (CCl4) on the gene and protein expression in rat livers. Adult Wistar rats were administered CCl4, and livers were harvested 6 or 24 h thereafter. The analysis of mitochondrial proteins on 2D gels showed the upregulation of two proteins involved in stress (catalase and uricase). Among the downregulated proteins, enzymes related to the metabolism of lipids and aminoacids were affected. Additionally, alpha-2-macroglobulin and senescence marker protein, two proteins whose decrease in expression has been connected to hepatocyte damage, were decreased. Several of the upregulated genes are involved in stress response, DNA and protein damage, and repair. Genes coding for several enzymes involved in different metabolic pathways, including some P450, were downregulated in the treated animals. In conclusion, a single dose of CCl4 caused gene and protein expression changes that can be relate to its mechanism of toxicity. Results from both technologies support previous publications and provide possible new toxicity markers. However, the correlation between gene and protein expression at a given time point is less apparent, partly as a result of different regulatory mechanisms between gene and protein expression. (C) 2002 Elsevier Science (USA).
C1 Hoffmann La Roche Ag, Genet PRGT, CH-4070 Basel, Switzerland.
   Hoffmann La Roche Ag, Nonclin Safety PRNS, CH-4070 Basel, Switzerland.
C3 Roche Holding; Roche Holding
RP Fountoulakis, M (corresponding author), Hoffmann La Roche Ag, Genet PRGT, CH-4070 Basel, Switzerland.
RI Suter-Dick, Laura/A-9093-2019
OI Suter-Dick, Laura/0000-0002-1449-3913
CR Bartosiewicz MJ, 2001, J PHARMACOL EXP THER, V297, P895
   Berndt P, 1999, ELECTROPHORESIS, V20, P3521, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3521::AID-ELPS3521>3.0.CO;2-8
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Bruccoleri A, 1997, HEPATOLOGY, V25, P133, DOI 10.1053/jhep.1997.v25.pm0008985279
   Buetler TM, 1998, HEPATOLOGY, V28, P1551, DOI 10.1002/hep.510280615
   Bulera SJ, 2001, HEPATOLOGY, V33, P1239, DOI 10.1053/jhep.2001.23560
   CALABRESE EJ, 1993, TOXICOL APPL PHARM, V121, P1, DOI 10.1006/taap.1993.1121
   CARFAGNA MA, 2000, TOXICOL SCI, V54, P383
   CARVER MP, 2000, TOXICOL SCI, V54, P383
   Castro GD, 1997, RES COMMUN MOL PATH, V95, P253
   Cohen SD, 1997, TOXICOL APPL PHARM, V143, P1, DOI 10.1006/taap.1996.8074
   Cohen SD, 1997, DRUG METAB REV, V29, P59, DOI 10.3109/03602539709037573
   DeCicco LA, 1998, TOXICOL LETT, V98, P115, DOI 10.1016/S0378-4274(98)00110-6
   EDWARDS MJ, 1993, TOXICOL APPL PHARM, V119, P275, DOI 10.1006/taap.1993.1069
   Fielden MR, 2001, TOXICOL SCI, V60, P6, DOI 10.1093/toxsci/60.1.6
   Fountoulakis M, 2000, ELECTROPHORESIS, V21, P2148, DOI 10.1002/1522-2683(20000601)21:11<2148::AID-ELPS2148>3.0.CO;2-X
   Fountoulakis M, 2002, ELECTROPHORESIS, V23, P311, DOI 10.1002/1522-2683(200202)23:2<311::AID-ELPS311>3.0.CO;2-0
   Fountoulakis M, 1997, ANAL BIOCHEM, V250, P153, DOI 10.1006/abio.1997.2213
   FRENEAUX E, 1988, HEPATOLOGY, V8, P1056, DOI 10.1002/hep.1840080513
   Fromenty B, 1997, J HEPATOL, V26, P43, DOI 10.1016/S0168-8278(97)80496-5
   Fujita T, 1996, MECH AGEING DEV, V87, P219, DOI 10.1016/0047-6374(96)01711-3
   GAO F, 1989, NUCLEIC ACIDS RES, V17, P4629, DOI 10.1093/nar/17.12.4629
   GEBHARDT R, 1994, HEPATOLOGY, V20, P684, DOI 10.1016/0270-9139(94)90105-8
   HARTMANN E, 1993, EUR J BIOCHEM, V214, P375, DOI 10.1111/j.1432-1033.1993.tb17933.x
   Holden PR, 2000, J BIOCHEM MOL TOXIC, V14, P283, DOI 10.1002/1099-0461(2000)14:5<283::AID-JBT7>3.0.CO;2-S
   Langen H, 1997, ELECTROPHORESIS, V18, P2085, DOI 10.1002/elps.1150181135
   NEMALI MR, 1989, TOXICOL APPL PHARM, V97, P72, DOI 10.1016/0041-008X(89)90056-2
   Newsholme SJ, 2000, ELECTROPHORESIS, V21, P2122, DOI 10.1002/1522-2683(20000601)21:11<2122::AID-ELPS2122>3.0.CO;2-#
   Reilly TP, 2001, BIOCHEM BIOPH RES CO, V282, P321, DOI 10.1006/bbrc.2001.4576
   RIKANS LE, 1989, DRUG METAB REV, V20, P87, DOI 10.3109/03602538908994145
   ROMERO G, 1994, LIFE SCI, V55, P981, DOI 10.1016/0024-3205(94)00632-6
   RUEPP S, 2000, TOXICOL SCI, V54, P384
   Schiaffonati L, 1997, LIVER, V17, P183
   Serfas MS, 1997, CELL GROWTH DIFFER, V8, P951
   Stoyanovsky DA, 1999, CHEM RES TOXICOL, V12, P730, DOI 10.1021/tx9900371
   Su ZZ, 1997, P NATL ACAD SCI USA, V94, P9125, DOI 10.1073/pnas.94.17.9125
   SUTER L, 2000, TOXICOL SCI, V54, P383
   VANBEZOOIJEN RL, 1994, EXP GERONTOL, V29, P187, DOI 10.1016/0531-5565(94)90050-7
   Waring JF, 2001, TOXICOL LETT, V120, P359, DOI 10.1016/S0378-4274(01)00267-3
   WEBER FL, 1992, GASTROENTEROLOGY, V102, P1700, DOI 10.1016/0016-5085(92)91733-K
   Yata Y, 1999, J HEPATOL, V30, P419, DOI 10.1016/S0168-8278(99)80100-7
NR 41
TC 46
Z9 47
U1 0
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0041-008X
J9 TOXICOL APPL PHARM
JI Toxicol. Appl. Pharmacol.
PD AUG 15
PY 2002
VL 183
IS 1
BP 71
EP 80
DI 10.1006/taap.2002.9460
PG 10
WC Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Toxicology
GA 591KV
UT WOS:000177879700008
PM 12217644
DA 2024-02-19
ER

PT J
AU Wu, N
   Carpino, G
   Ceci, L
   Baiocchi, L
   Francis, H
   Kennedy, L
   Zhou, TH
   Chen, LX
   Sato, K
   Kyritsi, K
   Meadows, V
   Ekser, B
   Franchitto, A
   Mancinelli, R
   Onori, P
   Gaudio, E
   Glaser, S
   Alpini, G
AF Wu, Nan
   Carpino, Guido
   Ceci, Ludovica
   Baiocchi, Leonardo
   Francis, Heather
   Kennedy, Lindsey
   Zhou, Tianhao
   Chen, Lixian
   Sato, Keisaku
   Kyritsi, Konstantina
   Meadows, Vik
   Ekser, Burcin
   Franchitto, Antonio
   Mancinelli, Romina
   Onori, Paolo
   Gaudio, Eugenio
   Glaser, Shannon
   Alpini, Gianfranco
TI Melatonin receptor 1A, but not 1B, knockout decreases biliary damage and
   liver fibrosis during cholestatic liver injury
SO HEPATOLOGY
LA English
DT Article; Early Access
ID CHOLANGIOCYTE HYPERPLASIA; MT2 MELATONIN; SENESCENCE; CELLS; ACTIVATION;
   EXPRESSION; SECRETION; RESPONSES
AB Background and Aims Melatonin reduces biliary damage and liver fibrosis in cholestatic models by interaction with melatonin receptors 1A (MT1) and 1B (MT2). MT1 and MT2 can form heterodimers and homodimers, but MT1 and MT2 can heterodimerize with the orphan receptor G protein-coupled receptor 50 (GPR50). MT1/GPR50 dimerization blocks melatonin binding, but MT2/GPR50 dimerization does not affect melatonin binding. GPR50 can dimerize with TGF beta receptor type I (TGF beta RI) to activate this receptor. We aimed to determine the differential roles of MT1 and MT2 during cholestasis. Approach and Results Wild-type (WT), MT1 knockout (KO), MT2KO, and MT1/MT2 double KO (DKO) mice underwent sham or bile duct ligation (BDL); these mice were also treated with melatonin. BDL WT and multidrug resistance 2 KO (Mdr2(-/-)) mice received mismatch, MT1, or MT2 Vivo-Morpholino. Biliary expression of MT1 and GPR50 increases in cholestatic rodents and human primary sclerosing cholangitis (PSC) samples. Loss of MT1 in BDL and Mdr2(-/-) mice ameliorated biliary and liver damage, whereas these parameters were enhanced following loss of MT2 and in DKO mice. Interestingly, melatonin treatment alleviated BDL-induced biliary and liver injury in BDL WT and BDL MT2KO mice but not in BDL MT1KO or BDL DKO mice, demonstrating melatonin's interaction with MT1. Loss of MT2 or DKO mice exhibited enhanced GPR50/TGF beta R1 signaling, which was reduced by loss of MT1. Conclusions Melatonin ameliorates liver phenotypes through MT1, whereas down-regulation of MT2 promotes liver damage through GPR50/TGF beta R1 activation. Blocking GPR50/TGF beta R1 binding through modulation of melatonin signaling may be a therapeutic approach for PSC.
C1 [Wu, Nan; Ceci, Ludovica; Francis, Heather; Kennedy, Lindsey; Zhou, Tianhao; Chen, Lixian; Sato, Keisaku; Kyritsi, Konstantina; Meadows, Vik; Alpini, Gianfranco] Indiana Univ, Hepatol & Gastroenterol, Med, Indianapolis, IN 46204 USA.
   [Carpino, Guido] Univ Rome Foro Italico, Div Hlth Sci, Dept Movement Human & Hlth Sci, Rome, Italy.
   [Baiocchi, Leonardo] Univ Tor Vergata, Hepatol Unit, Rome, Italy.
   [Francis, Heather; Kennedy, Lindsey; Alpini, Gianfranco] Richard L Roudebush VA Med Ctr, Indianapolis, IN USA.
   [Ekser, Burcin] Indiana Univ, Dept Surg, Div Transplant Surg, Indianapolis, IN USA.
   [Franchitto, Antonio; Mancinelli, Romina; Onori, Paolo; Gaudio, Eugenio] Sapienza Univ Rome, Dept Anat Histol Forens Med & Orthoped Sci, Rome, Italy.
   [Glaser, Shannon] Texas A& M Univ, Coll Med, Dept Med Physiol, Bryan, TX USA.
C3 Indiana University System; Indiana University-Purdue University
   Indianapolis; Foro Italico University of Rome; University of Rome Tor
   Vergata; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana
   University System; Indiana University-Purdue University Indianapolis;
   Sapienza University Rome; Texas A&M University System; Texas A&M
   University College Station
RP Alpini, G (corresponding author), Richard L Roudebush VA Med Ctr, Indiana Ctr Liver Res, 702 Rotary Circle, Indianapolis, IN 46202 USA.; Alpini, G (corresponding author), Indiana Univ, Gastroenterol, Med, 702 Rotary Circle, Indianapolis, IN 46202 USA.
EM galpini@iu.edu
RI Ekser, Burcin/I-3288-2019; Carpino, Guido/AAB-9692-2019; Chen,
   Lixian/ABH-3076-2021
OI Ekser, Burcin/0000-0003-0741-8007; CARPINO, Guido/0000-0001-8570-2519;
   Kennedy, Lindsey/0000-0001-9224-8940
FU Hickam Endowed Chair, Gastroenterology, Medicine, Indiana University;
   Indiana University Health-Indiana University School of Medicine
   Strategic Research Initiative; US Department of Veteran's Affairs,
   Biomedical Laboratory Research and Development Service [5I01BX000574,
   1I01BX003031]; National Institutes of Health [DK108959, DK119421,
   DK054811, DK115184, DK076898, DK107310, DK110035, DK062975, AA028711];
   PSC Partners Seeking a Cure; Sapienza University funds
   [RM1181642BEF570E]
FX This work was supported by the Hickam Endowed Chair, Gastroenterology,
   Medicine, Indiana University; the Indiana University Health-Indiana
   University School of Medicine Strategic Research Initiative; VA Merit
   awards (5I01BX000574, to G. A.; (1I01BX003031, to H. F.) from the US
   Department of Veteran's Affairs, Biomedical Laboratory Research and
   Development Service; the National Institutes of Health (DK108959,
   DK119421, to H. F.; DK054811, DK115184, DK076898, DK107310, DK110035,
   DK062975; AA028711, to G. A. and S.G.); PSC Partners Seeking a Cure (to
   G. A.); and Sapienza University funds (RM1181642BEF570E, to P. O.). This
   material results from work supported by resources at the Central Texas
   Veterans Health Care System (Temple, TX), the Richard L. Roudebush VA
   Medical Center (Indianapolis, IN), and the Medical Physiology, Medical
   Research Building (Temple, TX). The views expressed in this article are
   those of the authors and do not necessarily represent the Department of
   Veterans Affairs' views.
CR Anisimov VN, 2003, INT J CANCER, V103, P300, DOI 10.1002/ijc.10827
   Aust S, 2008, WIEN MED WOCHENSCHR, V158, P575, DOI 10.1007/s10354-008-0599-7
   Ayoub MA, 2004, MOL PHARMACOL, V66, P312, DOI 10.1124/mol.104.000398
   Baba K, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004302
   Baiocchi L, 2019, AM J PHYSIOL-GASTR L, V317, pG651, DOI 10.1152/ajpgi.00110.2019
   Chen LJ, 2014, BIOCHEMISTRY-US, V53, P2827, DOI 10.1021/bi500092e
   Chen LX, 2019, BBA-MOL BASIS DIS, V1865, P1525, DOI 10.1016/j.bbadis.2019.03.002
   Chen Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.22
   Drazen DL, 2001, NEUROENDOCRINOLOGY, V74, P178, DOI 10.1159/000054684
   Gerdin MJ, 2004, FASEB J, V18, P1646, DOI 10.1096/fj.03-1339com
   Gerdin MJ, 2004, BIOCHEM PHARMACOL, V67, P2023, DOI 10.1016/j.bcp.2004.01.027
   Glaser S, 2010, HEPATOLOGY, V52, P204, DOI 10.1002/hep.23657
   Han D, 2019, J PINEAL RES, V67, DOI 10.1111/jpi.12571
   Han YY, 2011, AM J PHYSIOL-GASTR L, V301, pG623, DOI 10.1152/ajpgi.00118.2011
   Hu CX, 2019, J CELL MOL MED, V23, P7151, DOI 10.1111/jcmm.14634
   Kennedy L, 2019, FASEB J, V33, P10269, DOI 10.1096/fj.201802606R
   Kyritsi K, 2020, GENE EXPRESSION, V20, P89, DOI 10.3727/105221620X15889714507961
   Kyritsi K, 2021, HEPATOLOGY, V73, P2397, DOI 10.1002/hep.31497
   Levoye A, 2006, EMBO J, V25, P3012, DOI 10.1038/sj.emboj.7601193
   Li DY, 2013, INT J MOL SCI, V14, P11208, DOI 10.3390/ijms140611208
   Mathes AM, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8090408
   McArthur K, 2011, DIABETES, V60, P1314, DOI 10.2337/db10-1557
   Montagnese S, 2013, LIVER INT, V33, P203, DOI 10.1111/liv.12026
   Naji L, 2004, LIFE SCI, V74, P2227, DOI 10.1016/j.lfs.2003.08.046
   Ostrycharz E, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249667
   Ou TH, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040748
   Peschke E, 2002, J PINEAL RES, V33, P63, DOI 10.1034/j.1600-079X.2002.02919.x
   Renzi A, 2013, HEPATOLOGY, V57, P1130, DOI 10.1002/hep.26105
   Renzi A, 2011, AM J PHYSIOL-GASTR L, V301, pG634, DOI 10.1152/ajpgi.00206.2011
   Sanchez-Hidalgo M, 2009, EXP GERONTOL, V44, P328, DOI 10.1016/j.exger.2009.02.002
   Saran AR, 2020, GASTROENTEROLOGY, V158, P1948, DOI 10.1053/j.gastro.2020.01.050
   SCHNEIDER HG, 1992, ENDOCRINOLOGY, V131, P1383, DOI 10.1210/en.131.3.1383
   Shajari S, 2015, J PINEAL RES, V59, P391, DOI 10.1111/jpi.12271
   Sampaio LDS, 2008, INT J DEV NEUROSCI, V26, P277, DOI 10.1016/j.ijdevneu.2008.02.001
   Sugden D, 2004, PIGM CELL RES, V17, P454, DOI 10.1111/j.1600-0749.2004.00185.x
   Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993
   Wan Y, 2017, AM J PATHOL, V187, P2788, DOI 10.1016/j.ajpath.2017.08.027
   Wan Y, 2017, HEPATOLOGY, V66, P528, DOI 10.1002/hep.29138
   Wojciech S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03609-x
   Wu N, 2018, AM J PATHOL, V188, P2264, DOI 10.1016/j.ajpath.2018.06.015
   Wu N, 2017, FASEB J, V31, P4305, DOI 10.1096/fj.201700097R
   Wu N, 2016, HEPATOLOGY, V64, P865, DOI 10.1002/hep.28622
   Zhou TH, 2018, LAB INVEST, V98, P1449, DOI 10.1038/s41374-018-0093-9
   Zou R, 2010, ACTA PHARMACOL SIN, V31, P43, DOI 10.1038/aps.2009.174
NR 44
TC 9
Z9 10
U1 5
U2 17
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD 2022 APR
PY 2022
VL 75
IS 4
BP 797
EP 813
DI 10.1002/hep.32233
EA NOV 2021
PG 17
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA ZT3KV
UT WOS:000722116300001
PM 34743371
OA Green Accepted, Green Submitted
DA 2024-02-19
ER

PT J
AU Muradian, KK
   Utko, NA
   Fraifeld, V
   Mozzhukhina, TG
   Pishel, IN
   Litoshenko, AY
AF Muradian, KK
   Utko, NA
   Fraifeld, V
   Mozzhukhina, TG
   Pishel, IN
   Litoshenko, AY
TI Superoxide dismutase, catalase and glutathione peroxidase activities in
   the liver of young and old mice: linear regression and correlation
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
DE superoxide dismutase; catalase; glutathione peroxidase; liver; mice;
   aging
ID OXIDATIVE STRESS; DROSOPHILA; LONGEVITY; SELECTION; DAMAGE
AB Activities of superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GP) were determined in the liver of 15 young (3-5 months) and 15 old (23-26 months) female CBA mice. Although, the activities of all three enzymes decreased in aging, only the SOD decline was statistically significant (P < 0.01). The pair wise correlation analysis exhibited an almost identical positive correlation between SOD and CAT in the liver of both young and old mice (r = 0.57), whereas the correlative links between the enzymatic pairs of SOD-GP and CAT-GP were increased in aging. Close to zero in the young group (r = -0.08), the coefficient of correlation between SOD and GP became highly significant in the group of old mice (r = 0.66; P < 0.01). When the coefficients of pair wise and partial correlation were compared, practically no differences were found for the young mice, whereas all three partial coefficients were decreased in the group of old animals. Estimation of the linear regression between the enzymatic pairs revealed higher coefficients of regression and lower intercepts in the group of old mice. The results imply stronger correlative links between the antioxidant enzymes in the liver of old mice, compared with the same indices in the liver of young animals. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
C1 Ukraine Acad Med Sci, Inst Gerontol, UA-04114 Kiev, Ukraine.
   Ben Gurion Univ Negev, Dept Clin Pharmacol, Multidisciplinary Ctr Study Aging, IL-84105 Beer Sheva, Israel.
C3 National Academy of Medical Sciences of Ukraine; D. F. Chebotarev
   Institute of Gerontology of the National Academy of Medical Sciences of
   Ukraine; Ben Gurion University
RP Muradian, KK (corresponding author), Ukraine Acad Med Sci, Inst Gerontol, 67 Vyshgorodskaya Str, UA-04114 Kiev, Ukraine.
EM tamur@carrier.kiev.ua
RI Muradiam, Khachik/Y-4272-2019
OI Muradiam, Khachik/0000-0003-2515-6952; Fraifeld,
   Vadim/0000-0002-4525-0535; Pishel, Iryna/0000-0002-5267-6817
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Allen RG, 2000, FREE RADICAL BIO MED, V28, P463, DOI 10.1016/S0891-5849(99)00242-7
   Arking R, 2000, EXP GERONTOL, V35, P167, DOI 10.1016/S0531-5565(99)00094-7
   BARKTE A, 2001, EXP GERONTOL, V36, P21
   Bazsó-Dombi E, 2000, ARCH GERONTOL GERIAT, V31, P233, DOI 10.1016/S0167-4943(00)00084-4
   Cutler R., 1984, Free Radicals in Biology, V6, P371
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Harshman LG, 2000, J GERONTOL A-BIOL, V55, pB415, DOI 10.1093/gerona/55.9.B415
   Herrero A, 1998, MECH AGEING DEV, V103, P133, DOI 10.1016/S0047-6374(98)00035-9
   Hu HL, 2000, MECH AGEING DEV, V121, P217
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   NISHIKIMI M, 1972, BIOCHEM BIOPH RES CO, V46, P849, DOI 10.1016/S0006-291X(72)80218-3
   Nose K, 2000, BIOL PHARM BULL, V23, P897
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   SOHAL RS, 1989, MECH AGEING DEV, V49, P129, DOI 10.1016/0047-6374(89)90096-1
   Tower J, 2000, MECH AGEING DEV, V118, P1, DOI 10.1016/S0047-6374(00)00152-4
   Yan LJ, 2000, FREE RADICAL BIO MED, V29, P1143, DOI 10.1016/S0891-5849(00)00423-8
NR 17
TC 24
Z9 26
U1 1
U2 5
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-4943
EI 1872-6976
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PD NOV-DEC
PY 2002
VL 35
IS 3
BP 205
EP 214
AR PII S0167-4943(02)00025-0
DI 10.1016/S0167-4943(02)00025-0
PG 10
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 600UG
UT WOS:000178409700002
PM 14764359
DA 2024-02-19
ER

PT J
AU Ma, TY
   Wei, XH
   Wu, XM
   Du, JQ
AF Ma, Tianyou
   Wei, Xiaohui
   Wu, Xiaoming
   Du, Jianqiang
TI Trends and future projections of liver cancer incidence in Hong Kong: a
   population-based study
SO ARCHIVES OF PUBLIC HEALTH
LA English
DT Article
DE Liver cancer, incidence; Period analysis; Cohort effect; Demographic
   factors
ID PERIOD-COHORT ANALYSIS; GLOBAL BURDEN; TIME TRENDS; MANAGEMENT;
   MORTALITY; DISEASE
AB BackgroundLiver cancer remains a significant burden in Hong Kong. We sought to examine trends in liver cancer incidence using 30 years of cancer registry data in Hong Kong. Additionally, we aimed to assess the impact of age, period and birth cohort on liver cancer incidence, provided projections for liver cancer incidence until 2030, and examined the drivers of liver cancer incidence.MethodsData on liver cancer incidence were collected from the Hong Kong Cancer Registry (HKCaR). We assessed age, period, and birth cohort effects using age-period-cohort (APC) models. We employed Bayesian APC analysis with integrated nested Laplace approximations to project the future burden of liver cancer in Hong Kong. Furthermore, we attributed the changes in new liver cancer cases to population growth, population ageing, and epidemiological changes.ResultsThe study included a total of 51,333 individuals, of whom 39,287 (76.53%) were male. From 1991 to 2020, the age-standardized liver cancer incidence rate in Hong Kong continued declining, while the number of new cases increased significantly, especially among males. The net drift, representing the overall annual percentage change of the age-adjusted rate, was - 3.06% (95% confidence interval [CI]: -3.31% to -2.80%) for males and - 3.85% (95% CI: -4.61% to -3.09%) for females. Local drift, which estimates the annual percentage change over time specific to age group, decreased in all age groups for both sexes, with a more pronounced decrease in younger age groups. The period and cohort risk of developing liver cancer also showed decreasing trends for both sexes. The study projected a decline in liver cancer cases for males but an increase for females in Hong Kong, with an estimated 1,083 cases in males and 710 cases in females by 2030. Demographic decomposition analysis revealed that while population growth and ageing were the main drivers of increased liver cancer cases, epidemiologic shifts mostly offset these factors.ConclusionThe period and cohort risk of developing liver cancer in Hong Kong declined due to epidemiological changes. Although the age-standardized incidence rates of liver cancer have also declined, demographic and epidemiological factors have led to lower case expectations in males but a likely increase in females. Further research and epidemiological assessment of the disease are needed.
C1 [Ma, Tianyou] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Lab Dis Prevent & Control & Hlth Promot Shaanxi Pr, Xian, Shaanxi, Peoples R China.
   [Wei, Xiaohui] Xi An Jiao Tong Univ, Shaanxi Prov Canc Hosp, Med Coll, Dept Med Oncol 3, Xian, Shaanxi, Peoples R China.
   [Wu, Xiaoming; Du, Jianqiang] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Key Lab Biomed Informat Engn, Minist Educ, 28 Xianning West Rd, Xian 710049, Shaanxi, Peoples R China.
C3 Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong
   University
RP Du, JQ (corresponding author), Xi An Jiao Tong Univ, Sch Life Sci & Technol, Key Lab Biomed Informat Engn, Minist Educ, 28 Xianning West Rd, Xian 710049, Shaanxi, Peoples R China.
EM jqdu@xjtu.edu.cn
FU We would like to express our gratitude to the individuals who have
   contributed to the Hong Kong Cancer Registry.
FX We would like to express our gratitude to the individuals who have
   contributed to the Hong Kong Cancer Registry.
CR Chang AY, 2019, LANCET PUBLIC HEALTH, V4, pE159, DOI 10.1016/S2468-2667(19)30019-2
   Chen GF, 2017, LIVER INT, V37, P59, DOI 10.1111/liv.13309
   Cheng XJ, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003138
   Cheng XJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216613
   Chui AMN, 2020, GLOB HLTH MED-JPN, V2, P312, DOI 10.35772/ghm.2020.01062
   De Clercq E, 2010, VIRUSES-BASEL, V2, P1279, DOI 10.3390/v2061279
   Du ZB, 2020, BIOMARK RES, V8, DOI 10.1186/s40364-020-00195-3
   Health Do, 2019, Surveillance of viral Hepatitis in Hong Kong-2018 report
   Huang JJ, 2021, LIVER CANCER, V10, P330, DOI 10.1159/000515304
   Hui YT, 2018, LIVER INT, V38, P1911, DOI 10.1111/liv.13926
   Jacobs D, 2021, JAMA DERMATOL, V157, P59, DOI 10.1001/jamadermatol.2020.4102
   Knoll M, 2020, BMC MED RES METHODOL, V20, DOI 10.1186/s12874-020-01133-5
   Liu KSH, 2019, J INFECT DIS, V219, P1924, DOI 10.1093/infdis/jiz038
   Liu ZQ, 2019, J HEPATOL, V70, P674, DOI 10.1016/j.jhep.2018.12.001
   Lok WY, 2021, OBSTET GYNECOL INT, V2021, DOI 10.1155/2021/9912743
   Petrick JL, 2020, INT J CANCER, V147, P317, DOI 10.1002/ijc.32723
   Razavi-Shearer D, 2018, LANCET GASTROENTEROL, V3, P383, DOI 10.1016/S2468-1253(18)30056-6
   Registry HKC., 2021, Overview of Hong Kong Cancer Statistics of 2019
   Riebler A, 2017, BIOMETRICAL J, V59, P531, DOI 10.1002/bimj.201500263
   Riebler A, 2012, ANN APPL STAT, V6, P304, DOI 10.1214/11-AOAS498
   Rosenberg PS, 2014, CANCER EPIDEM BIOMAR, V23, P2296, DOI 10.1158/1055-9965.EPI-14-0300
   Rutherford MJ, 2021, INT J CANCER, V149, P2020, DOI 10.1002/ijc.33767
   Smith TR, 2016, STAT SCI, V31, P591, DOI 10.1214/16-STS580
   Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660
   Tang CM, 2014, WORLD J GASTROENTERO, V20, P6262, DOI 10.3748/wjg.v20.i20.6262
   United Nations DoEaSA Population Division, 2022, World Population prospects 2022: Online Edition
   Yau ATC, 2016, FOOD ADDIT CONTAM A, V33, P1026, DOI 10.1080/19440049.2016.1184995
   Zou ZY, 2020, CIRCULATION, V141, P790, DOI 10.1161/CIRCULATIONAHA.119.042864
NR 28
TC 0
Z9 0
U1 4
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0778-7367
EI 2049-3258
J9 ARCH PUBLIC HEALTH
JI Arch. PUblic Health
PD OCT 3
PY 2023
VL 81
IS 1
AR 179
DI 10.1186/s13690-023-01191-3
PG 9
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA S9RV9
UT WOS:001074475200001
PM 37789405
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Hack, V
   Schmid, D
   Breitkreutz, R
   StahlHenning, C
   Drings, P
   Kinscherf, R
   Taut, F
   Holm, E
   Droge, W
AF Hack, V
   Schmid, D
   Breitkreutz, R
   StahlHenning, C
   Drings, P
   Kinscherf, R
   Taut, F
   Holm, E
   Droge, W
TI Cystine levels, cystine flux, and protein catabolism in cancer cachexia,
   HIV/SIV infection, and senescence
SO FASEB JOURNAL
LA English
DT Article
DE skeletal muscle catabolism; HIV infection; cancer; plasma cystine level;
   glutamine exchange rate; controlled constructive metabolism
ID ACQUIRED IMMUNODEFICIENCY SYNDROME; AMINO-ACID-CONCENTRATIONS;
   VIRUS-INFECTION; METABOLISM; EXERCISE; CYSTEINE; ALANINE; GLUCOSE; UREA
AB Patients with skeletal muscle catabolism (cachexia) fail to conserve the skeletal muscle protein and release lar re amounts of nitrogen as urea. Previous studies suggest that the threshold for the conversion of amino acids into other forms of chemical energy and the concomitant production of urea are regulated by the plasma cystine level and hepatic cysteine catabolism. Studies of plasma amino acid exchange rates in the lower extremities now show that healthy young subjects regulate their plasma cystine level in a process that may be described as controlled constructive catabolism. The term controlled describes the fact that the release of cystine and other amino acids from the peripheral tissue is negatively correlated with (certain) plasma amino acid levels. The term constructive describes the fact that the release of cystine is correlated with an increase of the plasma cystine level. The regulation of the plasma cystine level is disturbed in conditions with progressive skeletal muscle catabolism including cancer, HIV infection, and old age. These conditions show also a low plasma glutamine:cystine ratio indicative of an impaired hepatic cystine catabolism. In HIV (+) patients and SIV-infected macaques, a decrease of the plasma cystine level was found to coincide with the decrease of CD4(+) T cells.
C1 DEUTSCH KREBSFORSCHUNGSZENTRUM,DIV IMMUNOCHEM,D-69120 HEIDELBERG,GERMANY.
   UNIV HEIDELBERG,MED CLIN MANNHEIM 1,DEPT PATHOPHYSIOL,D-68167 MANNHEIM,GERMANY.
   GERMAN PRIMATE CTR,DEPT VIROL & IMMUNOL,D-37077 GOTTINGEN,GERMANY.
   HOSP THORAX DIS,D-69126 HEIDELBERG,GERMANY.
   UNIV HEIDELBERG,DEPT ANESTHESIOL,D-69120 HEIDELBERG,GERMANY.
C3 Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht
   Karls University Heidelberg; Deutsches Primatenzentrum (DPZ); Ruprecht
   Karls University Heidelberg
RI Kinscherf, Ralf/AAV-7164-2021
CR AOKI T, 1993, CLIN IMMUNOL IMMUNOP, V69, P253, DOI 10.1006/clin.1993.1178
   Aoki T T, 1972, Adv Enzyme Regul, V10, P145, DOI 10.1016/0065-2571(72)90011-8
   BARBEY K, 1963, Z KREISLAUFFORSCH, V52, P1129
   BELLA DL, 1995, AM J PHYSIOL-ENDOC M, V269, pE910, DOI 10.1152/ajpendo.1995.269.5.E910
   BRENNAN MF, 1977, CANCER RES, V37, P2359
   BRENNAN MF, 1986, DIGEST DIS SCI, V31, pS77, DOI 10.1007/BF01295991
   CHAWLA RK, 1984, GASTROENTEROLOGY, V87, P770
   CHEN MK, 1993, ANN SURG, V217, P655, DOI 10.1097/00000658-199306000-00007
   DEWYS WD, 1980, AM J MED, V69, P491, DOI 10.1016/S0149-2918(05)80001-3
   DIAMOND JM, 1992, NATURE, V357, P362, DOI 10.1038/357362a0
   DOHM GL, 1986, EXERCISE SPORT SCI R, V14, P143
   DROGE W, 1988, BIOL CHEM H-S, V369, P143, DOI 10.1515/bchm3.1988.369.1.143
   DROGE W, 1996, ANTIOXIDANTS DIS MEC, V28, P581
   ECK HP, 1991, LANCET, V338, P346, DOI 10.1016/0140-6736(91)90482-5
   FEIN R, 1985, CANCER, V56, P2512, DOI 10.1002/1097-0142(19851115)56:10<2512::AID-CNCR2820561032>3.0.CO;2-9
   FONTANA L, 1986, IMMUNOBIOLOGY, V171, P425, DOI 10.1016/S0171-2985(86)80074-2
   FRIEDMAN PJ, 1987, NUTR RES, V7, P707, DOI 10.1016/S0271-5317(87)80101-X
   Gross A, 1996, AIDS RES HUM RETROV, V12, P1639, DOI 10.1089/aid.1996.12.1639
   GRUNFELD C, 1991, GASTROINTESTINAL NUT, P207
   Hack V, 1996, FASEB J, V10, P1219, DOI 10.1096/fasebj.10.10.8751725
   HORTIN GL, 1994, CLIN CHEM, V40, P785
   Kinscherf R, 1996, J MOL MED-JMM, V74, P393, DOI 10.1007/BF00210633
   KOHASHI N, 1978, J BIOCHEM-TOKYO, V84, P159, DOI 10.1093/oxfordjournals.jbchem.a132104
   KOTLER DP, 1985, AM J CLIN NUTR, V42, P1255, DOI 10.1093/ajcn/42.6.1255
   LAWSON DH, 1982, ANNU REV NUTR, V2, P277, DOI 10.1146/annurev.nu.02.070182.001425
   LONG CL, 1976, AM J CLIN NUTR, V29, P380, DOI 10.1093/ajcn/29.4.380
   OWEN OE, 1969, J CLIN INVEST, V48, P584
   PISTERS PWT, 1993, CRIT REV CL LAB SCI, V30, P223, DOI 10.3109/10408369309084669
   POLI G, 1985, CLIN EXP IMMUNOL, V62, P128
   SHAW JHF, 1987, SURGERY, V101, P181
   SHAW JHF, 1985, SURGERY, V97, P557
   STIPANUK MH, 1986, ANNU REV NUTR, V6, P179, DOI 10.1146/annurev.nu.06.070186.001143
   STRAIN AJ, 1979, INVEST CELL PATHOL, V2, P181
   UBUKA T, 1992, Amino Acids (Vienna), V2, P143, DOI 10.1007/BF00806085
   ULLUM H, 1995, J EXP MED, V182, P789, DOI 10.1084/jem.182.3.789
   VIRU A, 1987, SPORTS MED, V4, P95, DOI 10.2165/00007256-198704020-00003
   Warren S, 1932, AM J MED SCI, V184, P610, DOI 10.1097/00000441-193211000-00002
   WATERHOUSE C, 1979, CANCER RES, V39, P1968
NR 38
TC 52
Z9 59
U1 0
U2 2
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD JAN
PY 1997
VL 11
IS 1
BP 84
EP 92
DI 10.1096/fasebj.11.1.9034170
PG 9
WC Biochemistry & Molecular Biology; Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA WK147
UT WOS:A1997WK14700012
PM 9034170
DA 2024-02-19
ER

PT J
AU Skrzypek, D
   Cichon, A
AF Skrzypek, D
   Cichon, A
TI Electron spin resonance (ESR) studies of the iron (III) oxide
   nanoparticles: evidence of ageing effect
SO PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS
LA English
DT Article; Proceedings Paper
CT International Symposium on Medical Physics
CY NOV 13-15, 2003
CL Ustron, POLAND
SP Univ Silesia, A Chelkowski Inst Phys
DE superparamagnetism; iron oxide; ESR; contrast agents
ID SIZE
AB Superparamagnetic nanoparticles are currently under investigation as potential contrast agents for magnetic resonance imaging of the liver. The iron (III) oxide nanoparticles coated with dextran derivative were examined by ESR method in the range temperature from 90 K to 350 K at X-band frequency. The colloidal stability and grain size iron nanoparticles change with time and aggregation of particles become pronounced. The ESR spectrum recorded for this sample is complex: the small signals are attributed to the superparamagnetic fraction of the particles because of specific temperature dependence. The ferromagnetic fraction of larger particles gives the line with high intensity and with slight variations in ESR parameters.
C1 Silesian Univ, A Chelkowski Inst Phys, PL-40007 Katowice, Poland.
C3 University of Silesia in Katowice
RP Skrzypek, D (corresponding author), Silesian Univ, A Chelkowski Inst Phys, Uniwersytecka 4, PL-40007 Katowice, Poland.
EM dskrzyp@us.edu.pl
CR Bakuzis AF, 1999, J APPL PHYS, V85, P7480, DOI 10.1063/1.369383
   Gazeau F, 1999, J MAGN MAGN MATER, V202, P535, DOI 10.1016/S0304-8853(99)00156-0
   Kim DK, 2001, J MAGN MAGN MATER, V225, P256, DOI 10.1016/S0304-8853(00)01255-5
   Kliava J, 1999, J MAGN MAGN MATER, V205, P328, DOI 10.1016/S0304-8853(99)00510-7
NR 4
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1120-1797
EI 1724-191X
J9 PHYS MEDICA
JI Phys. Medica
PY 2004
VL 20
SU 1
BP 99
EP 101
PG 3
WC Radiology, Nuclear Medicine & Medical Imaging
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Radiology, Nuclear Medicine & Medical Imaging
GA 902CI
UT WOS:000227328500032
DA 2024-02-19
ER

PT J
AU TUMMINO, PJ
   GAFNI, A
AF TUMMINO, PJ
   GAFNI, A
TI A COMPARATIVE-STUDY OF SUCCINATE-SUPPORTED RESPIRATION AND ATP/ADP
   TRANSLOCATION IN LIVER-MITOCHONDRIA FROM ADULT AND OLD RATS
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE LIVER MITOCHONDRIA; RESPIRATION; ADENINE NUCLEOTIDE TRANSLOCASE; AGING
ID ADENINE-NUCLEOTIDE TRANSLOCASE; AGE-DEPENDENT CHANGES;
   OXIDATIVE-PHOSPHORYLATION; EXTRA-MITOCHONDRIAL; INTRA-MITOCHONDRIAL; ATP
   SYNTHESIS; METABOLISM; DECLINE; ACID
AB This study was undertaken to compare the rates of succinate-supported hepatic mitochondrial respiration between 12 months (adult) and 29 months (old) male Fischer 344 rats.  Experiments were also performed to determine the activity of adenine nucleotide translocase and the effect of its inhibition on mitochondrial respiration.  Succinate-supported state 3 mitochondrial respiration was found to decline 20% between 12 and 29 months of age in rat liver, along with a similar 25% decrease in the respiratory control ratio with age.  Adenine nucleotide translocase activity is shown to decrease 39% from adult to old rat liver mitochondria.  This decrease does not, however, account for the decline in state 3 respiration, since translocase activity is approximately 50% greater than state 3 respiration in both adult and old rats.  Therefore, adenine nucleotide translocase is not rate-limiting for state 3 mitochondrial respiration.
   Neither the rate of succinate permeation into the mitochondrion nor the rate of electron transport is rate-limiting for state 3 respiration, indicated by the greatly increased oxygen consumption with addition of the uncoupler carbonyl cyanide m-chlorophenyl hydrazone (m-CCCP).  These processes, therefore, are not responsible for the observed decline in state 3 respiration.  The implications and possible cause of the age-related decrease in the maximal rate of ATP-synthesis are discussed.
C1 UNIV MICHIGAN,DEPT BIOL CHEM,ANN ARBOR,MI 48109.
C3 University of Michigan System; University of Michigan
RP GAFNI, A (corresponding author), UNIV MICHIGAN,INST GERONTOL,ANN ARBOR,MI 48109, USA.
FU NIA NIH HHS [T32 AG 00114] Funding Source: Medline
CR ARCOS JC, 1967, EXP CELL RES, V48, P448, DOI 10.1016/0014-4827(67)90368-0
   CHANCE B, 1955, J BIOL CHEM, V217, P409
   CHIU YJD, 1980, EXP GERONTOL, V15, P511, DOI 10.1016/0531-5565(80)90003-0
   CLANDININ MT, 1983, MECH AGEING DEV, V22, P205, DOI 10.1016/0047-6374(83)90076-3
   DARNOLD JR, 1990, MECH AGEING DEV, V53, P157, DOI 10.1016/0047-6374(90)90067-P
   DAVIS EJ, 1984, ARCH BIOCHEM BIOPHYS, V233, P573, DOI 10.1016/0003-9861(84)90481-8
   ERECINSKA M, 1982, J MEMBRANE BIOL, V70, P1, DOI 10.1007/BF01871584
   Estabrook R.W., 1967, METHOD ENZYMOL, V10, P41, DOI DOI 10.1016/0076-6879(67)10010-4
   FORMAN NG, 1983, J BIOL CHEM, V258, P8649
   GROEN AK, 1982, J BIOL CHEM, V257, P2754
   HANSFORD RG, 1983, BIOCHIM BIOPHYS ACTA, V726, P41, DOI 10.1016/0304-4173(83)90010-1
   HORTON AA, 1981, MECH AGEING DEV, V17, P253, DOI 10.1016/0047-6374(81)90062-2
   INAMDAR AR, 1974, J GERONTOL, V29, P638, DOI 10.1093/geronj/29.6.638
   JACOBS EE, 1960, J BIOL CHEM, V235, P531
   JACOBUS WE, 1982, J BIOL CHEM, V257, P2397
   Johnson D., 1967, Methods Enzymol, V10, P94, DOI DOI 10.1016/0076-6879(67)10018-9
   KIM JH, 1988, MECH AGEING DEV, V46, P263
   KLINGENBERG M, 1985, ENZYMES BIOL MEMBR, V4, P511
   KUNZ W, 1981, ARCH BIOCHEM BIOPHYS, V209, P219, DOI 10.1016/0003-9861(81)90274-5
   KUSTER U, 1976, BIOCHIM BIOPHYS ACTA, V440, P391, DOI 10.1016/0005-2728(76)90073-6
   LANOUE KF, 1986, BIOCHEMISTRY-US, V25, P7667, DOI 10.1021/bi00371a058
   LEMASTERS JJ, 1979, J BIOL CHEM, V254, P1248
   MOREADITH RW, 1982, J BIOL CHEM, V257, P899
   MURFITT RR, 1978, MECH AGEING DEV, V8, P197, DOI 10.1016/0047-6374(78)90018-0
   NOHL H, 1978, EUR J BIOCHEM, V90, P385, DOI 10.1111/j.1432-1033.1978.tb12615.x
   NOHL H, 1980, MECH AGEING DEV, V14, P137, DOI 10.1016/0047-6374(80)90112-8
   NOHL H, 1982, GERONTOLOGY, V28, P354, DOI 10.1159/000212556
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   STUCKI JW, 1980, EUR J BIOCHEM, V109, P269, DOI 10.1111/j.1432-1033.1980.tb04792.x
   SZAMOSI T, 1972, EXP GERONTOL, V7, P83, DOI 10.1016/0531-5565(72)90002-2
   VANDERMEER R, 1980, BIOCHIM BIOPHYS ACTA, V591, P488, DOI 10.1016/0005-2728(80)90179-6
   WANDERS RJA, 1981, FEBS LETT, V132, P201, DOI 10.1016/0014-5793(81)81160-X
   WEINBACH EC, 1959, J BIOL CHEM, V234, P412
   WEINDRUCH RH, 1980, MECH AGEING DEV, V12, P375, DOI 10.1016/0047-6374(80)90070-6
   WILLIAMSON JR, 1981, J BIOL CHEM, V256, P7287
NR 35
TC 24
Z9 25
U1 0
U2 2
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD JUN 14
PY 1991
VL 59
IS 1-2
BP 177
EP 188
DI 10.1016/0047-6374(91)90083-C
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA FR468
UT WOS:A1991FR46800015
PM 1890881
OA Green Published
DA 2024-02-19
ER

PT J
AU NAGATA, T
AF NAGATA, T
TI LIGHT AND ELECTRON-MICROSCOPIC AUTORADIOGRAPHIC STUDIES ON
   MACROMOLECULAR-SYNTHESIS IN DIGESTIVE ORGANS OF AGING MICE
SO CELLULAR AND MOLECULAR BIOLOGY
LA English
DT Article; Proceedings Paper
CT 4th International Symposium on Radioautography, as a Satellite Symposium
   of the 25th Annual Meeting of the
   Clinical-Electron-Microscopy-Society-of-Japan
CY SEP 28-OCT 02, 1993
CL MATSUMOTO, JAPAN
SP CLIN ELECTRON MICROSCOPY SOC JAPAN
DE MICROSCOPIC AUTORADIOGRAPHY; MOUSE MACROMOLECULAR SYNTHESIS; NUCLEIC
   ACIDS; PROTEINS; GLUCIDES; LIPIDS
ID IMAGE-ANALYSIS; AUTORADIOGRAPHY; LIVERS; MOUSE
AB For the purpose of analyzing the changes of macromolecular synthesis in aging animals, we have developed methodologies for quantitative light and electron microscopic radioautography. The methodologies were applied to DNA, RNA, protein, glucides and lipids syntheses of digestive organs, especially of the liver and the pancreas of aging strain ddY mice, demonstrating the incorporations of respective precursors, H-3-thymidine, H-3-uridine, H-3-leucine, H-3-glucosamine, S-35-sulfuric acid and H-3-glycerol. Characteristic differences have been observed between the respective macromolecular syntheses in respective aging groups, from prenatal (embryonic day 19)to postnatal newborn period (postnatal day 1), from suckling (postnatal day 3) to weaning (postnatal day 14), juvenile (postnatal 1 month), young adult (postnatal 2 month) and senescent periods (6 and 12 months up to 2 years). These results are extensively analyzed and reviewed.
RP NAGATA, T (corresponding author), SHINSHU UNIV,SCH MED,DEPT ANAT & CELL BIOL,MATSUMOTO,NAGANO 390,JAPAN.
CR Duan H., 1992, J CLIN ELECT MICROSC, V25, P452
   DUAN HJ, 1993, CELL MOL BIOL, V39, P309
   JAMIESON JD, 1967, J CELL BIOL, V34, P577, DOI 10.1083/jcb.34.2.577
   LEBLOND CP, 1981, AM J ANAT, V160, P113
   MA H, 1990, ACTA ANAT NIPPON, V63, P137
   MA H, 1992, J CLIN ELECT MICROSC, V25, P536
   MA HJ, 1991, CELL MOL BIOL, V37, P607
   MA HJ, 1990, CELL MOL BIOL, V36, P73
   MA HJ, 1990, CELL MOL BIOL, V36, P589
   MORITA T, 1994, HISTOCHEMISTRY, V101, P13
   MORITA T, 1993, CELL MOL BIOL, V39, P875
   MURATA F, 1979, ACTA HISTOCHEM CYTOC, V12, P443, DOI 10.1267/ahc.12.443
   NAGATA T, 1967, Medical Journal of Shinshu University, V12, P93
   NAGATA T, 1977, HISTOCHEMISTRY, V54, P75, DOI 10.1007/BF00493331
   NAGATA T, 1966, HISTOCHEMISTRY, V7, P370, DOI 10.1007/BF00306625
   NAGATA T, 1977, ACTA PHARMACOL TOX, V41, P62
   NAGATA T, 1988, Japanese Journal of Clinical Electron Microscopy, V21, P756
   NAGATA T, 1982, HISTOCHEM J, V14, P197, DOI 10.1007/BF01041214
   NAGATA T, 1967, HISTOCHEMISTRY, V10, P305, DOI 10.1007/BF00304312
   NAGATA T, 1986, Japanese Journal of Clinical Electron Microscopy, V19, P486
   NAGATA T, 1993, ACTA HISTOCHEM CYTOC, V26, P281, DOI 10.1267/ahc.26.281
   NAGATA T, 1990, NATIONAL TRAINING CO, P139
   NAGATA T, 1982, SAIBO CELL, V14, P40
   NAGATA T, 1991, WHO BIREGIONAL TRAIN, P73
   NAGATA T, 1993, ACTA HISTOCHEM CYTOC, V26, P481
   NAGATA T, 1982, RADIOAUTOGRAPHY DATA
   Nagata T., 1992, J CLIN ELECTRON MICR, V25, P646
   NAGATA T, 1988, GLYCOCONJUGATES MED, P252
   NAGATA T, 1992, RECENT ADV CELLULAR, V6, P9
   Nagata T., 1985, HISTO CYTOCHEMISTRY, P207
   NAGATA T, 1984, 11TH P INT C EL MICR, V2, P2281
   Nagata T., 1967, ACTA ANAT NIPPON, V42, P162
   Nagata T., 1990, J CLIN ELECTRON MICR, V23, P841
   Nagata T., 1993, CHINESE J HISTOCHEM, V2, P106
   OLIVEIRA SF, 1991, CELL MOL BIOL, V37, P315
NR 35
TC 28
Z9 31
U1 0
U2 1
PU CELLULAR & MOLECULAR BIOLOGY
PI NOISY-LE-GRAND
PA PROF R WEGMANN RESIDENCE HAUSSMANN 1 AVENUE DU PAVE NEUF, 93160
   NOISY-LE-GRAND, FRANCE
SN 0145-5680
J9 CELL MOL BIOL
JI Cell. Mol. Biol.
PD FEB
PY 1995
VL 41
IS 1
BP 21
EP 38
PG 18
WC Biochemistry & Molecular Biology; Cell Biology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA QJ065
UT WOS:A1995QJ06500004
PM 7773134
DA 2024-02-19
ER

PT J
AU Koslow, JA
   Bell, J
   Virtue, P
   Smith, DC
AF Koslow, JA
   Bell, J
   Virtue, P
   Smith, DC
TI Fecundity and its variability in orange roughy: Effects of population
   density, condition, egg size, and senescence
SO JOURNAL OF FISH BIOLOGY
LA English
DT Article
DE fecundity; density-dependence; condition factor; senescence; orange
   roughy
ID HOPLOSTETHUS-ATLANTICUS; NEW-ZEALAND; STOCK DISCRIMINATION; SLOPE
   WATERS; TRACHICHTHYIDAE; FISHES; MANAGEMENT; PRECISION; PATTERNS;
   BIOMASS
AB Fecundity of orange roughy in 1987-1989 adjusted for standard length (S.L.) varied significantly between New South Wales (42 787 eggs female(-1)) South Australia (35 339 eggs female(-1)) and east Tasmania (31 085 eggs female (-1)). Only 10-17% of the variability in fecundity of eastern Tasmania orange roughy was explained by S.L. in any year from 1987-1992. However, liver condition and age of the fish, in combination with S.L., explained 27% of the variation in fecundity. Fecundity declined in fish over 60 years old. It was also significantly correlated with lipid levels in the ovary, in particular, with triacylglycerol as a proportion of the total lipid fraction. Significant interannual changes in fecundity appeared to be related to the impact of fishing. From 1987-1992, the orange roughy stock off east Tasmania was reduced by 50% by the fishery, and mean fecundity increased 20% over that period. This compensatory increase in individual fecundity, combined with an apparent increase in the proportion of females spawning annually from 54 to 71%, limited the decline in the population's egg production over this period to approximately 15%. (C) 1995 The Fisheries Society of the British Isles
C1 NEW S WALES AGR & FISHERIES,FISHERIES RES INST,CRONULLA,NSW 2230,AUSTRALIA.
   CSIRO,DIV OCEANOG,HOBART,TAS 7001,AUSTRALIA.
   MARINE SCI LABS,CENT AGEING FACIL,QUEENSCLIFF,VIC 3225,AUSTRALIA.
C3 NSW Department of Primary Industries; Commonwealth Scientific &
   Industrial Research Organisation (CSIRO)
RP Koslow, JA (corresponding author), CSIRO,DIV FISHERIES,POB 1538,HOBART,TAS 7001,AUSTRALIA.
OI Virtue, Patti/0000-0002-9870-1256
CR ADAMS PB, 1980, FISH B-NOAA, V78, P1
   ALMATAR SM, 1989, J CONSEIL, V45, P113
   BAGENAL T B, 1973, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V164, P186
   Bagenal T.B., 1978, P75
   BEAMISH RJ, 1981, CAN J FISH AQUAT SCI, V38, P982, DOI 10.1139/f81-132
   BELL JD, 1992, J FISH BIOL, V40, P107, DOI 10.1111/j.1095-8649.1992.tb02558.x
   BENSON AA, 1975, SCI AM, V232, P77, DOI 10.1038/scientificamerican0375-76
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   CLARK MR, 1994, NEW ZEAL J MAR FRESH, V28, P193, DOI 10.1080/00288330.1994.9516607
   CONROY AM, 1989, NEW ZEAL J MAR FRESH, V23, P525, DOI 10.1080/00288330.1989.9516388
   EDMONDS JS, 1991, AUST J MAR FRESH RES, V42, P383
   ELLIOTT NG, 1992, AUST J MAR FRESH RES, V43, P1561
   ELLIOTT NG, 1995, J FISH BIOL, V46, P202, DOI 10.1111/j.1095-8649.1995.tb05962.x
   FENTON GE, 1991, MAR BIOL, V109, P197, DOI 10.1007/BF01319387
   GOLOVAN GA, 1984, J ICHTHYOLOGY, V24, P113
   Hislop J.R.G., 1984, Fish reproduction: Strategies and tactics, P311
   HUNTER JR, 1992, FISH B-NOAA, V90, P101
   JOHNSON L, 1972, J FISH RES BOARD CAN, V29, P731, DOI 10.1139/f72-118
   KAITARANTA JK, 1981, COMP BIOCHEM PHYS B, V69, P725, DOI 10.1016/0305-0491(81)90376-X
   KJORSVIK E, 1990, ADV MAR BIOL, V26, P71, DOI 10.1016/S0065-2881(08)60199-6
   KOSLOW JA, 1992, CAN J FISH AQUAT SCI, V49, P210, DOI 10.1139/f92-025
   KOSLOW JA, 1995, IN PRESS AUSTR J FRE
   LASKER R, 1985, CAN J FISH AQUAT SCI, V42, P31, DOI 10.1139/f85-260
   LASKER R, 1985, NOAA NMFS36 TECHN RE
   LESTER RJG, 1988, MAR BIOL, V99, P137, DOI 10.1007/BF00644988
   NICHOLS PD, 1991, PHYTOCHEMISTRY, V30, P3109
   NIKOLSKY G, 1973, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V164, P174
   Nikolsky G. V., 1969, THEORY FISH POPULATI
   PANKHURST NW, 1988, ENVIRON BIOL FISH, V21, P101, DOI 10.1007/BF00004846
   PANKHURST NW, 1987, J FISH BIOL, V30, P193, DOI 10.1111/j.1095-8649.1987.tb05745.x
   PANKHURST NW, 1987, NEW ZEAL J MAR FRESH, V21, P295, DOI 10.1080/00288330.1987.9516225
   RAITT D, 1968, POPULATION DYNAMICS
   Rothschild B. J., 1986, DYNAMICS MARINE FISH
   ROTHSCHILD BJ, 1989, J CONSEIL, V45, P131
   ROTHSCHILD BJ, 1989, J CONSEIL, V45, P136
   Sargent J. R., 1976, BIOCHEMICAL BIOPHYSI, P149
   Sargent J.R., 1989, Fish Nutrition, Fish Nutrition, P153
   SAVILLE A, 1964, RAPPORT PROCES VERBA, V153, P164
   SIMPSON AC, 1956, SEA FISHERIES THEIR
   SMITH DC, 1995, IN PRESS CANADIAN J
   SMITH DC, 1992, P WORKSHOP AGE GROWT, P116
   SMOLENSKI AJ, 1993, MAR BIOL, V116, P219, DOI 10.1007/BF00350011
   STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052
   STEWART BD, 1995, IN PRESS CANADIAN J
   THOMAS PM, 1988, FISH PHYSL PHYSL D A, V11, P347
   VOLKMAN J K, 1991, Journal of Planar Chromatography - Modern TLC, V4, P19
   WHITE DC, 1979, OECOLOGIA, V40, P51, DOI 10.1007/BF00388810
   WINEMILLER KO, 1992, CAN J FISH AQUAT SCI, V49, P2196, DOI 10.1139/f92-242
   ZELDIS JR, 1993, B MAR SCI, V53, P864
   1990, SPSS REFERENCE GUIDE
NR 50
TC 65
Z9 80
U1 0
U2 12
PU ACADEMIC PRESS LTD
PI LONDON
PA 24-28 OVAL RD, LONDON, ENGLAND NW1 7DX
SN 0022-1112
J9 J FISH BIOL
JI J. Fish Biol.
PD DEC
PY 1995
VL 47
IS 6
BP 1063
EP 1080
DI 10.1111/j.1095-8649.1995.tb06030.x
PG 18
WC Fisheries; Marine & Freshwater Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Fisheries; Marine & Freshwater Biology
GA TP036
UT WOS:A1995TP03600013
DA 2024-02-19
ER

PT J
AU Kumar, A
   Bellar, A
   Mishra, S
   Sekar, J
   Welch, N
   Dasarathy, S
AF Kumar, Avinash
   Bellar, Annette
   Mishra, Saurabh
   Sekar, Jinendiran
   Welch, Nicole
   Dasarathy, Srinivasan
TI L-Isoleucine reverses hyperammonemia-induced myotube mitochondrial
   dysfunction and post-mitotic senescence
SO JOURNAL OF NUTRITIONAL BIOCHEMISTRY
LA English
DT Article
DE hyperammonemia; cataplerosis; anaplerosis; mitochondrial oxidation;
   L-isoleucine; myotube.
ID ACID TRANSPORTER EXPRESSION; SKELETAL-MUSCLE; AMINO-ACID; AMMONIA
   METABOLISM; PROTEIN-SYNTHESIS; LEUCINE; CHAIN; LIVER; DEHYDROGENASE;
   PROTEOSTASIS
AB Perturbations in the metabolism of ammonia, a cytotoxic endogenous metabolite, occur in a number of chronic diseases, with consequent hyperam-monemia. Increased skeletal muscle ammonia uptake causes metabolic, molecular, and phenotype alterations including cataplerosis of (loss of tricarboxylic acid cycle (TCA) cycle intermediate) alpha-ketoglutarate (alpha KG), mitochondrial oxidative dysfunction, and senescence-associated molecular phenotype (SAMP). L-Isoleucine (Ile) is an essential, branched-chain amino acid (BCAA) that simultaneously provides acetyl-CoA as an oxidative substrate and succinyl-CoA for anaplerosis (providing TCA cycle intermediates). Our multiomics analyses in myotubes and skeletal muscle from hyperammonemic mice and human patients with cirrhosis showed perturbations in BCAA transporters and catabolism. We, therefore, determined if Ile reverses hyperammonemia-induced im-paired mitochondrial oxidative function and SAMP. Studies were performed in differentiated murine C2C12 myotubes that were early passage, late passage (senescent), or those depleted of LAT1/SLC7A5 and human induced pluripotent stem cell-derived myotubes (hiPSCM). Ile reverses hyperammonemia-induced reduction in the maximum respiratory capacity, complex I, II, and III functions in early passage murine myotubes and hiPSCM. Consistently, low ATP content and impaired global protein synthesis (high energy requiring cellular process) during hyperammonemia are reversed by Ile in murine myotubes and hiPSCM. Lower abundance of critical regulators of protein synthesis in mTORC1 signaling, and increased phosphorylation of eukaryotic initiation factor 2 alpha are also reversed by Ile. Genetic depletion studies showed that Ile responses are independent of the amino acid transporter LAT1/SLC7A5. Our studies show that Ile reverses the hyperammonemia-induced impaired mitochondrial oxidative function, cataplerosis, and SAMP in a LAT1/SLC7A5 transporter-independent manner.(c) 2023 Elsevier Inc. All rights reserved.
C1 [Bellar, Annette; Mishra, Saurabh; Sekar, Jinendiran; Welch, Nicole; Dasarathy, Srinivasan] Cleveland Clin, Lerner Res Inst, Dept Inflammat & Immun, Cleveland Hts, OH USA.
   [Kumar, Avinash] All India Inst Med Sci, Dept Gastroenterol Hepatol & Nutr, New Delhi, India.
   [Dasarathy, Srinivasan] Cleveland Clin, Lerner Res Inst, Dept Inflammat & Immun, 9500 Euclid Ave,NE4 208, Cleveland Hts, OH 44195 USA.
C3 Cleveland Clinic Foundation; All India Institute of Medical Sciences
   (AIIMS) New Delhi; Cleveland Clinic Foundation
RP Dasarathy, S (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Inflammat & Immun, Cleveland Hts, OH USA.; Dasarathy, S (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Inflammat & Immun, 9500 Euclid Ave,NE4 208, Cleveland Hts, OH 44195 USA.
EM dasaras@ccf.org
OI Sekar, Jinendiran/0000-0002-8044-1628; Dasarathy,
   Srinivasan/0000-0003-1774-0104
FU American College of Gastroenterology [K08 AA028794, R01 GM119174, R01
   DK113196, P50 AA024333, R01 AA021890, 3U01AA026976-03S1, U01 AA 026976,
   R56HL141744, U01 DK061732, 5U01DK062470-17S2, R21 AR 071046]; NIH
FX Grant nos. R01 GM119174; R01 DK113196; P50 AA024333; R01 AA021890;
   3U01AA026976-03S1; U01 AA 026976; R56HL141744; U01 DK061732;
   5U01DK062470-17S2; R21 AR 071046 are awarded to SD, and the American
   College of Gastroenterology and NIH K08 AA028794 are awarded to NW.
CR Adeva MM, 2012, METABOLISM, V61, P1495, DOI 10.1016/j.metabol.2012.07.007
   Adeva-Andany MM, 2017, AMINO ACIDS, V49, P1005, DOI 10.1007/s00726-017-2412-7
   AFTRING RP, 1986, AM J PHYSIOL, V250, pE599, DOI 10.1152/ajpendo.1986.250.5.E599
   Appuhamy JADRN, 2012, J NUTR, V142, P484, DOI 10.3945/jn.111.152595
   Atherton PJ, 2010, AMINO ACIDS, V38, P1533, DOI 10.1007/s00726-009-0377-x
   Attaway AH, 2023, J PHYSIOL-LONDON, V601, P567, DOI 10.1113/JP283700
   Bak LK, 2009, METAB BRAIN DIS, V24, P135, DOI 10.1007/s11011-008-9123-4
   Bellar A, 2023, CLIN TRANSL MED, V13, DOI 10.1002/ctm2.1276
   Bisbach CM, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107606
   Calvert LD, 2008, EUR RESPIR J, V31, P751, DOI 10.1183/09031936.00164106
   Chen HW, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2016.33
   Church DD, 2020, NUTRIENTS, V12, DOI 10.3390/nu12123717
   COOPER AJL, 1987, NEUROCHEM PATHOL, V6, P67, DOI 10.1007/BF02833601
   Damink SWMO, 2007, HEPATOLOGY, V45, P560, DOI 10.1002/hep.21463
   Dasarathy S, 2018, CURR OPIN CLIN NUTR, V21, P30, DOI 10.1097/MCO.0000000000000426
   Dasarathy S, 2017, METAB BRAIN DIS, V32, P529, DOI 10.1007/s11011-016-9938-3
   Davuluri G, 2021, HEPATOLOGY, V73, P1892, DOI 10.1002/hep.31524
   Davuluri G, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00451-18
   Davuluri G, 2016, J PHYSIOL-LONDON, V594, P7341, DOI 10.1113/JP272796
   Davuluri G, 2016, J HEPATOL, V65, P929, DOI 10.1016/j.jhep.2016.06.004
   Deshmukh AS, 2015, MOL CELL PROTEOMICS, V14, P841, DOI 10.1074/mcp.M114.044222
   Dickinson JM, 2013, CLIN NUTR, V32, P273, DOI 10.1016/j.clnu.2012.07.009
   Doi M, 2003, BIOCHEM BIOPH RES CO, V312, P1111, DOI 10.1016/j.bbrc.2003.11.039
   Drummond MJ, 2010, AM J PHYSIOL-ENDOC M, V298, pE1011, DOI 10.1152/ajpendo.00690.2009
   GANDA OP, 1976, METABOLISM, V25, P427, DOI 10.1016/0026-0495(76)90075-5
   HAUSSINGER D, 1982, EUR J BIOCHEM, V126, P69, DOI 10.1111/j.1432-1033.1982.tb06747.x
   HEATH DF, 1968, BIOCHEM J, V110, P313, DOI 10.1042/bj1100313
   Hershey JWB, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011528
   Hodson N, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010023
   Holecek M, 2000, METABOLISM, V49, P1330, DOI 10.1053/meta.2000.9531
   Holecek M, 2020, METABOLITES, V10, DOI 10.3390/metabo10080324
   Holecek M, 2018, NUTR METAB, V15, DOI 10.1186/s12986-018-0271-1
   Holecek M, 2011, AMINO ACIDS, V40, P575, DOI 10.1007/s00726-010-0679-z
   Jalan R, 2003, METAB BRAIN DIS, V18, P37, DOI 10.1023/A:1021978618745
   Jang C, 2019, CELL METAB, V30, P594, DOI 10.1016/j.cmet.2019.06.002
   Johansen ML, 2007, NEUROCHEM INT, V50, P1042, DOI 10.1016/j.neuint.2007.01.009
   Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629
   Kumar A, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.154089
   Kumar A, 2019, FREE RADICAL BIO MED, V145, P284, DOI 10.1016/j.freeradbiomed.2019.09.031
   Lindqvist LM, 2018, CURR OPIN GENET DEV, V48, P104, DOI 10.1016/j.gde.2017.11.003
   LOCKWOOD AH, 1979, J CLIN INVEST, V63, P449, DOI 10.1172/JCI109322
   Mann G, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.702826
   McDaniel J, 2016, AM J PHYSIOL-GASTR L, V310, pG163, DOI 10.1152/ajpgi.00322.2015
   Medeiros WM, 2014, EUR J PREV CARDIOL, V21, P135, DOI 10.1177/2047487312460520
   Mishra S, 2023, AGING CELL, V22, DOI 10.1111/acel.13852
   Neinast M, 2019, ANNU REV PHYSIOL, V81, P139, DOI 10.1146/annurev-physiol-020518-114455
   Panov A, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23074047
   Poncet N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089547
   Qiu J, 2013, P NATL ACAD SCI USA, V110, P18162, DOI 10.1073/pnas.1317049110
   Qiu J, 2012, AM J PHYSIOL-ENDOC M, V303, pE983, DOI 10.1152/ajpendo.00183.2012
   Rawat J, 2023, BIOTECHNOL PROGR, V39, DOI 10.1002/btpr.3298
   Sakusic A, 2018, CRIT CARE MED, V46, pE897, DOI 10.1097/CCM.0000000000003278
   Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]
   Shi L, 2015, CURR OPIN CELL BIOL, V33, P125, DOI 10.1016/j.ceb.2015.02.003
   Singh SS, 2021, CELL PHYSIOL BIOCHEM, V55, P91, DOI 10.33594/000000327
   Sun XC, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-26
   Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72
   Szwiega S, 2021, AM J CLIN NUTR, V113, P410, DOI 10.1093/ajcn/nqaa323
   Thomas KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088653
   Tsien C, 2015, HEPATOLOGY, V61, P2018, DOI 10.1002/hep.27717
   Walker V, 2014, ADV CLIN CHEM, V67, P73, DOI 10.1016/bs.acc.2014.09.002
   Wang Q, 2015, AM J CANCER RES, V5, P1281
   Welch N, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101023
   Wright G, 2011, LIVER INT, V31, P163, DOI 10.1111/j.1478-3231.2010.02302.x
   Ye F, 2013, ANAL BIOCHEM, V437, P52, DOI 10.1016/j.ab.2013.02.010
   Zeng N, 2019, J NUTR HEALTH AGING, V23, P354, DOI 10.1007/s12603-019-1171-4
NR 66
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0955-2863
EI 1873-4847
J9 J NUTR BIOCHEM
JI J. Nutr. Biochem.
PD JAN
PY 2024
VL 123
AR 109498
DI 10.1016/j.jnutbio.2023.109498
EA DEC 2023
PG 14
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA DK7P1
UT WOS:001132003300001
PM 37871767
DA 2024-02-19
ER

PT J
AU Pearah, A
   Ramatchandirin, B
   Liu, T
   Wolf, RM
   Ikeda, A
   Radovick, S
   Sesaki, H
   Wondisford, FE
   O'Rourke, B
   He, L
AF Pearah, Alexia
   Ramatchandirin, Balamurugan
   Liu, Ting
   Wolf, Risa M.
   Ikeda, Arisa
   Radovick, Sally
   Sesaki, Hiromi
   Wondisford, Fredric E.
   O'Rourke, Brian
   He, Ling
TI Blocking AMPKaS496 phosphorylation improves mitochondrial dynamics and
   hyperglycemia in aging and obesity
SO CELL CHEMICAL BIOLOGY
LA English
DT Article; Early Access
ID ACTIVATED PROTEIN-KINASE; INSULIN-RESISTANCE; OXIDATIVE STRESS;
   METFORMIN; FISSION; FUSION; AMPK; AGE; GLUCONEOGENESIS; SUPPRESSION
AB Impaired mitochondrial dynamics causes aging-related or metabolic diseases. Yet, the molecular mecha-nism responsible for the impairment of mitochondrial dynamics is still not well understood. Here, we report that elevated blood insulin and/or glucagon levels downregulate mitochondrial fission through directly phos-phorylating AMPKa at S496 by AKT or PKA, resulting in the impairment of AMPK-MFF-DRP1 signaling and mitochondrial dynamics and activity. Since there are significantly increased AMPKa1 phosphorylation at S496 in the liver of elderly mice, obese mice, and obese patients, we, therefore, designed AMPK-specific tar-geting peptides (Pa496m and Pa496h) to block AMPKa1S496 phosphorylation and found that these targeting peptides can increase AMPK kinase activity, augment mitochondrial fission and oxidation, and reduce ROS, leading to the rejuvenation of mitochondria. Furthermore, these AMPK targeting peptides robustly suppress liver glucose production in obese mice. Our data suggest these targeting peptides are promising therapeutic agents for improving mitochondrial dynamics and activity and alleviating hyperglycemia in elderly and obese patients.
C1 [Pearah, Alexia; Ramatchandirin, Balamurugan; Wolf, Risa M.; He, Ling] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21287 USA.
   [Liu, Ting; O'Rourke, Brian] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21287 USA.
   [Ikeda, Arisa; Sesaki, Hiromi] Johns Hopkins Univ, Dept Cell Biol, Sch Med, Baltimore, MD 21287 USA.
   [Radovick, Sally; Wondisford, Fredric E.] Rutgers Robert Wood Johnson Med Sch, Dept Pediat, New Brunswick, NJ 08901 USA.
   [Radovick, Sally; Wondisford, Fredric E.] Rutgers Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ 08901 USA.
   [He, Ling] Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD 21287 USA.
   [He, Ling] Johns Hopkins Univ, Dept Mol Sci, Sch Med, Baltimore, MD 21287 USA.
C3 Johns Hopkins University; Johns Hopkins University; Johns Hopkins
   University; Rutgers University System; Rutgers University New Brunswick;
   Rutgers University Biomedical & Health Sciences; Rutgers University
   System; Rutgers University New Brunswick; Rutgers University Biomedical
   & Health Sciences; Johns Hopkins University; Johns Hopkins University
RP He, L (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21287 USA.; He, L (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD 21287 USA.
EM heling@jhmi.edu
FU National Institute of Diabetes and Digestive and Kidney Diseases
   [R01DK120309, R01DK107641, R35GM144103]
FX This work was supported in part by grants from the National Institute of
   Diabetes and Digestive and Kidney Diseases: R01DK120309, R01DK107641,
   and R35GM144103.
CR Abdul-Ghani MA, 2008, CURR DIABETES REP, V8, P173, DOI 10.1007/s11892-008-0030-1
   Akbari M, 2019, AGEING RES REV, V54, DOI 10.1016/j.arr.2019.100940
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Bohovych I, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00109
   Cao J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00163-w
   Cao J, 2014, J BIOL CHEM, V289, P20435, DOI 10.1074/jbc.M114.567271
   Cheng ZY, 2009, NAT MED, V15, P1307, DOI 10.1038/nm.2049
   Chow HM, 2019, NAT NEUROSCI, V22, P1806, DOI 10.1038/s41593-019-0505-1
   DAVIES SP, 1994, EUR J BIOCHEM, V223, P351, DOI 10.1111/j.1432-1033.1994.tb19001.x
   Djouder N, 2010, EMBO J, V29, P469, DOI 10.1038/emboj.2009.339
   DUBUC PU, 1977, DIABETES, V26, P841, DOI 10.2337/diab.26.9.841
   Dutta S, 2016, LIFE SCI, V152, P244, DOI 10.1016/j.lfs.2015.10.025
   Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150
   Fan RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020443
   Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287
   GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0
   GUMBINER B, 1989, DIABETES, V38, P1549, DOI 10.2337/diabetes.38.12.1549
   Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311
   Hawley SA, 2014, BIOCHEM J, V459, P275, DOI 10.1042/BJ20131344
   He L, 2016, J BIOL CHEM, V291, P10562, DOI 10.1074/jbc.M116.719666
   He L, 2013, MOL ENDOCRINOL, V27, P1322, DOI 10.1210/me.2012-1413
   He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016
   Horman S, 2006, J BIOL CHEM, V281, P5335, DOI 10.1074/jbc.M506850200
   Hou YJ, 2019, NAT REV NEUROL, V15, P565, DOI 10.1038/s41582-019-0244-7
   Jendrach M, 2005, MECH AGEING DEV, V126, P813, DOI 10.1016/j.mad.2005.03.002
   Le TH, 2004, HEPATOLOGY, V39, P1423, DOI 10.1002/hep.20202
   Lee S, 2007, J BIOL CHEM, V282, P22977, DOI 10.1074/jbc.M700679200
   Li BH, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00214
   Li XW, 2021, J AM CHEM SOC, V143, P639, DOI 10.1021/jacs.0c11566
   Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002
   Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110
   Lopez J, 2015, BRIT J CANCER, V112, P957, DOI 10.1038/bjc.2015.85
   Luo C, 2016, TRENDS CANCER, V2, P619, DOI 10.1016/j.trecan.2016.09.006
   Mai S, 2010, J CELL SCI, V123, P917, DOI 10.1242/jcs.059246
   Mansouri A, 2018, GASTROENTEROLOGY, V155, P629, DOI 10.1053/j.gastro.2018.06.083
   Melanson KJ, 1998, J GERONTOL A-BIOL, V53, pB409, DOI 10.1093/gerona/53A.6.B409
   Meng SM, 2015, J BIOL CHEM, V290, P3793, DOI 10.1074/jbc.M114.604421
   MINAKER KL, 1982, DIABETES, V31, P851, DOI 10.2337/diabetes.31.10.851
   Mishra A, 2011, P NATL ACAD SCI USA, V108, P16883, DOI 10.1073/pnas.1108795108
   Molina AJA, 2009, DIABETES, V58, P2303, DOI 10.2337/db07-1781
   Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151
   Navarro A, 2004, AM J PHYSIOL-REG I, V287, pR1244, DOI 10.1152/ajpregu.00226.2004
   Ning JY, 2011, ENDOCRINOLOGY, V152, P3143, DOI 10.1210/en.2011-0155
   Peng JH, 2022, J BIOL CHEM, V298, DOI 10.1016/j.jbc.2022.101621
   Polonsky KS, 1996, NEW ENGL J MED, V334, P777, DOI 10.1056/NEJM199603213341207
   Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012
   Safiulina D, 2019, EMBO J, V38, DOI 10.15252/embj.201899384
   Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017
   Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536
   Sergi D, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00532
   Shami GJ, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82884-z
   Shin HW, 1997, J BIOCHEM-TOKYO, V122, P525
   Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611
   Stevic R, 2007, AGE AGEING, V36, P459, DOI 10.1093/ageing/afm076
   Sun N, 2017, NAT PROTOC, V12, P1576, DOI 10.1038/nprot.2017.060
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Supinski G.S., 2020, Chest, V157, P310, DOI [10.1016/j.chest.2019.08.2182, DOI 10.1016/J.CHEST.2019.08.2182, DOI 10.1016/j.chest.2019.08.2182]
   TAUCHI H, 1968, J GERONTOL, V23, P454, DOI 10.1093/geronj/23.4.454
   Tilokani L, 2022, SCI ADV, V8, DOI 10.1126/sciadv.abo7956
   Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wang L, 2022, SIGNAL TRANSDUCT TAR, V7, DOI 10.1038/s41392-022-00904-4
   Wang Y, 2019, CELL REP, V29, P1511, DOI 10.1016/j.celrep.2019.09.070
   Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031
   Yamada T, 2022, ISCIENCE, V25, DOI 10.1016/j.isci.2022.103996
   Yamada T, 2018, CELL METAB, V28, P588, DOI 10.1016/j.cmet.2018.06.014
   Yang WB, 2019, J ENDOCRINOL, V241, P265, DOI 10.1530/JOE-19-0081
   Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
NR 71
TC 1
Z9 1
U1 1
U2 1
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2451-9456
EI 2451-9448
J9 CELL CHEM BIOL
JI Cell Chem. Biol.
PD 2023 DEC 21
PY 2023
VL 30
IS 12
DI 10.1016/j.chembiol.2023.09.017
EA DEC 2023
PG 23
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA FN8P8
UT WOS:001146611800001
PM 37890479
DA 2024-02-19
ER

PT J
AU KIHARA, M
   NICKANDER, KK
   LOW, PA
AF KIHARA, M
   NICKANDER, KK
   LOW, PA
TI THE EFFECT OF AGING ON ENDONEURIAL BLOOD-FLOW, HYPEREMIC RESPONSE AND
   OXYGEN-FREE RADICALS IN RAT SCIATIC-NERVE
SO BRAIN RESEARCH
LA English
DT Article
DE AGING; ENDONEURIAL BLOOD FLOW; OXYGEN FREE RADICAL
ID PERIPHERAL-NERVE; BRAIN; AGE; INNERVATION; METABOLISM; RESISTANCE;
   VESSELS; LIVER; HEART
AB Electrophysiologic abnormalities and reduced energy metabolic rate develop in aging ne-es. We investigated the effects of aging on nerve blood flow (NBF) in Fischer rats aged 2, 12, 24 and 30 months. NBF regressed negatively with increasing age and this decline was associated with an increase in nerve vascular resistance. Twenty minutes of nerve stimulation resulted in an increase in blood flow by about 50% in adult animals and did not decline with increasing age. As indices of oxygen free radical activity, we measured conjugated dienes; hydroperoxides, and norepinephrine from 2 to 30 months. There was a gradual decline with increasing age of all indices. We conclude that NBF declines with aging due to reduced microvascular caliber. These vessels retain their hyperemic response and oxygen free radical activity is less with increasing age.
C1 MAYO CLIN & MAYO FDN,DEPT NEUROL,NEUROPHYSIOL LAB,ROCHESTER,MN 55905.
C3 Mayo Clinic
FU NINDS NIH HHS [N01 NS72302, R01 NS2 2352, NS14302] Funding Source:
   Medline
CR APPENZELLER O, 1984, BRAIN RES, V304, P383, DOI 10.1016/0006-8993(84)90344-5
   Buege J A, 1978, Methods Enzymol, V52, P302
   CONNELLY CM, 1959, REV MOD PHYS, V31, P475, DOI 10.1103/RevModPhys.31.475
   CRANEFIELD PF, 1957, J NEUROCHEM, V1, P245, DOI 10.1111/j.1471-4159.1957.tb12078.x
   DOUGLAS WW, 1957, J PHYSIOL-LONDON, V139, P400, DOI 10.1113/jphysiol.1957.sp005900
   Floyd R A, 1988, Basic Life Sci, V49, P1015
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   FOLKOW B, 1952, ACTA PHYSIOL SCAND, V25, P49, DOI 10.1111/j.1748-1716.1952.tb00858.x
   FUCCI L, 1983, P NATL ACAD SCI-BIOL, V80, P1521, DOI 10.1073/pnas.80.6.1521
   FURNESS JB, 1974, J PHYSIOL-LONDON, V239, P75, DOI 10.1113/jphysiol.1974.sp010556
   HARMON HJ, 1987, MECH AGEING DEV, V38, P167, DOI 10.1016/0047-6374(87)90076-5
   KIHARA M, 1990, J PHYSIOL-LONDON, V422, P145, DOI 10.1113/jphysiol.1990.sp017977
   KIHARA M, IN PRESS J PHYSL
   KUCHINO Y, 1987, NATURE, V327, P77, DOI 10.1038/327077a0
   LOW PA, 1990, MUSCLE NERVE, V13, P152, DOI 10.1002/mus.880130212
   LOW PA, 1986, J PHYSIOL-LONDON, V374, P263, DOI 10.1113/jphysiol.1986.sp016078
   LOW PA, IN PRESS DIABETES
   METZGER H, 1977, OXYGEN TRANSPORT TIS, V3, P713
   MONAFO WW, 1988, EXP NEUROL, V99, P607, DOI 10.1016/0014-4886(88)90177-X
   RECHTHAND E, 1986, BRAIN RES, V374, P185, DOI 10.1016/0006-8993(86)90409-9
   RECKNAGEL RO, 1966, LAB INVEST, V15, P132
   REISS U, 1976, BIOCHEM BIOPH RES CO, V73, P255, DOI 10.1016/0006-291X(76)90701-4
   RITCHIE JM, 1967, J PHYSIOL-LONDON, V188, P309, DOI 10.1113/jphysiol.1967.sp008141
   SAWADA M, 1987, MECH AGEING DEV, V41, P125, DOI 10.1016/0047-6374(87)90057-1
   SCHMELZER JD, 1987, EXP NEUROL, V96, P612, DOI 10.1016/0014-4886(87)90223-8
   SCHMELZER JD, 1989, P NATL ACAD SCI USA, V86, P1639, DOI 10.1073/pnas.86.5.1639
   SOHAL RS, 1986, ADV FREE RADICAL BIO, V2, P117, DOI 10.1016/S8755-9668(86)80026-6
   THERASSE J, 1987, J CHROMATOGR-BIOMED, V413, P237, DOI 10.1016/0378-4347(87)80232-3
   WARD KK, 1989, BRAIN, V112, P197, DOI 10.1093/brain/112.1.197
   ZOCHODNE DW, 1988, BRAIN RES, V461, P10, DOI 10.1016/0006-8993(88)90720-2
   ZOCHODNE DW, 1990, BRAIN RES, V519, P112, DOI 10.1016/0006-8993(90)90067-L
NR 31
TC 23
Z9 23
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0006-8993
J9 BRAIN RES
JI Brain Res.
PD OCT 18
PY 1991
VL 562
IS 1
BP 1
EP 5
DI 10.1016/0006-8993(91)91178-4
PG 5
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA GP150
UT WOS:A1991GP15000001
PM 1799863
DA 2024-02-19
ER

PT J
AU Zvezdina, ND
   Mal'chenko, LA
   Fateeva, VI
   Brodsky, VY
AF Zvezdina, N. D.
   Mal'chenko, L. A.
   Fateeva, V. I.
   Brodsky, V. Ya.
TI Signaling factors of self-organization of protein synthesis rhythm in
   hepatocyte cultures - Gangliosides and catecholamines function
   independently
SO RUSSIAN JOURNAL OF DEVELOPMENTAL BIOLOGY
LA English
DT Article
DE cell-cell interactions; intercellular cooperation; cell
   self-organization; self-organization of protein synthesis rhythm;
   hepatocytes; gangliosides; noradrenaline; phenylephrine; isoproterenol;
   adrenolytic agents
ID SYNCHRONIZATION; ABROGATION
AB Considering the data on the low level of self-organization (self-synchronization) of protein synthesis rhythm in aging, we studied the possible interference of the signaling factors of self-organization, gangliosides and catecholamines, as well as catecholamine reception. Experiments were carried out on primary cultures of rat hepatocytes on slides. Inhibited ganglioside synthesis did not prevent the organization of protein synthesis rhythm by the alpha-adrenomimetic agent phenylephrine. Upon the blockade of alpha-receptors by prazosin, the protein synthesis rhythm was observed after the exposure to gangliosides. alpha-Adrenolytic agents prazosin and benoxathian abolished the synchronizing effect of the beta-adrenomimetic isoproterenol. A mixture of alpha-and beta-adrenomimetic agents inhibited the protein synthesis rhythm-organizing effect of noradrenaline. Thus, the signaling molecules of self-organization of protein synthesis function independently via specific receptors.
C1 [Zvezdina, N. D.; Mal'chenko, L. A.; Fateeva, V. I.; Brodsky, V. Ya.] Russian Acad Sci, NK Koltsov Dev Biol Inst, Moscow 119991, Russia.
C3 Russian Academy of Sciences
RP Zvezdina, ND (corresponding author), Russian Acad Sci, NK Koltsov Dev Biol Inst, Ul Vavilova 26, Moscow 119991, Russia.
EM brodsky.idb@bk.ru
CR Brodskii V Ia, 2006, Ontogenez, V37, P63
   Brodskii V Ia, 2006, Ontogenez, V37, P384
   Brodsky V. Ya., 2005, Ontogenez, V36, P9
   Brodsky VY, 1997, IZV AKAD NAUK BIOL+, P389
   Brodsky VY, 2000, CELL BIOL INT, V24, P211, DOI 10.1006/cbir.1999.0505
   Brodsky VY, 2003, CELL BIOL INT, V27, P965, DOI 10.1016/j.cellbi.2003.07.006
   BRODSKY VY, 2007, J HIGH RES CHROMATOG, V31, P65
   CHIN KV, 1988, INT J BIOCHEM, V20, P1313, DOI 10.1016/0020-711X(88)90236-4
   Curran J, 2007, CIRC RES, V100, P391, DOI 10.1161/01.RES.0000258172.74570.e6
   Deng W, 2000, J NATL CANCER I, V92, P912, DOI 10.1093/jnci/92.11.912
   Li RX, 1997, J BIOL CHEM, V272, P1349, DOI 10.1074/jbc.272.2.1349
   Li RX, 1996, CANCER RES, V56, P4602
   McLeod LE, 2001, FEBS LETT, V489, P225, DOI 10.1016/S0014-5793(01)02100-7
   Nakamura Y., 1993, J BIOCH, V103, P396
   Olshefski R, 1998, J NEUROCHEM, V70, P467
   Ozkok Elif, 1999, Journal of Basic and Clinical Physiology and Pharmacology, V10, P337
   PROZOROVSKAYA M P, 1983, Fiziologicheskii Zhurnal SSSR Imeni I M Sechenova, V69, P1244
   SANAE F, 1989, CANCER RES, V49, P6242
   Wang LJ, 2003, BIOCHEM J, V373, P603, DOI 10.1042/BJ20030454
   ZVEZDINA ND, 2003, IZV AKAD NAUK BIOL+, P14
NR 20
TC 4
Z9 5
U1 1
U2 2
PU MAIK NAUKA/INTERPERIODICA/SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013-1578 USA
SN 1062-3604
EI 1608-3326
J9 RUSS J DEV BIOL+
JI Russ. J. Dev. Biol.
PD MAY
PY 2008
VL 39
IS 3
BP 158
EP 167
DI 10.1134/S106236040803003X
PG 10
WC Developmental Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Developmental Biology
GA 313TT
UT WOS:000256763600003
DA 2024-02-19
ER

PT J
AU VONZGLINICKI, T
   WISWEDEL, I
   TRUMPER, L
   AUGUSTIN, W
AF VONZGLINICKI, T
   WISWEDEL, I
   TRUMPER, L
   AUGUSTIN, W
TI MORPHOLOGICAL-CHANGES OF ISOLATED RAT-LIVER MITOCHONDRIA DURING FE2+
   ASCORBATE-INDUCED PEROXIDATION AND THE EFFECT OF THIOCTACID
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE MITOCHONDRIA; LIPID PEROXIDATION; AGING; THIOCTACID; ALPHA-LIPOIC ACID
ID MICROSOMAL LIPID-PEROXIDATION; ARBITRARY PARTICLES; INTRACELLULAR WATER;
   STEREOLOGY; GROWTH
AB Fe2+/ascorbate-induced peroxidation of isolated rat liver mitochondria leads to initial volume changes and, ultimately, to severe damage characterized by gross swelling and loss of cristae and matrix material. Only the last phase is associated with significant production of malondialdehyde. The shrinkage of mitochondria during the onset of peroxidation matches changes observed in mitochondria of aging animals. Thioctacid (alpha-lipoic acid) prevents this initial shrinkage. However, its main effect in the system studied here is inhibition of active respiration.
C1 MED ACAD MAGDEBURG, INST BIOCHEM, O-3090 MAGDEBURG, GERMANY.
RP VONZGLINICKI, T (corresponding author), INST PATHOL, CHARITE SCHUMANNSTR 20-21, W-1040 BERLIN, GERMANY.
OI von Zglinicki, Thomas/0000-0002-5939-0248
CR BAST A, 1988, BIOCHIM BIOPHYS ACTA, V963, P558, DOI 10.1016/0005-2760(88)90326-8
   Buege J A, 1978, Methods Enzymol, V52, P302
   CRUZORIVE LM, 1986, J MICROSC-OXFORD, V143, P47, DOI 10.1111/j.1365-2818.1986.tb02765.x
   DAVID H, 1985, EXP PATHOL-JENA, P1
   EHRENTHAL W, 1986, INTERDISZIPLINAERE B, P155
   GUNDERSEN HJG, 1985, J MICROSC-OXFORD, V138, P127, DOI 10.1111/j.1365-2818.1985.tb02607.x
   GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x
   HANSFORD RG, 1983, BIOCHIM BIOPHYS ACTA, V726, P41, DOI 10.1016/0304-4173(83)90010-1
   Harman D., 1986, FREE RADICALS AGING, P3
   Jones D. P., 1985, OXIDATIVE STRESS, P151
   MILLER DM, 1989, ARCH BIOCHEM BIOPHYS, V271, P113, DOI 10.1016/0003-9861(89)90261-0
   OZAKI M, 1988, BIOCHEM J, V250, P589, DOI 10.1042/bj2500589
   SCHOLICH H, 1989, BIOCHIM BIOPHYS ACTA, V1001, P256, DOI 10.1016/0005-2760(89)90108-2
   STEINBRECHT I, 1983, BIOMED BIOCHIM ACTA, V42, P335
   STEINBRECHT I, 1970, ACTA BIOL MED GER, V25, P731
   TRUMPER L, 1989, BIOMED BIOCHIM ACTA, V48, P743
   VLADIMIROV YA, 1980, ADV LIPID RES, V17, P173
   VONZGLINICKI T, 1988, SCANNING MICROSCOPY, V2, P1791
   VONZGLINICKI T, 1987, MECH AGEING DEV, V38, P179, DOI 10.1016/0047-6374(87)90077-7
   Weibel E.R, 1979, STEREOLOGICAL METHOD, V1, P415
   WISWEDEL I, 1988, BIOCHIM BIOPHYS ACTA, V934, P80, DOI 10.1016/0005-2728(88)90122-3
NR 21
TC 9
Z9 9
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD MAR
PY 1991
VL 57
IS 3
BP 233
EP 246
DI 10.1016/0047-6374(91)90049-6
PG 14
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA EZ038
UT WOS:A1991EZ03800003
PM 2056778
DA 2024-02-19
ER

PT J
AU Si, HW
   Zhang, LY
   Liu, SQ
   LeRoith, T
   Virgous, C
AF Si, Hongwei
   Zhang, Longyun
   Liu, Siqin
   LeRoith, Tanya
   Virgous, Carlos
TI High corn oil dietary intake improves health and longevity of aging mice
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Corn oil; Aging mice; Longevity; Health
ID UNIFYING HYPOTHESIS; ALZHEIMERS-DISEASE; CHOLESTEROL; METABOLISM;
   MITOCHONDRIA; PHYTOSTEROLS; RESVERATROL; SURVIVAL; OBESITY; IMPACT
AB Corn oil has been recommended as a replacement for saturated fats because of its high levels of poly- and monounsaturated fatty acids. In the present study, we tested whether very high levels of corn oil (58.6% fat-derived calories, FDC) intake improve health and longevity of aging mice. Twelve month old male C57BL/6 mice were fed a normal diet (10% FDC of corn oil, N) or a high fat diet (58.6% FDC of corn oil, HF) for 13-15 months. Our results show that a HF diet significantly increased the longevity of the aged mice (at 25 months of age, 53.8% of mice died in the N group, whereas the mortality rate was only 23.2% in the HF group). High corn oil also reversed aging-increased blood lipids including triglyceride, total cholesterol and LDL. Similarly, high corn oil intake overturned aging-raised pro-inflammatory markers including IL-1 beta, IL-6, and monocyte chemotactic protein-1 (MCP-1) in the blood. In addition, corn oil intake reversed aging-damaged rotarod performance and liver function. Interestingly, the HF group was significantly heavier than the N group (53.6 g/mouse vs. 41.3 g/mouse); however, both HF and N groups had the same calorie intake (12.48 kcal/d/mouse vs. 12.24 kcal/d/mouse). Although, the HF group's food consumption was lower than that of the N group (2.4 g/d/mouse vs. 3.4 g/d/mouse). These results suggest that if total calorie consumption stays in the normal range, very high levels of corn oil intake improve health and longevity of aging mice. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Si, Hongwei; Zhang, Longyun; Liu, Siqin] Tennessee State Univ, Dept Family & Consumer Sci, Nashville, TN 37209 USA.
   [LeRoith, Tanya] Virginia Tech, Virginia Maryland Reg Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA.
   [Virgous, Carlos] Meharry Med Coll, Anim Care Facil, Nashville, TN 37208 USA.
C3 Tennessee State University; Virginia Polytechnic Institute & State
   University; Meharry Medical College
RP Si, HW (corresponding author), Tennessee State Univ, Dept Family & Consumer Sci, Nashville, TN 37209 USA.
EM hsi@tnstate.edu
OI LeRoith, Tanya/0000-0002-1196-6949
FU National Institute of Food and Agriculture of USDA, Evans-Allen program
   [TENX-1103-FS]
FX We are grateful for the support of the National Institute of Food and
   Agriculture of USDA, Evans-Allen program (TENX-1103-FS, to H. Si) for
   this work.
CR AHRENS EH, 1957, LANCET, V1, P943
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Brod SA, 2000, INFLAMM RES, V49, P561, DOI 10.1007/s000110050632
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   Chang TS, 2004, J BIOL CHEM, V279, P41975, DOI 10.1074/jbc.M407707200
   Chung HY, 2006, ANTIOXID REDOX SIGN, V8, P572, DOI 10.1089/ars.2006.8.572
   Coyle CA, 2008, PHYSIOL BEHAV, V95, P168, DOI 10.1016/j.physbeh.2008.05.014
   DUPONT J, 1990, J AM COLL NUTR, V9, P438, DOI 10.1080/07315724.1990.10720403
   Elmadfa I, 1999, EUR J NUTR, V38, P286, DOI 10.1007/s003940050079
   Ferrucci L, 2005, BLOOD, V105, P2294, DOI 10.1182/blood-2004-07-2599
   Frisard M, 2006, ENDOCRINE, V29, P27, DOI 10.1385/ENDO:29:1:27
   Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Heininger K, 2000, HUM PSYCHOPHARM CLIN, V15, P1, DOI 10.1002/(SICI)1099-1077(200001)15:1<1::AID-HUP153>3.0.CO;2-1
   Heininger K, 2000, REV NEUROSCIENCE, V11, P213
   HILL P, 1979, J AM DIET ASSOC, V75, P414
   Howell TJ, 1998, J LIPID RES, V39, P892
   Jiang Q, 2003, FASEB J, V17, P816, DOI 10.1096/fj.02-0877com
   Labinskyy N, 2006, CURR MED CHEM, V13, P989, DOI 10.2174/092986706776360987
   LANDERS RE, 1981, J AM OIL CHEM SOC, V58, P255, DOI 10.1007/BF02582352
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   National Toxicology Program, 1994, Natl Toxicol Program Tech Rep Ser, V426, P1
   Ostlund RE, 2002, AM J CLIN NUTR, V75, P1000, DOI 10.1093/ajcn/75.6.1000
   REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939
   Si HW, 2011, J NUTR, V141, P1095, DOI 10.3945/jn.110.134270
   Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6
   Sung YY, 2014, ENVIRON TOXICOL PHAR, V38, P41, DOI 10.1016/j.etap.2014.04.028
   USDA, 2014, CORN MARK OUTL
   Veenbergen S, 2010, ANN RHEUM DIS, V69, P276, DOI 10.1136/ard.2008.100867
   Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044
   Zou Y, 2003, FASEB J, V17, P320, DOI 10.1096/fj.03-0849fje
NR 31
TC 10
Z9 13
U1 1
U2 15
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD OCT
PY 2014
VL 58
BP 244
EP 249
DI 10.1016/j.exger.2014.09.001
PG 6
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA AU1UX
UT WOS:000345406600034
PM 25193556
DA 2024-02-19
ER

PT J
AU Biagiotti, E
   Malatesta, M
   Capellacci, S
   Fattoretti, P
   Gazzanelli, G
   Ninfali, P
AF Biagiotti, E
   Malatesta, M
   Capellacci, S
   Fattoretti, P
   Gazzanelli, G
   Ninfali, P
TI Quantification of G6PD in small and large intestine of rat during aging
SO ACTA HISTOCHEMICA
LA English
DT Article
DE rat duodenum; rat colon; glucose-6-phosphate dehydrogenase;
   6-phosphogluconate dehydrogenase; optical microscopy analysis;
   electronic microscopy analysis
ID LIVER PARENCHYMAL-CELLS; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE ACTIVITY;
   ENDOPLASMIC-RETICULUM; OXIDATIVE STRESS; BRAIN-AREAS; PROTEIN; RABBIT;
   QUANTITATION; LOCALIZATION; TURNOVER
AB Numerous studies have demonstrated a decrease in glucose-6-phosphate dehydrogenase (G6PD) activity during aging in many cell types, including red blood cells, fibroblasts and lens cells. Moreover, the intracellular activity of G6PD has been shown to be regulated by binding to cell organelles. To investigate whether binding of G6PD to cell organelles is related with the decrease in its activity during aging, distribution patterns of G6PD activity and protein were assessed in small (SI) and large (LI) intestine of 3-month-old and 28-month-old rats. Enzyme activity, as measured spectrophotometrically, did not show any significant change with aging in SI or LI. Enzyme histochemistry, performed by subtracting activity staining of 6-phosphogluconate dehydrogenase (6PGD) from that of G6PD, showed a lower net G6PD activity in SI and LI epithelium of old rats in comparison with young rats. G6PD activity did not change significantly with aging in the muscularis externa of SI and LI. Immunoelectron microscopic analysis of G6PD protein allowed us to measure the density of G6PD molecules in cellular compartments, and the fraction of enzyme bound to cell organelles. In SI and LI epithelia, density of G6PD molecules was higher in old rats than in young rats; however, the fraction of enzyme bound to cell organelles also increased with aging. These data suggest that G6PD activity in epithelium of SI and LI decreases with aging due to the accumulation of significant amounts of enzyme bound to cell organelles, a condition which makes it less active than the soluble enzyme.
C1 Univ Urbino, Inst Biochim G Fornaini, I-61029 Urbino, Italy.
   Univ Urbino, Hist Inst, I-61029 Urbino, Italy.
   INRCA, N Masera Res Dept, Neurobiol Aging Lab, I-60121 Ancona, Italy.
C3 University of Urbino; University of Urbino; IRCCS INRCA
RP Ninfali, P (corresponding author), Univ Urbino, Inst Chim Biol G Fornaini, Via A Saffi 2, I-61029 Urbino, Italy.
RI Fattoretti, Patrizia/A-8152-2011
OI Fattoretti, Patrizia/0000-0003-1998-0080; MALATESTA,
   Manuela/0000-0001-8196-9232; NINFALI, PAOLINO/0000-0003-4471-725X
CR Biagiotti E, 2000, J HISTOCHEM CYTOCHEM, V48, P971, DOI 10.1177/002215540004800710
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   DOVRAT A, 1981, EXP EYE RES, V33, P651, DOI 10.1016/S0014-4835(81)80105-4
   Dreyfus J C, 1978, Curr Top Cell Regul, V14, P243
   Duncan J., 1977, Attention and performance, VVI, P49
   Frederiks WM, 2001, HISTOCHEM J, V33, P345, DOI 10.1023/A:1012427224822
   GRIGOR MR, 1984, ARCH BIOCHEM BIOPHYS, V229, P612, DOI 10.1016/0003-9861(84)90194-2
   Hyoh Y, 2002, GUT, V50, P71, DOI 10.1136/gut.50.1.71
   Ishibashi T, 1999, HISTOCHEM CELL BIOL, V112, P221, DOI 10.1007/s004180050410
   LUZZATTO L, 1985, ADV HUM GENET, V14, P217
   MAGNANI M, 1979, MECH AGEING DEV, V11, P209, DOI 10.1016/0047-6374(79)90057-5
   MEIHUIZEN SP, 1980, MECH AGEING DEV, V13, P111, DOI 10.1016/0047-6374(80)90054-8
   NINFALI P, 1994, PREP BIOCHEM, V24, P1, DOI 10.1080/10826069408010078
   Ninfali P, 1996, RESTOR NEUROL NEUROS, V10, P69, DOI 10.3233/RNN-1996-10202
   NINFALI P, 1987, MOL CELL BIOCHEM, V75, P85
   NINFALI P, 1991, MOL CELL BIOCHEM, V106, P151
   NINFALI P, 1990, J EXP ZOOL, V254, P6, DOI 10.1002/jez.1402540103
   Ninfali P, 2001, ACTA HISTOCHEM, V103, P287, DOI 10.1078/0065-1281-00599
   Ninfali P, 2000, BRAIN RES PROTOC, V5, P115, DOI 10.1016/S1385-299X(99)00063-X
   Ninfali P, 1997, BRAIN RES PROTOC, V1, P357, DOI 10.1016/S1385-299X(97)00011-1
   OZOLS J, 1993, P NATL ACAD SCI USA, V90, P5302, DOI 10.1073/pnas.90.11.5302
   PANDOLFI PP, 1995, EMBO J, V14, P5209, DOI 10.1002/j.1460-2075.1995.tb00205.x
   PERSICO MG, 1986, NUCLEIC ACIDS RES, V14, P2511, DOI 10.1093/nar/14.6.2511
   REITER RJ, 1995, FASEB J, V9, P526, DOI 10.1096/fasebj.9.7.7737461
   Saltzman JR, 1998, GASTROENTEROL CLIN N, V27, P309, DOI 10.1016/S0889-8553(05)70005-4
   SIMMONS DL, 1989, ARCH BIOCHEM BIOPHYS, V271, P10, DOI 10.1016/0003-9861(89)90250-6
   STANTON RC, 1991, J BIOL CHEM, V266, P12442
   STARKEREED PE, 1989, ARCH BIOCHEM BIOPHYS, V275, P559, DOI 10.1016/0003-9861(89)90402-5
   SWEZEY RR, 1986, J CELL BIOL, V103, P1509, DOI 10.1083/jcb.103.4.1509
   Tian WN, 1998, J BIOL CHEM, V273, P10609, DOI 10.1074/jbc.273.17.10609
   TOPHAM CM, 1986, EUR J BIOCHEM, V156, P555, DOI 10.1111/j.1432-1033.1986.tb09615.x
   Van Noorden C. J. F., 1992, ENZYME HISTOCHEMISTR
   VanNoorden CJF, 1997, BBA-PROTEIN STRUCT M, V1342, P141, DOI 10.1016/S0167-4838(97)00061-7
   Wells PG, 1997, MUTAT RES-FUND MOL M, V396, P65, DOI 10.1016/S0027-5107(97)00175-9
NR 34
TC 5
Z9 5
U1 0
U2 3
PU URBAN & FISCHER VERLAG
PI JENA
PA BRANCH OFFICE JENA, P O BOX 100537, D-07705 JENA, GERMANY
SN 0065-1281
J9 ACTA HISTOCHEM
JI Acta Histochem.
PY 2002
VL 104
IS 3
BP 225
EP 234
DI 10.1078/0065-1281-00667
PG 10
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 601DG
UT WOS:000178430800002
PM 12389736
DA 2024-02-19
ER

PT J
AU Sharideh, H
   Zhandi, M
   Zeinoaldini, S
   Zaghari, M
   Sadeghi, M
AF Sharideh, H.
   Zhandi, M.
   Zeinoaldini, S.
   Zaghari, M.
   Sadeghi, M.
TI The effect of dietary coenzyme Q10 on plasma metabolites and hepatic
   gene expression in broiler breeder hens
SO BRITISH POULTRY SCIENCE
LA English
DT Article; Early Access
DE Adiponectin; body weight; coenzyme Q10; hen; metabolites
ID INSULIN-RESISTANCE; VITAMIN-E; CHICKEN; Q(10); AGE; SUPPLEMENTATION;
   PERFORMANCE; PARAMETERS; DISEASE; ACID
AB 1. This study was performed to evaluate the effects of dietary supplementation of coenzyme Q10 (CoQ10) on laying rate, body weight, plasma metabolites and some liver gene expression in broiler breeder hens. 2. A total of 128 broiler breeder hens (Arbor Acres Plus, 47 weeks of age) were randomly distributed to four dietary groups supplemented with different levels of CoQ10 (0, 300, 600 or 900 mg/kg diet) with four replicates of eight hens each. During 47-54 weeks of age, laying rate, egg mass and body weight were recorded weekly. To assay plasma biochemical indicators, blood samples were collected at 54 weeks of age. At the end of the experiment, for evaluating the abdominal fat weight, liver weight and expression of the adiponectin and proliferator-activated receptor-alpha (PPAR-alpha) genes in the liver, eight hens per treatment were selected, weighed and humanely killed by decapitation. 3. Dietary supplementation of CoQ10 linearly decreased abdominal fat weight, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities by increased levels of CoQ10. The plasma levels of glucose, cholesterol and alkaline phosphatase (ALP) activity were quadratically decreased by increased levels of CoQ10. The best plasma levels of glucose, cholesterol and ALP activity were estimated at 562.5, 633.3 and 517.8 mg CoQ10/kg diet, respectively. Adiponectin and PPAR alpha gene expression exhibited a linear increased by increased levels of CoQ10. 4. In conclusion, addition of CoQ10 to the diet influenced lipid metabolism and expression of the adiponectin and PPAR-alpha genes, which might be partially due to the improvement in mitochondrial metabolism and energy production. However, further studies are necessary to determine the effects of CoQ10 on these indicators in broiler breeder hens during ageing.
C1 [Sharideh, H.; Zhandi, M.; Zeinoaldini, S.; Zaghari, M.; Sadeghi, M.] Univ Tehran, Dept Anim Sci, Coll Agr & Nat Resources, Karaj, Iran.
C3 University of Tehran
RP Zhandi, M (corresponding author), Univ Tehran, Dept Anim Sci, Coll Agr & Nat Resources, Karaj, Iran.
EM mzhandi@ut.ac.ir
RI Sharideh, Hossein/ABI-3131-2020
OI Sharideh, Hossein/0000-0002-3112-6525; Zhandi, Mahdi/0000-0003-2886-9747
FU College of Agriculture and Natural Resources, University of Tehran
   [731305816.24]
FX The financial support of College of Agriculture and Natural Resources,
   University of Tehran under the grant number [731305816.24].
CR Abadi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060722
   Amin MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089169
   Ashkani-Esfahani S, 2016, IRAN RED CRESCENT ME, V18, DOI 10.5812/ircmj.29166
   Breque C, 2006, MOL REPROD DEV, V73, P1045, DOI 10.1002/mrd.20498
   Carmona MC, 2009, INT J OBESITY, V33, P204, DOI 10.1038/ijo.2008.265
   Cassy Sandrine, 2004, Reprod Biol Endocrinol, V2, P72
   Combs TP, 2014, REV ENDOCR METAB DIS, V15, P137, DOI 10.1007/s11154-013-9280-6
   Dikmen BY, 2007, BRIT POULTRY SCI, V48, P98, DOI 10.1080/00071660601161412
   Farhangi MA, 2014, ARCH MED RES, V45, P589, DOI 10.1016/j.arcmed.2014.11.001
   Faure M, 2017, POULTRY SCI, V96, P2459, DOI 10.3382/ps/pex025
   Geng AL, 2004, POULTRY SCI, V83, P1587, DOI 10.1093/ps/83.9.1587
   Gholami M, 2018, GYNECOL ENDOCRINOL, V34, P1059, DOI 10.1080/09513590.2018.1481944
   Gopi M., 2015, Asian Journal of Animal and Veterinary Advances, V10, P311, DOI 10.3923/ajava.2015.311.322
   Gopi M, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-518
   Honda K, 2013, BIOSCI BIOTECH BIOCH, V77, P1572, DOI 10.1271/bbb.130039
   Iaffaldano N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194219
   Lapointe J, 2014, J ANIM PHYSIOL AN N, V98, P809, DOI 10.1111/jpn.12160
   Maddineni S, 2005, ENDOCRINOLOGY, V146, P4250, DOI 10.1210/en.2005-0254
   Noordam R, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00236
   Ramachandran R, 2007, DOMEST ANIM ENDOCRIN, V33, P19, DOI 10.1016/j.domaniend.2006.04.004
   Schmelzer C, 2011, IUBMB LIFE, V63, P42, DOI 10.1002/iub.413
   Schmelzer C, 2010, MOL NUTR FOOD RES, V54, P805, DOI 10.1002/mnfr.200900155
   Sharideh H, 2016, J ANIM PHYSIOL AN N, V100, P316, DOI 10.1111/jpn.12372
   Shetty RA, 2014, EXP GERONTOL, V58, P208, DOI 10.1016/j.exger.2014.08.007
   Shiraishi J, 2011, PHYSIOL BEHAV, V103, P233, DOI 10.1016/j.physbeh.2011.02.008
   STOUT RW, 1973, ATHEROSCLEROSIS, V18, P153, DOI 10.1016/0021-9150(73)90126-3
   Takahashi K, 2013, MECH AGEING DEV, V134, P580, DOI 10.1016/j.mad.2013.11.010
   Vasiliev AV, 2011, B EXP BIOL MED+, V150, P416, DOI 10.1007/s10517-011-1156-8
   Walzem RL, 2014, ADV NUTR, V5, P199, DOI 10.3945/an.113.004747
   Yan J, 2014, J ANIM PHYSIOL AN N, V98, P530, DOI 10.1111/jpn.12107
   Zaghari M, 2013, J APPL POULTRY RES, V22, P808, DOI 10.3382/japr.2012-00718
NR 31
TC 3
Z9 4
U1 0
U2 10
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0007-1668
EI 1466-1799
J9 BRIT POULTRY SCI
JI Br. Poult. Sci.
PD 2020 MAY 3
PY 2020
VL 61
IS 3
BP 281
EP 286
DI 10.1080/00071668.2020.1720908
EA FEB 2020
PG 6
WC Agriculture, Dairy & Animal Science
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture
GA MI0BS
UT WOS:000513372900001
PM 31973572
DA 2024-02-19
ER

PT J
AU Moser, VC
   Phillips, PM
   McDaniel, KL
   Zehr, RD
   MacMillan, DK
   MacPhail, RC
AF Moser, Virginia C.
   Phillips, Pamela M.
   McDaniel, Katherine L.
   Zehr, Robert D.
   MacMillan, Denise K.
   MacPhail, Robert C.
TI CARBARYL AND 1-NAPHTHOL TISSUE LEVELS AND RELATED CHOLINESTERASE
   INHIBITION IN MALE BROWN NORWAY RATS FROM PREWEANING TO SENESCENCE
SO JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES
LA English
DT Article
ID ASSESSING CHILDRENS RISKS; GENE-EXPRESSION;
   PHARMACOKINETIC/PHARMACODYNAMIC MODEL; ANTICHOLINESTERASE INSECTICIDES;
   PHARMACOKINETIC DIFFERENCES; AGE; METABOLISM; CYTOCHROME-P450;
   SENSITIVITY; TOXICOKINETICS
AB Studies incorporating both toxicokinetic and dynamic factors provide insight into chemical sensitivity differences across the life span. Tissue (brain, plasma, liver) levels of the N-methyl carbamate carbaryl, and its metabolite 1-naphthol, were determined and related to brain and RBC cholinesterase (ChE) inhibition in the same animals. Dose-response (3, 7.5, 15, or 22.5 mg/kg, 40-45 min postdosing) and time course (3 or 15 mg/kg at 30, 60, 120, or 240 min postdosing) of acute effects of carbaryl (oral gavage) in preweanling (postnatal day [PND] 18) and adult male Brown Norway rats from adolescence to senescence (1, 4, 12, 24 mo) were compared. At all ages there were dose-related increases in carbaryl and 1-naphthol in the dose-response study, and the time-course study showed highest carbaryl levels at 30 min postdosing. There were, however, age-related differences in that the 1- and 4-mo rats showed the lowest levels of carbaryl and 1-naphthol, and PND18 and 24-mo rats had similar, higher levels. The fastest clearance (shortest half-lives) was observed in 1- and 4-mo rats. Carbaryl levels were generally higher than 1-naphthol in brain and plasma, but in liver, 1-naphthol levels were similar to or greater than carbaryl. Brain ChE inhibition closely tracked brain carbaryl concentrations regardless of the time after dosing, but there was more variability in the relationship between RBC ChE and plasma carbaryl levels. Within-subject analyses suggested somewhat more brain ChE inhibition at lower carbaryl levels only in the PND18 rats. These findings may reflect maturation followed by decline in kinetic factors over the life span.
C1 [Moser, Virginia C.; Phillips, Pamela M.; McDaniel, Katherine L.; MacPhail, Robert C.] US EPA, Neurotoxicol Branch, Tox Assessment Div, Natl Hlth & Environm Effects Res Lab,Off Res & De, Res Triangle Pk, NC 27711 USA.
   [Zehr, Robert D.; MacMillan, Denise K.] US EPA, Analyt Chem Res Core, Res Cores Unit, Natl Hlth & Environm Effects Res Lab,Off Res & De, Res Triangle Pk, NC 27711 USA.
C3 United States Environmental Protection Agency; United States
   Environmental Protection Agency
RP Moser, VC (corresponding author), US EPA, MD B105-04, Res Triangle Pk, NC 27711 USA.
EM Moser.ginger@epa.gov
OI MacMillan, Denise/0000-0002-8424-6651
CR Aldridge W.N., 1975, ENZYME INHIBITORS SU
   Anastassiades M, 2003, J AOAC INT, V86, P412
   Asaoka Y, 2010, J VET MED SCI, V72, P471, DOI 10.1292/jvms.09-0397
   Beaudouin R, 2010, REGUL TOXICOL PHARM, V57, P103, DOI 10.1016/j.yrtph.2010.01.005
   Billings D., 2013, TOXICOLOGIST, V132, P191
   Bouchard M, 2008, INT ARCH OCC ENV HEA, V81, P355, DOI 10.1007/s00420-007-0220-1
   BRODEUR J, 1963, P SOC EXP BIOL MED, V114, P509, DOI 10.3181/00379727-114-28716
   Clewell HJ, 2004, TOXICOL SCI, V79, P381, DOI 10.1093/toxsci/kfh109
   CRANMER MF, 1986, NEUROTOXICOLOGY, V7, P247
   EHRICH M, 1992, J TOXICOL ENV HEALTH, V36, P411, DOI 10.1080/15287399209531648
   Elbarbry FA, 2007, J BIOCHEM MOL TOXIC, V21, P41, DOI 10.1002/jbt.20156
   FERNANDEZ Y, 1982, TOXICOL LETT, V13, P253
   Ginsberg G, 2004, J TOXICOL ENV HEAL A, V67, P297, DOI 10.1080/15287390490273550
   Ginsberg G, 2004, TOXICOL APPL PHARM, V198, P164, DOI 10.1016/j.taap.2003.10.010
   Herr DW, 2010, TOXICOLOGY, V276, P172, DOI 10.1016/j.tox.2010.08.001
   JOHNSON CD, 1975, ANAL BIOCHEM, V64, P229, DOI 10.1016/0003-2697(75)90423-6
   Kinirons MT, 2004, BRIT J CLIN PHARMACO, V57, P540, DOI 10.1111/j.1365-2125.2004.02096.x
   Klasassen DlmC., 2001, CASARETT DOULLS TOXI, P763
   KNAAK JB, 1971, B WORLD HEALTH ORGAN, V44, P121
   KNAAK JB, 1968, J AGR FOOD CHEM, V16, P465, DOI 10.1021/jf60157a022
   Lee JS, 2008, TOXICOL SCI, V106, P263, DOI 10.1093/toxsci/kfn144
   Lehotay SJ, 2005, J AOAC INT, V88, P615
   Mack CM, 2007, J TOXICOL ENV HEAL A, V70, P439, DOI 10.1080/15287390600755299
   MAY DG, 1992, J PHARMACOL EXP THER, V262, P1057
   McDaniel KL, 2007, TOXICOL SCI, V98, P552, DOI 10.1093/toxsci/kfm114
   Mori K, 2007, TOXICOL PATHOL, V35, P242, DOI 10.1080/01926230601156286
   Mortensen SR, 1998, TOXICOLOGY, V125, P13, DOI 10.1016/S0300-483X(97)00157-1
   Moser V. C., 2011, TOXICOLOGIST, V120, P286
   Moser V. C., 2012, TOXICOLOGIST, V126, P555
   Moser VC, 2010, TOXICOL SCI, V114, P113, DOI 10.1093/toxsci/kfp286
   MOUNT ME, 1981, TOXICOL APPL PHARM, V58, P282, DOI 10.1016/0041-008X(81)90433-6
   Nong A, 2008, J TOXICOL ENV HEAL A, V71, P1363, DOI 10.1080/15287390802271608
   Phillips PM, 2010, J AM ASSOC LAB ANIM, V49, P792
   Saghir SA, 2012, CRIT REV TOXICOL, V42, P323, DOI 10.3109/10408444.2012.674100
   Shealy DB, 1997, ENVIRON HEALTH PERSP, V105, P510, DOI 10.2307/3433579
   STROTHER A, 1980, XENOBIOTICA, V10, P113, DOI 10.3109/00498258009033737
   TAKAHASHI RN, 1991, NEUROTOXICOL TERATOL, V13, P21, DOI 10.1016/0892-0362(91)90023-P
   Tang J, 2002, CHEM-BIOL INTERACT, V141, P229, DOI 10.1016/S0009-2797(02)00074-1
   Thomas RP, 2002, J GASTROINTEST SURG, V6, P445, DOI 10.1016/S1091-255X(01)00010-5
   Thompson CM, 2009, J TOXICOL ENV HEAL B, V12, P1, DOI 10.1080/10937400802545060
   Timchalk C, 2007, TOXICOL SCI, V98, P348, DOI 10.1093/toxsci/kfm119
   Tornero-Velez R, 2010, TOXICOL APPL PHARM, V244, P208, DOI 10.1016/j.taap.2009.12.034
   Yun KU, 2010, ARCH TOXICOL, V84, P939, DOI 10.1007/s00204-010-0520-1
NR 43
TC 3
Z9 5
U1 0
U2 7
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 1528-7394
EI 1087-2620
J9 J TOXICOL ENV HEAL A
JI J. Toxicol. Env. Health Part A
PD OCT 18
PY 2013
VL 76
IS 20
BP 1151
EP 1167
DI 10.1080/15287394.2013.844751
PG 17
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Toxicology
GA 257FS
UT WOS:000327369600003
PM 24279816
DA 2024-02-19
ER

PT J
AU Londero, AP
   Orsaria, M
   Marzinotto, S
   Grassi, T
   Fruscalzo, A
   Calcagno, A
   Bertozzi, S
   Nardini, N
   Stella, E
   Lellé, RJ
   Driul, L
   Tell, G
   Mariuzzi, L
AF Londero, Ambrogio P.
   Orsaria, Maria
   Marzinotto, Stefania
   Grassi, Tiziana
   Fruscalzo, Arrigo
   Calcagno, Angelo
   Bertozzi, Serena
   Nardini, Nastassia
   Stella, Enrica
   Lelle, Ralph J.
   Driul, Lorenza
   Tell, Gianluca
   Mariuzzi, Laura
TI Placental aging and oxidation damage in a tissue micro-array model: an
   immunohistochemistry study
SO HISTOCHEMISTRY AND CELL BIOLOGY
LA English
DT Article
DE 8-OHdG; p53; p21; APE1/Ref-1; IL-6; IL8; Placenta; Preeclampsia; IUGR
ID INTRAUTERINE GROWTH RESTRICTION; TELOMERASE ACTIVITY; PREECLAMPTIC
   WOMEN; DNA-DAMAGE; P53; APE1/REF-1; APOPTOSIS; PREGNANCY; EXPRESSION;
   PROTEIN
AB To evaluate the expression of markers correlated with cellular senescence and DNA damage (8-hydroxy-2'-deoxy-guanosine (8-OHdG), p53, p21, APE1/Ref-1 (APE1), interleukin (IL-6 and IL-8) in placentas from healthy and pathologic pregnancies. This retrospective study considered a placental tissue micro-array containing 92 controls from different gestational ages and 158 pathological cases including preeclampsia (PE), HELLP syndrome (hemolysis, elevated liver enzymes, low platelet count), small for gestational age (SGA) fetuses, and intrauterine growth restriction (IUGR) occurring at different gestational ages. In this study, we demonstrated a significant influence of gestational age on the expression in the trophoblast of 8-OHdG, p53, p21, APE1, and IL-6. In placentas of cases affected by PE, HELLP, or IUGR, there was an increased expression of 8-OHdG, p53, APE1, and IL-6 compared to controls (only IL-8 was significantly decreased in cases). In both groups of pathology between 22- and 34-week gestation and after 34-week gestation, APE1 levels were higher in the trophoblast of women affected by hypertensive disorders of pregnancy than women carrying an IUGR fetus. The cytoplasmic expression of 8-OHdG was increased in placentas in IUGR cases compared to PE or HELLP pregnancies. In cases after 34-week gestation, p21 was higher in SGA and IUGR than in controls and late PE. Moreover, p53 was increased after 34-week gestation in IUGR pregnancies. Placentas from pathological pregnancies had an altered expression of 8-OHdG, p53, p21, APE1, IL-6, and IL-8. The alterations of intracellular pathways involving these elements may be the cause or the consequence of placental dysfunction, but in any case reflect an impaired placental function, possibly due to increased aging velocity in pathologic cases.
C1 [Londero, Ambrogio P.; Grassi, Tiziana; Calcagno, Angelo; Stella, Enrica; Driul, Lorenza] Univ Udine, Clin Obstet & Gynecol, Deparment Expt Clin & Med Sci, Piazzale SM Misericordia, I-33100 Udine, Italy.
   [Londero, Ambrogio P.] S Polo Hosp, Unit Obstet & Gynecol, I-34074 Monfalcone, GO, Italy.
   [Orsaria, Maria; Marzinotto, Stefania; Nardini, Nastassia; Tell, Gianluca; Mariuzzi, Laura] Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy.
   [Fruscalzo, Arrigo] St Franziskus Hosp, Frauenklin, Munster, Germany.
   [Fruscalzo, Arrigo; Lelle, Ralph J.] Univ Hosp Munster, Clin Obstet & Gynecol, Albert Schweitzer Campus 1,Gebaude A1, D-48149 Munster, Germany.
   [Fruscalzo, Arrigo; Lelle, Ralph J.] Univ Hosp Munster, Inst Pathol, Albert Schweitzer Campus 1,Gebaude A1, D-48149 Munster, Germany.
   [Bertozzi, Serena] IRCCS CRO, Dept Surg Oncol, I-33081 Aviano, PN, Italy.
C3 University of Udine; University of Udine; St. Franziskus-Hospital; IRCCS
   Aviano (CRO)
RP Londero, AP (corresponding author), Univ Udine, Clin Obstet & Gynecol, Deparment Expt Clin & Med Sci, Piazzale SM Misericordia, I-33100 Udine, Italy.; Londero, AP (corresponding author), S Polo Hosp, Unit Obstet & Gynecol, I-34074 Monfalcone, GO, Italy.
EM ambrogio.londero@gmail.com
RI Fruscalzo, Arrigo/AAB-8133-2022; Orsaria, Maria/AAH-6310-2021; Londero,
   Ambrogio P/E-8033-2011; Orsaria, Maria/HKO-5411-2023
OI Londero, Ambrogio P/0000-0001-6429-1220; Tell,
   Gianluca/0000-0001-8845-6448; Fruscalzo, Arrigo/0000-0002-8958-6049;
   Orsaria, Maria/0000-0001-9978-8130; DRIUL, Lorenza/0000-0003-1896-9410
CR Amu S, 2006, PEDIATR RES, V59, P254, DOI 10.1203/01.pdr.0000196332.37565.7d
   Barchiesi A, 2015, NUCLEIC ACIDS RES, V43, P5451, DOI 10.1093/nar/gkv433
   Baxter JSK, 2004, OBSTET GYNECOL SURV, V59, P838, DOI 10.1097/01.ogx.0000146948.19308.c5
   Biron-Shental T, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.036
   Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165
   Burton DGA, 2014, CELL MOL LIFE SCI, V71, P4373, DOI 10.1007/s00018-014-1691-3
   Cesaratto L, 2013, PLOS ONE, V8, DOI [10.1371/jour-nal.pone.0070909, DOI 10.1371/JOUR-NAL.PONE.0070909]
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Costa FD, 2013, ULTRASOUND OBST GYN, V42, P5, DOI DOI 10.1002/U0G.12591
   Davy P, 2009, PLACENTA, V30, P539, DOI 10.1016/j.placenta.2009.03.005
   Endo H, 2005, INT J MOL MED, V16, P79
   Ewen ME, 1996, BBA-REV CANCER, V1242, P181, DOI 10.1016/0304-419X(95)00010-D
   Fruscalzo A, 2012, HISTOCHEM CELL BIOL, V138, P925, DOI 10.1007/s00418-012-0997-1
   Fujimaki A, 2011, PLACENTA, V32, P367, DOI 10.1016/j.placenta.2011.02.004
   Hahn-Zoric M, 2002, PEDIATR RES, V51, P201, DOI 10.1203/00006450-200202000-00013
   Hayakawa T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116480
   Heazell AEP, 2008, PLACENTA, V29, P175, DOI 10.1016/j.placenta.2007.11.002
   Heazell AEP, 2011, APOPTOSIS, V16, P135, DOI 10.1007/s10495-010-0551-3
   Izutsu T, 1998, PLACENTA, V19, P613, DOI 10.1016/S0143-4004(98)90022-4
   Jeschke U, 2006, INT J GYNECOL PATHOL, V25, P354, DOI 10.1097/01.pgp.0000225838.29127.6
   JONES CJP, 1980, PLACENTA, V1, P61, DOI 10.1016/S0143-4004(80)80016-6
   Ju ZY, 2007, ANN NY ACAD SCI, V1100, P333, DOI 10.1196/annals.1395.036
   Kimura C, 2013, J MATERN-FETAL NEO M, V26, P491, DOI 10.3109/14767058.2012.733766
   Kudo T, 2000, PLACENTA, V21, P493, DOI 10.1053/plac.2000.0538
   Levy R, 2002, AM J OBSTET GYNECOL, V186, P1056, DOI 10.1067/mob.2002.122250
   Ljungman M, 2000, NEOPLASIA, V2, P208, DOI 10.1038/sj.neo.7900073
   Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028
   Londero AP, 2013, GYNECOL ENDOCRINOL, V29, P666, DOI 10.3109/09513590.2013.798273
   Madlener S, 2013, P NATL ACAD SCI USA, V110, P17844, DOI 10.1073/pnas.1304784110
   MIYASHITA T, 1995, J BIOL CHEM, V270, P26049, DOI 10.1074/jbc.270.44.26049
   REED M, 1995, P NATL ACAD SCI USA, V92, P9455, DOI 10.1073/pnas.92.21.9455
   Rossé T, 1998, NATURE, V391, P496, DOI 10.1038/35160
   Rossi A, 2013, EUR J OBSTET GYN R B, V170, P348, DOI 10.1016/j.ejogrb.2013.06.037
   Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036
   Sargent IL, 2006, TRENDS IMMUNOL, V27, P399, DOI 10.1016/j.it.2006.06.009
   Takagi Y, 2004, VIRCHOWS ARCH, V444, P49, DOI 10.1007/s00428-003-0903-2
   Tamura D, 2011, PRENATAL DIAG, V31, P1046, DOI 10.1002/pd.2829
   Tell G, 2005, ANTIOXID REDOX SIGN, V7, P367, DOI 10.1089/ars.2005.7.367
   Tell G, 2010, MOL CELL BIOL, V30, P366, DOI 10.1128/MCB.01174-09
   Thakur S, 2015, CELL BIOCHEM FUNCT, V33, P101, DOI 10.1002/cbf.3100
   Thakur S, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.42
   Vascotto C, 2007, J PROTEOME RES, V6, P160, DOI 10.1021/pr060315z
   Vascotto C, 2009, MOL CELL BIOL, V29, P1834, DOI 10.1128/MCB.01337-08
   Visentin S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/401595
   Wang Y, 1998, PLACENTA, V19, P581, DOI 10.1016/S0143-4004(98)90018-2
   Young ARJ, 2009, EMBO REP, V10, P228, DOI 10.1038/embor.2009.22
NR 46
TC 41
Z9 42
U1 1
U2 21
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0948-6143
EI 1432-119X
J9 HISTOCHEM CELL BIOL
JI Histochem. Cell Biol.
PD AUG
PY 2016
VL 146
IS 2
BP 191
EP 204
DI 10.1007/s00418-016-1435-6
PG 14
WC Cell Biology; Microscopy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Microscopy
GA DS3IJ
UT WOS:000380676000007
PM 27106773
OA Green Published
DA 2024-02-19
ER

PT J
AU Grieb, BC
   Boyd, K
   Mitra, R
   Eischen, CM
AF Grieb, Brian C.
   Boyd, Kelli
   Mitra, Ramkrishna
   Eischen, Christine M.
TI Haploinsufficiency of the Myc regulator Mtbp extends survival and delays
   tumor development in aging mice
SO AGING-US
LA English
DT Article
DE Mtbp; Myc; aging; longevity; lymphoma
ID MODEL ORGANISMS; GENE-EXPRESSION; LONGEVITY; RESTRICTION;
   DIFFERENTIATION; METABOLISM; ACTIVATION; CANCER
AB Alterations of specific genes can modulate aging. Myc, a transcription factor that regulates the expression of many genes involved in critical cellular functions was shown to have a role in controlling longevity. Decreased expression of Myc inhibited many of the deleterious effects of aging and increased lifespan in mice. Without altering Myc expression, reduced levels of Mtbp, a recently identified regulator of Myc, limit Myc transcriptional activity and proliferation, while increased levels promote Myc-mediated effects. To determine the contribution of Mtbp to the effects of Myc on aging, we studied a large cohort of Mtbp heterozygous mice and littermate matched wild-type controls. Mtbp haploinsufficiency significantly increased longevity and maximal survival in mice. Reduced levels of Mtbp did not alter locomotor activity, litter size, or body size, but Mtbp heterozygous mice did exhibit elevated markers of metabolism, particularly in the liver. Mtbp(+/-)mice also had a significant delay in spontaneous cancer development, which was most prominent in the hematopoietic system, and an altered tumor spectrum compared to Mtbp(+/+) mice. Therefore, the data suggest Mtbp is a regulator of longevity in mice that mimics some, but not all, of the properties of Myc in aging.
C1 [Grieb, Brian C.; Boyd, Kelli; Eischen, Christine M.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA.
   [Mitra, Ramkrishna; Eischen, Christine M.] Thomas Jefferson Univ, Dept Canc Biol, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA.
C3 Vanderbilt University; Jefferson University
RP Eischen, CM (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA.; Eischen, CM (corresponding author), Thomas Jefferson Univ, Dept Canc Biol, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA.
EM christine.eischen@jefferson.edu
OI mitra, ramkrishna/0000-0002-6181-9066; Grieb, Brian/0000-0003-3980-8050
FU NCI Cancer Center [P30CA056036, P30CA068485]; Mouse Metabolic
   Phenotyping Core [U24DK059637];  [F30AG039164];  [T32GM007347]; 
   [R01CA148950]
FX These studies were supported by F30AG039164 (BCG), T32GM007347 (BCG),
   R01CA148950 (CME), the NCI Cancer Center Support Grant P30CA056036, the
   Mouse Metabolic Phenotyping Core supported in part by U24DK059637, and
   the NCI Cancer Center Support Grant P30CA068485 utilizing the
   Translational Pathology Shared Resources.
CR Agarwal N, 2011, CELL DEATH DIFFER, V18, P1208, DOI 10.1038/cdd.2010.189
   Anisimov VN, 2004, EXP GERONTOL, V39, P305, DOI 10.1016/j.exger.2003.12.007
   BEYER HS, 1992, J LAB CLIN MED, V119, P38
   Boos D, 2013, SCIENCE, V340, P981, DOI 10.1126/science.1237448
   Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616
   Brown SJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-442
   Chen SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086164
   Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014
   Dang CV, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014217
   Dhahbi JM, 1999, AM J PHYSIOL-ENDOC M, V277, pE352, DOI 10.1152/ajpendo.1999.277.2.E352
   Eberhardy SR, 2001, J BIOL CHEM, V276, P48562, DOI 10.1074/jbc.M109014200
   Eberhardy SR, 2002, J BIOL CHEM, V277, P40156, DOI 10.1074/jbc.M207441200
   FRITH CH, 1983, LAB ANIM SCI, V33, P273
   Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823
   Grieb BC, 2014, MOL CANCER RES, V12, P1216, DOI 10.1158/1541-7786.MCR-14-0069
   Grieb BC, 2014, CANCER RES, V74, P3591, DOI 10.1158/0008-5472.CAN-13-2149
   Herkert Barbara, 2010, Genes Cancer, V1, P580, DOI 10.1177/1947601910379012
   Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042
   Hettmer S, 2015, ELIFE, V4, DOI 10.7554/eLife.09436
   Hofmann JW, 2015, CELL, V160, P477, DOI 10.1016/j.cell.2014.12.016
   Iritani BM, 1999, P NATL ACAD SCI USA, V96, P13180, DOI 10.1073/pnas.96.23.13180
   Iwakuma T, 2008, ONCOGENE, V27, P1813, DOI 10.1038/sj.onc.1210827
   Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861
   Justice JN, 2014, AGE, V36, P583, DOI 10.1007/s11357-013-9589-9
   Kim JW, 2004, MOL CELL BIOL, V24, P5923, DOI 10.1128/MCB.24.13.5923-5936.2004
   Kuningas M, 2008, AGING CELL, V7, P270, DOI 10.1111/j.1474-9726.2008.00366.x
   Ladiges W, 2009, AGING CELL, V8, P346, DOI 10.1111/j.1474-9726.2009.00491.x
   Lee C, 2011, ONCOGENE, V30, P3305, DOI 10.1038/onc.2011.91
   Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231
   MILTENBERGER RJ, 1995, MOL CELL BIOL, V15, P2527
   Morrish F, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014225
   O'Connell BC, 2003, J BIOL CHEM, V278, P12563, DOI 10.1074/jbc.M210462200
   Odvody J, 2010, ONCOGENE, V29, P3287, DOI 10.1038/onc.2010.82
   Peck B, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00096
   Pettan-Brewer C, 2011, PATHOBIOL AGING AGE, V1, DOI 10.3402/pba.v1i0.7202
   Saini A, 2012, EXP PHYSIOL, V97, P400, DOI 10.1113/expphysiol.2011.061028
   Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278
   Skytthe A, 2003, TWIN RES, V6, P448, DOI 10.1375/twin.6.5.448
   Stine ZE, 2015, CANCER DISCOV, V5, P1024, DOI 10.1158/2159-8290.CD-15-0507
   Stratikopoulos E, 2008, P NATL ACAD SCI USA, V105, P19378, DOI 10.1073/pnas.0809223105
   Tansey WP, 2014, NEW J SCI, DOI DOI 10.1155/2014/757534
   WAGNER AJ, 1993, CELL GROWTH DIFFER, V4, P879
   Walkey CJ, 2008, J BIOL CHEM, V283, P24290, DOI 10.1074/jbc.C800139200
   Wang Y, 2014, DIABETES METAB J, V38, P321, DOI 10.4093/dmj.2014.38.5.321
   Wenz Tina, 2011, J Aging Res, V2011, P810619, DOI 10.4061/2011/810619
   Wilson CS, 2016, J DIABETES, V8, P120, DOI 10.1111/1753-0407.12263
   Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105
NR 47
TC 6
Z9 6
U1 0
U2 0
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD OCT
PY 2016
VL 8
IS 10
BP 2590
EP +
DI 10.18632/aging.101092
PG 13
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA EF4OZ
UT WOS:000390311800025
PM 27803394
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU SIMON, D
   PREZIOSI, P
   BARRETTCONNOR, E
   ROGER, M
   SAINTPAUL, M
   NAHOUL, K
   PAPOZ, L
AF SIMON, D
   PREZIOSI, P
   BARRETTCONNOR, E
   ROGER, M
   SAINTPAUL, M
   NAHOUL, K
   PAPOZ, L
TI THE INFLUENCE OF AGING ON PLASMA SEX-HORMONES IN MEN - THE TELECOM-STUDY
SO AMERICAN JOURNAL OF EPIDEMIOLOGY
LA English
DT Article
DE AGING; ESTRADIOL; ESTRONE; MEN; SEX HORMONES; TESTOSTERONE
ID ISCHEMIC HEART-DISEASE; MIDDLE-AGED MEN; LUTEINIZING-HORMONE;
   DIABETES-MELLITUS; OBESE MEN; REPRODUCTIVE HORMONES;
   MYOCARDIAL-INFARCTION; TESTOSTERONE LEVELS; SERUM TESTOSTERONE; HEPATIC
   CIRRHOSIS
AB From April 1985 to July 1987, 1,408 healthy white men aged 20-60 years in Paris, France, recruited on an occupational basis, underwent a physical examination and measurements of plasma sex hormones in a cross-sectional study. Both total testosterone and estradiol showed a significant stepwise decrease with age (p < 0.001) starting in the early adult years, while estrone did not vary. These relations of testosterone and estradiol with age remained significant after adjustment for body mass index, subscapular skinfold, and tobacco and alcohol consumptions, and they were not modified by exclusion of the men who reported chronic disease. Both the mechanism for the early decrease in testosterone and its clinical significance merit further investigation.
C1 FDN RECH HORMONOL, F-75014 PARIS, FRANCE.
   DIRECT ACT SOCIALE ENFANCE & SANTE LABS, PARIS, FRANCE.
   UNIV CALIF SAN DIEGO, DEPT COMMUNITY & FAMILY MED M007, LA JOLLA, CA 92093 USA.
   HOP HENRI MONDOR, SERV ENDOCRINOL, F-94010 CRETEIL, FRANCE.
   HOP HENRI MONDOR, DEPT SANTE PUBL, F-94010 CRETEIL, FRANCE.
C3 University of California System; University of California San Diego;
   Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique
   Hopitaux Paris (APHP); Hopital Universitaire Henri-Mondor - APHP;
   Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique
   Hopitaux Paris (APHP); Hopital Universitaire Henri-Mondor - APHP
RP SIMON, D (corresponding author), INSERM, U21, 16 AVE PAUL VAILLANT COUTURIER, F-94807 VILLEJUIF, FRANCE.
CR AHLUWALIA B, 1981, CANCER, V48, P2267, DOI 10.1002/1097-0142(19811115)48:10<2267::AID-CNCR2820481023>3.0.CO;2-R
   ANDO S, 1984, J ENDOCRINOL INVEST, V7, P21, DOI 10.1007/BF03348370
   [Anonymous], 1986, LANCET, V2, P552
   BAKER HWG, 1976, Q J MED, V45, P145
   BARRETTCONNOR E, 1990, AM J EPIDEMIOL, V132, P895, DOI 10.1093/oxfordjournals.aje.a115732
   BARRETTCONNOR E, 1988, CIRCULATION, V78, P539, DOI 10.1161/01.CIR.78.3.539
   BARRETTCONNOR E, 1990, SMOKING HORMONE RELA, P183
   BJORNTORP P, 1990, DIABETES ANN, P373
   BOGARDUS C, 1984, DIABETES, V33, P311, DOI 10.2337/diabetes.33.4.311
   BONITHONKOPP C, 1988, ATHEROSCLEROSIS, V71, P71, DOI 10.1016/0021-9150(88)90303-6
   CASTANIER M, 1970, CR ACAD SCI D NAT, V271, P1787
   CHOPRA IJ, 1973, ANN INTERN MED, V79, P198, DOI 10.7326/0003-4819-79-2-198
   CICERO TJ, 1982, ALCOHOL CLIN EXP RES, V6, P207, DOI 10.1111/j.1530-0277.1982.tb04964.x
   COON PJ, 1989, METABOLISM, V38, P1201, DOI 10.1016/0026-0495(89)90160-1
   COPPAGE WS, 1965, NEW ENGL J MED, V273, P902, DOI 10.1056/NEJM196510212731704
   DAI WS, 1988, AM J EPIDEMIOL, V128, P796, DOI 10.1093/oxfordjournals.aje.a115033
   DAI WS, 1981, AM J EPIDEMIOL, V114, P804, DOI 10.1093/oxfordjournals.aje.a113251
   DAVIDSON JM, 1983, J CLIN ENDOCR METAB, V57, P71, DOI 10.1210/jcem-57-1-71
   DESLYPERE JP, 1984, J CLIN ENDOCR METAB, V59, P955, DOI 10.1210/jcem-59-5-955
   DESLYPERE JP, 1985, J CLIN ENDOCR METAB, V61, P564, DOI 10.1210/jcem-61-3-564
   ELDRUP E, 1987, CLIN BIOCHEM, V20, P105, DOI 10.1016/S0009-9120(87)80108-X
   GANDY HM, 1968, J CLIN ENDOCR METAB, V28, P949, DOI 10.1210/jcem-28-7-949
   GHANADIAN R, 1979, BRIT J CANCER, V39, P696, DOI 10.1038/bjc.1979.122
   GORDON GG, 1976, NEW ENGL J MED, V295, P793, DOI 10.1056/NEJM197610072951501
   HARMAN SM, 1980, J CLIN ENDOCR METAB, V51, P35, DOI 10.1210/jcem-51-1-35
   HEMSELL DL, 1974, J CLIN ENDOCR METAB, V38, P476, DOI 10.1210/jcem-38-3-476
   HUGHES GS, 1989, J HYPERTENS, V7, P181
   LACERDA LD, 1973, J CLIN ENDOCR METAB, V37, P366, DOI 10.1210/jcem-37-3-366
   LICHTENSTEIN MJ, 1987, AM J EPIDEMIOL, V126, P647, DOI 10.1093/oxfordjournals.aje.a114704
   LINDHOLM J, 1982, AM J MED, V73, P648, DOI 10.1016/0002-9343(82)90405-3
   LONGCOPE C, 1978, J CLIN ENDOCR METAB, V46, P146, DOI 10.1210/jcem-46-1-146
   NEAVES WB, 1984, J CLIN ENDOCR METAB, V59, P756, DOI 10.1210/jcem-59-4-756
   NIMROD A, 1975, J CLIN ENDOCR METAB, V40, P367, DOI 10.1210/jcem-40-3-367
   OSEGBE DN, 1988, J UROLOGY, V140, P160, DOI 10.1016/S0022-5347(17)41518-7
   PHILLIPS GB, 1984, AM J MED, V76, P1041, DOI 10.1016/0002-9343(84)90855-6
   PIKE KN, 1973, ACTA ENDOCRINOL-COP, V74, P792
   REINBERG A, 1975, ACTA ENDOCRINOL-COP, V80, P732, DOI 10.1530/acta.0.0800732
   REMES K, 1979, SCAND J CLIN LAB INV, V39, P743, DOI 10.3109/00365517909108166
   Roger M, 1979, Ann Pediatr (Paris), V26, P239
   RUDMAN D, 1988, J CLIN EPIDEMIOL, V41, P231, DOI 10.1016/0895-4356(88)90126-6
   SCHNEIDER G, 1979, J CLIN ENDOCR METAB, V48, P633, DOI 10.1210/jcem-48-4-633
   SCHOLLER R, 1984, J STEROID BIOCHEM, V20, P203, DOI 10.1016/0022-4731(84)90207-3
   SMALS AGH, 1976, J CLIN ENDOCR METAB, V42, P979, DOI 10.1210/jcem-42-5-979
   SOLOWAY MS, 1989, UROLOGY, V33, P53, DOI 10.1016/0090-4295(89)90107-6
   SPARROW D, 1980, J CLIN ENDOCR METAB, V51, P508, DOI 10.1210/jcem-51-3-508
   SRINIVASAN SR, 1986, CIRCULATION, V74, P1226, DOI 10.1161/01.CIR.74.6.1226
   STANIK S, 1981, J CLIN ENDOCR METAB, V53, P828, DOI 10.1210/jcem-53-4-828
   SUTTON JR, 1973, BRIT MED J, V1, P520, DOI 10.1136/bmj.1.5852.520
   SWARTZ CM, 1987, J AM GERIATR SOC, V35, P39, DOI 10.1111/j.1532-5415.1987.tb01317.x
   VERMEULEN A, 1967, TESTOSTERONE, P170
   ZUMOFF B, 1990, J CLIN ENDOCR METAB, V71, P929, DOI 10.1210/jcem-71-4-929
   1985, SAS USERS GUIDE BASI
NR 52
TC 133
Z9 139
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0002-9262
EI 1476-6256
J9 AM J EPIDEMIOL
JI Am. J. Epidemiol.
PD APR 1
PY 1992
VL 135
IS 7
BP 783
EP 791
DI 10.1093/oxfordjournals.aje.a116365
PG 9
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health
GA HW647
UT WOS:A1992HW64700008
PM 1595678
DA 2024-02-19
ER

EF